id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
129650515|NCT05072106|466677130|FG000|Overall Study|Progressive disease|3|||
129650516|NCT05072106|466677131|FG001|Overall Study|Progressive disease|3|||
129650517|NCT05072106|466677130|FG000|Overall Study|Compassionate use|3|||
129650518|NCT05072106|466677131|FG001|Overall Study|Compassionate use|1|||
129650519|NCT05072106|466677130|FG000|Overall Study|Withdrawal by Subject|1|||
129650520|NCT05072106|466677131|FG001|Overall Study|Withdrawal by Subject|0|||
129650521|NCT03839459|466677132|FG000|Overall Study|Withdrawal by Subject|2|||
129650522|NCT03839459|466677132|FG000|Overall Study|progression of disease|3|||
129650523|NCT02542293|466677137|FG000|Overall Study|Death|367|||
129650524|NCT02542293|466677138|FG001|Overall Study|Death|377|||
129650525|NCT02542293|466677137|FG000|Overall Study|Withdrawal by Subject|8|||
129650526|NCT02542293|466677138|FG001|Overall Study|Withdrawal by Subject|19|||
129650527|NCT01458951|466677141|FG000|Overall Study|Other|1|||
129650528|NCT01458951|466677142|FG001|Overall Study|Other|0|||
129650529|NCT01458951|466677143|FG002|Overall Study|Other|0|||
129650530|NCT01458951|466677141|FG000|Overall Study|Protocol Violation|5|||
129650531|NCT01458951|466677142|FG001|Overall Study|Protocol Violation|1|||
129650532|NCT01458951|466677143|FG002|Overall Study|Protocol Violation|0|||
129650533|NCT01458951|466677141|FG000|Overall Study|Withdrawal by Subject|2|||
129650534|NCT01458951|466677142|FG001|Overall Study|Withdrawal by Subject|0|||
129650535|NCT01458951|466677143|FG002|Overall Study|Withdrawal by Subject|2|||
129650536|NCT01458951|466677141|FG000|Overall Study|Adverse Event|7|||
129650537|NCT01458951|466677142|FG001|Overall Study|Adverse Event|0|||
129650538|NCT01458951|466677143|FG002|Overall Study|Adverse Event|2|||
129650539|NCT01458951|466677141|FG000|Overall Study|Insufficient Clinical Response|17|||
129650540|NCT01458951|466677142|FG001|Overall Study|Insufficient Clinical Response|0|||
129650541|NCT01458951|466677143|FG002|Overall Study|Insufficient Clinical Response|11|||
129650542|NCT02963558|466677146|FG000|Overall Study|Withdrawn by investigator|1|||
129650543|NCT02963558|466677147|FG001|Overall Study|Withdrawn by investigator|0|||
129650544|NCT02963558|466677146|FG000|Overall Study|Withdrawal by Subject|0|||
129650545|NCT02963558|466677147|FG001|Overall Study|Withdrawal by Subject|1|||
129650546|NCT01573767|466677148|FG000|Overall Study|Adverse Event|0|||
129650547|NCT01573767|466677149|FG001|Overall Study|Adverse Event|1|||
129650548|NCT01573767|466677150|FG002|Overall Study|Adverse Event|0|||
129650549|NCT01573767|466677151|FG003|Overall Study|Adverse Event|1|||
129650550|NCT01573767|466677148|FG000|Overall Study|Lack of Efficacy|18|||
129650551|NCT01573767|466677149|FG001|Overall Study|Lack of Efficacy|15|||
129650552|NCT01573767|466677150|FG002|Overall Study|Lack of Efficacy|12|||
129650553|NCT01573767|466677151|FG003|Overall Study|Lack of Efficacy|17|||
129650554|NCT01573767|466677148|FG000|Overall Study|Protocol Violation|3|||
129650555|NCT01573767|466677149|FG001|Overall Study|Protocol Violation|1|||
129650556|NCT01573767|466677150|FG002|Overall Study|Protocol Violation|1|||
129650557|NCT01573767|466677151|FG003|Overall Study|Protocol Violation|3|||
129650558|NCT01573767|466677148|FG000|Overall Study|Lost to Follow-up|0|||
129650559|NCT01573767|466677149|FG001|Overall Study|Lost to Follow-up|1|||
129650560|NCT01573767|466677150|FG002|Overall Study|Lost to Follow-up|1|||
129650561|NCT01573767|466677151|FG003|Overall Study|Lost to Follow-up|1|||
129650562|NCT01573767|466677148|FG000|Overall Study|Physician Decision|1|||
129650563|NCT01573767|466677149|FG001|Overall Study|Physician Decision|2|||
129650564|NCT01573767|466677150|FG002|Overall Study|Physician Decision|0|||
129650565|NCT01573767|466677151|FG003|Overall Study|Physician Decision|2|||
129650566|NCT01573767|466677148|FG000|Overall Study|Withdrawal by Subject|0|||
129650567|NCT01573767|466677149|FG001|Overall Study|Withdrawal by Subject|1|||
129650568|NCT01573767|466677150|FG002|Overall Study|Withdrawal by Subject|0|||
129650569|NCT01573767|466677151|FG003|Overall Study|Withdrawal by Subject|0|||
129650570|NCT01371877|466677154|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
129650571|NCT01371877|466677155|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
129650572|NCT00869557|466677156|FG000|Randomized Phase|Lost to Follow-up|2|||
129650573|NCT00869557|466677157|FG001|Randomized Phase|Lost to Follow-up|1|||
129650574|NCT00869557|466677156|FG000|Randomized Phase|Investigator's Discretion|1|||
129650575|NCT00869557|466677157|FG001|Randomized Phase|Investigator's Discretion|0|||
129650576|NCT00869557|466677156|FG000|Randomized Phase|Withdrew Consent|0|||
129650577|NCT00869557|466677157|FG001|Randomized Phase|Withdrew Consent|1|||
129650578|NCT00869557|466677156|FG000|Extension Phase|Adverse Event|2|||
129650579|NCT00869557|466677157|FG001|Extension Phase|Adverse Event|2|||
129650580|NCT00869557|466677156|FG000|Extension Phase|Lack of Efficacy|1|||
129650581|NCT00869557|466677157|FG001|Extension Phase|Lack of Efficacy|0|||
129650582|NCT00869557|466677156|FG000|Extension Phase|Lost to Follow-up|3|||
129983770|NCT02980731|467903757|FG000|Overall Study|Death|63|||
129650583|NCT00869557|466677157|FG001|Extension Phase|Lost to Follow-up|1|||
129983771|NCT02980731|467903757|FG000|Overall Study|Withdrawal by Subject|6|||
129650584|NCT00869557|466677156|FG000|Extension Phase|Investigator's Discretion|2|||
129650585|NCT00869557|466677157|FG001|Extension Phase|Investigator's Discretion|0|||
129650586|NCT00869557|466677156|FG000|Extension Phase|Withdrew Consent|2|||
129650587|NCT00869557|466677157|FG001|Extension Phase|Withdrew Consent|0|||
129650588|NCT01143064|466677160|FG000|Overall Study|Death|109|||
129650589|NCT01143064|466677161|FG001|Overall Study|Death|91|||
129650590|NCT01143064|466677160|FG000|Overall Study|Adverse Event|0|||
129650591|NCT01143064|466677161|FG001|Overall Study|Adverse Event|1|||
129650592|NCT01143064|466677160|FG000|Overall Study|Withdrawal by Subject|7|||
129650593|NCT01143064|466677161|FG001|Overall Study|Withdrawal by Subject|5|||
129650594|NCT01143064|466677160|FG000|Overall Study|Lost to Follow-up|17|||
129650595|NCT01143064|466677161|FG001|Overall Study|Lost to Follow-up|14|||
129650596|NCT01143064|466677160|FG000|Overall Study|Physician Decision|0|||
129650597|NCT01143064|466677161|FG001|Overall Study|Physician Decision|4|||
129650598|NCT02255552|466677164|FG000|Overall Study|Participants enrolled into another study|0|||
129650599|NCT02255552|466677165|FG001|Overall Study|Participants enrolled into another study|11|||
129650600|NCT02255552|466677164|FG000|Overall Study|Withdrawal by Subject|1|||
129650601|NCT02255552|466677165|FG001|Overall Study|Withdrawal by Subject|4|||
129650602|NCT03747302|466677168|FG000|Overall Study|Withdrawal by Subject|1|||
129650603|NCT03747302|466677169|FG001|Overall Study|Withdrawal by Subject|2|||
129983772|NCT02980731|467903757|FG000|Overall Study|Lost to Follow-up|5|||
129983773|NCT02980731|467903757|FG000|Overall Study|Study terminated by Sponsor|4|||
129983774|NCT02980731|467903757|FG000|Overall Study|Completed survival follow-up period|65|||
129983775|NCT02980731|467903757|FG000|Overall Study|COVID-19 infection|1|||
129983776|NCT02980731|467903757|FG000|Overall Study|Other, not specified|66|||
129983777|NCT03809429|467903760|FG000|Overall Study|Withdrawal by Subject|7|||
129983778|NCT03809429|467903761|FG001|Overall Study|Withdrawal by Subject|3|||
129983779|NCT03809429|467903760|FG000|Overall Study|Adverse Event|6|||
129983780|NCT03809429|467903761|FG001|Overall Study|Adverse Event|9|||
129983781|NCT03809429|467903760|FG000|Overall Study|COVID-19|3|||
129983782|NCT03809429|467903761|FG001|Overall Study|COVID-19|1|||
129983783|NCT03809429|467903760|FG000|Overall Study|Participant was discontinued by investigator|12|||
129983784|NCT03809429|467903761|FG001|Overall Study|Participant was discontinued by investigator|7|||
129983785|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Adverse Event|6|||
129983786|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Adverse Event|6|||
129983787|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Death|1|||
129983788|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Death|1|||
129983789|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129983790|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129983791|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
129983792|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
129983793|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Physician Decision|1|||
129983794|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Physician Decision|4|||
129983795|NCT03828747|467903762|FG000|Double-Blind Treatment Period|Various reasons|5|||
129983796|NCT03828747|467903763|FG001|Double-Blind Treatment Period|Various reasons|3|||
129983797|NCT03828747|467903762|FG000|Open-Label Extension|Adverse Event|9|||
129983798|NCT03828747|467903763|FG001|Open-Label Extension|Adverse Event|7|||
129983799|NCT03828747|467903762|FG000|Open-Label Extension|Death|0|||
129983800|NCT03828747|467903763|FG001|Open-Label Extension|Death|2|||
129983801|NCT03828747|467903762|FG000|Open-Label Extension|Lost to Follow-up|4|||
129983802|NCT03828747|467903763|FG001|Open-Label Extension|Lost to Follow-up|0|||
129983803|NCT03828747|467903762|FG000|Open-Label Extension|Withdrawal by Subject|31|||
129983804|NCT03828747|467903763|FG001|Open-Label Extension|Withdrawal by Subject|30|||
129983805|NCT03828747|467903762|FG000|Open-Label Extension|Various reasons|4|||
129983806|NCT03828747|467903763|FG001|Open-Label Extension|Various reasons|4|||
129983807|NCT03828747|467903762|FG000|Open-Label Extension|Physician Decision|6|||
129983808|NCT03828747|467903763|FG001|Open-Label Extension|Physician Decision|2|||
129983809|NCT01144052|467903764|FG000|Overall Study|Withdrawal by Subject|1|||
129983810|NCT01144052|467903765|FG001|Overall Study|Withdrawal by Subject|1|||
129983811|NCT00424385|467903766|FG000|Cohort 0|Withdrawal by Subject|5|||
129983812|NCT00424385|467903766|FG000|Cohort 0|Physician Decision|1|||
129983813|NCT00424385|467903766|FG000|Cohort 1|Withdrawal by Subject|1|||
129983814|NCT02683876|467903767|FG000|Overall Study|samples damaged during shipping|2|||
129983815|NCT02683876|467903768|FG001|Overall Study|samples damaged during shipping|0|||
129983816|NCT03980808|467903785|FG000|Overall Study|Lost to Follow-up|2|||
129983817|NCT03980808|467903786|FG001|Overall Study|Lost to Follow-up|2|||
129983818|NCT01655693|467903787|FG000|Overall Study|Progression of Disease|92|||
129983819|NCT01655693|467903788|FG001|Overall Study|Progression of Disease|76|||
129983820|NCT01655693|467903789|FG002|Overall Study|Progression of Disease|58|||
129983821|NCT01655693|467903787|FG000|Overall Study|Death|8|||
129983822|NCT01655693|467903788|FG001|Overall Study|Death|9|||
129983823|NCT01655693|467903789|FG002|Overall Study|Death|12|||
129983824|NCT01655693|467903787|FG000|Overall Study|Serious Adverse Event|3|||
129983825|NCT01655693|467903788|FG001|Overall Study|Serious Adverse Event|15|||
129983826|NCT01655693|467903789|FG002|Overall Study|Serious Adverse Event|11|||
129983827|NCT01655693|467903787|FG000|Overall Study|Withdrawal by Subject|3|||
129983828|NCT01655693|467903788|FG001|Overall Study|Withdrawal by Subject|2|||
129983829|NCT01655693|467903789|FG002|Overall Study|Withdrawal by Subject|20|||
129650604|NCT03448939|466677172|FG000|Overall Study|Adverse Event|5|||
129650605|NCT03448939|466677173|FG001|Overall Study|Adverse Event|1|||
129650606|NCT03448939|466677172|FG000|Overall Study|Lost to Follow-up|6|||
129650607|NCT03448939|466677173|FG001|Overall Study|Lost to Follow-up|6|||
129443562|NCT04147234|465924421|FG003|Overall Study|Adverse Event|0|||
129983830|NCT01655693|467903787|FG000|Overall Study|Adverse Event|3|||
129983831|NCT01655693|467903788|FG001|Overall Study|Adverse Event|11|||
129983832|NCT01655693|467903789|FG002|Overall Study|Adverse Event|3|||
129983833|NCT01655693|467903787|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
129983834|NCT01655693|467903788|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
129983835|NCT01655693|467903789|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
129650608|NCT03448939|466677172|FG000|Overall Study|Pregnancy|1|||
129650609|NCT03448939|466677173|FG001|Overall Study|Pregnancy|1|||
129650610|NCT03448939|466677172|FG000|Overall Study|Withdrawal by Subject|9|||
129650611|NCT03448939|466677173|FG001|Overall Study|Withdrawal by Subject|3|||
129650612|NCT00894790|466677174|FG000|Overall Study|Protocol Violation|0|||
129650613|NCT00894790|466677175|FG001|Overall Study|Protocol Violation|1|||
129650614|NCT00894790|466677174|FG000|Overall Study|Lost to Follow-up|0|||
129650615|NCT00894790|466677175|FG001|Overall Study|Lost to Follow-up|1|||
129650616|NCT00894790|466677174|FG000|Overall Study|Did not meet entrance criteria|1|||
129650617|NCT00894790|466677175|FG001|Overall Study|Did not meet entrance criteria|0|||
129650618|NCT01472965|466677176|FG000|Overall Study|Withdrawal by Subject|1|||
129650619|NCT01472965|466677177|FG001|Overall Study|Withdrawal by Subject|0|||
129650620|NCT00628095|466677178|FG000|Overall Study|Adverse Event|5|||
129650621|NCT00628095|466677179|FG001|Overall Study|Adverse Event|3|||
129983836|NCT01655693|467903787|FG000|Overall Study|Non-Compliance|0|||
129983837|NCT01655693|467903788|FG001|Overall Study|Non-Compliance|0|||
129983838|NCT01655693|467903789|FG002|Overall Study|Non-Compliance|7|||
129983839|NCT01655693|467903787|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
129761464|NCT00383552|467089168|FG000|Overall Study|Adverse Event|7|||
129761465|NCT00383552|467089169|FG001|Overall Study|Adverse Event|6|||
129761466|NCT00383552|467089170|FG002|Overall Study|Adverse Event|9|||
129761467|NCT00383552|467089171|FG003|Overall Study|Adverse Event|6|||
129761468|NCT00383552|467089168|FG000|Overall Study|Lack of Efficacy|4|||
129761469|NCT00383552|467089169|FG001|Overall Study|Lack of Efficacy|13|||
129761470|NCT00383552|467089170|FG002|Overall Study|Lack of Efficacy|29|||
129761471|NCT00383552|467089171|FG003|Overall Study|Lack of Efficacy|42|||
129761472|NCT00383552|467089168|FG000|Overall Study|Lost to Follow-up|0|||
129761473|NCT00383552|467089169|FG001|Overall Study|Lost to Follow-up|1|||
129761474|NCT00383552|467089170|FG002|Overall Study|Lost to Follow-up|5|||
129761475|NCT00383552|467089171|FG003|Overall Study|Lost to Follow-up|1|||
129761476|NCT00383552|467089168|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
129761477|NCT00383552|467089169|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
129761478|NCT00383552|467089170|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
129983840|NCT01655693|467903788|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
129983841|NCT01655693|467903789|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
129983842|NCT01655693|467903787|FG000|Overall Study|Protocol Violation|1|||
129983843|NCT01655693|467903788|FG001|Overall Study|Protocol Violation|0|||
129983844|NCT01655693|467903789|FG002|Overall Study|Protocol Violation|3|||
129983845|NCT01655693|467903787|FG000|Overall Study|Lost to Follow-up|1|||
129983846|NCT01655693|467903788|FG001|Overall Study|Lost to Follow-up|0|||
129983847|NCT01655693|467903789|FG002|Overall Study|Lost to Follow-up|1|||
129983848|NCT01655693|467903787|FG000|Overall Study|Screening Failure|1|||
129983849|NCT01655693|467903788|FG001|Overall Study|Screening Failure|0|||
129983850|NCT01655693|467903789|FG002|Overall Study|Screening Failure|0|||
129983851|NCT01655693|467903787|FG000|Overall Study|Other|8|||
129983852|NCT01655693|467903788|FG001|Overall Study|Other|6|||
129983853|NCT01655693|467903789|FG002|Overall Study|Other|15|||
129983854|NCT00929110|467903790|FG000|Overall Study|Adverse Event|40|||
129983855|NCT00929110|467903791|FG001|Overall Study|Adverse Event|29|||
129983856|NCT00929110|467903792|FG002|Overall Study|Adverse Event|18|||
129983857|NCT00929110|467903790|FG000|Overall Study|Subject withdrew consent|40|||
129983858|NCT00929110|467903791|FG001|Overall Study|Subject withdrew consent|23|||
129983859|NCT00929110|467903792|FG002|Overall Study|Subject withdrew consent|26|||
129983860|NCT00929110|467903790|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
129983861|NCT00929110|467903791|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
129983862|NCT00929110|467903792|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
129983863|NCT00929110|467903790|FG000|Overall Study|Lost to Follow-up|7|||
129983864|NCT00929110|467903791|FG001|Overall Study|Lost to Follow-up|7|||
129983865|NCT00929110|467903792|FG002|Overall Study|Lost to Follow-up|3|||
129983866|NCT00929110|467903790|FG000|Overall Study|Protocol deviation|5|||
129983867|NCT00929110|467903791|FG001|Overall Study|Protocol deviation|2|||
129983868|NCT00929110|467903792|FG002|Overall Study|Protocol deviation|4|||
129983869|NCT00929110|467903790|FG000|Overall Study|Administrative problems|4|||
129650622|NCT00628095|466677178|FG000|Overall Study|Lack of Efficacy|0|||
129761479|NCT00383552|467089171|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
129983870|NCT00929110|467903791|FG001|Overall Study|Administrative problems|1|||
129650623|NCT00628095|466677179|FG001|Overall Study|Lack of Efficacy|3|||
129983871|NCT00929110|467903792|FG002|Overall Study|Administrative problems|2|||
129983872|NCT00929110|467903790|FG000|Overall Study|Death|2|||
129983873|NCT00929110|467903791|FG001|Overall Study|Death|2|||
129983874|NCT00929110|467903792|FG002|Overall Study|Death|2|||
129983875|NCT00929110|467903790|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129983876|NCT00929110|467903791|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129983877|NCT00929110|467903792|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129983878|NCT00929110|467903790|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129650624|NCT00628095|466677178|FG000|Overall Study|Withdrawal by Subject|2|||
129650625|NCT00628095|466677179|FG001|Overall Study|Withdrawal by Subject|0|||
129983879|NCT00929110|467903791|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129650626|NCT00628095|466677178|FG000|Overall Study|Other|0|||
129650627|NCT00628095|466677179|FG001|Overall Study|Other|1|||
129650628|NCT03235115|466677183|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129983880|NCT00929110|467903792|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129983881|NCT00929110|467903790|FG000|Overall Study|Patient inability to use the device|0|||
129983882|NCT00929110|467903791|FG001|Overall Study|Patient inability to use the device|1|||
129983883|NCT00929110|467903792|FG002|Overall Study|Patient inability to use the device|0|||
129983884|NCT00620282|467903793|FG000|Overall Study|Adverse Event|0|||
129983885|NCT00620282|467903794|FG001|Overall Study|Adverse Event|1|||
129983886|NCT00620282|467903795|FG002|Overall Study|Adverse Event|0|||
129983887|NCT00620282|467903793|FG000|Overall Study|Arterial line unable to be placed|0|||
129983888|NCT00620282|467903794|FG001|Overall Study|Arterial line unable to be placed|0|||
129983889|NCT00620282|467903795|FG002|Overall Study|Arterial line unable to be placed|1|||
129650629|NCT03235115|466677184|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129650630|NCT03235115|466677185|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129650631|NCT03235115|466677186|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129650632|NCT03235115|466677187|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
129650633|NCT03235115|466677188|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
129650634|NCT00006305|466677191|FG000|Overall Study|Withdrawal by Subject|17|||
129650635|NCT00006305|466677192|FG001|Overall Study|Withdrawal by Subject|10|||
129650636|NCT00006305|466677193|FG002|Overall Study|Withdrawal by Subject|15|||
129650637|NCT00006305|466677194|FG003|Overall Study|Withdrawal by Subject|14|||
129650638|NCT00662558|466677195|FG000|Overall Study|Adverse Event|21|||
129650639|NCT00662558|466677196|FG001|Overall Study|Adverse Event|59|||
129650640|NCT00662558|466677195|FG000|Overall Study|Lack of Efficacy|4|||
129983890|NCT00620282|467903793|FG000|Overall Study|Withdrawal by Subject|0|||
129983891|NCT00620282|467903794|FG001|Overall Study|Withdrawal by Subject|1|||
129650641|NCT00662558|466677196|FG001|Overall Study|Lack of Efficacy|7|||
129650642|NCT00662558|466677195|FG000|Overall Study|Lost to Follow-up|13|||
129650643|NCT00662558|466677196|FG001|Overall Study|Lost to Follow-up|10|||
129650644|NCT00662558|466677195|FG000|Overall Study|Other|9|||
129650645|NCT00662558|466677196|FG001|Overall Study|Other|14|||
129650646|NCT00662558|466677195|FG000|Overall Study|Withdrawal by Subject|7|||
129650647|NCT00662558|466677196|FG001|Overall Study|Withdrawal by Subject|12|||
129650648|NCT00662558|466677195|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
129650649|NCT00662558|466677196|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
129650650|NCT01711619|466677197|FG000|Overall Study|Early study termination|10|||
129650651|NCT01711619|466677198|FG001|Overall Study|Early study termination|14|||
129650652|NCT01711619|466677197|FG000|Overall Study|Withdrawal by Subject|3|||
129650653|NCT01711619|466677198|FG001|Overall Study|Withdrawal by Subject|7|||
129650654|NCT01711619|466677197|FG000|Overall Study|Protocol Violation|2|||
129650655|NCT01711619|466677198|FG001|Overall Study|Protocol Violation|3|||
129650656|NCT01711619|466677197|FG000|Overall Study|Adverse Event|2|||
129650657|NCT01711619|466677198|FG001|Overall Study|Adverse Event|0|||
129650658|NCT01711619|466677197|FG000|Overall Study|Lost to Follow-up|1|||
129983892|NCT00620282|467903795|FG002|Overall Study|Withdrawal by Subject|0|||
129983893|NCT02703259|467903796|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
129983894|NCT02703259|467903797|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
129650659|NCT01711619|466677198|FG001|Overall Study|Lost to Follow-up|0|||
129650660|NCT00503997|466677199|FG000|Overall Study|disease progression|1|||
129650661|NCT00503997|466677199|FG000|Overall Study|Adverse Event|5|||
129650662|NCT00503997|466677199|FG000|Overall Study|Death|1|||
129650663|NCT00503997|466677199|FG000|Overall Study|Withdrawal by Subject|1|||
129650664|NCT01195844|466677200|FG000|Overall Study|Fecal sample not collected|40|||
129650665|NCT01432275|466677204|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
129650666|NCT01432275|466677205|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
129650667|NCT01432275|466677204|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
129650668|NCT01432275|466677205|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
129650669|NCT01432275|466677204|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
129650670|NCT01432275|466677205|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
129983895|NCT02703259|467903796|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
129983896|NCT02703259|467903797|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
129650671|NCT01432275|466677204|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
129650672|NCT01432275|466677205|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
129650673|NCT01432275|466677204|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
129650674|NCT01432275|466677205|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
129707674|NCT03710889|466892096|FG000|Overall Study|Adverse Event|2|||
129650675|NCT01432275|466677204|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
129983897|NCT02703259|467903796|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
129650676|NCT01432275|466677205|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
129650677|NCT01432275|466677204|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
129650678|NCT01432275|466677205|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
129650679|NCT01432275|466677204|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
129650680|NCT01432275|466677205|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
129650681|NCT01432275|466677204|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
129650682|NCT01432275|466677205|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
129650683|NCT02565706|466677206|FG000|Overall Study|Withdrawal by Subject|5|||
129650684|NCT02565706|466677207|FG001|Overall Study|Withdrawal by Subject|7|||
129650685|NCT02565706|466677208|FG002|Overall Study|Withdrawal by Subject|7|||
129650686|NCT02565706|466677209|FG003|Overall Study|Withdrawal by Subject|11|||
129650687|NCT02565706|466677206|FG000|Overall Study|Lost to Follow-up|72|||
129650688|NCT02565706|466677207|FG001|Overall Study|Lost to Follow-up|75|||
129650689|NCT02565706|466677208|FG002|Overall Study|Lost to Follow-up|82|||
129650690|NCT02565706|466677209|FG003|Overall Study|Lost to Follow-up|74|||
129650691|NCT00835679|466677215|FG000|Overall Study|Withdrawal by Subject|1|||
129650692|NCT00835679|466677216|FG001|Overall Study|Withdrawal by Subject|0|||
129650693|NCT00835679|466677217|FG002|Overall Study|Withdrawal by Subject|0|||
129650694|NCT00835679|466677218|FG003|Overall Study|Withdrawal by Subject|0|||
129650695|NCT03802565|466677221|FG000|Overall Study|Adverse Event|0|||
129650696|NCT03802565|466677222|FG001|Overall Study|Adverse Event|1|||
129650697|NCT03802565|466677223|FG002|Overall Study|Adverse Event|2|||
129650698|NCT03802565|466677224|FG003|Overall Study|Adverse Event|1|||
129650699|NCT03802565|466677225|FG004|Overall Study|Adverse Event|1|||
129650700|NCT03802565|466677221|FG000|Overall Study|Withdrawal by Subject|2|||
129650701|NCT03802565|466677222|FG001|Overall Study|Withdrawal by Subject|2|||
129650702|NCT03802565|466677223|FG002|Overall Study|Withdrawal by Subject|2|||
129650703|NCT03802565|466677224|FG003|Overall Study|Withdrawal by Subject|0|||
129650704|NCT03802565|466677225|FG004|Overall Study|Withdrawal by Subject|1|||
129650705|NCT03802565|466677221|FG000|Overall Study|Protocol Violation|2|||
129650706|NCT03802565|466677222|FG001|Overall Study|Protocol Violation|1|||
129650707|NCT03802565|466677223|FG002|Overall Study|Protocol Violation|4|||
129650708|NCT03802565|466677224|FG003|Overall Study|Protocol Violation|5|||
129650709|NCT03802565|466677225|FG004|Overall Study|Protocol Violation|1|||
129650710|NCT03802565|466677221|FG000|Overall Study|Lost to Follow-up|0|||
129650711|NCT03802565|466677222|FG001|Overall Study|Lost to Follow-up|0|||
129650712|NCT03802565|466677223|FG002|Overall Study|Lost to Follow-up|1|||
129650713|NCT03802565|466677224|FG003|Overall Study|Lost to Follow-up|0|||
129650714|NCT03802565|466677225|FG004|Overall Study|Lost to Follow-up|0|||
129650715|NCT03802565|466677221|FG000|Overall Study|Subjects Related to Each Other|1|||
129650716|NCT03802565|466677222|FG001|Overall Study|Subjects Related to Each Other|0|||
129650717|NCT03802565|466677223|FG002|Overall Study|Subjects Related to Each Other|0|||
129650718|NCT03802565|466677224|FG003|Overall Study|Subjects Related to Each Other|2|||
129650719|NCT03802565|466677225|FG004|Overall Study|Subjects Related to Each Other|1|||
129650720|NCT03802565|466677221|FG000|Overall Study|Elevated Enzymes|0|||
129650721|NCT03802565|466677222|FG001|Overall Study|Elevated Enzymes|0|||
129650722|NCT03802565|466677223|FG002|Overall Study|Elevated Enzymes|0|||
129650723|NCT03802565|466677224|FG003|Overall Study|Elevated Enzymes|0|||
129650724|NCT03802565|466677225|FG004|Overall Study|Elevated Enzymes|2|||
129650725|NCT05020899|466677226|FG000|8 Week Follow-up|Lost to Follow-up|3|||
129650726|NCT05020899|466677227|FG001|8 Week Follow-up|Lost to Follow-up|6|||
129650727|NCT05020899|466677226|FG000|12 Week Follow-up|Lost to Follow-up|1|||
129650728|NCT05020899|466677227|FG001|12 Week Follow-up|Lost to Follow-up|0|||
129761480|NCT00383552|467089168|FG000|Overall Study|Did not wish to continue (related)|1|||
129761481|NCT00383552|467089169|FG001|Overall Study|Did not wish to continue (related)|0|||
129983898|NCT02703259|467903797|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
129983899|NCT03122223|467903802|FG000|Overall Study|Withdrawal by Subject|2|||
129983900|NCT03122223|467903803|FG001|Overall Study|Withdrawal by Subject|2|||
129983901|NCT03122223|467903804|FG002|Overall Study|Withdrawal by Subject|1|||
129983902|NCT03122223|467903805|FG003|Overall Study|Withdrawal by Subject|0|||
129983903|NCT03122223|467903802|FG000|Overall Study|Lost to Follow-up|0|||
129983904|NCT03122223|467903803|FG001|Overall Study|Lost to Follow-up|2|||
129983905|NCT03122223|467903804|FG002|Overall Study|Lost to Follow-up|2|||
129983906|NCT03122223|467903805|FG003|Overall Study|Lost to Follow-up|0|||
129539357|NCT00198107|466266848|FG000|Double-Blind Period|Adverse Event|1|||
129650729|NCT05020899|466677226|FG000|12 Week Follow-up|Death|0|||
129650730|NCT05020899|466677227|FG001|12 Week Follow-up|Death|1|||
129650731|NCT02124759|466677228|FG000|Overall Study|Withdrawal by Subject|3|||
129650732|NCT02124759|466677229|FG001|Overall Study|Withdrawal by Subject|1|||
129650733|NCT02124759|466677230|FG002|Overall Study|Withdrawal by Subject|1|||
129650734|NCT02124759|466677228|FG000|Overall Study|Screen Fail|2|||
129650735|NCT02124759|466677229|FG001|Overall Study|Screen Fail|2|||
129650736|NCT02124759|466677230|FG002|Overall Study|Screen Fail|3|||
129983907|NCT03122223|467903802|FG000|Overall Study|Participant unable to adhere|1|||
129650737|NCT01068626|466677233|FG000|Overall Study|Adverse Event|3|||
129650738|NCT01068626|466677234|FG001|Overall Study|Adverse Event|0|||
129650739|NCT01068626|466677233|FG000|Overall Study|Withdrawal by Subject|0|||
129650740|NCT01068626|466677234|FG001|Overall Study|Withdrawal by Subject|2|||
129650741|NCT01785849|466677235|FG000|Overall Study|Death|7|||
129650742|NCT01785849|466677236|FG001|Overall Study|Death|9|||
129650743|NCT01785849|466677235|FG000|Overall Study|Protocol Specified Criteria|29|||
129650744|NCT01785849|466677236|FG001|Overall Study|Protocol Specified Criteria|1|||
129650745|NCT01785849|466677235|FG000|Overall Study|Withdrawal by Subject|15|||
129650746|NCT01785849|466677236|FG001|Overall Study|Withdrawal by Subject|12|||
129983908|NCT03122223|467903803|FG001|Overall Study|Participant unable to adhere|1|||
129983909|NCT03122223|467903804|FG002|Overall Study|Participant unable to adhere|1|||
129983910|NCT03122223|467903805|FG003|Overall Study|Participant unable to adhere|0|||
129983911|NCT01820585|467903807|FG000|Overall Study|Adverse Event|9|||
129983912|NCT01820585|467903808|FG001|Overall Study|Adverse Event|13|||
129983913|NCT01820585|467903809|FG002|Overall Study|Adverse Event|23|||
129983914|NCT01820585|467903810|FG003|Overall Study|Adverse Event|34|||
129983915|NCT01820585|467903807|FG000|Overall Study|Lack of Efficacy|9|||
129650747|NCT01785849|466677235|FG000|Overall Study|Sponsor Decision|0|||
129650748|NCT01785849|466677236|FG001|Overall Study|Sponsor Decision|1|||
129983916|NCT01820585|467903808|FG001|Overall Study|Lack of Efficacy|7|||
129983917|NCT01820585|467903809|FG002|Overall Study|Lack of Efficacy|5|||
129983918|NCT01820585|467903810|FG003|Overall Study|Lack of Efficacy|1|||
129983919|NCT01820585|467903807|FG000|Overall Study|Withdrawal by Subject|3|||
129983920|NCT01820585|467903808|FG001|Overall Study|Withdrawal by Subject|7|||
129650749|NCT01785849|466677235|FG000|Overall Study|Lost to Follow-up|10|||
129650750|NCT01785849|466677236|FG001|Overall Study|Lost to Follow-up|11|||
129650751|NCT04340843|466677237|FG000|Overall Study|Adverse Event|0|||
129650752|NCT04340843|466677238|FG001|Overall Study|Adverse Event|2|||
129650753|NCT04340843|466677237|FG000|Overall Study|Withdrawal by Subject|0|||
129650754|NCT04340843|466677238|FG001|Overall Study|Withdrawal by Subject|2|||
129650755|NCT04249622|466677239|FG000|Overall Study|Withdrawal by Subject|1|||
129650756|NCT04249622|466677240|FG001|Overall Study|Withdrawal by Subject|1|||
129650757|NCT04249622|466677239|FG000|Overall Study|Alternative therapy|1|||
129650758|NCT04249622|466677240|FG001|Overall Study|Alternative therapy|0|||
129650759|NCT04249622|466677239|FG000|Overall Study|Discontinuation of pertuzumab|1|||
129650760|NCT04249622|466677240|FG001|Overall Study|Discontinuation of pertuzumab|0|||
129650761|NCT01634659|466677244|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
129650762|NCT01634659|466677245|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
129650763|NCT01634659|466677244|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
129650764|NCT01634659|466677245|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
129650765|NCT00875433|466677246|FG000|Overall Study|Progressive disease|41|||
129650766|NCT00875433|466677246|FG000|Overall Study|Other Adverse Event|14|||
129650767|NCT00875433|466677246|FG000|Overall Study|Withdrawal by Subject|2|||
129650768|NCT00875433|466677246|FG000|Overall Study|Other|3|||
129650769|NCT00793624|466677247|FG000|Overall Study|Adverse Event|18|||
129650770|NCT00793624|466677248|FG001|Overall Study|Adverse Event|16|||
129650771|NCT00793624|466677249|FG002|Overall Study|Adverse Event|15|||
129650772|NCT00793624|466677250|FG003|Overall Study|Adverse Event|20|||
129650773|NCT00793624|466677247|FG000|Overall Study|Lost to Follow-up|2|||
129650774|NCT00793624|466677248|FG001|Overall Study|Lost to Follow-up|2|||
129650775|NCT00793624|466677249|FG002|Overall Study|Lost to Follow-up|4|||
129650776|NCT00793624|466677250|FG003|Overall Study|Lost to Follow-up|0|||
129650777|NCT00793624|466677247|FG000|Overall Study|Withdrawal by Subject|20|||
129650778|NCT00793624|466677248|FG001|Overall Study|Withdrawal by Subject|9|||
129650779|NCT00793624|466677249|FG002|Overall Study|Withdrawal by Subject|11|||
129650780|NCT00793624|466677250|FG003|Overall Study|Withdrawal by Subject|14|||
129650781|NCT00793624|466677247|FG000|Overall Study|Lack of Efficacy|9|||
129983921|NCT01820585|467903809|FG002|Overall Study|Withdrawal by Subject|3|||
129983922|NCT01820585|467903810|FG003|Overall Study|Withdrawal by Subject|8|||
129983923|NCT01820585|467903807|FG000|Overall Study|Lost to Follow-up|3|||
129983924|NCT01820585|467903808|FG001|Overall Study|Lost to Follow-up|3|||
129983925|NCT01820585|467903809|FG002|Overall Study|Lost to Follow-up|0|||
129650782|NCT00793624|466677248|FG001|Overall Study|Lack of Efficacy|2|||
129650783|NCT00793624|466677249|FG002|Overall Study|Lack of Efficacy|1|||
129650784|NCT00793624|466677250|FG003|Overall Study|Lack of Efficacy|3|||
129650785|NCT00793624|466677247|FG000|Overall Study|Non compliance with protocol|2|||
129650786|NCT00793624|466677248|FG001|Overall Study|Non compliance with protocol|3|||
129650787|NCT00793624|466677249|FG002|Overall Study|Non compliance with protocol|2|||
129650788|NCT00793624|466677250|FG003|Overall Study|Non compliance with protocol|3|||
129650789|NCT00793624|466677247|FG000|Overall Study|Other reason not described above|6|||
129650790|NCT00793624|466677248|FG001|Overall Study|Other reason not described above|4|||
129650791|NCT00793624|466677249|FG002|Overall Study|Other reason not described above|6|||
129650792|NCT00793624|466677250|FG003|Overall Study|Other reason not described above|3|||
129983926|NCT01820585|467903810|FG003|Overall Study|Lost to Follow-up|3|||
129983927|NCT01820585|467903807|FG000|Overall Study|Protocol Violation|3|||
129983928|NCT01820585|467903808|FG001|Overall Study|Protocol Violation|1|||
129650793|NCT02921750|466678505|FG000|Overall Study|Adverse Event|1|||
129650794|NCT02921750|466678506|FG001|Overall Study|Adverse Event|2|||
129650795|NCT02921750|466678505|FG000|Overall Study|Withdrawal by Subject|1|||
129650796|NCT02921750|466678506|FG001|Overall Study|Withdrawal by Subject|1|||
129650797|NCT02921750|466678505|FG000|Overall Study|Lost to Follow-up|3|||
129650798|NCT02921750|466678506|FG001|Overall Study|Lost to Follow-up|3|||
129650799|NCT02921750|466678505|FG000|Overall Study|Wound healed|3|||
129650800|NCT02921750|466678506|FG001|Overall Study|Wound healed|3|||
129650801|NCT02921750|466678505|FG000|Overall Study|Serious Adverse Event|1|||
129650802|NCT02921750|466678506|FG001|Overall Study|Serious Adverse Event|2|||
129650803|NCT03309696|466678507|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
129650804|NCT03309696|466678508|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
129650805|NCT03309696|466678509|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
129650806|NCT03309696|466678510|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
129650807|NCT05940077|466678511|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
129650808|NCT00328094|466678512|FG000|Overall Study|Physician Decision|3|||
129650809|NCT00328094|466678513|FG001|Overall Study|Physician Decision|3|||
129650810|NCT02368210|466678514|FG000|Overall Study|Withdrawal by Subject|1|||
129650811|NCT02368210|466678515|FG001|Overall Study|Withdrawal by Subject|0|||
129650812|NCT02368210|466678514|FG000|Overall Study|Adverse Event|0|||
129650813|NCT02368210|466678515|FG001|Overall Study|Adverse Event|1|||
129650814|NCT00078949|466678516|FG000|Overall Study|No treated|4|||
129650815|NCT00078949|466678517|FG001|Overall Study|No treated|5|||
129650816|NCT00078949|466678518|FG002|Overall Study|No treated|3|||
129650817|NCT00078949|466678519|FG003|Overall Study|No treated|3|||
129650818|NCT02309723|466678520|FG000|Overall Study|Withdrawal by Subject|24|||
129650819|NCT02309723|466678521|FG001|Overall Study|Withdrawal by Subject|23|||
129650820|NCT02309723|466678522|FG002|Overall Study|Withdrawal by Subject|24|||
129650821|NCT01565668|466678523|FG000|Overall Study|Death|2|||
129650822|NCT01565668|466678524|FG001|Overall Study|Death|1|||
129650823|NCT01565668|466678523|FG000|Overall Study|Lack of Efficacy|4|||
129650824|NCT01565668|466678524|FG001|Overall Study|Lack of Efficacy|2|||
129650825|NCT01565668|466678523|FG000|Overall Study|Participant went on Hospice Care|1|||
129650826|NCT01565668|466678524|FG001|Overall Study|Participant went on Hospice Care|0|||
129650827|NCT01565668|466678523|FG000|Overall Study|Adverse Event|6|||
129650828|NCT01565668|466678524|FG001|Overall Study|Adverse Event|1|||
129650829|NCT01565668|466678523|FG000|Overall Study|Randomized, but never received drug|0|||
129650830|NCT01565668|466678524|FG001|Overall Study|Randomized, but never received drug|2|||
129650831|NCT01565668|466678523|FG000|Overall Study|Progressive disease|13|||
129650832|NCT01565668|466678524|FG001|Overall Study|Progressive disease|14|||
129650833|NCT01565668|466678523|FG000|Overall Study|Withdrawal by Subject|1|||
129650834|NCT01565668|466678524|FG001|Overall Study|Withdrawal by Subject|3|||
129650835|NCT01565668|466678523|FG000|Overall Study|HSCT Transplant|11|||
129650836|NCT01565668|466678524|FG001|Overall Study|HSCT Transplant|15|||
129650837|NCT03570554|466678525|FG000|Overall Study|Non-compliance with study drug|0|||
129650838|NCT03570554|466678526|FG001|Overall Study|Non-compliance with study drug|0|||
129650839|NCT03570554|466678527|FG002|Overall Study|Non-compliance with study drug|1|||
129650840|NCT03570554|466678528|FG003|Overall Study|Non-compliance with study drug|0|||
129650841|NCT03570554|466678525|FG000|Overall Study|Adverse Event|0|||
129650842|NCT03570554|466678526|FG001|Overall Study|Adverse Event|0|||
129650843|NCT03570554|466678527|FG002|Overall Study|Adverse Event|0|||
129650844|NCT03570554|466678528|FG003|Overall Study|Adverse Event|1|||
129650845|NCT02604550|466678531|FG000|Overall Study|Lost to Follow-up|7|||
129650846|NCT02604550|466678532|FG001|Overall Study|Lost to Follow-up|6|||
129650847|NCT02604550|466678531|FG000|Overall Study|Withdrawal by Subject|0|||
129650848|NCT02604550|466678532|FG001|Overall Study|Withdrawal by Subject|1|||
129650849|NCT02604550|466678531|FG000|Overall Study|Incomplete data using paper journal|18|||
129650850|NCT02604550|466678532|FG001|Overall Study|Incomplete data using paper journal|19|||
129650851|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
129650852|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
129650853|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
129650854|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
129650855|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|Death|1|||
129650856|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|Death|1|||
129650857|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
129650858|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
129650859|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
129650860|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
129650861|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
129650862|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
129650863|NCT00033657|466678536|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
129650864|NCT00033657|466678537|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
129650865|NCT00033657|466678536|FG000|Surgical Resection|not complete resection|0|||
129650866|NCT00033657|466678537|FG001|Surgical Resection|not complete resection|3|||
129650867|NCT00033657|466678536|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
129650868|NCT00033657|466678537|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
129650869|NCT00033657|466678536|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
129650870|NCT00033657|466678537|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
129650871|NCT00033657|466678536|FG000|Adjuvant Chemotherapy|Death|2|||
129650872|NCT00033657|466678537|FG001|Adjuvant Chemotherapy|Death|1|||
129650873|NCT00033657|466678536|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
129650874|NCT00033657|466678537|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
129650875|NCT00033657|466678536|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
129650876|NCT00033657|466678537|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
129650877|NCT00033657|466678536|FG000|Adjuvant Chemotherapy|Other|0|||
129650878|NCT00033657|466678537|FG001|Adjuvant Chemotherapy|Other|2|||
129650879|NCT04093492|466678538|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
129650880|NCT04093492|466678539|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
129650881|NCT04093492|466678540|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
129650882|NCT04093492|466678541|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
129650883|NCT04093492|466678538|FG000|25 Weeks Gestational Age (GA)|No response|5|||
129650884|NCT04093492|466678539|FG001|25 Weeks Gestational Age (GA)|No response|5|||
129650885|NCT04093492|466678540|FG002|25 Weeks Gestational Age (GA)|No response|5|||
129650886|NCT04093492|466678541|FG003|25 Weeks Gestational Age (GA)|No response|2|||
129650887|NCT04093492|466678538|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
129650888|NCT04093492|466678539|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
129650889|NCT04093492|466678540|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
129650890|NCT04093492|466678541|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
129650891|NCT04093492|466678538|FG000|30 Weeks GA|Delivered before assessment|1|||
129650892|NCT04093492|466678539|FG001|30 Weeks GA|Delivered before assessment|2|||
129650893|NCT04093492|466678540|FG002|30 Weeks GA|Delivered before assessment|0|||
129650894|NCT04093492|466678541|FG003|30 Weeks GA|Delivered before assessment|0|||
129650895|NCT04093492|466678538|FG000|30 Weeks GA|No response|7|||
129650896|NCT04093492|466678539|FG001|30 Weeks GA|No response|5|||
129650897|NCT04093492|466678540|FG002|30 Weeks GA|No response|5|||
129650898|NCT04093492|466678541|FG003|30 Weeks GA|No response|2|||
129650899|NCT04093492|466678538|FG000|30 Weeks GA|Lost to Follow-up|0|||
129650900|NCT04093492|466678539|FG001|30 Weeks GA|Lost to Follow-up|1|||
129650901|NCT04093492|466678540|FG002|30 Weeks GA|Lost to Follow-up|0|||
129650902|NCT04093492|466678541|FG003|30 Weeks GA|Lost to Follow-up|0|||
129650903|NCT04093492|466678538|FG000|34 Weeks GA|Delivered before assessment|6|||
129650904|NCT04093492|466678539|FG001|34 Weeks GA|Delivered before assessment|3|||
129650905|NCT04093492|466678540|FG002|34 Weeks GA|Delivered before assessment|0|||
129650906|NCT04093492|466678541|FG003|34 Weeks GA|Delivered before assessment|0|||
129650907|NCT04093492|466678538|FG000|34 Weeks GA|No response|0|||
129650908|NCT04093492|466678539|FG001|34 Weeks GA|No response|7|||
129650909|NCT04093492|466678540|FG002|34 Weeks GA|No response|5|||
129650910|NCT04093492|466678541|FG003|34 Weeks GA|No response|3|||
129650911|NCT04093492|466678538|FG000|34 Weeks GA|Lost to Follow-up|0|||
129650912|NCT04093492|466678539|FG001|34 Weeks GA|Lost to Follow-up|1|||
129650913|NCT04093492|466678540|FG002|34 Weeks GA|Lost to Follow-up|0|||
129650914|NCT04093492|466678541|FG003|34 Weeks GA|Lost to Follow-up|0|||
129650915|NCT00329641|466678542|FG000|Overall Study|Did not start treatment|1|||
129650916|NCT00329641|466678542|FG000|Overall Study|Not eligible|1|||
129650917|NCT00329641|466678542|FG000|Overall Study|Adverse Event|3|||
129650918|NCT00329641|466678542|FG000|Overall Study|Other reason, not protocol specified|1|||
129650919|NCT02945254|466678545|FG000|Overall Study|Lost to Follow-up|1|||
129650920|NCT02945254|466678546|FG001|Overall Study|Lost to Follow-up|0|||
129650921|NCT02945254|466678545|FG000|Overall Study|Withdrawal by Subject|1|||
129650922|NCT02945254|466678546|FG001|Overall Study|Withdrawal by Subject|0|||
129650923|NCT03422159|466678551|FG000|Overall Study|Exclusion due to terminal disease|2|||
129650924|NCT03422159|466678552|FG001|Overall Study|Exclusion due to terminal disease|1|||
129650925|NCT02631070|466678553|FG000|Overall Study|Withdrawal by Subject|35|||
129761482|NCT00383552|467089170|FG002|Overall Study|Did not wish to continue (related)|2|||
129761483|NCT00383552|467089171|FG003|Overall Study|Did not wish to continue (related)|3|||
129761484|NCT00383552|467089168|FG000|Overall Study|Noncompliance with the protocol|11|||
129761485|NCT00383552|467089169|FG001|Overall Study|Noncompliance with the protocol|6|||
129761486|NCT00383552|467089170|FG002|Overall Study|Noncompliance with the protocol|8|||
129761487|NCT00383552|467089171|FG003|Overall Study|Noncompliance with the protocol|10|||
129761488|NCT00383552|467089168|FG000|Overall Study|Did not meet protocol eligibility|8|||
129761489|NCT00383552|467089169|FG001|Overall Study|Did not meet protocol eligibility|6|||
129761490|NCT00383552|467089170|FG002|Overall Study|Did not meet protocol eligibility|2|||
129761491|NCT00383552|467089171|FG003|Overall Study|Did not meet protocol eligibility|3|||
129761492|NCT00383552|467089168|FG000|Overall Study|Administrative|1|||
129761493|NCT00383552|467089169|FG001|Overall Study|Administrative|0|||
129761494|NCT00383552|467089170|FG002|Overall Study|Administrative|1|||
129761495|NCT00383552|467089171|FG003|Overall Study|Administrative|1|||
129761496|NCT02055898|467089172|FG000|First Intervention (5 Days)|Physician Decision|2|||
129761497|NCT02055898|467089173|FG001|First Intervention (5 Days)|Physician Decision|0|||
129761498|NCT02055898|467089172|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
129761499|NCT02055898|467089173|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
129761500|NCT01620060|467089174|FG000|Overall Study|Adverse Event|9|||
129761501|NCT01620060|467089174|FG000|Overall Study|Protocol Violation|1|||
129761502|NCT01620060|467089174|FG000|Overall Study|Withdrawal by Subject|1|||
129761503|NCT01620060|467089174|FG000|Overall Study|Did not comply with Study Produre|1|||
129761504|NCT01620060|467089174|FG000|Overall Study|Family emergency|1|||
129761505|NCT01620060|467089174|FG000|Overall Study|Per Sponsor Decision|2|||
129761506|NCT00231777|467089175|FG000|Overall Study|Lost to Follow-up|3|||
129761507|NCT00231777|467089176|FG001|Overall Study|Lost to Follow-up|0|||
129761508|NCT00231777|467089175|FG000|Overall Study|Other|3|||
129761509|NCT00231777|467089176|FG001|Overall Study|Other|2|||
129761510|NCT04551989|467089179|FG000|Overall Study|Adverse Event|4|||
129761511|NCT04551989|467089179|FG000|Overall Study|Protocol Violation|3|||
129761512|NCT04551989|467089179|FG000|Overall Study|Lost to Follow-up|1|||
129761513|NCT04551989|467089179|FG000|Overall Study|Physician Decision|3|||
129761514|NCT04698343|467089180|FG000|Overall Study|Withdrawal by Subject|6|||
129761515|NCT04698343|467089180|FG000|Overall Study|Physician Decision|2|||
129761516|NCT04698343|467089180|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
129761517|NCT04698343|467089180|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
129761518|NCT04698343|467089180|FG000|Overall Study|Personal reasons|3|||
129761519|NCT04698343|467089180|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
129761520|NCT00088530|467089181|FG000|Overall Study|Progressive/Relapsed Disease|28|||
129761521|NCT00088530|467089182|FG001|Overall Study|Progressive/Relapsed Disease|39|||
129761522|NCT00088530|467089181|FG000|Overall Study|Adverse Event|15|||
129761523|NCT00088530|467089182|FG001|Overall Study|Adverse Event|9|||
129983929|NCT01820585|467903809|FG002|Overall Study|Protocol Violation|1|||
129983930|NCT01820585|467903810|FG003|Overall Study|Protocol Violation|1|||
129983931|NCT01820585|467903807|FG000|Overall Study|Subject non-compliance|0|||
129983932|NCT01820585|467903808|FG001|Overall Study|Subject non-compliance|0|||
129983933|NCT01820585|467903809|FG002|Overall Study|Subject non-compliance|1|||
129983934|NCT01820585|467903810|FG003|Overall Study|Subject non-compliance|2|||
129983935|NCT01820585|467903807|FG000|Overall Study|at sponsor request|0|||
129983936|NCT01820585|467903808|FG001|Overall Study|at sponsor request|0|||
129983937|NCT01820585|467903809|FG002|Overall Study|at sponsor request|1|||
129983938|NCT01820585|467903810|FG003|Overall Study|at sponsor request|0|||
129983939|NCT01820585|467903807|FG000|Overall Study|Pregnancy|0|||
129983940|NCT01820585|467903808|FG001|Overall Study|Pregnancy|1|||
129983941|NCT01820585|467903809|FG002|Overall Study|Pregnancy|0|||
129983942|NCT01820585|467903810|FG003|Overall Study|Pregnancy|0|||
129983943|NCT01712659|467903811|FG000|Dose Escalation|Physician Decision|0|||
129983944|NCT01712659|467903812|FG001|Dose Escalation|Physician Decision|1|||
129983945|NCT01712659|467903813|FG002|Dose Escalation|Physician Decision|0|||
129983946|NCT01712659|467903814|FG003|Dose Escalation|Physician Decision|0|||
129983947|NCT01712659|467903815|FG004|Dose Escalation|Physician Decision|0|||
129983948|NCT01712659|467903811|FG000|Dose Escalation|Unable to take study drug|0|||
129983949|NCT01712659|467903812|FG001|Dose Escalation|Unable to take study drug|1|||
129983950|NCT01712659|467903813|FG002|Dose Escalation|Unable to take study drug|0|||
129983951|NCT01712659|467903814|FG003|Dose Escalation|Unable to take study drug|0|||
129983952|NCT01712659|467903815|FG004|Dose Escalation|Unable to take study drug|0|||
129983953|NCT01712659|467903811|FG000|Dose Expansion|Early disease progression|1|||
129983954|NCT01712659|467903812|FG001|Dose Expansion|Early disease progression|0|||
129983955|NCT01712659|467903813|FG002|Dose Expansion|Early disease progression|0|||
129983956|NCT01712659|467903814|FG003|Dose Expansion|Early disease progression|0|||
129983957|NCT01712659|467903815|FG004|Dose Expansion|Early disease progression|0|||
129983958|NCT01712659|467903811|FG000|Dose Expansion|Physician Decision|1|||
129983959|NCT01712659|467903812|FG001|Dose Expansion|Physician Decision|0|||
129983960|NCT01712659|467903813|FG002|Dose Expansion|Physician Decision|0|||
129983961|NCT01712659|467903814|FG003|Dose Expansion|Physician Decision|0|||
129983962|NCT01712659|467903815|FG004|Dose Expansion|Physician Decision|0|||
129983963|NCT00548262|467903816|FG000|Overall Study|Death|21|||
129983964|NCT00548262|467903816|FG000|Overall Study|Adverse Event|2|||
129983965|NCT00548262|467903816|FG000|Overall Study|Lack of Efficacy|4|||
129983966|NCT00548262|467903816|FG000|Overall Study|Lost to Follow-up|1|||
129983967|NCT00548262|467903816|FG000|Overall Study|Other|3|||
129983968|NCT00548262|467903816|FG000|Overall Study|Withdrawal by Subject|1|||
129443563|NCT04147234|465924422|FG004|Overall Study|Adverse Event|1|||
129539358|NCT00198107|466266849|FG001|Double-Blind Period|Adverse Event|1|||
129761524|NCT00088530|467089181|FG000|Overall Study|Withdrawal by Subject|2|||
129761525|NCT00088530|467089182|FG001|Overall Study|Withdrawal by Subject|5|||
129983969|NCT02285153|467903817|FG000|Overall Study|Adverse Event|1|||
129983970|NCT02285153|467903818|FG001|Overall Study|Adverse Event|0|||
129983971|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
129983972|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
129983973|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
129983974|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
129983975|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
129761526|NCT00088530|467089181|FG000|Overall Study|Lost to Follow-up|2|||
129761527|NCT00088530|467089182|FG001|Overall Study|Lost to Follow-up|0|||
129761528|NCT00088530|467089181|FG000|Overall Study|Physician Decision|2|||
129761529|NCT00088530|467089182|FG001|Overall Study|Physician Decision|0|||
129761530|NCT00088530|467089181|FG000|Overall Study|Sponsor decision|0|||
129761531|NCT00088530|467089182|FG001|Overall Study|Sponsor decision|1|||
129761532|NCT00088530|467089181|FG000|Overall Study|Patient never treated|1|||
129761533|NCT00088530|467089182|FG001|Overall Study|Patient never treated|0|||
129761534|NCT00739401|467089183|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
129983976|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
129983977|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
129983978|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
129983979|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
129761535|NCT00739401|467089183|FG000|Overall Study|Death|3|||
129761536|NCT00739401|467089183|FG000|Overall Study|Withdrawal by Subject|4|||
129761537|NCT04575155|467089184|FG000|2 Month|Withdrawal by Subject|1|||
129761538|NCT04575155|467089185|FG001|2 Month|Withdrawal by Subject|1|||
129761539|NCT04575155|467089184|FG000|2 Month|Lost to Follow-up|5|||
129761540|NCT04575155|467089185|FG001|2 Month|Lost to Follow-up|3|||
129761541|NCT04575155|467089184|FG000|2 Month|Ineligible|1|||
129761542|NCT04575155|467089185|FG001|2 Month|Ineligible|0|||
129761543|NCT00467740|467089186|FG000|Overall Study|Adverse Event|0|||
129761544|NCT00467740|467089187|FG001|Overall Study|Adverse Event|0|||
129761545|NCT00467740|467089188|FG002|Overall Study|Adverse Event|1|||
129761546|NCT00467740|467089189|FG003|Overall Study|Adverse Event|0|||
129761547|NCT00467740|467089190|FG004|Overall Study|Adverse Event|0|||
129761548|NCT00467740|467089186|FG000|Overall Study|Protocol Violation|0|||
129761549|NCT00467740|467089187|FG001|Overall Study|Protocol Violation|0|||
129761550|NCT00467740|467089188|FG002|Overall Study|Protocol Violation|1|||
129761551|NCT00467740|467089189|FG003|Overall Study|Protocol Violation|0|||
129761552|NCT00467740|467089190|FG004|Overall Study|Protocol Violation|0|||
129983980|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
129983981|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
129983982|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
129983983|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
129983984|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
129983985|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
129761553|NCT00467740|467089186|FG000|Overall Study|Lost to Follow-up|0|||
129761554|NCT00467740|467089187|FG001|Overall Study|Lost to Follow-up|1|||
129761555|NCT00467740|467089188|FG002|Overall Study|Lost to Follow-up|0|||
129761556|NCT00467740|467089189|FG003|Overall Study|Lost to Follow-up|0|||
129761557|NCT00467740|467089190|FG004|Overall Study|Lost to Follow-up|0|||
129761558|NCT00467740|467089186|FG000|Overall Study|Withdrawal by Subject|1|||
129761559|NCT00467740|467089187|FG001|Overall Study|Withdrawal by Subject|1|||
129761560|NCT00467740|467089188|FG002|Overall Study|Withdrawal by Subject|0|||
129761561|NCT00467740|467089189|FG003|Overall Study|Withdrawal by Subject|1|||
129761562|NCT00467740|467089190|FG004|Overall Study|Withdrawal by Subject|0|||
129983986|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
129983987|NCT02544451|467903820|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
129983988|NCT02544451|467903821|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
129983989|NCT02544451|467903822|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
129983990|NCT02544451|467903823|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
129983991|NCT02544451|467903820|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
129983992|NCT02544451|467903821|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
129983993|NCT02544451|467903822|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
129983994|NCT02544451|467903823|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
129761563|NCT00467740|467089186|FG000|Overall Study|Lack of Efficacy|0|||
129761564|NCT00467740|467089187|FG001|Overall Study|Lack of Efficacy|1|||
129761565|NCT00467740|467089188|FG002|Overall Study|Lack of Efficacy|0|||
129761566|NCT00467740|467089189|FG003|Overall Study|Lack of Efficacy|0|||
129761567|NCT00467740|467089190|FG004|Overall Study|Lack of Efficacy|0|||
129761568|NCT02903160|467089191|FG000|Overall Study|Adverse Event|2|||
129761569|NCT02903160|467089191|FG000|Overall Study|Death|1|||
129761570|NCT02903160|467089191|FG000|Overall Study|Lost to Follow-up|2|||
129761571|NCT02903160|467089191|FG000|Overall Study|Withdrawal by Subject|1|||
129761572|NCT02903160|467089191|FG000|Overall Study|Medical Insurance Barriers|1|||
129761573|NCT00730158|467089195|FG000|Overall Study|Withdrawal by Subject|1|||
129761574|NCT00730158|467089196|FG001|Overall Study|Withdrawal by Subject|1|||
129761575|NCT04678115|467089197|FG000|Overall Study|Lost to Follow-up|1|||
129761576|NCT04678115|467089198|FG001|Overall Study|Lost to Follow-up|0|||
129761577|NCT00844376|467089199|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
129761578|NCT00844376|467089200|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
129761579|NCT00660192|467089201|FG000|Overall Study|Lost to Follow-up|2|||
129761580|NCT00660192|467089202|FG001|Overall Study|Lost to Follow-up|3|||
129761581|NCT00982735|467089203|FG000|Overall Study|Lost to Follow-up|6|||
129761582|NCT00982735|467089203|FG000|Overall Study|Patient ineligible for trial|224|||
129761583|NCT01601535|467089206|FG000|Phase 1|Adverse Event|1|||
129761584|NCT01601535|467089207|FG001|Phase 1|Adverse Event|0|||
129761585|NCT01601535|467089208|FG002|Phase 1|Adverse Event|2|||
129761586|NCT01601535|467089209|FG003|Phase 1|Adverse Event|1|||
129761587|NCT01601535|467089210|FG004|Phase 1|Adverse Event|0|||
129761588|NCT01601535|467089211|FG005|Phase 1|Adverse Event|0|||
129761589|NCT01601535|467089206|FG000|Phase 1|Withdrawal by Subject|2|||
129761590|NCT01601535|467089207|FG001|Phase 1|Withdrawal by Subject|1|||
129761591|NCT01601535|467089208|FG002|Phase 1|Withdrawal by Subject|1|||
129761592|NCT01601535|467089209|FG003|Phase 1|Withdrawal by Subject|2|||
129761593|NCT01601535|467089210|FG004|Phase 1|Withdrawal by Subject|0|||
129761594|NCT01601535|467089211|FG005|Phase 1|Withdrawal by Subject|0|||
129761595|NCT01601535|467089206|FG000|Phase 1|Progressive Disease|2|||
129761596|NCT01601535|467089207|FG001|Phase 1|Progressive Disease|3|||
129761597|NCT01601535|467089208|FG002|Phase 1|Progressive Disease|2|||
129761598|NCT01601535|467089209|FG003|Phase 1|Progressive Disease|1|||
129761599|NCT01601535|467089210|FG004|Phase 1|Progressive Disease|0|||
129761600|NCT01601535|467089211|FG005|Phase 1|Progressive Disease|0|||
129761601|NCT01601535|467089206|FG000|Phase 1|Started Another Treatment|1|||
129761602|NCT01601535|467089207|FG001|Phase 1|Started Another Treatment|2|||
129761603|NCT01601535|467089208|FG002|Phase 1|Started Another Treatment|0|||
129761604|NCT01601535|467089209|FG003|Phase 1|Started Another Treatment|0|||
129650926|NCT02631070|466678554|FG001|Overall Study|Withdrawal by Subject|13|||
129650927|NCT02631070|466678553|FG000|Overall Study|Death|45|||
129650928|NCT02631070|466678554|FG001|Overall Study|Death|24|||
129650929|NCT02631070|466678553|FG000|Overall Study|Lost to Follow-up|5|||
129650930|NCT02631070|466678554|FG001|Overall Study|Lost to Follow-up|1|||
129761605|NCT01601535|467089210|FG004|Phase 1|Started Another Treatment|0|||
129761606|NCT01601535|467089211|FG005|Phase 1|Started Another Treatment|0|||
129650931|NCT02631070|466678553|FG000|Overall Study|Transition to rollover protocol|52|||
129650932|NCT02631070|466678554|FG001|Overall Study|Transition to rollover protocol|21|||
129650933|NCT02631070|466678553|FG000|Overall Study|Other reasons|12|||
129650934|NCT02631070|466678554|FG001|Overall Study|Other reasons|5|||
129650935|NCT00980018|466678560|FG000|Overall Study|Adverse Event|8|||
129650936|NCT00980018|466678560|FG000|Overall Study|Patient withdrew consent|3|||
129650937|NCT00980018|466678560|FG000|Overall Study|Lost to Follow-up|1|||
129650938|NCT00087126|466678561|FG000|Overall Study|Ineligible - second primary|1|||
129650939|NCT00087126|466678561|FG000|Overall Study|Never treated|1|||
129650940|NCT01832818|466678562|FG000|Overall Study|Lost to Follow-up|6|||
129650941|NCT00934856|466678565|FG000|Feasibility Part|Progressive disease|4|||
129650942|NCT00934856|466678566|FG001|Feasibility Part|Progressive disease|4|||
129650943|NCT00934856|466678567|FG002|Feasibility Part|Progressive disease|2|||
129650944|NCT00934856|466678568|FG003|Feasibility Part|Progressive disease|3|||
129650945|NCT00934856|466678569|FG004|Feasibility Part|Progressive disease|0|||
129650946|NCT00934856|466678570|FG005|Feasibility Part|Progressive disease|0|||
129650947|NCT00934856|466678565|FG000|Feasibility Part|Physician Decision|0|||
129650948|NCT00934856|466678566|FG001|Feasibility Part|Physician Decision|0|||
129650949|NCT00934856|466678567|FG002|Feasibility Part|Physician Decision|1|||
129650950|NCT00934856|466678568|FG003|Feasibility Part|Physician Decision|0|||
129650951|NCT00934856|466678569|FG004|Feasibility Part|Physician Decision|0|||
129650952|NCT00934856|466678570|FG005|Feasibility Part|Physician Decision|0|||
129650953|NCT00934856|466678565|FG000|Feasibility Part|Adverse Event|1|||
129650954|NCT00934856|466678566|FG001|Feasibility Part|Adverse Event|1|||
129650955|NCT00934856|466678567|FG002|Feasibility Part|Adverse Event|0|||
129650956|NCT00934856|466678568|FG003|Feasibility Part|Adverse Event|1|||
129650957|NCT00934856|466678569|FG004|Feasibility Part|Adverse Event|0|||
129650958|NCT00934856|466678570|FG005|Feasibility Part|Adverse Event|2|||
129650959|NCT00934856|466678565|FG000|Feasibility Part|Withdrawal by Subject|0|||
129650960|NCT00934856|466678566|FG001|Feasibility Part|Withdrawal by Subject|0|||
129650961|NCT00934856|466678567|FG002|Feasibility Part|Withdrawal by Subject|0|||
129650962|NCT00934856|466678568|FG003|Feasibility Part|Withdrawal by Subject|1|||
129650963|NCT00934856|466678569|FG004|Feasibility Part|Withdrawal by Subject|0|||
129650964|NCT00934856|466678570|FG005|Feasibility Part|Withdrawal by Subject|1|||
129650965|NCT00934856|466678565|FG000|Extension Part|Adverse Event|0|||
129650966|NCT00934856|466678566|FG001|Extension Part|Adverse Event|0|||
129650967|NCT00934856|466678567|FG002|Extension Part|Adverse Event|0|||
129650968|NCT00934856|466678568|FG003|Extension Part|Adverse Event|1|||
129650969|NCT00934856|466678569|FG004|Extension Part|Adverse Event|4|||
129650970|NCT00934856|466678570|FG005|Extension Part|Adverse Event|4|||
129650971|NCT00934856|466678565|FG000|Extension Part|Progressive disease|0|||
129650972|NCT00934856|466678566|FG001|Extension Part|Progressive disease|0|||
129650973|NCT00934856|466678567|FG002|Extension Part|Progressive disease|0|||
129983995|NCT01489891|467903824|FG000|Overall Study|Endoscopy failure|1|||
129650974|NCT00934856|466678568|FG003|Extension Part|Progressive disease|1|||
129650975|NCT00934856|466678569|FG004|Extension Part|Progressive disease|0|||
129650976|NCT00934856|466678570|FG005|Extension Part|Progressive disease|0|||
129650977|NCT00934856|466678565|FG000|Extension Part|Non-compliance with drug|0|||
129761607|NCT01601535|467089206|FG000|Phase 2|Adverse Event|0|||
129650978|NCT00934856|466678566|FG001|Extension Part|Non-compliance with drug|0|||
129650979|NCT00934856|466678567|FG002|Extension Part|Non-compliance with drug|0|||
129650980|NCT00934856|466678568|FG003|Extension Part|Non-compliance with drug|0|||
129650981|NCT00934856|466678569|FG004|Extension Part|Non-compliance with drug|0|||
129650982|NCT00934856|466678570|FG005|Extension Part|Non-compliance with drug|1|||
129650983|NCT01256385|466678571|FG000|Overall Study|Physician Decision|1|||
129650984|NCT01256385|466678572|FG001|Overall Study|Physician Decision|1|||
129650985|NCT01256385|466678571|FG000|Overall Study|Withdrawal by Subject|2|||
129650986|NCT01256385|466678572|FG001|Overall Study|Withdrawal by Subject|2|||
129650987|NCT00401960|466678575|FG000|Overall Study|Lost to Follow-up|3|||
129650988|NCT00401960|466678576|FG001|Overall Study|Lost to Follow-up|0|||
129650989|NCT00401960|466678575|FG000|Overall Study|Death|2|||
129650990|NCT00401960|466678576|FG001|Overall Study|Death|0|||
129650991|NCT02649426|466678577|FG000|Overall Study|Follow-up on going|1|||
129650992|NCT02649426|466678578|FG001|Overall Study|Follow-up on going|26|||
129650993|NCT02649426|466678579|FG002|Overall Study|Follow-up on going|28|||
129650994|NCT02649426|466678580|FG003|Overall Study|Follow-up on going|31|||
129650995|NCT01606202|466678581|FG000|Overall Study|Adverse Event|5|||
129650996|NCT01606202|466678582|FG001|Overall Study|Adverse Event|0|||
129650997|NCT01606202|466678581|FG000|Overall Study|Withdrawal by Subject|2|||
129650998|NCT01606202|466678582|FG001|Overall Study|Withdrawal by Subject|1|||
129650999|NCT01606202|466678581|FG000|Overall Study|Personal problems|0|||
129651000|NCT01606202|466678582|FG001|Overall Study|Personal problems|1|||
129651001|NCT01606202|466678581|FG000|Overall Study|Problems with administration|0|||
129651002|NCT01606202|466678582|FG001|Overall Study|Problems with administration|1|||
129651003|NCT02584959|466678583|FG000|Period 1|Withdrawn from study|3|||
129651004|NCT02584959|466678584|FG001|Period 1|Withdrawn from study|4|||
129761608|NCT01601535|467089207|FG001|Phase 2|Adverse Event|0|||
129761609|NCT01601535|467089208|FG002|Phase 2|Adverse Event|0|||
129761610|NCT01601535|467089209|FG003|Phase 2|Adverse Event|0|||
129761611|NCT01601535|467089210|FG004|Phase 2|Adverse Event|5|||
129761612|NCT01601535|467089211|FG005|Phase 2|Adverse Event|1|||
129761613|NCT01601535|467089206|FG000|Phase 2|Withdrawal by Subject|0|||
129761614|NCT01601535|467089207|FG001|Phase 2|Withdrawal by Subject|0|||
129761615|NCT01601535|467089208|FG002|Phase 2|Withdrawal by Subject|0|||
129761616|NCT01601535|467089209|FG003|Phase 2|Withdrawal by Subject|0|||
129761617|NCT01601535|467089210|FG004|Phase 2|Withdrawal by Subject|8|||
129761618|NCT01601535|467089211|FG005|Phase 2|Withdrawal by Subject|2|||
129761619|NCT01601535|467089206|FG000|Phase 2|Progressive Disease|0|||
129761620|NCT01601535|467089207|FG001|Phase 2|Progressive Disease|0|||
129761621|NCT01601535|467089208|FG002|Phase 2|Progressive Disease|0|||
129761622|NCT01601535|467089209|FG003|Phase 2|Progressive Disease|0|||
129761623|NCT01601535|467089210|FG004|Phase 2|Progressive Disease|5|||
129761624|NCT01601535|467089211|FG005|Phase 2|Progressive Disease|7|||
129761625|NCT01601535|467089206|FG000|Phase 2|Started Another Treatment|0|||
129761626|NCT01601535|467089207|FG001|Phase 2|Started Another Treatment|0|||
129761627|NCT01601535|467089208|FG002|Phase 2|Started Another Treatment|0|||
129761628|NCT01601535|467089209|FG003|Phase 2|Started Another Treatment|0|||
129761629|NCT01601535|467089210|FG004|Phase 2|Started Another Treatment|1|||
129761630|NCT01601535|467089211|FG005|Phase 2|Started Another Treatment|2|||
129761631|NCT01787461|467089214|FG000|Overall Study|Adverse Event|4|||
129761632|NCT01787461|467089215|FG001|Overall Study|Adverse Event|3|||
129761633|NCT01787461|467089214|FG000|Overall Study|Lost to Follow-up|3|||
129761634|NCT01787461|467089215|FG001|Overall Study|Lost to Follow-up|2|||
129761635|NCT01787461|467089214|FG000|Overall Study|No longer met eligibility criteria|1|||
129761636|NCT01787461|467089215|FG001|Overall Study|No longer met eligibility criteria|0|||
129761637|NCT01787461|467089214|FG000|Overall Study|Withdrawal by Subject|3|||
129761638|NCT01787461|467089215|FG001|Overall Study|Withdrawal by Subject|4|||
129761639|NCT01787461|467089214|FG000|Overall Study|Protocol Violation|3|||
129761640|NCT01787461|467089215|FG001|Overall Study|Protocol Violation|0|||
129761641|NCT04879628|467089216|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
129761642|NCT04879628|467089217|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
129761643|NCT04879628|467089218|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
129761644|NCT04879628|467089219|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
129761645|NCT04879628|467089216|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
129761646|NCT04879628|467089217|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
129761647|NCT04879628|467089218|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
129761648|NCT04879628|467089219|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
129761649|NCT04879628|467089216|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
129761650|NCT04879628|467089217|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
129443564|NCT04147234|465924423|FG005|Overall Study|Adverse Event|0|||
129761651|NCT04879628|467089218|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
129761652|NCT04879628|467089219|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
129651005|NCT02584959|466678585|FG002|Period 1|Withdrawn from study|0|||
129651006|NCT02584959|466678583|FG000|Period 2|Withdrawn from study|6|||
129761653|NCT04879628|467089216|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
129761654|NCT04879628|467089217|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
129761655|NCT04879628|467089218|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
129761656|NCT04879628|467089219|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
129761657|NCT03649074|467089220|FG000|Overall Study|Lost to Follow-up|2|||
129761658|NCT03649074|467089221|FG001|Overall Study|Lost to Follow-up|1|||
129761659|NCT03649074|467089220|FG000|Overall Study|Adverse Event|1|||
129761660|NCT03649074|467089221|FG001|Overall Study|Adverse Event|0|||
129761661|NCT03649074|467089220|FG000|Overall Study|Physician Decision|1|||
129761662|NCT03649074|467089221|FG001|Overall Study|Physician Decision|0|||
129761663|NCT03649074|467089220|FG000|Overall Study|Withdrawal by Subject|0|||
129761664|NCT03649074|467089221|FG001|Overall Study|Withdrawal by Subject|2|||
129761665|NCT03649074|467089220|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
129761666|NCT03649074|467089221|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
129761667|NCT03649074|467089220|FG000|Overall Study|Other|1|||
129761668|NCT03649074|467089221|FG001|Overall Study|Other|0|||
129761669|NCT00556894|467089222|FG000|Overall Study|Adverse Event|2|||
129761670|NCT00556894|467089223|FG001|Overall Study|Adverse Event|3|||
129761671|NCT00556894|467089224|FG002|Overall Study|Adverse Event|3|||
129761672|NCT00556894|467089222|FG000|Overall Study|Death|1|||
129761673|NCT00556894|467089223|FG001|Overall Study|Death|0|||
129761674|NCT00556894|467089224|FG002|Overall Study|Death|0|||
129761675|NCT00556894|467089222|FG000|Overall Study|regulatory decision in Bulgaria|10|||
129761676|NCT00556894|467089223|FG001|Overall Study|regulatory decision in Bulgaria|14|||
129761677|NCT00556894|467089224|FG002|Overall Study|regulatory decision in Bulgaria|13|||
129761678|NCT00556894|467089222|FG000|Overall Study|Change in therapy|2|||
129761679|NCT00556894|467089223|FG001|Overall Study|Change in therapy|1|||
129761680|NCT00556894|467089224|FG002|Overall Study|Change in therapy|2|||
129761681|NCT00556894|467089222|FG000|Overall Study|Withdrawal by Subject|1|||
129761682|NCT00556894|467089223|FG001|Overall Study|Withdrawal by Subject|1|||
129761683|NCT00556894|467089224|FG002|Overall Study|Withdrawal by Subject|1|||
129761684|NCT04612725|467089227|FG000|Overall Study|Adverse Event|1|||
129761685|NCT04612725|467089228|FG001|Overall Study|Adverse Event|3|||
129761686|NCT04612725|467089229|FG002|Overall Study|Adverse Event|1|||
129761687|NCT04612725|467089230|FG003|Overall Study|Adverse Event|0|||
129761688|NCT04612725|467089231|FG004|Overall Study|Adverse Event|1|||
129761689|NCT04612725|467089227|FG000|Overall Study|Lost to Follow-up|0|||
129761690|NCT04612725|467089228|FG001|Overall Study|Lost to Follow-up|1|||
129761691|NCT04612725|467089229|FG002|Overall Study|Lost to Follow-up|0|||
129761692|NCT04612725|467089230|FG003|Overall Study|Lost to Follow-up|0|||
129761693|NCT04612725|467089231|FG004|Overall Study|Lost to Follow-up|0|||
129761694|NCT04612725|467089227|FG000|Overall Study|Physician Decision|2|||
129761695|NCT04612725|467089228|FG001|Overall Study|Physician Decision|0|||
129761696|NCT04612725|467089229|FG002|Overall Study|Physician Decision|0|||
129761697|NCT04612725|467089230|FG003|Overall Study|Physician Decision|0|||
129761698|NCT04612725|467089231|FG004|Overall Study|Physician Decision|0|||
129761699|NCT04612725|467089227|FG000|Overall Study|Study terminated by sponsor|3|||
129761700|NCT04612725|467089228|FG001|Overall Study|Study terminated by sponsor|1|||
129761701|NCT04612725|467089229|FG002|Overall Study|Study terminated by sponsor|2|||
129761702|NCT04612725|467089230|FG003|Overall Study|Study terminated by sponsor|4|||
129761703|NCT04612725|467089231|FG004|Overall Study|Study terminated by sponsor|5|||
129761704|NCT04612725|467089227|FG000|Overall Study|Withdrawal by Subject|8|||
129761705|NCT04612725|467089228|FG001|Overall Study|Withdrawal by Subject|3|||
129761706|NCT04612725|467089229|FG002|Overall Study|Withdrawal by Subject|5|||
129761707|NCT04612725|467089230|FG003|Overall Study|Withdrawal by Subject|1|||
129761708|NCT04612725|467089231|FG004|Overall Study|Withdrawal by Subject|9|||
129761709|NCT04612725|467089227|FG000|Overall Study|Other|0|||
129761710|NCT04612725|467089228|FG001|Overall Study|Other|0|||
129761711|NCT04612725|467089229|FG002|Overall Study|Other|0|||
129761712|NCT04612725|467089230|FG003|Overall Study|Other|0|||
129761713|NCT04612725|467089231|FG004|Overall Study|Other|1|||
129651007|NCT02584959|466678584|FG001|Period 2|Withdrawn from study|1|||
129651008|NCT02584959|466678585|FG002|Period 2|Withdrawn from study|2|||
129761714|NCT04875195|467089232|FG000|Overall Study|Death|9|||
129761715|NCT04875195|467089233|FG001|Overall Study|Death|3|||
129761716|NCT04875195|467089232|FG000|Overall Study|Withdrawal by Subject|2|||
129539359|NCT00198107|466266850|FG002|Double-Blind Period|Adverse Event|0|||
129761717|NCT04875195|467089233|FG001|Overall Study|Withdrawal by Subject|1|||
129761718|NCT04875195|467089232|FG000|Overall Study|Ongoing in study|49|||
129761719|NCT04875195|467089233|FG001|Overall Study|Ongoing in study|2|||
129761720|NCT05190120|467089234|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
129761721|NCT05190120|467089235|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
129761722|NCT05190120|467089236|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
129761723|NCT05190120|467089237|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
129761724|NCT05190120|467089234|FG000|Overall Study|Lost to Follow-up|5|||
129761725|NCT05190120|467089235|FG001|Overall Study|Lost to Follow-up|0|||
129761726|NCT05190120|467089236|FG002|Overall Study|Lost to Follow-up|2|||
129761727|NCT05190120|467089237|FG003|Overall Study|Lost to Follow-up|3|||
129761728|NCT02354235|467089238|FG000|Overall Study|Adverse Event|2|||
129761729|NCT02354235|467089239|FG001|Overall Study|Adverse Event|2|||
129761730|NCT02354235|467089238|FG000|Overall Study|Physician Decision|0|||
129761731|NCT02354235|467089239|FG001|Overall Study|Physician Decision|1|||
129761732|NCT02354235|467089238|FG000|Overall Study|Withdrawal by Subject|1|||
129761733|NCT02354235|467089239|FG001|Overall Study|Withdrawal by Subject|3|||
129761734|NCT02354235|467089238|FG000|Overall Study|Conflict with the stopping criteria|0|||
129761735|NCT02354235|467089239|FG001|Overall Study|Conflict with the stopping criteria|1|||
129761736|NCT03069352|467089240|FG000|Overall Study|Ongoing|12|||
129761737|NCT03069352|467089241|FG001|Overall Study|Ongoing|40|||
129761738|NCT02621424|467089242|FG000|Overall Study|Withdrawal by Subject|1|||
129761739|NCT02621424|467089243|FG001|Overall Study|Withdrawal by Subject|2|||
129761740|NCT04750642|467089246|FG000|Overall Study|Adverse Event|1|||
129761741|NCT04750642|467089247|FG001|Overall Study|Adverse Event|0|||
129761742|NCT04750642|467089246|FG000|Overall Study|Withdrawal by Subject|0|||
129761743|NCT04750642|467089247|FG001|Overall Study|Withdrawal by Subject|1|||
129761744|NCT04750642|467089246|FG000|Overall Study|Protocol Violation|0|||
129761745|NCT04750642|467089247|FG001|Overall Study|Protocol Violation|1|||
129761746|NCT00336024|467089249|FG000|Overall Study|Death|2|||
129761747|NCT00336024|467089250|FG001|Overall Study|Death|1|||
129761748|NCT00336024|467089249|FG000|Overall Study|Physician Decision|4|||
129761749|NCT00336024|467089250|FG001|Overall Study|Physician Decision|1|||
129761750|NCT00336024|467089249|FG000|Overall Study|Protocol Violation|1|||
129761751|NCT00336024|467089250|FG001|Overall Study|Protocol Violation|0|||
129761752|NCT00336024|467089249|FG000|Overall Study|Withdrawal by Subject|1|||
129761753|NCT00336024|467089250|FG001|Overall Study|Withdrawal by Subject|2|||
129761754|NCT00336024|467089249|FG000|Overall Study|Failure to fulfill consolidation|1|||
129761755|NCT00336024|467089250|FG001|Overall Study|Failure to fulfill consolidation|1|||
129761756|NCT00336024|467089249|FG000|Overall Study|Progressive Disease|4|||
129761757|NCT00336024|467089250|FG001|Overall Study|Progressive Disease|7|||
129761758|NCT00336024|467089249|FG000|Overall Study|Ineligible|7|||
129761759|NCT00336024|467089250|FG001|Overall Study|Ineligible|7|||
129800163|NCT00925990|467236213|FG001|Overall Study|Lost to Follow-up|3|||
129800164|NCT00925990|467236212|FG000|Overall Study|Physician Decision|1|||
129800165|NCT00925990|467236213|FG001|Overall Study|Physician Decision|1|||
129983996|NCT01489891|467903825|FG001|Overall Study|Endoscopy failure|0|||
129983997|NCT00998790|467903826|FG000|Overall Study|Withdrawal by Subject|21|||
129983998|NCT03001076|467903827|FG000|Overall Study|Withdrawal by patient|2|||
129983999|NCT03001076|467903828|FG001|Overall Study|Withdrawal by patient|0|||
129800166|NCT00925990|467236212|FG000|Overall Study|moved out of state, missed medication|0|||
129800167|NCT00925990|467236213|FG001|Overall Study|moved out of state, missed medication|2|||
129800168|NCT00737438|467236216|FG000|Overall Study|Withdrawal by Subject|2|||
129800169|NCT00737438|467236216|FG000|Overall Study|Patient ineligible|1|||
129800170|NCT04950166|467236223|FG000|Overall Study|Withdrawal by Subject|1|||
129800171|NCT00857415|467236224|FG000|Overall Study|Image acquisition failure|2|||
129800172|NCT00857415|467236225|FG001|Overall Study|Image acquisition failure|0|||
129800173|NCT00857415|467236224|FG000|Overall Study|Invalid image or not imaged|3|||
129800174|NCT00857415|467236225|FG001|Overall Study|Invalid image or not imaged|0|||
129800175|NCT00857415|467236224|FG000|Overall Study|Subject still living at end of study|110|||
129800176|NCT00857415|467236225|FG001|Overall Study|Subject still living at end of study|0|||
129800177|NCT00857415|467236224|FG000|Overall Study|Deceased with no autopsy|2|||
129800178|NCT00857415|467236225|FG001|Overall Study|Deceased with no autopsy|0|||
129800179|NCT01822678|467236230|FG000|Overall Study|Withdrawal by Subject|5|||
129800180|NCT01822678|467236231|FG001|Overall Study|Withdrawal by Subject|4|||
129800181|NCT01822678|467236232|FG002|Overall Study|Withdrawal by Subject|4|||
129800182|NCT01822678|467236230|FG000|Overall Study|Adverse Event|4|||
129800183|NCT01822678|467236231|FG001|Overall Study|Adverse Event|3|||
129800184|NCT01822678|467236232|FG002|Overall Study|Adverse Event|1|||
129651009|NCT00195494|466678590|FG000|Year 1|Adverse Event|0|||
129800185|NCT01822678|467236230|FG000|Overall Study|Lack of Efficacy|3|||
129800186|NCT01822678|467236231|FG001|Overall Study|Lack of Efficacy|6|||
129800187|NCT01822678|467236232|FG002|Overall Study|Lack of Efficacy|5|||
129800188|NCT01822678|467236230|FG000|Overall Study|Lost to Follow-up|0|||
129800189|NCT01822678|467236231|FG001|Overall Study|Lost to Follow-up|2|||
129800190|NCT01822678|467236232|FG002|Overall Study|Lost to Follow-up|1|||
129800191|NCT00764504|467236233|FG000|Overall Study|Death|12|||
129800192|NCT00764504|467236234|FG001|Overall Study|Death|6|||
129800193|NCT00764504|467236235|FG002|Overall Study|Death|13|||
129800194|NCT00764504|467236233|FG000|Overall Study|Revision of Device|12|||
129800195|NCT00764504|467236234|FG001|Overall Study|Revision of Device|23|||
129800196|NCT00764504|467236235|FG002|Overall Study|Revision of Device|14|||
129800197|NCT00764504|467236233|FG000|Overall Study|Physician Decision|1|||
129800198|NCT00764504|467236234|FG001|Overall Study|Physician Decision|0|||
129800199|NCT00764504|467236235|FG002|Overall Study|Physician Decision|0|||
129800200|NCT00764504|467236233|FG000|Overall Study|Withdrawal by Subject|1|||
129800201|NCT00764504|467236234|FG001|Overall Study|Withdrawal by Subject|7|||
129984000|NCT03001076|467903827|FG000|Overall Study|Other|1|||
129761760|NCT00644423|467091271|FG000|Overall Study|Lost to Follow-up|1|||
129761761|NCT00644423|467091272|FG001|Overall Study|Lost to Follow-up|1|||
129761762|NCT01519323|467091277|FG000|Overall Study|Death|3|||
129761763|NCT01519323|467091278|FG001|Overall Study|Death|2|||
129761764|NCT01519323|467091277|FG000|Overall Study|Study terminated by sponsor|0|||
129761765|NCT01519323|467091278|FG001|Overall Study|Study terminated by sponsor|1|||
129761766|NCT03096834|467091289|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
129761767|NCT03096834|467091290|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
129761768|NCT03096834|467091291|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
129761769|NCT03096834|467091292|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
129761770|NCT03096834|467091289|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
129761771|NCT03096834|467091290|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
129761772|NCT03096834|467091291|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
129761773|NCT03096834|467091292|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
129761774|NCT03096834|467091289|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
129761775|NCT03096834|467091290|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
129761776|NCT03096834|467091291|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
129761777|NCT03096834|467091292|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
129761778|NCT03096834|467091289|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
129761779|NCT03096834|467091290|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
129761780|NCT03096834|467091291|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
129761781|NCT03096834|467091292|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
129761782|NCT03096834|467091289|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
129761783|NCT03096834|467091290|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
129761784|NCT03096834|467091291|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
129761785|NCT03096834|467091292|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
129761786|NCT03096834|467091289|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
129761787|NCT03096834|467091290|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
129761788|NCT03096834|467091291|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
129761789|NCT03096834|467091292|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
129761790|NCT03096834|467091289|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
129761791|NCT03096834|467091290|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
129761792|NCT03096834|467091291|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
129761793|NCT03096834|467091292|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
129761794|NCT03096834|467091289|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
129761795|NCT03096834|467091290|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
129761796|NCT03096834|467091291|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
129761797|NCT03096834|467091292|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
129761798|NCT03096834|467091289|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
129761799|NCT03096834|467091290|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
129761800|NCT03096834|467091291|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
129761801|NCT03096834|467091292|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
129761802|NCT03096834|467091289|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
129761803|NCT03096834|467091290|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
129761804|NCT03096834|467091291|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
129761805|NCT03096834|467091292|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
129761806|NCT03096834|467091289|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
129761807|NCT03096834|467091290|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
129761808|NCT03096834|467091291|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
129761809|NCT03096834|467091292|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
129761810|NCT03096834|467091289|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
129761811|NCT03096834|467091290|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
129761812|NCT03096834|467091291|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
129761813|NCT03096834|467091292|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
129761814|NCT04416204|467091293|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
129761815|NCT04416204|467091294|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
129761816|NCT04416204|467091295|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
129761817|NCT04416204|467091296|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
129761818|NCT04456504|467091297|FG000|Overall Study|Lost to Follow-up|2|||
129761819|NCT01131507|467091298|FG000|Overall Study|Adverse Event|1|||
129761820|NCT01131507|467091298|FG000|Overall Study|Lost to Follow-up|1|||
129761821|NCT01131507|467091298|FG000|Overall Study|Withdrawal by Subject|1|||
129761822|NCT01393158|467091307|FG000|Overall Study|Adverse Event|1|||
129761823|NCT01393158|467091308|FG001|Overall Study|Adverse Event|0|||
129761824|NCT00762359|467091309|FG000|Overall Study|Adverse Event|20|||
129761825|NCT00762359|467091310|FG001|Overall Study|Adverse Event|23|||
129761826|NCT00762359|467091309|FG000|Overall Study|Protocol Violation|21|||
129761827|NCT00762359|467091310|FG001|Overall Study|Protocol Violation|13|||
129761828|NCT00762359|467091309|FG000|Overall Study|Withdrawal by Subject|13|||
129761829|NCT00762359|467091310|FG001|Overall Study|Withdrawal by Subject|10|||
129761830|NCT00762359|467091309|FG000|Overall Study|Lack of Efficacy|0|||
129761831|NCT00762359|467091310|FG001|Overall Study|Lack of Efficacy|4|||
129761832|NCT00762359|467091309|FG000|Overall Study|Institution closed|2|||
129651010|NCT00195494|466678591|FG001|Year 1|Adverse Event|0|||
129761833|NCT00762359|467091310|FG001|Overall Study|Institution closed|3|||
129761834|NCT00762359|467091309|FG000|Overall Study|Physician Decision|2|||
129761835|NCT00762359|467091310|FG001|Overall Study|Physician Decision|3|||
129761836|NCT00762359|467091309|FG000|Overall Study|Removal|0|||
129761837|NCT00762359|467091310|FG001|Overall Study|Removal|1|||
129761838|NCT00762359|467091309|FG000|Overall Study|Withdrew consent|1|||
129761839|NCT00762359|467091310|FG001|Overall Study|Withdrew consent|0|||
129761840|NCT01453049|467091311|FG000|Overall Study|Protocol Violation|2|||
129761841|NCT01453049|467091312|FG001|Overall Study|Protocol Violation|5|||
129761842|NCT01453049|467091311|FG000|Overall Study|Lost to Follow-up|2|||
129761843|NCT01453049|467091312|FG001|Overall Study|Lost to Follow-up|1|||
129761844|NCT01453049|467091311|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
129761845|NCT01453049|467091312|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
129761846|NCT01453049|467091311|FG000|Overall Study|Withdrawal by Subject|1|||
129761847|NCT01453049|467091312|FG001|Overall Study|Withdrawal by Subject|0|||
129761848|NCT01453049|467091311|FG000|Overall Study|Randomized in Error|1|||
129761849|NCT01453049|467091312|FG001|Overall Study|Randomized in Error|0|||
129761850|NCT01451723|467091314|FG000|Overall Study|study halted|6|||
129761851|NCT01451723|467091315|FG001|Overall Study|study halted|5|||
129651011|NCT00195494|466678592|FG002|Year 1|Adverse Event|0|||
129651012|NCT00195494|466678593|FG003|Year 1|Adverse Event|0|||
129651013|NCT00195494|466678594|FG004|Year 1|Adverse Event|34|||
129651014|NCT00195494|466678595|FG005|Year 1|Adverse Event|27|||
129651015|NCT00195494|466678590|FG000|Year 1|System Toxicity|0|||
129651016|NCT00195494|466678591|FG001|Year 1|System Toxicity|0|||
129651017|NCT00195494|466678592|FG002|Year 1|System Toxicity|0|||
129651018|NCT00195494|466678593|FG003|Year 1|System Toxicity|0|||
129651019|NCT00195494|466678594|FG004|Year 1|System Toxicity|0|||
129651020|NCT00195494|466678595|FG005|Year 1|System Toxicity|1|||
129651021|NCT00195494|466678590|FG000|Year 1|Lack of Efficacy|0|||
129651022|NCT00195494|466678591|FG001|Year 1|Lack of Efficacy|0|||
129651023|NCT00195494|466678592|FG002|Year 1|Lack of Efficacy|0|||
129651024|NCT00195494|466678593|FG003|Year 1|Lack of Efficacy|0|||
129651025|NCT00195494|466678594|FG004|Year 1|Lack of Efficacy|24|||
129651026|NCT00195494|466678595|FG005|Year 1|Lack of Efficacy|9|||
129651027|NCT00195494|466678590|FG000|Year 1|Compliance|0|||
129651028|NCT00195494|466678591|FG001|Year 1|Compliance|0|||
129651029|NCT00195494|466678592|FG002|Year 1|Compliance|0|||
129651030|NCT00195494|466678593|FG003|Year 1|Compliance|0|||
129651031|NCT00195494|466678594|FG004|Year 1|Compliance|5|||
129651032|NCT00195494|466678595|FG005|Year 1|Compliance|1|||
129651033|NCT00195494|466678590|FG000|Year 1|Lost to Follow-up|0|||
129651034|NCT00195494|466678591|FG001|Year 1|Lost to Follow-up|0|||
129651035|NCT00195494|466678592|FG002|Year 1|Lost to Follow-up|0|||
129651036|NCT00195494|466678593|FG003|Year 1|Lost to Follow-up|0|||
129651037|NCT00195494|466678594|FG004|Year 1|Lost to Follow-up|1|||
129651038|NCT00195494|466678595|FG005|Year 1|Lost to Follow-up|0|||
129651039|NCT00195494|466678590|FG000|Year 1|Missed >4 consecutive doses|0|||
129651040|NCT00195494|466678591|FG001|Year 1|Missed >4 consecutive doses|0|||
129651041|NCT00195494|466678592|FG002|Year 1|Missed >4 consecutive doses|0|||
129651042|NCT00195494|466678593|FG003|Year 1|Missed >4 consecutive doses|0|||
129651043|NCT00195494|466678594|FG004|Year 1|Missed >4 consecutive doses|3|||
129651044|NCT00195494|466678595|FG005|Year 1|Missed >4 consecutive doses|2|||
129651045|NCT00195494|466678590|FG000|Year 1|Protocol deviation|0|||
129651046|NCT00195494|466678591|FG001|Year 1|Protocol deviation|0|||
129651047|NCT00195494|466678592|FG002|Year 1|Protocol deviation|0|||
129651048|NCT00195494|466678593|FG003|Year 1|Protocol deviation|0|||
129651049|NCT00195494|466678594|FG004|Year 1|Protocol deviation|2|||
129651050|NCT00195494|466678595|FG005|Year 1|Protocol deviation|3|||
129651051|NCT00195494|466678590|FG000|Year 1|Physician Decision|0|||
129651052|NCT00195494|466678591|FG001|Year 1|Physician Decision|0|||
129651053|NCT00195494|466678592|FG002|Year 1|Physician Decision|0|||
129651054|NCT00195494|466678593|FG003|Year 1|Physician Decision|0|||
129651055|NCT00195494|466678594|FG004|Year 1|Physician Decision|1|||
129651056|NCT00195494|466678595|FG005|Year 1|Physician Decision|0|||
129651057|NCT00195494|466678590|FG000|Year 1|Withdrawal by Subject|0|||
129651058|NCT00195494|466678591|FG001|Year 1|Withdrawal by Subject|0|||
129651059|NCT00195494|466678592|FG002|Year 1|Withdrawal by Subject|0|||
129651060|NCT00195494|466678593|FG003|Year 1|Withdrawal by Subject|0|||
129651061|NCT00195494|466678594|FG004|Year 1|Withdrawal by Subject|8|||
129651062|NCT00195494|466678595|FG005|Year 1|Withdrawal by Subject|9|||
129651063|NCT00195494|466678590|FG000|Year 1|Protocol Violation|0|||
129651064|NCT00195494|466678591|FG001|Year 1|Protocol Violation|0|||
129651065|NCT00195494|466678592|FG002|Year 1|Protocol Violation|0|||
129651066|NCT00195494|466678593|FG003|Year 1|Protocol Violation|0|||
129651067|NCT00195494|466678594|FG004|Year 1|Protocol Violation|1|||
129651068|NCT00195494|466678595|FG005|Year 1|Protocol Violation|1|||
129651069|NCT00195494|466678590|FG000|Year 2|Adverse Event|3|||
129651070|NCT00195494|466678591|FG001|Year 2|Adverse Event|7|||
129651071|NCT00195494|466678592|FG002|Year 2|Adverse Event|5|||
129651072|NCT00195494|466678593|FG003|Year 2|Adverse Event|9|||
129651073|NCT00195494|466678594|FG004|Year 2|Adverse Event|0|||
129651074|NCT00195494|466678595|FG005|Year 2|Adverse Event|0|||
129651075|NCT00195494|466678590|FG000|Year 2|Lack of Efficacy|0|||
129872987|NCT00766675|467494090|FG000|Overall Study|Adverse Event|16|||
129872988|NCT00766675|467494090|FG000|Overall Study|Lost to Follow-up|2|||
129872989|NCT00766675|467494090|FG000|Overall Study|Withdrawal by Subject|11|||
129872990|NCT00766675|467494090|FG000|Overall Study|Protocol Violation|8|||
129872991|NCT00766675|467494090|FG000|Overall Study|Participant took prohibited medication|1|||
129872992|NCT00766675|467494090|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
129872993|NCT00766675|467494090|FG000|Overall Study|Insufficient therapy|1|||
129872994|NCT01984697|467494091|FG000|Overall Study|Adverse Event|0|||
129872995|NCT01984697|467494092|FG001|Overall Study|Adverse Event|0|||
129872996|NCT01984697|467494093|FG002|Overall Study|Adverse Event|2|||
129872997|NCT01984697|467494094|FG003|Overall Study|Adverse Event|0|||
129872998|NCT01984697|467494095|FG004|Overall Study|Adverse Event|0|||
129872999|NCT01984697|467494091|FG000|Overall Study|Lost to Follow-up|14|||
129873000|NCT01984697|467494092|FG001|Overall Study|Lost to Follow-up|5|||
129873001|NCT01984697|467494093|FG002|Overall Study|Lost to Follow-up|10|||
129873002|NCT01984697|467494094|FG003|Overall Study|Lost to Follow-up|6|||
129873003|NCT01984697|467494095|FG004|Overall Study|Lost to Follow-up|21|||
129873004|NCT01984697|467494091|FG000|Overall Study|Physician Decision|3|||
129873005|NCT01984697|467494092|FG001|Overall Study|Physician Decision|0|||
129873006|NCT01984697|467494093|FG002|Overall Study|Physician Decision|0|||
129873007|NCT01984697|467494094|FG003|Overall Study|Physician Decision|1|||
129873008|NCT01984697|467494095|FG004|Overall Study|Physician Decision|0|||
129873009|NCT01984697|467494091|FG000|Overall Study|Protocol Violation|8|||
129873010|NCT01984697|467494092|FG001|Overall Study|Protocol Violation|5|||
129873011|NCT01984697|467494093|FG002|Overall Study|Protocol Violation|3|||
129873012|NCT01984697|467494094|FG003|Overall Study|Protocol Violation|2|||
129873013|NCT01984697|467494095|FG004|Overall Study|Protocol Violation|0|||
129873014|NCT01984697|467494091|FG000|Overall Study|Withdrawal by Subject|15|||
129873015|NCT01984697|467494092|FG001|Overall Study|Withdrawal by Subject|21|||
129873016|NCT01984697|467494093|FG002|Overall Study|Withdrawal by Subject|13|||
129873017|NCT01984697|467494094|FG003|Overall Study|Withdrawal by Subject|11|||
129873018|NCT01984697|467494095|FG004|Overall Study|Withdrawal by Subject|13|||
129873019|NCT01984697|467494091|FG000|Overall Study|Missed last follow-up visit|1|||
129873020|NCT01984697|467494092|FG001|Overall Study|Missed last follow-up visit|0|||
129873021|NCT01984697|467494093|FG002|Overall Study|Missed last follow-up visit|0|||
129873022|NCT01984697|467494094|FG003|Overall Study|Missed last follow-up visit|0|||
129873023|NCT01984697|467494095|FG004|Overall Study|Missed last follow-up visit|0|||
129873024|NCT01984697|467494091|FG000|Overall Study|Death|0|||
129873025|NCT01984697|467494092|FG001|Overall Study|Death|0|||
129873026|NCT01984697|467494093|FG002|Overall Study|Death|0|||
129873027|NCT01984697|467494094|FG003|Overall Study|Death|1|||
129873028|NCT01984697|467494095|FG004|Overall Study|Death|0|||
129873029|NCT01984697|467494091|FG000|Overall Study|Pregnancy|2|||
129873030|NCT01984697|467494092|FG001|Overall Study|Pregnancy|0|||
129873031|NCT01984697|467494093|FG002|Overall Study|Pregnancy|1|||
129873032|NCT01984697|467494094|FG003|Overall Study|Pregnancy|0|||
129873033|NCT01984697|467494095|FG004|Overall Study|Pregnancy|1|||
129873034|NCT00847405|467494096|FG000|First Intervention|Adverse Event|0|||
129873035|NCT00847405|467494097|FG001|First Intervention|Adverse Event|1|||
129873036|NCT00847405|467494096|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129873037|NCT00847405|467494097|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129873038|NCT00949715|467494099|FG000|Overall Study|Physician Decision|1|||
129873039|NCT00949715|467494100|FG001|Overall Study|Physician Decision|0|||
129873040|NCT00949715|467494099|FG000|Overall Study|Lost to Follow-up|1|||
129873041|NCT00949715|467494100|FG001|Overall Study|Lost to Follow-up|0|||
129873042|NCT00949715|467494099|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
129873043|NCT00949715|467494100|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
129873044|NCT01352585|467494101|FG000|Overall Study|Adverse Event|2|||
129873045|NCT01352585|467494102|FG001|Overall Study|Adverse Event|1|||
129873046|NCT01352585|467494101|FG000|Overall Study|Lost to Follow-up|1|||
129873047|NCT01352585|467494102|FG001|Overall Study|Lost to Follow-up|0|||
129873048|NCT01352585|467494101|FG000|Overall Study|Other|5|||
129873049|NCT01352585|467494102|FG001|Overall Study|Other|2|||
129873050|NCT05050578|467494105|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
129873051|NCT05050578|467494106|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
129984001|NCT03001076|467903828|FG001|Overall Study|Other|0|||
129873052|NCT05050578|467494105|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
129873053|NCT05050578|467494106|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
129873054|NCT05050578|467494105|FG000|Period 2, 30 Days|Protocol Violation|0|||
129873055|NCT05050578|467494106|FG001|Period 2, 30 Days|Protocol Violation|1|||
129873056|NCT02243280|467494107|FG000|Treated|Adverse Event|1|||
129873057|NCT02243280|467494108|FG001|Treated|Adverse Event|0|||
129873058|NCT02243280|467494109|FG002|Treated|Adverse Event|0|||
129873059|NCT02243280|467494110|FG003|Treated|Adverse Event|0|||
129873060|NCT02243280|467494111|FG004|Treated|Adverse Event|0|||
129873061|NCT02243280|467494112|FG005|Treated|Adverse Event|0|||
129873062|NCT02243280|467494113|FG006|Treated|Adverse Event|0|||
129873063|NCT02243280|467494114|FG007|Treated|Adverse Event|0|||
129873064|NCT02243280|467494115|FG008|Treated|Adverse Event|0|||
129873065|NCT02243280|467494116|FG009|Treated|Adverse Event|0|||
129984002|NCT03001076|467903827|FG000|Overall Study|Adverse Event|3|||
129873066|NCT02243280|467494117|FG010|Treated|Adverse Event|1|||
129873067|NCT02243280|467494107|FG000|Treated|Lost to Follow-up|0|||
129873068|NCT02243280|467494108|FG001|Treated|Lost to Follow-up|0|||
129873069|NCT02243280|467494109|FG002|Treated|Lost to Follow-up|0|||
129873070|NCT02243280|467494110|FG003|Treated|Lost to Follow-up|0|||
129873071|NCT02243280|467494111|FG004|Treated|Lost to Follow-up|0|||
129873072|NCT02243280|467494112|FG005|Treated|Lost to Follow-up|0|||
129873073|NCT02243280|467494113|FG006|Treated|Lost to Follow-up|0|||
129873074|NCT02243280|467494114|FG007|Treated|Lost to Follow-up|0|||
129873075|NCT02243280|467494115|FG008|Treated|Lost to Follow-up|1|||
129873076|NCT02243280|467494116|FG009|Treated|Lost to Follow-up|0|||
129873077|NCT02243280|467494117|FG010|Treated|Lost to Follow-up|2|||
129873078|NCT03928028|467494124|FG000|Overall Study|Physician Decision|9|||
129873079|NCT03928028|467494125|FG001|Overall Study|Physician Decision|6|||
129873080|NCT03928028|467494126|FG002|Overall Study|Physician Decision|3|||
129873081|NCT03928028|467494124|FG000|Overall Study|Withdrawal by Subject|12|||
129873082|NCT03928028|467494125|FG001|Overall Study|Withdrawal by Subject|3|||
129873083|NCT03928028|467494126|FG002|Overall Study|Withdrawal by Subject|3|||
129873084|NCT02710292|467494127|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
129873085|NCT02710292|467494128|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
129873086|NCT02710292|467494127|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
129873087|NCT02710292|467494128|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
129873088|NCT04525547|467494129|FG000|Overall Study|Not treated with Ofev|2|||
129873089|NCT04525547|467494129|FG000|Overall Study|Off-label use|2|||
129873090|NCT04525547|467494129|FG000|Overall Study|Lost to Follow-up|1|||
129873091|NCT03122119|467494130|FG000|Overall Study|Did not meet eligibility critria|1|||
129873092|NCT00800202|467494131|FG000|Overall Study|Adverse Event|7|||
129873093|NCT00800202|467494132|FG001|Overall Study|Adverse Event|6|||
129873094|NCT00800202|467494131|FG000|Overall Study|Death|1|||
129873095|NCT00800202|467494132|FG001|Overall Study|Death|0|||
129873096|NCT00800202|467494131|FG000|Overall Study|Other|5|||
129873097|NCT00800202|467494132|FG001|Overall Study|Other|0|||
129873098|NCT00800202|467494131|FG000|Overall Study|Disease Progression|54|||
129873099|NCT00800202|467494132|FG001|Overall Study|Disease Progression|18|||
129873100|NCT04425902|467494133|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
129873101|NCT04669600|467494143|FG000|Overall Study|Withdrawal by Subject|1|||
129873102|NCT04669600|467494143|FG000|Overall Study|Other|6|||
129873103|NCT00710606|467494146|FG000|Overall Study|Adverse Event|0|||
129873104|NCT00710606|467494147|FG001|Overall Study|Adverse Event|2|||
129873105|NCT00514683|467494152|FG000|Overall Study|Not treated|2|||
129873106|NCT00514683|467494153|FG001|Overall Study|Not treated|1|||
129873107|NCT00514683|467494154|FG002|Overall Study|Not treated|0|||
129873108|NCT00514683|467494155|FG003|Overall Study|Not treated|0|||
129873109|NCT00514683|467494156|FG004|Overall Study|Not treated|1|||
129873110|NCT00514683|467494152|FG000|Overall Study|Adverse Event|21|||
129873111|NCT00514683|467494153|FG001|Overall Study|Adverse Event|20|||
129873112|NCT00514683|467494154|FG002|Overall Study|Adverse Event|15|||
129873113|NCT00514683|467494155|FG003|Overall Study|Adverse Event|13|||
129873114|NCT00514683|467494156|FG004|Overall Study|Adverse Event|27|||
129873115|NCT00514683|467494152|FG000|Overall Study|Protocol Violation|1|||
129873116|NCT00514683|467494153|FG001|Overall Study|Protocol Violation|1|||
129873117|NCT00514683|467494154|FG002|Overall Study|Protocol Violation|0|||
129873118|NCT00514683|467494155|FG003|Overall Study|Protocol Violation|1|||
129873119|NCT00514683|467494156|FG004|Overall Study|Protocol Violation|0|||
129873120|NCT00514683|467494152|FG000|Overall Study|Withdrawal by Subject|2|||
129873121|NCT00514683|467494153|FG001|Overall Study|Withdrawal by Subject|2|||
129873122|NCT00514683|467494154|FG002|Overall Study|Withdrawal by Subject|1|||
129873123|NCT00514683|467494155|FG003|Overall Study|Withdrawal by Subject|0|||
129873124|NCT00514683|467494156|FG004|Overall Study|Withdrawal by Subject|4|||
129873125|NCT00514683|467494152|FG000|Overall Study|Reason other than listed above|0|||
129873126|NCT00514683|467494153|FG001|Overall Study|Reason other than listed above|1|||
129873127|NCT00514683|467494154|FG002|Overall Study|Reason other than listed above|2|||
129873128|NCT00514683|467494155|FG003|Overall Study|Reason other than listed above|0|||
129873129|NCT00514683|467494156|FG004|Overall Study|Reason other than listed above|1|||
129873130|NCT00335452|467494157|FG000|Overall Study|Death|156|||
129873131|NCT00335452|467494158|FG001|Overall Study|Death|144|||
129873132|NCT00335452|467494159|FG002|Overall Study|Death|158|||
129873133|NCT00335452|467494160|FG003|Overall Study|Death|129|||
129873134|NCT00335452|467494157|FG000|Overall Study|Lost to Follow-up|2|||
129873135|NCT00335452|467494158|FG001|Overall Study|Lost to Follow-up|3|||
129873136|NCT00335452|467494159|FG002|Overall Study|Lost to Follow-up|1|||
129539360|NCT00198107|466266848|FG000|Double-Blind Period|Lack of Efficacy|2|||
129873137|NCT00335452|467494160|FG003|Overall Study|Lost to Follow-up|2|||
129873138|NCT02736825|467494162|FG000|Overall Study|Lost to Follow-up|10|||
129873139|NCT02736825|467494163|FG001|Overall Study|Lost to Follow-up|11|||
129873140|NCT02736825|467494162|FG000|Overall Study|Early Termination|0|||
129873141|NCT02736825|467494163|FG001|Overall Study|Early Termination|1|||
129873142|NCT01564368|467494172|FG000|Overall Study|Ineligible|18|||
129873143|NCT01564368|467494172|FG000|Overall Study|Not Randomized in Parent study|116|||
129873144|NCT01564368|467494172|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
129873145|NCT01564368|467494172|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
129873146|NCT02901626|467494173|FG000|Overall Study|Lost to Follow-up|1|||
129873147|NCT02901626|467494174|FG001|Overall Study|Lost to Follow-up|1|||
129873148|NCT00331344|467494175|FG000|Phase I|Adverse Event|0|||
129873149|NCT00331344|467494176|FG001|Phase I|Adverse Event|0|||
129873150|NCT00331344|467494177|FG002|Phase I|Adverse Event|0|||
129873151|NCT00331344|467494178|FG003|Phase I|Adverse Event|1|||
129873152|NCT00331344|467494179|FG004|Phase I|Adverse Event|2|||
129873153|NCT00331344|467494180|FG005|Phase I|Adverse Event|2|||
129873154|NCT00331344|467494181|FG006|Phase I|Adverse Event|0|||
129873155|NCT00331344|467494182|FG007|Phase I|Adverse Event|1|||
129873156|NCT00331344|467494183|FG008|Phase I|Adverse Event|0|||
129873157|NCT00331344|467494175|FG000|Phase II|Death|0|||
129873158|NCT00331344|467494176|FG001|Phase II|Death|0|||
129873159|NCT00331344|467494177|FG002|Phase II|Death|0|||
129873160|NCT00331344|467494178|FG003|Phase II|Death|0|||
129873161|NCT00331344|467494179|FG004|Phase II|Death|0|||
129873162|NCT00331344|467494180|FG005|Phase II|Death|0|||
129873163|NCT00331344|467494181|FG006|Phase II|Death|0|||
129873164|NCT00331344|467494182|FG007|Phase II|Death|0|||
129873165|NCT00331344|467494183|FG008|Phase II|Death|4|||
129873166|NCT01373931|467494184|FG000|Lead-in Period|Adverse Event|2|||
129873167|NCT01373931|467494185|FG001|Lead-in Period|Adverse Event|0|||
129873168|NCT01373931|467494184|FG000|Period 1|Adverse Event|2|||
129873169|NCT01373931|467494185|FG001|Period 1|Adverse Event|0|||
129873170|NCT01373931|467494184|FG000|Period 1|Withdrawal by Subject|0|||
129873171|NCT01373931|467494185|FG001|Period 1|Withdrawal by Subject|2|||
129651076|NCT00195494|466678591|FG001|Year 2|Lack of Efficacy|1|||
129651077|NCT00195494|466678592|FG002|Year 2|Lack of Efficacy|7|||
129651078|NCT00195494|466678593|FG003|Year 2|Lack of Efficacy|7|||
129651079|NCT00195494|466678594|FG004|Year 2|Lack of Efficacy|0|||
129651080|NCT00195494|466678595|FG005|Year 2|Lack of Efficacy|0|||
129651081|NCT00195494|466678590|FG000|Year 2|Compliance|1|||
129651082|NCT00195494|466678591|FG001|Year 2|Compliance|0|||
129651083|NCT00195494|466678592|FG002|Year 2|Compliance|0|||
129651084|NCT00195494|466678593|FG003|Year 2|Compliance|2|||
129651085|NCT00195494|466678594|FG004|Year 2|Compliance|0|||
129651086|NCT00195494|466678595|FG005|Year 2|Compliance|0|||
129651087|NCT00195494|466678590|FG000|Year 2|Lost to Follow-up|0|||
129651088|NCT00195494|466678591|FG001|Year 2|Lost to Follow-up|0|||
129651089|NCT00195494|466678592|FG002|Year 2|Lost to Follow-up|1|||
129651090|NCT00195494|466678593|FG003|Year 2|Lost to Follow-up|1|||
129651091|NCT00195494|466678594|FG004|Year 2|Lost to Follow-up|0|||
129651092|NCT00195494|466678595|FG005|Year 2|Lost to Follow-up|0|||
129651093|NCT00195494|466678590|FG000|Year 2|Missed >4 consecutive doses|1|||
129651094|NCT00195494|466678591|FG001|Year 2|Missed >4 consecutive doses|1|||
129651095|NCT00195494|466678592|FG002|Year 2|Missed >4 consecutive doses|1|||
129651096|NCT00195494|466678593|FG003|Year 2|Missed >4 consecutive doses|0|||
129761852|NCT00443040|467091318|FG000|Overall Study|Withdrawal by Subject|1|||
129761853|NCT00443040|467091319|FG001|Overall Study|Withdrawal by Subject|0|||
129761854|NCT00443040|467091320|FG002|Overall Study|Withdrawal by Subject|0|||
129761855|NCT00443040|467091318|FG000|Overall Study|Converted to an open laparotomy|3|||
129761856|NCT00443040|467091319|FG001|Overall Study|Converted to an open laparotomy|0|||
129761857|NCT00443040|467091320|FG002|Overall Study|Converted to an open laparotomy|1|||
129761858|NCT04245111|467091324|FG000|Overall Study|Lost to Follow-up|5|||
129761859|NCT04245111|467091325|FG001|Overall Study|Lost to Follow-up|1|||
129761860|NCT04245111|467091326|FG002|Overall Study|Lost to Follow-up|1|||
129761861|NCT03192176|467091332|FG000|Overall Study|Adverse Event|1|||
129761862|NCT03192176|467091333|FG001|Overall Study|Adverse Event|0|||
129761863|NCT03192176|467091334|FG002|Overall Study|Adverse Event|4|||
129761864|NCT03192176|467091335|FG003|Overall Study|Adverse Event|5|||
129761865|NCT03192176|467091336|FG004|Overall Study|Adverse Event|3|||
129761866|NCT03192176|467091337|FG005|Overall Study|Adverse Event|2|||
129761867|NCT03192176|467091338|FG006|Overall Study|Adverse Event|3|||
129984003|NCT03001076|467903828|FG001|Overall Study|Adverse Event|3|||
129984004|NCT03001076|467903827|FG000|Overall Study|Sponsor decision|1|||
129443565|NCT04147234|465924424|FG006|Overall Study|Adverse Event|0|||
129651097|NCT00195494|466678594|FG004|Year 2|Missed >4 consecutive doses|0|||
129651098|NCT00195494|466678595|FG005|Year 2|Missed >4 consecutive doses|0|||
129651099|NCT00195494|466678590|FG000|Year 2|Protocol deviation|0|||
129651100|NCT00195494|466678591|FG001|Year 2|Protocol deviation|1|||
129761868|NCT03192176|467091339|FG007|Overall Study|Adverse Event|3|||
129761869|NCT03192176|467091332|FG000|Overall Study|Lost to Follow-up|0|||
129761870|NCT03192176|467091333|FG001|Overall Study|Lost to Follow-up|0|||
129873172|NCT04857034|467494186|FG000|Placebo-Controlled Period|Request to discontinue|2|||
129651101|NCT00195494|466678592|FG002|Year 2|Protocol deviation|0|||
129651102|NCT00195494|466678593|FG003|Year 2|Protocol deviation|0|||
129651103|NCT00195494|466678594|FG004|Year 2|Protocol deviation|0|||
129873173|NCT04857034|467494187|FG001|Placebo-Controlled Period|Request to discontinue|2|||
129873174|NCT04857034|467494188|FG002|Placebo-Controlled Period|Request to discontinue|0|||
129873175|NCT04857034|467494189|FG003|Placebo-Controlled Period|Request to discontinue|0|||
129873176|NCT04857034|467494190|FG004|Placebo-Controlled Period|Request to discontinue|0|||
129873177|NCT04857034|467494186|FG000|Placebo-Controlled Period|withdrew consent|1|||
129761871|NCT03192176|467091334|FG002|Overall Study|Lost to Follow-up|1|||
129761872|NCT03192176|467091335|FG003|Overall Study|Lost to Follow-up|2|||
129761873|NCT03192176|467091336|FG004|Overall Study|Lost to Follow-up|3|||
129761874|NCT03192176|467091337|FG005|Overall Study|Lost to Follow-up|1|||
129761875|NCT03192176|467091338|FG006|Overall Study|Lost to Follow-up|1|||
129761876|NCT03192176|467091339|FG007|Overall Study|Lost to Follow-up|1|||
129761877|NCT03192176|467091332|FG000|Overall Study|Physician Decision|1|||
129761878|NCT03192176|467091333|FG001|Overall Study|Physician Decision|0|||
129761879|NCT03192176|467091334|FG002|Overall Study|Physician Decision|0|||
129873178|NCT04857034|467494187|FG001|Placebo-Controlled Period|withdrew consent|1|||
129873179|NCT04857034|467494188|FG002|Placebo-Controlled Period|withdrew consent|2|||
129873180|NCT04857034|467494189|FG003|Placebo-Controlled Period|withdrew consent|0|||
129873181|NCT04857034|467494190|FG004|Placebo-Controlled Period|withdrew consent|0|||
129873182|NCT04857034|467494186|FG000|Placebo-Controlled Period|Pregnancy|1|||
129873183|NCT04857034|467494187|FG001|Placebo-Controlled Period|Pregnancy|1|||
129984005|NCT03001076|467903828|FG001|Overall Study|Sponsor decision|0|||
129984006|NCT03001076|467903827|FG000|Overall Study|Lost to Follow-up|0|||
129984007|NCT03001076|467903828|FG001|Overall Study|Lost to Follow-up|2|||
129984008|NCT00948766|467903829|FG000|Core Study|Adverse Event|73|||
129984009|NCT00948766|467903830|FG001|Core Study|Adverse Event|51|||
129984010|NCT00948766|467903829|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
129984011|NCT00948766|467903830|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
129984012|NCT00948766|467903829|FG000|Core Study|Patient Withdrew Consent|27|||
129984013|NCT00948766|467903830|FG001|Core Study|Patient Withdrew Consent|46|||
129984014|NCT00948766|467903829|FG000|Core Study|Lost to Follow-up|3|||
129984015|NCT00948766|467903830|FG001|Core Study|Lost to Follow-up|2|||
129984016|NCT00948766|467903829|FG000|Core Study|Administrative Problems|2|||
129984017|NCT00948766|467903830|FG001|Core Study|Administrative Problems|2|||
129984018|NCT00948766|467903829|FG000|Core Study|Death|1|||
129984019|NCT00948766|467903830|FG001|Core Study|Death|1|||
129984020|NCT00948766|467903829|FG000|Core Study|Protocol Deviation|8|||
129984021|NCT00948766|467903830|FG001|Core Study|Protocol Deviation|10|||
129984022|NCT00948766|467903829|FG000|Extension Study|Adverse Event|43|||
129984023|NCT00948766|467903830|FG001|Extension Study|Adverse Event|0|||
129984024|NCT00948766|467903829|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
129984025|NCT00948766|467903830|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
129984026|NCT00948766|467903829|FG000|Extension Study|Study Drug No Longer Required|1|||
129984027|NCT00948766|467903830|FG001|Extension Study|Study Drug No Longer Required|0|||
129984028|NCT00948766|467903829|FG000|Extension Study|Patient Withdrew Consent|32|||
129984029|NCT00948766|467903830|FG001|Extension Study|Patient Withdrew Consent|0|||
129984030|NCT00948766|467903829|FG000|Extension Study|Lost to Follow-up|8|||
129984031|NCT00948766|467903830|FG001|Extension Study|Lost to Follow-up|0|||
129984032|NCT00948766|467903829|FG000|Extension Study|Administrative Problems|1|||
129984033|NCT00948766|467903830|FG001|Extension Study|Administrative Problems|0|||
129984034|NCT00948766|467903829|FG000|Extension Study|Death|4|||
129984035|NCT00948766|467903830|FG001|Extension Study|Death|0|||
129984036|NCT03189745|467903834|FG000|Overall Study|Conflict in work schedule of participant|1|||
129984037|NCT03189745|467903835|FG001|Overall Study|Conflict in work schedule of participant|1|||
129984038|NCT02729831|467903836|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
129984039|NCT02729831|467903837|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
129984040|NCT02729831|467903838|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
129984041|NCT02729831|467903839|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
129984042|NCT02729831|467903836|FG000|1 Week Post-visit|Lost to Follow-up|43|||
129984043|NCT02729831|467903837|FG001|1 Week Post-visit|Lost to Follow-up|40|||
129984044|NCT02729831|467903838|FG002|1 Week Post-visit|Lost to Follow-up|38|||
129984045|NCT02729831|467903839|FG003|1 Week Post-visit|Lost to Follow-up|36|||
129984046|NCT02729831|467903836|FG000|6 Month Follow-up|Lost to Follow-up|54|||
129984047|NCT02729831|467903837|FG001|6 Month Follow-up|Lost to Follow-up|51|||
129984048|NCT02729831|467903838|FG002|6 Month Follow-up|Lost to Follow-up|48|||
129761880|NCT03192176|467091335|FG003|Overall Study|Physician Decision|0|||
129761881|NCT03192176|467091336|FG004|Overall Study|Physician Decision|0|||
129761882|NCT03192176|467091337|FG005|Overall Study|Physician Decision|2|||
129761883|NCT03192176|467091338|FG006|Overall Study|Physician Decision|1|||
129761884|NCT03192176|467091339|FG007|Overall Study|Physician Decision|0|||
129761885|NCT03192176|467091332|FG000|Overall Study|Protocol Deviation|1|||
129761886|NCT03192176|467091333|FG001|Overall Study|Protocol Deviation|1|||
129761887|NCT03192176|467091334|FG002|Overall Study|Protocol Deviation|0|||
129761888|NCT03192176|467091335|FG003|Overall Study|Protocol Deviation|0|||
129761889|NCT03192176|467091336|FG004|Overall Study|Protocol Deviation|2|||
129873184|NCT04857034|467494188|FG002|Placebo-Controlled Period|Pregnancy|0|||
129873185|NCT04857034|467494189|FG003|Placebo-Controlled Period|Pregnancy|0|||
129984049|NCT02729831|467903839|FG003|6 Month Follow-up|Lost to Follow-up|42|||
129984050|NCT02729831|467903836|FG000|6 Month Follow-up|Death|1|||
129984051|NCT02729831|467903837|FG001|6 Month Follow-up|Death|3|||
129984052|NCT02729831|467903838|FG002|6 Month Follow-up|Death|0|||
129984053|NCT02729831|467903839|FG003|6 Month Follow-up|Death|1|||
129984054|NCT01373151|467903840|FG000|Period 1|Lack of Efficacy|3|||
129984055|NCT01373151|467903841|FG001|Period 1|Lack of Efficacy|0|||
129984056|NCT01373151|467903842|FG002|Period 1|Lack of Efficacy|0|||
129984057|NCT01373151|467903843|FG003|Period 1|Lack of Efficacy|0|||
129984058|NCT01373151|467903844|FG004|Period 1|Lack of Efficacy|1|||
129984059|NCT01373151|467903845|FG005|Period 1|Lack of Efficacy|0|||
129984060|NCT01373151|467903846|FG006|Period 1|Lack of Efficacy|0|||
129761890|NCT03192176|467091337|FG005|Overall Study|Protocol Deviation|0|||
129761891|NCT03192176|467091338|FG006|Overall Study|Protocol Deviation|0|||
129761892|NCT03192176|467091339|FG007|Overall Study|Protocol Deviation|0|||
129761893|NCT03192176|467091332|FG000|Overall Study|Withdrawal by Subject|3|||
129761894|NCT03192176|467091333|FG001|Overall Study|Withdrawal by Subject|4|||
129761895|NCT03192176|467091334|FG002|Overall Study|Withdrawal by Subject|0|||
129761896|NCT03192176|467091335|FG003|Overall Study|Withdrawal by Subject|4|||
129873186|NCT04857034|467494190|FG004|Placebo-Controlled Period|Pregnancy|0|||
129873187|NCT04857034|467494186|FG000|Placebo-Controlled Period|Ongoing study period|0|||
129873188|NCT04857034|467494187|FG001|Placebo-Controlled Period|Ongoing study period|1|||
129873189|NCT04857034|467494188|FG002|Placebo-Controlled Period|Ongoing study period|0|||
129873190|NCT04857034|467494189|FG003|Placebo-Controlled Period|Ongoing study period|0|||
129873191|NCT04857034|467494190|FG004|Placebo-Controlled Period|Ongoing study period|0|||
129873192|NCT04857034|467494186|FG000|Active Treatment Period|Lack of Efficacy|1|||
129873193|NCT04857034|467494187|FG001|Active Treatment Period|Lack of Efficacy|0|||
129873194|NCT04857034|467494188|FG002|Active Treatment Period|Lack of Efficacy|0|||
129873195|NCT04857034|467494189|FG003|Active Treatment Period|Lack of Efficacy|0|||
129873196|NCT04857034|467494190|FG004|Active Treatment Period|Lack of Efficacy|0|||
129873197|NCT04857034|467494186|FG000|Active Treatment Period|request to discontinue|0|||
129873198|NCT04857034|467494187|FG001|Active Treatment Period|request to discontinue|1|||
129873199|NCT04857034|467494188|FG002|Active Treatment Period|request to discontinue|0|||
129873200|NCT04857034|467494189|FG003|Active Treatment Period|request to discontinue|1|||
129873201|NCT04857034|467494190|FG004|Active Treatment Period|request to discontinue|0|||
129873202|NCT04857034|467494186|FG000|Active Treatment Period|administrative reason by sponsor|1|||
129873203|NCT04857034|467494187|FG001|Active Treatment Period|administrative reason by sponsor|5|||
129873204|NCT04857034|467494188|FG002|Active Treatment Period|administrative reason by sponsor|0|||
129873205|NCT04857034|467494189|FG003|Active Treatment Period|administrative reason by sponsor|2|||
129873206|NCT04857034|467494190|FG004|Active Treatment Period|administrative reason by sponsor|2|||
129873207|NCT04857034|467494186|FG000|Active Treatment Period|other reasons|1|||
129873208|NCT04857034|467494187|FG001|Active Treatment Period|other reasons|1|||
129873209|NCT04857034|467494188|FG002|Active Treatment Period|other reasons|0|||
129873210|NCT04857034|467494189|FG003|Active Treatment Period|other reasons|0|||
129873211|NCT04857034|467494190|FG004|Active Treatment Period|other reasons|1|||
129873212|NCT04857034|467494186|FG000|Active Treatment Period|Ongoing Study Period|2|||
129873213|NCT04857034|467494187|FG001|Active Treatment Period|Ongoing Study Period|4|||
129873214|NCT04857034|467494188|FG002|Active Treatment Period|Ongoing Study Period|0|||
129873215|NCT04857034|467494189|FG003|Active Treatment Period|Ongoing Study Period|1|||
129873216|NCT04857034|467494190|FG004|Active Treatment Period|Ongoing Study Period|0|||
129873217|NCT00659490|467494191|FG000|Overall Study|Lost to Follow-up|2|||
129873218|NCT00659490|467494192|FG001|Overall Study|Lost to Follow-up|0|||
129873219|NCT00659490|467494193|FG002|Overall Study|Lost to Follow-up|1|||
129873220|NCT05674890|467494198|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
129873221|NCT05674890|467494199|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
129873222|NCT05674890|467494198|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
129873223|NCT05674890|467494199|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
129873224|NCT05674890|467494198|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
129873225|NCT05674890|467494199|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
129873226|NCT00827541|467494200|FG000|Overall Study|Exitus|1|||
129873227|NCT00827541|467494201|FG001|Overall Study|Exitus|8|||
129873228|NCT00827541|467494200|FG000|Overall Study|Other|1|||
129873229|NCT00827541|467494201|FG001|Overall Study|Other|3|||
129873230|NCT00827541|467494200|FG000|Overall Study|Pathogen not susceptible|1|||
129984061|NCT01373151|467903840|FG000|Period 1|Adverse Event|0|||
129984062|NCT01373151|467903841|FG001|Period 1|Adverse Event|0|||
129761897|NCT03192176|467091336|FG004|Overall Study|Withdrawal by Subject|3|||
129761898|NCT03192176|467091337|FG005|Overall Study|Withdrawal by Subject|4|||
129761899|NCT03192176|467091338|FG006|Overall Study|Withdrawal by Subject|4|||
129761900|NCT03192176|467091339|FG007|Overall Study|Withdrawal by Subject|2|||
129761901|NCT03192176|467091332|FG000|Overall Study|Miscellaneous|1|||
129761902|NCT03192176|467091333|FG001|Overall Study|Miscellaneous|0|||
129761903|NCT03192176|467091334|FG002|Overall Study|Miscellaneous|1|||
129761904|NCT03192176|467091335|FG003|Overall Study|Miscellaneous|1|||
129761905|NCT03192176|467091336|FG004|Overall Study|Miscellaneous|1|||
129761906|NCT03192176|467091337|FG005|Overall Study|Miscellaneous|2|||
129761907|NCT03192176|467091338|FG006|Overall Study|Miscellaneous|0|||
129761908|NCT03192176|467091339|FG007|Overall Study|Miscellaneous|1|||
129761909|NCT03532542|467091342|FG000|Overall Study|Death|1|||
129761910|NCT03532542|467091343|FG001|Overall Study|Death|0|||
129761911|NCT03532542|467091342|FG000|Overall Study|Study Terminated by Sponsor|41|||
129761912|NCT03532542|467091343|FG001|Overall Study|Study Terminated by Sponsor|65|||
129761913|NCT03532542|467091342|FG000|Overall Study|Withdrawal by Subject|6|||
129761914|NCT03532542|467091343|FG001|Overall Study|Withdrawal by Subject|5|||
129761915|NCT00718510|467091345|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
129761916|NCT00718510|467091346|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129761917|NCT00718510|467091345|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
129761918|NCT00718510|467091346|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
129984063|NCT01373151|467903842|FG002|Period 1|Adverse Event|1|||
129984064|NCT01373151|467903843|FG003|Period 1|Adverse Event|0|||
129984065|NCT01373151|467903844|FG004|Period 1|Adverse Event|4|||
129984066|NCT01373151|467903845|FG005|Period 1|Adverse Event|3|||
129984067|NCT01373151|467903846|FG006|Period 1|Adverse Event|0|||
129984068|NCT01373151|467903840|FG000|Period 1|Withdrawal by Subject|2|||
129984069|NCT01373151|467903841|FG001|Period 1|Withdrawal by Subject|0|||
129984070|NCT01373151|467903842|FG002|Period 1|Withdrawal by Subject|3|||
129984071|NCT01373151|467903843|FG003|Period 1|Withdrawal by Subject|1|||
129984072|NCT01373151|467903844|FG004|Period 1|Withdrawal by Subject|0|||
129984073|NCT01373151|467903845|FG005|Period 1|Withdrawal by Subject|1|||
129984074|NCT01373151|467903846|FG006|Period 1|Withdrawal by Subject|0|||
129984075|NCT01373151|467903840|FG000|Period 2|Lack of Efficacy|9|||
129984076|NCT01373151|467903841|FG001|Period 2|Lack of Efficacy|0|||
129984077|NCT01373151|467903842|FG002|Period 2|Lack of Efficacy|0|||
129984078|NCT01373151|467903843|FG003|Period 2|Lack of Efficacy|1|||
129984079|NCT01373151|467903844|FG004|Period 2|Lack of Efficacy|2|||
129984080|NCT01373151|467903845|FG005|Period 2|Lack of Efficacy|0|||
129984081|NCT01373151|467903846|FG006|Period 2|Lack of Efficacy|3|||
129984082|NCT01373151|467903840|FG000|Period 2|Adverse Event|0|||
129984083|NCT01373151|467903841|FG001|Period 2|Adverse Event|0|||
129984084|NCT01373151|467903842|FG002|Period 2|Adverse Event|3|||
129984085|NCT01373151|467903843|FG003|Period 2|Adverse Event|3|||
129984086|NCT01373151|467903844|FG004|Period 2|Adverse Event|0|||
129984087|NCT01373151|467903845|FG005|Period 2|Adverse Event|0|||
129984088|NCT01373151|467903846|FG006|Period 2|Adverse Event|1|||
129984089|NCT01373151|467903840|FG000|Period 2|subject request to discontinue|0|||
129984090|NCT01373151|467903841|FG001|Period 2|subject request to discontinue|1|||
129984091|NCT01373151|467903842|FG002|Period 2|subject request to discontinue|0|||
129984092|NCT01373151|467903843|FG003|Period 2|subject request to discontinue|0|||
129984093|NCT01373151|467903844|FG004|Period 2|subject request to discontinue|0|||
129984094|NCT01373151|467903845|FG005|Period 2|subject request to discontinue|0|||
129984095|NCT01373151|467903846|FG006|Period 2|subject request to discontinue|0|||
129984096|NCT01373151|467903840|FG000|Period 2|Withdrawal by Subject|0|||
129984097|NCT01373151|467903841|FG001|Period 2|Withdrawal by Subject|0|||
129984098|NCT01373151|467903842|FG002|Period 2|Withdrawal by Subject|0|||
129984099|NCT01373151|467903843|FG003|Period 2|Withdrawal by Subject|1|||
129984100|NCT01373151|467903844|FG004|Period 2|Withdrawal by Subject|0|||
129984101|NCT01373151|467903845|FG005|Period 2|Withdrawal by Subject|0|||
129984102|NCT01373151|467903846|FG006|Period 2|Withdrawal by Subject|0|||
129984103|NCT01373151|467903840|FG000|Period 2|Other|0|||
129984104|NCT01373151|467903841|FG001|Period 2|Other|0|||
129984105|NCT01373151|467903842|FG002|Period 2|Other|1|||
129984106|NCT01373151|467903843|FG003|Period 2|Other|0|||
129984107|NCT01373151|467903844|FG004|Period 2|Other|0|||
129984108|NCT01373151|467903845|FG005|Period 2|Other|0|||
129984109|NCT01373151|467903846|FG006|Period 2|Other|1|||
129984110|NCT03117998|467903847|FG000|Overall Study|Adverse Event|1|||
129984111|NCT03117998|467903848|FG001|Overall Study|Adverse Event|0|||
129984112|NCT03117998|467903849|FG002|Overall Study|Adverse Event|0|||
129984113|NCT03117998|467903850|FG003|Overall Study|Adverse Event|0|||
129761919|NCT02314052|467091347|FG000|Cycle One|Adverse Event|0|||
129984114|NCT03117998|467903851|FG004|Overall Study|Adverse Event|0|||
129443566|NCT02596620|465924425|FG000|Overall Study|Lost to Follow-up|1|||
129761920|NCT02314052|467091348|FG001|Cycle One|Adverse Event|0|||
129761921|NCT02314052|467091349|FG002|Cycle One|Adverse Event|0|||
129761922|NCT02314052|467091350|FG003|Cycle One|Adverse Event|1|||
129984115|NCT03117998|467903852|FG005|Overall Study|Adverse Event|0|||
129984116|NCT03117998|467903847|FG000|Overall Study|Withdrawal by Subject|0|||
129984117|NCT03117998|467903848|FG001|Overall Study|Withdrawal by Subject|0|||
129984118|NCT03117998|467903849|FG002|Overall Study|Withdrawal by Subject|2|||
129984119|NCT03117998|467903850|FG003|Overall Study|Withdrawal by Subject|3|||
129984120|NCT03117998|467903851|FG004|Overall Study|Withdrawal by Subject|3|||
129984121|NCT03117998|467903852|FG005|Overall Study|Withdrawal by Subject|0|||
129984122|NCT03117998|467903847|FG000|Overall Study|Physician Decision|0|||
129984123|NCT03117998|467903848|FG001|Overall Study|Physician Decision|1|||
129984124|NCT03117998|467903849|FG002|Overall Study|Physician Decision|1|||
129984125|NCT03117998|467903850|FG003|Overall Study|Physician Decision|0|||
129984126|NCT03117998|467903851|FG004|Overall Study|Physician Decision|0|||
129984127|NCT03117998|467903852|FG005|Overall Study|Physician Decision|0|||
129984128|NCT03117998|467903847|FG000|Overall Study|Lost to Follow-up|0|||
129984129|NCT03117998|467903848|FG001|Overall Study|Lost to Follow-up|0|||
129984130|NCT03117998|467903849|FG002|Overall Study|Lost to Follow-up|0|||
129761923|NCT02314052|467091351|FG004|Cycle One|Adverse Event|0|||
129761924|NCT02314052|467091352|FG005|Cycle One|Adverse Event|0|||
129761925|NCT00117637|467091353|FG000|First Intervention (Period 1)|Adverse Event|11|||
129761926|NCT00117637|467091354|FG001|First Intervention (Period 1)|Adverse Event|16|||
129761927|NCT00117637|467091353|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
129761928|NCT00117637|467091354|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
129761929|NCT00117637|467091353|FG000|First Intervention (Period 1)|Protocol Violation|1|||
129761930|NCT00117637|467091354|FG001|First Intervention (Period 1)|Protocol Violation|0|||
129761931|NCT00117637|467091353|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
129761932|NCT00117637|467091354|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
129761933|NCT00117637|467091353|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
129761934|NCT00117637|467091354|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
129873231|NCT00827541|467494201|FG001|Overall Study|Pathogen not susceptible|0|||
129873232|NCT00827541|467494200|FG000|Overall Study|Lack of effectiveness|1|||
129873233|NCT00827541|467494201|FG001|Overall Study|Lack of effectiveness|0|||
129873234|NCT01649232|467494202|FG000|Overall Study|Physician Decision|2|||
129873235|NCT01649232|467494203|FG001|Overall Study|Physician Decision|0|||
129873236|NCT02228967|467494204|FG000|Overall Study|Lost to Follow-up|146|||
129873237|NCT02228967|467494205|FG001|Overall Study|Lost to Follow-up|142|||
129873238|NCT02228967|467494204|FG000|Overall Study|Withdrawal by Subject|13|||
129873239|NCT02228967|467494205|FG001|Overall Study|Withdrawal by Subject|18|||
129873240|NCT00520975|467494206|FG000|Overall Study|Disease progression|31|||
129873241|NCT00520975|467494207|FG001|Overall Study|Disease progression|23|||
129873242|NCT00520975|467494206|FG000|Overall Study|Adverse Event|7|||
129873243|NCT00520975|467494207|FG001|Overall Study|Adverse Event|10|||
129873244|NCT00520975|467494206|FG000|Overall Study|Death|0|||
129873245|NCT00520975|467494207|FG001|Overall Study|Death|2|||
129873246|NCT00520975|467494206|FG000|Overall Study|Withdrawal by Subject|3|||
129873247|NCT00520975|467494207|FG001|Overall Study|Withdrawal by Subject|5|||
129873248|NCT00520975|467494206|FG000|Overall Study|Other therapy|2|||
129873249|NCT00520975|467494207|FG001|Overall Study|Other therapy|4|||
129873250|NCT00520975|467494206|FG000|Overall Study|Other reasons|4|||
129873251|NCT00520975|467494207|FG001|Overall Study|Other reasons|2|||
129873252|NCT00520975|467494206|FG000|Overall Study|Not start protocol therapy|1|||
129873253|NCT00520975|467494207|FG001|Overall Study|Not start protocol therapy|2|||
129873254|NCT04810221|467494208|FG000|Overall Study|Physician Decision|3|||
129873255|NCT03642938|467494209|FG000|Overall Study|Withdrawal by Subject|0|||
129873256|NCT03642938|467494210|FG001|Overall Study|Withdrawal by Subject|0|||
129873257|NCT03642938|467494211|FG002|Overall Study|Withdrawal by Subject|0|||
129873258|NCT03642938|467494212|FG003|Overall Study|Withdrawal by Subject|1|||
129984131|NCT03117998|467903850|FG003|Overall Study|Lost to Follow-up|1|||
129984132|NCT03117998|467903851|FG004|Overall Study|Lost to Follow-up|4|||
129984133|NCT03117998|467903852|FG005|Overall Study|Lost to Follow-up|0|||
129984134|NCT03117998|467903847|FG000|Overall Study|Subject noncompliance|0|||
129984135|NCT03117998|467903848|FG001|Overall Study|Subject noncompliance|0|||
129984136|NCT03117998|467903849|FG002|Overall Study|Subject noncompliance|1|||
129984137|NCT03117998|467903850|FG003|Overall Study|Subject noncompliance|0|||
129984138|NCT03117998|467903851|FG004|Overall Study|Subject noncompliance|0|||
129984139|NCT03117998|467903852|FG005|Overall Study|Subject noncompliance|2|||
129984140|NCT03117998|467903847|FG000|Overall Study|Protocol Violation|0|||
129984141|NCT03117998|467903848|FG001|Overall Study|Protocol Violation|0|||
129984142|NCT03117998|467903849|FG002|Overall Study|Protocol Violation|0|||
129984143|NCT03117998|467903850|FG003|Overall Study|Protocol Violation|0|||
129984144|NCT03117998|467903851|FG004|Overall Study|Protocol Violation|0|||
129984145|NCT03117998|467903852|FG005|Overall Study|Protocol Violation|1|||
129984146|NCT00438672|467903853|FG000|Overall Study|Lost to Follow-up|7|||
129984147|NCT00438672|467903854|FG001|Overall Study|Lost to Follow-up|9|||
129984148|NCT01468181|467903858|FG000|Overall Study|Adverse Event|8|||
129984149|NCT01468181|467903859|FG001|Overall Study|Adverse Event|1|||
129984150|NCT01468181|467903860|FG002|Overall Study|Adverse Event|6|||
129984151|NCT01468181|467903861|FG003|Overall Study|Adverse Event|2|||
129873259|NCT00105235|467494213|FG000|Overall Study|Death|4|||
129873260|NCT00105235|467494213|FG000|Overall Study|Physician Decision|1|||
129873261|NCT00105235|467494213|FG000|Overall Study|Withdrawal by Subject|2|||
129873262|NCT01964326|467494214|FG000|Overall Study|Adverse Event|48|||
129873263|NCT01964326|467494214|FG000|Overall Study|Death|2|||
129873264|NCT01964326|467494214|FG000|Overall Study|Protocol Violation|4|||
129873265|NCT01964326|467494214|FG000|Overall Study|Lost to Follow-up|88|||
129873266|NCT01964326|467494214|FG000|Overall Study|Withdrawal by Subject|87|||
129873267|NCT01964326|467494214|FG000|Overall Study|Pregnancy|1|||
129984152|NCT01468181|467903862|FG004|Overall Study|Adverse Event|2|||
129984153|NCT01468181|467903858|FG000|Overall Study|Protocol Violation|2|||
129984154|NCT01468181|467903859|FG001|Overall Study|Protocol Violation|0|||
129984155|NCT01468181|467903860|FG002|Overall Study|Protocol Violation|1|||
129984156|NCT01468181|467903861|FG003|Overall Study|Protocol Violation|0|||
129984157|NCT01468181|467903862|FG004|Overall Study|Protocol Violation|1|||
129984158|NCT01468181|467903858|FG000|Overall Study|Physician Decision|0|||
129984159|NCT01468181|467903859|FG001|Overall Study|Physician Decision|0|||
129984160|NCT01468181|467903860|FG002|Overall Study|Physician Decision|0|||
129984161|NCT01468181|467903861|FG003|Overall Study|Physician Decision|1|||
129984162|NCT01468181|467903862|FG004|Overall Study|Physician Decision|1|||
129984163|NCT01468181|467903858|FG000|Overall Study|Lost to Follow-up|0|||
129984164|NCT01468181|467903859|FG001|Overall Study|Lost to Follow-up|0|||
129984165|NCT01468181|467903860|FG002|Overall Study|Lost to Follow-up|1|||
129984166|NCT01468181|467903861|FG003|Overall Study|Lost to Follow-up|0|||
129984167|NCT01468181|467903862|FG004|Overall Study|Lost to Follow-up|1|||
129984168|NCT01468181|467903858|FG000|Overall Study|Withdrawal by Subject|0|||
129984169|NCT01468181|467903859|FG001|Overall Study|Withdrawal by Subject|1|||
129984170|NCT01468181|467903860|FG002|Overall Study|Withdrawal by Subject|0|||
129984171|NCT01468181|467903861|FG003|Overall Study|Withdrawal by Subject|0|||
129984172|NCT01468181|467903862|FG004|Overall Study|Withdrawal by Subject|0|||
129984173|NCT04828837|467903863|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
129984174|NCT04828837|467903864|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
129984175|NCT04828837|467903863|FG000|Overall Study|Lost to Follow-up|2|||
129984176|NCT04828837|467903864|FG001|Overall Study|Lost to Follow-up|6|||
129984177|NCT04828837|467903863|FG000|Overall Study|Lack of Efficacy|1|||
129539361|NCT00198107|466266849|FG001|Double-Blind Period|Lack of Efficacy|0|||
129761935|NCT00117637|467091353|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
129761936|NCT00117637|467091354|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
129761937|NCT00117637|467091353|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
129761938|NCT00117637|467091354|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
129761939|NCT00117637|467091353|FG000|First Intervention (Period 1)|reason not reported|0|||
129761940|NCT00117637|467091354|FG001|First Intervention (Period 1)|reason not reported|1|||
129761941|NCT00117637|467091353|FG000|Second Intervention (Period 2)|Adverse Event|0|||
129761942|NCT00117637|467091354|FG001|Second Intervention (Period 2)|Adverse Event|9|||
129761943|NCT00117637|467091353|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
129761944|NCT00117637|467091354|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
129761945|NCT00117637|467091353|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
129761946|NCT00117637|467091354|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
129761947|NCT00117637|467091353|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
129761948|NCT00117637|467091354|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
129761949|NCT00117637|467091353|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
129761950|NCT00117637|467091354|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
129873268|NCT01964326|467494214|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
129873269|NCT01964326|467494214|FG000|Overall Study|Physician Decision|55|||
129761951|NCT00117637|467091353|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
129761952|NCT00117637|467091354|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
129761953|NCT00117637|467091353|FG000|Second Intervention (Period 2)|reason not reported|1|||
129873270|NCT01964326|467494214|FG000|Overall Study|Investigator Discretion|1|||
129873271|NCT01964326|467494214|FG000|Overall Study|Other|9|||
129873272|NCT01964326|467494214|FG000|Overall Study|Did not meet eligibility criteria|1|||
129873273|NCT02347657|467494215|FG000|Overall Study|Physician Decision|0|||
129873274|NCT02347657|467494216|FG001|Overall Study|Physician Decision|1|||
129873275|NCT02347657|467494215|FG000|Overall Study|Adverse Event|8|||
129873276|NCT02347657|467494216|FG001|Overall Study|Adverse Event|4|||
129873277|NCT02347657|467494215|FG000|Overall Study|Withdrawal by Subject|6|||
129873278|NCT02347657|467494216|FG001|Overall Study|Withdrawal by Subject|7|||
129873279|NCT02347657|467494215|FG000|Overall Study|Randomized but not treated|1|||
129873280|NCT02347657|467494216|FG001|Overall Study|Randomized but not treated|0|||
129873281|NCT02347657|467494215|FG000|Overall Study|Other|3|||
129873282|NCT02347657|467494216|FG001|Overall Study|Other|3|||
129873283|NCT01995539|467494217|FG000|Overall Study|Screening Failure|1|||
129873284|NCT01995539|467494217|FG000|Overall Study|Withdrawal by Investigator|15|||
129873285|NCT01995539|467494217|FG000|Overall Study|Withdrawal by Subject|11|||
129873286|NCT01995539|467494217|FG000|Overall Study|Lost to Follow-up|5|||
129873287|NCT01995539|467494217|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
129873288|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
129873289|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
129873290|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
129873291|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
129873292|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
129873293|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
129873294|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
129873295|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
129873296|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
129873297|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
129984178|NCT04828837|467903864|FG001|Overall Study|Lack of Efficacy|0|||
129984179|NCT04828837|467903863|FG000|Overall Study|Admitted due to pneumothorax.|1|||
129984180|NCT04828837|467903864|FG001|Overall Study|Admitted due to pneumothorax.|0|||
129984181|NCT04828837|467903863|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
129984182|NCT04828837|467903864|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
129984183|NCT00545753|467903865|FG000|Overall Study|Withdrawal by Subject|0|||
129984184|NCT00545753|467903866|FG001|Overall Study|Withdrawal by Subject|1|||
129984185|NCT00545753|467903867|FG002|Overall Study|Withdrawal by Subject|10|||
129984186|NCT00545753|467903865|FG000|Overall Study|Lost to Follow-up|13|||
129984187|NCT00545753|467903866|FG001|Overall Study|Lost to Follow-up|3|||
129984188|NCT00545753|467903867|FG002|Overall Study|Lost to Follow-up|12|||
129984189|NCT00545753|467903865|FG000|Overall Study|Protocol Violation|3|||
129984190|NCT00545753|467903866|FG001|Overall Study|Protocol Violation|1|||
129984191|NCT00545753|467903867|FG002|Overall Study|Protocol Violation|4|||
129984192|NCT02297139|467903868|FG000|Overall Study|Disease progression|0|||
129984193|NCT02297139|467903869|FG001|Overall Study|Disease progression|1|||
129984194|NCT02297139|467903868|FG000|Overall Study|Study drug toxicity|0|||
129984195|NCT02297139|467903869|FG001|Overall Study|Study drug toxicity|4|||
129984196|NCT02297139|467903868|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129984197|NCT02297139|467903869|FG001|Overall Study|Participant request to discontinue study treatment|1|||
129984198|NCT02297139|467903868|FG000|Overall Study|Maximum clinical benefit|1|||
129984199|NCT02297139|467903869|FG001|Overall Study|Maximum clinical benefit|0|||
129984200|NCT02297139|467903868|FG000|Overall Study|Administrative reason by sponsor|0|||
129984201|NCT02297139|467903869|FG001|Overall Study|Administrative reason by sponsor|2|||
129984202|NCT02297139|467903868|FG000|Overall Study|Other reasons|0|||
129984203|NCT02297139|467903869|FG001|Overall Study|Other reasons|8|||
129984204|NCT01942785|467903870|FG000|Overall Study|Adverse Event|2|||
129984205|NCT01942785|467903870|FG000|Overall Study|Withdrawal by Subject|1|||
129984206|NCT01942785|467903870|FG000|Overall Study|Protocol Violation|1|||
129984207|NCT00552929|467903873|FG000|Overall Study|Lost to Follow-up|0|||
129984208|NCT00552929|467903874|FG001|Overall Study|Lost to Follow-up|0|||
129984209|NCT00552929|467903875|FG002|Overall Study|Lost to Follow-up|0|||
129984210|NCT00552929|467903876|FG003|Overall Study|Lost to Follow-up|0|||
129984211|NCT00552929|467903877|FG004|Overall Study|Lost to Follow-up|0|||
129984212|NCT00552929|467903878|FG005|Overall Study|Lost to Follow-up|0|||
129984213|NCT00552929|467903879|FG006|Overall Study|Lost to Follow-up|0|||
129984214|NCT00552929|467903880|FG007|Overall Study|Lost to Follow-up|0|||
129984215|NCT00552929|467903881|FG008|Overall Study|Lost to Follow-up|1|||
129984216|NCT00552929|467903882|FG009|Overall Study|Lost to Follow-up|0|||
129984217|NCT00552929|467903873|FG000|Overall Study|Not Eligible|0|||
129984218|NCT00552929|467903874|FG001|Overall Study|Not Eligible|0|||
129984219|NCT00552929|467903875|FG002|Overall Study|Not Eligible|0|||
129984220|NCT00552929|467903876|FG003|Overall Study|Not Eligible|0|||
129984221|NCT00552929|467903877|FG004|Overall Study|Not Eligible|0|||
129984222|NCT00552929|467903878|FG005|Overall Study|Not Eligible|1|||
129984223|NCT00552929|467903879|FG006|Overall Study|Not Eligible|0|||
129984224|NCT00552929|467903880|FG007|Overall Study|Not Eligible|0|||
129761954|NCT00117637|467091354|FG001|Second Intervention (Period 2)|reason not reported|0|||
129761955|NCT01582061|467091355|FG000|Overall Study|Lack of Efficacy|3|||
129761956|NCT01582061|467091356|FG001|Overall Study|Lack of Efficacy|23|||
129761957|NCT01582061|467091355|FG000|Overall Study|Adverse Event|12|||
129761958|NCT01582061|467091356|FG001|Overall Study|Adverse Event|8|||
129761959|NCT01582061|467091355|FG000|Overall Study|Withdrawal by Subject|10|||
129761960|NCT01582061|467091356|FG001|Overall Study|Withdrawal by Subject|4|||
129761961|NCT01582061|467091355|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129761962|NCT01582061|467091356|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129761963|NCT01582061|467091355|FG000|Overall Study|Death|0|||
129761964|NCT01582061|467091356|FG001|Overall Study|Death|1|||
129761965|NCT01582061|467091355|FG000|Overall Study|condition no longer requires study drug|1|||
129761966|NCT01582061|467091356|FG001|Overall Study|condition no longer requires study drug|0|||
129761967|NCT01582061|467091355|FG000|Overall Study|Lost to Follow-up|1|||
129761968|NCT01582061|467091356|FG001|Overall Study|Lost to Follow-up|0|||
129761969|NCT02756338|467091357|FG000|Overall Study|Withdrawn by Investigator|1|||
129761970|NCT02756338|467091357|FG000|Overall Study|Device Replaced with Pacemaker|4|||
129761971|NCT00300755|467091362|FG000|Overall Study|Adverse Event|1|||
129761972|NCT00300755|467091363|FG001|Overall Study|Adverse Event|2|||
129761973|NCT00300755|467091364|FG002|Overall Study|Adverse Event|1|||
129761974|NCT00300755|467091362|FG000|Overall Study|Withdrawal by Subject|0|||
129761975|NCT00300755|467091363|FG001|Overall Study|Withdrawal by Subject|2|||
129984225|NCT00552929|467903881|FG008|Overall Study|Not Eligible|0|||
129984226|NCT00552929|467903882|FG009|Overall Study|Not Eligible|0|||
129984227|NCT01147536|467903886|FG000|Overall Study|Administrative study close|2|||
129984228|NCT01147536|467903886|FG000|Overall Study|Death|1|||
129984229|NCT04577001|467903887|FG000|Overall Study|Subject became ineligible|0|||
129984230|NCT04577001|467903888|FG001|Overall Study|Subject became ineligible|1|||
129761976|NCT00300755|467091364|FG002|Overall Study|Withdrawal by Subject|0|||
129761977|NCT00300755|467091362|FG000|Overall Study|Protocol Violation|0|||
129761978|NCT00300755|467091363|FG001|Overall Study|Protocol Violation|0|||
129984231|NCT05110690|467903889|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
129761979|NCT00300755|467091364|FG002|Overall Study|Protocol Violation|1|||
129984232|NCT05110690|467903889|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
129761980|NCT02694744|467091368|FG000|Overall Study|Adverse Event|2|||
129761981|NCT02694744|467091369|FG001|Overall Study|Adverse Event|1|||
129761982|NCT02694744|467091368|FG000|Overall Study|Withdrawal by Subject|2|||
129761983|NCT02694744|467091369|FG001|Overall Study|Withdrawal by Subject|1|||
129761984|NCT02694744|467091368|FG000|Overall Study|Physician Decision|1|||
129761985|NCT02694744|467091369|FG001|Overall Study|Physician Decision|2|||
129761986|NCT02694744|467091368|FG000|Overall Study|Lost to Follow-up|1|||
129761987|NCT02694744|467091369|FG001|Overall Study|Lost to Follow-up|0|||
129761988|NCT02694744|467091368|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
129761989|NCT02694744|467091369|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
129761990|NCT00686777|467091370|FG000|Overall Study|Adverse Event|2|||
129761991|NCT00686777|467091370|FG000|Overall Study|Pregnancy|1|||
129873298|NCT00261495|467494218|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
129984233|NCT05110690|467903889|FG000|Completion of Intervention|Lost to Follow-up|1|||
129984234|NCT05110690|467903889|FG000|Completion of Intervention|Death|1|||
129984235|NCT05110690|467903889|FG000|Completion of Intervention|Withdrawal by Subject|2|||
129984236|NCT03973931|467903892|FG000|Overall Study|Lost to Follow-up|47|||
129984237|NCT03973931|467903893|FG001|Overall Study|Lost to Follow-up|63|||
129984238|NCT03973931|467903894|FG002|Overall Study|Lost to Follow-up|51|||
129984239|NCT03973931|467903895|FG003|Overall Study|Lost to Follow-up|54|||
129984240|NCT03973931|467903892|FG000|Overall Study|opted out|6|||
129984241|NCT03973931|467903893|FG001|Overall Study|opted out|5|||
129984242|NCT03973931|467903894|FG002|Overall Study|opted out|5|||
129984243|NCT03973931|467903895|FG003|Overall Study|opted out|1|||
129984244|NCT00925353|467903896|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
129984245|NCT03507777|467905426|FG000|Overall Study|Lost to Follow-up|5|||
129984246|NCT03507777|467905427|FG001|Overall Study|Lost to Follow-up|7|||
129984247|NCT03507777|467905426|FG000|Overall Study|Withdrawal by Subject|6|||
129984248|NCT03507777|467905427|FG001|Overall Study|Withdrawal by Subject|11|||
129984249|NCT03507777|467905426|FG000|Overall Study|Death|30|||
129984250|NCT03507777|467905427|FG001|Overall Study|Death|44|||
129984251|NCT03507777|467905426|FG000|Overall Study|Other Reasons|3|||
129984252|NCT03507777|467905427|FG001|Overall Study|Other Reasons|8|||
129984253|NCT01879722|467905428|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129761992|NCT00686777|467091370|FG000|Overall Study|Withdrawal by Subject|2|||
129761993|NCT00686777|467091370|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
129761994|NCT00686777|467091370|FG000|Overall Study|No Visit|1|||
129761995|NCT01945021|467091371|FG000|Overall Study|Adverse Event|1|||
129761996|NCT01945021|467091371|FG000|Overall Study|Withdrawal of consent|12|||
129761997|NCT01945021|467091371|FG000|Overall Study|Lost to Follow-up|5|||
129761998|NCT01945021|467091371|FG000|Overall Study|Death|65|||
129761999|NCT03582215|467091372|FG000|Overall Study|Adverse Event|1|||
129762000|NCT03582215|467091373|FG001|Overall Study|Adverse Event|0|||
129762001|NCT03582215|467091374|FG002|Overall Study|Adverse Event|0|||
129762002|NCT03582215|467091375|FG003|Overall Study|Adverse Event|0|||
129762003|NCT03582215|467091376|FG004|Overall Study|Adverse Event|0|||
129762004|NCT03582215|467091377|FG005|Overall Study|Adverse Event|0|||
129762005|NCT03582215|467091378|FG006|Overall Study|Adverse Event|2|||
129762006|NCT03582215|467091379|FG007|Overall Study|Adverse Event|2|||
129762007|NCT02163902|467091380|FG000|Overall Study|Subject's Request|3|||
129762008|NCT02163902|467091381|FG001|Overall Study|Subject's Request|4|||
129762009|NCT02163902|467091380|FG000|Overall Study|Lost to Follow-up|6|||
129762010|NCT02163902|467091381|FG001|Overall Study|Lost to Follow-up|7|||
129762011|NCT02163902|467091380|FG000|Overall Study|Administrative Decision|2|||
129762012|NCT02163902|467091381|FG001|Overall Study|Administrative Decision|2|||
129762013|NCT02174731|467091382|FG000|Overall Study|Participant decision|67|||
129762014|NCT02174731|467091383|FG001|Overall Study|Participant decision|64|||
129762015|NCT02174731|467091382|FG000|Overall Study|Incorrect enrolment before randomization|0|||
129762016|NCT02174731|467091383|FG001|Overall Study|Incorrect enrolment before randomization|1|||
129762017|NCT02174731|467091382|FG000|Overall Study|Missing|2|||
129762018|NCT02174731|467091383|FG001|Overall Study|Missing|0|||
129762019|NCT03119259|467091384|FG000|Overall Study|Withdrawn as no longer eligible|1|||
129762020|NCT03119259|467091385|FG001|Overall Study|Withdrawn as no longer eligible|0|||
129762021|NCT03119259|467091384|FG000|Overall Study|Withdrawal by Subject|4|||
129873299|NCT00261495|467494219|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
129984254|NCT01879722|467905429|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129984255|NCT01879722|467905430|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129984256|NCT01879722|467905431|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129984257|NCT01879722|467905432|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
129984258|NCT01879722|467905433|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
129984259|NCT01879722|467905434|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
129762022|NCT03119259|467091385|FG001|Overall Study|Withdrawal by Subject|2|||
129762023|NCT03119259|467091384|FG000|Overall Study|Lost to Follow-up|0|||
129762024|NCT03119259|467091385|FG001|Overall Study|Lost to Follow-up|1|||
129762025|NCT01168349|467091393|FG000|Overall Study|Death|157|||
129762026|NCT01168349|467091393|FG000|Overall Study|Lost to Follow-up|34|||
129762027|NCT01168349|467091393|FG000|Overall Study|Withdrawal by Subject|9|||
129984260|NCT01879722|467905435|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
129984261|NCT01879722|467905436|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
129984262|NCT01879722|467905437|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
129984263|NCT01879722|467905428|FG000|Overall Study|Voluntary Withdrawal|0|||
129984264|NCT01879722|467905429|FG001|Overall Study|Voluntary Withdrawal|0|||
129984265|NCT01879722|467905430|FG002|Overall Study|Voluntary Withdrawal|0|||
129984266|NCT01879722|467905431|FG003|Overall Study|Voluntary Withdrawal|0|||
129984267|NCT01879722|467905432|FG004|Overall Study|Voluntary Withdrawal|0|||
129984268|NCT01879722|467905433|FG005|Overall Study|Voluntary Withdrawal|0|||
129984269|NCT01879722|467905434|FG006|Overall Study|Voluntary Withdrawal|0|||
129984270|NCT01879722|467905435|FG007|Overall Study|Voluntary Withdrawal|0|||
129984271|NCT01879722|467905436|FG008|Overall Study|Voluntary Withdrawal|1|||
129984272|NCT01879722|467905437|FG009|Overall Study|Voluntary Withdrawal|0|||
129984273|NCT01253304|467905438|FG000|Overall Study|Adverse Event|0|||
129984274|NCT01253304|467905439|FG001|Overall Study|Adverse Event|0|||
129984275|NCT01253304|467905440|FG002|Overall Study|Adverse Event|0|||
129984276|NCT01253304|467905441|FG003|Overall Study|Adverse Event|1|||
129984277|NCT01327495|467905442|FG000|Overall Study|Adverse Event|2|||
129984278|NCT01327495|467905443|FG001|Overall Study|Adverse Event|1|||
129984279|NCT01327495|467905444|FG002|Overall Study|Adverse Event|1|||
129984280|NCT01327495|467905445|FG003|Overall Study|Adverse Event|0|||
129984281|NCT01327495|467905446|FG004|Overall Study|Adverse Event|0|||
129984282|NCT01327495|467905447|FG005|Overall Study|Adverse Event|2|||
129984283|NCT01327495|467905442|FG000|Overall Study|Withdrawal by Subject|0|||
129984284|NCT01327495|467905443|FG001|Overall Study|Withdrawal by Subject|1|||
129984285|NCT01327495|467905444|FG002|Overall Study|Withdrawal by Subject|1|||
129984286|NCT01327495|467905445|FG003|Overall Study|Withdrawal by Subject|0|||
129984287|NCT01327495|467905446|FG004|Overall Study|Withdrawal by Subject|1|||
129984288|NCT01327495|467905447|FG005|Overall Study|Withdrawal by Subject|0|||
129984289|NCT01327495|467905442|FG000|Overall Study|Physician Decision|0|||
129984290|NCT01327495|467905443|FG001|Overall Study|Physician Decision|0|||
129984291|NCT01327495|467905444|FG002|Overall Study|Physician Decision|0|||
129984292|NCT01327495|467905445|FG003|Overall Study|Physician Decision|0|||
129984293|NCT01327495|467905446|FG004|Overall Study|Physician Decision|2|||
129984294|NCT01327495|467905447|FG005|Overall Study|Physician Decision|0|||
129984295|NCT00006011|467905448|FG000|Overall Study|Disease progression|13|||
129984296|NCT00006011|467905449|FG001|Overall Study|Disease progression|6|||
129762028|NCT01168349|467091393|FG000|Overall Study|Kidney transplantation|3|||
129762029|NCT01168349|467091393|FG000|Overall Study|Other|22|||
129873300|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
129873301|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
129873302|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
129873303|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
129873304|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
129873305|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
129873306|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
129873307|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
129873308|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
129873309|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
129873310|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
129873311|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
129873312|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
129873313|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
129873314|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
129873315|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
129873316|NCT00261495|467494218|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
129873317|NCT00261495|467494219|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
129873318|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
129873319|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
129873320|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
129873321|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
129873322|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
129873323|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
129873324|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129873325|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
129873326|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
129873327|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
129873328|NCT00261495|467494218|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
129984297|NCT00006011|467905450|FG002|Overall Study|Disease progression|26|||
129984298|NCT00006011|467905448|FG000|Overall Study|Refused further treatment|15|||
129984299|NCT00006011|467905449|FG001|Overall Study|Refused further treatment|13|||
129984300|NCT00006011|467905450|FG002|Overall Study|Refused further treatment|26|||
129984301|NCT00006011|467905448|FG000|Overall Study|Adverse Event|15|||
129873329|NCT00261495|467494219|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129873330|NCT01059630|467494220|FG000|Overall Study|Death|100|||
129873331|NCT01059630|467494221|FG001|Overall Study|Death|84|||
129873332|NCT01059630|467494220|FG000|Overall Study|Lost to Follow-up|4|||
129873333|NCT01059630|467494221|FG001|Overall Study|Lost to Follow-up|1|||
129873334|NCT01059630|467494220|FG000|Overall Study|Physician Decision|2|||
129873335|NCT01059630|467494221|FG001|Overall Study|Physician Decision|4|||
129873336|NCT01059630|467494220|FG000|Overall Study|Withdrawal by Subject|21|||
129873337|NCT01059630|467494221|FG001|Overall Study|Withdrawal by Subject|14|||
129873338|NCT03351738|467494222|FG000|Overall Study|Withdrawal by Subject|0|||
129873339|NCT03351738|467494223|FG001|Overall Study|Withdrawal by Subject|1|||
129873340|NCT03351738|467494224|FG002|Overall Study|Withdrawal by Subject|0|||
129873341|NCT03351738|467494225|FG003|Overall Study|Withdrawal by Subject|1|||
129873342|NCT03351738|467494226|FG004|Overall Study|Withdrawal by Subject|0|||
129873343|NCT03351738|467494227|FG005|Overall Study|Withdrawal by Subject|0|||
129873344|NCT01375205|467494228|FG000|Overall Study|Lost to Follow-up|15|||
129984302|NCT00006011|467905449|FG001|Overall Study|Adverse Event|39|||
129984303|NCT00006011|467905450|FG002|Overall Study|Adverse Event|5|||
129984304|NCT00006011|467905448|FG000|Overall Study|Death|0|||
129984305|NCT00006011|467905449|FG001|Overall Study|Death|1|||
129873345|NCT01375205|467494229|FG001|Overall Study|Lost to Follow-up|12|||
129873346|NCT01375205|467494228|FG000|Overall Study|Withdrawal by Subject|6|||
129873347|NCT01375205|467494229|FG001|Overall Study|Withdrawal by Subject|1|||
129873348|NCT05687032|467494230|FG000|Treatment Phase|Adverse Event|13|||
129873349|NCT05687032|467494230|FG000|Treatment Phase|Death|1|||
129873350|NCT05687032|467494230|FG000|Treatment Phase|Physician Decision|3|||
129873351|NCT05687032|467494230|FG000|Treatment Phase|Progressive disease|9|||
129873352|NCT05687032|467494230|FG000|Treatment Phase|Withdrawal by Subject|5|||
129873353|NCT05687032|467494230|FG000|Follow-Up Phase|Death|16|||
129873354|NCT05687032|467494230|FG000|Follow-Up Phase|Ongoing|26|||
129873355|NCT05614089|467494231|FG000|Overall Study|Pregnancy|5|||
129873356|NCT05614089|467494232|FG001|Overall Study|Pregnancy|2|||
129873357|NCT05614089|467494231|FG000|Overall Study|Lost to Follow-up|5|||
129873358|NCT05614089|467494232|FG001|Overall Study|Lost to Follow-up|1|||
129873359|NCT05614089|467494231|FG000|Overall Study|Death|0|||
129873360|NCT05614089|467494232|FG001|Overall Study|Death|1|||
129873361|NCT05614089|467494231|FG000|Overall Study|Adverse Event|1|||
129873362|NCT05614089|467494232|FG001|Overall Study|Adverse Event|0|||
129873363|NCT00701038|467494244|FG000|Overall Study|study amended pilot group of patients|4|||
129873364|NCT00701038|467494245|FG001|Overall Study|study amended pilot group of patients|4|||
129873365|NCT01064297|467494248|FG000|Overall Study|Lost to Follow-up|791|||
129873366|NCT01064297|467494249|FG001|Overall Study|Lost to Follow-up|48|||
129873367|NCT01064297|467494250|FG002|Overall Study|Lost to Follow-up|133|||
129873368|NCT04058353|467494256|FG000|Overall Study|Adverse Event|2|||
129873369|NCT04058353|467494257|FG001|Overall Study|Adverse Event|1|||
129873370|NCT04058353|467494256|FG000|Overall Study|Physician Decision|1|||
129873371|NCT04058353|467494257|FG001|Overall Study|Physician Decision|0|||
129873372|NCT04058353|467494256|FG000|Overall Study|Other|1|||
129873373|NCT04058353|467494257|FG001|Overall Study|Other|0|||
129873374|NCT03444376|467494260|FG000|Part A|Disease relapse or Progression|1|||
129873375|NCT03444376|467494260|FG000|Part A|Withdrawal by Subject|2|||
129873376|NCT03444376|467494260|FG000|Part A|Adverse Event|1|||
129873377|NCT03444376|467494260|FG000|Part B|Disease relapse or Progression|18|||
129873378|NCT03444376|467494260|FG000|Part B|Withdrawal by Subject|2|||
129873379|NCT03444376|467494260|FG000|Part B|Adverse Event|2|||
129873380|NCT03444376|467494260|FG000|Part B|Physician Decision|1|||
129873381|NCT03444376|467494260|FG000|Part C|Disease relapse or Progression|43|||
129873382|NCT03444376|467494260|FG000|Part C|Withdrawal by Subject|5|||
129873383|NCT03444376|467494260|FG000|Part C|Adverse Event|2|||
129873384|NCT03444376|467494260|FG000|Part C|Physician Decision|2|||
129873385|NCT03444376|467494260|FG000|Part C|Death|1|||
129891086|NCT01723826|467559612|FG002|Overall Study|Withdrawal by Subject|27|||
129984306|NCT00006011|467905450|FG002|Overall Study|Death|2|||
129984307|NCT00006011|467905448|FG000|Overall Study|Other|4|||
129984308|NCT00006011|467905449|FG001|Overall Study|Other|2|||
129984309|NCT00006011|467905450|FG002|Overall Study|Other|5|||
129984310|NCT00006011|467905448|FG000|Overall Study|Ineligible|18|||
129984311|NCT00006011|467905449|FG001|Overall Study|Ineligible|16|||
129984312|NCT00006011|467905450|FG002|Overall Study|Ineligible|9|||
129984313|NCT03212989|467905452|FG000|Overall Study|Physician Decision|8|||
129984314|NCT03047395|467905455|FG000|Overall Study|Adverse Event|142|||
129984315|NCT03047395|467905455|FG000|Overall Study|Withdrawal by Subject|155|||
129891087|NCT01723826|467559613|FG003|Overall Study|Withdrawal by Subject|48|||
129891088|NCT02408549|467559616|FG000|Overall Study|Adverse Event|15|||
129891089|NCT02408549|467559616|FG000|Overall Study|Death|4|||
129891090|NCT02408549|467559616|FG000|Overall Study|Lack of Efficacy|17|||
129891091|NCT02408549|467559616|FG000|Overall Study|Protocol Violation|4|||
129891092|NCT02408549|467559616|FG000|Overall Study|Lost to Follow-up|6|||
129891093|NCT02408549|467559616|FG000|Overall Study|Consent withdrawn|30|||
129891094|NCT02408549|467559616|FG000|Overall Study|Neurology research program closing at site|1|||
129984316|NCT03047395|467905455|FG000|Overall Study|Lost to Follow-up|144|||
129873386|NCT03308825|467495596|FG000|Overall Study|Lost to Follow-up|2|||
129873387|NCT03308825|467495597|FG001|Overall Study|Lost to Follow-up|2|||
129873388|NCT03308825|467495598|FG002|Overall Study|Lost to Follow-up|1|||
129873389|NCT03308825|467495599|FG003|Overall Study|Lost to Follow-up|0|||
129873390|NCT03308825|467495596|FG000|Overall Study|Protocol Violation|0|||
129873391|NCT03308825|467495597|FG001|Overall Study|Protocol Violation|2|||
129873392|NCT03308825|467495598|FG002|Overall Study|Protocol Violation|0|||
129873393|NCT03308825|467495599|FG003|Overall Study|Protocol Violation|0|||
129873394|NCT00685945|467495600|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
129873395|NCT03183388|467495601|FG000|Overall Study|Lost to Follow-up|3|||
129873396|NCT03183388|467495602|FG001|Overall Study|Lost to Follow-up|5|||
129873397|NCT03183388|467495601|FG000|Overall Study|Physician Decision|1|||
129762030|NCT01168349|467091393|FG000|Overall Study|Protocol Violation|76|||
129762031|NCT03535974|467091394|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
129762032|NCT03535974|467091395|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
129762033|NCT03535974|467091396|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
129762034|NCT03535974|467091394|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
129762035|NCT03535974|467091395|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
129873398|NCT03183388|467495602|FG001|Overall Study|Physician Decision|4|||
129873399|NCT03183388|467495601|FG000|Overall Study|Withdrawal by Subject|4|||
129873400|NCT03183388|467495602|FG001|Overall Study|Withdrawal by Subject|1|||
129873401|NCT03183388|467495601|FG000|Overall Study|Moved|1|||
129873402|NCT03183388|467495602|FG001|Overall Study|Moved|0|||
129873403|NCT03183388|467495601|FG000|Overall Study|Met Exclusion Criteria|2|||
129873404|NCT03183388|467495602|FG001|Overall Study|Met Exclusion Criteria|2|||
129873405|NCT03183388|467495601|FG000|Overall Study|COVID Pandemic Related|2|||
129873406|NCT03183388|467495602|FG001|Overall Study|COVID Pandemic Related|4|||
129873407|NCT01728792|467495603|FG000|Overall Study|Withdrawal of Consent|1|||
129873408|NCT01728792|467495604|FG001|Overall Study|Withdrawal of Consent|1|||
129873409|NCT01728792|467495605|FG002|Overall Study|Withdrawal of Consent|0|||
129873410|NCT01728792|467495606|FG003|Overall Study|Withdrawal of Consent|1|||
129873411|NCT01728792|467495607|FG004|Overall Study|Withdrawal of Consent|0|||
129873412|NCT01728792|467495603|FG000|Overall Study|Lost to Follow-up|2|||
129873413|NCT01728792|467495604|FG001|Overall Study|Lost to Follow-up|1|||
129873414|NCT01728792|467495605|FG002|Overall Study|Lost to Follow-up|4|||
129873415|NCT01728792|467495606|FG003|Overall Study|Lost to Follow-up|2|||
129873416|NCT01728792|467495607|FG004|Overall Study|Lost to Follow-up|0|||
129873417|NCT04277455|467495610|FG000|Overall Study|Lost to Follow-up|1|||
129873418|NCT04737109|467495611|FG000|Study Treatment|Disease Progression|5|||
129873419|NCT04737109|467495612|FG001|Study Treatment|Disease Progression|0|||
129873420|NCT04737109|467495613|FG002|Study Treatment|Disease Progression|0|||
129873421|NCT04737109|467495614|FG003|Study Treatment|Disease Progression|0|||
129873422|NCT04737109|467495611|FG000|Study Treatment|Death on study|1|||
129873423|NCT04737109|467495612|FG001|Study Treatment|Death on study|0|||
129873424|NCT04737109|467495613|FG002|Study Treatment|Death on study|0|||
129873425|NCT04737109|467495614|FG003|Study Treatment|Death on study|0|||
129984317|NCT03047395|467905455|FG000|Overall Study|COVID-19 Infection|2|||
129984318|NCT03047395|467905455|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
129984319|NCT03047395|467905455|FG000|Overall Study|Other, Not Specified|117|||
129984320|NCT03484273|467905456|FG000|Overall Study|Equipment Malfunction|1|||
129984321|NCT03484273|467905456|FG000|Overall Study|Data excluded from analysis|1|||
129984322|NCT00560066|467905459|FG000|Overall Study|Death|2|||
129984323|NCT00560066|467905460|FG001|Overall Study|Death|1|||
129984324|NCT00560066|467905459|FG000|Overall Study|Withdrawal by Subject|0|||
129984325|NCT00560066|467905460|FG001|Overall Study|Withdrawal by Subject|3|||
129984326|NCT00560066|467905459|FG000|Overall Study|Lost to Follow-up|4|||
129984327|NCT00560066|467905460|FG001|Overall Study|Lost to Follow-up|10|||
129984328|NCT00560066|467905459|FG000|Overall Study|Protocol Violation|0|||
129984329|NCT00560066|467905460|FG001|Overall Study|Protocol Violation|1|||
129984330|NCT00560066|467905459|FG000|Overall Study|Administrative reason|0|||
129984331|NCT00560066|467905460|FG001|Overall Study|Administrative reason|5|||
129984332|NCT00560066|467905459|FG000|Overall Study|Missing primary reason|0|||
129984333|NCT00560066|467905460|FG001|Overall Study|Missing primary reason|2|||
129984334|NCT01258595|467905467|FG000|Overall Study|Lost to Follow-up|1|||
129873426|NCT01582789|467495619|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129873427|NCT01582789|467495620|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129873428|NCT02259517|467495621|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
129873429|NCT02259517|467495622|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
129984335|NCT01258595|467905468|FG001|Overall Study|Lost to Follow-up|0|||
129984336|NCT01258595|467905467|FG000|Overall Study|Withdrawal by Subject|0|||
129873430|NCT02259517|467495623|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
129984337|NCT01258595|467905468|FG001|Overall Study|Withdrawal by Subject|1|||
129873431|NCT02259517|467495621|FG000|Overall Study|Withdrawal by Subject|0|||
129873432|NCT02259517|467495622|FG001|Overall Study|Withdrawal by Subject|0|||
129873433|NCT02259517|467495623|FG002|Overall Study|Withdrawal by Subject|3|||
129873434|NCT02276066|467495624|FG000|Overall Study|Lost to Follow-up|21|||
129984338|NCT04738292|467905469|FG000|Overall Study|Death|1|||
129984339|NCT01056718|467905473|FG000|Overall Study|Withdrawal by Subject|2|||
129984340|NCT01056718|467905473|FG000|Overall Study|Ischemia on baseline stress test|1|||
129984341|NCT05086276|467905474|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
129984342|NCT05086276|467905475|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
129984343|NCT00895154|467905476|FG000|Overall Study|Lost to Follow-up|1|||
129984344|NCT00895154|467905477|FG001|Overall Study|Lost to Follow-up|1|||
129984345|NCT00895154|467905476|FG000|Overall Study|Withdrawal by Subject|0|||
129984346|NCT00895154|467905477|FG001|Overall Study|Withdrawal by Subject|1|||
129984347|NCT01993927|467905478|FG000|Overall Study|Case Report Forms Uncollected|18|||
129984348|NCT01993927|467905478|FG000|Overall Study|Protocol Violation|11|||
129984349|NCT00777088|467905479|FG000|Overall Study|PED Treatment not attempted|1|||
129984350|NCT00287690|467905480|FG000|Overall Study|Protocol Violation|20|||
129984351|NCT00287690|467905481|FG001|Overall Study|Protocol Violation|26|||
129984352|NCT05017103|467905483|FG000|Overall Study|Death|2|||
129984353|NCT01747551|467905484|FG000|Overall Study|Progressive Disease|24|||
129984354|NCT01747551|467905485|FG001|Overall Study|Progressive Disease|17|||
129984355|NCT01747551|467905484|FG000|Overall Study|Death|3|||
129984356|NCT01747551|467905485|FG001|Overall Study|Death|1|||
129984357|NCT01747551|467905484|FG000|Overall Study|Adverse Event|7|||
129984358|NCT01747551|467905485|FG001|Overall Study|Adverse Event|1|||
129984359|NCT01747551|467905484|FG000|Overall Study|Prolonged Treatment Delay|2|||
129984360|NCT01747551|467905485|FG001|Overall Study|Prolonged Treatment Delay|0|||
129984361|NCT01747551|467905484|FG000|Overall Study|Withdrawal by Subject|3|||
129984362|NCT01747551|467905485|FG001|Overall Study|Withdrawal by Subject|1|||
129984363|NCT01747551|467905484|FG000|Overall Study|Physician Decision|2|||
129984364|NCT01747551|467905485|FG001|Overall Study|Physician Decision|1|||
129984365|NCT01747551|467905484|FG000|Overall Study|Other|2|||
129984366|NCT01747551|467905485|FG001|Overall Study|Other|0|||
129984367|NCT01142115|467905486|FG000|First Intervention|Lack of Efficacy|1|||
129984368|NCT01142115|467905487|FG001|First Intervention|Lack of Efficacy|1|||
129984369|NCT01142115|467905486|FG000|First Intervention|Adverse Event|1|||
129984370|NCT01142115|467905487|FG001|First Intervention|Adverse Event|0|||
129984371|NCT03406078|467905488|FG000|Overall Study|Death|1|||
129984372|NCT03406078|467905489|FG001|Overall Study|Death|0|||
129984373|NCT03406078|467905488|FG000|Overall Study|Lost to Follow-up|0|||
129984374|NCT03406078|467905489|FG001|Overall Study|Lost to Follow-up|1|||
129984375|NCT03406078|467905488|FG000|Overall Study|Withdrawal by Subject|5|||
129984376|NCT03406078|467905489|FG001|Overall Study|Withdrawal by Subject|2|||
129984377|NCT02091206|467905490|FG000|Treatment Period|Adverse Event|0|||
129984378|NCT02091206|467905491|FG001|Treatment Period|Adverse Event|1|||
129984379|NCT02091206|467905492|FG002|Treatment Period|Adverse Event|0|||
129984380|NCT02091206|467905493|FG003|Treatment Period|Adverse Event|0|||
129984381|NCT02091206|467905490|FG000|Treatment Period|Met withdrawal criteria|0|||
129984382|NCT02091206|467905491|FG001|Treatment Period|Met withdrawal criteria|0|||
129984383|NCT02091206|467905492|FG002|Treatment Period|Met withdrawal criteria|1|||
129984384|NCT02091206|467905493|FG003|Treatment Period|Met withdrawal criteria|0|||
129984385|NCT02091206|467905490|FG000|Taper Period|Participant refused study drug|1|||
129984386|NCT02091206|467905491|FG001|Taper Period|Participant refused study drug|0|||
129984387|NCT02091206|467905492|FG002|Taper Period|Participant refused study drug|0|||
129984388|NCT02091206|467905493|FG003|Taper Period|Participant refused study drug|1|||
129984389|NCT02091206|467905490|FG000|Taper Period|Lost to Follow-up|0|||
129984390|NCT02091206|467905491|FG001|Taper Period|Lost to Follow-up|0|||
129984391|NCT02091206|467905492|FG002|Taper Period|Lost to Follow-up|0|||
129984392|NCT02091206|467905493|FG003|Taper Period|Lost to Follow-up|1|||
129984393|NCT00700778|467905494|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
129984394|NCT00350103|467905497|FG000|Overall Study|Adverse Event|12|||
129984395|NCT00350103|467905498|FG001|Overall Study|Adverse Event|29|||
129984396|NCT00350103|467905499|FG002|Overall Study|Adverse Event|17|||
129984397|NCT00350103|467905497|FG000|Overall Study|Lack of Efficacy|5|||
129984398|NCT00350103|467905498|FG001|Overall Study|Lack of Efficacy|1|||
129984399|NCT00350103|467905499|FG002|Overall Study|Lack of Efficacy|3|||
129539362|NCT00198107|466266850|FG002|Double-Blind Period|Lack of Efficacy|0|||
129873435|NCT02276066|467495625|FG001|Overall Study|Lost to Follow-up|11|||
129984400|NCT00350103|467905497|FG000|Overall Study|Withdrawal by Subject|6|||
129873436|NCT01191840|467495633|FG000|Overall Study|withdrew consent|2|||
129984401|NCT00350103|467905498|FG001|Overall Study|Withdrawal by Subject|6|||
129984402|NCT00350103|467905499|FG002|Overall Study|Withdrawal by Subject|8|||
129539363|NCT00198107|466266848|FG000|Double-Blind Period|Lost to Follow-up|2|||
129651104|NCT00195494|466678595|FG005|Year 2|Protocol deviation|0|||
129873437|NCT01191840|467495634|FG001|Overall Study|withdrew consent|1|||
129984403|NCT00350103|467905497|FG000|Overall Study|Protocol Violation|0|||
129984404|NCT00350103|467905498|FG001|Overall Study|Protocol Violation|0|||
129984405|NCT00350103|467905499|FG002|Overall Study|Protocol Violation|1|||
129984406|NCT00350103|467905497|FG000|Overall Study|Unsatisfactory Compliance|2|||
129984407|NCT00350103|467905498|FG001|Overall Study|Unsatisfactory Compliance|2|||
129984408|NCT00350103|467905499|FG002|Overall Study|Unsatisfactory Compliance|1|||
129984409|NCT00350103|467905497|FG000|Overall Study|Investigator´s decision|1|||
129984410|NCT00350103|467905498|FG001|Overall Study|Investigator´s decision|1|||
129984411|NCT00350103|467905499|FG002|Overall Study|Investigator´s decision|0|||
129984412|NCT00350103|467905497|FG000|Overall Study|Exclusion criteria met|0|||
129984413|NCT00350103|467905498|FG001|Overall Study|Exclusion criteria met|0|||
129984414|NCT00350103|467905499|FG002|Overall Study|Exclusion criteria met|1|||
129984415|NCT00350103|467905497|FG000|Overall Study|Patient relocated|0|||
129984416|NCT00350103|467905498|FG001|Overall Study|Patient relocated|0|||
129984417|NCT00350103|467905499|FG002|Overall Study|Patient relocated|1|||
129984418|NCT00350103|467905497|FG000|Overall Study|Need for prohibited medication|1|||
129984419|NCT00350103|467905498|FG001|Overall Study|Need for prohibited medication|0|||
129984420|NCT00350103|467905499|FG002|Overall Study|Need for prohibited medication|0|||
129984421|NCT00350103|467905497|FG000|Overall Study|Personal reasons|0|||
129984422|NCT00350103|467905498|FG001|Overall Study|Personal reasons|0|||
129984423|NCT00350103|467905499|FG002|Overall Study|Personal reasons|1|||
129984424|NCT00350103|467905497|FG000|Overall Study|Patient stopped feeling pain|1|||
129984425|NCT00350103|467905498|FG001|Overall Study|Patient stopped feeling pain|0|||
129873438|NCT01191840|467495633|FG000|Overall Study|Subject discontinued treatment|1|||
129873439|NCT01191840|467495634|FG001|Overall Study|Subject discontinued treatment|2|||
129984426|NCT00350103|467905499|FG002|Overall Study|Patient stopped feeling pain|0|||
129984427|NCT00350103|467905497|FG000|Overall Study|PR greater than 250ms|0|||
129984428|NCT00350103|467905498|FG001|Overall Study|PR greater than 250ms|0|||
129984429|NCT00350103|467905499|FG002|Overall Study|PR greater than 250ms|1|||
129984430|NCT00350103|467905497|FG000|Overall Study|Wrong calculation of QT interval|0|||
129984431|NCT00350103|467905498|FG001|Overall Study|Wrong calculation of QT interval|0|||
129873440|NCT01191840|467495633|FG000|Overall Study|Lost to Follow-up|4|||
129873441|NCT01191840|467495634|FG001|Overall Study|Lost to Follow-up|6|||
129984432|NCT00350103|467905499|FG002|Overall Study|Wrong calculation of QT interval|1|||
129984433|NCT00350103|467905497|FG000|Overall Study|Sponsor mistake|1|||
129984434|NCT00350103|467905498|FG001|Overall Study|Sponsor mistake|0|||
129984435|NCT00350103|467905499|FG002|Overall Study|Sponsor mistake|0|||
129984436|NCT00350103|467905497|FG000|Overall Study|Randomization mistake|0|||
129539364|NCT00198107|466266849|FG001|Double-Blind Period|Lost to Follow-up|1|||
129539365|NCT00198107|466266850|FG002|Double-Blind Period|Lost to Follow-up|0|||
129539366|NCT00198107|466266848|FG000|Double-Blind Period|Physician Decision|1|||
129539367|NCT00198107|466266849|FG001|Double-Blind Period|Physician Decision|0|||
129984437|NCT00350103|467905498|FG001|Overall Study|Randomization mistake|1|||
129984438|NCT00350103|467905499|FG002|Overall Study|Randomization mistake|1|||
129984439|NCT00350103|467905497|FG000|Overall Study|Sponsor´s decision|0|||
129984440|NCT00350103|467905498|FG001|Overall Study|Sponsor´s decision|1|||
129539368|NCT00198107|466266850|FG002|Double-Blind Period|Physician Decision|0|||
129539369|NCT00198107|466266848|FG000|Double-Blind Period|Withdrawal by Subject|0|||
129539370|NCT00198107|466266849|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129539371|NCT00198107|466266850|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129539372|NCT00198107|466266848|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
129539373|NCT00198107|466266849|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
129539374|NCT00198107|466266850|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
129539375|NCT02383966|466266856|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
129539376|NCT02383966|466266857|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
129539377|NCT02383966|466266856|FG000|Overall Study|Randomized, but not treated|1|||
129539378|NCT02383966|466266857|FG001|Overall Study|Randomized, but not treated|3|||
129539379|NCT02163759|466266858|FG000|Overall Study|Withdrawal by Subject|1|||
129539380|NCT02163759|466266859|FG001|Overall Study|Withdrawal by Subject|5|||
129539381|NCT02163759|466266860|FG002|Overall Study|Withdrawal by Subject|1|||
129539382|NCT02163759|466266858|FG000|Overall Study|Adverse Event|0|||
129539383|NCT02163759|466266859|FG001|Overall Study|Adverse Event|0|||
129539384|NCT02163759|466266860|FG002|Overall Study|Adverse Event|1|||
129539385|NCT02163759|466266858|FG000|Overall Study|Death|0|||
129539386|NCT02163759|466266859|FG001|Overall Study|Death|0|||
129539387|NCT02163759|466266860|FG002|Overall Study|Death|1|||
129539388|NCT00451191|466266872|FG000|Overall Study|withdrawal or received alternate tx|15|||
129539389|NCT00451191|466266873|FG001|Overall Study|withdrawal or received alternate tx|11|||
129539390|NCT03575806|466266885|FG000|Overall Study|Withdrawal by Subject|0|||
129539391|NCT03575806|466266886|FG001|Overall Study|Withdrawal by Subject|2|||
129539392|NCT03575806|466266885|FG000|Overall Study|Protocol Violation|0|||
129539393|NCT03575806|466266886|FG001|Overall Study|Protocol Violation|2|||
129873442|NCT01191840|467495633|FG000|Overall Study|Non Staph Infection|4|||
129539394|NCT00219349|466266887|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
129539395|NCT00219349|466266887|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
129539396|NCT00219349|466266887|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
129539397|NCT00219349|466266887|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
129539398|NCT02777554|466266889|FG000|Overall Study|Adverse Event|4|||
129539399|NCT02777554|466266890|FG001|Overall Study|Adverse Event|4|||
129539400|NCT02777554|466266891|FG002|Overall Study|Adverse Event|0|||
129539401|NCT02777554|466266892|FG003|Overall Study|Adverse Event|1|||
129984441|NCT00350103|467905499|FG002|Overall Study|Sponsor´s decision|0|||
129984442|NCT00350103|467905497|FG000|Overall Study|Lost, Reason unknown|1|||
129984443|NCT00350103|467905498|FG001|Overall Study|Lost, Reason unknown|1|||
129984444|NCT00350103|467905499|FG002|Overall Study|Lost, Reason unknown|0|||
129984445|NCT02712905|467905500|FG000|Monotherapy|Death|2|||
129984446|NCT02712905|467905501|FG001|Monotherapy|Death|5|||
129984447|NCT02712905|467905502|FG002|Monotherapy|Death|0|||
129984448|NCT02712905|467905503|FG003|Monotherapy|Death|3|||
129984449|NCT02712905|467905504|FG004|Monotherapy|Death|15|||
129984450|NCT02712905|467905505|FG005|Monotherapy|Death|1|||
129984451|NCT02712905|467905506|FG006|Monotherapy|Death|3|||
129984452|NCT02712905|467905507|FG007|Monotherapy|Death|3|||
129984453|NCT02712905|467905508|FG008|Monotherapy|Death|0|||
129984454|NCT02712905|467905509|FG009|Monotherapy|Death|27|||
129984455|NCT02712905|467905510|FG010|Monotherapy|Death|2|||
129984456|NCT02712905|467905511|FG011|Monotherapy|Death|5|||
129984457|NCT02712905|467905512|FG012|Monotherapy|Death|0|||
129984458|NCT02712905|467905513|FG013|Monotherapy|Death|0|||
129984459|NCT02712905|467905514|FG014|Monotherapy|Death|0|||
129984460|NCT02712905|467905515|FG015|Monotherapy|Death|0|||
129984461|NCT02712905|467905516|FG016|Monotherapy|Death|0|||
129984462|NCT02712905|467905517|FG017|Monotherapy|Death|0|||
129984463|NCT02712905|467905500|FG000|Monotherapy|Lost to Follow-up|0|||
129984464|NCT02712905|467905501|FG001|Monotherapy|Lost to Follow-up|1|||
129984465|NCT02712905|467905502|FG002|Monotherapy|Lost to Follow-up|0|||
129984466|NCT02712905|467905503|FG003|Monotherapy|Lost to Follow-up|1|||
129984467|NCT02712905|467905504|FG004|Monotherapy|Lost to Follow-up|0|||
129984468|NCT02712905|467905505|FG005|Monotherapy|Lost to Follow-up|0|||
129984469|NCT02712905|467905506|FG006|Monotherapy|Lost to Follow-up|0|||
129984470|NCT02712905|467905507|FG007|Monotherapy|Lost to Follow-up|0|||
129984471|NCT02712905|467905508|FG008|Monotherapy|Lost to Follow-up|0|||
129984472|NCT02712905|467905509|FG009|Monotherapy|Lost to Follow-up|2|||
129984473|NCT02712905|467905510|FG010|Monotherapy|Lost to Follow-up|0|||
129984474|NCT02712905|467905511|FG011|Monotherapy|Lost to Follow-up|0|||
129984475|NCT02712905|467905512|FG012|Monotherapy|Lost to Follow-up|0|||
129984476|NCT02712905|467905513|FG013|Monotherapy|Lost to Follow-up|0|||
129984477|NCT02712905|467905514|FG014|Monotherapy|Lost to Follow-up|0|||
129984478|NCT02712905|467905515|FG015|Monotherapy|Lost to Follow-up|0|||
129984479|NCT02712905|467905516|FG016|Monotherapy|Lost to Follow-up|0|||
129984480|NCT02712905|467905517|FG017|Monotherapy|Lost to Follow-up|0|||
129984481|NCT02712905|467905500|FG000|Monotherapy|Physician Decision|1|||
129984482|NCT02712905|467905501|FG001|Monotherapy|Physician Decision|0|||
129984483|NCT02712905|467905502|FG002|Monotherapy|Physician Decision|0|||
129984484|NCT02712905|467905503|FG003|Monotherapy|Physician Decision|1|||
129984485|NCT02712905|467905504|FG004|Monotherapy|Physician Decision|0|||
129984486|NCT02712905|467905505|FG005|Monotherapy|Physician Decision|0|||
129984487|NCT02712905|467905506|FG006|Monotherapy|Physician Decision|0|||
129984488|NCT02712905|467905507|FG007|Monotherapy|Physician Decision|0|||
129984489|NCT02712905|467905508|FG008|Monotherapy|Physician Decision|0|||
129984490|NCT02712905|467905509|FG009|Monotherapy|Physician Decision|1|||
129984491|NCT02712905|467905510|FG010|Monotherapy|Physician Decision|0|||
129984492|NCT02712905|467905511|FG011|Monotherapy|Physician Decision|0|||
129984493|NCT02712905|467905512|FG012|Monotherapy|Physician Decision|0|||
129984494|NCT02712905|467905513|FG013|Monotherapy|Physician Decision|0|||
129984495|NCT02712905|467905514|FG014|Monotherapy|Physician Decision|0|||
129984496|NCT02712905|467905515|FG015|Monotherapy|Physician Decision|0|||
129984497|NCT02712905|467905516|FG016|Monotherapy|Physician Decision|0|||
129984498|NCT02712905|467905517|FG017|Monotherapy|Physician Decision|0|||
129984499|NCT02712905|467905500|FG000|Monotherapy|Study Terminated by Sponsor|0|||
129984500|NCT02712905|467905501|FG001|Monotherapy|Study Terminated by Sponsor|0|||
129984501|NCT02712905|467905502|FG002|Monotherapy|Study Terminated by Sponsor|0|||
129984502|NCT02712905|467905503|FG003|Monotherapy|Study Terminated by Sponsor|0|||
129984503|NCT02712905|467905504|FG004|Monotherapy|Study Terminated by Sponsor|1|||
129984504|NCT02712905|467905505|FG005|Monotherapy|Study Terminated by Sponsor|0|||
129984505|NCT02712905|467905506|FG006|Monotherapy|Study Terminated by Sponsor|0|||
129984506|NCT02712905|467905507|FG007|Monotherapy|Study Terminated by Sponsor|0|||
129984507|NCT02712905|467905508|FG008|Monotherapy|Study Terminated by Sponsor|0|||
129984508|NCT02712905|467905509|FG009|Monotherapy|Study Terminated by Sponsor|2|||
129984509|NCT02712905|467905510|FG010|Monotherapy|Study Terminated by Sponsor|0|||
129984510|NCT02712905|467905511|FG011|Monotherapy|Study Terminated by Sponsor|0|||
129984511|NCT02712905|467905512|FG012|Monotherapy|Study Terminated by Sponsor|0|||
129984512|NCT02712905|467905513|FG013|Monotherapy|Study Terminated by Sponsor|0|||
129984513|NCT02712905|467905514|FG014|Monotherapy|Study Terminated by Sponsor|0|||
129984514|NCT02712905|467905515|FG015|Monotherapy|Study Terminated by Sponsor|0|||
129984515|NCT02712905|467905516|FG016|Monotherapy|Study Terminated by Sponsor|0|||
129984516|NCT02712905|467905517|FG017|Monotherapy|Study Terminated by Sponsor|0|||
129984517|NCT02712905|467905500|FG000|Monotherapy|Withdrawal by Subject|0|||
129984518|NCT02712905|467905501|FG001|Monotherapy|Withdrawal by Subject|0|||
129984519|NCT02712905|467905502|FG002|Monotherapy|Withdrawal by Subject|1|||
129984520|NCT02712905|467905503|FG003|Monotherapy|Withdrawal by Subject|0|||
129984521|NCT02712905|467905504|FG004|Monotherapy|Withdrawal by Subject|2|||
129984522|NCT02712905|467905505|FG005|Monotherapy|Withdrawal by Subject|0|||
129984523|NCT02712905|467905506|FG006|Monotherapy|Withdrawal by Subject|0|||
129984524|NCT02712905|467905507|FG007|Monotherapy|Withdrawal by Subject|0|||
129984525|NCT02712905|467905508|FG008|Monotherapy|Withdrawal by Subject|0|||
129984526|NCT02712905|467905509|FG009|Monotherapy|Withdrawal by Subject|4|||
129984527|NCT02712905|467905510|FG010|Monotherapy|Withdrawal by Subject|1|||
129984528|NCT02712905|467905511|FG011|Monotherapy|Withdrawal by Subject|2|||
129984529|NCT02712905|467905512|FG012|Monotherapy|Withdrawal by Subject|0|||
129984530|NCT02712905|467905513|FG013|Monotherapy|Withdrawal by Subject|0|||
129984531|NCT02712905|467905514|FG014|Monotherapy|Withdrawal by Subject|0|||
129984532|NCT02712905|467905515|FG015|Monotherapy|Withdrawal by Subject|0|||
129984533|NCT02712905|467905516|FG016|Monotherapy|Withdrawal by Subject|0|||
129984534|NCT02712905|467905517|FG017|Monotherapy|Withdrawal by Subject|0|||
129984535|NCT02712905|467905500|FG000|Monotherapy|Started New Cancer Drug|0|||
129984536|NCT02712905|467905501|FG001|Monotherapy|Started New Cancer Drug|0|||
129984537|NCT02712905|467905502|FG002|Monotherapy|Started New Cancer Drug|0|||
129984538|NCT02712905|467905503|FG003|Monotherapy|Started New Cancer Drug|0|||
129984539|NCT02712905|467905504|FG004|Monotherapy|Started New Cancer Drug|0|||
129984540|NCT02712905|467905505|FG005|Monotherapy|Started New Cancer Drug|1|||
129984541|NCT02712905|467905506|FG006|Monotherapy|Started New Cancer Drug|0|||
129984542|NCT02712905|467905507|FG007|Monotherapy|Started New Cancer Drug|0|||
129984543|NCT02712905|467905508|FG008|Monotherapy|Started New Cancer Drug|0|||
129984544|NCT02712905|467905509|FG009|Monotherapy|Started New Cancer Drug|0|||
129984545|NCT02712905|467905510|FG010|Monotherapy|Started New Cancer Drug|0|||
129984546|NCT02712905|467905511|FG011|Monotherapy|Started New Cancer Drug|0|||
129984547|NCT02712905|467905512|FG012|Monotherapy|Started New Cancer Drug|0|||
129984548|NCT02712905|467905513|FG013|Monotherapy|Started New Cancer Drug|0|||
129984549|NCT02712905|467905514|FG014|Monotherapy|Started New Cancer Drug|0|||
129984550|NCT02712905|467905515|FG015|Monotherapy|Started New Cancer Drug|0|||
129984551|NCT02712905|467905516|FG016|Monotherapy|Started New Cancer Drug|0|||
129984552|NCT02712905|467905517|FG017|Monotherapy|Started New Cancer Drug|0|||
129984553|NCT02712905|467905500|FG000|Monotherapy|Adverse Event|0|||
129984554|NCT02712905|467905501|FG001|Monotherapy|Adverse Event|0|||
129984555|NCT02712905|467905502|FG002|Monotherapy|Adverse Event|0|||
129984556|NCT02712905|467905503|FG003|Monotherapy|Adverse Event|0|||
129984557|NCT02712905|467905504|FG004|Monotherapy|Adverse Event|0|||
129984558|NCT02712905|467905505|FG005|Monotherapy|Adverse Event|0|||
129984559|NCT02712905|467905506|FG006|Monotherapy|Adverse Event|0|||
129984560|NCT02712905|467905507|FG007|Monotherapy|Adverse Event|0|||
129984561|NCT02712905|467905508|FG008|Monotherapy|Adverse Event|1|||
129984562|NCT02712905|467905509|FG009|Monotherapy|Adverse Event|0|||
129984563|NCT02712905|467905510|FG010|Monotherapy|Adverse Event|0|||
129984564|NCT02712905|467905511|FG011|Monotherapy|Adverse Event|0|||
129984565|NCT02712905|467905512|FG012|Monotherapy|Adverse Event|0|||
129984566|NCT02712905|467905513|FG013|Monotherapy|Adverse Event|0|||
129984567|NCT02712905|467905514|FG014|Monotherapy|Adverse Event|0|||
129984568|NCT02712905|467905515|FG015|Monotherapy|Adverse Event|0|||
129984569|NCT02712905|467905516|FG016|Monotherapy|Adverse Event|0|||
129984570|NCT02712905|467905517|FG017|Monotherapy|Adverse Event|0|||
129984571|NCT02712905|467905500|FG000|Combination Therapy|Death|0|||
129984572|NCT02712905|467905501|FG001|Combination Therapy|Death|0|||
129984573|NCT02712905|467905502|FG002|Combination Therapy|Death|0|||
129984574|NCT02712905|467905503|FG003|Combination Therapy|Death|0|||
129984575|NCT02712905|467905504|FG004|Combination Therapy|Death|0|||
129984576|NCT02712905|467905505|FG005|Combination Therapy|Death|0|||
129984577|NCT02712905|467905506|FG006|Combination Therapy|Death|0|||
129984578|NCT02712905|467905507|FG007|Combination Therapy|Death|0|||
129984579|NCT02712905|467905508|FG008|Combination Therapy|Death|0|||
129984580|NCT02712905|467905509|FG009|Combination Therapy|Death|0|||
129984581|NCT02712905|467905510|FG010|Combination Therapy|Death|0|||
129984582|NCT02712905|467905511|FG011|Combination Therapy|Death|0|||
129984583|NCT02712905|467905512|FG012|Combination Therapy|Death|5|||
129984584|NCT02712905|467905513|FG013|Combination Therapy|Death|6|||
129984585|NCT02712905|467905514|FG014|Combination Therapy|Death|1|||
129984586|NCT02712905|467905515|FG015|Combination Therapy|Death|3|||
129984587|NCT02712905|467905516|FG016|Combination Therapy|Death|1|||
129873443|NCT01191840|467495634|FG001|Overall Study|Non Staph Infection|3|||
129873444|NCT01191840|467495633|FG000|Overall Study|ineligible at enrollment|1|||
129873445|NCT01191840|467495634|FG001|Overall Study|ineligible at enrollment|0|||
129873446|NCT01191840|467495633|FG000|Overall Study|IRB approval lapse|0|||
129873447|NCT01191840|467495634|FG001|Overall Study|IRB approval lapse|2|||
129873448|NCT01191840|467495633|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
129984588|NCT02712905|467905517|FG017|Combination Therapy|Death|3|||
129984589|NCT02712905|467905500|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
129984590|NCT02712905|467905501|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
129984591|NCT02712905|467905502|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
129984592|NCT02712905|467905503|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
129984593|NCT02712905|467905504|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
129984594|NCT02712905|467905505|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
129984595|NCT02712905|467905506|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
129984596|NCT02712905|467905507|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
129984597|NCT02712905|467905508|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
129984598|NCT02712905|467905509|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
129984599|NCT02712905|467905510|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
129984600|NCT02712905|467905511|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
129984601|NCT02712905|467905512|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
129984602|NCT02712905|467905513|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
129984603|NCT02712905|467905514|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
129984604|NCT02712905|467905515|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
129984605|NCT02712905|467905516|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
129984606|NCT02712905|467905517|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
129984607|NCT02712905|467905500|FG000|Combination Therapy|Withdrawal by Subject|0|||
129984608|NCT02712905|467905501|FG001|Combination Therapy|Withdrawal by Subject|0|||
129984609|NCT02712905|467905502|FG002|Combination Therapy|Withdrawal by Subject|0|||
129984610|NCT02712905|467905503|FG003|Combination Therapy|Withdrawal by Subject|0|||
129984611|NCT02712905|467905504|FG004|Combination Therapy|Withdrawal by Subject|0|||
129984612|NCT02712905|467905505|FG005|Combination Therapy|Withdrawal by Subject|0|||
129984613|NCT02712905|467905506|FG006|Combination Therapy|Withdrawal by Subject|0|||
129984614|NCT02712905|467905507|FG007|Combination Therapy|Withdrawal by Subject|0|||
129984615|NCT02712905|467905508|FG008|Combination Therapy|Withdrawal by Subject|0|||
129984616|NCT02712905|467905509|FG009|Combination Therapy|Withdrawal by Subject|0|||
129984617|NCT02712905|467905510|FG010|Combination Therapy|Withdrawal by Subject|0|||
129984618|NCT02712905|467905511|FG011|Combination Therapy|Withdrawal by Subject|0|||
129984619|NCT02712905|467905512|FG012|Combination Therapy|Withdrawal by Subject|0|||
129984620|NCT02712905|467905513|FG013|Combination Therapy|Withdrawal by Subject|0|||
129984621|NCT02712905|467905514|FG014|Combination Therapy|Withdrawal by Subject|0|||
129984622|NCT02712905|467905515|FG015|Combination Therapy|Withdrawal by Subject|1|||
129984623|NCT02712905|467905516|FG016|Combination Therapy|Withdrawal by Subject|0|||
129984624|NCT02712905|467905517|FG017|Combination Therapy|Withdrawal by Subject|2|||
129984625|NCT02712905|467905500|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984626|NCT02712905|467905501|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984627|NCT02712905|467905502|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984628|NCT02712905|467905503|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984629|NCT02712905|467905504|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984630|NCT02712905|467905505|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984631|NCT02712905|467905506|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984632|NCT02712905|467905507|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984633|NCT02712905|467905508|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984634|NCT02712905|467905509|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984635|NCT02712905|467905510|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984636|NCT02712905|467905511|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984637|NCT02712905|467905512|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984638|NCT02712905|467905513|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984639|NCT02712905|467905514|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984640|NCT02712905|467905515|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
129984641|NCT02712905|467905516|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984642|NCT02712905|467905517|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
129984643|NCT00320528|467905518|FG000|Study Period II|Adverse Event|3|||
129984644|NCT00320528|467905519|FG001|Study Period II|Adverse Event|4|||
129539402|NCT02777554|466266893|FG004|Overall Study|Adverse Event|0|||
129539403|NCT02777554|466266894|FG005|Overall Study|Adverse Event|0|||
129539404|NCT02777554|466266889|FG000|Overall Study|Withdrawal by Subject|3|||
129539405|NCT02777554|466266890|FG001|Overall Study|Withdrawal by Subject|1|||
129539406|NCT02777554|466266891|FG002|Overall Study|Withdrawal by Subject|1|||
129539407|NCT02777554|466266892|FG003|Overall Study|Withdrawal by Subject|0|||
129539408|NCT02777554|466266893|FG004|Overall Study|Withdrawal by Subject|0|||
129539409|NCT02777554|466266894|FG005|Overall Study|Withdrawal by Subject|0|||
129873449|NCT01191840|467495634|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
129873450|NCT01191840|467495633|FG000|Overall Study|Withdrawal by Subject|2|||
129539410|NCT02777554|466266889|FG000|Overall Study|Discharged early due to hurricane|22|||
129539411|NCT02777554|466266890|FG001|Overall Study|Discharged early due to hurricane|20|||
129539412|NCT02777554|466266891|FG002|Overall Study|Discharged early due to hurricane|0|||
129539413|NCT02777554|466266892|FG003|Overall Study|Discharged early due to hurricane|0|||
129539414|NCT02777554|466266893|FG004|Overall Study|Discharged early due to hurricane|0|||
129539415|NCT02777554|466266894|FG005|Overall Study|Discharged early due to hurricane|0|||
129873451|NCT01191840|467495634|FG001|Overall Study|Withdrawal by Subject|0|||
129539416|NCT02777554|466266889|FG000|Overall Study|Other - Miscellaneous|1|||
129873452|NCT00790452|467495635|FG000|Overall Study|Drug supply issue|1|||
129984645|NCT00320528|467905520|FG002|Study Period II|Adverse Event|8|||
129984646|NCT00320528|467905518|FG000|Study Period II|Parent/Caregiver Decision|8|||
129984647|NCT00320528|467905519|FG001|Study Period II|Parent/Caregiver Decision|3|||
129984648|NCT00320528|467905520|FG002|Study Period II|Parent/Caregiver Decision|11|||
129984649|NCT00320528|467905518|FG000|Study Period II|Withdrawal by Subject|0|||
129984650|NCT00320528|467905519|FG001|Study Period II|Withdrawal by Subject|1|||
129984651|NCT00320528|467905520|FG002|Study Period II|Withdrawal by Subject|1|||
129984652|NCT00320528|467905518|FG000|Study Period II|Entry Criteria Exclusion|0|||
129984653|NCT00320528|467905519|FG001|Study Period II|Entry Criteria Exclusion|2|||
129984654|NCT00320528|467905520|FG002|Study Period II|Entry Criteria Exclusion|2|||
129984655|NCT00320528|467905518|FG000|Study Period III|Adverse Event|1|||
129984656|NCT00320528|467905519|FG001|Study Period III|Adverse Event|0|||
129984657|NCT00320528|467905520|FG002|Study Period III|Adverse Event|0|||
129984658|NCT00320528|467905518|FG000|Study Period III|Lost to Follow-up|1|||
129984659|NCT00320528|467905519|FG001|Study Period III|Lost to Follow-up|0|||
129984660|NCT00320528|467905520|FG002|Study Period III|Lost to Follow-up|0|||
129984661|NCT00320528|467905518|FG000|Study Period III|Withdrawal by Subject|1|||
129984662|NCT00320528|467905519|FG001|Study Period III|Withdrawal by Subject|1|||
129984663|NCT00320528|467905520|FG002|Study Period III|Withdrawal by Subject|2|||
129984664|NCT00320528|467905518|FG000|Study Period III|Lack of Efficacy|2|||
129984665|NCT00320528|467905519|FG001|Study Period III|Lack of Efficacy|0|||
129984666|NCT00320528|467905520|FG002|Study Period III|Lack of Efficacy|0|||
129984667|NCT00320528|467905518|FG000|Study Period III|Parent/Caregiver Decision|14|||
129984668|NCT00320528|467905519|FG001|Study Period III|Parent/Caregiver Decision|3|||
129984669|NCT00320528|467905520|FG002|Study Period III|Parent/Caregiver Decision|11|||
129984670|NCT00320528|467905518|FG000|Study Period III|Protocol Violation|0|||
129984671|NCT00320528|467905519|FG001|Study Period III|Protocol Violation|1|||
129984672|NCT00320528|467905520|FG002|Study Period III|Protocol Violation|0|||
129984673|NCT00320528|467905518|FG000|Study Period III|Physician Decision|0|||
129984674|NCT00320528|467905519|FG001|Study Period III|Physician Decision|1|||
129984675|NCT00320528|467905520|FG002|Study Period III|Physician Decision|2|||
129984676|NCT00320528|467905518|FG000|Study Period III|Sponsor Decision|0|||
129539417|NCT02777554|466266890|FG001|Overall Study|Other - Miscellaneous|0|||
129539418|NCT02777554|466266891|FG002|Overall Study|Other - Miscellaneous|0|||
129539419|NCT02777554|466266892|FG003|Overall Study|Other - Miscellaneous|0|||
129539420|NCT02777554|466266893|FG004|Overall Study|Other - Miscellaneous|0|||
129539421|NCT02777554|466266894|FG005|Overall Study|Other - Miscellaneous|0|||
129539422|NCT00270205|466266895|FG000|Overall Study|Lost to Follow-up|1|||
129539423|NCT00270205|466266896|FG001|Overall Study|Lost to Follow-up|0|||
129539424|NCT00270205|466266897|FG002|Overall Study|Lost to Follow-up|0|||
129539425|NCT00270205|466266898|FG003|Overall Study|Lost to Follow-up|1|||
129539426|NCT00066573|466266899|FG000|Overall Study|Did not received protocol treatment|28|||
129539427|NCT00066573|466266900|FG001|Overall Study|Did not received protocol treatment|28|||
129539428|NCT00869362|466266901|FG000|Overall Study|Death|0|||
129539429|NCT00869362|466266902|FG001|Overall Study|Death|2|||
129539430|NCT00869362|466266901|FG000|Overall Study|Lost to Follow-up|1|||
129539431|NCT00869362|466266902|FG001|Overall Study|Lost to Follow-up|3|||
129539432|NCT02213666|466266903|FG000|Overall Study|Withdrawal by Subject|1|||
129539433|NCT03246152|466266907|FG000|Overall Study|Lost to Follow-up|2|||
129539434|NCT03246152|466266907|FG000|Overall Study|Protocol Violation|1|||
129539435|NCT01374516|466266910|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
129539436|NCT01374516|466266911|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
129539437|NCT01374516|466266910|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
129539438|NCT01374516|466266911|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
129539439|NCT01374516|466266910|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
129539440|NCT01374516|466266911|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
129539441|NCT01374516|466266910|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
129539442|NCT01374516|466266911|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
129539443|NCT01374516|466266910|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
129539444|NCT01374516|466266911|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
129539445|NCT01374516|466266910|FG000|Surveillance Expansion Period|Protocol Violation|386|||
129539446|NCT01374516|466266911|FG001|Surveillance Expansion Period|Protocol Violation|217|||
129539447|NCT01374516|466266910|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
129539448|NCT01374516|466266911|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
129539449|NCT01374516|466266910|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
129539450|NCT01374516|466266911|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
129539451|NCT01374516|466266910|FG000|Surveillance Expansion Period|Serious adverse event|20|||
129651105|NCT00195494|466678590|FG000|Year 2|Physician Decision|1|||
129984677|NCT00320528|467905519|FG001|Study Period III|Sponsor Decision|0|||
129984678|NCT00320528|467905520|FG002|Study Period III|Sponsor Decision|1|||
129984679|NCT00320528|467905518|FG000|Study Period III|Atomoxetine Commercially Available|68|||
129984680|NCT00320528|467905519|FG001|Study Period III|Atomoxetine Commercially Available|25|||
129984681|NCT00320528|467905520|FG002|Study Period III|Atomoxetine Commercially Available|90|||
129984682|NCT04664400|467905521|FG000|Overall Study|Withdrawal by Subject|2|||
129984683|NCT01011153|467905526|FG000|Overall Study|Less than 78 cases completed|8|||
129984684|NCT01011153|467905527|FG001|Overall Study|Less than 78 cases completed|11|||
129984685|NCT01011153|467905528|FG002|Overall Study|Less than 78 cases completed|9|||
129984686|NCT03014479|467905529|FG000|Overall Study|Adverse Event|0|||
129984687|NCT03014479|467905530|FG001|Overall Study|Adverse Event|1|||
129984688|NCT03014479|467905529|FG000|Overall Study|Voluntary Withdrawal|0|||
129984689|NCT03014479|467905530|FG001|Overall Study|Voluntary Withdrawal|2|||
129984690|NCT03014479|467905529|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
129984691|NCT03014479|467905530|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
129984692|NCT01394978|467905536|FG000|Overall Study|Withdrawal by Subject|2|||
129984693|NCT01394978|467905537|FG001|Overall Study|Withdrawal by Subject|4|||
129984694|NCT01394978|467905536|FG000|Overall Study|Lost to Follow-up|13|||
129539452|NCT01374516|466266911|FG001|Surveillance Expansion Period|Serious adverse event|5|||
129539453|NCT03219372|466266915|FG000|Overall Study|Withdrawal by Subject|1|||
129539454|NCT03219372|466266916|FG001|Overall Study|Withdrawal by Subject|0|||
129539455|NCT04145531|466266917|FG000|Part A|Adverse Event|2|||
129539456|NCT04145531|466266918|FG001|Part A|Adverse Event|12|||
129539457|NCT04145531|466266919|FG002|Part A|Adverse Event|6|||
129539458|NCT04145531|466266920|FG003|Part A|Adverse Event|0|||
129539459|NCT04145531|466266917|FG000|Part A|Death|1|||
129539460|NCT04145531|466266918|FG001|Part A|Death|2|||
129539461|NCT04145531|466266919|FG002|Part A|Death|0|||
129539462|NCT04145531|466266920|FG003|Part A|Death|0|||
129539463|NCT04145531|466266917|FG000|Part A|Physician Decision|2|||
129539464|NCT04145531|466266918|FG001|Part A|Physician Decision|5|||
129539465|NCT04145531|466266919|FG002|Part A|Physician Decision|2|||
129539466|NCT04145531|466266920|FG003|Part A|Physician Decision|0|||
129539467|NCT04145531|466266917|FG000|Part A|Progressive disease|0|||
129539468|NCT04145531|466266918|FG001|Part A|Progressive disease|2|||
129873453|NCT00790452|467495636|FG001|Overall Study|Drug supply issue|0|||
129873454|NCT01802437|467495637|FG000|Overall Study|Lost to Follow-up|1|||
129873455|NCT01802437|467495638|FG001|Overall Study|Lost to Follow-up|0|||
129873456|NCT01802437|467495637|FG000|Overall Study|Withdrawal by Subject|3|||
129873457|NCT01802437|467495638|FG001|Overall Study|Withdrawal by Subject|4|||
129873458|NCT04082884|467495639|FG000|Overall Study|Withdrawal by Subject|1|||
129539469|NCT04145531|466266919|FG002|Part A|Progressive disease|1|||
129539470|NCT04145531|466266920|FG003|Part A|Progressive disease|0|||
129539471|NCT04145531|466266917|FG000|Part A|Protocol deviation|0|||
129539472|NCT04145531|466266918|FG001|Part A|Protocol deviation|0|||
129539473|NCT04145531|466266919|FG002|Part A|Protocol deviation|1|||
129539474|NCT04145531|466266920|FG003|Part A|Protocol deviation|0|||
129539475|NCT04145531|466266917|FG000|Part A|Withdrawal by parent or guardian|1|||
129539476|NCT04145531|466266918|FG001|Part A|Withdrawal by parent or guardian|0|||
129539477|NCT04145531|466266919|FG002|Part A|Withdrawal by parent or guardian|0|||
129539478|NCT04145531|466266920|FG003|Part A|Withdrawal by parent or guardian|0|||
129539479|NCT04145531|466266917|FG000|Part A|Withdrawal by participant|0|||
129539480|NCT04145531|466266918|FG001|Part A|Withdrawal by participant|0|||
129539481|NCT04145531|466266919|FG002|Part A|Withdrawal by participant|1|||
129539482|NCT04145531|466266920|FG003|Part A|Withdrawal by participant|0|||
129539483|NCT04145531|466266917|FG000|Part A|Other|0|||
129539484|NCT04145531|466266918|FG001|Part A|Other|0|||
129539485|NCT04145531|466266919|FG002|Part A|Other|1|||
129539486|NCT04145531|466266920|FG003|Part A|Other|0|||
129539487|NCT04145531|466266917|FG000|Part B|Adverse Event|0|||
129539488|NCT04145531|466266918|FG001|Part B|Adverse Event|0|||
129539489|NCT04145531|466266919|FG002|Part B|Adverse Event|0|||
129539490|NCT04145531|466266920|FG003|Part B|Adverse Event|21|||
129539491|NCT04145531|466266917|FG000|Part B|Physician Decision|0|||
129539492|NCT04145531|466266918|FG001|Part B|Physician Decision|0|||
129539493|NCT04145531|466266919|FG002|Part B|Physician Decision|0|||
129539494|NCT04145531|466266920|FG003|Part B|Physician Decision|7|||
129539495|NCT04145531|466266917|FG000|Part B|Progressive disease|0|||
129539496|NCT04145531|466266918|FG001|Part B|Progressive disease|0|||
129984695|NCT01394978|467905537|FG001|Overall Study|Lost to Follow-up|20|||
129539497|NCT04145531|466266919|FG002|Part B|Progressive disease|0|||
129539498|NCT04145531|466266920|FG003|Part B|Progressive disease|1|||
129539499|NCT04145531|466266917|FG000|Part B|Recurrent disease|0|||
129539500|NCT04145531|466266918|FG001|Part B|Recurrent disease|0|||
129539501|NCT04145531|466266919|FG002|Part B|Recurrent disease|0|||
129539502|NCT04145531|466266920|FG003|Part B|Recurrent disease|1|||
129539503|NCT04145531|466266917|FG000|Part B|Withdrawal by parent or guardian|0|||
129539504|NCT04145531|466266918|FG001|Part B|Withdrawal by parent or guardian|0|||
129539505|NCT04145531|466266919|FG002|Part B|Withdrawal by parent or guardian|0|||
129539506|NCT04145531|466266920|FG003|Part B|Withdrawal by parent or guardian|3|||
129984696|NCT01394978|467905536|FG000|Overall Study|Death|6|||
129539507|NCT04145531|466266917|FG000|Part B|Withdrawal by participant|0|||
129539508|NCT04145531|466266918|FG001|Part B|Withdrawal by participant|0|||
129539509|NCT04145531|466266919|FG002|Part B|Withdrawal by participant|0|||
129539510|NCT04145531|466266920|FG003|Part B|Withdrawal by participant|1|||
129539511|NCT04145531|466266917|FG000|Part B|Other|0|||
129539512|NCT04145531|466266918|FG001|Part B|Other|0|||
129984697|NCT01394978|467905537|FG001|Overall Study|Death|7|||
129539513|NCT04145531|466266919|FG002|Part B|Other|0|||
129539514|NCT04145531|466266920|FG003|Part B|Other|1|||
129539515|NCT04629534|466266921|FG000|Overall Study|Physician Decision|1|||
129539516|NCT04629534|466266922|FG001|Overall Study|Physician Decision|0|||
129539517|NCT04629534|466266921|FG000|Overall Study|Protocol Violation|0|||
129539518|NCT04629534|466266922|FG001|Overall Study|Protocol Violation|2|||
129539519|NCT03732534|466266923|FG000|Overall Study|Study terminated by Sponsor|6|||
129539520|NCT02797951|466266924|FG000|Overall Study|Adverse Event|4|||
129539521|NCT02797951|466266924|FG000|Overall Study|Death|1|||
129539522|NCT02797951|466266924|FG000|Overall Study|Lack of Efficacy|19|||
129539523|NCT02797951|466266924|FG000|Overall Study|Lost to Follow-up|4|||
129539524|NCT02797951|466266924|FG000|Overall Study|Physician Decision|6|||
129539525|NCT02797951|466266924|FG000|Overall Study|Withdrawal by Subject|15|||
129539526|NCT00814502|466266925|FG000|Overall Study|Adverse Event|1|||
129873459|NCT00642902|467495647|FG000|Overall Study|Adverse Event|0|||
129873460|NCT00642902|467495648|FG001|Overall Study|Adverse Event|1|||
129873461|NCT00642902|467495649|FG002|Overall Study|Adverse Event|3|||
129873462|NCT00642902|467495650|FG003|Overall Study|Adverse Event|1|||
129873463|NCT00642902|467495647|FG000|Overall Study|Lost to Follow-up|1|||
129873464|NCT00642902|467495648|FG001|Overall Study|Lost to Follow-up|1|||
129873465|NCT00642902|467495649|FG002|Overall Study|Lost to Follow-up|0|||
129873466|NCT00642902|467495650|FG003|Overall Study|Lost to Follow-up|0|||
129873467|NCT00642902|467495647|FG000|Overall Study|Lack of Efficacy|0|||
129873468|NCT00642902|467495648|FG001|Overall Study|Lack of Efficacy|3|||
129873469|NCT00642902|467495649|FG002|Overall Study|Lack of Efficacy|3|||
129873470|NCT00642902|467495650|FG003|Overall Study|Lack of Efficacy|0|||
129873471|NCT00642902|467495647|FG000|Overall Study|Death|1|||
129873472|NCT00642902|467495648|FG001|Overall Study|Death|0|||
129873473|NCT00642902|467495649|FG002|Overall Study|Death|0|||
129873474|NCT00642902|467495650|FG003|Overall Study|Death|0|||
129873475|NCT00642902|467495647|FG000|Overall Study|Premature termination of clinical trial|37|||
129873476|NCT00642902|467495648|FG001|Overall Study|Premature termination of clinical trial|32|||
129873477|NCT00642902|467495649|FG002|Overall Study|Premature termination of clinical trial|35|||
129873478|NCT00642902|467495650|FG003|Overall Study|Premature termination of clinical trial|35|||
129873479|NCT00642902|467495647|FG000|Overall Study|Randomized, but not treated|0|||
129873480|NCT00642902|467495648|FG001|Overall Study|Randomized, but not treated|0|||
129873481|NCT00642902|467495649|FG002|Overall Study|Randomized, but not treated|1|||
129873482|NCT00642902|467495650|FG003|Overall Study|Randomized, but not treated|0|||
129873483|NCT00642902|467495647|FG000|Overall Study|Other|1|||
129873484|NCT00642902|467495648|FG001|Overall Study|Other|5|||
129873485|NCT00642902|467495649|FG002|Overall Study|Other|1|||
129873486|NCT00642902|467495650|FG003|Overall Study|Other|4|||
129873487|NCT03953898|467495651|FG000|Overall Study|Lack of Efficacy|8|||
129873488|NCT03953898|467495651|FG000|Overall Study|Death|3|||
129873489|NCT03953898|467495651|FG000|Overall Study|Withdrawal by Subject|2|||
129873490|NCT03953898|467495651|FG000|Overall Study|Adverse Event|1|||
129873491|NCT01538472|467495653|FG000|Overall Study|Disease Progression|3|||
129873492|NCT01538472|467495653|FG000|Overall Study|Death|1|||
129873493|NCT02309112|467495654|FG000|Overall Study|Withdrawal by Subject|1|||
129873494|NCT02309112|467495655|FG001|Overall Study|Withdrawal by Subject|0|||
129873495|NCT02309112|467495656|FG002|Overall Study|Withdrawal by Subject|1|||
129873496|NCT02309112|467495654|FG000|Overall Study|Lost to Follow-up|0|||
129873497|NCT02309112|467495655|FG001|Overall Study|Lost to Follow-up|1|||
129873498|NCT02309112|467495656|FG002|Overall Study|Lost to Follow-up|0|||
129873499|NCT01376323|467495658|FG000|Overall Study|Adverse Event|1|||
129873500|NCT01376323|467495659|FG001|Overall Study|Adverse Event|0|||
129873501|NCT01376323|467495660|FG002|Overall Study|Adverse Event|0|||
129873502|NCT01376323|467495661|FG003|Overall Study|Adverse Event|2|||
129873503|NCT01376323|467495662|FG004|Overall Study|Adverse Event|0|||
129873504|NCT01376323|467495658|FG000|Overall Study|Lost to Follow-up|0|||
129873505|NCT01376323|467495659|FG001|Overall Study|Lost to Follow-up|0|||
129873506|NCT01376323|467495660|FG002|Overall Study|Lost to Follow-up|0|||
129873507|NCT01376323|467495661|FG003|Overall Study|Lost to Follow-up|2|||
129873508|NCT01376323|467495662|FG004|Overall Study|Lost to Follow-up|0|||
129873509|NCT01376323|467495658|FG000|Overall Study|Physician Decision|1|||
129873510|NCT01376323|467495659|FG001|Overall Study|Physician Decision|0|||
129873511|NCT01376323|467495660|FG002|Overall Study|Physician Decision|2|||
129873512|NCT01376323|467495661|FG003|Overall Study|Physician Decision|1|||
129539527|NCT00814502|466266926|FG001|Overall Study|Adverse Event|0|||
129539528|NCT00814502|466266925|FG000|Overall Study|Withdrawal by Subject|0|||
129539529|NCT00814502|466266926|FG001|Overall Study|Withdrawal by Subject|2|||
129539530|NCT03735849|466266931|FG000|Overall Study|Lost to Follow-up|1|||
129651106|NCT00195494|466678591|FG001|Year 2|Physician Decision|1|||
129873513|NCT01376323|467495662|FG004|Overall Study|Physician Decision|1|||
129873514|NCT01376323|467495658|FG000|Overall Study|Withdrawal by Subject|0|||
129873515|NCT01376323|467495659|FG001|Overall Study|Withdrawal by Subject|1|||
129873516|NCT01376323|467495660|FG002|Overall Study|Withdrawal by Subject|1|||
129873517|NCT01376323|467495661|FG003|Overall Study|Withdrawal by Subject|0|||
129873518|NCT01376323|467495662|FG004|Overall Study|Withdrawal by Subject|0|||
129873519|NCT04681729|467495663|FG000|Overall Study|Lack of Efficacy|2|||
129873520|NCT04681729|467495664|FG001|Overall Study|Lack of Efficacy|2|||
129873521|NCT04681729|467495663|FG000|Overall Study|Withdrawal by Subject|8|||
129873522|NCT04681729|467495664|FG001|Overall Study|Withdrawal by Subject|9|||
129873523|NCT00499863|467495666|FG000|Overall Study|Lack of Efficacy|21|||
129873524|NCT00499863|467495667|FG001|Overall Study|Lack of Efficacy|27|||
129873525|NCT00499863|467495666|FG000|Overall Study|Protocol Violation|12|||
129873526|NCT00499863|467495667|FG001|Overall Study|Protocol Violation|7|||
129873527|NCT00499863|467495666|FG000|Overall Study|Withdrawal by Subject|6|||
129873528|NCT00499863|467495667|FG001|Overall Study|Withdrawal by Subject|4|||
129873529|NCT00499863|467495666|FG000|Overall Study|Adverse Event|8|||
129873530|NCT00499863|467495667|FG001|Overall Study|Adverse Event|2|||
129873531|NCT00499863|467495666|FG000|Overall Study|Sponsor decision|2|||
129873532|NCT00499863|467495667|FG001|Overall Study|Sponsor decision|2|||
129873533|NCT00499863|467495666|FG000|Overall Study|Lost to Follow-up|1|||
129873534|NCT00499863|467495667|FG001|Overall Study|Lost to Follow-up|1|||
129873535|NCT03759834|467495668|FG000|Overall Study|Withdrawal by Subject|1|||
129873536|NCT05701995|467495669|FG000|Pre-Treatment|Randomization Error|1|||
129873537|NCT05701995|467495670|FG001|Pre-Treatment|Randomization Error|1|||
129873538|NCT05701995|467495669|FG000|Treatment|Withdrawal by Subject|8|||
129873539|NCT05701995|467495670|FG001|Treatment|Withdrawal by Subject|4|||
129873540|NCT05701995|467495669|FG000|Treatment|Lost to Follow-up|2|||
129873541|NCT05701995|467495670|FG001|Treatment|Lost to Follow-up|3|||
129873542|NCT05701995|467495669|FG000|Treatment|Adverse Event|3|||
129873543|NCT05701995|467495670|FG001|Treatment|Adverse Event|1|||
129873544|NCT05701995|467495669|FG000|Treatment|Other Reason|1|||
129873545|NCT05701995|467495670|FG001|Treatment|Other Reason|1|||
129873546|NCT05701995|467495669|FG000|Treatment|Death|1|||
129873547|NCT05701995|467495670|FG001|Treatment|Death|0|||
129873548|NCT05701995|467495669|FG000|Treatment|Physician Decision|0|||
129873549|NCT05701995|467495670|FG001|Treatment|Physician Decision|1|||
129873550|NCT00504426|467495671|FG000|Overall Study|Adverse Event|0|||
129873551|NCT00504426|467495672|FG001|Overall Study|Adverse Event|0|||
129873552|NCT00504426|467495673|FG002|Overall Study|Adverse Event|2|||
129873553|NCT00504426|467495674|FG003|Overall Study|Adverse Event|0|||
129873554|NCT00504426|467495671|FG000|Overall Study|Protocol Violation|1|||
129873555|NCT00504426|467495672|FG001|Overall Study|Protocol Violation|1|||
129873556|NCT00504426|467495673|FG002|Overall Study|Protocol Violation|2|||
129873557|NCT00504426|467495674|FG003|Overall Study|Protocol Violation|0|||
129873558|NCT00504426|467495671|FG000|Overall Study|Withdrawal by Subject|2|||
129873559|NCT00504426|467495672|FG001|Overall Study|Withdrawal by Subject|0|||
129873560|NCT00504426|467495673|FG002|Overall Study|Withdrawal by Subject|0|||
129873561|NCT00504426|467495674|FG003|Overall Study|Withdrawal by Subject|0|||
129873562|NCT00633464|467495676|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
129873563|NCT00633464|467495677|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
129873564|NCT00633464|467495676|FG000|Overall Study|Never Treated (Randomized in error)|0|||
129873565|NCT00633464|467495677|FG001|Overall Study|Never Treated (Randomized in error)|1|||
129873566|NCT02612064|467495678|FG000|Overall Study|Withdrawal by Subject|1|||
129873567|NCT02612064|467495679|FG001|Overall Study|Withdrawal by Subject|1|||
129873568|NCT02612064|467495678|FG000|Overall Study|Other|0|||
129873569|NCT02612064|467495679|FG001|Overall Study|Other|2|||
129873570|NCT01669798|467495680|FG000|Overall Study|Physician Decision|5|||
129873571|NCT00717860|467495682|FG000|Overall Study|Clinical adverse experience|5|||
129873572|NCT00717860|467495683|FG001|Overall Study|Clinical adverse experience|9|||
129873573|NCT00717860|467495682|FG000|Overall Study|Laboratory adverse experience|2|||
129873574|NCT00717860|467495683|FG001|Overall Study|Laboratory adverse experience|2|||
129873575|NCT00717860|467495682|FG000|Overall Study|Lack of Efficacy|7|||
129873576|NCT00717860|467495683|FG001|Overall Study|Lack of Efficacy|13|||
129873577|NCT00717860|467495682|FG000|Overall Study|Discontinued for other reason|6|||
129873578|NCT00717860|467495683|FG001|Overall Study|Discontinued for other reason|1|||
129873579|NCT00717860|467495682|FG000|Overall Study|Withdrew consent|7|||
129873580|NCT00717860|467495683|FG001|Overall Study|Withdrew consent|3|||
129873581|NCT00698646|467495684|FG000|Overall Study|Adverse Event|8|||
129873582|NCT00698646|467495685|FG001|Overall Study|Adverse Event|7|||
129873583|NCT00698646|467495686|FG002|Overall Study|Adverse Event|8|||
129873584|NCT00698646|467495684|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
129873585|NCT00698646|467495685|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
129873586|NCT00698646|467495686|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
129873587|NCT00698646|467495684|FG000|Overall Study|Protocol Deviation|6|||
129539531|NCT03735849|466266932|FG001|Overall Study|Lost to Follow-up|0|||
129873588|NCT00698646|467495685|FG001|Overall Study|Protocol Deviation|2|||
129873589|NCT00698646|467495686|FG002|Overall Study|Protocol Deviation|3|||
129873590|NCT00698646|467495684|FG000|Overall Study|Withdrawal by Subject|10|||
129873591|NCT00698646|467495685|FG001|Overall Study|Withdrawal by Subject|11|||
129873592|NCT00698646|467495686|FG002|Overall Study|Withdrawal by Subject|8|||
129873593|NCT00698646|467495684|FG000|Overall Study|Lost to Follow-up|0|||
129873594|NCT00698646|467495685|FG001|Overall Study|Lost to Follow-up|0|||
129873595|NCT00698646|467495686|FG002|Overall Study|Lost to Follow-up|2|||
129873596|NCT00698646|467495684|FG000|Overall Study|Administrative problems|1|||
129873597|NCT00698646|467495685|FG001|Overall Study|Administrative problems|0|||
129873598|NCT00698646|467495686|FG002|Overall Study|Administrative problems|1|||
129873599|NCT00279201|467495687|FG000|Initiation|Death|1|||
129873600|NCT00279201|467495688|FG001|Initiation|Death|5|||
129873601|NCT00279201|467495689|FG002|Initiation|Death|0|||
129873602|NCT00279201|467495690|FG003|Initiation|Death|0|||
129873603|NCT00279201|467495691|FG004|Initiation|Death|0|||
129873604|NCT00279201|467495692|FG005|Initiation|Death|0|||
129873605|NCT00279201|467495687|FG000|Initiation|Adverse Event|6|||
129873606|NCT00279201|467495688|FG001|Initiation|Adverse Event|15|||
129873607|NCT00279201|467495689|FG002|Initiation|Adverse Event|0|||
129873608|NCT00279201|467495690|FG003|Initiation|Adverse Event|0|||
129873609|NCT00279201|467495691|FG004|Initiation|Adverse Event|0|||
129873610|NCT00279201|467495692|FG005|Initiation|Adverse Event|0|||
129873611|NCT00279201|467495687|FG000|Initiation|Lost to Follow-up|42|||
129873612|NCT00279201|467495688|FG001|Initiation|Lost to Follow-up|41|||
129873613|NCT00279201|467495689|FG002|Initiation|Lost to Follow-up|0|||
129873614|NCT00279201|467495690|FG003|Initiation|Lost to Follow-up|0|||
129873615|NCT00279201|467495691|FG004|Initiation|Lost to Follow-up|0|||
129873616|NCT00279201|467495692|FG005|Initiation|Lost to Follow-up|0|||
129873617|NCT00279201|467495687|FG000|Initiation|Entry Criteria Exclusion|7|||
129873618|NCT00279201|467495688|FG001|Initiation|Entry Criteria Exclusion|9|||
129873619|NCT00279201|467495689|FG002|Initiation|Entry Criteria Exclusion|0|||
129873620|NCT00279201|467495690|FG003|Initiation|Entry Criteria Exclusion|0|||
129873621|NCT00279201|467495691|FG004|Initiation|Entry Criteria Exclusion|0|||
129873622|NCT00279201|467495692|FG005|Initiation|Entry Criteria Exclusion|0|||
129873623|NCT00279201|467495687|FG000|Initiation|Protocol Violation|9|||
129873624|NCT00279201|467495688|FG001|Initiation|Protocol Violation|10|||
129873625|NCT00279201|467495689|FG002|Initiation|Protocol Violation|0|||
129873626|NCT00279201|467495690|FG003|Initiation|Protocol Violation|0|||
129873627|NCT00279201|467495691|FG004|Initiation|Protocol Violation|0|||
129873628|NCT00279201|467495692|FG005|Initiation|Protocol Violation|0|||
129873629|NCT00279201|467495687|FG000|Initiation|Withdrawal by Subject|35|||
129873630|NCT00279201|467495688|FG001|Initiation|Withdrawal by Subject|41|||
129873631|NCT00279201|467495689|FG002|Initiation|Withdrawal by Subject|0|||
129873632|NCT00279201|467495690|FG003|Initiation|Withdrawal by Subject|0|||
129873633|NCT00279201|467495691|FG004|Initiation|Withdrawal by Subject|0|||
129873634|NCT00279201|467495692|FG005|Initiation|Withdrawal by Subject|0|||
129873635|NCT00279201|467495687|FG000|Initiation|Physician Decision|15|||
129873636|NCT00279201|467495688|FG001|Initiation|Physician Decision|18|||
129873637|NCT00279201|467495689|FG002|Initiation|Physician Decision|0|||
129873638|NCT00279201|467495690|FG003|Initiation|Physician Decision|0|||
129873639|NCT00279201|467495691|FG004|Initiation|Physician Decision|0|||
129873640|NCT00279201|467495692|FG005|Initiation|Physician Decision|0|||
129873641|NCT00279201|467495687|FG000|Initiation|Sponsor Decision|13|||
129873642|NCT00279201|467495688|FG001|Initiation|Sponsor Decision|5|||
129873643|NCT00279201|467495689|FG002|Initiation|Sponsor Decision|0|||
129873644|NCT00279201|467495690|FG003|Initiation|Sponsor Decision|0|||
129873645|NCT00279201|467495691|FG004|Initiation|Sponsor Decision|0|||
129873646|NCT00279201|467495692|FG005|Initiation|Sponsor Decision|0|||
129873647|NCT00279201|467495687|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873648|NCT00279201|467495688|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
129873649|NCT00279201|467495689|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873650|NCT00279201|467495690|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873651|NCT00279201|467495691|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873652|NCT00279201|467495692|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
129873653|NCT00279201|467495687|FG000|Maintenance|Lack of Efficacy|32|||
129873654|NCT00279201|467495688|FG001|Maintenance|Lack of Efficacy|30|||
129873655|NCT00279201|467495689|FG002|Maintenance|Lack of Efficacy|0|||
129873656|NCT00279201|467495690|FG003|Maintenance|Lack of Efficacy|0|||
129873657|NCT00279201|467495691|FG004|Maintenance|Lack of Efficacy|0|||
129873658|NCT00279201|467495692|FG005|Maintenance|Lack of Efficacy|0|||
129873659|NCT00279201|467495687|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
129873660|NCT00279201|467495688|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
129873661|NCT00279201|467495689|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129873662|NCT00279201|467495690|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129873663|NCT00279201|467495691|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129873664|NCT00279201|467495692|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
129984698|NCT01081132|467905538|FG000|Overall Study|Lack of Efficacy|25|||
129984699|NCT01081132|467905539|FG001|Overall Study|Lack of Efficacy|9|||
129873665|NCT00279201|467495687|FG000|Maintenance|Adverse Event|4|||
129873666|NCT00279201|467495688|FG001|Maintenance|Adverse Event|4|||
129873667|NCT00279201|467495689|FG002|Maintenance|Adverse Event|0|||
129873668|NCT00279201|467495690|FG003|Maintenance|Adverse Event|0|||
129873669|NCT00279201|467495691|FG004|Maintenance|Adverse Event|0|||
129873670|NCT00279201|467495692|FG005|Maintenance|Adverse Event|0|||
129873671|NCT00279201|467495687|FG000|Maintenance|Death|4|||
129873672|NCT00279201|467495688|FG001|Maintenance|Death|4|||
129873673|NCT00279201|467495689|FG002|Maintenance|Death|0|||
129873674|NCT00279201|467495690|FG003|Maintenance|Death|0|||
129873675|NCT00279201|467495691|FG004|Maintenance|Death|0|||
129984700|NCT01081132|467905538|FG000|Overall Study|Withdrawal by Subject|13|||
129984701|NCT01081132|467905539|FG001|Overall Study|Withdrawal by Subject|16|||
129984702|NCT01081132|467905538|FG000|Overall Study|Lost to Follow-up|4|||
129984703|NCT01081132|467905539|FG001|Overall Study|Lost to Follow-up|11|||
129984704|NCT01081132|467905538|FG000|Overall Study|Adverse Event|3|||
129984705|NCT01081132|467905539|FG001|Overall Study|Adverse Event|9|||
129984706|NCT01081132|467905538|FG000|Overall Study|Non Compliance|4|||
129873676|NCT00279201|467495692|FG005|Maintenance|Death|0|||
129873677|NCT00279201|467495687|FG000|Maintenance|Lost to Follow-up|17|||
129873678|NCT00279201|467495688|FG001|Maintenance|Lost to Follow-up|13|||
129873679|NCT00279201|467495689|FG002|Maintenance|Lost to Follow-up|0|||
129873680|NCT00279201|467495690|FG003|Maintenance|Lost to Follow-up|0|||
129984707|NCT01081132|467905539|FG001|Overall Study|Non Compliance|2|||
129984708|NCT01081132|467905538|FG000|Overall Study|Lack Of Compliance|0|||
129984709|NCT01081132|467905539|FG001|Overall Study|Lack Of Compliance|1|||
129984710|NCT01081132|467905538|FG000|Overall Study|Missed Visits|1|||
129984711|NCT01081132|467905539|FG001|Overall Study|Missed Visits|1|||
129873681|NCT00279201|467495691|FG004|Maintenance|Lost to Follow-up|0|||
129984712|NCT01081132|467905538|FG000|Overall Study|Stopped Taking Meds|2|||
129984713|NCT01081132|467905539|FG001|Overall Study|Stopped Taking Meds|0|||
129984714|NCT01081132|467905538|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
129984715|NCT01081132|467905539|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
129984716|NCT01081132|467905538|FG000|Overall Study|Declined Taper Phase|0|||
129984717|NCT01081132|467905539|FG001|Overall Study|Declined Taper Phase|1|||
129984718|NCT01081132|467905538|FG000|Overall Study|Protocol Violation|3|||
129984719|NCT01081132|467905539|FG001|Overall Study|Protocol Violation|1|||
129984720|NCT02019667|467905540|FG000|First Intervention (6 Months)|Adverse Event|0|||
129984721|NCT02019667|467905541|FG001|First Intervention (6 Months)|Adverse Event|1|||
129984722|NCT02019667|467905540|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
129443567|NCT02596620|465924426|FG001|Overall Study|Lost to Follow-up|1|||
129873682|NCT00279201|467495692|FG005|Maintenance|Lost to Follow-up|0|||
129873683|NCT00279201|467495687|FG000|Maintenance|Entry Criteria Exclusion|1|||
129873684|NCT00279201|467495688|FG001|Maintenance|Entry Criteria Exclusion|4|||
129873685|NCT00279201|467495689|FG002|Maintenance|Entry Criteria Exclusion|0|||
129873686|NCT00279201|467495690|FG003|Maintenance|Entry Criteria Exclusion|0|||
129873687|NCT00279201|467495691|FG004|Maintenance|Entry Criteria Exclusion|0|||
129873688|NCT00279201|467495692|FG005|Maintenance|Entry Criteria Exclusion|0|||
129873689|NCT00279201|467495687|FG000|Maintenance|Protocol Violation|16|||
129873690|NCT00279201|467495688|FG001|Maintenance|Protocol Violation|24|||
129873691|NCT00279201|467495689|FG002|Maintenance|Protocol Violation|0|||
129873692|NCT00279201|467495690|FG003|Maintenance|Protocol Violation|0|||
129873693|NCT00279201|467495691|FG004|Maintenance|Protocol Violation|0|||
129873694|NCT00279201|467495692|FG005|Maintenance|Protocol Violation|0|||
129873695|NCT00279201|467495687|FG000|Maintenance|Withdrawal by Subject|18|||
129873696|NCT00279201|467495688|FG001|Maintenance|Withdrawal by Subject|18|||
129873697|NCT00279201|467495689|FG002|Maintenance|Withdrawal by Subject|0|||
129873698|NCT00279201|467495690|FG003|Maintenance|Withdrawal by Subject|0|||
129873699|NCT00279201|467495691|FG004|Maintenance|Withdrawal by Subject|0|||
129873700|NCT00279201|467495692|FG005|Maintenance|Withdrawal by Subject|0|||
129873701|NCT00279201|467495687|FG000|Maintenance|Physician Decision|9|||
129873702|NCT00279201|467495688|FG001|Maintenance|Physician Decision|9|||
129873703|NCT00279201|467495689|FG002|Maintenance|Physician Decision|0|||
129873704|NCT00279201|467495690|FG003|Maintenance|Physician Decision|0|||
129873705|NCT00279201|467495691|FG004|Maintenance|Physician Decision|0|||
129873706|NCT00279201|467495692|FG005|Maintenance|Physician Decision|0|||
129873707|NCT00279201|467495687|FG000|Maintenance|Sponsor Decision|4|||
129873708|NCT00279201|467495688|FG001|Maintenance|Sponsor Decision|0|||
129873709|NCT00279201|467495689|FG002|Maintenance|Sponsor Decision|0|||
129873710|NCT00279201|467495690|FG003|Maintenance|Sponsor Decision|0|||
129873711|NCT00279201|467495691|FG004|Maintenance|Sponsor Decision|0|||
129873712|NCT00279201|467495692|FG005|Maintenance|Sponsor Decision|0|||
129873713|NCT00279201|467495687|FG000|Maintenance|HbA1c>7.5%|123|||
129873714|NCT00279201|467495688|FG001|Maintenance|HbA1c>7.5%|126|||
129873715|NCT00279201|467495689|FG002|Maintenance|HbA1c>7.5%|0|||
129873716|NCT00279201|467495690|FG003|Maintenance|HbA1c>7.5%|0|||
129873717|NCT00279201|467495691|FG004|Maintenance|HbA1c>7.5%|0|||
129873718|NCT00279201|467495692|FG005|Maintenance|HbA1c>7.5%|0|||
129873719|NCT00279201|467495687|FG000|Intensification Addendum|Withdrawal by Subject|0|||
129873720|NCT00279201|467495688|FG001|Intensification Addendum|Withdrawal by Subject|0|||
129873721|NCT00279201|467495689|FG002|Intensification Addendum|Withdrawal by Subject|12|||
129873722|NCT00279201|467495690|FG003|Intensification Addendum|Withdrawal by Subject|14|||
129873723|NCT00279201|467495691|FG004|Intensification Addendum|Withdrawal by Subject|9|||
129873724|NCT00279201|467495692|FG005|Intensification Addendum|Withdrawal by Subject|18|||
129873725|NCT00279201|467495687|FG000|Intensification Addendum|Lost to Follow-up|0|||
129984723|NCT02019667|467905541|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
129984724|NCT02019667|467905540|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
129984725|NCT02019667|467905541|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
129984726|NCT02101385|467905544|FG000|Study Treatment|Disease Progression|9|||
129873726|NCT00279201|467495688|FG001|Intensification Addendum|Lost to Follow-up|0|||
129873727|NCT00279201|467495689|FG002|Intensification Addendum|Lost to Follow-up|4|||
129873728|NCT00279201|467495690|FG003|Intensification Addendum|Lost to Follow-up|6|||
129873729|NCT00279201|467495691|FG004|Intensification Addendum|Lost to Follow-up|7|||
129873730|NCT00279201|467495692|FG005|Intensification Addendum|Lost to Follow-up|7|||
129873731|NCT00279201|467495687|FG000|Intensification Addendum|Protocol Violation|0|||
129873732|NCT00279201|467495688|FG001|Intensification Addendum|Protocol Violation|0|||
129873733|NCT00279201|467495689|FG002|Intensification Addendum|Protocol Violation|2|||
129873734|NCT00279201|467495690|FG003|Intensification Addendum|Protocol Violation|2|||
129873735|NCT00279201|467495691|FG004|Intensification Addendum|Protocol Violation|6|||
129873736|NCT00279201|467495692|FG005|Intensification Addendum|Protocol Violation|6|||
129873737|NCT00279201|467495687|FG000|Intensification Addendum|Adverse Event|0|||
129873738|NCT00279201|467495688|FG001|Intensification Addendum|Adverse Event|0|||
129873739|NCT00279201|467495689|FG002|Intensification Addendum|Adverse Event|0|||
129873740|NCT00279201|467495690|FG003|Intensification Addendum|Adverse Event|4|||
129873741|NCT00279201|467495691|FG004|Intensification Addendum|Adverse Event|1|||
129873742|NCT00279201|467495692|FG005|Intensification Addendum|Adverse Event|3|||
129873743|NCT00279201|467495687|FG000|Intensification Addendum|Physician Decision|0|||
129873744|NCT00279201|467495688|FG001|Intensification Addendum|Physician Decision|0|||
129873745|NCT00279201|467495689|FG002|Intensification Addendum|Physician Decision|4|||
129873746|NCT00279201|467495690|FG003|Intensification Addendum|Physician Decision|1|||
129873747|NCT00279201|467495691|FG004|Intensification Addendum|Physician Decision|3|||
129873748|NCT00279201|467495692|FG005|Intensification Addendum|Physician Decision|2|||
129873749|NCT00279201|467495687|FG000|Intensification Addendum|Sponsor Decision|0|||
129873750|NCT00279201|467495688|FG001|Intensification Addendum|Sponsor Decision|0|||
129873751|NCT00279201|467495689|FG002|Intensification Addendum|Sponsor Decision|0|||
129873752|NCT00279201|467495690|FG003|Intensification Addendum|Sponsor Decision|0|||
129873753|NCT00279201|467495691|FG004|Intensification Addendum|Sponsor Decision|1|||
129873754|NCT00279201|467495692|FG005|Intensification Addendum|Sponsor Decision|1|||
129873755|NCT00279201|467495687|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
129873756|NCT00279201|467495688|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
129873757|NCT00279201|467495689|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
129873758|NCT00279201|467495690|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
129873759|NCT00279201|467495691|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
129873760|NCT00279201|467495692|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
129873761|NCT00279201|467495687|FG000|Intensification Addendum|Lack of Efficacy|0|||
129873762|NCT00279201|467495688|FG001|Intensification Addendum|Lack of Efficacy|0|||
129873763|NCT00279201|467495689|FG002|Intensification Addendum|Lack of Efficacy|0|||
129873764|NCT00279201|467495690|FG003|Intensification Addendum|Lack of Efficacy|1|||
129873765|NCT00279201|467495691|FG004|Intensification Addendum|Lack of Efficacy|1|||
129873766|NCT00279201|467495692|FG005|Intensification Addendum|Lack of Efficacy|0|||
129873767|NCT00279201|467495687|FG000|Intensification Addendum|Death|0|||
129873768|NCT00279201|467495688|FG001|Intensification Addendum|Death|0|||
129873769|NCT00279201|467495689|FG002|Intensification Addendum|Death|0|||
129873770|NCT00279201|467495690|FG003|Intensification Addendum|Death|0|||
129873771|NCT00279201|467495691|FG004|Intensification Addendum|Death|1|||
129873772|NCT00279201|467495692|FG005|Intensification Addendum|Death|0|||
129873773|NCT02390531|467495695|FG000|Overall Study|Death|0|||
129873774|NCT02390531|467495696|FG001|Overall Study|Death|2|||
129873775|NCT02390531|467495697|FG002|Overall Study|Death|0|||
129873776|NCT02390531|467495698|FG003|Overall Study|Death|1|||
129873777|NCT02390531|467495699|FG004|Overall Study|Death|0|||
129873778|NCT02390531|467495700|FG005|Overall Study|Death|0|||
129873779|NCT02390531|467495701|FG006|Overall Study|Death|0|||
129873780|NCT02390531|467495702|FG007|Overall Study|Death|1|||
129873781|NCT02390531|467495695|FG000|Overall Study|Protocol Violation|0|||
129873782|NCT02390531|467495696|FG001|Overall Study|Protocol Violation|0|||
129873783|NCT02390531|467495697|FG002|Overall Study|Protocol Violation|0|||
129873784|NCT02390531|467495698|FG003|Overall Study|Protocol Violation|0|||
129873785|NCT02390531|467495699|FG004|Overall Study|Protocol Violation|1|||
129873786|NCT02390531|467495700|FG005|Overall Study|Protocol Violation|0|||
129873787|NCT02390531|467495701|FG006|Overall Study|Protocol Violation|2|||
129873788|NCT02390531|467495702|FG007|Overall Study|Protocol Violation|0|||
129873789|NCT00511875|467495703|FG000|Overall Study|Lost to Follow-up|4|||
129873790|NCT00511875|467495704|FG001|Overall Study|Lost to Follow-up|0|||
129873791|NCT00511875|467495703|FG000|Overall Study|Missing variables|1|||
129873792|NCT00511875|467495704|FG001|Overall Study|Missing variables|0|||
129984727|NCT02101385|467905545|FG001|Study Treatment|Disease Progression|3|||
129873793|NCT00542880|467495705|FG000|Period 1|Eligibility criteria not fulfilled|2|||
129873794|NCT00542880|467495706|FG001|Period 1|Eligibility criteria not fulfilled|6|||
129873795|NCT00542880|467495705|FG000|Period 1|Adverse Event|2|||
129873796|NCT00542880|467495706|FG001|Period 1|Adverse Event|2|||
129873797|NCT00542880|467495705|FG000|Period 1|Development of study-specific criteria|1|||
129873798|NCT00542880|467495706|FG001|Period 1|Development of study-specific criteria|2|||
129873799|NCT00542880|467495705|FG000|Period 1|Withdrawal by Subject|1|||
129873800|NCT00542880|467495706|FG001|Period 1|Withdrawal by Subject|1|||
129873801|NCT00542880|467495705|FG000|Period 1|Protocol Violation|0|||
129873802|NCT00542880|467495706|FG001|Period 1|Protocol Violation|1|||
129873803|NCT00542880|467495705|FG000|Period 2|Adverse Event|5|||
129873804|NCT00542880|467495706|FG001|Period 2|Adverse Event|7|||
129873805|NCT00542880|467495705|FG000|Period 2|Eligibility not fulfilled|0|||
129873806|NCT00542880|467495706|FG001|Period 2|Eligibility not fulfilled|1|||
129873807|NCT00542880|467495705|FG000|Period 2|Discontinuation criteria|2|||
129873808|NCT00542880|467495706|FG001|Period 2|Discontinuation criteria|0|||
129873809|NCT00542880|467495705|FG000|Period 2|Severe non-compliance|0|||
129873810|NCT00542880|467495706|FG001|Period 2|Severe non-compliance|1|||
129873811|NCT00542880|467495705|FG000|Period 2|Other|0|||
129873812|NCT00542880|467495706|FG001|Period 2|Other|1|||
129873813|NCT00542880|467495705|FG000|Period 3|Adverse Event|0|||
129873814|NCT00542880|467495706|FG001|Period 3|Adverse Event|2|||
129873815|NCT00696384|467495707|FG000|Open Label Phase|Adverse Event|27|||
129873816|NCT00696384|467495708|FG001|Open Label Phase|Adverse Event|0|||
129873817|NCT00696384|467495709|FG002|Open Label Phase|Adverse Event|0|||
129873818|NCT00696384|467495707|FG000|Open Label Phase|Protocol Violation|18|||
129873819|NCT00696384|467495708|FG001|Open Label Phase|Protocol Violation|0|||
129873820|NCT00696384|467495709|FG002|Open Label Phase|Protocol Violation|0|||
129873821|NCT00696384|467495707|FG000|Open Label Phase|Lost to Follow-up|24|||
129873822|NCT00696384|467495708|FG001|Open Label Phase|Lost to Follow-up|0|||
129873823|NCT00696384|467495709|FG002|Open Label Phase|Lost to Follow-up|0|||
129873824|NCT00696384|467495707|FG000|Open Label Phase|Withdrawal by Subject|37|||
129873825|NCT00696384|467495708|FG001|Open Label Phase|Withdrawal by Subject|0|||
129873826|NCT00696384|467495709|FG002|Open Label Phase|Withdrawal by Subject|0|||
129873827|NCT00696384|467495707|FG000|Open Label Phase|Other|6|||
129873828|NCT00696384|467495708|FG001|Open Label Phase|Other|0|||
129873829|NCT00696384|467495709|FG002|Open Label Phase|Other|0|||
129873830|NCT00696384|467495707|FG000|Open Label Phase|Lack of Efficacy|3|||
129873831|NCT00696384|467495708|FG001|Open Label Phase|Lack of Efficacy|0|||
129873832|NCT00696384|467495709|FG002|Open Label Phase|Lack of Efficacy|0|||
129873833|NCT00696384|467495707|FG000|Open Label Phase|Physician Decision|4|||
129873834|NCT00696384|467495708|FG001|Open Label Phase|Physician Decision|0|||
129873835|NCT00696384|467495709|FG002|Open Label Phase|Physician Decision|0|||
129873836|NCT00696384|467495707|FG000|Double Blind Phase|Adverse Event|0|||
129873837|NCT00696384|467495708|FG001|Double Blind Phase|Adverse Event|2|||
129873838|NCT00696384|467495709|FG002|Double Blind Phase|Adverse Event|2|||
129873839|NCT00696384|467495707|FG000|Double Blind Phase|Lost to Follow-up|0|||
129873840|NCT00696384|467495708|FG001|Double Blind Phase|Lost to Follow-up|2|||
129873841|NCT00696384|467495709|FG002|Double Blind Phase|Lost to Follow-up|1|||
129873842|NCT00696384|467495707|FG000|Double Blind Phase|Withdrawal by Subject|0|||
129873843|NCT00696384|467495708|FG001|Double Blind Phase|Withdrawal by Subject|4|||
129873844|NCT00696384|467495709|FG002|Double Blind Phase|Withdrawal by Subject|3|||
129873845|NCT00696384|467495707|FG000|Double Blind Phase|Lack of Efficacy|0|||
129873846|NCT00696384|467495708|FG001|Double Blind Phase|Lack of Efficacy|1|||
129873847|NCT00696384|467495709|FG002|Double Blind Phase|Lack of Efficacy|0|||
129873848|NCT00696384|467495707|FG000|Double Blind Phase|Physician Decision|0|||
129873849|NCT00696384|467495708|FG001|Double Blind Phase|Physician Decision|2|||
129873850|NCT00696384|467495709|FG002|Double Blind Phase|Physician Decision|0|||
129873851|NCT01678131|467495710|FG000|Overall Study|Adverse Event|0|||
129873852|NCT01678131|467495711|FG001|Overall Study|Adverse Event|1|||
129873853|NCT01678131|467495712|FG002|Overall Study|Adverse Event|0|||
129873854|NCT01678131|467495710|FG000|Overall Study|Withdrawal by Subject|0|||
129873855|NCT01678131|467495711|FG001|Overall Study|Withdrawal by Subject|0|||
129873856|NCT01678131|467495712|FG002|Overall Study|Withdrawal by Subject|2|||
129873857|NCT02027402|467495714|FG000|Overall Study|Withdrawal by Subject|4|||
129873858|NCT02027402|467495715|FG001|Overall Study|Withdrawal by Subject|1|||
129873859|NCT00941798|467495719|FG000|Overall Study|Withdrawal by Subject|72|||
129873860|NCT00941798|467495720|FG001|Overall Study|Withdrawal by Subject|74|||
129873861|NCT00941798|467495719|FG000|Overall Study|Adverse Event|43|||
129873862|NCT00941798|467495720|FG001|Overall Study|Adverse Event|23|||
129873863|NCT00941798|467495719|FG000|Overall Study|Lost to Follow-up|29|||
129873864|NCT00941798|467495720|FG001|Overall Study|Lost to Follow-up|23|||
129873865|NCT00941798|467495719|FG000|Overall Study|Protocol Violation|17|||
129873866|NCT00941798|467495720|FG001|Overall Study|Protocol Violation|20|||
129873867|NCT00941798|467495719|FG000|Overall Study|Administrative problems|13|||
129873868|NCT00941798|467495720|FG001|Overall Study|Administrative problems|23|||
129873869|NCT00941798|467495719|FG000|Overall Study|Lack of Efficacy|10|||
129873870|NCT00941798|467495720|FG001|Overall Study|Lack of Efficacy|17|||
129873871|NCT00941798|467495719|FG000|Overall Study|Patient's inability to use device|6|||
129873872|NCT00941798|467495720|FG001|Overall Study|Patient's inability to use device|1|||
129873873|NCT00941798|467495719|FG000|Overall Study|Abnormal test procedure results|3|||
129873874|NCT00941798|467495720|FG001|Overall Study|Abnormal test procedure results|1|||
129873875|NCT00941798|467495719|FG000|Overall Study|Abnormal laboratory values|1|||
129873876|NCT00941798|467495720|FG001|Overall Study|Abnormal laboratory values|2|||
129873877|NCT00941798|467495719|FG000|Overall Study|Death|0|||
129873878|NCT00941798|467495720|FG001|Overall Study|Death|1|||
129891095|NCT02408549|467559616|FG000|Overall Study|Site closure|1|||
129984728|NCT02101385|467905544|FG000|Study Treatment|Alternative therapy|0|||
129984729|NCT02101385|467905545|FG001|Study Treatment|Alternative therapy|1|||
129873879|NCT04179721|467495723|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
129873880|NCT04179721|467495724|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
129873881|NCT04179721|467495723|FG000|Overall Study|Lost to Follow-up|0|||
129873882|NCT04179721|467495724|FG001|Overall Study|Lost to Follow-up|1|||
129873883|NCT00112580|467495725|FG000|Overall Study|Adverse Event|1|||
129873884|NCT00112580|467495726|FG001|Overall Study|Adverse Event|2|||
129873885|NCT00112580|467495725|FG000|Overall Study|Disease progression|5|||
129873886|NCT00112580|467495726|FG001|Overall Study|Disease progression|16|||
129873887|NCT00112580|467495725|FG000|Overall Study|Participant withdrew consent|2|||
129873888|NCT00112580|467495726|FG001|Overall Study|Participant withdrew consent|1|||
129873889|NCT05619003|467495727|FG000|Overall Study|Adverse Event|1|||
129873890|NCT01682213|467496610|FG000|Overall Study|Withdrawal by Subject|2|||
129873891|NCT00742079|467496611|FG000|Overall Study|Lost to Follow-up|0|||
129873892|NCT00742079|467496612|FG001|Overall Study|Lost to Follow-up|1|||
129873893|NCT01264380|467496613|FG000|Period C|Disease Progression|0|||
129873894|NCT01264380|467496614|FG001|Period C|Disease Progression|0|||
129873895|NCT01264380|467496615|FG002|Period C|Disease Progression|4|||
129873896|NCT01264380|467496613|FG000|Period C|Death|0|||
129873897|NCT01264380|467496614|FG001|Period C|Death|0|||
129873898|NCT01264380|467496615|FG002|Period C|Death|2|||
129873899|NCT01264380|467496613|FG000|Period C|Follow-up for survival status|0|||
129873900|NCT01264380|467496614|FG001|Period C|Follow-up for survival status|0|||
129873901|NCT01264380|467496615|FG002|Period C|Follow-up for survival status|6|||
129984730|NCT02101385|467905544|FG000|Study Treatment|No treatment, per protocol criteria|0|||
129984731|NCT02101385|467905545|FG001|Study Treatment|No treatment, per protocol criteria|4|||
129984732|NCT02101385|467905544|FG000|Study Treatment|Patient Non compliance|0|||
129984733|NCT02101385|467905545|FG001|Study Treatment|Patient Non compliance|2|||
129984734|NCT02101385|467905544|FG000|Study Treatment|Withdrawal by Subject|5|||
129443568|NCT00867113|465924427|FG000|Treatment Period|Adverse Event|15|||
129873902|NCT01264380|467496613|FG000|Period C|Withdrawal by Subject|0|||
129873903|NCT01264380|467496614|FG001|Period C|Withdrawal by Subject|0|||
129873904|NCT01264380|467496615|FG002|Period C|Withdrawal by Subject|1|||
129873905|NCT01264380|467496613|FG000|Period C|Adverse Event|0|||
129873906|NCT01264380|467496614|FG001|Period C|Adverse Event|0|||
129873907|NCT01264380|467496615|FG002|Period C|Adverse Event|1|||
129873908|NCT01147822|467496616|FG000|Overall Study|Lost to Follow-up|14|||
129873909|NCT01147822|467496617|FG001|Overall Study|Lost to Follow-up|6|||
129873910|NCT01147822|467496616|FG000|Overall Study|Withdrawal by Subject|10|||
129873911|NCT01147822|467496617|FG001|Overall Study|Withdrawal by Subject|16|||
129873912|NCT01147822|467496616|FG000|Overall Study|Physician Decision|9|||
129873913|NCT01147822|467496617|FG001|Overall Study|Physician Decision|8|||
129539532|NCT03735849|466266933|FG002|Overall Study|Lost to Follow-up|0|||
129539533|NCT03735849|466266931|FG000|Overall Study|Participant unable to adhere to visit|1|||
129873914|NCT01147822|467496616|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
129539534|NCT03735849|466266932|FG001|Overall Study|Participant unable to adhere to visit|0|||
129539535|NCT03735849|466266933|FG002|Overall Study|Participant unable to adhere to visit|0|||
129539536|NCT03735849|466266931|FG000|Overall Study|Not Randomized|0|||
129539537|NCT03735849|466266932|FG001|Overall Study|Not Randomized|0|||
129539538|NCT03735849|466266933|FG002|Overall Study|Not Randomized|4|||
129539539|NCT04585906|466266936|FG000|Overall Study|Lost to Follow-up|8|||
129539540|NCT04585906|466266937|FG001|Overall Study|Lost to Follow-up|5|||
129539541|NCT01050998|466266938|FG000|Overall Study|Adverse Event|1|||
129539542|NCT01050998|466266939|FG001|Overall Study|Adverse Event|0|||
129539543|NCT01050998|466266940|FG002|Overall Study|Adverse Event|1|||
129539544|NCT01050998|466266941|FG003|Overall Study|Adverse Event|0|||
129539545|NCT01050998|466266942|FG004|Overall Study|Adverse Event|2|||
129539546|NCT01050998|466266938|FG000|Overall Study|Withdrawal by Subject|0|||
129539547|NCT01050998|466266939|FG001|Overall Study|Withdrawal by Subject|0|||
129539548|NCT01050998|466266940|FG002|Overall Study|Withdrawal by Subject|0|||
129539549|NCT01050998|466266941|FG003|Overall Study|Withdrawal by Subject|1|||
129539550|NCT01050998|466266942|FG004|Overall Study|Withdrawal by Subject|3|||
129539551|NCT01050998|466266938|FG000|Overall Study|Other|3|||
129539552|NCT01050998|466266939|FG001|Overall Study|Other|2|||
129539553|NCT01050998|466266940|FG002|Overall Study|Other|1|||
129539554|NCT01050998|466266941|FG003|Overall Study|Other|1|||
129539555|NCT01050998|466266942|FG004|Overall Study|Other|5|||
129539556|NCT01050998|466266938|FG000|Overall Study|Data integrity issues|0|||
129539557|NCT01050998|466266939|FG001|Overall Study|Data integrity issues|0|||
129539558|NCT01050998|466266940|FG002|Overall Study|Data integrity issues|1|||
129539559|NCT01050998|466266941|FG003|Overall Study|Data integrity issues|1|||
129539560|NCT01050998|466266942|FG004|Overall Study|Data integrity issues|4|||
129539561|NCT02219477|466266949|FG000|Overall Study|Adverse Event|0|||
129539562|NCT02219477|466266950|FG001|Overall Study|Adverse Event|1|||
129873915|NCT01147822|467496617|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
129984735|NCT02101385|467905545|FG001|Study Treatment|Withdrawal by Subject|2|||
129873916|NCT01147822|467496616|FG000|Overall Study|Protocol Violation|1|||
129873917|NCT01147822|467496617|FG001|Overall Study|Protocol Violation|1|||
129873918|NCT01226511|467496618|FG000|Acute Treatment Period|Adverse Event|7|||
129539563|NCT02219477|466266951|FG002|Overall Study|Adverse Event|1|||
129539564|NCT02219477|466266949|FG000|Overall Study|Withdrawal by Subject|0|||
129539565|NCT02219477|466266950|FG001|Overall Study|Withdrawal by Subject|1|||
129539566|NCT02219477|466266951|FG002|Overall Study|Withdrawal by Subject|0|||
129539567|NCT00234533|466266958|FG000|Overall Study|Withdrawal by Subject|6|||
129539568|NCT00234533|466266958|FG000|Overall Study|Adverse Event|2|||
129539569|NCT00234533|466266958|FG000|Overall Study|Enrolled but not treated|3|||
129539570|NCT00945815|466266961|FG000|Overall Study|Death|3|||
129539571|NCT00945815|466266961|FG000|Overall Study|Not protocol specified|1|||
129539572|NCT00945815|466266961|FG000|Overall Study|Ineligible|3|||
129539573|NCT00945815|466266961|FG000|Overall Study|Did not begin protocol therapy|1|||
129539574|NCT01314261|466266964|FG000|Overall Study|Adverse Event|1|||
129539575|NCT01314261|466266965|FG001|Overall Study|Adverse Event|0|||
129539576|NCT01314261|466266966|FG002|Overall Study|Adverse Event|0|||
129539577|NCT01314261|466266967|FG003|Overall Study|Adverse Event|0|||
129539578|NCT01314261|466266964|FG000|Overall Study|Withdrawal by Subject|0|||
129539579|NCT01314261|466266965|FG001|Overall Study|Withdrawal by Subject|3|||
129539580|NCT01314261|466266966|FG002|Overall Study|Withdrawal by Subject|1|||
129539581|NCT01314261|466266967|FG003|Overall Study|Withdrawal by Subject|0|||
129539582|NCT01314261|466266964|FG000|Overall Study|Lost to Follow-up|1|||
129539583|NCT01314261|466266965|FG001|Overall Study|Lost to Follow-up|0|||
129539584|NCT01314261|466266966|FG002|Overall Study|Lost to Follow-up|2|||
129539585|NCT01314261|466266967|FG003|Overall Study|Lost to Follow-up|2|||
129539586|NCT01314261|466266964|FG000|Overall Study|Virologic Failure|0|||
129539587|NCT01314261|466266965|FG001|Overall Study|Virologic Failure|1|||
129539588|NCT01314261|466266966|FG002|Overall Study|Virologic Failure|0|||
129539589|NCT01314261|466266967|FG003|Overall Study|Virologic Failure|1|||
129539590|NCT04524507|466266968|FG000|Overall Study|Lost to Follow-up|2|||
129539591|NCT04524507|466266969|FG001|Overall Study|Lost to Follow-up|4|||
129539592|NCT04524507|466266968|FG000|Overall Study|Withdrawal by Subject|2|||
129539593|NCT04524507|466266969|FG001|Overall Study|Withdrawal by Subject|9|||
129539594|NCT04524507|466266968|FG000|Overall Study|Death|2|||
129539595|NCT04524507|466266969|FG001|Overall Study|Death|10|||
129539596|NCT01383317|466266970|FG000|Overall Study|Lost to Follow-up|2|||
129539597|NCT01383317|466266971|FG001|Overall Study|Lost to Follow-up|1|||
129539598|NCT01383317|466266970|FG000|Overall Study|Death|1|||
129539599|NCT01383317|466266971|FG001|Overall Study|Death|0|||
129539600|NCT01383317|466266970|FG000|Overall Study|Adverse Event|0|||
129539601|NCT01383317|466266971|FG001|Overall Study|Adverse Event|1|||
129539602|NCT00422227|466266972|FG000|Overall Study|Adverse Event|3|||
129539603|NCT00422227|466266973|FG001|Overall Study|Adverse Event|8|||
129539604|NCT00422227|466266972|FG000|Overall Study|Lost to Follow-up|1|||
129539605|NCT00422227|466266973|FG001|Overall Study|Lost to Follow-up|3|||
129539606|NCT00422227|466266972|FG000|Overall Study|Withdrawal by Subject|0|||
129539607|NCT00422227|466266973|FG001|Overall Study|Withdrawal by Subject|4|||
129984736|NCT02101385|467905544|FG000|Study Treatment|screen failure|1|||
129984737|NCT02101385|467905545|FG001|Study Treatment|screen failure|0|||
129984738|NCT02101385|467905544|FG000|Study Treatment|AE/Side Effects/Complications|8|||
129984739|NCT02101385|467905545|FG001|Study Treatment|AE/Side Effects/Complications|0|||
129984740|NCT02101385|467905544|FG000|Study Treatment|Lost to Follow-up|1|||
129984741|NCT02101385|467905545|FG001|Study Treatment|Lost to Follow-up|0|||
129984742|NCT02101385|467905544|FG000|Study Treatment|Disease Progression before treatment|1|||
129984743|NCT02101385|467905545|FG001|Study Treatment|Disease Progression before treatment|0|||
129984744|NCT02101385|467905544|FG000|Study Treatment|Death|1|||
129984745|NCT02101385|467905545|FG001|Study Treatment|Death|0|||
129984746|NCT02101385|467905544|FG000|Follow up|Lost to Follow-up|4|||
129539608|NCT01790633|466266974|FG000|Overall Study|Protocol Violation|1|||
129539609|NCT01790633|466266975|FG001|Overall Study|Protocol Violation|2|||
129539610|NCT01790633|466266974|FG000|Overall Study|Did not have serology performed|47|||
129539611|NCT01790633|466266975|FG001|Overall Study|Did not have serology performed|0|||
129539612|NCT01790633|466266974|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
129539613|NCT01790633|466266975|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
129539614|NCT00157157|466266976|FG000|Overall Study|Withdrawal by Subject|6|||
129539615|NCT00157157|466266976|FG000|Overall Study|Physician Decision|1|||
129539616|NCT00157157|466266976|FG000|Overall Study|Lost to Follow-up|1|||
129873919|NCT01226511|467496619|FG001|Acute Treatment Period|Adverse Event|6|||
129873920|NCT01226511|467496618|FG000|Acute Treatment Period|Lack of Efficacy|2|||
129873921|NCT01226511|467496619|FG001|Acute Treatment Period|Lack of Efficacy|1|||
129873922|NCT01226511|467496618|FG000|Acute Treatment Period|Lost to Follow-up|3|||
129873923|NCT01226511|467496619|FG001|Acute Treatment Period|Lost to Follow-up|6|||
129873924|NCT01226511|467496618|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
129873925|NCT01226511|467496619|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
129539617|NCT00157157|466266976|FG000|Overall Study|Enrolled in another study|1|||
129984747|NCT02101385|467905545|FG001|Follow up|Lost to Follow-up|9|||
129984748|NCT02101385|467905544|FG000|Follow up|Refused to follow up|5|||
129891096|NCT02408549|467559616|FG000|Overall Study|Pregnancy|1|||
129539618|NCT00157157|466266976|FG000|Overall Study|Met exclusion criteria|1|||
129539619|NCT00157157|466266976|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
129539620|NCT01241591|466268728|FG000|Overall Study|Lack of Efficacy|5|||
129539621|NCT01241591|466268729|FG001|Overall Study|Lack of Efficacy|2|||
129539622|NCT01241591|466268730|FG002|Overall Study|Lack of Efficacy|2|||
129539623|NCT01241591|466268731|FG003|Overall Study|Lack of Efficacy|3|||
129539624|NCT01241591|466268728|FG000|Overall Study|Protocol Violation|5|||
129539625|NCT01241591|466268729|FG001|Overall Study|Protocol Violation|2|||
129539626|NCT01241591|466268730|FG002|Overall Study|Protocol Violation|3|||
129539627|NCT01241591|466268731|FG003|Overall Study|Protocol Violation|0|||
129539628|NCT01241591|466268728|FG000|Overall Study|Lost to Follow-up|1|||
129539629|NCT01241591|466268729|FG001|Overall Study|Lost to Follow-up|2|||
129539630|NCT01241591|466268730|FG002|Overall Study|Lost to Follow-up|2|||
129539631|NCT01241591|466268731|FG003|Overall Study|Lost to Follow-up|2|||
129539632|NCT01241591|466268728|FG000|Overall Study|Screen Failure|3|||
129539633|NCT01241591|466268729|FG001|Overall Study|Screen Failure|2|||
129539634|NCT01241591|466268730|FG002|Overall Study|Screen Failure|1|||
129539635|NCT01241591|466268731|FG003|Overall Study|Screen Failure|0|||
129539636|NCT01241591|466268728|FG000|Overall Study|Withdrawal by Subject|6|||
129984749|NCT02101385|467905545|FG001|Follow up|Refused to follow up|4|||
129984750|NCT02101385|467905544|FG000|Follow up|Death|21|||
129984751|NCT02101385|467905545|FG001|Follow up|Death|39|||
129984752|NCT02101385|467905544|FG000|Follow up|study completed|33|||
129984753|NCT02101385|467905545|FG001|Follow up|study completed|52|||
129984754|NCT02101385|467905544|FG000|Follow up|screen failure|2|||
129984755|NCT02101385|467905545|FG001|Follow up|screen failure|0|||
129984756|NCT02101385|467905544|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
129984757|NCT02101385|467905545|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
129984758|NCT02101385|467905544|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
129984759|NCT02101385|467905545|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
129984760|NCT02101385|467905544|FG000|Follow up|Withdrawal by Subject|2|||
129984761|NCT02101385|467905545|FG001|Follow up|Withdrawal by Subject|2|||
129984762|NCT02101385|467905544|FG000|Follow up|PI requested closure of site|0|||
129984763|NCT02101385|467905545|FG001|Follow up|PI requested closure of site|5|||
129984764|NCT02432196|467905546|FG000|Overall Study|Exit - did not receive study device|1|||
129984765|NCT02432196|467905546|FG000|Overall Study|Death|2|||
129984766|NCT02432196|467905546|FG000|Overall Study|Reoperation|3|||
129984767|NCT05038163|467905547|FG000|Stage 1|Did not complete survey|374|||
129984768|NCT05038163|467905548|FG001|Stage 1|Did not complete survey|0|||
129984769|NCT05038163|467905549|FG002|Stage 1|Did not complete survey|0|||
129984770|NCT05038163|467905550|FG003|Stage 1|Did not complete survey|0|||
129984771|NCT05038163|467905551|FG004|Stage 1|Did not complete survey|0|||
129984772|NCT05038163|467905552|FG005|Stage 1|Did not complete survey|0|||
129443569|NCT00867113|465924427|FG000|Treatment Period|Death|2|||
129539637|NCT01241591|466268729|FG001|Overall Study|Withdrawal by Subject|4|||
129539638|NCT01241591|466268730|FG002|Overall Study|Withdrawal by Subject|2|||
129539639|NCT01241591|466268731|FG003|Overall Study|Withdrawal by Subject|2|||
129539640|NCT01241591|466268728|FG000|Overall Study|Other|0|||
129539641|NCT01241591|466268729|FG001|Overall Study|Other|1|||
129539642|NCT01241591|466268730|FG002|Overall Study|Other|0|||
129539643|NCT01241591|466268731|FG003|Overall Study|Other|1|||
129539644|NCT01241591|466268728|FG000|Overall Study|Adverse Event|3|||
129539645|NCT01241591|466268729|FG001|Overall Study|Adverse Event|11|||
129539646|NCT01241591|466268730|FG002|Overall Study|Adverse Event|12|||
129539647|NCT01241591|466268731|FG003|Overall Study|Adverse Event|4|||
129539648|NCT01945034|466268732|FG000|Overall Study|Medication Error|0|||
129539649|NCT01945034|466268733|FG001|Overall Study|Medication Error|1|||
129539650|NCT01945034|466268734|FG002|Overall Study|Medication Error|0|||
129539651|NCT01945034|466268732|FG000|Overall Study|Withdrawal by Subject|0|||
129539652|NCT01945034|466268733|FG001|Overall Study|Withdrawal by Subject|3|||
129539653|NCT01945034|466268734|FG002|Overall Study|Withdrawal by Subject|1|||
129539654|NCT01945034|466268732|FG000|Overall Study|Other|0|||
129539655|NCT01945034|466268733|FG001|Overall Study|Other|1|||
129539656|NCT01945034|466268734|FG002|Overall Study|Other|3|||
129539657|NCT01945034|466268732|FG000|Overall Study|Lost to Follow-up|0|||
129539658|NCT01945034|466268733|FG001|Overall Study|Lost to Follow-up|0|||
129539659|NCT01945034|466268734|FG002|Overall Study|Lost to Follow-up|2|||
129539660|NCT01945034|466268732|FG000|Overall Study|Protocol Violation|1|||
129539661|NCT01945034|466268733|FG001|Overall Study|Protocol Violation|0|||
129539662|NCT01945034|466268734|FG002|Overall Study|Protocol Violation|1|||
129539663|NCT02147132|466268735|FG000|Overall Study|Lost to Follow-up|1|||
129539664|NCT02147132|466268736|FG001|Overall Study|Lost to Follow-up|0|||
129539665|NCT02147132|466268737|FG002|Overall Study|Lost to Follow-up|0|||
129539666|NCT02147132|466268738|FG003|Overall Study|Lost to Follow-up|0|||
129984773|NCT05038163|467905547|FG000|Stage 2|Did not complete Stage 2 survey|0|||
129984774|NCT05038163|467905548|FG001|Stage 2|Did not complete Stage 2 survey|29|||
129984775|NCT05038163|467905549|FG002|Stage 2|Did not complete Stage 2 survey|30|||
129539667|NCT01798056|466268739|FG000|Overall Study|Serious Adverse Event|13|||
129539668|NCT01798056|466268740|FG001|Overall Study|Serious Adverse Event|12|||
129539669|NCT01798056|466268739|FG000|Overall Study|Withdrawal by Subject|12|||
129539670|NCT01798056|466268740|FG001|Overall Study|Withdrawal by Subject|9|||
129539671|NCT01798056|466268739|FG000|Overall Study|Migrated/moved from study area|1|||
129539672|NCT01798056|466268740|FG001|Overall Study|Migrated/moved from study area|1|||
129539673|NCT01798056|466268739|FG000|Overall Study|Lost to Follow-up|1|||
129539674|NCT01798056|466268740|FG001|Overall Study|Lost to Follow-up|1|||
129539675|NCT01798056|466268739|FG000|Overall Study|Other|0|||
129539676|NCT01798056|466268740|FG001|Overall Study|Other|2|||
129539677|NCT02842736|466268743|FG000|Overall Study|Lost to Follow-up|13|||
129539678|NCT02842736|466268743|FG000|Overall Study|Intervention for menstrual bleeding|17|||
129539679|NCT02842736|466268743|FG000|Overall Study|Withdrawal by Subject|4|||
129539680|NCT02842736|466268743|FG000|Overall Study|Pregnancy|3|||
129539681|NCT02842736|466268743|FG000|Overall Study|Hysterectomy for fibroids|2|||
129539682|NCT02842736|466268743|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
129539683|NCT02842736|466268743|FG000|Overall Study|IUD: Mirena|1|||
129539684|NCT03323034|466268745|FG000|Overall Study|Lack of Efficacy|5|||
129539685|NCT03323034|466268746|FG001|Overall Study|Lack of Efficacy|5|||
129539686|NCT03323034|466268747|FG002|Overall Study|Lack of Efficacy|6|||
129539687|NCT03323034|466268748|FG003|Overall Study|Lack of Efficacy|5|||
129539688|NCT03323034|466268749|FG004|Overall Study|Lack of Efficacy|5|||
129539689|NCT03323034|466268745|FG000|Overall Study|Physician Decision|0|||
129539690|NCT03323034|466268746|FG001|Overall Study|Physician Decision|0|||
129539691|NCT03323034|466268747|FG002|Overall Study|Physician Decision|0|||
129539692|NCT03323034|466268748|FG003|Overall Study|Physician Decision|0|||
129539693|NCT03323034|466268749|FG004|Overall Study|Physician Decision|1|||
129539694|NCT03323034|466268745|FG000|Overall Study|Withdrawal by Subject|1|||
129539695|NCT03323034|466268746|FG001|Overall Study|Withdrawal by Subject|1|||
129539696|NCT03323034|466268747|FG002|Overall Study|Withdrawal by Subject|0|||
129539697|NCT03323034|466268748|FG003|Overall Study|Withdrawal by Subject|1|||
129539698|NCT03323034|466268749|FG004|Overall Study|Withdrawal by Subject|0|||
129539699|NCT02646566|466268750|FG000|Overall Study|Lost to Follow-up|5|||
129539700|NCT02646566|466268751|FG001|Overall Study|Lost to Follow-up|4|||
129539701|NCT02646566|466268752|FG002|Overall Study|Lost to Follow-up|5|||
129539702|NCT02646566|466268750|FG000|Overall Study|Treatment failure|1|||
129873926|NCT01226511|467496618|FG000|Acute Treatment Period|Protocol Violation|5|||
129873927|NCT01226511|467496619|FG001|Acute Treatment Period|Protocol Violation|5|||
129873928|NCT01226511|467496618|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
129873929|NCT01226511|467496619|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
129873930|NCT01226511|467496618|FG000|Extension Treatment Period|Adverse Event|8|||
129873931|NCT01226511|467496619|FG001|Extension Treatment Period|Adverse Event|8|||
129873932|NCT01226511|467496618|FG000|Extension Treatment Period|Lack of Efficacy|3|||
129873933|NCT01226511|467496619|FG001|Extension Treatment Period|Lack of Efficacy|2|||
129873934|NCT01226511|467496618|FG000|Extension Treatment Period|Lost to Follow-up|4|||
129873935|NCT01226511|467496619|FG001|Extension Treatment Period|Lost to Follow-up|3|||
129873936|NCT01226511|467496618|FG000|Extension Treatment Period|Protocol Violation|2|||
129873937|NCT01226511|467496619|FG001|Extension Treatment Period|Protocol Violation|2|||
129873938|NCT01226511|467496618|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
129873939|NCT01226511|467496619|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
129873940|NCT01226511|467496618|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
129873941|NCT01226511|467496619|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
129873942|NCT01226511|467496618|FG000|Extension Treatment Period|Sponsor Decision|1|||
129873943|NCT01226511|467496619|FG001|Extension Treatment Period|Sponsor Decision|1|||
129873944|NCT01226511|467496618|FG000|Taper Period|Adverse Event|1|||
129873945|NCT01226511|467496619|FG001|Taper Period|Adverse Event|0|||
129873946|NCT01226511|467496618|FG000|Taper Period|Lost to Follow-up|2|||
129873947|NCT01226511|467496619|FG001|Taper Period|Lost to Follow-up|2|||
129873948|NCT01226511|467496618|FG000|Taper Period|Protocol Violation|1|||
129873949|NCT01226511|467496619|FG001|Taper Period|Protocol Violation|0|||
129873950|NCT01226511|467496618|FG000|Taper Period|Parent/Caregiver Decision|1|||
129873951|NCT01226511|467496619|FG001|Taper Period|Parent/Caregiver Decision|1|||
129873952|NCT01337986|467496620|FG000|Overall Study|Adverse Event|2|||
129873953|NCT01337986|467496621|FG001|Overall Study|Adverse Event|2|||
129539703|NCT02646566|466268751|FG001|Overall Study|Treatment failure|0|||
129539704|NCT02646566|466268752|FG002|Overall Study|Treatment failure|0|||
129539705|NCT02815540|466268755|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
129539706|NCT02222246|466268756|FG000|Overall Study|No Emergency Department Visits|27|||
129539707|NCT02222246|466268757|FG001|Overall Study|No Emergency Department Visits|26|||
129539708|NCT02222246|466268756|FG000|Overall Study|Physician Decision|0|||
129873954|NCT01337986|467496620|FG000|Overall Study|Lost to Follow-up|1|||
129873955|NCT01337986|467496621|FG001|Overall Study|Lost to Follow-up|0|||
129539709|NCT02222246|466268757|FG001|Overall Study|Physician Decision|1|||
129539710|NCT02660489|466268758|FG000|Overall Study|Lost to Follow-up|1|||
129539711|NCT02660489|466268759|FG001|Overall Study|Lost to Follow-up|1|||
129539712|NCT02660489|466268758|FG000|Overall Study|Adverse Event|1|||
129539713|NCT02660489|466268759|FG001|Overall Study|Adverse Event|3|||
129539714|NCT02660489|466268758|FG000|Overall Study|no rhinovirus infection|4|||
129539715|NCT02660489|466268759|FG001|Overall Study|no rhinovirus infection|4|||
129873956|NCT01337986|467496620|FG000|Overall Study|Protocol Violation|0|||
129873957|NCT01337986|467496621|FG001|Overall Study|Protocol Violation|3|||
129873958|NCT01520402|467496622|FG000|Overall Study|Withdrawal by Subject|2|||
129873959|NCT01520402|467496622|FG000|Overall Study|Physician Decision|3|||
129873960|NCT01722162|467496624|FG000|Overall Study|Withdrawal by Subject|1|||
129873961|NCT01722162|467496625|FG001|Overall Study|Withdrawal by Subject|1|||
129873962|NCT01722162|467496624|FG000|Overall Study|Found ineligible|1|||
129873963|NCT01722162|467496625|FG001|Overall Study|Found ineligible|0|||
129873964|NCT01722162|467496624|FG000|Overall Study|Unrelated to study adverse event|2|||
129873965|NCT01722162|467496625|FG001|Overall Study|Unrelated to study adverse event|2|||
129873966|NCT01722162|467496624|FG000|Overall Study|Adverse Event|1|||
129873967|NCT01722162|467496625|FG001|Overall Study|Adverse Event|1|||
129873968|NCT01722162|467496624|FG000|Overall Study|Insurance denial post enrollment|0|||
129873969|NCT01722162|467496625|FG001|Overall Study|Insurance denial post enrollment|1|||
129873970|NCT01722162|467496624|FG000|Overall Study|Noncompliance|0|||
129873971|NCT01722162|467496625|FG001|Overall Study|Noncompliance|1|||
129873972|NCT03170375|467496626|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
129873973|NCT03170375|467496627|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
129873974|NCT03170375|467496628|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
129873975|NCT03170375|467496626|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
129873976|NCT03170375|467496627|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
129873977|NCT03170375|467496628|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
129873978|NCT00763958|467496629|FG000|Overall Study|did not meet final criteria|4|||
129873979|NCT00763958|467496630|FG001|Overall Study|did not meet final criteria|4|||
129873980|NCT00763958|467496629|FG000|Overall Study|Lost to Follow-up|10|||
129873981|NCT00763958|467496630|FG001|Overall Study|Lost to Follow-up|2|||
129873982|NCT00763958|467496629|FG000|Overall Study|Believed they were receiving placebo|0|||
129873983|NCT00763958|467496630|FG001|Overall Study|Believed they were receiving placebo|5|||
129873984|NCT02535364|467496633|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
129873985|NCT02535364|467496633|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
129873986|NCT02535364|467496633|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
129873987|NCT02535364|467496633|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
129873988|NCT02535364|467496633|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
129873989|NCT02535364|467496633|FG000|Part B Screening|Death|2|||
129873990|NCT02535364|467496633|FG000|Part B Screening|Physician Decision|1|||
129873991|NCT02535364|467496633|FG000|Part B Screening|Withdrawal by Subject|1|||
129873992|NCT02535364|467496633|FG000|Part B Screening|Adverse Event|1|||
129873993|NCT02535364|467496633|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
129873994|NCT02535364|467496633|FG000|Study Treatment|Death|1|||
129873995|NCT02535364|467496633|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
129873996|NCT02535364|467496633|FG000|12-Month Follow-up Period|Disease progression|22|||
129873997|NCT02535364|467496633|FG000|12-Month Follow-up Period|Death|5|||
129873998|NCT02535364|467496633|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
129539716|NCT02064231|466268760|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
129539717|NCT02064231|466268761|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
129539718|NCT02064231|466268762|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
129539719|NCT02064231|466268763|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
129539720|NCT02064231|466268760|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
129539721|NCT02064231|466268761|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
129539722|NCT02064231|466268762|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
129539723|NCT02064231|466268763|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
129539724|NCT02064231|466268760|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
129539725|NCT02064231|466268761|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
129539726|NCT02064231|466268762|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
129539727|NCT02064231|466268763|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
129539728|NCT02064231|466268760|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
129539729|NCT02064231|466268761|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
129539730|NCT02064231|466268762|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
129873999|NCT02535364|467496633|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
129874000|NCT02535364|467496633|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
129874001|NCT00571701|467496634|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
129874002|NCT00571701|467496635|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
129874003|NCT00571701|467496634|FG000|First Intervention 12 Months|Death|1|||
129874004|NCT00571701|467496635|FG001|First Intervention 12 Months|Death|0|||
129874005|NCT00571701|467496634|FG000|Second Intervention 12 Months|Adverse Event|0|||
129874006|NCT00571701|467496635|FG001|Second Intervention 12 Months|Adverse Event|1|||
129874007|NCT00571701|467496634|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
129874008|NCT00571701|467496635|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
129874009|NCT04766086|467496639|FG000|Overall Study|Lost to Follow-up|3|||
129874010|NCT04766086|467496640|FG001|Overall Study|Lost to Follow-up|5|||
129874011|NCT04766086|467496641|FG002|Overall Study|Lost to Follow-up|3|||
129874012|NCT04766086|467496639|FG000|Overall Study|Withdrawal by Subject|1|||
129874013|NCT04766086|467496640|FG001|Overall Study|Withdrawal by Subject|1|||
129874014|NCT04766086|467496641|FG002|Overall Study|Withdrawal by Subject|2|||
129874015|NCT04766086|467496639|FG000|Overall Study|Other|0|||
129874016|NCT04766086|467496640|FG001|Overall Study|Other|0|||
129874017|NCT04766086|467496641|FG002|Overall Study|Other|1|||
129874018|NCT03815019|467496642|FG000|Overall Study|Withdrawal by Subject|6|||
129874019|NCT03815019|467496643|FG001|Overall Study|Withdrawal by Subject|8|||
129874020|NCT01320943|467496644|FG000|Overall Study|Lost to Follow-up|1|||
129874021|NCT01320943|467496645|FG001|Overall Study|Lost to Follow-up|0|||
129874022|NCT01320943|467496644|FG000|Overall Study|Physician Decision|0|||
129874023|NCT01320943|467496645|FG001|Overall Study|Physician Decision|1|||
129874024|NCT01320943|467496644|FG000|Overall Study|Randomized but not Treated|0|||
129874025|NCT01320943|467496645|FG001|Overall Study|Randomized but not Treated|1|||
129874026|NCT03937219|467496646|FG000|Overall Study|Death|223|||
129874027|NCT03937219|467496647|FG001|Overall Study|Death|211|||
129874028|NCT03937219|467496646|FG000|Overall Study|Withdrawal by Subject|17|||
129874029|NCT03937219|467496647|FG001|Overall Study|Withdrawal by Subject|25|||
129874030|NCT03937219|467496646|FG000|Overall Study|Lost to Follow-up|3|||
129874031|NCT03937219|467496647|FG001|Overall Study|Lost to Follow-up|4|||
129874032|NCT00532155|467496648|FG000|Overall Study|Adverse Event|66|||
129874033|NCT00532155|467496649|FG001|Overall Study|Adverse Event|123|||
129874034|NCT00532155|467496648|FG000|Overall Study|Lack of Efficacy|332|||
129874035|NCT00532155|467496649|FG001|Overall Study|Lack of Efficacy|255|||
129874036|NCT00532155|467496648|FG000|Overall Study|Protocol Violation|1|||
129874037|NCT00532155|467496649|FG001|Overall Study|Protocol Violation|3|||
129874038|NCT00532155|467496648|FG000|Overall Study|Lost to Follow-up|2|||
129874039|NCT00532155|467496649|FG001|Overall Study|Lost to Follow-up|0|||
129874040|NCT00532155|467496648|FG000|Overall Study|Physician Decision|16|||
129874041|NCT00532155|467496649|FG001|Overall Study|Physician Decision|15|||
129874042|NCT00532155|467496648|FG000|Overall Study|Withdrawal by Subject|23|||
129874043|NCT00532155|467496649|FG001|Overall Study|Withdrawal by Subject|44|||
129874044|NCT00532155|467496648|FG000|Overall Study|Consent withdrawn|5|||
129874045|NCT00532155|467496649|FG001|Overall Study|Consent withdrawn|7|||
129874046|NCT00532155|467496648|FG000|Overall Study|Moved|1|||
129874047|NCT00532155|467496649|FG001|Overall Study|Moved|0|||
129874048|NCT00532155|467496648|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
129874049|NCT00532155|467496649|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
129874050|NCT00532155|467496648|FG000|Overall Study|Occurence of a second cancer|0|||
129874051|NCT00532155|467496649|FG001|Overall Study|Occurence of a second cancer|1|||
129874052|NCT00532155|467496648|FG000|Overall Study|Occurence of a secondary cancer|0|||
129874053|NCT00532155|467496649|FG001|Overall Study|Occurence of a secondary cancer|1|||
129874054|NCT00532155|467496648|FG000|Overall Study|Promotor ended study|1|||
129874055|NCT00532155|467496649|FG001|Overall Study|Promotor ended study|0|||
129874056|NCT00532155|467496648|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
129874057|NCT00532155|467496649|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
129874058|NCT00532155|467496648|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
129874059|NCT00532155|467496649|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
129874060|NCT00532155|467496648|FG000|Overall Study|Study stopped|1|||
129874061|NCT00532155|467496649|FG001|Overall Study|Study stopped|0|||
129874062|NCT00532155|467496648|FG000|Overall Study|Study terminated by sponsor|1|||
129874063|NCT00532155|467496649|FG001|Overall Study|Study terminated by sponsor|0|||
129874064|NCT00532155|467496648|FG000|Overall Study|Study termination stop further treatment|4|||
129874065|NCT00532155|467496649|FG001|Overall Study|Study termination stop further treatment|0|||
129874066|NCT00532155|467496648|FG000|Overall Study|Did not receive study medication|2|||
129874067|NCT00532155|467496649|FG001|Overall Study|Did not receive study medication|6|||
129874068|NCT03483038|467496650|FG000|Overall Study|Subjects still in follow-up|18|||
129874069|NCT02134925|467496651|FG000|Overall Study|Withdrawal by Subject|1|||
129874070|NCT02134925|467496652|FG001|Overall Study|Withdrawal by Subject|0|||
129874071|NCT02134925|467496651|FG000|Overall Study|Cancel|1|||
129874072|NCT02134925|467496652|FG001|Overall Study|Cancel|6|||
129874073|NCT04987762|467496653|FG000|Overall Study|Study was Terminated by Sponsor|103|||
129874074|NCT02158884|467496658|FG000|Baseline Assessment|Missed performance assessment|3|||
129874075|NCT02158884|467496658|FG000|Baseline Assessment|Missed SMFA|1|||
129874076|NCT02158884|467496658|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
129874077|NCT02158884|467496658|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
129874078|NCT02158884|467496658|FG000|6 Month Assessment|Missed SMFA|20|||
129874079|NCT02158884|467496658|FG000|12 Month Assessment|Missed SMFA|17|||
129874080|NCT03988166|467496661|FG000|Overall Study|Lost to Follow-up|2|||
129874081|NCT03988166|467496661|FG000|Overall Study|Death|1|||
129874082|NCT03248375|467496662|FG000|Overall Study|Lost to Follow-up|5|||
129874083|NCT00316173|467496667|FG000|Run-in Phase|Adverse Event|1|||
129874084|NCT00316173|467496668|FG001|Run-in Phase|Adverse Event|0|||
129874085|NCT00316173|467496667|FG000|Run-in Phase|Protocol Violation|1|||
129874086|NCT00316173|467496668|FG001|Run-in Phase|Protocol Violation|0|||
129874087|NCT00316173|467496667|FG000|Run-in Phase|Study Follow-up Stopped|5|||
129874088|NCT00316173|467496668|FG001|Run-in Phase|Study Follow-up Stopped|0|||
129874089|NCT00316173|467496667|FG000|Treatment Phase|Adverse Event|0|||
129874090|NCT00316173|467496668|FG001|Treatment Phase|Adverse Event|1|||
129874091|NCT00316173|467496667|FG000|Treatment Phase|Lack of Efficacy|0|||
129874092|NCT00316173|467496668|FG001|Treatment Phase|Lack of Efficacy|3|||
129874093|NCT00316173|467496667|FG000|Treatment Phase|Lost to Follow-up|0|||
129874094|NCT00316173|467496668|FG001|Treatment Phase|Lost to Follow-up|3|||
129874095|NCT00316173|467496667|FG000|Treatment Phase|Withdrawal by Subject|0|||
129874096|NCT00316173|467496668|FG001|Treatment Phase|Withdrawal by Subject|1|||
129874097|NCT00316173|467496667|FG000|Treatment Phase|Study Follow-up Stopped|0|||
129874098|NCT00316173|467496668|FG001|Treatment Phase|Study Follow-up Stopped|34|||
129874099|NCT03764072|467496669|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874100|NCT03764072|467496670|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874101|NCT03764072|467496671|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
129874102|NCT03764072|467496672|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874103|NCT03764072|467496673|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874104|NCT03764072|467496674|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
129874105|NCT03764072|467496669|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
129874106|NCT03764072|467496670|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
129874107|NCT03764072|467496671|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
129874108|NCT03764072|467496672|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
129874109|NCT03764072|467496673|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
129874110|NCT03764072|467496674|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
129874111|NCT03764072|467496669|FG000|Overall Study|Lost to Follow-up|0|||
129874112|NCT03764072|467496670|FG001|Overall Study|Lost to Follow-up|0|||
129874113|NCT03764072|467496671|FG002|Overall Study|Lost to Follow-up|0|||
129874114|NCT03764072|467496672|FG003|Overall Study|Lost to Follow-up|0|||
129874115|NCT03764072|467496673|FG004|Overall Study|Lost to Follow-up|1|||
129874116|NCT03764072|467496674|FG005|Overall Study|Lost to Follow-up|0|||
129874117|NCT00558064|467496675|FG000|Overall Study|Adverse Event|3|||
129874118|NCT00558064|467496676|FG001|Overall Study|Adverse Event|2|||
129874119|NCT00558064|467496675|FG000|Overall Study|Lack of Efficacy|0|||
129874120|NCT00558064|467496676|FG001|Overall Study|Lack of Efficacy|1|||
129874121|NCT00558064|467496675|FG000|Overall Study|Protocol Violation|1|||
129874122|NCT00558064|467496676|FG001|Overall Study|Protocol Violation|0|||
129874123|NCT00558064|467496675|FG000|Overall Study|Lost to Follow-up|0|||
129874124|NCT00558064|467496676|FG001|Overall Study|Lost to Follow-up|1|||
129874125|NCT00558064|467496675|FG000|Overall Study|Withdrawal by Subject|0|||
129874126|NCT00558064|467496676|FG001|Overall Study|Withdrawal by Subject|1|||
129874127|NCT00558064|467496675|FG000|Overall Study|No visit within allowance period|1|||
129874128|NCT00558064|467496676|FG001|Overall Study|No visit within allowance period|0|||
129874129|NCT00982930|467496679|FG000|Overall Study|Adverse Event|1|||
129874130|NCT00982930|467496679|FG000|Overall Study|Withdrawal by Subject|1|||
129874131|NCT00982930|467496679|FG000|Overall Study|Administrative Problems|2|||
129874132|NCT01489189|467496680|FG000|Overall Study|Withdrawal by Subject|20|||
129874133|NCT01489189|467496681|FG001|Overall Study|Withdrawal by Subject|23|||
129874134|NCT01489189|467496680|FG000|Overall Study|Death|10|||
129874135|NCT01489189|467496681|FG001|Overall Study|Death|8|||
129874136|NCT01489189|467496680|FG000|Overall Study|Missed Visit|1|||
129874137|NCT01489189|467496681|FG001|Overall Study|Missed Visit|4|||
129874138|NCT05597722|467496682|FG000|Overall Study|Study was terminated|6|||
129874139|NCT05597722|467496683|FG001|Overall Study|Study was terminated|1|||
129874140|NCT00404495|467496684|FG000|Overall Study|Death|37|||
129874141|NCT00404495|467496685|FG001|Overall Study|Death|11|||
129874142|NCT00404495|467496684|FG000|Overall Study|Lost to Follow-up|5|||
129874143|NCT00404495|467496685|FG001|Overall Study|Lost to Follow-up|0|||
129874144|NCT00404495|467496684|FG000|Overall Study|Other|1|||
129874145|NCT00404495|467496685|FG001|Overall Study|Other|0|||
129874146|NCT00404495|467496684|FG000|Overall Study|Withdrawal by Subject|1|||
129874147|NCT00404495|467496685|FG001|Overall Study|Withdrawal by Subject|0|||
129874148|NCT04108000|467496686|FG000|Overall Study|Death of patient|1|||
129874149|NCT04108000|467496687|FG001|Overall Study|Death of patient|0|||
129874150|NCT04108000|467496688|FG002|Overall Study|Death of patient|1|||
129874151|NCT04108000|467496689|FG003|Overall Study|Death of patient|0|||
129874152|NCT04108000|467496686|FG000|Overall Study|Withdrawal by Subject|2|||
129874153|NCT04108000|467496687|FG001|Overall Study|Withdrawal by Subject|2|||
129874154|NCT04108000|467496688|FG002|Overall Study|Withdrawal by Subject|0|||
129874155|NCT04108000|467496689|FG003|Overall Study|Withdrawal by Subject|0|||
129874156|NCT04108000|467496686|FG000|Overall Study|Death of surrogate partner|0|||
129874157|NCT04108000|467496687|FG001|Overall Study|Death of surrogate partner|1|||
129874158|NCT04108000|467496688|FG002|Overall Study|Death of surrogate partner|0|||
129874159|NCT04108000|467496689|FG003|Overall Study|Death of surrogate partner|1|||
129874160|NCT03750006|467496693|FG000|Overall Study|Withdrawal by Subject|8|||
129874161|NCT03750006|467496693|FG000|Overall Study|COVID PANDEMIC|11|||
129874162|NCT03881696|467496694|FG000|Overall Study|Adverse Event|2|||
129874163|NCT03881696|467496695|FG001|Overall Study|Adverse Event|0|||
129874164|NCT03881696|467496694|FG000|Overall Study|Withdrawal by Subject|2|||
129874165|NCT03881696|467496695|FG001|Overall Study|Withdrawal by Subject|0|||
129874166|NCT03881696|467496694|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
129874167|NCT03881696|467496695|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
129874168|NCT03881696|467496694|FG000|Overall Study|Failure to meet continuation criteria|1|||
129874169|NCT03881696|467496695|FG001|Overall Study|Failure to meet continuation criteria|0|||
129874170|NCT01679301|467497883|FG000|Screening Period|screen failure|3|||
129874171|NCT01679301|467497884|FG001|Screening Period|screen failure|0|||
129874172|NCT01679301|467497885|FG002|Screening Period|screen failure|0|||
129874173|NCT02026232|467497886|FG000|Overall Study|incomplete visit/missing data|3|||
129874174|NCT02026232|467497887|FG001|Overall Study|incomplete visit/missing data|2|||
129874175|NCT01529008|467497888|FG000|Bone Marrow Harvesting|Physician Decision|1|||
129874176|NCT01529008|467497889|FG001|Bone Marrow Harvesting|Physician Decision|1|||
129874177|NCT01529008|467497888|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
129874178|NCT01529008|467497889|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
129874179|NCT01529008|467497888|FG000|Treatment|Adverse Event|6|||
129874180|NCT01529008|467497889|FG001|Treatment|Adverse Event|0|||
129874181|NCT01529008|467497888|FG000|Treatment|Other|3|||
129874182|NCT01529008|467497889|FG001|Treatment|Other|1|||
129874183|NCT01529008|467497888|FG000|Efficacy Analysis|Protocol Violation|2|||
129874184|NCT01529008|467497889|FG001|Efficacy Analysis|Protocol Violation|0|||
129874185|NCT01529008|467497888|FG000|Efficacy Analysis|Physician Decision|0|||
129874186|NCT01529008|467497889|FG001|Efficacy Analysis|Physician Decision|1|||
129874187|NCT01529008|467497888|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
129874188|NCT01529008|467497889|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
129874189|NCT01382602|467497890|FG000|Overall Study|Protocol Violation|0|||
129874190|NCT01382602|467497891|FG001|Overall Study|Protocol Violation|3|||
129874191|NCT01382602|467497890|FG000|Overall Study|Withdrawal by Subject|0|||
129874192|NCT01382602|467497891|FG001|Overall Study|Withdrawal by Subject|1|||
129874193|NCT01392300|467497898|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
129874194|NCT01392300|467497899|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
129874195|NCT01392300|467497900|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
129874196|NCT01392300|467497898|FG000|Main Period (MP)|Withdrawal by Subject|5|||
129874197|NCT01392300|467497899|FG001|Main Period (MP)|Withdrawal by Subject|1|||
129874198|NCT01392300|467497900|FG002|Main Period (MP)|Withdrawal by Subject|0|||
129874199|NCT01392300|467497898|FG000|Main Period (MP)|Lost to Follow-up|3|||
129874200|NCT01392300|467497899|FG001|Main Period (MP)|Lost to Follow-up|3|||
129874201|NCT01392300|467497900|FG002|Main Period (MP)|Lost to Follow-up|0|||
129874202|NCT01392300|467497898|FG000|Main Period (MP)|Non-compliance|1|||
129874203|NCT01392300|467497899|FG001|Main Period (MP)|Non-compliance|0|||
129874204|NCT01392300|467497900|FG002|Main Period (MP)|Non-compliance|0|||
129874205|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
129874206|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
129874207|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
129874208|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
129874209|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
129874210|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
129874211|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
129874212|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
129874213|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
129874214|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Death|0|||
129874215|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Death|0|||
129874216|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Death|4|||
129874217|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
129874218|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
129874219|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
129874220|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
129874221|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
129874222|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
129874223|NCT01392300|467497898|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
129874224|NCT01392300|467497899|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
129874225|NCT01392300|467497900|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
129874226|NCT05056870|467497905|FG000|Period 1|Site COVID-19 Related|3|||
129874227|NCT05056870|467497906|FG001|Period 1|Site COVID-19 Related|3|||
129874228|NCT05056870|467497905|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129874229|NCT05056870|467497906|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
129874230|NCT05056870|467497905|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
129874231|NCT05056870|467497906|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129874232|NCT05056870|467497905|FG000|Period 2|COVID-19 Related|1|||
129874233|NCT05056870|467497906|FG001|Period 2|COVID-19 Related|0|||
129874234|NCT05056870|467497905|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
129874235|NCT05056870|467497906|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
129874236|NCT00676130|467497909|FG000|Overall Study|Lost to Follow-up|0|||
129874237|NCT00676130|467497910|FG001|Overall Study|Lost to Follow-up|1|||
129874238|NCT00676130|467497909|FG000|Overall Study|Found ineligible|3|||
129874239|NCT00676130|467497910|FG001|Overall Study|Found ineligible|2|||
129874240|NCT00676130|467497909|FG000|Overall Study|Withdrawal by Subject|0|||
129874241|NCT00676130|467497910|FG001|Overall Study|Withdrawal by Subject|1|||
129874242|NCT01181726|467497911|FG000|First Intervention|Adverse Event|1|||
129874243|NCT01181726|467497912|FG001|First Intervention|Adverse Event|0|||
129874244|NCT00429663|467497916|FG000|Overall Study|Lost to Follow-up|24|||
129874245|NCT00429663|467497917|FG001|Overall Study|Lost to Follow-up|31|||
129874246|NCT00429663|467497916|FG000|Overall Study|Physician Decision|6|||
129874247|NCT00429663|467497917|FG001|Overall Study|Physician Decision|3|||
129874248|NCT00429663|467497916|FG000|Overall Study|Withdrawal by Subject|2|||
129874249|NCT00429663|467497917|FG001|Overall Study|Withdrawal by Subject|5|||
129874250|NCT00429663|467497916|FG000|Overall Study|Death|4|||
129874251|NCT00429663|467497917|FG001|Overall Study|Death|0|||
129874252|NCT03261271|467497923|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
129874253|NCT03261271|467497924|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
129874254|NCT01932697|467497925|FG000|Overall Study|Received a different amount of tx|1|||
129874255|NCT01932697|467497926|FG001|Overall Study|Received a different amount of tx|0|||
129874256|NCT01932697|467497925|FG000|Overall Study|Ineligible|1|||
129874257|NCT01932697|467497926|FG001|Overall Study|Ineligible|0|||
129874258|NCT01114204|467497927|FG000|Overall Study|Adverse Event|3|||
129874259|NCT01114204|467497928|FG001|Overall Study|Adverse Event|2|||
129874260|NCT01114204|467497927|FG000|Overall Study|Lost to Follow-up|1|||
129874261|NCT01114204|467497928|FG001|Overall Study|Lost to Follow-up|0|||
129874262|NCT01114204|467497927|FG000|Overall Study|Withdrawal by Subject|10|||
129874263|NCT01114204|467497928|FG001|Overall Study|Withdrawal by Subject|6|||
129874264|NCT01114204|467497927|FG000|Overall Study|Death|1|||
129874265|NCT01114204|467497928|FG001|Overall Study|Death|0|||
129874266|NCT01114204|467497927|FG000|Overall Study|Other-Personal reasons|2|||
129874267|NCT01114204|467497928|FG001|Overall Study|Other-Personal reasons|0|||
129874268|NCT01114204|467497927|FG000|Overall Study|Other-Medical monitor request|1|||
129874269|NCT01114204|467497928|FG001|Overall Study|Other-Medical monitor request|0|||
129874270|NCT01114204|467497927|FG000|Overall Study|Other-Participant request|2|||
129874271|NCT01114204|467497928|FG001|Overall Study|Other-Participant request|0|||
129874272|NCT01114204|467497927|FG000|Overall Study|Other-Protocol Violation|1|||
129874273|NCT01114204|467497928|FG001|Overall Study|Other-Protocol Violation|0|||
129874274|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
129874275|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
129874276|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
129874277|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
129874278|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
129874279|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
129874280|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
129874281|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
129874282|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
129874283|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
129874284|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
129874285|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
129874286|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129874287|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129874288|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129874289|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
129874290|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
129874291|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129874292|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129874293|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129874294|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Death|2|||
129874295|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Death|2|||
129874296|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Death|0|||
129874297|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Death|0|||
129874298|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Death|0|||
129874299|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
129874300|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
129874301|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
129874302|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
129874303|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
129874304|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874305|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
129874306|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874307|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874308|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
129874309|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
129874310|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
129874311|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
129874312|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
129874313|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
129874314|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
129874315|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874316|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874317|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874318|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
129874319|NCT03420781|467497929|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
129874320|NCT03420781|467497930|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874321|NCT03420781|467497931|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874322|NCT03420781|467497932|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874323|NCT03420781|467497933|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
129874324|NCT03420781|467497929|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874325|NCT03420781|467497930|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874326|NCT03420781|467497931|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874327|NCT03420781|467497932|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
129874328|NCT03420781|467497933|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
129874329|NCT03420781|467497929|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874330|NCT03420781|467497930|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874331|NCT03420781|467497931|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874332|NCT03420781|467497932|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
129874333|NCT03420781|467497933|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
129874334|NCT03420781|467497929|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
129874335|NCT03420781|467497930|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
129874336|NCT03420781|467497931|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
129874337|NCT03420781|467497932|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
129874338|NCT03420781|467497933|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
129874339|NCT00246337|467497934|FG000|Overall Study|Lost to Follow-up|3|||
129874340|NCT00246337|467497935|FG001|Overall Study|Lost to Follow-up|0|||
129874341|NCT00246337|467497936|FG002|Overall Study|Lost to Follow-up|0|||
129874342|NCT00246337|467497937|FG003|Overall Study|Lost to Follow-up|0|||
129874343|NCT00246337|467497938|FG004|Overall Study|Lost to Follow-up|2|||
129874344|NCT00246337|467497939|FG005|Overall Study|Lost to Follow-up|2|||
129874345|NCT00246337|467497940|FG006|Overall Study|Lost to Follow-up|1|||
129874346|NCT00246337|467497941|FG007|Overall Study|Lost to Follow-up|2|||
129874347|NCT00246337|467497942|FG008|Overall Study|Lost to Follow-up|0|||
129874348|NCT00246337|467497934|FG000|Overall Study|Protocol Violation|1|||
129874349|NCT00246337|467497935|FG001|Overall Study|Protocol Violation|0|||
129874350|NCT00246337|467497936|FG002|Overall Study|Protocol Violation|0|||
129874351|NCT00246337|467497937|FG003|Overall Study|Protocol Violation|0|||
129874352|NCT00246337|467497938|FG004|Overall Study|Protocol Violation|1|||
129874353|NCT00246337|467497939|FG005|Overall Study|Protocol Violation|0|||
129874354|NCT00246337|467497940|FG006|Overall Study|Protocol Violation|1|||
129874355|NCT00246337|467497941|FG007|Overall Study|Protocol Violation|1|||
129874356|NCT00246337|467497942|FG008|Overall Study|Protocol Violation|0|||
129874357|NCT00246337|467497934|FG000|Overall Study|Withdrawal by Subject|2|||
129874358|NCT00246337|467497935|FG001|Overall Study|Withdrawal by Subject|0|||
129874359|NCT00246337|467497936|FG002|Overall Study|Withdrawal by Subject|0|||
129874360|NCT00246337|467497937|FG003|Overall Study|Withdrawal by Subject|0|||
129874361|NCT00246337|467497938|FG004|Overall Study|Withdrawal by Subject|0|||
129874362|NCT00246337|467497939|FG005|Overall Study|Withdrawal by Subject|0|||
129874363|NCT00246337|467497940|FG006|Overall Study|Withdrawal by Subject|1|||
129874364|NCT00246337|467497941|FG007|Overall Study|Withdrawal by Subject|1|||
129874365|NCT00246337|467497942|FG008|Overall Study|Withdrawal by Subject|0|||
129874366|NCT00246337|467497934|FG000|Overall Study|Lack of Qualifying Event|8|||
129874367|NCT00246337|467497935|FG001|Overall Study|Lack of Qualifying Event|2|||
129874368|NCT00246337|467497936|FG002|Overall Study|Lack of Qualifying Event|1|||
129874369|NCT00246337|467497937|FG003|Overall Study|Lack of Qualifying Event|1|||
129874370|NCT00246337|467497938|FG004|Overall Study|Lack of Qualifying Event|1|||
129874371|NCT00246337|467497939|FG005|Overall Study|Lack of Qualifying Event|3|||
129874372|NCT00246337|467497940|FG006|Overall Study|Lack of Qualifying Event|3|||
129874373|NCT00246337|467497941|FG007|Overall Study|Lack of Qualifying Event|2|||
129874374|NCT00246337|467497942|FG008|Overall Study|Lack of Qualifying Event|5|||
129874375|NCT00246337|467497934|FG000|Overall Study|Site Terminated|10|||
129874376|NCT00246337|467497935|FG001|Overall Study|Site Terminated|0|||
129874377|NCT00246337|467497936|FG002|Overall Study|Site Terminated|0|||
129874378|NCT00246337|467497937|FG003|Overall Study|Site Terminated|0|||
129874379|NCT00246337|467497938|FG004|Overall Study|Site Terminated|0|||
129874380|NCT00246337|467497939|FG005|Overall Study|Site Terminated|7|||
129874381|NCT00246337|467497940|FG006|Overall Study|Site Terminated|1|||
129874382|NCT00246337|467497941|FG007|Overall Study|Site Terminated|6|||
129874383|NCT00246337|467497942|FG008|Overall Study|Site Terminated|2|||
129874384|NCT00246337|467497934|FG000|Overall Study|Abnormal baseline lab values|7|||
129874385|NCT00246337|467497935|FG001|Overall Study|Abnormal baseline lab values|0|||
129874386|NCT00246337|467497936|FG002|Overall Study|Abnormal baseline lab values|2|||
129874387|NCT00246337|467497937|FG003|Overall Study|Abnormal baseline lab values|0|||
129874388|NCT00246337|467497938|FG004|Overall Study|Abnormal baseline lab values|0|||
129874389|NCT00246337|467497939|FG005|Overall Study|Abnormal baseline lab values|2|||
129874390|NCT00246337|467497940|FG006|Overall Study|Abnormal baseline lab values|2|||
129874391|NCT00246337|467497941|FG007|Overall Study|Abnormal baseline lab values|0|||
129874392|NCT00246337|467497942|FG008|Overall Study|Abnormal baseline lab values|4|||
129874393|NCT00246337|467497934|FG000|Overall Study|Overwhelmed|0|||
129874394|NCT00246337|467497935|FG001|Overall Study|Overwhelmed|0|||
129874395|NCT00246337|467497936|FG002|Overall Study|Overwhelmed|0|||
129874396|NCT00246337|467497937|FG003|Overall Study|Overwhelmed|0|||
129874397|NCT00246337|467497938|FG004|Overall Study|Overwhelmed|0|||
129874398|NCT00246337|467497939|FG005|Overall Study|Overwhelmed|1|||
129874399|NCT00246337|467497940|FG006|Overall Study|Overwhelmed|0|||
129874400|NCT00246337|467497941|FG007|Overall Study|Overwhelmed|0|||
129539731|NCT02064231|466268763|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
129874401|NCT00246337|467497942|FG008|Overall Study|Overwhelmed|0|||
129874402|NCT00246337|467497934|FG000|Overall Study|Protocol Violator|1|||
129874403|NCT00246337|467497935|FG001|Overall Study|Protocol Violator|0|||
129874404|NCT00246337|467497936|FG002|Overall Study|Protocol Violator|0|||
129874405|NCT00246337|467497937|FG003|Overall Study|Protocol Violator|0|||
129874406|NCT00246337|467497938|FG004|Overall Study|Protocol Violator|0|||
129874407|NCT00246337|467497939|FG005|Overall Study|Protocol Violator|0|||
129874408|NCT00246337|467497940|FG006|Overall Study|Protocol Violator|0|||
129874409|NCT00246337|467497941|FG007|Overall Study|Protocol Violator|0|||
129874410|NCT00246337|467497942|FG008|Overall Study|Protocol Violator|0|||
129874411|NCT00246337|467497934|FG000|Overall Study|Reported as completing trial in error|0|||
129874412|NCT00246337|467497935|FG001|Overall Study|Reported as completing trial in error|0|||
129874413|NCT00246337|467497936|FG002|Overall Study|Reported as completing trial in error|0|||
129874414|NCT00246337|467497937|FG003|Overall Study|Reported as completing trial in error|0|||
129874415|NCT00246337|467497938|FG004|Overall Study|Reported as completing trial in error|0|||
129874416|NCT00246337|467497939|FG005|Overall Study|Reported as completing trial in error|0|||
129874417|NCT00246337|467497940|FG006|Overall Study|Reported as completing trial in error|0|||
129874418|NCT00246337|467497941|FG007|Overall Study|Reported as completing trial in error|1|||
129874419|NCT00246337|467497942|FG008|Overall Study|Reported as completing trial in error|0|||
129874420|NCT02696564|467497947|FG000|Overall Study|Death|1|||
129874421|NCT02696564|467497948|FG001|Overall Study|Death|2|||
129874422|NCT02696564|467497947|FG000|Overall Study|Withdrawal by Subject|3|||
129874423|NCT02696564|467497948|FG001|Overall Study|Withdrawal by Subject|2|||
129874424|NCT02696564|467497947|FG000|Overall Study|Lost to Follow-up|3|||
129874425|NCT02696564|467497948|FG001|Overall Study|Lost to Follow-up|3|||
129874426|NCT02696564|467497947|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
129874427|NCT02696564|467497948|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
129874428|NCT02696564|467497947|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
129874429|NCT02696564|467497948|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
129874430|NCT02696564|467497947|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
129874431|NCT02696564|467497948|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
129874432|NCT02696564|467497947|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
129874433|NCT02696564|467497948|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
129874434|NCT02696564|467497947|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
129874435|NCT02696564|467497948|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
129874436|NCT03124199|467497951|FG000|Overall Study|Lost to Follow-up|4|||
129874437|NCT03056534|467497964|FG000|Overall Study|Participant withdrew consent|8|||
129874438|NCT03056534|467497964|FG000|Overall Study|Participant not able to return|6|||
129874439|NCT03056534|467497964|FG000|Overall Study|Lost to Follow-up|37|||
129874440|NCT03056534|467497964|FG000|Overall Study|Investigator judgment|1|||
129874441|NCT03056534|467497964|FG000|Overall Study|Death|4|||
129874442|NCT03056534|467497964|FG000|Overall Study|Adverse Event|1|||
129874443|NCT03056534|467497964|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
129874444|NCT01313286|467497971|FG000|Period 1|Withdrawal by Subject|2|||
129762036|NCT03535974|467091396|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
129874445|NCT01313286|467497972|FG001|Period 1|Withdrawal by Subject|0|||
129874446|NCT00654901|467497973|FG000|Overall Study|Lost to Follow-up|1|||
129762037|NCT04059549|467091397|FG000|Overall Study|Withdrawal by Subject|2|||
129874447|NCT00654901|467497974|FG001|Overall Study|Lost to Follow-up|0|||
129874448|NCT00654901|467497975|FG002|Overall Study|Lost to Follow-up|1|||
129874449|NCT00654901|467497976|FG003|Overall Study|Lost to Follow-up|0|||
129874450|NCT00654901|467497973|FG000|Overall Study|Withdrawal by Subject|3|||
129874451|NCT00654901|467497974|FG001|Overall Study|Withdrawal by Subject|0|||
129874452|NCT00654901|467497975|FG002|Overall Study|Withdrawal by Subject|1|||
129874453|NCT00654901|467497976|FG003|Overall Study|Withdrawal by Subject|0|||
129874454|NCT04241094|467497984|FG000|Overall Study|Dropped out of treatment|4|||
129874455|NCT04241094|467497984|FG000|Overall Study|Ineligible after clinical assessment|2|||
129874456|NCT04241094|467497984|FG000|Overall Study|Lost to Follow-up|2|||
129874457|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
129874458|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
129874459|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
129874460|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
129874461|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
129874462|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
129874463|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
129874464|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
129874465|NCT02332590|467497985|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
129874466|NCT02332590|467497986|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
129874467|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
129874468|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
129874469|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
129874470|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
129874471|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
129874472|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
129874473|NCT02332590|467497985|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
129874474|NCT02332590|467497986|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
129874475|NCT04739761|467498000|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
129874476|NCT04739761|467498001|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
129874477|NCT04739761|467498000|FG000|Overall Study|By complete response from the participant|1|||
129874478|NCT04739761|467498001|FG001|Overall Study|By complete response from the participant|0|||
129874479|NCT04739761|467498000|FG000|Overall Study|Lost to Follow-up|3|||
129874480|NCT04739761|467498001|FG001|Overall Study|Lost to Follow-up|3|||
129874481|NCT04739761|467498000|FG000|Overall Study|Death|13|||
129874482|NCT04739761|467498001|FG001|Overall Study|Death|13|||
129874483|NCT04739761|467498000|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
129874484|NCT04739761|467498001|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
129874485|NCT04739761|467498000|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
129874486|NCT04739761|467498001|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
129874487|NCT04739761|467498000|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
129874488|NCT04739761|467498001|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
129874489|NCT04739761|467498000|FG000|Overall Study|Adverse Event|0|||
129874490|NCT04739761|467498001|FG001|Overall Study|Adverse Event|3|||
129874491|NCT04739761|467498000|FG000|Overall Study|Participant decision|1|||
129874492|NCT04739761|467498001|FG001|Overall Study|Participant decision|0|||
129874493|NCT04739761|467498000|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
129874494|NCT04739761|467498001|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
129874495|NCT04739761|467498000|FG000|Overall Study|Participant immediately started next line of treatment|1|||
129874496|NCT04739761|467498001|FG001|Overall Study|Participant immediately started next line of treatment|0|||
129874497|NCT04739761|467498000|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
129874498|NCT04739761|467498001|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
129874499|NCT04739761|467498000|FG000|Overall Study|Lack of clinical benefit|1|||
129874500|NCT04739761|467498001|FG001|Overall Study|Lack of clinical benefit|0|||
129874501|NCT04739761|467498000|FG000|Overall Study|Disease progression|5|||
129874502|NCT04739761|467498001|FG001|Overall Study|Disease progression|5|||
129874503|NCT04739761|467498000|FG000|Overall Study|Withdrawal by Subject|14|||
129874504|NCT04739761|467498001|FG001|Overall Study|Withdrawal by Subject|13|||
129874505|NCT04739761|467498000|FG000|Overall Study|Protocol Violation|1|||
129874506|NCT04739761|467498001|FG001|Overall Study|Protocol Violation|0|||
129874507|NCT04739761|467498000|FG000|Overall Study|Physician Decision|2|||
129874508|NCT04739761|467498001|FG001|Overall Study|Physician Decision|0|||
129874509|NCT01061333|467498003|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
129874510|NCT01061333|467498004|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
129874511|NCT02044848|467499460|FG000|Overall Study|Administrative Problems|2|||
129874512|NCT02044848|467499461|FG001|Overall Study|Administrative Problems|3|||
129874513|NCT01493960|467499462|FG000|Overall Study|Adverse Event|0|||
129874514|NCT01493960|467499463|FG001|Overall Study|Adverse Event|1|||
129874515|NCT01493960|467499462|FG000|Overall Study|Lack of Efficacy|15|||
129874516|NCT01493960|467499463|FG001|Overall Study|Lack of Efficacy|9|||
129874517|NCT01493960|467499462|FG000|Overall Study|Protocol Violation|3|||
129874518|NCT01493960|467499463|FG001|Overall Study|Protocol Violation|0|||
129874519|NCT01493960|467499462|FG000|Overall Study|Withdrawal by Subject|10|||
129874520|NCT01493960|467499463|FG001|Overall Study|Withdrawal by Subject|4|||
129874521|NCT01493960|467499462|FG000|Overall Study|Non-specified|4|||
129874522|NCT01493960|467499463|FG001|Overall Study|Non-specified|4|||
129874523|NCT01160484|467499470|FG000|Overall Study|Lack of Efficacy|9|||
129874524|NCT01160484|467499470|FG000|Overall Study|Adverse Event|6|||
129874525|NCT01160484|467499470|FG000|Overall Study|Withdrawal by Subject|2|||
129874526|NCT01160484|467499470|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
129874527|NCT00803101|467499471|FG000|Overall Study|Death / Serious Adverse Event|4|||
129874528|NCT00803101|467499472|FG001|Overall Study|Death / Serious Adverse Event|6|||
129874529|NCT00803101|467499471|FG000|Overall Study|Withdrawal by Subject|6|||
129874530|NCT00803101|467499472|FG001|Overall Study|Withdrawal by Subject|4|||
129874531|NCT00803101|467499471|FG000|Overall Study|Lost to Follow-up|2|||
129874532|NCT00803101|467499472|FG001|Overall Study|Lost to Follow-up|2|||
129874533|NCT00803101|467499471|FG000|Overall Study|Protocol Violation|1|||
129874534|NCT00803101|467499472|FG001|Overall Study|Protocol Violation|7|||
129874535|NCT00803101|467499471|FG000|Overall Study|Surgery finished outside protocol window|1|||
129874536|NCT00803101|467499472|FG001|Overall Study|Surgery finished outside protocol window|1|||
129874537|NCT00803101|467499471|FG000|Overall Study|Patient died outside SAE report period|1|||
129874538|NCT00803101|467499472|FG001|Overall Study|Patient died outside SAE report period|0|||
129874539|NCT00803101|467499471|FG000|Overall Study|Patient did not attend scheduled visit|2|||
129874540|NCT00803101|467499472|FG001|Overall Study|Patient did not attend scheduled visit|1|||
129874541|NCT00803101|467499471|FG000|Overall Study|Patient did not have surgery|1|||
129874542|NCT00803101|467499472|FG001|Overall Study|Patient did not have surgery|1|||
129874543|NCT01782742|467499473|FG000|Double-blind Treatment Phase|Adverse Event|1|||
129874544|NCT01782742|467499474|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129874545|NCT00332332|467499479|FG000|Overall Study|Adverse Event|13|||
129874546|NCT00332332|467499479|FG000|Overall Study|Death|1|||
129874547|NCT00332332|467499479|FG000|Overall Study|Withdrawal by Subject|8|||
129874548|NCT00332332|467499479|FG000|Overall Study|Physician Decision|1|||
129874549|NCT00332332|467499479|FG000|Overall Study|Lost to Follow-up|3|||
129874550|NCT00332332|467499479|FG000|Overall Study|Protocol deviation|4|||
129874551|NCT00332332|467499479|FG000|Overall Study|Noncompliance|2|||
129874552|NCT00332332|467499479|FG000|Overall Study|Disease progression|2|||
129874553|NCT00332332|467499479|FG000|Overall Study|Other|18|||
129874554|NCT00332332|467499479|FG000|Overall Study|Did not receive study treatment|16|||
129874555|NCT02790073|467499480|FG000|Overall Study|Death|1|||
129874556|NCT02790073|467499480|FG000|Overall Study|Withdrawal from HD|1|||
129874557|NCT02790073|467499480|FG000|Overall Study|Withdrawal by Subject|1|||
129874558|NCT00674570|467499487|FG000|Overall Study|Withdrawal by Subject|0|||
129874559|NCT00674570|467499488|FG001|Overall Study|Withdrawal by Subject|2|||
129874560|NCT00674570|467499489|FG002|Overall Study|Withdrawal by Subject|0|||
129874561|NCT03633929|467499490|FG000|Overall Study|Lost to Follow-up|1|||
129874562|NCT03633929|467499490|FG000|Overall Study|Did not login to software. Did not participate|3|||
129874563|NCT04461795|467499492|FG000|Overall Study|Lost to Follow-up|2|||
129874564|NCT04461795|467499492|FG000|Overall Study|Withdrawal by Subject|2|||
129874565|NCT04461795|467499492|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
129874566|NCT00185640|467499493|FG000|Overall Study|Not Eligible|4|||
129874567|NCT00185640|467499493|FG000|Overall Study|Withdrawal by Subject|3|||
129874568|NCT00185640|467499493|FG000|Overall Study|Death|138|||
129874569|NCT00058422|467499494|FG000|Overall Study|Not treated|2|||
129874570|NCT02287584|467499495|FG000|the Double-blind Phase|Adverse Event|17|||
129874571|NCT02287584|467499496|FG001|the Double-blind Phase|Adverse Event|17|||
129874572|NCT02287584|467499497|FG002|the Double-blind Phase|Adverse Event|12|||
129874573|NCT02287584|467499498|FG003|the Double-blind Phase|Adverse Event|0|||
129874574|NCT02287584|467499499|FG004|the Double-blind Phase|Adverse Event|0|||
129874575|NCT02287584|467499500|FG005|the Double-blind Phase|Adverse Event|0|||
129874576|NCT02287584|467499495|FG000|the Double-blind Phase|Lack of Efficacy|18|||
129874577|NCT02287584|467499496|FG001|the Double-blind Phase|Lack of Efficacy|8|||
129874578|NCT02287584|467499497|FG002|the Double-blind Phase|Lack of Efficacy|8|||
129874579|NCT02287584|467499498|FG003|the Double-blind Phase|Lack of Efficacy|0|||
129874580|NCT02287584|467499499|FG004|the Double-blind Phase|Lack of Efficacy|0|||
129874581|NCT02287584|467499500|FG005|the Double-blind Phase|Lack of Efficacy|0|||
129874582|NCT02287584|467499495|FG000|the Double-blind Phase|Lost to Follow-up|0|||
129874583|NCT02287584|467499496|FG001|the Double-blind Phase|Lost to Follow-up|1|||
129874584|NCT02287584|467499497|FG002|the Double-blind Phase|Lost to Follow-up|1|||
129874585|NCT02287584|467499498|FG003|the Double-blind Phase|Lost to Follow-up|0|||
129874586|NCT02287584|467499499|FG004|the Double-blind Phase|Lost to Follow-up|0|||
129874587|NCT02287584|467499500|FG005|the Double-blind Phase|Lost to Follow-up|0|||
129651107|NCT00195494|466678592|FG002|Year 2|Physician Decision|0|||
129874588|NCT02287584|467499495|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
129874589|NCT02287584|467499496|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
129539732|NCT04887922|466268764|FG000|1st Randomization|Decided not to have surgery|0|||
129539733|NCT04887922|466268765|FG001|1st Randomization|Decided not to have surgery|1|||
129539734|NCT04887922|466268766|FG002|1st Randomization|Decided not to have surgery|0|||
129874590|NCT02287584|467499497|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
129874591|NCT02287584|467499498|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
129874592|NCT02287584|467499499|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
129874593|NCT02287584|467499500|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
129874594|NCT02287584|467499495|FG000|the Double-blind Phase|Pregnancy|0|||
129874595|NCT02287584|467499496|FG001|the Double-blind Phase|Pregnancy|1|||
129874596|NCT02287584|467499497|FG002|the Double-blind Phase|Pregnancy|0|||
129874597|NCT02287584|467499498|FG003|the Double-blind Phase|Pregnancy|0|||
129874598|NCT02287584|467499499|FG004|the Double-blind Phase|Pregnancy|0|||
129874599|NCT02287584|467499500|FG005|the Double-blind Phase|Pregnancy|0|||
129874600|NCT02287584|467499495|FG000|the Double-blind Phase|Protocol Violation|0|||
129874601|NCT02287584|467499496|FG001|the Double-blind Phase|Protocol Violation|3|||
129874602|NCT02287584|467499497|FG002|the Double-blind Phase|Protocol Violation|0|||
129874603|NCT02287584|467499498|FG003|the Double-blind Phase|Protocol Violation|0|||
129874604|NCT02287584|467499499|FG004|the Double-blind Phase|Protocol Violation|0|||
129874605|NCT02287584|467499500|FG005|the Double-blind Phase|Protocol Violation|0|||
129874606|NCT02287584|467499495|FG000|the Double-blind Phase|other reasons|0|||
129874607|NCT02287584|467499496|FG001|the Double-blind Phase|other reasons|0|||
129874608|NCT02287584|467499497|FG002|the Double-blind Phase|other reasons|1|||
129874609|NCT02287584|467499498|FG003|the Double-blind Phase|other reasons|0|||
129874610|NCT02287584|467499499|FG004|the Double-blind Phase|other reasons|0|||
129874611|NCT02287584|467499500|FG005|the Double-blind Phase|other reasons|0|||
129874612|NCT02287584|467499495|FG000|the Open-label Phase|Did not receive drug|0|||
129874613|NCT02287584|467499496|FG001|the Open-label Phase|Did not receive drug|0|||
129874614|NCT02287584|467499497|FG002|the Open-label Phase|Did not receive drug|0|||
129874615|NCT02287584|467499498|FG003|the Open-label Phase|Did not receive drug|7|||
129874616|NCT02287584|467499499|FG004|the Open-label Phase|Did not receive drug|6|||
129874617|NCT02287584|467499500|FG005|the Open-label Phase|Did not receive drug|4|||
129874618|NCT02287584|467499495|FG000|the Open-label Phase|Adverse Event|0|||
129874619|NCT02287584|467499496|FG001|the Open-label Phase|Adverse Event|0|||
129874620|NCT02287584|467499497|FG002|the Open-label Phase|Adverse Event|0|||
129874621|NCT02287584|467499498|FG003|the Open-label Phase|Adverse Event|15|||
129874622|NCT02287584|467499499|FG004|the Open-label Phase|Adverse Event|12|||
129874623|NCT02287584|467499500|FG005|the Open-label Phase|Adverse Event|16|||
129874624|NCT02287584|467499495|FG000|the Open-label Phase|Lack of Efficacy|0|||
129874625|NCT02287584|467499496|FG001|the Open-label Phase|Lack of Efficacy|0|||
129874626|NCT02287584|467499497|FG002|the Open-label Phase|Lack of Efficacy|0|||
129874627|NCT02287584|467499498|FG003|the Open-label Phase|Lack of Efficacy|8|||
129874628|NCT02287584|467499499|FG004|the Open-label Phase|Lack of Efficacy|3|||
129874629|NCT02287584|467499500|FG005|the Open-label Phase|Lack of Efficacy|7|||
129874630|NCT02287584|467499495|FG000|the Open-label Phase|Lost to Follow-up|0|||
129874631|NCT02287584|467499496|FG001|the Open-label Phase|Lost to Follow-up|0|||
129874632|NCT02287584|467499497|FG002|the Open-label Phase|Lost to Follow-up|0|||
129874633|NCT02287584|467499498|FG003|the Open-label Phase|Lost to Follow-up|4|||
129874634|NCT02287584|467499499|FG004|the Open-label Phase|Lost to Follow-up|1|||
129874635|NCT02287584|467499500|FG005|the Open-label Phase|Lost to Follow-up|2|||
129874636|NCT02287584|467499495|FG000|the Open-label Phase|Withdrawal by Subject|0|||
129874637|NCT02287584|467499496|FG001|the Open-label Phase|Withdrawal by Subject|0|||
129874638|NCT02287584|467499497|FG002|the Open-label Phase|Withdrawal by Subject|0|||
129874639|NCT02287584|467499498|FG003|the Open-label Phase|Withdrawal by Subject|18|||
129874640|NCT02287584|467499499|FG004|the Open-label Phase|Withdrawal by Subject|29|||
129874641|NCT02287584|467499500|FG005|the Open-label Phase|Withdrawal by Subject|21|||
129874642|NCT02287584|467499495|FG000|the Open-label Phase|non-compliance|0|||
129874643|NCT02287584|467499496|FG001|the Open-label Phase|non-compliance|0|||
129874644|NCT02287584|467499497|FG002|the Open-label Phase|non-compliance|0|||
129874645|NCT02287584|467499498|FG003|the Open-label Phase|non-compliance|2|||
129874646|NCT02287584|467499499|FG004|the Open-label Phase|non-compliance|5|||
129874647|NCT02287584|467499500|FG005|the Open-label Phase|non-compliance|1|||
129874648|NCT02287584|467499495|FG000|the Open-label Phase|other reasons|0|||
129874649|NCT02287584|467499496|FG001|the Open-label Phase|other reasons|0|||
129874650|NCT02287584|467499497|FG002|the Open-label Phase|other reasons|0|||
129874651|NCT02287584|467499498|FG003|the Open-label Phase|other reasons|3|||
129874652|NCT02287584|467499499|FG004|the Open-label Phase|other reasons|6|||
129874653|NCT02287584|467499500|FG005|the Open-label Phase|other reasons|6|||
129874654|NCT03430063|467499503|FG000|Overall Study|Adverse Event|0|||
129874655|NCT03430063|467499504|FG001|Overall Study|Adverse Event|1|||
129874656|NCT03430063|467499505|FG002|Overall Study|Adverse Event|0|||
129874657|NCT03430063|467499503|FG000|Overall Study|Death|3|||
129874658|NCT03430063|467499504|FG001|Overall Study|Death|2|||
129874659|NCT03430063|467499505|FG002|Overall Study|Death|3|||
129874660|NCT03430063|467499503|FG000|Overall Study|Lost to Follow-up|0|||
129874661|NCT03430063|467499504|FG001|Overall Study|Lost to Follow-up|1|||
129874662|NCT03430063|467499505|FG002|Overall Study|Lost to Follow-up|0|||
129874663|NCT03430063|467499503|FG000|Overall Study|Withdrawal by Subject|0|||
129874664|NCT03430063|467499504|FG001|Overall Study|Withdrawal by Subject|0|||
129874665|NCT03430063|467499505|FG002|Overall Study|Withdrawal by Subject|1|||
129874666|NCT03430063|467499503|FG000|Overall Study|Withdrawal of consent|3|||
129874667|NCT03430063|467499504|FG001|Overall Study|Withdrawal of consent|1|||
129874668|NCT03430063|467499505|FG002|Overall Study|Withdrawal of consent|2|||
129874669|NCT03430063|467499503|FG000|Overall Study|Progressive disease|1|||
129874670|NCT03430063|467499504|FG001|Overall Study|Progressive disease|2|||
129874671|NCT03430063|467499505|FG002|Overall Study|Progressive disease|1|||
129874672|NCT03430063|467499503|FG000|Overall Study|Other un-specified|1|||
129874673|NCT03430063|467499504|FG001|Overall Study|Other un-specified|1|||
129874674|NCT03430063|467499505|FG002|Overall Study|Other un-specified|0|||
129874675|NCT03430063|467499503|FG000|Overall Study|Randomized, but never treated|0|||
129874676|NCT03430063|467499504|FG001|Overall Study|Randomized, but never treated|0|||
129874677|NCT03430063|467499505|FG002|Overall Study|Randomized, but never treated|1|||
129874678|NCT02798211|467499506|FG000|Period 1|Adverse Event|1|||
129874679|NCT02798211|467499507|FG001|Period 1|Adverse Event|1|||
129874680|NCT02798211|467499508|FG002|Period 1|Adverse Event|0|||
129874681|NCT02798211|467499509|FG003|Period 1|Adverse Event|0|||
129874682|NCT02798211|467499510|FG004|Period 1|Adverse Event|0|||
129874683|NCT02798211|467499511|FG005|Period 1|Adverse Event|0|||
129874684|NCT02798211|467499506|FG000|Period 1|Lost to Follow-up|2|||
129874685|NCT02798211|467499507|FG001|Period 1|Lost to Follow-up|1|||
129874686|NCT02798211|467499508|FG002|Period 1|Lost to Follow-up|0|||
129874687|NCT02798211|467499509|FG003|Period 1|Lost to Follow-up|0|||
129874688|NCT02798211|467499510|FG004|Period 1|Lost to Follow-up|0|||
129874689|NCT02798211|467499511|FG005|Period 1|Lost to Follow-up|0|||
129874690|NCT02798211|467499506|FG000|Period 1|Protocol Violation|0|||
129874691|NCT02798211|467499507|FG001|Period 1|Protocol Violation|0|||
129874692|NCT02798211|467499508|FG002|Period 1|Protocol Violation|2|||
129874693|NCT02798211|467499509|FG003|Period 1|Protocol Violation|0|||
129874694|NCT02798211|467499510|FG004|Period 1|Protocol Violation|0|||
129874695|NCT02798211|467499511|FG005|Period 1|Protocol Violation|0|||
129874696|NCT02798211|467499506|FG000|Period 1|Withdrawal by Subject|1|||
129874697|NCT02798211|467499507|FG001|Period 1|Withdrawal by Subject|1|||
129874698|NCT02798211|467499508|FG002|Period 1|Withdrawal by Subject|0|||
129874699|NCT02798211|467499509|FG003|Period 1|Withdrawal by Subject|0|||
129874700|NCT02798211|467499510|FG004|Period 1|Withdrawal by Subject|0|||
129874701|NCT02798211|467499511|FG005|Period 1|Withdrawal by Subject|0|||
129874702|NCT02798211|467499506|FG000|Period 1|Death|0|||
129874703|NCT02798211|467499507|FG001|Period 1|Death|0|||
129874704|NCT02798211|467499508|FG002|Period 1|Death|1|||
129874705|NCT02798211|467499509|FG003|Period 1|Death|0|||
129874706|NCT02798211|467499510|FG004|Period 1|Death|0|||
129874707|NCT02798211|467499511|FG005|Period 1|Death|0|||
129874708|NCT02798211|467499506|FG000|Period 1|Withdrawal of Informed Consent|2|||
129874709|NCT02798211|467499507|FG001|Period 1|Withdrawal of Informed Consent|7|||
129874710|NCT02798211|467499508|FG002|Period 1|Withdrawal of Informed Consent|3|||
129874711|NCT02798211|467499509|FG003|Period 1|Withdrawal of Informed Consent|0|||
129874712|NCT02798211|467499510|FG004|Period 1|Withdrawal of Informed Consent|0|||
129874713|NCT02798211|467499511|FG005|Period 1|Withdrawal of Informed Consent|0|||
129874714|NCT02798211|467499506|FG000|Period 2|Withdrawal by Subject|2|||
129874715|NCT02798211|467499507|FG001|Period 2|Withdrawal by Subject|0|||
129874716|NCT02798211|467499508|FG002|Period 2|Withdrawal by Subject|0|||
129874717|NCT02798211|467499509|FG003|Period 2|Withdrawal by Subject|0|||
129874718|NCT02798211|467499510|FG004|Period 2|Withdrawal by Subject|2|||
129874719|NCT02798211|467499511|FG005|Period 2|Withdrawal by Subject|2|||
129874720|NCT02798211|467499506|FG000|Period 2|Adverse Event|5|||
129874721|NCT02798211|467499507|FG001|Period 2|Adverse Event|0|||
129874722|NCT02798211|467499508|FG002|Period 2|Adverse Event|0|||
129874723|NCT02798211|467499509|FG003|Period 2|Adverse Event|0|||
129874724|NCT02798211|467499510|FG004|Period 2|Adverse Event|1|||
129874725|NCT02798211|467499511|FG005|Period 2|Adverse Event|0|||
129874726|NCT02798211|467499506|FG000|Period 2|Lack of Efficacy|1|||
129874727|NCT02798211|467499507|FG001|Period 2|Lack of Efficacy|0|||
129874728|NCT02798211|467499508|FG002|Period 2|Lack of Efficacy|0|||
129874729|NCT02798211|467499509|FG003|Period 2|Lack of Efficacy|1|||
129874730|NCT02798211|467499510|FG004|Period 2|Lack of Efficacy|0|||
129874731|NCT02798211|467499511|FG005|Period 2|Lack of Efficacy|1|||
129874732|NCT02798211|467499506|FG000|Period 2|Lost to Follow-up|3|||
129874733|NCT02798211|467499507|FG001|Period 2|Lost to Follow-up|0|||
129874734|NCT02798211|467499508|FG002|Period 2|Lost to Follow-up|0|||
129874735|NCT02798211|467499509|FG003|Period 2|Lost to Follow-up|0|||
129874736|NCT02798211|467499510|FG004|Period 2|Lost to Follow-up|2|||
129874737|NCT02798211|467499511|FG005|Period 2|Lost to Follow-up|0|||
129874738|NCT02798211|467499506|FG000|Period 2|Physician Decision|1|||
129874739|NCT02798211|467499507|FG001|Period 2|Physician Decision|0|||
129874740|NCT02798211|467499508|FG002|Period 2|Physician Decision|0|||
129874741|NCT02798211|467499509|FG003|Period 2|Physician Decision|1|||
129874742|NCT02798211|467499510|FG004|Period 2|Physician Decision|1|||
129874743|NCT02798211|467499511|FG005|Period 2|Physician Decision|0|||
129874744|NCT02798211|467499506|FG000|Period 2|Pregnancy|0|||
129874745|NCT02798211|467499507|FG001|Period 2|Pregnancy|0|||
129874746|NCT02798211|467499508|FG002|Period 2|Pregnancy|0|||
129874747|NCT02798211|467499509|FG003|Period 2|Pregnancy|2|||
129874748|NCT02798211|467499510|FG004|Period 2|Pregnancy|0|||
129874749|NCT02798211|467499511|FG005|Period 2|Pregnancy|0|||
129874750|NCT02798211|467499506|FG000|Period 2|Technical problems|1|||
129874751|NCT02798211|467499507|FG001|Period 2|Technical problems|0|||
129874752|NCT02798211|467499508|FG002|Period 2|Technical problems|0|||
129874753|NCT02798211|467499509|FG003|Period 2|Technical problems|1|||
129874754|NCT02798211|467499510|FG004|Period 2|Technical problems|0|||
129874755|NCT02798211|467499511|FG005|Period 2|Technical problems|0|||
129874756|NCT02798211|467499506|FG000|Period 2|Withdrawal of Informed Consent|1|||
129874757|NCT02798211|467499507|FG001|Period 2|Withdrawal of Informed Consent|0|||
129874758|NCT02798211|467499508|FG002|Period 2|Withdrawal of Informed Consent|0|||
129874759|NCT02798211|467499509|FG003|Period 2|Withdrawal of Informed Consent|2|||
129874760|NCT02798211|467499510|FG004|Period 2|Withdrawal of Informed Consent|2|||
129874761|NCT02798211|467499511|FG005|Period 2|Withdrawal of Informed Consent|3|||
129874762|NCT01982435|467499512|FG000|Overall Study|Adverse Event|1|||
129874763|NCT01982435|467499513|FG001|Overall Study|Adverse Event|0|||
129874764|NCT05292534|467499514|FG000|Overall Study|Protocol Violation|3|||
129874765|NCT05292534|467499515|FG001|Overall Study|Protocol Violation|4|||
129874766|NCT05292534|467499514|FG000|Overall Study|Withdrawal by Subject|0|||
129874767|NCT05292534|467499515|FG001|Overall Study|Withdrawal by Subject|1|||
129874768|NCT03086018|467499517|FG000|Final Testing for End of Trial|Adverse Event|1|||
129874769|NCT03086018|467499517|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
129874770|NCT01892345|467499518|FG000|Overall Study|Adverse Event|0|||
129874771|NCT01892345|467499519|FG001|Overall Study|Adverse Event|2|||
129874772|NCT01892345|467499518|FG000|Overall Study|Death|1|||
129874773|NCT01892345|467499519|FG001|Overall Study|Death|0|||
129874774|NCT01892345|467499518|FG000|Overall Study|Lost to Follow-up|3|||
129874775|NCT01892345|467499519|FG001|Overall Study|Lost to Follow-up|0|||
129874776|NCT01892345|467499518|FG000|Overall Study|Withdrawal by Subject|12|||
129874777|NCT01892345|467499519|FG001|Overall Study|Withdrawal by Subject|1|||
129874778|NCT02748694|467499520|FG000|Overall Study|Voluntary Withdrawal|0|||
129874779|NCT02748694|467499521|FG001|Overall Study|Voluntary Withdrawal|0|||
129874780|NCT02748694|467499522|FG002|Overall Study|Voluntary Withdrawal|0|||
129874781|NCT02748694|467499523|FG003|Overall Study|Voluntary Withdrawal|0|||
129874782|NCT02748694|467499524|FG004|Overall Study|Voluntary Withdrawal|0|||
129874783|NCT02748694|467499525|FG005|Overall Study|Voluntary Withdrawal|0|||
129874784|NCT02748694|467499526|FG006|Overall Study|Voluntary Withdrawal|0|||
129874785|NCT02748694|467499527|FG007|Overall Study|Voluntary Withdrawal|0|||
129874786|NCT02748694|467499528|FG008|Overall Study|Voluntary Withdrawal|0|||
129874787|NCT02748694|467499529|FG009|Overall Study|Voluntary Withdrawal|0|||
129874788|NCT02748694|467499530|FG010|Overall Study|Voluntary Withdrawal|0|||
129874789|NCT02748694|467499531|FG011|Overall Study|Voluntary Withdrawal|0|||
129874790|NCT02748694|467499532|FG012|Overall Study|Voluntary Withdrawal|0|||
129874791|NCT02748694|467499533|FG013|Overall Study|Voluntary Withdrawal|0|||
129874792|NCT02748694|467499534|FG014|Overall Study|Voluntary Withdrawal|2|||
129874793|NCT01473381|467499535|FG000|Overall Study|Adverse Event|8|||
129874794|NCT01473381|467499536|FG001|Overall Study|Adverse Event|20|||
129874795|NCT01473381|467499537|FG002|Overall Study|Adverse Event|25|||
129874796|NCT01473381|467499538|FG003|Overall Study|Adverse Event|17|||
129874797|NCT01473381|467499535|FG000|Overall Study|Insufficient Therapeutic Response|10|||
129874798|NCT01473381|467499536|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129874799|NCT01473381|467499537|FG002|Overall Study|Insufficient Therapeutic Response|2|||
129874800|NCT01473381|467499538|FG003|Overall Study|Insufficient Therapeutic Response|3|||
129874801|NCT01473381|467499535|FG000|Overall Study|Protocol Violation|17|||
129874802|NCT01473381|467499536|FG001|Overall Study|Protocol Violation|23|||
129874803|NCT01473381|467499537|FG002|Overall Study|Protocol Violation|19|||
129874804|NCT01473381|467499538|FG003|Overall Study|Protocol Violation|17|||
129874805|NCT01473381|467499535|FG000|Overall Study|Withdrawal of Consent|20|||
129984776|NCT05038163|467905550|FG003|Stage 2|Did not complete Stage 2 survey|24|||
129984777|NCT05038163|467905551|FG004|Stage 2|Did not complete Stage 2 survey|21|||
129984778|NCT05038163|467905552|FG005|Stage 2|Did not complete Stage 2 survey|100|||
129984779|NCT01905150|467905553|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
129984780|NCT01905150|467905554|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
129984781|NCT03762200|467905559|FG000|Overall Study|Death|2|||
129984782|NCT02631577|467905560|FG000|Overall Study|Death|1|||
129984783|NCT02631577|467905561|FG001|Overall Study|Death|7|||
129984784|NCT02631577|467905560|FG000|Overall Study|Withdrawal by Subject|0|||
129984785|NCT02631577|467905561|FG001|Overall Study|Withdrawal by Subject|3|||
129984786|NCT01593787|467905562|FG000|Overall Study|Adverse Event|1|||
129874806|NCT01473381|467499536|FG001|Overall Study|Withdrawal of Consent|21|||
129874807|NCT01473381|467499537|FG002|Overall Study|Withdrawal of Consent|20|||
129984787|NCT01593787|467905563|FG001|Overall Study|Adverse Event|0|||
129874808|NCT01473381|467499538|FG003|Overall Study|Withdrawal of Consent|26|||
129984788|NCT01593787|467905564|FG002|Overall Study|Adverse Event|0|||
129874809|NCT01473381|467499535|FG000|Overall Study|Lost to Follow-up|25|||
129874810|NCT01473381|467499536|FG001|Overall Study|Lost to Follow-up|28|||
129874811|NCT01473381|467499537|FG002|Overall Study|Lost to Follow-up|35|||
129874812|NCT01473381|467499538|FG003|Overall Study|Lost to Follow-up|23|||
129874813|NCT01473381|467499535|FG000|Overall Study|Other Reasons|0|||
129874814|NCT01473381|467499536|FG001|Overall Study|Other Reasons|0|||
129874815|NCT01473381|467499537|FG002|Overall Study|Other Reasons|1|||
129874816|NCT01473381|467499538|FG003|Overall Study|Other Reasons|3|||
129874817|NCT04026165|467499542|FG000|Run-in Placebo Period|Enrollment Error|13|||
129874818|NCT04026165|467499543|FG001|Run-in Placebo Period|Enrollment Error|0|||
129874819|NCT04026165|467499544|FG002|Run-in Placebo Period|Enrollment Error|0|||
129874820|NCT04026165|467499545|FG003|Run-in Placebo Period|Enrollment Error|0|||
129874821|NCT04026165|467499542|FG000|Run-in Placebo Period|Run-in Failure|4|||
129874822|NCT04026165|467499543|FG001|Run-in Placebo Period|Run-in Failure|0|||
129874823|NCT04026165|467499544|FG002|Run-in Placebo Period|Run-in Failure|0|||
129874824|NCT04026165|467499545|FG003|Run-in Placebo Period|Run-in Failure|0|||
129874825|NCT04026165|467499542|FG000|Run-in Placebo Period|Protocol Violation|2|||
129874826|NCT04026165|467499543|FG001|Run-in Placebo Period|Protocol Violation|0|||
129874827|NCT04026165|467499544|FG002|Run-in Placebo Period|Protocol Violation|0|||
129874828|NCT04026165|467499545|FG003|Run-in Placebo Period|Protocol Violation|0|||
129874829|NCT04026165|467499542|FG000|Run-in Placebo Period|Withdrew Consent|2|||
129874830|NCT04026165|467499543|FG001|Run-in Placebo Period|Withdrew Consent|0|||
129874831|NCT04026165|467499544|FG002|Run-in Placebo Period|Withdrew Consent|0|||
129874832|NCT04026165|467499545|FG003|Run-in Placebo Period|Withdrew Consent|0|||
129874833|NCT04026165|467499542|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
129874834|NCT04026165|467499543|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
129874835|NCT04026165|467499544|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
129874836|NCT04026165|467499545|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
129874837|NCT04026165|467499542|FG000|Run-in SEL Period|Run-in Failure|0|||
129874838|NCT04026165|467499543|FG001|Run-in SEL Period|Run-in Failure|26|||
129874839|NCT04026165|467499544|FG002|Run-in SEL Period|Run-in Failure|0|||
129874840|NCT04026165|467499545|FG003|Run-in SEL Period|Run-in Failure|0|||
129874841|NCT04026165|467499542|FG000|Run-in SEL Period|Withdrew Consent|0|||
129874842|NCT04026165|467499543|FG001|Run-in SEL Period|Withdrew Consent|10|||
129874843|NCT04026165|467499544|FG002|Run-in SEL Period|Withdrew Consent|0|||
129874844|NCT04026165|467499545|FG003|Run-in SEL Period|Withdrew Consent|0|||
129874845|NCT04026165|467499542|FG000|Run-in SEL Period|Enrollment Error|0|||
129874846|NCT04026165|467499543|FG001|Run-in SEL Period|Enrollment Error|4|||
129874847|NCT04026165|467499544|FG002|Run-in SEL Period|Enrollment Error|0|||
129874848|NCT04026165|467499545|FG003|Run-in SEL Period|Enrollment Error|0|||
129874849|NCT04026165|467499542|FG000|Run-in SEL Period|Protocol Violation|0|||
129874850|NCT04026165|467499543|FG001|Run-in SEL Period|Protocol Violation|3|||
129874851|NCT04026165|467499544|FG002|Run-in SEL Period|Protocol Violation|0|||
129874852|NCT04026165|467499545|FG003|Run-in SEL Period|Protocol Violation|0|||
129874853|NCT04026165|467499542|FG000|Run-in SEL Period|Investigator's Discretion|0|||
129874854|NCT04026165|467499543|FG001|Run-in SEL Period|Investigator's Discretion|2|||
129874855|NCT04026165|467499544|FG002|Run-in SEL Period|Investigator's Discretion|0|||
129874856|NCT04026165|467499545|FG003|Run-in SEL Period|Investigator's Discretion|0|||
129874857|NCT04026165|467499542|FG000|Run-in SEL Period|Death|0|||
129874858|NCT04026165|467499543|FG001|Run-in SEL Period|Death|1|||
129874859|NCT04026165|467499544|FG002|Run-in SEL Period|Death|0|||
129874860|NCT04026165|467499545|FG003|Run-in SEL Period|Death|0|||
129874861|NCT04026165|467499542|FG000|Randomized Period|Withdrew Consent|0|||
129874862|NCT04026165|467499543|FG001|Randomized Period|Withdrew Consent|0|||
129874863|NCT04026165|467499544|FG002|Randomized Period|Withdrew Consent|5|||
129874864|NCT04026165|467499545|FG003|Randomized Period|Withdrew Consent|8|||
129874865|NCT04026165|467499542|FG000|Randomized Period|Death|0|||
129874866|NCT04026165|467499543|FG001|Randomized Period|Death|0|||
129874867|NCT04026165|467499544|FG002|Randomized Period|Death|5|||
129874868|NCT04026165|467499545|FG003|Randomized Period|Death|7|||
129874869|NCT04026165|467499542|FG000|Randomized Period|Investigator's Discretion|0|||
129874870|NCT04026165|467499543|FG001|Randomized Period|Investigator's Discretion|0|||
129874871|NCT04026165|467499544|FG002|Randomized Period|Investigator's Discretion|2|||
129874872|NCT04026165|467499545|FG003|Randomized Period|Investigator's Discretion|2|||
129874873|NCT04026165|467499542|FG000|Randomized Period|Lost to Follow-up|0|||
129874874|NCT04026165|467499543|FG001|Randomized Period|Lost to Follow-up|0|||
129874875|NCT04026165|467499544|FG002|Randomized Period|Lost to Follow-up|2|||
129874876|NCT04026165|467499545|FG003|Randomized Period|Lost to Follow-up|2|||
129874877|NCT02487810|467499546|FG000|Overall Study|Withdrawal by Subject|1|||
129874878|NCT02487810|467499547|FG001|Overall Study|Withdrawal by Subject|0|||
129874879|NCT01889186|467499548|FG000|Overall Study|Adverse event- not related to progression|18|||
129874880|NCT01889186|467499549|FG001|Overall Study|Adverse event- not related to progression|5|||
129874881|NCT01889186|467499548|FG000|Overall Study|Adverse event- related to progression|7|||
129874882|NCT01889186|467499549|FG001|Overall Study|Adverse event- related to progression|2|||
129874883|NCT01889186|467499548|FG000|Overall Study|COVID-19 logistical restrictions|1|||
129874884|NCT01889186|467499549|FG001|Overall Study|COVID-19 logistical restrictions|0|||
129874885|NCT01889186|467499548|FG000|Overall Study|Investigator request|1|||
129874886|NCT01889186|467499549|FG001|Overall Study|Investigator request|1|||
129874887|NCT01889186|467499548|FG000|Overall Study|Progressive disease- Richter's|12|||
129874888|NCT01889186|467499549|FG001|Overall Study|Progressive disease- Richter's|7|||
129874889|NCT01889186|467499548|FG000|Overall Study|Progressive disease per protocol|46|||
129874890|NCT01889186|467499549|FG001|Overall Study|Progressive disease per protocol|17|||
129874891|NCT01889186|467499548|FG000|Overall Study|Stem cell transplant|2|||
129874892|NCT01889186|467499549|FG001|Overall Study|Stem cell transplant|1|||
129874893|NCT01889186|467499548|FG000|Overall Study|Withdrew consent|2|||
129874894|NCT01889186|467499549|FG001|Overall Study|Withdrew consent|3|||
129874895|NCT01889186|467499548|FG000|Overall Study|Other, not specified|18|||
129874896|NCT01889186|467499549|FG001|Overall Study|Other, not specified|15|||
129874897|NCT00441701|467499552|FG000|Overall Study|Adverse Event|3|||
129874898|NCT00441701|467499553|FG001|Overall Study|Adverse Event|2|||
129874899|NCT00441701|467499554|FG002|Overall Study|Adverse Event|1|||
129874900|NCT00441701|467499555|FG003|Overall Study|Adverse Event|0|||
129874901|NCT00441701|467499556|FG004|Overall Study|Adverse Event|2|||
129874902|NCT00441701|467499557|FG005|Overall Study|Adverse Event|2|||
129874903|NCT00441701|467499558|FG006|Overall Study|Adverse Event|0|||
129874904|NCT00441701|467499559|FG007|Overall Study|Adverse Event|0|||
129874905|NCT00441701|467499560|FG008|Overall Study|Adverse Event|0|||
129874906|NCT00441701|467499561|FG009|Overall Study|Adverse Event|0|||
129874907|NCT00441701|467499552|FG000|Overall Study|Lack of Efficacy|2|||
129874908|NCT00441701|467499553|FG001|Overall Study|Lack of Efficacy|0|||
129874909|NCT00441701|467499554|FG002|Overall Study|Lack of Efficacy|2|||
129874910|NCT00441701|467499555|FG003|Overall Study|Lack of Efficacy|2|||
129874911|NCT00441701|467499556|FG004|Overall Study|Lack of Efficacy|0|||
129874912|NCT00441701|467499557|FG005|Overall Study|Lack of Efficacy|1|||
129874913|NCT00441701|467499558|FG006|Overall Study|Lack of Efficacy|0|||
129874914|NCT00441701|467499559|FG007|Overall Study|Lack of Efficacy|0|||
129874915|NCT00441701|467499560|FG008|Overall Study|Lack of Efficacy|0|||
129874916|NCT00441701|467499561|FG009|Overall Study|Lack of Efficacy|0|||
129874917|NCT00441701|467499552|FG000|Overall Study|Withdrawal by Subject|0|||
129874918|NCT00441701|467499553|FG001|Overall Study|Withdrawal by Subject|2|||
129874919|NCT00441701|467499554|FG002|Overall Study|Withdrawal by Subject|1|||
129874920|NCT00441701|467499555|FG003|Overall Study|Withdrawal by Subject|1|||
129874921|NCT00441701|467499556|FG004|Overall Study|Withdrawal by Subject|0|||
129874922|NCT00441701|467499557|FG005|Overall Study|Withdrawal by Subject|0|||
129874923|NCT00441701|467499558|FG006|Overall Study|Withdrawal by Subject|0|||
129874924|NCT00441701|467499559|FG007|Overall Study|Withdrawal by Subject|0|||
129874925|NCT00441701|467499560|FG008|Overall Study|Withdrawal by Subject|0|||
129874926|NCT00441701|467499561|FG009|Overall Study|Withdrawal by Subject|0|||
129874927|NCT00077064|467499562|FG000|Overall Study|Adverse Event|0|||
129874928|NCT00077064|467499563|FG001|Overall Study|Adverse Event|4|||
129874929|NCT00077064|467499562|FG000|Overall Study|Patient refusal|0|||
129874930|NCT00077064|467499563|FG001|Overall Study|Patient refusal|2|||
129874931|NCT04710927|467499564|FG000|Overall Study|Lost to Follow-up|7|||
129874932|NCT04710927|467499565|FG001|Overall Study|Lost to Follow-up|6|||
129874933|NCT04710927|467499566|FG002|Overall Study|Lost to Follow-up|5|||
129874934|NCT00621543|467499567|FG000|Overall Study|Lost to Follow-up|23|||
129874935|NCT02007434|467499569|FG000|Overall Study|Lost to Follow-up|0|||
129874936|NCT02007434|467499570|FG001|Overall Study|Lost to Follow-up|1|||
129874937|NCT02007434|467499571|FG002|Overall Study|Lost to Follow-up|0|||
129874938|NCT02007434|467499572|FG003|Overall Study|Lost to Follow-up|0|||
129874939|NCT02007434|467499573|FG004|Overall Study|Lost to Follow-up|0|||
129874940|NCT02007434|467499574|FG005|Overall Study|Lost to Follow-up|0|||
129874941|NCT02007434|467499575|FG006|Overall Study|Lost to Follow-up|0|||
129874942|NCT02007434|467499576|FG007|Overall Study|Lost to Follow-up|0|||
129874943|NCT02007434|467499569|FG000|Overall Study|Non-compliance|1|||
129874944|NCT02007434|467499570|FG001|Overall Study|Non-compliance|0|||
129874945|NCT02007434|467499571|FG002|Overall Study|Non-compliance|1|||
129874946|NCT02007434|467499572|FG003|Overall Study|Non-compliance|0|||
129874947|NCT02007434|467499573|FG004|Overall Study|Non-compliance|0|||
129874948|NCT02007434|467499574|FG005|Overall Study|Non-compliance|0|||
129874949|NCT02007434|467499575|FG006|Overall Study|Non-compliance|0|||
129874950|NCT02007434|467499576|FG007|Overall Study|Non-compliance|0|||
129874951|NCT01287611|467499577|FG000|Overall Study|Lost to Follow-up|29|||
129874952|NCT01287611|467499578|FG001|Overall Study|Lost to Follow-up|16|||
129874953|NCT01287611|467499577|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
129874954|NCT01287611|467499578|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
129874955|NCT02192970|467499581|FG000|Overall Study|Lost to Follow-up|6|||
129874956|NCT02192970|467499582|FG001|Overall Study|Lost to Follow-up|0|||
129874957|NCT04074590|467499583|FG000|Overall Study|Adverse Event|1|||
129874958|NCT04074590|467499584|FG001|Overall Study|Adverse Event|0|||
129874959|NCT04074590|467499583|FG000|Overall Study|Physician Decision|1|||
129874960|NCT04074590|467499584|FG001|Overall Study|Physician Decision|0|||
129874961|NCT04074590|467499583|FG000|Overall Study|Withdrawal by Subject|2|||
129651108|NCT00195494|466678593|FG003|Year 2|Physician Decision|0|||
129874962|NCT04074590|467499584|FG001|Overall Study|Withdrawal by Subject|0|||
129874963|NCT00691132|467499585|FG000|Overall Study|Adverse Event|2|||
129874964|NCT00691132|467499586|FG001|Overall Study|Adverse Event|3|||
129874965|NCT00691132|467499585|FG000|Overall Study|Withdrawal by Subject|10|||
129874966|NCT00691132|467499586|FG001|Overall Study|Withdrawal by Subject|10|||
129874967|NCT03954743|467499587|FG000|Overall Study|Adverse Event|1|||
129874968|NCT03954743|467499588|FG001|Overall Study|Adverse Event|0|||
129874969|NCT03954743|467499587|FG000|Overall Study|Lost to Follow-up|6|||
129874970|NCT03954743|467499588|FG001|Overall Study|Lost to Follow-up|4|||
129874971|NCT03954743|467499587|FG000|Overall Study|Protocol Violation|1|||
129874972|NCT03954743|467499588|FG001|Overall Study|Protocol Violation|0|||
129874973|NCT03954743|467499587|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
129984789|NCT03981861|467905570|FG000|Overall Study|Withdrawal by Subject|3|||
129984790|NCT05618912|467905571|FG000|Overall Study|Lost to Follow-up|14|||
129984791|NCT05618912|467905572|FG001|Overall Study|Lost to Follow-up|19|||
129984792|NCT01022112|467905573|FG000|Overall Study|Adverse Event|1|||
129984793|NCT01022112|467905574|FG001|Overall Study|Adverse Event|2|||
129984794|NCT01022112|467905575|FG002|Overall Study|Adverse Event|0|||
129984795|NCT01022112|467905576|FG003|Overall Study|Adverse Event|1|||
129984796|NCT01022112|467905577|FG004|Overall Study|Adverse Event|0|||
129984797|NCT01022112|467905573|FG000|Overall Study|Lack of Efficacy|1|||
129984798|NCT01022112|467905574|FG001|Overall Study|Lack of Efficacy|0|||
129984799|NCT01022112|467905575|FG002|Overall Study|Lack of Efficacy|0|||
129984800|NCT01022112|467905576|FG003|Overall Study|Lack of Efficacy|0|||
129874974|NCT03954743|467499588|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
129874975|NCT03954743|467499587|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
129874976|NCT03954743|467499588|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129874977|NCT02387996|467499593|FG000|Overall Study|Disease Progression|167|||
129874978|NCT02387996|467499593|FG000|Overall Study|Study Drug Toxicity|31|||
129874979|NCT02387996|467499593|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
129874980|NCT02387996|467499593|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
129874981|NCT02387996|467499593|FG000|Overall Study|Subject Withdrew Consent|5|||
129874982|NCT02387996|467499593|FG000|Overall Study|Lost to Follow-up|1|||
129874983|NCT02387996|467499593|FG000|Overall Study|Poor/Non-Compliance|1|||
129874984|NCT02387996|467499593|FG000|Overall Study|Other Reasons|5|||
129874985|NCT02387996|467499593|FG000|Overall Study|Death|1|||
129874986|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
129874987|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
129874988|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
129874989|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
129984801|NCT01022112|467905577|FG004|Overall Study|Lack of Efficacy|1|||
129984802|NCT01022112|467905573|FG000|Overall Study|Physician Decision|0|||
129984803|NCT01022112|467905574|FG001|Overall Study|Physician Decision|0|||
129984804|NCT01022112|467905575|FG002|Overall Study|Physician Decision|1|||
129984805|NCT01022112|467905576|FG003|Overall Study|Physician Decision|0|||
129984806|NCT01022112|467905577|FG004|Overall Study|Physician Decision|1|||
129984807|NCT01022112|467905573|FG000|Overall Study|Withdrawal by Subject|0|||
129984808|NCT01022112|467905574|FG001|Overall Study|Withdrawal by Subject|1|||
129984809|NCT01022112|467905575|FG002|Overall Study|Withdrawal by Subject|2|||
129984810|NCT01022112|467905576|FG003|Overall Study|Withdrawal by Subject|2|||
129984811|NCT01022112|467905577|FG004|Overall Study|Withdrawal by Subject|1|||
129984812|NCT01022112|467905573|FG000|Overall Study|Fasting plasma glucose level increased|1|||
129984813|NCT01022112|467905574|FG001|Overall Study|Fasting plasma glucose level increased|0|||
129984814|NCT01022112|467905575|FG002|Overall Study|Fasting plasma glucose level increased|0|||
129984815|NCT01022112|467905576|FG003|Overall Study|Fasting plasma glucose level increased|0|||
129984816|NCT01022112|467905577|FG004|Overall Study|Fasting plasma glucose level increased|7|||
129651109|NCT00195494|466678594|FG004|Year 2|Physician Decision|0|||
129874990|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
129984817|NCT00432666|467907405|FG000|Main Period|Adverse Event|1|||
129984818|NCT00432666|467907406|FG001|Main Period|Adverse Event|1|||
129539735|NCT04887922|466268767|FG003|1st Randomization|Decided not to have surgery|0|||
129539736|NCT04887922|466268768|FG004|1st Randomization|Decided not to have surgery|0|||
129539737|NCT02985996|466268769|FG000|Overall Study|Withdrawal by Subject|0|||
129539738|NCT02985996|466268770|FG001|Overall Study|Withdrawal by Subject|0|||
129984819|NCT00432666|467907405|FG000|Main Period|Consent Withdrawn|1|||
129984820|NCT00432666|467907406|FG001|Main Period|Consent Withdrawn|0|||
129984821|NCT00432666|467907405|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
129984822|NCT00432666|467907406|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
129984823|NCT00432666|467907405|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
129984824|NCT00432666|467907406|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
129984825|NCT00432666|467907405|FG000|Open-Label Extension Period|Adverse Event|5|||
129984826|NCT00432666|467907406|FG001|Open-Label Extension Period|Adverse Event|0|||
129984827|NCT00432666|467907405|FG000|Open-Label Extension Period|Consent withdrawn|10|||
129984828|NCT00432666|467907406|FG001|Open-Label Extension Period|Consent withdrawn|0|||
129984829|NCT00432666|467907405|FG000|Open-Label Extension Period|Physician Decision|3|||
129984830|NCT00432666|467907406|FG001|Open-Label Extension Period|Physician Decision|0|||
129984831|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
129984832|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
129984833|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
129984834|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
129984835|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
129984836|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
129984837|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
129984838|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
129984839|NCT00978627|467907407|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
129984840|NCT00978627|467907408|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
129984841|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
129984842|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
129984843|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
129984844|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
129984845|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
129984846|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
129984847|NCT00978627|467907407|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
129984848|NCT00978627|467907408|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
129984849|NCT02516332|467907409|FG000|Overall Study|Withdrawal by Subject|2|||
129984850|NCT02516332|467907410|FG001|Overall Study|Withdrawal by Subject|1|||
129984851|NCT02516332|467907411|FG002|Overall Study|Withdrawal by Subject|2|||
129984852|NCT03037931|467907412|FG000|Overall Study|Death|354|||
129984853|NCT03037931|467907413|FG001|Overall Study|Death|367|||
129984854|NCT03037931|467907412|FG000|Overall Study|Lost to Follow-up|7|||
129984855|NCT03037931|467907413|FG001|Overall Study|Lost to Follow-up|4|||
129984856|NCT03037931|467907412|FG000|Overall Study|Withdrawal by Subject|48|||
129984857|NCT03037931|467907413|FG001|Overall Study|Withdrawal by Subject|41|||
129984858|NCT00605215|467907414|FG000|Overall Study|Death|0|||
129984859|NCT00605215|467907415|FG001|Overall Study|Death|0|||
129984860|NCT00605215|467907416|FG002|Overall Study|Death|1|||
129984861|NCT00605215|467907414|FG000|Overall Study|Adverse Event|19|||
129984862|NCT00605215|467907415|FG001|Overall Study|Adverse Event|21|||
129984863|NCT00605215|467907416|FG002|Overall Study|Adverse Event|26|||
129984864|NCT00605215|467907414|FG000|Overall Study|Refusal to sign the re-consent form|8|||
129984865|NCT00605215|467907415|FG001|Overall Study|Refusal to sign the re-consent form|3|||
129984866|NCT00605215|467907416|FG002|Overall Study|Refusal to sign the re-consent form|3|||
129984867|NCT00605215|467907414|FG000|Overall Study|Withdrawal by Subject|39|||
129984868|NCT00605215|467907415|FG001|Overall Study|Withdrawal by Subject|37|||
129984869|NCT00605215|467907416|FG002|Overall Study|Withdrawal by Subject|27|||
129984870|NCT00605215|467907414|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
129984871|NCT00605215|467907415|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
129984872|NCT00605215|467907416|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
129984873|NCT00605215|467907414|FG000|Overall Study|Protocol Violation|3|||
129984874|NCT00605215|467907415|FG001|Overall Study|Protocol Violation|4|||
129984875|NCT00605215|467907416|FG002|Overall Study|Protocol Violation|1|||
129984876|NCT00605215|467907414|FG000|Overall Study|Pregnancy|8|||
129984877|NCT00605215|467907415|FG001|Overall Study|Pregnancy|5|||
129984878|NCT00605215|467907416|FG002|Overall Study|Pregnancy|4|||
129984879|NCT00605215|467907414|FG000|Overall Study|Lost to Follow-up|8|||
129984880|NCT00605215|467907415|FG001|Overall Study|Lost to Follow-up|5|||
129984881|NCT00605215|467907416|FG002|Overall Study|Lost to Follow-up|2|||
129984882|NCT00605215|467907414|FG000|Overall Study|Other than specified|0|||
129984883|NCT00605215|467907415|FG001|Overall Study|Other than specified|2|||
129984884|NCT00605215|467907416|FG002|Overall Study|Other than specified|1|||
129984885|NCT02914275|467907419|FG000|Overall Study|Lost to Follow-up|84|||
129984886|NCT02914275|467907420|FG001|Overall Study|Lost to Follow-up|29|||
129984887|NCT02914275|467907419|FG000|Overall Study|Withdrawal by Subject|26|||
129984888|NCT02914275|467907420|FG001|Overall Study|Withdrawal by Subject|10|||
129984889|NCT02914275|467907419|FG000|Overall Study|Protocol Violation|1|||
129984890|NCT02914275|467907420|FG001|Overall Study|Protocol Violation|1|||
129984891|NCT02914275|467907419|FG000|Overall Study|Physician Decision|3|||
129984892|NCT02914275|467907420|FG001|Overall Study|Physician Decision|1|||
129984893|NCT02914275|467907419|FG000|Overall Study|Other|4|||
129984894|NCT02914275|467907420|FG001|Overall Study|Other|1|||
129984895|NCT02914275|467907419|FG000|Overall Study|Excluded due to invalid informed consent|3|||
129984896|NCT02914275|467907420|FG001|Overall Study|Excluded due to invalid informed consent|0|||
129984897|NCT01302067|467907425|FG000|Overall Study|Death|0|||
129984898|NCT01302067|467907426|FG001|Overall Study|Death|0|||
129984899|NCT01302067|467907427|FG002|Overall Study|Death|1|||
129984900|NCT01302067|467907425|FG000|Overall Study|Physician Decision|9|||
129984901|NCT01302067|467907426|FG001|Overall Study|Physician Decision|5|||
129984902|NCT01302067|467907427|FG002|Overall Study|Physician Decision|14|||
129984903|NCT01302067|467907425|FG000|Overall Study|Lack of Efficacy|8|||
129984904|NCT01302067|467907426|FG001|Overall Study|Lack of Efficacy|4|||
129984905|NCT01302067|467907427|FG002|Overall Study|Lack of Efficacy|2|||
129984906|NCT01302067|467907425|FG000|Overall Study|Lost to Follow-up|9|||
129984907|NCT01302067|467907426|FG001|Overall Study|Lost to Follow-up|4|||
129984908|NCT01302067|467907427|FG002|Overall Study|Lost to Follow-up|15|||
129984909|NCT01302067|467907425|FG000|Overall Study|Withdrawal by Subject|13|||
129984910|NCT01302067|467907426|FG001|Overall Study|Withdrawal by Subject|6|||
129984911|NCT01302067|467907427|FG002|Overall Study|Withdrawal by Subject|10|||
129984912|NCT01302067|467907425|FG000|Overall Study|Other|1|||
129984913|NCT01302067|467907426|FG001|Overall Study|Other|1|||
129984914|NCT01302067|467907427|FG002|Overall Study|Other|3|||
129984915|NCT01302067|467907425|FG000|Overall Study|Protocol Violation|11|||
129984916|NCT01302067|467907426|FG001|Overall Study|Protocol Violation|0|||
129984917|NCT01302067|467907427|FG002|Overall Study|Protocol Violation|8|||
129984918|NCT01302067|467907425|FG000|Overall Study|Adverse Event|27|||
129984919|NCT01302067|467907426|FG001|Overall Study|Adverse Event|14|||
129984920|NCT01302067|467907427|FG002|Overall Study|Adverse Event|45|||
129984921|NCT02738203|467907429|FG000|Overall Study|Failed IUD Insertion|2|||
129984922|NCT02738203|467907430|FG001|Overall Study|Failed IUD Insertion|2|||
129984923|NCT02738203|467907429|FG000|Overall Study|Protocol Violation|0|||
129984924|NCT02738203|467907430|FG001|Overall Study|Protocol Violation|1|||
129984925|NCT03241927|467907431|FG000|Overall Study|study terminated|1|||
129984926|NCT03241927|467907432|FG001|Overall Study|study terminated|0|||
129984927|NCT02704754|467907433|FG000|Overall Study|Lost to Follow-up|1|||
129984928|NCT02704754|467907434|FG001|Overall Study|Lost to Follow-up|1|||
129984929|NCT02704754|467907433|FG000|Overall Study|Lack of Efficacy|1|||
129984930|NCT02704754|467907434|FG001|Overall Study|Lack of Efficacy|0|||
129984931|NCT02704754|467907433|FG000|Overall Study|Withdrawal by Subject|1|||
129984932|NCT02704754|467907434|FG001|Overall Study|Withdrawal by Subject|0|||
129984933|NCT00423943|467907435|FG000|Overall Study|Withdrawal by Subject|3|||
129984934|NCT00423943|467907436|FG001|Overall Study|Withdrawal by Subject|1|||
129984935|NCT02383056|467907440|FG000|Overall Study|Adverse Event|1|||
129984936|NCT02383056|467907441|FG001|Overall Study|Adverse Event|0|||
129984937|NCT02383056|467907440|FG000|Overall Study|Lost to Follow-up|0|||
129984938|NCT02383056|467907441|FG001|Overall Study|Lost to Follow-up|2|||
129984939|NCT04214600|467907442|FG000|Overall Study|Lost to Follow-up|9|||
129984940|NCT04214600|467907443|FG001|Overall Study|Lost to Follow-up|14|||
129984941|NCT03245151|467907448|FG000|Overall Study|Withdrawal by Subject|2|||
129984942|NCT03245151|467907449|FG001|Overall Study|Withdrawal by Subject|0|||
129984943|NCT03245151|467907450|FG002|Overall Study|Withdrawal by Subject|0|||
129984944|NCT03245151|467907451|FG003|Overall Study|Withdrawal by Subject|2|||
129984945|NCT03245151|467907452|FG004|Overall Study|Withdrawal by Subject|1|||
129984946|NCT03245151|467907448|FG000|Overall Study|Death|3|||
129984947|NCT03245151|467907449|FG001|Overall Study|Death|14|||
129984948|NCT03245151|467907450|FG002|Overall Study|Death|9|||
129984949|NCT03245151|467907451|FG003|Overall Study|Death|16|||
129984950|NCT03245151|467907452|FG004|Overall Study|Death|7|||
129984951|NCT03245151|467907448|FG000|Overall Study|Sponsor's decision|0|||
129984952|NCT03245151|467907449|FG001|Overall Study|Sponsor's decision|1|||
129984953|NCT03245151|467907450|FG002|Overall Study|Sponsor's decision|0|||
129984954|NCT03245151|467907451|FG003|Overall Study|Sponsor's decision|0|||
129984955|NCT03245151|467907452|FG004|Overall Study|Sponsor's decision|0|||
129984956|NCT02366468|467907453|FG000|Overall Study|Adverse Event|2|||
129984957|NCT02366468|467907454|FG001|Overall Study|Adverse Event|0|||
129984958|NCT02366468|467907453|FG000|Overall Study|Withdrawal by Subject|1|||
129984959|NCT02366468|467907454|FG001|Overall Study|Withdrawal by Subject|5|||
129984960|NCT02366468|467907453|FG000|Overall Study|Lost to Follow-up|2|||
129984961|NCT02366468|467907454|FG001|Overall Study|Lost to Follow-up|0|||
129984962|NCT02366468|467907453|FG000|Overall Study|Death|1|||
129984963|NCT02366468|467907454|FG001|Overall Study|Death|2|||
129984964|NCT02366468|467907453|FG000|Overall Study|Other|0|||
129984965|NCT02366468|467907454|FG001|Overall Study|Other|2|||
129984966|NCT04797650|467907455|FG000|Overall Study|Reason Not Specified|5|||
129984967|NCT04797650|467907456|FG001|Overall Study|Reason Not Specified|12|||
129984968|NCT04797650|467907457|FG002|Overall Study|Reason Not Specified|5|||
129984969|NCT04797650|467907455|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
129984970|NCT04797650|467907456|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
129984971|NCT04797650|467907457|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
129984972|NCT04797650|467907455|FG000|Overall Study|Lack of Efficacy|1|||
129984973|NCT04797650|467907456|FG001|Overall Study|Lack of Efficacy|0|||
129984974|NCT04797650|467907457|FG002|Overall Study|Lack of Efficacy|1|||
129984975|NCT04797650|467907455|FG000|Overall Study|Non-compliance with Study Drug|0|||
129984976|NCT04797650|467907456|FG001|Overall Study|Non-compliance with Study Drug|0|||
129984977|NCT04797650|467907457|FG002|Overall Study|Non-compliance with Study Drug|2|||
129984978|NCT04797650|467907455|FG000|Overall Study|Lost to Follow-up|4|||
129984979|NCT04797650|467907456|FG001|Overall Study|Lost to Follow-up|6|||
129984980|NCT04797650|467907457|FG002|Overall Study|Lost to Follow-up|1|||
129984981|NCT00657020|467907458|FG000|PERIOD 1|Adverse Event|0|||
129984982|NCT00657020|467907459|FG001|PERIOD 1|Adverse Event|1|||
129984983|NCT04772898|467907460|FG000|Overall Study|Withdrawal by Subject|0|||
129984984|NCT04772898|467907461|FG001|Overall Study|Withdrawal by Subject|1|||
129984985|NCT02947087|467907462|FG000|Overall Study|Withdrawal by Subject|3|||
129984986|NCT02947087|467907463|FG001|Overall Study|Withdrawal by Subject|2|||
129984987|NCT00434213|467907467|FG000|Overall Study|Adverse Event|12|||
129984988|NCT00434213|467907467|FG000|Overall Study|Lack of Efficacy|9|||
129984989|NCT00434213|467907467|FG000|Overall Study|Lost to Follow-up|14|||
129984990|NCT00434213|467907467|FG000|Overall Study|Withdrawal by Subject|7|||
129984991|NCT00434213|467907467|FG000|Overall Study|Protocol Violation|3|||
129984992|NCT00434213|467907467|FG000|Overall Study|Unable to comply with study visit window|2|||
129984993|NCT00434213|467907467|FG000|Overall Study|Application site reaction|1|||
129984994|NCT00434213|467907467|FG000|Overall Study|Non-compliant to study schedule|1|||
129984995|NCT00774930|467907471|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
129984996|NCT00774930|467907472|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
129984997|NCT00774930|467907471|FG000|DB Phase|Adverse Event|1|||
129984998|NCT00774930|467907472|FG001|DB Phase|Adverse Event|2|||
129984999|NCT00774930|467907471|FG000|DB Phase|Subject Decision|1|||
129985000|NCT00774930|467907472|FG001|DB Phase|Subject Decision|5|||
129985001|NCT00774930|467907471|FG000|DB Phase|Sponsor Decision|0|||
129985002|NCT00774930|467907472|FG001|DB Phase|Sponsor Decision|1|||
129985003|NCT00774930|467907471|FG000|DB Phase|Disease Progression|1|||
129985004|NCT00774930|467907472|FG001|DB Phase|Disease Progression|1|||
129985005|NCT00774930|467907471|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
129985006|NCT00774930|467907472|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
129985007|NCT00774930|467907471|FG000|IOL Phase|Adverse Event|1|||
129985008|NCT00774930|467907472|FG001|IOL Phase|Adverse Event|1|||
129985009|NCT00774930|467907471|FG000|IOL Phase|Subject Decision|4|||
129985010|NCT00774930|467907472|FG001|IOL Phase|Subject Decision|3|||
129985011|NCT00774930|467907471|FG000|IOL Phase|Physician Decision|3|||
129985012|NCT00774930|467907472|FG001|IOL Phase|Physician Decision|2|||
129985013|NCT00774930|467907471|FG000|IOL Phase|Sponsor Decision|1|||
129985014|NCT00774930|467907472|FG001|IOL Phase|Sponsor Decision|0|||
129985015|NCT00774930|467907471|FG000|IOL Phase|Disease Progression|2|||
129985016|NCT00774930|467907472|FG001|IOL Phase|Disease Progression|1|||
129985017|NCT00774930|467907471|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
129985018|NCT00774930|467907472|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
129985019|NCT00774930|467907471|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
129985020|NCT00774930|467907472|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
129985021|NCT00774930|467907471|FG000|IOL Phase|Other|1|||
129985022|NCT00774930|467907472|FG001|IOL Phase|Other|0|||
129985023|NCT00774930|467907471|FG000|IOL Phase|Brain radiation|0|||
129985024|NCT00774930|467907472|FG001|IOL Phase|Brain radiation|1|||
129985025|NCT00774930|467907471|FG000|LTOLE Phase|Adverse Event|7|||
129985026|NCT00774930|467907472|FG001|LTOLE Phase|Adverse Event|3|||
129985027|NCT00774930|467907471|FG000|LTOLE Phase|Subject decision|0|||
129985028|NCT00774930|467907472|FG001|LTOLE Phase|Subject decision|5|||
129985029|NCT00774930|467907471|FG000|LTOLE Phase|Physician Decision|4|||
129985030|NCT00774930|467907472|FG001|LTOLE Phase|Physician Decision|1|||
129985031|NCT00774930|467907471|FG000|LTOLE Phase|Sponsor decision|2|||
129985032|NCT00774930|467907472|FG001|LTOLE Phase|Sponsor decision|1|||
129985033|NCT00774930|467907471|FG000|LTOLE Phase|Disease Progression|2|||
129985034|NCT00774930|467907472|FG001|LTOLE Phase|Disease Progression|5|||
129985035|NCT00774930|467907471|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
129985036|NCT00774930|467907472|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
129985037|NCT00774930|467907471|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
129985038|NCT00774930|467907472|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
129985039|NCT00766363|467907473|FG000|Overall Study|Withdrawal by Subject|1|||
129985040|NCT00766363|467907474|FG001|Overall Study|Withdrawal by Subject|0|||
129985041|NCT00766363|467907475|FG002|Overall Study|Withdrawal by Subject|0|||
129985042|NCT00766363|467907476|FG003|Overall Study|Withdrawal by Subject|0|||
129985043|NCT00766363|467907473|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
129985044|NCT00766363|467907474|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
129985045|NCT00766363|467907475|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
129985046|NCT00766363|467907476|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
129985047|NCT03020576|467907481|FG000|Overall Study|Withdrawal by Subject|1|||
129985048|NCT03020576|467907482|FG001|Overall Study|Withdrawal by Subject|2|||
129985049|NCT01153321|467907483|FG000|Overall Study|Development of study withdrawal criteria|0|||
129985050|NCT01153321|467907484|FG001|Overall Study|Development of study withdrawal criteria|1|||
129985051|NCT01153321|467907483|FG000|Overall Study|Withdrawal by Subject|0|||
129985052|NCT01153321|467907484|FG001|Overall Study|Withdrawal by Subject|1|||
129985053|NCT01153321|467907483|FG000|Overall Study|Adverse Event|1|||
129985054|NCT01153321|467907484|FG001|Overall Study|Adverse Event|1|||
129985055|NCT01177800|467907486|FG000|Overall Study|Adverse Event|9|||
129985056|NCT01177800|467907487|FG001|Overall Study|Adverse Event|3|||
129985057|NCT01177800|467907486|FG000|Overall Study|Protocol Violation|0|||
129985058|NCT01177800|467907487|FG001|Overall Study|Protocol Violation|1|||
129985059|NCT01177800|467907486|FG000|Overall Study|Physician Decision|1|||
129985060|NCT01177800|467907487|FG001|Overall Study|Physician Decision|0|||
129985061|NCT01177800|467907486|FG000|Overall Study|Withdrawal of informed consent|0|||
129985062|NCT01177800|467907487|FG001|Overall Study|Withdrawal of informed consent|1|||
129985063|NCT03527550|467907488|FG000|Overall Study|Lost to Follow-up|4|||
129985064|NCT03527550|467907489|FG001|Overall Study|Lost to Follow-up|2|||
129985065|NCT03527550|467907488|FG000|Overall Study|Withdrawal by Subject|4|||
129985066|NCT03527550|467907489|FG001|Overall Study|Withdrawal by Subject|1|||
129985067|NCT03527550|467907488|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
129985068|NCT03527550|467907489|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
129985069|NCT00911937|467907490|FG000|Overall Study|Death|1|||
129985070|NCT00911937|467907491|FG001|Overall Study|Death|0|||
129985071|NCT00911937|467907490|FG000|Overall Study|Lost to Follow-up|8|||
129985072|NCT00911937|467907491|FG001|Overall Study|Lost to Follow-up|5|||
129985073|NCT00911937|467907490|FG000|Overall Study|Withdrawal by Subject|10|||
129985074|NCT00911937|467907491|FG001|Overall Study|Withdrawal by Subject|7|||
129985075|NCT00911937|467907490|FG000|Overall Study|Withdrawn due to pregnancy|1|||
129985076|NCT00911937|467907491|FG001|Overall Study|Withdrawn due to pregnancy|0|||
129985077|NCT00911937|467907490|FG000|Overall Study|Adverse Event|11|||
129985078|NCT00911937|467907491|FG001|Overall Study|Adverse Event|25|||
129985079|NCT00911937|467907490|FG000|Overall Study|Lack of Efficacy|11|||
129985080|NCT00911937|467907491|FG001|Overall Study|Lack of Efficacy|6|||
129985081|NCT00911937|467907490|FG000|Overall Study|Did not meet inclusion criteria|9|||
129985082|NCT00911937|467907491|FG001|Overall Study|Did not meet inclusion criteria|11|||
129985083|NCT00911937|467907490|FG000|Overall Study|Protocol Violation|14|||
129985084|NCT00911937|467907491|FG001|Overall Study|Protocol Violation|23|||
129985085|NCT00911937|467907490|FG000|Overall Study|Randomized but not treated|13|||
129985086|NCT00911937|467907491|FG001|Overall Study|Randomized but not treated|13|||
129985087|NCT00911937|467907490|FG000|Overall Study|Other|9|||
129985088|NCT00911937|467907491|FG001|Overall Study|Other|5|||
129985089|NCT01498679|467907495|FG000|Overall Study|Adverse Event|1|||
129985090|NCT01498679|467907496|FG001|Overall Study|Adverse Event|4|||
129985091|NCT01498679|467907495|FG000|Overall Study|Lack of Efficacy|72|||
129985092|NCT01498679|467907496|FG001|Overall Study|Lack of Efficacy|12|||
129985093|NCT01498679|467907495|FG000|Overall Study|Protocol Violation|4|||
129985094|NCT01498679|467907496|FG001|Overall Study|Protocol Violation|0|||
129985095|NCT01498679|467907495|FG000|Overall Study|Physician Decision|0|||
129985096|NCT01498679|467907496|FG001|Overall Study|Physician Decision|2|||
129985097|NCT01498679|467907495|FG000|Overall Study|Withdrawal by Subject|12|||
129985098|NCT01498679|467907496|FG001|Overall Study|Withdrawal by Subject|4|||
129985099|NCT01844687|467907498|FG000|Visit 1|Protocol Violation|3|||
129985100|NCT01844687|467907498|FG000|Visit 1|Lost to Follow-up|5|||
129985101|NCT01844687|467907498|FG000|Visit 2|Withdrawal by Subject|1|||
129985102|NCT01844687|467907498|FG000|Visit 2|Protocol Violation|1|||
129985103|NCT01844687|467907498|FG000|Visit 3|Lost to Follow-up|1|||
129985104|NCT01844687|467907498|FG000|Visit 3|Withdrawal by Subject|3|||
129985105|NCT01844687|467907498|FG000|Visit 3|child care problems|1|||
129985106|NCT01844687|467907498|FG000|Visit 4|Pregnancy|1|||
129985107|NCT01844687|467907498|FG000|Visit 4|Lost to Follow-up|1|||
129985108|NCT01844687|467907498|FG000|Visit 4|Withdrawal by Subject|2|||
129985109|NCT00635427|467907505|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985110|NCT00635427|467907506|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985111|NCT00635427|467907507|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
129985112|NCT00635427|467907508|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985113|NCT00635427|467907509|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
129985114|NCT00635427|467907505|FG000|Overall Study|Death|0|||
129985115|NCT00635427|467907506|FG001|Overall Study|Death|0|||
129985116|NCT00635427|467907507|FG002|Overall Study|Death|0|||
129985117|NCT00635427|467907508|FG003|Overall Study|Death|1|||
129985118|NCT00635427|467907509|FG004|Overall Study|Death|0|||
129985119|NCT00635427|467907505|FG000|Overall Study|Termination Of Study By Sponsor|12|||
129985120|NCT00635427|467907506|FG001|Overall Study|Termination Of Study By Sponsor|6|||
129985121|NCT00635427|467907507|FG002|Overall Study|Termination Of Study By Sponsor|10|||
129985122|NCT00635427|467907508|FG003|Overall Study|Termination Of Study By Sponsor|6|||
129985123|NCT00635427|467907509|FG004|Overall Study|Termination Of Study By Sponsor|6|||
129985124|NCT00635427|467907505|FG000|Overall Study|Withdrawal Of Consent|0|||
129985125|NCT00635427|467907506|FG001|Overall Study|Withdrawal Of Consent|0|||
129985126|NCT00635427|467907507|FG002|Overall Study|Withdrawal Of Consent|0|||
129985127|NCT00635427|467907508|FG003|Overall Study|Withdrawal Of Consent|2|||
129985128|NCT00635427|467907509|FG004|Overall Study|Withdrawal Of Consent|2|||
129985129|NCT02706899|467907515|FG000|Overall Study|Withdrawal by Subject|1|||
129985130|NCT02706899|467907516|FG001|Overall Study|Withdrawal by Subject|0|||
129985131|NCT02706899|467907515|FG000|Overall Study|Death|8|||
129985132|NCT02706899|467907516|FG001|Overall Study|Death|0|||
129985133|NCT02706899|467907515|FG000|Overall Study|Study Termination by Sponsor|4|||
129985134|NCT02706899|467907516|FG001|Overall Study|Study Termination by Sponsor|6|||
129985135|NCT00324675|467907517|FG000|Overall Study|Adverse Event|1|||
129985136|NCT00324675|467907518|FG001|Overall Study|Adverse Event|0|||
129985137|NCT00735475|467907519|FG000|Overall Study|Adverse Event|0|||
129985138|NCT00735475|467907520|FG001|Overall Study|Adverse Event|1|||
129985139|NCT00735475|467907519|FG000|Overall Study|Death|1|||
129985140|NCT00735475|467907520|FG001|Overall Study|Death|1|||
129985141|NCT00735475|467907519|FG000|Overall Study|Lost to Follow-up|3|||
129985142|NCT00735475|467907520|FG001|Overall Study|Lost to Follow-up|3|||
129985143|NCT00735475|467907519|FG000|Overall Study|Physician Decision|0|||
129985144|NCT00735475|467907520|FG001|Overall Study|Physician Decision|1|||
129985145|NCT00735475|467907519|FG000|Overall Study|Withdrawal by Subject|4|||
129985146|NCT00735475|467907520|FG001|Overall Study|Withdrawal by Subject|5|||
129985147|NCT02442336|467907522|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
129985148|NCT02442336|467907522|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
129985149|NCT02442336|467907522|FG000|Overall Study|Lost to Follow-up|11|||
129985150|NCT00844532|467907524|FG000|Overall Study|Death|16|||
129985151|NCT00844532|467907524|FG000|Overall Study|Withdrawal by Subject|16|||
129985152|NCT00844532|467907524|FG000|Overall Study|Lost to Follow-up|7|||
129985153|NCT01080716|467907525|FG000|Part 1|Physician Decision|1|||
129985154|NCT01080716|467907526|FG001|Part 1|Physician Decision|0|||
129985155|NCT01080716|467907527|FG002|Part 1|Physician Decision|0|||
129985156|NCT01080716|467907528|FG003|Part 1|Physician Decision|0|||
129985157|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
129985158|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
129985159|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
129985160|NCT02270515|467907529|FG000|Intervention Period 1: 0-6 Months|Death|7|||
129985161|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
129985162|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
129985163|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
129985164|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Death|5|||
129985165|NCT02270515|467907529|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
129985166|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
129985167|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
129985168|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
129985169|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Death|3|||
129985170|NCT02270515|467907529|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
129985171|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
129985172|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
129985173|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
129985174|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
129985175|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
129985176|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
129985177|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
129985178|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
129985179|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
129985180|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
129985181|NCT01237587|467907532|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
129985182|NCT01237587|467907533|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
129985183|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
129985184|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
129985185|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
129985186|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
129985187|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
129985188|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
129985189|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
129985190|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
129985191|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
129985192|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
129985193|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
129985194|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
129985195|NCT01237587|467907532|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
129985196|NCT01237587|467907533|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
129985197|NCT01237587|467907532|FG000|Taper Phase|Adverse Event|0|||
129985198|NCT01237587|467907533|FG001|Taper Phase|Adverse Event|2|||
129985199|NCT01237587|467907532|FG000|Taper Phase|Protocol Violation|2|||
129985200|NCT01237587|467907533|FG001|Taper Phase|Protocol Violation|0|||
129985201|NCT01237587|467907532|FG000|Taper Phase|Lack of Efficacy|2|||
129985202|NCT01237587|467907533|FG001|Taper Phase|Lack of Efficacy|5|||
129985203|NCT01237587|467907532|FG000|Taper Phase|Parent/Guardian Decision|0|||
129985204|NCT01237587|467907533|FG001|Taper Phase|Parent/Guardian Decision|2|||
129985205|NCT01237587|467907532|FG000|Taper Phase|Sponsor Decision|1|||
129985206|NCT01237587|467907533|FG001|Taper Phase|Sponsor Decision|0|||
129985207|NCT01237587|467907532|FG000|Taper Phase|Withdrawal by Subject|0|||
129985208|NCT01237587|467907533|FG001|Taper Phase|Withdrawal by Subject|1|||
129985209|NCT00633880|467907538|FG000|Open Label Titration|Lack of Efficacy|1|||
129985210|NCT00633880|467907539|FG001|Open Label Titration|Lack of Efficacy|0|||
129985211|NCT00633880|467907540|FG002|Open Label Titration|Lack of Efficacy|0|||
129985212|NCT00633880|467907538|FG000|Open Label Titration|Adverse Event|13|||
129985213|NCT00633880|467907539|FG001|Open Label Titration|Adverse Event|0|||
129985214|NCT00633880|467907540|FG002|Open Label Titration|Adverse Event|0|||
129985215|NCT00633880|467907538|FG000|Open Label Titration|Treatment Failure|55|||
129985216|NCT00633880|467907539|FG001|Open Label Titration|Treatment Failure|0|||
129985217|NCT00633880|467907540|FG002|Open Label Titration|Treatment Failure|0|||
129985218|NCT00633880|467907538|FG000|Open Label Titration|Protocol Violation|6|||
129985219|NCT00633880|467907539|FG001|Open Label Titration|Protocol Violation|0|||
129985220|NCT00633880|467907540|FG002|Open Label Titration|Protocol Violation|0|||
129985221|NCT00633880|467907538|FG000|Open Label Titration|Physician Decision|1|||
129985222|NCT00633880|467907539|FG001|Open Label Titration|Physician Decision|0|||
129985223|NCT00633880|467907540|FG002|Open Label Titration|Physician Decision|0|||
129985224|NCT00633880|467907538|FG000|Open Label Titration|Withdrawal by Subject|4|||
129985225|NCT00633880|467907539|FG001|Open Label Titration|Withdrawal by Subject|0|||
129985226|NCT00633880|467907540|FG002|Open Label Titration|Withdrawal by Subject|0|||
129985227|NCT03208036|467907541|FG000|Baseline Assessment|Withdrawal by Subject|1|||
129985228|NCT03208036|467907542|FG001|Baseline Assessment|Withdrawal by Subject|1|||
129985229|NCT03208036|467907541|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
129985230|NCT03208036|467907542|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
129985231|NCT03208036|467907541|FG000|Intervention|Withdrawal by Subject|3|||
129985232|NCT03208036|467907542|FG001|Intervention|Withdrawal by Subject|2|||
129539739|NCT02985996|466268771|FG002|Overall Study|Withdrawal by Subject|1|||
129539740|NCT02985996|466268772|FG003|Overall Study|Withdrawal by Subject|0|||
129539741|NCT02985996|466268773|FG004|Overall Study|Withdrawal by Subject|0|||
129539742|NCT02985996|466268769|FG000|Overall Study|Protocol Violation|0|||
129539743|NCT02985996|466268770|FG001|Overall Study|Protocol Violation|1|||
129539744|NCT02985996|466268771|FG002|Overall Study|Protocol Violation|0|||
129539745|NCT02985996|466268772|FG003|Overall Study|Protocol Violation|0|||
129539746|NCT02985996|466268773|FG004|Overall Study|Protocol Violation|0|||
129539747|NCT00401726|466268774|FG000|Overall Study|Adverse Event|34|||
129539748|NCT00401726|466268775|FG001|Overall Study|Adverse Event|45|||
129539749|NCT00401726|466268774|FG000|Overall Study|Death|0|||
129539750|NCT00401726|466268775|FG001|Overall Study|Death|3|||
129539751|NCT00401726|466268774|FG000|Overall Study|Sponsor Request|0|||
129539752|NCT00401726|466268775|FG001|Overall Study|Sponsor Request|1|||
129539753|NCT00401726|466268774|FG000|Overall Study|Physician Decision|3|||
129539754|NCT00401726|466268775|FG001|Overall Study|Physician Decision|6|||
129539755|NCT00401726|466268774|FG000|Overall Study|Lost to Follow-up|23|||
129539756|NCT00401726|466268775|FG001|Overall Study|Lost to Follow-up|20|||
129539757|NCT00401726|466268774|FG000|Overall Study|Protocol Violation|6|||
129539758|NCT00401726|466268775|FG001|Overall Study|Protocol Violation|3|||
129985233|NCT03208036|467907541|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
129985234|NCT03208036|467907542|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
129985235|NCT01879553|467907544|FG000|Overall Study|Withdrawal by Subject|1|||
129985236|NCT01879553|467907545|FG001|Overall Study|Withdrawal by Subject|0|||
129985237|NCT00760474|467907554|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
129985238|NCT00760474|467907555|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
129985239|NCT00760474|467907554|FG000|Placebo Washout Period|Other|0|||
129539759|NCT00401726|466268774|FG000|Overall Study|Withdrawal by Subject|18|||
129539760|NCT00401726|466268775|FG001|Overall Study|Withdrawal by Subject|24|||
129539761|NCT00401726|466268774|FG000|Overall Study|Lack of Efficacy|4|||
129539762|NCT00401726|466268775|FG001|Overall Study|Lack of Efficacy|6|||
129539763|NCT00401726|466268774|FG000|Overall Study|Protocol Deviation|9|||
129539764|NCT00401726|466268775|FG001|Overall Study|Protocol Deviation|4|||
129985240|NCT00760474|467907555|FG001|Placebo Washout Period|Other|1|||
129985241|NCT00760474|467907554|FG000|Period 2 (P2)|Lost to Follow-up|1|||
129985242|NCT00760474|467907555|FG001|Period 2 (P2)|Lost to Follow-up|0|||
129985243|NCT00760474|467907554|FG000|Period 2 (P2)|Adverse Event|0|||
129985244|NCT00760474|467907555|FG001|Period 2 (P2)|Adverse Event|1|||
129539765|NCT00442572|466268776|FG000|Overall Study|Relapse|8|||
129539766|NCT00442572|466268777|FG001|Overall Study|Relapse|1|||
129539767|NCT00442572|466268776|FG000|Overall Study|Lost to Follow-up|0|||
129539768|NCT00442572|466268777|FG001|Overall Study|Lost to Follow-up|1|||
129539769|NCT00442572|466268776|FG000|Overall Study|Withdrawal by Subject|0|||
129539770|NCT00442572|466268777|FG001|Overall Study|Withdrawal by Subject|1|||
129539771|NCT01901393|466268778|FG000|Overall Study|Adverse Event|1|||
129539772|NCT01901393|466268779|FG001|Overall Study|Adverse Event|0|||
129539773|NCT04246593|466268781|FG000|Overall Study|Withdrawal by Subject|14|||
129539774|NCT04246593|466268782|FG001|Overall Study|Withdrawal by Subject|13|||
129539775|NCT04246593|466268781|FG000|Overall Study|Lost to Follow-up|124|||
129539776|NCT04246593|466268782|FG001|Overall Study|Lost to Follow-up|71|||
129539777|NCT04246593|466268781|FG000|Overall Study|Moved out of area/became ineligible|3|||
129539778|NCT04246593|466268782|FG001|Overall Study|Moved out of area/became ineligible|1|||
129539779|NCT04246593|466268781|FG000|Overall Study|Reason unknown|4|||
129539780|NCT04246593|466268782|FG001|Overall Study|Reason unknown|2|||
129985245|NCT02217501|467907561|FG000|Overall Study|Death|3|||
129985246|NCT02217501|467907562|FG001|Overall Study|Death|4|||
129985247|NCT00565851|467909190|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
129985248|NCT00565851|467909191|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
129985249|NCT00565851|467909192|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
129985250|NCT00565851|467909193|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
129985251|NCT00565851|467909194|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
129985252|NCT00565851|467909195|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
129985253|NCT00565851|467909196|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
129985254|NCT00565851|467909197|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
129985255|NCT00565851|467909190|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985256|NCT00565851|467909191|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
129985257|NCT00565851|467909192|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985258|NCT00565851|467909193|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
129985259|NCT00565851|467909194|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985260|NCT00565851|467909195|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
129985261|NCT00565851|467909196|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
129985262|NCT00565851|467909197|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
129985263|NCT00969709|467909202|FG000|Overall Study|Adverse Event|3|||
129985264|NCT00969709|467909203|FG001|Overall Study|Adverse Event|13|||
129985265|NCT00969709|467909204|FG002|Overall Study|Adverse Event|26|||
129985266|NCT00969709|467909205|FG003|Overall Study|Adverse Event|12|||
129985267|NCT00969709|467909202|FG000|Overall Study|Lack of Efficacy|7|||
129985268|NCT00969709|467909203|FG001|Overall Study|Lack of Efficacy|4|||
129985269|NCT00969709|467909204|FG002|Overall Study|Lack of Efficacy|1|||
129985270|NCT00969709|467909205|FG003|Overall Study|Lack of Efficacy|3|||
129985271|NCT00969709|467909202|FG000|Overall Study|Protocol Violation|9|||
129985272|NCT00969709|467909203|FG001|Overall Study|Protocol Violation|5|||
129985273|NCT00969709|467909204|FG002|Overall Study|Protocol Violation|9|||
129985274|NCT00969709|467909205|FG003|Overall Study|Protocol Violation|10|||
129985275|NCT00969709|467909202|FG000|Overall Study|Withdrawal by Subject|9|||
129985276|NCT00969709|467909203|FG001|Overall Study|Withdrawal by Subject|12|||
129985277|NCT00969709|467909204|FG002|Overall Study|Withdrawal by Subject|11|||
129985278|NCT00969709|467909205|FG003|Overall Study|Withdrawal by Subject|23|||
129985279|NCT00969709|467909202|FG000|Overall Study|Lost to Follow-up|10|||
129985280|NCT00969709|467909203|FG001|Overall Study|Lost to Follow-up|14|||
129985281|NCT00969709|467909204|FG002|Overall Study|Lost to Follow-up|8|||
129985282|NCT00969709|467909205|FG003|Overall Study|Lost to Follow-up|15|||
129985283|NCT00969709|467909202|FG000|Overall Study|Other reasons|0|||
129985284|NCT00969709|467909203|FG001|Overall Study|Other reasons|0|||
129985285|NCT00969709|467909204|FG002|Overall Study|Other reasons|3|||
129985286|NCT00969709|467909205|FG003|Overall Study|Other reasons|0|||
129985287|NCT03695237|467909206|FG000|Overall Study|Withdrawal by Subject|1|||
129985288|NCT03695237|467909207|FG001|Overall Study|Withdrawal by Subject|3|||
129985289|NCT03695237|467909206|FG000|Overall Study|Lost to Follow-up|1|||
129985290|NCT03695237|467909207|FG001|Overall Study|Lost to Follow-up|2|||
129985291|NCT03695237|467909206|FG000|Overall Study|Other, Not Specified|8|||
129985292|NCT03695237|467909207|FG001|Overall Study|Other, Not Specified|2|||
129985293|NCT01342341|467909210|FG000|Overall Study|Lost to Follow-up|4|||
129985294|NCT01342341|467909211|FG001|Overall Study|Lost to Follow-up|4|||
129985295|NCT01789567|467909212|FG000|Overall Study|Death|6|||
129539781|NCT02369874|466268784|FG000|Overall Study|Lost to Follow-up|2|||
129539782|NCT02369874|466268785|FG001|Overall Study|Lost to Follow-up|2|||
129985296|NCT00091169|467909213|FG000|Overall Study|Disease progression|3|||
129985297|NCT00091169|467909214|FG001|Overall Study|Disease progression|1|||
129985298|NCT00091169|467909213|FG000|Overall Study|Adverse Event|11|||
129985299|NCT00091169|467909214|FG001|Overall Study|Adverse Event|17|||
129985300|NCT00091169|467909213|FG000|Overall Study|Death|4|||
129985301|NCT00091169|467909214|FG001|Overall Study|Death|1|||
129985302|NCT00091169|467909213|FG000|Overall Study|Withdrawal by Subject|10|||
129985303|NCT00091169|467909214|FG001|Overall Study|Withdrawal by Subject|13|||
129985304|NCT00091169|467909213|FG000|Overall Study|Other|3|||
129985305|NCT00091169|467909214|FG001|Overall Study|Other|4|||
129985306|NCT00091169|467909213|FG000|Overall Study|Not start protocol therapy|26|||
129985307|NCT00091169|467909214|FG001|Overall Study|Not start protocol therapy|17|||
129985308|NCT00872989|467909215|FG000|Overall Study|Adverse Event|7|||
129985309|NCT00872989|467909216|FG001|Overall Study|Adverse Event|15|||
129985310|NCT00872989|467909215|FG000|Overall Study|Withdrawal by Subject|8|||
129985311|NCT00872989|467909216|FG001|Overall Study|Withdrawal by Subject|5|||
129985312|NCT00872989|467909215|FG000|Overall Study|Progression/relapse|47|||
129985313|NCT00872989|467909216|FG001|Overall Study|Progression/relapse|35|||
129985314|NCT00872989|467909215|FG000|Overall Study|Not protocol specified|3|||
129985315|NCT00872989|467909216|FG001|Overall Study|Not protocol specified|8|||
129985316|NCT00266227|467909219|FG000|Initial Treatment|Adverse Event|0|||
129985317|NCT00266227|467909220|FG001|Initial Treatment|Adverse Event|0|||
129985318|NCT00266227|467909221|FG002|Initial Treatment|Adverse Event|13|||
129985319|NCT00266227|467909219|FG000|Initial Treatment|Lost to Follow-up|0|||
129985320|NCT00266227|467909220|FG001|Initial Treatment|Lost to Follow-up|0|||
129985321|NCT00266227|467909221|FG002|Initial Treatment|Lost to Follow-up|6|||
129985322|NCT00266227|467909219|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
129985323|NCT00266227|467909220|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
129985324|NCT00266227|467909221|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
129985325|NCT00266227|467909219|FG000|Initial Treatment|Physician decision to withdraw|0|||
129985326|NCT00266227|467909220|FG001|Initial Treatment|Physician decision to withdraw|0|||
129985327|NCT00266227|467909221|FG002|Initial Treatment|Physician decision to withdraw|12|||
129985328|NCT00266227|467909219|FG000|Initial Treatment|Pregnancy|0|||
129985329|NCT00266227|467909220|FG001|Initial Treatment|Pregnancy|0|||
129985330|NCT00266227|467909221|FG002|Initial Treatment|Pregnancy|1|||
129985331|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Death|1|||
129985332|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Death|0|||
129985333|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Death|0|||
129985334|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
129985335|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
129985336|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
129985337|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
129985338|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
129985339|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
129985340|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
129985341|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
129985342|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
129985343|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
129985344|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
129985345|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
129985346|NCT00266227|467909219|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
129985347|NCT00266227|467909220|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
129985348|NCT00266227|467909221|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
129985349|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Death|1|||
129985350|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Death|1|||
129985351|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Death|0|||
129985352|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
129985353|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
129985354|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
129985355|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
129985356|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
129985357|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
129985358|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
129985359|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
129985360|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
129985361|NCT00266227|467909219|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
129985362|NCT00266227|467909220|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
129985363|NCT00266227|467909221|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
129985364|NCT03725085|467909226|FG000|Overall Study|Lost to Follow-up|2|||
129985365|NCT02245737|467909228|FG000|Overall Study|Adverse Event|23|||
129985366|NCT02245737|467909229|FG001|Overall Study|Adverse Event|26|||
129985367|NCT02245737|467909230|FG002|Overall Study|Adverse Event|33|||
129985368|NCT02245737|467909228|FG000|Overall Study|Condition Worsened|9|||
129985369|NCT02245737|467909229|FG001|Overall Study|Condition Worsened|10|||
129985370|NCT02245737|467909230|FG002|Overall Study|Condition Worsened|9|||
129985371|NCT02245737|467909228|FG000|Overall Study|Death|2|||
129985372|NCT02245737|467909229|FG001|Overall Study|Death|4|||
129985373|NCT02245737|467909230|FG002|Overall Study|Death|4|||
129985374|NCT02245737|467909228|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
129985375|NCT02245737|467909229|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
129985376|NCT02245737|467909230|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
129985377|NCT02245737|467909228|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
129985378|NCT02245737|467909229|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
129985379|NCT02245737|467909230|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
129985380|NCT02245737|467909228|FG000|Overall Study|Lost to Follow-up|2|||
129985381|NCT02245737|467909229|FG001|Overall Study|Lost to Follow-up|5|||
129985382|NCT02245737|467909230|FG002|Overall Study|Lost to Follow-up|4|||
129985383|NCT02245737|467909228|FG000|Overall Study|Other-determined by Investigator|9|||
129985384|NCT02245737|467909229|FG001|Overall Study|Other-determined by Investigator|10|||
129985385|NCT02245737|467909230|FG002|Overall Study|Other-determined by Investigator|10|||
129985386|NCT02245737|467909228|FG000|Overall Study|Physician Decision|6|||
129985387|NCT02245737|467909229|FG001|Overall Study|Physician Decision|3|||
129985388|NCT02245737|467909230|FG002|Overall Study|Physician Decision|6|||
129985389|NCT02245737|467909228|FG000|Overall Study|Protocol Violation|3|||
129985390|NCT02245737|467909229|FG001|Overall Study|Protocol Violation|2|||
129985391|NCT02245737|467909230|FG002|Overall Study|Protocol Violation|3|||
129985392|NCT02245737|467909228|FG000|Overall Study|Withdrawal by Subject|40|||
129985393|NCT02245737|467909229|FG001|Overall Study|Withdrawal by Subject|41|||
129985394|NCT02245737|467909230|FG002|Overall Study|Withdrawal by Subject|44|||
129985395|NCT02245737|467909228|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
129985396|NCT02245737|467909229|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
129985397|NCT02245737|467909230|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
129985398|NCT02245737|467909228|FG000|Overall Study|Sponsor Decision|445|||
129985399|NCT02245737|467909229|FG001|Overall Study|Sponsor Decision|430|||
129985400|NCT02245737|467909230|FG002|Overall Study|Sponsor Decision|432|||
129985401|NCT01552603|467909232|FG000|Overall Study|Physician Decision|1|||
129985402|NCT00446043|467909237|FG000|Overall Study|Adverse Event|9|||
129985403|NCT00446043|467909237|FG000|Overall Study|Withdrawal by Subject|70|||
129985404|NCT00446043|467909237|FG000|Overall Study|Protocol Violation|2|||
129985405|NCT00446043|467909237|FG000|Overall Study|Lost to Follow-up|42|||
129985406|NCT00446043|467909237|FG000|Overall Study|Pregnancy|2|||
129985407|NCT01983254|467909243|FG000|Overall Study|Death|6|||
129985408|NCT01983254|467909244|FG001|Overall Study|Death|6|||
129985409|NCT01983254|467909243|FG000|Overall Study|Lost to Follow-up|17|||
129985410|NCT01983254|467909244|FG001|Overall Study|Lost to Follow-up|16|||
129985411|NCT01983254|467909243|FG000|Overall Study|too ill|11|||
129985412|NCT01983254|467909244|FG001|Overall Study|too ill|8|||
129985413|NCT04988867|467909249|FG000|Overall Study|Study terminated by Sponsor|12|||
129985414|NCT04988867|467909249|FG000|Overall Study|Adverse Event|2|||
129985415|NCT04988867|467909249|FG000|Overall Study|Study drug noncompliance|1|||
129985416|NCT01699503|467909252|FG000|Overall Study|Death|31|||
129985417|NCT01699503|467909253|FG001|Overall Study|Death|40|||
129985418|NCT01699503|467909252|FG000|Overall Study|Withdrawal by Subject|65|||
129985419|NCT01699503|467909253|FG001|Overall Study|Withdrawal by Subject|57|||
129985420|NCT01699503|467909252|FG000|Overall Study|Lost to Follow-up|121|||
129985421|NCT01699503|467909253|FG001|Overall Study|Lost to Follow-up|117|||
129985422|NCT01699503|467909252|FG000|Overall Study|Excluded due to quality|783|||
129985423|NCT01699503|467909253|FG001|Overall Study|Excluded due to quality|791|||
129985424|NCT01631227|467909259|FG000|Overall Study|withdrawn consent|27|||
129985425|NCT01631227|467909260|FG001|Overall Study|withdrawn consent|21|||
129985426|NCT01631227|467909259|FG000|Overall Study|Adverse Event|1|||
129985427|NCT01631227|467909260|FG001|Overall Study|Adverse Event|0|||
129985428|NCT01631227|467909259|FG000|Overall Study|administrative|2|||
129985429|NCT01631227|467909260|FG001|Overall Study|administrative|1|||
129985430|NCT00768079|467909263|FG000|Overall Study|Lost to Follow-up|2|||
129985431|NCT00768079|467909264|FG001|Overall Study|Lost to Follow-up|0|||
129985432|NCT00768079|467909265|FG002|Overall Study|Lost to Follow-up|4|||
129985433|NCT00768079|467909263|FG000|Overall Study|Participant incarcerated|0|||
129985434|NCT00768079|467909264|FG001|Overall Study|Participant incarcerated|1|||
129985435|NCT00768079|467909265|FG002|Overall Study|Participant incarcerated|0|||
129985436|NCT01097707|467909266|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129762038|NCT04059549|467091398|FG001|Overall Study|Withdrawal by Subject|0|||
129985437|NCT01097707|467909267|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129985438|NCT01097707|467909268|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129985439|NCT01097707|467909269|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129985440|NCT01097707|467909270|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129985441|NCT01097707|467909266|FG000|Overall Study|Adverse Event|4|||
129985442|NCT01097707|467909267|FG001|Overall Study|Adverse Event|2|||
129985443|NCT01097707|467909268|FG002|Overall Study|Adverse Event|3|||
129985444|NCT01097707|467909269|FG003|Overall Study|Adverse Event|1|||
129985445|NCT01097707|467909270|FG004|Overall Study|Adverse Event|3|||
129985446|NCT01097707|467909266|FG000|Overall Study|Entry Criteria Not Met|2|||
129985447|NCT01097707|467909267|FG001|Overall Study|Entry Criteria Not Met|1|||
129985448|NCT01097707|467909268|FG002|Overall Study|Entry Criteria Not Met|1|||
129985449|NCT01097707|467909269|FG003|Overall Study|Entry Criteria Not Met|0|||
129985450|NCT01097707|467909270|FG004|Overall Study|Entry Criteria Not Met|1|||
129985451|NCT01097707|467909266|FG000|Overall Study|Lack of Efficacy|1|||
129985452|NCT01097707|467909267|FG001|Overall Study|Lack of Efficacy|0|||
129985453|NCT01097707|467909268|FG002|Overall Study|Lack of Efficacy|0|||
129985454|NCT01097707|467909269|FG003|Overall Study|Lack of Efficacy|1|||
129985455|NCT01097707|467909270|FG004|Overall Study|Lack of Efficacy|0|||
129985456|NCT01097707|467909266|FG000|Overall Study|Lost to Follow-up|1|||
129985457|NCT01097707|467909267|FG001|Overall Study|Lost to Follow-up|1|||
129985458|NCT01097707|467909268|FG002|Overall Study|Lost to Follow-up|2|||
129985459|NCT01097707|467909269|FG003|Overall Study|Lost to Follow-up|0|||
129985460|NCT01097707|467909270|FG004|Overall Study|Lost to Follow-up|3|||
129985461|NCT01097707|467909266|FG000|Overall Study|Protocol Violation|2|||
129985462|NCT01097707|467909267|FG001|Overall Study|Protocol Violation|2|||
129985463|NCT01097707|467909268|FG002|Overall Study|Protocol Violation|3|||
129985464|NCT01097707|467909269|FG003|Overall Study|Protocol Violation|2|||
129985465|NCT01097707|467909270|FG004|Overall Study|Protocol Violation|2|||
129985466|NCT01097707|467909266|FG000|Overall Study|Sponsor Decision|31|||
129985467|NCT01097707|467909267|FG001|Overall Study|Sponsor Decision|31|||
129985468|NCT01097707|467909268|FG002|Overall Study|Sponsor Decision|34|||
129985469|NCT01097707|467909269|FG003|Overall Study|Sponsor Decision|35|||
129985470|NCT01097707|467909270|FG004|Overall Study|Sponsor Decision|36|||
129985471|NCT01097707|467909266|FG000|Overall Study|Withdrawal by Subject|3|||
129985472|NCT01097707|467909267|FG001|Overall Study|Withdrawal by Subject|6|||
129985473|NCT01097707|467909268|FG002|Overall Study|Withdrawal by Subject|1|||
129985474|NCT01097707|467909269|FG003|Overall Study|Withdrawal by Subject|4|||
129985475|NCT01097707|467909270|FG004|Overall Study|Withdrawal by Subject|3|||
129985476|NCT01097707|467909266|FG000|Overall Study|Reason unknown|0|||
129985477|NCT01097707|467909267|FG001|Overall Study|Reason unknown|0|||
129985478|NCT01097707|467909268|FG002|Overall Study|Reason unknown|0|||
129985479|NCT01097707|467909269|FG003|Overall Study|Reason unknown|0|||
129985480|NCT01097707|467909270|FG004|Overall Study|Reason unknown|1|||
129985481|NCT02207569|467909272|FG000|1-Month|Death|6|||
129985482|NCT02207569|467909272|FG000|1-Month|Withdrawal by Subject|2|||
129985483|NCT02207569|467909272|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
129985484|NCT02207569|467909272|FG000|6-Month|Death|8|||
129985485|NCT02207569|467909272|FG000|6-Month|Withdrawal by Subject|2|||
129985486|NCT02207569|467909272|FG000|12-Month|Death|14|||
129985487|NCT02207569|467909272|FG000|12-Month|Withdrawal by Subject|2|||
129985488|NCT02207569|467909272|FG000|24-Month|Death|23|||
129985489|NCT02207569|467909272|FG000|24-Month|Withdrawal by Subject|3|||
129985490|NCT02207569|467909272|FG000|36-Month|Death|23|||
129985491|NCT02207569|467909272|FG000|36-Month|Withdrawal by Subject|4|||
129985492|NCT02207569|467909272|FG000|48-Month|Death|25|||
129985493|NCT02207569|467909272|FG000|48-Month|Withdrawal by Subject|2|||
129985494|NCT02207569|467909272|FG000|48-Month|Lost to Follow-up|4|||
129985495|NCT02207569|467909272|FG000|60-Month|Death|1|||
129985496|NCT02207569|467909272|FG000|60-Month|Lost to Follow-up|1|||
129985497|NCT02207569|467909272|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
129985498|NCT02207569|467909272|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
129985499|NCT01236534|467909273|FG000|Overall Study|Adverse Event|3|||
129985500|NCT01236534|467909274|FG001|Overall Study|Adverse Event|0|||
129985501|NCT05383508|467909283|FG000|Overall Study|Withdrawal by Subject|1|||
129985502|NCT05383508|467909284|FG001|Overall Study|Withdrawal by Subject|0|||
129985503|NCT05383508|467909285|FG002|Overall Study|Withdrawal by Subject|1|||
129985504|NCT05383508|467909286|FG003|Overall Study|Withdrawal by Subject|1|||
129985505|NCT05383508|467909287|FG004|Overall Study|Withdrawal by Subject|2|||
129985506|NCT05383508|467909288|FG005|Overall Study|Withdrawal by Subject|0|||
129985507|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
129762039|NCT02678351|467091400|FG000|Overall Study|Withdrawal by Subject|1|||
129985508|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
129985509|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
129985510|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
129985511|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
129985512|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
129985513|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
129985514|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
129985515|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
129985516|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
129985517|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
129985518|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
129985519|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
129985520|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
129985521|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
129985522|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
129985523|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
129985524|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
129985525|NCT03412747|467909291|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
129985526|NCT03412747|467909292|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
129985527|NCT03412747|467909293|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
129985528|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
129985529|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
129985530|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
129985531|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
129985532|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
129985533|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
129985534|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
129985535|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
129985536|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
129985537|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
129985538|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
129985539|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
129985540|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
129985541|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
129985542|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
129985543|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
129985544|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
129985545|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
129443570|NCT00867113|465924427|FG000|Treatment Period|Withdrawal by Subject|19|||
129443571|NCT00867113|465924427|FG000|Treatment Period|Lost to Follow-up|3|||
129443572|NCT00867113|465924427|FG000|Treatment Period|Administrative problems|1|||
129443573|NCT00867113|465924427|FG000|Treatment Period|Disease progression/relapse|1|||
129443574|NCT00867113|465924427|FG000|Treatment Period|Protocol Violation|4|||
129443575|NCT00867113|465924427|FG000|Post Treatment After Survival Follow-up|Death|1|||
129443576|NCT00867113|465924427|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
129443577|NCT00867113|465924427|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
129443578|NCT00867113|465924427|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
129443579|NCT01886313|465924428|FG000|Overall Study|Adverse Event|1|||
129443580|NCT01886313|465924429|FG001|Overall Study|Adverse Event|1|||
129443581|NCT02066051|465924430|FG000|Overall Study|Subject developed active GVHD|1|||
129443582|NCT01610687|465924431|FG000|Overall Study|Lack of Efficacy|26|||
129443583|NCT01610687|465924431|FG000|Overall Study|Adverse Event|18|||
129443584|NCT01610687|465924431|FG000|Overall Study|Moved out of area|6|||
129443585|NCT01610687|465924431|FG000|Overall Study|Withdrawal by Subject|7|||
129443586|NCT01610687|465924431|FG000|Overall Study|Lost to Follow-up|4|||
129443587|NCT01610687|465924431|FG000|Overall Study|Symptom control without study medication|2|||
129443588|NCT01610687|465924431|FG000|Overall Study|Unable to make journey|1|||
129443589|NCT01610687|465924431|FG000|Overall Study|Death|1|||
129443590|NCT01610687|465924431|FG000|Overall Study|Cannabis affecting job|1|||
129443591|NCT01610687|465924431|FG000|Overall Study|Felt more alter without study medication|1|||
129443592|NCT02430051|465924432|FG000|Overall Study|Withdrawal by Subject|6|||
129443593|NCT02430051|465924433|FG001|Overall Study|Withdrawal by Subject|3|||
129443594|NCT02430051|465924432|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
129443595|NCT02430051|465924433|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
129443596|NCT02430051|465924432|FG000|Overall Study|Protocol Violation|1|||
129443597|NCT02430051|465924433|FG001|Overall Study|Protocol Violation|0|||
129443598|NCT02019420|465924434|FG000|Overall Study|Did not receive study drug|2|||
129443599|NCT02019420|465924435|FG001|Overall Study|Did not receive study drug|2|||
129443600|NCT02019420|465924434|FG000|Overall Study|Withdrawal by Subject|1|||
129443601|NCT02019420|465924435|FG001|Overall Study|Withdrawal by Subject|3|||
129443602|NCT02019420|465924434|FG000|Overall Study|At request of sponsor or investigator|0|||
129443603|NCT02019420|465924435|FG001|Overall Study|At request of sponsor or investigator|1|||
129443604|NCT02019420|465924434|FG000|Overall Study|Death|104|||
129443605|NCT02019420|465924435|FG001|Overall Study|Death|99|||
129443606|NCT02019420|465924434|FG000|Overall Study|Transferred to other care facility|1|||
129443607|NCT02019420|465924435|FG001|Overall Study|Transferred to other care facility|1|||
129443608|NCT01093625|465924436|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
129443609|NCT01093625|465924437|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
129443610|NCT01093625|465924436|FG000|2-Week Visit|Withdrawal by Subject|1|||
129443611|NCT01093625|465924437|FG001|2-Week Visit|Withdrawal by Subject|0|||
129443612|NCT01093625|465924436|FG000|1-Month Visit|Lost to Follow-up|2|||
129443613|NCT01093625|465924437|FG001|1-Month Visit|Lost to Follow-up|0|||
129443614|NCT01093625|465924436|FG000|3-Month Visit|Lost to Follow-up|2|||
129443615|NCT01093625|465924437|FG001|3-Month Visit|Lost to Follow-up|0|||
129443616|NCT01093625|465924436|FG000|6-Month Visit|Withdrawal by Subject|6|||
129985546|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
129985547|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
129985548|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
129985549|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
129985550|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
129985551|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
129985552|NCT03412747|467909291|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
129985553|NCT03412747|467909292|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
129985554|NCT03412747|467909293|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
129985555|NCT02081417|467909294|FG000|Overall Study|Lost to Follow-up|26|||
129985556|NCT02081417|467909295|FG001|Overall Study|Lost to Follow-up|23|||
129539783|NCT02369874|466268786|FG002|Overall Study|Lost to Follow-up|2|||
129539784|NCT02369874|466268784|FG000|Overall Study|Withdrawal by Subject|7|||
129539785|NCT02369874|466268785|FG001|Overall Study|Withdrawal by Subject|9|||
129539786|NCT02369874|466268786|FG002|Overall Study|Withdrawal by Subject|27|||
129539787|NCT02369874|466268784|FG000|Overall Study|Miscellaneous|1|||
129539788|NCT02369874|466268785|FG001|Overall Study|Miscellaneous|1|||
129539789|NCT02369874|466268786|FG002|Overall Study|Miscellaneous|0|||
129539790|NCT02369874|466268784|FG000|Overall Study|On Treatment/Off Study|34|||
129539791|NCT02369874|466268785|FG001|Overall Study|On Treatment/Off Study|45|||
129539792|NCT02369874|466268786|FG002|Overall Study|On Treatment/Off Study|32|||
129539793|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
129539794|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
129539795|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
129539796|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
129539797|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
129539798|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Death|1|||
129539799|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Death|0|||
129539800|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Death|0|||
129539801|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Death|0|||
129539802|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Death|0|||
129539803|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
129539804|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
129539805|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
129539806|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
129539807|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
129539808|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
129539809|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
129539810|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
129985557|NCT02081417|467909294|FG000|Overall Study|Moved Away|1|||
129539811|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
129539812|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
129539813|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
129539814|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
129539815|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
129539816|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
129539817|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
129539818|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
129539819|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
129539820|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
129539821|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
129539822|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
129539823|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
129539824|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
129539825|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
129539826|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
129539827|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
129539828|NCT00634933|466268789|FG000|Part A: Baseline to Week 24|Other|1|||
129539829|NCT00634933|466268790|FG001|Part A: Baseline to Week 24|Other|8|||
129539830|NCT00634933|466268791|FG002|Part A: Baseline to Week 24|Other|5|||
129539831|NCT00634933|466268792|FG003|Part A: Baseline to Week 24|Other|0|||
129539832|NCT00634933|466268793|FG004|Part A: Baseline to Week 24|Other|0|||
129539833|NCT00634933|466268789|FG000|Between Part A and Part B|Physician Decision|0|||
129539834|NCT00634933|466268790|FG001|Between Part A and Part B|Physician Decision|1|||
129539835|NCT00634933|466268791|FG002|Between Part A and Part B|Physician Decision|0|||
129539836|NCT00634933|466268792|FG003|Between Part A and Part B|Physician Decision|0|||
129539837|NCT00634933|466268793|FG004|Between Part A and Part B|Physician Decision|0|||
129539838|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
129539839|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
129539840|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
129985558|NCT02081417|467909295|FG001|Overall Study|Moved Away|2|||
129539841|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
129985559|NCT02081417|467909294|FG000|Overall Study|Incarcerated|2|||
129985560|NCT02081417|467909295|FG001|Overall Study|Incarcerated|2|||
129985561|NCT02081417|467909294|FG000|Overall Study|Death|4|||
129985562|NCT02081417|467909295|FG001|Overall Study|Death|3|||
129985563|NCT02081417|467909294|FG000|Overall Study|Withdrawal by Subject|4|||
129985564|NCT02081417|467909295|FG001|Overall Study|Withdrawal by Subject|0|||
129985565|NCT02081417|467909294|FG000|Overall Study|Admitted to Residential Treatment|2|||
129985566|NCT02081417|467909295|FG001|Overall Study|Admitted to Residential Treatment|0|||
129985567|NCT02081417|467909294|FG000|Overall Study|Did not start treatment|17|||
129985568|NCT02081417|467909295|FG001|Overall Study|Did not start treatment|21|||
129985569|NCT01157676|467909298|FG000|Randomization|Death|1|||
129985570|NCT01157676|467909299|FG001|Randomization|Death|1|||
129985571|NCT01157676|467909298|FG000|Randomization|unresectable|2|||
129985572|NCT01157676|467909299|FG001|Randomization|unresectable|3|||
129985573|NCT01157676|467909298|FG000|Randomization|Withdrawal by Subject|17|||
129985574|NCT01157676|467909299|FG001|Randomization|Withdrawal by Subject|13|||
129985575|NCT01157676|467909298|FG000|Randomization|Physician Decision|1|||
129985576|NCT01157676|467909299|FG001|Randomization|Physician Decision|0|||
129985577|NCT01157676|467909298|FG000|Surgery|underwent open cystectomy|0|||
129985578|NCT01157676|467909299|FG001|Surgery|underwent open cystectomy|4|||
129985579|NCT01157676|467909298|FG000|Surgery|converted to open procedure|0|||
129985580|NCT01157676|467909299|FG001|Surgery|converted to open procedure|5|||
129985581|NCT01157676|467909298|FG000|Surgery|underwent robotic cystectomy|1|||
129985582|NCT01157676|467909299|FG001|Surgery|underwent robotic cystectomy|0|||
129985583|NCT00468104|467909303|FG000|First Intervention|Protocol Violation|2|||
129985584|NCT00468104|467909304|FG001|First Intervention|Protocol Violation|1|||
129985585|NCT00468104|467909303|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
129985586|NCT00468104|467909304|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
129985587|NCT00468104|467909303|FG000|First Intervention|died within 3 weeks|1|||
129985588|NCT00468104|467909304|FG001|First Intervention|died within 3 weeks|0|||
129985589|NCT00468104|467909303|FG000|First Intervention|malposition/blocked chest tube tube|2|||
129985590|NCT00468104|467909304|FG001|First Intervention|malposition/blocked chest tube tube|0|||
129985591|NCT00468104|467909303|FG000|First Intervention|large lung mass with minimal effusion|1|||
129985592|NCT00468104|467909304|FG001|First Intervention|large lung mass with minimal effusion|0|||
129985593|NCT00468104|467909303|FG000|First Intervention|associated prolonged pneumothorax|1|||
129985594|NCT00468104|467909304|FG001|First Intervention|associated prolonged pneumothorax|0|||
129985595|NCT00468104|467909303|FG000|First Intervention|trapped lung|1|||
129985596|NCT00468104|467909304|FG001|First Intervention|trapped lung|0|||
129985597|NCT00468104|467909303|FG000|Second Intervention|Withdrawal by Subject|5|||
129985598|NCT00468104|467909304|FG001|Second Intervention|Withdrawal by Subject|2|||
129985599|NCT00468104|467909303|FG000|Second Intervention|discarded for malposition of chest tube|0|||
129985600|NCT00468104|467909304|FG001|Second Intervention|discarded for malposition of chest tube|2|||
129985601|NCT01263665|467909305|FG000|Overall Study|Withdrew Consent|1|||
129985602|NCT01263665|467909305|FG000|Overall Study|Lost to Follow-up|3|||
129985603|NCT01263665|467909305|FG000|Overall Study|Death|2|||
129985604|NCT01263665|467909305|FG000|Overall Study|Amputation above the ankle|1|||
129539842|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
129539843|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
129985605|NCT01263665|467909305|FG000|Overall Study|Surgical Bypass|2|||
129985606|NCT00381615|467909308|FG000|Overall Study|Withdrawal by Subject|1|||
129985607|NCT00381615|467909309|FG001|Overall Study|Withdrawal by Subject|3|||
129985608|NCT00381615|467909310|FG002|Overall Study|Withdrawal by Subject|0|||
129985609|NCT00381615|467909311|FG003|Overall Study|Withdrawal by Subject|1|||
129985610|NCT00381615|467909308|FG000|Overall Study|Lost to Follow-up|3|||
129985611|NCT00381615|467909309|FG001|Overall Study|Lost to Follow-up|2|||
129985612|NCT00381615|467909310|FG002|Overall Study|Lost to Follow-up|0|||
129985613|NCT00381615|467909311|FG003|Overall Study|Lost to Follow-up|1|||
129985614|NCT00381615|467909308|FG000|Overall Study|Protocol Violation|0|||
129985615|NCT00381615|467909309|FG001|Overall Study|Protocol Violation|0|||
129985616|NCT00381615|467909310|FG002|Overall Study|Protocol Violation|1|||
129985617|NCT00381615|467909311|FG003|Overall Study|Protocol Violation|0|||
129985618|NCT01801735|467909316|FG000|Overall Study|Adverse Event|79|||
129985619|NCT01801735|467909316|FG000|Overall Study|Lack of Efficacy|28|||
129985620|NCT01801735|467909316|FG000|Overall Study|Withdrawal by Subject|27|||
129985621|NCT01801735|467909316|FG000|Overall Study|Protocol Violation|25|||
129985622|NCT01801735|467909316|FG000|Overall Study|Lost to Follow-up|15|||
129985623|NCT01801735|467909316|FG000|Overall Study|Non-compliance with Trial Drug|13|||
129985624|NCT01801735|467909316|FG000|Overall Study|Physician Decision|3|||
129985625|NCT01801735|467909316|FG000|Overall Study|Death|1|||
129985626|NCT01801735|467909316|FG000|Overall Study|Other, including site closure|19|||
129985627|NCT01435616|467909317|FG000|Overall Study|Adverse Event|39|||
129985628|NCT01435616|467909318|FG001|Overall Study|Adverse Event|21|||
129985629|NCT01435616|467909317|FG000|Overall Study|Death|7|||
129985630|NCT01435616|467909318|FG001|Overall Study|Death|2|||
129985631|NCT01435616|467909317|FG000|Overall Study|Lost to Follow-up|22|||
129985632|NCT01435616|467909318|FG001|Overall Study|Lost to Follow-up|13|||
129985633|NCT01435616|467909317|FG000|Overall Study|Protocol Violation|16|||
129985634|NCT01435616|467909318|FG001|Overall Study|Protocol Violation|13|||
129985635|NCT01435616|467909317|FG000|Overall Study|Withdrawal by Subject|66|||
129985636|NCT01435616|467909318|FG001|Overall Study|Withdrawal by Subject|24|||
129985637|NCT01435616|467909317|FG000|Overall Study|Physician Decision|20|||
129539844|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
129539845|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
129539846|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
129539847|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
129539848|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
129539849|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
129539850|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
129539851|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
129539852|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
129539853|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
129539854|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
129539855|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
129539856|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
129539857|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
129539858|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
129539859|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
129539860|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
129539861|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
129539862|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
129539863|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
129539864|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
129539865|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
129539866|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
129539867|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
129539868|NCT00634933|466268789|FG000|Part B: Week 24 to Week 52|Other|0|||
129539869|NCT00634933|466268790|FG001|Part B: Week 24 to Week 52|Other|0|||
129539870|NCT00634933|466268791|FG002|Part B: Week 24 to Week 52|Other|5|||
129539871|NCT00634933|466268792|FG003|Part B: Week 24 to Week 52|Other|0|||
129539872|NCT00634933|466268793|FG004|Part B: Week 24 to Week 52|Other|1|||
129539873|NCT02058849|466268794|FG000|Overall Study|Hospitalization|1|||
129539874|NCT02058849|466268795|FG001|Overall Study|Hospitalization|1|||
129539875|NCT02058849|466268794|FG000|Overall Study|Death|1|||
129539876|NCT02058849|466268795|FG001|Overall Study|Death|0|||
129539877|NCT02058849|466268794|FG000|Overall Study|Lost to Follow-up|1|||
129874991|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
129539878|NCT02058849|466268795|FG001|Overall Study|Lost to Follow-up|0|||
129539879|NCT02058849|466268794|FG000|Overall Study|Withdrawal by Subject|4|||
129651110|NCT00195494|466678595|FG005|Year 2|Physician Decision|0|||
129651111|NCT00195494|466678590|FG000|Year 2|Withdrawal by Subject|1|||
129539880|NCT02058849|466268795|FG001|Overall Study|Withdrawal by Subject|0|||
129539881|NCT01049360|466268796|FG000|Period 1|Adverse Event|0|||
129539882|NCT01049360|466268797|FG001|Period 1|Adverse Event|1|||
129539883|NCT01049360|466268798|FG002|Period 1|Adverse Event|0|||
129539884|NCT01049360|466268799|FG003|Period 1|Adverse Event|1|||
129539885|NCT01049360|466268800|FG004|Period 1|Adverse Event|0|||
129539886|NCT01049360|466268801|FG005|Period 1|Adverse Event|0|||
129539887|NCT01049360|466268802|FG006|Period 1|Adverse Event|0|||
129539888|NCT01049360|466268803|FG007|Period 1|Adverse Event|1|||
129539889|NCT01049360|466268804|FG008|Period 1|Adverse Event|0|||
129539890|NCT01049360|466268805|FG009|Period 1|Adverse Event|0|||
129539891|NCT01049360|466268806|FG010|Period 1|Adverse Event|0|||
129539892|NCT01049360|466268807|FG011|Period 1|Adverse Event|0|||
129539893|NCT01049360|466268808|FG012|Period 1|Adverse Event|1|||
129539894|NCT01049360|466268809|FG013|Period 1|Adverse Event|1|||
129539895|NCT01049360|466268810|FG014|Period 1|Adverse Event|0|||
129539896|NCT01049360|466268811|FG015|Period 1|Adverse Event|0|||
129539897|NCT01049360|466268812|FG016|Period 1|Adverse Event|1|||
129539898|NCT01049360|466268813|FG017|Period 1|Adverse Event|0|||
129539899|NCT01049360|466268814|FG018|Period 1|Adverse Event|1|||
129539900|NCT01049360|466268815|FG019|Period 1|Adverse Event|0|||
129539901|NCT01049360|466268796|FG000|Period 1|Did not meet inc/exc criteria|0|||
129539902|NCT01049360|466268797|FG001|Period 1|Did not meet inc/exc criteria|0|||
129539903|NCT01049360|466268798|FG002|Period 1|Did not meet inc/exc criteria|0|||
129539904|NCT01049360|466268799|FG003|Period 1|Did not meet inc/exc criteria|0|||
129539905|NCT01049360|466268800|FG004|Period 1|Did not meet inc/exc criteria|0|||
129539906|NCT01049360|466268801|FG005|Period 1|Did not meet inc/exc criteria|0|||
129539907|NCT01049360|466268802|FG006|Period 1|Did not meet inc/exc criteria|0|||
129539908|NCT01049360|466268803|FG007|Period 1|Did not meet inc/exc criteria|1|||
129539909|NCT01049360|466268804|FG008|Period 1|Did not meet inc/exc criteria|1|||
129539910|NCT01049360|466268805|FG009|Period 1|Did not meet inc/exc criteria|0|||
129539911|NCT01049360|466268806|FG010|Period 1|Did not meet inc/exc criteria|0|||
129539912|NCT01049360|466268807|FG011|Period 1|Did not meet inc/exc criteria|0|||
129539913|NCT01049360|466268808|FG012|Period 1|Did not meet inc/exc criteria|0|||
129539914|NCT01049360|466268809|FG013|Period 1|Did not meet inc/exc criteria|0|||
129539915|NCT01049360|466268810|FG014|Period 1|Did not meet inc/exc criteria|0|||
129539916|NCT01049360|466268811|FG015|Period 1|Did not meet inc/exc criteria|0|||
129539917|NCT01049360|466268812|FG016|Period 1|Did not meet inc/exc criteria|0|||
129539918|NCT01049360|466268813|FG017|Period 1|Did not meet inc/exc criteria|0|||
129539919|NCT01049360|466268814|FG018|Period 1|Did not meet inc/exc criteria|0|||
129539920|NCT01049360|466268815|FG019|Period 1|Did not meet inc/exc criteria|0|||
129539921|NCT01049360|466268796|FG000|Period 1|Withdrawal by Subject|0|||
129539922|NCT01049360|466268797|FG001|Period 1|Withdrawal by Subject|0|||
129539923|NCT01049360|466268798|FG002|Period 1|Withdrawal by Subject|0|||
129539924|NCT01049360|466268799|FG003|Period 1|Withdrawal by Subject|0|||
129539925|NCT01049360|466268800|FG004|Period 1|Withdrawal by Subject|0|||
129539926|NCT01049360|466268801|FG005|Period 1|Withdrawal by Subject|0|||
129539927|NCT01049360|466268802|FG006|Period 1|Withdrawal by Subject|0|||
129539928|NCT01049360|466268803|FG007|Period 1|Withdrawal by Subject|0|||
129539929|NCT01049360|466268804|FG008|Period 1|Withdrawal by Subject|1|||
129539930|NCT01049360|466268805|FG009|Period 1|Withdrawal by Subject|0|||
129539931|NCT01049360|466268806|FG010|Period 1|Withdrawal by Subject|1|||
129539932|NCT01049360|466268807|FG011|Period 1|Withdrawal by Subject|0|||
129539933|NCT01049360|466268808|FG012|Period 1|Withdrawal by Subject|1|||
129539934|NCT01049360|466268809|FG013|Period 1|Withdrawal by Subject|0|||
129539935|NCT01049360|466268810|FG014|Period 1|Withdrawal by Subject|0|||
129539936|NCT01049360|466268811|FG015|Period 1|Withdrawal by Subject|0|||
129539937|NCT01049360|466268812|FG016|Period 1|Withdrawal by Subject|0|||
129539938|NCT01049360|466268813|FG017|Period 1|Withdrawal by Subject|0|||
129539939|NCT01049360|466268814|FG018|Period 1|Withdrawal by Subject|0|||
129539940|NCT01049360|466268815|FG019|Period 1|Withdrawal by Subject|0|||
129539941|NCT01049360|466268796|FG000|Period 2|Protocol Violation|0|||
129539942|NCT01049360|466268797|FG001|Period 2|Protocol Violation|0|||
129539943|NCT01049360|466268798|FG002|Period 2|Protocol Violation|0|||
129539944|NCT01049360|466268799|FG003|Period 2|Protocol Violation|1|||
129539945|NCT01049360|466268800|FG004|Period 2|Protocol Violation|0|||
129539946|NCT01049360|466268801|FG005|Period 2|Protocol Violation|0|||
129539947|NCT01049360|466268802|FG006|Period 2|Protocol Violation|0|||
129539948|NCT01049360|466268803|FG007|Period 2|Protocol Violation|0|||
129539949|NCT01049360|466268804|FG008|Period 2|Protocol Violation|0|||
129539950|NCT01049360|466268805|FG009|Period 2|Protocol Violation|0|||
129539951|NCT01049360|466268806|FG010|Period 2|Protocol Violation|0|||
129539952|NCT01049360|466268807|FG011|Period 2|Protocol Violation|0|||
129539953|NCT01049360|466268808|FG012|Period 2|Protocol Violation|0|||
129539954|NCT01049360|466268809|FG013|Period 2|Protocol Violation|0|||
129539955|NCT01049360|466268810|FG014|Period 2|Protocol Violation|1|||
129539956|NCT01049360|466268811|FG015|Period 2|Protocol Violation|1|||
129539957|NCT01049360|466268812|FG016|Period 2|Protocol Violation|0|||
129539958|NCT01049360|466268813|FG017|Period 2|Protocol Violation|0|||
129539959|NCT01049360|466268814|FG018|Period 2|Protocol Violation|0|||
129539960|NCT01049360|466268815|FG019|Period 2|Protocol Violation|0|||
129539961|NCT01049360|466268796|FG000|Period 2|Adverse Event|0|||
129539962|NCT01049360|466268797|FG001|Period 2|Adverse Event|1|||
129539963|NCT01049360|466268798|FG002|Period 2|Adverse Event|0|||
129539964|NCT01049360|466268799|FG003|Period 2|Adverse Event|0|||
129539965|NCT01049360|466268800|FG004|Period 2|Adverse Event|0|||
129539966|NCT01049360|466268801|FG005|Period 2|Adverse Event|0|||
129539967|NCT01049360|466268802|FG006|Period 2|Adverse Event|0|||
129539968|NCT01049360|466268803|FG007|Period 2|Adverse Event|0|||
129539969|NCT01049360|466268804|FG008|Period 2|Adverse Event|1|||
129539970|NCT01049360|466268805|FG009|Period 2|Adverse Event|0|||
129539971|NCT01049360|466268806|FG010|Period 2|Adverse Event|0|||
129539972|NCT01049360|466268807|FG011|Period 2|Adverse Event|0|||
129539973|NCT01049360|466268808|FG012|Period 2|Adverse Event|0|||
129539974|NCT01049360|466268809|FG013|Period 2|Adverse Event|0|||
129539975|NCT01049360|466268810|FG014|Period 2|Adverse Event|0|||
129539976|NCT01049360|466268811|FG015|Period 2|Adverse Event|0|||
129539977|NCT01049360|466268812|FG016|Period 2|Adverse Event|0|||
129539978|NCT01049360|466268813|FG017|Period 2|Adverse Event|0|||
129539979|NCT01049360|466268814|FG018|Period 2|Adverse Event|0|||
129539980|NCT01049360|466268815|FG019|Period 2|Adverse Event|1|||
129539981|NCT01049360|466268796|FG000|Period 2|Withdrawal by Subject|0|||
129539982|NCT01049360|466268797|FG001|Period 2|Withdrawal by Subject|0|||
129539983|NCT01049360|466268798|FG002|Period 2|Withdrawal by Subject|0|||
129539984|NCT01049360|466268799|FG003|Period 2|Withdrawal by Subject|1|||
129539985|NCT01049360|466268800|FG004|Period 2|Withdrawal by Subject|0|||
129539986|NCT01049360|466268801|FG005|Period 2|Withdrawal by Subject|0|||
129539987|NCT01049360|466268802|FG006|Period 2|Withdrawal by Subject|0|||
129539988|NCT01049360|466268803|FG007|Period 2|Withdrawal by Subject|0|||
129539989|NCT01049360|466268804|FG008|Period 2|Withdrawal by Subject|0|||
129539990|NCT01049360|466268805|FG009|Period 2|Withdrawal by Subject|0|||
129539991|NCT01049360|466268806|FG010|Period 2|Withdrawal by Subject|0|||
129539992|NCT01049360|466268807|FG011|Period 2|Withdrawal by Subject|0|||
129539993|NCT01049360|466268808|FG012|Period 2|Withdrawal by Subject|0|||
129539994|NCT01049360|466268809|FG013|Period 2|Withdrawal by Subject|0|||
129539995|NCT01049360|466268810|FG014|Period 2|Withdrawal by Subject|1|||
129539996|NCT01049360|466268811|FG015|Period 2|Withdrawal by Subject|0|||
129539997|NCT01049360|466268812|FG016|Period 2|Withdrawal by Subject|0|||
129539998|NCT01049360|466268813|FG017|Period 2|Withdrawal by Subject|0|||
129539999|NCT01049360|466268814|FG018|Period 2|Withdrawal by Subject|0|||
129540000|NCT01049360|466268815|FG019|Period 2|Withdrawal by Subject|1|||
129540001|NCT01049360|466268796|FG000|Period 2|Lack of Efficacy|0|||
129540002|NCT01049360|466268797|FG001|Period 2|Lack of Efficacy|0|||
129540003|NCT01049360|466268798|FG002|Period 2|Lack of Efficacy|0|||
129540004|NCT01049360|466268799|FG003|Period 2|Lack of Efficacy|0|||
129540005|NCT01049360|466268800|FG004|Period 2|Lack of Efficacy|0|||
129540006|NCT01049360|466268801|FG005|Period 2|Lack of Efficacy|1|||
129540007|NCT01049360|466268802|FG006|Period 2|Lack of Efficacy|0|||
129540008|NCT01049360|466268803|FG007|Period 2|Lack of Efficacy|0|||
129540009|NCT01049360|466268804|FG008|Period 2|Lack of Efficacy|0|||
129540010|NCT01049360|466268805|FG009|Period 2|Lack of Efficacy|0|||
129540011|NCT01049360|466268806|FG010|Period 2|Lack of Efficacy|0|||
129540012|NCT01049360|466268807|FG011|Period 2|Lack of Efficacy|0|||
129540013|NCT01049360|466268808|FG012|Period 2|Lack of Efficacy|0|||
129540014|NCT01049360|466268809|FG013|Period 2|Lack of Efficacy|0|||
129540015|NCT01049360|466268810|FG014|Period 2|Lack of Efficacy|0|||
129540016|NCT01049360|466268811|FG015|Period 2|Lack of Efficacy|0|||
129540017|NCT01049360|466268812|FG016|Period 2|Lack of Efficacy|0|||
129540018|NCT01049360|466268813|FG017|Period 2|Lack of Efficacy|0|||
129540019|NCT01049360|466268814|FG018|Period 2|Lack of Efficacy|0|||
129540020|NCT01049360|466268815|FG019|Period 2|Lack of Efficacy|0|||
129540021|NCT01049360|466268796|FG000|Period 4|Protocol Violation|0|||
129540022|NCT01049360|466268797|FG001|Period 4|Protocol Violation|0|||
129540023|NCT01049360|466268798|FG002|Period 4|Protocol Violation|0|||
129540024|NCT01049360|466268799|FG003|Period 4|Protocol Violation|0|||
129540025|NCT01049360|466268800|FG004|Period 4|Protocol Violation|0|||
129540026|NCT01049360|466268801|FG005|Period 4|Protocol Violation|0|||
129540027|NCT01049360|466268802|FG006|Period 4|Protocol Violation|0|||
129540028|NCT01049360|466268803|FG007|Period 4|Protocol Violation|0|||
129540029|NCT01049360|466268804|FG008|Period 4|Protocol Violation|0|||
129540030|NCT01049360|466268805|FG009|Period 4|Protocol Violation|0|||
129540031|NCT01049360|466268806|FG010|Period 4|Protocol Violation|0|||
129540032|NCT01049360|466268807|FG011|Period 4|Protocol Violation|0|||
129540033|NCT01049360|466268808|FG012|Period 4|Protocol Violation|0|||
129540034|NCT01049360|466268809|FG013|Period 4|Protocol Violation|0|||
129540035|NCT01049360|466268810|FG014|Period 4|Protocol Violation|0|||
129540036|NCT01049360|466268811|FG015|Period 4|Protocol Violation|0|||
129540037|NCT01049360|466268812|FG016|Period 4|Protocol Violation|0|||
129540038|NCT01049360|466268813|FG017|Period 4|Protocol Violation|1|||
129540039|NCT01049360|466268814|FG018|Period 4|Protocol Violation|0|||
129540040|NCT01049360|466268815|FG019|Period 4|Protocol Violation|0|||
129540041|NCT01049360|466268796|FG000|Period 4|Withdrawal by Subject|0|||
129540042|NCT01049360|466268797|FG001|Period 4|Withdrawal by Subject|0|||
129540043|NCT01049360|466268798|FG002|Period 4|Withdrawal by Subject|0|||
129540044|NCT01049360|466268799|FG003|Period 4|Withdrawal by Subject|1|||
129540045|NCT01049360|466268800|FG004|Period 4|Withdrawal by Subject|0|||
129540046|NCT01049360|466268801|FG005|Period 4|Withdrawal by Subject|0|||
129540047|NCT01049360|466268802|FG006|Period 4|Withdrawal by Subject|0|||
129540048|NCT01049360|466268803|FG007|Period 4|Withdrawal by Subject|0|||
129540049|NCT01049360|466268804|FG008|Period 4|Withdrawal by Subject|0|||
129540050|NCT01049360|466268805|FG009|Period 4|Withdrawal by Subject|0|||
129540051|NCT01049360|466268806|FG010|Period 4|Withdrawal by Subject|0|||
129540052|NCT01049360|466268807|FG011|Period 4|Withdrawal by Subject|0|||
129540053|NCT01049360|466268808|FG012|Period 4|Withdrawal by Subject|0|||
129540054|NCT01049360|466268809|FG013|Period 4|Withdrawal by Subject|0|||
129540055|NCT01049360|466268810|FG014|Period 4|Withdrawal by Subject|0|||
129540056|NCT01049360|466268811|FG015|Period 4|Withdrawal by Subject|0|||
129540057|NCT01049360|466268812|FG016|Period 4|Withdrawal by Subject|0|||
129540058|NCT01049360|466268813|FG017|Period 4|Withdrawal by Subject|0|||
129540059|NCT01049360|466268814|FG018|Period 4|Withdrawal by Subject|0|||
129540060|NCT01049360|466268815|FG019|Period 4|Withdrawal by Subject|0|||
129540061|NCT01694849|466268816|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
129540062|NCT01694849|466268817|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
129540063|NCT01694849|466268818|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
129540064|NCT01694849|466268816|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
129540065|NCT01694849|466268817|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
129540066|NCT01694849|466268818|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
129540067|NCT01694849|466268816|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
129540068|NCT01694849|466268817|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
129540069|NCT01694849|466268818|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
129540070|NCT01694849|466268816|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
129540071|NCT01694849|466268817|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
129540072|NCT01694849|466268818|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
129540073|NCT01694849|466268816|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
129540074|NCT01694849|466268817|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
129540075|NCT01694849|466268818|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
129540076|NCT01694849|466268816|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
129540077|NCT01694849|466268817|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
129540078|NCT01694849|466268818|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
129540079|NCT01694849|466268816|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
129540080|NCT01694849|466268817|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
129540081|NCT01694849|466268818|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
129540082|NCT01694849|466268816|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
129540083|NCT01694849|466268817|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
129540084|NCT01694849|466268818|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
129540085|NCT01012765|466268819|FG000|Treatment Period 1|Adverse Event|1|||
129540086|NCT01012765|466268820|FG001|Treatment Period 1|Adverse Event|0|||
129540087|NCT01012765|466268821|FG002|Treatment Period 1|Adverse Event|1|||
129540088|NCT01012765|466268822|FG003|Treatment Period 1|Adverse Event|0|||
129540089|NCT01012765|466268823|FG004|Treatment Period 1|Adverse Event|0|||
129540090|NCT01012765|466268824|FG005|Treatment Period 1|Adverse Event|0|||
129540091|NCT01012765|466268819|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129540092|NCT01012765|466268820|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129540093|NCT01012765|466268821|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129540094|NCT01012765|466268822|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129540095|NCT01012765|466268823|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129540096|NCT01012765|466268824|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129540097|NCT01012765|466268819|FG000|Treatment Period 1|Administrative problems|0|||
129540098|NCT01012765|466268820|FG001|Treatment Period 1|Administrative problems|0|||
129540099|NCT01012765|466268821|FG002|Treatment Period 1|Administrative problems|1|||
129540100|NCT01012765|466268822|FG003|Treatment Period 1|Administrative problems|1|||
129540101|NCT01012765|466268823|FG004|Treatment Period 1|Administrative problems|1|||
129540102|NCT01012765|466268824|FG005|Treatment Period 1|Administrative problems|0|||
129762040|NCT00988884|467091401|FG000|Overall Study|Adverse Event|0|||
129540103|NCT01012765|466268819|FG000|Treatment Period 1|Protocol Violation|0|||
129540104|NCT01012765|466268820|FG001|Treatment Period 1|Protocol Violation|0|||
129540105|NCT01012765|466268821|FG002|Treatment Period 1|Protocol Violation|0|||
129540106|NCT01012765|466268822|FG003|Treatment Period 1|Protocol Violation|2|||
129540107|NCT01012765|466268823|FG004|Treatment Period 1|Protocol Violation|1|||
129540108|NCT01012765|466268824|FG005|Treatment Period 1|Protocol Violation|0|||
129540109|NCT01012765|466268819|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
129540110|NCT01012765|466268820|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
129540111|NCT01012765|466268821|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
129540112|NCT01012765|466268822|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
129540113|NCT01012765|466268823|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
129540114|NCT01012765|466268824|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
129540115|NCT01012765|466268819|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129540116|NCT01012765|466268820|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129540117|NCT01012765|466268821|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129540118|NCT01012765|466268822|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129540119|NCT01012765|466268823|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129540120|NCT01012765|466268824|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129540121|NCT01012765|466268819|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
129540122|NCT01012765|466268820|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
129540123|NCT01012765|466268821|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
129540124|NCT01012765|466268822|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
129540125|NCT01012765|466268823|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
129540126|NCT01012765|466268824|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
129540127|NCT01012765|466268819|FG000|Treatment Period 2|Adverse Event|0|||
129540128|NCT01012765|466268820|FG001|Treatment Period 2|Adverse Event|1|||
129540129|NCT01012765|466268821|FG002|Treatment Period 2|Adverse Event|1|||
129540130|NCT01012765|466268822|FG003|Treatment Period 2|Adverse Event|0|||
129540131|NCT01012765|466268823|FG004|Treatment Period 2|Adverse Event|0|||
129540132|NCT01012765|466268824|FG005|Treatment Period 2|Adverse Event|0|||
129540133|NCT01012765|466268819|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
129540134|NCT01012765|466268820|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
129540135|NCT01012765|466268821|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
129540136|NCT01012765|466268822|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
129540137|NCT01012765|466268823|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
129540138|NCT01012765|466268824|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
129540139|NCT01326312|466268825|FG000|Overall Study|Adverse Event|11|||
129540140|NCT01326312|466268826|FG001|Overall Study|Adverse Event|11|||
129540141|NCT01326312|466268827|FG002|Overall Study|Adverse Event|1|||
129540142|NCT01326312|466268825|FG000|Overall Study|Withdrawal by Subject|1|||
129540143|NCT01326312|466268826|FG001|Overall Study|Withdrawal by Subject|2|||
129540144|NCT01326312|466268827|FG002|Overall Study|Withdrawal by Subject|1|||
129540145|NCT01326312|466268825|FG000|Overall Study|Protocol Violation|0|||
129540146|NCT01326312|466268826|FG001|Overall Study|Protocol Violation|1|||
129651112|NCT00195494|466678591|FG001|Year 2|Withdrawal by Subject|5|||
129540147|NCT01326312|466268827|FG002|Overall Study|Protocol Violation|0|||
129762041|NCT00988884|467091402|FG001|Overall Study|Adverse Event|1|||
129762042|NCT00988884|467091401|FG000|Overall Study|Lost to Follow-up|20|||
129762043|NCT00988884|467091402|FG001|Overall Study|Lost to Follow-up|16|||
129762044|NCT00988884|467091401|FG000|Overall Study|Protocol Violation|0|||
129762045|NCT00988884|467091402|FG001|Overall Study|Protocol Violation|1|||
129762046|NCT00988884|467091401|FG000|Overall Study|Withdrawal by Subject|15|||
129762047|NCT00988884|467091402|FG001|Overall Study|Withdrawal by Subject|18|||
129762048|NCT01919229|467091403|FG000|Overall Study|Subject/guardian decision|0|||
129762049|NCT01919229|467091404|FG001|Overall Study|Subject/guardian decision|0|||
129762050|NCT01919229|467091405|FG002|Overall Study|Subject/guardian decision|1|||
129762051|NCT00626275|467091406|FG000|Part A - Treatment Period 1|Adverse Event|1|||
129762052|NCT00626275|467091407|FG001|Part A - Treatment Period 1|Adverse Event|0|||
129762053|NCT00626275|467091408|FG002|Part A - Treatment Period 1|Adverse Event|0|||
129762054|NCT00626275|467091409|FG003|Part A - Treatment Period 1|Adverse Event|0|||
129762055|NCT00626275|467091410|FG004|Part A - Treatment Period 1|Adverse Event|0|||
129762056|NCT00626275|467091411|FG005|Part A - Treatment Period 1|Adverse Event|0|||
129762057|NCT00626275|467091412|FG006|Part A - Treatment Period 1|Adverse Event|0|||
129762058|NCT00626275|467091413|FG007|Part A - Treatment Period 1|Adverse Event|0|||
129762059|NCT00626275|467091406|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129762060|NCT00626275|467091407|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129762061|NCT00626275|467091408|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
129762062|NCT00626275|467091409|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129762063|NCT00626275|467091410|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129540148|NCT01326312|466268825|FG000|Overall Study|Lack of Efficacy|13|||
129651113|NCT00195494|466678592|FG002|Year 2|Withdrawal by Subject|4|||
129651114|NCT00195494|466678593|FG003|Year 2|Withdrawal by Subject|3|||
129651115|NCT00195494|466678594|FG004|Year 2|Withdrawal by Subject|0|||
129651116|NCT00195494|466678595|FG005|Year 2|Withdrawal by Subject|0|||
129651117|NCT00195494|466678590|FG000|Year 2|System toxicity|0|||
129651118|NCT00195494|466678591|FG001|Year 2|System toxicity|0|||
129651119|NCT00195494|466678592|FG002|Year 2|System toxicity|0|||
129651120|NCT00195494|466678593|FG003|Year 2|System toxicity|1|||
129651121|NCT00195494|466678594|FG004|Year 2|System toxicity|0|||
129651122|NCT00195494|466678595|FG005|Year 2|System toxicity|0|||
129651123|NCT02020512|466678596|FG000|Overall Study|Adverse Event|1|||
129651124|NCT02020512|466678596|FG000|Overall Study|Lost to Follow-up|3|||
129651125|NCT02020512|466678596|FG000|Overall Study|Protocol Violation|4|||
129651126|NCT04769739|466678605|FG000|Overall Study|Colorectal cancer obstruction|2|||
129651127|NCT04769739|466678606|FG001|Overall Study|Colorectal cancer obstruction|0|||
129651128|NCT04769739|466678607|FG002|Overall Study|Colorectal cancer obstruction|0|||
129651129|NCT04769739|466678608|FG003|Overall Study|Colorectal cancer obstruction|0|||
129651130|NCT04769739|466678605|FG000|Overall Study|Failed cecal intubation|1|||
129651131|NCT04769739|466678606|FG001|Overall Study|Failed cecal intubation|0|||
129651132|NCT04769739|466678607|FG002|Overall Study|Failed cecal intubation|0|||
129651133|NCT04769739|466678608|FG003|Overall Study|Failed cecal intubation|1|||
129651134|NCT04769739|466678605|FG000|Overall Study|Poor bowel preparation|0|||
129651135|NCT04769739|466678606|FG001|Overall Study|Poor bowel preparation|0|||
129651136|NCT04769739|466678607|FG002|Overall Study|Poor bowel preparation|0|||
129651137|NCT04769739|466678608|FG003|Overall Study|Poor bowel preparation|1|||
129651138|NCT03689543|466678609|FG000|Overall Study|Adverse Event|0|||
129651139|NCT03689543|466678610|FG001|Overall Study|Adverse Event|0|||
129651140|NCT03689543|466678611|FG002|Overall Study|Adverse Event|1|||
129651141|NCT00932451|466678612|FG000|Overall Study|Withdrawal by Subject|69|||
129651142|NCT00932451|466678612|FG000|Overall Study|Lost to Follow-up|22|||
129651143|NCT00932451|466678612|FG000|Overall Study|Death|726|||
129651144|NCT00932451|466678612|FG000|Overall Study|Other reasons|5|||
129651145|NCT02968433|466678630|FG000|Overall Study|Withdrawal by Subject|1|||
129651146|NCT00637806|466678631|FG000|Double-blind Phase|Study Discontinued|2|||
129651147|NCT00637806|466678632|FG001|Double-blind Phase|Study Discontinued|0|||
129651148|NCT00637806|466678633|FG002|Double-blind Phase|Study Discontinued|1|||
129651149|NCT00637806|466678634|FG003|Double-blind Phase|Study Discontinued|0|||
129651150|NCT00637806|466678631|FG000|Extension Phase|Study Discontinued|0|||
129651151|NCT00637806|466678632|FG001|Extension Phase|Study Discontinued|0|||
129651152|NCT00637806|466678633|FG002|Extension Phase|Study Discontinued|0|||
129651153|NCT00637806|466678634|FG003|Extension Phase|Study Discontinued|1|||
129651154|NCT00622336|466678635|FG000|Treatment Phase|Progression of Disease|181|||
129651155|NCT00622336|466678635|FG000|Treatment Phase|Adverse Event|46|||
129651156|NCT00622336|466678635|FG000|Treatment Phase|Other|40|||
129651157|NCT00622336|466678635|FG000|Treatment Phase|Death|14|||
129651158|NCT00622336|466678635|FG000|Treatment Phase|Lack of therapeutic effect|13|||
129651159|NCT00622336|466678635|FG000|Treatment Phase|Withdrawal by Subject|13|||
129651160|NCT00622336|466678635|FG000|Treatment Phase|Lost to Follow-up|2|||
129651161|NCT00622336|466678635|FG000|Extension Phase|Adverse Event|2|||
129651162|NCT00622336|466678635|FG000|Extension Phase|Progressive Disease|6|||
129651163|NCT00622336|466678635|FG000|Extension Phase|Lack of therapeutic effect|2|||
129651164|NCT00622336|466678635|FG000|Extension Phase|Withdrawal by Subject|1|||
129540149|NCT01326312|466268826|FG001|Overall Study|Lack of Efficacy|7|||
129540150|NCT01326312|466268827|FG002|Overall Study|Lack of Efficacy|1|||
129540151|NCT01326312|466268825|FG000|Overall Study|Death|1|||
129540152|NCT01326312|466268826|FG001|Overall Study|Death|0|||
129540153|NCT01326312|466268827|FG002|Overall Study|Death|1|||
129540154|NCT01326312|466268825|FG000|Overall Study|progressive disease|0|||
129540155|NCT01326312|466268826|FG001|Overall Study|progressive disease|1|||
129540156|NCT01326312|466268827|FG002|Overall Study|progressive disease|1|||
129540157|NCT01326312|466268825|FG000|Overall Study|Study terminated by Sponsor|8|||
129540158|NCT01326312|466268826|FG001|Overall Study|Study terminated by Sponsor|32|||
129540159|NCT01326312|466268827|FG002|Overall Study|Study terminated by Sponsor|46|||
129540160|NCT01326312|466268825|FG000|Overall Study|Treatment arm terminated|19|||
129540161|NCT01326312|466268826|FG001|Overall Study|Treatment arm terminated|0|||
129540162|NCT01326312|466268827|FG002|Overall Study|Treatment arm terminated|0|||
129540163|NCT01326312|466268825|FG000|Overall Study|QTc > 500|0|||
129540164|NCT01326312|466268826|FG001|Overall Study|QTc > 500|1|||
129540165|NCT01326312|466268827|FG002|Overall Study|QTc > 500|0|||
129540166|NCT00499694|466268832|FG000|Overall Study|Patient never received treatment.|1|||
129540167|NCT02304484|466268833|FG000|Overall Study|Death|9|||
129540168|NCT02304484|466268833|FG000|Overall Study|Withdrawal by Subject|14|||
129540169|NCT02304484|466268833|FG000|Overall Study|Lost to Follow-up|2|||
129540170|NCT04338685|466268834|FG000|Overall Study|Death|3|||
129540171|NCT04338685|466268835|FG001|Overall Study|Death|4|||
129540172|NCT04338685|466268836|FG002|Overall Study|Death|2|||
129540173|NCT04338685|466268837|FG003|Overall Study|Death|4|||
129540174|NCT04338685|466268838|FG004|Overall Study|Death|4|||
129540175|NCT04338685|466268839|FG005|Overall Study|Death|8|||
129540176|NCT04338685|466268840|FG006|Overall Study|Death|1|||
129540177|NCT04338685|466268841|FG007|Overall Study|Death|0|||
129540178|NCT04338685|466268842|FG008|Overall Study|Death|0|||
129540179|NCT04338685|466268834|FG000|Overall Study|Study terminated by Sponsor|0|||
129540180|NCT04338685|466268835|FG001|Overall Study|Study terminated by Sponsor|0|||
129540181|NCT04338685|466268836|FG002|Overall Study|Study terminated by Sponsor|1|||
129540182|NCT04338685|466268837|FG003|Overall Study|Study terminated by Sponsor|4|||
129540183|NCT04338685|466268838|FG004|Overall Study|Study terminated by Sponsor|0|||
129540184|NCT04338685|466268839|FG005|Overall Study|Study terminated by Sponsor|5|||
129540185|NCT04338685|466268840|FG006|Overall Study|Study terminated by Sponsor|2|||
129540186|NCT04338685|466268841|FG007|Overall Study|Study terminated by Sponsor|4|||
129540187|NCT04338685|466268842|FG008|Overall Study|Study terminated by Sponsor|1|||
129540188|NCT04338685|466268834|FG000|Overall Study|Withdrawal by Subject|1|||
129540189|NCT04338685|466268835|FG001|Overall Study|Withdrawal by Subject|2|||
129540190|NCT04338685|466268836|FG002|Overall Study|Withdrawal by Subject|0|||
129540191|NCT04338685|466268837|FG003|Overall Study|Withdrawal by Subject|2|||
129540192|NCT04338685|466268838|FG004|Overall Study|Withdrawal by Subject|0|||
129540193|NCT04338685|466268839|FG005|Overall Study|Withdrawal by Subject|5|||
129540194|NCT04338685|466268840|FG006|Overall Study|Withdrawal by Subject|1|||
129540195|NCT04338685|466268841|FG007|Overall Study|Withdrawal by Subject|1|||
129540196|NCT04338685|466268842|FG008|Overall Study|Withdrawal by Subject|0|||
129540197|NCT02967055|466268843|FG000|Overall Study|Excluded|40|||
129540198|NCT02967055|466268843|FG000|Overall Study|Screen fail|3|||
129540199|NCT02967055|466268843|FG000|Overall Study|Lost to Follow-up|2|||
129540200|NCT02967055|466268843|FG000|Overall Study|Stopped due to side effects|3|||
129540201|NCT02967055|466268843|FG000|Overall Study|Stopped due to drug cost|1|||
129540202|NCT00145795|466268844|FG000|Overall Study|Adverse Event|1|||
129540203|NCT00145795|466268845|FG001|Overall Study|Adverse Event|0|||
129540204|NCT00976989|466268846|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129540205|NCT00976989|466268847|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
129540206|NCT00976989|466268848|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
129540207|NCT00976989|466268846|FG000|Overall Study|Death|5|||
129540208|NCT00976989|466268847|FG001|Overall Study|Death|7|||
129540209|NCT00976989|466268848|FG002|Overall Study|Death|10|||
129540210|NCT00976989|466268846|FG000|Overall Study|Refused Treatment|4|||
129540211|NCT00976989|466268847|FG001|Overall Study|Refused Treatment|3|||
129540212|NCT00976989|466268848|FG002|Overall Study|Refused Treatment|5|||
129540213|NCT00976989|466268846|FG000|Overall Study|Failure to Return|2|||
129540214|NCT00976989|466268847|FG001|Overall Study|Failure to Return|1|||
129540215|NCT00976989|466268848|FG002|Overall Study|Failure to Return|0|||
129540216|NCT00976989|466268846|FG000|Overall Study|Recurrence of Disease|0|||
129540217|NCT00976989|466268847|FG001|Overall Study|Recurrence of Disease|1|||
129540218|NCT00976989|466268848|FG002|Overall Study|Recurrence of Disease|0|||
129540219|NCT00976989|466268846|FG000|Overall Study|Other|1|||
129540220|NCT00976989|466268847|FG001|Overall Study|Other|0|||
129540221|NCT00976989|466268848|FG002|Overall Study|Other|1|||
129540222|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
129540223|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
129540224|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
129540225|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
129540226|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
129540227|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
129540228|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
129540229|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
129540230|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
129540231|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
129540232|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
129540233|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
129540234|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
129540235|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
129540236|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
129540237|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
129540238|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
129540239|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
129540240|NCT00570492|466268849|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
129540241|NCT00570492|466268850|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
129540242|NCT00570492|466268851|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
129540243|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129540244|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
129540245|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
129540246|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
129540247|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
129540248|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
129540249|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
129540250|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
129540251|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
129540252|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
129540253|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
129540254|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
129540255|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
129540256|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
129540257|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
129540258|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
129540259|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
129540260|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
129540261|NCT00570492|466268849|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
129540262|NCT00570492|466268850|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
129540263|NCT00570492|466268851|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
129540264|NCT00908375|466268852|FG000|Overall Study|Withdrawal by Subject|2|||
129540265|NCT00908375|466268853|FG001|Overall Study|Withdrawal by Subject|4|||
129540266|NCT00908375|466268852|FG000|Overall Study|Lost to Follow-up|8|||
129540267|NCT00908375|466268853|FG001|Overall Study|Lost to Follow-up|6|||
129540268|NCT00752206|466268855|FG000|Overall Study|Disease progression|8|||
129540269|NCT00752206|466268856|FG001|Overall Study|Disease progression|11|||
129540270|NCT00752206|466268855|FG000|Overall Study|Pregnancy|1|||
129540271|NCT00752206|466268856|FG001|Overall Study|Pregnancy|0|||
129540272|NCT00678652|466268857|FG000|Overall Study|Protocol Violation|2|||
129540273|NCT00678652|466268858|FG001|Overall Study|Protocol Violation|0|||
129540274|NCT00678652|466268859|FG002|Overall Study|Protocol Violation|0|||
129540275|NCT00678652|466268860|FG003|Overall Study|Protocol Violation|0|||
129540276|NCT00678652|466268857|FG000|Overall Study|Pregnancy|0|||
129540277|NCT00678652|466268858|FG001|Overall Study|Pregnancy|0|||
129540278|NCT00678652|466268859|FG002|Overall Study|Pregnancy|1|||
129540279|NCT00678652|466268860|FG003|Overall Study|Pregnancy|0|||
129540280|NCT00678652|466268857|FG000|Overall Study|Relocation|1|||
129540281|NCT00678652|466268858|FG001|Overall Study|Relocation|0|||
129540282|NCT00678652|466268859|FG002|Overall Study|Relocation|0|||
129540283|NCT00678652|466268860|FG003|Overall Study|Relocation|0|||
129540284|NCT03958045|466268863|FG000|Overall Study|Withdrawal by Subject|1|||
129540285|NCT02283411|466268864|FG000|Overall Study|Withdrawal by Subject|3|||
129540286|NCT02283411|466268864|FG000|Overall Study|Screen Failed|28|||
129540287|NCT04409262|466268865|FG000|Overall Study|Adverse Event|0|||
129540288|NCT04409262|466268866|FG001|Overall Study|Adverse Event|2|||
129540289|NCT04409262|466268865|FG000|Overall Study|Death|55|||
129540290|NCT04409262|466268866|FG001|Overall Study|Death|97|||
129540291|NCT04409262|466268865|FG000|Overall Study|Lost to Follow-up|12|||
129540292|NCT04409262|466268866|FG001|Overall Study|Lost to Follow-up|23|||
129540293|NCT04409262|466268865|FG000|Overall Study|Lack of Staff|0|||
129540294|NCT04409262|466268866|FG001|Overall Study|Lack of Staff|1|||
129540295|NCT04409262|466268865|FG000|Overall Study|Protocol Violation|3|||
129540296|NCT04409262|466268866|FG001|Overall Study|Protocol Violation|1|||
129540297|NCT04409262|466268865|FG000|Overall Study|Withdrawal by Subject|5|||
129540298|NCT04409262|466268866|FG001|Overall Study|Withdrawal by Subject|10|||
129540299|NCT02500732|466268867|FG000|Overall Study|Physician Decision|0|||
129540300|NCT02500732|466268868|FG001|Overall Study|Physician Decision|1|||
129540301|NCT02396849|466268869|FG000|Overall Study|Lost to Follow-up|1|||
129540302|NCT02396849|466268870|FG001|Overall Study|Lost to Follow-up|1|||
129540303|NCT02396849|466268869|FG000|Overall Study|Did not tolerate intervention|1|||
129540304|NCT02396849|466268870|FG001|Overall Study|Did not tolerate intervention|1|||
129540305|NCT04794491|466268875|FG000|Overall Study|Adverse Event|1|||
129540306|NCT04794491|466268875|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
129540307|NCT04794491|466268875|FG000|Overall Study|Noncompliance With Study Intervention|1|||
129540308|NCT04794491|466268875|FG000|Overall Study|Withdrawal by Subject|2|||
129540309|NCT00931515|466268876|FG000|Overall Study|Lost to Follow-up|2|||
129540310|NCT00931515|466268877|FG001|Overall Study|Lost to Follow-up|5|||
129540311|NCT03759340|466268878|FG000|Overall Study|Adverse Event|2|||
129540312|NCT03759340|466268878|FG000|Overall Study|Lost to Follow-up|1|||
129540313|NCT03759340|466268878|FG000|Overall Study|Withdrawal by Subject|15|||
129540314|NCT03759340|466268878|FG000|Overall Study|Study Terminated by Sponsor|38|||
129540315|NCT03289676|466268881|FG000|Overall Study|Withdrawal by Subject|2|||
129540316|NCT03289676|466268882|FG001|Overall Study|Withdrawal by Subject|0|||
129540317|NCT03289676|466268881|FG000|Overall Study|Protocol Violation|2|||
129540318|NCT03289676|466268882|FG001|Overall Study|Protocol Violation|0|||
129540319|NCT03289676|466268881|FG000|Overall Study|Lost to Follow-up|0|||
129762064|NCT00626275|467091411|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129540320|NCT03289676|466268882|FG001|Overall Study|Lost to Follow-up|1|||
129540321|NCT02711306|466268883|FG000|Overall Study|Withdrawal by Subject|2|||
129540322|NCT02711306|466268884|FG001|Overall Study|Withdrawal by Subject|2|||
129540323|NCT02260804|466268891|FG000|Induction Study Period|Protocol Violation|2|||
129540324|NCT02260804|466268892|FG001|Induction Study Period|Protocol Violation|0|||
129540325|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
129540326|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
129540327|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
129540328|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
129540329|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
129540330|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
129540331|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
129540332|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
129540333|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
129540334|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
129540335|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
129540336|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
129540337|NCT02260804|466268891|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
129540338|NCT02260804|466268892|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
129540339|NCT02260804|466268891|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
129540340|NCT02260804|466268892|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
129540341|NCT02260804|466268891|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
129540342|NCT02260804|466268892|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
129540343|NCT02260804|466268891|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
129540344|NCT02260804|466268892|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
129647062|NCT02543892|466663778|FG000|Received Vaccination 2|Adverse Event|0|||
129647063|NCT02543892|466663779|FG001|Received Vaccination 2|Adverse Event|1|||
129647064|NCT02543892|466663780|FG002|Received Vaccination 2|Adverse Event|0|||
129647065|NCT02543892|466663781|FG003|Received Vaccination 2|Adverse Event|0|||
129647066|NCT02543892|466663782|FG004|Received Vaccination 2|Adverse Event|0|||
129647067|NCT02543892|466663783|FG005|Received Vaccination 2|Adverse Event|0|||
129647068|NCT02543892|466663784|FG006|Received Vaccination 2|Adverse Event|0|||
129647069|NCT02543892|466663785|FG007|Received Vaccination 2|Adverse Event|0|||
129647070|NCT02543892|466663778|FG000|Had Immunology Data|Withdrawal by Subject|0|||
129647071|NCT02543892|466663779|FG001|Had Immunology Data|Withdrawal by Subject|0|||
129647072|NCT02543892|466663780|FG002|Had Immunology Data|Withdrawal by Subject|0|||
129647073|NCT02543892|466663781|FG003|Had Immunology Data|Withdrawal by Subject|0|||
129647074|NCT02543892|466663782|FG004|Had Immunology Data|Withdrawal by Subject|0|||
129651165|NCT00622336|466678635|FG000|Extension Phase|Lost to Follow-up|1|||
129651166|NCT00622336|466678635|FG000|Extension Phase|Other|9|||
129651167|NCT04506905|466678638|FG000|Overall Study|Lost to Follow-up|1|||
129651168|NCT04506905|466678639|FG001|Overall Study|Lost to Follow-up|0|||
129540345|NCT02513732|466270351|FG000|Overall Study|Lost to Follow-up|11|||
129540346|NCT02513732|466270351|FG000|Overall Study|Death|9|||
129540347|NCT02513732|466270351|FG000|Overall Study|Changing hospital|2|||
129540348|NCT01740297|466270352|FG000|Overall Study|Withdrawal by Subject|4|||
129540349|NCT01740297|466270353|FG001|Overall Study|Withdrawal by Subject|16|||
129985638|NCT01435616|467909318|FG001|Overall Study|Physician Decision|7|||
129540350|NCT01740297|466270354|FG002|Overall Study|Withdrawal by Subject|17|||
129985639|NCT01435616|467909317|FG000|Overall Study|Sponsor Decision|1|||
129985640|NCT01435616|467909318|FG001|Overall Study|Sponsor Decision|0|||
129985641|NCT04860297|467909319|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
129985642|NCT04860297|467909320|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
129985643|NCT04860297|467909321|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
129985644|NCT04860297|467909322|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
129985645|NCT04860297|467909323|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
129985646|NCT04860297|467909324|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
129985647|NCT04860297|467909325|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
129985648|NCT04860297|467909326|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
129985649|NCT04860297|467909319|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
129985650|NCT04860297|467909320|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
129985651|NCT04860297|467909321|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
129985652|NCT04860297|467909322|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
129985653|NCT04860297|467909323|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
129985654|NCT04860297|467909324|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
129985655|NCT04860297|467909325|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
129985656|NCT04860297|467909326|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
129985657|NCT04860297|467909319|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
129985658|NCT04860297|467909320|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
129985659|NCT04860297|467909321|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
129985660|NCT04860297|467909322|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
129985661|NCT04860297|467909323|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
129985662|NCT04860297|467909324|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
129985663|NCT04860297|467909325|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
129985664|NCT04860297|467909326|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
129985665|NCT04860297|467909319|FG000|Part B (Booster Dose)|Other Than Specified|0|||
129985666|NCT04860297|467909320|FG001|Part B (Booster Dose)|Other Than Specified|0|||
129985667|NCT04860297|467909321|FG002|Part B (Booster Dose)|Other Than Specified|0|||
129985668|NCT04860297|467909322|FG003|Part B (Booster Dose)|Other Than Specified|0|||
129985669|NCT04860297|467909323|FG004|Part B (Booster Dose)|Other Than Specified|0|||
129985670|NCT04860297|467909324|FG005|Part B (Booster Dose)|Other Than Specified|1|||
129985671|NCT04860297|467909325|FG006|Part B (Booster Dose)|Other Than Specified|1|||
129985672|NCT04860297|467909326|FG007|Part B (Booster Dose)|Other Than Specified|0|||
129985673|NCT04860297|467909319|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985674|NCT04860297|467909320|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985675|NCT04860297|467909321|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985676|NCT04860297|467909322|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985677|NCT04860297|467909323|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985678|NCT04860297|467909324|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
129985679|NCT04860297|467909325|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
129985680|NCT04860297|467909326|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
129985681|NCT04860297|467909319|FG000|Part B (Booster Dose)|Death|0|||
129985682|NCT04860297|467909320|FG001|Part B (Booster Dose)|Death|0|||
129985683|NCT04860297|467909321|FG002|Part B (Booster Dose)|Death|0|||
129985684|NCT04860297|467909322|FG003|Part B (Booster Dose)|Death|0|||
129985685|NCT04860297|467909323|FG004|Part B (Booster Dose)|Death|1|||
129985686|NCT04860297|467909324|FG005|Part B (Booster Dose)|Death|2|||
129985687|NCT04860297|467909325|FG006|Part B (Booster Dose)|Death|1|||
129985688|NCT04860297|467909326|FG007|Part B (Booster Dose)|Death|0|||
129985689|NCT04860297|467909319|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
129985690|NCT04860297|467909320|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
129985691|NCT04860297|467909321|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
129985692|NCT04860297|467909322|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
129985693|NCT04860297|467909323|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
129985694|NCT04860297|467909324|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
129985695|NCT04860297|467909325|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
129985696|NCT04860297|467909326|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
129540351|NCT01740297|466270352|FG000|Overall Study|Death|8|||
129540352|NCT01740297|466270353|FG001|Overall Study|Death|46|||
129540353|NCT01740297|466270354|FG002|Overall Study|Death|40|||
129540354|NCT01740297|466270352|FG000|Overall Study|Lost to Follow-up|1|||
129540355|NCT01740297|466270353|FG001|Overall Study|Lost to Follow-up|2|||
129540356|NCT01740297|466270354|FG002|Overall Study|Lost to Follow-up|4|||
129540357|NCT00718809|466270362|FG000|Overall Study|Disease progression|9|||
129540358|NCT00718809|466270363|FG001|Overall Study|Disease progression|7|||
129540359|NCT00718809|466270362|FG000|Overall Study|Adverse Event|1|||
129540360|NCT00718809|466270363|FG001|Overall Study|Adverse Event|1|||
129540361|NCT00718809|466270362|FG000|Overall Study|Withdrawal by Subject|0|||
129540362|NCT00718809|466270363|FG001|Overall Study|Withdrawal by Subject|1|||
129540363|NCT00718809|466270362|FG000|Overall Study|Lost to Follow-up|1|||
129540364|NCT00718809|466270363|FG001|Overall Study|Lost to Follow-up|0|||
129540365|NCT00718809|466270362|FG000|Overall Study|Noncompliance|1|||
129540366|NCT00718809|466270363|FG001|Overall Study|Noncompliance|0|||
129540367|NCT00463385|466270364|FG000|Overall Study|Other|4|||
129540368|NCT00463385|466270365|FG001|Overall Study|Other|3|||
129540369|NCT00463385|466270366|FG002|Overall Study|Other|6|||
129540370|NCT00463385|466270367|FG003|Overall Study|Other|4|||
129540371|NCT00463385|466270364|FG000|Overall Study|Adverse Event|5|||
129540372|NCT00463385|466270365|FG001|Overall Study|Adverse Event|8|||
129540373|NCT00463385|466270366|FG002|Overall Study|Adverse Event|4|||
129540374|NCT00463385|466270367|FG003|Overall Study|Adverse Event|2|||
129540375|NCT00463385|466270364|FG000|Overall Study|Lack of Efficacy|6|||
129540376|NCT00463385|466270365|FG001|Overall Study|Lack of Efficacy|6|||
129540377|NCT00463385|466270366|FG002|Overall Study|Lack of Efficacy|7|||
129540378|NCT00463385|466270367|FG003|Overall Study|Lack of Efficacy|9|||
129540379|NCT00463385|466270364|FG000|Overall Study|Withdrawal by Subject|3|||
129540380|NCT00463385|466270365|FG001|Overall Study|Withdrawal by Subject|3|||
129540381|NCT00463385|466270366|FG002|Overall Study|Withdrawal by Subject|3|||
129540382|NCT00463385|466270367|FG003|Overall Study|Withdrawal by Subject|4|||
129540383|NCT00463385|466270364|FG000|Overall Study|Lost to Follow-up|0|||
129540384|NCT00463385|466270365|FG001|Overall Study|Lost to Follow-up|0|||
129540385|NCT00463385|466270366|FG002|Overall Study|Lost to Follow-up|0|||
129540386|NCT00463385|466270367|FG003|Overall Study|Lost to Follow-up|1|||
129540387|NCT00463385|466270364|FG000|Overall Study|Death|2|||
129540388|NCT00463385|466270365|FG001|Overall Study|Death|1|||
129540389|NCT00463385|466270366|FG002|Overall Study|Death|2|||
129540390|NCT00463385|466270367|FG003|Overall Study|Death|0|||
129540391|NCT00463385|466270364|FG000|Overall Study|Missing|2|||
129540392|NCT00463385|466270365|FG001|Overall Study|Missing|0|||
129540393|NCT00463385|466270366|FG002|Overall Study|Missing|0|||
129540394|NCT00463385|466270367|FG003|Overall Study|Missing|2|||
129540395|NCT00463385|466270364|FG000|Overall Study|1 participant received commercial drug|0|||
129540396|NCT00463385|466270365|FG001|Overall Study|1 participant received commercial drug|1|||
129540397|NCT00463385|466270366|FG002|Overall Study|1 participant received commercial drug|0|||
129540398|NCT00463385|466270367|FG003|Overall Study|1 participant received commercial drug|0|||
129540399|NCT00344968|466270370|FG000|Overall Study|Adverse Event|5|||
129540400|NCT00344968|466270371|FG001|Overall Study|Adverse Event|4|||
129540401|NCT00344968|466270372|FG002|Overall Study|Adverse Event|15|||
129540402|NCT00344968|466270370|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129540403|NCT00344968|466270371|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129540404|NCT00344968|466270372|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129540405|NCT00344968|466270370|FG000|Overall Study|Protocol Violation|2|||
129540406|NCT00344968|466270371|FG001|Overall Study|Protocol Violation|2|||
129762065|NCT00626275|467091412|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129540407|NCT00344968|466270372|FG002|Overall Study|Protocol Violation|5|||
129540408|NCT00344968|466270370|FG000|Overall Study|Withdrawal by Subject|14|||
129540409|NCT00344968|466270371|FG001|Overall Study|Withdrawal by Subject|31|||
129540410|NCT00344968|466270372|FG002|Overall Study|Withdrawal by Subject|27|||
129540411|NCT00344968|466270370|FG000|Overall Study|Lost to Follow-up|24|||
129540412|NCT00344968|466270371|FG001|Overall Study|Lost to Follow-up|37|||
129540413|NCT00344968|466270372|FG002|Overall Study|Lost to Follow-up|37|||
129540414|NCT00344968|466270370|FG000|Overall Study|Death|11|||
129540415|NCT00344968|466270371|FG001|Overall Study|Death|27|||
129540416|NCT00344968|466270372|FG002|Overall Study|Death|31|||
129540417|NCT00344968|466270370|FG000|Overall Study|Other|0|||
129540418|NCT00344968|466270371|FG001|Overall Study|Other|1|||
129540419|NCT00344968|466270372|FG002|Overall Study|Other|0|||
129540420|NCT01422876|466270373|FG000|Week 24|Lost to Follow-up|1|||
129540421|NCT01422876|466270374|FG001|Week 24|Lost to Follow-up|1|||
129540422|NCT01422876|466270375|FG002|Week 24|Lost to Follow-up|2|||
129540423|NCT01422876|466270376|FG003|Week 24|Lost to Follow-up|4|||
129540424|NCT01422876|466270377|FG004|Week 24|Lost to Follow-up|2|||
129540425|NCT01422876|466270378|FG005|Week 24|Lost to Follow-up|0|||
129540426|NCT01422876|466270379|FG006|Week 24|Lost to Follow-up|1|||
129540427|NCT01422876|466270380|FG007|Week 24|Lost to Follow-up|3|||
129540428|NCT01422876|466270381|FG008|Week 24|Lost to Follow-up|3|||
129540429|NCT01422876|466270382|FG009|Week 24|Lost to Follow-up|4|||
129540430|NCT01422876|466270373|FG000|Week 24|Consent withdrawn|5|||
129540431|NCT01422876|466270374|FG001|Week 24|Consent withdrawn|1|||
129540432|NCT01422876|466270375|FG002|Week 24|Consent withdrawn|3|||
129540433|NCT01422876|466270376|FG003|Week 24|Consent withdrawn|4|||
129540434|NCT01422876|466270377|FG004|Week 24|Consent withdrawn|5|||
129540435|NCT01422876|466270378|FG005|Week 24|Consent withdrawn|6|||
129540436|NCT01422876|466270379|FG006|Week 24|Consent withdrawn|5|||
129540437|NCT01422876|466270380|FG007|Week 24|Consent withdrawn|4|||
129540438|NCT01422876|466270381|FG008|Week 24|Consent withdrawn|3|||
129540439|NCT01422876|466270382|FG009|Week 24|Consent withdrawn|6|||
129540440|NCT01422876|466270373|FG000|Week 24|Death|0|||
129540441|NCT01422876|466270374|FG001|Week 24|Death|1|||
129540442|NCT01422876|466270375|FG002|Week 24|Death|0|||
129540443|NCT01422876|466270376|FG003|Week 24|Death|0|||
129540444|NCT01422876|466270377|FG004|Week 24|Death|0|||
129540445|NCT01422876|466270378|FG005|Week 24|Death|0|||
129540446|NCT01422876|466270379|FG006|Week 24|Death|0|||
129985697|NCT04811131|467909333|FG000|Overall Study|Adverse Event|0|||
129540447|NCT01422876|466270380|FG007|Week 24|Death|0|||
129540448|NCT01422876|466270381|FG008|Week 24|Death|0|||
129540449|NCT01422876|466270382|FG009|Week 24|Death|0|||
129540450|NCT01422876|466270373|FG000|Week 52|Lost to Follow-up|3|||
129540451|NCT01422876|466270374|FG001|Week 52|Lost to Follow-up|5|||
129540452|NCT01422876|466270375|FG002|Week 52|Lost to Follow-up|7|||
129540453|NCT01422876|466270376|FG003|Week 52|Lost to Follow-up|5|||
129540454|NCT01422876|466270377|FG004|Week 52|Lost to Follow-up|8|||
129540455|NCT01422876|466270378|FG005|Week 52|Lost to Follow-up|5|||
129540456|NCT01422876|466270379|FG006|Week 52|Lost to Follow-up|5|||
129540457|NCT01422876|466270380|FG007|Week 52|Lost to Follow-up|8|||
129540458|NCT01422876|466270381|FG008|Week 52|Lost to Follow-up|7|||
129540459|NCT01422876|466270382|FG009|Week 52|Lost to Follow-up|8|||
129540460|NCT01422876|466270373|FG000|Week 52|Consent withdrawn|9|||
129540461|NCT01422876|466270374|FG001|Week 52|Consent withdrawn|4|||
129540462|NCT01422876|466270375|FG002|Week 52|Consent withdrawn|6|||
129540463|NCT01422876|466270376|FG003|Week 52|Consent withdrawn|12|||
129540464|NCT01422876|466270377|FG004|Week 52|Consent withdrawn|7|||
129540465|NCT01422876|466270378|FG005|Week 52|Consent withdrawn|12|||
129540466|NCT01422876|466270379|FG006|Week 52|Consent withdrawn|10|||
129540467|NCT01422876|466270380|FG007|Week 52|Consent withdrawn|12|||
129540468|NCT01422876|466270381|FG008|Week 52|Consent withdrawn|13|||
129540469|NCT01422876|466270382|FG009|Week 52|Consent withdrawn|9|||
129540470|NCT01422876|466270373|FG000|Week 52|Death|0|||
129540471|NCT01422876|466270374|FG001|Week 52|Death|1|||
129540472|NCT01422876|466270375|FG002|Week 52|Death|0|||
129540473|NCT01422876|466270376|FG003|Week 52|Death|1|||
129540474|NCT01422876|466270377|FG004|Week 52|Death|0|||
129540475|NCT01422876|466270378|FG005|Week 52|Death|0|||
129540476|NCT01422876|466270379|FG006|Week 52|Death|1|||
129540477|NCT01422876|466270380|FG007|Week 52|Death|3|||
129540478|NCT01422876|466270381|FG008|Week 52|Death|1|||
129540479|NCT01422876|466270382|FG009|Week 52|Death|0|||
129540480|NCT00536991|466270391|FG000|Overall Study|Withdrawal by Subject|10|||
129540481|NCT00536991|466270391|FG000|Overall Study|Physician Decision|1|||
129540482|NCT00536991|466270391|FG000|Overall Study|patient ineligible|2|||
129540483|NCT00054639|466270392|FG000|Overall Study|Lack of Efficacy|1|||
129540484|NCT00054639|466270392|FG000|Overall Study|Physician Decision|1|||
129540485|NCT01600755|466270393|FG000|Overall Study|Withdrawal by Subject|6|||
129540486|NCT04621227|466270402|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
129540487|NCT04621227|466270402|FG000|Period 3 (29 Days)|Adverse Event|1|||
129540488|NCT04621227|466270402|FG000|Period 8 (2 Days)|Adverse Event|1|||
129540489|NCT00558831|466270405|FG000|Overall Study|Lost to Follow-up|1|||
129540490|NCT00447265|466270406|FG000|Overall Study|Physician Decision|1|||
129540491|NCT00447265|466270407|FG001|Overall Study|Physician Decision|0|||
129540492|NCT02204449|466270410|FG000|Overall Study|Lost to Follow-up|7|||
129540493|NCT02204449|466270411|FG001|Overall Study|Lost to Follow-up|9|||
129540494|NCT02204449|466270410|FG000|Overall Study|Death|0|||
129540495|NCT02204449|466270411|FG001|Overall Study|Death|1|||
129540496|NCT02204449|466270410|FG000|Overall Study|Withdrawal by Subject|0|||
129540497|NCT02204449|466270411|FG001|Overall Study|Withdrawal by Subject|1|||
129540498|NCT00503035|466270412|FG000|Overall Study|Lost to Follow-up|2|||
129540499|NCT00503035|466270412|FG000|Overall Study|Physician Decision|3|||
129540500|NCT00503035|466270412|FG000|Overall Study|Ineligible|15|||
129540501|NCT05028816|466270415|FG000|Overall Study|Lost to Follow-up|5|||
129540502|NCT05028816|466270416|FG001|Overall Study|Lost to Follow-up|3|||
129540503|NCT05028816|466270415|FG000|Overall Study|Withdrawal by Subject|4|||
129540504|NCT05028816|466270416|FG001|Overall Study|Withdrawal by Subject|1|||
129540505|NCT05028816|466270415|FG000|Overall Study|Physician Decision|1|||
129540506|NCT05028816|466270416|FG001|Overall Study|Physician Decision|0|||
129540507|NCT01342445|466270417|FG000|Overall Study|Experienced side effects|0|||
129540508|NCT01342445|466270418|FG001|Overall Study|Experienced side effects|2|||
129540509|NCT05299359|466270419|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
129540510|NCT05299359|466270420|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
129540511|NCT05299359|466270419|FG000|Main Part: Day 1 up to Day 366|Other|2|||
129540512|NCT05299359|466270420|FG001|Main Part: Day 1 up to Day 366|Other|0|||
129540513|NCT05299359|466270419|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
129540514|NCT05299359|466270420|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
129540515|NCT05299359|466270419|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
129540516|NCT05299359|466270420|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
129540517|NCT05299359|466270419|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
129540518|NCT05299359|466270420|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
129540519|NCT05299359|466270419|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
129540520|NCT05299359|466270420|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
129540521|NCT05299359|466270419|FG000|Extension Part: Day 1 to Day 366|Other|0|||
129540522|NCT05299359|466270420|FG001|Extension Part: Day 1 to Day 366|Other|1|||
129540523|NCT02392078|466270421|FG000|Overall Study|Did not have procedure|32|||
129540524|NCT02392078|466270422|FG001|Overall Study|Did not have procedure|43|||
129540525|NCT02392078|466270423|FG002|Overall Study|Did not have procedure|20|||
129540526|NCT02392078|466270424|FG003|Overall Study|Did not have procedure|1|||
129540527|NCT02652793|466270427|FG000|Overall Study|Adverse Event|1|||
129540528|NCT02652793|466270427|FG000|Overall Study|Lost to Follow-up|2|||
129540529|NCT02652793|466270427|FG000|Overall Study|Withdrawal by Subject|1|||
129540530|NCT03868410|466270428|FG000|Overall Study|Physician Decision|0|||
129540531|NCT03868410|466270429|FG001|Overall Study|Physician Decision|1|||
129540532|NCT01059175|466270430|FG000|Overall Study|Death|17|||
129540533|NCT01059175|466270431|FG001|Overall Study|Death|17|||
129540534|NCT01059175|466270430|FG000|Overall Study|Adverse Event|4|||
129540535|NCT01059175|466270431|FG001|Overall Study|Adverse Event|2|||
129540536|NCT01059175|466270430|FG000|Overall Study|Lost to Follow-up|0|||
129540537|NCT01059175|466270431|FG001|Overall Study|Lost to Follow-up|1|||
129540538|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Adverse Event|4|||
129540539|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Adverse Event|3|||
129540540|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Adverse Event|0|||
129540541|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Adverse Event|0|||
129540542|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Death|24|||
129540543|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Death|9|||
129540544|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Death|0|||
129540545|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Death|0|||
129540546|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
129540547|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
129540548|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
129540549|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
129540550|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Physician Decision|4|||
129540551|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Physician Decision|1|||
129540552|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Physician Decision|0|||
129540553|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Physician Decision|0|||
129540554|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Progressive disease|1|||
129540555|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Progressive disease|0|||
129540556|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Progressive disease|0|||
129540557|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Progressive disease|0|||
129540558|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
129540559|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
129540560|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
129540561|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
129540562|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
129540563|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
129540564|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
129540565|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
129540566|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
129540567|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
129540568|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
129540569|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
129540570|NCT04579666|466270432|FG000|RTP (Up to Week 52)|Other|2|||
129540571|NCT04579666|466270433|FG001|RTP (Up to Week 52)|Other|0|||
129540572|NCT04579666|466270434|FG002|RTP (Up to Week 52)|Other|0|||
129540573|NCT04579666|466270435|FG003|RTP (Up to Week 52)|Other|0|||
129540574|NCT04579666|466270432|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
129540575|NCT04579666|466270433|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
129540576|NCT04579666|466270434|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
129540577|NCT04579666|466270435|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
129540578|NCT04579666|466270432|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
129540579|NCT04579666|466270433|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
129540580|NCT04579666|466270434|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
129540581|NCT04579666|466270435|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
129540582|NCT04579666|466270432|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
129540583|NCT04579666|466270433|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
129540584|NCT04579666|466270434|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
129540585|NCT04579666|466270435|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
129540586|NCT04579666|466270432|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
129540587|NCT04579666|466270433|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
129540588|NCT04579666|466270434|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
129540589|NCT04579666|466270435|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
129540590|NCT04579666|466270432|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
129540591|NCT04579666|466270433|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
129540592|NCT04579666|466270434|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
129540593|NCT04579666|466270435|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
129540594|NCT05450198|466270436|FG000|Overall Study|Withdrawal by Subject|1|||
129540595|NCT05450198|466270437|FG001|Overall Study|Withdrawal by Subject|1|||
129540596|NCT05450198|466270438|FG002|Overall Study|Withdrawal by Subject|2|||
129540597|NCT05450198|466270439|FG003|Overall Study|Withdrawal by Subject|0|||
129540598|NCT05450198|466270436|FG000|Overall Study|Lost to Follow-up|1|||
129540599|NCT05450198|466270437|FG001|Overall Study|Lost to Follow-up|0|||
129540600|NCT05450198|466270438|FG002|Overall Study|Lost to Follow-up|2|||
129540601|NCT05450198|466270439|FG003|Overall Study|Lost to Follow-up|1|||
129540602|NCT01243762|466270449|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
129540603|NCT01243762|466270450|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
129540604|NCT01243762|466270451|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
129540605|NCT01243762|466270452|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
129540606|NCT01243762|466270453|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
129540607|NCT01243762|466270454|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
129540608|NCT01243762|466270455|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
129540609|NCT01243762|466270449|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
129540610|NCT01243762|466270450|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
129540611|NCT01243762|466270451|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
129540612|NCT01243762|466270452|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
129540613|NCT01243762|466270453|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
129540614|NCT01243762|466270454|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
129540615|NCT01243762|466270455|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
129540616|NCT01243762|466270449|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
129540617|NCT01243762|466270450|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
129540618|NCT01243762|466270451|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
129540619|NCT01243762|466270452|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
129540620|NCT01243762|466270453|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
129540621|NCT01243762|466270454|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
129540622|NCT01243762|466270455|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
129540623|NCT01243762|466270449|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
129540624|NCT01243762|466270450|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
129540625|NCT01243762|466270451|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
129540626|NCT01243762|466270452|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
129540627|NCT01243762|466270453|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
129540628|NCT01243762|466270454|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
129540629|NCT01243762|466270455|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
129762066|NCT00626275|467091413|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
129540630|NCT01243762|466270449|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
129540631|NCT01243762|466270450|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
129540632|NCT01243762|466270451|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
129540633|NCT01243762|466270452|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
129540634|NCT01243762|466270453|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
129540635|NCT01243762|466270454|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
129540636|NCT01243762|466270455|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
129540637|NCT01243762|466270449|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
129540638|NCT01243762|466270450|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
129540639|NCT01243762|466270451|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
129540640|NCT01243762|466270452|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
129540641|NCT01243762|466270453|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
129540642|NCT01243762|466270454|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
129540643|NCT01243762|466270455|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
129540644|NCT01243762|466270449|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
129540645|NCT01243762|466270450|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
129540646|NCT01243762|466270451|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
129540647|NCT01243762|466270452|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
129540648|NCT01243762|466270453|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
129540649|NCT01243762|466270454|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
129540650|NCT01243762|466270455|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
129540651|NCT01243762|466270449|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
129540652|NCT01243762|466270450|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
129540653|NCT01243762|466270451|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
129540654|NCT01243762|466270452|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
129540655|NCT01243762|466270453|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
129540656|NCT01243762|466270454|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
129540657|NCT01243762|466270455|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
129540658|NCT02059265|466270456|FG000|Overall Study|Ineligible|4|||
129540659|NCT04359758|466270461|FG000|Overall Study|Protocol Violation|3|||
129540660|NCT04359758|466270462|FG001|Overall Study|Protocol Violation|2|||
129540661|NCT03605758|466270463|FG000|Overall Study|Lost to Follow-up|2|||
129540662|NCT03605758|466270464|FG001|Overall Study|Lost to Follow-up|1|||
129540663|NCT03605758|466270463|FG000|Overall Study|Illness|0|||
129540664|NCT03605758|466270464|FG001|Overall Study|Illness|1|||
129540665|NCT03605758|466270463|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
129540666|NCT03605758|466270464|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
129540667|NCT04753606|466270465|FG000|Overall Study|Adverse Event|1|||
129540668|NCT04753606|466270466|FG001|Overall Study|Adverse Event|0|||
129540669|NCT04753606|466270467|FG002|Overall Study|Adverse Event|0|||
129540670|NCT00489411|466270468|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
129540671|NCT00489411|466270469|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
129540672|NCT00489411|466270468|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
129540673|NCT00489411|466270469|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
129540674|NCT00489411|466270468|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
129540675|NCT00489411|466270469|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
129540676|NCT00489411|466270468|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
129540677|NCT00489411|466270469|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
129540678|NCT00489411|466270468|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
129540679|NCT00489411|466270469|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
129540680|NCT01748162|466270470|FG000|Overall Study|no additional croup episodes to evaluate|2|||
129540681|NCT01748162|466270471|FG001|Overall Study|no additional croup episodes to evaluate|2|||
129540682|NCT01748162|466270470|FG000|Overall Study|participant consented but did not begin|0|||
129540683|NCT01748162|466270471|FG001|Overall Study|participant consented but did not begin|1|||
129540684|NCT01748162|466270470|FG000|Overall Study|reasons not available|3|||
129540685|NCT01748162|466270471|FG001|Overall Study|reasons not available|2|||
129540686|NCT03841331|466270472|FG000|Overall Study|Withdrawal by Subject|4|||
129540687|NCT03841331|466270473|FG001|Overall Study|Withdrawal by Subject|9|||
129540688|NCT03841331|466270472|FG000|Overall Study|Lost to Follow-up|5|||
129540689|NCT03841331|466270473|FG001|Overall Study|Lost to Follow-up|1|||
129540690|NCT02743117|466270474|FG000|Overall Study|Lost to Follow-up|0|||
129540691|NCT02743117|466270475|FG001|Overall Study|Lost to Follow-up|1|||
129540692|NCT02743117|466270474|FG000|Overall Study|Other|1|||
129540693|NCT02743117|466270475|FG001|Overall Study|Other|0|||
129540694|NCT01207219|466270476|FG000|Overall Study|changed diagnosis during study period|5|||
129540695|NCT01207219|466270477|FG001|Overall Study|changed diagnosis during study period|3|||
129540696|NCT01207219|466270478|FG002|Overall Study|changed diagnosis during study period|1|||
129540697|NCT01207219|466270476|FG000|Overall Study|Lost to Follow-up|6|||
129540698|NCT01207219|466270477|FG001|Overall Study|Lost to Follow-up|8|||
129540699|NCT01207219|466270478|FG002|Overall Study|Lost to Follow-up|6|||
129540700|NCT03532048|466270481|FG000|Overall Study|Lost to Follow-up|12|||
129540701|NCT03532048|466270482|FG001|Overall Study|Lost to Follow-up|17|||
129540702|NCT03532048|466270481|FG000|Overall Study|Withdrawal by Subject|7|||
129540703|NCT03532048|466270482|FG001|Overall Study|Withdrawal by Subject|0|||
129540704|NCT00596466|466270489|FG000|Overall Study|Lack of Efficacy|5|||
129540705|NCT00596466|466270489|FG000|Overall Study|Adverse Event|4|||
129540706|NCT00596466|466270489|FG000|Overall Study|Withdrawal by Subject|2|||
129540707|NCT00596466|466270489|FG000|Overall Study|Protocol Violation|2|||
129540708|NCT00596466|466270489|FG000|Overall Study|Unpecified|2|||
129540709|NCT00596466|466270489|FG000|Overall Study|Enrolled, not treated|2|||
129540710|NCT01298323|466270491|FG000|Overall Study|Adverse Event|2|||
129540711|NCT01298323|466270492|FG001|Overall Study|Adverse Event|4|||
129540712|NCT01298323|466270491|FG000|Overall Study|Death|11|||
129540713|NCT01298323|466270492|FG001|Overall Study|Death|16|||
129540714|NCT01298323|466270491|FG000|Overall Study|Lost to Follow-up|1|||
129540715|NCT01298323|466270492|FG001|Overall Study|Lost to Follow-up|0|||
129540716|NCT01298323|466270491|FG000|Overall Study|Withdrawal by Subject|6|||
129540717|NCT01298323|466270492|FG001|Overall Study|Withdrawal by Subject|3|||
129540718|NCT01298323|466270491|FG000|Overall Study|Protocol Violation|1|||
129540719|NCT01298323|466270492|FG001|Overall Study|Protocol Violation|0|||
129540720|NCT01298323|466270491|FG000|Overall Study|Other|10|||
129540721|NCT01298323|466270492|FG001|Overall Study|Other|9|||
129540722|NCT01298323|466270491|FG000|Overall Study|Ongoing|55|||
129540723|NCT01298323|466270492|FG001|Overall Study|Ongoing|55|||
129540724|NCT01298323|466270491|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129540725|NCT01298323|466270492|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129540726|NCT02950831|466270494|FG000|Overall Study|Lost to Follow-up|1|||
129540727|NCT02950831|466270494|FG000|Overall Study|Withdrawal by Subject|3|||
129540728|NCT02950831|466270494|FG000|Overall Study|stimulation trail failure|5|||
129540729|NCT01965600|466270495|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
129540730|NCT01965600|466270496|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
129540731|NCT01965600|466270497|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
129540732|NCT01965600|466270498|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
129540733|NCT01965600|466270495|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
129540734|NCT01965600|466270496|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
129540735|NCT01965600|466270497|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
129540736|NCT01965600|466270498|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
129540737|NCT01965600|466270495|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
129540738|NCT01965600|466270496|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
129540739|NCT01965600|466270497|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
129540740|NCT01965600|466270498|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
129540741|NCT01965600|466270495|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
129540742|NCT01965600|466270496|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
129540743|NCT01965600|466270497|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
129540744|NCT01965600|466270498|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
129540745|NCT01965600|466270495|FG000|Second Intervention|Study terminated by Sponsor|0|||
129540746|NCT01965600|466270496|FG001|Second Intervention|Study terminated by Sponsor|0|||
129540747|NCT01965600|466270497|FG002|Second Intervention|Study terminated by Sponsor|2|||
129540748|NCT01965600|466270498|FG003|Second Intervention|Study terminated by Sponsor|2|||
129540749|NCT03418727|466270504|FG000|Overall Study|Adverse Event|1|||
129540750|NCT03418727|466270505|FG001|Overall Study|Adverse Event|2|||
129540751|NCT03418727|466270506|FG002|Overall Study|Adverse Event|0|||
129540752|NCT03418727|466270504|FG000|Overall Study|Withdrawal by Subject|0|||
129540753|NCT03418727|466270505|FG001|Overall Study|Withdrawal by Subject|0|||
129540754|NCT03418727|466270506|FG002|Overall Study|Withdrawal by Subject|2|||
129540755|NCT00686894|466270511|FG000|Overall Study|Relapse|2|||
129540756|NCT00686894|466270511|FG000|Overall Study|Protocol Violation|4|||
129762067|NCT00626275|467091406|FG000|Part B|Lost to Follow-up|0|||
129762068|NCT00626275|467091407|FG001|Part B|Lost to Follow-up|0|||
129762069|NCT00626275|467091408|FG002|Part B|Lost to Follow-up|0|||
129762070|NCT00626275|467091409|FG003|Part B|Lost to Follow-up|0|||
129762071|NCT00626275|467091410|FG004|Part B|Lost to Follow-up|0|||
129762072|NCT00626275|467091411|FG005|Part B|Lost to Follow-up|0|||
129762073|NCT00626275|467091412|FG006|Part B|Lost to Follow-up|1|||
129540757|NCT01396434|466270512|FG000|Overall Study|Lost to Follow-up|1|||
129540758|NCT01396434|466270513|FG001|Overall Study|Lost to Follow-up|0|||
129540759|NCT01396434|466270514|FG002|Overall Study|Lost to Follow-up|0|||
129540760|NCT01396434|466270512|FG000|Overall Study|Other|10|||
129540761|NCT01396434|466270513|FG001|Overall Study|Other|0|||
129540762|NCT01396434|466270514|FG002|Overall Study|Other|0|||
129540763|NCT04678557|466270515|FG000|Overall Study|Withdrawal by Subject|1|||
129540764|NCT04678557|466270516|FG001|Overall Study|Withdrawal by Subject|0|||
129540765|NCT04678557|466270515|FG000|Overall Study|Lack of Efficacy|0|||
129762074|NCT00626275|467091413|FG007|Part B|Lost to Follow-up|0|||
129762075|NCT00626275|467091406|FG000|Part B|Withdrawal by Subject|0|||
129762076|NCT00626275|467091407|FG001|Part B|Withdrawal by Subject|0|||
129762077|NCT00626275|467091408|FG002|Part B|Withdrawal by Subject|0|||
129762078|NCT00626275|467091409|FG003|Part B|Withdrawal by Subject|0|||
129762079|NCT00626275|467091410|FG004|Part B|Withdrawal by Subject|0|||
129762080|NCT00626275|467091411|FG005|Part B|Withdrawal by Subject|0|||
129762081|NCT00626275|467091412|FG006|Part B|Withdrawal by Subject|0|||
129762082|NCT00626275|467091413|FG007|Part B|Withdrawal by Subject|1|||
129762083|NCT04999839|467091414|FG000|Overall Study|Adverse Event|1|||
129762084|NCT04999839|467091415|FG001|Overall Study|Adverse Event|1|||
129762085|NCT04999839|467091416|FG002|Overall Study|Adverse Event|1|||
129762086|NCT04999839|467091417|FG003|Overall Study|Adverse Event|1|||
129762087|NCT04999839|467091418|FG004|Overall Study|Adverse Event|1|||
129762088|NCT04999839|467091414|FG000|Overall Study|Lost to Follow-up|2|||
129762089|NCT04999839|467091415|FG001|Overall Study|Lost to Follow-up|0|||
129762090|NCT04999839|467091416|FG002|Overall Study|Lost to Follow-up|2|||
129762091|NCT04999839|467091417|FG003|Overall Study|Lost to Follow-up|4|||
129762092|NCT04999839|467091418|FG004|Overall Study|Lost to Follow-up|1|||
129762093|NCT04999839|467091414|FG000|Overall Study|Withdrawal by Subject|6|||
129762094|NCT04999839|467091415|FG001|Overall Study|Withdrawal by Subject|5|||
129762095|NCT04999839|467091416|FG002|Overall Study|Withdrawal by Subject|3|||
129762096|NCT04999839|467091417|FG003|Overall Study|Withdrawal by Subject|2|||
129762097|NCT04999839|467091418|FG004|Overall Study|Withdrawal by Subject|2|||
129762098|NCT04999839|467091414|FG000|Overall Study|Lack of Efficacy|0|||
129762099|NCT04999839|467091415|FG001|Overall Study|Lack of Efficacy|1|||
129762100|NCT04999839|467091416|FG002|Overall Study|Lack of Efficacy|0|||
129762101|NCT04999839|467091417|FG003|Overall Study|Lack of Efficacy|0|||
129762102|NCT04999839|467091418|FG004|Overall Study|Lack of Efficacy|0|||
129762103|NCT04999839|467091414|FG000|Overall Study|Physician Decision|0|||
129762104|NCT04999839|467091415|FG001|Overall Study|Physician Decision|0|||
129762105|NCT04999839|467091416|FG002|Overall Study|Physician Decision|0|||
129762106|NCT04999839|467091417|FG003|Overall Study|Physician Decision|0|||
129762107|NCT04999839|467091418|FG004|Overall Study|Physician Decision|1|||
129762108|NCT04999839|467091414|FG000|Overall Study|Sponsor request|0|||
129762109|NCT04999839|467091415|FG001|Overall Study|Sponsor request|1|||
129762110|NCT04999839|467091416|FG002|Overall Study|Sponsor request|0|||
129762111|NCT04999839|467091417|FG003|Overall Study|Sponsor request|0|||
129762112|NCT04999839|467091418|FG004|Overall Study|Sponsor request|0|||
129762113|NCT04999839|467091414|FG000|Overall Study|Other|0|||
129762114|NCT04999839|467091415|FG001|Overall Study|Other|0|||
129762115|NCT04999839|467091416|FG002|Overall Study|Other|1|||
129762116|NCT04999839|467091417|FG003|Overall Study|Other|0|||
129762117|NCT04999839|467091418|FG004|Overall Study|Other|0|||
129762118|NCT01362348|467091419|FG000|Overall Study|Protocol-defined stopping criteria|9|||
129762119|NCT01362348|467091419|FG000|Overall Study|Study closed/terminated|5|||
129762120|NCT02734693|467091422|FG000|Overall Study|Adverse Event|1|||
129762121|NCT02734693|467091423|FG001|Overall Study|Adverse Event|3|||
129762122|NCT02734693|467091424|FG002|Overall Study|Adverse Event|3|||
129762123|NCT02734693|467091422|FG000|Overall Study|Lack of Efficacy|1|||
129762124|NCT02734693|467091423|FG001|Overall Study|Lack of Efficacy|0|||
129762125|NCT02734693|467091424|FG002|Overall Study|Lack of Efficacy|0|||
129762126|NCT02734693|467091422|FG000|Overall Study|Lost to Follow-up|2|||
129762127|NCT02734693|467091423|FG001|Overall Study|Lost to Follow-up|0|||
129762128|NCT02734693|467091424|FG002|Overall Study|Lost to Follow-up|0|||
129762129|NCT02734693|467091422|FG000|Overall Study|Protocol Violation|1|||
129762130|NCT02734693|467091423|FG001|Overall Study|Protocol Violation|0|||
129762131|NCT02734693|467091424|FG002|Overall Study|Protocol Violation|0|||
129762132|NCT02734693|467091422|FG000|Overall Study|Withdrawal by Subject|1|||
129762133|NCT02734693|467091423|FG001|Overall Study|Withdrawal by Subject|0|||
129762134|NCT02734693|467091424|FG002|Overall Study|Withdrawal by Subject|0|||
129762135|NCT02898454|467091430|FG000|Overall Study|Adverse Event|4|||
129762136|NCT02898454|467091431|FG001|Overall Study|Adverse Event|1|||
129762137|NCT02898454|467091432|FG002|Overall Study|Adverse Event|2|||
129762138|NCT02898454|467091430|FG000|Overall Study|Protocol Violation|1|||
129762139|NCT02898454|467091431|FG001|Overall Study|Protocol Violation|0|||
129762140|NCT02898454|467091432|FG002|Overall Study|Protocol Violation|1|||
129762141|NCT02898454|467091430|FG000|Overall Study|Lack of Efficacy|4|||
129762142|NCT02898454|467091431|FG001|Overall Study|Lack of Efficacy|1|||
129762143|NCT02898454|467091432|FG002|Overall Study|Lack of Efficacy|0|||
129762144|NCT02898454|467091430|FG000|Overall Study|Withdrawal by Subject|6|||
129762145|NCT02898454|467091431|FG001|Overall Study|Withdrawal by Subject|3|||
129762146|NCT02898454|467091432|FG002|Overall Study|Withdrawal by Subject|3|||
129762147|NCT02898454|467091430|FG000|Overall Study|Lost to Follow-up|1|||
129762148|NCT02898454|467091431|FG001|Overall Study|Lost to Follow-up|0|||
129762149|NCT02898454|467091432|FG002|Overall Study|Lost to Follow-up|0|||
129762150|NCT02898454|467091430|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
129762151|NCT02898454|467091431|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
129762152|NCT02898454|467091432|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
129540766|NCT04678557|466270516|FG001|Overall Study|Lack of Efficacy|13|||
129540767|NCT04678557|466270515|FG000|Overall Study|Safety Evaluation|0|||
129540768|NCT04678557|466270516|FG001|Overall Study|Safety Evaluation|1|||
129540769|NCT02207413|466270517|FG000|Overall Study|Withdrawal by Subject|1|||
129540770|NCT02207413|466270518|FG001|Overall Study|Withdrawal by Subject|0|||
129540771|NCT02207413|466270519|FG002|Overall Study|Withdrawal by Subject|0|||
129540772|NCT02207413|466270520|FG003|Overall Study|Withdrawal by Subject|0|||
129540773|NCT02207413|466270521|FG004|Overall Study|Withdrawal by Subject|3|||
129540774|NCT02207413|466270522|FG005|Overall Study|Withdrawal by Subject|7|||
129540775|NCT02207413|466270517|FG000|Overall Study|Lost to Follow-up|0|||
129540776|NCT02207413|466270518|FG001|Overall Study|Lost to Follow-up|0|||
129540777|NCT02207413|466270519|FG002|Overall Study|Lost to Follow-up|0|||
129540778|NCT02207413|466270520|FG003|Overall Study|Lost to Follow-up|1|||
129540779|NCT02207413|466270521|FG004|Overall Study|Lost to Follow-up|1|||
129540780|NCT02207413|466270522|FG005|Overall Study|Lost to Follow-up|5|||
129540781|NCT02207413|466270517|FG000|Overall Study|Adverse Event|0|||
129540782|NCT02207413|466270518|FG001|Overall Study|Adverse Event|0|||
129540783|NCT02207413|466270519|FG002|Overall Study|Adverse Event|0|||
129540784|NCT02207413|466270520|FG003|Overall Study|Adverse Event|0|||
129540785|NCT02207413|466270521|FG004|Overall Study|Adverse Event|2|||
129540786|NCT02207413|466270522|FG005|Overall Study|Adverse Event|1|||
129540787|NCT02207413|466270517|FG000|Overall Study|Migrated/moved from study area|0|||
129540788|NCT02207413|466270518|FG001|Overall Study|Migrated/moved from study area|0|||
129540789|NCT02207413|466270519|FG002|Overall Study|Migrated/moved from study area|0|||
129540790|NCT02207413|466270520|FG003|Overall Study|Migrated/moved from study area|0|||
129540791|NCT02207413|466270521|FG004|Overall Study|Migrated/moved from study area|1|||
129540792|NCT02207413|466270522|FG005|Overall Study|Migrated/moved from study area|0|||
129540793|NCT00761462|466272409|FG000|Treatment|Subjects never received study medication|23|||
129540794|NCT00761462|466272410|FG001|Treatment|Subjects never received study medication|12|||
129540795|NCT00761462|466272409|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
129540796|NCT00761462|466272410|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
129540797|NCT00761462|466272409|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
129540798|NCT00761462|466272410|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
129540799|NCT00761462|466272409|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
129540800|NCT00761462|466272410|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
129540801|NCT01479777|466272411|FG000|Overall Study|Physician Decision|2|||
129540802|NCT01013207|466272415|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
129540803|NCT01541644|466272420|FG000|Overall Study|Withdrawal by Subject|3|||
129540804|NCT02389621|466272421|FG000|Treatment Period|Withdrawal by Subject|1|||
129540805|NCT02389621|466272422|FG001|Treatment Period|Withdrawal by Subject|1|||
129540806|NCT02389621|466272421|FG000|Posttreatment Period|Adverse Event|3|||
129540807|NCT02389621|466272422|FG001|Posttreatment Period|Adverse Event|1|||
129540808|NCT02389621|466272421|FG000|Posttreatment Period|Withdrawal by Subject|3|||
129540809|NCT02389621|466272422|FG001|Posttreatment Period|Withdrawal by Subject|2|||
129540810|NCT02389621|466272421|FG000|Posttreatment Period|Lost to Follow-up|1|||
129540811|NCT02389621|466272422|FG001|Posttreatment Period|Lost to Follow-up|1|||
129540812|NCT02389621|466272421|FG000|Posttreatment Period|Other - Miscellaneous|2|||
129540813|NCT02389621|466272422|FG001|Posttreatment Period|Other - Miscellaneous|0|||
129540814|NCT00953017|466272436|FG000|Overall Study|DId not show up for colonoscopy|4|||
129540815|NCT00953017|466272437|FG001|Overall Study|DId not show up for colonoscopy|4|||
129540816|NCT00953017|466272438|FG002|Overall Study|DId not show up for colonoscopy|5|||
129540817|NCT00953017|466272439|FG003|Overall Study|DId not show up for colonoscopy|4|||
129540818|NCT00953017|466272436|FG000|Overall Study|Incomplete data|1|||
129540819|NCT00953017|466272437|FG001|Overall Study|Incomplete data|1|||
129540820|NCT00953017|466272438|FG002|Overall Study|Incomplete data|0|||
129540821|NCT00953017|466272439|FG003|Overall Study|Incomplete data|0|||
129540822|NCT00953017|466272436|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
129540823|NCT00953017|466272437|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
129540824|NCT00953017|466272438|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
129540825|NCT00953017|466272439|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
129540826|NCT00953017|466272436|FG000|Overall Study|Brown stool prior to procedure|0|||
129540827|NCT00953017|466272437|FG001|Overall Study|Brown stool prior to procedure|0|||
129540828|NCT00953017|466272438|FG002|Overall Study|Brown stool prior to procedure|1|||
129540829|NCT00953017|466272439|FG003|Overall Study|Brown stool prior to procedure|0|||
129540830|NCT00449761|466272442|FG000|Overall Study|Disease progression|12|||
129540831|NCT00449761|466272442|FG000|Overall Study|Death|5|||
129540832|NCT00449761|466272442|FG000|Overall Study|New cancer therapy|1|||
129540833|NCT03735680|466272443|FG000|Overall Study|Withdrawal by Subject|0|||
129540834|NCT03735680|466272444|FG001|Overall Study|Withdrawal by Subject|1|||
129540835|NCT03735680|466272445|FG002|Overall Study|Withdrawal by Subject|0|||
129540836|NCT03735680|466272446|FG003|Overall Study|Withdrawal by Subject|0|||
129540837|NCT03735680|466272447|FG004|Overall Study|Withdrawal by Subject|0|||
129540838|NCT03735680|466272448|FG005|Overall Study|Withdrawal by Subject|1|||
129540839|NCT03735680|466272443|FG000|Overall Study|Patient unable or unwilling to continue|0|||
129540840|NCT03735680|466272444|FG001|Overall Study|Patient unable or unwilling to continue|0|||
129540841|NCT03735680|466272445|FG002|Overall Study|Patient unable or unwilling to continue|1|||
129540842|NCT03735680|466272446|FG003|Overall Study|Patient unable or unwilling to continue|0|||
129540843|NCT03735680|466272447|FG004|Overall Study|Patient unable or unwilling to continue|0|||
129540844|NCT03735680|466272448|FG005|Overall Study|Patient unable or unwilling to continue|0|||
129540845|NCT01548573|466272453|FG000|Overall Study|Death|3|||
129540846|NCT01548573|466272453|FG000|Overall Study|Withdrawal by Subject|2|||
129540847|NCT01366846|466272454|FG000|Overall Study|Withdrawal by Subject|2|||
129540848|NCT01366846|466272455|FG001|Overall Study|Withdrawal by Subject|0|||
129540849|NCT01366846|466272456|FG002|Overall Study|Withdrawal by Subject|0|||
129540850|NCT01366846|466272457|FG003|Overall Study|Withdrawal by Subject|0|||
129540851|NCT01366846|466272454|FG000|Overall Study|Communication Difficulties|1|||
129540852|NCT01366846|466272455|FG001|Overall Study|Communication Difficulties|4|||
129540853|NCT01366846|466272456|FG002|Overall Study|Communication Difficulties|0|||
129540854|NCT01366846|466272457|FG003|Overall Study|Communication Difficulties|1|||
129540855|NCT01366846|466272454|FG000|Overall Study|Scheduling Conflicts|0|||
129540856|NCT01366846|466272455|FG001|Overall Study|Scheduling Conflicts|0|||
129540857|NCT01366846|466272456|FG002|Overall Study|Scheduling Conflicts|1|||
129540858|NCT01366846|466272457|FG003|Overall Study|Scheduling Conflicts|0|||
129540859|NCT05064436|466272463|FG000|Overall Study|Other Reasons|1|||
129540860|NCT05064436|466272464|FG001|Overall Study|Other Reasons|0|||
129540861|NCT01711736|466272466|FG000|Overall Study|Lost to Follow-up|4|||
129540862|NCT01711736|466272467|FG001|Overall Study|Lost to Follow-up|1|||
129540863|NCT01711736|466272466|FG000|Overall Study|Withdrawal by Subject|6|||
129540864|NCT01711736|466272467|FG001|Overall Study|Withdrawal by Subject|6|||
129540865|NCT01711736|466272466|FG000|Overall Study|Migrated/moved from study area|2|||
129540866|NCT01711736|466272467|FG001|Overall Study|Migrated/moved from study area|1|||
129540867|NCT02957149|466272468|FG000|Overall Study|Withdrawal by Subject|5|||
129540868|NCT00643006|466272469|FG000|Overall Study|Lost to Follow-up|5|||
129540869|NCT00643006|466272470|FG001|Overall Study|Lost to Follow-up|4|||
129540870|NCT02506101|466272471|FG000|Overall Study|Transportation issues|1|||
129540871|NCT02506101|466272472|FG001|Overall Study|Transportation issues|0|||
129540872|NCT02506101|466272471|FG000|Overall Study|No enrollment and staff unavailability|1|||
129540873|NCT02506101|466272472|FG001|Overall Study|No enrollment and staff unavailability|0|||
129540874|NCT01151085|466272474|FG000|Overall Study|Lost to Follow-up|31|||
129540875|NCT01151085|466272474|FG000|Overall Study|Protocol Violation|25|||
129540876|NCT01308476|466272475|FG000|Overall Study|Lost to Follow-up|2|||
129540877|NCT01308476|466272476|FG001|Overall Study|Lost to Follow-up|2|||
129540878|NCT01308476|466272475|FG000|Overall Study|Other|1|||
129540879|NCT01308476|466272476|FG001|Overall Study|Other|0|||
129540880|NCT00812968|466272477|FG000|Overall Study|Relapse after erythroid response|6|||
129540881|NCT00812968|466272477|FG000|Overall Study|Disease progression|1|||
129540882|NCT00812968|466272477|FG000|Overall Study|No further treatment required|1|||
129540883|NCT00812968|466272477|FG000|Overall Study|Study closed due to marketing approval|3|||
129540884|NCT04196023|466272479|FG000|Overall Study|Withdrawal by Subject|0|||
129540885|NCT04196023|466272480|FG001|Overall Study|Withdrawal by Subject|1|||
129540886|NCT04196023|466272479|FG000|Overall Study|Adverse Event|3|||
129540887|NCT04196023|466272480|FG001|Overall Study|Adverse Event|1|||
129540888|NCT04196023|466272479|FG000|Overall Study|Lost to Follow-up|0|||
129540889|NCT04196023|466272480|FG001|Overall Study|Lost to Follow-up|1|||
129540890|NCT03358407|466272481|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540891|NCT03358407|466272482|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540892|NCT03358407|466272483|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
129540893|NCT03358407|466272484|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540894|NCT03358407|466272485|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540895|NCT03358407|466272486|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540896|NCT03358407|466272487|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540897|NCT03358407|466272488|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540898|NCT03358407|466272489|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540899|NCT03358407|466272490|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
129540900|NCT03358407|466272481|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540901|NCT03358407|466272482|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540902|NCT03358407|466272483|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540903|NCT03358407|466272484|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540904|NCT03358407|466272485|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
129540905|NCT03358407|466272486|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540906|NCT03358407|466272487|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540907|NCT03358407|466272488|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540908|NCT03358407|466272489|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540909|NCT03358407|466272490|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540910|NCT03358407|466272481|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129762153|NCT00647296|467091433|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129762154|NCT00647296|467091434|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129762155|NCT00647296|467091435|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
129762156|NCT00647296|467091436|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
129762157|NCT00647296|467091433|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
129762158|NCT00647296|467091434|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
129762159|NCT00647296|467091435|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
129762160|NCT00647296|467091436|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
129762161|NCT00647296|467091433|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
129762162|NCT00647296|467091434|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
129762163|NCT00647296|467091435|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
129762164|NCT00647296|467091436|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
129762165|NCT00647296|467091433|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
129762166|NCT00647296|467091434|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
129762167|NCT00647296|467091435|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
129762168|NCT00647296|467091436|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
129762169|NCT00647296|467091433|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
129762170|NCT00647296|467091434|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
129762171|NCT00647296|467091435|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
129762172|NCT00647296|467091436|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
129762173|NCT00647296|467091433|FG000|Part 2: 4-week Placebo Washout|Death|3|||
129762174|NCT00647296|467091434|FG001|Part 2: 4-week Placebo Washout|Death|0|||
129762175|NCT00647296|467091435|FG002|Part 2: 4-week Placebo Washout|Death|0|||
129762176|NCT00647296|467091436|FG003|Part 2: 4-week Placebo Washout|Death|0|||
129762177|NCT00647296|467091433|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
129762178|NCT00647296|467091434|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
129762179|NCT00647296|467091435|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
129762180|NCT00647296|467091436|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
129762181|NCT00647296|467091433|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
129762182|NCT00647296|467091434|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
129762183|NCT00647296|467091435|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
129762184|NCT00647296|467091436|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
129762185|NCT00647296|467091433|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
129762186|NCT00647296|467091434|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
129762187|NCT00647296|467091435|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
129762188|NCT00647296|467091436|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
129762189|NCT00647296|467091433|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
129762190|NCT00647296|467091434|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
129762191|NCT00647296|467091435|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
129762192|NCT00647296|467091436|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
129762193|NCT00647296|467091433|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
129762194|NCT00647296|467091434|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
129762195|NCT00647296|467091435|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
129762196|NCT00647296|467091436|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
129762197|NCT03883581|467091437|FG000|Overall Study|Withdrawal by Subject|4|||
129762198|NCT02926638|467091438|FG000|Overall Study|Progression|2|||
129762199|NCT02926638|467091439|FG001|Overall Study|Progression|5|||
129762200|NCT02926638|467091438|FG000|Overall Study|Ineligible|1|||
129762201|NCT02926638|467091439|FG001|Overall Study|Ineligible|0|||
129762202|NCT02926638|467091438|FG000|Overall Study|Not protocol specified|1|||
129762203|NCT02926638|467091439|FG001|Overall Study|Not protocol specified|0|||
129762204|NCT01908426|467092589|FG000|Overall Study|Adverse Event|98|||
129762205|NCT01908426|467092590|FG001|Overall Study|Adverse Event|11|||
129762206|NCT01908426|467092589|FG000|Overall Study|Clinical Deterioration|72|||
129762207|NCT01908426|467092590|FG001|Overall Study|Clinical Deterioration|38|||
129762208|NCT01908426|467092589|FG000|Overall Study|Lack of Efficacy|3|||
129762209|NCT01908426|467092590|FG001|Overall Study|Lack of Efficacy|0|||
129762210|NCT01908426|467092589|FG000|Overall Study|Lost to Follow-up|0|||
129762211|NCT01908426|467092590|FG001|Overall Study|Lost to Follow-up|1|||
129762212|NCT01908426|467092589|FG000|Overall Study|Physician Decision|3|||
129762213|NCT01908426|467092590|FG001|Overall Study|Physician Decision|3|||
129762214|NCT01908426|467092589|FG000|Overall Study|Withdrawal by Subject|11|||
129762215|NCT01908426|467092590|FG001|Overall Study|Withdrawal by Subject|6|||
129762216|NCT01908426|467092589|FG000|Overall Study|Progressive Disease|206|||
129762217|NCT01908426|467092590|FG001|Overall Study|Progressive Disease|152|||
129762218|NCT01908426|467092589|FG000|Overall Study|Protocol Violation|1|||
129762219|NCT01908426|467092590|FG001|Overall Study|Protocol Violation|0|||
129762220|NCT01908426|467092589|FG000|Overall Study|No Study Treatment Given|3|||
129762221|NCT01908426|467092590|FG001|Overall Study|No Study Treatment Given|0|||
129762222|NCT02426580|467092591|FG000|Overall Study|Death|2|||
129762223|NCT02426580|467092592|FG001|Overall Study|Death|2|||
129762224|NCT02426580|467092591|FG000|Overall Study|Lost to Follow-up|0|||
129762225|NCT02426580|467092592|FG001|Overall Study|Lost to Follow-up|9|||
129762226|NCT02426580|467092591|FG000|Overall Study|transfer to hemodialysis|5|||
129762227|NCT02426580|467092592|FG001|Overall Study|transfer to hemodialysis|5|||
129762228|NCT02426580|467092591|FG000|Overall Study|Kidney transplant|3|||
129762229|NCT02426580|467092592|FG001|Overall Study|Kidney transplant|0|||
129762230|NCT02426580|467092591|FG000|Overall Study|Allergic to egg white|1|||
129762231|NCT02426580|467092592|FG001|Overall Study|Allergic to egg white|0|||
129762232|NCT00882440|467092593|FG000|Overall Study|Adverse Event|2|||
129762233|NCT00882440|467092594|FG001|Overall Study|Adverse Event|2|||
129762234|NCT00882440|467092595|FG002|Overall Study|Adverse Event|2|||
129762235|NCT00882440|467092596|FG003|Overall Study|Adverse Event|1|||
129762236|NCT00882440|467092597|FG004|Overall Study|Adverse Event|1|||
129762237|NCT00882440|467092598|FG005|Overall Study|Adverse Event|4|||
129762238|NCT00882440|467092599|FG006|Overall Study|Adverse Event|2|||
129762239|NCT00882440|467092593|FG000|Overall Study|Lack of Efficacy|3|||
129762240|NCT00882440|467092594|FG001|Overall Study|Lack of Efficacy|5|||
129762241|NCT00882440|467092595|FG002|Overall Study|Lack of Efficacy|2|||
129762242|NCT00882440|467092596|FG003|Overall Study|Lack of Efficacy|0|||
129762243|NCT00882440|467092597|FG004|Overall Study|Lack of Efficacy|0|||
129762244|NCT00882440|467092598|FG005|Overall Study|Lack of Efficacy|3|||
129762245|NCT00882440|467092599|FG006|Overall Study|Lack of Efficacy|0|||
129762246|NCT00882440|467092593|FG000|Overall Study|Lost to Follow-up|2|||
129762247|NCT00882440|467092594|FG001|Overall Study|Lost to Follow-up|0|||
129762248|NCT00882440|467092595|FG002|Overall Study|Lost to Follow-up|1|||
129762249|NCT00882440|467092596|FG003|Overall Study|Lost to Follow-up|1|||
129762250|NCT00882440|467092597|FG004|Overall Study|Lost to Follow-up|1|||
129762251|NCT00882440|467092598|FG005|Overall Study|Lost to Follow-up|0|||
129762252|NCT00882440|467092599|FG006|Overall Study|Lost to Follow-up|1|||
129762253|NCT00882440|467092593|FG000|Overall Study|Protocol Violation|0|||
129762254|NCT00882440|467092594|FG001|Overall Study|Protocol Violation|0|||
129762255|NCT00882440|467092595|FG002|Overall Study|Protocol Violation|1|||
129762256|NCT00882440|467092596|FG003|Overall Study|Protocol Violation|1|||
129762257|NCT00882440|467092597|FG004|Overall Study|Protocol Violation|1|||
129762258|NCT00882440|467092598|FG005|Overall Study|Protocol Violation|0|||
129762259|NCT00882440|467092599|FG006|Overall Study|Protocol Violation|0|||
129762260|NCT00882440|467092593|FG000|Overall Study|Withdrawal by Subject|2|||
129762261|NCT00882440|467092594|FG001|Overall Study|Withdrawal by Subject|1|||
129762262|NCT00882440|467092595|FG002|Overall Study|Withdrawal by Subject|1|||
129762263|NCT00882440|467092596|FG003|Overall Study|Withdrawal by Subject|0|||
129762264|NCT00882440|467092597|FG004|Overall Study|Withdrawal by Subject|6|||
129762265|NCT00882440|467092598|FG005|Overall Study|Withdrawal by Subject|0|||
129762266|NCT00882440|467092599|FG006|Overall Study|Withdrawal by Subject|1|||
129762267|NCT00882440|467092593|FG000|Overall Study|Patient Uncooperative|2|||
129762268|NCT00882440|467092594|FG001|Overall Study|Patient Uncooperative|0|||
129762269|NCT00882440|467092595|FG002|Overall Study|Patient Uncooperative|0|||
129762270|NCT00882440|467092596|FG003|Overall Study|Patient Uncooperative|0|||
129762271|NCT00882440|467092597|FG004|Overall Study|Patient Uncooperative|1|||
129762272|NCT00882440|467092598|FG005|Overall Study|Patient Uncooperative|0|||
129762273|NCT00882440|467092599|FG006|Overall Study|Patient Uncooperative|0|||
129762274|NCT05482308|467092603|FG000|Overall Study|Withdrawal by Subject|1|||
129762275|NCT05482308|467092604|FG001|Overall Study|Withdrawal by Subject|0|||
129762276|NCT05482308|467092603|FG000|Overall Study|No longer meets eligibility criteria|0|||
129762277|NCT05482308|467092604|FG001|Overall Study|No longer meets eligibility criteria|1|||
129762278|NCT00416624|467092613|FG000|Overall Study|Withdrawal by Subject|1|||
129762279|NCT00416624|467092614|FG001|Overall Study|Withdrawal by Subject|6|||
129762280|NCT00416624|467092615|FG002|Overall Study|Withdrawal by Subject|4|||
129762281|NCT00416624|467092616|FG003|Overall Study|Withdrawal by Subject|9|||
129762282|NCT00416624|467092613|FG000|Overall Study|Death|4|||
129762283|NCT00416624|467092614|FG001|Overall Study|Death|7|||
129762284|NCT00416624|467092615|FG002|Overall Study|Death|7|||
129762285|NCT00416624|467092616|FG003|Overall Study|Death|1|||
129762286|NCT00416624|467092613|FG000|Overall Study|Adverse Event|8|||
129762287|NCT00416624|467092614|FG001|Overall Study|Adverse Event|3|||
129762288|NCT00416624|467092615|FG002|Overall Study|Adverse Event|2|||
129762289|NCT00416624|467092616|FG003|Overall Study|Adverse Event|2|||
129762290|NCT00416624|467092613|FG000|Overall Study|Other|8|||
129762291|NCT00416624|467092614|FG001|Overall Study|Other|11|||
129762292|NCT00416624|467092615|FG002|Overall Study|Other|5|||
129762293|NCT00416624|467092616|FG003|Overall Study|Other|5|||
129762294|NCT00416624|467092613|FG000|Overall Study|Cancel|1|||
129762295|NCT00416624|467092614|FG001|Overall Study|Cancel|0|||
129762296|NCT00416624|467092615|FG002|Overall Study|Cancel|0|||
129762297|NCT00416624|467092616|FG003|Overall Study|Cancel|0|||
129762298|NCT00768989|467092619|FG000|Prior to Week 24|Withdrawal by Subject|1|||
129762299|NCT00768989|467092620|FG001|Prior to Week 24|Withdrawal by Subject|0|||
129762300|NCT00768989|467092619|FG000|Prior to Week 24|Adverse Event|3|||
129762301|NCT00768989|467092620|FG001|Prior to Week 24|Adverse Event|0|||
129762302|NCT00768989|467092619|FG000|Prior to Week 24|Lost to Follow-up|0|||
129762303|NCT00768989|467092620|FG001|Prior to Week 24|Lost to Follow-up|1|||
129762304|NCT00768989|467092619|FG000|Prior to Week 24|Protocol Violation|0|||
129762305|NCT00768989|467092620|FG001|Prior to Week 24|Protocol Violation|2|||
129762306|NCT00768989|467092619|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
129762307|NCT00768989|467092620|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
129762308|NCT00768989|467092619|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
129762309|NCT00768989|467092620|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
129762310|NCT00768989|467092619|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
129762311|NCT00768989|467092620|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
129762312|NCT00768989|467092619|FG000|On or After Week 36|Lack of Efficacy|1|||
129762313|NCT00768989|467092620|FG001|On or After Week 36|Lack of Efficacy|0|||
129762314|NCT00768989|467092619|FG000|On or After Week 36|Adverse Event|0|||
129762315|NCT00768989|467092620|FG001|On or After Week 36|Adverse Event|1|||
129762316|NCT00768989|467092619|FG000|On or After Week 36|Lost to Follow-up|1|||
129762317|NCT00768989|467092620|FG001|On or After Week 36|Lost to Follow-up|0|||
129762318|NCT00768989|467092619|FG000|On or After Week 36|Poor Compliance|1|||
129762319|NCT00768989|467092620|FG001|On or After Week 36|Poor Compliance|0|||
129762320|NCT00768989|467092619|FG000|On or After Week 36|Protocol Violation|1|||
129762321|NCT00768989|467092620|FG001|On or After Week 36|Protocol Violation|0|||
129762322|NCT00768989|467092619|FG000|On or After Week 36|Did not attend termination visit|2|||
129762323|NCT00768989|467092620|FG001|On or After Week 36|Did not attend termination visit|0|||
129762324|NCT00768989|467092619|FG000|On or After Week 36|Sponsor Termination|45|||
129762325|NCT00768989|467092620|FG001|On or After Week 36|Sponsor Termination|26|||
129762326|NCT03661723|467092621|FG000|Overall Study|Disease Progression|4|||
129762327|NCT03661723|467092622|FG001|Overall Study|Disease Progression|24|||
129762328|NCT03661723|467092623|FG002|Overall Study|Disease Progression|4|||
129762329|NCT03661723|467092624|FG003|Overall Study|Disease Progression|19|||
129762330|NCT03661723|467092621|FG000|Overall Study|Withdrawal by Subject|1|||
129762331|NCT03661723|467092622|FG001|Overall Study|Withdrawal by Subject|0|||
129762332|NCT03661723|467092623|FG002|Overall Study|Withdrawal by Subject|2|||
129762333|NCT03661723|467092624|FG003|Overall Study|Withdrawal by Subject|4|||
129762334|NCT03661723|467092621|FG000|Overall Study|Physician Decision|1|||
129762335|NCT03661723|467092622|FG001|Overall Study|Physician Decision|0|||
129762336|NCT03661723|467092623|FG002|Overall Study|Physician Decision|0|||
129762337|NCT03661723|467092624|FG003|Overall Study|Physician Decision|0|||
129762338|NCT03661723|467092621|FG000|Overall Study|Clinical Deterioration|0|||
129762339|NCT03661723|467092622|FG001|Overall Study|Clinical Deterioration|0|||
129762340|NCT03661723|467092623|FG002|Overall Study|Clinical Deterioration|0|||
129762341|NCT03661723|467092624|FG003|Overall Study|Clinical Deterioration|1|||
129762342|NCT03452540|467092628|FG000|Overall Study|Adverse Event|1|||
129762343|NCT03452540|467092628|FG000|Overall Study|Withdrawal by Subject|1|||
129762344|NCT03452540|467092628|FG000|Overall Study|Other SAE and AE|2|||
129762345|NCT01045460|467092631|FG000|Overall Study|Physician Decision|3|||
129762346|NCT01045460|467092632|FG001|Overall Study|Physician Decision|2|||
129762347|NCT01045460|467092631|FG000|Overall Study|Lost to Follow-up|0|||
129762348|NCT01045460|467092632|FG001|Overall Study|Lost to Follow-up|1|||
129762349|NCT01045460|467092631|FG000|Overall Study|Lack of Efficacy|3|||
129762350|NCT01045460|467092632|FG001|Overall Study|Lack of Efficacy|0|||
129762351|NCT00524485|467092633|FG000|Overall Study|Withdrawal by Subject|5|||
129762352|NCT00436332|467092634|FG000|Overall Study|Adverse Event|9|||
129762353|NCT00436332|467092634|FG000|Overall Study|Withdrawal by Subject|2|||
129762354|NCT00436332|467092634|FG000|Overall Study|Progression|59|||
129762355|NCT00436332|467092634|FG000|Overall Study|Death|2|||
129762356|NCT00436332|467092634|FG000|Overall Study|Not Protocol Specified|6|||
129762357|NCT00436332|467092634|FG000|Overall Study|Ineligible|2|||
129762358|NCT00436332|467092634|FG000|Overall Study|Never Received Treatment|3|||
129762359|NCT00472108|467092635|FG000|Overall Study|Lost to Follow-up|0|||
129762360|NCT00472108|467092636|FG001|Overall Study|Lost to Follow-up|1|||
129762361|NCT01339689|467092639|FG000|Overall Study|Adverse Event|1|||
129762362|NCT01339689|467092640|FG001|Overall Study|Adverse Event|2|||
129762363|NCT01339689|467092639|FG000|Overall Study|Lost to Follow-up|9|||
129762364|NCT01339689|467092640|FG001|Overall Study|Lost to Follow-up|3|||
129762365|NCT01339689|467092639|FG000|Overall Study|Withdrawal by Subject|3|||
129762366|NCT01339689|467092640|FG001|Overall Study|Withdrawal by Subject|0|||
129762367|NCT01339689|467092639|FG000|Overall Study|Noncompliance|1|||
129762368|NCT01339689|467092640|FG001|Overall Study|Noncompliance|0|||
129762369|NCT01339689|467092639|FG000|Overall Study|Relocated out of area|0|||
129762370|NCT01339689|467092640|FG001|Overall Study|Relocated out of area|1|||
129762371|NCT01339689|467092639|FG000|Overall Study|Other|2|||
129762372|NCT01339689|467092640|FG001|Overall Study|Other|2|||
129762373|NCT01339689|467092639|FG000|Overall Study|multiple reasons|1|||
129762374|NCT01339689|467092640|FG001|Overall Study|multiple reasons|1|||
129762375|NCT00667888|467092641|FG000|Overall Study|Death|1|||
129762376|NCT00667888|467092642|FG001|Overall Study|Death|1|||
129762377|NCT00667888|467092641|FG000|Overall Study|Withdrawal by Subject|6|||
129762378|NCT00667888|467092642|FG001|Overall Study|Withdrawal by Subject|3|||
129762379|NCT00667888|467092641|FG000|Overall Study|Proceed with other treatment|3|||
129762380|NCT00667888|467092642|FG001|Overall Study|Proceed with other treatment|3|||
129762381|NCT00667888|467092641|FG000|Overall Study|Ineligible after SIM|0|||
129762382|NCT00667888|467092642|FG001|Overall Study|Ineligible after SIM|2|||
129762383|NCT00883779|467092643|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
129762384|NCT00883779|467092644|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
129762385|NCT00883779|467092643|FG000|Primary Study Treatment Phase|Disease progression|75|||
129762386|NCT00883779|467092644|FG001|Primary Study Treatment Phase|Disease progression|59|||
129762387|NCT00883779|467092643|FG000|Primary Study Treatment Phase|Adverse Event|16|||
129762388|NCT00883779|467092644|FG001|Primary Study Treatment Phase|Adverse Event|16|||
129762389|NCT00883779|467092643|FG000|Primary Study Treatment Phase|Death|2|||
129762390|NCT00883779|467092644|FG001|Primary Study Treatment Phase|Death|3|||
129762391|NCT00883779|467092643|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
129762392|NCT00883779|467092644|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
129762393|NCT00883779|467092643|FG000|Primary Study Treatment Phase|Other|3|||
129762394|NCT00883779|467092644|FG001|Primary Study Treatment Phase|Other|0|||
129762395|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Adverse Event|2|||
129762396|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Adverse Event|3|||
129762397|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Death|1|||
129762398|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Death|3|||
129762399|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
129762400|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
129762401|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
129540911|NCT03358407|466272482|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540912|NCT03358407|466272483|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540913|NCT03358407|466272484|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540914|NCT03358407|466272485|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540915|NCT03358407|466272486|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
129540916|NCT03358407|466272487|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540917|NCT03358407|466272488|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
129540918|NCT03358407|466272489|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540919|NCT03358407|466272490|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
129540920|NCT03358407|466272481|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540921|NCT03358407|466272482|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540922|NCT03358407|466272483|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540923|NCT03358407|466272484|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540924|NCT03358407|466272485|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540925|NCT03358407|466272486|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
129540926|NCT03358407|466272487|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540927|NCT03358407|466272488|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
129540928|NCT03358407|466272489|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540929|NCT03358407|466272490|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
129540930|NCT03358407|466272481|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540931|NCT03358407|466272482|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540932|NCT03358407|466272483|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540933|NCT03358407|466272484|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540934|NCT03358407|466272485|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540935|NCT03358407|466272486|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
129540936|NCT03358407|466272487|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
129540937|NCT03358407|466272488|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540938|NCT03358407|466272489|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540939|NCT03358407|466272490|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
129540940|NCT03358407|466272481|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540941|NCT03358407|466272482|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540942|NCT03358407|466272483|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540943|NCT03358407|466272484|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540944|NCT03358407|466272485|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540945|NCT03358407|466272486|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
129540946|NCT03358407|466272487|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
129540947|NCT03358407|466272488|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
129540948|NCT03358407|466272489|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540949|NCT03358407|466272490|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
129540950|NCT01283009|466272491|FG000|Overall Study|Death|83|||
129540951|NCT01283009|466272492|FG001|Overall Study|Death|78|||
129540952|NCT01283009|466272491|FG000|Overall Study|Study ended early|23|||
129540953|NCT01283009|466272492|FG001|Overall Study|Study ended early|26|||
129762402|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
129762403|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Disease progression|103|||
129762404|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Disease progression|122|||
129762405|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Other|3|||
129762406|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Other|0|||
129762407|NCT00883779|467092643|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
129762408|NCT00883779|467092644|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
129762409|NCT00883779|467092643|FG000|Off-study Phase|Death|185|||
129762410|NCT00883779|467092644|FG001|Off-study Phase|Death|174|||
129762411|NCT00883779|467092643|FG000|Off-study Phase|Refused treatment|1|||
129762412|NCT00883779|467092644|FG001|Off-study Phase|Refused treatment|1|||
129762413|NCT00883779|467092643|FG000|Off-study Phase|Failure to return|5|||
129762414|NCT00883779|467092644|FG001|Off-study Phase|Failure to return|6|||
129762415|NCT00883779|467092643|FG000|Off-study Phase|Other|18|||
129762416|NCT00883779|467092644|FG001|Off-study Phase|Other|21|||
129762417|NCT02140047|467092645|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129762418|NCT02140047|467092646|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129762419|NCT02140047|467092647|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129762420|NCT00499681|467092648|FG000|Overall Study|toxicity|0|||
129762421|NCT00499681|467092649|FG001|Overall Study|toxicity|1|||
129762422|NCT00499681|467092648|FG000|Overall Study|disease progression|0|||
129762423|NCT00499681|467092649|FG001|Overall Study|disease progression|1|||
129762424|NCT00079040|467092650|FG000|Overall Study|Withdrew before treatment|1|||
129762425|NCT00079040|467092650|FG000|Overall Study|Ineligible|1|||
129762426|NCT00325897|467092651|FG000|Overall Study|Lost to Follow-up|12|||
129762427|NCT00325897|467092652|FG001|Overall Study|Lost to Follow-up|13|||
129762428|NCT03915717|467092655|FG000|Overall Study|EchoMark Not Implanted|6|||
129762429|NCT03748823|467092657|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129762430|NCT03748823|467092658|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
129762431|NCT03748823|467092657|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
129762432|NCT03748823|467092658|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
129762433|NCT03748823|467092657|FG000|Extension Period|Withdrawal by Subject|9|||
129762434|NCT03748823|467092658|FG001|Extension Period|Withdrawal by Subject|12|||
129762435|NCT03748823|467092657|FG000|Extension Period|Death|2|||
129762436|NCT03748823|467092658|FG001|Extension Period|Death|2|||
129762437|NCT03748823|467092657|FG000|Extension Period|Other than Specified|0|||
129762438|NCT03748823|467092658|FG001|Extension Period|Other than Specified|1|||
129762439|NCT03748823|467092657|FG000|Extension Period|Protocol Violation|1|||
129762440|NCT03748823|467092658|FG001|Extension Period|Protocol Violation|0|||
129762441|NCT03748823|467092657|FG000|Extension Period|Lost to Follow-up|0|||
129762442|NCT03748823|467092658|FG001|Extension Period|Lost to Follow-up|1|||
129762443|NCT03748823|467092657|FG000|Extension Period|Lack of Efficacy|0|||
129762444|NCT03748823|467092658|FG001|Extension Period|Lack of Efficacy|1|||
129762445|NCT03748823|467092657|FG000|Extension Period|Physician Decision|1|||
129762446|NCT03748823|467092658|FG001|Extension Period|Physician Decision|2|||
129762447|NCT01664910|467092662|FG000|Overall Study|Adverse Event|0|||
129762448|NCT01664910|467092663|FG001|Overall Study|Adverse Event|0|||
129762449|NCT01664910|467092664|FG002|Overall Study|Adverse Event|1|||
129762450|NCT01011673|467092665|FG000|Randomized|Secondary headache|2|||
129762451|NCT01011673|467092666|FG001|Randomized|Secondary headache|1|||
129762452|NCT01011673|467092665|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
129762453|NCT01011673|467092666|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
129762454|NCT01632020|467092667|FG000|Overall Study|Withdrawal by Subject|1|||
129762455|NCT01632020|467092668|FG001|Overall Study|Withdrawal by Subject|0|||
129762456|NCT01632020|467092667|FG000|Overall Study|Adverse Event|1|||
129762457|NCT01632020|467092668|FG001|Overall Study|Adverse Event|0|||
129762458|NCT00549640|467092670|FG000|Overall Study|Withdrawal by Subject|6|||
129762459|NCT00549640|467092671|FG001|Overall Study|Withdrawal by Subject|12|||
129762460|NCT00549640|467092670|FG000|Overall Study|Adverse Event|5|||
129762461|NCT00549640|467092671|FG001|Overall Study|Adverse Event|0|||
129762462|NCT00549640|467092670|FG000|Overall Study|Lost to Follow-up|7|||
129762463|NCT00549640|467092671|FG001|Overall Study|Lost to Follow-up|4|||
129762464|NCT00399516|467092680|FG000|Overall Study|Lost to Follow-up|2|||
129762465|NCT00539981|467092683|FG000|Overall Study|Adverse events (AE)|3|||
129762466|NCT00539981|467092684|FG001|Overall Study|Adverse events (AE)|3|||
129762467|NCT00539981|467092683|FG000|Overall Study|Lost to Follow-up|260|||
129762468|NCT00539981|467092684|FG001|Overall Study|Lost to Follow-up|251|||
129762469|NCT00539981|467092683|FG000|Overall Study|Withdrew consent|22|||
129762470|NCT00539981|467092684|FG001|Overall Study|Withdrew consent|14|||
129762471|NCT00539981|467092683|FG000|Overall Study|Death|1|||
129762472|NCT00539981|467092684|FG001|Overall Study|Death|1|||
129762473|NCT00539981|467092683|FG000|Overall Study|Other reason-unspecified|9|||
129762474|NCT00539981|467092684|FG001|Overall Study|Other reason-unspecified|13|||
129762475|NCT02675907|467092685|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
129762476|NCT02675907|467092686|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
129762477|NCT02675907|467092685|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
129762478|NCT02675907|467092686|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
129762479|NCT02675907|467092685|FG000|Study Overall|Lack of Efficacy|1|||
129762480|NCT02675907|467092686|FG001|Study Overall|Lack of Efficacy|0|||
129762481|NCT02675907|467092685|FG000|Study Overall|Withdrawal by Subject|2|||
129762482|NCT02675907|467092686|FG001|Study Overall|Withdrawal by Subject|2|||
129762483|NCT02675907|467092685|FG000|Study Overall|Lost to Follow-up|0|||
129762484|NCT02675907|467092686|FG001|Study Overall|Lost to Follow-up|2|||
129762485|NCT01611792|467092687|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
129762486|NCT01611792|467092688|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
129762487|NCT01611792|467092687|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
129762488|NCT01611792|467092688|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
129762489|NCT01129622|467092689|FG000|Overall Study|Withdrawal by Subject|2|||
129762490|NCT00591006|467092690|FG000|Overall Study|Withdrawal by Subject|0|||
129762491|NCT00591006|467092691|FG001|Overall Study|Withdrawal by Subject|0|||
129762492|NCT00591006|467092692|FG002|Overall Study|Withdrawal by Subject|0|||
129762493|NCT00591006|467092693|FG003|Overall Study|Withdrawal by Subject|0|||
129762494|NCT00591006|467092694|FG004|Overall Study|Withdrawal by Subject|0|||
129762495|NCT00591006|467092695|FG005|Overall Study|Withdrawal by Subject|0|||
129762496|NCT00591006|467092696|FG006|Overall Study|Withdrawal by Subject|0|||
129762497|NCT00591006|467092697|FG007|Overall Study|Withdrawal by Subject|0|||
129762498|NCT00591006|467092698|FG008|Overall Study|Withdrawal by Subject|0|||
129762499|NCT00591006|467092699|FG009|Overall Study|Withdrawal by Subject|0|||
129762500|NCT00591006|467092700|FG010|Overall Study|Withdrawal by Subject|0|||
129762501|NCT00591006|467092701|FG011|Overall Study|Withdrawal by Subject|0|||
129762502|NCT00591006|467092702|FG012|Overall Study|Withdrawal by Subject|0|||
129762503|NCT00591006|467092703|FG013|Overall Study|Withdrawal by Subject|0|||
129762504|NCT00591006|467092704|FG014|Overall Study|Withdrawal by Subject|0|||
129762505|NCT00591006|467092705|FG015|Overall Study|Withdrawal by Subject|1|||
129762506|NCT00591006|467092706|FG016|Overall Study|Withdrawal by Subject|0|||
129762507|NCT00591006|467092707|FG017|Overall Study|Withdrawal by Subject|0|||
129762508|NCT00591006|467092708|FG018|Overall Study|Withdrawal by Subject|0|||
129762509|NCT00591006|467092709|FG019|Overall Study|Withdrawal by Subject|0|||
129762510|NCT00591006|467092710|FG020|Overall Study|Withdrawal by Subject|0|||
129762511|NCT00591006|467092711|FG021|Overall Study|Withdrawal by Subject|0|||
129762512|NCT00591006|467092712|FG022|Overall Study|Withdrawal by Subject|0|||
129762513|NCT00591006|467092713|FG023|Overall Study|Withdrawal by Subject|1|||
129762514|NCT00591006|467092690|FG000|Overall Study|Adverse Event|0|||
129762515|NCT00591006|467092691|FG001|Overall Study|Adverse Event|0|||
129762516|NCT00591006|467092692|FG002|Overall Study|Adverse Event|0|||
129762517|NCT00591006|467092693|FG003|Overall Study|Adverse Event|0|||
129762518|NCT00591006|467092694|FG004|Overall Study|Adverse Event|0|||
129762519|NCT00591006|467092695|FG005|Overall Study|Adverse Event|0|||
129762520|NCT00591006|467092696|FG006|Overall Study|Adverse Event|0|||
129762521|NCT00591006|467092697|FG007|Overall Study|Adverse Event|0|||
129762522|NCT00591006|467092698|FG008|Overall Study|Adverse Event|0|||
129762523|NCT00591006|467092699|FG009|Overall Study|Adverse Event|0|||
129762524|NCT00591006|467092700|FG010|Overall Study|Adverse Event|0|||
129762525|NCT00591006|467092701|FG011|Overall Study|Adverse Event|0|||
129762526|NCT00591006|467092702|FG012|Overall Study|Adverse Event|0|||
129762527|NCT00591006|467092703|FG013|Overall Study|Adverse Event|0|||
129762528|NCT00591006|467092704|FG014|Overall Study|Adverse Event|0|||
129762529|NCT00591006|467092705|FG015|Overall Study|Adverse Event|0|||
129762530|NCT00591006|467092706|FG016|Overall Study|Adverse Event|0|||
129762531|NCT00591006|467092707|FG017|Overall Study|Adverse Event|0|||
129762532|NCT00591006|467092708|FG018|Overall Study|Adverse Event|0|||
129762533|NCT00591006|467092709|FG019|Overall Study|Adverse Event|0|||
129762534|NCT00591006|467092710|FG020|Overall Study|Adverse Event|0|||
129762535|NCT00591006|467092711|FG021|Overall Study|Adverse Event|0|||
129762536|NCT00591006|467092712|FG022|Overall Study|Adverse Event|1|||
129762537|NCT00591006|467092713|FG023|Overall Study|Adverse Event|0|||
129762538|NCT00689390|467092714|FG000|Overall Study|Adverse Event|19|||
129762539|NCT00689390|467092715|FG001|Overall Study|Adverse Event|0|||
129762540|NCT00689390|467092714|FG000|Overall Study|Lost to Follow-up|179|||
129762541|NCT00689390|467092715|FG001|Overall Study|Lost to Follow-up|7|||
129762542|NCT00689390|467092714|FG000|Overall Study|Withdrawal by Subject|117|||
129762543|NCT00689390|467092715|FG001|Overall Study|Withdrawal by Subject|3|||
129762544|NCT00689390|467092714|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
129762545|NCT00689390|467092715|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
129762546|NCT00689390|467092714|FG000|Overall Study|Non-Compliance With Protocol|21|||
129762547|NCT00689390|467092715|FG001|Overall Study|Non-Compliance With Protocol|0|||
129762548|NCT00689390|467092714|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
129762549|NCT00689390|467092715|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
129762550|NCT00689390|467092714|FG000|Overall Study|Administrative|37|||
129762551|NCT00689390|467092715|FG001|Overall Study|Administrative|0|||
129762552|NCT02343263|467092716|FG000|Overall Study|Physician Decision|5|||
129762553|NCT02343263|467092717|FG001|Overall Study|Physician Decision|3|||
129762554|NCT02343263|467092718|FG002|Overall Study|Physician Decision|1|||
129762555|NCT00525512|467092732|FG000|Double-Blind Phase|Adverse Event|48|||
129762556|NCT00525512|467092733|FG001|Double-Blind Phase|Adverse Event|28|||
129762557|NCT00525512|467092734|FG002|Double-Blind Phase|Adverse Event|0|||
129762558|NCT00525512|467092735|FG003|Double-Blind Phase|Adverse Event|0|||
129762559|NCT00525512|467092732|FG000|Double-Blind Phase|Protocol Violation|3|||
129762560|NCT00525512|467092733|FG001|Double-Blind Phase|Protocol Violation|1|||
129762561|NCT00525512|467092734|FG002|Double-Blind Phase|Protocol Violation|0|||
129762562|NCT00525512|467092735|FG003|Double-Blind Phase|Protocol Violation|0|||
129762563|NCT00525512|467092732|FG000|Double-Blind Phase|Lost to Follow-up|3|||
129762564|NCT00525512|467092733|FG001|Double-Blind Phase|Lost to Follow-up|7|||
129762565|NCT00525512|467092734|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129762566|NCT00525512|467092735|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129762567|NCT00525512|467092732|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
129762568|NCT00525512|467092733|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
129762569|NCT00525512|467092734|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129762570|NCT00525512|467092735|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129762571|NCT00525512|467092732|FG000|Double-Blind Phase|Lack of Efficacy|13|||
129762572|NCT00525512|467092733|FG001|Double-Blind Phase|Lack of Efficacy|5|||
129762573|NCT00525512|467092734|FG002|Double-Blind Phase|Lack of Efficacy|0|||
129762574|NCT00525512|467092735|FG003|Double-Blind Phase|Lack of Efficacy|0|||
129762575|NCT00525512|467092732|FG000|Double-Blind Phase|Other reason (not specified)|12|||
129762576|NCT00525512|467092733|FG001|Double-Blind Phase|Other reason (not specified)|13|||
129762577|NCT00525512|467092734|FG002|Double-Blind Phase|Other reason (not specified)|0|||
129762578|NCT00525512|467092735|FG003|Double-Blind Phase|Other reason (not specified)|0|||
129762579|NCT00525512|467092732|FG000|Open-Label Phase|Adverse Event|0|||
129762580|NCT00525512|467092733|FG001|Open-Label Phase|Adverse Event|0|||
129762581|NCT00525512|467092734|FG002|Open-Label Phase|Adverse Event|1|||
129762582|NCT00525512|467092735|FG003|Open-Label Phase|Adverse Event|0|||
129762583|NCT00525512|467092732|FG000|Open-Label Phase|Lost to Follow-up|0|||
129762584|NCT00525512|467092733|FG001|Open-Label Phase|Lost to Follow-up|0|||
129762585|NCT00525512|467092734|FG002|Open-Label Phase|Lost to Follow-up|1|||
129762586|NCT00525512|467092735|FG003|Open-Label Phase|Lost to Follow-up|0|||
129762587|NCT00525512|467092732|FG000|Open-Label Phase|Other reason (not specified)|0|||
129762588|NCT00525512|467092733|FG001|Open-Label Phase|Other reason (not specified)|0|||
129762589|NCT00525512|467092734|FG002|Open-Label Phase|Other reason (not specified)|4|||
129762590|NCT00525512|467092735|FG003|Open-Label Phase|Other reason (not specified)|5|||
129762591|NCT03289208|467092740|FG000|Overall Study|Adverse Event|1|||
129762592|NCT03289208|467092741|FG001|Overall Study|Adverse Event|0|||
129762593|NCT03289208|467092742|FG002|Overall Study|Adverse Event|0|||
129762594|NCT03353675|467092747|FG000|Overall Study|Adverse Event|4|||
129762595|NCT03346434|467094667|FG000|Overall Study|Randomized in Error|0|||
129762596|NCT03346434|467094668|FG001|Overall Study|Randomized in Error|0|||
129762597|NCT03346434|467094669|FG002|Overall Study|Randomized in Error|0|||
129762598|NCT03346434|467094670|FG003|Overall Study|Randomized in Error|0|||
129762599|NCT03346434|467094671|FG004|Overall Study|Randomized in Error|1|||
129762600|NCT03346434|467094672|FG005|Overall Study|Randomized in Error|0|||
129762601|NCT03346434|467094667|FG000|Overall Study|Withdrawal by Subject|0|||
129762602|NCT03346434|467094668|FG001|Overall Study|Withdrawal by Subject|0|||
129762603|NCT03346434|467094669|FG002|Overall Study|Withdrawal by Subject|1|||
129762604|NCT03346434|467094670|FG003|Overall Study|Withdrawal by Subject|0|||
129762605|NCT03346434|467094671|FG004|Overall Study|Withdrawal by Subject|1|||
129762606|NCT03346434|467094672|FG005|Overall Study|Withdrawal by Subject|0|||
129762607|NCT03346434|467094667|FG000|Overall Study|Lost to Follow-up|0|||
129762608|NCT03346434|467094668|FG001|Overall Study|Lost to Follow-up|0|||
129762609|NCT03346434|467094669|FG002|Overall Study|Lost to Follow-up|0|||
129762610|NCT03346434|467094670|FG003|Overall Study|Lost to Follow-up|0|||
129762611|NCT03346434|467094671|FG004|Overall Study|Lost to Follow-up|1|||
129762612|NCT03346434|467094672|FG005|Overall Study|Lost to Follow-up|1|||
129762613|NCT03346434|467094667|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129762614|NCT03346434|467094668|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129762615|NCT03346434|467094669|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129762616|NCT03346434|467094670|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
129762617|NCT03346434|467094671|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
129762618|NCT03346434|467094672|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
129762619|NCT03525444|467094673|FG000|Overall Study|Adverse Event|0|||
129762620|NCT03525444|467094674|FG001|Overall Study|Adverse Event|1|||
129762621|NCT03525444|467094673|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129762622|NCT03525444|467094674|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
129762623|NCT03525444|467094673|FG000|Overall Study|Other|0|||
129762624|NCT03525444|467094674|FG001|Overall Study|Other|1|||
129762625|NCT01419236|467094678|FG000|Overall Study|Adverse Event|1|||
129762626|NCT01419236|467094679|FG001|Overall Study|Adverse Event|0|||
129762627|NCT01419236|467094678|FG000|Overall Study|Lack of Efficacy|0|||
129762628|NCT01419236|467094679|FG001|Overall Study|Lack of Efficacy|1|||
129762629|NCT01419236|467094678|FG000|Overall Study|Lost to Follow-up|1|||
129762630|NCT01419236|467094679|FG001|Overall Study|Lost to Follow-up|0|||
129762631|NCT01419236|467094678|FG000|Overall Study|Physician Decision|1|||
129762632|NCT01419236|467094679|FG001|Overall Study|Physician Decision|0|||
129762633|NCT01419236|467094678|FG000|Overall Study|Withdrawal by Subject|1|||
129762634|NCT01419236|467094679|FG001|Overall Study|Withdrawal by Subject|4|||
129762635|NCT01419236|467094678|FG000|Overall Study|Entry Criteria Not Met|1|||
129762636|NCT01419236|467094679|FG001|Overall Study|Entry Criteria Not Met|0|||
129762637|NCT02250326|467094680|FG000|Treatment|Death|1|||
129762638|NCT02250326|467094681|FG001|Treatment|Death|13|||
129762639|NCT02250326|467094682|FG002|Treatment|Death|2|||
129762640|NCT02250326|467094680|FG000|Treatment|Adverse Event|8|||
129762641|NCT02250326|467094681|FG001|Treatment|Adverse Event|8|||
129762642|NCT02250326|467094682|FG002|Treatment|Adverse Event|9|||
129762643|NCT02250326|467094680|FG000|Treatment|Progressive Disease|42|||
129762644|NCT02250326|467094681|FG001|Treatment|Progressive Disease|40|||
129762645|NCT02250326|467094682|FG002|Treatment|Progressive Disease|47|||
129762646|NCT02250326|467094680|FG000|Treatment|Symptomatic Deterioration|9|||
129762647|NCT02250326|467094681|FG001|Treatment|Symptomatic Deterioration|4|||
129762648|NCT02250326|467094682|FG002|Treatment|Symptomatic Deterioration|10|||
129762649|NCT02250326|467094680|FG000|Treatment|Withdrawal by Subject|11|||
129762650|NCT02250326|467094681|FG001|Treatment|Withdrawal by Subject|6|||
129762651|NCT02250326|467094682|FG002|Treatment|Withdrawal by Subject|4|||
129762652|NCT02250326|467094680|FG000|Treatment|Other reasons|8|||
129762653|NCT02250326|467094681|FG001|Treatment|Other reasons|7|||
129762654|NCT02250326|467094682|FG002|Treatment|Other reasons|7|||
129762655|NCT02250326|467094680|FG000|Extension Period|Progressive Disease|0|||
129762656|NCT02250326|467094681|FG001|Extension Period|Progressive Disease|2|||
129762657|NCT02250326|467094682|FG002|Extension Period|Progressive Disease|0|||
129762658|NCT02250326|467094680|FG000|Extension Period|Withdrawal by Subject|0|||
129762659|NCT02250326|467094681|FG001|Extension Period|Withdrawal by Subject|1|||
129762660|NCT02250326|467094682|FG002|Extension Period|Withdrawal by Subject|0|||
129762661|NCT02250326|467094680|FG000|Extension Period|Withdrawal by investigator|0|||
129762662|NCT02250326|467094681|FG001|Extension Period|Withdrawal by investigator|1|||
129762663|NCT02250326|467094682|FG002|Extension Period|Withdrawal by investigator|0|||
129762664|NCT00866177|467094683|FG000|Overall Study|Withdrawal by Subject|1|||
129762665|NCT00866177|467094683|FG000|Overall Study|Not Treated|151|||
129762666|NCT03585660|467094684|FG000|Overall Study|operator error|1|||
129762667|NCT03585660|467094684|FG000|Overall Study|technical error|2|||
129762668|NCT03585660|467094684|FG000|Overall Study|hip prosthesis|2|||
129762669|NCT03585660|467094684|FG000|Overall Study|did not undergo biopsy|8|||
129762670|NCT03585660|467094684|FG000|Overall Study|scanner problem|2|||
129762671|NCT00435409|467094685|FG000|Overall Study|Protocol Violation|1|||
129762672|NCT00435409|467094686|FG001|Overall Study|Protocol Violation|2|||
129762673|NCT00435409|467094687|FG002|Overall Study|Protocol Violation|0|||
129762674|NCT00435409|467094685|FG000|Overall Study|Lost to Follow-up|1|||
129762675|NCT00435409|467094686|FG001|Overall Study|Lost to Follow-up|2|||
129762676|NCT00435409|467094687|FG002|Overall Study|Lost to Follow-up|0|||
129762677|NCT00435409|467094685|FG000|Overall Study|Death|8|||
129762678|NCT00435409|467094686|FG001|Overall Study|Death|6|||
129762679|NCT00435409|467094687|FG002|Overall Study|Death|6|||
129762680|NCT00435409|467094685|FG000|Overall Study|Objective progression or relapse|158|||
129762681|NCT00435409|467094686|FG001|Overall Study|Objective progression or relapse|93|||
129762682|NCT00435409|467094687|FG002|Overall Study|Objective progression or relapse|58|||
129762683|NCT00435409|467094685|FG000|Overall Study|Global deterioration of health status|0|||
129762684|NCT00435409|467094686|FG001|Overall Study|Global deterioration of health status|0|||
129762685|NCT00435409|467094687|FG002|Overall Study|Global deterioration of health status|4|||
129762686|NCT00435409|467094685|FG000|Overall Study|Withdrawal by Subject|8|||
129762687|NCT00435409|467094686|FG001|Overall Study|Withdrawal by Subject|7|||
129762688|NCT00435409|467094687|FG002|Overall Study|Withdrawal by Subject|1|||
129762689|NCT00435409|467094685|FG000|Overall Study|Other|45|||
129762690|NCT00435409|467094686|FG001|Overall Study|Other|30|||
129762691|NCT00435409|467094687|FG002|Overall Study|Other|1|||
129762692|NCT00435409|467094685|FG000|Overall Study|Adverse Event|0|||
129762693|NCT00435409|467094686|FG001|Overall Study|Adverse Event|0|||
129762694|NCT00435409|467094687|FG002|Overall Study|Adverse Event|8|||
129762695|NCT00435409|467094685|FG000|Overall Study|Sponsor decision|0|||
129762696|NCT00435409|467094686|FG001|Overall Study|Sponsor decision|3|||
129762697|NCT00435409|467094687|FG002|Overall Study|Sponsor decision|0|||
129762698|NCT05635461|467094690|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129762699|NCT05635461|467094691|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129762700|NCT05635461|467094692|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129762701|NCT05635461|467094693|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129762702|NCT05635461|467094694|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
129762703|NCT05635461|467094695|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
129762704|NCT05635461|467094690|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129762705|NCT05635461|467094691|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
129762706|NCT05635461|467094692|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129762707|NCT05635461|467094693|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129762708|NCT05635461|467094694|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129762709|NCT05635461|467094695|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
129762710|NCT05635461|467094690|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129762711|NCT05635461|467094691|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129762712|NCT05635461|467094692|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129762713|NCT05635461|467094693|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
129762714|NCT05635461|467094694|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129762715|NCT05635461|467094695|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
129762716|NCT03760029|467094698|FG000|Overall Study|Death|1|||
129762717|NCT03760029|467094699|FG001|Overall Study|Death|0|||
129762718|NCT03760029|467094700|FG002|Overall Study|Death|0|||
129762719|NCT03760029|467094698|FG000|Overall Study|Lost to Follow-up|0|||
129762720|NCT03760029|467094699|FG001|Overall Study|Lost to Follow-up|2|||
129762721|NCT03760029|467094700|FG002|Overall Study|Lost to Follow-up|1|||
129762722|NCT03760029|467094698|FG000|Overall Study|Withdrawal by Subject|1|||
129762723|NCT03760029|467094699|FG001|Overall Study|Withdrawal by Subject|4|||
129762724|NCT03760029|467094700|FG002|Overall Study|Withdrawal by Subject|1|||
129762725|NCT03760029|467094698|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129762726|NCT03760029|467094699|FG001|Overall Study|Withdrawal by parent/guardian|4|||
129762727|NCT03760029|467094700|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129762728|NCT03760029|467094698|FG000|Overall Study|Other|2|||
129762729|NCT03760029|467094699|FG001|Overall Study|Other|1|||
129762730|NCT03760029|467094700|FG002|Overall Study|Other|0|||
129762731|NCT04890652|467094704|FG000|Overall Study|Withdrawal by Subject|2|||
129762732|NCT02269124|467094711|FG000|Overall Study|Lost to Follow-up|1|||
129762733|NCT02269124|467094712|FG001|Overall Study|Lost to Follow-up|0|||
129762734|NCT02269124|467094711|FG000|Overall Study|Withdrawal by Subject|0|||
129762735|NCT02269124|467094712|FG001|Overall Study|Withdrawal by Subject|2|||
129762736|NCT00614575|467094713|FG000|Overall Study|Adverse Event|106|||
129762737|NCT00614575|467094713|FG000|Overall Study|Lost to Follow-up|55|||
129762738|NCT00614575|467094713|FG000|Overall Study|Lack of Efficacy|14|||
129762739|NCT00614575|467094713|FG000|Overall Study|Withdrawal by Subject|6|||
129762740|NCT00614575|467094713|FG000|Overall Study|Death|3|||
129762741|NCT00614575|467094713|FG000|Overall Study|Physician Decision|2|||
129762742|NCT00614575|467094713|FG000|Overall Study|No data were collected.|18|||
129762743|NCT00614575|467094713|FG000|Overall Study|Irregularly enrolled patients|23|||
129762744|NCT00614575|467094713|FG000|Overall Study|No treatment|1|||
129762745|NCT01600885|467094714|FG000|First Period|Adverse Event|1|||
129762746|NCT01600885|467094715|FG001|First Period|Adverse Event|1|||
129762747|NCT01600885|467094714|FG000|First Period|moved out of area|1|||
129762748|NCT01600885|467094715|FG001|First Period|moved out of area|0|||
129762749|NCT00005906|467094722|FG000|Overall Study|Lack of Efficacy|3|||
129762750|NCT00286442|467094723|FG000|Overall Study|Hyperglycemic Rescue|19|||
129762751|NCT00286442|467094724|FG001|Overall Study|Hyperglycemic Rescue|17|||
129762752|NCT00286442|467094725|FG002|Overall Study|Hyperglycemic Rescue|25|||
129762753|NCT00286442|467094723|FG000|Overall Study|Adverse Event|7|||
129762754|NCT00286442|467094724|FG001|Overall Study|Adverse Event|6|||
129762755|NCT00286442|467094725|FG002|Overall Study|Adverse Event|1|||
129762756|NCT00286442|467094723|FG000|Overall Study|Protocol Violation|2|||
129762757|NCT00286442|467094724|FG001|Overall Study|Protocol Violation|4|||
129762758|NCT00286442|467094725|FG002|Overall Study|Protocol Violation|2|||
129762759|NCT00286442|467094723|FG000|Overall Study|Lost to Follow-up|5|||
129762760|NCT00286442|467094724|FG001|Overall Study|Lost to Follow-up|2|||
129762761|NCT00286442|467094725|FG002|Overall Study|Lost to Follow-up|1|||
129762762|NCT00286442|467094723|FG000|Overall Study|Physician Decision|1|||
129762763|NCT00286442|467094724|FG001|Overall Study|Physician Decision|1|||
129762764|NCT00286442|467094725|FG002|Overall Study|Physician Decision|1|||
129762765|NCT00286442|467094723|FG000|Overall Study|Administrative Error|1|||
129762766|NCT00286442|467094724|FG001|Overall Study|Administrative Error|1|||
129762767|NCT00286442|467094725|FG002|Overall Study|Administrative Error|0|||
129762768|NCT00286442|467094723|FG000|Overall Study|Withdrawal by Subject|2|||
129762769|NCT00286442|467094724|FG001|Overall Study|Withdrawal by Subject|14|||
129762770|NCT00286442|467094725|FG002|Overall Study|Withdrawal by Subject|2|||
129762771|NCT04571944|467094728|FG000|Overall Study|Death|1|||
129762772|NCT04571944|467094729|FG001|Overall Study|Death|0|||
129762773|NCT04571944|467094728|FG000|Overall Study|Withdrawal by Subject|3|||
129762774|NCT04571944|467094729|FG001|Overall Study|Withdrawal by Subject|0|||
129762775|NCT04571944|467094728|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
129762776|NCT04571944|467094729|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
129762777|NCT00292942|467094730|FG000|Overall Study|Withdrawal by Subject|0|||
129762778|NCT00292942|467094731|FG001|Overall Study|Withdrawal by Subject|0|||
129762779|NCT00292942|467094732|FG002|Overall Study|Withdrawal by Subject|1|||
129762780|NCT00292942|467094733|FG003|Overall Study|Withdrawal by Subject|0|||
129762781|NCT00292942|467094730|FG000|Overall Study|Adverse Event|0|||
129762782|NCT00292942|467094731|FG001|Overall Study|Adverse Event|0|||
129762783|NCT00292942|467094732|FG002|Overall Study|Adverse Event|0|||
129762784|NCT00292942|467094733|FG003|Overall Study|Adverse Event|1|||
129762785|NCT00651924|467094734|FG000|Overall Study|Withdrawal by PI|0|||
129762786|NCT00651924|467094735|FG001|Overall Study|Withdrawal by PI|2|||
129762787|NCT00651924|467094734|FG000|Overall Study|Withdrawal by Subject|0|||
129762788|NCT00651924|467094735|FG001|Overall Study|Withdrawal by Subject|5|||
129762789|NCT00960063|467094736|FG000|Overall Study|Adverse Event|1|||
129762790|NCT00960063|467094737|FG001|Overall Study|Adverse Event|0|||
129762791|NCT00960063|467094738|FG002|Overall Study|Adverse Event|0|||
129762792|NCT00960063|467094736|FG000|Overall Study|Progression of Disease|0|||
129762793|NCT00960063|467094737|FG001|Overall Study|Progression of Disease|0|||
129762794|NCT00960063|467094738|FG002|Overall Study|Progression of Disease|3|||
129762795|NCT05083351|467094740|FG000|Overall Study|Adverse Event|3|||
129762796|NCT05083351|467094740|FG000|Overall Study|Did not meet data inclusion criteria|8|||
129762797|NCT05083351|467094740|FG000|Overall Study|Did not meet eligibility criteria|19|||
129762798|NCT05083351|467094740|FG000|Overall Study|Study Staff Decision|19|||
129762799|NCT01759420|467094742|FG000|Overall Study|Screen failure|5|||
129762800|NCT01759420|467094742|FG000|Overall Study|Inaccurate EKG machine readings|1|||
129762801|NCT04258423|467094751|FG000|Overall Study|Study Closure|2|||
129762802|NCT04258423|467094752|FG001|Overall Study|Study Closure|2|||
129762803|NCT00321789|467094753|FG000|Overall Study|Lost to Follow-up|4|||
129762804|NCT00321789|467094754|FG001|Overall Study|Lost to Follow-up|7|||
129762805|NCT00321789|467094753|FG000|Overall Study|Withdrawal by Subject|6|||
129762806|NCT00321789|467094754|FG001|Overall Study|Withdrawal by Subject|6|||
129762807|NCT00321789|467094753|FG000|Overall Study|Protocol Violation|5|||
129762808|NCT00321789|467094754|FG001|Overall Study|Protocol Violation|3|||
129762809|NCT03309020|467094757|FG000|Overall Study|Death|1|||
129762810|NCT03309020|467094758|FG001|Overall Study|Death|0|||
129762811|NCT03309020|467094757|FG000|Overall Study|Did not undergo surgery|2|||
129762812|NCT03309020|467094758|FG001|Overall Study|Did not undergo surgery|1|||
129762813|NCT02362724|467094759|FG000|Overall Study|Withdrawal by Subject|3|||
129762814|NCT02362724|467094760|FG001|Overall Study|Withdrawal by Subject|1|||
129762815|NCT02362724|467094759|FG000|Overall Study|Adverse Event|3|||
129762816|NCT02362724|467094760|FG001|Overall Study|Adverse Event|0|||
129762817|NCT00402168|467094761|FG000|Randomized|Lost to Follow-up|1|||
129762818|NCT00402168|467094762|FG001|Randomized|Lost to Follow-up|0|||
129762819|NCT00402168|467094761|FG000|Randomized|Withdrawal by Subject|0|||
129762820|NCT00402168|467094762|FG001|Randomized|Withdrawal by Subject|1|||
129762821|NCT00402168|467094761|FG000|Treatment (up to 12 Months)|Death|0|||
129762822|NCT00402168|467094762|FG001|Treatment (up to 12 Months)|Death|1|||
129762823|NCT00402168|467094761|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
129762824|NCT00402168|467094762|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
129762825|NCT00402168|467094761|FG000|Treatment (up to 12 Months)|non-specified|0|||
129762826|NCT00402168|467094762|FG001|Treatment (up to 12 Months)|non-specified|1|||
129762827|NCT00402168|467094761|FG000|Long Term (LT)|Adverse Event|1|||
129762828|NCT00402168|467094762|FG001|Long Term (LT)|Adverse Event|5|||
129762829|NCT00402168|467094761|FG000|Long Term (LT)|Withdrawal by Subject|4|||
129762830|NCT00402168|467094762|FG001|Long Term (LT)|Withdrawal by Subject|7|||
129762831|NCT00402168|467094761|FG000|Long Term (LT)|Pregnancy|0|||
129762832|NCT00402168|467094762|FG001|Long Term (LT)|Pregnancy|1|||
129762833|NCT00402168|467094761|FG000|Long Term (LT)|Lost to Follow-up|1|||
129762834|NCT00402168|467094762|FG001|Long Term (LT)|Lost to Follow-up|0|||
129762835|NCT00402168|467094761|FG000|Long Term (LT)|Death|4|||
129762836|NCT00402168|467094762|FG001|Long Term (LT)|Death|0|||
129762837|NCT00402168|467094761|FG000|Long Term (LT)|Lack of Efficacy|0|||
129762838|NCT00402168|467094762|FG001|Long Term (LT)|Lack of Efficacy|2|||
129762839|NCT00402168|467094761|FG000|Long Term (LT)|non-specified|1|||
129762840|NCT00402168|467094762|FG001|Long Term (LT)|non-specified|2|||
129762841|NCT00402168|467094761|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
129762842|NCT00402168|467094762|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
129762843|NCT00402168|467094761|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
129762844|NCT00402168|467094762|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
129762845|NCT02025179|467094763|FG000|Overall Study|Lost to Follow-up|0|||
129762846|NCT02025179|467094764|FG001|Overall Study|Lost to Follow-up|0|||
129762847|NCT02025179|467094765|FG002|Overall Study|Lost to Follow-up|1|||
129762848|NCT00601835|467094771|FG000|Overall Study|Withdrawal by Subject|9|||
129762849|NCT00601835|467094772|FG001|Overall Study|Withdrawal by Subject|6|||
129762850|NCT00601835|467094771|FG000|Overall Study|Physician Decision|1|||
129762851|NCT00601835|467094772|FG001|Overall Study|Physician Decision|0|||
129762852|NCT00601835|467094771|FG000|Overall Study|Lost to Follow-up|37|||
129762853|NCT00601835|467094772|FG001|Overall Study|Lost to Follow-up|5|||
129762854|NCT00601835|467094771|FG000|Overall Study|Adverse Event|1|||
129762855|NCT00601835|467094772|FG001|Overall Study|Adverse Event|1|||
129762856|NCT00601835|467094771|FG000|Overall Study|Relocate|12|||
129762857|NCT00601835|467094772|FG001|Overall Study|Relocate|2|||
129762858|NCT00395746|467094773|FG000|Overall Study|Adverse Event|5|||
129762859|NCT00395746|467094774|FG001|Overall Study|Adverse Event|2|||
129762860|NCT00395746|467094775|FG002|Overall Study|Adverse Event|2|||
129762861|NCT00395746|467094773|FG000|Overall Study|Protocol Violation|0|||
129762862|NCT00395746|467094774|FG001|Overall Study|Protocol Violation|1|||
129762863|NCT00395746|467094775|FG002|Overall Study|Protocol Violation|0|||
129762864|NCT00395746|467094773|FG000|Overall Study|Lack of Efficacy|2|||
129762865|NCT00395746|467094774|FG001|Overall Study|Lack of Efficacy|0|||
129762866|NCT00395746|467094775|FG002|Overall Study|Lack of Efficacy|17|||
129762867|NCT00395746|467094773|FG000|Overall Study|Hypoglycaemia|2|||
129762868|NCT00395746|467094774|FG001|Overall Study|Hypoglycaemia|1|||
129762869|NCT00395746|467094775|FG002|Overall Study|Hypoglycaemia|0|||
129762870|NCT00395746|467094773|FG000|Overall Study|Subject decision|0|||
129762871|NCT00395746|467094774|FG001|Overall Study|Subject decision|0|||
129762872|NCT00395746|467094775|FG002|Overall Study|Subject decision|1|||
129762873|NCT00395746|467094773|FG000|Overall Study|Withdrawal of consent|0|||
129762874|NCT00395746|467094774|FG001|Overall Study|Withdrawal of consent|0|||
129762875|NCT00395746|467094775|FG002|Overall Study|Withdrawal of consent|1|||
129762876|NCT00395746|467094773|FG000|Overall Study|Difficultulty in use of device|0|||
129762877|NCT00395746|467094774|FG001|Overall Study|Difficultulty in use of device|0|||
129762878|NCT00395746|467094775|FG002|Overall Study|Difficultulty in use of device|1|||
129762879|NCT00395746|467094773|FG000|Overall Study|Unable to visit site on schedule|1|||
129762880|NCT00395746|467094774|FG001|Overall Study|Unable to visit site on schedule|0|||
129762881|NCT00395746|467094775|FG002|Overall Study|Unable to visit site on schedule|0|||
129762882|NCT03137992|467094780|FG000|Washout Period 1|Adverse Event|1|||
129762883|NCT03137992|467094781|FG001|Washout Period 1|Adverse Event|1|||
129762884|NCT03137992|467094782|FG002|Washout Period 1|Adverse Event|0|||
129762885|NCT03137992|467094783|FG003|Washout Period 1|Adverse Event|0|||
129762886|NCT03137992|467094784|FG004|Washout Period 1|Adverse Event|0|||
129762887|NCT03137992|467094785|FG005|Washout Period 1|Adverse Event|1|||
129762888|NCT03137992|467094780|FG000|Washout Period 1|Withdrawal by Subject|0|||
129762889|NCT03137992|467094781|FG001|Washout Period 1|Withdrawal by Subject|1|||
129762890|NCT03137992|467094782|FG002|Washout Period 1|Withdrawal by Subject|1|||
129762891|NCT03137992|467094783|FG003|Washout Period 1|Withdrawal by Subject|0|||
129762892|NCT03137992|467094784|FG004|Washout Period 1|Withdrawal by Subject|0|||
129762893|NCT03137992|467094785|FG005|Washout Period 1|Withdrawal by Subject|0|||
129762894|NCT03137992|467094780|FG000|Washout Period 1|Principal Investigator Discretion|0|||
129762895|NCT03137992|467094781|FG001|Washout Period 1|Principal Investigator Discretion|1|||
129762896|NCT03137992|467094782|FG002|Washout Period 1|Principal Investigator Discretion|0|||
129762897|NCT03137992|467094783|FG003|Washout Period 1|Principal Investigator Discretion|0|||
129762898|NCT03137992|467094784|FG004|Washout Period 1|Principal Investigator Discretion|0|||
129762899|NCT03137992|467094785|FG005|Washout Period 1|Principal Investigator Discretion|0|||
129762900|NCT03137992|467094780|FG000|Washout Period 1|COPD Exacerbation|1|||
129762901|NCT03137992|467094781|FG001|Washout Period 1|COPD Exacerbation|1|||
129762902|NCT03137992|467094782|FG002|Washout Period 1|COPD Exacerbation|1|||
129762903|NCT03137992|467094783|FG003|Washout Period 1|COPD Exacerbation|0|||
129762904|NCT03137992|467094784|FG004|Washout Period 1|COPD Exacerbation|1|||
129762905|NCT03137992|467094785|FG005|Washout Period 1|COPD Exacerbation|1|||
129762906|NCT03137992|467094780|FG000|Washout Period 1|Subject Noncompliance|1|||
129762907|NCT03137992|467094781|FG001|Washout Period 1|Subject Noncompliance|0|||
129762908|NCT03137992|467094782|FG002|Washout Period 1|Subject Noncompliance|0|||
129762909|NCT03137992|467094783|FG003|Washout Period 1|Subject Noncompliance|0|||
129762910|NCT03137992|467094784|FG004|Washout Period 1|Subject Noncompliance|1|||
129762911|NCT03137992|467094785|FG005|Washout Period 1|Subject Noncompliance|0|||
129762912|NCT03137992|467094780|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
129762913|NCT03137992|467094781|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
129762914|NCT03137992|467094782|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
129762915|NCT03137992|467094783|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
129762916|NCT03137992|467094784|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
129762917|NCT03137992|467094785|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
129762918|NCT03137992|467094780|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
129762919|NCT03137992|467094781|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
129762920|NCT03137992|467094782|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
129762921|NCT03137992|467094783|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
129762922|NCT03137992|467094784|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
129762923|NCT03137992|467094785|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
129762924|NCT03137992|467094780|FG000|Period 2 (Visit 3)|Adverse Event|0|||
129762925|NCT03137992|467094781|FG001|Period 2 (Visit 3)|Adverse Event|1|||
129762926|NCT03137992|467094782|FG002|Period 2 (Visit 3)|Adverse Event|0|||
129762927|NCT03137992|467094783|FG003|Period 2 (Visit 3)|Adverse Event|0|||
129762928|NCT03137992|467094784|FG004|Period 2 (Visit 3)|Adverse Event|0|||
129762929|NCT03137992|467094785|FG005|Period 2 (Visit 3)|Adverse Event|0|||
129762930|NCT03137992|467094780|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
129762931|NCT03137992|467094781|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
129762932|NCT03137992|467094782|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
129762933|NCT03137992|467094783|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
129762934|NCT03137992|467094784|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
129762935|NCT03137992|467094785|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
129762936|NCT03137992|467094780|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129762937|NCT03137992|467094781|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
129762938|NCT03137992|467094782|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129762939|NCT03137992|467094783|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129762940|NCT03137992|467094784|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
129762941|NCT03137992|467094785|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
129762942|NCT03137992|467094780|FG000|Washout Period 2|COPD Exacerbation|1|||
129762943|NCT03137992|467094781|FG001|Washout Period 2|COPD Exacerbation|1|||
129762944|NCT03137992|467094782|FG002|Washout Period 2|COPD Exacerbation|0|||
129762945|NCT03137992|467094783|FG003|Washout Period 2|COPD Exacerbation|0|||
129762946|NCT03137992|467094784|FG004|Washout Period 2|COPD Exacerbation|1|||
129762947|NCT03137992|467094785|FG005|Washout Period 2|COPD Exacerbation|0|||
129762948|NCT03137992|467094780|FG000|Washout Period 2|Subject Non-compliance|0|||
129762949|NCT03137992|467094781|FG001|Washout Period 2|Subject Non-compliance|1|||
129762950|NCT03137992|467094782|FG002|Washout Period 2|Subject Non-compliance|0|||
129762951|NCT03137992|467094783|FG003|Washout Period 2|Subject Non-compliance|0|||
129762952|NCT03137992|467094784|FG004|Washout Period 2|Subject Non-compliance|0|||
129762953|NCT03137992|467094785|FG005|Washout Period 2|Subject Non-compliance|0|||
129762954|NCT03137992|467094780|FG000|Washout Period 2|Adverse Event|0|||
129762955|NCT03137992|467094781|FG001|Washout Period 2|Adverse Event|0|||
129762956|NCT03137992|467094782|FG002|Washout Period 2|Adverse Event|0|||
129762957|NCT03137992|467094783|FG003|Washout Period 2|Adverse Event|1|||
129762958|NCT03137992|467094784|FG004|Washout Period 2|Adverse Event|1|||
129762959|NCT03137992|467094785|FG005|Washout Period 2|Adverse Event|0|||
129762960|NCT03137992|467094780|FG000|Washout Period 2|Withdrawal by Subject|1|||
129762961|NCT03137992|467094781|FG001|Washout Period 2|Withdrawal by Subject|0|||
129762962|NCT03137992|467094782|FG002|Washout Period 2|Withdrawal by Subject|0|||
129762963|NCT03137992|467094783|FG003|Washout Period 2|Withdrawal by Subject|0|||
129762964|NCT03137992|467094784|FG004|Washout Period 2|Withdrawal by Subject|1|||
129762965|NCT03137992|467094785|FG005|Washout Period 2|Withdrawal by Subject|0|||
129762966|NCT03137992|467094780|FG000|Washout Period 2|Sponsor Decision|0|||
129762967|NCT03137992|467094781|FG001|Washout Period 2|Sponsor Decision|0|||
129762968|NCT03137992|467094782|FG002|Washout Period 2|Sponsor Decision|0|||
129762969|NCT03137992|467094783|FG003|Washout Period 2|Sponsor Decision|0|||
129762970|NCT03137992|467094784|FG004|Washout Period 2|Sponsor Decision|0|||
129762971|NCT03137992|467094785|FG005|Washout Period 2|Sponsor Decision|1|||
129762972|NCT03137992|467094780|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
129762973|NCT03137992|467094781|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
129762974|NCT03137992|467094782|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
129762975|NCT03137992|467094783|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
129762976|NCT03137992|467094784|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
129762977|NCT03137992|467094785|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
129762978|NCT03137992|467094780|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
129762979|NCT03137992|467094781|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
129762980|NCT03137992|467094782|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
129762981|NCT03137992|467094783|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
129762982|NCT03137992|467094784|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
129762983|NCT03137992|467094785|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
129762984|NCT03137992|467094780|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
129762985|NCT03137992|467094781|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129762986|NCT03137992|467094782|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
129762987|NCT03137992|467094783|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129762988|NCT03137992|467094784|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129762989|NCT03137992|467094785|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
129762990|NCT03137992|467094780|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129762991|NCT03137992|467094781|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129762992|NCT03137992|467094782|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129762993|NCT03137992|467094783|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
129762994|NCT03137992|467094784|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129762995|NCT03137992|467094785|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
129762996|NCT03137992|467094780|FG000|Part 2 (Open-label Extension)|Per study team|1|||
129762997|NCT03137992|467094781|FG001|Part 2 (Open-label Extension)|Per study team|0|||
129762998|NCT03137992|467094782|FG002|Part 2 (Open-label Extension)|Per study team|0|||
129762999|NCT03137992|467094783|FG003|Part 2 (Open-label Extension)|Per study team|0|||
129763000|NCT03137992|467094784|FG004|Part 2 (Open-label Extension)|Per study team|0|||
129763001|NCT03137992|467094785|FG005|Part 2 (Open-label Extension)|Per study team|0|||
129763002|NCT03137992|467094780|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129763003|NCT03137992|467094781|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129763004|NCT03137992|467094782|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129763005|NCT03137992|467094783|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129763006|NCT03137992|467094784|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
129763007|NCT03137992|467094785|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
129763008|NCT02370420|467094786|FG000|Overall Study|Physician Decision|3|||
129763009|NCT02370420|467094787|FG001|Overall Study|Physician Decision|3|||
129763010|NCT02370420|467094786|FG000|Overall Study|Lost to Follow-up|11|||
129763011|NCT02370420|467094787|FG001|Overall Study|Lost to Follow-up|9|||
129763012|NCT03077542|467094788|FG000|Overall Study|Death|4|||
129763013|NCT03077542|467094789|FG001|Overall Study|Death|0|||
129763014|NCT03077542|467094788|FG000|Overall Study|Physician Decision|6|||
129763015|NCT03077542|467094789|FG001|Overall Study|Physician Decision|1|||
129763016|NCT03077542|467094788|FG000|Overall Study|Withdrawal by Subject|0|||
129763017|NCT03077542|467094789|FG001|Overall Study|Withdrawal by Subject|1|||
129763018|NCT00795704|467094790|FG000|Overall Study|Withdrawal by Subject|3|||
129763019|NCT00795704|467094791|FG001|Overall Study|Withdrawal by Subject|2|||
129763020|NCT00795704|467094790|FG000|Overall Study|Adverse Event|1|||
129763021|NCT00795704|467094791|FG001|Overall Study|Adverse Event|1|||
129763022|NCT03980730|467094792|FG000|Overall Study|Study Terminated by Sponsor|0|||
129763023|NCT03980730|467094793|FG001|Overall Study|Study Terminated by Sponsor|3|||
129763024|NCT03980730|467094792|FG000|Overall Study|Adverse Event|2|||
129763025|NCT03980730|467094793|FG001|Overall Study|Adverse Event|0|||
129763026|NCT03980730|467094792|FG000|Overall Study|Sponsor Request|0|||
129763027|NCT03980730|467094793|FG001|Overall Study|Sponsor Request|1|||
129763028|NCT01300728|467094794|FG000|Overall Study|Withdrawal by Subject|1|||
129763029|NCT01300728|467094795|FG001|Overall Study|Withdrawal by Subject|1|||
129763030|NCT01300728|467094794|FG000|Overall Study|Physician Decision|1|||
129763031|NCT01300728|467094795|FG001|Overall Study|Physician Decision|0|||
129763032|NCT00880620|467094798|FG000|Overall Study|Adverse Event|4|||
129763033|NCT00880620|467094799|FG001|Overall Study|Adverse Event|5|||
129763034|NCT00880620|467094800|FG002|Overall Study|Adverse Event|15|||
129763035|NCT00880620|467094801|FG003|Overall Study|Adverse Event|15|||
129763036|NCT00880620|467094798|FG000|Overall Study|Death|0|||
129763037|NCT00880620|467094799|FG001|Overall Study|Death|0|||
129763038|NCT00880620|467094800|FG002|Overall Study|Death|1|||
129763039|NCT00880620|467094801|FG003|Overall Study|Death|0|||
129763040|NCT00880620|467094798|FG000|Overall Study|Lack of Efficacy|12|||
129763041|NCT00880620|467094799|FG001|Overall Study|Lack of Efficacy|4|||
129763042|NCT00880620|467094800|FG002|Overall Study|Lack of Efficacy|0|||
129763043|NCT00880620|467094801|FG003|Overall Study|Lack of Efficacy|1|||
129763044|NCT00880620|467094798|FG000|Overall Study|Lost to Follow-up|0|||
129763045|NCT00880620|467094799|FG001|Overall Study|Lost to Follow-up|1|||
129763046|NCT00880620|467094800|FG002|Overall Study|Lost to Follow-up|1|||
129763047|NCT00880620|467094801|FG003|Overall Study|Lost to Follow-up|0|||
129763048|NCT00880620|467094798|FG000|Overall Study|Protocol Violation|0|||
129763049|NCT00880620|467094799|FG001|Overall Study|Protocol Violation|1|||
129763050|NCT00880620|467094800|FG002|Overall Study|Protocol Violation|0|||
129763051|NCT00880620|467094801|FG003|Overall Study|Protocol Violation|2|||
129763052|NCT00880620|467094798|FG000|Overall Study|Withdrawal by Subject|4|||
129763053|NCT00880620|467094799|FG001|Overall Study|Withdrawal by Subject|3|||
129763054|NCT00880620|467094800|FG002|Overall Study|Withdrawal by Subject|1|||
129763055|NCT00880620|467094801|FG003|Overall Study|Withdrawal by Subject|3|||
129763056|NCT00880620|467094798|FG000|Overall Study|Noncompliance|0|||
129763057|NCT00880620|467094799|FG001|Overall Study|Noncompliance|0|||
129763058|NCT00880620|467094800|FG002|Overall Study|Noncompliance|1|||
129763059|NCT00880620|467094801|FG003|Overall Study|Noncompliance|1|||
129763060|NCT00880620|467094798|FG000|Overall Study|Other|1|||
129763061|NCT00880620|467094799|FG001|Overall Study|Other|1|||
129763062|NCT00880620|467094800|FG002|Overall Study|Other|2|||
129763063|NCT00880620|467094801|FG003|Overall Study|Other|2|||
129763064|NCT00301808|467094805|FG000|Overall Study|Adverse Event|5|||
129763065|NCT00301808|467094805|FG000|Overall Study|Death|3|||
129763066|NCT00301808|467094805|FG000|Overall Study|Lack of Efficacy|4|||
129763067|NCT05893862|467094810|FG000|Overall Study|Physician Decision|0|||
129763068|NCT05893862|467094811|FG001|Overall Study|Physician Decision|1|||
129763069|NCT05893862|467094812|FG002|Overall Study|Physician Decision|0|||
129763070|NCT05893862|467094813|FG003|Overall Study|Physician Decision|0|||
129763071|NCT05893862|467094814|FG004|Overall Study|Physician Decision|1|||
129763072|NCT05893862|467094815|FG005|Overall Study|Physician Decision|0|||
129763073|NCT05893862|467094810|FG000|Overall Study|Withdrawal by Subject|1|||
129763074|NCT05893862|467094811|FG001|Overall Study|Withdrawal by Subject|7|||
129763075|NCT05893862|467094812|FG002|Overall Study|Withdrawal by Subject|1|||
129763076|NCT05893862|467094813|FG003|Overall Study|Withdrawal by Subject|3|||
129763077|NCT05893862|467094814|FG004|Overall Study|Withdrawal by Subject|3|||
129763078|NCT05893862|467094815|FG005|Overall Study|Withdrawal by Subject|2|||
129763079|NCT05893862|467094810|FG000|Overall Study|Adverse Event|1|||
129763080|NCT05893862|467094811|FG001|Overall Study|Adverse Event|4|||
129763081|NCT05893862|467094812|FG002|Overall Study|Adverse Event|2|||
129763082|NCT05893862|467094813|FG003|Overall Study|Adverse Event|2|||
129763083|NCT05893862|467094814|FG004|Overall Study|Adverse Event|1|||
129763084|NCT05893862|467094815|FG005|Overall Study|Adverse Event|0|||
129763085|NCT02919761|467094816|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
129763086|NCT02919761|467094817|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
129763087|NCT02919761|467094818|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
129763088|NCT02919761|467094816|FG000|Part 1: Open Label|Adverse Event|1|||
129763089|NCT02919761|467094817|FG001|Part 1: Open Label|Adverse Event|0|||
129763090|NCT02919761|467094818|FG002|Part 1: Open Label|Adverse Event|0|||
129763091|NCT02919761|467094816|FG000|Part 1: Open Label|Lost to Follow-up|1|||
129763092|NCT02919761|467094817|FG001|Part 1: Open Label|Lost to Follow-up|0|||
129763093|NCT02919761|467094818|FG002|Part 1: Open Label|Lost to Follow-up|0|||
129763094|NCT02919761|467094816|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
129763095|NCT02919761|467094817|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
129763096|NCT02919761|467094818|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
129763097|NCT02919761|467094816|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
129763098|NCT02919761|467094817|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
129763099|NCT02919761|467094818|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
129763100|NCT02919761|467094816|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
129763101|NCT02919761|467094817|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
129763102|NCT02919761|467094818|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
129763103|NCT02919761|467094816|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
129763104|NCT02919761|467094817|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
129763105|NCT02919761|467094818|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
129763106|NCT02919761|467094816|FG000|Part 1: Open Label|Termination by Sponsor|1|||
129763107|NCT02919761|467094817|FG001|Part 1: Open Label|Termination by Sponsor|0|||
129763108|NCT02919761|467094818|FG002|Part 1: Open Label|Termination by Sponsor|0|||
129763109|NCT02919761|467094816|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
129763110|NCT02919761|467094817|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
129763111|NCT02919761|467094818|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
129763112|NCT02919761|467094816|FG000|Part 2: Double-blind|Adverse Event|0|||
129763113|NCT02919761|467094817|FG001|Part 2: Double-blind|Adverse Event|1|||
129763114|NCT02919761|467094818|FG002|Part 2: Double-blind|Adverse Event|0|||
129763115|NCT02919761|467094816|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
129763116|NCT02919761|467094817|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
129763117|NCT02919761|467094818|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
129763118|NCT02919761|467094816|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
129763119|NCT02919761|467094817|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
129763120|NCT02919761|467094818|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
129763121|NCT02919761|467094816|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
129763122|NCT02919761|467094817|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
129763123|NCT02919761|467094818|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
129763124|NCT02919761|467094816|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
129763125|NCT02919761|467094817|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
129874992|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
129874993|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Physician Decision|4|||
129874994|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Physician Decision|1|||
129874995|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Physician Decision|3|||
129874996|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Physician Decision|0|||
129874997|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Physician Decision|0|||
129874998|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Physician Decision|1|||
129874999|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Physician Decision|0|||
129875000|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Other|0|||
129875001|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Other|1|||
129875002|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Other|0|||
129875003|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Other|0|||
129875004|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Other|0|||
129875005|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Other|0|||
129875006|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Other|0|||
129875007|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875008|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875009|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875010|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875011|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875012|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
129875013|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
129875014|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
129875015|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
129875016|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
129875017|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
129875018|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
129875019|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
129875020|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
129875021|NCT05375955|467499602|FG000|Treatment (12 Weeks)|Pregnancy|0|||
129875022|NCT05375955|467499603|FG001|Treatment (12 Weeks)|Pregnancy|0|||
129875023|NCT05375955|467499604|FG002|Treatment (12 Weeks)|Pregnancy|1|||
129875024|NCT05375955|467499605|FG003|Treatment (12 Weeks)|Pregnancy|0|||
129875025|NCT05375955|467499606|FG004|Treatment (12 Weeks)|Pregnancy|0|||
129875026|NCT05375955|467499607|FG005|Treatment (12 Weeks)|Pregnancy|0|||
129875027|NCT05375955|467499608|FG006|Treatment (12 Weeks)|Pregnancy|0|||
129875028|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875029|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875030|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
129763126|NCT02919761|467094818|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
129763127|NCT02919761|467094816|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
129763128|NCT02919761|467094817|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
129763129|NCT02919761|467094818|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
129763130|NCT02919761|467094816|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
129763131|NCT02919761|467094817|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
129763132|NCT02919761|467094818|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
129763133|NCT02429830|467094821|FG000|Overall Study|Lost to Follow-up|1|||
129763134|NCT02429830|467094821|FG000|Overall Study|Device Explant|2|||
129763135|NCT00948064|467096169|FG000|Phase I|No treatment received|1|||
129763136|NCT00948064|467096170|FG001|Phase I|No treatment received|0|||
129763137|NCT00948064|467096171|FG002|Phase I|No treatment received|0|||
129763138|NCT00948064|467096169|FG000|Phase II|Physician Decision|0|||
129763139|NCT00948064|467096170|FG001|Phase II|Physician Decision|0|||
129763140|NCT00948064|467096171|FG002|Phase II|Physician Decision|1|||
129763141|NCT00948064|467096169|FG000|Phase II|Withdrawal by Subject|0|||
129763142|NCT00948064|467096170|FG001|Phase II|Withdrawal by Subject|1|||
129763143|NCT00948064|467096171|FG002|Phase II|Withdrawal by Subject|0|||
129763144|NCT02741128|467096182|FG000|Overall Study|Protocol Violation|4|||
129763145|NCT02741128|467096183|FG001|Overall Study|Protocol Violation|1|||
129763146|NCT02741128|467096182|FG000|Overall Study|Withdrawal by Subject|2|||
129763147|NCT02741128|467096183|FG001|Overall Study|Withdrawal by Subject|0|||
129763148|NCT02741128|467096182|FG000|Overall Study|Lost to Follow-up|1|||
129763149|NCT02741128|467096183|FG001|Overall Study|Lost to Follow-up|0|||
129763150|NCT02973100|467096184|FG000|Overall Study|Adverse Event|1|||
129763151|NCT02973100|467096185|FG001|Overall Study|Adverse Event|2|||
129763152|NCT02973100|467096186|FG002|Overall Study|Adverse Event|1|||
129763153|NCT02973100|467096187|FG003|Overall Study|Adverse Event|2|||
129763154|NCT02973100|467096184|FG000|Overall Study|Lost to Follow-up|3|||
129763155|NCT02973100|467096185|FG001|Overall Study|Lost to Follow-up|1|||
129763156|NCT02973100|467096186|FG002|Overall Study|Lost to Follow-up|1|||
129763157|NCT02973100|467096187|FG003|Overall Study|Lost to Follow-up|0|||
129763158|NCT02973100|467096184|FG000|Overall Study|Withdrawal by Subject|3|||
129763159|NCT02973100|467096185|FG001|Overall Study|Withdrawal by Subject|5|||
129763160|NCT02973100|467096186|FG002|Overall Study|Withdrawal by Subject|1|||
129763161|NCT02973100|467096187|FG003|Overall Study|Withdrawal by Subject|4|||
129763162|NCT02973100|467096184|FG000|Overall Study|Notification of change in address|0|||
129763163|NCT02973100|467096185|FG001|Overall Study|Notification of change in address|0|||
129763164|NCT02973100|467096186|FG002|Overall Study|Notification of change in address|0|||
129763165|NCT02973100|467096187|FG003|Overall Study|Notification of change in address|1|||
129763166|NCT02973100|467096184|FG000|Overall Study|Failed to attend Safety followup period|0|||
129763167|NCT02973100|467096185|FG001|Overall Study|Failed to attend Safety followup period|0|||
129763168|NCT02973100|467096186|FG002|Overall Study|Failed to attend Safety followup period|1|||
129763169|NCT02973100|467096187|FG003|Overall Study|Failed to attend Safety followup period|0|||
129763170|NCT01419769|467096188|FG000|Overall Study|Did not receive the AXIOS stent|3|||
129763171|NCT01419769|467096188|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
129763172|NCT00878501|467096189|FG000|Overall Study|Adverse Event|11|||
129763173|NCT00878501|467096190|FG001|Overall Study|Adverse Event|3|||
129763174|NCT00878501|467096191|FG002|Overall Study|Adverse Event|3|||
129763175|NCT00878501|467096189|FG000|Overall Study|Lack of Efficacy|2|||
129763176|NCT00878501|467096190|FG001|Overall Study|Lack of Efficacy|1|||
129763177|NCT00878501|467096191|FG002|Overall Study|Lack of Efficacy|0|||
129763178|NCT00878501|467096189|FG000|Overall Study|Withdrawal by Subject|2|||
129763179|NCT00878501|467096190|FG001|Overall Study|Withdrawal by Subject|1|||
129763180|NCT00878501|467096191|FG002|Overall Study|Withdrawal by Subject|2|||
129763181|NCT00878501|467096189|FG000|Overall Study|Protocol Violation|0|||
129763182|NCT00878501|467096190|FG001|Overall Study|Protocol Violation|0|||
129763183|NCT00878501|467096191|FG002|Overall Study|Protocol Violation|1|||
129763184|NCT00878501|467096189|FG000|Overall Study|Incorrect enrolment|1|||
129763185|NCT00878501|467096190|FG001|Overall Study|Incorrect enrolment|2|||
129763186|NCT00878501|467096191|FG002|Overall Study|Incorrect enrolment|0|||
129763187|NCT00878501|467096189|FG000|Overall Study|Intake of prohibited concom. medication|0|||
129763188|NCT00878501|467096190|FG001|Overall Study|Intake of prohibited concom. medication|0|||
129763189|NCT00878501|467096191|FG002|Overall Study|Intake of prohibited concom. medication|1|||
129875031|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129763190|NCT00878501|467096189|FG000|Overall Study|Mis-randomisation of patient|1|||
129763191|NCT00878501|467096190|FG001|Overall Study|Mis-randomisation of patient|0|||
129763192|NCT00878501|467096191|FG002|Overall Study|Mis-randomisation of patient|0|||
129763193|NCT00878501|467096189|FG000|Overall Study|Administrative|0|||
129763194|NCT00878501|467096190|FG001|Overall Study|Administrative|0|||
129763195|NCT00878501|467096191|FG002|Overall Study|Administrative|1|||
129763196|NCT00812708|467096194|FG000|Overall Study|Device could not be implanted|2|||
129763197|NCT00812708|467096194|FG000|Overall Study|Lack of medical insurance|1|||
129763198|NCT00812708|467096194|FG000|Overall Study|Switched to another study|1|||
129763199|NCT00812708|467096194|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
129763200|NCT00812708|467096194|FG000|Overall Study|Signed consent but later withdrew|3|||
129763201|NCT01959503|467096195|FG000|Overall Study|Death|2|||
129763202|NCT01959503|467096196|FG001|Overall Study|Death|1|||
129763203|NCT01959503|467096195|FG000|Overall Study|Randomized but not treated|1|||
129763204|NCT01959503|467096196|FG001|Overall Study|Randomized but not treated|1|||
129763205|NCT01600326|467096197|FG000|Overall Study|Lost to Follow-up|1|||
129763206|NCT01600326|467096198|FG001|Overall Study|Lost to Follow-up|1|||
129763207|NCT03224130|467096199|FG000|Overall Study|consent issue|0|||
129763208|NCT03224130|467096200|FG001|Overall Study|consent issue|1|||
129763209|NCT03287791|467096203|FG000|Overall Study|Insufficient Therapeutic Response|0|||
129763210|NCT03287791|467096204|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129763211|NCT03287791|467096205|FG002|Overall Study|Insufficient Therapeutic Response|1|||
129763212|NCT03287791|467096203|FG000|Overall Study|Adverse Event|0|||
129763213|NCT03287791|467096204|FG001|Overall Study|Adverse Event|4|||
129763214|NCT03287791|467096205|FG002|Overall Study|Adverse Event|3|||
129763215|NCT03287791|467096203|FG000|Overall Study|Withdrawal by Subject|12|||
129763216|NCT03287791|467096204|FG001|Overall Study|Withdrawal by Subject|12|||
129763217|NCT03287791|467096205|FG002|Overall Study|Withdrawal by Subject|17|||
129763218|NCT03287791|467096203|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
129763219|NCT03287791|467096204|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
129763220|NCT03287791|467096205|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
129763221|NCT03287791|467096203|FG000|Overall Study|Lost to Follow-up|8|||
129763222|NCT03287791|467096204|FG001|Overall Study|Lost to Follow-up|14|||
129763223|NCT03287791|467096205|FG002|Overall Study|Lost to Follow-up|11|||
129763224|NCT03287791|467096203|FG000|Overall Study|Protocol Violation|7|||
129763225|NCT03287791|467096204|FG001|Overall Study|Protocol Violation|2|||
129763226|NCT03287791|467096205|FG002|Overall Study|Protocol Violation|1|||
129763227|NCT03287791|467096203|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
129763228|NCT03287791|467096204|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
129763229|NCT03287791|467096205|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
129763230|NCT03287791|467096203|FG000|Overall Study|Too much time between 2 visits|0|||
129763231|NCT03287791|467096204|FG001|Overall Study|Too much time between 2 visits|1|||
129763232|NCT03287791|467096205|FG002|Overall Study|Too much time between 2 visits|0|||
129763233|NCT03287791|467096203|FG000|Overall Study|Non-compliance|0|||
129763234|NCT03287791|467096204|FG001|Overall Study|Non-compliance|1|||
129763235|NCT03287791|467096205|FG002|Overall Study|Non-compliance|0|||
129763236|NCT03287791|467096203|FG000|Overall Study|Did not meet inclusion criteria|1|||
129763237|NCT03287791|467096204|FG001|Overall Study|Did not meet inclusion criteria|0|||
129763238|NCT03287791|467096205|FG002|Overall Study|Did not meet inclusion criteria|0|||
129763239|NCT03095651|467096207|FG000|Overall Study|Lost to Follow-up|1|||
129763240|NCT03095651|467096208|FG001|Overall Study|Lost to Follow-up|1|||
129763241|NCT03095651|467096209|FG002|Overall Study|Lost to Follow-up|0|||
129763242|NCT03095651|467096210|FG003|Overall Study|Lost to Follow-up|1|||
129763243|NCT03095651|467096211|FG004|Overall Study|Lost to Follow-up|0|||
129763244|NCT03095651|467096212|FG005|Overall Study|Lost to Follow-up|0|||
129763245|NCT03095651|467096213|FG006|Overall Study|Lost to Follow-up|0|||
129763246|NCT03095651|467096214|FG007|Overall Study|Lost to Follow-up|0|||
129763247|NCT03095651|467096207|FG000|Overall Study|Withdrawal by Subject|0|||
129763248|NCT03095651|467096208|FG001|Overall Study|Withdrawal by Subject|0|||
129763249|NCT03095651|467096209|FG002|Overall Study|Withdrawal by Subject|0|||
129763250|NCT03095651|467096210|FG003|Overall Study|Withdrawal by Subject|0|||
129763251|NCT03095651|467096211|FG004|Overall Study|Withdrawal by Subject|0|||
129763252|NCT03095651|467096212|FG005|Overall Study|Withdrawal by Subject|1|||
129763253|NCT03095651|467096213|FG006|Overall Study|Withdrawal by Subject|0|||
129763254|NCT03095651|467096214|FG007|Overall Study|Withdrawal by Subject|0|||
129763255|NCT04247347|467096221|FG000|Overall Study|Withdrawal by Subject|2|||
129763256|NCT04247347|467096222|FG001|Overall Study|Withdrawal by Subject|3|||
129763257|NCT04247347|467096223|FG002|Overall Study|Withdrawal by Subject|3|||
129763258|NCT04247347|467096221|FG000|Overall Study|Lost to Follow-up|1|||
129763259|NCT04247347|467096222|FG001|Overall Study|Lost to Follow-up|1|||
129763260|NCT04247347|467096223|FG002|Overall Study|Lost to Follow-up|1|||
129763261|NCT03562195|467096224|FG000|Overall Study|Adverse Event|0|||
129763262|NCT03562195|467096225|FG001|Overall Study|Adverse Event|6|||
129763263|NCT03562195|467096224|FG000|Overall Study|Lack of Efficacy|0|||
129763264|NCT03562195|467096225|FG001|Overall Study|Lack of Efficacy|5|||
129763265|NCT03562195|467096224|FG000|Overall Study|Protocol Violation|0|||
129763266|NCT03562195|467096225|FG001|Overall Study|Protocol Violation|1|||
129763267|NCT03562195|467096224|FG000|Overall Study|Lost to Follow-up|0|||
129763268|NCT03562195|467096225|FG001|Overall Study|Lost to Follow-up|1|||
129763269|NCT03562195|467096224|FG000|Overall Study|Physician Decision|1|||
129763270|NCT03562195|467096225|FG001|Overall Study|Physician Decision|0|||
129763271|NCT03562195|467096224|FG000|Overall Study|Withdrawal by Subject|3|||
129763272|NCT03562195|467096225|FG001|Overall Study|Withdrawal by Subject|0|||
129763273|NCT02529852|467096226|FG000|Overall Study|Withdrawal by Subject|2|||
129763274|NCT04664153|467096227|FG000|Overall Study|Lack of Efficacy|0|||
129763275|NCT04664153|467096228|FG001|Overall Study|Lack of Efficacy|0|||
129763276|NCT04664153|467096229|FG002|Overall Study|Lack of Efficacy|1|||
129763277|NCT04664153|467096230|FG003|Overall Study|Lack of Efficacy|0|||
129763278|NCT04664153|467096227|FG000|Overall Study|Physician Decision|0|||
129763279|NCT04664153|467096228|FG001|Overall Study|Physician Decision|0|||
129763280|NCT04664153|467096229|FG002|Overall Study|Physician Decision|1|||
129763281|NCT04664153|467096230|FG003|Overall Study|Physician Decision|0|||
129763282|NCT04664153|467096227|FG000|Overall Study|Withdrawal by Subject|3|||
129763283|NCT04664153|467096228|FG001|Overall Study|Withdrawal by Subject|2|||
129763284|NCT04664153|467096229|FG002|Overall Study|Withdrawal by Subject|1|||
129763285|NCT04664153|467096230|FG003|Overall Study|Withdrawal by Subject|2|||
129763286|NCT04664153|467096227|FG000|Overall Study|Other|0|||
129763287|NCT04664153|467096228|FG001|Overall Study|Other|1|||
129763288|NCT04664153|467096229|FG002|Overall Study|Other|0|||
129763289|NCT04664153|467096230|FG003|Overall Study|Other|0|||
129763290|NCT04664153|467096227|FG000|Overall Study|Adverse Event|4|||
129763291|NCT04664153|467096228|FG001|Overall Study|Adverse Event|0|||
129763292|NCT04664153|467096229|FG002|Overall Study|Adverse Event|1|||
129763293|NCT04664153|467096230|FG003|Overall Study|Adverse Event|0|||
129763294|NCT00097500|467096231|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
129763295|NCT00097500|467096232|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
129763296|NCT00097500|467096231|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
129763297|NCT00097500|467096232|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
129763298|NCT00097500|467096231|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
129763299|NCT00097500|467096232|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
129763300|NCT00097500|467096231|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129763301|NCT00097500|467096232|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
129763302|NCT00097500|467096231|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
129763303|NCT00097500|467096232|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
129763304|NCT00097500|467096231|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
129763305|NCT00097500|467096232|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
129763306|NCT00097500|467096231|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
129763307|NCT00097500|467096232|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
129763308|NCT00642356|467096238|FG000|Overall Study|Adverse Event|1|||
129763309|NCT00642356|467096239|FG001|Overall Study|Adverse Event|0|||
129763310|NCT00642356|467096238|FG000|Overall Study|Protocol Violation|0|||
129763311|NCT00642356|467096239|FG001|Overall Study|Protocol Violation|3|||
129763312|NCT00642356|467096238|FG000|Overall Study|Lack of Efficacy|1|||
129763313|NCT00642356|467096239|FG001|Overall Study|Lack of Efficacy|0|||
129763314|NCT01009060|467096240|FG000|Overall Study|Adverse Event|1|||
129763315|NCT01009060|467096241|FG001|Overall Study|Adverse Event|2|||
129763316|NCT01009060|467096240|FG000|Overall Study|Protocol Violation|0|||
129763317|NCT01009060|467096241|FG001|Overall Study|Protocol Violation|1|||
129763318|NCT01009060|467096240|FG000|Overall Study|Lost to Follow-up|1|||
129763319|NCT01009060|467096241|FG001|Overall Study|Lost to Follow-up|0|||
129763320|NCT01009060|467096240|FG000|Overall Study|Physician Decision|1|||
129763321|NCT01009060|467096241|FG001|Overall Study|Physician Decision|1|||
129763322|NCT01009060|467096240|FG000|Overall Study|Withdrawal by Subject|1|||
129763323|NCT01009060|467096241|FG001|Overall Study|Withdrawal by Subject|1|||
129763324|NCT00265564|467096242|FG000|Overall Study|Lost to Follow-up|5|||
129763325|NCT00265564|467096243|FG001|Overall Study|Lost to Follow-up|7|||
129763326|NCT00265564|467096242|FG000|Overall Study|met exclusion criteria|5|||
129763327|NCT00265564|467096243|FG001|Overall Study|met exclusion criteria|2|||
129763328|NCT04913610|467096252|FG000|Randomized Participants|Did Not Receive Treatment|0|||
129763329|NCT04913610|467096253|FG001|Randomized Participants|Did Not Receive Treatment|0|||
129763330|NCT04913610|467096254|FG002|Randomized Participants|Did Not Receive Treatment|1|||
129763331|NCT04913610|467096255|FG003|Randomized Participants|Did Not Receive Treatment|1|||
129763332|NCT04913610|467096256|FG004|Randomized Participants|Did Not Receive Treatment|0|||
129763333|NCT04913610|467096252|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
129763334|NCT04913610|467096253|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
129763335|NCT04913610|467096254|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
129763336|NCT04913610|467096255|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
129763337|NCT04913610|467096256|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
129763338|NCT00659061|467096257|FG000|Overall Study|Migration due to political unrest|21|||
129763339|NCT00659061|467096258|FG001|Overall Study|Migration due to political unrest|15|||
129763340|NCT01277744|467096261|FG000|Overall Study|Physician Decision|2|||
129763341|NCT01650558|467096264|FG000|Overall Study|Migration out of study area|61|||
129763342|NCT01650558|467096265|FG001|Overall Study|Migration out of study area|71|||
129763343|NCT01650558|467096266|FG002|Overall Study|Migration out of study area|56|||
129763344|NCT01650558|467096264|FG000|Overall Study|Lost to Follow-up|10|||
129763345|NCT01650558|467096265|FG001|Overall Study|Lost to Follow-up|13|||
129763346|NCT01650558|467096266|FG002|Overall Study|Lost to Follow-up|6|||
129540954|NCT01283009|466272491|FG000|Overall Study|Withdrawal by Subject|10|||
129763347|NCT01650558|467096264|FG000|Overall Study|Death|10|||
129763348|NCT01650558|467096265|FG001|Overall Study|Death|6|||
129763349|NCT01650558|467096266|FG002|Overall Study|Death|8|||
129763350|NCT01650558|467096264|FG000|Overall Study|Withdrawal by Subject|1|||
129763351|NCT01650558|467096265|FG001|Overall Study|Withdrawal by Subject|1|||
129763352|NCT01650558|467096266|FG002|Overall Study|Withdrawal by Subject|3|||
129763353|NCT01650558|467096264|FG000|Overall Study|Non-compliant participant|1|||
129763354|NCT01650558|467096265|FG001|Overall Study|Non-compliant participant|0|||
129763355|NCT01650558|467096266|FG002|Overall Study|Non-compliant participant|2|||
129763356|NCT01650558|467096264|FG000|Overall Study|Physician Decision|0|||
129763357|NCT01650558|467096265|FG001|Overall Study|Physician Decision|1|||
129763358|NCT01650558|467096266|FG002|Overall Study|Physician Decision|0|||
129763359|NCT03740048|467096268|FG000|Overall Study|Withdrawal by Subject|1|||
129763360|NCT03740048|467096269|FG001|Overall Study|Withdrawal by Subject|1|||
129763361|NCT03740048|467096268|FG000|Overall Study|Death|1|||
129763362|NCT03740048|467096269|FG001|Overall Study|Death|6|||
129763363|NCT03740048|467096268|FG000|Overall Study|Switched to thrice-weekly HD|2|||
129763364|NCT03740048|467096269|FG001|Overall Study|Switched to thrice-weekly HD|0|||
129763365|NCT03740048|467096268|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
129763366|NCT03740048|467096269|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
129763367|NCT03740048|467096268|FG000|Overall Study|Lost to Follow-up|0|||
129763368|NCT03740048|467096269|FG001|Overall Study|Lost to Follow-up|1|||
129763369|NCT03740048|467096268|FG000|Overall Study|Non-compliance with HD|0|||
129763370|NCT03740048|467096269|FG001|Overall Study|Non-compliance with HD|1|||
129763371|NCT01476722|467096270|FG000|Overall Study|Adverse Event|1|||
129763372|NCT03261336|467096271|FG000|Overall Study|Adverse Event|1|||
129763373|NCT01069484|467096273|FG000|Overall Study|Death-in-near-family|1|||
129540955|NCT01283009|466272492|FG001|Overall Study|Withdrawal by Subject|8|||
129540956|NCT01283009|466272491|FG000|Overall Study|Physician Decision|1|||
129540957|NCT01283009|466272492|FG001|Overall Study|Physician Decision|1|||
129763374|NCT01069484|467096274|FG001|Overall Study|Death-in-near-family|0|||
129763375|NCT01069484|467096273|FG000|Overall Study|No specific reason|8|||
129763376|NCT01069484|467096274|FG001|Overall Study|No specific reason|2|||
129763377|NCT01069484|467096273|FG000|Overall Study|Illness mother or child|3|||
129763378|NCT01069484|467096274|FG001|Overall Study|Illness mother or child|1|||
129763379|NCT00644358|467096276|FG000|Overall Study|Adverse Event|124|||
129763380|NCT00644358|467096276|FG000|Overall Study|Lost to Follow-up|105|||
129763381|NCT00644358|467096276|FG000|Overall Study|Consent Withdrawal|64|||
129763382|NCT00644358|467096276|FG000|Overall Study|Lack of Effectiveness|39|||
129763383|NCT00644358|467096276|FG000|Overall Study|Protocol Violation|5|||
129763384|NCT00644358|467096276|FG000|Overall Study|Noncompliance|14|||
129763385|NCT00644358|467096276|FG000|Overall Study|Other Unspecified|11|||
129763386|NCT00758771|467096283|FG000|Overall Study|Withdrawal by Subject|1|||
129763387|NCT00758771|467096284|FG001|Overall Study|Withdrawal by Subject|1|||
129763388|NCT00758771|467096283|FG000|Overall Study|Did not meet eligibility criteria|2|||
129763389|NCT00758771|467096284|FG001|Overall Study|Did not meet eligibility criteria|4|||
129763390|NCT00528957|467096285|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
129763391|NCT00528957|467096286|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
129763392|NCT00528957|467096285|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
129763393|NCT00528957|467096286|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
129763394|NCT00528957|467096285|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
129763395|NCT00528957|467096286|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
129763396|NCT00528957|467096285|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
129763397|NCT00528957|467096286|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
129763398|NCT00528957|467096285|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
129763399|NCT00528957|467096286|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
129763400|NCT00528957|467096285|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
129763401|NCT00528957|467096286|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
129763402|NCT00528957|467096285|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
129763403|NCT00528957|467096286|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
129763404|NCT00528957|467096285|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
129763405|NCT00528957|467096286|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
129763406|NCT00528957|467096285|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
129763407|NCT00528957|467096286|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
129763408|NCT00528957|467096285|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
129763409|NCT00528957|467096286|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
129763410|NCT00528957|467096285|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
129763411|NCT00528957|467096286|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
129763412|NCT00528957|467096285|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
129763413|NCT00528957|467096286|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
129763414|NCT00528957|467096285|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
129763415|NCT00528957|467096286|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
129763416|NCT00528957|467096285|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
129763417|NCT00528957|467096286|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
129763418|NCT00528957|467096285|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
129763419|NCT00528957|467096286|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
129763420|NCT00528957|467096285|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
129763421|NCT00528957|467096286|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
129763422|NCT02051764|467096291|FG000|Overall Study|Study terminated by sponsor|0|||
129763423|NCT02051764|467096292|FG001|Overall Study|Study terminated by sponsor|7|||
129763424|NCT03624881|467096293|FG000|Overall Study|Screen Failure|14|||
129763425|NCT03624881|467096294|FG001|Overall Study|Screen Failure|0|||
129763426|NCT03624881|467096293|FG000|Overall Study|No Catheter Inserted|6|||
129763427|NCT03624881|467096294|FG001|Overall Study|No Catheter Inserted|1|||
129763428|NCT03624881|467096293|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
129763429|NCT03624881|467096294|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
129763430|NCT03624881|467096293|FG000|Overall Study|Death|2|||
129763431|NCT03624881|467096294|FG001|Overall Study|Death|0|||
129763432|NCT03624881|467096293|FG000|Overall Study|Lost to Follow-up|10|||
129763433|NCT03624881|467096294|FG001|Overall Study|Lost to Follow-up|4|||
129763434|NCT03624881|467096293|FG000|Overall Study|Withdrawal by Subject|12|||
129763435|NCT03624881|467096294|FG001|Overall Study|Withdrawal by Subject|1|||
129763436|NCT03155724|467096298|FG000|Overall Study|Death|3|||
129763437|NCT03155724|467096298|FG000|Overall Study|Physician Decision|1|||
129763438|NCT03155724|467096298|FG000|Overall Study|Study closure|7|||
129763439|NCT01400698|467096300|FG000|Overall Study|Lost to Follow-up|2|||
129763440|NCT01400698|467096301|FG001|Overall Study|Lost to Follow-up|5|||
129763441|NCT01400698|467096302|FG002|Overall Study|Lost to Follow-up|2|||
129763442|NCT01400698|467096303|FG003|Overall Study|Lost to Follow-up|1|||
129763443|NCT01400698|467096304|FG004|Overall Study|Lost to Follow-up|4|||
129763444|NCT01400698|467096305|FG005|Overall Study|Lost to Follow-up|3|||
129763445|NCT01400698|467096300|FG000|Overall Study|Withdrawal by Subject|8|||
129763446|NCT01400698|467096301|FG001|Overall Study|Withdrawal by Subject|2|||
129763447|NCT01400698|467096302|FG002|Overall Study|Withdrawal by Subject|0|||
129763448|NCT01400698|467096303|FG003|Overall Study|Withdrawal by Subject|4|||
129763449|NCT01400698|467096304|FG004|Overall Study|Withdrawal by Subject|1|||
129763450|NCT01400698|467096305|FG005|Overall Study|Withdrawal by Subject|3|||
129763451|NCT01400698|467096300|FG000|Overall Study|Protocol Violation|0|||
129763452|NCT01400698|467096301|FG001|Overall Study|Protocol Violation|1|||
129763453|NCT01400698|467096302|FG002|Overall Study|Protocol Violation|0|||
129763454|NCT01400698|467096303|FG003|Overall Study|Protocol Violation|0|||
129763455|NCT01400698|467096304|FG004|Overall Study|Protocol Violation|1|||
129763456|NCT01400698|467096305|FG005|Overall Study|Protocol Violation|0|||
129763457|NCT01400698|467096300|FG000|Overall Study|Non-compliance|0|||
129763458|NCT01400698|467096301|FG001|Overall Study|Non-compliance|1|||
129763459|NCT01400698|467096302|FG002|Overall Study|Non-compliance|0|||
129763460|NCT01400698|467096303|FG003|Overall Study|Non-compliance|1|||
129763461|NCT01400698|467096304|FG004|Overall Study|Non-compliance|0|||
129763462|NCT01400698|467096305|FG005|Overall Study|Non-compliance|0|||
129763463|NCT01400698|467096300|FG000|Overall Study|Adverse Event|1|||
129763464|NCT01400698|467096301|FG001|Overall Study|Adverse Event|0|||
129763465|NCT01400698|467096302|FG002|Overall Study|Adverse Event|0|||
129763466|NCT01400698|467096303|FG003|Overall Study|Adverse Event|0|||
129763467|NCT01400698|467096304|FG004|Overall Study|Adverse Event|0|||
129763468|NCT01400698|467096305|FG005|Overall Study|Adverse Event|0|||
129763469|NCT01400698|467096300|FG000|Overall Study|Other|4|||
129763470|NCT01400698|467096301|FG001|Overall Study|Other|2|||
129763471|NCT01400698|467096302|FG002|Overall Study|Other|0|||
129763472|NCT01400698|467096303|FG003|Overall Study|Other|2|||
129763473|NCT01400698|467096304|FG004|Overall Study|Other|1|||
129763474|NCT01400698|467096305|FG005|Overall Study|Other|0|||
129763475|NCT02587520|467098048|FG000|Overall Study|Protocol Violation|2|||
129763476|NCT02587520|467098049|FG001|Overall Study|Protocol Violation|0|||
129763477|NCT02587520|467098050|FG002|Overall Study|Protocol Violation|0|||
129763478|NCT02587520|467098051|FG003|Overall Study|Protocol Violation|2|||
129763479|NCT02587520|467098052|FG004|Overall Study|Protocol Violation|0|||
129763480|NCT02587520|467098053|FG005|Overall Study|Protocol Violation|1|||
129763481|NCT02587520|467098054|FG006|Overall Study|Protocol Violation|1|||
129763482|NCT02587520|467098055|FG007|Overall Study|Protocol Violation|1|||
129763483|NCT02587520|467098056|FG008|Overall Study|Protocol Violation|3|||
129763484|NCT02587520|467098057|FG009|Overall Study|Protocol Violation|3|||
129763485|NCT02587520|467098058|FG010|Overall Study|Protocol Violation|1|||
129763486|NCT02587520|467098059|FG011|Overall Study|Protocol Violation|2|||
129763487|NCT02587520|467098060|FG012|Overall Study|Protocol Violation|0|||
129763488|NCT02587520|467098061|FG013|Overall Study|Protocol Violation|0|||
129763489|NCT02587520|467098062|FG014|Overall Study|Protocol Violation|0|||
129763490|NCT02587520|467098063|FG015|Overall Study|Protocol Violation|0|||
129763491|NCT02587520|467098064|FG016|Overall Study|Protocol Violation|0|||
129763492|NCT02587520|467098065|FG017|Overall Study|Protocol Violation|0|||
129763493|NCT02587520|467098048|FG000|Overall Study|Adverse Event|0|||
129763494|NCT02587520|467098049|FG001|Overall Study|Adverse Event|0|||
129763495|NCT02587520|467098050|FG002|Overall Study|Adverse Event|0|||
129763496|NCT02587520|467098051|FG003|Overall Study|Adverse Event|0|||
129763497|NCT02587520|467098052|FG004|Overall Study|Adverse Event|0|||
129763498|NCT02587520|467098053|FG005|Overall Study|Adverse Event|0|||
129763499|NCT02587520|467098054|FG006|Overall Study|Adverse Event|0|||
129763500|NCT02587520|467098055|FG007|Overall Study|Adverse Event|0|||
129763501|NCT02587520|467098056|FG008|Overall Study|Adverse Event|0|||
129763502|NCT02587520|467098057|FG009|Overall Study|Adverse Event|0|||
129763503|NCT02587520|467098058|FG010|Overall Study|Adverse Event|0|||
129763504|NCT02587520|467098059|FG011|Overall Study|Adverse Event|1|||
129763505|NCT02587520|467098060|FG012|Overall Study|Adverse Event|0|||
129763506|NCT02587520|467098061|FG013|Overall Study|Adverse Event|0|||
129763507|NCT02587520|467098062|FG014|Overall Study|Adverse Event|0|||
129763508|NCT02587520|467098063|FG015|Overall Study|Adverse Event|0|||
129763509|NCT02587520|467098064|FG016|Overall Study|Adverse Event|0|||
129763510|NCT02587520|467098065|FG017|Overall Study|Adverse Event|0|||
129763511|NCT02587520|467098048|FG000|Overall Study|Withdrawal by Subject|0|||
129763512|NCT02587520|467098049|FG001|Overall Study|Withdrawal by Subject|0|||
129763513|NCT02587520|467098050|FG002|Overall Study|Withdrawal by Subject|1|||
129763514|NCT02587520|467098051|FG003|Overall Study|Withdrawal by Subject|1|||
129763515|NCT02587520|467098052|FG004|Overall Study|Withdrawal by Subject|0|||
129763516|NCT02587520|467098053|FG005|Overall Study|Withdrawal by Subject|1|||
129763517|NCT02587520|467098054|FG006|Overall Study|Withdrawal by Subject|1|||
129763518|NCT02587520|467098055|FG007|Overall Study|Withdrawal by Subject|0|||
129763519|NCT02587520|467098056|FG008|Overall Study|Withdrawal by Subject|0|||
129763520|NCT02587520|467098057|FG009|Overall Study|Withdrawal by Subject|0|||
129763521|NCT02587520|467098058|FG010|Overall Study|Withdrawal by Subject|0|||
129763522|NCT02587520|467098059|FG011|Overall Study|Withdrawal by Subject|0|||
129763523|NCT02587520|467098060|FG012|Overall Study|Withdrawal by Subject|0|||
129763524|NCT02587520|467098061|FG013|Overall Study|Withdrawal by Subject|1|||
129763525|NCT02587520|467098062|FG014|Overall Study|Withdrawal by Subject|0|||
129763526|NCT02587520|467098063|FG015|Overall Study|Withdrawal by Subject|0|||
129763527|NCT02587520|467098064|FG016|Overall Study|Withdrawal by Subject|0|||
129763528|NCT02587520|467098065|FG017|Overall Study|Withdrawal by Subject|0|||
129763529|NCT02587520|467098048|FG000|Overall Study|Lost to Follow-up|0|||
129763530|NCT02587520|467098049|FG001|Overall Study|Lost to Follow-up|2|||
129763531|NCT02587520|467098050|FG002|Overall Study|Lost to Follow-up|0|||
129763532|NCT02587520|467098051|FG003|Overall Study|Lost to Follow-up|2|||
129763533|NCT02587520|467098052|FG004|Overall Study|Lost to Follow-up|0|||
129763534|NCT02587520|467098053|FG005|Overall Study|Lost to Follow-up|1|||
129763535|NCT02587520|467098054|FG006|Overall Study|Lost to Follow-up|1|||
129763536|NCT02587520|467098055|FG007|Overall Study|Lost to Follow-up|1|||
129763537|NCT02587520|467098056|FG008|Overall Study|Lost to Follow-up|0|||
129763538|NCT02587520|467098057|FG009|Overall Study|Lost to Follow-up|2|||
129763539|NCT02587520|467098058|FG010|Overall Study|Lost to Follow-up|2|||
129763540|NCT02587520|467098059|FG011|Overall Study|Lost to Follow-up|1|||
129763541|NCT02587520|467098060|FG012|Overall Study|Lost to Follow-up|0|||
129763542|NCT02587520|467098061|FG013|Overall Study|Lost to Follow-up|0|||
129763543|NCT02587520|467098062|FG014|Overall Study|Lost to Follow-up|0|||
129763544|NCT02587520|467098063|FG015|Overall Study|Lost to Follow-up|0|||
129763545|NCT02587520|467098064|FG016|Overall Study|Lost to Follow-up|0|||
129763546|NCT02587520|467098065|FG017|Overall Study|Lost to Follow-up|0|||
129763547|NCT03924622|467098066|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
129763548|NCT03924622|467098067|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129763549|NCT03924622|467098068|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129763550|NCT03924622|467098069|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
129763551|NCT03924622|467098070|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129763552|NCT03924622|467098071|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
129763553|NCT02412306|467098073|FG000|Overall Study|Lost to Follow-up|0|||
129763554|NCT02412306|467098074|FG001|Overall Study|Lost to Follow-up|1|||
129763555|NCT02412306|467098075|FG002|Overall Study|Lost to Follow-up|0|||
129763556|NCT02412306|467098076|FG003|Overall Study|Lost to Follow-up|0|||
129763557|NCT02412306|467098077|FG004|Overall Study|Lost to Follow-up|0|||
129763558|NCT02412306|467098073|FG000|Overall Study|Withdrawal by Subject|0|||
129763559|NCT02412306|467098074|FG001|Overall Study|Withdrawal by Subject|0|||
129763560|NCT02412306|467098075|FG002|Overall Study|Withdrawal by Subject|1|||
129763561|NCT02412306|467098076|FG003|Overall Study|Withdrawal by Subject|0|||
129763562|NCT02412306|467098077|FG004|Overall Study|Withdrawal by Subject|0|||
129763563|NCT02412306|467098073|FG000|Overall Study|Death|5|||
129763564|NCT02412306|467098074|FG001|Overall Study|Death|7|||
129763565|NCT02412306|467098075|FG002|Overall Study|Death|15|||
129763566|NCT02412306|467098076|FG003|Overall Study|Death|0|||
129763567|NCT02412306|467098077|FG004|Overall Study|Death|2|||
129763568|NCT05543265|467098085|FG000|Overall Study|Lost to Follow-up|3|||
129763569|NCT05543265|467098086|FG001|Overall Study|Lost to Follow-up|3|||
129763570|NCT05543265|467098085|FG000|Overall Study|Withdrawal by Subject|0|||
129763571|NCT05543265|467098086|FG001|Overall Study|Withdrawal by Subject|1|||
129875032|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129763572|NCT05316597|467098087|FG000|First Session|Withdrawal by Subject|0|||
129763573|NCT05316597|467098088|FG001|First Session|Withdrawal by Subject|1|||
129763574|NCT05316597|467098087|FG000|Washout Period|Lost to Follow-up|1|||
129763575|NCT05316597|467098088|FG001|Washout Period|Lost to Follow-up|2|||
129763576|NCT05316597|467098087|FG000|Washout Period|Physician Decision|1|||
129763577|NCT05316597|467098088|FG001|Washout Period|Physician Decision|1|||
129763578|NCT05316597|467098087|FG000|Washout Period|Excluded before second session|1|||
129875033|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875034|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
129875035|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
129875036|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875037|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
129875038|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875039|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875040|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
129875041|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
129875042|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Other|0|||
129875043|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Other|1|||
129875044|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Other|0|||
129875045|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Other|0|||
129875046|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Other|0|||
129875047|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Other|0|||
129875048|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Other|0|||
129875049|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
129875050|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129763579|NCT05316597|467098088|FG001|Washout Period|Excluded before second session|1|||
129763580|NCT05316597|467098087|FG000|Washout Period|Withdrawal by Subject|0|||
129763581|NCT05316597|467098088|FG001|Washout Period|Withdrawal by Subject|4|||
129763582|NCT05526716|467098089|FG000|Overall Study|Death|1|||
129763583|NCT05526716|467098090|FG001|Overall Study|Death|2|||
129763584|NCT05526716|467098089|FG000|Overall Study|Lost to Follow-up|17|||
129763585|NCT05526716|467098090|FG001|Overall Study|Lost to Follow-up|15|||
129875051|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
129875052|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129875053|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129763586|NCT05526716|467098089|FG000|Overall Study|Physician Decision|0|||
129763587|NCT05526716|467098090|FG001|Overall Study|Physician Decision|1|||
129540958|NCT01283009|466272491|FG000|Overall Study|Lost to Follow-up|1|||
129540959|NCT01283009|466272492|FG001|Overall Study|Lost to Follow-up|0|||
129540960|NCT01283009|466272491|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
129540961|NCT01283009|466272492|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
129540962|NCT00505765|466272495|FG000|Overall Study|Withdrawal by Subject|1|||
129540963|NCT00505765|466272496|FG001|Overall Study|Withdrawal by Subject|0|||
129540964|NCT00505765|466272497|FG002|Overall Study|Withdrawal by Subject|0|||
129540965|NCT00505765|466272495|FG000|Overall Study|Adverse Event|1|||
129540966|NCT00505765|466272496|FG001|Overall Study|Adverse Event|2|||
129540967|NCT00505765|466272497|FG002|Overall Study|Adverse Event|0|||
129540968|NCT00505765|466272495|FG000|Overall Study|Noncompliance|0|||
129540969|NCT00505765|466272496|FG001|Overall Study|Noncompliance|1|||
129540970|NCT00505765|466272497|FG002|Overall Study|Noncompliance|3|||
129540971|NCT00779857|466272498|FG000|Overall Study|Death|1|||
129540972|NCT00779857|466272498|FG000|Overall Study|Withdrawal by Subject|3|||
129540973|NCT00779857|466272498|FG000|Overall Study|Missed Visit|2|||
129540974|NCT04640168|466272499|FG000|Overall Study|Withdrawal by Subject|8|||
129540975|NCT04640168|466272500|FG001|Overall Study|Withdrawal by Subject|7|||
129540976|NCT04640168|466272499|FG000|Overall Study|Lost to Follow-up|1|||
129540977|NCT04640168|466272500|FG001|Overall Study|Lost to Follow-up|0|||
129540978|NCT04640168|466272499|FG000|Overall Study|Enrolled but not treated|12|||
129540979|NCT04640168|466272500|FG001|Overall Study|Enrolled but not treated|12|||
129540980|NCT04366258|466272508|FG000|Baseline Assessments|Screen Failure|21|||
129540981|NCT04366258|466272508|FG000|Baseline Assessments|Early Termination|3|||
129540982|NCT01725217|466272509|FG000|Overall Study|Withdrawal by Subject|1|||
129540983|NCT01725217|466272510|FG001|Overall Study|Withdrawal by Subject|0|||
129540984|NCT01725217|466272511|FG002|Overall Study|Withdrawal by Subject|0|||
129540985|NCT00308555|466272512|FG000|Overall Study|Withdrawal by Subject|1|||
129540986|NCT00308555|466272513|FG001|Overall Study|Withdrawal by Subject|0|||
129540987|NCT00308555|466272512|FG000|Overall Study|Physician Decision|2|||
129540988|NCT00308555|466272513|FG001|Overall Study|Physician Decision|0|||
129540989|NCT00276458|466272514|FG000|Overall Study|Adverse Event|0|||
129540990|NCT00276458|466272515|FG001|Overall Study|Adverse Event|2|||
129540991|NCT00276458|466272514|FG000|Overall Study|Lost to Follow-up|2|||
129540992|NCT00276458|466272515|FG001|Overall Study|Lost to Follow-up|2|||
129540993|NCT00276458|466272514|FG000|Overall Study|Protocol Violation|4|||
129540994|NCT00276458|466272515|FG001|Overall Study|Protocol Violation|3|||
129540995|NCT02940392|466272518|FG000|Overall Study|Lost to Follow-up|3|||
129540996|NCT02940392|466272518|FG000|Overall Study|Retreatment|3|||
129540997|NCT02940392|466272518|FG000|Overall Study|Death|2|||
129540998|NCT04964960|466272519|FG000|Overall Study|Withdrawal by Subject|1|||
129540999|NCT02686749|466272520|FG000|Overall Study|terminated for poor enrollment|2|||
129541000|NCT02686749|466272521|FG001|Overall Study|terminated for poor enrollment|2|||
129541001|NCT05147311|466272524|FG000|Overall Study|Did not complete survey|2|||
129541002|NCT05147311|466272525|FG001|Overall Study|Did not complete survey|1|||
129541003|NCT05147311|466272524|FG000|Overall Study|Patient too sick|1|||
129541004|NCT05147311|466272525|FG001|Overall Study|Patient too sick|2|||
129541005|NCT05147311|466272524|FG000|Overall Study|Death|0|||
129541006|NCT05147311|466272525|FG001|Overall Study|Death|1|||
129541007|NCT05147311|466272524|FG000|Overall Study|Declined survey|1|||
129541008|NCT05147311|466272525|FG001|Overall Study|Declined survey|0|||
129541009|NCT04365387|466272528|FG000|Overall Study|Adverse Event|4|||
129541010|NCT04365387|466272529|FG001|Overall Study|Adverse Event|2|||
129541011|NCT04365387|466272528|FG000|Overall Study|Participants request|14|||
129541012|NCT04365387|466272529|FG001|Overall Study|Participants request|14|||
129541013|NCT04365387|466272528|FG000|Overall Study|Lost to Follow-up|8|||
129541014|NCT04365387|466272529|FG001|Overall Study|Lost to Follow-up|5|||
129541015|NCT04365387|466272528|FG000|Overall Study|Protocol deviation|3|||
129541016|NCT04365387|466272529|FG001|Overall Study|Protocol deviation|4|||
129541017|NCT04365387|466272528|FG000|Overall Study|Participant compliance with visit schedule|1|||
129541018|NCT04365387|466272529|FG001|Overall Study|Participant compliance with visit schedule|0|||
129541019|NCT04365387|466272528|FG000|Overall Study|Participant incarcerated|1|||
129541020|NCT04365387|466272529|FG001|Overall Study|Participant incarcerated|0|||
129541021|NCT04365387|466272528|FG000|Overall Study|Participant moved out of town (relocated)|0|||
129541022|NCT04365387|466272529|FG001|Overall Study|Participant moved out of town (relocated)|1|||
129541023|NCT04365387|466272528|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
129541024|NCT04365387|466272529|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
129541025|NCT04365387|466272528|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
129541026|NCT04365387|466272529|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
129541027|NCT00480077|466272530|FG000|Overall Study|Death|19|||
129541028|NCT00480077|466272531|FG001|Overall Study|Death|15|||
129541029|NCT00480077|466272530|FG000|Overall Study|early exit|12|||
129541030|NCT00480077|466272531|FG001|Overall Study|early exit|11|||
129541031|NCT04298229|466272536|FG000|Overall Study|Physician Decision|1|||
129541032|NCT04298229|466272537|FG001|Overall Study|Physician Decision|1|||
129541033|NCT04298229|466272536|FG000|Overall Study|Withdrawal by Subject|1|||
129541034|NCT04298229|466272537|FG001|Overall Study|Withdrawal by Subject|1|||
129541035|NCT04298229|466272536|FG000|Overall Study|Did not receive IV loop diuretics|2|||
129541036|NCT04298229|466272537|FG001|Overall Study|Did not receive IV loop diuretics|0|||
129763588|NCT05526716|467098089|FG000|Overall Study|Randomized by mistake without study treatment|0|||
129763589|NCT05526716|467098090|FG001|Overall Study|Randomized by mistake without study treatment|1|||
129763590|NCT05526716|467098089|FG000|Overall Study|Withdrawal by Subject|12|||
129763591|NCT05526716|467098090|FG001|Overall Study|Withdrawal by Subject|12|||
129763592|NCT05526716|467098089|FG000|Overall Study|Not reported|0|||
129763593|NCT05526716|467098090|FG001|Overall Study|Not reported|2|||
129763594|NCT04750824|467098094|FG000|Overall Study|Toxicity/intolerability|3|||
129763595|NCT04750824|467098095|FG001|Overall Study|Toxicity/intolerability|1|||
129763596|NCT04750824|467098094|FG000|Overall Study|Death|1|||
129763597|NCT04750824|467098095|FG001|Overall Study|Death|3|||
129763598|NCT04750824|467098094|FG000|Overall Study|Scheduled duration of therapy complete|1|||
129763599|NCT04750824|467098095|FG001|Overall Study|Scheduled duration of therapy complete|9|||
129763600|NCT04750824|467098094|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
129763601|NCT04750824|467098095|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
129763602|NCT00807911|467098096|FG000|Overall Study|Withdrawal by Subject|12|||
129763603|NCT00807911|467098097|FG001|Overall Study|Withdrawal by Subject|10|||
129763604|NCT00807911|467098096|FG000|Overall Study|Ineligible|0|||
129763605|NCT00807911|467098097|FG001|Overall Study|Ineligible|4|||
129763606|NCT03547518|467098100|FG000|Overall Study|Lost to Follow-up|2|||
129763607|NCT03547518|467098101|FG001|Overall Study|Lost to Follow-up|0|||
129763608|NCT04349891|467098108|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
129763609|NCT04349891|467098109|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
129763610|NCT04349891|467098108|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
129763611|NCT04349891|467098109|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
129763612|NCT04349891|467098108|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
129763613|NCT04349891|467098109|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
129763614|NCT04349891|467098108|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
129763615|NCT04349891|467098109|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
129763616|NCT02927301|467098112|FG000|Overall Study|Death|39|||
129763617|NCT02927301|467098112|FG000|Overall Study|Lost to Follow-up|8|||
129763618|NCT02927301|467098112|FG000|Overall Study|Physician Decision|2|||
129763619|NCT02927301|467098112|FG000|Overall Study|Withdrawal by Subject|12|||
129763620|NCT02927301|467098112|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
129763621|NCT02201524|467098115|FG000|Overall Study|Adverse Event|0|||
129763622|NCT02201524|467098116|FG001|Overall Study|Adverse Event|2|||
129763623|NCT02201524|467098117|FG002|Overall Study|Adverse Event|1|||
129763624|NCT02201524|467098118|FG003|Overall Study|Adverse Event|0|||
129763625|NCT02201524|467098115|FG000|Overall Study|Insufficient clinical response|1|||
129763626|NCT02201524|467098116|FG001|Overall Study|Insufficient clinical response|0|||
129763627|NCT02201524|467098117|FG002|Overall Study|Insufficient clinical response|0|||
129875054|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129875055|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
129875056|NCT05375955|467499602|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875057|NCT05375955|467499603|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
129875058|NCT05375955|467499604|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875059|NCT05375955|467499605|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
129875060|NCT05375955|467499606|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875061|NCT05375955|467499607|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
129875062|NCT05375955|467499608|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
129541037|NCT00262119|466272539|FG000|Overall Study|Lost to Follow-up|38|||
129541038|NCT00262119|466272540|FG001|Overall Study|Lost to Follow-up|51|||
129541039|NCT00262119|466272541|FG002|Overall Study|Lost to Follow-up|42|||
129541040|NCT00262119|466272539|FG000|Overall Study|Death|20|||
129763628|NCT02201524|467098118|FG003|Overall Study|Insufficient clinical response|0|||
129985698|NCT04811131|467909334|FG001|Overall Study|Adverse Event|0|||
129875063|NCT02063828|467499611|FG000|Overall Study|Withdrawal by Subject|4|||
129875064|NCT02063828|467499612|FG001|Overall Study|Withdrawal by Subject|6|||
129875065|NCT02063828|467499613|FG002|Overall Study|Withdrawal by Subject|3|||
129875066|NCT02063828|467499611|FG000|Overall Study|Death|0|||
129875067|NCT02063828|467499612|FG001|Overall Study|Death|0|||
129875068|NCT02063828|467499613|FG002|Overall Study|Death|1|||
129875069|NCT00733980|467499616|FG000|Overall Study|Adverse Event|5|||
129875070|NCT00733980|467499617|FG001|Overall Study|Adverse Event|2|||
129875071|NCT00733980|467499616|FG000|Overall Study|Lack of Efficacy|0|||
129875072|NCT00733980|467499617|FG001|Overall Study|Lack of Efficacy|1|||
129875073|NCT00733980|467499616|FG000|Overall Study|Protocol Violation|2|||
129875074|NCT00733980|467499617|FG001|Overall Study|Protocol Violation|1|||
129875075|NCT00733980|467499616|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
129875076|NCT00733980|467499617|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
129875077|NCT00733980|467499616|FG000|Overall Study|Lost to Follow-up|6|||
129875078|NCT00733980|467499617|FG001|Overall Study|Lost to Follow-up|11|||
129875079|NCT00733980|467499616|FG000|Overall Study|Physician Decision|2|||
129875080|NCT00733980|467499617|FG001|Overall Study|Physician Decision|3|||
129875081|NCT00733980|467499616|FG000|Overall Study|Withdrawal by Subject|6|||
129875082|NCT00733980|467499617|FG001|Overall Study|Withdrawal by Subject|2|||
129875083|NCT02010632|467499618|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
129875084|NCT02010632|467499619|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
129875085|NCT06387472|467499623|FG000|Overall Study|Withdrawal by Subject|1|||
129875086|NCT06387472|467499623|FG000|Overall Study|Lost to Follow-up|2|||
129875087|NCT06387472|467499623|FG000|Overall Study|Physician Decision|1|||
129875088|NCT01679236|467501804|FG000|Overall Study|Lost to Follow-up|15|||
129875089|NCT01679236|467501805|FG001|Overall Study|Lost to Follow-up|15|||
129875090|NCT00975221|467501807|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
129875091|NCT00975221|467501808|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
129875092|NCT00975221|467501807|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
129875093|NCT00975221|467501808|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
129875094|NCT00975221|467501807|FG000|Titration Phase (Weeks 1-12)|Other|0|||
129875095|NCT00975221|467501808|FG001|Titration Phase (Weeks 1-12)|Other|1|||
129875096|NCT00975221|467501807|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
129875097|NCT00975221|467501808|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
129875098|NCT00975221|467501807|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
129875099|NCT00975221|467501808|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
129875100|NCT00975221|467501807|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
129875101|NCT00975221|467501808|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
129875102|NCT03935217|467501809|FG000|Overall Study|Adverse Event|1|||
129875103|NCT03935217|467501810|FG001|Overall Study|Adverse Event|0|||
129875104|NCT03935217|467501809|FG000|Overall Study|Lost to Follow-up|0|||
129875105|NCT03935217|467501810|FG001|Overall Study|Lost to Follow-up|1|||
129875106|NCT03935217|467501809|FG000|Overall Study|Withdrawal by Subject|0|||
129875107|NCT03935217|467501810|FG001|Overall Study|Withdrawal by Subject|2|||
129875108|NCT03559218|467501811|FG000|Overall Study|Withdrawal by Subject|1|||
129875109|NCT03559218|467501812|FG001|Overall Study|Withdrawal by Subject|0|||
129875110|NCT03237858|467501819|FG000|Overall Study|Death|19|||
129875111|NCT03237858|467501819|FG000|Overall Study|Withdrawal by Subject|37|||
129875112|NCT01862991|467501820|FG000|Overall Study|Lost to Follow-up|2|||
129875113|NCT01862991|467501821|FG001|Overall Study|Lost to Follow-up|1|||
129875114|NCT01862991|467501822|FG002|Overall Study|Lost to Follow-up|1|||
129875115|NCT01862991|467501820|FG000|Overall Study|Protocol Violation|1|||
129875116|NCT01862991|467501821|FG001|Overall Study|Protocol Violation|0|||
129875117|NCT01862991|467501822|FG002|Overall Study|Protocol Violation|0|||
129875118|NCT04858802|467501823|FG000|Overall Study|Lost to Follow-up|1|||
129875119|NCT04858802|467501824|FG001|Overall Study|Lost to Follow-up|1|||
129875120|NCT04858802|467501823|FG000|Overall Study|Withdrawal by Subject|1|||
129875121|NCT04858802|467501824|FG001|Overall Study|Withdrawal by Subject|1|||
129875122|NCT01108458|467501825|FG000|Overall Study|Withdrawal by Subject|1|||
129875123|NCT04170686|467501826|FG000|Screening|Physician Decision|12|||
129875124|NCT04170686|467501827|FG001|Screening|Physician Decision|13|||
129875125|NCT04170686|467501826|FG000|Randomization and Treatment|Lost to Follow-up|26|||
129875126|NCT04170686|467501827|FG001|Randomization and Treatment|Lost to Follow-up|15|||
129875127|NCT03328143|467501828|FG000|Overall Study|Declined|3|||
129875128|NCT03328143|467501828|FG000|Overall Study|Required increased sedation|4|||
129875129|NCT03328143|467501828|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
129875130|NCT03328143|467501828|FG000|Overall Study|Surgery cancelled|1|||
129875131|NCT02305381|467501829|FG000|Overall Study|Unclassified|5|||
129875132|NCT02305381|467501830|FG001|Overall Study|Unclassified|5|||
129875133|NCT02305381|467501831|FG002|Overall Study|Unclassified|7|||
129875134|NCT02487498|467501835|FG000|Period: Period 1|Adverse Event|2|||
129875135|NCT02487498|467501836|FG001|Period: Period 1|Adverse Event|4|||
129875136|NCT02487498|467501835|FG000|Period: Period 1|Subject/guardian decision|2|||
129875137|NCT02487498|467501836|FG001|Period: Period 1|Subject/guardian decision|4|||
129875138|NCT02487498|467501835|FG000|Period: Period 1|Lost to Follow-up|0|||
129875139|NCT02487498|467501836|FG001|Period: Period 1|Lost to Follow-up|2|||
129875140|NCT02487498|467501835|FG000|Period: Period 1|Lack of Efficacy|1|||
129875141|NCT02487498|467501836|FG001|Period: Period 1|Lack of Efficacy|0|||
129875142|NCT02487498|467501835|FG000|Period: Period 1|Physician Decision|0|||
129875143|NCT02487498|467501836|FG001|Period: Period 1|Physician Decision|1|||
129875144|NCT02487498|467501835|FG000|Period: Period 1|Protocol deviation|1|||
129875145|NCT02487498|467501836|FG001|Period: Period 1|Protocol deviation|0|||
129875146|NCT02487498|467501835|FG000|Period: Washout|Subject/guardian decision|0|||
129875147|NCT02487498|467501836|FG001|Period: Washout|Subject/guardian decision|5|||
129875148|NCT02487498|467501835|FG000|Period: Washout|Lack of Efficacy|1|||
129875149|NCT02487498|467501836|FG001|Period: Washout|Lack of Efficacy|1|||
129875150|NCT02487498|467501835|FG000|Period: Washout|Physician Decision|1|||
129875151|NCT02487498|467501836|FG001|Period: Washout|Physician Decision|0|||
129875152|NCT02487498|467501835|FG000|Period: Washout|Non-compliance with study treatment|0|||
129875153|NCT02487498|467501836|FG001|Period: Washout|Non-compliance with study treatment|1|||
129875154|NCT02487498|467501835|FG000|Period: Period 2|Adverse Event|2|||
129875155|NCT02487498|467501836|FG001|Period: Period 2|Adverse Event|2|||
129875156|NCT02487498|467501835|FG000|Period: Period 2|Subject/guardian decision|2|||
129875157|NCT02487498|467501836|FG001|Period: Period 2|Subject/guardian decision|1|||
129875158|NCT02487498|467501835|FG000|Period: Period 2|Lost to Follow-up|1|||
129875159|NCT02487498|467501836|FG001|Period: Period 2|Lost to Follow-up|1|||
129875160|NCT02487498|467501835|FG000|Period: Period 2|Death|0|||
129875161|NCT02487498|467501836|FG001|Period: Period 2|Death|1|||
129875162|NCT02487498|467501835|FG000|Period: Period 2|Physician Decision|1|||
129875163|NCT02487498|467501836|FG001|Period: Period 2|Physician Decision|0|||
129875164|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Adverse Event|0|||
129541041|NCT00262119|466272540|FG001|Overall Study|Death|19|||
129541042|NCT00262119|466272541|FG002|Overall Study|Death|16|||
129541043|NCT01683565|466272542|FG000|Overall Study|Lost to Follow-up|2|||
129541044|NCT01683565|466272543|FG001|Overall Study|Lost to Follow-up|0|||
129541045|NCT01683565|466272542|FG000|Overall Study|Discontinued Intervention|1|||
129541046|NCT01683565|466272543|FG001|Overall Study|Discontinued Intervention|1|||
129541047|NCT00071006|466272544|FG000|Overall Study|Lack of Efficacy|7|||
129541048|NCT00071006|466272544|FG000|Overall Study|Adverse Event|1|||
129541049|NCT00071006|466272544|FG000|Overall Study|Withdrawal by Subject|1|||
129541050|NCT00071006|466272544|FG000|Overall Study|Other|3|||
129541051|NCT00859313|466272545|FG000|Overall Study|Lack of Efficacy|2|||
129541052|NCT00859313|466272545|FG000|Overall Study|Adverse Event|1|||
129541053|NCT00859313|466272545|FG000|Overall Study|staff error|1|||
129541054|NCT05261126|466272546|FG000|Overall Study|Death|0|||
129541055|NCT05261126|466272547|FG001|Overall Study|Death|0|||
129541056|NCT05261126|466272548|FG002|Overall Study|Death|1|||
129541057|NCT05261126|466272549|FG003|Overall Study|Death|0|||
129541058|NCT05261126|466272550|FG004|Overall Study|Death|0|||
129541059|NCT05261126|466272546|FG000|Overall Study|Lost to Follow-up|0|||
129541060|NCT05261126|466272547|FG001|Overall Study|Lost to Follow-up|0|||
129541061|NCT05261126|466272548|FG002|Overall Study|Lost to Follow-up|0|||
129541062|NCT05261126|466272549|FG003|Overall Study|Lost to Follow-up|0|||
129541063|NCT05261126|466272550|FG004|Overall Study|Lost to Follow-up|1|||
129541064|NCT05261126|466272546|FG000|Overall Study|Physician Decision|1|||
129541065|NCT05261126|466272547|FG001|Overall Study|Physician Decision|0|||
129541066|NCT05261126|466272548|FG002|Overall Study|Physician Decision|0|||
129541067|NCT05261126|466272549|FG003|Overall Study|Physician Decision|0|||
129541068|NCT05261126|466272550|FG004|Overall Study|Physician Decision|0|||
129541069|NCT05261126|466272546|FG000|Overall Study|Screen Failure|0|||
129541070|NCT05261126|466272547|FG001|Overall Study|Screen Failure|0|||
129541071|NCT05261126|466272548|FG002|Overall Study|Screen Failure|0|||
129541072|NCT05261126|466272549|FG003|Overall Study|Screen Failure|0|||
129541073|NCT05261126|466272550|FG004|Overall Study|Screen Failure|1|||
129541074|NCT05261126|466272546|FG000|Overall Study|Withdrawal by Subject|1|||
129541075|NCT05261126|466272547|FG001|Overall Study|Withdrawal by Subject|0|||
129541076|NCT05261126|466272548|FG002|Overall Study|Withdrawal by Subject|1|||
129541077|NCT05261126|466272549|FG003|Overall Study|Withdrawal by Subject|1|||
129541078|NCT05261126|466272550|FG004|Overall Study|Withdrawal by Subject|0|||
129541079|NCT05261126|466272546|FG000|Overall Study|Not Recorded|0|||
129541080|NCT05261126|466272547|FG001|Overall Study|Not Recorded|0|||
129541081|NCT05261126|466272548|FG002|Overall Study|Not Recorded|0|||
129541082|NCT05261126|466272549|FG003|Overall Study|Not Recorded|1|||
129541083|NCT05261126|466272550|FG004|Overall Study|Not Recorded|0|||
129541084|NCT05570604|466272551|FG000|Overall Study|Lost to Follow-up|1|||
129541085|NCT05570604|466272552|FG001|Overall Study|Lost to Follow-up|5|||
129541086|NCT05570604|466272551|FG000|Overall Study|Illness|2|||
129541087|NCT05570604|466272552|FG001|Overall Study|Illness|2|||
129541088|NCT00145119|466272555|FG000|Overall Study|Death|45|||
129541089|NCT05437211|466272562|FG000|Overall Study|Patient's decision|1|||
129541090|NCT05437211|466272563|FG001|Overall Study|Patient's decision|1|||
129541091|NCT04410991|466272565|FG000|Overall Study|Poor compliance to protocol|5|||
129541092|NCT04410991|466272566|FG001|Overall Study|Poor compliance to protocol|4|||
129541093|NCT04410991|466272565|FG000|Overall Study|Withdrawal by Subject|59|||
129541094|NCT04410991|466272566|FG001|Overall Study|Withdrawal by Subject|55|||
129541095|NCT04410991|466272565|FG000|Overall Study|Other|10|||
129541096|NCT04410991|466272566|FG001|Overall Study|Other|4|||
129541097|NCT01463631|466272574|FG000|Overall Study|Withdrawal by Subject|0|||
129541098|NCT01463631|466272575|FG001|Overall Study|Withdrawal by Subject|0|||
129541099|NCT01463631|466272576|FG002|Overall Study|Withdrawal by Subject|0|||
129541100|NCT01463631|466272577|FG003|Overall Study|Withdrawal by Subject|1|||
129541101|NCT01463631|466272574|FG000|Overall Study|Death|0|||
129541102|NCT01463631|466272575|FG001|Overall Study|Death|0|||
129541103|NCT01463631|466272576|FG002|Overall Study|Death|1|||
129541104|NCT01463631|466272577|FG003|Overall Study|Death|0|||
129541105|NCT01463631|466272574|FG000|Overall Study|Progressive Disease|0|||
129541106|NCT01463631|466272575|FG001|Overall Study|Progressive Disease|0|||
129541107|NCT01463631|466272576|FG002|Overall Study|Progressive Disease|0|||
129541108|NCT01463631|466272577|FG003|Overall Study|Progressive Disease|5|||
129541109|NCT05966129|466272578|FG000|Overall Study|Death|1|||
129541110|NCT05966129|466272579|FG001|Overall Study|Death|2|||
129541111|NCT05966129|466272578|FG000|Overall Study|Lost to Follow-up|63|||
129541112|NCT05966129|466272579|FG001|Overall Study|Lost to Follow-up|66|||
129541113|NCT05966129|466272578|FG000|Overall Study|Protocol Violation|1|||
129541114|NCT05966129|466272579|FG001|Overall Study|Protocol Violation|0|||
129541115|NCT05966129|466272578|FG000|Overall Study|Withdrawal by Subject|26|||
129541116|NCT05966129|466272579|FG001|Overall Study|Withdrawal by Subject|25|||
129541117|NCT05966129|466272578|FG000|Overall Study|Surgery not completed|63|||
129541118|NCT05966129|466272579|FG001|Overall Study|Surgery not completed|69|||
129541119|NCT05966129|466272578|FG000|Overall Study|Surgery logistics issue|2|||
129541120|NCT05966129|466272579|FG001|Overall Study|Surgery logistics issue|1|||
129541121|NCT03145207|466272580|FG000|Overall Study|volunteer started taking allergy shots|1|||
129541122|NCT03145207|466272580|FG000|Overall Study|baseline blood pressure high|1|||
129541123|NCT01302366|466274269|FG000|Overall Study|patient choice or noncompliance|5|||
129541124|NCT00467051|466274270|FG000|Overall Study|Adverse Event|2|||
129541125|NCT00934661|466274271|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
129541126|NCT00934661|466274272|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
129541127|NCT00003526|466274273|FG000|Overall Study|Not evaluable|6|||
129541128|NCT01453296|466274276|FG000|Treatment Period 1|Adverse Event|0|||
129541129|NCT01453296|466274277|FG001|Treatment Period 1|Adverse Event|1|||
129541130|NCT01453296|466274276|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
129541131|NCT01453296|466274277|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
129541132|NCT01453296|466274276|FG000|Treatment Period 2|Adverse Event|1|||
129541133|NCT01453296|466274277|FG001|Treatment Period 2|Adverse Event|0|||
129541134|NCT01453296|466274276|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129541135|NCT01453296|466274277|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129541136|NCT00620776|466274278|FG000|Overall Study|Did not receive treatment|3|||
129541137|NCT00620776|466274279|FG001|Overall Study|Did not receive treatment|5|||
129541138|NCT00620776|466274278|FG000|Overall Study|Adverse Event|2|||
129541139|NCT00620776|466274279|FG001|Overall Study|Adverse Event|3|||
129541140|NCT00620776|466274278|FG000|Overall Study|Lack of Efficacy|2|||
129541141|NCT00620776|466274279|FG001|Overall Study|Lack of Efficacy|1|||
129541142|NCT00620776|466274278|FG000|Overall Study|Lost to Follow-up|2|||
129541143|NCT00620776|466274279|FG001|Overall Study|Lost to Follow-up|5|||
129541144|NCT00620776|466274278|FG000|Overall Study|Withdrawal by Subject|3|||
129541145|NCT00620776|466274279|FG001|Overall Study|Withdrawal by Subject|2|||
129541146|NCT03205046|466274287|FG000|Overall Study|Death|10|||
129541147|NCT03205046|466274288|FG001|Overall Study|Death|6|||
129541148|NCT03205046|466274287|FG000|Overall Study|Withdrawal by Subject|1|||
129541149|NCT03205046|466274288|FG001|Overall Study|Withdrawal by Subject|2|||
129541150|NCT03205046|466274287|FG000|Overall Study|Lost to Follow-up|0|||
129541151|NCT03205046|466274288|FG001|Overall Study|Lost to Follow-up|1|||
129541152|NCT03205046|466274287|FG000|Overall Study|Study terminated by sponsor|2|||
129541153|NCT03205046|466274288|FG001|Overall Study|Study terminated by sponsor|1|||
129541154|NCT01023815|466274289|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
129541155|NCT01023815|466274290|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
129541156|NCT01023815|466274291|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
129541157|NCT01023815|466274292|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
129541158|NCT01023815|466274289|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
129541159|NCT01023815|466274290|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
129541160|NCT01023815|466274291|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
129541161|NCT01023815|466274292|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
129541162|NCT01023815|466274289|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
129541163|NCT01023815|466274290|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
129541164|NCT01023815|466274291|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
129541165|NCT01023815|466274292|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
129541166|NCT01023815|466274289|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
129541167|NCT01023815|466274290|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
129541168|NCT01023815|466274291|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
129541169|NCT01023815|466274292|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
129541170|NCT01023815|466274289|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
129541171|NCT01023815|466274290|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
129651169|NCT04506905|466678640|FG002|Overall Study|Lost to Follow-up|0|||
129763629|NCT02201524|467098115|FG000|Overall Study|Lost to Follow-up|0|||
129541172|NCT01023815|466274291|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
129541173|NCT01023815|466274292|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
129541174|NCT03253809|466274295|FG000|Overall Study|Unable to obtain study related data|14|||
129541175|NCT03992456|466274296|FG000|Overall Study|Withdrawal by Subject|1|||
129541176|NCT03992456|466274297|FG001|Overall Study|Withdrawal by Subject|0|||
129541177|NCT03992456|466274296|FG000|Overall Study|Disease progression|4|||
129541178|NCT03992456|466274297|FG001|Overall Study|Disease progression|5|||
129541179|NCT03992456|466274296|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
129541180|NCT03992456|466274297|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
129541181|NCT00910000|466274301|FG000|Overall Study|Adverse Event|0|||
129541182|NCT00910000|466274302|FG001|Overall Study|Adverse Event|3|||
129541183|NCT00910000|466274303|FG002|Overall Study|Adverse Event|2|||
129541184|NCT00910000|466274304|FG003|Overall Study|Adverse Event|2|||
129541185|NCT00910000|466274305|FG004|Overall Study|Adverse Event|0|||
129541186|NCT00910000|466274306|FG005|Overall Study|Adverse Event|1|||
129541187|NCT00910000|466274301|FG000|Overall Study|Withdrawal by Subject|0|||
129541188|NCT00910000|466274302|FG001|Overall Study|Withdrawal by Subject|0|||
129541189|NCT00910000|466274303|FG002|Overall Study|Withdrawal by Subject|1|||
129541190|NCT00910000|466274304|FG003|Overall Study|Withdrawal by Subject|0|||
129541191|NCT00910000|466274305|FG004|Overall Study|Withdrawal by Subject|1|||
129541192|NCT00910000|466274306|FG005|Overall Study|Withdrawal by Subject|0|||
129541193|NCT01977625|466274307|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
129541194|NCT01977625|466274308|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129541195|NCT01977625|466274307|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129541196|NCT01977625|466274308|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129541197|NCT04113746|466274309|FG000|Overall Study|Lost to Follow-up|4|||
129541198|NCT04113746|466274310|FG001|Overall Study|Lost to Follow-up|4|||
129541199|NCT02594384|466274311|FG000|Overall Study|Disease Progression|3|||
129541200|NCT02594384|466274312|FG001|Overall Study|Disease Progression|7|||
129541201|NCT02594384|466274313|FG002|Overall Study|Disease Progression|0|||
129541202|NCT02594384|466274314|FG003|Overall Study|Disease Progression|2|||
129541203|NCT02594384|466274315|FG004|Overall Study|Disease Progression|2|||
129541204|NCT02594384|466274316|FG005|Overall Study|Disease Progression|12|||
129541205|NCT02594384|466274317|FG006|Overall Study|Disease Progression|5|||
129541206|NCT02594384|466274318|FG007|Overall Study|Disease Progression|5|||
129541207|NCT02594384|466274311|FG000|Overall Study|Adverse Event|0|||
129541208|NCT02594384|466274312|FG001|Overall Study|Adverse Event|1|||
129541209|NCT02594384|466274313|FG002|Overall Study|Adverse Event|4|||
129541210|NCT02594384|466274314|FG003|Overall Study|Adverse Event|1|||
129651170|NCT04506905|466678641|FG003|Overall Study|Lost to Follow-up|1|||
129651171|NCT04506905|466678642|FG004|Overall Study|Lost to Follow-up|0|||
129651172|NCT04506905|466678643|FG005|Overall Study|Lost to Follow-up|0|||
129651173|NCT04506905|466678644|FG006|Overall Study|Lost to Follow-up|0|||
129651174|NCT04506905|466678645|FG007|Overall Study|Lost to Follow-up|0|||
129651175|NCT04506905|466678646|FG008|Overall Study|Lost to Follow-up|0|||
129651176|NCT04506905|466678638|FG000|Overall Study|Withdrawal by Subject|0|||
129651177|NCT04506905|466678639|FG001|Overall Study|Withdrawal by Subject|0|||
129651178|NCT04506905|466678640|FG002|Overall Study|Withdrawal by Subject|0|||
129651179|NCT04506905|466678641|FG003|Overall Study|Withdrawal by Subject|2|||
129651180|NCT04506905|466678642|FG004|Overall Study|Withdrawal by Subject|0|||
129651181|NCT04506905|466678643|FG005|Overall Study|Withdrawal by Subject|0|||
129651182|NCT04506905|466678644|FG006|Overall Study|Withdrawal by Subject|0|||
129651183|NCT04506905|466678645|FG007|Overall Study|Withdrawal by Subject|0|||
129651184|NCT04506905|466678646|FG008|Overall Study|Withdrawal by Subject|0|||
129651185|NCT02502266|466679588|FG000|Overall Study|Adverse Event|0|||
129651186|NCT02502266|466679589|FG001|Overall Study|Adverse Event|0|||
129651187|NCT02502266|466679590|FG002|Overall Study|Adverse Event|0|||
129651188|NCT02502266|466679591|FG003|Overall Study|Adverse Event|0|||
129651189|NCT02502266|466679592|FG004|Overall Study|Adverse Event|1|||
129651190|NCT02502266|466679593|FG005|Overall Study|Adverse Event|1|||
129651191|NCT02502266|466679594|FG006|Overall Study|Adverse Event|1|||
129651192|NCT02502266|466679588|FG000|Overall Study|Withdrawal by Subject|30|||
129651193|NCT02502266|466679589|FG001|Overall Study|Withdrawal by Subject|15|||
129651194|NCT02502266|466679590|FG002|Overall Study|Withdrawal by Subject|16|||
129651195|NCT02502266|466679591|FG003|Overall Study|Withdrawal by Subject|0|||
129541211|NCT02594384|466274315|FG004|Overall Study|Adverse Event|0|||
129651196|NCT02502266|466679592|FG004|Overall Study|Withdrawal by Subject|0|||
129651197|NCT02502266|466679593|FG005|Overall Study|Withdrawal by Subject|0|||
129763630|NCT02201524|467098116|FG001|Overall Study|Lost to Follow-up|0|||
129651198|NCT02502266|466679594|FG006|Overall Study|Withdrawal by Subject|0|||
129651199|NCT02502266|466679588|FG000|Overall Study|Still on Treatment|0|||
129651200|NCT02502266|466679589|FG001|Overall Study|Still on Treatment|0|||
129651201|NCT02502266|466679590|FG002|Overall Study|Still on Treatment|1|||
129651202|NCT02502266|466679591|FG003|Overall Study|Still on Treatment|0|||
129651203|NCT02502266|466679592|FG004|Overall Study|Still on Treatment|0|||
129651204|NCT02502266|466679593|FG005|Overall Study|Still on Treatment|0|||
129651205|NCT02502266|466679594|FG006|Overall Study|Still on Treatment|0|||
129651206|NCT02502266|466679588|FG000|Overall Study|Other Reasons|19|||
129651207|NCT02502266|466679589|FG001|Overall Study|Other Reasons|6|||
129651208|NCT02502266|466679590|FG002|Overall Study|Other Reasons|14|||
129651209|NCT02502266|466679591|FG003|Overall Study|Other Reasons|0|||
129651210|NCT02502266|466679592|FG004|Overall Study|Other Reasons|1|||
129651211|NCT02502266|466679593|FG005|Overall Study|Other Reasons|1|||
129651212|NCT02502266|466679594|FG006|Overall Study|Other Reasons|0|||
129651213|NCT02502266|466679588|FG000|Overall Study|Arm 4 Discontinued|0|||
129651214|NCT02502266|466679589|FG001|Overall Study|Arm 4 Discontinued|0|||
129651215|NCT02502266|466679590|FG002|Overall Study|Arm 4 Discontinued|0|||
129651216|NCT02502266|466679591|FG003|Overall Study|Arm 4 Discontinued|52|||
129651217|NCT02502266|466679592|FG004|Overall Study|Arm 4 Discontinued|0|||
129651218|NCT02502266|466679593|FG005|Overall Study|Arm 4 Discontinued|0|||
129651219|NCT02502266|466679594|FG006|Overall Study|Arm 4 Discontinued|0|||
129651220|NCT02502266|466679588|FG000|Overall Study|Never treated|0|||
129651221|NCT02502266|466679589|FG001|Overall Study|Never treated|0|||
129651222|NCT02502266|466679590|FG002|Overall Study|Never treated|0|||
129651223|NCT02502266|466679591|FG003|Overall Study|Never treated|0|||
129651224|NCT02502266|466679592|FG004|Overall Study|Never treated|0|||
129651225|NCT02502266|466679593|FG005|Overall Study|Never treated|1|||
129651226|NCT02502266|466679594|FG006|Overall Study|Never treated|0|||
129651227|NCT03605849|466679596|FG000|Overall Study|Adverse Event|20|||
129651228|NCT03605849|466679597|FG001|Overall Study|Adverse Event|21|||
129651229|NCT03605849|466679598|FG002|Overall Study|Adverse Event|29|||
129651230|NCT03605849|466679599|FG003|Overall Study|Adverse Event|11|||
129651231|NCT03605849|466679596|FG000|Overall Study|Lack of Efficacy|4|||
129651232|NCT03605849|466679597|FG001|Overall Study|Lack of Efficacy|7|||
129651233|NCT03605849|466679598|FG002|Overall Study|Lack of Efficacy|9|||
129651234|NCT03605849|466679599|FG003|Overall Study|Lack of Efficacy|2|||
129651235|NCT03605849|466679596|FG000|Overall Study|Lost to Follow-up|8|||
129651236|NCT03605849|466679597|FG001|Overall Study|Lost to Follow-up|8|||
129651237|NCT03605849|466679598|FG002|Overall Study|Lost to Follow-up|14|||
129651238|NCT03605849|466679599|FG003|Overall Study|Lost to Follow-up|11|||
129651239|NCT03605849|466679596|FG000|Overall Study|Non-compliance With IMP|6|||
129763631|NCT02201524|467098117|FG002|Overall Study|Lost to Follow-up|2|||
129763632|NCT02201524|467098118|FG003|Overall Study|Lost to Follow-up|0|||
129651240|NCT03605849|466679597|FG001|Overall Study|Non-compliance With IMP|5|||
129651241|NCT03605849|466679598|FG002|Overall Study|Non-compliance With IMP|2|||
129651242|NCT03605849|466679599|FG003|Overall Study|Non-compliance With IMP|1|||
129651243|NCT03605849|466679596|FG000|Overall Study|Protocol Deviation|1|||
129763633|NCT02201524|467098115|FG000|Overall Study|No longer meets eligibility criteria|0|||
129763634|NCT02201524|467098116|FG001|Overall Study|No longer meets eligibility criteria|0|||
129763635|NCT02201524|467098117|FG002|Overall Study|No longer meets eligibility criteria|0|||
129763636|NCT02201524|467098118|FG003|Overall Study|No longer meets eligibility criteria|2|||
129763637|NCT02201524|467098115|FG000|Overall Study|Protocol Violation|0|||
129763638|NCT02201524|467098116|FG001|Overall Study|Protocol Violation|0|||
129763639|NCT02201524|467098117|FG002|Overall Study|Protocol Violation|0|||
129763640|NCT02201524|467098118|FG003|Overall Study|Protocol Violation|1|||
129763641|NCT02201524|467098115|FG000|Overall Study|Withdrawal by Subject|0|||
129763642|NCT02201524|467098116|FG001|Overall Study|Withdrawal by Subject|0|||
129763643|NCT02201524|467098117|FG002|Overall Study|Withdrawal by Subject|1|||
129763644|NCT02201524|467098118|FG003|Overall Study|Withdrawal by Subject|1|||
129763645|NCT02201524|467098115|FG000|Overall Study|Other|1|||
129763646|NCT02201524|467098116|FG001|Overall Study|Other|1|||
129763647|NCT02201524|467098117|FG002|Overall Study|Other|0|||
129763648|NCT02201524|467098118|FG003|Overall Study|Other|0|||
129763649|NCT02914639|467098120|FG000|Overall Study|Withdrawal by Subject|0|||
129763650|NCT02914639|467098121|FG001|Overall Study|Withdrawal by Subject|2|||
129763651|NCT01018030|467098122|FG000|Overall Study|Adverse Event|10|||
129763652|NCT01018030|467098123|FG001|Overall Study|Adverse Event|5|||
129763653|NCT01018030|467098124|FG002|Overall Study|Adverse Event|5|||
129763654|NCT01018030|467098122|FG000|Overall Study|Withdrawal by Subject|2|||
129763655|NCT01018030|467098123|FG001|Overall Study|Withdrawal by Subject|2|||
129763656|NCT01018030|467098124|FG002|Overall Study|Withdrawal by Subject|4|||
129763657|NCT01018030|467098122|FG000|Overall Study|Lost to Follow-up|2|||
129763658|NCT01018030|467098123|FG001|Overall Study|Lost to Follow-up|0|||
129763659|NCT01018030|467098124|FG002|Overall Study|Lost to Follow-up|3|||
129763660|NCT01018030|467098122|FG000|Overall Study|Protocol Violation|2|||
129763661|NCT01018030|467098123|FG001|Overall Study|Protocol Violation|1|||
129763662|NCT01018030|467098124|FG002|Overall Study|Protocol Violation|0|||
129763663|NCT01018030|467098122|FG000|Overall Study|Physician Decision|1|||
129763664|NCT01018030|467098123|FG001|Overall Study|Physician Decision|0|||
129763665|NCT01018030|467098124|FG002|Overall Study|Physician Decision|1|||
129763666|NCT01018030|467098122|FG000|Overall Study|Lack of Efficacy|1|||
129763667|NCT01018030|467098123|FG001|Overall Study|Lack of Efficacy|0|||
129763668|NCT01018030|467098124|FG002|Overall Study|Lack of Efficacy|0|||
129763669|NCT01018030|467098122|FG000|Overall Study|Did Not Receive Study Drug|1|||
129763670|NCT01018030|467098123|FG001|Overall Study|Did Not Receive Study Drug|3|||
129763671|NCT01018030|467098124|FG002|Overall Study|Did Not Receive Study Drug|0|||
129763672|NCT03617172|467098125|FG000|Overall Study|Lost to Follow-up|1|||
129763673|NCT03617172|467098126|FG001|Overall Study|Lost to Follow-up|0|||
129763674|NCT00189540|467098127|FG000|Overall Study|Withdrawal by Subject|3|||
129763675|NCT00189540|467098128|FG001|Overall Study|Withdrawal by Subject|0|||
129763676|NCT00189540|467098127|FG000|Overall Study|Death|4|||
129763677|NCT00189540|467098128|FG001|Overall Study|Death|1|||
129763678|NCT01089504|467098129|FG000|Overall Study|Lost to Follow-up|1|||
129763679|NCT01089504|467098130|FG001|Overall Study|Lost to Follow-up|1|||
129763680|NCT01089504|467098129|FG000|Overall Study|Withdrawal by Subject|2|||
129763681|NCT01089504|467098130|FG001|Overall Study|Withdrawal by Subject|0|||
129763682|NCT01924845|467098131|FG000|Overall Study|Adverse Event|3|||
129763683|NCT01924845|467098131|FG000|Overall Study|Withdrawal by Subject|2|||
129763684|NCT01924845|467098131|FG000|Overall Study|Protocol Violation|1|||
129763685|NCT00062439|467098132|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
129763686|NCT00062439|467098132|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
129763687|NCT00062439|467098132|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
129763688|NCT00062439|467098132|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
129763689|NCT00062439|467098132|FG000|Post Chemoradiation Assessment|Death|1|||
129541212|NCT02594384|466274316|FG005|Overall Study|Adverse Event|6|||
129541213|NCT02594384|466274317|FG006|Overall Study|Adverse Event|1|||
129541214|NCT02594384|466274318|FG007|Overall Study|Adverse Event|1|||
129541215|NCT02594384|466274311|FG000|Overall Study|Withdrawal by Subject|0|||
129541216|NCT02594384|466274312|FG001|Overall Study|Withdrawal by Subject|0|||
129541217|NCT02594384|466274313|FG002|Overall Study|Withdrawal by Subject|0|||
129541218|NCT02594384|466274314|FG003|Overall Study|Withdrawal by Subject|1|||
129541219|NCT02594384|466274315|FG004|Overall Study|Withdrawal by Subject|0|||
129541220|NCT02594384|466274316|FG005|Overall Study|Withdrawal by Subject|0|||
129541221|NCT02594384|466274317|FG006|Overall Study|Withdrawal by Subject|0|||
129541222|NCT02594384|466274318|FG007|Overall Study|Withdrawal by Subject|1|||
129541223|NCT02594384|466274311|FG000|Overall Study|Physician Decision|0|||
129541224|NCT02594384|466274312|FG001|Overall Study|Physician Decision|0|||
129541225|NCT02594384|466274313|FG002|Overall Study|Physician Decision|0|||
129541226|NCT02594384|466274314|FG003|Overall Study|Physician Decision|0|||
129541227|NCT02594384|466274315|FG004|Overall Study|Physician Decision|0|||
129541228|NCT02594384|466274316|FG005|Overall Study|Physician Decision|1|||
129541229|NCT02594384|466274317|FG006|Overall Study|Physician Decision|2|||
129541230|NCT02594384|466274318|FG007|Overall Study|Physician Decision|0|||
129651244|NCT03605849|466679597|FG001|Overall Study|Protocol Deviation|2|||
129541231|NCT02594384|466274311|FG000|Overall Study|Progressive Leukocytosis|0|||
129541232|NCT02594384|466274312|FG001|Overall Study|Progressive Leukocytosis|0|||
129541233|NCT02594384|466274313|FG002|Overall Study|Progressive Leukocytosis|1|||
129541234|NCT02594384|466274314|FG003|Overall Study|Progressive Leukocytosis|0|||
129541235|NCT02594384|466274315|FG004|Overall Study|Progressive Leukocytosis|0|||
129541236|NCT02594384|466274316|FG005|Overall Study|Progressive Leukocytosis|0|||
129541237|NCT02594384|466274317|FG006|Overall Study|Progressive Leukocytosis|0|||
129541238|NCT02594384|466274318|FG007|Overall Study|Progressive Leukocytosis|0|||
129541239|NCT02594384|466274311|FG000|Overall Study|Lack of Efficacy|0|||
129541240|NCT02594384|466274312|FG001|Overall Study|Lack of Efficacy|0|||
129541241|NCT02594384|466274313|FG002|Overall Study|Lack of Efficacy|0|||
129541242|NCT02594384|466274314|FG003|Overall Study|Lack of Efficacy|0|||
129541243|NCT02594384|466274315|FG004|Overall Study|Lack of Efficacy|1|||
129541244|NCT02594384|466274316|FG005|Overall Study|Lack of Efficacy|0|||
129541245|NCT02594384|466274317|FG006|Overall Study|Lack of Efficacy|0|||
129541246|NCT02594384|466274318|FG007|Overall Study|Lack of Efficacy|0|||
129541247|NCT02594384|466274311|FG000|Overall Study|Substantial noncompliance|0|||
129541248|NCT02594384|466274312|FG001|Overall Study|Substantial noncompliance|0|||
129541249|NCT02594384|466274313|FG002|Overall Study|Substantial noncompliance|0|||
129541250|NCT02594384|466274314|FG003|Overall Study|Substantial noncompliance|0|||
129541251|NCT02594384|466274315|FG004|Overall Study|Substantial noncompliance|0|||
129541252|NCT02594384|466274316|FG005|Overall Study|Substantial noncompliance|0|||
129763690|NCT00062439|467098132|FG000|Post Chemoradiation Assessment|Disease progression|2|||
129763691|NCT00062439|467098132|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
129763692|NCT00062439|467098132|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
129763693|NCT00062439|467098132|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
129763694|NCT00062439|467098132|FG000|Surgery|Physician Decision|4|||
129763695|NCT00062439|467098132|FG000|Surgery|Death|1|||
129763696|NCT00062439|467098132|FG000|Surgery|Adverse Event|2|||
129763697|NCT00062439|467098132|FG000|Consolidation Chemotherapy|Adverse Event|2|||
129763698|NCT00001832|467098136|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
129763699|NCT00001832|467098137|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
129763700|NCT00001832|467098138|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
129763701|NCT00001832|467098139|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
129763702|NCT00001832|467098140|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
129763703|NCT00001832|467098141|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
129763704|NCT00001832|467098142|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
129763705|NCT00001832|467098143|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
129541253|NCT02594384|466274317|FG006|Overall Study|Substantial noncompliance|1|||
129541254|NCT02594384|466274318|FG007|Overall Study|Substantial noncompliance|0|||
129541255|NCT03919669|466274321|FG000|Overall Study|Withdrawal by Subject|1|||
129541256|NCT03919669|466274322|FG001|Overall Study|Withdrawal by Subject|0|||
129541257|NCT03919669|466274323|FG002|Overall Study|Withdrawal by Subject|0|||
129541258|NCT03125382|466274324|FG000|Randomization|screening failure|1|||
129541259|NCT03125382|466274325|FG001|Randomization|screening failure|4|||
129541260|NCT03125382|466274326|FG002|Randomization|screening failure|2|||
129541261|NCT03125382|466274327|FG003|Randomization|screening failure|0|||
129541262|NCT03125382|466274324|FG000|Follow-up|Death|1|||
129541263|NCT03125382|466274325|FG001|Follow-up|Death|2|||
129541264|NCT03125382|466274326|FG002|Follow-up|Death|1|||
129541265|NCT03125382|466274327|FG003|Follow-up|Death|2|||
129541266|NCT03125382|466274324|FG000|Follow-up|Lost to Follow-up|1|||
129541267|NCT03125382|466274325|FG001|Follow-up|Lost to Follow-up|4|||
129541268|NCT03125382|466274326|FG002|Follow-up|Lost to Follow-up|3|||
129541269|NCT03125382|466274327|FG003|Follow-up|Lost to Follow-up|1|||
129763706|NCT00001832|467098144|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
129763707|NCT00001832|467098145|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
129763708|NCT00001832|467098146|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
129763709|NCT00001832|467098147|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
129763710|NCT00001832|467098148|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
129763711|NCT00001832|467098149|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
129763712|NCT00001832|467098150|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
129763713|NCT00001832|467098136|FG000|Treatment Period|Death during treatment|0|||
129763714|NCT00001832|467098137|FG001|Treatment Period|Death during treatment|0|||
129763715|NCT00001832|467098138|FG002|Treatment Period|Death during treatment|0|||
129541270|NCT02319642|466274328|FG000|Overall Study|Adverse Event|2|||
129541271|NCT02319642|466274329|FG001|Overall Study|Adverse Event|4|||
129541272|NCT02319642|466274328|FG000|Overall Study|Lack of Efficacy|1|||
129541273|NCT02319642|466274329|FG001|Overall Study|Lack of Efficacy|1|||
129541274|NCT02319642|466274328|FG000|Overall Study|Withdrawal by Subject|1|||
129541275|NCT02319642|466274329|FG001|Overall Study|Withdrawal by Subject|1|||
129541276|NCT04668066|466274330|FG000|Part 1: Treatment Phase|Adverse Event|0|||
129541277|NCT04668066|466274331|FG001|Part 1: Treatment Phase|Adverse Event|0|||
129541278|NCT04668066|466274332|FG002|Part 1: Treatment Phase|Adverse Event|0|||
129541279|NCT04668066|466274333|FG003|Part 1: Treatment Phase|Adverse Event|0|||
129541280|NCT04668066|466274334|FG004|Part 1: Treatment Phase|Adverse Event|0|||
129541281|NCT04668066|466274335|FG005|Part 1: Treatment Phase|Adverse Event|0|||
129541282|NCT04668066|466274336|FG006|Part 1: Treatment Phase|Adverse Event|0|||
129541283|NCT04668066|466274337|FG007|Part 1: Treatment Phase|Adverse Event|0|||
129541284|NCT04668066|466274338|FG008|Part 1: Treatment Phase|Adverse Event|0|||
129541285|NCT04668066|466274339|FG009|Part 1: Treatment Phase|Adverse Event|0|||
129541286|NCT04668066|466274340|FG010|Part 1: Treatment Phase|Adverse Event|0|||
129541287|NCT04668066|466274341|FG011|Part 1: Treatment Phase|Adverse Event|1|||
129541288|NCT04668066|466274342|FG012|Part 1: Treatment Phase|Adverse Event|1|||
129541289|NCT04668066|466274343|FG013|Part 1: Treatment Phase|Adverse Event|0|||
129541290|NCT04668066|466274344|FG014|Part 1: Treatment Phase|Adverse Event|0|||
129541291|NCT04668066|466274345|FG015|Part 1: Treatment Phase|Adverse Event|0|||
129541292|NCT04668066|466274346|FG016|Part 1: Treatment Phase|Adverse Event|0|||
129541293|NCT04668066|466274347|FG017|Part 1: Treatment Phase|Adverse Event|0|||
129763716|NCT00001832|467098139|FG003|Treatment Period|Death during treatment|0|||
129763717|NCT00001832|467098140|FG004|Treatment Period|Death during treatment|0|||
129763718|NCT00001832|467098141|FG005|Treatment Period|Death during treatment|1|||
129763719|NCT00001832|467098142|FG006|Treatment Period|Death during treatment|0|||
129763720|NCT00001832|467098143|FG007|Treatment Period|Death during treatment|0|||
129763721|NCT00001832|467098144|FG008|Treatment Period|Death during treatment|0|||
129763722|NCT00001832|467098145|FG009|Treatment Period|Death during treatment|0|||
129763723|NCT00001832|467098146|FG010|Treatment Period|Death during treatment|0|||
129763724|NCT00001832|467098147|FG011|Treatment Period|Death during treatment|0|||
129763725|NCT00001832|467098148|FG012|Treatment Period|Death during treatment|0|||
129763726|NCT00001832|467098149|FG013|Treatment Period|Death during treatment|0|||
129763727|NCT00001832|467098150|FG014|Treatment Period|Death during treatment|0|||
129763728|NCT00001832|467098136|FG000|Treatment Period|Not treated|0|||
129763729|NCT00001832|467098137|FG001|Treatment Period|Not treated|0|||
129763730|NCT00001832|467098138|FG002|Treatment Period|Not treated|0|||
129763731|NCT00001832|467098139|FG003|Treatment Period|Not treated|0|||
129763732|NCT00001832|467098140|FG004|Treatment Period|Not treated|0|||
129763733|NCT00001832|467098141|FG005|Treatment Period|Not treated|0|||
129763734|NCT00001832|467098142|FG006|Treatment Period|Not treated|0|||
129763735|NCT00001832|467098143|FG007|Treatment Period|Not treated|1|||
129763736|NCT00001832|467098144|FG008|Treatment Period|Not treated|0|||
129763737|NCT00001832|467098145|FG009|Treatment Period|Not treated|0|||
129763738|NCT00001832|467098146|FG010|Treatment Period|Not treated|0|||
129763739|NCT00001832|467098147|FG011|Treatment Period|Not treated|0|||
129763740|NCT00001832|467098148|FG012|Treatment Period|Not treated|0|||
129763741|NCT00001832|467098149|FG013|Treatment Period|Not treated|0|||
129763742|NCT00001832|467098150|FG014|Treatment Period|Not treated|0|||
129763743|NCT02546609|467098151|FG000|Overall Study|Withdrawal by Subject|0|||
129763744|NCT02546609|467098152|FG001|Overall Study|Withdrawal by Subject|1|||
129763745|NCT02546609|467098153|FG002|Overall Study|Withdrawal by Subject|2|||
129763746|NCT02546609|467098151|FG000|Overall Study|Adverse Event|0|||
129763747|NCT02546609|467098152|FG001|Overall Study|Adverse Event|6|||
129763748|NCT02546609|467098153|FG002|Overall Study|Adverse Event|1|||
129763749|NCT02546609|467098151|FG000|Overall Study|Protocol Violation|0|||
129763750|NCT02546609|467098152|FG001|Overall Study|Protocol Violation|1|||
129763751|NCT02546609|467098153|FG002|Overall Study|Protocol Violation|1|||
129763752|NCT02546609|467098151|FG000|Overall Study|Lost to Follow-up|2|||
129763753|NCT02546609|467098152|FG001|Overall Study|Lost to Follow-up|3|||
129763754|NCT02546609|467098153|FG002|Overall Study|Lost to Follow-up|1|||
129763755|NCT02546609|467098151|FG000|Overall Study|travel or work schedule restriction|0|||
129763756|NCT02546609|467098152|FG001|Overall Study|travel or work schedule restriction|0|||
129763757|NCT02546609|467098153|FG002|Overall Study|travel or work schedule restriction|2|||
129763758|NCT00914849|467098154|FG000|Overall Study|Withdrawal by Subject|1|||
129763759|NCT00914849|467098155|FG001|Overall Study|Withdrawal by Subject|0|||
129763760|NCT00914849|467098154|FG000|Overall Study|Not eligible|0|||
129763761|NCT00914849|467098155|FG001|Overall Study|Not eligible|1|||
129763762|NCT05106959|467098156|FG000|Overall Study|Lost to Follow-up|1|||
129763763|NCT01292486|467098157|FG000|Overall Study|Protocol Violation|2|||
129541294|NCT04668066|466274348|FG018|Part 1: Treatment Phase|Adverse Event|0|||
129763764|NCT01292486|467098157|FG000|Overall Study|Did not meet screening criteria|2|||
129763765|NCT01292486|467098157|FG000|Overall Study|Adverse Event|1|||
129763766|NCT01292486|467098157|FG000|Overall Study|Physician Decision|1|||
129763767|NCT04602390|467098158|FG000|Overall Study|Withdrawal by Subject|0|||
129763768|NCT04602390|467098159|FG001|Overall Study|Withdrawal by Subject|0|||
129763769|NCT04602390|467098160|FG002|Overall Study|Withdrawal by Subject|0|||
129763770|NCT04602390|467098161|FG003|Overall Study|Withdrawal by Subject|0|||
129763771|NCT04602390|467098162|FG004|Overall Study|Withdrawal by Subject|1|||
129763772|NCT04602390|467098163|FG005|Overall Study|Withdrawal by Subject|0|||
129763773|NCT04602390|467098158|FG000|Overall Study|Adverse Event|0|||
129763774|NCT04602390|467098159|FG001|Overall Study|Adverse Event|0|||
129541295|NCT04668066|466274330|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541296|NCT04668066|466274331|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541297|NCT04668066|466274332|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
129541298|NCT04668066|466274333|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541299|NCT04668066|466274334|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541300|NCT04668066|466274335|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541301|NCT04668066|466274336|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541302|NCT04668066|466274337|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541303|NCT04668066|466274338|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541304|NCT04668066|466274339|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
129763775|NCT04602390|467098160|FG002|Overall Study|Adverse Event|0|||
129763776|NCT04602390|467098161|FG003|Overall Study|Adverse Event|0|||
129763777|NCT04602390|467098162|FG004|Overall Study|Adverse Event|0|||
129763778|NCT04602390|467098163|FG005|Overall Study|Adverse Event|1|||
129763779|NCT01553084|467098164|FG000|Overall Study|Withdrawal by Subject|15|||
129763780|NCT01553084|467098165|FG001|Overall Study|Withdrawal by Subject|13|||
129763781|NCT01553084|467098166|FG002|Overall Study|Withdrawal by Subject|35|||
129763782|NCT03988400|467098167|FG000|Overall Study|Adverse Event|1|||
129763783|NCT03988400|467098168|FG001|Overall Study|Adverse Event|0|||
129763784|NCT03988400|467098167|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
129763785|NCT03988400|467098168|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
129763786|NCT03988400|467098167|FG000|Overall Study|Lost to Follow-up|0|||
129763787|NCT03988400|467098168|FG001|Overall Study|Lost to Follow-up|1|||
129763788|NCT04201431|467098170|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
129763789|NCT04201431|467098171|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
129763790|NCT04201431|467098172|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
129763791|NCT01546857|467098173|FG000|Overall Study|Withdrawal by Subject|2|||
129763792|NCT01546857|467098174|FG001|Overall Study|Withdrawal by Subject|3|||
129763793|NCT02358473|467098175|FG000|Overall Study|Disease Progession|6|||
129763794|NCT02358473|467098175|FG000|Overall Study|Adverse Event|3|||
129763795|NCT02358473|467098175|FG000|Overall Study|Withdrawal by Subject|2|||
129763796|NCT02358473|467098175|FG000|Overall Study|Physician Decision|2|||
129763797|NCT02240485|467098176|FG000|3 Months Post-admission|Lost to Follow-up|1|||
129763798|NCT02240485|467098177|FG001|3 Months Post-admission|Lost to Follow-up|5|||
129763799|NCT02240485|467098176|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
129763800|NCT02240485|467098177|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
129763801|NCT02240485|467098176|FG000|9 Months Post-admission|Lost to Follow-up|3|||
129763802|NCT02240485|467098177|FG001|9 Months Post-admission|Lost to Follow-up|1|||
129763803|NCT02240485|467098176|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
129763804|NCT02240485|467098177|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
129763805|NCT02240485|467098176|FG000|18 Months Post-admission|Lost to Follow-up|1|||
129763806|NCT02240485|467098177|FG001|18 Months Post-admission|Lost to Follow-up|1|||
129763807|NCT02240485|467098176|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
129763808|NCT02240485|467098177|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
129763809|NCT00953667|467098178|FG000|Overall Study|Lost to Follow-up|11|||
129763810|NCT00953667|467098178|FG000|Overall Study|Physician Decision|35|||
129763811|NCT00953667|467098178|FG000|Overall Study|Withdrawal by Subject|63|||
129763812|NCT00953667|467098178|FG000|Overall Study|Adverse Event|10|||
129763813|NCT00953667|467098178|FG000|Overall Study|poor venous access,unable to draw blood|4|||
129763814|NCT04819945|467098179|FG000|Overall Study|Lost to Follow-up|1|||
129763815|NCT00475670|467098180|FG000|Overall Study|Death|0|||
129763816|NCT00475670|467098181|FG001|Overall Study|Death|1|||
129763817|NCT00475670|467098180|FG000|Overall Study|Lack of Efficacy|3|||
129763818|NCT00475670|467098181|FG001|Overall Study|Lack of Efficacy|34|||
129763819|NCT00475670|467098180|FG000|Overall Study|Refused treatment|0|||
129763820|NCT00475670|467098181|FG001|Overall Study|Refused treatment|2|||
129541305|NCT04668066|466274340|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541306|NCT04668066|466274341|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541307|NCT04668066|466274342|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541308|NCT04668066|466274343|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541309|NCT04668066|466274344|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541310|NCT04668066|466274345|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541311|NCT04668066|466274346|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541312|NCT04668066|466274347|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
129763821|NCT00475670|467098180|FG000|Overall Study|Failure to Return|0|||
129763822|NCT00475670|467098181|FG001|Overall Study|Failure to Return|1|||
129763823|NCT00475670|467098180|FG000|Overall Study|Other|0|||
129763824|NCT00475670|467098181|FG001|Overall Study|Other|3|||
129763825|NCT04949191|467098182|FG000|Overall Study|Non-compliance with Study Drug|1|||
129763826|NCT04949191|467098183|FG001|Overall Study|Non-compliance with Study Drug|0|||
129763827|NCT04949191|467098184|FG002|Overall Study|Non-compliance with Study Drug|0|||
129763828|NCT04949191|467098185|FG003|Overall Study|Non-compliance with Study Drug|0|||
129763829|NCT04949191|467098182|FG000|Overall Study|Progressive Disease|0|||
129763830|NCT04949191|467098183|FG001|Overall Study|Progressive Disease|1|||
129763831|NCT04949191|467098184|FG002|Overall Study|Progressive Disease|0|||
129763832|NCT04949191|467098185|FG003|Overall Study|Progressive Disease|0|||
129985699|NCT04811131|467909335|FG002|Overall Study|Adverse Event|1|||
129541313|NCT04668066|466274348|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
129541314|NCT04668066|466274330|FG000|Part 1: Treatment Phase|Other|0|||
129541315|NCT04668066|466274331|FG001|Part 1: Treatment Phase|Other|0|||
129541316|NCT04668066|466274332|FG002|Part 1: Treatment Phase|Other|0|||
129541317|NCT04668066|466274333|FG003|Part 1: Treatment Phase|Other|0|||
129541318|NCT04668066|466274334|FG004|Part 1: Treatment Phase|Other|0|||
129541319|NCT04668066|466274335|FG005|Part 1: Treatment Phase|Other|0|||
129541320|NCT04668066|466274336|FG006|Part 1: Treatment Phase|Other|0|||
129541321|NCT04668066|466274337|FG007|Part 1: Treatment Phase|Other|0|||
129541322|NCT04668066|466274338|FG008|Part 1: Treatment Phase|Other|0|||
129541323|NCT04668066|466274339|FG009|Part 1: Treatment Phase|Other|0|||
129541324|NCT04668066|466274340|FG010|Part 1: Treatment Phase|Other|0|||
129541325|NCT04668066|466274341|FG011|Part 1: Treatment Phase|Other|1|||
129541326|NCT04668066|466274342|FG012|Part 1: Treatment Phase|Other|0|||
129541327|NCT04668066|466274343|FG013|Part 1: Treatment Phase|Other|0|||
129541328|NCT04668066|466274344|FG014|Part 1: Treatment Phase|Other|0|||
129541329|NCT04668066|466274345|FG015|Part 1: Treatment Phase|Other|0|||
129541330|NCT04668066|466274346|FG016|Part 1: Treatment Phase|Other|0|||
129541331|NCT04668066|466274347|FG017|Part 1: Treatment Phase|Other|0|||
129541332|NCT04668066|466274348|FG018|Part 1: Treatment Phase|Other|0|||
129541333|NCT04668066|466274330|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541334|NCT04668066|466274331|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541335|NCT04668066|466274332|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541336|NCT04668066|466274333|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541337|NCT04668066|466274334|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541338|NCT04668066|466274335|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541339|NCT04668066|466274336|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541340|NCT04668066|466274337|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541341|NCT04668066|466274338|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541342|NCT04668066|466274339|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541343|NCT04668066|466274340|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541344|NCT04668066|466274341|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541345|NCT04668066|466274342|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
129541346|NCT04668066|466274343|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541347|NCT04668066|466274344|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541348|NCT04668066|466274345|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
129541349|NCT04668066|466274346|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541350|NCT04668066|466274347|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541351|NCT04668066|466274348|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
129541352|NCT04668066|466274330|FG000|Part 1: Follow-Up|Adverse Event|0|||
129541353|NCT04668066|466274331|FG001|Part 1: Follow-Up|Adverse Event|0|||
129541354|NCT04668066|466274332|FG002|Part 1: Follow-Up|Adverse Event|0|||
129541355|NCT04668066|466274333|FG003|Part 1: Follow-Up|Adverse Event|0|||
129541356|NCT04668066|466274334|FG004|Part 1: Follow-Up|Adverse Event|0|||
129541357|NCT04668066|466274335|FG005|Part 1: Follow-Up|Adverse Event|0|||
129541358|NCT04668066|466274336|FG006|Part 1: Follow-Up|Adverse Event|0|||
129541359|NCT04668066|466274337|FG007|Part 1: Follow-Up|Adverse Event|0|||
129541360|NCT04668066|466274338|FG008|Part 1: Follow-Up|Adverse Event|0|||
129541361|NCT04668066|466274339|FG009|Part 1: Follow-Up|Adverse Event|0|||
129541362|NCT04668066|466274340|FG010|Part 1: Follow-Up|Adverse Event|0|||
129541363|NCT04668066|466274341|FG011|Part 1: Follow-Up|Adverse Event|1|||
129541364|NCT04668066|466274342|FG012|Part 1: Follow-Up|Adverse Event|0|||
129541365|NCT04668066|466274343|FG013|Part 1: Follow-Up|Adverse Event|0|||
129541366|NCT04668066|466274344|FG014|Part 1: Follow-Up|Adverse Event|0|||
129541367|NCT04668066|466274345|FG015|Part 1: Follow-Up|Adverse Event|0|||
129541368|NCT04668066|466274346|FG016|Part 1: Follow-Up|Adverse Event|0|||
129541369|NCT04668066|466274347|FG017|Part 1: Follow-Up|Adverse Event|0|||
129541370|NCT04668066|466274348|FG018|Part 1: Follow-Up|Adverse Event|0|||
129541371|NCT04668066|466274330|FG000|Part 1: Follow-Up|Other|0|||
129541372|NCT04668066|466274331|FG001|Part 1: Follow-Up|Other|0|||
129541373|NCT04668066|466274332|FG002|Part 1: Follow-Up|Other|0|||
129541374|NCT04668066|466274333|FG003|Part 1: Follow-Up|Other|0|||
129541375|NCT04668066|466274334|FG004|Part 1: Follow-Up|Other|0|||
129541376|NCT04668066|466274335|FG005|Part 1: Follow-Up|Other|0|||
129541377|NCT04668066|466274336|FG006|Part 1: Follow-Up|Other|0|||
129763833|NCT04949191|467098182|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
129541378|NCT04668066|466274337|FG007|Part 1: Follow-Up|Other|0|||
129541379|NCT04668066|466274338|FG008|Part 1: Follow-Up|Other|0|||
129541380|NCT04668066|466274339|FG009|Part 1: Follow-Up|Other|0|||
129541381|NCT04668066|466274340|FG010|Part 1: Follow-Up|Other|0|||
129541382|NCT04668066|466274341|FG011|Part 1: Follow-Up|Other|1|||
129541383|NCT04668066|466274342|FG012|Part 1: Follow-Up|Other|1|||
129541384|NCT04668066|466274343|FG013|Part 1: Follow-Up|Other|0|||
129541385|NCT04668066|466274344|FG014|Part 1: Follow-Up|Other|0|||
129541386|NCT04668066|466274345|FG015|Part 1: Follow-Up|Other|0|||
129541387|NCT04668066|466274346|FG016|Part 1: Follow-Up|Other|0|||
129541388|NCT04668066|466274347|FG017|Part 1: Follow-Up|Other|0|||
129541389|NCT04668066|466274348|FG018|Part 1: Follow-Up|Other|0|||
129541390|NCT04668066|466274330|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541391|NCT04668066|466274331|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541392|NCT04668066|466274332|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541393|NCT04668066|466274333|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
129763834|NCT04949191|467098183|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
129763835|NCT04949191|467098184|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
129763836|NCT04949191|467098185|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
129763837|NCT04949191|467098182|FG000|Overall Study|Sponsor Terminated Study|0|||
129763838|NCT04949191|467098183|FG001|Overall Study|Sponsor Terminated Study|0|||
129763839|NCT04949191|467098184|FG002|Overall Study|Sponsor Terminated Study|1|||
129763840|NCT04949191|467098185|FG003|Overall Study|Sponsor Terminated Study|1|||
129763841|NCT01046565|467098190|FG000|Overall Study|Adverse Event|2|||
129763842|NCT01046565|467098190|FG000|Overall Study|Withdrawal by Subject|7|||
129763843|NCT00918385|467098191|FG000|Monotherapy|Adverse Event|1|||
129763844|NCT00918385|467098192|FG001|Monotherapy|Adverse Event|6|||
129763845|NCT00918385|467098191|FG000|Monotherapy|Complicating illness|1|||
129763846|NCT00918385|467098192|FG001|Monotherapy|Complicating illness|0|||
129763847|NCT00918385|467098191|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
129763848|NCT00918385|467098192|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
129763849|NCT00918385|467098191|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
129763850|NCT00918385|467098192|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
129763851|NCT00918385|467098191|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
129763852|NCT00918385|467098192|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
129763853|NCT00918385|467098191|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
129763854|NCT00918385|467098192|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
129763855|NCT00771914|467098195|FG000|Overall Study|Physician Decision|0|||
129763856|NCT00771914|467098196|FG001|Overall Study|Physician Decision|0|||
129763857|NCT00771914|467098197|FG002|Overall Study|Physician Decision|0|||
129763858|NCT00771914|467098198|FG003|Overall Study|Physician Decision|1|||
129763859|NCT00771914|467098195|FG000|Overall Study|Lost to Follow-up|0|||
129763860|NCT00771914|467098196|FG001|Overall Study|Lost to Follow-up|0|||
129763861|NCT00771914|467098197|FG002|Overall Study|Lost to Follow-up|0|||
129763862|NCT00771914|467098198|FG003|Overall Study|Lost to Follow-up|1|||
129763863|NCT02978417|467098201|FG000|Overall Study|Lost to Follow-up|2|||
129763864|NCT02978417|467098202|FG001|Overall Study|Lost to Follow-up|2|||
129763865|NCT03416868|467098210|FG000|Overall Study|Withdrawal by Subject|2|||
129763866|NCT03416868|467098210|FG000|Overall Study|Lost to Follow-up|1|||
129763867|NCT01323582|467098211|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
129763868|NCT01323582|467098212|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
129763869|NCT01323582|467098211|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
129763870|NCT01323582|467098212|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
129763871|NCT01323582|467098211|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
129763872|NCT01323582|467098212|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
129763873|NCT00960375|467098215|FG000|Overall Study|Lost to Follow-up|20|||
129763874|NCT00960375|467098216|FG001|Overall Study|Lost to Follow-up|22|||
129763875|NCT03557970|467098217|FG000|Overall Study|Study closure|1|||
129763876|NCT03557970|467098218|FG001|Overall Study|Study closure|0|||
129763877|NCT03557970|467098217|FG000|Overall Study|Physician Decision|0|||
129763878|NCT03557970|467098218|FG001|Overall Study|Physician Decision|1|||
129763879|NCT03557970|467098217|FG000|Overall Study|Death|0|||
129763880|NCT03557970|467098218|FG001|Overall Study|Death|1|||
129763881|NCT00112736|467098219|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
129763882|NCT00112736|467098220|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
129763883|NCT05435339|467098221|FG000|Overall Study|Death|1|||
129763884|NCT05435339|467098222|FG001|Overall Study|Death|0|||
129763885|NCT05435339|467098223|FG002|Overall Study|Death|3|||
129763886|NCT05435339|467098224|FG003|Overall Study|Death|1|||
129763887|NCT05435339|467098225|FG004|Overall Study|Death|3|||
129763888|NCT05435339|467098226|FG005|Overall Study|Death|2|||
129763889|NCT05435339|467098227|FG006|Overall Study|Death|4|||
129763890|NCT05435339|467098228|FG007|Overall Study|Death|6|||
129763891|NCT05435339|467098221|FG000|Overall Study|Sponsor Decision|0|||
129763892|NCT05435339|467098222|FG001|Overall Study|Sponsor Decision|1|||
129763893|NCT05435339|467098223|FG002|Overall Study|Sponsor Decision|0|||
129763894|NCT05435339|467098224|FG003|Overall Study|Sponsor Decision|0|||
129763895|NCT05435339|467098225|FG004|Overall Study|Sponsor Decision|2|||
129763896|NCT05435339|467098226|FG005|Overall Study|Sponsor Decision|1|||
129763897|NCT05435339|467098227|FG006|Overall Study|Sponsor Decision|2|||
129763898|NCT05435339|467098228|FG007|Overall Study|Sponsor Decision|2|||
129763899|NCT05435339|467098221|FG000|Overall Study|Withdrawal by Subject|0|||
129763900|NCT05435339|467098222|FG001|Overall Study|Withdrawal by Subject|0|||
129763901|NCT05435339|467098223|FG002|Overall Study|Withdrawal by Subject|0|||
129763902|NCT05435339|467098224|FG003|Overall Study|Withdrawal by Subject|0|||
129763903|NCT05435339|467098225|FG004|Overall Study|Withdrawal by Subject|1|||
129763904|NCT05435339|467098226|FG005|Overall Study|Withdrawal by Subject|0|||
129763905|NCT05435339|467098227|FG006|Overall Study|Withdrawal by Subject|1|||
129763906|NCT05435339|467098228|FG007|Overall Study|Withdrawal by Subject|1|||
129763907|NCT03473236|467098230|FG000|Overall Study|Withdrawal by Subject|0|||
129985700|NCT04811131|467909336|FG003|Overall Study|Adverse Event|0|||
129541394|NCT04668066|466274334|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541395|NCT04668066|466274335|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541396|NCT04668066|466274336|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541397|NCT04668066|466274337|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541398|NCT04668066|466274338|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541399|NCT04668066|466274339|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541400|NCT04668066|466274340|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541401|NCT04668066|466274341|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541402|NCT04668066|466274342|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
129541403|NCT04668066|466274343|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541404|NCT04668066|466274344|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541405|NCT04668066|466274345|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
129541406|NCT04668066|466274346|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541407|NCT04668066|466274347|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541408|NCT04668066|466274348|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
129541409|NCT04668066|466274330|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541410|NCT04668066|466274331|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541411|NCT04668066|466274332|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541412|NCT04668066|466274333|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541413|NCT04668066|466274334|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541414|NCT04668066|466274335|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129763908|NCT03473236|467098231|FG001|Overall Study|Withdrawal by Subject|0|||
129763909|NCT03473236|467098232|FG002|Overall Study|Withdrawal by Subject|0|||
129763910|NCT03473236|467098233|FG003|Overall Study|Withdrawal by Subject|0|||
129763911|NCT03473236|467098234|FG004|Overall Study|Withdrawal by Subject|0|||
129763912|NCT03473236|467098235|FG005|Overall Study|Withdrawal by Subject|1|||
129763913|NCT03473236|467098236|FG006|Overall Study|Withdrawal by Subject|0|||
129763914|NCT03473236|467098237|FG007|Overall Study|Withdrawal by Subject|0|||
129763915|NCT03473236|467098238|FG008|Overall Study|Withdrawal by Subject|1|||
129763916|NCT03473236|467098239|FG009|Overall Study|Withdrawal by Subject|0|||
129763917|NCT00849940|467098240|FG000|Overall Study|Physician Decision|4|||
129763918|NCT01927497|467098241|FG000|Overall Study|Death|0|||
129763919|NCT01927497|467098242|FG001|Overall Study|Death|1|||
129763920|NCT01927497|467098241|FG000|Overall Study|Protocol Violation|2|||
129763921|NCT01927497|467098242|FG001|Overall Study|Protocol Violation|0|||
129763922|NCT03409796|467100228|FG000|Overall Study|Adverse Event|2|||
129763923|NCT03409796|467100229|FG001|Overall Study|Adverse Event|0|||
129763924|NCT03409796|467100228|FG000|Overall Study|Other|0|||
129763925|NCT03409796|467100229|FG001|Overall Study|Other|1|||
129763926|NCT00740220|467100230|FG000|Overall Study|screen failures (non-COPD patients)|9|||
129763927|NCT01602224|467100231|FG000|Overall Study|Adverse Event|0|||
129763928|NCT01602224|467100232|FG001|Overall Study|Adverse Event|1|||
129763929|NCT01602224|467100233|FG002|Overall Study|Adverse Event|0|||
129763930|NCT01602224|467100231|FG000|Overall Study|Investigator Decison|1|||
129763931|NCT01602224|467100232|FG001|Overall Study|Investigator Decison|0|||
129763932|NCT01602224|467100233|FG002|Overall Study|Investigator Decison|0|||
129763933|NCT01602224|467100231|FG000|Overall Study|Lost to Follow-up|0|||
129763934|NCT01602224|467100232|FG001|Overall Study|Lost to Follow-up|0|||
129763935|NCT01602224|467100233|FG002|Overall Study|Lost to Follow-up|1|||
129763936|NCT01602224|467100231|FG000|Overall Study|Protocol Violation|0|||
129763937|NCT01602224|467100232|FG001|Overall Study|Protocol Violation|1|||
129763938|NCT01602224|467100233|FG002|Overall Study|Protocol Violation|0|||
129763939|NCT01602224|467100231|FG000|Overall Study|Sponsor Decision|2|||
129763940|NCT01602224|467100232|FG001|Overall Study|Sponsor Decision|3|||
129763941|NCT01602224|467100233|FG002|Overall Study|Sponsor Decision|2|||
129763942|NCT01602224|467100231|FG000|Overall Study|Withdrawal by Subject|5|||
129763943|NCT01602224|467100232|FG001|Overall Study|Withdrawal by Subject|3|||
129763944|NCT01602224|467100233|FG002|Overall Study|Withdrawal by Subject|3|||
129763945|NCT01352117|467100234|FG000|Overall Study|Death|15|||
129763946|NCT01352117|467100235|FG001|Overall Study|Death|16|||
129763947|NCT01352117|467100234|FG000|Overall Study|Withdrawal by Subject|1|||
129763948|NCT01352117|467100235|FG001|Overall Study|Withdrawal by Subject|0|||
129763949|NCT01352117|467100234|FG000|Overall Study|Lost to Follow-up|2|||
129763950|NCT01352117|467100235|FG001|Overall Study|Lost to Follow-up|7|||
129763951|NCT01352117|467100234|FG000|Overall Study|Non-adherent to study requirements|1|||
129763952|NCT01352117|467100235|FG001|Overall Study|Non-adherent to study requirements|1|||
129763953|NCT01352117|467100234|FG000|Overall Study|Did not initiate study treatment|1|||
129541415|NCT04668066|466274336|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541416|NCT04668066|466274337|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129763954|NCT01352117|467100235|FG001|Overall Study|Did not initiate study treatment|0|||
129763955|NCT01352117|467100234|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
129763956|NCT01352117|467100235|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
129763957|NCT00633477|467100236|FG000|Overall Study|Death|1|||
129763958|NCT00633477|467100237|FG001|Overall Study|Death|0|||
129985701|NCT04811131|467909333|FG000|Overall Study|Lack of Efficacy|0|||
129541417|NCT04668066|466274338|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541418|NCT04668066|466274339|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129651245|NCT03605849|466679598|FG002|Overall Study|Protocol Deviation|1|||
129763959|NCT00633477|467100236|FG000|Overall Study|Randomized but not treated|1|||
129763960|NCT00633477|467100237|FG001|Overall Study|Randomized but not treated|0|||
129763961|NCT00770653|467100241|FG000|Overall Study|Adverse Event|13|||
129763962|NCT00770653|467100242|FG001|Overall Study|Adverse Event|5|||
129763963|NCT00770653|467100241|FG000|Overall Study|Protocol Violation|8|||
129763964|NCT00770653|467100242|FG001|Overall Study|Protocol Violation|6|||
129763965|NCT00770653|467100241|FG000|Overall Study|Withdrawal by Subject|4|||
129763966|NCT00770653|467100242|FG001|Overall Study|Withdrawal by Subject|7|||
129763967|NCT00770653|467100241|FG000|Overall Study|Lack of Compliance|1|||
129763968|NCT00770653|467100242|FG001|Overall Study|Lack of Compliance|4|||
129763969|NCT00770653|467100241|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
129763970|NCT00770653|467100242|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
129763971|NCT00770653|467100241|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
129763972|NCT00770653|467100242|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
129763973|NCT00770653|467100241|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
129763974|NCT00770653|467100242|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
129763975|NCT00770653|467100241|FG000|Overall Study|Lost to Follow-up|1|||
129763976|NCT00770653|467100242|FG001|Overall Study|Lost to Follow-up|2|||
129763977|NCT00770653|467100241|FG000|Overall Study|Physician Decision|1|||
129763978|NCT00770653|467100242|FG001|Overall Study|Physician Decision|0|||
129763979|NCT04906499|467100248|FG000|Overall Study|Lack of time|1|||
129763980|NCT00179621|467100249|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
129763981|NCT00179621|467100250|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
129763982|NCT00179621|467100251|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
129763983|NCT00179621|467100252|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
129763984|NCT00179621|467100249|FG000|Double-Blind Period|Adverse Event|2|||
129763985|NCT00179621|467100250|FG001|Double-Blind Period|Adverse Event|7|||
129763986|NCT00179621|467100251|FG002|Double-Blind Period|Adverse Event|4|||
129763987|NCT00179621|467100252|FG003|Double-Blind Period|Adverse Event|0|||
129763988|NCT00179621|467100249|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129763989|NCT00179621|467100250|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129763990|NCT00179621|467100251|FG002|Double-Blind Period|Withdrawal by Subject|3|||
129763991|NCT00179621|467100252|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129763992|NCT00179621|467100249|FG000|Double-Blind Period|Death|0|||
129763993|NCT00179621|467100250|FG001|Double-Blind Period|Death|1|||
129763994|NCT00179621|467100251|FG002|Double-Blind Period|Death|2|||
129763995|NCT00179621|467100252|FG003|Double-Blind Period|Death|0|||
129763996|NCT00179621|467100249|FG000|Double-Blind Period|Protocol Violation|1|||
129763997|NCT00179621|467100250|FG001|Double-Blind Period|Protocol Violation|0|||
129763998|NCT00179621|467100251|FG002|Double-Blind Period|Protocol Violation|0|||
129763999|NCT00179621|467100252|FG003|Double-Blind Period|Protocol Violation|0|||
129764000|NCT00179621|467100249|FG000|Double-Blind Period|Other|0|||
129764001|NCT00179621|467100250|FG001|Double-Blind Period|Other|2|||
129443617|NCT01093625|465924437|FG001|6-Month Visit|Withdrawal by Subject|7|||
129764002|NCT00179621|467100251|FG002|Double-Blind Period|Other|2|||
129764003|NCT00179621|467100252|FG003|Double-Blind Period|Other|0|||
129764004|NCT00179621|467100249|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
129764005|NCT00179621|467100250|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
129764006|NCT00179621|467100251|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
129764007|NCT00179621|467100252|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
129764008|NCT00179621|467100249|FG000|Open-Label Period|Adverse Event|0|||
129764009|NCT00179621|467100250|FG001|Open-Label Period|Adverse Event|6|||
129764010|NCT00179621|467100251|FG002|Open-Label Period|Adverse Event|5|||
129764011|NCT00179621|467100252|FG003|Open-Label Period|Adverse Event|6|||
129764012|NCT00179621|467100249|FG000|Open-Label Period|Withdrawal by Subject|0|||
129764013|NCT00179621|467100250|FG001|Open-Label Period|Withdrawal by Subject|2|||
129764014|NCT00179621|467100251|FG002|Open-Label Period|Withdrawal by Subject|2|||
129764015|NCT00179621|467100252|FG003|Open-Label Period|Withdrawal by Subject|2|||
129764016|NCT00179621|467100249|FG000|Open-Label Period|Death|0|||
129764017|NCT00179621|467100250|FG001|Open-Label Period|Death|0|||
129764018|NCT00179621|467100251|FG002|Open-Label Period|Death|1|||
129764019|NCT00179621|467100252|FG003|Open-Label Period|Death|2|||
129764020|NCT00179621|467100249|FG000|Open-Label Period|Other|0|||
129764021|NCT00179621|467100250|FG001|Open-Label Period|Other|1|||
129764022|NCT00179621|467100251|FG002|Open-Label Period|Other|1|||
129764023|NCT00179621|467100252|FG003|Open-Label Period|Other|2|||
129764024|NCT00262860|467100259|FG000|Overall Study|Adverse Event|2|||
129764025|NCT02891174|467100271|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
129764026|NCT02891174|467100272|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
129764027|NCT02891174|467100271|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
129764028|NCT02891174|467100272|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
129764029|NCT02891174|467100271|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
129764030|NCT02891174|467100272|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
129764031|NCT02891174|467100271|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
129764032|NCT02891174|467100272|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
129764033|NCT02891174|467100271|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
129764034|NCT02891174|467100272|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
129764035|NCT02891174|467100271|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
129764036|NCT02891174|467100272|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
129764037|NCT02891174|467100271|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
129764038|NCT02891174|467100272|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
129764039|NCT04124939|467100273|FG000|Overall Study|Lost to Follow-up|1|||
129764040|NCT04124939|467100274|FG001|Overall Study|Lost to Follow-up|3|||
129764041|NCT04235140|467100275|FG000|Overall Study|Adverse Event|2|||
129764042|NCT04235140|467100275|FG000|Overall Study|Lost to Follow-up|1|||
129764043|NCT04235140|467100275|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
129764044|NCT04235140|467100275|FG000|Overall Study|Commercial drug is available for participants|7|||
129764045|NCT00672555|467100277|FG000|Overall Study|Lost to Follow-up|4|||
129764046|NCT00672555|467100277|FG000|Overall Study|Did not want to answer questionnaire|2|||
129764047|NCT00419393|467100278|FG000|Overall Study|Adverse Event|5|||
129764048|NCT00419393|467100278|FG000|Overall Study|Protocol Violation|5|||
129764049|NCT00419393|467100278|FG000|Overall Study|Withdrawal by Subject|7|||
129764050|NCT00419393|467100278|FG000|Overall Study|Other: Sponsor request|3|||
129764051|NCT00419393|467100278|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
129764052|NCT00419393|467100278|FG000|Overall Study|Other: Site closure|1|||
129764053|NCT00419393|467100278|FG000|Overall Study|Other: Other health problems|1|||
129764054|NCT00419393|467100278|FG000|Overall Study|Other: Investigator decision|1|||
129764055|NCT04516746|467100281|FG000|Overall Study|Randomized but not Treated|51|||
129764056|NCT04516746|467100282|FG001|Overall Study|Randomized but not Treated|19|||
129764057|NCT04516746|467100281|FG000|Overall Study|Adverse Event|0|||
129764058|NCT04516746|467100282|FG001|Overall Study|Adverse Event|1|||
129764059|NCT04516746|467100281|FG000|Overall Study|Death|62|||
129764060|NCT04516746|467100282|FG001|Overall Study|Death|32|||
129764061|NCT04516746|467100281|FG000|Overall Study|Lost to Follow-up|3431|||
129764062|NCT04516746|467100282|FG001|Overall Study|Lost to Follow-up|1831|||
129764063|NCT04516746|467100281|FG000|Overall Study|Withdrawal by Subject|1946|||
129764064|NCT04516746|467100282|FG001|Overall Study|Withdrawal by Subject|1696|||
129764065|NCT04516746|467100281|FG000|Overall Study|Physician Decision|10|||
129764066|NCT04516746|467100282|FG001|Overall Study|Physician Decision|8|||
129764067|NCT04516746|467100281|FG000|Overall Study|Other|35|||
129541419|NCT04668066|466274340|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541420|NCT04668066|466274341|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541421|NCT04668066|466274342|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541422|NCT04668066|466274343|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541423|NCT04668066|466274344|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541424|NCT04668066|466274345|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541425|NCT04668066|466274346|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541426|NCT04668066|466274347|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
129541427|NCT04668066|466274348|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
129541428|NCT04668066|466274330|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541429|NCT04668066|466274331|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541430|NCT04668066|466274332|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541431|NCT04668066|466274333|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541432|NCT04668066|466274334|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541433|NCT04668066|466274335|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541434|NCT04668066|466274336|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541435|NCT04668066|466274337|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541436|NCT04668066|466274338|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541437|NCT04668066|466274339|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541438|NCT04668066|466274340|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541439|NCT04668066|466274341|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541440|NCT04668066|466274342|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541441|NCT04668066|466274343|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541442|NCT04668066|466274344|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541443|NCT04668066|466274345|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541444|NCT04668066|466274346|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541445|NCT04668066|466274347|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
129541446|NCT04668066|466274348|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
129541447|NCT04668066|466274330|FG000|Part 2: Treatment Phase|Other|0|||
129541448|NCT04668066|466274331|FG001|Part 2: Treatment Phase|Other|0|||
129541449|NCT04668066|466274332|FG002|Part 2: Treatment Phase|Other|0|||
129541450|NCT04668066|466274333|FG003|Part 2: Treatment Phase|Other|0|||
129541451|NCT04668066|466274334|FG004|Part 2: Treatment Phase|Other|0|||
129541452|NCT04668066|466274335|FG005|Part 2: Treatment Phase|Other|0|||
129541453|NCT04668066|466274336|FG006|Part 2: Treatment Phase|Other|0|||
129541454|NCT04668066|466274337|FG007|Part 2: Treatment Phase|Other|0|||
129541455|NCT04668066|466274338|FG008|Part 2: Treatment Phase|Other|0|||
129541456|NCT04668066|466274339|FG009|Part 2: Treatment Phase|Other|0|||
129541457|NCT04668066|466274340|FG010|Part 2: Treatment Phase|Other|0|||
129541458|NCT04668066|466274341|FG011|Part 2: Treatment Phase|Other|0|||
129541459|NCT04668066|466274342|FG012|Part 2: Treatment Phase|Other|0|||
129541460|NCT04668066|466274343|FG013|Part 2: Treatment Phase|Other|0|||
129541461|NCT04668066|466274344|FG014|Part 2: Treatment Phase|Other|0|||
129541462|NCT04668066|466274345|FG015|Part 2: Treatment Phase|Other|0|||
129541463|NCT04668066|466274346|FG016|Part 2: Treatment Phase|Other|0|||
129541464|NCT04668066|466274347|FG017|Part 2: Treatment Phase|Other|0|||
129541465|NCT04668066|466274348|FG018|Part 2: Treatment Phase|Other|1|||
129541466|NCT04668066|466274330|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541467|NCT04668066|466274331|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541468|NCT04668066|466274332|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541469|NCT04668066|466274333|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541470|NCT04668066|466274334|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
129764068|NCT04516746|467100282|FG001|Overall Study|Other|16|||
129764069|NCT01751061|467100283|FG000|Overall Study|Death|1|||
129764070|NCT01751061|467100284|FG001|Overall Study|Death|0|||
129541471|NCT04668066|466274335|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541472|NCT04668066|466274336|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541473|NCT04668066|466274337|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541474|NCT04668066|466274338|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541475|NCT04668066|466274339|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541476|NCT04668066|466274340|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541477|NCT04668066|466274341|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541478|NCT04668066|466274342|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541479|NCT04668066|466274343|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541480|NCT04668066|466274344|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541481|NCT04668066|466274345|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541482|NCT04668066|466274346|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541483|NCT04668066|466274347|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
129541484|NCT04668066|466274348|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
129541485|NCT04505592|466274349|FG000|Overall Study|Death|2|||
129541486|NCT04505592|466274350|FG001|Overall Study|Death|1|||
129541487|NCT01015118|466274355|FG000|Overall Study|Protocol Violation|5|||
129541488|NCT01015118|466274356|FG001|Overall Study|Protocol Violation|6|||
129541489|NCT01015118|466274355|FG000|Overall Study|Withdrawal by Subject|103|||
129541490|NCT01015118|466274356|FG001|Overall Study|Withdrawal by Subject|27|||
129541491|NCT01015118|466274355|FG000|Overall Study|Other Adverse Event (AE)|141|||
129541492|NCT01015118|466274356|FG001|Overall Study|Other Adverse Event (AE)|33|||
129541493|NCT01015118|466274355|FG000|Overall Study|Worsening or AE of underlying disease|5|||
129541494|NCT01015118|466274356|FG001|Overall Study|Worsening or AE of underlying disease|4|||
129541495|NCT01015118|466274355|FG000|Overall Study|Progressive disease|364|||
129541496|NCT01015118|466274356|FG001|Overall Study|Progressive disease|229|||
129541497|NCT01015118|466274355|FG000|Overall Study|Not treated|9|||
129541498|NCT01015118|466274356|FG001|Overall Study|Not treated|5|||
129541499|NCT01015118|466274355|FG000|Overall Study|Other than stated above|42|||
129541500|NCT01015118|466274356|FG001|Overall Study|Other than stated above|23|||
129541501|NCT03522506|466274357|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129541502|NCT03522506|466274358|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129541503|NCT03522506|466274359|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129541504|NCT03522506|466274360|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129541505|NCT03522506|466274357|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129541506|NCT03522506|466274358|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129541507|NCT03522506|466274359|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129541508|NCT03522506|466274360|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
129541509|NCT02388906|466274361|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
129541510|NCT02388906|466274362|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129541511|NCT02388906|466274361|FG000|Treatment Period|Disease progression|121|||
129541512|NCT02388906|466274362|FG001|Treatment Period|Disease progression|100|||
129541513|NCT02388906|466274361|FG000|Treatment Period|Study drug toxicity|41|||
129541514|NCT02388906|466274362|FG001|Treatment Period|Study drug toxicity|208|||
129541515|NCT02388906|466274361|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
129541516|NCT02388906|466274362|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
129541517|NCT02388906|466274361|FG000|Treatment Period|Participant request to stop treatment|5|||
129541518|NCT02388906|466274362|FG001|Treatment Period|Participant request to stop treatment|9|||
129541519|NCT02388906|466274361|FG000|Treatment Period|Participant withdrew consent|2|||
129541520|NCT02388906|466274362|FG001|Treatment Period|Participant withdrew consent|3|||
129541521|NCT02388906|466274361|FG000|Treatment Period|Poor/non-compliance|0|||
129541522|NCT02388906|466274362|FG001|Treatment Period|Poor/non-compliance|1|||
129541523|NCT02388906|466274361|FG000|Treatment Period|Participant no longer meets study criteria|0|||
129541524|NCT02388906|466274362|FG001|Treatment Period|Participant no longer meets study criteria|1|||
129541525|NCT02388906|466274361|FG000|Treatment Period|Other reasons|3|||
129541526|NCT02388906|466274362|FG001|Treatment Period|Other reasons|3|||
129541527|NCT04784455|466274363|FG000|Overall Study|Death|4|||
129541528|NCT03901274|466274366|FG000|Overall Study|Lost to Follow-up|120|||
129541529|NCT03901274|466274367|FG001|Overall Study|Lost to Follow-up|124|||
129541530|NCT03901274|466274366|FG000|Overall Study|Withdrawal by Subject|0|||
129541531|NCT03901274|466274367|FG001|Overall Study|Withdrawal by Subject|6|||
129541532|NCT04527380|466274368|FG000|Overall Study|Lack of Efficacy|0|||
129541533|NCT04527380|466274369|FG001|Overall Study|Lack of Efficacy|1|||
129541534|NCT04527380|466274368|FG000|Overall Study|Withdrawal by Subject|1|||
129541535|NCT04527380|466274369|FG001|Overall Study|Withdrawal by Subject|0|||
129541536|NCT04411641|466274370|FG000|DB Period|Other|7|||
129541537|NCT04411641|466274371|FG001|DB Period|Other|27|||
129541538|NCT04411641|466274372|FG002|DB Period|Other|0|||
129541539|NCT04411641|466274373|FG003|DB Period|Other|0|||
129541540|NCT04411641|466274370|FG000|DB Period|Withdrawal by Subject|67|||
129541541|NCT04411641|466274371|FG001|DB Period|Withdrawal by Subject|122|||
129541542|NCT04411641|466274372|FG002|DB Period|Withdrawal by Subject|0|||
129541543|NCT04411641|466274373|FG003|DB Period|Withdrawal by Subject|0|||
129541544|NCT04411641|466274370|FG000|DB Period|Progressive disease|76|||
129541545|NCT04411641|466274371|FG001|DB Period|Progressive disease|116|||
129541546|NCT04411641|466274372|FG002|DB Period|Progressive disease|0|||
129541547|NCT04411641|466274373|FG003|DB Period|Progressive disease|0|||
129541548|NCT04411641|466274370|FG000|DB Period|Poor compliance to protocol|1|||
129541549|NCT04411641|466274371|FG001|DB Period|Poor compliance to protocol|5|||
129541550|NCT04411641|466274372|FG002|DB Period|Poor compliance to protocol|0|||
129541551|NCT04411641|466274373|FG003|DB Period|Poor compliance to protocol|0|||
129541552|NCT04411641|466274370|FG000|DB Period|Lack of Efficacy|19|||
129541553|NCT04411641|466274371|FG001|DB Period|Lack of Efficacy|19|||
129541554|NCT04411641|466274372|FG002|DB Period|Lack of Efficacy|0|||
129541555|NCT04411641|466274373|FG003|DB Period|Lack of Efficacy|0|||
129541556|NCT04411641|466274370|FG000|DB Period|Adverse Event|13|||
129541557|NCT04411641|466274371|FG001|DB Period|Adverse Event|29|||
129541558|NCT04411641|466274372|FG002|DB Period|Adverse Event|0|||
129541559|NCT04411641|466274373|FG003|DB Period|Adverse Event|0|||
129541560|NCT04411641|466274370|FG000|DB Period|Randomized and not treated|2|||
129541561|NCT04411641|466274371|FG001|DB Period|Randomized and not treated|2|||
129541562|NCT04411641|466274372|FG002|DB Period|Randomized and not treated|0|||
129541563|NCT04411641|466274373|FG003|DB Period|Randomized and not treated|0|||
129541564|NCT04411641|466274370|FG000|OL|Withdrawal by Subject|0|||
129541565|NCT04411641|466274371|FG001|OL|Withdrawal by Subject|0|||
129541566|NCT04411641|466274372|FG002|OL|Withdrawal by Subject|6|||
129541567|NCT04411641|466274373|FG003|OL|Withdrawal by Subject|17|||
129541568|NCT04411641|466274370|FG000|OL|Progressive disease|0|||
129541569|NCT04411641|466274371|FG001|OL|Progressive disease|0|||
129541570|NCT04411641|466274372|FG002|OL|Progressive disease|1|||
129541571|NCT04411641|466274373|FG003|OL|Progressive disease|2|||
129541572|NCT04411641|466274370|FG000|OL|Poor compliance to protocol|0|||
129541573|NCT04411641|466274371|FG001|OL|Poor compliance to protocol|0|||
129541574|NCT04411641|466274372|FG002|OL|Poor compliance to protocol|1|||
129541575|NCT04411641|466274373|FG003|OL|Poor compliance to protocol|0|||
129541576|NCT04411641|466274370|FG000|OL|Adverse Event|0|||
129541577|NCT04411641|466274371|FG001|OL|Adverse Event|0|||
129541578|NCT04411641|466274372|FG002|OL|Adverse Event|1|||
129541579|NCT04411641|466274373|FG003|OL|Adverse Event|0|||
129541580|NCT04411641|466274370|FG000|OL|Other|0|||
129541581|NCT04411641|466274371|FG001|OL|Other|0|||
129541582|NCT04411641|466274372|FG002|OL|Other|0|||
129541583|NCT04411641|466274373|FG003|OL|Other|6|||
129541584|NCT03282123|466274378|FG000|Overall Study|Withdrawal by Subject|5|||
129541585|NCT01195662|466274381|FG000|Double Blind Treatment Period|Adverse Event|4|||
129541586|NCT01195662|466274382|FG001|Double Blind Treatment Period|Adverse Event|1|||
129541587|NCT01195662|466274383|FG002|Double Blind Treatment Period|Adverse Event|2|||
129541588|NCT01195662|466274381|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
129541589|NCT01195662|466274382|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
129541590|NCT01195662|466274383|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
129541591|NCT01195662|466274381|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
129541592|NCT01195662|466274382|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
129541593|NCT01195662|466274383|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
129541594|NCT01195662|466274381|FG000|Double Blind Treatment Period|Administrative reason|2|||
129541595|NCT01195662|466274382|FG001|Double Blind Treatment Period|Administrative reason|1|||
129541596|NCT01195662|466274383|FG002|Double Blind Treatment Period|Administrative reason|1|||
129541597|NCT01195662|466274381|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
129541598|NCT01195662|466274382|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
129541599|NCT01195662|466274383|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
129541600|NCT01195662|466274381|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
129541601|NCT01195662|466274382|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
129541602|NCT01195662|466274383|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
129541603|NCT01195662|466274381|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
129541604|NCT01195662|466274382|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
129541605|NCT01195662|466274383|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
129541606|NCT01195662|466274381|FG000|Double Blind Treatment Period|Non-specified|3|||
129541607|NCT01195662|466274382|FG001|Double Blind Treatment Period|Non-specified|0|||
129541608|NCT01195662|466274383|FG002|Double Blind Treatment Period|Non-specified|0|||
129541609|NCT01195662|466274381|FG000|Double Blind Treatment Period|Missing disposition information|0|||
129541610|NCT01195662|466274382|FG001|Double Blind Treatment Period|Missing disposition information|1|||
129541611|NCT01195662|466274383|FG002|Double Blind Treatment Period|Missing disposition information|1|||
129651246|NCT03605849|466679599|FG003|Overall Study|Protocol Deviation|3|||
129541612|NCT01195662|466274381|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
129541613|NCT01195662|466274382|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
129541614|NCT01195662|466274383|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
129541615|NCT01195662|466274381|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
129541616|NCT01195662|466274382|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
129541617|NCT01195662|466274383|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
129541618|NCT01215968|466274384|FG000|Overall Study|Adverse Event|0|||
129541619|NCT01215968|466274385|FG001|Overall Study|Adverse Event|2|||
129541620|NCT01215968|466274384|FG000|Overall Study|Protocol Violation|2|||
129541621|NCT01215968|466274385|FG001|Overall Study|Protocol Violation|4|||
129541622|NCT01215968|466274384|FG000|Overall Study|Not received study drug|0|||
129541623|NCT01215968|466274385|FG001|Overall Study|Not received study drug|1|||
129541624|NCT05643573|466274387|FG000|Overall Study|Adverse Event|117|||
129541625|NCT05643573|466274388|FG001|Overall Study|Adverse Event|90|||
129541626|NCT05643573|466274387|FG000|Overall Study|Death|53|||
129541627|NCT05643573|466274388|FG001|Overall Study|Death|57|||
129541628|NCT05643573|466274387|FG000|Overall Study|Lost to Follow-up|6|||
129541629|NCT05643573|466274388|FG001|Overall Study|Lost to Follow-up|3|||
129541630|NCT05643573|466274387|FG000|Overall Study|Other|18|||
129541631|NCT05643573|466274388|FG001|Overall Study|Other|15|||
129541632|NCT05643573|466274387|FG000|Overall Study|Outcome event|64|||
129541633|NCT05643573|466274388|FG001|Overall Study|Outcome event|36|||
129541634|NCT05643573|466274387|FG000|Overall Study|Physician Decision|33|||
129541635|NCT05643573|466274388|FG001|Overall Study|Physician Decision|19|||
129541636|NCT05643573|466274387|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
129541637|NCT05643573|466274388|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
129541638|NCT05643573|466274387|FG000|Overall Study|Site terminated by sponsor|10|||
129541639|NCT05643573|466274388|FG001|Overall Study|Site terminated by sponsor|10|||
129541640|NCT05643573|466274387|FG000|Overall Study|Study terminated by sponsor|1|||
129541641|NCT05643573|466274388|FG001|Overall Study|Study terminated by sponsor|0|||
129541642|NCT05643573|466274387|FG000|Overall Study|Withdrawal by Subject|178|||
129541643|NCT05643573|466274388|FG001|Overall Study|Withdrawal by Subject|130|||
129541644|NCT04768881|466274391|FG000|Overall Study|Completed Study Follow-up|0|||
129541645|NCT04768881|466274392|FG001|Overall Study|Completed Study Follow-up|2|||
129541646|NCT04768881|466274391|FG000|Overall Study|Death|3|||
129541647|NCT04768881|466274392|FG001|Overall Study|Death|2|||
129541648|NCT04768881|466274391|FG000|Overall Study|Study Terminated by Sponsor|2|||
129541649|NCT04768881|466274392|FG001|Overall Study|Study Terminated by Sponsor|2|||
129541650|NCT04768881|466274391|FG000|Overall Study|Withdrawal by Subject|2|||
129541651|NCT04768881|466274392|FG001|Overall Study|Withdrawal by Subject|0|||
129541652|NCT04768881|466274391|FG000|Overall Study|Other|2|||
129541653|NCT04768881|466274392|FG001|Overall Study|Other|0|||
129541654|NCT04089566|466274394|FG000|Overall Study|Death|0|||
129541655|NCT04089566|466274395|FG001|Overall Study|Death|6|||
129541656|NCT04089566|466274396|FG002|Overall Study|Death|10|||
129541657|NCT04089566|466274397|FG003|Overall Study|Death|0|||
129541658|NCT04089566|466274398|FG004|Overall Study|Death|0|||
129541659|NCT04089566|466274399|FG005|Overall Study|Death|0|||
129541660|NCT04089566|466274394|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
129541661|NCT04089566|466274395|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
129541662|NCT04089566|466274396|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
129541663|NCT04089566|466274397|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
129541664|NCT04089566|466274398|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
129541665|NCT04089566|466274399|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
129541666|NCT04089566|466274394|FG000|Overall Study|Reason not Specified|0|||
129541667|NCT04089566|466274395|FG001|Overall Study|Reason not Specified|4|||
129541668|NCT04089566|466274396|FG002|Overall Study|Reason not Specified|4|||
129541669|NCT04089566|466274397|FG003|Overall Study|Reason not Specified|1|||
129541670|NCT04089566|466274398|FG004|Overall Study|Reason not Specified|0|||
129541671|NCT04089566|466274399|FG005|Overall Study|Reason not Specified|0|||
129541672|NCT01958619|466274405|FG000|Overall Study|Protocol Violation|2|||
129541673|NCT01958619|466274406|FG001|Overall Study|Protocol Violation|0|||
129541674|NCT01958619|466274407|FG002|Overall Study|Protocol Violation|1|||
129541675|NCT01958619|466274408|FG003|Overall Study|Protocol Violation|0|||
129541676|NCT01003691|466274413|FG000|Overall Study|Adverse Event|0|||
129541677|NCT01003691|466274414|FG001|Overall Study|Adverse Event|0|||
129541678|NCT01003691|466274415|FG002|Overall Study|Adverse Event|0|||
129764071|NCT01751061|467100283|FG000|Overall Study|patient death|5|||
129764072|NCT01751061|467100284|FG001|Overall Study|patient death|0|||
129764073|NCT01751061|467100283|FG000|Overall Study|Lost to Follow-up|40|||
129764074|NCT01751061|467100284|FG001|Overall Study|Lost to Follow-up|25|||
129541679|NCT01003691|466274416|FG003|Overall Study|Adverse Event|1|||
129541680|NCT00167414|466274417|FG000|Overall Study|Death|10|||
129541681|NCT01875731|466274418|FG000|Overall Study|Fail to obtain lab sample|1|||
129541682|NCT01875731|466274419|FG001|Overall Study|Fail to obtain lab sample|0|||
129764075|NCT01751061|467100283|FG000|Overall Study|patient regained decisional capacity|4|||
129541683|NCT00157820|466274422|FG000|Randomized|Physician Decision|4|||
129764076|NCT01751061|467100284|FG001|Overall Study|patient regained decisional capacity|8|||
129764077|NCT01751061|467100283|FG000|Overall Study|Withdrawal by Subject|4|||
129764078|NCT01751061|467100284|FG001|Overall Study|Withdrawal by Subject|1|||
129443618|NCT01093625|465924436|FG000|6-Month Visit|Lost to Follow-up|2|||
129443619|NCT01093625|465924437|FG001|6-Month Visit|Lost to Follow-up|2|||
129443620|NCT01093625|465924436|FG000|1-Year Visit|Lost to Follow-up|5|||
129443621|NCT01093625|465924437|FG001|1-Year Visit|Lost to Follow-up|3|||
129443622|NCT02846532|465924443|FG000|Overall Study|Lost to Follow-up|0|||
129443623|NCT02846532|465924444|FG001|Overall Study|Lost to Follow-up|1|||
129443624|NCT02846532|465924445|FG002|Overall Study|Lost to Follow-up|1|||
129443625|NCT02846532|465924443|FG000|Overall Study|Withdrawal by Subject|1|||
129443626|NCT02846532|465924444|FG001|Overall Study|Withdrawal by Subject|2|||
129443627|NCT02846532|465924445|FG002|Overall Study|Withdrawal by Subject|0|||
129443628|NCT03951220|465924446|FG000|Overall Study|Withdrawal by Subject|9|||
129443629|NCT03951220|465924447|FG001|Overall Study|Withdrawal by Subject|2|||
129443630|NCT03951220|465924448|FG002|Overall Study|Withdrawal by Subject|0|||
129443631|NCT06132425|465924449|FG000|Overall Study|Withdrawal by Subject|3|||
129443632|NCT06132425|465924450|FG001|Overall Study|Withdrawal by Subject|0|||
129443633|NCT06132425|465924449|FG000|Overall Study|Did not follow study instructions|0|||
129443634|NCT06132425|465924450|FG001|Overall Study|Did not follow study instructions|2|||
129443635|NCT06132425|465924449|FG000|Overall Study|Lost to Follow-up|3|||
129443636|NCT06132425|465924450|FG001|Overall Study|Lost to Follow-up|5|||
129443637|NCT04598477|465924452|FG000|Overall Study|Adverse Event|2|||
129443638|NCT04598477|465924453|FG001|Overall Study|Adverse Event|0|||
129443639|NCT04598477|465924452|FG000|Overall Study|Death|0|||
129443640|NCT04598477|465924453|FG001|Overall Study|Death|1|||
129443641|NCT04598477|465924452|FG000|Overall Study|Lost to Follow-up|1|||
129443642|NCT04598477|465924453|FG001|Overall Study|Lost to Follow-up|0|||
129443643|NCT04598477|465924452|FG000|Overall Study|Physician Decision|7|||
129443644|NCT04598477|465924453|FG001|Overall Study|Physician Decision|2|||
129443645|NCT04598477|465924452|FG000|Overall Study|Pregnancy|0|||
129443646|NCT04598477|465924453|FG001|Overall Study|Pregnancy|1|||
129443647|NCT04598477|465924452|FG000|Overall Study|Requires Prohibited Medication|0|||
129443648|NCT04598477|465924453|FG001|Overall Study|Requires Prohibited Medication|1|||
129443649|NCT04598477|465924452|FG000|Overall Study|Study Terminated by Sponsor|18|||
129443650|NCT04598477|465924453|FG001|Overall Study|Study Terminated by Sponsor|12|||
129443651|NCT04598477|465924452|FG000|Overall Study|Withdrawal by Subject|16|||
129443652|NCT04598477|465924453|FG001|Overall Study|Withdrawal by Subject|12|||
129443653|NCT04598477|465924452|FG000|Overall Study|Other|15|||
129443654|NCT04598477|465924453|FG001|Overall Study|Other|8|||
129443655|NCT05579990|465924461|FG000|Overall Study|Lost to Follow-up|3|||
129443656|NCT02499770|465924463|FG000|Overall Study|Death|17|||
129443657|NCT02499770|465924464|FG001|Overall Study|Death|56|||
129443658|NCT02499770|465924463|FG000|Overall Study|Study completion|1|||
129443659|NCT02499770|465924464|FG001|Overall Study|Study completion|10|||
129443660|NCT02499770|465924463|FG000|Overall Study|Withdrawal by Subject|0|||
129443661|NCT02499770|465924464|FG001|Overall Study|Withdrawal by Subject|7|||
129443662|NCT02499770|465924463|FG000|Overall Study|Lost to Follow-up|0|||
129443663|NCT02499770|465924464|FG001|Overall Study|Lost to Follow-up|2|||
129443664|NCT02499770|465924463|FG000|Overall Study|Subject declined further treatment|1|||
129443665|NCT02499770|465924464|FG001|Overall Study|Subject declined further treatment|0|||
129443666|NCT02499770|465924463|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
129443667|NCT02499770|465924464|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
129443668|NCT02499770|465924463|FG000|Overall Study|Randomized but not enrolled|0|||
129443669|NCT02499770|465924464|FG001|Overall Study|Randomized but not enrolled|1|||
129443670|NCT01019980|465924467|FG000|Overall Study|Drug not available.|2|||
129443671|NCT01019980|465924468|FG001|Overall Study|Drug not available.|0|||
129443672|NCT02383589|465924484|FG000|Treatment Period|Adverse Event|1|||
129443673|NCT02383589|465924485|FG001|Treatment Period|Adverse Event|3|||
129443674|NCT02383589|465924484|FG000|Treatment Period|Lost to Follow-up|0|||
129443675|NCT02383589|465924485|FG001|Treatment Period|Lost to Follow-up|1|||
129443676|NCT02383589|465924484|FG000|Treatment Period|Withdrawal by Subject|0|||
129443677|NCT02383589|465924485|FG001|Treatment Period|Withdrawal by Subject|5|||
129443678|NCT02383589|465924484|FG000|Treatment Period|Non-compliance with study drug|0|||
129443679|NCT02383589|465924485|FG001|Treatment Period|Non-compliance with study drug|1|||
129443680|NCT02383589|465924484|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
129443681|NCT02383589|465924485|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
129443682|NCT02383589|465924484|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
129443683|NCT02383589|465924485|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
129443684|NCT02383589|465924484|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
129443685|NCT02383589|465924485|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
129443686|NCT04225806|465924486|FG000|Overall Study|Trial termination|15|||
129443687|NCT02408861|465924487|FG000|Overall Study|Death|0|||
129443688|NCT02408861|465924488|FG001|Overall Study|Death|3|||
129443689|NCT02408861|465924489|FG002|Overall Study|Death|1|||
129764079|NCT01751061|467100283|FG000|Overall Study|Physician Decision|2|||
129764080|NCT01751061|467100284|FG001|Overall Study|Physician Decision|0|||
129764081|NCT00446849|467100288|FG000|Acute Phase|Lack of Efficacy|64|||
129764082|NCT00446849|467100288|FG000|Acute Phase|Protocol Violation|10|||
129764083|NCT00446849|467100288|FG000|Acute Phase|Consent withdrawn|4|||
129764084|NCT00446849|467100288|FG000|Acute Phase|Lost to Follow-up|2|||
129764085|NCT00446849|467100288|FG000|Acute Phase|Physician Decision|1|||
129764086|NCT00446849|467100288|FG000|Acute Phase|noncompliance|1|||
129764087|NCT00446849|467100288|FG000|Maintenance Phase|Lack of Efficacy|40|||
129764088|NCT00446849|467100288|FG000|Maintenance Phase|Protocol Violation|7|||
129764089|NCT00446849|467100288|FG000|Maintenance Phase|Adverse Event|6|||
129764090|NCT00446849|467100288|FG000|Maintenance Phase|Consent withdrawn|5|||
129764091|NCT00446849|467100288|FG000|Maintenance Phase|Lost to Follow-up|3|||
129764092|NCT00446849|467100288|FG000|Maintenance Phase|Pregnancy|1|||
129764093|NCT00446849|467100288|FG000|Maintenance Phase|noncompliance|2|||
129764094|NCT00446849|467100288|FG000|Maintenance Phase|prohibited medication use|2|||
129764095|NCT00446849|467100288|FG000|Maintenance Phase|antibiotic use|1|||
129764096|NCT00446849|467100288|FG000|Maintenance Phase|study closure|1|||
129764097|NCT00446849|467100288|FG000|Maintenance Phase|hydrocodone use|1|||
129764098|NCT00446849|467100288|FG000|Maintenance Phase|concomitant medication use|1|||
129764099|NCT01194830|467100291|FG000|Overall Study|Adverse Event|3|||
129764100|NCT01194830|467100292|FG001|Overall Study|Adverse Event|2|||
129764101|NCT01194830|467100291|FG000|Overall Study|Protocol Violation|5|||
129764102|NCT01194830|467100292|FG001|Overall Study|Protocol Violation|4|||
129764103|NCT01194830|467100291|FG000|Overall Study|Lost to Follow-up|9|||
129764104|NCT01194830|467100292|FG001|Overall Study|Lost to Follow-up|7|||
129764105|NCT01194830|467100291|FG000|Overall Study|Withdrawal by Subject|2|||
129764106|NCT01194830|467100292|FG001|Overall Study|Withdrawal by Subject|1|||
129764107|NCT01194830|467100291|FG000|Overall Study|Lack of Efficacy|1|||
129764108|NCT01194830|467100292|FG001|Overall Study|Lack of Efficacy|1|||
129764109|NCT01194830|467100291|FG000|Overall Study|Non-compliance issues|4|||
129764110|NCT01194830|467100292|FG001|Overall Study|Non-compliance issues|4|||
129764111|NCT01194830|467100291|FG000|Overall Study|Other Reason|12|||
129764112|NCT01194830|467100292|FG001|Overall Study|Other Reason|8|||
129764113|NCT03115359|467100293|FG000|Overall Study|Withdrawal by Subject|29|||
129764114|NCT03115359|467100294|FG001|Overall Study|Withdrawal by Subject|39|||
129764115|NCT03115359|467100293|FG000|Overall Study|Scheduling conflict|25|||
129764116|NCT03115359|467100294|FG001|Overall Study|Scheduling conflict|23|||
129764117|NCT03115359|467100293|FG000|Overall Study|Personal reasons including health|12|||
129764118|NCT03115359|467100294|FG001|Overall Study|Personal reasons including health|9|||
129764119|NCT03115359|467100293|FG000|Overall Study|Transportation barriers|3|||
129764120|NCT03115359|467100294|FG001|Overall Study|Transportation barriers|0|||
129764121|NCT03115359|467100293|FG000|Overall Study|No longer interested|5|||
129764122|NCT03115359|467100294|FG001|Overall Study|No longer interested|4|||
129764123|NCT03115359|467100293|FG000|Overall Study|No reason provided|45|||
129764124|NCT03115359|467100294|FG001|Overall Study|No reason provided|47|||
129764125|NCT01815918|467100297|FG000|Overall Study|Patient samples not analyzable|3|||
129764126|NCT01815918|467100298|FG001|Overall Study|Patient samples not analyzable|4|||
129764127|NCT01815918|467100297|FG000|Overall Study|Lack of Efficacy|15|||
129764128|NCT01815918|467100298|FG001|Overall Study|Lack of Efficacy|15|||
129764129|NCT03284710|467100301|FG000|Overall Study|Withdrawal by Subject|1|||
129764130|NCT03284710|467100302|FG001|Overall Study|Withdrawal by Subject|0|||
129764131|NCT03284710|467100303|FG002|Overall Study|Withdrawal by Subject|1|||
129764132|NCT03284710|467100304|FG003|Overall Study|Withdrawal by Subject|6|||
129764133|NCT03284710|467100301|FG000|Overall Study|Lost to Follow-up|3|||
129764134|NCT03284710|467100302|FG001|Overall Study|Lost to Follow-up|3|||
129764135|NCT03284710|467100303|FG002|Overall Study|Lost to Follow-up|1|||
129764136|NCT03284710|467100304|FG003|Overall Study|Lost to Follow-up|0|||
129764137|NCT03284710|467100301|FG000|Overall Study|Physician Decision|1|||
129764138|NCT03284710|467100302|FG001|Overall Study|Physician Decision|0|||
129764139|NCT03284710|467100303|FG002|Overall Study|Physician Decision|0|||
129764140|NCT03284710|467100304|FG003|Overall Study|Physician Decision|0|||
129764141|NCT03284710|467100301|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
129764142|NCT03284710|467100302|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129764143|NCT03284710|467100303|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129764144|NCT03284710|467100304|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
129764145|NCT03284710|467100301|FG000|Overall Study|HIV Infection|0|||
129764146|NCT03284710|467100302|FG001|Overall Study|HIV Infection|2|||
129764147|NCT03284710|467100303|FG002|Overall Study|HIV Infection|2|||
129764148|NCT03284710|467100304|FG003|Overall Study|HIV Infection|1|||
129764149|NCT02814916|467100311|FG000|Overall Study|Withdrawal of consent|0|||
129764150|NCT02814916|467100312|FG001|Overall Study|Withdrawal of consent|2|||
129764151|NCT02814916|467100313|FG002|Overall Study|Withdrawal of consent|0|||
129764152|NCT02814916|467100311|FG000|Overall Study|Lost to Follow-up|0|||
129764153|NCT02814916|467100312|FG001|Overall Study|Lost to Follow-up|1|||
129764154|NCT02814916|467100313|FG002|Overall Study|Lost to Follow-up|0|||
129764155|NCT02814916|467100311|FG000|Overall Study|Other, not specified|0|||
129541684|NCT00157820|466274423|FG001|Randomized|Physician Decision|2|||
129541685|NCT00157820|466274424|FG002|Randomized|Physician Decision|3|||
129541686|NCT00157820|466274422|FG000|Randomized|Withdrawal by Subject|1|||
129541687|NCT00157820|466274423|FG001|Randomized|Withdrawal by Subject|2|||
129541688|NCT00157820|466274424|FG002|Randomized|Withdrawal by Subject|3|||
129541689|NCT00157820|466274422|FG000|Randomized|Protocol Violation|2|||
129541690|NCT00157820|466274423|FG001|Randomized|Protocol Violation|1|||
129541691|NCT00157820|466274424|FG002|Randomized|Protocol Violation|2|||
129541692|NCT00157820|466274422|FG000|1st 8 Month|Death|7|||
129541693|NCT00157820|466274423|FG001|1st 8 Month|Death|8|||
129541694|NCT00157820|466274424|FG002|1st 8 Month|Death|3|||
129541695|NCT00157820|466274422|FG000|1st 8 Month|Lost to Follow-up|1|||
129541696|NCT00157820|466274423|FG001|1st 8 Month|Lost to Follow-up|2|||
129541697|NCT00157820|466274424|FG002|1st 8 Month|Lost to Follow-up|1|||
129541698|NCT00157820|466274422|FG000|1st 8 Month|Premature cross-over|0|||
129541699|NCT00157820|466274423|FG001|1st 8 Month|Premature cross-over|2|||
129541700|NCT00157820|466274424|FG002|1st 8 Month|Premature cross-over|2|||
129541701|NCT00157820|466274422|FG000|2nd 8 Months|Death|3|||
129541702|NCT00157820|466274423|FG001|2nd 8 Months|Death|1|||
129541703|NCT00157820|466274424|FG002|2nd 8 Months|Death|3|||
129541704|NCT00157820|466274422|FG000|2nd 8 Months|Lost to Follow-up|1|||
129541705|NCT00157820|466274423|FG001|2nd 8 Months|Lost to Follow-up|5|||
129541706|NCT00157820|466274424|FG002|2nd 8 Months|Lost to Follow-up|2|||
129541707|NCT00157820|466274422|FG000|2nd 8 Months|Premature cross-over|1|||
129541708|NCT00157820|466274423|FG001|2nd 8 Months|Premature cross-over|7|||
129541709|NCT00157820|466274424|FG002|2nd 8 Months|Premature cross-over|9|||
129541710|NCT00223990|466274427|FG000|Overall Study|Moved from area|2|||
129541711|NCT00223990|466274428|FG001|Overall Study|Moved from area|1|||
129541712|NCT00223990|466274427|FG000|Overall Study|Withdrawal by Subject|4|||
129541713|NCT00223990|466274428|FG001|Overall Study|Withdrawal by Subject|8|||
129541714|NCT00223990|466274427|FG000|Overall Study|Lost to Follow-up|1|||
129541715|NCT00223990|466274428|FG001|Overall Study|Lost to Follow-up|0|||
129541716|NCT00509223|466276132|FG000|Overall Study|Lost to Follow-up|1|||
129541717|NCT00509223|466276133|FG001|Overall Study|Lost to Follow-up|1|||
129541718|NCT00509223|466276132|FG000|Overall Study|Adverse Event|1|||
129541719|NCT00509223|466276133|FG001|Overall Study|Adverse Event|1|||
129541720|NCT00509223|466276132|FG000|Overall Study|Withdrawal by Subject|25|||
129541721|NCT00509223|466276133|FG001|Overall Study|Withdrawal by Subject|6|||
129541722|NCT00509223|466276132|FG000|Overall Study|Including: subject change of address|5|||
129541723|NCT00509223|466276133|FG001|Overall Study|Including: subject change of address|2|||
129541724|NCT00509223|466276132|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
129541725|NCT00509223|466276133|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
129541726|NCT00437294|466276137|FG000|Overall Study|Adverse Event|5|||
129541727|NCT00437294|466276138|FG001|Overall Study|Adverse Event|4|||
129541728|NCT00437294|466276137|FG000|Overall Study|Death|5|||
129541729|NCT00437294|466276138|FG001|Overall Study|Death|2|||
129541730|NCT00437294|466276137|FG000|Overall Study|Physician Decision|0|||
129541731|NCT00437294|466276138|FG001|Overall Study|Physician Decision|3|||
129541732|NCT00437294|466276137|FG000|Overall Study|Withdrawal by Subject|5|||
129541733|NCT00437294|466276138|FG001|Overall Study|Withdrawal by Subject|0|||
129541734|NCT00437294|466276137|FG000|Overall Study|Progressive Disease|19|||
129541735|NCT00437294|466276138|FG001|Overall Study|Progressive Disease|23|||
129541736|NCT00437294|466276137|FG000|Overall Study|Sponsor Decision|8|||
129541737|NCT00437294|466276138|FG001|Overall Study|Sponsor Decision|9|||
129541738|NCT00437294|466276137|FG000|Overall Study|Protocol Violation|0|||
129541739|NCT00437294|466276138|FG001|Overall Study|Protocol Violation|1|||
129541740|NCT00437294|466276137|FG000|Overall Study|Entry criteria not met|1|||
129541741|NCT00437294|466276138|FG001|Overall Study|Entry criteria not met|1|||
129541742|NCT01473602|466276145|FG000|Overall Study|Adverse Event|1|||
129541743|NCT01473602|466276146|FG001|Overall Study|Adverse Event|2|||
129541744|NCT01473602|466276145|FG000|Overall Study|Death|0|||
129541745|NCT01473602|466276146|FG001|Overall Study|Death|1|||
129541746|NCT01473602|466276145|FG000|Overall Study|Lost to Follow-up|1|||
129541747|NCT01473602|466276146|FG001|Overall Study|Lost to Follow-up|1|||
129541748|NCT01473602|466276145|FG000|Overall Study|Withdrawal by Subject|5|||
129541749|NCT01473602|466276146|FG001|Overall Study|Withdrawal by Subject|4|||
129541750|NCT01473602|466276145|FG000|Overall Study|Physician Decision|1|||
129541751|NCT01473602|466276146|FG001|Overall Study|Physician Decision|0|||
129541752|NCT00560573|466276148|FG000|Overall Study|Death|4|||
129541753|NCT00560573|466276149|FG001|Overall Study|Death|1|||
129541754|NCT00560573|466276150|FG002|Overall Study|Death|4|||
129541755|NCT00560573|466276151|FG003|Overall Study|Death|5|||
129541756|NCT00560573|466276152|FG004|Overall Study|Death|1|||
129541757|NCT00560573|466276153|FG005|Overall Study|Death|10|||
129541758|NCT00560573|466276148|FG000|Overall Study|Lost to Follow-up|0|||
129541759|NCT00560573|466276149|FG001|Overall Study|Lost to Follow-up|0|||
129541760|NCT00560573|466276150|FG002|Overall Study|Lost to Follow-up|0|||
129541761|NCT00560573|466276151|FG003|Overall Study|Lost to Follow-up|1|||
129541762|NCT00560573|466276152|FG004|Overall Study|Lost to Follow-up|1|||
129541763|NCT00560573|466276153|FG005|Overall Study|Lost to Follow-up|0|||
129541764|NCT00560573|466276148|FG000|Overall Study|Withdrawal by Subject|0|||
129541765|NCT00560573|466276149|FG001|Overall Study|Withdrawal by Subject|0|||
129541766|NCT00560573|466276150|FG002|Overall Study|Withdrawal by Subject|0|||
129541767|NCT00560573|466276151|FG003|Overall Study|Withdrawal by Subject|1|||
129541768|NCT00560573|466276152|FG004|Overall Study|Withdrawal by Subject|1|||
129541769|NCT00560573|466276153|FG005|Overall Study|Withdrawal by Subject|0|||
129541770|NCT00560573|466276148|FG000|Overall Study|Other|2|||
129541771|NCT00560573|466276149|FG001|Overall Study|Other|2|||
129541772|NCT00560573|466276150|FG002|Overall Study|Other|2|||
129541773|NCT00560573|466276151|FG003|Overall Study|Other|3|||
129541774|NCT00560573|466276152|FG004|Overall Study|Other|3|||
129541775|NCT00560573|466276153|FG005|Overall Study|Other|3|||
129541776|NCT00560573|466276148|FG000|Overall Study|Enrolled, not treated|0|||
129541777|NCT00560573|466276149|FG001|Overall Study|Enrolled, not treated|0|||
129541778|NCT00560573|466276150|FG002|Overall Study|Enrolled, not treated|0|||
129541779|NCT00560573|466276151|FG003|Overall Study|Enrolled, not treated|0|||
129541780|NCT00560573|466276152|FG004|Overall Study|Enrolled, not treated|1|||
129541781|NCT00560573|466276153|FG005|Overall Study|Enrolled, not treated|0|||
129541782|NCT02674568|466276157|FG000|Overall Study|Withdrawal by Subject|5|||
129541783|NCT02674568|466276157|FG000|Overall Study|Death|303|||
129541784|NCT02674568|466276157|FG000|Overall Study|Physician Decision|2|||
129541785|NCT02674568|466276157|FG000|Overall Study|Lost to Follow-up|9|||
129541786|NCT02674568|466276157|FG000|Overall Study|Other, Not Specified|20|||
129541787|NCT00968539|466276158|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
129541788|NCT00968539|466276159|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
129541789|NCT00457249|466276160|FG000|Overall Study|Lost to Follow-up|3|||
129541790|NCT00457249|466276161|FG001|Overall Study|Lost to Follow-up|0|||
129541791|NCT00457249|466276160|FG000|Overall Study|Protocol Violation|4|||
129541792|NCT00457249|466276161|FG001|Overall Study|Protocol Violation|1|||
129541793|NCT00457249|466276160|FG000|Overall Study|Withdrawal by Subject|3|||
129541794|NCT00457249|466276161|FG001|Overall Study|Withdrawal by Subject|1|||
129541795|NCT00457249|466276160|FG000|Overall Study|Serious Adverse Events|2|||
129541796|NCT00457249|466276161|FG001|Overall Study|Serious Adverse Events|0|||
129541797|NCT00396318|466276162|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
129541798|NCT00326118|466276163|FG000|Active Phase|Withdrawal by Subject|4|||
129541799|NCT00326118|466276164|FG001|Active Phase|Withdrawal by Subject|1|||
129541800|NCT00938392|466276165|FG000|Overall Study|Adverse Event|0|||
129541801|NCT00938392|466276166|FG001|Overall Study|Adverse Event|1|||
129541802|NCT00938392|466276165|FG000|Overall Study|Withdrawal by Subject|0|||
129541803|NCT00938392|466276166|FG001|Overall Study|Withdrawal by Subject|1|||
129541804|NCT00938392|466276165|FG000|Overall Study|Lost to Follow-up|2|||
129541805|NCT00938392|466276166|FG001|Overall Study|Lost to Follow-up|2|||
129541806|NCT02916056|466276167|FG000|Overall Study|Adverse Event|6|||
129541807|NCT02916056|466276167|FG000|Overall Study|Lost to Follow-up|1|||
129541808|NCT02916056|466276167|FG000|Overall Study|Other|12|||
129541809|NCT02916056|466276167|FG000|Overall Study|Protocol Violation|1|||
129541810|NCT02916056|466276167|FG000|Overall Study|Withdrawal by Subject|8|||
129541811|NCT02916056|466276167|FG000|Overall Study|Study Terminated by Sponsor|269|||
129541812|NCT00290511|466276168|FG000|Overall Study|Adverse Event|1|||
129541813|NCT00290511|466276168|FG000|Overall Study|Death|1|||
129541814|NCT00290511|466276168|FG000|Overall Study|Physician Decision|1|||
129541815|NCT00290511|466276168|FG000|Overall Study|Withdrawal by Subject|1|||
129541816|NCT00124709|466276169|FG000|Overall Study|Randomized but did not take medication|3|||
129541817|NCT00124709|466276170|FG001|Overall Study|Randomized but did not take medication|1|||
129541818|NCT00124709|466276169|FG000|Overall Study|Adverse Event|3|||
129541819|NCT00124709|466276170|FG001|Overall Study|Adverse Event|0|||
129541820|NCT00124709|466276169|FG000|Overall Study|Lack of Efficacy|5|||
129541821|NCT00124709|466276170|FG001|Overall Study|Lack of Efficacy|10|||
129541822|NCT00124709|466276169|FG000|Overall Study|Protocol Violation|3|||
129541823|NCT00124709|466276170|FG001|Overall Study|Protocol Violation|5|||
129541824|NCT00124709|466276169|FG000|Overall Study|Withdrawal by Subject|127|||
129541825|NCT00124709|466276170|FG001|Overall Study|Withdrawal by Subject|136|||
129541826|NCT00124709|466276169|FG000|Overall Study|Lost to Follow-up|114|||
129541827|NCT00124709|466276170|FG001|Overall Study|Lost to Follow-up|120|||
129541828|NCT00122954|466276171|FG000|Overall Study|Withdrawal by Subject|2|||
129541829|NCT00122954|466276172|FG001|Overall Study|Withdrawal by Subject|2|||
129541830|NCT00122954|466276171|FG000|Overall Study|Protocol Violation|0|||
129541831|NCT00122954|466276172|FG001|Overall Study|Protocol Violation|1|||
129541832|NCT01728376|466276173|FG000|Overall Study|Adverse Event|1|||
129541833|NCT01728376|466276174|FG001|Overall Study|Adverse Event|1|||
129541834|NCT01728376|466276175|FG002|Overall Study|Adverse Event|1|||
129541835|NCT01728376|466276176|FG003|Overall Study|Adverse Event|1|||
129985702|NCT04811131|467909334|FG001|Overall Study|Lack of Efficacy|0|||
129541836|NCT01728376|466276177|FG004|Overall Study|Adverse Event|1|||
129541837|NCT01728376|466276178|FG005|Overall Study|Adverse Event|0|||
129541838|NCT01728376|466276173|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
129541839|NCT01728376|466276174|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
129541840|NCT01728376|466276175|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
129541841|NCT01728376|466276176|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
129764156|NCT02814916|467100312|FG001|Overall Study|Other, not specified|1|||
129764157|NCT02814916|467100313|FG002|Overall Study|Other, not specified|0|||
129875165|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Adverse Event|0|||
129875166|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Adverse Event|0|||
129875167|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Adverse Event|0|||
129875168|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Adverse Event|0|||
129875169|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Adverse Event|1|||
129875170|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Adverse Event|0|||
129875171|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Adverse Event|1|||
129875172|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Adverse Event|0|||
129875173|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Adverse Event|0|||
129875174|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875175|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875176|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875177|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
129875178|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
129875179|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
129875180|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875181|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875182|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875183|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
129875184|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Physician Decision|0|||
129875185|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Physician Decision|0|||
129875186|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Physician Decision|0|||
129875187|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Physician Decision|0|||
129875188|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Physician Decision|0|||
129875189|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Physician Decision|0|||
129875190|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Physician Decision|1|||
129875191|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Physician Decision|0|||
129875192|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Physician Decision|0|||
129875193|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Physician Decision|0|||
129875194|NCT05044325|467501837|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875195|NCT05044325|467501838|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875196|NCT05044325|467501839|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
129875197|NCT05044325|467501840|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875198|NCT05044325|467501841|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875199|NCT05044325|467501842|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875200|NCT05044325|467501843|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875201|NCT05044325|467501844|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875202|NCT05044325|467501845|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875203|NCT05044325|467501846|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
129875204|NCT05044325|467501837|FG000|Part A:Treatment Period 2|Adverse Event|0|||
129875205|NCT05044325|467501838|FG001|Part A:Treatment Period 2|Adverse Event|1|||
129875206|NCT05044325|467501839|FG002|Part A:Treatment Period 2|Adverse Event|0|||
129875207|NCT05044325|467501840|FG003|Part A:Treatment Period 2|Adverse Event|0|||
129875208|NCT05044325|467501841|FG004|Part A:Treatment Period 2|Adverse Event|1|||
129875209|NCT05044325|467501842|FG005|Part A:Treatment Period 2|Adverse Event|1|||
129875210|NCT05044325|467501843|FG006|Part A:Treatment Period 2|Adverse Event|0|||
129875211|NCT05044325|467501844|FG007|Part A:Treatment Period 2|Adverse Event|0|||
129875212|NCT05044325|467501845|FG008|Part A:Treatment Period 2|Adverse Event|0|||
129875213|NCT05044325|467501846|FG009|Part A:Treatment Period 2|Adverse Event|0|||
129875214|NCT05044325|467501837|FG000|Part A:Treatment Period 2|Physician Decision|0|||
129875215|NCT05044325|467501838|FG001|Part A:Treatment Period 2|Physician Decision|0|||
129875216|NCT05044325|467501839|FG002|Part A:Treatment Period 2|Physician Decision|0|||
129875217|NCT05044325|467501840|FG003|Part A:Treatment Period 2|Physician Decision|0|||
129875218|NCT05044325|467501841|FG004|Part A:Treatment Period 2|Physician Decision|0|||
129875219|NCT05044325|467501842|FG005|Part A:Treatment Period 2|Physician Decision|1|||
129875220|NCT05044325|467501843|FG006|Part A:Treatment Period 2|Physician Decision|0|||
129875221|NCT05044325|467501844|FG007|Part A:Treatment Period 2|Physician Decision|0|||
129875222|NCT05044325|467501845|FG008|Part A:Treatment Period 2|Physician Decision|0|||
129875223|NCT05044325|467501846|FG009|Part A:Treatment Period 2|Physician Decision|0|||
129875224|NCT05044325|467501837|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875225|NCT05044325|467501838|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875226|NCT05044325|467501839|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875227|NCT05044325|467501840|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
129875228|NCT05044325|467501841|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
129875229|NCT05044325|467501842|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875230|NCT05044325|467501843|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129764158|NCT01706458|467100321|FG000|Overall Study|Physician Decision|3|||
129443690|NCT02408861|465924490|FG003|Overall Study|Death|2|||
129443691|NCT02408861|465924491|FG004|Overall Study|Death|4|||
129443692|NCT02408861|465924492|FG005|Overall Study|Death|1|||
129443693|NCT02408861|465924493|FG006|Overall Study|Death|0|||
129443694|NCT02408861|465924487|FG000|Overall Study|Lost to Follow-up|0|||
129443695|NCT02408861|465924488|FG001|Overall Study|Lost to Follow-up|0|||
129443696|NCT02408861|465924489|FG002|Overall Study|Lost to Follow-up|1|||
129443697|NCT02408861|465924490|FG003|Overall Study|Lost to Follow-up|1|||
129443698|NCT02408861|465924491|FG004|Overall Study|Lost to Follow-up|4|||
129443699|NCT02408861|465924492|FG005|Overall Study|Lost to Follow-up|2|||
129443700|NCT02408861|465924493|FG006|Overall Study|Lost to Follow-up|1|||
129443701|NCT02408861|465924487|FG000|Overall Study|Disease Progression|0|||
129443702|NCT02408861|465924488|FG001|Overall Study|Disease Progression|0|||
129443703|NCT02408861|465924489|FG002|Overall Study|Disease Progression|1|||
129443704|NCT02408861|465924490|FG003|Overall Study|Disease Progression|0|||
129443705|NCT02408861|465924491|FG004|Overall Study|Disease Progression|3|||
129443706|NCT02408861|465924492|FG005|Overall Study|Disease Progression|1|||
129443707|NCT02408861|465924493|FG006|Overall Study|Disease Progression|1|||
129443708|NCT02408861|465924487|FG000|Overall Study|Adverse Event|1|||
129443709|NCT02408861|465924488|FG001|Overall Study|Adverse Event|0|||
129443710|NCT02408861|465924489|FG002|Overall Study|Adverse Event|1|||
129443711|NCT02408861|465924490|FG003|Overall Study|Adverse Event|0|||
129443712|NCT02408861|465924491|FG004|Overall Study|Adverse Event|2|||
129443713|NCT02408861|465924492|FG005|Overall Study|Adverse Event|0|||
129443714|NCT02408861|465924493|FG006|Overall Study|Adverse Event|0|||
129443715|NCT02408861|465924487|FG000|Overall Study|Physician Decision|1|||
129443716|NCT02408861|465924488|FG001|Overall Study|Physician Decision|1|||
129443717|NCT02408861|465924489|FG002|Overall Study|Physician Decision|1|||
129443718|NCT02408861|465924490|FG003|Overall Study|Physician Decision|0|||
129443719|NCT02408861|465924491|FG004|Overall Study|Physician Decision|0|||
129443720|NCT02408861|465924492|FG005|Overall Study|Physician Decision|1|||
129443721|NCT02408861|465924493|FG006|Overall Study|Physician Decision|0|||
129443722|NCT02408861|465924487|FG000|Overall Study|Protocol Violation|1|||
129443723|NCT02408861|465924488|FG001|Overall Study|Protocol Violation|0|||
129443724|NCT02408861|465924489|FG002|Overall Study|Protocol Violation|0|||
129443725|NCT02408861|465924490|FG003|Overall Study|Protocol Violation|0|||
129443726|NCT02408861|465924491|FG004|Overall Study|Protocol Violation|0|||
129443727|NCT02408861|465924492|FG005|Overall Study|Protocol Violation|0|||
129443728|NCT02408861|465924493|FG006|Overall Study|Protocol Violation|0|||
129443729|NCT02408861|465924487|FG000|Overall Study|Withdrawal by Subject|0|||
129443730|NCT02408861|465924488|FG001|Overall Study|Withdrawal by Subject|0|||
129443731|NCT02408861|465924489|FG002|Overall Study|Withdrawal by Subject|0|||
129443732|NCT02408861|465924490|FG003|Overall Study|Withdrawal by Subject|0|||
129443733|NCT02408861|465924491|FG004|Overall Study|Withdrawal by Subject|1|||
129443734|NCT02408861|465924492|FG005|Overall Study|Withdrawal by Subject|1|||
129443735|NCT02408861|465924493|FG006|Overall Study|Withdrawal by Subject|0|||
129443736|NCT02408861|465924487|FG000|Overall Study|Other Treatment|0|||
129443737|NCT02408861|465924488|FG001|Overall Study|Other Treatment|0|||
129443738|NCT02408861|465924489|FG002|Overall Study|Other Treatment|0|||
129443739|NCT02408861|465924490|FG003|Overall Study|Other Treatment|0|||
129443740|NCT02408861|465924491|FG004|Overall Study|Other Treatment|0|||
129443741|NCT02408861|465924492|FG005|Overall Study|Other Treatment|1|||
129443742|NCT02408861|465924493|FG006|Overall Study|Other Treatment|1|||
129443743|NCT05460273|465924494|FG000|Overall Study|Death|43|||
129443744|NCT05460273|465924495|FG001|Overall Study|Death|9|||
129443745|NCT05460273|465924494|FG000|Overall Study|Lost to Follow-up|7|||
129443746|NCT05460273|465924495|FG001|Overall Study|Lost to Follow-up|0|||
129443747|NCT05460273|465924494|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
129443748|NCT05460273|465924495|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
129443749|NCT04124614|465924496|FG000|Placebo Run-in Period|Not Randomized|34|||
129443750|NCT04124614|465924497|FG001|Placebo Run-in Period|Not Randomized|0|||
129443751|NCT04124614|465924498|FG002|Placebo Run-in Period|Not Randomized|0|||
129443752|NCT04124614|465924496|FG000|Double Blind Treatment Period|Adverse Event|0|||
129443753|NCT04124614|465924497|FG001|Double Blind Treatment Period|Adverse Event|7|||
129443754|NCT04124614|465924498|FG002|Double Blind Treatment Period|Adverse Event|22|||
129443755|NCT04124614|465924496|FG000|Double Blind Treatment Period|Death|0|||
129443756|NCT04124614|465924497|FG001|Double Blind Treatment Period|Death|0|||
129443757|NCT04124614|465924498|FG002|Double Blind Treatment Period|Death|1|||
129443758|NCT04124614|465924496|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
129443759|NCT04124614|465924497|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
129443760|NCT04124614|465924498|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
129443761|NCT04124614|465924496|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
129443762|NCT04124614|465924497|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
129443763|NCT04124614|465924498|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
129443764|NCT04124614|465924496|FG000|Double Blind Treatment Period|Physician Decision|0|||
129541842|NCT01728376|466276177|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
129541843|NCT01728376|466276178|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
129541844|NCT01728376|466276173|FG000|Overall Study|No relevant bacteria|2|||
129541845|NCT01728376|466276174|FG001|Overall Study|No relevant bacteria|0|||
129541846|NCT01728376|466276175|FG002|Overall Study|No relevant bacteria|0|||
129541847|NCT01728376|466276176|FG003|Overall Study|No relevant bacteria|0|||
129541848|NCT01728376|466276177|FG004|Overall Study|No relevant bacteria|1|||
129541849|NCT01728376|466276178|FG005|Overall Study|No relevant bacteria|1|||
129541850|NCT01728376|466276173|FG000|Overall Study|Did not receive treatment|0|||
129541851|NCT01728376|466276174|FG001|Overall Study|Did not receive treatment|1|||
129541852|NCT01728376|466276175|FG002|Overall Study|Did not receive treatment|0|||
129541853|NCT01728376|466276176|FG003|Overall Study|Did not receive treatment|0|||
129541854|NCT01728376|466276177|FG004|Overall Study|Did not receive treatment|0|||
129541855|NCT01728376|466276178|FG005|Overall Study|Did not receive treatment|0|||
129541856|NCT01728376|466276173|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
129541857|NCT01728376|466276174|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
129541858|NCT01728376|466276175|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
129541859|NCT01728376|466276176|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
129541860|NCT01728376|466276177|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
129541861|NCT01728376|466276178|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
129541862|NCT03526549|466276183|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
129541863|NCT03526549|466276184|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
129541864|NCT03526549|466276183|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
129541865|NCT03526549|466276184|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
129541866|NCT03526549|466276183|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
129541867|NCT03526549|466276184|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
129541868|NCT03526549|466276183|FG000|Open-label Phase|Adverse Event|4|||
129541869|NCT03526549|466276184|FG001|Open-label Phase|Adverse Event|0|||
129541870|NCT03526549|466276183|FG000|Open-label Phase|Withdrawal by Subject|54|||
129541871|NCT03526549|466276184|FG001|Open-label Phase|Withdrawal by Subject|0|||
129541872|NCT03526549|466276183|FG000|Open-label Phase|Lost to Follow-up|35|||
129541873|NCT03526549|466276184|FG001|Open-label Phase|Lost to Follow-up|0|||
129541874|NCT03526549|466276183|FG000|Open-label Phase|Other than Specified|5|||
129541875|NCT03526549|466276184|FG001|Open-label Phase|Other than Specified|0|||
129541876|NCT05981365|466276191|FG000|Period 1|Adverse Event|1|||
129541877|NCT05981365|466276192|FG001|Period 1|Adverse Event|0|||
129541878|NCT04780776|466276193|FG000|Titration Week 1-5|Lost to Follow-up|2|||
129541879|NCT04780776|466276194|FG001|Titration Week 1-5|Lost to Follow-up|8|||
129541880|NCT04780776|466276193|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
129541881|NCT04780776|466276194|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
129541882|NCT04780776|466276193|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
129541883|NCT04780776|466276194|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
129541884|NCT03113760|466276195|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
129541885|NCT03113760|466276196|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
129541886|NCT03113760|466276197|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
129541887|NCT03113760|466276198|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
129541888|NCT03113760|466276195|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
129541889|NCT03113760|466276196|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
129541890|NCT03113760|466276197|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
129541891|NCT03113760|466276198|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
129541892|NCT03113760|466276195|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
129541893|NCT03113760|466276196|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
129541894|NCT03113760|466276197|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
129541895|NCT03113760|466276198|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
129541896|NCT03927989|466276199|FG000|Overall Study|Withdrawal by Subject|0|||
129541897|NCT03927989|466276200|FG001|Overall Study|Withdrawal by Subject|1|||
129541898|NCT03480243|466276202|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
129541899|NCT03480243|466276202|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
129541900|NCT05770401|466276218|FG000|Overall Study|Lost to Follow-up|5|||
129541901|NCT05770401|466276219|FG001|Overall Study|Lost to Follow-up|4|||
129541902|NCT00402298|466276220|FG000|Overall Study|Withdrawal by Subject|1|||
129541903|NCT00402298|466276221|FG001|Overall Study|Withdrawal by Subject|0|||
129541904|NCT05048875|466276222|FG000|Overall Study|Withdrawal by Subject|1|||
129541905|NCT05048875|466276223|FG001|Overall Study|Withdrawal by Subject|0|||
129541906|NCT05048875|466276224|FG002|Overall Study|Withdrawal by Subject|0|||
129541907|NCT05048875|466276225|FG003|Overall Study|Withdrawal by Subject|0|||
129541908|NCT05048875|466276226|FG004|Overall Study|Withdrawal by Subject|0|||
129541909|NCT05048875|466276227|FG005|Overall Study|Withdrawal by Subject|0|||
129541910|NCT05048875|466276228|FG006|Overall Study|Withdrawal by Subject|0|||
129541911|NCT05048875|466276229|FG007|Overall Study|Withdrawal by Subject|0|||
129541912|NCT05048875|466276222|FG000|Overall Study|Adverse Event|0|||
129541913|NCT05048875|466276223|FG001|Overall Study|Adverse Event|0|||
129541914|NCT05048875|466276224|FG002|Overall Study|Adverse Event|0|||
129541915|NCT05048875|466276225|FG003|Overall Study|Adverse Event|1|||
129541916|NCT05048875|466276226|FG004|Overall Study|Adverse Event|0|||
129541917|NCT05048875|466276227|FG005|Overall Study|Adverse Event|0|||
129541918|NCT05048875|466276228|FG006|Overall Study|Adverse Event|0|||
129541919|NCT05048875|466276229|FG007|Overall Study|Adverse Event|0|||
129541920|NCT02255422|466276234|FG000|Overall Study|Withdrawal by Subject|0|||
129541921|NCT02255422|466276235|FG001|Overall Study|Withdrawal by Subject|0|||
129541922|NCT02255422|466276236|FG002|Overall Study|Withdrawal by Subject|0|||
129541923|NCT02255422|466276237|FG003|Overall Study|Withdrawal by Subject|0|||
129541924|NCT02255422|466276238|FG004|Overall Study|Withdrawal by Subject|0|||
129541925|NCT02255422|466276239|FG005|Overall Study|Withdrawal by Subject|0|||
129541926|NCT02255422|466276240|FG006|Overall Study|Withdrawal by Subject|2|||
129541927|NCT02255422|466276234|FG000|Overall Study|Lost to Follow-up|0|||
129541928|NCT02255422|466276235|FG001|Overall Study|Lost to Follow-up|0|||
129541929|NCT02255422|466276236|FG002|Overall Study|Lost to Follow-up|1|||
129541930|NCT02255422|466276237|FG003|Overall Study|Lost to Follow-up|0|||
129541931|NCT02255422|466276238|FG004|Overall Study|Lost to Follow-up|0|||
129541932|NCT02255422|466276239|FG005|Overall Study|Lost to Follow-up|0|||
129541933|NCT02255422|466276240|FG006|Overall Study|Lost to Follow-up|0|||
129541934|NCT00938366|466276241|FG000|Overall Study|Withdrawal by Subject|1|||
129541935|NCT00938366|466276242|FG001|Overall Study|Withdrawal by Subject|0|||
129541936|NCT01250418|466276249|FG000|Overall Study|monitor data failure|1|||
129541937|NCT01250418|466276250|FG001|Overall Study|monitor data failure|1|||
129541938|NCT01761565|466276251|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
129541939|NCT05182840|466276253|FG000|Run-in Period|Not treated|0|||
129541940|NCT05182840|466276254|FG001|Run-in Period|Not treated|1|||
129541941|NCT05182840|466276255|FG002|Run-in Period|Not treated|0|||
129541942|NCT05182840|466276256|FG003|Run-in Period|Not treated|0|||
129541943|NCT05182840|466276257|FG004|Run-in Period|Not treated|0|||
129541944|NCT05182840|466276258|FG005|Run-in Period|Not treated|0|||
129541945|NCT05182840|466276259|FG006|Run-in Period|Not treated|0|||
129541946|NCT05182840|466276260|FG007|Run-in Period|Not treated|0|||
129541947|NCT05182840|466276261|FG008|Run-in Period|Not treated|0|||
129541948|NCT05182840|466276262|FG009|Run-in Period|Not treated|0|||
129541949|NCT05182840|466276253|FG000|Run-in Period|Other reason but not sponsor termination|14|||
129541950|NCT05182840|466276254|FG001|Run-in Period|Other reason but not sponsor termination|18|||
129541951|NCT05182840|466276255|FG002|Run-in Period|Other reason but not sponsor termination|0|||
129541952|NCT05182840|466276256|FG003|Run-in Period|Other reason but not sponsor termination|0|||
129541953|NCT05182840|466276257|FG004|Run-in Period|Other reason but not sponsor termination|0|||
129541954|NCT05182840|466276258|FG005|Run-in Period|Other reason but not sponsor termination|0|||
129541955|NCT05182840|466276259|FG006|Run-in Period|Other reason but not sponsor termination|0|||
129541956|NCT05182840|466276260|FG007|Run-in Period|Other reason but not sponsor termination|0|||
129541957|NCT05182840|466276261|FG008|Run-in Period|Other reason but not sponsor termination|0|||
129541958|NCT05182840|466276262|FG009|Run-in Period|Other reason but not sponsor termination|0|||
129541959|NCT05182840|466276253|FG000|Run-in Period|No reason available|2|||
129541960|NCT05182840|466276254|FG001|Run-in Period|No reason available|2|||
129541961|NCT05182840|466276255|FG002|Run-in Period|No reason available|0|||
129541962|NCT05182840|466276256|FG003|Run-in Period|No reason available|0|||
129541963|NCT05182840|466276257|FG004|Run-in Period|No reason available|0|||
129541964|NCT05182840|466276258|FG005|Run-in Period|No reason available|0|||
129541965|NCT05182840|466276259|FG006|Run-in Period|No reason available|0|||
129541966|NCT05182840|466276260|FG007|Run-in Period|No reason available|0|||
129541967|NCT05182840|466276261|FG008|Run-in Period|No reason available|0|||
129541968|NCT05182840|466276262|FG009|Run-in Period|No reason available|0|||
129541969|NCT05182840|466276253|FG000|Run-in Period|Burden of study procedures|2|||
129541970|NCT05182840|466276254|FG001|Run-in Period|Burden of study procedures|2|||
129541971|NCT05182840|466276255|FG002|Run-in Period|Burden of study procedures|0|||
129541972|NCT05182840|466276256|FG003|Run-in Period|Burden of study procedures|0|||
129541973|NCT05182840|466276257|FG004|Run-in Period|Burden of study procedures|0|||
129541974|NCT05182840|466276258|FG005|Run-in Period|Burden of study procedures|0|||
129541975|NCT05182840|466276259|FG006|Run-in Period|Burden of study procedures|0|||
129541976|NCT05182840|466276260|FG007|Run-in Period|Burden of study procedures|0|||
129541977|NCT05182840|466276261|FG008|Run-in Period|Burden of study procedures|0|||
129541978|NCT05182840|466276262|FG009|Run-in Period|Burden of study procedures|0|||
129541979|NCT05182840|466276253|FG000|Run-in Period|Change of residence|1|||
129541980|NCT05182840|466276254|FG001|Run-in Period|Change of residence|0|||
129541981|NCT05182840|466276255|FG002|Run-in Period|Change of residence|0|||
129541982|NCT05182840|466276256|FG003|Run-in Period|Change of residence|0|||
129541983|NCT05182840|466276257|FG004|Run-in Period|Change of residence|0|||
129541984|NCT05182840|466276258|FG005|Run-in Period|Change of residence|0|||
129541985|NCT05182840|466276259|FG006|Run-in Period|Change of residence|0|||
129541986|NCT05182840|466276260|FG007|Run-in Period|Change of residence|0|||
129541987|NCT05182840|466276261|FG008|Run-in Period|Change of residence|0|||
129541988|NCT05182840|466276262|FG009|Run-in Period|Change of residence|0|||
129541989|NCT05182840|466276253|FG000|Run-in Period|Adverse Event|5|||
129541990|NCT05182840|466276254|FG001|Run-in Period|Adverse Event|5|||
129541991|NCT05182840|466276255|FG002|Run-in Period|Adverse Event|0|||
129541992|NCT05182840|466276256|FG003|Run-in Period|Adverse Event|0|||
129541993|NCT05182840|466276257|FG004|Run-in Period|Adverse Event|0|||
129541994|NCT05182840|466276258|FG005|Run-in Period|Adverse Event|0|||
129541995|NCT05182840|466276259|FG006|Run-in Period|Adverse Event|0|||
129541996|NCT05182840|466276260|FG007|Run-in Period|Adverse Event|0|||
129541997|NCT05182840|466276261|FG008|Run-in Period|Adverse Event|0|||
129541998|NCT05182840|466276262|FG009|Run-in Period|Adverse Event|0|||
129541999|NCT05182840|466276253|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
129542000|NCT05182840|466276254|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
129542001|NCT05182840|466276255|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542002|NCT05182840|466276256|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542003|NCT05182840|466276257|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542004|NCT05182840|466276258|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542005|NCT05182840|466276259|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542006|NCT05182840|466276260|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542007|NCT05182840|466276261|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542008|NCT05182840|466276262|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
129542009|NCT05182840|466276253|FG000|Treatment Period|Reason missing|0|||
129542010|NCT05182840|466276254|FG001|Treatment Period|Reason missing|0|||
129542011|NCT05182840|466276255|FG002|Treatment Period|Reason missing|1|||
129542012|NCT05182840|466276256|FG003|Treatment Period|Reason missing|0|||
129542013|NCT05182840|466276257|FG004|Treatment Period|Reason missing|0|||
129542014|NCT05182840|466276258|FG005|Treatment Period|Reason missing|0|||
129542015|NCT05182840|466276259|FG006|Treatment Period|Reason missing|0|||
129542016|NCT05182840|466276260|FG007|Treatment Period|Reason missing|0|||
129542017|NCT05182840|466276261|FG008|Treatment Period|Reason missing|0|||
129542018|NCT05182840|466276262|FG009|Treatment Period|Reason missing|0|||
129542019|NCT05182840|466276253|FG000|Treatment Period|Other but not sponsor termination|0|||
129542020|NCT05182840|466276254|FG001|Treatment Period|Other but not sponsor termination|0|||
129542021|NCT05182840|466276255|FG002|Treatment Period|Other but not sponsor termination|8|||
129542022|NCT05182840|466276256|FG003|Treatment Period|Other but not sponsor termination|6|||
129542023|NCT05182840|466276257|FG004|Treatment Period|Other but not sponsor termination|6|||
129542024|NCT05182840|466276258|FG005|Treatment Period|Other but not sponsor termination|7|||
129542025|NCT05182840|466276259|FG006|Treatment Period|Other but not sponsor termination|5|||
129542026|NCT05182840|466276260|FG007|Treatment Period|Other but not sponsor termination|8|||
129542027|NCT05182840|466276261|FG008|Treatment Period|Other but not sponsor termination|7|||
129542028|NCT05182840|466276262|FG009|Treatment Period|Other but not sponsor termination|2|||
129542029|NCT05182840|466276253|FG000|Treatment Period|Protocol deviation|0|||
129542030|NCT05182840|466276254|FG001|Treatment Period|Protocol deviation|0|||
129542031|NCT05182840|466276255|FG002|Treatment Period|Protocol deviation|0|||
129542032|NCT05182840|466276256|FG003|Treatment Period|Protocol deviation|0|||
129542033|NCT05182840|466276257|FG004|Treatment Period|Protocol deviation|0|||
129542034|NCT05182840|466276258|FG005|Treatment Period|Protocol deviation|0|||
129542035|NCT05182840|466276259|FG006|Treatment Period|Protocol deviation|0|||
129542036|NCT05182840|466276260|FG007|Treatment Period|Protocol deviation|0|||
129542037|NCT05182840|466276261|FG008|Treatment Period|Protocol deviation|1|||
129542038|NCT05182840|466276262|FG009|Treatment Period|Protocol deviation|0|||
129542039|NCT05182840|466276253|FG000|Treatment Period|No reason available|0|||
129542040|NCT05182840|466276254|FG001|Treatment Period|No reason available|0|||
129542041|NCT05182840|466276255|FG002|Treatment Period|No reason available|0|||
129542042|NCT05182840|466276256|FG003|Treatment Period|No reason available|1|||
129542043|NCT05182840|466276257|FG004|Treatment Period|No reason available|0|||
129542044|NCT05182840|466276258|FG005|Treatment Period|No reason available|2|||
129542045|NCT05182840|466276259|FG006|Treatment Period|No reason available|0|||
129542046|NCT05182840|466276260|FG007|Treatment Period|No reason available|1|||
129542047|NCT05182840|466276261|FG008|Treatment Period|No reason available|0|||
129542048|NCT05182840|466276262|FG009|Treatment Period|No reason available|0|||
129542049|NCT05182840|466276253|FG000|Treatment Period|Burden of study procedures|0|||
129542050|NCT05182840|466276254|FG001|Treatment Period|Burden of study procedures|0|||
129542051|NCT05182840|466276255|FG002|Treatment Period|Burden of study procedures|0|||
129542052|NCT05182840|466276256|FG003|Treatment Period|Burden of study procedures|0|||
129542053|NCT05182840|466276257|FG004|Treatment Period|Burden of study procedures|1|||
129542054|NCT05182840|466276258|FG005|Treatment Period|Burden of study procedures|0|||
129542055|NCT05182840|466276259|FG006|Treatment Period|Burden of study procedures|0|||
129542056|NCT05182840|466276260|FG007|Treatment Period|Burden of study procedures|0|||
129542057|NCT05182840|466276261|FG008|Treatment Period|Burden of study procedures|0|||
129542058|NCT05182840|466276262|FG009|Treatment Period|Burden of study procedures|0|||
129542059|NCT05182840|466276253|FG000|Treatment Period|Change of residence|0|||
129542060|NCT05182840|466276254|FG001|Treatment Period|Change of residence|0|||
129542061|NCT05182840|466276255|FG002|Treatment Period|Change of residence|0|||
129542062|NCT05182840|466276256|FG003|Treatment Period|Change of residence|0|||
129542063|NCT05182840|466276257|FG004|Treatment Period|Change of residence|0|||
129542064|NCT05182840|466276258|FG005|Treatment Period|Change of residence|1|||
129542065|NCT05182840|466276259|FG006|Treatment Period|Change of residence|0|||
129542066|NCT05182840|466276260|FG007|Treatment Period|Change of residence|0|||
129542067|NCT05182840|466276261|FG008|Treatment Period|Change of residence|0|||
129542068|NCT05182840|466276262|FG009|Treatment Period|Change of residence|0|||
129542069|NCT05182840|466276253|FG000|Treatment Period|Adverse Event|0|||
129542070|NCT05182840|466276254|FG001|Treatment Period|Adverse Event|0|||
129542071|NCT05182840|466276255|FG002|Treatment Period|Adverse Event|4|||
129542072|NCT05182840|466276256|FG003|Treatment Period|Adverse Event|16|||
129542073|NCT05182840|466276257|FG004|Treatment Period|Adverse Event|12|||
129542074|NCT05182840|466276258|FG005|Treatment Period|Adverse Event|6|||
129542075|NCT05182840|466276259|FG006|Treatment Period|Adverse Event|4|||
129542076|NCT05182840|466276260|FG007|Treatment Period|Adverse Event|8|||
129542077|NCT05182840|466276261|FG008|Treatment Period|Adverse Event|16|||
129542078|NCT05182840|466276262|FG009|Treatment Period|Adverse Event|5|||
129542079|NCT05182840|466276253|FG000|Treatment Period|Not treated with study drug|0|||
129542080|NCT05182840|466276254|FG001|Treatment Period|Not treated with study drug|0|||
129542081|NCT05182840|466276255|FG002|Treatment Period|Not treated with study drug|0|||
129542082|NCT05182840|466276256|FG003|Treatment Period|Not treated with study drug|1|||
129542083|NCT05182840|466276257|FG004|Treatment Period|Not treated with study drug|0|||
129542084|NCT05182840|466276258|FG005|Treatment Period|Not treated with study drug|0|||
129542085|NCT05182840|466276259|FG006|Treatment Period|Not treated with study drug|1|||
129542086|NCT05182840|466276260|FG007|Treatment Period|Not treated with study drug|1|||
129542087|NCT05182840|466276261|FG008|Treatment Period|Not treated with study drug|0|||
129542088|NCT05182840|466276262|FG009|Treatment Period|Not treated with study drug|0|||
129542089|NCT02161380|466276263|FG000|Overall Study|Lost to Follow-up|0|||
129542090|NCT02161380|466276264|FG001|Overall Study|Lost to Follow-up|1|||
129542091|NCT02161380|466276265|FG002|Overall Study|Lost to Follow-up|0|||
129542092|NCT02161380|466276266|FG003|Overall Study|Lost to Follow-up|0|||
129542093|NCT02268214|466276273|FG000|Overall Study|Subject no longer meets study criteria|0|||
129542094|NCT02268214|466276274|FG001|Overall Study|Subject no longer meets study criteria|2|||
129542095|NCT02268214|466276275|FG002|Overall Study|Subject no longer meets study criteria|0|||
129542096|NCT02268214|466276273|FG000|Overall Study|Pregnancy|2|||
129542097|NCT02268214|466276274|FG001|Overall Study|Pregnancy|2|||
129542098|NCT02268214|466276275|FG002|Overall Study|Pregnancy|1|||
129542099|NCT02268214|466276273|FG000|Overall Study|Lost to Follow-up|3|||
129542100|NCT02268214|466276274|FG001|Overall Study|Lost to Follow-up|3|||
129542101|NCT02268214|466276275|FG002|Overall Study|Lost to Follow-up|4|||
129542102|NCT02268214|466276273|FG000|Overall Study|Lack of Efficacy|1|||
129542103|NCT02268214|466276274|FG001|Overall Study|Lack of Efficacy|0|||
129542104|NCT02268214|466276275|FG002|Overall Study|Lack of Efficacy|2|||
129542105|NCT02268214|466276273|FG000|Overall Study|Adverse Event|11|||
129542106|NCT02268214|466276274|FG001|Overall Study|Adverse Event|14|||
129542107|NCT02268214|466276275|FG002|Overall Study|Adverse Event|9|||
129542108|NCT02268214|466276273|FG000|Overall Study|Withdrawal by Subject|4|||
129542109|NCT02268214|466276274|FG001|Overall Study|Withdrawal by Subject|5|||
129542110|NCT02268214|466276275|FG002|Overall Study|Withdrawal by Subject|10|||
129542111|NCT02268214|466276273|FG000|Overall Study|Subject request to discontinue treatment|10|||
129542112|NCT02268214|466276274|FG001|Overall Study|Subject request to discontinue treatment|8|||
129542113|NCT02268214|466276275|FG002|Overall Study|Subject request to discontinue treatment|6|||
129542114|NCT02268214|466276273|FG000|Overall Study|Poor/non-compliance|2|||
129542115|NCT02268214|466276274|FG001|Overall Study|Poor/non-compliance|1|||
129542116|NCT02268214|466276275|FG002|Overall Study|Poor/non-compliance|2|||
129542117|NCT02268214|466276273|FG000|Overall Study|Other reasons|7|||
129542118|NCT02268214|466276274|FG001|Overall Study|Other reasons|3|||
129542119|NCT02268214|466276275|FG002|Overall Study|Other reasons|3|||
129542120|NCT02268214|466276273|FG000|Overall Study|Not entering long-term period|2|||
129542121|NCT02268214|466276274|FG001|Overall Study|Not entering long-term period|3|||
129542122|NCT02268214|466276275|FG002|Overall Study|Not entering long-term period|5|||
129542123|NCT04342390|466276276|FG000|Overall Study|Lost to Follow-up|3|||
129542124|NCT04342390|466276277|FG001|Overall Study|Lost to Follow-up|0|||
129542125|NCT01083121|466276289|FG000|Overall Study|Use of Humira outside the approved label|81|||
129542126|NCT05403502|466276290|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
129542127|NCT05403502|466276290|FG000|Humalog Lead-In Period|Physician Decision|2|||
129542128|NCT05403502|466276290|FG000|Humalog Lead-In Period|Protocol Violation|1|||
129542129|NCT05403502|466276290|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
129542130|NCT05403502|466276290|FG000|Lyumjev Treatment Period|Physician Decision|2|||
129542131|NCT01054443|466276291|FG000|Overall Study|Withdrawal by Subject|0|||
129542132|NCT01054443|466276292|FG001|Overall Study|Withdrawal by Subject|0|||
129542133|NCT01054443|466276293|FG002|Overall Study|Withdrawal by Subject|0|||
129542134|NCT01054443|466276294|FG003|Overall Study|Withdrawal by Subject|1|||
129542135|NCT00985114|466276295|FG000|Overall Study|Adverse Event|1|||
129542136|NCT00985114|466276296|FG001|Overall Study|Adverse Event|0|||
129542137|NCT00985114|466276295|FG000|Overall Study|Withdrawal by Subject|0|||
129542138|NCT00985114|466276296|FG001|Overall Study|Withdrawal by Subject|2|||
129542139|NCT01119118|466276297|FG000|Overall Study|Adverse Event|1|||
129542140|NCT01593761|466276301|FG000|Overall Study|Lost to Follow-up|1|||
129542141|NCT01593761|466276301|FG000|Overall Study|culture negative for MRSA at baseline|5|||
129542142|NCT01593761|466276301|FG000|Overall Study|positive for hepatitis C virus|1|||
129542143|NCT01593761|466276301|FG000|Overall Study|secondary cellulitis|1|||
129542144|NCT01300741|466278698|FG000|Overall Study|Lens deposits|1|||
129542145|NCT01300741|466278698|FG000|Overall Study|Lost to Follow-up|1|||
129542146|NCT01300741|466278698|FG000|Overall Study|Discomfort|1|||
129542147|NCT01339273|466278699|FG000|Overall Study|Lost to Follow-up|8|||
129542148|NCT01339273|466278700|FG001|Overall Study|Lost to Follow-up|8|||
129542149|NCT00726882|466278701|FG000|Overall Study|Withdrawal by Subject|5|||
129542150|NCT00726882|466278701|FG000|Overall Study|Lost to Follow-up|7|||
129542151|NCT00726882|466278701|FG000|Overall Study|Other|10|||
129542152|NCT02526017|466278702|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542153|NCT02526017|466278703|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542154|NCT02526017|466278704|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542155|NCT02526017|466278705|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542156|NCT02526017|466278706|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
129542157|NCT02526017|466278707|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542158|NCT02526017|466278708|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542159|NCT02526017|466278709|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542160|NCT02526017|466278710|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
129542161|NCT04341727|466278719|FG000|Overall Study|Withdrawal by Subject|0|||
129542162|NCT04341727|466278720|FG001|Overall Study|Withdrawal by Subject|0|||
129542163|NCT04341727|466278721|FG002|Overall Study|Withdrawal by Subject|1|||
129542164|NCT04341727|466278722|FG003|Overall Study|Withdrawal by Subject|0|||
129542165|NCT04341727|466278719|FG000|Overall Study|Lost to Follow-up|0|||
129542166|NCT04341727|466278720|FG001|Overall Study|Lost to Follow-up|0|||
129542167|NCT04341727|466278721|FG002|Overall Study|Lost to Follow-up|0|||
129542168|NCT04341727|466278722|FG003|Overall Study|Lost to Follow-up|1|||
129542169|NCT05604521|466278723|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
129542170|NCT05604521|466278724|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
129542171|NCT05604521|466278723|FG000|Overall Study|Adverse Event|1|||
129542172|NCT05604521|466278724|FG001|Overall Study|Adverse Event|0|||
129542173|NCT01491737|466278730|FG000|Overall Study|Withdrawal by Subject|20|||
129542174|NCT01491737|466278731|FG001|Overall Study|Withdrawal by Subject|17|||
129542175|NCT01491737|466278730|FG000|Overall Study|Lost to Follow-up|2|||
129542176|NCT01491737|466278731|FG001|Overall Study|Lost to Follow-up|10|||
129542177|NCT01491737|466278730|FG000|Overall Study|Death|63|||
129542178|NCT01491737|466278731|FG001|Overall Study|Death|57|||
129542179|NCT01491737|466278730|FG000|Overall Study|Study Termination by Sponsor|36|||
129542180|NCT01491737|466278731|FG001|Overall Study|Study Termination by Sponsor|36|||
129542181|NCT01491737|466278730|FG000|Overall Study|Reason Not Specified|8|||
129542182|NCT01491737|466278731|FG001|Overall Study|Reason Not Specified|9|||
129542183|NCT01976663|466278732|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
129542184|NCT01976663|466278732|FG000|Overall Study|Personal Reasons|6|||
129542185|NCT01976663|466278732|FG000|Overall Study|Withdrawal by Subject|4|||
129542186|NCT01976663|466278732|FG000|Overall Study|Screen Failure|3|||
129542187|NCT01976663|466278732|FG000|Overall Study|Adverse Event|2|||
129542188|NCT01976663|466278732|FG000|Overall Study|Lost to Follow-up|3|||
129542189|NCT01817764|466278733|FG000|Overall Study|Adverse Event|7|||
129542190|NCT01817764|466278734|FG001|Overall Study|Adverse Event|10|||
129542191|NCT01817764|466278733|FG000|Overall Study|Lack of Efficacy|9|||
129542192|NCT01817764|466278734|FG001|Overall Study|Lack of Efficacy|7|||
129542193|NCT01817764|466278733|FG000|Overall Study|Protocol Violation|7|||
129542194|NCT01817764|466278734|FG001|Overall Study|Protocol Violation|5|||
129542195|NCT01817764|466278733|FG000|Overall Study|Lost to Follow-up|1|||
129542196|NCT01817764|466278734|FG001|Overall Study|Lost to Follow-up|4|||
129542197|NCT01817764|466278733|FG000|Overall Study|Withdrawal by Subject|10|||
129542198|NCT01817764|466278734|FG001|Overall Study|Withdrawal by Subject|12|||
129542199|NCT04888377|466278735|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
129542200|NCT04888377|466278736|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
129542201|NCT04888377|466278735|FG000|Overall Study|Physician Decision|6|||
129542202|NCT04888377|466278736|FG001|Overall Study|Physician Decision|6|||
129542203|NCT04888377|466278735|FG000|Overall Study|Withdrawal by Subject|7|||
129542204|NCT04888377|466278736|FG001|Overall Study|Withdrawal by Subject|3|||
129542205|NCT00526162|466278737|FG000|Overall Study|Device not implanted|3|||
129542206|NCT05279807|466278738|FG000|Overall Study|Withdrawal by Subject|1|||
129542207|NCT05279807|466278739|FG001|Overall Study|Withdrawal by Subject|0|||
129542208|NCT05279807|466278738|FG000|Overall Study|Adverse Event|0|||
129542209|NCT05279807|466278739|FG001|Overall Study|Adverse Event|1|||
129542210|NCT05279807|466278738|FG000|Overall Study|Laboratory Abnormal Results|1|||
129542211|NCT05279807|466278739|FG001|Overall Study|Laboratory Abnormal Results|0|||
129542212|NCT05993299|466278740|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
129542213|NCT05993299|466278740|FG000|Overall Study|Ongoing|4|||
129542214|NCT03110107|466278741|FG000|Treatment Period|Disease Progression|3|||
129542215|NCT03110107|466278742|FG001|Treatment Period|Disease Progression|9|||
129542216|NCT03110107|466278743|FG002|Treatment Period|Disease Progression|8|||
129542217|NCT03110107|466278744|FG003|Treatment Period|Disease Progression|11|||
129542218|NCT03110107|466278745|FG004|Treatment Period|Disease Progression|8|||
129542219|NCT03110107|466278746|FG005|Treatment Period|Disease Progression|4|||
129542220|NCT03110107|466278747|FG006|Treatment Period|Disease Progression|6|||
129542221|NCT03110107|466278748|FG007|Treatment Period|Disease Progression|7|||
129542222|NCT03110107|466278749|FG008|Treatment Period|Disease Progression|2|||
129542223|NCT03110107|466278750|FG009|Treatment Period|Disease Progression|10|||
129542224|NCT03110107|466278751|FG010|Treatment Period|Disease Progression|5|||
129542225|NCT03110107|466278752|FG011|Treatment Period|Disease Progression|2|||
129542226|NCT03110107|466278753|FG012|Treatment Period|Disease Progression|0|||
129542227|NCT03110107|466278754|FG013|Treatment Period|Disease Progression|5|||
129542228|NCT03110107|466278755|FG014|Treatment Period|Disease Progression|14|||
129542229|NCT03110107|466278756|FG015|Treatment Period|Disease Progression|14|||
129542230|NCT03110107|466278757|FG016|Treatment Period|Disease Progression|4|||
129542231|NCT03110107|466278758|FG017|Treatment Period|Disease Progression|3|||
129542232|NCT03110107|466278759|FG018|Treatment Period|Disease Progression|16|||
129542233|NCT03110107|466278760|FG019|Treatment Period|Disease Progression|14|||
129542234|NCT03110107|466278761|FG020|Treatment Period|Disease Progression|12|||
129542235|NCT03110107|466278762|FG021|Treatment Period|Disease Progression|16|||
129542236|NCT03110107|466278763|FG022|Treatment Period|Disease Progression|18|||
129542237|NCT03110107|466278764|FG023|Treatment Period|Disease Progression|13|||
129542238|NCT03110107|466278765|FG024|Treatment Period|Disease Progression|16|||
129542239|NCT03110107|466278766|FG025|Treatment Period|Disease Progression|31|||
129542240|NCT03110107|466278741|FG000|Treatment Period|Study drug toxicity|1|||
129542241|NCT03110107|466278742|FG001|Treatment Period|Study drug toxicity|0|||
129542242|NCT03110107|466278743|FG002|Treatment Period|Study drug toxicity|1|||
129542243|NCT03110107|466278744|FG003|Treatment Period|Study drug toxicity|2|||
129542244|NCT03110107|466278745|FG004|Treatment Period|Study drug toxicity|0|||
129542245|NCT03110107|466278746|FG005|Treatment Period|Study drug toxicity|3|||
129542246|NCT03110107|466278747|FG006|Treatment Period|Study drug toxicity|1|||
129542247|NCT03110107|466278748|FG007|Treatment Period|Study drug toxicity|1|||
129764159|NCT01706458|467100322|FG001|Overall Study|Physician Decision|4|||
129875231|NCT05044325|467501844|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875232|NCT05044325|467501845|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875233|NCT05044325|467501846|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
129875234|NCT00755222|467501847|FG000|Overall Study|Withdrawal by Subject|4|||
129875235|NCT00755222|467501848|FG001|Overall Study|Withdrawal by Subject|2|||
129875236|NCT00755222|467501847|FG000|Overall Study|Adverse Event|2|||
129875237|NCT00755222|467501848|FG001|Overall Study|Adverse Event|0|||
129875238|NCT00755222|467501847|FG000|Overall Study|Protocol Violation|2|||
129875239|NCT00755222|467501848|FG001|Overall Study|Protocol Violation|0|||
129875240|NCT02243202|467501849|FG000|Overall Study|Adverse Event|5|||
129875241|NCT02243202|467501850|FG001|Overall Study|Adverse Event|6|||
129875242|NCT02243202|467501851|FG002|Overall Study|Adverse Event|10|||
129875243|NCT02243202|467501852|FG003|Overall Study|Adverse Event|4|||
129875244|NCT02243202|467501849|FG000|Overall Study|Lost to Follow-up|9|||
129875245|NCT02243202|467501850|FG001|Overall Study|Lost to Follow-up|9|||
129875246|NCT02243202|467501851|FG002|Overall Study|Lost to Follow-up|14|||
129875247|NCT02243202|467501852|FG003|Overall Study|Lost to Follow-up|11|||
129875248|NCT02243202|467501849|FG000|Overall Study|Protocol Violation|3|||
129875249|NCT02243202|467501850|FG001|Overall Study|Protocol Violation|1|||
129875250|NCT02243202|467501851|FG002|Overall Study|Protocol Violation|2|||
129875251|NCT02243202|467501852|FG003|Overall Study|Protocol Violation|1|||
129875252|NCT02243202|467501849|FG000|Overall Study|Withdrawal by Subject|7|||
129875253|NCT02243202|467501850|FG001|Overall Study|Withdrawal by Subject|6|||
129875254|NCT02243202|467501851|FG002|Overall Study|Withdrawal by Subject|4|||
129875255|NCT02243202|467501852|FG003|Overall Study|Withdrawal by Subject|4|||
129875256|NCT02243202|467501849|FG000|Overall Study|Other|1|||
129875257|NCT02243202|467501850|FG001|Overall Study|Other|3|||
129875258|NCT02243202|467501851|FG002|Overall Study|Other|1|||
129875259|NCT02243202|467501852|FG003|Overall Study|Other|2|||
129875260|NCT02243202|467501849|FG000|Overall Study|Randomized but not received treatment|0|||
129875261|NCT02243202|467501850|FG001|Overall Study|Randomized but not received treatment|0|||
129875262|NCT02243202|467501851|FG002|Overall Study|Randomized but not received treatment|0|||
129875263|NCT02243202|467501852|FG003|Overall Study|Randomized but not received treatment|1|||
129875264|NCT02013388|467501859|FG000|Overall Study|work emergency|1|||
129875265|NCT02013388|467501860|FG001|Overall Study|work emergency|0|||
129875266|NCT02013388|467501861|FG002|Overall Study|work emergency|0|||
129875267|NCT02013388|467501862|FG003|Overall Study|work emergency|0|||
129875268|NCT02013388|467501863|FG004|Overall Study|work emergency|1|||
129875269|NCT02013388|467501864|FG005|Overall Study|work emergency|0|||
129875270|NCT02013388|467501865|FG006|Overall Study|work emergency|0|||
129875271|NCT02013388|467501866|FG007|Overall Study|work emergency|0|||
129875272|NCT04207840|467501867|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
129875273|NCT04207840|467501868|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
129875274|NCT04207840|467501869|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
129875275|NCT04207840|467501867|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
129875276|NCT04207840|467501868|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
129875277|NCT04207840|467501869|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
129875278|NCT03243422|467501870|FG000|Overall Study|Death|20|||
129875279|NCT03243422|467501871|FG001|Overall Study|Death|21|||
129875280|NCT03243422|467501870|FG000|Overall Study|Lost to Follow-up|9|||
129875281|NCT03243422|467501871|FG001|Overall Study|Lost to Follow-up|21|||
129875282|NCT03243422|467501870|FG000|Overall Study|Withdrawal by Subject|22|||
129875283|NCT03243422|467501871|FG001|Overall Study|Withdrawal by Subject|8|||
129875284|NCT02173054|467501872|FG000|Overall Study|lack of compliance|1|||
129875285|NCT02173054|467501873|FG001|Overall Study|lack of compliance|0|||
129875286|NCT02173054|467501874|FG002|Overall Study|lack of compliance|0|||
129875287|NCT02173054|467501872|FG000|Overall Study|Withdrawal by Subject|0|||
129875288|NCT02173054|467501873|FG001|Overall Study|Withdrawal by Subject|0|||
129875289|NCT02173054|467501874|FG002|Overall Study|Withdrawal by Subject|1|||
129875290|NCT00991341|467501881|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
129875291|NCT00991341|467501882|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
129875292|NCT00991341|467501881|FG000|Overall Study|Death|3|||
129875293|NCT00991341|467501882|FG001|Overall Study|Death|0|||
129875294|NCT00991341|467501881|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
129875295|NCT00991341|467501882|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
129875296|NCT00991341|467501881|FG000|Overall Study|Physician Decision|1|||
129875297|NCT00991341|467501882|FG001|Overall Study|Physician Decision|2|||
129875298|NCT00991341|467501881|FG000|Overall Study|Withdrawal by Subject|3|||
129985703|NCT04811131|467909335|FG002|Overall Study|Lack of Efficacy|0|||
129985704|NCT04811131|467909336|FG003|Overall Study|Lack of Efficacy|1|||
129985705|NCT04811131|467909333|FG000|Overall Study|Lost to Follow-up|0|||
129985706|NCT04811131|467909334|FG001|Overall Study|Lost to Follow-up|1|||
129985707|NCT04811131|467909335|FG002|Overall Study|Lost to Follow-up|0|||
129985708|NCT04811131|467909336|FG003|Overall Study|Lost to Follow-up|0|||
129985709|NCT04811131|467909333|FG000|Overall Study|Sponsor request|31|||
129985710|NCT04811131|467909334|FG001|Overall Study|Sponsor request|35|||
129985711|NCT04811131|467909335|FG002|Overall Study|Sponsor request|27|||
129542248|NCT03110107|466278749|FG008|Treatment Period|Study drug toxicity|3|||
129542249|NCT03110107|466278750|FG009|Treatment Period|Study drug toxicity|2|||
129542250|NCT03110107|466278751|FG010|Treatment Period|Study drug toxicity|0|||
129542251|NCT03110107|466278752|FG011|Treatment Period|Study drug toxicity|2|||
129542252|NCT03110107|466278753|FG012|Treatment Period|Study drug toxicity|0|||
129542253|NCT03110107|466278754|FG013|Treatment Period|Study drug toxicity|0|||
129542254|NCT03110107|466278755|FG014|Treatment Period|Study drug toxicity|2|||
129542255|NCT03110107|466278756|FG015|Treatment Period|Study drug toxicity|3|||
129542256|NCT03110107|466278757|FG016|Treatment Period|Study drug toxicity|3|||
129542257|NCT03110107|466278758|FG017|Treatment Period|Study drug toxicity|3|||
129542258|NCT03110107|466278759|FG018|Treatment Period|Study drug toxicity|1|||
129542259|NCT03110107|466278760|FG019|Treatment Period|Study drug toxicity|2|||
129542260|NCT03110107|466278761|FG020|Treatment Period|Study drug toxicity|2|||
129542261|NCT03110107|466278762|FG021|Treatment Period|Study drug toxicity|0|||
129542262|NCT03110107|466278763|FG022|Treatment Period|Study drug toxicity|2|||
129542263|NCT03110107|466278764|FG023|Treatment Period|Study drug toxicity|6|||
129542264|NCT03110107|466278765|FG024|Treatment Period|Study drug toxicity|7|||
129542265|NCT03110107|466278766|FG025|Treatment Period|Study drug toxicity|6|||
129542266|NCT03110107|466278741|FG000|Treatment Period|Death|0|||
129542267|NCT03110107|466278742|FG001|Treatment Period|Death|0|||
129542268|NCT03110107|466278743|FG002|Treatment Period|Death|0|||
129542269|NCT03110107|466278744|FG003|Treatment Period|Death|0|||
129542270|NCT03110107|466278745|FG004|Treatment Period|Death|0|||
129542271|NCT03110107|466278746|FG005|Treatment Period|Death|0|||
129542272|NCT03110107|466278747|FG006|Treatment Period|Death|0|||
129542273|NCT03110107|466278748|FG007|Treatment Period|Death|0|||
129542274|NCT03110107|466278749|FG008|Treatment Period|Death|0|||
129542275|NCT03110107|466278750|FG009|Treatment Period|Death|0|||
129542276|NCT03110107|466278751|FG010|Treatment Period|Death|0|||
129542277|NCT03110107|466278752|FG011|Treatment Period|Death|0|||
129542278|NCT03110107|466278753|FG012|Treatment Period|Death|1|||
129542279|NCT03110107|466278754|FG013|Treatment Period|Death|0|||
129542280|NCT03110107|466278755|FG014|Treatment Period|Death|0|||
129542281|NCT03110107|466278756|FG015|Treatment Period|Death|0|||
129542282|NCT03110107|466278757|FG016|Treatment Period|Death|0|||
129542283|NCT03110107|466278758|FG017|Treatment Period|Death|0|||
129542284|NCT03110107|466278759|FG018|Treatment Period|Death|0|||
129542285|NCT03110107|466278760|FG019|Treatment Period|Death|0|||
129542286|NCT03110107|466278761|FG020|Treatment Period|Death|0|||
129542287|NCT03110107|466278762|FG021|Treatment Period|Death|0|||
129542288|NCT03110107|466278763|FG022|Treatment Period|Death|0|||
129542289|NCT03110107|466278764|FG023|Treatment Period|Death|0|||
129542290|NCT03110107|466278765|FG024|Treatment Period|Death|0|||
129542291|NCT03110107|466278766|FG025|Treatment Period|Death|0|||
129542292|NCT03110107|466278741|FG000|Treatment Period|Adverse Event|0|||
129542293|NCT03110107|466278742|FG001|Treatment Period|Adverse Event|0|||
129542294|NCT03110107|466278743|FG002|Treatment Period|Adverse Event|1|||
129542295|NCT03110107|466278744|FG003|Treatment Period|Adverse Event|0|||
129542296|NCT03110107|466278745|FG004|Treatment Period|Adverse Event|0|||
129542297|NCT03110107|466278746|FG005|Treatment Period|Adverse Event|2|||
129542298|NCT03110107|466278747|FG006|Treatment Period|Adverse Event|0|||
129542299|NCT03110107|466278748|FG007|Treatment Period|Adverse Event|2|||
129542300|NCT03110107|466278749|FG008|Treatment Period|Adverse Event|0|||
129542301|NCT03110107|466278750|FG009|Treatment Period|Adverse Event|1|||
129542302|NCT03110107|466278751|FG010|Treatment Period|Adverse Event|0|||
129542303|NCT03110107|466278752|FG011|Treatment Period|Adverse Event|0|||
129542304|NCT03110107|466278753|FG012|Treatment Period|Adverse Event|0|||
129542305|NCT03110107|466278754|FG013|Treatment Period|Adverse Event|0|||
129542306|NCT03110107|466278755|FG014|Treatment Period|Adverse Event|0|||
129542307|NCT03110107|466278756|FG015|Treatment Period|Adverse Event|2|||
129542308|NCT03110107|466278757|FG016|Treatment Period|Adverse Event|0|||
129542309|NCT03110107|466278758|FG017|Treatment Period|Adverse Event|1|||
129542310|NCT03110107|466278759|FG018|Treatment Period|Adverse Event|2|||
129542311|NCT03110107|466278760|FG019|Treatment Period|Adverse Event|1|||
129542312|NCT03110107|466278761|FG020|Treatment Period|Adverse Event|4|||
129542313|NCT03110107|466278762|FG021|Treatment Period|Adverse Event|2|||
129542314|NCT03110107|466278763|FG022|Treatment Period|Adverse Event|2|||
129542315|NCT03110107|466278764|FG023|Treatment Period|Adverse Event|2|||
129542316|NCT03110107|466278765|FG024|Treatment Period|Adverse Event|2|||
129542317|NCT03110107|466278766|FG025|Treatment Period|Adverse Event|4|||
129542318|NCT03110107|466278741|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
129651247|NCT03605849|466679596|FG000|Overall Study|Withdrawal by Subject|33|||
129542319|NCT03110107|466278742|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
129542320|NCT03110107|466278743|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
129651248|NCT03605849|466679597|FG001|Overall Study|Withdrawal by Subject|28|||
129542321|NCT03110107|466278744|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
129542322|NCT03110107|466278745|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
129542323|NCT03110107|466278746|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
129651249|NCT03605849|466679598|FG002|Overall Study|Withdrawal by Subject|30|||
129542324|NCT03110107|466278747|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
129542325|NCT03110107|466278748|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
129542326|NCT03110107|466278749|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
129542327|NCT03110107|466278750|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
129542328|NCT03110107|466278751|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
129542329|NCT03110107|466278752|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
129542330|NCT03110107|466278753|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
129542331|NCT03110107|466278754|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
129542332|NCT03110107|466278755|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
129542333|NCT03110107|466278756|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
129542334|NCT03110107|466278757|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
129542335|NCT03110107|466278758|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
129542336|NCT03110107|466278759|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
129542337|NCT03110107|466278760|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
129542338|NCT03110107|466278761|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
129542339|NCT03110107|466278762|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
129542340|NCT03110107|466278763|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
129542341|NCT03110107|466278764|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
129542342|NCT03110107|466278765|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
129542343|NCT03110107|466278766|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
129542344|NCT03110107|466278741|FG000|Treatment Period|Participant withdrew consent|0|||
129542345|NCT03110107|466278742|FG001|Treatment Period|Participant withdrew consent|0|||
129542346|NCT03110107|466278743|FG002|Treatment Period|Participant withdrew consent|1|||
129542347|NCT03110107|466278744|FG003|Treatment Period|Participant withdrew consent|0|||
129542348|NCT03110107|466278745|FG004|Treatment Period|Participant withdrew consent|4|||
129542349|NCT03110107|466278746|FG005|Treatment Period|Participant withdrew consent|3|||
129542350|NCT03110107|466278747|FG006|Treatment Period|Participant withdrew consent|0|||
129542351|NCT03110107|466278748|FG007|Treatment Period|Participant withdrew consent|0|||
129542352|NCT03110107|466278749|FG008|Treatment Period|Participant withdrew consent|0|||
129542353|NCT03110107|466278750|FG009|Treatment Period|Participant withdrew consent|1|||
129542354|NCT03110107|466278751|FG010|Treatment Period|Participant withdrew consent|0|||
129542355|NCT03110107|466278752|FG011|Treatment Period|Participant withdrew consent|0|||
129542356|NCT03110107|466278753|FG012|Treatment Period|Participant withdrew consent|0|||
129542357|NCT03110107|466278754|FG013|Treatment Period|Participant withdrew consent|0|||
129542358|NCT03110107|466278755|FG014|Treatment Period|Participant withdrew consent|0|||
129542359|NCT03110107|466278756|FG015|Treatment Period|Participant withdrew consent|0|||
129542360|NCT03110107|466278757|FG016|Treatment Period|Participant withdrew consent|0|||
129542361|NCT03110107|466278758|FG017|Treatment Period|Participant withdrew consent|0|||
129542362|NCT03110107|466278759|FG018|Treatment Period|Participant withdrew consent|0|||
129542363|NCT03110107|466278760|FG019|Treatment Period|Participant withdrew consent|1|||
129542364|NCT03110107|466278761|FG020|Treatment Period|Participant withdrew consent|0|||
129542365|NCT03110107|466278762|FG021|Treatment Period|Participant withdrew consent|2|||
129542366|NCT03110107|466278763|FG022|Treatment Period|Participant withdrew consent|0|||
129542367|NCT03110107|466278764|FG023|Treatment Period|Participant withdrew consent|0|||
129542368|NCT03110107|466278765|FG024|Treatment Period|Participant withdrew consent|0|||
129542369|NCT03110107|466278766|FG025|Treatment Period|Participant withdrew consent|2|||
129542370|NCT03110107|466278741|FG000|Treatment Period|Participants no longer meets study criteria|0|||
129542371|NCT03110107|466278742|FG001|Treatment Period|Participants no longer meets study criteria|0|||
129542372|NCT03110107|466278743|FG002|Treatment Period|Participants no longer meets study criteria|0|||
129542373|NCT03110107|466278744|FG003|Treatment Period|Participants no longer meets study criteria|0|||
129542374|NCT03110107|466278745|FG004|Treatment Period|Participants no longer meets study criteria|0|||
129542375|NCT03110107|466278746|FG005|Treatment Period|Participants no longer meets study criteria|0|||
129542376|NCT03110107|466278747|FG006|Treatment Period|Participants no longer meets study criteria|0|||
129542377|NCT03110107|466278748|FG007|Treatment Period|Participants no longer meets study criteria|0|||
129542378|NCT03110107|466278749|FG008|Treatment Period|Participants no longer meets study criteria|0|||
129542379|NCT03110107|466278750|FG009|Treatment Period|Participants no longer meets study criteria|0|||
129542380|NCT03110107|466278751|FG010|Treatment Period|Participants no longer meets study criteria|0|||
129542381|NCT03110107|466278752|FG011|Treatment Period|Participants no longer meets study criteria|0|||
129542382|NCT03110107|466278753|FG012|Treatment Period|Participants no longer meets study criteria|0|||
129707675|NCT03710889|466892096|FG000|Overall Study|Protocol Deviation|1|||
129707676|NCT00570713|466892097|FG000|Overall Study|Adverse Event|16|||
129707677|NCT00570713|466892098|FG001|Overall Study|Adverse Event|9|||
129707678|NCT00570713|466892097|FG000|Overall Study|Death|7|||
129707679|NCT00570713|466892098|FG001|Overall Study|Death|7|||
129707680|NCT00570713|466892097|FG000|Overall Study|Lack of Efficacy|40|||
129542383|NCT03110107|466278754|FG013|Treatment Period|Participants no longer meets study criteria|0|||
129542384|NCT03110107|466278755|FG014|Treatment Period|Participants no longer meets study criteria|0|||
129542385|NCT03110107|466278756|FG015|Treatment Period|Participants no longer meets study criteria|0|||
129542386|NCT03110107|466278757|FG016|Treatment Period|Participants no longer meets study criteria|0|||
129542387|NCT03110107|466278758|FG017|Treatment Period|Participants no longer meets study criteria|0|||
129542388|NCT03110107|466278759|FG018|Treatment Period|Participants no longer meets study criteria|0|||
129542389|NCT03110107|466278760|FG019|Treatment Period|Participants no longer meets study criteria|0|||
129542390|NCT03110107|466278761|FG020|Treatment Period|Participants no longer meets study criteria|0|||
129542391|NCT03110107|466278762|FG021|Treatment Period|Participants no longer meets study criteria|0|||
129542392|NCT03110107|466278763|FG022|Treatment Period|Participants no longer meets study criteria|0|||
129542393|NCT03110107|466278764|FG023|Treatment Period|Participants no longer meets study criteria|1|||
129651250|NCT03605849|466679599|FG003|Overall Study|Withdrawal by Subject|28|||
129651251|NCT03605849|466679596|FG000|Overall Study|Site Terminated by Sponsor|0|||
129542394|NCT03110107|466278765|FG024|Treatment Period|Participants no longer meets study criteria|0|||
129542395|NCT03110107|466278766|FG025|Treatment Period|Participants no longer meets study criteria|0|||
129542396|NCT03110107|466278741|FG000|Treatment Period|Other Reasons|0|||
129542397|NCT03110107|466278742|FG001|Treatment Period|Other Reasons|0|||
129542398|NCT03110107|466278743|FG002|Treatment Period|Other Reasons|1|||
129542399|NCT03110107|466278744|FG003|Treatment Period|Other Reasons|1|||
129542400|NCT03110107|466278745|FG004|Treatment Period|Other Reasons|0|||
129542401|NCT03110107|466278746|FG005|Treatment Period|Other Reasons|1|||
129542402|NCT03110107|466278747|FG006|Treatment Period|Other Reasons|0|||
129542403|NCT03110107|466278748|FG007|Treatment Period|Other Reasons|0|||
129542404|NCT03110107|466278749|FG008|Treatment Period|Other Reasons|0|||
129542405|NCT03110107|466278750|FG009|Treatment Period|Other Reasons|0|||
129542406|NCT03110107|466278751|FG010|Treatment Period|Other Reasons|0|||
129542407|NCT03110107|466278752|FG011|Treatment Period|Other Reasons|0|||
129542408|NCT03110107|466278753|FG012|Treatment Period|Other Reasons|0|||
129542409|NCT03110107|466278754|FG013|Treatment Period|Other Reasons|0|||
129542410|NCT03110107|466278755|FG014|Treatment Period|Other Reasons|0|||
129542411|NCT03110107|466278756|FG015|Treatment Period|Other Reasons|0|||
129542412|NCT03110107|466278757|FG016|Treatment Period|Other Reasons|0|||
129542413|NCT03110107|466278758|FG017|Treatment Period|Other Reasons|0|||
129542414|NCT03110107|466278759|FG018|Treatment Period|Other Reasons|0|||
129542415|NCT03110107|466278760|FG019|Treatment Period|Other Reasons|0|||
129542416|NCT03110107|466278761|FG020|Treatment Period|Other Reasons|0|||
129542417|NCT03110107|466278762|FG021|Treatment Period|Other Reasons|0|||
129542418|NCT03110107|466278763|FG022|Treatment Period|Other Reasons|0|||
129542419|NCT03110107|466278764|FG023|Treatment Period|Other Reasons|0|||
129542420|NCT03110107|466278765|FG024|Treatment Period|Other Reasons|1|||
129542421|NCT03110107|466278766|FG025|Treatment Period|Other Reasons|0|||
129542422|NCT03586427|466278774|FG000|Overall Study|Lost to Follow-up|0|||
129542423|NCT03586427|466278775|FG001|Overall Study|Lost to Follow-up|3|||
129542424|NCT03586427|466278776|FG002|Overall Study|Lost to Follow-up|1|||
129542425|NCT03586427|466278777|FG003|Overall Study|Lost to Follow-up|3|||
129542426|NCT03586427|466278778|FG004|Overall Study|Lost to Follow-up|3|||
129542427|NCT03586427|466278774|FG000|Overall Study|Withdrawal by Subject|0|||
129542428|NCT03586427|466278775|FG001|Overall Study|Withdrawal by Subject|1|||
129542429|NCT03586427|466278776|FG002|Overall Study|Withdrawal by Subject|2|||
129542430|NCT03586427|466278777|FG003|Overall Study|Withdrawal by Subject|1|||
129542431|NCT03586427|466278778|FG004|Overall Study|Withdrawal by Subject|1|||
129542432|NCT03586427|466278774|FG000|Overall Study|Adverse Event|0|||
129542433|NCT03586427|466278775|FG001|Overall Study|Adverse Event|0|||
129542434|NCT03586427|466278776|FG002|Overall Study|Adverse Event|1|||
129542435|NCT03586427|466278777|FG003|Overall Study|Adverse Event|0|||
129542436|NCT03586427|466278778|FG004|Overall Study|Adverse Event|0|||
129651252|NCT03605849|466679597|FG001|Overall Study|Site Terminated by Sponsor|0|||
129542437|NCT03586427|466278774|FG000|Overall Study|Protocol Violation|0|||
129542438|NCT03586427|466278775|FG001|Overall Study|Protocol Violation|0|||
129542439|NCT03586427|466278776|FG002|Overall Study|Protocol Violation|1|||
129542440|NCT03586427|466278777|FG003|Overall Study|Protocol Violation|0|||
129542441|NCT03586427|466278778|FG004|Overall Study|Protocol Violation|1|||
129542442|NCT03586427|466278774|FG000|Overall Study|Noncompliance with study drug|0|||
129651253|NCT03605849|466679598|FG002|Overall Study|Site Terminated by Sponsor|0|||
129651254|NCT03605849|466679599|FG003|Overall Study|Site Terminated by Sponsor|1|||
129651255|NCT03605849|466679596|FG000|Overall Study|Physician Decision|2|||
129651256|NCT03605849|466679597|FG001|Overall Study|Physician Decision|1|||
129651257|NCT03605849|466679598|FG002|Overall Study|Physician Decision|2|||
129651258|NCT03605849|466679599|FG003|Overall Study|Physician Decision|1|||
129651259|NCT03605849|466679596|FG000|Overall Study|Enrolled, but not Treated|2|||
129542443|NCT03586427|466278775|FG001|Overall Study|Noncompliance with study drug|0|||
129542444|NCT03586427|466278776|FG002|Overall Study|Noncompliance with study drug|1|||
129542445|NCT03586427|466278777|FG003|Overall Study|Noncompliance with study drug|0|||
129542446|NCT03586427|466278778|FG004|Overall Study|Noncompliance with study drug|0|||
129542447|NCT00494234|466278779|FG000|Overall Study|Withdrawal by Subject|1|||
129542448|NCT00494234|466278780|FG001|Overall Study|Withdrawal by Subject|0|||
129542449|NCT00494234|466278779|FG000|Overall Study|Disease progression|11|||
129542450|NCT00494234|466278780|FG001|Overall Study|Disease progression|8|||
129542451|NCT00494234|466278779|FG000|Overall Study|Death|2|||
129542452|NCT00494234|466278780|FG001|Overall Study|Death|1|||
129542453|NCT03193996|466278781|FG000|Overall Study|Withdrawal by Subject|4|||
129542454|NCT03193996|466278781|FG000|Overall Study|Lost to Follow-up|4|||
129542455|NCT03193996|466278781|FG000|Overall Study|Physician Decision|2|||
129542456|NCT03193996|466278781|FG000|Overall Study|Pregnancy|1|||
129542457|NCT03193996|466278781|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
129542458|NCT03193996|466278781|FG000|Overall Study|Complicating disease|1|||
129542459|NCT00423137|466278782|FG000|Overall Study|Lost to Follow-up|0|||
129542460|NCT00423137|466278783|FG001|Overall Study|Lost to Follow-up|0|||
129542461|NCT00423137|466278784|FG002|Overall Study|Lost to Follow-up|1|||
129542462|NCT00423137|466278785|FG003|Overall Study|Lost to Follow-up|0|||
129542463|NCT00423137|466278782|FG000|Overall Study|Protocol Violation|0|||
129542464|NCT00423137|466278783|FG001|Overall Study|Protocol Violation|0|||
129542465|NCT00423137|466278784|FG002|Overall Study|Protocol Violation|0|||
129542466|NCT00423137|466278785|FG003|Overall Study|Protocol Violation|1|||
129542467|NCT00423137|466278782|FG000|Overall Study|Adverse Event Study disease worse|1|||
129542468|NCT00423137|466278783|FG001|Overall Study|Adverse Event Study disease worse|0|||
129542469|NCT00423137|466278784|FG002|Overall Study|Adverse Event Study disease worse|3|||
129542470|NCT00423137|466278785|FG003|Overall Study|Adverse Event Study disease worse|1|||
129542471|NCT00423137|466278782|FG000|Overall Study|Adverse Event Other|0|||
129542472|NCT00423137|466278783|FG001|Overall Study|Adverse Event Other|0|||
129542473|NCT00423137|466278784|FG002|Overall Study|Adverse Event Other|2|||
129542474|NCT00423137|466278785|FG003|Overall Study|Adverse Event Other|0|||
129542475|NCT00593385|466278787|FG000|Overall Study|Death|14|||
129542476|NCT00593385|466278787|FG000|Overall Study|Lost to Follow-up|17|||
129542477|NCT00593385|466278787|FG000|Overall Study|Withdrawal by Subject|9|||
129542478|NCT01471197|466278788|FG000|Overall Study|Disease Progression|4|||
129542479|NCT01471197|466278789|FG001|Overall Study|Disease Progression|2|||
129542480|NCT01471197|466278788|FG000|Overall Study|Death|1|||
129542481|NCT01471197|466278789|FG001|Overall Study|Death|0|||
129542482|NCT01471197|466278788|FG000|Overall Study|Study Drug Toxicity|1|||
129542483|NCT01471197|466278789|FG001|Overall Study|Study Drug Toxicity|0|||
129542484|NCT00924313|466278795|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
129542485|NCT01012609|466278796|FG000|Overall Study|Withdrawal by Subject|1|||
129542486|NCT01012609|466278797|FG001|Overall Study|Withdrawal by Subject|1|||
129542487|NCT03557775|466278798|FG000|Overall Study|Withdrawal by Subject|1|||
129542488|NCT03557775|466278799|FG001|Overall Study|Withdrawal by Subject|2|||
129542489|NCT03557775|466278800|FG002|Overall Study|Withdrawal by Subject|4|||
129542490|NCT03557775|466278798|FG000|Overall Study|Physician Decision|0|||
129542491|NCT03557775|466278799|FG001|Overall Study|Physician Decision|1|||
129542492|NCT03557775|466278800|FG002|Overall Study|Physician Decision|0|||
129542493|NCT00483119|466278801|FG000|Overall Study|Adverse Event|0|||
129542494|NCT00483119|466278802|FG001|Overall Study|Adverse Event|1|||
129542495|NCT00483119|466278801|FG000|Overall Study|Physician Decision|1|||
129542496|NCT00483119|466278802|FG001|Overall Study|Physician Decision|0|||
129542497|NCT03426995|466278803|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542498|NCT03426995|466278804|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542499|NCT03426995|466278805|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
129542500|NCT03426995|466278806|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542501|NCT03426995|466278807|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542502|NCT03426995|466278808|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542503|NCT03426995|466278809|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542504|NCT03426995|466278810|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542505|NCT03426995|466278811|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542506|NCT03426995|466278812|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542507|NCT03426995|466278813|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542508|NCT03426995|466278814|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542509|NCT03426995|466278815|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542510|NCT03426995|466278816|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542511|NCT03426995|466278817|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542512|NCT03426995|466278818|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542513|NCT03426995|466278819|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542514|NCT03426995|466278820|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542515|NCT03426995|466278821|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
129542516|NCT03426995|466278803|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542517|NCT03426995|466278804|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542518|NCT03426995|466278805|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542519|NCT03426995|466278806|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542520|NCT03426995|466278807|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542521|NCT03426995|466278808|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
129542522|NCT03426995|466278809|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542523|NCT03426995|466278810|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542524|NCT03426995|466278811|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542525|NCT03426995|466278812|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542526|NCT03426995|466278813|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542527|NCT03426995|466278814|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542528|NCT03426995|466278815|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542529|NCT03426995|466278816|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542530|NCT03426995|466278817|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542531|NCT03426995|466278818|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542532|NCT03426995|466278819|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542533|NCT03426995|466278820|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542534|NCT03426995|466278821|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
129542535|NCT03426995|466278803|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542536|NCT03426995|466278804|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542537|NCT03426995|466278805|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542538|NCT03426995|466278806|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542539|NCT03426995|466278807|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
129542540|NCT03426995|466278808|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
129542541|NCT03426995|466278809|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542542|NCT03426995|466278810|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542543|NCT03426995|466278811|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542544|NCT03426995|466278812|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542545|NCT03426995|466278813|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542546|NCT03426995|466278814|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542547|NCT03426995|466278815|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542548|NCT03426995|466278816|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542549|NCT03426995|466278817|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542550|NCT03426995|466278818|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542551|NCT03426995|466278819|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542552|NCT03426995|466278820|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542553|NCT03426995|466278821|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
129542554|NCT03426995|466278803|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542555|NCT03426995|466278804|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542556|NCT03426995|466278805|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542557|NCT03426995|466278806|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542558|NCT03426995|466278807|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542559|NCT03426995|466278808|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542560|NCT03426995|466278809|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542561|NCT03426995|466278810|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542562|NCT03426995|466278811|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542563|NCT03426995|466278812|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542564|NCT03426995|466278813|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
129542565|NCT03426995|466278814|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542566|NCT03426995|466278815|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542567|NCT03426995|466278816|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542568|NCT03426995|466278817|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542569|NCT03426995|466278818|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542570|NCT03426995|466278819|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542571|NCT03426995|466278820|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542572|NCT03426995|466278821|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
129542573|NCT03426995|466278803|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542574|NCT03426995|466278804|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542575|NCT03426995|466278805|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542576|NCT03426995|466278806|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542577|NCT03426995|466278807|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542578|NCT03426995|466278808|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542579|NCT03426995|466278809|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542580|NCT03426995|466278810|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
129542581|NCT03426995|466278811|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542582|NCT03426995|466278812|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542583|NCT03426995|466278813|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542584|NCT03426995|466278814|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542585|NCT03426995|466278815|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542586|NCT03426995|466278816|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129875299|NCT00991341|467501882|FG001|Overall Study|Withdrawal by Subject|4|||
129875300|NCT01330316|467501901|FG000|Overall Study|Adverse Event|2|||
129875301|NCT01330316|467501902|FG001|Overall Study|Adverse Event|2|||
129875302|NCT01330316|467501901|FG000|Overall Study|Lack of Efficacy|0|||
129875303|NCT01330316|467501902|FG001|Overall Study|Lack of Efficacy|10|||
129875304|NCT01330316|467501901|FG000|Overall Study|Lost to Follow-up|0|||
129875305|NCT01330316|467501902|FG001|Overall Study|Lost to Follow-up|1|||
129875306|NCT01330316|467501901|FG000|Overall Study|Withdrawal by Subject|0|||
129875307|NCT01330316|467501902|FG001|Overall Study|Withdrawal by Subject|1|||
129875308|NCT01330316|467501901|FG000|Overall Study|other than above|0|||
129875309|NCT01330316|467501902|FG001|Overall Study|other than above|1|||
129875310|NCT00215540|467501903|FG000|Overall Study|Withdrew from study medication|1|||
129875311|NCT00215540|467501904|FG001|Overall Study|Withdrew from study medication|0|||
129875312|NCT00215540|467501905|FG002|Overall Study|Withdrew from study medication|0|||
129875313|NCT03010462|467501906|FG000|Overall Study|Withdrawal by Subject|3|||
129875314|NCT03010462|467501907|FG001|Overall Study|Withdrawal by Subject|1|||
129875315|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
129875316|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
129875317|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
129875318|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
129875319|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
129875320|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
129875321|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
129875322|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
129875323|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
129875324|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
129875325|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
129875326|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
129875327|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
129875328|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
129875329|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
129875330|NCT03145766|467501908|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
129875331|NCT03145766|467501909|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129875332|NCT03145766|467501910|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129875333|NCT03145766|467501911|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
129875334|NCT03145766|467501912|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
129875335|NCT03145766|467501908|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
129875336|NCT03145766|467501909|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129875337|NCT03145766|467501910|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129875338|NCT03145766|467501911|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
129875339|NCT03145766|467501912|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
129875340|NCT03145766|467501908|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
129875341|NCT03145766|467501909|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
129875342|NCT03145766|467501910|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
129875343|NCT03145766|467501911|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
129875344|NCT03145766|467501912|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
129875345|NCT03145766|467501908|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129875346|NCT03145766|467501909|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129875347|NCT03145766|467501910|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
129875348|NCT03145766|467501911|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
129875349|NCT03145766|467501912|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
129875350|NCT02799472|467501916|FG000|Overall Study|Withdrawal by Subject|2|||
129875351|NCT02799472|467501917|FG001|Overall Study|Withdrawal by Subject|4|||
129875352|NCT02799472|467501916|FG000|Overall Study|Lack of Efficacy|2|||
129875353|NCT02799472|467501917|FG001|Overall Study|Lack of Efficacy|0|||
129875354|NCT02799472|467501916|FG000|Overall Study|Lost to Follow-up|0|||
129875355|NCT02799472|467501917|FG001|Overall Study|Lost to Follow-up|1|||
129875356|NCT02801669|467501918|FG000|Overall Study|Death|66|||
129875357|NCT02801669|467501919|FG001|Overall Study|Death|69|||
129875358|NCT02801669|467501918|FG000|Overall Study|Withdrawal by Subject|81|||
129875359|NCT02801669|467501919|FG001|Overall Study|Withdrawal by Subject|77|||
129875360|NCT02801669|467501918|FG000|Overall Study|Other|4|||
129875361|NCT02801669|467501919|FG001|Overall Study|Other|6|||
129875362|NCT01782872|467501923|FG000|Overall Study|Protocol Violation|0|||
129875363|NCT01782872|467501924|FG001|Overall Study|Protocol Violation|0|||
129875364|NCT01782872|467501925|FG002|Overall Study|Protocol Violation|0|||
129875365|NCT01782872|467501926|FG003|Overall Study|Protocol Violation|1|||
129875366|NCT01782872|467501923|FG000|Overall Study|Withdrawal by Subject|0|||
129764160|NCT02384551|467100326|FG000|Overall Study|Lost to Follow-up|13|||
129764161|NCT02384551|467100327|FG001|Overall Study|Lost to Follow-up|14|||
129764162|NCT02384551|467100328|FG002|Overall Study|Lost to Follow-up|14|||
129764163|NCT02384551|467100329|FG003|Overall Study|Lost to Follow-up|14|||
129764164|NCT04742556|467100332|FG000|Overall Study|Withdrawal by Subject|0|||
129764165|NCT04742556|467100333|FG001|Overall Study|Withdrawal by Subject|1|||
129542587|NCT03426995|466278817|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542588|NCT03426995|466278818|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542589|NCT03426995|466278819|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542590|NCT03426995|466278820|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542591|NCT03426995|466278821|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
129542592|NCT03426995|466278803|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542593|NCT03426995|466278804|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542594|NCT03426995|466278805|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542595|NCT03426995|466278806|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542596|NCT03426995|466278807|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542597|NCT03426995|466278808|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542598|NCT03426995|466278809|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542599|NCT03426995|466278810|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542600|NCT03426995|466278811|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542601|NCT03426995|466278812|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542602|NCT03426995|466278813|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542603|NCT03426995|466278814|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542604|NCT03426995|466278815|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542605|NCT03426995|466278816|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542606|NCT03426995|466278817|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
129542607|NCT03426995|466278818|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
129542608|NCT03426995|466278819|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542609|NCT03426995|466278820|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542610|NCT03426995|466278821|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
129542611|NCT03426995|466278803|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542612|NCT03426995|466278804|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542613|NCT03426995|466278805|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542614|NCT03426995|466278806|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542615|NCT03426995|466278807|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542616|NCT03426995|466278808|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542617|NCT03426995|466278809|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542618|NCT03426995|466278810|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542619|NCT03426995|466278811|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542620|NCT03426995|466278812|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542621|NCT03426995|466278813|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542622|NCT03426995|466278814|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542623|NCT03426995|466278815|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542624|NCT03426995|466278816|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542625|NCT03426995|466278817|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
129542626|NCT03426995|466278818|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
129542627|NCT03426995|466278819|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542628|NCT03426995|466278820|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542629|NCT03426995|466278821|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
129542630|NCT05939388|466278822|FG000|Overall Study|Lost to Follow-up|1|||
129542631|NCT00602667|466278823|FG000|Overall Study|Still on Therapy|0|||
129542632|NCT00602667|466278824|FG001|Overall Study|Still on Therapy|2|||
129542633|NCT00602667|466278825|FG002|Overall Study|Still on Therapy|2|||
129542634|NCT00602667|466278823|FG000|Overall Study|Death|0|||
129542635|NCT00602667|466278824|FG001|Overall Study|Death|1|||
129542636|NCT00602667|466278825|FG002|Overall Study|Death|1|||
129542637|NCT00602667|466278823|FG000|Overall Study|Family request|3|||
129542638|NCT00602667|466278824|FG001|Overall Study|Family request|25|||
129542639|NCT00602667|466278825|FG002|Overall Study|Family request|6|||
129542640|NCT00602667|466278823|FG000|Overall Study|Excessive toxicity|1|||
129542641|NCT00602667|466278824|FG001|Overall Study|Excessive toxicity|1|||
129542642|NCT00602667|466278825|FG002|Overall Study|Excessive toxicity|0|||
129542643|NCT00602667|466278823|FG000|Overall Study|Second malignancy|0|||
129542644|NCT00602667|466278824|FG001|Overall Study|Second malignancy|1|||
129542645|NCT00602667|466278825|FG002|Overall Study|Second malignancy|0|||
129542646|NCT00602667|466278823|FG000|Overall Study|Physician Decision|2|||
129542647|NCT00602667|466278824|FG001|Overall Study|Physician Decision|3|||
129542648|NCT00602667|466278825|FG002|Overall Study|Physician Decision|8|||
129542649|NCT00602667|466278823|FG000|Overall Study|Progressive disease|13|||
129764166|NCT04742556|467100334|FG002|Overall Study|Withdrawal by Subject|0|||
129542650|NCT00602667|466278824|FG001|Overall Study|Progressive disease|48|||
129542651|NCT00602667|466278825|FG002|Overall Study|Progressive disease|45|||
129542652|NCT00602667|466278823|FG000|Overall Study|Progressive disease prior to therapy|0|||
129542653|NCT00602667|466278824|FG001|Overall Study|Progressive disease prior to therapy|0|||
129542654|NCT00602667|466278825|FG002|Overall Study|Progressive disease prior to therapy|1|||
129542655|NCT04410978|466278831|FG000|Overall Study|Poor compliance to protocol|2|||
129542656|NCT04410978|466278832|FG001|Overall Study|Poor compliance to protocol|4|||
129542657|NCT04410978|466278831|FG000|Overall Study|Withdrawal by Subject|64|||
129542658|NCT04410978|466278832|FG001|Overall Study|Withdrawal by Subject|66|||
129542659|NCT04410978|466278831|FG000|Overall Study|Other|6|||
129542660|NCT04410978|466278832|FG001|Overall Study|Other|7|||
129542661|NCT04410978|466278831|FG000|Overall Study|Missing study status|1|||
129542662|NCT04410978|466278832|FG001|Overall Study|Missing study status|0|||
129542663|NCT00885677|466278839|FG000|Overall Study|Death|40|||
129542664|NCT00885677|466278840|FG001|Overall Study|Death|34|||
129542665|NCT00885677|466278839|FG000|Overall Study|Lost to Follow-up|15|||
129542666|NCT00885677|466278840|FG001|Overall Study|Lost to Follow-up|13|||
129542667|NCT00885677|466278839|FG000|Overall Study|Protocol Violation|54|||
129542668|NCT00885677|466278840|FG001|Overall Study|Protocol Violation|54|||
129542669|NCT00885677|466278839|FG000|Overall Study|premature study closure|41|||
129542670|NCT00885677|466278840|FG001|Overall Study|premature study closure|44|||
129542671|NCT00885677|466278839|FG000|Overall Study|device/lead revision or replacement|7|||
129542672|NCT00885677|466278840|FG001|Overall Study|device/lead revision or replacement|6|||
129542673|NCT00885677|466278839|FG000|Overall Study|Heart transplantation|1|||
129542674|NCT00885677|466278840|FG001|Overall Study|Heart transplantation|0|||
129542675|NCT00885677|466278839|FG000|Overall Study|Inclusion/exclusion not met|25|||
129542676|NCT00885677|466278840|FG001|Overall Study|Inclusion/exclusion not met|27|||
129542677|NCT00972309|466278841|FG000|Overall Study|Switched to alternative treatment|0|||
129542678|NCT00972309|466278842|FG001|Overall Study|Switched to alternative treatment|2|||
129542679|NCT00972309|466278841|FG000|Overall Study|Refused further treatment|0|||
129542680|NCT00972309|466278842|FG001|Overall Study|Refused further treatment|1|||
129542681|NCT00972309|466278841|FG000|Overall Study|Late determination of ineligibility|0|||
129542682|NCT00972309|466278842|FG001|Overall Study|Late determination of ineligibility|1|||
129542683|NCT00972309|466278841|FG000|Overall Study|Second malignancy|1|||
129542684|NCT00972309|466278842|FG001|Overall Study|Second malignancy|1|||
129542685|NCT00972309|466278841|FG000|Overall Study|Visa issues|0|||
129542686|NCT00972309|466278842|FG001|Overall Study|Visa issues|1|||
129542687|NCT00972309|466278841|FG000|Overall Study|Secondary cancer (SCC)|0|||
129542688|NCT00972309|466278842|FG001|Overall Study|Secondary cancer (SCC)|1|||
129542689|NCT00972309|466278841|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
129542690|NCT00972309|466278842|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
129542691|NCT00972309|466278841|FG000|Overall Study|Lost to Follow-up|1|||
129542692|NCT00972309|466278842|FG001|Overall Study|Lost to Follow-up|1|||
129542693|NCT00972309|466278841|FG000|Overall Study|Disease progression on study|10|||
129542694|NCT00972309|466278842|FG001|Overall Study|Disease progression on study|4|||
129542695|NCT00948896|466278843|FG000|Randomization to 24 Months of Age|Death|1|||
129542696|NCT00948896|466278844|FG001|Randomization to 24 Months of Age|Death|0|||
129542697|NCT00948896|466278845|FG002|Randomization to 24 Months of Age|Death|0|||
129542698|NCT00948896|466278846|FG003|Randomization to 24 Months of Age|Death|0|||
129542699|NCT00948896|466278847|FG004|Randomization to 24 Months of Age|Death|2|||
129542700|NCT00948896|466278848|FG005|Randomization to 24 Months of Age|Death|1|||
129542701|NCT00948896|466278849|FG006|Randomization to 24 Months of Age|Death|2|||
129542702|NCT00948896|466278850|FG007|Randomization to 24 Months of Age|Death|1|||
129542703|NCT00948896|466278843|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
129542704|NCT00948896|466278844|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
129542705|NCT00948896|466278845|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
129542706|NCT00948896|466278846|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
129542707|NCT00948896|466278847|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
129542708|NCT00948896|466278848|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
129542709|NCT00948896|466278849|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
129542710|NCT00948896|466278850|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
129542711|NCT00948896|466278843|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
129542712|NCT00948896|466278844|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
129542713|NCT00948896|466278845|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
129542714|NCT00948896|466278846|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
129542715|NCT00948896|466278847|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
129542716|NCT00948896|466278848|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
129651260|NCT03605849|466679597|FG001|Overall Study|Enrolled, but not Treated|2|||
129651261|NCT03605849|466679598|FG002|Overall Study|Enrolled, but not Treated|3|||
129651262|NCT03605849|466679599|FG003|Overall Study|Enrolled, but not Treated|2|||
129651263|NCT03605849|466679596|FG000|Overall Study|Other (COVID-19 Related)|0|||
129542717|NCT00948896|466278849|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
129651264|NCT03605849|466679597|FG001|Overall Study|Other (COVID-19 Related)|1|||
129542718|NCT00948896|466278850|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
129542719|NCT00948896|466278843|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
129542720|NCT00948896|466278844|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
129542721|NCT00948896|466278845|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
129542722|NCT00948896|466278846|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
129542723|NCT00948896|466278847|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
129542724|NCT00948896|466278848|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
129542725|NCT00948896|466278849|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
129542726|NCT00948896|466278850|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
129542727|NCT00948896|466278843|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
129542728|NCT00948896|466278844|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
129542729|NCT00948896|466278845|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
129542730|NCT00948896|466278846|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
129542731|NCT00948896|466278847|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
129542732|NCT00948896|466278848|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
129542733|NCT00948896|466278849|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
129542734|NCT00948896|466278850|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
129542735|NCT00948896|466278843|FG000|24 Months of Age to 36 Months of Age|Death|0|||
129542736|NCT00948896|466278844|FG001|24 Months of Age to 36 Months of Age|Death|2|||
129542737|NCT00948896|466278845|FG002|24 Months of Age to 36 Months of Age|Death|2|||
129542738|NCT00948896|466278846|FG003|24 Months of Age to 36 Months of Age|Death|0|||
129542739|NCT00948896|466278847|FG004|24 Months of Age to 36 Months of Age|Death|0|||
129542740|NCT00948896|466278848|FG005|24 Months of Age to 36 Months of Age|Death|1|||
129542741|NCT00948896|466278849|FG006|24 Months of Age to 36 Months of Age|Death|0|||
129542742|NCT00948896|466278850|FG007|24 Months of Age to 36 Months of Age|Death|0|||
129542743|NCT00948896|466278843|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
129542744|NCT00948896|466278844|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
129542745|NCT00948896|466278845|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
129542746|NCT00948896|466278846|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
129542747|NCT00948896|466278847|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
129542748|NCT00948896|466278848|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
129542749|NCT00948896|466278849|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
129542750|NCT00948896|466278850|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
129542751|NCT00948896|466278843|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
129542752|NCT00948896|466278844|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
129542753|NCT00948896|466278845|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
129542754|NCT00948896|466278846|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
129542755|NCT00948896|466278847|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
129542756|NCT00948896|466278848|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
129542757|NCT00948896|466278849|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
129542758|NCT00948896|466278850|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
129542759|NCT00948896|466278843|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
129542760|NCT00948896|466278844|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
129542761|NCT00948896|466278845|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
129542762|NCT00948896|466278846|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
129542763|NCT00948896|466278847|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
129542764|NCT00948896|466278848|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
129542765|NCT00948896|466278849|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
129542766|NCT00948896|466278850|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
129542767|NCT00948896|466278843|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129764167|NCT04742556|467100332|FG000|Overall Study|Adverse Event|0|||
129764168|NCT04742556|467100333|FG001|Overall Study|Adverse Event|0|||
129764169|NCT04742556|467100334|FG002|Overall Study|Adverse Event|2|||
129764170|NCT04742556|467100332|FG000|Overall Study|Clinical disease progression|0|||
129764171|NCT04742556|467100333|FG001|Overall Study|Clinical disease progression|1|||
129764172|NCT04742556|467100334|FG002|Overall Study|Clinical disease progression|2|||
129764173|NCT04742556|467100332|FG000|Overall Study|Objective disease progression|3|||
129764174|NCT04742556|467100333|FG001|Overall Study|Objective disease progression|2|||
129764175|NCT04742556|467100334|FG002|Overall Study|Objective disease progression|4|||
129764176|NCT01903356|467100340|FG000|Overall Study|Lost to Follow-up|7|||
129764177|NCT01903356|467100340|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
129764178|NCT01903356|467100340|FG000|Overall Study|Violated the dosage and administration|3|||
129764179|NCT04196686|467100345|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
129764180|NCT04196686|467100346|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
129764181|NCT03448406|467100348|FG000|Overall Study|Noncompliance of scheduled visits|1|||
129764182|NCT03448406|467100349|FG001|Overall Study|Noncompliance of scheduled visits|2|||
129875367|NCT01782872|467501924|FG001|Overall Study|Withdrawal by Subject|1|||
129764183|NCT03448406|467100348|FG000|Overall Study|Withdrawal by Subject|1|||
129764184|NCT03448406|467100349|FG001|Overall Study|Withdrawal by Subject|2|||
129764185|NCT03448406|467100348|FG000|Overall Study|Protocol Violation|1|||
129764186|NCT03448406|467100349|FG001|Overall Study|Protocol Violation|0|||
129764187|NCT03448406|467100348|FG000|Overall Study|Adverse Event|8|||
129764188|NCT03448406|467100349|FG001|Overall Study|Adverse Event|9|||
129764189|NCT02542865|467100357|FG000|Overall Study|Identified as screen failure|1|||
129764190|NCT02542865|467100358|FG001|Overall Study|Identified as screen failure|0|||
129764191|NCT02542865|467100357|FG000|Overall Study|Withdrawal by Subject|16|||
129764192|NCT02542865|467100358|FG001|Overall Study|Withdrawal by Subject|0|||
129764193|NCT02913482|467100359|FG000|Overall Study|Death|0|||
129764194|NCT02913482|467100360|FG001|Overall Study|Death|2|||
129764195|NCT02913482|467100361|FG002|Overall Study|Death|2|||
129764196|NCT02913482|467100359|FG000|Overall Study|Progressive Disease|1|||
129764197|NCT02913482|467100360|FG001|Overall Study|Progressive Disease|1|||
129764198|NCT02913482|467100361|FG002|Overall Study|Progressive Disease|1|||
129764199|NCT02913482|467100359|FG000|Overall Study|Reason not specified|0|||
129764200|NCT02913482|467100360|FG001|Overall Study|Reason not specified|0|||
129764201|NCT02913482|467100361|FG002|Overall Study|Reason not specified|1|||
129764202|NCT02913482|467100359|FG000|Overall Study|Withdrawal by Subject|0|||
129764203|NCT02913482|467100360|FG001|Overall Study|Withdrawal by Subject|1|||
129764204|NCT02913482|467100361|FG002|Overall Study|Withdrawal by Subject|1|||
129764205|NCT00083889|467100363|FG000|Overall Study|Adverse Event|76|||
129764206|NCT00083889|467100364|FG001|Overall Study|Adverse Event|86|||
129764207|NCT00083889|467100363|FG000|Overall Study|Protocol Violation|2|||
129764208|NCT00083889|467100364|FG001|Overall Study|Protocol Violation|2|||
129764209|NCT00083889|467100363|FG000|Overall Study|Withdrawal by Subject|22|||
129764210|NCT00083889|467100364|FG001|Overall Study|Withdrawal by Subject|24|||
129764211|NCT00083889|467100363|FG000|Overall Study|Lack of Efficacy|240|||
129764212|NCT00083889|467100364|FG001|Overall Study|Lack of Efficacy|219|||
129764213|NCT00083889|467100363|FG000|Overall Study|Decision of sponsor|32|||
129764214|NCT00083889|467100364|FG001|Overall Study|Decision of sponsor|4|||
129764215|NCT00083889|467100363|FG000|Overall Study|Randomized: did not take study drug|0|||
129764216|NCT00083889|467100364|FG001|Overall Study|Randomized: did not take study drug|15|||
129764217|NCT00083889|467100363|FG000|Overall Study|Completed on marketed sunitinub|3|||
129764218|NCT00083889|467100364|FG001|Overall Study|Completed on marketed sunitinub|0|||
129764219|NCT00083889|467100363|FG000|Overall Study|Crossover to SU011248|0|||
129764220|NCT00083889|467100364|FG001|Overall Study|Crossover to SU011248|25|||
129764221|NCT05135871|467100366|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
129764222|NCT05135871|467100367|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
129764223|NCT05135871|467100368|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
129764224|NCT05135871|467100369|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
129764225|NCT03914417|467100371|FG000|Overall Study|Withdrawal by Subject|2|||
129764226|NCT01247324|467100376|FG000|Overall Study|Death|6|||
129764227|NCT01247324|467100377|FG001|Overall Study|Death|10|||
129764228|NCT01247324|467100376|FG000|Overall Study|Physician Decision|2|||
129764229|NCT01247324|467100377|FG001|Overall Study|Physician Decision|3|||
129764230|NCT01247324|467100376|FG000|Overall Study|Non-compliance with study drug|3|||
129764231|NCT01247324|467100377|FG001|Overall Study|Non-compliance with study drug|0|||
129764232|NCT01247324|467100376|FG000|Overall Study|Lack of Efficacy|24|||
129764233|NCT01247324|467100377|FG001|Overall Study|Lack of Efficacy|14|||
129764234|NCT01247324|467100376|FG000|Overall Study|Non-compliance|3|||
129764235|NCT01247324|467100377|FG001|Overall Study|Non-compliance|2|||
129764236|NCT01247324|467100376|FG000|Overall Study|Pregnancy|5|||
129764237|NCT01247324|467100377|FG001|Overall Study|Pregnancy|10|||
129764238|NCT01247324|467100376|FG000|Overall Study|Protocol Violation|1|||
129764239|NCT01247324|467100377|FG001|Overall Study|Protocol Violation|1|||
129764240|NCT01247324|467100376|FG000|Overall Study|Reason not specified|42|||
129764241|NCT01247324|467100377|FG001|Overall Study|Reason not specified|32|||
129764242|NCT01247324|467100376|FG000|Overall Study|Consent withdrawn by participant|41|||
129764243|NCT01247324|467100377|FG001|Overall Study|Consent withdrawn by participant|56|||
129764244|NCT01247324|467100376|FG000|Overall Study|Adverse Event|49|||
129764245|NCT01247324|467100377|FG001|Overall Study|Adverse Event|35|||
129764246|NCT01247324|467100376|FG000|Overall Study|Lost to Follow-up|3|||
129764247|NCT01247324|467100377|FG001|Overall Study|Lost to Follow-up|6|||
129764248|NCT01247324|467100376|FG000|Overall Study|Study Terminated by Sponsor|4|||
129764249|NCT01247324|467100377|FG001|Overall Study|Study Terminated by Sponsor|1|||
129764250|NCT01247324|467100376|FG000|Overall Study|Missing|2|||
129764251|NCT01247324|467100377|FG001|Overall Study|Missing|1|||
129764252|NCT03035032|467102413|FG000|Overall Study|Adverse Event|2|||
129764253|NCT03035032|467102413|FG000|Overall Study|Death|9|||
129985712|NCT04811131|467909336|FG003|Overall Study|Sponsor request|10|||
129764254|NCT03035032|467102413|FG000|Overall Study|Lost to Follow-up|1|||
129764255|NCT03035032|467102413|FG000|Overall Study|Progressive Disease|22|||
129764256|NCT03035032|467102413|FG000|Overall Study|Protocol Violation|2|||
129764257|NCT03035032|467102413|FG000|Overall Study|Withdrawal by Subject|2|||
129764258|NCT03035032|467102413|FG000|Overall Study|Physician Decision|5|||
129764259|NCT00836589|467102414|FG000|Overall Study|Lost to Follow-up|246|||
129764260|NCT00836589|467102414|FG000|Overall Study|Death|429|||
129764261|NCT00836589|467102414|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
129764262|NCT02399215|467102436|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
129764263|NCT02399215|467102436|FG000|Overall Study|Withdrawal by Subject|1|||
129764264|NCT04529083|467102437|FG000|Overall Study|Withdrawal by Subject|3|||
129764265|NCT01176032|467102441|FG000|Overall Study|Adverse Event|1|||
129764266|NCT01176032|467102442|FG001|Overall Study|Adverse Event|0|||
129764267|NCT01176032|467102441|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129764268|NCT01176032|467102442|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129764269|NCT01176032|467102441|FG000|Overall Study|Protocol Violation|1|||
129764270|NCT01176032|467102442|FG001|Overall Study|Protocol Violation|0|||
129764271|NCT01176032|467102441|FG000|Overall Study|Informed consent withdrawn|3|||
129764272|NCT01176032|467102442|FG001|Overall Study|Informed consent withdrawn|0|||
129764273|NCT01176032|467102441|FG000|Overall Study|Other|1|||
129764274|NCT01176032|467102442|FG001|Overall Study|Other|0|||
129764275|NCT01469221|467102443|FG000|Double Blind Phase|Protocol Violation|1|||
129764276|NCT01469221|467102444|FG001|Double Blind Phase|Protocol Violation|0|||
129764277|NCT01469221|467102445|FG002|Double Blind Phase|Protocol Violation|0|||
129764278|NCT01469221|467102443|FG000|Double Blind Phase|Physician Decision|1|||
129764279|NCT01469221|467102444|FG001|Double Blind Phase|Physician Decision|1|||
129764280|NCT01469221|467102445|FG002|Double Blind Phase|Physician Decision|0|||
129764281|NCT01469221|467102443|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
129764282|NCT01469221|467102444|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
129764283|NCT01469221|467102445|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
129764284|NCT03186209|467102451|FG000|Overall Study|Withdrawal by Subject|11|||
129764285|NCT03186209|467102452|FG001|Overall Study|Withdrawal by Subject|22|||
129764286|NCT03186209|467102451|FG000|Overall Study|Pregnancy|1|||
129764287|NCT03186209|467102452|FG001|Overall Study|Pregnancy|0|||
129764288|NCT03186209|467102451|FG000|Overall Study|Adverse Event|4|||
129764289|NCT03186209|467102452|FG001|Overall Study|Adverse Event|0|||
129764290|NCT03186209|467102451|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
129764291|NCT03186209|467102452|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
129764292|NCT03186209|467102451|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
129764293|NCT03186209|467102452|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
129764294|NCT03186209|467102451|FG000|Overall Study|Fail to meet randomization criteria|0|||
129764295|NCT03186209|467102452|FG001|Overall Study|Fail to meet randomization criteria|1|||
129764296|NCT03186209|467102451|FG000|Overall Study|Lost to Follow-up|0|||
129764297|NCT03186209|467102452|FG001|Overall Study|Lost to Follow-up|1|||
129764298|NCT04739982|467102458|FG000|Overall Study|Lost to Follow-up|176|||
129764299|NCT04739982|467102459|FG001|Overall Study|Lost to Follow-up|65|||
129764300|NCT04739982|467102458|FG000|Overall Study|Withdrawal by Subject|19|||
129764301|NCT04739982|467102459|FG001|Overall Study|Withdrawal by Subject|0|||
129764302|NCT04739982|467102458|FG000|Overall Study|Protocol Violation|0|||
129764303|NCT04739982|467102459|FG001|Overall Study|Protocol Violation|5|||
129764304|NCT04079296|467102460|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
129764305|NCT04079296|467102461|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
129764306|NCT04079296|467102462|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
129764307|NCT04079296|467102463|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
129764308|NCT04079296|467102464|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
129764309|NCT04079296|467102460|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
129764310|NCT04079296|467102461|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
129764311|NCT04079296|467102462|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
129764312|NCT04079296|467102463|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
129764313|NCT04079296|467102464|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
129764314|NCT04079296|467102460|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129764315|NCT04079296|467102461|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129764316|NCT04079296|467102462|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129764317|NCT04079296|467102463|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
129764318|NCT04079296|467102464|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
129764319|NCT04079296|467102460|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129764320|NCT04079296|467102461|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129764321|NCT04079296|467102462|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129764322|NCT04079296|467102463|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
129764323|NCT04079296|467102464|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
129764324|NCT04079296|467102460|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129764325|NCT04079296|467102461|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129764326|NCT04079296|467102462|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129764327|NCT04079296|467102463|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
129764328|NCT04079296|467102464|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
129764329|NCT04079296|467102460|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
129764330|NCT04079296|467102461|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
129764331|NCT04079296|467102462|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
129764332|NCT04079296|467102463|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
129764333|NCT04079296|467102464|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
129764334|NCT04079296|467102460|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
129764335|NCT04079296|467102461|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
129764336|NCT04079296|467102462|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
129764337|NCT04079296|467102463|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
129764338|NCT04079296|467102464|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
129764339|NCT04079296|467102460|FG000|Dose Expansion Phase (168 Days)|Death|0|||
129764340|NCT04079296|467102461|FG001|Dose Expansion Phase (168 Days)|Death|0|||
129764341|NCT04079296|467102462|FG002|Dose Expansion Phase (168 Days)|Death|0|||
129764342|NCT04079296|467102463|FG003|Dose Expansion Phase (168 Days)|Death|1|||
129764343|NCT04079296|467102464|FG004|Dose Expansion Phase (168 Days)|Death|0|||
129764344|NCT01346358|467102477|FG000|Overall Study|Withdrawal by Subject|1|||
129764345|NCT01346358|467102478|FG001|Overall Study|Withdrawal by Subject|0|||
129764346|NCT01346358|467102479|FG002|Overall Study|Withdrawal by Subject|1|||
129764347|NCT01346358|467102480|FG003|Overall Study|Withdrawal by Subject|1|||
129764348|NCT01346358|467102481|FG004|Overall Study|Withdrawal by Subject|0|||
129764349|NCT01346358|467102482|FG005|Overall Study|Withdrawal by Subject|2|||
129764350|NCT01346358|467102483|FG006|Overall Study|Withdrawal by Subject|1|||
129764351|NCT01346358|467102484|FG007|Overall Study|Withdrawal by Subject|1|||
129764352|NCT01346358|467102485|FG008|Overall Study|Withdrawal by Subject|1|||
129764353|NCT01346358|467102477|FG000|Overall Study|Adverse Event|1|||
129764354|NCT01346358|467102478|FG001|Overall Study|Adverse Event|0|||
129764355|NCT01346358|467102479|FG002|Overall Study|Adverse Event|0|||
129764356|NCT01346358|467102480|FG003|Overall Study|Adverse Event|0|||
129764357|NCT01346358|467102481|FG004|Overall Study|Adverse Event|1|||
129764358|NCT01346358|467102482|FG005|Overall Study|Adverse Event|0|||
129764359|NCT01346358|467102483|FG006|Overall Study|Adverse Event|0|||
129764360|NCT01346358|467102484|FG007|Overall Study|Adverse Event|0|||
129764361|NCT01346358|467102485|FG008|Overall Study|Adverse Event|1|||
129764362|NCT01346358|467102477|FG000|Overall Study|Non-Compliance|0|||
129764363|NCT01346358|467102478|FG001|Overall Study|Non-Compliance|0|||
129764364|NCT01346358|467102479|FG002|Overall Study|Non-Compliance|0|||
129764365|NCT01346358|467102480|FG003|Overall Study|Non-Compliance|0|||
129764366|NCT01346358|467102481|FG004|Overall Study|Non-Compliance|0|||
129764367|NCT01346358|467102482|FG005|Overall Study|Non-Compliance|0|||
129764368|NCT01346358|467102483|FG006|Overall Study|Non-Compliance|0|||
129764369|NCT01346358|467102484|FG007|Overall Study|Non-Compliance|2|||
129764370|NCT01346358|467102485|FG008|Overall Study|Non-Compliance|0|||
129764371|NCT01346358|467102477|FG000|Overall Study|Physician Decision|0|||
129764372|NCT01346358|467102478|FG001|Overall Study|Physician Decision|1|||
129764373|NCT01346358|467102479|FG002|Overall Study|Physician Decision|0|||
129764374|NCT01346358|467102480|FG003|Overall Study|Physician Decision|0|||
129764375|NCT01346358|467102481|FG004|Overall Study|Physician Decision|0|||
129764376|NCT01346358|467102482|FG005|Overall Study|Physician Decision|0|||
129764377|NCT01346358|467102483|FG006|Overall Study|Physician Decision|0|||
129764378|NCT01346358|467102484|FG007|Overall Study|Physician Decision|1|||
129764379|NCT01346358|467102485|FG008|Overall Study|Physician Decision|1|||
129764380|NCT05058365|467102488|FG000|Overall Study|Migration|1|||
129764381|NCT05058365|467102489|FG001|Overall Study|Migration|1|||
129764382|NCT00702702|467102490|FG000|Overall Study|Study prematurely terminated|56|||
129764383|NCT04038359|467102491|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
129764384|NCT04038359|467102492|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
129764385|NCT04038359|467102491|FG000|Overall Study|Death|8|||
129764386|NCT04038359|467102492|FG001|Overall Study|Death|7|||
129764387|NCT04038359|467102491|FG000|Overall Study|Lost to Follow-up|3|||
129764388|NCT04038359|467102492|FG001|Overall Study|Lost to Follow-up|0|||
129764389|NCT04038359|467102491|FG000|Overall Study|Participant Moved|1|||
129764390|NCT04038359|467102492|FG001|Overall Study|Participant Moved|0|||
129764391|NCT04038359|467102491|FG000|Overall Study|Withdrawal by Subject|4|||
129764392|NCT04038359|467102492|FG001|Overall Study|Withdrawal by Subject|3|||
129764393|NCT04038359|467102491|FG000|Overall Study|Physician Decision|3|||
129764394|NCT04038359|467102492|FG001|Overall Study|Physician Decision|2|||
129764395|NCT04038359|467102491|FG000|Overall Study|Adverse Event|0|||
129764396|NCT04038359|467102492|FG001|Overall Study|Adverse Event|2|||
129764397|NCT04038359|467102491|FG000|Overall Study|Progressive Disease|0|||
129764398|NCT04038359|467102492|FG001|Overall Study|Progressive Disease|1|||
129764399|NCT02004236|467102493|FG000|Overall Study|Lack of Efficacy|0|||
129764400|NCT02004236|467102494|FG001|Overall Study|Lack of Efficacy|0|||
129764401|NCT02004236|467102495|FG002|Overall Study|Lack of Efficacy|16|||
129764402|NCT05121766|467102496|FG000|Overall Study|Covid reinfection|3|||
129764403|NCT05121766|467102497|FG001|Overall Study|Covid reinfection|0|||
129764404|NCT05121766|467102496|FG000|Overall Study|Withdrawal by Subject|3|||
129764405|NCT05121766|467102497|FG001|Overall Study|Withdrawal by Subject|1|||
129764406|NCT05121766|467102496|FG000|Overall Study|Adverse Event|2|||
129764407|NCT05121766|467102497|FG001|Overall Study|Adverse Event|4|||
129764408|NCT05121766|467102496|FG000|Overall Study|Lost to Follow-up|0|||
129764409|NCT05121766|467102497|FG001|Overall Study|Lost to Follow-up|1|||
129764410|NCT03259230|467102499|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
129764411|NCT03259230|467102500|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
129764412|NCT01033240|467102501|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
129764413|NCT01033240|467102502|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
129764414|NCT01033240|467102503|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
129764415|NCT01033240|467102501|FG000|Overall Study|Death|2|||
129764416|NCT01033240|467102502|FG001|Overall Study|Death|0|||
129764417|NCT01033240|467102503|FG002|Overall Study|Death|0|||
129764418|NCT01033240|467102501|FG000|Overall Study|Withdrew Consent|2|||
129764419|NCT01033240|467102502|FG001|Overall Study|Withdrew Consent|9|||
129764420|NCT01033240|467102503|FG002|Overall Study|Withdrew Consent|2|||
129764421|NCT01033240|467102501|FG000|Overall Study|Disease Progression|35|||
129764422|NCT01033240|467102502|FG001|Overall Study|Disease Progression|32|||
129764423|NCT01033240|467102503|FG002|Overall Study|Disease Progression|41|||
129764424|NCT01033240|467102501|FG000|Overall Study|Investigator Discretion|0|||
129764425|NCT01033240|467102502|FG001|Overall Study|Investigator Discretion|0|||
129764426|NCT01033240|467102503|FG002|Overall Study|Investigator Discretion|2|||
129764427|NCT01033240|467102501|FG000|Overall Study|Other|0|||
129764428|NCT01033240|467102502|FG001|Overall Study|Other|1|||
129764429|NCT01033240|467102503|FG002|Overall Study|Other|2|||
129764430|NCT02960217|467102505|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
129764431|NCT02960217|467102506|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
129764432|NCT02960217|467102505|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
129764433|NCT02960217|467102506|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
129764434|NCT02960217|467102505|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
129764435|NCT02960217|467102506|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
129764436|NCT02960217|467102505|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
129764437|NCT02960217|467102506|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
129764438|NCT02960217|467102505|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
129764439|NCT02960217|467102506|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
129764440|NCT02960217|467102505|FG000|Open-Label Extension Phase|Adverse Event|1|||
129764441|NCT02960217|467102506|FG001|Open-Label Extension Phase|Adverse Event|0|||
129764442|NCT02960217|467102505|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
129764443|NCT02960217|467102506|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
129764444|NCT02960217|467102505|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
129764445|NCT02960217|467102506|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
129764446|NCT02960217|467102505|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
129764447|NCT02960217|467102506|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
129764448|NCT00625131|467102507|FG000|Overall Study|Lost to Follow-up|3|||
129764449|NCT00625131|467102508|FG001|Overall Study|Lost to Follow-up|2|||
129764450|NCT00625131|467102509|FG002|Overall Study|Lost to Follow-up|0|||
129764451|NCT00625131|467102507|FG000|Overall Study|Withdrawal by Subject|1|||
129764452|NCT00625131|467102508|FG001|Overall Study|Withdrawal by Subject|0|||
129764453|NCT00625131|467102509|FG002|Overall Study|Withdrawal by Subject|5|||
129764454|NCT00918281|467102512|FG000|Overall Study|Physician Decision|29|||
129764455|NCT01743469|467102513|FG000|Active Treatment Phase|Adverse Event|10|||
129764456|NCT01743469|467102514|FG001|Active Treatment Phase|Adverse Event|5|||
129764457|NCT01743469|467102515|FG002|Active Treatment Phase|Adverse Event|8|||
129764458|NCT01743469|467102516|FG003|Active Treatment Phase|Adverse Event|1|||
129764459|NCT01743469|467102513|FG000|Active Treatment Phase|Disease Progression|40|||
129764460|NCT01743469|467102514|FG001|Active Treatment Phase|Disease Progression|47|||
129764461|NCT01743469|467102515|FG002|Active Treatment Phase|Disease Progression|30|||
129764462|NCT01743469|467102516|FG003|Active Treatment Phase|Disease Progression|20|||
129764463|NCT01743469|467102513|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
129764464|NCT01743469|467102514|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
129764465|NCT01743469|467102515|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
129764466|NCT01743469|467102516|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
129764467|NCT01743469|467102513|FG000|Active Treatment Phase|Missing|1|||
129764468|NCT01743469|467102514|FG001|Active Treatment Phase|Missing|0|||
129764469|NCT01743469|467102515|FG002|Active Treatment Phase|Missing|0|||
129764470|NCT01743469|467102516|FG003|Active Treatment Phase|Missing|0|||
129764471|NCT01743469|467102513|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
129764472|NCT01743469|467102514|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
129764473|NCT01743469|467102515|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
129764474|NCT01743469|467102516|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
129764475|NCT01743469|467102513|FG000|Follow-up Period - Post-Treatment|Death|43|||
129764476|NCT01743469|467102514|FG001|Follow-up Period - Post-Treatment|Death|47|||
129764477|NCT01743469|467102515|FG002|Follow-up Period - Post-Treatment|Death|22|||
129764478|NCT01743469|467102516|FG003|Follow-up Period - Post-Treatment|Death|16|||
129764479|NCT01743469|467102513|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
129764480|NCT01743469|467102514|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
129764481|NCT01743469|467102515|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
129764482|NCT01743469|467102516|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
129764483|NCT00317473|467102517|FG000|Overall Study|Withdrawal by Subject|2|||
129764484|NCT00317473|467102518|FG001|Overall Study|Withdrawal by Subject|1|||
129764485|NCT00317473|467102519|FG002|Overall Study|Withdrawal by Subject|2|||
129764486|NCT00317473|467102520|FG003|Overall Study|Withdrawal by Subject|1|||
129764487|NCT00317473|467102521|FG004|Overall Study|Withdrawal by Subject|3|||
129764488|NCT00317473|467102522|FG005|Overall Study|Withdrawal by Subject|1|||
129764489|NCT00317473|467102517|FG000|Overall Study|Relocation|1|||
129764490|NCT00317473|467102518|FG001|Overall Study|Relocation|0|||
129764491|NCT00317473|467102519|FG002|Overall Study|Relocation|1|||
129764492|NCT00317473|467102520|FG003|Overall Study|Relocation|1|||
129764493|NCT00317473|467102521|FG004|Overall Study|Relocation|5|||
129764494|NCT00317473|467102522|FG005|Overall Study|Relocation|2|||
129764495|NCT00317473|467102517|FG000|Overall Study|Death|1|||
129764496|NCT00317473|467102518|FG001|Overall Study|Death|0|||
129764497|NCT00317473|467102519|FG002|Overall Study|Death|0|||
129764498|NCT00317473|467102520|FG003|Overall Study|Death|0|||
129764499|NCT00317473|467102521|FG004|Overall Study|Death|0|||
129764500|NCT00317473|467102522|FG005|Overall Study|Death|0|||
129764501|NCT00317473|467102517|FG000|Overall Study|Other|0|||
129764502|NCT00317473|467102518|FG001|Overall Study|Other|2|||
129764503|NCT00317473|467102519|FG002|Overall Study|Other|0|||
129764504|NCT00317473|467102520|FG003|Overall Study|Other|0|||
129764505|NCT00317473|467102521|FG004|Overall Study|Other|0|||
129764506|NCT00317473|467102522|FG005|Overall Study|Other|0|||
129764507|NCT00388349|467102523|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
129764508|NCT00388349|467102524|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
129764509|NCT00168844|467102525|FG000|Overall Study|Adverse Event|31|||
129764510|NCT00168844|467102526|FG001|Overall Study|Adverse Event|32|||
129764511|NCT00168844|467102527|FG002|Overall Study|Adverse Event|48|||
129764512|NCT00168844|467102525|FG000|Overall Study|Lost to Follow-up|4|||
129764513|NCT00168844|467102526|FG001|Overall Study|Lost to Follow-up|5|||
129764514|NCT00168844|467102527|FG002|Overall Study|Lost to Follow-up|11|||
129764515|NCT00168844|467102525|FG000|Overall Study|Withdrawal by Subject|12|||
129764516|NCT00168844|467102526|FG001|Overall Study|Withdrawal by Subject|9|||
129764517|NCT00168844|467102527|FG002|Overall Study|Withdrawal by Subject|19|||
129764518|NCT00168844|467102525|FG000|Overall Study|Protocol Violation|2|||
129764519|NCT00168844|467102526|FG001|Overall Study|Protocol Violation|2|||
129764520|NCT00168844|467102527|FG002|Overall Study|Protocol Violation|4|||
129764521|NCT00168844|467102525|FG000|Overall Study|Other|6|||
129764522|NCT00168844|467102526|FG001|Overall Study|Other|7|||
129764523|NCT00168844|467102527|FG002|Overall Study|Other|9|||
129764524|NCT02138890|467102536|FG000|Overall Study|Adverse Event|1|||
129764525|NCT02138890|467102537|FG001|Overall Study|Adverse Event|0|||
129764526|NCT01446159|467102540|FG000|Overall Study|Withdrawal by Subject|1|||
129764527|NCT01446159|467102541|FG001|Overall Study|Withdrawal by Subject|0|||
129764528|NCT01446159|467102542|FG002|Overall Study|Withdrawal by Subject|14|||
129764529|NCT01446159|467102543|FG003|Overall Study|Withdrawal by Subject|11|||
129764530|NCT01446159|467102540|FG000|Overall Study|Lost to Follow-up|0|||
129764531|NCT01446159|467102541|FG001|Overall Study|Lost to Follow-up|0|||
129764532|NCT01446159|467102542|FG002|Overall Study|Lost to Follow-up|1|||
129764533|NCT01446159|467102543|FG003|Overall Study|Lost to Follow-up|2|||
129764534|NCT01446159|467102540|FG000|Overall Study|Death|2|||
129764535|NCT01446159|467102541|FG001|Overall Study|Death|3|||
129764536|NCT01446159|467102542|FG002|Overall Study|Death|43|||
129764537|NCT01446159|467102543|FG003|Overall Study|Death|36|||
129764538|NCT01446159|467102540|FG000|Overall Study|Other|0|||
129764539|NCT01446159|467102541|FG001|Overall Study|Other|0|||
129764540|NCT01446159|467102542|FG002|Overall Study|Other|13|||
129764541|NCT01446159|467102543|FG003|Overall Study|Other|13|||
129764542|NCT00537394|467102544|FG000|First Year of Follow-up|Death|7|||
129764543|NCT00537394|467102545|FG001|First Year of Follow-up|Death|0|||
129764544|NCT00537394|467102546|FG002|First Year of Follow-up|Death|0|||
129764545|NCT00537394|467102544|FG000|First Year of Follow-up|Severe debilitation|1|||
129764546|NCT00537394|467102545|FG001|First Year of Follow-up|Severe debilitation|0|||
129764547|NCT00537394|467102546|FG002|First Year of Follow-up|Severe debilitation|1|||
129764548|NCT00537394|467102544|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
129764549|NCT00537394|467102545|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
129764550|NCT00537394|467102546|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
129764551|NCT00537394|467102544|FG000|First Year of Follow-up|Lost to Follow-up|1|||
129764552|NCT00537394|467102545|FG001|First Year of Follow-up|Lost to Follow-up|5|||
129764553|NCT00537394|467102546|FG002|First Year of Follow-up|Lost to Follow-up|1|||
129764554|NCT00537394|467102544|FG000|2nd Year of Follow-up|Death|4|||
129764555|NCT00537394|467102545|FG001|2nd Year of Follow-up|Death|1|||
129764556|NCT00537394|467102546|FG002|2nd Year of Follow-up|Death|2|||
129764557|NCT00537394|467102544|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
129764558|NCT00537394|467102545|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
129764559|NCT00537394|467102546|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
129764560|NCT00537394|467102544|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
129764561|NCT00537394|467102545|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
129764562|NCT00537394|467102546|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
129764563|NCT00537394|467102544|FG000|2nd Year of Follow-up|Clinic site closure|1|||
129764564|NCT00537394|467102545|FG001|2nd Year of Follow-up|Clinic site closure|0|||
129764565|NCT00537394|467102546|FG002|2nd Year of Follow-up|Clinic site closure|0|||
129764566|NCT00685165|467102548|FG000|Washout Period of 14 Days|Adverse Event|1|||
129764567|NCT00685165|467102549|FG001|Washout Period of 14 Days|Adverse Event|0|||
129764568|NCT00795535|467102557|FG000|Overall Study|incomplete data and technical problems|20|||
129764569|NCT00556075|467102558|FG000|Overall Study|Lost to Follow-up|3|||
129764570|NCT00556075|467102559|FG001|Overall Study|Lost to Follow-up|0|||
129764571|NCT00556075|467102560|FG002|Overall Study|Lost to Follow-up|3|||
129764572|NCT00556075|467102558|FG000|Overall Study|Withdrawal by Subject|3|||
129764573|NCT00556075|467102559|FG001|Overall Study|Withdrawal by Subject|3|||
129764574|NCT00556075|467102560|FG002|Overall Study|Withdrawal by Subject|0|||
129764575|NCT00556075|467102558|FG000|Overall Study|Protocol Violation|1|||
129764576|NCT00556075|467102559|FG001|Overall Study|Protocol Violation|1|||
129764577|NCT00556075|467102560|FG002|Overall Study|Protocol Violation|3|||
129764578|NCT00556075|467102558|FG000|Overall Study|Not eligible|1|||
129764579|NCT00556075|467102559|FG001|Overall Study|Not eligible|1|||
129764580|NCT00556075|467102560|FG002|Overall Study|Not eligible|2|||
129764581|NCT00556075|467102558|FG000|Overall Study|Adverse Event|1|||
129764582|NCT00556075|467102559|FG001|Overall Study|Adverse Event|2|||
129764583|NCT00556075|467102560|FG002|Overall Study|Adverse Event|0|||
129764584|NCT00556075|467102558|FG000|Overall Study|Personal issues|4|||
129764585|NCT00556075|467102559|FG001|Overall Study|Personal issues|1|||
129764586|NCT00556075|467102560|FG002|Overall Study|Personal issues|0|||
129764587|NCT00556075|467102558|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
129764588|NCT00556075|467102559|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
129764589|NCT00556075|467102560|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
129764590|NCT02485691|467102561|FG000|Overall Study|Adverse Event|25|||
129764591|NCT02485691|467102562|FG001|Overall Study|Adverse Event|11|||
129764592|NCT02485691|467102561|FG000|Overall Study|Poor compliance to protocol|0|||
129764593|NCT02485691|467102562|FG001|Overall Study|Poor compliance to protocol|1|||
129764594|NCT02485691|467102561|FG000|Overall Study|Disease progression|57|||
129764595|NCT02485691|467102562|FG001|Overall Study|Disease progression|92|||
129764596|NCT02485691|467102561|FG000|Overall Study|Investigator's decision|23|||
129764597|NCT02485691|467102562|FG001|Overall Study|Investigator's decision|5|||
129764598|NCT02485691|467102561|FG000|Overall Study|Participant's request|13|||
129764599|NCT02485691|467102562|FG001|Overall Study|Participant's request|6|||
129764600|NCT02485691|467102561|FG000|Overall Study|Other reason|8|||
129764601|NCT02485691|467102562|FG001|Overall Study|Other reason|9|||
129764602|NCT02485691|467102561|FG000|Overall Study|Randomized and not treated|3|||
129764603|NCT02485691|467102562|FG001|Overall Study|Randomized and not treated|2|||
129764604|NCT03836625|467102563|FG000|Overall Study|Lost to Follow-up|9|||
129764605|NCT03836625|467102564|FG001|Overall Study|Lost to Follow-up|9|||
129764606|NCT03836625|467102563|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
129764607|NCT03836625|467102564|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
129764608|NCT03836625|467102563|FG000|Overall Study|Death|0|||
129764609|NCT03836625|467102564|FG001|Overall Study|Death|1|||
129764610|NCT03836625|467102563|FG000|Overall Study|Refused follow-up|0|||
129764611|NCT03836625|467102564|FG001|Overall Study|Refused follow-up|1|||
129764612|NCT01420861|467102567|FG000|Overall Study|Adverse Event|2|||
129764613|NCT01420861|467102567|FG000|Overall Study|Study terminated by Sponsor|7|||
129764614|NCT01420861|467102567|FG000|Overall Study|Screen failure|7|||
129764615|NCT01420861|467102567|FG000|Overall Study|Randomized not Treated|2|||
129764616|NCT04764162|467102568|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
129764617|NCT04764162|467102569|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
129764618|NCT03361137|467102570|FG000|Overall Study|Reason not specified|1|||
129764619|NCT03361137|467102571|FG001|Overall Study|Reason not specified|0|||
129764620|NCT03361137|467102572|FG002|Overall Study|Reason not specified|0|||
129764621|NCT03361137|467102573|FG003|Overall Study|Reason not specified|0|||
129764622|NCT03361137|467102574|FG004|Overall Study|Reason not specified|0|||
129764623|NCT03413891|467102575|FG000|Overall Study|Lost to Follow-up|2|||
129764624|NCT03413891|467102576|FG001|Overall Study|Lost to Follow-up|1|||
129764625|NCT03413891|467102575|FG000|Overall Study|Protocol Violation|0|||
129764626|NCT03413891|467102576|FG001|Overall Study|Protocol Violation|1|||
129764627|NCT04905134|467102579|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
129764628|NCT04905134|467102579|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
129764629|NCT03009058|467102580|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
129764630|NCT05556265|467102581|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129764631|NCT05556265|467102582|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
129764632|NCT05556265|467102583|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129764633|NCT05556265|467102584|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129764634|NCT05556265|467102585|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
129764635|NCT05556265|467102581|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129764636|NCT05556265|467102582|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
129764637|NCT05556265|467102583|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129764638|NCT05556265|467102584|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129764639|NCT05556265|467102585|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
129764640|NCT05556265|467102581|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129764641|NCT05556265|467102582|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
129764642|NCT05556265|467102583|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129764643|NCT05556265|467102584|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129764644|NCT05556265|467102585|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
129764645|NCT05556265|467102581|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
129764646|NCT05556265|467102582|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
129764647|NCT05556265|467102583|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
129764648|NCT05556265|467102584|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
129764649|NCT05556265|467102585|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
129764650|NCT05556265|467102581|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
129764651|NCT05556265|467102582|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
129764652|NCT05556265|467102583|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
129764653|NCT05556265|467102584|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
129764654|NCT05556265|467102585|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
129764655|NCT05556265|467102581|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
129764656|NCT05556265|467102582|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
129764657|NCT05556265|467102583|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
129764658|NCT05556265|467102584|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
129764659|NCT05556265|467102585|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
129764660|NCT05556265|467102581|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
129764661|NCT05556265|467102582|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
129764662|NCT05556265|467102583|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
129764663|NCT05556265|467102584|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
129764664|NCT05556265|467102585|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
129764665|NCT05556265|467102581|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
129764666|NCT05556265|467102582|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
129764667|NCT05556265|467102583|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
129764668|NCT05556265|467102584|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
129764669|NCT05556265|467102585|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
129764670|NCT05556265|467102581|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
129764671|NCT05556265|467102582|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
129764672|NCT05556265|467102583|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
129764673|NCT05556265|467102584|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
129764674|NCT05556265|467102585|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
129764675|NCT01486966|467102588|FG000|Overall Study|Adverse Event|0|||
129764676|NCT01486966|467102589|FG001|Overall Study|Adverse Event|1|||
129764677|NCT01486966|467102588|FG000|Overall Study|Withdrawal by Subject|0|||
129764678|NCT01486966|467102589|FG001|Overall Study|Withdrawal by Subject|1|||
129764679|NCT02153086|467104566|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
129764680|NCT02153086|467104566|FG000|Overall Study|Other|2|||
129764681|NCT01317472|467104567|FG000|Overall Study|Withdrawal by Subject|1|||
129764682|NCT01317472|467104568|FG001|Overall Study|Withdrawal by Subject|0|||
129764683|NCT01317472|467104567|FG000|Overall Study|Unrelated hospitalization|1|||
129764684|NCT01317472|467104568|FG001|Overall Study|Unrelated hospitalization|0|||
129764685|NCT05546476|467104569|FG000|Period 1: Part A|Adverse Event|2|||
129764686|NCT05546476|467104570|FG001|Period 1: Part A|Adverse Event|0|||
129764687|NCT05546476|467104571|FG002|Period 1: Part A|Adverse Event|0|||
129764688|NCT05546476|467104572|FG003|Period 1: Part A|Adverse Event|1|||
129764689|NCT05546476|467104569|FG000|Period 1: Part A|Death|4|||
129764690|NCT05546476|467104570|FG001|Period 1: Part A|Death|4|||
129764691|NCT05546476|467104571|FG002|Period 1: Part A|Death|5|||
129764692|NCT05546476|467104572|FG003|Period 1: Part A|Death|6|||
129764693|NCT05546476|467104569|FG000|Period 1: Part A|Lack of Efficacy|0|||
129764694|NCT05546476|467104570|FG001|Period 1: Part A|Lack of Efficacy|0|||
129764695|NCT05546476|467104571|FG002|Period 1: Part A|Lack of Efficacy|0|||
129764696|NCT05546476|467104572|FG003|Period 1: Part A|Lack of Efficacy|1|||
129764697|NCT05546476|467104569|FG000|Period 1: Part A|Lost to Follow-up|0|||
129764698|NCT05546476|467104570|FG001|Period 1: Part A|Lost to Follow-up|0|||
129764699|NCT05546476|467104571|FG002|Period 1: Part A|Lost to Follow-up|0|||
129764700|NCT05546476|467104572|FG003|Period 1: Part A|Lost to Follow-up|1|||
129764701|NCT05546476|467104569|FG000|Period 1: Part A|Physician Decision|1|||
129764702|NCT05546476|467104570|FG001|Period 1: Part A|Physician Decision|0|||
129764703|NCT05546476|467104571|FG002|Period 1: Part A|Physician Decision|0|||
129764704|NCT05546476|467104572|FG003|Period 1: Part A|Physician Decision|0|||
129764705|NCT05546476|467104569|FG000|Period 1: Part A|Progressive disease|3|||
129764706|NCT05546476|467104570|FG001|Period 1: Part A|Progressive disease|5|||
129764707|NCT05546476|467104571|FG002|Period 1: Part A|Progressive disease|0|||
129764708|NCT05546476|467104572|FG003|Period 1: Part A|Progressive disease|1|||
129764709|NCT05546476|467104569|FG000|Period 1: Part A|Withdrawal by Subject|1|||
129764710|NCT05546476|467104570|FG001|Period 1: Part A|Withdrawal by Subject|1|||
129764711|NCT05546476|467104571|FG002|Period 1: Part A|Withdrawal by Subject|1|||
129764712|NCT05546476|467104572|FG003|Period 1: Part A|Withdrawal by Subject|2|||
129764713|NCT05546476|467104569|FG000|Period 1: Part A|Global deterioration of health status|2|||
129764714|NCT05546476|467104570|FG001|Period 1: Part A|Global deterioration of health status|2|||
129764715|NCT05546476|467104571|FG002|Period 1: Part A|Global deterioration of health status|1|||
129764716|NCT05546476|467104572|FG003|Period 1: Part A|Global deterioration of health status|4|||
129764717|NCT05546476|467104569|FG000|Period 1: Part A|Other: Unspecified|0|||
129764718|NCT05546476|467104570|FG001|Period 1: Part A|Other: Unspecified|2|||
129764719|NCT05546476|467104571|FG002|Period 1: Part A|Other: Unspecified|0|||
129764720|NCT05546476|467104572|FG003|Period 1: Part A|Other: Unspecified|0|||
129764721|NCT05546476|467104569|FG000|Period 2: Part B|Ongoing|26|||
129764722|NCT05546476|467104570|FG001|Period 2: Part B|Ongoing|27|||
129764723|NCT05546476|467104571|FG002|Period 2: Part B|Ongoing|35|||
129764724|NCT05546476|467104572|FG003|Period 2: Part B|Ongoing|29|||
129764725|NCT02953652|467104573|FG000|Overall Study|Adverse Event|18|||
129764726|NCT02953652|467104573|FG000|Overall Study|Withdrawal by Subject|6|||
129764727|NCT02953652|467104573|FG000|Overall Study|Protocol Violation|1|||
129764728|NCT02953652|467104573|FG000|Overall Study|Disease Progression|27|||
129764729|NCT00772538|467104574|FG000|Overall Study|Adverse Event|6|||
129764730|NCT00772538|467104575|FG001|Overall Study|Adverse Event|6|||
129764731|NCT00772538|467104574|FG000|Overall Study|Protocol Violation|3|||
129764732|NCT00772538|467104575|FG001|Overall Study|Protocol Violation|3|||
129764733|NCT00772538|467104574|FG000|Overall Study|Lost to Follow-up|1|||
129764734|NCT00772538|467104575|FG001|Overall Study|Lost to Follow-up|1|||
129764735|NCT00772538|467104574|FG000|Overall Study|Withdrawal by Subject|3|||
129764736|NCT00772538|467104575|FG001|Overall Study|Withdrawal by Subject|8|||
129764737|NCT00772538|467104574|FG000|Overall Study|Lack of Efficacy|0|||
129764738|NCT00772538|467104575|FG001|Overall Study|Lack of Efficacy|1|||
129764739|NCT00772538|467104574|FG000|Overall Study|Other|7|||
129764740|NCT00772538|467104575|FG001|Overall Study|Other|7|||
129764741|NCT00713609|467104578|FG000|Overall Study|Adverse Event|2|||
129764742|NCT00713609|467104579|FG001|Overall Study|Adverse Event|0|||
129764743|NCT00713609|467104580|FG002|Overall Study|Adverse Event|2|||
129764744|NCT00713609|467104581|FG003|Overall Study|Adverse Event|2|||
129764745|NCT00713609|467104582|FG004|Overall Study|Adverse Event|3|||
129764746|NCT00713609|467104583|FG005|Overall Study|Adverse Event|1|||
129764747|NCT00713609|467104578|FG000|Overall Study|Lost to Follow-up|5|||
129764748|NCT00713609|467104579|FG001|Overall Study|Lost to Follow-up|7|||
129764749|NCT00713609|467104580|FG002|Overall Study|Lost to Follow-up|5|||
129764750|NCT00713609|467104581|FG003|Overall Study|Lost to Follow-up|5|||
129764751|NCT00713609|467104582|FG004|Overall Study|Lost to Follow-up|7|||
129764752|NCT00713609|467104583|FG005|Overall Study|Lost to Follow-up|0|||
129764753|NCT00713609|467104578|FG000|Overall Study|Lack of Efficacy|1|||
129764754|NCT00713609|467104579|FG001|Overall Study|Lack of Efficacy|3|||
129764755|NCT00713609|467104580|FG002|Overall Study|Lack of Efficacy|0|||
129764756|NCT00713609|467104581|FG003|Overall Study|Lack of Efficacy|0|||
129764757|NCT00713609|467104582|FG004|Overall Study|Lack of Efficacy|1|||
129764758|NCT00713609|467104583|FG005|Overall Study|Lack of Efficacy|0|||
129764759|NCT00713609|467104578|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
129764760|NCT00713609|467104579|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
129764761|NCT00713609|467104580|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
129764762|NCT00713609|467104581|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
129764763|NCT00713609|467104582|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
129764764|NCT00713609|467104583|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
129764765|NCT00713609|467104578|FG000|Overall Study|Withdrawal by Subject|6|||
129764766|NCT00713609|467104579|FG001|Overall Study|Withdrawal by Subject|1|||
129764767|NCT00713609|467104580|FG002|Overall Study|Withdrawal by Subject|5|||
129764768|NCT00713609|467104581|FG003|Overall Study|Withdrawal by Subject|1|||
129764769|NCT00713609|467104582|FG004|Overall Study|Withdrawal by Subject|5|||
129875368|NCT01782872|467501925|FG002|Overall Study|Withdrawal by Subject|0|||
129875369|NCT01782872|467501926|FG003|Overall Study|Withdrawal by Subject|0|||
129542768|NCT00948896|466278844|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129764770|NCT00713609|467104583|FG005|Overall Study|Withdrawal by Subject|7|||
129764771|NCT00713609|467104578|FG000|Overall Study|Protocol Violation|6|||
129764772|NCT00713609|467104579|FG001|Overall Study|Protocol Violation|3|||
129764773|NCT00713609|467104580|FG002|Overall Study|Protocol Violation|1|||
129764774|NCT00713609|467104581|FG003|Overall Study|Protocol Violation|1|||
129764775|NCT00713609|467104582|FG004|Overall Study|Protocol Violation|2|||
129764776|NCT00713609|467104583|FG005|Overall Study|Protocol Violation|0|||
129764777|NCT03780452|467104584|FG000|Overall Study|Screening failure|2|||
129764778|NCT01001221|467104585|FG000|Overall Study|Adverse Event|1|||
129764779|NCT01001221|467104586|FG001|Overall Study|Adverse Event|2|||
129764780|NCT01001221|467104587|FG002|Overall Study|Adverse Event|0|||
129764781|NCT01001221|467104588|FG003|Overall Study|Adverse Event|2|||
129764782|NCT01001221|467104589|FG004|Overall Study|Adverse Event|0|||
129764783|NCT01001221|467104585|FG000|Overall Study|Disease progression|3|||
129764784|NCT01001221|467104586|FG001|Overall Study|Disease progression|2|||
129764785|NCT01001221|467104587|FG002|Overall Study|Disease progression|2|||
129764786|NCT01001221|467104588|FG003|Overall Study|Disease progression|4|||
129764787|NCT01001221|467104589|FG004|Overall Study|Disease progression|0|||
129764788|NCT01001221|467104585|FG000|Overall Study|Other|1|||
129764789|NCT01001221|467104586|FG001|Overall Study|Other|1|||
129764790|NCT01001221|467104587|FG002|Overall Study|Other|0|||
129764791|NCT01001221|467104588|FG003|Overall Study|Other|0|||
129764792|NCT01001221|467104589|FG004|Overall Study|Other|0|||
129764793|NCT01001221|467104585|FG000|Overall Study|Not treated; protocol exclusion|0|||
129764794|NCT01001221|467104586|FG001|Overall Study|Not treated; protocol exclusion|0|||
129764795|NCT01001221|467104587|FG002|Overall Study|Not treated; protocol exclusion|1|||
129764796|NCT01001221|467104588|FG003|Overall Study|Not treated; protocol exclusion|0|||
129764797|NCT01001221|467104589|FG004|Overall Study|Not treated; protocol exclusion|0|||
129764798|NCT01791244|467104591|FG000|Overall Study|Adverse Event|5|||
129764799|NCT01791244|467104592|FG001|Overall Study|Adverse Event|7|||
129764800|NCT01791244|467104591|FG000|Overall Study|Insufficient clinical response|10|||
129764801|NCT01791244|467104592|FG001|Overall Study|Insufficient clinical response|10|||
129764802|NCT01791244|467104591|FG000|Overall Study|Laboratory Abnormality|0|||
129764803|NCT01791244|467104592|FG001|Overall Study|Laboratory Abnormality|1|||
129764804|NCT01383928|467104593|FG000|Overall Study|Initiation of ASCT|2|||
129764805|NCT01383928|467104594|FG001|Overall Study|Initiation of ASCT|1|||
129764806|NCT01383928|467104595|FG002|Overall Study|Initiation of ASCT|18|||
129764807|NCT01383928|467104593|FG000|Overall Study|Adverse Event|1|||
129764808|NCT01383928|467104594|FG001|Overall Study|Adverse Event|2|||
129764809|NCT01383928|467104595|FG002|Overall Study|Adverse Event|8|||
129764810|NCT01383928|467104593|FG000|Overall Study|Other|1|||
129764811|NCT01383928|467104594|FG001|Overall Study|Other|3|||
129764812|NCT01383928|467104595|FG002|Overall Study|Other|4|||
129764813|NCT01383928|467104593|FG000|Overall Study|Progressive Disease|1|||
129764814|NCT01383928|467104594|FG001|Overall Study|Progressive Disease|1|||
129764815|NCT01383928|467104595|FG002|Overall Study|Progressive Disease|5|||
129764816|NCT01383928|467104593|FG000|Overall Study|Withdrawal by Subject|0|||
129764817|NCT01383928|467104594|FG001|Overall Study|Withdrawal by Subject|0|||
129764818|NCT01383928|467104595|FG002|Overall Study|Withdrawal by Subject|4|||
129764819|NCT01383928|467104593|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
129764820|NCT01383928|467104594|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129764821|NCT01383928|467104595|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
129764822|NCT01149096|467104597|FG000|Overall Study|Lost to Follow-up|0|||
129764823|NCT01149096|467104598|FG001|Overall Study|Lost to Follow-up|1|||
129764824|NCT03651765|467104602|FG000|Overall Study|Adverse Event|6|||
129764825|NCT03651765|467104602|FG000|Overall Study|Lack of Efficacy|18|||
129764826|NCT03651765|467104602|FG000|Overall Study|Lost to Follow-up|5|||
129764827|NCT03651765|467104602|FG000|Overall Study|Non-Compliance with Study Drug|4|||
129764828|NCT03651765|467104602|FG000|Overall Study|Physician Decision|6|||
129764829|NCT03651765|467104602|FG000|Overall Study|Pregnancy|1|||
129764830|NCT03651765|467104602|FG000|Overall Study|Discontinued by Sponsor|40|||
129764831|NCT03651765|467104602|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
129764832|NCT03651765|467104602|FG000|Overall Study|Withdrawal by Subject|24|||
129764833|NCT03651765|467104602|FG000|Overall Study|Miscellaneous|6|||
129764834|NCT00703014|467104608|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
129764835|NCT00703014|467104609|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
129764836|NCT00703014|467104610|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129764837|NCT00703014|467104611|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129764838|NCT00703014|467104608|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129764839|NCT00703014|467104609|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
129764840|NCT00703014|467104610|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
129764841|NCT00703014|467104611|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
129764842|NCT05468814|467104614|FG000|Overall Study|Lost to Follow-up|5|||
129764843|NCT05468814|467104615|FG001|Overall Study|Lost to Follow-up|6|||
129764844|NCT04716426|467104616|FG000|Overall Study|Vaccination|1|||
129764845|NCT04716426|467104617|FG001|Overall Study|Vaccination|1|||
129764846|NCT04716426|467104616|FG000|Overall Study|Contamination|1|||
129764847|NCT04716426|467104617|FG001|Overall Study|Contamination|0|||
129764848|NCT03668873|467104619|FG000|Overall Study|Lost to Follow-up|6|||
129764849|NCT03668873|467104620|FG001|Overall Study|Lost to Follow-up|3|||
129764850|NCT01521117|467104621|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
129764851|NCT01521117|467104622|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129764852|NCT01521117|467104621|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
129764853|NCT01521117|467104622|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
129764854|NCT01521117|467104621|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129764855|NCT01521117|467104622|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
129764856|NCT00784563|467104623|FG000|Years 1 & 2|Withdrawal by Subject|3|||
129764857|NCT00784563|467104624|FG001|Years 1 & 2|Withdrawal by Subject|2|||
129764858|NCT00784563|467104625|FG002|Years 1 & 2|Withdrawal by Subject|0|||
129764859|NCT00784563|467104623|FG000|Years 1 & 2|Adverse Event|0|||
129764860|NCT00784563|467104624|FG001|Years 1 & 2|Adverse Event|3|||
129764861|NCT00784563|467104625|FG002|Years 1 & 2|Adverse Event|0|||
129764862|NCT00784563|467104623|FG000|Year 3|Withdrawal by Subject|0|||
129764863|NCT00784563|467104624|FG001|Year 3|Withdrawal by Subject|0|||
129764864|NCT00784563|467104625|FG002|Year 3|Withdrawal by Subject|2|||
129764865|NCT00784563|467104623|FG000|Year 3|Adverse Event|0|||
129764866|NCT00784563|467104624|FG001|Year 3|Adverse Event|0|||
129764867|NCT00784563|467104625|FG002|Year 3|Adverse Event|1|||
129764868|NCT00374140|467104632|FG000|Overall Study|Lost to Follow-up|1|||
129764869|NCT00374140|467104632|FG000|Overall Study|Protocol Violation|1|||
129764870|NCT04576988|467104633|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
129764871|NCT04576988|467104634|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
129764872|NCT04576988|467104633|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
129764873|NCT04576988|467104634|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
129764874|NCT04576988|467104633|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
129764875|NCT04576988|467104634|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
129764876|NCT04576988|467104633|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
129764877|NCT04576988|467104634|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
129764878|NCT04576988|467104633|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
129764879|NCT04576988|467104634|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
129764880|NCT04576988|467104633|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
129764881|NCT04576988|467104634|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
129764882|NCT04576988|467104633|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
129764883|NCT04576988|467104634|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
129764884|NCT04576988|467104633|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
129764885|NCT04576988|467104634|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
129764886|NCT04576988|467104633|FG000|Long Term Double Blind (LTDB)|Death|2|||
129764887|NCT04576988|467104634|FG001|Long Term Double Blind (LTDB)|Death|1|||
129764888|NCT04576988|467104633|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
129764889|NCT04576988|467104634|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
129764890|NCT00617734|467104635|FG000|Overall Study|Withdrew Consent|2|||
129764891|NCT00617734|467104636|FG001|Overall Study|Withdrew Consent|0|||
129764892|NCT00617734|467104635|FG000|Overall Study|Adverse Event|4|||
129764893|NCT00617734|467104636|FG001|Overall Study|Adverse Event|1|||
129764894|NCT00617734|467104635|FG000|Overall Study|Protocol Violation|1|||
129764895|NCT00617734|467104636|FG001|Overall Study|Protocol Violation|0|||
129764896|NCT00617734|467104635|FG000|Overall Study|Found Ineligible After Randomization|1|||
129764897|NCT00617734|467104636|FG001|Overall Study|Found Ineligible After Randomization|4|||
129764898|NCT00617734|467104635|FG000|Overall Study|Lost to Follow-up|0|||
129764899|NCT00617734|467104636|FG001|Overall Study|Lost to Follow-up|1|||
129764900|NCT01844765|467104637|FG000|Overall Study|Adverse Event|6|||
129764901|NCT01844765|467104638|FG001|Overall Study|Adverse Event|8|||
129764902|NCT01844765|467104637|FG000|Overall Study|Withdrawal by Subject|2|||
129764903|NCT01844765|467104638|FG001|Overall Study|Withdrawal by Subject|3|||
129764904|NCT01844765|467104637|FG000|Overall Study|Disease progression|1|||
129764905|NCT01844765|467104638|FG001|Overall Study|Disease progression|0|||
129764906|NCT01844765|467104637|FG000|Overall Study|Administrative problems|3|||
129764907|NCT01844765|467104638|FG001|Overall Study|Administrative problems|4|||
129764908|NCT01844765|467104637|FG000|Overall Study|Protocol deviation|2|||
129764909|NCT01844765|467104638|FG001|Overall Study|Protocol deviation|0|||
129764910|NCT01844765|467104637|FG000|Overall Study|Untreated|1|||
129764911|NCT01844765|467104638|FG001|Overall Study|Untreated|0|||
129764912|NCT03221556|467104640|FG000|Allocation|post-randomization exclusion|0|||
129764913|NCT03221556|467104641|FG001|Allocation|post-randomization exclusion|1|||
129764914|NCT03221556|467104640|FG000|Follow-Up|Withdrawal by Subject|0|||
129764915|NCT03221556|467104641|FG001|Follow-Up|Withdrawal by Subject|1|||
129764916|NCT00506350|467104642|FG000|Overall Study|Serious Adverse Event|1|||
129764917|NCT00506350|467104643|FG001|Overall Study|Serious Adverse Event|0|||
129875370|NCT03299686|467501937|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
129764918|NCT00506350|467104644|FG002|Overall Study|Serious Adverse Event|0|||
129764919|NCT00506350|467104645|FG003|Overall Study|Serious Adverse Event|0|||
129764920|NCT00506350|467104646|FG004|Overall Study|Serious Adverse Event|0|||
129764921|NCT00506350|467104647|FG005|Overall Study|Serious Adverse Event|0|||
129764922|NCT00506350|467104648|FG006|Overall Study|Serious Adverse Event|0|||
129764923|NCT00506350|467104649|FG007|Overall Study|Serious Adverse Event|0|||
129764924|NCT00506350|467104650|FG008|Overall Study|Serious Adverse Event|0|||
129764925|NCT00506350|467104642|FG000|Overall Study|Adverse Event|0|||
129764926|NCT00506350|467104643|FG001|Overall Study|Adverse Event|0|||
129764927|NCT00506350|467104644|FG002|Overall Study|Adverse Event|0|||
129764928|NCT00506350|467104645|FG003|Overall Study|Adverse Event|0|||
129764929|NCT00506350|467104646|FG004|Overall Study|Adverse Event|0|||
129764930|NCT00506350|467104647|FG005|Overall Study|Adverse Event|0|||
129764931|NCT00506350|467104648|FG006|Overall Study|Adverse Event|0|||
129764932|NCT00506350|467104649|FG007|Overall Study|Adverse Event|1|||
129764933|NCT00506350|467104650|FG008|Overall Study|Adverse Event|1|||
129764934|NCT00506350|467104642|FG000|Overall Study|Protocol Violation|0|||
129764935|NCT00506350|467104643|FG001|Overall Study|Protocol Violation|0|||
129764936|NCT00506350|467104644|FG002|Overall Study|Protocol Violation|1|||
129764937|NCT00506350|467104645|FG003|Overall Study|Protocol Violation|0|||
129764938|NCT00506350|467104646|FG004|Overall Study|Protocol Violation|0|||
129764939|NCT00506350|467104647|FG005|Overall Study|Protocol Violation|0|||
129764940|NCT00506350|467104648|FG006|Overall Study|Protocol Violation|1|||
129764941|NCT00506350|467104649|FG007|Overall Study|Protocol Violation|0|||
129764942|NCT00506350|467104650|FG008|Overall Study|Protocol Violation|0|||
129764943|NCT00506350|467104642|FG000|Overall Study|Withdrawal by Subject|0|||
129764944|NCT00506350|467104643|FG001|Overall Study|Withdrawal by Subject|1|||
129764945|NCT00506350|467104644|FG002|Overall Study|Withdrawal by Subject|1|||
129764946|NCT00506350|467104645|FG003|Overall Study|Withdrawal by Subject|1|||
129764947|NCT00506350|467104646|FG004|Overall Study|Withdrawal by Subject|4|||
129764948|NCT00506350|467104647|FG005|Overall Study|Withdrawal by Subject|1|||
129764949|NCT00506350|467104648|FG006|Overall Study|Withdrawal by Subject|1|||
129764950|NCT00506350|467104649|FG007|Overall Study|Withdrawal by Subject|2|||
129764951|NCT00506350|467104650|FG008|Overall Study|Withdrawal by Subject|0|||
129764952|NCT00506350|467104642|FG000|Overall Study|Lost to Follow-up|1|||
129764953|NCT00506350|467104643|FG001|Overall Study|Lost to Follow-up|1|||
129764954|NCT00506350|467104644|FG002|Overall Study|Lost to Follow-up|1|||
129764955|NCT00506350|467104645|FG003|Overall Study|Lost to Follow-up|1|||
129764956|NCT00506350|467104646|FG004|Overall Study|Lost to Follow-up|2|||
129764957|NCT00506350|467104647|FG005|Overall Study|Lost to Follow-up|1|||
129764958|NCT00506350|467104648|FG006|Overall Study|Lost to Follow-up|0|||
129764959|NCT00506350|467104649|FG007|Overall Study|Lost to Follow-up|0|||
129764960|NCT00506350|467104650|FG008|Overall Study|Lost to Follow-up|2|||
129764961|NCT00506350|467104642|FG000|Overall Study|Medical Reason|0|||
129764962|NCT00506350|467104643|FG001|Overall Study|Medical Reason|0|||
129764963|NCT00506350|467104644|FG002|Overall Study|Medical Reason|0|||
129764964|NCT00506350|467104645|FG003|Overall Study|Medical Reason|0|||
129764965|NCT00506350|467104646|FG004|Overall Study|Medical Reason|1|||
129764966|NCT00506350|467104647|FG005|Overall Study|Medical Reason|0|||
129764967|NCT00506350|467104648|FG006|Overall Study|Medical Reason|0|||
129764968|NCT00506350|467104649|FG007|Overall Study|Medical Reason|0|||
129764969|NCT00506350|467104650|FG008|Overall Study|Medical Reason|0|||
129764970|NCT00506350|467104642|FG000|Overall Study|Other|1|||
129764971|NCT00506350|467104643|FG001|Overall Study|Other|1|||
129764972|NCT00506350|467104644|FG002|Overall Study|Other|3|||
129764973|NCT00506350|467104645|FG003|Overall Study|Other|0|||
129764974|NCT00506350|467104646|FG004|Overall Study|Other|3|||
129764975|NCT00506350|467104647|FG005|Overall Study|Other|0|||
129764976|NCT00506350|467104648|FG006|Overall Study|Other|0|||
129764977|NCT00506350|467104649|FG007|Overall Study|Other|2|||
129764978|NCT00506350|467104650|FG008|Overall Study|Other|2|||
129764979|NCT01691794|467104651|FG000|Overall Study|Poor/Non-Compliance|1|||
129764980|NCT01691794|467104652|FG001|Overall Study|Poor/Non-Compliance|4|||
129764981|NCT01691794|467104653|FG002|Overall Study|Poor/Non-Compliance|1|||
129764982|NCT01691794|467104651|FG000|Overall Study|Death|0|||
129764983|NCT01691794|467104652|FG001|Overall Study|Death|0|||
129764984|NCT01691794|467104653|FG002|Overall Study|Death|1|||
129764985|NCT01691794|467104651|FG000|Overall Study|Lack of Efficacy|0|||
129764986|NCT01691794|467104652|FG001|Overall Study|Lack of Efficacy|7|||
129764987|NCT01691794|467104653|FG002|Overall Study|Lack of Efficacy|1|||
129764988|NCT01691794|467104651|FG000|Overall Study|Participant request to discontinue|0|||
129764989|NCT01691794|467104652|FG001|Overall Study|Participant request to discontinue|1|||
129764990|NCT01691794|467104653|FG002|Overall Study|Participant request to discontinue|0|||
129875371|NCT03299686|467501938|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
129764991|NCT01691794|467104651|FG000|Overall Study|Adverse Event|0|||
129764992|NCT01691794|467104652|FG001|Overall Study|Adverse Event|1|||
129764993|NCT01691794|467104653|FG002|Overall Study|Adverse Event|1|||
129764994|NCT01691794|467104651|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
129764995|NCT01691794|467104652|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
129764996|NCT01691794|467104653|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
129875372|NCT03299686|467501937|FG000|Treatment Epoch|Physician Decision|1|||
129875373|NCT03299686|467501938|FG001|Treatment Epoch|Physician Decision|0|||
129764997|NCT01691794|467104651|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
129764998|NCT01691794|467104652|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
129764999|NCT01691794|467104653|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
129765000|NCT04972786|467104654|FG000|First Intervention (1 Day)|Adverse Event|1|||
129765001|NCT04972786|467104655|FG001|First Intervention (1 Day)|Adverse Event|0|||
129765002|NCT00844844|467104656|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
129765003|NCT00844844|467104656|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
129765004|NCT00844844|467104656|FG000|Extension Treatment Period|Adverse Event|2|||
129765005|NCT00844844|467104656|FG000|Post Treatment Period|Withdrawal by Subject|1|||
129765006|NCT03905096|467104657|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
129765007|NCT03905096|467104658|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
129765008|NCT02016781|467104660|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
129765009|NCT02016781|467104661|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
129765010|NCT02016781|467104660|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
129765011|NCT02016781|467104661|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
129765012|NCT02016781|467104660|FG000|Final Database Lock|Withdrawal by Subject|2|||
129765013|NCT02016781|467104661|FG001|Final Database Lock|Withdrawal by Subject|1|||
129765014|NCT02016781|467104660|FG000|Final Database Lock|Lost to Follow-up|11|||
129765015|NCT02016781|467104661|FG001|Final Database Lock|Lost to Follow-up|4|||
129765016|NCT02016781|467104660|FG000|Final Database Lock|Missing data|0|||
129765017|NCT02016781|467104661|FG001|Final Database Lock|Missing data|3|||
129765018|NCT04886154|467104662|FG000|Overall Study|Adverse Event|0|||
129765019|NCT04886154|467104663|FG001|Overall Study|Adverse Event|0|||
129765020|NCT04886154|467104664|FG002|Overall Study|Adverse Event|0|||
129765021|NCT04886154|467104665|FG003|Overall Study|Adverse Event|0|||
129765022|NCT04886154|467104666|FG004|Overall Study|Adverse Event|1|||
129765023|NCT04886154|467104667|FG005|Overall Study|Adverse Event|0|||
129765024|NCT04886154|467104668|FG006|Overall Study|Adverse Event|0|||
129765025|NCT04886154|467104669|FG007|Overall Study|Adverse Event|1|||
129765026|NCT04886154|467104670|FG008|Overall Study|Adverse Event|1|||
129765027|NCT04886154|467104671|FG009|Overall Study|Adverse Event|0|||
129765028|NCT04886154|467104672|FG010|Overall Study|Adverse Event|0|||
129765029|NCT04886154|467104673|FG011|Overall Study|Adverse Event|1|||
129765030|NCT04886154|467104674|FG012|Overall Study|Adverse Event|0|||
129765031|NCT04886154|467104675|FG013|Overall Study|Adverse Event|0|||
129765032|NCT04886154|467104676|FG014|Overall Study|Adverse Event|3|||
129765033|NCT04886154|467104662|FG000|Overall Study|Lost to Follow-up|1|||
129765034|NCT04886154|467104663|FG001|Overall Study|Lost to Follow-up|0|||
129765035|NCT04886154|467104664|FG002|Overall Study|Lost to Follow-up|2|||
129765036|NCT04886154|467104665|FG003|Overall Study|Lost to Follow-up|0|||
129765037|NCT04886154|467104666|FG004|Overall Study|Lost to Follow-up|17|||
129765038|NCT04886154|467104667|FG005|Overall Study|Lost to Follow-up|7|||
129765039|NCT04886154|467104668|FG006|Overall Study|Lost to Follow-up|8|||
129765040|NCT04886154|467104669|FG007|Overall Study|Lost to Follow-up|7|||
129765041|NCT04886154|467104670|FG008|Overall Study|Lost to Follow-up|8|||
129765042|NCT04886154|467104671|FG009|Overall Study|Lost to Follow-up|0|||
129765043|NCT04886154|467104672|FG010|Overall Study|Lost to Follow-up|2|||
129765044|NCT04886154|467104673|FG011|Overall Study|Lost to Follow-up|0|||
129765045|NCT04886154|467104674|FG012|Overall Study|Lost to Follow-up|0|||
129765046|NCT04886154|467104675|FG013|Overall Study|Lost to Follow-up|0|||
129765047|NCT04886154|467104676|FG014|Overall Study|Lost to Follow-up|0|||
129765048|NCT04886154|467104662|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765049|NCT04886154|467104663|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765050|NCT04886154|467104664|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765051|NCT04886154|467104665|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765052|NCT04886154|467104666|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765053|NCT04886154|467104667|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765054|NCT04886154|467104668|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
129765055|NCT04886154|467104669|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765056|NCT04886154|467104670|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765057|NCT04886154|467104671|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765058|NCT04886154|467104672|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765059|NCT04886154|467104673|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765060|NCT04886154|467104674|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765061|NCT04886154|467104675|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765062|NCT04886154|467104676|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
129765063|NCT04886154|467104662|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765064|NCT04886154|467104663|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765065|NCT04886154|467104664|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765066|NCT04886154|467104665|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765067|NCT04886154|467104666|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129875374|NCT03299686|467501937|FG000|Treatment Epoch|Adverse Event|8|||
129765068|NCT04886154|467104667|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129875375|NCT03299686|467501938|FG001|Treatment Epoch|Adverse Event|4|||
129875376|NCT03299686|467501937|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
129765069|NCT04886154|467104668|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129765070|NCT04886154|467104669|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129765071|NCT04886154|467104670|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765072|NCT04886154|467104671|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765073|NCT04886154|467104672|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765074|NCT04886154|467104673|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765075|NCT04886154|467104674|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765076|NCT04886154|467104675|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129765077|NCT04886154|467104676|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129765078|NCT04886154|467104662|FG000|Overall Study|Other, Not Specified|0|||
129765079|NCT04886154|467104663|FG001|Overall Study|Other, Not Specified|0|||
129765080|NCT04886154|467104664|FG002|Overall Study|Other, Not Specified|0|||
129765081|NCT04886154|467104665|FG003|Overall Study|Other, Not Specified|0|||
129765082|NCT04886154|467104666|FG004|Overall Study|Other, Not Specified|11|||
129765083|NCT04886154|467104667|FG005|Overall Study|Other, Not Specified|8|||
129765084|NCT04886154|467104668|FG006|Overall Study|Other, Not Specified|9|||
129765085|NCT04886154|467104669|FG007|Overall Study|Other, Not Specified|10|||
129765086|NCT04886154|467104670|FG008|Overall Study|Other, Not Specified|6|||
129765087|NCT04886154|467104671|FG009|Overall Study|Other, Not Specified|1|||
129765088|NCT04886154|467104672|FG010|Overall Study|Other, Not Specified|1|||
129765089|NCT04886154|467104673|FG011|Overall Study|Other, Not Specified|2|||
129765090|NCT04886154|467104674|FG012|Overall Study|Other, Not Specified|1|||
129765091|NCT04886154|467104675|FG013|Overall Study|Other, Not Specified|2|||
129765092|NCT04886154|467104676|FG014|Overall Study|Other, Not Specified|3|||
129765093|NCT02336282|467104691|FG000|Overall Study|Unrelated illness|1|||
129765094|NCT02336282|467104691|FG000|Overall Study|Uncomfortable with technology|1|||
129765095|NCT02336282|467104691|FG000|Overall Study|Lost to Follow-up|1|||
129765096|NCT02336282|467104691|FG000|Overall Study|Not enough time to complete sessions|2|||
129765097|NCT03724942|467104693|FG000|Overall Study|Adverse Event|20|||
129765098|NCT03724942|467104694|FG001|Overall Study|Adverse Event|14|||
129765099|NCT03724942|467104693|FG000|Overall Study|Lack of Efficacy|0|||
129765100|NCT03724942|467104694|FG001|Overall Study|Lack of Efficacy|1|||
129765101|NCT03724942|467104693|FG000|Overall Study|Physician Decision|5|||
129765102|NCT03724942|467104694|FG001|Overall Study|Physician Decision|2|||
129765103|NCT03724942|467104693|FG000|Overall Study|Protocol Violation|1|||
129765104|NCT03724942|467104694|FG001|Overall Study|Protocol Violation|0|||
129765105|NCT03724942|467104693|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
129765106|NCT03724942|467104694|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
129765107|NCT03724942|467104693|FG000|Overall Study|Withdrawal by Legal Representative|3|||
129765108|NCT03724942|467104694|FG001|Overall Study|Withdrawal by Legal Representative|0|||
129765109|NCT00668148|467104708|FG000|Overall Study|Adverse Event|5|||
129765110|NCT00668148|467104708|FG000|Overall Study|Subject Non-compliance|1|||
129765111|NCT00668148|467104708|FG000|Overall Study|Progressive Disease Before Treatment|2|||
129765112|NCT00668148|467104708|FG000|Overall Study|Withdrawal of Consent|2|||
129765113|NCT04875975|467104711|FG000|Overall Study|Adverse Event|1|||
129765114|NCT04875975|467104712|FG001|Overall Study|Adverse Event|2|||
129765115|NCT04875975|467104711|FG000|Overall Study|Lack of Efficacy|2|||
129765116|NCT04875975|467104712|FG001|Overall Study|Lack of Efficacy|2|||
129765117|NCT04875975|467104711|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
129765118|NCT04875975|467104712|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
129765119|NCT04875975|467104711|FG000|Overall Study|Relapse With Insults|0|||
129765120|NCT04875975|467104712|FG001|Overall Study|Relapse With Insults|1|||
129765121|NCT04875975|467104711|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
129765122|NCT04875975|467104712|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
129765123|NCT05472090|467104713|FG000|Overall Study|Adverse Event|2|||
129765124|NCT05472090|467104714|FG001|Overall Study|Adverse Event|3|||
129765125|NCT05472090|467104713|FG000|Overall Study|Lack of Efficacy|1|||
129765126|NCT05472090|467104714|FG001|Overall Study|Lack of Efficacy|0|||
129765127|NCT05472090|467104713|FG000|Overall Study|Physician Decision|1|||
129765128|NCT05472090|467104714|FG001|Overall Study|Physician Decision|0|||
129765129|NCT05472090|467104713|FG000|Overall Study|Withdrawal by Subject|2|||
129765130|NCT05472090|467104714|FG001|Overall Study|Withdrawal by Subject|0|||
129765131|NCT05472090|467104713|FG000|Overall Study|Lost to Follow-up|0|||
129765132|NCT05472090|467104714|FG001|Overall Study|Lost to Follow-up|3|||
129765133|NCT01350999|467104716|FG000|Overall Study|Adverse Event|4|||
129765134|NCT01350999|467104717|FG001|Overall Study|Adverse Event|9|||
129765135|NCT01350999|467104718|FG002|Overall Study|Adverse Event|10|||
129765136|NCT01350999|467104716|FG000|Overall Study|Voluntary withdrawal|3|||
129765137|NCT01350999|467104717|FG001|Overall Study|Voluntary withdrawal|4|||
129765138|NCT01350999|467104718|FG002|Overall Study|Voluntary withdrawal|6|||
129765139|NCT01350999|467104716|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
129765140|NCT01350999|467104717|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
129765141|NCT01350999|467104718|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
129765142|NCT01766050|467106710|FG000|Overall Study|Adverse Event|1|||
129765143|NCT01766050|467106710|FG000|Overall Study|Lost to Follow-up|1|||
129765144|NCT01766050|467106710|FG000|Overall Study|Withdrawal by Subject|2|||
129765145|NCT00089297|467106712|FG000|Overall Study|Adverse Event|9|||
129765146|NCT00089297|467106712|FG000|Overall Study|Death|1|||
129765147|NCT00089297|467106712|FG000|Overall Study|Withdrawal by Subject|12|||
129765148|NCT00089297|467106712|FG000|Overall Study|Disease progression|2|||
129765149|NCT00089297|467106712|FG000|Overall Study|Ineligible|11|||
129765150|NCT00089297|467106712|FG000|Overall Study|Secondary malignancy|1|||
129765151|NCT00089297|467106712|FG000|Overall Study|IRB approval not ready|1|||
129765152|NCT00089297|467106712|FG000|Overall Study|Non-compliance|1|||
129765153|NCT01910298|467106715|FG000|Overall Study|Adverse Event|1|||
129765154|NCT01910298|467106716|FG001|Overall Study|Adverse Event|0|||
129765155|NCT01910298|467106715|FG000|Overall Study|Withdrawal by Subject|2|||
129765156|NCT01910298|467106716|FG001|Overall Study|Withdrawal by Subject|7|||
129765157|NCT01910298|467106715|FG000|Overall Study|Protocol Deviation|0|||
129765158|NCT01910298|467106716|FG001|Overall Study|Protocol Deviation|5|||
129765159|NCT01910298|467106715|FG000|Overall Study|Lost to Follow-up|1|||
129765160|NCT01910298|467106716|FG001|Overall Study|Lost to Follow-up|1|||
129765161|NCT01910298|467106715|FG000|Overall Study|Study Terminated by Sponsor|1|||
129765162|NCT01910298|467106716|FG001|Overall Study|Study Terminated by Sponsor|17|||
129765163|NCT01910298|467106715|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129765164|NCT01910298|467106716|FG001|Overall Study|Other Miscellaneous Reasons|2|||
129765165|NCT03037385|467106719|FG000|Overall Study|Adverse Event|0|||
129765166|NCT03037385|467106720|FG001|Overall Study|Adverse Event|0|||
129765167|NCT03037385|467106721|FG002|Overall Study|Adverse Event|1|||
129765168|NCT03037385|467106722|FG003|Overall Study|Adverse Event|0|||
129765169|NCT03037385|467106723|FG004|Overall Study|Adverse Event|0|||
129765170|NCT03037385|467106724|FG005|Overall Study|Adverse Event|0|||
129765171|NCT03037385|467106725|FG006|Overall Study|Adverse Event|0|||
129765172|NCT03037385|467106726|FG007|Overall Study|Adverse Event|0|||
129765173|NCT03037385|467106727|FG008|Overall Study|Adverse Event|0|||
129765174|NCT03037385|467106728|FG009|Overall Study|Adverse Event|6|||
129765175|NCT03037385|467106719|FG000|Overall Study|Death|1|||
129765176|NCT03037385|467106720|FG001|Overall Study|Death|4|||
129765177|NCT03037385|467106721|FG002|Overall Study|Death|2|||
129765178|NCT03037385|467106722|FG003|Overall Study|Death|2|||
129765179|NCT03037385|467106723|FG004|Overall Study|Death|5|||
129765180|NCT03037385|467106724|FG005|Overall Study|Death|2|||
129765181|NCT03037385|467106725|FG006|Overall Study|Death|1|||
129765182|NCT03037385|467106726|FG007|Overall Study|Death|4|||
129765183|NCT03037385|467106727|FG008|Overall Study|Death|3|||
129765184|NCT03037385|467106728|FG009|Overall Study|Death|240|||
129765185|NCT03037385|467106719|FG000|Overall Study|Initiation of Another Therapy|1|||
129765186|NCT03037385|467106720|FG001|Overall Study|Initiation of Another Therapy|0|||
129765187|NCT03037385|467106721|FG002|Overall Study|Initiation of Another Therapy|0|||
129765188|NCT03037385|467106722|FG003|Overall Study|Initiation of Another Therapy|0|||
129765189|NCT03037385|467106723|FG004|Overall Study|Initiation of Another Therapy|0|||
129765190|NCT03037385|467106724|FG005|Overall Study|Initiation of Another Therapy|0|||
129765191|NCT03037385|467106725|FG006|Overall Study|Initiation of Another Therapy|0|||
129765192|NCT03037385|467106726|FG007|Overall Study|Initiation of Another Therapy|1|||
129765193|NCT03037385|467106727|FG008|Overall Study|Initiation of Another Therapy|0|||
129765194|NCT03037385|467106728|FG009|Overall Study|Initiation of Another Therapy|2|||
129765195|NCT03037385|467106719|FG000|Overall Study|Lost to Follow-up|0|||
129765196|NCT03037385|467106720|FG001|Overall Study|Lost to Follow-up|0|||
129765197|NCT03037385|467106721|FG002|Overall Study|Lost to Follow-up|0|||
129765198|NCT03037385|467106722|FG003|Overall Study|Lost to Follow-up|0|||
129765199|NCT03037385|467106723|FG004|Overall Study|Lost to Follow-up|0|||
129765200|NCT03037385|467106724|FG005|Overall Study|Lost to Follow-up|1|||
129765201|NCT03037385|467106725|FG006|Overall Study|Lost to Follow-up|0|||
129765202|NCT03037385|467106726|FG007|Overall Study|Lost to Follow-up|0|||
129765203|NCT03037385|467106727|FG008|Overall Study|Lost to Follow-up|0|||
129765204|NCT03037385|467106728|FG009|Overall Study|Lost to Follow-up|16|||
129765205|NCT03037385|467106719|FG000|Overall Study|Physician Decision|0|||
129765206|NCT03037385|467106720|FG001|Overall Study|Physician Decision|0|||
129765207|NCT03037385|467106721|FG002|Overall Study|Physician Decision|0|||
129765208|NCT03037385|467106722|FG003|Overall Study|Physician Decision|0|||
129765209|NCT03037385|467106723|FG004|Overall Study|Physician Decision|0|||
129765210|NCT03037385|467106724|FG005|Overall Study|Physician Decision|0|||
129765211|NCT03037385|467106725|FG006|Overall Study|Physician Decision|0|||
129765212|NCT03037385|467106726|FG007|Overall Study|Physician Decision|0|||
129765213|NCT03037385|467106727|FG008|Overall Study|Physician Decision|0|||
129765214|NCT03037385|467106728|FG009|Overall Study|Physician Decision|1|||
129765215|NCT03037385|467106719|FG000|Overall Study|Progressive Disease|0|||
129765216|NCT03037385|467106720|FG001|Overall Study|Progressive Disease|1|||
129765217|NCT03037385|467106721|FG002|Overall Study|Progressive Disease|1|||
129765218|NCT03037385|467106722|FG003|Overall Study|Progressive Disease|5|||
129765219|NCT03037385|467106723|FG004|Overall Study|Progressive Disease|2|||
129765220|NCT03037385|467106724|FG005|Overall Study|Progressive Disease|0|||
129765221|NCT03037385|467106725|FG006|Overall Study|Progressive Disease|1|||
129765222|NCT03037385|467106726|FG007|Overall Study|Progressive Disease|0|||
129765223|NCT03037385|467106727|FG008|Overall Study|Progressive Disease|0|||
129765224|NCT03037385|467106728|FG009|Overall Study|Progressive Disease|30|||
129765225|NCT03037385|467106719|FG000|Overall Study|Withdrawal by Subject|0|||
129765226|NCT03037385|467106720|FG001|Overall Study|Withdrawal by Subject|0|||
129765227|NCT03037385|467106721|FG002|Overall Study|Withdrawal by Subject|1|||
129765228|NCT03037385|467106722|FG003|Overall Study|Withdrawal by Subject|2|||
129765229|NCT03037385|467106723|FG004|Overall Study|Withdrawal by Subject|1|||
129765230|NCT03037385|467106724|FG005|Overall Study|Withdrawal by Subject|3|||
129765231|NCT03037385|467106725|FG006|Overall Study|Withdrawal by Subject|0|||
129765232|NCT03037385|467106726|FG007|Overall Study|Withdrawal by Subject|0|||
129765233|NCT03037385|467106727|FG008|Overall Study|Withdrawal by Subject|0|||
129765234|NCT03037385|467106728|FG009|Overall Study|Withdrawal by Subject|52|||
129765235|NCT03037385|467106719|FG000|Overall Study|Reason Not Specified|0|||
129765236|NCT03037385|467106720|FG001|Overall Study|Reason Not Specified|1|||
129765237|NCT03037385|467106721|FG002|Overall Study|Reason Not Specified|0|||
129765238|NCT03037385|467106722|FG003|Overall Study|Reason Not Specified|4|||
129765239|NCT03037385|467106723|FG004|Overall Study|Reason Not Specified|3|||
129765240|NCT03037385|467106724|FG005|Overall Study|Reason Not Specified|6|||
129765241|NCT03037385|467106725|FG006|Overall Study|Reason Not Specified|2|||
129765242|NCT03037385|467106726|FG007|Overall Study|Reason Not Specified|0|||
129765243|NCT03037385|467106727|FG008|Overall Study|Reason Not Specified|1|||
129765244|NCT03037385|467106728|FG009|Overall Study|Reason Not Specified|181|||
129765245|NCT04515771|467106733|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
129765246|NCT04515771|467106734|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
129651265|NCT03605849|466679598|FG002|Overall Study|Other (COVID-19 Related)|1|||
129651266|NCT03605849|466679599|FG003|Overall Study|Other (COVID-19 Related)|0|||
129651267|NCT03605849|466679596|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
129651268|NCT03605849|466679597|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
129651269|NCT03605849|466679598|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
129651270|NCT03605849|466679599|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
129651271|NCT00590538|466679600|FG000|Overall Study|Study terminated before completed|2|||
129651272|NCT00985426|466679601|FG000|Overall Study|Adverse Event|0|||
129651273|NCT00985426|466679602|FG001|Overall Study|Adverse Event|1|||
129651274|NCT00985426|466679601|FG000|Overall Study|Subject Non-Compliance|3|||
129651275|NCT00985426|466679602|FG001|Overall Study|Subject Non-Compliance|3|||
129651276|NCT00985426|466679601|FG000|Overall Study|Withdrawal by Subject|12|||
129651277|NCT00985426|466679602|FG001|Overall Study|Withdrawal by Subject|16|||
129651278|NCT00985426|466679601|FG000|Overall Study|Lost to Follow-up|8|||
129651279|NCT00985426|466679602|FG001|Overall Study|Lost to Follow-up|10|||
129651280|NCT00985426|466679601|FG000|Overall Study|Death|7|||
129651281|NCT00985426|466679602|FG001|Overall Study|Death|3|||
129651282|NCT00985426|466679601|FG000|Overall Study|Protocol Violation|2|||
129651283|NCT00985426|466679602|FG001|Overall Study|Protocol Violation|0|||
129651284|NCT00985426|466679601|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
129651285|NCT00985426|466679602|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
129651286|NCT02971800|466679603|FG000|Overall Study|Protocol Violation|1|||
129651287|NCT02971800|466679603|FG000|Overall Study|Withdrawal by Subject|1|||
129651288|NCT02971800|466679603|FG000|Overall Study|Exclusion criteria prior intervention|1|||
129651289|NCT02971800|466679603|FG000|Overall Study|Number evaluable participant already reached|4|||
129651290|NCT01149421|466679604|FG000|Overall Study|Adverse Event|22|||
129651291|NCT01149421|466679605|FG001|Overall Study|Adverse Event|6|||
129651292|NCT01149421|466679606|FG002|Overall Study|Adverse Event|11|||
129651293|NCT01149421|466679604|FG000|Overall Study|Withdrawal by Subject|20|||
129651294|NCT01149421|466679605|FG001|Overall Study|Withdrawal by Subject|12|||
129651295|NCT01149421|466679606|FG002|Overall Study|Withdrawal by Subject|13|||
129651296|NCT01149421|466679604|FG000|Overall Study|Sponsor Decision|0|||
129651297|NCT01149421|466679605|FG001|Overall Study|Sponsor Decision|1|||
129651298|NCT01149421|466679606|FG002|Overall Study|Sponsor Decision|1|||
129651299|NCT01149421|466679604|FG000|Overall Study|Lost to Follow-up|2|||
129651300|NCT01149421|466679605|FG001|Overall Study|Lost to Follow-up|4|||
129651301|NCT01149421|466679606|FG002|Overall Study|Lost to Follow-up|5|||
129651302|NCT01149421|466679604|FG000|Overall Study|Physician Decision|5|||
129651303|NCT01149421|466679605|FG001|Overall Study|Physician Decision|3|||
129651304|NCT01149421|466679606|FG002|Overall Study|Physician Decision|6|||
129651305|NCT01149421|466679604|FG000|Overall Study|Entry Criteria Not Met|1|||
129651306|NCT01149421|466679605|FG001|Overall Study|Entry Criteria Not Met|1|||
129651307|NCT01149421|466679606|FG002|Overall Study|Entry Criteria Not Met|2|||
129651308|NCT01149421|466679604|FG000|Overall Study|Protocol Violation|2|||
129651309|NCT01149421|466679605|FG001|Overall Study|Protocol Violation|2|||
129651310|NCT01149421|466679606|FG002|Overall Study|Protocol Violation|6|||
129651311|NCT03738800|466679609|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
129651312|NCT03738800|466679610|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129765247|NCT04515771|467106733|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
129765248|NCT04515771|467106734|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
129765249|NCT04515771|467106733|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
129765250|NCT04515771|467106734|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
129765251|NCT01021020|467106735|FG000|Period I|Protocol Violation|1|||
129765252|NCT01021020|467106735|FG000|Period I|Withdrawal by Subject|1|||
129765253|NCT01021020|467106735|FG000|14 Day Washout Period A|Physician Decision|1|||
129765254|NCT00948246|467106738|FG000|Overall Study|Lost to Follow-up|11|||
129765255|NCT00948246|467106738|FG000|Overall Study|Adverse Event|11|||
129765256|NCT00948246|467106738|FG000|Overall Study|Death|1|||
129765257|NCT00948246|467106738|FG000|Overall Study|Withdrawal by Subject|1|||
129765258|NCT03598036|467106741|FG000|Overall Study|Withdrawal by Subject|1|||
129765259|NCT03598036|467106742|FG001|Overall Study|Withdrawal by Subject|0|||
129765260|NCT04199351|467106743|FG000|Overall Study|Decision by sponsor|0|||
129765261|NCT04199351|467106744|FG001|Overall Study|Decision by sponsor|0|||
129765262|NCT04199351|467106745|FG002|Overall Study|Decision by sponsor|0|||
129765263|NCT04199351|467106746|FG003|Overall Study|Decision by sponsor|2|||
129765264|NCT04199351|467106747|FG004|Overall Study|Decision by sponsor|0|||
129765265|NCT04199351|467106748|FG005|Overall Study|Decision by sponsor|0|||
129765266|NCT04199351|467106749|FG006|Overall Study|Decision by sponsor|0|||
129765267|NCT04199351|467106750|FG007|Overall Study|Decision by sponsor|0|||
129765268|NCT04199351|467106751|FG008|Overall Study|Decision by sponsor|0|||
129765269|NCT04199351|467106752|FG009|Overall Study|Decision by sponsor|6|||
129765270|NCT04199351|467106743|FG000|Overall Study|Lost to Follow-up|0|||
129765271|NCT04199351|467106744|FG001|Overall Study|Lost to Follow-up|0|||
129765272|NCT04199351|467106745|FG002|Overall Study|Lost to Follow-up|1|||
129765273|NCT04199351|467106746|FG003|Overall Study|Lost to Follow-up|0|||
129765274|NCT04199351|467106747|FG004|Overall Study|Lost to Follow-up|0|||
129765275|NCT04199351|467106748|FG005|Overall Study|Lost to Follow-up|1|||
129765276|NCT04199351|467106749|FG006|Overall Study|Lost to Follow-up|0|||
129765277|NCT04199351|467106750|FG007|Overall Study|Lost to Follow-up|0|||
129765278|NCT04199351|467106751|FG008|Overall Study|Lost to Follow-up|0|||
129765279|NCT04199351|467106752|FG009|Overall Study|Lost to Follow-up|0|||
129765280|NCT04199351|467106743|FG000|Overall Study|Withdrawal by Subject|0|||
129765281|NCT04199351|467106744|FG001|Overall Study|Withdrawal by Subject|1|||
129765282|NCT04199351|467106745|FG002|Overall Study|Withdrawal by Subject|0|||
129765283|NCT04199351|467106746|FG003|Overall Study|Withdrawal by Subject|0|||
129765284|NCT04199351|467106747|FG004|Overall Study|Withdrawal by Subject|1|||
129765285|NCT04199351|467106748|FG005|Overall Study|Withdrawal by Subject|4|||
129765286|NCT04199351|467106749|FG006|Overall Study|Withdrawal by Subject|2|||
129765287|NCT04199351|467106750|FG007|Overall Study|Withdrawal by Subject|0|||
129765288|NCT04199351|467106751|FG008|Overall Study|Withdrawal by Subject|3|||
129765289|NCT04199351|467106752|FG009|Overall Study|Withdrawal by Subject|0|||
129765290|NCT01838694|467106753|FG000|Overall Study|Adverse Event|0|||
129765291|NCT01838694|467106754|FG001|Overall Study|Adverse Event|1|||
129765292|NCT03623243|467106755|FG000|Overall Study|Adverse Event|15|||
129765293|NCT03623243|467106755|FG000|Overall Study|Guardian Decision|1|||
129765294|NCT03623243|467106755|FG000|Overall Study|New Therapy for Study Indication|1|||
129765295|NCT03623243|467106755|FG000|Overall Study|Protocol Deviation|3|||
129765296|NCT03623243|467106755|FG000|Overall Study|Physician Decision|4|||
129765297|NCT03623243|467106755|FG000|Overall Study|Patient Decision|15|||
129765298|NCT02177695|467106759|FG000|ITT Analysis|Ineligible|5|||
129765299|NCT02177695|467106760|FG001|ITT Analysis|Ineligible|5|||
129765300|NCT02177695|467106759|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
129765301|NCT02177695|467106760|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
129765302|NCT02177695|467106759|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
129765303|NCT02177695|467106760|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
129765304|NCT02177695|467106759|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
129765305|NCT02177695|467106760|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
129765306|NCT00979901|467106761|FG000|Overall Study|Adverse Event|1|||
129765307|NCT00979901|467106762|FG001|Overall Study|Adverse Event|3|||
129765308|NCT00979901|467106763|FG002|Overall Study|Adverse Event|9|||
129765309|NCT00979901|467106764|FG003|Overall Study|Adverse Event|2|||
129765310|NCT00979901|467106761|FG000|Overall Study|Lack of Efficacy|8|||
129765311|NCT00979901|467106762|FG001|Overall Study|Lack of Efficacy|4|||
129765312|NCT00979901|467106763|FG002|Overall Study|Lack of Efficacy|9|||
129765313|NCT00979901|467106764|FG003|Overall Study|Lack of Efficacy|0|||
129765314|NCT00979901|467106761|FG000|Overall Study|Lost to Follow-up|1|||
129765315|NCT00979901|467106762|FG001|Overall Study|Lost to Follow-up|1|||
129765316|NCT00979901|467106763|FG002|Overall Study|Lost to Follow-up|2|||
129765317|NCT00979901|467106764|FG003|Overall Study|Lost to Follow-up|0|||
129765318|NCT00979901|467106761|FG000|Overall Study|Protocol Violation|2|||
129765319|NCT00979901|467106762|FG001|Overall Study|Protocol Violation|2|||
129765320|NCT00979901|467106763|FG002|Overall Study|Protocol Violation|7|||
129765321|NCT00979901|467106764|FG003|Overall Study|Protocol Violation|1|||
129765322|NCT00979901|467106761|FG000|Overall Study|Withdrawal by Subject|2|||
129765323|NCT00979901|467106762|FG001|Overall Study|Withdrawal by Subject|1|||
129765324|NCT00979901|467106763|FG002|Overall Study|Withdrawal by Subject|1|||
129765325|NCT00979901|467106764|FG003|Overall Study|Withdrawal by Subject|1|||
129765326|NCT00979901|467106761|FG000|Overall Study|Noncompliance|1|||
129765327|NCT00979901|467106762|FG001|Overall Study|Noncompliance|0|||
129765328|NCT00979901|467106763|FG002|Overall Study|Noncompliance|0|||
129765329|NCT00979901|467106764|FG003|Overall Study|Noncompliance|0|||
129765330|NCT00979901|467106761|FG000|Overall Study|out-of-state|1|||
129765331|NCT00979901|467106762|FG001|Overall Study|out-of-state|0|||
129765332|NCT00979901|467106763|FG002|Overall Study|out-of-state|0|||
129765333|NCT00979901|467106764|FG003|Overall Study|out-of-state|0|||
129765334|NCT00979901|467106761|FG000|Overall Study|vacation|1|||
129765335|NCT00979901|467106762|FG001|Overall Study|vacation|0|||
129765336|NCT00979901|467106763|FG002|Overall Study|vacation|0|||
129765337|NCT00979901|467106764|FG003|Overall Study|vacation|0|||
129765338|NCT00979901|467106761|FG000|Overall Study|elevated lab values pre-randomization|1|||
129765339|NCT00979901|467106762|FG001|Overall Study|elevated lab values pre-randomization|0|||
129765340|NCT00979901|467106763|FG002|Overall Study|elevated lab values pre-randomization|0|||
129765341|NCT00979901|467106764|FG003|Overall Study|elevated lab values pre-randomization|0|||
129765342|NCT00979901|467106761|FG000|Overall Study|Discontinued in Error|0|||
129765343|NCT00979901|467106762|FG001|Overall Study|Discontinued in Error|1|||
129765344|NCT00979901|467106763|FG002|Overall Study|Discontinued in Error|0|||
129765345|NCT00979901|467106764|FG003|Overall Study|Discontinued in Error|0|||
129765346|NCT00979901|467106761|FG000|Overall Study|Left Country|0|||
129765347|NCT00979901|467106762|FG001|Overall Study|Left Country|0|||
129765348|NCT00979901|467106763|FG002|Overall Study|Left Country|1|||
129765349|NCT00979901|467106764|FG003|Overall Study|Left Country|0|||
129765350|NCT00979901|467106761|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
129765351|NCT00979901|467106762|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
129765352|NCT00979901|467106763|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
129765353|NCT00979901|467106764|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
129765354|NCT02182895|467106775|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
129765355|NCT02182895|467106776|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
129765356|NCT00286468|467106777|FG000|Overall Study|Hyperglycemic Rescue|28|||
129765357|NCT00286468|467106778|FG001|Overall Study|Hyperglycemic Rescue|30|||
129765358|NCT00286468|467106779|FG002|Overall Study|Hyperglycemic Rescue|31|||
129765359|NCT00286468|467106777|FG000|Overall Study|Adverse Event|2|||
129765360|NCT00286468|467106778|FG001|Overall Study|Adverse Event|6|||
129765361|NCT00286468|467106779|FG002|Overall Study|Adverse Event|4|||
129765362|NCT00286468|467106777|FG000|Overall Study|Protocol Violation|0|||
129765363|NCT00286468|467106778|FG001|Overall Study|Protocol Violation|3|||
129765364|NCT00286468|467106779|FG002|Overall Study|Protocol Violation|1|||
129765365|NCT00286468|467106777|FG000|Overall Study|Lost to Follow-up|1|||
129765366|NCT00286468|467106778|FG001|Overall Study|Lost to Follow-up|1|||
129765367|NCT00286468|467106779|FG002|Overall Study|Lost to Follow-up|2|||
129765368|NCT00286468|467106777|FG000|Overall Study|Withdrawal by Subject|3|||
129765369|NCT00286468|467106778|FG001|Overall Study|Withdrawal by Subject|8|||
129765370|NCT00286468|467106779|FG002|Overall Study|Withdrawal by Subject|11|||
129765371|NCT00286468|467106777|FG000|Overall Study|Physician Decision|3|||
129765372|NCT00286468|467106778|FG001|Overall Study|Physician Decision|2|||
129765373|NCT00286468|467106779|FG002|Overall Study|Physician Decision|1|||
129765374|NCT03305666|467106780|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
129765375|NCT03305666|467106781|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
129765376|NCT02230410|467106783|FG000|Overall Study|Screen Failure|3|||
129765377|NCT02587221|467106788|FG000|Overall Study|Adverse Event|3|||
129765378|NCT02587221|467106789|FG001|Overall Study|Adverse Event|3|||
129765379|NCT02587221|467106788|FG000|Overall Study|Death|33|||
129765380|NCT02587221|467106789|FG001|Overall Study|Death|34|||
129765381|NCT02587221|467106788|FG000|Overall Study|Withdrawal by Subject|66|||
129765382|NCT02587221|467106789|FG001|Overall Study|Withdrawal by Subject|61|||
129765383|NCT02587221|467106788|FG000|Overall Study|Lost to Follow-up|21|||
129765384|NCT02587221|467106789|FG001|Overall Study|Lost to Follow-up|19|||
129765385|NCT02587221|467106788|FG000|Overall Study|Protocol Violation|6|||
129765386|NCT02587221|467106789|FG001|Overall Study|Protocol Violation|5|||
129765387|NCT02587221|467106788|FG000|Overall Study|Other Reason or Unspecified|2|||
129765388|NCT02587221|467106789|FG001|Overall Study|Other Reason or Unspecified|1|||
129765389|NCT02388269|467106795|FG000|Overall Study|Adverse Event|2|||
129765390|NCT02388269|467106796|FG001|Overall Study|Adverse Event|0|||
129765391|NCT02388269|467106797|FG002|Overall Study|Adverse Event|0|||
129765392|NCT02388269|467106795|FG000|Overall Study|Withdrawal by Subject|1|||
129765393|NCT02388269|467106796|FG001|Overall Study|Withdrawal by Subject|2|||
129765394|NCT02388269|467106797|FG002|Overall Study|Withdrawal by Subject|0|||
129765395|NCT02388269|467106795|FG000|Overall Study|less than 50% stimulations|1|||
129765396|NCT02388269|467106796|FG001|Overall Study|less than 50% stimulations|0|||
129765397|NCT02388269|467106797|FG002|Overall Study|less than 50% stimulations|0|||
129765398|NCT02388269|467106795|FG000|Overall Study|no diary data|3|||
129765399|NCT02388269|467106796|FG001|Overall Study|no diary data|0|||
129765400|NCT02388269|467106797|FG002|Overall Study|no diary data|0|||
129765401|NCT02388269|467106795|FG000|Overall Study|Protocol Violation|2|||
129765402|NCT02388269|467106796|FG001|Overall Study|Protocol Violation|0|||
129765403|NCT02388269|467106797|FG002|Overall Study|Protocol Violation|0|||
129765404|NCT02388269|467106795|FG000|Overall Study|Screen Failure|0|||
129765405|NCT02388269|467106796|FG001|Overall Study|Screen Failure|0|||
129765406|NCT02388269|467106797|FG002|Overall Study|Screen Failure|10|||
129765407|NCT02242942|467106800|FG000|Overall Study|Death|17|||
129765408|NCT02242942|467106801|FG001|Overall Study|Death|20|||
129765409|NCT02242942|467106802|FG002|Overall Study|Death|2|||
129765410|NCT02242942|467106800|FG000|Overall Study|Physician Decision|1|||
129765411|NCT02242942|467106801|FG001|Overall Study|Physician Decision|0|||
129765412|NCT02242942|467106802|FG002|Overall Study|Physician Decision|0|||
129765413|NCT02242942|467106800|FG000|Overall Study|Withdrawal by Subject|8|||
129765414|NCT02242942|467106801|FG001|Overall Study|Withdrawal by Subject|10|||
129765415|NCT02242942|467106802|FG002|Overall Study|Withdrawal by Subject|0|||
129765416|NCT02242942|467106800|FG000|Overall Study|On-going in Study|190|||
129765417|NCT02242942|467106801|FG001|Overall Study|On-going in Study|186|||
129765418|NCT02242942|467106802|FG002|Overall Study|On-going in Study|11|||
129765419|NCT00551759|467106803|FG000|Overall Study|Adverse Event|7|||
129765420|NCT00551759|467106803|FG000|Overall Study|Death|5|||
129765421|NCT00551759|467106803|FG000|Overall Study|Ineligible|1|||
129765422|NCT01451606|467106808|FG000|Overall Study|Withdrawal by Subject|4|||
129765423|NCT01451606|467106809|FG001|Overall Study|Withdrawal by Subject|3|||
129765424|NCT02163538|467106812|FG000|Overall Study|Protocol Violation|1|||
129765425|NCT02163538|467106813|FG001|Overall Study|Protocol Violation|0|||
129765426|NCT02163538|467106812|FG000|Overall Study|Physician Decision|0|||
129765427|NCT02163538|467106813|FG001|Overall Study|Physician Decision|1|||
129765428|NCT01283139|467106814|FG000|Overall Study|Lost to Follow-up|5|||
129765429|NCT01283139|467106815|FG001|Overall Study|Lost to Follow-up|2|||
129765430|NCT01283139|467106816|FG002|Overall Study|Lost to Follow-up|3|||
129765431|NCT01283139|467106817|FG003|Overall Study|Lost to Follow-up|1|||
129765432|NCT01283139|467106814|FG000|Overall Study|Withdrawal by Subject|8|||
129765433|NCT01283139|467106815|FG001|Overall Study|Withdrawal by Subject|8|||
129765434|NCT01283139|467106816|FG002|Overall Study|Withdrawal by Subject|6|||
129765435|NCT01283139|467106817|FG003|Overall Study|Withdrawal by Subject|8|||
129765436|NCT01283139|467106814|FG000|Overall Study|Death|2|||
129765437|NCT01283139|467106815|FG001|Overall Study|Death|0|||
129765438|NCT01283139|467106816|FG002|Overall Study|Death|2|||
129765439|NCT01283139|467106817|FG003|Overall Study|Death|2|||
129765440|NCT01283139|467106814|FG000|Overall Study|Lack of Efficacy|1|||
129765441|NCT01283139|467106815|FG001|Overall Study|Lack of Efficacy|2|||
129765442|NCT01283139|467106816|FG002|Overall Study|Lack of Efficacy|2|||
129765443|NCT01283139|467106817|FG003|Overall Study|Lack of Efficacy|1|||
129765444|NCT01283139|467106814|FG000|Overall Study|Early termination due to AE/SAE|1|||
129765445|NCT01283139|467106815|FG001|Overall Study|Early termination due to AE/SAE|1|||
129765446|NCT01283139|467106816|FG002|Overall Study|Early termination due to AE/SAE|0|||
129765447|NCT01283139|467106817|FG003|Overall Study|Early termination due to AE/SAE|0|||
129765448|NCT01283139|467106814|FG000|Overall Study|Participant's refusal to continue|0|||
129765449|NCT01283139|467106815|FG001|Overall Study|Participant's refusal to continue|3|||
129765450|NCT01283139|467106816|FG002|Overall Study|Participant's refusal to continue|1|||
129765451|NCT01283139|467106817|FG003|Overall Study|Participant's refusal to continue|1|||
129765452|NCT01283139|467106814|FG000|Overall Study|Pregnancy|0|||
129765453|NCT01283139|467106815|FG001|Overall Study|Pregnancy|1|||
129765454|NCT01283139|467106816|FG002|Overall Study|Pregnancy|1|||
129765455|NCT01283139|467106817|FG003|Overall Study|Pregnancy|0|||
129765456|NCT01283139|467106814|FG000|Overall Study|Missed follow-up visit|0|||
129765457|NCT01283139|467106815|FG001|Overall Study|Missed follow-up visit|1|||
129765458|NCT01283139|467106816|FG002|Overall Study|Missed follow-up visit|2|||
129765459|NCT01283139|467106817|FG003|Overall Study|Missed follow-up visit|2|||
129765460|NCT01283139|467106814|FG000|Overall Study|Participant randomized in error|0|||
129765461|NCT01283139|467106815|FG001|Overall Study|Participant randomized in error|0|||
129765462|NCT01283139|467106816|FG002|Overall Study|Participant randomized in error|1|||
129765463|NCT01283139|467106817|FG003|Overall Study|Participant randomized in error|0|||
129765464|NCT00762164|467106818|FG000|Overall Study|Lost to Follow-up|1|||
129765465|NCT00762164|467106819|FG001|Overall Study|Lost to Follow-up|1|||
129765466|NCT00762164|467106818|FG000|Overall Study|Discontinued medication|2|||
129765467|NCT00762164|467106819|FG001|Overall Study|Discontinued medication|0|||
129765468|NCT00762164|467106818|FG000|Overall Study|Withdrawal by Subject|0|||
129765469|NCT00762164|467106819|FG001|Overall Study|Withdrawal by Subject|1|||
129765470|NCT02954536|467106820|FG000|Overall Study|Adverse Event|2|||
129765471|NCT02954536|467106820|FG000|Overall Study|Death|12|||
129765472|NCT00604565|467106828|FG000|Overall Study|Study terminated|0|||
129765473|NCT00604565|467106829|FG001|Overall Study|Study terminated|3|||
129765474|NCT04292535|467106831|FG000|Overall Study|Withdrawal by Subject|0|||
129765475|NCT04292535|467106832|FG001|Overall Study|Withdrawal by Subject|0|||
129765476|NCT04292535|467106833|FG002|Overall Study|Withdrawal by Subject|0|||
129765477|NCT04292535|467106834|FG003|Overall Study|Withdrawal by Subject|0|||
129765478|NCT04292535|467106835|FG004|Overall Study|Withdrawal by Subject|0|||
129765479|NCT04292535|467106836|FG005|Overall Study|Withdrawal by Subject|0|||
129875377|NCT03299686|467501938|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
129765480|NCT04292535|467106837|FG006|Overall Study|Withdrawal by Subject|0|||
129765481|NCT04292535|467106838|FG007|Overall Study|Withdrawal by Subject|1|||
129765482|NCT04292535|467106839|FG008|Overall Study|Withdrawal by Subject|0|||
129765483|NCT04292535|467106840|FG009|Overall Study|Withdrawal by Subject|0|||
129765484|NCT04292535|467106841|FG010|Overall Study|Withdrawal by Subject|0|||
129765485|NCT04292535|467106842|FG011|Overall Study|Withdrawal by Subject|0|||
129765486|NCT04292535|467106843|FG012|Overall Study|Withdrawal by Subject|0|||
129765487|NCT04292535|467106844|FG013|Overall Study|Withdrawal by Subject|0|||
129765488|NCT04292535|467106831|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765489|NCT04292535|467106832|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765490|NCT04292535|467106833|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765491|NCT04292535|467106834|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765492|NCT04292535|467106835|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765493|NCT04292535|467106836|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765494|NCT04292535|467106837|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765495|NCT04292535|467106838|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
129765496|NCT04292535|467106839|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765497|NCT04292535|467106840|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765498|NCT04292535|467106841|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765499|NCT04292535|467106842|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
129765500|NCT04292535|467106843|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
129765501|NCT04292535|467106844|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
129765502|NCT04292535|467106831|FG000|Overall Study|Report of Dizziness|0|||
129765503|NCT04292535|467106832|FG001|Overall Study|Report of Dizziness|0|||
129765504|NCT04292535|467106833|FG002|Overall Study|Report of Dizziness|0|||
129765505|NCT04292535|467106834|FG003|Overall Study|Report of Dizziness|0|||
129765506|NCT04292535|467106835|FG004|Overall Study|Report of Dizziness|0|||
129765507|NCT04292535|467106836|FG005|Overall Study|Report of Dizziness|0|||
129765508|NCT04292535|467106837|FG006|Overall Study|Report of Dizziness|0|||
129765509|NCT04292535|467106838|FG007|Overall Study|Report of Dizziness|0|||
129765510|NCT04292535|467106839|FG008|Overall Study|Report of Dizziness|0|||
129765511|NCT04292535|467106840|FG009|Overall Study|Report of Dizziness|0|||
129765512|NCT04292535|467106841|FG010|Overall Study|Report of Dizziness|0|||
129765513|NCT04292535|467106842|FG011|Overall Study|Report of Dizziness|0|||
129765514|NCT04292535|467106843|FG012|Overall Study|Report of Dizziness|0|||
129765515|NCT04292535|467106844|FG013|Overall Study|Report of Dizziness|1|||
129765516|NCT04292535|467106831|FG000|Overall Study|Equipment Failure|0|||
129765517|NCT04292535|467106832|FG001|Overall Study|Equipment Failure|0|||
129765518|NCT04292535|467106833|FG002|Overall Study|Equipment Failure|0|||
129765519|NCT04292535|467106834|FG003|Overall Study|Equipment Failure|0|||
129765520|NCT04292535|467106835|FG004|Overall Study|Equipment Failure|0|||
129765521|NCT04292535|467106836|FG005|Overall Study|Equipment Failure|0|||
129765522|NCT04292535|467106837|FG006|Overall Study|Equipment Failure|0|||
129765523|NCT04292535|467106838|FG007|Overall Study|Equipment Failure|0|||
129765524|NCT04292535|467106839|FG008|Overall Study|Equipment Failure|0|||
129765525|NCT04292535|467106840|FG009|Overall Study|Equipment Failure|0|||
129765526|NCT04292535|467106841|FG010|Overall Study|Equipment Failure|0|||
129765527|NCT04292535|467106842|FG011|Overall Study|Equipment Failure|1|||
129765528|NCT04292535|467106843|FG012|Overall Study|Equipment Failure|0|||
129765529|NCT04292535|467106844|FG013|Overall Study|Equipment Failure|0|||
129765530|NCT00517296|467106845|FG000|Overall Study|Withdrawal by Subject|1|||
129765531|NCT00517296|467106846|FG001|Overall Study|Withdrawal by Subject|0|||
129765532|NCT04609319|467106848|FG000|Overall Study|Death|64|||
129765533|NCT04609319|467106849|FG001|Overall Study|Death|49|||
129765534|NCT04609319|467106850|FG002|Overall Study|Death|1|||
129765535|NCT04609319|467106848|FG000|Overall Study|Withdrawal of consent|15|||
129765536|NCT04609319|467106849|FG001|Overall Study|Withdrawal of consent|3|||
129765537|NCT04609319|467106850|FG002|Overall Study|Withdrawal of consent|0|||
129765538|NCT04609319|467106848|FG000|Overall Study|Lost to Follow-up|20|||
129765539|NCT04609319|467106849|FG001|Overall Study|Lost to Follow-up|33|||
129765540|NCT04609319|467106850|FG002|Overall Study|Lost to Follow-up|0|||
129765541|NCT04609319|467106848|FG000|Overall Study|Alive until end of follow-up|60|||
129765542|NCT04609319|467106849|FG001|Overall Study|Alive until end of follow-up|53|||
129765543|NCT04609319|467106850|FG002|Overall Study|Alive until end of follow-up|1|||
129765544|NCT01253291|467106851|FG000|Overall Study|Withdrawal by Subject|1|||
129765545|NCT01253291|467106852|FG001|Overall Study|Withdrawal by Subject|1|||
129765546|NCT01253291|467106853|FG002|Overall Study|Withdrawal by Subject|0|||
129765547|NCT01253291|467106854|FG003|Overall Study|Withdrawal by Subject|0|||
129765548|NCT01253291|467106855|FG004|Overall Study|Withdrawal by Subject|0|||
129765549|NCT01253291|467106851|FG000|Overall Study|Adverse Event|0|||
129765550|NCT01253291|467106852|FG001|Overall Study|Adverse Event|1|||
129765551|NCT01253291|467106853|FG002|Overall Study|Adverse Event|0|||
129765552|NCT01253291|467106854|FG003|Overall Study|Adverse Event|0|||
129765553|NCT01253291|467106855|FG004|Overall Study|Adverse Event|0|||
129765554|NCT01253291|467106851|FG000|Overall Study|Lack of Efficacy|1|||
129765555|NCT01253291|467106852|FG001|Overall Study|Lack of Efficacy|0|||
129765556|NCT01253291|467106853|FG002|Overall Study|Lack of Efficacy|0|||
129875378|NCT03745222|467501939|FG000|Overall Study|Withdrawal by Subject|0|||
129765557|NCT01253291|467106854|FG003|Overall Study|Lack of Efficacy|0|||
129765558|NCT01253291|467106855|FG004|Overall Study|Lack of Efficacy|0|||
129765559|NCT01253291|467106851|FG000|Overall Study|Physician Decision|2|||
129765560|NCT01253291|467106852|FG001|Overall Study|Physician Decision|0|||
129765561|NCT01253291|467106853|FG002|Overall Study|Physician Decision|0|||
129765562|NCT01253291|467106854|FG003|Overall Study|Physician Decision|0|||
129765563|NCT01253291|467106855|FG004|Overall Study|Physician Decision|2|||
129765564|NCT02234843|467106864|FG000|Overall Study|Death|1|||
129765565|NCT02234843|467106865|FG001|Overall Study|Death|0|||
129765566|NCT02234843|467106866|FG002|Overall Study|Death|0|||
129765567|NCT02234843|467106867|FG003|Overall Study|Death|0|||
129765568|NCT02234843|467106868|FG004|Overall Study|Death|0|||
129765569|NCT02234843|467106869|FG005|Overall Study|Death|0|||
129765570|NCT02234843|467106870|FG006|Overall Study|Death|0|||
129765571|NCT02234843|467106871|FG007|Overall Study|Death|0|||
129765572|NCT02234843|467106872|FG008|Overall Study|Death|0|||
129765573|NCT02234843|467106873|FG009|Overall Study|Death|0|||
129765574|NCT02234843|467106864|FG000|Overall Study|Protocol Violation|1|||
129765575|NCT02234843|467106865|FG001|Overall Study|Protocol Violation|0|||
129765576|NCT02234843|467106866|FG002|Overall Study|Protocol Violation|1|||
129765577|NCT02234843|467106867|FG003|Overall Study|Protocol Violation|0|||
129765578|NCT02234843|467106868|FG004|Overall Study|Protocol Violation|0|||
129765579|NCT02234843|467106869|FG005|Overall Study|Protocol Violation|0|||
129765580|NCT02234843|467106870|FG006|Overall Study|Protocol Violation|0|||
129765581|NCT02234843|467106871|FG007|Overall Study|Protocol Violation|0|||
129765582|NCT02234843|467106872|FG008|Overall Study|Protocol Violation|0|||
129765583|NCT02234843|467106873|FG009|Overall Study|Protocol Violation|0|||
129765584|NCT02234843|467106864|FG000|Overall Study|Efficacy outcome reached|2|||
129765585|NCT02234843|467106865|FG001|Overall Study|Efficacy outcome reached|0|||
129765586|NCT02234843|467106866|FG002|Overall Study|Efficacy outcome reached|0|||
129765587|NCT02234843|467106867|FG003|Overall Study|Efficacy outcome reached|0|||
129765588|NCT02234843|467106868|FG004|Overall Study|Efficacy outcome reached|0|||
129765589|NCT02234843|467106869|FG005|Overall Study|Efficacy outcome reached|2|||
129765590|NCT02234843|467106870|FG006|Overall Study|Efficacy outcome reached|0|||
129765591|NCT02234843|467106871|FG007|Overall Study|Efficacy outcome reached|0|||
129765592|NCT02234843|467106872|FG008|Overall Study|Efficacy outcome reached|0|||
129765593|NCT02234843|467106873|FG009|Overall Study|Efficacy outcome reached|0|||
129765594|NCT02234843|467106864|FG000|Overall Study|Patient convenience|2|||
129765595|NCT02234843|467106865|FG001|Overall Study|Patient convenience|0|||
129765596|NCT02234843|467106866|FG002|Overall Study|Patient convenience|0|||
129765597|NCT02234843|467106867|FG003|Overall Study|Patient convenience|0|||
129765598|NCT02234843|467106868|FG004|Overall Study|Patient convenience|0|||
129765599|NCT02234843|467106869|FG005|Overall Study|Patient convenience|1|||
129765600|NCT02234843|467106870|FG006|Overall Study|Patient convenience|0|||
129765601|NCT02234843|467106871|FG007|Overall Study|Patient convenience|0|||
129765602|NCT02234843|467106872|FG008|Overall Study|Patient convenience|0|||
129765603|NCT02234843|467106873|FG009|Overall Study|Patient convenience|0|||
129765604|NCT02234843|467106864|FG000|Overall Study|Withdrawal by Subject|5|||
129765605|NCT02234843|467106865|FG001|Overall Study|Withdrawal by Subject|1|||
129765606|NCT02234843|467106866|FG002|Overall Study|Withdrawal by Subject|1|||
129765607|NCT02234843|467106867|FG003|Overall Study|Withdrawal by Subject|0|||
129765608|NCT02234843|467106868|FG004|Overall Study|Withdrawal by Subject|0|||
129765609|NCT02234843|467106869|FG005|Overall Study|Withdrawal by Subject|7|||
129765610|NCT02234843|467106870|FG006|Overall Study|Withdrawal by Subject|0|||
129765611|NCT02234843|467106871|FG007|Overall Study|Withdrawal by Subject|0|||
129765612|NCT02234843|467106872|FG008|Overall Study|Withdrawal by Subject|0|||
129765613|NCT02234843|467106873|FG009|Overall Study|Withdrawal by Subject|0|||
129765614|NCT02234843|467106864|FG000|Overall Study|Recovery|1|||
129765615|NCT02234843|467106865|FG001|Overall Study|Recovery|0|||
129765616|NCT02234843|467106866|FG002|Overall Study|Recovery|0|||
129765617|NCT02234843|467106867|FG003|Overall Study|Recovery|0|||
129765618|NCT02234843|467106868|FG004|Overall Study|Recovery|0|||
129765619|NCT02234843|467106869|FG005|Overall Study|Recovery|0|||
129765620|NCT02234843|467106870|FG006|Overall Study|Recovery|0|||
129765621|NCT02234843|467106871|FG007|Overall Study|Recovery|0|||
129765622|NCT02234843|467106872|FG008|Overall Study|Recovery|0|||
129765623|NCT02234843|467106873|FG009|Overall Study|Recovery|0|||
129765624|NCT02234843|467106864|FG000|Overall Study|Other|0|||
129765625|NCT02234843|467106865|FG001|Overall Study|Other|2|||
129765626|NCT02234843|467106866|FG002|Overall Study|Other|0|||
129765627|NCT02234843|467106867|FG003|Overall Study|Other|1|||
129765628|NCT02234843|467106868|FG004|Overall Study|Other|0|||
129765629|NCT02234843|467106869|FG005|Overall Study|Other|1|||
129765630|NCT02234843|467106870|FG006|Overall Study|Other|0|||
129765631|NCT02234843|467106871|FG007|Overall Study|Other|1|||
129765632|NCT02234843|467106872|FG008|Overall Study|Other|0|||
129765633|NCT02234843|467106873|FG009|Overall Study|Other|0|||
129765634|NCT02234843|467106864|FG000|Overall Study|Physician Decision|4|||
129765635|NCT02234843|467106865|FG001|Overall Study|Physician Decision|1|||
129765636|NCT02234843|467106866|FG002|Overall Study|Physician Decision|0|||
129765637|NCT02234843|467106867|FG003|Overall Study|Physician Decision|1|||
129765638|NCT02234843|467106868|FG004|Overall Study|Physician Decision|0|||
129875379|NCT03745222|467501940|FG001|Overall Study|Withdrawal by Subject|1|||
129707681|NCT00570713|466892098|FG001|Overall Study|Lack of Efficacy|49|||
129707682|NCT00570713|466892097|FG000|Overall Study|Physician Decision|2|||
129707683|NCT00570713|466892098|FG001|Overall Study|Physician Decision|2|||
129707684|NCT00570713|466892097|FG000|Overall Study|Withdrawal by Subject|3|||
129707685|NCT00570713|466892098|FG001|Overall Study|Withdrawal by Subject|3|||
129707686|NCT00570713|466892097|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
129707687|NCT00570713|466892098|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
129707688|NCT04881760|466892099|FG000|Overall Study|Adverse Event|0|||
129707689|NCT04881760|466892100|FG001|Overall Study|Adverse Event|1|||
129707690|NCT04881760|466892101|FG002|Overall Study|Adverse Event|1|||
129707691|NCT04881760|466892102|FG003|Overall Study|Adverse Event|0|||
129707692|NCT04881760|466892103|FG004|Overall Study|Adverse Event|1|||
129707693|NCT04881760|466892104|FG005|Overall Study|Adverse Event|1|||
129707694|NCT04881760|466892105|FG006|Overall Study|Adverse Event|2|||
129707695|NCT04881760|466892099|FG000|Overall Study|Death|0|||
129707696|NCT04881760|466892100|FG001|Overall Study|Death|0|||
129707697|NCT04881760|466892101|FG002|Overall Study|Death|0|||
129707698|NCT04881760|466892102|FG003|Overall Study|Death|1|||
129707699|NCT04881760|466892103|FG004|Overall Study|Death|0|||
129707700|NCT04881760|466892104|FG005|Overall Study|Death|0|||
129707701|NCT04881760|466892105|FG006|Overall Study|Death|0|||
129707702|NCT04881760|466892099|FG000|Overall Study|Lost to Follow-up|5|||
129707703|NCT04881760|466892100|FG001|Overall Study|Lost to Follow-up|7|||
129707704|NCT04881760|466892101|FG002|Overall Study|Lost to Follow-up|5|||
129707705|NCT04881760|466892102|FG003|Overall Study|Lost to Follow-up|1|||
129707706|NCT04881760|466892103|FG004|Overall Study|Lost to Follow-up|2|||
129707707|NCT04881760|466892104|FG005|Overall Study|Lost to Follow-up|4|||
129707708|NCT04881760|466892105|FG006|Overall Study|Lost to Follow-up|4|||
129707709|NCT04881760|466892099|FG000|Overall Study|Withdrawal by Subject|13|||
129707710|NCT04881760|466892100|FG001|Overall Study|Withdrawal by Subject|1|||
129707711|NCT04881760|466892101|FG002|Overall Study|Withdrawal by Subject|1|||
129707712|NCT04881760|466892102|FG003|Overall Study|Withdrawal by Subject|4|||
129707713|NCT04881760|466892103|FG004|Overall Study|Withdrawal by Subject|2|||
129707714|NCT04881760|466892104|FG005|Overall Study|Withdrawal by Subject|1|||
129707715|NCT04881760|466892105|FG006|Overall Study|Withdrawal by Subject|2|||
129707716|NCT04881760|466892099|FG000|Overall Study|Randomized but Never Treated|0|||
129707717|NCT04881760|466892100|FG001|Overall Study|Randomized but Never Treated|0|||
129707718|NCT04881760|466892101|FG002|Overall Study|Randomized but Never Treated|0|||
129707719|NCT04881760|466892102|FG003|Overall Study|Randomized but Never Treated|1|||
129707720|NCT04881760|466892103|FG004|Overall Study|Randomized but Never Treated|0|||
129707721|NCT04881760|466892104|FG005|Overall Study|Randomized but Never Treated|0|||
129707722|NCT04881760|466892105|FG006|Overall Study|Randomized but Never Treated|0|||
129707723|NCT04881760|466892099|FG000|Overall Study|Inadvertent Enrollment|2|||
129707724|NCT04881760|466892100|FG001|Overall Study|Inadvertent Enrollment|0|||
129707725|NCT04881760|466892101|FG002|Overall Study|Inadvertent Enrollment|0|||
129707726|NCT04881760|466892102|FG003|Overall Study|Inadvertent Enrollment|0|||
129707727|NCT04881760|466892103|FG004|Overall Study|Inadvertent Enrollment|0|||
129707728|NCT04881760|466892104|FG005|Overall Study|Inadvertent Enrollment|0|||
129707729|NCT04881760|466892105|FG006|Overall Study|Inadvertent Enrollment|0|||
129707730|NCT04881760|466892099|FG000|Overall Study|Site Closure|0|||
129707731|NCT04881760|466892100|FG001|Overall Study|Site Closure|0|||
129707732|NCT04881760|466892101|FG002|Overall Study|Site Closure|0|||
129707733|NCT04881760|466892102|FG003|Overall Study|Site Closure|1|||
129707734|NCT04881760|466892103|FG004|Overall Study|Site Closure|0|||
129707735|NCT04881760|466892104|FG005|Overall Study|Site Closure|0|||
129707736|NCT04881760|466892105|FG006|Overall Study|Site Closure|0|||
129707737|NCT01538199|466892109|FG000|Overall Study|Lost to Follow-up|1|||
129707738|NCT01538199|466892110|FG001|Overall Study|Lost to Follow-up|2|||
129707739|NCT01538199|466892111|FG002|Overall Study|Lost to Follow-up|1|||
129707740|NCT01538199|466892112|FG003|Overall Study|Lost to Follow-up|0|||
129707741|NCT01538199|466892109|FG000|Overall Study|participant did not have time|1|||
129707742|NCT01538199|466892110|FG001|Overall Study|participant did not have time|0|||
129707743|NCT01538199|466892111|FG002|Overall Study|participant did not have time|0|||
129707744|NCT01538199|466892112|FG003|Overall Study|participant did not have time|2|||
129707745|NCT01538199|466892109|FG000|Overall Study|Lack of Efficacy|0|||
129707746|NCT01538199|466892110|FG001|Overall Study|Lack of Efficacy|1|||
129707747|NCT01538199|466892111|FG002|Overall Study|Lack of Efficacy|0|||
129707748|NCT01538199|466892112|FG003|Overall Study|Lack of Efficacy|0|||
129707749|NCT05899829|466892113|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
129707750|NCT05899829|466892114|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
129707751|NCT05899829|466892113|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
129707752|NCT05899829|466892114|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
129765639|NCT02234843|467106869|FG005|Overall Study|Physician Decision|0|||
129765640|NCT02234843|467106870|FG006|Overall Study|Physician Decision|0|||
129765641|NCT02234843|467106871|FG007|Overall Study|Physician Decision|1|||
129765642|NCT02234843|467106872|FG008|Overall Study|Physician Decision|0|||
129765643|NCT02234843|467106873|FG009|Overall Study|Physician Decision|0|||
129765644|NCT02234843|467106864|FG000|Overall Study|Adverse Event|5|||
129765645|NCT02234843|467106865|FG001|Overall Study|Adverse Event|1|||
129765646|NCT02234843|467106866|FG002|Overall Study|Adverse Event|1|||
129765647|NCT02234843|467106867|FG003|Overall Study|Adverse Event|3|||
129765648|NCT02234843|467106868|FG004|Overall Study|Adverse Event|2|||
129765649|NCT02234843|467106869|FG005|Overall Study|Adverse Event|1|||
129765650|NCT02234843|467106870|FG006|Overall Study|Adverse Event|0|||
129765651|NCT02234843|467106871|FG007|Overall Study|Adverse Event|0|||
129765652|NCT02234843|467106872|FG008|Overall Study|Adverse Event|1|||
129765653|NCT02234843|467106873|FG009|Overall Study|Adverse Event|0|||
129765654|NCT02234843|467106864|FG000|Overall Study|Non-compliance with study drug|1|||
129765655|NCT02234843|467106865|FG001|Overall Study|Non-compliance with study drug|0|||
129765656|NCT02234843|467106866|FG002|Overall Study|Non-compliance with study drug|0|||
129765657|NCT02234843|467106867|FG003|Overall Study|Non-compliance with study drug|0|||
129765658|NCT02234843|467106868|FG004|Overall Study|Non-compliance with study drug|0|||
129765659|NCT02234843|467106869|FG005|Overall Study|Non-compliance with study drug|1|||
129765660|NCT02234843|467106870|FG006|Overall Study|Non-compliance with study drug|1|||
129765661|NCT02234843|467106871|FG007|Overall Study|Non-compliance with study drug|0|||
129765662|NCT02234843|467106872|FG008|Overall Study|Non-compliance with study drug|0|||
129765663|NCT02234843|467106873|FG009|Overall Study|Non-compliance with study drug|0|||
129765664|NCT02234843|467106864|FG000|Overall Study|Lost to Follow-up|0|||
129765665|NCT02234843|467106865|FG001|Overall Study|Lost to Follow-up|1|||
129765666|NCT02234843|467106866|FG002|Overall Study|Lost to Follow-up|0|||
129765667|NCT02234843|467106867|FG003|Overall Study|Lost to Follow-up|0|||
129765668|NCT02234843|467106868|FG004|Overall Study|Lost to Follow-up|0|||
129765669|NCT02234843|467106869|FG005|Overall Study|Lost to Follow-up|0|||
129765670|NCT02234843|467106870|FG006|Overall Study|Lost to Follow-up|1|||
129765671|NCT02234843|467106871|FG007|Overall Study|Lost to Follow-up|0|||
129765672|NCT02234843|467106872|FG008|Overall Study|Lost to Follow-up|0|||
129765673|NCT02234843|467106873|FG009|Overall Study|Lost to Follow-up|0|||
129765674|NCT01607957|467106876|FG000|Overall Study|Not treated|1|||
129765675|NCT01607957|467106877|FG001|Overall Study|Not treated|1|||
129765676|NCT01607957|467106876|FG000|Overall Study|Death|367|||
129765677|NCT01607957|467106877|FG001|Overall Study|Death|211|||
129765678|NCT01607957|467106876|FG000|Overall Study|Lost to Follow-up|3|||
129765679|NCT01607957|467106877|FG001|Overall Study|Lost to Follow-up|3|||
129765680|NCT01607957|467106876|FG000|Overall Study|Participant refusal|1|||
129765681|NCT01607957|467106877|FG001|Overall Study|Participant refusal|0|||
129765682|NCT00945009|467106880|FG000|Overall Study|Lack of Efficacy|10|||
129765683|NCT00945009|467106881|FG001|Overall Study|Lack of Efficacy|0|||
129765684|NCT00945009|467106882|FG002|Overall Study|Lack of Efficacy|0|||
129765685|NCT00945009|467106880|FG000|Overall Study|Physician Decision|21|||
129765686|NCT00945009|467106881|FG001|Overall Study|Physician Decision|4|||
129765687|NCT00945009|467106882|FG002|Overall Study|Physician Decision|3|||
129765688|NCT00945009|467106880|FG000|Overall Study|Protocol Violation|6|||
129765689|NCT00945009|467106881|FG001|Overall Study|Protocol Violation|1|||
129765690|NCT00945009|467106882|FG002|Overall Study|Protocol Violation|0|||
129765691|NCT00945009|467106880|FG000|Overall Study|Withdrawal by Subject|1|||
129765692|NCT00945009|467106881|FG001|Overall Study|Withdrawal by Subject|0|||
129765693|NCT00945009|467106882|FG002|Overall Study|Withdrawal by Subject|0|||
129765694|NCT00945009|467106880|FG000|Overall Study|Ineligible|6|||
129765695|NCT00945009|467106881|FG001|Overall Study|Ineligible|1|||
129765696|NCT00945009|467106882|FG002|Overall Study|Ineligible|0|||
129765697|NCT00945009|467106880|FG000|Overall Study|Inevaluable|0|||
129765698|NCT00945009|467106881|FG001|Overall Study|Inevaluable|1|||
129765699|NCT00945009|467106882|FG002|Overall Study|Inevaluable|0|||
129765700|NCT00945009|467106880|FG000|Overall Study|Refusal of further protocol|1|||
129765701|NCT00945009|467106881|FG001|Overall Study|Refusal of further protocol|0|||
129765702|NCT00945009|467106882|FG002|Overall Study|Refusal of further protocol|0|||
129765703|NCT03919773|467106883|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
129765704|NCT03919773|467106884|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
129765705|NCT03919773|467106883|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
129765706|NCT03919773|467106884|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
129765707|NCT04659044|467106885|FG000|Induction|Physician Decision|1|||
129765708|NCT04659044|467106885|FG000|Induction|Adverse Event|2|||
129765709|NCT04607668|467108312|FG000|Overall Study|Death|49|||
129875380|NCT03745222|467501941|FG002|Overall Study|Withdrawal by Subject|0|||
129875381|NCT02709005|467501942|FG000|Overall Study|Lost to Follow-up|1|||
129875382|NCT02709005|467501943|FG001|Overall Study|Lost to Follow-up|1|||
129875383|NCT02709005|467501942|FG000|Overall Study|Withdrawal by Subject|3|||
129765710|NCT04607668|467108313|FG001|Overall Study|Death|26|||
129765711|NCT04607668|467108312|FG000|Overall Study|Lost to Follow-up|3|||
129765712|NCT04607668|467108313|FG001|Overall Study|Lost to Follow-up|4|||
129765713|NCT04607668|467108312|FG000|Overall Study|Study terminated by Sponsor|92|||
129765714|NCT04607668|467108313|FG001|Overall Study|Study terminated by Sponsor|114|||
129765715|NCT04607668|467108312|FG000|Overall Study|Withdrawal by Subject|12|||
129765716|NCT04607668|467108313|FG001|Overall Study|Withdrawal by Subject|11|||
129765717|NCT04607668|467108312|FG000|Overall Study|Other, unspecified|8|||
129765718|NCT04607668|467108313|FG001|Overall Study|Other, unspecified|7|||
129765719|NCT00474487|467108314|FG000|Overall Study|Withdrawal by Subject|6|||
129765720|NCT00474487|467108315|FG001|Overall Study|Withdrawal by Subject|0|||
129765721|NCT00474487|467108316|FG002|Overall Study|Withdrawal by Subject|0|||
129765722|NCT00474487|467108317|FG003|Overall Study|Withdrawal by Subject|0|||
129765723|NCT00474487|467108314|FG000|Overall Study|Lost to Follow-up|20|||
129765724|NCT00474487|467108315|FG001|Overall Study|Lost to Follow-up|1|||
129765725|NCT00474487|467108316|FG002|Overall Study|Lost to Follow-up|7|||
129765726|NCT00474487|467108317|FG003|Overall Study|Lost to Follow-up|0|||
129765727|NCT00474487|467108314|FG000|Overall Study|Inappropriate enrollment|4|||
129765728|NCT00474487|467108315|FG001|Overall Study|Inappropriate enrollment|0|||
129765729|NCT00474487|467108316|FG002|Overall Study|Inappropriate enrollment|7|||
129765730|NCT00474487|467108317|FG003|Overall Study|Inappropriate enrollment|0|||
129765731|NCT00474487|467108314|FG000|Overall Study|Death|0|||
129765732|NCT00474487|467108315|FG001|Overall Study|Death|1|||
129765733|NCT00474487|467108316|FG002|Overall Study|Death|0|||
129765734|NCT00474487|467108317|FG003|Overall Study|Death|0|||
129765735|NCT02766023|467108318|FG000|Overall Study|Lost to Follow-up|23|||
129765736|NCT02766023|467108319|FG001|Overall Study|Lost to Follow-up|11|||
129765737|NCT02766023|467108318|FG000|Overall Study|Pregnancy|1|||
129765738|NCT02766023|467108319|FG001|Overall Study|Pregnancy|0|||
129765739|NCT02766023|467108318|FG000|Overall Study|Adverse Event|1|||
129765740|NCT02766023|467108319|FG001|Overall Study|Adverse Event|0|||
129765741|NCT02766023|467108318|FG000|Overall Study|Withdrawal by Subject|4|||
129765742|NCT02766023|467108319|FG001|Overall Study|Withdrawal by Subject|5|||
129765743|NCT02766023|467108318|FG000|Overall Study|Physician Decision|1|||
129542769|NCT00948896|466278845|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129542770|NCT00948896|466278846|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
129542771|NCT00948896|466278847|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129542772|NCT00948896|466278848|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129542773|NCT00948896|466278849|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129542774|NCT00948896|466278850|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
129542775|NCT03795233|466278851|FG000|Overall Study|Withdrawal by Subject|2|||
129542776|NCT03795233|466278852|FG001|Overall Study|Withdrawal by Subject|1|||
129542777|NCT03795233|466278851|FG000|Overall Study|Lost to Follow-up|1|||
129542778|NCT03795233|466278852|FG001|Overall Study|Lost to Follow-up|0|||
129542779|NCT03795233|466278851|FG000|Overall Study|Death|1|||
129542780|NCT03795233|466278852|FG001|Overall Study|Death|0|||
129542781|NCT01869959|466278857|FG000|Randomization Period|Physician Decision|0|||
129542782|NCT01869959|466278858|FG001|Randomization Period|Physician Decision|0|||
129542783|NCT01869959|466278859|FG002|Randomization Period|Physician Decision|0|||
129542784|NCT01869959|466278860|FG003|Randomization Period|Physician Decision|0|||
129542785|NCT01869959|466278861|FG004|Randomization Period|Physician Decision|1|||
129765744|NCT02766023|467108319|FG001|Overall Study|Physician Decision|0|||
129765745|NCT02766023|467108318|FG000|Overall Study|Not Eligible at Enrollment|0|||
129765746|NCT02766023|467108319|FG001|Overall Study|Not Eligible at Enrollment|1|||
129765747|NCT01488045|467108320|FG000|Overall Study|Withdrawal by Subject|6|||
129765748|NCT01488045|467108321|FG001|Overall Study|Withdrawal by Subject|11|||
129765749|NCT01488045|467108320|FG000|Overall Study|Failure to present for colonoscopy|3|||
129765750|NCT01488045|467108321|FG001|Overall Study|Failure to present for colonoscopy|6|||
129765751|NCT01488045|467108320|FG000|Overall Study|Failure to report exclusion criteria|0|||
129765752|NCT01488045|467108321|FG001|Overall Study|Failure to report exclusion criteria|1|||
129765753|NCT05365217|467108323|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129765754|NCT05365217|467108324|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129765755|NCT00656513|467108328|FG000|Overall Study|Protocol Violation|1|||
129875384|NCT02709005|467501943|FG001|Overall Study|Withdrawal by Subject|0|||
129875385|NCT01959347|467501944|FG000|Overall Study|Protocol Violation|9|||
129875386|NCT01959347|467501945|FG001|Overall Study|Protocol Violation|7|||
129875387|NCT01282801|467501946|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
129875388|NCT01282801|467501947|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
129875389|NCT01060553|467501948|FG000|Overall Study|Lost to Follow-up|3|||
129875390|NCT01060553|467501949|FG001|Overall Study|Lost to Follow-up|5|||
129875391|NCT01060553|467501948|FG000|Overall Study|Withdrawal by Subject|5|||
129875392|NCT01060553|467501949|FG001|Overall Study|Withdrawal by Subject|5|||
129875393|NCT01060553|467501948|FG000|Overall Study|Lack of Efficacy|1|||
129875394|NCT01060553|467501949|FG001|Overall Study|Lack of Efficacy|0|||
129875395|NCT04707196|467501951|FG000|Overall Study|Withdrawal by Subject|9|||
129875396|NCT04707196|467501952|FG001|Overall Study|Withdrawal by Subject|6|||
129875397|NCT04707196|467501951|FG000|Overall Study|Lost to Follow-up|1|||
129875398|NCT04707196|467501952|FG001|Overall Study|Lost to Follow-up|0|||
129542786|NCT01869959|466278857|FG000|Treatment Period|Adverse Event|1|||
129765756|NCT00656513|467108329|FG001|Overall Study|Protocol Violation|0|||
129542787|NCT01869959|466278858|FG001|Treatment Period|Adverse Event|0|||
129542788|NCT01869959|466278859|FG002|Treatment Period|Adverse Event|3|||
129542789|NCT01869959|466278860|FG003|Treatment Period|Adverse Event|1|||
129542790|NCT01869959|466278861|FG004|Treatment Period|Adverse Event|0|||
129542791|NCT01869959|466278857|FG000|Treatment Period|Sponsor decision|0|||
129542792|NCT01869959|466278858|FG001|Treatment Period|Sponsor decision|1|||
129542793|NCT01869959|466278859|FG002|Treatment Period|Sponsor decision|0|||
129542794|NCT01869959|466278860|FG003|Treatment Period|Sponsor decision|1|||
129542795|NCT01869959|466278861|FG004|Treatment Period|Sponsor decision|0|||
129542796|NCT01869959|466278857|FG000|Treatment Period|Withdrawal by Subject|0|||
129542797|NCT01869959|466278858|FG001|Treatment Period|Withdrawal by Subject|1|||
129542798|NCT01869959|466278859|FG002|Treatment Period|Withdrawal by Subject|0|||
129542799|NCT01869959|466278860|FG003|Treatment Period|Withdrawal by Subject|0|||
129542800|NCT01869959|466278861|FG004|Treatment Period|Withdrawal by Subject|0|||
129542801|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
129542802|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
129542803|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
129542804|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
129542805|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
129542806|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
129542807|NCT00828009|466278862|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
129542808|NCT00828009|466278862|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
129542809|NCT00828009|466278862|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
129542810|NCT00828009|466278862|FG000|Step 2 - Maintenance Therapy|Death|1|||
129542811|NCT00828009|466278862|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
129542812|NCT00828009|466278862|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
129542813|NCT00828009|466278862|FG000|Step 2 - Maintenance Therapy|Other|1|||
129542814|NCT00563706|466280331|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
129542815|NCT00563706|466280332|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
129542816|NCT00563706|466280333|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
129542817|NCT00563706|466280334|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
129542818|NCT00563706|466280335|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
129542819|NCT00563706|466280336|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
129542820|NCT00563706|466280337|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
129542821|NCT00563706|466280338|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
129542822|NCT00563706|466280339|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
129542823|NCT00563706|466280331|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
129542824|NCT00563706|466280332|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
129542825|NCT00563706|466280333|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
129542826|NCT00563706|466280334|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
129542827|NCT00563706|466280335|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
129542828|NCT00563706|466280336|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
129542829|NCT00563706|466280337|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
129542830|NCT00563706|466280338|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
129542831|NCT00563706|466280339|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
129542832|NCT00563706|466280331|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
129542833|NCT00563706|466280332|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
129542834|NCT00563706|466280333|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
129542835|NCT00563706|466280334|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
129542836|NCT00563706|466280335|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
129542837|NCT00563706|466280336|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
129542838|NCT00563706|466280337|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
129542839|NCT00563706|466280338|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
129542840|NCT00563706|466280339|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
129542841|NCT00563706|466280331|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
129542842|NCT00563706|466280332|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129542843|NCT00563706|466280333|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129542844|NCT00563706|466280334|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129542845|NCT00563706|466280335|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129542846|NCT00563706|466280336|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129542847|NCT00563706|466280337|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129765757|NCT00656513|467108330|FG002|Overall Study|Protocol Violation|2|||
129765758|NCT00656513|467108328|FG000|Overall Study|Withdrawal by Subject|0|||
129765759|NCT00656513|467108329|FG001|Overall Study|Withdrawal by Subject|11|||
129542848|NCT00563706|466280338|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
129765760|NCT00656513|467108330|FG002|Overall Study|Withdrawal by Subject|4|||
129765761|NCT00656513|467108328|FG000|Overall Study|Death|0|||
129542849|NCT00563706|466280339|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
129542850|NCT00563706|466280331|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542851|NCT00563706|466280332|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542852|NCT00563706|466280333|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542853|NCT00563706|466280334|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542854|NCT00563706|466280335|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542855|NCT00563706|466280336|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542856|NCT00563706|466280337|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
129542857|NCT00563706|466280338|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
129542858|NCT00563706|466280339|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
129542859|NCT01361308|466280342|FG000|Overall Study|Withdrawal by Subject|9|||
129542860|NCT01361308|466280343|FG001|Overall Study|Withdrawal by Subject|13|||
129542861|NCT01361308|466280342|FG000|Overall Study|Physician Decision|3|||
129542862|NCT01361308|466280343|FG001|Overall Study|Physician Decision|3|||
129542863|NCT01361308|466280342|FG000|Overall Study|Lack of Efficacy|2|||
129542864|NCT01361308|466280343|FG001|Overall Study|Lack of Efficacy|0|||
129542865|NCT01361308|466280342|FG000|Overall Study|Protocol Violation|1|||
129542866|NCT01361308|466280343|FG001|Overall Study|Protocol Violation|0|||
129542867|NCT01361308|466280342|FG000|Overall Study|Lost to Follow-up|5|||
129542868|NCT01361308|466280343|FG001|Overall Study|Lost to Follow-up|4|||
129542869|NCT01361308|466280342|FG000|Overall Study|Adverse Event|8|||
129542870|NCT01361308|466280343|FG001|Overall Study|Adverse Event|4|||
129542871|NCT01361308|466280342|FG000|Overall Study|Eligibility Criteria Not Met|2|||
129542872|NCT01361308|466280343|FG001|Overall Study|Eligibility Criteria Not Met|3|||
129542873|NCT01361308|466280342|FG000|Overall Study|Failed C-SSRS|5|||
129542874|NCT01361308|466280343|FG001|Overall Study|Failed C-SSRS|2|||
129542875|NCT01361308|466280342|FG000|Overall Study|Other|0|||
129542876|NCT01361308|466280343|FG001|Overall Study|Other|1|||
129542877|NCT00700115|466280352|FG000|Overall Study|Withdrawal by Subject|1|||
129542878|NCT00700115|466280353|FG001|Overall Study|Withdrawal by Subject|0|||
129542879|NCT00700115|466280352|FG000|Overall Study|Lost to Follow-up|0|||
129542880|NCT00700115|466280353|FG001|Overall Study|Lost to Follow-up|1|||
129542881|NCT02503215|466280354|FG000|Overall Study|Unable to wear compression stockings|1|||
129542882|NCT02503215|466280354|FG000|Overall Study|Unable to use positive airway pressure|2|||
129542883|NCT02983305|466280359|FG000|Overall Study|incomplete data|2|||
129542884|NCT02983305|466280360|FG001|Overall Study|incomplete data|0|||
129542885|NCT00822237|466280361|FG000|Dose 1 Vaccination|Not vaccinated|3|||
129542886|NCT00822237|466280362|FG001|Dose 1 Vaccination|Not vaccinated|0|||
129542887|NCT00822237|466280361|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
129542888|NCT00822237|466280362|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
129542889|NCT00822237|466280361|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
129542890|NCT00822237|466280362|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
129542891|NCT00822237|466280361|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
129542892|NCT00822237|466280362|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
129542893|NCT00822237|466280361|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
129542894|NCT00822237|466280362|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
129542895|NCT01646268|466280363|FG000|Overall Study|Adverse Event|6|||
129542896|NCT01646268|466280364|FG001|Overall Study|Adverse Event|7|||
129542897|NCT01646268|466280363|FG000|Overall Study|Lack of Efficacy|1|||
129542898|NCT01646268|466280364|FG001|Overall Study|Lack of Efficacy|3|||
129542899|NCT01646268|466280363|FG000|Overall Study|Protocol Violation|0|||
129542900|NCT01646268|466280364|FG001|Overall Study|Protocol Violation|1|||
129542901|NCT01646268|466280363|FG000|Overall Study|Withdrawal by Subject|2|||
129542902|NCT01646268|466280364|FG001|Overall Study|Withdrawal by Subject|5|||
129542903|NCT01646268|466280363|FG000|Overall Study|Other|2|||
129542904|NCT01646268|466280364|FG001|Overall Study|Other|0|||
129542905|NCT01519635|466280369|FG000|Overall Study|Withdrawal by Subject|0|||
129542906|NCT01519635|466280370|FG001|Overall Study|Withdrawal by Subject|1|||
129542907|NCT01519635|466280369|FG000|Overall Study|No possibility to put a catheter|1|||
129542908|NCT01519635|466280370|FG001|Overall Study|No possibility to put a catheter|2|||
129542909|NCT02325414|466280371|FG000|Overall Study|Withdrawal by Subject|3|||
129542910|NCT02325414|466280372|FG001|Overall Study|Withdrawal by Subject|1|||
129542911|NCT02325414|466280371|FG000|Overall Study|Lost to Follow-up|5|||
129542912|NCT02325414|466280372|FG001|Overall Study|Lost to Follow-up|5|||
129542913|NCT00347776|466280373|FG000|1.5 Month Follow-up|Death|2|||
129542914|NCT00347776|466280374|FG001|1.5 Month Follow-up|Death|0|||
129542915|NCT00347776|466280375|FG002|1.5 Month Follow-up|Death|0|||
129542916|NCT00347776|466280373|FG000|1.5 Month Follow-up|reached the endpoint|12|||
129542917|NCT00347776|466280374|FG001|1.5 Month Follow-up|reached the endpoint|8|||
129542918|NCT00347776|466280375|FG002|1.5 Month Follow-up|reached the endpoint|12|||
129765762|NCT00656513|467108329|FG001|Overall Study|Death|0|||
129542919|NCT00347776|466280373|FG000|6 Month Follow-up|Death|2|||
129542920|NCT00347776|466280374|FG001|6 Month Follow-up|Death|1|||
129542921|NCT00347776|466280375|FG002|6 Month Follow-up|Death|3|||
129542922|NCT00347776|466280373|FG000|6 Month Follow-up|reached endpont|20|||
129542923|NCT00347776|466280374|FG001|6 Month Follow-up|reached endpont|12|||
129542924|NCT00347776|466280375|FG002|6 Month Follow-up|reached endpont|15|||
129542925|NCT00347776|466280373|FG000|12 Month Follow-up|Lost to Follow-up|7|||
129542926|NCT00347776|466280374|FG001|12 Month Follow-up|Lost to Follow-up|6|||
129542927|NCT00347776|466280375|FG002|12 Month Follow-up|Lost to Follow-up|6|||
129542928|NCT00347776|466280373|FG000|12 Month Follow-up|Death|3|||
129542929|NCT00347776|466280374|FG001|12 Month Follow-up|Death|4|||
129542930|NCT00347776|466280375|FG002|12 Month Follow-up|Death|4|||
129542931|NCT00347776|466280373|FG000|12 Month Follow-up|Reached endpoint|13|||
129542932|NCT00347776|466280374|FG001|12 Month Follow-up|Reached endpoint|6|||
129542933|NCT00347776|466280375|FG002|12 Month Follow-up|Reached endpoint|9|||
129542934|NCT00299546|466280376|FG000|Overall Study|Death|3|||
129542935|NCT00299546|466280377|FG001|Overall Study|Death|2|||
129542936|NCT00299546|466280378|FG002|Overall Study|Death|0|||
129542937|NCT00299546|466280376|FG000|Overall Study|Lost to Follow-up|2|||
129542938|NCT00299546|466280377|FG001|Overall Study|Lost to Follow-up|2|||
129542939|NCT00299546|466280378|FG002|Overall Study|Lost to Follow-up|5|||
129542940|NCT00299546|466280376|FG000|Overall Study|Adverse Event|37|||
129542941|NCT00299546|466280377|FG001|Overall Study|Adverse Event|22|||
129542942|NCT00299546|466280378|FG002|Overall Study|Adverse Event|27|||
129542943|NCT00299546|466280376|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
129542944|NCT00299546|466280377|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
129542945|NCT00299546|466280378|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
129542946|NCT00299546|466280376|FG000|Overall Study|Other|24|||
129542947|NCT00299546|466280377|FG001|Overall Study|Other|26|||
129542948|NCT00299546|466280378|FG002|Overall Study|Other|19|||
129542949|NCT00299546|466280376|FG000|Overall Study|Not treated|0|||
129542950|NCT00299546|466280377|FG001|Overall Study|Not treated|1|||
129542951|NCT00299546|466280378|FG002|Overall Study|Not treated|1|||
129542952|NCT03099265|466280379|FG000|Overall Study|Adverse Event|1|||
129542953|NCT00518531|466280383|FG000|Treatment Period 1|Adverse Event|5|||
129542954|NCT00518531|466280384|FG001|Treatment Period 1|Adverse Event|0|||
129542955|NCT00518531|466280383|FG000|Treatment Period 1|Lost to Follow-up|5|||
129542956|NCT00518531|466280384|FG001|Treatment Period 1|Lost to Follow-up|3|||
129542957|NCT00518531|466280383|FG000|Treatment Period 1|Physician Decision|1|||
129542958|NCT00518531|466280384|FG001|Treatment Period 1|Physician Decision|0|||
129542959|NCT00518531|466280383|FG000|Treatment Period 1|Protocol Violation|2|||
129542960|NCT00518531|466280384|FG001|Treatment Period 1|Protocol Violation|0|||
129542961|NCT00518531|466280383|FG000|Treatment Period 1|Withdrawal by Subject|4|||
129542962|NCT00518531|466280384|FG001|Treatment Period 1|Withdrawal by Subject|6|||
129542963|NCT00518531|466280383|FG000|Treatment Period 1|Early crossover|1|||
129542964|NCT00518531|466280384|FG001|Treatment Period 1|Early crossover|3|||
129542965|NCT00518531|466280383|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129542966|NCT00518531|466280384|FG001|Treatment Period 2|Withdrawal by Subject|8|||
129542967|NCT00518531|466280383|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
129542968|NCT00518531|466280384|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
129542969|NCT00518531|466280383|FG000|Treatment Period 2|Adverse Event|1|||
129542970|NCT00518531|466280384|FG001|Treatment Period 2|Adverse Event|7|||
129542971|NCT00518531|466280383|FG000|Treatment Period 2|Protocol-specified criteria|0|||
129542972|NCT00518531|466280384|FG001|Treatment Period 2|Protocol-specified criteria|1|||
129542973|NCT00518531|466280383|FG000|Treatment Period 2|Non-compliance|1|||
129542974|NCT00518531|466280384|FG001|Treatment Period 2|Non-compliance|2|||
129542975|NCT00602927|466280387|FG000|Period 1: 13 Days|Protocol Violation|2|||
129542976|NCT00602927|466280388|FG001|Period 1: 13 Days|Protocol Violation|4|||
129542977|NCT00602927|466280387|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
129542978|NCT00602927|466280388|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
129542979|NCT00602927|466280387|FG000|Period 1: 13 Days|Time|1|||
129542980|NCT00602927|466280388|FG001|Period 1: 13 Days|Time|0|||
129542981|NCT00602927|466280387|FG000|Period 1: 13 Days|Claustrophobia|0|||
129542982|NCT00602927|466280388|FG001|Period 1: 13 Days|Claustrophobia|1|||
129542983|NCT00602927|466280387|FG000|Period 2: 14 Days|Protocol Violation|0|||
129542984|NCT00602927|466280388|FG001|Period 2: 14 Days|Protocol Violation|2|||
129542985|NCT00602927|466280387|FG000|Period 3: 13 Days|Protocol Violation|0|||
129542986|NCT00602927|466280388|FG001|Period 3: 13 Days|Protocol Violation|1|||
129542987|NCT00602927|466280387|FG000|Period 3: 13 Days|MRI data quality|2|||
129542988|NCT00602927|466280388|FG001|Period 3: 13 Days|MRI data quality|2|||
129542989|NCT00478933|466280392|FG000|Overall Study|Protocol Violation|22|||
129542990|NCT00478933|466280392|FG000|Overall Study|Informed consent not verified|3|||
129542991|NCT00478933|466280392|FG000|Overall Study|Inadequate data available|53|||
129542992|NCT03772574|466280393|FG000|Overall Study|Protocol Violation|2|||
129542993|NCT03772574|466280394|FG001|Overall Study|Protocol Violation|0|||
129542994|NCT03772574|466280395|FG002|Overall Study|Protocol Violation|0|||
129542995|NCT03772574|466280393|FG000|Overall Study|Discomfort|0|||
129542996|NCT03772574|466280394|FG001|Overall Study|Discomfort|5|||
129542997|NCT03772574|466280395|FG002|Overall Study|Discomfort|4|||
129707753|NCT01280968|466892117|FG000|Overall Study|Lost to Follow-up|8|||
129707754|NCT01280968|466892118|FG001|Overall Study|Lost to Follow-up|2|||
129707755|NCT01280968|466892117|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
129707756|NCT01280968|466892118|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
129707757|NCT01280968|466892117|FG000|Overall Study|Commuting Problems|2|||
129542998|NCT01298362|466280399|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
129542999|NCT01298362|466280400|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
129543000|NCT00762073|466280409|FG000|Overall Study|Lack of Efficacy|1|||
129543001|NCT00762073|466280410|FG001|Overall Study|Lack of Efficacy|1|||
129543002|NCT00762073|466280411|FG002|Overall Study|Lack of Efficacy|0|||
129543003|NCT00762073|466280412|FG003|Overall Study|Lack of Efficacy|0|||
129543004|NCT00762073|466280409|FG000|Overall Study|Adverse Event|1|||
129543005|NCT00762073|466280410|FG001|Overall Study|Adverse Event|0|||
129543006|NCT00762073|466280411|FG002|Overall Study|Adverse Event|1|||
129543007|NCT00762073|466280412|FG003|Overall Study|Adverse Event|1|||
129543008|NCT00762073|466280409|FG000|Overall Study|Significant Subject Noncompliance|0|||
129543009|NCT00762073|466280410|FG001|Overall Study|Significant Subject Noncompliance|1|||
129543010|NCT00762073|466280411|FG002|Overall Study|Significant Subject Noncompliance|0|||
129543011|NCT00762073|466280412|FG003|Overall Study|Significant Subject Noncompliance|1|||
129543012|NCT00762073|466280409|FG000|Overall Study|Withdrawal by Subject|1|||
129543013|NCT00762073|466280410|FG001|Overall Study|Withdrawal by Subject|2|||
129543014|NCT00762073|466280411|FG002|Overall Study|Withdrawal by Subject|1|||
129543015|NCT00762073|466280412|FG003|Overall Study|Withdrawal by Subject|1|||
129543016|NCT00762073|466280409|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
129543017|NCT00762073|466280410|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
129543018|NCT00762073|466280411|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
129543019|NCT00762073|466280412|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
129543020|NCT00491322|466280414|FG000|Overall Study|Protocol Violation|1|||
129543021|NCT00491322|466280415|FG001|Overall Study|Protocol Violation|0|||
129543022|NCT00491322|466280414|FG000|Overall Study|Pregnancy|0|||
129543023|NCT00491322|466280415|FG001|Overall Study|Pregnancy|1|||
129543024|NCT00455923|466280416|FG000|Overall Study|Pregnancy|0|||
129543025|NCT00455923|466280417|FG001|Overall Study|Pregnancy|2|||
129543026|NCT00455923|466280416|FG000|Overall Study|Other|3|||
129543027|NCT00455923|466280417|FG001|Overall Study|Other|1|||
129543028|NCT02331680|466280419|FG000|Overall Study|Adverse Event|3|||
129543029|NCT02331680|466280420|FG001|Overall Study|Adverse Event|0|||
129543030|NCT02331680|466280421|FG002|Overall Study|Adverse Event|2|||
129543031|NCT02331680|466280419|FG000|Overall Study|Physician Decision|1|||
129543032|NCT02331680|466280420|FG001|Overall Study|Physician Decision|1|||
129543033|NCT02331680|466280421|FG002|Overall Study|Physician Decision|2|||
129543034|NCT02331680|466280419|FG000|Overall Study|Withdrawal by Subject|0|||
129543035|NCT02331680|466280420|FG001|Overall Study|Withdrawal by Subject|1|||
129543036|NCT02331680|466280421|FG002|Overall Study|Withdrawal by Subject|2|||
129543037|NCT02331680|466280419|FG000|Overall Study|Met withdrawal criteria|2|||
129543038|NCT02331680|466280420|FG001|Overall Study|Met withdrawal criteria|2|||
129543039|NCT02331680|466280421|FG002|Overall Study|Met withdrawal criteria|5|||
129543040|NCT02331680|466280419|FG000|Overall Study|Non-compliance with study drug|0|||
129543041|NCT02331680|466280420|FG001|Overall Study|Non-compliance with study drug|0|||
129543042|NCT02331680|466280421|FG002|Overall Study|Non-compliance with study drug|1|||
129543043|NCT02331680|466280419|FG000|Overall Study|Protocol Violation|0|||
129543044|NCT02331680|466280420|FG001|Overall Study|Protocol Violation|0|||
129543045|NCT02331680|466280421|FG002|Overall Study|Protocol Violation|3|||
129543046|NCT02279888|466280422|FG000|Overall Study|Death|326|||
129543047|NCT02279888|466280422|FG000|Overall Study|Withdrawal by Subject|38|||
129543048|NCT02279888|466280422|FG000|Overall Study|Lost to Follow-up|21|||
129543049|NCT02279888|466280422|FG000|Overall Study|Physician Decision|62|||
129543050|NCT02279888|466280422|FG000|Overall Study|Subject Non-compliance|43|||
129543051|NCT02279888|466280422|FG000|Overall Study|Not implanted|14|||
129543052|NCT02279888|466280422|FG000|Overall Study|Visit not performed|26|||
129543053|NCT01891669|466280423|FG000|Overall Study|Death|0|||
129543054|NCT01891669|466280424|FG001|Overall Study|Death|0|||
129543055|NCT01891669|466280425|FG002|Overall Study|Death|0|||
129543056|NCT01891669|466280426|FG003|Overall Study|Death|0|||
129543057|NCT01891669|466280427|FG004|Overall Study|Death|0|||
129543058|NCT01891669|466280428|FG005|Overall Study|Death|0|||
129543059|NCT01891669|466280429|FG006|Overall Study|Death|0|||
129543060|NCT01891669|466280430|FG007|Overall Study|Death|1|||
129543061|NCT01891669|466280431|FG008|Overall Study|Death|0|||
129543062|NCT01891669|466280432|FG009|Overall Study|Death|1|||
129543063|NCT01891669|466280423|FG000|Overall Study|Withdrawal by Subject|1|||
129543064|NCT01891669|466280424|FG001|Overall Study|Withdrawal by Subject|1|||
129543065|NCT01891669|466280425|FG002|Overall Study|Withdrawal by Subject|0|||
129543066|NCT01891669|466280426|FG003|Overall Study|Withdrawal by Subject|0|||
129543067|NCT01891669|466280427|FG004|Overall Study|Withdrawal by Subject|0|||
129543068|NCT01891669|466280428|FG005|Overall Study|Withdrawal by Subject|0|||
129543069|NCT01891669|466280429|FG006|Overall Study|Withdrawal by Subject|1|||
129543070|NCT01891669|466280430|FG007|Overall Study|Withdrawal by Subject|2|||
129543071|NCT01891669|466280431|FG008|Overall Study|Withdrawal by Subject|1|||
129543072|NCT01891669|466280432|FG009|Overall Study|Withdrawal by Subject|1|||
129543073|NCT01891669|466280423|FG000|Overall Study|Other|1|||
129543074|NCT01891669|466280424|FG001|Overall Study|Other|0|||
129543075|NCT01891669|466280425|FG002|Overall Study|Other|0|||
129543076|NCT01891669|466280426|FG003|Overall Study|Other|0|||
129543077|NCT01891669|466280427|FG004|Overall Study|Other|0|||
129543078|NCT01891669|466280428|FG005|Overall Study|Other|0|||
129543079|NCT01891669|466280429|FG006|Overall Study|Other|0|||
129543080|NCT01891669|466280430|FG007|Overall Study|Other|1|||
129543081|NCT01891669|466280431|FG008|Overall Study|Other|0|||
129543082|NCT01891669|466280432|FG009|Overall Study|Other|0|||
129543083|NCT05153629|466280434|FG000|Overall Study|Withdrawal by Subject|0|||
129543084|NCT05153629|466280435|FG001|Overall Study|Withdrawal by Subject|2|||
129543085|NCT03743571|466280438|FG000|Overall Study|Withdrawal by Subject|1|||
129543086|NCT03743571|466280439|FG001|Overall Study|Withdrawal by Subject|1|||
129543087|NCT03743571|466280438|FG000|Overall Study|Lost to Follow-up|1|||
129543088|NCT03743571|466280439|FG001|Overall Study|Lost to Follow-up|2|||
129543089|NCT04115488|466280440|FG000|Overall Study|Adverse Event|8|||
129543090|NCT04115488|466280441|FG001|Overall Study|Adverse Event|4|||
129543091|NCT04115488|466280440|FG000|Overall Study|Withdrawal by Subject|3|||
129543092|NCT04115488|466280441|FG001|Overall Study|Withdrawal by Subject|6|||
129543093|NCT04115488|466280440|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
129543094|NCT04115488|466280441|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
129543095|NCT04115488|466280440|FG000|Overall Study|Patient 's location change|1|||
129543096|NCT04115488|466280441|FG001|Overall Study|Patient 's location change|0|||
129543097|NCT04115488|466280440|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
129543098|NCT04115488|466280441|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
129543099|NCT02576951|466280464|FG000|Overall Study|Lost to Follow-up|0|||
129543100|NCT02576951|466280465|FG001|Overall Study|Lost to Follow-up|0|||
129543101|NCT02576951|466280466|FG002|Overall Study|Lost to Follow-up|2|||
129543102|NCT02576951|466280467|FG003|Overall Study|Lost to Follow-up|2|||
129543103|NCT02576951|466280464|FG000|Overall Study|Withdrawal by Subject|1|||
129543104|NCT02576951|466280465|FG001|Overall Study|Withdrawal by Subject|0|||
129543105|NCT02576951|466280466|FG002|Overall Study|Withdrawal by Subject|0|||
129543106|NCT02576951|466280467|FG003|Overall Study|Withdrawal by Subject|2|||
129543107|NCT02576951|466280464|FG000|Overall Study|Protocol Violation|0|||
129543108|NCT02576951|466280465|FG001|Overall Study|Protocol Violation|0|||
129543109|NCT02576951|466280466|FG002|Overall Study|Protocol Violation|0|||
129543110|NCT02576951|466280467|FG003|Overall Study|Protocol Violation|1|||
129543111|NCT03280628|466282023|FG000|Overall Study|Lost to Follow-up|8|||
129543112|NCT03280628|466282024|FG001|Overall Study|Lost to Follow-up|6|||
129543113|NCT03280628|466282025|FG002|Overall Study|Lost to Follow-up|11|||
129543114|NCT03839693|466282030|FG000|Overall Study|Lost to Follow-up|0|||
129543115|NCT03839693|466282031|FG001|Overall Study|Lost to Follow-up|2|||
129543116|NCT03839693|466282032|FG002|Overall Study|Lost to Follow-up|2|||
129543117|NCT03839693|466282030|FG000|Overall Study|Withdrawal by Subject|1|||
129543118|NCT03839693|466282031|FG001|Overall Study|Withdrawal by Subject|0|||
129543119|NCT03839693|466282032|FG002|Overall Study|Withdrawal by Subject|2|||
129543120|NCT03839693|466282030|FG000|Overall Study|subject moved out of the area|1|||
129543121|NCT03839693|466282031|FG001|Overall Study|subject moved out of the area|0|||
129543122|NCT03839693|466282032|FG002|Overall Study|subject moved out of the area|0|||
129543123|NCT03433482|466282033|FG000|Overall Study|Lost to Follow-up|1|||
129543124|NCT03433482|466282034|FG001|Overall Study|Lost to Follow-up|0|||
129543125|NCT03433482|466282035|FG002|Overall Study|Lost to Follow-up|1|||
129543126|NCT03433482|466282036|FG003|Overall Study|Lost to Follow-up|1|||
129543127|NCT03433482|466282033|FG000|Overall Study|Withdrawal by Subject|0|||
129543128|NCT03433482|466282034|FG001|Overall Study|Withdrawal by Subject|0|||
129543129|NCT03433482|466282035|FG002|Overall Study|Withdrawal by Subject|1|||
129543130|NCT03433482|466282036|FG003|Overall Study|Withdrawal by Subject|0|||
129543131|NCT03433482|466282033|FG000|Overall Study|Unknown reason|0|||
129543132|NCT03433482|466282034|FG001|Overall Study|Unknown reason|0|||
129543133|NCT03433482|466282035|FG002|Overall Study|Unknown reason|2|||
129543134|NCT03433482|466282036|FG003|Overall Study|Unknown reason|0|||
129543135|NCT00594568|466282037|FG000|Initial Treatment|Adverse Event|51|||
129543136|NCT00594568|466282038|FG001|Initial Treatment|Adverse Event|121|||
129543137|NCT00594568|466282039|FG002|Initial Treatment|Adverse Event|144|||
129543138|NCT00594568|466282037|FG000|Initial Treatment|Death|6|||
129543139|NCT00594568|466282038|FG001|Initial Treatment|Death|11|||
129543140|NCT00594568|466282039|FG002|Initial Treatment|Death|15|||
129543141|NCT00594568|466282037|FG000|Initial Treatment|Lost to Follow-up|4|||
129543142|NCT00594568|466282038|FG001|Initial Treatment|Lost to Follow-up|1|||
129543143|NCT00594568|466282039|FG002|Initial Treatment|Lost to Follow-up|4|||
129543144|NCT00594568|466282037|FG000|Initial Treatment|Physician Decision|3|||
129543145|NCT00594568|466282038|FG001|Initial Treatment|Physician Decision|2|||
129543146|NCT00594568|466282039|FG002|Initial Treatment|Physician Decision|4|||
129543147|NCT00594568|466282037|FG000|Initial Treatment|Protocol Violation|2|||
129543148|NCT00594568|466282038|FG001|Initial Treatment|Protocol Violation|2|||
129543149|NCT00594568|466282039|FG002|Initial Treatment|Protocol Violation|5|||
129543150|NCT00594568|466282037|FG000|Initial Treatment|Withdrawal by Subject|25|||
129543151|NCT00594568|466282038|FG001|Initial Treatment|Withdrawal by Subject|31|||
129543152|NCT00594568|466282039|FG002|Initial Treatment|Withdrawal by Subject|46|||
129543153|NCT00594568|466282037|FG000|Initial Treatment|Sponsor decision|193|||
129543154|NCT00594568|466282038|FG001|Initial Treatment|Sponsor decision|142|||
129543155|NCT00594568|466282039|FG002|Initial Treatment|Sponsor decision|147|||
129543156|NCT00594568|466282037|FG000|Initial Treatment|Caregiver decision|21|||
129543157|NCT00594568|466282038|FG001|Initial Treatment|Caregiver decision|36|||
129543158|NCT00594568|466282039|FG002|Initial Treatment|Caregiver decision|36|||
129543159|NCT00594568|466282037|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
129543160|NCT00594568|466282038|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
129543161|NCT00594568|466282039|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
129543162|NCT00594568|466282037|FG000|Initial Treatment|Entry criteria exclusion|0|||
129543163|NCT00594568|466282038|FG001|Initial Treatment|Entry criteria exclusion|1|||
129543164|NCT00594568|466282039|FG002|Initial Treatment|Entry criteria exclusion|1|||
129543165|NCT00594568|466282037|FG000|Delayed Start|Death|0|||
129543166|NCT00594568|466282038|FG001|Delayed Start|Death|0|||
129543167|NCT00594568|466282039|FG002|Delayed Start|Death|1|||
129543168|NCT00594568|466282037|FG000|Delayed Start|Adverse Event|12|||
129543169|NCT00594568|466282038|FG001|Delayed Start|Adverse Event|2|||
129543170|NCT00594568|466282039|FG002|Delayed Start|Adverse Event|2|||
129543171|NCT00594568|466282037|FG000|Delayed Start|Withdrawal by Subject|4|||
129543172|NCT00594568|466282038|FG001|Delayed Start|Withdrawal by Subject|3|||
129543173|NCT00594568|466282039|FG002|Delayed Start|Withdrawal by Subject|0|||
129543174|NCT00594568|466282037|FG000|Delayed Start|Physician Decision|0|||
129543175|NCT00594568|466282038|FG001|Delayed Start|Physician Decision|0|||
129543176|NCT00594568|466282039|FG002|Delayed Start|Physician Decision|1|||
129543177|NCT00594568|466282037|FG000|Delayed Start|Lost to Follow-up|0|||
129543178|NCT00594568|466282038|FG001|Delayed Start|Lost to Follow-up|0|||
129543179|NCT00594568|466282039|FG002|Delayed Start|Lost to Follow-up|1|||
129543180|NCT00594568|466282037|FG000|Delayed Start|Caregiver Decision|5|||
129543181|NCT00594568|466282038|FG001|Delayed Start|Caregiver Decision|6|||
129543182|NCT00594568|466282039|FG002|Delayed Start|Caregiver Decision|2|||
129543183|NCT00594568|466282037|FG000|Delayed Start|Sponsor Decision|77|||
129543184|NCT00594568|466282038|FG001|Delayed Start|Sponsor Decision|66|||
129543185|NCT00594568|466282039|FG002|Delayed Start|Sponsor Decision|59|||
129543186|NCT00594568|466282037|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
129543187|NCT00594568|466282038|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
129543188|NCT00594568|466282039|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
129543189|NCT00594568|466282037|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
129543190|NCT00594568|466282038|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
129543191|NCT00594568|466282039|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
129543192|NCT00594568|466282037|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
129543193|NCT00594568|466282038|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
129543194|NCT00594568|466282039|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
129543195|NCT00594568|466282037|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
129543196|NCT00594568|466282038|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
129543197|NCT00594568|466282039|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
129543198|NCT00594568|466282037|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
129543199|NCT00594568|466282038|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
129543200|NCT00594568|466282039|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
129543201|NCT00594568|466282037|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
129543202|NCT00594568|466282038|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
129543203|NCT00594568|466282039|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
129543204|NCT04311411|466282040|FG000|Overall Study|Adverse Event|2|||
129543205|NCT04311411|466282041|FG001|Overall Study|Adverse Event|3|||
129543206|NCT04311411|466282042|FG002|Overall Study|Adverse Event|2|||
129543207|NCT04311411|466282040|FG000|Overall Study|Withdrawal by Subject|3|||
129543208|NCT04311411|466282041|FG001|Overall Study|Withdrawal by Subject|3|||
129543209|NCT04311411|466282042|FG002|Overall Study|Withdrawal by Subject|0|||
129543210|NCT03722849|466282046|FG000|Overall Study|Withdrawal by Subject|1|||
129543211|NCT03722849|466282047|FG001|Overall Study|Withdrawal by Subject|1|||
129543212|NCT05644756|466282048|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
129543213|NCT05644756|466282048|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
129543214|NCT03985982|466282049|FG000|Double-Blind Phase|Lost to Follow-up|4|||
129543215|NCT03985982|466282050|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129543216|NCT03985982|466282051|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129543217|NCT03985982|466282049|FG000|Double-Blind Phase|Physician Decision|1|||
129543218|NCT03985982|466282050|FG001|Double-Blind Phase|Physician Decision|0|||
129543219|NCT03985982|466282051|FG002|Double-Blind Phase|Physician Decision|0|||
129543220|NCT03985982|466282049|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
129543221|NCT03985982|466282050|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
129543222|NCT03985982|466282051|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129543223|NCT03985982|466282049|FG000|Double-Blind Phase|COVID-19|1|||
129543224|NCT03985982|466282050|FG001|Double-Blind Phase|COVID-19|0|||
129543225|NCT03985982|466282051|FG002|Double-Blind Phase|COVID-19|0|||
129543226|NCT03985982|466282049|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
129543227|NCT03985982|466282050|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
129543228|NCT03985982|466282051|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
129543229|NCT03985982|466282049|FG000|Open-Label Phase|Lost to Follow-up|0|||
129543230|NCT03985982|466282050|FG001|Open-Label Phase|Lost to Follow-up|0|||
129543231|NCT03985982|466282051|FG002|Open-Label Phase|Lost to Follow-up|13|||
129543232|NCT03985982|466282049|FG000|Open-Label Phase|Physician Decision|0|||
129543233|NCT03985982|466282050|FG001|Open-Label Phase|Physician Decision|0|||
129543234|NCT03985982|466282051|FG002|Open-Label Phase|Physician Decision|2|||
129543235|NCT03985982|466282049|FG000|Open-Label Phase|Withdrawal by Subject|0|||
129543236|NCT03985982|466282050|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129543237|NCT03985982|466282051|FG002|Open-Label Phase|Withdrawal by Subject|11|||
129543238|NCT00348348|466282056|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
129543239|NCT00348348|466282057|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
129543240|NCT00348348|466282056|FG000|Overall Study|Lack of Efficacy|1|||
129543241|NCT00348348|466282057|FG001|Overall Study|Lack of Efficacy|1|||
129543242|NCT00348348|466282056|FG000|Overall Study|Lost to Follow-up|8|||
129543243|NCT00348348|466282057|FG001|Overall Study|Lost to Follow-up|10|||
129543244|NCT00348348|466282056|FG000|Overall Study|Withdrawal by Subject|4|||
129543245|NCT00348348|466282057|FG001|Overall Study|Withdrawal by Subject|1|||
129543246|NCT00348348|466282056|FG000|Overall Study|Other|7|||
129543247|NCT00348348|466282057|FG001|Overall Study|Other|4|||
129543248|NCT00348348|466282056|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
129543249|NCT00348348|466282057|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
129543250|NCT00348348|466282056|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
129543251|NCT00348348|466282057|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
129543252|NCT00348348|466282056|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
129543253|NCT00348348|466282057|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
129543254|NCT00348348|466282056|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
129543255|NCT00348348|466282057|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
129543256|NCT00348348|466282056|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
129543257|NCT00348348|466282057|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
129543258|NCT00348348|466282056|FG000|Overall Study|Adverse event probably related to study|1|||
129543259|NCT00348348|466282057|FG001|Overall Study|Adverse event probably related to study|0|||
129543260|NCT04983589|466282058|FG000|Overall Study|Withdrawal by Subject|0|||
129543261|NCT04983589|466282059|FG001|Overall Study|Withdrawal by Subject|3|||
129543262|NCT04983589|466282058|FG000|Overall Study|COVID-19 Infection|1|||
129543263|NCT04983589|466282059|FG001|Overall Study|COVID-19 Infection|0|||
129543264|NCT04983589|466282058|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
129543265|NCT04983589|466282059|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
129543266|NCT00924820|466282060|FG000|Overall Study|Death|2|||
129543267|NCT00924820|466282060|FG000|Overall Study|Ineligible, Screen Failure|5|||
129543268|NCT01353586|466282061|FG000|Overall Study|Procedure terminated prior to ablation|3|||
129543269|NCT01353586|466282062|FG001|Overall Study|Procedure terminated prior to ablation|0|||
129543270|NCT01353586|466282061|FG000|Overall Study|Never had insertion of study catheter|4|||
129543271|NCT01353586|466282062|FG001|Overall Study|Never had insertion of study catheter|1|||
129543272|NCT01353586|466282061|FG000|Overall Study|Neurological exam not done|0|||
129543273|NCT01353586|466282062|FG001|Overall Study|Neurological exam not done|1|||
129543274|NCT00978120|466282063|FG000|Overall Study|Death|0|||
129543275|NCT00978120|466282064|FG001|Overall Study|Death|0|||
129543276|NCT00978120|466282065|FG002|Overall Study|Death|0|||
129543277|NCT00978120|466282066|FG003|Overall Study|Death|1|||
129543278|NCT00978120|466282063|FG000|Overall Study|Lost to Follow-up|0|||
129543279|NCT00978120|466282064|FG001|Overall Study|Lost to Follow-up|0|||
129543280|NCT00978120|466282065|FG002|Overall Study|Lost to Follow-up|3|||
129543281|NCT00978120|466282066|FG003|Overall Study|Lost to Follow-up|0|||
129543282|NCT00978120|466282063|FG000|Overall Study|Withdrawal by Subject|2|||
129543283|NCT00978120|466282064|FG001|Overall Study|Withdrawal by Subject|0|||
129543284|NCT00978120|466282065|FG002|Overall Study|Withdrawal by Subject|0|||
129543285|NCT00978120|466282066|FG003|Overall Study|Withdrawal by Subject|0|||
129543286|NCT00978120|466282063|FG000|Overall Study|Moved out of state|0|||
129543287|NCT00978120|466282064|FG001|Overall Study|Moved out of state|0|||
129543288|NCT00978120|466282065|FG002|Overall Study|Moved out of state|0|||
129651313|NCT03738800|466679611|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129765763|NCT00656513|467108330|FG002|Overall Study|Death|1|||
129765764|NCT00656513|467108328|FG000|Overall Study|Missing data|0|||
129765765|NCT00656513|467108329|FG001|Overall Study|Missing data|11|||
129543289|NCT00978120|466282066|FG003|Overall Study|Moved out of state|1|||
129543290|NCT01068418|466282075|FG000|Overall Study|Physician Decision|12|||
129543291|NCT03155269|466282076|FG000|Overall Study|Withdrawal by Subject|4|||
129543292|NCT03155269|466282077|FG001|Overall Study|Withdrawal by Subject|5|||
129543293|NCT03155269|466282076|FG000|Overall Study|Lost to Follow-up|1|||
129543294|NCT03155269|466282077|FG001|Overall Study|Lost to Follow-up|2|||
129543295|NCT00943826|466282078|FG000|Concurrent Phase|Adverse Event|50|||
129543296|NCT00943826|466282079|FG001|Concurrent Phase|Adverse Event|27|||
129543297|NCT00943826|466282078|FG000|Concurrent Phase|Withdrew consent|3|||
129765766|NCT00656513|467108330|FG002|Overall Study|Missing data|9|||
129765767|NCT00656513|467108328|FG000|Overall Study|Incomplete treatment|3|||
129543298|NCT00943826|466282079|FG001|Concurrent Phase|Withdrew consent|7|||
129543299|NCT00943826|466282078|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
129543300|NCT00943826|466282079|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
129543301|NCT00943826|466282078|FG000|Concurrent Phase|Administrative reasons|2|||
129543302|NCT00943826|466282079|FG001|Concurrent Phase|Administrative reasons|1|||
129543303|NCT00943826|466282078|FG000|Concurrent Phase|Protocol Violation|1|||
129543304|NCT00943826|466282079|FG001|Concurrent Phase|Protocol Violation|0|||
129543305|NCT00943826|466282078|FG000|Maintenance Phase|Adverse Event|31|||
129543306|NCT00943826|466282079|FG001|Maintenance Phase|Adverse Event|30|||
129543307|NCT00943826|466282078|FG000|Maintenance Phase|Withdrew consent|2|||
129543308|NCT00943826|466282079|FG001|Maintenance Phase|Withdrew consent|4|||
129543309|NCT00943826|466282078|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
129543310|NCT00943826|466282079|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
129543311|NCT00943826|466282078|FG000|Maintenance Phase|Administrative reasons|4|||
129543312|NCT00943826|466282079|FG001|Maintenance Phase|Administrative reasons|1|||
129543313|NCT00943826|466282078|FG000|Maintenance Phase|Failure to return|0|||
129543314|NCT00943826|466282079|FG001|Maintenance Phase|Failure to return|1|||
129543315|NCT00943826|466282078|FG000|Monotherapy Phase|Adverse Event|42|||
129543316|NCT00943826|466282079|FG001|Monotherapy Phase|Adverse Event|5|||
129543317|NCT00943826|466282078|FG000|Monotherapy Phase|Administrative reasons|11|||
129543318|NCT00943826|466282079|FG001|Monotherapy Phase|Administrative reasons|5|||
129543319|NCT00943826|466282078|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
129543320|NCT00943826|466282079|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
129543321|NCT00943826|466282078|FG000|Monotherapy Phase|Withdrew Consent|2|||
129543322|NCT00943826|466282079|FG001|Monotherapy Phase|Withdrew Consent|3|||
129543323|NCT00943826|466282078|FG000|Monotherapy Phase|Failure to return|2|||
129543324|NCT00943826|466282079|FG001|Monotherapy Phase|Failure to return|1|||
129543325|NCT00943826|466282078|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
129543326|NCT00943826|466282079|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
129543327|NCT00943826|466282078|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
129543328|NCT00943826|466282079|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
129543329|NCT00943826|466282078|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
129543330|NCT00943826|466282079|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
129543331|NCT00943826|466282078|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
129543332|NCT00943826|466282079|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
129543333|NCT00326625|466282080|FG000|Overall Study|Adverse Event|20|||
129543334|NCT00326625|466282081|FG001|Overall Study|Adverse Event|9|||
129543335|NCT00326625|466282080|FG000|Overall Study|Withdrawal by Subject|15|||
129543336|NCT00326625|466282081|FG001|Overall Study|Withdrawal by Subject|12|||
129543337|NCT00326625|466282080|FG000|Overall Study|Death|18|||
129543338|NCT00326625|466282081|FG001|Overall Study|Death|16|||
129543339|NCT00326625|466282080|FG000|Overall Study|Lost to Follow-up|1|||
129543340|NCT00326625|466282081|FG001|Overall Study|Lost to Follow-up|0|||
129543341|NCT00326625|466282080|FG000|Overall Study|prescheduled medical intervention|0|||
129543342|NCT00326625|466282081|FG001|Overall Study|prescheduled medical intervention|1|||
129543343|NCT01265875|466282086|FG000|Overall Study|Uncooperative/unreliable|1|||
129543344|NCT05275673|466282087|FG000|Overall Study|Study Termination by Sponsor|2|||
129543345|NCT05275673|466282088|FG001|Overall Study|Study Termination by Sponsor|3|||
129543346|NCT05275673|466282087|FG000|Overall Study|Death|1|||
129543347|NCT05275673|466282088|FG001|Overall Study|Death|0|||
129543348|NCT05275673|466282087|FG000|Overall Study|Withdrawal by Subject|1|||
129543349|NCT05275673|466282088|FG001|Overall Study|Withdrawal by Subject|0|||
129543350|NCT02335411|466282091|FG000|Overall Study|Death|223|||
129543351|NCT02335411|466282092|FG001|Overall Study|Death|22|||
129543352|NCT02335411|466282093|FG002|Overall Study|Death|26|||
129543353|NCT02335411|466282091|FG000|Overall Study|Physician Decision|3|||
129543354|NCT02335411|466282092|FG001|Overall Study|Physician Decision|0|||
129543355|NCT02335411|466282093|FG002|Overall Study|Physician Decision|0|||
129543356|NCT02335411|466282091|FG000|Overall Study|Protocol Violation|1|||
129543357|NCT02335411|466282092|FG001|Overall Study|Protocol Violation|0|||
129543358|NCT02335411|466282093|FG002|Overall Study|Protocol Violation|0|||
129543359|NCT02335411|466282091|FG000|Overall Study|Withdrawal by Subject|11|||
129543360|NCT02335411|466282092|FG001|Overall Study|Withdrawal by Subject|0|||
129543361|NCT02335411|466282093|FG002|Overall Study|Withdrawal by Subject|3|||
129543362|NCT02335411|466282091|FG000|Overall Study|Sponsor Decision|12|||
129765768|NCT00656513|467108329|FG001|Overall Study|Incomplete treatment|0|||
129765769|NCT00656513|467108330|FG002|Overall Study|Incomplete treatment|0|||
129543363|NCT02335411|466282092|FG001|Overall Study|Sponsor Decision|3|||
129543364|NCT02335411|466282093|FG002|Overall Study|Sponsor Decision|2|||
129543365|NCT02335411|466282091|FG000|Overall Study|Adverse Event|9|||
129543366|NCT02335411|466282092|FG001|Overall Study|Adverse Event|0|||
129543367|NCT02335411|466282093|FG002|Overall Study|Adverse Event|0|||
129543368|NCT03075826|466282094|FG000|Overall Study|Withdrawal by Subject|1|||
129543369|NCT03075826|466282094|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
129765770|NCT00656513|467108328|FG000|Overall Study|Treatment completed outside of timeframe|0|||
129765771|NCT00656513|467108329|FG001|Overall Study|Treatment completed outside of timeframe|3|||
129765772|NCT00656513|467108330|FG002|Overall Study|Treatment completed outside of timeframe|1|||
129765773|NCT00656513|467108328|FG000|Overall Study|Missing baseline form|0|||
129765774|NCT00656513|467108329|FG001|Overall Study|Missing baseline form|5|||
129765775|NCT00656513|467108330|FG002|Overall Study|Missing baseline form|5|||
129765776|NCT03405792|467108331|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
129765777|NCT03405792|467108332|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
129765778|NCT03405792|467108331|FG000|Overall Study|o Did not receive pembrolizumab|1|||
129765779|NCT03405792|467108332|FG001|Overall Study|o Did not receive pembrolizumab|0|||
129765780|NCT03962491|467108333|FG000|Overall Study|Lost to Follow-up|4|||
129765781|NCT03962491|467108334|FG001|Overall Study|Lost to Follow-up|5|||
129765782|NCT03882021|467108337|FG000|Enrollment|Procedure aborted/cancelled|2|||
129765783|NCT03882021|467108337|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
129765784|NCT03882021|467108337|FG000|Enrollment to 3-Month|Death|1|||
129765785|NCT03882021|467108337|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
129765786|NCT03882021|467108337|FG000|Enrollment to 3-Month|Missed Visit|4|||
129765787|NCT03882021|467108337|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
129765788|NCT03882021|467108337|FG000|6-Month to 12-Month Visit|Death|1|||
129765789|NCT03882021|467108337|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
129765790|NCT03796728|467108341|FG000|Overall Study|Lost to Follow-up|8|||
129765791|NCT03796728|467108341|FG000|Overall Study|Reason not Specified|16|||
129765792|NCT00333775|467108342|FG000|Overall Study|Death|144|||
129765793|NCT00333775|467108343|FG001|Overall Study|Death|149|||
129765794|NCT00333775|467108344|FG002|Overall Study|Death|143|||
129765795|NCT00333775|467108342|FG000|Overall Study|In Follow-up When Study Stopped|87|||
129765796|NCT00333775|467108343|FG001|Overall Study|In Follow-up When Study Stopped|92|||
129765797|NCT00333775|467108344|FG002|Overall Study|In Follow-up When Study Stopped|96|||
129765798|NCT00333775|467108342|FG000|Overall Study|Lost to Follow-up|10|||
129765799|NCT00333775|467108343|FG001|Overall Study|Lost to Follow-up|7|||
129765800|NCT00333775|467108344|FG002|Overall Study|Lost to Follow-up|8|||
129765801|NCT02476617|467108348|FG000|Overall Study|Adverse Event|1|||
129765802|NCT02476617|467108348|FG000|Overall Study|Lost to Follow-up|1|||
129765803|NCT03486912|467108349|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
129765804|NCT03486912|467108350|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
129765805|NCT03486912|467108351|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
129765806|NCT03486912|467108352|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
129765807|NCT03486912|467108349|FG000|Treatment Period|Withdrawal by Subject|3|||
129765808|NCT03486912|467108350|FG001|Treatment Period|Withdrawal by Subject|3|||
129765809|NCT03486912|467108351|FG002|Treatment Period|Withdrawal by Subject|3|||
129765810|NCT03486912|467108352|FG003|Treatment Period|Withdrawal by Subject|2|||
129765811|NCT03486912|467108349|FG000|Treatment Period|Other Reasons|0|||
129765812|NCT03486912|467108350|FG001|Treatment Period|Other Reasons|2|||
129765813|NCT03486912|467108351|FG002|Treatment Period|Other Reasons|1|||
129765814|NCT03486912|467108352|FG003|Treatment Period|Other Reasons|1|||
129765815|NCT03486912|467108349|FG000|Treatment Period|Adverse Event|0|||
129765816|NCT03486912|467108350|FG001|Treatment Period|Adverse Event|1|||
129765817|NCT03486912|467108351|FG002|Treatment Period|Adverse Event|1|||
129765818|NCT03486912|467108352|FG003|Treatment Period|Adverse Event|0|||
129765819|NCT03486912|467108349|FG000|Treatment Period|Lost to Follow-up|1|||
129765820|NCT03486912|467108350|FG001|Treatment Period|Lost to Follow-up|0|||
129765821|NCT03486912|467108351|FG002|Treatment Period|Lost to Follow-up|0|||
129765822|NCT03486912|467108352|FG003|Treatment Period|Lost to Follow-up|2|||
129765823|NCT02491684|467108353|FG000|Treatment Phase|Adverse Event|2|||
129765824|NCT02491684|467108354|FG001|Treatment Phase|Adverse Event|2|||
129765825|NCT02491684|467108353|FG000|Treatment Phase|Incorrect randomisation|1|||
129765826|NCT02491684|467108354|FG001|Treatment Phase|Incorrect randomisation|0|||
129765827|NCT02491684|467108353|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
129765828|NCT02491684|467108354|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
129765829|NCT01263769|467108357|FG000|Overall Study|Non-Compliant with treatment|1|||
129765830|NCT04842747|467108362|FG000|Overall Study|Withdrawal by Subject|6|||
129765831|NCT04842747|467108363|FG001|Overall Study|Withdrawal by Subject|2|||
129765832|NCT04842747|467108362|FG000|Overall Study|Lost to Follow-up|1|||
129765833|NCT04842747|467108363|FG001|Overall Study|Lost to Follow-up|2|||
129765834|NCT04842747|467108362|FG000|Overall Study|Physician Decision|1|||
129765835|NCT04842747|467108363|FG001|Overall Study|Physician Decision|0|||
129765836|NCT04842747|467108362|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
129765837|NCT04842747|467108363|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
129765838|NCT02559622|467108364|FG000|Overall Study|Progressive disease|0|||
129765839|NCT02559622|467108365|FG001|Overall Study|Progressive disease|1|||
129765840|NCT02559622|467108366|FG002|Overall Study|Progressive disease|0|||
129765841|NCT02559622|467108367|FG003|Overall Study|Progressive disease|0|||
129765842|NCT02559622|467108364|FG000|Overall Study|Adverse Event|0|||
129765843|NCT02559622|467108365|FG001|Overall Study|Adverse Event|2|||
129543370|NCT00650806|466282095|FG000|Overall Study|Adverse Event|0|||
129543371|NCT00650806|466282096|FG001|Overall Study|Adverse Event|5|||
129543372|NCT00650806|466282097|FG002|Overall Study|Adverse Event|3|||
129543373|NCT00650806|466282098|FG003|Overall Study|Adverse Event|4|||
129543374|NCT00650806|466282095|FG000|Overall Study|Lost to Follow-up|7|||
129543375|NCT00650806|466282096|FG001|Overall Study|Lost to Follow-up|6|||
129543376|NCT00650806|466282097|FG002|Overall Study|Lost to Follow-up|11|||
129543377|NCT00650806|466282098|FG003|Overall Study|Lost to Follow-up|10|||
129543378|NCT00650806|466282095|FG000|Overall Study|Protocol Violation|0|||
129543379|NCT00650806|466282096|FG001|Overall Study|Protocol Violation|0|||
129543380|NCT00650806|466282097|FG002|Overall Study|Protocol Violation|0|||
129543381|NCT00650806|466282098|FG003|Overall Study|Protocol Violation|1|||
129543382|NCT00650806|466282095|FG000|Overall Study|Pregnancy|0|||
129543383|NCT00650806|466282096|FG001|Overall Study|Pregnancy|0|||
129543384|NCT00650806|466282097|FG002|Overall Study|Pregnancy|0|||
129543385|NCT00650806|466282098|FG003|Overall Study|Pregnancy|1|||
129543386|NCT00650806|466282095|FG000|Overall Study|Withdrawal by Subject|7|||
129543387|NCT00650806|466282096|FG001|Overall Study|Withdrawal by Subject|5|||
129543388|NCT00650806|466282097|FG002|Overall Study|Withdrawal by Subject|8|||
129543389|NCT00650806|466282098|FG003|Overall Study|Withdrawal by Subject|6|||
129543390|NCT00650806|466282095|FG000|Overall Study|Noncompliance with study drug regimen|1|||
129543391|NCT00650806|466282096|FG001|Overall Study|Noncompliance with study drug regimen|1|||
129543392|NCT00650806|466282097|FG002|Overall Study|Noncompliance with study drug regimen|0|||
129543393|NCT00650806|466282098|FG003|Overall Study|Noncompliance with study drug regimen|0|||
129543394|NCT00650806|466282095|FG000|Overall Study|Study terminated by sponsor|2|||
129543395|NCT00650806|466282096|FG001|Overall Study|Study terminated by sponsor|3|||
129543396|NCT00650806|466282097|FG002|Overall Study|Study terminated by sponsor|5|||
129543397|NCT00650806|466282098|FG003|Overall Study|Study terminated by sponsor|4|||
129543398|NCT00650806|466282095|FG000|Overall Study|Other|1|||
129543399|NCT00650806|466282096|FG001|Overall Study|Other|1|||
129543400|NCT00650806|466282097|FG002|Overall Study|Other|2|||
129543401|NCT00650806|466282098|FG003|Overall Study|Other|0|||
129543402|NCT04456998|466282099|FG000|Overall Study|Adverse Event|0|||
129543403|NCT04456998|466282100|FG001|Overall Study|Adverse Event|4|||
129543404|NCT04456998|466282099|FG000|Overall Study|Protocol Deviation|0|||
129543405|NCT04456998|466282100|FG001|Overall Study|Protocol Deviation|1|||
129543406|NCT04456998|466282099|FG000|Overall Study|Withdrawal by Subject|0|||
129543407|NCT04456998|466282100|FG001|Overall Study|Withdrawal by Subject|1|||
129543408|NCT04882085|466282104|FG000|Overall Study|Death|6|||
129543409|NCT04882085|466282105|FG001|Overall Study|Death|9|||
129543410|NCT04882085|466282104|FG000|Overall Study|Withdrawal by Subject|0|||
129543411|NCT04882085|466282105|FG001|Overall Study|Withdrawal by Subject|3|||
129543412|NCT04882085|466282104|FG000|Overall Study|Randomized not treated|1|||
129543413|NCT04882085|466282105|FG001|Overall Study|Randomized not treated|0|||
129543414|NCT00400985|466282106|FG000|Overall Study|Withdrawal by Subject|5|||
129543415|NCT00400985|466282106|FG000|Overall Study|system modification|8|||
129543416|NCT00400985|466282106|FG000|Overall Study|Death|30|||
129543417|NCT00400985|466282106|FG000|Overall Study|Lost to Follow-up|9|||
129543418|NCT00965562|466282107|FG000|Overall Study|Lost to Follow-up|1|||
129543419|NCT00965562|466282108|FG001|Overall Study|Lost to Follow-up|2|||
129543420|NCT00965562|466282109|FG002|Overall Study|Lost to Follow-up|3|||
129543421|NCT00965562|466282107|FG000|Overall Study|Withdrawal by Subject|2|||
129543422|NCT00965562|466282108|FG001|Overall Study|Withdrawal by Subject|2|||
129543423|NCT00965562|466282109|FG002|Overall Study|Withdrawal by Subject|0|||
129543424|NCT03792633|466282114|FG000|Overall Study|Alternative Treatment|17|||
129543425|NCT03792633|466282115|FG001|Overall Study|Alternative Treatment|19|||
129543426|NCT03792633|466282114|FG000|Overall Study|Death|2|||
129543427|NCT03792633|466282115|FG001|Overall Study|Death|0|||
129543428|NCT03792633|466282114|FG000|Overall Study|Disease progression|8|||
129543429|NCT03792633|466282115|FG001|Overall Study|Disease progression|9|||
129543430|NCT03792633|466282114|FG000|Overall Study|Lost to Follow-up|1|||
129543431|NCT03792633|466282115|FG001|Overall Study|Lost to Follow-up|1|||
129543432|NCT03792633|466282114|FG000|Overall Study|Screen fail|1|||
129543433|NCT03792633|466282115|FG001|Overall Study|Screen fail|0|||
129543434|NCT03792633|466282114|FG000|Overall Study|Second malignancy|0|||
129543435|NCT03792633|466282115|FG001|Overall Study|Second malignancy|1|||
129543436|NCT03179462|466282118|FG000|Overall Study|screening failure|1|||
129543437|NCT03179462|466282119|FG001|Overall Study|screening failure|2|||
129875399|NCT04707196|467501951|FG000|Overall Study|Protocol Violation|4|||
129875400|NCT04707196|467501952|FG001|Overall Study|Protocol Violation|1|||
129875401|NCT04707196|467501951|FG000|Overall Study|Adverse Event|2|||
129543438|NCT03179462|466282120|FG002|Overall Study|screening failure|0|||
129543439|NCT04636437|466282121|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
129543440|NCT04636437|466282122|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
129543441|NCT04636437|466282123|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
129543442|NCT04636437|466282121|FG000|Overall Study|Started weight loss drug/program|2|||
129543443|NCT04636437|466282122|FG001|Overall Study|Started weight loss drug/program|1|||
129543444|NCT04636437|466282123|FG002|Overall Study|Started weight loss drug/program|1|||
129543445|NCT04636437|466282121|FG000|Overall Study|Lost to Follow-up|3|||
129543446|NCT04636437|466282122|FG001|Overall Study|Lost to Follow-up|1|||
129543447|NCT04636437|466282123|FG002|Overall Study|Lost to Follow-up|4|||
129543448|NCT04636437|466282121|FG000|Overall Study|Participant or physician decision|3|||
129543449|NCT04636437|466282122|FG001|Overall Study|Participant or physician decision|1|||
129543450|NCT04636437|466282123|FG002|Overall Study|Participant or physician decision|1|||
129543451|NCT00816166|466282124|FG000|Overall Study|Lost to Follow-up|6|||
129543452|NCT00816166|466282125|FG001|Overall Study|Lost to Follow-up|10|||
129543453|NCT00816166|466282124|FG000|Overall Study|Death|4|||
129543454|NCT00816166|466282125|FG001|Overall Study|Death|2|||
129543455|NCT00352664|466282126|FG000|Overall Study|Withdrawal by Subject|7|||
129543456|NCT00352664|466282127|FG001|Overall Study|Withdrawal by Subject|0|||
129543457|NCT01233284|466282128|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
129543458|NCT01233284|466282129|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129543459|NCT01233284|466282130|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129543460|NCT01233284|466282131|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129543461|NCT01233284|466282132|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129543462|NCT01233284|466282128|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129543463|NCT01233284|466282129|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
129543464|NCT01233284|466282130|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129543465|NCT01233284|466282131|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129543466|NCT01233284|466282132|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129543467|NCT01233284|466282128|FG000|Period 1 (4 Weeks)|Other|0|||
129543468|NCT01233284|466282129|FG001|Period 1 (4 Weeks)|Other|0|||
129543469|NCT01233284|466282130|FG002|Period 1 (4 Weeks)|Other|1|||
129543470|NCT01233284|466282131|FG003|Period 1 (4 Weeks)|Other|0|||
129543471|NCT01233284|466282132|FG004|Period 1 (4 Weeks)|Other|0|||
129543472|NCT01233284|466282128|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129543473|NCT01233284|466282129|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129543474|NCT01233284|466282130|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
129543475|NCT01233284|466282131|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129543476|NCT01233284|466282132|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129543477|NCT01233284|466282128|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129543478|NCT01233284|466282129|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129543479|NCT01233284|466282130|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
129543480|NCT01233284|466282131|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129543481|NCT01233284|466282132|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129543482|NCT01233284|466282128|FG000|Period 3 (4 Weeks)|Other|0|||
129543483|NCT01233284|466282129|FG001|Period 3 (4 Weeks)|Other|0|||
129543484|NCT01233284|466282130|FG002|Period 3 (4 Weeks)|Other|0|||
129543485|NCT01233284|466282131|FG003|Period 3 (4 Weeks)|Other|1|||
129543486|NCT01233284|466282132|FG004|Period 3 (4 Weeks)|Other|0|||
129543487|NCT01233284|466282128|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
129543488|NCT01233284|466282129|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
129765844|NCT02559622|467108366|FG002|Overall Study|Adverse Event|2|||
129765845|NCT02559622|467108367|FG003|Overall Study|Adverse Event|2|||
129765846|NCT02559622|467108364|FG000|Overall Study|Patient/guardian decision|1|||
129765847|NCT02559622|467108365|FG001|Overall Study|Patient/guardian decision|2|||
129765848|NCT02559622|467108366|FG002|Overall Study|Patient/guardian decision|0|||
129765849|NCT02559622|467108367|FG003|Overall Study|Patient/guardian decision|1|||
129543489|NCT01233284|466282130|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
129543490|NCT01233284|466282131|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
129543491|NCT01233284|466282132|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
129543492|NCT01233284|466282128|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
129543493|NCT01233284|466282129|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
129543494|NCT01233284|466282130|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
129543495|NCT01233284|466282131|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
129543496|NCT01233284|466282132|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
129543497|NCT01058707|466282133|FG000|Overall Study|Disease Progression|15|||
129765850|NCT04011540|467108373|FG000|Overall Study|Lost to Follow-up|9|||
129765851|NCT04011540|467108374|FG001|Overall Study|Lost to Follow-up|6|||
129765852|NCT03019406|467108375|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
129875402|NCT04707196|467501952|FG001|Overall Study|Adverse Event|2|||
129543498|NCT01058707|466282134|FG001|Overall Study|Disease Progression|20|||
129543499|NCT01058707|466282135|FG002|Overall Study|Disease Progression|20|||
129543500|NCT01058707|466282136|FG003|Overall Study|Disease Progression|15|||
129543501|NCT01058707|466282137|FG004|Overall Study|Disease Progression|23|||
129543502|NCT01058707|466282138|FG005|Overall Study|Disease Progression|10|||
129543503|NCT01058707|466282139|FG006|Overall Study|Disease Progression|12|||
129543504|NCT01058707|466282133|FG000|Overall Study|Adverse Event|11|||
129543505|NCT01058707|466282134|FG001|Overall Study|Adverse Event|4|||
129543506|NCT01058707|466282135|FG002|Overall Study|Adverse Event|7|||
129543507|NCT01058707|466282136|FG003|Overall Study|Adverse Event|6|||
129543508|NCT01058707|466282137|FG004|Overall Study|Adverse Event|7|||
129543509|NCT01058707|466282138|FG005|Overall Study|Adverse Event|3|||
129543510|NCT01058707|466282139|FG006|Overall Study|Adverse Event|1|||
129765853|NCT03019406|467108376|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
129765854|NCT03019406|467108377|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
129765855|NCT03019406|467108378|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
129543511|NCT01058707|466282133|FG000|Overall Study|Subject Decision|5|||
129543512|NCT01058707|466282134|FG001|Overall Study|Subject Decision|3|||
129543513|NCT01058707|466282135|FG002|Overall Study|Subject Decision|3|||
129543514|NCT01058707|466282136|FG003|Overall Study|Subject Decision|1|||
129543515|NCT01058707|466282137|FG004|Overall Study|Subject Decision|2|||
129543516|NCT01058707|466282138|FG005|Overall Study|Subject Decision|3|||
129543517|NCT01058707|466282139|FG006|Overall Study|Subject Decision|6|||
129543518|NCT01058707|466282133|FG000|Overall Study|Lost to Follow-up|0|||
129543519|NCT01058707|466282134|FG001|Overall Study|Lost to Follow-up|0|||
129543520|NCT01058707|466282135|FG002|Overall Study|Lost to Follow-up|1|||
129543521|NCT01058707|466282136|FG003|Overall Study|Lost to Follow-up|0|||
129543522|NCT01058707|466282137|FG004|Overall Study|Lost to Follow-up|0|||
129543523|NCT01058707|466282138|FG005|Overall Study|Lost to Follow-up|0|||
129543524|NCT01058707|466282139|FG006|Overall Study|Lost to Follow-up|0|||
129543525|NCT01058707|466282133|FG000|Overall Study|Reason Not Specified|0|||
129543526|NCT01058707|466282134|FG001|Overall Study|Reason Not Specified|3|||
129543527|NCT01058707|466282135|FG002|Overall Study|Reason Not Specified|2|||
129543528|NCT01058707|466282136|FG003|Overall Study|Reason Not Specified|0|||
129543529|NCT01058707|466282137|FG004|Overall Study|Reason Not Specified|7|||
129543530|NCT01058707|466282138|FG005|Overall Study|Reason Not Specified|1|||
129543531|NCT01058707|466282139|FG006|Overall Study|Reason Not Specified|7|||
129543532|NCT01821391|466282140|FG000|Overall Study|Adverse Event|1|||
129543533|NCT01821391|466282141|FG001|Overall Study|Adverse Event|0|||
129543534|NCT00795886|466282143|FG000|Overall Study|Death|10|||
129543535|NCT05554471|466282149|FG000|Overall Study|Physician Decision|2|||
129543536|NCT05554471|466282150|FG001|Overall Study|Physician Decision|1|||
129543537|NCT05554471|466282149|FG000|Overall Study|Lost to Follow-up|2|||
129543538|NCT05554471|466282150|FG001|Overall Study|Lost to Follow-up|1|||
129543539|NCT05554471|466282149|FG000|Overall Study|Death|0|||
129543540|NCT05554471|466282150|FG001|Overall Study|Death|1|||
129543541|NCT04880850|466282151|FG000|Overall Study|Death|2|||
129543542|NCT04880850|466282152|FG001|Overall Study|Death|1|||
129543543|NCT04880850|466282151|FG000|Overall Study|Lost to Follow-up|3|||
129543544|NCT04880850|466282152|FG001|Overall Study|Lost to Follow-up|6|||
129543545|NCT04880850|466282151|FG000|Overall Study|Physician Decision|2|||
129543546|NCT04880850|466282152|FG001|Overall Study|Physician Decision|1|||
129543547|NCT04880850|466282151|FG000|Overall Study|Withdrawal by Subject|9|||
129543548|NCT04880850|466282152|FG001|Overall Study|Withdrawal by Subject|10|||
129543549|NCT01608321|466282153|FG000|Overall Study|Withdrawal by Subject|1|||
129543550|NCT01608321|466282154|FG001|Overall Study|Withdrawal by Subject|0|||
129543551|NCT03417102|466282155|FG000|Overall Study|Adverse Event|0|||
129543552|NCT03417102|466282156|FG001|Overall Study|Adverse Event|1|||
129543553|NCT03417102|466282155|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
129543554|NCT03417102|466282156|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
129543555|NCT03417102|466282155|FG000|Overall Study|Other|0|||
129543556|NCT03417102|466282156|FG001|Overall Study|Other|1|||
129543557|NCT02062385|466282157|FG000|Overall Study|Adverse Event|19|||
129543558|NCT02062385|466282158|FG001|Overall Study|Adverse Event|13|||
129543559|NCT02062385|466282159|FG002|Overall Study|Adverse Event|1|||
129543560|NCT02062385|466282160|FG003|Overall Study|Adverse Event|0|||
129543561|NCT02062385|466282157|FG000|Overall Study|Protocol Violation|1|||
129543562|NCT02062385|466282158|FG001|Overall Study|Protocol Violation|0|||
129543563|NCT02062385|466282159|FG002|Overall Study|Protocol Violation|0|||
129543564|NCT02062385|466282160|FG003|Overall Study|Protocol Violation|0|||
129543565|NCT02062385|466282157|FG000|Overall Study|Incomplete EPI by database lock|2|||
129543566|NCT02062385|466282158|FG001|Overall Study|Incomplete EPI by database lock|0|||
129543567|NCT02062385|466282159|FG002|Overall Study|Incomplete EPI by database lock|0|||
129543568|NCT02062385|466282160|FG003|Overall Study|Incomplete EPI by database lock|0|||
129543569|NCT02062385|466282157|FG000|Overall Study|Moved|10|||
129765856|NCT01339832|467108381|FG000|Overall Study|Lost to Follow-up|3|||
129765857|NCT01339832|467108381|FG000|Overall Study|Death|11|||
129765858|NCT00231816|467108382|FG000|Overall Study|Adverse Event|1|||
129543570|NCT02062385|466282158|FG001|Overall Study|Moved|11|||
129543571|NCT02062385|466282159|FG002|Overall Study|Moved|1|||
129543572|NCT02062385|466282160|FG003|Overall Study|Moved|0|||
129543573|NCT02062385|466282157|FG000|Overall Study|Withdrawn by parent/guardian|46|||
129543574|NCT02062385|466282158|FG001|Overall Study|Withdrawn by parent/guardian|41|||
129543575|NCT02062385|466282159|FG002|Overall Study|Withdrawn by parent/guardian|9|||
129543576|NCT02062385|466282160|FG003|Overall Study|Withdrawn by parent/guardian|8|||
129543577|NCT02062385|466282157|FG000|Overall Study|Death|0|||
129543578|NCT02062385|466282158|FG001|Overall Study|Death|0|||
129543579|NCT02062385|466282159|FG002|Overall Study|Death|0|||
129543580|NCT02062385|466282160|FG003|Overall Study|Death|1|||
129543581|NCT02062385|466282157|FG000|Overall Study|Lost to Follow-up|0|||
129543582|NCT02062385|466282158|FG001|Overall Study|Lost to Follow-up|0|||
129543583|NCT02062385|466282159|FG002|Overall Study|Lost to Follow-up|1|||
129543584|NCT02062385|466282160|FG003|Overall Study|Lost to Follow-up|0|||
129543585|NCT00526227|466282161|FG000|Overall Study|Device not implanted|1|||
129543586|NCT00526227|466282161|FG000|Overall Study|Death|1|||
129765859|NCT00231816|467108383|FG001|Overall Study|Adverse Event|0|||
129543587|NCT03222856|466282164|FG000|Overall Study|Adverse Event|6|||
129543588|NCT03222856|466282164|FG000|Overall Study|Death|1|||
129543589|NCT01721369|466282165|FG000|Overall Study|Not initial etiological diagnosis|12|||
129543590|NCT00706901|466283572|FG000|Overall Study|Lost to Follow-up|2|||
129543591|NCT00706901|466283573|FG001|Overall Study|Lost to Follow-up|3|||
129543592|NCT00706901|466283574|FG002|Overall Study|Lost to Follow-up|2|||
129543593|NCT00706901|466283572|FG000|Overall Study|Withdrawal by Subject|4|||
129543594|NCT00706901|466283573|FG001|Overall Study|Withdrawal by Subject|2|||
129543595|NCT00706901|466283574|FG002|Overall Study|Withdrawal by Subject|5|||
129543596|NCT00706901|466283572|FG000|Overall Study|In Jail|1|||
129543597|NCT00706901|466283573|FG001|Overall Study|In Jail|0|||
129543598|NCT00706901|466283574|FG002|Overall Study|In Jail|1|||
129543599|NCT00706901|466283572|FG000|Overall Study|Death|1|||
129543600|NCT00706901|466283573|FG001|Overall Study|Death|0|||
129543601|NCT00706901|466283574|FG002|Overall Study|Death|0|||
129543602|NCT04478994|466283575|FG000|Overall Study|Withdrawal by Subject|1|||
129543603|NCT04478994|466283576|FG001|Overall Study|Withdrawal by Subject|1|||
129543604|NCT01100073|466283577|FG000|Overall Study|Lack of Efficacy|4|||
129543605|NCT01100073|466283577|FG000|Overall Study|Insufficient Tolerability|21|||
129543606|NCT01100073|466283577|FG000|Overall Study|Withdrawal by Subject|13|||
129543607|NCT01100073|466283577|FG000|Overall Study|Lost to Follow-up|39|||
129543608|NCT01100073|466283577|FG000|Overall Study|Lack of effect + patient's wish|2|||
129543609|NCT01100073|466283577|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
129543610|NCT01100073|466283577|FG000|Overall Study|Other|8|||
129543611|NCT01100073|466283577|FG000|Overall Study|Missing|5|||
129543612|NCT01656850|466283578|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
129543613|NCT01656850|466283579|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
129543614|NCT00685763|466283585|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
129543615|NCT00685763|466283585|FG000|Overall Study|Protocol Violation|1|||
129543616|NCT01741259|466283586|FG000|Overall Study|Protocol Violation|6|||
129543617|NCT01741259|466283587|FG001|Overall Study|Protocol Violation|4|||
129543618|NCT01741259|466283586|FG000|Overall Study|Withdrawal by Subject|0|||
129543619|NCT01741259|466283587|FG001|Overall Study|Withdrawal by Subject|2|||
129543620|NCT00698009|466283588|FG000|Overall Study|Withdrawal by Subject|1|||
129543621|NCT02856282|466283594|FG000|Overall Study|Withdrawal by Subject|1|||
129543622|NCT00057330|466283595|FG000|Overall Study|Adverse Event|9|||
129543623|NCT00057330|466283596|FG001|Overall Study|Adverse Event|12|||
129543624|NCT00057330|466283595|FG000|Overall Study|Death|1|||
129543625|NCT00057330|466283596|FG001|Overall Study|Death|0|||
129543626|NCT00057330|466283595|FG000|Overall Study|Protocol Violation|1|||
129543627|NCT00057330|466283596|FG001|Overall Study|Protocol Violation|1|||
129543628|NCT00057330|466283595|FG000|Overall Study|Withdrawal by Subject|115|||
129543629|NCT00057330|466283596|FG001|Overall Study|Withdrawal by Subject|84|||
129543630|NCT00057330|466283595|FG000|Overall Study|Lost to Follow-up|745|||
129543631|NCT00057330|466283596|FG001|Overall Study|Lost to Follow-up|617|||
129543632|NCT00057330|466283595|FG000|Overall Study|Physician Decision|1|||
129543633|NCT00057330|466283596|FG001|Overall Study|Physician Decision|0|||
129543634|NCT00057330|466283595|FG000|Overall Study|Other|260|||
129543635|NCT00057330|466283596|FG001|Overall Study|Other|206|||
129543636|NCT02074982|466283597|FG000|Overall Study|Adverse Event|15|||
129543637|NCT02074982|466283598|FG001|Overall Study|Adverse Event|7|||
129543638|NCT02074982|466283597|FG000|Overall Study|Lack of Efficacy|6|||
129543639|NCT02074982|466283598|FG001|Overall Study|Lack of Efficacy|1|||
129543640|NCT02074982|466283597|FG000|Overall Study|Lost to Follow-up|9|||
129543641|NCT02074982|466283598|FG001|Overall Study|Lost to Follow-up|10|||
129543642|NCT02074982|466283597|FG000|Overall Study|Non-compliance with study treatment|0|||
129543643|NCT02074982|466283598|FG001|Overall Study|Non-compliance with study treatment|2|||
129543644|NCT02074982|466283597|FG000|Overall Study|Physician Decision|1|||
129543645|NCT02074982|466283598|FG001|Overall Study|Physician Decision|1|||
129543646|NCT02074982|466283597|FG000|Overall Study|Pregnancy|1|||
129543647|NCT02074982|466283598|FG001|Overall Study|Pregnancy|2|||
129543648|NCT02074982|466283597|FG000|Overall Study|Protocol deviation|4|||
129543649|NCT02074982|466283598|FG001|Overall Study|Protocol deviation|3|||
129543650|NCT02074982|466283597|FG000|Overall Study|Technical problems|0|||
129543651|NCT02074982|466283598|FG001|Overall Study|Technical problems|2|||
129543652|NCT02074982|466283597|FG000|Overall Study|Subject/guardian decision|15|||
129543653|NCT02074982|466283598|FG001|Overall Study|Subject/guardian decision|24|||
129765860|NCT00231816|467108382|FG000|Overall Study|Lost to Follow-up|8|||
129543654|NCT02074982|466283597|FG000|Overall Study|Death|0|||
129543655|NCT02074982|466283598|FG001|Overall Study|Death|2|||
129543656|NCT02094573|466283601|FG000|Overall Study|Adverse Event|4|||
129543657|NCT02094573|466283602|FG001|Overall Study|Adverse Event|14|||
129543658|NCT02094573|466283601|FG000|Overall Study|Clinical Progressive Disease|9|||
129543659|NCT02094573|466283602|FG001|Overall Study|Clinical Progressive Disease|13|||
129543660|NCT02094573|466283601|FG000|Overall Study|Death|11|||
129543661|NCT02094573|466283602|FG001|Overall Study|Death|3|||
129543662|NCT02094573|466283601|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
129543663|NCT02094573|466283602|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
129543664|NCT02094573|466283601|FG000|Overall Study|Non-compliance with Study Drug|1|||
129543665|NCT02094573|466283602|FG001|Overall Study|Non-compliance with Study Drug|1|||
129543666|NCT02094573|466283601|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
129543667|NCT02094573|466283602|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
129543668|NCT02094573|466283601|FG000|Overall Study|Physician Decision|4|||
129543669|NCT02094573|466283602|FG001|Overall Study|Physician Decision|4|||
129543670|NCT02094573|466283601|FG000|Overall Study|Site Terminated by Sponsor|10|||
129543671|NCT02094573|466283602|FG001|Overall Study|Site Terminated by Sponsor|17|||
129543672|NCT02094573|466283601|FG000|Overall Study|Withdrawal by Subject|6|||
129543673|NCT02094573|466283602|FG001|Overall Study|Withdrawal by Subject|8|||
129543674|NCT02094573|466283601|FG000|Overall Study|Randomized but not Treated|3|||
129543675|NCT02094573|466283602|FG001|Overall Study|Randomized but not Treated|0|||
129543676|NCT04633434|466283609|FG000|Overall Study|Lost to Follow-up|32|||
129543677|NCT04633434|466283610|FG001|Overall Study|Lost to Follow-up|32|||
129543678|NCT01605370|466283620|FG000|Overall Study|Adverse Event|1|||
129543679|NCT01605370|466283621|FG001|Overall Study|Adverse Event|0|||
129543680|NCT00183170|466283634|FG000|First Intervention|Did not complete study|1|||
129543681|NCT00183170|466283635|FG001|First Intervention|Did not complete study|0|||
129543682|NCT00183170|466283634|FG000|First Intervention|Did not meet targeted BrAC|1|||
129543683|NCT00183170|466283635|FG001|First Intervention|Did not meet targeted BrAC|0|||
129543684|NCT00183170|466283634|FG000|Washout 1 Week|Did not complete study|6|||
129543685|NCT00183170|466283635|FG001|Washout 1 Week|Did not complete study|8|||
129543686|NCT00183170|466283634|FG000|Second Intervention|Did not complete study|1|||
129543687|NCT00183170|466283635|FG001|Second Intervention|Did not complete study|0|||
129543688|NCT00183170|466283634|FG000|Second Intervention|Did not meet targeted BrAC|0|||
129543689|NCT00183170|466283635|FG001|Second Intervention|Did not meet targeted BrAC|2|||
129543690|NCT00761969|466283636|FG000|Overall Study|Death|112|||
129543691|NCT00761969|466283637|FG001|Overall Study|Death|47|||
129543692|NCT00761969|466283636|FG000|Overall Study|Lost to Follow-up|88|||
129543693|NCT00761969|466283637|FG001|Overall Study|Lost to Follow-up|93|||
129543694|NCT00585468|466283640|FG000|First Intervention|Withdrawal by Subject|1|||
129543695|NCT00585468|466283641|FG001|First Intervention|Withdrawal by Subject|1|||
129543696|NCT03733301|466283648|FG000|Overall Study|Screen Fail|1|||
129543697|NCT03733301|466283649|FG001|Overall Study|Screen Fail|0|||
129543698|NCT03733301|466283650|FG002|Overall Study|Screen Fail|0|||
129543699|NCT03733301|466283648|FG000|Overall Study|Non-compliance|1|||
129543700|NCT03733301|466283649|FG001|Overall Study|Non-compliance|0|||
129543701|NCT03733301|466283650|FG002|Overall Study|Non-compliance|0|||
129543702|NCT03733301|466283648|FG000|Overall Study|Lack of Efficacy|2|||
129543703|NCT03733301|466283649|FG001|Overall Study|Lack of Efficacy|3|||
129543704|NCT03733301|466283650|FG002|Overall Study|Lack of Efficacy|0|||
129543705|NCT03733301|466283648|FG000|Overall Study|Adverse Event|0|||
129543706|NCT03733301|466283649|FG001|Overall Study|Adverse Event|1|||
129543707|NCT03733301|466283650|FG002|Overall Study|Adverse Event|3|||
129543708|NCT03733301|466283648|FG000|Overall Study|Withdrawal by Subject|3|||
129543709|NCT03733301|466283649|FG001|Overall Study|Withdrawal by Subject|5|||
129543710|NCT03733301|466283650|FG002|Overall Study|Withdrawal by Subject|1|||
129543711|NCT00877799|466283653|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
129543712|NCT00877799|466283654|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
129543713|NCT00877799|466283655|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
129543714|NCT00877799|466283656|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
129543715|NCT00877799|466283657|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
129543716|NCT00877799|466283653|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
129543717|NCT00877799|466283654|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
129543718|NCT00877799|466283655|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
129543719|NCT00877799|466283656|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
129543720|NCT00877799|466283657|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
129543721|NCT00877799|466283653|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
129543722|NCT00877799|466283654|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
129543723|NCT00877799|466283655|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
129543724|NCT00877799|466283656|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
129543725|NCT00877799|466283657|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
129543726|NCT00877799|466283653|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
129543727|NCT00877799|466283654|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
129543728|NCT00877799|466283655|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
129543729|NCT00877799|466283656|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
129543730|NCT00877799|466283657|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
129543731|NCT00877799|466283653|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
129543732|NCT00877799|466283654|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
129543733|NCT00877799|466283655|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
129543734|NCT00877799|466283656|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
129543735|NCT00877799|466283657|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
129543736|NCT04054011|466283658|FG000|Overall Study|COVID|3|||
129543737|NCT03707145|466283659|FG000|Overall Study|Lost to Follow-up|0|||
129543738|NCT03707145|466283660|FG001|Overall Study|Lost to Follow-up|1|||
129543739|NCT03707145|466283661|FG002|Overall Study|Lost to Follow-up|1|||
129543740|NCT03707145|466283662|FG003|Overall Study|Lost to Follow-up|0|||
129543741|NCT04455620|466283666|FG000|Overall Study|Withdrawal by Subject|0|||
129543742|NCT04455620|466283667|FG001|Overall Study|Withdrawal by Subject|0|||
129543743|NCT04455620|466283668|FG002|Overall Study|Withdrawal by Subject|2|||
129543744|NCT04455620|466283669|FG003|Overall Study|Withdrawal by Subject|0|||
129543745|NCT04455620|466283670|FG004|Overall Study|Withdrawal by Subject|1|||
129543746|NCT04455620|466283666|FG000|Overall Study|Lost to Follow-up|0|||
129543747|NCT04455620|466283667|FG001|Overall Study|Lost to Follow-up|0|||
129543748|NCT04455620|466283668|FG002|Overall Study|Lost to Follow-up|1|||
129543749|NCT04455620|466283669|FG003|Overall Study|Lost to Follow-up|1|||
129543750|NCT04455620|466283670|FG004|Overall Study|Lost to Follow-up|0|||
129543751|NCT04455620|466283666|FG000|Overall Study|Death|1|||
129543752|NCT04455620|466283667|FG001|Overall Study|Death|6|||
129543753|NCT04455620|466283668|FG002|Overall Study|Death|20|||
129543754|NCT04455620|466283669|FG003|Overall Study|Death|1|||
129543755|NCT04455620|466283670|FG004|Overall Study|Death|7|||
129543756|NCT04455620|466283666|FG000|Overall Study|Study Termination|0|||
129543757|NCT04455620|466283667|FG001|Overall Study|Study Termination|2|||
129543758|NCT04455620|466283668|FG002|Overall Study|Study Termination|1|||
129543759|NCT04455620|466283669|FG003|Overall Study|Study Termination|0|||
129543760|NCT04455620|466283670|FG004|Overall Study|Study Termination|6|||
129543761|NCT02851069|466283672|FG000|Overall Study|Failure to Return|3|||
129543762|NCT02851069|466283672|FG000|Overall Study|Other|3|||
129543763|NCT03539952|466283681|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
129543764|NCT03539952|466283682|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
129543765|NCT03539952|466283681|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
129543766|NCT03539952|466283682|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
129543767|NCT03539952|466283681|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
129543768|NCT03539952|466283682|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
129543769|NCT03539952|466283681|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
129543770|NCT03539952|466283682|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
129543771|NCT03539952|466283681|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
129543772|NCT03539952|466283682|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
129543773|NCT03539952|466283681|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
129543774|NCT03539952|466283682|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
129543775|NCT03539952|466283681|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
129543776|NCT03539952|466283682|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
129543777|NCT03075215|466283683|FG000|12-Month Primary Endpoint|Death|152|||
129543778|NCT03075215|466283683|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
129543779|NCT03075215|466283683|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
129543780|NCT03075215|466283683|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
129543781|NCT02756182|466283684|FG000|Overall Study|StudyTechnical Difficulties|4|||
129543782|NCT02146365|466283685|FG000|Overall Study|Lost to Follow-up|2|||
129543783|NCT02146365|466283686|FG001|Overall Study|Lost to Follow-up|1|||
129543784|NCT02146365|466283687|FG002|Overall Study|Lost to Follow-up|3|||
129543785|NCT02146365|466283688|FG003|Overall Study|Lost to Follow-up|3|||
129543786|NCT02146365|466283689|FG004|Overall Study|Lost to Follow-up|1|||
129543787|NCT02146365|466283690|FG005|Overall Study|Lost to Follow-up|1|||
129543788|NCT02146365|466283691|FG006|Overall Study|Lost to Follow-up|0|||
129543789|NCT02146365|466283692|FG007|Overall Study|Lost to Follow-up|1|||
129543790|NCT02146365|466283685|FG000|Overall Study|Withdrawal by Subject|1|||
129543791|NCT02146365|466283686|FG001|Overall Study|Withdrawal by Subject|2|||
129543792|NCT02146365|466283687|FG002|Overall Study|Withdrawal by Subject|1|||
129543793|NCT02146365|466283688|FG003|Overall Study|Withdrawal by Subject|5|||
129543794|NCT02146365|466283689|FG004|Overall Study|Withdrawal by Subject|1|||
129543795|NCT02146365|466283690|FG005|Overall Study|Withdrawal by Subject|0|||
129543796|NCT02146365|466283691|FG006|Overall Study|Withdrawal by Subject|0|||
129543797|NCT02146365|466283692|FG007|Overall Study|Withdrawal by Subject|0|||
129543798|NCT02146365|466283685|FG000|Overall Study|Unable to Comply with Protocol|0|||
129543799|NCT02146365|466283686|FG001|Overall Study|Unable to Comply with Protocol|1|||
129543800|NCT02146365|466283687|FG002|Overall Study|Unable to Comply with Protocol|1|||
129543801|NCT02146365|466283688|FG003|Overall Study|Unable to Comply with Protocol|0|||
129543802|NCT02146365|466283689|FG004|Overall Study|Unable to Comply with Protocol|0|||
129543803|NCT02146365|466283690|FG005|Overall Study|Unable to Comply with Protocol|0|||
129543804|NCT02146365|466283691|FG006|Overall Study|Unable to Comply with Protocol|0|||
129543805|NCT02146365|466283692|FG007|Overall Study|Unable to Comply with Protocol|0|||
129543806|NCT02146365|466283685|FG000|Overall Study|Other|1|||
129543807|NCT02146365|466283686|FG001|Overall Study|Other|0|||
129543808|NCT02146365|466283687|FG002|Overall Study|Other|2|||
129543809|NCT02146365|466283688|FG003|Overall Study|Other|1|||
129543810|NCT02146365|466283689|FG004|Overall Study|Other|0|||
129543811|NCT02146365|466283690|FG005|Overall Study|Other|0|||
129543812|NCT02146365|466283691|FG006|Overall Study|Other|0|||
129543813|NCT02146365|466283692|FG007|Overall Study|Other|0|||
129543814|NCT01843660|466283693|FG000|Overall Study|Other|30|||
129543815|NCT01977482|466283694|FG000|Overall Study|Adverse Event|0|||
129543816|NCT01977482|466283695|FG001|Overall Study|Adverse Event|1|||
129543817|NCT01977482|466283696|FG002|Overall Study|Adverse Event|1|||
129543818|NCT01977482|466283697|FG003|Overall Study|Adverse Event|0|||
129543819|NCT01977482|466283698|FG004|Overall Study|Adverse Event|2|||
129543820|NCT01977482|466283699|FG005|Overall Study|Adverse Event|0|||
129543821|NCT01977482|466283694|FG000|Overall Study|Lost to Follow-up|1|||
129543822|NCT01977482|466283695|FG001|Overall Study|Lost to Follow-up|0|||
129543823|NCT01977482|466283696|FG002|Overall Study|Lost to Follow-up|0|||
129543824|NCT01977482|466283697|FG003|Overall Study|Lost to Follow-up|0|||
129543825|NCT01977482|466283698|FG004|Overall Study|Lost to Follow-up|0|||
129543826|NCT01977482|466283699|FG005|Overall Study|Lost to Follow-up|0|||
129543827|NCT01977482|466283694|FG000|Overall Study|Physician Decision|0|||
129543828|NCT01977482|466283695|FG001|Overall Study|Physician Decision|1|||
129543829|NCT01977482|466283696|FG002|Overall Study|Physician Decision|0|||
129543830|NCT01977482|466283697|FG003|Overall Study|Physician Decision|0|||
129543831|NCT01977482|466283698|FG004|Overall Study|Physician Decision|0|||
129543832|NCT01977482|466283699|FG005|Overall Study|Physician Decision|0|||
129543833|NCT01977482|466283694|FG000|Overall Study|Protocol Violation|0|||
129543834|NCT01977482|466283695|FG001|Overall Study|Protocol Violation|0|||
129543835|NCT01977482|466283696|FG002|Overall Study|Protocol Violation|1|||
129543836|NCT01977482|466283697|FG003|Overall Study|Protocol Violation|0|||
129543837|NCT01977482|466283698|FG004|Overall Study|Protocol Violation|0|||
129543838|NCT01977482|466283699|FG005|Overall Study|Protocol Violation|0|||
129543839|NCT01977482|466283694|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
129543840|NCT01977482|466283695|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
129543841|NCT01977482|466283696|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
129543842|NCT01977482|466283697|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
129543843|NCT01977482|466283698|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
129543844|NCT01977482|466283699|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
129543845|NCT01977482|466283694|FG000|Overall Study|Withdrawal by Subject|2|||
129543846|NCT01977482|466283695|FG001|Overall Study|Withdrawal by Subject|4|||
129543847|NCT01977482|466283696|FG002|Overall Study|Withdrawal by Subject|1|||
129543848|NCT01977482|466283697|FG003|Overall Study|Withdrawal by Subject|3|||
129543849|NCT01977482|466283698|FG004|Overall Study|Withdrawal by Subject|1|||
129543850|NCT01977482|466283699|FG005|Overall Study|Withdrawal by Subject|5|||
129543851|NCT00209560|466283700|FG000|Overall Study|Lack of Efficacy|1|||
129543852|NCT00209560|466283701|FG001|Overall Study|Lack of Efficacy|0|||
129543853|NCT01319994|466285322|FG000|Overall Study|Protocol Violation|7|||
129543854|NCT01319994|466285323|FG001|Overall Study|Protocol Violation|6|||
129543855|NCT01340794|466285324|FG000|Overall Study|Withdrawal by Subject|0|||
129543856|NCT01340794|466285325|FG001|Overall Study|Withdrawal by Subject|1|||
129543857|NCT01118949|466285328|FG000|Overall Study|Adverse Event|5|||
129543858|NCT01118949|466285328|FG000|Overall Study|Withdrawal by Subject|4|||
129543859|NCT03606109|466285337|FG000|Overall Study|Lost to Follow-up|2|||
129543860|NCT03606109|466285338|FG001|Overall Study|Lost to Follow-up|1|||
129543861|NCT03669640|466285339|FG000|Overall Study|Study Terminated by Sponsor|0|||
129543862|NCT03669640|466285340|FG001|Overall Study|Study Terminated by Sponsor|0|||
129543863|NCT03669640|466285341|FG002|Overall Study|Study Terminated by Sponsor|0|||
129543864|NCT03669640|466285342|FG003|Overall Study|Study Terminated by Sponsor|0|||
129543865|NCT03669640|466285343|FG004|Overall Study|Study Terminated by Sponsor|1|||
129543866|NCT03669640|466285344|FG005|Overall Study|Study Terminated by Sponsor|0|||
129543867|NCT03669640|466285339|FG000|Overall Study|Lost to Follow-up|0|||
129543868|NCT03669640|466285340|FG001|Overall Study|Lost to Follow-up|0|||
129543869|NCT03669640|466285341|FG002|Overall Study|Lost to Follow-up|2|||
129543870|NCT03669640|466285342|FG003|Overall Study|Lost to Follow-up|0|||
129543871|NCT03669640|466285343|FG004|Overall Study|Lost to Follow-up|0|||
129543872|NCT03669640|466285344|FG005|Overall Study|Lost to Follow-up|0|||
129543873|NCT03669640|466285339|FG000|Overall Study|Death|0|||
129543874|NCT03669640|466285340|FG001|Overall Study|Death|0|||
129543875|NCT03669640|466285341|FG002|Overall Study|Death|1|||
129543876|NCT03669640|466285342|FG003|Overall Study|Death|0|||
129543877|NCT03669640|466285343|FG004|Overall Study|Death|0|||
129543878|NCT03669640|466285344|FG005|Overall Study|Death|0|||
129543879|NCT03669640|466285339|FG000|Overall Study|Withdrawal by Subject|1|||
129543880|NCT03669640|466285340|FG001|Overall Study|Withdrawal by Subject|2|||
129543881|NCT03669640|466285341|FG002|Overall Study|Withdrawal by Subject|1|||
129543882|NCT03669640|466285342|FG003|Overall Study|Withdrawal by Subject|0|||
129543883|NCT03669640|466285343|FG004|Overall Study|Withdrawal by Subject|1|||
129543884|NCT03669640|466285344|FG005|Overall Study|Withdrawal by Subject|3|||
129543885|NCT03669640|466285339|FG000|Overall Study|Protocol Violation|1|||
129543886|NCT03669640|466285340|FG001|Overall Study|Protocol Violation|0|||
129543887|NCT03669640|466285341|FG002|Overall Study|Protocol Violation|0|||
129543888|NCT03669640|466285342|FG003|Overall Study|Protocol Violation|0|||
129543889|NCT03669640|466285343|FG004|Overall Study|Protocol Violation|0|||
129543890|NCT03669640|466285344|FG005|Overall Study|Protocol Violation|0|||
129543891|NCT03669640|466285339|FG000|Overall Study|Physician Decision|0|||
129543892|NCT03669640|466285340|FG001|Overall Study|Physician Decision|2|||
129543893|NCT03669640|466285341|FG002|Overall Study|Physician Decision|0|||
129543894|NCT03669640|466285342|FG003|Overall Study|Physician Decision|0|||
129543895|NCT03669640|466285343|FG004|Overall Study|Physician Decision|0|||
129543896|NCT03669640|466285344|FG005|Overall Study|Physician Decision|0|||
129543897|NCT03669640|466285339|FG000|Overall Study|Disease Relapse|1|||
129543898|NCT03669640|466285340|FG001|Overall Study|Disease Relapse|0|||
129543899|NCT03669640|466285341|FG002|Overall Study|Disease Relapse|0|||
129543900|NCT03669640|466285342|FG003|Overall Study|Disease Relapse|0|||
129543901|NCT03669640|466285343|FG004|Overall Study|Disease Relapse|0|||
129543902|NCT03669640|466285344|FG005|Overall Study|Disease Relapse|0|||
129543903|NCT03669640|466285339|FG000|Overall Study|Adverse Event|2|||
129543904|NCT03669640|466285340|FG001|Overall Study|Adverse Event|1|||
129543905|NCT03669640|466285341|FG002|Overall Study|Adverse Event|0|||
129543906|NCT03669640|466285342|FG003|Overall Study|Adverse Event|0|||
129543907|NCT03669640|466285343|FG004|Overall Study|Adverse Event|1|||
129543908|NCT03669640|466285344|FG005|Overall Study|Adverse Event|0|||
129543909|NCT03533608|466285345|FG000|Overall Study|Withdrawal by Subject|3|||
129543910|NCT03533608|466285345|FG000|Overall Study|Physician Decision|2|||
129543911|NCT03514121|466285346|FG000|Overall Study|Withdrawal by Subject|0|||
129543912|NCT03514121|466285347|FG001|Overall Study|Withdrawal by Subject|0|||
129543913|NCT03514121|466285348|FG002|Overall Study|Withdrawal by Subject|0|||
129543914|NCT03514121|466285349|FG003|Overall Study|Withdrawal by Subject|0|||
129543915|NCT03514121|466285350|FG004|Overall Study|Withdrawal by Subject|1|||
129543916|NCT03514121|466285351|FG005|Overall Study|Withdrawal by Subject|2|||
129543917|NCT03514121|466285352|FG006|Overall Study|Withdrawal by Subject|1|||
129543918|NCT03514121|466285353|FG007|Overall Study|Withdrawal by Subject|1|||
129543919|NCT03514121|466285354|FG008|Overall Study|Withdrawal by Subject|7|||
129543920|NCT03514121|466285355|FG009|Overall Study|Withdrawal by Subject|2|||
129543921|NCT03514121|466285346|FG000|Overall Study|Death|0|||
129543922|NCT03514121|466285347|FG001|Overall Study|Death|0|||
129543923|NCT03514121|466285348|FG002|Overall Study|Death|0|||
129543924|NCT03514121|466285349|FG003|Overall Study|Death|0|||
129543925|NCT03514121|466285350|FG004|Overall Study|Death|0|||
129543926|NCT03514121|466285351|FG005|Overall Study|Death|3|||
129543927|NCT03514121|466285352|FG006|Overall Study|Death|2|||
129543928|NCT03514121|466285353|FG007|Overall Study|Death|1|||
129543929|NCT03514121|466285354|FG008|Overall Study|Death|26|||
129543930|NCT03514121|466285355|FG009|Overall Study|Death|3|||
129543931|NCT03514121|466285346|FG000|Overall Study|Lost to Follow-up|0|||
129543932|NCT03514121|466285347|FG001|Overall Study|Lost to Follow-up|0|||
129543933|NCT03514121|466285348|FG002|Overall Study|Lost to Follow-up|1|||
129543934|NCT03514121|466285349|FG003|Overall Study|Lost to Follow-up|0|||
129543935|NCT03514121|466285350|FG004|Overall Study|Lost to Follow-up|0|||
129543936|NCT03514121|466285351|FG005|Overall Study|Lost to Follow-up|0|||
129543937|NCT03514121|466285352|FG006|Overall Study|Lost to Follow-up|0|||
129543938|NCT03514121|466285353|FG007|Overall Study|Lost to Follow-up|0|||
129543939|NCT03514121|466285354|FG008|Overall Study|Lost to Follow-up|1|||
129543940|NCT03514121|466285355|FG009|Overall Study|Lost to Follow-up|0|||
129543941|NCT03514121|466285346|FG000|Overall Study|Adverse Event|0|||
129543942|NCT03514121|466285347|FG001|Overall Study|Adverse Event|0|||
129543943|NCT03514121|466285348|FG002|Overall Study|Adverse Event|0|||
129543944|NCT03514121|466285349|FG003|Overall Study|Adverse Event|0|||
129543945|NCT03514121|466285350|FG004|Overall Study|Adverse Event|0|||
129543946|NCT03514121|466285351|FG005|Overall Study|Adverse Event|0|||
129543947|NCT03514121|466285352|FG006|Overall Study|Adverse Event|1|||
129543948|NCT03514121|466285353|FG007|Overall Study|Adverse Event|0|||
129543949|NCT03514121|466285354|FG008|Overall Study|Adverse Event|0|||
129543950|NCT03514121|466285355|FG009|Overall Study|Adverse Event|0|||
129543951|NCT03514121|466285346|FG000|Overall Study|Other|0|||
129543952|NCT03514121|466285347|FG001|Overall Study|Other|1|||
129543953|NCT03514121|466285348|FG002|Overall Study|Other|1|||
129543954|NCT03514121|466285349|FG003|Overall Study|Other|0|||
129543955|NCT03514121|466285350|FG004|Overall Study|Other|1|||
129543956|NCT03514121|466285351|FG005|Overall Study|Other|2|||
129543957|NCT03514121|466285352|FG006|Overall Study|Other|3|||
129543958|NCT03514121|466285353|FG007|Overall Study|Other|2|||
129543959|NCT03514121|466285354|FG008|Overall Study|Other|7|||
129543960|NCT03514121|466285355|FG009|Overall Study|Other|3|||
129765861|NCT00231816|467108383|FG001|Overall Study|Lost to Follow-up|5|||
129765862|NCT00231816|467108382|FG000|Overall Study|Protocol Violation|2|||
129765863|NCT00231816|467108383|FG001|Overall Study|Protocol Violation|3|||
129543961|NCT03514121|466285346|FG000|Overall Study|Study termination by Sponsor|0|||
129543962|NCT03514121|466285347|FG001|Overall Study|Study termination by Sponsor|0|||
129543963|NCT03514121|466285348|FG002|Overall Study|Study termination by Sponsor|0|||
129543964|NCT03514121|466285349|FG003|Overall Study|Study termination by Sponsor|0|||
129543965|NCT03514121|466285350|FG004|Overall Study|Study termination by Sponsor|0|||
129543966|NCT03514121|466285351|FG005|Overall Study|Study termination by Sponsor|0|||
129543967|NCT03514121|466285352|FG006|Overall Study|Study termination by Sponsor|0|||
129543968|NCT03514121|466285353|FG007|Overall Study|Study termination by Sponsor|0|||
129765864|NCT00231816|467108382|FG000|Overall Study|Withdrawal by Subject|3|||
129543969|NCT03514121|466285354|FG008|Overall Study|Study termination by Sponsor|11|||
129543970|NCT03514121|466285355|FG009|Overall Study|Study termination by Sponsor|3|||
129543971|NCT03514121|466285346|FG000|Overall Study|Investigator decision|0|||
129543972|NCT03514121|466285347|FG001|Overall Study|Investigator decision|0|||
129543973|NCT03514121|466285348|FG002|Overall Study|Investigator decision|0|||
129543974|NCT03514121|466285349|FG003|Overall Study|Investigator decision|0|||
129543975|NCT03514121|466285350|FG004|Overall Study|Investigator decision|0|||
129543976|NCT03514121|466285351|FG005|Overall Study|Investigator decision|0|||
129543977|NCT03514121|466285352|FG006|Overall Study|Investigator decision|0|||
129543978|NCT03514121|466285353|FG007|Overall Study|Investigator decision|0|||
129543979|NCT03514121|466285354|FG008|Overall Study|Investigator decision|1|||
129543980|NCT03514121|466285355|FG009|Overall Study|Investigator decision|0|||
129543981|NCT04242264|466285356|FG000|Overall Study|Lost to Follow-up|2|||
129543982|NCT04242264|466285357|FG001|Overall Study|Lost to Follow-up|2|||
129543983|NCT04242264|466285358|FG002|Overall Study|Lost to Follow-up|1|||
129543984|NCT04242264|466285359|FG003|Overall Study|Lost to Follow-up|1|||
129543985|NCT04242264|466285356|FG000|Overall Study|Withdrawal by Subject|1|||
129543986|NCT04242264|466285357|FG001|Overall Study|Withdrawal by Subject|0|||
129543987|NCT04242264|466285358|FG002|Overall Study|Withdrawal by Subject|0|||
129543988|NCT04242264|466285359|FG003|Overall Study|Withdrawal by Subject|0|||
129543989|NCT00471237|466285363|FG000|Overall Study|Adverse Event|6|||
129543990|NCT00471237|466285364|FG001|Overall Study|Adverse Event|5|||
129543991|NCT00471237|466285365|FG002|Overall Study|Adverse Event|4|||
129543992|NCT00471237|466285366|FG003|Overall Study|Adverse Event|8|||
129543993|NCT00471237|466285367|FG004|Overall Study|Adverse Event|7|||
129543994|NCT00471237|466285368|FG005|Overall Study|Adverse Event|5|||
129543995|NCT00471237|466285369|FG006|Overall Study|Adverse Event|0|||
129543996|NCT00471237|466285363|FG000|Overall Study|Lost to Follow-up|1|||
129543997|NCT00471237|466285364|FG001|Overall Study|Lost to Follow-up|1|||
129543998|NCT00471237|466285365|FG002|Overall Study|Lost to Follow-up|0|||
129543999|NCT00471237|466285366|FG003|Overall Study|Lost to Follow-up|2|||
129544000|NCT00471237|466285367|FG004|Overall Study|Lost to Follow-up|3|||
129544001|NCT00471237|466285368|FG005|Overall Study|Lost to Follow-up|0|||
129544002|NCT00471237|466285369|FG006|Overall Study|Lost to Follow-up|0|||
129544003|NCT00471237|466285363|FG000|Overall Study|Protocol Violation|3|||
129544004|NCT00471237|466285364|FG001|Overall Study|Protocol Violation|6|||
129544005|NCT00471237|466285365|FG002|Overall Study|Protocol Violation|3|||
129544006|NCT00471237|466285366|FG003|Overall Study|Protocol Violation|2|||
129544007|NCT00471237|466285367|FG004|Overall Study|Protocol Violation|2|||
129544008|NCT00471237|466285368|FG005|Overall Study|Protocol Violation|4|||
129544009|NCT00471237|466285369|FG006|Overall Study|Protocol Violation|1|||
129544010|NCT00471237|466285363|FG000|Overall Study|Withdrawal by Subject|8|||
129544011|NCT00471237|466285364|FG001|Overall Study|Withdrawal by Subject|6|||
129544012|NCT00471237|466285365|FG002|Overall Study|Withdrawal by Subject|5|||
129544013|NCT00471237|466285366|FG003|Overall Study|Withdrawal by Subject|8|||
129544014|NCT00471237|466285367|FG004|Overall Study|Withdrawal by Subject|7|||
129544015|NCT00471237|466285368|FG005|Overall Study|Withdrawal by Subject|4|||
129544016|NCT00471237|466285369|FG006|Overall Study|Withdrawal by Subject|2|||
129544017|NCT00471237|466285363|FG000|Overall Study|Sponsor terminated study|20|||
129544018|NCT00471237|466285364|FG001|Overall Study|Sponsor terminated study|23|||
129544019|NCT00471237|466285365|FG002|Overall Study|Sponsor terminated study|19|||
129544020|NCT00471237|466285366|FG003|Overall Study|Sponsor terminated study|22|||
129544021|NCT00471237|466285367|FG004|Overall Study|Sponsor terminated study|18|||
129544022|NCT00471237|466285368|FG005|Overall Study|Sponsor terminated study|24|||
129544023|NCT00471237|466285369|FG006|Overall Study|Sponsor terminated study|0|||
129544024|NCT00471237|466285363|FG000|Overall Study|Non-compliance|0|||
129544025|NCT00471237|466285364|FG001|Overall Study|Non-compliance|1|||
129544026|NCT00471237|466285365|FG002|Overall Study|Non-compliance|0|||
129544027|NCT00471237|466285366|FG003|Overall Study|Non-compliance|1|||
129544028|NCT00471237|466285367|FG004|Overall Study|Non-compliance|0|||
129544029|NCT00471237|466285368|FG005|Overall Study|Non-compliance|0|||
129544030|NCT00471237|466285369|FG006|Overall Study|Non-compliance|0|||
129544031|NCT00471237|466285363|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
129544032|NCT00471237|466285364|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
129544033|NCT00471237|466285365|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
129544034|NCT00471237|466285366|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
129544035|NCT00471237|466285367|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
129544036|NCT00471237|466285368|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
129544037|NCT00471237|466285369|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
129544038|NCT00471237|466285363|FG000|Overall Study|Early stopping due to non-efficacy|1|||
129544039|NCT00471237|466285364|FG001|Overall Study|Early stopping due to non-efficacy|0|||
129544040|NCT00471237|466285365|FG002|Overall Study|Early stopping due to non-efficacy|0|||
129544041|NCT00471237|466285366|FG003|Overall Study|Early stopping due to non-efficacy|0|||
129544042|NCT00471237|466285367|FG004|Overall Study|Early stopping due to non-efficacy|1|||
129544043|NCT00471237|466285368|FG005|Overall Study|Early stopping due to non-efficacy|0|||
129544044|NCT00471237|466285369|FG006|Overall Study|Early stopping due to non-efficacy|0|||
129544045|NCT00471237|466285363|FG000|Overall Study|Participant planned to travel to abraod|1|||
129544046|NCT00471237|466285364|FG001|Overall Study|Participant planned to travel to abraod|0|||
129544047|NCT00471237|466285365|FG002|Overall Study|Participant planned to travel to abraod|0|||
129544048|NCT00471237|466285366|FG003|Overall Study|Participant planned to travel to abraod|0|||
129544049|NCT00471237|466285367|FG004|Overall Study|Participant planned to travel to abraod|0|||
129544050|NCT00471237|466285368|FG005|Overall Study|Participant planned to travel to abraod|1|||
129544051|NCT00471237|466285369|FG006|Overall Study|Participant planned to travel to abraod|0|||
129544052|NCT00471237|466285363|FG000|Overall Study|High parathyroid hormone|0|||
129544053|NCT00471237|466285364|FG001|Overall Study|High parathyroid hormone|0|||
129544054|NCT00471237|466285365|FG002|Overall Study|High parathyroid hormone|1|||
129544055|NCT00471237|466285366|FG003|Overall Study|High parathyroid hormone|0|||
129544056|NCT00471237|466285367|FG004|Overall Study|High parathyroid hormone|0|||
129544057|NCT00471237|466285368|FG005|Overall Study|High parathyroid hormone|0|||
129544058|NCT00471237|466285369|FG006|Overall Study|High parathyroid hormone|0|||
129544059|NCT00471237|466285363|FG000|Overall Study|Participant lost medication|0|||
129544060|NCT00471237|466285364|FG001|Overall Study|Participant lost medication|0|||
129544061|NCT00471237|466285365|FG002|Overall Study|Participant lost medication|0|||
129544062|NCT00471237|466285366|FG003|Overall Study|Participant lost medication|0|||
129544063|NCT00471237|466285367|FG004|Overall Study|Participant lost medication|1|||
129544064|NCT00471237|466285368|FG005|Overall Study|Participant lost medication|0|||
129544065|NCT00471237|466285369|FG006|Overall Study|Participant lost medication|0|||
129544066|NCT00471237|466285363|FG000|Overall Study|Administration of prohibited medicine|0|||
129544067|NCT00471237|466285364|FG001|Overall Study|Administration of prohibited medicine|0|||
129544068|NCT00471237|466285365|FG002|Overall Study|Administration of prohibited medicine|0|||
129544069|NCT00471237|466285366|FG003|Overall Study|Administration of prohibited medicine|0|||
129544070|NCT00471237|466285367|FG004|Overall Study|Administration of prohibited medicine|1|||
129544071|NCT00471237|466285368|FG005|Overall Study|Administration of prohibited medicine|0|||
129544072|NCT00471237|466285369|FG006|Overall Study|Administration of prohibited medicine|0|||
129544073|NCT00471237|466285363|FG000|Overall Study|Participant shifted residence|0|||
129544074|NCT00471237|466285364|FG001|Overall Study|Participant shifted residence|0|||
129544075|NCT00471237|466285365|FG002|Overall Study|Participant shifted residence|0|||
129544076|NCT00471237|466285366|FG003|Overall Study|Participant shifted residence|0|||
129544077|NCT00471237|466285367|FG004|Overall Study|Participant shifted residence|1|||
129544078|NCT00471237|466285368|FG005|Overall Study|Participant shifted residence|0|||
129544079|NCT00471237|466285369|FG006|Overall Study|Participant shifted residence|0|||
129544080|NCT00471237|466285363|FG000|Overall Study|Participant's decision|0|||
129544081|NCT00471237|466285364|FG001|Overall Study|Participant's decision|0|||
129544082|NCT00471237|466285365|FG002|Overall Study|Participant's decision|0|||
129544083|NCT00471237|466285366|FG003|Overall Study|Participant's decision|0|||
129544084|NCT00471237|466285367|FG004|Overall Study|Participant's decision|0|||
129544085|NCT00471237|466285368|FG005|Overall Study|Participant's decision|1|||
129544086|NCT00471237|466285369|FG006|Overall Study|Participant's decision|0|||
129544087|NCT00578448|466285370|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
129544088|NCT00578448|466285370|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
129544089|NCT00578448|466285370|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
129544090|NCT00578448|466285370|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
129544091|NCT01976104|466285371|FG000|Overall Study|Adverse Event|0|||
129544092|NCT01976104|466285372|FG001|Overall Study|Adverse Event|0|||
129544093|NCT01976104|466285373|FG002|Overall Study|Adverse Event|1|||
129544094|NCT01976104|466285374|FG003|Overall Study|Adverse Event|0|||
129544095|NCT01976104|466285371|FG000|Overall Study|Lost to Follow-up|3|||
129544096|NCT01976104|466285372|FG001|Overall Study|Lost to Follow-up|0|||
129544097|NCT01976104|466285373|FG002|Overall Study|Lost to Follow-up|1|||
129544098|NCT01976104|466285374|FG003|Overall Study|Lost to Follow-up|1|||
129544099|NCT01976104|466285371|FG000|Overall Study|Subject Choice|0|||
129544100|NCT01976104|466285372|FG001|Overall Study|Subject Choice|1|||
129544101|NCT01976104|466285373|FG002|Overall Study|Subject Choice|0|||
129544102|NCT01976104|466285374|FG003|Overall Study|Subject Choice|1|||
129544103|NCT01976104|466285371|FG000|Overall Study|Withdrawal by Subject|3|||
129544104|NCT01976104|466285372|FG001|Overall Study|Withdrawal by Subject|0|||
129544105|NCT01976104|466285373|FG002|Overall Study|Withdrawal by Subject|0|||
129544106|NCT01976104|466285374|FG003|Overall Study|Withdrawal by Subject|1|||
129544107|NCT01976104|466285371|FG000|Overall Study|Other|0|||
129544108|NCT01976104|466285372|FG001|Overall Study|Other|1|||
129544109|NCT01976104|466285373|FG002|Overall Study|Other|0|||
129544110|NCT01976104|466285374|FG003|Overall Study|Other|0|||
129544111|NCT01317199|466285375|FG000|Dose-escalation Phase 1|Physician Decision|5|||
129544112|NCT01317199|466285376|FG001|Dose-escalation Phase 1|Physician Decision|0|||
129544113|NCT01317199|466285377|FG002|Dose-escalation Phase 1|Physician Decision|0|||
129544114|NCT01317199|466285378|FG003|Dose-escalation Phase 1|Physician Decision|0|||
129544115|NCT01317199|466285375|FG000|Dose-escalation Phase 1|Disease progression|1|||
129544116|NCT01317199|466285376|FG001|Dose-escalation Phase 1|Disease progression|0|||
129544117|NCT01317199|466285377|FG002|Dose-escalation Phase 1|Disease progression|0|||
129544118|NCT01317199|466285378|FG003|Dose-escalation Phase 1|Disease progression|0|||
129544119|NCT01317199|466285375|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
129544120|NCT01317199|466285376|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
129544121|NCT01317199|466285377|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
129544122|NCT01317199|466285378|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
129544123|NCT01317199|466285375|FG000|Randomized Phase 2|Disease progression|0|||
129544124|NCT01317199|466285376|FG001|Randomized Phase 2|Disease progression|3|||
129544125|NCT01317199|466285377|FG002|Randomized Phase 2|Disease progression|7|||
129544126|NCT01317199|466285378|FG003|Randomized Phase 2|Disease progression|5|||
129544127|NCT01317199|466285375|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
129544128|NCT01317199|466285376|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
129544129|NCT01317199|466285377|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
129544130|NCT01317199|466285378|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
129544131|NCT01317199|466285375|FG000|Randomized Phase 2|Adverse Event|0|||
129544132|NCT01317199|466285376|FG001|Randomized Phase 2|Adverse Event|0|||
129544133|NCT01317199|466285377|FG002|Randomized Phase 2|Adverse Event|0|||
129544134|NCT01317199|466285378|FG003|Randomized Phase 2|Adverse Event|1|||
129544135|NCT01317199|466285375|FG000|Randomized Phase 2|Comorbidities|0|||
129544136|NCT01317199|466285376|FG001|Randomized Phase 2|Comorbidities|2|||
129544137|NCT01317199|466285377|FG002|Randomized Phase 2|Comorbidities|2|||
129544138|NCT01317199|466285378|FG003|Randomized Phase 2|Comorbidities|2|||
129544139|NCT01317199|466285375|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
129544140|NCT01317199|466285376|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
129544141|NCT01317199|466285377|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
129544142|NCT01317199|466285378|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
129544143|NCT01317199|466285375|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
129544144|NCT01317199|466285376|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
129544145|NCT01317199|466285377|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
129544146|NCT01317199|466285378|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
129544147|NCT01317199|466285375|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
129544148|NCT01317199|466285376|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
129544149|NCT01317199|466285377|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
129544150|NCT01317199|466285378|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
129544151|NCT01317199|466285375|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
129544152|NCT01317199|466285376|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
129544153|NCT01317199|466285377|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
129544154|NCT01317199|466285378|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
129544155|NCT01353209|466285379|FG000|Overall Study|Adverse Event|1|||
129544156|NCT01353209|466285380|FG001|Overall Study|Adverse Event|1|||
129544157|NCT01301625|466285386|FG000|Overall Study|Death|5|||
129544158|NCT01301625|466285386|FG000|Overall Study|Not Due|21|||
129544159|NCT01301625|466285386|FG000|Overall Study|Expected|8|||
129544160|NCT01301625|466285386|FG000|Overall Study|Lost to Follow-up|1|||
129544161|NCT03237325|466285390|FG000|Overall Study|Lost to Follow-up|3|||
129544162|NCT03237325|466285391|FG001|Overall Study|Lost to Follow-up|5|||
129544163|NCT03237325|466285390|FG000|Overall Study|Physician Decision|2|||
129544164|NCT03237325|466285391|FG001|Overall Study|Physician Decision|4|||
129544165|NCT03237325|466285390|FG000|Overall Study|Withdrawal by Subject|9|||
129544166|NCT03237325|466285391|FG001|Overall Study|Withdrawal by Subject|12|||
129544167|NCT03237325|466285390|FG000|Overall Study|Noncompliance with Study Procedures|1|||
129544168|NCT03237325|466285391|FG001|Overall Study|Noncompliance with Study Procedures|1|||
129544169|NCT03237325|466285390|FG000|Overall Study|Termination by Sponsor|0|||
129544170|NCT03237325|466285391|FG001|Overall Study|Termination by Sponsor|1|||
129544171|NCT03237325|466285390|FG000|Overall Study|Reason other than described|0|||
129544172|NCT03237325|466285391|FG001|Overall Study|Reason other than described|2|||
129544173|NCT02684370|466285392|FG000|Part A|Adverse Event|2|||
129544174|NCT02684370|466285393|FG001|Part A|Adverse Event|0|||
129544175|NCT02684370|466285394|FG002|Part A|Adverse Event|1|||
129544176|NCT02684370|466285395|FG003|Part A|Adverse Event|0|||
129544177|NCT02684370|466285396|FG004|Part A|Adverse Event|0|||
129544178|NCT02684370|466285397|FG005|Part A|Adverse Event|0|||
129544179|NCT02684370|466285392|FG000|Part A|Lost to Follow-up|1|||
129544180|NCT02684370|466285393|FG001|Part A|Lost to Follow-up|1|||
129765865|NCT00231816|467108383|FG001|Overall Study|Withdrawal by Subject|3|||
129985713|NCT04811131|467909333|FG000|Overall Study|Withdrawal by Subject|3|||
129544181|NCT02684370|466285394|FG002|Part A|Lost to Follow-up|0|||
129544182|NCT02684370|466285395|FG003|Part A|Lost to Follow-up|0|||
129544183|NCT02684370|466285396|FG004|Part A|Lost to Follow-up|0|||
129544184|NCT02684370|466285397|FG005|Part A|Lost to Follow-up|0|||
129544185|NCT02684370|466285392|FG000|Part A|Subject Withdrawal|1|||
129544186|NCT02684370|466285393|FG001|Part A|Subject Withdrawal|0|||
129544187|NCT02684370|466285394|FG002|Part A|Subject Withdrawal|3|||
129544188|NCT02684370|466285395|FG003|Part A|Subject Withdrawal|0|||
129544189|NCT02684370|466285396|FG004|Part A|Subject Withdrawal|0|||
129544190|NCT02684370|466285397|FG005|Part A|Subject Withdrawal|0|||
129544191|NCT02684370|466285392|FG000|Part A|Other|0|||
129544192|NCT02684370|466285393|FG001|Part A|Other|0|||
129544193|NCT02684370|466285394|FG002|Part A|Other|1|||
129544194|NCT02684370|466285395|FG003|Part A|Other|0|||
129544195|NCT02684370|466285396|FG004|Part A|Other|0|||
129544196|NCT02684370|466285397|FG005|Part A|Other|0|||
129544197|NCT02684370|466285392|FG000|Part B|Adverse Event|0|||
129544198|NCT02684370|466285393|FG001|Part B|Adverse Event|0|||
129544199|NCT02684370|466285394|FG002|Part B|Adverse Event|0|||
129544200|NCT02684370|466285395|FG003|Part B|Adverse Event|0|||
129544201|NCT02684370|466285396|FG004|Part B|Adverse Event|2|||
129544202|NCT02684370|466285397|FG005|Part B|Adverse Event|1|||
129544203|NCT02684370|466285392|FG000|Part B|Lost to Follow-up|0|||
129544204|NCT02684370|466285393|FG001|Part B|Lost to Follow-up|0|||
129544205|NCT02684370|466285394|FG002|Part B|Lost to Follow-up|0|||
129544206|NCT02684370|466285395|FG003|Part B|Lost to Follow-up|1|||
129544207|NCT02684370|466285396|FG004|Part B|Lost to Follow-up|2|||
129544208|NCT02684370|466285397|FG005|Part B|Lost to Follow-up|5|||
129544209|NCT02684370|466285392|FG000|Part B|Subject Withdrawal|0|||
129544210|NCT02684370|466285393|FG001|Part B|Subject Withdrawal|0|||
129544211|NCT02684370|466285394|FG002|Part B|Subject Withdrawal|0|||
129544212|NCT02684370|466285395|FG003|Part B|Subject Withdrawal|1|||
129544213|NCT02684370|466285396|FG004|Part B|Subject Withdrawal|1|||
129544214|NCT02684370|466285397|FG005|Part B|Subject Withdrawal|2|||
129544215|NCT04221373|466285398|FG000|Overall Study|Physician Decision|4|||
129544216|NCT04221373|466285399|FG001|Overall Study|Physician Decision|0|||
129544217|NCT00627094|466285405|FG000|Overall Study|Adverse Event|8|||
129544218|NCT00627094|466285406|FG001|Overall Study|Adverse Event|7|||
129544219|NCT00627094|466285405|FG000|Overall Study|Lost to Follow-up|1|||
129544220|NCT00627094|466285406|FG001|Overall Study|Lost to Follow-up|0|||
129544221|NCT00627094|466285405|FG000|Overall Study|Withdrawal by Subject|1|||
129544222|NCT00627094|466285406|FG001|Overall Study|Withdrawal by Subject|1|||
129544223|NCT00627094|466285405|FG000|Overall Study|ulcer healed|1|||
129544224|NCT00627094|466285406|FG001|Overall Study|ulcer healed|7|||
129544225|NCT00627094|466285405|FG000|Overall Study|Other reason|1|||
129544226|NCT00627094|466285406|FG001|Overall Study|Other reason|0|||
129544227|NCT00138658|466285407|FG000|Overall Study|Adverse Event|23|||
129544228|NCT00138658|466285407|FG000|Overall Study|Death|1|||
129544229|NCT00138658|466285407|FG000|Overall Study|Disease Progression|21|||
129544230|NCT00138658|466285407|FG000|Overall Study|Physician Decision|11|||
129544231|NCT00138658|466285407|FG000|Overall Study|Withdrawal by Subject|5|||
129544232|NCT04637815|466285412|FG000|Overall Study|Death|1|||
129544233|NCT04637815|466285413|FG001|Overall Study|Death|0|||
129544234|NCT04637815|466285412|FG000|Overall Study|Lost to Follow-up|5|||
129544235|NCT04637815|466285413|FG001|Overall Study|Lost to Follow-up|2|||
129544236|NCT00320801|466285414|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
129544237|NCT00320801|466285415|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
129544238|NCT00320801|466285416|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
129544239|NCT00320801|466285417|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
129544240|NCT00320801|466285414|FG000|Open-label Run-in Period|Adverse Event|33|||
129544241|NCT00320801|466285415|FG001|Open-label Run-in Period|Adverse Event|0|||
129544242|NCT00320801|466285416|FG002|Open-label Run-in Period|Adverse Event|0|||
129544243|NCT00320801|466285417|FG003|Open-label Run-in Period|Adverse Event|0|||
129544244|NCT00320801|466285414|FG000|Open-label Run-in Period|Administrative|10|||
129544245|NCT00320801|466285415|FG001|Open-label Run-in Period|Administrative|0|||
129544246|NCT00320801|466285416|FG002|Open-label Run-in Period|Administrative|0|||
129544247|NCT00320801|466285417|FG003|Open-label Run-in Period|Administrative|0|||
129544248|NCT00320801|466285414|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
129544249|NCT00320801|466285415|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
129544250|NCT00320801|466285416|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
129544251|NCT00320801|466285417|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
129544252|NCT00320801|466285414|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
129544253|NCT00320801|466285415|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
129544254|NCT00320801|466285416|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
129544255|NCT00320801|466285417|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
129544256|NCT00320801|466285414|FG000|Open-label Run-in Period|Did not qualify|1|||
129544257|NCT00320801|466285415|FG001|Open-label Run-in Period|Did not qualify|0|||
129544258|NCT00320801|466285416|FG002|Open-label Run-in Period|Did not qualify|0|||
129765866|NCT00231816|467108382|FG000|Overall Study|Other|2|||
129544259|NCT00320801|466285417|FG003|Open-label Run-in Period|Did not qualify|0|||
129544260|NCT00320801|466285414|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129544261|NCT00320801|466285415|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129544262|NCT00320801|466285416|FG002|Double-blind Phase|Withdrawal by Subject|1|||
129544263|NCT00320801|466285417|FG003|Double-blind Phase|Withdrawal by Subject|0|||
129544264|NCT00320801|466285414|FG000|Double-blind Phase|Adverse Event|0|||
129544265|NCT00320801|466285415|FG001|Double-blind Phase|Adverse Event|2|||
129544266|NCT00320801|466285416|FG002|Double-blind Phase|Adverse Event|8|||
129544267|NCT00320801|466285417|FG003|Double-blind Phase|Adverse Event|0|||
129544268|NCT00320801|466285414|FG000|Double-blind Phase|Administrative|0|||
129544269|NCT00320801|466285415|FG001|Double-blind Phase|Administrative|0|||
129544270|NCT00320801|466285416|FG002|Double-blind Phase|Administrative|4|||
129544271|NCT00320801|466285417|FG003|Double-blind Phase|Administrative|0|||
129765867|NCT00231816|467108383|FG001|Overall Study|Other|1|||
129544272|NCT00320801|466285414|FG000|Double-blind Phase|Lack of Efficacy|0|||
129544273|NCT00320801|466285415|FG001|Double-blind Phase|Lack of Efficacy|9|||
129544274|NCT00320801|466285416|FG002|Double-blind Phase|Lack of Efficacy|1|||
129544275|NCT00320801|466285417|FG003|Double-blind Phase|Lack of Efficacy|0|||
129544276|NCT00320801|466285414|FG000|Extension Phase|Withdrawal by Subject|0|||
129544277|NCT00320801|466285415|FG001|Extension Phase|Withdrawal by Subject|0|||
129544278|NCT00320801|466285416|FG002|Extension Phase|Withdrawal by Subject|0|||
129544279|NCT00320801|466285417|FG003|Extension Phase|Withdrawal by Subject|6|||
129544280|NCT00320801|466285414|FG000|Extension Phase|Adverse Event|0|||
129544281|NCT00320801|466285415|FG001|Extension Phase|Adverse Event|0|||
129544282|NCT00320801|466285416|FG002|Extension Phase|Adverse Event|0|||
129544283|NCT00320801|466285417|FG003|Extension Phase|Adverse Event|8|||
129544284|NCT00320801|466285414|FG000|Extension Phase|Administrative|0|||
129544285|NCT00320801|466285415|FG001|Extension Phase|Administrative|0|||
129765868|NCT00468169|467108384|FG000|Overall Study|Withdrawal by Subject|1|||
129765869|NCT00468169|467108385|FG001|Overall Study|Withdrawal by Subject|0|||
129765870|NCT01126749|467108390|FG000|Phase 1b|Other|0|||
129765871|NCT01126749|467108391|FG001|Phase 1b|Other|1|||
129765872|NCT01126749|467108392|FG002|Phase 1b|Other|0|||
129765873|NCT01126749|467108393|FG003|Phase 1b|Other|0|||
129765874|NCT01126749|467108390|FG000|Phase 1b|Withdrawal by Subject|0|||
129765875|NCT01126749|467108391|FG001|Phase 1b|Withdrawal by Subject|1|||
129765876|NCT01126749|467108392|FG002|Phase 1b|Withdrawal by Subject|0|||
129765877|NCT01126749|467108393|FG003|Phase 1b|Withdrawal by Subject|0|||
129765878|NCT01126749|467108390|FG000|Phase 1b|Death|3|||
129544286|NCT00320801|466285416|FG002|Extension Phase|Administrative|0|||
129544287|NCT00320801|466285417|FG003|Extension Phase|Administrative|29|||
129544288|NCT00320801|466285414|FG000|Extension Phase|Lack of Efficacy|0|||
129544289|NCT00320801|466285415|FG001|Extension Phase|Lack of Efficacy|0|||
129544290|NCT00320801|466285416|FG002|Extension Phase|Lack of Efficacy|0|||
129544291|NCT00320801|466285417|FG003|Extension Phase|Lack of Efficacy|2|||
129544292|NCT00320801|466285414|FG000|Extension Phase|Lost to Follow-up|0|||
129544293|NCT00320801|466285415|FG001|Extension Phase|Lost to Follow-up|0|||
129544294|NCT00320801|466285416|FG002|Extension Phase|Lost to Follow-up|0|||
129544295|NCT00320801|466285417|FG003|Extension Phase|Lost to Follow-up|3|||
129544296|NCT00337727|466285418|FG000|Overall Study|Adverse Event|5|||
129544297|NCT00337727|466285419|FG001|Overall Study|Adverse Event|3|||
129544298|NCT00337727|466285418|FG000|Overall Study|Lost to Follow-up|5|||
129544299|NCT00337727|466285419|FG001|Overall Study|Lost to Follow-up|4|||
129544300|NCT00337727|466285418|FG000|Overall Study|Physician Decision|1|||
129544301|NCT00337727|466285419|FG001|Overall Study|Physician Decision|0|||
129544302|NCT00337727|466285418|FG000|Overall Study|Protocol Violation|4|||
129544303|NCT00337727|466285419|FG001|Overall Study|Protocol Violation|0|||
129544304|NCT00337727|466285418|FG000|Overall Study|Withdrawal by Subject|3|||
129544305|NCT00337727|466285419|FG001|Overall Study|Withdrawal by Subject|5|||
129544306|NCT00577031|466285420|FG000|Overall Study|Adverse Event|52|||
129544307|NCT00577031|466285420|FG000|Overall Study|Progression of disease|93|||
129544308|NCT00577031|466285420|FG000|Overall Study|Protocol Violation|5|||
129544309|NCT00577031|466285420|FG000|Overall Study|Participant withdrew consent|13|||
129544310|NCT00577031|466285420|FG000|Overall Study|Participant non-compliance|5|||
129544311|NCT00577031|466285420|FG000|Overall Study|Need for surgery|17|||
129544312|NCT00577031|466285420|FG000|Overall Study|Medical decision|14|||
129544313|NCT00577031|466285420|FG000|Overall Study|Death|6|||
129544314|NCT06067191|466285421|FG000|Overall Study|Withdrawal by Subject|0|||
129544315|NCT06067191|466285422|FG001|Overall Study|Withdrawal by Subject|1|||
129544316|NCT04764669|466285424|FG000|Overall Study|Adverse Event|1|||
129544317|NCT04764669|466285425|FG001|Overall Study|Adverse Event|0|||
129544318|NCT04764669|466285426|FG002|Overall Study|Adverse Event|1|||
129544319|NCT04764669|466285427|FG003|Overall Study|Adverse Event|0|||
129544320|NCT04764669|466285424|FG000|Overall Study|Subject Choice|0|||
129544321|NCT04764669|466285425|FG001|Overall Study|Subject Choice|0|||
129544322|NCT04764669|466285426|FG002|Overall Study|Subject Choice|1|||
129544323|NCT04764669|466285427|FG003|Overall Study|Subject Choice|0|||
129544324|NCT04764669|466285424|FG000|Overall Study|Withdrawal by Subject|2|||
129765879|NCT01126749|467108391|FG001|Phase 1b|Death|4|||
129544325|NCT04764669|466285425|FG001|Overall Study|Withdrawal by Subject|0|||
129544326|NCT04764669|466285426|FG002|Overall Study|Withdrawal by Subject|0|||
129544327|NCT04764669|466285427|FG003|Overall Study|Withdrawal by Subject|0|||
129544328|NCT00807040|466285428|FG000|Overall Study|Death|24|||
129544329|NCT00807040|466285429|FG001|Overall Study|Death|29|||
129544330|NCT00807040|466285428|FG000|Overall Study|Withdrawal by Subject|8|||
129544331|NCT00807040|466285429|FG001|Overall Study|Withdrawal by Subject|6|||
129544332|NCT00807040|466285428|FG000|Overall Study|Lost to Follow-up|4|||
129544333|NCT00807040|466285429|FG001|Overall Study|Lost to Follow-up|6|||
129544334|NCT00625846|466285430|FG000|Overall Study|Withdrawal by Subject|2|||
129544335|NCT00625846|466285431|FG001|Overall Study|Withdrawal by Subject|0|||
129765880|NCT01126749|467108392|FG002|Phase 1b|Death|0|||
129765881|NCT01126749|467108393|FG003|Phase 1b|Death|0|||
129765882|NCT01126749|467108390|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
129765883|NCT01126749|467108391|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
129544336|NCT00625846|466285432|FG002|Overall Study|Withdrawal by Subject|1|||
129544337|NCT00625846|466285433|FG003|Overall Study|Withdrawal by Subject|2|||
129544338|NCT01067339|466285440|FG000|Overall Study|Withdrawal by Subject|6|||
129544339|NCT01067339|466285441|FG001|Overall Study|Withdrawal by Subject|5|||
129544340|NCT00890409|466285442|FG000|Overall Study|Lost to Follow-up|20|||
129544341|NCT00890409|466285443|FG001|Overall Study|Lost to Follow-up|21|||
129544342|NCT00769132|466285445|FG000|Period 1|Adverse Event|1|||
129544343|NCT00769132|466285446|FG001|Period 1|Adverse Event|0|||
129544344|NCT00769132|466285447|FG002|Period 1|Adverse Event|0|||
129544345|NCT00769132|466285448|FG003|Period 1|Adverse Event|1|||
129544346|NCT00769132|466285445|FG000|Period 2|Withdrawal by Subject|0|||
129544347|NCT00769132|466285446|FG001|Period 2|Withdrawal by Subject|0|||
129544348|NCT00769132|466285447|FG002|Period 2|Withdrawal by Subject|0|||
129544349|NCT00769132|466285448|FG003|Period 2|Withdrawal by Subject|1|||
129544350|NCT00769132|466285445|FG000|Period 3|Withdrawal by Subject|1|||
129544351|NCT00769132|466285446|FG001|Period 3|Withdrawal by Subject|0|||
129544352|NCT00769132|466285447|FG002|Period 3|Withdrawal by Subject|0|||
129544353|NCT00769132|466285448|FG003|Period 3|Withdrawal by Subject|0|||
129544354|NCT00769132|466285445|FG000|Period 4|Withdrawal by Subject|0|||
129544355|NCT00769132|466285446|FG001|Period 4|Withdrawal by Subject|1|||
129544356|NCT00769132|466285447|FG002|Period 4|Withdrawal by Subject|0|||
129544357|NCT00769132|466285448|FG003|Period 4|Withdrawal by Subject|0|||
129544358|NCT00557830|466285452|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
129544359|NCT00557830|466285453|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
129544360|NCT00557830|466285454|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
129544361|NCT00557830|466285452|FG000|Screening Treatment Phase|Adverse Event|2|||
129544362|NCT00557830|466285453|FG001|Screening Treatment Phase|Adverse Event|0|||
129544363|NCT00557830|466285454|FG002|Screening Treatment Phase|Adverse Event|0|||
129544364|NCT00557830|466285452|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
129544365|NCT00557830|466285453|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
129544366|NCT00557830|466285454|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
129544367|NCT00538473|466285455|FG000|Overall Study|Adverse Event|1|||
129544368|NCT00538473|466285456|FG001|Overall Study|Adverse Event|0|||
129544369|NCT01833897|466285457|FG000|Overall Study|Lack of Efficacy|1|||
129544370|NCT00669110|466285458|FG000|Overall Study|Adverse Event|4|||
129544371|NCT00669110|466285459|FG001|Overall Study|Adverse Event|3|||
129544372|NCT00669110|466285458|FG000|Overall Study|Caregiver request|3|||
129544373|NCT00669110|466285459|FG001|Overall Study|Caregiver request|2|||
129544374|NCT00669110|466285458|FG000|Overall Study|Physician Decision|0|||
129544375|NCT00669110|466285459|FG001|Overall Study|Physician Decision|1|||
129544376|NCT00669110|466285458|FG000|Overall Study|Lost to Follow-up|1|||
129544377|NCT00669110|466285459|FG001|Overall Study|Lost to Follow-up|0|||
129544378|NCT00669110|466285458|FG000|Overall Study|Protocol Violation|0|||
129544379|NCT00669110|466285459|FG001|Overall Study|Protocol Violation|5|||
129544380|NCT00669110|466285458|FG000|Overall Study|Withdrawal by Subject|0|||
129544381|NCT00669110|466285459|FG001|Overall Study|Withdrawal by Subject|2|||
129544382|NCT00127192|466285460|FG000|Overall Study|Adverse Event|0|||
129544383|NCT00127192|466285461|FG001|Overall Study|Adverse Event|1|||
129544384|NCT00127192|466285462|FG002|Overall Study|Adverse Event|1|||
129544385|NCT00127192|466285463|FG003|Overall Study|Adverse Event|1|||
129544386|NCT00127192|466285464|FG004|Overall Study|Adverse Event|0|||
129544387|NCT00127192|466285460|FG000|Overall Study|Lack of Efficacy|2|||
129544388|NCT00127192|466285461|FG001|Overall Study|Lack of Efficacy|0|||
129544389|NCT00127192|466285462|FG002|Overall Study|Lack of Efficacy|0|||
129544390|NCT00127192|466285463|FG003|Overall Study|Lack of Efficacy|0|||
129544391|NCT00127192|466285464|FG004|Overall Study|Lack of Efficacy|2|||
129544392|NCT00127192|466285460|FG000|Overall Study|Withdrawal by Subject|0|||
129544393|NCT00127192|466285461|FG001|Overall Study|Withdrawal by Subject|0|||
129544394|NCT00127192|466285462|FG002|Overall Study|Withdrawal by Subject|1|||
129544395|NCT00127192|466285463|FG003|Overall Study|Withdrawal by Subject|0|||
129544396|NCT00127192|466285464|FG004|Overall Study|Withdrawal by Subject|3|||
129544397|NCT00127192|466285460|FG000|Overall Study|Adverse event in pre-treatment period|1|||
129544398|NCT00127192|466285461|FG001|Overall Study|Adverse event in pre-treatment period|0|||
129544399|NCT00127192|466285462|FG002|Overall Study|Adverse event in pre-treatment period|0|||
129544400|NCT00127192|466285463|FG003|Overall Study|Adverse event in pre-treatment period|0|||
129544401|NCT00127192|466285464|FG004|Overall Study|Adverse event in pre-treatment period|0|||
129544402|NCT01870921|466285465|FG000|Overall Study|Subject decision|80|||
129544403|NCT01870921|466285465|FG000|Overall Study|Severe non-compliance to protocol|7|||
129544404|NCT01870921|466285465|FG000|Overall Study|Subject Lost to Follow up|2|||
129544405|NCT01870921|466285465|FG000|Overall Study|Other|1|||
129544406|NCT04409509|466285468|FG000|Overall Study|Failure to meet randomization requirement|1|||
129544407|NCT04409509|466285469|FG001|Overall Study|Failure to meet randomization requirement|0|||
129544408|NCT04409509|466285468|FG000|Overall Study|Adverse Event|0|||
129544409|NCT04409509|466285469|FG001|Overall Study|Adverse Event|1|||
129544410|NCT04409509|466285468|FG000|Overall Study|Death|11|||
129544411|NCT04409509|466285469|FG001|Overall Study|Death|10|||
129544412|NCT04409509|466285468|FG000|Overall Study|Non-compliance with study drug|0|||
129544413|NCT04409509|466285469|FG001|Overall Study|Non-compliance with study drug|1|||
129544414|NCT04409509|466285468|FG000|Overall Study|Lost to Follow-up|0|||
129544415|NCT04409509|466285469|FG001|Overall Study|Lost to Follow-up|3|||
129544416|NCT04409509|466285468|FG000|Overall Study|Withdrawal by Subject|0|||
129544417|NCT04409509|466285469|FG001|Overall Study|Withdrawal by Subject|3|||
129544418|NCT04409509|466285468|FG000|Overall Study|Randomized by mistake|0|||
129544419|NCT04409509|466285469|FG001|Overall Study|Randomized by mistake|1|||
129544420|NCT04409509|466285468|FG000|Overall Study|Other|1|||
129544421|NCT04409509|466285469|FG001|Overall Study|Other|1|||
129544422|NCT00077766|466285470|FG000|Overall Study|Adverse Event|1|||
129544423|NCT00077766|466285471|FG001|Overall Study|Adverse Event|1|||
129544424|NCT00077766|466285470|FG000|Overall Study|Withdrawal by Subject|4|||
129544425|NCT00077766|466285471|FG001|Overall Study|Withdrawal by Subject|3|||
129544426|NCT00077766|466285470|FG000|Overall Study|Death|12|||
129544427|NCT00077766|466285471|FG001|Overall Study|Death|10|||
129544428|NCT00077766|466285470|FG000|Overall Study|Lost to Follow-up|2|||
129544429|NCT00077766|466285471|FG001|Overall Study|Lost to Follow-up|0|||
129544430|NCT00077766|466285470|FG000|Overall Study|Protocol Violation|1|||
129544431|NCT00077766|466285471|FG001|Overall Study|Protocol Violation|0|||
129544432|NCT00077766|466285470|FG000|Overall Study|Kidney Transplantation|9|||
129544433|NCT00077766|466285471|FG001|Overall Study|Kidney Transplantation|5|||
129544434|NCT00077766|466285470|FG000|Overall Study|Transplantation|5|||
129544435|NCT00077766|466285471|FG001|Overall Study|Transplantation|1|||
129544436|NCT00077766|466285470|FG000|Overall Study|Investigators Discretion|1|||
129544437|NCT00077766|466285471|FG001|Overall Study|Investigators Discretion|0|||
129544438|NCT00077766|466285470|FG000|Overall Study|Participant's decision|1|||
129544439|NCT00077766|466285471|FG001|Overall Study|Participant's decision|0|||
129544440|NCT00077766|466285470|FG000|Overall Study|Dialysis Discontinued|1|||
129544441|NCT00077766|466285471|FG001|Overall Study|Dialysis Discontinued|0|||
129544442|NCT00077766|466285470|FG000|Overall Study|Dialysis|0|||
129544443|NCT00077766|466285471|FG001|Overall Study|Dialysis|1|||
129544444|NCT00077766|466285470|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
129544445|NCT00077766|466285471|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
129544446|NCT00077766|466285470|FG000|Overall Study|Started Nocturnal Dialysis|0|||
129544447|NCT00077766|466285471|FG001|Overall Study|Started Nocturnal Dialysis|1|||
129544448|NCT00077766|466285470|FG000|Overall Study|Stop Dialysis|0|||
129544449|NCT00077766|466285471|FG001|Overall Study|Stop Dialysis|1|||
129544450|NCT00077766|466285470|FG000|Overall Study|Participants Vacation|2|||
129544451|NCT00077766|466285471|FG001|Overall Study|Participants Vacation|1|||
129544452|NCT01886105|466285472|FG000|Overall Study|Lack of Efficacy|3|||
129544453|NCT03843775|466285473|FG000|Overall Study|Adverse Event|1|||
129544454|NCT03843775|466285474|FG001|Overall Study|Adverse Event|1|||
129544455|NCT03843775|466285473|FG000|Overall Study|Lack of Efficacy|2|||
129544456|NCT03843775|466285474|FG001|Overall Study|Lack of Efficacy|6|||
129544457|NCT03843775|466285473|FG000|Overall Study|Withdrawal by Subject|0|||
129544458|NCT03843775|466285474|FG001|Overall Study|Withdrawal by Subject|1|||
129544459|NCT04150107|466285477|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
129544460|NCT04150107|466285478|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
129544461|NCT04150107|466285477|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
129544462|NCT04150107|466285478|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
129544463|NCT02184988|466285483|FG000|Overall Study|Pregnancy|2|||
129544464|NCT02184988|466285483|FG000|Overall Study|Adverse Event|2|||
129544465|NCT02184988|466285483|FG000|Overall Study|moving away/travelling/unable to complet|6|||
129544466|NCT02184988|466285483|FG000|Overall Study|work scheduling issues|4|||
129544467|NCT02184988|466285483|FG000|Overall Study|various other reasons|9|||
129544468|NCT02184988|466285483|FG000|Overall Study|Lost to Follow-up|32|||
129544469|NCT03188991|466285484|FG000|Overall Study|Withdrawal by Subject|0|||
129544470|NCT03188991|466285485|FG001|Overall Study|Withdrawal by Subject|0|||
129544471|NCT03188991|466285486|FG002|Overall Study|Withdrawal by Subject|0|||
129544472|NCT03188991|466285487|FG003|Overall Study|Withdrawal by Subject|1|||
129544473|NCT03255226|466286874|FG000|Overall Study|Adverse Event|2|||
129765884|NCT01126749|467108392|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
129765885|NCT01126749|467108393|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
129544474|NCT03255226|466286874|FG000|Overall Study|Physician Decision|3|||
129544475|NCT03255226|466286874|FG000|Overall Study|Withdrawal by Subject|1|||
129544476|NCT03255226|466286874|FG000|Overall Study|Serum or blood sodium increased|4|||
129544477|NCT03255226|466286874|FG000|Overall Study|Serum or blood potassium increased|4|||
129544478|NCT01035229|466286875|FG000|Overall Study|Adverse Event|61|||
129544479|NCT01035229|466286876|FG001|Overall Study|Adverse Event|14|||
129544480|NCT01035229|466286875|FG000|Overall Study|Withdrawal by Subject|20|||
129544481|NCT01035229|466286876|FG001|Overall Study|Withdrawal by Subject|7|||
129544482|NCT01035229|466286875|FG000|Overall Study|Lost to Follow-up|1|||
129544483|NCT01035229|466286876|FG001|Overall Study|Lost to Follow-up|0|||
129544484|NCT01035229|466286875|FG000|Overall Study|Administrative problems|1|||
129544485|NCT01035229|466286876|FG001|Overall Study|Administrative problems|1|||
129544486|NCT01035229|466286875|FG000|Overall Study|Death|13|||
129544487|NCT01035229|466286876|FG001|Overall Study|Death|5|||
129544488|NCT01035229|466286875|FG000|Overall Study|New cancer therapy|2|||
129544489|NCT01035229|466286876|FG001|Overall Study|New cancer therapy|0|||
129544490|NCT01035229|466286875|FG000|Overall Study|Protocol Violation|0|||
129544491|NCT01035229|466286876|FG001|Overall Study|Protocol Violation|2|||
129544492|NCT01035229|466286875|FG000|Overall Study|Sponsor's decision to end study|3|||
129544493|NCT01035229|466286876|FG001|Overall Study|Sponsor's decision to end study|3|||
129544494|NCT01035229|466286875|FG000|Overall Study|Disease Progression|261|||
129544495|NCT01035229|466286876|FG001|Overall Study|Disease Progression|152|||
129544496|NCT00798707|466286877|FG000|Overall Study|Adverse Event|6|||
129544497|NCT00798707|466286878|FG001|Overall Study|Adverse Event|8|||
129544498|NCT00798707|466286879|FG002|Overall Study|Adverse Event|8|||
129544499|NCT00798707|466286877|FG000|Overall Study|Failed to return|2|||
129544500|NCT00798707|466286878|FG001|Overall Study|Failed to return|2|||
129544501|NCT00798707|466286879|FG002|Overall Study|Failed to return|0|||
129544502|NCT00798707|466286877|FG000|Overall Study|Investigator|0|||
129651314|NCT03738800|466679609|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
129651315|NCT03738800|466679610|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
129651316|NCT03738800|466679611|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
129651317|NCT03738800|466679609|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
129651318|NCT03738800|466679610|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129651319|NCT03738800|466679611|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
129651320|NCT00766467|466679614|FG000|Overall Study|Withdrawal by Subject|7|||
129651321|NCT00766467|466679615|FG001|Overall Study|Withdrawal by Subject|2|||
129651322|NCT00766467|466679614|FG000|Overall Study|Adverse Event|1|||
129651323|NCT00766467|466679615|FG001|Overall Study|Adverse Event|1|||
129651324|NCT00766467|466679614|FG000|Overall Study|Protocol Violation|2|||
129651325|NCT00766467|466679615|FG001|Overall Study|Protocol Violation|4|||
129651326|NCT00766467|466679614|FG000|Overall Study|Tumor Progression on Study|0|||
129651327|NCT00766467|466679615|FG001|Overall Study|Tumor Progression on Study|1|||
129651328|NCT00766467|466679614|FG000|Overall Study|Physician Decision|1|||
129651329|NCT00766467|466679615|FG001|Overall Study|Physician Decision|0|||
129651330|NCT01404208|466679621|FG000|Overall Study|Discontinued|3|||
129651331|NCT01404208|466679622|FG001|Overall Study|Discontinued|0|||
129651332|NCT01522235|466679624|FG000|Overall Study|Physician Decision|1|||
129651333|NCT01522235|466679625|FG001|Overall Study|Physician Decision|1|||
129651334|NCT01870297|466679628|FG000|Overall Study|Adverse Event|0|||
129651335|NCT01870297|466679629|FG001|Overall Study|Adverse Event|0|||
129651336|NCT01870297|466679630|FG002|Overall Study|Adverse Event|0|||
129651337|NCT01870297|466679631|FG003|Overall Study|Adverse Event|0|||
129651338|NCT01870297|466679632|FG004|Overall Study|Adverse Event|2|||
129651339|NCT01870297|466679633|FG005|Overall Study|Adverse Event|0|||
129651340|NCT01870297|466679634|FG006|Overall Study|Adverse Event|0|||
129651341|NCT01870297|466679628|FG000|Overall Study|Lost to Follow-up|0|||
129651342|NCT01870297|466679629|FG001|Overall Study|Lost to Follow-up|1|||
129651343|NCT01870297|466679630|FG002|Overall Study|Lost to Follow-up|1|||
129651344|NCT01870297|466679631|FG003|Overall Study|Lost to Follow-up|0|||
129544503|NCT00798707|466286878|FG001|Overall Study|Investigator|1|||
129544504|NCT00798707|466286879|FG002|Overall Study|Investigator|2|||
129544505|NCT00798707|466286877|FG000|Overall Study|Lack of Efficacy|2|||
129544506|NCT00798707|466286878|FG001|Overall Study|Lack of Efficacy|2|||
129544507|NCT00798707|466286879|FG002|Overall Study|Lack of Efficacy|1|||
129544508|NCT00798707|466286877|FG000|Overall Study|Lost to Follow-up|5|||
129544509|NCT00798707|466286878|FG001|Overall Study|Lost to Follow-up|6|||
129544510|NCT00798707|466286879|FG002|Overall Study|Lost to Follow-up|6|||
129544511|NCT00798707|466286877|FG000|Overall Study|Other|0|||
129544512|NCT00798707|466286878|FG001|Overall Study|Other|1|||
129544513|NCT00798707|466286879|FG002|Overall Study|Other|0|||
129544514|NCT00798707|466286877|FG000|Overall Study|Protocol Violation|4|||
129544515|NCT00798707|466286878|FG001|Overall Study|Protocol Violation|0|||
129544516|NCT00798707|466286879|FG002|Overall Study|Protocol Violation|2|||
129544517|NCT00798707|466286877|FG000|Overall Study|Withdrawal by Subject|3|||
129544518|NCT00798707|466286878|FG001|Overall Study|Withdrawal by Subject|8|||
129544519|NCT00798707|466286879|FG002|Overall Study|Withdrawal by Subject|2|||
129544520|NCT00798707|466286877|FG000|Overall Study|Randomized not treated|4|||
129544521|NCT00798707|466286878|FG001|Overall Study|Randomized not treated|5|||
129544522|NCT00798707|466286879|FG002|Overall Study|Randomized not treated|1|||
129651345|NCT01870297|466679632|FG004|Overall Study|Lost to Follow-up|0|||
129651346|NCT01870297|466679633|FG005|Overall Study|Lost to Follow-up|0|||
129651347|NCT01870297|466679634|FG006|Overall Study|Lost to Follow-up|0|||
129651348|NCT01870297|466679628|FG000|Overall Study|Withdrawal by Subject|0|||
129544523|NCT03256526|466286882|FG000|Overall Study|Adverse Event|1|||
129544524|NCT03256526|466286883|FG001|Overall Study|Adverse Event|0|||
129544525|NCT03256526|466286884|FG002|Overall Study|Adverse Event|1|||
129544526|NCT03256526|466286882|FG000|Overall Study|Lost to Follow-up|1|||
129544527|NCT03256526|466286883|FG001|Overall Study|Lost to Follow-up|0|||
129651349|NCT01870297|466679629|FG001|Overall Study|Withdrawal by Subject|0|||
129765886|NCT01126749|467108390|FG000|Phase 2|Study Termination by Sponsor|0|||
129875403|NCT04707196|467501951|FG000|Overall Study|Death|3|||
129544528|NCT03256526|466286884|FG002|Overall Study|Lost to Follow-up|2|||
129544529|NCT02875340|466286885|FG000|Overall Study|Death|2|||
129544530|NCT02875340|466286885|FG000|Overall Study|Withdrawal by Subject|2|||
129544531|NCT02875340|466286885|FG000|Overall Study|Physician Decision|3|||
129544532|NCT02875340|466286885|FG000|Overall Study|Adverse Event|1|||
129544533|NCT01160770|466286886|FG000|Overall Study|Adverse Event|10|||
129544534|NCT01160770|466286886|FG000|Overall Study|Protocol Violation|2|||
129544535|NCT01160770|466286886|FG000|Overall Study|Subject/parent/caregiver request|33|||
129544536|NCT01160770|466286886|FG000|Overall Study|Physician Decision|1|||
129544537|NCT01160770|466286886|FG000|Overall Study|Lost to Follow-up|7|||
129544538|NCT01160770|466286886|FG000|Overall Study|Study termination or sponsor request|1|||
129544539|NCT01160770|466286886|FG000|Overall Study|Death|9|||
129544540|NCT01160770|466286886|FG000|Overall Study|Lack of Efficacy|15|||
129544541|NCT01160770|466286886|FG000|Overall Study|Other Reasons|1|||
129544542|NCT03457727|466286887|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
129544543|NCT03457727|466286888|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
129544544|NCT03457727|466286889|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
129544545|NCT03457727|466286890|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
129544546|NCT00929201|466286891|FG000|Period 1|Withdrawal by Subject|0|||
129544547|NCT00929201|466286892|FG001|Period 1|Withdrawal by Subject|1|||
129544548|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
129544549|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
129544550|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
129544551|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
129544552|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
129544553|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
129544554|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
129544555|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
129544556|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
129544557|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
129544558|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
129544559|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
129544560|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
129544561|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
129544562|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
129544563|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
129544564|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
129544565|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
129544566|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
129544567|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
129544568|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
129544569|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
129544570|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
129544571|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
129544572|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
129544573|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
129544574|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
129544575|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
129544576|NCT01299272|466286895|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
129544577|NCT01299272|466286896|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
129544578|NCT01299272|466286897|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
129544579|NCT01299272|466286898|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
129544580|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
129544581|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
129544582|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
129544583|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
129544584|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
129544585|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
129544586|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
129544587|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
129544588|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
129544589|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
129544590|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
129544591|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
129544592|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
129544593|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
129544594|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
129544595|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
129544596|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
129544597|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
129544598|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
129544599|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
129544600|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
129544601|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
129544602|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
129544603|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
129544604|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
129544605|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
129544606|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
129765887|NCT01126749|467108391|FG001|Phase 2|Study Termination by Sponsor|0|||
129765888|NCT01126749|467108392|FG002|Phase 2|Study Termination by Sponsor|12|||
129765889|NCT01126749|467108393|FG003|Phase 2|Study Termination by Sponsor|6|||
129765890|NCT01126749|467108390|FG000|Phase 2|Other|0|||
129765891|NCT01126749|467108391|FG001|Phase 2|Other|0|||
129765892|NCT01126749|467108392|FG002|Phase 2|Other|4|||
129544607|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
129544608|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
129544609|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
129544610|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
129544611|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
129544612|NCT01299272|466286895|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
129544613|NCT01299272|466286896|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
129544614|NCT01299272|466286897|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
129544615|NCT01299272|466286898|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
129544616|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
129544617|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
129544618|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
129544619|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
129544620|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
129544621|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
129544622|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
129544623|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
129544624|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
129544625|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
129544626|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
129544627|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
129544628|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
129544629|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
129544630|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
129544631|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
129544632|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
129544633|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
129544634|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
129544635|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
129544636|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
129544637|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
129647075|NCT02543892|466663783|FG005|Had Immunology Data|Withdrawal by Subject|0|||
129647076|NCT02543892|466663784|FG006|Had Immunology Data|Withdrawal by Subject|1|||
129647077|NCT02543892|466663785|FG007|Had Immunology Data|Withdrawal by Subject|0|||
129647078|NCT01500213|466663786|FG000|Overall Study|Adverse Event|35|||
129647079|NCT01500213|466663787|FG001|Overall Study|Adverse Event|35|||
129647080|NCT01500213|466663786|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
129647081|NCT01500213|466663787|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
129647082|NCT01500213|466663786|FG000|Overall Study|Withdrawal by Subject|28|||
129647083|NCT01500213|466663787|FG001|Overall Study|Withdrawal by Subject|37|||
129647084|NCT01500213|466663786|FG000|Overall Study|Death|7|||
129647085|NCT01500213|466663787|FG001|Overall Study|Death|3|||
129647086|NCT01500213|466663786|FG000|Overall Study|Disease Progression|13|||
129647087|NCT01500213|466663787|FG001|Overall Study|Disease Progression|21|||
129647088|NCT01500213|466663786|FG000|Overall Study|Protocol Violation|19|||
129647089|NCT01500213|466663787|FG001|Overall Study|Protocol Violation|19|||
129647090|NCT01500213|466663786|FG000|Overall Study|Physician Decision|12|||
129647091|NCT01500213|466663787|FG001|Overall Study|Physician Decision|10|||
129647092|NCT01500213|466663786|FG000|Overall Study|Lack of Efficacy|9|||
129647093|NCT01500213|466663787|FG001|Overall Study|Lack of Efficacy|7|||
129647094|NCT01500213|466663786|FG000|Overall Study|Lost to Follow-up|3|||
129647095|NCT01500213|466663787|FG001|Overall Study|Lost to Follow-up|6|||
129647096|NCT01500213|466663786|FG000|Overall Study|Other Reasons|7|||
129647097|NCT01500213|466663787|FG001|Overall Study|Other Reasons|5|||
129544638|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
129544639|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
129544640|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
129544641|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
129544642|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
129544643|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
129544644|NCT01299272|466286895|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
129544645|NCT01299272|466286896|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
129544646|NCT01299272|466286897|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
129544647|NCT01299272|466286898|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
129544648|NCT00464308|466286899|FG000|Overall Study|Adverse Event|22|||
129544649|NCT00464308|466286900|FG001|Overall Study|Adverse Event|27|||
129544650|NCT00464308|466286901|FG002|Overall Study|Adverse Event|16|||
129544651|NCT00464308|466286899|FG000|Overall Study|Lost to Follow-up|29|||
129544652|NCT00464308|466286900|FG001|Overall Study|Lost to Follow-up|19|||
129544653|NCT00464308|466286901|FG002|Overall Study|Lost to Follow-up|20|||
129544654|NCT00464308|466286899|FG000|Overall Study|Patient discontinued and other reasons|17|||
129544655|NCT00464308|466286900|FG001|Overall Study|Patient discontinued and other reasons|17|||
129544656|NCT00464308|466286901|FG002|Overall Study|Patient discontinued and other reasons|23|||
129544657|NCT00464308|466286899|FG000|Overall Study|Physician Decision|1|||
129544658|NCT00464308|466286900|FG001|Overall Study|Physician Decision|0|||
129544659|NCT00464308|466286901|FG002|Overall Study|Physician Decision|0|||
129544660|NCT01513759|466286902|FG000|Overall Study|Protocol Violation|4|||
129544661|NCT01513759|466286902|FG000|Overall Study|Death during catheter placement|1|||
129544662|NCT00630994|466286903|FG000|Overall Study|Adverse Event|1|||
129544663|NCT00630994|466286903|FG000|Overall Study|Disease Progression|1|||
129544664|NCT00630994|466286903|FG000|Overall Study|Lack of Efficacy|1|||
129544665|NCT00630994|466286903|FG000|Overall Study|Other|1|||
129544666|NCT03286426|466286904|FG000|Overall Study|Physician Decision|3|||
129544667|NCT05553600|466286905|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
129544668|NCT05553600|466286906|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
129544669|NCT05553600|466286907|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
129544670|NCT05553600|466286908|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
129544671|NCT05553600|466286905|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
129544672|NCT05553600|466286906|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
129544673|NCT05553600|466286907|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
129544674|NCT05553600|466286908|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
129544675|NCT05553600|466286905|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
129544676|NCT05553600|466286906|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
129544677|NCT05553600|466286907|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
129544678|NCT05553600|466286908|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
129544679|NCT05553600|466286905|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
129544680|NCT05553600|466286906|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
129544681|NCT05553600|466286907|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
129544682|NCT05553600|466286908|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
129651350|NCT01870297|466679630|FG002|Overall Study|Withdrawal by Subject|0|||
129651351|NCT01870297|466679631|FG003|Overall Study|Withdrawal by Subject|0|||
129651352|NCT01870297|466679632|FG004|Overall Study|Withdrawal by Subject|1|||
129651353|NCT01870297|466679633|FG005|Overall Study|Withdrawal by Subject|1|||
129651354|NCT01870297|466679634|FG006|Overall Study|Withdrawal by Subject|1|||
129651355|NCT01870297|466679628|FG000|Overall Study|Sponsor Decision|0|||
129651356|NCT01870297|466679629|FG001|Overall Study|Sponsor Decision|6|||
129651357|NCT01870297|466679630|FG002|Overall Study|Sponsor Decision|0|||
129651358|NCT01870297|466679631|FG003|Overall Study|Sponsor Decision|0|||
129651359|NCT01870297|466679632|FG004|Overall Study|Sponsor Decision|0|||
129651360|NCT01870297|466679633|FG005|Overall Study|Sponsor Decision|0|||
129651361|NCT01870297|466679634|FG006|Overall Study|Sponsor Decision|1|||
129651362|NCT00337779|466679635|FG000|Overall Study|Withdrawal by Subject|10|||
129651363|NCT00337779|466679636|FG001|Overall Study|Withdrawal by Subject|12|||
129651364|NCT00337779|466679635|FG000|Overall Study|Sponsor decision|1|||
129651365|NCT00337779|466679636|FG001|Overall Study|Sponsor decision|1|||
129651366|NCT00337779|466679635|FG000|Overall Study|Physician Decision|3|||
129651367|NCT00337779|466679636|FG001|Overall Study|Physician Decision|6|||
129765893|NCT01126749|467108393|FG003|Phase 2|Other|2|||
129544683|NCT05553600|466286905|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
129544684|NCT05553600|466286906|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
129544685|NCT05553600|466286907|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
129651368|NCT00337779|466679635|FG000|Overall Study|Protocol Violation|1|||
129651369|NCT00337779|466679636|FG001|Overall Study|Protocol Violation|1|||
129651370|NCT00337779|466679635|FG000|Overall Study|Lost to Follow-up|6|||
129651371|NCT00337779|466679636|FG001|Overall Study|Lost to Follow-up|5|||
129544686|NCT05553600|466286908|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
129544687|NCT05553600|466286905|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
129544688|NCT05553600|466286906|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
129544689|NCT05553600|466286907|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
129544690|NCT05553600|466286908|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
129544691|NCT05553600|466286905|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
129544692|NCT05553600|466286906|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
129544693|NCT05553600|466286907|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
129544694|NCT05553600|466286908|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
129544695|NCT05553600|466286905|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
129544696|NCT05553600|466286906|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
129544697|NCT05553600|466286907|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
129544698|NCT05553600|466286908|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
129544699|NCT05553600|466286905|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
129544700|NCT05553600|466286906|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
129544701|NCT05553600|466286907|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
129544702|NCT05553600|466286908|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
129544703|NCT05553600|466286905|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
129544704|NCT05553600|466286906|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
129544705|NCT05553600|466286907|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
129544706|NCT05553600|466286908|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
129544707|NCT05553600|466286905|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
129544708|NCT05553600|466286906|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
129544709|NCT05553600|466286907|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
129544710|NCT05553600|466286908|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
129651372|NCT00337779|466679635|FG000|Overall Study|Adverse Event|28|||
129651373|NCT00337779|466679636|FG001|Overall Study|Adverse Event|51|||
129651374|NCT00337779|466679635|FG000|Overall Study|Pregnancy|3|||
129651375|NCT00337779|466679636|FG001|Overall Study|Pregnancy|2|||
129651376|NCT00337779|466679635|FG000|Overall Study|Death|0|||
129651377|NCT00337779|466679636|FG001|Overall Study|Death|1|||
129651378|NCT03008278|466679637|FG000|Overall Study|Progressive Disease|0|||
129651379|NCT03008278|466679638|FG001|Overall Study|Progressive Disease|0|||
129651380|NCT03008278|466679639|FG002|Overall Study|Progressive Disease|32|||
129651381|NCT03008278|466679637|FG000|Overall Study|Adverse Event|0|||
129651382|NCT03008278|466679638|FG001|Overall Study|Adverse Event|0|||
129651383|NCT03008278|466679639|FG002|Overall Study|Adverse Event|4|||
129651384|NCT03008278|466679637|FG000|Overall Study|Withdrawal by Subject|0|||
129651385|NCT03008278|466679638|FG001|Overall Study|Withdrawal by Subject|0|||
129651386|NCT03008278|466679639|FG002|Overall Study|Withdrawal by Subject|3|||
129651387|NCT03008278|466679637|FG000|Overall Study|Physician Decision|0|||
129651388|NCT03008278|466679638|FG001|Overall Study|Physician Decision|2|||
129651389|NCT03008278|466679639|FG002|Overall Study|Physician Decision|0|||
129651390|NCT00513357|466679640|FG000|Overall Study|did not receive allocated placebo|2|||
129651391|NCT00513357|466679641|FG001|Overall Study|did not receive allocated placebo|3|||
129651392|NCT00513357|466679640|FG000|Overall Study|Adverse Event|4|||
129651393|NCT00513357|466679641|FG001|Overall Study|Adverse Event|2|||
129651394|NCT00513357|466679640|FG000|Overall Study|Death|2|||
129651395|NCT00513357|466679641|FG001|Overall Study|Death|0|||
129651396|NCT00513357|466679640|FG000|Overall Study|Withdrawal by Subject|5|||
129651397|NCT00513357|466679641|FG001|Overall Study|Withdrawal by Subject|4|||
129651398|NCT00513357|466679640|FG000|Overall Study|Disease Progression|2|||
129651399|NCT00513357|466679641|FG001|Overall Study|Disease Progression|1|||
129651400|NCT01162122|466679642|FG000|Overall Study|Withdrawal by Subject|52|||
129651401|NCT01162122|466679643|FG001|Overall Study|Withdrawal by Subject|43|||
129651402|NCT01162122|466679642|FG000|Overall Study|Lost to Follow-up|73|||
129651403|NCT01162122|466679643|FG001|Overall Study|Lost to Follow-up|91|||
129651404|NCT01162122|466679642|FG000|Overall Study|Adverse Event|3|||
129651405|NCT01162122|466679643|FG001|Overall Study|Adverse Event|2|||
129651406|NCT01162122|466679642|FG000|Overall Study|Death|51|||
129651407|NCT01162122|466679643|FG001|Overall Study|Death|46|||
129651408|NCT01162122|466679642|FG000|Overall Study|Protocol Violation|2|||
129651409|NCT01162122|466679643|FG001|Overall Study|Protocol Violation|2|||
129651410|NCT01162122|466679642|FG000|Overall Study|Inappropriate enrollment|5|||
129651411|NCT01162122|466679643|FG001|Overall Study|Inappropriate enrollment|4|||
129651412|NCT01162122|466679642|FG000|Overall Study|Administrative reason|1|||
129651413|NCT01162122|466679643|FG001|Overall Study|Administrative reason|1|||
129651414|NCT01162122|466679642|FG000|Overall Study|Unable to classify|3|||
129651415|NCT01162122|466679643|FG001|Overall Study|Unable to classify|7|||
129651416|NCT01162122|466679642|FG000|Overall Study|Missing primary reason|1|||
129651417|NCT01162122|466679643|FG001|Overall Study|Missing primary reason|0|||
129651418|NCT00422422|466679647|FG000|Overall Study|Lack of Efficacy|1|||
129651419|NCT00422422|466679647|FG000|Overall Study|Protocol Violation|1|||
129651420|NCT00422422|466679647|FG000|Overall Study|Withdrawal by Subject|2|||
129651421|NCT00422422|466679647|FG000|Overall Study|SAE, non-fatal|1|||
129651422|NCT00422422|466679647|FG000|Overall Study|AE, non-serious non-fatal|5|||
129651423|NCT03313310|466679648|FG000|Phase 2|Lost to Follow-up|4|||
129651424|NCT03313310|466679649|FG001|Phase 2|Lost to Follow-up|0|||
129651425|NCT03313310|466679648|FG000|Phase 3|Lost to Follow-up|0|||
129651426|NCT03313310|466679649|FG001|Phase 3|Lost to Follow-up|1|||
129651427|NCT01217385|466679650|FG000|Overall Study|Withdrawal by Subject|3|||
129651428|NCT01217385|466679650|FG000|Overall Study|DOSI not performed/not eval|12|||
129651429|NCT01217385|466679650|FG000|Overall Study|Central Path not Available|1|||
129651430|NCT01217385|466679650|FG000|Overall Study|Normal Breast TOI not available|10|||
129651431|NCT00090987|466679651|FG000|Overall Study|Adverse Event|5|||
129651432|NCT00090987|466679651|FG000|Overall Study|Lack of Efficacy|7|||
129651433|NCT00090987|466679651|FG000|Overall Study|Withdrawal by Subject|3|||
129651434|NCT00090987|466679651|FG000|Overall Study|alternative therapy|1|||
129544711|NCT05553600|466286905|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
129544712|NCT05553600|466286906|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
129544713|NCT05553600|466286907|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
129544714|NCT05553600|466286908|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
129544715|NCT04930536|466286909|FG000|Overall Study|Adverse Event|1|||
129544716|NCT04930536|466286910|FG001|Overall Study|Adverse Event|0|||
129544717|NCT04930536|466286909|FG000|Overall Study|Disease Progression|2|||
129544718|NCT04930536|466286910|FG001|Overall Study|Disease Progression|0|||
129544719|NCT04930536|466286909|FG000|Overall Study|Patient Decision|4|||
129544720|NCT04930536|466286910|FG001|Overall Study|Patient Decision|2|||
129651435|NCT00090987|466679651|FG000|Overall Study|Non-compliance|4|||
129651436|NCT00090987|466679651|FG000|Overall Study|Incarcerated|1|||
129651437|NCT02079636|466679653|FG000|Overall Study|Death|2|||
129651438|NCT02079636|466679654|FG001|Overall Study|Death|1|||
129651439|NCT02079636|466679655|FG002|Overall Study|Death|0|||
129651440|NCT02079636|466679656|FG003|Overall Study|Death|5|||
129651441|NCT02079636|466679657|FG004|Overall Study|Death|1|||
129651442|NCT02079636|466679658|FG005|Overall Study|Death|2|||
129651443|NCT02079636|466679659|FG006|Overall Study|Death|1|||
129651444|NCT02079636|466679660|FG007|Overall Study|Death|0|||
129651445|NCT02079636|466679661|FG008|Overall Study|Death|0|||
129651446|NCT02079636|466679662|FG009|Overall Study|Death|0|||
129651447|NCT02079636|466679663|FG010|Overall Study|Death|0|||
129651448|NCT02079636|466679664|FG011|Overall Study|Death|1|||
129651449|NCT02079636|466679665|FG012|Overall Study|Death|1|||
129651450|NCT02079636|466679666|FG013|Overall Study|Death|0|||
129651451|NCT02079636|466679667|FG014|Overall Study|Death|2|||
129651452|NCT02079636|466679653|FG000|Overall Study|Adverse Event|1|||
129651453|NCT02079636|466679654|FG001|Overall Study|Adverse Event|1|||
129651454|NCT02079636|466679655|FG002|Overall Study|Adverse Event|0|||
129651455|NCT02079636|466679656|FG003|Overall Study|Adverse Event|1|||
129651456|NCT02079636|466679657|FG004|Overall Study|Adverse Event|1|||
129651457|NCT02079636|466679658|FG005|Overall Study|Adverse Event|2|||
129651458|NCT02079636|466679659|FG006|Overall Study|Adverse Event|0|||
129651459|NCT02079636|466679660|FG007|Overall Study|Adverse Event|0|||
129651460|NCT02079636|466679661|FG008|Overall Study|Adverse Event|0|||
129651461|NCT02079636|466679662|FG009|Overall Study|Adverse Event|0|||
129651462|NCT02079636|466679663|FG010|Overall Study|Adverse Event|0|||
129651463|NCT02079636|466679664|FG011|Overall Study|Adverse Event|0|||
129651464|NCT02079636|466679665|FG012|Overall Study|Adverse Event|0|||
129651465|NCT02079636|466679666|FG013|Overall Study|Adverse Event|0|||
129651466|NCT02079636|466679667|FG014|Overall Study|Adverse Event|0|||
129651467|NCT02079636|466679653|FG000|Overall Study|Progressive disease|0|||
129651468|NCT02079636|466679654|FG001|Overall Study|Progressive disease|0|||
129651469|NCT02079636|466679655|FG002|Overall Study|Progressive disease|0|||
129651470|NCT02079636|466679656|FG003|Overall Study|Progressive disease|2|||
129651471|NCT02079636|466679657|FG004|Overall Study|Progressive disease|0|||
129651472|NCT02079636|466679658|FG005|Overall Study|Progressive disease|0|||
129651473|NCT02079636|466679659|FG006|Overall Study|Progressive disease|0|||
129651474|NCT02079636|466679660|FG007|Overall Study|Progressive disease|0|||
129651475|NCT02079636|466679661|FG008|Overall Study|Progressive disease|0|||
129651476|NCT02079636|466679662|FG009|Overall Study|Progressive disease|0|||
129651477|NCT02079636|466679663|FG010|Overall Study|Progressive disease|0|||
129651478|NCT02079636|466679664|FG011|Overall Study|Progressive disease|0|||
129544721|NCT04930536|466286909|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
129651479|NCT02079636|466679665|FG012|Overall Study|Progressive disease|1|||
129651480|NCT02079636|466679666|FG013|Overall Study|Progressive disease|0|||
129875404|NCT04707196|467501952|FG001|Overall Study|Death|1|||
129544722|NCT04930536|466286910|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
129651481|NCT02079636|466679667|FG014|Overall Study|Progressive disease|0|||
129651482|NCT02079636|466679653|FG000|Overall Study|Withdrawal by Subject|0|||
129651483|NCT02079636|466679654|FG001|Overall Study|Withdrawal by Subject|0|||
129651484|NCT02079636|466679655|FG002|Overall Study|Withdrawal by Subject|0|||
129651485|NCT02079636|466679656|FG003|Overall Study|Withdrawal by Subject|4|||
129651486|NCT02079636|466679657|FG004|Overall Study|Withdrawal by Subject|0|||
129765894|NCT01126749|467108390|FG000|Phase 2|Withdrawal by Subject|0|||
129765895|NCT01126749|467108391|FG001|Phase 2|Withdrawal by Subject|0|||
129765896|NCT01126749|467108392|FG002|Phase 2|Withdrawal by Subject|0|||
129765897|NCT01126749|467108393|FG003|Phase 2|Withdrawal by Subject|2|||
129765898|NCT01126749|467108390|FG000|Phase 2|Lost to Follow-up|0|||
129765899|NCT01126749|467108391|FG001|Phase 2|Lost to Follow-up|0|||
129765900|NCT01126749|467108392|FG002|Phase 2|Lost to Follow-up|0|||
129765901|NCT01126749|467108393|FG003|Phase 2|Lost to Follow-up|1|||
129765902|NCT01126749|467108390|FG000|Phase 2|Death|0|||
129765903|NCT01126749|467108391|FG001|Phase 2|Death|0|||
129765904|NCT01126749|467108392|FG002|Phase 2|Death|22|||
129765905|NCT01126749|467108393|FG003|Phase 2|Death|22|||
129765906|NCT01126749|467108390|FG000|Phase 2|Adverse Event|0|||
129765907|NCT01126749|467108391|FG001|Phase 2|Adverse Event|0|||
129765908|NCT01126749|467108392|FG002|Phase 2|Adverse Event|0|||
129765909|NCT01126749|467108393|FG003|Phase 2|Adverse Event|1|||
129765910|NCT02183675|467108395|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
129765911|NCT02183675|467108396|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
129765912|NCT02183675|467108397|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
129765913|NCT02183675|467108398|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
129765914|NCT02183675|467108399|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
129765915|NCT02183675|467108400|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
129765916|NCT01614249|467108405|FG000|Overall Study|Lost to Follow-up|11|||
129765917|NCT01614249|467108406|FG001|Overall Study|Lost to Follow-up|23|||
129765918|NCT05498649|467108407|FG000|Overall Study|Lost to Follow-up|1|||
129765919|NCT02946580|467108411|FG000|Overall Study|Withdrawal by Subject|1|||
129765920|NCT02946580|467108412|FG001|Overall Study|Withdrawal by Subject|2|||
129765921|NCT02946580|467108411|FG000|Overall Study|Adverse Event|0|||
129765922|NCT02946580|467108412|FG001|Overall Study|Adverse Event|2|||
129765923|NCT02946580|467108411|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
129765924|NCT02946580|467108412|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
129765925|NCT02761330|467108413|FG000|Treatment Week 1|Withdrawal by Subject|0|||
129765926|NCT02761330|467108414|FG001|Treatment Week 1|Withdrawal by Subject|0|||
129765927|NCT02761330|467108415|FG002|Treatment Week 1|Withdrawal by Subject|0|||
129765928|NCT02761330|467108416|FG003|Treatment Week 1|Withdrawal by Subject|1|||
129765929|NCT02761330|467108417|FG004|Treatment Week 1|Withdrawal by Subject|0|||
129765930|NCT02761330|467108418|FG005|Treatment Week 1|Withdrawal by Subject|1|||
129765931|NCT03043313|467108421|FG000|Overall Study|Withdrawal by Subject|5|||
129765932|NCT03043313|467108422|FG001|Overall Study|Withdrawal by Subject|1|||
129765933|NCT03043313|467108423|FG002|Overall Study|Withdrawal by Subject|1|||
129765934|NCT03043313|467108421|FG000|Overall Study|Lost to Follow-up|1|||
129765935|NCT03043313|467108422|FG001|Overall Study|Lost to Follow-up|1|||
129765936|NCT03043313|467108423|FG002|Overall Study|Lost to Follow-up|0|||
129765937|NCT03043313|467108421|FG000|Overall Study|Death|28|||
129765938|NCT03043313|467108422|FG001|Overall Study|Death|26|||
129765939|NCT03043313|467108423|FG002|Overall Study|Death|17|||
129765940|NCT03043313|467108421|FG000|Overall Study|Participation terminated by sponsor|11|||
129765941|NCT03043313|467108422|FG001|Overall Study|Participation terminated by sponsor|13|||
129544723|NCT01432600|466286911|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
129544724|NCT01432600|466286912|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
129544725|NCT01432600|466286913|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
129544726|NCT03286400|466286917|FG000|Overall Study|Death|10|||
129544727|NCT03286400|466286917|FG000|Overall Study|Lost to Follow-up|10|||
129544728|NCT03286400|466286917|FG000|Overall Study|Physician Decision|1|||
129544729|NCT03286400|466286917|FG000|Overall Study|Scheduling difficulty|4|||
129544730|NCT00826176|466286920|FG000|Overall Study|Lost to Follow-up|1|||
129544731|NCT00826176|466286921|FG001|Overall Study|Lost to Follow-up|0|||
129544732|NCT00826176|466286920|FG000|Overall Study|Subject Withdrew Consent|3|||
129544733|NCT00826176|466286921|FG001|Overall Study|Subject Withdrew Consent|0|||
129544734|NCT00826176|466286920|FG000|Overall Study|Administrative|9|||
129544735|NCT00826176|466286921|FG001|Overall Study|Administrative|0|||
129544736|NCT00297882|466286927|FG000|Day 14|Lack of Efficacy|12|||
129544737|NCT00297882|466286928|FG001|Day 14|Lack of Efficacy|49|||
129544738|NCT00297882|466286927|FG000|Day 28|Lost to Follow-up|13|||
129544739|NCT00297882|466286928|FG001|Day 28|Lost to Follow-up|23|||
129544740|NCT00297882|466286927|FG000|Day 28|Lack of Efficacy|3|||
129544741|NCT00297882|466286928|FG001|Day 28|Lack of Efficacy|0|||
129544742|NCT04484805|466286929|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
129544743|NCT04484805|466286930|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
129765942|NCT03043313|467108423|FG002|Overall Study|Participation terminated by sponsor|13|||
129765943|NCT00980954|467108424|FG000|Overall Study|Protocol Violation|9|||
129765944|NCT00980954|467108425|FG001|Overall Study|Protocol Violation|15|||
129765945|NCT02657889|467108426|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
129765946|NCT02657889|467108427|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
129765947|NCT02657889|467108428|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
129765948|NCT02657889|467108429|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
129765949|NCT02657889|467108426|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
129765950|NCT02657889|467108427|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
129765951|NCT02657889|467108428|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
129765952|NCT02657889|467108429|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
129765953|NCT02657889|467108426|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
129765954|NCT02657889|467108427|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
129765955|NCT02657889|467108428|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
129765956|NCT02657889|467108429|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
129765957|NCT02657889|467108426|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
129765958|NCT02657889|467108427|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
129765959|NCT02657889|467108428|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
129765960|NCT02657889|467108429|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
129765961|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
129765962|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
129765963|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
129765964|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
129765965|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
129765966|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
129765967|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
129765968|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
129765969|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
129765970|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
129765971|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
129765972|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
129765973|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
129765974|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
129765975|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
129765976|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
129765977|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
129765978|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
129765979|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
129765980|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
129765981|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
129765982|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
129765983|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
129765984|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
129765985|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
129765986|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
129765987|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
129765988|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
129765989|NCT02657889|467108426|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
129765990|NCT02657889|467108427|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
129765991|NCT02657889|467108428|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
129765992|NCT02657889|467108429|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
129765993|NCT01576341|467108430|FG000|Overall Study|Withdrawal by Subject|24|||
129765994|NCT01576341|467108430|FG000|Overall Study|Adverse Event|10|||
129765995|NCT01576341|467108430|FG000|Overall Study|Death|21|||
129765996|NCT01576341|467108430|FG000|Overall Study|Physician Decision|2|||
129765997|NCT01576341|467108430|FG000|Overall Study|Lost to Follow-up|2|||
129765998|NCT01576341|467108430|FG000|Overall Study|Kidney transplantation|10|||
129765999|NCT01576341|467108430|FG000|Overall Study|Protocol Violation|12|||
129766000|NCT01576341|467108430|FG000|Overall Study|Other|12|||
129766001|NCT03341299|467108431|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
129766002|NCT03341299|467108432|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
129766003|NCT03341299|467108433|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
129766004|NCT03341299|467108434|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
129766005|NCT00791934|467108436|FG000|Overall Study|Withdrawal by Subject|2|||
129766006|NCT00791934|467108436|FG000|Overall Study|Did not consent for extended follow-up|13|||
129766007|NCT02018562|467108438|FG000|Overall Study|Withdrawal by Subject|2|||
129766008|NCT02018562|467108439|FG001|Overall Study|Withdrawal by Subject|0|||
129766009|NCT02018562|467108438|FG000|Overall Study|Discharged prior to study completion|1|||
129766010|NCT02018562|467108439|FG001|Overall Study|Discharged prior to study completion|0|||
129766011|NCT05194124|467108440|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766012|NCT05194124|467108441|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766013|NCT05194124|467108442|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766014|NCT05194124|467108443|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
129766015|NCT05194124|467108444|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766016|NCT05194124|467108445|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
129766017|NCT05194124|467108446|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766018|NCT05194124|467108447|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766019|NCT05194124|467108448|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766020|NCT05194124|467108449|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
129766021|NCT05194124|467108440|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766022|NCT05194124|467108441|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766023|NCT05194124|467108442|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766024|NCT05194124|467108443|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766025|NCT05194124|467108444|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766026|NCT05194124|467108445|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766027|NCT05194124|467108446|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766028|NCT05194124|467108447|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766029|NCT05194124|467108448|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
129766030|NCT05194124|467108449|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
129766031|NCT03642873|467108450|FG000|Third Intervention (1 Day)|Screen failure|0|||
129766032|NCT03642873|467108451|FG001|Third Intervention (1 Day)|Screen failure|0|||
129766033|NCT03642873|467108452|FG002|Third Intervention (1 Day)|Screen failure|0|||
129766034|NCT03642873|467108453|FG003|Third Intervention (1 Day)|Screen failure|0|||
129766035|NCT03642873|467108454|FG004|Third Intervention (1 Day)|Screen failure|1|||
129766036|NCT03642873|467108455|FG005|Third Intervention (1 Day)|Screen failure|0|||
129766037|NCT03589859|467108462|FG000|Overall Study|Withdrawal by Subject|0|||
129766038|NCT03589859|467108463|FG001|Overall Study|Withdrawal by Subject|6|||
129766039|NCT04966013|467108464|FG000|Overall Study|Withdrawal by Subject|0|||
129766040|NCT04966013|467108465|FG001|Overall Study|Withdrawal by Subject|2|||
129766041|NCT04966013|467108466|FG002|Overall Study|Withdrawal by Subject|1|||
129766042|NCT04966013|467108464|FG000|Overall Study|Adverse Event|2|||
129766043|NCT04966013|467108465|FG001|Overall Study|Adverse Event|1|||
129766044|NCT04966013|467108466|FG002|Overall Study|Adverse Event|1|||
129766045|NCT03518086|467108470|FG000|Overall Study|Adverse Event|23|||
129766046|NCT03518086|467108471|FG001|Overall Study|Adverse Event|15|||
129766047|NCT03518086|467108472|FG002|Overall Study|Adverse Event|3|||
129766048|NCT03518086|467108473|FG003|Overall Study|Adverse Event|2|||
129766049|NCT03518086|467108470|FG000|Overall Study|Withdrawal by Subject|8|||
129766050|NCT03518086|467108471|FG001|Overall Study|Withdrawal by Subject|5|||
129766051|NCT03518086|467108472|FG002|Overall Study|Withdrawal by Subject|1|||
129766052|NCT03518086|467108473|FG003|Overall Study|Withdrawal by Subject|0|||
129766053|NCT03518086|467108470|FG000|Overall Study|Lack of Efficacy|5|||
129766054|NCT03518086|467108471|FG001|Overall Study|Lack of Efficacy|5|||
129766055|NCT03518086|467108472|FG002|Overall Study|Lack of Efficacy|0|||
129766056|NCT03518086|467108473|FG003|Overall Study|Lack of Efficacy|2|||
129766057|NCT03518086|467108470|FG000|Overall Study|Protocol Violation|1|||
129766058|NCT03518086|467108471|FG001|Overall Study|Protocol Violation|5|||
129766059|NCT03518086|467108472|FG002|Overall Study|Protocol Violation|1|||
129766060|NCT03518086|467108473|FG003|Overall Study|Protocol Violation|3|||
129766061|NCT03518086|467108470|FG000|Overall Study|Lost to Follow-up|0|||
129766062|NCT03518086|467108471|FG001|Overall Study|Lost to Follow-up|3|||
129766063|NCT03518086|467108472|FG002|Overall Study|Lost to Follow-up|0|||
129766064|NCT03518086|467108473|FG003|Overall Study|Lost to Follow-up|0|||
129766065|NCT03518086|467108470|FG000|Overall Study|Insufficient Diary Data|0|||
129766066|NCT03518086|467108471|FG001|Overall Study|Insufficient Diary Data|2|||
129651487|NCT02079636|466679658|FG005|Overall Study|Withdrawal by Subject|1|||
129651488|NCT02079636|466679659|FG006|Overall Study|Withdrawal by Subject|0|||
129651489|NCT02079636|466679660|FG007|Overall Study|Withdrawal by Subject|0|||
129651490|NCT02079636|466679661|FG008|Overall Study|Withdrawal by Subject|0|||
129651491|NCT02079636|466679662|FG009|Overall Study|Withdrawal by Subject|2|||
129651492|NCT02079636|466679663|FG010|Overall Study|Withdrawal by Subject|1|||
129651493|NCT02079636|466679664|FG011|Overall Study|Withdrawal by Subject|1|||
129651494|NCT02079636|466679665|FG012|Overall Study|Withdrawal by Subject|1|||
129651495|NCT02079636|466679666|FG013|Overall Study|Withdrawal by Subject|0|||
129651496|NCT02079636|466679667|FG014|Overall Study|Withdrawal by Subject|2|||
129651497|NCT02079636|466679653|FG000|Overall Study|Physician Decision|0|||
129651498|NCT02079636|466679654|FG001|Overall Study|Physician Decision|0|||
129651499|NCT02079636|466679655|FG002|Overall Study|Physician Decision|0|||
129766067|NCT03518086|467108472|FG002|Overall Study|Insufficient Diary Data|0|||
129766068|NCT03518086|467108473|FG003|Overall Study|Insufficient Diary Data|0|||
129766069|NCT03518086|467108470|FG000|Overall Study|Non- compliance to Protocol|0|||
129766070|NCT03518086|467108471|FG001|Overall Study|Non- compliance to Protocol|1|||
129766071|NCT03518086|467108472|FG002|Overall Study|Non- compliance to Protocol|0|||
129766072|NCT03518086|467108473|FG003|Overall Study|Non- compliance to Protocol|0|||
129766073|NCT03518086|467108470|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
129651500|NCT02079636|466679656|FG003|Overall Study|Physician Decision|0|||
129651501|NCT02079636|466679657|FG004|Overall Study|Physician Decision|0|||
129651502|NCT02079636|466679658|FG005|Overall Study|Physician Decision|1|||
129651503|NCT02079636|466679659|FG006|Overall Study|Physician Decision|0|||
129651504|NCT02079636|466679660|FG007|Overall Study|Physician Decision|0|||
129766074|NCT03518086|467108471|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
129766075|NCT03518086|467108472|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
129766076|NCT03518086|467108473|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
129766077|NCT03518086|467108470|FG000|Overall Study|Site Terminated by Sponsor|0|||
129766078|NCT03518086|467108471|FG001|Overall Study|Site Terminated by Sponsor|1|||
129766079|NCT03518086|467108472|FG002|Overall Study|Site Terminated by Sponsor|0|||
129766080|NCT03518086|467108473|FG003|Overall Study|Site Terminated by Sponsor|0|||
129766081|NCT03518086|467108470|FG000|Overall Study|Pregnancy|0|||
129766082|NCT03518086|467108471|FG001|Overall Study|Pregnancy|0|||
129766083|NCT03518086|467108472|FG002|Overall Study|Pregnancy|0|||
129766084|NCT03518086|467108473|FG003|Overall Study|Pregnancy|2|||
129875405|NCT04707196|467501951|FG000|Overall Study|Non-compliance with study drug|1|||
129875406|NCT04707196|467501952|FG001|Overall Study|Non-compliance with study drug|0|||
129875407|NCT04707196|467501951|FG000|Overall Study|Progressive disease|9|||
129875408|NCT04707196|467501952|FG001|Overall Study|Progressive disease|10|||
129875409|NCT01862796|467501953|FG000|Overall Study|Prohibited medications|0|||
129875410|NCT01862796|467501954|FG001|Overall Study|Prohibited medications|0|||
129875411|NCT01862796|467501955|FG002|Overall Study|Prohibited medications|1|||
129875412|NCT00728962|467501963|FG000|Implant Placement Surgery|Adverse Event|8|||
129875413|NCT00728962|467501963|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
129875414|NCT00728962|467501963|FG000|Implant Placement Surgery|Protocol Violation|1|||
129875415|NCT00728962|467501963|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
129875416|NCT00728962|467501963|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
129875417|NCT04954586|467501964|FG000|Overall Study|Withdrawal by Subject|5|||
129875418|NCT00779779|467501965|FG000|Overall Study|Adverse Event|1|||
129875419|NCT00779779|467501965|FG000|Overall Study|Protocol Violation|14|||
129875420|NCT00779779|467501965|FG000|Overall Study|Withdrawal by Subject|4|||
129875421|NCT00779779|467501965|FG000|Overall Study|Lost to Follow-up|5|||
129875422|NCT02552238|467501970|FG000|Overall Study|Withdrawal by Subject|2|||
129875423|NCT02552238|467501970|FG000|Overall Study|Adverse Event|2|||
129875424|NCT05158296|467501971|FG000|Overall Study|Sponsor Decision|2|||
129875425|NCT05158296|467501972|FG001|Overall Study|Sponsor Decision|3|||
129875426|NCT05158296|467501973|FG002|Overall Study|Sponsor Decision|2|||
129875427|NCT02036645|467501979|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875428|NCT02036645|467501980|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875429|NCT02036645|467501981|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875430|NCT02036645|467501982|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875431|NCT02036645|467501983|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875432|NCT02036645|467501984|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875433|NCT02036645|467501985|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
129875434|NCT02036645|467501986|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875435|NCT02036645|467501987|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129651505|NCT02079636|466679661|FG008|Overall Study|Physician Decision|0|||
129651506|NCT02079636|466679662|FG009|Overall Study|Physician Decision|1|||
129651507|NCT02079636|466679663|FG010|Overall Study|Physician Decision|1|||
129651508|NCT02079636|466679664|FG011|Overall Study|Physician Decision|0|||
129651509|NCT02079636|466679665|FG012|Overall Study|Physician Decision|0|||
129651510|NCT02079636|466679666|FG013|Overall Study|Physician Decision|0|||
129651511|NCT02079636|466679667|FG014|Overall Study|Physician Decision|1|||
129651512|NCT02079636|466679653|FG000|Overall Study|Lost to Follow-up|0|||
129651513|NCT02079636|466679654|FG001|Overall Study|Lost to Follow-up|0|||
129651514|NCT02079636|466679655|FG002|Overall Study|Lost to Follow-up|0|||
129651515|NCT02079636|466679656|FG003|Overall Study|Lost to Follow-up|0|||
129651516|NCT02079636|466679657|FG004|Overall Study|Lost to Follow-up|0|||
129651517|NCT02079636|466679658|FG005|Overall Study|Lost to Follow-up|0|||
129651518|NCT02079636|466679659|FG006|Overall Study|Lost to Follow-up|0|||
129651519|NCT02079636|466679660|FG007|Overall Study|Lost to Follow-up|1|||
129651520|NCT02079636|466679661|FG008|Overall Study|Lost to Follow-up|0|||
129651521|NCT02079636|466679662|FG009|Overall Study|Lost to Follow-up|0|||
129651522|NCT02079636|466679663|FG010|Overall Study|Lost to Follow-up|0|||
129875436|NCT02036645|467501988|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875437|NCT02036645|467501989|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875438|NCT02036645|467501990|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
129875439|NCT02036645|467501979|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875440|NCT02036645|467501980|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875441|NCT02036645|467501981|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875442|NCT02036645|467501982|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
129875443|NCT02036645|467501983|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129651523|NCT02079636|466679664|FG011|Overall Study|Lost to Follow-up|0|||
129651524|NCT02079636|466679665|FG012|Overall Study|Lost to Follow-up|0|||
129651525|NCT02079636|466679666|FG013|Overall Study|Lost to Follow-up|0|||
129651526|NCT02079636|466679667|FG014|Overall Study|Lost to Follow-up|0|||
129651527|NCT00725101|466679668|FG000|Overall Study|Death|3|||
129875444|NCT02036645|467501984|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875445|NCT02036645|467501985|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875446|NCT02036645|467501986|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875447|NCT02036645|467501987|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875448|NCT02036645|467501988|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875449|NCT02036645|467501989|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875450|NCT02036645|467501990|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
129875451|NCT02404389|467501991|FG000|Overall Study|Adverse Event|1|||
129544744|NCT04484805|466286929|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
129875452|NCT02404389|467501992|FG001|Overall Study|Adverse Event|0|||
129544745|NCT04484805|466286930|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
129544746|NCT02116309|466286932|FG000|Overall Study|Lost to Follow-up|0|||
129544747|NCT02116309|466286933|FG001|Overall Study|Lost to Follow-up|1|||
129544748|NCT00848965|466286934|FG000|Overall Study|Adverse Event|1|||
129544749|NCT00848965|466286934|FG000|Overall Study|Withdrawal by Subject|1|||
129544750|NCT03710824|466286935|FG000|Overall Study|Withdrawal by Subject|1|||
129544751|NCT03710824|466286935|FG000|Overall Study|Lost to Follow-up|3|||
129544752|NCT03710824|466286935|FG000|Overall Study|Adverse Event|25|||
129544753|NCT03710824|466286935|FG000|Overall Study|Treatment discontinuation|2|||
129544754|NCT02329834|466286936|FG000|Overall Study|Physician Decision|1|||
129544755|NCT02329834|466286937|FG001|Overall Study|Physician Decision|0|||
129544756|NCT05102162|466286942|FG000|Overall Study|Withdrawal by Subject|3|||
129544757|NCT05102162|466286943|FG001|Overall Study|Withdrawal by Subject|0|||
129544758|NCT05102162|466286942|FG000|Overall Study|Baseline cultures negative|4|||
129544759|NCT05102162|466286943|FG001|Overall Study|Baseline cultures negative|2|||
129544760|NCT05102162|466286942|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
129544761|NCT05102162|466286943|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
129544762|NCT05102162|466286942|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
129544763|NCT05102162|466286943|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
129544764|NCT01165424|466286944|FG000|Overall Study|Clinical adverse experiences|1|||
129544765|NCT01165424|466286944|FG000|Overall Study|Laboratory adverse experiences|1|||
129544766|NCT01165424|466286944|FG000|Overall Study|Did not meet entry criteria|1|||
129544767|NCT01165424|466286944|FG000|Overall Study|Participant moved (relocated)|1|||
129544768|NCT02181673|466286945|FG000|Up to Week 24|Adverse Event|2|||
129544769|NCT02181673|466286946|FG001|Up to Week 24|Adverse Event|0|||
129544770|NCT02181673|466286947|FG002|Up to Week 24|Adverse Event|3|||
129544771|NCT02181673|466286945|FG000|Up to Week 24|Death|1|||
129544772|NCT02181673|466286946|FG001|Up to Week 24|Death|0|||
129544773|NCT02181673|466286947|FG002|Up to Week 24|Death|0|||
129544774|NCT02181673|466286945|FG000|Up to Week 24|Lack of Efficacy|1|||
129544775|NCT02181673|466286946|FG001|Up to Week 24|Lack of Efficacy|0|||
129544776|NCT02181673|466286947|FG002|Up to Week 24|Lack of Efficacy|0|||
129544777|NCT02181673|466286945|FG000|Up to Week 24|Lost to Follow-up|1|||
129544778|NCT02181673|466286946|FG001|Up to Week 24|Lost to Follow-up|0|||
129544779|NCT02181673|466286947|FG002|Up to Week 24|Lost to Follow-up|0|||
129544780|NCT02181673|466286945|FG000|Up to Week 24|Physician Decision|0|||
129544781|NCT02181673|466286946|FG001|Up to Week 24|Physician Decision|0|||
129544782|NCT02181673|466286947|FG002|Up to Week 24|Physician Decision|3|||
129544783|NCT02181673|466286945|FG000|Up to Week 24|Withdrawal by Subject|10|||
129544784|NCT02181673|466286946|FG001|Up to Week 24|Withdrawal by Subject|0|||
129544785|NCT02181673|466286947|FG002|Up to Week 24|Withdrawal by Subject|1|||
129544786|NCT02181673|466286945|FG000|Up to Week 24|Other|2|||
129544787|NCT02181673|466286946|FG001|Up to Week 24|Other|0|||
129544788|NCT02181673|466286947|FG002|Up to Week 24|Other|3|||
129544789|NCT02181673|466286945|FG000|Up to Week 24|Randomized not Treated|0|||
129544790|NCT02181673|466286946|FG001|Up to Week 24|Randomized not Treated|0|||
129544791|NCT02181673|466286947|FG002|Up to Week 24|Randomized not Treated|1|||
129544792|NCT02181673|466286945|FG000|Week 24-Week 60|Adverse Event|0|||
129544793|NCT02181673|466286946|FG001|Week 24-Week 60|Adverse Event|4|||
129544794|NCT02181673|466286947|FG002|Week 24-Week 60|Adverse Event|10|||
129544795|NCT02181673|466286945|FG000|Week 24-Week 60|Other|0|||
129544796|NCT02181673|466286946|FG001|Week 24-Week 60|Other|2|||
129544797|NCT02181673|466286947|FG002|Week 24-Week 60|Other|1|||
129544798|NCT02181673|466286945|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
129544799|NCT02181673|466286946|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
129544800|NCT02181673|466286947|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
129544801|NCT02181673|466286945|FG000|Week 24-Week 60|Pregnancy|0|||
129544802|NCT02181673|466286946|FG001|Week 24-Week 60|Pregnancy|0|||
129544803|NCT02181673|466286947|FG002|Week 24-Week 60|Pregnancy|1|||
129544804|NCT02181673|466286945|FG000|Week 24-Week 60|Lack of Efficacy|0|||
129544805|NCT02181673|466286946|FG001|Week 24-Week 60|Lack of Efficacy|0|||
129544806|NCT02181673|466286947|FG002|Week 24-Week 60|Lack of Efficacy|1|||
129544807|NCT02181673|466286945|FG000|Week 24-Week 60|Lost to Follow-up|0|||
129544808|NCT02181673|466286946|FG001|Week 24-Week 60|Lost to Follow-up|0|||
129544809|NCT02181673|466286947|FG002|Week 24-Week 60|Lost to Follow-up|1|||
129544810|NCT02181673|466286945|FG000|Week 24-Week 60|Physician Decision|0|||
129875453|NCT02404389|467501993|FG002|Overall Study|Adverse Event|1|||
129875454|NCT02404389|467501994|FG003|Overall Study|Adverse Event|0|||
129875455|NCT02404389|467501995|FG004|Overall Study|Adverse Event|2|||
129875456|NCT02404389|467501991|FG000|Overall Study|Subject/guardian decision|1|||
129875457|NCT02404389|467501992|FG001|Overall Study|Subject/guardian decision|0|||
129875458|NCT02404389|467501993|FG002|Overall Study|Subject/guardian decision|0|||
129875459|NCT02404389|467501994|FG003|Overall Study|Subject/guardian decision|1|||
129875460|NCT02404389|467501995|FG004|Overall Study|Subject/guardian decision|1|||
129875461|NCT00652938|467501999|FG000|Overall Study|Adverse Event|1|||
129875462|NCT00652938|467502000|FG001|Overall Study|Adverse Event|0|||
129875463|NCT00652938|467502001|FG002|Overall Study|Adverse Event|2|||
129875464|NCT00652938|467501999|FG000|Overall Study|Withdrawal by Subject|0|||
129875465|NCT00652938|467502000|FG001|Overall Study|Withdrawal by Subject|6|||
129875466|NCT00652938|467502001|FG002|Overall Study|Withdrawal by Subject|1|||
129875467|NCT00652938|467501999|FG000|Overall Study|Lost to Follow-up|0|||
129875468|NCT00652938|467502000|FG001|Overall Study|Lost to Follow-up|0|||
129875469|NCT00652938|467502001|FG002|Overall Study|Lost to Follow-up|2|||
129875470|NCT00652938|467501999|FG000|Overall Study|fear of blood sampling|0|||
129875471|NCT00652938|467502000|FG001|Overall Study|fear of blood sampling|1|||
129875472|NCT00652938|467502001|FG002|Overall Study|fear of blood sampling|0|||
129875473|NCT03324880|467502002|FG000|Overall Study|Adverse Event|0|||
129875474|NCT03324880|467502003|FG001|Overall Study|Adverse Event|2|||
129875475|NCT03324880|467502002|FG000|Overall Study|Withdrawal by Subject|2|||
129875476|NCT03324880|467502003|FG001|Overall Study|Withdrawal by Subject|2|||
129875477|NCT03324880|467502002|FG000|Overall Study|Lost to Follow-up|0|||
129875478|NCT03324880|467502003|FG001|Overall Study|Lost to Follow-up|1|||
129875479|NCT03324880|467502002|FG000|Overall Study|Product Recall|0|||
129875480|NCT03324880|467502003|FG001|Overall Study|Product Recall|1|||
129875481|NCT01412801|467502004|FG000|Overall Study|Death|0|||
129875482|NCT01412801|467502005|FG001|Overall Study|Death|1|||
129875483|NCT01412801|467502006|FG002|Overall Study|Death|0|||
129875484|NCT01412801|467502007|FG003|Overall Study|Death|4|||
129875485|NCT01412801|467502008|FG004|Overall Study|Death|2|||
129875486|NCT01412801|467502009|FG005|Overall Study|Death|2|||
129875487|NCT01412801|467502004|FG000|Overall Study|Lost to Follow-up|1|||
129875488|NCT01412801|467502005|FG001|Overall Study|Lost to Follow-up|2|||
129875489|NCT01412801|467502006|FG002|Overall Study|Lost to Follow-up|4|||
129875490|NCT01412801|467502007|FG003|Overall Study|Lost to Follow-up|0|||
129875491|NCT01412801|467502008|FG004|Overall Study|Lost to Follow-up|1|||
129875492|NCT01412801|467502009|FG005|Overall Study|Lost to Follow-up|1|||
129875493|NCT01412801|467502004|FG000|Overall Study|Withdrawal by Subject|3|||
129651528|NCT00725101|466679668|FG000|Overall Study|Lost to Follow-up|353|||
129651529|NCT00725101|466679668|FG000|Overall Study|Protocol Violation|1|||
129651530|NCT00725101|466679668|FG000|Overall Study|Withdrawal by Subject|127|||
129651531|NCT00725101|466679668|FG000|Overall Study|not specified/no reason given|11|||
129651532|NCT01592292|466679669|FG000|Overall Study|Follow-up loss|3|||
129651533|NCT01592292|466679670|FG001|Overall Study|Follow-up loss|3|||
129651534|NCT01592292|466679671|FG002|Overall Study|Follow-up loss|1|||
129651535|NCT01592292|466679672|FG003|Overall Study|Follow-up loss|0|||
129651536|NCT01592292|466679669|FG000|Overall Study|Withdrew consent|2|||
129651537|NCT01592292|466679670|FG001|Overall Study|Withdrew consent|1|||
129651538|NCT01592292|466679671|FG002|Overall Study|Withdrew consent|0|||
129651539|NCT01592292|466679672|FG003|Overall Study|Withdrew consent|0|||
129651540|NCT01592292|466679669|FG000|Overall Study|Other|1|||
129651541|NCT01592292|466679670|FG001|Overall Study|Other|1|||
129651542|NCT01592292|466679671|FG002|Overall Study|Other|2|||
129651543|NCT01592292|466679672|FG003|Overall Study|Other|1|||
129651544|NCT04148287|466679674|FG000|Overall Study|Death|2|||
129651545|NCT03164265|466679675|FG000|Overall Study|Physician Decision|3|||
129651546|NCT03912428|466679678|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
129651547|NCT03912428|466679679|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
129651548|NCT03912428|466679680|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
129651549|NCT03912428|466679681|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
129651550|NCT03912428|466679678|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
129651551|NCT03912428|466679679|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
129875494|NCT01412801|467502005|FG001|Overall Study|Withdrawal by Subject|2|||
129875495|NCT01412801|467502006|FG002|Overall Study|Withdrawal by Subject|1|||
129875496|NCT01412801|467502007|FG003|Overall Study|Withdrawal by Subject|0|||
129651552|NCT03912428|466679680|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
129651553|NCT03912428|466679681|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
129875497|NCT01412801|467502008|FG004|Overall Study|Withdrawal by Subject|0|||
129875498|NCT01412801|467502009|FG005|Overall Study|Withdrawal by Subject|0|||
129875499|NCT01412801|467502004|FG000|Overall Study|Relocated to another area|0|||
129875500|NCT01412801|467502005|FG001|Overall Study|Relocated to another area|0|||
129875501|NCT01412801|467502006|FG002|Overall Study|Relocated to another area|2|||
129875502|NCT01412801|467502007|FG003|Overall Study|Relocated to another area|0|||
129875503|NCT01412801|467502008|FG004|Overall Study|Relocated to another area|0|||
129875504|NCT01412801|467502009|FG005|Overall Study|Relocated to another area|0|||
129875505|NCT00116272|467502010|FG000|Overall Study|Lost to Follow-up|11|||
129875506|NCT00116272|467502011|FG001|Overall Study|Lost to Follow-up|6|||
129875507|NCT01547299|467502014|FG000|Overall Study|Withdrawal by Subject|2|||
129875508|NCT01547299|467502015|FG001|Overall Study|Withdrawal by Subject|2|||
129875509|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
129875510|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875511|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875512|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875513|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875514|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875515|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129875516|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
129875517|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875518|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875519|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875520|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875521|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875522|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129875523|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
129875524|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875525|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875526|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875527|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875528|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875529|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129875530|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
129875531|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875532|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875533|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875534|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875535|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875536|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129875537|NCT01576718|467502016|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
129875538|NCT01576718|467502017|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875539|NCT01576718|467502018|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875540|NCT01576718|467502019|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875541|NCT01576718|467502020|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875542|NCT01576718|467502021|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875543|NCT01576718|467502022|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129875544|NCT01576718|467502016|FG000|Treatment Period|Adverse Event|0|||
129875545|NCT01576718|467502017|FG001|Treatment Period|Adverse Event|1|||
129875546|NCT01576718|467502018|FG002|Treatment Period|Adverse Event|1|||
129875547|NCT01576718|467502019|FG003|Treatment Period|Adverse Event|1|||
129875548|NCT01576718|467502020|FG004|Treatment Period|Adverse Event|1|||
129875549|NCT01576718|467502021|FG005|Treatment Period|Adverse Event|1|||
129875550|NCT01576718|467502022|FG006|Treatment Period|Adverse Event|0|||
129875551|NCT01576718|467502016|FG000|Treatment Period|Withdrawal by Subject|0|||
129875552|NCT01576718|467502017|FG001|Treatment Period|Withdrawal by Subject|1|||
129875553|NCT01576718|467502018|FG002|Treatment Period|Withdrawal by Subject|1|||
129875554|NCT01576718|467502019|FG003|Treatment Period|Withdrawal by Subject|0|||
129875555|NCT01576718|467502020|FG004|Treatment Period|Withdrawal by Subject|2|||
129875556|NCT01576718|467502021|FG005|Treatment Period|Withdrawal by Subject|4|||
129875557|NCT01576718|467502022|FG006|Treatment Period|Withdrawal by Subject|2|||
129875558|NCT01576718|467502016|FG000|Treatment Period|Physician Decision|0|||
129875559|NCT01576718|467502017|FG001|Treatment Period|Physician Decision|1|||
129875560|NCT01576718|467502018|FG002|Treatment Period|Physician Decision|1|||
129875561|NCT01576718|467502019|FG003|Treatment Period|Physician Decision|1|||
129875562|NCT01576718|467502020|FG004|Treatment Period|Physician Decision|1|||
129875563|NCT01576718|467502021|FG005|Treatment Period|Physician Decision|0|||
129875564|NCT01576718|467502022|FG006|Treatment Period|Physician Decision|0|||
129539304|NCT01397409|466265251|FG009|Stage 2|Adverse Event|0|||
129875565|NCT01576718|467502016|FG000|Treatment Period|Protocol Violation|0|||
129875566|NCT01576718|467502017|FG001|Treatment Period|Protocol Violation|5|||
129875567|NCT01576718|467502018|FG002|Treatment Period|Protocol Violation|4|||
129875568|NCT01576718|467502019|FG003|Treatment Period|Protocol Violation|10|||
129875569|NCT01576718|467502020|FG004|Treatment Period|Protocol Violation|6|||
129875570|NCT01576718|467502021|FG005|Treatment Period|Protocol Violation|8|||
129539305|NCT01397409|466265242|FG000|Stage 2|Personal Reasons|0|||
129766085|NCT05967260|467108474|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
129766086|NCT05967260|467108475|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
129766087|NCT03253393|467108477|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
129766088|NCT03253393|467108478|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
129766089|NCT03253393|467108479|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
129766090|NCT02994108|467110285|FG000|Intervention Messages|Withdrawal by Subject|2|||
129766091|NCT02994108|467110286|FG001|Intervention Messages|Withdrawal by Subject|0|||
129766092|NCT02994108|467110285|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
129766093|NCT02994108|467110286|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
129766094|NCT02994108|467110285|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
129766095|NCT02994108|467110286|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
129766096|NCT02994108|467110285|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
129651554|NCT03912428|466679678|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
129766097|NCT02994108|467110286|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
129766098|NCT02081677|467110287|FG000|Overall Study|Adverse Event|0|||
129766099|NCT02081677|467110288|FG001|Overall Study|Adverse Event|0|||
129766100|NCT02081677|467110289|FG002|Overall Study|Adverse Event|1|||
129766101|NCT02081677|467110290|FG003|Overall Study|Adverse Event|0|||
129766102|NCT02081677|467110287|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129766103|NCT02081677|467110288|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129766104|NCT02081677|467110289|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
129766105|NCT02081677|467110290|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129766106|NCT02081677|467110287|FG000|Overall Study|Not comfortable with lens care system|1|||
129766107|NCT02081677|467110288|FG001|Overall Study|Not comfortable with lens care system|0|||
129766108|NCT02081677|467110289|FG002|Overall Study|Not comfortable with lens care system|0|||
129766109|NCT02081677|467110290|FG003|Overall Study|Not comfortable with lens care system|0|||
129766110|NCT02081677|467110287|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129766111|NCT02081677|467110288|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129766112|NCT02081677|467110289|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
129766113|NCT02081677|467110290|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
129766114|NCT01097668|467110291|FG000|Overall Study|Withdrawal by Subject|1|||
129766115|NCT01097668|467110292|FG001|Overall Study|Withdrawal by Subject|2|||
129766116|NCT01097668|467110291|FG000|Overall Study|Lost to Follow-up|1|||
129766117|NCT01097668|467110292|FG001|Overall Study|Lost to Follow-up|0|||
129766118|NCT01428258|467110293|FG000|Intervention 1|Withdrawal by Subject|2|||
129766119|NCT01428258|467110294|FG001|Intervention 1|Withdrawal by Subject|0|||
129766120|NCT00248625|467110295|FG000|Overall Study|Withdrawal by Subject|0|||
129766121|NCT00248625|467110296|FG001|Overall Study|Withdrawal by Subject|2|||
129766122|NCT02443688|467110299|FG000|Overall Study|Adverse Event|2|||
129766123|NCT02443688|467110300|FG001|Overall Study|Adverse Event|3|||
129766124|NCT02443688|467110301|FG002|Overall Study|Adverse Event|2|||
129766125|NCT02443688|467110299|FG000|Overall Study|Lost to Follow-up|1|||
129766126|NCT02443688|467110300|FG001|Overall Study|Lost to Follow-up|0|||
129766127|NCT02443688|467110301|FG002|Overall Study|Lost to Follow-up|0|||
129766128|NCT02443688|467110299|FG000|Overall Study|Physician Decision|3|||
129766129|NCT02443688|467110300|FG001|Overall Study|Physician Decision|0|||
129766130|NCT02443688|467110301|FG002|Overall Study|Physician Decision|1|||
129766131|NCT02443688|467110299|FG000|Overall Study|Pregnancy|0|||
129766132|NCT02443688|467110300|FG001|Overall Study|Pregnancy|0|||
129766133|NCT02443688|467110301|FG002|Overall Study|Pregnancy|1|||
129766134|NCT02443688|467110299|FG000|Overall Study|Withdrawal by Subject|3|||
129766135|NCT02443688|467110300|FG001|Overall Study|Withdrawal by Subject|3|||
129766136|NCT02443688|467110301|FG002|Overall Study|Withdrawal by Subject|4|||
129766137|NCT02443688|467110299|FG000|Overall Study|Non-compliance with study drug|1|||
129766138|NCT02443688|467110300|FG001|Overall Study|Non-compliance with study drug|2|||
129766139|NCT02443688|467110301|FG002|Overall Study|Non-compliance with study drug|4|||
129766140|NCT02443688|467110299|FG000|Overall Study|Sponsor Request|2|||
129766141|NCT02443688|467110300|FG001|Overall Study|Sponsor Request|1|||
129766142|NCT02443688|467110301|FG002|Overall Study|Sponsor Request|0|||
129766143|NCT03182374|467110302|FG000|Overall Study|Lost to Follow-up|3|||
129766144|NCT03182374|467110303|FG001|Overall Study|Lost to Follow-up|2|||
129766145|NCT03182374|467110302|FG000|Overall Study|Lack of Efficacy|8|||
129766146|NCT03182374|467110303|FG001|Overall Study|Lack of Efficacy|14|||
129766147|NCT03182374|467110302|FG000|Overall Study|Withdrawal by Subject|1|||
129766148|NCT03182374|467110303|FG001|Overall Study|Withdrawal by Subject|1|||
129766149|NCT03182374|467110302|FG000|Overall Study|exit for non-compliance|1|||
129766150|NCT03182374|467110303|FG001|Overall Study|exit for non-compliance|1|||
129766151|NCT03182374|467110302|FG000|Overall Study|one subject was randomized but not treated|1|||
129766152|NCT03182374|467110303|FG001|Overall Study|one subject was randomized but not treated|0|||
129766153|NCT03182374|467110302|FG000|Overall Study|Other reasons|0|||
129651555|NCT03912428|466679679|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
129651556|NCT03912428|466679680|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
129651557|NCT03912428|466679681|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
129651558|NCT03233204|466679682|FG000|Overall Study|Adverse Event|1|||
129651559|NCT03233204|466679682|FG000|Overall Study|Death|1|||
129651560|NCT03233204|466679682|FG000|Overall Study|Withdrawal by Subject|1|||
129651561|NCT03233204|466679682|FG000|Overall Study|Progressive Disease|3|||
129651562|NCT02680834|466679683|FG000|Overall Study|Physician Decision|5|||
129651563|NCT02680834|466679684|FG001|Overall Study|Physician Decision|2|||
129651564|NCT02680834|466679683|FG000|Overall Study|Withdrawal by Subject|6|||
129651565|NCT02680834|466679684|FG001|Overall Study|Withdrawal by Subject|0|||
129651566|NCT02680834|466679683|FG000|Overall Study|Lost to Follow-up|0|||
129651567|NCT02680834|466679684|FG001|Overall Study|Lost to Follow-up|1|||
129651568|NCT02889835|466679685|FG000|Overall Study|Lost to Follow-up|13|||
129651569|NCT02889835|466679686|FG001|Overall Study|Lost to Follow-up|13|||
129651570|NCT02889835|466679687|FG002|Overall Study|Lost to Follow-up|13|||
129651571|NCT02889835|466679685|FG000|Overall Study|Withdrawal by Subject|2|||
129651572|NCT02889835|466679686|FG001|Overall Study|Withdrawal by Subject|2|||
129651573|NCT02889835|466679687|FG002|Overall Study|Withdrawal by Subject|2|||
129651574|NCT02889835|466679685|FG000|Overall Study|Protocol Violation|1|||
129651575|NCT02889835|466679686|FG001|Overall Study|Protocol Violation|1|||
129651576|NCT02889835|466679687|FG002|Overall Study|Protocol Violation|1|||
129651577|NCT02889835|466679685|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
129651578|NCT02889835|466679686|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
129651579|NCT02889835|466679687|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
129651580|NCT02889835|466679685|FG000|Overall Study|Death|1|||
129651581|NCT02889835|466679686|FG001|Overall Study|Death|1|||
129651582|NCT02889835|466679687|FG002|Overall Study|Death|1|||
129651583|NCT00224406|466681636|FG000|Overall Study|Re-transplant|0|||
129651584|NCT00224406|466681637|FG001|Overall Study|Re-transplant|2|||
129651585|NCT00224406|466681636|FG000|Overall Study|Death|0|||
129651586|NCT00224406|466681637|FG001|Overall Study|Death|1|||
129651587|NCT00224406|466681636|FG000|Overall Study|Transplant cancelled|0|||
129651588|NCT00224406|466681637|FG001|Overall Study|Transplant cancelled|4|||
129651589|NCT00224406|466681636|FG000|Overall Study|Drug not delivered|2|||
129651590|NCT00224406|466681637|FG001|Overall Study|Drug not delivered|0|||
129651591|NCT00224406|466681636|FG000|Overall Study|Other|4|||
129651592|NCT00224406|466681637|FG001|Overall Study|Other|0|||
129651593|NCT00224406|466681636|FG000|Overall Study|Transplant cancelled|3|||
129651594|NCT00224406|466681637|FG001|Overall Study|Transplant cancelled|0|||
129651595|NCT05459558|466681642|FG000|Overall Study|Adverse Event|1|||
129651596|NCT05459558|466681643|FG001|Overall Study|Adverse Event|0|||
129651597|NCT05459558|466681644|FG002|Overall Study|Adverse Event|0|||
129651598|NCT05459558|466681642|FG000|Overall Study|Scheduling issue|0|||
129651599|NCT05459558|466681643|FG001|Overall Study|Scheduling issue|1|||
129651600|NCT05459558|466681644|FG002|Overall Study|Scheduling issue|3|||
129651601|NCT05459558|466681642|FG000|Overall Study|Withdrawal by Subject|0|||
129651602|NCT05459558|466681643|FG001|Overall Study|Withdrawal by Subject|0|||
129651603|NCT05459558|466681644|FG002|Overall Study|Withdrawal by Subject|2|||
129651604|NCT01777139|466681645|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
129651605|NCT01777139|466681646|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
129651606|NCT01777139|466681645|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
129651607|NCT01777139|466681646|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
129651608|NCT01777139|466681645|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
129651609|NCT01777139|466681646|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
129651610|NCT01777139|466681645|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
129651611|NCT01777139|466681646|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
129651612|NCT01777139|466681645|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
129651613|NCT01777139|466681646|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
129651614|NCT01777139|466681645|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
129651615|NCT01777139|466681646|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
129651616|NCT01777139|466681645|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
129651617|NCT01777139|466681646|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
129651618|NCT01777139|466681645|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
129651619|NCT01777139|466681646|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
129651620|NCT05625477|466681647|FG000|Overall Study|Lost to Follow-up|2|||
129651621|NCT05625477|466681648|FG001|Overall Study|Lost to Follow-up|2|||
129651622|NCT05625477|466681649|FG002|Overall Study|Lost to Follow-up|1|||
129651623|NCT05625477|466681650|FG003|Overall Study|Lost to Follow-up|1|||
129651624|NCT05625477|466681651|FG004|Overall Study|Lost to Follow-up|0|||
129651625|NCT05625477|466681647|FG000|Overall Study|Covid quarantine|1|||
129651626|NCT05625477|466681648|FG001|Overall Study|Covid quarantine|0|||
129651627|NCT05625477|466681649|FG002|Overall Study|Covid quarantine|0|||
129651628|NCT05625477|466681650|FG003|Overall Study|Covid quarantine|0|||
129651629|NCT05625477|466681651|FG004|Overall Study|Covid quarantine|0|||
129766154|NCT03182374|467110303|FG001|Overall Study|Other reasons|3|||
129766155|NCT03085095|467110304|FG000|Overall Study|Adverse Event|23|||
129766156|NCT03085095|467110305|FG001|Overall Study|Adverse Event|8|||
129766157|NCT03085095|467110304|FG000|Overall Study|Protocol Violation|0|||
129766158|NCT03085095|467110305|FG001|Overall Study|Protocol Violation|1|||
129766159|NCT03085095|467110304|FG000|Overall Study|Lost to Follow-up|2|||
129766160|NCT03085095|467110305|FG001|Overall Study|Lost to Follow-up|1|||
129766161|NCT03085095|467110304|FG000|Overall Study|Withdrawal by Subject|17|||
129766162|NCT03085095|467110305|FG001|Overall Study|Withdrawal by Subject|6|||
129766163|NCT03085095|467110304|FG000|Overall Study|Physician Decision|9|||
129766164|NCT03085095|467110305|FG001|Overall Study|Physician Decision|3|||
129766165|NCT03085095|467110304|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
129766166|NCT03085095|467110305|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
129766167|NCT03085095|467110304|FG000|Overall Study|Did not Receive Study Drug|2|||
129766168|NCT03085095|467110305|FG001|Overall Study|Did not Receive Study Drug|2|||
129766169|NCT03085095|467110304|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
129766170|NCT03085095|467110305|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
129766171|NCT00408317|467110306|FG000|First Intervention Period|Adverse Event|0|||
129766172|NCT00408317|467110307|FG001|First Intervention Period|Adverse Event|1|||
129766173|NCT00408317|467110306|FG000|Second Intervention Period|Adverse Event|2|||
129766174|NCT00408317|467110307|FG001|Second Intervention Period|Adverse Event|0|||
129766175|NCT00408317|467110306|FG000|Second Intervention Period|Protocol Violation|0|||
129766176|NCT00408317|467110307|FG001|Second Intervention Period|Protocol Violation|1|||
129766177|NCT00408317|467110306|FG000|Second Intervention Period|Withdrawal of consent|0|||
129766178|NCT00408317|467110307|FG001|Second Intervention Period|Withdrawal of consent|1|||
129766179|NCT03822117|467110308|FG000|Overall Study|Death|18|||
129766180|NCT03822117|467110309|FG001|Overall Study|Death|17|||
129766181|NCT03822117|467110310|FG002|Overall Study|Death|12|||
129766182|NCT03822117|467110311|FG003|Overall Study|Death|4|||
129766183|NCT03822117|467110308|FG000|Overall Study|Lost to Follow-up|1|||
129766184|NCT03822117|467110309|FG001|Overall Study|Lost to Follow-up|2|||
129766185|NCT03822117|467110310|FG002|Overall Study|Lost to Follow-up|3|||
129766186|NCT03822117|467110311|FG003|Overall Study|Lost to Follow-up|0|||
129766187|NCT03822117|467110308|FG000|Overall Study|Study Terminated by Sponsor|25|||
129766188|NCT03822117|467110309|FG001|Overall Study|Study Terminated by Sponsor|11|||
129766189|NCT03822117|467110310|FG002|Overall Study|Study Terminated by Sponsor|6|||
129766190|NCT03822117|467110311|FG003|Overall Study|Study Terminated by Sponsor|0|||
129766191|NCT03822117|467110308|FG000|Overall Study|Withdrawal by Subject|4|||
129766192|NCT03822117|467110309|FG001|Overall Study|Withdrawal by Subject|0|||
129766193|NCT03822117|467110310|FG002|Overall Study|Withdrawal by Subject|3|||
129766194|NCT03822117|467110311|FG003|Overall Study|Withdrawal by Subject|0|||
129766195|NCT03822117|467110308|FG000|Overall Study|Disease Progression|1|||
129766196|NCT03822117|467110309|FG001|Overall Study|Disease Progression|2|||
129766197|NCT03822117|467110310|FG002|Overall Study|Disease Progression|1|||
129766198|NCT03822117|467110311|FG003|Overall Study|Disease Progression|0|||
129766199|NCT03822117|467110308|FG000|Overall Study|Never Returned to Hospital|0|||
129766200|NCT03822117|467110309|FG001|Overall Study|Never Returned to Hospital|0|||
129766201|NCT03822117|467110310|FG002|Overall Study|Never Returned to Hospital|1|||
129766202|NCT03822117|467110311|FG003|Overall Study|Never Returned to Hospital|0|||
129766203|NCT01074502|467110312|FG000|Overall Study|Withdrawal by Subject|1|||
129766204|NCT03198715|467110313|FG000|Overall Study|Death|0|||
129766205|NCT03198715|467110314|FG001|Overall Study|Death|0|||
129766206|NCT03198715|467110315|FG002|Overall Study|Death|1|||
129766207|NCT03198715|467110316|FG003|Overall Study|Death|0|||
129766208|NCT03198715|467110317|FG004|Overall Study|Death|2|||
129766209|NCT03198715|467110313|FG000|Overall Study|Other|0|||
129766210|NCT03198715|467110314|FG001|Overall Study|Other|1|||
129766211|NCT03198715|467110315|FG002|Overall Study|Other|1|||
129766212|NCT03198715|467110316|FG003|Overall Study|Other|0|||
129766213|NCT03198715|467110317|FG004|Overall Study|Other|0|||
129766214|NCT00616759|467110318|FG000|Overall Study|Physician Decision|2|||
129766215|NCT00616759|467110319|FG001|Overall Study|Physician Decision|0|||
129766216|NCT00616759|467110318|FG000|Overall Study|Withdrawal by Subject|1|||
129766217|NCT00616759|467110319|FG001|Overall Study|Withdrawal by Subject|2|||
129766218|NCT00726063|467110323|FG000|Overall Study|Adverse Event|9|||
129766219|NCT00726063|467110324|FG001|Overall Study|Adverse Event|7|||
129766220|NCT02007096|467110325|FG000|Overall Study|medication not available|2|||
129766221|NCT02007096|467110326|FG001|Overall Study|medication not available|0|||
129766222|NCT02007096|467110325|FG000|Overall Study|did not inject saline|0|||
129766223|NCT02007096|467110326|FG001|Overall Study|did not inject saline|3|||
129766224|NCT02007096|467110325|FG000|Overall Study|did not follow postoperative protocol|8|||
129766225|NCT02007096|467110326|FG001|Overall Study|did not follow postoperative protocol|11|||
129766226|NCT02007096|467110325|FG000|Overall Study|converted to open surgery|1|||
129766227|NCT02007096|467110326|FG001|Overall Study|converted to open surgery|1|||
129766228|NCT02007096|467110325|FG000|Overall Study|no mesh placed|0|||
129766229|NCT02007096|467110326|FG001|Overall Study|no mesh placed|1|||
129766230|NCT05176314|467110328|FG000|Overall Study|Lost to Follow-up|2|||
129766231|NCT05176314|467110328|FG000|Overall Study|Physician Decision|1|||
129875571|NCT01576718|467502022|FG006|Treatment Period|Protocol Violation|12|||
129875572|NCT01576718|467502016|FG000|Treatment Period|Sponsor request|0|||
129875573|NCT01576718|467502017|FG001|Treatment Period|Sponsor request|1|||
129875574|NCT01576718|467502018|FG002|Treatment Period|Sponsor request|0|||
129875575|NCT01576718|467502019|FG003|Treatment Period|Sponsor request|0|||
129875576|NCT01576718|467502020|FG004|Treatment Period|Sponsor request|0|||
129875577|NCT01576718|467502021|FG005|Treatment Period|Sponsor request|1|||
129875578|NCT01576718|467502022|FG006|Treatment Period|Sponsor request|0|||
129875579|NCT01576718|467502016|FG000|Treatment Period|Met stopping criteria|0|||
129875580|NCT01576718|467502017|FG001|Treatment Period|Met stopping criteria|16|||
129875581|NCT01576718|467502018|FG002|Treatment Period|Met stopping criteria|13|||
129875582|NCT01576718|467502019|FG003|Treatment Period|Met stopping criteria|19|||
129875583|NCT01576718|467502020|FG004|Treatment Period|Met stopping criteria|16|||
129875584|NCT01576718|467502021|FG005|Treatment Period|Met stopping criteria|33|||
129875585|NCT01576718|467502022|FG006|Treatment Period|Met stopping criteria|15|||
129875586|NCT01576718|467502016|FG000|Treatment Period|Lost to Follow-up|0|||
129875587|NCT01576718|467502017|FG001|Treatment Period|Lost to Follow-up|0|||
129875588|NCT01576718|467502018|FG002|Treatment Period|Lost to Follow-up|0|||
129875589|NCT01576718|467502019|FG003|Treatment Period|Lost to Follow-up|0|||
129875590|NCT01576718|467502020|FG004|Treatment Period|Lost to Follow-up|1|||
129875591|NCT01576718|467502021|FG005|Treatment Period|Lost to Follow-up|0|||
129875592|NCT01576718|467502022|FG006|Treatment Period|Lost to Follow-up|0|||
129875593|NCT01576718|467502016|FG000|Treatment Period|Noncompliance to study medication|0|||
129875594|NCT01576718|467502017|FG001|Treatment Period|Noncompliance to study medication|0|||
129875595|NCT01576718|467502018|FG002|Treatment Period|Noncompliance to study medication|0|||
129875596|NCT01576718|467502019|FG003|Treatment Period|Noncompliance to study medication|0|||
129875597|NCT01576718|467502020|FG004|Treatment Period|Noncompliance to study medication|0|||
129875598|NCT01576718|467502021|FG005|Treatment Period|Noncompliance to study medication|1|||
129875599|NCT01576718|467502022|FG006|Treatment Period|Noncompliance to study medication|1|||
129875600|NCT00045708|467504063|FG000|Phase 1|early progressive disease|0|||
129875601|NCT00045708|467504064|FG001|Phase 1|early progressive disease|1|||
129875602|NCT00045708|467504065|FG002|Phase 1|early progressive disease|0|||
129875603|NCT00284141|467504066|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
129875604|NCT00284141|467504066|FG000|Overall Study|Adverse Event|19|||
129875605|NCT00284141|467504066|FG000|Overall Study|Participant's request|9|||
129875606|NCT00284141|467504066|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
129875607|NCT00284141|467504066|FG000|Overall Study|Clinical deterioration / death|2|||
129875608|NCT00284141|467504066|FG000|Overall Study|General decline|1|||
129875609|NCT00284141|467504066|FG000|Overall Study|Pneumonia|1|||
129875610|NCT00284141|467504066|FG000|Overall Study|Did not take study medication|2|||
129875611|NCT00284141|467504066|FG000|Overall Study|Ongoing treatment|2|||
129875612|NCT04382924|467504068|FG000|Overall Study|Death|2|||
129875613|NCT04382924|467504069|FG001|Overall Study|Death|5|||
129875614|NCT04382924|467504070|FG002|Overall Study|Death|4|||
129875615|NCT04382924|467504068|FG000|Overall Study|Protocol Violation|0|||
129875616|NCT04382924|467504069|FG001|Overall Study|Protocol Violation|1|||
129875617|NCT04382924|467504070|FG002|Overall Study|Protocol Violation|1|||
129875618|NCT04382924|467504068|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
129875619|NCT04382924|467504069|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
129875620|NCT04382924|467504070|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
129875621|NCT04382924|467504068|FG000|Overall Study|Withdrawal by Subject|6|||
129875622|NCT04382924|467504069|FG001|Overall Study|Withdrawal by Subject|3|||
129875623|NCT04382924|467504070|FG002|Overall Study|Withdrawal by Subject|6|||
129875624|NCT01559454|467504071|FG000|Overall Study|Lost to Follow-up|3|||
129875625|NCT01559454|467504072|FG001|Overall Study|Lost to Follow-up|2|||
129875626|NCT01559454|467504071|FG000|Overall Study|Withdrawal by Subject|0|||
129875627|NCT01559454|467504072|FG001|Overall Study|Withdrawal by Subject|1|||
129875628|NCT01559454|467504071|FG000|Overall Study|Physician Decision|0|||
129875629|NCT01559454|467504072|FG001|Overall Study|Physician Decision|1|||
129875630|NCT01559454|467504071|FG000|Overall Study|Protocol Violation|0|||
129875631|NCT01559454|467504072|FG001|Overall Study|Protocol Violation|1|||
129875632|NCT01559454|467504071|FG000|Overall Study|Lack of Efficacy|0|||
129875633|NCT01559454|467504072|FG001|Overall Study|Lack of Efficacy|1|||
129875634|NCT02207725|467504073|FG000|Overall Study|Did Not Receive Treatment|0|||
129875635|NCT02207725|467504074|FG001|Overall Study|Did Not Receive Treatment|1|||
129875636|NCT02207725|467504075|FG002|Overall Study|Did Not Receive Treatment|1|||
129875637|NCT02207725|467504076|FG003|Overall Study|Did Not Receive Treatment|1|||
129875638|NCT01966003|467504077|FG000|Overall Study|Death|43|||
129875639|NCT01966003|467504078|FG001|Overall Study|Death|36|||
129875640|NCT01966003|467504077|FG000|Overall Study|Protocol Violation|6|||
129875641|NCT01966003|467504078|FG001|Overall Study|Protocol Violation|4|||
129875642|NCT01966003|467504077|FG000|Overall Study|Lost to Follow-up|4|||
129875643|NCT01966003|467504078|FG001|Overall Study|Lost to Follow-up|3|||
129875644|NCT01966003|467504077|FG000|Overall Study|Physician Decision|12|||
129875645|NCT01966003|467504078|FG001|Overall Study|Physician Decision|13|||
129875646|NCT01966003|467504077|FG000|Overall Study|Withdrawal by Subject|29|||
129651630|NCT01092637|466681652|FG000|Overall Study|Death|47|||
129651631|NCT01092637|466681653|FG001|Overall Study|Death|49|||
129651632|NCT03292458|466681654|FG000|Period 1|Adverse Event|2|||
129651633|NCT03292458|466681655|FG001|Period 1|Adverse Event|0|||
129651634|NCT00593606|466681656|FG000|Overall Study|Adverse Event|13|||
129651635|NCT00593606|466681656|FG000|Overall Study|Withdrawal by Subject|1|||
129651636|NCT00593606|466681656|FG000|Overall Study|Protocol Violation|3|||
129651637|NCT00593606|466681656|FG000|Overall Study|Lost to Follow-up|2|||
129651638|NCT00593606|466681656|FG000|Overall Study|Run-In Failure|5|||
129651639|NCT00593606|466681656|FG000|Overall Study|Screen Failure|3|||
129651640|NCT02278367|466681657|FG000|Overall Study|Physician Decision|5|||
129651641|NCT02278367|466681658|FG001|Overall Study|Physician Decision|0|||
129651642|NCT02278367|466681657|FG000|Overall Study|Withdrawal by Subject|5|||
129651643|NCT02278367|466681658|FG001|Overall Study|Withdrawal by Subject|0|||
129651644|NCT00308750|466681663|FG000|Overall Study|Adverse Event|9|||
129651645|NCT00308750|466681664|FG001|Overall Study|Adverse Event|9|||
129651646|NCT00308750|466681665|FG002|Overall Study|Adverse Event|13|||
129651647|NCT00308750|466681663|FG000|Overall Study|Withdrawal by Subject|6|||
129651648|NCT00308750|466681664|FG001|Overall Study|Withdrawal by Subject|2|||
129651649|NCT00308750|466681665|FG002|Overall Study|Withdrawal by Subject|3|||
129651650|NCT00308750|466681663|FG000|Overall Study|Physician Decision|3|||
129651651|NCT00308750|466681664|FG001|Overall Study|Physician Decision|4|||
129651652|NCT00308750|466681665|FG002|Overall Study|Physician Decision|3|||
129651653|NCT00308750|466681663|FG000|Overall Study|Sponsor Decision|1|||
129651654|NCT00308750|466681664|FG001|Overall Study|Sponsor Decision|0|||
129651655|NCT00308750|466681665|FG002|Overall Study|Sponsor Decision|0|||
129651656|NCT00308750|466681663|FG000|Overall Study|Disease Progression|47|||
129651657|NCT00308750|466681664|FG001|Overall Study|Disease Progression|24|||
129651658|NCT00308750|466681665|FG002|Overall Study|Disease Progression|28|||
129651659|NCT00308750|466681663|FG000|Overall Study|Unrelated Complication|3|||
129651660|NCT00308750|466681664|FG001|Overall Study|Unrelated Complication|0|||
129651661|NCT00308750|466681665|FG002|Overall Study|Unrelated Complication|1|||
129651662|NCT00308750|466681663|FG000|Overall Study|Death|1|||
129651663|NCT00308750|466681664|FG001|Overall Study|Death|0|||
129651664|NCT00308750|466681665|FG002|Overall Study|Death|1|||
129651665|NCT00308750|466681663|FG000|Overall Study|Protocol Violation|1|||
129651666|NCT00308750|466681664|FG001|Overall Study|Protocol Violation|0|||
129651667|NCT00308750|466681665|FG002|Overall Study|Protocol Violation|0|||
129651668|NCT00308750|466681663|FG000|Overall Study|New Primary Disease Identified|1|||
129651669|NCT00308750|466681664|FG001|Overall Study|New Primary Disease Identified|1|||
129651670|NCT00308750|466681665|FG002|Overall Study|New Primary Disease Identified|0|||
129651671|NCT01358578|466681666|FG000|Induction Period|Adverse Event|2|||
129651672|NCT01358578|466681667|FG001|Induction Period|Adverse Event|4|||
129651673|NCT01358578|466681668|FG002|Induction Period|Adverse Event|2|||
129651674|NCT01358578|466681669|FG003|Induction Period|Adverse Event|6|||
129651675|NCT01358578|466681670|FG004|Induction Period|Adverse Event|0|||
129651676|NCT01358578|466681671|FG005|Induction Period|Adverse Event|0|||
129651677|NCT01358578|466681666|FG000|Induction Period|Lack of Efficacy|0|||
129651678|NCT01358578|466681667|FG001|Induction Period|Lack of Efficacy|0|||
129651679|NCT01358578|466681668|FG002|Induction Period|Lack of Efficacy|9|||
129651680|NCT01358578|466681669|FG003|Induction Period|Lack of Efficacy|1|||
129651681|NCT01358578|466681670|FG004|Induction Period|Lack of Efficacy|0|||
129651682|NCT01358578|466681671|FG005|Induction Period|Lack of Efficacy|0|||
129651683|NCT01358578|466681666|FG000|Induction Period|Lost to Follow-up|0|||
129651684|NCT01358578|466681667|FG001|Induction Period|Lost to Follow-up|0|||
129651685|NCT01358578|466681668|FG002|Induction Period|Lost to Follow-up|1|||
129651686|NCT01358578|466681669|FG003|Induction Period|Lost to Follow-up|4|||
129651687|NCT01358578|466681670|FG004|Induction Period|Lost to Follow-up|0|||
129651688|NCT01358578|466681671|FG005|Induction Period|Lost to Follow-up|0|||
129651689|NCT01358578|466681666|FG000|Induction Period|Physician Decision|2|||
129651690|NCT01358578|466681667|FG001|Induction Period|Physician Decision|1|||
129651691|NCT01358578|466681668|FG002|Induction Period|Physician Decision|2|||
129651692|NCT01358578|466681669|FG003|Induction Period|Physician Decision|0|||
129651693|NCT01358578|466681670|FG004|Induction Period|Physician Decision|0|||
129651694|NCT01358578|466681671|FG005|Induction Period|Physician Decision|0|||
129651695|NCT01358578|466681666|FG000|Induction Period|Protocol Deviation|3|||
129651696|NCT01358578|466681667|FG001|Induction Period|Protocol Deviation|5|||
129651697|NCT01358578|466681668|FG002|Induction Period|Protocol Deviation|0|||
129651698|NCT01358578|466681669|FG003|Induction Period|Protocol Deviation|3|||
129651699|NCT01358578|466681670|FG004|Induction Period|Protocol Deviation|0|||
129651700|NCT01358578|466681671|FG005|Induction Period|Protocol Deviation|0|||
129651701|NCT01358578|466681666|FG000|Induction Period|technical problems|0|||
129651702|NCT01358578|466681667|FG001|Induction Period|technical problems|0|||
129651703|NCT01358578|466681668|FG002|Induction Period|technical problems|1|||
129651704|NCT01358578|466681669|FG003|Induction Period|technical problems|1|||
129651705|NCT01358578|466681670|FG004|Induction Period|technical problems|0|||
129651706|NCT01358578|466681671|FG005|Induction Period|technical problems|0|||
129651707|NCT01358578|466681666|FG000|Induction Period|Withdrawal by Subject|5|||
129875647|NCT01966003|467504078|FG001|Overall Study|Withdrawal by Subject|19|||
129875648|NCT01966003|467504077|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
129875649|NCT01966003|467504078|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
129875650|NCT01966003|467504077|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
129875651|NCT01966003|467504078|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
129875652|NCT01966003|467504077|FG000|Overall Study|Other|1|||
129875653|NCT01966003|467504078|FG001|Overall Study|Other|1|||
129875654|NCT00615264|467504081|FG000|Overall Study|Withdrawal by Subject|17|||
129875655|NCT00615264|467504082|FG001|Overall Study|Withdrawal by Subject|19|||
129875656|NCT00615264|467504081|FG000|Overall Study|Lost to Follow-up|6|||
129875657|NCT00615264|467504082|FG001|Overall Study|Lost to Follow-up|13|||
129875658|NCT00615264|467504081|FG000|Overall Study|Adverse Event|8|||
129875659|NCT00615264|467504082|FG001|Overall Study|Adverse Event|5|||
129875660|NCT00615264|467504081|FG000|Overall Study|Death|1|||
129875661|NCT00615264|467504082|FG001|Overall Study|Death|1|||
129875662|NCT00615264|467504081|FG000|Overall Study|Protocol Violation|11|||
129875663|NCT00615264|467504082|FG001|Overall Study|Protocol Violation|7|||
129875664|NCT00615264|467504081|FG000|Overall Study|Not defined|7|||
129875665|NCT00615264|467504082|FG001|Overall Study|Not defined|4|||
129875666|NCT00615264|467504081|FG000|Overall Study|Dermal Hypersensitivity|0|||
129875667|NCT00615264|467504082|FG001|Overall Study|Dermal Hypersensitivity|3|||
129875668|NCT01492686|467504085|FG000|Double-blind Phase|Adverse Event|0|||
129875669|NCT01492686|467504086|FG001|Double-blind Phase|Adverse Event|2|||
129875670|NCT01492686|467504085|FG000|Double-blind Phase|Physician Decision|0|||
129875671|NCT01492686|467504086|FG001|Double-blind Phase|Physician Decision|1|||
129875672|NCT01492686|467504085|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129875673|NCT01492686|467504086|FG001|Double-blind Phase|Withdrawal by Subject|2|||
129875674|NCT01492686|467504085|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
129875675|NCT01492686|467504086|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
129875676|NCT01492686|467504085|FG000|Open-label Phase|Adverse Event|1|||
129875677|NCT01492686|467504086|FG001|Open-label Phase|Adverse Event|2|||
129875678|NCT01492686|467504085|FG000|Open-label Phase|Physician Decision|1|||
129875679|NCT01492686|467504086|FG001|Open-label Phase|Physician Decision|0|||
129875680|NCT01492686|467504085|FG000|Open-label Phase|Withdrawal by Subject|6|||
129875681|NCT01492686|467504086|FG001|Open-label Phase|Withdrawal by Subject|7|||
129875682|NCT01492686|467504085|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
129875683|NCT01492686|467504086|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
129875684|NCT02255357|467504096|FG000|Overall Study|Physician Decision|10|||
129875685|NCT02255357|467504097|FG001|Overall Study|Physician Decision|24|||
129875686|NCT00509236|467504098|FG000|Overall Study|Adverse Event|7|||
129875687|NCT00509236|467504099|FG001|Overall Study|Adverse Event|9|||
129875688|NCT00509236|467504098|FG000|Overall Study|Withdrawal by Subject|5|||
129875689|NCT00509236|467504099|FG001|Overall Study|Withdrawal by Subject|10|||
129875690|NCT00509236|467504098|FG000|Overall Study|Protocol Violation|3|||
129875691|NCT00509236|467504099|FG001|Overall Study|Protocol Violation|0|||
129875692|NCT00509236|467504098|FG000|Overall Study|Excluded Medication|1|||
129875693|NCT00509236|467504099|FG001|Overall Study|Excluded Medication|1|||
129875694|NCT00509236|467504098|FG000|Overall Study|Scheduled Kidney Transplant|1|||
129875695|NCT00509236|467504099|FG001|Overall Study|Scheduled Kidney Transplant|0|||
129875696|NCT00927355|467504100|FG000|Overall Study|Adverse Event|1|||
129875697|NCT00927355|467504101|FG001|Overall Study|Adverse Event|1|||
129875698|NCT00792103|467504102|FG000|Overall Study|Enrolled, not treated|15|||
129875699|NCT00792103|467504102|FG000|Overall Study|Lost to Follow-up|17|||
129875700|NCT00792103|467504102|FG000|Overall Study|Adverse Event|25|||
129875701|NCT00792103|467504102|FG000|Overall Study|Withdrawal by Subject|52|||
129875702|NCT00792103|467504102|FG000|Overall Study|Protocol Violation|10|||
129875703|NCT00792103|467504102|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
129875704|NCT01572389|467504104|FG000|Overall Study|Death|1|||
129875705|NCT01572389|467504105|FG001|Overall Study|Death|3|||
129875706|NCT01572389|467504104|FG000|Overall Study|Withdrawal by Subject|14|||
129875707|NCT01572389|467504105|FG001|Overall Study|Withdrawal by Subject|2|||
129875708|NCT01572389|467504104|FG000|Overall Study|Lost to Follow-up|25|||
129875709|NCT01572389|467504105|FG001|Overall Study|Lost to Follow-up|14|||
129875710|NCT01572389|467504104|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
129875711|NCT01572389|467504105|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
129875712|NCT01287520|467504106|FG000|Overall Study|Adverse Event|2|||
129875713|NCT01287520|467504107|FG001|Overall Study|Adverse Event|2|||
129875714|NCT01287520|467504108|FG002|Overall Study|Adverse Event|2|||
129875715|NCT01287520|467504109|FG003|Overall Study|Adverse Event|1|||
129875716|NCT01287520|467504110|FG004|Overall Study|Adverse Event|1|||
129875717|NCT01287520|467504111|FG005|Overall Study|Adverse Event|2|||
129875718|NCT01287520|467504112|FG006|Overall Study|Adverse Event|0|||
129875719|NCT01287520|467504113|FG007|Overall Study|Adverse Event|2|||
129875720|NCT01287520|467504114|FG008|Overall Study|Adverse Event|0|||
129875721|NCT01287520|467504106|FG000|Overall Study|Physician Decision|1|||
129875722|NCT01287520|467504107|FG001|Overall Study|Physician Decision|1|||
129875723|NCT01287520|467504108|FG002|Overall Study|Physician Decision|2|||
129875724|NCT01287520|467504109|FG003|Overall Study|Physician Decision|0|||
129875725|NCT01287520|467504110|FG004|Overall Study|Physician Decision|1|||
129875726|NCT01287520|467504111|FG005|Overall Study|Physician Decision|1|||
129875727|NCT01287520|467504112|FG006|Overall Study|Physician Decision|0|||
129875728|NCT01287520|467504113|FG007|Overall Study|Physician Decision|1|||
129875729|NCT01287520|467504114|FG008|Overall Study|Physician Decision|0|||
129875730|NCT01287520|467504106|FG000|Overall Study|Progressive disease|0|||
129875731|NCT01287520|467504107|FG001|Overall Study|Progressive disease|4|||
129875732|NCT01287520|467504108|FG002|Overall Study|Progressive disease|1|||
129875733|NCT01287520|467504109|FG003|Overall Study|Progressive disease|6|||
129875734|NCT01287520|467504110|FG004|Overall Study|Progressive disease|1|||
129875735|NCT01287520|467504111|FG005|Overall Study|Progressive disease|0|||
129875736|NCT01287520|467504112|FG006|Overall Study|Progressive disease|2|||
129875737|NCT01287520|467504113|FG007|Overall Study|Progressive disease|2|||
129875738|NCT01287520|467504114|FG008|Overall Study|Progressive disease|4|||
129875739|NCT01287520|467504106|FG000|Overall Study|Withdrawal by Subject|0|||
129875740|NCT01287520|467504107|FG001|Overall Study|Withdrawal by Subject|0|||
129875741|NCT01287520|467504108|FG002|Overall Study|Withdrawal by Subject|0|||
129875742|NCT01287520|467504109|FG003|Overall Study|Withdrawal by Subject|0|||
129875743|NCT01287520|467504110|FG004|Overall Study|Withdrawal by Subject|0|||
129875744|NCT01287520|467504111|FG005|Overall Study|Withdrawal by Subject|1|||
129875745|NCT01287520|467504112|FG006|Overall Study|Withdrawal by Subject|0|||
129875746|NCT01287520|467504113|FG007|Overall Study|Withdrawal by Subject|0|||
129875747|NCT01287520|467504114|FG008|Overall Study|Withdrawal by Subject|1|||
129875748|NCT03673462|467504115|FG000|Overall Study|Adverse Event|11|||
129875749|NCT03673462|467504116|FG001|Overall Study|Adverse Event|1|||
129875750|NCT03673462|467504115|FG000|Overall Study|Protocol Violation|25|||
129875751|NCT03673462|467504116|FG001|Overall Study|Protocol Violation|11|||
129875752|NCT03673462|467504115|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
129875753|NCT03673462|467504116|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
129875754|NCT03673462|467504115|FG000|Overall Study|Lost to Follow-up|102|||
129875755|NCT03673462|467504116|FG001|Overall Study|Lost to Follow-up|19|||
129875756|NCT02768662|467504117|FG000|Overall Study|Adverse Event|1|||
129875757|NCT02768662|467504117|FG000|Overall Study|Lost to Follow-up|4|||
129875758|NCT02768662|467504117|FG000|Overall Study|Withdrawal by Subject|3|||
129875759|NCT02768662|467504117|FG000|Overall Study|Study terminated by Sponsor|78|||
129875760|NCT01800201|467504118|FG000|Overall Study|Withdrawal by Subject|2|||
129875761|NCT01800201|467504119|FG001|Overall Study|Withdrawal by Subject|0|||
129875762|NCT01800201|467504118|FG000|Overall Study|patient privacy concerns|1|||
129875763|NCT01800201|467504119|FG001|Overall Study|patient privacy concerns|1|||
129875764|NCT01800201|467504118|FG000|Overall Study|did not want to use device|0|||
129875765|NCT01800201|467504119|FG001|Overall Study|did not want to use device|1|||
129875766|NCT01800201|467504118|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
129875767|NCT01800201|467504119|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
129875768|NCT05061537|467504125|FG000|Treatment Phase|Progressive disease|0|||
129875769|NCT05061537|467504126|FG001|Treatment Phase|Progressive disease|1|||
129875770|NCT05061537|467504127|FG002|Treatment Phase|Progressive disease|2|||
129875771|NCT05061537|467504128|FG003|Treatment Phase|Progressive disease|0|||
129875772|NCT05061537|467504129|FG004|Treatment Phase|Progressive disease|0|||
129875773|NCT05061537|467504125|FG000|Treatment Phase|Adverse Event|0|||
129875774|NCT05061537|467504126|FG001|Treatment Phase|Adverse Event|0|||
129875775|NCT05061537|467504127|FG002|Treatment Phase|Adverse Event|2|||
129875776|NCT05061537|467504128|FG003|Treatment Phase|Adverse Event|0|||
129875777|NCT05061537|467504129|FG004|Treatment Phase|Adverse Event|0|||
129875778|NCT05061537|467504125|FG000|Treatment Phase|Global deterioration of health status|0|||
129875779|NCT05061537|467504126|FG001|Treatment Phase|Global deterioration of health status|1|||
129875780|NCT05061537|467504127|FG002|Treatment Phase|Global deterioration of health status|0|||
129875781|NCT05061537|467504128|FG003|Treatment Phase|Global deterioration of health status|0|||
129875782|NCT05061537|467504129|FG004|Treatment Phase|Global deterioration of health status|0|||
129875783|NCT05061537|467504125|FG000|Follow up|Other|2|||
129875784|NCT05061537|467504126|FG001|Follow up|Other|0|||
129875785|NCT05061537|467504127|FG002|Follow up|Other|2|||
129875786|NCT05061537|467504128|FG003|Follow up|Other|0|||
129875787|NCT05061537|467504129|FG004|Follow up|Other|0|||
129875788|NCT05061537|467504125|FG000|Follow up|Study terminated by sponsor|0|||
129875789|NCT05061537|467504126|FG001|Follow up|Study terminated by sponsor|0|||
129875790|NCT05061537|467504127|FG002|Follow up|Study terminated by sponsor|2|||
129875791|NCT05061537|467504128|FG003|Follow up|Study terminated by sponsor|0|||
129875792|NCT05061537|467504129|FG004|Follow up|Study terminated by sponsor|0|||
129875793|NCT05061537|467504125|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
129875794|NCT05061537|467504126|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
129875795|NCT05061537|467504127|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
129875796|NCT05061537|467504128|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
129875797|NCT05061537|467504129|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
129875798|NCT05061537|467504125|FG000|Long-term Follow-up|Death|0|||
129875799|NCT05061537|467504126|FG001|Long-term Follow-up|Death|1|||
129875800|NCT05061537|467504127|FG002|Long-term Follow-up|Death|0|||
129875801|NCT05061537|467504128|FG003|Long-term Follow-up|Death|0|||
129875802|NCT05061537|467504129|FG004|Long-term Follow-up|Death|0|||
129875803|NCT03502616|467504130|FG000|Up to Week 16|Withdrawal by Subject|1|||
129875804|NCT03502616|467504131|FG001|Up to Week 16|Withdrawal by Subject|2|||
129875805|NCT03502616|467504130|FG000|Up to Week 16|Lost to Follow-up|0|||
129875806|NCT03502616|467504131|FG001|Up to Week 16|Lost to Follow-up|1|||
129875807|NCT03502616|467504130|FG000|Up to Week 16|Randomized, but not treated|1|||
129875808|NCT03502616|467504131|FG001|Up to Week 16|Randomized, but not treated|0|||
129875809|NCT03502616|467504130|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
129875810|NCT03502616|467504131|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
129875811|NCT03502616|467504130|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
129875812|NCT03502616|467504131|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
129875813|NCT03541044|467504144|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
129875814|NCT03541044|467504145|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
129875815|NCT03541044|467504144|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
129875816|NCT03541044|467504145|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
129875817|NCT01153269|467504146|FG000|Overall Study|Withdrawal by Subject|1|||
129875818|NCT01153269|467504146|FG000|Overall Study|Antiretroviral therapy break|1|||
129875819|NCT02635724|467504147|FG000|Overall Study|Withdrawal by Subject|0|||
129875820|NCT02635724|467504148|FG001|Overall Study|Withdrawal by Subject|1|||
129875821|NCT02635724|467504149|FG002|Overall Study|Withdrawal by Subject|0|||
129875822|NCT00860067|467504150|FG000|Overall Study|Lost to Follow-up|46|||
129875823|NCT00860067|467504151|FG001|Overall Study|Lost to Follow-up|9|||
129875824|NCT00860067|467504152|FG002|Overall Study|Lost to Follow-up|9|||
129875825|NCT00860067|467504150|FG000|Overall Study|Withdrawal by Subject|4|||
129875826|NCT00860067|467504151|FG001|Overall Study|Withdrawal by Subject|0|||
129875827|NCT00860067|467504152|FG002|Overall Study|Withdrawal by Subject|0|||
129875828|NCT00860067|467504150|FG000|Overall Study|Pregnancy|1|||
129875829|NCT00860067|467504151|FG001|Overall Study|Pregnancy|0|||
129875830|NCT00860067|467504152|FG002|Overall Study|Pregnancy|0|||
129875831|NCT02424591|467504157|FG000|Overall Study|Protocol Violation|2|||
129875832|NCT02424591|467504158|FG001|Overall Study|Protocol Violation|3|||
129875833|NCT01446796|467504159|FG000|Overall Study|Withdrawal by Subject|1|||
129875834|NCT01446796|467504160|FG001|Overall Study|Withdrawal by Subject|0|||
129875835|NCT01498822|467504161|FG000|Overall Study|Protocol Violation|8|||
129875836|NCT01498822|467504162|FG001|Overall Study|Protocol Violation|4|||
129875837|NCT01498822|467504161|FG000|Overall Study|Other Reason|5|||
129875838|NCT01498822|467504162|FG001|Overall Study|Other Reason|2|||
129875839|NCT01498822|467504161|FG000|Overall Study|Lack of Efficacy|7|||
129875840|NCT01498822|467504162|FG001|Overall Study|Lack of Efficacy|2|||
129875841|NCT01498822|467504161|FG000|Overall Study|AE, non-serious non-fatal|8|||
129875842|NCT01498822|467504162|FG001|Overall Study|AE, non-serious non-fatal|17|||
129875843|NCT01498822|467504161|FG000|Overall Study|SAE, non-fatal|2|||
129875844|NCT01498822|467504162|FG001|Overall Study|SAE, non-fatal|2|||
129875845|NCT01498822|467504161|FG000|Overall Study|Adverse Event, serious fatal|1|||
129875846|NCT01498822|467504162|FG001|Overall Study|Adverse Event, serious fatal|1|||
129875847|NCT01498822|467504161|FG000|Overall Study|Withdrawal by Subject|15|||
129875848|NCT01498822|467504162|FG001|Overall Study|Withdrawal by Subject|25|||
129875849|NCT01498822|467504161|FG000|Overall Study|Lost to Follow-up|8|||
129875850|NCT01498822|467504162|FG001|Overall Study|Lost to Follow-up|3|||
129875851|NCT01674621|467504163|FG000|Overall Study|Adverse Event|3|||
129875852|NCT01674621|467504164|FG001|Overall Study|Adverse Event|2|||
129651708|NCT01358578|466681667|FG001|Induction Period|Withdrawal by Subject|5|||
129875853|NCT01674621|467504165|FG002|Overall Study|Adverse Event|5|||
129875854|NCT01674621|467504166|FG003|Overall Study|Adverse Event|5|||
129875855|NCT01674621|467504167|FG004|Overall Study|Adverse Event|1|||
129875856|NCT01674621|467504163|FG000|Overall Study|Inability to Complete Study Procedures|0|||
129875857|NCT01674621|467504164|FG001|Overall Study|Inability to Complete Study Procedures|0|||
129875858|NCT01674621|467504165|FG002|Overall Study|Inability to Complete Study Procedures|0|||
129875859|NCT01674621|467504166|FG003|Overall Study|Inability to Complete Study Procedures|0|||
129875860|NCT01674621|467504167|FG004|Overall Study|Inability to Complete Study Procedures|2|||
129875861|NCT01674621|467504163|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129651709|NCT01358578|466681668|FG002|Induction Period|Withdrawal by Subject|10|||
129651710|NCT01358578|466681669|FG003|Induction Period|Withdrawal by Subject|6|||
129651711|NCT01358578|466681670|FG004|Induction Period|Withdrawal by Subject|0|||
129875862|NCT01674621|467504164|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129875863|NCT01674621|467504165|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129875864|NCT01674621|467504166|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
129875865|NCT01674621|467504167|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
129875866|NCT01674621|467504163|FG000|Overall Study|Withdrawal by Subject|2|||
129875867|NCT01674621|467504164|FG001|Overall Study|Withdrawal by Subject|5|||
129875868|NCT01674621|467504165|FG002|Overall Study|Withdrawal by Subject|2|||
129875869|NCT01674621|467504166|FG003|Overall Study|Withdrawal by Subject|0|||
129875870|NCT01674621|467504167|FG004|Overall Study|Withdrawal by Subject|1|||
129875871|NCT01674621|467504163|FG000|Overall Study|Other than specified|0|||
129875872|NCT01674621|467504164|FG001|Overall Study|Other than specified|1|||
129875873|NCT01674621|467504165|FG002|Overall Study|Other than specified|0|||
129875874|NCT01674621|467504166|FG003|Overall Study|Other than specified|0|||
129875875|NCT01674621|467504167|FG004|Overall Study|Other than specified|2|||
129875876|NCT01148862|467504170|FG000|Second Intervention|Withdrawal by Subject|0|||
129875877|NCT01148862|467504171|FG001|Second Intervention|Withdrawal by Subject|2|||
129875878|NCT01597505|467504175|FG000|Overall Study|Physician Decision|5|||
129875879|NCT01597505|467504176|FG001|Overall Study|Physician Decision|0|||
129875880|NCT01597505|467504175|FG000|Overall Study|Adverse Event|19|||
129875881|NCT01597505|467504176|FG001|Overall Study|Adverse Event|7|||
129875882|NCT01597505|467504175|FG000|Overall Study|Lost to Follow-up|4|||
129875883|NCT01597505|467504176|FG001|Overall Study|Lost to Follow-up|2|||
129875884|NCT01597505|467504175|FG000|Overall Study|Withdrawal by Subject|10|||
129875885|NCT01597505|467504176|FG001|Overall Study|Withdrawal by Subject|18|||
129875886|NCT01597505|467504175|FG000|Overall Study|Other|5|||
129875887|NCT01597505|467504176|FG001|Overall Study|Other|6|||
129875888|NCT01597505|467504175|FG000|Overall Study|Missing|1|||
129875889|NCT01597505|467504176|FG001|Overall Study|Missing|0|||
129875890|NCT05454410|467504177|FG000|Overall Study|Withdrawal by Subject|0|||
129875891|NCT05454410|467504178|FG001|Overall Study|Withdrawal by Subject|0|||
129875892|NCT05454410|467504179|FG002|Overall Study|Withdrawal by Subject|1|||
129875893|NCT05454410|467504180|FG003|Overall Study|Withdrawal by Subject|1|||
129875894|NCT05004688|467504191|FG000|Overall Study|Protocol Violation|7|||
129875895|NCT05004688|467504191|FG000|Overall Study|Physician Decision|2|||
129875896|NCT05004688|467504191|FG000|Overall Study|Withdrawal by Subject|2|||
129875897|NCT00895622|467504192|FG000|Overall Study|Protocol Violation|5|||
129875898|NCT00895622|467504193|FG001|Overall Study|Protocol Violation|4|||
129875899|NCT00895622|467504194|FG002|Overall Study|Protocol Violation|4|||
129875900|NCT03724396|467504195|FG000|Overall Study|Lost to Follow-up|1|||
129875901|NCT03724396|467504196|FG001|Overall Study|Lost to Follow-up|1|||
129875902|NCT03724396|467504195|FG000|Overall Study|Withdrawal by Subject|1|||
129875903|NCT03724396|467504196|FG001|Overall Study|Withdrawal by Subject|0|||
129875904|NCT03879408|467504197|FG000|Overall Study|Lost to Follow-up|0|||
129875905|NCT03879408|467504198|FG001|Overall Study|Lost to Follow-up|3|||
129875906|NCT03879408|467504199|FG002|Overall Study|Lost to Follow-up|2|||
129875907|NCT03879408|467504200|FG003|Overall Study|Lost to Follow-up|1|||
129875908|NCT03879408|467504201|FG004|Overall Study|Lost to Follow-up|0|||
129875909|NCT03879408|467504197|FG000|Overall Study|Withdrawal by Subject|2|||
129875910|NCT03879408|467504198|FG001|Overall Study|Withdrawal by Subject|1|||
129875911|NCT03879408|467504199|FG002|Overall Study|Withdrawal by Subject|1|||
129875912|NCT03879408|467504200|FG003|Overall Study|Withdrawal by Subject|0|||
129875913|NCT03879408|467504201|FG004|Overall Study|Withdrawal by Subject|1|||
129875914|NCT01490125|467504202|FG000|Period I|Adverse Event|4|||
129875915|NCT01490125|467504203|FG001|Period I|Adverse Event|1|||
129875916|NCT01490125|467504204|FG002|Period I|Adverse Event|1|||
129875917|NCT01490125|467504205|FG003|Period I|Adverse Event|3|||
129875918|NCT01490125|467504206|FG004|Period I|Adverse Event|2|||
129875919|NCT01490125|467504207|FG005|Period I|Adverse Event|4|||
129875920|NCT01490125|467504202|FG000|Period I|Protocol Violation|1|||
129875921|NCT01490125|467504203|FG001|Period I|Protocol Violation|1|||
129875922|NCT01490125|467504204|FG002|Period I|Protocol Violation|1|||
129875923|NCT01490125|467504205|FG003|Period I|Protocol Violation|1|||
129875924|NCT01490125|467504206|FG004|Period I|Protocol Violation|0|||
129875925|NCT01490125|467504207|FG005|Period I|Protocol Violation|0|||
129875926|NCT01490125|467504202|FG000|Period I|Withdrawal by Subject|1|||
129875927|NCT01490125|467504203|FG001|Period I|Withdrawal by Subject|3|||
129875928|NCT01490125|467504204|FG002|Period I|Withdrawal by Subject|2|||
129875929|NCT01490125|467504205|FG003|Period I|Withdrawal by Subject|1|||
129875930|NCT01490125|467504206|FG004|Period I|Withdrawal by Subject|2|||
129875931|NCT01490125|467504207|FG005|Period I|Withdrawal by Subject|1|||
129875932|NCT01490125|467504202|FG000|Period II|Adverse Event|2|||
129875933|NCT01490125|467504203|FG001|Period II|Adverse Event|3|||
129875934|NCT01490125|467504204|FG002|Period II|Adverse Event|2|||
129875935|NCT01490125|467504205|FG003|Period II|Adverse Event|2|||
129875936|NCT01490125|467504206|FG004|Period II|Adverse Event|4|||
129875937|NCT01490125|467504207|FG005|Period II|Adverse Event|2|||
129875938|NCT01490125|467504202|FG000|Period II|Protocol Violation|0|||
129875939|NCT01490125|467504203|FG001|Period II|Protocol Violation|0|||
129875940|NCT01490125|467504204|FG002|Period II|Protocol Violation|1|||
129875941|NCT01490125|467504205|FG003|Period II|Protocol Violation|1|||
129875942|NCT01490125|467504206|FG004|Period II|Protocol Violation|0|||
129875943|NCT01490125|467504207|FG005|Period II|Protocol Violation|0|||
129875944|NCT01490125|467504202|FG000|Period II|Lost to Follow-up|0|||
129875945|NCT01490125|467504203|FG001|Period II|Lost to Follow-up|1|||
129875946|NCT01490125|467504204|FG002|Period II|Lost to Follow-up|0|||
129875947|NCT01490125|467504205|FG003|Period II|Lost to Follow-up|0|||
129875948|NCT01490125|467504206|FG004|Period II|Lost to Follow-up|0|||
129875949|NCT01490125|467504207|FG005|Period II|Lost to Follow-up|0|||
129875950|NCT01490125|467504202|FG000|Period II|Withdrawal by Subject|1|||
129875951|NCT01490125|467504203|FG001|Period II|Withdrawal by Subject|0|||
129875952|NCT01490125|467504204|FG002|Period II|Withdrawal by Subject|0|||
129875953|NCT01490125|467504205|FG003|Period II|Withdrawal by Subject|0|||
129875954|NCT01490125|467504206|FG004|Period II|Withdrawal by Subject|0|||
129875955|NCT01490125|467504207|FG005|Period II|Withdrawal by Subject|0|||
129875956|NCT01490125|467504202|FG000|Period III|Adverse Event|3|||
129875957|NCT01490125|467504203|FG001|Period III|Adverse Event|1|||
129875958|NCT01490125|467504204|FG002|Period III|Adverse Event|0|||
129875959|NCT01490125|467504205|FG003|Period III|Adverse Event|1|||
129875960|NCT01490125|467504206|FG004|Period III|Adverse Event|0|||
129875961|NCT01490125|467504207|FG005|Period III|Adverse Event|0|||
129875962|NCT01490125|467504202|FG000|Period III|Death|0|||
129875963|NCT01490125|467504203|FG001|Period III|Death|0|||
129875964|NCT01490125|467504204|FG002|Period III|Death|0|||
129875965|NCT01490125|467504205|FG003|Period III|Death|1|||
129875966|NCT01490125|467504206|FG004|Period III|Death|0|||
129875967|NCT01490125|467504207|FG005|Period III|Death|0|||
129875968|NCT01490125|467504202|FG000|Period III|Lack of Efficacy|0|||
129875969|NCT01490125|467504203|FG001|Period III|Lack of Efficacy|0|||
129875970|NCT01490125|467504204|FG002|Period III|Lack of Efficacy|0|||
129875971|NCT01490125|467504205|FG003|Period III|Lack of Efficacy|0|||
129875972|NCT01490125|467504206|FG004|Period III|Lack of Efficacy|1|||
129875973|NCT01490125|467504207|FG005|Period III|Lack of Efficacy|0|||
129875974|NCT02237508|467504209|FG000|Overall Study|Withdrawal by Subject|0|||
129875975|NCT02237508|467504210|FG001|Overall Study|Withdrawal by Subject|2|||
129875976|NCT02237508|467504211|FG002|Overall Study|Withdrawal by Subject|0|||
129875977|NCT02237508|467504212|FG003|Overall Study|Withdrawal by Subject|1|||
129875978|NCT02237508|467504213|FG004|Overall Study|Withdrawal by Subject|0|||
129875979|NCT02237508|467504214|FG005|Overall Study|Withdrawal by Subject|1|||
129875980|NCT02237508|467504215|FG006|Overall Study|Withdrawal by Subject|1|||
129875981|NCT02237508|467504216|FG007|Overall Study|Withdrawal by Subject|0|||
129875982|NCT02237508|467504217|FG008|Overall Study|Withdrawal by Subject|1|||
129875983|NCT02237508|467504218|FG009|Overall Study|Withdrawal by Subject|0|||
129875984|NCT02237508|467504209|FG000|Overall Study|Physician Decision|0|||
129875985|NCT02237508|467504210|FG001|Overall Study|Physician Decision|1|||
129875986|NCT02237508|467504211|FG002|Overall Study|Physician Decision|0|||
129875987|NCT02237508|467504212|FG003|Overall Study|Physician Decision|0|||
129875988|NCT02237508|467504213|FG004|Overall Study|Physician Decision|0|||
129875989|NCT02237508|467504214|FG005|Overall Study|Physician Decision|0|||
129875990|NCT02237508|467504215|FG006|Overall Study|Physician Decision|0|||
129875991|NCT02237508|467504216|FG007|Overall Study|Physician Decision|0|||
129875992|NCT02237508|467504217|FG008|Overall Study|Physician Decision|0|||
129875993|NCT02237508|467504218|FG009|Overall Study|Physician Decision|0|||
129875994|NCT02237508|467504209|FG000|Overall Study|Protocol Violation|0|||
129875995|NCT02237508|467504210|FG001|Overall Study|Protocol Violation|0|||
129875996|NCT02237508|467504211|FG002|Overall Study|Protocol Violation|1|||
129875997|NCT02237508|467504212|FG003|Overall Study|Protocol Violation|0|||
129875998|NCT02237508|467504213|FG004|Overall Study|Protocol Violation|0|||
129875999|NCT02237508|467504214|FG005|Overall Study|Protocol Violation|0|||
129876000|NCT02237508|467504215|FG006|Overall Study|Protocol Violation|0|||
129876001|NCT02237508|467504216|FG007|Overall Study|Protocol Violation|0|||
129876002|NCT02237508|467504217|FG008|Overall Study|Protocol Violation|0|||
129876003|NCT02237508|467504218|FG009|Overall Study|Protocol Violation|0|||
129876004|NCT04000594|467504219|FG000|Overall Study|Withdrawal by Subject|1|||
129876005|NCT04000594|467504220|FG001|Overall Study|Withdrawal by Subject|0|||
129876006|NCT04000594|467504221|FG002|Overall Study|Withdrawal by Subject|0|||
129876007|NCT04522180|467504222|FG000|Overall Study|Investigator judgement|3|||
129876008|NCT04522180|467504223|FG001|Overall Study|Investigator judgement|4|||
129876009|NCT04522180|467504222|FG000|Overall Study|Voluntary withdrawal|1|||
129876010|NCT04522180|467504223|FG001|Overall Study|Voluntary withdrawal|0|||
129876011|NCT04522180|467504222|FG000|Overall Study|Pregnancy|0|||
129876012|NCT04522180|467504223|FG001|Overall Study|Pregnancy|1|||
129876013|NCT04522180|467504222|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
129876014|NCT04522180|467504223|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
129876015|NCT04522180|467504222|FG000|Overall Study|Reason not specified|8|||
129876016|NCT04522180|467504223|FG001|Overall Study|Reason not specified|5|||
129876017|NCT05807919|467504224|FG000|Overall Study|Received antibiotics - excluded|0|||
129876018|NCT05807919|467504225|FG001|Overall Study|Received antibiotics - excluded|1|||
129876019|NCT05807919|467504224|FG000|Overall Study|Withdrawal by Subject|0|||
129876020|NCT05807919|467504225|FG001|Overall Study|Withdrawal by Subject|3|||
129876021|NCT05807919|467504224|FG000|Overall Study|Adverse Event|1|||
129876022|NCT05807919|467504225|FG001|Overall Study|Adverse Event|1|||
129876023|NCT01905046|467504226|FG000|Months 13-24|Withdrawal by Subject|10|||
129876024|NCT01905046|467504227|FG001|Months 13-24|Withdrawal by Subject|10|||
129876025|NCT01905046|467504226|FG000|Months 13-24|Adverse Event|3|||
129876026|NCT01905046|467504227|FG001|Months 13-24|Adverse Event|2|||
129876027|NCT01905046|467504226|FG000|Months 13-24|Protocol Violation|3|||
129876028|NCT01905046|467504227|FG001|Months 13-24|Protocol Violation|3|||
129876029|NCT01905046|467504226|FG000|Months 13-24|Physician Decision|1|||
129876030|NCT01905046|467504227|FG001|Months 13-24|Physician Decision|0|||
129876031|NCT03489057|467504232|FG000|Overall Study|Lost to Follow-up|16|||
129876032|NCT03489057|467504233|FG001|Overall Study|Lost to Follow-up|16|||
129876033|NCT03489057|467504234|FG002|Overall Study|Lost to Follow-up|14|||
129876034|NCT03489057|467504235|FG003|Overall Study|Lost to Follow-up|14|||
129876035|NCT03489057|467504232|FG000|Overall Study|Withdrawal by Subject|12|||
129876036|NCT03489057|467504233|FG001|Overall Study|Withdrawal by Subject|12|||
129876037|NCT03489057|467504234|FG002|Overall Study|Withdrawal by Subject|8|||
129876038|NCT03489057|467504235|FG003|Overall Study|Withdrawal by Subject|8|||
129876039|NCT03489057|467504232|FG000|Overall Study|Protocol Violation|7|||
129876040|NCT03489057|467504233|FG001|Overall Study|Protocol Violation|7|||
129876041|NCT03489057|467504234|FG002|Overall Study|Protocol Violation|2|||
129876042|NCT03489057|467504235|FG003|Overall Study|Protocol Violation|2|||
129876043|NCT01368900|467504238|FG000|Overall Study|Lost to Follow-up|7|||
129876044|NCT04027348|467504241|FG000|Overall Study|Adverse Event|2|||
129876045|NCT02487472|467504242|FG000|Overall Study|Did not complete telephonic interviews|9|||
129876046|NCT02487472|467504242|FG000|Overall Study|Other|2|||
129876047|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
129876048|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
129876049|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
129876050|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
129876051|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
129876052|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
129876053|NCT02034708|467504245|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
129876054|NCT02034708|467504246|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
129876055|NCT01552954|467504247|FG000|Overall Study|Adverse Event|1|||
129876056|NCT01552954|467504248|FG001|Overall Study|Adverse Event|2|||
129876057|NCT01552954|467504247|FG000|Overall Study|Lost to Follow-up|1|||
129876058|NCT01552954|467504248|FG001|Overall Study|Lost to Follow-up|1|||
129876059|NCT01552954|467504247|FG000|Overall Study|Withdrawal by Subject|1|||
129876060|NCT01552954|467504248|FG001|Overall Study|Withdrawal by Subject|1|||
129876061|NCT01552954|467504247|FG000|Overall Study|Protocol Violation|1|||
129876062|NCT01552954|467504248|FG001|Overall Study|Protocol Violation|2|||
129876063|NCT01552954|467504247|FG000|Overall Study|diagnosed DM|1|||
129876064|NCT01552954|467504248|FG001|Overall Study|diagnosed DM|0|||
129876065|NCT04843930|467504249|FG000|Randomization|Withdrawal by Subject|6|||
129876066|NCT04843930|467504250|FG001|Randomization|Withdrawal by Subject|6|||
129876067|NCT04843930|467504251|FG002|Randomization|Withdrawal by Subject|0|||
129876068|NCT04843930|467504252|FG003|Randomization|Withdrawal by Subject|0|||
129876069|NCT04843930|467504249|FG000|Week 6 Assessment|Adverse Event|3|||
129876070|NCT04843930|467504250|FG001|Week 6 Assessment|Adverse Event|0|||
129876071|NCT04843930|467504251|FG002|Week 6 Assessment|Adverse Event|0|||
129876072|NCT04843930|467504252|FG003|Week 6 Assessment|Adverse Event|0|||
129876073|NCT04843930|467504249|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
129876074|NCT04843930|467504250|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
129876075|NCT04843930|467504251|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
129876076|NCT04843930|467504252|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
129876077|NCT04843930|467504249|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
129876078|NCT04843930|467504250|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
129876079|NCT04843930|467504251|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
129876080|NCT04843930|467504252|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
129876081|NCT01931735|467504253|FG000|Randomized Phase|Lost to Follow-up|2|||
129876082|NCT01931735|467504254|FG001|Randomized Phase|Lost to Follow-up|2|||
129876083|NCT01931735|467504255|FG002|Randomized Phase|Lost to Follow-up|5|||
129876084|NCT01931735|467504256|FG003|Randomized Phase|Lost to Follow-up|0|||
129876085|NCT01931735|467504253|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
129876086|NCT01931735|467504254|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
129876087|NCT01931735|467504255|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
129876088|NCT01931735|467504256|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
129876089|NCT01931735|467504253|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
129876090|NCT01931735|467504254|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
129876091|NCT01931735|467504255|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
129876092|NCT01931735|467504256|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
129876093|NCT02719990|467504257|FG000|Overall Study|Physician Decision|2|||
129876094|NCT02719990|467504257|FG000|Overall Study|Withdrawal by Subject|2|||
129876095|NCT02719990|467504257|FG000|Overall Study|Study Terminated By Sponsor|32|||
129876096|NCT01833143|467504261|FG000|Overall Study|Not Treated|1|||
129876097|NCT03995784|467504262|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
129876098|NCT00369681|467506391|FG000|Overall Study|Death|1|||
129876099|NCT02991482|467506392|FG000|Overall Study|Disease progression|56|||
129876100|NCT02991482|467506393|FG001|Overall Study|Disease progression|47|||
129876101|NCT02991482|467506392|FG000|Overall Study|Death|4|||
129876102|NCT02991482|467506393|FG001|Overall Study|Death|4|||
129876103|NCT02991482|467506392|FG000|Overall Study|Adverse Event|1|||
129876104|NCT02991482|467506393|FG001|Overall Study|Adverse Event|6|||
129876105|NCT02991482|467506392|FG000|Overall Study|Patient decision|1|||
129876106|NCT02991482|467506393|FG001|Overall Study|Patient decision|1|||
129876107|NCT02991482|467506392|FG000|Overall Study|Physician Decision|0|||
129876108|NCT02991482|467506393|FG001|Overall Study|Physician Decision|6|||
129876109|NCT02991482|467506392|FG000|Overall Study|Clinical deterioration|1|||
129876110|NCT02991482|467506393|FG001|Overall Study|Clinical deterioration|0|||
129876111|NCT02991482|467506392|FG000|Overall Study|Patient feeling too unwell|1|||
129876112|NCT02991482|467506393|FG001|Overall Study|Patient feeling too unwell|0|||
129876113|NCT02991482|467506392|FG000|Overall Study|Worsening of performance status|0|||
129876114|NCT02991482|467506393|FG001|Overall Study|Worsening of performance status|1|||
129876115|NCT02991482|467506392|FG000|Overall Study|Death prior to study drug initiation|1|||
129876116|NCT02991482|467506393|FG001|Overall Study|Death prior to study drug initiation|0|||
129876117|NCT02991482|467506392|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
129876118|NCT02991482|467506393|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
129876119|NCT02396537|467506400|FG000|Overall Study|Protocol Violation|0|||
129876120|NCT02396537|467506401|FG001|Overall Study|Protocol Violation|1|||
129876121|NCT00871403|467506402|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
129876122|NCT00871403|467506403|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
129876123|NCT00871403|467506404|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
129876124|NCT00871403|467506402|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
129876125|NCT00871403|467506403|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
129876126|NCT00871403|467506404|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
129876127|NCT00871403|467506402|FG000|Combination Treatment Phase|Adverse Event|0|||
129876128|NCT00871403|467506403|FG001|Combination Treatment Phase|Adverse Event|17|||
129876129|NCT00871403|467506404|FG002|Combination Treatment Phase|Adverse Event|2|||
129876130|NCT00871403|467506402|FG000|Combination Treatment Phase|Disease Progression|0|||
129876131|NCT00871403|467506403|FG001|Combination Treatment Phase|Disease Progression|8|||
129876132|NCT00871403|467506404|FG002|Combination Treatment Phase|Disease Progression|5|||
129876133|NCT00871403|467506402|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
129876134|NCT00871403|467506403|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
129876135|NCT00871403|467506404|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
129876136|NCT00871403|467506402|FG000|Combination Treatment Phase|Physician Decision|0|||
129876137|NCT00871403|467506403|FG001|Combination Treatment Phase|Physician Decision|1|||
129876138|NCT00871403|467506404|FG002|Combination Treatment Phase|Physician Decision|3|||
129876139|NCT00871403|467506402|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
129876140|NCT00871403|467506403|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
129876141|NCT00871403|467506404|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
129876142|NCT00871403|467506402|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
129876143|NCT00871403|467506403|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
129876144|NCT00871403|467506404|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
129876145|NCT04887948|467506405|FG000|Overall Study|Death|1|||
129876146|NCT04887948|467506406|FG001|Overall Study|Death|0|||
129876147|NCT04887948|467506407|FG002|Overall Study|Death|0|||
129876148|NCT04887948|467506405|FG000|Overall Study|Lost to Follow-up|1|||
129876149|NCT04887948|467506406|FG001|Overall Study|Lost to Follow-up|0|||
129876150|NCT04887948|467506407|FG002|Overall Study|Lost to Follow-up|3|||
129876151|NCT04887948|467506405|FG000|Overall Study|Physician Decision|0|||
129876152|NCT04887948|467506406|FG001|Overall Study|Physician Decision|4|||
129876153|NCT04887948|467506407|FG002|Overall Study|Physician Decision|1|||
129876154|NCT04887948|467506405|FG000|Overall Study|Protocol Violation|1|||
129876155|NCT04887948|467506406|FG001|Overall Study|Protocol Violation|1|||
129876156|NCT04887948|467506407|FG002|Overall Study|Protocol Violation|0|||
129876157|NCT04887948|467506405|FG000|Overall Study|Withdrawal by Subject|0|||
129876158|NCT04887948|467506406|FG001|Overall Study|Withdrawal by Subject|6|||
129876159|NCT04887948|467506407|FG002|Overall Study|Withdrawal by Subject|1|||
129876160|NCT04887948|467506405|FG000|Overall Study|No longer met eligibility criteria|1|||
129876161|NCT04887948|467506406|FG001|Overall Study|No longer met eligibility criteria|2|||
129876162|NCT04887948|467506407|FG002|Overall Study|No longer met eligibility criteria|1|||
129876163|NCT04887948|467506405|FG000|Overall Study|Other|2|||
129876164|NCT04887948|467506406|FG001|Overall Study|Other|1|||
129876165|NCT04887948|467506407|FG002|Overall Study|Other|1|||
129876166|NCT00787319|467506411|FG000|Overall Study|Lost to Follow-up|2|||
129876167|NCT00787319|467506411|FG000|Overall Study|Withdrawal by Subject|15|||
129876168|NCT00787319|467506411|FG000|Overall Study|Adverse Event|3|||
129876169|NCT00787319|467506411|FG000|Overall Study|Objective progression or relapse|30|||
129876170|NCT00787319|467506411|FG000|Overall Study|Lack of Efficacy|1|||
129876171|NCT00787319|467506411|FG000|Overall Study|Budget exhausted/exceeded|1|||
129876172|NCT00787319|467506411|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
129876173|NCT00787319|467506411|FG000|Overall Study|No health insurance reimbursement|2|||
129876174|NCT00787319|467506411|FG000|Overall Study|Stabilized disease findings|3|||
129876175|NCT00787319|467506411|FG000|Overall Study|Inactive disease|5|||
129876176|NCT01932294|467506412|FG000|Overall Study|Death|43|||
129876177|NCT01932294|467506412|FG000|Overall Study|Lost to Follow-up|8|||
129876178|NCT01932294|467506412|FG000|Overall Study|VAD Implantation|20|||
129876179|NCT01932294|467506412|FG000|Overall Study|Heart Transplantation|16|||
129876180|NCT01932294|467506412|FG000|Overall Study|Transferred to other hospitals|12|||
129876181|NCT04415151|467506413|FG000|Overall Study|Death|1|||
129876182|NCT04415151|467506414|FG001|Overall Study|Death|1|||
129876183|NCT04415151|467506413|FG000|Overall Study|Withdrawal by Subject|1|||
129651712|NCT01358578|466681671|FG005|Induction Period|Withdrawal by Subject|0|||
129651713|NCT01358578|466681666|FG000|Maintenance Period|Adverse Event|2|||
129651714|NCT01358578|466681667|FG001|Maintenance Period|Adverse Event|7|||
129651715|NCT01358578|466681668|FG002|Maintenance Period|Adverse Event|0|||
129651716|NCT01358578|466681669|FG003|Maintenance Period|Adverse Event|6|||
129651717|NCT01358578|466681670|FG004|Maintenance Period|Adverse Event|4|||
129651718|NCT01358578|466681671|FG005|Maintenance Period|Adverse Event|3|||
129651719|NCT01358578|466681666|FG000|Maintenance Period|Lack of Efficacy|10|||
129651720|NCT01358578|466681667|FG001|Maintenance Period|Lack of Efficacy|2|||
129651721|NCT01358578|466681668|FG002|Maintenance Period|Lack of Efficacy|0|||
129651722|NCT01358578|466681669|FG003|Maintenance Period|Lack of Efficacy|11|||
129651723|NCT01358578|466681670|FG004|Maintenance Period|Lack of Efficacy|3|||
129651724|NCT01358578|466681671|FG005|Maintenance Period|Lack of Efficacy|0|||
129651725|NCT01358578|466681666|FG000|Maintenance Period|Lost to Follow-up|4|||
129651726|NCT01358578|466681667|FG001|Maintenance Period|Lost to Follow-up|0|||
129651727|NCT01358578|466681668|FG002|Maintenance Period|Lost to Follow-up|0|||
129651728|NCT01358578|466681669|FG003|Maintenance Period|Lost to Follow-up|5|||
129651729|NCT01358578|466681670|FG004|Maintenance Period|Lost to Follow-up|1|||
129651730|NCT01358578|466681671|FG005|Maintenance Period|Lost to Follow-up|1|||
129651731|NCT01358578|466681666|FG000|Maintenance Period|Non-compliance with study treatment|3|||
129651732|NCT01358578|466681667|FG001|Maintenance Period|Non-compliance with study treatment|1|||
129651733|NCT01358578|466681668|FG002|Maintenance Period|Non-compliance with study treatment|0|||
129651734|NCT01358578|466681669|FG003|Maintenance Period|Non-compliance with study treatment|2|||
129651735|NCT01358578|466681670|FG004|Maintenance Period|Non-compliance with study treatment|1|||
129651736|NCT01358578|466681671|FG005|Maintenance Period|Non-compliance with study treatment|2|||
129651737|NCT01358578|466681666|FG000|Maintenance Period|Physician Decision|0|||
129651738|NCT01358578|466681667|FG001|Maintenance Period|Physician Decision|1|||
129651739|NCT01358578|466681668|FG002|Maintenance Period|Physician Decision|0|||
129651740|NCT01358578|466681669|FG003|Maintenance Period|Physician Decision|1|||
129651741|NCT01358578|466681670|FG004|Maintenance Period|Physician Decision|0|||
129651742|NCT01358578|466681671|FG005|Maintenance Period|Physician Decision|0|||
129651743|NCT01358578|466681666|FG000|Maintenance Period|Pregnancy|1|||
129651744|NCT01358578|466681667|FG001|Maintenance Period|Pregnancy|0|||
129651745|NCT01358578|466681668|FG002|Maintenance Period|Pregnancy|0|||
129651746|NCT01358578|466681669|FG003|Maintenance Period|Pregnancy|0|||
129651747|NCT01358578|466681670|FG004|Maintenance Period|Pregnancy|0|||
129651748|NCT01358578|466681671|FG005|Maintenance Period|Pregnancy|0|||
129651749|NCT01358578|466681666|FG000|Maintenance Period|Protocol deviation|7|||
129651750|NCT01358578|466681667|FG001|Maintenance Period|Protocol deviation|4|||
129651751|NCT01358578|466681668|FG002|Maintenance Period|Protocol deviation|0|||
129651752|NCT01358578|466681669|FG003|Maintenance Period|Protocol deviation|2|||
129876184|NCT04415151|467506414|FG001|Overall Study|Withdrawal by Subject|0|||
129876185|NCT00638235|467506420|FG000|Overall Study|Lost to Follow-up|31|||
129876186|NCT00638235|467506421|FG001|Overall Study|Lost to Follow-up|3|||
129876187|NCT00638235|467506422|FG002|Overall Study|Lost to Follow-up|18|||
129651753|NCT01358578|466681670|FG004|Maintenance Period|Protocol deviation|2|||
129651754|NCT01358578|466681671|FG005|Maintenance Period|Protocol deviation|2|||
129651755|NCT01358578|466681666|FG000|Maintenance Period|Withdrawal by Subject|12|||
129651756|NCT01358578|466681667|FG001|Maintenance Period|Withdrawal by Subject|7|||
129651757|NCT01358578|466681668|FG002|Maintenance Period|Withdrawal by Subject|2|||
129651758|NCT01358578|466681669|FG003|Maintenance Period|Withdrawal by Subject|15|||
129651759|NCT01358578|466681670|FG004|Maintenance Period|Withdrawal by Subject|6|||
129651760|NCT01358578|466681671|FG005|Maintenance Period|Withdrawal by Subject|3|||
129651761|NCT01358578|466681666|FG000|Follow-up Period|Adverse Event|1|||
129651762|NCT01358578|466681667|FG001|Follow-up Period|Adverse Event|1|||
129651763|NCT01358578|466681668|FG002|Follow-up Period|Adverse Event|0|||
129651764|NCT01358578|466681669|FG003|Follow-up Period|Adverse Event|0|||
129651765|NCT01358578|466681670|FG004|Follow-up Period|Adverse Event|0|||
129651766|NCT01358578|466681671|FG005|Follow-up Period|Adverse Event|0|||
129651767|NCT01358578|466681666|FG000|Follow-up Period|Lack of Efficacy|3|||
129651768|NCT01358578|466681667|FG001|Follow-up Period|Lack of Efficacy|0|||
129651769|NCT01358578|466681668|FG002|Follow-up Period|Lack of Efficacy|4|||
129651770|NCT01358578|466681669|FG003|Follow-up Period|Lack of Efficacy|1|||
129651771|NCT01358578|466681670|FG004|Follow-up Period|Lack of Efficacy|0|||
129876188|NCT00638235|467506423|FG003|Overall Study|Lost to Follow-up|10|||
129876189|NCT00638235|467506424|FG004|Overall Study|Lost to Follow-up|13|||
129876190|NCT00638235|467506425|FG005|Overall Study|Lost to Follow-up|26|||
129876191|NCT00638235|467506426|FG006|Overall Study|Lost to Follow-up|0|||
129876192|NCT00638235|467506427|FG007|Overall Study|Lost to Follow-up|1|||
129651772|NCT01358578|466681671|FG005|Follow-up Period|Lack of Efficacy|0|||
129651773|NCT01358578|466681666|FG000|Follow-up Period|Lost to Follow-up|0|||
129651774|NCT01358578|466681667|FG001|Follow-up Period|Lost to Follow-up|1|||
129651775|NCT01358578|466681668|FG002|Follow-up Period|Lost to Follow-up|0|||
129651776|NCT01358578|466681669|FG003|Follow-up Period|Lost to Follow-up|4|||
129651777|NCT01358578|466681670|FG004|Follow-up Period|Lost to Follow-up|0|||
129651778|NCT01358578|466681671|FG005|Follow-up Period|Lost to Follow-up|0|||
129876193|NCT00638235|467506428|FG008|Overall Study|Lost to Follow-up|18|||
129876194|NCT03505476|467506431|FG000|Overall Study|Physician Decision|18|||
129876195|NCT03505476|467506431|FG000|Overall Study|Device Malfunctioned|101|||
129876196|NCT03505476|467506431|FG000|Overall Study|Data Corrupt|6|||
129876197|NCT03505476|467506431|FG000|Overall Study|Device application insufficiant|3|||
129876198|NCT00659984|467506436|FG000|Overall Study|Adverse Event|1|||
129876199|NCT02228395|467506437|FG000|First Intervention Period|No longer willing to participate|1|||
129876200|NCT02228395|467506438|FG001|First Intervention Period|No longer willing to participate|0|||
129876201|NCT02228395|467506439|FG002|First Intervention Period|No longer willing to participate|0|||
129876202|NCT02228395|467506437|FG000|First Intervention Period|Unable to comply with study dates|0|||
129876203|NCT02228395|467506438|FG001|First Intervention Period|Unable to comply with study dates|1|||
129876204|NCT02228395|467506439|FG002|First Intervention Period|Unable to comply with study dates|1|||
129876205|NCT02569437|467506442|FG000|Overall Study|Lost to Follow-up|12|||
129876206|NCT02569437|467506443|FG001|Overall Study|Lost to Follow-up|14|||
129876207|NCT00985985|467506444|FG000|Overall Study|Adverse Event|4|||
129876208|NCT00985985|467506445|FG001|Overall Study|Adverse Event|2|||
129876209|NCT00985985|467506446|FG002|Overall Study|Adverse Event|2|||
129876210|NCT00985985|467506447|FG003|Overall Study|Adverse Event|2|||
129876211|NCT00985985|467506444|FG000|Overall Study|Lost to Follow-up|4|||
129876212|NCT00985985|467506445|FG001|Overall Study|Lost to Follow-up|11|||
129876213|NCT00985985|467506446|FG002|Overall Study|Lost to Follow-up|2|||
129876214|NCT00985985|467506447|FG003|Overall Study|Lost to Follow-up|3|||
129876215|NCT00985985|467506444|FG000|Overall Study|Protocol Violation|1|||
129876216|NCT00985985|467506445|FG001|Overall Study|Protocol Violation|2|||
129876217|NCT00985985|467506446|FG002|Overall Study|Protocol Violation|0|||
129876218|NCT00985985|467506447|FG003|Overall Study|Protocol Violation|1|||
129876219|NCT00985985|467506444|FG000|Overall Study|Lack of Efficacy|5|||
129876220|NCT00985985|467506445|FG001|Overall Study|Lack of Efficacy|6|||
129876221|NCT00985985|467506446|FG002|Overall Study|Lack of Efficacy|1|||
129876222|NCT00985985|467506447|FG003|Overall Study|Lack of Efficacy|3|||
129876223|NCT00985985|467506444|FG000|Overall Study|Withdrawal by Subject|4|||
129876224|NCT00985985|467506445|FG001|Overall Study|Withdrawal by Subject|2|||
129876225|NCT00985985|467506446|FG002|Overall Study|Withdrawal by Subject|2|||
129876226|NCT00985985|467506447|FG003|Overall Study|Withdrawal by Subject|2|||
129876227|NCT00985985|467506444|FG000|Overall Study|Other Reason|6|||
129876228|NCT00985985|467506445|FG001|Overall Study|Other Reason|1|||
129876229|NCT00985985|467506446|FG002|Overall Study|Other Reason|4|||
129876230|NCT00985985|467506447|FG003|Overall Study|Other Reason|2|||
129876231|NCT03587142|467506448|FG000|Overall Study|Lost to Follow-up|5|||
129876232|NCT03587142|467506449|FG001|Overall Study|Lost to Follow-up|3|||
129876233|NCT03587142|467506448|FG000|Overall Study|Did not complete the f4 visit|3|||
129876234|NCT03587142|467506449|FG001|Overall Study|Did not complete the f4 visit|7|||
129876235|NCT00708435|467506450|FG000|Overall Study|Death / Serious Adverse Event|10|||
129876236|NCT00708435|467506451|FG001|Overall Study|Death / Serious Adverse Event|5|||
129876237|NCT00708435|467506450|FG000|Overall Study|Lost to Follow-up|9|||
129876238|NCT00708435|467506451|FG001|Overall Study|Lost to Follow-up|4|||
129876239|NCT00708435|467506450|FG000|Overall Study|Withdrawal by Subject|3|||
129876240|NCT00708435|467506451|FG001|Overall Study|Withdrawal by Subject|7|||
129876241|NCT00708435|467506450|FG000|Overall Study|Adverse Event|1|||
129876242|NCT00708435|467506451|FG001|Overall Study|Adverse Event|0|||
129876243|NCT00708435|467506450|FG000|Overall Study|Protocol Violation|0|||
129876244|NCT00708435|467506451|FG001|Overall Study|Protocol Violation|1|||
129876245|NCT00708435|467506450|FG000|Overall Study|Intervention by primary care physician|1|||
129876246|NCT00708435|467506451|FG001|Overall Study|Intervention by primary care physician|0|||
129876247|NCT00708435|467506450|FG000|Overall Study|Refused hospitalization|1|||
129876248|NCT00708435|467506451|FG001|Overall Study|Refused hospitalization|0|||
129876249|NCT01691521|467506452|FG000|Overall Study|Adverse Event|4|||
129876250|NCT01691521|467506453|FG001|Overall Study|Adverse Event|0|||
129876251|NCT01691521|467506454|FG002|Overall Study|Adverse Event|1|||
129876252|NCT01691521|467506452|FG000|Overall Study|Lack of Efficacy|1|||
129876253|NCT01691521|467506453|FG001|Overall Study|Lack of Efficacy|1|||
129876254|NCT01691521|467506454|FG002|Overall Study|Lack of Efficacy|2|||
129876255|NCT01691521|467506452|FG000|Overall Study|Protocol Violation|0|||
129876256|NCT01691521|467506453|FG001|Overall Study|Protocol Violation|3|||
129876257|NCT01691521|467506454|FG002|Overall Study|Protocol Violation|0|||
129876258|NCT01691521|467506452|FG000|Overall Study|Lost to Follow-up|0|||
129876259|NCT01691521|467506453|FG001|Overall Study|Lost to Follow-up|2|||
129876260|NCT01691521|467506454|FG002|Overall Study|Lost to Follow-up|2|||
129876261|NCT01691521|467506452|FG000|Overall Study|Physician Decision|2|||
129876262|NCT01691521|467506453|FG001|Overall Study|Physician Decision|1|||
129876263|NCT01691521|467506454|FG002|Overall Study|Physician Decision|0|||
129876264|NCT01691521|467506452|FG000|Overall Study|Withdrawal by Subject|5|||
129876265|NCT01691521|467506453|FG001|Overall Study|Withdrawal by Subject|9|||
129876266|NCT01691521|467506454|FG002|Overall Study|Withdrawal by Subject|4|||
129876267|NCT00312702|467506458|FG000|Immunization Phase|Lost to Follow-up|0|||
129876268|NCT00312702|467506459|FG001|Immunization Phase|Lost to Follow-up|1|||
129876269|NCT00312702|467506460|FG002|Immunization Phase|Lost to Follow-up|0|||
129876270|NCT00770432|467506461|FG000|Overall Study|Other|4|||
129876271|NCT00770432|467506462|FG001|Overall Study|Other|6|||
129876272|NCT00770432|467506461|FG000|Overall Study|Non-compliance|0|||
129876273|NCT00770432|467506462|FG001|Overall Study|Non-compliance|1|||
129876274|NCT00988221|467506465|FG000|Part I|Adverse Event|0|||
129876275|NCT00988221|467506466|FG001|Part I|Adverse Event|1|||
129876276|NCT00988221|467506467|FG002|Part I|Adverse Event|2|||
129876277|NCT00988221|467506468|FG003|Part I|Adverse Event|0|||
129876278|NCT00988221|467506465|FG000|Part I|Insufficient Therapeutic Response|4|||
129876279|NCT00988221|467506466|FG001|Part I|Insufficient Therapeutic Response|6|||
129876280|NCT00988221|467506467|FG002|Part I|Insufficient Therapeutic Response|5|||
129876281|NCT00988221|467506468|FG003|Part I|Insufficient Therapeutic Response|0|||
129876282|NCT00988221|467506465|FG000|Part I|Refused Treatment|0|||
129876283|NCT00988221|467506466|FG001|Part I|Refused Treatment|2|||
129876284|NCT00988221|467506467|FG002|Part I|Refused Treatment|1|||
129876285|NCT00988221|467506468|FG003|Part I|Refused Treatment|0|||
129876286|NCT00988221|467506465|FG000|Part I|Lost to Follow-up|0|||
129876287|NCT00988221|467506466|FG001|Part I|Lost to Follow-up|1|||
129876288|NCT00988221|467506467|FG002|Part I|Lost to Follow-up|0|||
129876289|NCT00988221|467506468|FG003|Part I|Lost to Follow-up|0|||
129876290|NCT00988221|467506465|FG000|Part II|Adverse Event|1|||
129876291|NCT00988221|467506466|FG001|Part II|Adverse Event|0|||
129876292|NCT00988221|467506467|FG002|Part II|Adverse Event|0|||
129876293|NCT00988221|467506468|FG003|Part II|Adverse Event|1|||
129876294|NCT00988221|467506465|FG000|Part II|Withdrawal by Subject|0|||
129876295|NCT00988221|467506466|FG001|Part II|Withdrawal by Subject|0|||
129876296|NCT00988221|467506467|FG002|Part II|Withdrawal by Subject|2|||
129876297|NCT00988221|467506468|FG003|Part II|Withdrawal by Subject|2|||
129876298|NCT00988221|467506465|FG000|Part II|Reason not Specified|0|||
129876299|NCT00988221|467506466|FG001|Part II|Reason not Specified|0|||
129876300|NCT00988221|467506467|FG002|Part II|Reason not Specified|1|||
129876301|NCT00988221|467506468|FG003|Part II|Reason not Specified|0|||
129876302|NCT00988221|467506465|FG000|Part III|Adverse Event|1|||
129876303|NCT00988221|467506466|FG001|Part III|Adverse Event|0|||
129876304|NCT00988221|467506467|FG002|Part III|Adverse Event|1|||
129876305|NCT00988221|467506468|FG003|Part III|Adverse Event|0|||
129876306|NCT00988221|467506465|FG000|Part III|Insufficient Therapeutic Response|0|||
129876307|NCT00988221|467506466|FG001|Part III|Insufficient Therapeutic Response|1|||
129876308|NCT00988221|467506467|FG002|Part III|Insufficient Therapeutic Response|1|||
129876309|NCT00988221|467506468|FG003|Part III|Insufficient Therapeutic Response|0|||
129876310|NCT00988221|467506465|FG000|Part III|Refused Treatment|0|||
129876311|NCT00988221|467506466|FG001|Part III|Refused Treatment|0|||
129876312|NCT00988221|467506467|FG002|Part III|Refused Treatment|1|||
129876313|NCT00988221|467506468|FG003|Part III|Refused Treatment|0|||
129876314|NCT02756832|467506471|FG000|Overall Study|Lost for Observation after Baseline|6|||
129876315|NCT02756832|467506471|FG000|Overall Study|Lost for Observation|13|||
129876316|NCT02756832|467506471|FG000|Overall Study|Patient's Unwillingness|12|||
129876317|NCT02756832|467506471|FG000|Overall Study|Insufficient Efficacy|2|||
129876318|NCT02756832|467506471|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
129876319|NCT02756832|467506471|FG000|Overall Study|Reason not Specified|9|||
129876320|NCT02756832|467506471|FG000|Overall Study|Protocol Deviation|10|||
129876321|NCT01364597|467506472|FG000|Overall Study|Adverse Event|4|||
129876322|NCT01364597|467506473|FG001|Overall Study|Adverse Event|5|||
129876323|NCT01364597|467506474|FG002|Overall Study|Adverse Event|16|||
129876324|NCT01364597|467506475|FG003|Overall Study|Adverse Event|7|||
129876325|NCT01364597|467506472|FG000|Overall Study|Lack of Efficacy|4|||
129876326|NCT01364597|467506473|FG001|Overall Study|Lack of Efficacy|4|||
129876327|NCT01364597|467506474|FG002|Overall Study|Lack of Efficacy|23|||
129876328|NCT01364597|467506475|FG003|Overall Study|Lack of Efficacy|8|||
129876329|NCT01364597|467506472|FG000|Overall Study|Protocol Violation|0|||
129876330|NCT01364597|467506473|FG001|Overall Study|Protocol Violation|0|||
129876331|NCT01364597|467506474|FG002|Overall Study|Protocol Violation|2|||
129876332|NCT01364597|467506475|FG003|Overall Study|Protocol Violation|0|||
129876333|NCT01364597|467506472|FG000|Overall Study|Lost to Follow-up|0|||
129876334|NCT01364597|467506473|FG001|Overall Study|Lost to Follow-up|0|||
129876335|NCT01364597|467506474|FG002|Overall Study|Lost to Follow-up|5|||
129876336|NCT01364597|467506475|FG003|Overall Study|Lost to Follow-up|3|||
129876337|NCT01364597|467506472|FG000|Overall Study|Withdrawal by Subject|4|||
129876338|NCT01364597|467506473|FG001|Overall Study|Withdrawal by Subject|1|||
129876339|NCT01364597|467506474|FG002|Overall Study|Withdrawal by Subject|18|||
129876340|NCT01364597|467506475|FG003|Overall Study|Withdrawal by Subject|6|||
129876341|NCT01364597|467506472|FG000|Overall Study|Non compliance|1|||
129876342|NCT01364597|467506473|FG001|Overall Study|Non compliance|0|||
129539306|NCT01397409|466265243|FG001|Stage 2|Personal Reasons|0|||
129876343|NCT01364597|467506474|FG002|Overall Study|Non compliance|1|||
129876344|NCT01364597|467506475|FG003|Overall Study|Non compliance|0|||
129876345|NCT01364597|467506472|FG000|Overall Study|Lack of compliance|1|||
129876346|NCT01364597|467506473|FG001|Overall Study|Lack of compliance|0|||
129876347|NCT01364597|467506474|FG002|Overall Study|Lack of compliance|0|||
129876348|NCT01364597|467506475|FG003|Overall Study|Lack of compliance|0|||
129876349|NCT01364597|467506472|FG000|Overall Study|End of treatment epilepsy|1|||
129876350|NCT01364597|467506473|FG001|Overall Study|End of treatment epilepsy|0|||
129876351|NCT01364597|467506474|FG002|Overall Study|End of treatment epilepsy|0|||
129876352|NCT01364597|467506475|FG003|Overall Study|End of treatment epilepsy|0|||
129876353|NCT01364597|467506472|FG000|Overall Study|No Seizures|1|||
129876354|NCT01364597|467506473|FG001|Overall Study|No Seizures|0|||
129876355|NCT01364597|467506474|FG002|Overall Study|No Seizures|0|||
129876356|NCT01364597|467506475|FG003|Overall Study|No Seizures|0|||
129876357|NCT01364597|467506472|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
129876358|NCT01364597|467506473|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
129876359|NCT01364597|467506474|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
129876360|NCT01364597|467506475|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
129876361|NCT01364597|467506472|FG000|Overall Study|Cure|1|||
129876362|NCT01364597|467506473|FG001|Overall Study|Cure|0|||
129876363|NCT01364597|467506474|FG002|Overall Study|Cure|0|||
129876364|NCT01364597|467506475|FG003|Overall Study|Cure|0|||
129876365|NCT01364597|467506472|FG000|Overall Study|Patient was moving|0|||
129876366|NCT01364597|467506473|FG001|Overall Study|Patient was moving|1|||
129876367|NCT01364597|467506474|FG002|Overall Study|Patient was moving|0|||
129876368|NCT01364597|467506475|FG003|Overall Study|Patient was moving|0|||
129876369|NCT01364597|467506472|FG000|Overall Study|Seizures resolved|0|||
129876370|NCT01364597|467506473|FG001|Overall Study|Seizures resolved|0|||
129876371|NCT01364597|467506474|FG002|Overall Study|Seizures resolved|1|||
129876372|NCT01364597|467506475|FG003|Overall Study|Seizures resolved|0|||
129876373|NCT01364597|467506472|FG000|Overall Study|Patient became seizure-free after surgery|0|||
129876374|NCT01364597|467506473|FG001|Overall Study|Patient became seizure-free after surgery|0|||
129876375|NCT01364597|467506474|FG002|Overall Study|Patient became seizure-free after surgery|1|||
129876376|NCT01364597|467506475|FG003|Overall Study|Patient became seizure-free after surgery|0|||
129876377|NCT01364597|467506472|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
129876378|NCT01364597|467506473|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
129876379|NCT01364597|467506474|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
129876380|NCT01364597|467506475|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
129876381|NCT01364597|467506472|FG000|Overall Study|Patient cured from Epilepsy|0|||
129876382|NCT01364597|467506473|FG001|Overall Study|Patient cured from Epilepsy|0|||
129876383|NCT01364597|467506474|FG002|Overall Study|Patient cured from Epilepsy|1|||
129876384|NCT01364597|467506475|FG003|Overall Study|Patient cured from Epilepsy|0|||
129876385|NCT01364597|467506472|FG000|Overall Study|Investigator decision|0|||
129876386|NCT01364597|467506473|FG001|Overall Study|Investigator decision|0|||
129876387|NCT01364597|467506474|FG002|Overall Study|Investigator decision|1|||
129876388|NCT01364597|467506475|FG003|Overall Study|Investigator decision|0|||
129876389|NCT01364597|467506472|FG000|Overall Study|Sponsor recommended discontinuation|0|||
129876390|NCT01364597|467506473|FG001|Overall Study|Sponsor recommended discontinuation|0|||
129876391|NCT01364597|467506474|FG002|Overall Study|Sponsor recommended discontinuation|0|||
129876392|NCT01364597|467506475|FG003|Overall Study|Sponsor recommended discontinuation|1|||
129876393|NCT01364597|467506472|FG000|Overall Study|Parents went abroad with the patient|0|||
129876394|NCT01364597|467506473|FG001|Overall Study|Parents went abroad with the patient|0|||
129876395|NCT01364597|467506474|FG002|Overall Study|Parents went abroad with the patient|1|||
129876396|NCT01364597|467506475|FG003|Overall Study|Parents went abroad with the patient|0|||
129876397|NCT01364597|467506472|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
129876398|NCT01364597|467506473|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
129876399|NCT01364597|467506474|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
129876400|NCT01364597|467506475|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
129876401|NCT01364597|467506472|FG000|Overall Study|BRV administration dropout|0|||
129876402|NCT01364597|467506473|FG001|Overall Study|BRV administration dropout|0|||
129876403|NCT01364597|467506474|FG002|Overall Study|BRV administration dropout|1|||
129876404|NCT01364597|467506475|FG003|Overall Study|BRV administration dropout|0|||
129876405|NCT01364597|467506472|FG000|Overall Study|Dropout|0|||
129876406|NCT01364597|467506473|FG001|Overall Study|Dropout|0|||
129876407|NCT01364597|467506474|FG002|Overall Study|Dropout|3|||
129876408|NCT01364597|467506475|FG003|Overall Study|Dropout|1|||
129876409|NCT01364597|467506472|FG000|Overall Study|Unreliable subject|0|||
129876410|NCT01364597|467506473|FG001|Overall Study|Unreliable subject|0|||
129876411|NCT01364597|467506474|FG002|Overall Study|Unreliable subject|0|||
129876412|NCT01364597|467506475|FG003|Overall Study|Unreliable subject|1|||
129876413|NCT01364597|467506472|FG000|Overall Study|Other|0|||
129876414|NCT01364597|467506473|FG001|Overall Study|Other|0|||
129876415|NCT01364597|467506474|FG002|Overall Study|Other|0|||
129876416|NCT01364597|467506475|FG003|Overall Study|Other|1|||
129876417|NCT03579290|467506485|FG000|Overall Study|Lost to Follow-up|9|||
129876418|NCT03131960|467506488|FG000|Overall Study|Adverse Event|0|||
129876419|NCT03131960|467506489|FG001|Overall Study|Adverse Event|1|||
129876420|NCT01781390|467506490|FG000|Overall Study|Withdrawal of Consent|0|||
129876421|NCT01781390|467506491|FG001|Overall Study|Withdrawal of Consent|3|||
129876422|NCT01781390|467506492|FG002|Overall Study|Withdrawal of Consent|1|||
129876423|NCT01781390|467506490|FG000|Overall Study|Lost to Follow-up|1|||
129876424|NCT01781390|467506491|FG001|Overall Study|Lost to Follow-up|1|||
129876425|NCT01781390|467506492|FG002|Overall Study|Lost to Follow-up|1|||
129876426|NCT01781390|467506490|FG000|Overall Study|Adverse Event|1|||
129876427|NCT01781390|467506491|FG001|Overall Study|Adverse Event|2|||
129876428|NCT01781390|467506492|FG002|Overall Study|Adverse Event|1|||
129876429|NCT01781390|467506490|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
129876430|NCT01781390|467506491|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
129876431|NCT01781390|467506492|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
129876432|NCT00622713|467506495|FG000|Overall Study|Adverse Event|35|||
129876433|NCT00622713|467506495|FG000|Overall Study|Administrative problems|4|||
129876434|NCT00622713|467506495|FG000|Overall Study|Withdrawal by Subject|11|||
129876435|NCT00622713|467506495|FG000|Overall Study|Lost to Follow-up|5|||
129876436|NCT00622713|467506495|FG000|Overall Study|Death|2|||
129876437|NCT00622713|467506495|FG000|Overall Study|Subject no longer required study drug|1|||
129876438|NCT00622713|467506495|FG000|Overall Study|Did not meet eligibility criteria|1|||
129876439|NCT04404478|467506499|FG000|Overall Study|Withdrawal by Subject|1|||
129876440|NCT04404478|467506500|FG001|Overall Study|Withdrawal by Subject|3|||
129876441|NCT03485911|467506501|FG000|Part 1|Perceived lack of efficacy|1|||
129876442|NCT03485911|467506502|FG001|Part 1|Perceived lack of efficacy|1|||
129876443|NCT03485911|467506503|FG002|Part 1|Perceived lack of efficacy|2|||
129876444|NCT03485911|467506504|FG003|Part 1|Perceived lack of efficacy|0|||
129876445|NCT03485911|467506501|FG000|Part 1|Subject withdrew consent|0|||
129876446|NCT03485911|467506502|FG001|Part 1|Subject withdrew consent|1|||
129876447|NCT03485911|467506503|FG002|Part 1|Subject withdrew consent|0|||
129876448|NCT03485911|467506504|FG003|Part 1|Subject withdrew consent|1|||
129876449|NCT03485911|467506501|FG000|Part 1|Lab abnormalities/AEs|3|||
129876450|NCT03485911|467506502|FG001|Part 1|Lab abnormalities/AEs|1|||
129876451|NCT03485911|467506503|FG002|Part 1|Lab abnormalities/AEs|1|||
129876452|NCT03485911|467506504|FG003|Part 1|Lab abnormalities/AEs|0|||
129876453|NCT03485911|467506501|FG000|Part 1|Withdrew Consent prior to dosing|0|||
129876454|NCT03485911|467506502|FG001|Part 1|Withdrew Consent prior to dosing|0|||
129876455|NCT03485911|467506503|FG002|Part 1|Withdrew Consent prior to dosing|0|||
129876456|NCT03485911|467506504|FG003|Part 1|Withdrew Consent prior to dosing|1|||
129876457|NCT03485911|467506501|FG000|Part 1|Other NOS|0|||
129876458|NCT03485911|467506502|FG001|Part 1|Other NOS|0|||
129876459|NCT03485911|467506503|FG002|Part 1|Other NOS|0|||
129876460|NCT03485911|467506504|FG003|Part 1|Other NOS|1|||
129876461|NCT03485911|467506501|FG000|Part 2|Perceived lack of efficacy|5|||
129876462|NCT03485911|467506502|FG001|Part 2|Perceived lack of efficacy|3|||
129876463|NCT03485911|467506503|FG002|Part 2|Perceived lack of efficacy|0|||
129876464|NCT03485911|467506504|FG003|Part 2|Perceived lack of efficacy|2|||
129876465|NCT03485911|467506501|FG000|Part 2|Subject withdrew consent|1|||
129876466|NCT03485911|467506502|FG001|Part 2|Subject withdrew consent|0|||
129876467|NCT03485911|467506503|FG002|Part 2|Subject withdrew consent|2|||
129876468|NCT03485911|467506504|FG003|Part 2|Subject withdrew consent|1|||
129876469|NCT03485911|467506501|FG000|Part 2|Lab abnormalities/AEs|1|||
129876470|NCT03485911|467506502|FG001|Part 2|Lab abnormalities/AEs|2|||
129876471|NCT03485911|467506503|FG002|Part 2|Lab abnormalities/AEs|0|||
129651779|NCT01358578|466681666|FG000|Follow-up Period|non- compliance with study treatment|1|||
129876472|NCT03485911|467506504|FG003|Part 2|Lab abnormalities/AEs|0|||
129876473|NCT03485911|467506501|FG000|Part 2|Other NOS|0|||
129876474|NCT03485911|467506502|FG001|Part 2|Other NOS|1|||
129876475|NCT03485911|467506503|FG002|Part 2|Other NOS|0|||
129876476|NCT03485911|467506504|FG003|Part 2|Other NOS|0|||
129876477|NCT03485911|467506501|FG000|Part 2|Intercurrent illness/new medical condition|1|||
129876478|NCT03485911|467506502|FG001|Part 2|Intercurrent illness/new medical condition|0|||
129876479|NCT03485911|467506503|FG002|Part 2|Intercurrent illness/new medical condition|0|||
129876480|NCT03485911|467506504|FG003|Part 2|Intercurrent illness/new medical condition|0|||
129876481|NCT03485911|467506501|FG000|Part 2|Investigator judgement|1|||
129876482|NCT03485911|467506502|FG001|Part 2|Investigator judgement|0|||
129876483|NCT03485911|467506503|FG002|Part 2|Investigator judgement|0|||
129876484|NCT03485911|467506504|FG003|Part 2|Investigator judgement|0|||
129876485|NCT03485911|467506501|FG000|Part 3|Perceived lack of efficacy|2|||
129876486|NCT03485911|467506502|FG001|Part 3|Perceived lack of efficacy|2|||
129651780|NCT01358578|466681667|FG001|Follow-up Period|non- compliance with study treatment|0|||
129651781|NCT01358578|466681668|FG002|Follow-up Period|non- compliance with study treatment|0|||
129876487|NCT03485911|467506503|FG002|Part 3|Perceived lack of efficacy|2|||
129876488|NCT03485911|467506504|FG003|Part 3|Perceived lack of efficacy|0|||
129876489|NCT03485911|467506501|FG000|Part 3|Subject withdrew consent|1|||
129876490|NCT03485911|467506502|FG001|Part 3|Subject withdrew consent|4|||
129876491|NCT03485911|467506503|FG002|Part 3|Subject withdrew consent|0|||
129876492|NCT03485911|467506504|FG003|Part 3|Subject withdrew consent|1|||
129876493|NCT03485911|467506501|FG000|Part 3|Lab abnormalities/AEs|1|||
129876494|NCT03485911|467506502|FG001|Part 3|Lab abnormalities/AEs|1|||
129876495|NCT03485911|467506503|FG002|Part 3|Lab abnormalities/AEs|0|||
129876496|NCT03485911|467506504|FG003|Part 3|Lab abnormalities/AEs|2|||
129876497|NCT03485911|467506501|FG000|Part 3|Other NOS|1|||
129876498|NCT03485911|467506502|FG001|Part 3|Other NOS|1|||
129876499|NCT03485911|467506503|FG002|Part 3|Other NOS|0|||
129876500|NCT03485911|467506504|FG003|Part 3|Other NOS|0|||
129876501|NCT03485911|467506501|FG000|Part 3|Intercurrent illness/new medical condition|0|||
129876502|NCT03485911|467506502|FG001|Part 3|Intercurrent illness/new medical condition|1|||
129876503|NCT03485911|467506503|FG002|Part 3|Intercurrent illness/new medical condition|1|||
129876504|NCT03485911|467506504|FG003|Part 3|Intercurrent illness/new medical condition|0|||
129876505|NCT03485911|467506501|FG000|Part 3|Sponsor discontinuation|1|||
129876506|NCT03485911|467506502|FG001|Part 3|Sponsor discontinuation|0|||
129876507|NCT03485911|467506503|FG002|Part 3|Sponsor discontinuation|0|||
129876508|NCT03485911|467506504|FG003|Part 3|Sponsor discontinuation|0|||
129876509|NCT03485911|467506501|FG000|Part 3|Berotralstat provided by alternative means|13|||
129876510|NCT03485911|467506502|FG001|Part 3|Berotralstat provided by alternative means|13|||
129876511|NCT03485911|467506503|FG002|Part 3|Berotralstat provided by alternative means|7|||
129876512|NCT03485911|467506504|FG003|Part 3|Berotralstat provided by alternative means|7|||
129876513|NCT00782496|467506509|FG000|Overall Study|Lost to Follow-up|14|||
129876514|NCT00782496|467506510|FG001|Overall Study|Lost to Follow-up|15|||
129876515|NCT00990340|467506513|FG000|First 14-day Treatment|Not Compliant|2|||
129876516|NCT00990340|467506514|FG001|First 14-day Treatment|Not Compliant|1|||
129876517|NCT00990340|467506513|FG000|First 14-day Treatment|Lost to Follow-up|2|||
129876518|NCT00990340|467506514|FG001|First 14-day Treatment|Lost to Follow-up|1|||
129876519|NCT00990340|467506513|FG000|First 14-day Treatment|Protocol Violation|2|||
129876520|NCT00990340|467506514|FG001|First 14-day Treatment|Protocol Violation|2|||
129876521|NCT01987817|467506516|FG000|Overall Study|Adverse Event|4|||
129876522|NCT01987817|467506517|FG001|Overall Study|Adverse Event|0|||
129876523|NCT01987817|467506516|FG000|Overall Study|Withdrawal by Subject|1|||
129876524|NCT01987817|467506517|FG001|Overall Study|Withdrawal by Subject|1|||
129876525|NCT01987817|467506516|FG000|Overall Study|Physician Decision|1|||
129876526|NCT01987817|467506517|FG001|Overall Study|Physician Decision|0|||
129876527|NCT02070484|467506518|FG000|Overall Study|Withdrawal by Subject|1|||
129876528|NCT02070484|467506519|FG001|Overall Study|Withdrawal by Subject|0|||
129876529|NCT00682643|467506520|FG000|Overall Study|Adverse Event|12|||
129876530|NCT00682643|467506521|FG001|Overall Study|Adverse Event|23|||
129876531|NCT00682643|467506520|FG000|Overall Study|Lack of Efficacy|2|||
129876532|NCT00682643|467506521|FG001|Overall Study|Lack of Efficacy|0|||
129876533|NCT00682643|467506520|FG000|Overall Study|Protocol Violation|38|||
129876534|NCT00682643|467506521|FG001|Overall Study|Protocol Violation|76|||
129876535|NCT00682643|467506520|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
129876536|NCT00682643|467506521|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
129876537|NCT00682643|467506520|FG000|Overall Study|Lost to Follow-up|1|||
129876538|NCT00682643|467506521|FG001|Overall Study|Lost to Follow-up|6|||
129876539|NCT00682643|467506520|FG000|Overall Study|Physician Decision|2|||
129876540|NCT00682643|467506521|FG001|Overall Study|Physician Decision|6|||
129876541|NCT00682643|467506520|FG000|Overall Study|Withdrawal by Subject|19|||
129876542|NCT00682643|467506521|FG001|Overall Study|Withdrawal by Subject|53|||
129876543|NCT00682643|467506520|FG000|Overall Study|Did Not Receive Study Drug|1|||
129876544|NCT00682643|467506521|FG001|Overall Study|Did Not Receive Study Drug|1|||
129876545|NCT01852058|467506524|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
129876546|NCT01852058|467506525|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876547|NCT01852058|467506526|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876548|NCT01852058|467506527|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876549|NCT01852058|467506528|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876550|NCT01852058|467506529|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876551|NCT01852058|467506530|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876552|NCT01852058|467506531|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876553|NCT01852058|467506532|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876554|NCT01852058|467506533|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876555|NCT01852058|467506534|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876556|NCT01852058|467506535|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
129876557|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876558|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876559|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876560|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876561|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
129876562|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876563|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876564|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876565|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876566|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876567|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876568|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
129876569|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876570|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129651782|NCT01358578|466681669|FG003|Follow-up Period|non- compliance with study treatment|0|||
129876571|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876572|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876573|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
129876574|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
129876575|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876576|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876577|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876578|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876579|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876580|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
129876581|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876582|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876583|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876584|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876585|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
129876586|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876587|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876588|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876589|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876590|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876591|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876592|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
129876593|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876594|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876595|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876596|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876597|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
129876598|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
129876599|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876600|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876601|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876602|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876603|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876604|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
129876605|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876606|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876607|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876608|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
129876609|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876610|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876611|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876612|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876613|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876614|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876615|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876616|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
129876617|NCT01852058|467506524|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876618|NCT01852058|467506525|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876619|NCT01852058|467506526|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876620|NCT01852058|467506527|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876621|NCT01852058|467506528|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
129876622|NCT01852058|467506529|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
129876623|NCT01852058|467506530|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876624|NCT01852058|467506531|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876625|NCT01852058|467506532|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876626|NCT01852058|467506533|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876627|NCT01852058|467506534|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876628|NCT01852058|467506535|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
129876629|NCT01852058|467506524|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876630|NCT01852058|467506525|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876631|NCT01852058|467506526|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876632|NCT01852058|467506527|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876633|NCT01852058|467506528|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876634|NCT01852058|467506529|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876635|NCT01852058|467506530|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876636|NCT01852058|467506531|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
129876637|NCT01852058|467506532|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876638|NCT01852058|467506533|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876639|NCT01852058|467506534|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876640|NCT01852058|467506535|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
129876641|NCT01852058|467506524|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876642|NCT01852058|467506525|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876643|NCT01852058|467506526|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876644|NCT01852058|467506527|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876645|NCT01852058|467506528|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876646|NCT01852058|467506529|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876647|NCT01852058|467506530|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876648|NCT01852058|467506531|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876649|NCT01852058|467506532|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
129876650|NCT01852058|467506533|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876651|NCT01852058|467506534|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876652|NCT01852058|467506535|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
129876653|NCT00622180|467506536|FG000|Overall Study|Lost to Follow-up|1|||
129876654|NCT00622180|467506537|FG001|Overall Study|Lost to Follow-up|2|||
129876655|NCT01353222|467506540|FG000|Overall Study|Death|30|||
129876656|NCT01353222|467506541|FG001|Overall Study|Death|30|||
129876657|NCT01353222|467506540|FG000|Overall Study|Withdrawal by Subject|8|||
129876658|NCT01353222|467506541|FG001|Overall Study|Withdrawal by Subject|5|||
129876659|NCT01353222|467506540|FG000|Overall Study|Study Terminated|31|||
129876660|NCT01353222|467506541|FG001|Overall Study|Study Terminated|37|||
129876661|NCT01353222|467506540|FG000|Overall Study|Site closed research department|1|||
129876662|NCT01353222|467506541|FG001|Overall Study|Site closed research department|0|||
129876663|NCT02636270|467506542|FG000|Overall Study|Adverse Event|1|||
129876664|NCT02636270|467506543|FG001|Overall Study|Adverse Event|0|||
129876665|NCT02636270|467506544|FG002|Overall Study|Adverse Event|0|||
129876666|NCT02636270|467506542|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
129876667|NCT02636270|467506543|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
129876668|NCT02636270|467506544|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
129876669|NCT01119898|467506545|FG000|Overall Study|Adverse Event|4|||
129876670|NCT01119898|467506546|FG001|Overall Study|Adverse Event|5|||
129876671|NCT01119898|467506545|FG000|Overall Study|Withdrawal by Subject|1|||
129876672|NCT01119898|467506546|FG001|Overall Study|Withdrawal by Subject|4|||
129876673|NCT01119898|467506545|FG000|Overall Study|Lack of Efficacy|0|||
129876674|NCT01119898|467506546|FG001|Overall Study|Lack of Efficacy|2|||
129876675|NCT01119898|467506545|FG000|Overall Study|Protocol Violation|1|||
129876676|NCT01119898|467506546|FG001|Overall Study|Protocol Violation|1|||
129876677|NCT01119898|467506545|FG000|Overall Study|Medical procedure|1|||
129876678|NCT01119898|467506546|FG001|Overall Study|Medical procedure|0|||
129876679|NCT01119898|467506545|FG000|Overall Study|Randomized in error did not participate|1|||
129876680|NCT01119898|467506546|FG001|Overall Study|Randomized in error did not participate|0|||
129876681|NCT01806584|467506547|FG000|Overall Study|Adverse Event|2|||
129876682|NCT01806584|467506548|FG001|Overall Study|Adverse Event|1|||
129876683|NCT01806584|467506547|FG000|Overall Study|Death|1|||
129876684|NCT01806584|467506548|FG001|Overall Study|Death|0|||
129876685|NCT01806584|467506547|FG000|Overall Study|Lost to Follow-up|0|||
129876686|NCT01806584|467506548|FG001|Overall Study|Lost to Follow-up|2|||
129876687|NCT01806584|467506547|FG000|Overall Study|Study terminated by sponsor|9|||
129876688|NCT01806584|467506548|FG001|Overall Study|Study terminated by sponsor|14|||
129876689|NCT01806584|467506547|FG000|Overall Study|Withdrawal by Subject|1|||
129876690|NCT01806584|467506548|FG001|Overall Study|Withdrawal by Subject|1|||
129876691|NCT01806584|467506547|FG000|Overall Study|Other unspecified|1|||
129876692|NCT01806584|467506548|FG001|Overall Study|Other unspecified|0|||
129876693|NCT04398537|467506555|FG000|Overall Study|Physician Decision|10|||
129876694|NCT04398537|467506556|FG001|Overall Study|Physician Decision|15|||
129876695|NCT02202434|467509148|FG000|Overall Study|Death|70|||
129876696|NCT02202434|467509149|FG001|Overall Study|Death|39|||
129876697|NCT02202434|467509150|FG002|Overall Study|Death|13|||
129876698|NCT02202434|467509151|FG003|Overall Study|Death|27|||
129876699|NCT02202434|467509148|FG000|Overall Study|Lost to Follow-up|1|||
129876700|NCT02202434|467509149|FG001|Overall Study|Lost to Follow-up|1|||
129876701|NCT02202434|467509150|FG002|Overall Study|Lost to Follow-up|1|||
129876702|NCT02202434|467509151|FG003|Overall Study|Lost to Follow-up|0|||
129876703|NCT02202434|467509148|FG000|Overall Study|Physician Decision|2|||
129876704|NCT02202434|467509149|FG001|Overall Study|Physician Decision|3|||
129544811|NCT02181673|466286946|FG001|Week 24-Week 60|Physician Decision|0|||
129544812|NCT02181673|466286947|FG002|Week 24-Week 60|Physician Decision|1|||
129876705|NCT02202434|467509150|FG002|Overall Study|Physician Decision|0|||
129876706|NCT02202434|467509151|FG003|Overall Study|Physician Decision|0|||
129876707|NCT02202434|467509148|FG000|Overall Study|Withdrawal by Subject|13|||
129876708|NCT02202434|467509149|FG001|Overall Study|Withdrawal by Subject|14|||
129876709|NCT02202434|467509150|FG002|Overall Study|Withdrawal by Subject|1|||
129876710|NCT02202434|467509151|FG003|Overall Study|Withdrawal by Subject|4|||
129876711|NCT02202434|467509148|FG000|Overall Study|Completed Study|1|||
129876712|NCT02202434|467509149|FG001|Overall Study|Completed Study|0|||
129876713|NCT02202434|467509150|FG002|Overall Study|Completed Study|0|||
129876714|NCT02202434|467509151|FG003|Overall Study|Completed Study|0|||
129876715|NCT02202434|467509148|FG000|Overall Study|Visit Missed|21|||
129876716|NCT02202434|467509149|FG001|Overall Study|Visit Missed|12|||
129876717|NCT02202434|467509150|FG002|Overall Study|Visit Missed|0|||
129876718|NCT02202434|467509151|FG003|Overall Study|Visit Missed|5|||
129876719|NCT02202434|467509148|FG000|Overall Study|Other|1|||
129876720|NCT02202434|467509149|FG001|Overall Study|Other|0|||
129876721|NCT02202434|467509150|FG002|Overall Study|Other|0|||
129876722|NCT02202434|467509151|FG003|Overall Study|Other|1|||
129876723|NCT03610737|467509154|FG000|Overall Study|Withdrawal by Subject|1|||
129876724|NCT03610737|467509155|FG001|Overall Study|Withdrawal by Subject|5|||
129876725|NCT03610737|467509154|FG000|Overall Study|Death|1|||
129876726|NCT03610737|467509155|FG001|Overall Study|Death|0|||
129876727|NCT03610737|467509154|FG000|Overall Study|Not treated|5|||
129876728|NCT03610737|467509155|FG001|Overall Study|Not treated|2|||
129876729|NCT03610737|467509154|FG000|Overall Study|Missed Visit|1|||
129876730|NCT03610737|467509155|FG001|Overall Study|Missed Visit|2|||
129876731|NCT02312856|467509157|FG000|Overall Study|Death|1|||
129876732|NCT02312856|467509157|FG000|Overall Study|Lost to Follow-up|3|||
129876733|NCT03075904|467509159|FG000|Overall Study|Physician Decision|3|||
129876734|NCT03075904|467509159|FG000|Overall Study|Need for Medication not Permitted|1|||
129876735|NCT04581200|467509160|FG000|Overall Study|Lost to Follow-up|6|||
129876736|NCT04581200|467509161|FG001|Overall Study|Lost to Follow-up|5|||
129876737|NCT03528174|467509162|FG000|Overall Study|Adverse Event|1|||
129876738|NCT03528174|467509162|FG000|Overall Study|sensors dislodged|1|||
129876739|NCT03002038|467509163|FG000|Overall Study|Adverse Event|3|||
129876740|NCT03002038|467509164|FG001|Overall Study|Adverse Event|1|||
129876741|NCT03002038|467509163|FG000|Overall Study|Withdrawal by Subject|8|||
129876742|NCT03002038|467509164|FG001|Overall Study|Withdrawal by Subject|4|||
129876743|NCT03002038|467509163|FG000|Overall Study|Immigration to another region|0|||
129876744|NCT03002038|467509164|FG001|Overall Study|Immigration to another region|2|||
129876745|NCT00979602|467509173|FG000|Overall Study|Serious Adverse Event|5|||
129876746|NCT00979602|467509174|FG001|Overall Study|Serious Adverse Event|3|||
129876747|NCT00979602|467509173|FG000|Overall Study|Protocol Violation|3|||
129876748|NCT00979602|467509174|FG001|Overall Study|Protocol Violation|0|||
129876749|NCT00979602|467509173|FG000|Overall Study|Withdrawal by Subject|31|||
129876750|NCT00979602|467509174|FG001|Overall Study|Withdrawal by Subject|25|||
129876751|NCT00979602|467509173|FG000|Overall Study|Lost to Follow-up|100|||
129876752|NCT00979602|467509174|FG001|Overall Study|Lost to Follow-up|96|||
129876753|NCT00979602|467509173|FG000|Overall Study|Migrated/moved from study area|3|||
129876754|NCT00979602|467509174|FG001|Overall Study|Migrated/moved from study area|6|||
129876755|NCT00979602|467509173|FG000|Overall Study|Others|3|||
129876756|NCT00979602|467509174|FG001|Overall Study|Others|3|||
129876757|NCT02904902|467509175|FG000|Overall Study|Withdrawal by Subject|1|||
129876758|NCT01719237|467509176|FG000|Overall Study|Physician Decision|0|||
129876759|NCT01719237|467509177|FG001|Overall Study|Physician Decision|1|||
129651783|NCT01358578|466681670|FG004|Follow-up Period|non- compliance with study treatment|0|||
129876760|NCT02712398|467509178|FG000|Overall Study|Withdrawal by Subject|6|||
129651784|NCT01358578|466681671|FG005|Follow-up Period|non- compliance with study treatment|0|||
129651785|NCT01358578|466681666|FG000|Follow-up Period|Pregnancy|1|||
129651786|NCT01358578|466681667|FG001|Follow-up Period|Pregnancy|0|||
129651787|NCT01358578|466681668|FG002|Follow-up Period|Pregnancy|0|||
129876761|NCT02712398|467509178|FG000|Overall Study|Lost to Follow-up|6|||
129651788|NCT01358578|466681669|FG003|Follow-up Period|Pregnancy|0|||
129651789|NCT01358578|466681670|FG004|Follow-up Period|Pregnancy|0|||
129876762|NCT02712398|467509178|FG000|Overall Study|Sponsor Decision|1|||
129651790|NCT01358578|466681671|FG005|Follow-up Period|Pregnancy|0|||
129876763|NCT02712398|467509178|FG000|Overall Study|Physician Decision|1|||
129876764|NCT02712398|467509178|FG000|Overall Study|Death|2|||
129876765|NCT02712398|467509178|FG000|Overall Study|Re-operation|21|||
129876766|NCT01216163|467509187|FG000|Overall Study|Withdrawal by Subject|1|||
129876767|NCT01216163|467509188|FG001|Overall Study|Withdrawal by Subject|1|||
129876768|NCT01216163|467509189|FG002|Overall Study|Withdrawal by Subject|0|||
129876769|NCT02914314|467509190|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129876770|NCT02914314|467509191|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129876771|NCT02914314|467509192|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
129876772|NCT02914314|467509193|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
129876773|NCT02914314|467509190|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
129876774|NCT02914314|467509191|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
129876775|NCT02914314|467509192|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
129876776|NCT02914314|467509193|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
129876777|NCT02914314|467509190|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129651791|NCT01358578|466681666|FG000|Follow-up Period|Withdrawal by Subject|3|||
129651792|NCT01358578|466681667|FG001|Follow-up Period|Withdrawal by Subject|3|||
129651793|NCT01358578|466681668|FG002|Follow-up Period|Withdrawal by Subject|1|||
129651794|NCT01358578|466681669|FG003|Follow-up Period|Withdrawal by Subject|12|||
129651795|NCT01358578|466681670|FG004|Follow-up Period|Withdrawal by Subject|0|||
129651796|NCT01358578|466681671|FG005|Follow-up Period|Withdrawal by Subject|0|||
129651797|NCT01358578|466681666|FG000|Follow-up Period|Physician Decision|1|||
129651798|NCT01358578|466681667|FG001|Follow-up Period|Physician Decision|1|||
129651799|NCT01358578|466681668|FG002|Follow-up Period|Physician Decision|0|||
129651800|NCT01358578|466681669|FG003|Follow-up Period|Physician Decision|2|||
129651801|NCT01358578|466681670|FG004|Follow-up Period|Physician Decision|0|||
129651802|NCT01358578|466681671|FG005|Follow-up Period|Physician Decision|0|||
129651803|NCT02304380|466681672|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129651804|NCT02304380|466681673|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129651805|NCT02304380|466681674|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129651806|NCT02304380|466681675|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
129651807|NCT02304380|466681676|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129651808|NCT02304380|466681677|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
129651809|NCT00577005|466681678|FG000|Overall Study|Lost to Follow-up|3|||
129651810|NCT00577005|466681679|FG001|Overall Study|Lost to Follow-up|2|||
129651811|NCT00577005|466681678|FG000|Overall Study|Withdrawal by Subject|2|||
129651812|NCT00577005|466681679|FG001|Overall Study|Withdrawal by Subject|1|||
129651813|NCT01004432|466681680|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
129651814|NCT01004432|466681681|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129651815|NCT01004432|466681682|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129651816|NCT01004432|466681683|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129651817|NCT01004432|466681684|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
129651818|NCT01004432|466681680|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
129651819|NCT01004432|466681681|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129651820|NCT01004432|466681682|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129651821|NCT01004432|466681683|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129876778|NCT02914314|467509191|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129876779|NCT02914314|467509192|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
129876780|NCT02914314|467509193|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
129876781|NCT02914314|467509190|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
129876782|NCT02914314|467509191|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
129876783|NCT02914314|467509192|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
129876784|NCT02914314|467509193|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
129876785|NCT02914314|467509190|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
129876786|NCT02914314|467509191|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
129651822|NCT01004432|466681684|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
129651823|NCT01004432|466681680|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
129651824|NCT01004432|466681681|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129651825|NCT01004432|466681682|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129651826|NCT01004432|466681683|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129651827|NCT01004432|466681684|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
129651828|NCT01004432|466681680|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
129651829|NCT01004432|466681681|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129651830|NCT01004432|466681682|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129651831|NCT01004432|466681683|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129651832|NCT01004432|466681684|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
129651833|NCT01004432|466681680|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
129651834|NCT01004432|466681681|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129651835|NCT01004432|466681682|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129651836|NCT01004432|466681683|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129651837|NCT01004432|466681684|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
129651838|NCT01004432|466681680|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
129651839|NCT01004432|466681681|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
129651840|NCT01004432|466681682|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
129876787|NCT02914314|467509192|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
129876788|NCT02914314|467509193|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
129651841|NCT01004432|466681683|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
129651842|NCT01004432|466681684|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
129651843|NCT01004432|466681680|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
129651844|NCT01004432|466681681|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
129651845|NCT01004432|466681682|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
129651846|NCT01004432|466681683|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
129651847|NCT01004432|466681684|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
129651848|NCT01004432|466681680|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
129651849|NCT01004432|466681681|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
129651850|NCT01004432|466681682|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
129651851|NCT01004432|466681683|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
129651852|NCT01004432|466681684|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
129651853|NCT01004432|466681680|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129651854|NCT01004432|466681681|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129651855|NCT01004432|466681682|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129651856|NCT01004432|466681683|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
129651857|NCT01004432|466681684|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
129651858|NCT01004432|466681680|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
129651859|NCT01004432|466681681|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
129651860|NCT01004432|466681682|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
129651861|NCT01004432|466681683|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
129651862|NCT01004432|466681684|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
129651863|NCT01004432|466681680|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
129651864|NCT01004432|466681681|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
129651865|NCT01004432|466681682|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
129651866|NCT01004432|466681683|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
129651867|NCT01004432|466681684|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
129651868|NCT01004432|466681680|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
129651869|NCT01004432|466681681|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
129651870|NCT01004432|466681682|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
129651871|NCT01004432|466681683|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
129651872|NCT01004432|466681684|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
129651873|NCT01004432|466681680|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129651874|NCT01004432|466681681|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129651875|NCT01004432|466681682|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129651876|NCT01004432|466681683|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
129651877|NCT01004432|466681684|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
129651878|NCT01004432|466681680|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129651879|NCT01004432|466681681|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129651880|NCT01004432|466681682|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129651881|NCT01004432|466681683|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
129651882|NCT01004432|466681684|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
129651883|NCT01004432|466681680|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129651884|NCT01004432|466681681|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129651885|NCT01004432|466681682|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129651886|NCT01004432|466681683|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
129651887|NCT01004432|466681684|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
129651888|NCT02667626|466681685|FG000|Overall Study|Withdrawal by Subject|0|||
129651889|NCT02667626|466681686|FG001|Overall Study|Withdrawal by Subject|1|||
129651890|NCT01125813|466681687|FG000|Overall Study|Death|1|||
129651891|NCT01125813|466681687|FG000|Overall Study|Withdrawal by Subject|1|||
129651892|NCT01125813|466681687|FG000|Overall Study|Screen Failures|4|||
129651893|NCT02539134|466681688|FG000|Overall Study|Lost to Follow-up|1|||
129651894|NCT02539134|466681689|FG001|Overall Study|Lost to Follow-up|0|||
129651895|NCT02539134|466681690|FG002|Overall Study|Lost to Follow-up|0|||
129651896|NCT02539134|466681691|FG003|Overall Study|Lost to Follow-up|0|||
129651897|NCT02539134|466681692|FG004|Overall Study|Lost to Follow-up|0|||
129651898|NCT02539134|466681693|FG005|Overall Study|Lost to Follow-up|0|||
129651899|NCT02327013|466681694|FG000|Overall Study|Adverse Event|4|||
129651900|NCT02327013|466681695|FG001|Overall Study|Adverse Event|4|||
129651901|NCT02327013|466681696|FG002|Overall Study|Adverse Event|3|||
129651902|NCT02327013|466681697|FG003|Overall Study|Adverse Event|0|||
129651903|NCT02327013|466681698|FG004|Overall Study|Adverse Event|1|||
129651904|NCT02327013|466681694|FG000|Overall Study|Lack of Efficacy|2|||
129651905|NCT02327013|466681695|FG001|Overall Study|Lack of Efficacy|0|||
129876789|NCT01859793|467509197|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
129651906|NCT02327013|466681696|FG002|Overall Study|Lack of Efficacy|5|||
129876790|NCT01859793|467509198|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
129651907|NCT02327013|466681697|FG003|Overall Study|Lack of Efficacy|0|||
129651908|NCT02327013|466681698|FG004|Overall Study|Lack of Efficacy|1|||
129651909|NCT02327013|466681694|FG000|Overall Study|Non-compliance with IMP|1|||
129651910|NCT02327013|466681695|FG001|Overall Study|Non-compliance with IMP|2|||
129651911|NCT02327013|466681696|FG002|Overall Study|Non-compliance with IMP|7|||
129651912|NCT02327013|466681697|FG003|Overall Study|Non-compliance with IMP|0|||
129651913|NCT02327013|466681698|FG004|Overall Study|Non-compliance with IMP|0|||
129651914|NCT02327013|466681694|FG000|Overall Study|Withdrawal of Consent|1|||
129651915|NCT02327013|466681695|FG001|Overall Study|Withdrawal of Consent|0|||
129651916|NCT02327013|466681696|FG002|Overall Study|Withdrawal of Consent|3|||
129651917|NCT02327013|466681697|FG003|Overall Study|Withdrawal of Consent|0|||
129651918|NCT02327013|466681698|FG004|Overall Study|Withdrawal of Consent|0|||
129651919|NCT02327013|466681694|FG000|Overall Study|Lost to Follow-up|2|||
129651920|NCT02327013|466681695|FG001|Overall Study|Lost to Follow-up|4|||
129651921|NCT02327013|466681696|FG002|Overall Study|Lost to Follow-up|5|||
129651922|NCT02327013|466681697|FG003|Overall Study|Lost to Follow-up|0|||
129651923|NCT02327013|466681698|FG004|Overall Study|Lost to Follow-up|0|||
129651924|NCT02327013|466681694|FG000|Overall Study|Administrative or other reason(s)|1|||
129651925|NCT02327013|466681695|FG001|Overall Study|Administrative or other reason(s)|5|||
129651926|NCT02327013|466681696|FG002|Overall Study|Administrative or other reason(s)|11|||
129651927|NCT02327013|466681697|FG003|Overall Study|Administrative or other reason(s)|1|||
129651928|NCT02327013|466681698|FG004|Overall Study|Administrative or other reason(s)|1|||
129651929|NCT02327013|466681694|FG000|Overall Study|Protocol Violation|0|||
129651930|NCT02327013|466681695|FG001|Overall Study|Protocol Violation|0|||
129651931|NCT02327013|466681696|FG002|Overall Study|Protocol Violation|3|||
129651932|NCT02327013|466681697|FG003|Overall Study|Protocol Violation|0|||
129651933|NCT02327013|466681698|FG004|Overall Study|Protocol Violation|1|||
129651934|NCT02327013|466681694|FG000|Overall Study|Withdrawal before treatment|2|||
129651935|NCT02327013|466681695|FG001|Overall Study|Withdrawal before treatment|1|||
129651936|NCT02327013|466681696|FG002|Overall Study|Withdrawal before treatment|5|||
129651937|NCT02327013|466681697|FG003|Overall Study|Withdrawal before treatment|0|||
129651938|NCT02327013|466681698|FG004|Overall Study|Withdrawal before treatment|0|||
129651939|NCT04258254|466681699|FG000|Overall Study|Withdrawal by Subject|0|||
129651940|NCT04258254|466681700|FG001|Overall Study|Withdrawal by Subject|1|||
129651941|NCT04258254|466681701|FG002|Overall Study|Withdrawal by Subject|0|||
129651942|NCT04829331|466681702|FG000|Overall Study|Lost to Follow-up|1|||
129651943|NCT04829331|466681703|FG001|Overall Study|Lost to Follow-up|0|||
129651944|NCT00616603|466681705|FG000|Overall Study|Physician Decision|2|||
129651945|NCT00616603|466681706|FG001|Overall Study|Physician Decision|0|||
129651946|NCT00616603|466681707|FG002|Overall Study|Physician Decision|2|||
129651947|NCT02223819|466681721|FG000|Overall Study|Lost to Follow-up|2|||
129651948|NCT02956057|466681722|FG000|Overall Study|Discontinued intervention|14|||
129651949|NCT02956057|466681723|FG001|Overall Study|Discontinued intervention|10|||
129651950|NCT02956057|466681724|FG002|Overall Study|Discontinued intervention|7|||
129651951|NCT02956057|466681725|FG003|Overall Study|Discontinued intervention|14|||
129651952|NCT02956057|466681726|FG004|Overall Study|Discontinued intervention|4|||
129651953|NCT02956057|466681727|FG005|Overall Study|Discontinued intervention|17|||
129651954|NCT02956057|466681722|FG000|Overall Study|Lost to Follow-up|0|||
129651955|NCT02956057|466681723|FG001|Overall Study|Lost to Follow-up|2|||
129651956|NCT02956057|466681724|FG002|Overall Study|Lost to Follow-up|1|||
129651957|NCT02956057|466681725|FG003|Overall Study|Lost to Follow-up|1|||
129651958|NCT02956057|466681726|FG004|Overall Study|Lost to Follow-up|1|||
129651959|NCT02956057|466681727|FG005|Overall Study|Lost to Follow-up|0|||
129651960|NCT00367484|466681734|FG000|Overall Study|Adverse Event|7|||
129651961|NCT00367484|466681734|FG000|Overall Study|Withdrew informed consent|5|||
129651962|NCT00367484|466681734|FG000|Overall Study|Travel to USA|1|||
129651963|NCT00367484|466681734|FG000|Overall Study|Lost to Follow-up|1|||
129651964|NCT00367484|466681734|FG000|Overall Study|Protocol Violation|1|||
129651965|NCT00367484|466681734|FG000|Overall Study|The choice of the patient|1|||
129651966|NCT00367484|466681734|FG000|Overall Study|Lack of Efficacy|1|||
129651967|NCT00908076|466681735|FG000|Overall Study|Lack of Efficacy|1|||
129651968|NCT00908076|466681736|FG001|Overall Study|Lack of Efficacy|1|||
129651969|NCT02382796|466681737|FG000|Overall Study|Global deterioration of health status|1|||
129651970|NCT02382796|466681737|FG000|Overall Study|Objective progression or relapse|3|||
129651971|NCT02382796|466681737|FG000|Overall Study|Commercial dacomitinib became available|3|||
129651972|NCT04007107|466681744|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
129651973|NCT04007107|466681745|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
129651974|NCT04007107|466681746|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
129651975|NCT04007107|466681747|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
129651976|NCT04068688|466681753|FG000|Overall Study|Lost to Follow-up|1|||
129651977|NCT04068688|466681754|FG001|Overall Study|Lost to Follow-up|1|||
129651978|NCT04068688|466681755|FG002|Overall Study|Lost to Follow-up|0|||
129651979|NCT04068688|466681756|FG003|Overall Study|Lost to Follow-up|0|||
129651980|NCT04068688|466681757|FG004|Overall Study|Lost to Follow-up|5|||
129651981|NCT04068688|466681758|FG005|Overall Study|Lost to Follow-up|5|||
129651982|NCT04068688|466681759|FG006|Overall Study|Lost to Follow-up|0|||
129651983|NCT04068688|466681760|FG007|Overall Study|Lost to Follow-up|0|||
129651984|NCT04068688|466681761|FG008|Overall Study|Lost to Follow-up|1|||
129651985|NCT04068688|466681762|FG009|Overall Study|Lost to Follow-up|0|||
129651986|NCT04068688|466681753|FG000|Overall Study|Withdrawal by Subject|1|||
129651987|NCT04068688|466681754|FG001|Overall Study|Withdrawal by Subject|1|||
129651988|NCT04068688|466681755|FG002|Overall Study|Withdrawal by Subject|0|||
129651989|NCT04068688|466681756|FG003|Overall Study|Withdrawal by Subject|0|||
129651990|NCT04068688|466681757|FG004|Overall Study|Withdrawal by Subject|0|||
129651991|NCT04068688|466681758|FG005|Overall Study|Withdrawal by Subject|0|||
129651992|NCT04068688|466681759|FG006|Overall Study|Withdrawal by Subject|0|||
129651993|NCT04068688|466681760|FG007|Overall Study|Withdrawal by Subject|0|||
129651994|NCT04068688|466681761|FG008|Overall Study|Withdrawal by Subject|0|||
129651995|NCT04068688|466681762|FG009|Overall Study|Withdrawal by Subject|0|||
129651996|NCT04068688|466681753|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
129651997|NCT04068688|466681754|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
129651998|NCT04068688|466681755|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129651999|NCT04068688|466681756|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652000|NCT04068688|466681757|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652001|NCT04068688|466681758|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652002|NCT04068688|466681759|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652003|NCT04068688|466681760|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652004|NCT04068688|466681761|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652005|NCT04068688|466681762|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
129652006|NCT04679051|466681763|FG000|Overall Study|felt tired after restricted time in bed|3|||
129652007|NCT04679051|466681764|FG001|Overall Study|felt tired after restricted time in bed|0|||
129652008|NCT04679051|466681763|FG000|Overall Study|discomfort with blood pressure cuff|2|||
129652009|NCT04679051|466681764|FG001|Overall Study|discomfort with blood pressure cuff|0|||
129652010|NCT04679051|466681763|FG000|Overall Study|scheduling conflict|1|||
129652011|NCT04679051|466681764|FG001|Overall Study|scheduling conflict|1|||
129652012|NCT04679051|466681763|FG000|Overall Study|Protocol Violation|0|||
129652013|NCT04679051|466681764|FG001|Overall Study|Protocol Violation|4|||
129652014|NCT02554318|466681765|FG000|Overall Study|Withdrawal by Subject|10|||
129652015|NCT02554318|466681766|FG001|Overall Study|Withdrawal by Subject|8|||
129652016|NCT01273155|466681771|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
129652017|NCT01273155|466681772|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
129652018|NCT01273155|466681773|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
129652019|NCT01273155|466681774|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
129652020|NCT01273155|466681775|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
129652021|NCT01273155|466681776|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
129652022|NCT01273155|466681777|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
129652023|NCT01273155|466681771|FG000|Overall Study|Change in liver function/no longer eval.|0|||
129652024|NCT01273155|466681772|FG001|Overall Study|Change in liver function/no longer eval.|1|||
129652025|NCT01273155|466681773|FG002|Overall Study|Change in liver function/no longer eval.|0|||
129652026|NCT01273155|466681774|FG003|Overall Study|Change in liver function/no longer eval.|0|||
129652027|NCT01273155|466681775|FG004|Overall Study|Change in liver function/no longer eval.|1|||
129652028|NCT01273155|466681776|FG005|Overall Study|Change in liver function/no longer eval.|0|||
129652029|NCT01273155|466681777|FG006|Overall Study|Change in liver function/no longer eval.|0|||
129652030|NCT01273155|466681771|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
129652031|NCT01273155|466681772|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
129652032|NCT01273155|466681773|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
129652033|NCT01273155|466681774|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
129652034|NCT01273155|466681775|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
129652035|NCT01273155|466681776|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
129652036|NCT01273155|466681777|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
129652037|NCT01273155|466681771|FG000|Overall Study|Died during Cycle 1|0|||
129652038|NCT01273155|466681772|FG001|Overall Study|Died during Cycle 1|0|||
129652039|NCT01273155|466681773|FG002|Overall Study|Died during Cycle 1|1|||
129652040|NCT01273155|466681774|FG003|Overall Study|Died during Cycle 1|1|||
129652041|NCT01273155|466681775|FG004|Overall Study|Died during Cycle 1|0|||
129652042|NCT01273155|466681776|FG005|Overall Study|Died during Cycle 1|2|||
129652043|NCT01273155|466681777|FG006|Overall Study|Died during Cycle 1|2|||
129652044|NCT01273155|466681771|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
129652045|NCT01273155|466681772|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
129652046|NCT01273155|466681773|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
129652047|NCT01273155|466681774|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
129652048|NCT01273155|466681775|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
129652049|NCT01273155|466681776|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
129652050|NCT01273155|466681777|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
129876791|NCT01859793|467509197|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
129876792|NCT01859793|467509198|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
129652051|NCT01438814|466681783|FG000|Overall Study|Adverse Event|3|||
129652052|NCT01438814|466681784|FG001|Overall Study|Adverse Event|3|||
129652053|NCT01438814|466681783|FG000|Overall Study|Protocol Violation|1|||
129876793|NCT01859793|467509197|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129652054|NCT01438814|466681784|FG001|Overall Study|Protocol Violation|2|||
129652055|NCT01438814|466681783|FG000|Overall Study|Lost to Follow-up|4|||
129652056|NCT01438814|466681784|FG001|Overall Study|Lost to Follow-up|3|||
129652057|NCT01438814|466681783|FG000|Overall Study|Withdrawal by Subject|4|||
129652058|NCT01438814|466681784|FG001|Overall Study|Withdrawal by Subject|2|||
129652059|NCT01438814|466681783|FG000|Overall Study|Other|2|||
129652060|NCT01438814|466681784|FG001|Overall Study|Other|4|||
129652061|NCT00990665|466681785|FG000|Overall Study|Unsuccessful Implant|8|||
129652062|NCT00990665|466681785|FG000|Overall Study|Death|29|||
129652063|NCT00990665|466681785|FG000|Overall Study|Heart Transplant|1|||
129652064|NCT00990665|466681785|FG000|Overall Study|Withdrawal by Subject|6|||
129652065|NCT00990665|466681785|FG000|Overall Study|Lost to Follow-up|1|||
129652066|NCT00990665|466681785|FG000|Overall Study|System Explant|3|||
129652067|NCT00672841|466681786|FG000|Overall Study|Comfort care|1|||
129652068|NCT00672841|466681787|FG001|Overall Study|Comfort care|4|||
129652069|NCT00672841|466681786|FG000|Overall Study|icteric specimens|0|||
129652070|NCT00672841|466681787|FG001|Overall Study|icteric specimens|3|||
129652071|NCT00672841|466681786|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
129652072|NCT00672841|466681787|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
129652073|NCT00672841|466681786|FG000|Overall Study|Adverse Event|0|||
129652074|NCT00672841|466681787|FG001|Overall Study|Adverse Event|3|||
129652075|NCT00672841|466681786|FG000|Overall Study|Pregnancy|0|||
129652076|NCT00672841|466681787|FG001|Overall Study|Pregnancy|1|||
129652077|NCT03578146|466681788|FG000|Overall Study|Did Not Receive Treatment|1|||
129652078|NCT03578146|466681789|FG001|Overall Study|Did Not Receive Treatment|0|||
129652079|NCT03578146|466681790|FG002|Overall Study|Did Not Receive Treatment|0|||
129652080|NCT03578146|466681791|FG003|Overall Study|Did Not Receive Treatment|0|||
129652081|NCT03578146|466681792|FG004|Overall Study|Did Not Receive Treatment|0|||
129652082|NCT03578146|466681793|FG005|Overall Study|Did Not Receive Treatment|2|||
129652083|NCT03578146|466681788|FG000|Overall Study|Lost to Follow-up|0|||
129652084|NCT03578146|466681789|FG001|Overall Study|Lost to Follow-up|1|||
129652085|NCT03578146|466681790|FG002|Overall Study|Lost to Follow-up|1|||
129652086|NCT03578146|466681791|FG003|Overall Study|Lost to Follow-up|0|||
129652087|NCT03578146|466681792|FG004|Overall Study|Lost to Follow-up|0|||
129652088|NCT03578146|466681793|FG005|Overall Study|Lost to Follow-up|1|||
129652089|NCT01717391|466681794|FG000|Overall Study|Withdrawal by Subject|5|||
129652090|NCT01717391|466681794|FG000|Overall Study|Physician Decision|1|||
129652091|NCT01717391|466681794|FG000|Overall Study|FLT technical failure|3|||
129652092|NCT03677934|466681795|FG000|Overall Study|Adverse Event|1|||
129652093|NCT03677934|466681796|FG001|Overall Study|Adverse Event|1|||
129652094|NCT03677934|466681795|FG000|Overall Study|Death|8|||
129652095|NCT03677934|466681796|FG001|Overall Study|Death|4|||
129652096|NCT03677934|466681795|FG000|Overall Study|Lost to Follow-up|3|||
129652097|NCT03677934|466681796|FG001|Overall Study|Lost to Follow-up|0|||
129652098|NCT03677934|466681795|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129652099|NCT03677934|466681796|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129652100|NCT03677934|466681795|FG000|Overall Study|Physician Decision|0|||
129652101|NCT03677934|466681796|FG001|Overall Study|Physician Decision|1|||
129652102|NCT03677934|466681795|FG000|Overall Study|Withdrawal by Subject|1|||
129652103|NCT03677934|466681796|FG001|Overall Study|Withdrawal by Subject|7|||
129652104|NCT01731470|466681798|FG000|Overall Study|Withdrawal by Subject|1|||
129652105|NCT01731470|466681798|FG000|Overall Study|Did not meet study criteria|1|||
129652106|NCT00335959|466681799|FG000|Overall Study|Adverse Event|2|||
129652107|NCT00335959|466681799|FG000|Overall Study|Ineligible|1|||
129652108|NCT02450552|466681803|FG000|Overall Study|Withdrawal by Subject|4|||
129652109|NCT02450552|466681804|FG001|Overall Study|Withdrawal by Subject|0|||
129652110|NCT02450552|466681805|FG002|Overall Study|Withdrawal by Subject|4|||
129652111|NCT02450552|466681803|FG000|Overall Study|Physician Decision|1|||
129652112|NCT02450552|466681804|FG001|Overall Study|Physician Decision|0|||
129652113|NCT02450552|466681805|FG002|Overall Study|Physician Decision|1|||
129652114|NCT01876979|466681811|FG000|Overall Study|Physician Decision|2|||
129652115|NCT01876979|466681812|FG001|Overall Study|Physician Decision|3|||
129652116|NCT00948506|466681813|FG000|Overall Study|Withdrawal by Subject|3|||
129652117|NCT00948506|466681814|FG001|Overall Study|Withdrawal by Subject|1|||
129652118|NCT00824382|466681815|FG000|Overall Study|Adverse Event|4|||
129652119|NCT00824382|466681816|FG001|Overall Study|Adverse Event|1|||
129652120|NCT00824382|466681817|FG002|Overall Study|Adverse Event|1|||
129652121|NCT00824382|466681818|FG003|Overall Study|Adverse Event|4|||
129652122|NCT00824382|466681815|FG000|Overall Study|Protocol Violation|1|||
129652123|NCT00824382|466681816|FG001|Overall Study|Protocol Violation|0|||
129652124|NCT00824382|466681817|FG002|Overall Study|Protocol Violation|0|||
129652125|NCT00824382|466681818|FG003|Overall Study|Protocol Violation|1|||
129652126|NCT00824382|466681815|FG000|Overall Study|Investigator's decision|0|||
129652127|NCT00824382|466681816|FG001|Overall Study|Investigator's decision|1|||
129652128|NCT00824382|466681817|FG002|Overall Study|Investigator's decision|2|||
129652129|NCT00824382|466681818|FG003|Overall Study|Investigator's decision|0|||
129652130|NCT00721279|466681819|FG000|Overall Study|Lack of Efficacy|6|||
129652131|NCT00721279|466681820|FG001|Overall Study|Lack of Efficacy|3|||
129652132|NCT00721279|466681819|FG000|Overall Study|Tolerability insufficient|5|||
129652133|NCT00721279|466681820|FG001|Overall Study|Tolerability insufficient|2|||
129652134|NCT00721279|466681819|FG000|Overall Study|Withdrawal by Subject|13|||
129652135|NCT00721279|466681820|FG001|Overall Study|Withdrawal by Subject|3|||
129652136|NCT00721279|466681819|FG000|Overall Study|Other|12|||
129652137|NCT00721279|466681820|FG001|Overall Study|Other|16|||
129652138|NCT03467763|466681821|FG000|Overall Study|Lost to Follow-up|1|||
129652139|NCT03467763|466681821|FG000|Overall Study|Protocol Violation|2|||
129652140|NCT02407054|466681822|FG000|Overall Study|Adverse Event|1|||
129652141|NCT02407054|466681823|FG001|Overall Study|Adverse Event|4|||
129652142|NCT02407054|466681824|FG002|Overall Study|Adverse Event|1|||
129652143|NCT02407054|466681822|FG000|Overall Study|Non-compliance with Study|0|||
129652144|NCT02407054|466681823|FG001|Overall Study|Non-compliance with Study|2|||
129652145|NCT02407054|466681824|FG002|Overall Study|Non-compliance with Study|1|||
129652146|NCT02407054|466681822|FG000|Overall Study|Physician Decision|1|||
129652147|NCT02407054|466681823|FG001|Overall Study|Physician Decision|3|||
129652148|NCT02407054|466681824|FG002|Overall Study|Physician Decision|3|||
129652149|NCT02407054|466681822|FG000|Overall Study|Withdrawal by Subject|5|||
129652150|NCT02407054|466681823|FG001|Overall Study|Withdrawal by Subject|9|||
129652151|NCT02407054|466681824|FG002|Overall Study|Withdrawal by Subject|2|||
129652152|NCT00131365|466681825|FG000|Overall Study|Withdrawal by Subject|1|||
129652153|NCT00131365|466681825|FG000|Overall Study|Alternative treatment|3|||
129652154|NCT04608344|466681826|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
129652155|NCT04608344|466681827|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
129652156|NCT04608344|466681826|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
129652157|NCT04608344|466681827|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
129652158|NCT02044874|466681828|FG000|Overall Study|Adverse Event|5|||
129652159|NCT02044874|466681829|FG001|Overall Study|Adverse Event|6|||
129652160|NCT02044874|466681830|FG002|Overall Study|Adverse Event|6|||
129652161|NCT02044874|466681828|FG000|Overall Study|Withdrawal by Subject|8|||
129652162|NCT02044874|466681829|FG001|Overall Study|Withdrawal by Subject|16|||
129652163|NCT02044874|466681830|FG002|Overall Study|Withdrawal by Subject|23|||
129652164|NCT02044874|466681828|FG000|Overall Study|Physician Decision|0|||
129652165|NCT02044874|466681829|FG001|Overall Study|Physician Decision|2|||
129652166|NCT02044874|466681830|FG002|Overall Study|Physician Decision|1|||
129652167|NCT02044874|466681828|FG000|Overall Study|Lost to Follow-up|10|||
129652168|NCT02044874|466681829|FG001|Overall Study|Lost to Follow-up|27|||
129652169|NCT02044874|466681830|FG002|Overall Study|Lost to Follow-up|21|||
129652170|NCT02044874|466681828|FG000|Overall Study|Sponsor Decision|0|||
129652171|NCT02044874|466681829|FG001|Overall Study|Sponsor Decision|1|||
129652172|NCT02044874|466681830|FG002|Overall Study|Sponsor Decision|1|||
129652173|NCT02044874|466681828|FG000|Overall Study|Other|7|||
129652174|NCT02044874|466681829|FG001|Overall Study|Other|3|||
129652175|NCT02044874|466681830|FG002|Overall Study|Other|8|||
129652176|NCT00415597|466681831|FG000|Enrollment|Withdrawal by Subject|1|||
129652177|NCT00415597|466681831|FG000|Enrollment|Protocol Violation|1|||
129652178|NCT00415597|466681831|FG000|Treatment|Adverse Event|110|||
129652179|NCT00415597|466681831|FG000|Treatment|Lack of Efficacy|39|||
129652180|NCT00415597|466681831|FG000|Treatment|Protocol Violation|67|||
129652181|NCT00415597|466681831|FG000|Treatment|Physician Decision|3|||
129652182|NCT00415597|466681831|FG000|Treatment|Withdrawal by Subject|51|||
129652183|NCT00415597|466681831|FG000|Treatment|Lost to Follow-up|28|||
129652184|NCT00415597|466681831|FG000|Treatment|Drug Screen|2|||
129652185|NCT00415597|466681831|FG000|Treatment|Administrative|3|||
129652186|NCT00415597|466681831|FG000|Treatment|Sponsor Decision|1|||
129652187|NCT00415597|466681831|FG000|Treatment|Multiple Reasons|1|||
129652188|NCT01447927|466681832|FG000|Overall Study|Adverse Event|4|||
129652189|NCT01447927|466681833|FG001|Overall Study|Adverse Event|3|||
129652190|NCT01447927|466681832|FG000|Overall Study|Withdrawal by Subject|1|||
129652191|NCT01447927|466681833|FG001|Overall Study|Withdrawal by Subject|0|||
129652192|NCT04102865|466681835|FG000|Overall Study|Adverse Event|4|||
129652193|NCT04102865|466681836|FG001|Overall Study|Adverse Event|0|||
129652194|NCT04102865|466681835|FG000|Overall Study|Lost to Follow-up|1|||
129652195|NCT04102865|466681836|FG001|Overall Study|Lost to Follow-up|0|||
129652196|NCT04102865|466681835|FG000|Overall Study|Withdrawal by Subject|2|||
129652197|NCT04102865|466681836|FG001|Overall Study|Withdrawal by Subject|0|||
129652198|NCT01764997|466681837|FG000|Run-in Period|Adverse Event|15|||
129652199|NCT01764997|466681838|FG001|Run-in Period|Adverse Event|0|||
129652200|NCT01764997|466681839|FG002|Run-in Period|Adverse Event|0|||
129652201|NCT01764997|466681840|FG003|Run-in Period|Adverse Event|0|||
129652202|NCT01764997|466681841|FG004|Run-in Period|Adverse Event|0|||
129652203|NCT01764997|466681837|FG000|Run-in Period|Lack of Efficacy|5|||
129652204|NCT01764997|466681838|FG001|Run-in Period|Lack of Efficacy|0|||
129652205|NCT01764997|466681839|FG002|Run-in Period|Lack of Efficacy|0|||
129766232|NCT05176314|467110328|FG000|Overall Study|Adverse Event|1|||
129652206|NCT01764997|466681840|FG003|Run-in Period|Lack of Efficacy|0|||
129652207|NCT01764997|466681841|FG004|Run-in Period|Lack of Efficacy|0|||
129652208|NCT01764997|466681837|FG000|Run-in Period|Poor compliance to protocol|1|||
129652209|NCT01764997|466681838|FG001|Run-in Period|Poor compliance to protocol|0|||
129652210|NCT01764997|466681839|FG002|Run-in Period|Poor compliance to protocol|0|||
129652211|NCT01764997|466681840|FG003|Run-in Period|Poor compliance to protocol|0|||
129652212|NCT01764997|466681841|FG004|Run-in Period|Poor compliance to protocol|0|||
129652213|NCT01764997|466681837|FG000|Run-in Period|Other than specified above|17|||
129652214|NCT01764997|466681838|FG001|Run-in Period|Other than specified above|0|||
129652215|NCT01764997|466681839|FG002|Run-in Period|Other than specified above|0|||
129652216|NCT01764997|466681840|FG003|Run-in Period|Other than specified above|0|||
129652217|NCT01764997|466681841|FG004|Run-in Period|Other than specified above|0|||
129652218|NCT01764997|466681837|FG000|Study Drug Treatment Period|Adverse Event|0|||
129652219|NCT01764997|466681838|FG001|Study Drug Treatment Period|Adverse Event|1|||
129652220|NCT01764997|466681839|FG002|Study Drug Treatment Period|Adverse Event|0|||
129652221|NCT01764997|466681840|FG003|Study Drug Treatment Period|Adverse Event|0|||
129652222|NCT01764997|466681841|FG004|Study Drug Treatment Period|Adverse Event|24|||
129652223|NCT01764997|466681837|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
129652224|NCT01764997|466681838|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
129652225|NCT01764997|466681839|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
129652226|NCT01764997|466681840|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
129652227|NCT01764997|466681841|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
129652228|NCT01764997|466681837|FG000|Study Drug Treatment Period|Other than specified above|0|||
129652229|NCT01764997|466681838|FG001|Study Drug Treatment Period|Other than specified above|0|||
129652230|NCT01764997|466681839|FG002|Study Drug Treatment Period|Other than specified above|0|||
129652231|NCT01764997|466681840|FG003|Study Drug Treatment Period|Other than specified above|0|||
129652232|NCT01764997|466681841|FG004|Study Drug Treatment Period|Other than specified above|10|||
129652233|NCT04438499|466681850|FG000|Overall Study|Lack of Efficacy|3|||
129652234|NCT04918355|466681851|FG000|Overall Study|no qualifying health encounter|497|||
129652235|NCT04918355|466681852|FG001|Overall Study|no qualifying health encounter|192|||
129652236|NCT04918355|466681853|FG002|Overall Study|no qualifying health encounter|438|||
129652237|NCT04918355|466681854|FG003|Overall Study|no qualifying health encounter|424|||
129652238|NCT04683939|466681856|FG000|Overall Study|Study termination by the sponsor|0|||
129652239|NCT04683939|466681857|FG001|Overall Study|Study termination by the sponsor|1|||
129652240|NCT04683939|466681858|FG002|Overall Study|Study termination by the sponsor|2|||
129652241|NCT04683939|466681859|FG003|Overall Study|Study termination by the sponsor|2|||
129652242|NCT04683939|466681856|FG000|Overall Study|Death|1|||
129652243|NCT04683939|466681857|FG001|Overall Study|Death|1|||
129652244|NCT04683939|466681858|FG002|Overall Study|Death|2|||
129652245|NCT04683939|466681859|FG003|Overall Study|Death|1|||
129652246|NCT04683939|466681856|FG000|Overall Study|Withdrawal by Subject|1|||
129652247|NCT04683939|466681857|FG001|Overall Study|Withdrawal by Subject|0|||
129652248|NCT04683939|466681858|FG002|Overall Study|Withdrawal by Subject|0|||
129652249|NCT04683939|466681859|FG003|Overall Study|Withdrawal by Subject|0|||
129652250|NCT04683939|466681856|FG000|Overall Study|Physician Decision|1|||
129652251|NCT04683939|466681857|FG001|Overall Study|Physician Decision|0|||
129652252|NCT04683939|466681858|FG002|Overall Study|Physician Decision|0|||
129652253|NCT04683939|466681859|FG003|Overall Study|Physician Decision|0|||
129652254|NCT04683939|466681856|FG000|Overall Study|Lost to Follow-up|0|||
129652255|NCT04683939|466681857|FG001|Overall Study|Lost to Follow-up|1|||
129652256|NCT04683939|466681858|FG002|Overall Study|Lost to Follow-up|0|||
129652257|NCT04683939|466681859|FG003|Overall Study|Lost to Follow-up|0|||
129652258|NCT01556997|466683774|FG000|Overall Study|Adverse Event|10|||
129652259|NCT01556997|466683775|FG001|Overall Study|Adverse Event|12|||
129652260|NCT01556997|466683776|FG002|Overall Study|Adverse Event|12|||
129652261|NCT01556997|466683774|FG000|Overall Study|Lost to Follow-up|6|||
129652262|NCT01556997|466683775|FG001|Overall Study|Lost to Follow-up|6|||
129652263|NCT01556997|466683776|FG002|Overall Study|Lost to Follow-up|4|||
129652264|NCT01556997|466683774|FG000|Overall Study|Physician Decision|1|||
129652265|NCT01556997|466683775|FG001|Overall Study|Physician Decision|1|||
129652266|NCT01556997|466683776|FG002|Overall Study|Physician Decision|1|||
129876794|NCT01859793|467509198|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129876795|NCT01859793|467509197|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
129876796|NCT01859793|467509198|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
129876797|NCT01735396|467509202|FG000|Overall Study|not evaluable|1|||
129876798|NCT02002182|467509203|FG000|Overall Study|Withdraw from study|3|||
129876799|NCT02002182|467509204|FG001|Overall Study|Withdraw from study|1|||
129876800|NCT02002182|467509203|FG000|Overall Study|Health Reasons|1|||
129876801|NCT02002182|467509204|FG001|Overall Study|Health Reasons|0|||
129539307|NCT01397409|466265244|FG002|Stage 2|Personal Reasons|0|||
129652267|NCT01556997|466683774|FG000|Overall Study|Withdrawal by Subject|7|||
129652268|NCT01556997|466683775|FG001|Overall Study|Withdrawal by Subject|6|||
129652269|NCT01556997|466683776|FG002|Overall Study|Withdrawal by Subject|8|||
129652270|NCT01556997|466683774|FG000|Overall Study|Other|2|||
129652271|NCT01556997|466683775|FG001|Overall Study|Other|3|||
129652272|NCT01556997|466683776|FG002|Overall Study|Other|7|||
129652273|NCT04643964|466683785|FG000|Overall Study|Lost to Follow-up|55|||
129652274|NCT04643964|466683786|FG001|Overall Study|Lost to Follow-up|59|||
129876802|NCT02002182|467509203|FG000|Overall Study|Death|1|||
129876803|NCT02002182|467509204|FG001|Overall Study|Death|0|||
129876804|NCT04146896|467509205|FG000|Overall Study|Adverse Event|5|||
129652275|NCT04643964|466683787|FG002|Overall Study|Lost to Follow-up|54|||
129876805|NCT04146896|467509206|FG001|Overall Study|Adverse Event|8|||
129876806|NCT04146896|467509205|FG000|Overall Study|Lack of Efficacy|3|||
129876807|NCT04146896|467509206|FG001|Overall Study|Lack of Efficacy|2|||
129876808|NCT04146896|467509205|FG000|Overall Study|Lost to Follow-up|0|||
129876809|NCT04146896|467509206|FG001|Overall Study|Lost to Follow-up|1|||
129876810|NCT04146896|467509205|FG000|Overall Study|Non-compliance|5|||
129876811|NCT04146896|467509206|FG001|Overall Study|Non-compliance|4|||
129876812|NCT04146896|467509205|FG000|Overall Study|Withdrawal by Subject|3|||
129652276|NCT04643964|466683788|FG003|Overall Study|Lost to Follow-up|129|||
129652277|NCT04643964|466683789|FG004|Overall Study|Lost to Follow-up|48|||
129652278|NCT04643964|466683785|FG000|Overall Study|Failed attention check|1|||
129652279|NCT04643964|466683786|FG001|Overall Study|Failed attention check|8|||
129652280|NCT04643964|466683787|FG002|Overall Study|Failed attention check|2|||
129652281|NCT04643964|466683788|FG003|Overall Study|Failed attention check|14|||
129652282|NCT04643964|466683789|FG004|Overall Study|Failed attention check|11|||
129652283|NCT05932225|466683790|FG000|Overall Study|Lost to Follow-up|0|||
129652284|NCT05932225|466683791|FG001|Overall Study|Lost to Follow-up|1|||
129876813|NCT04146896|467509206|FG001|Overall Study|Withdrawal by Subject|5|||
129876814|NCT04146896|467509205|FG000|Overall Study|Randomized in error|1|||
129876815|NCT04146896|467509206|FG001|Overall Study|Randomized in error|2|||
129876816|NCT04296890|467509207|FG000|Overall Study|Withdrawal by Subject|1|||
129652285|NCT05932225|466683792|FG002|Overall Study|Lost to Follow-up|0|||
129652286|NCT05932225|466683790|FG000|Overall Study|Withdrawal by Subject|1|||
129652287|NCT05932225|466683791|FG001|Overall Study|Withdrawal by Subject|0|||
129652288|NCT05932225|466683792|FG002|Overall Study|Withdrawal by Subject|0|||
129652289|NCT05932225|466683790|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
129652290|NCT05932225|466683791|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
129652291|NCT05932225|466683792|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
129652292|NCT02638129|466683793|FG000|Overall Study|Study terminated|28|||
129652293|NCT02638129|466683794|FG001|Overall Study|Study terminated|30|||
129652294|NCT02949908|466683795|FG000|Overall Study|Study termination|2|||
129652295|NCT01472939|466683796|FG000|Overall Study|Adverse Event|3|||
129652296|NCT01472939|466683797|FG001|Overall Study|Adverse Event|7|||
129652297|NCT01472939|466683798|FG002|Overall Study|Adverse Event|7|||
129652298|NCT01472939|466683799|FG003|Overall Study|Adverse Event|14|||
129652299|NCT01472939|466683796|FG000|Overall Study|Lack of Efficacy|1|||
129652300|NCT01472939|466683797|FG001|Overall Study|Lack of Efficacy|0|||
129652301|NCT01472939|466683798|FG002|Overall Study|Lack of Efficacy|0|||
129652302|NCT01472939|466683799|FG003|Overall Study|Lack of Efficacy|1|||
129652303|NCT01472939|466683796|FG000|Overall Study|Lost to Follow-up|3|||
129652304|NCT01472939|466683797|FG001|Overall Study|Lost to Follow-up|0|||
129652305|NCT01472939|466683798|FG002|Overall Study|Lost to Follow-up|2|||
129652306|NCT01472939|466683799|FG003|Overall Study|Lost to Follow-up|0|||
129652307|NCT01472939|466683796|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
129652308|NCT01472939|466683797|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
129652309|NCT01472939|466683798|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
129652310|NCT01472939|466683799|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
129652311|NCT01472939|466683796|FG000|Overall Study|Prohibited Medication|0|||
129652312|NCT01472939|466683797|FG001|Overall Study|Prohibited Medication|1|||
129652313|NCT01472939|466683798|FG002|Overall Study|Prohibited Medication|0|||
129652314|NCT01472939|466683799|FG003|Overall Study|Prohibited Medication|0|||
129652315|NCT01472939|466683796|FG000|Overall Study|Withdrawal By PI|1|||
129652316|NCT01472939|466683797|FG001|Overall Study|Withdrawal By PI|0|||
129652317|NCT01472939|466683798|FG002|Overall Study|Withdrawal By PI|0|||
129652318|NCT01472939|466683799|FG003|Overall Study|Withdrawal By PI|0|||
129652319|NCT01472939|466683796|FG000|Overall Study|Protocol Violation|3|||
129652320|NCT01472939|466683797|FG001|Overall Study|Protocol Violation|3|||
129652321|NCT01472939|466683798|FG002|Overall Study|Protocol Violation|0|||
129652322|NCT01472939|466683799|FG003|Overall Study|Protocol Violation|1|||
129652323|NCT01472939|466683796|FG000|Overall Study|Withdrawal by Subject|9|||
129652324|NCT01472939|466683797|FG001|Overall Study|Withdrawal by Subject|3|||
129876817|NCT04296890|467509207|FG000|Overall Study|Death|62|||
129876818|NCT04296890|467509207|FG000|Overall Study|Lost to Follow-up|3|||
129876819|NCT04296890|467509207|FG000|Overall Study|Other than specified|2|||
129652325|NCT01472939|466683798|FG002|Overall Study|Withdrawal by Subject|1|||
129652326|NCT01472939|466683799|FG003|Overall Study|Withdrawal by Subject|4|||
129652327|NCT00114738|466683800|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
129876820|NCT05400746|467509208|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
129876821|NCT05400746|467509209|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
129876822|NCT05400746|467509210|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
129876823|NCT02277743|467509215|FG000|Overall Study|Protocol Violation|1|||
129652328|NCT00114738|466683801|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
129652329|NCT00114738|466683802|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
129652330|NCT00114738|466683800|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
129652331|NCT00114738|466683801|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
129707758|NCT01280968|466892118|FG001|Overall Study|Commuting Problems|0|||
129652332|NCT00114738|466683802|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
129652333|NCT00114738|466683800|FG000|Screening for Randomization|Neuropathy|17|||
129652334|NCT00114738|466683801|FG001|Screening for Randomization|Neuropathy|0|||
129652335|NCT00114738|466683802|FG002|Screening for Randomization|Neuropathy|0|||
129652336|NCT00114738|466683800|FG000|Screening for Randomization|Progressive disease|2|||
129652337|NCT00114738|466683801|FG001|Screening for Randomization|Progressive disease|0|||
129652338|NCT00114738|466683802|FG002|Screening for Randomization|Progressive disease|0|||
129652339|NCT00114738|466683800|FG000|Screening for Randomization|CNS Hemorrhage|1|||
129652340|NCT00114738|466683801|FG001|Screening for Randomization|CNS Hemorrhage|0|||
129652341|NCT00114738|466683802|FG002|Screening for Randomization|CNS Hemorrhage|0|||
129652342|NCT00114738|466683800|FG000|Screening for Randomization|Other|1|||
129652343|NCT00114738|466683801|FG001|Screening for Randomization|Other|0|||
129652344|NCT00114738|466683802|FG002|Screening for Randomization|Other|0|||
129652345|NCT00388297|466683805|FG000|Overall Study|Lost to Follow-up|16|||
129652346|NCT00388297|466683806|FG001|Overall Study|Lost to Follow-up|12|||
129652347|NCT00388297|466683807|FG002|Overall Study|Lost to Follow-up|11|||
129652348|NCT00388297|466683808|FG003|Overall Study|Lost to Follow-up|8|||
129652349|NCT02607280|466683809|FG000|Overall Study|Adverse Event|4|||
129652350|NCT02607280|466683810|FG001|Overall Study|Adverse Event|0|||
129652351|NCT02607280|466683809|FG000|Overall Study|Decrease in CrCl <15|0|||
129652352|NCT02607280|466683810|FG001|Overall Study|Decrease in CrCl <15|1|||
129652353|NCT03435224|466683816|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
129652354|NCT04472026|466683817|FG000|Overall Study|Lost to Follow-up|5|||
129652355|NCT01777295|466683818|FG000|Overall Study|Withdrawal by Subject|2|||
129652356|NCT01777295|466683819|FG001|Overall Study|Withdrawal by Subject|2|||
129652357|NCT01777295|466683818|FG000|Overall Study|Pregnancy|0|||
129652358|NCT01777295|466683819|FG001|Overall Study|Pregnancy|1|||
129652359|NCT01777295|466683818|FG000|Overall Study|Personal problem|1|||
129652360|NCT01777295|466683819|FG001|Overall Study|Personal problem|0|||
129652361|NCT01777295|466683818|FG000|Overall Study|Investigator call for AEs check|1|||
129652362|NCT01777295|466683819|FG001|Overall Study|Investigator call for AEs check|0|||
129652363|NCT01069419|466683820|FG000|Overall Study|Adverse Event|233|||
129652364|NCT01069419|466683820|FG000|Overall Study|Lack of Efficacy|332|||
129652365|NCT01069419|466683820|FG000|Overall Study|Lost to Follow-up|49|||
129652366|NCT01069419|466683820|FG000|Overall Study|Remission of disease|11|||
129652367|NCT01069419|466683820|FG000|Overall Study|Withdrawal by Subject|34|||
129652368|NCT01069419|466683820|FG000|Overall Study|Other Reason|43|||
129652369|NCT01069419|466683820|FG000|Overall Study|Missing termination information|13|||
129652370|NCT04526574|466683821|FG000|Overall Study|Protocol Violation|3|||
129652371|NCT04526574|466683822|FG001|Overall Study|Protocol Violation|1|||
129652372|NCT04526574|466683821|FG000|Overall Study|Withdrawal by Subject|12|||
129652373|NCT04526574|466683822|FG001|Overall Study|Withdrawal by Subject|9|||
129652374|NCT04526574|466683821|FG000|Overall Study|Other|1|||
129652375|NCT04526574|466683822|FG001|Overall Study|Other|2|||
129652376|NCT04526574|466683821|FG000|Overall Study|Adverse Event|1|||
129652377|NCT04526574|466683822|FG001|Overall Study|Adverse Event|1|||
129652378|NCT04526574|466683821|FG000|Overall Study|Death|2|||
129652379|NCT04526574|466683822|FG001|Overall Study|Death|3|||
129652380|NCT04526574|466683821|FG000|Overall Study|Lost to Follow-up|9|||
129652381|NCT04526574|466683822|FG001|Overall Study|Lost to Follow-up|9|||
129652382|NCT04526574|466683821|FG000|Overall Study|No longer meets eligibility criteria|8|||
129652383|NCT04526574|466683822|FG001|Overall Study|No longer meets eligibility criteria|8|||
129652384|NCT02248974|466683825|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
129652385|NCT02248974|466683826|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
129652386|NCT02248974|466683825|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
129652387|NCT02248974|466683826|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
129652388|NCT02248974|466683825|FG000|1-Day Follow-Up|Enrolled in another study|1|||
129652389|NCT02248974|466683826|FG001|1-Day Follow-Up|Enrolled in another study|0|||
129652390|NCT02248974|466683825|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
129652391|NCT02248974|466683826|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
129652392|NCT02248974|466683825|FG000|1-Week Follow-Up|Enrolled in another study|1|||
129652393|NCT02248974|466683826|FG001|1-Week Follow-Up|Enrolled in another study|1|||
129652394|NCT02248974|466683825|FG000|1-Week Follow-Up|Transferred to another facility|1|||
129652395|NCT02248974|466683826|FG001|1-Week Follow-Up|Transferred to another facility|0|||
129652396|NCT02248974|466683825|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
129652397|NCT02248974|466683826|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
129652398|NCT02248974|466683825|FG000|1-Week Follow-Up|Death|1|||
129652399|NCT02248974|466683826|FG001|1-Week Follow-Up|Death|1|||
129652400|NCT02248974|466683825|FG000|1-Week Follow-Up|Excluded because of age|0|||
129652401|NCT02248974|466683826|FG001|1-Week Follow-Up|Excluded because of age|1|||
129652402|NCT02248974|466683825|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
129652403|NCT02248974|466683826|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
129652404|NCT02248974|466683825|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
129652405|NCT02248974|466683826|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
129652406|NCT02248974|466683825|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
129652407|NCT02248974|466683826|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
129652408|NCT02248974|466683825|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
129652409|NCT02248974|466683826|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
129652410|NCT02248974|466683825|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
129652411|NCT02248974|466683826|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
129652412|NCT02332239|466683827|FG000|Overall Study|Lost to Follow-up|4|||
129652413|NCT02332239|466683828|FG001|Overall Study|Lost to Follow-up|6|||
129652414|NCT00115037|466683829|FG000|Phase1|Lost to Follow-up|16|||
129652415|NCT00115037|466683830|FG001|Phase1|Lost to Follow-up|23|||
129652416|NCT00115037|466683831|FG002|Phase1|Lost to Follow-up|0|||
129652417|NCT00115037|466683832|FG003|Phase1|Lost to Follow-up|0|||
129652418|NCT00115037|466683833|FG004|Phase1|Lost to Follow-up|0|||
129652419|NCT00115037|466683834|FG005|Phase1|Lost to Follow-up|0|||
129652420|NCT00115037|466683829|FG000|Phase1|Withdrawal by Subject|9|||
129652421|NCT00115037|466683830|FG001|Phase1|Withdrawal by Subject|4|||
129652422|NCT00115037|466683831|FG002|Phase1|Withdrawal by Subject|0|||
129652423|NCT00115037|466683832|FG003|Phase1|Withdrawal by Subject|0|||
129652424|NCT00115037|466683833|FG004|Phase1|Withdrawal by Subject|0|||
129652425|NCT00115037|466683834|FG005|Phase1|Withdrawal by Subject|0|||
129652426|NCT00115037|466683829|FG000|Phase2|Death|0|||
129652427|NCT00115037|466683830|FG001|Phase2|Death|0|||
129652428|NCT00115037|466683831|FG002|Phase2|Death|1|||
129652429|NCT00115037|466683832|FG003|Phase2|Death|0|||
129652430|NCT00115037|466683833|FG004|Phase2|Death|0|||
129652431|NCT00115037|466683834|FG005|Phase2|Death|1|||
129652432|NCT00115037|466683829|FG000|Phase2|Withdrawal by Subject|0|||
129652433|NCT00115037|466683830|FG001|Phase2|Withdrawal by Subject|0|||
129652434|NCT00115037|466683831|FG002|Phase2|Withdrawal by Subject|2|||
129652435|NCT00115037|466683832|FG003|Phase2|Withdrawal by Subject|1|||
129652436|NCT00115037|466683833|FG004|Phase2|Withdrawal by Subject|2|||
129652437|NCT00115037|466683834|FG005|Phase2|Withdrawal by Subject|1|||
129652438|NCT00115037|466683829|FG000|Phase2|Lost to Follow-up|0|||
129652439|NCT00115037|466683830|FG001|Phase2|Lost to Follow-up|0|||
129652440|NCT00115037|466683831|FG002|Phase2|Lost to Follow-up|12|||
129652441|NCT00115037|466683832|FG003|Phase2|Lost to Follow-up|14|||
129652442|NCT00115037|466683833|FG004|Phase2|Lost to Follow-up|4|||
129652443|NCT00115037|466683834|FG005|Phase2|Lost to Follow-up|10|||
129652444|NCT00396877|466683835|FG000|Overall Study|Lost to Follow-up|2|||
129652445|NCT00396877|466683836|FG001|Overall Study|Lost to Follow-up|1|||
129652446|NCT00396877|466683835|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
129652447|NCT00396877|466683836|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
129652448|NCT00334802|466683837|FG000|Overall Study|Progressive Disease|2|||
129652449|NCT00334802|466683838|FG001|Overall Study|Progressive Disease|24|||
129652450|NCT00334802|466683837|FG000|Overall Study|Toxicity|1|||
129652451|NCT00334802|466683838|FG001|Overall Study|Toxicity|5|||
129652452|NCT00334802|466683837|FG000|Overall Study|Lack of Efficacy|1|||
129652453|NCT00334802|466683838|FG001|Overall Study|Lack of Efficacy|3|||
129652454|NCT00334802|466683837|FG000|Overall Study|Patient Condition Aggrevated|1|||
129652455|NCT00334802|466683838|FG001|Overall Study|Patient Condition Aggrevated|0|||
129652456|NCT00334802|466683837|FG000|Overall Study|Physician Decision|1|||
129652457|NCT00334802|466683838|FG001|Overall Study|Physician Decision|0|||
129652458|NCT00334802|466683837|FG000|Overall Study|Withdrawal by Subject|0|||
129652459|NCT00334802|466683838|FG001|Overall Study|Withdrawal by Subject|4|||
129652460|NCT00334802|466683837|FG000|Overall Study|Adverse Event|0|||
129652461|NCT00334802|466683838|FG001|Overall Study|Adverse Event|3|||
129652462|NCT00334802|466683837|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
129652463|NCT00334802|466683838|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
129652464|NCT03436199|466683839|FG000|Overall Study|Adverse Event|15|||
129652465|NCT03436199|466683840|FG001|Overall Study|Adverse Event|40|||
129652466|NCT03436199|466683841|FG002|Overall Study|Adverse Event|7|||
129652467|NCT03436199|466683839|FG000|Overall Study|Withdrawal by Subject|4|||
129652468|NCT03436199|466683840|FG001|Overall Study|Withdrawal by Subject|10|||
129652469|NCT03436199|466683841|FG002|Overall Study|Withdrawal by Subject|3|||
129652470|NCT03436199|466683839|FG000|Overall Study|Lost to Follow-up|1|||
129652471|NCT03436199|466683840|FG001|Overall Study|Lost to Follow-up|0|||
129652472|NCT03436199|466683841|FG002|Overall Study|Lost to Follow-up|2|||
129652473|NCT03436199|466683839|FG000|Overall Study|Protocol Violation|1|||
129652474|NCT03436199|466683840|FG001|Overall Study|Protocol Violation|1|||
129652475|NCT03436199|466683841|FG002|Overall Study|Protocol Violation|0|||
129652476|NCT03436199|466683839|FG000|Overall Study|Physician Decision|0|||
129652477|NCT03436199|466683840|FG001|Overall Study|Physician Decision|1|||
129652478|NCT03436199|466683841|FG002|Overall Study|Physician Decision|0|||
129652479|NCT03436199|466683839|FG000|Overall Study|Could not return to clinic|1|||
129652480|NCT03436199|466683840|FG001|Overall Study|Could not return to clinic|0|||
129652481|NCT03436199|466683841|FG002|Overall Study|Could not return to clinic|0|||
129652482|NCT03436199|466683839|FG000|Overall Study|Withdrawn per physician|0|||
129652483|NCT03436199|466683840|FG001|Overall Study|Withdrawn per physician|1|||
129652484|NCT03436199|466683841|FG002|Overall Study|Withdrawn per physician|0|||
129652485|NCT00085098|466683842|FG000|Overall Study|Withdrawal by Subject|0|||
129652486|NCT00085098|466683843|FG001|Overall Study|Withdrawal by Subject|1|||
129652487|NCT00085098|466683842|FG000|Overall Study|Ineligible|1|||
129652488|NCT00085098|466683843|FG001|Overall Study|Ineligible|1|||
129652489|NCT03515629|466683844|FG000|Overall Study|Death|0|||
129652490|NCT03515629|466683845|FG001|Overall Study|Death|1|||
129652491|NCT03515629|466683846|FG002|Overall Study|Death|1|||
129652492|NCT03515629|466683844|FG000|Overall Study|Progressive disease|0|||
129652493|NCT03515629|466683845|FG001|Overall Study|Progressive disease|1|||
129652494|NCT03515629|466683846|FG002|Overall Study|Progressive disease|0|||
129652495|NCT01886781|466683847|FG000|Overall Study|Protocol Violation|5|||
129652496|NCT01886781|466683848|FG001|Overall Study|Protocol Violation|0|||
129652497|NCT01886781|466683847|FG000|Overall Study|Adverse Event|1|||
129652498|NCT01886781|466683848|FG001|Overall Study|Adverse Event|0|||
129652499|NCT01886781|466683847|FG000|Overall Study|Lost to Follow-up|5|||
129652500|NCT01886781|466683848|FG001|Overall Study|Lost to Follow-up|0|||
129652501|NCT01886781|466683847|FG000|Overall Study|Withdrawal by Subject|2|||
129652502|NCT01886781|466683848|FG001|Overall Study|Withdrawal by Subject|1|||
129652503|NCT01886781|466683847|FG000|Overall Study|Worsening of symptoms|1|||
129652504|NCT01886781|466683848|FG001|Overall Study|Worsening of symptoms|1|||
129652505|NCT00424021|466683849|FG000|NCT00046319 Study Period|Adverse Event|1|||
129652506|NCT00424021|466683850|FG001|NCT00046319 Study Period|Adverse Event|0|||
129652507|NCT00424021|466683851|FG002|NCT00046319 Study Period|Adverse Event|1|||
129652508|NCT00424021|466683852|FG003|NCT00046319 Study Period|Adverse Event|1|||
129652509|NCT00424021|466683849|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
129652510|NCT00424021|466683850|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
129652511|NCT00424021|466683851|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
129652512|NCT00424021|466683852|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
129652513|NCT00424021|466683849|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
129652514|NCT00424021|466683850|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
129652515|NCT00424021|466683851|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
129652516|NCT00424021|466683852|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
129652517|NCT00424021|466683849|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
129652518|NCT00424021|466683850|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
129652519|NCT00424021|466683851|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
129652520|NCT00424021|466683852|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
129652521|NCT00424021|466683849|FG000|AMB-220-E Study Period|Adverse Event|1|||
129652522|NCT00424021|466683850|FG001|AMB-220-E Study Period|Adverse Event|1|||
129652523|NCT00424021|466683851|FG002|AMB-220-E Study Period|Adverse Event|3|||
129652524|NCT00424021|466683852|FG003|AMB-220-E Study Period|Adverse Event|7|||
129652525|NCT00424021|466683849|FG000|AMB-220-E Study Period|Death|0|||
129652526|NCT00424021|466683850|FG001|AMB-220-E Study Period|Death|0|||
129652527|NCT00424021|466683851|FG002|AMB-220-E Study Period|Death|1|||
129652528|NCT00424021|466683852|FG003|AMB-220-E Study Period|Death|1|||
129652529|NCT00424021|466683849|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
129652530|NCT00424021|466683850|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
129652531|NCT00424021|466683851|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
129652532|NCT00424021|466683852|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
129652533|NCT00424021|466683849|FG000|AMB-220-E Study Period|Physician Decision|0|||
129652534|NCT00424021|466683850|FG001|AMB-220-E Study Period|Physician Decision|0|||
129652535|NCT00424021|466683851|FG002|AMB-220-E Study Period|Physician Decision|0|||
129652536|NCT00424021|466683852|FG003|AMB-220-E Study Period|Physician Decision|1|||
129652537|NCT03769194|466683853|FG000|Overall Study|Withdrawal by Subject|0|||
129652538|NCT03769194|466683854|FG001|Overall Study|Withdrawal by Subject|7|||
129652539|NCT03769194|466683855|FG002|Overall Study|Withdrawal by Subject|4|||
129652540|NCT03769194|466683856|FG003|Overall Study|Withdrawal by Subject|1|||
129652541|NCT03769194|466683853|FG000|Overall Study|moved from study area|0|||
129652542|NCT03769194|466683854|FG001|Overall Study|moved from study area|2|||
129652543|NCT03769194|466683855|FG002|Overall Study|moved from study area|1|||
129652544|NCT03769194|466683856|FG003|Overall Study|moved from study area|1|||
129652545|NCT03769194|466683853|FG000|Overall Study|Lost to Follow-up|3|||
129652546|NCT03769194|466683854|FG001|Overall Study|Lost to Follow-up|6|||
129652547|NCT03769194|466683855|FG002|Overall Study|Lost to Follow-up|3|||
129652548|NCT03769194|466683856|FG003|Overall Study|Lost to Follow-up|6|||
129652549|NCT03769194|466683853|FG000|Overall Study|other|1|||
129652550|NCT03769194|466683854|FG001|Overall Study|other|3|||
129652551|NCT03769194|466683855|FG002|Overall Study|other|0|||
129652552|NCT03769194|466683856|FG003|Overall Study|other|1|||
129876824|NCT02277743|467509216|FG001|Overall Study|Protocol Violation|1|||
129652553|NCT03597022|466683859|FG000|Overall Study|Premature termination of the study|7|||
129652554|NCT03597022|466683860|FG001|Overall Study|Premature termination of the study|7|||
129652555|NCT03597022|466683861|FG002|Overall Study|Premature termination of the study|8|||
129652556|NCT03597022|466683859|FG000|Overall Study|Serious adverse event|1|||
129876825|NCT02277743|467509217|FG002|Overall Study|Protocol Violation|1|||
129876826|NCT02277743|467509215|FG000|Overall Study|Adverse Event|10|||
129652557|NCT03597022|466683860|FG001|Overall Study|Serious adverse event|1|||
129652558|NCT03597022|466683861|FG002|Overall Study|Serious adverse event|0|||
129652559|NCT01672294|466683863|FG000|Overall Study|Withdrawal by Subject|4|||
129652560|NCT01672294|466683864|FG001|Overall Study|Withdrawal by Subject|4|||
129652561|NCT01672294|466683865|FG002|Overall Study|Withdrawal by Subject|4|||
129876827|NCT02277743|467509216|FG001|Overall Study|Adverse Event|6|||
129652562|NCT01672294|466683866|FG003|Overall Study|Withdrawal by Subject|4|||
129652563|NCT01672294|466683863|FG000|Overall Study|Excluded by study|1|||
129652564|NCT01672294|466683864|FG001|Overall Study|Excluded by study|1|||
129652565|NCT01672294|466683865|FG002|Overall Study|Excluded by study|0|||
129652566|NCT01672294|466683866|FG003|Overall Study|Excluded by study|0|||
129652567|NCT01672294|466683863|FG000|Overall Study|Lost to Follow-up|1|||
129652568|NCT01672294|466683864|FG001|Overall Study|Lost to Follow-up|16|||
129652569|NCT01672294|466683865|FG002|Overall Study|Lost to Follow-up|7|||
129652570|NCT01672294|466683866|FG003|Overall Study|Lost to Follow-up|9|||
129652571|NCT03887117|466683867|FG000|Overall Study|Discontinued prematurely|0|||
129652572|NCT03887117|466683868|FG001|Overall Study|Discontinued prematurely|1|||
129652573|NCT03887117|466683869|FG002|Overall Study|Discontinued prematurely|1|||
129652574|NCT03887117|466683870|FG003|Overall Study|Discontinued prematurely|2|||
129652575|NCT01739764|466683871|FG000|Overall Study|Adverse Event|0|||
129652576|NCT01739764|466683872|FG001|Overall Study|Adverse Event|3|||
129652577|NCT01739764|466683873|FG002|Overall Study|Adverse Event|4|||
129652578|NCT01739764|466683871|FG000|Overall Study|Death|4|||
129652579|NCT01739764|466683872|FG001|Overall Study|Death|6|||
129652580|NCT01739764|466683873|FG002|Overall Study|Death|38|||
129652581|NCT01739764|466683871|FG000|Overall Study|Lost to Follow-up|0|||
129652582|NCT01739764|466683872|FG001|Overall Study|Lost to Follow-up|0|||
129652583|NCT01739764|466683873|FG002|Overall Study|Lost to Follow-up|5|||
129652584|NCT01739764|466683871|FG000|Overall Study|Non-Compliance|0|||
129652585|NCT01739764|466683872|FG001|Overall Study|Non-Compliance|0|||
129652586|NCT01739764|466683873|FG002|Overall Study|Non-Compliance|1|||
129652587|NCT01739764|466683871|FG000|Overall Study|Multiple Reasons|3|||
129652588|NCT01739764|466683872|FG001|Overall Study|Multiple Reasons|2|||
129652589|NCT01739764|466683873|FG002|Overall Study|Multiple Reasons|3|||
129652590|NCT01739764|466683871|FG000|Overall Study|Physician Decision|2|||
129652591|NCT01739764|466683872|FG001|Overall Study|Physician Decision|2|||
129652592|NCT01739764|466683873|FG002|Overall Study|Physician Decision|4|||
129652593|NCT01739764|466683871|FG000|Overall Study|Progressive Disease|3|||
129652594|NCT01739764|466683872|FG001|Overall Study|Progressive Disease|5|||
129652595|NCT01739764|466683873|FG002|Overall Study|Progressive Disease|16|||
129652596|NCT01739764|466683871|FG000|Overall Study|Protocol Violation|0|||
129652597|NCT01739764|466683872|FG001|Overall Study|Protocol Violation|0|||
129652598|NCT01739764|466683873|FG002|Overall Study|Protocol Violation|2|||
129652599|NCT01739764|466683871|FG000|Overall Study|Study Terminated by Sponsor|8|||
129652600|NCT01739764|466683872|FG001|Overall Study|Study Terminated by Sponsor|13|||
129652601|NCT01739764|466683873|FG002|Overall Study|Study Terminated by Sponsor|26|||
129652602|NCT01739764|466683871|FG000|Overall Study|Withdrawal by Subject|6|||
129652603|NCT01739764|466683872|FG001|Overall Study|Withdrawal by Subject|5|||
129652604|NCT01739764|466683873|FG002|Overall Study|Withdrawal by Subject|27|||
129652605|NCT01389258|466683874|FG000|Overall Study|Lost to Follow-up|5|||
129652606|NCT00926536|466683875|FG000|Overall Study|Physician Decision|1|||
129652607|NCT00926536|466683876|FG001|Overall Study|Physician Decision|2|||
129652608|NCT03013985|466683877|FG000|Overall Study|Protocol Violation|2|||
129652609|NCT03013985|466683878|FG001|Overall Study|Protocol Violation|2|||
129652610|NCT03013985|466683877|FG000|Overall Study|Withdrawal by Subject|14|||
129652611|NCT03013985|466683878|FG001|Overall Study|Withdrawal by Subject|17|||
129652612|NCT01080391|466683879|FG000|Overall Study|Randomized but not treated|7|||
129652613|NCT01080391|466683880|FG001|Overall Study|Randomized but not treated|4|||
129652614|NCT01534208|466683881|FG000|Overall Study|Lost to Follow-up|19|||
129652615|NCT01534208|466683882|FG001|Overall Study|Lost to Follow-up|14|||
129652616|NCT01534208|466683881|FG000|Overall Study|Withdrawal by Subject|6|||
129652617|NCT01534208|466683882|FG001|Overall Study|Withdrawal by Subject|20|||
129652618|NCT01534208|466683881|FG000|Overall Study|Adverse Event|15|||
129652619|NCT01534208|466683882|FG001|Overall Study|Adverse Event|8|||
129652620|NCT01534208|466683881|FG000|Overall Study|Physician Decision|2|||
129652621|NCT01534208|466683882|FG001|Overall Study|Physician Decision|0|||
129652622|NCT01534208|466683881|FG000|Overall Study|Lack of Efficacy|0|||
129652623|NCT01534208|466683882|FG001|Overall Study|Lack of Efficacy|3|||
129652624|NCT01534208|466683881|FG000|Overall Study|Protocol Violation|2|||
129876828|NCT02277743|467509217|FG002|Overall Study|Adverse Event|6|||
129876829|NCT02277743|467509215|FG000|Overall Study|Lack of Efficacy|11|||
129652625|NCT01534208|466683882|FG001|Overall Study|Protocol Violation|2|||
129652626|NCT01534208|466683881|FG000|Overall Study|Sponsor decision|4|||
129652627|NCT01534208|466683882|FG001|Overall Study|Sponsor decision|1|||
129652628|NCT01534208|466683881|FG000|Overall Study|Subject relocation|2|||
129652629|NCT01534208|466683882|FG001|Overall Study|Subject relocation|0|||
129652630|NCT01534208|466683881|FG000|Overall Study|Lab assessment|2|||
129652631|NCT01534208|466683882|FG001|Overall Study|Lab assessment|1|||
129652632|NCT01534208|466683881|FG000|Overall Study|Eligibility error|3|||
129876830|NCT02277743|467509216|FG001|Overall Study|Lack of Efficacy|4|||
129652633|NCT01534208|466683882|FG001|Overall Study|Eligibility error|0|||
129652634|NCT01534208|466683881|FG000|Overall Study|PCP decision|1|||
129652635|NCT01534208|466683882|FG001|Overall Study|PCP decision|0|||
129652636|NCT01534208|466683881|FG000|Overall Study|Needed prohibited meds|1|||
129652637|NCT01534208|466683882|FG001|Overall Study|Needed prohibited meds|0|||
129652638|NCT01904903|466683883|FG000|Overall Study|Withdrawal by Subject|1|||
129652639|NCT01260584|466683884|FG000|Period 1|Protocol Violation|0|||
129652640|NCT01260584|466683885|FG001|Period 1|Protocol Violation|0|||
129652641|NCT01260584|466683886|FG002|Period 1|Protocol Violation|1|||
129652642|NCT01260584|466683887|FG003|Period 1|Protocol Violation|1|||
129652643|NCT01260584|466683884|FG000|Period 1|Adverse Event|0|||
129652644|NCT01260584|466683885|FG001|Period 1|Adverse Event|0|||
129652645|NCT01260584|466683886|FG002|Period 1|Adverse Event|1|||
129652646|NCT01260584|466683887|FG003|Period 1|Adverse Event|0|||
129652647|NCT01260584|466683884|FG000|Period 2|Protocol Violation|0|||
129652648|NCT01260584|466683885|FG001|Period 2|Protocol Violation|2|||
129652649|NCT01260584|466683886|FG002|Period 2|Protocol Violation|3|||
129652650|NCT01260584|466683887|FG003|Period 2|Protocol Violation|1|||
129652651|NCT01260584|466683884|FG000|Period 2|Adverse Event|1|||
129652652|NCT01260584|466683885|FG001|Period 2|Adverse Event|0|||
129652653|NCT01260584|466683886|FG002|Period 2|Adverse Event|2|||
129652654|NCT01260584|466683887|FG003|Period 2|Adverse Event|0|||
129652655|NCT01260584|466683884|FG000|Period 2|Withdrawal by Subject|0|||
129652656|NCT01260584|466683885|FG001|Period 2|Withdrawal by Subject|1|||
129652657|NCT01260584|466683886|FG002|Period 2|Withdrawal by Subject|0|||
129652658|NCT01260584|466683887|FG003|Period 2|Withdrawal by Subject|0|||
129652659|NCT00586508|466683892|FG000|Overall Study|Progressive disease|52|||
129652660|NCT00586508|466683893|FG001|Overall Study|Progressive disease|8|||
129652661|NCT00586508|466683892|FG000|Overall Study|Death|0|||
129652662|NCT00586508|466683893|FG001|Overall Study|Death|1|||
129652663|NCT00586508|466683892|FG000|Overall Study|Adverse Event|12|||
129652664|NCT00586508|466683893|FG001|Overall Study|Adverse Event|4|||
129652665|NCT00586508|466683892|FG000|Overall Study|Withdrawal by Subject|4|||
129652666|NCT00586508|466683893|FG001|Overall Study|Withdrawal by Subject|0|||
129652667|NCT00561470|466683894|FG000|Overall Study|Adverse Event|74|||
129652668|NCT00561470|466683895|FG001|Overall Study|Adverse Event|163|||
129652669|NCT00561470|466683894|FG000|Overall Study|Disease progression|437|||
129652670|NCT00561470|466683895|FG001|Overall Study|Disease progression|305|||
129652671|NCT00561470|466683894|FG000|Overall Study|poor compliance to protocol|4|||
129652672|NCT00561470|466683895|FG001|Overall Study|poor compliance to protocol|4|||
129652673|NCT00561470|466683894|FG000|Overall Study|Lost to Follow-up|2|||
129652674|NCT00561470|466683895|FG001|Overall Study|Lost to Follow-up|0|||
129652675|NCT00561470|466683894|FG000|Overall Study|Physician Decision|21|||
129652676|NCT00561470|466683895|FG001|Overall Study|Physician Decision|20|||
129652677|NCT00561470|466683894|FG000|Overall Study|Consent Withdrawn|2|||
129652678|NCT00561470|466683895|FG001|Overall Study|Consent Withdrawn|6|||
129652679|NCT00561470|466683894|FG000|Overall Study|Subject request|43|||
129652680|NCT00561470|466683895|FG001|Overall Study|Subject request|77|||
129652681|NCT00561470|466683894|FG000|Overall Study|Metastatic surgery|10|||
129652682|NCT00561470|466683895|FG001|Overall Study|Metastatic surgery|12|||
129652683|NCT00561470|466683894|FG000|Overall Study|Unauthorized procedure|3|||
129652684|NCT00561470|466683895|FG001|Overall Study|Unauthorized procedure|1|||
129652685|NCT00561470|466683894|FG000|Overall Study|Randomized but not treated|5|||
129652686|NCT00561470|466683895|FG001|Overall Study|Randomized but not treated|5|||
129652687|NCT00561470|466683894|FG000|Overall Study|Missed visit window|1|||
129652688|NCT00561470|466683895|FG001|Overall Study|Missed visit window|4|||
129652689|NCT00561470|466683894|FG000|Overall Study|Planning surgery|1|||
129652690|NCT00561470|466683895|FG001|Overall Study|Planning surgery|1|||
129652691|NCT00561470|466683894|FG000|Overall Study|Ongoing Treatment|11|||
129652692|NCT00561470|466683895|FG001|Overall Study|Ongoing Treatment|14|||
129652693|NCT03434249|466683896|FG000|Overall Study|Adverse Event|1|||
129652694|NCT03434249|466683897|FG001|Overall Study|Adverse Event|0|||
129652695|NCT03434249|466683896|FG000|Overall Study|Lost to Follow-up|0|||
129652696|NCT03434249|466683897|FG001|Overall Study|Lost to Follow-up|1|||
129652697|NCT03434249|466683896|FG000|Overall Study|Non-compliance of family|2|||
129652698|NCT03434249|466683897|FG001|Overall Study|Non-compliance of family|1|||
129652699|NCT03434249|466683896|FG000|Overall Study|Difficulties in completing daily diary|2|||
129652700|NCT03434249|466683897|FG001|Overall Study|Difficulties in completing daily diary|1|||
129652701|NCT02918552|466683898|FG000|Overall Study|Failed Pharmacokinetics|1|||
129652702|NCT02918552|466683899|FG001|Overall Study|Failed Pharmacokinetics|0|||
129652703|NCT02918552|466683898|FG000|Overall Study|Withdrawal by Subject|0|||
129876831|NCT02277743|467509217|FG002|Overall Study|Lack of Efficacy|3|||
129652704|NCT02918552|466683899|FG001|Overall Study|Withdrawal by Subject|1|||
129652705|NCT02918552|466683898|FG000|Overall Study|Lost to Follow-up|0|||
129652706|NCT02918552|466683899|FG001|Overall Study|Lost to Follow-up|1|||
129652707|NCT03325894|466683900|FG000|Overall Study|Adverse Event|2|||
129652708|NCT03325894|466683901|FG001|Overall Study|Adverse Event|3|||
129652709|NCT03325894|466683900|FG000|Overall Study|Protocol Violation|1|||
129652710|NCT03325894|466683901|FG001|Overall Study|Protocol Violation|2|||
129652711|NCT03325894|466683900|FG000|Overall Study|Withdrawal by Subject|10|||
129652712|NCT03325894|466683901|FG001|Overall Study|Withdrawal by Subject|6|||
129652713|NCT03325894|466683900|FG000|Overall Study|Lost to Follow-up|4|||
129652714|NCT03325894|466683901|FG001|Overall Study|Lost to Follow-up|9|||
129652715|NCT03325894|466683900|FG000|Overall Study|Lack of Efficacy|8|||
129652716|NCT03325894|466683901|FG001|Overall Study|Lack of Efficacy|14|||
129652717|NCT03325894|466683900|FG000|Overall Study|Study Terminated by Sponsor|38|||
129652718|NCT03325894|466683901|FG001|Overall Study|Study Terminated by Sponsor|43|||
129652719|NCT03325894|466683900|FG000|Overall Study|Other (Not received Treatment)|1|||
129652720|NCT03325894|466683901|FG001|Overall Study|Other (Not received Treatment)|0|||
129652721|NCT04395274|466683902|FG000|Overall Study|Lost to Follow-up|20|||
129652722|NCT04395274|466683903|FG001|Overall Study|Lost to Follow-up|11|||
129652723|NCT04395274|466683902|FG000|Overall Study|Withdrawal by Subject|13|||
129652724|NCT04395274|466683903|FG001|Overall Study|Withdrawal by Subject|10|||
129652725|NCT04395274|466683902|FG000|Overall Study|Moved Abroad|0|||
129652726|NCT04395274|466683903|FG001|Overall Study|Moved Abroad|1|||
129652727|NCT01001598|466683906|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
129652728|NCT01001598|466683906|FG000|Overall Study|Adverse Event|1|||
129652729|NCT02920177|466683911|FG000|Overall Study|Withdrawal by Subject|1|||
129652730|NCT02920177|466683912|FG001|Overall Study|Withdrawal by Subject|1|||
129652731|NCT02920177|466683911|FG000|Overall Study|Physician Decision|1|||
129652732|NCT02920177|466683912|FG001|Overall Study|Physician Decision|0|||
129652733|NCT02920177|466683911|FG000|Overall Study|Lost to Follow-up|0|||
129652734|NCT02920177|466683912|FG001|Overall Study|Lost to Follow-up|1|||
129652735|NCT02054910|466683913|FG000|Overall Study|Lost to Follow-up|4|||
129652736|NCT02054910|466683914|FG001|Overall Study|Lost to Follow-up|1|||
129652737|NCT01096589|466683916|FG000|Overall Study|Adverse Event|2|||
129652738|NCT01096589|466683917|FG001|Overall Study|Adverse Event|1|||
129652739|NCT01096589|466683918|FG002|Overall Study|Adverse Event|2|||
129652740|NCT01096589|466683919|FG003|Overall Study|Adverse Event|1|||
129652741|NCT01096589|466683916|FG000|Overall Study|Withdrawal by Subject|2|||
129652742|NCT01096589|466683917|FG001|Overall Study|Withdrawal by Subject|1|||
129652743|NCT01096589|466683918|FG002|Overall Study|Withdrawal by Subject|1|||
129652744|NCT01096589|466683919|FG003|Overall Study|Withdrawal by Subject|1|||
129652745|NCT01096589|466683916|FG000|Overall Study|Compliance with protocol|0|||
129652746|NCT01096589|466683917|FG001|Overall Study|Compliance with protocol|0|||
129652747|NCT01096589|466683918|FG002|Overall Study|Compliance with protocol|1|||
129652748|NCT01096589|466683919|FG003|Overall Study|Compliance with protocol|0|||
129652749|NCT01096589|466683916|FG000|Overall Study|found treatment exhausting|0|||
129652750|NCT01096589|466683917|FG001|Overall Study|found treatment exhausting|0|||
129652751|NCT01096589|466683918|FG002|Overall Study|found treatment exhausting|0|||
129652752|NCT01096589|466683919|FG003|Overall Study|found treatment exhausting|1|||
129652753|NCT03673345|466683920|FG000|Overall Study|Lost to Follow-up|1|||
129652754|NCT03673345|466683921|FG001|Overall Study|Lost to Follow-up|0|||
129652755|NCT03673345|466683922|FG002|Overall Study|Lost to Follow-up|3|||
129652756|NCT03673345|466683923|FG003|Overall Study|Lost to Follow-up|3|||
129652757|NCT03673345|466683924|FG004|Overall Study|Lost to Follow-up|2|||
129652758|NCT03673345|466683925|FG005|Overall Study|Lost to Follow-up|1|||
129652759|NCT03673345|466683926|FG006|Overall Study|Lost to Follow-up|0|||
129652760|NCT03673345|466683927|FG007|Overall Study|Lost to Follow-up|0|||
129652761|NCT03673345|466683920|FG000|Overall Study|Withdrawal by Subject|1|||
129652762|NCT03673345|466683921|FG001|Overall Study|Withdrawal by Subject|0|||
129652763|NCT03673345|466683922|FG002|Overall Study|Withdrawal by Subject|4|||
129652764|NCT03673345|466683923|FG003|Overall Study|Withdrawal by Subject|2|||
129652765|NCT03673345|466683924|FG004|Overall Study|Withdrawal by Subject|0|||
129652766|NCT03673345|466683925|FG005|Overall Study|Withdrawal by Subject|0|||
129652767|NCT03673345|466683926|FG006|Overall Study|Withdrawal by Subject|0|||
129652768|NCT03673345|466683927|FG007|Overall Study|Withdrawal by Subject|0|||
129652769|NCT03673345|466683920|FG000|Overall Study|Physician Decision|0|||
129652770|NCT03673345|466683921|FG001|Overall Study|Physician Decision|0|||
129652771|NCT03673345|466683922|FG002|Overall Study|Physician Decision|2|||
129652772|NCT03673345|466683923|FG003|Overall Study|Physician Decision|0|||
129652773|NCT03673345|466683924|FG004|Overall Study|Physician Decision|0|||
129652774|NCT03673345|466683925|FG005|Overall Study|Physician Decision|0|||
129652775|NCT03673345|466683926|FG006|Overall Study|Physician Decision|0|||
129652776|NCT03673345|466683927|FG007|Overall Study|Physician Decision|0|||
129652777|NCT01362244|466683928|FG000|Overall Study|Adverse Event|3|||
129652778|NCT01362244|466683929|FG001|Overall Study|Adverse Event|5|||
129652779|NCT01362244|466683928|FG000|Overall Study|Lack of Efficacy|5|||
129652780|NCT01362244|466683929|FG001|Overall Study|Lack of Efficacy|11|||
129652781|NCT01362244|466683928|FG000|Overall Study|Lost to Follow-up|0|||
129876832|NCT02277743|467509215|FG000|Overall Study|Other than specified above|18|||
129876833|NCT02277743|467509216|FG001|Overall Study|Other than specified above|5|||
129876834|NCT02277743|467509217|FG002|Overall Study|Other than specified above|16|||
129876835|NCT01224158|467509218|FG000|Overall Study|Withdrawal by Subject|1|||
129652782|NCT01362244|466683929|FG001|Overall Study|Lost to Follow-up|2|||
129652783|NCT01362244|466683928|FG000|Overall Study|Protocol Violation|5|||
129652784|NCT01362244|466683929|FG001|Overall Study|Protocol Violation|1|||
129652785|NCT01362244|466683928|FG000|Overall Study|Withdrawal by Subject|2|||
129652786|NCT01362244|466683929|FG001|Overall Study|Withdrawal by Subject|1|||
129652787|NCT01362244|466683928|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
129652788|NCT01362244|466683929|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
129652789|NCT01362244|466683928|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
129652790|NCT01362244|466683929|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
129652791|NCT02000882|466685603|FG000|Overall Study|Adverse Event|3|||
129652792|NCT02000882|466685603|FG000|Overall Study|Physician Decision|2|||
129652793|NCT02000882|466685603|FG000|Overall Study|Withdrawal by Subject|1|||
129652794|NCT00549601|466685604|FG000|Randomized|Protocol Violation|0|||
129652795|NCT00549601|466685605|FG001|Randomized|Protocol Violation|0|||
129652796|NCT00549601|466685606|FG002|Randomized|Protocol Violation|1|||
129652797|NCT00549601|466685604|FG000|Randomized|Withdrawal by Subject|0|||
129652798|NCT00549601|466685605|FG001|Randomized|Withdrawal by Subject|1|||
129652799|NCT00549601|466685606|FG002|Randomized|Withdrawal by Subject|1|||
129652800|NCT00549601|466685604|FG000|Received Study Drug|Adverse Event|2|||
129652801|NCT00549601|466685605|FG001|Received Study Drug|Adverse Event|5|||
129652802|NCT00549601|466685606|FG002|Received Study Drug|Adverse Event|1|||
129652803|NCT00549601|466685604|FG000|Received Study Drug|Death|0|||
129652804|NCT00549601|466685605|FG001|Received Study Drug|Death|1|||
129652805|NCT00549601|466685606|FG002|Received Study Drug|Death|0|||
129652806|NCT00549601|466685604|FG000|Received Study Drug|Lost to Follow-up|0|||
129652807|NCT00549601|466685605|FG001|Received Study Drug|Lost to Follow-up|1|||
129652808|NCT00549601|466685606|FG002|Received Study Drug|Lost to Follow-up|1|||
129652809|NCT00549601|466685604|FG000|Received Study Drug|Protocol Violation|3|||
129652810|NCT00549601|466685605|FG001|Received Study Drug|Protocol Violation|4|||
129652811|NCT00549601|466685606|FG002|Received Study Drug|Protocol Violation|1|||
129652812|NCT00549601|466685604|FG000|Received Study Drug|Withdrawal by Subject|2|||
129652813|NCT00549601|466685605|FG001|Received Study Drug|Withdrawal by Subject|0|||
129652814|NCT00549601|466685606|FG002|Received Study Drug|Withdrawal by Subject|1|||
129652815|NCT00908596|466685610|FG000|Overall Study|Other reasons|46|||
129652816|NCT00908596|466685611|FG001|Overall Study|Other reasons|6|||
129652817|NCT00908596|466685612|FG002|Overall Study|Other reasons|2|||
129652818|NCT00908596|466685613|FG003|Overall Study|Other reasons|0|||
129652819|NCT00908596|466685610|FG000|Overall Study|Lost to Follow-up|0|||
129652820|NCT00908596|466685611|FG001|Overall Study|Lost to Follow-up|1|||
129652821|NCT00908596|466685612|FG002|Overall Study|Lost to Follow-up|12|||
129652822|NCT00908596|466685613|FG003|Overall Study|Lost to Follow-up|4|||
129652823|NCT00908596|466685610|FG000|Overall Study|Death|0|||
129652824|NCT00908596|466685611|FG001|Overall Study|Death|5|||
129652825|NCT00908596|466685612|FG002|Overall Study|Death|57|||
129652826|NCT00908596|466685613|FG003|Overall Study|Death|32|||
129652827|NCT00908596|466685610|FG000|Overall Study|Protocol Violation|1|||
129652828|NCT00908596|466685611|FG001|Overall Study|Protocol Violation|0|||
129652829|NCT00908596|466685612|FG002|Overall Study|Protocol Violation|0|||
129652830|NCT00908596|466685613|FG003|Overall Study|Protocol Violation|0|||
129652831|NCT00908596|466685610|FG000|Overall Study|Withdrawal by Subject|0|||
129652832|NCT00908596|466685611|FG001|Overall Study|Withdrawal by Subject|1|||
129652833|NCT00908596|466685612|FG002|Overall Study|Withdrawal by Subject|3|||
129652834|NCT00908596|466685613|FG003|Overall Study|Withdrawal by Subject|1|||
129652835|NCT01709864|466685614|FG000|Overall Study|Physician Decision|0|||
129652836|NCT01709864|466685615|FG001|Overall Study|Physician Decision|1|||
129652837|NCT01709864|466685614|FG000|Overall Study|subject/guardian decision|5|||
129652838|NCT01709864|466685615|FG001|Overall Study|subject/guardian decision|6|||
129652839|NCT01709864|466685614|FG000|Overall Study|Lost to Follow-up|1|||
129652840|NCT01709864|466685615|FG001|Overall Study|Lost to Follow-up|0|||
129652841|NCT01709864|466685614|FG000|Overall Study|non-compliance with study treatment|1|||
129652842|NCT01709864|466685615|FG001|Overall Study|non-compliance with study treatment|1|||
129652843|NCT01709864|466685614|FG000|Overall Study|Adverse Event|0|||
129652844|NCT01709864|466685615|FG001|Overall Study|Adverse Event|2|||
129652845|NCT01709864|466685614|FG000|Overall Study|Death|0|||
129652846|NCT01709864|466685615|FG001|Overall Study|Death|1|||
129652847|NCT02661061|466685618|FG000|Overall Study|Lack of Efficacy|1|||
129652848|NCT02661061|466685619|FG001|Overall Study|Lack of Efficacy|1|||
129652849|NCT02661061|466685618|FG000|Overall Study|Withdrawal by Subject|1|||
129652850|NCT02661061|466685619|FG001|Overall Study|Withdrawal by Subject|1|||
129652851|NCT01492101|466685622|FG000|Overall Study|Death|323|||
129652852|NCT01492101|466685623|FG001|Overall Study|Death|322|||
129652853|NCT01492101|466685622|FG000|Overall Study|Withdrawal by Subject|14|||
129652854|NCT01492101|466685623|FG001|Overall Study|Withdrawal by Subject|18|||
129652855|NCT01492101|466685622|FG000|Overall Study|Lost to Follow-up|0|||
129652856|NCT01492101|466685623|FG001|Overall Study|Lost to Follow-up|2|||
129652857|NCT02696434|466685624|FG000|Overall Study|Adverse Event|3|||
129652858|NCT02696434|466685625|FG001|Overall Study|Adverse Event|1|||
129652859|NCT02696434|466685624|FG000|Overall Study|Lost to Follow-up|5|||
129652860|NCT02696434|466685625|FG001|Overall Study|Lost to Follow-up|4|||
129652861|NCT02696434|466685624|FG000|Overall Study|Withdrawal by Subject|14|||
129652862|NCT02696434|466685625|FG001|Overall Study|Withdrawal by Subject|12|||
129652863|NCT02696434|466685624|FG000|Overall Study|Physician Decision|0|||
129652864|NCT02696434|466685625|FG001|Overall Study|Physician Decision|1|||
129652865|NCT00316914|466685644|FG000|Overall Study|Withdrawal by Subject|5|||
129652866|NCT00316914|466685645|FG001|Overall Study|Withdrawal by Subject|3|||
129652867|NCT00316914|466685644|FG000|Overall Study|Adverse Event|8|||
129652868|NCT00316914|466685645|FG001|Overall Study|Adverse Event|7|||
129652869|NCT00316914|466685644|FG000|Overall Study|Other Problems|6|||
129652870|NCT00316914|466685645|FG001|Overall Study|Other Problems|11|||
129652871|NCT00316914|466685644|FG000|Overall Study|Missing end of treatment documentation|14|||
129652872|NCT00316914|466685645|FG001|Overall Study|Missing end of treatment documentation|15|||
129652873|NCT04105010|466685646|FG000|Overall Study|Death|3|||
129652874|NCT04105010|466685647|FG001|Overall Study|Death|1|||
129652875|NCT04105010|466685648|FG002|Overall Study|Death|1|||
129652876|NCT04105010|466685649|FG003|Overall Study|Death|54|||
129652877|NCT04105010|466685646|FG000|Overall Study|Lost to Follow-up|0|||
129652878|NCT04105010|466685647|FG001|Overall Study|Lost to Follow-up|0|||
129652879|NCT04105010|466685648|FG002|Overall Study|Lost to Follow-up|0|||
129652880|NCT04105010|466685649|FG003|Overall Study|Lost to Follow-up|4|||
129652881|NCT04105010|466685646|FG000|Overall Study|Withdrawal by Subject|8|||
129652882|NCT04105010|466685647|FG001|Overall Study|Withdrawal by Subject|1|||
129652883|NCT04105010|466685648|FG002|Overall Study|Withdrawal by Subject|1|||
129652884|NCT04105010|466685649|FG003|Overall Study|Withdrawal by Subject|4|||
129652885|NCT04105010|466685646|FG000|Overall Study|Other reason|4|||
129652886|NCT04105010|466685647|FG001|Overall Study|Other reason|7|||
129652887|NCT04105010|466685648|FG002|Overall Study|Other reason|0|||
129652888|NCT04105010|466685649|FG003|Overall Study|Other reason|19|||
129652889|NCT01675154|466685650|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
129652890|NCT01675154|466685651|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
129652891|NCT01675154|466685652|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
129652892|NCT01675154|466685653|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
129652893|NCT00427999|466685654|FG000|Overall Study|Adverse Event|6|||
129652894|NCT00427999|466685654|FG000|Overall Study|Abnormal laboratory values|1|||
129652895|NCT00427999|466685654|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
129652896|NCT00427999|466685654|FG000|Overall Study|Protocol Violation|2|||
129652897|NCT00427999|466685654|FG000|Overall Study|Withdrawal by Subject|9|||
129876836|NCT01224158|467509219|FG001|Overall Study|Withdrawal by Subject|0|||
129876837|NCT02055157|467509220|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
129876838|NCT02055157|467509221|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
129876839|NCT02055157|467509222|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
129876840|NCT02055157|467509223|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
129876841|NCT02055157|467509220|FG000|Initial 6 Months|Adverse Event|0|||
129876842|NCT02055157|467509221|FG001|Initial 6 Months|Adverse Event|0|||
129876843|NCT02055157|467509222|FG002|Initial 6 Months|Adverse Event|0|||
129876844|NCT02055157|467509223|FG003|Initial 6 Months|Adverse Event|1|||
129876845|NCT02055157|467509220|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
129876846|NCT02055157|467509221|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
129876847|NCT02055157|467509222|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
129652898|NCT00427999|466685654|FG000|Overall Study|Death|1|||
129652899|NCT02380859|466685655|FG000|Overall Study|Withdrawal by Subject|2|||
129652900|NCT02380859|466685656|FG001|Overall Study|Withdrawal by Subject|0|||
129652901|NCT02284568|466685657|FG000|Overall Study|Adverse Event|2|||
129652902|NCT02284568|466685658|FG001|Overall Study|Adverse Event|9|||
129876848|NCT02055157|467509223|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
129876849|NCT02055157|467509220|FG000|18-month Extension|Investigator decision|0|||
129539308|NCT01397409|466265245|FG003|Stage 2|Personal Reasons|0|||
129539309|NCT01397409|466265246|FG004|Stage 2|Personal Reasons|1|||
129539310|NCT01397409|466265247|FG005|Stage 2|Personal Reasons|0|||
129539311|NCT01397409|466265248|FG006|Stage 2|Personal Reasons|0|||
129539312|NCT01397409|466265249|FG007|Stage 2|Personal Reasons|0|||
129539313|NCT01397409|466265250|FG008|Stage 2|Personal Reasons|0|||
129539314|NCT01397409|466265251|FG009|Stage 2|Personal Reasons|0|||
129539315|NCT01397409|466265242|FG000|Stage 2|Other Miscellaneous Reasons|0|||
129539316|NCT01397409|466265243|FG001|Stage 2|Other Miscellaneous Reasons|0|||
129539317|NCT01397409|466265244|FG002|Stage 2|Other Miscellaneous Reasons|0|||
129539318|NCT01397409|466265245|FG003|Stage 2|Other Miscellaneous Reasons|0|||
129539319|NCT01397409|466265246|FG004|Stage 2|Other Miscellaneous Reasons|1|||
129539320|NCT01397409|466265247|FG005|Stage 2|Other Miscellaneous Reasons|1|||
129539321|NCT01397409|466265248|FG006|Stage 2|Other Miscellaneous Reasons|0|||
129539322|NCT01397409|466265249|FG007|Stage 2|Other Miscellaneous Reasons|0|||
129539323|NCT01397409|466265250|FG008|Stage 2|Other Miscellaneous Reasons|0|||
129539324|NCT01397409|466265251|FG009|Stage 2|Other Miscellaneous Reasons|0|||
129539325|NCT01397409|466265242|FG000|Stage 3|Adverse Event|0|||
129539326|NCT01397409|466265243|FG001|Stage 3|Adverse Event|0|||
129539327|NCT01397409|466265244|FG002|Stage 3|Adverse Event|0|||
129539328|NCT01397409|466265245|FG003|Stage 3|Adverse Event|0|||
129539329|NCT01397409|466265246|FG004|Stage 3|Adverse Event|0|||
129539330|NCT01397409|466265247|FG005|Stage 3|Adverse Event|0|||
129539331|NCT01397409|466265248|FG006|Stage 3|Adverse Event|0|||
129539332|NCT01397409|466265249|FG007|Stage 3|Adverse Event|1|||
129539333|NCT01397409|466265250|FG008|Stage 3|Adverse Event|0|||
129539334|NCT01397409|466265251|FG009|Stage 3|Adverse Event|0|||
129539335|NCT01397409|466265242|FG000|Stage 3|Other Miscellaneous Reasons|0|||
129539336|NCT01397409|466265243|FG001|Stage 3|Other Miscellaneous Reasons|0|||
129539337|NCT01397409|466265244|FG002|Stage 3|Other Miscellaneous Reasons|0|||
129539338|NCT01397409|466265245|FG003|Stage 3|Other Miscellaneous Reasons|0|||
129652903|NCT02284568|466685659|FG002|Overall Study|Adverse Event|4|||
129652904|NCT02284568|466685657|FG000|Overall Study|Withdrawal by Subject|22|||
129652905|NCT02284568|466685658|FG001|Overall Study|Withdrawal by Subject|21|||
129652906|NCT02284568|466685659|FG002|Overall Study|Withdrawal by Subject|1|||
129652907|NCT02284568|466685657|FG000|Overall Study|Noncompliance with study drug admin|1|||
129652908|NCT02284568|466685658|FG001|Overall Study|Noncompliance with study drug admin|2|||
129652909|NCT02284568|466685659|FG002|Overall Study|Noncompliance with study drug admin|0|||
129652910|NCT02284568|466685657|FG000|Overall Study|Noncompliance|1|||
129652911|NCT02284568|466685658|FG001|Overall Study|Noncompliance|0|||
129652912|NCT02284568|466685659|FG002|Overall Study|Noncompliance|0|||
129652913|NCT02284568|466685657|FG000|Overall Study|Protocol Violation|0|||
129652914|NCT02284568|466685658|FG001|Overall Study|Protocol Violation|1|||
129652915|NCT02284568|466685659|FG002|Overall Study|Protocol Violation|0|||
129652916|NCT02284568|466685657|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
129652917|NCT02284568|466685658|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
129652918|NCT02284568|466685659|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
129652919|NCT02284568|466685657|FG000|Overall Study|Lost to Follow-up|0|||
129652920|NCT02284568|466685658|FG001|Overall Study|Lost to Follow-up|3|||
129652921|NCT02284568|466685659|FG002|Overall Study|Lost to Follow-up|0|||
129652922|NCT02284568|466685657|FG000|Overall Study|Lack of Efficacy|4|||
129652923|NCT02284568|466685658|FG001|Overall Study|Lack of Efficacy|7|||
129652924|NCT02284568|466685659|FG002|Overall Study|Lack of Efficacy|0|||
129652925|NCT02284568|466685657|FG000|Overall Study|Other|1|||
129652926|NCT02284568|466685658|FG001|Overall Study|Other|2|||
129652927|NCT02284568|466685659|FG002|Overall Study|Other|0|||
129652928|NCT02284568|466685657|FG000|Overall Study|Withdrew before taking study drug|0|||
129652929|NCT02284568|466685658|FG001|Overall Study|Withdrew before taking study drug|1|||
129652930|NCT02284568|466685659|FG002|Overall Study|Withdrew before taking study drug|0|||
129652931|NCT05323994|466685660|FG000|Overall Study|Protocol Violation|1|||
129652932|NCT01420679|466685666|FG000|Overall Study|Disease Progression|3|||
129652933|NCT01420679|466685667|FG001|Overall Study|Disease Progression|2|||
129652934|NCT01420679|466685666|FG000|Overall Study|Adverse Event|4|||
129652935|NCT01420679|466685667|FG001|Overall Study|Adverse Event|0|||
129652936|NCT01420679|466685666|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
129652937|NCT01420679|466685667|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
129652938|NCT01420679|466685666|FG000|Overall Study|Patient Decision|1|||
129652939|NCT01420679|466685667|FG001|Overall Study|Patient Decision|0|||
129652940|NCT01420679|466685666|FG000|Overall Study|Investigator Decision|1|||
129652941|NCT01420679|466685667|FG001|Overall Study|Investigator Decision|2|||
129652942|NCT01420679|466685666|FG000|Overall Study|Sponsor Decision|3|||
129652943|NCT01420679|466685667|FG001|Overall Study|Sponsor Decision|3|||
129652944|NCT01420679|466685666|FG000|Overall Study|Other|1|||
129652945|NCT01420679|466685667|FG001|Overall Study|Other|0|||
129652946|NCT00943670|466685668|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
129652947|NCT00943670|466685668|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
129652948|NCT00943670|466685668|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
129652949|NCT00943670|466685668|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
129652950|NCT00943670|466685668|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
129652951|NCT00943670|466685668|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
129652952|NCT00943670|466685668|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
129652953|NCT00943670|466685668|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
129652954|NCT00943670|466685668|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
129652955|NCT00943670|466685668|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
129652956|NCT03956615|466685669|FG000|Overall Study|No multiple myeloma confirmed|2|||
129652957|NCT03956615|466685669|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
129652958|NCT03956615|466685669|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
129652959|NCT03956615|466685669|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
129652960|NCT03000530|466685678|FG000|Overall Study|Adverse Event|0|||
129652961|NCT03000530|466685679|FG001|Overall Study|Adverse Event|0|||
129652962|NCT03000530|466685680|FG002|Overall Study|Adverse Event|2|||
129876850|NCT02055157|467509221|FG001|18-month Extension|Investigator decision|1|||
129876851|NCT02055157|467509222|FG002|18-month Extension|Investigator decision|0|||
129652963|NCT03000530|466685678|FG000|Overall Study|Lost to Follow-up|0|||
129876852|NCT02055157|467509223|FG003|18-month Extension|Investigator decision|0|||
129876853|NCT02055157|467509220|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
129876854|NCT02055157|467509221|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
129652964|NCT03000530|466685679|FG001|Overall Study|Lost to Follow-up|3|||
129652965|NCT03000530|466685680|FG002|Overall Study|Lost to Follow-up|1|||
129652966|NCT03000530|466685678|FG000|Overall Study|Withdrawal by Subject|0|||
129652967|NCT03000530|466685679|FG001|Overall Study|Withdrawal by Subject|2|||
129652968|NCT03000530|466685680|FG002|Overall Study|Withdrawal by Subject|1|||
129652969|NCT00312572|466685684|FG000|Overall Study|Adverse Event|10|||
129652970|NCT00312572|466685685|FG001|Overall Study|Adverse Event|16|||
129652971|NCT00312572|466685684|FG000|Overall Study|Lost to Follow-up|1|||
129652972|NCT00312572|466685685|FG001|Overall Study|Lost to Follow-up|1|||
129652973|NCT00312572|466685684|FG000|Overall Study|Administrative|4|||
129652974|NCT00312572|466685685|FG001|Overall Study|Administrative|2|||
129652975|NCT00312572|466685684|FG000|Overall Study|Lack of Efficacy|1|||
129652976|NCT00312572|466685685|FG001|Overall Study|Lack of Efficacy|2|||
129652977|NCT01430624|466685686|FG000|Overall Study|Lost to Follow-up|23|||
129652978|NCT01430624|466685687|FG001|Overall Study|Lost to Follow-up|29|||
129652979|NCT01430624|466685688|FG002|Overall Study|Lost to Follow-up|27|||
129652980|NCT01430624|466685686|FG000|Overall Study|technical or eligibility|5|||
129652981|NCT01430624|466685687|FG001|Overall Study|technical or eligibility|5|||
129652982|NCT01430624|466685688|FG002|Overall Study|technical or eligibility|2|||
129652983|NCT02614131|466685693|FG000|Overall Study|Withdrawal by Subject|1|||
129652984|NCT02614131|466685694|FG001|Overall Study|Withdrawal by Subject|0|||
129652985|NCT02614131|466685695|FG002|Overall Study|Withdrawal by Subject|0|||
129652986|NCT02614131|466685696|FG003|Overall Study|Withdrawal by Subject|0|||
129652987|NCT02614131|466685697|FG004|Overall Study|Withdrawal by Subject|0|||
129652988|NCT02614131|466685698|FG005|Overall Study|Withdrawal by Subject|0|||
129652989|NCT02614131|466685699|FG006|Overall Study|Withdrawal by Subject|0|||
129652990|NCT02614131|466685693|FG000|Overall Study|Adverse Event|0|||
129652991|NCT02614131|466685694|FG001|Overall Study|Adverse Event|0|||
129652992|NCT02614131|466685695|FG002|Overall Study|Adverse Event|0|||
129544813|NCT02230332|466286950|FG000|Overall Study|Adverse Event|2|||
129544814|NCT02230332|466286951|FG001|Overall Study|Adverse Event|1|||
129544815|NCT02230332|466286950|FG000|Overall Study|Lost to Follow-up|1|||
129544816|NCT02230332|466286951|FG001|Overall Study|Lost to Follow-up|0|||
129544817|NCT02230332|466286950|FG000|Overall Study|Protocol Violation|1|||
129544818|NCT02230332|466286951|FG001|Overall Study|Protocol Violation|0|||
129544819|NCT01036594|466286953|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
129544820|NCT01036594|466286954|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
129544821|NCT01036594|466286953|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
129544822|NCT01036594|466286954|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
129544823|NCT01036594|466286953|FG000|Week 12 Evaluation|Adverse Event|5|||
129544824|NCT01036594|466286954|FG001|Week 12 Evaluation|Adverse Event|0|||
129544825|NCT01036594|466286953|FG000|Week 12 Evaluation|Physician Decision|1|||
129544826|NCT01036594|466286954|FG001|Week 12 Evaluation|Physician Decision|0|||
129544827|NCT01036594|466286953|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
129544828|NCT01036594|466286954|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
129544829|NCT01036594|466286953|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
129544830|NCT01036594|466286954|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
129544831|NCT01036594|466286953|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
129544832|NCT01036594|466286954|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
129544833|NCT01036594|466286953|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
129544834|NCT01036594|466286954|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
129544835|NCT01036594|466286953|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
129544836|NCT01036594|466286954|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
129544837|NCT03664024|466286958|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
129544838|NCT03664024|466286958|FG000|Overall Study|Lost to Follow-up|2|||
129652993|NCT02614131|466685696|FG003|Overall Study|Adverse Event|0|||
129652994|NCT02614131|466685697|FG004|Overall Study|Adverse Event|0|||
129652995|NCT02614131|466685698|FG005|Overall Study|Adverse Event|0|||
129652996|NCT02614131|466685699|FG006|Overall Study|Adverse Event|1|||
129652997|NCT01285492|466685704|FG000|Overall Study|Adverse Event|11|||
129766233|NCT01231984|467110329|FG000|Study Period 1|Withdrawal by Subject|0|||
129766234|NCT01231984|467110330|FG001|Study Period 1|Withdrawal by Subject|0|||
129766235|NCT01231984|467110331|FG002|Study Period 1|Withdrawal by Subject|0|||
129766236|NCT01231984|467110332|FG003|Study Period 1|Withdrawal by Subject|1|||
129766237|NCT01231984|467110329|FG000|Study Period 1|Lost to Follow-up|1|||
129766238|NCT01231984|467110330|FG001|Study Period 1|Lost to Follow-up|1|||
129766239|NCT01231984|467110331|FG002|Study Period 1|Lost to Follow-up|1|||
129766240|NCT01231984|467110332|FG003|Study Period 1|Lost to Follow-up|0|||
129766241|NCT01231984|467110329|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
129766242|NCT01231984|467110330|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
129766243|NCT01231984|467110331|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
129766244|NCT01231984|467110332|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
129766245|NCT01231984|467110329|FG000|Study Period 1|Screen Failure|0|||
129766246|NCT01231984|467110330|FG001|Study Period 1|Screen Failure|0|||
129766247|NCT01231984|467110331|FG002|Study Period 1|Screen Failure|0|||
129766248|NCT01231984|467110332|FG003|Study Period 1|Screen Failure|1|||
129766249|NCT01231984|467110329|FG000|Study Period 1|Non-compliance with study requirements|5|||
129544839|NCT03664024|466286958|FG000|Overall Study|Withdrawal by Subject|2|||
129544840|NCT03664024|466286958|FG000|Overall Study|Death|80|||
129544841|NCT00227591|466286959|FG000|Overall Study|Withdrawal by Subject|1|||
129766250|NCT01231984|467110330|FG001|Study Period 1|Non-compliance with study requirements|0|||
129766251|NCT01231984|467110331|FG002|Study Period 1|Non-compliance with study requirements|2|||
129652998|NCT01285492|466685705|FG001|Overall Study|Adverse Event|0|||
129652999|NCT01285492|466685704|FG000|Overall Study|Protocol Violation|3|||
129653000|NCT01285492|466685705|FG001|Overall Study|Protocol Violation|0|||
129653001|NCT01285492|466685704|FG000|Overall Study|Withdrawal by Subject|2|||
129653002|NCT01285492|466685705|FG001|Overall Study|Withdrawal by Subject|1|||
129653003|NCT01285492|466685704|FG000|Overall Study|Death|1|||
129653004|NCT01285492|466685705|FG001|Overall Study|Death|0|||
129653005|NCT01797094|466685706|FG000|Overall Study|Adverse Event|1|||
129653006|NCT01797094|466685707|FG001|Overall Study|Adverse Event|1|||
129653007|NCT01797094|466685706|FG000|Overall Study|Personal Reasons|4|||
129653008|NCT01797094|466685707|FG001|Overall Study|Personal Reasons|0|||
129876855|NCT02055157|467509222|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
129876856|NCT02055157|467509223|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
129876857|NCT03976466|467509224|FG000|Overall Study|Lost to Follow-up|1|||
129876858|NCT03976466|467509225|FG001|Overall Study|Lost to Follow-up|3|||
129876859|NCT00733499|467509230|FG000|Pre-operative|Protocol Violation|0|||
129876860|NCT00733499|467509231|FG001|Pre-operative|Protocol Violation|1|||
129876861|NCT00733499|467509230|FG000|3 Months Follow-up|Death|1|||
129876862|NCT00733499|467509231|FG001|3 Months Follow-up|Death|2|||
129876863|NCT00733499|467509230|FG000|6 Months Follow-up|Death|0|||
129876864|NCT00733499|467509231|FG001|6 Months Follow-up|Death|2|||
129876865|NCT00733499|467509230|FG000|6 Months Follow-up|Adverse Event|0|||
129876866|NCT00733499|467509231|FG001|6 Months Follow-up|Adverse Event|1|||
129876867|NCT00733499|467509230|FG000|12 Months Follow-up|Death|2|||
129876868|NCT00733499|467509231|FG001|12 Months Follow-up|Death|1|||
129876869|NCT00733499|467509230|FG000|24 Months Follow-up|Death|0|||
129876870|NCT00733499|467509231|FG001|24 Months Follow-up|Death|1|||
129876871|NCT00733499|467509230|FG000|5 Year Followup|Adverse Event|2|||
129876872|NCT00733499|467509231|FG001|5 Year Followup|Adverse Event|2|||
129876873|NCT00733499|467509230|FG000|5 Year Followup|Non device related AE|0|||
129876874|NCT00733499|467509231|FG001|5 Year Followup|Non device related AE|1|||
129876875|NCT00733499|467509230|FG000|5 Year Followup|Revision of Study Implant|0|||
129876876|NCT00733499|467509231|FG001|5 Year Followup|Revision of Study Implant|1|||
129876877|NCT00733499|467509230|FG000|5 Year Followup|Lost to Follow-up|2|||
129876878|NCT00733499|467509231|FG001|5 Year Followup|Lost to Follow-up|0|||
129876879|NCT00733499|467509230|FG000|5 Year Followup|Death|13|||
129876880|NCT00733499|467509231|FG001|5 Year Followup|Death|19|||
129876881|NCT00733499|467509230|FG000|5 Year Followup|missing, unable to locate|0|||
129876882|NCT00733499|467509231|FG001|5 Year Followup|missing, unable to locate|1|||
129876883|NCT00733499|467509230|FG000|5 Year Followup|Withdrawal by Subject|4|||
129876884|NCT00733499|467509231|FG001|5 Year Followup|Withdrawal by Subject|1|||
129876885|NCT00733499|467509230|FG000|10 Year Followup|Death|9|||
129876886|NCT00733499|467509231|FG001|10 Year Followup|Death|7|||
129876887|NCT00733499|467509230|FG000|10 Year Followup|Adverse Event|3|||
129876888|NCT00733499|467509231|FG001|10 Year Followup|Adverse Event|3|||
129876889|NCT00733499|467509230|FG000|10 Year Followup|Lost to Follow-up|3|||
129876890|NCT00733499|467509231|FG001|10 Year Followup|Lost to Follow-up|2|||
129876891|NCT00733499|467509230|FG000|10 Year Followup|Withdrawal by Subject|5|||
129876892|NCT00733499|467509231|FG001|10 Year Followup|Withdrawal by Subject|5|||
129876893|NCT00733499|467509230|FG000|10 Year Followup|missing, unable to locate|0|||
129876894|NCT00733499|467509231|FG001|10 Year Followup|missing, unable to locate|2|||
129876895|NCT02739347|467509232|FG000|Overall Study|Adverse Event|3|||
129876896|NCT02739347|467509233|FG001|Overall Study|Adverse Event|0|||
129876897|NCT02739347|467509232|FG000|Overall Study|Protocol Violation|0|||
129876898|NCT02739347|467509233|FG001|Overall Study|Protocol Violation|1|||
129876899|NCT02739347|467509232|FG000|Overall Study|Lost to Follow-up|0|||
129876900|NCT02739347|467509233|FG001|Overall Study|Lost to Follow-up|2|||
129876901|NCT03929562|467509234|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
129876902|NCT03929562|467509235|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
129876903|NCT03929562|467509234|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
129876904|NCT03929562|467509235|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
129876905|NCT03929562|467509234|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
129876906|NCT03929562|467509235|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
129653009|NCT01797094|466685706|FG000|Overall Study|Protocol Violation|0|||
129653010|NCT01797094|466685707|FG001|Overall Study|Protocol Violation|1|||
129653011|NCT01797094|466685706|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129653012|NCT01797094|466685707|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129876907|NCT01778556|467509236|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
129876908|NCT01778556|467509237|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
129876909|NCT01778556|467509236|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129876910|NCT01778556|467509237|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
129876911|NCT01778556|467509236|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
129876912|NCT01778556|467509237|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
129876913|NCT01778556|467509236|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
129876914|NCT01778556|467509237|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
129876915|NCT01235403|467509241|FG000|Overall Study|Adverse Event|14|||
129653013|NCT03217968|466685710|FG000|Overall Study|Withdrawal by Subject|4|||
129876916|NCT01235403|467509241|FG000|Overall Study|Lost to Follow-up|2|||
129876917|NCT01235403|467509241|FG000|Overall Study|Withdrawal by Subject|4|||
129876918|NCT01235403|467509241|FG000|Overall Study|Lack of Efficacy|2|||
129876919|NCT01235403|467509241|FG000|Overall Study|Other reasons for premature termination|4|||
129876920|NCT02296190|467509242|FG000|Overall Study|Lost to Follow-up|0|||
129876921|NCT02296190|467509243|FG001|Overall Study|Lost to Follow-up|0|||
129876922|NCT02296190|467509244|FG002|Overall Study|Lost to Follow-up|0|||
129876923|NCT02296190|467509245|FG003|Overall Study|Lost to Follow-up|0|||
129653014|NCT03217968|466685710|FG000|Overall Study|Lost to Follow-up|1|||
129653015|NCT03217968|466685710|FG000|Overall Study|Protocol Violation|6|||
129653016|NCT00634049|466685722|FG000|Overall Study|Never received study drug|1|||
129653017|NCT00634049|466685722|FG000|Overall Study|Died prior to receiving study drug|1|||
129653018|NCT00634049|466685722|FG000|Overall Study|Screening failure|1|||
129653019|NCT00314132|466685723|FG000|Overall Study|Lost to Follow-up|3|||
129653020|NCT00314132|466685724|FG001|Overall Study|Lost to Follow-up|13|||
129653021|NCT00314132|466685723|FG000|Overall Study|Withdrawal by Subject|3|||
129653022|NCT00314132|466685724|FG001|Overall Study|Withdrawal by Subject|5|||
129653023|NCT00314132|466685723|FG000|Overall Study|Adverse Event|1|||
129653024|NCT00314132|466685724|FG001|Overall Study|Adverse Event|0|||
129653025|NCT00314132|466685723|FG000|Overall Study|Physician Decision|1|||
129653026|NCT00314132|466685724|FG001|Overall Study|Physician Decision|0|||
129653027|NCT00045734|466685725|FG000|Overall Study|Protocol Violation|1|||
129653028|NCT03482167|466685726|FG000|Allocated to Intervention|Physician Decision|1|||
129653029|NCT03482167|466685727|FG001|Allocated to Intervention|Physician Decision|2|||
129653030|NCT03482167|466685726|FG000|Received Intervention|Adverse Event|3|||
129653031|NCT03482167|466685727|FG001|Received Intervention|Adverse Event|1|||
129653032|NCT03482167|466685726|FG000|Received Intervention|Physician Decision|1|||
129653033|NCT03482167|466685727|FG001|Received Intervention|Physician Decision|1|||
129653034|NCT03482167|466685726|FG000|Received Intervention|Withdrawal by Subject|1|||
129653035|NCT03482167|466685727|FG001|Received Intervention|Withdrawal by Subject|0|||
129653036|NCT05079230|466685738|FG000|Overall Study|Study Terminated by Sponsor|101|||
129653037|NCT05079230|466685739|FG001|Overall Study|Study Terminated by Sponsor|102|||
129653038|NCT05079230|466685738|FG000|Overall Study|Death|72|||
129653039|NCT05079230|466685739|FG001|Overall Study|Death|66|||
129653040|NCT05079230|466685738|FG000|Overall Study|Withdrew Consent|16|||
129653041|NCT05079230|466685739|FG001|Overall Study|Withdrew Consent|18|||
129653042|NCT05079230|466685738|FG000|Overall Study|Lost to Follow-up|0|||
129653043|NCT05079230|466685739|FG001|Overall Study|Lost to Follow-up|3|||
129653044|NCT01524783|466685740|FG000|Blinded Period|Adverse Event|64|||
129653045|NCT01524783|466685741|FG001|Blinded Period|Adverse Event|7|||
129653046|NCT01524783|466685742|FG002|Blinded Period|Adverse Event|0|||
129653047|NCT01524783|466685740|FG000|Blinded Period|Disease Progression|89|||
129653048|NCT01524783|466685741|FG001|Blinded Period|Disease Progression|75|||
129653049|NCT01524783|466685742|FG002|Blinded Period|Disease Progression|0|||
129653050|NCT01524783|466685740|FG000|Blinded Period|Withdrawal by Subject|19|||
129653051|NCT01524783|466685741|FG001|Blinded Period|Withdrawal by Subject|6|||
129653052|NCT01524783|466685742|FG002|Blinded Period|Withdrawal by Subject|0|||
129653053|NCT01524783|466685740|FG000|Blinded Period|Protocol deviation|2|||
129653054|NCT01524783|466685741|FG001|Blinded Period|Protocol deviation|1|||
129653055|NCT01524783|466685742|FG002|Blinded Period|Protocol deviation|0|||
129653056|NCT01524783|466685740|FG000|Blinded Period|Death|5|||
129653057|NCT01524783|466685741|FG001|Blinded Period|Death|2|||
129653058|NCT01524783|466685742|FG002|Blinded Period|Death|0|||
129653059|NCT01524783|466685740|FG000|Open-label Period|Disease progression|13|||
129653060|NCT01524783|466685741|FG001|Open-label Period|Disease progression|0|||
129653061|NCT01524783|466685742|FG002|Open-label Period|Disease progression|2|||
129653062|NCT01524783|466685740|FG000|Open-label Period|Administrative problems|5|||
129653063|NCT01524783|466685741|FG001|Open-label Period|Administrative problems|0|||
129653064|NCT01524783|466685742|FG002|Open-label Period|Administrative problems|2|||
129653065|NCT01524783|466685740|FG000|Open-label Period|Adverse Event|5|||
129653066|NCT01524783|466685741|FG001|Open-label Period|Adverse Event|0|||
129653067|NCT01524783|466685742|FG002|Open-label Period|Adverse Event|1|||
129653068|NCT01524783|466685740|FG000|Open-label Period|Withdrawal by Subject|2|||
129653069|NCT01524783|466685741|FG001|Open-label Period|Withdrawal by Subject|0|||
129653070|NCT01524783|466685742|FG002|Open-label Period|Withdrawal by Subject|1|||
129876924|NCT02296190|467509246|FG004|Overall Study|Lost to Follow-up|1|||
129653071|NCT01524783|466685740|FG000|Open-label Period|Protocol deviation|1|||
129653072|NCT01524783|466685741|FG001|Open-label Period|Protocol deviation|0|||
129653073|NCT01524783|466685742|FG002|Open-label Period|Protocol deviation|0|||
129653074|NCT05153148|466685745|FG000|Overall Study|Adverse Event|1|||
129653075|NCT05153148|466685746|FG001|Overall Study|Adverse Event|0|||
129653076|NCT05153148|466685747|FG002|Overall Study|Adverse Event|3|||
129653077|NCT05153148|466685748|FG003|Overall Study|Adverse Event|5|||
129653078|NCT05153148|466685745|FG000|Overall Study|Lost to Follow-up|1|||
129653079|NCT05153148|466685746|FG001|Overall Study|Lost to Follow-up|1|||
129653080|NCT05153148|466685747|FG002|Overall Study|Lost to Follow-up|2|||
129653081|NCT05153148|466685748|FG003|Overall Study|Lost to Follow-up|0|||
129876925|NCT02296190|467509247|FG005|Overall Study|Lost to Follow-up|0|||
129653082|NCT05153148|466685745|FG000|Overall Study|Withdrawal by Subject|6|||
129653083|NCT05153148|466685746|FG001|Overall Study|Withdrawal by Subject|8|||
129653084|NCT05153148|466685747|FG002|Overall Study|Withdrawal by Subject|6|||
129653085|NCT05153148|466685748|FG003|Overall Study|Withdrawal by Subject|8|||
129653086|NCT05153148|466685745|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
129653087|NCT05153148|466685746|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
129653088|NCT05153148|466685747|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
129653089|NCT05153148|466685748|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
129653090|NCT05153148|466685745|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
129653091|NCT05153148|466685746|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
129653092|NCT05153148|466685747|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
129653093|NCT05153148|466685748|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
129653094|NCT05153148|466685745|FG000|Overall Study|Reason not Specified|1|||
129653095|NCT05153148|466685746|FG001|Overall Study|Reason not Specified|1|||
129653096|NCT05153148|466685747|FG002|Overall Study|Reason not Specified|1|||
129653097|NCT05153148|466685748|FG003|Overall Study|Reason not Specified|1|||
129653098|NCT01732471|466685749|FG000|Overall Study|Withdrawal by Subject|1|||
129653099|NCT01712334|466685750|FG000|Treatment Period 1|Randomized in Error|0|||
129653100|NCT01712334|466685751|FG001|Treatment Period 1|Randomized in Error|2|||
129653101|NCT01253174|466685752|FG000|Period 1|Randomized but not treated|0|||
129653102|NCT01253174|466685753|FG001|Period 1|Randomized but not treated|1|||
129653103|NCT01253174|466685754|FG002|Period 1|Randomized but not treated|1|||
129653104|NCT01253174|466685755|FG003|Period 1|Randomized but not treated|0|||
129653105|NCT01253174|466685756|FG004|Period 1|Randomized but not treated|1|||
129653106|NCT01253174|466685757|FG005|Period 1|Randomized but not treated|0|||
129653107|NCT01253174|466685752|FG000|Period 2|Adverse Event|0|||
129653108|NCT01253174|466685753|FG001|Period 2|Adverse Event|0|||
129653109|NCT01253174|466685754|FG002|Period 2|Adverse Event|1|||
129653110|NCT01253174|466685755|FG003|Period 2|Adverse Event|0|||
129653111|NCT01253174|466685756|FG004|Period 2|Adverse Event|0|||
129653112|NCT01253174|466685757|FG005|Period 2|Adverse Event|0|||
129653113|NCT01253174|466685752|FG000|Period 3|Withdrawal by Subject|0|||
129653114|NCT01253174|466685753|FG001|Period 3|Withdrawal by Subject|1|||
129653115|NCT01253174|466685754|FG002|Period 3|Withdrawal by Subject|0|||
129653116|NCT01253174|466685755|FG003|Period 3|Withdrawal by Subject|0|||
129653117|NCT01253174|466685756|FG004|Period 3|Withdrawal by Subject|1|||
129653118|NCT01253174|466685757|FG005|Period 3|Withdrawal by Subject|0|||
129653119|NCT01253174|466685752|FG000|Period 3|Pregnancy|0|||
129653120|NCT01253174|466685753|FG001|Period 3|Pregnancy|0|||
129653121|NCT01253174|466685754|FG002|Period 3|Pregnancy|1|||
129653122|NCT01253174|466685755|FG003|Period 3|Pregnancy|0|||
129653123|NCT01253174|466685756|FG004|Period 3|Pregnancy|0|||
129653124|NCT01253174|466685757|FG005|Period 3|Pregnancy|0|||
129653125|NCT02267135|466685758|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
129876926|NCT02296190|467509242|FG000|Overall Study|Failure to induce PSVT|6|||
129876927|NCT02296190|467509243|FG001|Overall Study|Failure to induce PSVT|10|||
129876928|NCT02296190|467509244|FG002|Overall Study|Failure to induce PSVT|5|||
129876929|NCT02296190|467509245|FG003|Overall Study|Failure to induce PSVT|13|||
129876930|NCT02296190|467509246|FG004|Overall Study|Failure to induce PSVT|8|||
129876931|NCT02296190|467509247|FG005|Overall Study|Failure to induce PSVT|0|||
129876932|NCT02296190|467509242|FG000|Overall Study|Physician Decision|1|||
129876933|NCT02296190|467509243|FG001|Overall Study|Physician Decision|1|||
129876934|NCT02296190|467509244|FG002|Overall Study|Physician Decision|0|||
129876935|NCT02296190|467509245|FG003|Overall Study|Physician Decision|1|||
129876936|NCT02296190|467509246|FG004|Overall Study|Physician Decision|2|||
129876937|NCT02296190|467509247|FG005|Overall Study|Physician Decision|0|||
129876938|NCT02296190|467509242|FG000|Overall Study|Withdrawal by Subject|0|||
129876939|NCT02296190|467509243|FG001|Overall Study|Withdrawal by Subject|1|||
129653126|NCT02267135|466685759|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
129653127|NCT02267135|466685758|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
129653128|NCT02267135|466685759|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
129653129|NCT02267135|466685758|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
129876940|NCT02296190|467509244|FG002|Overall Study|Withdrawal by Subject|0|||
129653130|NCT02267135|466685759|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
129653131|NCT02267135|466685758|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
129653132|NCT02267135|466685759|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
129653133|NCT02267135|466685758|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
129653134|NCT02267135|466685759|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
129653135|NCT02892513|466685760|FG000|Overall Study|Withdrawal by Subject|0|||
129653136|NCT02892513|466685761|FG001|Overall Study|Withdrawal by Subject|1|||
129653137|NCT00900731|466685762|FG000|Overall Study|Adverse Event|31|||
129653138|NCT00900731|466685763|FG001|Overall Study|Adverse Event|27|||
129876941|NCT02296190|467509245|FG003|Overall Study|Withdrawal by Subject|0|||
129876942|NCT02296190|467509246|FG004|Overall Study|Withdrawal by Subject|0|||
129876943|NCT02296190|467509247|FG005|Overall Study|Withdrawal by Subject|0|||
129876944|NCT02296190|467509242|FG000|Overall Study|PSVT < 5 minutes|5|||
129653139|NCT00900731|466685762|FG000|Overall Study|Withdrawal by Subject|8|||
129653140|NCT00900731|466685763|FG001|Overall Study|Withdrawal by Subject|7|||
129653141|NCT00900731|466685762|FG000|Overall Study|Protocol Deviation|8|||
129653142|NCT00900731|466685763|FG001|Overall Study|Protocol Deviation|11|||
129876945|NCT02296190|467509243|FG001|Overall Study|PSVT < 5 minutes|6|||
129876946|NCT02296190|467509244|FG002|Overall Study|PSVT < 5 minutes|6|||
129876947|NCT02296190|467509245|FG003|Overall Study|PSVT < 5 minutes|6|||
129876948|NCT02296190|467509246|FG004|Overall Study|PSVT < 5 minutes|5|||
129653143|NCT00900731|466685762|FG000|Overall Study|Administrative Problems|5|||
129653144|NCT00900731|466685763|FG001|Overall Study|Administrative Problems|4|||
129653145|NCT00900731|466685762|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
129653146|NCT00900731|466685763|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129653147|NCT00900731|466685762|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
129653148|NCT00900731|466685763|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
129653149|NCT00900731|466685762|FG000|Overall Study|Lost to Follow-up|2|||
129653150|NCT00900731|466685763|FG001|Overall Study|Lost to Follow-up|3|||
129653151|NCT00900731|466685762|FG000|Overall Study|Lack of Efficacy|1|||
129653152|NCT00900731|466685763|FG001|Overall Study|Lack of Efficacy|3|||
129653153|NCT00900731|466685762|FG000|Overall Study|Death|0|||
129653154|NCT00900731|466685763|FG001|Overall Study|Death|2|||
129653155|NCT03806231|466685764|FG000|Overall Study|Physician Decision|1|||
129653156|NCT03806231|466685765|FG001|Overall Study|Physician Decision|0|||
129653157|NCT03806231|466685764|FG000|Overall Study|Withdrawal by Subject|1|||
129653158|NCT03806231|466685765|FG001|Overall Study|Withdrawal by Subject|0|||
129653159|NCT02919267|466685766|FG000|Overall Study|Protocol Violation|0|||
129653160|NCT02919267|466685767|FG001|Overall Study|Protocol Violation|3|||
129876949|NCT02296190|467509247|FG005|Overall Study|PSVT < 5 minutes|0|||
129876950|NCT02296190|467509242|FG000|Overall Study|Patient was given Propofol|0|||
129876951|NCT02296190|467509243|FG001|Overall Study|Patient was given Propofol|1|||
129876952|NCT02296190|467509244|FG002|Overall Study|Patient was given Propofol|0|||
129876953|NCT02296190|467509245|FG003|Overall Study|Patient was given Propofol|1|||
129876954|NCT02296190|467509246|FG004|Overall Study|Patient was given Propofol|0|||
129876955|NCT02296190|467509247|FG005|Overall Study|Patient was given Propofol|0|||
129876956|NCT02296190|467509242|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
129876957|NCT02296190|467509243|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
129876958|NCT02296190|467509244|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
129876959|NCT02296190|467509245|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
129876960|NCT02296190|467509246|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
129876961|NCT02296190|467509247|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
129876962|NCT02296190|467509242|FG000|Overall Study|Blood pressure <100 after sedation|0|||
129876963|NCT02296190|467509243|FG001|Overall Study|Blood pressure <100 after sedation|0|||
129876964|NCT02296190|467509244|FG002|Overall Study|Blood pressure <100 after sedation|0|||
129876965|NCT02296190|467509245|FG003|Overall Study|Blood pressure <100 after sedation|1|||
129876966|NCT02296190|467509246|FG004|Overall Study|Blood pressure <100 after sedation|0|||
129876967|NCT02296190|467509247|FG005|Overall Study|Blood pressure <100 after sedation|0|||
129876968|NCT02296190|467509242|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876969|NCT02296190|467509243|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
129876970|NCT02296190|467509244|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
129876971|NCT02296190|467509245|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876972|NCT02296190|467509246|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876973|NCT02296190|467509247|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
129876974|NCT02296190|467509242|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
129876975|NCT02296190|467509243|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
129876976|NCT02296190|467509244|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
129876977|NCT02296190|467509245|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
129876978|NCT02296190|467509246|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
129876979|NCT02296190|467509247|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
129876980|NCT02296190|467509242|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876981|NCT02296190|467509243|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
129876982|NCT02296190|467509244|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876983|NCT02296190|467509245|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876984|NCT02296190|467509246|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876985|NCT02296190|467509247|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
129876986|NCT02296190|467509242|FG000|Overall Study|Lab result not available in time|1|||
129653161|NCT02919267|466685768|FG002|Overall Study|Protocol Violation|3|||
129876987|NCT02296190|467509243|FG001|Overall Study|Lab result not available in time|0|||
129876988|NCT02296190|467509244|FG002|Overall Study|Lab result not available in time|0|||
129653162|NCT02919267|466685769|FG003|Overall Study|Protocol Violation|4|||
129653163|NCT00628927|466685770|FG000|Overall Study|Problems performing blood draw|6|||
129653164|NCT00628927|466685771|FG001|Overall Study|Problems performing blood draw|0|||
129876989|NCT02296190|467509245|FG003|Overall Study|Lab result not available in time|0|||
129876990|NCT02296190|467509246|FG004|Overall Study|Lab result not available in time|0|||
129876991|NCT02296190|467509247|FG005|Overall Study|Lab result not available in time|0|||
129876992|NCT03682705|467509248|FG000|Overall Study|Adverse Event|1|||
129876993|NCT03682705|467509249|FG001|Overall Study|Adverse Event|1|||
129876994|NCT03682705|467509250|FG002|Overall Study|Adverse Event|1|||
129876995|NCT03682705|467509251|FG003|Overall Study|Adverse Event|0|||
129876996|NCT03682705|467509252|FG004|Overall Study|Adverse Event|1|||
129876997|NCT03682705|467509253|FG005|Overall Study|Adverse Event|1|||
129876998|NCT03682705|467509248|FG000|Overall Study|Withdrawal by Subject|1|||
129876999|NCT03682705|467509249|FG001|Overall Study|Withdrawal by Subject|3|||
129877000|NCT03682705|467509250|FG002|Overall Study|Withdrawal by Subject|2|||
129877001|NCT03682705|467509251|FG003|Overall Study|Withdrawal by Subject|4|||
129877002|NCT03682705|467509252|FG004|Overall Study|Withdrawal by Subject|0|||
129877003|NCT03682705|467509253|FG005|Overall Study|Withdrawal by Subject|1|||
129653165|NCT00628927|466685770|FG000|Overall Study|Lost to Follow-up|1|||
129653166|NCT00628927|466685771|FG001|Overall Study|Lost to Follow-up|0|||
129653167|NCT00628927|466685770|FG000|Overall Study|Equipment failure|1|||
129653168|NCT00628927|466685771|FG001|Overall Study|Equipment failure|0|||
129653169|NCT02093390|466685772|FG000|Overall Study|Withdrawal by Subject|0|||
129653170|NCT02093390|466685773|FG001|Overall Study|Withdrawal by Subject|1|||
129653171|NCT02437188|466687955|FG000|Overall Study|Randomized but did not receive surgery|4|||
129653172|NCT02437188|466687956|FG001|Overall Study|Randomized but did not receive surgery|8|||
129653173|NCT02437188|466687955|FG000|Overall Study|Adverse Event|0|||
129877004|NCT03682705|467509248|FG000|Overall Study|Other, not specified|0|||
129877005|NCT03682705|467509249|FG001|Overall Study|Other, not specified|0|||
129653174|NCT02437188|466687956|FG001|Overall Study|Adverse Event|1|||
129877006|NCT03682705|467509250|FG002|Overall Study|Other, not specified|0|||
129877007|NCT03682705|467509251|FG003|Overall Study|Other, not specified|1|||
129653175|NCT01172808|466687957|FG000|Overall Study|Adverse Event|8|||
129653176|NCT01172808|466687958|FG001|Overall Study|Adverse Event|4|||
129653177|NCT01172808|466687959|FG002|Overall Study|Adverse Event|8|||
129653178|NCT01172808|466687960|FG003|Overall Study|Adverse Event|3|||
129653179|NCT01172808|466687957|FG000|Overall Study|Lack of Efficacy|1|||
129653180|NCT01172808|466687958|FG001|Overall Study|Lack of Efficacy|0|||
129653181|NCT01172808|466687959|FG002|Overall Study|Lack of Efficacy|0|||
129653182|NCT01172808|466687960|FG003|Overall Study|Lack of Efficacy|0|||
129653183|NCT01172808|466687957|FG000|Overall Study|Protocol Violation|2|||
129653184|NCT01172808|466687958|FG001|Overall Study|Protocol Violation|2|||
129653185|NCT01172808|466687959|FG002|Overall Study|Protocol Violation|2|||
129653186|NCT01172808|466687960|FG003|Overall Study|Protocol Violation|0|||
129653187|NCT01172808|466687957|FG000|Overall Study|Lost to Follow-up|0|||
129653188|NCT01172808|466687958|FG001|Overall Study|Lost to Follow-up|1|||
129653189|NCT01172808|466687959|FG002|Overall Study|Lost to Follow-up|1|||
129653190|NCT01172808|466687960|FG003|Overall Study|Lost to Follow-up|3|||
129877008|NCT03682705|467509252|FG004|Overall Study|Other, not specified|2|||
129877009|NCT03682705|467509253|FG005|Overall Study|Other, not specified|0|||
129877010|NCT03682705|467509248|FG000|Overall Study|Lost to Follow-up|0|||
129877011|NCT03682705|467509249|FG001|Overall Study|Lost to Follow-up|0|||
129653191|NCT01172808|466687957|FG000|Overall Study|Withdrawal by Subject|4|||
129653192|NCT01172808|466687958|FG001|Overall Study|Withdrawal by Subject|1|||
129653193|NCT01172808|466687959|FG002|Overall Study|Withdrawal by Subject|3|||
129653194|NCT01172808|466687960|FG003|Overall Study|Withdrawal by Subject|2|||
129653195|NCT01172808|466687957|FG000|Overall Study|Other|6|||
129653196|NCT01172808|466687958|FG001|Overall Study|Other|5|||
129877012|NCT03682705|467509250|FG002|Overall Study|Lost to Follow-up|0|||
129877013|NCT03682705|467509251|FG003|Overall Study|Lost to Follow-up|0|||
129877014|NCT03682705|467509252|FG004|Overall Study|Lost to Follow-up|3|||
129877015|NCT03682705|467509253|FG005|Overall Study|Lost to Follow-up|0|||
129877016|NCT00117156|467509255|FG000|Overall Study|Adverse Event|9|||
129877017|NCT00117156|467509255|FG000|Overall Study|Physician Decision|1|||
129877018|NCT00117156|467509255|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
129877019|NCT01919970|467509256|FG000|Overall Study|Withdrawal by Subject|3|||
129877020|NCT01919970|467509257|FG001|Overall Study|Withdrawal by Subject|0|||
129877021|NCT04043962|467509258|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
129877022|NCT04043962|467509258|FG000|Post-Treatment|Withdrawal by Subject|5|||
129877023|NCT04043962|467509258|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
129877024|NCT04615182|467509259|FG000|Overall Study|Re-transplanted|2|||
129877025|NCT04615182|467509259|FG000|Overall Study|Protocol Violation|6|||
129653197|NCT01172808|466687959|FG002|Overall Study|Other|9|||
129653198|NCT01172808|466687960|FG003|Overall Study|Other|7|||
129653199|NCT03246061|466687961|FG000|Overall Study|Still in follow-up|15|||
129653200|NCT03246061|466687962|FG001|Overall Study|Still in follow-up|21|||
129877026|NCT04615182|467509259|FG000|Overall Study|Death|6|||
129877027|NCT04615182|467509259|FG000|Overall Study|Death and protocol violation|1|||
129653201|NCT01937715|466687963|FG000|Overall Study|Death|0|||
129653202|NCT01937715|466687964|FG001|Overall Study|Death|0|||
129653203|NCT01937715|466687965|FG002|Overall Study|Death|0|||
129653204|NCT01937715|466687966|FG003|Overall Study|Death|1|||
129653205|NCT01937715|466687967|FG004|Overall Study|Death|0|||
129653206|NCT01937715|466687963|FG000|Overall Study|Withdrawal by Subject|0|||
129877028|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
129877029|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
129877030|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
129877031|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
129877032|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
129877033|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
129653207|NCT01937715|466687964|FG001|Overall Study|Withdrawal by Subject|1|||
129653208|NCT01937715|466687965|FG002|Overall Study|Withdrawal by Subject|0|||
129877034|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
129877035|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
129877036|NCT01336621|467509260|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
129877037|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
129653209|NCT01937715|466687966|FG003|Overall Study|Withdrawal by Subject|0|||
129653210|NCT01937715|466687967|FG004|Overall Study|Withdrawal by Subject|2|||
129653211|NCT01937715|466687963|FG000|Overall Study|Other|0|||
129653212|NCT01937715|466687964|FG001|Overall Study|Other|0|||
129653213|NCT01937715|466687965|FG002|Overall Study|Other|0|||
129653214|NCT01937715|466687966|FG003|Overall Study|Other|3|||
129653215|NCT01937715|466687967|FG004|Overall Study|Other|0|||
129653216|NCT02864316|466687968|FG000|Overall Study|Progressive Disease|2|||
129653217|NCT02864316|466687969|FG001|Overall Study|Progressive Disease|1|||
129653218|NCT02864316|466687968|FG000|Overall Study|Adverse Event|0|||
129653219|NCT02864316|466687969|FG001|Overall Study|Adverse Event|1|||
129653220|NCT01887288|466687970|FG000|Overall Study|The study was terminated and the PI has|16|||
129653221|NCT03114657|466687971|FG000|Overall Study|Adverse Event|9|||
129653222|NCT03114657|466687972|FG001|Overall Study|Adverse Event|6|||
129653223|NCT03114657|466687971|FG000|Overall Study|Death|4|||
129653224|NCT03114657|466687972|FG001|Overall Study|Death|0|||
129653225|NCT03114657|466687971|FG000|Overall Study|Multiple Reasons|1|||
129653226|NCT03114657|466687972|FG001|Overall Study|Multiple Reasons|2|||
129653227|NCT03114657|466687971|FG000|Overall Study|Physician Decision|2|||
129653228|NCT03114657|466687972|FG001|Overall Study|Physician Decision|2|||
129653229|NCT03114657|466687971|FG000|Overall Study|Study Terminated By Sponsor|355|||
129653230|NCT03114657|466687972|FG001|Overall Study|Study Terminated By Sponsor|374|||
129653231|NCT03114657|466687971|FG000|Overall Study|Symptomatic Deterioration|0|||
129877038|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
129877039|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
129877040|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
129877041|NCT01336621|467509260|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
129877042|NCT01126060|467509263|FG000|Overall Study|Protocol Violation|0|||
129877043|NCT01126060|467509264|FG001|Overall Study|Protocol Violation|2|||
129877044|NCT01874145|467509265|FG000|Core Period|Non-compliance|1|||
129877045|NCT01874145|467509266|FG001|Core Period|Non-compliance|0|||
129877046|NCT01874145|467509265|FG000|Core Period|Protocol Violation|1|||
129877047|NCT01874145|467509266|FG001|Core Period|Protocol Violation|1|||
129877048|NCT01874145|467509265|FG000|Core Period|Physician Decision|1|||
129877049|NCT01874145|467509266|FG001|Core Period|Physician Decision|1|||
129877050|NCT01874145|467509265|FG000|Core Period|Adverse Event|0|||
129877051|NCT01874145|467509266|FG001|Core Period|Adverse Event|1|||
129877052|NCT01874145|467509265|FG000|Core Period|Withdrawal by Subject|0|||
129877053|NCT01874145|467509266|FG001|Core Period|Withdrawal by Subject|4|||
129877054|NCT01874145|467509265|FG000|Extension Period|Adverse Event|3|||
129877055|NCT01874145|467509266|FG001|Extension Period|Adverse Event|2|||
129877056|NCT01874145|467509265|FG000|Extension Period|Withdrawal by Subject|2|||
129877057|NCT01874145|467509266|FG001|Extension Period|Withdrawal by Subject|1|||
129653232|NCT03114657|466687972|FG001|Overall Study|Symptomatic Deterioration|1|||
129653233|NCT03114657|466687971|FG000|Overall Study|Withdrawal by Subject|28|||
129653234|NCT03114657|466687972|FG001|Overall Study|Withdrawal by Subject|22|||
129653235|NCT01179737|466687974|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
129653236|NCT01179737|466687975|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
129653237|NCT01179737|466687976|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
129877058|NCT01874145|467509265|FG000|Extension Period|Lost to Follow-up|1|||
129877059|NCT01874145|467509266|FG001|Extension Period|Lost to Follow-up|1|||
129877060|NCT00402337|467509271|FG000|Overall Study|Adverse Event|0|||
129653238|NCT01179737|466687977|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
129653239|NCT01179737|466687974|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
129653240|NCT01179737|466687975|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
129653241|NCT01179737|466687976|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
129877061|NCT00402337|467509272|FG001|Overall Study|Adverse Event|2|||
129877062|NCT00402337|467509273|FG002|Overall Study|Adverse Event|2|||
129653242|NCT01179737|466687977|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
129653243|NCT01179737|466687974|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
129653244|NCT01179737|466687975|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
129877063|NCT00402337|467509274|FG003|Overall Study|Adverse Event|3|||
129877064|NCT00402337|467509275|FG004|Overall Study|Adverse Event|2|||
129653245|NCT01179737|466687976|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
129653246|NCT01179737|466687977|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
129653247|NCT01179737|466687974|FG000|Cohort 1 & Cohort 2|Death|0|||
129653248|NCT01179737|466687975|FG001|Cohort 1 & Cohort 2|Death|0|||
129653249|NCT01179737|466687976|FG002|Cohort 1 & Cohort 2|Death|1|||
129653250|NCT01179737|466687977|FG003|Cohort 1 & Cohort 2|Death|0|||
129653251|NCT01179737|466687974|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
129653252|NCT01179737|466687975|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
129653253|NCT01179737|466687976|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
129653254|NCT01179737|466687977|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
129653255|NCT01179737|466687974|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
129653256|NCT01179737|466687975|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
129653257|NCT01179737|466687976|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
129653258|NCT01179737|466687977|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
129653259|NCT01179737|466687974|FG000|Extension|The study was terminated|3|||
129653260|NCT01179737|466687975|FG001|Extension|The study was terminated|0|||
129653261|NCT01179737|466687976|FG002|Extension|The study was terminated|0|||
129653262|NCT01179737|466687977|FG003|Extension|The study was terminated|0|||
129653263|NCT01546038|466687978|FG000|Overall Study|Death|15|||
129653264|NCT01546038|466687979|FG001|Overall Study|Death|6|||
129653265|NCT01546038|466687980|FG002|Overall Study|Death|4|||
129653266|NCT01546038|466687981|FG003|Overall Study|Death|2|||
129653267|NCT01546038|466687982|FG004|Overall Study|Death|9|||
129653268|NCT01546038|466687983|FG005|Overall Study|Death|3|||
129653269|NCT01546038|466687984|FG006|Overall Study|Death|46|||
129653270|NCT01546038|466687985|FG007|Overall Study|Death|76|||
129653271|NCT01546038|466687986|FG008|Overall Study|Death|39|||
129653272|NCT01546038|466687978|FG000|Overall Study|Lost to Follow-up|0|||
129653273|NCT01546038|466687979|FG001|Overall Study|Lost to Follow-up|0|||
129653274|NCT01546038|466687980|FG002|Overall Study|Lost to Follow-up|0|||
129653275|NCT01546038|466687981|FG003|Overall Study|Lost to Follow-up|0|||
129653276|NCT01546038|466687982|FG004|Overall Study|Lost to Follow-up|1|||
129653277|NCT01546038|466687983|FG005|Overall Study|Lost to Follow-up|0|||
129653278|NCT01546038|466687984|FG006|Overall Study|Lost to Follow-up|2|||
129653279|NCT01546038|466687985|FG007|Overall Study|Lost to Follow-up|1|||
129653280|NCT01546038|466687986|FG008|Overall Study|Lost to Follow-up|0|||
129653281|NCT01546038|466687978|FG000|Overall Study|Withdrawal by Subject|1|||
129653282|NCT01546038|466687979|FG001|Overall Study|Withdrawal by Subject|0|||
129653283|NCT01546038|466687980|FG002|Overall Study|Withdrawal by Subject|0|||
129653284|NCT01546038|466687981|FG003|Overall Study|Withdrawal by Subject|1|||
129653285|NCT01546038|466687982|FG004|Overall Study|Withdrawal by Subject|0|||
129653286|NCT01546038|466687983|FG005|Overall Study|Withdrawal by Subject|1|||
129653287|NCT01546038|466687984|FG006|Overall Study|Withdrawal by Subject|3|||
129653288|NCT01546038|466687985|FG007|Overall Study|Withdrawal by Subject|3|||
129653289|NCT01546038|466687986|FG008|Overall Study|Withdrawal by Subject|1|||
129653290|NCT01546038|466687978|FG000|Overall Study|: Randomized, not treated|0|||
129653291|NCT01546038|466687979|FG001|Overall Study|: Randomized, not treated|0|||
129653292|NCT01546038|466687980|FG002|Overall Study|: Randomized, not treated|0|||
129653293|NCT01546038|466687981|FG003|Overall Study|: Randomized, not treated|0|||
129653294|NCT01546038|466687982|FG004|Overall Study|: Randomized, not treated|0|||
129653295|NCT01546038|466687983|FG005|Overall Study|: Randomized, not treated|0|||
129653296|NCT01546038|466687984|FG006|Overall Study|: Randomized, not treated|2|||
129653297|NCT01546038|466687985|FG007|Overall Study|: Randomized, not treated|4|||
129653298|NCT01546038|466687986|FG008|Overall Study|: Randomized, not treated|3|||
129653299|NCT04245202|466687987|FG000|Overall Study|Lack of Efficacy|10|||
129653300|NCT04245202|466687988|FG001|Overall Study|Lack of Efficacy|1|||
129653301|NCT00717275|466687989|FG000|Overall Study|Premature study termination.|3|||
129653302|NCT03329248|466687992|FG000|Overall Study|Progressive Disease|6|||
129653303|NCT01254721|466687997|FG000|Overall Study|Lost to Follow-up|0|||
129653304|NCT01254721|466687998|FG001|Overall Study|Lost to Follow-up|4|||
129653305|NCT01254721|466687997|FG000|Overall Study|Lack of Efficacy|4|||
129653306|NCT01254721|466687998|FG001|Overall Study|Lack of Efficacy|2|||
129653307|NCT01254721|466687997|FG000|Overall Study|Death|0|||
129653308|NCT01254721|466687998|FG001|Overall Study|Death|1|||
129653309|NCT01254721|466687997|FG000|Overall Study|technical problum|1|||
129653310|NCT01254721|466687998|FG001|Overall Study|technical problum|0|||
129653311|NCT01254721|466687997|FG000|Overall Study|Adverse Event|2|||
129653312|NCT01254721|466687998|FG001|Overall Study|Adverse Event|3|||
129653313|NCT01254721|466687997|FG000|Overall Study|Withdrawal by Subject|8|||
129653314|NCT01254721|466687998|FG001|Overall Study|Withdrawal by Subject|11|||
129653315|NCT01254721|466687997|FG000|Overall Study|Wrongly randomization|0|||
129653316|NCT01254721|466687998|FG001|Overall Study|Wrongly randomization|1|||
129653317|NCT00987402|466687999|FG000|Overall Study|Insufficient data entry|86|||
129653318|NCT00987402|466688000|FG001|Overall Study|Insufficient data entry|98|||
129653319|NCT01362517|466688001|FG000|Overall Study|Protocol Violation|1|||
129653320|NCT01362517|466688001|FG000|Overall Study|Lost to Follow-up|1|||
129653321|NCT01121536|466688003|FG000|Overall Study|Adverse Event|63|||
129653322|NCT01121536|466688003|FG000|Overall Study|Lack of Efficacy|35|||
129653323|NCT01121536|466688003|FG000|Overall Study|Withdrawal by Subject|65|||
129653324|NCT01121536|466688003|FG000|Overall Study|Protocol Violation|20|||
129653325|NCT01121536|466688003|FG000|Overall Study|Noncompliance with study medication|12|||
129653326|NCT01121536|466688003|FG000|Overall Study|Noncompliance with study procedures|9|||
129653327|NCT01121536|466688003|FG000|Overall Study|Lost to Follow-up|39|||
129653328|NCT01121536|466688003|FG000|Overall Study|Other|118|||
129653329|NCT00568334|466688004|FG000|Overall Study|Withdrawal by Subject|0|||
129653330|NCT00568334|466688005|FG001|Overall Study|Withdrawal by Subject|1|||
129653331|NCT00568334|466688004|FG000|Overall Study|Lost to Follow-up|1|||
129653332|NCT00568334|466688005|FG001|Overall Study|Lost to Follow-up|0|||
129653333|NCT00306787|466688006|FG000|Overall Study|Discontinued without taking study drug|208|||
129653334|NCT00306787|466688007|FG001|Overall Study|Discontinued without taking study drug|215|||
129653335|NCT00306787|466688006|FG000|Overall Study|Adverse Event|1|||
129653336|NCT00306787|466688007|FG001|Overall Study|Adverse Event|1|||
129653337|NCT00306787|466688006|FG000|Overall Study|Lack of Efficacy|1|||
129653338|NCT00306787|466688007|FG001|Overall Study|Lack of Efficacy|0|||
129653339|NCT00306787|466688006|FG000|Overall Study|Protocol Violation|8|||
129653340|NCT00306787|466688007|FG001|Overall Study|Protocol Violation|10|||
129653341|NCT00306787|466688006|FG000|Overall Study|Withdrawal by Subject|2|||
129653342|NCT00306787|466688007|FG001|Overall Study|Withdrawal by Subject|9|||
129653343|NCT00306787|466688006|FG000|Overall Study|Lost to Follow-up|9|||
129653344|NCT00306787|466688007|FG001|Overall Study|Lost to Follow-up|6|||
129653345|NCT00306787|466688006|FG000|Overall Study|Administrative problems|4|||
129653346|NCT00306787|466688007|FG001|Overall Study|Administrative problems|0|||
129653347|NCT00306787|466688006|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129653348|NCT00306787|466688007|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129653349|NCT02273908|466688008|FG000|Overall Study|Adverse Event|16|||
129653350|NCT02273908|466688009|FG001|Overall Study|Adverse Event|0|||
129653351|NCT02273908|466688008|FG000|Overall Study|Lost to Follow-up|10|||
129653352|NCT02273908|466688009|FG001|Overall Study|Lost to Follow-up|1|||
129653353|NCT02273908|466688008|FG000|Overall Study|Did not meet entrance criteria|3|||
129653354|NCT02273908|466688009|FG001|Overall Study|Did not meet entrance criteria|2|||
129653355|NCT02273908|466688008|FG000|Overall Study|Withdrawal by Subject|4|||
129653356|NCT02273908|466688009|FG001|Overall Study|Withdrawal by Subject|2|||
129653357|NCT04908475|466688010|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
129653358|NCT04908475|466688011|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129653359|NCT04908475|466688012|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129653360|NCT04908475|466688013|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129653361|NCT04908475|466688014|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129653362|NCT04908475|466688015|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129653363|NCT04908475|466688010|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
129653364|NCT04908475|466688011|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129653365|NCT04908475|466688012|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129653366|NCT04908475|466688013|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129653367|NCT04908475|466688014|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129653368|NCT04908475|466688015|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
129653369|NCT04908475|466688010|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
129653370|NCT04908475|466688011|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129653371|NCT04908475|466688012|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129653372|NCT04908475|466688013|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129653373|NCT04908475|466688014|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129653374|NCT04908475|466688015|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
129653375|NCT04908475|466688010|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129653376|NCT04908475|466688011|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
129653377|NCT04908475|466688012|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
129653378|NCT04908475|466688013|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
129653379|NCT04908475|466688014|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129653380|NCT04908475|466688015|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129653381|NCT04908475|466688010|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
129653382|NCT04908475|466688011|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
129653383|NCT04908475|466688012|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
129653384|NCT04908475|466688013|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
129653385|NCT04908475|466688014|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
129653386|NCT04908475|466688015|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
129877065|NCT00402337|467509271|FG000|Overall Study|Noncompliance|0|||
129877066|NCT00402337|467509272|FG001|Overall Study|Noncompliance|0|||
129653387|NCT04908475|466688010|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
129653388|NCT04908475|466688011|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
129653389|NCT04908475|466688012|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
129653390|NCT04908475|466688013|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
129653391|NCT04908475|466688014|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
129653392|NCT04908475|466688015|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
129877067|NCT00402337|467509273|FG002|Overall Study|Noncompliance|0|||
129653393|NCT03913104|466688018|FG000|Overall Study|Lost to Follow-up|20|||
129653394|NCT03913104|466688018|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
129653395|NCT03913104|466688018|FG000|Overall Study|Withdrawal by Subject|2|||
129653396|NCT01074255|466688019|FG000|Overall Study|Did not receive EMEND|2|||
129653397|NCT01593254|466688020|FG000|Overall Study|Disease progression|2|||
129653398|NCT01593254|466688021|FG001|Overall Study|Disease progression|7|||
129653399|NCT01593254|466688020|FG000|Overall Study|Study drug toxicity|6|||
129653400|NCT01593254|466688021|FG001|Overall Study|Study drug toxicity|20|||
129653401|NCT01593254|466688020|FG000|Overall Study|Death|3|||
129653402|NCT01593254|466688021|FG001|Overall Study|Death|3|||
129653403|NCT01593254|466688020|FG000|Overall Study|AE unrelated to study drug|0|||
129653404|NCT01593254|466688021|FG001|Overall Study|AE unrelated to study drug|1|||
129653405|NCT01593254|466688020|FG000|Overall Study|participant request to discontinue study treatment|1|||
129653406|NCT01593254|466688021|FG001|Overall Study|participant request to discontinue study treatment|3|||
129653407|NCT01593254|466688020|FG000|Overall Study|participant withdrew consent|0|||
129653408|NCT01593254|466688021|FG001|Overall Study|participant withdrew consent|9|||
129653409|NCT01593254|466688020|FG000|Overall Study|lost to follow up|1|||
129653410|NCT01593254|466688021|FG001|Overall Study|lost to follow up|6|||
129653411|NCT01593254|466688020|FG000|Overall Study|maximum clinical benefit|1|||
129653412|NCT01593254|466688021|FG001|Overall Study|maximum clinical benefit|2|||
129653413|NCT01593254|466688020|FG000|Overall Study|Poor/non compliance|1|||
129653414|NCT01593254|466688021|FG001|Overall Study|Poor/non compliance|1|||
129653415|NCT01593254|466688020|FG000|Overall Study|Pregnancy|0|||
129653416|NCT01593254|466688021|FG001|Overall Study|Pregnancy|3|||
129653417|NCT01593254|466688020|FG000|Overall Study|participant no longer meets study criteria|1|||
129653418|NCT01593254|466688021|FG001|Overall Study|participant no longer meets study criteria|1|||
129653419|NCT01593254|466688020|FG000|Overall Study|Admin reason by sponsor|7|||
129653420|NCT01593254|466688021|FG001|Overall Study|Admin reason by sponsor|3|||
129653421|NCT01593254|466688020|FG000|Overall Study|Imatinib treatment failure|2|||
129653422|NCT01593254|466688021|FG001|Overall Study|Imatinib treatment failure|0|||
129653423|NCT01593254|466688020|FG000|Overall Study|Other Reasons|61|||
129653424|NCT01593254|466688021|FG001|Overall Study|Other Reasons|115|||
129653425|NCT01887678|466688022|FG000|Overall Study|Adverse Event|4|||
129653426|NCT01887678|466688023|FG001|Overall Study|Adverse Event|6|||
129653427|NCT01887678|466688022|FG000|Overall Study|Exceeded rescue medication dosage|4|||
129653428|NCT01887678|466688023|FG001|Overall Study|Exceeded rescue medication dosage|5|||
129653429|NCT01887678|466688022|FG000|Overall Study|Withdrawal of consent|3|||
129653430|NCT01887678|466688023|FG001|Overall Study|Withdrawal of consent|4|||
129653431|NCT01887678|466688022|FG000|Overall Study|Lost to Follow-up|4|||
129653432|NCT01887678|466688023|FG001|Overall Study|Lost to Follow-up|2|||
129653433|NCT01887678|466688022|FG000|Overall Study|Deterioration of clinical condition|0|||
129653434|NCT01887678|466688023|FG001|Overall Study|Deterioration of clinical condition|4|||
129653435|NCT01887678|466688022|FG000|Overall Study|Lack of Efficacy|1|||
129653436|NCT01887678|466688023|FG001|Overall Study|Lack of Efficacy|2|||
129653437|NCT01887678|466688022|FG000|Overall Study|Non-compliance|0|||
129653438|NCT01887678|466688023|FG001|Overall Study|Non-compliance|3|||
129653439|NCT01887678|466688022|FG000|Overall Study|Specified|1|||
129653440|NCT01887678|466688023|FG001|Overall Study|Specified|2|||
129653441|NCT00791492|466688024|FG000|Overall Study|Withdrawal by Subject|1|||
129653442|NCT00791492|466688025|FG001|Overall Study|Withdrawal by Subject|2|||
129653443|NCT00791492|466688024|FG000|Overall Study|Liver transplantation|5|||
129653444|NCT00791492|466688025|FG001|Overall Study|Liver transplantation|1|||
129653445|NCT00076999|466688026|FG000|Overall Study|Adverse Event|2|||
129653446|NCT00076999|466688027|FG001|Overall Study|Adverse Event|8|||
129653447|NCT00076999|466688028|FG002|Overall Study|Adverse Event|6|||
129653448|NCT00076999|466688029|FG003|Overall Study|Adverse Event|0|||
129653449|NCT00076999|466688030|FG004|Overall Study|Adverse Event|2|||
129653450|NCT00076999|466688026|FG000|Overall Study|Protocol Violation|0|||
129653451|NCT00076999|466688027|FG001|Overall Study|Protocol Violation|3|||
129653452|NCT00076999|466688028|FG002|Overall Study|Protocol Violation|4|||
129653453|NCT00076999|466688029|FG003|Overall Study|Protocol Violation|0|||
129653454|NCT00076999|466688030|FG004|Overall Study|Protocol Violation|9|||
129877068|NCT00402337|467509274|FG003|Overall Study|Noncompliance|0|||
129653455|NCT00076999|466688026|FG000|Overall Study|Lost to Follow-up|2|||
129653456|NCT00076999|466688027|FG001|Overall Study|Lost to Follow-up|1|||
129653457|NCT00076999|466688028|FG002|Overall Study|Lost to Follow-up|0|||
129653458|NCT00076999|466688029|FG003|Overall Study|Lost to Follow-up|0|||
129653459|NCT00076999|466688030|FG004|Overall Study|Lost to Follow-up|0|||
129653460|NCT00076999|466688026|FG000|Overall Study|Withdrawal by Subject|0|||
129653461|NCT00076999|466688027|FG001|Overall Study|Withdrawal by Subject|4|||
129653462|NCT00076999|466688028|FG002|Overall Study|Withdrawal by Subject|3|||
129653463|NCT00076999|466688029|FG003|Overall Study|Withdrawal by Subject|0|||
129877069|NCT00402337|467509275|FG004|Overall Study|Noncompliance|2|||
129653464|NCT00076999|466688030|FG004|Overall Study|Withdrawal by Subject|1|||
129653465|NCT00076999|466688026|FG000|Overall Study|Other reason (not specified)|8|||
129653466|NCT00076999|466688027|FG001|Overall Study|Other reason (not specified)|8|||
129653467|NCT00076999|466688028|FG002|Overall Study|Other reason (not specified)|4|||
129653468|NCT00076999|466688029|FG003|Overall Study|Other reason (not specified)|1|||
129653469|NCT00076999|466688030|FG004|Overall Study|Other reason (not specified)|13|||
129877070|NCT00402337|467509271|FG000|Overall Study|Withdrawal by Subject|5|||
129877071|NCT00402337|467509272|FG001|Overall Study|Withdrawal by Subject|3|||
129877072|NCT00402337|467509273|FG002|Overall Study|Withdrawal by Subject|1|||
129877073|NCT00402337|467509274|FG003|Overall Study|Withdrawal by Subject|6|||
129877074|NCT00402337|467509275|FG004|Overall Study|Withdrawal by Subject|4|||
129877075|NCT00402337|467509271|FG000|Overall Study|Lost to Follow-up|0|||
129877076|NCT00402337|467509272|FG001|Overall Study|Lost to Follow-up|0|||
129877077|NCT00402337|467509273|FG002|Overall Study|Lost to Follow-up|1|||
129877078|NCT00402337|467509274|FG003|Overall Study|Lost to Follow-up|2|||
129877079|NCT00402337|467509275|FG004|Overall Study|Lost to Follow-up|0|||
129877080|NCT00402337|467509271|FG000|Overall Study|Physician Decision|0|||
129877081|NCT00402337|467509272|FG001|Overall Study|Physician Decision|0|||
129877082|NCT00402337|467509273|FG002|Overall Study|Physician Decision|0|||
129877083|NCT00402337|467509274|FG003|Overall Study|Physician Decision|1|||
129653470|NCT02603562|466688043|FG000|Overall Study|Lost to Follow-up|1|||
129653471|NCT01380691|466688058|FG000|Washout (7 Days)|Protocol Violation|0|||
129653472|NCT01380691|466688059|FG001|Washout (7 Days)|Protocol Violation|0|||
129653473|NCT01380691|466688060|FG002|Washout (7 Days)|Protocol Violation|0|||
129653474|NCT01380691|466688061|FG003|Washout (7 Days)|Protocol Violation|1|||
129653475|NCT01380691|466688058|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
129653476|NCT01380691|466688059|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
129653477|NCT01380691|466688060|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
129653478|NCT01380691|466688061|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
129653479|NCT01987232|466688062|FG000|Overall Study|Ongoing in Study|0|||
129653480|NCT01987232|466688063|FG001|Overall Study|Ongoing in Study|0|||
129653481|NCT01987232|466688064|FG002|Overall Study|Ongoing in Study|0|||
129653482|NCT01987232|466688065|FG003|Overall Study|Ongoing in Study|1|||
129653483|NCT01987232|466688066|FG004|Overall Study|Ongoing in Study|0|||
129653484|NCT00232596|466688073|FG000|6-Week Titration Phase|Adverse Event|6|||
129653485|NCT00232596|466688074|FG001|6-Week Titration Phase|Adverse Event|19|||
129653486|NCT00232596|466688073|FG000|6-Week Titration Phase|Failed to Return|2|||
129653487|NCT00232596|466688074|FG001|6-Week Titration Phase|Failed to Return|1|||
129653488|NCT00232596|466688073|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
129653489|NCT00232596|466688074|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
129653490|NCT00232596|466688073|FG000|6-Week Titration Phase|Protocol Violation|1|||
129653491|NCT00232596|466688074|FG001|6-Week Titration Phase|Protocol Violation|3|||
129653492|NCT00232596|466688073|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
129653493|NCT00232596|466688074|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
129653494|NCT00232596|466688073|FG000|6-Week Titration Phase|Other|3|||
129653495|NCT00232596|466688074|FG001|6-Week Titration Phase|Other|3|||
129653496|NCT00232596|466688073|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
129653497|NCT00232596|466688074|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
129653498|NCT00232596|466688073|FG000|12-Week Maintenance Phase|Adverse Event|7|||
129653499|NCT00232596|466688074|FG001|12-Week Maintenance Phase|Adverse Event|22|||
129653500|NCT00232596|466688073|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
129653501|NCT00232596|466688074|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
129653502|NCT00232596|466688073|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
129653503|NCT00232596|466688074|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
129653504|NCT00232596|466688073|FG000|12-Week Maintenance Phase|Other|1|||
129653505|NCT00232596|466688074|FG001|12-Week Maintenance Phase|Other|3|||
129653506|NCT03426436|466688075|FG000|Overall Study|Incorrect lead placement|12|||
129877084|NCT00402337|467509275|FG004|Overall Study|Physician Decision|0|||
129877085|NCT00402337|467509271|FG000|Overall Study|Other Reason|0|||
129877086|NCT00402337|467509272|FG001|Overall Study|Other Reason|1|||
129877087|NCT00402337|467509273|FG002|Overall Study|Other Reason|0|||
129877088|NCT00402337|467509274|FG003|Overall Study|Other Reason|0|||
129877089|NCT00402337|467509275|FG004|Overall Study|Other Reason|0|||
129877090|NCT02178566|467509276|FG000|Overall Study|patient did not complete due to noncompliance|0|||
129877091|NCT02178566|467509277|FG001|Overall Study|patient did not complete due to noncompliance|1|||
129877092|NCT02658630|467509284|FG000|Overall Study|Withdrawal by Subject|4|||
129877093|NCT01521884|467509286|FG000|Overall Study|Non Responders|10|||
129877094|NCT01521884|467509286|FG000|Overall Study|Adverse Event|5|||
129877095|NCT01521884|467509286|FG000|Overall Study|Pregnancy|1|||
129877096|NCT01521884|467509286|FG000|Overall Study|Withdrawal by Subject|1|||
129653507|NCT03426436|466688075|FG000|Overall Study|Withdrawal by Subject|2|||
129653508|NCT03426436|466688075|FG000|Overall Study|Consent issue|1|||
129653509|NCT03426436|466688075|FG000|Overall Study|ECGs not saved|4|||
129653510|NCT00932698|466688076|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
129877097|NCT01521884|467509286|FG000|Overall Study|Physician Decision|2|||
129877098|NCT01521884|467509286|FG000|Overall Study|Protocol Violation|3|||
129877099|NCT01521884|467509286|FG000|Overall Study|Participant non-eligible|1|||
129877100|NCT01521884|467509286|FG000|Overall Study|Lost to Follow-up|4|||
129877101|NCT02821819|467509287|FG000|Overall Study|Protocol Violation|1|||
129653511|NCT00932698|466688077|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
129653512|NCT00932698|466688078|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
129653513|NCT00932698|466688079|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
129653514|NCT00932698|466688080|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
129653515|NCT00932698|466688081|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
129653516|NCT00932698|466688082|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
129653517|NCT00932698|466688083|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
129653518|NCT00932698|466688084|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
129653519|NCT00932698|466688085|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
129653520|NCT00932698|466688086|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
129653521|NCT00932698|466688076|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653522|NCT00932698|466688077|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129653523|NCT00932698|466688078|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653524|NCT00932698|466688079|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129653525|NCT00932698|466688080|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653526|NCT00932698|466688081|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129653527|NCT00932698|466688082|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
129653528|NCT00932698|466688083|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653529|NCT00932698|466688084|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653530|NCT00932698|466688085|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653531|NCT00932698|466688086|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
129653532|NCT00932698|466688076|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
129653533|NCT00932698|466688077|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
129653534|NCT00932698|466688078|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
129653535|NCT00932698|466688079|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
129653536|NCT00932698|466688080|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
129653537|NCT00932698|466688081|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
129653538|NCT00932698|466688082|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
129653539|NCT00932698|466688083|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
129653540|NCT00932698|466688084|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
129653541|NCT00932698|466688085|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
129653542|NCT00932698|466688086|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
129653543|NCT00932698|466688076|FG000|Part 1 (Dose Escalation)|Other|0|||
129653544|NCT00932698|466688077|FG001|Part 1 (Dose Escalation)|Other|0|||
129653545|NCT00932698|466688078|FG002|Part 1 (Dose Escalation)|Other|1|||
129653546|NCT00932698|466688079|FG003|Part 1 (Dose Escalation)|Other|0|||
129653547|NCT00932698|466688080|FG004|Part 1 (Dose Escalation)|Other|0|||
129653548|NCT00932698|466688081|FG005|Part 1 (Dose Escalation)|Other|0|||
129653549|NCT00932698|466688082|FG006|Part 1 (Dose Escalation)|Other|1|||
129653550|NCT00932698|466688083|FG007|Part 1 (Dose Escalation)|Other|0|||
129653551|NCT00932698|466688084|FG008|Part 1 (Dose Escalation)|Other|0|||
129653552|NCT00932698|466688085|FG009|Part 1 (Dose Escalation)|Other|0|||
129653553|NCT00932698|466688086|FG010|Part 1 (Dose Escalation)|Other|0|||
129653554|NCT00932698|466688076|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653555|NCT00932698|466688077|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653556|NCT00932698|466688078|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653557|NCT00932698|466688079|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653558|NCT00932698|466688080|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653559|NCT00932698|466688081|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653560|NCT00932698|466688082|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
129653561|NCT00932698|466688083|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
129653562|NCT00932698|466688084|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
129653563|NCT00932698|466688085|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
129653564|NCT00932698|466688086|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
129653565|NCT00932698|466688076|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653566|NCT00932698|466688077|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653567|NCT00932698|466688078|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653568|NCT00932698|466688079|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653569|NCT00932698|466688080|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653570|NCT00932698|466688081|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653571|NCT00932698|466688082|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653572|NCT00932698|466688083|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
129653573|NCT00932698|466688084|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
129653574|NCT00932698|466688085|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
129877102|NCT03565068|467509288|FG000|Overall Study|Protocol Violation|0|||
129653575|NCT00932698|466688086|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
129653576|NCT00932698|466688076|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
129653577|NCT00932698|466688077|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
129653578|NCT00932698|466688078|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
129653579|NCT00932698|466688079|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
129653580|NCT00932698|466688080|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
129877103|NCT03565068|467509289|FG001|Overall Study|Protocol Violation|0|||
129653581|NCT00932698|466688081|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
129653582|NCT00932698|466688082|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
129653583|NCT00932698|466688083|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
129653584|NCT00932698|466688084|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
129653585|NCT00932698|466688085|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
129653586|NCT00932698|466688086|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
129653587|NCT00655681|466688087|FG000|Overall Study|Lost to Follow-up|1|||
129653588|NCT00655681|466688088|FG001|Overall Study|Lost to Follow-up|1|||
129653589|NCT02429310|466688089|FG000|Overall Study|Lost to Follow-up|1|||
129653590|NCT02429310|466688090|FG001|Overall Study|Lost to Follow-up|2|||
129653591|NCT02429310|466688089|FG000|Overall Study|Protocol Violation|1|||
129653592|NCT02429310|466688090|FG001|Overall Study|Protocol Violation|1|||
129653593|NCT00394433|466688091|FG000|Overall Study|Adverse Event|2|||
129653594|NCT00394433|466688091|FG000|Overall Study|Alternative Therapy|1|||
129653595|NCT01554176|466688092|FG000|Treatment Phase|Protocol Violation|1|||
129653596|NCT01554176|466688093|FG001|Treatment Phase|Protocol Violation|2|||
129653597|NCT01554176|466688094|FG002|Treatment Phase|Protocol Violation|0|||
129653598|NCT01554176|466688095|FG003|Treatment Phase|Protocol Violation|0|||
129653599|NCT01554176|466688096|FG004|Treatment Phase|Protocol Violation|0|||
129653600|NCT01554176|466688092|FG000|Treatment Phase|Physician Decision|1|||
129653601|NCT01554176|466688093|FG001|Treatment Phase|Physician Decision|1|||
129653602|NCT01554176|466688094|FG002|Treatment Phase|Physician Decision|0|||
129653603|NCT01554176|466688095|FG003|Treatment Phase|Physician Decision|0|||
129653604|NCT01554176|466688096|FG004|Treatment Phase|Physician Decision|0|||
129653605|NCT01554176|466688092|FG000|Treatment Phase|Lack of Efficacy|0|||
129653606|NCT01554176|466688093|FG001|Treatment Phase|Lack of Efficacy|1|||
129653607|NCT01554176|466688094|FG002|Treatment Phase|Lack of Efficacy|0|||
129653608|NCT01554176|466688095|FG003|Treatment Phase|Lack of Efficacy|0|||
129653609|NCT01554176|466688096|FG004|Treatment Phase|Lack of Efficacy|0|||
129653610|NCT01554176|466688092|FG000|Treatment Phase|Adverse event, non-fatal|1|||
129653611|NCT01554176|466688093|FG001|Treatment Phase|Adverse event, non-fatal|1|||
129653612|NCT01554176|466688094|FG002|Treatment Phase|Adverse event, non-fatal|0|||
129653613|NCT01554176|466688095|FG003|Treatment Phase|Adverse event, non-fatal|0|||
129653614|NCT01554176|466688096|FG004|Treatment Phase|Adverse event, non-fatal|0|||
129653615|NCT01554176|466688092|FG000|Treatment Phase|Non-compliance with study drug|1|||
129653616|NCT01554176|466688093|FG001|Treatment Phase|Non-compliance with study drug|0|||
129653617|NCT01554176|466688094|FG002|Treatment Phase|Non-compliance with study drug|0|||
129653618|NCT01554176|466688095|FG003|Treatment Phase|Non-compliance with study drug|0|||
129653619|NCT01554176|466688096|FG004|Treatment Phase|Non-compliance with study drug|0|||
129653620|NCT01554176|466688092|FG000|Treatment Phase|Withdrawal by Subject|1|||
129653621|NCT01554176|466688093|FG001|Treatment Phase|Withdrawal by Subject|0|||
129653622|NCT01554176|466688094|FG002|Treatment Phase|Withdrawal by Subject|0|||
129653623|NCT01554176|466688095|FG003|Treatment Phase|Withdrawal by Subject|0|||
129653624|NCT01554176|466688096|FG004|Treatment Phase|Withdrawal by Subject|0|||
129653625|NCT01554176|466688092|FG000|Treatment Phase|Lost to Follow-up|3|||
129653626|NCT01554176|466688093|FG001|Treatment Phase|Lost to Follow-up|0|||
129653627|NCT01554176|466688094|FG002|Treatment Phase|Lost to Follow-up|0|||
129653628|NCT01554176|466688095|FG003|Treatment Phase|Lost to Follow-up|0|||
129653629|NCT01554176|466688096|FG004|Treatment Phase|Lost to Follow-up|0|||
129653630|NCT01554176|466688092|FG000|Run-out Phase|Protocol Violation|0|||
129653631|NCT01554176|466688093|FG001|Run-out Phase|Protocol Violation|0|||
129653632|NCT01554176|466688094|FG002|Run-out Phase|Protocol Violation|0|||
129653633|NCT01554176|466688095|FG003|Run-out Phase|Protocol Violation|1|||
129653634|NCT01554176|466688096|FG004|Run-out Phase|Protocol Violation|0|||
129653635|NCT00386425|466688097|FG000|Overall Study|Physician Decision|3|||
129653636|NCT00386425|466688098|FG001|Overall Study|Physician Decision|0|||
129653637|NCT00386425|466688099|FG002|Overall Study|Physician Decision|0|||
129653638|NCT00386425|466688097|FG000|Overall Study|Withdrawal by Subject|0|||
129653639|NCT00386425|466688098|FG001|Overall Study|Withdrawal by Subject|1|||
129653640|NCT00386425|466688099|FG002|Overall Study|Withdrawal by Subject|0|||
129653641|NCT03053427|466688100|FG000|Overall Study|Adverse Event|4|||
129653642|NCT03053427|466688101|FG001|Overall Study|Adverse Event|4|||
129653643|NCT03053427|466688100|FG000|Overall Study|Lack of Efficacy|1|||
129653644|NCT03053427|466688101|FG001|Overall Study|Lack of Efficacy|3|||
129653645|NCT03053427|466688100|FG000|Overall Study|Lost to Follow-up|2|||
129653646|NCT03053427|466688101|FG001|Overall Study|Lost to Follow-up|2|||
129653647|NCT03053427|466688100|FG000|Overall Study|Worsening of the target disease|0|||
129653648|NCT03053427|466688101|FG001|Overall Study|Worsening of the target disease|1|||
129653649|NCT03053427|466688100|FG000|Overall Study|Protocol Deviation|3|||
129653650|NCT03053427|466688101|FG001|Overall Study|Protocol Deviation|3|||
129653651|NCT03053427|466688100|FG000|Overall Study|Withdrawal by Subject|3|||
129653652|NCT03053427|466688101|FG001|Overall Study|Withdrawal by Subject|2|||
129653653|NCT03053427|466688100|FG000|Overall Study|Miscellaneous|0|||
129653654|NCT03053427|466688101|FG001|Overall Study|Miscellaneous|1|||
129653655|NCT02172040|466688105|FG000|Overall Study|Adverse Event|0|||
129653656|NCT02172040|466688106|FG001|Overall Study|Adverse Event|2|||
129653657|NCT02172040|466688107|FG002|Overall Study|Adverse Event|0|||
129653658|NCT02172040|466688108|FG003|Overall Study|Adverse Event|0|||
129653659|NCT02172040|466688105|FG000|Overall Study|Protocol Violation|0|||
129653660|NCT02172040|466688106|FG001|Overall Study|Protocol Violation|1|||
129653661|NCT02172040|466688107|FG002|Overall Study|Protocol Violation|0|||
129653662|NCT02172040|466688108|FG003|Overall Study|Protocol Violation|0|||
129877104|NCT03565068|467509290|FG002|Overall Study|Protocol Violation|0|||
129877105|NCT03565068|467509291|FG003|Overall Study|Protocol Violation|0|||
129877106|NCT03565068|467509292|FG004|Overall Study|Protocol Violation|1|||
129877107|NCT03565068|467509293|FG005|Overall Study|Protocol Violation|0|||
129877108|NCT03565068|467509294|FG006|Overall Study|Protocol Violation|0|||
129877109|NCT03565068|467509295|FG007|Overall Study|Protocol Violation|1|||
129877110|NCT03565068|467509296|FG008|Overall Study|Protocol Violation|0|||
129877111|NCT03565068|467509288|FG000|Overall Study|Sponsor decision|0|||
129877112|NCT03565068|467509289|FG001|Overall Study|Sponsor decision|0|||
129877113|NCT03565068|467509290|FG002|Overall Study|Sponsor decision|0|||
129877114|NCT03565068|467509291|FG003|Overall Study|Sponsor decision|0|||
129877115|NCT03565068|467509292|FG004|Overall Study|Sponsor decision|1|||
129653663|NCT02172040|466688105|FG000|Overall Study|Withdrawal by Subject|0|||
129653664|NCT02172040|466688106|FG001|Overall Study|Withdrawal by Subject|0|||
129653665|NCT02172040|466688107|FG002|Overall Study|Withdrawal by Subject|1|||
129653666|NCT02172040|466688108|FG003|Overall Study|Withdrawal by Subject|0|||
129653667|NCT02172040|466688105|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
129653668|NCT02172040|466688106|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
129653669|NCT02172040|466688107|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
129653670|NCT02172040|466688108|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
129653671|NCT02172040|466688105|FG000|Overall Study|Family emergency abroad|0|||
129653672|NCT02172040|466688106|FG001|Overall Study|Family emergency abroad|0|||
129653673|NCT02172040|466688107|FG002|Overall Study|Family emergency abroad|0|||
129653674|NCT02172040|466688108|FG003|Overall Study|Family emergency abroad|1|||
129653675|NCT01324570|466688115|FG000|Overall Study|Adverse Event|4|||
129653676|NCT01324570|466688116|FG001|Overall Study|Adverse Event|7|||
129653677|NCT01324570|466688115|FG000|Overall Study|Withdrawal by Subject|0|||
129653678|NCT01324570|466688116|FG001|Overall Study|Withdrawal by Subject|3|||
129653679|NCT01324570|466688115|FG000|Overall Study|Lack of Efficacy|0|||
129653680|NCT01324570|466688116|FG001|Overall Study|Lack of Efficacy|1|||
129653681|NCT01324570|466688115|FG000|Overall Study|Confirmed or suspected diversion|0|||
129653682|NCT01324570|466688116|FG001|Overall Study|Confirmed or suspected diversion|1|||
129653683|NCT01324570|466688115|FG000|Overall Study|Administrative|0|||
129653684|NCT01324570|466688116|FG001|Overall Study|Administrative|2|||
129653685|NCT02607306|466688117|FG000|Overall Study|Adverse Event|8|||
129653686|NCT02607306|466688118|FG001|Overall Study|Adverse Event|6|||
129653687|NCT02607306|466688119|FG002|Overall Study|Adverse Event|6|||
129653688|NCT02607306|466688117|FG000|Overall Study|Unclassified|1|||
129653689|NCT02607306|466688118|FG001|Overall Study|Unclassified|4|||
129653690|NCT02607306|466688119|FG002|Overall Study|Unclassified|0|||
129653691|NCT02607306|466688117|FG000|Overall Study|Withdrawal by Subject|8|||
129653692|NCT02607306|466688118|FG001|Overall Study|Withdrawal by Subject|10|||
129653693|NCT02607306|466688119|FG002|Overall Study|Withdrawal by Subject|2|||
129653694|NCT02607306|466688117|FG000|Overall Study|Lack of Efficacy|0|||
129653695|NCT02607306|466688118|FG001|Overall Study|Lack of Efficacy|1|||
129653696|NCT02607306|466688119|FG002|Overall Study|Lack of Efficacy|1|||
129653697|NCT02607306|466688117|FG000|Overall Study|Protocol Violation|4|||
129653698|NCT02607306|466688118|FG001|Overall Study|Protocol Violation|2|||
129653699|NCT02607306|466688119|FG002|Overall Study|Protocol Violation|1|||
129653700|NCT00435019|466688125|FG000|Overall Study|Adverse Event|1|||
129653701|NCT00435019|466688126|FG001|Overall Study|Adverse Event|0|||
129653702|NCT00435019|466688125|FG000|Overall Study|Lack of Efficacy|1|||
129653703|NCT00435019|466688126|FG001|Overall Study|Lack of Efficacy|2|||
129653704|NCT00435019|466688125|FG000|Overall Study|Protocol Violation|3|||
129653705|NCT00435019|466688126|FG001|Overall Study|Protocol Violation|1|||
129877116|NCT03565068|467509293|FG005|Overall Study|Sponsor decision|1|||
129653706|NCT00435019|466688125|FG000|Overall Study|Personal reasons for withdrawal|8|||
129653707|NCT00435019|466688126|FG001|Overall Study|Personal reasons for withdrawal|7|||
129653708|NCT01764659|466688132|FG000|Overall Study|Death|1|||
129653709|NCT01764659|466688132|FG000|Overall Study|Physician Decision|1|||
129653710|NCT01298141|466688133|FG000|Overall Study|Adverse Event|3|||
129653711|NCT01298141|466688133|FG000|Overall Study|Refusal of Required Study Procedures|1|||
129653712|NCT01298141|466688133|FG000|Overall Study|Withdrawal by Subject|6|||
129653713|NCT01298141|466688133|FG000|Overall Study|Termination of Study by the Investigator|5|||
129877117|NCT03565068|467509294|FG006|Overall Study|Sponsor decision|0|||
129653714|NCT01298141|466688133|FG000|Overall Study|Other|5|||
129653715|NCT01298141|466688133|FG000|Overall Study|Lost to Follow-up|1|||
129653716|NCT01298141|466688133|FG000|Overall Study|Death|6|||
129653717|NCT01298141|466688133|FG000|Overall Study|Not treated|4|||
129653718|NCT01854879|466688137|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
129877118|NCT03565068|467509295|FG007|Overall Study|Sponsor decision|0|||
129877119|NCT03565068|467509296|FG008|Overall Study|Sponsor decision|0|||
129877120|NCT03565068|467509288|FG000|Overall Study|Withdrawal by Subject|0|||
129877121|NCT03565068|467509289|FG001|Overall Study|Withdrawal by Subject|0|||
129544842|NCT02057549|466286961|FG000|Overall Study|Lost to Follow-up|1|||
129544843|NCT02057549|466286962|FG001|Overall Study|Lost to Follow-up|0|||
129544844|NCT02057549|466286961|FG000|Overall Study|Physician Decision|1|||
129544845|NCT02057549|466286962|FG001|Overall Study|Physician Decision|0|||
129544846|NCT02057549|466286961|FG000|Overall Study|Withdrawal by Subject|1|||
129544847|NCT02057549|466286962|FG001|Overall Study|Withdrawal by Subject|0|||
129544848|NCT01418365|466286965|FG000|First Intervention|Withdrawal by Subject|0|||
129544849|NCT01418365|466286966|FG001|First Intervention|Withdrawal by Subject|1|||
129544850|NCT01418365|466286965|FG000|First Intervention|Non-compliance|1|||
129544851|NCT01418365|466286966|FG001|First Intervention|Non-compliance|0|||
129544852|NCT01418365|466286965|FG000|Second Intervention|Withdrawal by Subject|0|||
129544853|NCT01418365|466286966|FG001|Second Intervention|Withdrawal by Subject|1|||
129544854|NCT00690573|466286979|FG000|Overall Study|Lack of Efficacy|8|||
129544855|NCT00690573|466286979|FG000|Overall Study|Withdrawal by Subject|1|||
129544856|NCT03505606|466288320|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
129544857|NCT03505606|466288321|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
129544858|NCT03505606|466288322|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
129544859|NCT03505606|466288320|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
129544860|NCT03505606|466288321|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
129544861|NCT03505606|466288322|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
129544862|NCT03505606|466288320|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
129544863|NCT03505606|466288321|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
129544864|NCT03505606|466288322|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
129544865|NCT03505606|466288320|FG000|Overall Study|Poor compliance with refractive correction|0|||
129544866|NCT03505606|466288321|FG001|Overall Study|Poor compliance with refractive correction|0|||
129544867|NCT03505606|466288322|FG002|Overall Study|Poor compliance with refractive correction|1|||
129544868|NCT03505606|466288320|FG000|Overall Study|Insufficient anisometropia|0|||
129544869|NCT03505606|466288321|FG001|Overall Study|Insufficient anisometropia|0|||
129544870|NCT03505606|466288322|FG002|Overall Study|Insufficient anisometropia|2|||
129544871|NCT03505606|466288320|FG000|Overall Study|Ectopia Lentis|0|||
129544872|NCT03505606|466288321|FG001|Overall Study|Ectopia Lentis|0|||
129544873|NCT03505606|466288322|FG002|Overall Study|Ectopia Lentis|1|||
129544874|NCT03505606|466288320|FG000|Overall Study|alternation of amblyopic eye|0|||
129544875|NCT03505606|466288321|FG001|Overall Study|alternation of amblyopic eye|1|||
129544876|NCT03505606|466288322|FG002|Overall Study|alternation of amblyopic eye|0|||
129544877|NCT02087865|466288324|FG000|Overall Study|Withdrawal by Subject|6|||
129544878|NCT02087865|466288325|FG001|Overall Study|Withdrawal by Subject|0|||
129544879|NCT02087865|466288326|FG002|Overall Study|Withdrawal by Subject|1|||
129544880|NCT02087865|466288324|FG000|Overall Study|Lost to Follow-up|0|||
129544881|NCT02087865|466288325|FG001|Overall Study|Lost to Follow-up|0|||
129544882|NCT02087865|466288326|FG002|Overall Study|Lost to Follow-up|1|||
129544883|NCT02087865|466288324|FG000|Overall Study|Drug Non-compliance|0|||
129544884|NCT02087865|466288325|FG001|Overall Study|Drug Non-compliance|2|||
129544885|NCT02087865|466288326|FG002|Overall Study|Drug Non-compliance|0|||
129544886|NCT02087865|466288324|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
129544887|NCT02087865|466288325|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
129544888|NCT02087865|466288326|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
129544889|NCT01392469|466288329|FG000|Overall Study|Adverse Event|2|||
129544890|NCT01392469|466288329|FG000|Overall Study|Withdrawal by Subject|1|||
129544891|NCT01392469|466288329|FG000|Overall Study|Protocol Violation|1|||
129544892|NCT00648739|466288332|FG000|Overall Study|Adverse Event|1|||
129544893|NCT00648739|466288333|FG001|Overall Study|Adverse Event|0|||
129544894|NCT00648739|466288334|FG002|Overall Study|Adverse Event|1|||
129544895|NCT00648739|466288335|FG003|Overall Study|Adverse Event|2|||
129544896|NCT00648739|466288336|FG004|Overall Study|Adverse Event|1|||
129544897|NCT00648739|466288337|FG005|Overall Study|Adverse Event|0|||
129544898|NCT00648739|466288338|FG006|Overall Study|Adverse Event|0|||
129544899|NCT00648739|466288332|FG000|Overall Study|Withdrawal by Subject|1|||
129544900|NCT00648739|466288333|FG001|Overall Study|Withdrawal by Subject|0|||
129544901|NCT00648739|466288334|FG002|Overall Study|Withdrawal by Subject|1|||
129544902|NCT00648739|466288335|FG003|Overall Study|Withdrawal by Subject|0|||
129544903|NCT00648739|466288336|FG004|Overall Study|Withdrawal by Subject|0|||
129544904|NCT00648739|466288337|FG005|Overall Study|Withdrawal by Subject|2|||
129544905|NCT00648739|466288338|FG006|Overall Study|Withdrawal by Subject|0|||
129544906|NCT00648739|466288332|FG000|Overall Study|Lack of Efficacy|0|||
129544907|NCT00648739|466288333|FG001|Overall Study|Lack of Efficacy|0|||
129544908|NCT00648739|466288334|FG002|Overall Study|Lack of Efficacy|0|||
129544909|NCT00648739|466288335|FG003|Overall Study|Lack of Efficacy|0|||
129544910|NCT00648739|466288336|FG004|Overall Study|Lack of Efficacy|1|||
129544911|NCT00648739|466288337|FG005|Overall Study|Lack of Efficacy|2|||
129544912|NCT00648739|466288338|FG006|Overall Study|Lack of Efficacy|0|||
129544913|NCT00648739|466288332|FG000|Overall Study|Investigator Considered it Advisable|0|||
129544914|NCT00648739|466288333|FG001|Overall Study|Investigator Considered it Advisable|0|||
129653719|NCT01854879|466688137|FG000|Overall Study|screen fail|3|||
129653720|NCT01854879|466688137|FG000|Overall Study|incomplete data set|1|||
129653721|NCT01211483|466689821|FG000|Phase 1b|Death|6|||
129653722|NCT01211483|466689822|FG001|Phase 1b|Death|0|||
129653723|NCT01211483|466689823|FG002|Phase 1b|Death|0|||
129653724|NCT01211483|466689824|FG003|Phase 1b|Death|0|||
129653725|NCT01211483|466689821|FG000|Phase 1b|Withdrawal by Subject|1|||
129653726|NCT01211483|466689822|FG001|Phase 1b|Withdrawal by Subject|0|||
129653727|NCT01211483|466689823|FG002|Phase 1b|Withdrawal by Subject|0|||
129653728|NCT01211483|466689824|FG003|Phase 1b|Withdrawal by Subject|0|||
129653729|NCT01211483|466689821|FG000|Phase 2|Lost to Follow-up|0|||
129653730|NCT01211483|466689822|FG001|Phase 2|Lost to Follow-up|1|||
129653731|NCT01211483|466689823|FG002|Phase 2|Lost to Follow-up|1|||
129653732|NCT01211483|466689824|FG003|Phase 2|Lost to Follow-up|2|||
129653733|NCT01211483|466689821|FG000|Phase 2|Death|0|||
129653734|NCT01211483|466689822|FG001|Phase 2|Death|64|||
129653735|NCT01211483|466689823|FG002|Phase 2|Death|53|||
129653736|NCT01211483|466689824|FG003|Phase 2|Death|53|||
129653737|NCT01211483|466689821|FG000|Phase 2|Withdrawal by Subject|0|||
129653738|NCT01211483|466689822|FG001|Phase 2|Withdrawal by Subject|1|||
129653739|NCT01211483|466689823|FG002|Phase 2|Withdrawal by Subject|10|||
129653740|NCT01211483|466689824|FG003|Phase 2|Withdrawal by Subject|5|||
129653741|NCT01211483|466689821|FG000|Phase 2|Study terminated by Sponsor|0|||
129653742|NCT01211483|466689822|FG001|Phase 2|Study terminated by Sponsor|6|||
129653743|NCT01211483|466689823|FG002|Phase 2|Study terminated by Sponsor|8|||
129653744|NCT01211483|466689824|FG003|Phase 2|Study terminated by Sponsor|11|||
129653745|NCT00460265|466689825|FG000|Overall Study|Lost to Follow-up|14|||
129653746|NCT00460265|466689826|FG001|Overall Study|Lost to Follow-up|15|||
129653747|NCT00460265|466689825|FG000|Overall Study|Physician Decision|1|||
129653748|NCT00460265|466689826|FG001|Overall Study|Physician Decision|2|||
129653749|NCT00460265|466689825|FG000|Overall Study|Withdrawal by Subject|10|||
129653750|NCT00460265|466689826|FG001|Overall Study|Withdrawal by Subject|25|||
129653751|NCT00460265|466689825|FG000|Overall Study|Ongoing|60|||
129653752|NCT00460265|466689826|FG001|Overall Study|Ongoing|47|||
129653753|NCT02719353|466689827|FG000|First Intervention|Physician Decision|0|||
129653754|NCT02719353|466689828|FG001|First Intervention|Physician Decision|1|||
129877122|NCT03565068|467509290|FG002|Overall Study|Withdrawal by Subject|1|||
129877123|NCT03565068|467509291|FG003|Overall Study|Withdrawal by Subject|0|||
129877124|NCT03565068|467509292|FG004|Overall Study|Withdrawal by Subject|2|||
129877125|NCT03565068|467509293|FG005|Overall Study|Withdrawal by Subject|0|||
129877126|NCT03565068|467509294|FG006|Overall Study|Withdrawal by Subject|1|||
129877127|NCT03565068|467509295|FG007|Overall Study|Withdrawal by Subject|5|||
129877128|NCT03565068|467509296|FG008|Overall Study|Withdrawal by Subject|1|||
129877129|NCT03565068|467509288|FG000|Overall Study|Physician Decision|0|||
129877130|NCT03565068|467509289|FG001|Overall Study|Physician Decision|0|||
129877131|NCT03565068|467509290|FG002|Overall Study|Physician Decision|0|||
129877132|NCT03565068|467509291|FG003|Overall Study|Physician Decision|0|||
129877133|NCT03565068|467509292|FG004|Overall Study|Physician Decision|0|||
129877134|NCT03565068|467509293|FG005|Overall Study|Physician Decision|0|||
129877135|NCT03565068|467509294|FG006|Overall Study|Physician Decision|0|||
129877136|NCT03565068|467509295|FG007|Overall Study|Physician Decision|1|||
129877137|NCT03565068|467509296|FG008|Overall Study|Physician Decision|0|||
129877138|NCT03565068|467509288|FG000|Overall Study|Lost to Follow-up|0|||
129877139|NCT03565068|467509289|FG001|Overall Study|Lost to Follow-up|0|||
129877140|NCT03565068|467509290|FG002|Overall Study|Lost to Follow-up|0|||
129877141|NCT03565068|467509291|FG003|Overall Study|Lost to Follow-up|0|||
129877142|NCT03565068|467509292|FG004|Overall Study|Lost to Follow-up|0|||
129877143|NCT03565068|467509293|FG005|Overall Study|Lost to Follow-up|0|||
129877144|NCT03565068|467509294|FG006|Overall Study|Lost to Follow-up|0|||
129877145|NCT03565068|467509295|FG007|Overall Study|Lost to Follow-up|1|||
129877146|NCT03565068|467509296|FG008|Overall Study|Lost to Follow-up|0|||
129877147|NCT00085202|467509297|FG000|Overall Study|Still on therapy|2|||
129877148|NCT00085202|467509298|FG001|Overall Study|Still on therapy|0|||
129877149|NCT00085202|467509297|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
129877150|NCT00085202|467509298|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
129877151|NCT00085202|467509297|FG000|Overall Study|Excessive toxicity|6|||
129653755|NCT01917344|466689830|FG000|Overall Study|Withdrawal by Subject|1|||
129653756|NCT00412217|466689831|FG000|Overall Study|Insufficient Data Available|8|||
129653757|NCT00412217|466689832|FG001|Overall Study|Insufficient Data Available|3|||
129653758|NCT00412217|466689831|FG000|Overall Study|Death|5|||
129653759|NCT00412217|466689832|FG001|Overall Study|Death|4|||
129653760|NCT00412217|466689831|FG000|Overall Study|Disease Progression|2|||
129653761|NCT00412217|466689832|FG001|Overall Study|Disease Progression|3|||
129653762|NCT00412217|466689831|FG000|Overall Study|Investigator Decision|1|||
129653763|NCT00412217|466689832|FG001|Overall Study|Investigator Decision|0|||
129653764|NCT00412217|466689831|FG000|Overall Study|Withdrawal by Subject|2|||
129653765|NCT00412217|466689832|FG001|Overall Study|Withdrawal by Subject|0|||
129653766|NCT00412217|466689831|FG000|Overall Study|Lost to Follow-up|1|||
129877152|NCT00085202|467509298|FG001|Overall Study|Excessive toxicity|5|||
129877153|NCT00085202|467509297|FG000|Overall Study|Non-specified|3|||
129877154|NCT00085202|467509298|FG001|Overall Study|Non-specified|5|||
129877155|NCT00085202|467509297|FG000|Overall Study|Withdrawal by Subject|2|||
129877156|NCT00085202|467509298|FG001|Overall Study|Withdrawal by Subject|1|||
129877157|NCT00085202|467509297|FG000|Overall Study|Physician Decision|4|||
129877158|NCT00085202|467509298|FG001|Overall Study|Physician Decision|1|||
129877159|NCT00085202|467509297|FG000|Overall Study|Progressive disease|1|||
129877160|NCT00085202|467509298|FG001|Overall Study|Progressive disease|11|||
129877161|NCT01435655|467509300|FG000|Overall Study|Death|2|||
129877162|NCT01435655|467509300|FG000|Overall Study|Other|1|||
129877163|NCT01436201|467509301|FG000|Overall Study|Adverse Event|2|||
129877164|NCT01436201|467509301|FG000|Overall Study|Withdrawal by Subject|1|||
129877165|NCT01436201|467509301|FG000|Overall Study|Protocol Violation|1|||
129877166|NCT00263328|467509302|FG000|Overall Study|Death|0|||
129877167|NCT00263328|467509303|FG001|Overall Study|Death|0|||
129877168|NCT00263328|467509304|FG002|Overall Study|Death|1|||
129877169|NCT00263328|467509302|FG000|Overall Study|Lost to Follow-up|1|||
129877170|NCT00263328|467509303|FG001|Overall Study|Lost to Follow-up|1|||
129877171|NCT00263328|467509304|FG002|Overall Study|Lost to Follow-up|0|||
129877172|NCT00263328|467509302|FG000|Overall Study|Withdrawal by Subject|3|||
129877173|NCT00263328|467509303|FG001|Overall Study|Withdrawal by Subject|0|||
129877174|NCT00263328|467509304|FG002|Overall Study|Withdrawal by Subject|1|||
129877175|NCT00263328|467509302|FG000|Overall Study|Other|3|||
129877176|NCT00263328|467509303|FG001|Overall Study|Other|0|||
129877177|NCT00263328|467509304|FG002|Overall Study|Other|1|||
129877178|NCT00263328|467509302|FG000|Overall Study|Adverse Event|1|||
129877179|NCT00263328|467509303|FG001|Overall Study|Adverse Event|1|||
129877180|NCT00263328|467509304|FG002|Overall Study|Adverse Event|4|||
129877181|NCT01301274|467509308|FG000|Overall Study|Physician Decision|2|||
129877182|NCT01301274|467509309|FG001|Overall Study|Physician Decision|1|||
129877183|NCT04512066|467509310|FG000|Double-blind Treatment Period|Adverse Event|6|||
129877184|NCT04512066|467509311|FG001|Double-blind Treatment Period|Adverse Event|4|||
129877185|NCT04512066|467509312|FG002|Double-blind Treatment Period|Adverse Event|5|||
129877186|NCT04512066|467509313|FG003|Double-blind Treatment Period|Adverse Event|1|||
129877187|NCT04512066|467509314|FG004|Double-blind Treatment Period|Adverse Event|0|||
129877188|NCT04512066|467509315|FG005|Double-blind Treatment Period|Adverse Event|0|||
129877189|NCT04512066|467509310|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
129877190|NCT04512066|467509311|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
129877191|NCT04512066|467509312|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
129877192|NCT04512066|467509313|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
129544915|NCT00648739|466288334|FG002|Overall Study|Investigator Considered it Advisable|0|||
129544916|NCT00648739|466288335|FG003|Overall Study|Investigator Considered it Advisable|0|||
129544917|NCT00648739|466288336|FG004|Overall Study|Investigator Considered it Advisable|0|||
129544918|NCT00648739|466288337|FG005|Overall Study|Investigator Considered it Advisable|1|||
129544919|NCT00648739|466288338|FG006|Overall Study|Investigator Considered it Advisable|1|||
129544920|NCT00648739|466288332|FG000|Overall Study|Death|0|||
129544921|NCT00648739|466288333|FG001|Overall Study|Death|1|||
129544922|NCT00648739|466288334|FG002|Overall Study|Death|0|||
129544923|NCT00648739|466288335|FG003|Overall Study|Death|0|||
129544924|NCT00648739|466288336|FG004|Overall Study|Death|0|||
129544925|NCT00648739|466288337|FG005|Overall Study|Death|0|||
129544926|NCT00648739|466288338|FG006|Overall Study|Death|0|||
129544927|NCT00648739|466288332|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
129544928|NCT00648739|466288333|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
129544929|NCT00648739|466288334|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
129544930|NCT00648739|466288335|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
129544931|NCT00648739|466288336|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
129544932|NCT00648739|466288337|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
129544933|NCT00648739|466288338|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
129544934|NCT00648739|466288332|FG000|Overall Study|Follow-up Visits Not Completed|0|||
129544935|NCT00648739|466288333|FG001|Overall Study|Follow-up Visits Not Completed|1|||
129544936|NCT00648739|466288334|FG002|Overall Study|Follow-up Visits Not Completed|0|||
129544937|NCT00648739|466288335|FG003|Overall Study|Follow-up Visits Not Completed|0|||
129544938|NCT00648739|466288336|FG004|Overall Study|Follow-up Visits Not Completed|0|||
129544939|NCT00648739|466288337|FG005|Overall Study|Follow-up Visits Not Completed|0|||
129544940|NCT00648739|466288338|FG006|Overall Study|Follow-up Visits Not Completed|0|||
129544941|NCT00564486|466288343|FG000|Overall Study|Adverse Event|0|||
129544942|NCT00564486|466288344|FG001|Overall Study|Adverse Event|1|||
129544943|NCT00564486|466288345|FG002|Overall Study|Adverse Event|0|||
129544944|NCT00564486|466288346|FG003|Overall Study|Adverse Event|0|||
129544945|NCT00564486|466288343|FG000|Overall Study|Withdrawal by Subject|4|||
129544946|NCT00564486|466288344|FG001|Overall Study|Withdrawal by Subject|0|||
129877193|NCT04512066|467509314|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
129877194|NCT04512066|467509315|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
129877195|NCT04512066|467509310|FG000|Double-blind Treatment Period|Physician Decision|1|||
129544947|NCT00564486|466288345|FG002|Overall Study|Withdrawal by Subject|0|||
129544948|NCT00564486|466288346|FG003|Overall Study|Withdrawal by Subject|5|||
129877196|NCT04512066|467509311|FG001|Double-blind Treatment Period|Physician Decision|0|||
129877197|NCT04512066|467509312|FG002|Double-blind Treatment Period|Physician Decision|1|||
129653767|NCT00412217|466689832|FG001|Overall Study|Lost to Follow-up|4|||
129653768|NCT00412217|466689831|FG000|Overall Study|Study Terminated by Sponsor|26|||
129653769|NCT00412217|466689832|FG001|Overall Study|Study Terminated by Sponsor|33|||
129653770|NCT00412217|466689831|FG000|Overall Study|Other|1|||
129653771|NCT00412217|466689832|FG001|Overall Study|Other|1|||
129653772|NCT01398410|466689834|FG000|Overall Study|Adverse Event|12|||
129653773|NCT01398410|466689835|FG001|Overall Study|Adverse Event|16|||
129653774|NCT01398410|466689834|FG000|Overall Study|Participants Choice|8|||
129653775|NCT01398410|466689835|FG001|Overall Study|Participants Choice|11|||
129653776|NCT01398410|466689834|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
129653777|NCT01398410|466689835|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
129653778|NCT01398410|466689834|FG000|Overall Study|Other|36|||
129653779|NCT01398410|466689835|FG001|Overall Study|Other|29|||
129653780|NCT02470403|466689836|FG000|Overall Study|Adverse Event|1|||
129653781|NCT02470403|466689837|FG001|Overall Study|Adverse Event|0|||
129653782|NCT02470403|466689838|FG002|Overall Study|Adverse Event|0|||
129653783|NCT02470403|466689839|FG003|Overall Study|Adverse Event|0|||
129653784|NCT02470403|466689840|FG004|Overall Study|Adverse Event|0|||
129653785|NCT02470403|466689836|FG000|Overall Study|Lost to Follow-up|0|||
129653786|NCT02470403|466689837|FG001|Overall Study|Lost to Follow-up|1|||
129653787|NCT02470403|466689838|FG002|Overall Study|Lost to Follow-up|0|||
129653788|NCT02470403|466689839|FG003|Overall Study|Lost to Follow-up|0|||
129653789|NCT02470403|466689840|FG004|Overall Study|Lost to Follow-up|0|||
129653790|NCT02470403|466689836|FG000|Overall Study|Subject/guardian decision|1|||
129653791|NCT02470403|466689837|FG001|Overall Study|Subject/guardian decision|0|||
129653792|NCT02470403|466689838|FG002|Overall Study|Subject/guardian decision|0|||
129653793|NCT02470403|466689839|FG003|Overall Study|Subject/guardian decision|4|||
129653794|NCT02470403|466689840|FG004|Overall Study|Subject/guardian decision|0|||
129653795|NCT03209518|466689843|FG000|Overall Study|Case Report Forms Uncollected|1|||
129653796|NCT03209518|466689843|FG000|Overall Study|Protocol Deviation|1|||
129653797|NCT00236899|466689844|FG000|Overall Study|Adverse Event (Study Related)|1|||
129653798|NCT00236899|466689845|FG001|Overall Study|Adverse Event (Study Related)|1|||
129653799|NCT00236899|466689846|FG002|Overall Study|Adverse Event (Study Related)|2|||
129653800|NCT00236899|466689847|FG003|Overall Study|Adverse Event (Study Related)|1|||
129653801|NCT00236899|466689844|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
129653802|NCT00236899|466689845|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
129653803|NCT00236899|466689846|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
129653804|NCT00236899|466689847|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
129653805|NCT00236899|466689844|FG000|Overall Study|Death (Study Disease)|1|||
129653806|NCT00236899|466689845|FG001|Overall Study|Death (Study Disease)|4|||
129653807|NCT00236899|466689846|FG002|Overall Study|Death (Study Disease)|0|||
129653808|NCT00236899|466689847|FG003|Overall Study|Death (Study Disease)|0|||
129653809|NCT00236899|466689844|FG000|Overall Study|Death (Not Study Related)|2|||
129653810|NCT00236899|466689845|FG001|Overall Study|Death (Not Study Related)|0|||
129653811|NCT00236899|466689846|FG002|Overall Study|Death (Not Study Related)|0|||
129653812|NCT00236899|466689847|FG003|Overall Study|Death (Not Study Related)|0|||
129653813|NCT00236899|466689844|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
129653814|NCT00236899|466689845|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
129653815|NCT00236899|466689846|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
129653816|NCT00236899|466689847|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
129653817|NCT00236899|466689844|FG000|Overall Study|Lost to Follow-up|0|||
129653818|NCT00236899|466689845|FG001|Overall Study|Lost to Follow-up|1|||
129653819|NCT00236899|466689846|FG002|Overall Study|Lost to Follow-up|0|||
129653820|NCT00236899|466689847|FG003|Overall Study|Lost to Follow-up|0|||
129653821|NCT00236899|466689844|FG000|Overall Study|Entry Criteria Exclusion|0|||
129653822|NCT00236899|466689845|FG001|Overall Study|Entry Criteria Exclusion|1|||
129653823|NCT00236899|466689846|FG002|Overall Study|Entry Criteria Exclusion|1|||
129653824|NCT00236899|466689847|FG003|Overall Study|Entry Criteria Exclusion|0|||
129653825|NCT00236899|466689844|FG000|Overall Study|Protocol Violation|1|||
129653826|NCT00236899|466689845|FG001|Overall Study|Protocol Violation|0|||
129653827|NCT00236899|466689846|FG002|Overall Study|Protocol Violation|0|||
129653828|NCT00236899|466689847|FG003|Overall Study|Protocol Violation|0|||
129653829|NCT00236899|466689844|FG000|Overall Study|Withdrawal by Subject|6|||
129653830|NCT00236899|466689845|FG001|Overall Study|Withdrawal by Subject|4|||
129653831|NCT00236899|466689846|FG002|Overall Study|Withdrawal by Subject|5|||
129653832|NCT00236899|466689847|FG003|Overall Study|Withdrawal by Subject|2|||
129653833|NCT00236899|466689844|FG000|Overall Study|Physician Decision|7|||
129653834|NCT00236899|466689845|FG001|Overall Study|Physician Decision|8|||
129653835|NCT00236899|466689846|FG002|Overall Study|Physician Decision|7|||
129653836|NCT00236899|466689847|FG003|Overall Study|Physician Decision|6|||
129653837|NCT00236899|466689844|FG000|Overall Study|Satisfactory Response|2|||
129653838|NCT00236899|466689845|FG001|Overall Study|Satisfactory Response|0|||
129653839|NCT00236899|466689846|FG002|Overall Study|Satisfactory Response|0|||
129653840|NCT00236899|466689847|FG003|Overall Study|Satisfactory Response|1|||
129653841|NCT00236899|466689844|FG000|Overall Study|Lack of Efficacy|18|||
129653842|NCT00236899|466689845|FG001|Overall Study|Lack of Efficacy|18|||
129653843|NCT00236899|466689846|FG002|Overall Study|Lack of Efficacy|25|||
129653844|NCT00236899|466689847|FG003|Overall Study|Lack of Efficacy|23|||
129653845|NCT03379792|466689848|FG000|Overall Study|Physician Decision|0|||
129653846|NCT03379792|466689849|FG001|Overall Study|Physician Decision|0|||
129653847|NCT03379792|466689850|FG002|Overall Study|Physician Decision|0|||
129877198|NCT04512066|467509313|FG003|Double-blind Treatment Period|Physician Decision|0|||
129544949|NCT00564486|466288343|FG000|Overall Study|Subject refused to have blood drawn|0|||
129544950|NCT00564486|466288344|FG001|Overall Study|Subject refused to have blood drawn|0|||
129544951|NCT00564486|466288345|FG002|Overall Study|Subject refused to have blood drawn|1|||
129544952|NCT00564486|466288346|FG003|Overall Study|Subject refused to have blood drawn|0|||
129544953|NCT00564486|466288343|FG000|Overall Study|Lost to Follow-up|3|||
129544954|NCT00564486|466288344|FG001|Overall Study|Lost to Follow-up|0|||
129544955|NCT00564486|466288345|FG002|Overall Study|Lost to Follow-up|2|||
129544956|NCT00564486|466288346|FG003|Overall Study|Lost to Follow-up|2|||
129544957|NCT03862807|466288351|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
129544958|NCT04362761|466288352|FG000|Part A (48 Weeks)|Adverse Event|2|||
129544959|NCT04362761|466288352|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
129544960|NCT04362761|466288352|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
129544961|NCT04362761|466288352|FG000|Part A (48 Weeks)|Other|5|||
129544962|NCT04362761|466288352|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
129544963|NCT04362761|466288352|FG000|Part B (86 Weeks)|Other|4|||
129544964|NCT00684645|466288353|FG000|Overall Study|Death|2|||
129544965|NCT00684645|466288353|FG000|Overall Study|Progressive disease|67|||
129544966|NCT00684645|466288353|FG000|Overall Study|Adverse Event|27|||
129544967|NCT00684645|466288353|FG000|Overall Study|Lost to Follow-up|3|||
129544968|NCT00684645|466288353|FG000|Overall Study|Other|15|||
129544969|NCT02525627|466288367|FG000|Overall Study|Revision|1|||
129544970|NCT02525627|466288368|FG001|Overall Study|Revision|1|||
129544971|NCT02525627|466288367|FG000|Overall Study|Withdrawal by Subject|1|||
129544972|NCT02525627|466288368|FG001|Overall Study|Withdrawal by Subject|2|||
129544973|NCT02525627|466288367|FG000|Overall Study|Death|1|||
129544974|NCT02525627|466288368|FG001|Overall Study|Death|0|||
129544975|NCT02525627|466288367|FG000|Overall Study|Site terminated|11|||
129544976|NCT02525627|466288368|FG001|Overall Study|Site terminated|10|||
129544977|NCT03746080|466288369|FG000|Overall Study|In follow up|2|||
129544978|NCT03746080|466288369|FG000|Overall Study|Death|15|||
129544979|NCT01473589|466288370|FG000|Overall Study|Adverse Event|1|||
129544980|NCT01473589|466288371|FG001|Overall Study|Adverse Event|1|||
129544981|NCT01473589|466288370|FG000|Overall Study|Death|2|||
129544982|NCT01473589|466288371|FG001|Overall Study|Death|0|||
129544983|NCT01473589|466288370|FG000|Overall Study|Lost to Follow-up|2|||
129544984|NCT01473589|466288371|FG001|Overall Study|Lost to Follow-up|2|||
129544985|NCT01473589|466288370|FG000|Overall Study|Protocol Violation|1|||
129544986|NCT01473589|466288371|FG001|Overall Study|Protocol Violation|0|||
129544987|NCT01473589|466288370|FG000|Overall Study|Withdrawal by Subject|5|||
129544988|NCT01473589|466288371|FG001|Overall Study|Withdrawal by Subject|11|||
129544989|NCT01473589|466288370|FG000|Overall Study|Physician Decision|0|||
129544990|NCT01473589|466288371|FG001|Overall Study|Physician Decision|1|||
129544991|NCT01473589|466288370|FG000|Overall Study|Entry criteria not met|0|||
129544992|NCT01473589|466288371|FG001|Overall Study|Entry criteria not met|1|||
129544993|NCT01819467|466288372|FG000|Overall Study|Physician Decision|20|||
129544994|NCT01819467|466288373|FG001|Overall Study|Physician Decision|9|||
129544995|NCT01607398|466288377|FG000|Overall Study|Adverse Event|0|||
129544996|NCT01607398|466288378|FG001|Overall Study|Adverse Event|2|||
129544997|NCT01607398|466288377|FG000|Overall Study|Severe COPD|2|||
129544998|NCT01607398|466288378|FG001|Overall Study|Severe COPD|0|||
129544999|NCT04139642|466288381|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
129545000|NCT04139642|466288382|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
129545001|NCT00433771|466288384|FG000|Overall Study|screen fail|14|||
129545002|NCT00433771|466288384|FG000|Overall Study|Treated and later found to be ineligible|2|||
129545003|NCT00433771|466288384|FG000|Overall Study|Death|2|||
129545004|NCT00433771|466288384|FG000|Overall Study|Failure to deploy stent|1|||
129545005|NCT00539006|466288388|FG000|Pre-treatment|Other|0|||
129545006|NCT00539006|466288389|FG001|Pre-treatment|Other|1|||
129545007|NCT00539006|466288390|FG002|Pre-treatment|Other|0|||
129545008|NCT00539006|466288391|FG003|Pre-treatment|Other|0|||
129545009|NCT00539006|466288388|FG000|Treatment Period 1|Lost to Follow-up|0|||
129545010|NCT00539006|466288389|FG001|Treatment Period 1|Lost to Follow-up|0|||
129545011|NCT00539006|466288390|FG002|Treatment Period 1|Lost to Follow-up|1|||
129545012|NCT00539006|466288391|FG003|Treatment Period 1|Lost to Follow-up|0|||
129545013|NCT00539006|466288388|FG000|Treatment Period 1|Protocol Violation|0|||
129545014|NCT00539006|466288389|FG001|Treatment Period 1|Protocol Violation|0|||
129877199|NCT04512066|467509314|FG004|Double-blind Treatment Period|Physician Decision|0|||
129545015|NCT00539006|466288390|FG002|Treatment Period 1|Protocol Violation|1|||
129545016|NCT00539006|466288391|FG003|Treatment Period 1|Protocol Violation|0|||
129545017|NCT00539006|466288388|FG000|Treatment Period 1|Lack of Efficacy|0|||
129545018|NCT00539006|466288389|FG001|Treatment Period 1|Lack of Efficacy|0|||
129545019|NCT00539006|466288390|FG002|Treatment Period 1|Lack of Efficacy|0|||
129653848|NCT03379792|466689851|FG003|Overall Study|Physician Decision|1|||
129653849|NCT03379792|466689852|FG004|Overall Study|Physician Decision|0|||
129653850|NCT03379792|466689853|FG005|Overall Study|Physician Decision|0|||
129653851|NCT03379792|466689848|FG000|Overall Study|Withdrawal by Subject|0|||
129653852|NCT03379792|466689849|FG001|Overall Study|Withdrawal by Subject|0|||
129653853|NCT03379792|466689850|FG002|Overall Study|Withdrawal by Subject|0|||
129653854|NCT03379792|466689851|FG003|Overall Study|Withdrawal by Subject|0|||
129653855|NCT03379792|466689852|FG004|Overall Study|Withdrawal by Subject|1|||
129877200|NCT04512066|467509315|FG005|Double-blind Treatment Period|Physician Decision|0|||
129877201|NCT04512066|467509310|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129877202|NCT04512066|467509311|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
129877203|NCT04512066|467509312|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
129877204|NCT04512066|467509313|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
129877205|NCT04512066|467509314|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
129877206|NCT04512066|467509315|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
129877207|NCT04512066|467509310|FG000|Extension Period|Adverse Event|0|||
129877208|NCT04512066|467509311|FG001|Extension Period|Adverse Event|1|||
129877209|NCT04512066|467509312|FG002|Extension Period|Adverse Event|4|||
129877210|NCT04512066|467509313|FG003|Extension Period|Adverse Event|3|||
129877211|NCT04512066|467509314|FG004|Extension Period|Adverse Event|1|||
129877212|NCT04512066|467509315|FG005|Extension Period|Adverse Event|3|||
129877213|NCT04512066|467509310|FG000|Extension Period|Death|0|||
129877214|NCT04512066|467509311|FG001|Extension Period|Death|0|||
129877215|NCT04512066|467509312|FG002|Extension Period|Death|0|||
129877216|NCT04512066|467509313|FG003|Extension Period|Death|0|||
129877217|NCT04512066|467509314|FG004|Extension Period|Death|0|||
129877218|NCT04512066|467509315|FG005|Extension Period|Death|1|||
129877219|NCT04512066|467509310|FG000|Extension Period|Lack of Efficacy|0|||
129877220|NCT04512066|467509311|FG001|Extension Period|Lack of Efficacy|4|||
129877221|NCT04512066|467509312|FG002|Extension Period|Lack of Efficacy|4|||
129877222|NCT04512066|467509313|FG003|Extension Period|Lack of Efficacy|1|||
129877223|NCT04512066|467509314|FG004|Extension Period|Lack of Efficacy|3|||
129877224|NCT04512066|467509315|FG005|Extension Period|Lack of Efficacy|3|||
129877225|NCT04512066|467509310|FG000|Extension Period|Lost to Follow-up|0|||
129877226|NCT04512066|467509311|FG001|Extension Period|Lost to Follow-up|1|||
129877227|NCT04512066|467509312|FG002|Extension Period|Lost to Follow-up|5|||
129877228|NCT04512066|467509313|FG003|Extension Period|Lost to Follow-up|2|||
129877229|NCT04512066|467509314|FG004|Extension Period|Lost to Follow-up|3|||
129877230|NCT04512066|467509315|FG005|Extension Period|Lost to Follow-up|2|||
129877231|NCT04512066|467509310|FG000|Extension Period|Non-compliance with study drug|0|||
129877232|NCT04512066|467509311|FG001|Extension Period|Non-compliance with study drug|1|||
129877233|NCT04512066|467509312|FG002|Extension Period|Non-compliance with study drug|0|||
129877234|NCT04512066|467509313|FG003|Extension Period|Non-compliance with study drug|0|||
129877235|NCT04512066|467509314|FG004|Extension Period|Non-compliance with study drug|0|||
129877236|NCT04512066|467509315|FG005|Extension Period|Non-compliance with study drug|1|||
129877237|NCT04512066|467509310|FG000|Extension Period|Other|0|||
129877238|NCT04512066|467509311|FG001|Extension Period|Other|2|||
129877239|NCT04512066|467509312|FG002|Extension Period|Other|0|||
129877240|NCT04512066|467509313|FG003|Extension Period|Other|0|||
129877241|NCT04512066|467509314|FG004|Extension Period|Other|0|||
129877242|NCT04512066|467509315|FG005|Extension Period|Other|0|||
129877243|NCT04512066|467509310|FG000|Extension Period|Physician Decision|0|||
129877244|NCT04512066|467509311|FG001|Extension Period|Physician Decision|2|||
129653856|NCT03379792|466689853|FG005|Overall Study|Withdrawal by Subject|1|||
129653857|NCT02854605|466689854|FG000|Overall Study|Adverse Event|1|||
129653858|NCT02854605|466689855|FG001|Overall Study|Adverse Event|5|||
129653859|NCT02854605|466689856|FG002|Overall Study|Adverse Event|2|||
129653860|NCT02854605|466689854|FG000|Overall Study|Lost to Follow-up|0|||
129653861|NCT02854605|466689855|FG001|Overall Study|Lost to Follow-up|2|||
129653862|NCT02854605|466689856|FG002|Overall Study|Lost to Follow-up|0|||
129653863|NCT02854605|466689854|FG000|Overall Study|Withdrew Consent|1|||
129653864|NCT02854605|466689855|FG001|Overall Study|Withdrew Consent|0|||
129653865|NCT02854605|466689856|FG002|Overall Study|Withdrew Consent|1|||
129653866|NCT02854605|466689854|FG000|Overall Study|Investigator's Discretion|1|||
129653867|NCT02854605|466689855|FG001|Overall Study|Investigator's Discretion|0|||
129877245|NCT04512066|467509312|FG002|Extension Period|Physician Decision|0|||
129877246|NCT04512066|467509313|FG003|Extension Period|Physician Decision|1|||
129877247|NCT04512066|467509314|FG004|Extension Period|Physician Decision|1|||
129877248|NCT04512066|467509315|FG005|Extension Period|Physician Decision|0|||
129877249|NCT04512066|467509310|FG000|Extension Period|Withdrawal by Subject|0|||
129877250|NCT04512066|467509311|FG001|Extension Period|Withdrawal by Subject|3|||
129877251|NCT04512066|467509312|FG002|Extension Period|Withdrawal by Subject|7|||
129877252|NCT04512066|467509313|FG003|Extension Period|Withdrawal by Subject|11|||
129877253|NCT04512066|467509314|FG004|Extension Period|Withdrawal by Subject|8|||
129877254|NCT04512066|467509315|FG005|Extension Period|Withdrawal by Subject|4|||
129877255|NCT03520400|467509316|FG000|Overall Study|Physician Decision|15|||
129877256|NCT03520400|467509317|FG001|Overall Study|Physician Decision|7|||
129653868|NCT02854605|466689856|FG002|Overall Study|Investigator's Discretion|0|||
129877257|NCT01654601|467509323|FG000|1st Administration|Withdrawal by Subject|2|||
129877258|NCT01654601|467509324|FG001|1st Administration|Withdrawal by Subject|0|||
129877259|NCT01654601|467509323|FG000|1st Administration|Protocol Violation|0|||
129877260|NCT01654601|467509324|FG001|1st Administration|Protocol Violation|2|||
129877261|NCT01654601|467509323|FG000|2nd Administration|Adverse Event|1|||
129877262|NCT01654601|467509324|FG001|2nd Administration|Adverse Event|0|||
129877263|NCT01654601|467509323|FG000|2nd Administration|Protocol Violation|0|||
129877264|NCT01654601|467509324|FG001|2nd Administration|Protocol Violation|1|||
129877265|NCT02272725|467509325|FG000|Overall Study|equipment malfunction|2|||
129877266|NCT02272725|467509326|FG001|Overall Study|equipment malfunction|0|||
129877267|NCT00597714|467510714|FG000|Overall Study|Death|56|||
129877268|NCT00597714|467510715|FG001|Overall Study|Death|46|||
129877269|NCT00597714|467510716|FG002|Overall Study|Death|0|||
129877270|NCT00597714|467510714|FG000|Overall Study|Recipient death|0|||
129877271|NCT00597714|467510715|FG001|Overall Study|Recipient death|0|||
129877272|NCT00597714|467510716|FG002|Overall Study|Recipient death|10|||
129877273|NCT01350141|467510717|FG000|Overall Study|Lost to Follow-up|1|||
129877274|NCT01350141|467510718|FG001|Overall Study|Lost to Follow-up|0|||
129877275|NCT01350141|467510719|FG002|Overall Study|Lost to Follow-up|1|||
129877276|NCT01350141|467510717|FG000|Overall Study|Withdrawal by Subject|1|||
129877277|NCT01350141|467510718|FG001|Overall Study|Withdrawal by Subject|0|||
129877278|NCT01350141|467510719|FG002|Overall Study|Withdrawal by Subject|0|||
129877279|NCT01350141|467510717|FG000|Overall Study|Randomized but not treated|1|||
129877280|NCT01350141|467510718|FG001|Overall Study|Randomized but not treated|0|||
129877281|NCT01350141|467510719|FG002|Overall Study|Randomized but not treated|0|||
129877282|NCT00519896|467510720|FG000|Overall Study|Protocol Violation|1|||
129877283|NCT00519896|467510720|FG000|Overall Study|Adverse Event|1|||
129877284|NCT01588990|467510721|FG000|Phase A|Withdrawal by Subject|5|||
129877285|NCT01588990|467510721|FG000|Phase A|Physician Decision|11|||
129877286|NCT01588990|467510721|FG000|Phase A|Other|14|||
129877287|NCT01588990|467510721|FG000|Phase A|Lost to Follow-up|1|||
129877288|NCT01588990|467510721|FG000|Phase A|Death|5|||
129877289|NCT01588990|467510721|FG000|Phase A|Adverse Event|28|||
129877290|NCT01588990|467510721|FG000|Phase A|Still on therapy at end of study|6|||
129877291|NCT01588990|467510721|FG000|Phase B|Adverse Event|2|||
129877292|NCT01588990|467510721|FG000|Phase B|Still on therapy at end of study|5|||
129877293|NCT01588990|467510721|FG000|Phase B|Withdrawal by Subject|3|||
129877294|NCT01588990|467510721|FG000|Phase B|Physician Decision|4|||
129877295|NCT01588990|467510721|FG000|Phase B|Other|2|||
129877296|NCT02367716|467510726|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
129877297|NCT00539643|467510727|FG000|Overall Study|Adverse Event|1|||
129877298|NCT00539643|467510728|FG001|Overall Study|Adverse Event|0|||
129877299|NCT00539643|467510727|FG000|Overall Study|Death|2|||
129877300|NCT00539643|467510728|FG001|Overall Study|Death|1|||
129877301|NCT00539643|467510727|FG000|Overall Study|Physician Decision|3|||
129877302|NCT00539643|467510728|FG001|Overall Study|Physician Decision|1|||
129877303|NCT00539643|467510727|FG000|Overall Study|Withdrawal by Subject|0|||
129877304|NCT00539643|467510728|FG001|Overall Study|Withdrawal by Subject|1|||
129877305|NCT01480596|467510733|FG000|Overall Study|Adverse Event|3|||
129877306|NCT01480596|467510734|FG001|Overall Study|Adverse Event|0|||
129877307|NCT01480596|467510733|FG000|Overall Study|MG exacerbation or change in medication|2|||
129877308|NCT01480596|467510734|FG001|Overall Study|MG exacerbation or change in medication|2|||
129877309|NCT04503096|467510735|FG000|Overall Study|Withdrawal by Subject|3|||
129877310|NCT02343003|467510736|FG000|Overall Study|Withdrawal by Subject|9|||
129877311|NCT02343003|467510737|FG001|Overall Study|Withdrawal by Subject|4|||
129877312|NCT02343003|467510736|FG000|Overall Study|Lost to Follow-up|5|||
129877313|NCT02343003|467510737|FG001|Overall Study|Lost to Follow-up|1|||
129877314|NCT02343003|467510736|FG000|Overall Study|Protocol Violation|1|||
129877315|NCT02343003|467510737|FG001|Overall Study|Protocol Violation|0|||
129877316|NCT02343003|467510736|FG000|Overall Study|Death|0|||
129877317|NCT02343003|467510737|FG001|Overall Study|Death|1|||
129877318|NCT02343003|467510736|FG000|Overall Study|exclusion criteria met|1|||
129545020|NCT00539006|466288391|FG003|Treatment Period 1|Lack of Efficacy|1|||
129545021|NCT00539006|466288388|FG000|Washout|Adverse Event|2|||
129877319|NCT02343003|467510737|FG001|Overall Study|exclusion criteria met|1|||
129877320|NCT02343003|467510736|FG000|Overall Study|terminated by sponsor|2|||
129877321|NCT02343003|467510737|FG001|Overall Study|terminated by sponsor|0|||
129877322|NCT02281760|467510739|FG000|Overall Study|Withdrawal by Subject|1|||
129877323|NCT01576367|467510744|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129877324|NCT01576367|467510744|FG000|Overall Study|Moved to commercial use after 6 months|1|||
129877325|NCT01453348|467510745|FG000|Overall Study|Death|0|||
129877326|NCT01453348|467510746|FG001|Overall Study|Death|0|||
129877327|NCT01453348|467510747|FG002|Overall Study|Death|1|||
129877328|NCT01453348|467510745|FG000|Overall Study|Withdrawal by Subject|0|||
129877329|NCT01453348|467510746|FG001|Overall Study|Withdrawal by Subject|1|||
129545022|NCT00539006|466288389|FG001|Washout|Adverse Event|1|||
129545023|NCT00539006|466288390|FG002|Washout|Adverse Event|0|||
129877330|NCT01453348|467510747|FG002|Overall Study|Withdrawal by Subject|0|||
129877331|NCT01453348|467510745|FG000|Overall Study|Protocol Violation|1|||
129877332|NCT01453348|467510746|FG001|Overall Study|Protocol Violation|0|||
129877333|NCT01453348|467510747|FG002|Overall Study|Protocol Violation|0|||
129877334|NCT04359771|467510752|FG000|Overall Study|Lack of Efficacy|2|||
129877335|NCT04359771|467510753|FG001|Overall Study|Lack of Efficacy|2|||
129877336|NCT03592277|467510754|FG000|Overall Study|Withdrawal by Subject|6|||
129877337|NCT03592277|467510755|FG001|Overall Study|Withdrawal by Subject|8|||
129877338|NCT00954733|467510756|FG000|Overall Study|blood gas machine did not work|1|||
129877339|NCT01462162|467510759|FG000|Overall Study|Adverse Event|5|||
129877340|NCT01462162|467510759|FG000|Overall Study|Lack of Efficacy|4|||
129877341|NCT01462162|467510759|FG000|Overall Study|Abnormal laboratory parameters|1|||
129877342|NCT01462162|467510759|FG000|Overall Study|Other|2|||
129877343|NCT01346514|467510760|FG000|Overall Study|Lost to Follow-up|19|||
129877344|NCT01346514|467510761|FG001|Overall Study|Lost to Follow-up|30|||
129877345|NCT01346514|467510760|FG000|Overall Study|Withdrawal by Subject|7|||
129877346|NCT01346514|467510761|FG001|Overall Study|Withdrawal by Subject|3|||
129877347|NCT01346514|467510760|FG000|Overall Study|Death|3|||
129877348|NCT01346514|467510761|FG001|Overall Study|Death|4|||
129877349|NCT00909480|467510762|FG000|Overall Study|Adverse Event|5|||
129877350|NCT00909480|467510763|FG001|Overall Study|Adverse Event|3|||
129877351|NCT00909480|467510762|FG000|Overall Study|Protocol Violation|6|||
129877352|NCT00909480|467510763|FG001|Overall Study|Protocol Violation|8|||
129877353|NCT00909480|467510762|FG000|Overall Study|Withdrawal criteria|9|||
129877354|NCT00909480|467510763|FG001|Overall Study|Withdrawal criteria|11|||
129877355|NCT00909480|467510762|FG000|Overall Study|Unclassified|18|||
129877356|NCT00909480|467510763|FG001|Overall Study|Unclassified|19|||
129877357|NCT01215357|467510767|FG000|Overall Study|Withdrawal by Subject|3|||
129877358|NCT01215357|467510767|FG000|Overall Study|Protocol Violation|9|||
129877359|NCT04772053|467510782|FG000|Overall Study|Physician Decision|2|||
129877360|NCT04772053|467510782|FG000|Overall Study|Withdrawal by Subject|3|||
129877361|NCT04772053|467510782|FG000|Overall Study|Study Terminated by Sponsor|1|||
129877362|NCT04599101|467510783|FG000|Overall Study|Lost to Follow-up|5|||
129877363|NCT04599101|467510784|FG001|Overall Study|Lost to Follow-up|5|||
129877364|NCT00098254|467510789|FG000|Overall Study|Adverse Event|2|||
129877365|NCT00098254|467510789|FG000|Overall Study|Death|1|||
129877366|NCT02118337|467510790|FG000|Overall Study|Other|1|||
129877367|NCT02118337|467510791|FG001|Overall Study|Other|0|||
129877368|NCT02118337|467510792|FG002|Overall Study|Other|0|||
129877369|NCT02118337|467510793|FG003|Overall Study|Other|0|||
129877370|NCT02118337|467510794|FG004|Overall Study|Other|2|||
129877371|NCT02118337|467510795|FG005|Overall Study|Other|3|||
129877372|NCT02118337|467510796|FG006|Overall Study|Other|1|||
129877373|NCT02118337|467510797|FG007|Overall Study|Other|28|||
129877374|NCT02118337|467510798|FG008|Overall Study|Other|15|||
129877375|NCT02118337|467510790|FG000|Overall Study|Lost to Follow-up|0|||
129877376|NCT02118337|467510791|FG001|Overall Study|Lost to Follow-up|0|||
129877377|NCT02118337|467510792|FG002|Overall Study|Lost to Follow-up|0|||
129877378|NCT02118337|467510793|FG003|Overall Study|Lost to Follow-up|0|||
129877379|NCT02118337|467510794|FG004|Overall Study|Lost to Follow-up|0|||
129877380|NCT02118337|467510795|FG005|Overall Study|Lost to Follow-up|0|||
129877381|NCT02118337|467510796|FG006|Overall Study|Lost to Follow-up|0|||
129877382|NCT02118337|467510797|FG007|Overall Study|Lost to Follow-up|1|||
129877383|NCT02118337|467510798|FG008|Overall Study|Lost to Follow-up|0|||
129877384|NCT02118337|467510790|FG000|Overall Study|Withdrawal by Subject|1|||
129877385|NCT02118337|467510791|FG001|Overall Study|Withdrawal by Subject|3|||
129877386|NCT02118337|467510792|FG002|Overall Study|Withdrawal by Subject|2|||
129877387|NCT02118337|467510793|FG003|Overall Study|Withdrawal by Subject|1|||
129877388|NCT02118337|467510794|FG004|Overall Study|Withdrawal by Subject|2|||
129877389|NCT02118337|467510795|FG005|Overall Study|Withdrawal by Subject|2|||
129877390|NCT02118337|467510796|FG006|Overall Study|Withdrawal by Subject|1|||
129877391|NCT02118337|467510797|FG007|Overall Study|Withdrawal by Subject|4|||
129877392|NCT02118337|467510798|FG008|Overall Study|Withdrawal by Subject|2|||
129877393|NCT02118337|467510790|FG000|Overall Study|Death|2|||
129877394|NCT02118337|467510791|FG001|Overall Study|Death|2|||
129877395|NCT02118337|467510792|FG002|Overall Study|Death|1|||
129877396|NCT02118337|467510793|FG003|Overall Study|Death|2|||
129877397|NCT02118337|467510794|FG004|Overall Study|Death|5|||
129877398|NCT02118337|467510795|FG005|Overall Study|Death|1|||
129653869|NCT02854605|466689854|FG000|Overall Study|Protocol Violation|0|||
129877399|NCT02118337|467510796|FG006|Overall Study|Death|2|||
129877400|NCT02118337|467510797|FG007|Overall Study|Death|9|||
129877401|NCT02118337|467510798|FG008|Overall Study|Death|4|||
129877402|NCT03300570|467510804|FG000|Overall Study|Adverse Event|0|||
129877403|NCT03300570|467510805|FG001|Overall Study|Adverse Event|1|||
129877404|NCT03300570|467510804|FG000|Overall Study|Withdrawal by Subject|1|||
129877405|NCT03300570|467510805|FG001|Overall Study|Withdrawal by Subject|0|||
129877406|NCT03300570|467510804|FG000|Overall Study|Inadequate bowel prep|1|||
129877407|NCT03300570|467510805|FG001|Overall Study|Inadequate bowel prep|0|||
129877408|NCT03188120|467510806|FG000|Overall Study|Adverse Event|4|||
129653870|NCT02854605|466689855|FG001|Overall Study|Protocol Violation|0|||
129877409|NCT03188120|467510806|FG000|Overall Study|Insufficient Effectiveness|8|||
129877410|NCT03188120|467510806|FG000|Overall Study|Improved|12|||
129877411|NCT03188120|467510806|FG000|Overall Study|Lost to Follow-up|7|||
129877412|NCT03188120|467510806|FG000|Overall Study|Other than specified|3|||
129877413|NCT03188120|467510806|FG000|Overall Study|No visit after the first visit|13|||
129877414|NCT02978443|467510808|FG000|Overall Study|Withdrawal by Subject|1|||
129877415|NCT02978443|467510808|FG000|Overall Study|Adverse Event|3|||
129877416|NCT02978443|467510808|FG000|Overall Study|Disease Progression on study|6|||
129877417|NCT02978443|467510808|FG000|Overall Study|Death|1|||
129877418|NCT02978443|467510808|FG000|Overall Study|Physician Decision|1|||
129877419|NCT02978443|467510808|FG000|Overall Study|Switch to alternative therapy|1|||
129877420|NCT02978443|467510808|FG000|Overall Study|Refused further treatment|1|||
129877421|NCT00717314|467510809|FG000|Overall Study|Adverse Event|3|||
129877422|NCT00717314|467510810|FG001|Overall Study|Adverse Event|2|||
129877423|NCT00717314|467510809|FG000|Overall Study|Protocol Violation|1|||
129877424|NCT00717314|467510810|FG001|Overall Study|Protocol Violation|0|||
129877425|NCT00717314|467510809|FG000|Overall Study|Lost to Follow-up|1|||
129877426|NCT00717314|467510810|FG001|Overall Study|Lost to Follow-up|5|||
129877427|NCT00717314|467510809|FG000|Overall Study|Withdrawal by Subject|1|||
129877428|NCT00717314|467510810|FG001|Overall Study|Withdrawal by Subject|3|||
129877429|NCT04631705|467510812|FG000|Overall Study|Withdrawal by Subject|0|||
129877430|NCT04631705|467510813|FG001|Overall Study|Withdrawal by Subject|0|||
129877431|NCT04631705|467510814|FG002|Overall Study|Withdrawal by Subject|0|||
129877432|NCT04631705|467510815|FG003|Overall Study|Withdrawal by Subject|0|||
129877433|NCT04631705|467510816|FG004|Overall Study|Withdrawal by Subject|0|||
129877434|NCT04631705|467510817|FG005|Overall Study|Withdrawal by Subject|0|||
129877435|NCT04631705|467510818|FG006|Overall Study|Withdrawal by Subject|1|||
129877436|NCT04631705|467510819|FG007|Overall Study|Withdrawal by Subject|0|||
129877437|NCT04631705|467510820|FG008|Overall Study|Withdrawal by Subject|0|||
129877438|NCT02130284|467510821|FG000|Overall Study|Withdrawal by Subject|3|||
129877439|NCT02130284|467510821|FG000|Overall Study|Subject Withdrew Consent|1|||
129877440|NCT02130284|467510821|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
129877441|NCT02130284|467510821|FG000|Overall Study|Subject was screened as backup for study|3|||
129877442|NCT02130284|467510821|FG000|Overall Study|Screen Failure|1|||
129877443|NCT03238300|467510825|FG000|Baseline (Before Intervention)|Physician Decision|0|||
129877444|NCT03238300|467510826|FG001|Baseline (Before Intervention)|Physician Decision|1|||
129877445|NCT03238300|467510825|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
129877446|NCT03238300|467510826|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
129877447|NCT03238300|467510825|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
129877448|NCT03238300|467510826|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
129877449|NCT03238300|467510825|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
129877450|NCT03238300|467510826|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
129877451|NCT00110890|467510832|FG000|Overall Study|Adverse Event|30|||
129877452|NCT00110890|467510833|FG001|Overall Study|Adverse Event|7|||
129877453|NCT00110890|467510832|FG000|Overall Study|Death|16|||
129877454|NCT00110890|467510833|FG001|Overall Study|Death|9|||
129877455|NCT00110890|467510832|FG000|Overall Study|Lost to Follow-up|3|||
129877456|NCT00110890|467510833|FG001|Overall Study|Lost to Follow-up|1|||
129877457|NCT00110890|467510832|FG000|Overall Study|Physician Decision|4|||
129877458|NCT00110890|467510833|FG001|Overall Study|Physician Decision|5|||
129877459|NCT00110890|467510832|FG000|Overall Study|Withdrawal by Subject|17|||
129877460|NCT00110890|467510833|FG001|Overall Study|Withdrawal by Subject|5|||
129877461|NCT00110890|467510832|FG000|Overall Study|Protocol Deviation|1|||
129877462|NCT00110890|467510833|FG001|Overall Study|Protocol Deviation|0|||
129877463|NCT00110890|467510832|FG000|Overall Study|Noncompliance|10|||
129877464|NCT00110890|467510833|FG001|Overall Study|Noncompliance|0|||
129877465|NCT00110890|467510832|FG000|Overall Study|Kidney Transplant|16|||
129877466|NCT00110890|467510833|FG001|Overall Study|Kidney Transplant|12|||
129877467|NCT00110890|467510832|FG000|Overall Study|Invest. Product Commercially Available|217|||
129877468|NCT00110890|467510833|FG001|Overall Study|Invest. Product Commercially Available|110|||
129877469|NCT00110890|467510832|FG000|Overall Study|Other|34|||
129877470|NCT00110890|467510833|FG001|Overall Study|Other|23|||
129877471|NCT00110890|467510832|FG000|Overall Study|Ineligibility determined|3|||
129877472|NCT00110890|467510833|FG001|Overall Study|Ineligibility determined|0|||
129877473|NCT00110890|467510832|FG000|Overall Study|Requirement for alternative therapy|0|||
129877474|NCT00110890|467510833|FG001|Overall Study|Requirement for alternative therapy|1|||
129877475|NCT00110890|467510832|FG000|Overall Study|Disease progression|0|||
129877476|NCT00110890|467510833|FG001|Overall Study|Disease progression|1|||
129877477|NCT00110890|467510832|FG000|Overall Study|Parathyroidectomy|0|||
129877478|NCT00110890|467510833|FG001|Overall Study|Parathyroidectomy|1|||
129877479|NCT00110890|467510832|FG000|Overall Study|Did not enter follow-up phase|10|||
129877480|NCT00110890|467510833|FG001|Overall Study|Did not enter follow-up phase|4|||
129877481|NCT01975220|467510834|FG000|Test Period 1|Not treated|0|||
129877482|NCT01975220|467510835|FG001|Test Period 1|Not treated|1|||
129877483|NCT01975220|467510836|FG002|Test Period 1|Not treated|0|||
129877484|NCT01975220|467510837|FG003|Test Period 1|Not treated|0|||
129877485|NCT01975220|467510838|FG004|Test Period 1|Not treated|0|||
129877486|NCT01975220|467510839|FG005|Test Period 1|Not treated|0|||
129877487|NCT02839343|467510840|FG000|Overall Study|Withdrawal by Subject|3|||
129877488|NCT02839343|467510841|FG001|Overall Study|Withdrawal by Subject|1|||
129877489|NCT02839343|467510840|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
129877490|NCT02839343|467510841|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
129877491|NCT02839343|467510840|FG000|Overall Study|Adverse Event|1|||
129877492|NCT02839343|467510841|FG001|Overall Study|Adverse Event|0|||
129877493|NCT00661661|467510842|FG000|Overall Study|Adverse Event|99|||
129877494|NCT00661661|467510843|FG001|Overall Study|Adverse Event|24|||
129877495|NCT00661661|467510842|FG000|Overall Study|Lack of Efficacy|3|||
129877496|NCT00661661|467510843|FG001|Overall Study|Lack of Efficacy|2|||
129877497|NCT00661661|467510842|FG000|Overall Study|Lost to Follow-up|0|||
129877498|NCT00661661|467510843|FG001|Overall Study|Lost to Follow-up|1|||
129877499|NCT00661661|467510842|FG000|Overall Study|Withdrawal by Subject|15|||
129877500|NCT00661661|467510843|FG001|Overall Study|Withdrawal by Subject|5|||
129877501|NCT00661661|467510842|FG000|Overall Study|Other|22|||
129877502|NCT00661661|467510843|FG001|Overall Study|Other|7|||
129877503|NCT00661661|467510842|FG000|Overall Study|Not assigned treatment|1|||
129877504|NCT00661661|467510843|FG001|Overall Study|Not assigned treatment|0|||
129877505|NCT01893827|467510844|FG000|Overall Study|Lost to Follow-up|19|||
129877506|NCT01893827|467510845|FG001|Overall Study|Lost to Follow-up|26|||
129877507|NCT00445679|467510848|FG000|Overall Study|Adverse Event|22|||
129877508|NCT00445679|467510849|FG001|Overall Study|Adverse Event|12|||
129877509|NCT00445679|467510850|FG002|Overall Study|Adverse Event|30|||
129877510|NCT00445679|467510851|FG003|Overall Study|Adverse Event|19|||
129877511|NCT00445679|467510848|FG000|Overall Study|Failed to return|1|||
129877512|NCT00445679|467510849|FG001|Overall Study|Failed to return|3|||
129877513|NCT00445679|467510850|FG002|Overall Study|Failed to return|2|||
129877514|NCT00445679|467510851|FG003|Overall Study|Failed to return|2|||
129877515|NCT00445679|467510848|FG000|Overall Study|Physician Decision|0|||
129877516|NCT00445679|467510849|FG001|Overall Study|Physician Decision|0|||
129877517|NCT00445679|467510850|FG002|Overall Study|Physician Decision|1|||
129877518|NCT00445679|467510851|FG003|Overall Study|Physician Decision|0|||
129877519|NCT00445679|467510848|FG000|Overall Study|Lost to Follow-up|10|||
129877520|NCT00445679|467510849|FG001|Overall Study|Lost to Follow-up|6|||
129877521|NCT00445679|467510850|FG002|Overall Study|Lost to Follow-up|6|||
129877522|NCT00445679|467510851|FG003|Overall Study|Lost to Follow-up|5|||
129877523|NCT00445679|467510848|FG000|Overall Study|Compliance|3|||
129877524|NCT00445679|467510849|FG001|Overall Study|Compliance|2|||
129877525|NCT00445679|467510850|FG002|Overall Study|Compliance|1|||
129877526|NCT00445679|467510851|FG003|Overall Study|Compliance|2|||
129877527|NCT00445679|467510848|FG000|Overall Study|Withdrawal of Informed Consent|0|||
129877528|NCT00445679|467510849|FG001|Overall Study|Withdrawal of Informed Consent|0|||
129877529|NCT00445679|467510850|FG002|Overall Study|Withdrawal of Informed Consent|1|||
129877530|NCT00445679|467510851|FG003|Overall Study|Withdrawal of Informed Consent|0|||
129877531|NCT00445679|467510848|FG000|Overall Study|Protocol Violation|2|||
129877532|NCT00445679|467510849|FG001|Overall Study|Protocol Violation|3|||
129877533|NCT00445679|467510850|FG002|Overall Study|Protocol Violation|3|||
129877534|NCT00445679|467510851|FG003|Overall Study|Protocol Violation|1|||
129877535|NCT00445679|467510848|FG000|Overall Study|Withdrawal by Subject|8|||
129877536|NCT00445679|467510849|FG001|Overall Study|Withdrawal by Subject|14|||
129877537|NCT00445679|467510850|FG002|Overall Study|Withdrawal by Subject|20|||
129877538|NCT00445679|467510851|FG003|Overall Study|Withdrawal by Subject|18|||
129877539|NCT00445679|467510848|FG000|Overall Study|Lack of Efficacy|2|||
129877540|NCT00445679|467510849|FG001|Overall Study|Lack of Efficacy|6|||
129877541|NCT00445679|467510850|FG002|Overall Study|Lack of Efficacy|2|||
129877542|NCT00445679|467510851|FG003|Overall Study|Lack of Efficacy|0|||
129877543|NCT03535337|467510855|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
129877544|NCT03535337|467510856|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
129877545|NCT03535337|467510857|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
129877546|NCT03535337|467510858|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
129545024|NCT00539006|466288391|FG003|Washout|Adverse Event|0|||
129545025|NCT00539006|466288388|FG000|Washout|Protocol Violation|1|||
129545026|NCT00539006|466288389|FG001|Washout|Protocol Violation|1|||
129545027|NCT00539006|466288390|FG002|Washout|Protocol Violation|0|||
129545028|NCT00539006|466288391|FG003|Washout|Protocol Violation|0|||
129545029|NCT00539006|466288388|FG000|Washout|Withdrawal by Subject|0|||
129545030|NCT00539006|466288389|FG001|Washout|Withdrawal by Subject|2|||
129877547|NCT03535337|467510859|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
129877548|NCT03535337|467510860|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
129545031|NCT00539006|466288390|FG002|Washout|Withdrawal by Subject|0|||
129877549|NCT03535337|467510861|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
129877550|NCT03535337|467510862|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
129877551|NCT03535337|467510863|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
129877552|NCT03535337|467510864|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
129877553|NCT02089230|467510865|FG000|Overall Study|Death|0|||
129877554|NCT02089230|467510866|FG001|Overall Study|Death|0|||
129877555|NCT02089230|467510867|FG002|Overall Study|Death|2|||
129877556|NCT02089230|467510865|FG000|Overall Study|Seeking Alternative Therapy|0|||
129545032|NCT00539006|466288391|FG003|Washout|Withdrawal by Subject|0|||
129545033|NCT00539006|466288388|FG000|Washout|Failed to meet continuation criteria|16|||
129877557|NCT02089230|467510866|FG001|Overall Study|Seeking Alternative Therapy|0|||
129877558|NCT02089230|467510867|FG002|Overall Study|Seeking Alternative Therapy|4|||
129877559|NCT02392611|467512668|FG000|Overall Study|Adverse Event|0|||
129877560|NCT02392611|467512669|FG001|Overall Study|Adverse Event|0|||
129877561|NCT02392611|467512670|FG002|Overall Study|Adverse Event|0|||
129877562|NCT02392611|467512671|FG003|Overall Study|Adverse Event|1|||
129877563|NCT02392611|467512672|FG004|Overall Study|Adverse Event|0|||
129877564|NCT02392611|467512673|FG005|Overall Study|Adverse Event|0|||
129877565|NCT02392611|467512674|FG006|Overall Study|Adverse Event|0|||
129877566|NCT02392611|467512675|FG007|Overall Study|Adverse Event|0|||
129877567|NCT02392611|467512676|FG008|Overall Study|Adverse Event|0|||
129877568|NCT02392611|467512668|FG000|Overall Study|Progressive disease|0|||
129877569|NCT02392611|467512669|FG001|Overall Study|Progressive disease|0|||
129877570|NCT02392611|467512670|FG002|Overall Study|Progressive disease|0|||
129877571|NCT02392611|467512671|FG003|Overall Study|Progressive disease|2|||
129877572|NCT02392611|467512672|FG004|Overall Study|Progressive disease|1|||
129877573|NCT02392611|467512673|FG005|Overall Study|Progressive disease|0|||
129877574|NCT02392611|467512674|FG006|Overall Study|Progressive disease|0|||
129877575|NCT02392611|467512675|FG007|Overall Study|Progressive disease|0|||
129877576|NCT02392611|467512676|FG008|Overall Study|Progressive disease|0|||
129877577|NCT02392611|467512668|FG000|Overall Study|Death|1|||
129877578|NCT02392611|467512669|FG001|Overall Study|Death|0|||
129877579|NCT02392611|467512670|FG002|Overall Study|Death|0|||
129877580|NCT02392611|467512671|FG003|Overall Study|Death|0|||
129877581|NCT02392611|467512672|FG004|Overall Study|Death|0|||
129877582|NCT02392611|467512673|FG005|Overall Study|Death|1|||
129877583|NCT02392611|467512674|FG006|Overall Study|Death|0|||
129877584|NCT02392611|467512675|FG007|Overall Study|Death|0|||
129877585|NCT02392611|467512676|FG008|Overall Study|Death|0|||
129877586|NCT02392611|467512668|FG000|Overall Study|Withdrawal by Subject|0|||
129877587|NCT02392611|467512669|FG001|Overall Study|Withdrawal by Subject|0|||
129877588|NCT02392611|467512670|FG002|Overall Study|Withdrawal by Subject|0|||
129877589|NCT02392611|467512671|FG003|Overall Study|Withdrawal by Subject|1|||
129877590|NCT02392611|467512672|FG004|Overall Study|Withdrawal by Subject|0|||
129877591|NCT02392611|467512673|FG005|Overall Study|Withdrawal by Subject|0|||
129877592|NCT02392611|467512674|FG006|Overall Study|Withdrawal by Subject|0|||
129877593|NCT02392611|467512675|FG007|Overall Study|Withdrawal by Subject|0|||
129877594|NCT02392611|467512676|FG008|Overall Study|Withdrawal by Subject|0|||
129877595|NCT02392611|467512668|FG000|Overall Study|Lost to Follow-up|0|||
129877596|NCT02392611|467512669|FG001|Overall Study|Lost to Follow-up|0|||
129877597|NCT02392611|467512670|FG002|Overall Study|Lost to Follow-up|0|||
129877598|NCT02392611|467512671|FG003|Overall Study|Lost to Follow-up|0|||
129877599|NCT02392611|467512672|FG004|Overall Study|Lost to Follow-up|0|||
129877600|NCT02392611|467512673|FG005|Overall Study|Lost to Follow-up|0|||
129877601|NCT02392611|467512674|FG006|Overall Study|Lost to Follow-up|1|||
129877602|NCT02392611|467512675|FG007|Overall Study|Lost to Follow-up|0|||
129877603|NCT02392611|467512676|FG008|Overall Study|Lost to Follow-up|0|||
129877604|NCT02392611|467512668|FG000|Overall Study|Enrolled, not treated|0|||
129877605|NCT02392611|467512669|FG001|Overall Study|Enrolled, not treated|0|||
129877606|NCT02392611|467512670|FG002|Overall Study|Enrolled, not treated|0|||
129877607|NCT02392611|467512671|FG003|Overall Study|Enrolled, not treated|2|||
129877608|NCT02392611|467512672|FG004|Overall Study|Enrolled, not treated|0|||
129877609|NCT02392611|467512673|FG005|Overall Study|Enrolled, not treated|0|||
129877610|NCT02392611|467512674|FG006|Overall Study|Enrolled, not treated|0|||
129877611|NCT02392611|467512675|FG007|Overall Study|Enrolled, not treated|0|||
129877612|NCT02392611|467512676|FG008|Overall Study|Enrolled, not treated|0|||
129877613|NCT03585296|467512692|FG000|Overall Study|Adverse Event|1|||
129877614|NCT03585296|467512692|FG000|Overall Study|Lost to Follow-up|2|||
129877615|NCT03585296|467512692|FG000|Overall Study|Withdrawal by Subject|2|||
129877616|NCT00462670|467512693|FG000|Overall Study|Adverse Event|3|||
129877617|NCT00462670|467512694|FG001|Overall Study|Adverse Event|5|||
129877618|NCT00462670|467512693|FG000|Overall Study|Lack of Efficacy|1|||
129877619|NCT00462670|467512694|FG001|Overall Study|Lack of Efficacy|0|||
129877620|NCT00462670|467512693|FG000|Overall Study|Protocol Violation|1|||
129877621|NCT00462670|467512694|FG001|Overall Study|Protocol Violation|0|||
129877622|NCT00462670|467512693|FG000|Overall Study|Resolution of signs and symptoms|0|||
129653871|NCT02854605|466689856|FG002|Overall Study|Protocol Violation|1|||
129877623|NCT00462670|467512694|FG001|Overall Study|Resolution of signs and symptoms|2|||
129877624|NCT02110732|467512695|FG000|Overall Study|Physician Decision|5|||
129877625|NCT02110732|467512696|FG001|Overall Study|Physician Decision|2|||
129877626|NCT02110732|467512695|FG000|Overall Study|Lost to Follow-up|1|||
129877627|NCT02110732|467512696|FG001|Overall Study|Lost to Follow-up|1|||
129877628|NCT00633932|467512698|FG000|Overall Study|Adverse Event|1|||
129877629|NCT00633932|467512699|FG001|Overall Study|Adverse Event|3|||
129877630|NCT00633932|467512700|FG002|Overall Study|Adverse Event|4|||
129877631|NCT00633932|467512698|FG000|Overall Study|Withdrawal by Subject|3|||
129877632|NCT00633932|467512699|FG001|Overall Study|Withdrawal by Subject|9|||
129877633|NCT00633932|467512700|FG002|Overall Study|Withdrawal by Subject|1|||
129877634|NCT00633932|467512698|FG000|Overall Study|Lost to Follow-up|1|||
129877635|NCT00633932|467512699|FG001|Overall Study|Lost to Follow-up|0|||
129877636|NCT00633932|467512700|FG002|Overall Study|Lost to Follow-up|2|||
129877637|NCT00633932|467512698|FG000|Overall Study|Protocol Violation|5|||
129877638|NCT00633932|467512699|FG001|Overall Study|Protocol Violation|2|||
129877639|NCT00633932|467512700|FG002|Overall Study|Protocol Violation|3|||
129877640|NCT00633932|467512698|FG000|Overall Study|Physician Decision|0|||
129877641|NCT00633932|467512699|FG001|Overall Study|Physician Decision|0|||
129877642|NCT00633932|467512700|FG002|Overall Study|Physician Decision|1|||
129877643|NCT00633932|467512698|FG000|Overall Study|Doctor's judgement|1|||
129877644|NCT00633932|467512699|FG001|Overall Study|Doctor's judgement|0|||
129877645|NCT00633932|467512700|FG002|Overall Study|Doctor's judgement|0|||
129877646|NCT00633932|467512698|FG000|Overall Study|Moved Away|1|||
129877647|NCT00633932|467512699|FG001|Overall Study|Moved Away|0|||
129877648|NCT00633932|467512700|FG002|Overall Study|Moved Away|0|||
129877649|NCT00482274|467512701|FG000|Overall Study|Adverse Event|1|||
129877650|NCT04836858|467512702|FG000|Overall Study|Adverse Event|0|||
129877651|NCT04836858|467512703|FG001|Overall Study|Adverse Event|0|||
129877652|NCT04836858|467512704|FG002|Overall Study|Adverse Event|0|||
129877653|NCT04836858|467512705|FG003|Overall Study|Adverse Event|1|||
129877654|NCT04836858|467512702|FG000|Overall Study|Lost to Follow-up|1|||
129877655|NCT04836858|467512703|FG001|Overall Study|Lost to Follow-up|0|||
129877656|NCT04836858|467512704|FG002|Overall Study|Lost to Follow-up|0|||
129877657|NCT04836858|467512705|FG003|Overall Study|Lost to Follow-up|0|||
129877658|NCT04836858|467512702|FG000|Overall Study|Subject/Guardian decision|3|||
129877659|NCT04836858|467512703|FG001|Overall Study|Subject/Guardian decision|0|||
129877660|NCT04836858|467512704|FG002|Overall Study|Subject/Guardian decision|0|||
129877661|NCT04836858|467512705|FG003|Overall Study|Subject/Guardian decision|1|||
129877662|NCT04836858|467512702|FG000|Overall Study|Randomized but not treated|4|||
129877663|NCT04836858|467512703|FG001|Overall Study|Randomized but not treated|0|||
129877664|NCT04836858|467512704|FG002|Overall Study|Randomized but not treated|0|||
129877665|NCT04836858|467512705|FG003|Overall Study|Randomized but not treated|0|||
129877666|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
129877667|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
129877668|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Adverse Event|2|||
129877669|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Adverse Event|5|||
129877670|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
129877671|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
129877672|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
129877673|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
129877674|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Randomized by error|0|||
129877675|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Randomized by error|5|||
129877676|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
129877677|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
129877678|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
129877679|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
129877680|NCT02948959|467512706|FG000|52 Weeks Treatment Period|Change of residence location|0|||
129877681|NCT02948959|467512707|FG001|52 Weeks Treatment Period|Change of residence location|1|||
129877682|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
129877683|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
129877684|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
129877685|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
129877686|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
129877687|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
129877688|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
129877689|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
129877690|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
129877691|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
129877692|NCT02948959|467512706|FG000|12 Weeks Follow-up Period|Study site closure|1|||
129877693|NCT02948959|467512707|FG001|12 Weeks Follow-up Period|Study site closure|0|||
129877694|NCT00810082|467512710|FG000|Overall Study|Lost to Follow-up|0|||
129877695|NCT00810082|467512711|FG001|Overall Study|Lost to Follow-up|4|||
129877696|NCT02508532|467512714|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877697|NCT02508532|467512715|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877698|NCT02508532|467512716|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877699|NCT02508532|467512717|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129653872|NCT01897571|466689861|FG000|Overall Study|Lost to Follow-up|3|||
129653873|NCT01897571|466689862|FG001|Overall Study|Lost to Follow-up|0|||
129877700|NCT02508532|467512718|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877701|NCT02508532|467512719|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877702|NCT02508532|467512720|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
129877703|NCT02508532|467512721|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877704|NCT02508532|467512722|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
129877705|NCT02508532|467512714|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877706|NCT02508532|467512715|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877707|NCT02508532|467512716|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877708|NCT02508532|467512717|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877709|NCT02508532|467512718|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877710|NCT02508532|467512719|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877711|NCT02508532|467512720|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877712|NCT02508532|467512721|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
129877713|NCT02508532|467512722|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
129877714|NCT02508532|467512714|FG000|Part 2 - Treatment|Disease Progression|0|||
129877715|NCT02508532|467512715|FG001|Part 2 - Treatment|Disease Progression|0|||
129877716|NCT02508532|467512716|FG002|Part 2 - Treatment|Disease Progression|0|||
129877717|NCT02508532|467512717|FG003|Part 2 - Treatment|Disease Progression|0|||
129877718|NCT02508532|467512718|FG004|Part 2 - Treatment|Disease Progression|0|||
129877719|NCT02508532|467512719|FG005|Part 2 - Treatment|Disease Progression|0|||
129877720|NCT02508532|467512720|FG006|Part 2 - Treatment|Disease Progression|0|||
129877721|NCT02508532|467512721|FG007|Part 2 - Treatment|Disease Progression|0|||
129877722|NCT02508532|467512722|FG008|Part 2 - Treatment|Disease Progression|118|||
129877723|NCT02508532|467512714|FG000|Part 2 - Treatment|Adverse Event|0|||
129877724|NCT02508532|467512715|FG001|Part 2 - Treatment|Adverse Event|0|||
129877725|NCT02508532|467512716|FG002|Part 2 - Treatment|Adverse Event|0|||
129877726|NCT02508532|467512717|FG003|Part 2 - Treatment|Adverse Event|0|||
129877727|NCT02508532|467512718|FG004|Part 2 - Treatment|Adverse Event|0|||
129877728|NCT02508532|467512719|FG005|Part 2 - Treatment|Adverse Event|0|||
129877729|NCT02508532|467512720|FG006|Part 2 - Treatment|Adverse Event|0|||
129877730|NCT02508532|467512721|FG007|Part 2 - Treatment|Adverse Event|0|||
129877731|NCT02508532|467512722|FG008|Part 2 - Treatment|Adverse Event|49|||
129877732|NCT02508532|467512714|FG000|Part 2 - Treatment|Physician Decision|0|||
129877733|NCT02508532|467512715|FG001|Part 2 - Treatment|Physician Decision|0|||
129877734|NCT02508532|467512716|FG002|Part 2 - Treatment|Physician Decision|0|||
129877735|NCT02508532|467512717|FG003|Part 2 - Treatment|Physician Decision|0|||
129877736|NCT02508532|467512718|FG004|Part 2 - Treatment|Physician Decision|0|||
129877737|NCT02508532|467512719|FG005|Part 2 - Treatment|Physician Decision|0|||
129877738|NCT02508532|467512720|FG006|Part 2 - Treatment|Physician Decision|0|||
129877739|NCT02508532|467512721|FG007|Part 2 - Treatment|Physician Decision|0|||
129877740|NCT02508532|467512722|FG008|Part 2 - Treatment|Physician Decision|12|||
129877741|NCT02508532|467512714|FG000|Part 2 - Treatment|Administrative|0|||
129877742|NCT02508532|467512715|FG001|Part 2 - Treatment|Administrative|0|||
129877743|NCT02508532|467512716|FG002|Part 2 - Treatment|Administrative|0|||
129877744|NCT02508532|467512717|FG003|Part 2 - Treatment|Administrative|0|||
129877745|NCT02508532|467512718|FG004|Part 2 - Treatment|Administrative|0|||
129877746|NCT02508532|467512719|FG005|Part 2 - Treatment|Administrative|0|||
129877747|NCT02508532|467512720|FG006|Part 2 - Treatment|Administrative|0|||
129877748|NCT02508532|467512721|FG007|Part 2 - Treatment|Administrative|0|||
129877749|NCT02508532|467512722|FG008|Part 2 - Treatment|Administrative|3|||
129877750|NCT02508532|467512714|FG000|Part 2 - Treatment|Sponsor Decision|0|||
129877751|NCT02508532|467512715|FG001|Part 2 - Treatment|Sponsor Decision|0|||
129877752|NCT02508532|467512716|FG002|Part 2 - Treatment|Sponsor Decision|0|||
129877753|NCT02508532|467512717|FG003|Part 2 - Treatment|Sponsor Decision|0|||
129877754|NCT02508532|467512718|FG004|Part 2 - Treatment|Sponsor Decision|0|||
129877755|NCT02508532|467512719|FG005|Part 2 - Treatment|Sponsor Decision|0|||
129877756|NCT02508532|467512720|FG006|Part 2 - Treatment|Sponsor Decision|0|||
129877757|NCT02508532|467512721|FG007|Part 2 - Treatment|Sponsor Decision|0|||
129877758|NCT02508532|467512722|FG008|Part 2 - Treatment|Sponsor Decision|28|||
129877759|NCT02508532|467512714|FG000|Part 2 - Treatment|Death|0|||
129877760|NCT02508532|467512715|FG001|Part 2 - Treatment|Death|0|||
129877761|NCT02508532|467512716|FG002|Part 2 - Treatment|Death|0|||
129877762|NCT02508532|467512717|FG003|Part 2 - Treatment|Death|0|||
129877763|NCT02508532|467512718|FG004|Part 2 - Treatment|Death|0|||
129877764|NCT02508532|467512719|FG005|Part 2 - Treatment|Death|0|||
129877765|NCT02508532|467512720|FG006|Part 2 - Treatment|Death|0|||
129877766|NCT02508532|467512721|FG007|Part 2 - Treatment|Death|0|||
129877767|NCT02508532|467512722|FG008|Part 2 - Treatment|Death|1|||
129877768|NCT02508532|467512714|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
129877769|NCT02508532|467512715|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
129877770|NCT02508532|467512716|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
129877771|NCT02508532|467512717|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
129877772|NCT02508532|467512718|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
129877773|NCT02508532|467512719|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
129877774|NCT02508532|467512720|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
129877775|NCT02508532|467512721|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
129877776|NCT02508532|467512722|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
129877777|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
129877778|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877779|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877780|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877781|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877782|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877783|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
129877784|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
129877785|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
129877786|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
129877787|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877788|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
129877789|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877790|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877791|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877792|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877793|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
129877794|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
129877795|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Death|0|||
129877796|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Death|4|||
129877797|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Death|2|||
129877798|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Death|4|||
129877799|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Death|3|||
129877800|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Death|0|||
129877801|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Death|0|||
129877802|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Death|1|||
129877803|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Death|111|||
129877804|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
129877805|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
129877806|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
129877807|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877808|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877809|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877810|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877811|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
129877812|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
129877813|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877814|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877815|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877816|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877817|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877818|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877819|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877820|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
129877821|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
129877822|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877823|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877824|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
129877825|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877826|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
129877827|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877828|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877829|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
129877830|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
129877831|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877832|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877833|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877834|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877835|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877836|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877837|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877838|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
129877839|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
129877840|NCT02508532|467512714|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
129877841|NCT02508532|467512715|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
129877842|NCT02508532|467512716|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
129877843|NCT02508532|467512717|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
129877844|NCT02508532|467512718|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
129877845|NCT02508532|467512719|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
129877846|NCT02508532|467512720|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
129877847|NCT02508532|467512721|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
129877848|NCT02508532|467512722|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
129877849|NCT03097861|467512723|FG000|Overall Study|Adverse Event|3|||
129877850|NCT03097861|467512724|FG001|Overall Study|Adverse Event|8|||
129877851|NCT03097861|467512725|FG002|Overall Study|Adverse Event|4|||
129877852|NCT03097861|467512723|FG000|Overall Study|Investigator Decision|0|||
129877853|NCT03097861|467512724|FG001|Overall Study|Investigator Decision|1|||
129877854|NCT03097861|467512725|FG002|Overall Study|Investigator Decision|0|||
129877855|NCT03097861|467512723|FG000|Overall Study|Lost to Follow-up|0|||
129877856|NCT03097861|467512724|FG001|Overall Study|Lost to Follow-up|7|||
129877857|NCT03097861|467512725|FG002|Overall Study|Lost to Follow-up|1|||
129877858|NCT03097861|467512723|FG000|Overall Study|Withdrawal by Subject|1|||
129877859|NCT03097861|467512724|FG001|Overall Study|Withdrawal by Subject|5|||
129877860|NCT03097861|467512725|FG002|Overall Study|Withdrawal by Subject|3|||
129877861|NCT03097861|467512723|FG000|Overall Study|Reason not provided|3|||
129877862|NCT03097861|467512724|FG001|Overall Study|Reason not provided|1|||
129877863|NCT03097861|467512725|FG002|Overall Study|Reason not provided|1|||
129877864|NCT05672680|467512726|FG000|Overall Study|Patient Did Not Complete the Form|5|||
129877865|NCT05672680|467512727|FG001|Overall Study|Patient Did Not Complete the Form|4|||
129877866|NCT05672680|467512726|FG000|Overall Study|Procedure Aborted|1|||
129877867|NCT05672680|467512727|FG001|Overall Study|Procedure Aborted|0|||
129877868|NCT00943306|467512728|FG000|Overall Study|Physician Decision|1|||
129877869|NCT00943306|467512728|FG000|Overall Study|Death|1|||
129877870|NCT00943306|467512728|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
129877871|NCT01395823|467512740|FG000|Overall Study|Death|4|||
129877872|NCT01395823|467512741|FG001|Overall Study|Death|4|||
129877873|NCT01395823|467512740|FG000|Overall Study|Physician Decision|3|||
129877874|NCT01395823|467512741|FG001|Overall Study|Physician Decision|1|||
129877875|NCT01395823|467512740|FG000|Overall Study|Lost to Follow-up|1|||
129877876|NCT01395823|467512741|FG001|Overall Study|Lost to Follow-up|0|||
129877877|NCT01395823|467512740|FG000|Overall Study|Transplant|1|||
129877878|NCT01395823|467512741|FG001|Overall Study|Transplant|0|||
129877879|NCT01395823|467512740|FG000|Overall Study|GI symptoms|1|||
129877880|NCT01395823|467512741|FG001|Overall Study|GI symptoms|0|||
129877881|NCT01395823|467512740|FG000|Overall Study|Withdrawal by Subject|5|||
129877882|NCT01395823|467512741|FG001|Overall Study|Withdrawal by Subject|4|||
129877883|NCT01036022|467512742|FG000|Overall Study|Adverse Event|1|||
129877884|NCT01036022|467512743|FG001|Overall Study|Adverse Event|3|||
129877885|NCT01036022|467512744|FG002|Overall Study|Adverse Event|2|||
129877886|NCT01036022|467512745|FG003|Overall Study|Adverse Event|1|||
129877887|NCT01036022|467512746|FG004|Overall Study|Adverse Event|0|||
129877888|NCT01036022|467512747|FG005|Overall Study|Adverse Event|2|||
129877889|NCT01036022|467512742|FG000|Overall Study|Lack of Efficacy|1|||
129877890|NCT01036022|467512743|FG001|Overall Study|Lack of Efficacy|1|||
129877891|NCT01036022|467512744|FG002|Overall Study|Lack of Efficacy|1|||
129877892|NCT01036022|467512745|FG003|Overall Study|Lack of Efficacy|0|||
129877893|NCT01036022|467512746|FG004|Overall Study|Lack of Efficacy|1|||
129877894|NCT01036022|467512747|FG005|Overall Study|Lack of Efficacy|1|||
129877895|NCT01036022|467512742|FG000|Overall Study|Physician Decision|0|||
129877896|NCT01036022|467512743|FG001|Overall Study|Physician Decision|0|||
129877897|NCT01036022|467512744|FG002|Overall Study|Physician Decision|1|||
129877898|NCT01036022|467512745|FG003|Overall Study|Physician Decision|0|||
129877899|NCT01036022|467512746|FG004|Overall Study|Physician Decision|0|||
129877900|NCT01036022|467512747|FG005|Overall Study|Physician Decision|0|||
129877901|NCT01036022|467512742|FG000|Overall Study|Withdrawal by Subject|0|||
129877902|NCT01036022|467512743|FG001|Overall Study|Withdrawal by Subject|0|||
129877903|NCT01036022|467512744|FG002|Overall Study|Withdrawal by Subject|0|||
129877904|NCT01036022|467512745|FG003|Overall Study|Withdrawal by Subject|1|||
129877905|NCT01036022|467512746|FG004|Overall Study|Withdrawal by Subject|2|||
129877906|NCT01036022|467512747|FG005|Overall Study|Withdrawal by Subject|0|||
129877907|NCT00576732|467512748|FG000|DOUBLE BLIND|Adverse Event|0|||
129877908|NCT00576732|467512749|FG001|DOUBLE BLIND|Adverse Event|0|||
129877909|NCT00576732|467512750|FG002|DOUBLE BLIND|Adverse Event|1|||
129877910|NCT00576732|467512751|FG003|DOUBLE BLIND|Adverse Event|0|||
129877911|NCT00576732|467512752|FG004|DOUBLE BLIND|Adverse Event|0|||
129877912|NCT00576732|467512753|FG005|DOUBLE BLIND|Adverse Event|0|||
129877913|NCT00576732|467512748|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
129877914|NCT00576732|467512749|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
129653874|NCT01897571|466689863|FG002|Overall Study|Lost to Follow-up|0|||
129877915|NCT00576732|467512750|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
129877916|NCT00576732|467512751|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
129877917|NCT00576732|467512752|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
129877918|NCT00576732|467512753|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
129877919|NCT00576732|467512748|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
129877920|NCT00576732|467512749|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
129877921|NCT00576732|467512750|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
129877922|NCT00576732|467512751|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
129877923|NCT00576732|467512752|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
129877924|NCT00576732|467512753|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
129877925|NCT00576732|467512748|FG000|DOUBLE BLIND|OTHER|0|||
129877926|NCT00576732|467512749|FG001|DOUBLE BLIND|OTHER|2|||
129877927|NCT00576732|467512750|FG002|DOUBLE BLIND|OTHER|1|||
129877928|NCT00576732|467512751|FG003|DOUBLE BLIND|OTHER|0|||
129877929|NCT00576732|467512752|FG004|DOUBLE BLIND|OTHER|0|||
129877930|NCT00576732|467512753|FG005|DOUBLE BLIND|OTHER|0|||
129877931|NCT00576732|467512748|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
129877932|NCT00576732|467512749|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
129877933|NCT00576732|467512750|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
129877934|NCT00576732|467512751|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
129877935|NCT00576732|467512752|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
129877936|NCT00576732|467512753|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
129877937|NCT00576732|467512748|FG000|DOUBLE BLIND|Protocol Violation|1|||
129877938|NCT00576732|467512749|FG001|DOUBLE BLIND|Protocol Violation|0|||
129877939|NCT00576732|467512750|FG002|DOUBLE BLIND|Protocol Violation|0|||
129877940|NCT00576732|467512751|FG003|DOUBLE BLIND|Protocol Violation|0|||
129877941|NCT00576732|467512752|FG004|DOUBLE BLIND|Protocol Violation|0|||
129877942|NCT00576732|467512753|FG005|DOUBLE BLIND|Protocol Violation|0|||
129877943|NCT00576732|467512748|FG000|OPEN LABEL|Adverse Event|0|||
129877944|NCT00576732|467512749|FG001|OPEN LABEL|Adverse Event|0|||
129877945|NCT00576732|467512750|FG002|OPEN LABEL|Adverse Event|0|||
129877946|NCT00576732|467512751|FG003|OPEN LABEL|Adverse Event|4|||
129877947|NCT00576732|467512752|FG004|OPEN LABEL|Adverse Event|0|||
129877948|NCT00576732|467512753|FG005|OPEN LABEL|Adverse Event|1|||
129877949|NCT00576732|467512748|FG000|OPEN LABEL|Lost to Follow-up|0|||
129877950|NCT00576732|467512749|FG001|OPEN LABEL|Lost to Follow-up|0|||
129877951|NCT00576732|467512750|FG002|OPEN LABEL|Lost to Follow-up|0|||
129877952|NCT00576732|467512751|FG003|OPEN LABEL|Lost to Follow-up|2|||
129877953|NCT00576732|467512752|FG004|OPEN LABEL|Lost to Follow-up|1|||
129877954|NCT00576732|467512753|FG005|OPEN LABEL|Lost to Follow-up|1|||
129877955|NCT00576732|467512748|FG000|OPEN LABEL|Withdrawal by Subject|0|||
129877956|NCT00576732|467512749|FG001|OPEN LABEL|Withdrawal by Subject|0|||
129877957|NCT00576732|467512750|FG002|OPEN LABEL|Withdrawal by Subject|0|||
129877958|NCT00576732|467512751|FG003|OPEN LABEL|Withdrawal by Subject|1|||
129877959|NCT00576732|467512752|FG004|OPEN LABEL|Withdrawal by Subject|0|||
129877960|NCT00576732|467512753|FG005|OPEN LABEL|Withdrawal by Subject|1|||
129877961|NCT00576732|467512748|FG000|OPEN LABEL|OTHER|0|||
129877962|NCT00576732|467512749|FG001|OPEN LABEL|OTHER|0|||
129877963|NCT00576732|467512750|FG002|OPEN LABEL|OTHER|0|||
129877964|NCT00576732|467512751|FG003|OPEN LABEL|OTHER|0|||
129877965|NCT00576732|467512752|FG004|OPEN LABEL|OTHER|0|||
129877966|NCT00576732|467512753|FG005|OPEN LABEL|OTHER|2|||
129877967|NCT00576732|467512748|FG000|OPEN LABEL|Lack of Efficacy|0|||
129877968|NCT00576732|467512749|FG001|OPEN LABEL|Lack of Efficacy|0|||
129877969|NCT00576732|467512750|FG002|OPEN LABEL|Lack of Efficacy|0|||
129877970|NCT00576732|467512751|FG003|OPEN LABEL|Lack of Efficacy|2|||
129877971|NCT00576732|467512752|FG004|OPEN LABEL|Lack of Efficacy|2|||
129877972|NCT00576732|467512753|FG005|OPEN LABEL|Lack of Efficacy|3|||
129877973|NCT00576732|467512748|FG000|OPEN LABEL|Protocol Violation|0|||
129877974|NCT00576732|467512749|FG001|OPEN LABEL|Protocol Violation|0|||
129877975|NCT00576732|467512750|FG002|OPEN LABEL|Protocol Violation|0|||
129877976|NCT00576732|467512751|FG003|OPEN LABEL|Protocol Violation|2|||
129877977|NCT00576732|467512752|FG004|OPEN LABEL|Protocol Violation|1|||
129877978|NCT00576732|467512753|FG005|OPEN LABEL|Protocol Violation|0|||
129545034|NCT00539006|466288389|FG001|Washout|Failed to meet continuation criteria|5|||
129545035|NCT00539006|466288390|FG002|Washout|Failed to meet continuation criteria|14|||
129545036|NCT00539006|466288391|FG003|Washout|Failed to meet continuation criteria|6|||
129545037|NCT00539006|466288388|FG000|Washout|Other|1|||
129545038|NCT00539006|466288389|FG001|Washout|Other|1|||
129545039|NCT00539006|466288390|FG002|Washout|Other|2|||
129545040|NCT00539006|466288391|FG003|Washout|Other|3|||
129545041|NCT00539006|466288388|FG000|Treatment Period 2|Protocol Violation|1|||
129545042|NCT00539006|466288389|FG001|Treatment Period 2|Protocol Violation|0|||
129545043|NCT00539006|466288390|FG002|Treatment Period 2|Protocol Violation|0|||
129545044|NCT00539006|466288391|FG003|Treatment Period 2|Protocol Violation|0|||
129545045|NCT00539006|466288388|FG000|Treatment Period 2|Other|0|||
129545046|NCT00539006|466288389|FG001|Treatment Period 2|Other|1|||
129653875|NCT01897571|466689864|FG003|Overall Study|Lost to Follow-up|0|||
129877979|NCT05076149|467512757|FG000|Overall Study|Adverse Event|3|||
129877980|NCT05076149|467512758|FG001|Overall Study|Adverse Event|9|||
129877981|NCT05076149|467512757|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129877982|NCT05076149|467512758|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
129877983|NCT05076149|467512757|FG000|Overall Study|Lost to Follow-up|0|||
129545047|NCT00539006|466288390|FG002|Treatment Period 2|Other|0|||
129545048|NCT00539006|466288391|FG003|Treatment Period 2|Other|0|||
129545049|NCT02353572|466288394|FG000|Overall Study|Withdrawal by Subject|1|||
129877984|NCT05076149|467512758|FG001|Overall Study|Lost to Follow-up|1|||
129877985|NCT05076149|467512757|FG000|Overall Study|Commercial drug is available for participant|0|||
129877986|NCT05076149|467512758|FG001|Overall Study|Commercial drug is available for participant|1|||
129877987|NCT05076149|467512757|FG000|Overall Study|Other non compliance|1|||
129877988|NCT05076149|467512758|FG001|Overall Study|Other non compliance|1|||
129877989|NCT05076149|467512757|FG000|Overall Study|Physician Decision|0|||
129877990|NCT05076149|467512758|FG001|Overall Study|Physician Decision|1|||
129877991|NCT05076149|467512757|FG000|Overall Study|Other|5|||
129877992|NCT05076149|467512758|FG001|Overall Study|Other|4|||
129877993|NCT05096208|467512759|FG000|Overall Study|Lost to Follow-up|3|||
129877994|NCT05096208|467512760|FG001|Overall Study|Lost to Follow-up|5|||
129877995|NCT05096208|467512761|FG002|Overall Study|Lost to Follow-up|5|||
129877996|NCT05096208|467512762|FG003|Overall Study|Lost to Follow-up|2|||
129877997|NCT05096208|467512759|FG000|Overall Study|Withdrawal by Subject|0|||
129877998|NCT05096208|467512760|FG001|Overall Study|Withdrawal by Subject|1|||
129877999|NCT05096208|467512761|FG002|Overall Study|Withdrawal by Subject|2|||
129878000|NCT05096208|467512762|FG003|Overall Study|Withdrawal by Subject|3|||
129878001|NCT05096208|467512759|FG000|Overall Study|No longer met eligibility criteria|1|||
129878002|NCT05096208|467512760|FG001|Overall Study|No longer met eligibility criteria|0|||
129878003|NCT05096208|467512761|FG002|Overall Study|No longer met eligibility criteria|0|||
129878004|NCT05096208|467512762|FG003|Overall Study|No longer met eligibility criteria|0|||
129878005|NCT05096208|467512759|FG000|Overall Study|Other|0|||
129878006|NCT05096208|467512760|FG001|Overall Study|Other|0|||
129878007|NCT05096208|467512761|FG002|Overall Study|Other|1|||
129878008|NCT05096208|467512762|FG003|Overall Study|Other|0|||
129878009|NCT02087501|467512763|FG000|Overall Study|Death|7|||
129878010|NCT02087501|467512763|FG000|Overall Study|Open repair of aneurysm|1|||
129878011|NCT02087501|467512763|FG000|Overall Study|Lost to Follow-up|2|||
129878012|NCT00094328|467512764|FG000|Overall Study|Lost to Follow-up|1|||
129878013|NCT01483937|467512765|FG000|Overall Study|Withdrawal by Subject|4|||
129878014|NCT01483937|467512766|FG001|Overall Study|Withdrawal by Subject|3|||
129878015|NCT01875185|467512768|FG000|Overall Study|study was terminated|52|||
129878016|NCT01875185|467512769|FG001|Overall Study|study was terminated|48|||
129878017|NCT04838613|467512770|FG000|Overall Study|Withdrawal by Subject|3|||
129878018|NCT04838613|467512771|FG001|Overall Study|Withdrawal by Subject|6|||
129878019|NCT04838613|467512770|FG000|Overall Study|Protocol Deviation|3|||
129878020|NCT04838613|467512771|FG001|Overall Study|Protocol Deviation|2|||
129878021|NCT04838613|467512770|FG000|Overall Study|Technical Problems|0|||
129878022|NCT04838613|467512771|FG001|Overall Study|Technical Problems|5|||
129878023|NCT04838613|467512770|FG000|Overall Study|Physician Decision|2|||
129878024|NCT04838613|467512771|FG001|Overall Study|Physician Decision|0|||
129878025|NCT01686581|467512772|FG000|Overall Study|Side-effects or Health Problems|15|||
129878026|NCT01686581|467512772|FG000|Overall Study|Lack of Efficacy|90|||
129878027|NCT01686581|467512772|FG000|Overall Study|Participant Concerned about Risks|6|||
129878028|NCT01686581|467512772|FG000|Overall Study|Thinks Injections Too Painful|8|||
129878029|NCT01686581|467512772|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
129878030|NCT01686581|467512772|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
129878031|NCT01686581|467512772|FG000|Overall Study|Thinks it is Inconvenient|17|||
129878032|NCT01686581|467512772|FG000|Overall Study|Other Miscellaneous Reasons|36|||
129878033|NCT01686581|467512772|FG000|Overall Study|Reason Missing|1|||
129878034|NCT00399763|467512773|FG000|Overall Study|Lost to Follow-up|2|||
129878035|NCT00399763|467512774|FG001|Overall Study|Lost to Follow-up|3|||
129878036|NCT04182880|467512775|FG000|Overall Study|Pregnancy|1|||
129878037|NCT04182880|467512776|FG001|Overall Study|Pregnancy|0|||
129878038|NCT03389477|467512777|FG000|Step 1|Withdrawal by Subject|1|||
129878039|NCT03389477|467512778|FG001|Step 1|Withdrawal by Subject|0|||
129878040|NCT03389477|467512777|FG000|Step 2|Withdrawal by Subject|1|||
129878041|NCT03389477|467512778|FG001|Step 2|Withdrawal by Subject|2|||
129878042|NCT03389477|467512777|FG000|Step 2|Disease progression|1|||
129878043|NCT03389477|467512778|FG001|Step 2|Disease progression|0|||
129878044|NCT03389477|467512777|FG000|Step 2|Death|0|||
129878045|NCT03389477|467512778|FG001|Step 2|Death|1|||
129878046|NCT03389477|467512777|FG000|Step 2|Poor performance status and nutrition|0|||
129878047|NCT03389477|467512778|FG001|Step 2|Poor performance status and nutrition|1|||
129878048|NCT03389477|467512777|FG000|Step 3|Withdrawal after 3 cycles|0|||
129878049|NCT03389477|467512778|FG001|Step 3|Withdrawal after 3 cycles|1|||
129878050|NCT03389477|467512777|FG000|Step 3|Still receiving active treatment|4|||
129878051|NCT03389477|467512778|FG001|Step 3|Still receiving active treatment|0|||
129878052|NCT03389477|467512777|FG000|Step 3|Progressive disease after 2 cycles|1|||
129878053|NCT03389477|467512778|FG001|Step 3|Progressive disease after 2 cycles|0|||
129878054|NCT03403426|467512781|FG000|Overall Study|Death|1|||
129878055|NCT03403426|467512781|FG000|Overall Study|Lost to Follow-up|2|||
129878056|NCT03021668|467512782|FG000|Overall Study|Physician Decision|0|||
129878057|NCT03021668|467512783|FG001|Overall Study|Physician Decision|1|||
129878058|NCT00909428|467512784|FG000|Overall Study|Lost to Follow-up|13|||
129878059|NCT00909428|467512785|FG001|Overall Study|Lost to Follow-up|10|||
129878060|NCT00909428|467512786|FG002|Overall Study|Lost to Follow-up|9|||
129878061|NCT01122381|467512787|FG000|Overall Study|study terminated early|0|||
129878062|NCT01122381|467512788|FG001|Overall Study|study terminated early|1|||
129878063|NCT02217280|467512789|FG000|Overall Study|Withdrawal by Subject|2|||
129878064|NCT02217280|467512789|FG000|Overall Study|Post-consent sceen fail|2|||
129878065|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
129878066|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
129878067|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
129545050|NCT02353572|466288394|FG000|Overall Study|Study terminated|2|||
129545051|NCT00244881|466288401|FG000|Overall Study|Withdrawal by Subject|3|||
129878068|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
129878069|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
129878070|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
129878071|NCT00116844|467512792|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
129878072|NCT00116844|467512793|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
129878073|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
129878074|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
129878075|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
129878076|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
129878077|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
129878078|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
129878079|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
129878080|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
129878081|NCT00116844|467512792|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
129878082|NCT00116844|467512793|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
129878083|NCT01933880|467512794|FG000|Overall Study|Withdrawal by Subject|5|||
129878084|NCT01933880|467512795|FG001|Overall Study|Withdrawal by Subject|0|||
129878085|NCT01933880|467512794|FG000|Overall Study|Lack of Efficacy|1|||
129878086|NCT01933880|467512795|FG001|Overall Study|Lack of Efficacy|0|||
129878087|NCT01933880|467512794|FG000|Overall Study|Concomitant medication Interference|0|||
129878088|NCT01933880|467512795|FG001|Overall Study|Concomitant medication Interference|1|||
129878089|NCT01933880|467512794|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
129878090|NCT01933880|467512795|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
129878091|NCT01933880|467512794|FG000|Overall Study|Other|4|||
129878092|NCT01933880|467512795|FG001|Overall Study|Other|0|||
129878093|NCT01933880|467512794|FG000|Overall Study|Protocol Violation|1|||
129878094|NCT01933880|467512795|FG001|Overall Study|Protocol Violation|0|||
129878095|NCT02395133|467512796|FG000|Overall Study|Adverse Event|4|||
129878096|NCT02395133|467512797|FG001|Overall Study|Adverse Event|1|||
129878097|NCT02395133|467512798|FG002|Overall Study|Adverse Event|3|||
129878098|NCT02395133|467512799|FG003|Overall Study|Adverse Event|0|||
129878099|NCT02395133|467512796|FG000|Overall Study|Lack of Efficacy|1|||
129878100|NCT02395133|467512797|FG001|Overall Study|Lack of Efficacy|0|||
129878101|NCT02395133|467512798|FG002|Overall Study|Lack of Efficacy|1|||
129878102|NCT02395133|467512799|FG003|Overall Study|Lack of Efficacy|1|||
129878103|NCT02395133|467512796|FG000|Overall Study|Protocol Violation|1|||
129878104|NCT02395133|467512797|FG001|Overall Study|Protocol Violation|1|||
129878105|NCT02395133|467512798|FG002|Overall Study|Protocol Violation|0|||
129878106|NCT02395133|467512799|FG003|Overall Study|Protocol Violation|3|||
129878107|NCT02395133|467512796|FG000|Overall Study|Lost to Follow-up|0|||
129878108|NCT02395133|467512797|FG001|Overall Study|Lost to Follow-up|1|||
129878109|NCT02395133|467512798|FG002|Overall Study|Lost to Follow-up|1|||
129878110|NCT02395133|467512799|FG003|Overall Study|Lost to Follow-up|0|||
129878111|NCT02395133|467512796|FG000|Overall Study|Pregnancy|0|||
129878112|NCT02395133|467512797|FG001|Overall Study|Pregnancy|0|||
129878113|NCT02395133|467512798|FG002|Overall Study|Pregnancy|3|||
129878114|NCT02395133|467512799|FG003|Overall Study|Pregnancy|0|||
129878115|NCT02395133|467512796|FG000|Overall Study|Consent withdrawn with no reason given|1|||
129878116|NCT02395133|467512797|FG001|Overall Study|Consent withdrawn with no reason given|3|||
129878117|NCT02395133|467512798|FG002|Overall Study|Consent withdrawn with no reason given|0|||
129878118|NCT02395133|467512799|FG003|Overall Study|Consent withdrawn with no reason given|2|||
129878119|NCT02395133|467512796|FG000|Overall Study|Consent withdrawn with personal reason|0|||
129878120|NCT02395133|467512797|FG001|Overall Study|Consent withdrawn with personal reason|1|||
129878121|NCT02395133|467512798|FG002|Overall Study|Consent withdrawn with personal reason|0|||
129878122|NCT02395133|467512799|FG003|Overall Study|Consent withdrawn with personal reason|3|||
129878123|NCT02395133|467512796|FG000|Overall Study|Sponsor decision|2|||
129878124|NCT02395133|467512797|FG001|Overall Study|Sponsor decision|0|||
129878125|NCT02395133|467512798|FG002|Overall Study|Sponsor decision|0|||
129878126|NCT02395133|467512799|FG003|Overall Study|Sponsor decision|1|||
129878127|NCT02395133|467512796|FG000|Overall Study|Other than specified above|5|||
129878128|NCT02395133|467512797|FG001|Overall Study|Other than specified above|2|||
129878129|NCT02395133|467512798|FG002|Overall Study|Other than specified above|2|||
129878130|NCT02395133|467512799|FG003|Overall Study|Other than specified above|4|||
129878131|NCT00962247|467512800|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
129878132|NCT00962247|467512800|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
129878133|NCT03474549|467512801|FG000|Overall Study|Death|31|||
129878134|NCT03474549|467512801|FG000|Overall Study|Lost to Follow-up|4|||
129878135|NCT03474549|467512801|FG000|Overall Study|Withdrawal by Subject|2|||
129878136|NCT00738101|467512806|FG000|Overall Study|Physician Decision|5|||
129878137|NCT00738101|467512806|FG000|Overall Study|Death|1|||
129878138|NCT00738101|467512806|FG000|Overall Study|Repeat enrollment|1|||
129878139|NCT00709059|467512813|FG000|Overall Study|Lost to Follow-up|34|||
129878140|NCT00709059|467512813|FG000|Overall Study|Withdrawal by Subject|19|||
129878141|NCT00709059|467512813|FG000|Overall Study|Physician Decision|7|||
129878142|NCT00709059|467512813|FG000|Overall Study|Disease complication|3|||
129878143|NCT00709059|467512813|FG000|Overall Study|Side effects|20|||
129878144|NCT00709059|467512813|FG000|Overall Study|Serious side effects|11|||
129878145|NCT01786330|467512814|FG000|Overall Study|Withdrawal by Subject|0|||
129878146|NCT01786330|467512815|FG001|Overall Study|Withdrawal by Subject|1|||
129878147|NCT01786330|467512814|FG000|Overall Study|Lost to Follow-up|0|||
129878148|NCT01786330|467512815|FG001|Overall Study|Lost to Follow-up|1|||
129878149|NCT01786330|467512814|FG000|Overall Study|Excluded intraoperatively|0|||
129878150|NCT01786330|467512815|FG001|Overall Study|Excluded intraoperatively|1|||
129878151|NCT01786330|467512814|FG000|Overall Study|Protocol Violation|1|||
129878152|NCT01786330|467512815|FG001|Overall Study|Protocol Violation|0|||
129878153|NCT02969525|467512820|FG000|Double-Blind Period|Adverse Event|0|||
129653876|NCT01897571|466689865|FG004|Overall Study|Lost to Follow-up|2|||
129878154|NCT02969525|467512821|FG001|Double-Blind Period|Adverse Event|0|||
129878155|NCT02969525|467512822|FG002|Double-Blind Period|Adverse Event|1|||
129878156|NCT02969525|467512823|FG003|Double-Blind Period|Adverse Event|1|||
129878157|NCT02969525|467512824|FG004|Double-Blind Period|Adverse Event|0|||
129878158|NCT02969525|467512825|FG005|Double-Blind Period|Adverse Event|0|||
129878159|NCT02969525|467512826|FG006|Double-Blind Period|Adverse Event|0|||
129878160|NCT02969525|467512827|FG007|Double-Blind Period|Adverse Event|0|||
129878161|NCT02969525|467512828|FG008|Double-Blind Period|Adverse Event|0|||
129878162|NCT02969525|467512829|FG009|Double-Blind Period|Adverse Event|0|||
129878163|NCT02969525|467512830|FG010|Double-Blind Period|Adverse Event|0|||
129878164|NCT02969525|467512831|FG011|Double-Blind Period|Adverse Event|0|||
129878165|NCT02969525|467512820|FG000|Double-Blind Period|LOW EGFR|0|||
129878166|NCT02969525|467512821|FG001|Double-Blind Period|LOW EGFR|0|||
129878167|NCT02969525|467512822|FG002|Double-Blind Period|LOW EGFR|0|||
129878168|NCT02969525|467512823|FG003|Double-Blind Period|LOW EGFR|1|||
129878169|NCT02969525|467512824|FG004|Double-Blind Period|LOW EGFR|0|||
129878170|NCT02969525|467512825|FG005|Double-Blind Period|LOW EGFR|0|||
129878171|NCT02969525|467512826|FG006|Double-Blind Period|LOW EGFR|0|||
129878172|NCT02969525|467512827|FG007|Double-Blind Period|LOW EGFR|0|||
129878173|NCT02969525|467512828|FG008|Double-Blind Period|LOW EGFR|0|||
129878174|NCT02969525|467512829|FG009|Double-Blind Period|LOW EGFR|0|||
129878175|NCT02969525|467512830|FG010|Double-Blind Period|LOW EGFR|0|||
129878176|NCT02969525|467512831|FG011|Double-Blind Period|LOW EGFR|0|||
129878177|NCT02969525|467512820|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
129878178|NCT02969525|467512821|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878179|NCT02969525|467512822|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878180|NCT02969525|467512823|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
129878181|NCT02969525|467512824|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878182|NCT02969525|467512825|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878183|NCT02969525|467512826|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878184|NCT02969525|467512827|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878185|NCT02969525|467512828|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878186|NCT02969525|467512829|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878187|NCT02969525|467512830|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878188|NCT02969525|467512831|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
129878189|NCT02969525|467512820|FG000|Dose-Blind Period|Adverse Event|0|||
129878190|NCT02969525|467512821|FG001|Dose-Blind Period|Adverse Event|0|||
129878191|NCT02969525|467512822|FG002|Dose-Blind Period|Adverse Event|0|||
129878192|NCT02969525|467512823|FG003|Dose-Blind Period|Adverse Event|0|||
129878193|NCT02969525|467512824|FG004|Dose-Blind Period|Adverse Event|0|||
129878194|NCT02969525|467512825|FG005|Dose-Blind Period|Adverse Event|0|||
129878195|NCT02969525|467512826|FG006|Dose-Blind Period|Adverse Event|0|||
129878196|NCT02969525|467512827|FG007|Dose-Blind Period|Adverse Event|0|||
129878197|NCT02969525|467512828|FG008|Dose-Blind Period|Adverse Event|0|||
129878198|NCT02969525|467512829|FG009|Dose-Blind Period|Adverse Event|1|||
129878199|NCT02969525|467512830|FG010|Dose-Blind Period|Adverse Event|1|||
129878200|NCT02969525|467512831|FG011|Dose-Blind Period|Adverse Event|1|||
129878201|NCT02969525|467512820|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
129878202|NCT02969525|467512821|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
129878203|NCT02969525|467512822|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
129878204|NCT02969525|467512823|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
129878205|NCT02969525|467512824|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
129878206|NCT02969525|467512825|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
129878207|NCT02969525|467512826|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
129878208|NCT02969525|467512827|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
129878209|NCT02969525|467512828|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
129878210|NCT02969525|467512829|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
129878211|NCT02969525|467512830|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
129878212|NCT02969525|467512831|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
129653877|NCT01897571|466689866|FG005|Overall Study|Lost to Follow-up|0|||
129878213|NCT02969525|467512820|FG000|Dose-Blind Period|Non-cooperating patient|0|||
129878214|NCT02969525|467512821|FG001|Dose-Blind Period|Non-cooperating patient|0|||
129878215|NCT02969525|467512822|FG002|Dose-Blind Period|Non-cooperating patient|0|||
129878216|NCT02969525|467512823|FG003|Dose-Blind Period|Non-cooperating patient|0|||
129878217|NCT02969525|467512824|FG004|Dose-Blind Period|Non-cooperating patient|0|||
129878218|NCT02969525|467512825|FG005|Dose-Blind Period|Non-cooperating patient|0|||
129878219|NCT02969525|467512826|FG006|Dose-Blind Period|Non-cooperating patient|0|||
129878220|NCT02969525|467512827|FG007|Dose-Blind Period|Non-cooperating patient|0|||
129878221|NCT02969525|467512828|FG008|Dose-Blind Period|Non-cooperating patient|0|||
129878222|NCT02969525|467512829|FG009|Dose-Blind Period|Non-cooperating patient|0|||
129878223|NCT02969525|467512830|FG010|Dose-Blind Period|Non-cooperating patient|0|||
129878224|NCT02969525|467512831|FG011|Dose-Blind Period|Non-cooperating patient|1|||
129878225|NCT02969525|467512820|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878226|NCT02969525|467512821|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878227|NCT02969525|467512822|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878228|NCT02969525|467512823|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878229|NCT02969525|467512824|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878230|NCT02969525|467512825|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878231|NCT02969525|467512826|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878232|NCT02969525|467512827|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878233|NCT02969525|467512828|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878234|NCT02969525|467512829|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878235|NCT02969525|467512830|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
129878236|NCT02969525|467512831|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
129878237|NCT02172625|467512832|FG000|Overall Study|Adverse Event|0|||
129878238|NCT02172625|467512833|FG001|Overall Study|Adverse Event|1|||
129878239|NCT02172625|467512832|FG000|Overall Study|Pregnancy|0|||
129878240|NCT02172625|467512833|FG001|Overall Study|Pregnancy|1|||
129878241|NCT02172625|467512832|FG000|Overall Study|car accident|0|||
129878242|NCT02172625|467512833|FG001|Overall Study|car accident|1|||
129878243|NCT03445065|467512834|FG000|Overall Study|Withdrawal by Subject|3|||
129878244|NCT03445065|467512835|FG001|Overall Study|Withdrawal by Subject|6|||
129878245|NCT03445065|467512836|FG002|Overall Study|Withdrawal by Subject|2|||
129878246|NCT03445065|467512837|FG003|Overall Study|Withdrawal by Subject|2|||
129878247|NCT03445065|467512834|FG000|Overall Study|Other|4|||
129878248|NCT03445065|467512835|FG001|Overall Study|Other|3|||
129878249|NCT03445065|467512836|FG002|Overall Study|Other|3|||
129878250|NCT03445065|467512837|FG003|Overall Study|Other|1|||
129878251|NCT03315130|467512838|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
129878252|NCT03315130|467512839|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
129878253|NCT03315130|467512840|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
129878254|NCT03315130|467512841|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
129878255|NCT03315130|467512838|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
129878256|NCT03315130|467512839|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
129878257|NCT03315130|467512840|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
129878258|NCT03315130|467512841|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
129878259|NCT03315130|467512838|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
129878260|NCT03315130|467512839|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
129878261|NCT03315130|467512840|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
129878262|NCT03315130|467512841|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
129878263|NCT03315130|467512838|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
129878264|NCT03315130|467512839|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
129878265|NCT03315130|467512840|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
129878266|NCT03315130|467512841|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
129878267|NCT03315130|467512838|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
129878268|NCT03315130|467512839|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
129878269|NCT03315130|467512840|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
129878270|NCT03315130|467512841|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
129878271|NCT03315130|467512838|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
129878272|NCT03315130|467512839|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
129878273|NCT03315130|467512840|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
129878274|NCT03315130|467512841|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
129878275|NCT00524030|467512842|FG000|Overall Study|Lack of Efficacy|10|||
129878276|NCT00524030|467512843|FG001|Overall Study|Lack of Efficacy|24|||
129878277|NCT00524030|467512842|FG000|Overall Study|Lost to Follow-up|0|||
129878278|NCT00524030|467512843|FG001|Overall Study|Lost to Follow-up|2|||
129878279|NCT00524030|467512842|FG000|Overall Study|Withdrawal by Subject|3|||
129878280|NCT00524030|467512843|FG001|Overall Study|Withdrawal by Subject|8|||
129878281|NCT00524030|467512842|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
129878282|NCT00524030|467512843|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
129878283|NCT00524030|467512842|FG000|Overall Study|Protocol Violation|0|||
129878284|NCT00524030|467512843|FG001|Overall Study|Protocol Violation|1|||
129878285|NCT00524030|467512842|FG000|Overall Study|Pregnancy|1|||
129878286|NCT00524030|467512843|FG001|Overall Study|Pregnancy|0|||
129878287|NCT00524030|467512842|FG000|Overall Study|Adverse Event|3|||
129653878|NCT01897571|466689867|FG006|Overall Study|Lost to Follow-up|0|||
129653879|NCT01897571|466689868|FG007|Overall Study|Lost to Follow-up|0|||
129653880|NCT01897571|466689869|FG008|Overall Study|Lost to Follow-up|1|||
129653881|NCT01897571|466689870|FG009|Overall Study|Lost to Follow-up|2|||
129653882|NCT01897571|466689871|FG010|Overall Study|Lost to Follow-up|4|||
129653883|NCT01897571|466689861|FG000|Overall Study|Withdrawal by Subject|0|||
129653884|NCT01897571|466689862|FG001|Overall Study|Withdrawal by Subject|0|||
129653885|NCT01897571|466689863|FG002|Overall Study|Withdrawal by Subject|0|||
129653886|NCT01897571|466689864|FG003|Overall Study|Withdrawal by Subject|0|||
129653887|NCT01897571|466689865|FG004|Overall Study|Withdrawal by Subject|0|||
129653888|NCT01897571|466689866|FG005|Overall Study|Withdrawal by Subject|0|||
129653889|NCT01897571|466689867|FG006|Overall Study|Withdrawal by Subject|0|||
129653890|NCT01897571|466689868|FG007|Overall Study|Withdrawal by Subject|1|||
129653891|NCT01897571|466689869|FG008|Overall Study|Withdrawal by Subject|4|||
129653892|NCT01897571|466689870|FG009|Overall Study|Withdrawal by Subject|3|||
129653893|NCT01897571|466689871|FG010|Overall Study|Withdrawal by Subject|1|||
129653894|NCT01897571|466689861|FG000|Overall Study|Other|1|||
129653895|NCT01897571|466689862|FG001|Overall Study|Other|0|||
129653896|NCT01897571|466689863|FG002|Overall Study|Other|0|||
129653897|NCT01897571|466689864|FG003|Overall Study|Other|3|||
129653898|NCT01897571|466689865|FG004|Overall Study|Other|3|||
129653899|NCT01897571|466689866|FG005|Overall Study|Other|4|||
129653900|NCT01897571|466689867|FG006|Overall Study|Other|7|||
129653901|NCT01897571|466689868|FG007|Overall Study|Other|0|||
129653902|NCT01897571|466689869|FG008|Overall Study|Other|0|||
129653903|NCT01897571|466689870|FG009|Overall Study|Other|0|||
129653904|NCT01897571|466689871|FG010|Overall Study|Other|0|||
129653905|NCT01897571|466689861|FG000|Overall Study|Enrolled in rollover study|0|||
129653906|NCT01897571|466689862|FG001|Overall Study|Enrolled in rollover study|0|||
129653907|NCT01897571|466689863|FG002|Overall Study|Enrolled in rollover study|0|||
129653908|NCT01897571|466689864|FG003|Overall Study|Enrolled in rollover study|0|||
129653909|NCT01897571|466689865|FG004|Overall Study|Enrolled in rollover study|0|||
129653910|NCT01897571|466689866|FG005|Overall Study|Enrolled in rollover study|0|||
129653911|NCT01897571|466689867|FG006|Overall Study|Enrolled in rollover study|0|||
129653912|NCT01897571|466689868|FG007|Overall Study|Enrolled in rollover study|9|||
129653913|NCT01897571|466689869|FG008|Overall Study|Enrolled in rollover study|7|||
129653914|NCT01897571|466689870|FG009|Overall Study|Enrolled in rollover study|9|||
129653915|NCT01897571|466689871|FG010|Overall Study|Enrolled in rollover study|1|||
129653916|NCT01897571|466689861|FG000|Overall Study|Death|2|||
129653917|NCT01897571|466689862|FG001|Overall Study|Death|2|||
129653918|NCT01897571|466689863|FG002|Overall Study|Death|3|||
129653919|NCT01897571|466689864|FG003|Overall Study|Death|6|||
129653920|NCT01897571|466689865|FG004|Overall Study|Death|7|||
129653921|NCT01897571|466689866|FG005|Overall Study|Death|9|||
129653922|NCT01897571|466689867|FG006|Overall Study|Death|5|||
129653923|NCT01897571|466689868|FG007|Overall Study|Death|22|||
129653924|NCT01897571|466689869|FG008|Overall Study|Death|23|||
129653925|NCT01897571|466689870|FG009|Overall Study|Death|129|||
129653926|NCT01897571|466689871|FG010|Overall Study|Death|59|||
129653927|NCT00089635|466689873|FG000|Overall Study|Adverse Event|2|||
129653928|NCT00089635|466689873|FG000|Overall Study|Death|17|||
129653929|NCT00089635|466689873|FG000|Overall Study|Disease Progression|12|||
129653930|NCT00089635|466689873|FG000|Overall Study|Lost to Follow-up|3|||
129653931|NCT00089635|466689873|FG000|Overall Study|Withdrawal by Subject|6|||
129653932|NCT00089635|466689873|FG000|Overall Study|Ineligibility determined|1|||
129653933|NCT00089635|466689873|FG000|Overall Study|Other|2|||
129653934|NCT02943785|466689874|FG000|Overall Study|Adverse Event|112|||
129653935|NCT02943785|466689875|FG001|Overall Study|Adverse Event|97|||
129653936|NCT02943785|466689874|FG000|Overall Study|Withdrawal by Subject|63|||
129653937|NCT02943785|466689875|FG001|Overall Study|Withdrawal by Subject|126|||
129653938|NCT02943785|466689874|FG000|Overall Study|Physician Decision|23|||
129653939|NCT02943785|466689875|FG001|Overall Study|Physician Decision|47|||
129653940|NCT02943785|466689874|FG000|Overall Study|Death|46|||
129653941|NCT02943785|466689875|FG001|Overall Study|Death|46|||
129653942|NCT02943785|466689874|FG000|Overall Study|Lost to Follow-up|1|||
129653943|NCT02943785|466689875|FG001|Overall Study|Lost to Follow-up|0|||
129653944|NCT02943785|466689874|FG000|Overall Study|Other|16|||
129653945|NCT02943785|466689875|FG001|Overall Study|Other|19|||
129653946|NCT02943785|466689874|FG000|Overall Study|Did not receive any study medication|21|||
129653947|NCT02943785|466689875|FG001|Overall Study|Did not receive any study medication|28|||
129653948|NCT00821015|466689879|FG000|Overall Study|Lost to Follow-up|12|||
129653949|NCT03170609|466689880|FG000|Overall Study|Death|0|||
129653950|NCT03170609|466689881|FG001|Overall Study|Death|0|||
129653951|NCT03170609|466689882|FG002|Overall Study|Death|1|||
129653952|NCT03170609|466689883|FG003|Overall Study|Death|0|||
129878288|NCT00524030|467512843|FG001|Overall Study|Adverse Event|21|||
129878289|NCT00524030|467512842|FG000|Overall Study|Death|0|||
129653953|NCT03170609|466689884|FG004|Overall Study|Death|0|||
129878290|NCT00524030|467512843|FG001|Overall Study|Death|1|||
129653954|NCT03170609|466689885|FG005|Overall Study|Death|0|||
129653955|NCT03170609|466689886|FG006|Overall Study|Death|0|||
129878291|NCT00429494|467514277|FG000|Overall Study|Withdrawal by Subject|9|||
129878292|NCT00429494|467514277|FG000|Overall Study|Death|6|||
129878293|NCT00976703|467514278|FG000|Overall Study|Physician Decision|1|||
129878294|NCT00976703|467514279|FG001|Overall Study|Physician Decision|1|||
129878295|NCT00976703|467514278|FG000|Overall Study|ineligible for study|2|||
129878296|NCT00976703|467514279|FG001|Overall Study|ineligible for study|2|||
129878297|NCT03075501|467514282|FG000|Overall Study|Scheduling difficulties|15|||
129878298|NCT03075501|467514283|FG001|Overall Study|Scheduling difficulties|9|||
129878299|NCT00957931|467514286|FG000|Overall Study|Death|4|||
129878300|NCT00857805|467514287|FG000|Overall Study|Withdrawal by Subject|1|||
129878301|NCT00857805|467514288|FG001|Overall Study|Withdrawal by Subject|1|||
129878302|NCT04867785|467514289|FG000|Overall Study|Adverse Event|1|||
129878303|NCT04867785|467514290|FG001|Overall Study|Adverse Event|0|||
129878304|NCT04867785|467514291|FG002|Overall Study|Adverse Event|1|||
129878305|NCT04867785|467514292|FG003|Overall Study|Adverse Event|0|||
129878306|NCT04867785|467514293|FG004|Overall Study|Adverse Event|0|||
129878307|NCT04867785|467514294|FG005|Overall Study|Adverse Event|0|||
129878308|NCT04867785|467514295|FG006|Overall Study|Adverse Event|0|||
129878309|NCT04867785|467514296|FG007|Overall Study|Adverse Event|2|||
129878310|NCT04867785|467514289|FG000|Overall Study|Lost to Follow-up|4|||
129878311|NCT04867785|467514290|FG001|Overall Study|Lost to Follow-up|4|||
129878312|NCT04867785|467514291|FG002|Overall Study|Lost to Follow-up|3|||
129878313|NCT04867785|467514292|FG003|Overall Study|Lost to Follow-up|2|||
129878314|NCT04867785|467514293|FG004|Overall Study|Lost to Follow-up|0|||
129878315|NCT04867785|467514294|FG005|Overall Study|Lost to Follow-up|1|||
129878316|NCT04867785|467514295|FG006|Overall Study|Lost to Follow-up|0|||
129878317|NCT04867785|467514296|FG007|Overall Study|Lost to Follow-up|1|||
129878318|NCT04867785|467514289|FG000|Overall Study|Withdrawal by Subject|6|||
129878319|NCT04867785|467514290|FG001|Overall Study|Withdrawal by Subject|2|||
129878320|NCT04867785|467514291|FG002|Overall Study|Withdrawal by Subject|2|||
129878321|NCT04867785|467514292|FG003|Overall Study|Withdrawal by Subject|1|||
129878322|NCT04867785|467514293|FG004|Overall Study|Withdrawal by Subject|2|||
129878323|NCT04867785|467514294|FG005|Overall Study|Withdrawal by Subject|0|||
129878324|NCT04867785|467514295|FG006|Overall Study|Withdrawal by Subject|2|||
129878325|NCT04867785|467514296|FG007|Overall Study|Withdrawal by Subject|5|||
129878326|NCT04867785|467514289|FG000|Overall Study|Physician Decision|0|||
129878327|NCT04867785|467514290|FG001|Overall Study|Physician Decision|0|||
129878328|NCT04867785|467514291|FG002|Overall Study|Physician Decision|0|||
129878329|NCT04867785|467514292|FG003|Overall Study|Physician Decision|0|||
129878330|NCT04867785|467514293|FG004|Overall Study|Physician Decision|0|||
129878331|NCT04867785|467514294|FG005|Overall Study|Physician Decision|0|||
129878332|NCT04867785|467514295|FG006|Overall Study|Physician Decision|0|||
129878333|NCT04867785|467514296|FG007|Overall Study|Physician Decision|1|||
129878334|NCT04867785|467514289|FG000|Overall Study|Inadvertent Enrollment|0|||
129878335|NCT04867785|467514290|FG001|Overall Study|Inadvertent Enrollment|0|||
129878336|NCT04867785|467514291|FG002|Overall Study|Inadvertent Enrollment|0|||
129878337|NCT04867785|467514292|FG003|Overall Study|Inadvertent Enrollment|1|||
129878338|NCT04867785|467514293|FG004|Overall Study|Inadvertent Enrollment|1|||
129878339|NCT04867785|467514294|FG005|Overall Study|Inadvertent Enrollment|0|||
129878340|NCT04867785|467514295|FG006|Overall Study|Inadvertent Enrollment|0|||
129878341|NCT04867785|467514296|FG007|Overall Study|Inadvertent Enrollment|1|||
129878342|NCT04867785|467514289|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129878343|NCT04867785|467514290|FG001|Overall Study|Eligibility Criteria Not Met|0|||
129878344|NCT04867785|467514291|FG002|Overall Study|Eligibility Criteria Not Met|0|||
129878345|NCT04867785|467514292|FG003|Overall Study|Eligibility Criteria Not Met|0|||
129878346|NCT04867785|467514293|FG004|Overall Study|Eligibility Criteria Not Met|0|||
129878347|NCT04867785|467514294|FG005|Overall Study|Eligibility Criteria Not Met|0|||
129878348|NCT04867785|467514295|FG006|Overall Study|Eligibility Criteria Not Met|0|||
129878349|NCT04867785|467514296|FG007|Overall Study|Eligibility Criteria Not Met|1|||
129878350|NCT01289041|467514297|FG000|Overall Study|Adverse Event|24|||
129878351|NCT01289041|467514297|FG000|Overall Study|Physician Decision|1|||
129878352|NCT01289041|467514297|FG000|Overall Study|Progressive Disease|41|||
129878353|NCT01289041|467514297|FG000|Overall Study|Withdrawal by Subject|3|||
129878354|NCT01289041|467514297|FG000|Overall Study|Death|1|||
129878355|NCT01062763|467514298|FG000|Overall Study|Adverse Event|3|||
129878356|NCT01062763|467514299|FG001|Overall Study|Adverse Event|4|||
129878357|NCT02494921|467514301|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
129878358|NCT02494921|467514302|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
129878359|NCT02494921|467514303|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
129878360|NCT02494921|467514304|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
129878361|NCT02494921|467514305|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
129878362|NCT02494921|467514301|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
129878363|NCT02494921|467514302|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
129878364|NCT02494921|467514303|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
129878365|NCT02494921|467514304|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
129878366|NCT02494921|467514305|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
129878367|NCT02494921|467514301|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878368|NCT02494921|467514302|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878369|NCT02494921|467514303|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
129878370|NCT02494921|467514304|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878371|NCT02494921|467514305|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
129878372|NCT02714868|467514313|FG000|Overall Study|Withdrawal by Subject|3|||
129878373|NCT02714868|467514314|FG001|Overall Study|Withdrawal by Subject|0|||
129878374|NCT02714868|467514313|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
129878375|NCT02714868|467514314|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
129878376|NCT02714868|467514313|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
129878377|NCT02714868|467514314|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
129878378|NCT04399356|467514321|FG000|Overall Study|Lost to Follow-up|1|||
129878379|NCT04399356|467514322|FG001|Overall Study|Lost to Follow-up|1|||
129878380|NCT04399356|467514321|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
129878381|NCT04399356|467514322|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
129878382|NCT04399356|467514321|FG000|Overall Study|Withdrawal by Subject|1|||
129878383|NCT04399356|467514322|FG001|Overall Study|Withdrawal by Subject|0|||
129878384|NCT00154310|467514323|FG000|Overall Study|Adverse Event|19|||
129878385|NCT00154310|467514324|FG001|Overall Study|Adverse Event|9|||
129878386|NCT00154310|467514323|FG000|Overall Study|Lack of Efficacy|5|||
129878387|NCT00154310|467514324|FG001|Overall Study|Lack of Efficacy|4|||
129878388|NCT00154310|467514323|FG000|Overall Study|Protocol Violation|4|||
129878389|NCT00154310|467514324|FG001|Overall Study|Protocol Violation|2|||
129878390|NCT00154310|467514323|FG000|Overall Study|Withdrawal by Subject|9|||
129878391|NCT00154310|467514324|FG001|Overall Study|Withdrawal by Subject|3|||
129878392|NCT00154310|467514323|FG000|Overall Study|Lost to Follow-up|0|||
129878393|NCT00154310|467514324|FG001|Overall Study|Lost to Follow-up|8|||
129878394|NCT00154310|467514323|FG000|Overall Study|Administrative problems|0|||
129878395|NCT00154310|467514324|FG001|Overall Study|Administrative problems|1|||
129878396|NCT00154310|467514323|FG000|Overall Study|Death|0|||
129878397|NCT00154310|467514324|FG001|Overall Study|Death|1|||
129878398|NCT03447730|467514325|FG000|Overall Study|Adverse Event|0|||
129878399|NCT03447730|467514326|FG001|Overall Study|Adverse Event|2|||
129878400|NCT03447730|467514327|FG002|Overall Study|Adverse Event|0|||
129878401|NCT01834222|467514336|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
129878402|NCT04251065|467514337|FG000|Overall Study|Death|2|||
129878403|NCT04251065|467514337|FG000|Overall Study|Lack of Efficacy|3|||
129878404|NCT04251065|467514337|FG000|Overall Study|Death|1|||
129878405|NCT01054573|467514338|FG000|Overall Study|Adverse Event|1|||
129878406|NCT01054573|467514339|FG001|Overall Study|Adverse Event|0|||
129878407|NCT01054573|467514340|FG002|Overall Study|Adverse Event|1|||
129878408|NCT01054573|467514341|FG003|Overall Study|Adverse Event|1|||
129878409|NCT01054573|467514338|FG000|Overall Study|Lost to Follow-up|0|||
129878410|NCT01054573|467514339|FG001|Overall Study|Lost to Follow-up|2|||
129878411|NCT01054573|467514340|FG002|Overall Study|Lost to Follow-up|0|||
129878412|NCT01054573|467514341|FG003|Overall Study|Lost to Follow-up|0|||
129878413|NCT01054573|467514338|FG000|Overall Study|Withdrawal by Subject|0|||
129878414|NCT01054573|467514339|FG001|Overall Study|Withdrawal by Subject|2|||
129878415|NCT01054573|467514340|FG002|Overall Study|Withdrawal by Subject|2|||
129878416|NCT01054573|467514341|FG003|Overall Study|Withdrawal by Subject|1|||
129878417|NCT05266963|467514345|FG000|Drug Period A|Withdrawal by Subject|0|||
129878418|NCT05266963|467514346|FG001|Drug Period A|Withdrawal by Subject|1|||
129878419|NCT01725386|467514347|FG000|Overall Study|Death|84|||
129878420|NCT01725386|467514348|FG001|Overall Study|Death|40|||
129878421|NCT01725386|467514347|FG000|Overall Study|Lost to Follow-up|81|||
129878422|NCT01725386|467514348|FG001|Overall Study|Lost to Follow-up|6|||
129878423|NCT01725386|467514347|FG000|Overall Study|Withdrawal by Subject|10|||
129878424|NCT01725386|467514348|FG001|Overall Study|Withdrawal by Subject|0|||
129878425|NCT03812536|467514349|FG000|Overall Study|Protocol Violation|2|||
129878426|NCT03812536|467514350|FG001|Overall Study|Protocol Violation|0|||
129878427|NCT03812536|467514349|FG000|Overall Study|Withdrawal by Subject|1|||
129878428|NCT03812536|467514350|FG001|Overall Study|Withdrawal by Subject|1|||
129878429|NCT00152009|467514351|FG000|Overall Study|Adverse Event|9|||
129878430|NCT00152009|467514352|FG001|Overall Study|Adverse Event|13|||
129878431|NCT00152009|467514353|FG002|Overall Study|Adverse Event|20|||
129878432|NCT00152009|467514354|FG003|Overall Study|Adverse Event|1|||
129878433|NCT00152009|467514351|FG000|Overall Study|Protocol Violation|3|||
129878434|NCT00152009|467514352|FG001|Overall Study|Protocol Violation|0|||
129878435|NCT00152009|467514353|FG002|Overall Study|Protocol Violation|0|||
129878436|NCT00152009|467514354|FG003|Overall Study|Protocol Violation|1|||
129878437|NCT00152009|467514351|FG000|Overall Study|Withdrawal by Subject|2|||
129878438|NCT00152009|467514352|FG001|Overall Study|Withdrawal by Subject|3|||
129878439|NCT00152009|467514353|FG002|Overall Study|Withdrawal by Subject|4|||
129878440|NCT00152009|467514354|FG003|Overall Study|Withdrawal by Subject|9|||
129878441|NCT00152009|467514351|FG000|Overall Study|Lost to Follow-up|2|||
129878442|NCT00152009|467514352|FG001|Overall Study|Lost to Follow-up|4|||
129878443|NCT00152009|467514353|FG002|Overall Study|Lost to Follow-up|3|||
129878444|NCT00152009|467514354|FG003|Overall Study|Lost to Follow-up|3|||
129878445|NCT00152009|467514351|FG000|Overall Study|Lack of Efficacy|8|||
129878446|NCT00152009|467514352|FG001|Overall Study|Lack of Efficacy|6|||
129878447|NCT00152009|467514353|FG002|Overall Study|Lack of Efficacy|7|||
129878448|NCT00152009|467514354|FG003|Overall Study|Lack of Efficacy|15|||
129878449|NCT00152009|467514351|FG000|Overall Study|ECG abnormalities|2|||
129878450|NCT00152009|467514352|FG001|Overall Study|ECG abnormalities|2|||
129878451|NCT00152009|467514353|FG002|Overall Study|ECG abnormalities|2|||
129878452|NCT00152009|467514354|FG003|Overall Study|ECG abnormalities|1|||
129878453|NCT00152009|467514351|FG000|Overall Study|Sponsor's decision|3|||
129878454|NCT00152009|467514352|FG001|Overall Study|Sponsor's decision|3|||
129878455|NCT00152009|467514353|FG002|Overall Study|Sponsor's decision|1|||
129878456|NCT00152009|467514354|FG003|Overall Study|Sponsor's decision|3|||
129878457|NCT01306201|467514356|FG000|Overall Study|Arrhythmia|4|||
129878458|NCT01306201|467514356|FG000|Overall Study|Files could not be processed|3|||
129878459|NCT01306201|467514356|FG000|Overall Study|Files unreadable|3|||
129878460|NCT04702568|467514357|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
129878461|NCT04702568|467514358|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
129878462|NCT04702568|467514357|FG000|Overall Study|Pregnancy|1|||
129878463|NCT04702568|467514358|FG001|Overall Study|Pregnancy|0|||
129878464|NCT04702568|467514357|FG000|Overall Study|Bone marrow transplant|1|||
129878465|NCT04702568|467514358|FG001|Overall Study|Bone marrow transplant|0|||
129878466|NCT04702568|467514357|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
129878467|NCT04702568|467514358|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
129878468|NCT04702568|467514357|FG000|Overall Study|Withdrawal by Subject|0|||
129878469|NCT04702568|467514358|FG001|Overall Study|Withdrawal by Subject|2|||
129878470|NCT00393523|467514359|FG000|Overall Study|Lost to Follow-up|0|||
129878471|NCT00393523|467514360|FG001|Overall Study|Lost to Follow-up|0|||
129878472|NCT00393523|467514361|FG002|Overall Study|Lost to Follow-up|0|||
129878473|NCT00393523|467514362|FG003|Overall Study|Lost to Follow-up|2|||
129878474|NCT00393523|467514363|FG004|Overall Study|Lost to Follow-up|1|||
129878475|NCT00393523|467514359|FG000|Overall Study|Protocol Violation|6|||
129878476|NCT00393523|467514360|FG001|Overall Study|Protocol Violation|2|||
129878477|NCT00393523|467514361|FG002|Overall Study|Protocol Violation|0|||
129878478|NCT00393523|467514362|FG003|Overall Study|Protocol Violation|1|||
129878479|NCT00393523|467514363|FG004|Overall Study|Protocol Violation|0|||
129878480|NCT00393523|467514359|FG000|Overall Study|Withdrawal by Subject|6|||
129878481|NCT00393523|467514360|FG001|Overall Study|Withdrawal by Subject|7|||
129878482|NCT00393523|467514361|FG002|Overall Study|Withdrawal by Subject|2|||
129878483|NCT00393523|467514362|FG003|Overall Study|Withdrawal by Subject|3|||
129878484|NCT00393523|467514363|FG004|Overall Study|Withdrawal by Subject|0|||
129878485|NCT00393523|467514359|FG000|Overall Study|Difficulties in specimen collection|0|||
129878486|NCT00393523|467514360|FG001|Overall Study|Difficulties in specimen collection|0|||
129878487|NCT00393523|467514361|FG002|Overall Study|Difficulties in specimen collection|1|||
129878488|NCT00393523|467514362|FG003|Overall Study|Difficulties in specimen collection|0|||
129878489|NCT00393523|467514363|FG004|Overall Study|Difficulties in specimen collection|0|||
129878490|NCT00393523|467514359|FG000|Overall Study|Vaccine supply issue|0|||
129878491|NCT00393523|467514360|FG001|Overall Study|Vaccine supply issue|0|||
129878492|NCT00393523|467514361|FG002|Overall Study|Vaccine supply issue|1|||
129878493|NCT00393523|467514362|FG003|Overall Study|Vaccine supply issue|0|||
129878494|NCT00393523|467514363|FG004|Overall Study|Vaccine supply issue|0|||
129878495|NCT04091360|467514364|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878496|NCT04091360|467514365|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878497|NCT04091360|467514366|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878498|NCT04091360|467514367|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878499|NCT04091360|467514368|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878500|NCT04091360|467514369|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878501|NCT04091360|467514370|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878502|NCT04091360|467514371|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
129878503|NCT04091360|467514372|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
129878504|NCT04091360|467514373|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
129878505|NCT04091360|467514364|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878506|NCT04091360|467514365|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878507|NCT04091360|467514366|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878508|NCT04091360|467514367|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878509|NCT04091360|467514368|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878510|NCT04091360|467514369|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129545052|NCT03159611|466288402|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
129545053|NCT03159611|466288403|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
129545054|NCT03159611|466288402|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
129545055|NCT03159611|466288403|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
129545056|NCT03159611|466288402|FG000|Overall Study|Protocol Violation|7|||
129545057|NCT03159611|466288403|FG001|Overall Study|Protocol Violation|4|||
129545058|NCT03159611|466288402|FG000|Overall Study|Adverse Event|1|||
129545059|NCT03159611|466288403|FG001|Overall Study|Adverse Event|0|||
129545060|NCT03159611|466288402|FG000|Overall Study|Withdrawal by Subject|1|||
129878511|NCT04091360|467514370|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
129878512|NCT04091360|467514371|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
129878513|NCT04091360|467514372|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878514|NCT04091360|467514373|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
129878515|NCT04091360|467514364|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878516|NCT04091360|467514365|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878517|NCT04091360|467514366|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878518|NCT04091360|467514367|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878519|NCT04091360|467514368|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878520|NCT04091360|467514369|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878521|NCT04091360|467514370|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
129878522|NCT04091360|467514371|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878523|NCT04091360|467514372|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
129878524|NCT04091360|467514373|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
129878525|NCT00423852|467514374|FG000|Overall Study|Removed pior to the high-dose portion|3|||
129878526|NCT00572624|467514375|FG000|Overall Study|Lost to Follow-up|10|||
129878527|NCT00572624|467514376|FG001|Overall Study|Lost to Follow-up|4|||
129878528|NCT00572624|467514375|FG000|Overall Study|Wanted to do a different diet program|1|||
129878529|NCT00572624|467514376|FG001|Overall Study|Wanted to do a different diet program|0|||
129878530|NCT00572624|467514375|FG000|Overall Study|Medication change|1|||
129878531|NCT00572624|467514376|FG001|Overall Study|Medication change|0|||
129878532|NCT00572624|467514375|FG000|Overall Study|Started a new job-- no time for study|1|||
129878533|NCT00572624|467514376|FG001|Overall Study|Started a new job-- no time for study|0|||
129878534|NCT00572624|467514375|FG000|Overall Study|Admitted to being a smoker|1|||
129878535|NCT00572624|467514376|FG001|Overall Study|Admitted to being a smoker|0|||
129878536|NCT00572624|467514375|FG000|Overall Study|Refused to do the stress test|1|||
129878537|NCT00572624|467514376|FG001|Overall Study|Refused to do the stress test|0|||
129878538|NCT00572624|467514375|FG000|Overall Study|Problem with vascular access|1|||
129878539|NCT00572624|467514376|FG001|Overall Study|Problem with vascular access|0|||
129878540|NCT00572624|467514375|FG000|Overall Study|Health issues unrelated to the study|1|||
129878541|NCT00572624|467514376|FG001|Overall Study|Health issues unrelated to the study|0|||
129878542|NCT01515189|467514378|FG000|Induction|Disease Progression|109|||
129878543|NCT01515189|467514379|FG001|Induction|Disease Progression|155|||
129878544|NCT01515189|467514378|FG000|Induction|Study drug toxicity|86|||
129878545|NCT01515189|467514379|FG001|Induction|Study drug toxicity|36|||
129878546|NCT01515189|467514378|FG000|Induction|Death|24|||
129878547|NCT01515189|467514379|FG001|Induction|Death|17|||
129878548|NCT01515189|467514378|FG000|Induction|Adverse Event|14|||
129878549|NCT01515189|467514379|FG001|Induction|Adverse Event|9|||
129878550|NCT01515189|467514378|FG000|Induction|Withdrawal by Subject|3|||
129878551|NCT01515189|467514379|FG001|Induction|Withdrawal by Subject|9|||
129878552|NCT01515189|467514378|FG000|Induction|No longer meets study criteria|0|||
129878553|NCT01515189|467514379|FG001|Induction|No longer meets study criteria|2|||
129878554|NCT01515189|467514378|FG000|Induction|Lost to Follow-up|1|||
129878555|NCT01515189|467514379|FG001|Induction|Lost to Follow-up|0|||
129878556|NCT01515189|467514378|FG000|Induction|Other|0|||
129878557|NCT01515189|467514379|FG001|Induction|Other|4|||
129878558|NCT01515189|467514378|FG000|First Re-Induction Phase|Disease progression|6|||
129878559|NCT01515189|467514379|FG001|First Re-Induction Phase|Disease progression|14|||
129878560|NCT01515189|467514378|FG000|First Re-Induction Phase|Study drug toxicity|5|||
129878561|NCT01515189|467514379|FG001|First Re-Induction Phase|Study drug toxicity|0|||
129878562|NCT01515189|467514378|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
129878563|NCT01515189|467514379|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
129878564|NCT01515189|467514378|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
129878565|NCT01515189|467514379|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
129878566|NCT01515189|467514378|FG000|First Re-Induction Phase|Other|1|||
129878567|NCT01515189|467514379|FG001|First Re-Induction Phase|Other|0|||
129878568|NCT03787680|467514380|FG000|Overall Study|Physician Decision|2|||
129878569|NCT03787680|467514381|FG001|Overall Study|Physician Decision|3|||
129878570|NCT03787680|467514380|FG000|Overall Study|Adverse Event|7|||
129878571|NCT03787680|467514381|FG001|Overall Study|Adverse Event|3|||
129878572|NCT03787680|467514380|FG000|Overall Study|Withdrawal by Subject|2|||
129878573|NCT03787680|467514381|FG001|Overall Study|Withdrawal by Subject|1|||
129878574|NCT05458024|467514384|FG000|Overall Study|Withdrawal by Subject|1|||
129878575|NCT05458024|467514385|FG001|Overall Study|Withdrawal by Subject|1|||
129878576|NCT05229653|467514389|FG000|Overall Study|Lost to Follow-up|1|||
129878577|NCT05229653|467514390|FG001|Overall Study|Lost to Follow-up|0|||
129878578|NCT02667886|467514391|FG000|Dose Escalation (Part A)|Adverse Event|1|||
129878579|NCT02667886|467514392|FG001|Dose Escalation (Part A)|Adverse Event|3|||
129878580|NCT02667886|467514393|FG002|Dose Escalation (Part A)|Adverse Event|1|||
129878581|NCT02667886|467514394|FG003|Dose Escalation (Part A)|Adverse Event|0|||
129878582|NCT02667886|467514395|FG004|Dose Escalation (Part A)|Adverse Event|0|||
129707759|NCT01280968|466892117|FG000|Overall Study|Anxiety|2|||
129878583|NCT02667886|467514391|FG000|Dose Escalation (Part A)|Disease Progression|1|||
129878584|NCT02667886|467514392|FG001|Dose Escalation (Part A)|Disease Progression|4|||
129878585|NCT02667886|467514393|FG002|Dose Escalation (Part A)|Disease Progression|3|||
129878586|NCT02667886|467514394|FG003|Dose Escalation (Part A)|Disease Progression|0|||
129878587|NCT02667886|467514395|FG004|Dose Escalation (Part A)|Disease Progression|0|||
129878588|NCT02667886|467514391|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878589|NCT02667886|467514392|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878590|NCT02667886|467514393|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
129878591|NCT02667886|467514394|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878592|NCT02667886|467514395|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
129878593|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Adverse Event|0|||
129878594|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Adverse Event|0|||
129878595|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Adverse Event|0|||
129878596|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Adverse Event|9|||
129878597|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Adverse Event|0|||
129878598|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878599|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878600|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878601|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
129878602|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
129878603|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Disease Progression|0|||
129878604|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Disease Progression|0|||
129878605|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Disease Progression|0|||
129878606|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Disease Progression|38|||
129878607|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Disease Progression|0|||
129878608|NCT02667886|467514391|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878609|NCT02667886|467514392|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878610|NCT02667886|467514393|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878611|NCT02667886|467514394|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
129878612|NCT02667886|467514395|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
129878613|NCT02667886|467514391|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878614|NCT02667886|467514392|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878615|NCT02667886|467514393|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878616|NCT02667886|467514394|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
129878617|NCT02667886|467514395|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
129878618|NCT02667886|467514391|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
129878619|NCT02667886|467514392|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
129878620|NCT02667886|467514393|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
129878621|NCT02667886|467514394|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
129878622|NCT02667886|467514395|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
129878623|NCT00594217|467514396|FG000|Overall Study|Withdrawal by Subject|1|||
129878624|NCT00594217|467514397|FG001|Overall Study|Withdrawal by Subject|3|||
129878625|NCT00747123|467514398|FG000|Overall Study|Investigator's request|0|||
129878626|NCT00747123|467514399|FG001|Overall Study|Investigator's request|0|||
129878627|NCT00747123|467514400|FG002|Overall Study|Investigator's request|1|||
129878628|NCT00747123|467514401|FG003|Overall Study|Investigator's request|0|||
129878629|NCT00747123|467514398|FG000|Overall Study|Withdrew consent|0|||
129878630|NCT00747123|467514399|FG001|Overall Study|Withdrew consent|1|||
129878631|NCT00747123|467514400|FG002|Overall Study|Withdrew consent|0|||
129878632|NCT00747123|467514401|FG003|Overall Study|Withdrew consent|0|||
129878633|NCT00747123|467514398|FG000|Overall Study|Adverse Event|0|||
129878634|NCT00747123|467514399|FG001|Overall Study|Adverse Event|1|||
129878635|NCT00747123|467514400|FG002|Overall Study|Adverse Event|0|||
129878636|NCT00747123|467514401|FG003|Overall Study|Adverse Event|1|||
129878637|NCT03635489|467514402|FG000|Overall Study|Death|19|||
129878638|NCT03635489|467514403|FG001|Overall Study|Death|13|||
129878639|NCT03635489|467514402|FG000|Overall Study|Lost to Follow-up|1|||
129878640|NCT03635489|467514403|FG001|Overall Study|Lost to Follow-up|2|||
129878641|NCT03635489|467514402|FG000|Overall Study|Withdrawal by Subject|1|||
129878642|NCT03635489|467514403|FG001|Overall Study|Withdrawal by Subject|2|||
129878643|NCT03635489|467514402|FG000|Overall Study|Study Ended by Sponsor|28|||
129878644|NCT03635489|467514403|FG001|Overall Study|Study Ended by Sponsor|34|||
129878645|NCT01657266|467514407|FG000|Overall Study|Lost to Follow-up|2|||
129878646|NCT01657266|467514408|FG001|Overall Study|Lost to Follow-up|2|||
129878647|NCT01657266|467514407|FG000|Overall Study|Adverse Event|2|||
129878648|NCT01657266|467514408|FG001|Overall Study|Adverse Event|3|||
129878649|NCT01807650|467514409|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
129878650|NCT01807650|467514409|FG000|Overall Study|Adverse Event|5|||
129878651|NCT01807650|467514409|FG000|Overall Study|Other|2|||
129878652|NCT00736489|467514410|FG000|Period 1|Lost to Follow-up|1|||
129878653|NCT00736489|467514411|FG001|Period 1|Lost to Follow-up|0|||
129878654|NCT00736489|467514412|FG002|Period 1|Lost to Follow-up|0|||
129878655|NCT00736489|467514413|FG003|Period 1|Lost to Follow-up|0|||
129878656|NCT00736489|467514414|FG004|Period 1|Lost to Follow-up|0|||
129878657|NCT00736489|467514415|FG005|Period 1|Lost to Follow-up|0|||
129878658|NCT00736489|467514410|FG000|Period 1|Withdrawal by Subject|0|||
129878659|NCT00736489|467514411|FG001|Period 1|Withdrawal by Subject|0|||
129878660|NCT00736489|467514412|FG002|Period 1|Withdrawal by Subject|0|||
129878661|NCT00736489|467514413|FG003|Period 1|Withdrawal by Subject|0|||
129878662|NCT00736489|467514414|FG004|Period 1|Withdrawal by Subject|0|||
129878663|NCT00736489|467514415|FG005|Period 1|Withdrawal by Subject|1|||
129878664|NCT01125722|467514416|FG000|Overall Study|Withdrawal by Subject|2|||
129878665|NCT01125722|467514417|FG001|Overall Study|Withdrawal by Subject|1|||
129878666|NCT01125722|467514416|FG000|Overall Study|Lost to Follow-up|1|||
129878667|NCT01125722|467514417|FG001|Overall Study|Lost to Follow-up|0|||
129878668|NCT00118898|467514419|FG000|Overall Study|Death|6|||
129878669|NCT00118898|467514420|FG001|Overall Study|Death|11|||
129878670|NCT00118898|467514421|FG002|Overall Study|Death|6|||
129878671|NCT00118898|467514422|FG003|Overall Study|Death|8|||
129878672|NCT00118898|467514419|FG000|Overall Study|Lost to Follow-up|26|||
129878673|NCT00118898|467514420|FG001|Overall Study|Lost to Follow-up|34|||
129878674|NCT00118898|467514421|FG002|Overall Study|Lost to Follow-up|33|||
129878675|NCT00118898|467514422|FG003|Overall Study|Lost to Follow-up|33|||
129878676|NCT00118898|467514419|FG000|Overall Study|Withdrawal by Subject|10|||
129878677|NCT00118898|467514420|FG001|Overall Study|Withdrawal by Subject|5|||
129878678|NCT00118898|467514421|FG002|Overall Study|Withdrawal by Subject|8|||
129878679|NCT00118898|467514422|FG003|Overall Study|Withdrawal by Subject|8|||
129878680|NCT00118898|467514419|FG000|Overall Study|Site Closure|33|||
129878681|NCT00118898|467514420|FG001|Overall Study|Site Closure|31|||
129878682|NCT00118898|467514421|FG002|Overall Study|Site Closure|28|||
129878683|NCT00118898|467514422|FG003|Overall Study|Site Closure|37|||
129878684|NCT00118898|467514419|FG000|Overall Study|Severe debilitation|1|||
129878685|NCT00118898|467514420|FG001|Overall Study|Severe debilitation|4|||
129878686|NCT00118898|467514421|FG002|Overall Study|Severe debilitation|6|||
129878687|NCT00118898|467514422|FG003|Overall Study|Severe debilitation|4|||
129878688|NCT00118898|467514419|FG000|Overall Study|Not compliant with requirements|11|||
129878689|NCT00118898|467514420|FG001|Overall Study|Not compliant with requirements|13|||
129878690|NCT00118898|467514421|FG002|Overall Study|Not compliant with requirements|11|||
129878691|NCT00118898|467514422|FG003|Overall Study|Not compliant with requirements|11|||
129878692|NCT00118898|467514419|FG000|Overall Study|Not able to get to clinic|34|||
129878693|NCT00118898|467514420|FG001|Overall Study|Not able to get to clinic|43|||
129878694|NCT00118898|467514421|FG002|Overall Study|Not able to get to clinic|31|||
129878695|NCT00118898|467514422|FG003|Overall Study|Not able to get to clinic|40|||
129878696|NCT01816763|467515556|FG000|Overall Study|The main reason for an incomplete survey|4|||
129878697|NCT01816763|467515557|FG001|Overall Study|The main reason for an incomplete survey|15|||
129878698|NCT01816763|467515558|FG002|Overall Study|The main reason for an incomplete survey|11|||
129878699|NCT00311155|467515561|FG000|Overall Study|Adverse Event|21|||
129878700|NCT00311155|467515561|FG000|Overall Study|Withdrawal by Subject|17|||
129878701|NCT00311155|467515561|FG000|Overall Study|Did not meet entry criteria|55|||
129878702|NCT02243631|467515564|FG000|Overall Study|no synovial fluid on second aspirate|0|||
129878703|NCT02243631|467515565|FG001|Overall Study|no synovial fluid on second aspirate|1|||
129878704|NCT01785628|467515568|FG000|Overall Study|Lost to Follow-up|2|||
129878705|NCT01785628|467515569|FG001|Overall Study|Lost to Follow-up|3|||
129878706|NCT00840996|467515570|FG000|Overall Study|Withdrawal by Subject|1|||
129878707|NCT00840996|467515571|FG001|Overall Study|Withdrawal by Subject|0|||
129878708|NCT03285295|467515572|FG000|Alinity s HBsAg|Protocol Violation|11|||
129878709|NCT03285295|467515573|FG001|Alinity s HBsAg|Protocol Violation|0|||
129878710|NCT03285295|467515574|FG002|Alinity s HBsAg|Protocol Violation|0|||
129878711|NCT03285295|467515575|FG003|Alinity s HBsAg|Protocol Violation|0|||
129878712|NCT03285295|467515576|FG004|Alinity s HBsAg|Protocol Violation|0|||
129878713|NCT03285295|467515572|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
129878714|NCT03285295|467515573|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878715|NCT03285295|467515574|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878716|NCT03285295|467515575|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878717|NCT03285295|467515576|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
129878718|NCT03285295|467515572|FG000|Alinity s HBsAg|No Results Generated|74|||
129878719|NCT03285295|467515573|FG001|Alinity s HBsAg|No Results Generated|6|||
129878720|NCT03285295|467515574|FG002|Alinity s HBsAg|No Results Generated|0|||
129878721|NCT03285295|467515575|FG003|Alinity s HBsAg|No Results Generated|0|||
129878722|NCT03285295|467515576|FG004|Alinity s HBsAg|No Results Generated|0|||
129878723|NCT03285295|467515572|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
129878724|NCT03285295|467515573|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
129878725|NCT03285295|467515574|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
129878726|NCT03285295|467515575|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
129878727|NCT03285295|467515576|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
129878728|NCT03285295|467515572|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
129878729|NCT03285295|467515573|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878730|NCT03285295|467515574|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878731|NCT03285295|467515575|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878732|NCT03285295|467515576|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
129878733|NCT03285295|467515572|FG000|Alinity s HTLV I/II|No Results Generated|70|||
129878734|NCT03285295|467515573|FG001|Alinity s HTLV I/II|No Results Generated|0|||
129878735|NCT03285295|467515574|FG002|Alinity s HTLV I/II|No Results Generated|0|||
129878736|NCT03285295|467515575|FG003|Alinity s HTLV I/II|No Results Generated|0|||
129878737|NCT03285295|467515576|FG004|Alinity s HTLV I/II|No Results Generated|0|||
129878738|NCT03285295|467515572|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
129878739|NCT03285295|467515573|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878740|NCT03285295|467515574|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878741|NCT03285295|467515575|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878742|NCT03285295|467515576|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
129878743|NCT03285295|467515572|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
129878744|NCT03285295|467515573|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
129878745|NCT03285295|467515574|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
129878746|NCT03285295|467515575|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
129653956|NCT03170609|466689880|FG000|Overall Study|Withdrawal by Subject|1|||
129653957|NCT03170609|466689881|FG001|Overall Study|Withdrawal by Subject|2|||
129653958|NCT03170609|466689882|FG002|Overall Study|Withdrawal by Subject|0|||
129653959|NCT03170609|466689883|FG003|Overall Study|Withdrawal by Subject|0|||
129653960|NCT03170609|466689884|FG004|Overall Study|Withdrawal by Subject|0|||
129653961|NCT03170609|466689885|FG005|Overall Study|Withdrawal by Subject|0|||
129653962|NCT03170609|466689886|FG006|Overall Study|Withdrawal by Subject|1|||
129878747|NCT03285295|467515576|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
129878748|NCT03285295|467515572|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
129878749|NCT03285295|467515573|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878750|NCT03285295|467515574|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878751|NCT03285295|467515575|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878752|NCT03285295|467515576|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
129878753|NCT03285295|467515572|FG000|Alinity s Anti-HCV|No Results Generated|71|||
129878754|NCT03285295|467515573|FG001|Alinity s Anti-HCV|No Results Generated|0|||
129878755|NCT03285295|467515574|FG002|Alinity s Anti-HCV|No Results Generated|0|||
129878756|NCT03285295|467515575|FG003|Alinity s Anti-HCV|No Results Generated|0|||
129878757|NCT03285295|467515576|FG004|Alinity s Anti-HCV|No Results Generated|0|||
129878758|NCT03285295|467515572|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
129878759|NCT03285295|467515573|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878760|NCT03285295|467515574|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878761|NCT03285295|467515575|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878762|NCT03285295|467515576|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
129878763|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
129878764|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878765|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878766|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878767|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
129878768|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
129878769|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878770|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878771|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878772|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
129878773|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
129878774|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878775|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878776|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878777|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
129878778|NCT03285295|467515572|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
129878779|NCT03285295|467515573|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878780|NCT03285295|467515574|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878781|NCT03285295|467515575|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878782|NCT03285295|467515576|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
129878783|NCT03285295|467515572|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
129878784|NCT03285295|467515573|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
129878785|NCT03285295|467515574|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
129878786|NCT03285295|467515575|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
129878787|NCT03285295|467515576|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
129878788|NCT03285295|467515572|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
129878789|NCT03285295|467515573|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
129878790|NCT03285295|467515574|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
129878791|NCT03285295|467515575|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
129653963|NCT03170609|466689880|FG000|Overall Study|Lost to Follow-up|1|||
129653964|NCT03170609|466689881|FG001|Overall Study|Lost to Follow-up|0|||
129878792|NCT03285295|467515576|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
129653965|NCT03170609|466689882|FG002|Overall Study|Lost to Follow-up|5|||
129653966|NCT03170609|466689883|FG003|Overall Study|Lost to Follow-up|2|||
129878793|NCT03285295|467515572|FG000|Alinity s Anti-HBc|No Results Generated|70|||
129878794|NCT03285295|467515573|FG001|Alinity s Anti-HBc|No Results Generated|0|||
129878795|NCT03285295|467515574|FG002|Alinity s Anti-HBc|No Results Generated|0|||
129878796|NCT03285295|467515575|FG003|Alinity s Anti-HBc|No Results Generated|0|||
129878797|NCT03285295|467515576|FG004|Alinity s Anti-HBc|No Results Generated|0|||
129878798|NCT03285295|467515572|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
129878799|NCT03285295|467515573|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878800|NCT03285295|467515574|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878801|NCT03285295|467515575|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878802|NCT03285295|467515576|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
129878803|NCT03285295|467515572|FG000|Alinity s Chagas|Protocol Violation|76|||
129878804|NCT03285295|467515573|FG001|Alinity s Chagas|Protocol Violation|0|||
129878805|NCT03285295|467515574|FG002|Alinity s Chagas|Protocol Violation|0|||
129878806|NCT03285295|467515575|FG003|Alinity s Chagas|Protocol Violation|0|||
129878807|NCT03285295|467515576|FG004|Alinity s Chagas|Protocol Violation|0|||
129878808|NCT03285295|467515572|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
129878809|NCT03285295|467515573|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
129878810|NCT03285295|467515574|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
129878811|NCT03285295|467515575|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
129878812|NCT03285295|467515576|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
129878813|NCT03285295|467515572|FG000|Alinity s Chagas|No Results Generated|105|||
129878814|NCT03285295|467515573|FG001|Alinity s Chagas|No Results Generated|0|||
129878815|NCT03285295|467515574|FG002|Alinity s Chagas|No Results Generated|0|||
129878816|NCT03285295|467515575|FG003|Alinity s Chagas|No Results Generated|0|||
129878817|NCT03285295|467515576|FG004|Alinity s Chagas|No Results Generated|0|||
129878818|NCT03285295|467515572|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
129878819|NCT03285295|467515573|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878820|NCT03285295|467515574|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878821|NCT03285295|467515575|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878822|NCT03285295|467515576|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
129878823|NCT02746575|467515577|FG000|Overall Study|Surgery cancelled or time chaned|13|||
129878824|NCT02746575|467515577|FG000|Overall Study|Received epidural|10|||
129878825|NCT02746575|467515577|FG000|Overall Study|Withdrawal by Subject|3|||
129878826|NCT02746575|467515577|FG000|Overall Study|Bradycardia/hypotension|9|||
129878827|NCT02746575|467515577|FG000|Overall Study|Study paused|8|||
129878828|NCT02746575|467515577|FG000|Overall Study|put on beta-blocker|3|||
129878829|NCT02746575|467515577|FG000|Overall Study|type of surgery|1|||
129878830|NCT02746575|467515577|FG000|Overall Study|typ of surgery|1|||
129878831|NCT02746575|467515577|FG000|Overall Study|PI unavailable|1|||
129878832|NCT02746575|467515577|FG000|Overall Study|Unknown history of CVA|1|||
129878833|NCT03239873|467515578|FG000|Overall Study|Lost to Follow-up|15|||
129878834|NCT03239873|467515579|FG001|Overall Study|Lost to Follow-up|16|||
129878835|NCT03239873|467515578|FG000|Overall Study|Physician Decision|1|||
129878836|NCT03239873|467515579|FG001|Overall Study|Physician Decision|0|||
129878837|NCT03239873|467515578|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
129878838|NCT03239873|467515579|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
129878839|NCT03239873|467515578|FG000|Overall Study|Withdrawal by Subject|2|||
129878840|NCT03239873|467515579|FG001|Overall Study|Withdrawal by Subject|0|||
129878841|NCT03239873|467515578|FG000|Overall Study|Contraindication to study medication|1|||
129878842|NCT03239873|467515579|FG001|Overall Study|Contraindication to study medication|0|||
129878843|NCT03239873|467515578|FG000|Overall Study|Protocol Violation|1|||
129878844|NCT03239873|467515579|FG001|Overall Study|Protocol Violation|0|||
129878845|NCT00605319|467515584|FG000|Overall Study|Adverse Event|6|||
129878846|NCT02670538|467515585|FG000|Overall Study|Withdrawal of Consent|8|||
129878847|NCT02670538|467515586|FG001|Overall Study|Withdrawal of Consent|6|||
129878848|NCT02670538|467515587|FG002|Overall Study|Withdrawal of Consent|5|||
129878849|NCT02670538|467515585|FG000|Overall Study|Lost to Follow-up|8|||
129878850|NCT02670538|467515586|FG001|Overall Study|Lost to Follow-up|12|||
129878851|NCT02670538|467515587|FG002|Overall Study|Lost to Follow-up|7|||
129878852|NCT02670538|467515585|FG000|Overall Study|Adverse Event|5|||
129653967|NCT03170609|466689884|FG004|Overall Study|Lost to Follow-up|1|||
129653968|NCT03170609|466689885|FG005|Overall Study|Lost to Follow-up|1|||
129653969|NCT03170609|466689886|FG006|Overall Study|Lost to Follow-up|0|||
129653970|NCT03170609|466689880|FG000|Overall Study|Other|1|||
129878853|NCT02670538|467515586|FG001|Overall Study|Adverse Event|5|||
129878854|NCT02670538|467515587|FG002|Overall Study|Adverse Event|11|||
129653971|NCT03170609|466689881|FG001|Overall Study|Other|0|||
129653972|NCT03170609|466689882|FG002|Overall Study|Other|0|||
129653973|NCT03170609|466689883|FG003|Overall Study|Other|0|||
129878855|NCT02670538|467515585|FG000|Overall Study|Lack of Efficacy|7|||
129878856|NCT02670538|467515586|FG001|Overall Study|Lack of Efficacy|1|||
129878857|NCT02670538|467515587|FG002|Overall Study|Lack of Efficacy|2|||
129878858|NCT02670538|467515585|FG000|Overall Study|Protocol Violation|3|||
129878859|NCT02670538|467515586|FG001|Overall Study|Protocol Violation|4|||
129878860|NCT02670538|467515587|FG002|Overall Study|Protocol Violation|1|||
129878861|NCT02670538|467515585|FG000|Overall Study|Noncompliance with Study Drug|1|||
129878862|NCT02670538|467515586|FG001|Overall Study|Noncompliance with Study Drug|3|||
129878863|NCT02670538|467515587|FG002|Overall Study|Noncompliance with Study Drug|2|||
129878864|NCT02670538|467515585|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129878865|NCT02670538|467515586|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129878866|NCT02670538|467515587|FG002|Overall Study|Other Miscellaneous Reasons|2|||
129878867|NCT01250119|467515588|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
129878868|NCT01250119|467515589|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
129878869|NCT01250119|467515588|FG000|Diagnostic Phase|Participants Not Tested|44|||
129878870|NCT01250119|467515589|FG001|Diagnostic Phase|Participants Not Tested|0|||
129878871|NCT01250119|467515588|FG000|Treatment Phase|Progressive Disease|0|||
129878872|NCT01250119|467515589|FG001|Treatment Phase|Progressive Disease|32|||
129878873|NCT01250119|467515588|FG000|Treatment Phase|Death|0|||
129878874|NCT01250119|467515589|FG001|Treatment Phase|Death|2|||
129878875|NCT01250119|467515588|FG000|Treatment Phase|Withdrawal by Subject|0|||
129878876|NCT01250119|467515589|FG001|Treatment Phase|Withdrawal by Subject|1|||
129878877|NCT01250119|467515588|FG000|Treatment Phase|Adverse Event|0|||
129878878|NCT01250119|467515589|FG001|Treatment Phase|Adverse Event|2|||
129878879|NCT01250119|467515588|FG000|Treatment Phase|Unknown reason|0|||
129878880|NCT01250119|467515589|FG001|Treatment Phase|Unknown reason|4|||
129878881|NCT02887989|467515590|FG000|Overall Study|Withdrawal by Subject|8|||
129878882|NCT02887989|467515591|FG001|Overall Study|Withdrawal by Subject|11|||
129878883|NCT02887989|467515590|FG000|Overall Study|Death|1|||
129878884|NCT02887989|467515591|FG001|Overall Study|Death|0|||
129878885|NCT05648357|467515595|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
129878886|NCT00255346|467515596|FG000|Overall Study|Adverse Event|1|||
129878887|NCT00255346|467515597|FG001|Overall Study|Adverse Event|0|||
129878888|NCT00255346|467515598|FG002|Overall Study|Adverse Event|0|||
129878889|NCT00255346|467515599|FG003|Overall Study|Adverse Event|0|||
129878890|NCT00255346|467515600|FG004|Overall Study|Adverse Event|0|||
129878891|NCT00674323|467515601|FG000|Overall Study|Adverse Event|0|||
129878892|NCT00674323|467515602|FG001|Overall Study|Adverse Event|1|||
129878893|NCT00674323|467515603|FG002|Overall Study|Adverse Event|0|||
129878894|NCT00674323|467515601|FG000|Overall Study|Protocol Violation|1|||
129878895|NCT00674323|467515602|FG001|Overall Study|Protocol Violation|0|||
129878896|NCT00674323|467515603|FG002|Overall Study|Protocol Violation|0|||
129878897|NCT02045433|467515610|FG000|Overall Study|Withdrawal by Subject|1|||
129878898|NCT00409786|467515611|FG000|Overall Study|Withdrawal by Subject|3|||
129878899|NCT01678820|467515612|FG000|Overall Study|Study Terminated by Sponsor|45|||
129878900|NCT01678820|467515613|FG001|Overall Study|Study Terminated by Sponsor|43|||
129878901|NCT01678820|467515614|FG002|Overall Study|Study Terminated by Sponsor|43|||
129878902|NCT01678820|467515612|FG000|Overall Study|Withdrawal by Subject|2|||
129878903|NCT01678820|467515613|FG001|Overall Study|Withdrawal by Subject|5|||
129878904|NCT01678820|467515614|FG002|Overall Study|Withdrawal by Subject|2|||
129878905|NCT01678820|467515612|FG000|Overall Study|Protocol Specified Criteria|2|||
129878906|NCT01678820|467515613|FG001|Overall Study|Protocol Specified Criteria|3|||
129878907|NCT01678820|467515614|FG002|Overall Study|Protocol Specified Criteria|1|||
129878908|NCT01678820|467515612|FG000|Overall Study|Adverse Event|2|||
129878909|NCT01678820|467515613|FG001|Overall Study|Adverse Event|2|||
129878910|NCT01678820|467515614|FG002|Overall Study|Adverse Event|2|||
129878911|NCT01678820|467515612|FG000|Overall Study|Lost to Follow-up|7|||
129878912|NCT01678820|467515613|FG001|Overall Study|Lost to Follow-up|2|||
129878913|NCT01678820|467515614|FG002|Overall Study|Lost to Follow-up|2|||
129878914|NCT01678820|467515612|FG000|Overall Study|Non-compliance with study drug|0|||
129878915|NCT01678820|467515613|FG001|Overall Study|Non-compliance with study drug|1|||
129878916|NCT01678820|467515614|FG002|Overall Study|Non-compliance with study drug|0|||
129878917|NCT01678820|467515612|FG000|Overall Study|Physician Decision|0|||
129878918|NCT01678820|467515613|FG001|Overall Study|Physician Decision|0|||
129878919|NCT01678820|467515614|FG002|Overall Study|Physician Decision|1|||
129878920|NCT01678820|467515612|FG000|Overall Study|Protocol Violation|4|||
129878921|NCT01678820|467515613|FG001|Overall Study|Protocol Violation|5|||
129878922|NCT01678820|467515614|FG002|Overall Study|Protocol Violation|4|||
129878923|NCT01678820|467515612|FG000|Overall Study|Not treated with double-blind study drug|0|||
129878924|NCT01678820|467515613|FG001|Overall Study|Not treated with double-blind study drug|2|||
129878925|NCT01678820|467515614|FG002|Overall Study|Not treated with double-blind study drug|2|||
129878926|NCT02306265|467515615|FG000|Overall Study|Withdrawal by Subject|1|||
129878927|NCT04488003|467515616|FG000|Assessed for Eligibility|Screen Failure|24|||
129878928|NCT04488003|467515617|FG001|Assessed for Eligibility|Screen Failure|0|||
129878929|NCT04488003|467515618|FG002|Assessed for Eligibility|Screen Failure|0|||
129878930|NCT04488003|467515616|FG000|Assessed for Eligibility|Adverse Event|1|||
129878931|NCT04488003|467515617|FG001|Assessed for Eligibility|Adverse Event|0|||
129878932|NCT04488003|467515618|FG002|Assessed for Eligibility|Adverse Event|0|||
129878933|NCT04488003|467515616|FG000|Assessed for Eligibility|Death|1|||
129878934|NCT04488003|467515617|FG001|Assessed for Eligibility|Death|0|||
129878935|NCT04488003|467515618|FG002|Assessed for Eligibility|Death|0|||
129878936|NCT04488003|467515616|FG000|Assessed for Eligibility|Physician Decision|1|||
129878937|NCT04488003|467515617|FG001|Assessed for Eligibility|Physician Decision|0|||
129878938|NCT04488003|467515618|FG002|Assessed for Eligibility|Physician Decision|0|||
129878939|NCT04488003|467515616|FG000|Allocated to Treatment|Progressive Disease|51|||
129878940|NCT04488003|467515617|FG001|Allocated to Treatment|Progressive Disease|0|||
129878941|NCT04488003|467515618|FG002|Allocated to Treatment|Progressive Disease|0|||
129878942|NCT04488003|467515616|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
129878943|NCT04488003|467515617|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
129878944|NCT04488003|467515618|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
129878945|NCT04488003|467515616|FG000|Allocated to Treatment|Adverse Event|6|||
129878946|NCT04488003|467515617|FG001|Allocated to Treatment|Adverse Event|0|||
129878947|NCT04488003|467515618|FG002|Allocated to Treatment|Adverse Event|0|||
129878948|NCT04488003|467515616|FG000|Allocated to Treatment|Other|5|||
129878949|NCT04488003|467515617|FG001|Allocated to Treatment|Other|0|||
129878950|NCT04488003|467515618|FG002|Allocated to Treatment|Other|0|||
129878951|NCT04488003|467515616|FG000|Allocated to Treatment|Physician Decision|4|||
129878952|NCT04488003|467515617|FG001|Allocated to Treatment|Physician Decision|0|||
129878953|NCT04488003|467515618|FG002|Allocated to Treatment|Physician Decision|0|||
129878954|NCT04488003|467515616|FG000|Allocated to Treatment|Death|4|||
129878955|NCT04488003|467515617|FG001|Allocated to Treatment|Death|0|||
129878956|NCT04488003|467515618|FG002|Allocated to Treatment|Death|0|||
129878957|NCT01350505|467515622|FG000|Overall Study|Lost to Follow-up|4|||
129878958|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
129878959|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
129878960|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
129878961|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
129878962|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
129878963|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
129878964|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
129878965|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
129878966|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
129878967|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
129878968|NCT02307513|467515627|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
129878969|NCT02307513|467515628|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
129878970|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
129878971|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
129878972|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
129878973|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
129878974|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
129878975|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
129878976|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
129878977|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
129878978|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
129878979|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
129878980|NCT02307513|467515627|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
129878981|NCT02307513|467515628|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
129878982|NCT02307513|467515627|FG000|Long-term Extension|Physician Decision|1|||
129878983|NCT02307513|467515628|FG001|Long-term Extension|Physician Decision|0|||
129878984|NCT00744263|467515629|FG000|Overall Study|Death|3006|||
129878985|NCT00744263|467515630|FG001|Overall Study|Death|3005|||
129878986|NCT00744263|467515629|FG000|Overall Study|Lost to Follow-up|2038|||
129878987|NCT00744263|467515630|FG001|Overall Study|Lost to Follow-up|2135|||
129878988|NCT00744263|467515629|FG000|Overall Study|Withdrawal by Subject|166|||
129878989|NCT00744263|467515630|FG001|Overall Study|Withdrawal by Subject|150|||
129878990|NCT00744263|467515629|FG000|Overall Study|Physician Decision|20|||
129878991|NCT00744263|467515630|FG001|Overall Study|Physician Decision|23|||
129878992|NCT00744263|467515629|FG000|Overall Study|Protocol Violation|3|||
129878993|NCT00744263|467515630|FG001|Overall Study|Protocol Violation|5|||
129878994|NCT00744263|467515629|FG000|Overall Study|Adverse Event|1|||
129878995|NCT00744263|467515630|FG001|Overall Study|Adverse Event|0|||
129878996|NCT00744263|467515629|FG000|Overall Study|Other|2|||
129878997|NCT00744263|467515630|FG001|Overall Study|Other|2|||
129878998|NCT02213328|467515634|FG000|Overall Study|Withdrawal by Subject|10|||
129878999|NCT02213328|467515634|FG000|Overall Study|Physician Decision|2|||
129879000|NCT02213328|467515634|FG000|Overall Study|Lost to Follow-up|16|||
129879001|NCT02487095|467515640|FG000|Dose Expansion|Unable to scan/restage participant|0|||
129879002|NCT02487095|467515641|FG001|Dose Expansion|Unable to scan/restage participant|0|||
129879003|NCT02487095|467515642|FG002|Dose Expansion|Unable to scan/restage participant|0|||
129879004|NCT02487095|467515643|FG003|Dose Expansion|Unable to scan/restage participant|0|||
129879005|NCT02487095|467515644|FG004|Dose Expansion|Unable to scan/restage participant|1|||
129879006|NCT05778526|467515647|FG000|Overall Study|Lost to Follow-up|0|||
129879007|NCT05778526|467515648|FG001|Overall Study|Lost to Follow-up|1|||
129879008|NCT05778526|467515649|FG002|Overall Study|Lost to Follow-up|3|||
129879009|NCT05778526|467515647|FG000|Overall Study|Protocol Violation|0|||
129879010|NCT05778526|467515648|FG001|Overall Study|Protocol Violation|0|||
129879011|NCT05778526|467515649|FG002|Overall Study|Protocol Violation|8|||
129879012|NCT03108157|467515650|FG000|Overall Study|Protocol Violation|15|||
129879013|NCT03108157|467515651|FG001|Overall Study|Protocol Violation|4|||
129879014|NCT01279343|467515654|FG000|Overall Study|Did not receive treatment|2|||
129879015|NCT01279343|467515655|FG001|Overall Study|Did not receive treatment|6|||
129879016|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129879017|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
129879018|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129879019|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
129879020|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
129879021|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
129879022|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
129879023|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
129879024|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
129879025|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
129879026|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
129879027|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
129879028|NCT04534114|467515656|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
129879029|NCT04534114|467515657|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
129879030|NCT04534114|467515658|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
129879031|NCT04534114|467515659|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
129879032|NCT04534114|467515656|FG000|Main Treatment Period|Physician Decision|0|||
129879033|NCT04534114|467515657|FG001|Main Treatment Period|Physician Decision|0|||
129879034|NCT04534114|467515658|FG002|Main Treatment Period|Physician Decision|0|||
129879035|NCT04534114|467515659|FG003|Main Treatment Period|Physician Decision|1|||
129879036|NCT04534114|467515656|FG000|Main Treatment Period|Death|1|||
129879037|NCT04534114|467515657|FG001|Main Treatment Period|Death|0|||
129879038|NCT04534114|467515658|FG002|Main Treatment Period|Death|0|||
129879039|NCT04534114|467515659|FG003|Main Treatment Period|Death|1|||
129879040|NCT04534114|467515656|FG000|Main Treatment Period|Other reason|1|||
129879041|NCT04534114|467515657|FG001|Main Treatment Period|Other reason|1|||
129879042|NCT04534114|467515658|FG002|Main Treatment Period|Other reason|0|||
129879043|NCT04534114|467515659|FG003|Main Treatment Period|Other reason|0|||
129879044|NCT04534114|467515656|FG000|Main Treatment Period|Participant decision|1|||
129879045|NCT04534114|467515657|FG001|Main Treatment Period|Participant decision|3|||
129879046|NCT04534114|467515658|FG002|Main Treatment Period|Participant decision|3|||
129879047|NCT04534114|467515659|FG003|Main Treatment Period|Participant decision|1|||
129879048|NCT04534114|467515656|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
129879049|NCT04534114|467515657|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
129879050|NCT04534114|467515658|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
129879051|NCT04534114|467515659|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
129879052|NCT04534114|467515656|FG000|Main Treatment Period|Adverse Event|4|||
129879053|NCT04534114|467515657|FG001|Main Treatment Period|Adverse Event|2|||
129879054|NCT04534114|467515658|FG002|Main Treatment Period|Adverse Event|1|||
129879055|NCT04534114|467515659|FG003|Main Treatment Period|Adverse Event|2|||
129879056|NCT04534114|467515656|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
129879057|NCT04534114|467515657|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
129879058|NCT04534114|467515658|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
129879059|NCT04534114|467515659|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
129879060|NCT04534114|467515656|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
129879061|NCT04534114|467515657|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
129879062|NCT04534114|467515658|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
129879063|NCT04534114|467515659|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
129879064|NCT04534114|467515656|FG000|Extension Treatment Period|Other reason|0|||
129879065|NCT04534114|467515657|FG001|Extension Treatment Period|Other reason|1|||
129879066|NCT04534114|467515658|FG002|Extension Treatment Period|Other reason|0|||
129879067|NCT04534114|467515659|FG003|Extension Treatment Period|Other reason|0|||
129879068|NCT04534114|467515656|FG000|Extension Treatment Period|Death|0|||
129879069|NCT04534114|467515657|FG001|Extension Treatment Period|Death|0|||
129879070|NCT04534114|467515658|FG002|Extension Treatment Period|Death|1|||
129879071|NCT04534114|467515659|FG003|Extension Treatment Period|Death|2|||
129879072|NCT04534114|467515656|FG000|Extension Treatment Period|Adverse Event|0|||
129879073|NCT04534114|467515657|FG001|Extension Treatment Period|Adverse Event|1|||
129879074|NCT04534114|467515658|FG002|Extension Treatment Period|Adverse Event|0|||
129879075|NCT04534114|467515659|FG003|Extension Treatment Period|Adverse Event|1|||
129879076|NCT04534114|467515656|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
129879077|NCT04534114|467515657|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
129879078|NCT04534114|467515658|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
129879079|NCT04534114|467515659|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
129879080|NCT03287414|467515660|FG000|Treatment Epoch|Adverse Event|0|||
129879081|NCT03287414|467515661|FG001|Treatment Epoch|Adverse Event|1|||
129879082|NCT03287414|467515660|FG000|Treatment Epoch|Study terminated by sponsor|2|||
129879083|NCT03287414|467515661|FG001|Treatment Epoch|Study terminated by sponsor|2|||
129879084|NCT03287414|467515660|FG000|Treatment Epoch|Subject/Guardian decision|4|||
129879085|NCT03287414|467515661|FG001|Treatment Epoch|Subject/Guardian decision|0|||
129879086|NCT03287414|467515660|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
129879087|NCT03287414|467515661|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
129879088|NCT03287414|467515660|FG000|Treatment Epoch|Withdrawal by Subject|1|||
129879089|NCT03287414|467515661|FG001|Treatment Epoch|Withdrawal by Subject|0|||
129879090|NCT03287414|467515660|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
129879091|NCT03287414|467515661|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
129879092|NCT03287414|467515660|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
129879093|NCT03287414|467515661|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
129879094|NCT02759185|467515662|FG000|Stage 1|Adverse Event|0|||
129879095|NCT02759185|467515663|FG001|Stage 1|Adverse Event|1|||
129879096|NCT02759185|467515664|FG002|Stage 1|Adverse Event|3|||
129879097|NCT02759185|467515665|FG003|Stage 1|Adverse Event|0|||
129879098|NCT02759185|467515666|FG004|Stage 1|Adverse Event|0|||
129879099|NCT02759185|467515667|FG005|Stage 1|Adverse Event|0|||
129879100|NCT02759185|467515668|FG006|Stage 1|Adverse Event|0|||
129879101|NCT02759185|467515662|FG000|Stage 1|Withdrawal by Subject|1|||
129879102|NCT02759185|467515663|FG001|Stage 1|Withdrawal by Subject|0|||
129879103|NCT02759185|467515664|FG002|Stage 1|Withdrawal by Subject|0|||
129879104|NCT02759185|467515665|FG003|Stage 1|Withdrawal by Subject|0|||
129879105|NCT02759185|467515666|FG004|Stage 1|Withdrawal by Subject|0|||
129879106|NCT02759185|467515667|FG005|Stage 1|Withdrawal by Subject|0|||
129879107|NCT02759185|467515668|FG006|Stage 1|Withdrawal by Subject|0|||
129879108|NCT02759185|467515662|FG000|Stage 2|Adverse Event|0|||
129879109|NCT02759185|467515663|FG001|Stage 2|Adverse Event|0|||
129879110|NCT02759185|467515664|FG002|Stage 2|Adverse Event|0|||
129879111|NCT02759185|467515665|FG003|Stage 2|Adverse Event|0|||
129879112|NCT02759185|467515666|FG004|Stage 2|Adverse Event|1|||
129879113|NCT02759185|467515667|FG005|Stage 2|Adverse Event|2|||
129879114|NCT02759185|467515668|FG006|Stage 2|Adverse Event|0|||
129879115|NCT02759185|467515662|FG000|Stage 2|Withdrawal by Subject|0|||
129879116|NCT02759185|467515663|FG001|Stage 2|Withdrawal by Subject|0|||
129879117|NCT02759185|467515664|FG002|Stage 2|Withdrawal by Subject|0|||
129879118|NCT02759185|467515665|FG003|Stage 2|Withdrawal by Subject|0|||
129879119|NCT02759185|467515666|FG004|Stage 2|Withdrawal by Subject|1|||
129879120|NCT02759185|467515667|FG005|Stage 2|Withdrawal by Subject|1|||
129879121|NCT02759185|467515668|FG006|Stage 2|Withdrawal by Subject|1|||
129879122|NCT02613221|467515674|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
129879123|NCT02613221|467515674|FG000|Overall Study|Adverse Event|2|||
129879124|NCT02613221|467515674|FG000|Overall Study|Voluntary Discontinuation|1|||
129879125|NCT02613221|467515674|FG000|Overall Study|Delayed Treatment|1|||
129879126|NCT02613221|467515674|FG000|Overall Study|Enrolled but Not Treated|1|||
129879127|NCT01008475|467515677|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
129879128|NCT01008475|467515678|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
129879129|NCT01008475|467515679|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
129879130|NCT01008475|467515680|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
129879131|NCT01008475|467515681|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
129879132|NCT01008475|467515682|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
129879133|NCT01008475|467515683|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
129879134|NCT02668016|467515684|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
129879135|NCT02668016|467515684|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
129879136|NCT02668016|467515684|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
129879137|NCT02668016|467515684|FG000|Month 4|Withdrawal due to severe symptoms|1|||
129879138|NCT02668016|467515684|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
129879139|NCT02668016|467515684|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
129879140|NCT02668016|467515684|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
129879141|NCT02668016|467515684|FG000|Month 6|Withdrawal due to severe symptoms|2|||
129879142|NCT02668016|467515684|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
129879143|NCT02668016|467515684|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
129879144|NCT02668016|467515684|FG000|Month 8|Withdrawal due to severe symptoms|1|||
129879145|NCT02668016|467515684|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
129879146|NCT02668016|467515684|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
129879147|NCT02668016|467515684|FG000|Month 10|Withdrawal due to severe symptoms|1|||
129879148|NCT02668016|467515684|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
129879149|NCT02917941|467515686|FG000|Treatment Period|Adverse Event|11|||
129879150|NCT02917941|467515686|FG000|Treatment Period|Progressive Disease|11|||
129879151|NCT02917941|467515686|FG000|Treatment Period|Reason not Specified|2|||
129879152|NCT02917941|467515686|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
129879153|NCT02917941|467515686|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
129879154|NCT02946918|467515698|FG000|Overall Study|Patient unblinded himself|1|||
129879155|NCT02946918|467515699|FG001|Overall Study|Patient unblinded himself|0|||
129879156|NCT02946918|467515698|FG000|Overall Study|Physician Decision|0|||
129879157|NCT02946918|467515699|FG001|Overall Study|Physician Decision|2|||
129879158|NCT02946918|467515698|FG000|Overall Study|Ran out of study medication|0|||
129879159|NCT02946918|467515699|FG001|Overall Study|Ran out of study medication|1|||
129879160|NCT00069784|467515700|FG000|Overall Study|Adverse Event|105|||
129879161|NCT00069784|467515701|FG001|Overall Study|Adverse Event|0|||
129879162|NCT00069784|467515700|FG000|Overall Study|Withdrawal by Subject|1090|||
129879163|NCT00069784|467515701|FG001|Overall Study|Withdrawal by Subject|0|||
129879164|NCT00069784|467515700|FG000|Overall Study|Other|17|||
129879165|NCT00069784|467515701|FG001|Overall Study|Other|0|||
129879166|NCT01672853|467515706|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
129879167|NCT01672853|467515707|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
129879168|NCT01672853|467515708|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
129879169|NCT01672853|467515706|FG000|Overall Study|Pregnancy|0|||
129879170|NCT01672853|467515707|FG001|Overall Study|Pregnancy|1|||
129879171|NCT01672853|467515708|FG002|Overall Study|Pregnancy|0|||
129879172|NCT01672853|467515706|FG000|Overall Study|Investigator's Discretion|1|||
129879173|NCT01672853|467515707|FG001|Overall Study|Investigator's Discretion|0|||
129879174|NCT01672853|467515708|FG002|Overall Study|Investigator's Discretion|0|||
129879175|NCT01672853|467515706|FG000|Overall Study|Withdrew Consent|5|||
129879176|NCT01672853|467515707|FG001|Overall Study|Withdrew Consent|5|||
129879177|NCT01672853|467515708|FG002|Overall Study|Withdrew Consent|5|||
129879178|NCT01672853|467515706|FG000|Overall Study|Adverse Event|4|||
129879179|NCT01672853|467515707|FG001|Overall Study|Adverse Event|6|||
129879180|NCT01672853|467515708|FG002|Overall Study|Adverse Event|8|||
129879181|NCT01672853|467515706|FG000|Overall Study|Lost to Follow-up|0|||
129879182|NCT01672853|467515707|FG001|Overall Study|Lost to Follow-up|1|||
129879183|NCT01672853|467515708|FG002|Overall Study|Lost to Follow-up|0|||
129879184|NCT01672853|467515706|FG000|Overall Study|Randomized but Never Treated|0|||
129879185|NCT01672853|467515707|FG001|Overall Study|Randomized but Never Treated|0|||
129879186|NCT01672853|467515708|FG002|Overall Study|Randomized but Never Treated|1|||
129879187|NCT00663117|467517132|FG000|Overall Study|Lack of Efficacy|1|||
129879188|NCT00663117|467517133|FG001|Overall Study|Lack of Efficacy|0|||
129879189|NCT01992549|467517139|FG000|Overall Study|Lost to Follow-up|2|||
129879190|NCT01992549|467517139|FG000|Overall Study|Serious Adverse Event|1|||
129879191|NCT01992549|467517139|FG000|Overall Study|Product Switch to Extend Half Life|1|||
129879192|NCT01590771|467517140|FG000|Overall Study|Other Protocol Specified Criteria|5|||
129879193|NCT01590771|467517141|FG001|Overall Study|Other Protocol Specified Criteria|14|||
129879194|NCT01590771|467517140|FG000|Overall Study|Withdrawal by Subject|8|||
129879195|NCT01590771|467517141|FG001|Overall Study|Withdrawal by Subject|15|||
129879196|NCT01590771|467517140|FG000|Overall Study|Protocol Violation|1|||
129879197|NCT01590771|467517141|FG001|Overall Study|Protocol Violation|2|||
129879198|NCT01590771|467517140|FG000|Overall Study|Lost to Follow-up|1|||
129879199|NCT01590771|467517141|FG001|Overall Study|Lost to Follow-up|1|||
129879200|NCT01590771|467517140|FG000|Overall Study|Lack of Efficacy|1|||
129879201|NCT01590771|467517141|FG001|Overall Study|Lack of Efficacy|0|||
129879202|NCT01590771|467517140|FG000|Overall Study|Adverse Event|3|||
129879203|NCT01590771|467517141|FG001|Overall Study|Adverse Event|7|||
129879204|NCT00767104|467517147|FG000|Overall Study|Lost to Follow-up|1|||
129879205|NCT00767104|467517148|FG001|Overall Study|Lost to Follow-up|2|||
129879206|NCT01900054|467517156|FG000|Overall Study|Physician Decision|1|||
129879207|NCT01900054|467517156|FG000|Overall Study|Withdrawal by Subject|1|||
129879208|NCT01186328|467517157|FG000|Overall Study|Death|1|||
129879209|NCT01186328|467517158|FG001|Overall Study|Death|0|||
129879210|NCT01186328|467517159|FG002|Overall Study|Death|0|||
129879211|NCT03015116|467517164|FG000|Overall Study|Lost to Follow-up|3|||
129879212|NCT03015116|467517165|FG001|Overall Study|Lost to Follow-up|0|||
129879213|NCT03015116|467517166|FG002|Overall Study|Lost to Follow-up|2|||
129879214|NCT03015116|467517164|FG000|Overall Study|Withdrawal by Subject|3|||
129879215|NCT03015116|467517165|FG001|Overall Study|Withdrawal by Subject|1|||
129879216|NCT03015116|467517166|FG002|Overall Study|Withdrawal by Subject|0|||
129879217|NCT03015116|467517164|FG000|Overall Study|Subject has New Medical Status|1|||
129879218|NCT03015116|467517165|FG001|Overall Study|Subject has New Medical Status|0|||
129879219|NCT03015116|467517166|FG002|Overall Study|Subject has New Medical Status|0|||
129879220|NCT03015116|467517164|FG000|Overall Study|Physician Decision|0|||
129879221|NCT03015116|467517165|FG001|Overall Study|Physician Decision|1|||
129879222|NCT03015116|467517166|FG002|Overall Study|Physician Decision|0|||
129879223|NCT02200939|467517171|FG000|Overall Study|Participant withdrew consent|0|||
129879224|NCT02200939|467517172|FG001|Overall Study|Participant withdrew consent|1|||
129879225|NCT02200939|467517171|FG000|Overall Study|Lost to Follow-up|2|||
129879226|NCT02200939|467517172|FG001|Overall Study|Lost to Follow-up|9|||
129879227|NCT02200939|467517171|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
129879228|NCT02200939|467517172|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
129879229|NCT02762981|467517173|FG000|Overall Study|Adverse Event|2|||
129879230|NCT02762981|467517174|FG001|Overall Study|Adverse Event|3|||
129879231|NCT02762981|467517175|FG002|Overall Study|Adverse Event|1|||
129879232|NCT02762981|467517176|FG003|Overall Study|Adverse Event|1|||
129879233|NCT02762981|467517177|FG004|Overall Study|Adverse Event|3|||
129879234|NCT02762981|467517173|FG000|Overall Study|Physician Decision|0|||
129879235|NCT02762981|467517174|FG001|Overall Study|Physician Decision|1|||
129879236|NCT02762981|467517175|FG002|Overall Study|Physician Decision|0|||
129879237|NCT02762981|467517176|FG003|Overall Study|Physician Decision|0|||
129879238|NCT02762981|467517177|FG004|Overall Study|Physician Decision|1|||
129879239|NCT02762981|467517173|FG000|Overall Study|Disease progression|11|||
129879240|NCT02762981|467517174|FG001|Overall Study|Disease progression|23|||
129879241|NCT02762981|467517175|FG002|Overall Study|Disease progression|4|||
129879242|NCT02762981|467517176|FG003|Overall Study|Disease progression|10|||
129879243|NCT02762981|467517177|FG004|Overall Study|Disease progression|1|||
129879244|NCT02762981|467517173|FG000|Overall Study|Enrolled not treated|1|||
129879245|NCT02762981|467517174|FG001|Overall Study|Enrolled not treated|5|||
129879246|NCT02762981|467517175|FG002|Overall Study|Enrolled not treated|0|||
129879247|NCT02762981|467517176|FG003|Overall Study|Enrolled not treated|2|||
129879248|NCT02762981|467517177|FG004|Overall Study|Enrolled not treated|0|||
129879249|NCT02762981|467517173|FG000|Overall Study|Other|2|||
129879250|NCT02762981|467517174|FG001|Overall Study|Other|3|||
129879251|NCT02762981|467517175|FG002|Overall Study|Other|1|||
129879252|NCT02762981|467517176|FG003|Overall Study|Other|0|||
129879253|NCT02762981|467517177|FG004|Overall Study|Other|0|||
129879254|NCT02762981|467517173|FG000|Overall Study|Missing|1|||
129879255|NCT02762981|467517174|FG001|Overall Study|Missing|0|||
129879256|NCT02762981|467517175|FG002|Overall Study|Missing|0|||
129879257|NCT02762981|467517176|FG003|Overall Study|Missing|0|||
129879258|NCT02762981|467517177|FG004|Overall Study|Missing|0|||
129879259|NCT02762981|467517173|FG000|Overall Study|Withdrawal by Subject|0|||
129879260|NCT02762981|467517174|FG001|Overall Study|Withdrawal by Subject|5|||
129879261|NCT02762981|467517175|FG002|Overall Study|Withdrawal by Subject|1|||
129879262|NCT02762981|467517176|FG003|Overall Study|Withdrawal by Subject|3|||
129879263|NCT02762981|467517177|FG004|Overall Study|Withdrawal by Subject|0|||
129879264|NCT02176421|467517178|FG000|Overall Study|Lost to Follow-up|4|||
129879265|NCT02176421|467517178|FG000|Overall Study|Adverse Event|1|||
129879266|NCT00584805|467517181|FG000|Overall Study|No longer at risk of exposure|39|||
129879267|NCT00584805|467517181|FG000|Overall Study|Relocation|36|||
129879268|NCT00584805|467517181|FG000|Overall Study|Withdrawal by Subject|18|||
129879269|NCT00584805|467517181|FG000|Overall Study|Non-compliance|1|||
129879270|NCT00584805|467517181|FG000|Overall Study|Lost to follow up|3|||
129879271|NCT00584805|467517181|FG000|Overall Study|Screen failures|2|||
129879272|NCT02341456|467517185|FG000|Overall Study|Disease progression|2|||
129879273|NCT02341456|467517186|FG001|Overall Study|Disease progression|3|||
129879274|NCT02341456|467517187|FG002|Overall Study|Disease progression|1|||
129879275|NCT02341456|467517185|FG000|Overall Study|Death|1|||
129879276|NCT02341456|467517186|FG001|Overall Study|Death|1|||
129879277|NCT02341456|467517187|FG002|Overall Study|Death|1|||
129879278|NCT02341456|467517185|FG000|Overall Study|Withdrawal by Subject|0|||
129879279|NCT02341456|467517186|FG001|Overall Study|Withdrawal by Subject|1|||
129879280|NCT02341456|467517187|FG002|Overall Study|Withdrawal by Subject|1|||
129879281|NCT02341456|467517185|FG000|Overall Study|Moved to local access programme.|0|||
129879282|NCT02341456|467517186|FG001|Overall Study|Moved to local access programme.|1|||
129879283|NCT02341456|467517187|FG002|Overall Study|Moved to local access programme.|1|||
129879284|NCT02341456|467517185|FG000|Overall Study|Physician Decision|1|||
129879285|NCT02341456|467517186|FG001|Overall Study|Physician Decision|0|||
129879286|NCT02341456|467517187|FG002|Overall Study|Physician Decision|0|||
129879287|NCT01077362|467517188|FG000|Overall Study|Lack of Efficacy|13|||
129879288|NCT01077362|467517189|FG001|Overall Study|Lack of Efficacy|8|||
129879289|NCT01077362|467517190|FG002|Overall Study|Lack of Efficacy|10|||
129879290|NCT01077362|467517188|FG000|Overall Study|Lost to Follow-up|1|||
129879291|NCT01077362|467517189|FG001|Overall Study|Lost to Follow-up|0|||
129879292|NCT01077362|467517190|FG002|Overall Study|Lost to Follow-up|3|||
129879293|NCT01077362|467517188|FG000|Overall Study|Adverse Event|12|||
129879294|NCT01077362|467517189|FG001|Overall Study|Adverse Event|7|||
129653974|NCT03170609|466689884|FG004|Overall Study|Other|0|||
129653975|NCT03170609|466689885|FG005|Overall Study|Other|1|||
129879295|NCT01077362|467517190|FG002|Overall Study|Adverse Event|4|||
129879296|NCT01077362|467517188|FG000|Overall Study|Withdrawal by Subject|5|||
129879297|NCT01077362|467517189|FG001|Overall Study|Withdrawal by Subject|3|||
129879298|NCT01077362|467517190|FG002|Overall Study|Withdrawal by Subject|5|||
129879299|NCT01077362|467517188|FG000|Overall Study|Other|0|||
129879300|NCT01077362|467517189|FG001|Overall Study|Other|1|||
129879301|NCT01077362|467517190|FG002|Overall Study|Other|2|||
129879302|NCT00301080|467517191|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
129879303|NCT00301080|467517192|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879304|NCT00301080|467517193|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879305|NCT00301080|467517194|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879306|NCT00301080|467517195|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
129879307|NCT01641926|467517196|FG000|Overall Study|Adverse Event|5|||
129879308|NCT01641926|467517197|FG001|Overall Study|Adverse Event|2|||
129879309|NCT01641926|467517198|FG002|Overall Study|Adverse Event|3|||
129879310|NCT01641926|467517199|FG003|Overall Study|Adverse Event|1|||
129879311|NCT01641926|467517196|FG000|Overall Study|Lost to Follow-up|2|||
129879312|NCT01641926|467517197|FG001|Overall Study|Lost to Follow-up|2|||
129879313|NCT01641926|467517198|FG002|Overall Study|Lost to Follow-up|1|||
129879314|NCT01641926|467517199|FG003|Overall Study|Lost to Follow-up|0|||
129879315|NCT01641926|467517196|FG000|Overall Study|Physician Decision|6|||
129879316|NCT01641926|467517197|FG001|Overall Study|Physician Decision|5|||
129879317|NCT01641926|467517198|FG002|Overall Study|Physician Decision|0|||
129879318|NCT01641926|467517199|FG003|Overall Study|Physician Decision|1|||
129879319|NCT01641926|467517196|FG000|Overall Study|Protocol Violation|1|||
129879320|NCT01641926|467517197|FG001|Overall Study|Protocol Violation|0|||
129879321|NCT01641926|467517198|FG002|Overall Study|Protocol Violation|0|||
129879322|NCT01641926|467517199|FG003|Overall Study|Protocol Violation|1|||
129879323|NCT01641926|467517196|FG000|Overall Study|Withdrawal by Subject|13|||
129879324|NCT01641926|467517197|FG001|Overall Study|Withdrawal by Subject|5|||
129879325|NCT01641926|467517198|FG002|Overall Study|Withdrawal by Subject|6|||
129879326|NCT01641926|467517199|FG003|Overall Study|Withdrawal by Subject|1|||
129879327|NCT01641926|467517196|FG000|Overall Study|Not Treated|1|||
129879328|NCT01641926|467517197|FG001|Overall Study|Not Treated|1|||
129879329|NCT01641926|467517198|FG002|Overall Study|Not Treated|1|||
129879330|NCT01641926|467517199|FG003|Overall Study|Not Treated|0|||
129879331|NCT02567825|467517206|FG000|Overall Study|No follow-up post-randomization|5|||
129879332|NCT02567825|467517207|FG001|Overall Study|No follow-up post-randomization|1|||
129879333|NCT02567825|467517206|FG000|Overall Study|Follow-up less than 23 months|16|||
129879334|NCT02567825|467517207|FG001|Overall Study|Follow-up less than 23 months|20|||
129879335|NCT01540565|467517209|FG000|Overall Study|Ineligible|2|||
129879336|NCT04145037|467517210|FG000|Overall Study|Study terminated|2|||
129879337|NCT04145037|467517211|FG001|Overall Study|Study terminated|0|||
129879338|NCT04145037|467517210|FG000|Overall Study|Withdrawal by Subject|1|||
129879339|NCT04145037|467517211|FG001|Overall Study|Withdrawal by Subject|0|||
129879340|NCT04145037|467517210|FG000|Overall Study|Lost to Follow-up|1|||
129879341|NCT04145037|467517211|FG001|Overall Study|Lost to Follow-up|0|||
129879342|NCT00130793|467517212|FG000|Overall Study|Lost to Follow-up|1|||
129879343|NCT00130793|467517213|FG001|Overall Study|Lost to Follow-up|4|||
129879344|NCT00130793|467517212|FG000|Overall Study|Withdrew consent|2|||
129879345|NCT00130793|467517213|FG001|Overall Study|Withdrew consent|0|||
129879346|NCT00453102|467517216|FG000|Overall Study|Withdrawal by Subject|2|||
129879347|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
129879348|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
129879349|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
129879350|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
129879351|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
129879352|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
129879353|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
129879354|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
129879355|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
129879356|NCT03500640|467517222|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
129879357|NCT03500640|467517223|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
129879358|NCT03500640|467517224|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
129879359|NCT03500640|467517222|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
129879360|NCT03500640|467517223|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
129879361|NCT03500640|467517224|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
129879362|NCT03500640|467517222|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
129879363|NCT03500640|467517223|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
129879364|NCT03500640|467517224|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
129879365|NCT03500640|467517222|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
129879366|NCT03500640|467517223|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
129879367|NCT03500640|467517224|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
129879368|NCT03500640|467517222|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
129879369|NCT03500640|467517223|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
129879370|NCT03500640|467517224|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
129879371|NCT03500640|467517222|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
129879372|NCT03500640|467517223|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
129879373|NCT03500640|467517224|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
129879374|NCT03500640|467517222|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
129879375|NCT03500640|467517223|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
129879376|NCT03500640|467517224|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
129879377|NCT01650519|467517225|FG000|Overall Study|Withdrawal by Subject|1|||
129879378|NCT01650519|467517226|FG001|Overall Study|Withdrawal by Subject|0|||
129879379|NCT05067933|467517235|FG000|Overall Study|Withdrawal by Subject|2|||
129879380|NCT05067933|467517236|FG001|Overall Study|Withdrawal by Subject|0|||
129879381|NCT05067933|467517237|FG002|Overall Study|Withdrawal by Subject|0|||
129879382|NCT05067933|467517238|FG003|Overall Study|Withdrawal by Subject|0|||
129879383|NCT05067933|467517239|FG004|Overall Study|Withdrawal by Subject|0|||
129879384|NCT05067933|467517240|FG005|Overall Study|Withdrawal by Subject|0|||
129879385|NCT05067933|467517235|FG000|Overall Study|Lost to Follow-up|1|||
129879386|NCT05067933|467517236|FG001|Overall Study|Lost to Follow-up|1|||
129879387|NCT05067933|467517237|FG002|Overall Study|Lost to Follow-up|1|||
129879388|NCT05067933|467517238|FG003|Overall Study|Lost to Follow-up|2|||
129879389|NCT05067933|467517239|FG004|Overall Study|Lost to Follow-up|1|||
129879390|NCT05067933|467517240|FG005|Overall Study|Lost to Follow-up|0|||
129879391|NCT05067933|467517235|FG000|Overall Study|Miscellaneous|1|||
129879392|NCT05067933|467517236|FG001|Overall Study|Miscellaneous|0|||
129879393|NCT05067933|467517237|FG002|Overall Study|Miscellaneous|0|||
129879394|NCT05067933|467517238|FG003|Overall Study|Miscellaneous|0|||
129879395|NCT05067933|467517239|FG004|Overall Study|Miscellaneous|0|||
129879396|NCT05067933|467517240|FG005|Overall Study|Miscellaneous|0|||
129879397|NCT05067933|467517235|FG000|Overall Study|Death|0|||
129879398|NCT05067933|467517236|FG001|Overall Study|Death|0|||
129879399|NCT05067933|467517237|FG002|Overall Study|Death|0|||
129879400|NCT05067933|467517238|FG003|Overall Study|Death|1|||
129879401|NCT05067933|467517239|FG004|Overall Study|Death|0|||
129879402|NCT05067933|467517240|FG005|Overall Study|Death|0|||
129879403|NCT02234063|467517253|FG000|Overall Study|Lost to Follow-up|235|||
129879404|NCT02234063|467517254|FG001|Overall Study|Lost to Follow-up|42|||
129879405|NCT02234063|467517253|FG000|Overall Study|Withdrawal by Subject|20|||
129879406|NCT02234063|467517254|FG001|Overall Study|Withdrawal by Subject|1|||
129879407|NCT02669095|467517259|FG000|Overall Study|Adverse Event|1|||
129879408|NCT02669095|467517260|FG001|Overall Study|Adverse Event|0|||
129879409|NCT02669095|467517259|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129879410|NCT02669095|467517260|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129879411|NCT02669095|467517259|FG000|Overall Study|Torn Lens|0|||
129879412|NCT02669095|467517260|FG001|Overall Study|Torn Lens|1|||
129879413|NCT02669095|467517259|FG000|Overall Study|Visit 5 assessments not completed|0|||
129879414|NCT02669095|467517260|FG001|Overall Study|Visit 5 assessments not completed|1|||
129879415|NCT00926003|467517261|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
129879416|NCT00926003|467517262|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
129879417|NCT00926003|467517263|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
129879418|NCT00926003|467517261|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
129879419|NCT00926003|467517262|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
129879420|NCT00926003|467517263|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
129879421|NCT01396317|467517264|FG000|Overall Study|Adverse Event|1|||
129879422|NCT01396317|467517265|FG001|Overall Study|Adverse Event|0|||
129879423|NCT02294474|467517266|FG000|Overall Study|Adverse Event|7|||
129879424|NCT02294474|467517267|FG001|Overall Study|Adverse Event|7|||
129879425|NCT02294474|467517266|FG000|Overall Study|Lack of Efficacy|2|||
129879426|NCT02294474|467517267|FG001|Overall Study|Lack of Efficacy|1|||
129879427|NCT02294474|467517266|FG000|Overall Study|Protocol Violation|4|||
129879428|NCT02294474|467517267|FG001|Overall Study|Protocol Violation|2|||
129879429|NCT02294474|467517266|FG000|Overall Study|Other than specified above|12|||
129879430|NCT02294474|467517267|FG001|Overall Study|Other than specified above|12|||
129879431|NCT05200936|467517269|FG000|Overall Study|Withdrawal by Subject|2|||
129879432|NCT05200936|467517270|FG001|Overall Study|Withdrawal by Subject|2|||
129879433|NCT05200936|467517269|FG000|Overall Study|Lost to Follow-up|2|||
129879434|NCT05200936|467517270|FG001|Overall Study|Lost to Follow-up|0|||
129879435|NCT05200936|467517269|FG000|Overall Study|Pregnancy|0|||
129879436|NCT05200936|467517270|FG001|Overall Study|Pregnancy|1|||
129879437|NCT03443713|467517271|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
129879438|NCT03443713|467517272|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
129879439|NCT03443713|467517273|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
129879440|NCT02944656|467517275|FG000|Overall Study|No longer eligible|3|||
129879441|NCT02944656|467517276|FG001|Overall Study|No longer eligible|0|||
129879442|NCT02944656|467517275|FG000|Overall Study|Lost to Follow-up|7|||
129879443|NCT02944656|467517276|FG001|Overall Study|Lost to Follow-up|10|||
129879444|NCT05879198|467517279|FG000|Overall Study|Lost to Follow-up|1|||
129879445|NCT02073097|467517280|FG000|Overall Study|Adverse Event|0|||
129879446|NCT02073097|467517281|FG001|Overall Study|Adverse Event|0|||
129879447|NCT02073097|467517282|FG002|Overall Study|Adverse Event|0|||
129879448|NCT02073097|467517283|FG003|Overall Study|Adverse Event|0|||
129879449|NCT02073097|467517284|FG004|Overall Study|Adverse Event|0|||
129879450|NCT02073097|467517285|FG005|Overall Study|Adverse Event|0|||
129879451|NCT02073097|467517286|FG006|Overall Study|Adverse Event|0|||
129879452|NCT02073097|467517287|FG007|Overall Study|Adverse Event|2|||
129879453|NCT02073097|467517280|FG000|Overall Study|Withdrawal by Subject|0|||
129879454|NCT02073097|467517281|FG001|Overall Study|Withdrawal by Subject|0|||
129879455|NCT02073097|467517282|FG002|Overall Study|Withdrawal by Subject|0|||
129879456|NCT02073097|467517283|FG003|Overall Study|Withdrawal by Subject|0|||
129879457|NCT02073097|467517284|FG004|Overall Study|Withdrawal by Subject|0|||
129879458|NCT02073097|467517285|FG005|Overall Study|Withdrawal by Subject|0|||
129879459|NCT02073097|467517286|FG006|Overall Study|Withdrawal by Subject|0|||
129879460|NCT02073097|467517287|FG007|Overall Study|Withdrawal by Subject|2|||
129879461|NCT02073097|467517280|FG000|Overall Study|Death|0|||
129879462|NCT02073097|467517281|FG001|Overall Study|Death|0|||
129879463|NCT02073097|467517282|FG002|Overall Study|Death|0|||
129879464|NCT02073097|467517283|FG003|Overall Study|Death|0|||
129879465|NCT02073097|467517284|FG004|Overall Study|Death|0|||
129879466|NCT02073097|467517285|FG005|Overall Study|Death|0|||
129879467|NCT02073097|467517286|FG006|Overall Study|Death|0|||
129879468|NCT02073097|467517287|FG007|Overall Study|Death|1|||
129879469|NCT02073097|467517280|FG000|Overall Study|Physician Decision|0|||
129879470|NCT02073097|467517281|FG001|Overall Study|Physician Decision|0|||
129879471|NCT02073097|467517282|FG002|Overall Study|Physician Decision|0|||
129879472|NCT02073097|467517283|FG003|Overall Study|Physician Decision|0|||
129879473|NCT02073097|467517284|FG004|Overall Study|Physician Decision|0|||
129879474|NCT02073097|467517285|FG005|Overall Study|Physician Decision|0|||
129879475|NCT02073097|467517286|FG006|Overall Study|Physician Decision|0|||
129879476|NCT02073097|467517287|FG007|Overall Study|Physician Decision|1|||
129879477|NCT02769065|467519315|FG000|Overall Study|Voluntary Withdrawal|1|||
129879478|NCT02769065|467519316|FG001|Overall Study|Voluntary Withdrawal|0|||
129879479|NCT02769065|467519317|FG002|Overall Study|Voluntary Withdrawal|0|||
129879480|NCT02769065|467519318|FG003|Overall Study|Voluntary Withdrawal|0|||
129879481|NCT02769065|467519319|FG004|Overall Study|Voluntary Withdrawal|0|||
129879482|NCT02769065|467519320|FG005|Overall Study|Voluntary Withdrawal|0|||
129879483|NCT02769065|467519321|FG006|Overall Study|Voluntary Withdrawal|0|||
129879484|NCT02769065|467519322|FG007|Overall Study|Voluntary Withdrawal|0|||
129879485|NCT02769065|467519323|FG008|Overall Study|Voluntary Withdrawal|0|||
129879486|NCT02769065|467519324|FG009|Overall Study|Voluntary Withdrawal|0|||
129879487|NCT02769065|467519325|FG010|Overall Study|Voluntary Withdrawal|0|||
129879488|NCT02769065|467519326|FG011|Overall Study|Voluntary Withdrawal|0|||
129879489|NCT02769065|467519327|FG012|Overall Study|Voluntary Withdrawal|0|||
129879490|NCT02769065|467519328|FG013|Overall Study|Voluntary Withdrawal|0|||
129879491|NCT02769065|467519329|FG014|Overall Study|Voluntary Withdrawal|0|||
129879492|NCT02769065|467519330|FG015|Overall Study|Voluntary Withdrawal|0|||
129879493|NCT02769065|467519331|FG016|Overall Study|Voluntary Withdrawal|0|||
129879494|NCT02769065|467519332|FG017|Overall Study|Voluntary Withdrawal|0|||
129879495|NCT02769065|467519333|FG018|Overall Study|Voluntary Withdrawal|0|||
129879496|NCT02769065|467519334|FG019|Overall Study|Voluntary Withdrawal|0|||
129879497|NCT02769065|467519335|FG020|Overall Study|Voluntary Withdrawal|0|||
129879498|NCT02769065|467519336|FG021|Overall Study|Voluntary Withdrawal|0|||
129879499|NCT02769065|467519337|FG022|Overall Study|Voluntary Withdrawal|0|||
129879500|NCT02769065|467519338|FG023|Overall Study|Voluntary Withdrawal|0|||
129879501|NCT02769065|467519339|FG024|Overall Study|Voluntary Withdrawal|0|||
129879502|NCT02769065|467519340|FG025|Overall Study|Voluntary Withdrawal|0|||
129879503|NCT02769065|467519341|FG026|Overall Study|Voluntary Withdrawal|0|||
129879504|NCT02769065|467519342|FG027|Overall Study|Voluntary Withdrawal|0|||
129879505|NCT02769065|467519343|FG028|Overall Study|Voluntary Withdrawal|0|||
129879506|NCT02769065|467519344|FG029|Overall Study|Voluntary Withdrawal|0|||
129879507|NCT02769065|467519315|FG000|Overall Study|Reason Not Specified|0|||
129879508|NCT02769065|467519316|FG001|Overall Study|Reason Not Specified|0|||
129879509|NCT02769065|467519317|FG002|Overall Study|Reason Not Specified|0|||
129879510|NCT02769065|467519318|FG003|Overall Study|Reason Not Specified|0|||
129879511|NCT02769065|467519319|FG004|Overall Study|Reason Not Specified|0|||
129879512|NCT02769065|467519320|FG005|Overall Study|Reason Not Specified|0|||
129879513|NCT02769065|467519321|FG006|Overall Study|Reason Not Specified|1|||
129879514|NCT02769065|467519322|FG007|Overall Study|Reason Not Specified|0|||
129879515|NCT02769065|467519323|FG008|Overall Study|Reason Not Specified|0|||
129879516|NCT02769065|467519324|FG009|Overall Study|Reason Not Specified|0|||
129879517|NCT02769065|467519325|FG010|Overall Study|Reason Not Specified|0|||
129879518|NCT02769065|467519326|FG011|Overall Study|Reason Not Specified|0|||
129879519|NCT02769065|467519327|FG012|Overall Study|Reason Not Specified|0|||
129879520|NCT02769065|467519328|FG013|Overall Study|Reason Not Specified|0|||
129879521|NCT02769065|467519329|FG014|Overall Study|Reason Not Specified|0|||
129879522|NCT02769065|467519330|FG015|Overall Study|Reason Not Specified|0|||
129879523|NCT02769065|467519331|FG016|Overall Study|Reason Not Specified|0|||
129879524|NCT02769065|467519332|FG017|Overall Study|Reason Not Specified|0|||
129879525|NCT02769065|467519333|FG018|Overall Study|Reason Not Specified|0|||
129879526|NCT02769065|467519334|FG019|Overall Study|Reason Not Specified|0|||
129879527|NCT02769065|467519335|FG020|Overall Study|Reason Not Specified|0|||
129879528|NCT02769065|467519336|FG021|Overall Study|Reason Not Specified|0|||
129879529|NCT02769065|467519337|FG022|Overall Study|Reason Not Specified|0|||
129879530|NCT02769065|467519338|FG023|Overall Study|Reason Not Specified|0|||
129879531|NCT02769065|467519339|FG024|Overall Study|Reason Not Specified|0|||
129879532|NCT02769065|467519340|FG025|Overall Study|Reason Not Specified|0|||
129879533|NCT02769065|467519341|FG026|Overall Study|Reason Not Specified|0|||
129879534|NCT02769065|467519342|FG027|Overall Study|Reason Not Specified|0|||
129879535|NCT02769065|467519343|FG028|Overall Study|Reason Not Specified|0|||
129879536|NCT02769065|467519344|FG029|Overall Study|Reason Not Specified|0|||
129879537|NCT02769065|467519315|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879538|NCT02769065|467519316|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879539|NCT02769065|467519317|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879540|NCT02769065|467519318|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879541|NCT02769065|467519319|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879542|NCT02769065|467519320|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879543|NCT02769065|467519321|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879544|NCT02769065|467519322|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879545|NCT02769065|467519323|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879546|NCT02769065|467519324|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879547|NCT02769065|467519325|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
129879548|NCT02769065|467519326|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879549|NCT02769065|467519327|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879550|NCT02769065|467519328|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879551|NCT02769065|467519329|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879552|NCT02769065|467519330|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879553|NCT02769065|467519331|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879554|NCT02769065|467519332|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879555|NCT02769065|467519333|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879556|NCT02769065|467519334|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879557|NCT02769065|467519335|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879558|NCT02769065|467519336|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879559|NCT02769065|467519337|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879560|NCT02769065|467519338|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879561|NCT02769065|467519339|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879562|NCT02769065|467519340|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879563|NCT02769065|467519341|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879564|NCT02769065|467519342|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879565|NCT02769065|467519343|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879566|NCT02769065|467519344|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
129879567|NCT02764775|467519347|FG000|Overall Study|Death|1|||
129879568|NCT02764775|467519347|FG000|Overall Study|Lost to Follow-up|2|||
129879569|NCT02764775|467519347|FG000|Overall Study|Withdrawal by Subject|3|||
129879570|NCT04022889|467519350|FG000|Stage 1: Period 1|Adverse Event|1|||
129879571|NCT04022889|467519351|FG001|Stage 1: Period 1|Adverse Event|0|||
129879572|NCT04022889|467519352|FG002|Stage 1: Period 1|Adverse Event|0|||
129879573|NCT04022889|467519350|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
129879574|NCT04022889|467519351|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
129879575|NCT04022889|467519352|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
129879576|NCT04022889|467519350|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
129879577|NCT04022889|467519351|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
129879578|NCT04022889|467519352|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
129879579|NCT04022889|467519350|FG000|Stage 2|Screen Failure|0|||
129879580|NCT04022889|467519351|FG001|Stage 2|Screen Failure|0|||
129879581|NCT04022889|467519352|FG002|Stage 2|Screen Failure|3|||
129879582|NCT04022889|467519350|FG000|Stage 2|Ineligible for apheresis donation|0|||
129879583|NCT04022889|467519351|FG001|Stage 2|Ineligible for apheresis donation|0|||
129879584|NCT04022889|467519352|FG002|Stage 2|Ineligible for apheresis donation|2|||
129879585|NCT04022889|467519350|FG000|Stage 2|Adverse Event|0|||
129879586|NCT04022889|467519351|FG001|Stage 2|Adverse Event|0|||
129879587|NCT04022889|467519352|FG002|Stage 2|Adverse Event|2|||
129879588|NCT04022889|467519350|FG000|Stage 2|Protocol Violation|0|||
129879589|NCT04022889|467519351|FG001|Stage 2|Protocol Violation|0|||
129879590|NCT04022889|467519352|FG002|Stage 2|Protocol Violation|1|||
129653976|NCT03170609|466689886|FG006|Overall Study|Other|0|||
129653977|NCT01281956|466689887|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
129653978|NCT01281956|466689888|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
129653979|NCT01857102|466689901|FG000|Period 1|No longer meets Eligibility Criteria|0|||
129653980|NCT01857102|466689902|FG001|Period 1|No longer meets Eligibility Criteria|2|||
129653981|NCT01857102|466689901|FG000|Period 1|Lost to Follow-up|0|||
129879591|NCT04022889|467519350|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
129879592|NCT04022889|467519351|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
129879593|NCT04022889|467519352|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
129879594|NCT02291432|467519355|FG000|Overall Study|Withdrawal by Subject|2|||
129879595|NCT02145078|467519356|FG000|Overall Study|Death|1|||
129879596|NCT02145078|467519356|FG000|Overall Study|Reason not given|3|||
129879597|NCT03327402|467519357|FG000|Overall Study|Withdrawal by Subject|1|||
129879598|NCT03327402|467519357|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
129879599|NCT02440594|467519361|FG000|Overall Study|Lost to Follow-up|34|||
129653982|NCT01857102|466689902|FG001|Period 1|Lost to Follow-up|3|||
129653983|NCT01857102|466689901|FG000|Period 1|Unsatisfactory Lens Fit|1|||
129879600|NCT02440594|467519362|FG001|Overall Study|Lost to Follow-up|33|||
129879601|NCT02440594|467519363|FG002|Overall Study|Lost to Follow-up|54|||
129879602|NCT02440594|467519364|FG003|Overall Study|Lost to Follow-up|47|||
129879603|NCT02440594|467519365|FG004|Overall Study|Lost to Follow-up|5|||
129879604|NCT02440594|467519366|FG005|Overall Study|Lost to Follow-up|4|||
129879605|NCT02440594|467519367|FG006|Overall Study|Lost to Follow-up|28|||
129879606|NCT02440594|467519368|FG007|Overall Study|Lost to Follow-up|48|||
129879607|NCT02440594|467519361|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
129879608|NCT02440594|467519362|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
129879609|NCT02440594|467519363|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
129879610|NCT02440594|467519364|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
129879611|NCT02440594|467519365|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
129879612|NCT02440594|467519366|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
129879613|NCT02440594|467519367|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
129879614|NCT02440594|467519368|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
129879615|NCT02440594|467519361|FG000|Overall Study|Withdrawal by Subject|81|||
129879616|NCT02440594|467519362|FG001|Overall Study|Withdrawal by Subject|67|||
129879617|NCT02440594|467519363|FG002|Overall Study|Withdrawal by Subject|59|||
129879618|NCT02440594|467519364|FG003|Overall Study|Withdrawal by Subject|38|||
129879619|NCT02440594|467519365|FG004|Overall Study|Withdrawal by Subject|2|||
129879620|NCT02440594|467519366|FG005|Overall Study|Withdrawal by Subject|2|||
129879621|NCT02440594|467519367|FG006|Overall Study|Withdrawal by Subject|7|||
129879622|NCT02440594|467519368|FG007|Overall Study|Withdrawal by Subject|7|||
129879623|NCT02440594|467519361|FG000|Overall Study|Administratively w/drawn|3|||
129879624|NCT02440594|467519362|FG001|Overall Study|Administratively w/drawn|2|||
129879625|NCT02440594|467519363|FG002|Overall Study|Administratively w/drawn|0|||
129879626|NCT02440594|467519364|FG003|Overall Study|Administratively w/drawn|0|||
129879627|NCT02440594|467519365|FG004|Overall Study|Administratively w/drawn|0|||
129879628|NCT02440594|467519366|FG005|Overall Study|Administratively w/drawn|0|||
129879629|NCT02440594|467519367|FG006|Overall Study|Administratively w/drawn|2|||
129879630|NCT02440594|467519368|FG007|Overall Study|Administratively w/drawn|1|||
129879631|NCT03810313|467519369|FG000|Overall Study|Study terminated by sponsor|164|||
129879632|NCT03810313|467519370|FG001|Overall Study|Study terminated by sponsor|159|||
129879633|NCT03810313|467519369|FG000|Overall Study|Subject decision|10|||
129879634|NCT03810313|467519370|FG001|Overall Study|Subject decision|11|||
129879635|NCT03810313|467519369|FG000|Overall Study|Lost to Follow-up|3|||
129879636|NCT03810313|467519370|FG001|Overall Study|Lost to Follow-up|3|||
129879637|NCT03810313|467519369|FG000|Overall Study|Adverse Event|2|||
129879638|NCT03810313|467519370|FG001|Overall Study|Adverse Event|1|||
129879639|NCT03810313|467519369|FG000|Overall Study|Death|2|||
129879640|NCT03810313|467519370|FG001|Overall Study|Death|1|||
129879641|NCT03810313|467519369|FG000|Overall Study|Physician Decision|0|||
129879642|NCT03810313|467519370|FG001|Overall Study|Physician Decision|1|||
129879643|NCT03029780|467519373|FG000|Overall Study|Disease Progression|20|||
129879644|NCT03029780|467519374|FG001|Overall Study|Disease Progression|22|||
129879645|NCT03029780|467519373|FG000|Overall Study|Study Drug Toxicity|15|||
129879646|NCT03029780|467519374|FG001|Overall Study|Study Drug Toxicity|11|||
129879647|NCT03029780|467519373|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129879648|NCT03029780|467519374|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129879649|NCT03029780|467519373|FG000|Overall Study|Participant request to discontinue study treatment|4|||
129879650|NCT03029780|467519374|FG001|Overall Study|Participant request to discontinue study treatment|1|||
129879651|NCT03029780|467519373|FG000|Overall Study|Maximum clinical benefit|1|||
129879652|NCT03029780|467519374|FG001|Overall Study|Maximum clinical benefit|0|||
129879653|NCT03029780|467519373|FG000|Overall Study|Participant no longer meets study criteria|0|||
129879654|NCT03029780|467519374|FG001|Overall Study|Participant no longer meets study criteria|1|||
129879655|NCT03029780|467519373|FG000|Overall Study|Other reasons|6|||
129879656|NCT03029780|467519374|FG001|Overall Study|Other reasons|6|||
129879657|NCT03029780|467519373|FG000|Overall Study|Not reported|1|||
129879658|NCT03029780|467519374|FG001|Overall Study|Not reported|1|||
129879659|NCT03029780|467519373|FG000|Overall Study|Death|2|||
129879660|NCT03029780|467519374|FG001|Overall Study|Death|6|||
129879661|NCT03066622|467519375|FG000|Overall Study|Lost to Follow-up|24|||
129879662|NCT03066622|467519376|FG001|Overall Study|Lost to Follow-up|25|||
129879663|NCT03066622|467519375|FG000|Overall Study|Withdrawal by Subject|2|||
129879664|NCT03066622|467519376|FG001|Overall Study|Withdrawal by Subject|1|||
129653984|NCT01857102|466689902|FG001|Period 1|Unsatisfactory Lens Fit|0|||
129879665|NCT01111838|467519377|FG000|Overall Study|Patient Ineligible|2|||
129879666|NCT01111838|467519377|FG000|Overall Study|Not Treated|3|||
129879667|NCT01111838|467519377|FG000|Overall Study|Clinical deterioration|1|||
129879668|NCT01111838|467519377|FG000|Overall Study|Other Complicating Disease|1|||
129879669|NCT00641719|467519378|FG000|Overall Study|Lack of Efficacy|1|||
129879670|NCT00641719|467519379|FG001|Overall Study|Lack of Efficacy|2|||
129879671|NCT00641719|467519378|FG000|Overall Study|Adverse Event|24|||
129879672|NCT00641719|467519379|FG001|Overall Study|Adverse Event|29|||
129879673|NCT00641719|467519378|FG000|Overall Study|Withdrawal by Subject|4|||
129879674|NCT00641719|467519379|FG001|Overall Study|Withdrawal by Subject|4|||
129879675|NCT00641719|467519378|FG000|Overall Study|Reason Not Specified|1|||
129879676|NCT00641719|467519379|FG001|Overall Study|Reason Not Specified|2|||
129879677|NCT03303469|467519380|FG000|Overall Study|Lost to Follow-up|2|||
129879678|NCT04741802|467519382|FG000|Overall Study|Death|1|||
129879679|NCT04741802|467519382|FG000|Overall Study|Lost to Follow-up|11|||
129879680|NCT01785563|467519384|FG000|Overall Study|Physician Decision|10|||
129879681|NCT01785563|467519384|FG000|Overall Study|Withdrawal by Subject|1|||
129879682|NCT01785563|467519384|FG000|Overall Study|Protocol Violation|2|||
129879683|NCT01872910|467519385|FG000|Overall Study|Lost to Follow-up|2|||
129879684|NCT01872910|467519386|FG001|Overall Study|Lost to Follow-up|0|||
129879685|NCT01872910|467519387|FG002|Overall Study|Lost to Follow-up|2|||
129879686|NCT01872910|467519388|FG003|Overall Study|Lost to Follow-up|0|||
129879687|NCT01872910|467519389|FG004|Overall Study|Lost to Follow-up|0|||
129879688|NCT01872910|467519390|FG005|Overall Study|Lost to Follow-up|0|||
129879689|NCT01616771|467519391|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
129879690|NCT00100932|467519392|FG000|Overall Study|Adverse Event|11|||
129879691|NCT00100932|467519393|FG001|Overall Study|Adverse Event|2|||
129879692|NCT00100932|467519392|FG000|Overall Study|Withdrawal by Subject|6|||
129879693|NCT00100932|467519393|FG001|Overall Study|Withdrawal by Subject|0|||
129879694|NCT00100932|467519392|FG000|Overall Study|Progressive Disease|44|||
129879695|NCT00100932|467519393|FG001|Overall Study|Progressive Disease|18|||
129879696|NCT00100932|467519392|FG000|Overall Study|Physician Decision|7|||
129879697|NCT00100932|467519393|FG001|Overall Study|Physician Decision|5|||
129879698|NCT00100932|467519392|FG000|Overall Study|Other|5|||
129879699|NCT00100932|467519393|FG001|Overall Study|Other|2|||
129879700|NCT00744328|467519394|FG000|Overall Study|Lost to Follow-up|2|||
129879701|NCT00744328|467519395|FG001|Overall Study|Lost to Follow-up|5|||
129879702|NCT00744328|467519396|FG002|Overall Study|Lost to Follow-up|3|||
129879703|NCT00744328|467519394|FG000|Overall Study|Withdrawal by Subject|5|||
129879704|NCT00744328|467519395|FG001|Overall Study|Withdrawal by Subject|3|||
129879705|NCT00744328|467519396|FG002|Overall Study|Withdrawal by Subject|4|||
129879706|NCT00744328|467519394|FG000|Overall Study|Found ineligible after randomization|0|||
129879707|NCT00744328|467519395|FG001|Overall Study|Found ineligible after randomization|0|||
129879708|NCT00744328|467519396|FG002|Overall Study|Found ineligible after randomization|1|||
129879709|NCT02387216|467519401|FG000|Overall Study|Progressive disease|2|||
129879710|NCT02387216|467519402|FG001|Overall Study|Progressive disease|0|||
129879711|NCT02387216|467519401|FG000|Overall Study|Withdrawal by Subject|3|||
129879712|NCT02387216|467519402|FG001|Overall Study|Withdrawal by Subject|5|||
129879713|NCT02387216|467519401|FG000|Overall Study|Physician Decision|2|||
129879714|NCT02387216|467519402|FG001|Overall Study|Physician Decision|0|||
129879715|NCT02387216|467519401|FG000|Overall Study|Sponsor Decision|28|||
129879716|NCT02387216|467519402|FG001|Overall Study|Sponsor Decision|12|||
129879717|NCT02387216|467519401|FG000|Overall Study|Death|60|||
129879718|NCT02387216|467519402|FG001|Overall Study|Death|23|||
129879719|NCT02387216|467519401|FG000|Overall Study|Other|5|||
129879720|NCT02387216|467519402|FG001|Overall Study|Other|4|||
129879721|NCT02387216|467519401|FG000|Overall Study|Lost to Follow-up|0|||
129879722|NCT02387216|467519402|FG001|Overall Study|Lost to Follow-up|3|||
129879723|NCT04041440|467519403|FG000|Overall Study|Withdrawal by Subject|0|||
129879724|NCT04041440|467519404|FG001|Overall Study|Withdrawal by Subject|1|||
129879725|NCT04041440|467519403|FG000|Overall Study|Lost to Follow-up|0|||
129879726|NCT04041440|467519404|FG001|Overall Study|Lost to Follow-up|1|||
129879727|NCT02247804|467519409|FG000|Treatment Period 1|Adverse Event|9|||
129879728|NCT02247804|467519410|FG001|Treatment Period 1|Adverse Event|2|||
129879729|NCT02247804|467519411|FG002|Treatment Period 1|Adverse Event|0|||
129879730|NCT02247804|467519409|FG000|Treatment Period 1|Lack of Efficacy|0|||
129879731|NCT02247804|467519410|FG001|Treatment Period 1|Lack of Efficacy|0|||
129879732|NCT02247804|467519411|FG002|Treatment Period 1|Lack of Efficacy|2|||
129879733|NCT02247804|467519409|FG000|Treatment Period 1|Lost to Follow-up|1|||
129879734|NCT02247804|467519410|FG001|Treatment Period 1|Lost to Follow-up|0|||
129879735|NCT02247804|467519411|FG002|Treatment Period 1|Lost to Follow-up|2|||
129879736|NCT02247804|467519409|FG000|Treatment Period 1|Personal Reasons|7|||
129879737|NCT02247804|467519410|FG001|Treatment Period 1|Personal Reasons|1|||
129879738|NCT02247804|467519411|FG002|Treatment Period 1|Personal Reasons|2|||
129879739|NCT02247804|467519409|FG000|Treatment Period 1|Protocol Deviation|0|||
129879740|NCT02247804|467519410|FG001|Treatment Period 1|Protocol Deviation|0|||
129879741|NCT02247804|467519411|FG002|Treatment Period 1|Protocol Deviation|1|||
129879742|NCT02247804|467519409|FG000|Treatment Period 1|Randomized but not Treated|5|||
129879743|NCT02247804|467519410|FG001|Treatment Period 1|Randomized but not Treated|1|||
129879744|NCT02247804|467519411|FG002|Treatment Period 1|Randomized but not Treated|1|||
129879745|NCT02247804|467519409|FG000|Treatment Period 2|Adverse Event|6|||
129879746|NCT02247804|467519410|FG001|Treatment Period 2|Adverse Event|3|||
129879747|NCT02247804|467519411|FG002|Treatment Period 2|Adverse Event|3|||
129879748|NCT02247804|467519409|FG000|Treatment Period 2|Lack of Efficacy|0|||
129879749|NCT02247804|467519410|FG001|Treatment Period 2|Lack of Efficacy|0|||
129879750|NCT02247804|467519411|FG002|Treatment Period 2|Lack of Efficacy|1|||
129879751|NCT02247804|467519409|FG000|Treatment Period 2|Lost to Follow-up|0|||
129879752|NCT02247804|467519410|FG001|Treatment Period 2|Lost to Follow-up|1|||
129879753|NCT02247804|467519411|FG002|Treatment Period 2|Lost to Follow-up|1|||
129879754|NCT02247804|467519409|FG000|Treatment Period 2|Personal Reasons|2|||
129879755|NCT02247804|467519410|FG001|Treatment Period 2|Personal Reasons|1|||
129879756|NCT02247804|467519411|FG002|Treatment Period 2|Personal Reasons|1|||
129879757|NCT02247804|467519409|FG000|Treatment Period 2|Reason not Specified|0|||
129879758|NCT02247804|467519410|FG001|Treatment Period 2|Reason not Specified|0|||
129879759|NCT02247804|467519411|FG002|Treatment Period 2|Reason not Specified|2|||
129879760|NCT02247804|467519409|FG000|Treatment Period 3|Adverse Event|4|||
129879761|NCT02247804|467519410|FG001|Treatment Period 3|Adverse Event|3|||
129879762|NCT02247804|467519411|FG002|Treatment Period 3|Adverse Event|3|||
129879763|NCT02247804|467519409|FG000|Treatment Period 3|Lack of Efficacy|0|||
129879764|NCT02247804|467519410|FG001|Treatment Period 3|Lack of Efficacy|1|||
129879765|NCT02247804|467519411|FG002|Treatment Period 3|Lack of Efficacy|0|||
129879766|NCT02247804|467519409|FG000|Treatment Period 3|Lost to Follow-up|1|||
129879767|NCT02247804|467519410|FG001|Treatment Period 3|Lost to Follow-up|2|||
129879768|NCT02247804|467519411|FG002|Treatment Period 3|Lost to Follow-up|2|||
129879769|NCT02247804|467519409|FG000|Treatment Period 3|Personal Reasons|4|||
129879770|NCT02247804|467519410|FG001|Treatment Period 3|Personal Reasons|3|||
129879771|NCT02247804|467519411|FG002|Treatment Period 3|Personal Reasons|2|||
129879772|NCT02247804|467519409|FG000|Treatment Period 3|Reason not Specified|2|||
129879773|NCT02247804|467519410|FG001|Treatment Period 3|Reason not Specified|1|||
129879774|NCT02247804|467519411|FG002|Treatment Period 3|Reason not Specified|3|||
129879775|NCT02917265|467519412|FG000|Overall Study|Physician Decision|1|||
129879776|NCT02917265|467519413|FG001|Overall Study|Physician Decision|0|||
129879777|NCT02917265|467519412|FG000|Overall Study|Withdrawal by Subject|1|||
129879778|NCT02917265|467519413|FG001|Overall Study|Withdrawal by Subject|0|||
129879779|NCT00980005|467519414|FG000|Overall Study|Withdrawal by Subject|6|||
129879780|NCT00980005|467519415|FG001|Overall Study|Withdrawal by Subject|17|||
129879781|NCT00980005|467519414|FG000|Overall Study|Lost to Follow-up|37|||
129653985|NCT01857102|466689901|FG000|Period 1|Unsatisfactory Visual Response|1|||
129879782|NCT00980005|467519415|FG001|Overall Study|Lost to Follow-up|43|||
129879783|NCT00980005|467519414|FG000|Overall Study|Other|4|||
129879784|NCT00980005|467519415|FG001|Overall Study|Other|3|||
129879785|NCT00692406|467519416|FG000|Overall Study|PI dropped, bad data|57|||
129879786|NCT01617005|467519417|FG000|Overall Study|Pregnancy|1|||
129879787|NCT01617005|467519417|FG000|Overall Study|Lack of motivation for treatment|1|||
129879788|NCT05952297|467519422|FG000|Overall Study|Withdrawal by Subject|1|||
129879789|NCT05952297|467519423|FG001|Overall Study|Withdrawal by Subject|0|||
129879790|NCT00525265|467519426|FG000|Overall Study|Protocol Violation|1|||
129879791|NCT00525265|467519427|FG001|Overall Study|Protocol Violation|0|||
129879792|NCT03107377|467519428|FG000|Overall Study|Adverse Event|3|||
129879793|NCT03107377|467519429|FG001|Overall Study|Adverse Event|3|||
129879794|NCT03107377|467519428|FG000|Overall Study|Protocol Violation|9|||
129879795|NCT03107377|467519429|FG001|Overall Study|Protocol Violation|12|||
129879796|NCT03107377|467519428|FG000|Overall Study|Physician Decision|3|||
129879797|NCT03107377|467519429|FG001|Overall Study|Physician Decision|6|||
129879798|NCT03107377|467519428|FG000|Overall Study|Pregnancy|7|||
129879799|NCT03107377|467519429|FG001|Overall Study|Pregnancy|7|||
129879800|NCT03107377|467519428|FG000|Overall Study|Withdrawal by Subject|16|||
129879801|NCT03107377|467519429|FG001|Overall Study|Withdrawal by Subject|22|||
129879802|NCT03107377|467519428|FG000|Overall Study|Lost to Follow-up|37|||
129879803|NCT03107377|467519429|FG001|Overall Study|Lost to Follow-up|34|||
129879804|NCT03107377|467519428|FG000|Overall Study|Other reason not specified|16|||
129879805|NCT03107377|467519429|FG001|Overall Study|Other reason not specified|15|||
129879806|NCT00211237|467519430|FG000|Baseline|Withdrew|1|||
129879807|NCT00211237|467519431|FG001|Baseline|Withdrew|3|||
129879808|NCT00211237|467519432|FG002|Baseline|Withdrew|0|||
129879809|NCT00211237|467519430|FG000|Baseline|Refused random assignment|1|||
129879810|NCT00211237|467519431|FG001|Baseline|Refused random assignment|0|||
129879811|NCT00211237|467519432|FG002|Baseline|Refused random assignment|0|||
129879812|NCT00211237|467519430|FG000|1 Month|Death|2|||
129879813|NCT00211237|467519431|FG001|1 Month|Death|1|||
129879814|NCT00211237|467519432|FG002|1 Month|Death|0|||
129879815|NCT00211237|467519430|FG000|1 Month|Lost to Follow-up|0|||
129879816|NCT00211237|467519431|FG001|1 Month|Lost to Follow-up|2|||
129879817|NCT00211237|467519432|FG002|1 Month|Lost to Follow-up|0|||
129879818|NCT00211237|467519430|FG000|1 Month|Withdrew|0|||
129879819|NCT00211237|467519431|FG001|1 Month|Withdrew|4|||
129879820|NCT00211237|467519432|FG002|1 Month|Withdrew|0|||
129879821|NCT00211237|467519430|FG000|1 Month|Additional surgery needed|1|||
129879822|NCT00211237|467519431|FG001|1 Month|Additional surgery needed|0|||
129879823|NCT00211237|467519432|FG002|1 Month|Additional surgery needed|0|||
129879824|NCT00211237|467519430|FG000|1 Month|Non-medical problem|0|||
129879825|NCT00211237|467519431|FG001|1 Month|Non-medical problem|2|||
129879826|NCT00211237|467519432|FG002|1 Month|Non-medical problem|0|||
129879827|NCT00211237|467519430|FG000|3 Months|Death|7|||
129879828|NCT00211237|467519431|FG001|3 Months|Death|3|||
129879829|NCT00211237|467519432|FG002|3 Months|Death|0|||
129879830|NCT00211237|467519430|FG000|3 Months|Could not comply with protocol|1|||
129879831|NCT00211237|467519431|FG001|3 Months|Could not comply with protocol|0|||
129879832|NCT00211237|467519432|FG002|3 Months|Could not comply with protocol|0|||
129879833|NCT00211237|467519430|FG000|3 Months|Withdrew|0|||
129879834|NCT00211237|467519431|FG001|3 Months|Withdrew|1|||
129879835|NCT00211237|467519432|FG002|3 Months|Withdrew|0|||
129879836|NCT00211237|467519430|FG000|3 Months|Non-medical problem|0|||
129879837|NCT00211237|467519431|FG001|3 Months|Non-medical problem|0|||
129879838|NCT00211237|467519432|FG002|3 Months|Non-medical problem|1|||
129879839|NCT00211237|467519430|FG000|6 Months|Death|6|||
129879840|NCT00211237|467519431|FG001|6 Months|Death|0|||
129879841|NCT00211237|467519432|FG002|6 Months|Death|3|||
129879842|NCT00211237|467519430|FG000|6 Months|Lost to Follow-up|2|||
129879843|NCT00211237|467519431|FG001|6 Months|Lost to Follow-up|0|||
129879844|NCT00211237|467519432|FG002|6 Months|Lost to Follow-up|0|||
129879845|NCT00211237|467519430|FG000|6 Months|Could not comply with protocol|0|||
129879846|NCT00211237|467519431|FG001|6 Months|Could not comply with protocol|2|||
129879847|NCT00211237|467519432|FG002|6 Months|Could not comply with protocol|0|||
129879848|NCT00211237|467519430|FG000|12 Months|Death|8|||
129879849|NCT00211237|467519431|FG001|12 Months|Death|2|||
129879850|NCT00211237|467519432|FG002|12 Months|Death|3|||
129879851|NCT00211237|467519430|FG000|12 Months|Lost to Follow-up|1|||
129879852|NCT00211237|467519431|FG001|12 Months|Lost to Follow-up|0|||
129879853|NCT00211237|467519432|FG002|12 Months|Lost to Follow-up|1|||
129879854|NCT00211237|467519430|FG000|12 Months|Withdrew|0|||
129879855|NCT00211237|467519431|FG001|12 Months|Withdrew|0|||
129879856|NCT00211237|467519432|FG002|12 Months|Withdrew|1|||
129879857|NCT00211237|467519430|FG000|12 Months|unrelated medical problem|0|||
129879858|NCT00211237|467519431|FG001|12 Months|unrelated medical problem|0|||
129879859|NCT00211237|467519432|FG002|12 Months|unrelated medical problem|1|||
129879860|NCT04078035|467519433|FG000|Session 2|Lost to Follow-up|3|||
129879861|NCT04078035|467519434|FG001|Session 2|Lost to Follow-up|1|||
129879862|NCT04078035|467519433|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
129879863|NCT04078035|467519434|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
129879864|NCT01013792|467519437|FG000|Overall Study|Study suspended|2|||
129879865|NCT01013792|467519438|FG001|Overall Study|Study suspended|1|||
129879866|NCT01013792|467519437|FG000|Overall Study|Adverse Event|0|||
129879867|NCT01013792|467519438|FG001|Overall Study|Adverse Event|3|||
129879868|NCT01013792|467519437|FG000|Overall Study|Lost to Follow-up|0|||
129879869|NCT01013792|467519438|FG001|Overall Study|Lost to Follow-up|1|||
129879870|NCT02100722|467519439|FG000|Overall Study|Withdrawal pre-procedure|4|||
129879871|NCT02100722|467519440|FG001|Overall Study|Withdrawal pre-procedure|9|||
129879872|NCT02100722|467519439|FG000|Overall Study|Withdrawal post-procedure|0|||
129879873|NCT02100722|467519440|FG001|Overall Study|Withdrawal post-procedure|3|||
129879874|NCT02100722|467519439|FG000|Overall Study|Lost to Follow-up|2|||
129879875|NCT02100722|467519440|FG001|Overall Study|Lost to Follow-up|2|||
129879876|NCT02100722|467519439|FG000|Overall Study|Continuing on study|751|||
129879877|NCT02100722|467519440|FG001|Overall Study|Continuing on study|729|||
129879878|NCT02541383|467519444|FG000|Overall Study|Death|50|||
129879879|NCT02541383|467519445|FG001|Overall Study|Death|37|||
129879880|NCT02541383|467519446|FG002|Overall Study|Death|48|||
129879881|NCT02541383|467519447|FG003|Overall Study|Death|41|||
129879882|NCT02541383|467519448|FG004|Overall Study|Death|21|||
129879883|NCT02541383|467519449|FG005|Overall Study|Death|25|||
129879884|NCT02541383|467519444|FG000|Overall Study|Lost to Follow-up|5|||
129879885|NCT02541383|467519445|FG001|Overall Study|Lost to Follow-up|3|||
129879886|NCT02541383|467519446|FG002|Overall Study|Lost to Follow-up|1|||
129879887|NCT02541383|467519447|FG003|Overall Study|Lost to Follow-up|1|||
129879888|NCT02541383|467519448|FG004|Overall Study|Lost to Follow-up|3|||
129879889|NCT02541383|467519449|FG005|Overall Study|Lost to Follow-up|0|||
129879890|NCT02541383|467519444|FG000|Overall Study|Consent withdrawn|5|||
129879891|NCT02541383|467519445|FG001|Overall Study|Consent withdrawn|6|||
129879892|NCT02541383|467519446|FG002|Overall Study|Consent withdrawn|1|||
129879893|NCT02541383|467519447|FG003|Overall Study|Consent withdrawn|1|||
129879894|NCT02541383|467519448|FG004|Overall Study|Consent withdrawn|0|||
129879895|NCT02541383|467519449|FG005|Overall Study|Consent withdrawn|0|||
129653986|NCT01857102|466689902|FG001|Period 1|Unsatisfactory Visual Response|0|||
129879896|NCT02541383|467519444|FG000|Overall Study|Sponsor's decision|1|||
129879897|NCT02541383|467519445|FG001|Overall Study|Sponsor's decision|1|||
129879898|NCT02541383|467519446|FG002|Overall Study|Sponsor's decision|0|||
129879899|NCT02541383|467519447|FG003|Overall Study|Sponsor's decision|0|||
129879900|NCT02541383|467519448|FG004|Overall Study|Sponsor's decision|0|||
129879901|NCT02541383|467519449|FG005|Overall Study|Sponsor's decision|0|||
129879902|NCT05796518|467519452|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
129879903|NCT02954458|467519453|FG000|Overall Study|Adverse Event|0|||
129879904|NCT02954458|467519454|FG001|Overall Study|Adverse Event|0|||
129879905|NCT02954458|467519455|FG002|Overall Study|Adverse Event|0|||
129879906|NCT02954458|467519456|FG003|Overall Study|Adverse Event|1|||
129879907|NCT02954458|467519453|FG000|Overall Study|Withdrawal by Subject|0|||
129879908|NCT02954458|467519454|FG001|Overall Study|Withdrawal by Subject|0|||
129879909|NCT02954458|467519455|FG002|Overall Study|Withdrawal by Subject|0|||
129879910|NCT02954458|467519456|FG003|Overall Study|Withdrawal by Subject|1|||
129879911|NCT02954458|467519453|FG000|Overall Study|Physician Decision|0|||
129879912|NCT02954458|467519454|FG001|Overall Study|Physician Decision|0|||
129879913|NCT02954458|467519455|FG002|Overall Study|Physician Decision|1|||
129879914|NCT02954458|467519456|FG003|Overall Study|Physician Decision|1|||
129879915|NCT02954458|467519453|FG000|Overall Study|Lost to Follow-up|1|||
129879916|NCT02954458|467519454|FG001|Overall Study|Lost to Follow-up|0|||
129879917|NCT02954458|467519455|FG002|Overall Study|Lost to Follow-up|0|||
129879918|NCT02954458|467519456|FG003|Overall Study|Lost to Follow-up|1|||
129879919|NCT02954458|467519453|FG000|Overall Study|Death|0|||
129879920|NCT02954458|467519454|FG001|Overall Study|Death|0|||
129879921|NCT02954458|467519455|FG002|Overall Study|Death|0|||
129879922|NCT02954458|467519456|FG003|Overall Study|Death|1|||
129879923|NCT02954458|467519453|FG000|Overall Study|Other|0|||
129879924|NCT02954458|467519454|FG001|Overall Study|Other|0|||
129879925|NCT02954458|467519455|FG002|Overall Study|Other|0|||
129879926|NCT02954458|467519456|FG003|Overall Study|Other|7|||
129879927|NCT02690077|467519457|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
129879928|NCT02690077|467519458|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
129879929|NCT02690077|467519457|FG000|Overall Study|Withdrawal by Subject|0|||
129879930|NCT02690077|467519458|FG001|Overall Study|Withdrawal by Subject|5|||
129879931|NCT02690077|467519457|FG000|Overall Study|Excluded by IRB|0|||
129879932|NCT02690077|467519458|FG001|Overall Study|Excluded by IRB|2|||
129879933|NCT01845974|467519459|FG000|Overall Study|screen failure|1|||
129879934|NCT01845974|467519460|FG001|Overall Study|screen failure|0|||
129879935|NCT05408468|467519461|FG000|Overall Study|Lost to Follow-up|3|||
129879936|NCT05408468|467519462|FG001|Overall Study|Lost to Follow-up|1|||
129879937|NCT05408468|467519461|FG000|Overall Study|Physician Decision|1|||
129879938|NCT05408468|467519462|FG001|Overall Study|Physician Decision|0|||
129879939|NCT05408468|467519461|FG000|Overall Study|Overwhelmed by clinical situation|3|||
129879940|NCT05408468|467519462|FG001|Overall Study|Overwhelmed by clinical situation|0|||
129879941|NCT05408468|467519461|FG000|Overall Study|Personal illness precluding participation|1|||
129879942|NCT05408468|467519462|FG001|Overall Study|Personal illness precluding participation|0|||
129879943|NCT05408468|467519461|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
129879944|NCT05408468|467519462|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
129879945|NCT04186403|467519463|FG000|Overall Study|Adverse Event|1|||
129879946|NCT04186403|467519464|FG001|Overall Study|Adverse Event|8|||
129879947|NCT04186403|467519463|FG000|Overall Study|Lost to Follow-up|7|||
129879948|NCT04186403|467519464|FG001|Overall Study|Lost to Follow-up|3|||
129879949|NCT04186403|467519463|FG000|Overall Study|Physician Decision|1|||
129879950|NCT04186403|467519464|FG001|Overall Study|Physician Decision|0|||
129879951|NCT04186403|467519463|FG000|Overall Study|Withdrawal by Subject|7|||
129879952|NCT04186403|467519464|FG001|Overall Study|Withdrawal by Subject|8|||
129879953|NCT04186403|467519463|FG000|Overall Study|Other: Not Related to Covid-19|3|||
129879954|NCT04186403|467519464|FG001|Overall Study|Other: Not Related to Covid-19|0|||
129879955|NCT00405639|467519467|FG000|Overall Study|Withdrawal by Subject|1|||
129879956|NCT00405639|467519468|FG001|Overall Study|Withdrawal by Subject|0|||
129879957|NCT00405639|467519467|FG000|Overall Study|Adverse Event|1|||
129879958|NCT00405639|467519468|FG001|Overall Study|Adverse Event|0|||
129879959|NCT00405639|467519467|FG000|Overall Study|Seizure prior to receiving BNP|1|||
129879960|NCT00405639|467519468|FG001|Overall Study|Seizure prior to receiving BNP|0|||
129879961|NCT00612534|467519469|FG000|Overall Study|Adverse Event|0|||
129879962|NCT00612534|467519470|FG001|Overall Study|Adverse Event|4|||
129879963|NCT00612534|467519471|FG002|Overall Study|Adverse Event|2|||
129879964|NCT00612534|467519472|FG003|Overall Study|Adverse Event|1|||
129879965|NCT00612534|467519469|FG000|Overall Study|Lack of Efficacy|13|||
129879966|NCT00612534|467519470|FG001|Overall Study|Lack of Efficacy|12|||
129879967|NCT00612534|467519471|FG002|Overall Study|Lack of Efficacy|5|||
129879968|NCT00612534|467519472|FG003|Overall Study|Lack of Efficacy|16|||
129879969|NCT00612534|467519469|FG000|Overall Study|Other Reason|0|||
129879970|NCT00612534|467519470|FG001|Overall Study|Other Reason|1|||
129879971|NCT00612534|467519471|FG002|Overall Study|Other Reason|0|||
129879972|NCT00612534|467519472|FG003|Overall Study|Other Reason|0|||
129879973|NCT00265330|467519473|FG000|Overall Study|Adverse Event|41|||
129879974|NCT00265330|467519473|FG000|Overall Study|Lost to Follow-up|8|||
129879975|NCT00265330|467519473|FG000|Overall Study|Withdrawal by Subject|34|||
129879976|NCT00265330|467519473|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
129879977|NCT00265330|467519473|FG000|Overall Study|Lack of Efficacy|4|||
129879978|NCT00265330|467519473|FG000|Overall Study|Family Scheduling Conflicts|1|||
129879979|NCT00265330|467519473|FG000|Overall Study|Began Taking Formulary Geodon|1|||
129879980|NCT00265330|467519473|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
129879981|NCT00265330|467519473|FG000|Overall Study|Site Closed by Sponsor|1|||
129879982|NCT00265330|467519473|FG000|Overall Study|Principal Investigators Request|1|||
129879983|NCT00265330|467519473|FG000|Overall Study|Withdrew Consent|1|||
129879984|NCT00265330|467519473|FG000|Overall Study|Protocol Violation|1|||
129879985|NCT01065350|467519478|FG000|Overall Study|Received incorrect drug allocation|0|||
129879986|NCT01065350|467519479|FG001|Overall Study|Received incorrect drug allocation|1|||
129879987|NCT02716038|467519486|FG000|Overall Study|Not evaluable|1|||
129879988|NCT02716038|467519486|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
129879989|NCT02716038|467519486|FG000|Overall Study|Unresectable|3|||
129879990|NCT03573908|467519487|FG000|Treatment Period|Adverse Event|4|||
129879991|NCT03573908|467519488|FG001|Treatment Period|Adverse Event|9|||
129879992|NCT03573908|467519489|FG002|Treatment Period|Adverse Event|0|||
129879993|NCT03573908|467519490|FG003|Treatment Period|Adverse Event|0|||
129879994|NCT03573908|467519491|FG004|Treatment Period|Adverse Event|0|||
129879995|NCT03573908|467519487|FG000|Treatment Period|Protocol Violation|1|||
129879996|NCT03573908|467519488|FG001|Treatment Period|Protocol Violation|0|||
129879997|NCT03573908|467519489|FG002|Treatment Period|Protocol Violation|0|||
129879998|NCT03573908|467519490|FG003|Treatment Period|Protocol Violation|0|||
129879999|NCT03573908|467519491|FG004|Treatment Period|Protocol Violation|0|||
129880000|NCT03573908|467519487|FG000|Treatment Period|Withdrawal by Subject|7|||
129880001|NCT03573908|467519488|FG001|Treatment Period|Withdrawal by Subject|5|||
129880002|NCT03573908|467519489|FG002|Treatment Period|Withdrawal by Subject|0|||
129880003|NCT03573908|467519490|FG003|Treatment Period|Withdrawal by Subject|0|||
129880004|NCT03573908|467519491|FG004|Treatment Period|Withdrawal by Subject|0|||
129880005|NCT03573908|467519487|FG000|Treatment Period|Lost to Follow-up|7|||
129880006|NCT03573908|467519488|FG001|Treatment Period|Lost to Follow-up|6|||
129880007|NCT03573908|467519489|FG002|Treatment Period|Lost to Follow-up|0|||
129880008|NCT03573908|467519490|FG003|Treatment Period|Lost to Follow-up|0|||
129880009|NCT03573908|467519491|FG004|Treatment Period|Lost to Follow-up|0|||
129880010|NCT03573908|467519487|FG000|Treatment Period|Pregnancy|1|||
129880011|NCT03573908|467519488|FG001|Treatment Period|Pregnancy|0|||
129880012|NCT03573908|467519489|FG002|Treatment Period|Pregnancy|0|||
129880013|NCT03573908|467519490|FG003|Treatment Period|Pregnancy|0|||
129880014|NCT03573908|467519491|FG004|Treatment Period|Pregnancy|0|||
129880015|NCT03573908|467519487|FG000|Treatment Period|Other, Not Specified|4|||
129880016|NCT03573908|467519488|FG001|Treatment Period|Other, Not Specified|6|||
129880017|NCT03573908|467519489|FG002|Treatment Period|Other, Not Specified|0|||
129880018|NCT03573908|467519490|FG003|Treatment Period|Other, Not Specified|0|||
129880019|NCT03573908|467519491|FG004|Treatment Period|Other, Not Specified|0|||
129880020|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Adverse Event|0|||
129880021|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Adverse Event|0|||
129880022|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Adverse Event|3|||
129880023|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Adverse Event|0|||
129880024|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Adverse Event|0|||
129880025|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880026|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880027|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880028|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129880029|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
129880030|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880031|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880032|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
129880033|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880034|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
129880035|NCT03573908|467519487|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
129880036|NCT03573908|467519488|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
129880037|NCT03573908|467519489|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
129880038|NCT03573908|467519490|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
129880039|NCT03573908|467519491|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
129880040|NCT04006925|467519492|FG000|Overall Study|Side effects|2|||
129880041|NCT04006925|467519493|FG001|Overall Study|Side effects|0|||
129880042|NCT01555164|467519497|FG000|Overall Study|Adverse Event|5|||
129880043|NCT01555164|467519498|FG001|Overall Study|Adverse Event|7|||
129880044|NCT01555164|467519497|FG000|Overall Study|Hyperglycemia|0|||
129880045|NCT01555164|467519498|FG001|Overall Study|Hyperglycemia|1|||
129880046|NCT01555164|467519497|FG000|Overall Study|Investigator's Discretion|2|||
129880047|NCT01555164|467519498|FG001|Overall Study|Investigator's Discretion|2|||
129653987|NCT01857102|466689901|FG000|Period 1|Physician Decision|1|||
129880048|NCT01555164|467519497|FG000|Overall Study|Lost to Follow-up|4|||
129880049|NCT01555164|467519498|FG001|Overall Study|Lost to Follow-up|3|||
129880050|NCT01555164|467519497|FG000|Overall Study|Protocol Violation|9|||
129880051|NCT01555164|467519498|FG001|Overall Study|Protocol Violation|5|||
129880052|NCT01555164|467519497|FG000|Overall Study|Subject Non-compliance|14|||
129880053|NCT01555164|467519498|FG001|Overall Study|Subject Non-compliance|6|||
129880054|NCT01555164|467519497|FG000|Overall Study|Subject Withdrew Consent|6|||
129880055|NCT01555164|467519498|FG001|Overall Study|Subject Withdrew Consent|11|||
129880056|NCT01709305|467519503|FG000|Phase 1|Clinical Adverse Event|80|||
129880057|NCT01709305|467519504|FG001|Phase 1|Clinical Adverse Event|0|||
129880058|NCT01709305|467519505|FG002|Phase 1|Clinical Adverse Event|0|||
129653988|NCT01857102|466689902|FG001|Period 1|Physician Decision|0|||
129653989|NCT01857102|466689901|FG000|Period 2|Lens Discomfort|1|||
129880059|NCT01709305|467519506|FG003|Phase 1|Clinical Adverse Event|0|||
129880060|NCT01709305|467519507|FG004|Phase 1|Clinical Adverse Event|0|||
129880061|NCT01709305|467519503|FG000|Phase 1|Death|2|||
129880062|NCT01709305|467519504|FG001|Phase 1|Death|0|||
129880063|NCT01709305|467519505|FG002|Phase 1|Death|0|||
129880064|NCT01709305|467519506|FG003|Phase 1|Death|0|||
129880065|NCT01709305|467519507|FG004|Phase 1|Death|0|||
129880066|NCT01709305|467519503|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
129880067|NCT01709305|467519504|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880068|NCT01709305|467519505|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880069|NCT01709305|467519506|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880070|NCT01709305|467519507|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
129880071|NCT01709305|467519503|FG000|Phase 1|Laboratory Adverse Event|16|||
129880072|NCT01709305|467519504|FG001|Phase 1|Laboratory Adverse Event|0|||
129880073|NCT01709305|467519505|FG002|Phase 1|Laboratory Adverse Event|0|||
129880074|NCT01709305|467519506|FG003|Phase 1|Laboratory Adverse Event|0|||
129880075|NCT01709305|467519507|FG004|Phase 1|Laboratory Adverse Event|0|||
129880076|NCT01709305|467519503|FG000|Phase 1|Lost to Follow-up|147|||
129880077|NCT01709305|467519504|FG001|Phase 1|Lost to Follow-up|0|||
129880078|NCT01709305|467519505|FG002|Phase 1|Lost to Follow-up|0|||
129880079|NCT01709305|467519506|FG003|Phase 1|Lost to Follow-up|0|||
129880080|NCT01709305|467519507|FG004|Phase 1|Lost to Follow-up|0|||
129880081|NCT01709305|467519503|FG000|Phase 1|Travel, moving, etc.|30|||
129880082|NCT01709305|467519504|FG001|Phase 1|Travel, moving, etc.|0|||
129880083|NCT01709305|467519505|FG002|Phase 1|Travel, moving, etc.|0|||
129880084|NCT01709305|467519506|FG003|Phase 1|Travel, moving, etc.|0|||
129880085|NCT01709305|467519507|FG004|Phase 1|Travel, moving, etc.|0|||
129880086|NCT01709305|467519503|FG000|Phase 1|Physician Decision|13|||
129880087|NCT01709305|467519504|FG001|Phase 1|Physician Decision|0|||
129880088|NCT01709305|467519505|FG002|Phase 1|Physician Decision|0|||
129880089|NCT01709305|467519506|FG003|Phase 1|Physician Decision|0|||
129880090|NCT01709305|467519507|FG004|Phase 1|Physician Decision|0|||
129880091|NCT01709305|467519503|FG000|Phase 1|Protocol Violation|118|||
129880092|NCT01709305|467519504|FG001|Phase 1|Protocol Violation|0|||
129880093|NCT01709305|467519505|FG002|Phase 1|Protocol Violation|0|||
129880094|NCT01709305|467519506|FG003|Phase 1|Protocol Violation|0|||
129880095|NCT01709305|467519507|FG004|Phase 1|Protocol Violation|0|||
129880096|NCT01709305|467519503|FG000|Phase 1|Withdrawal by Subject|218|||
129880097|NCT01709305|467519504|FG001|Phase 1|Withdrawal by Subject|0|||
129880098|NCT01709305|467519505|FG002|Phase 1|Withdrawal by Subject|0|||
129880099|NCT01709305|467519506|FG003|Phase 1|Withdrawal by Subject|0|||
129880100|NCT01709305|467519507|FG004|Phase 1|Withdrawal by Subject|0|||
129880101|NCT01709305|467519503|FG000|Phase 2|Clinical Adverse Event|0|||
129880102|NCT01709305|467519504|FG001|Phase 2|Clinical Adverse Event|10|||
129880103|NCT01709305|467519505|FG002|Phase 2|Clinical Adverse Event|10|||
129880104|NCT01709305|467519506|FG003|Phase 2|Clinical Adverse Event|6|||
129880105|NCT01709305|467519507|FG004|Phase 2|Clinical Adverse Event|11|||
129880106|NCT01709305|467519503|FG000|Phase 2|Death|0|||
129880107|NCT01709305|467519504|FG001|Phase 2|Death|0|||
129880108|NCT01709305|467519505|FG002|Phase 2|Death|1|||
129880109|NCT01709305|467519506|FG003|Phase 2|Death|0|||
129880110|NCT01709305|467519507|FG004|Phase 2|Death|0|||
129880111|NCT01709305|467519503|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880112|NCT01709305|467519504|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880113|NCT01709305|467519505|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880114|NCT01709305|467519506|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
129880115|NCT01709305|467519507|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
129880116|NCT01709305|467519503|FG000|Phase 2|Laboratory Adverse Event|0|||
129880117|NCT01709305|467519504|FG001|Phase 2|Laboratory Adverse Event|1|||
129880118|NCT01709305|467519505|FG002|Phase 2|Laboratory Adverse Event|0|||
129880119|NCT01709305|467519506|FG003|Phase 2|Laboratory Adverse Event|1|||
129880120|NCT01709305|467519507|FG004|Phase 2|Laboratory Adverse Event|1|||
129880121|NCT01709305|467519503|FG000|Phase 2|Lost to Follow-up|0|||
129880122|NCT01709305|467519504|FG001|Phase 2|Lost to Follow-up|10|||
129880123|NCT01709305|467519505|FG002|Phase 2|Lost to Follow-up|6|||
129880124|NCT01709305|467519506|FG003|Phase 2|Lost to Follow-up|9|||
129880125|NCT01709305|467519507|FG004|Phase 2|Lost to Follow-up|5|||
129880126|NCT01709305|467519503|FG000|Phase 2|Travel, moving, etc.|0|||
129880127|NCT01709305|467519504|FG001|Phase 2|Travel, moving, etc.|2|||
129880128|NCT01709305|467519505|FG002|Phase 2|Travel, moving, etc.|3|||
129880129|NCT01709305|467519506|FG003|Phase 2|Travel, moving, etc.|3|||
129880130|NCT01709305|467519507|FG004|Phase 2|Travel, moving, etc.|5|||
129653990|NCT01857102|466689902|FG001|Period 2|Lens Discomfort|0|||
129880131|NCT01709305|467519503|FG000|Phase 2|Physician Decision|0|||
129880132|NCT01709305|467519504|FG001|Phase 2|Physician Decision|2|||
129880133|NCT01709305|467519505|FG002|Phase 2|Physician Decision|0|||
129880134|NCT01709305|467519506|FG003|Phase 2|Physician Decision|1|||
129880135|NCT01709305|467519507|FG004|Phase 2|Physician Decision|2|||
129880136|NCT01709305|467519503|FG000|Phase 2|Protocol Violation|0|||
129880137|NCT01709305|467519504|FG001|Phase 2|Protocol Violation|19|||
129880138|NCT01709305|467519505|FG002|Phase 2|Protocol Violation|19|||
129880139|NCT01709305|467519506|FG003|Phase 2|Protocol Violation|13|||
129880140|NCT01709305|467519507|FG004|Phase 2|Protocol Violation|9|||
129880141|NCT01709305|467519503|FG000|Phase 2|Withdrawal by Subject|0|||
129880142|NCT01709305|467519504|FG001|Phase 2|Withdrawal by Subject|8|||
129880143|NCT01709305|467519505|FG002|Phase 2|Withdrawal by Subject|6|||
129880144|NCT01709305|467519506|FG003|Phase 2|Withdrawal by Subject|15|||
129880145|NCT01709305|467519507|FG004|Phase 2|Withdrawal by Subject|12|||
129880146|NCT00171873|467519510|FG000|Overall Study|Withdrawal by Subject|4|||
129880147|NCT00171873|467519511|FG001|Overall Study|Withdrawal by Subject|2|||
129880148|NCT00171873|467519510|FG000|Overall Study|Adverse Event|5|||
129880149|NCT00171873|467519511|FG001|Overall Study|Adverse Event|0|||
129880150|NCT00171873|467519510|FG000|Overall Study|Switched to Octreotide|0|||
129880151|NCT00171873|467519511|FG001|Overall Study|Switched to Octreotide|1|||
129880152|NCT01382940|467521116|FG000|Overall Study|Adverse Event|19|||
129880153|NCT01382940|467521116|FG000|Overall Study|Lost to Follow-up|4|||
129880154|NCT01382940|467521116|FG000|Overall Study|Physician Decision|7|||
129880155|NCT01382940|467521116|FG000|Overall Study|Withdrawal by Subject|23|||
129880156|NCT01382940|467521116|FG000|Overall Study|Protocol Violation|20|||
129880157|NCT00976482|467521119|FG000|Overall Study|Death|208|||
129880158|NCT00976482|467521119|FG000|Overall Study|Withdrawal by Subject|45|||
129880159|NCT00976482|467521119|FG000|Overall Study|Center terminated|1|||
129880160|NCT00976482|467521119|FG000|Overall Study|Protocol Violation|5|||
129880161|NCT00720902|467521122|FG000|Overall Study|Withdrawal by Subject|1|||
129880162|NCT00720902|467521123|FG001|Overall Study|Withdrawal by Subject|0|||
129880163|NCT00720902|467521122|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
129880164|NCT00720902|467521123|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
129880165|NCT01486758|467521124|FG000|Overall Study|Lost to Follow-up|0|||
129880166|NCT01486758|467521125|FG001|Overall Study|Lost to Follow-up|1|||
129880167|NCT02254408|467521135|FG000|Overall Study|Randomized But Not Treated|1|||
129880168|NCT02254408|467521136|FG001|Overall Study|Randomized But Not Treated|3|||
129880169|NCT02254408|467521135|FG000|Overall Study|Adverse Event|1|||
129880170|NCT02254408|467521136|FG001|Overall Study|Adverse Event|0|||
129880171|NCT02254408|467521135|FG000|Overall Study|Death|2|||
129880172|NCT02254408|467521136|FG001|Overall Study|Death|3|||
129880173|NCT02254408|467521135|FG000|Overall Study|Investigator's Discretion|0|||
129880174|NCT02254408|467521136|FG001|Overall Study|Investigator's Discretion|1|||
129880175|NCT02254408|467521135|FG000|Overall Study|Withdrawal by Subject|3|||
129880176|NCT02254408|467521136|FG001|Overall Study|Withdrawal by Subject|3|||
129880177|NCT02254408|467521135|FG000|Overall Study|Lost to Follow-up|1|||
129880178|NCT02254408|467521136|FG001|Overall Study|Lost to Follow-up|0|||
129880179|NCT02914184|467521138|FG000|Overall Study|Lost to Follow-up|7|||
129880180|NCT02914184|467521139|FG001|Overall Study|Lost to Follow-up|10|||
129880181|NCT02914184|467521140|FG002|Overall Study|Lost to Follow-up|8|||
129880182|NCT02914184|467521141|FG003|Overall Study|Lost to Follow-up|7|||
129880183|NCT02914184|467521138|FG000|Overall Study|Withdrawal by Subject|4|||
129880184|NCT02914184|467521139|FG001|Overall Study|Withdrawal by Subject|2|||
129880185|NCT02914184|467521140|FG002|Overall Study|Withdrawal by Subject|7|||
129880186|NCT02914184|467521141|FG003|Overall Study|Withdrawal by Subject|3|||
129880187|NCT02914184|467521138|FG000|Overall Study|Other|1|||
129880188|NCT02914184|467521139|FG001|Overall Study|Other|0|||
129880189|NCT02914184|467521140|FG002|Overall Study|Other|0|||
129880190|NCT02914184|467521141|FG003|Overall Study|Other|0|||
129880191|NCT02914184|467521138|FG000|Overall Study|Migrated/moved from the study area|2|||
129880192|NCT02914184|467521139|FG001|Overall Study|Migrated/moved from the study area|1|||
129880193|NCT02914184|467521140|FG002|Overall Study|Migrated/moved from the study area|2|||
129880194|NCT02914184|467521141|FG003|Overall Study|Migrated/moved from the study area|1|||
129880195|NCT00798174|467521142|FG000|Overall Study|inability to implant azygos coil|3|||
129880196|NCT00798174|467521143|FG001|Overall Study|inability to implant azygos coil|3|||
129880197|NCT00798174|467521142|FG000|Overall Study|Inability to sedate for DFT testing|1|||
129880198|NCT00798174|467521143|FG001|Overall Study|Inability to sedate for DFT testing|0|||
129880199|NCT01478113|467521144|FG000|Overall Study|Withdrawal by Subject|0|||
129880200|NCT01478113|467521145|FG001|Overall Study|Withdrawal by Subject|1|||
129880201|NCT01478113|467521144|FG000|Overall Study|Physician Decision|1|||
129880202|NCT01478113|467521145|FG001|Overall Study|Physician Decision|0|||
129880203|NCT03093428|467521153|FG000|Overall Study|Not eligible for treatment|2|||
129880204|NCT03093428|467521154|FG001|Overall Study|Not eligible for treatment|1|||
129880205|NCT03093428|467521153|FG000|Overall Study|Progression|14|||
129880206|NCT03093428|467521154|FG001|Overall Study|Progression|4|||
129880207|NCT03093428|467521153|FG000|Overall Study|Death|1|||
129880208|NCT03093428|467521154|FG001|Overall Study|Death|0|||
129880209|NCT03093428|467521153|FG000|Overall Study|Adverse Event|1|||
129880210|NCT03093428|467521154|FG001|Overall Study|Adverse Event|0|||
129880211|NCT03093428|467521153|FG000|Overall Study|Withdrawal by Subject|1|||
129880212|NCT03093428|467521154|FG001|Overall Study|Withdrawal by Subject|1|||
129880213|NCT01642602|467521155|FG000|Overall Study|Adverse Event|2|||
129880214|NCT03377790|467521156|FG000|Overall Study|Withdrawal by Subject|1|||
129880215|NCT03377790|467521157|FG001|Overall Study|Withdrawal by Subject|0|||
129880216|NCT03377790|467521156|FG000|Overall Study|Adverse Event|1|||
129880217|NCT03377790|467521157|FG001|Overall Study|Adverse Event|0|||
129880218|NCT03377790|467521156|FG000|Overall Study|Lost to Follow-up|0|||
129880219|NCT03377790|467521157|FG001|Overall Study|Lost to Follow-up|2|||
129880220|NCT03377790|467521156|FG000|Overall Study|Randomized but not treated|1|||
129880221|NCT03377790|467521157|FG001|Overall Study|Randomized but not treated|0|||
129880222|NCT03377790|467521156|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
129880223|NCT03377790|467521157|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
129880224|NCT03101241|467521160|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
129880225|NCT03101241|467521161|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
129880226|NCT03101241|467521160|FG000|Overall Study|Participant withdrew consent|3|||
129880227|NCT03101241|467521161|FG001|Overall Study|Participant withdrew consent|1|||
129880228|NCT03101241|467521160|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
129880229|NCT03101241|467521161|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
129880230|NCT03101241|467521160|FG000|Overall Study|Lost to Follow-up|2|||
129880231|NCT03101241|467521161|FG001|Overall Study|Lost to Follow-up|0|||
129880232|NCT03101241|467521160|FG000|Overall Study|Lack of Efficacy|0|||
129880233|NCT03101241|467521161|FG001|Overall Study|Lack of Efficacy|1|||
129880234|NCT03101241|467521160|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
129880235|NCT03101241|467521161|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
129880236|NCT04498247|467521162|FG000|Overall Study|Lost to Follow-up|0|||
129880237|NCT04498247|467521163|FG001|Overall Study|Lost to Follow-up|0|||
129880238|NCT04498247|467521164|FG002|Overall Study|Lost to Follow-up|0|||
129880239|NCT04498247|467521165|FG003|Overall Study|Lost to Follow-up|1|||
129880240|NCT04498247|467521166|FG004|Overall Study|Lost to Follow-up|0|||
129880241|NCT04498247|467521167|FG005|Overall Study|Lost to Follow-up|0|||
129880242|NCT04498247|467521168|FG006|Overall Study|Lost to Follow-up|0|||
129880243|NCT04498247|467521169|FG007|Overall Study|Lost to Follow-up|0|||
129880244|NCT04498247|467521162|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
129653991|NCT01857102|466689901|FG000|Period 2|Unsatisfactory Lens Fit|1|||
129653992|NCT01857102|466689902|FG001|Period 2|Unsatisfactory Lens Fit|0|||
129653993|NCT01490697|466689903|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
129653994|NCT01490697|466689904|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
129653995|NCT00090584|466689905|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
129653996|NCT00090584|466689906|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
129880245|NCT04498247|467521163|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880246|NCT04498247|467521164|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880247|NCT04498247|467521165|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880248|NCT04498247|467521166|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880249|NCT04498247|467521167|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880250|NCT04498247|467521168|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880251|NCT04498247|467521169|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
129880252|NCT04498247|467521162|FG000|Overall Study|Withdrawal by Subject|0|||
129880253|NCT04498247|467521163|FG001|Overall Study|Withdrawal by Subject|8|||
129880254|NCT04498247|467521164|FG002|Overall Study|Withdrawal by Subject|0|||
129880255|NCT04498247|467521165|FG003|Overall Study|Withdrawal by Subject|7|||
129880256|NCT04498247|467521166|FG004|Overall Study|Withdrawal by Subject|0|||
129880257|NCT04498247|467521167|FG005|Overall Study|Withdrawal by Subject|0|||
129880258|NCT04498247|467521168|FG006|Overall Study|Withdrawal by Subject|1|||
129880259|NCT04498247|467521169|FG007|Overall Study|Withdrawal by Subject|0|||
129880260|NCT04498247|467521162|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880261|NCT04498247|467521163|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
129880262|NCT04498247|467521164|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880263|NCT04498247|467521165|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
129880264|NCT04498247|467521166|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880265|NCT04498247|467521167|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880266|NCT04498247|467521168|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
129880267|NCT04498247|467521169|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
129880268|NCT03469349|467521170|FG000|Overall Study|Withdrawal by Subject|1|||
129880269|NCT03469349|467521171|FG001|Overall Study|Withdrawal by Subject|3|||
129880270|NCT03469349|467521170|FG000|Overall Study|Progressive Disease|0|||
129880271|NCT03469349|467521171|FG001|Overall Study|Progressive Disease|1|||
129880272|NCT03469349|467521170|FG000|Overall Study|Lost to Follow-up|2|||
129880273|NCT03469349|467521171|FG001|Overall Study|Lost to Follow-up|2|||
129880274|NCT03469349|467521170|FG000|Overall Study|Adverse Event|2|||
129880275|NCT03469349|467521171|FG001|Overall Study|Adverse Event|4|||
129880276|NCT01381874|467521173|FG000|Overall Study|Lost to Follow-up|1|||
129880277|NCT01381874|467521174|FG001|Overall Study|Lost to Follow-up|1|||
129880278|NCT01381874|467521175|FG002|Overall Study|Lost to Follow-up|0|||
129880279|NCT01381874|467521173|FG000|Overall Study|Withdrawal by Subject|9|||
129880280|NCT01381874|467521174|FG001|Overall Study|Withdrawal by Subject|10|||
129653997|NCT00090584|466689905|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
129653998|NCT00090584|466689906|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
129653999|NCT02117713|466689915|FG000|Week 48|Adverse Event|4|||
129654000|NCT02117713|466689915|FG000|Week 48|Withdrawal by caregiver|2|||
129654001|NCT02117713|466689915|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
129880281|NCT01381874|467521175|FG002|Overall Study|Withdrawal by Subject|9|||
129880282|NCT01381874|467521173|FG000|Overall Study|Other|67|||
129880283|NCT01381874|467521174|FG001|Overall Study|Other|52|||
129880284|NCT01381874|467521175|FG002|Overall Study|Other|67|||
129880285|NCT01737996|467521176|FG000|Overall Study|Adverse Event|0|||
129880286|NCT01737996|467521177|FG001|Overall Study|Adverse Event|1|||
129880287|NCT01737996|467521178|FG002|Overall Study|Adverse Event|1|||
129880288|NCT01737996|467521176|FG000|Overall Study|Withdrawal by Subject|0|||
129880289|NCT01737996|467521177|FG001|Overall Study|Withdrawal by Subject|0|||
129880290|NCT01737996|467521178|FG002|Overall Study|Withdrawal by Subject|1|||
129880291|NCT00452413|467521179|FG000|Overall Study|Progressive Disease|4|||
129880292|NCT00452413|467521180|FG001|Overall Study|Progressive Disease|11|||
129880293|NCT00452413|467521181|FG002|Overall Study|Progressive Disease|30|||
129880294|NCT00452413|467521179|FG000|Overall Study|Withdrawal by Subject|0|||
129880295|NCT00452413|467521180|FG001|Overall Study|Withdrawal by Subject|1|||
129880296|NCT00452413|467521181|FG002|Overall Study|Withdrawal by Subject|4|||
129880297|NCT00452413|467521179|FG000|Overall Study|Adverse Event|0|||
129880298|NCT00452413|467521180|FG001|Overall Study|Adverse Event|0|||
129880299|NCT00452413|467521181|FG002|Overall Study|Adverse Event|5|||
129880300|NCT00452413|467521179|FG000|Overall Study|Physician Decision|0|||
129880301|NCT00452413|467521180|FG001|Overall Study|Physician Decision|0|||
129880302|NCT00452413|467521181|FG002|Overall Study|Physician Decision|4|||
129880303|NCT00452413|467521179|FG000|Overall Study|Death due to study disease|0|||
129880304|NCT00452413|467521180|FG001|Overall Study|Death due to study disease|0|||
129880305|NCT00452413|467521181|FG002|Overall Study|Death due to study disease|2|||
129880306|NCT00452413|467521179|FG000|Overall Study|Death due to adverse event (AE)|0|||
129880307|NCT00452413|467521180|FG001|Overall Study|Death due to adverse event (AE)|0|||
129880308|NCT00452413|467521181|FG002|Overall Study|Death due to adverse event (AE)|1|||
129880309|NCT00452413|467521179|FG000|Overall Study|On treatment|0|||
129880310|NCT00452413|467521180|FG001|Overall Study|On treatment|0|||
129880311|NCT00452413|467521181|FG002|Overall Study|On treatment|3|||
129880312|NCT01248962|467521182|FG000|Overall Study|Withdrawal by Subject|1|||
129880313|NCT01248962|467521183|FG001|Overall Study|Withdrawal by Subject|1|||
129880314|NCT01248962|467521182|FG000|Overall Study|Adverse Event|2|||
129880315|NCT01248962|467521183|FG001|Overall Study|Adverse Event|1|||
129880316|NCT01248962|467521182|FG000|Overall Study|Complete Response after 4 Cycles|1|||
129880317|NCT01248962|467521183|FG001|Overall Study|Complete Response after 4 Cycles|0|||
129880318|NCT01248962|467521182|FG000|Overall Study|Complete Response after 3 Cycles|0|||
129880319|NCT01248962|467521183|FG001|Overall Study|Complete Response after 3 Cycles|1|||
129880320|NCT01248962|467521182|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
129880321|NCT01248962|467521183|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
129880322|NCT03119610|467521185|FG000|Overall Study|Adverse Event|1|||
129880323|NCT03119610|467521186|FG001|Overall Study|Adverse Event|0|||
129880324|NCT03119610|467521185|FG000|Overall Study|Lost to Follow-up|0|||
129880325|NCT03119610|467521186|FG001|Overall Study|Lost to Follow-up|1|||
129880326|NCT00114634|467521187|FG000|Overall Study|failure to return forms|3|||
129880327|NCT03283696|467521188|FG000|Overall Study|Physician Decision|5|||
129880328|NCT03283696|467521189|FG001|Overall Study|Physician Decision|6|||
129880329|NCT03283696|467521188|FG000|Overall Study|Withdrawal by Subject|2|||
129880330|NCT03283696|467521189|FG001|Overall Study|Withdrawal by Subject|0|||
129880331|NCT00557622|467521193|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
129880332|NCT00557622|467521194|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
129880333|NCT00557622|467521193|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
129880334|NCT00557622|467521194|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
129880335|NCT00557622|467521193|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
129880336|NCT00557622|467521194|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
129880337|NCT01539863|467521195|FG000|Overall Study|Lost to Follow-up|5|||
129880338|NCT01539863|467521196|FG001|Overall Study|Lost to Follow-up|4|||
129880339|NCT02765490|467521199|FG000|Overall Study|Lost to Follow-up|1|||
129880340|NCT02765490|467521200|FG001|Overall Study|Lost to Follow-up|1|||
129880341|NCT02765490|467521199|FG000|Overall Study|Other|0|||
129880342|NCT02765490|467521200|FG001|Overall Study|Other|1|||
129880343|NCT02765490|467521199|FG000|Overall Study|Death|0|||
129880344|NCT02765490|467521200|FG001|Overall Study|Death|1|||
129880345|NCT01468922|467521201|FG000|Overall Study|Screening failure|0|||
129880346|NCT01468922|467521202|FG001|Overall Study|Screening failure|0|||
129880347|NCT01468922|467521203|FG002|Overall Study|Screening failure|0|||
129880348|NCT01468922|467521204|FG003|Overall Study|Screening failure|0|||
129880349|NCT01468922|467521205|FG004|Overall Study|Screening failure|0|||
129880350|NCT01468922|467521206|FG005|Overall Study|Screening failure|0|||
129880351|NCT01468922|467521207|FG006|Overall Study|Screening failure|0|||
129880352|NCT01468922|467521208|FG007|Overall Study|Screening failure|0|||
129880353|NCT01468922|467521209|FG008|Overall Study|Screening failure|1|||
129880354|NCT01468922|467521201|FG000|Overall Study|Per patient choice|1|||
129880355|NCT01468922|467521202|FG001|Overall Study|Per patient choice|0|||
129880356|NCT01468922|467521203|FG002|Overall Study|Per patient choice|0|||
129880357|NCT01468922|467521204|FG003|Overall Study|Per patient choice|0|||
129880358|NCT01468922|467521205|FG004|Overall Study|Per patient choice|0|||
129880359|NCT01468922|467521206|FG005|Overall Study|Per patient choice|0|||
129880360|NCT01468922|467521207|FG006|Overall Study|Per patient choice|0|||
129880361|NCT01468922|467521208|FG007|Overall Study|Per patient choice|0|||
129880362|NCT01468922|467521209|FG008|Overall Study|Per patient choice|0|||
129880363|NCT01468922|467521201|FG000|Overall Study|Switched to alternative treatment|1|||
129880364|NCT01468922|467521202|FG001|Overall Study|Switched to alternative treatment|0|||
129880365|NCT01468922|467521203|FG002|Overall Study|Switched to alternative treatment|0|||
129880366|NCT01468922|467521204|FG003|Overall Study|Switched to alternative treatment|0|||
129880367|NCT01468922|467521205|FG004|Overall Study|Switched to alternative treatment|1|||
129880368|NCT01468922|467521206|FG005|Overall Study|Switched to alternative treatment|0|||
129880369|NCT01468922|467521207|FG006|Overall Study|Switched to alternative treatment|0|||
129880370|NCT01468922|467521208|FG007|Overall Study|Switched to alternative treatment|0|||
129880371|NCT01468922|467521209|FG008|Overall Study|Switched to alternative treatment|0|||
129880372|NCT01468922|467521201|FG000|Overall Study|Enrolled on new protocol|0|||
129880373|NCT01468922|467521202|FG001|Overall Study|Enrolled on new protocol|0|||
129880374|NCT01468922|467521203|FG002|Overall Study|Enrolled on new protocol|0|||
129880375|NCT01468922|467521204|FG003|Overall Study|Enrolled on new protocol|0|||
129880376|NCT01468922|467521205|FG004|Overall Study|Enrolled on new protocol|1|||
129880377|NCT01468922|467521206|FG005|Overall Study|Enrolled on new protocol|0|||
129880378|NCT01468922|467521207|FG006|Overall Study|Enrolled on new protocol|0|||
129880379|NCT01468922|467521208|FG007|Overall Study|Enrolled on new protocol|0|||
129880380|NCT01468922|467521209|FG008|Overall Study|Enrolled on new protocol|0|||
129880381|NCT01468922|467521201|FG000|Overall Study|Adverse Event|0|||
129880382|NCT01468922|467521202|FG001|Overall Study|Adverse Event|0|||
129880383|NCT01468922|467521203|FG002|Overall Study|Adverse Event|0|||
129880384|NCT01468922|467521204|FG003|Overall Study|Adverse Event|0|||
129880385|NCT01468922|467521205|FG004|Overall Study|Adverse Event|0|||
129880386|NCT01468922|467521206|FG005|Overall Study|Adverse Event|0|||
129880387|NCT01468922|467521207|FG006|Overall Study|Adverse Event|0|||
129880388|NCT01468922|467521208|FG007|Overall Study|Adverse Event|1|||
129880389|NCT01468922|467521209|FG008|Overall Study|Adverse Event|0|||
129880390|NCT01468922|467521201|FG000|Overall Study|Infection of blood|0|||
129880391|NCT01468922|467521202|FG001|Overall Study|Infection of blood|0|||
129880392|NCT01468922|467521203|FG002|Overall Study|Infection of blood|0|||
129880393|NCT01468922|467521204|FG003|Overall Study|Infection of blood|0|||
129880394|NCT01468922|467521205|FG004|Overall Study|Infection of blood|0|||
129880395|NCT01468922|467521206|FG005|Overall Study|Infection of blood|0|||
129880396|NCT01468922|467521207|FG006|Overall Study|Infection of blood|0|||
129880397|NCT01468922|467521208|FG007|Overall Study|Infection of blood|1|||
129880398|NCT01468922|467521209|FG008|Overall Study|Infection of blood|0|||
129880399|NCT01468922|467521201|FG000|Overall Study|Patient choice - surgery|0|||
129880400|NCT01468922|467521202|FG001|Overall Study|Patient choice - surgery|0|||
129880401|NCT01468922|467521203|FG002|Overall Study|Patient choice - surgery|0|||
129880402|NCT01468922|467521204|FG003|Overall Study|Patient choice - surgery|0|||
129880403|NCT01468922|467521205|FG004|Overall Study|Patient choice - surgery|0|||
129880404|NCT01468922|467521206|FG005|Overall Study|Patient choice - surgery|0|||
129880405|NCT01468922|467521207|FG006|Overall Study|Patient choice - surgery|0|||
129880406|NCT01468922|467521208|FG007|Overall Study|Patient choice - surgery|1|||
129880407|NCT01468922|467521209|FG008|Overall Study|Patient choice - surgery|0|||
129880408|NCT01468922|467521201|FG000|Overall Study|Refused further treatment|0|||
129880409|NCT01468922|467521202|FG001|Overall Study|Refused further treatment|0|||
129880410|NCT01468922|467521203|FG002|Overall Study|Refused further treatment|0|||
129880411|NCT01468922|467521204|FG003|Overall Study|Refused further treatment|0|||
129880412|NCT01468922|467521205|FG004|Overall Study|Refused further treatment|0|||
129880413|NCT01468922|467521206|FG005|Overall Study|Refused further treatment|0|||
129880414|NCT01468922|467521207|FG006|Overall Study|Refused further treatment|0|||
129880415|NCT01468922|467521208|FG007|Overall Study|Refused further treatment|1|||
129880416|NCT01468922|467521209|FG008|Overall Study|Refused further treatment|0|||
129880417|NCT00007475|467521216|FG000|Overall Study|Withdrawal by Subject|1|||
129880418|NCT00007475|467521217|FG001|Overall Study|Withdrawal by Subject|0|||
129880419|NCT00007475|467521218|FG002|Overall Study|Withdrawal by Subject|0|||
129880420|NCT00007475|467521219|FG003|Overall Study|Withdrawal by Subject|0|||
129880421|NCT00007475|467521216|FG000|Overall Study|Adverse Event|3|||
129880422|NCT00007475|467521217|FG001|Overall Study|Adverse Event|0|||
129880423|NCT00007475|467521218|FG002|Overall Study|Adverse Event|0|||
129880424|NCT00007475|467521219|FG003|Overall Study|Adverse Event|0|||
129880425|NCT01719224|467521220|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
129880426|NCT01719224|467521221|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
129880427|NCT03000673|467521222|FG000|Overall Study|Withdrawal by Subject|1|||
129880428|NCT03000673|467521223|FG001|Overall Study|Withdrawal by Subject|0|||
129880429|NCT03000673|467521224|FG002|Overall Study|Withdrawal by Subject|0|||
129880430|NCT03000673|467521225|FG003|Overall Study|Withdrawal by Subject|0|||
129880431|NCT01121484|467521227|FG000|Overall Study|Adverse Event|12|||
129880432|NCT01121484|467521228|FG001|Overall Study|Adverse Event|5|||
129880433|NCT01121484|467521227|FG000|Overall Study|Lack of Efficacy|3|||
129880434|NCT01121484|467521228|FG001|Overall Study|Lack of Efficacy|11|||
129880435|NCT01121484|467521227|FG000|Overall Study|Lost to Follow-up|5|||
129880436|NCT01121484|467521228|FG001|Overall Study|Lost to Follow-up|9|||
129880437|NCT01121484|467521227|FG000|Overall Study|Physician Decision|0|||
129880438|NCT01121484|467521228|FG001|Overall Study|Physician Decision|3|||
129880439|NCT01121484|467521227|FG000|Overall Study|Protocol Violation|1|||
129880440|NCT01121484|467521228|FG001|Overall Study|Protocol Violation|0|||
129880441|NCT01121484|467521227|FG000|Overall Study|Withdrawal by Subject|8|||
129880442|NCT01121484|467521228|FG001|Overall Study|Withdrawal by Subject|7|||
129880443|NCT01121484|467521227|FG000|Overall Study|Discontinuation of study by sponsor|0|||
129880444|NCT01121484|467521228|FG001|Overall Study|Discontinuation of study by sponsor|1|||
129880445|NCT01121484|467521227|FG000|Overall Study|Other|3|||
129880446|NCT01121484|467521228|FG001|Overall Study|Other|3|||
129880447|NCT01121484|467521227|FG000|Overall Study|Randomized, not treated|1|||
129880448|NCT01121484|467521228|FG001|Overall Study|Randomized, not treated|4|||
129880449|NCT01512745|467521229|FG000|Overall Study|Adverse Event|22|||
129880450|NCT01512745|467521230|FG001|Overall Study|Adverse Event|3|||
129880451|NCT01512745|467521229|FG000|Overall Study|Death|9|||
129880452|NCT01512745|467521230|FG001|Overall Study|Death|13|||
129880453|NCT01512745|467521229|FG000|Overall Study|Withdrawal by Subject|2|||
129880454|NCT01512745|467521230|FG001|Overall Study|Withdrawal by Subject|2|||
129880455|NCT01512745|467521229|FG000|Overall Study|Lost to Follow-up|4|||
129880456|NCT01512745|467521230|FG001|Overall Study|Lost to Follow-up|0|||
129880457|NCT01512745|467521229|FG000|Overall Study|Lack of Efficacy|2|||
129880458|NCT01512745|467521230|FG001|Overall Study|Lack of Efficacy|2|||
129880459|NCT01512745|467521229|FG000|Overall Study|Protocol Violation|1|||
129880460|NCT01512745|467521230|FG001|Overall Study|Protocol Violation|0|||
129880461|NCT02357810|467521231|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
129880462|NCT02357810|467521231|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
129880463|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Adverse Event|5|||
129880464|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
129880465|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
129880466|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
129880467|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Death|1|||
129880468|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Physician Decision|1|||
129880469|NCT02357810|467521231|FG000|Reached 12 Weeks Response|Other|1|||
129880470|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
129880471|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
129880472|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
129880473|NCT02357810|467521231|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
129880474|NCT02357810|467521231|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
129880475|NCT02357810|467521231|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
129880476|NCT00936221|467521232|FG000|Overall Study|Withdrawal by Subject|1|||
129880477|NCT00936221|467521233|FG001|Overall Study|Withdrawal by Subject|1|||
129880478|NCT03820323|467521234|FG000|Overall Study|Lost to Follow-up|2|||
129880479|NCT03820323|467521235|FG001|Overall Study|Lost to Follow-up|1|||
129880480|NCT03820323|467521234|FG000|Overall Study|Missed 12-month visit|22|||
129880481|NCT03820323|467521235|FG001|Overall Study|Missed 12-month visit|14|||
129880482|NCT03820323|467521234|FG000|Overall Study|Death|2|||
129880483|NCT03820323|467521235|FG001|Overall Study|Death|1|||
129880484|NCT03820323|467521234|FG000|Overall Study|Transferred out|13|||
129880485|NCT03820323|467521235|FG001|Overall Study|Transferred out|11|||
129880486|NCT03820323|467521234|FG000|Overall Study|Terminated|0|||
129880487|NCT03820323|467521235|FG001|Overall Study|Terminated|3|||
129880488|NCT03820323|467521234|FG000|Overall Study|Withdrawal by Subject|1|||
129880489|NCT03820323|467521235|FG001|Overall Study|Withdrawal by Subject|6|||
129880490|NCT03151395|467521236|FG000|Overall Study|Adverse Event|2|||
129880491|NCT03151395|467521236|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
129880492|NCT03151395|467521236|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
129880493|NCT03151395|467521236|FG000|Overall Study|Unspecified reason|4|||
129880494|NCT00879996|467521237|FG000|Overall Study|Lost to Follow-up|7|||
129880495|NCT00879996|467521238|FG001|Overall Study|Lost to Follow-up|6|||
129880496|NCT00879996|467521237|FG000|Overall Study|non-compliance|6|||
129880497|NCT00879996|467521238|FG001|Overall Study|non-compliance|4|||
129880498|NCT00879996|467521237|FG000|Overall Study|Physician Decision|1|||
129880499|NCT00879996|467521238|FG001|Overall Study|Physician Decision|2|||
129880500|NCT00879996|467521237|FG000|Overall Study|psychiatric problem|0|||
129880501|NCT00879996|467521238|FG001|Overall Study|psychiatric problem|1|||
129880502|NCT00879996|467521237|FG000|Overall Study|put on parole|1|||
129880503|NCT00879996|467521238|FG001|Overall Study|put on parole|0|||
129880504|NCT02597933|467521243|FG000|Overall Study|Withdrawal by Subject|7|||
129880505|NCT02597933|467521244|FG001|Overall Study|Withdrawal by Subject|5|||
129880506|NCT02597933|467521243|FG000|Overall Study|Protocol Violation|2|||
129880507|NCT02597933|467521244|FG001|Overall Study|Protocol Violation|2|||
129880508|NCT02597933|467521243|FG000|Overall Study|Adverse Event|20|||
129880509|NCT02597933|467521244|FG001|Overall Study|Adverse Event|28|||
129880510|NCT02597933|467521243|FG000|Overall Study|Not treated|2|||
129880511|NCT02597933|467521244|FG001|Overall Study|Not treated|2|||
129880512|NCT02597933|467521243|FG000|Overall Study|Other than stated above|7|||
129880513|NCT02597933|467521244|FG001|Overall Study|Other than stated above|14|||
129880514|NCT02223754|467521247|FG000|Period 1|Adverse Event|1|||
129880515|NCT02223754|467521248|FG001|Period 1|Adverse Event|0|||
129880516|NCT02223754|467521247|FG000|Period 1|Lost to Follow-up|0|||
129880517|NCT02223754|467521248|FG001|Period 1|Lost to Follow-up|1|||
129880518|NCT02223754|467521247|FG000|Period 1|Protocol Violation|2|||
129880519|NCT02223754|467521248|FG001|Period 1|Protocol Violation|4|||
129880520|NCT02223754|467521247|FG000|Period 1|Withdrawal by Subject|0|||
129880521|NCT02223754|467521248|FG001|Period 1|Withdrawal by Subject|4|||
129880522|NCT02223754|467521247|FG000|Period 1|Test Article No Longer Available|1|||
129880523|NCT02223754|467521248|FG001|Period 1|Test Article No Longer Available|5|||
129880524|NCT02223754|467521247|FG000|Period 1|Unsatisfactory Visual Response|0|||
129880525|NCT02223754|467521248|FG001|Period 1|Unsatisfactory Visual Response|1|||
129880526|NCT02223754|467521247|FG000|Period 2|Adverse Event|0|||
129880527|NCT02223754|467521248|FG001|Period 2|Adverse Event|1|||
129880528|NCT02223754|467521247|FG000|Period 2|Protocol Violation|1|||
129880529|NCT02223754|467521248|FG001|Period 2|Protocol Violation|0|||
129880530|NCT02223754|467521247|FG000|Period 2|Lens Discomfort|1|||
129880531|NCT02223754|467521248|FG001|Period 2|Lens Discomfort|1|||
129880532|NCT02223754|467521247|FG000|Period 2|Lost to Follow-up|1|||
129880533|NCT02223754|467521248|FG001|Period 2|Lost to Follow-up|0|||
129880534|NCT02223754|467521247|FG000|Period 2|Test Article No Longer Available|0|||
129880535|NCT02223754|467521248|FG001|Period 2|Test Article No Longer Available|1|||
129880536|NCT04395183|467521249|FG000|Overall Study|Withdrawal by Subject|1|||
129880537|NCT04395183|467521250|FG001|Overall Study|Withdrawal by Subject|0|||
129880538|NCT04395183|467521251|FG002|Overall Study|Withdrawal by Subject|2|||
129880539|NCT04395183|467521252|FG003|Overall Study|Withdrawal by Subject|2|||
129880540|NCT00510458|467521256|FG000|Overall Study|5 year not evaluable/missed|21|||
129880541|NCT00510458|467521256|FG000|Overall Study|Death|1|||
129880542|NCT00510458|467521256|FG000|Overall Study|Terminated|14|||
129880543|NCT00510458|467521256|FG000|Overall Study|Lost to Follow-up|6|||
129880544|NCT00510458|467521256|FG000|Overall Study|Withdrawal by Subject|3|||
129880545|NCT00510458|467521256|FG000|Overall Study|Revision|2|||
129880546|NCT02569710|467521257|FG000|Overall Study|Adverse Event|1|||
129880547|NCT02569710|467521258|FG001|Overall Study|Adverse Event|0|||
129880548|NCT02569710|467521259|FG002|Overall Study|Adverse Event|0|||
129880549|NCT02569710|467521260|FG003|Overall Study|Adverse Event|0|||
129880550|NCT02569710|467521261|FG004|Overall Study|Adverse Event|0|||
129880551|NCT02569710|467521262|FG005|Overall Study|Adverse Event|0|||
129880552|NCT02569710|467521263|FG006|Overall Study|Adverse Event|0|||
129880553|NCT02569710|467521264|FG007|Overall Study|Adverse Event|0|||
129880554|NCT02569710|467521265|FG008|Overall Study|Adverse Event|0|||
129880555|NCT02569710|467521266|FG009|Overall Study|Adverse Event|0|||
129880556|NCT02569710|467521257|FG000|Overall Study|Lost to Follow-up|0|||
129880557|NCT02569710|467521258|FG001|Overall Study|Lost to Follow-up|0|||
129880558|NCT02569710|467521259|FG002|Overall Study|Lost to Follow-up|0|||
129880559|NCT02569710|467521260|FG003|Overall Study|Lost to Follow-up|0|||
129880560|NCT02569710|467521261|FG004|Overall Study|Lost to Follow-up|0|||
129880561|NCT02569710|467521262|FG005|Overall Study|Lost to Follow-up|0|||
129880562|NCT02569710|467521263|FG006|Overall Study|Lost to Follow-up|1|||
129880563|NCT02569710|467521264|FG007|Overall Study|Lost to Follow-up|0|||
129880564|NCT02569710|467521265|FG008|Overall Study|Lost to Follow-up|1|||
129880565|NCT02569710|467521266|FG009|Overall Study|Lost to Follow-up|0|||
129880566|NCT02569710|467521257|FG000|Overall Study|Virologic failure|0|||
129880567|NCT02569710|467521258|FG001|Overall Study|Virologic failure|0|||
129880568|NCT02569710|467521259|FG002|Overall Study|Virologic failure|0|||
129880569|NCT02569710|467521260|FG003|Overall Study|Virologic failure|0|||
129880570|NCT02569710|467521261|FG004|Overall Study|Virologic failure|1|||
129880571|NCT02569710|467521262|FG005|Overall Study|Virologic failure|0|||
129880572|NCT02569710|467521263|FG006|Overall Study|Virologic failure|1|||
129880573|NCT02569710|467521264|FG007|Overall Study|Virologic failure|0|||
129880574|NCT02569710|467521265|FG008|Overall Study|Virologic failure|0|||
129654002|NCT02117713|466689915|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
129880575|NCT02569710|467521266|FG009|Overall Study|Virologic failure|0|||
129654003|NCT02117713|466689915|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
129880576|NCT02569710|467521257|FG000|Overall Study|Withdrawal by Subject|0|||
129880577|NCT02569710|467521258|FG001|Overall Study|Withdrawal by Subject|0|||
129880578|NCT02569710|467521259|FG002|Overall Study|Withdrawal by Subject|0|||
129880579|NCT02569710|467521260|FG003|Overall Study|Withdrawal by Subject|0|||
129880580|NCT02569710|467521261|FG004|Overall Study|Withdrawal by Subject|0|||
129880581|NCT02569710|467521262|FG005|Overall Study|Withdrawal by Subject|1|||
129880582|NCT02569710|467521263|FG006|Overall Study|Withdrawal by Subject|0|||
129880583|NCT02569710|467521264|FG007|Overall Study|Withdrawal by Subject|0|||
129880584|NCT02569710|467521265|FG008|Overall Study|Withdrawal by Subject|0|||
129880585|NCT02569710|467521266|FG009|Overall Study|Withdrawal by Subject|0|||
129880586|NCT00539279|467521267|FG000|Treatment|Withdrawal by Subject|10|||
129880587|NCT00539279|467521268|FG001|Treatment|Withdrawal by Subject|8|||
129880588|NCT00539279|467521267|FG000|Treatment|Death|1|||
129880589|NCT00539279|467521268|FG001|Treatment|Death|0|||
129880590|NCT00539279|467521267|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
129880591|NCT00539279|467521268|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
129880592|NCT00539279|467521267|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
129880593|NCT00539279|467521268|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
129880594|NCT01338012|467521269|FG000|Overall Study|Death|4|||
129880595|NCT01338012|467521269|FG000|Overall Study|Study terminated|4|||
129880596|NCT02714205|467521270|FG000|Overall Study|Cannot tolerate medication|1|||
129880597|NCT02714205|467521271|FG001|Overall Study|Cannot tolerate medication|0|||
129880598|NCT02714205|467521270|FG000|Overall Study|Adverse Event|2|||
129880599|NCT02714205|467521271|FG001|Overall Study|Adverse Event|0|||
129880600|NCT02714205|467521270|FG000|Overall Study|Too busy|1|||
129880601|NCT02714205|467521271|FG001|Overall Study|Too busy|0|||
129880602|NCT02714205|467521270|FG000|Overall Study|Incomplete outcome data|0|||
129880603|NCT02714205|467521271|FG001|Overall Study|Incomplete outcome data|1|||
129880604|NCT01693692|467521272|FG000|Overall Study|Withdrawal by Subject|12|||
129880605|NCT01693692|467521273|FG001|Overall Study|Withdrawal by Subject|10|||
129880606|NCT01693692|467521274|FG002|Overall Study|Withdrawal by Subject|11|||
129880607|NCT01693692|467521272|FG000|Overall Study|Adverse Event|7|||
129880608|NCT01693692|467521273|FG001|Overall Study|Adverse Event|14|||
129880609|NCT01693692|467521274|FG002|Overall Study|Adverse Event|9|||
129880610|NCT01693692|467521272|FG000|Overall Study|Physician Decision|0|||
129880611|NCT01693692|467521273|FG001|Overall Study|Physician Decision|0|||
129880612|NCT01693692|467521274|FG002|Overall Study|Physician Decision|1|||
129880613|NCT01693692|467521272|FG000|Overall Study|Protocol Violation|5|||
129880614|NCT01693692|467521273|FG001|Overall Study|Protocol Violation|4|||
129880615|NCT01693692|467521274|FG002|Overall Study|Protocol Violation|6|||
129880616|NCT01693692|467521272|FG000|Overall Study|Lost to Follow-up|2|||
129880617|NCT01693692|467521273|FG001|Overall Study|Lost to Follow-up|2|||
129880618|NCT01693692|467521274|FG002|Overall Study|Lost to Follow-up|3|||
129880619|NCT01693692|467521272|FG000|Overall Study|Other|4|||
129880620|NCT01693692|467521273|FG001|Overall Study|Other|4|||
129880621|NCT01693692|467521274|FG002|Overall Study|Other|6|||
129880622|NCT04567693|467523154|FG000|Overall Study|Death|0|||
129880623|NCT04567693|467523155|FG001|Overall Study|Death|0|||
129880624|NCT04567693|467523156|FG002|Overall Study|Death|2|||
129880625|NCT04567693|467523154|FG000|Overall Study|Lost to Follow-up|1|||
129880626|NCT04567693|467523155|FG001|Overall Study|Lost to Follow-up|0|||
129880627|NCT04567693|467523156|FG002|Overall Study|Lost to Follow-up|2|||
129880628|NCT04567693|467523154|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
129880629|NCT04567693|467523155|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
129880630|NCT04567693|467523156|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
129880631|NCT04105972|467523163|FG000|Overall Study|Adverse Event|2|||
129880632|NCT04105972|467523164|FG001|Overall Study|Adverse Event|1|||
129880633|NCT00553202|467523165|FG000|Overall Study|Death|16|||
129880634|NCT00553202|467523165|FG000|Overall Study|Lost to Follow-up|1|||
129880635|NCT00553202|467523165|FG000|Overall Study|Physician Decision|28|||
129880636|NCT00553202|467523165|FG000|Overall Study|Withdrawal by Subject|1|||
129880637|NCT00553202|467523165|FG000|Overall Study|No donor identified|16|||
129880638|NCT00553202|467523165|FG000|Overall Study|Fails to meet organ function|6|||
129880639|NCT02593305|467523166|FG000|Post 1|Comparison only group. No intervention.|0|||
129880640|NCT02593305|467523167|FG001|Post 1|Comparison only group. No intervention.|0|||
129880641|NCT02593305|467523168|FG002|Post 1|Comparison only group. No intervention.|10|||
129880642|NCT01161472|467523169|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
129880643|NCT01161472|467523170|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129880644|NCT01161472|467523171|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129880645|NCT01161472|467523172|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
129880646|NCT00768430|467523195|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
129880647|NCT00768430|467523196|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
129880648|NCT00041756|467523198|FG000|Overall Study|Adverse Event|4|||
129880649|NCT00041756|467523199|FG001|Overall Study|Adverse Event|10|||
129880650|NCT00041756|467523200|FG002|Overall Study|Adverse Event|6|||
129880651|NCT00041756|467523201|FG003|Overall Study|Adverse Event|11|||
129880652|NCT00041756|467523202|FG004|Overall Study|Adverse Event|34|||
129880653|NCT00041756|467523198|FG000|Overall Study|Protocol Violation|1|||
129880654|NCT00041756|467523199|FG001|Overall Study|Protocol Violation|1|||
129880655|NCT00041756|467523200|FG002|Overall Study|Protocol Violation|2|||
129880656|NCT00041756|467523201|FG003|Overall Study|Protocol Violation|2|||
129880657|NCT00041756|467523202|FG004|Overall Study|Protocol Violation|1|||
129880658|NCT00041756|467523198|FG000|Overall Study|Withdrawal by Subject|3|||
129880659|NCT00041756|467523199|FG001|Overall Study|Withdrawal by Subject|3|||
129880660|NCT00041756|467523200|FG002|Overall Study|Withdrawal by Subject|4|||
129880661|NCT00041756|467523201|FG003|Overall Study|Withdrawal by Subject|2|||
129880662|NCT00041756|467523202|FG004|Overall Study|Withdrawal by Subject|3|||
129880663|NCT00041756|467523198|FG000|Overall Study|Lost to Follow-up|0|||
129880664|NCT00041756|467523199|FG001|Overall Study|Lost to Follow-up|1|||
129654004|NCT02117713|466689915|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
129654005|NCT02028169|466689917|FG000|Overall Study|Lost to Follow-up|21|||
129654006|NCT02028169|466689917|FG000|Overall Study|Lack of Efficacy|2|||
129654007|NCT02028169|466689917|FG000|Overall Study|Withdrawal by Subject|2|||
129654008|NCT02028169|466689917|FG000|Overall Study|Adverse Event|1|||
129654009|NCT02028169|466689917|FG000|Overall Study|Cessation of Drug|1|||
129654010|NCT02028169|466689917|FG000|Overall Study|Concomitant Medication Usage|1|||
129654011|NCT04907227|466689918|FG000|Overall Study|Death|12|||
129654012|NCT04907227|466689919|FG001|Overall Study|Death|8|||
129654013|NCT04907227|466689918|FG000|Overall Study|Withdrawal by Subject|2|||
129880665|NCT00041756|467523200|FG002|Overall Study|Lost to Follow-up|0|||
129654014|NCT04907227|466689919|FG001|Overall Study|Withdrawal by Subject|2|||
129654015|NCT04907227|466689918|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
129654016|NCT04907227|466689919|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129654017|NCT04907227|466689918|FG000|Overall Study|Sponsor Decision|25|||
129654018|NCT04907227|466689919|FG001|Overall Study|Sponsor Decision|30|||
129654019|NCT04907227|466689918|FG000|Overall Study|Physician Decision|1|||
129654020|NCT04907227|466689919|FG001|Overall Study|Physician Decision|0|||
129654021|NCT02208050|466689920|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
129654022|NCT02208050|466689921|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
129654023|NCT00432276|466689923|FG000|Overall Study|Hyperglycemic Rescue|44|||
129654024|NCT00432276|466689924|FG001|Overall Study|Hyperglycemic Rescue|87|||
129654025|NCT00432276|466689923|FG000|Overall Study|Adverse Event|13|||
129654026|NCT00432276|466689924|FG001|Overall Study|Adverse Event|16|||
129654027|NCT00432276|466689923|FG000|Overall Study|Protocol Violation|25|||
129654028|NCT00432276|466689924|FG001|Overall Study|Protocol Violation|20|||
129654029|NCT00432276|466689923|FG000|Overall Study|Lost to Follow-up|6|||
129654030|NCT00432276|466689924|FG001|Overall Study|Lost to Follow-up|2|||
129654031|NCT00432276|466689923|FG000|Overall Study|Withdrawal by Subject|25|||
129654032|NCT00432276|466689924|FG001|Overall Study|Withdrawal by Subject|20|||
129654033|NCT00432276|466689923|FG000|Overall Study|Physician Decision|6|||
129654034|NCT00432276|466689924|FG001|Overall Study|Physician Decision|8|||
129654035|NCT00432276|466689923|FG000|Overall Study|Other|2|||
129654036|NCT00432276|466689924|FG001|Overall Study|Other|3|||
129654037|NCT00467961|466689925|FG000|Overall Study|Technical Failures|5|||
129654038|NCT00467961|466689925|FG000|Overall Study|Disease Progression|2|||
129654039|NCT05249127|466689926|FG000|Overall Study|Protocol Violation|13|||
129654040|NCT05249127|466689926|FG000|Overall Study|Physician Decision|4|||
129654041|NCT05249127|466689926|FG000|Overall Study|Withdrawal by Subject|2|||
129654042|NCT05249127|466689926|FG000|Overall Study|Participant Non-compliance|1|||
129654043|NCT02073565|466689928|FG000|Cohort A|Withdrawal by Subject|1|||
129654044|NCT02073565|466689929|FG001|Cohort A|Withdrawal by Subject|0|||
129654045|NCT02073565|466689928|FG000|Cohort B|Withdrawal by Subject|1|||
129654046|NCT02073565|466689929|FG001|Cohort B|Withdrawal by Subject|2|||
129654047|NCT02073565|466689928|FG000|Cohort C|Withdrawal by Subject|0|||
129654048|NCT02073565|466689929|FG001|Cohort C|Withdrawal by Subject|2|||
129654049|NCT02073565|466689928|FG000|Cohort C|Lost to Follow-up|0|||
129654050|NCT02073565|466689929|FG001|Cohort C|Lost to Follow-up|2|||
129654051|NCT03168919|466689932|FG000|Overall Study|Withdrawal by Subject|2|||
129654052|NCT01085136|466689933|FG000|Part A|Other Adverse event|223|||
129654053|NCT01085136|466689934|FG001|Part A|Other Adverse event|0|||
129654054|NCT01085136|466689935|FG002|Part A|Other Adverse event|0|||
129654055|NCT01085136|466689933|FG000|Part A|Protocol Violation|3|||
129654056|NCT01085136|466689934|FG001|Part A|Protocol Violation|0|||
129654057|NCT01085136|466689935|FG002|Part A|Protocol Violation|0|||
129654058|NCT01085136|466689933|FG000|Part A|Lost to Follow-up|3|||
129880666|NCT00041756|467523201|FG003|Overall Study|Lost to Follow-up|1|||
129880667|NCT00041756|467523202|FG004|Overall Study|Lost to Follow-up|0|||
129880668|NCT00041756|467523198|FG000|Overall Study|Unable to meet protocol criteria|0|||
129880669|NCT00041756|467523199|FG001|Overall Study|Unable to meet protocol criteria|0|||
129880670|NCT00041756|467523200|FG002|Overall Study|Unable to meet protocol criteria|1|||
129880671|NCT00041756|467523201|FG003|Overall Study|Unable to meet protocol criteria|0|||
129880672|NCT00041756|467523202|FG004|Overall Study|Unable to meet protocol criteria|1|||
129880673|NCT00041756|467523198|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
129880674|NCT00041756|467523199|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
129880675|NCT00041756|467523200|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
129880676|NCT00041756|467523201|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
129654059|NCT01085136|466689934|FG001|Part A|Lost to Follow-up|0|||
129654060|NCT01085136|466689935|FG002|Part A|Lost to Follow-up|0|||
129880677|NCT00041756|467523202|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
129654061|NCT01085136|466689933|FG000|Part A|Refusal to continue trial medication|64|||
129654062|NCT01085136|466689934|FG001|Part A|Refusal to continue trial medication|0|||
129654063|NCT01085136|466689935|FG002|Part A|Refusal to continue trial medication|0|||
129654064|NCT01085136|466689933|FG000|Part A|Other reason not defined above|30|||
129654065|NCT01085136|466689934|FG001|Part A|Other reason not defined above|0|||
129654066|NCT01085136|466689935|FG002|Part A|Other reason not defined above|0|||
129654067|NCT01085136|466689933|FG000|Part B|Other AE|0|||
129880678|NCT03980184|467523203|FG000|Overall Study|Dropped out before treatment|2|||
129880679|NCT03980184|467523204|FG001|Overall Study|Dropped out before treatment|2|||
129880680|NCT03980184|467523203|FG000|Overall Study|Lost to Follow-up|11|||
129880681|NCT03980184|467523204|FG001|Overall Study|Lost to Follow-up|13|||
129880682|NCT00603265|467523205|FG000|Overall Study|Adverse Event|2|||
129880683|NCT00603265|467523206|FG001|Overall Study|Adverse Event|11|||
129880684|NCT00603265|467523207|FG002|Overall Study|Adverse Event|1|||
129880685|NCT00603265|467523205|FG000|Overall Study|Withdrawal by Subject|1|||
129880686|NCT00603265|467523206|FG001|Overall Study|Withdrawal by Subject|2|||
129880687|NCT00603265|467523207|FG002|Overall Study|Withdrawal by Subject|1|||
129880688|NCT00603265|467523205|FG000|Overall Study|Lack of Efficacy|3|||
129880689|NCT00603265|467523206|FG001|Overall Study|Lack of Efficacy|0|||
129880690|NCT00603265|467523207|FG002|Overall Study|Lack of Efficacy|3|||
129880691|NCT00603265|467523205|FG000|Overall Study|Lost to Follow-up|0|||
129880692|NCT00603265|467523206|FG001|Overall Study|Lost to Follow-up|1|||
129880693|NCT00603265|467523207|FG002|Overall Study|Lost to Follow-up|0|||
129880694|NCT00603265|467523205|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
129880695|NCT00603265|467523206|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
129880696|NCT00603265|467523207|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
129880697|NCT00603265|467523205|FG000|Overall Study|Participant Left Country, No Responses|0|||
129880698|NCT00603265|467523206|FG001|Overall Study|Participant Left Country, No Responses|1|||
129880699|NCT00603265|467523207|FG002|Overall Study|Participant Left Country, No Responses|0|||
129880700|NCT00603265|467523205|FG000|Overall Study|Protocol Violation|1|||
129880701|NCT00603265|467523206|FG001|Overall Study|Protocol Violation|0|||
129880702|NCT00603265|467523207|FG002|Overall Study|Protocol Violation|0|||
129880703|NCT02002884|467523209|FG000|Main Period (MP)|Other|0|||
129880704|NCT02002884|467523210|FG001|Main Period (MP)|Other|3|||
129880705|NCT02002884|467523211|FG002|Main Period (MP)|Other|3|||
129880706|NCT02002884|467523212|FG003|Main Period (MP)|Other|0|||
129880707|NCT02002884|467523209|FG000|Main Period (MP)|Adverse Event|0|||
129880708|NCT02002884|467523210|FG001|Main Period (MP)|Adverse Event|1|||
129880709|NCT02002884|467523211|FG002|Main Period (MP)|Adverse Event|1|||
129880710|NCT02002884|467523212|FG003|Main Period (MP)|Adverse Event|0|||
129880711|NCT02002884|467523209|FG000|Main Period (MP)|Withdrawal by Subject|6|||
129880712|NCT02002884|467523210|FG001|Main Period (MP)|Withdrawal by Subject|2|||
129880713|NCT02002884|467523211|FG002|Main Period (MP)|Withdrawal by Subject|2|||
129880714|NCT02002884|467523212|FG003|Main Period (MP)|Withdrawal by Subject|0|||
129880715|NCT02002884|467523209|FG000|Main Period (MP)|Lost to Follow-up|0|||
129880716|NCT02002884|467523210|FG001|Main Period (MP)|Lost to Follow-up|0|||
129880717|NCT02002884|467523211|FG002|Main Period (MP)|Lost to Follow-up|2|||
129880718|NCT02002884|467523212|FG003|Main Period (MP)|Lost to Follow-up|0|||
129880719|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Other|0|||
129880720|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Other|0|||
129880721|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Other|0|||
129880722|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Other|24|||
129880723|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
129880724|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
129880725|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
129880726|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
129880727|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
129880728|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
129880729|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
129880730|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
129880731|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
129880732|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
129880733|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
129880734|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
129880735|NCT02002884|467523209|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
129880736|NCT02002884|467523210|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
129880737|NCT02002884|467523211|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
129880738|NCT02002884|467523212|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
129880739|NCT02966002|467523213|FG000|Overall Study|Withdrawal by Subject|2|||
129880740|NCT02966002|467523213|FG000|Overall Study|Adverse Event|1|||
129880741|NCT02966002|467523213|FG000|Overall Study|Lost to Follow-up|1|||
129880742|NCT01112514|467523214|FG000|Overall Study|Lost to Follow-up|1|||
129880743|NCT01118455|467523215|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
129880744|NCT01118455|467523216|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
129880745|NCT02632786|467523227|FG000|Overall Study|Adverse Event|2|||
129880746|NCT02632786|467523228|FG001|Overall Study|Adverse Event|1|||
129880747|NCT02632786|467523227|FG000|Overall Study|Death|3|||
129880748|NCT02632786|467523228|FG001|Overall Study|Death|2|||
129880749|NCT02632786|467523227|FG000|Overall Study|Physician Decision|5|||
129880750|NCT02632786|467523228|FG001|Overall Study|Physician Decision|4|||
129880751|NCT02632786|467523227|FG000|Overall Study|Withdrawal by Subject|1|||
129654068|NCT01085136|466689934|FG001|Part B|Other AE|29|||
129880752|NCT02632786|467523228|FG001|Overall Study|Withdrawal by Subject|0|||
129880753|NCT01928225|467523229|FG000|Overall Study|Pregnancy|1|||
129880754|NCT01928225|467523230|FG001|Overall Study|Pregnancy|0|||
129880755|NCT01928225|467523229|FG000|Overall Study|basaloid cervical cancer|1|||
129880756|NCT01928225|467523230|FG001|Overall Study|basaloid cervical cancer|0|||
129880757|NCT01928225|467523229|FG000|Overall Study|Lost to Follow-up|1|||
129880758|NCT01928225|467523230|FG001|Overall Study|Lost to Follow-up|3|||
129880759|NCT01454830|467523234|FG000|Overall Study|Withdrawal by Subject|4|||
129654069|NCT01085136|466689935|FG002|Part B|Other AE|8|||
129654070|NCT01085136|466689933|FG000|Part B|Refusal to continue trial medication|0|||
129654071|NCT01085136|466689934|FG001|Part B|Refusal to continue trial medication|12|||
129654072|NCT01085136|466689935|FG002|Part B|Refusal to continue trial medication|7|||
129654073|NCT01085136|466689933|FG000|Part B|Not treated|0|||
129654074|NCT01085136|466689934|FG001|Part B|Not treated|4|||
129654075|NCT01085136|466689935|FG002|Part B|Not treated|8|||
129654076|NCT01085136|466689933|FG000|Part B|Other reason not defined above|0|||
129654077|NCT01085136|466689934|FG001|Part B|Other reason not defined above|6|||
129654078|NCT01085136|466689935|FG002|Part B|Other reason not defined above|3|||
129654079|NCT02678000|466689937|FG000|PART 2|Adverse Event|0|||
129654080|NCT02678000|466689938|FG001|PART 2|Adverse Event|0|||
129654081|NCT02678000|466689939|FG002|PART 2|Adverse Event|2|||
129654082|NCT02678000|466689940|FG003|PART 2|Adverse Event|1|||
129654083|NCT02678000|466689941|FG004|PART 2|Adverse Event|0|||
129654084|NCT02678000|466689937|FG000|PART 2|Withdrawal by Subject|0|||
129654085|NCT02678000|466689938|FG001|PART 2|Withdrawal by Subject|0|||
129654086|NCT02678000|466689939|FG002|PART 2|Withdrawal by Subject|1|||
129654087|NCT02678000|466689940|FG003|PART 2|Withdrawal by Subject|0|||
129654088|NCT02678000|466689941|FG004|PART 2|Withdrawal by Subject|0|||
129654089|NCT02360475|466689943|FG000|Overall Study|Lost to Follow-up|4|||
129654090|NCT02360475|466689944|FG001|Overall Study|Lost to Follow-up|12|||
129654091|NCT02360475|466689945|FG002|Overall Study|Lost to Follow-up|6|||
129654092|NCT02360475|466689946|FG003|Overall Study|Lost to Follow-up|4|||
129654093|NCT02360475|466689943|FG000|Overall Study|Withdrawal by Subject|0|||
129654094|NCT02360475|466689944|FG001|Overall Study|Withdrawal by Subject|1|||
129654095|NCT02360475|466689945|FG002|Overall Study|Withdrawal by Subject|2|||
129654096|NCT02360475|466689946|FG003|Overall Study|Withdrawal by Subject|0|||
129654097|NCT02360475|466689943|FG000|Overall Study|Migrated/moved from study area|0|||
129654098|NCT02360475|466689944|FG001|Overall Study|Migrated/moved from study area|0|||
129654099|NCT02360475|466689945|FG002|Overall Study|Migrated/moved from study area|0|||
129654100|NCT02360475|466689946|FG003|Overall Study|Migrated/moved from study area|1|||
129654101|NCT03759366|466689948|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
129654102|NCT03759366|466689948|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
129654103|NCT03759366|466689948|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
129654104|NCT03759366|466689948|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
129654105|NCT03759366|466689948|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
129654106|NCT03759366|466689948|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
129654107|NCT03759366|466689948|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
129654108|NCT04226495|466689949|FG000|Overall Study|Withdrawal by Subject|3|||
129654109|NCT04226495|466689950|FG001|Overall Study|Withdrawal by Subject|3|||
129654110|NCT04226495|466689949|FG000|Overall Study|PI discretion|3|||
129654111|NCT04226495|466689950|FG001|Overall Study|PI discretion|4|||
129654112|NCT00539032|466689951|FG000|Overall Study|Withdrawal by Subject|2|||
129654113|NCT00539032|466689952|FG001|Overall Study|Withdrawal by Subject|1|||
129654114|NCT01210352|466689953|FG000|Overall Study|Adverse Event|0|||
129654115|NCT01210352|466689954|FG001|Overall Study|Adverse Event|0|||
129880760|NCT01454830|467523235|FG001|Overall Study|Withdrawal by Subject|4|||
129880761|NCT01454830|467523234|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
129880762|NCT01454830|467523235|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
129880763|NCT01454830|467523234|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
129880764|NCT01454830|467523235|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
129880765|NCT01454830|467523234|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
129880766|NCT01454830|467523235|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
129880767|NCT01454830|467523234|FG000|Overall Study|Withdrawal - no polysomnography|3|||
129880768|NCT01454830|467523235|FG001|Overall Study|Withdrawal - no polysomnography|2|||
129880769|NCT00152763|467523236|FG000|Overall Study|Death|4|||
129880770|NCT00152763|467523237|FG001|Overall Study|Death|1|||
129880771|NCT00152763|467523238|FG002|Overall Study|Death|2|||
129880772|NCT00152763|467523239|FG003|Overall Study|Death|1|||
129654116|NCT01210352|466689955|FG002|Overall Study|Adverse Event|0|||
129654117|NCT01210352|466689956|FG003|Overall Study|Adverse Event|0|||
129654118|NCT01210352|466689957|FG004|Overall Study|Adverse Event|0|||
129654119|NCT01210352|466689958|FG005|Overall Study|Adverse Event|0|||
129880773|NCT00152763|467523236|FG000|Overall Study|Lost to Follow-up|6|||
129654120|NCT01210352|466689959|FG006|Overall Study|Adverse Event|0|||
129880774|NCT00152763|467523237|FG001|Overall Study|Lost to Follow-up|4|||
129880775|NCT00152763|467523238|FG002|Overall Study|Lost to Follow-up|2|||
129880776|NCT00152763|467523239|FG003|Overall Study|Lost to Follow-up|13|||
129880777|NCT00569803|467523242|FG000|Overall Study|Lost to Follow-up|1|||
129880778|NCT00569803|467523243|FG001|Overall Study|Lost to Follow-up|0|||
129880779|NCT00569803|467523244|FG002|Overall Study|Lost to Follow-up|0|||
129880780|NCT00569803|467523245|FG003|Overall Study|Lost to Follow-up|0|||
129880781|NCT00569803|467523246|FG004|Overall Study|Lost to Follow-up|0|||
129880782|NCT00569803|467523247|FG005|Overall Study|Lost to Follow-up|0|||
129880783|NCT00569803|467523248|FG006|Overall Study|Lost to Follow-up|0|||
129880784|NCT00569803|467523249|FG007|Overall Study|Lost to Follow-up|0|||
129880785|NCT00569803|467523242|FG000|Overall Study|injection syringe leaked during dosing|0|||
129880786|NCT00569803|467523243|FG001|Overall Study|injection syringe leaked during dosing|0|||
129880787|NCT00569803|467523244|FG002|Overall Study|injection syringe leaked during dosing|0|||
129880788|NCT00569803|467523245|FG003|Overall Study|injection syringe leaked during dosing|1|||
129880789|NCT00569803|467523246|FG004|Overall Study|injection syringe leaked during dosing|0|||
129880790|NCT00569803|467523247|FG005|Overall Study|injection syringe leaked during dosing|0|||
129880791|NCT00569803|467523248|FG006|Overall Study|injection syringe leaked during dosing|0|||
129880792|NCT00569803|467523249|FG007|Overall Study|injection syringe leaked during dosing|0|||
129880793|NCT00569803|467523242|FG000|Overall Study|Withdrawal by Subject|0|||
129880794|NCT00569803|467523243|FG001|Overall Study|Withdrawal by Subject|0|||
129880795|NCT00569803|467523244|FG002|Overall Study|Withdrawal by Subject|0|||
129880796|NCT00569803|467523245|FG003|Overall Study|Withdrawal by Subject|0|||
129880797|NCT00569803|467523246|FG004|Overall Study|Withdrawal by Subject|0|||
129880798|NCT00569803|467523247|FG005|Overall Study|Withdrawal by Subject|0|||
129880799|NCT00569803|467523248|FG006|Overall Study|Withdrawal by Subject|0|||
129880800|NCT00569803|467523249|FG007|Overall Study|Withdrawal by Subject|1|||
129880801|NCT01993823|467523250|FG000|Overall Study|Requested by the patient|6|||
129880802|NCT01993823|467523251|FG001|Overall Study|Requested by the patient|11|||
129880803|NCT01993823|467523250|FG000|Overall Study|Protocol Violation|0|||
129880804|NCT01993823|467523251|FG001|Overall Study|Protocol Violation|1|||
129880805|NCT01993823|467523250|FG000|Overall Study|Lost to Follow-up|1|||
129880806|NCT01993823|467523251|FG001|Overall Study|Lost to Follow-up|4|||
129880807|NCT01235975|467523254|FG000|Overall Study|Serious Adverse Event|0|||
129880808|NCT01235975|467523255|FG001|Overall Study|Serious Adverse Event|1|||
129880809|NCT01235975|467523254|FG000|Overall Study|Withdrawal by Subject|8|||
129880810|NCT01235975|467523255|FG001|Overall Study|Withdrawal by Subject|2|||
129880811|NCT01235975|467523254|FG000|Overall Study|Migrated/moved from study area|2|||
129880812|NCT01235975|467523255|FG001|Overall Study|Migrated/moved from study area|1|||
129880813|NCT01235975|467523254|FG000|Overall Study|Lost to Follow-up|7|||
129880814|NCT01235975|467523255|FG001|Overall Study|Lost to Follow-up|3|||
129880815|NCT00791921|467523256|FG000|Overall Study|Protocol planed|24|||
129880816|NCT00791921|467523257|FG001|Overall Study|Protocol planed|88|||
129880817|NCT00791921|467523256|FG000|Overall Study|Withdrawal by Subject|1|||
129880818|NCT00791921|467523257|FG001|Overall Study|Withdrawal by Subject|2|||
129880819|NCT00791921|467523256|FG000|Overall Study|Adverse Event|8|||
129880820|NCT00791921|467523257|FG001|Overall Study|Adverse Event|2|||
129880821|NCT00791921|467523256|FG000|Overall Study|Lack of Efficacy|0|||
129880822|NCT00791921|467523257|FG001|Overall Study|Lack of Efficacy|2|||
129880823|NCT00791921|467523256|FG000|Overall Study|Lack of study drug administration|1|||
129880824|NCT00791921|467523257|FG001|Overall Study|Lack of study drug administration|1|||
129880825|NCT00791921|467523256|FG000|Overall Study|Reason other than those above|0|||
129880826|NCT00791921|467523257|FG001|Overall Study|Reason other than those above|1|||
129880827|NCT00474175|467523259|FG000|Overall Study|Lack of Efficacy|0|||
129880828|NCT00474175|467523260|FG001|Overall Study|Lack of Efficacy|0|||
129880829|NCT00474175|467523261|FG002|Overall Study|Lack of Efficacy|1|||
129880830|NCT00474175|467523259|FG000|Overall Study|Withdrawal by Subject|0|||
129880831|NCT00474175|467523260|FG001|Overall Study|Withdrawal by Subject|1|||
129880832|NCT00474175|467523261|FG002|Overall Study|Withdrawal by Subject|1|||
129880833|NCT00474175|467523259|FG000|Overall Study|Ineligible|1|||
129880834|NCT00474175|467523260|FG001|Overall Study|Ineligible|3|||
129880835|NCT00474175|467523261|FG002|Overall Study|Ineligible|1|||
129880836|NCT00474175|467523259|FG000|Overall Study|Protocol Violation|0|||
129880837|NCT00474175|467523260|FG001|Overall Study|Protocol Violation|2|||
129880838|NCT00474175|467523261|FG002|Overall Study|Protocol Violation|1|||
129880839|NCT00474175|467523259|FG000|Overall Study|Administrative|0|||
129880840|NCT00474175|467523260|FG001|Overall Study|Administrative|1|||
129880841|NCT00474175|467523261|FG002|Overall Study|Administrative|0|||
129880842|NCT01460160|467523265|FG000|Treatment Phase|Lack of Efficacy|3|||
129880843|NCT01460160|467523265|FG000|Treatment Phase|Study Drug Toxicity|2|||
129880844|NCT01460160|467523265|FG000|Treatment Phase|Adverse Event|8|||
129880845|NCT01460160|467523265|FG000|Treatment Phase|Withdrawal by Subject|4|||
129880846|NCT01460160|467523265|FG000|Treatment Phase|Death|2|||
129880847|NCT01460160|467523265|FG000|Treatment Phase|Other reasons|9|||
129654121|NCT01210352|466689960|FG007|Overall Study|Adverse Event|2|||
129880848|NCT01460160|467523265|FG000|Follow-up Phase|Withdrawal by Subject|4|||
129880849|NCT01460160|467523265|FG000|Follow-up Phase|Death|14|||
129880850|NCT01460160|467523265|FG000|Follow-up Phase|Lost to Follow-up|7|||
129880851|NCT01460160|467523265|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
129880852|NCT01460160|467523265|FG000|Follow-up Phase|Other and not reported reasons|5|||
129880853|NCT02091739|467523267|FG000|MP: 16 Weeks|Adverse Event|1|||
129880854|NCT02091739|467523268|FG001|MP: 16 Weeks|Adverse Event|1|||
129880855|NCT02091739|467523269|FG002|MP: 16 Weeks|Adverse Event|1|||
129880856|NCT02091739|467523270|FG003|MP: 16 Weeks|Adverse Event|0|||
129880857|NCT02091739|467523271|FG004|MP: 16 Weeks|Adverse Event|0|||
129880858|NCT02091739|467523267|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
129880859|NCT02091739|467523268|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
129880860|NCT02091739|467523269|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
129880861|NCT02091739|467523270|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
129880862|NCT02091739|467523271|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
129880863|NCT02091739|467523267|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
129880864|NCT02091739|467523268|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
129880865|NCT02091739|467523269|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
129880866|NCT02091739|467523270|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
129880867|NCT02091739|467523271|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
129880868|NCT02091739|467523267|FG000|EP: 48 Weeks|Other|0|||
129880869|NCT02091739|467523268|FG001|EP: 48 Weeks|Other|0|||
129880870|NCT02091739|467523269|FG002|EP: 48 Weeks|Other|0|||
129880871|NCT02091739|467523270|FG003|EP: 48 Weeks|Other|1|||
129880872|NCT02091739|467523271|FG004|EP: 48 Weeks|Other|0|||
129880873|NCT02091739|467523267|FG000|EP: 48 Weeks|Death|0|||
129880874|NCT02091739|467523268|FG001|EP: 48 Weeks|Death|0|||
129880875|NCT02091739|467523269|FG002|EP: 48 Weeks|Death|0|||
129880876|NCT02091739|467523270|FG003|EP: 48 Weeks|Death|3|||
129880877|NCT02091739|467523271|FG004|EP: 48 Weeks|Death|2|||
129880878|NCT02091739|467523267|FG000|EP: 48 Weeks|Adverse Event|0|||
129880879|NCT02091739|467523268|FG001|EP: 48 Weeks|Adverse Event|0|||
129880880|NCT02091739|467523269|FG002|EP: 48 Weeks|Adverse Event|0|||
129880881|NCT02091739|467523270|FG003|EP: 48 Weeks|Adverse Event|2|||
129880882|NCT02091739|467523271|FG004|EP: 48 Weeks|Adverse Event|6|||
129880883|NCT02091739|467523267|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
129880884|NCT02091739|467523268|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
129880885|NCT02091739|467523269|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
129880886|NCT02091739|467523270|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
129880887|NCT02091739|467523271|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
129880888|NCT00192023|467523272|FG000|Period III - Double-Blind|Adverse Event|3|||
129880889|NCT00192023|467523273|FG001|Period III - Double-Blind|Adverse Event|0|||
129880890|NCT00192023|467523272|FG000|Period III - Double-Blind|Physician Decision|2|||
129880891|NCT00192023|467523273|FG001|Period III - Double-Blind|Physician Decision|0|||
129880892|NCT00192023|467523272|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
129880893|NCT00192023|467523273|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
129880894|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
129880895|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
129880896|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
129880897|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
129880898|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
129880899|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
129880900|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
129880901|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
129880902|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
129880903|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
129880904|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
129880905|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
129880906|NCT00192023|467523272|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
129880907|NCT00192023|467523273|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
129880908|NCT02086162|467523280|FG000|Overall Study|Withdrawal by Subject|4|||
129880909|NCT02086162|467523281|FG001|Overall Study|Withdrawal by Subject|4|||
129880910|NCT02086162|467523280|FG000|Overall Study|moved|1|||
129880911|NCT02086162|467523281|FG001|Overall Study|moved|1|||
129880912|NCT02086162|467523280|FG000|Overall Study|Lost to Follow-up|4|||
129880913|NCT02086162|467523281|FG001|Overall Study|Lost to Follow-up|2|||
129880914|NCT02086162|467523280|FG000|Overall Study|Death|1|||
129880915|NCT02086162|467523281|FG001|Overall Study|Death|0|||
129880916|NCT01027364|467523282|FG000|Overall Study|Adverse Event|1|||
129880917|NCT01027364|467523283|FG001|Overall Study|Adverse Event|0|||
129880918|NCT01027364|467523284|FG002|Overall Study|Adverse Event|1|||
129880919|NCT01027364|467523285|FG003|Overall Study|Adverse Event|0|||
129880920|NCT01027364|467523282|FG000|Overall Study|Lost to Follow-up|1|||
129880921|NCT01027364|467523283|FG001|Overall Study|Lost to Follow-up|0|||
129880922|NCT01027364|467523284|FG002|Overall Study|Lost to Follow-up|0|||
129880923|NCT01027364|467523285|FG003|Overall Study|Lost to Follow-up|0|||
129880924|NCT01027364|467523282|FG000|Overall Study|Protocol Violation|1|||
129880925|NCT01027364|467523283|FG001|Overall Study|Protocol Violation|0|||
129880926|NCT01027364|467523284|FG002|Overall Study|Protocol Violation|0|||
129880927|NCT01027364|467523285|FG003|Overall Study|Protocol Violation|1|||
129880928|NCT01027364|467523282|FG000|Overall Study|Withdrawal by Subject|1|||
129880929|NCT01027364|467523283|FG001|Overall Study|Withdrawal by Subject|2|||
129880930|NCT01027364|467523284|FG002|Overall Study|Withdrawal by Subject|0|||
129880931|NCT01027364|467523285|FG003|Overall Study|Withdrawal by Subject|0|||
129880932|NCT03662997|467523286|FG000|Overall Study|Adverse Event|0|||
129880933|NCT03662997|467523287|FG001|Overall Study|Adverse Event|2|||
129880934|NCT03662997|467523288|FG002|Overall Study|Adverse Event|0|||
129880935|NCT03662997|467523289|FG003|Overall Study|Adverse Event|0|||
129880936|NCT00675506|467523293|FG000|Overall Study|Lost to Follow-up|1|||
129880937|NCT00675506|467523294|FG001|Overall Study|Lost to Follow-up|5|||
129880938|NCT00675506|467523293|FG000|Overall Study|Lost interest|3|||
129880939|NCT00675506|467523294|FG001|Overall Study|Lost interest|5|||
129880940|NCT00675506|467523293|FG000|Overall Study|Elevated fasting glucose|2|||
129880941|NCT00675506|467523294|FG001|Overall Study|Elevated fasting glucose|1|||
129880942|NCT00675506|467523293|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
129880943|NCT00675506|467523294|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
129880944|NCT00675506|467523293|FG000|Overall Study|Elevated IGF-1|2|||
129880945|NCT00675506|467523294|FG001|Overall Study|Elevated IGF-1|0|||
129880946|NCT00675506|467523293|FG000|Overall Study|Hypersensitivity Reaction|1|||
129880947|NCT00675506|467523294|FG001|Overall Study|Hypersensitivity Reaction|0|||
129880948|NCT00675506|467523293|FG000|Overall Study|Disclosed history of cancer|1|||
129880949|NCT00675506|467523294|FG001|Overall Study|Disclosed history of cancer|0|||
129880950|NCT00675506|467523293|FG000|Overall Study|Declined participation|1|||
129880951|NCT00675506|467523294|FG001|Overall Study|Declined participation|0|||
129880952|NCT00675506|467523293|FG000|Overall Study|Schedule conflict|0|||
129880953|NCT00675506|467523294|FG001|Overall Study|Schedule conflict|1|||
129880954|NCT02912468|467523296|FG000|Overall Study|Adverse Event|3|||
129880955|NCT02912468|467523297|FG001|Overall Study|Adverse Event|2|||
129880956|NCT02912468|467523296|FG000|Overall Study|Withdrawal by Subject|6|||
129880957|NCT02912468|467523297|FG001|Overall Study|Withdrawal by Subject|2|||
129880958|NCT02912468|467523296|FG000|Overall Study|Randomized and not treated|0|||
129880959|NCT02912468|467523297|FG001|Overall Study|Randomized and not treated|1|||
129880960|NCT01320735|467523298|FG000|Overall Study|Adverse Event|3|||
129880961|NCT01320735|467523298|FG000|Overall Study|Withdrawal by Subject|3|||
129880962|NCT01320735|467523298|FG000|Overall Study|Lost to Follow-up|13|||
129880963|NCT01320735|467523298|FG000|Overall Study|Administrative Reason|6|||
129880964|NCT01320735|467523298|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
129880965|NCT01320735|467523298|FG000|Overall Study|Protocol Violation|1|||
129880966|NCT01320735|467523298|FG000|Overall Study|Other|1|||
129880967|NCT01320735|467523298|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
129880968|NCT01320735|467523298|FG000|Overall Study|Investigator Unable to be Contacted|17|||
129880969|NCT01913639|467523301|FG000|Overall Study|Not Eligible|3|||
129880970|NCT01225822|467523311|FG000|Overall Study|Adverse Event|13|||
129880971|NCT01225822|467523312|FG001|Overall Study|Adverse Event|31|||
129880972|NCT01225822|467523313|FG002|Overall Study|Adverse Event|18|||
129880973|NCT01225822|467523314|FG003|Overall Study|Adverse Event|23|||
129880974|NCT01225822|467523315|FG004|Overall Study|Adverse Event|14|||
129880975|NCT01225822|467523311|FG000|Overall Study|Protocol Violation|6|||
129880976|NCT01225822|467523312|FG001|Overall Study|Protocol Violation|8|||
129880977|NCT01225822|467523313|FG002|Overall Study|Protocol Violation|6|||
129880978|NCT01225822|467523314|FG003|Overall Study|Protocol Violation|7|||
129880979|NCT01225822|467523315|FG004|Overall Study|Protocol Violation|4|||
129880980|NCT01225822|467523311|FG000|Overall Study|Lost to Follow-up|0|||
129880981|NCT01225822|467523312|FG001|Overall Study|Lost to Follow-up|0|||
129880982|NCT01225822|467523313|FG002|Overall Study|Lost to Follow-up|0|||
129880983|NCT01225822|467523314|FG003|Overall Study|Lost to Follow-up|1|||
129880984|NCT01225822|467523315|FG004|Overall Study|Lost to Follow-up|0|||
129880985|NCT01225822|467523311|FG000|Overall Study|Withdrawal by Subject|6|||
129880986|NCT01225822|467523312|FG001|Overall Study|Withdrawal by Subject|7|||
129880987|NCT01225822|467523313|FG002|Overall Study|Withdrawal by Subject|7|||
129880988|NCT01225822|467523314|FG003|Overall Study|Withdrawal by Subject|11|||
129880989|NCT01225822|467523315|FG004|Overall Study|Withdrawal by Subject|6|||
129880990|NCT01225822|467523311|FG000|Overall Study|Other|13|||
129880991|NCT01225822|467523312|FG001|Overall Study|Other|10|||
129880992|NCT01225822|467523313|FG002|Overall Study|Other|7|||
129880993|NCT01225822|467523314|FG003|Overall Study|Other|10|||
129880994|NCT01225822|467523315|FG004|Overall Study|Other|7|||
129880995|NCT01290822|467523316|FG000|Overall Study|Withdrawal by Subject|1|||
129880996|NCT01290822|467523316|FG000|Overall Study|Physician Decision|10|||
129880997|NCT05644353|467523320|FG000|Overall Study|Physician Decision|1|||
129880998|NCT05644353|467523321|FG001|Overall Study|Physician Decision|0|||
129880999|NCT05644353|467523322|FG002|Overall Study|Physician Decision|0|||
129881000|NCT05644353|467523323|FG003|Overall Study|Physician Decision|0|||
129881001|NCT05644353|467523324|FG004|Overall Study|Physician Decision|0|||
129881002|NCT05644353|467523325|FG005|Overall Study|Physician Decision|0|||
129881003|NCT05644353|467523320|FG000|Overall Study|Protocol Violation|1|||
129881004|NCT05644353|467523321|FG001|Overall Study|Protocol Violation|0|||
129881005|NCT05644353|467523322|FG002|Overall Study|Protocol Violation|0|||
129881006|NCT05644353|467523323|FG003|Overall Study|Protocol Violation|0|||
129881007|NCT05644353|467523324|FG004|Overall Study|Protocol Violation|0|||
129881008|NCT05644353|467523325|FG005|Overall Study|Protocol Violation|0|||
129881009|NCT05644353|467523320|FG000|Overall Study|Withdrawal by Subject|0|||
129654122|NCT01210352|466689961|FG008|Overall Study|Adverse Event|1|||
129654123|NCT01210352|466689953|FG000|Overall Study|Lack of Efficacy|0|||
129654124|NCT01210352|466689954|FG001|Overall Study|Lack of Efficacy|0|||
129654125|NCT01210352|466689955|FG002|Overall Study|Lack of Efficacy|0|||
129654126|NCT01210352|466689956|FG003|Overall Study|Lack of Efficacy|0|||
129654127|NCT01210352|466689957|FG004|Overall Study|Lack of Efficacy|0|||
129654128|NCT01210352|466689958|FG005|Overall Study|Lack of Efficacy|0|||
129654129|NCT01210352|466689959|FG006|Overall Study|Lack of Efficacy|1|||
129654130|NCT01210352|466689960|FG007|Overall Study|Lack of Efficacy|0|||
129654131|NCT01210352|466689961|FG008|Overall Study|Lack of Efficacy|0|||
129654132|NCT01210352|466689953|FG000|Overall Study|Physician Decision|0|||
129654133|NCT01210352|466689954|FG001|Overall Study|Physician Decision|0|||
129654134|NCT01210352|466689955|FG002|Overall Study|Physician Decision|0|||
129654135|NCT01210352|466689956|FG003|Overall Study|Physician Decision|0|||
129654136|NCT01210352|466689957|FG004|Overall Study|Physician Decision|0|||
129654137|NCT01210352|466689958|FG005|Overall Study|Physician Decision|0|||
129654138|NCT01210352|466689959|FG006|Overall Study|Physician Decision|0|||
129654139|NCT01210352|466689960|FG007|Overall Study|Physician Decision|1|||
129654140|NCT01210352|466689961|FG008|Overall Study|Physician Decision|2|||
129654141|NCT01210352|466689953|FG000|Overall Study|Withdrawal by Subject|0|||
129654142|NCT01210352|466689954|FG001|Overall Study|Withdrawal by Subject|0|||
129654143|NCT01210352|466689955|FG002|Overall Study|Withdrawal by Subject|1|||
129654144|NCT01210352|466689956|FG003|Overall Study|Withdrawal by Subject|0|||
129654145|NCT01210352|466689957|FG004|Overall Study|Withdrawal by Subject|0|||
129654146|NCT01210352|466689958|FG005|Overall Study|Withdrawal by Subject|0|||
129654147|NCT01210352|466689959|FG006|Overall Study|Withdrawal by Subject|1|||
129654148|NCT01210352|466689960|FG007|Overall Study|Withdrawal by Subject|0|||
129654149|NCT01210352|466689961|FG008|Overall Study|Withdrawal by Subject|1|||
129654150|NCT01210352|466689953|FG000|Overall Study|Patient Discharged Early|0|||
129654151|NCT01210352|466689954|FG001|Overall Study|Patient Discharged Early|0|||
129654152|NCT01210352|466689955|FG002|Overall Study|Patient Discharged Early|1|||
129654153|NCT01210352|466689956|FG003|Overall Study|Patient Discharged Early|0|||
129654154|NCT01210352|466689957|FG004|Overall Study|Patient Discharged Early|0|||
129654155|NCT01210352|466689958|FG005|Overall Study|Patient Discharged Early|0|||
129654156|NCT01210352|466689959|FG006|Overall Study|Patient Discharged Early|0|||
129654157|NCT01210352|466689960|FG007|Overall Study|Patient Discharged Early|0|||
129654158|NCT01210352|466689961|FG008|Overall Study|Patient Discharged Early|0|||
129654159|NCT00422292|466689962|FG000|Overall Study|Serious adverse events|1|||
129654160|NCT00422292|466689963|FG001|Overall Study|Serious adverse events|4|||
129654161|NCT00422292|466689964|FG002|Overall Study|Serious adverse events|0|||
129654162|NCT00422292|466689965|FG003|Overall Study|Serious adverse events|0|||
129881010|NCT05644353|467523321|FG001|Overall Study|Withdrawal by Subject|2|||
129545061|NCT03159611|466288403|FG001|Overall Study|Withdrawal by Subject|1|||
129545062|NCT03159611|466288402|FG000|Overall Study|Non-compliance with protocol requirement|3|||
129545063|NCT03159611|466288403|FG001|Overall Study|Non-compliance with protocol requirement|2|||
129545064|NCT03159611|466288402|FG000|Overall Study|Inability to perform procedures|1|||
129545065|NCT03159611|466288403|FG001|Overall Study|Inability to perform procedures|0|||
129545066|NCT00518011|466288406|FG000|Overall Study|Death|1|||
129545067|NCT00518011|466288407|FG001|Overall Study|Death|1|||
129545068|NCT00518011|466288406|FG000|Overall Study|Adverse Event|2|||
129545069|NCT00518011|466288407|FG001|Overall Study|Adverse Event|3|||
129545070|NCT00518011|466288406|FG000|Overall Study|Disease Progression|2|||
129545071|NCT00518011|466288407|FG001|Overall Study|Disease Progression|2|||
129545072|NCT00518011|466288406|FG000|Overall Study|Other Reasons|3|||
129545073|NCT00518011|466288407|FG001|Overall Study|Other Reasons|2|||
129545074|NCT00518011|466288406|FG000|Overall Study|Withdrawal by Subject|1|||
129545075|NCT00518011|466288407|FG001|Overall Study|Withdrawal by Subject|0|||
129545076|NCT03409328|466288408|FG000|Overall Study|Lost to Follow-up|6|||
129545077|NCT03409328|466288409|FG001|Overall Study|Lost to Follow-up|3|||
129545078|NCT03930615|466288412|FG000|Overall Study|Death|9|||
129545079|NCT03930615|466288413|FG001|Overall Study|Death|3|||
129881011|NCT05644353|467523322|FG002|Overall Study|Withdrawal by Subject|0|||
129545080|NCT03930615|466288412|FG000|Overall Study|Lost to Follow-up|1|||
129545081|NCT03930615|466288413|FG001|Overall Study|Lost to Follow-up|2|||
129545082|NCT03930615|466288412|FG000|Overall Study|Physician Decision|3|||
129545083|NCT03930615|466288413|FG001|Overall Study|Physician Decision|4|||
129545084|NCT03930615|466288412|FG000|Overall Study|Withdrawal by Subject|13|||
129654163|NCT00422292|466689962|FG000|Overall Study|Adverse Event|1|||
129654164|NCT00422292|466689963|FG001|Overall Study|Adverse Event|0|||
129654165|NCT00422292|466689964|FG002|Overall Study|Adverse Event|1|||
129654166|NCT00422292|466689965|FG003|Overall Study|Adverse Event|0|||
129654167|NCT00422292|466689962|FG000|Overall Study|Protocol Violation|4|||
129654168|NCT00422292|466689963|FG001|Overall Study|Protocol Violation|25|||
129654169|NCT00422292|466689964|FG002|Overall Study|Protocol Violation|8|||
129654170|NCT00422292|466689965|FG003|Overall Study|Protocol Violation|5|||
129654171|NCT00422292|466689962|FG000|Overall Study|Lost to Follow-up|6|||
129654172|NCT00422292|466689963|FG001|Overall Study|Lost to Follow-up|12|||
129654173|NCT00422292|466689964|FG002|Overall Study|Lost to Follow-up|6|||
129654174|NCT00422292|466689965|FG003|Overall Study|Lost to Follow-up|6|||
129654175|NCT00422292|466689962|FG000|Overall Study|Withdrawal by Subject|6|||
129654176|NCT00422292|466689963|FG001|Overall Study|Withdrawal by Subject|25|||
129654177|NCT00422292|466689964|FG002|Overall Study|Withdrawal by Subject|7|||
129654178|NCT00422292|466689965|FG003|Overall Study|Withdrawal by Subject|13|||
129654179|NCT02440854|466689966|FG000|Overall Study|Relocation of patient|1|||
129654180|NCT02440854|466689966|FG000|Overall Study|Death|6|||
129654181|NCT02440854|466689966|FG000|Overall Study|Lost to Follow-up|10|||
129654182|NCT02440854|466689966|FG000|Overall Study|Afatinib discontinuation|46|||
129654183|NCT02440854|466689966|FG000|Overall Study|stopped study at earlier timepoint|14|||
129654184|NCT02440854|466689966|FG000|Overall Study|Study medication not received|1|||
129654185|NCT02440854|466689966|FG000|Overall Study|Violation of inclusion criteria|2|||
129654186|NCT02243046|466689967|FG000|Overall Study|Lost to Follow-up|1|||
129654187|NCT02243046|466689968|FG001|Overall Study|Lost to Follow-up|1|||
129654188|NCT02243046|466689969|FG002|Overall Study|Lost to Follow-up|4|||
129654189|NCT03338569|466689970|FG000|Overall Study|Physician Decision|8|||
129654190|NCT03338569|466689971|FG001|Overall Study|Physician Decision|3|||
129654191|NCT03338569|466689970|FG000|Overall Study|Withdrawal by Subject|0|||
129654192|NCT03338569|466689971|FG001|Overall Study|Withdrawal by Subject|1|||
129654193|NCT03338569|466689970|FG000|Overall Study|Lost to Follow-up|0|||
129654194|NCT03338569|466689971|FG001|Overall Study|Lost to Follow-up|1|||
129654195|NCT02669082|466689972|FG000|Overall Study|Adverse Event|1|||
129654196|NCT04852276|466689973|FG000|Overall Study|Death|2|||
129654197|NCT04852276|466689974|FG001|Overall Study|Death|0|||
129654198|NCT04852276|466689973|FG000|Overall Study|Lost to Follow-up|15|||
129654199|NCT04852276|466689974|FG001|Overall Study|Lost to Follow-up|9|||
129654200|NCT04852276|466689973|FG000|Overall Study|Withdrawal by Subject|26|||
129654201|NCT04852276|466689974|FG001|Overall Study|Withdrawal by Subject|6|||
129654202|NCT02824562|466691936|FG000|Overall Study|Lost to Follow-up|3|||
129654203|NCT02824562|466691937|FG001|Overall Study|Lost to Follow-up|4|||
129654204|NCT02824562|466691936|FG000|Overall Study|Death|0|||
129654205|NCT02824562|466691937|FG001|Overall Study|Death|1|||
129654206|NCT02168777|466691938|FG000|Overall Study|Withdrawal by Subject|1|||
129654207|NCT02168777|466691939|FG001|Overall Study|Withdrawal by Subject|0|||
129654208|NCT02168777|466691940|FG002|Overall Study|Withdrawal by Subject|2|||
129654209|NCT02168777|466691938|FG000|Overall Study|Adverse Event|1|||
129654210|NCT02168777|466691939|FG001|Overall Study|Adverse Event|0|||
129654211|NCT02168777|466691940|FG002|Overall Study|Adverse Event|1|||
129654212|NCT02168777|466691938|FG000|Overall Study|Disease recurrence|0|||
129654213|NCT02168777|466691939|FG001|Overall Study|Disease recurrence|0|||
129654214|NCT02168777|466691940|FG002|Overall Study|Disease recurrence|1|||
129654215|NCT02168777|466691938|FG000|Overall Study|Radiological disease progression|0|||
129654216|NCT02168777|466691939|FG001|Overall Study|Radiological disease progression|5|||
129654217|NCT02168777|466691940|FG002|Overall Study|Radiological disease progression|5|||
129654218|NCT02168777|466691938|FG000|Overall Study|Clinical disease progression|0|||
129654219|NCT02168777|466691939|FG001|Overall Study|Clinical disease progression|1|||
129654220|NCT02168777|466691940|FG002|Overall Study|Clinical disease progression|2|||
129654221|NCT02168777|466691938|FG000|Overall Study|Other reason|0|||
129654222|NCT02168777|466691939|FG001|Overall Study|Other reason|1|||
129654223|NCT02168777|466691940|FG002|Overall Study|Other reason|0|||
129654224|NCT05243563|466691941|FG000|Overall Study|Withdrawal by Subject|1|||
129654225|NCT05243563|466691942|FG001|Overall Study|Withdrawal by Subject|0|||
129654226|NCT05243563|466691941|FG000|Overall Study|Physician Decision|1|||
129654227|NCT05243563|466691942|FG001|Overall Study|Physician Decision|0|||
129654228|NCT02474355|466691946|FG000|Overall Study|Other|43|||
129654229|NCT02474355|466691946|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
129654230|NCT02474355|466691946|FG000|Overall Study|Lost to Follow-up|98|||
129654231|NCT02474355|466691946|FG000|Overall Study|Withdrawal by Subject|124|||
129654232|NCT02474355|466691946|FG000|Overall Study|Death|1361|||
129654233|NCT01066793|466691947|FG000|Overall Study|Death|4|||
129654234|NCT01066793|466691948|FG001|Overall Study|Death|1|||
129654235|NCT01066793|466691949|FG002|Overall Study|Death|1|||
129654236|NCT01066793|466691950|FG003|Overall Study|Death|0|||
129654237|NCT01066793|466691951|FG004|Overall Study|Death|0|||
129654238|NCT01066793|466691952|FG005|Overall Study|Death|0|||
129654239|NCT01066793|466691947|FG000|Overall Study|Lack of Efficacy|2|||
129654240|NCT01066793|466691948|FG001|Overall Study|Lack of Efficacy|1|||
129654241|NCT01066793|466691949|FG002|Overall Study|Lack of Efficacy|0|||
129654242|NCT01066793|466691950|FG003|Overall Study|Lack of Efficacy|0|||
129654243|NCT01066793|466691951|FG004|Overall Study|Lack of Efficacy|0|||
129654244|NCT01066793|466691952|FG005|Overall Study|Lack of Efficacy|0|||
129654245|NCT01066793|466691947|FG000|Overall Study|Lost to Follow-up|180|||
129654246|NCT01066793|466691948|FG001|Overall Study|Lost to Follow-up|39|||
129654247|NCT01066793|466691949|FG002|Overall Study|Lost to Follow-up|82|||
129654248|NCT01066793|466691950|FG003|Overall Study|Lost to Follow-up|16|||
129654249|NCT01066793|466691951|FG004|Overall Study|Lost to Follow-up|0|||
129654250|NCT01066793|466691952|FG005|Overall Study|Lost to Follow-up|1|||
129654251|NCT01066793|466691947|FG000|Overall Study|Physician Decision|3|||
129654252|NCT01066793|466691948|FG001|Overall Study|Physician Decision|0|||
129654253|NCT01066793|466691949|FG002|Overall Study|Physician Decision|0|||
129654254|NCT01066793|466691950|FG003|Overall Study|Physician Decision|0|||
129654255|NCT01066793|466691951|FG004|Overall Study|Physician Decision|0|||
129654256|NCT01066793|466691952|FG005|Overall Study|Physician Decision|0|||
129654257|NCT01066793|466691947|FG000|Overall Study|Protocol Violation|3|||
129654258|NCT01066793|466691948|FG001|Overall Study|Protocol Violation|2|||
129654259|NCT01066793|466691949|FG002|Overall Study|Protocol Violation|2|||
129654260|NCT01066793|466691950|FG003|Overall Study|Protocol Violation|0|||
129654261|NCT01066793|466691951|FG004|Overall Study|Protocol Violation|0|||
129654262|NCT01066793|466691952|FG005|Overall Study|Protocol Violation|0|||
129654263|NCT01066793|466691947|FG000|Overall Study|Withdrawal by Subject|7|||
129654264|NCT01066793|466691948|FG001|Overall Study|Withdrawal by Subject|4|||
129654265|NCT01066793|466691949|FG002|Overall Study|Withdrawal by Subject|1|||
129654266|NCT01066793|466691950|FG003|Overall Study|Withdrawal by Subject|0|||
129654267|NCT01066793|466691951|FG004|Overall Study|Withdrawal by Subject|0|||
129654268|NCT01066793|466691952|FG005|Overall Study|Withdrawal by Subject|0|||
129654269|NCT01066793|466691947|FG000|Overall Study|Early Termination|3|||
129654270|NCT01066793|466691948|FG001|Overall Study|Early Termination|0|||
129654271|NCT01066793|466691949|FG002|Overall Study|Early Termination|0|||
129654272|NCT01066793|466691950|FG003|Overall Study|Early Termination|0|||
129654273|NCT01066793|466691951|FG004|Overall Study|Early Termination|0|||
129654274|NCT01066793|466691952|FG005|Overall Study|Early Termination|0|||
129654275|NCT01066793|466691947|FG000|Overall Study|Lab test not done|7|||
129654276|NCT01066793|466691948|FG001|Overall Study|Lab test not done|0|||
129654277|NCT01066793|466691949|FG002|Overall Study|Lab test not done|0|||
129654278|NCT01066793|466691950|FG003|Overall Study|Lab test not done|1|||
129654279|NCT01066793|466691951|FG004|Overall Study|Lab test not done|0|||
129654280|NCT01066793|466691952|FG005|Overall Study|Lab test not done|0|||
129654281|NCT01066793|466691947|FG000|Overall Study|Miscellaneous|4|||
129654282|NCT01066793|466691948|FG001|Overall Study|Miscellaneous|5|||
129654283|NCT01066793|466691949|FG002|Overall Study|Miscellaneous|6|||
129654284|NCT01066793|466691950|FG003|Overall Study|Miscellaneous|0|||
129654285|NCT01066793|466691951|FG004|Overall Study|Miscellaneous|0|||
129654286|NCT01066793|466691952|FG005|Overall Study|Miscellaneous|0|||
129654287|NCT01066793|466691947|FG000|Overall Study|Non-responders|104|||
129654288|NCT01066793|466691948|FG001|Overall Study|Non-responders|5|||
129654289|NCT01066793|466691949|FG002|Overall Study|Non-responders|11|||
129654290|NCT01066793|466691950|FG003|Overall Study|Non-responders|25|||
129654291|NCT01066793|466691951|FG004|Overall Study|Non-responders|0|||
129654292|NCT01066793|466691952|FG005|Overall Study|Non-responders|0|||
129654293|NCT01066793|466691947|FG000|Overall Study|Other|15|||
129654294|NCT01066793|466691948|FG001|Overall Study|Other|5|||
129654295|NCT01066793|466691949|FG002|Overall Study|Other|6|||
129654296|NCT01066793|466691950|FG003|Overall Study|Other|2|||
129654297|NCT01066793|466691951|FG004|Overall Study|Other|0|||
129654298|NCT01066793|466691952|FG005|Overall Study|Other|0|||
129654299|NCT01066793|466691947|FG000|Overall Study|Relapse|20|||
129881012|NCT05644353|467523323|FG003|Overall Study|Withdrawal by Subject|0|||
129881013|NCT05644353|467523324|FG004|Overall Study|Withdrawal by Subject|1|||
129881014|NCT05644353|467523325|FG005|Overall Study|Withdrawal by Subject|0|||
129881015|NCT05644353|467523320|FG000|Overall Study|Lost to Follow-up|0|||
129881016|NCT05644353|467523321|FG001|Overall Study|Lost to Follow-up|0|||
129881017|NCT05644353|467523322|FG002|Overall Study|Lost to Follow-up|1|||
129881018|NCT05644353|467523323|FG003|Overall Study|Lost to Follow-up|0|||
129881019|NCT05644353|467523324|FG004|Overall Study|Lost to Follow-up|0|||
129881020|NCT05644353|467523325|FG005|Overall Study|Lost to Follow-up|0|||
129881021|NCT03679767|467523326|FG000|Overall Study|Death|16|||
129881022|NCT03679767|467523327|FG001|Overall Study|Death|11|||
129881023|NCT03679767|467523328|FG002|Overall Study|Death|17|||
129881024|NCT03679767|467523329|FG003|Overall Study|Death|10|||
129881025|NCT03679767|467523326|FG000|Overall Study|Lost to Follow-up|1|||
129881026|NCT03679767|467523327|FG001|Overall Study|Lost to Follow-up|1|||
129881027|NCT03679767|467523328|FG002|Overall Study|Lost to Follow-up|1|||
129881028|NCT03679767|467523329|FG003|Overall Study|Lost to Follow-up|1|||
129881029|NCT03679767|467523326|FG000|Overall Study|Withdrawal by Subject|0|||
129881030|NCT03679767|467523327|FG001|Overall Study|Withdrawal by Subject|0|||
129881031|NCT03679767|467523328|FG002|Overall Study|Withdrawal by Subject|0|||
129881032|NCT03679767|467523329|FG003|Overall Study|Withdrawal by Subject|1|||
129881033|NCT03679767|467523326|FG000|Overall Study|Follow-up Completed|18|||
129654300|NCT01066793|466691948|FG001|Overall Study|Relapse|8|||
129654301|NCT01066793|466691949|FG002|Overall Study|Relapse|2|||
129654302|NCT01066793|466691950|FG003|Overall Study|Relapse|3|||
129654303|NCT01066793|466691951|FG004|Overall Study|Relapse|0|||
129654304|NCT01066793|466691952|FG005|Overall Study|Relapse|0|||
129881034|NCT03679767|467523327|FG001|Overall Study|Follow-up Completed|11|||
129881035|NCT03679767|467523328|FG002|Overall Study|Follow-up Completed|11|||
129881036|NCT03679767|467523329|FG003|Overall Study|Follow-up Completed|20|||
129654305|NCT01066793|466691947|FG000|Overall Study|Result Not Available|1|||
129654306|NCT01066793|466691948|FG001|Overall Study|Result Not Available|0|||
129654307|NCT01066793|466691949|FG002|Overall Study|Result Not Available|0|||
129654308|NCT01066793|466691950|FG003|Overall Study|Result Not Available|0|||
129654309|NCT01066793|466691951|FG004|Overall Study|Result Not Available|0|||
129654310|NCT01066793|466691952|FG005|Overall Study|Result Not Available|0|||
129654311|NCT01066793|466691947|FG000|Overall Study|Treatment Interrupted|1|||
129654312|NCT01066793|466691948|FG001|Overall Study|Treatment Interrupted|1|||
129654313|NCT01066793|466691949|FG002|Overall Study|Treatment Interrupted|0|||
129654314|NCT01066793|466691950|FG003|Overall Study|Treatment Interrupted|0|||
129654315|NCT01066793|466691951|FG004|Overall Study|Treatment Interrupted|0|||
129654316|NCT01066793|466691952|FG005|Overall Study|Treatment Interrupted|0|||
129654317|NCT01066793|466691947|FG000|Overall Study|Treatment Never Started|18|||
129654318|NCT01066793|466691948|FG001|Overall Study|Treatment Never Started|5|||
129654319|NCT01066793|466691949|FG002|Overall Study|Treatment Never Started|4|||
129654320|NCT01066793|466691950|FG003|Overall Study|Treatment Never Started|1|||
129654321|NCT01066793|466691951|FG004|Overall Study|Treatment Never Started|0|||
129654322|NCT01066793|466691952|FG005|Overall Study|Treatment Never Started|0|||
129654323|NCT01066793|466691947|FG000|Overall Study|Treatment Stopped|2|||
129654324|NCT01066793|466691948|FG001|Overall Study|Treatment Stopped|1|||
129654325|NCT01066793|466691949|FG002|Overall Study|Treatment Stopped|0|||
129654326|NCT01066793|466691950|FG003|Overall Study|Treatment Stopped|1|||
129654327|NCT01066793|466691951|FG004|Overall Study|Treatment Stopped|0|||
129654328|NCT01066793|466691952|FG005|Overall Study|Treatment Stopped|0|||
129654329|NCT01911793|466691954|FG000|Overall Study|Physician Decision|1|||
129654330|NCT01911793|466691955|FG001|Overall Study|Physician Decision|5|||
129654331|NCT03334422|466691956|FG000|Overall Study|Adverse Event|1|||
129654332|NCT03334422|466691957|FG001|Overall Study|Adverse Event|3|||
129654333|NCT03334422|466691958|FG002|Overall Study|Adverse Event|2|||
129654334|NCT03334422|466691959|FG003|Overall Study|Adverse Event|2|||
129654335|NCT03334422|466691956|FG000|Overall Study|Lack of Efficacy|10|||
129654336|NCT03334422|466691957|FG001|Overall Study|Lack of Efficacy|2|||
129654337|NCT03334422|466691958|FG002|Overall Study|Lack of Efficacy|7|||
129654338|NCT03334422|466691959|FG003|Overall Study|Lack of Efficacy|3|||
129654339|NCT03334422|466691956|FG000|Overall Study|Withdrawal by Subject|8|||
129654340|NCT03334422|466691957|FG001|Overall Study|Withdrawal by Subject|3|||
129654341|NCT03334422|466691958|FG002|Overall Study|Withdrawal by Subject|1|||
129654342|NCT03334422|466691959|FG003|Overall Study|Withdrawal by Subject|0|||
129654343|NCT03334422|466691956|FG000|Overall Study|Lost to Follow-up|0|||
129654344|NCT03334422|466691957|FG001|Overall Study|Lost to Follow-up|0|||
129881037|NCT03679767|467523326|FG000|Overall Study|Entered Hospice Care|0|||
129881038|NCT03679767|467523327|FG001|Overall Study|Entered Hospice Care|0|||
129881039|NCT03679767|467523328|FG002|Overall Study|Entered Hospice Care|0|||
129881040|NCT03679767|467523329|FG003|Overall Study|Entered Hospice Care|1|||
129881041|NCT03679767|467523326|FG000|Overall Study|Progressive Disease|0|||
129881042|NCT03679767|467523327|FG001|Overall Study|Progressive Disease|0|||
129881043|NCT03679767|467523328|FG002|Overall Study|Progressive Disease|0|||
129881044|NCT03679767|467523329|FG003|Overall Study|Progressive Disease|1|||
129881045|NCT01407354|467523330|FG000|First Intervention|Withdrawal by Subject|0|||
129881046|NCT01407354|467523331|FG001|First Intervention|Withdrawal by Subject|2|||
129881047|NCT01407354|467523330|FG000|First Intervention|Adverse Event|1|||
129881048|NCT01407354|467523331|FG001|First Intervention|Adverse Event|0|||
129881049|NCT01407354|467523330|FG000|First Intervention|Physician Decision|1|||
129881050|NCT01407354|467523331|FG001|First Intervention|Physician Decision|0|||
129881051|NCT02204579|467523332|FG000|Overall Study|Screen failures|2|||
129881052|NCT03556358|467523335|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
129881053|NCT03556358|467523336|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
129881054|NCT03556358|467523335|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
129881055|NCT03556358|467523336|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
129881056|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
129881057|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
129881058|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
129881059|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
129654345|NCT03334422|466691958|FG002|Overall Study|Lost to Follow-up|0|||
129654346|NCT03334422|466691959|FG003|Overall Study|Lost to Follow-up|1|||
129654347|NCT03334422|466691956|FG000|Overall Study|Inability to obtain laboratory samples|0|||
129654348|NCT03334422|466691957|FG001|Overall Study|Inability to obtain laboratory samples|1|||
129654349|NCT03334422|466691958|FG002|Overall Study|Inability to obtain laboratory samples|0|||
129881060|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
129881061|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
129654350|NCT03334422|466691959|FG003|Overall Study|Inability to obtain laboratory samples|0|||
129654351|NCT03334422|466691956|FG000|Overall Study|Pregnancy|0|||
129654352|NCT03334422|466691957|FG001|Overall Study|Pregnancy|1|||
129654353|NCT03334422|466691958|FG002|Overall Study|Pregnancy|0|||
129654354|NCT03334422|466691959|FG003|Overall Study|Pregnancy|0|||
129654355|NCT02697916|466691960|FG000|Overall Study|Death|357|||
129654356|NCT02697916|466691961|FG001|Overall Study|Death|315|||
129654357|NCT02697916|466691960|FG000|Overall Study|Withdrawal by Subject|221|||
129654358|NCT02697916|466691961|FG001|Overall Study|Withdrawal by Subject|393|||
129654359|NCT01698268|466691964|FG000|Overall Study|Physician Decision|2|||
129654360|NCT01698268|466691965|FG001|Overall Study|Physician Decision|1|||
129654361|NCT00298363|466691966|FG000|Overall Study|Lost to Follow-up|0|||
129654362|NCT00298363|466691967|FG001|Overall Study|Lost to Follow-up|0|||
129654363|NCT00298363|466691968|FG002|Overall Study|Lost to Follow-up|1|||
129654364|NCT00298363|466691966|FG000|Overall Study|Physician Decision|4|||
129654365|NCT00298363|466691967|FG001|Overall Study|Physician Decision|1|||
129654366|NCT00298363|466691968|FG002|Overall Study|Physician Decision|0|||
129654367|NCT00298363|466691966|FG000|Overall Study|Protocol Violation|1|||
129654368|NCT00298363|466691967|FG001|Overall Study|Protocol Violation|1|||
129654369|NCT00298363|466691968|FG002|Overall Study|Protocol Violation|0|||
129654370|NCT00298363|466691966|FG000|Overall Study|Withdrawal by Subject|5|||
129654371|NCT00298363|466691967|FG001|Overall Study|Withdrawal by Subject|1|||
129654372|NCT00298363|466691968|FG002|Overall Study|Withdrawal by Subject|3|||
129654373|NCT00298363|466691966|FG000|Overall Study|Adverse Event|5|||
129654374|NCT00298363|466691967|FG001|Overall Study|Adverse Event|2|||
129654375|NCT00298363|466691968|FG002|Overall Study|Adverse Event|2|||
129654376|NCT00298363|466691966|FG000|Overall Study|Lack of Efficacy|2|||
129654377|NCT00298363|466691967|FG001|Overall Study|Lack of Efficacy|3|||
129654378|NCT00298363|466691968|FG002|Overall Study|Lack of Efficacy|0|||
129654379|NCT04710368|466691969|FG000|Overall Study|Withdrawal by Subject|9|||
129654380|NCT04710368|466691969|FG000|Overall Study|Lost to Follow-up|4|||
129654381|NCT04710368|466691969|FG000|Overall Study|Death|2|||
129654382|NCT04710368|466691969|FG000|Overall Study|Patient preference|11|||
129654383|NCT04710368|466691969|FG000|Overall Study|Treatment discontinuation|1|||
129654384|NCT00135356|466691970|FG000|Overall Study|Adverse Event|6|||
129654385|NCT00135356|466691971|FG001|Overall Study|Adverse Event|2|||
129654386|NCT00135356|466691970|FG000|Overall Study|Lack of Efficacy|2|||
129654387|NCT00135356|466691971|FG001|Overall Study|Lack of Efficacy|0|||
129654388|NCT00135356|466691970|FG000|Overall Study|Lost to Follow-up|3|||
129654389|NCT00135356|466691971|FG001|Overall Study|Lost to Follow-up|1|||
129654390|NCT00135356|466691970|FG000|Overall Study|Surgery for abdominal fat|1|||
129654391|NCT00135356|466691971|FG001|Overall Study|Surgery for abdominal fat|0|||
129654392|NCT00135356|466691970|FG000|Overall Study|Change in antiviral regimen|0|||
129654393|NCT00135356|466691971|FG001|Overall Study|Change in antiviral regimen|1|||
129654394|NCT00135356|466691970|FG000|Overall Study|Poor/noncompliance|1|||
129654395|NCT00135356|466691971|FG001|Overall Study|Poor/noncompliance|1|||
129654396|NCT00135356|466691970|FG000|Overall Study|No longer meets study criteria|2|||
129654397|NCT00135356|466691971|FG001|Overall Study|No longer meets study criteria|0|||
129654398|NCT00135356|466691970|FG000|Overall Study|Withdrawal by Subject|2|||
129654399|NCT00135356|466691971|FG001|Overall Study|Withdrawal by Subject|4|||
129654400|NCT00153816|466691972|FG000|Overall Study|Death|6|||
129654401|NCT00153816|466691973|FG001|Overall Study|Death|5|||
129654402|NCT00153816|466691974|FG002|Overall Study|Death|4|||
129654403|NCT00153816|466691975|FG003|Overall Study|Death|6|||
129654404|NCT00153816|466691976|FG004|Overall Study|Death|0|||
129654405|NCT00153816|466691977|FG005|Overall Study|Death|2|||
129654406|NCT00153816|466691972|FG000|Overall Study|Lost to Follow-up|7|||
129654407|NCT00153816|466691973|FG001|Overall Study|Lost to Follow-up|8|||
129654408|NCT00153816|466691974|FG002|Overall Study|Lost to Follow-up|5|||
129654409|NCT00153816|466691975|FG003|Overall Study|Lost to Follow-up|8|||
129654410|NCT00153816|466691976|FG004|Overall Study|Lost to Follow-up|7|||
129654411|NCT00153816|466691977|FG005|Overall Study|Lost to Follow-up|9|||
129654412|NCT00153816|466691972|FG000|Overall Study|Withdrawal by Subject|9|||
129654413|NCT00153816|466691973|FG001|Overall Study|Withdrawal by Subject|9|||
129654414|NCT00153816|466691974|FG002|Overall Study|Withdrawal by Subject|9|||
129654415|NCT00153816|466691975|FG003|Overall Study|Withdrawal by Subject|4|||
129654416|NCT00153816|466691976|FG004|Overall Study|Withdrawal by Subject|1|||
129654417|NCT00153816|466691977|FG005|Overall Study|Withdrawal by Subject|5|||
129654418|NCT00153816|466691972|FG000|Overall Study|Follow-up exam not done|8|||
129654419|NCT00153816|466691973|FG001|Overall Study|Follow-up exam not done|7|||
129654420|NCT00153816|466691974|FG002|Overall Study|Follow-up exam not done|11|||
129654421|NCT00153816|466691975|FG003|Overall Study|Follow-up exam not done|10|||
129654422|NCT00153816|466691976|FG004|Overall Study|Follow-up exam not done|8|||
129654423|NCT00153816|466691977|FG005|Overall Study|Follow-up exam not done|9|||
129654424|NCT00153816|466691972|FG000|Overall Study|Follow-up exam done, histology missing|2|||
129654425|NCT00153816|466691973|FG001|Overall Study|Follow-up exam done, histology missing|3|||
129654426|NCT00153816|466691974|FG002|Overall Study|Follow-up exam done, histology missing|3|||
129654427|NCT00153816|466691975|FG003|Overall Study|Follow-up exam done, histology missing|3|||
129654428|NCT00153816|466691976|FG004|Overall Study|Follow-up exam done, histology missing|1|||
129654429|NCT00153816|466691977|FG005|Overall Study|Follow-up exam done, histology missing|2|||
129654430|NCT01533688|466691978|FG000|Overall Study|Withdrawal by Subject|5|||
129654431|NCT01533688|466691979|FG001|Overall Study|Withdrawal by Subject|4|||
129654432|NCT01533688|466691980|FG002|Overall Study|Withdrawal by Subject|3|||
129654433|NCT01533688|466691978|FG000|Overall Study|Medically unstable|1|||
129654434|NCT01533688|466691979|FG001|Overall Study|Medically unstable|3|||
129654435|NCT01533688|466691980|FG002|Overall Study|Medically unstable|3|||
129654436|NCT01533688|466691978|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
129654437|NCT01533688|466691979|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
129654438|NCT01533688|466691980|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
129654439|NCT02509078|466691985|FG000|Overall Study|Protocol Violation|1|||
129654440|NCT02509078|466691986|FG001|Overall Study|Protocol Violation|1|||
129654441|NCT00253370|466691987|FG000|Overall Study|Adverse Event|18|||
129654442|NCT00253370|466691987|FG000|Overall Study|Disease progression|13|||
129654443|NCT00253370|466691987|FG000|Overall Study|Death|2|||
129654444|NCT00253370|466691987|FG000|Overall Study|Withdrawal by Subject|6|||
129654445|NCT00253370|466691987|FG000|Overall Study|Non-protocol therapy|1|||
129654446|NCT00253370|466691987|FG000|Overall Study|Physician Decision|1|||
129654447|NCT00253370|466691987|FG000|Overall Study|Protocol Violation|1|||
129654448|NCT00253370|466691987|FG000|Overall Study|Abdominal pain due to disease|1|||
129654449|NCT05916131|466691988|FG000|Overall Study|Lost to Follow-up|0|||
129654450|NCT05916131|466691989|FG001|Overall Study|Lost to Follow-up|0|||
129654451|NCT05916131|466691990|FG002|Overall Study|Lost to Follow-up|1|||
129654452|NCT05916131|466691991|FG003|Overall Study|Lost to Follow-up|0|||
129654453|NCT00904839|466691994|FG000|Overall Study|Adverse Event|0|||
129654454|NCT00904839|466691995|FG001|Overall Study|Adverse Event|5|||
129654455|NCT00904839|466691996|FG002|Overall Study|Adverse Event|4|||
129654456|NCT00904839|466691994|FG000|Overall Study|Protocol Violation|0|||
129654457|NCT00904839|466691995|FG001|Overall Study|Protocol Violation|1|||
129654458|NCT00904839|466691996|FG002|Overall Study|Protocol Violation|1|||
129654459|NCT00904839|466691994|FG000|Overall Study|Lost to Follow-up|0|||
129654460|NCT00904839|466691995|FG001|Overall Study|Lost to Follow-up|1|||
129654461|NCT00904839|466691996|FG002|Overall Study|Lost to Follow-up|2|||
129654462|NCT00904839|466691994|FG000|Overall Study|Withdrawal by Subject|0|||
129654463|NCT00904839|466691995|FG001|Overall Study|Withdrawal by Subject|2|||
129654464|NCT00904839|466691996|FG002|Overall Study|Withdrawal by Subject|0|||
129654465|NCT00904839|466691994|FG000|Overall Study|Not treated|1|||
129654466|NCT00904839|466691995|FG001|Overall Study|Not treated|0|||
129654467|NCT00904839|466691996|FG002|Overall Study|Not treated|1|||
129654468|NCT00904839|466691994|FG000|Overall Study|Other than above|0|||
129654469|NCT00904839|466691995|FG001|Overall Study|Other than above|9|||
129654470|NCT00904839|466691996|FG002|Overall Study|Other than above|7|||
129654471|NCT00553358|466691999|FG000|Overall Study|Randomized but did not receive treatment|3|||
129654472|NCT00553358|466692000|FG001|Overall Study|Randomized but did not receive treatment|3|||
129654473|NCT00553358|466692001|FG002|Overall Study|Randomized but did not receive treatment|1|||
129654474|NCT00553358|466691999|FG000|Overall Study|Lost to Follow-up|22|||
129654475|NCT00553358|466692000|FG001|Overall Study|Lost to Follow-up|26|||
129654476|NCT00553358|466692001|FG002|Overall Study|Lost to Follow-up|18|||
129654477|NCT00553358|466691999|FG000|Overall Study|Withdrew completely|23|||
129654478|NCT00553358|466692000|FG001|Overall Study|Withdrew completely|33|||
129654479|NCT00553358|466692001|FG002|Overall Study|Withdrew completely|34|||
129654480|NCT00553358|466691999|FG000|Overall Study|Died during clinical follow-up|25|||
129654481|NCT00553358|466692000|FG001|Overall Study|Died during clinical follow-up|29|||
129654482|NCT00553358|466692001|FG002|Overall Study|Died during clinical follow-up|32|||
129654483|NCT00553358|466691999|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
129654484|NCT00553358|466692000|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
129654485|NCT00553358|466692001|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
129654486|NCT00553358|466691999|FG000|Overall Study|Died after clinical follow-up ended|1|||
129654487|NCT00553358|466692000|FG001|Overall Study|Died after clinical follow-up ended|2|||
129654488|NCT00553358|466692001|FG002|Overall Study|Died after clinical follow-up ended|0|||
129654489|NCT00553358|466691999|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
129654490|NCT00553358|466692000|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
129654491|NCT00553358|466692001|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
129654492|NCT05268016|466692003|FG000|Overall Study|Unacceptable toxicity or AE|2|||
129654493|NCT05268016|466692004|FG001|Overall Study|Unacceptable toxicity or AE|2|||
129654494|NCT05268016|466692005|FG002|Overall Study|Unacceptable toxicity or AE|4|||
129654495|NCT05268016|466692006|FG003|Overall Study|Unacceptable toxicity or AE|3|||
129654496|NCT05268016|466692007|FG004|Overall Study|Unacceptable toxicity or AE|1|||
129654497|NCT05268016|466692003|FG000|Overall Study|Withdrawal by Subject|1|||
129654498|NCT05268016|466692004|FG001|Overall Study|Withdrawal by Subject|3|||
129881062|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
129881063|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
129654499|NCT05268016|466692005|FG002|Overall Study|Withdrawal by Subject|2|||
129654500|NCT05268016|466692006|FG003|Overall Study|Withdrawal by Subject|2|||
129654501|NCT05268016|466692007|FG004|Overall Study|Withdrawal by Subject|1|||
129654502|NCT05268016|466692003|FG000|Overall Study|Lost to Follow-up|4|||
129654503|NCT05268016|466692004|FG001|Overall Study|Lost to Follow-up|7|||
129654504|NCT05268016|466692005|FG002|Overall Study|Lost to Follow-up|1|||
129654505|NCT05268016|466692006|FG003|Overall Study|Lost to Follow-up|3|||
129654506|NCT05268016|466692007|FG004|Overall Study|Lost to Follow-up|5|||
129654507|NCT05268016|466692003|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
129654508|NCT05268016|466692004|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
129654509|NCT05268016|466692005|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
129654510|NCT05268016|466692006|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
129654511|NCT05268016|466692007|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
129654512|NCT05268016|466692003|FG000|Overall Study|Lack of Efficacy|0|||
129654513|NCT05268016|466692004|FG001|Overall Study|Lack of Efficacy|0|||
129654514|NCT05268016|466692005|FG002|Overall Study|Lack of Efficacy|0|||
129654515|NCT05268016|466692006|FG003|Overall Study|Lack of Efficacy|0|||
129654516|NCT05268016|466692007|FG004|Overall Study|Lack of Efficacy|4|||
129654517|NCT05268016|466692003|FG000|Overall Study|Physician Decision|0|||
129654518|NCT05268016|466692004|FG001|Overall Study|Physician Decision|0|||
129654519|NCT05268016|466692005|FG002|Overall Study|Physician Decision|0|||
129654520|NCT05268016|466692006|FG003|Overall Study|Physician Decision|1|||
129654521|NCT05268016|466692007|FG004|Overall Study|Physician Decision|0|||
129654522|NCT05268016|466692003|FG000|Overall Study|Other|1|||
129654523|NCT05268016|466692004|FG001|Overall Study|Other|0|||
129654524|NCT05268016|466692005|FG002|Overall Study|Other|1|||
129654525|NCT05268016|466692006|FG003|Overall Study|Other|2|||
129654526|NCT05268016|466692007|FG004|Overall Study|Other|0|||
129654527|NCT00404924|466692008|FG000|Overall Study|Adverse Event|75|||
129654528|NCT00404924|466692009|FG001|Overall Study|Adverse Event|16|||
129654529|NCT00404924|466692008|FG000|Overall Study|Condition under investigation worsened|475|||
129654530|NCT00404924|466692009|FG001|Overall Study|Condition under investigation worsened|264|||
129654531|NCT00404924|466692008|FG000|Overall Study|Lost to Follow-up|1|||
129654532|NCT00404924|466692009|FG001|Overall Study|Lost to Follow-up|1|||
129654533|NCT00404924|466692008|FG000|Overall Study|Withdrawal by Subject|26|||
129654534|NCT00404924|466692009|FG001|Overall Study|Withdrawal by Subject|13|||
129654535|NCT00404924|466692008|FG000|Overall Study|Other|25|||
129654536|NCT00404924|466692009|FG001|Overall Study|Other|11|||
129654537|NCT00404924|466692008|FG000|Overall Study|Randomised but not received treatment|1|||
129654538|NCT00404924|466692009|FG001|Overall Study|Randomised but not received treatment|1|||
129654539|NCT00187278|466692018|FG000|Overall Study|Protocol Violation|10|||
129654540|NCT00187278|466692019|FG001|Overall Study|Protocol Violation|13|||
129654541|NCT00803205|466692020|FG000|Overall Study|Adverse Event|7|||
129654542|NCT00803205|466692021|FG001|Overall Study|Adverse Event|2|||
129654543|NCT00803205|466692020|FG000|Overall Study|Lost to Follow-up|1|||
129654544|NCT00803205|466692021|FG001|Overall Study|Lost to Follow-up|0|||
129654545|NCT00803205|466692020|FG000|Overall Study|Withdrawal by Subject|9|||
129654546|NCT00803205|466692021|FG001|Overall Study|Withdrawal by Subject|9|||
129654547|NCT00803205|466692020|FG000|Overall Study|Physician Decision|1|||
129654548|NCT00803205|466692021|FG001|Overall Study|Physician Decision|0|||
129654549|NCT00803205|466692020|FG000|Overall Study|Protocol Violation|1|||
129654550|NCT00803205|466692021|FG001|Overall Study|Protocol Violation|1|||
129654551|NCT00803205|466692020|FG000|Overall Study|Medical Monitor Decision|1|||
129654552|NCT00803205|466692021|FG001|Overall Study|Medical Monitor Decision|0|||
129654553|NCT00803205|466692020|FG000|Overall Study|Acquired a Lung Infection|0|||
129654554|NCT00803205|466692021|FG001|Overall Study|Acquired a Lung Infection|1|||
129654555|NCT00803205|466692020|FG000|Overall Study|Sponsor Decision|0|||
129654556|NCT00803205|466692021|FG001|Overall Study|Sponsor Decision|1|||
129654557|NCT00270231|466692023|FG000|First Intervention|Lost to Follow-up|1|||
129654558|NCT00270231|466692024|FG001|First Intervention|Lost to Follow-up|1|||
129654559|NCT00270231|466692023|FG000|Washout Period|Lost to Follow-up|1|||
129654560|NCT00270231|466692024|FG001|Washout Period|Lost to Follow-up|0|||
129654561|NCT00270231|466692023|FG000|Second Intervention|Lost to Follow-up|0|||
129881064|NCT03556358|467523335|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
129881065|NCT03556358|467523336|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
129654562|NCT00270231|466692024|FG001|Second Intervention|Lost to Follow-up|1|||
129654563|NCT02735096|466692025|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
129881066|NCT01351025|467523337|FG000|Week 0 - 20|Lost to Follow-up|2|||
129654564|NCT00379808|466692026|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
129654565|NCT00379808|466692027|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
129881067|NCT01351025|467523338|FG001|Week 0 - 20|Lost to Follow-up|1|||
129881068|NCT01351025|467523337|FG000|Week 0 - 20|Withdrawal by Subject|1|||
129881069|NCT01351025|467523338|FG001|Week 0 - 20|Withdrawal by Subject|0|||
129654566|NCT04299048|466692033|FG000|Overall Study|Death|1|||
129654567|NCT04299048|466692033|FG000|Overall Study|Global deterioration of health status|2|||
129654568|NCT04299048|466692033|FG000|Overall Study|Enrolled and not treated|1|||
129881070|NCT01351025|467523337|FG000|Week 24 - 44|Lost to Follow-up|0|||
129881071|NCT01351025|467523338|FG001|Week 24 - 44|Lost to Follow-up|2|||
129881072|NCT01351025|467523337|FG000|Week 24 - 44|Site closed|0|||
129881073|NCT01351025|467523338|FG001|Week 24 - 44|Site closed|1|||
129654569|NCT00508157|466692035|FG000|Overall Study|Adverse Event|0|||
129654570|NCT00508157|466692036|FG001|Overall Study|Adverse Event|1|||
129881074|NCT01351025|467523337|FG000|Week 24 - 44|unable to get to clinic|1|||
129881075|NCT01351025|467523338|FG001|Week 24 - 44|unable to get to clinic|1|||
129881076|NCT01861522|467523343|FG000|Overall Study|Adverse Event|1|||
129881077|NCT01861522|467523344|FG001|Overall Study|Adverse Event|0|||
129881078|NCT01861522|467523343|FG000|Overall Study|Withdrawal by Subject|2|||
129881079|NCT01861522|467523344|FG001|Overall Study|Withdrawal by Subject|0|||
129881080|NCT00550550|467523345|FG000|Overall Study|Adverse Event|13|||
129881081|NCT00550550|467523346|FG001|Overall Study|Adverse Event|5|||
129881082|NCT00550550|467523345|FG000|Overall Study|Treatment Failure|0|||
129881083|NCT00550550|467523346|FG001|Overall Study|Treatment Failure|1|||
129881084|NCT00550550|467523345|FG000|Overall Study|Lost to Follow-up|4|||
129881085|NCT00550550|467523346|FG001|Overall Study|Lost to Follow-up|0|||
129881086|NCT00550550|467523345|FG000|Overall Study|Withdrawal by Subject|10|||
129881087|NCT00550550|467523346|FG001|Overall Study|Withdrawal by Subject|8|||
129881088|NCT00550550|467523345|FG000|Overall Study|Protocol Violation|5|||
129881089|NCT00550550|467523346|FG001|Overall Study|Protocol Violation|14|||
129881090|NCT00550550|467523345|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
129881091|NCT00550550|467523346|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
129881092|NCT00550550|467523345|FG000|Overall Study|Randomized But Not Treated|1|||
129881093|NCT00550550|467523346|FG001|Overall Study|Randomized But Not Treated|0|||
129881094|NCT00381641|467523349|FG000|Overall Study|Withdrawal by Subject|0|||
129881095|NCT00381641|467523350|FG001|Overall Study|Withdrawal by Subject|2|||
129881096|NCT01598298|467523351|FG000|Overall Study|Not eligible|5|||
129881097|NCT01598298|467523352|FG001|Overall Study|Not eligible|5|||
129881098|NCT01598298|467523351|FG000|Overall Study|Adverse Event|21|||
129881099|NCT01598298|467523352|FG001|Overall Study|Adverse Event|19|||
129881100|NCT01598298|467523351|FG000|Overall Study|Progression/relapse|0|||
129881101|NCT01598298|467523352|FG001|Overall Study|Progression/relapse|2|||
129881102|NCT01598298|467523351|FG000|Overall Study|Withdrawal by Subject|10|||
129881103|NCT01598298|467523352|FG001|Overall Study|Withdrawal by Subject|15|||
129881104|NCT01598298|467523351|FG000|Overall Study|Other reason (not protocol specified)|4|||
129881105|NCT01598298|467523352|FG001|Overall Study|Other reason (not protocol specified)|0|||
129881106|NCT03813147|467523353|FG000|Overall Study|Lack of Efficacy|4|||
129881107|NCT03813147|467523354|FG001|Overall Study|Lack of Efficacy|4|||
129881108|NCT03813147|467523353|FG000|Overall Study|Physician Decision|2|||
129881109|NCT03813147|467523354|FG001|Overall Study|Physician Decision|1|||
129881110|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
129881111|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
129881112|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
129881113|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
129881114|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
129881115|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
129881116|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Death|0|||
129881117|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Death|1|||
129545085|NCT03930615|466288413|FG001|Overall Study|Withdrawal by Subject|2|||
129545086|NCT03930615|466288412|FG000|Overall Study|Not treated|1|||
129881118|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Adverse Event|11|||
129881119|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Adverse Event|11|||
129881120|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
129881121|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
129881122|NCT02936037|467524790|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129881123|NCT02936037|467524791|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129881124|NCT02936037|467524790|FG000|Open Label Extension|Adverse Event|0|||
129881125|NCT02936037|467524791|FG001|Open Label Extension|Adverse Event|3|||
129881126|NCT02936037|467524790|FG000|Open Label Extension|Other|0|||
129881127|NCT02936037|467524791|FG001|Open Label Extension|Other|3|||
129881128|NCT02936037|467524790|FG000|Open Label Extension|Withdrawal by Subject|0|||
129881129|NCT02936037|467524791|FG001|Open Label Extension|Withdrawal by Subject|4|||
129881130|NCT04666922|467524792|FG000|Overall Study|Withdrawal by Subject|1|||
129881131|NCT04666922|467524793|FG001|Overall Study|Withdrawal by Subject|0|||
129881132|NCT04666922|467524794|FG002|Overall Study|Withdrawal by Subject|0|||
129881133|NCT04666922|467524795|FG003|Overall Study|Withdrawal by Subject|0|||
129881134|NCT04666922|467524796|FG004|Overall Study|Withdrawal by Subject|0|||
129881135|NCT04666922|467524797|FG005|Overall Study|Withdrawal by Subject|0|||
129881136|NCT04666922|467524798|FG006|Overall Study|Withdrawal by Subject|0|||
129881137|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
129881138|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881139|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881140|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881141|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
129881142|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
129881143|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129545087|NCT03930615|466288413|FG001|Overall Study|Not treated|1|||
129881144|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881145|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881146|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
129881147|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
129881148|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881149|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881150|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881151|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
129881152|NCT00244374|467524799|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
129881153|NCT00244374|467524800|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881154|NCT00244374|467524801|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881155|NCT00244374|467524802|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881156|NCT00244374|467524803|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
129881157|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
129881158|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881159|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881160|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881161|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
129881162|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
129881163|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881164|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881165|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881166|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
129881167|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
129881168|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881169|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881170|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881171|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
129881172|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
129881173|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881174|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881175|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881176|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
129881177|NCT00244374|467524799|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
129881178|NCT00244374|467524800|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881179|NCT00244374|467524801|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881180|NCT00244374|467524802|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881181|NCT00244374|467524803|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
129881182|NCT03722264|467524804|FG000|Overall Study|Physician Decision|3|||
129881183|NCT02959671|467524805|FG000|Overall Study|Adverse Event|2|||
129881184|NCT02959671|467524805|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
129881185|NCT03462706|467524806|FG000|Overall Study|Polyp was pedunculated|1|||
129881186|NCT03462706|467524807|FG001|Overall Study|Polyp was pedunculated|0|||
129881187|NCT03462706|467524808|FG002|Overall Study|Polyp was pedunculated|1|||
129881188|NCT03462706|467524809|FG003|Overall Study|Polyp was pedunculated|0|||
129881189|NCT03462706|467524806|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
129881190|NCT03462706|467524807|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
129881191|NCT03462706|467524808|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
129881192|NCT03462706|467524809|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
129881193|NCT04651114|467524816|FG000|Overall Study|Withdrawal by Subject|8|||
129881194|NCT01923896|467524821|FG000|Overall Study|Adverse Event|1|||
129881195|NCT01923896|467524822|FG001|Overall Study|Adverse Event|0|||
129881196|NCT00474929|467524827|FG000|Overall Study|Withdrawal by Subject|0|||
129881197|NCT00474929|467524828|FG001|Overall Study|Withdrawal by Subject|1|||
129881198|NCT00474929|467524829|FG002|Overall Study|Withdrawal by Subject|0|||
129881199|NCT00474929|467524830|FG003|Overall Study|Withdrawal by Subject|0|||
129881200|NCT00474929|467524831|FG004|Overall Study|Withdrawal by Subject|0|||
129881201|NCT00474929|467524827|FG000|Overall Study|Unrelated medical condition|0|||
129881202|NCT00474929|467524828|FG001|Overall Study|Unrelated medical condition|0|||
129881203|NCT00474929|467524829|FG002|Overall Study|Unrelated medical condition|1|||
129881204|NCT00474929|467524830|FG003|Overall Study|Unrelated medical condition|0|||
129654571|NCT00508157|466692035|FG000|Overall Study|Subject Withdrew Consent|1|||
129654572|NCT00508157|466692036|FG001|Overall Study|Subject Withdrew Consent|0|||
129654573|NCT00508157|466692035|FG000|Overall Study|Lost to Follow-up|1|||
129654574|NCT00508157|466692036|FG001|Overall Study|Lost to Follow-up|0|||
129654575|NCT00508157|466692035|FG000|Overall Study|Subject no longer met study criteria|0|||
129654576|NCT00508157|466692036|FG001|Overall Study|Subject no longer met study criteria|1|||
129881205|NCT00474929|467524831|FG004|Overall Study|Unrelated medical condition|0|||
129881206|NCT00474929|467524827|FG000|Overall Study|Physician Decision|0|||
129881207|NCT00474929|467524828|FG001|Overall Study|Physician Decision|0|||
129881208|NCT00474929|467524829|FG002|Overall Study|Physician Decision|1|||
129881209|NCT00474929|467524830|FG003|Overall Study|Physician Decision|2|||
129881210|NCT00474929|467524831|FG004|Overall Study|Physician Decision|0|||
129881211|NCT03661996|467524834|FG000|Overall Study|Adverse Event|0|||
129881212|NCT03661996|467524835|FG001|Overall Study|Adverse Event|0|||
129881213|NCT03661996|467524836|FG002|Overall Study|Adverse Event|1|||
129881214|NCT03661996|467524837|FG003|Overall Study|Adverse Event|1|||
129881215|NCT03661996|467524838|FG004|Overall Study|Adverse Event|0|||
129881216|NCT03661996|467524834|FG000|Overall Study|Lost to Follow-up|5|||
129881217|NCT03661996|467524835|FG001|Overall Study|Lost to Follow-up|1|||
129881218|NCT03661996|467524836|FG002|Overall Study|Lost to Follow-up|2|||
129881219|NCT03661996|467524837|FG003|Overall Study|Lost to Follow-up|2|||
129881220|NCT03661996|467524838|FG004|Overall Study|Lost to Follow-up|6|||
129881221|NCT03661996|467524834|FG000|Overall Study|Physician Decision|1|||
129881222|NCT03661996|467524835|FG001|Overall Study|Physician Decision|1|||
129881223|NCT03661996|467524836|FG002|Overall Study|Physician Decision|1|||
129881224|NCT03661996|467524837|FG003|Overall Study|Physician Decision|2|||
129881225|NCT03661996|467524838|FG004|Overall Study|Physician Decision|0|||
129881226|NCT03661996|467524834|FG000|Overall Study|Protocol Violation|0|||
129881227|NCT03661996|467524835|FG001|Overall Study|Protocol Violation|0|||
129881228|NCT03661996|467524836|FG002|Overall Study|Protocol Violation|0|||
129881229|NCT03661996|467524837|FG003|Overall Study|Protocol Violation|0|||
129881230|NCT03661996|467524838|FG004|Overall Study|Protocol Violation|1|||
129881231|NCT03661996|467524834|FG000|Overall Study|Withdrawal by Subject|3|||
129881232|NCT03661996|467524835|FG001|Overall Study|Withdrawal by Subject|5|||
129881233|NCT03661996|467524836|FG002|Overall Study|Withdrawal by Subject|1|||
129881234|NCT03661996|467524837|FG003|Overall Study|Withdrawal by Subject|7|||
129881235|NCT03661996|467524838|FG004|Overall Study|Withdrawal by Subject|7|||
129881236|NCT03661996|467524834|FG000|Overall Study|Sponsors Decision|2|||
129881237|NCT03661996|467524835|FG001|Overall Study|Sponsors Decision|0|||
129881238|NCT03661996|467524836|FG002|Overall Study|Sponsors Decision|0|||
129881239|NCT03661996|467524837|FG003|Overall Study|Sponsors Decision|0|||
129881240|NCT03661996|467524838|FG004|Overall Study|Sponsors Decision|0|||
129881241|NCT03661996|467524834|FG000|Overall Study|Other|1|||
129881242|NCT03661996|467524835|FG001|Overall Study|Other|1|||
129881243|NCT03661996|467524836|FG002|Overall Study|Other|1|||
129881244|NCT03661996|467524837|FG003|Overall Study|Other|1|||
129881245|NCT03661996|467524838|FG004|Overall Study|Other|0|||
129881246|NCT00068380|467524839|FG000|Overall Study|Withdrawal by Subject|3|||
129881247|NCT00068380|467524839|FG000|Overall Study|Adverse Event|2|||
129881248|NCT01190215|467524840|FG000|Up to Month 6|Lost to Follow-up|2|||
129881249|NCT01190215|467524841|FG001|Up to Month 6|Lost to Follow-up|0|||
129881250|NCT00067990|467524858|FG000|Overall Study|Death|5|||
129881251|NCT00067990|467524859|FG001|Overall Study|Death|7|||
129881252|NCT00067990|467524858|FG000|Overall Study|ESRD, Non IF/TA|1|||
129881253|NCT00067990|467524859|FG001|Overall Study|ESRD, Non IF/TA|3|||
129881254|NCT00067990|467524858|FG000|Overall Study|Withdrawal by Subject|4|||
129881255|NCT00067990|467524859|FG001|Overall Study|Withdrawal by Subject|12|||
129881256|NCT01973491|467524860|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
129881257|NCT01973491|467524860|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
129881258|NCT01973491|467524860|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
129881259|NCT00422799|467524861|FG000|Overall Study|Withdrawal by Subject|6|||
129881260|NCT00422799|467524861|FG000|Overall Study|Adverse Event|7|||
129881261|NCT01965158|467524862|FG000|Overall Study|Adverse Event|14|||
129881262|NCT01965158|467524863|FG001|Overall Study|Adverse Event|5|||
129881263|NCT01965158|467524862|FG000|Overall Study|Withdrawal by Subject|16|||
129881264|NCT01965158|467524863|FG001|Overall Study|Withdrawal by Subject|24|||
129654577|NCT00508157|466692035|FG000|Overall Study|Other known cause|0|||
129881265|NCT01965158|467524862|FG000|Overall Study|Lost to Follow-up|7|||
129881266|NCT01965158|467524863|FG001|Overall Study|Lost to Follow-up|5|||
129881267|NCT01965158|467524862|FG000|Overall Study|Protocol Violation|1|||
129881268|NCT01965158|467524863|FG001|Overall Study|Protocol Violation|1|||
129881269|NCT01965158|467524862|FG000|Overall Study|Other - Miscellaneous|3|||
129881270|NCT01965158|467524863|FG001|Overall Study|Other - Miscellaneous|0|||
129881271|NCT01619787|467524864|FG000|Overall Study|Lost to Follow-up|5|||
129881272|NCT03321006|467524867|FG000|Overall Study|Death|1|||
129881273|NCT03321006|467524868|FG001|Overall Study|Death|0|||
129881274|NCT03321006|467524867|FG000|Overall Study|Lack of Efficacy|1|||
129654578|NCT00508157|466692036|FG001|Overall Study|Other known cause|1|||
129881275|NCT03321006|467524868|FG001|Overall Study|Lack of Efficacy|0|||
129881276|NCT03560258|467524869|FG000|Overall Study|Lost to Follow-up|3|||
129881277|NCT03560258|467524870|FG001|Overall Study|Lost to Follow-up|0|||
129881278|NCT03560258|467524871|FG002|Overall Study|Lost to Follow-up|0|||
129881279|NCT03560258|467524869|FG000|Overall Study|Protocol Violation|0|||
129881280|NCT03560258|467524870|FG001|Overall Study|Protocol Violation|1|||
129881281|NCT03560258|467524871|FG002|Overall Study|Protocol Violation|0|||
129881282|NCT03560258|467524869|FG000|Overall Study|Withdrawal by Subject|0|||
129881283|NCT03560258|467524870|FG001|Overall Study|Withdrawal by Subject|0|||
129881284|NCT03560258|467524871|FG002|Overall Study|Withdrawal by Subject|1|||
129881285|NCT02006121|467524872|FG000|Double Blind Phase|Adverse Event|6|||
129881286|NCT02006121|467524873|FG001|Double Blind Phase|Adverse Event|0|||
129881287|NCT02006121|467524872|FG000|Double Blind Phase|Lack of Efficacy|1|||
129881288|NCT02006121|467524873|FG001|Double Blind Phase|Lack of Efficacy|16|||
129881289|NCT02006121|467524872|FG000|Double Blind Phase|Withdrawal by Subject|3|||
129881290|NCT02006121|467524873|FG001|Double Blind Phase|Withdrawal by Subject|4|||
129881291|NCT02006121|467524872|FG000|Double Blind Phase|Non-compliance with study drug|1|||
129881292|NCT02006121|467524873|FG001|Double Blind Phase|Non-compliance with study drug|3|||
129881293|NCT02006121|467524872|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
129881294|NCT02006121|467524873|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
129881295|NCT02006121|467524872|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
129881296|NCT02006121|467524873|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
129881297|NCT02006121|467524872|FG000|Open Label Phase|Adverse Event|15|||
129881298|NCT02006121|467524873|FG001|Open Label Phase|Adverse Event|0|||
129881299|NCT02006121|467524872|FG000|Open Label Phase|Lack of Efficacy|2|||
129881300|NCT02006121|467524873|FG001|Open Label Phase|Lack of Efficacy|0|||
129881301|NCT02006121|467524872|FG000|Open Label Phase|Protocol Violation|2|||
129881302|NCT02006121|467524873|FG001|Open Label Phase|Protocol Violation|0|||
129881303|NCT02006121|467524872|FG000|Open Label Phase|Withdrawal by Subject|3|||
129881304|NCT02006121|467524873|FG001|Open Label Phase|Withdrawal by Subject|0|||
129881305|NCT02006121|467524872|FG000|Open Label Phase|Non-compliance with study drug|3|||
129881306|NCT02006121|467524873|FG001|Open Label Phase|Non-compliance with study drug|0|||
129881307|NCT00245856|467524889|FG000|Period Two|Withdrawal by Subject|0|||
129881308|NCT00245856|467524890|FG001|Period Two|Withdrawal by Subject|1|||
129881309|NCT01003184|467524891|FG000|Overall Study|Adverse Event|12|||
129881310|NCT01003184|467524892|FG001|Overall Study|Adverse Event|5|||
129881311|NCT01003184|467524891|FG000|Overall Study|Lost to Follow-up|1|||
129881312|NCT01003184|467524892|FG001|Overall Study|Lost to Follow-up|0|||
129881313|NCT01003184|467524891|FG000|Overall Study|Loss of glucose control|1|||
129654579|NCT02069093|466692037|FG000|Overall Study|Disease progression|14|||
129654580|NCT02069093|466692037|FG000|Overall Study|New cancer therapy|1|||
129654581|NCT02069093|466692037|FG000|Overall Study|Death|1|||
129881314|NCT01003184|467524892|FG001|Overall Study|Loss of glucose control|1|||
129881315|NCT01003184|467524891|FG000|Overall Study|Protocol Violation|3|||
129654582|NCT02069093|466692037|FG000|Overall Study|Administrative problems|1|||
129654583|NCT02069093|466692037|FG000|Overall Study|Withdrawal by Subject|2|||
129881316|NCT01003184|467524892|FG001|Overall Study|Protocol Violation|0|||
129881317|NCT01003184|467524891|FG000|Overall Study|Withdrawal by Subject|1|||
129881318|NCT01003184|467524892|FG001|Overall Study|Withdrawal by Subject|6|||
129881319|NCT01003184|467524891|FG000|Overall Study|Physician Decision|1|||
129881320|NCT01003184|467524892|FG001|Overall Study|Physician Decision|0|||
129881321|NCT02693834|467524894|FG000|Baseline Measurement|Withdrawal by Subject|1|||
129881322|NCT02693834|467524895|FG001|Baseline Measurement|Withdrawal by Subject|0|||
129881323|NCT02693834|467524894|FG000|Baseline Measurement|Adverse Event|1|||
129881324|NCT02693834|467524895|FG001|Baseline Measurement|Adverse Event|0|||
129881325|NCT02693834|467524894|FG000|Week 2 Practice|Adverse Event|0|||
129881326|NCT02693834|467524895|FG001|Week 2 Practice|Adverse Event|1|||
129654584|NCT02069093|466692037|FG000|Overall Study|Abnormal laboratory values|1|||
129654585|NCT02069093|466692037|FG000|Overall Study|Adverse Event|10|||
129654586|NCT03564795|466692038|FG000|Overall Study|Withdrawal by Subject|3|||
129654587|NCT03564795|466692038|FG000|Overall Study|Lost to Follow-up|6|||
129654588|NCT03564795|466692038|FG000|Overall Study|Physician Decision|2|||
129654589|NCT02906033|466692039|FG000|Baseline|Protocol Violation|37|||
129881327|NCT04848662|467524896|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
129881328|NCT04848662|467524897|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
129881329|NCT01107743|467524906|FG000|Overall Study|Protocol Violation|46|||
129881330|NCT00308737|467524907|FG000|Overall Study|Adverse Event|104|||
129881331|NCT00308737|467524908|FG001|Overall Study|Adverse Event|9|||
129881332|NCT00308737|467524909|FG002|Overall Study|Adverse Event|0|||
129881333|NCT00308737|467524907|FG000|Overall Study|Death|4|||
129881334|NCT00308737|467524908|FG001|Overall Study|Death|3|||
129881335|NCT00308737|467524909|FG002|Overall Study|Death|0|||
129881336|NCT00308737|467524907|FG000|Overall Study|Lost to Follow-up|56|||
129881337|NCT00308737|467524908|FG001|Overall Study|Lost to Follow-up|80|||
129654590|NCT02906033|466692040|FG001|Baseline|Protocol Violation|33|||
129654591|NCT02906033|466692039|FG000|Follow-up|Lost to Follow-up|46|||
129881338|NCT00308737|467524909|FG002|Overall Study|Lost to Follow-up|5|||
129881339|NCT00308737|467524907|FG000|Overall Study|Physician Decision|15|||
129881340|NCT00308737|467524908|FG001|Overall Study|Physician Decision|2|||
129881341|NCT00308737|467524909|FG002|Overall Study|Physician Decision|1|||
129881342|NCT00308737|467524907|FG000|Overall Study|Protocol Violation|34|||
129881343|NCT00308737|467524908|FG001|Overall Study|Protocol Violation|9|||
129881344|NCT00308737|467524909|FG002|Overall Study|Protocol Violation|5|||
129881345|NCT00308737|467524907|FG000|Overall Study|Withdrawal by Subject|218|||
129881346|NCT00308737|467524908|FG001|Overall Study|Withdrawal by Subject|166|||
129881347|NCT00308737|467524909|FG002|Overall Study|Withdrawal by Subject|18|||
129881348|NCT00308737|467524907|FG000|Overall Study|Various|32|||
129881349|NCT00308737|467524908|FG001|Overall Study|Various|20|||
129881350|NCT00308737|467524909|FG002|Overall Study|Various|8|||
129881351|NCT00089895|467524910|FG000|Overall Study|Consent Withdrawn|11|||
129881352|NCT00089895|467524911|FG001|Overall Study|Consent Withdrawn|14|||
129881353|NCT00089895|467524910|FG000|Overall Study|Technical reason|7|||
129881354|NCT00089895|467524911|FG001|Overall Study|Technical reason|2|||
129881355|NCT00089895|467524910|FG000|Overall Study|Surgery|0|||
129881356|NCT00089895|467524911|FG001|Overall Study|Surgery|1|||
129881357|NCT00089895|467524910|FG000|Overall Study|Bleeding|0|||
129881358|NCT00089895|467524911|FG001|Overall Study|Bleeding|2|||
129881359|NCT00089895|467524910|FG000|Overall Study|Physician Decision|3|||
129881360|NCT00089895|467524911|FG001|Overall Study|Physician Decision|7|||
129881361|NCT00089895|467524910|FG000|Overall Study|Exclusion criteria met|6|||
129881362|NCT00089895|467524911|FG001|Overall Study|Exclusion criteria met|6|||
129881363|NCT00089895|467524910|FG000|Overall Study|Not otherwise specified|4|||
129881364|NCT00089895|467524911|FG001|Overall Study|Not otherwise specified|8|||
129881365|NCT00089895|467524910|FG000|Overall Study|Missing|4|||
129545088|NCT04611152|466288416|FG000|Overall Study|Adverse Event|9|||
129545089|NCT04611152|466288417|FG001|Overall Study|Adverse Event|8|||
129545090|NCT04611152|466288416|FG000|Overall Study|Non-compliance with study schedule|1|||
129545091|NCT04611152|466288417|FG001|Overall Study|Non-compliance with study schedule|3|||
129545092|NCT04611152|466288416|FG000|Overall Study|Withdrawal by Subject|5|||
129545093|NCT04611152|466288417|FG001|Overall Study|Withdrawal by Subject|6|||
129545094|NCT04611152|466288416|FG000|Overall Study|Lost to Follow-up|11|||
129545095|NCT04611152|466288417|FG001|Overall Study|Lost to Follow-up|2|||
129545096|NCT03644927|466288420|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
129545097|NCT03644927|466288421|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
129545098|NCT00956813|466288425|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
129545099|NCT00956813|466288426|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
129545100|NCT00956813|466288425|FG000|Flaxseed and Placebo|Ineligible|3|||
129545101|NCT00956813|466288426|FG001|Flaxseed and Placebo|Ineligible|1|||
129545102|NCT04797637|466288427|FG000|Overall Study|Lost to Follow-up|23|||
129545103|NCT04797637|466288428|FG001|Overall Study|Lost to Follow-up|32|||
129545104|NCT04797637|466288427|FG000|Overall Study|Withdrawal by Subject|0|||
129545105|NCT04797637|466288428|FG001|Overall Study|Withdrawal by Subject|1|||
129545106|NCT03917654|466288435|FG000|Year 1|Withdrawal by Subject|1|||
129545107|NCT03917654|466288436|FG001|Year 1|Withdrawal by Subject|0|||
129545108|NCT03917654|466288437|FG002|Year 1|Withdrawal by Subject|0|||
129545109|NCT03917654|466288438|FG003|Year 1|Withdrawal by Subject|0|||
129545110|NCT03917654|466288439|FG004|Year 1|Withdrawal by Subject|0|||
129545111|NCT03917654|466288440|FG005|Year 1|Withdrawal by Subject|1|||
129545112|NCT03917654|466288441|FG006|Year 1|Withdrawal by Subject|6|||
129545113|NCT03917654|466288442|FG007|Year 1|Withdrawal by Subject|2|||
129545114|NCT03917654|466288443|FG008|Year 1|Withdrawal by Subject|5|||
129545115|NCT03917654|466288444|FG009|Year 1|Withdrawal by Subject|3|||
129545116|NCT03917654|466288445|FG010|Year 1|Withdrawal by Subject|1|||
129545117|NCT03917654|466288446|FG011|Year 1|Withdrawal by Subject|0|||
129545118|NCT03917654|466288435|FG000|Year 1|Travel|0|||
129545119|NCT03917654|466288436|FG001|Year 1|Travel|1|||
129545120|NCT03917654|466288437|FG002|Year 1|Travel|1|||
129545121|NCT03917654|466288438|FG003|Year 1|Travel|0|||
129545122|NCT03917654|466288439|FG004|Year 1|Travel|4|||
129545123|NCT03917654|466288440|FG005|Year 1|Travel|4|||
129545124|NCT03917654|466288441|FG006|Year 1|Travel|10|||
129545125|NCT03917654|466288442|FG007|Year 1|Travel|8|||
129545126|NCT03917654|466288443|FG008|Year 1|Travel|2|||
129881366|NCT00089895|467524911|FG001|Overall Study|Missing|2|||
129881367|NCT01535274|467524912|FG000|Overall Study|Determined to be ineligible|0|||
129881368|NCT01535274|467524913|FG001|Overall Study|Determined to be ineligible|1|||
129881369|NCT01535274|467524912|FG000|Overall Study|Misallocated to propofol intervention|0|||
129881370|NCT01535274|467524913|FG001|Overall Study|Misallocated to propofol intervention|1|||
129881371|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
129545127|NCT03917654|466288444|FG009|Year 1|Travel|5|||
129545128|NCT03917654|466288445|FG010|Year 1|Travel|3|||
129545129|NCT03917654|466288446|FG011|Year 1|Travel|3|||
129545130|NCT03917654|466288435|FG000|Year 1|Subject moved away from site|0|||
129545131|NCT03917654|466288436|FG001|Year 1|Subject moved away from site|1|||
129881372|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
129881373|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
129881374|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
129881375|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
129881376|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
129881377|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
129881378|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
129881379|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
129881380|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
129881381|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
129881382|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
129881383|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881384|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881385|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881386|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881387|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
129881388|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
129881389|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
129881390|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881391|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881392|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881393|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
129881394|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
129881395|NCT02778399|467524915|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881396|NCT02778399|467524916|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881397|NCT02778399|467524917|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881398|NCT02778399|467524918|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
129881399|NCT02778399|467524919|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
129881400|NCT02778399|467524920|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
129881401|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
129881402|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
129881403|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
129881404|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
129881405|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
129881406|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
129881407|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
129881408|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
129881409|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
129881410|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
129881411|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
129881412|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
129881413|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881414|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
129881415|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881416|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881417|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881418|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
129881419|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
129881420|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
129881421|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
129881422|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
129881423|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
129881424|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
129881425|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
129881426|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881427|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
129881428|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881429|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881430|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
129881431|NCT02778399|467524915|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
129881432|NCT02778399|467524916|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
129881433|NCT02778399|467524917|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
129881434|NCT02778399|467524918|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
129881435|NCT02778399|467524919|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
129881436|NCT02778399|467524920|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
129881437|NCT00447954|467524927|FG000|Overall Study|Adverse Event|0|||
129881438|NCT00447954|467524928|FG001|Overall Study|Adverse Event|2|||
129881439|NCT00447954|467524929|FG002|Overall Study|Adverse Event|0|||
129881440|NCT00447954|467524927|FG000|Overall Study|Withdrawal by Subject|0|||
129881441|NCT00447954|467524928|FG001|Overall Study|Withdrawal by Subject|1|||
129881442|NCT00447954|467524929|FG002|Overall Study|Withdrawal by Subject|1|||
129881443|NCT00447954|467524927|FG000|Overall Study|Lost to Follow-up|0|||
129881444|NCT00447954|467524928|FG001|Overall Study|Lost to Follow-up|1|||
129881445|NCT00447954|467524929|FG002|Overall Study|Lost to Follow-up|0|||
129881446|NCT00447954|467524927|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
129881447|NCT00447954|467524928|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
129881448|NCT00447954|467524929|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
129881449|NCT00856661|467524930|FG000|Overall Study|Death|15|||
129881450|NCT00856661|467524931|FG001|Overall Study|Death|18|||
129881451|NCT00856661|467524930|FG000|Overall Study|Protocol Violation|2|||
129881452|NCT00856661|467524931|FG001|Overall Study|Protocol Violation|1|||
129881453|NCT00856661|467524930|FG000|Overall Study|Withdrawal by Subject|1|||
129881454|NCT00856661|467524931|FG001|Overall Study|Withdrawal by Subject|2|||
129881455|NCT00856661|467524930|FG000|Overall Study|Lost to Follow-up|1|||
129881456|NCT00856661|467524931|FG001|Overall Study|Lost to Follow-up|3|||
129881457|NCT00856661|467524930|FG000|Overall Study|Physician Judgement|8|||
129881458|NCT00856661|467524931|FG001|Overall Study|Physician Judgement|5|||
129881459|NCT02120664|467524932|FG000|Overall Study|Withdrawal by Subject|0|||
129881460|NCT02120664|467524933|FG001|Overall Study|Withdrawal by Subject|0|||
129881461|NCT02120664|467524934|FG002|Overall Study|Withdrawal by Subject|0|||
129881462|NCT02120664|467524935|FG003|Overall Study|Withdrawal by Subject|1|||
129881463|NCT02120664|467524936|FG004|Overall Study|Withdrawal by Subject|0|||
129881464|NCT03916744|467524937|FG000|Overall Study|Withdrawal by Subject|0|||
129881465|NCT03916744|467524938|FG001|Overall Study|Withdrawal by Subject|1|||
129881466|NCT03916744|467524939|FG002|Overall Study|Withdrawal by Subject|2|||
129881467|NCT04524598|467524940|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
129881468|NCT04524598|467524941|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
129881469|NCT04524598|467524942|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
129881470|NCT04524598|467524943|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
129881471|NCT04524598|467524944|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
129881472|NCT04524598|467524940|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
129881473|NCT04524598|467524941|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
129881474|NCT04524598|467524942|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881475|NCT04524598|467524943|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881476|NCT04524598|467524944|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881477|NCT04524598|467524940|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
129881478|NCT04524598|467524941|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
129881479|NCT04524598|467524942|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
129881480|NCT04524598|467524943|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
129881481|NCT04524598|467524944|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
129881482|NCT04524598|467524940|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
129881483|NCT04524598|467524941|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
129881484|NCT04524598|467524942|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
129881485|NCT04524598|467524943|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
129881486|NCT04524598|467524944|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
129881487|NCT04524598|467524940|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881488|NCT04524598|467524941|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881489|NCT04524598|467524942|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
129881490|NCT04524598|467524943|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
129881491|NCT04524598|467524944|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881492|NCT04524598|467524940|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
129881493|NCT04524598|467524941|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
129881494|NCT04524598|467524942|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
129881495|NCT04524598|467524943|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
129881496|NCT04524598|467524944|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
129881497|NCT04524598|467524940|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881498|NCT04524598|467524941|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881499|NCT04524598|467524942|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881500|NCT04524598|467524943|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
129881501|NCT04524598|467524944|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
129881502|NCT04152343|467524945|FG000|Overall Study|Transplanted|5|||
129881503|NCT04152343|467524945|FG000|Overall Study|Death|20|||
129881504|NCT04152343|467524945|FG000|Overall Study|Lost to Follow-up|3|||
129881505|NCT02090634|467524950|FG000|Overall Study|Lost to Follow-up|0|||
129881506|NCT02090634|467524951|FG001|Overall Study|Lost to Follow-up|1|||
129881507|NCT02090634|467524950|FG000|Overall Study|Death|0|||
129881508|NCT02090634|467524951|FG001|Overall Study|Death|1|||
129881509|NCT02090634|467524950|FG000|Overall Study|Protocol Violation|3|||
129654592|NCT02906033|466692040|FG001|Follow-up|Lost to Follow-up|62|||
129881510|NCT02090634|467524951|FG001|Overall Study|Protocol Violation|1|||
129881511|NCT02090634|467524950|FG000|Overall Study|Adverse Event|2|||
129881512|NCT02090634|467524951|FG001|Overall Study|Adverse Event|0|||
129881513|NCT01965938|467524952|FG000|Overall Study|Withdrawal by Subject|1|||
129881514|NCT01965938|467524953|FG001|Overall Study|Withdrawal by Subject|0|||
129881515|NCT01164228|467524954|FG000|Overall Study|Progression|24|||
129881516|NCT01164228|467524955|FG001|Overall Study|Progression|25|||
129881517|NCT01164228|467524954|FG000|Overall Study|Adverse Event|13|||
129881518|NCT01164228|467524955|FG001|Overall Study|Adverse Event|7|||
129881519|NCT01164228|467524954|FG000|Overall Study|Death|1|||
129881520|NCT01164228|467524955|FG001|Overall Study|Death|1|||
129881521|NCT01164228|467524954|FG000|Overall Study|Withdrawal by Subject|2|||
129881522|NCT01164228|467524955|FG001|Overall Study|Withdrawal by Subject|0|||
129881523|NCT01164228|467524954|FG000|Overall Study|Physician Decision|1|||
129881524|NCT01164228|467524955|FG001|Overall Study|Physician Decision|2|||
129881525|NCT01164228|467524954|FG000|Overall Study|Symptomatic deterioration|1|||
129881526|NCT01164228|467524955|FG001|Overall Study|Symptomatic deterioration|0|||
129881527|NCT01164228|467524954|FG000|Overall Study|Never started treatment|1|||
129881528|NCT01164228|467524955|FG001|Overall Study|Never started treatment|3|||
129881529|NCT01164228|467524954|FG000|Overall Study|Ineligible|1|||
129881530|NCT01164228|467524955|FG001|Overall Study|Ineligible|0|||
129881531|NCT03757234|467524956|FG000|Overall Study|Adverse Event|0|||
129881532|NCT03757234|467524957|FG001|Overall Study|Adverse Event|0|||
129881533|NCT03757234|467524958|FG002|Overall Study|Adverse Event|0|||
129881534|NCT03757234|467524959|FG003|Overall Study|Adverse Event|0|||
129881535|NCT03757234|467524960|FG004|Overall Study|Adverse Event|1|||
129881536|NCT03757234|467524956|FG000|Overall Study|Lost to Follow-up|1|||
129881537|NCT03757234|467524957|FG001|Overall Study|Lost to Follow-up|0|||
129881538|NCT03757234|467524958|FG002|Overall Study|Lost to Follow-up|0|||
129881539|NCT03757234|467524959|FG003|Overall Study|Lost to Follow-up|0|||
129881540|NCT03757234|467524960|FG004|Overall Study|Lost to Follow-up|1|||
129881541|NCT03757234|467524956|FG000|Overall Study|Withdrawal by Subject|1|||
129881542|NCT03757234|467524957|FG001|Overall Study|Withdrawal by Subject|1|||
129881543|NCT03757234|467524958|FG002|Overall Study|Withdrawal by Subject|0|||
129881544|NCT03757234|467524959|FG003|Overall Study|Withdrawal by Subject|1|||
129881545|NCT03757234|467524960|FG004|Overall Study|Withdrawal by Subject|2|||
129881546|NCT03757234|467524956|FG000|Overall Study|Other|1|||
129881547|NCT03757234|467524957|FG001|Overall Study|Other|1|||
129881548|NCT03757234|467524958|FG002|Overall Study|Other|0|||
129881549|NCT03757234|467524959|FG003|Overall Study|Other|0|||
129881550|NCT03757234|467524960|FG004|Overall Study|Other|0|||
129881551|NCT01871558|467524963|FG000|Overall Study|Other reason|0|||
129881552|NCT01871558|467524964|FG001|Overall Study|Other reason|1|||
129881553|NCT01871558|467524963|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
129881554|NCT01871558|467524964|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
129881555|NCT01871558|467524963|FG000|Overall Study|Withdrawal by Subject|2|||
129881556|NCT01871558|467524964|FG001|Overall Study|Withdrawal by Subject|0|||
129881557|NCT01103960|467524970|FG000|Overall Study|Adverse Event|2|||
129881558|NCT01103960|467524971|FG001|Overall Study|Adverse Event|1|||
129881559|NCT01103960|467524970|FG000|Overall Study|Withdrawal by Subject|2|||
129881560|NCT01103960|467524971|FG001|Overall Study|Withdrawal by Subject|1|||
129881561|NCT01103960|467524970|FG000|Overall Study|Other|1|||
129881562|NCT01103960|467524971|FG001|Overall Study|Other|0|||
129881563|NCT04287868|467524978|FG000|Overall Study|Screening fail|1|||
129881564|NCT04287868|467524979|FG001|Overall Study|Screening fail|0|||
129881565|NCT02105636|467526945|FG000|Pre-Treatment|Disease Progression|1|||
129881566|NCT02105636|467526946|FG001|Pre-Treatment|Disease Progression|0|||
129881567|NCT02105636|467526945|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
129654593|NCT01333956|466692051|FG000|Overall Study|Lost to Follow-up|1|||
129654594|NCT01333956|466692052|FG001|Overall Study|Lost to Follow-up|2|||
129654595|NCT01333956|466692053|FG002|Overall Study|Lost to Follow-up|0|||
129881568|NCT02105636|467526946|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
129654596|NCT01333956|466692054|FG003|Overall Study|Lost to Follow-up|1|||
129654597|NCT01333956|466692051|FG000|Overall Study|Unable to complete study procedure|1|||
129881569|NCT02105636|467526945|FG000|Pre-Treatment|Participant withdrew consent|0|||
129654598|NCT01333956|466692052|FG001|Overall Study|Unable to complete study procedure|0|||
129881570|NCT02105636|467526946|FG001|Pre-Treatment|Participant withdrew consent|6|||
129881571|NCT02105636|467526945|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129881572|NCT02105636|467526946|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
129881573|NCT02105636|467526945|FG000|Treatment|Study Drug Toxicity|14|||
129881574|NCT02105636|467526946|FG001|Treatment|Study Drug Toxicity|10|||
129881575|NCT02105636|467526945|FG000|Treatment|Adverse event unrelated to study drug|19|||
129881576|NCT02105636|467526946|FG001|Treatment|Adverse event unrelated to study drug|3|||
129881577|NCT02105636|467526945|FG000|Treatment|Participant request to discontinue study treatment|8|||
129881578|NCT02105636|467526946|FG001|Treatment|Participant request to discontinue study treatment|6|||
129881579|NCT02105636|467526945|FG000|Treatment|Participant withdrew consent|5|||
129881580|NCT02105636|467526946|FG001|Treatment|Participant withdrew consent|1|||
129881581|NCT02105636|467526945|FG000|Treatment|Lost to Follow-up|1|||
129881582|NCT02105636|467526946|FG001|Treatment|Lost to Follow-up|0|||
129881583|NCT02105636|467526945|FG000|Treatment|Maximum Clinical Benefit|1|||
129881584|NCT02105636|467526946|FG001|Treatment|Maximum Clinical Benefit|3|||
129881585|NCT02105636|467526945|FG000|Treatment|Poor/Non-compliance|0|||
129881586|NCT02105636|467526946|FG001|Treatment|Poor/Non-compliance|1|||
129881587|NCT02105636|467526945|FG000|Treatment|Participant no longer meets study criteria|1|||
129881588|NCT02105636|467526946|FG001|Treatment|Participant no longer meets study criteria|0|||
129881589|NCT02105636|467526945|FG000|Treatment|Other reasons|1|||
129881590|NCT02105636|467526946|FG001|Treatment|Other reasons|0|||
129881591|NCT02105636|467526945|FG000|Treatment|Disease Progression|185|||
129881592|NCT02105636|467526946|FG001|Treatment|Disease Progression|87|||
129881593|NCT00235443|467526948|FG000|Overall Study|Adverse Event|4|||
129881594|NCT00235443|467526949|FG001|Overall Study|Adverse Event|12|||
129881595|NCT00235443|467526950|FG002|Overall Study|Adverse Event|17|||
129881596|NCT00235443|467526951|FG003|Overall Study|Adverse Event|44|||
129881597|NCT00235443|467526952|FG004|Overall Study|Adverse Event|10|||
129881598|NCT00235443|467526953|FG005|Overall Study|Adverse Event|15|||
129881599|NCT00235443|467526948|FG000|Overall Study|Lack of Efficacy|0|||
129881600|NCT00235443|467526949|FG001|Overall Study|Lack of Efficacy|1|||
129881601|NCT00235443|467526950|FG002|Overall Study|Lack of Efficacy|5|||
129881602|NCT00235443|467526951|FG003|Overall Study|Lack of Efficacy|12|||
129881603|NCT00235443|467526952|FG004|Overall Study|Lack of Efficacy|2|||
129881604|NCT00235443|467526953|FG005|Overall Study|Lack of Efficacy|9|||
129881605|NCT00235443|467526948|FG000|Overall Study|Withdrawal by Subject|3|||
129881606|NCT00235443|467526949|FG001|Overall Study|Withdrawal by Subject|9|||
129881607|NCT00235443|467526950|FG002|Overall Study|Withdrawal by Subject|25|||
129881608|NCT00235443|467526951|FG003|Overall Study|Withdrawal by Subject|24|||
129881609|NCT00235443|467526952|FG004|Overall Study|Withdrawal by Subject|10|||
129881610|NCT00235443|467526953|FG005|Overall Study|Withdrawal by Subject|12|||
129881611|NCT00235443|467526948|FG000|Overall Study|Lost to Follow-up|0|||
129881612|NCT00235443|467526949|FG001|Overall Study|Lost to Follow-up|8|||
129881613|NCT00235443|467526950|FG002|Overall Study|Lost to Follow-up|6|||
129881614|NCT00235443|467526951|FG003|Overall Study|Lost to Follow-up|6|||
129881615|NCT00235443|467526952|FG004|Overall Study|Lost to Follow-up|4|||
129881616|NCT00235443|467526953|FG005|Overall Study|Lost to Follow-up|3|||
129881617|NCT00235443|467526948|FG000|Overall Study|Unsatisfactory compliance|0|||
129881618|NCT00235443|467526949|FG001|Overall Study|Unsatisfactory compliance|2|||
129881619|NCT00235443|467526950|FG002|Overall Study|Unsatisfactory compliance|3|||
129881620|NCT00235443|467526951|FG003|Overall Study|Unsatisfactory compliance|4|||
129881621|NCT00235443|467526952|FG004|Overall Study|Unsatisfactory compliance|1|||
129881622|NCT00235443|467526953|FG005|Overall Study|Unsatisfactory compliance|0|||
129881623|NCT00235443|467526948|FG000|Overall Study|Other reasons for premature termination|1|||
129881624|NCT00235443|467526949|FG001|Overall Study|Other reasons for premature termination|6|||
129881625|NCT00235443|467526950|FG002|Overall Study|Other reasons for premature termination|6|||
129881626|NCT00235443|467526951|FG003|Overall Study|Other reasons for premature termination|7|||
129881627|NCT00235443|467526952|FG004|Overall Study|Other reasons for premature termination|3|||
129881628|NCT00235443|467526953|FG005|Overall Study|Other reasons for premature termination|6|||
129881629|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
129881630|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
129881631|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
129881632|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
129881633|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
129881634|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
129881635|NCT03029247|467526954|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
129881636|NCT03029247|467526955|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
129881637|NCT01976364|467526958|FG000|Main Study (36 Months)|Adverse Event|63|||
129881638|NCT01976364|467526959|FG001|Main Study (36 Months)|Adverse Event|0|||
129881639|NCT01976364|467526960|FG002|Main Study (36 Months)|Adverse Event|0|||
129881640|NCT01976364|467526958|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
129881641|NCT01976364|467526959|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
129881642|NCT01976364|467526960|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
129881643|NCT01976364|467526958|FG000|Main Study (36 Months)|Other|13|||
129881644|NCT01976364|467526959|FG001|Main Study (36 Months)|Other|0|||
129881645|NCT01976364|467526960|FG002|Main Study (36 Months)|Other|0|||
129881646|NCT01976364|467526958|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
129881647|NCT01976364|467526959|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
129881648|NCT01976364|467526960|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
129881649|NCT01976364|467526958|FG000|Main Study (36 Months)|Medication error|1|||
129881650|NCT01976364|467526959|FG001|Main Study (36 Months)|Medication error|0|||
129881651|NCT01976364|467526960|FG002|Main Study (36 Months)|Medication error|0|||
129881652|NCT01976364|467526958|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
129881653|NCT01976364|467526959|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
129881654|NCT01976364|467526960|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
129881655|NCT01976364|467526958|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
129881656|NCT01976364|467526959|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
129881657|NCT01976364|467526960|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
129881658|NCT01976364|467526958|FG000|Main Study (36 Months)|Protocol Violation|13|||
129881659|NCT01976364|467526959|FG001|Main Study (36 Months)|Protocol Violation|0|||
129881660|NCT01976364|467526960|FG002|Main Study (36 Months)|Protocol Violation|0|||
129881661|NCT01976364|467526958|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
129881662|NCT01976364|467526959|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
129881663|NCT01976364|467526960|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
129881664|NCT01976364|467526958|FG000|Main Study (36 Months)|Death|5|||
129881665|NCT01976364|467526959|FG001|Main Study (36 Months)|Death|0|||
129881666|NCT01976364|467526960|FG002|Main Study (36 Months)|Death|0|||
129881667|NCT01976364|467526958|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
129881668|NCT01976364|467526959|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
129881669|NCT01976364|467526960|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
129881670|NCT01976364|467526958|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
129881671|NCT01976364|467526959|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
129881672|NCT01976364|467526960|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
129881673|NCT01976364|467526958|FG000|Sub-study (12 Months)|Protocol Violation|0|||
129881674|NCT01976364|467526959|FG001|Sub-study (12 Months)|Protocol Violation|1|||
129881675|NCT01976364|467526960|FG002|Sub-study (12 Months)|Protocol Violation|1|||
129881676|NCT01976364|467526958|FG000|Sub-study (12 Months)|Adverse Event|0|||
129881677|NCT01976364|467526959|FG001|Sub-study (12 Months)|Adverse Event|4|||
129707760|NCT01280968|466892118|FG001|Overall Study|Anxiety|0|||
129881678|NCT01976364|467526960|FG002|Sub-study (12 Months)|Adverse Event|3|||
129881679|NCT02318719|467526962|FG000|Double-blind Phase|Adverse Event|7|||
129881680|NCT02318719|467526963|FG001|Double-blind Phase|Adverse Event|6|||
129881681|NCT02318719|467526964|FG002|Double-blind Phase|Adverse Event|12|||
129881682|NCT02318719|467526965|FG003|Double-blind Phase|Adverse Event|4|||
129881683|NCT02318719|467526966|FG004|Double-blind Phase|Adverse Event|0|||
129881684|NCT02318719|467526962|FG000|Double-blind Phase|Lack of Efficacy|5|||
129881685|NCT02318719|467526963|FG001|Double-blind Phase|Lack of Efficacy|0|||
129881686|NCT02318719|467526964|FG002|Double-blind Phase|Lack of Efficacy|1|||
129881687|NCT02318719|467526965|FG003|Double-blind Phase|Lack of Efficacy|1|||
129881688|NCT02318719|467526966|FG004|Double-blind Phase|Lack of Efficacy|0|||
129881689|NCT02318719|467526962|FG000|Double-blind Phase|Protocol Violation|0|||
129881690|NCT02318719|467526963|FG001|Double-blind Phase|Protocol Violation|1|||
129881691|NCT02318719|467526964|FG002|Double-blind Phase|Protocol Violation|3|||
129881692|NCT02318719|467526965|FG003|Double-blind Phase|Protocol Violation|0|||
129881693|NCT02318719|467526966|FG004|Double-blind Phase|Protocol Violation|0|||
129881694|NCT02318719|467526962|FG000|Double-blind Phase|Withdrawal by Subject|25|||
129881695|NCT02318719|467526963|FG001|Double-blind Phase|Withdrawal by Subject|7|||
129881696|NCT02318719|467526964|FG002|Double-blind Phase|Withdrawal by Subject|9|||
129881697|NCT02318719|467526965|FG003|Double-blind Phase|Withdrawal by Subject|10|||
129881698|NCT02318719|467526966|FG004|Double-blind Phase|Withdrawal by Subject|0|||
129881699|NCT02318719|467526962|FG000|Double-blind Phase|Other|1|||
129881700|NCT02318719|467526963|FG001|Double-blind Phase|Other|2|||
129881701|NCT02318719|467526964|FG002|Double-blind Phase|Other|0|||
129881702|NCT02318719|467526965|FG003|Double-blind Phase|Other|0|||
129881703|NCT02318719|467526966|FG004|Double-blind Phase|Other|0|||
129881704|NCT02318719|467526962|FG000|Open-label Extension Phase|Adverse Event|0|||
129881705|NCT02318719|467526963|FG001|Open-label Extension Phase|Adverse Event|0|||
129881706|NCT02318719|467526964|FG002|Open-label Extension Phase|Adverse Event|0|||
129881707|NCT02318719|467526965|FG003|Open-label Extension Phase|Adverse Event|0|||
129881708|NCT02318719|467526966|FG004|Open-label Extension Phase|Adverse Event|15|||
129881709|NCT02318719|467526962|FG000|Open-label Extension Phase|Death|0|||
129881710|NCT02318719|467526963|FG001|Open-label Extension Phase|Death|0|||
129881711|NCT02318719|467526964|FG002|Open-label Extension Phase|Death|0|||
129881712|NCT02318719|467526965|FG003|Open-label Extension Phase|Death|0|||
129881713|NCT02318719|467526966|FG004|Open-label Extension Phase|Death|1|||
129881714|NCT02318719|467526962|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
129881715|NCT02318719|467526963|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
129881716|NCT02318719|467526964|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
129881717|NCT02318719|467526965|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
129881718|NCT02318719|467526966|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
129881719|NCT02318719|467526962|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
129881720|NCT02318719|467526963|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
129881721|NCT02318719|467526964|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
129881722|NCT02318719|467526965|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
129881723|NCT02318719|467526966|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
129881724|NCT02318719|467526962|FG000|Open-label Extension Phase|Other|0|||
129881725|NCT02318719|467526963|FG001|Open-label Extension Phase|Other|0|||
129881726|NCT02318719|467526964|FG002|Open-label Extension Phase|Other|0|||
129881727|NCT02318719|467526965|FG003|Open-label Extension Phase|Other|0|||
129881728|NCT02318719|467526966|FG004|Open-label Extension Phase|Other|7|||
129881729|NCT01868035|467526967|FG000|Overall Study|Lost to Follow-up|3|||
129881730|NCT01868035|467526967|FG000|Overall Study|Withdrawal by Subject|1|||
129881731|NCT01868035|467526967|FG000|Overall Study|Progressive Disease|2|||
129881732|NCT01868035|467526967|FG000|Overall Study|Non-compliance|1|||
129881733|NCT00432835|467526968|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
129881734|NCT00432835|467526969|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
129881735|NCT00423293|467526970|FG000|Overall Study|Ineligible / No protocol treatment|11|||
129881736|NCT01912222|467526971|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
129881737|NCT01912222|467526972|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
129881738|NCT01912222|467526973|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
129881739|NCT01912222|467526971|FG000|Part B: Treatment Period|Progressive disease|10|||
129881740|NCT01912222|467526972|FG001|Part B: Treatment Period|Progressive disease|12|||
129881741|NCT01912222|467526973|FG002|Part B: Treatment Period|Progressive disease|15|||
129881742|NCT01912222|467526971|FG000|Part B: Treatment Period|Adverse Event|1|||
129881743|NCT01912222|467526972|FG001|Part B: Treatment Period|Adverse Event|2|||
129881744|NCT01912222|467526973|FG002|Part B: Treatment Period|Adverse Event|3|||
129881745|NCT01912222|467526971|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
129881746|NCT01912222|467526972|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
129881747|NCT01912222|467526973|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
129881748|NCT03154359|467526974|FG000|Overall Study|Adverse Event|1|||
129881749|NCT03154359|467526974|FG000|Overall Study|Lack of Efficacy|2|||
129881750|NCT03154359|467526974|FG000|Overall Study|Lost to Follow-up|3|||
129881751|NCT03154359|467526974|FG000|Overall Study|Physician Decision|3|||
129881752|NCT03154359|467526974|FG000|Overall Study|Protocol Violation|4|||
129881753|NCT03154359|467526974|FG000|Overall Study|Withdrawal by Subject|5|||
129881754|NCT03154359|467526974|FG000|Overall Study|Disruption of study due to COVID-19|4|||
129881755|NCT00562978|467526975|FG000|Overall Study|Patient had imaging dose only|1|||
129881756|NCT00562978|467526976|FG001|Overall Study|Patient had imaging dose only|11|||
129881757|NCT00152971|467526978|FG000|Overall Study|Adverse Event|12|||
129881758|NCT00152971|467526979|FG001|Overall Study|Adverse Event|10|||
129881759|NCT00152971|467526980|FG002|Overall Study|Adverse Event|9|||
129881760|NCT00152971|467526978|FG000|Overall Study|Protocol Violation|10|||
129881761|NCT00152971|467526979|FG001|Overall Study|Protocol Violation|11|||
129881762|NCT00152971|467526980|FG002|Overall Study|Protocol Violation|8|||
129881763|NCT00152971|467526978|FG000|Overall Study|Lost to Follow-up|17|||
129881764|NCT00152971|467526979|FG001|Overall Study|Lost to Follow-up|14|||
129881765|NCT00152971|467526980|FG002|Overall Study|Lost to Follow-up|13|||
129881766|NCT00152971|467526978|FG000|Overall Study|Withdrawal by Subject|9|||
129881767|NCT00152971|467526979|FG001|Overall Study|Withdrawal by Subject|8|||
129881768|NCT00152971|467526980|FG002|Overall Study|Withdrawal by Subject|14|||
129881769|NCT00152971|467526978|FG000|Overall Study|Other|3|||
129881770|NCT00152971|467526979|FG001|Overall Study|Other|5|||
129881771|NCT00152971|467526980|FG002|Overall Study|Other|5|||
129881772|NCT00152971|467526978|FG000|Treatment|Adverse Event|49|||
129881773|NCT00152971|467526979|FG001|Treatment|Adverse Event|40|||
129881774|NCT00152971|467526980|FG002|Treatment|Adverse Event|54|||
129881775|NCT00152971|467526978|FG000|Treatment|Protocol Violation|8|||
129881776|NCT00152971|467526979|FG001|Treatment|Protocol Violation|6|||
129881777|NCT00152971|467526980|FG002|Treatment|Protocol Violation|10|||
129881778|NCT00152971|467526978|FG000|Treatment|Lost to Follow-up|1|||
129881779|NCT00152971|467526979|FG001|Treatment|Lost to Follow-up|2|||
129881780|NCT00152971|467526980|FG002|Treatment|Lost to Follow-up|1|||
129881781|NCT00152971|467526978|FG000|Treatment|Withdrawal by Subject|4|||
129881782|NCT00152971|467526979|FG001|Treatment|Withdrawal by Subject|4|||
129881783|NCT00152971|467526980|FG002|Treatment|Withdrawal by Subject|5|||
129881784|NCT00152971|467526978|FG000|Treatment|Other|9|||
129881785|NCT00152971|467526979|FG001|Treatment|Other|11|||
129881786|NCT00152971|467526980|FG002|Treatment|Other|10|||
129881787|NCT03125941|467526987|FG000|Overall Study|did not receive intervention|1|||
129881788|NCT03125941|467526988|FG001|Overall Study|did not receive intervention|2|||
129881789|NCT03853317|467526989|FG000|Overall Study|Progressive Disease|5|||
129881790|NCT03853317|467526989|FG000|Overall Study|Adverse Event|1|||
129881791|NCT03853317|467526989|FG000|Overall Study|Death|1|||
129881792|NCT03853317|467526989|FG000|Overall Study|other event|2|||
129881793|NCT00779584|467526990|FG000|Overall Study|Protocol Violation|0|||
129881794|NCT00779584|467526991|FG001|Overall Study|Protocol Violation|0|||
129881795|NCT00779584|467526992|FG002|Overall Study|Protocol Violation|0|||
129881796|NCT00779584|467526993|FG003|Overall Study|Protocol Violation|0|||
129881797|NCT00779584|467526994|FG004|Overall Study|Protocol Violation|0|||
129881798|NCT00779584|467526995|FG005|Overall Study|Protocol Violation|1|||
129881799|NCT00779584|467526996|FG006|Overall Study|Protocol Violation|0|||
129881800|NCT00779584|467526997|FG007|Overall Study|Protocol Violation|0|||
129881801|NCT00779584|467526998|FG008|Overall Study|Protocol Violation|0|||
129881802|NCT00779584|467526990|FG000|Overall Study|Withdrawal by Subject|1|||
129881803|NCT00779584|467526991|FG001|Overall Study|Withdrawal by Subject|1|||
129881804|NCT00779584|467526992|FG002|Overall Study|Withdrawal by Subject|2|||
129881805|NCT00779584|467526993|FG003|Overall Study|Withdrawal by Subject|0|||
129881806|NCT00779584|467526994|FG004|Overall Study|Withdrawal by Subject|0|||
129881807|NCT00779584|467526995|FG005|Overall Study|Withdrawal by Subject|2|||
129654599|NCT01333956|466692053|FG002|Overall Study|Unable to complete study procedure|0|||
129654600|NCT01333956|466692054|FG003|Overall Study|Unable to complete study procedure|1|||
129654601|NCT01333956|466692051|FG000|Overall Study|Withdrawal by Subject|0|||
129654602|NCT01333956|466692052|FG001|Overall Study|Withdrawal by Subject|2|||
129654603|NCT01333956|466692053|FG002|Overall Study|Withdrawal by Subject|1|||
129654604|NCT01333956|466692054|FG003|Overall Study|Withdrawal by Subject|0|||
129654605|NCT02240069|466692055|FG000|Overall Study|Withdrawal by Subject|5|||
129654606|NCT02240069|466692056|FG001|Overall Study|Withdrawal by Subject|5|||
129654607|NCT02240069|466692057|FG002|Overall Study|Withdrawal by Subject|2|||
129654608|NCT03723070|466692058|FG000|Overall Study|Lost to Follow-up|2|||
129654609|NCT03723070|466692058|FG000|Overall Study|Physician Decision|1|||
129654610|NCT03723070|466692058|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
129654611|NCT00474786|466692059|FG000|Overall Study|Not Meeting Study Criteria|0|||
129654612|NCT00474786|466692060|FG001|Overall Study|Not Meeting Study Criteria|1|||
129654613|NCT00474786|466692059|FG000|Overall Study|Investigator Request|2|||
129654614|NCT00474786|466692060|FG001|Overall Study|Investigator Request|1|||
129654615|NCT00474786|466692059|FG000|Overall Study|Death|189|||
129654616|NCT00474786|466692060|FG001|Overall Study|Death|170|||
129654617|NCT00474786|466692059|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
129654618|NCT00474786|466692060|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
129654619|NCT00474786|466692059|FG000|Overall Study|Lost to Follow-up|4|||
129654620|NCT00474786|466692060|FG001|Overall Study|Lost to Follow-up|7|||
129654621|NCT00474786|466692059|FG000|Overall Study|Protocol Violation|2|||
129654622|NCT00474786|466692060|FG001|Overall Study|Protocol Violation|0|||
129654623|NCT00474786|466692059|FG000|Overall Study|Withdrawal by Subject|15|||
129654624|NCT00474786|466692060|FG001|Overall Study|Withdrawal by Subject|15|||
129654625|NCT00474786|466692059|FG000|Overall Study|Other|5|||
129654626|NCT00474786|466692060|FG001|Overall Study|Other|0|||
129654627|NCT03646305|466692063|FG000|Overall Study|Lost to Follow-up|4|||
129654628|NCT03646305|466692064|FG001|Overall Study|Lost to Follow-up|2|||
129654629|NCT03646305|466692065|FG002|Overall Study|Lost to Follow-up|2|||
129654630|NCT03646305|466692066|FG003|Overall Study|Lost to Follow-up|1|||
129654631|NCT03646305|466692063|FG000|Overall Study|Withdrawal by Subject|1|||
129654632|NCT03646305|466692064|FG001|Overall Study|Withdrawal by Subject|0|||
129654633|NCT03646305|466692065|FG002|Overall Study|Withdrawal by Subject|0|||
129654634|NCT03646305|466692066|FG003|Overall Study|Withdrawal by Subject|1|||
129654635|NCT03417024|466692067|FG000|Overall Study|Study Termination prior to follow-up|11|||
129654636|NCT03417024|466692067|FG000|Overall Study|Physician Decision|2|||
129654637|NCT02195427|466692068|FG000|Overall Study|Did not consent to study extension|13|||
129654638|NCT02195427|466692069|FG001|Overall Study|Did not consent to study extension|9|||
129654639|NCT02195427|466692068|FG000|Overall Study|Withdrawal by Subject|4|||
129654640|NCT02195427|466692069|FG001|Overall Study|Withdrawal by Subject|2|||
129881808|NCT00779584|467526996|FG006|Overall Study|Withdrawal by Subject|1|||
129881809|NCT00779584|467526997|FG007|Overall Study|Withdrawal by Subject|0|||
129881810|NCT00779584|467526998|FG008|Overall Study|Withdrawal by Subject|0|||
129881811|NCT00779584|467526990|FG000|Overall Study|Lost to Follow-up|0|||
129881812|NCT00779584|467526991|FG001|Overall Study|Lost to Follow-up|0|||
129881813|NCT00779584|467526992|FG002|Overall Study|Lost to Follow-up|0|||
129881814|NCT00779584|467526993|FG003|Overall Study|Lost to Follow-up|0|||
129881815|NCT00779584|467526994|FG004|Overall Study|Lost to Follow-up|1|||
129881816|NCT00779584|467526995|FG005|Overall Study|Lost to Follow-up|0|||
129881817|NCT00779584|467526996|FG006|Overall Study|Lost to Follow-up|0|||
129881818|NCT00779584|467526997|FG007|Overall Study|Lost to Follow-up|0|||
129881819|NCT00779584|467526998|FG008|Overall Study|Lost to Follow-up|0|||
129881820|NCT00779584|467526990|FG000|Overall Study|Progression of Disease|0|||
129881821|NCT00779584|467526991|FG001|Overall Study|Progression of Disease|1|||
129881822|NCT00779584|467526992|FG002|Overall Study|Progression of Disease|2|||
129881823|NCT00779584|467526993|FG003|Overall Study|Progression of Disease|6|||
129881824|NCT00779584|467526994|FG004|Overall Study|Progression of Disease|5|||
129881825|NCT00779584|467526995|FG005|Overall Study|Progression of Disease|1|||
129881826|NCT00779584|467526996|FG006|Overall Study|Progression of Disease|4|||
129881827|NCT00779584|467526997|FG007|Overall Study|Progression of Disease|2|||
129881828|NCT00779584|467526998|FG008|Overall Study|Progression of Disease|1|||
129881829|NCT00779584|467526990|FG000|Overall Study|Adverse Event|1|||
129881830|NCT00779584|467526991|FG001|Overall Study|Adverse Event|0|||
129881831|NCT00779584|467526992|FG002|Overall Study|Adverse Event|2|||
129881832|NCT00779584|467526993|FG003|Overall Study|Adverse Event|0|||
129881833|NCT00779584|467526994|FG004|Overall Study|Adverse Event|0|||
129881834|NCT00779584|467526995|FG005|Overall Study|Adverse Event|0|||
129654641|NCT02195427|466692068|FG000|Overall Study|Lost to Follow-up|0|||
129654642|NCT02195427|466692069|FG001|Overall Study|Lost to Follow-up|1|||
129654643|NCT02195427|466692068|FG000|Overall Study|Protocol Violation|7|||
129654644|NCT02195427|466692069|FG001|Overall Study|Protocol Violation|14|||
129654645|NCT02195427|466692068|FG000|Overall Study|Conditional re-treatment at W52|2|||
129654646|NCT02195427|466692069|FG001|Overall Study|Conditional re-treatment at W52|1|||
129707761|NCT01280968|466892117|FG000|Overall Study|Adverse Event|1|||
129881835|NCT00779584|467526996|FG006|Overall Study|Adverse Event|2|||
129881836|NCT00779584|467526997|FG007|Overall Study|Adverse Event|1|||
129881837|NCT00779584|467526998|FG008|Overall Study|Adverse Event|1|||
129881838|NCT00779584|467526990|FG000|Overall Study|Symptomatic Deterioration|1|||
129881839|NCT00779584|467526991|FG001|Overall Study|Symptomatic Deterioration|1|||
129881840|NCT00779584|467526992|FG002|Overall Study|Symptomatic Deterioration|1|||
129881841|NCT00779584|467526993|FG003|Overall Study|Symptomatic Deterioration|0|||
129881842|NCT00779584|467526994|FG004|Overall Study|Symptomatic Deterioration|0|||
129881843|NCT00779584|467526995|FG005|Overall Study|Symptomatic Deterioration|1|||
129881844|NCT00779584|467526996|FG006|Overall Study|Symptomatic Deterioration|1|||
129881845|NCT00779584|467526997|FG007|Overall Study|Symptomatic Deterioration|0|||
129881846|NCT00779584|467526998|FG008|Overall Study|Symptomatic Deterioration|0|||
129881847|NCT00779584|467526990|FG000|Overall Study|Ongoing in Study|0|||
129881848|NCT00779584|467526991|FG001|Overall Study|Ongoing in Study|0|||
129881849|NCT00779584|467526992|FG002|Overall Study|Ongoing in Study|0|||
129881850|NCT00779584|467526993|FG003|Overall Study|Ongoing in Study|0|||
129881851|NCT00779584|467526994|FG004|Overall Study|Ongoing in Study|1|||
129881852|NCT00779584|467526995|FG005|Overall Study|Ongoing in Study|1|||
129881853|NCT00779584|467526996|FG006|Overall Study|Ongoing in Study|0|||
129881854|NCT00779584|467526997|FG007|Overall Study|Ongoing in Study|0|||
129881855|NCT00779584|467526998|FG008|Overall Study|Ongoing in Study|0|||
129881856|NCT00406419|467527001|FG000|Overall Study|Death|3|||
129881857|NCT00406419|467527002|FG001|Overall Study|Death|1|||
129881858|NCT00406419|467527003|FG002|Overall Study|Death|4|||
129881859|NCT00406419|467527001|FG000|Overall Study|Protocol Violation|6|||
129881860|NCT00406419|467527002|FG001|Overall Study|Protocol Violation|2|||
129881861|NCT00406419|467527003|FG002|Overall Study|Protocol Violation|5|||
129881862|NCT00406419|467527001|FG000|Overall Study|Study Terminated by Sponsor|260|||
129881863|NCT00406419|467527002|FG001|Overall Study|Study Terminated by Sponsor|288|||
129881864|NCT00406419|467527003|FG002|Overall Study|Study Terminated by Sponsor|282|||
129881865|NCT00406419|467527001|FG000|Overall Study|Withdrawal by Subject|17|||
129881866|NCT00406419|467527002|FG001|Overall Study|Withdrawal by Subject|24|||
129881867|NCT00406419|467527003|FG002|Overall Study|Withdrawal by Subject|26|||
129881868|NCT00406419|467527001|FG000|Overall Study|Lack of Efficacy|12|||
129881869|NCT00406419|467527002|FG001|Overall Study|Lack of Efficacy|1|||
129881870|NCT00406419|467527003|FG002|Overall Study|Lack of Efficacy|6|||
129545132|NCT03917654|466288437|FG002|Year 1|Subject moved away from site|0|||
129545133|NCT03917654|466288438|FG003|Year 1|Subject moved away from site|0|||
129545134|NCT03917654|466288439|FG004|Year 1|Subject moved away from site|0|||
129545135|NCT03917654|466288440|FG005|Year 1|Subject moved away from site|0|||
129545136|NCT03917654|466288441|FG006|Year 1|Subject moved away from site|1|||
129545137|NCT03917654|466288442|FG007|Year 1|Subject moved away from site|2|||
129545138|NCT03917654|466288443|FG008|Year 1|Subject moved away from site|1|||
129545139|NCT03917654|466288444|FG009|Year 1|Subject moved away from site|0|||
129545140|NCT03917654|466288445|FG010|Year 1|Subject moved away from site|0|||
129545141|NCT03917654|466288446|FG011|Year 1|Subject moved away from site|3|||
129545142|NCT03917654|466288435|FG000|Year 1|Spouse/Family member request|0|||
129545143|NCT03917654|466288436|FG001|Year 1|Spouse/Family member request|0|||
129545144|NCT03917654|466288437|FG002|Year 1|Spouse/Family member request|1|||
129545145|NCT03917654|466288438|FG003|Year 1|Spouse/Family member request|0|||
129545146|NCT03917654|466288439|FG004|Year 1|Spouse/Family member request|1|||
129545147|NCT03917654|466288440|FG005|Year 1|Spouse/Family member request|0|||
129545148|NCT03917654|466288441|FG006|Year 1|Spouse/Family member request|0|||
129545149|NCT03917654|466288442|FG007|Year 1|Spouse/Family member request|2|||
129545150|NCT03917654|466288443|FG008|Year 1|Spouse/Family member request|0|||
129545151|NCT03917654|466288444|FG009|Year 1|Spouse/Family member request|0|||
129545152|NCT03917654|466288445|FG010|Year 1|Spouse/Family member request|0|||
129545153|NCT03917654|466288446|FG011|Year 1|Spouse/Family member request|1|||
129545154|NCT03917654|466288435|FG000|Year 1|Death|0|||
129545155|NCT03917654|466288436|FG001|Year 1|Death|0|||
129545156|NCT03917654|466288437|FG002|Year 1|Death|0|||
129545157|NCT03917654|466288438|FG003|Year 1|Death|0|||
129545158|NCT03917654|466288439|FG004|Year 1|Death|0|||
129545159|NCT03917654|466288440|FG005|Year 1|Death|0|||
129545160|NCT03917654|466288441|FG006|Year 1|Death|0|||
129545161|NCT03917654|466288442|FG007|Year 1|Death|0|||
129545162|NCT03917654|466288443|FG008|Year 1|Death|1|||
129881871|NCT00406419|467527001|FG000|Overall Study|Non-Compliance with Study Drug|5|||
129881872|NCT00406419|467527002|FG001|Overall Study|Non-Compliance with Study Drug|6|||
129881873|NCT00406419|467527003|FG002|Overall Study|Non-Compliance with Study Drug|3|||
129881874|NCT00406419|467527001|FG000|Overall Study|Adverse Event|10|||
129881875|NCT00406419|467527002|FG001|Overall Study|Adverse Event|12|||
129881876|NCT00406419|467527003|FG002|Overall Study|Adverse Event|16|||
129545163|NCT03917654|466288444|FG009|Year 1|Death|1|||
129545164|NCT03917654|466288445|FG010|Year 1|Death|0|||
129545165|NCT03917654|466288446|FG011|Year 1|Death|0|||
129545166|NCT03917654|466288435|FG000|Year 1|Lost to Follow-up|0|||
129545167|NCT03917654|466288436|FG001|Year 1|Lost to Follow-up|0|||
129545168|NCT03917654|466288437|FG002|Year 1|Lost to Follow-up|0|||
129881877|NCT00406419|467527001|FG000|Overall Study|Lost to Follow-up|11|||
129881878|NCT00406419|467527002|FG001|Overall Study|Lost to Follow-up|10|||
129881879|NCT00406419|467527003|FG002|Overall Study|Lost to Follow-up|5|||
129881880|NCT02878213|467527004|FG000|Overall Study|Withdrawal by Subject|2|||
129881881|NCT02878213|467527004|FG000|Overall Study|Adverse Event|1|||
129881882|NCT02494206|467527020|FG000|Overall Study|Adverse Event|1|||
129881883|NCT02494206|467527020|FG000|Overall Study|Disease Progression|1|||
129881884|NCT04986982|467527022|FG000|Overall Study|Withdrawal by Subject|3|||
129881885|NCT04986982|467527023|FG001|Overall Study|Withdrawal by Subject|1|||
129881886|NCT04986982|467527022|FG000|Overall Study|Lack of Efficacy|0|||
129881887|NCT04986982|467527023|FG001|Overall Study|Lack of Efficacy|2|||
129881888|NCT04986982|467527022|FG000|Overall Study|Ineligibility|3|||
129881889|NCT04986982|467527023|FG001|Overall Study|Ineligibility|0|||
129881890|NCT04986982|467527022|FG000|Overall Study|Adverse Event|4|||
129881891|NCT04986982|467527023|FG001|Overall Study|Adverse Event|4|||
129881892|NCT04986982|467527022|FG000|Overall Study|Lost to Follow-up|0|||
129881893|NCT04986982|467527023|FG001|Overall Study|Lost to Follow-up|1|||
129881894|NCT04986982|467527022|FG000|Overall Study|Sponsor's discretion|1|||
129881895|NCT04986982|467527023|FG001|Overall Study|Sponsor's discretion|0|||
129881896|NCT01155661|467527024|FG000|Overall Study|Adverse Event|101|||
129881897|NCT01155661|467527024|FG000|Overall Study|Death|1|||
129881898|NCT01155661|467527024|FG000|Overall Study|Lack of Efficacy|32|||
129881899|NCT01155661|467527024|FG000|Overall Study|Lost to Follow-up|22|||
129881900|NCT01155661|467527024|FG000|Overall Study|Physician Decision|3|||
129881901|NCT01155661|467527024|FG000|Overall Study|Protocol Violation|35|||
129881902|NCT01155661|467527024|FG000|Overall Study|Withdrawal by Subject|73|||
129881903|NCT01155661|467527024|FG000|Overall Study|Sponsor Decision|13|||
129881904|NCT01396395|467527028|FG000|Overall Study|Withdrawal by Subject|10|||
129881905|NCT01396395|467527029|FG001|Overall Study|Withdrawal by Subject|12|||
129881906|NCT01396395|467527028|FG000|Overall Study|Protocol Violation|3|||
129881907|NCT01396395|467527029|FG001|Overall Study|Protocol Violation|1|||
129881908|NCT01396395|467527028|FG000|Overall Study|Adverse Event|10|||
129881909|NCT01396395|467527029|FG001|Overall Study|Adverse Event|2|||
129881910|NCT01396395|467527028|FG000|Overall Study|Lost to Follow-up|17|||
129881911|NCT01396395|467527029|FG001|Overall Study|Lost to Follow-up|11|||
129881912|NCT01396395|467527028|FG000|Overall Study|Other|0|||
129881913|NCT01396395|467527029|FG001|Overall Study|Other|1|||
129881914|NCT00882921|467527032|FG000|Overall Study|Death|2|||
129881915|NCT00882921|467527032|FG000|Overall Study|Other|3|||
129881916|NCT00882921|467527032|FG000|Overall Study|Lost to Follow-up|2|||
129881917|NCT00882921|467527032|FG000|Overall Study|Termination By Investigator|3|||
129881918|NCT00882921|467527032|FG000|Overall Study|Withdrawal Of Consent|1|||
129881919|NCT01370005|467527033|FG000|Overall Study|Not treated|1|||
129881920|NCT01370005|467527034|FG001|Overall Study|Not treated|0|||
129881921|NCT01370005|467527035|FG002|Overall Study|Not treated|0|||
129881922|NCT01370005|467527033|FG000|Overall Study|Adverse Event|5|||
129881923|NCT01370005|467527034|FG001|Overall Study|Adverse Event|5|||
129881924|NCT01370005|467527035|FG002|Overall Study|Adverse Event|6|||
129881925|NCT01370005|467527033|FG000|Overall Study|Lack of Efficacy|1|||
129881926|NCT01370005|467527034|FG001|Overall Study|Lack of Efficacy|0|||
129881927|NCT01370005|467527035|FG002|Overall Study|Lack of Efficacy|0|||
129881928|NCT01370005|467527033|FG000|Overall Study|Non compliant with protocol|0|||
129881929|NCT01370005|467527034|FG001|Overall Study|Non compliant with protocol|1|||
129881930|NCT01370005|467527035|FG002|Overall Study|Non compliant with protocol|2|||
129881931|NCT01370005|467527033|FG000|Overall Study|Lost to Follow-up|1|||
129881932|NCT01370005|467527034|FG001|Overall Study|Lost to Follow-up|1|||
129881933|NCT01370005|467527035|FG002|Overall Study|Lost to Follow-up|1|||
129881934|NCT01370005|467527033|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
129881935|NCT01370005|467527034|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
129881936|NCT01370005|467527035|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
129881937|NCT01370005|467527033|FG000|Overall Study|Other reason not defined above|3|||
129881938|NCT01370005|467527034|FG001|Overall Study|Other reason not defined above|0|||
129881939|NCT01370005|467527035|FG002|Overall Study|Other reason not defined above|2|||
129881940|NCT02009696|467527036|FG000|Overall Study|Withdrawal by Subject|2|||
129881941|NCT02302066|467527037|FG000|Overall Study|Adverse Event|1|||
129654647|NCT02655419|466692070|FG000|Overall Study|Enrolled but not treated|1|||
129881942|NCT02302066|467527038|FG001|Overall Study|Adverse Event|1|||
129881943|NCT02302066|467527039|FG002|Overall Study|Adverse Event|3|||
129881944|NCT02302066|467527040|FG003|Overall Study|Adverse Event|0|||
129881945|NCT02302066|467527037|FG000|Overall Study|Lost to Follow-up|4|||
129881946|NCT02302066|467527038|FG001|Overall Study|Lost to Follow-up|5|||
129881947|NCT02302066|467527039|FG002|Overall Study|Lost to Follow-up|24|||
129881948|NCT02302066|467527040|FG003|Overall Study|Lost to Follow-up|7|||
129881949|NCT02302066|467527037|FG000|Overall Study|Withdrawal by Subject|25|||
129881950|NCT02302066|467527038|FG001|Overall Study|Withdrawal by Subject|58|||
129881951|NCT02302066|467527039|FG002|Overall Study|Withdrawal by Subject|124|||
129881952|NCT02302066|467527040|FG003|Overall Study|Withdrawal by Subject|33|||
129881953|NCT02302066|467527037|FG000|Overall Study|Pregnancy|2|||
129881954|NCT02302066|467527038|FG001|Overall Study|Pregnancy|10|||
129881955|NCT02302066|467527039|FG002|Overall Study|Pregnancy|12|||
129881956|NCT02302066|467527040|FG003|Overall Study|Pregnancy|0|||
129881957|NCT02302066|467527037|FG000|Overall Study|Reason Not Specified|1|||
129881958|NCT02302066|467527038|FG001|Overall Study|Reason Not Specified|1|||
129881959|NCT02302066|467527039|FG002|Overall Study|Reason Not Specified|9|||
129881960|NCT02302066|467527040|FG003|Overall Study|Reason Not Specified|1|||
129881961|NCT05490329|467527041|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
129881962|NCT05490329|467527042|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
129881963|NCT05490329|467527041|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
129881964|NCT05490329|467527042|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
129881965|NCT05490329|467527041|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
129881966|NCT05490329|467527042|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
129881967|NCT02460263|467527043|FG000|Transition Period|Withdrawal by Subject|1|||
129881968|NCT02460263|467527043|FG000|Transition Period|Death|1|||
129881969|NCT03176238|467527044|FG000|Overall Study|Unacceptable AEs|15|||
129881970|NCT03176238|467527045|FG001|Overall Study|Unacceptable AEs|8|||
129881971|NCT03176238|467527044|FG000|Overall Study|Abnormal lab value(s)|2|||
129881972|NCT03176238|467527045|FG001|Overall Study|Abnormal lab value(s)|0|||
129654648|NCT02655419|466692071|FG001|Overall Study|Enrolled but not treated|5|||
129881973|NCT03176238|467527044|FG000|Overall Study|Inter-current illness|0|||
129881974|NCT03176238|467527045|FG001|Overall Study|Inter-current illness|1|||
129881975|NCT03176238|467527044|FG000|Overall Study|Consent withdrawal|14|||
129881976|NCT03176238|467527045|FG001|Overall Study|Consent withdrawal|2|||
129881977|NCT03176238|467527044|FG000|Overall Study|Lost to Follow-up|3|||
129881978|NCT03176238|467527045|FG001|Overall Study|Lost to Follow-up|0|||
129881979|NCT03176238|467527044|FG000|Overall Study|Administrative problems|1|||
129881980|NCT03176238|467527045|FG001|Overall Study|Administrative problems|0|||
129881981|NCT03176238|467527044|FG000|Overall Study|Death|3|||
129881982|NCT03176238|467527045|FG001|Overall Study|Death|0|||
129881983|NCT03176238|467527044|FG000|Overall Study|Disease Progression|133|||
129881984|NCT03176238|467527045|FG001|Overall Study|Disease Progression|22|||
129881985|NCT03176238|467527044|FG000|Overall Study|Tx duration completed per EAP|0|||
129881986|NCT03176238|467527045|FG001|Overall Study|Tx duration completed per EAP|1|||
129881987|NCT03176238|467527044|FG000|Overall Study|Patient is switched to commercial drug|16|||
129881988|NCT03176238|467527045|FG001|Overall Study|Patient is switched to commercial drug|1|||
129881989|NCT03176238|467527044|FG000|Overall Study|Protocol Violation|1|||
129881990|NCT03176238|467527045|FG001|Overall Study|Protocol Violation|0|||
129881991|NCT03176238|467527044|FG000|Overall Study|Changes in the patient's condition|2|||
129881992|NCT03176238|467527045|FG001|Overall Study|Changes in the patient's condition|1|||
129881993|NCT03176238|467527044|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
129881994|NCT03176238|467527045|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
129881995|NCT02301156|467527046|FG000|Overall Study|Adverse Event|13|||
129881996|NCT02301156|467527047|FG001|Overall Study|Adverse Event|14|||
129881997|NCT02301156|467527046|FG000|Overall Study|Death|1|||
129881998|NCT02301156|467527047|FG001|Overall Study|Death|5|||
129881999|NCT02301156|467527046|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
129882000|NCT02301156|467527047|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
129882001|NCT02301156|467527046|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
129882002|NCT02301156|467527047|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
129882003|NCT02301156|467527046|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
129654649|NCT02655419|466692070|FG000|Overall Study|Withdrawal by Subject|4|||
129654650|NCT02655419|466692071|FG001|Overall Study|Withdrawal by Subject|1|||
129654651|NCT02655419|466692070|FG000|Overall Study|Other|0|||
129654652|NCT02655419|466692071|FG001|Overall Study|Other|1|||
129654653|NCT00207727|466692072|FG000|Overall Study|Withdrawal by Subject|0|||
129654654|NCT00207727|466692073|FG001|Overall Study|Withdrawal by Subject|0|||
129654655|NCT00207727|466692074|FG002|Overall Study|Withdrawal by Subject|0|||
129654656|NCT00207727|466692075|FG003|Overall Study|Withdrawal by Subject|0|||
129654657|NCT00207727|466692076|FG004|Overall Study|Withdrawal by Subject|1|||
129654658|NCT00207727|466692072|FG000|Overall Study|Lost to Follow-up|0|||
129654659|NCT00207727|466692073|FG001|Overall Study|Lost to Follow-up|1|||
129654660|NCT00207727|466692074|FG002|Overall Study|Lost to Follow-up|0|||
129654661|NCT00207727|466692075|FG003|Overall Study|Lost to Follow-up|0|||
129882004|NCT02301156|467527047|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
129882005|NCT02301156|467527046|FG000|Overall Study|Reason not Specified|6|||
129882006|NCT02301156|467527047|FG001|Overall Study|Reason not Specified|3|||
129882007|NCT02638623|467527049|FG000|Overall Study|Surgery timing|5|||
129882008|NCT02638623|467527050|FG001|Overall Study|Surgery timing|6|||
129882009|NCT02638623|467527049|FG000|Overall Study|Not given intervention|2|||
129882010|NCT02638623|467527050|FG001|Overall Study|Not given intervention|0|||
129882011|NCT00886639|467527051|FG000|Overall Study|acute exacerbation|14|||
129882012|NCT00886639|467527051|FG000|Overall Study|non-compliance|2|||
129654662|NCT00207727|466692076|FG004|Overall Study|Lost to Follow-up|0|||
129654663|NCT00207727|466692072|FG000|Overall Study|Other|38|||
129882013|NCT03203694|467527052|FG000|Overall Study|Withdrawal by Subject|2|||
129882014|NCT03203694|467527053|FG001|Overall Study|Withdrawal by Subject|0|||
129882015|NCT03203694|467527054|FG002|Overall Study|Withdrawal by Subject|0|||
129882016|NCT03203694|467527055|FG003|Overall Study|Withdrawal by Subject|0|||
129882017|NCT03203694|467527056|FG004|Overall Study|Withdrawal by Subject|0|||
129882018|NCT03203694|467527057|FG005|Overall Study|Withdrawal by Subject|0|||
129882019|NCT02875834|467527058|FG000|Open-label Phase|Withdrawal by Subject|3|||
129882020|NCT02875834|467527059|FG001|Open-label Phase|Withdrawal by Subject|0|||
129882021|NCT02875834|467527060|FG002|Open-label Phase|Withdrawal by Subject|0|||
129882022|NCT02875834|467527061|FG003|Open-label Phase|Withdrawal by Subject|0|||
129882023|NCT02875834|467527058|FG000|Open-label Phase|(Not collected)|4|||
129882024|NCT02875834|467527059|FG001|Open-label Phase|(Not collected)|0|||
129882025|NCT02875834|467527060|FG002|Open-label Phase|(Not collected)|0|||
129882026|NCT02875834|467527061|FG003|Open-label Phase|(Not collected)|0|||
129882027|NCT02875834|467527058|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
129882028|NCT02875834|467527059|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
129882029|NCT02875834|467527060|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
129882030|NCT02875834|467527061|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
129882031|NCT02875834|467527058|FG000|Randomized Treatment Phase|Protocol Violation|0|||
129882032|NCT02875834|467527059|FG001|Randomized Treatment Phase|Protocol Violation|2|||
129882033|NCT02875834|467527060|FG002|Randomized Treatment Phase|Protocol Violation|0|||
129882034|NCT02875834|467527061|FG003|Randomized Treatment Phase|Protocol Violation|0|||
129882035|NCT02875834|467527058|FG000|Randomized Treatment Phase|(Not collected)|0|||
129882036|NCT02875834|467527059|FG001|Randomized Treatment Phase|(Not collected)|9|||
129882037|NCT02875834|467527060|FG002|Randomized Treatment Phase|(Not collected)|10|||
129882038|NCT02875834|467527061|FG003|Randomized Treatment Phase|(Not collected)|9|||
129882039|NCT01032044|467527062|FG000|Overall Study|Protocol Violation|14|||
129654664|NCT00207727|466692073|FG001|Overall Study|Other|41|||
129654665|NCT00207727|466692074|FG002|Overall Study|Other|41|||
129654666|NCT00207727|466692075|FG003|Overall Study|Other|37|||
129654667|NCT00207727|466692076|FG004|Overall Study|Other|33|||
129654668|NCT00463840|466692081|FG000|Overall Study|Disease progression|7|||
129654669|NCT00463840|466692081|FG000|Overall Study|Withdrawal by Subject|2|||
129654670|NCT00463840|466692081|FG000|Overall Study|Adverse Event|3|||
129654671|NCT01653327|466692082|FG000|Overall Study|Withdrawal by Subject|1|||
129654672|NCT04607980|466692083|FG000|Overall Study|Adverse Event|3|||
129654673|NCT04607980|466692084|FG001|Overall Study|Adverse Event|4|||
129882040|NCT01032044|467527063|FG001|Overall Study|Protocol Violation|8|||
129882041|NCT01032044|467527062|FG000|Overall Study|Adverse Event|0|||
129882042|NCT01032044|467527063|FG001|Overall Study|Adverse Event|1|||
129882043|NCT01032044|467527062|FG000|Overall Study|Lost to Follow-up|11|||
129882044|NCT01032044|467527063|FG001|Overall Study|Lost to Follow-up|11|||
129882045|NCT03311230|467527064|FG000|Overall Study|Withdrawal by Subject|1|||
129882046|NCT03311230|467527065|FG001|Overall Study|Withdrawal by Subject|4|||
129882047|NCT03311230|467527066|FG002|Overall Study|Withdrawal by Subject|2|||
129882048|NCT03311230|467527067|FG003|Overall Study|Withdrawal by Subject|7|||
129882049|NCT03311230|467527064|FG000|Overall Study|Unrelated injury|0|||
129882050|NCT03311230|467527065|FG001|Overall Study|Unrelated injury|1|||
129882051|NCT03311230|467527066|FG002|Overall Study|Unrelated injury|0|||
129882052|NCT03311230|467527067|FG003|Overall Study|Unrelated injury|0|||
129882053|NCT03342053|467527068|FG000|Overall Study|Adverse Event|2|||
129882054|NCT03342053|467527069|FG001|Overall Study|Adverse Event|0|||
129882055|NCT03342053|467527068|FG000|Overall Study|Withdrawal by Subject|0|||
129882056|NCT03342053|467527069|FG001|Overall Study|Withdrawal by Subject|1|||
129882057|NCT01302938|467527070|FG000|Overall Study|Withdrawal by Subject|1|||
129882058|NCT01302938|467527071|FG001|Overall Study|Withdrawal by Subject|0|||
129882059|NCT01302938|467527070|FG000|Overall Study|Adverse Event|1|||
129882060|NCT01302938|467527071|FG001|Overall Study|Adverse Event|0|||
129882061|NCT01233609|467527072|FG000|Overall Study|Death|1|||
129882062|NCT01233609|467527073|FG001|Overall Study|Death|0|||
129882063|NCT01233609|467527072|FG000|Overall Study|Lost to Follow-up|3|||
129882064|NCT01233609|467527073|FG001|Overall Study|Lost to Follow-up|1|||
129882065|NCT01233609|467527072|FG000|Overall Study|Adverse Event|2|||
129882066|NCT01233609|467527073|FG001|Overall Study|Adverse Event|1|||
129882067|NCT01233609|467527072|FG000|Overall Study|Withdrawal by Subject|3|||
129882068|NCT01233609|467527073|FG001|Overall Study|Withdrawal by Subject|0|||
129882069|NCT02961374|467527074|FG000|Overall Study|Adverse Event|4|||
129882070|NCT00735644|467527075|FG000|Overall Study|Did not receive study vaccine|0|||
129882071|NCT00735644|467527076|FG001|Overall Study|Did not receive study vaccine|1|||
129654674|NCT04607980|466692083|FG000|Overall Study|Death|0|||
129654675|NCT04607980|466692084|FG001|Overall Study|Death|1|||
129654676|NCT04607980|466692083|FG000|Overall Study|Withdrawal by Subject|2|||
129882072|NCT00735644|467527077|FG002|Overall Study|Did not receive study vaccine|0|||
129654677|NCT04607980|466692084|FG001|Overall Study|Withdrawal by Subject|5|||
129654678|NCT04607980|466692083|FG000|Overall Study|Lost to Follow-up|4|||
129882073|NCT00735644|467527078|FG003|Overall Study|Did not receive study vaccine|0|||
129882074|NCT00735644|467527079|FG004|Overall Study|Did not receive study vaccine|0|||
129654679|NCT04607980|466692084|FG001|Overall Study|Lost to Follow-up|8|||
129654680|NCT04607980|466692083|FG000|Overall Study|Protocol Violation|0|||
129654681|NCT04607980|466692084|FG001|Overall Study|Protocol Violation|3|||
129654682|NCT04607980|466692083|FG000|Overall Study|Other|3|||
129654683|NCT04607980|466692084|FG001|Overall Study|Other|0|||
129654684|NCT03774394|466693516|FG000|Overall Study|Withdrawal by Subject|2|||
129654685|NCT03774394|466693517|FG001|Overall Study|Withdrawal by Subject|0|||
129654686|NCT01313221|466693520|FG000|Overall Study|Protocol Violation|0|||
129654687|NCT01313221|466693521|FG001|Overall Study|Protocol Violation|1|||
129654688|NCT01313221|466693522|FG002|Overall Study|Protocol Violation|1|||
129654689|NCT01313221|466693520|FG000|Overall Study|Non-compliance|3|||
129654690|NCT01313221|466693521|FG001|Overall Study|Non-compliance|0|||
129654691|NCT01313221|466693522|FG002|Overall Study|Non-compliance|2|||
129654692|NCT01313221|466693520|FG000|Overall Study|Withdrawal by Subject|2|||
129654693|NCT01313221|466693521|FG001|Overall Study|Withdrawal by Subject|3|||
129654694|NCT01313221|466693522|FG002|Overall Study|Withdrawal by Subject|5|||
129654695|NCT01313221|466693520|FG000|Overall Study|Requirement for alternative therapy|0|||
129654696|NCT01313221|466693521|FG001|Overall Study|Requirement for alternative therapy|1|||
129654697|NCT01313221|466693522|FG002|Overall Study|Requirement for alternative therapy|1|||
129882075|NCT00735644|467527075|FG000|Overall Study|Withdrawal by Subject|0|||
129882076|NCT00735644|467527076|FG001|Overall Study|Withdrawal by Subject|1|||
129882077|NCT00735644|467527077|FG002|Overall Study|Withdrawal by Subject|1|||
129882078|NCT00735644|467527078|FG003|Overall Study|Withdrawal by Subject|1|||
129882079|NCT00735644|467527079|FG004|Overall Study|Withdrawal by Subject|0|||
129882080|NCT02041923|467527082|FG000|Overall Study|Lost to Follow-up|26|||
129882081|NCT02041923|467527083|FG001|Overall Study|Lost to Follow-up|30|||
129882082|NCT00874432|467527091|FG000|Overall Study|Withdrawal by Subject|1|||
129882083|NCT00874432|467527092|FG001|Overall Study|Withdrawal by Subject|0|||
129882084|NCT00874432|467527093|FG002|Overall Study|Withdrawal by Subject|0|||
129882085|NCT00874432|467527094|FG003|Overall Study|Withdrawal by Subject|0|||
129882086|NCT00874432|467527091|FG000|Overall Study|Physician Decision|1|||
129882087|NCT00874432|467527092|FG001|Overall Study|Physician Decision|0|||
129882088|NCT00874432|467527093|FG002|Overall Study|Physician Decision|0|||
129882089|NCT00874432|467527094|FG003|Overall Study|Physician Decision|0|||
129882090|NCT00874432|467527091|FG000|Overall Study|Other|1|||
129882091|NCT00874432|467527092|FG001|Overall Study|Other|2|||
129882092|NCT00874432|467527093|FG002|Overall Study|Other|8|||
129882093|NCT00874432|467527094|FG003|Overall Study|Other|3|||
129882094|NCT01518946|467527095|FG000|Open-label Phase|Other|4|||
129882095|NCT01518946|467527096|FG001|Open-label Phase|Other|0|||
129882096|NCT01518946|467527097|FG002|Open-label Phase|Other|0|||
129882097|NCT01518946|467527095|FG000|Randomized Phase (First Intervention)|Other|0|||
129882098|NCT01518946|467527096|FG001|Randomized Phase (First Intervention)|Other|1|||
129882099|NCT01518946|467527097|FG002|Randomized Phase (First Intervention)|Other|0|||
129882100|NCT00384059|467527098|FG000|Infant Series|Not consented|2|||
129882101|NCT00384059|467527099|FG001|Infant Series|Not consented|6|||
129882102|NCT00384059|467527098|FG000|Infant Series|Withdrawal by Subject|2|||
129882103|NCT00384059|467527099|FG001|Infant Series|Withdrawal by Subject|2|||
129882104|NCT00384059|467527098|FG000|Infant Series|Adverse Event|1|||
129882105|NCT00384059|467527099|FG001|Infant Series|Adverse Event|2|||
129882106|NCT00384059|467527098|FG000|Infant Series|Protocol Violation|1|||
129882107|NCT00384059|467527099|FG001|Infant Series|Protocol Violation|2|||
129882108|NCT00384059|467527098|FG000|Infant Series|Lost to Follow-up|0|||
129882109|NCT00384059|467527099|FG001|Infant Series|Lost to Follow-up|1|||
129882110|NCT00384059|467527098|FG000|After Infant Series|Protocol Violation|2|||
129882111|NCT00384059|467527099|FG001|After Infant Series|Protocol Violation|3|||
129882112|NCT00384059|467527098|FG000|After Infant Series|Withdrawal by Subject|2|||
129882113|NCT00384059|467527099|FG001|After Infant Series|Withdrawal by Subject|2|||
129882114|NCT00384059|467527098|FG000|After Infant Series|Failed to Return|0|||
129882115|NCT00384059|467527099|FG001|After Infant Series|Failed to Return|2|||
129882116|NCT00384059|467527098|FG000|After Infant Series|Adverse Event|0|||
129882117|NCT00384059|467527099|FG001|After Infant Series|Adverse Event|1|||
129882118|NCT00384059|467527098|FG000|After Infant Series|Physician Decision|0|||
129882119|NCT00384059|467527099|FG001|After Infant Series|Physician Decision|1|||
129654698|NCT01313221|466693520|FG000|Overall Study|Lost to Follow-up|6|||
129654699|NCT01313221|466693521|FG001|Overall Study|Lost to Follow-up|3|||
129654700|NCT01313221|466693522|FG002|Overall Study|Lost to Follow-up|1|||
129882120|NCT00384059|467527098|FG000|After Infant Series|Lost to Follow-up|0|||
129882121|NCT00384059|467527099|FG001|After Infant Series|Lost to Follow-up|1|||
129882122|NCT00384059|467527098|FG000|Toddler Dose|Lost to Follow-up|1|||
129882123|NCT00384059|467527099|FG001|Toddler Dose|Lost to Follow-up|1|||
129882124|NCT00384059|467527098|FG000|Toddler Dose|Failed to return|0|||
129882125|NCT00384059|467527099|FG001|Toddler Dose|Failed to return|1|||
129882126|NCT01167179|467528740|FG000|Overall Study|disease recurrence|4|||
129654701|NCT01313221|466693520|FG000|Overall Study|Other|1|||
129654702|NCT01313221|466693521|FG001|Overall Study|Other|0|||
129654703|NCT01313221|466693522|FG002|Overall Study|Other|0|||
129882127|NCT01167179|467528741|FG001|Overall Study|disease recurrence|4|||
129654704|NCT01313221|466693520|FG000|Overall Study|Adverse Event|0|||
129654705|NCT01313221|466693521|FG001|Overall Study|Adverse Event|0|||
129654706|NCT01313221|466693522|FG002|Overall Study|Adverse Event|7|||
129654707|NCT01313221|466693520|FG000|Overall Study|Disease progression|0|||
129654708|NCT01313221|466693521|FG001|Overall Study|Disease progression|0|||
129654709|NCT01313221|466693522|FG002|Overall Study|Disease progression|2|||
129654710|NCT01313221|466693520|FG000|Overall Study|Physician Decision|0|||
129654711|NCT01313221|466693521|FG001|Overall Study|Physician Decision|0|||
129654712|NCT01313221|466693522|FG002|Overall Study|Physician Decision|2|||
129654713|NCT01313221|466693520|FG000|Overall Study|Pregnancy|0|||
129654714|NCT01313221|466693521|FG001|Overall Study|Pregnancy|0|||
129654715|NCT01313221|466693522|FG002|Overall Study|Pregnancy|2|||
129654716|NCT00994214|466693523|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
129654717|NCT00994214|466693524|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
129654718|NCT00994214|466693525|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
129654719|NCT00994214|466693526|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
129654720|NCT00994214|466693523|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
129654721|NCT00994214|466693524|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
129654722|NCT00994214|466693525|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
129654723|NCT00994214|466693526|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
129654724|NCT00994214|466693523|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
129654725|NCT00994214|466693524|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
129654726|NCT00994214|466693525|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
129654727|NCT00994214|466693526|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
129654728|NCT00994214|466693523|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
129654729|NCT00994214|466693524|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
129654730|NCT00994214|466693525|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
129654731|NCT00994214|466693526|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
129654732|NCT00994214|466693523|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
129654733|NCT00994214|466693524|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
129654734|NCT00994214|466693525|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
129654735|NCT00994214|466693526|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
129654736|NCT00994214|466693523|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
129654737|NCT00994214|466693524|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
129654738|NCT00994214|466693525|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
129654739|NCT00994214|466693526|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
129654740|NCT04767529|466693530|FG000|Overall Study|Adverse Event|0|||
129654741|NCT04767529|466693531|FG001|Overall Study|Adverse Event|4|||
129654742|NCT04767529|466693532|FG002|Overall Study|Adverse Event|3|||
129654743|NCT04767529|466693530|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
129654744|NCT04767529|466693531|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
129654745|NCT04767529|466693532|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
129654746|NCT04767529|466693530|FG000|Overall Study|Required use of a prohibited medication|0|||
129654747|NCT04767529|466693531|FG001|Overall Study|Required use of a prohibited medication|1|||
129654748|NCT04767529|466693532|FG002|Overall Study|Required use of a prohibited medication|0|||
129654749|NCT04767529|466693530|FG000|Overall Study|Withdrawal by Subject|7|||
129654750|NCT04767529|466693531|FG001|Overall Study|Withdrawal by Subject|5|||
129654751|NCT04767529|466693532|FG002|Overall Study|Withdrawal by Subject|4|||
129654752|NCT04767529|466693530|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
129654753|NCT04767529|466693531|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
129654754|NCT04767529|466693532|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
129654755|NCT04767529|466693530|FG000|Overall Study|Lost to Follow-up|0|||
129654756|NCT04767529|466693531|FG001|Overall Study|Lost to Follow-up|2|||
129654757|NCT04767529|466693532|FG002|Overall Study|Lost to Follow-up|3|||
129654758|NCT01716520|466693533|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
129654759|NCT01716520|466693534|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129654760|NCT01716520|466693535|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
129654761|NCT01716520|466693536|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
129654762|NCT01716520|466693537|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
129654763|NCT01716520|466693538|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
129654764|NCT01716520|466693533|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
129654765|NCT01716520|466693534|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654766|NCT01716520|466693535|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
129654767|NCT01716520|466693536|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
129654768|NCT01716520|466693537|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654769|NCT01716520|466693538|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
129654770|NCT01716520|466693533|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129707762|NCT01280968|466892118|FG001|Overall Study|Adverse Event|0|||
129882128|NCT01167179|467528740|FG000|Overall Study|Death|4|||
129882129|NCT01167179|467528741|FG001|Overall Study|Death|10|||
129882130|NCT01167179|467528740|FG000|Overall Study|Withdrawal by Subject|1|||
129882131|NCT01167179|467528741|FG001|Overall Study|Withdrawal by Subject|2|||
129882132|NCT01167179|467528740|FG000|Overall Study|diverse|6|||
129882133|NCT01167179|467528741|FG001|Overall Study|diverse|5|||
129882134|NCT02781506|467528742|FG000|Overall Study|Adverse Event|5|||
129882135|NCT01158378|467528743|FG000|Overall Study|Death|4|||
129882136|NCT01158378|467528744|FG001|Overall Study|Death|5|||
129882137|NCT01158378|467528743|FG000|Overall Study|Lost to Follow-up|2|||
129882138|NCT01158378|467528744|FG001|Overall Study|Lost to Follow-up|4|||
129882139|NCT01158378|467528743|FG000|Overall Study|Withdrawal by Subject|4|||
129882140|NCT01158378|467528744|FG001|Overall Study|Withdrawal by Subject|0|||
129882141|NCT03017235|467528745|FG000|Overall Study|Withdrawal by Subject|4|||
129882142|NCT03017235|467528746|FG001|Overall Study|Withdrawal by Subject|3|||
129882143|NCT03017235|467528745|FG000|Overall Study|Lost to Follow-up|2|||
129882144|NCT03017235|467528746|FG001|Overall Study|Lost to Follow-up|7|||
129882145|NCT03017235|467528745|FG000|Overall Study|Adverse Event|0|||
129882146|NCT03017235|467528746|FG001|Overall Study|Adverse Event|1|||
129882147|NCT03017235|467528745|FG000|Overall Study|Protocol Violation|2|||
129882148|NCT03017235|467528746|FG001|Overall Study|Protocol Violation|1|||
129882149|NCT03017235|467528745|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
129882150|NCT03017235|467528746|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
129882151|NCT02593539|467528750|FG000|Overall Study|Adverse Event|1|||
129882152|NCT00649389|467528751|FG000|Overall Study|Adverse Event|22|||
129882153|NCT00649389|467528752|FG001|Overall Study|Adverse Event|46|||
129882154|NCT00649389|467528753|FG002|Overall Study|Adverse Event|38|||
129882155|NCT00649389|467528754|FG003|Overall Study|Adverse Event|48|||
129882156|NCT00649389|467528751|FG000|Overall Study|Lost to Follow-up|15|||
129882157|NCT00649389|467528752|FG001|Overall Study|Lost to Follow-up|17|||
129882158|NCT00649389|467528753|FG002|Overall Study|Lost to Follow-up|21|||
129882159|NCT00649389|467528754|FG003|Overall Study|Lost to Follow-up|26|||
129882160|NCT00649389|467528751|FG000|Overall Study|Protocol Violation|11|||
129882161|NCT00649389|467528752|FG001|Overall Study|Protocol Violation|13|||
129882162|NCT00649389|467528753|FG002|Overall Study|Protocol Violation|9|||
129882163|NCT00649389|467528754|FG003|Overall Study|Protocol Violation|8|||
129882164|NCT00649389|467528751|FG000|Overall Study|Withdrawal by Subject|20|||
129882165|NCT00649389|467528752|FG001|Overall Study|Withdrawal by Subject|21|||
129882166|NCT00649389|467528753|FG002|Overall Study|Withdrawal by Subject|19|||
129882167|NCT00649389|467528754|FG003|Overall Study|Withdrawal by Subject|23|||
129882168|NCT00649389|467528751|FG000|Overall Study|Other|3|||
129882169|NCT00649389|467528752|FG001|Overall Study|Other|9|||
129882170|NCT00649389|467528753|FG002|Overall Study|Other|1|||
129882171|NCT00649389|467528754|FG003|Overall Study|Other|6|||
129882172|NCT01806740|467528755|FG000|Overall Study|Withdrawal by Subject|4|||
129545169|NCT03917654|466288438|FG003|Year 1|Lost to Follow-up|0|||
129545170|NCT03917654|466288439|FG004|Year 1|Lost to Follow-up|0|||
129545171|NCT03917654|466288440|FG005|Year 1|Lost to Follow-up|0|||
129545172|NCT03917654|466288441|FG006|Year 1|Lost to Follow-up|2|||
129545173|NCT03917654|466288442|FG007|Year 1|Lost to Follow-up|0|||
129545174|NCT03917654|466288443|FG008|Year 1|Lost to Follow-up|0|||
129545175|NCT03917654|466288444|FG009|Year 1|Lost to Follow-up|0|||
129545176|NCT03917654|466288445|FG010|Year 1|Lost to Follow-up|0|||
129545177|NCT03917654|466288446|FG011|Year 1|Lost to Follow-up|0|||
129545178|NCT03917654|466288435|FG000|Year 1|Missed visits|0|||
129545179|NCT03917654|466288436|FG001|Year 1|Missed visits|0|||
129545180|NCT03917654|466288437|FG002|Year 1|Missed visits|0|||
129545181|NCT03917654|466288438|FG003|Year 1|Missed visits|0|||
129545182|NCT03917654|466288439|FG004|Year 1|Missed visits|0|||
129545183|NCT03917654|466288440|FG005|Year 1|Missed visits|0|||
129545184|NCT03917654|466288441|FG006|Year 1|Missed visits|0|||
129545185|NCT03917654|466288442|FG007|Year 1|Missed visits|0|||
129545186|NCT03917654|466288443|FG008|Year 1|Missed visits|0|||
129545187|NCT03917654|466288444|FG009|Year 1|Missed visits|0|||
129882173|NCT01806740|467528755|FG000|Overall Study|Physician Decision|1|||
129545188|NCT03917654|466288445|FG010|Year 1|Missed visits|1|||
129545189|NCT03917654|466288446|FG011|Year 1|Missed visits|1|||
129654771|NCT01716520|466693534|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129882174|NCT01806740|467528755|FG000|Overall Study|Patient's refusal of treatment|1|||
129882175|NCT00592319|467528758|FG000|Overall Study|Lost to Follow-up|0|||
129882176|NCT00592319|467528759|FG001|Overall Study|Lost to Follow-up|3|||
129882177|NCT02757521|467528763|FG000|Overall Study|Adverse Event|1|||
129882178|NCT02757521|467528764|FG001|Overall Study|Adverse Event|0|||
129882179|NCT00003511|467528765|FG000|Overall Study|Not evaluable|4|||
129882180|NCT00312858|467528773|FG000|Overall Study|Adverse Event|0|||
129882181|NCT00312858|467528774|FG001|Overall Study|Adverse Event|1|||
129882182|NCT00312858|467528773|FG000|Overall Study|Lost to Follow-up|25|||
129545190|NCT03917654|466288435|FG000|Year 1|Pregnancy|0|||
129545191|NCT03917654|466288436|FG001|Year 1|Pregnancy|0|||
129545192|NCT03917654|466288437|FG002|Year 1|Pregnancy|0|||
129545193|NCT03917654|466288438|FG003|Year 1|Pregnancy|0|||
129882183|NCT00312858|467528774|FG001|Overall Study|Lost to Follow-up|42|||
129882184|NCT00312858|467528773|FG000|Overall Study|Protocol Violation|3|||
129882185|NCT00312858|467528774|FG001|Overall Study|Protocol Violation|8|||
129654772|NCT01716520|466693535|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129654773|NCT01716520|466693536|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129654774|NCT01716520|466693537|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129654775|NCT01716520|466693538|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129882186|NCT00312858|467528773|FG000|Overall Study|Withdraw by Participant|20|||
129882187|NCT00312858|467528774|FG001|Overall Study|Withdraw by Participant|20|||
129882188|NCT00312858|467528773|FG000|Overall Study|Participant Moved|11|||
129882189|NCT00312858|467528774|FG001|Overall Study|Participant Moved|10|||
129882190|NCT00312858|467528773|FG000|Overall Study|Other|9|||
129882191|NCT00312858|467528774|FG001|Overall Study|Other|12|||
129882192|NCT00802659|467528775|FG000|Overall Study|Physician Decision|0|||
129882193|NCT00802659|467528776|FG001|Overall Study|Physician Decision|1|||
129882194|NCT00802659|467528777|FG002|Overall Study|Physician Decision|0|||
129882195|NCT00802659|467528778|FG003|Overall Study|Physician Decision|0|||
129882196|NCT05340751|467528781|FG000|Overall Study|Physician Decision|3|||
129882197|NCT04399551|467528782|FG000|Overall Study|Adverse Event|15|||
129882198|NCT04399551|467528782|FG000|Overall Study|Withdrawal by Subject|6|||
129882199|NCT04399551|467528782|FG000|Overall Study|Physician Decision|3|||
129882200|NCT04399551|467528782|FG000|Overall Study|Lost to Follow-up|2|||
129882201|NCT04399551|467528782|FG000|Overall Study|Protocol Deviation|2|||
129882202|NCT01014975|467528783|FG000|Overall Study|Withdrawal by Subject|1|||
129882203|NCT01014975|467528784|FG001|Overall Study|Withdrawal by Subject|0|||
129882204|NCT01014975|467528785|FG002|Overall Study|Withdrawal by Subject|1|||
129882205|NCT01014975|467528783|FG000|Overall Study|Death|3|||
129882206|NCT01014975|467528784|FG001|Overall Study|Death|3|||
129882207|NCT01014975|467528785|FG002|Overall Study|Death|4|||
129882208|NCT01014975|467528783|FG000|Overall Study|Lost to Follow-up|0|||
129882209|NCT01014975|467528784|FG001|Overall Study|Lost to Follow-up|0|||
129882210|NCT01014975|467528785|FG002|Overall Study|Lost to Follow-up|1|||
129882211|NCT01336634|467528788|FG000|Overall Study|Study closed/terminated|5|||
129882212|NCT01336634|467528789|FG001|Overall Study|Study closed/terminated|6|||
129882213|NCT01336634|467528790|FG002|Overall Study|Study closed/terminated|6|||
129882214|NCT01336634|467528788|FG000|Overall Study|Lost to Follow-up|2|||
129882215|NCT01336634|467528789|FG001|Overall Study|Lost to Follow-up|1|||
129882216|NCT01336634|467528790|FG002|Overall Study|Lost to Follow-up|1|||
129882217|NCT01336634|467528788|FG000|Overall Study|Physician Decision|1|||
129882218|NCT01336634|467528789|FG001|Overall Study|Physician Decision|1|||
129882219|NCT01336634|467528790|FG002|Overall Study|Physician Decision|0|||
129882220|NCT01336634|467528788|FG000|Overall Study|Withdrawal by Subject|6|||
129882221|NCT01336634|467528789|FG001|Overall Study|Withdrawal by Subject|0|||
129882222|NCT01336634|467528790|FG002|Overall Study|Withdrawal by Subject|2|||
129882223|NCT02961881|467528791|FG000|Overall Study|Adverse Event|1|||
129882224|NCT02961881|467528792|FG001|Overall Study|Adverse Event|2|||
129882225|NCT02961881|467528793|FG002|Overall Study|Adverse Event|2|||
129882226|NCT02961881|467528794|FG003|Overall Study|Adverse Event|0|||
129882227|NCT02961881|467528795|FG004|Overall Study|Adverse Event|1|||
129882228|NCT02961881|467528791|FG000|Overall Study|Participant request|0|||
129882229|NCT02961881|467528792|FG001|Overall Study|Participant request|2|||
129882230|NCT02961881|467528793|FG002|Overall Study|Participant request|0|||
129882231|NCT02961881|467528794|FG003|Overall Study|Participant request|0|||
129882232|NCT02961881|467528795|FG004|Overall Study|Participant request|0|||
129654776|NCT01716520|466693533|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129654777|NCT01716520|466693534|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
129654778|NCT01716520|466693535|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129654779|NCT01716520|466693536|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129654780|NCT01716520|466693537|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129654781|NCT01716520|466693538|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
129654782|NCT01716520|466693533|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129654783|NCT01716520|466693534|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129654784|NCT01716520|466693535|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129654785|NCT01716520|466693536|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129654786|NCT01716520|466693537|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129654787|NCT01716520|466693538|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
129654788|NCT01716520|466693533|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
129654789|NCT01716520|466693534|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
129882233|NCT02961881|467528791|FG000|Overall Study|Disease progression|1|||
129882234|NCT02961881|467528792|FG001|Overall Study|Disease progression|0|||
129882235|NCT02961881|467528793|FG002|Overall Study|Disease progression|1|||
129882236|NCT02961881|467528794|FG003|Overall Study|Disease progression|0|||
129882237|NCT02961881|467528795|FG004|Overall Study|Disease progression|0|||
129882238|NCT01863043|467528796|FG000|Overall Study|Death|6|||
129882239|NCT01863043|467528797|FG001|Overall Study|Death|1|||
129882240|NCT01863043|467528796|FG000|Overall Study|Withdrawal by Subject|0|||
129882241|NCT01863043|467528797|FG001|Overall Study|Withdrawal by Subject|2|||
129882242|NCT01863043|467528796|FG000|Overall Study|Adverse Event|7|||
129882243|NCT01863043|467528797|FG001|Overall Study|Adverse Event|8|||
129654790|NCT01716520|466693535|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
129654791|NCT01716520|466693536|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
129654792|NCT01716520|466693537|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
129654793|NCT01716520|466693538|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
129654794|NCT01716520|466693533|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
129654795|NCT01716520|466693534|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
129654796|NCT01716520|466693535|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
129654797|NCT01716520|466693536|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
129654798|NCT01716520|466693537|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
129654799|NCT01716520|466693538|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
129654800|NCT01716520|466693533|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129654801|NCT01716520|466693534|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129654802|NCT01716520|466693535|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129654803|NCT01716520|466693536|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129654804|NCT01716520|466693537|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129654805|NCT01716520|466693538|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129654806|NCT01716520|466693533|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654807|NCT01716520|466693534|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654808|NCT01716520|466693535|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654809|NCT01716520|466693536|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
129654810|NCT01716520|466693537|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654811|NCT01716520|466693538|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
129654812|NCT01716520|466693533|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
129654813|NCT01716520|466693534|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
129654814|NCT01716520|466693535|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
129654815|NCT01716520|466693536|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
129654816|NCT01716520|466693537|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
129654817|NCT01716520|466693538|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
129654818|NCT01716520|466693533|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
129654819|NCT01716520|466693534|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129654820|NCT01716520|466693535|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129654821|NCT01716520|466693536|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129654822|NCT01716520|466693537|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129654823|NCT01716520|466693538|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
129654824|NCT01716520|466693533|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129654825|NCT01716520|466693534|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129654826|NCT01716520|466693535|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129654827|NCT01716520|466693536|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129654828|NCT01716520|466693537|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
129654829|NCT01716520|466693538|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
129882244|NCT01863043|467528796|FG000|Overall Study|exclusion criteria found after enrollment|0|||
129882245|NCT01863043|467528797|FG001|Overall Study|exclusion criteria found after enrollment|1|||
129882246|NCT01912781|467528798|FG000|Overall Study|Withdrawal by Subject|2|||
129882247|NCT01912781|467528799|FG001|Overall Study|Withdrawal by Subject|0|||
129882248|NCT00854295|467528802|FG000|Overall Study|Death|7|||
129882249|NCT00854295|467528803|FG001|Overall Study|Death|0|||
129882250|NCT00854295|467528804|FG002|Overall Study|Death|1|||
129882251|NCT00854295|467528805|FG003|Overall Study|Death|1|||
129882252|NCT00854295|467528802|FG000|Overall Study|Adverse Event|6|||
129882253|NCT00854295|467528803|FG001|Overall Study|Adverse Event|1|||
129882254|NCT00854295|467528804|FG002|Overall Study|Adverse Event|1|||
129882255|NCT00854295|467528805|FG003|Overall Study|Adverse Event|3|||
129882256|NCT00854295|467528802|FG000|Overall Study|Lost to Follow-up|18|||
129882257|NCT00854295|467528803|FG001|Overall Study|Lost to Follow-up|5|||
129882258|NCT00854295|467528804|FG002|Overall Study|Lost to Follow-up|21|||
129882259|NCT00854295|467528805|FG003|Overall Study|Lost to Follow-up|21|||
129882260|NCT00854295|467528802|FG000|Overall Study|Physician Decision|10|||
129882261|NCT00854295|467528803|FG001|Overall Study|Physician Decision|0|||
129882262|NCT00854295|467528804|FG002|Overall Study|Physician Decision|0|||
129882263|NCT00854295|467528805|FG003|Overall Study|Physician Decision|0|||
129882264|NCT04250337|467528806|FG000|Overall Study|Adverse Event|0|||
129882265|NCT04250337|467528807|FG001|Overall Study|Adverse Event|3|||
129882266|NCT04250337|467528806|FG000|Overall Study|Lack of Efficacy|1|||
129882267|NCT04250337|467528807|FG001|Overall Study|Lack of Efficacy|3|||
129882268|NCT04250337|467528806|FG000|Overall Study|Physician Decision|1|||
129882269|NCT04250337|467528807|FG001|Overall Study|Physician Decision|0|||
129882270|NCT04250337|467528806|FG000|Overall Study|Protocol Deviation|2|||
129882271|NCT04250337|467528807|FG001|Overall Study|Protocol Deviation|2|||
129882272|NCT04250337|467528806|FG000|Overall Study|Withdrawal by Subject|4|||
129882273|NCT04250337|467528807|FG001|Overall Study|Withdrawal by Subject|3|||
129882274|NCT05033743|467528813|FG000|Overall Study|Lost to Follow-up|1|||
129882275|NCT05033743|467528813|FG000|Overall Study|Protocol Violation|2|||
129882276|NCT05033743|467528813|FG000|Overall Study|Withdrawal by Subject|1|||
129882277|NCT04537897|467528814|FG000|Overall Study|Other than listed|0|||
129882278|NCT04537897|467528815|FG001|Overall Study|Other than listed|0|||
129882279|NCT04537897|467528816|FG002|Overall Study|Other than listed|0|||
129882280|NCT04537897|467528817|FG003|Overall Study|Other than listed|0|||
129882281|NCT04537897|467528818|FG004|Overall Study|Other than listed|0|||
129882282|NCT04537897|467528819|FG005|Overall Study|Other than listed|0|||
129882283|NCT04537897|467528820|FG006|Overall Study|Other than listed|1|||
129882284|NCT04537897|467528821|FG007|Overall Study|Other than listed|0|||
129882285|NCT04537897|467528822|FG008|Overall Study|Other than listed|0|||
129882286|NCT04537897|467528814|FG000|Overall Study|Adverse Event|0|||
129882287|NCT04537897|467528815|FG001|Overall Study|Adverse Event|0|||
129882288|NCT04537897|467528816|FG002|Overall Study|Adverse Event|0|||
129882289|NCT04537897|467528817|FG003|Overall Study|Adverse Event|1|||
129882290|NCT04537897|467528818|FG004|Overall Study|Adverse Event|0|||
129882291|NCT04537897|467528819|FG005|Overall Study|Adverse Event|0|||
129882292|NCT04537897|467528820|FG006|Overall Study|Adverse Event|0|||
129882293|NCT04537897|467528821|FG007|Overall Study|Adverse Event|0|||
129882294|NCT04537897|467528822|FG008|Overall Study|Adverse Event|0|||
129882295|NCT04537897|467528814|FG000|Overall Study|Withdrawal by Subject|0|||
129882296|NCT04537897|467528815|FG001|Overall Study|Withdrawal by Subject|1|||
129882297|NCT04537897|467528816|FG002|Overall Study|Withdrawal by Subject|0|||
129882298|NCT04537897|467528817|FG003|Overall Study|Withdrawal by Subject|0|||
129882299|NCT04537897|467528818|FG004|Overall Study|Withdrawal by Subject|0|||
129882300|NCT04537897|467528819|FG005|Overall Study|Withdrawal by Subject|0|||
129882301|NCT04537897|467528820|FG006|Overall Study|Withdrawal by Subject|0|||
129882302|NCT04537897|467528821|FG007|Overall Study|Withdrawal by Subject|0|||
129882303|NCT04537897|467528822|FG008|Overall Study|Withdrawal by Subject|0|||
129882304|NCT00197028|467528826|FG000|Overall Study|Adverse Event|2|||
129882305|NCT00197028|467528827|FG001|Overall Study|Adverse Event|2|||
129882306|NCT00197028|467528826|FG000|Overall Study|Protocol Violation|2|||
129882307|NCT00197028|467528827|FG001|Overall Study|Protocol Violation|1|||
129882308|NCT00197028|467528826|FG000|Overall Study|Withdrawal by Subject|8|||
129882309|NCT00197028|467528827|FG001|Overall Study|Withdrawal by Subject|12|||
129882310|NCT00197028|467528826|FG000|Overall Study|Lost to Follow-up|1|||
129882311|NCT00197028|467528827|FG001|Overall Study|Lost to Follow-up|0|||
129882312|NCT00197028|467528826|FG000|Overall Study|Other|3|||
129882313|NCT00197028|467528827|FG001|Overall Study|Other|6|||
129882314|NCT00885352|467528832|FG000|Overall Study|Adverse Event|2|||
129882315|NCT00885352|467528833|FG001|Overall Study|Adverse Event|3|||
129882316|NCT00885352|467528832|FG000|Overall Study|Lost to Follow-up|2|||
129882317|NCT00885352|467528833|FG001|Overall Study|Lost to Follow-up|2|||
129882318|NCT00885352|467528832|FG000|Overall Study|Physician Decision|0|||
129882319|NCT00885352|467528833|FG001|Overall Study|Physician Decision|3|||
129882320|NCT00885352|467528832|FG000|Overall Study|Protocol Violation|0|||
129882321|NCT00885352|467528833|FG001|Overall Study|Protocol Violation|2|||
129882322|NCT00885352|467528832|FG000|Overall Study|Withdrawal by Subject|1|||
129882323|NCT00885352|467528833|FG001|Overall Study|Withdrawal by Subject|5|||
129882324|NCT00885352|467528832|FG000|Overall Study|Contradiction to study medication|0|||
129882325|NCT00885352|467528833|FG001|Overall Study|Contradiction to study medication|2|||
129882326|NCT00885352|467528832|FG000|Overall Study|Excluded medication|2|||
129882327|NCT00885352|467528833|FG001|Overall Study|Excluded medication|2|||
129882328|NCT00885352|467528832|FG000|Overall Study|Lab abnormalities|1|||
129882329|NCT00885352|467528833|FG001|Overall Study|Lab abnormalities|1|||
129882330|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
129882331|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
129882332|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129882333|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
129882334|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
129882335|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
129882336|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
129882337|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
129882338|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
129882339|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
129882340|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
129882341|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
129882342|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
129882343|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
129882344|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
129882345|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
129882346|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
129882347|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
129882348|NCT00365378|467528834|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
129882349|NCT00365378|467528835|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
129882350|NCT00365378|467528836|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
129882351|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
129882352|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
129882353|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
129882354|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
129882355|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
129882356|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
129882357|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
129882358|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
129882359|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
129654830|NCT01716520|466693533|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129654831|NCT01716520|466693534|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
129654832|NCT01716520|466693535|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129654833|NCT01716520|466693536|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129654834|NCT01716520|466693537|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129654835|NCT01716520|466693538|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
129654836|NCT01716520|466693533|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129654837|NCT01716520|466693534|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129654838|NCT01716520|466693535|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129654839|NCT01716520|466693536|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129654840|NCT01716520|466693537|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129654841|NCT01716520|466693538|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
129654842|NCT01716520|466693533|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129654843|NCT01716520|466693534|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129654844|NCT01716520|466693535|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
129654845|NCT01716520|466693536|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129654846|NCT01716520|466693537|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129654847|NCT01716520|466693538|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129654848|NCT01937884|466693542|FG000|Overall Study|Withdrawal by Subject|1|||
129654849|NCT01937884|466693543|FG001|Overall Study|Withdrawal by Subject|0|||
129654850|NCT00004088|466693544|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
129654851|NCT00004088|466693544|FG000|Overall Study|Withdrawal by Subject|1|||
129654852|NCT00004088|466693544|FG000|Overall Study|Protocol Violation|3|||
129654853|NCT00004088|466693544|FG000|Overall Study|Physician Decision|1|||
129654854|NCT02636699|466693551|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
129654855|NCT02636699|466693552|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
129654856|NCT02636699|466693553|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
129654857|NCT02636699|466693551|FG000|Screening Period|Withdrawal by Subject|0|||
129654858|NCT02636699|466693552|FG001|Screening Period|Withdrawal by Subject|0|||
129654859|NCT02636699|466693553|FG002|Screening Period|Withdrawal by Subject|23|||
129654860|NCT02636699|466693551|FG000|Screening Period|Adverse Event|0|||
129654861|NCT02636699|466693552|FG001|Screening Period|Adverse Event|0|||
129654862|NCT02636699|466693553|FG002|Screening Period|Adverse Event|1|||
129654863|NCT02636699|466693551|FG000|Screening Period|Other not specified|0|||
129654864|NCT02636699|466693552|FG001|Screening Period|Other not specified|0|||
129654865|NCT02636699|466693553|FG002|Screening Period|Other not specified|3|||
129654866|NCT02636699|466693551|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
129654867|NCT02636699|466693552|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
129654868|NCT02636699|466693553|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
129654869|NCT02636699|466693551|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
129654870|NCT02636699|466693552|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
129654871|NCT02636699|466693553|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
129654872|NCT02636699|466693551|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
129654873|NCT02636699|466693552|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
129654874|NCT02636699|466693553|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
129654875|NCT02636699|466693551|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
129654876|NCT02636699|466693552|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
129654877|NCT02636699|466693553|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
129654878|NCT02636699|466693551|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
129654879|NCT02636699|466693552|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
129654880|NCT02636699|466693553|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
129654881|NCT02636699|466693551|FG000|Treatment and Follow-up Periods|Other|3|||
129654882|NCT02636699|466693552|FG001|Treatment and Follow-up Periods|Other|1|||
129882360|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
129882361|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
129654883|NCT02636699|466693553|FG002|Treatment and Follow-up Periods|Other|0|||
129654884|NCT00981058|466693556|FG000|Overall Study|Progressive Disease|38|||
129654885|NCT00981058|466693557|FG001|Overall Study|Progressive Disease|31|||
129654886|NCT00981058|466693556|FG000|Overall Study|Lost to Follow-up|3|||
129654887|NCT00981058|466693557|FG001|Overall Study|Lost to Follow-up|2|||
129882362|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
129882363|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
129882364|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
129882365|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
129882366|NCT00365378|467528834|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
129882367|NCT00365378|467528835|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
129882368|NCT00365378|467528836|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
129882369|NCT00365378|467528834|FG000|Extension|Adverse Event|0|||
129882370|NCT00365378|467528835|FG001|Extension|Adverse Event|0|||
129882371|NCT00365378|467528836|FG002|Extension|Adverse Event|1|||
129882372|NCT00365378|467528834|FG000|Extension|Moved|0|||
129882373|NCT00365378|467528835|FG001|Extension|Moved|0|||
129882374|NCT00365378|467528836|FG002|Extension|Moved|8|||
129882375|NCT00365378|467528834|FG000|Extension|Lost to Follow-up|0|||
129882376|NCT00365378|467528835|FG001|Extension|Lost to Follow-up|0|||
129882377|NCT00365378|467528836|FG002|Extension|Lost to Follow-up|57|||
129882378|NCT00365378|467528834|FG000|Extension|Protocol Violation|0|||
129882379|NCT00365378|467528835|FG001|Extension|Protocol Violation|0|||
129882380|NCT00365378|467528836|FG002|Extension|Protocol Violation|2|||
129882381|NCT00365378|467528834|FG000|Extension|Withdrawal by Subject|0|||
129882382|NCT00365378|467528835|FG001|Extension|Withdrawal by Subject|0|||
129882383|NCT00365378|467528836|FG002|Extension|Withdrawal by Subject|98|||
129882384|NCT00365378|467528834|FG000|Extension|Other|0|||
129882385|NCT00365378|467528835|FG001|Extension|Other|0|||
129882386|NCT00365378|467528836|FG002|Extension|Other|31|||
129882387|NCT04161807|467528842|FG000|Overall Study|Withdrawal by Subject|2|||
129882388|NCT04161807|467528842|FG000|Overall Study|Performed only 1 treatment|2|||
129882389|NCT00669903|467528845|FG000|Overall Study|Adverse Event|0|||
129882390|NCT00669903|467528846|FG001|Overall Study|Adverse Event|1|||
129882391|NCT00669903|467528847|FG002|Overall Study|Adverse Event|3|||
129882392|NCT00669903|467528848|FG003|Overall Study|Adverse Event|1|||
129882393|NCT00669903|467528845|FG000|Overall Study|Withdrawal by Subject|0|||
129882394|NCT00669903|467528846|FG001|Overall Study|Withdrawal by Subject|2|||
129882395|NCT00669903|467528847|FG002|Overall Study|Withdrawal by Subject|2|||
129882396|NCT00669903|467528848|FG003|Overall Study|Withdrawal by Subject|2|||
129882397|NCT00669903|467528845|FG000|Overall Study|Lost to Follow-up|1|||
129882398|NCT00669903|467528846|FG001|Overall Study|Lost to Follow-up|1|||
129882399|NCT00669903|467528847|FG002|Overall Study|Lost to Follow-up|0|||
129882400|NCT00669903|467528848|FG003|Overall Study|Lost to Follow-up|1|||
129882401|NCT00669903|467528845|FG000|Overall Study|Protocol Violation|0|||
129882402|NCT00669903|467528846|FG001|Overall Study|Protocol Violation|1|||
129882403|NCT00669903|467528847|FG002|Overall Study|Protocol Violation|0|||
129882404|NCT00669903|467528848|FG003|Overall Study|Protocol Violation|0|||
129882405|NCT04789577|467528851|FG000|Overall Study|Withdrawal by Subject|1|||
129882406|NCT04789577|467528852|FG001|Overall Study|Withdrawal by Subject|1|||
129545194|NCT03917654|466288439|FG004|Year 1|Pregnancy|0|||
129545195|NCT03917654|466288440|FG005|Year 1|Pregnancy|0|||
129882407|NCT04789577|467528853|FG002|Overall Study|Withdrawal by Subject|1|||
129882408|NCT04789577|467528854|FG003|Overall Study|Withdrawal by Subject|3|||
129882409|NCT04789577|467528855|FG004|Overall Study|Withdrawal by Subject|1|||
129882410|NCT04789577|467528856|FG005|Overall Study|Withdrawal by Subject|7|||
129882411|NCT04789577|467528857|FG006|Overall Study|Withdrawal by Subject|1|||
129545196|NCT03917654|466288441|FG006|Year 1|Pregnancy|0|||
129545197|NCT03917654|466288442|FG007|Year 1|Pregnancy|1|||
129545198|NCT03917654|466288443|FG008|Year 1|Pregnancy|0|||
129545199|NCT03917654|466288444|FG009|Year 1|Pregnancy|1|||
129545200|NCT03917654|466288445|FG010|Year 1|Pregnancy|0|||
129545201|NCT03917654|466288446|FG011|Year 1|Pregnancy|0|||
129545202|NCT03917654|466288435|FG000|Year 2|Travel|1|||
129545203|NCT03917654|466288436|FG001|Year 2|Travel|0|||
129545204|NCT03917654|466288437|FG002|Year 2|Travel|0|||
129545205|NCT03917654|466288438|FG003|Year 2|Travel|0|||
129545206|NCT03917654|466288439|FG004|Year 2|Travel|1|||
129545207|NCT03917654|466288440|FG005|Year 2|Travel|1|||
129545208|NCT03917654|466288441|FG006|Year 2|Travel|2|||
129545209|NCT03917654|466288442|FG007|Year 2|Travel|1|||
129545210|NCT03917654|466288443|FG008|Year 2|Travel|0|||
129545211|NCT03917654|466288444|FG009|Year 2|Travel|1|||
129545212|NCT03917654|466288445|FG010|Year 2|Travel|0|||
129545213|NCT03917654|466288446|FG011|Year 2|Travel|1|||
129545214|NCT03917654|466288435|FG000|Year 2|Married|1|||
129545215|NCT03917654|466288436|FG001|Year 2|Married|0|||
129545216|NCT03917654|466288437|FG002|Year 2|Married|0|||
129545217|NCT03917654|466288438|FG003|Year 2|Married|0|||
129545218|NCT03917654|466288439|FG004|Year 2|Married|0|||
129882412|NCT04789577|467528851|FG000|Overall Study|Lost to Follow-up|7|||
129882413|NCT04789577|467528852|FG001|Overall Study|Lost to Follow-up|12|||
129882414|NCT04789577|467528853|FG002|Overall Study|Lost to Follow-up|7|||
129545219|NCT03917654|466288440|FG005|Year 2|Married|0|||
129545220|NCT03917654|466288441|FG006|Year 2|Married|1|||
129545221|NCT03917654|466288442|FG007|Year 2|Married|1|||
129545222|NCT03917654|466288443|FG008|Year 2|Married|0|||
129545223|NCT03917654|466288444|FG009|Year 2|Married|0|||
129545224|NCT03917654|466288445|FG010|Year 2|Married|0|||
129545225|NCT03917654|466288446|FG011|Year 2|Married|0|||
129545226|NCT03917654|466288435|FG000|Year 2|Subject moved away from site|1|||
129882415|NCT04789577|467528854|FG003|Overall Study|Lost to Follow-up|10|||
129882416|NCT04789577|467528855|FG004|Overall Study|Lost to Follow-up|8|||
129882417|NCT04789577|467528856|FG005|Overall Study|Lost to Follow-up|6|||
129882418|NCT04789577|467528857|FG006|Overall Study|Lost to Follow-up|10|||
129882419|NCT04789577|467528851|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
129882420|NCT04789577|467528852|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
129882421|NCT04789577|467528853|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
129882422|NCT04789577|467528854|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
129882423|NCT04789577|467528855|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
129882424|NCT04789577|467528856|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
129882425|NCT04789577|467528857|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
129882426|NCT04789577|467528851|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
129882427|NCT04789577|467528852|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
129882428|NCT04789577|467528853|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
129882429|NCT04789577|467528854|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
129882430|NCT04789577|467528855|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
129882431|NCT04789577|467528856|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
129882432|NCT04789577|467528857|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
129654888|NCT00981058|466693556|FG000|Overall Study|Physician Decision|4|||
129654889|NCT00981058|466693557|FG001|Overall Study|Physician Decision|5|||
129654890|NCT00981058|466693556|FG000|Overall Study|Randomization Error|0|||
129654891|NCT00981058|466693557|FG001|Overall Study|Randomization Error|1|||
129654892|NCT00981058|466693556|FG000|Overall Study|Withdrawal by Subject|24|||
129654893|NCT00981058|466693557|FG001|Overall Study|Withdrawal by Subject|22|||
129654894|NCT02305446|466693564|FG000|Overall Study|Adverse Event|1|||
129654895|NCT01636947|466693565|FG000|Overall Study|Not Treated|2|||
129654896|NCT01636947|466693566|FG001|Overall Study|Not Treated|2|||
129654897|NCT01636947|466693565|FG000|Overall Study|Lost to Follow-up|4|||
129654898|NCT01636947|466693566|FG001|Overall Study|Lost to Follow-up|0|||
129654899|NCT01636947|466693565|FG000|Overall Study|Protocol Violation|1|||
129654900|NCT01636947|466693566|FG001|Overall Study|Protocol Violation|1|||
129654901|NCT01636947|466693565|FG000|Overall Study|Withdrawal by Subject|3|||
129654902|NCT01636947|466693566|FG001|Overall Study|Withdrawal by Subject|3|||
129654903|NCT01636947|466693565|FG000|Overall Study|Adverse Event|1|||
129654904|NCT01636947|466693566|FG001|Overall Study|Adverse Event|1|||
129654905|NCT01636947|466693565|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129654906|NCT01636947|466693566|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
129654907|NCT00957424|466693567|FG000|Overall Study|Lost to Follow-up|19|||
129654908|NCT00957424|466693567|FG000|Overall Study|Protocol Violation|3|||
129654909|NCT00957424|466693567|FG000|Overall Study|Withdrawal by Subject|1|||
129654910|NCT05182606|466693574|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
129654911|NCT01167634|466693577|FG000|Overall Study|Lost to Follow-up|1|||
129654912|NCT01167634|466693578|FG001|Overall Study|Lost to Follow-up|3|||
129654913|NCT01167634|466693579|FG002|Overall Study|Lost to Follow-up|3|||
129654914|NCT01167634|466693580|FG003|Overall Study|Lost to Follow-up|4|||
129654915|NCT01167634|466693577|FG000|Overall Study|Withdrawal by Subject|1|||
129654916|NCT01167634|466693578|FG001|Overall Study|Withdrawal by Subject|1|||
129654917|NCT01167634|466693579|FG002|Overall Study|Withdrawal by Subject|0|||
129654918|NCT01167634|466693580|FG003|Overall Study|Withdrawal by Subject|0|||
129654919|NCT00369161|466693581|FG000|Overall Study|Adverse Event|15|||
129654920|NCT00369161|466693582|FG001|Overall Study|Adverse Event|13|||
129654921|NCT00369161|466693581|FG000|Overall Study|Abnormal laboratory value|0|||
129654922|NCT00369161|466693582|FG001|Overall Study|Abnormal laboratory value|1|||
129654923|NCT00369161|466693581|FG000|Overall Study|Lack of Efficacy|3|||
129654924|NCT00369161|466693582|FG001|Overall Study|Lack of Efficacy|1|||
129654925|NCT00369161|466693581|FG000|Overall Study|Protocol Violation|0|||
129654926|NCT00369161|466693582|FG001|Overall Study|Protocol Violation|2|||
129654927|NCT00369161|466693581|FG000|Overall Study|Withdrawal by Subject|2|||
129654928|NCT00369161|466693582|FG001|Overall Study|Withdrawal by Subject|3|||
129654929|NCT00369161|466693581|FG000|Overall Study|Death|1|||
129654930|NCT00369161|466693582|FG001|Overall Study|Death|2|||
129654931|NCT00369161|466693581|FG000|Overall Study|Graft loss|4|||
129654932|NCT00369161|466693582|FG001|Overall Study|Graft loss|0|||
129654933|NCT00369161|466693581|FG000|Overall Study|Administrative Problem|2|||
129654934|NCT00369161|466693582|FG001|Overall Study|Administrative Problem|2|||
129654935|NCT02147067|466693585|FG000|Overall Study|Withdrawal by Subject|2|||
129654936|NCT02147067|466693586|FG001|Overall Study|Withdrawal by Subject|2|||
129654937|NCT02603107|466693587|FG000|Randomized Phase|Withdrew consent|8|||
129882433|NCT01827254|467528859|FG000|Overall Study|Death|10|||
129882434|NCT01827254|467528859|FG000|Overall Study|Case report form not completed|4|||
129882435|NCT01827254|467528859|FG000|Overall Study|Invalidated centre|3|||
129654938|NCT02603107|466693588|FG001|Randomized Phase|Withdrew consent|15|||
129654939|NCT02603107|466693587|FG000|Randomized Phase|Lost to Follow-up|1|||
129654940|NCT02603107|466693588|FG001|Randomized Phase|Lost to Follow-up|3|||
129654941|NCT02603107|466693587|FG000|Randomized Phase|Adverse Event|2|||
129654942|NCT02603107|466693588|FG001|Randomized Phase|Adverse Event|0|||
129882436|NCT01827254|467528859|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
129882437|NCT01827254|467528859|FG000|Overall Study|Did not complete re-challenge|1|||
129882438|NCT01827254|467528859|FG000|Overall Study|Disease progression|36|||
129882439|NCT01827254|467528859|FG000|Overall Study|Intolerance to treatment|4|||
129882440|NCT01923389|467528867|FG000|Overall Study|Protocol Violation|1|||
129882441|NCT01923389|467528868|FG001|Overall Study|Protocol Violation|0|||
129882442|NCT03292146|467528874|FG000|Baseline to 12 Months|Relocation|1|||
129882443|NCT03292146|467528875|FG001|Baseline to 12 Months|Relocation|0|||
129882444|NCT03292146|467528874|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
129882445|NCT03292146|467528875|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
129882446|NCT03292146|467528874|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
129882447|NCT03292146|467528875|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
129882448|NCT03292146|467528874|FG000|12 Months to 24 Months|Planning pregnancy|2|||
129882449|NCT03292146|467528875|FG001|12 Months to 24 Months|Planning pregnancy|2|||
129882450|NCT03292146|467528874|FG000|12 Months to 24 Months|Personal reasons|1|||
129882451|NCT03292146|467528875|FG001|12 Months to 24 Months|Personal reasons|0|||
129882452|NCT03292146|467528874|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
129882453|NCT03292146|467528875|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
129882454|NCT00545363|467528878|FG000|Overall Study|Adverse Event|6|||
129882455|NCT00545363|467528879|FG001|Overall Study|Adverse Event|7|||
129882456|NCT00545363|467528878|FG000|Overall Study|Withdrawal by Subject|6|||
129882457|NCT00545363|467528879|FG001|Overall Study|Withdrawal by Subject|5|||
129882458|NCT00545363|467528878|FG000|Overall Study|Non-compliance|3|||
129882459|NCT00545363|467528879|FG001|Overall Study|Non-compliance|1|||
129882460|NCT00545363|467528878|FG000|Overall Study|Did not meet entry criteria|1|||
129882461|NCT00545363|467528879|FG001|Overall Study|Did not meet entry criteria|1|||
129882462|NCT00545363|467528878|FG000|Overall Study|Lost to Follow-up|2|||
129882463|NCT00545363|467528879|FG001|Overall Study|Lost to Follow-up|0|||
129882464|NCT00545363|467528878|FG000|Overall Study|Other|1|||
129882465|NCT00545363|467528879|FG001|Overall Study|Other|1|||
129882466|NCT00366301|467528880|FG000|Overall Study|Lost to Follow-up|4|||
129882467|NCT00366301|467528881|FG001|Overall Study|Lost to Follow-up|4|||
129882468|NCT00366301|467528882|FG002|Overall Study|Lost to Follow-up|3|||
129882469|NCT00366301|467528883|FG003|Overall Study|Lost to Follow-up|7|||
129882470|NCT00366301|467528880|FG000|Overall Study|Withdrawal by Subject|4|||
129882471|NCT00366301|467528881|FG001|Overall Study|Withdrawal by Subject|2|||
129882472|NCT00366301|467528882|FG002|Overall Study|Withdrawal by Subject|1|||
129882473|NCT00366301|467528883|FG003|Overall Study|Withdrawal by Subject|1|||
129882474|NCT01348776|467528888|FG000|Overall Study|Lost to Follow-up|3|||
129882475|NCT01463293|467528889|FG000|Overall Study|Lost to Follow-up|1|||
129882476|NCT01463293|467528890|FG001|Overall Study|Lost to Follow-up|4|||
129882477|NCT01463293|467528891|FG002|Overall Study|Lost to Follow-up|5|||
129882478|NCT01463293|467528889|FG000|Overall Study|Adverse Event|1|||
129882479|NCT01463293|467528890|FG001|Overall Study|Adverse Event|2|||
129882480|NCT01463293|467528891|FG002|Overall Study|Adverse Event|0|||
129882481|NCT01463293|467528889|FG000|Overall Study|Withdrawal by Subject|4|||
129882482|NCT01463293|467528890|FG001|Overall Study|Withdrawal by Subject|10|||
129882483|NCT01463293|467528891|FG002|Overall Study|Withdrawal by Subject|5|||
129882484|NCT01463293|467528889|FG000|Overall Study|Other|0|||
129882485|NCT01463293|467528890|FG001|Overall Study|Other|0|||
129882486|NCT01463293|467528891|FG002|Overall Study|Other|2|||
129882487|NCT00309608|467528892|FG000|Overall Study|Adverse Event|1|||
129654943|NCT02603107|466693587|FG000|Randomized Phase|Death|1|||
129654944|NCT02603107|466693588|FG001|Randomized Phase|Death|1|||
129654945|NCT02603107|466693587|FG000|Randomized Phase|Non-compliance with study drug|1|||
129545227|NCT03917654|466288436|FG001|Year 2|Subject moved away from site|0|||
129545228|NCT03917654|466288437|FG002|Year 2|Subject moved away from site|0|||
129545229|NCT03917654|466288438|FG003|Year 2|Subject moved away from site|0|||
129654946|NCT02603107|466693588|FG001|Randomized Phase|Non-compliance with study drug|1|||
129654947|NCT02603107|466693587|FG000|Randomized Phase|Investigator's discretion|0|||
129654948|NCT02603107|466693588|FG001|Randomized Phase|Investigator's discretion|1|||
129654949|NCT02603107|466693587|FG000|Randomized Phase|Lack of Efficacy|1|||
129654950|NCT02603107|466693588|FG001|Randomized Phase|Lack of Efficacy|0|||
129654951|NCT02603107|466693587|FG000|Randomized Phase|Protocol Violation|1|||
129654952|NCT02603107|466693588|FG001|Randomized Phase|Protocol Violation|0|||
129654953|NCT02603107|466693587|FG000|Optional Extension Phase|Lost to Follow-up|3|||
129882488|NCT00309608|467528893|FG001|Overall Study|Adverse Event|5|||
129882489|NCT00309608|467528894|FG002|Overall Study|Adverse Event|3|||
129882490|NCT00309608|467528895|FG003|Overall Study|Adverse Event|2|||
129882491|NCT00309608|467528896|FG004|Overall Study|Adverse Event|3|||
129882492|NCT00309608|467528892|FG000|Overall Study|Protocol Violation|2|||
129882493|NCT00309608|467528893|FG001|Overall Study|Protocol Violation|0|||
129882494|NCT00309608|467528894|FG002|Overall Study|Protocol Violation|0|||
129882495|NCT00309608|467528895|FG003|Overall Study|Protocol Violation|0|||
129882496|NCT00309608|467528896|FG004|Overall Study|Protocol Violation|0|||
129882497|NCT00309608|467528892|FG000|Overall Study|Lost to Follow-up|0|||
129882498|NCT00309608|467528893|FG001|Overall Study|Lost to Follow-up|0|||
129882499|NCT00309608|467528894|FG002|Overall Study|Lost to Follow-up|2|||
129882500|NCT00309608|467528895|FG003|Overall Study|Lost to Follow-up|0|||
129545230|NCT03917654|466288439|FG004|Year 2|Subject moved away from site|1|||
129545231|NCT03917654|466288440|FG005|Year 2|Subject moved away from site|0|||
129545232|NCT03917654|466288441|FG006|Year 2|Subject moved away from site|2|||
129545233|NCT03917654|466288442|FG007|Year 2|Subject moved away from site|3|||
129545234|NCT03917654|466288443|FG008|Year 2|Subject moved away from site|0|||
129545235|NCT03917654|466288444|FG009|Year 2|Subject moved away from site|2|||
129545236|NCT03917654|466288445|FG010|Year 2|Subject moved away from site|0|||
129545237|NCT03917654|466288446|FG011|Year 2|Subject moved away from site|1|||
129545238|NCT03917654|466288435|FG000|Year 2|Year 2 Screening failure|0|||
129545239|NCT03917654|466288436|FG001|Year 2|Year 2 Screening failure|1|||
129545240|NCT03917654|466288437|FG002|Year 2|Year 2 Screening failure|0|||
129545241|NCT03917654|466288438|FG003|Year 2|Year 2 Screening failure|0|||
129545242|NCT03917654|466288439|FG004|Year 2|Year 2 Screening failure|2|||
129545243|NCT03917654|466288440|FG005|Year 2|Year 2 Screening failure|0|||
129545244|NCT03917654|466288441|FG006|Year 2|Year 2 Screening failure|4|||
129545245|NCT03917654|466288442|FG007|Year 2|Year 2 Screening failure|3|||
129545246|NCT03917654|466288443|FG008|Year 2|Year 2 Screening failure|10|||
129545247|NCT03917654|466288444|FG009|Year 2|Year 2 Screening failure|2|||
129545248|NCT03917654|466288445|FG010|Year 2|Year 2 Screening failure|1|||
129545249|NCT03917654|466288446|FG011|Year 2|Year 2 Screening failure|1|||
129545250|NCT03917654|466288435|FG000|Year 2|Death|0|||
129545251|NCT03917654|466288436|FG001|Year 2|Death|0|||
129545252|NCT03917654|466288437|FG002|Year 2|Death|0|||
129545253|NCT03917654|466288438|FG003|Year 2|Death|0|||
129545254|NCT03917654|466288439|FG004|Year 2|Death|0|||
129545255|NCT03917654|466288440|FG005|Year 2|Death|1|||
129545256|NCT03917654|466288441|FG006|Year 2|Death|0|||
129545257|NCT03917654|466288442|FG007|Year 2|Death|0|||
129545258|NCT03917654|466288443|FG008|Year 2|Death|1|||
129545259|NCT03917654|466288444|FG009|Year 2|Death|1|||
129545260|NCT03917654|466288445|FG010|Year 2|Death|0|||
129545261|NCT03917654|466288446|FG011|Year 2|Death|0|||
129545262|NCT03917654|466288435|FG000|Year 2|Withdrawal by Subject|0|||
129545263|NCT03917654|466288436|FG001|Year 2|Withdrawal by Subject|0|||
129545264|NCT03917654|466288437|FG002|Year 2|Withdrawal by Subject|0|||
129545265|NCT03917654|466288438|FG003|Year 2|Withdrawal by Subject|0|||
129545266|NCT03917654|466288439|FG004|Year 2|Withdrawal by Subject|0|||
129545267|NCT03917654|466288440|FG005|Year 2|Withdrawal by Subject|0|||
129545268|NCT03917654|466288441|FG006|Year 2|Withdrawal by Subject|3|||
129545269|NCT03917654|466288442|FG007|Year 2|Withdrawal by Subject|0|||
129545270|NCT03917654|466288443|FG008|Year 2|Withdrawal by Subject|2|||
129545271|NCT03917654|466288444|FG009|Year 2|Withdrawal by Subject|5|||
129545272|NCT03917654|466288445|FG010|Year 2|Withdrawal by Subject|0|||
129545273|NCT03917654|466288446|FG011|Year 2|Withdrawal by Subject|0|||
129545274|NCT03917654|466288435|FG000|Year 2|Spouse/family member request|0|||
129545275|NCT03917654|466288436|FG001|Year 2|Spouse/family member request|0|||
129545276|NCT03917654|466288437|FG002|Year 2|Spouse/family member request|0|||
129545277|NCT03917654|466288438|FG003|Year 2|Spouse/family member request|0|||
129545278|NCT03917654|466288439|FG004|Year 2|Spouse/family member request|0|||
129545279|NCT03917654|466288440|FG005|Year 2|Spouse/family member request|0|||
129545280|NCT03917654|466288441|FG006|Year 2|Spouse/family member request|1|||
129545281|NCT03917654|466288442|FG007|Year 2|Spouse/family member request|0|||
129545282|NCT03917654|466288443|FG008|Year 2|Spouse/family member request|0|||
129545283|NCT03917654|466288444|FG009|Year 2|Spouse/family member request|0|||
129545284|NCT03917654|466288445|FG010|Year 2|Spouse/family member request|0|||
129545285|NCT03917654|466288446|FG011|Year 2|Spouse/family member request|0|||
129545286|NCT03917654|466288435|FG000|Year 2|Lost to Follow-up|0|||
129545287|NCT03917654|466288436|FG001|Year 2|Lost to Follow-up|0|||
129545288|NCT03917654|466288437|FG002|Year 2|Lost to Follow-up|0|||
129545289|NCT03917654|466288438|FG003|Year 2|Lost to Follow-up|0|||
129545290|NCT03917654|466288439|FG004|Year 2|Lost to Follow-up|0|||
129545291|NCT03917654|466288440|FG005|Year 2|Lost to Follow-up|0|||
129545292|NCT03917654|466288441|FG006|Year 2|Lost to Follow-up|1|||
129545293|NCT03917654|466288442|FG007|Year 2|Lost to Follow-up|0|||
129545294|NCT03917654|466288443|FG008|Year 2|Lost to Follow-up|1|||
129545295|NCT03917654|466288444|FG009|Year 2|Lost to Follow-up|0|||
129545296|NCT03917654|466288445|FG010|Year 2|Lost to Follow-up|0|||
129545297|NCT03917654|466288446|FG011|Year 2|Lost to Follow-up|1|||
129545298|NCT03917654|466288435|FG000|Year 2|Adverse Event|0|||
129545299|NCT03917654|466288436|FG001|Year 2|Adverse Event|0|||
129545300|NCT03917654|466288437|FG002|Year 2|Adverse Event|0|||
129545301|NCT03917654|466288438|FG003|Year 2|Adverse Event|0|||
129545302|NCT03917654|466288439|FG004|Year 2|Adverse Event|0|||
129545303|NCT03917654|466288440|FG005|Year 2|Adverse Event|0|||
129545304|NCT03917654|466288441|FG006|Year 2|Adverse Event|0|||
129545305|NCT03917654|466288442|FG007|Year 2|Adverse Event|0|||
129545306|NCT03917654|466288443|FG008|Year 2|Adverse Event|0|||
129545307|NCT03917654|466288444|FG009|Year 2|Adverse Event|1|||
129545308|NCT03917654|466288445|FG010|Year 2|Adverse Event|0|||
129545309|NCT03917654|466288446|FG011|Year 2|Adverse Event|0|||
129545310|NCT00905437|466288449|FG000|Overall Study|Adverse Event|3|||
129654954|NCT02603107|466693588|FG001|Optional Extension Phase|Lost to Follow-up|3|||
129654955|NCT02603107|466693587|FG000|Optional Extension Phase|Withdrew consent|3|||
129654956|NCT02603107|466693588|FG001|Optional Extension Phase|Withdrew consent|2|||
129654957|NCT02603107|466693587|FG000|Optional Extension Phase|Investigator's discretion|2|||
129654958|NCT02603107|466693588|FG001|Optional Extension Phase|Investigator's discretion|2|||
129654959|NCT02603107|466693587|FG000|Optional Extension Phase|Pregnancy|0|||
129654960|NCT02603107|466693588|FG001|Optional Extension Phase|Pregnancy|3|||
129654961|NCT02603107|466693587|FG000|Optional Extension Phase|Adverse Event|0|||
129654962|NCT02603107|466693588|FG001|Optional Extension Phase|Adverse Event|2|||
129654963|NCT02603107|466693587|FG000|Optional Extension Phase|Not treated in extension phase|0|||
129654964|NCT02603107|466693588|FG001|Optional Extension Phase|Not treated in extension phase|1|||
129654965|NCT02603107|466693587|FG000|Optional Extension Phase|Protocol Violation|1|||
129654966|NCT02603107|466693588|FG001|Optional Extension Phase|Protocol Violation|0|||
129654967|NCT01404949|466693589|FG000|Overall Study|Not Treated|1|||
129654968|NCT03411902|466693590|FG000|Overall Study|Lost to Follow-up|3|||
129654969|NCT03411902|466693591|FG001|Overall Study|Lost to Follow-up|0|||
129654970|NCT00419159|466693592|FG000|Overall Study|Adverse Event|7|||
129654971|NCT00419159|466693593|FG001|Overall Study|Adverse Event|15|||
129654972|NCT00419159|466693592|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129654973|NCT00419159|466693593|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129654974|NCT00419159|466693592|FG000|Overall Study|Subject's no longer requires study drug|0|||
129654975|NCT00419159|466693593|FG001|Overall Study|Subject's no longer requires study drug|1|||
129654976|NCT00419159|466693592|FG000|Overall Study|Protocol Violation|1|||
129654977|NCT00419159|466693593|FG001|Overall Study|Protocol Violation|0|||
129654978|NCT00419159|466693592|FG000|Overall Study|Withdrawal by Subject|10|||
129654979|NCT00419159|466693593|FG001|Overall Study|Withdrawal by Subject|3|||
129654980|NCT00419159|466693592|FG000|Overall Study|Lost to Follow-up|0|||
129654981|NCT00419159|466693593|FG001|Overall Study|Lost to Follow-up|1|||
129654982|NCT00419159|466693592|FG000|Overall Study|Death|2|||
129654983|NCT00419159|466693593|FG001|Overall Study|Death|2|||
129654984|NCT00419159|466693592|FG000|Overall Study|Disease progression|79|||
129654985|NCT00419159|466693593|FG001|Overall Study|Disease progression|76|||
129654986|NCT01017601|466693594|FG000|Overall Study|Disease Progression|12|||
129654987|NCT01017601|466693595|FG001|Overall Study|Disease Progression|12|||
129654988|NCT01017601|466693594|FG000|Overall Study|Withdrawal by Subject|0|||
129654989|NCT01017601|466693595|FG001|Overall Study|Withdrawal by Subject|1|||
129654990|NCT00574795|466693597|FG000|Infant Series|Withdrawal by Subject|2|||
129654991|NCT00574795|466693597|FG000|Infant Series|Protocol Violation|2|||
129654992|NCT00574795|466693597|FG000|Infant Series|Adverse Event|1|||
129654993|NCT00574795|466693597|FG000|After Infant Series|Withdrawal by Subject|1|||
129654994|NCT00574795|466693597|FG000|After Infant Series|Adverse Event|2|||
129654995|NCT00574795|466693597|FG000|Toddler Dose|Withdrawal by Subject|1|||
129654996|NCT02638259|466693598|FG000|Treatment Period 1|Adverse Event|1|||
129654997|NCT02638259|466693599|FG001|Treatment Period 1|Adverse Event|5|||
129654998|NCT02638259|466693598|FG000|Treatment Period 1|Death|0|||
129654999|NCT02638259|466693599|FG001|Treatment Period 1|Death|1|||
129655000|NCT02638259|466693598|FG000|Treatment Period 1|Lack of Efficacy|0|||
129655001|NCT02638259|466693599|FG001|Treatment Period 1|Lack of Efficacy|1|||
129655002|NCT02638259|466693598|FG000|Treatment Period 1|Protocol Violation|0|||
129655003|NCT02638259|466693599|FG001|Treatment Period 1|Protocol Violation|3|||
129655004|NCT02638259|466693598|FG000|Treatment Period 1|Withdrawal by Subject|4|||
129655005|NCT02638259|466693599|FG001|Treatment Period 1|Withdrawal by Subject|6|||
129655006|NCT02638259|466693598|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
129655007|NCT02638259|466693599|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
129655008|NCT02638259|466693598|FG000|Treatment Period 2|Adverse Event|5|||
129655009|NCT02638259|466693599|FG001|Treatment Period 2|Adverse Event|4|||
129655010|NCT02638259|466693598|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129655011|NCT02638259|466693599|FG001|Treatment Period 2|Withdrawal by Subject|7|||
129655012|NCT01706575|466693600|FG000|Overall Study|Participant Withdrew Consent|4|||
129655013|NCT01706575|466693600|FG000|Overall Study|Lost to Follow-up|2|||
129655014|NCT01706575|466693600|FG000|Overall Study|Started but not Treated|6|||
129655015|NCT01094782|466693601|FG000|Overall Study|Withdrawal by Subject|5|||
129655016|NCT01094782|466693602|FG001|Overall Study|Withdrawal by Subject|5|||
129882501|NCT00309608|467528896|FG004|Overall Study|Lost to Follow-up|1|||
129882502|NCT00309608|467528892|FG000|Overall Study|Withdrawal by Subject|1|||
129655017|NCT01094782|466693603|FG002|Overall Study|Withdrawal by Subject|1|||
129655018|NCT01094782|466693604|FG003|Overall Study|Withdrawal by Subject|5|||
129655019|NCT01094782|466693605|FG004|Overall Study|Withdrawal by Subject|5|||
129655020|NCT01094782|466693606|FG005|Overall Study|Withdrawal by Subject|0|||
129655021|NCT01094782|466693601|FG000|Overall Study|Lost to Follow-up|1|||
129655022|NCT01094782|466693602|FG001|Overall Study|Lost to Follow-up|0|||
129655023|NCT01094782|466693603|FG002|Overall Study|Lost to Follow-up|0|||
129655024|NCT01094782|466693604|FG003|Overall Study|Lost to Follow-up|2|||
129655025|NCT01094782|466693605|FG004|Overall Study|Lost to Follow-up|1|||
129655026|NCT01094782|466693606|FG005|Overall Study|Lost to Follow-up|4|||
129655027|NCT01094782|466693601|FG000|Overall Study|Positive Drug Screen|2|||
129882503|NCT00309608|467528893|FG001|Overall Study|Withdrawal by Subject|4|||
129882504|NCT00309608|467528894|FG002|Overall Study|Withdrawal by Subject|2|||
129882505|NCT00309608|467528895|FG003|Overall Study|Withdrawal by Subject|0|||
129882506|NCT00309608|467528896|FG004|Overall Study|Withdrawal by Subject|0|||
129882507|NCT00309608|467528892|FG000|Overall Study|Other incl. Lack of efficacy|10|||
129882508|NCT00309608|467528893|FG001|Overall Study|Other incl. Lack of efficacy|4|||
129882509|NCT00309608|467528894|FG002|Overall Study|Other incl. Lack of efficacy|3|||
129882510|NCT00309608|467528895|FG003|Overall Study|Other incl. Lack of efficacy|4|||
129882511|NCT00309608|467528896|FG004|Overall Study|Other incl. Lack of efficacy|0|||
129882512|NCT00621296|467528903|FG000|Overall Study|Adverse Event|2|||
129882513|NCT00621296|467528903|FG000|Overall Study|Lack of Efficacy|1|||
129882514|NCT00621296|467528903|FG000|Overall Study|Physician Decision|7|||
129882515|NCT00621296|467528903|FG000|Overall Study|Unmatch Criteria|1|||
129882516|NCT00621296|467528903|FG000|Overall Study|Stopping Criteria|3|||
129882517|NCT02049710|467528904|FG000|Overall Study|Lost to Follow-up|319|||
129655028|NCT01094782|466693602|FG001|Overall Study|Positive Drug Screen|2|||
129655029|NCT01094782|466693603|FG002|Overall Study|Positive Drug Screen|1|||
129655030|NCT01094782|466693604|FG003|Overall Study|Positive Drug Screen|1|||
129882518|NCT02049710|467528905|FG001|Overall Study|Lost to Follow-up|324|||
129882519|NCT00386308|467530423|FG000|Overall Study|Adverse Event|3|||
129882520|NCT00386308|467530424|FG001|Overall Study|Adverse Event|3|||
129882521|NCT00386308|467530423|FG000|Overall Study|Protocol Violation|2|||
129882522|NCT00386308|467530424|FG001|Overall Study|Protocol Violation|5|||
129882523|NCT00386308|467530423|FG000|Overall Study|Lack of Efficacy|0|||
129882524|NCT00386308|467530424|FG001|Overall Study|Lack of Efficacy|2|||
129882525|NCT00386308|467530423|FG000|Overall Study|Lost to Follow-up|10|||
129882526|NCT00386308|467530424|FG001|Overall Study|Lost to Follow-up|6|||
129882527|NCT00386308|467530423|FG000|Overall Study|Withdrawal by Subject|6|||
129882528|NCT00386308|467530424|FG001|Overall Study|Withdrawal by Subject|2|||
129882529|NCT00386308|467530423|FG000|Overall Study|Other Event|8|||
129882530|NCT00386308|467530424|FG001|Overall Study|Other Event|1|||
129882531|NCT02906683|467530425|FG000|Overall Study|Adverse Event|0|||
129882532|NCT02906683|467530426|FG001|Overall Study|Adverse Event|1|||
129882533|NCT02906683|467530427|FG002|Overall Study|Adverse Event|0|||
129882534|NCT02906683|467530425|FG000|Overall Study|Physician Decision|0|||
129882535|NCT02906683|467530426|FG001|Overall Study|Physician Decision|1|||
129882536|NCT02906683|467530427|FG002|Overall Study|Physician Decision|1|||
129882537|NCT02906683|467530425|FG000|Overall Study|Withdrawal by Subject|0|||
129882538|NCT02906683|467530426|FG001|Overall Study|Withdrawal by Subject|2|||
129882539|NCT02906683|467530427|FG002|Overall Study|Withdrawal by Subject|1|||
129882540|NCT02906683|467530425|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
129882541|NCT02906683|467530426|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
129882542|NCT02906683|467530427|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
129882543|NCT02906683|467530425|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
129882544|NCT02906683|467530426|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
129882545|NCT02906683|467530427|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
129882546|NCT01340482|467530428|FG000|Overall Study|Adverse Event|2|||
129882547|NCT01340482|467530429|FG001|Overall Study|Adverse Event|0|||
129655031|NCT01094782|466693605|FG004|Overall Study|Positive Drug Screen|3|||
129655032|NCT01094782|466693606|FG005|Overall Study|Positive Drug Screen|2|||
129655033|NCT01094782|466693601|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
129655034|NCT01094782|466693602|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
129655035|NCT01094782|466693603|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
129655036|NCT01094782|466693604|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
129655037|NCT01094782|466693605|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
129655038|NCT01094782|466693606|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
129655039|NCT01094782|466693601|FG000|Overall Study|Unable to Complete Questionnaires|0|||
129655040|NCT01094782|466693602|FG001|Overall Study|Unable to Complete Questionnaires|1|||
129655041|NCT01094782|466693603|FG002|Overall Study|Unable to Complete Questionnaires|0|||
129655042|NCT01094782|466693604|FG003|Overall Study|Unable to Complete Questionnaires|0|||
129655043|NCT01094782|466693605|FG004|Overall Study|Unable to Complete Questionnaires|0|||
129655044|NCT01094782|466693606|FG005|Overall Study|Unable to Complete Questionnaires|0|||
129655045|NCT01094782|466693601|FG000|Overall Study|Healthy Subject Had Pain|0|||
129882548|NCT01340482|467530430|FG002|Overall Study|Adverse Event|0|||
129882549|NCT01282476|467530431|FG000|Overall Study|Death|11|||
129882550|NCT00437125|467530434|FG000|Overall Study|Adverse Event|12|||
129882551|NCT00437125|467530434|FG000|Overall Study|Death|1|||
129882552|NCT00437125|467530434|FG000|Overall Study|Clinical Relapse|1|||
129882553|NCT00437125|467530434|FG000|Overall Study|Lack of Efficacy|1|||
129882554|NCT00437125|467530434|FG000|Overall Study|Lost to Follow-up|1|||
129882555|NCT00437125|467530434|FG000|Overall Study|Withdrawal by Subject|13|||
129882556|NCT00437125|467530434|FG000|Overall Study|Withdrawal by Caregiver|2|||
129882557|NCT00437125|467530434|FG000|Overall Study|Physician Decision|1|||
129882558|NCT02248961|467530435|FG000|Overall Study|Adverse Event|1|||
129882559|NCT02248961|467530436|FG001|Overall Study|Adverse Event|0|||
129882560|NCT02248961|467530435|FG000|Overall Study|Withdrawal by Subject|1|||
129882561|NCT02248961|467530436|FG001|Overall Study|Withdrawal by Subject|2|||
129882562|NCT02248961|467530435|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
129882563|NCT02248961|467530436|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
129882564|NCT00453310|467530441|FG000|Overall Study|Progression of Disease|10|||
129882565|NCT01267825|467530442|FG000|Overall Study|study terminated. no data collected.|1|||
129882566|NCT01267825|467530443|FG001|Overall Study|study terminated. no data collected.|0|||
129882567|NCT00871351|467530446|FG000|Overall Study|Withdrawal by Subject|1|||
129882568|NCT00871351|467530447|FG001|Overall Study|Withdrawal by Subject|0|||
129882569|NCT00871351|467530448|FG002|Overall Study|Withdrawal by Subject|0|||
129882570|NCT00871351|467530446|FG000|Overall Study|Adverse Event|3|||
129882571|NCT00871351|467530447|FG001|Overall Study|Adverse Event|1|||
129882572|NCT00871351|467530448|FG002|Overall Study|Adverse Event|0|||
129882573|NCT00744237|467530449|FG000|Overall Study|Lack of Efficacy|1|||
129882574|NCT00744237|467530450|FG001|Overall Study|Lack of Efficacy|1|||
129882575|NCT00744237|467530451|FG002|Overall Study|Lack of Efficacy|0|||
129882576|NCT00744237|467530449|FG000|Overall Study|Withdrawal by Subject|9|||
129882577|NCT00744237|467530450|FG001|Overall Study|Withdrawal by Subject|5|||
129882578|NCT00744237|467530451|FG002|Overall Study|Withdrawal by Subject|3|||
129882579|NCT00744237|467530449|FG000|Overall Study|Lost to Follow-up|1|||
129882580|NCT00744237|467530450|FG001|Overall Study|Lost to Follow-up|1|||
129882581|NCT00744237|467530451|FG002|Overall Study|Lost to Follow-up|1|||
129882582|NCT00744237|467530449|FG000|Overall Study|Protocol Violation|3|||
129882583|NCT00744237|467530450|FG001|Overall Study|Protocol Violation|4|||
129882584|NCT00744237|467530451|FG002|Overall Study|Protocol Violation|3|||
129882585|NCT00744237|467530449|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
129882586|NCT00744237|467530450|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
129882587|NCT00744237|467530451|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
129882588|NCT00744237|467530449|FG000|Overall Study|Dosing Error|1|||
129882589|NCT00744237|467530450|FG001|Overall Study|Dosing Error|0|||
129882590|NCT00744237|467530451|FG002|Overall Study|Dosing Error|1|||
129882591|NCT00744237|467530449|FG000|Overall Study|Study Drug Error|1|||
129882592|NCT00744237|467530450|FG001|Overall Study|Study Drug Error|0|||
129882593|NCT00744237|467530451|FG002|Overall Study|Study Drug Error|0|||
129882594|NCT00744237|467530449|FG000|Overall Study|Prohibited Concomitant Medication|0|||
129882595|NCT00744237|467530450|FG001|Overall Study|Prohibited Concomitant Medication|0|||
129882596|NCT00744237|467530451|FG002|Overall Study|Prohibited Concomitant Medication|1|||
129882597|NCT00744237|467530449|FG000|Overall Study|Poor Compliance|0|||
129882598|NCT00744237|467530450|FG001|Overall Study|Poor Compliance|2|||
129882599|NCT00744237|467530451|FG002|Overall Study|Poor Compliance|0|||
129882600|NCT00744237|467530449|FG000|Overall Study|Administrative. Site Closed|1|||
129882601|NCT00744237|467530450|FG001|Overall Study|Administrative. Site Closed|1|||
129882602|NCT00744237|467530451|FG002|Overall Study|Administrative. Site Closed|1|||
129882603|NCT00744237|467530449|FG000|Overall Study|Adverse Event|9|||
129882604|NCT00744237|467530450|FG001|Overall Study|Adverse Event|13|||
129882605|NCT00744237|467530451|FG002|Overall Study|Adverse Event|5|||
129882606|NCT02791490|467530453|FG000|Overall Study|Lost to Follow-up|1|||
129882607|NCT02791490|467530454|FG001|Overall Study|Lost to Follow-up|2|||
129882608|NCT02791490|467530453|FG000|Overall Study|Withdrawal by Subject|2|||
129882609|NCT02791490|467530454|FG001|Overall Study|Withdrawal by Subject|6|||
129882610|NCT01984424|467530455|FG000|Overall Study|Withdrawal by Subject|3|||
129882611|NCT01984424|467530456|FG001|Overall Study|Withdrawal by Subject|5|||
129882612|NCT01984424|467530455|FG000|Overall Study|Sponsor Decision|0|||
129882613|NCT01984424|467530456|FG001|Overall Study|Sponsor Decision|1|||
129882614|NCT01984424|467530455|FG000|Overall Study|Lost to Follow-up|0|||
129882615|NCT01984424|467530456|FG001|Overall Study|Lost to Follow-up|1|||
129882616|NCT02802319|467530457|FG000|Overall Study|Physician Decision|2|||
129882617|NCT02802319|467530458|FG001|Overall Study|Physician Decision|1|||
129882618|NCT02802319|467530457|FG000|Overall Study|Lost to Follow-up|0|||
129882619|NCT02802319|467530458|FG001|Overall Study|Lost to Follow-up|4|||
129882620|NCT00077636|467530459|FG000|Overall Study|Refused Treatment|9|||
129882621|NCT00077636|467530460|FG001|Overall Study|Refused Treatment|31|||
129882622|NCT00077636|467530459|FG000|Overall Study|Admin|3|||
129882623|NCT00077636|467530460|FG001|Overall Study|Admin|3|||
129882624|NCT00077636|467530459|FG000|Overall Study|Withdrawal by Subject|2|||
129882625|NCT00077636|467530460|FG001|Overall Study|Withdrawal by Subject|2|||
129882626|NCT00077636|467530459|FG000|Overall Study|Adverse Event|17|||
129882627|NCT00077636|467530460|FG001|Overall Study|Adverse Event|34|||
129882628|NCT00077636|467530459|FG000|Overall Study|Protocol Violation|0|||
129882629|NCT00077636|467530460|FG001|Overall Study|Protocol Violation|2|||
129882630|NCT00077636|467530459|FG000|Overall Study|Lost to Follow-up|10|||
129882631|NCT00077636|467530460|FG001|Overall Study|Lost to Follow-up|18|||
129882632|NCT00077636|467530459|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
129882633|NCT00077636|467530460|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
129545311|NCT00905437|466288450|FG001|Overall Study|Adverse Event|2|||
129655046|NCT01094782|466693602|FG001|Overall Study|Healthy Subject Had Pain|1|||
129655047|NCT01094782|466693603|FG002|Overall Study|Healthy Subject Had Pain|0|||
129655048|NCT01094782|466693604|FG003|Overall Study|Healthy Subject Had Pain|0|||
129655049|NCT01094782|466693605|FG004|Overall Study|Healthy Subject Had Pain|0|||
129655050|NCT01094782|466693606|FG005|Overall Study|Healthy Subject Had Pain|0|||
129882634|NCT02032173|467530461|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
129882635|NCT03321513|467530464|FG000|Overall Study|Death|11|||
129882636|NCT03321513|467530465|FG001|Overall Study|Death|5|||
129882637|NCT03321513|467530464|FG000|Overall Study|Withdrawal by Subject|5|||
129882638|NCT03321513|467530465|FG001|Overall Study|Withdrawal by Subject|10|||
129882639|NCT03321513|467530464|FG000|Overall Study|Lost to Follow-up|10|||
129882640|NCT03321513|467530465|FG001|Overall Study|Lost to Follow-up|11|||
129882641|NCT01993017|467530466|FG000|Overall Study|Death|23|||
129882642|NCT01993017|467530467|FG001|Overall Study|Death|26|||
129882643|NCT01993017|467530468|FG002|Overall Study|Death|18|||
129882644|NCT01993017|467530466|FG000|Overall Study|Could not be contacted|43|||
129882645|NCT01993017|467530467|FG001|Overall Study|Could not be contacted|42|||
129882646|NCT01993017|467530468|FG002|Overall Study|Could not be contacted|38|||
129882647|NCT01993017|467530466|FG000|Overall Study|Dropped out|19|||
129882648|NCT01993017|467530467|FG001|Overall Study|Dropped out|6|||
129882649|NCT01993017|467530468|FG002|Overall Study|Dropped out|11|||
129882650|NCT01993017|467530466|FG000|Overall Study|Other reasons|17|||
129882651|NCT01993017|467530467|FG001|Overall Study|Other reasons|11|||
129882652|NCT01993017|467530468|FG002|Overall Study|Other reasons|7|||
129882653|NCT01993017|467530466|FG000|Overall Study|Ineligible after randomization|4|||
129882654|NCT01993017|467530467|FG001|Overall Study|Ineligible after randomization|5|||
129882655|NCT01993017|467530468|FG002|Overall Study|Ineligible after randomization|5|||
129882656|NCT01683994|467530471|FG000|Overall Study|Withdrawal by Subject|1|||
129882657|NCT01683994|467530472|FG001|Overall Study|Withdrawal by Subject|0|||
129882658|NCT01683994|467530473|FG002|Overall Study|Withdrawal by Subject|0|||
129882659|NCT01683994|467530474|FG003|Overall Study|Withdrawal by Subject|1|||
129882660|NCT01683994|467530475|FG004|Overall Study|Withdrawal by Subject|0|||
129882661|NCT01683994|467530471|FG000|Overall Study|Intercurrent illness|0|||
129882662|NCT01683994|467530472|FG001|Overall Study|Intercurrent illness|0|||
129882663|NCT01683994|467530473|FG002|Overall Study|Intercurrent illness|0|||
129882664|NCT01683994|467530474|FG003|Overall Study|Intercurrent illness|2|||
129882665|NCT01683994|467530475|FG004|Overall Study|Intercurrent illness|1|||
129882666|NCT00999661|467530477|FG000|Overall Study|Lost to Follow-up|59|||
129882667|NCT00999661|467530477|FG000|Overall Study|Adverse Event|1|||
129882668|NCT00999661|467530477|FG000|Overall Study|Withdrawal by Subject|1|||
129882669|NCT00999661|467530477|FG000|Overall Study|Not meeting eligibility criteria|9|||
129882670|NCT00917267|467530478|FG000|Overall Study|Adverse Event|15|||
129882671|NCT00917267|467530479|FG001|Overall Study|Adverse Event|36|||
129882672|NCT00917267|467530478|FG000|Overall Study|Physician Decision|2|||
129882673|NCT00917267|467530479|FG001|Overall Study|Physician Decision|4|||
129882674|NCT00917267|467530478|FG000|Overall Study|Protocol Violation|9|||
129882675|NCT00917267|467530479|FG001|Overall Study|Protocol Violation|18|||
129882676|NCT00917267|467530478|FG000|Overall Study|Withdrawal by Subject|5|||
129882677|NCT00917267|467530479|FG001|Overall Study|Withdrawal by Subject|12|||
129882678|NCT00917267|467530478|FG000|Overall Study|Lost to follow up|0|||
129882679|NCT00917267|467530479|FG001|Overall Study|Lost to follow up|2|||
129882680|NCT00917267|467530478|FG000|Overall Study|Entry Criteria Not Met|1|||
129882681|NCT00917267|467530479|FG001|Overall Study|Entry Criteria Not Met|0|||
129545312|NCT00905437|466288449|FG000|Overall Study|Lost to Follow-up|0|||
129545313|NCT00905437|466288450|FG001|Overall Study|Lost to Follow-up|1|||
129545314|NCT00905437|466288449|FG000|Overall Study|Withdrawal by Subject|0|||
129545315|NCT00905437|466288450|FG001|Overall Study|Withdrawal by Subject|1|||
129545316|NCT00905437|466288449|FG000|Overall Study|Other|5|||
129545317|NCT00905437|466288450|FG001|Overall Study|Other|6|||
129545318|NCT01306968|466288453|FG000|Overall Study|Lost to Follow-up|1|||
129545319|NCT01306968|466288454|FG001|Overall Study|Lost to Follow-up|1|||
129545320|NCT01306968|466288455|FG002|Overall Study|Lost to Follow-up|0|||
129545321|NCT01306968|466288456|FG003|Overall Study|Lost to Follow-up|0|||
129545322|NCT01306968|466288453|FG000|Overall Study|Physician Decision|0|||
129545323|NCT01306968|466288454|FG001|Overall Study|Physician Decision|1|||
129545324|NCT01306968|466288455|FG002|Overall Study|Physician Decision|0|||
129545325|NCT01306968|466288456|FG003|Overall Study|Physician Decision|0|||
129545326|NCT01306968|466288453|FG000|Overall Study|Relocated and left active duty|0|||
129545327|NCT01306968|466288454|FG001|Overall Study|Relocated and left active duty|1|||
129545328|NCT01306968|466288455|FG002|Overall Study|Relocated and left active duty|1|||
129655051|NCT01094782|466693601|FG000|Overall Study|Hypertension|0|||
129882682|NCT00917267|467530478|FG000|Overall Study|Sponsor Decision|5|||
129882683|NCT00917267|467530479|FG001|Overall Study|Sponsor Decision|5|||
129882684|NCT00917267|467530478|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
129882685|NCT00917267|467530479|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
129882686|NCT02960763|467530481|FG000|Step 1|Withdrawal by Subject|10|||
129882687|NCT02960763|467530482|FG001|Step 1|Withdrawal by Subject|8|||
129882688|NCT02960763|467530483|FG002|Step 1|Withdrawal by Subject|13|||
129882689|NCT02960763|467530484|FG003|Step 1|Withdrawal by Subject|0|||
129882690|NCT02960763|467530485|FG004|Step 1|Withdrawal by Subject|0|||
129882691|NCT02960763|467530481|FG000|Step 1|Lost to Follow-up|7|||
129882692|NCT02960763|467530482|FG001|Step 1|Lost to Follow-up|9|||
129882693|NCT02960763|467530483|FG002|Step 1|Lost to Follow-up|12|||
129882694|NCT02960763|467530484|FG003|Step 1|Lost to Follow-up|0|||
129882695|NCT02960763|467530485|FG004|Step 1|Lost to Follow-up|0|||
129882696|NCT02960763|467530481|FG000|Step 1|Death|1|||
129882697|NCT02960763|467530482|FG001|Step 1|Death|1|||
129882698|NCT02960763|467530483|FG002|Step 1|Death|1|||
129882699|NCT02960763|467530484|FG003|Step 1|Death|0|||
129882700|NCT02960763|467530485|FG004|Step 1|Death|0|||
129882701|NCT02960763|467530481|FG000|Step 1|Investigator discretion|1|||
129882702|NCT02960763|467530482|FG001|Step 1|Investigator discretion|0|||
129882703|NCT02960763|467530483|FG002|Step 1|Investigator discretion|1|||
129882704|NCT02960763|467530484|FG003|Step 1|Investigator discretion|0|||
129882705|NCT02960763|467530485|FG004|Step 1|Investigator discretion|0|||
129882706|NCT02960763|467530481|FG000|Step 1|Other|0|||
129882707|NCT02960763|467530482|FG001|Step 1|Other|0|||
129882708|NCT02960763|467530483|FG002|Step 1|Other|1|||
129882709|NCT02960763|467530484|FG003|Step 1|Other|0|||
129882710|NCT02960763|467530485|FG004|Step 1|Other|0|||
129882711|NCT02960763|467530481|FG000|Step 2|Withdrawal by Subject|0|||
129882712|NCT02960763|467530482|FG001|Step 2|Withdrawal by Subject|0|||
129882713|NCT02960763|467530483|FG002|Step 2|Withdrawal by Subject|0|||
129882714|NCT02960763|467530484|FG003|Step 2|Withdrawal by Subject|7|||
129882715|NCT02960763|467530485|FG004|Step 2|Withdrawal by Subject|3|||
129882716|NCT02960763|467530481|FG000|Step 2|Lost to Follow-up|0|||
129882717|NCT02960763|467530482|FG001|Step 2|Lost to Follow-up|0|||
129882718|NCT02960763|467530483|FG002|Step 2|Lost to Follow-up|0|||
129882719|NCT02960763|467530484|FG003|Step 2|Lost to Follow-up|4|||
129882720|NCT02960763|467530485|FG004|Step 2|Lost to Follow-up|1|||
129882721|NCT02960763|467530481|FG000|Step 2|Investigator discretion|0|||
129882722|NCT02960763|467530482|FG001|Step 2|Investigator discretion|0|||
129882723|NCT02960763|467530483|FG002|Step 2|Investigator discretion|0|||
129882724|NCT02960763|467530484|FG003|Step 2|Investigator discretion|0|||
129882725|NCT02960763|467530485|FG004|Step 2|Investigator discretion|1|||
129882726|NCT03638635|467530489|FG000|Initial Hospitalization|Study terminated prematurely|0|||
129882727|NCT03638635|467530490|FG001|Initial Hospitalization|Study terminated prematurely|1|||
129882728|NCT03638635|467530489|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
129882729|NCT03638635|467530490|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
129882730|NCT03638635|467530489|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
129882731|NCT03638635|467530490|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
129882732|NCT00289770|467530496|FG000|Year 15|Withdrawal by Subject|1|||
129882733|NCT00313911|467530501|FG000|Overall Study|Serious adverse event|6|||
129882734|NCT00313911|467530502|FG001|Overall Study|Serious adverse event|1|||
129882735|NCT00313911|467530501|FG000|Overall Study|Adverse Event|2|||
129882736|NCT00313911|467530502|FG001|Overall Study|Adverse Event|3|||
129882737|NCT00313911|467530501|FG000|Overall Study|Protocol Violation|19|||
129882738|NCT00313911|467530502|FG001|Overall Study|Protocol Violation|10|||
129882739|NCT00313911|467530501|FG000|Overall Study|Lost to Follow-up|27|||
129882740|NCT00313911|467530502|FG001|Overall Study|Lost to Follow-up|14|||
129882741|NCT00313911|467530501|FG000|Overall Study|Withdrawal by Subject|39|||
129882742|NCT00313911|467530502|FG001|Overall Study|Withdrawal by Subject|12|||
129545329|NCT01306968|466288456|FG003|Overall Study|Relocated and left active duty|1|||
129545330|NCT01306968|466288453|FG000|Overall Study|Withdrew - time commitment|0|||
129545331|NCT01306968|466288454|FG001|Overall Study|Withdrew - time commitment|0|||
129545332|NCT01306968|466288455|FG002|Overall Study|Withdrew - time commitment|0|||
129545333|NCT01306968|466288456|FG003|Overall Study|Withdrew - time commitment|2|||
129545334|NCT01306968|466288453|FG000|Overall Study|Withdrew over privacy concerns|0|||
129545335|NCT01306968|466288454|FG001|Overall Study|Withdrew over privacy concerns|0|||
129545336|NCT01306968|466288455|FG002|Overall Study|Withdrew over privacy concerns|0|||
129545337|NCT01306968|466288456|FG003|Overall Study|Withdrew over privacy concerns|1|||
129545338|NCT03252015|466288457|FG000|Overall Study|Withdrawal by Subject|0|||
129882743|NCT00313911|467530501|FG000|Overall Study|Did not meet age criteria|1|||
129882744|NCT00313911|467530502|FG001|Overall Study|Did not meet age criteria|1|||
129882745|NCT01372605|467530505|FG000|Overall Study|Death|1|||
129882746|NCT01372605|467530506|FG001|Overall Study|Death|2|||
129882747|NCT01372605|467530505|FG000|Overall Study|Lost to Follow-up|2|||
129882748|NCT01372605|467530506|FG001|Overall Study|Lost to Follow-up|1|||
129882749|NCT01372605|467530505|FG000|Overall Study|Withdrawal by Subject|4|||
129882750|NCT01372605|467530506|FG001|Overall Study|Withdrawal by Subject|7|||
129882751|NCT01372605|467530505|FG000|Overall Study|Moved|3|||
129882752|NCT01372605|467530506|FG001|Overall Study|Moved|0|||
129882753|NCT01372605|467530505|FG000|Overall Study|Changed medical home|2|||
129882754|NCT01372605|467530506|FG001|Overall Study|Changed medical home|0|||
129882755|NCT00951509|467530507|FG000|Overall Study|Withdrawal by Subject|2|||
129882756|NCT00582491|467530508|FG000|Overall Study|Withdrawal by Subject|1|||
129882757|NCT00582491|467530509|FG001|Overall Study|Withdrawal by Subject|0|||
129882758|NCT01003639|467530510|FG000|Overall Study|Lost to Follow-up|6|||
129882759|NCT01003639|467530511|FG001|Overall Study|Lost to Follow-up|9|||
129882760|NCT01003639|467530510|FG000|Overall Study|Withdrawal by Subject|9|||
129882761|NCT01003639|467530511|FG001|Overall Study|Withdrawal by Subject|5|||
129882762|NCT01003639|467530510|FG000|Overall Study|Lack of Efficacy|1|||
129882763|NCT01003639|467530511|FG001|Overall Study|Lack of Efficacy|6|||
129882764|NCT01003639|467530510|FG000|Overall Study|Adverse Event|0|||
129882765|NCT01003639|467530511|FG001|Overall Study|Adverse Event|1|||
129882766|NCT01003639|467530510|FG000|Overall Study|Protocol Violation|0|||
129882767|NCT01003639|467530511|FG001|Overall Study|Protocol Violation|1|||
129882768|NCT01003639|467530510|FG000|Overall Study|Physician Decision|1|||
129882769|NCT01003639|467530511|FG001|Overall Study|Physician Decision|0|||
129882770|NCT04362137|467530515|FG000|Overall Study|Death|9|||
129882771|NCT04362137|467530516|FG001|Overall Study|Death|3|||
129882772|NCT04362137|467530515|FG000|Overall Study|Patient decision|6|||
129882773|NCT04362137|467530516|FG001|Overall Study|Patient decision|3|||
129882774|NCT04362137|467530515|FG000|Overall Study|Adverse Event|1|||
129882775|NCT04362137|467530516|FG001|Overall Study|Adverse Event|0|||
129882776|NCT04362137|467530515|FG000|Overall Study|Lost to Follow-up|1|||
129882777|NCT04362137|467530516|FG001|Overall Study|Lost to Follow-up|0|||
129882778|NCT04362137|467530515|FG000|Overall Study|Protocol deviation|1|||
129882779|NCT04362137|467530516|FG001|Overall Study|Protocol deviation|0|||
129882780|NCT03306043|467530520|FG000|Overall Study|Adverse Event|1|||
129882781|NCT03306043|467530520|FG000|Overall Study|Lost to Follow-up|1|||
129882782|NCT03306043|467530520|FG000|Overall Study|Withdrawal by Subject|2|||
129882783|NCT00785538|467530521|FG000|Treatment Period|Adverse Event|1|||
129882784|NCT00785538|467530522|FG001|Treatment Period|Adverse Event|2|||
129882785|NCT00785538|467530523|FG002|Treatment Period|Adverse Event|2|||
129882786|NCT00785538|467530524|FG003|Treatment Period|Adverse Event|0|||
129882787|NCT00785538|467530521|FG000|Treatment Period|Withdrawal by Subject|0|||
129882788|NCT00785538|467530522|FG001|Treatment Period|Withdrawal by Subject|0|||
129882789|NCT00785538|467530523|FG002|Treatment Period|Withdrawal by Subject|0|||
129882790|NCT00785538|467530524|FG003|Treatment Period|Withdrawal by Subject|1|||
129882791|NCT01799720|467530525|FG000|Overall Study|Withdrawal by Subject|3|||
129882792|NCT01799720|467530526|FG001|Overall Study|Withdrawal by Subject|0|||
129882793|NCT01799720|467530527|FG002|Overall Study|Withdrawal by Subject|0|||
129882794|NCT01799720|467530525|FG000|Overall Study|Protocol Violation|0|||
129882795|NCT01799720|467530526|FG001|Overall Study|Protocol Violation|1|||
129882796|NCT01799720|467530527|FG002|Overall Study|Protocol Violation|0|||
129882797|NCT01799720|467530525|FG000|Overall Study|Pregnancy|0|||
129882798|NCT01799720|467530526|FG001|Overall Study|Pregnancy|0|||
129882799|NCT01799720|467530527|FG002|Overall Study|Pregnancy|1|||
129882800|NCT04276090|467530528|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
129882801|NCT04276090|467530529|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
129882802|NCT01234649|467530530|FG000|Overall Study|Withdrawal by Subject|32|||
129882803|NCT01234649|467530531|FG001|Overall Study|Withdrawal by Subject|26|||
129882804|NCT01234649|467530530|FG000|Overall Study|Pregnancy|6|||
129882805|NCT01234649|467530531|FG001|Overall Study|Pregnancy|6|||
129882806|NCT01234649|467530530|FG000|Overall Study|intolerant to side effects|4|||
129882807|NCT01234649|467530531|FG001|Overall Study|intolerant to side effects|3|||
129882808|NCT01234649|467530530|FG000|Overall Study|Allergic reaction|1|||
129882809|NCT01234649|467530531|FG001|Overall Study|Allergic reaction|0|||
129882810|NCT01234649|467530530|FG000|Overall Study|Lack of Efficacy|0|||
129882811|NCT01234649|467530531|FG001|Overall Study|Lack of Efficacy|3|||
129882812|NCT00318149|467530534|FG000|Overall Study|Adverse Event|0|||
129882813|NCT00318149|467530535|FG001|Overall Study|Adverse Event|0|||
129882814|NCT00318149|467530536|FG002|Overall Study|Adverse Event|0|||
129882815|NCT00318149|467530537|FG003|Overall Study|Adverse Event|0|||
129882816|NCT00318149|467530538|FG004|Overall Study|Adverse Event|0|||
129882817|NCT00318149|467530539|FG005|Overall Study|Adverse Event|2|||
129882818|NCT00785707|467530545|FG000|Overall Study|Lost to Follow-up|7|||
129882819|NCT00105586|467530546|FG000|Overall Study|Adverse Event|4|||
129882820|NCT00105586|467530547|FG001|Overall Study|Adverse Event|3|||
129882821|NCT00105586|467530546|FG000|Overall Study|Physician Decision|13|||
129882822|NCT00105586|467530547|FG001|Overall Study|Physician Decision|13|||
129882823|NCT02306122|467530548|FG000|Initial Physician Randomization|Physician Decision|0|||
129882824|NCT02306122|467530549|FG001|Initial Physician Randomization|Physician Decision|0|||
129882825|NCT02306122|467530550|FG002|Initial Physician Randomization|Physician Decision|0|||
129882826|NCT02306122|467530551|FG003|Initial Physician Randomization|Physician Decision|0|||
129882827|NCT02306122|467530552|FG004|Initial Physician Randomization|Physician Decision|0|||
129882828|NCT02306122|467530553|FG005|Initial Physician Randomization|Physician Decision|0|||
129882829|NCT02306122|467530554|FG006|Initial Physician Randomization|Physician Decision|0|||
129882830|NCT02306122|467530555|FG007|Initial Physician Randomization|Physician Decision|0|||
129882831|NCT02306122|467530556|FG008|Initial Physician Randomization|Physician Decision|1|||
129882832|NCT02306122|467530557|FG009|Initial Physician Randomization|Physician Decision|0|||
129882833|NCT02306122|467530558|FG010|Initial Physician Randomization|Physician Decision|0|||
129882834|NCT02262260|467530561|FG000|Overall Study|Adverse Event|4|||
129882835|NCT02262260|467530562|FG001|Overall Study|Adverse Event|1|||
129882836|NCT02262260|467530561|FG000|Overall Study|Withdrawal of consent|4|||
129882837|NCT02262260|467530562|FG001|Overall Study|Withdrawal of consent|2|||
129882838|NCT02262260|467530561|FG000|Overall Study|Lost to Follow-up|1|||
129882839|NCT02262260|467530562|FG001|Overall Study|Lost to Follow-up|2|||
129882840|NCT02262260|467530561|FG000|Overall Study|Protocol deviation|2|||
129882841|NCT02262260|467530562|FG001|Overall Study|Protocol deviation|5|||
129882842|NCT01794117|467530564|FG000|Overall Study|Adverse Event|1|||
129882843|NCT01794117|467530565|FG001|Overall Study|Adverse Event|0|||
129882844|NCT01794117|467530566|FG002|Overall Study|Adverse Event|0|||
129882845|NCT01794117|467530567|FG003|Overall Study|Adverse Event|0|||
129882846|NCT01794117|467530564|FG000|Overall Study|Participant noncompliance|0|||
129882847|NCT01794117|467530565|FG001|Overall Study|Participant noncompliance|1|||
129882848|NCT01794117|467530566|FG002|Overall Study|Participant noncompliance|0|||
129882849|NCT01794117|467530567|FG003|Overall Study|Participant noncompliance|0|||
129882850|NCT01794117|467530564|FG000|Overall Study|Refused further treatment|0|||
129882851|NCT01794117|467530565|FG001|Overall Study|Refused further treatment|2|||
129882852|NCT01794117|467530566|FG002|Overall Study|Refused further treatment|0|||
129882853|NCT01794117|467530567|FG003|Overall Study|Refused further treatment|0|||
129882854|NCT03734991|467530568|FG000|Overall Study|Adverse Event|4|||
129882855|NCT03734991|467530569|FG001|Overall Study|Adverse Event|0|||
129882856|NCT03734991|467530568|FG000|Overall Study|Lost to Follow-up|4|||
129882857|NCT03734991|467530569|FG001|Overall Study|Lost to Follow-up|0|||
129882858|NCT03734991|467530568|FG000|Overall Study|Physician Decision|0|||
129882859|NCT03734991|467530569|FG001|Overall Study|Physician Decision|1|||
129882860|NCT03734991|467530568|FG000|Overall Study|Pregnancy|1|||
129882861|NCT03734991|467530569|FG001|Overall Study|Pregnancy|0|||
129882862|NCT03734991|467530568|FG000|Overall Study|Withdrawal by Subject|6|||
129882863|NCT03734991|467530569|FG001|Overall Study|Withdrawal by Subject|3|||
129882864|NCT03734991|467530568|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
129882865|NCT03734991|467530569|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
129882866|NCT03734991|467530568|FG000|Overall Study|Other|2|||
129882867|NCT03734991|467530569|FG001|Overall Study|Other|2|||
129882868|NCT02322814|467530572|FG000|Overall Study|Death|7|||
129882869|NCT02322814|467530573|FG001|Overall Study|Death|29|||
129882870|NCT02322814|467530574|FG002|Overall Study|Death|32|||
129882871|NCT02322814|467530575|FG003|Overall Study|Death|23|||
129882872|NCT02322814|467530576|FG004|Overall Study|Death|14|||
129882873|NCT02322814|467530572|FG000|Overall Study|Lost to Follow-up|1|||
129882874|NCT02322814|467530573|FG001|Overall Study|Lost to Follow-up|3|||
129882875|NCT02322814|467530574|FG002|Overall Study|Lost to Follow-up|3|||
129882876|NCT02322814|467530575|FG003|Overall Study|Lost to Follow-up|1|||
129882877|NCT02322814|467530576|FG004|Overall Study|Lost to Follow-up|0|||
129882878|NCT02322814|467530572|FG000|Overall Study|Various Reasons|2|||
129882879|NCT02322814|467530573|FG001|Overall Study|Various Reasons|0|||
129882880|NCT02322814|467530574|FG002|Overall Study|Various Reasons|1|||
129882881|NCT02322814|467530575|FG003|Overall Study|Various Reasons|1|||
129882882|NCT02322814|467530576|FG004|Overall Study|Various Reasons|0|||
129882883|NCT02322814|467530572|FG000|Overall Study|Progressive Disease|0|||
129882884|NCT02322814|467530573|FG001|Overall Study|Progressive Disease|0|||
129882885|NCT02322814|467530574|FG002|Overall Study|Progressive Disease|0|||
129882886|NCT02322814|467530575|FG003|Overall Study|Progressive Disease|1|||
129882887|NCT02322814|467530576|FG004|Overall Study|Progressive Disease|1|||
129882888|NCT02322814|467530572|FG000|Overall Study|Protocol Violation|1|||
129882889|NCT02322814|467530573|FG001|Overall Study|Protocol Violation|0|||
129882890|NCT02322814|467530574|FG002|Overall Study|Protocol Violation|0|||
129882891|NCT02322814|467530575|FG003|Overall Study|Protocol Violation|0|||
129882892|NCT02322814|467530576|FG004|Overall Study|Protocol Violation|0|||
129882893|NCT02322814|467530572|FG000|Overall Study|Study Terminated by Sponsor|0|||
129882894|NCT02322814|467530573|FG001|Overall Study|Study Terminated by Sponsor|7|||
129882895|NCT02322814|467530574|FG002|Overall Study|Study Terminated by Sponsor|9|||
129882896|NCT02322814|467530575|FG003|Overall Study|Study Terminated by Sponsor|5|||
129882897|NCT02322814|467530576|FG004|Overall Study|Study Terminated by Sponsor|13|||
129882898|NCT02322814|467530572|FG000|Overall Study|Withdrawal by Subject|5|||
129882899|NCT02322814|467530573|FG001|Overall Study|Withdrawal by Subject|4|||
129882900|NCT02322814|467530574|FG002|Overall Study|Withdrawal by Subject|2|||
129882901|NCT02322814|467530575|FG003|Overall Study|Withdrawal by Subject|1|||
129882902|NCT02322814|467530576|FG004|Overall Study|Withdrawal by Subject|3|||
129882903|NCT00591864|467530577|FG000|Overall Study|Incomplete Imaging|5|||
129882904|NCT02459093|467530578|FG000|Overall Study|Protocol Violation|6|||
129882905|NCT02459093|467530579|FG001|Overall Study|Protocol Violation|11|||
129882906|NCT02459093|467530578|FG000|Overall Study|Lost to Follow-up|6|||
129882907|NCT02459093|467530579|FG001|Overall Study|Lost to Follow-up|7|||
129882908|NCT00118092|467530580|FG000|Overall Study|Withdrawal by Subject|1|||
129882909|NCT00118092|467530580|FG000|Overall Study|Protocol Violation|1|||
129882910|NCT02736968|467530588|FG000|Overall Study|Lost to Follow-up|0|||
129882911|NCT02736968|467530589|FG001|Overall Study|Lost to Follow-up|0|||
129882912|NCT02736968|467530590|FG002|Overall Study|Lost to Follow-up|0|||
129882913|NCT02736968|467530591|FG003|Overall Study|Lost to Follow-up|0|||
129882914|NCT02736968|467530592|FG004|Overall Study|Lost to Follow-up|0|||
129882915|NCT02736968|467530593|FG005|Overall Study|Lost to Follow-up|0|||
129882916|NCT02736968|467530594|FG006|Overall Study|Lost to Follow-up|5|||
129882917|NCT02736968|467530595|FG007|Overall Study|Lost to Follow-up|2|||
129882918|NCT02736968|467530588|FG000|Overall Study|COVID-19 Pandemic|0|||
129882919|NCT02736968|467530589|FG001|Overall Study|COVID-19 Pandemic|0|||
129882920|NCT02736968|467530590|FG002|Overall Study|COVID-19 Pandemic|0|||
129882921|NCT02736968|467530591|FG003|Overall Study|COVID-19 Pandemic|0|||
129882922|NCT02736968|467530592|FG004|Overall Study|COVID-19 Pandemic|0|||
129882923|NCT02736968|467530593|FG005|Overall Study|COVID-19 Pandemic|0|||
129882924|NCT02736968|467530594|FG006|Overall Study|COVID-19 Pandemic|2|||
129882925|NCT02736968|467530595|FG007|Overall Study|COVID-19 Pandemic|0|||
129882926|NCT02736968|467530588|FG000|Overall Study|Withdrawal by Subject|0|||
129882927|NCT02736968|467530589|FG001|Overall Study|Withdrawal by Subject|0|||
129882928|NCT02736968|467530590|FG002|Overall Study|Withdrawal by Subject|0|||
129882929|NCT02736968|467530591|FG003|Overall Study|Withdrawal by Subject|0|||
129882930|NCT02736968|467530592|FG004|Overall Study|Withdrawal by Subject|0|||
129882931|NCT02736968|467530593|FG005|Overall Study|Withdrawal by Subject|0|||
129882932|NCT02736968|467530594|FG006|Overall Study|Withdrawal by Subject|1|||
129882933|NCT02736968|467530595|FG007|Overall Study|Withdrawal by Subject|0|||
129882934|NCT00147225|467530596|FG000|Overall Study|Withdrawal by Subject|1|||
129882935|NCT00147225|467530597|FG001|Overall Study|Withdrawal by Subject|0|||
129882936|NCT00147225|467530598|FG002|Overall Study|Withdrawal by Subject|1|||
129882937|NCT00147225|467530599|FG003|Overall Study|Withdrawal by Subject|0|||
129882938|NCT00147225|467530600|FG004|Overall Study|Withdrawal by Subject|0|||
129882939|NCT00147225|467530601|FG005|Overall Study|Withdrawal by Subject|1|||
129882940|NCT00147225|467530596|FG000|Overall Study|Adverse Event|0|||
129882941|NCT00147225|467530597|FG001|Overall Study|Adverse Event|0|||
129882942|NCT00147225|467530598|FG002|Overall Study|Adverse Event|1|||
129882943|NCT00147225|467530599|FG003|Overall Study|Adverse Event|1|||
129882944|NCT00147225|467530600|FG004|Overall Study|Adverse Event|0|||
129882945|NCT00147225|467530601|FG005|Overall Study|Adverse Event|0|||
129882946|NCT00147225|467530596|FG000|Overall Study|Screen Failure|0|||
129882947|NCT00147225|467530597|FG001|Overall Study|Screen Failure|0|||
129882948|NCT00147225|467530598|FG002|Overall Study|Screen Failure|0|||
129882949|NCT00147225|467530599|FG003|Overall Study|Screen Failure|0|||
129882950|NCT00147225|467530600|FG004|Overall Study|Screen Failure|1|||
129882951|NCT00147225|467530601|FG005|Overall Study|Screen Failure|0|||
129882952|NCT00147225|467530596|FG000|Overall Study|Chemotherapy Changed|0|||
129882953|NCT00147225|467530597|FG001|Overall Study|Chemotherapy Changed|0|||
129882954|NCT00147225|467530598|FG002|Overall Study|Chemotherapy Changed|0|||
129882955|NCT00147225|467530599|FG003|Overall Study|Chemotherapy Changed|0|||
129882956|NCT00147225|467530600|FG004|Overall Study|Chemotherapy Changed|0|||
129882957|NCT00147225|467530601|FG005|Overall Study|Chemotherapy Changed|1|||
129882958|NCT03713021|467530606|FG000|Overall Study|Did not have CT sim scan available|6|||
129882959|NCT03713021|467530606|FG000|Overall Study|Not eligible|4|||
129882960|NCT03713021|467530606|FG000|Overall Study|Issues with TraceIT markers|5|||
129882961|NCT03391960|467530607|FG000|Overall Study|Protocol Violation|0|||
129882962|NCT03391960|467530608|FG001|Overall Study|Protocol Violation|0|||
129882963|NCT03545113|467532268|FG000|Overall Study|Surgery Cancelled|1|||
129882964|NCT03545113|467532269|FG001|Overall Study|Surgery Cancelled|0|||
129882965|NCT03545113|467532268|FG000|Overall Study|Death|1|||
129882966|NCT03545113|467532269|FG001|Overall Study|Death|0|||
129882967|NCT03545113|467532268|FG000|Overall Study|Adverse Event|2|||
129882968|NCT03545113|467532269|FG001|Overall Study|Adverse Event|0|||
129882969|NCT03545113|467532268|FG000|Overall Study|Received different surgery|1|||
129882970|NCT03545113|467532269|FG001|Overall Study|Received different surgery|0|||
129882971|NCT01804673|467532270|FG000|Overall Study|Adverse Event|4|||
129882972|NCT01804673|467532270|FG000|Overall Study|Withdrawal by Subject|1|||
129882973|NCT01804673|467532270|FG000|Overall Study|Lack of Efficacy|9|||
129882974|NCT01804673|467532270|FG000|Overall Study|Change to Oral Therapy|37|||
129882975|NCT01804673|467532270|FG000|Overall Study|No Further Therapy Required|84|||
129882976|NCT01804673|467532270|FG000|Overall Study|Use of Prohibited Medication|1|||
129882977|NCT01804673|467532270|FG000|Overall Study|Other|4|||
129882978|NCT01533714|467532271|FG000|Overall Study|Adverse Event|0|||
129882979|NCT01533714|467532272|FG001|Overall Study|Adverse Event|1|||
129882980|NCT01533714|467532273|FG002|Overall Study|Adverse Event|2|||
129882981|NCT01533714|467532274|FG003|Overall Study|Adverse Event|2|||
129882982|NCT01533714|467532275|FG004|Overall Study|Adverse Event|2|||
129882983|NCT01533714|467532276|FG005|Overall Study|Adverse Event|1|||
129882984|NCT01533714|467532271|FG000|Overall Study|Lack of Efficacy|0|||
129882985|NCT01533714|467532272|FG001|Overall Study|Lack of Efficacy|0|||
129882986|NCT01533714|467532273|FG002|Overall Study|Lack of Efficacy|0|||
129882987|NCT01533714|467532274|FG003|Overall Study|Lack of Efficacy|0|||
129882988|NCT01533714|467532275|FG004|Overall Study|Lack of Efficacy|0|||
129882989|NCT01533714|467532276|FG005|Overall Study|Lack of Efficacy|1|||
129882990|NCT01533714|467532271|FG000|Overall Study|Withdrawal by Subject|0|||
129882991|NCT01533714|467532272|FG001|Overall Study|Withdrawal by Subject|1|||
129882992|NCT01533714|467532273|FG002|Overall Study|Withdrawal by Subject|0|||
129882993|NCT01533714|467532274|FG003|Overall Study|Withdrawal by Subject|1|||
129882994|NCT01533714|467532275|FG004|Overall Study|Withdrawal by Subject|1|||
129882995|NCT01533714|467532276|FG005|Overall Study|Withdrawal by Subject|0|||
129882996|NCT01533714|467532271|FG000|Overall Study|Exclusion criteria|0|||
129882997|NCT01533714|467532272|FG001|Overall Study|Exclusion criteria|1|||
129882998|NCT01533714|467532273|FG002|Overall Study|Exclusion criteria|0|||
129882999|NCT01533714|467532274|FG003|Overall Study|Exclusion criteria|0|||
129883000|NCT01533714|467532275|FG004|Overall Study|Exclusion criteria|0|||
129883001|NCT01533714|467532276|FG005|Overall Study|Exclusion criteria|0|||
129883002|NCT01533714|467532271|FG000|Overall Study|Positive for purified protein derivative|0|||
129883003|NCT01533714|467532272|FG001|Overall Study|Positive for purified protein derivative|0|||
129883004|NCT01533714|467532273|FG002|Overall Study|Positive for purified protein derivative|1|||
129883005|NCT01533714|467532274|FG003|Overall Study|Positive for purified protein derivative|0|||
129883006|NCT01533714|467532275|FG004|Overall Study|Positive for purified protein derivative|1|||
129883007|NCT01533714|467532276|FG005|Overall Study|Positive for purified protein derivative|0|||
129883008|NCT01533714|467532271|FG000|Overall Study|Withdrawal criteria|0|||
129883009|NCT01533714|467532272|FG001|Overall Study|Withdrawal criteria|0|||
129883010|NCT01533714|467532273|FG002|Overall Study|Withdrawal criteria|1|||
129883011|NCT01533714|467532274|FG003|Overall Study|Withdrawal criteria|0|||
129883012|NCT01533714|467532275|FG004|Overall Study|Withdrawal criteria|3|||
129883013|NCT01533714|467532276|FG005|Overall Study|Withdrawal criteria|1|||
129883014|NCT01533714|467532271|FG000|Overall Study|Ineligibility reason|0|||
129883015|NCT01533714|467532272|FG001|Overall Study|Ineligibility reason|0|||
129883016|NCT01533714|467532273|FG002|Overall Study|Ineligibility reason|0|||
129883017|NCT01533714|467532274|FG003|Overall Study|Ineligibility reason|1|||
129883018|NCT01533714|467532275|FG004|Overall Study|Ineligibility reason|0|||
129883019|NCT01533714|467532276|FG005|Overall Study|Ineligibility reason|0|||
129883020|NCT00251927|467532283|FG000|Overall Study|Adverse Event|3|||
129883021|NCT00251927|467532284|FG001|Overall Study|Adverse Event|15|||
129883022|NCT00251927|467532283|FG000|Overall Study|Lack of Efficacy|22|||
129883023|NCT00251927|467532284|FG001|Overall Study|Lack of Efficacy|16|||
129883024|NCT00251927|467532283|FG000|Overall Study|Lost to Follow-up|22|||
129545339|NCT03252015|466288458|FG001|Overall Study|Withdrawal by Subject|1|||
129545340|NCT03252015|466288459|FG002|Overall Study|Withdrawal by Subject|1|||
129545341|NCT03252015|466288460|FG003|Overall Study|Withdrawal by Subject|0|||
129545342|NCT03252015|466288457|FG000|Overall Study|Adverse Event|1|||
129545343|NCT03252015|466288458|FG001|Overall Study|Adverse Event|0|||
129545344|NCT03252015|466288459|FG002|Overall Study|Adverse Event|0|||
129545345|NCT03252015|466288460|FG003|Overall Study|Adverse Event|1|||
129545346|NCT01329562|466288461|FG000|Overall Study|Protocol Violation|5|||
129545347|NCT01329562|466288462|FG001|Overall Study|Protocol Violation|3|||
129545348|NCT01329562|466288461|FG000|Overall Study|Lost to Follow-up|1|||
129545349|NCT01329562|466288462|FG001|Overall Study|Lost to Follow-up|1|||
129545350|NCT01329562|466288461|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
129545351|NCT01329562|466288462|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
129545352|NCT01329562|466288461|FG000|Overall Study|Physician Decision|0|||
129545353|NCT01329562|466288462|FG001|Overall Study|Physician Decision|1|||
129545354|NCT01525407|466288465|FG000|Overall Study|Change in recipient treatment plan|2|||
129545355|NCT01525407|466288466|FG001|Overall Study|Change in recipient treatment plan|2|||
129545356|NCT01525407|466288465|FG000|Overall Study|Withdrawal by Subject|0|||
129545357|NCT01525407|466288466|FG001|Overall Study|Withdrawal by Subject|1|||
129545358|NCT01525407|466288465|FG000|Overall Study|Transplant was delayed|0|||
129545359|NCT01525407|466288466|FG001|Overall Study|Transplant was delayed|1|||
129545360|NCT01525407|466288465|FG000|Overall Study|Delay in Transplant|1|||
129545361|NCT01525407|466288466|FG001|Overall Study|Delay in Transplant|0|||
129545362|NCT04502862|466288467|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
129545363|NCT04502862|466288468|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
129545364|NCT04502862|466288467|FG000|Overall Study|Withdrawal by Subject|1|||
129545365|NCT04502862|466288468|FG001|Overall Study|Withdrawal by Subject|0|||
129545366|NCT04502862|466288467|FG000|Overall Study|Adverse Event|1|||
129545367|NCT04502862|466288468|FG001|Overall Study|Adverse Event|1|||
129545368|NCT00242567|466289697|FG000|Overall Study|Adverse Event|70|||
129545369|NCT00242567|466289698|FG001|Overall Study|Adverse Event|43|||
129545370|NCT00242567|466289697|FG000|Overall Study|Disease Progression|17|||
129545371|NCT00242567|466289698|FG001|Overall Study|Disease Progression|22|||
129883025|NCT00251927|467532284|FG001|Overall Study|Lost to Follow-up|8|||
129883026|NCT00251927|467532283|FG000|Overall Study|Protocol Violation|1|||
129883027|NCT00251927|467532284|FG001|Overall Study|Protocol Violation|2|||
129883028|NCT00251927|467532283|FG000|Overall Study|Pregnancy|2|||
129883029|NCT00251927|467532284|FG001|Overall Study|Pregnancy|0|||
129883030|NCT00251927|467532283|FG000|Overall Study|Withdrawal by Subject|40|||
129883031|NCT00251927|467532284|FG001|Overall Study|Withdrawal by Subject|25|||
129883032|NCT00251927|467532283|FG000|Overall Study|Study-specific discont. achieved|13|||
129883033|NCT00251927|467532284|FG001|Overall Study|Study-specific discont. achieved|2|||
129545372|NCT00242567|466289697|FG000|Overall Study|Symptomatic deterioration|9|||
129545373|NCT00242567|466289698|FG001|Overall Study|Symptomatic deterioration|3|||
129883034|NCT00251927|467532283|FG000|Overall Study|Study procedure non-compliance|5|||
129883035|NCT00251927|467532284|FG001|Overall Study|Study procedure non-compliance|6|||
129883036|NCT02222896|467532296|FG000|Abdomen|Did not qualify|34|||
129883037|NCT02222896|467532297|FG001|Abdomen|Did not qualify|10|||
129883038|NCT02222896|467532298|FG002|Abdomen|Did not qualify|32|||
129883039|NCT02222896|467532296|FG000|Groin|Did not qualify|43|||
129883040|NCT02222896|467532297|FG001|Groin|Did not qualify|9|||
129883041|NCT02222896|467532298|FG002|Groin|Did not qualify|40|||
129883042|NCT02226172|467532301|FG000|Overall Study|Participant refused further follow-up|4|||
129883043|NCT02226172|467532301|FG000|Overall Study|Other|5|||
129883044|NCT02226172|467532301|FG000|Overall Study|Death|1|||
129883045|NCT02226172|467532301|FG000|Overall Study|Study terminated by sponsor|1|||
129883046|NCT02226172|467532301|FG000|Overall Study|Adverse Event|6|||
129883047|NCT01865617|467532302|FG000|Overall Study|Death|27|||
129883048|NCT01865617|467532303|FG001|Overall Study|Death|3|||
129883049|NCT01865617|467532304|FG002|Overall Study|Death|1|||
129883050|NCT01865617|467532305|FG003|Overall Study|Death|1|||
129883051|NCT01865617|467532306|FG004|Overall Study|Death|5|||
129883052|NCT01865617|467532307|FG005|Overall Study|Death|1|||
129883053|NCT01865617|467532308|FG006|Overall Study|Death|11|||
129883054|NCT01865617|467532309|FG007|Overall Study|Death|1|||
129883055|NCT01865617|467532310|FG008|Overall Study|Death|11|||
129883056|NCT01865617|467532311|FG009|Overall Study|Death|3|||
129883057|NCT01865617|467532312|FG010|Overall Study|Death|32|||
129883058|NCT01865617|467532313|FG011|Overall Study|Death|6|||
129883059|NCT01865617|467532314|FG012|Overall Study|Death|13|||
129883060|NCT01865617|467532302|FG000|Overall Study|Lost to Follow-up|2|||
129883061|NCT01865617|467532303|FG001|Overall Study|Lost to Follow-up|0|||
129883062|NCT01865617|467532304|FG002|Overall Study|Lost to Follow-up|0|||
129883063|NCT01865617|467532305|FG003|Overall Study|Lost to Follow-up|0|||
129883064|NCT01865617|467532306|FG004|Overall Study|Lost to Follow-up|0|||
129883065|NCT01865617|467532307|FG005|Overall Study|Lost to Follow-up|0|||
129883066|NCT01865617|467532308|FG006|Overall Study|Lost to Follow-up|0|||
129883067|NCT01865617|467532309|FG007|Overall Study|Lost to Follow-up|0|||
129883068|NCT01865617|467532310|FG008|Overall Study|Lost to Follow-up|0|||
129883069|NCT01865617|467532311|FG009|Overall Study|Lost to Follow-up|0|||
129883070|NCT01865617|467532312|FG010|Overall Study|Lost to Follow-up|0|||
129883071|NCT01865617|467532313|FG011|Overall Study|Lost to Follow-up|0|||
129883072|NCT01865617|467532314|FG012|Overall Study|Lost to Follow-up|0|||
129883073|NCT01865617|467532302|FG000|Overall Study|Withdrawal by Subject|1|||
129883074|NCT01865617|467532303|FG001|Overall Study|Withdrawal by Subject|0|||
129883075|NCT01865617|467532304|FG002|Overall Study|Withdrawal by Subject|0|||
129883076|NCT01865617|467532305|FG003|Overall Study|Withdrawal by Subject|0|||
129883077|NCT01865617|467532306|FG004|Overall Study|Withdrawal by Subject|0|||
129883078|NCT01865617|467532307|FG005|Overall Study|Withdrawal by Subject|0|||
129883079|NCT01865617|467532308|FG006|Overall Study|Withdrawal by Subject|0|||
129883080|NCT01865617|467532309|FG007|Overall Study|Withdrawal by Subject|0|||
129883081|NCT01865617|467532310|FG008|Overall Study|Withdrawal by Subject|0|||
129883082|NCT01865617|467532311|FG009|Overall Study|Withdrawal by Subject|0|||
129883083|NCT01865617|467532312|FG010|Overall Study|Withdrawal by Subject|0|||
129883084|NCT01865617|467532313|FG011|Overall Study|Withdrawal by Subject|0|||
129883085|NCT01865617|467532314|FG012|Overall Study|Withdrawal by Subject|0|||
129883086|NCT01865617|467532302|FG000|Overall Study|Patient proceeded to new therapy|0|||
129883087|NCT01865617|467532303|FG001|Overall Study|Patient proceeded to new therapy|0|||
129883088|NCT01865617|467532304|FG002|Overall Study|Patient proceeded to new therapy|0|||
129883089|NCT01865617|467532305|FG003|Overall Study|Patient proceeded to new therapy|0|||
129883090|NCT01865617|467532306|FG004|Overall Study|Patient proceeded to new therapy|2|||
129883091|NCT01865617|467532307|FG005|Overall Study|Patient proceeded to new therapy|0|||
129883092|NCT01865617|467532308|FG006|Overall Study|Patient proceeded to new therapy|0|||
129883093|NCT01865617|467532309|FG007|Overall Study|Patient proceeded to new therapy|0|||
129883094|NCT01865617|467532310|FG008|Overall Study|Patient proceeded to new therapy|0|||
129883095|NCT01865617|467532311|FG009|Overall Study|Patient proceeded to new therapy|0|||
129883096|NCT01865617|467532312|FG010|Overall Study|Patient proceeded to new therapy|0|||
129883097|NCT01865617|467532313|FG011|Overall Study|Patient proceeded to new therapy|0|||
129883098|NCT01865617|467532314|FG012|Overall Study|Patient proceeded to new therapy|0|||
129883099|NCT01865617|467532302|FG000|Overall Study|Other|0|||
129883100|NCT01865617|467532303|FG001|Overall Study|Other|0|||
129883101|NCT01865617|467532304|FG002|Overall Study|Other|0|||
129883102|NCT01865617|467532305|FG003|Overall Study|Other|0|||
129883103|NCT01865617|467532306|FG004|Overall Study|Other|0|||
129883104|NCT01865617|467532307|FG005|Overall Study|Other|0|||
129883105|NCT01865617|467532308|FG006|Overall Study|Other|1|||
129883106|NCT01865617|467532309|FG007|Overall Study|Other|0|||
129883107|NCT01865617|467532310|FG008|Overall Study|Other|0|||
129883108|NCT01865617|467532311|FG009|Overall Study|Other|0|||
129883109|NCT01865617|467532312|FG010|Overall Study|Other|0|||
129883110|NCT01865617|467532313|FG011|Overall Study|Other|0|||
129883111|NCT01865617|467532314|FG012|Overall Study|Other|0|||
129883112|NCT00258440|467532318|FG000|Overall Study|Withdrawal by Subject|0|||
129883113|NCT00258440|467532319|FG001|Overall Study|Withdrawal by Subject|0|||
129883114|NCT00258440|467532320|FG002|Overall Study|Withdrawal by Subject|1|||
129883115|NCT00737061|467532321|FG000|Waiting Period|Lost to Follow-up|6|||
129883116|NCT00737061|467532321|FG000|Waiting Period|Withdrawal by Subject|1|||
129883117|NCT00737061|467532321|FG000|Waiting Period|Bilateral placement failure|34|||
129883118|NCT00737061|467532321|FG000|Waiting Period|Deemed patent following HSG|26|||
129883119|NCT00737061|467532321|FG000|Waiting Period|Alternative contraception failure|3|||
129883120|NCT00737061|467532321|FG000|Waiting Period|Elected surgical tubal ligation|5|||
129883121|NCT00737061|467532321|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
129883122|NCT00737061|467532321|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
129883123|NCT00737061|467532321|FG000|1 Year Wearing Period|Discontinued reilance|3|||
129883124|NCT00737061|467532321|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
129883125|NCT00439179|467532323|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
129883126|NCT00439179|467532324|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
129883127|NCT00439179|467532325|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
129883128|NCT00439179|467532326|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
129883129|NCT01844115|467532330|FG000|Overall Study|Adverse Event|4|||
129883130|NCT01844115|467532331|FG001|Overall Study|Adverse Event|22|||
129883131|NCT01844115|467532330|FG000|Overall Study|Lack of Efficacy|1|||
129883132|NCT01844115|467532331|FG001|Overall Study|Lack of Efficacy|4|||
129883133|NCT01844115|467532330|FG000|Overall Study|Protocol Violation|12|||
129883134|NCT01844115|467532331|FG001|Overall Study|Protocol Violation|10|||
129883135|NCT01844115|467532330|FG000|Overall Study|Withdrawal by Subject|11|||
129883136|NCT01844115|467532331|FG001|Overall Study|Withdrawal by Subject|11|||
129883137|NCT01844115|467532330|FG000|Overall Study|Lost to Follow-up|11|||
129883138|NCT01844115|467532331|FG001|Overall Study|Lost to Follow-up|10|||
129883139|NCT01844115|467532330|FG000|Overall Study|Pregnancy|0|||
129883140|NCT01844115|467532331|FG001|Overall Study|Pregnancy|1|||
129883141|NCT00758160|467532332|FG000|Overall Study|No Longer Requires Study Medication|4|||
129883142|NCT00758160|467532332|FG000|Overall Study|Administration Problems|3|||
129883143|NCT00758160|467532332|FG000|Overall Study|Adverse Event|15|||
129883144|NCT00758160|467532332|FG000|Overall Study|Lack of Efficacy|10|||
129883145|NCT00758160|467532332|FG000|Overall Study|Lost to Follow-up|14|||
129883146|NCT00758160|467532332|FG000|Overall Study|Protocol Violation|12|||
129883147|NCT00758160|467532332|FG000|Overall Study|Withdrawal by Subject|8|||
129883148|NCT01613027|467532333|FG000|Overall Study|Lost to Follow-up|5|||
129883149|NCT01613027|467532333|FG000|Overall Study|Switched Physician|1|||
129883150|NCT01613027|467532333|FG000|Overall Study|Lack of Efficacy|1|||
129883151|NCT01613027|467532333|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
129883152|NCT00993317|467532334|FG000|Overall Study|Adverse Event|2|||
129883153|NCT00993317|467532335|FG001|Overall Study|Adverse Event|4|||
129883154|NCT00993317|467532334|FG000|Overall Study|Lack of Efficacy|18|||
129883155|NCT00993317|467532335|FG001|Overall Study|Lack of Efficacy|18|||
129883156|NCT00993317|467532334|FG000|Overall Study|Withdrawal by Subject|0|||
129883157|NCT00993317|467532335|FG001|Overall Study|Withdrawal by Subject|2|||
129883158|NCT00993317|467532334|FG000|Overall Study|Investigator's opinion|0|||
129883159|NCT00993317|467532335|FG001|Overall Study|Investigator's opinion|1|||
129883160|NCT00993317|467532334|FG000|Overall Study|Early study termination at the site|1|||
129883161|NCT00993317|467532335|FG001|Overall Study|Early study termination at the site|0|||
129883162|NCT02153359|467532336|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
129883163|NCT02153359|467532337|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
129883164|NCT04422639|467532338|FG000|Overall Study|Death|1|||
129883165|NCT04422639|467532339|FG001|Overall Study|Death|0|||
129883166|NCT04422639|467532338|FG000|Overall Study|study closed prior to completion of FU visits|0|||
129883167|NCT04422639|467532339|FG001|Overall Study|study closed prior to completion of FU visits|2|||
129883168|NCT01964521|467532340|FG000|Overall Study|Lost to Follow-up|4|||
129883169|NCT01108510|467532341|FG000|Overall Study|Randomized but Not Treated|5|||
129883170|NCT01108510|467532342|FG001|Overall Study|Randomized but Not Treated|1|||
129883171|NCT01108510|467532341|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
129883172|NCT01108510|467532342|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
129883173|NCT01108510|467532341|FG000|Overall Study|Adverse Event|26|||
129883174|NCT01108510|467532342|FG001|Overall Study|Adverse Event|19|||
129883175|NCT01108510|467532341|FG000|Overall Study|Lost to Follow-up|20|||
129883176|NCT01108510|467532342|FG001|Overall Study|Lost to Follow-up|17|||
129883177|NCT01108510|467532341|FG000|Overall Study|Withdrew Consent|21|||
129883178|NCT01108510|467532342|FG001|Overall Study|Withdrew Consent|15|||
129883179|NCT01108510|467532341|FG000|Overall Study|Investigator's Discretion|12|||
129883180|NCT01108510|467532342|FG001|Overall Study|Investigator's Discretion|10|||
129883181|NCT01108510|467532341|FG000|Overall Study|Participant Noncompliance|5|||
129883182|NCT01108510|467532342|FG001|Overall Study|Participant Noncompliance|7|||
129883183|NCT01108510|467532341|FG000|Overall Study|Lack of Efficacy|3|||
129883184|NCT01108510|467532342|FG001|Overall Study|Lack of Efficacy|0|||
129883185|NCT01108510|467532341|FG000|Overall Study|Pregnancy|0|||
129883186|NCT01108510|467532342|FG001|Overall Study|Pregnancy|3|||
129883187|NCT01108510|467532341|FG000|Overall Study|Death|1|||
129883188|NCT01108510|467532342|FG001|Overall Study|Death|1|||
129883189|NCT02796963|467532343|FG000|Overall Study|Lost to Follow-up|89|||
129545374|NCT00242567|466289697|FG000|Overall Study|Lack of Efficacy|2|||
129545375|NCT00242567|466289698|FG001|Overall Study|Lack of Efficacy|2|||
129545376|NCT00242567|466289697|FG000|Overall Study|Lost to Follow-up|9|||
129545377|NCT00242567|466289698|FG001|Overall Study|Lost to Follow-up|19|||
129545378|NCT00242567|466289697|FG000|Overall Study|Withdrawal by Subject|33|||
129883190|NCT02796963|467532344|FG001|Overall Study|Lost to Follow-up|76|||
129545379|NCT00242567|466289698|FG001|Overall Study|Withdrawal by Subject|28|||
129545380|NCT00242567|466289697|FG000|Overall Study|Protocol Violation|12|||
129545381|NCT00242567|466289698|FG001|Overall Study|Protocol Violation|12|||
129545382|NCT00242567|466289697|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
129545383|NCT00242567|466289698|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
129545384|NCT00242567|466289697|FG000|Overall Study|Other|14|||
129545385|NCT00242567|466289698|FG001|Overall Study|Other|9|||
129545386|NCT02729545|466289701|FG000|Overall Study|Pregnancy|1|||
129545387|NCT02729545|466289702|FG001|Overall Study|Pregnancy|1|||
129545388|NCT02729545|466289701|FG000|Overall Study|Lost to Follow-up|0|||
129545389|NCT02729545|466289702|FG001|Overall Study|Lost to Follow-up|1|||
129545390|NCT02729545|466289701|FG000|Overall Study|Withdrawal by Subject|2|||
129545391|NCT02729545|466289702|FG001|Overall Study|Withdrawal by Subject|3|||
129545392|NCT03079869|466289711|FG000|Overall Study|Adverse Event|6|||
129545393|NCT03079869|466289712|FG001|Overall Study|Adverse Event|8|||
129545394|NCT03079869|466289711|FG000|Overall Study|Withdrawal by Subject|4|||
129545395|NCT03079869|466289712|FG001|Overall Study|Withdrawal by Subject|1|||
129545396|NCT03079869|466289711|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
129545397|NCT03079869|466289712|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
129545398|NCT02411110|466289713|FG000|Treatment Period 1|Adverse Event|4|||
129545399|NCT02411110|466289714|FG001|Treatment Period 1|Adverse Event|2|||
129545400|NCT02411110|466289713|FG000|Treatment Period 1|Lost to Follow-up|1|||
129545401|NCT02411110|466289714|FG001|Treatment Period 1|Lost to Follow-up|0|||
129545402|NCT02411110|466289713|FG000|Treatment Period 1|Personal Reasons|2|||
129545403|NCT02411110|466289714|FG001|Treatment Period 1|Personal Reasons|5|||
129545404|NCT02411110|466289713|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
129545405|NCT02411110|466289714|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
129545406|NCT02411110|466289713|FG000|Treatment Period 2|Adverse Event|1|||
129545407|NCT02411110|466289714|FG001|Treatment Period 2|Adverse Event|0|||
129545408|NCT02411110|466289713|FG000|Treatment Period 2|Lost to Follow-up|0|||
129545409|NCT02411110|466289714|FG001|Treatment Period 2|Lost to Follow-up|2|||
129545410|NCT02411110|466289713|FG000|Treatment Period 2|Personal Reasons|0|||
129545411|NCT02411110|466289714|FG001|Treatment Period 2|Personal Reasons|2|||
129545412|NCT02871921|466289725|FG000|Overall Study|Withdrawal by Subject|34|||
129545413|NCT02871921|466289726|FG001|Overall Study|Withdrawal by Subject|27|||
129545414|NCT02871921|466289727|FG002|Overall Study|Withdrawal by Subject|27|||
129545415|NCT02871921|466289728|FG003|Overall Study|Withdrawal by Subject|30|||
129545416|NCT02325739|466289731|FG000|Phase I Part|Adverse Event|1|||
129545417|NCT02325739|466289732|FG001|Phase I Part|Adverse Event|0|||
129545418|NCT02325739|466289733|FG002|Phase I Part|Adverse Event|1|||
129545419|NCT02325739|466289734|FG003|Phase I Part|Adverse Event|2|||
129545420|NCT02325739|466289735|FG004|Phase I Part|Adverse Event|3|||
129545421|NCT02325739|466289736|FG005|Phase I Part|Adverse Event|1|||
129545422|NCT02325739|466289737|FG006|Phase I Part|Adverse Event|0|||
129545423|NCT02325739|466289738|FG007|Phase I Part|Adverse Event|2|||
129545424|NCT02325739|466289739|FG008|Phase I Part|Adverse Event|0|||
129545425|NCT02325739|466289740|FG009|Phase I Part|Adverse Event|0|||
129545426|NCT02325739|466289741|FG010|Phase I Part|Adverse Event|0|||
129545427|NCT02325739|466289731|FG000|Phase I Part|Progressive disease|9|||
129545428|NCT02325739|466289732|FG001|Phase I Part|Progressive disease|6|||
129545429|NCT02325739|466289733|FG002|Phase I Part|Progressive disease|3|||
129545430|NCT02325739|466289734|FG003|Phase I Part|Progressive disease|23|||
129545431|NCT02325739|466289735|FG004|Phase I Part|Progressive disease|14|||
129545432|NCT02325739|466289736|FG005|Phase I Part|Progressive disease|6|||
129545433|NCT02325739|466289737|FG006|Phase I Part|Progressive disease|6|||
129545434|NCT02325739|466289738|FG007|Phase I Part|Progressive disease|3|||
129545435|NCT02325739|466289739|FG008|Phase I Part|Progressive disease|0|||
129883191|NCT02796963|467532345|FG002|Overall Study|Lost to Follow-up|69|||
129883192|NCT02796963|467532346|FG003|Overall Study|Lost to Follow-up|72|||
129883193|NCT01258660|467532348|FG000|Overall Study|Adverse Event|2|||
129883194|NCT01258660|467532349|FG001|Overall Study|Adverse Event|4|||
129883195|NCT01258660|467532348|FG000|Overall Study|Withdrawal by Subject|3|||
129883196|NCT01258660|467532349|FG001|Overall Study|Withdrawal by Subject|0|||
129545436|NCT02325739|466289740|FG009|Phase I Part|Progressive disease|0|||
129545437|NCT02325739|466289741|FG010|Phase I Part|Progressive disease|0|||
129545438|NCT02325739|466289731|FG000|Phase I Part|Subject/guardian decision|1|||
129545439|NCT02325739|466289732|FG001|Phase I Part|Subject/guardian decision|0|||
129545440|NCT02325739|466289733|FG002|Phase I Part|Subject/guardian decision|1|||
129545441|NCT02325739|466289734|FG003|Phase I Part|Subject/guardian decision|1|||
129545442|NCT02325739|466289735|FG004|Phase I Part|Subject/guardian decision|0|||
129545443|NCT02325739|466289736|FG005|Phase I Part|Subject/guardian decision|0|||
129883197|NCT01258660|467532348|FG000|Overall Study|due to relocation|2|||
129883198|NCT01258660|467532349|FG001|Overall Study|due to relocation|0|||
129883199|NCT01258660|467532348|FG000|Overall Study|Protocol Violation|0|||
129883200|NCT01258660|467532349|FG001|Overall Study|Protocol Violation|1|||
129883201|NCT01258660|467532348|FG000|Overall Study|Invalid for primary analysis data set|4|||
129883202|NCT01258660|467532349|FG001|Overall Study|Invalid for primary analysis data set|6|||
129883203|NCT04192630|467532350|FG000|Overall Study|Discontinued before surgery|2|||
129883204|NCT04192630|467532351|FG001|Overall Study|Discontinued before surgery|0|||
129883205|NCT04192630|467532350|FG000|Overall Study|Discontinued after surgery|5|||
129883206|NCT04192630|467532351|FG001|Overall Study|Discontinued after surgery|3|||
129883207|NCT01193582|467532352|FG000|Vaccination Series|Withdrawal by Subject|11|||
129883208|NCT01193582|467532353|FG001|Vaccination Series|Withdrawal by Subject|13|||
129883209|NCT01193582|467532354|FG002|Vaccination Series|Withdrawal by Subject|8|||
129883210|NCT01193582|467532355|FG003|Vaccination Series|Withdrawal by Subject|3|||
129883211|NCT01193582|467532352|FG000|12 Month Follow-up|Death|0|||
129883212|NCT01193582|467532353|FG001|12 Month Follow-up|Death|0|||
129883213|NCT01193582|467532354|FG002|12 Month Follow-up|Death|1|||
129883214|NCT01193582|467532355|FG003|12 Month Follow-up|Death|0|||
129883215|NCT01193582|467532352|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
129883216|NCT01193582|467532353|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
129883217|NCT01193582|467532354|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
129883218|NCT01193582|467532355|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
129883219|NCT01425632|467532356|FG000|Overall Study|Adverse Event|0|||
129883220|NCT01425632|467532357|FG001|Overall Study|Adverse Event|1|||
129883221|NCT01425632|467532358|FG002|Overall Study|Adverse Event|1|||
129545444|NCT02325739|466289737|FG006|Phase I Part|Subject/guardian decision|0|||
129545445|NCT02325739|466289738|FG007|Phase I Part|Subject/guardian decision|1|||
129545446|NCT02325739|466289739|FG008|Phase I Part|Subject/guardian decision|0|||
129545447|NCT02325739|466289740|FG009|Phase I Part|Subject/guardian decision|0|||
129545448|NCT02325739|466289741|FG010|Phase I Part|Subject/guardian decision|0|||
129545449|NCT02325739|466289731|FG000|Phase I Part|Death|0|||
129545450|NCT02325739|466289732|FG001|Phase I Part|Death|0|||
129545451|NCT02325739|466289733|FG002|Phase I Part|Death|0|||
129545452|NCT02325739|466289734|FG003|Phase I Part|Death|0|||
129545453|NCT02325739|466289735|FG004|Phase I Part|Death|2|||
129545454|NCT02325739|466289736|FG005|Phase I Part|Death|0|||
129545455|NCT02325739|466289737|FG006|Phase I Part|Death|0|||
129545456|NCT02325739|466289738|FG007|Phase I Part|Death|0|||
129545457|NCT02325739|466289739|FG008|Phase I Part|Death|0|||
129545458|NCT02325739|466289740|FG009|Phase I Part|Death|0|||
129545459|NCT02325739|466289741|FG010|Phase I Part|Death|0|||
129545460|NCT02325739|466289731|FG000|Phase II Part|Adverse Event|0|||
129545461|NCT02325739|466289732|FG001|Phase II Part|Adverse Event|0|||
129545462|NCT02325739|466289733|FG002|Phase II Part|Adverse Event|0|||
129545463|NCT02325739|466289734|FG003|Phase II Part|Adverse Event|0|||
129545464|NCT02325739|466289735|FG004|Phase II Part|Adverse Event|0|||
129545465|NCT02325739|466289736|FG005|Phase II Part|Adverse Event|0|||
129545466|NCT02325739|466289737|FG006|Phase II Part|Adverse Event|0|||
129545467|NCT02325739|466289738|FG007|Phase II Part|Adverse Event|0|||
129545468|NCT02325739|466289739|FG008|Phase II Part|Adverse Event|4|||
129545469|NCT02325739|466289740|FG009|Phase II Part|Adverse Event|5|||
129545470|NCT02325739|466289741|FG010|Phase II Part|Adverse Event|1|||
129545471|NCT02325739|466289731|FG000|Phase II Part|Physician Decision|0|||
129545472|NCT02325739|466289732|FG001|Phase II Part|Physician Decision|0|||
129545473|NCT02325739|466289733|FG002|Phase II Part|Physician Decision|0|||
129545474|NCT02325739|466289734|FG003|Phase II Part|Physician Decision|0|||
129545475|NCT02325739|466289735|FG004|Phase II Part|Physician Decision|0|||
129545476|NCT02325739|466289736|FG005|Phase II Part|Physician Decision|0|||
129545477|NCT02325739|466289737|FG006|Phase II Part|Physician Decision|0|||
129545478|NCT02325739|466289738|FG007|Phase II Part|Physician Decision|0|||
129545479|NCT02325739|466289739|FG008|Phase II Part|Physician Decision|0|||
129545480|NCT02325739|466289740|FG009|Phase II Part|Physician Decision|1|||
129545481|NCT02325739|466289741|FG010|Phase II Part|Physician Decision|0|||
129545482|NCT02325739|466289731|FG000|Phase II Part|Progressive disease|0|||
129545483|NCT02325739|466289732|FG001|Phase II Part|Progressive disease|0|||
129545484|NCT02325739|466289733|FG002|Phase II Part|Progressive disease|0|||
129545485|NCT02325739|466289734|FG003|Phase II Part|Progressive disease|0|||
129545486|NCT02325739|466289735|FG004|Phase II Part|Progressive disease|0|||
129545487|NCT02325739|466289736|FG005|Phase II Part|Progressive disease|0|||
129883222|NCT01425632|467532356|FG000|Overall Study|Physician Decision|1|||
129883223|NCT01425632|467532357|FG001|Overall Study|Physician Decision|0|||
129883224|NCT01425632|467532358|FG002|Overall Study|Physician Decision|0|||
129545488|NCT02325739|466289737|FG006|Phase II Part|Progressive disease|0|||
129545489|NCT02325739|466289738|FG007|Phase II Part|Progressive disease|0|||
129545490|NCT02325739|466289739|FG008|Phase II Part|Progressive disease|22|||
129883225|NCT01425632|467532356|FG000|Overall Study|Protocol Violation|0|||
129883226|NCT01425632|467532357|FG001|Overall Study|Protocol Violation|0|||
129883227|NCT01425632|467532358|FG002|Overall Study|Protocol Violation|2|||
129545491|NCT02325739|466289740|FG009|Phase II Part|Progressive disease|29|||
129545492|NCT02325739|466289741|FG010|Phase II Part|Progressive disease|18|||
129545493|NCT02325739|466289731|FG000|Phase II Part|Subject/guardian decision|0|||
129883228|NCT01425632|467532356|FG000|Overall Study|Withdrawal by Subject|0|||
129883229|NCT01425632|467532357|FG001|Overall Study|Withdrawal by Subject|0|||
129883230|NCT01425632|467532358|FG002|Overall Study|Withdrawal by Subject|1|||
129883231|NCT01775930|467532365|FG000|Overall Study|Futility stopping boundary met|1|||
129883232|NCT01208415|467532368|FG000|Overall Study|Death|1|||
129883233|NCT01208415|467532368|FG000|Overall Study|Lost to Follow-up|2|||
129883234|NCT01208415|467532368|FG000|Overall Study|Withdrawal by Subject|3|||
129883235|NCT01208415|467532368|FG000|Overall Study|Device not placed|1|||
129883236|NCT01208415|467532368|FG000|Overall Study|Still be eligible for follow-up|33|||
129883237|NCT01115491|467532369|FG000|Overall Study|Death|22|||
129883238|NCT01115491|467532369|FG000|Overall Study|Adverse Event|3|||
129883239|NCT01115491|467532369|FG000|Overall Study|Lost to Follow-up|3|||
129883240|NCT01115491|467532369|FG000|Overall Study|Withdrawal by Subject|1|||
129883241|NCT01115491|467532369|FG000|Overall Study|Physician Decision|1|||
129883242|NCT04297241|467532370|FG000|Overall Study|Withdrawal by Subject|1|||
129883243|NCT04297241|467532370|FG000|Overall Study|Adverse Event|1|||
129883244|NCT04297241|467532370|FG000|Overall Study|Physician Decision|3|||
129883245|NCT03856996|467532374|FG000|Overall Study|Withdrawal by Subject|1|||
129883246|NCT03856996|467532375|FG001|Overall Study|Withdrawal by Subject|0|||
129883247|NCT03856996|467532374|FG000|Overall Study|Lost to Follow-up|0|||
129883248|NCT03856996|467532375|FG001|Overall Study|Lost to Follow-up|1|||
129883249|NCT03856996|467532374|FG000|Overall Study|Adverse Event|1|||
129883250|NCT03856996|467532375|FG001|Overall Study|Adverse Event|1|||
129883251|NCT03856996|467532374|FG000|Overall Study|Other|1|||
129883252|NCT03856996|467532375|FG001|Overall Study|Other|0|||
129883253|NCT02340520|467532378|FG000|Overall Study|Lost to Follow-up|1|||
129883254|NCT02340520|467532378|FG000|Overall Study|Patient did not take drug as specified|1|||
129883255|NCT02340520|467532378|FG000|Overall Study|Withdrawal by Subject|1|||
129883256|NCT01464255|467532379|FG000|Overall Study|unresolve corneal staining|0|||
129883257|NCT01464255|467532380|FG001|Overall Study|unresolve corneal staining|1|||
129883258|NCT01231503|467532381|FG000|Overall Study|Adverse Event|0|||
129883259|NCT01231503|467532382|FG001|Overall Study|Adverse Event|0|||
129883260|NCT01231503|467532383|FG002|Overall Study|Adverse Event|0|||
129883261|NCT01231503|467532384|FG003|Overall Study|Adverse Event|0|||
129883262|NCT01231503|467532385|FG004|Overall Study|Adverse Event|0|||
129883263|NCT01231503|467532386|FG005|Overall Study|Adverse Event|1|||
129883264|NCT01231503|467532387|FG006|Overall Study|Adverse Event|0|||
129883265|NCT01231503|467532388|FG007|Overall Study|Adverse Event|0|||
129883266|NCT01231503|467532381|FG000|Overall Study|Adverse event, serious fatal|0|||
129883267|NCT01231503|467532382|FG001|Overall Study|Adverse event, serious fatal|0|||
129883268|NCT01231503|467532383|FG002|Overall Study|Adverse event, serious fatal|1|||
129985714|NCT04811131|467909334|FG001|Overall Study|Withdrawal by Subject|1|||
129985715|NCT04811131|467909335|FG002|Overall Study|Withdrawal by Subject|3|||
129985716|NCT04811131|467909336|FG003|Overall Study|Withdrawal by Subject|1|||
129985717|NCT01528345|467909338|FG000|Overall Study|Adverse Event|10|||
129985718|NCT01528345|467909339|FG001|Overall Study|Adverse Event|1|||
129985719|NCT01528345|467909338|FG000|Overall Study|Death|1|||
129985720|NCT01528345|467909339|FG001|Overall Study|Death|1|||
129985721|NCT01528345|467909338|FG000|Overall Study|Non-compliance with study treatment|1|||
129985722|NCT01528345|467909339|FG001|Overall Study|Non-compliance with study treatment|0|||
129985723|NCT01528345|467909338|FG000|Overall Study|Progressive Disease|26|||
129985724|NCT01528345|467909339|FG001|Overall Study|Progressive Disease|40|||
129985725|NCT01528345|467909338|FG000|Overall Study|Study Terminated by Sponsor|4|||
129985726|NCT01528345|467909339|FG001|Overall Study|Study Terminated by Sponsor|8|||
129985727|NCT01528345|467909338|FG000|Overall Study|Subject/Guardian Decision|5|||
129985728|NCT01528345|467909339|FG001|Overall Study|Subject/Guardian Decision|0|||
129985729|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Death|1|||
129985730|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Death|1|||
129985731|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
129985732|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
129985733|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
129985734|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
129985735|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
129985736|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
129985737|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
129985738|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
129985739|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
129985740|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
129985741|NCT00371683|467909340|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
129985742|NCT00371683|467909341|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
129985743|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
129985744|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
129985745|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|Death|0|||
129883269|NCT01231503|467532384|FG003|Overall Study|Adverse event, serious fatal|1|||
129985746|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|Death|2|||
129985747|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
129985748|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
129985749|NCT00371683|467909340|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
129985750|NCT00371683|467909341|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
129985751|NCT03181789|467909343|FG000|Overall Study|Withdrawal by Subject|0|||
129985752|NCT03181789|467909344|FG001|Overall Study|Withdrawal by Subject|1|||
129985753|NCT03181789|467909345|FG002|Overall Study|Withdrawal by Subject|1|||
129985754|NCT03181789|467909346|FG003|Overall Study|Withdrawal by Subject|0|||
129985755|NCT03181789|467909343|FG000|Overall Study|Lost to Follow-up|7|||
129985756|NCT03181789|467909344|FG001|Overall Study|Lost to Follow-up|1|||
129985757|NCT03181789|467909345|FG002|Overall Study|Lost to Follow-up|0|||
129985758|NCT03181789|467909346|FG003|Overall Study|Lost to Follow-up|0|||
129985759|NCT03181789|467909343|FG000|Overall Study|Participant unable to adhere to visit|0|||
129985760|NCT03181789|467909344|FG001|Overall Study|Participant unable to adhere to visit|1|||
129985761|NCT03181789|467909345|FG002|Overall Study|Participant unable to adhere to visit|0|||
129985762|NCT03181789|467909346|FG003|Overall Study|Participant unable to adhere to visit|0|||
129985763|NCT01151410|467909347|FG000|Overall Study|Withdrawal by Subject|3|||
129985764|NCT01151410|467909348|FG001|Overall Study|Withdrawal by Subject|5|||
129985765|NCT01151410|467909347|FG000|Overall Study|Lost to Follow-up|3|||
129985766|NCT01151410|467909348|FG001|Overall Study|Lost to Follow-up|4|||
129985767|NCT01151410|467909347|FG000|Overall Study|Adverse Event|1|||
129985768|NCT01151410|467909348|FG001|Overall Study|Adverse Event|2|||
129985769|NCT01151410|467909347|FG000|Overall Study|Protocol deviation|2|||
129985770|NCT01151410|467909348|FG001|Overall Study|Protocol deviation|1|||
129985771|NCT01151410|467909347|FG000|Overall Study|Administrative problems|1|||
129985772|NCT01151410|467909348|FG001|Overall Study|Administrative problems|1|||
129985773|NCT01151410|467909347|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129985774|NCT01151410|467909348|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129985775|NCT01151410|467909347|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129985776|NCT01151410|467909348|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129985777|NCT02624791|467909349|FG000|Overall Study|Withdrawal by Subject|2|||
129985778|NCT02624791|467909350|FG001|Overall Study|Withdrawal by Subject|0|||
129985779|NCT02624791|467909351|FG002|Overall Study|Withdrawal by Subject|0|||
129985780|NCT02624791|467909352|FG003|Overall Study|Withdrawal by Subject|0|||
129985781|NCT02624791|467909353|FG004|Overall Study|Withdrawal by Subject|0|||
129985782|NCT02624791|467909354|FG005|Overall Study|Withdrawal by Subject|0|||
129985783|NCT00775463|467910716|FG000|Overall Study|Withdrawal by Subject|0|||
129985784|NCT00775463|467910717|FG001|Overall Study|Withdrawal by Subject|1|||
129985785|NCT00775463|467910716|FG000|Overall Study|Adverse Event|7|||
129985786|NCT00775463|467910717|FG001|Overall Study|Adverse Event|9|||
129985787|NCT00775463|467910716|FG000|Overall Study|Protocol Violation|2|||
129985788|NCT00775463|467910717|FG001|Overall Study|Protocol Violation|2|||
129985789|NCT00775463|467910716|FG000|Overall Study|Lost to Follow-up|1|||
129985790|NCT00775463|467910717|FG001|Overall Study|Lost to Follow-up|0|||
129985791|NCT00775463|467910716|FG000|Overall Study|Lack of Efficacy|1|||
129985792|NCT00775463|467910717|FG001|Overall Study|Lack of Efficacy|1|||
129985793|NCT01238900|467910718|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
129985794|NCT01238900|467910718|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
129985795|NCT03836716|467910719|FG000|Overall Study|Adverse Event|3|||
129985796|NCT03836716|467910719|FG000|Overall Study|Death|22|||
129985797|NCT03836716|467910719|FG000|Overall Study|Withdrawal by Subject|8|||
129985798|NCT03836716|467910719|FG000|Overall Study|Study terminated by sponsor|87|||
129985799|NCT01871805|467910729|FG000|Phase I|Death|7|||
129985800|NCT01871805|467910730|FG001|Phase I|Death|4|||
129985801|NCT01871805|467910731|FG002|Phase I|Death|6|||
129985802|NCT01871805|467910732|FG003|Phase I|Death|2|||
129985803|NCT01871805|467910733|FG004|Phase I|Death|9|||
129985804|NCT01871805|467910734|FG005|Phase I|Death|0|||
129883270|NCT01231503|467532385|FG004|Overall Study|Adverse event, serious fatal|0|||
129883271|NCT01231503|467532386|FG005|Overall Study|Adverse event, serious fatal|1|||
129883272|NCT01231503|467532387|FG006|Overall Study|Adverse event, serious fatal|0|||
129883273|NCT01231503|467532388|FG007|Overall Study|Adverse event, serious fatal|0|||
129545494|NCT02325739|466289732|FG001|Phase II Part|Subject/guardian decision|0|||
129545495|NCT02325739|466289733|FG002|Phase II Part|Subject/guardian decision|0|||
129545496|NCT02325739|466289734|FG003|Phase II Part|Subject/guardian decision|0|||
129545497|NCT02325739|466289735|FG004|Phase II Part|Subject/guardian decision|0|||
129545498|NCT02325739|466289736|FG005|Phase II Part|Subject/guardian decision|0|||
129883274|NCT01231503|467532381|FG000|Overall Study|Withdrawal by Subject|6|||
129883275|NCT01231503|467532382|FG001|Overall Study|Withdrawal by Subject|3|||
129883276|NCT01231503|467532383|FG002|Overall Study|Withdrawal by Subject|3|||
129883277|NCT01231503|467532384|FG003|Overall Study|Withdrawal by Subject|1|||
129883278|NCT01231503|467532385|FG004|Overall Study|Withdrawal by Subject|3|||
129883279|NCT01231503|467532386|FG005|Overall Study|Withdrawal by Subject|5|||
129883280|NCT01231503|467532387|FG006|Overall Study|Withdrawal by Subject|1|||
129655052|NCT01094782|466693602|FG001|Overall Study|Hypertension|0|||
129883281|NCT01231503|467532388|FG007|Overall Study|Withdrawal by Subject|2|||
129883282|NCT01231503|467532381|FG000|Overall Study|Lost to Follow-up|8|||
129883283|NCT01231503|467532382|FG001|Overall Study|Lost to Follow-up|10|||
129883284|NCT01231503|467532383|FG002|Overall Study|Lost to Follow-up|8|||
129883285|NCT01231503|467532384|FG003|Overall Study|Lost to Follow-up|5|||
129883286|NCT01231503|467532385|FG004|Overall Study|Lost to Follow-up|7|||
129883287|NCT01231503|467532386|FG005|Overall Study|Lost to Follow-up|9|||
129883288|NCT01231503|467532387|FG006|Overall Study|Lost to Follow-up|6|||
129883289|NCT01231503|467532388|FG007|Overall Study|Lost to Follow-up|6|||
129883290|NCT01231503|467532381|FG000|Overall Study|Protocol Violation|0|||
129883291|NCT01231503|467532382|FG001|Overall Study|Protocol Violation|0|||
129883292|NCT01231503|467532383|FG002|Overall Study|Protocol Violation|0|||
129883293|NCT01231503|467532384|FG003|Overall Study|Protocol Violation|1|||
129883294|NCT01231503|467532385|FG004|Overall Study|Protocol Violation|0|||
129883295|NCT01231503|467532386|FG005|Overall Study|Protocol Violation|0|||
129883296|NCT01231503|467532387|FG006|Overall Study|Protocol Violation|0|||
129883297|NCT01231503|467532388|FG007|Overall Study|Protocol Violation|0|||
129883298|NCT01586338|467532389|FG000|Overall Study|Adverse Event|3|||
129883299|NCT01586338|467532389|FG000|Overall Study|Lost to Follow-up|1|||
129883300|NCT01586338|467532389|FG000|Overall Study|Withdrawal by participant|3|||
129883301|NCT01586338|467532389|FG000|Overall Study|Other|1|||
129883302|NCT00284089|467532390|FG000|Multiple Dose Phase|Adverse Event|1|||
129883303|NCT00284089|467532391|FG001|Multiple Dose Phase|Adverse Event|0|||
129883304|NCT00284089|467532392|FG002|Multiple Dose Phase|Adverse Event|1|||
129883305|NCT00284089|467532393|FG003|Multiple Dose Phase|Adverse Event|1|||
129883306|NCT00284089|467532390|FG000|Multiple Dose Phase|Protocol Violation|0|||
129883307|NCT00284089|467532391|FG001|Multiple Dose Phase|Protocol Violation|0|||
129883308|NCT00284089|467532392|FG002|Multiple Dose Phase|Protocol Violation|1|||
129883309|NCT00284089|467532393|FG003|Multiple Dose Phase|Protocol Violation|0|||
129883310|NCT00284089|467532390|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
129883311|NCT00284089|467532391|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
129883312|NCT00284089|467532392|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
129883313|NCT00284089|467532393|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
129883314|NCT00284089|467532390|FG000|Multiple Dose Phase|Death|0|||
129883315|NCT00284089|467532391|FG001|Multiple Dose Phase|Death|0|||
129883316|NCT00284089|467532392|FG002|Multiple Dose Phase|Death|1|||
129883317|NCT00284089|467532393|FG003|Multiple Dose Phase|Death|1|||
129883318|NCT00284089|467532390|FG000|Extension Phase|Adverse Event|0|||
129883319|NCT00284089|467532391|FG001|Extension Phase|Adverse Event|0|||
129883320|NCT00284089|467532392|FG002|Extension Phase|Adverse Event|2|||
129883321|NCT00284089|467532393|FG003|Extension Phase|Adverse Event|2|||
129883322|NCT00284089|467532390|FG000|Extension Phase|condition no longer requires study drug|2|||
129883323|NCT00284089|467532391|FG001|Extension Phase|condition no longer requires study drug|0|||
129883324|NCT00284089|467532392|FG002|Extension Phase|condition no longer requires study drug|2|||
129883325|NCT00284089|467532393|FG003|Extension Phase|condition no longer requires study drug|7|||
129883326|NCT00284089|467532390|FG000|Extension Phase|Protocol Violation|0|||
129883327|NCT00284089|467532391|FG001|Extension Phase|Protocol Violation|0|||
129883328|NCT00284089|467532392|FG002|Extension Phase|Protocol Violation|1|||
129883329|NCT00284089|467532393|FG003|Extension Phase|Protocol Violation|0|||
129883330|NCT00284089|467532390|FG000|Extension Phase|Withdrawal by Subject|0|||
129883331|NCT00284089|467532391|FG001|Extension Phase|Withdrawal by Subject|0|||
129883332|NCT00284089|467532392|FG002|Extension Phase|Withdrawal by Subject|1|||
129883333|NCT00284089|467532393|FG003|Extension Phase|Withdrawal by Subject|3|||
129883334|NCT00180713|467532396|FG000|Overall Study|Withdrawal by Subject|2|||
129883335|NCT00180713|467532397|FG001|Overall Study|Withdrawal by Subject|0|||
129883336|NCT00180713|467532396|FG000|Overall Study|Adverse Event|3|||
129883337|NCT00180713|467532397|FG001|Overall Study|Adverse Event|3|||
129985805|NCT01871805|467910729|FG000|Phase I|Alive in Survival Follow-up|0|||
129985806|NCT01871805|467910730|FG001|Phase I|Alive in Survival Follow-up|2|||
129985807|NCT01871805|467910731|FG002|Phase I|Alive in Survival Follow-up|4|||
129985808|NCT01871805|467910732|FG003|Phase I|Alive in Survival Follow-up|5|||
129985809|NCT01871805|467910733|FG004|Phase I|Alive in Survival Follow-up|4|||
129985810|NCT01871805|467910734|FG005|Phase I|Alive in Survival Follow-up|0|||
129985811|NCT01871805|467910729|FG000|Phase I|Lost to Follow-up|0|||
129883338|NCT02401308|467532402|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
129883339|NCT02401308|467532403|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
129883340|NCT02998021|467532404|FG000|Overall Study|Withdrawal by Subject|3|||
129883341|NCT02998021|467532405|FG001|Overall Study|Withdrawal by Subject|1|||
129883342|NCT02998021|467532404|FG000|Overall Study|unsafe home|0|||
129883343|NCT02998021|467532405|FG001|Overall Study|unsafe home|1|||
129883344|NCT00655551|467532406|FG000|All Periods Combined|Adverse Event|0|||
129883345|NCT00655551|467532407|FG001|All Periods Combined|Adverse Event|3|||
129883346|NCT00655551|467532408|FG002|All Periods Combined|Adverse Event|4|||
129883347|NCT00655551|467532406|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
129883348|NCT00655551|467532407|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
129883349|NCT00655551|467532408|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
129883350|NCT00655551|467532406|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
129655053|NCT01094782|466693603|FG002|Overall Study|Hypertension|1|||
129655054|NCT01094782|466693604|FG003|Overall Study|Hypertension|0|||
129655055|NCT01094782|466693605|FG004|Overall Study|Hypertension|0|||
129655056|NCT01094782|466693606|FG005|Overall Study|Hypertension|0|||
129985812|NCT01871805|467910730|FG001|Phase I|Lost to Follow-up|1|||
129985813|NCT01871805|467910731|FG002|Phase I|Lost to Follow-up|3|||
129985814|NCT01871805|467910732|FG003|Phase I|Lost to Follow-up|0|||
129985815|NCT01871805|467910733|FG004|Phase I|Lost to Follow-up|0|||
129655057|NCT01094782|466693601|FG000|Overall Study|Wrong Pain Condition|0|||
129655058|NCT01094782|466693602|FG001|Overall Study|Wrong Pain Condition|0|||
129655059|NCT01094782|466693603|FG002|Overall Study|Wrong Pain Condition|0|||
129655060|NCT01094782|466693604|FG003|Overall Study|Wrong Pain Condition|2|||
129655061|NCT01094782|466693605|FG004|Overall Study|Wrong Pain Condition|1|||
129655062|NCT01094782|466693606|FG005|Overall Study|Wrong Pain Condition|1|||
129655063|NCT01094782|466693601|FG000|Overall Study|Recent Interventional Injection|0|||
129655064|NCT01094782|466693602|FG001|Overall Study|Recent Interventional Injection|0|||
129655065|NCT01094782|466693603|FG002|Overall Study|Recent Interventional Injection|0|||
129655066|NCT01094782|466693604|FG003|Overall Study|Recent Interventional Injection|0|||
129655067|NCT01094782|466693605|FG004|Overall Study|Recent Interventional Injection|0|||
129655068|NCT01094782|466693606|FG005|Overall Study|Recent Interventional Injection|1|||
129655069|NCT01094782|466693601|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129655070|NCT01094782|466693602|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129655071|NCT01094782|466693603|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129655072|NCT01094782|466693604|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129655073|NCT01094782|466693605|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
129655074|NCT01094782|466693606|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
129985816|NCT01871805|467910734|FG005|Phase I|Lost to Follow-up|0|||
129985817|NCT01871805|467910729|FG000|Phase II|Death|0|||
129985818|NCT01871805|467910730|FG001|Phase II|Death|0|||
129985819|NCT01871805|467910731|FG002|Phase II|Death|0|||
129985820|NCT01871805|467910732|FG003|Phase II|Death|0|||
129985821|NCT01871805|467910733|FG004|Phase II|Death|0|||
129883351|NCT00655551|467532407|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
129883352|NCT00655551|467532408|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
129883353|NCT00655551|467532406|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
129883354|NCT00655551|467532407|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
129655075|NCT01094782|466693601|FG000|Overall Study|Noncompliance With Study Schedule|0|||
129655076|NCT01094782|466693602|FG001|Overall Study|Noncompliance With Study Schedule|0|||
129655077|NCT01094782|466693603|FG002|Overall Study|Noncompliance With Study Schedule|0|||
129655078|NCT01094782|466693604|FG003|Overall Study|Noncompliance With Study Schedule|1|||
129655079|NCT01094782|466693605|FG004|Overall Study|Noncompliance With Study Schedule|0|||
129883355|NCT00655551|467532408|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
129883356|NCT01734434|467532409|FG000|Overall Study|Death Infant|3|||
129883357|NCT01734434|467532410|FG001|Overall Study|Death Infant|1|||
129883358|NCT01734434|467532411|FG002|Overall Study|Death Infant|17|||
129883359|NCT01734434|467532412|FG003|Overall Study|Death Infant|5|||
129883360|NCT01734434|467532409|FG000|Overall Study|Lost to Follow-up|2|||
129883361|NCT01734434|467532410|FG001|Overall Study|Lost to Follow-up|9|||
129883362|NCT01734434|467532411|FG002|Overall Study|Lost to Follow-up|67|||
129883363|NCT01734434|467532412|FG003|Overall Study|Lost to Follow-up|11|||
129883364|NCT01734434|467532409|FG000|Overall Study|No Live Birth|1|||
129883365|NCT01734434|467532410|FG001|Overall Study|No Live Birth|2|||
129883366|NCT01734434|467532411|FG002|Overall Study|No Live Birth|32|||
129883367|NCT01734434|467532412|FG003|Overall Study|No Live Birth|6|||
129883368|NCT01734434|467532409|FG000|Overall Study|Withdrawal by Subject|4|||
129985822|NCT01871805|467910734|FG005|Phase II|Death|45|||
129985823|NCT01871805|467910729|FG000|Phase II|Alive in Survival Follow-up|0|||
129985824|NCT01871805|467910730|FG001|Phase II|Alive in Survival Follow-up|0|||
129985825|NCT01871805|467910731|FG002|Phase II|Alive in Survival Follow-up|0|||
129985826|NCT01871805|467910732|FG003|Phase II|Alive in Survival Follow-up|0|||
129985827|NCT01871805|467910733|FG004|Phase II|Alive in Survival Follow-up|0|||
129985828|NCT01871805|467910734|FG005|Phase II|Alive in Survival Follow-up|29|||
129985829|NCT01871805|467910729|FG000|Phase II|Lost to Follow-up|0|||
129985830|NCT01871805|467910730|FG001|Phase II|Lost to Follow-up|0|||
129985831|NCT01871805|467910731|FG002|Phase II|Lost to Follow-up|0|||
129985832|NCT01871805|467910732|FG003|Phase II|Lost to Follow-up|0|||
129985833|NCT01871805|467910733|FG004|Phase II|Lost to Follow-up|0|||
129985834|NCT01871805|467910734|FG005|Phase II|Lost to Follow-up|13|||
129883369|NCT01734434|467532410|FG001|Overall Study|Withdrawal by Subject|0|||
129883370|NCT01734434|467532411|FG002|Overall Study|Withdrawal by Subject|8|||
129883371|NCT01734434|467532412|FG003|Overall Study|Withdrawal by Subject|1|||
129883372|NCT01734434|467532409|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
129985835|NCT01131182|467910735|FG000|Overall Study|Withdrawal by Subject|1|||
129985836|NCT01131182|467910736|FG001|Overall Study|Withdrawal by Subject|1|||
129985837|NCT01131182|467910735|FG000|Overall Study|Lost to Follow-up|14|||
129985838|NCT01131182|467910736|FG001|Overall Study|Lost to Follow-up|15|||
129985839|NCT01131182|467910735|FG000|Overall Study|Other Reason|1|||
129985840|NCT01131182|467910736|FG001|Overall Study|Other Reason|0|||
129985841|NCT01146782|467910742|FG000|Screening Cohort|Screen Failure|187|||
129883373|NCT01734434|467532410|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
129883374|NCT01734434|467532411|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
129883375|NCT01734434|467532412|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
129883376|NCT01734434|467532409|FG000|Overall Study|Subject Not Reachable|0|||
129883377|NCT01734434|467532410|FG001|Overall Study|Subject Not Reachable|0|||
129883378|NCT01734434|467532411|FG002|Overall Study|Subject Not Reachable|1|||
129883379|NCT01734434|467532412|FG003|Overall Study|Subject Not Reachable|0|||
129883380|NCT01734434|467532409|FG000|Overall Study|Treatment Defaulter|0|||
129883381|NCT01734434|467532410|FG001|Overall Study|Treatment Defaulter|0|||
129883382|NCT01734434|467532411|FG002|Overall Study|Treatment Defaulter|1|||
129883383|NCT01734434|467532412|FG003|Overall Study|Treatment Defaulter|0|||
129883384|NCT01734434|467532409|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
129883385|NCT01734434|467532410|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
129985842|NCT01146782|467910742|FG000|Screening Cohort|Lost to Follow-up|4|||
129985843|NCT01146782|467910742|FG000|Screening Cohort|Physician Decision|1|||
129985844|NCT01146782|467910742|FG000|Screening Cohort|Withdrawal by Subject|29|||
129985845|NCT01146782|467910742|FG000|Safety Cohort|Screen Failure|61|||
129985846|NCT01146782|467910742|FG000|Safety Cohort|Withdrawal by Subject|4|||
129985847|NCT01146782|467910742|FG000|Safety Cohort|Control AHI <5|4|||
129985848|NCT01146782|467910742|FG000|Safety Cohort|TST <4 hrs|14|||
129985849|NCT01146782|467910742|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
129985850|NCT01146782|467910742|FG000|Primary Endpoint Cohort|Physician Decision|1|||
129985851|NCT02656329|467910744|FG000|Overall Study|Lost to Follow-up|2|||
129985852|NCT02656329|467910745|FG001|Overall Study|Lost to Follow-up|3|||
129985853|NCT02656329|467910744|FG000|Overall Study|Withdrawal by Subject|7|||
129985854|NCT02656329|467910745|FG001|Overall Study|Withdrawal by Subject|6|||
129985855|NCT02656329|467910744|FG000|Overall Study|Study termination by Sponsor|150|||
129985856|NCT02656329|467910745|FG001|Overall Study|Study termination by Sponsor|142|||
129985857|NCT02656329|467910744|FG000|Overall Study|Other than specified above|5|||
129985858|NCT02656329|467910745|FG001|Overall Study|Other than specified above|6|||
129985859|NCT01139580|467910746|FG000|Overall Study|Adverse Event|5|||
129985860|NCT01139580|467910747|FG001|Overall Study|Adverse Event|4|||
129985861|NCT01139580|467910746|FG000|Overall Study|Lost to Follow-up|9|||
129985862|NCT01139580|467910747|FG001|Overall Study|Lost to Follow-up|1|||
129985863|NCT01139580|467910746|FG000|Overall Study|Lack of Efficacy|0|||
129985864|NCT01139580|467910747|FG001|Overall Study|Lack of Efficacy|2|||
129985865|NCT01139580|467910746|FG000|Overall Study|Withdrawal by Subject|6|||
129985866|NCT01139580|467910747|FG001|Overall Study|Withdrawal by Subject|9|||
129985867|NCT01139580|467910746|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
129985868|NCT01139580|467910747|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
129985869|NCT01139580|467910746|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
129985870|NCT01139580|467910747|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
129985871|NCT01139580|467910746|FG000|Overall Study|Misrandomized|1|||
129985872|NCT01139580|467910747|FG001|Overall Study|Misrandomized|0|||
129985873|NCT01139580|467910746|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
129985874|NCT01139580|467910747|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
129985875|NCT01139580|467910746|FG000|Overall Study|Participant Randomization in Error|0|||
129985876|NCT01139580|467910747|FG001|Overall Study|Participant Randomization in Error|1|||
129985877|NCT00911768|467910748|FG000|Overall Study|Protocol Violation|5|||
129985878|NCT00911768|467910749|FG001|Overall Study|Protocol Violation|4|||
129985879|NCT00911768|467910748|FG000|Overall Study|Withdrawal by Subject|1|||
129985880|NCT00911768|467910749|FG001|Overall Study|Withdrawal by Subject|0|||
129985881|NCT02842151|467910754|FG000|Overall Study|Adverse Event|1|||
129985882|NCT02842151|467910754|FG000|Overall Study|Subject moved too far away|1|||
129985883|NCT00591851|467910755|FG000|Overall Study|Withdrawal by Subject|3|||
129985884|NCT00591851|467910755|FG000|Overall Study|Adverse Event|2|||
129985885|NCT00591851|467910755|FG000|Overall Study|Progressive Disease|1|||
129985886|NCT02559895|467910756|FG000|Overall Study|Adverse Event|3|||
129985887|NCT02559895|467910757|FG001|Overall Study|Adverse Event|3|||
129985888|NCT02559895|467910758|FG002|Overall Study|Adverse Event|2|||
129985889|NCT02559895|467910759|FG003|Overall Study|Adverse Event|1|||
129985890|NCT02559895|467910756|FG000|Overall Study|Lack of Efficacy|2|||
129985891|NCT02559895|467910757|FG001|Overall Study|Lack of Efficacy|3|||
129985892|NCT02559895|467910758|FG002|Overall Study|Lack of Efficacy|2|||
129985893|NCT02559895|467910759|FG003|Overall Study|Lack of Efficacy|8|||
129985894|NCT02559895|467910756|FG000|Overall Study|Lost to Follow-up|22|||
129985895|NCT02559895|467910757|FG001|Overall Study|Lost to Follow-up|16|||
129985896|NCT02559895|467910758|FG002|Overall Study|Lost to Follow-up|12|||
129985897|NCT02559895|467910759|FG003|Overall Study|Lost to Follow-up|17|||
129985898|NCT02559895|467910756|FG000|Overall Study|Physician Decision|1|||
129985899|NCT02559895|467910757|FG001|Overall Study|Physician Decision|1|||
129985900|NCT02559895|467910758|FG002|Overall Study|Physician Decision|3|||
129985901|NCT02559895|467910759|FG003|Overall Study|Physician Decision|0|||
129985902|NCT02559895|467910756|FG000|Overall Study|Withdrawal by Subject|16|||
129985903|NCT02559895|467910757|FG001|Overall Study|Withdrawal by Subject|9|||
129985904|NCT02559895|467910758|FG002|Overall Study|Withdrawal by Subject|20|||
129985905|NCT02559895|467910759|FG003|Overall Study|Withdrawal by Subject|9|||
129985906|NCT02559895|467910756|FG000|Overall Study|Study Burden|10|||
129985907|NCT02559895|467910757|FG001|Overall Study|Study Burden|16|||
129985908|NCT02559895|467910758|FG002|Overall Study|Study Burden|12|||
129985909|NCT02559895|467910759|FG003|Overall Study|Study Burden|22|||
129985910|NCT02559895|467910756|FG000|Overall Study|Other|1|||
129985911|NCT02559895|467910757|FG001|Overall Study|Other|5|||
129985912|NCT02559895|467910758|FG002|Overall Study|Other|3|||
129985913|NCT02559895|467910759|FG003|Overall Study|Other|3|||
129985914|NCT00515853|467910760|FG000|Overall Study|Lost to Follow-up|9|||
129985915|NCT00515853|467910761|FG001|Overall Study|Lost to Follow-up|13|||
129985916|NCT00515853|467910760|FG000|Overall Study|Withdrawal by Subject|6|||
129985917|NCT00515853|467910761|FG001|Overall Study|Withdrawal by Subject|4|||
129985918|NCT01262027|467910762|FG000|Overall Study|Adverse Event|1|||
129985919|NCT01262027|467910762|FG000|Overall Study|Withdrawal by Subject|3|||
129985920|NCT01262027|467910762|FG000|Overall Study|Protocol Violation|1|||
129985921|NCT00589121|467910766|FG000|Overall Study|Protocol Violation|2|||
129985922|NCT00589121|467910767|FG001|Overall Study|Protocol Violation|6|||
129985923|NCT00589121|467910766|FG000|Overall Study|No protocol treatment received|0|||
129985924|NCT00589121|467910767|FG001|Overall Study|No protocol treatment received|1|||
129985925|NCT00847808|467910769|FG000|Overall Study|Adverse Event|7|||
129985926|NCT00847808|467910769|FG000|Overall Study|Protocol Violation|1|||
129985927|NCT00847808|467910769|FG000|Overall Study|Lost to Follow-up|1|||
129985928|NCT00847808|467910769|FG000|Overall Study|Withdrawal by Subject|4|||
129985929|NCT00847808|467910769|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
129985930|NCT00847808|467910769|FG000|Overall Study|Participant Took Excluded Medication|1|||
129985931|NCT01758900|467910776|FG000|Overall Study|difficulty for further intubation|7|||
129985932|NCT01758900|467910777|FG001|Overall Study|difficulty for further intubation|8|||
129985933|NCT01892540|467910779|FG000|Overall Study|Did not complete PET/MRI|0|||
129985934|NCT01892540|467910780|FG001|Overall Study|Did not complete PET/MRI|0|||
129985935|NCT01892540|467910781|FG002|Overall Study|Did not complete PET/MRI|2|||
129985936|NCT01892540|467910779|FG000|Overall Study|Did not fit in scanner|0|||
129985937|NCT01892540|467910780|FG001|Overall Study|Did not fit in scanner|0|||
129985938|NCT01892540|467910781|FG002|Overall Study|Did not fit in scanner|1|||
129985939|NCT01370590|467910782|FG000|Period 1|Adverse Event|8|||
129985940|NCT01370590|467910783|FG001|Period 1|Adverse Event|4|||
129985941|NCT01370590|467910782|FG000|Period 1|Lost to Follow-up|2|||
129985942|NCT01370590|467910783|FG001|Period 1|Lost to Follow-up|2|||
129985943|NCT01370590|467910782|FG000|Period 1|Protocol Violation|2|||
129985944|NCT01370590|467910783|FG001|Period 1|Protocol Violation|2|||
129985945|NCT01370590|467910782|FG000|Period 1|Withdrawal by Subject|4|||
129985946|NCT01370590|467910783|FG001|Period 1|Withdrawal by Subject|2|||
129985947|NCT01370590|467910782|FG000|Period 1|Could not access randomization system|0|||
129985948|NCT01370590|467910783|FG001|Period 1|Could not access randomization system|1|||
129655080|NCT01094782|466693606|FG005|Overall Study|Noncompliance With Study Schedule|0|||
129655081|NCT00957905|466693607|FG000|Part B|Not Treated|0|||
129655082|NCT00957905|466693608|FG001|Part B|Not Treated|1|||
129655083|NCT00957905|466693607|FG000|Part B|Physician Decision|0|||
129985949|NCT01370590|467910782|FG000|Crossover Washout Period|Adverse Event|1|||
129985950|NCT01370590|467910783|FG001|Crossover Washout Period|Adverse Event|4|||
129985951|NCT01370590|467910782|FG000|Crossover Washout Period|Lost to Follow-up|2|||
129545499|NCT02325739|466289737|FG006|Phase II Part|Subject/guardian decision|0|||
129545500|NCT02325739|466289738|FG007|Phase II Part|Subject/guardian decision|0|||
129545501|NCT02325739|466289739|FG008|Phase II Part|Subject/guardian decision|4|||
129545502|NCT02325739|466289740|FG009|Phase II Part|Subject/guardian decision|1|||
129545503|NCT02325739|466289741|FG010|Phase II Part|Subject/guardian decision|1|||
129545504|NCT03319368|466289746|FG000|Overall Study|Discharge swabs not collected from resident|57|||
129545505|NCT03319368|466289747|FG001|Overall Study|Discharge swabs not collected from resident|46|||
129545506|NCT03000075|466289748|FG000|Part A|Adverse Event|4|||
129545507|NCT03000075|466289749|FG001|Part A|Adverse Event|0|||
129545508|NCT03000075|466289750|FG002|Part A|Adverse Event|0|||
129545509|NCT03000075|466289751|FG003|Part A|Adverse Event|0|||
129545510|NCT03000075|466289752|FG004|Part A|Adverse Event|0|||
129545511|NCT03000075|466289753|FG005|Part A|Adverse Event|0|||
129545512|NCT03000075|466289754|FG006|Part A|Adverse Event|0|||
129985952|NCT01370590|467910783|FG001|Crossover Washout Period|Lost to Follow-up|0|||
129985953|NCT01370590|467910782|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
129985954|NCT01370590|467910783|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
129985955|NCT01370590|467910782|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
129985956|NCT01370590|467910783|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
129545513|NCT03000075|466289748|FG000|Part B|Not dosed due to AE|0|||
129545514|NCT03000075|466289749|FG001|Part B|Not dosed due to AE|0|||
129545515|NCT03000075|466289750|FG002|Part B|Not dosed due to AE|0|||
129985957|NCT01370590|467910782|FG000|Period 2|Adverse Event|0|||
129985958|NCT01370590|467910783|FG001|Period 2|Adverse Event|1|||
129985959|NCT01370590|467910782|FG000|Period 2|Withdrawal by Subject|1|||
129655084|NCT00957905|466693608|FG001|Part B|Physician Decision|1|||
129985960|NCT01370590|467910783|FG001|Period 2|Withdrawal by Subject|1|||
129985961|NCT05172050|467910784|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
129985962|NCT05172050|467910785|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
129985963|NCT05172050|467910786|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
129985964|NCT05172050|467910784|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
129985965|NCT05172050|467910785|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
129985966|NCT05172050|467910786|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
129985967|NCT05172050|467910784|FG000|Overall Study|Other|2|||
129985968|NCT05172050|467910785|FG001|Overall Study|Other|2|||
129985969|NCT05172050|467910786|FG002|Overall Study|Other|1|||
129985970|NCT00867308|467910789|FG000|Overall Study|Death|1|||
129985971|NCT00867308|467910790|FG001|Overall Study|Death|0|||
129985972|NCT00867308|467910789|FG000|Overall Study|Adverse Event|1|||
129545516|NCT03000075|466289751|FG003|Part B|Not dosed due to AE|0|||
129545517|NCT03000075|466289752|FG004|Part B|Not dosed due to AE|0|||
129545518|NCT03000075|466289753|FG005|Part B|Not dosed due to AE|2|||
129545519|NCT03000075|466289754|FG006|Part B|Not dosed due to AE|1|||
129545520|NCT03000075|466289748|FG000|Part B|Adverse Event|0|||
129545521|NCT03000075|466289749|FG001|Part B|Adverse Event|0|||
129545522|NCT03000075|466289750|FG002|Part B|Adverse Event|0|||
129545523|NCT03000075|466289751|FG003|Part B|Adverse Event|0|||
129545524|NCT03000075|466289752|FG004|Part B|Adverse Event|1|||
129545525|NCT03000075|466289753|FG005|Part B|Adverse Event|0|||
129545526|NCT03000075|466289754|FG006|Part B|Adverse Event|0|||
129545527|NCT00440193|466289759|FG000|Treatment Period|Adverse Event|74|||
129545528|NCT00440193|466289760|FG001|Treatment Period|Adverse Event|67|||
129545529|NCT00440193|466289759|FG000|Treatment Period|Death|19|||
129545530|NCT00440193|466289760|FG001|Treatment Period|Death|22|||
129545531|NCT00440193|466289759|FG000|Treatment Period|Lack of Efficacy|0|||
129545532|NCT00440193|466289760|FG001|Treatment Period|Lack of Efficacy|1|||
129545533|NCT00440193|466289759|FG000|Treatment Period|Lost to Follow-up|12|||
129545534|NCT00440193|466289760|FG001|Treatment Period|Lost to Follow-up|18|||
129545535|NCT00440193|466289759|FG000|Treatment Period|Physician Decision|3|||
129545536|NCT00440193|466289760|FG001|Treatment Period|Physician Decision|6|||
129545537|NCT00440193|466289759|FG000|Treatment Period|Protocol Violation|16|||
129545538|NCT00440193|466289760|FG001|Treatment Period|Protocol Violation|19|||
129545539|NCT00440193|466289759|FG000|Treatment Period|Withdrawal by Subject|36|||
129545540|NCT00440193|466289760|FG001|Treatment Period|Withdrawal by Subject|77|||
129545541|NCT00440193|466289759|FG000|Treatment Period|Clinical endpoint reached|28|||
129545542|NCT00440193|466289760|FG001|Treatment Period|Clinical endpoint reached|25|||
129545543|NCT00440193|466289759|FG000|Treatment Period|Study terminated by sponsor|102|||
129545544|NCT00440193|466289760|FG001|Treatment Period|Study terminated by sponsor|94|||
129545545|NCT00440193|466289759|FG000|Treatment Period|Protocol driven decision point|2|||
129545546|NCT00440193|466289760|FG001|Treatment Period|Protocol driven decision point|2|||
129545547|NCT00440193|466289759|FG000|Treatment Period|Switch to commercial drug|0|||
129545548|NCT00440193|466289760|FG001|Treatment Period|Switch to commercial drug|2|||
129545549|NCT00440193|466289759|FG000|Treatment Period|Technical problems|1|||
129545550|NCT00440193|466289760|FG001|Treatment Period|Technical problems|1|||
129545551|NCT00440193|466289759|FG000|Treatment Period|Participant convenience|5|||
129545552|NCT00440193|466289760|FG001|Treatment Period|Participant convenience|2|||
129545553|NCT00440193|466289759|FG000|Treatment Period|Participant did not receive treatment|7|||
129545554|NCT00440193|466289760|FG001|Treatment Period|Participant did not receive treatment|13|||
129545555|NCT00440193|466289759|FG000|Treatment Period|Site closed by investigator|0|||
129545556|NCT00440193|466289760|FG001|Treatment Period|Site closed by investigator|2|||
129545557|NCT00440193|466289759|FG000|Observational Period|Adverse Event|2|||
129545558|NCT00440193|466289760|FG001|Observational Period|Adverse Event|2|||
129545559|NCT00440193|466289759|FG000|Observational Period|Death|15|||
129545560|NCT00440193|466289760|FG001|Observational Period|Death|20|||
129545561|NCT00440193|466289759|FG000|Observational Period|Lost to Follow-up|12|||
129545562|NCT00440193|466289760|FG001|Observational Period|Lost to Follow-up|8|||
129545563|NCT00440193|466289759|FG000|Observational Period|Protocol Violation|1|||
129545564|NCT00440193|466289760|FG001|Observational Period|Protocol Violation|0|||
129545565|NCT00440193|466289759|FG000|Observational Period|Withdrawal by Subject|11|||
129545566|NCT00440193|466289760|FG001|Observational Period|Withdrawal by Subject|8|||
129545567|NCT00440193|466289759|FG000|Observational Period|Physician Decision|1|||
129545568|NCT00440193|466289760|FG001|Observational Period|Physician Decision|0|||
129545569|NCT00440193|466289759|FG000|Observational Period|Clinical endpoint reached|1|||
129545570|NCT00440193|466289760|FG001|Observational Period|Clinical endpoint reached|0|||
129545571|NCT00440193|466289759|FG000|Observational Period|Participant convenience|2|||
129545572|NCT00440193|466289760|FG001|Observational Period|Participant convenience|0|||
129545573|NCT00824993|466289761|FG000|Overall Study|Withdrawal by Subject|1|||
129545574|NCT00824993|466289762|FG001|Overall Study|Withdrawal by Subject|1|||
129545575|NCT00824993|466289761|FG000|Overall Study|Malignancy Relapse|9|||
129545576|NCT00824993|466289762|FG001|Overall Study|Malignancy Relapse|10|||
129985973|NCT00867308|467910790|FG001|Overall Study|Adverse Event|4|||
129985974|NCT00867308|467910789|FG000|Overall Study|Lack of Efficacy|6|||
129985975|NCT00867308|467910790|FG001|Overall Study|Lack of Efficacy|12|||
129985976|NCT00867308|467910789|FG000|Overall Study|Withdrawal by Subject|1|||
129985977|NCT00867308|467910790|FG001|Overall Study|Withdrawal by Subject|2|||
129985978|NCT00604825|467910791|FG000|Overall Study|Adverse Event|2|||
129985979|NCT00604825|467910792|FG001|Overall Study|Adverse Event|6|||
129985980|NCT00604825|467910793|FG002|Overall Study|Adverse Event|7|||
129985981|NCT00604825|467910794|FG003|Overall Study|Adverse Event|4|||
129985982|NCT00604825|467910791|FG000|Overall Study|Lost to Follow-up|0|||
129985983|NCT00604825|467910792|FG001|Overall Study|Lost to Follow-up|3|||
129985984|NCT00604825|467910793|FG002|Overall Study|Lost to Follow-up|1|||
129985985|NCT00604825|467910794|FG003|Overall Study|Lost to Follow-up|0|||
129985986|NCT00604825|467910791|FG000|Overall Study|Protocol Violation|0|||
129985987|NCT00604825|467910792|FG001|Overall Study|Protocol Violation|1|||
129985988|NCT00604825|467910793|FG002|Overall Study|Protocol Violation|0|||
129985989|NCT00604825|467910794|FG003|Overall Study|Protocol Violation|0|||
129985990|NCT00604825|467910791|FG000|Overall Study|Withdrawal by Subject|4|||
129545577|NCT00824993|466289761|FG000|Overall Study|Rapid Bone Loss|0|||
129545578|NCT00824993|466289762|FG001|Overall Study|Rapid Bone Loss|1|||
129545579|NCT00824993|466289761|FG000|Overall Study|Non-Compliant|2|||
129545580|NCT00824993|466289762|FG001|Overall Study|Non-Compliant|1|||
129545581|NCT00824993|466289761|FG000|Overall Study|Insurance Issue|2|||
129545582|NCT00824993|466289762|FG001|Overall Study|Insurance Issue|1|||
129545583|NCT00824993|466289761|FG000|Overall Study|Death|0|||
129545584|NCT00824993|466289762|FG001|Overall Study|Death|3|||
129545585|NCT00530621|466289765|FG000|Overall Study|Adverse Event|11|||
129545586|NCT00530621|466289766|FG001|Overall Study|Adverse Event|8|||
129545587|NCT00530621|466289765|FG000|Overall Study|Physician Decision|2|||
129545588|NCT00530621|466289766|FG001|Overall Study|Physician Decision|4|||
129545589|NCT00530621|466289765|FG000|Overall Study|Progressive Disease (PD)|47|||
129545590|NCT00530621|466289766|FG001|Overall Study|Progressive Disease (PD)|40|||
129545591|NCT00530621|466289765|FG000|Overall Study|Sponsor Decision|12|||
129545592|NCT00530621|466289766|FG001|Overall Study|Sponsor Decision|15|||
129545593|NCT00530621|466289765|FG000|Overall Study|Subject Decision|4|||
129545594|NCT00530621|466289766|FG001|Overall Study|Subject Decision|7|||
129545595|NCT00530621|466289765|FG000|Overall Study|Death|3|||
129545596|NCT00530621|466289766|FG001|Overall Study|Death|6|||
129545597|NCT00530621|466289765|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
129545598|NCT00530621|466289766|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
129545599|NCT02596009|466289767|FG000|Overall Study|Administrative problems|0|||
129545600|NCT02596009|466289768|FG001|Overall Study|Administrative problems|1|||
129545601|NCT02596009|466289769|FG002|Overall Study|Administrative problems|0|||
129545602|NCT02596009|466289770|FG003|Overall Study|Administrative problems|0|||
129545603|NCT02596009|466289771|FG004|Overall Study|Administrative problems|0|||
129545604|NCT02596009|466289772|FG005|Overall Study|Administrative problems|0|||
129545605|NCT02998645|466289773|FG000|Treatment Period 1|Adverse Event|6|||
129545606|NCT02998645|466289773|FG000|Treatment Period 1|Death|5|||
129545607|NCT02998645|466289773|FG000|Treatment Period 1|Technical Problems|4|||
129545608|NCT02998645|466289773|FG000|Treatment Period 1|Lack of Efficacy|2|||
129545609|NCT02998645|466289773|FG000|Treatment Period 1|Progressive disease|1|||
129545610|NCT02998645|466289773|FG000|Treatment Period 1|Subject/guardian decision|1|||
129545611|NCT02998645|466289773|FG000|Treatment Period 2|Lack of Efficacy|5|||
129545612|NCT02998645|466289773|FG000|Treatment Period 2|Adverse Event|2|||
129545613|NCT02998645|466289773|FG000|Treatment Period 2|Progressive disease|2|||
129545614|NCT02998645|466289773|FG000|Treatment Period 2|Physician Decision|1|||
129545615|NCT00605839|466289775|FG000|Overall Study|Protocol Violation|1|||
129545616|NCT00605839|466289776|FG001|Overall Study|Protocol Violation|0|||
129545617|NCT00605839|466289777|FG002|Overall Study|Protocol Violation|0|||
129545618|NCT02864953|466289778|FG000|Overall Study|Adverse Event|22|||
129545619|NCT02864953|466289779|FG001|Overall Study|Adverse Event|19|||
129545620|NCT02864953|466289778|FG000|Overall Study|Withdrawal by Subject|1|||
129545621|NCT02864953|466289779|FG001|Overall Study|Withdrawal by Subject|0|||
129545622|NCT02864953|466289778|FG000|Overall Study|Physician Decision|4|||
129545623|NCT02864953|466289779|FG001|Overall Study|Physician Decision|2|||
129545624|NCT02864953|466289778|FG000|Overall Study|Death|3|||
129545625|NCT02864953|466289779|FG001|Overall Study|Death|13|||
129545626|NCT02864953|466289778|FG000|Overall Study|Reason not specified|14|||
129545627|NCT02864953|466289779|FG001|Overall Study|Reason not specified|12|||
129545628|NCT02864953|466289778|FG000|Overall Study|Withdrew Prior to Dosing|9|||
129545629|NCT02864953|466289779|FG001|Overall Study|Withdrew Prior to Dosing|8|||
129545630|NCT01023022|466289780|FG000|Overall Study|Death|5|||
129545631|NCT01023022|466289780|FG000|Overall Study|Lost to Follow-up|7|||
129545632|NCT01023022|466289780|FG000|Overall Study|due to technical issues|2|||
129545633|NCT03728257|466289781|FG000|Overall Study|Death|3|||
129545634|NCT03728257|466289782|FG001|Overall Study|Death|0|||
129545635|NCT03128931|466289785|FG000|Overall Study|Physician Decision|1|||
129985991|NCT00604825|467910792|FG001|Overall Study|Withdrawal by Subject|3|||
129985992|NCT00604825|467910793|FG002|Overall Study|Withdrawal by Subject|5|||
129985993|NCT00604825|467910794|FG003|Overall Study|Withdrawal by Subject|5|||
129985994|NCT00604825|467910791|FG000|Overall Study|Lack of Efficacy|3|||
129985995|NCT00604825|467910792|FG001|Overall Study|Lack of Efficacy|2|||
129985996|NCT00604825|467910793|FG002|Overall Study|Lack of Efficacy|1|||
129985997|NCT00604825|467910794|FG003|Overall Study|Lack of Efficacy|0|||
129985998|NCT00604825|467910791|FG000|Overall Study|Did not meet eligibility criteria|0|||
129985999|NCT00604825|467910792|FG001|Overall Study|Did not meet eligibility criteria|0|||
129986000|NCT00604825|467910793|FG002|Overall Study|Did not meet eligibility criteria|2|||
129986001|NCT00604825|467910794|FG003|Overall Study|Did not meet eligibility criteria|0|||
129986002|NCT00604825|467910791|FG000|Overall Study|Physician Decision|0|||
129986003|NCT00604825|467910792|FG001|Overall Study|Physician Decision|0|||
129986004|NCT00604825|467910793|FG002|Overall Study|Physician Decision|0|||
129986005|NCT00604825|467910794|FG003|Overall Study|Physician Decision|1|||
129986006|NCT00604825|467910791|FG000|Overall Study|Exclusion criterion met|0|||
129986007|NCT00604825|467910792|FG001|Overall Study|Exclusion criterion met|0|||
129986008|NCT00604825|467910793|FG002|Overall Study|Exclusion criterion met|0|||
129986009|NCT00604825|467910794|FG003|Overall Study|Exclusion criterion met|1|||
129986010|NCT04617275|467910795|FG000|Treatment Period|Adverse Event|1|||
129986011|NCT04617275|467910796|FG001|Treatment Period|Adverse Event|6|||
129986012|NCT04617275|467910797|FG002|Treatment Period|Adverse Event|4|||
129986013|NCT04617275|467910798|FG003|Treatment Period|Adverse Event|6|||
129986014|NCT04617275|467910799|FG004|Treatment Period|Adverse Event|7|||
129986015|NCT04617275|467910800|FG005|Treatment Period|Adverse Event|8|||
129986016|NCT04617275|467910801|FG006|Treatment Period|Adverse Event|0|||
129986017|NCT04617275|467910802|FG007|Treatment Period|Adverse Event|12|||
129986018|NCT04617275|467910795|FG000|Treatment Period|Lost to Follow-up|0|||
129986019|NCT04617275|467910796|FG001|Treatment Period|Lost to Follow-up|0|||
129986020|NCT04617275|467910797|FG002|Treatment Period|Lost to Follow-up|2|||
129986021|NCT04617275|467910798|FG003|Treatment Period|Lost to Follow-up|0|||
129986022|NCT04617275|467910799|FG004|Treatment Period|Lost to Follow-up|0|||
129986023|NCT04617275|467910800|FG005|Treatment Period|Lost to Follow-up|3|||
129986024|NCT04617275|467910801|FG006|Treatment Period|Lost to Follow-up|0|||
129986025|NCT04617275|467910802|FG007|Treatment Period|Lost to Follow-up|2|||
129986026|NCT04617275|467910795|FG000|Treatment Period|No longer meets eligibility criteria|0|||
129986027|NCT04617275|467910796|FG001|Treatment Period|No longer meets eligibility criteria|0|||
129986028|NCT04617275|467910797|FG002|Treatment Period|No longer meets eligibility criteria|0|||
129986029|NCT04617275|467910798|FG003|Treatment Period|No longer meets eligibility criteria|1|||
129986030|NCT04617275|467910799|FG004|Treatment Period|No longer meets eligibility criteria|0|||
129986031|NCT04617275|467910800|FG005|Treatment Period|No longer meets eligibility criteria|0|||
129986032|NCT04617275|467910801|FG006|Treatment Period|No longer meets eligibility criteria|0|||
129986033|NCT04617275|467910802|FG007|Treatment Period|No longer meets eligibility criteria|0|||
129986034|NCT04617275|467910795|FG000|Treatment Period|Other|0|||
129986035|NCT04617275|467910796|FG001|Treatment Period|Other|1|||
129986036|NCT04617275|467910797|FG002|Treatment Period|Other|0|||
129986037|NCT04617275|467910798|FG003|Treatment Period|Other|0|||
129986038|NCT04617275|467910799|FG004|Treatment Period|Other|0|||
129986039|NCT04617275|467910800|FG005|Treatment Period|Other|0|||
129986040|NCT04617275|467910801|FG006|Treatment Period|Other|0|||
129986041|NCT04617275|467910802|FG007|Treatment Period|Other|0|||
129986042|NCT04617275|467910795|FG000|Treatment Period|Withdrawal by Subject|2|||
129986043|NCT04617275|467910796|FG001|Treatment Period|Withdrawal by Subject|0|||
129986044|NCT04617275|467910797|FG002|Treatment Period|Withdrawal by Subject|0|||
129986045|NCT04617275|467910798|FG003|Treatment Period|Withdrawal by Subject|2|||
129986046|NCT04617275|467910799|FG004|Treatment Period|Withdrawal by Subject|2|||
129986047|NCT04617275|467910800|FG005|Treatment Period|Withdrawal by Subject|0|||
129986048|NCT04617275|467910801|FG006|Treatment Period|Withdrawal by Subject|1|||
129986049|NCT04617275|467910802|FG007|Treatment Period|Withdrawal by Subject|2|||
129986050|NCT04617275|467910795|FG000|Follow-up Period|Adverse Event|1|||
129986051|NCT04617275|467910796|FG001|Follow-up Period|Adverse Event|1|||
129986052|NCT04617275|467910797|FG002|Follow-up Period|Adverse Event|2|||
129986053|NCT04617275|467910798|FG003|Follow-up Period|Adverse Event|3|||
129986054|NCT04617275|467910799|FG004|Follow-up Period|Adverse Event|4|||
129986055|NCT04617275|467910800|FG005|Follow-up Period|Adverse Event|3|||
129986056|NCT04617275|467910801|FG006|Follow-up Period|Adverse Event|0|||
129986057|NCT04617275|467910802|FG007|Follow-up Period|Adverse Event|3|||
129986058|NCT04617275|467910795|FG000|Follow-up Period|Lost to Follow-up|0|||
129986059|NCT04617275|467910796|FG001|Follow-up Period|Lost to Follow-up|1|||
129986060|NCT04617275|467910797|FG002|Follow-up Period|Lost to Follow-up|2|||
129986061|NCT04617275|467910798|FG003|Follow-up Period|Lost to Follow-up|0|||
129986062|NCT04617275|467910799|FG004|Follow-up Period|Lost to Follow-up|0|||
129986063|NCT04617275|467910800|FG005|Follow-up Period|Lost to Follow-up|4|||
129986064|NCT04617275|467910801|FG006|Follow-up Period|Lost to Follow-up|0|||
129986065|NCT04617275|467910802|FG007|Follow-up Period|Lost to Follow-up|3|||
129986066|NCT04617275|467910795|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
129545636|NCT03128931|466289785|FG000|Overall Study|Equipment Issues|3|||
129986067|NCT04617275|467910796|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
129986068|NCT04617275|467910797|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
129986069|NCT04617275|467910798|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
129986070|NCT04617275|467910799|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
129986071|NCT04617275|467910800|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
129986072|NCT04617275|467910801|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
129986073|NCT04617275|467910802|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
129986074|NCT04617275|467910795|FG000|Follow-up Period|Other|0|||
129986075|NCT04617275|467910796|FG001|Follow-up Period|Other|1|||
129986076|NCT04617275|467910797|FG002|Follow-up Period|Other|0|||
129986077|NCT04617275|467910798|FG003|Follow-up Period|Other|0|||
129986078|NCT04617275|467910799|FG004|Follow-up Period|Other|0|||
129986079|NCT04617275|467910800|FG005|Follow-up Period|Other|0|||
129986080|NCT04617275|467910801|FG006|Follow-up Period|Other|0|||
129986081|NCT04617275|467910802|FG007|Follow-up Period|Other|0|||
129986082|NCT04617275|467910795|FG000|Follow-up Period|Withdrawal by Subject|2|||
129986083|NCT04617275|467910796|FG001|Follow-up Period|Withdrawal by Subject|0|||
129986084|NCT04617275|467910797|FG002|Follow-up Period|Withdrawal by Subject|0|||
129986085|NCT04617275|467910798|FG003|Follow-up Period|Withdrawal by Subject|2|||
129986086|NCT04617275|467910799|FG004|Follow-up Period|Withdrawal by Subject|2|||
129986087|NCT04617275|467910800|FG005|Follow-up Period|Withdrawal by Subject|0|||
129986088|NCT04617275|467910801|FG006|Follow-up Period|Withdrawal by Subject|1|||
129986089|NCT04617275|467910802|FG007|Follow-up Period|Withdrawal by Subject|2|||
129986090|NCT04927884|467910815|FG000|Overall Study|Progressive Disease|2|||
129986091|NCT05593445|467910816|FG000|12-Week DBVC Period|Adverse Event|1|||
129986092|NCT05593445|467910817|FG001|12-Week DBVC Period|Adverse Event|0|||
129986093|NCT05593445|467910818|FG002|12-Week DBVC Period|Adverse Event|0|||
129986094|NCT05593445|467910819|FG003|12-Week DBVC Period|Adverse Event|0|||
129986095|NCT05593445|467910816|FG000|12-Week DBVC Period|Physician Decision|0|||
129986096|NCT05593445|467910817|FG001|12-Week DBVC Period|Physician Decision|1|||
129986097|NCT05593445|467910818|FG002|12-Week DBVC Period|Physician Decision|0|||
129986098|NCT05593445|467910819|FG003|12-Week DBVC Period|Physician Decision|0|||
129986099|NCT05593445|467910816|FG000|12-Week DBVC Period|Protocol Violation|0|||
129986100|NCT05593445|467910817|FG001|12-Week DBVC Period|Protocol Violation|1|||
129986101|NCT05593445|467910818|FG002|12-Week DBVC Period|Protocol Violation|0|||
129986102|NCT05593445|467910819|FG003|12-Week DBVC Period|Protocol Violation|0|||
129986103|NCT05593445|467910816|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
129986104|NCT05593445|467910817|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
129986105|NCT05593445|467910818|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
129986106|NCT05593445|467910819|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
129986107|NCT05593445|467910816|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
129986108|NCT05593445|467910817|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
129986109|NCT05593445|467910818|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
129986110|NCT05593445|467910819|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
129986111|NCT05593445|467910816|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
129986112|NCT05593445|467910817|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
129986113|NCT05593445|467910818|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
129986114|NCT05593445|467910819|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
129986115|NCT05593445|467910816|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
129986116|NCT05593445|467910817|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
129986117|NCT05593445|467910818|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
129986118|NCT05593445|467910819|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
129986119|NCT05593445|467910816|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129986120|NCT05593445|467910817|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129986121|NCT05593445|467910818|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
129986122|NCT05593445|467910819|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129986123|NCT05559476|467910820|FG000|Overall Study|Adverse Event|2|||
129655085|NCT00957905|466693607|FG000|Part B|Death|0|||
129655086|NCT00957905|466693608|FG001|Part B|Death|1|||
129986124|NCT05559476|467910821|FG001|Overall Study|Adverse Event|0|||
129986125|NCT05559476|467910820|FG000|Overall Study|Lost to Follow-up|13|||
129986126|NCT05559476|467910821|FG001|Overall Study|Lost to Follow-up|12|||
129986127|NCT05559476|467910820|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
129655087|NCT00957905|466693607|FG000|Part B|Protocol Violation|0|||
129655088|NCT00957905|466693608|FG001|Part B|Protocol Violation|1|||
129655089|NCT02073656|466693625|FG000|Primary Study|Lost to Follow-up|6|||
129655090|NCT02073656|466693625|FG000|Primary Study|Death|1|||
129655091|NCT02073656|466693625|FG000|Primary Study|Withdrew Consent|1|||
129655092|NCT02536781|466693628|FG000|Overall Study|Lost to Follow-up|2|||
129655093|NCT02536781|466693629|FG001|Overall Study|Lost to Follow-up|0|||
129655094|NCT03423147|466693630|FG000|Overall Study|Lost to Follow-up|5|||
129655095|NCT03423147|466693631|FG001|Overall Study|Lost to Follow-up|8|||
129655096|NCT03423147|466693630|FG000|Overall Study|Withdrawal by Subject|1|||
129986128|NCT05559476|467910821|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
129986129|NCT05559476|467910820|FG000|Overall Study|Other|0|||
129655097|NCT03423147|466693631|FG001|Overall Study|Withdrawal by Subject|0|||
129986130|NCT05559476|467910821|FG001|Overall Study|Other|2|||
129986131|NCT00727311|467910822|FG000|Overall Study|Did not receive drug|316|||
129986132|NCT00727311|467910822|FG000|Overall Study|Missing end of therapy data|205|||
129986133|NCT00727311|467910822|FG000|Overall Study|Adverse Event|58|||
129986134|NCT00727311|467910822|FG000|Overall Study|Lack of Efficacy|242|||
129986135|NCT00727311|467910822|FG000|Overall Study|Lost to Follow-up|73|||
129986136|NCT00727311|467910822|FG000|Overall Study|Withdrawal by Subject|77|||
129986137|NCT00727311|467910822|FG000|Overall Study|Other|97|||
129986138|NCT00727311|467910822|FG000|Overall Study|Multiple reasons|39|||
129986139|NCT03647488|467912041|FG000|Overall Study|Progressive disease|10|||
129986140|NCT03647488|467912042|FG001|Overall Study|Progressive disease|0|||
129986141|NCT03647488|467912043|FG002|Overall Study|Progressive disease|0|||
129986142|NCT03647488|467912041|FG000|Overall Study|Adverse Event|5|||
129986143|NCT03647488|467912042|FG001|Overall Study|Adverse Event|0|||
129986144|NCT03647488|467912043|FG002|Overall Study|Adverse Event|0|||
129986145|NCT03647488|467912041|FG000|Overall Study|Clinical progression|2|||
129986146|NCT03647488|467912042|FG001|Overall Study|Clinical progression|0|||
129986147|NCT03647488|467912043|FG002|Overall Study|Clinical progression|0|||
129986148|NCT03647488|467912041|FG000|Overall Study|Participant refused to take investigational product|1|||
129986149|NCT03647488|467912042|FG001|Overall Study|Participant refused to take investigational product|0|||
129986150|NCT03647488|467912043|FG002|Overall Study|Participant refused to take investigational product|0|||
129986151|NCT03694275|467912044|FG000|Overall Study|Adverse Event|0|||
129986152|NCT03694275|467912045|FG001|Overall Study|Adverse Event|1|||
129986153|NCT03694275|467912044|FG000|Overall Study|Reason not Specified|0|||
129986154|NCT03694275|467912045|FG001|Overall Study|Reason not Specified|1|||
129986155|NCT03541174|467912046|FG000|Part 1 Double-Blind|Adverse Event|6|||
129986156|NCT03541174|467912047|FG001|Part 1 Double-Blind|Adverse Event|5|||
129986157|NCT03541174|467912048|FG002|Part 1 Double-Blind|Adverse Event|2|||
129986158|NCT03541174|467912049|FG003|Part 1 Double-Blind|Adverse Event|0|||
129986159|NCT03541174|467912050|FG004|Part 1 Double-Blind|Adverse Event|0|||
129986160|NCT03541174|467912051|FG005|Part 1 Double-Blind|Adverse Event|0|||
129986161|NCT03541174|467912046|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
129986162|NCT03541174|467912047|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
129655098|NCT03423147|466693630|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
129655099|NCT03423147|466693631|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
129655100|NCT03423147|466693630|FG000|Overall Study|Age < 18|1|||
129655101|NCT03423147|466693631|FG001|Overall Study|Age < 18|0|||
129655102|NCT03423147|466693630|FG000|Overall Study|No Trial of Labor|0|||
129655103|NCT03423147|466693631|FG001|Overall Study|No Trial of Labor|1|||
129655104|NCT01048099|466693632|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
129655105|NCT01048099|466693632|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
129655106|NCT02258334|466693635|FG000|Overall Study|Adverse Event|1|||
129655107|NCT02258334|466693636|FG001|Overall Study|Adverse Event|0|||
129655108|NCT02258334|466693637|FG002|Overall Study|Adverse Event|0|||
129655109|NCT02258334|466693638|FG003|Overall Study|Adverse Event|0|||
129655110|NCT01969084|466693639|FG000|Overall Study|Adverse Event|0|||
129655111|NCT01969084|466693640|FG001|Overall Study|Adverse Event|1|||
129655112|NCT00862459|466693643|FG000|Overall Study|Lost to Follow-up|1|||
129655113|NCT00862459|466693644|FG001|Overall Study|Lost to Follow-up|2|||
129655114|NCT00862459|466693645|FG002|Overall Study|Lost to Follow-up|2|||
129655115|NCT00862459|466693643|FG000|Overall Study|Protocol Violation|1|||
129655116|NCT00862459|466693644|FG001|Overall Study|Protocol Violation|0|||
129655117|NCT00862459|466693645|FG002|Overall Study|Protocol Violation|0|||
129655118|NCT00862459|466693643|FG000|Overall Study|Withdrawal by Subject|1|||
129986163|NCT03541174|467912048|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
129986164|NCT03541174|467912049|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
129986165|NCT03541174|467912050|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
129986166|NCT03541174|467912051|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
129986167|NCT03541174|467912046|FG000|Part 1 Double-Blind|Other reasons|3|||
129986168|NCT03541174|467912047|FG001|Part 1 Double-Blind|Other reasons|2|||
129986169|NCT03541174|467912048|FG002|Part 1 Double-Blind|Other reasons|3|||
129986170|NCT03541174|467912049|FG003|Part 1 Double-Blind|Other reasons|0|||
129986171|NCT03541174|467912050|FG004|Part 1 Double-Blind|Other reasons|0|||
129986172|NCT03541174|467912051|FG005|Part 1 Double-Blind|Other reasons|0|||
129986173|NCT03541174|467912046|FG000|Part 2 Single-Blind|Adverse Event|0|||
129986174|NCT03541174|467912047|FG001|Part 2 Single-Blind|Adverse Event|0|||
129986175|NCT03541174|467912048|FG002|Part 2 Single-Blind|Adverse Event|0|||
129986176|NCT03541174|467912049|FG003|Part 2 Single-Blind|Adverse Event|25|||
129986177|NCT03541174|467912050|FG004|Part 2 Single-Blind|Adverse Event|0|||
129986178|NCT03541174|467912051|FG005|Part 2 Single-Blind|Adverse Event|0|||
129986179|NCT03541174|467912046|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
129986180|NCT03541174|467912047|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
129986181|NCT03541174|467912048|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
129655119|NCT00862459|466693644|FG001|Overall Study|Withdrawal by Subject|1|||
129655120|NCT00862459|466693645|FG002|Overall Study|Withdrawal by Subject|3|||
129986182|NCT03541174|467912049|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
129655121|NCT00862459|466693643|FG000|Overall Study|Adverse Event|0|||
129986183|NCT03541174|467912050|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
129986184|NCT03541174|467912051|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
129986185|NCT03541174|467912046|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
129545637|NCT04993339|466289786|FG000|Overall Study|Lost to Follow-up|0|||
129545638|NCT04993339|466289787|FG001|Overall Study|Lost to Follow-up|1|||
129545639|NCT04993339|466289786|FG000|Overall Study|no MRI scan|3|||
129545640|NCT04993339|466289787|FG001|Overall Study|no MRI scan|1|||
129545641|NCT00061568|466289788|FG000|Overall Study|Lost to Follow-up|12|||
129545642|NCT00061568|466289789|FG001|Overall Study|Lost to Follow-up|0|||
129545643|NCT00061568|466289788|FG000|Overall Study|Death|6|||
129545644|NCT00061568|466289789|FG001|Overall Study|Death|0|||
129545645|NCT00061568|466289788|FG000|Overall Study|Withdrawal by Subject|1|||
129545646|NCT00061568|466289789|FG001|Overall Study|Withdrawal by Subject|0|||
129545647|NCT01381068|466289793|FG000|Overall Study|Death|1|||
129545648|NCT01381068|466289794|FG001|Overall Study|Death|0|||
129545649|NCT01071278|466289795|FG000|Overall Study|Premature Discontinuation|254|||
129545650|NCT01071278|466289795|FG000|Overall Study|Completion Status Unknown|459|||
129545651|NCT00903409|466289796|FG000|Overall Study|Adverse Event|11|||
129545652|NCT00903409|466289797|FG001|Overall Study|Adverse Event|9|||
129545653|NCT00903409|466289796|FG000|Overall Study|Non-compliance with Protocol|1|||
129545654|NCT00903409|466289797|FG001|Overall Study|Non-compliance with Protocol|1|||
129545655|NCT00903409|466289796|FG000|Overall Study|Laboratory Abnormality|2|||
129545656|NCT00903409|466289797|FG001|Overall Study|Laboratory Abnormality|0|||
129545657|NCT00903409|466289796|FG000|Overall Study|Withdrawal by Subject|8|||
129545658|NCT00903409|466289797|FG001|Overall Study|Withdrawal by Subject|8|||
129545659|NCT00903409|466289796|FG000|Overall Study|Other|2|||
129545660|NCT00903409|466289797|FG001|Overall Study|Other|3|||
129545661|NCT00903409|466289796|FG000|Overall Study|Lost to Follow-up|2|||
129545662|NCT00903409|466289797|FG001|Overall Study|Lost to Follow-up|6|||
129545663|NCT00797316|466289798|FG000|Overall Study|Administrative problems|1|||
129545664|NCT00797316|466289799|FG001|Overall Study|Administrative problems|0|||
129545665|NCT00797316|466289798|FG000|Overall Study|Adverse Event|5|||
129545666|NCT00797316|466289799|FG001|Overall Study|Adverse Event|3|||
129545667|NCT00797316|466289798|FG000|Overall Study|Lost to Follow-up|4|||
129545668|NCT00797316|466289799|FG001|Overall Study|Lost to Follow-up|8|||
129545669|NCT00797316|466289798|FG000|Overall Study|Protocol Deviation|1|||
129545670|NCT00797316|466289799|FG001|Overall Study|Protocol Deviation|2|||
129545671|NCT00797316|466289798|FG000|Overall Study|Patient withdrew consent|12|||
129545672|NCT00797316|466289799|FG001|Overall Study|Patient withdrew consent|6|||
129545673|NCT00797316|466289798|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129545674|NCT00797316|466289799|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
129545675|NCT03239340|466289806|FG000|Overall Study|Other|26|||
129545676|NCT03239340|466289806|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
129545677|NCT03239340|466289806|FG000|Overall Study|Death|40|||
129545678|NCT03239340|466289806|FG000|Overall Study|Lost to Follow-up|2|||
129545679|NCT03239340|466289806|FG000|Overall Study|Physician Decision|16|||
129545680|NCT03239340|466289806|FG000|Overall Study|Withdrawal by Subject|27|||
129545681|NCT03868059|466289810|FG000|Overall Study|Adverse Event|3|||
129545682|NCT03868059|466289810|FG000|Overall Study|Lost to Follow-up|3|||
129545683|NCT03868059|466289810|FG000|Overall Study|Withdrawal by Subject|6|||
129545684|NCT02061293|466289811|FG000|Overall Study|Elevated Blood Pressure|1|||
129545685|NCT02061293|466289812|FG001|Overall Study|Elevated Blood Pressure|1|||
129545686|NCT04066894|466289813|FG000|Overall Study|Lack of Efficacy|1|||
129545687|NCT04066894|466289813|FG000|Overall Study|Screen Failure|1|||
129545688|NCT03494816|466289815|FG000|Overall Study|Protocol Violation|2|||
129545689|NCT03494816|466289815|FG000|Overall Study|Physician Decision|2|||
129545690|NCT03494816|466289815|FG000|Overall Study|Did not start trial treatment|1|||
129545691|NCT03494816|466289815|FG000|Overall Study|Adverse Event|1|||
129545692|NCT01283282|466289816|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
129545693|NCT01283282|466289817|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
129545694|NCT01283282|466289816|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
129545695|NCT01283282|466289817|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
129986186|NCT03541174|467912047|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
129545696|NCT01283282|466289816|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
129545697|NCT01283282|466289817|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
129545698|NCT00777920|466289818|FG000|Overall Study|Adverse Event|39|||
129545699|NCT00777920|466289818|FG000|Overall Study|Withdrawal of Consent|4|||
129545700|NCT00777920|466289818|FG000|Overall Study|Lost to Follow-up|1|||
129545701|NCT00777920|466289818|FG000|Overall Study|Investigator's discretion|1|||
129545702|NCT00777920|466289818|FG000|Overall Study|Clinical status did not improve|1|||
129545703|NCT00777920|466289818|FG000|Overall Study|Other, not specified|4|||
129545704|NCT00483717|466289819|FG000|Overall Study|Protocol Violation|5|||
129545705|NCT00483717|466289820|FG001|Overall Study|Protocol Violation|7|||
129545706|NCT00483717|466289819|FG000|Overall Study|Time of dosing missing|1|||
129545707|NCT00483717|466289820|FG001|Overall Study|Time of dosing missing|1|||
129545708|NCT00483717|466289819|FG000|Overall Study|No treatment for migraine|16|||
129545709|NCT00483717|466289820|FG001|Overall Study|No treatment for migraine|13|||
129986187|NCT03541174|467912048|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
129986188|NCT03541174|467912049|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
129986189|NCT03541174|467912050|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
129986190|NCT03541174|467912051|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
129986191|NCT03541174|467912046|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
129986192|NCT03541174|467912047|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
129986193|NCT03541174|467912048|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
129655122|NCT00862459|466693644|FG001|Overall Study|Adverse Event|1|||
129655123|NCT00862459|466693645|FG002|Overall Study|Adverse Event|0|||
129986194|NCT03541174|467912049|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
129986195|NCT03541174|467912050|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
129986196|NCT03541174|467912051|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
129986197|NCT03541174|467912046|FG000|Part 2 Single-Blind|Death|0|||
129986198|NCT03541174|467912047|FG001|Part 2 Single-Blind|Death|0|||
129986199|NCT03541174|467912048|FG002|Part 2 Single-Blind|Death|0|||
129986200|NCT03541174|467912049|FG003|Part 2 Single-Blind|Death|5|||
129986201|NCT03541174|467912050|FG004|Part 2 Single-Blind|Death|0|||
129986202|NCT03541174|467912051|FG005|Part 2 Single-Blind|Death|0|||
129986203|NCT03541174|467912046|FG000|Part 2 Single-Blind|Pregnancy|0|||
129986204|NCT03541174|467912047|FG001|Part 2 Single-Blind|Pregnancy|0|||
129986205|NCT03541174|467912048|FG002|Part 2 Single-Blind|Pregnancy|0|||
129986206|NCT03541174|467912049|FG003|Part 2 Single-Blind|Pregnancy|1|||
129986207|NCT03541174|467912050|FG004|Part 2 Single-Blind|Pregnancy|0|||
129986208|NCT03541174|467912051|FG005|Part 2 Single-Blind|Pregnancy|0|||
129986209|NCT03541174|467912046|FG000|Part 2 Single-Blind|Other reasons|0|||
129986210|NCT03541174|467912047|FG001|Part 2 Single-Blind|Other reasons|0|||
129986211|NCT03541174|467912048|FG002|Part 2 Single-Blind|Other reasons|0|||
129986212|NCT03541174|467912049|FG003|Part 2 Single-Blind|Other reasons|32|||
129986213|NCT03541174|467912050|FG004|Part 2 Single-Blind|Other reasons|0|||
129986214|NCT03541174|467912051|FG005|Part 2 Single-Blind|Other reasons|0|||
129986215|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986216|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986217|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986218|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
129986219|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
129986220|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
129986221|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986222|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986223|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986224|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
129986225|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
129986226|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
129986227|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986228|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986229|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986230|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986231|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
129986232|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
129986233|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129986234|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129986235|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129986236|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
129655124|NCT00862459|466693643|FG000|Overall Study|Personal reasons|1|||
129655125|NCT00862459|466693644|FG001|Overall Study|Personal reasons|0|||
129655126|NCT00862459|466693645|FG002|Overall Study|Personal reasons|0|||
129655127|NCT00862459|466693643|FG000|Overall Study|Operation|1|||
129655128|NCT00862459|466693644|FG001|Overall Study|Operation|1|||
129655129|NCT00862459|466693645|FG002|Overall Study|Operation|0|||
129655130|NCT00862459|466693643|FG000|Overall Study|Intravenous (IV) site problems|1|||
129655131|NCT00862459|466693644|FG001|Overall Study|Intravenous (IV) site problems|0|||
129986237|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
129986238|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
129986239|NCT03541174|467912046|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986240|NCT03541174|467912047|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986241|NCT03541174|467912048|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986242|NCT03541174|467912049|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986243|NCT03541174|467912050|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
129986244|NCT03541174|467912051|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
129986245|NCT02217332|467912054|FG000|Overall Study|Adverse Event|3|||
129986246|NCT02217332|467912054|FG000|Overall Study|Dose interruption >1 month|1|||
129986247|NCT02217332|467912054|FG000|Overall Study|Protocol Violation (eligibility)|1|||
129655132|NCT00862459|466693645|FG002|Overall Study|Intravenous (IV) site problems|1|||
129655133|NCT00862459|466693643|FG000|Overall Study|Unable to hold still for imaging|0|||
129655134|NCT00862459|466693644|FG001|Overall Study|Unable to hold still for imaging|1|||
129655135|NCT00862459|466693645|FG002|Overall Study|Unable to hold still for imaging|0|||
129655136|NCT00862459|466693643|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
129655137|NCT00862459|466693644|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
129655138|NCT00862459|466693645|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
129655139|NCT00862459|466693643|FG000|Overall Study|Administrative problems|0|||
129986248|NCT02217332|467912054|FG000|Overall Study|Withdrawal by Subject|1|||
129986249|NCT02217332|467912054|FG000|Overall Study|Lost to Follow-up|1|||
129986250|NCT02407990|467912055|FG000|Overall Study|Death|2|||
129986251|NCT02407990|467912056|FG001|Overall Study|Death|22|||
129986252|NCT02407990|467912057|FG002|Overall Study|Death|23|||
129986253|NCT02407990|467912058|FG003|Overall Study|Death|7|||
129986254|NCT02407990|467912059|FG004|Overall Study|Death|17|||
129986255|NCT02407990|467912060|FG005|Overall Study|Death|16|||
129986256|NCT02407990|467912061|FG006|Overall Study|Death|10|||
129986257|NCT02407990|467912062|FG007|Overall Study|Death|248|||
129986258|NCT02407990|467912055|FG000|Overall Study|Lost to Follow-up|0|||
129986259|NCT02407990|467912056|FG001|Overall Study|Lost to Follow-up|1|||
129986260|NCT02407990|467912057|FG002|Overall Study|Lost to Follow-up|0|||
129986261|NCT02407990|467912058|FG003|Overall Study|Lost to Follow-up|0|||
129986262|NCT02407990|467912059|FG004|Overall Study|Lost to Follow-up|0|||
129986263|NCT02407990|467912060|FG005|Overall Study|Lost to Follow-up|0|||
129986264|NCT02407990|467912061|FG006|Overall Study|Lost to Follow-up|0|||
129986265|NCT02407990|467912062|FG007|Overall Study|Lost to Follow-up|17|||
129986266|NCT02407990|467912055|FG000|Overall Study|Progressive Disease|0|||
129986267|NCT02407990|467912056|FG001|Overall Study|Progressive Disease|0|||
129986268|NCT02407990|467912057|FG002|Overall Study|Progressive Disease|0|||
129986269|NCT02407990|467912058|FG003|Overall Study|Progressive Disease|0|||
129986270|NCT02407990|467912059|FG004|Overall Study|Progressive Disease|0|||
129986271|NCT02407990|467912060|FG005|Overall Study|Progressive Disease|0|||
129986272|NCT02407990|467912061|FG006|Overall Study|Progressive Disease|0|||
129986273|NCT02407990|467912062|FG007|Overall Study|Progressive Disease|1|||
129986274|NCT02407990|467912055|FG000|Overall Study|Withdrawal by Subject|0|||
129986275|NCT02407990|467912056|FG001|Overall Study|Withdrawal by Subject|0|||
129986276|NCT02407990|467912057|FG002|Overall Study|Withdrawal by Subject|0|||
129986277|NCT02407990|467912058|FG003|Overall Study|Withdrawal by Subject|0|||
129986278|NCT02407990|467912059|FG004|Overall Study|Withdrawal by Subject|1|||
129986279|NCT02407990|467912060|FG005|Overall Study|Withdrawal by Subject|0|||
129986280|NCT02407990|467912061|FG006|Overall Study|Withdrawal by Subject|0|||
129986281|NCT02407990|467912062|FG007|Overall Study|Withdrawal by Subject|30|||
129986282|NCT02407990|467912055|FG000|Overall Study|Study Terminated by Sponsor|1|||
129986283|NCT02407990|467912056|FG001|Overall Study|Study Terminated by Sponsor|3|||
129986284|NCT02407990|467912057|FG002|Overall Study|Study Terminated by Sponsor|3|||
129986285|NCT02407990|467912058|FG003|Overall Study|Study Terminated by Sponsor|0|||
129986286|NCT02407990|467912059|FG004|Overall Study|Study Terminated by Sponsor|3|||
129986287|NCT02407990|467912060|FG005|Overall Study|Study Terminated by Sponsor|4|||
129986288|NCT02407990|467912061|FG006|Overall Study|Study Terminated by Sponsor|3|||
129986289|NCT02407990|467912062|FG007|Overall Study|Study Terminated by Sponsor|37|||
129986290|NCT02407990|467912055|FG000|Overall Study|Logistics|0|||
129986291|NCT02407990|467912056|FG001|Overall Study|Logistics|0|||
129986292|NCT02407990|467912057|FG002|Overall Study|Logistics|0|||
129986293|NCT02407990|467912058|FG003|Overall Study|Logistics|0|||
129986294|NCT02407990|467912059|FG004|Overall Study|Logistics|0|||
129986295|NCT02407990|467912060|FG005|Overall Study|Logistics|0|||
129986296|NCT02407990|467912061|FG006|Overall Study|Logistics|0|||
129986297|NCT02407990|467912062|FG007|Overall Study|Logistics|1|||
129986298|NCT02407990|467912055|FG000|Overall Study|Rolled into long-term extension study|0|||
129986299|NCT02407990|467912056|FG001|Overall Study|Rolled into long-term extension study|0|||
129986300|NCT02407990|467912057|FG002|Overall Study|Rolled into long-term extension study|0|||
129986301|NCT02407990|467912058|FG003|Overall Study|Rolled into long-term extension study|0|||
129986302|NCT02407990|467912059|FG004|Overall Study|Rolled into long-term extension study|0|||
129986303|NCT02407990|467912060|FG005|Overall Study|Rolled into long-term extension study|0|||
129986304|NCT02407990|467912061|FG006|Overall Study|Rolled into long-term extension study|0|||
129986305|NCT02407990|467912062|FG007|Overall Study|Rolled into long-term extension study|1|||
129986306|NCT00734097|467912063|FG000|Screening|Protocol Violation|12|||
129986307|NCT00734097|467912063|FG000|Screening|Withdrawal by Subject|5|||
129986308|NCT00734097|467912063|FG000|Screening|Lost to Follow-up|2|||
129986309|NCT00734097|467912063|FG000|Screening|Unconfirmed pregnancy|1|||
129986310|NCT00734097|467912063|FG000|Open Label|Lost to Follow-up|7|||
129986311|NCT00734097|467912063|FG000|Open Label|Withdrawal by Subject|5|||
129986312|NCT00734097|467912063|FG000|Open Label|Protocol Violation|4|||
129986313|NCT02233543|467912068|FG000|Period 1|Withdrawal by Subject|1|||
129986314|NCT02233543|467912069|FG001|Period 1|Withdrawal by Subject|0|||
129655140|NCT00862459|466693644|FG001|Overall Study|Administrative problems|1|||
129986315|NCT02233543|467912068|FG000|Period 1|Participants required other treatment.|2|||
129986316|NCT02233543|467912069|FG001|Period 1|Participants required other treatment.|3|||
129986317|NCT02233543|467912068|FG000|Period 2|Adverse Event|1|||
129986318|NCT02233543|467912069|FG001|Period 2|Adverse Event|0|||
129986319|NCT02233543|467912068|FG000|Period 2|Participant required other treatment.|0|||
129986320|NCT02233543|467912069|FG001|Period 2|Participant required other treatment.|1|||
129986321|NCT02233543|467912068|FG000|Period 2|COPD exacerbation|1|||
129986322|NCT02233543|467912069|FG001|Period 2|COPD exacerbation|0|||
129986323|NCT00603304|467912070|FG000|Overall Study|Lost to Follow-up|5|||
129986324|NCT00603304|467912071|FG001|Overall Study|Lost to Follow-up|7|||
129986325|NCT00603304|467912070|FG000|Overall Study|Withdrawal by Subject|8|||
129986326|NCT00603304|467912071|FG001|Overall Study|Withdrawal by Subject|5|||
129986327|NCT00603304|467912070|FG000|Overall Study|Protocol Violation|1|||
129986328|NCT00603304|467912071|FG001|Overall Study|Protocol Violation|0|||
129986329|NCT00603304|467912070|FG000|Overall Study|Adverse Event|4|||
129986330|NCT00603304|467912071|FG001|Overall Study|Adverse Event|2|||
129986331|NCT00603304|467912070|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
129986332|NCT00603304|467912071|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
129986333|NCT00603304|467912070|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
129986334|NCT00603304|467912071|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
129986335|NCT00603304|467912070|FG000|Overall Study|Exclusionary Medication|2|||
129986336|NCT00603304|467912071|FG001|Overall Study|Exclusionary Medication|3|||
129986337|NCT00603304|467912070|FG000|Overall Study|Non-Compliant|0|||
129986338|NCT00603304|467912071|FG001|Overall Study|Non-Compliant|1|||
129986339|NCT00603304|467912070|FG000|Overall Study|Moved Away|0|||
129986340|NCT00603304|467912071|FG001|Overall Study|Moved Away|2|||
129986341|NCT00603304|467912070|FG000|Overall Study|Other|2|||
129986342|NCT00603304|467912071|FG001|Overall Study|Other|0|||
129986343|NCT00603304|467912070|FG000|Overall Study|Patient Decision|2|||
129986344|NCT00603304|467912071|FG001|Overall Study|Patient Decision|0|||
129986345|NCT00616902|467912072|FG000|Overall Study|Termination of study|6|||
129986346|NCT00616902|467912073|FG001|Overall Study|Termination of study|6|||
129986347|NCT03573583|467912074|FG000|Overall Study|Lost to Follow-up|1|||
129986348|NCT03573583|467912075|FG001|Overall Study|Lost to Follow-up|0|||
129986349|NCT03573583|467912074|FG000|Overall Study|Withdrawal by Subject|1|||
129986350|NCT03573583|467912075|FG001|Overall Study|Withdrawal by Subject|1|||
129986351|NCT01227577|467912076|FG000|Overall Study|Protocol deviation|3|||
129986352|NCT01227577|467912076|FG000|Overall Study|Death|3|||
129986353|NCT01227577|467912076|FG000|Overall Study|Administrative problems|2|||
129655141|NCT00862459|466693645|FG002|Overall Study|Administrative problems|0|||
129655142|NCT04015518|466693650|FG000|Overall Study|Adverse Event|6|||
129655143|NCT04015518|466693651|FG001|Overall Study|Adverse Event|1|||
129986354|NCT01227577|467912076|FG000|Overall Study|Lost to Follow-up|1|||
129986355|NCT01227577|467912076|FG000|Overall Study|Withdrawal by Subject|4|||
129986356|NCT01227577|467912076|FG000|Overall Study|Lack of Efficacy|5|||
129986357|NCT01227577|467912076|FG000|Overall Study|Adverse Event|17|||
129986358|NCT00852540|467912077|FG000|Overall Study|Adverse Event|10|||
129986359|NCT00852540|467912078|FG001|Overall Study|Adverse Event|3|||
129986360|NCT00852540|467912077|FG000|Overall Study|Lack of Efficacy|15|||
129986361|NCT00852540|467912078|FG001|Overall Study|Lack of Efficacy|3|||
129986362|NCT00852540|467912077|FG000|Overall Study|Protocol Violation|1|||
129986363|NCT00852540|467912078|FG001|Overall Study|Protocol Violation|2|||
129986364|NCT00852540|467912077|FG000|Overall Study|Lost to Follow-up|2|||
129986365|NCT00852540|467912078|FG001|Overall Study|Lost to Follow-up|3|||
129986366|NCT00852540|467912077|FG000|Overall Study|Investigator Discretion|2|||
129986367|NCT00852540|467912078|FG001|Overall Study|Investigator Discretion|3|||
129986368|NCT00852540|467912077|FG000|Overall Study|Withdrawal by Subject|3|||
129986369|NCT00852540|467912078|FG001|Overall Study|Withdrawal by Subject|1|||
129986370|NCT00852540|467912077|FG000|Overall Study|Did Not Receive Study Drug|3|||
129986371|NCT00852540|467912078|FG001|Overall Study|Did Not Receive Study Drug|3|||
129986372|NCT01639495|467912079|FG000|Overall Study|Lost to Follow-up|6|||
129986373|NCT01639495|467912079|FG000|Overall Study|Consented but didn't have study catheter|4|||
129986374|NCT01639495|467912079|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
129986375|NCT01639495|467912079|FG000|Overall Study|No radiofrequency energy applied|2|||
129986376|NCT01119105|467912080|FG000|Overall Study|Withdrawal by Subject|1|||
129986377|NCT01119105|467912081|FG001|Overall Study|Withdrawal by Subject|1|||
129986378|NCT01119105|467912082|FG002|Overall Study|Withdrawal by Subject|1|||
129986379|NCT01119105|467912080|FG000|Overall Study|Lost to Follow-up|0|||
129986380|NCT01119105|467912081|FG001|Overall Study|Lost to Follow-up|2|||
129655144|NCT04015518|466693652|FG002|Overall Study|Adverse Event|1|||
129655145|NCT04015518|466693653|FG003|Overall Study|Adverse Event|3|||
129655146|NCT04015518|466693654|FG004|Overall Study|Adverse Event|3|||
129655147|NCT04015518|466693650|FG000|Overall Study|Lack of Efficacy|1|||
129655148|NCT04015518|466693651|FG001|Overall Study|Lack of Efficacy|0|||
129655149|NCT04015518|466693652|FG002|Overall Study|Lack of Efficacy|1|||
129655150|NCT04015518|466693653|FG003|Overall Study|Lack of Efficacy|0|||
129655151|NCT04015518|466693654|FG004|Overall Study|Lack of Efficacy|4|||
129655152|NCT04015518|466693650|FG000|Overall Study|Lost to Follow-up|0|||
129655153|NCT04015518|466693651|FG001|Overall Study|Lost to Follow-up|0|||
129655154|NCT04015518|466693652|FG002|Overall Study|Lost to Follow-up|0|||
129655155|NCT04015518|466693653|FG003|Overall Study|Lost to Follow-up|0|||
129655156|NCT04015518|466693654|FG004|Overall Study|Lost to Follow-up|1|||
129655157|NCT04015518|466693650|FG000|Overall Study|Withdrawal by Subject|0|||
129655158|NCT04015518|466693651|FG001|Overall Study|Withdrawal by Subject|1|||
129655159|NCT04015518|466693652|FG002|Overall Study|Withdrawal by Subject|0|||
129655160|NCT04015518|466693653|FG003|Overall Study|Withdrawal by Subject|1|||
129655161|NCT04015518|466693654|FG004|Overall Study|Withdrawal by Subject|1|||
129655162|NCT04015518|466693650|FG000|Overall Study|Patient did not come for consecutive visits|0|||
129655163|NCT04015518|466693651|FG001|Overall Study|Patient did not come for consecutive visits|1|||
129655164|NCT04015518|466693652|FG002|Overall Study|Patient did not come for consecutive visits|0|||
129655165|NCT04015518|466693653|FG003|Overall Study|Patient did not come for consecutive visits|0|||
129655166|NCT04015518|466693654|FG004|Overall Study|Patient did not come for consecutive visits|0|||
129655167|NCT04015518|466693650|FG000|Overall Study|not willing to travel due to Covid-19|0|||
129655168|NCT04015518|466693651|FG001|Overall Study|not willing to travel due to Covid-19|0|||
129655169|NCT04015518|466693652|FG002|Overall Study|not willing to travel due to Covid-19|1|||
129655170|NCT04015518|466693653|FG003|Overall Study|not willing to travel due to Covid-19|0|||
129655171|NCT04015518|466693654|FG004|Overall Study|not willing to travel due to Covid-19|0|||
129655172|NCT04015518|466693650|FG000|Overall Study|Patient wants to discontinue treatment|0|||
129655173|NCT04015518|466693651|FG001|Overall Study|Patient wants to discontinue treatment|0|||
129986381|NCT01119105|467912082|FG002|Overall Study|Lost to Follow-up|5|||
129986382|NCT01119105|467912080|FG000|Overall Study|Adverse Event|1|||
129655174|NCT04015518|466693652|FG002|Overall Study|Patient wants to discontinue treatment|0|||
129655175|NCT04015518|466693653|FG003|Overall Study|Patient wants to discontinue treatment|1|||
129655176|NCT04015518|466693654|FG004|Overall Study|Patient wants to discontinue treatment|0|||
129655177|NCT04015518|466693650|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
129655178|NCT04015518|466693651|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
129655179|NCT04015518|466693652|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
129655180|NCT04015518|466693653|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
129655181|NCT04015518|466693654|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
129655182|NCT04015518|466693650|FG000|Overall Study|Pregnancy|0|||
129655183|NCT04015518|466693651|FG001|Overall Study|Pregnancy|0|||
129655184|NCT04015518|466693652|FG002|Overall Study|Pregnancy|0|||
129655185|NCT04015518|466693653|FG003|Overall Study|Pregnancy|0|||
129655186|NCT04015518|466693654|FG004|Overall Study|Pregnancy|1|||
129655187|NCT04015518|466693650|FG000|Overall Study|Personal reasons|1|||
129655188|NCT04015518|466693651|FG001|Overall Study|Personal reasons|0|||
129655189|NCT04015518|466693652|FG002|Overall Study|Personal reasons|0|||
129655190|NCT04015518|466693653|FG003|Overall Study|Personal reasons|0|||
129986383|NCT01119105|467912081|FG001|Overall Study|Adverse Event|0|||
129986384|NCT01119105|467912082|FG002|Overall Study|Adverse Event|1|||
129986385|NCT01119105|467912080|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
129986386|NCT01119105|467912081|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
129986387|NCT01119105|467912082|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
129655191|NCT04015518|466693654|FG004|Overall Study|Personal reasons|1|||
129655192|NCT04015518|466693650|FG000|Overall Study|Withdrew consent|1|||
129655193|NCT04015518|466693651|FG001|Overall Study|Withdrew consent|0|||
129655194|NCT04015518|466693652|FG002|Overall Study|Withdrew consent|0|||
129655195|NCT04015518|466693653|FG003|Overall Study|Withdrew consent|0|||
129655196|NCT04015518|466693654|FG004|Overall Study|Withdrew consent|0|||
129986388|NCT01119105|467912080|FG000|Overall Study|Other|1|||
129986389|NCT01119105|467912081|FG001|Overall Study|Other|1|||
129986390|NCT01119105|467912082|FG002|Overall Study|Other|0|||
129986391|NCT01775475|467912083|FG000|Overall Study|Death|3|||
129655197|NCT04015518|466693650|FG000|Overall Study|Prostate carcinoma|1|||
129655198|NCT04015518|466693651|FG001|Overall Study|Prostate carcinoma|0|||
129655199|NCT04015518|466693652|FG002|Overall Study|Prostate carcinoma|0|||
129655200|NCT04015518|466693653|FG003|Overall Study|Prostate carcinoma|0|||
129655201|NCT04015518|466693654|FG004|Overall Study|Prostate carcinoma|0|||
129986392|NCT01775475|467912084|FG001|Overall Study|Death|3|||
129986393|NCT00618618|467912085|FG000|Overall Study|Patient Request|0|||
129986394|NCT00618618|467912086|FG001|Overall Study|Patient Request|0|||
129986395|NCT00618618|467912087|FG002|Overall Study|Patient Request|2|||
129986396|NCT00618618|467912088|FG003|Overall Study|Patient Request|0|||
129986397|NCT00618618|467912085|FG000|Overall Study|Inability to Complete Study Procedures|0|||
129986398|NCT00618618|467912086|FG001|Overall Study|Inability to Complete Study Procedures|1|||
129986399|NCT00618618|467912087|FG002|Overall Study|Inability to Complete Study Procedures|0|||
129986400|NCT00618618|467912088|FG003|Overall Study|Inability to Complete Study Procedures|0|||
129986401|NCT00618618|467912085|FG000|Overall Study|Lost to Follow-up|3|||
129986402|NCT00618618|467912086|FG001|Overall Study|Lost to Follow-up|0|||
129986403|NCT00618618|467912087|FG002|Overall Study|Lost to Follow-up|0|||
129986404|NCT00618618|467912088|FG003|Overall Study|Lost to Follow-up|1|||
129986405|NCT00618618|467912085|FG000|Overall Study|Non-compliance|1|||
129986406|NCT00618618|467912086|FG001|Overall Study|Non-compliance|1|||
129986407|NCT00618618|467912087|FG002|Overall Study|Non-compliance|0|||
129986408|NCT00618618|467912088|FG003|Overall Study|Non-compliance|0|||
129986409|NCT00618618|467912085|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
129986410|NCT00618618|467912086|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
129986411|NCT00618618|467912087|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
129986412|NCT00618618|467912088|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
129986413|NCT00618618|467912085|FG000|Overall Study|Death|0|||
129986414|NCT00618618|467912086|FG001|Overall Study|Death|1|||
129986415|NCT00618618|467912087|FG002|Overall Study|Death|0|||
129986416|NCT00618618|467912088|FG003|Overall Study|Death|0|||
129986417|NCT02929329|467912089|FG000|Overall Study|Withdrawal by Subject|24|||
129986418|NCT02929329|467912090|FG001|Overall Study|Withdrawal by Subject|21|||
129986419|NCT02929329|467912089|FG000|Overall Study|Lost to Follow-up|26|||
129986420|NCT02929329|467912090|FG001|Overall Study|Lost to Follow-up|20|||
129986421|NCT02929329|467912089|FG000|Overall Study|Death|1054|||
129986422|NCT02929329|467912090|FG001|Overall Study|Death|1051|||
129986423|NCT01183234|467912091|FG000|First Intervention|Adverse Event|1|||
129545710|NCT00483717|466289819|FG000|Overall Study|Lost to Follow-up|1|||
129545711|NCT00483717|466289820|FG001|Overall Study|Lost to Follow-up|0|||
129545712|NCT00483717|466289819|FG000|Overall Study|Withdrawal by Subject|1|||
129545713|NCT00483717|466289820|FG001|Overall Study|Withdrawal by Subject|0|||
129545714|NCT03878108|466289821|FG000|Overall Study|Adverse Event|1|||
129545715|NCT03878108|466289822|FG001|Overall Study|Adverse Event|0|||
129545716|NCT01682681|466289823|FG000|Overall Study|Lack of Efficacy|62|||
129545717|NCT01682681|466289823|FG000|Overall Study|Withdrawal by Subject|1|||
129545718|NCT01682681|466289823|FG000|Overall Study|Moved to other hospital|10|||
129545719|NCT01682681|466289823|FG000|Overall Study|Lost to Follow-up|174|||
129545720|NCT01682681|466289823|FG000|Overall Study|Adverse Event|46|||
129545721|NCT01682681|466289823|FG000|Overall Study|tapering of topiramate|5|||
129545722|NCT01682681|466289823|FG000|Overall Study|Other|21|||
129545723|NCT01682681|466289823|FG000|Overall Study|Low compliance|13|||
129545724|NCT00975000|466289824|FG000|Overall Study|Other|1|||
129545725|NCT00975000|466289825|FG001|Overall Study|Other|0|||
129545726|NCT00975000|466289824|FG000|Overall Study|Adverse Event|1|||
129545727|NCT00975000|466289825|FG001|Overall Study|Adverse Event|1|||
129545728|NCT00975000|466289824|FG000|Overall Study|Withdrawal by Subject|2|||
129545729|NCT00975000|466289825|FG001|Overall Study|Withdrawal by Subject|2|||
129545730|NCT00975000|466289824|FG000|Overall Study|Lost to Follow-up|0|||
129545731|NCT00975000|466289825|FG001|Overall Study|Lost to Follow-up|1|||
129545732|NCT00975000|466289824|FG000|Overall Study|Protocol-specified Criteria|1|||
129545733|NCT00975000|466289825|FG001|Overall Study|Protocol-specified Criteria|0|||
129545734|NCT00975000|466289824|FG000|Overall Study|Non-compliance|0|||
129545735|NCT00975000|466289825|FG001|Overall Study|Non-compliance|1|||
129545736|NCT01126359|466289826|FG000|First Intervention (20-minutes)|Physician Decision|0|||
129545737|NCT01126359|466289827|FG001|First Intervention (20-minutes)|Physician Decision|1|||
129545738|NCT00902486|466289828|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
129545739|NCT00902486|466289829|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
129545740|NCT00902486|466289830|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
129545741|NCT00902486|466289831|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
129986424|NCT01183234|467912092|FG001|First Intervention|Adverse Event|0|||
129986425|NCT00309959|467912101|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
129986426|NCT02937454|467912102|FG000|Overall Study|Adverse Event|0|||
129986427|NCT02937454|467912103|FG001|Overall Study|Adverse Event|1|||
129986428|NCT02937454|467912102|FG000|Overall Study|Death|98|||
129986429|NCT02937454|467912103|FG001|Overall Study|Death|95|||
129986430|NCT02937454|467912102|FG000|Overall Study|Lost to Follow-up|1|||
129986431|NCT02937454|467912103|FG001|Overall Study|Lost to Follow-up|1|||
129986432|NCT02937454|467912102|FG000|Overall Study|Physician Decision|0|||
129986433|NCT02937454|467912103|FG001|Overall Study|Physician Decision|1|||
129986434|NCT02937454|467912102|FG000|Overall Study|Protocol Violation|6|||
129986435|NCT02937454|467912103|FG001|Overall Study|Protocol Violation|10|||
129545742|NCT00902486|466289832|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
129986436|NCT02937454|467912102|FG000|Overall Study|Withdrawal by Subject|27|||
129986437|NCT02937454|467912103|FG001|Overall Study|Withdrawal by Subject|15|||
129986438|NCT02937454|467912102|FG000|Overall Study|Other|8|||
129986439|NCT02937454|467912103|FG001|Overall Study|Other|5|||
129986440|NCT00037830|467912106|FG000|Overall Study|Adverse Event|2|||
129986441|NCT00037830|467912107|FG001|Overall Study|Adverse Event|0|||
129986442|NCT00037830|467912108|FG002|Overall Study|Adverse Event|0|||
129986443|NCT00037830|467912106|FG000|Overall Study|Withdrawal by Subject|4|||
129986444|NCT00037830|467912107|FG001|Overall Study|Withdrawal by Subject|5|||
129986445|NCT00037830|467912108|FG002|Overall Study|Withdrawal by Subject|1|||
129986446|NCT00037830|467912106|FG000|Overall Study|Protocol Violation|2|||
129986447|NCT00037830|467912107|FG001|Overall Study|Protocol Violation|2|||
129986448|NCT00037830|467912108|FG002|Overall Study|Protocol Violation|0|||
129986449|NCT00037830|467912106|FG000|Overall Study|Unrelated Medical Problem|2|||
129986450|NCT00037830|467912107|FG001|Overall Study|Unrelated Medical Problem|0|||
129986451|NCT00037830|467912108|FG002|Overall Study|Unrelated Medical Problem|0|||
129986452|NCT01004848|467912109|FG000|Overall Study|Lost to Follow-up|55|||
129986453|NCT01004848|467912110|FG001|Overall Study|Lost to Follow-up|45|||
129986454|NCT03292432|467912111|FG000|Overall Study|Lost to Follow-up|11|||
129986455|NCT03292432|467912112|FG001|Overall Study|Lost to Follow-up|8|||
129986456|NCT03292432|467912111|FG000|Overall Study|Death|2|||
129986457|NCT03292432|467912112|FG001|Overall Study|Death|1|||
129986458|NCT03292432|467912111|FG000|Overall Study|Withdrawal by Subject|1|||
129655202|NCT04015518|466693650|FG000|Overall Study|Could not keep appointments due to work|1|||
129655203|NCT04015518|466693651|FG001|Overall Study|Could not keep appointments due to work|0|||
129655204|NCT04015518|466693652|FG002|Overall Study|Could not keep appointments due to work|0|||
129655205|NCT04015518|466693653|FG003|Overall Study|Could not keep appointments due to work|0|||
129655206|NCT04015518|466693654|FG004|Overall Study|Could not keep appointments due to work|0|||
129655207|NCT00505661|466693655|FG000|Overall Study|Not Eligible|4|||
129655208|NCT01738191|466693656|FG000|Overall Study|Withdrawal by Subject|4|||
129655209|NCT01738191|466693657|FG001|Overall Study|Withdrawal by Subject|1|||
129655210|NCT02109445|466693660|FG000|Overall Study|Symptomatic deterioration|2|||
129655211|NCT02109445|466693660|FG000|Overall Study|Adverse Event|1|||
129655212|NCT02578940|466695257|FG000|Overall Study|Screening failure|5|||
129655213|NCT02578940|466695257|FG000|Overall Study|Lost to Follow-up|1|||
129655214|NCT04591015|466695260|FG000|Overall Study|Death|6|||
129655215|NCT04591015|466695261|FG001|Overall Study|Death|4|||
129655216|NCT04591015|466695260|FG000|Overall Study|Withdrawal by Subject|6|||
129655217|NCT04591015|466695261|FG001|Overall Study|Withdrawal by Subject|3|||
129655218|NCT04591015|466695260|FG000|Overall Study|Lost to Follow-up|16|||
129655219|NCT04591015|466695261|FG001|Overall Study|Lost to Follow-up|11|||
129655220|NCT02686814|466695262|FG000|Overall Study|Physician Decision|14|||
129655221|NCT02686814|466695262|FG000|Overall Study|Withdrawal by Subject|4|||
129655222|NCT02686814|466695262|FG000|Overall Study|Death|1|||
129655223|NCT00290693|466695263|FG000|Overall Study|Withdrawal by Subject|2|||
129655224|NCT02907619|466695264|FG000|Overall Study|Study terminated by sponsor|18|||
129655225|NCT02907619|466695265|FG001|Overall Study|Study terminated by sponsor|18|||
129655226|NCT02907619|466695266|FG002|Overall Study|Study terminated by sponsor|19|||
129655227|NCT02907619|466695264|FG000|Overall Study|Death|0|||
129655228|NCT02907619|466695265|FG001|Overall Study|Death|0|||
129655229|NCT02907619|466695266|FG002|Overall Study|Death|1|||
129655230|NCT02907619|466695264|FG000|Overall Study|Withdrawal by Subject|1|||
129655231|NCT02907619|466695265|FG001|Overall Study|Withdrawal by Subject|1|||
129655232|NCT02907619|466695266|FG002|Overall Study|Withdrawal by Subject|0|||
129655233|NCT02907619|466695264|FG000|Overall Study|Other|0|||
129655234|NCT02907619|466695265|FG001|Overall Study|Other|1|||
129655235|NCT02907619|466695266|FG002|Overall Study|Other|0|||
129655236|NCT01908582|466695267|FG000|Period 2|Physician Decision|1|||
129655237|NCT01908582|466695267|FG000|Period 2|Withdrawal by Subject|1|||
129655238|NCT03484403|466695269|FG000|Overall Study|Withdrawal by Subject|6|||
129655239|NCT03484403|466695270|FG001|Overall Study|Withdrawal by Subject|4|||
129655240|NCT02722746|466695284|FG000|Overall Study|Withdrawal by Subject|0|||
129655241|NCT02722746|466695285|FG001|Overall Study|Withdrawal by Subject|1|||
129986459|NCT03292432|467912112|FG001|Overall Study|Withdrawal by Subject|2|||
129986460|NCT03292432|467912111|FG000|Overall Study|Site closed before any data collected|1|||
129986461|NCT03292432|467912112|FG001|Overall Study|Site closed before any data collected|0|||
129986462|NCT01014143|467912114|FG000|Second Intervention|Lost to Follow-up|2|||
129986463|NCT01014143|467912115|FG001|Second Intervention|Lost to Follow-up|0|||
129986464|NCT01014143|467912116|FG002|Second Intervention|Lost to Follow-up|0|||
129655242|NCT02722746|466695286|FG002|Overall Study|Withdrawal by Subject|0|||
129655243|NCT02722746|466695284|FG000|Overall Study|Protocol Violation|8|||
129655244|NCT02722746|466695285|FG001|Overall Study|Protocol Violation|4|||
129655245|NCT02722746|466695286|FG002|Overall Study|Protocol Violation|6|||
129655246|NCT02667587|466695287|FG000|Pre-Treatment|Not reported|1|||
129655247|NCT02667587|466695288|FG001|Pre-Treatment|Not reported|0|||
129655248|NCT02667587|466695287|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129655249|NCT02667587|466695288|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
129655250|NCT02667587|466695287|FG000|Pre-Treatment|Participant withdrew consent|0|||
129655251|NCT02667587|466695288|FG001|Pre-Treatment|Participant withdrew consent|1|||
129986465|NCT00495586|467912117|FG000|Overall Study|Withdrawal by Subject|4|||
129986466|NCT00495586|467912118|FG001|Overall Study|Withdrawal by Subject|4|||
129986467|NCT02038543|467912119|FG000|Overall Study|Screen Failure|0|||
129986468|NCT02038543|467912120|FG001|Overall Study|Screen Failure|0|||
129986469|NCT02038543|467912121|FG002|Overall Study|Screen Failure|0|||
129986470|NCT02038543|467912122|FG003|Overall Study|Screen Failure|1|||
129986471|NCT02038543|467912119|FG000|Overall Study|Withdrawal by Subject|0|||
129986472|NCT02038543|467912120|FG001|Overall Study|Withdrawal by Subject|0|||
129986473|NCT02038543|467912121|FG002|Overall Study|Withdrawal by Subject|0|||
129986474|NCT02038543|467912122|FG003|Overall Study|Withdrawal by Subject|1|||
129986475|NCT00158860|467912123|FG000|Overall Study|Adverse Event|3|||
129986476|NCT00158860|467912124|FG001|Overall Study|Adverse Event|6|||
129986477|NCT00158860|467912123|FG000|Overall Study|Lost to Follow-up|11|||
129986478|NCT00158860|467912124|FG001|Overall Study|Lost to Follow-up|17|||
129986479|NCT00158860|467912123|FG000|Overall Study|Protocol Violation|8|||
129986480|NCT00158860|467912124|FG001|Overall Study|Protocol Violation|23|||
129986481|NCT00158860|467912123|FG000|Overall Study|Withdrawal by Subject|7|||
129986482|NCT00158860|467912124|FG001|Overall Study|Withdrawal by Subject|17|||
129986483|NCT00158860|467912123|FG000|Overall Study|MOVING OUT OF STATE|1|||
129986484|NCT00158860|467912124|FG001|Overall Study|MOVING OUT OF STATE|0|||
129986485|NCT00158860|467912123|FG000|Overall Study|Pregnancy|3|||
129986486|NCT00158860|467912124|FG001|Overall Study|Pregnancy|3|||
129986487|NCT00158860|467912123|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
129986488|NCT00158860|467912124|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
129986489|NCT00158860|467912123|FG000|Overall Study|SPONSOR REQUEST|0|||
129986490|NCT00158860|467912124|FG001|Overall Study|SPONSOR REQUEST|1|||
129986491|NCT00158860|467912123|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
129986492|NCT00158860|467912124|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
129986493|NCT00158860|467912123|FG000|Overall Study|Closed per sponsor|0|||
129986494|NCT00158860|467912124|FG001|Overall Study|Closed per sponsor|1|||
129986495|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
129986496|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
129986497|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
129986498|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
129986499|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
129986500|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
129986501|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
129986502|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
129986503|NCT01029652|467912125|FG000|Core Study (0-12 Weeks)|Death|0|||
129986504|NCT01029652|467912126|FG001|Core Study (0-12 Weeks)|Death|1|||
129986505|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
129986506|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
129986507|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
129986508|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
129986509|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
129986510|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
129986511|NCT01029652|467912125|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
129986512|NCT01029652|467912126|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
129986513|NCT01029652|467912125|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
129986514|NCT01029652|467912126|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
129986515|NCT01029652|467912125|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
129986516|NCT01029652|467912126|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
129986517|NCT01029652|467912125|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
129986518|NCT01029652|467912126|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
129986519|NCT02095951|467912127|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
129986520|NCT02095951|467912128|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
129986521|NCT03618823|467912129|FG000|Overall Study|Lost to Follow-up|63|||
129986522|NCT03618823|467912130|FG001|Overall Study|Lost to Follow-up|61|||
129986523|NCT04638920|467912131|FG000|Overall Study|Withdrawal by Subject|5|||
129986524|NCT00964886|467912132|FG000|Overall Study|Lost to Follow-up|2|||
129986525|NCT00964886|467912133|FG001|Overall Study|Lost to Follow-up|2|||
129986526|NCT00964886|467912134|FG002|Overall Study|Lost to Follow-up|6|||
129986527|NCT00964886|467912135|FG003|Overall Study|Lost to Follow-up|4|||
129986528|NCT00964886|467912132|FG000|Overall Study|Withdrawal by Subject|6|||
129986529|NCT00964886|467912133|FG001|Overall Study|Withdrawal by Subject|2|||
129986530|NCT00964886|467912134|FG002|Overall Study|Withdrawal by Subject|5|||
129986531|NCT00964886|467912135|FG003|Overall Study|Withdrawal by Subject|3|||
129986532|NCT00964886|467912132|FG000|Overall Study|Adverse Event|3|||
129986533|NCT00964886|467912133|FG001|Overall Study|Adverse Event|1|||
129986534|NCT00964886|467912134|FG002|Overall Study|Adverse Event|5|||
129986535|NCT00964886|467912135|FG003|Overall Study|Adverse Event|2|||
129986536|NCT00964886|467912132|FG000|Overall Study|Protocol Violation|0|||
129986537|NCT00964886|467912133|FG001|Overall Study|Protocol Violation|2|||
129986538|NCT00964886|467912134|FG002|Overall Study|Protocol Violation|0|||
129986539|NCT00964886|467912135|FG003|Overall Study|Protocol Violation|0|||
129986540|NCT00523640|467912137|FG000|Overall Study|Death|1|||
129986541|NCT03775434|467912139|FG000|Overall Study|Adverse Event|2|||
129986542|NCT03775434|467912139|FG000|Overall Study|Withdrawal by Subject|1|||
129986543|NCT01859988|467912140|FG000|Overall Study|Withdrawal by Subject|6|||
129986544|NCT01859988|467912141|FG001|Overall Study|Withdrawal by Subject|3|||
129986545|NCT01859988|467912142|FG002|Overall Study|Withdrawal by Subject|4|||
129986546|NCT01859988|467912143|FG003|Overall Study|Withdrawal by Subject|3|||
129986547|NCT01859988|467912144|FG004|Overall Study|Withdrawal by Subject|2|||
129986548|NCT01859988|467912145|FG005|Overall Study|Withdrawal by Subject|2|||
129986549|NCT01859988|467912140|FG000|Overall Study|Lack of Efficacy|1|||
129986550|NCT01859988|467912141|FG001|Overall Study|Lack of Efficacy|1|||
129986551|NCT01859988|467912142|FG002|Overall Study|Lack of Efficacy|5|||
129986552|NCT01859988|467912143|FG003|Overall Study|Lack of Efficacy|0|||
129986553|NCT01859988|467912144|FG004|Overall Study|Lack of Efficacy|7|||
129986554|NCT01859988|467912145|FG005|Overall Study|Lack of Efficacy|9|||
129986555|NCT01859988|467912140|FG000|Overall Study|Physician Decision|1|||
129986556|NCT01859988|467912141|FG001|Overall Study|Physician Decision|3|||
129986557|NCT01859988|467912142|FG002|Overall Study|Physician Decision|1|||
129986558|NCT01859988|467912143|FG003|Overall Study|Physician Decision|3|||
129986559|NCT01859988|467912144|FG004|Overall Study|Physician Decision|4|||
129986560|NCT01859988|467912145|FG005|Overall Study|Physician Decision|1|||
129986561|NCT01859988|467912140|FG000|Overall Study|Adverse Event|2|||
129986562|NCT01859988|467912141|FG001|Overall Study|Adverse Event|1|||
129986563|NCT01859988|467912142|FG002|Overall Study|Adverse Event|3|||
129986564|NCT01859988|467912143|FG003|Overall Study|Adverse Event|1|||
129986565|NCT01859988|467912144|FG004|Overall Study|Adverse Event|2|||
129986566|NCT01859988|467912145|FG005|Overall Study|Adverse Event|2|||
129986567|NCT01859988|467912140|FG000|Overall Study|Lost to Follow-up|1|||
129986568|NCT01859988|467912141|FG001|Overall Study|Lost to Follow-up|2|||
129986569|NCT01859988|467912142|FG002|Overall Study|Lost to Follow-up|3|||
129986570|NCT01859988|467912143|FG003|Overall Study|Lost to Follow-up|0|||
129986571|NCT01859988|467912144|FG004|Overall Study|Lost to Follow-up|3|||
129986572|NCT01859988|467912145|FG005|Overall Study|Lost to Follow-up|2|||
129986573|NCT01859988|467912140|FG000|Overall Study|Protocol Violation|0|||
129986574|NCT01859988|467912141|FG001|Overall Study|Protocol Violation|0|||
129986575|NCT01859988|467912142|FG002|Overall Study|Protocol Violation|1|||
129986576|NCT01859988|467912143|FG003|Overall Study|Protocol Violation|0|||
129986577|NCT01859988|467912144|FG004|Overall Study|Protocol Violation|0|||
129986578|NCT01859988|467912145|FG005|Overall Study|Protocol Violation|0|||
129986579|NCT01859988|467912140|FG000|Overall Study|Other than specified above|0|||
129986580|NCT01859988|467912141|FG001|Overall Study|Other than specified above|2|||
129986581|NCT01859988|467912142|FG002|Overall Study|Other than specified above|11|||
129986582|NCT01859988|467912143|FG003|Overall Study|Other than specified above|3|||
129986583|NCT01859988|467912144|FG004|Overall Study|Other than specified above|5|||
129986584|NCT01859988|467912145|FG005|Overall Study|Other than specified above|3|||
129986585|NCT00468559|467912150|FG000|Open-label Treatment Phase|Adverse Event|5|||
129986586|NCT00468559|467912151|FG001|Open-label Treatment Phase|Adverse Event|0|||
129986587|NCT00468559|467912152|FG002|Open-label Treatment Phase|Adverse Event|0|||
129986588|NCT00468559|467912150|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
129986589|NCT00468559|467912151|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
129986590|NCT00468559|467912152|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
129986591|NCT00468559|467912150|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
129986592|NCT00468559|467912151|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
129986593|NCT00468559|467912152|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
129986594|NCT00468559|467912150|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
129986595|NCT00468559|467912151|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
129986596|NCT00468559|467912152|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
129986597|NCT00468559|467912150|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
129986598|NCT00468559|467912151|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
129986599|NCT00468559|467912152|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
129986600|NCT04602221|467912153|FG000|Overall Study|Discontinuation of trial treatment|0|||
129986601|NCT04602221|467912154|FG001|Overall Study|Discontinuation of trial treatment|0|||
129986602|NCT04602221|467912155|FG002|Overall Study|Discontinuation of trial treatment|1|||
129986603|NCT04602221|467912156|FG003|Overall Study|Discontinuation of trial treatment|0|||
129986604|NCT04602221|467912157|FG004|Overall Study|Discontinuation of trial treatment|0|||
129986605|NCT04602221|467912158|FG005|Overall Study|Discontinuation of trial treatment|0|||
129986606|NCT04602221|467912159|FG006|Overall Study|Discontinuation of trial treatment|0|||
129986607|NCT04602221|467912160|FG007|Overall Study|Discontinuation of trial treatment|0|||
129986608|NCT04602221|467912161|FG008|Overall Study|Discontinuation of trial treatment|0|||
129986609|NCT04602221|467912162|FG009|Overall Study|Discontinuation of trial treatment|0|||
129986610|NCT04602221|467912163|FG010|Overall Study|Discontinuation of trial treatment|0|||
129986611|NCT04602221|467912164|FG011|Overall Study|Discontinuation of trial treatment|0|||
129986612|NCT04602221|467912165|FG012|Overall Study|Discontinuation of trial treatment|0|||
129986613|NCT04602221|467912166|FG013|Overall Study|Discontinuation of trial treatment|0|||
129986614|NCT04602221|467912167|FG014|Overall Study|Discontinuation of trial treatment|0|||
129986615|NCT04602221|467912168|FG015|Overall Study|Discontinuation of trial treatment|0|||
129986616|NCT04602221|467912169|FG016|Overall Study|Discontinuation of trial treatment|0|||
129986617|NCT04602221|467912170|FG017|Overall Study|Discontinuation of trial treatment|0|||
129986618|NCT04602221|467912153|FG000|Overall Study|Other than listed|0|||
129986619|NCT04602221|467912154|FG001|Overall Study|Other than listed|0|||
129986620|NCT04602221|467912155|FG002|Overall Study|Other than listed|0|||
129986621|NCT04602221|467912156|FG003|Overall Study|Other than listed|0|||
129986622|NCT04602221|467912157|FG004|Overall Study|Other than listed|0|||
129986623|NCT04602221|467912158|FG005|Overall Study|Other than listed|0|||
129986624|NCT04602221|467912159|FG006|Overall Study|Other than listed|0|||
129986625|NCT04602221|467912160|FG007|Overall Study|Other than listed|0|||
129986626|NCT04602221|467912161|FG008|Overall Study|Other than listed|0|||
129986627|NCT04602221|467912162|FG009|Overall Study|Other than listed|0|||
129986628|NCT04602221|467912163|FG010|Overall Study|Other than listed|0|||
129986629|NCT04602221|467912164|FG011|Overall Study|Other than listed|0|||
129986630|NCT04602221|467912165|FG012|Overall Study|Other than listed|0|||
129986631|NCT04602221|467912166|FG013|Overall Study|Other than listed|0|||
129986632|NCT04602221|467912167|FG014|Overall Study|Other than listed|0|||
129986633|NCT04602221|467912168|FG015|Overall Study|Other than listed|1|||
129986634|NCT04602221|467912169|FG016|Overall Study|Other than listed|0|||
129986635|NCT04602221|467912170|FG017|Overall Study|Other than listed|1|||
129986636|NCT04602221|467912153|FG000|Overall Study|Withdrawal by Subject|0|||
129986637|NCT04602221|467912154|FG001|Overall Study|Withdrawal by Subject|0|||
129986638|NCT04602221|467912155|FG002|Overall Study|Withdrawal by Subject|0|||
129986639|NCT04602221|467912156|FG003|Overall Study|Withdrawal by Subject|0|||
129986640|NCT04602221|467912157|FG004|Overall Study|Withdrawal by Subject|0|||
129986641|NCT04602221|467912158|FG005|Overall Study|Withdrawal by Subject|0|||
129986642|NCT04602221|467912159|FG006|Overall Study|Withdrawal by Subject|0|||
129986643|NCT04602221|467912160|FG007|Overall Study|Withdrawal by Subject|0|||
129986644|NCT04602221|467912161|FG008|Overall Study|Withdrawal by Subject|0|||
129986645|NCT04602221|467912162|FG009|Overall Study|Withdrawal by Subject|0|||
129986646|NCT04602221|467912163|FG010|Overall Study|Withdrawal by Subject|0|||
129655252|NCT02667587|466695287|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
129655253|NCT02667587|466695288|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
129655254|NCT02667587|466695287|FG000|End of Treatment|Disease Progression|193|||
129655255|NCT02667587|466695288|FG001|End of Treatment|Disease Progression|226|||
129655256|NCT02667587|466695287|FG000|End of Treatment|Study Drug Toxicity|75|||
129655257|NCT02667587|466695288|FG001|End of Treatment|Study Drug Toxicity|19|||
129655258|NCT02667587|466695287|FG000|End of Treatment|Death|2|||
129986647|NCT04602221|467912164|FG011|Overall Study|Withdrawal by Subject|0|||
129986648|NCT04602221|467912165|FG012|Overall Study|Withdrawal by Subject|1|||
129986649|NCT04602221|467912166|FG013|Overall Study|Withdrawal by Subject|0|||
129986650|NCT04602221|467912167|FG014|Overall Study|Withdrawal by Subject|0|||
129986651|NCT04602221|467912168|FG015|Overall Study|Withdrawal by Subject|0|||
129986652|NCT04602221|467912169|FG016|Overall Study|Withdrawal by Subject|0|||
129986653|NCT04602221|467912170|FG017|Overall Study|Withdrawal by Subject|0|||
129986654|NCT04602221|467912153|FG000|Overall Study|Lost to Follow-up|0|||
129986655|NCT04602221|467912154|FG001|Overall Study|Lost to Follow-up|0|||
129986656|NCT04602221|467912155|FG002|Overall Study|Lost to Follow-up|0|||
129986657|NCT04602221|467912156|FG003|Overall Study|Lost to Follow-up|0|||
129986658|NCT04602221|467912157|FG004|Overall Study|Lost to Follow-up|0|||
129986659|NCT04602221|467912158|FG005|Overall Study|Lost to Follow-up|1|||
129986660|NCT04602221|467912159|FG006|Overall Study|Lost to Follow-up|0|||
129986661|NCT04602221|467912160|FG007|Overall Study|Lost to Follow-up|0|||
129986662|NCT04602221|467912161|FG008|Overall Study|Lost to Follow-up|0|||
129986663|NCT04602221|467912162|FG009|Overall Study|Lost to Follow-up|0|||
129655259|NCT02667587|466695288|FG001|End of Treatment|Death|1|||
129655260|NCT02667587|466695287|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
129655261|NCT02667587|466695288|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
129655262|NCT02667587|466695287|FG000|End of Treatment|participant request to discontinue treatment|33|||
129986664|NCT04602221|467912163|FG010|Overall Study|Lost to Follow-up|0|||
129986665|NCT04602221|467912164|FG011|Overall Study|Lost to Follow-up|0|||
129986666|NCT04602221|467912165|FG012|Overall Study|Lost to Follow-up|0|||
129986667|NCT04602221|467912166|FG013|Overall Study|Lost to Follow-up|0|||
129986668|NCT04602221|467912167|FG014|Overall Study|Lost to Follow-up|0|||
129986669|NCT04602221|467912168|FG015|Overall Study|Lost to Follow-up|0|||
129986670|NCT04602221|467912169|FG016|Overall Study|Lost to Follow-up|0|||
129986671|NCT04602221|467912170|FG017|Overall Study|Lost to Follow-up|0|||
129655263|NCT02667587|466695288|FG001|End of Treatment|participant request to discontinue treatment|35|||
129986672|NCT03538301|467912171|FG000|Overall Study|Adverse Event|1|||
129986673|NCT03538301|467912172|FG001|Overall Study|Adverse Event|4|||
129655264|NCT02667587|466695287|FG000|End of Treatment|participant withdrew consent|5|||
129986674|NCT03538301|467912173|FG002|Overall Study|Adverse Event|4|||
129986675|NCT03538301|467912171|FG000|Overall Study|Death|1|||
129986676|NCT03538301|467912172|FG001|Overall Study|Death|1|||
129986677|NCT03538301|467912173|FG002|Overall Study|Death|0|||
129986678|NCT03538301|467912171|FG000|Overall Study|Physician Decision|0|||
129655265|NCT02667587|466695288|FG001|End of Treatment|participant withdrew consent|6|||
129655266|NCT02667587|466695287|FG000|End of Treatment|Lost to Follow-up|1|||
129655267|NCT02667587|466695288|FG001|End of Treatment|Lost to Follow-up|2|||
129655268|NCT02667587|466695287|FG000|End of Treatment|maximum clinical benefit|4|||
129655269|NCT02667587|466695288|FG001|End of Treatment|maximum clinical benefit|4|||
129655270|NCT02667587|466695287|FG000|End of Treatment|poor or non compliant|0|||
129655271|NCT02667587|466695288|FG001|End of Treatment|poor or non compliant|1|||
129655272|NCT02667587|466695287|FG000|End of Treatment|participant no longer meets study criteria|1|||
129655273|NCT02667587|466695288|FG001|End of Treatment|participant no longer meets study criteria|1|||
129655274|NCT02667587|466695287|FG000|End of Treatment|administrative reason by sponsor|1|||
129655275|NCT02667587|466695288|FG001|End of Treatment|administrative reason by sponsor|29|||
129655276|NCT02667587|466695287|FG000|End of Treatment|other reasonse|21|||
129655277|NCT02667587|466695288|FG001|End of Treatment|other reasonse|10|||
129655278|NCT01134263|466695289|FG000|Overall Study|Serious adverse event|2|||
129655279|NCT01134263|466695290|FG001|Overall Study|Serious adverse event|1|||
129655280|NCT01134263|466695291|FG002|Overall Study|Serious adverse event|1|||
129655281|NCT01134263|466695292|FG003|Overall Study|Serious adverse event|1|||
129655282|NCT01134263|466695293|FG004|Overall Study|Serious adverse event|1|||
129655283|NCT01134263|466695289|FG000|Overall Study|Other adverse event|1|||
129655284|NCT01134263|466695290|FG001|Overall Study|Other adverse event|2|||
129655285|NCT01134263|466695291|FG002|Overall Study|Other adverse event|5|||
129655286|NCT01134263|466695292|FG003|Overall Study|Other adverse event|3|||
129655287|NCT01134263|466695293|FG004|Overall Study|Other adverse event|0|||
129655288|NCT01134263|466695289|FG000|Overall Study|Protocol Violation|8|||
129655289|NCT01134263|466695290|FG001|Overall Study|Protocol Violation|7|||
129655290|NCT01134263|466695291|FG002|Overall Study|Protocol Violation|2|||
129655291|NCT01134263|466695292|FG003|Overall Study|Protocol Violation|4|||
129655292|NCT01134263|466695293|FG004|Overall Study|Protocol Violation|2|||
129655293|NCT01134263|466695289|FG000|Overall Study|Lost to Follow-up|4|||
129655294|NCT01134263|466695290|FG001|Overall Study|Lost to Follow-up|3|||
129655295|NCT01134263|466695291|FG002|Overall Study|Lost to Follow-up|5|||
129655296|NCT01134263|466695292|FG003|Overall Study|Lost to Follow-up|3|||
129655297|NCT01134263|466695293|FG004|Overall Study|Lost to Follow-up|1|||
129655298|NCT01134263|466695289|FG000|Overall Study|Withdrawal by Subject|8|||
129655299|NCT01134263|466695290|FG001|Overall Study|Withdrawal by Subject|6|||
129655300|NCT01134263|466695291|FG002|Overall Study|Withdrawal by Subject|16|||
129655301|NCT01134263|466695292|FG003|Overall Study|Withdrawal by Subject|7|||
129655302|NCT01134263|466695293|FG004|Overall Study|Withdrawal by Subject|5|||
129655303|NCT01134263|466695289|FG000|Overall Study|Enrolled, but not treated|1|||
129655304|NCT01134263|466695290|FG001|Overall Study|Enrolled, but not treated|1|||
129655305|NCT01134263|466695291|FG002|Overall Study|Enrolled, but not treated|0|||
129655306|NCT01134263|466695292|FG003|Overall Study|Enrolled, but not treated|1|||
129655307|NCT01134263|466695293|FG004|Overall Study|Enrolled, but not treated|0|||
129655308|NCT01955109|466695299|FG000|Overall Study|Adverse Event|2|||
129655309|NCT01955109|466695300|FG001|Overall Study|Adverse Event|0|||
129655310|NCT01955109|466695299|FG000|Overall Study|Participant unwilling to continue|35|||
129655311|NCT01955109|466695300|FG001|Overall Study|Participant unwilling to continue|7|||
129655312|NCT01955109|466695299|FG000|Overall Study|Physician Decision|2|||
129655313|NCT01955109|466695300|FG001|Overall Study|Physician Decision|0|||
129655314|NCT01955109|466695299|FG000|Overall Study|Lost to Follow-up|3|||
129655315|NCT01955109|466695300|FG001|Overall Study|Lost to Follow-up|1|||
129655316|NCT01955109|466695299|FG000|Overall Study|Non-compliance|3|||
129655317|NCT01955109|466695300|FG001|Overall Study|Non-compliance|1|||
129655318|NCT00438256|466695304|FG000|Overall Study|Ineligible for Resection|2|||
129655319|NCT00438256|466695305|FG001|Overall Study|Ineligible for Resection|1|||
129655320|NCT00438256|466695306|FG002|Overall Study|Ineligible for Resection|1|||
129655321|NCT00438256|466695307|FG003|Overall Study|Ineligible for Resection|7|||
129655322|NCT00438256|466695304|FG000|Overall Study|Excluded final Diagnosis|0|||
129655323|NCT00438256|466695305|FG001|Overall Study|Excluded final Diagnosis|0|||
129655324|NCT00438256|466695306|FG002|Overall Study|Excluded final Diagnosis|0|||
129655325|NCT00438256|466695307|FG003|Overall Study|Excluded final Diagnosis|2|||
129655326|NCT01133288|466695308|FG000|Eligibility Assessment|met exclusion criteria|5|||
129655327|NCT01133288|466695308|FG000|Intervention Allocation|study terminated|2|||
129655328|NCT00750919|466695316|FG000|Overall Study|Adverse Event|9|||
129655329|NCT00750919|466695316|FG000|Overall Study|Withdrawal by Subject|1|||
129655330|NCT00750919|466695316|FG000|Overall Study|Lack of Efficacy|8|||
129655331|NCT00750919|466695316|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
129655332|NCT00750919|466695316|FG000|Overall Study|Other|36|||
129655333|NCT02912455|466695322|FG000|Overall Study|Withdrawal by Subject|0|||
129655334|NCT02912455|466695323|FG001|Overall Study|Withdrawal by Subject|1|||
129655335|NCT02912455|466695322|FG000|Overall Study|Lack of Efficacy|0|||
129655336|NCT02912455|466695323|FG001|Overall Study|Lack of Efficacy|1|||
129655337|NCT02912455|466695322|FG000|Overall Study|Lost to Follow-up|2|||
129655338|NCT02912455|466695323|FG001|Overall Study|Lost to Follow-up|1|||
129655339|NCT01810783|466695328|FG000|Overall Study|Adverse Event|32|||
129655340|NCT01810783|466695328|FG000|Overall Study|Withdrawal by Subject|22|||
129655341|NCT01810783|466695328|FG000|Overall Study|Lack of Efficacy|12|||
129986679|NCT03538301|467912172|FG001|Overall Study|Physician Decision|1|||
129986680|NCT03538301|467912173|FG002|Overall Study|Physician Decision|0|||
129986681|NCT03538301|467912171|FG000|Overall Study|Protocol Violation|0|||
129986682|NCT03538301|467912172|FG001|Overall Study|Protocol Violation|0|||
129986683|NCT03538301|467912173|FG002|Overall Study|Protocol Violation|1|||
129986684|NCT03538301|467912171|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
129986685|NCT03538301|467912172|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
129986686|NCT03538301|467912173|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
129986687|NCT04540887|467912174|FG000|Overall Study|Withdrawal by Subject|2|||
129986688|NCT05180500|467912175|FG000|Overall Study|Adverse Event|1|||
129986689|NCT05180500|467912176|FG001|Overall Study|Adverse Event|0|||
129986690|NCT05180500|467912175|FG000|Overall Study|Withdrawal by Subject|2|||
129986691|NCT05180500|467912176|FG001|Overall Study|Withdrawal by Subject|0|||
129986692|NCT05917470|467912177|FG000|Overall Study|Progressive Disease|1|||
129986693|NCT05917470|467912178|FG001|Overall Study|Progressive Disease|1|||
129986694|NCT05917470|467912179|FG002|Overall Study|Progressive Disease|2|||
129986695|NCT05917470|467912180|FG003|Overall Study|Progressive Disease|3|||
129986696|NCT05917470|467912181|FG004|Overall Study|Progressive Disease|1|||
129986697|NCT05917470|467912182|FG005|Overall Study|Progressive Disease|1|||
129986698|NCT05917470|467912183|FG006|Overall Study|Progressive Disease|0|||
129986699|NCT05917470|467912184|FG007|Overall Study|Progressive Disease|0|||
129986700|NCT05917470|467912177|FG000|Overall Study|Withdrawal by Subject|0|||
129986701|NCT05917470|467912178|FG001|Overall Study|Withdrawal by Subject|0|||
129986702|NCT05917470|467912179|FG002|Overall Study|Withdrawal by Subject|1|||
129986703|NCT05917470|467912180|FG003|Overall Study|Withdrawal by Subject|0|||
129986704|NCT05917470|467912181|FG004|Overall Study|Withdrawal by Subject|0|||
129986705|NCT05917470|467912182|FG005|Overall Study|Withdrawal by Subject|0|||
129986706|NCT05917470|467912183|FG006|Overall Study|Withdrawal by Subject|0|||
129986707|NCT05917470|467912184|FG007|Overall Study|Withdrawal by Subject|0|||
129986708|NCT05917470|467912177|FG000|Overall Study|Sponsor Decision|0|||
129986709|NCT05917470|467912178|FG001|Overall Study|Sponsor Decision|0|||
129986710|NCT05917470|467912179|FG002|Overall Study|Sponsor Decision|1|||
129986711|NCT05917470|467912180|FG003|Overall Study|Sponsor Decision|0|||
129986712|NCT05917470|467912181|FG004|Overall Study|Sponsor Decision|2|||
129986713|NCT05917470|467912182|FG005|Overall Study|Sponsor Decision|1|||
129986714|NCT05917470|467912183|FG006|Overall Study|Sponsor Decision|3|||
129986715|NCT05917470|467912184|FG007|Overall Study|Sponsor Decision|3|||
129986716|NCT05917470|467912177|FG000|Overall Study|Adverse Event|0|||
129986717|NCT05917470|467912178|FG001|Overall Study|Adverse Event|0|||
129986718|NCT05917470|467912179|FG002|Overall Study|Adverse Event|0|||
129986719|NCT05917470|467912180|FG003|Overall Study|Adverse Event|0|||
129986720|NCT05917470|467912181|FG004|Overall Study|Adverse Event|0|||
129986721|NCT05917470|467912182|FG005|Overall Study|Adverse Event|1|||
129986722|NCT05917470|467912183|FG006|Overall Study|Adverse Event|0|||
129986723|NCT05917470|467912184|FG007|Overall Study|Adverse Event|0|||
129986724|NCT02317432|467912185|FG000|Overall Study|Death|4|||
129986725|NCT02317432|467912186|FG001|Overall Study|Death|1|||
129986726|NCT02317432|467912185|FG000|Overall Study|Lost to Follow-up|0|||
129986727|NCT02317432|467912186|FG001|Overall Study|Lost to Follow-up|5|||
129986728|NCT02317432|467912185|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
129986729|NCT02317432|467912186|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
129986730|NCT03992846|467912191|FG000|Overall Study|Adverse Event|8|||
129986731|NCT03992846|467912192|FG001|Overall Study|Adverse Event|6|||
129986732|NCT03992846|467912193|FG002|Overall Study|Adverse Event|3|||
129986733|NCT03992846|467912191|FG000|Overall Study|Lost to Follow-up|0|||
129986734|NCT03992846|467912192|FG001|Overall Study|Lost to Follow-up|1|||
129986735|NCT03992846|467912193|FG002|Overall Study|Lost to Follow-up|1|||
129986736|NCT03992846|467912191|FG000|Overall Study|Pregnancy|2|||
129986737|NCT03992846|467912192|FG001|Overall Study|Pregnancy|0|||
129986738|NCT03992846|467912193|FG002|Overall Study|Pregnancy|1|||
129986739|NCT03992846|467912191|FG000|Overall Study|Protocol Violation|1|||
129986740|NCT03992846|467912192|FG001|Overall Study|Protocol Violation|2|||
129986741|NCT03992846|467912193|FG002|Overall Study|Protocol Violation|0|||
129986742|NCT03992846|467912191|FG000|Overall Study|Withdrawal by Subject|8|||
129986743|NCT03992846|467912192|FG001|Overall Study|Withdrawal by Subject|10|||
129986744|NCT03992846|467912193|FG002|Overall Study|Withdrawal by Subject|20|||
129986745|NCT03992846|467912191|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
129986746|NCT03992846|467912192|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
129986747|NCT03992846|467912193|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
129986748|NCT04058366|467914002|FG000|Overall Study|Adverse Event|14|||
129986749|NCT04058366|467914002|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
129986750|NCT04058366|467914002|FG000|Overall Study|Commercial drug is available for participants|6|||
129986751|NCT04058366|467914002|FG000|Overall Study|Death|1|||
129655342|NCT01810783|466695328|FG000|Overall Study|Lost to Follow-up|10|||
129986752|NCT04058366|467914002|FG000|Overall Study|Other non-compliance|2|||
129986753|NCT04058366|467914002|FG000|Overall Study|Other|6|||
129986754|NCT04343872|467914007|FG000|Overall Study|Lost to Follow-up|6|||
129986755|NCT04343872|467914008|FG001|Overall Study|Lost to Follow-up|3|||
129986756|NCT01850446|467914009|FG000|Overall Study|Lack of Efficacy|1|||
129986757|NCT01850446|467914010|FG001|Overall Study|Lack of Efficacy|0|||
129986758|NCT01850446|467914009|FG000|Overall Study|Withdrawal by Subject|4|||
129986759|NCT01850446|467914010|FG001|Overall Study|Withdrawal by Subject|0|||
129986760|NCT01850446|467914009|FG000|Overall Study|Protocol Violation|0|||
129986761|NCT01850446|467914010|FG001|Overall Study|Protocol Violation|2|||
129986762|NCT00759915|467914011|FG000|Overall Study|Withdrawal by Subject|1|||
129986763|NCT00759915|467914012|FG001|Overall Study|Withdrawal by Subject|0|||
129986764|NCT00759915|467914011|FG000|Overall Study|Adverse Event|0|||
129986765|NCT00759915|467914012|FG001|Overall Study|Adverse Event|1|||
129986766|NCT03730480|467914013|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
129986767|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
129986768|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
129986769|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
129986770|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
129986771|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
129986772|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
129986773|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
129986774|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
129986775|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
129986776|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
129986777|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
129986778|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
129986779|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
129986780|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
129986781|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
129986782|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
129986783|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
129986784|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
129986785|NCT02480153|467914014|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
129986786|NCT02480153|467914015|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
129986787|NCT02480153|467914016|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
129986788|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
129986789|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
129986790|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
129986791|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
129986792|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
129986793|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
129986794|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
129986795|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
129986796|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
129986797|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
129986798|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
129986799|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
129986800|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
129986801|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
129986802|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
129986803|NCT02480153|467914014|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
129986804|NCT02480153|467914015|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
129986805|NCT02480153|467914016|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
129986806|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
129986807|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
129986808|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
129986809|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
129986810|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
129986811|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
129986812|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
129986813|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
129986814|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
129986815|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
129986816|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
129986817|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
129986818|NCT02480153|467914014|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
129986819|NCT02480153|467914015|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
129986820|NCT02480153|467914016|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
129986821|NCT00512317|467914017|FG000|Overall Study|Insufficient clinical response|36|||
129986822|NCT00512317|467914017|FG000|Overall Study|Withdrawal by Subject|23|||
129986823|NCT00512317|467914017|FG000|Overall Study|Sponsor closure of study|21|||
129655343|NCT01810783|466695328|FG000|Overall Study|Protocol Violation|5|||
129986824|NCT00512317|467914017|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
129986825|NCT00512317|467914017|FG000|Overall Study|Adverse Event|13|||
129986826|NCT00512317|467914017|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
129986827|NCT00512317|467914017|FG000|Overall Study|Lost to Follow-up|2|||
129986828|NCT00512317|467914017|FG000|Overall Study|Other|2|||
129986829|NCT01813929|467914018|FG000|Overall Study|Withdrawal by Subject|0|||
129986830|NCT01813929|467914019|FG001|Overall Study|Withdrawal by Subject|1|||
129986831|NCT00007345|467914020|FG000|Overall Study|Refused further treatment|0|||
129986832|NCT00007345|467914021|FG001|Overall Study|Refused further treatment|7|||
129655344|NCT01810783|466695328|FG000|Overall Study|Non-compliance with IMP|4|||
129655345|NCT01810783|466695328|FG000|Overall Study|Adminstrative or other reason(s)|23|||
129655346|NCT01810783|466695328|FG000|Overall Study|Enrolled, not treated|1|||
129655347|NCT02134353|466695329|FG000|Overall Study|Adverse Event|10|||
129655348|NCT02134353|466695330|FG001|Overall Study|Adverse Event|6|||
129655349|NCT02134353|466695329|FG000|Overall Study|Lost to Follow-up|1|||
129655350|NCT02134353|466695330|FG001|Overall Study|Lost to Follow-up|1|||
129655351|NCT02134353|466695329|FG000|Overall Study|Lack of Efficacy|2|||
129655352|NCT02134353|466695330|FG001|Overall Study|Lack of Efficacy|1|||
129655353|NCT02134353|466695329|FG000|Overall Study|Withdrawal by Subject|12|||
129655354|NCT02134353|466695330|FG001|Overall Study|Withdrawal by Subject|13|||
129655355|NCT02134353|466695329|FG000|Overall Study|Death|0|||
129655356|NCT02134353|466695330|FG001|Overall Study|Death|1|||
129655357|NCT02134353|466695329|FG000|Overall Study|Pregnancy|0|||
129655358|NCT02134353|466695330|FG001|Overall Study|Pregnancy|1|||
129655359|NCT02134353|466695329|FG000|Overall Study|Relocation|1|||
129655360|NCT02134353|466695330|FG001|Overall Study|Relocation|0|||
129655361|NCT02134353|466695329|FG000|Overall Study|Other - Patient's Choice|0|||
129655362|NCT02134353|466695330|FG001|Overall Study|Other - Patient's Choice|1|||
129655363|NCT00477607|466695331|FG000|Overall Study|Lost to Follow-up|7|||
129655364|NCT00477607|466695332|FG001|Overall Study|Lost to Follow-up|7|||
129655365|NCT00358956|466695333|FG000|Overall Study|Adverse Event|3|||
129655366|NCT00358956|466695333|FG000|Overall Study|condition under investigation worsened|4|||
129655367|NCT00358956|466695333|FG000|Overall Study|Withdrawal by Subject|1|||
129655368|NCT04776018|466695334|FG000|Overall Study|Death|0|||
129655369|NCT04776018|466695335|FG001|Overall Study|Death|1|||
129655370|NCT04776018|466695336|FG002|Overall Study|Death|4|||
129655371|NCT04776018|466695337|FG003|Overall Study|Death|1|||
129655372|NCT04776018|466695338|FG004|Overall Study|Death|4|||
129655373|NCT04776018|466695339|FG005|Overall Study|Death|0|||
129655374|NCT04776018|466695340|FG006|Overall Study|Death|0|||
129655375|NCT04776018|466695334|FG000|Overall Study|Study terminated by sponsor|2|||
129655376|NCT04776018|466695335|FG001|Overall Study|Study terminated by sponsor|1|||
129655377|NCT04776018|466695336|FG002|Overall Study|Study terminated by sponsor|4|||
129655378|NCT04776018|466695337|FG003|Overall Study|Study terminated by sponsor|0|||
129655379|NCT04776018|466695338|FG004|Overall Study|Study terminated by sponsor|3|||
129883386|NCT01734434|467532411|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
129883387|NCT01734434|467532412|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
129883388|NCT01734434|467532409|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
129883389|NCT01734434|467532410|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
129883390|NCT01734434|467532411|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
129883391|NCT01734434|467532412|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
129883392|NCT01567865|467532417|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
129883393|NCT01567865|467532418|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
129986833|NCT00007345|467914020|FG000|Overall Study|Switched to alternative treatment|0|||
129655380|NCT04776018|466695339|FG005|Overall Study|Study terminated by sponsor|0|||
129655381|NCT04776018|466695340|FG006|Overall Study|Study terminated by sponsor|0|||
129655382|NCT04776018|466695334|FG000|Overall Study|Withdrawal by Subject|1|||
129655383|NCT04776018|466695335|FG001|Overall Study|Withdrawal by Subject|0|||
129655384|NCT04776018|466695336|FG002|Overall Study|Withdrawal by Subject|0|||
129655385|NCT04776018|466695337|FG003|Overall Study|Withdrawal by Subject|2|||
129655386|NCT04776018|466695338|FG004|Overall Study|Withdrawal by Subject|1|||
129655387|NCT04776018|466695339|FG005|Overall Study|Withdrawal by Subject|0|||
129655388|NCT04776018|466695340|FG006|Overall Study|Withdrawal by Subject|0|||
129655389|NCT04776018|466695334|FG000|Overall Study|Other|0|||
129655390|NCT04776018|466695335|FG001|Overall Study|Other|1|||
129655391|NCT04776018|466695336|FG002|Overall Study|Other|1|||
129655392|NCT04776018|466695337|FG003|Overall Study|Other|0|||
129655393|NCT04776018|466695338|FG004|Overall Study|Other|0|||
129655394|NCT04776018|466695339|FG005|Overall Study|Other|0|||
129655395|NCT04776018|466695340|FG006|Overall Study|Other|0|||
129655396|NCT04776018|466695334|FG000|Overall Study|Lost to Follow-up|0|||
129655397|NCT04776018|466695335|FG001|Overall Study|Lost to Follow-up|0|||
129655398|NCT04776018|466695336|FG002|Overall Study|Lost to Follow-up|1|||
129986834|NCT00007345|467914021|FG001|Overall Study|Switched to alternative treatment|3|||
129986835|NCT00007345|467914020|FG000|Overall Study|Intercurrent illness|1|||
129986836|NCT00007345|467914021|FG001|Overall Study|Intercurrent illness|0|||
129986837|NCT00007345|467914020|FG000|Overall Study|Death on study|1|||
129986838|NCT00007345|467914021|FG001|Overall Study|Death on study|1|||
129986839|NCT04433585|467914022|FG000|Overall Study|Withdrawal by Subject|15|||
129986840|NCT04433585|467914023|FG001|Overall Study|Withdrawal by Subject|3|||
129986841|NCT04433585|467914024|FG002|Overall Study|Withdrawal by Subject|15|||
129986842|NCT04433585|467914025|FG003|Overall Study|Withdrawal by Subject|6|||
129986843|NCT04433585|467914022|FG000|Overall Study|Adverse Event|10|||
129986844|NCT04433585|467914023|FG001|Overall Study|Adverse Event|4|||
129986845|NCT04433585|467914024|FG002|Overall Study|Adverse Event|1|||
129986846|NCT04433585|467914025|FG003|Overall Study|Adverse Event|0|||
129986847|NCT04433585|467914022|FG000|Overall Study|Due to the conflict in Ukraine|2|||
129986848|NCT04433585|467914023|FG001|Overall Study|Due to the conflict in Ukraine|1|||
129986849|NCT04433585|467914024|FG002|Overall Study|Due to the conflict in Ukraine|1|||
129986850|NCT04433585|467914025|FG003|Overall Study|Due to the conflict in Ukraine|2|||
129986851|NCT04433585|467914022|FG000|Overall Study|Physician Decision|1|||
129986852|NCT04433585|467914023|FG001|Overall Study|Physician Decision|2|||
129986853|NCT04433585|467914024|FG002|Overall Study|Physician Decision|0|||
129986854|NCT04433585|467914025|FG003|Overall Study|Physician Decision|0|||
129986855|NCT04433585|467914022|FG000|Overall Study|Lost to Follow-up|1|||
129986856|NCT04433585|467914023|FG001|Overall Study|Lost to Follow-up|1|||
129986857|NCT04433585|467914024|FG002|Overall Study|Lost to Follow-up|1|||
129986858|NCT04433585|467914025|FG003|Overall Study|Lost to Follow-up|0|||
129986859|NCT04433585|467914022|FG000|Overall Study|Lack of Efficacy|0|||
129986860|NCT04433585|467914023|FG001|Overall Study|Lack of Efficacy|1|||
129986861|NCT04433585|467914024|FG002|Overall Study|Lack of Efficacy|1|||
129986862|NCT04433585|467914025|FG003|Overall Study|Lack of Efficacy|1|||
129986863|NCT04433585|467914022|FG000|Overall Study|Death|0|||
129986864|NCT04433585|467914023|FG001|Overall Study|Death|1|||
129986865|NCT04433585|467914024|FG002|Overall Study|Death|0|||
129986866|NCT04433585|467914025|FG003|Overall Study|Death|0|||
129986867|NCT02074553|467914026|FG000|Intervention Period 1|Family Emergency|0|||
129986868|NCT02074553|467914027|FG001|Intervention Period 1|Family Emergency|0|||
129986869|NCT02074553|467914028|FG002|Intervention Period 1|Family Emergency|0|||
129986870|NCT02074553|467914029|FG003|Intervention Period 1|Family Emergency|1|||
129986871|NCT02074553|467914030|FG004|Intervention Period 1|Family Emergency|0|||
129986872|NCT02074553|467914031|FG005|Intervention Period 1|Family Emergency|0|||
129986873|NCT02074553|467914032|FG006|Intervention Period 1|Family Emergency|0|||
129986874|NCT02074553|467914033|FG007|Intervention Period 1|Family Emergency|0|||
129986875|NCT02074553|467914026|FG000|Washout Period 1|Adverse Event|1|||
129986876|NCT02074553|467914027|FG001|Washout Period 1|Adverse Event|0|||
129986877|NCT02074553|467914028|FG002|Washout Period 1|Adverse Event|0|||
129986878|NCT02074553|467914029|FG003|Washout Period 1|Adverse Event|0|||
129986879|NCT02074553|467914030|FG004|Washout Period 1|Adverse Event|0|||
129986880|NCT02074553|467914031|FG005|Washout Period 1|Adverse Event|0|||
129986881|NCT02074553|467914032|FG006|Washout Period 1|Adverse Event|0|||
129986882|NCT02074553|467914033|FG007|Washout Period 1|Adverse Event|0|||
129986883|NCT02074553|467914026|FG000|Washout Period 1|Physician Decision|0|||
129986884|NCT02074553|467914027|FG001|Washout Period 1|Physician Decision|0|||
129986885|NCT02074553|467914028|FG002|Washout Period 1|Physician Decision|0|||
129986886|NCT02074553|467914029|FG003|Washout Period 1|Physician Decision|1|||
129986887|NCT02074553|467914030|FG004|Washout Period 1|Physician Decision|0|||
129986888|NCT02074553|467914031|FG005|Washout Period 1|Physician Decision|0|||
129986889|NCT02074553|467914032|FG006|Washout Period 1|Physician Decision|0|||
129986890|NCT02074553|467914033|FG007|Washout Period 1|Physician Decision|0|||
129986891|NCT02074553|467914026|FG000|Washout Period 1|Other|0|||
129986892|NCT02074553|467914027|FG001|Washout Period 1|Other|0|||
129986893|NCT02074553|467914028|FG002|Washout Period 1|Other|0|||
129986894|NCT02074553|467914029|FG003|Washout Period 1|Other|0|||
129545743|NCT00902486|466289833|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
129545744|NCT00902486|466289828|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
129545745|NCT00902486|466289829|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
129545746|NCT00902486|466289830|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
129545747|NCT00902486|466289831|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
129545748|NCT00902486|466289832|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
129545749|NCT00902486|466289833|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
129545750|NCT00902486|466289828|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
129545751|NCT00902486|466289829|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
129986895|NCT02074553|467914030|FG004|Washout Period 1|Other|0|||
129986896|NCT02074553|467914031|FG005|Washout Period 1|Other|1|||
129986897|NCT02074553|467914032|FG006|Washout Period 1|Other|0|||
129986898|NCT02074553|467914033|FG007|Washout Period 1|Other|0|||
129986899|NCT02074553|467914026|FG000|Washout Period 2|Adverse Event|0|||
129986900|NCT02074553|467914027|FG001|Washout Period 2|Adverse Event|0|||
129986901|NCT02074553|467914028|FG002|Washout Period 2|Adverse Event|0|||
129655399|NCT04776018|466695337|FG003|Overall Study|Lost to Follow-up|0|||
129655400|NCT04776018|466695338|FG004|Overall Study|Lost to Follow-up|0|||
129655401|NCT04776018|466695339|FG005|Overall Study|Lost to Follow-up|0|||
129655402|NCT04776018|466695340|FG006|Overall Study|Lost to Follow-up|0|||
129655403|NCT02908074|466695341|FG000|Overall Study|sponsor/ICON decision|0|||
129655404|NCT02908074|466695342|FG001|Overall Study|sponsor/ICON decision|0|||
129655405|NCT02908074|466695343|FG002|Overall Study|sponsor/ICON decision|1|||
129655406|NCT02908074|466695344|FG003|Overall Study|sponsor/ICON decision|0|||
129655407|NCT02908074|466695345|FG004|Overall Study|sponsor/ICON decision|0|||
129655408|NCT02908074|466695346|FG005|Overall Study|sponsor/ICON decision|0|||
129655409|NCT02908074|466695341|FG000|Overall Study|Protocol Violation|0|||
129655410|NCT02908074|466695342|FG001|Overall Study|Protocol Violation|1|||
129655411|NCT02908074|466695343|FG002|Overall Study|Protocol Violation|0|||
129655412|NCT02908074|466695344|FG003|Overall Study|Protocol Violation|0|||
129655413|NCT02908074|466695345|FG004|Overall Study|Protocol Violation|0|||
129655414|NCT02908074|466695346|FG005|Overall Study|Protocol Violation|0|||
129655415|NCT02908074|466695341|FG000|Overall Study|Adverse Event|5|||
129655416|NCT02908074|466695342|FG001|Overall Study|Adverse Event|2|||
129655417|NCT02908074|466695343|FG002|Overall Study|Adverse Event|0|||
129655418|NCT02908074|466695344|FG003|Overall Study|Adverse Event|0|||
129655419|NCT02908074|466695345|FG004|Overall Study|Adverse Event|1|||
129655420|NCT02908074|466695346|FG005|Overall Study|Adverse Event|0|||
129655421|NCT02908074|466695341|FG000|Overall Study|AESI|1|||
129655422|NCT02908074|466695342|FG001|Overall Study|AESI|0|||
129655423|NCT02908074|466695343|FG002|Overall Study|AESI|1|||
129655424|NCT02908074|466695344|FG003|Overall Study|AESI|0|||
129655425|NCT02908074|466695345|FG004|Overall Study|AESI|1|||
129655426|NCT02908074|466695346|FG005|Overall Study|AESI|0|||
129655427|NCT02908074|466695341|FG000|Overall Study|Discontinuation criteria per protocol|0|||
129655428|NCT02908074|466695342|FG001|Overall Study|Discontinuation criteria per protocol|0|||
129655429|NCT02908074|466695343|FG002|Overall Study|Discontinuation criteria per protocol|1|||
129655430|NCT02908074|466695344|FG003|Overall Study|Discontinuation criteria per protocol|0|||
129655431|NCT02908074|466695345|FG004|Overall Study|Discontinuation criteria per protocol|0|||
129655432|NCT02908074|466695346|FG005|Overall Study|Discontinuation criteria per protocol|1|||
129655433|NCT02908074|466695341|FG000|Overall Study|Withdrawal by Subject|3|||
129655434|NCT02908074|466695342|FG001|Overall Study|Withdrawal by Subject|2|||
129655435|NCT02908074|466695343|FG002|Overall Study|Withdrawal by Subject|2|||
129986902|NCT02074553|467914029|FG003|Washout Period 2|Adverse Event|0|||
129986903|NCT02074553|467914030|FG004|Washout Period 2|Adverse Event|0|||
129986904|NCT02074553|467914031|FG005|Washout Period 2|Adverse Event|0|||
129986905|NCT02074553|467914032|FG006|Washout Period 2|Adverse Event|1|||
129986906|NCT02074553|467914033|FG007|Washout Period 2|Adverse Event|0|||
129986907|NCT02074553|467914026|FG000|Washout Period 2|Physician Decision|0|||
129986908|NCT02074553|467914027|FG001|Washout Period 2|Physician Decision|0|||
129986909|NCT02074553|467914028|FG002|Washout Period 2|Physician Decision|0|||
129986910|NCT02074553|467914029|FG003|Washout Period 2|Physician Decision|0|||
129986911|NCT02074553|467914030|FG004|Washout Period 2|Physician Decision|0|||
129986912|NCT02074553|467914031|FG005|Washout Period 2|Physician Decision|1|||
129986913|NCT02074553|467914032|FG006|Washout Period 2|Physician Decision|0|||
129986914|NCT02074553|467914033|FG007|Washout Period 2|Physician Decision|0|||
129986915|NCT02074553|467914026|FG000|Washout Period 2|Lost to Follow-up|0|||
129986916|NCT02074553|467914027|FG001|Washout Period 2|Lost to Follow-up|0|||
129986917|NCT02074553|467914028|FG002|Washout Period 2|Lost to Follow-up|1|||
129986918|NCT02074553|467914029|FG003|Washout Period 2|Lost to Follow-up|0|||
129986919|NCT02074553|467914030|FG004|Washout Period 2|Lost to Follow-up|0|||
129986920|NCT02074553|467914031|FG005|Washout Period 2|Lost to Follow-up|0|||
129986921|NCT02074553|467914032|FG006|Washout Period 2|Lost to Follow-up|0|||
129986922|NCT02074553|467914033|FG007|Washout Period 2|Lost to Follow-up|0|||
129986923|NCT02074553|467914026|FG000|Washout Period 3|Physician Decision|0|||
129986924|NCT02074553|467914027|FG001|Washout Period 3|Physician Decision|0|||
129986925|NCT02074553|467914028|FG002|Washout Period 3|Physician Decision|0|||
129986926|NCT02074553|467914029|FG003|Washout Period 3|Physician Decision|0|||
129986927|NCT02074553|467914030|FG004|Washout Period 3|Physician Decision|0|||
129986928|NCT02074553|467914031|FG005|Washout Period 3|Physician Decision|0|||
129986929|NCT02074553|467914032|FG006|Washout Period 3|Physician Decision|0|||
129986930|NCT02074553|467914033|FG007|Washout Period 3|Physician Decision|1|||
129986931|NCT01658150|467914034|FG000|Overall Study|Withdrawal by Subject|1|||
129986932|NCT02342743|467914035|FG000|Baseline Period|Withdrawal by Subject|3|||
129655436|NCT02908074|466695344|FG003|Overall Study|Withdrawal by Subject|2|||
129655437|NCT02908074|466695345|FG004|Overall Study|Withdrawal by Subject|2|||
129655438|NCT02908074|466695346|FG005|Overall Study|Withdrawal by Subject|2|||
129655439|NCT02908074|466695341|FG000|Overall Study|Lost to Follow-up|0|||
129655440|NCT02908074|466695342|FG001|Overall Study|Lost to Follow-up|1|||
129655441|NCT02908074|466695343|FG002|Overall Study|Lost to Follow-up|1|||
129655442|NCT02908074|466695344|FG003|Overall Study|Lost to Follow-up|1|||
129655443|NCT02908074|466695345|FG004|Overall Study|Lost to Follow-up|0|||
129986933|NCT02342743|467914035|FG000|Baseline Period|Lost to Follow-up|2|||
129986934|NCT02342743|467914035|FG000|Baseline Period|Change in prophylactic medication|3|||
129986935|NCT02342743|467914035|FG000|Baseline Period|Screening failure regarding baseline|7|||
129986936|NCT02342743|467914035|FG000|Treatment Period|Withdrawal by Subject|2|||
129986937|NCT02342743|467914035|FG000|Treatment Period|Lost to Follow-up|8|||
129986938|NCT02342743|467914035|FG000|Treatment Period|Change in prophylactic medication|1|||
129986939|NCT04875676|467914036|FG000|Overall Study|Lost to Follow-up|1|||
129986940|NCT04875676|467914037|FG001|Overall Study|Lost to Follow-up|0|||
129986941|NCT04875676|467914038|FG002|Overall Study|Lost to Follow-up|0|||
129986942|NCT04187989|467914039|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
129986943|NCT04187989|467914040|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
129986944|NCT04187989|467914039|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
129986945|NCT04187989|467914040|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
129986946|NCT03646656|467914041|FG000|Overall Study|Lost to Follow-up|1|||
129986947|NCT03646656|467914042|FG001|Overall Study|Lost to Follow-up|0|||
129986948|NCT03646656|467914041|FG000|Overall Study|Withdrawal by Subject|2|||
129986949|NCT03646656|467914042|FG001|Overall Study|Withdrawal by Subject|0|||
129986950|NCT03602066|467914043|FG000|Overall Study|Withdrawal by Subject|2|||
129986951|NCT03602066|467914044|FG001|Overall Study|Withdrawal by Subject|0|||
129986952|NCT03602066|467914043|FG000|Overall Study|Physician Decision|1|||
129986953|NCT03602066|467914044|FG001|Overall Study|Physician Decision|0|||
129986954|NCT00092495|467914045|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
129986955|NCT00092495|467914046|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
129986956|NCT00092495|467914047|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129986957|NCT00092495|467914048|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
129986958|NCT00092495|467914049|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129986959|NCT00092495|467914045|FG000|Base Study Vaccination Period|Extended|0|||
129986960|NCT00092495|467914046|FG001|Base Study Vaccination Period|Extended|0|||
129986961|NCT00092495|467914047|FG002|Base Study Vaccination Period|Extended|0|||
129986962|NCT00092495|467914048|FG003|Base Study Vaccination Period|Extended|1|||
129986963|NCT00092495|467914049|FG004|Base Study Vaccination Period|Extended|0|||
129986964|NCT00092495|467914045|FG000|Base Study Vaccination Period|*Clinical AE|1|||
129986965|NCT00092495|467914046|FG001|Base Study Vaccination Period|*Clinical AE|0|||
129986966|NCT00092495|467914047|FG002|Base Study Vaccination Period|*Clinical AE|1|||
129986967|NCT00092495|467914048|FG003|Base Study Vaccination Period|*Clinical AE|2|||
129986968|NCT00092495|467914049|FG004|Base Study Vaccination Period|*Clinical AE|0|||
129986969|NCT00092495|467914045|FG000|Base Study Vaccination Period|*Other reasons|1|||
129986970|NCT00092495|467914046|FG001|Base Study Vaccination Period|*Other reasons|0|||
129986971|NCT00092495|467914047|FG002|Base Study Vaccination Period|*Other reasons|0|||
129986972|NCT00092495|467914048|FG003|Base Study Vaccination Period|*Other reasons|1|||
129986973|NCT00092495|467914049|FG004|Base Study Vaccination Period|*Other reasons|0|||
129986974|NCT00092495|467914045|FG000|Base Study Vaccination Period|*Pregnancy|0|||
129986975|NCT00092495|467914046|FG001|Base Study Vaccination Period|*Pregnancy|2|||
129986976|NCT00092495|467914047|FG002|Base Study Vaccination Period|*Pregnancy|5|||
129986977|NCT00092495|467914048|FG003|Base Study Vaccination Period|*Pregnancy|7|||
129986978|NCT00092495|467914049|FG004|Base Study Vaccination Period|*Pregnancy|0|||
129986979|NCT00092495|467914045|FG000|Base Study Vaccination Period|Adverse Event|1|||
129986980|NCT00092495|467914046|FG001|Base Study Vaccination Period|Adverse Event|0|||
129986981|NCT00092495|467914047|FG002|Base Study Vaccination Period|Adverse Event|0|||
129986982|NCT00092495|467914048|FG003|Base Study Vaccination Period|Adverse Event|3|||
129986983|NCT00092495|467914049|FG004|Base Study Vaccination Period|Adverse Event|0|||
129986984|NCT00092495|467914045|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
129986985|NCT00092495|467914046|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
129986986|NCT00092495|467914047|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
129986987|NCT00092495|467914048|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
129986988|NCT00092495|467914049|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129986989|NCT00092495|467914045|FG000|Base Study Vaccination Period|Moved|3|||
129986990|NCT00092495|467914046|FG001|Base Study Vaccination Period|Moved|1|||
129986991|NCT00092495|467914047|FG002|Base Study Vaccination Period|Moved|2|||
129986992|NCT00092495|467914048|FG003|Base Study Vaccination Period|Moved|2|||
129986993|NCT00092495|467914049|FG004|Base Study Vaccination Period|Moved|0|||
129986994|NCT00092495|467914045|FG000|Base Study Vaccination Period|Other|1|||
129986995|NCT00092495|467914046|FG001|Base Study Vaccination Period|Other|1|||
129986996|NCT00092495|467914047|FG002|Base Study Vaccination Period|Other|0|||
129986997|NCT00092495|467914048|FG003|Base Study Vaccination Period|Other|2|||
129986998|NCT00092495|467914049|FG004|Base Study Vaccination Period|Other|0|||
129986999|NCT00092495|467914045|FG000|Base Study Vaccination Period|Pregnancy|2|||
129987000|NCT00092495|467914046|FG001|Base Study Vaccination Period|Pregnancy|0|||
129987001|NCT00092495|467914047|FG002|Base Study Vaccination Period|Pregnancy|0|||
129987002|NCT00092495|467914048|FG003|Base Study Vaccination Period|Pregnancy|0|||
129987003|NCT00092495|467914049|FG004|Base Study Vaccination Period|Pregnancy|0|||
129987004|NCT00092495|467914045|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
129987005|NCT00092495|467914046|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
129987006|NCT00092495|467914047|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
129987007|NCT00092495|467914048|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
129987008|NCT00092495|467914049|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
129987009|NCT00092495|467914045|FG000|Base Study Vaccination Period|Protocol Violation|1|||
129987010|NCT00092495|467914046|FG001|Base Study Vaccination Period|Protocol Violation|0|||
129987011|NCT00092495|467914047|FG002|Base Study Vaccination Period|Protocol Violation|0|||
129987012|NCT00092495|467914048|FG003|Base Study Vaccination Period|Protocol Violation|0|||
129987013|NCT00092495|467914049|FG004|Base Study Vaccination Period|Protocol Violation|0|||
129987014|NCT00092495|467914045|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
129987015|NCT00092495|467914046|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
129987016|NCT00092495|467914047|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
129987017|NCT00092495|467914048|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
129987018|NCT00092495|467914049|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129987019|NCT00092495|467914045|FG000|Base Study Follow-up Period|Extended|0|||
129987020|NCT00092495|467914046|FG001|Base Study Follow-up Period|Extended|0|||
129987021|NCT00092495|467914047|FG002|Base Study Follow-up Period|Extended|1|||
129987022|NCT00092495|467914048|FG003|Base Study Follow-up Period|Extended|2|||
129987023|NCT00092495|467914049|FG004|Base Study Follow-up Period|Extended|0|||
129987024|NCT00092495|467914045|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
129987025|NCT00092495|467914046|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
129987026|NCT00092495|467914047|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
129987027|NCT00092495|467914048|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
129987028|NCT00092495|467914049|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
129987029|NCT00092495|467914045|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
129987030|NCT00092495|467914046|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987031|NCT00092495|467914047|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987032|NCT00092495|467914048|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987033|NCT00092495|467914049|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
129987034|NCT00938470|467914056|FG000|Overall Study|Disease Progression|3|||
129987035|NCT00938470|467914057|FG001|Overall Study|Disease Progression|0|||
129987036|NCT00938470|467914056|FG000|Overall Study|Alternate Treatment|1|||
129987037|NCT00938470|467914057|FG001|Overall Study|Alternate Treatment|0|||
129987038|NCT00938470|467914056|FG000|Overall Study|Death|3|||
129987039|NCT00938470|467914057|FG001|Overall Study|Death|2|||
129987040|NCT00938470|467914056|FG000|Overall Study|Other Reason|0|||
129987041|NCT00938470|467914057|FG001|Overall Study|Other Reason|1|||
129987042|NCT01621568|467914059|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
129987043|NCT01621568|467914060|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
129987044|NCT01621568|467914059|FG000|Week 5-6 No Treatment|Death|1|||
129987045|NCT01621568|467914060|FG001|Week 5-6 No Treatment|Death|0|||
129987046|NCT02334423|467914061|FG000|Overall Study|Protocol Violation|10|||
129987047|NCT02334423|467914062|FG001|Overall Study|Protocol Violation|3|||
129987048|NCT02930226|467914063|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987049|NCT02930226|467914064|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987050|NCT02930226|467914065|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987051|NCT02930226|467914066|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987052|NCT02930226|467914067|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
129987053|NCT02930226|467914068|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
129987054|NCT00652327|467914069|FG000|Overall Study|Adverse Event|0|||
129987055|NCT00652327|467914070|FG001|Overall Study|Adverse Event|2|||
129987056|NCT00652327|467914069|FG000|Overall Study|Lost to Follow-up|0|||
129987057|NCT00652327|467914070|FG001|Overall Study|Lost to Follow-up|3|||
129987058|NCT01076647|467914071|FG000|Overall Study|Adverse Event|4|||
129987059|NCT01076647|467914072|FG001|Overall Study|Adverse Event|1|||
129987060|NCT01076647|467914071|FG000|Overall Study|Lack of Efficacy|0|||
129987061|NCT01076647|467914072|FG001|Overall Study|Lack of Efficacy|1|||
129987062|NCT01076647|467914071|FG000|Overall Study|Protocol Violation|7|||
129987063|NCT01076647|467914072|FG001|Overall Study|Protocol Violation|9|||
129987064|NCT01076647|467914071|FG000|Overall Study|Withdrawal criteria|2|||
129987065|NCT01076647|467914072|FG001|Overall Study|Withdrawal criteria|2|||
129987066|NCT01076647|467914071|FG000|Overall Study|Unclassified|12|||
129987067|NCT01076647|467914072|FG001|Overall Study|Unclassified|12|||
129987068|NCT00564889|467914078|FG000|Overall Study|Death|7|||
129987069|NCT00564889|467914078|FG000|Overall Study|Adverse Event|12|||
129987070|NCT00564889|467914078|FG000|Overall Study|Alternative treatment|3|||
129987071|NCT00564889|467914078|FG000|Overall Study|Disease progression|3|||
129987072|NCT00564889|467914078|FG000|Overall Study|Other, not specified|4|||
129987073|NCT03500159|467914079|FG000|Overall Study|Study Terminated|2|||
129987074|NCT03500159|467914080|FG001|Overall Study|Study Terminated|1|||
129987075|NCT02292927|467914085|FG000|Overall Study|Protocol Violation|13|||
129987076|NCT02292927|467914086|FG001|Overall Study|Protocol Violation|7|||
129987077|NCT00141219|467914090|FG000|Overall Study|Protocol violations|5|||
129655444|NCT02908074|466695346|FG005|Overall Study|Lost to Follow-up|1|||
129987078|NCT00141219|467914091|FG001|Overall Study|Protocol violations|4|||
129987079|NCT00141219|467914090|FG000|Overall Study|Adverse Event|8|||
129987080|NCT00141219|467914091|FG001|Overall Study|Adverse Event|6|||
129987081|NCT00141219|467914090|FG000|Overall Study|Lack of Efficacy|5|||
129987082|NCT00141219|467914091|FG001|Overall Study|Lack of Efficacy|4|||
129987083|NCT00141219|467914090|FG000|Overall Study|Withdrawal by Subject|6|||
129987084|NCT00141219|467914091|FG001|Overall Study|Withdrawal by Subject|2|||
129987085|NCT02224690|467914092|FG000|Overall Study|Adverse Event|8|||
129987086|NCT02224690|467914093|FG001|Overall Study|Adverse Event|1|||
129987087|NCT02224690|467914092|FG000|Overall Study|Met Withdrawal Criteria|4|||
129987088|NCT02224690|467914093|FG001|Overall Study|Met Withdrawal Criteria|0|||
129987089|NCT02224690|467914092|FG000|Overall Study|Use of G-tube|1|||
129987090|NCT02224690|467914093|FG001|Overall Study|Use of G-tube|0|||
129987091|NCT02224690|467914092|FG000|Overall Study|Did not meet eligibility criteria|1|||
129987092|NCT02224690|467914093|FG001|Overall Study|Did not meet eligibility criteria|0|||
129987093|NCT00122460|467914095|FG000|Overall Study|investigational study phase ongoing|7|||
129987094|NCT00122460|467914096|FG001|Overall Study|investigational study phase ongoing|1|||
129987095|NCT02595073|467914097|FG000|Overall Study|Progressive Disease|0|||
129987096|NCT02595073|467914098|FG001|Overall Study|Progressive Disease|1|||
129987097|NCT02595073|467914097|FG000|Overall Study|Protocol Violation|2|||
129987098|NCT02595073|467914098|FG001|Overall Study|Protocol Violation|0|||
129987099|NCT02962960|467914099|FG000|Overall Study|Withdrawal by Subject|1|||
129987100|NCT02962960|467914100|FG001|Overall Study|Withdrawal by Subject|1|||
129987101|NCT02962960|467914101|FG002|Overall Study|Withdrawal by Subject|0|||
129987102|NCT02962960|467914099|FG000|Overall Study|Adverse Event|1|||
129987103|NCT02962960|467914100|FG001|Overall Study|Adverse Event|1|||
129987104|NCT02962960|467914101|FG002|Overall Study|Adverse Event|0|||
129987105|NCT02962960|467914099|FG000|Overall Study|Protocol Violation|1|||
129987106|NCT02962960|467914100|FG001|Overall Study|Protocol Violation|0|||
129987107|NCT02962960|467914101|FG002|Overall Study|Protocol Violation|0|||
129987108|NCT02424734|467914102|FG000|Overall Study|Treatment stopped to be discharged home|2|||
129987109|NCT02424734|467914103|FG001|Overall Study|Treatment stopped to be discharged home|2|||
129987110|NCT02424734|467914104|FG002|Overall Study|Treatment stopped to be discharged home|0|||
129987111|NCT00752557|467914105|FG000|Overall Study|Withdrawal by Subject|4|||
129987112|NCT00752557|467914106|FG001|Overall Study|Withdrawal by Subject|3|||
129987113|NCT00752557|467914107|FG002|Overall Study|Withdrawal by Subject|3|||
129987114|NCT00752557|467914105|FG000|Overall Study|Unspecified resaons|0|||
129987115|NCT00752557|467914106|FG001|Overall Study|Unspecified resaons|2|||
129987116|NCT00752557|467914107|FG002|Overall Study|Unspecified resaons|2|||
129987117|NCT00752557|467914105|FG000|Overall Study|Lost to Follow-up|1|||
129987118|NCT00752557|467914106|FG001|Overall Study|Lost to Follow-up|0|||
129987119|NCT00752557|467914107|FG002|Overall Study|Lost to Follow-up|1|||
129987120|NCT00470366|467914108|FG000|Overall Study|Adverse Event|3|||
129987121|NCT00470366|467914108|FG000|Overall Study|Poor compliance|1|||
129987122|NCT02996474|467914109|FG000|Overall Study|Physician Decision|5|||
129987123|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
129987124|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
129987125|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
129987126|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
129987127|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
129987128|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
129987129|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
129987130|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
129987131|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
129987132|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
129987133|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
129987134|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
129987135|NCT04493502|467914110|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
129987136|NCT04493502|467914111|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
129987137|NCT04493502|467914110|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
129987138|NCT04493502|467914111|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
129987139|NCT04493502|467914110|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
129987140|NCT04493502|467914111|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
129987141|NCT04493502|467914110|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
129987142|NCT04493502|467914111|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
129987143|NCT04493502|467914110|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
129987144|NCT04493502|467914111|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
129987145|NCT04493502|467914110|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
129987146|NCT04493502|467914111|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
129987147|NCT04493502|467914110|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
129987148|NCT04493502|467914111|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
129987149|NCT00540046|467914112|FG000|Overall Study|Lost to Follow-up|33|||
129987150|NCT00540046|467914113|FG001|Overall Study|Lost to Follow-up|23|||
129987151|NCT02891837|467914114|FG000|Overall Study|Lost to Follow-up|2|||
129987152|NCT02891837|467914115|FG001|Overall Study|Lost to Follow-up|0|||
129987153|NCT02891837|467914114|FG000|Overall Study|Withdrawal by Subject|1|||
129987154|NCT02891837|467914115|FG001|Overall Study|Withdrawal by Subject|0|||
129987155|NCT01021215|467914123|FG000|Overall Study|Lost to Follow-up|3|||
129987156|NCT01021215|467914124|FG001|Overall Study|Lost to Follow-up|0|||
129987157|NCT02751320|467914125|FG000|Overall Study|Adverse Event|2|||
129987158|NCT02751320|467914125|FG000|Overall Study|Withdrawal by Subject|1|||
129987159|NCT02549196|467914126|FG000|Overall Study|Protocol Violation|0|||
129987160|NCT02549196|467914127|FG001|Overall Study|Protocol Violation|0|||
129987161|NCT02549196|467914128|FG002|Overall Study|Protocol Violation|0|||
129987162|NCT02549196|467914129|FG003|Overall Study|Protocol Violation|1|||
129987163|NCT02549196|467914126|FG000|Overall Study|Withdrawal by Subject|1|||
129987164|NCT02549196|467914127|FG001|Overall Study|Withdrawal by Subject|0|||
129987165|NCT02549196|467914128|FG002|Overall Study|Withdrawal by Subject|1|||
129987166|NCT02549196|467914129|FG003|Overall Study|Withdrawal by Subject|0|||
129987167|NCT00185965|467914132|FG000|Overall Study|Adverse Event|0|||
129987168|NCT00185965|467914133|FG001|Overall Study|Adverse Event|1|||
129987169|NCT01103362|467914134|FG000|Overall Study|study terminated|596|||
129987170|NCT02533531|467914135|FG000|Overall Study|Device did not turn on|1|||
129987171|NCT02047903|467914136|FG000|Overall Study|Adverse Event|14|||
129987172|NCT02047903|467914136|FG000|Overall Study|Serious adverse event|10|||
129987173|NCT02047903|467914136|FG000|Overall Study|Withdrawal by Subject|16|||
129987174|NCT02047903|467914136|FG000|Overall Study|Lost to Follow-up|4|||
129987175|NCT02047903|467914136|FG000|Overall Study|Reason not listed|6|||
129987176|NCT02047903|467914136|FG000|Overall Study|Not Treated|9|||
129987177|NCT01011387|467914143|FG000|Overall Study|Withdrawal by Subject|3|||
129987178|NCT01011387|467914143|FG000|Overall Study|Adverse Event|2|||
129987179|NCT01011387|467914143|FG000|Overall Study|Protocol Violation|1|||
129987180|NCT01226095|467914144|FG000|Overall Study|Poor compliance|1|||
129987181|NCT02665338|467914146|FG000|Overall Study|Withdrawal by Subject|0|||
129987182|NCT02665338|467914147|FG001|Overall Study|Withdrawal by Subject|1|||
129987183|NCT05326815|467914151|FG000|Overall Study|Withdrawal by Subject|3|||
129987184|NCT05326815|467914151|FG000|Overall Study|Did not complete required labs|6|||
129987185|NCT05326815|467914151|FG000|Overall Study|Screen fail- abnormal labs|5|||
129987186|NCT03562975|467914152|FG000|Overall Study|Death|1|||
129987187|NCT03562975|467914152|FG000|Overall Study|Lost to Follow-up|1|||
129987188|NCT03562975|467914152|FG000|Overall Study|Withdrawal by Subject|1|||
129987189|NCT02545933|467914153|FG000|Overall Study|Adverse Event|3|||
129987190|NCT02545933|467914154|FG001|Overall Study|Adverse Event|0|||
129987191|NCT02545933|467914155|FG002|Overall Study|Adverse Event|0|||
129987192|NCT02545933|467914153|FG000|Overall Study|Withdrawal by Subject|2|||
129987193|NCT02545933|467914154|FG001|Overall Study|Withdrawal by Subject|3|||
129987194|NCT02545933|467914155|FG002|Overall Study|Withdrawal by Subject|3|||
129987195|NCT02545933|467914153|FG000|Overall Study|Protocol Violation|1|||
129987196|NCT02545933|467914154|FG001|Overall Study|Protocol Violation|0|||
129987197|NCT02545933|467914155|FG002|Overall Study|Protocol Violation|1|||
129987198|NCT00935818|467914158|FG000|Overall Study|Withdrawal by Subject|45|||
129987199|NCT00935818|467914159|FG001|Overall Study|Withdrawal by Subject|50|||
129987200|NCT00935818|467914158|FG000|Overall Study|Lost to Follow-up|40|||
129987201|NCT00935818|467914159|FG001|Overall Study|Lost to Follow-up|42|||
129987202|NCT00935818|467914158|FG000|Overall Study|Adverse Event|6|||
129987203|NCT00935818|467914159|FG001|Overall Study|Adverse Event|7|||
129987204|NCT00935818|467914158|FG000|Overall Study|Physician Decision|0|||
129987205|NCT00935818|467914159|FG001|Overall Study|Physician Decision|1|||
129987206|NCT00979134|467914160|FG000|Overall Study|Disease progression|18|||
129987207|NCT00979134|467914161|FG001|Overall Study|Disease progression|2|||
129987208|NCT00979134|467914162|FG002|Overall Study|Disease progression|5|||
129987209|NCT00979134|467914160|FG000|Overall Study|Adverse Event|0|||
129987210|NCT00979134|467914161|FG001|Overall Study|Adverse Event|0|||
129987211|NCT00979134|467914162|FG002|Overall Study|Adverse Event|2|||
129987212|NCT00979134|467914160|FG000|Overall Study|Withdrawal by Subject|1|||
129987213|NCT00979134|467914161|FG001|Overall Study|Withdrawal by Subject|1|||
129987214|NCT00979134|467914162|FG002|Overall Study|Withdrawal by Subject|2|||
129987215|NCT00979134|467914160|FG000|Overall Study|Lost to Follow-up|2|||
129987216|NCT00979134|467914161|FG001|Overall Study|Lost to Follow-up|2|||
129987217|NCT00979134|467914162|FG002|Overall Study|Lost to Follow-up|0|||
129987218|NCT00979134|467914160|FG000|Overall Study|Death|4|||
129987219|NCT00979134|467914161|FG001|Overall Study|Death|0|||
129987220|NCT00979134|467914162|FG002|Overall Study|Death|26|||
129987221|NCT00979134|467914160|FG000|Overall Study|Other|8|||
129987222|NCT00979134|467914161|FG001|Overall Study|Other|1|||
129987223|NCT00979134|467914162|FG002|Overall Study|Other|5|||
129987224|NCT01076192|467916797|FG000|Overall Study|Other|197|||
129987225|NCT01034176|467916798|FG000|Overall Study|Physician Decision|2|||
129987226|NCT01034176|467916799|FG001|Overall Study|Physician Decision|0|||
129987227|NCT01034176|467916798|FG000|Overall Study|Withdrawal by Subject|0|||
129987228|NCT01034176|467916799|FG001|Overall Study|Withdrawal by Subject|1|||
129987229|NCT01034176|467916798|FG000|Overall Study|Lost to Follow-up|0|||
129987230|NCT01034176|467916799|FG001|Overall Study|Lost to Follow-up|1|||
129987231|NCT00107120|467916803|FG000|Overall Study|Adverse Event|4|||
129987232|NCT00107120|467916804|FG001|Overall Study|Adverse Event|1|||
129987233|NCT00107120|467916803|FG000|Overall Study|Lack of Efficacy|5|||
129987234|NCT00107120|467916804|FG001|Overall Study|Lack of Efficacy|5|||
129987235|NCT00107120|467916803|FG000|Overall Study|Protocol Violation|3|||
129987236|NCT00107120|467916804|FG001|Overall Study|Protocol Violation|0|||
129987237|NCT00107120|467916803|FG000|Overall Study|Withdrawal by Subject|8|||
129987238|NCT00107120|467916804|FG001|Overall Study|Withdrawal by Subject|9|||
129987239|NCT00107120|467916803|FG000|Overall Study|Lost to Follow-up|8|||
129987240|NCT00107120|467916804|FG001|Overall Study|Lost to Follow-up|6|||
129987241|NCT00107120|467916803|FG000|Overall Study|Pregnancy|0|||
129987242|NCT00107120|467916804|FG001|Overall Study|Pregnancy|1|||
129987243|NCT00107120|467916803|FG000|Overall Study|moving away from site|1|||
129987244|NCT00107120|467916804|FG001|Overall Study|moving away from site|1|||
129987245|NCT00107120|467916803|FG000|Overall Study|death of parent|0|||
129987246|NCT00107120|467916804|FG001|Overall Study|death of parent|1|||
129987247|NCT01635920|467916805|FG000|Overall Study|Adverse Event|1|||
129987248|NCT01635920|467916806|FG001|Overall Study|Adverse Event|0|||
129987249|NCT01635920|467916805|FG000|Overall Study|Lost to Follow-up|0|||
129987250|NCT01635920|467916806|FG001|Overall Study|Lost to Follow-up|1|||
129987251|NCT01635920|467916805|FG000|Overall Study|Subject decision|2|||
129987252|NCT01635920|467916806|FG001|Overall Study|Subject decision|0|||
129987253|NCT00194987|467916807|FG000|Overall Study|Withdrawal by Subject|0|||
129987254|NCT00194987|467916808|FG001|Overall Study|Withdrawal by Subject|3|||
129987255|NCT01664598|467916809|FG000|Overall Study|Sponsor Decision|1|||
129987256|NCT01664598|467916809|FG000|Overall Study|Withdrawal of Informed Consent|4|||
129987257|NCT01664598|467916809|FG000|Overall Study|Adverse Event|1|||
129987258|NCT00686725|467916810|FG000|Overall Study|Adverse Event|1|||
129987259|NCT00686725|467916811|FG001|Overall Study|Adverse Event|1|||
129987260|NCT00686725|467916810|FG000|Overall Study|Progressive Disease|17|||
129987261|NCT00686725|467916811|FG001|Overall Study|Progressive Disease|23|||
129987262|NCT00686725|467916810|FG000|Overall Study|Lost to Follow-up|7|||
129987263|NCT00686725|467916811|FG001|Overall Study|Lost to Follow-up|5|||
129987264|NCT00686725|467916810|FG000|Overall Study|Death|6|||
129987265|NCT00686725|467916811|FG001|Overall Study|Death|3|||
129987266|NCT00686725|467916810|FG000|Overall Study|Withdrawal by Subject|13|||
129987267|NCT00686725|467916811|FG001|Overall Study|Withdrawal by Subject|4|||
129987268|NCT00686725|467916810|FG000|Overall Study|Protocol Violation|1|||
129987269|NCT00686725|467916811|FG001|Overall Study|Protocol Violation|3|||
129987270|NCT00686725|467916810|FG000|Overall Study|Other|1|||
129987271|NCT00686725|467916811|FG001|Overall Study|Other|3|||
129987272|NCT02630693|467916815|FG000|Overall Study|No receive treatment|0|||
129987273|NCT02630693|467916816|FG001|Overall Study|No receive treatment|1|||
129987274|NCT01639560|467916817|FG000|Overall Study|Withdrawal by Subject|9|||
129987275|NCT01639560|467916818|FG001|Overall Study|Withdrawal by Subject|14|||
129987276|NCT01639560|467916817|FG000|Overall Study|Lack of Efficacy|1|||
129987277|NCT01639560|467916818|FG001|Overall Study|Lack of Efficacy|2|||
129987278|NCT01639560|467916817|FG000|Overall Study|Lost to Follow-up|9|||
129987279|NCT01639560|467916818|FG001|Overall Study|Lost to Follow-up|11|||
129987280|NCT01639560|467916817|FG000|Overall Study|Adverse Event|0|||
129987281|NCT01639560|467916818|FG001|Overall Study|Adverse Event|2|||
129987282|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
129987283|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987284|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987285|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987286|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987287|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
129987288|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
129987289|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987290|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987291|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987292|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987293|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
129987294|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
129987295|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987296|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987297|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987298|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987299|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
129987300|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
129987301|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987302|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987303|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987304|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987305|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
129987306|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
129987307|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987308|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987309|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987310|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987311|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
129987312|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
129987313|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987314|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987315|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987316|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987317|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
129987318|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
129987319|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987320|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987321|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987322|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987323|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
129987324|NCT01160289|467916819|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
129987325|NCT01160289|467916820|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987326|NCT01160289|467916821|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987327|NCT01160289|467916822|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987328|NCT01160289|467916823|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987329|NCT01160289|467916824|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
129987330|NCT01160289|467916819|FG000|Post-Randomization Period|Adverse Event|0|||
129987331|NCT01160289|467916820|FG001|Post-Randomization Period|Adverse Event|4|||
129987332|NCT01160289|467916821|FG002|Post-Randomization Period|Adverse Event|4|||
129987333|NCT01160289|467916822|FG003|Post-Randomization Period|Adverse Event|2|||
129987334|NCT01160289|467916823|FG004|Post-Randomization Period|Adverse Event|0|||
129987335|NCT01160289|467916824|FG005|Post-Randomization Period|Adverse Event|0|||
129987336|NCT01160289|467916819|FG000|Post-Randomization Period|Death|0|||
129987337|NCT01160289|467916820|FG001|Post-Randomization Period|Death|0|||
129987338|NCT01160289|467916821|FG002|Post-Randomization Period|Death|0|||
129987339|NCT01160289|467916822|FG003|Post-Randomization Period|Death|1|||
129987340|NCT01160289|467916823|FG004|Post-Randomization Period|Death|0|||
129987341|NCT01160289|467916824|FG005|Post-Randomization Period|Death|0|||
129987342|NCT01160289|467916819|FG000|Post-Randomization Period|Lack of Efficacy|0|||
129987343|NCT01160289|467916820|FG001|Post-Randomization Period|Lack of Efficacy|1|||
129987344|NCT01160289|467916821|FG002|Post-Randomization Period|Lack of Efficacy|0|||
129987345|NCT01160289|467916822|FG003|Post-Randomization Period|Lack of Efficacy|3|||
129987346|NCT01160289|467916823|FG004|Post-Randomization Period|Lack of Efficacy|0|||
129987347|NCT01160289|467916824|FG005|Post-Randomization Period|Lack of Efficacy|0|||
129987348|NCT01160289|467916819|FG000|Post-Randomization Period|Lost to Follow-up|0|||
129987349|NCT01160289|467916820|FG001|Post-Randomization Period|Lost to Follow-up|3|||
129987350|NCT01160289|467916821|FG002|Post-Randomization Period|Lost to Follow-up|2|||
129987351|NCT01160289|467916822|FG003|Post-Randomization Period|Lost to Follow-up|5|||
129987352|NCT01160289|467916823|FG004|Post-Randomization Period|Lost to Follow-up|3|||
129987353|NCT01160289|467916824|FG005|Post-Randomization Period|Lost to Follow-up|4|||
129987354|NCT01160289|467916819|FG000|Post-Randomization Period|Physician Decision|0|||
129987355|NCT01160289|467916820|FG001|Post-Randomization Period|Physician Decision|0|||
129987356|NCT01160289|467916821|FG002|Post-Randomization Period|Physician Decision|1|||
129987357|NCT01160289|467916822|FG003|Post-Randomization Period|Physician Decision|0|||
129987358|NCT01160289|467916823|FG004|Post-Randomization Period|Physician Decision|0|||
129987359|NCT01160289|467916824|FG005|Post-Randomization Period|Physician Decision|0|||
129987360|NCT01160289|467916819|FG000|Post-Randomization Period|Protocol Violation|0|||
129987361|NCT01160289|467916820|FG001|Post-Randomization Period|Protocol Violation|4|||
129987362|NCT01160289|467916821|FG002|Post-Randomization Period|Protocol Violation|2|||
129987363|NCT01160289|467916822|FG003|Post-Randomization Period|Protocol Violation|0|||
129987364|NCT01160289|467916823|FG004|Post-Randomization Period|Protocol Violation|1|||
129987365|NCT01160289|467916824|FG005|Post-Randomization Period|Protocol Violation|3|||
129987366|NCT01160289|467916819|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
129987367|NCT01160289|467916820|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
129987368|NCT01160289|467916821|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
129987369|NCT01160289|467916822|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
129987370|NCT01160289|467916823|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
129987371|NCT01160289|467916824|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
129987372|NCT01160289|467916819|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
129655445|NCT01900431|466695353|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
129655446|NCT01900431|466695354|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
129655447|NCT01900431|466695355|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
129655448|NCT01900431|466695353|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
129655449|NCT01900431|466695354|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
129655450|NCT01900431|466695355|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
129655451|NCT01900431|466695353|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
129987373|NCT01160289|467916820|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
129987374|NCT01160289|467916821|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
129987375|NCT01160289|467916822|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
129987376|NCT01160289|467916823|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
129987377|NCT01160289|467916824|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
129987378|NCT01160289|467916819|FG000|Post-Randomization Period|Sponsor Decision|0|||
129987379|NCT01160289|467916820|FG001|Post-Randomization Period|Sponsor Decision|1|||
129987380|NCT01160289|467916821|FG002|Post-Randomization Period|Sponsor Decision|0|||
129987381|NCT01160289|467916822|FG003|Post-Randomization Period|Sponsor Decision|0|||
129987382|NCT01160289|467916823|FG004|Post-Randomization Period|Sponsor Decision|0|||
129987383|NCT01160289|467916824|FG005|Post-Randomization Period|Sponsor Decision|0|||
129987384|NCT01156792|467916826|FG000|Overall Study|Adverse Event|1|||
129987385|NCT01156792|467916826|FG000|Overall Study|Lack of Efficacy|36|||
129987386|NCT01156792|467916826|FG000|Overall Study|Protocol Violation|6|||
129987387|NCT01156792|467916826|FG000|Overall Study|Lost to Follow-up|3|||
129987388|NCT01156792|467916826|FG000|Overall Study|Physician Decision|3|||
129987389|NCT01156792|467916826|FG000|Overall Study|Withdrawal by Subject|9|||
129987390|NCT01156792|467916826|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
129987391|NCT01474434|467916827|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
129987392|NCT01474434|467916828|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
129987393|NCT01474434|467916829|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
129987394|NCT01474434|467916830|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
129987395|NCT01474434|467916827|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
129987396|NCT01474434|467916828|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
129987397|NCT01474434|467916829|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
129987398|NCT01474434|467916830|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
129987399|NCT01474434|467916827|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
129987400|NCT01474434|467916828|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
129987401|NCT01474434|467916829|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
129987402|NCT01474434|467916830|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
129987403|NCT00993668|467916831|FG000|Single-Blind Period|Adverse Event|1|||
129987404|NCT00993668|467916832|FG001|Single-Blind Period|Adverse Event|1|||
129987405|NCT00993668|467916831|FG000|Single-Blind Period|Lack of Efficacy|0|||
129987406|NCT00993668|467916832|FG001|Single-Blind Period|Lack of Efficacy|1|||
129987407|NCT00993668|467916831|FG000|Single-Blind Period|Lost to Follow-up|3|||
129987408|NCT00993668|467916832|FG001|Single-Blind Period|Lost to Follow-up|1|||
129987409|NCT00993668|467916831|FG000|Open-Label Period|Adverse Event|9|||
129987410|NCT00993668|467916832|FG001|Open-Label Period|Adverse Event|8|||
129987411|NCT00993668|467916831|FG000|Open-Label Period|Lack of Efficacy|4|||
129987412|NCT00993668|467916832|FG001|Open-Label Period|Lack of Efficacy|3|||
129987413|NCT00993668|467916831|FG000|Open-Label Period|Withdrawal by Subject|4|||
129987414|NCT00993668|467916832|FG001|Open-Label Period|Withdrawal by Subject|3|||
129987415|NCT00993668|467916831|FG000|Open-Label Period|Lost to Follow-up|6|||
129987416|NCT00993668|467916832|FG001|Open-Label Period|Lost to Follow-up|1|||
129987417|NCT03606668|467916835|FG000|Overall Study|Screen Failure|1|||
129987418|NCT03606668|467916835|FG000|Overall Study|Lost to Follow-up|1|||
129987419|NCT02057523|467916839|FG000|Overall Study|Withdrawal by Subject|1|||
129987420|NCT02057523|467916839|FG000|Overall Study|Lack of Efficacy|1|||
129987421|NCT02399254|467916843|FG000|Overall Study|Physician Decision|2|||
129987422|NCT01656733|467916844|FG000|Overall Study|No permission to collect birth outcomes|0|||
129987423|NCT01656733|467916845|FG001|Overall Study|No permission to collect birth outcomes|1|||
129987424|NCT01656733|467916844|FG000|Overall Study|Delivery at another hospital|0|||
129987425|NCT01656733|467916845|FG001|Overall Study|Delivery at another hospital|2|||
129987426|NCT01656733|467916844|FG000|Overall Study|Spontaneous abortion|0|||
129987427|NCT01656733|467916845|FG001|Overall Study|Spontaneous abortion|1|||
129987428|NCT00682890|467916849|FG000|Overall Study|Lost to Follow-up|1|||
129987429|NCT00682890|467916850|FG001|Overall Study|Lost to Follow-up|1|||
129987430|NCT00682890|467916849|FG000|Overall Study|subject moved away|0|||
129987431|NCT00682890|467916850|FG001|Overall Study|subject moved away|1|||
129987432|NCT00682890|467916849|FG000|Overall Study|heavy menstrual bleeding|1|||
129987433|NCT00682890|467916850|FG001|Overall Study|heavy menstrual bleeding|0|||
129987434|NCT03545503|467916851|FG000|Overall Study|Protocol Violation|14|||
129987435|NCT03545503|467916852|FG001|Overall Study|Protocol Violation|16|||
129987436|NCT01506609|467916855|FG000|Overall Study|Adverse Event Related to Progression|0|||
129987437|NCT01506609|467916856|FG001|Overall Study|Adverse Event Related to Progression|0|||
129987438|NCT01506609|467916857|FG002|Overall Study|Adverse Event Related to Progression|0|||
129987439|NCT01506609|467916858|FG003|Overall Study|Adverse Event Related to Progression|3|||
129987440|NCT01506609|467916859|FG004|Overall Study|Adverse Event Related to Progression|7|||
129987441|NCT01506609|467916860|FG005|Overall Study|Adverse Event Related to Progression|3|||
129987442|NCT01506609|467916855|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
129655452|NCT01900431|466695354|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
129655453|NCT01900431|466695355|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
129655454|NCT01900431|466695353|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
129655455|NCT01900431|466695354|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
129655456|NCT01900431|466695355|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
129655457|NCT01900431|466695353|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
129655458|NCT01900431|466695354|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
129655459|NCT01900431|466695355|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
129655460|NCT01900431|466695353|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
129655461|NCT01900431|466695354|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
129655462|NCT01900431|466695355|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
129655463|NCT01900431|466695353|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
129655464|NCT01900431|466695354|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
129655465|NCT01900431|466695355|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
129655466|NCT01900431|466695353|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
129655467|NCT01900431|466695354|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
129655468|NCT01900431|466695355|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
129655469|NCT01900431|466695353|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
129655470|NCT01900431|466695354|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
129655471|NCT01900431|466695355|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
129655472|NCT03172364|466695356|FG000|Overall Study|Adverse Event|1|||
129655473|NCT03172364|466695357|FG001|Overall Study|Adverse Event|1|||
129655474|NCT03172364|466695356|FG000|Overall Study|Protocol Violation|1|||
129655475|NCT03172364|466695357|FG001|Overall Study|Protocol Violation|0|||
129655476|NCT03755518|466695358|FG000|Overall Study|Lack of Efficacy|10|||
129655477|NCT03755518|466695358|FG000|Overall Study|Adverse Event|7|||
129655478|NCT03755518|466695358|FG000|Overall Study|Study Terminated by Sponsor|5|||
129655479|NCT03755518|466695358|FG000|Overall Study|Death|1|||
129655480|NCT03755518|466695358|FG000|Overall Study|Withdrawal by Subject|3|||
129655481|NCT03755518|466695358|FG000|Overall Study|Progressive Disease|4|||
129655482|NCT03755518|466695358|FG000|Overall Study|Bone Marrow Transplant|4|||
129655483|NCT03755518|466695358|FG000|Overall Study|Physicians Decision|1|||
129655484|NCT03755518|466695358|FG000|Overall Study|Relapse|1|||
129655485|NCT03755518|466695358|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
129655486|NCT03755518|466695358|FG000|Overall Study|Withdrawal by PI|1|||
129655487|NCT02732327|466695359|FG000|Overall Study|Protocol Violation|0|||
129655488|NCT02732327|466695360|FG001|Overall Study|Protocol Violation|1|||
129655489|NCT04503668|466695361|FG000|Overall Study|Incomplete data|4|||
129655490|NCT04503668|466695362|FG001|Overall Study|Incomplete data|3|||
129655491|NCT04503668|466695361|FG000|Overall Study|Withdrawal by Subject|1|||
129655492|NCT04503668|466695362|FG001|Overall Study|Withdrawal by Subject|1|||
129655493|NCT04503668|466695361|FG000|Overall Study|Adverse Event|2|||
129655494|NCT04503668|466695362|FG001|Overall Study|Adverse Event|0|||
129655495|NCT00603382|466695363|FG000|Overall Study|Adverse Event|0|||
129655496|NCT00603382|466695364|FG001|Overall Study|Adverse Event|1|||
129655497|NCT00603382|466695365|FG002|Overall Study|Adverse Event|1|||
129655498|NCT00603382|466695366|FG003|Overall Study|Adverse Event|2|||
129655499|NCT00603382|466695367|FG004|Overall Study|Adverse Event|1|||
129655500|NCT00603382|466695368|FG005|Overall Study|Adverse Event|2|||
129655501|NCT00603382|466695363|FG000|Overall Study|Lack of Efficacy|14|||
129655502|NCT00603382|466695364|FG001|Overall Study|Lack of Efficacy|9|||
129655503|NCT00603382|466695365|FG002|Overall Study|Lack of Efficacy|3|||
129987443|NCT01506609|467916856|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
129987444|NCT01506609|467916857|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
129987445|NCT01506609|467916858|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
129655504|NCT00603382|466695366|FG003|Overall Study|Lack of Efficacy|6|||
129655505|NCT00603382|466695367|FG004|Overall Study|Lack of Efficacy|6|||
129655506|NCT00603382|466695368|FG005|Overall Study|Lack of Efficacy|11|||
129655507|NCT00603382|466695363|FG000|Overall Study|Protocol Violation|1|||
129655508|NCT00603382|466695364|FG001|Overall Study|Protocol Violation|0|||
129655509|NCT00603382|466695365|FG002|Overall Study|Protocol Violation|1|||
129655510|NCT00603382|466695366|FG003|Overall Study|Protocol Violation|2|||
129987446|NCT01506609|467916859|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
129987447|NCT01506609|467916860|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
129987448|NCT01506609|467916855|FG000|Overall Study|Withdrawal by Subject|0|||
129655511|NCT00603382|466695367|FG004|Overall Study|Protocol Violation|1|||
129987449|NCT01506609|467916856|FG001|Overall Study|Withdrawal by Subject|0|||
129655512|NCT00603382|466695368|FG005|Overall Study|Protocol Violation|0|||
129987450|NCT01506609|467916857|FG002|Overall Study|Withdrawal by Subject|0|||
129987451|NCT01506609|467916858|FG003|Overall Study|Withdrawal by Subject|9|||
129987452|NCT01506609|467916859|FG004|Overall Study|Withdrawal by Subject|7|||
129987453|NCT01506609|467916860|FG005|Overall Study|Withdrawal by Subject|7|||
129987454|NCT01506609|467916855|FG000|Overall Study|Lost to Follow-up|0|||
129987455|NCT01506609|467916856|FG001|Overall Study|Lost to Follow-up|0|||
129987456|NCT01506609|467916857|FG002|Overall Study|Lost to Follow-up|0|||
129987457|NCT01506609|467916858|FG003|Overall Study|Lost to Follow-up|1|||
129987458|NCT01506609|467916859|FG004|Overall Study|Lost to Follow-up|2|||
129987459|NCT01506609|467916860|FG005|Overall Study|Lost to Follow-up|0|||
129987460|NCT01506609|467916855|FG000|Overall Study|Sponsor Discontinued Study|0|||
129987461|NCT01506609|467916856|FG001|Overall Study|Sponsor Discontinued Study|0|||
129987462|NCT01506609|467916857|FG002|Overall Study|Sponsor Discontinued Study|0|||
129987463|NCT01506609|467916858|FG003|Overall Study|Sponsor Discontinued Study|2|||
129987464|NCT01506609|467916859|FG004|Overall Study|Sponsor Discontinued Study|2|||
129987465|NCT01506609|467916860|FG005|Overall Study|Sponsor Discontinued Study|0|||
129987466|NCT01506609|467916855|FG000|Overall Study|Progressive Disease per Protocol|1|||
129987467|NCT01506609|467916856|FG001|Overall Study|Progressive Disease per Protocol|0|||
129987468|NCT01506609|467916857|FG002|Overall Study|Progressive Disease per Protocol|0|||
129987469|NCT01506609|467916858|FG003|Overall Study|Progressive Disease per Protocol|64|||
129987470|NCT01506609|467916859|FG004|Overall Study|Progressive Disease per Protocol|57|||
129987471|NCT01506609|467916860|FG005|Overall Study|Progressive Disease per Protocol|74|||
129987472|NCT01506609|467916855|FG000|Overall Study|Other, Not Specified|0|||
129987473|NCT01506609|467916856|FG001|Overall Study|Other, Not Specified|0|||
129987474|NCT01506609|467916857|FG002|Overall Study|Other, Not Specified|0|||
129987475|NCT01506609|467916858|FG003|Overall Study|Other, Not Specified|10|||
129987476|NCT01506609|467916859|FG004|Overall Study|Other, Not Specified|7|||
129987477|NCT01506609|467916860|FG005|Overall Study|Other, Not Specified|3|||
129987478|NCT01506609|467916855|FG000|Overall Study|Missing / Unknown Reason|1|||
129987479|NCT01506609|467916856|FG001|Overall Study|Missing / Unknown Reason|0|||
129987480|NCT01506609|467916857|FG002|Overall Study|Missing / Unknown Reason|1|||
129987481|NCT01506609|467916858|FG003|Overall Study|Missing / Unknown Reason|4|||
129987482|NCT01506609|467916859|FG004|Overall Study|Missing / Unknown Reason|4|||
129987483|NCT01506609|467916860|FG005|Overall Study|Missing / Unknown Reason|2|||
129987484|NCT01605019|467916861|FG000|Overall Study|pt did not meet transplant endpoint|3|||
129987485|NCT01605019|467916862|FG001|Overall Study|pt did not meet transplant endpoint|0|||
129987486|NCT00862719|467916863|FG000|Overall Study|Disease Progression|5|||
129987487|NCT00862719|467916864|FG001|Overall Study|Disease Progression|0|||
129987488|NCT00862719|467916865|FG002|Overall Study|Disease Progression|1|||
129987489|NCT00862719|467916866|FG003|Overall Study|Disease Progression|0|||
129987490|NCT00862719|467916863|FG000|Overall Study|Death|5|||
129987491|NCT00862719|467916864|FG001|Overall Study|Death|6|||
129987492|NCT00862719|467916865|FG002|Overall Study|Death|1|||
129987493|NCT00862719|467916866|FG003|Overall Study|Death|1|||
129987494|NCT00862719|467916863|FG000|Overall Study|Engraftment failure|0|||
129987495|NCT00862719|467916864|FG001|Overall Study|Engraftment failure|0|||
129987496|NCT00862719|467916865|FG002|Overall Study|Engraftment failure|1|||
129987497|NCT00862719|467916866|FG003|Overall Study|Engraftment failure|0|||
129987498|NCT00862719|467916863|FG000|Overall Study|Veno-Occlusive Disease|0|||
129987499|NCT00862719|467916864|FG001|Overall Study|Veno-Occlusive Disease|0|||
129987500|NCT00862719|467916865|FG002|Overall Study|Veno-Occlusive Disease|1|||
129987501|NCT00862719|467916866|FG003|Overall Study|Veno-Occlusive Disease|0|||
129987502|NCT00324116|467916867|FG000|Overall Study|Adverse Event|5|||
129987503|NCT00324116|467916867|FG000|Overall Study|Lack of Efficacy|17|||
129987504|NCT00324116|467916867|FG000|Overall Study|Withdrawal by Subject|5|||
129987505|NCT00324116|467916867|FG000|Overall Study|Other|5|||
129987506|NCT01737827|467916868|FG000|Overall Study|Adverse Event|3|||
129987507|NCT01737827|467916869|FG001|Overall Study|Adverse Event|6|||
129987508|NCT01737827|467916870|FG002|Overall Study|Adverse Event|0|||
129987509|NCT01737827|467916868|FG000|Overall Study|Lost to Follow-up|0|||
129987510|NCT01737827|467916869|FG001|Overall Study|Lost to Follow-up|1|||
129987511|NCT01737827|467916870|FG002|Overall Study|Lost to Follow-up|0|||
129987512|NCT01737827|467916868|FG000|Overall Study|Physician Decision|0|||
129987513|NCT01737827|467916869|FG001|Overall Study|Physician Decision|2|||
129987514|NCT01737827|467916870|FG002|Overall Study|Physician Decision|0|||
129987515|NCT01737827|467916868|FG000|Overall Study|Progressive Disease|5|||
129987516|NCT01737827|467916869|FG001|Overall Study|Progressive Disease|16|||
129987517|NCT01737827|467916870|FG002|Overall Study|Progressive Disease|2|||
129987518|NCT01737827|467916868|FG000|Overall Study|Study Terminated by Sponsor|0|||
129987519|NCT01737827|467916869|FG001|Overall Study|Study Terminated by Sponsor|1|||
129987520|NCT01737827|467916870|FG002|Overall Study|Study Terminated by Sponsor|0|||
129987521|NCT01737827|467916868|FG000|Overall Study|Subject/Guardian Decision|0|||
129987522|NCT01737827|467916869|FG001|Overall Study|Subject/Guardian Decision|2|||
129987523|NCT01737827|467916870|FG002|Overall Study|Subject/Guardian Decision|0|||
129987524|NCT01451827|467916871|FG000|Overall Study|Adverse Event|2|||
129987525|NCT01451827|467916872|FG001|Overall Study|Adverse Event|0|||
129987526|NCT01451827|467916873|FG002|Overall Study|Adverse Event|1|||
129987527|NCT01451827|467916874|FG003|Overall Study|Adverse Event|1|||
129987528|NCT01451827|467916871|FG000|Overall Study|Protocol deviation|1|||
129987529|NCT01451827|467916872|FG001|Overall Study|Protocol deviation|0|||
129987530|NCT01451827|467916873|FG002|Overall Study|Protocol deviation|0|||
129987531|NCT01451827|467916874|FG003|Overall Study|Protocol deviation|0|||
129987532|NCT01451827|467916871|FG000|Overall Study|Lost to Follow-up|0|||
129987533|NCT01451827|467916872|FG001|Overall Study|Lost to Follow-up|3|||
129987534|NCT01451827|467916873|FG002|Overall Study|Lost to Follow-up|0|||
129987535|NCT01451827|467916874|FG003|Overall Study|Lost to Follow-up|2|||
129987536|NCT01451827|467916871|FG000|Overall Study|Participant met withdrawal criteria|0|||
129987537|NCT01451827|467916872|FG001|Overall Study|Participant met withdrawal criteria|2|||
129987538|NCT01451827|467916873|FG002|Overall Study|Participant met withdrawal criteria|0|||
129987539|NCT01451827|467916874|FG003|Overall Study|Participant met withdrawal criteria|0|||
129987540|NCT01451827|467916871|FG000|Overall Study|Withdrawal by Subject|0|||
129987541|NCT01451827|467916872|FG001|Overall Study|Withdrawal by Subject|0|||
129987542|NCT01451827|467916873|FG002|Overall Study|Withdrawal by Subject|1|||
129987543|NCT01451827|467916874|FG003|Overall Study|Withdrawal by Subject|1|||
129987544|NCT02971761|467916875|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
129987545|NCT00116753|467916876|FG000|Overall Study|Adverse Event|16|||
129987546|NCT00116753|467916877|FG001|Overall Study|Adverse Event|10|||
129987547|NCT00116753|467916878|FG002|Overall Study|Adverse Event|7|||
129987548|NCT00116753|467916876|FG000|Overall Study|Withdrawal by Subject|11|||
129987549|NCT00116753|467916877|FG001|Overall Study|Withdrawal by Subject|12|||
129987550|NCT00116753|467916878|FG002|Overall Study|Withdrawal by Subject|8|||
129987551|NCT00116753|467916876|FG000|Overall Study|Lost to Follow-up|0|||
129987552|NCT00116753|467916877|FG001|Overall Study|Lost to Follow-up|2|||
129987553|NCT00116753|467916878|FG002|Overall Study|Lost to Follow-up|1|||
129987554|NCT00116753|467916876|FG000|Overall Study|Protocol Violation|0|||
129987555|NCT00116753|467916877|FG001|Overall Study|Protocol Violation|0|||
129987556|NCT00116753|467916878|FG002|Overall Study|Protocol Violation|1|||
129987557|NCT00116753|467916876|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
129987558|NCT00116753|467916877|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
129987559|NCT00116753|467916878|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
129987560|NCT00116753|467916876|FG000|Overall Study|Disease Progression|3|||
129987561|NCT00116753|467916877|FG001|Overall Study|Disease Progression|4|||
129987562|NCT00116753|467916878|FG002|Overall Study|Disease Progression|3|||
129987563|NCT00116753|467916876|FG000|Overall Study|Abnormal Echocardiogram|0|||
129987564|NCT00116753|467916877|FG001|Overall Study|Abnormal Echocardiogram|0|||
129987565|NCT00116753|467916878|FG002|Overall Study|Abnormal Echocardiogram|1|||
129987566|NCT00116753|467916876|FG000|Overall Study|Progressive Parkinson's Disease|1|||
129987567|NCT00116753|467916877|FG001|Overall Study|Progressive Parkinson's Disease|0|||
129987568|NCT00116753|467916878|FG002|Overall Study|Progressive Parkinson's Disease|0|||
129987569|NCT00116753|467916876|FG000|Overall Study|Dosing Error|0|||
129987570|NCT00116753|467916877|FG001|Overall Study|Dosing Error|1|||
129987571|NCT00116753|467916878|FG002|Overall Study|Dosing Error|0|||
129987572|NCT01642251|467916879|FG000|Overall Study|Progressive disease|0|||
129987573|NCT01642251|467916880|FG001|Overall Study|Progressive disease|0|||
129987574|NCT01642251|467916881|FG002|Overall Study|Progressive disease|3|||
129987575|NCT01642251|467916882|FG003|Overall Study|Progressive disease|3|||
129987576|NCT01642251|467916879|FG000|Overall Study|Adverse Event|0|||
129987577|NCT01642251|467916880|FG001|Overall Study|Adverse Event|0|||
129987578|NCT01642251|467916881|FG002|Overall Study|Adverse Event|5|||
129987579|NCT01642251|467916882|FG003|Overall Study|Adverse Event|4|||
129987580|NCT01642251|467916879|FG000|Overall Study|Death|0|||
129987581|NCT01642251|467916880|FG001|Overall Study|Death|0|||
129987582|NCT01642251|467916881|FG002|Overall Study|Death|1|||
129987583|NCT01642251|467916882|FG003|Overall Study|Death|3|||
129987584|NCT01642251|467916879|FG000|Overall Study|Withdrawal by Subject|0|||
129987585|NCT01642251|467916880|FG001|Overall Study|Withdrawal by Subject|0|||
129987586|NCT01642251|467916881|FG002|Overall Study|Withdrawal by Subject|1|||
129987587|NCT01642251|467916882|FG003|Overall Study|Withdrawal by Subject|3|||
129987588|NCT01642251|467916879|FG000|Overall Study|Alternative therapy|0|||
129987589|NCT01642251|467916880|FG001|Overall Study|Alternative therapy|0|||
129987590|NCT01642251|467916881|FG002|Overall Study|Alternative therapy|0|||
129987591|NCT01642251|467916882|FG003|Overall Study|Alternative therapy|2|||
129987592|NCT01642251|467916879|FG000|Overall Study|Other complicating disease|0|||
129987593|NCT01642251|467916880|FG001|Overall Study|Other complicating disease|0|||
129987594|NCT01642251|467916881|FG002|Overall Study|Other complicating disease|1|||
129987595|NCT01642251|467916882|FG003|Overall Study|Other complicating disease|0|||
129987596|NCT01642251|467916879|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
129987597|NCT01642251|467916880|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
129987598|NCT01642251|467916881|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
129987599|NCT01642251|467916882|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
129987600|NCT01445301|467916883|FG000|Overall Study|Adverse Event|15|||
129987601|NCT01445301|467916884|FG001|Overall Study|Adverse Event|25|||
129987602|NCT01445301|467916885|FG002|Overall Study|Adverse Event|4|||
129987603|NCT01445301|467916883|FG000|Overall Study|Lack of Efficacy|0|||
129655513|NCT00603382|466695363|FG000|Overall Study|Lost to Follow-up|0|||
129655514|NCT00603382|466695364|FG001|Overall Study|Lost to Follow-up|1|||
129655515|NCT00603382|466695365|FG002|Overall Study|Lost to Follow-up|1|||
129655516|NCT00603382|466695366|FG003|Overall Study|Lost to Follow-up|1|||
129655517|NCT00603382|466695367|FG004|Overall Study|Lost to Follow-up|0|||
129655518|NCT00603382|466695368|FG005|Overall Study|Lost to Follow-up|1|||
129655519|NCT00603382|466695363|FG000|Overall Study|Physician Decision|0|||
129655520|NCT00603382|466695364|FG001|Overall Study|Physician Decision|0|||
129987604|NCT01445301|467916884|FG001|Overall Study|Lack of Efficacy|1|||
129987605|NCT01445301|467916885|FG002|Overall Study|Lack of Efficacy|0|||
129987606|NCT01445301|467916883|FG000|Overall Study|Protocol Violation|1|||
129987607|NCT01445301|467916884|FG001|Overall Study|Protocol Violation|0|||
129987608|NCT01445301|467916885|FG002|Overall Study|Protocol Violation|0|||
129987609|NCT01445301|467916883|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
129987610|NCT01445301|467916884|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
129987611|NCT01445301|467916885|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
129987612|NCT01445301|467916883|FG000|Overall Study|Physician Decision|0|||
129987613|NCT01445301|467916884|FG001|Overall Study|Physician Decision|2|||
129987614|NCT01445301|467916885|FG002|Overall Study|Physician Decision|0|||
129987615|NCT01445301|467916883|FG000|Overall Study|Withdrawal by Subject|5|||
129987616|NCT01445301|467916884|FG001|Overall Study|Withdrawal by Subject|6|||
129987617|NCT01445301|467916885|FG002|Overall Study|Withdrawal by Subject|4|||
129987618|NCT01605916|467916890|FG000|Overall Study|Adverse Event|1|||
129987619|NCT01605916|467916891|FG001|Overall Study|Adverse Event|0|||
129987620|NCT01605916|467916892|FG002|Overall Study|Adverse Event|0|||
129987621|NCT01605916|467916893|FG003|Overall Study|Adverse Event|1|||
129987622|NCT01605916|467916894|FG004|Overall Study|Adverse Event|0|||
129987623|NCT01605916|467916890|FG000|Overall Study|Lack of Efficacy|2|||
129987624|NCT01605916|467916891|FG001|Overall Study|Lack of Efficacy|3|||
129987625|NCT01605916|467916892|FG002|Overall Study|Lack of Efficacy|3|||
129987626|NCT01605916|467916893|FG003|Overall Study|Lack of Efficacy|5|||
129987627|NCT01605916|467916894|FG004|Overall Study|Lack of Efficacy|4|||
129987628|NCT01605916|467916890|FG000|Overall Study|Withdrawal by Subject|1|||
129987629|NCT01605916|467916891|FG001|Overall Study|Withdrawal by Subject|1|||
129987630|NCT01605916|467916892|FG002|Overall Study|Withdrawal by Subject|0|||
129987631|NCT01605916|467916893|FG003|Overall Study|Withdrawal by Subject|0|||
129987632|NCT01605916|467916894|FG004|Overall Study|Withdrawal by Subject|2|||
129987633|NCT00296400|467916897|FG000|Overall Study|Adverse Event|7|||
129987634|NCT00296400|467916898|FG001|Overall Study|Adverse Event|7|||
129987635|NCT00296400|467916899|FG002|Overall Study|Adverse Event|7|||
129987636|NCT00296400|467916897|FG000|Overall Study|Withdrawal by Subject|5|||
129987637|NCT00296400|467916898|FG001|Overall Study|Withdrawal by Subject|6|||
129987638|NCT00296400|467916899|FG002|Overall Study|Withdrawal by Subject|2|||
129987639|NCT00296400|467916897|FG000|Overall Study|Incorrect enrollment|2|||
129987640|NCT00296400|467916898|FG001|Overall Study|Incorrect enrollment|0|||
129987641|NCT00296400|467916899|FG002|Overall Study|Incorrect enrollment|0|||
129987642|NCT00296400|467916897|FG000|Overall Study|Protocol Violation|1|||
129987643|NCT00296400|467916898|FG001|Overall Study|Protocol Violation|1|||
129987644|NCT00296400|467916899|FG002|Overall Study|Protocol Violation|1|||
129987645|NCT00296400|467916897|FG000|Overall Study|Lost to Follow-up|1|||
129987646|NCT00296400|467916898|FG001|Overall Study|Lost to Follow-up|1|||
129987647|NCT00296400|467916899|FG002|Overall Study|Lost to Follow-up|2|||
129987648|NCT00296400|467916897|FG000|Overall Study|Study specific discontinuation criteria|0|||
129987649|NCT00296400|467916898|FG001|Overall Study|Study specific discontinuation criteria|0|||
129987650|NCT00296400|467916899|FG002|Overall Study|Study specific discontinuation criteria|1|||
129987651|NCT00296400|467916897|FG000|Overall Study|Visit 10 was performed earlier|0|||
129987652|NCT00296400|467916898|FG001|Overall Study|Visit 10 was performed earlier|1|||
129987653|NCT00296400|467916899|FG002|Overall Study|Visit 10 was performed earlier|0|||
129987654|NCT00296400|467916897|FG000|Overall Study|Pregnancy|1|||
129655521|NCT00603382|466695365|FG002|Overall Study|Physician Decision|2|||
129655522|NCT00603382|466695366|FG003|Overall Study|Physician Decision|0|||
129655523|NCT00603382|466695367|FG004|Overall Study|Physician Decision|1|||
129987655|NCT00296400|467916898|FG001|Overall Study|Pregnancy|2|||
129987656|NCT00296400|467916899|FG002|Overall Study|Pregnancy|0|||
129655524|NCT00603382|466695368|FG005|Overall Study|Physician Decision|3|||
129987657|NCT01014533|467916900|FG000|Overall Study|Protocol Violation|3|||
129655525|NCT00603382|466695363|FG000|Overall Study|Withdrawal by Subject|3|||
129987658|NCT01014533|467916901|FG001|Overall Study|Protocol Violation|2|||
129987659|NCT01014533|467916900|FG000|Overall Study|Withdrawal by Subject|2|||
129987660|NCT01014533|467916901|FG001|Overall Study|Withdrawal by Subject|0|||
129987661|NCT01014533|467916900|FG000|Overall Study|unable to come to appointment|0|||
129987662|NCT01014533|467916901|FG001|Overall Study|unable to come to appointment|3|||
129987663|NCT00412061|467916903|FG000|Double Blind Phase|Disease Progression|101|||
129987664|NCT00412061|467916904|FG001|Double Blind Phase|Disease Progression|154|||
129987665|NCT00412061|467916903|FG000|Double Blind Phase|Adverse Event|61|||
129987666|NCT00412061|467916904|FG001|Double Blind Phase|Adverse Event|16|||
129655526|NCT00603382|466695364|FG001|Overall Study|Withdrawal by Subject|3|||
129987667|NCT00412061|467916903|FG000|Double Blind Phase|Final Primary Analysis|26|||
129987668|NCT00412061|467916904|FG001|Double Blind Phase|Final Primary Analysis|14|||
129987669|NCT00412061|467916903|FG000|Double Blind Phase|Withdrawal by Subject|18|||
129987670|NCT00412061|467916904|FG001|Double Blind Phase|Withdrawal by Subject|20|||
129987671|NCT00412061|467916903|FG000|Double Blind Phase|Death|6|||
129987672|NCT00412061|467916904|FG001|Double Blind Phase|Death|3|||
129987673|NCT00412061|467916903|FG000|Double Blind Phase|Protocol Violation|3|||
129987674|NCT00412061|467916904|FG001|Double Blind Phase|Protocol Violation|4|||
129987675|NCT00412061|467916903|FG000|Double Blind Phase|New Cander Therapy|1|||
129987676|NCT00412061|467916904|FG001|Double Blind Phase|New Cander Therapy|1|||
129987677|NCT00412061|467916903|FG000|Double Blind Phase|Lost to Follow-up|0|||
129987678|NCT00412061|467916904|FG001|Double Blind Phase|Lost to Follow-up|1|||
129987679|NCT00412061|467916903|FG000|Open Label Phase|Disease Progression|0|||
129987680|NCT00412061|467916904|FG001|Open Label Phase|Disease Progression|86|||
129987681|NCT00412061|467916903|FG000|Open Label Phase|Adverse Event|0|||
129987682|NCT00412061|467916904|FG001|Open Label Phase|Adverse Event|46|||
129987683|NCT00412061|467916903|FG000|Open Label Phase|Withdrawal by Subject|0|||
129987684|NCT00412061|467916904|FG001|Open Label Phase|Withdrawal by Subject|15|||
129987685|NCT00412061|467916903|FG000|Open Label Phase|Administrative Problems|0|||
129987686|NCT00412061|467916904|FG001|Open Label Phase|Administrative Problems|13|||
129987687|NCT00412061|467916903|FG000|Open Label Phase|Death|0|||
129987688|NCT00412061|467916904|FG001|Open Label Phase|Death|7|||
129987689|NCT00412061|467916903|FG000|Open Label Phase|Lost to Follow-up|0|||
129987690|NCT00412061|467916904|FG001|Open Label Phase|Lost to Follow-up|2|||
129987691|NCT00412061|467916903|FG000|Open Label Phase|New Cancer Therapy|0|||
129987692|NCT00412061|467916904|FG001|Open Label Phase|New Cancer Therapy|1|||
129987693|NCT01942590|467916905|FG000|Overall Study|Withdrawal by Subject|0|||
129987694|NCT01942590|467916906|FG001|Overall Study|Withdrawal by Subject|1|||
129987695|NCT01942590|467916905|FG000|Overall Study|Adverse Event|1|||
129987696|NCT01942590|467916906|FG001|Overall Study|Adverse Event|0|||
129987697|NCT02433340|467916908|FG000|Overall Study|Adverse Event|0|||
129987698|NCT02433340|467916909|FG001|Overall Study|Adverse Event|0|||
129987699|NCT02433340|467916910|FG002|Overall Study|Adverse Event|1|||
129987700|NCT02433340|467916911|FG003|Overall Study|Adverse Event|0|||
129987701|NCT02433340|467916908|FG000|Overall Study|Withdrawal by Subject|1|||
129987702|NCT02433340|467916909|FG001|Overall Study|Withdrawal by Subject|0|||
129987703|NCT02433340|467916910|FG002|Overall Study|Withdrawal by Subject|1|||
129987704|NCT02433340|467916911|FG003|Overall Study|Withdrawal by Subject|2|||
129987705|NCT02433340|467916908|FG000|Overall Study|Lost to Follow-up|0|||
129987706|NCT02433340|467916909|FG001|Overall Study|Lost to Follow-up|1|||
129987707|NCT02433340|467916910|FG002|Overall Study|Lost to Follow-up|0|||
129987708|NCT02433340|467916911|FG003|Overall Study|Lost to Follow-up|0|||
129987709|NCT02433340|467916908|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
129987710|NCT02433340|467916909|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
129987711|NCT02433340|467916910|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
129987712|NCT02433340|467916911|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
129987713|NCT02433340|467916908|FG000|Overall Study|Other|0|||
129987714|NCT02433340|467916909|FG001|Overall Study|Other|1|||
129987715|NCT02433340|467916910|FG002|Overall Study|Other|0|||
129987716|NCT02433340|467916911|FG003|Overall Study|Other|0|||
129987717|NCT01178385|467916912|FG000|Overall Study|Withdrawal by Subject|2|||
129987718|NCT01178385|467916913|FG001|Overall Study|Withdrawal by Subject|0|||
129987719|NCT01688830|467916916|FG000|Overall Study|Lost to Follow-up|0|||
129987720|NCT01688830|467916917|FG001|Overall Study|Lost to Follow-up|0|||
129987721|NCT01688830|467916918|FG002|Overall Study|Lost to Follow-up|0|||
129987722|NCT01688830|467916919|FG003|Overall Study|Lost to Follow-up|0|||
129987723|NCT01688830|467916920|FG004|Overall Study|Lost to Follow-up|0|||
129987724|NCT01688830|467916921|FG005|Overall Study|Lost to Follow-up|0|||
129987725|NCT01688830|467916922|FG006|Overall Study|Lost to Follow-up|0|||
129987726|NCT01688830|467916923|FG007|Overall Study|Lost to Follow-up|0|||
129987727|NCT01688830|467916924|FG008|Overall Study|Lost to Follow-up|0|||
129987728|NCT01688830|467916925|FG009|Overall Study|Lost to Follow-up|0|||
129987729|NCT01688830|467916926|FG010|Overall Study|Lost to Follow-up|1|||
129987730|NCT01688830|467916927|FG011|Overall Study|Lost to Follow-up|0|||
129987731|NCT01688830|467916928|FG012|Overall Study|Lost to Follow-up|0|||
129987732|NCT01688830|467916929|FG013|Overall Study|Lost to Follow-up|0|||
129987733|NCT01688830|467916930|FG014|Overall Study|Lost to Follow-up|0|||
129987734|NCT01688830|467916931|FG015|Overall Study|Lost to Follow-up|0|||
129987735|NCT01688830|467916932|FG016|Overall Study|Lost to Follow-up|0|||
129987736|NCT01688830|467916933|FG017|Overall Study|Lost to Follow-up|0|||
129987737|NCT01688830|467916934|FG018|Overall Study|Lost to Follow-up|0|||
129987738|NCT01688830|467916935|FG019|Overall Study|Lost to Follow-up|0|||
129987739|NCT01688830|467916936|FG020|Overall Study|Lost to Follow-up|0|||
129987740|NCT04822597|467916937|FG000|Overall Study|Withdrawal by Subject|0|||
129987741|NCT04822597|467916938|FG001|Overall Study|Withdrawal by Subject|1|||
129987742|NCT04822597|467916939|FG002|Overall Study|Withdrawal by Subject|1|||
129987743|NCT04822597|467916940|FG003|Overall Study|Withdrawal by Subject|0|||
129987744|NCT04822597|467916937|FG000|Overall Study|Physician Decision|0|||
129655527|NCT00603382|466695365|FG002|Overall Study|Withdrawal by Subject|1|||
129655528|NCT00603382|466695366|FG003|Overall Study|Withdrawal by Subject|1|||
129655529|NCT00603382|466695367|FG004|Overall Study|Withdrawal by Subject|0|||
129655530|NCT00603382|466695368|FG005|Overall Study|Withdrawal by Subject|1|||
129655531|NCT03403621|466695369|FG000|Overall Study|Withdrawal by Subject|2|||
129987745|NCT04822597|467916938|FG001|Overall Study|Physician Decision|0|||
129987746|NCT04822597|467916939|FG002|Overall Study|Physician Decision|1|||
129655532|NCT03403621|466695370|FG001|Overall Study|Withdrawal by Subject|2|||
129655533|NCT00583102|466695371|FG000|Overall Study|Adverse Event|3|||
129655534|NCT03611582|466695374|FG000|Overall Study|Adverse Event|26|||
129655535|NCT03611582|466695375|FG001|Overall Study|Adverse Event|6|||
129655536|NCT03611582|466695374|FG000|Overall Study|Protocol Violation|0|||
129655537|NCT03611582|466695375|FG001|Overall Study|Protocol Violation|1|||
129655538|NCT03611582|466695374|FG000|Overall Study|Pregnancy|1|||
129655539|NCT03611582|466695375|FG001|Overall Study|Pregnancy|2|||
129655540|NCT03611582|466695374|FG000|Overall Study|Lack of Efficacy|0|||
129655541|NCT03611582|466695375|FG001|Overall Study|Lack of Efficacy|1|||
129655542|NCT03611582|466695374|FG000|Overall Study|At the discretion of the investigator|1|||
129655543|NCT03611582|466695375|FG001|Overall Study|At the discretion of the investigator|0|||
129655544|NCT03611582|466695374|FG000|Overall Study|Safety concern as judged by the investigator|1|||
129655545|NCT03611582|466695375|FG001|Overall Study|Safety concern as judged by the investigator|2|||
129655546|NCT03611582|466695374|FG000|Overall Study|Withdrawal by Subject|4|||
129655547|NCT03611582|466695375|FG001|Overall Study|Withdrawal by Subject|3|||
129655548|NCT03611582|466695374|FG000|Overall Study|Lost to Follow-up|18|||
129655549|NCT03611582|466695375|FG001|Overall Study|Lost to Follow-up|7|||
129655550|NCT03611582|466695374|FG000|Overall Study|other|17|||
129655551|NCT03611582|466695375|FG001|Overall Study|other|16|||
129655552|NCT01783821|466695376|FG000|Overall Study|Screen Failure|1|||
129655553|NCT01783821|466695377|FG001|Overall Study|Screen Failure|1|||
129655554|NCT02333383|466695378|FG000|Overall Study|Adalimumab discontinuation|21|||
129655555|NCT02333383|466695378|FG000|Overall Study|Lost to Follow-up|15|||
129655556|NCT02333383|466695378|FG000|Overall Study|Withdrawal by Subject|3|||
129655557|NCT02333383|466695378|FG000|Overall Study|Transfer to another hospital|2|||
129655558|NCT04459598|466695381|FG000|Overall Study|Adverse Event|1|||
129655559|NCT04459598|466695382|FG001|Overall Study|Adverse Event|1|||
129655560|NCT01907217|466695383|FG000|Overall Study|Withdrawal by Subject|0|||
129655561|NCT01907217|466695384|FG001|Overall Study|Withdrawal by Subject|2|||
129655562|NCT01078298|466695385|FG000|Overall Study|Lost to Follow-up|12|||
129655563|NCT01078298|466695386|FG001|Overall Study|Lost to Follow-up|13|||
129655564|NCT01078298|466695385|FG000|Overall Study|Withdrawal by Subject|31|||
129655565|NCT01078298|466695386|FG001|Overall Study|Withdrawal by Subject|33|||
129655566|NCT01078298|466695385|FG000|Overall Study|Protocol Violation|6|||
129655567|NCT01078298|466695386|FG001|Overall Study|Protocol Violation|6|||
129655568|NCT01078298|466695385|FG000|Overall Study|Adverse Event|6|||
129655569|NCT01078298|466695386|FG001|Overall Study|Adverse Event|5|||
129655570|NCT01078298|466695385|FG000|Overall Study|Death|2|||
129655571|NCT01078298|466695386|FG001|Overall Study|Death|0|||
129655572|NCT01078298|466695385|FG000|Overall Study|Did not meet entrance criteria|0|||
129655573|NCT01078298|466695386|FG001|Overall Study|Did not meet entrance criteria|1|||
129655574|NCT01078298|466695385|FG000|Overall Study|Other|24|||
129655575|NCT01078298|466695386|FG001|Overall Study|Other|32|||
129655576|NCT00866333|466695388|FG000|Overall Study|Withdrawal of consent|0|||
129655577|NCT00866333|466695389|FG001|Overall Study|Withdrawal of consent|1|||
129655578|NCT00866333|466695390|FG002|Overall Study|Withdrawal of consent|2|||
129655579|NCT00866333|466695388|FG000|Overall Study|Reason not Specified|3|||
129655580|NCT00866333|466695389|FG001|Overall Study|Reason not Specified|1|||
129655581|NCT00866333|466695390|FG002|Overall Study|Reason not Specified|1|||
129655582|NCT00866333|466695388|FG000|Overall Study|Study Terminated by Sponsor|2|||
129655583|NCT00866333|466695389|FG001|Overall Study|Study Terminated by Sponsor|5|||
129655584|NCT00866333|466695390|FG002|Overall Study|Study Terminated by Sponsor|9|||
129655585|NCT00350779|466695392|FG000|Overall Study|Adverse Event|4|||
129655586|NCT00350779|466695393|FG001|Overall Study|Adverse Event|2|||
129655587|NCT00350779|466695392|FG000|Overall Study|Lack of Efficacy|0|||
129987747|NCT04822597|467916940|FG003|Overall Study|Physician Decision|1|||
129655588|NCT00350779|466695393|FG001|Overall Study|Lack of Efficacy|4|||
129655589|NCT00350779|466695392|FG000|Overall Study|Lost to Follow-up|2|||
129655590|NCT00350779|466695393|FG001|Overall Study|Lost to Follow-up|0|||
129655591|NCT00350779|466695392|FG000|Overall Study|Physician Decision|2|||
129655592|NCT00350779|466695393|FG001|Overall Study|Physician Decision|4|||
129655593|NCT00350779|466695392|FG000|Overall Study|Protocol Violation|3|||
129655594|NCT00350779|466695393|FG001|Overall Study|Protocol Violation|1|||
129987748|NCT04822597|467916937|FG000|Overall Study|Subject withdrawn after enrollment|0|||
129655595|NCT00350779|466695392|FG000|Overall Study|Withdrawal by Subject|9|||
129655596|NCT00350779|466695393|FG001|Overall Study|Withdrawal by Subject|8|||
129655597|NCT00350779|466695392|FG000|Overall Study|Patient Moved|2|||
129987749|NCT04822597|467916938|FG001|Overall Study|Subject withdrawn after enrollment|1|||
129655598|NCT00350779|466695393|FG001|Overall Study|Patient Moved|1|||
129655599|NCT00350779|466695392|FG000|Overall Study|Non-compliance with study procedures|0|||
129655600|NCT00350779|466695393|FG001|Overall Study|Non-compliance with study procedures|1|||
129655601|NCT02012959|466695394|FG000|Treatment Phase A|Adverse Event|2|||
129655602|NCT02012959|466695395|FG001|Treatment Phase A|Adverse Event|0|||
129655603|NCT02012959|466695396|FG002|Treatment Phase A|Adverse Event|0|||
129655604|NCT02012959|466695397|FG003|Treatment Phase A|Adverse Event|0|||
129655605|NCT02012959|466695398|FG004|Treatment Phase A|Adverse Event|0|||
129655606|NCT03089853|466696403|FG000|Overall Study|Lost to Follow-up|2|||
129655607|NCT03089853|466696404|FG001|Overall Study|Lost to Follow-up|1|||
129655608|NCT00441363|466696405|FG000|Overall Study|Adverse Event|4|||
129655609|NCT00441363|466696406|FG001|Overall Study|Adverse Event|2|||
129655610|NCT00441363|466696405|FG000|Overall Study|Withdrawal by Subject|3|||
129655611|NCT00441363|466696406|FG001|Overall Study|Withdrawal by Subject|4|||
129655612|NCT00441363|466696405|FG000|Overall Study|Physician Decision|6|||
129655613|NCT00441363|466696406|FG001|Overall Study|Physician Decision|7|||
129655614|NCT00441363|466696405|FG000|Overall Study|Lost to Follow-up|2|||
129655615|NCT00441363|466696406|FG001|Overall Study|Lost to Follow-up|2|||
129655616|NCT00441363|466696405|FG000|Overall Study|Other|2|||
129655617|NCT00441363|466696406|FG001|Overall Study|Other|0|||
129655618|NCT04114656|466696409|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
129655619|NCT04114656|466696410|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
129655620|NCT04114656|466696409|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
129655621|NCT04114656|466696410|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
129655622|NCT04114656|466696409|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
129655623|NCT04114656|466696410|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
129655624|NCT04114656|466696409|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
129655625|NCT04114656|466696410|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
129655626|NCT04114656|466696409|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
129655627|NCT04114656|466696410|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
129655628|NCT03326518|466696416|FG000|Overall Study|Protocol Violation|1|||
129655629|NCT03326518|466696417|FG001|Overall Study|Protocol Violation|0|||
129655630|NCT03326518|466696418|FG002|Overall Study|Protocol Violation|0|||
129655631|NCT03326518|466696416|FG000|Overall Study|Withdrawal by Subject|1|||
129655632|NCT03326518|466696417|FG001|Overall Study|Withdrawal by Subject|0|||
129655633|NCT03326518|466696418|FG002|Overall Study|Withdrawal by Subject|0|||
129655634|NCT03326518|466696416|FG000|Overall Study|Lost to Follow-up|1|||
129655635|NCT03326518|466696417|FG001|Overall Study|Lost to Follow-up|0|||
129655636|NCT03326518|466696418|FG002|Overall Study|Lost to Follow-up|1|||
129655637|NCT01375374|466696421|FG000|Overall Study|Adverse Event|1|||
129655638|NCT02065518|466696422|FG000|Overall Study|Lost to Follow-up|3|||
129655639|NCT02065518|466696423|FG001|Overall Study|Lost to Follow-up|4|||
129655640|NCT02065518|466696424|FG002|Overall Study|Lost to Follow-up|0|||
129655641|NCT02065518|466696425|FG003|Overall Study|Lost to Follow-up|3|||
129655642|NCT02065518|466696422|FG000|Overall Study|Withdrawal by Subject|3|||
129655643|NCT02065518|466696423|FG001|Overall Study|Withdrawal by Subject|4|||
129655644|NCT02065518|466696424|FG002|Overall Study|Withdrawal by Subject|9|||
129655645|NCT02065518|466696425|FG003|Overall Study|Withdrawal by Subject|2|||
129987750|NCT04822597|467916939|FG002|Overall Study|Subject withdrawn after enrollment|0|||
129987751|NCT04822597|467916940|FG003|Overall Study|Subject withdrawn after enrollment|1|||
129987752|NCT04822597|467916937|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
129987753|NCT04822597|467916938|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
129987754|NCT04822597|467916939|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
129987755|NCT04822597|467916940|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
129987756|NCT01285609|467916941|FG000|Randomized|Progressive Disease|41|||
129987757|NCT01285609|467916942|FG001|Randomized|Progressive Disease|61|||
129987758|NCT01285609|467916941|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
129987759|NCT01285609|467916942|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
129987760|NCT01285609|467916941|FG000|Randomized|Study Drug Toxicity|13|||
129987761|NCT01285609|467916942|FG001|Randomized|Study Drug Toxicity|14|||
129987762|NCT01285609|467916941|FG000|Randomized|Death|5|||
129987763|NCT01285609|467916942|FG001|Randomized|Death|7|||
129987764|NCT01285609|467916941|FG000|Randomized|Withdrawal by Subject|8|||
129655646|NCT04849416|466696426|FG000|Overall Study|Ongoing Treatment|12|||
129655647|NCT04849416|466696427|FG001|Overall Study|Ongoing Treatment|5|||
129655648|NCT04849416|466696428|FG002|Overall Study|Ongoing Treatment|3|||
129655649|NCT04849416|466696426|FG000|Overall Study|On Post-Treatment Follow-up|8|||
129655650|NCT04849416|466696427|FG001|Overall Study|On Post-Treatment Follow-up|9|||
129655651|NCT04849416|466696428|FG002|Overall Study|On Post-Treatment Follow-up|10|||
129987765|NCT01285609|467916942|FG001|Randomized|Withdrawal by Subject|11|||
129655652|NCT04849416|466696426|FG000|Overall Study|Withdrawal by Subject|0|||
129655653|NCT04849416|466696427|FG001|Overall Study|Withdrawal by Subject|0|||
129655654|NCT04849416|466696428|FG002|Overall Study|Withdrawal by Subject|1|||
129655655|NCT04849416|466696426|FG000|Overall Study|Lost to Follow-up|1|||
129987766|NCT01285609|467916941|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
129987767|NCT01285609|467916942|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
129655656|NCT04849416|466696427|FG001|Overall Study|Lost to Follow-up|0|||
129655657|NCT04849416|466696428|FG002|Overall Study|Lost to Follow-up|0|||
129655658|NCT01038752|466696438|FG000|Overall Study|Tumor Progression|2|||
129655659|NCT01038752|466696439|FG001|Overall Study|Tumor Progression|2|||
129655660|NCT01038752|466696438|FG000|Overall Study|Lost to Follow-up|3|||
129655661|NCT01038752|466696439|FG001|Overall Study|Lost to Follow-up|3|||
129655662|NCT04165135|466696440|FG000|Overall Study|Protocol Violation|10|||
129655663|NCT04165135|466696440|FG000|Overall Study|Participants withdrawal of consent|5|||
129655664|NCT01618916|466696441|FG000|Overall Study|Adverse Event|1|||
129655665|NCT01618916|466696442|FG001|Overall Study|Adverse Event|0|||
129655666|NCT01618916|466696443|FG002|Overall Study|Adverse Event|0|||
129655667|NCT01618916|466696444|FG003|Overall Study|Adverse Event|0|||
129655668|NCT01618916|466696445|FG004|Overall Study|Adverse Event|0|||
129655669|NCT01618916|466696446|FG005|Overall Study|Adverse Event|0|||
129655670|NCT01618916|466696441|FG000|Overall Study|Withdrawal by Subject|0|||
129655671|NCT01618916|466696442|FG001|Overall Study|Withdrawal by Subject|1|||
129655672|NCT01618916|466696443|FG002|Overall Study|Withdrawal by Subject|1|||
129655673|NCT01618916|466696444|FG003|Overall Study|Withdrawal by Subject|0|||
129655674|NCT01618916|466696445|FG004|Overall Study|Withdrawal by Subject|1|||
129655675|NCT01618916|466696446|FG005|Overall Study|Withdrawal by Subject|0|||
129655676|NCT01618916|466696441|FG000|Overall Study|Lost to Follow-up|1|||
129987768|NCT01285609|467916941|FG000|Randomized|Undisclosed Reasons|1|||
129987769|NCT01285609|467916942|FG001|Randomized|Undisclosed Reasons|0|||
129987770|NCT01285609|467916941|FG000|Randomized|Randomized but not Treated|4|||
129987771|NCT01285609|467916942|FG001|Randomized|Randomized but not Treated|4|||
129987772|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
129987773|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
129987774|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
129987775|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
129987776|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
129987777|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
129987778|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
129987779|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
129987780|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Death|11|||
129987781|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Death|3|||
129655677|NCT01618916|466696442|FG001|Overall Study|Lost to Follow-up|0|||
129655678|NCT01618916|466696443|FG002|Overall Study|Lost to Follow-up|0|||
129655679|NCT01618916|466696444|FG003|Overall Study|Lost to Follow-up|2|||
129655680|NCT01618916|466696445|FG004|Overall Study|Lost to Follow-up|0|||
129655681|NCT01618916|466696446|FG005|Overall Study|Lost to Follow-up|0|||
129655682|NCT04521114|466696447|FG000|Overall Study|Lost to Follow-up|1|||
129987782|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
129987783|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
129987784|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Not Reported|0|||
129987785|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Not Reported|2|||
129655683|NCT04521114|466696448|FG001|Overall Study|Lost to Follow-up|2|||
129883394|NCT01567865|467532419|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
129883395|NCT01567865|467532420|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
129883396|NCT01567865|467532417|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
129883397|NCT01567865|467532418|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
129883398|NCT01567865|467532419|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
129883399|NCT01567865|467532420|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
129883400|NCT01051063|467532423|FG000|Overall Study|Death|2|||
129883401|NCT01051063|467532424|FG001|Overall Study|Death|2|||
129883402|NCT01051063|467532423|FG000|Overall Study|Withdrawal by Subject|1|||
129883403|NCT01051063|467532424|FG001|Overall Study|Withdrawal by Subject|1|||
129883404|NCT01051063|467532423|FG000|Overall Study|Termination of the study|5|||
129883405|NCT01051063|467532424|FG001|Overall Study|Termination of the study|0|||
129883406|NCT01051063|467532423|FG000|Overall Study|Moved from the study site area|1|||
129883407|NCT01051063|467532424|FG001|Overall Study|Moved from the study site area|0|||
129883408|NCT01051063|467532423|FG000|Overall Study|Other|1|||
129883409|NCT01051063|467532424|FG001|Overall Study|Other|0|||
129883410|NCT01051063|467532423|FG000|Overall Study|Lost to Follow-up|0|||
129987786|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
129987787|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
129987788|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
129883411|NCT01051063|467532424|FG001|Overall Study|Lost to Follow-up|1|||
129883412|NCT03857841|467532426|FG000|Overall Study|Death|1|||
129987789|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
129655684|NCT04521114|466696449|FG002|Overall Study|Lost to Follow-up|0|||
129655685|NCT04521114|466696447|FG000|Overall Study|Withdrawal by Subject|1|||
129655686|NCT04521114|466696448|FG001|Overall Study|Withdrawal by Subject|2|||
129883413|NCT03857841|467532427|FG001|Overall Study|Death|0|||
129883414|NCT03857841|467532428|FG002|Overall Study|Death|0|||
129883415|NCT03857841|467532429|FG003|Overall Study|Death|0|||
129987790|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
129987791|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
129987792|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
129987793|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
129987794|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
129987795|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
129987796|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
129987797|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
129987798|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
129987799|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
129987800|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
129987801|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
129987802|NCT01285609|467916941|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
129987803|NCT01285609|467916942|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
129987804|NCT01285609|467916941|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
129987805|NCT01285609|467916942|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
129987806|NCT03265938|467916952|FG000|Overall Study|Withdrawal by Subject|1|||
129987807|NCT03265938|467916952|FG000|Overall Study|Physician Decision|1|||
129987808|NCT03265938|467916952|FG000|Overall Study|friable mass|6|||
129987809|NCT02679508|467916953|FG000|Healing Phase|Protocol Violation|1|||
129987810|NCT02679508|467916954|FG001|Healing Phase|Protocol Violation|1|||
129987811|NCT02679508|467916953|FG000|Healing Phase|Lost to Follow-up|1|||
129987812|NCT02679508|467916954|FG001|Healing Phase|Lost to Follow-up|0|||
129987813|NCT02679508|467916953|FG000|Maintenance Phase|Adverse Event|12|||
129987814|NCT02679508|467916954|FG001|Maintenance Phase|Adverse Event|2|||
129987815|NCT02679508|467916953|FG000|Maintenance Phase|Lost to Follow-up|0|||
129987816|NCT02679508|467916954|FG001|Maintenance Phase|Lost to Follow-up|1|||
129987817|NCT02679508|467916953|FG000|Maintenance Phase|Withdrawal by Subject|15|||
129987818|NCT02679508|467916954|FG001|Maintenance Phase|Withdrawal by Subject|8|||
129987819|NCT02679508|467916953|FG000|Maintenance Phase|Other|5|||
129987820|NCT02679508|467916954|FG001|Maintenance Phase|Other|4|||
129987821|NCT03143166|467916955|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
129987822|NCT03616977|467916956|FG000|Period 1|Physician Decision|0|||
129987823|NCT03616977|467916957|FG001|Period 1|Physician Decision|1|||
129987824|NCT03616977|467916956|FG000|Period 3|Adverse Event|1|||
129987825|NCT03616977|467916957|FG001|Period 3|Adverse Event|1|||
129987826|NCT03683823|467916958|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
129987827|NCT03683823|467916959|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
129987828|NCT03683823|467916958|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
129987829|NCT03683823|467916959|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
129987830|NCT03683823|467916958|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
129987831|NCT03683823|467916959|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
129987832|NCT01323972|467916961|FG000|Overall Study|Withdrawal by Subject|1|||
129987833|NCT01323972|467916962|FG001|Overall Study|Withdrawal by Subject|0|||
129987834|NCT01323972|467916963|FG002|Overall Study|Withdrawal by Subject|1|||
129987835|NCT01323972|467916964|FG003|Overall Study|Withdrawal by Subject|0|||
129987836|NCT01323972|467916961|FG000|Overall Study|Migrated/moved from study area|1|||
129987837|NCT01323972|467916962|FG001|Overall Study|Migrated/moved from study area|2|||
129987838|NCT01323972|467916963|FG002|Overall Study|Migrated/moved from study area|0|||
129987839|NCT01323972|467916964|FG003|Overall Study|Migrated/moved from study area|0|||
129987840|NCT01323972|467916961|FG000|Overall Study|Lost to Follow-up|0|||
129987841|NCT01323972|467916962|FG001|Overall Study|Lost to Follow-up|1|||
129987842|NCT01323972|467916963|FG002|Overall Study|Lost to Follow-up|1|||
129987843|NCT01323972|467916964|FG003|Overall Study|Lost to Follow-up|1|||
129987844|NCT05000931|467916973|FG000|Overall Study|Lost to Follow-up|1|||
129987845|NCT00925132|467916974|FG000|Overall Study|Withdrawal by Subject|2|||
129987846|NCT00925132|467916975|FG001|Overall Study|Withdrawal by Subject|0|||
129987847|NCT00925132|467916976|FG002|Overall Study|Withdrawal by Subject|0|||
129987848|NCT00925132|467916977|FG003|Overall Study|Withdrawal by Subject|0|||
129987849|NCT00925132|467916978|FG004|Overall Study|Withdrawal by Subject|1|||
129987850|NCT00925132|467916974|FG000|Overall Study|Removed due to disease progression|0|||
129987851|NCT00925132|467916975|FG001|Overall Study|Removed due to disease progression|0|||
129987852|NCT00925132|467916976|FG002|Overall Study|Removed due to disease progression|0|||
129987853|NCT00925132|467916977|FG003|Overall Study|Removed due to disease progression|0|||
129987854|NCT00925132|467916978|FG004|Overall Study|Removed due to disease progression|4|||
129987855|NCT03141905|467916979|FG000|Overall Study|Death|3|||
129987856|NCT03141905|467916980|FG001|Overall Study|Death|2|||
129987857|NCT03141905|467916979|FG000|Overall Study|Withdrawal by Subject|1|||
129987858|NCT03141905|467916980|FG001|Overall Study|Withdrawal by Subject|0|||
129987859|NCT03141905|467916979|FG000|Overall Study|Lost to Follow-up|3|||
129987860|NCT03141905|467916980|FG001|Overall Study|Lost to Follow-up|7|||
129987861|NCT03141905|467916979|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
129655687|NCT04521114|466696449|FG002|Overall Study|Withdrawal by Subject|2|||
129655688|NCT04521114|466696447|FG000|Overall Study|Adverse Event|1|||
129655689|NCT04521114|466696448|FG001|Overall Study|Adverse Event|0|||
129655690|NCT04521114|466696449|FG002|Overall Study|Adverse Event|0|||
129655691|NCT04521114|466696447|FG000|Overall Study|Sponsor Wish|1|||
129655692|NCT04521114|466696448|FG001|Overall Study|Sponsor Wish|0|||
129655693|NCT04521114|466696449|FG002|Overall Study|Sponsor Wish|0|||
129655694|NCT04521114|466696447|FG000|Overall Study|Withdrawal of Consent|2|||
129655695|NCT04521114|466696448|FG001|Overall Study|Withdrawal of Consent|2|||
129655696|NCT04521114|466696449|FG002|Overall Study|Withdrawal of Consent|0|||
129655697|NCT01084538|466696457|FG000|Overall Study|Drug not available|30|||
129655698|NCT01084538|466696457|FG000|Overall Study|Adverse Event|9|||
129655699|NCT01084538|466696457|FG000|Overall Study|Kidney transplant|6|||
129655700|NCT01084538|466696457|FG000|Overall Study|Serious Adverse Event|3|||
129655701|NCT01084538|466696457|FG000|Overall Study|Lack of effectiveness|2|||
129655702|NCT01084538|466696457|FG000|Overall Study|Patient noncompliance|2|||
129655703|NCT01084538|466696457|FG000|Overall Study|Hyperphosphatemia|2|||
129655704|NCT01084538|466696457|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
129655705|NCT01084538|466696457|FG000|Overall Study|Change of residence|2|||
129655706|NCT01084538|466696457|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
129655707|NCT01084538|466696457|FG000|Overall Study|Reason unknown|8|||
129655708|NCT01625689|466696462|FG000|Overall Study|Migration|2|||
129655709|NCT01625689|466696463|FG001|Overall Study|Migration|1|||
129655710|NCT00106639|466696464|FG000|Overall Study|Adverse Event|3|||
129655711|NCT00106639|466696465|FG001|Overall Study|Adverse Event|4|||
129655712|NCT00106639|466696466|FG002|Overall Study|Adverse Event|1|||
129655713|NCT00106639|466696464|FG000|Overall Study|Protocol Violation|0|||
129655714|NCT00106639|466696465|FG001|Overall Study|Protocol Violation|1|||
129987862|NCT03141905|467916980|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
129987863|NCT02502799|467918738|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
129987864|NCT02502799|467918739|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
129987865|NCT02502799|467918740|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
129987866|NCT02502799|467918741|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
129987867|NCT02502799|467918738|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
129987868|NCT02502799|467918739|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
129987869|NCT02502799|467918740|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
129987870|NCT02502799|467918741|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
129987871|NCT02502799|467918738|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
129987872|NCT02502799|467918739|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
129987873|NCT02502799|467918740|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
129987874|NCT02502799|467918741|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
129987875|NCT02502799|467918738|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
129987876|NCT02502799|467918739|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
129987877|NCT02502799|467918740|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
129987878|NCT02502799|467918741|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
129987879|NCT02502799|467918738|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
129987880|NCT02502799|467918739|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
129987881|NCT02502799|467918740|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
129987882|NCT02502799|467918741|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
129987883|NCT00055601|467918744|FG000|Overall Study|Protocol Violation|1|||
129987884|NCT00055601|467918745|FG001|Overall Study|Protocol Violation|1|||
129987885|NCT00055601|467918744|FG000|Overall Study|No protocol treatment received|1|||
129987886|NCT00055601|467918745|FG001|Overall Study|No protocol treatment received|1|||
129987887|NCT00117845|467918746|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
129987888|NCT01022268|467918748|FG000|Overall Study|Withdrawal by Subject|1|||
129987889|NCT01022268|467918749|FG001|Overall Study|Withdrawal by Subject|0|||
129987890|NCT01022268|467918748|FG000|Overall Study|Withdrawal by Subject|1|||
129987891|NCT01022268|467918749|FG001|Overall Study|Withdrawal by Subject|0|||
129987892|NCT05087979|467918750|FG000|Overall Study|Converted to general anesthesia|1|||
129987893|NCT05087979|467918751|FG001|Overall Study|Converted to general anesthesia|0|||
129987894|NCT02915302|467918752|FG000|Overall Study|Adverse Event|3|||
129987895|NCT02915302|467918753|FG001|Overall Study|Adverse Event|0|||
129987896|NCT02915302|467918752|FG000|Overall Study|Protocol Violation|20|||
129987897|NCT02915302|467918753|FG001|Overall Study|Protocol Violation|27|||
129655715|NCT00106639|466696466|FG002|Overall Study|Protocol Violation|0|||
129987898|NCT02915302|467918752|FG000|Overall Study|Lost to Follow-up|19|||
129655716|NCT00106639|466696464|FG000|Overall Study|Withdrawal by Subject|0|||
129655717|NCT00106639|466696465|FG001|Overall Study|Withdrawal by Subject|1|||
129655718|NCT00106639|466696466|FG002|Overall Study|Withdrawal by Subject|0|||
129987899|NCT02915302|467918753|FG001|Overall Study|Lost to Follow-up|22|||
129987900|NCT02915302|467918752|FG000|Overall Study|Withdrawal by Subject|22|||
129655719|NCT00106639|466696464|FG000|Overall Study|Participant defaulted|0|||
129655720|NCT00106639|466696465|FG001|Overall Study|Participant defaulted|1|||
129655721|NCT00106639|466696466|FG002|Overall Study|Participant defaulted|1|||
129655722|NCT01210144|466696468|FG000|Overall Study|Lack of ovarian response|1|||
129655723|NCT01210144|466696469|FG001|Overall Study|Lack of ovarian response|0|||
129655724|NCT01210144|466696468|FG000|Overall Study|No fertilization|1|||
129655725|NCT01210144|466696469|FG001|Overall Study|No fertilization|0|||
129655726|NCT01210144|466696468|FG000|Overall Study|No transfer|1|||
129655727|NCT01210144|466696469|FG001|Overall Study|No transfer|0|||
129655728|NCT00494221|466696472|FG000|Overall Study|Death|15|||
129655729|NCT00494221|466696473|FG001|Overall Study|Death|9|||
129655730|NCT00494221|466696474|FG002|Overall Study|Death|14|||
129655731|NCT00494221|466696472|FG000|Overall Study|Withdrawal by Subject|1|||
129655732|NCT00494221|466696473|FG001|Overall Study|Withdrawal by Subject|2|||
129655733|NCT00494221|466696474|FG002|Overall Study|Withdrawal by Subject|0|||
129655734|NCT01714609|466696479|FG000|Overall Study|Protocol Violation|1|||
129655735|NCT01714609|466696480|FG001|Overall Study|Protocol Violation|0|||
129655736|NCT00630747|466696481|FG000|Overall Study|Death|1|||
129655737|NCT00630747|466696481|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
129655738|NCT00630747|466696481|FG000|Overall Study|Returned to country of origin|1|||
129655739|NCT02306694|466696484|FG000|Overall Study|Withdrawal by Subject|3|||
129655740|NCT02306694|466696484|FG000|Overall Study|Lost to Follow-up|1|||
129655741|NCT03782974|466696485|FG000|Overall Study|Withdrawal by Subject|7|||
129655742|NCT03782974|466696486|FG001|Overall Study|Withdrawal by Subject|7|||
129655743|NCT03782974|466696485|FG000|Overall Study|Pregnancy|1|||
129987901|NCT02915302|467918753|FG001|Overall Study|Withdrawal by Subject|29|||
129987902|NCT02915302|467918752|FG000|Overall Study|Other|1|||
129987903|NCT02915302|467918753|FG001|Overall Study|Other|0|||
129987904|NCT03207009|467918754|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
129987905|NCT02924428|467918755|FG000|Overall Study|Adverse Event|1|||
129987906|NCT02924428|467918756|FG001|Overall Study|Adverse Event|0|||
129987907|NCT02924428|467918755|FG000|Overall Study|Physician Decision|1|||
129987908|NCT02924428|467918756|FG001|Overall Study|Physician Decision|0|||
129987909|NCT02924428|467918755|FG000|Overall Study|Lost to Follow-up|2|||
129987910|NCT02924428|467918756|FG001|Overall Study|Lost to Follow-up|4|||
129987911|NCT02924428|467918755|FG000|Overall Study|Pregnancy|0|||
129987912|NCT02924428|467918756|FG001|Overall Study|Pregnancy|1|||
129987913|NCT02680002|467918757|FG000|Overall Study|Lost to Follow-up|5|||
129987914|NCT02680002|467918758|FG001|Overall Study|Lost to Follow-up|1|||
129987915|NCT02680002|467918759|FG002|Overall Study|Lost to Follow-up|4|||
129987916|NCT02680002|467918760|FG003|Overall Study|Lost to Follow-up|2|||
129987917|NCT02680002|467918761|FG004|Overall Study|Lost to Follow-up|0|||
129987918|NCT02680002|467918762|FG005|Overall Study|Lost to Follow-up|2|||
129987919|NCT02680002|467918757|FG000|Overall Study|Physician Decision|5|||
129987920|NCT02680002|467918758|FG001|Overall Study|Physician Decision|1|||
129987921|NCT02680002|467918759|FG002|Overall Study|Physician Decision|1|||
129987922|NCT02680002|467918760|FG003|Overall Study|Physician Decision|1|||
129987923|NCT02680002|467918761|FG004|Overall Study|Physician Decision|1|||
129987924|NCT02680002|467918762|FG005|Overall Study|Physician Decision|1|||
129987925|NCT02680002|467918757|FG000|Overall Study|Protocol Violation|1|||
129987926|NCT02680002|467918758|FG001|Overall Study|Protocol Violation|0|||
129987927|NCT02680002|467918759|FG002|Overall Study|Protocol Violation|1|||
129987928|NCT02680002|467918760|FG003|Overall Study|Protocol Violation|0|||
129987929|NCT02680002|467918761|FG004|Overall Study|Protocol Violation|1|||
129987930|NCT02680002|467918762|FG005|Overall Study|Protocol Violation|2|||
129987931|NCT02680002|467918757|FG000|Overall Study|Withdrawal by Subject|0|||
129987932|NCT02680002|467918758|FG001|Overall Study|Withdrawal by Subject|0|||
129987933|NCT02680002|467918759|FG002|Overall Study|Withdrawal by Subject|1|||
129655744|NCT03782974|466696486|FG001|Overall Study|Pregnancy|0|||
129655745|NCT00395642|466696487|FG000|Overall Study|Death|4|||
129987934|NCT02680002|467918760|FG003|Overall Study|Withdrawal by Subject|0|||
129987935|NCT02680002|467918761|FG004|Overall Study|Withdrawal by Subject|2|||
129987936|NCT02680002|467918762|FG005|Overall Study|Withdrawal by Subject|2|||
129987937|NCT02680002|467918757|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
129655746|NCT00395642|466696487|FG000|Overall Study|Lost to Follow-up|1|||
129655747|NCT00395642|466696487|FG000|Overall Study|Physician Decision|7|||
129655748|NCT00395642|466696487|FG000|Overall Study|Withdrawal by Subject|1|||
129655749|NCT00659776|466696497|FG000|Overall Study|Withdrawal by Subject|12|||
129655750|NCT00659776|466696498|FG001|Overall Study|Withdrawal by Subject|2|||
129655751|NCT00659776|466696499|FG002|Overall Study|Withdrawal by Subject|0|||
129655752|NCT01180049|466696500|FG000|Overall Study|Other|9|||
129655753|NCT01180049|466696501|FG001|Overall Study|Other|7|||
129655754|NCT01180049|466696500|FG000|Overall Study|Lost to Follow-up|8|||
129987938|NCT02680002|467918758|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
129987939|NCT02680002|467918759|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
129987940|NCT02680002|467918760|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
129987941|NCT02680002|467918761|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
129987942|NCT02680002|467918762|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
129987943|NCT02680002|467918757|FG000|Overall Study|Other|0|||
129987944|NCT02680002|467918758|FG001|Overall Study|Other|1|||
129987945|NCT02680002|467918759|FG002|Overall Study|Other|0|||
129987946|NCT02680002|467918760|FG003|Overall Study|Other|0|||
129655755|NCT01180049|466696501|FG001|Overall Study|Lost to Follow-up|6|||
129655756|NCT01180049|466696500|FG000|Overall Study|Death|36|||
129655757|NCT01180049|466696501|FG001|Overall Study|Death|35|||
129655758|NCT01905592|466696504|FG000|Overall Study|Disease Progression|51|||
129655759|NCT01905592|466696505|FG001|Overall Study|Disease Progression|110|||
129655760|NCT01905592|466696504|FG000|Overall Study|Toxicity|1|||
129655761|NCT01905592|466696505|FG001|Overall Study|Toxicity|16|||
129655762|NCT01905592|466696504|FG000|Overall Study|Physician Decision|0|||
129655763|NCT01905592|466696505|FG001|Overall Study|Physician Decision|2|||
129655764|NCT01905592|466696504|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
129655765|NCT01905592|466696505|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
129655766|NCT01905592|466696504|FG000|Overall Study|Protocol Violation|0|||
129655767|NCT01905592|466696505|FG001|Overall Study|Protocol Violation|1|||
129655768|NCT01905592|466696504|FG000|Overall Study|Sponsor's decision|1|||
129655769|NCT01905592|466696505|FG001|Overall Study|Sponsor's decision|1|||
129655770|NCT01905592|466696504|FG000|Overall Study|Not treated|7|||
129655771|NCT01905592|466696505|FG001|Overall Study|Not treated|3|||
129655772|NCT01905592|466696504|FG000|Overall Study|Withdrawal by Subject|10|||
129655773|NCT01905592|466696505|FG001|Overall Study|Withdrawal by Subject|2|||
129655774|NCT00642954|466698280|FG000|Overall Study|Progressive Disease|3|||
129655775|NCT00642954|466698281|FG001|Overall Study|Progressive Disease|3|||
129655776|NCT00642954|466698282|FG002|Overall Study|Progressive Disease|3|||
129655777|NCT00642954|466698283|FG003|Overall Study|Progressive Disease|3|||
129655778|NCT00642954|466698284|FG004|Overall Study|Progressive Disease|9|||
129655779|NCT00642954|466698280|FG000|Overall Study|Withdrawal by Subject|0|||
129655780|NCT00642954|466698281|FG001|Overall Study|Withdrawal by Subject|0|||
129655781|NCT00642954|466698282|FG002|Overall Study|Withdrawal by Subject|0|||
129655782|NCT00642954|466698283|FG003|Overall Study|Withdrawal by Subject|0|||
129655783|NCT00642954|466698284|FG004|Overall Study|Withdrawal by Subject|1|||
129655784|NCT00642954|466698280|FG000|Overall Study|Adverse Event|1|||
129655785|NCT00642954|466698281|FG001|Overall Study|Adverse Event|1|||
129655786|NCT00642954|466698282|FG002|Overall Study|Adverse Event|0|||
129655787|NCT00642954|466698283|FG003|Overall Study|Adverse Event|0|||
129655788|NCT00642954|466698284|FG004|Overall Study|Adverse Event|6|||
129655789|NCT01663857|466698285|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
129655790|NCT01663857|466698286|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
129655791|NCT01663857|466698287|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
129655792|NCT01663857|466698288|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
129655793|NCT01663857|466698285|FG000|Overall Study|Lost to Follow-up|0|||
129655794|NCT01663857|466698286|FG001|Overall Study|Lost to Follow-up|0|||
129655795|NCT01663857|466698287|FG002|Overall Study|Lost to Follow-up|3|||
129655796|NCT01663857|466698288|FG003|Overall Study|Lost to Follow-up|1|||
129655797|NCT03052920|466698289|FG000|Overall Study|Withdrawal by Subject|1|||
129655798|NCT03015194|466698290|FG000|Overall Study|Death|10|||
129655799|NCT03015194|466698290|FG000|Overall Study|Withdrawal by Subject|2|||
129655800|NCT00433017|466698292|FG000|Overall Study|Adverse Event|5|||
129655801|NCT00433017|466698293|FG001|Overall Study|Adverse Event|3|||
129655802|NCT00433017|466698292|FG000|Overall Study|Withdrawal by Subject|4|||
129655803|NCT00433017|466698293|FG001|Overall Study|Withdrawal by Subject|5|||
129655804|NCT00433017|466698292|FG000|Overall Study|Lost to Follow-up|3|||
129655805|NCT00433017|466698293|FG001|Overall Study|Lost to Follow-up|4|||
129655806|NCT00433017|466698292|FG000|Overall Study|Administrative problems|80|||
129655807|NCT00433017|466698293|FG001|Overall Study|Administrative problems|86|||
129655808|NCT00433017|466698292|FG000|Overall Study|Protocol Violation|1|||
129655809|NCT00433017|466698293|FG001|Overall Study|Protocol Violation|0|||
129655810|NCT00433017|466698292|FG000|Overall Study|Death|2|||
129655811|NCT00433017|466698293|FG001|Overall Study|Death|2|||
129655812|NCT00433017|466698292|FG000|Overall Study|Subject no longer requires study drug|1|||
129655813|NCT00433017|466698293|FG001|Overall Study|Subject no longer requires study drug|1|||
129655814|NCT01108237|466698296|FG000|Overall Study|No alignment data|2|||
129655815|NCT01108237|466698297|FG001|Overall Study|No alignment data|15|||
129655816|NCT01108237|466698296|FG000|Overall Study|Did not meet criteria for analysis|7|||
129655817|NCT01108237|466698297|FG001|Overall Study|Did not meet criteria for analysis|0|||
129655818|NCT00564278|466698299|FG000|Overall Study|Lost to Follow-up|35|||
129655819|NCT00564278|466698300|FG001|Overall Study|Lost to Follow-up|33|||
129655820|NCT00564278|466698299|FG000|Overall Study|Physician Decision|1|||
129655821|NCT00564278|466698300|FG001|Overall Study|Physician Decision|2|||
129655822|NCT00564278|466698299|FG000|Overall Study|Withdrawal by Subject|11|||
129655823|NCT00564278|466698300|FG001|Overall Study|Withdrawal by Subject|7|||
129655824|NCT06439095|466698301|FG000|Overall Study|Lost to Follow-up|2|||
129987947|NCT02680002|467918761|FG004|Overall Study|Other|1|||
129987948|NCT02680002|467918762|FG005|Overall Study|Other|0|||
129655825|NCT03341936|466698302|FG000|Overall Study|Ineligible|1|||
129655826|NCT03341936|466698302|FG000|Overall Study|Disease Progression|2|||
129655827|NCT03341936|466698302|FG000|Overall Study|Withdrew Consent|4|||
129655828|NCT03341936|466698302|FG000|Overall Study|Non-Compliance|1|||
129655829|NCT03341936|466698302|FG000|Overall Study|Physician Decision|1|||
129655830|NCT03341936|466698302|FG000|Overall Study|Withdrawal by Subject|1|||
129655831|NCT03341936|466698302|FG000|Overall Study|Other|1|||
129655832|NCT02368886|466698303|FG000|Overall Study|Cancel|1|||
129655833|NCT02368886|466698304|FG001|Overall Study|Cancel|1|||
129655834|NCT02368886|466698305|FG002|Overall Study|Cancel|1|||
129655835|NCT02368886|466698306|FG003|Overall Study|Cancel|3|||
129655836|NCT02368886|466698303|FG000|Overall Study|Ineligible|0|||
129655837|NCT02368886|466698304|FG001|Overall Study|Ineligible|0|||
129655838|NCT02368886|466698305|FG002|Overall Study|Ineligible|0|||
129655839|NCT02368886|466698306|FG003|Overall Study|Ineligible|1|||
129655840|NCT02131636|466698311|FG000|Overall Study|Personal Reasons|4|||
129655841|NCT02131636|466698312|FG001|Overall Study|Personal Reasons|4|||
129655842|NCT02131636|466698311|FG000|Overall Study|Lost to Follow-up|4|||
129655843|NCT02131636|466698312|FG001|Overall Study|Lost to Follow-up|0|||
129655844|NCT02131636|466698311|FG000|Overall Study|Adverse Event|4|||
129655845|NCT02131636|466698312|FG001|Overall Study|Adverse Event|1|||
129655846|NCT02173379|466698313|FG000|Overall Study|Lost to Follow-up|89|||
129655847|NCT02173379|466698314|FG001|Overall Study|Lost to Follow-up|81|||
129655848|NCT02173379|466698313|FG000|Overall Study|Withdrawal by Subject|24|||
129655849|NCT02173379|466698314|FG001|Overall Study|Withdrawal by Subject|29|||
129655850|NCT02173379|466698313|FG000|Overall Study|Physician Decision|8|||
129655851|NCT02173379|466698314|FG001|Overall Study|Physician Decision|8|||
129655852|NCT02173379|466698313|FG000|Overall Study|Death|75|||
129655853|NCT02173379|466698314|FG001|Overall Study|Death|72|||
129655854|NCT02173379|466698313|FG000|Overall Study|Other Reason|1|||
129655855|NCT02173379|466698314|FG001|Overall Study|Other Reason|0|||
129655856|NCT00715520|466698319|FG000|Overall Study|Screen failure|8|||
129655857|NCT00715520|466698320|FG001|Overall Study|Screen failure|1|||
129655858|NCT00715520|466698321|FG002|Overall Study|Screen failure|1|||
129655859|NCT00715520|466698319|FG000|Overall Study|Withdrawal by Subject|2|||
129655860|NCT00715520|466698320|FG001|Overall Study|Withdrawal by Subject|0|||
129655861|NCT00715520|466698321|FG002|Overall Study|Withdrawal by Subject|1|||
129655862|NCT02290925|466698323|FG000|First Period of Three Months|Lost to Follow-up|2|||
129655863|NCT02290925|466698324|FG001|First Period of Three Months|Lost to Follow-up|1|||
129655864|NCT02290925|466698323|FG000|First Period of Three Months|Death|1|||
129655865|NCT02290925|466698324|FG001|First Period of Three Months|Death|0|||
129655866|NCT02290925|466698323|FG000|First Period of Three Months|Insulin Started|1|||
129655867|NCT02290925|466698324|FG001|First Period of Three Months|Insulin Started|1|||
129655868|NCT02290925|466698323|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
129655869|NCT02290925|466698324|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
129655870|NCT02290925|466698323|FG000|Second Period of 3 Months|insulin started|0|||
129655871|NCT02290925|466698324|FG001|Second Period of 3 Months|insulin started|1|||
129655872|NCT04942210|466698325|FG000|Overall Study|Adverse Event|0|||
129655873|NCT04942210|466698326|FG001|Overall Study|Adverse Event|1|||
129655874|NCT04942210|466698325|FG000|Overall Study|Protocol Deviation|4|||
129655875|NCT04942210|466698326|FG001|Overall Study|Protocol Deviation|1|||
129655876|NCT04942210|466698325|FG000|Overall Study|Withdrawal by Subject|5|||
129655877|NCT04942210|466698326|FG001|Overall Study|Withdrawal by Subject|2|||
129655878|NCT04942210|466698325|FG000|Overall Study|Lost to Follow-up|16|||
129655879|NCT04942210|466698326|FG001|Overall Study|Lost to Follow-up|7|||
129655880|NCT04942210|466698325|FG000|Overall Study|Ongoing at the time of DBL date|60|||
129655881|NCT04942210|466698326|FG001|Overall Study|Ongoing at the time of DBL date|25|||
129655882|NCT04942210|466698325|FG000|Overall Study|Randomized but did not receive vaccination|3|||
129655883|NCT04942210|466698326|FG001|Overall Study|Randomized but did not receive vaccination|0|||
129987949|NCT02680002|467918757|FG000|Overall Study|Adverse Event|0|||
129987950|NCT02680002|467918758|FG001|Overall Study|Adverse Event|0|||
129987951|NCT02680002|467918759|FG002|Overall Study|Adverse Event|0|||
129987952|NCT02680002|467918760|FG003|Overall Study|Adverse Event|0|||
129987953|NCT02680002|467918761|FG004|Overall Study|Adverse Event|1|||
129987954|NCT02680002|467918762|FG005|Overall Study|Adverse Event|2|||
129987955|NCT03527173|467918765|FG000|Overall Study|Lost to Follow-up|4|||
129987956|NCT03527173|467918766|FG001|Overall Study|Lost to Follow-up|2|||
129987957|NCT03527173|467918765|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
129987958|NCT03527173|467918766|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
129655884|NCT05697627|466698327|FG000|Overall Study|Adverse Event|1|||
129655885|NCT02570750|466698328|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
129655886|NCT02570750|466698329|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
129655887|NCT02570750|466698328|FG000|Overall Study|Protocol deviation|4|||
129655888|NCT02570750|466698329|FG001|Overall Study|Protocol deviation|2|||
129655889|NCT02570750|466698328|FG000|Overall Study|Withdrawal by Subject|5|||
129655890|NCT02570750|466698329|FG001|Overall Study|Withdrawal by Subject|0|||
129655891|NCT02570750|466698328|FG000|Overall Study|Lost to Follow-up|2|||
129655892|NCT02570750|466698329|FG001|Overall Study|Lost to Follow-up|2|||
129655893|NCT02570750|466698328|FG000|Overall Study|Adverse Event|2|||
129655894|NCT02570750|466698329|FG001|Overall Study|Adverse Event|1|||
129655895|NCT04122625|466698330|FG000|Part A (up to 2.92 Years)|Death|2|||
129655896|NCT04122625|466698331|FG001|Part A (up to 2.92 Years)|Death|4|||
129655897|NCT04122625|466698332|FG002|Part A (up to 2.92 Years)|Death|0|||
129655898|NCT04122625|466698333|FG003|Part A (up to 2.92 Years)|Death|0|||
129987959|NCT03527173|467918765|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
129987960|NCT03527173|467918766|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
129987961|NCT03527173|467918765|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129987962|NCT03527173|467918766|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129987963|NCT01248780|467918771|FG000|Overall Study|Lack of Efficacy|2|||
129987964|NCT01248780|467918772|FG001|Overall Study|Lack of Efficacy|0|||
129987965|NCT01248780|467918771|FG000|Overall Study|Lost to Follow-up|0|||
129987966|NCT01248780|467918772|FG001|Overall Study|Lost to Follow-up|1|||
129987967|NCT01248780|467918771|FG000|Overall Study|Death|0|||
129987968|NCT01248780|467918772|FG001|Overall Study|Death|1|||
129987969|NCT01248780|467918771|FG000|Overall Study|Adverse Event|2|||
129987970|NCT01248780|467918772|FG001|Overall Study|Adverse Event|7|||
129987971|NCT01248780|467918771|FG000|Overall Study|Protocol Violation|1|||
129987972|NCT01248780|467918772|FG001|Overall Study|Protocol Violation|1|||
129987973|NCT01248780|467918771|FG000|Overall Study|Withdrawal by Subject|4|||
129987974|NCT01248780|467918772|FG001|Overall Study|Withdrawal by Subject|4|||
129987975|NCT01248780|467918771|FG000|Overall Study|Not treated|0|||
129987976|NCT01248780|467918772|FG001|Overall Study|Not treated|1|||
129987977|NCT02134977|467918773|FG000|Overall Study|Protocol Deviation|102|||
129987978|NCT04097301|467918774|FG000|Overall Study|Death|1|||
129987979|NCT04097301|467918774|FG000|Overall Study|Withdrawal by Subject|1|||
129987980|NCT04097301|467918774|FG000|Overall Study|Screening Failure|5|||
129987981|NCT01773291|467918775|FG000|Overall Study|Protocol Violation|1|||
129987982|NCT01773291|467918776|FG001|Overall Study|Protocol Violation|0|||
129987983|NCT01773291|467918777|FG002|Overall Study|Protocol Violation|0|||
129987984|NCT01773291|467918775|FG000|Overall Study|Withdrawal by Subject|0|||
129987985|NCT01773291|467918776|FG001|Overall Study|Withdrawal by Subject|0|||
129987986|NCT01773291|467918777|FG002|Overall Study|Withdrawal by Subject|1|||
129987987|NCT00203476|467918778|FG000|Overall Study|Lost to Follow-up|1|||
129987988|NCT00203476|467918779|FG001|Overall Study|Lost to Follow-up|0|||
129987989|NCT00203476|467918780|FG002|Overall Study|Lost to Follow-up|0|||
129987990|NCT00203476|467918778|FG000|Overall Study|Withdrawal by Subject|0|||
129987991|NCT00203476|467918779|FG001|Overall Study|Withdrawal by Subject|1|||
129987992|NCT00203476|467918780|FG002|Overall Study|Withdrawal by Subject|0|||
129987993|NCT01190514|467918781|FG000|First Intervention (Period 1)|Adverse Event|1|||
129987994|NCT01190514|467918782|FG001|First Intervention (Period 1)|Adverse Event|0|||
129987995|NCT01190514|467918783|FG002|First Intervention (Period 1)|Adverse Event|0|||
129987996|NCT01190514|467918784|FG003|First Intervention (Period 1)|Adverse Event|0|||
129987997|NCT01190514|467918781|FG000|Third Intervention (Period 3)|Adverse Event|1|||
129987998|NCT01190514|467918782|FG001|Third Intervention (Period 3)|Adverse Event|0|||
129987999|NCT01190514|467918783|FG002|Third Intervention (Period 3)|Adverse Event|0|||
129988000|NCT01190514|467918784|FG003|Third Intervention (Period 3)|Adverse Event|0|||
129988001|NCT03241225|467918785|FG000|Overall Study|Lost to Follow-up|2|||
129988002|NCT03241225|467918786|FG001|Overall Study|Lost to Follow-up|1|||
129988003|NCT03241225|467918785|FG000|Overall Study|Protocol Violation|4|||
129988004|NCT03241225|467918786|FG001|Overall Study|Protocol Violation|1|||
129988005|NCT03241225|467918785|FG000|Overall Study|Withdrawal by Subject|1|||
129988006|NCT03241225|467918786|FG001|Overall Study|Withdrawal by Subject|0|||
129988007|NCT01970345|467918791|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
129988008|NCT01970345|467918792|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
129988009|NCT01970345|467918791|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
129988010|NCT01970345|467918792|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
129988011|NCT03932812|467918799|FG000|Overall Study|Lost to Follow-up|12|||
129988012|NCT03932812|467918800|FG001|Overall Study|Lost to Follow-up|14|||
129988013|NCT03932812|467918799|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
129988014|NCT03932812|467918800|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
129988015|NCT02585232|467918805|FG000|Overall Study|Lost to Follow-up|8|||
129988016|NCT02585232|467918806|FG001|Overall Study|Lost to Follow-up|8|||
129988017|NCT02585232|467918805|FG000|Overall Study|Withdrawal by Subject|4|||
129988018|NCT02585232|467918806|FG001|Overall Study|Withdrawal by Subject|8|||
129988019|NCT03215810|467918807|FG000|Overall Study|Still responding to nivolumab|1|||
129988020|NCT03215810|467918807|FG000|Overall Study|Insufficient TIL growth|1|||
129988021|NCT03215810|467918807|FG000|Overall Study|Decline in performance status|1|||
129988022|NCT03215810|467918807|FG000|Overall Study|Withdrawal by Subject|1|||
129988023|NCT02313233|467918808|FG000|Overall Study|Withdrawal by Subject|1|||
129988024|NCT02313233|467918809|FG001|Overall Study|Withdrawal by Subject|2|||
129988025|NCT02313233|467918808|FG000|Overall Study|Administrative reason|1|||
129988026|NCT02313233|467918809|FG001|Overall Study|Administrative reason|1|||
129988027|NCT02679573|467918812|FG000|Overall Study|Adverse Event|13|||
129988028|NCT02679573|467918813|FG001|Overall Study|Adverse Event|6|||
129988029|NCT02679573|467918812|FG000|Overall Study|Lack of Efficacy|12|||
129655899|NCT04122625|466698334|FG004|Part A (up to 2.92 Years)|Death|0|||
129988030|NCT02679573|467918813|FG001|Overall Study|Lack of Efficacy|15|||
129988031|NCT02679573|467918812|FG000|Overall Study|Could not complete required study visits|6|||
129988032|NCT02679573|467918813|FG001|Overall Study|Could not complete required study visits|2|||
129988033|NCT02679573|467918812|FG000|Overall Study|Withdrawal by Subject|2|||
129988034|NCT02679573|467918813|FG001|Overall Study|Withdrawal by Subject|9|||
129655900|NCT04122625|466698335|FG005|Part A (up to 2.92 Years)|Death|0|||
129655901|NCT04122625|466698330|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
129655902|NCT04122625|466698331|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
129655903|NCT04122625|466698332|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
129655904|NCT04122625|466698333|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
129655905|NCT04122625|466698334|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
129655906|NCT04122625|466698335|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
129655907|NCT04122625|466698330|FG000|Part B (up to 2.33 Years)|Death|0|||
129655908|NCT04122625|466698331|FG001|Part B (up to 2.33 Years)|Death|0|||
129655909|NCT04122625|466698332|FG002|Part B (up to 2.33 Years)|Death|5|||
129655910|NCT04122625|466698333|FG003|Part B (up to 2.33 Years)|Death|7|||
129655911|NCT04122625|466698334|FG004|Part B (up to 2.33 Years)|Death|6|||
129655912|NCT04122625|466698335|FG005|Part B (up to 2.33 Years)|Death|7|||
129655913|NCT01410240|466698336|FG000|Overall Study|Physician Decision|0|||
129655914|NCT01410240|466698337|FG001|Overall Study|Physician Decision|0|||
129655915|NCT01410240|466698338|FG002|Overall Study|Physician Decision|1|||
129655916|NCT01410240|466698336|FG000|Overall Study|Missed week 6 assessments|1|||
129655917|NCT01410240|466698337|FG001|Overall Study|Missed week 6 assessments|1|||
129655918|NCT01410240|466698338|FG002|Overall Study|Missed week 6 assessments|1|||
129655919|NCT02776670|466698339|FG000|Overall Study|Adverse Event|0|||
129655920|NCT02776670|466698340|FG001|Overall Study|Adverse Event|2|||
129655921|NCT02776670|466698339|FG000|Overall Study|Protocol Violation|0|||
129655922|NCT02776670|466698340|FG001|Overall Study|Protocol Violation|2|||
129655923|NCT02776670|466698339|FG000|Overall Study|Withdrawal by Subject|0|||
129655924|NCT02776670|466698340|FG001|Overall Study|Withdrawal by Subject|1|||
129655925|NCT02776670|466698339|FG000|Overall Study|Other - Reason not given|0|||
129655926|NCT02776670|466698340|FG001|Overall Study|Other - Reason not given|1|||
129655927|NCT02697591|466698343|FG000|Overall Study|Lost to Follow-up|0|||
129655928|NCT02697591|466698344|FG001|Overall Study|Lost to Follow-up|0|||
129655929|NCT02697591|466698345|FG002|Overall Study|Lost to Follow-up|0|||
129655930|NCT02697591|466698346|FG003|Overall Study|Lost to Follow-up|0|||
129655931|NCT02697591|466698347|FG004|Overall Study|Lost to Follow-up|0|||
129655932|NCT02697591|466698348|FG005|Overall Study|Lost to Follow-up|1|||
129655933|NCT02697591|466698349|FG006|Overall Study|Lost to Follow-up|1|||
129655934|NCT02697591|466698350|FG007|Overall Study|Lost to Follow-up|0|||
129655935|NCT02697591|466698351|FG008|Overall Study|Lost to Follow-up|0|||
129655936|NCT02697591|466698352|FG009|Overall Study|Lost to Follow-up|1|||
129655937|NCT02697591|466698343|FG000|Overall Study|Withdrawal by Subject|1|||
129655938|NCT02697591|466698344|FG001|Overall Study|Withdrawal by Subject|1|||
129655939|NCT02697591|466698345|FG002|Overall Study|Withdrawal by Subject|2|||
129655940|NCT02697591|466698346|FG003|Overall Study|Withdrawal by Subject|1|||
129655941|NCT02697591|466698347|FG004|Overall Study|Withdrawal by Subject|7|||
129655942|NCT02697591|466698348|FG005|Overall Study|Withdrawal by Subject|6|||
129655943|NCT02697591|466698349|FG006|Overall Study|Withdrawal by Subject|9|||
129655944|NCT02697591|466698350|FG007|Overall Study|Withdrawal by Subject|1|||
129655945|NCT02697591|466698351|FG008|Overall Study|Withdrawal by Subject|6|||
129655946|NCT02697591|466698352|FG009|Overall Study|Withdrawal by Subject|10|||
129655947|NCT02697591|466698343|FG000|Overall Study|Physician Decision|1|||
129655948|NCT02697591|466698344|FG001|Overall Study|Physician Decision|0|||
129655949|NCT02697591|466698345|FG002|Overall Study|Physician Decision|0|||
129655950|NCT02697591|466698346|FG003|Overall Study|Physician Decision|0|||
129655951|NCT02697591|466698347|FG004|Overall Study|Physician Decision|1|||
129655952|NCT02697591|466698348|FG005|Overall Study|Physician Decision|2|||
129988035|NCT02679573|467918812|FG000|Overall Study|Death|2|||
129988036|NCT02679573|467918813|FG001|Overall Study|Death|0|||
129988037|NCT02679573|467918812|FG000|Overall Study|Physician Decision|2|||
129988038|NCT02679573|467918813|FG001|Overall Study|Physician Decision|4|||
129988039|NCT02679573|467918812|FG000|Overall Study|Lost to Follow-up|0|||
129988040|NCT02679573|467918813|FG001|Overall Study|Lost to Follow-up|3|||
129988041|NCT01502631|467918814|FG000|Overall Study|Adverse Event|5|||
129988042|NCT01502631|467918815|FG001|Overall Study|Adverse Event|8|||
129988043|NCT01502631|467918814|FG000|Overall Study|Lost to Follow-up|2|||
129655953|NCT02697591|466698349|FG006|Overall Study|Physician Decision|0|||
129655954|NCT02697591|466698350|FG007|Overall Study|Physician Decision|0|||
129655955|NCT02697591|466698351|FG008|Overall Study|Physician Decision|1|||
129655956|NCT02697591|466698352|FG009|Overall Study|Physician Decision|1|||
129655957|NCT02697591|466698343|FG000|Overall Study|Death|2|||
129655958|NCT02697591|466698344|FG001|Overall Study|Death|3|||
129655959|NCT02697591|466698345|FG002|Overall Study|Death|1|||
129655960|NCT02697591|466698346|FG003|Overall Study|Death|1|||
129655961|NCT02697591|466698347|FG004|Overall Study|Death|4|||
129655962|NCT02697591|466698348|FG005|Overall Study|Death|5|||
129988044|NCT01502631|467918815|FG001|Overall Study|Lost to Follow-up|2|||
129988045|NCT01502631|467918814|FG000|Overall Study|Participant withdrew consent|2|||
129988046|NCT01502631|467918815|FG001|Overall Study|Participant withdrew consent|4|||
129988047|NCT01502631|467918814|FG000|Overall Study|Participant non-compliant|1|||
129655963|NCT02697591|466698349|FG006|Overall Study|Death|3|||
129655964|NCT02697591|466698350|FG007|Overall Study|Death|1|||
129655965|NCT02697591|466698351|FG008|Overall Study|Death|1|||
129655966|NCT02697591|466698352|FG009|Overall Study|Death|5|||
129655967|NCT02697591|466698343|FG000|Overall Study|Reason not Specified|0|||
129655968|NCT02697591|466698344|FG001|Overall Study|Reason not Specified|0|||
129655969|NCT02697591|466698345|FG002|Overall Study|Reason not Specified|0|||
129655970|NCT02697591|466698346|FG003|Overall Study|Reason not Specified|1|||
129655971|NCT02697591|466698347|FG004|Overall Study|Reason not Specified|1|||
129655972|NCT02697591|466698348|FG005|Overall Study|Reason not Specified|2|||
129655973|NCT02697591|466698349|FG006|Overall Study|Reason not Specified|3|||
129655974|NCT02697591|466698350|FG007|Overall Study|Reason not Specified|1|||
129655975|NCT02697591|466698351|FG008|Overall Study|Reason not Specified|1|||
129655976|NCT02697591|466698352|FG009|Overall Study|Reason not Specified|3|||
129655977|NCT04379700|466698357|FG000|Overall Study|Withdrawal by Subject|10|||
129655978|NCT04379700|466698357|FG000|Overall Study|Screen Fail|4|||
129655979|NCT04379700|466698357|FG000|Overall Study|Lost to Follow-up|3|||
129655980|NCT00592592|466698358|FG000|Overall Study|Patient found ineligible upon chart review|1|||
129655981|NCT00530790|466698359|FG000|Overall Study|Adverse Event|2|||
129655982|NCT00530790|466698359|FG000|Overall Study|Withdrawal by Subject|2|||
129655983|NCT00530790|466698359|FG000|Overall Study|Physician Decision|1|||
129655984|NCT05053035|466698360|FG000|Overall Study|Withdrawal by Subject|1|||
129655985|NCT05053035|466698361|FG001|Overall Study|Withdrawal by Subject|0|||
129655986|NCT00938587|466698364|FG000|Overall Study|Adverse Event|2|||
129655987|NCT00938587|466698365|FG001|Overall Study|Adverse Event|0|||
129655988|NCT00938587|466698366|FG002|Overall Study|Adverse Event|0|||
129655989|NCT00938587|466698367|FG003|Overall Study|Adverse Event|2|||
129655990|NCT00938587|466698364|FG000|Overall Study|Did not meet entrance criteria|0|||
129655991|NCT00938587|466698365|FG001|Overall Study|Did not meet entrance criteria|0|||
129655992|NCT00938587|466698366|FG002|Overall Study|Did not meet entrance criteria|1|||
129655993|NCT00938587|466698367|FG003|Overall Study|Did not meet entrance criteria|0|||
129655994|NCT00938587|466698364|FG000|Overall Study|Withdrawal by Subject|1|||
129655995|NCT00938587|466698365|FG001|Overall Study|Withdrawal by Subject|1|||
129655996|NCT00938587|466698366|FG002|Overall Study|Withdrawal by Subject|0|||
129655997|NCT00938587|466698367|FG003|Overall Study|Withdrawal by Subject|0|||
129655998|NCT00048997|466698372|FG000|Overall Study|Protocol Violation|7|||
129655999|NCT00048997|466698373|FG001|Overall Study|Protocol Violation|2|||
129656000|NCT00048997|466698372|FG000|Overall Study|Withdrawal by Subject|6|||
129656001|NCT00048997|466698373|FG001|Overall Study|Withdrawal by Subject|1|||
129656002|NCT02819440|466698374|FG000|Overall Study|Adverse Event|3|||
129656003|NCT02819440|466698375|FG001|Overall Study|Adverse Event|1|||
129656004|NCT02819440|466698374|FG000|Overall Study|Lost to Follow-up|1|||
129656005|NCT02819440|466698375|FG001|Overall Study|Lost to Follow-up|3|||
129656006|NCT02819440|466698374|FG000|Overall Study|Withdrawal by Subject|9|||
129656007|NCT02819440|466698375|FG001|Overall Study|Withdrawal by Subject|8|||
129656008|NCT00575510|466698378|FG000|Overall Study|Lost to Follow-up|4|||
129656009|NCT00575510|466698379|FG001|Overall Study|Lost to Follow-up|6|||
129656010|NCT00575510|466698380|FG002|Overall Study|Lost to Follow-up|9|||
129656011|NCT00575510|466698378|FG000|Overall Study|Withdrawal by Subject|1|||
129656012|NCT00575510|466698379|FG001|Overall Study|Withdrawal by Subject|0|||
129656013|NCT00575510|466698380|FG002|Overall Study|Withdrawal by Subject|0|||
129656014|NCT00575510|466698378|FG000|Overall Study|Clinic Called Patient|7|||
129656015|NCT00575510|466698379|FG001|Overall Study|Clinic Called Patient|7|||
129656016|NCT00575510|466698380|FG002|Overall Study|Clinic Called Patient|7|||
129656017|NCT00575510|466698378|FG000|Overall Study|Pregnancy|0|||
129656018|NCT00575510|466698379|FG001|Overall Study|Pregnancy|0|||
129656019|NCT00575510|466698380|FG002|Overall Study|Pregnancy|1|||
129656020|NCT02697734|466698383|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
129656021|NCT02697734|466698384|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
129656022|NCT02697734|466698383|FG000|Core Phase - up to Week 48|Adverse Event|1|||
129656023|NCT02697734|466698384|FG001|Core Phase - up to Week 48|Adverse Event|2|||
129656024|NCT02697734|466698383|FG000|Core Phase - up to Week 48|Physician Decision|1|||
129656025|NCT02697734|466698384|FG001|Core Phase - up to Week 48|Physician Decision|0|||
129656026|NCT02697734|466698383|FG000|Optional Extension Phase|Adverse Event|5|||
129656027|NCT02697734|466698384|FG001|Optional Extension Phase|Adverse Event|1|||
129883416|NCT03857841|467532426|FG000|Overall Study|Study Terminated by Sponsor|1|||
129883417|NCT03857841|467532427|FG001|Overall Study|Study Terminated by Sponsor|0|||
129883418|NCT03857841|467532428|FG002|Overall Study|Study Terminated by Sponsor|0|||
129883419|NCT03857841|467532429|FG003|Overall Study|Study Terminated by Sponsor|0|||
129883420|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883421|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
129883422|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
129883423|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883424|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883425|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883426|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
129883427|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
129988048|NCT01502631|467918815|FG001|Overall Study|Participant non-compliant|0|||
129988049|NCT01502631|467918814|FG000|Overall Study|Investigator's decision|0|||
129988050|NCT01502631|467918815|FG001|Overall Study|Investigator's decision|1|||
129988051|NCT01502631|467918814|FG000|Overall Study|Other|10|||
129988052|NCT01502631|467918815|FG001|Overall Study|Other|5|||
129988053|NCT01293487|467918816|FG000|Overall Study|Lost to Follow-up|0|||
129988054|NCT01293487|467918817|FG001|Overall Study|Lost to Follow-up|0|||
129988055|NCT01293487|467918818|FG002|Overall Study|Lost to Follow-up|0|||
129988056|NCT01293487|467918819|FG003|Overall Study|Lost to Follow-up|1|||
129988057|NCT01293487|467918820|FG004|Overall Study|Lost to Follow-up|0|||
129988058|NCT01293487|467918821|FG005|Overall Study|Lost to Follow-up|0|||
129988059|NCT01293487|467918822|FG006|Overall Study|Lost to Follow-up|0|||
129988060|NCT01293487|467918823|FG007|Overall Study|Lost to Follow-up|0|||
129988061|NCT01293487|467918816|FG000|Overall Study|Withdrawal by Subject|0|||
129988062|NCT01293487|467918817|FG001|Overall Study|Withdrawal by Subject|0|||
129988063|NCT01293487|467918818|FG002|Overall Study|Withdrawal by Subject|0|||
129988064|NCT01293487|467918819|FG003|Overall Study|Withdrawal by Subject|0|||
129988065|NCT01293487|467918820|FG004|Overall Study|Withdrawal by Subject|0|||
129988066|NCT01293487|467918821|FG005|Overall Study|Withdrawal by Subject|0|||
129988067|NCT01293487|467918822|FG006|Overall Study|Withdrawal by Subject|0|||
129988068|NCT01293487|467918823|FG007|Overall Study|Withdrawal by Subject|2|||
129988069|NCT00395460|467918824|FG000|Overall Study|Withdrawal by Subject|1|||
129988070|NCT00395460|467918825|FG001|Overall Study|Withdrawal by Subject|0|||
129988071|NCT04223830|467918832|FG000|Overall Study|Lost to Follow-up|9|||
129988072|NCT04223830|467918832|FG000|Overall Study|Adverse Event|1|||
129988073|NCT01806623|467918833|FG000|Overall Study|Withdrawal by Subject|1|||
129988074|NCT01806623|467918833|FG000|Overall Study|Adverse Event|1|||
129988075|NCT01806623|467918833|FG000|Overall Study|Did not meet the inclusion criteria|56|||
129988076|NCT01964924|467918834|FG000|Trametinib Monotherapy|Progression|19|||
129656028|NCT02697734|466698383|FG000|Optional Extension Phase|Physician Decision|0|||
129656029|NCT02697734|466698384|FG001|Optional Extension Phase|Physician Decision|1|||
129656030|NCT02651688|466698387|FG000|Overall Study|Non-compliance|0|||
129988077|NCT01964924|467918835|FG001|Trametinib Monotherapy|Progression|0|||
129988078|NCT01153958|467918836|FG000|Overall Study|Study Terminated|36|||
129988079|NCT01153958|467918837|FG001|Overall Study|Study Terminated|32|||
129988080|NCT01034163|467918838|FG000|Overall Study|Treatment completed as per protocol|8|||
129988081|NCT01034163|467918839|FG001|Overall Study|Treatment completed as per protocol|7|||
129656031|NCT02651688|466698388|FG001|Overall Study|Non-compliance|0|||
129656032|NCT02651688|466698389|FG002|Overall Study|Non-compliance|1|||
129656033|NCT02651688|466698387|FG000|Overall Study|Principal Investigator (PI) decision|0|||
129656034|NCT02651688|466698388|FG001|Overall Study|Principal Investigator (PI) decision|2|||
129656035|NCT02651688|466698389|FG002|Overall Study|Principal Investigator (PI) decision|0|||
129656036|NCT02651688|466698387|FG000|Overall Study|Lost to Follow-up|1|||
129656037|NCT02651688|466698388|FG001|Overall Study|Lost to Follow-up|3|||
129656038|NCT02651688|466698389|FG002|Overall Study|Lost to Follow-up|0|||
129656039|NCT02651688|466698387|FG000|Overall Study|Withdrawal by Subject|1|||
129656040|NCT02651688|466698388|FG001|Overall Study|Withdrawal by Subject|0|||
129656041|NCT02651688|466698389|FG002|Overall Study|Withdrawal by Subject|2|||
129656042|NCT00731731|466698390|FG000|Overall Study|Protocol Violation|0|||
129656043|NCT00731731|466698391|FG001|Overall Study|Protocol Violation|0|||
129656044|NCT00731731|466698392|FG002|Overall Study|Protocol Violation|1|||
129656045|NCT00731731|466698390|FG000|Overall Study|Cancel prior to treatment|0|||
129656046|NCT00731731|466698391|FG001|Overall Study|Cancel prior to treatment|0|||
129656047|NCT00731731|466698392|FG002|Overall Study|Cancel prior to treatment|2|||
129656048|NCT03970200|466698393|FG000|Overall Study|Death|2|||
129656049|NCT03970200|466698394|FG001|Overall Study|Death|2|||
129656050|NCT03970200|466698395|FG002|Overall Study|Death|1|||
129656051|NCT03970200|466698393|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
129656052|NCT03970200|466698394|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
129656053|NCT03970200|466698395|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
129656054|NCT01693185|466698396|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
129656055|NCT01693185|466698397|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
129656056|NCT01429441|466698398|FG000|Overall Study|Adverse Event|5|||
129656057|NCT01429441|466698399|FG001|Overall Study|Adverse Event|1|||
129656058|NCT01429441|466698398|FG000|Overall Study|Death|0|||
129656059|NCT01429441|466698399|FG001|Overall Study|Death|2|||
129656060|NCT01429441|466698398|FG000|Overall Study|Lost to Follow-up|5|||
129656061|NCT01429441|466698399|FG001|Overall Study|Lost to Follow-up|2|||
129988082|NCT01034163|467918838|FG000|Overall Study|Withdrawal by Subject|8|||
129988083|NCT01034163|467918839|FG001|Overall Study|Withdrawal by Subject|2|||
129988084|NCT01034163|467918838|FG000|Overall Study|Protocol deviation|1|||
129988085|NCT01034163|467918839|FG001|Overall Study|Protocol deviation|0|||
129988086|NCT01034163|467918838|FG000|Overall Study|Disease progression|3|||
129988087|NCT01034163|467918839|FG001|Overall Study|Disease progression|4|||
129988088|NCT01034163|467918838|FG000|Overall Study|Adverse Event|6|||
129988089|NCT01034163|467918839|FG001|Overall Study|Adverse Event|0|||
129656062|NCT01429441|466698398|FG000|Overall Study|Physician Decision|1|||
129656063|NCT01429441|466698399|FG001|Overall Study|Physician Decision|0|||
129656064|NCT01429441|466698398|FG000|Overall Study|Withdrawal by Subject|27|||
129656065|NCT01429441|466698399|FG001|Overall Study|Withdrawal by Subject|18|||
129656066|NCT02279745|466698400|FG000|Overall Study|Adverse Event|7|||
129656067|NCT02279745|466698400|FG000|Overall Study|Death|6|||
129656068|NCT02279745|466698400|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
129656069|NCT02279745|466698400|FG000|Overall Study|Withdrawal by Subject|2|||
129656070|NCT02279745|466698400|FG000|Overall Study|Pregnancy|1|||
129656071|NCT02279745|466698400|FG000|Overall Study|Study Non-compliance|1|||
129656072|NCT02279745|466698400|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
129656073|NCT00380718|466698401|FG000|Overall Study|Adverse Event|1|||
129656074|NCT00380718|466698401|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
129656075|NCT01606748|466698402|FG000|Overall Study|Adverse Event|1|||
129656076|NCT01606748|466698403|FG001|Overall Study|Adverse Event|0|||
129656077|NCT01606748|466698402|FG000|Overall Study|Progressive Disease|1|||
129656078|NCT01606748|466698403|FG001|Overall Study|Progressive Disease|0|||
129656079|NCT01606748|466698402|FG000|Overall Study|Withdrawal by Subject|1|||
129656080|NCT01606748|466698403|FG001|Overall Study|Withdrawal by Subject|0|||
129656081|NCT03742258|466698407|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
129656082|NCT03742258|466698408|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
129656083|NCT03742258|466698409|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
129656084|NCT03742258|466698407|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
129656085|NCT03742258|466698408|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
129656086|NCT03742258|466698409|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
129656087|NCT03742258|466698407|FG000|Survival Follow-Up|Still in Follow-up|0|||
129656088|NCT03742258|466698408|FG001|Survival Follow-Up|Still in Follow-up|0|||
129656089|NCT03742258|466698409|FG002|Survival Follow-Up|Still in Follow-up|2|||
129656090|NCT02083653|466698410|FG000|Overall Study|Randomized but not Treated|0|||
129656091|NCT02083653|466698411|FG001|Overall Study|Randomized but not Treated|2|||
129656092|NCT02083653|466698412|FG002|Overall Study|Randomized but not Treated|7|||
129656093|NCT02083653|466698410|FG000|Overall Study|Adverse Event|12|||
129656094|NCT02083653|466698411|FG001|Overall Study|Adverse Event|5|||
129656095|NCT02083653|466698412|FG002|Overall Study|Adverse Event|4|||
129656096|NCT02083653|466698410|FG000|Overall Study|Lost to Follow-up|1|||
129656097|NCT02083653|466698411|FG001|Overall Study|Lost to Follow-up|0|||
129656098|NCT02083653|466698412|FG002|Overall Study|Lost to Follow-up|0|||
129656099|NCT02083653|466698410|FG000|Overall Study|Death|2|||
129656100|NCT02083653|466698411|FG001|Overall Study|Death|2|||
129656101|NCT02083653|466698412|FG002|Overall Study|Death|2|||
129656102|NCT02083653|466698410|FG000|Overall Study|Progressive Disease|65|||
129656103|NCT02083653|466698411|FG001|Overall Study|Progressive Disease|73|||
129656104|NCT02083653|466698412|FG002|Overall Study|Progressive Disease|63|||
129656105|NCT02083653|466698410|FG000|Overall Study|Withdrawal by Subject|2|||
129656106|NCT02083653|466698411|FG001|Overall Study|Withdrawal by Subject|1|||
129656107|NCT02083653|466698412|FG002|Overall Study|Withdrawal by Subject|2|||
129656108|NCT02083653|466698410|FG000|Overall Study|Other Events|0|||
129656109|NCT02083653|466698411|FG001|Overall Study|Other Events|2|||
129656110|NCT02083653|466698412|FG002|Overall Study|Other Events|2|||
129656111|NCT02083653|466698410|FG000|Overall Study|Reason Missing|0|||
129656112|NCT02083653|466698411|FG001|Overall Study|Reason Missing|0|||
129656113|NCT02083653|466698412|FG002|Overall Study|Reason Missing|4|||
129656114|NCT03084315|466698413|FG000|Overall Study|Lost to Follow-up|8|||
129656115|NCT03084315|466698414|FG001|Overall Study|Lost to Follow-up|7|||
129656116|NCT03084315|466698413|FG000|Overall Study|Withdrawal by Subject|2|||
129656117|NCT03084315|466698414|FG001|Overall Study|Withdrawal by Subject|2|||
129656118|NCT01952080|466698416|FG000|Overall Study|Withdrawal by Subject|0|||
129656119|NCT01952080|466698417|FG001|Overall Study|Withdrawal by Subject|0|||
129656120|NCT01952080|466698418|FG002|Overall Study|Withdrawal by Subject|0|||
129656121|NCT01952080|466698419|FG003|Overall Study|Withdrawal by Subject|1|||
129656122|NCT01952080|466698416|FG000|Overall Study|Protocol Non-compliance|0|||
129656123|NCT01952080|466698417|FG001|Overall Study|Protocol Non-compliance|1|||
129656124|NCT01952080|466698418|FG002|Overall Study|Protocol Non-compliance|0|||
129656125|NCT01952080|466698419|FG003|Overall Study|Protocol Non-compliance|0|||
129656126|NCT00564395|466698420|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
129656127|NCT00564395|466698421|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
129883428|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883429|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883430|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883431|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883432|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129656128|NCT00564395|466698420|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
129656129|NCT00564395|466698421|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
129656130|NCT00594386|466698422|FG000|Overall Study|Major protocol violation|2|||
129656131|NCT00594386|466698422|FG000|Overall Study|Lack of Efficacy|12|||
129656132|NCT00594386|466698422|FG000|Overall Study|Adverse Event|68|||
129656133|NCT00594386|466698422|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
129656134|NCT00594386|466698422|FG000|Overall Study|Subject withdrew consent|35|||
129656135|NCT00594386|466698422|FG000|Overall Study|Study ended per sponsor|115|||
129656136|NCT00594386|466698422|FG000|Overall Study|Lost to Follow-up|6|||
129656137|NCT00594386|466698422|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
129656138|NCT00594386|466698422|FG000|Overall Study|Other: Subject moved to Seattle|1|||
129656139|NCT00594386|466698422|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
129656140|NCT00594386|466698422|FG000|Overall Study|Other: Study terminated per investigator|2|||
129656141|NCT00594386|466698422|FG000|Overall Study|Other: Sponsor closure of study|1|||
129656142|NCT00594386|466698422|FG000|Overall Study|Other: Site terminated participation|1|||
129656143|NCT00594386|466698422|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
129656144|NCT00594386|466698422|FG000|Overall Study|Other: Loss of drivers license|1|||
129656145|NCT00094536|466698423|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
129656146|NCT00094536|466698423|FG000|Treatment and Follow-up|Adverse Event|4|||
129656147|NCT00094536|466698423|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
129656148|NCT00094536|466698423|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
129656149|NCT00094536|466698423|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
129656150|NCT00094536|466698423|FG000|Treatment and Follow-up|Subject non-compliance|9|||
129656151|NCT00094536|466698423|FG000|Treatment and Follow-up|Unable to attend visits|1|||
129656152|NCT01687283|466700199|FG000|Overall Study|Adverse Event|11|||
129656153|NCT01687283|466700200|FG001|Overall Study|Adverse Event|4|||
129656154|NCT01687283|466700199|FG000|Overall Study|Lack of Efficacy|3|||
129656155|NCT01687283|466700200|FG001|Overall Study|Lack of Efficacy|1|||
129656156|NCT01687283|466700199|FG000|Overall Study|Protocol Violation|1|||
129656157|NCT01687283|466700200|FG001|Overall Study|Protocol Violation|3|||
129656158|NCT01687283|466700199|FG000|Overall Study|protocol defined stopping criteria|8|||
129656159|NCT01687283|466700200|FG001|Overall Study|protocol defined stopping criteria|10|||
129656160|NCT01687283|466700199|FG000|Overall Study|Lost to Follow-up|1|||
129656161|NCT01687283|466700200|FG001|Overall Study|Lost to Follow-up|1|||
129656162|NCT01687283|466700199|FG000|Overall Study|Investigator discretion|2|||
129656163|NCT01687283|466700200|FG001|Overall Study|Investigator discretion|0|||
129656164|NCT01687283|466700199|FG000|Overall Study|Withdrawal by Subject|9|||
129656165|NCT01687283|466700200|FG001|Overall Study|Withdrawal by Subject|8|||
129656166|NCT01744483|466700203|FG000|Overall Study|Death|9|||
129656167|NCT01744483|466700204|FG001|Overall Study|Death|4|||
129656168|NCT01744483|466700205|FG002|Overall Study|Death|11|||
129656169|NCT01744483|466700203|FG000|Overall Study|Lost to Follow-up|8|||
129656170|NCT01744483|466700204|FG001|Overall Study|Lost to Follow-up|9|||
129656171|NCT01744483|466700205|FG002|Overall Study|Lost to Follow-up|11|||
129656172|NCT01744483|466700203|FG000|Overall Study|Protocol Violation|1|||
129656173|NCT01744483|466700204|FG001|Overall Study|Protocol Violation|2|||
129656174|NCT01744483|466700205|FG002|Overall Study|Protocol Violation|1|||
129656175|NCT01744483|466700203|FG000|Overall Study|Withdrawal by Subject|4|||
129656176|NCT01744483|466700204|FG001|Overall Study|Withdrawal by Subject|6|||
129656177|NCT01744483|466700205|FG002|Overall Study|Withdrawal by Subject|2|||
129656178|NCT01744483|466700203|FG000|Overall Study|No ICU Admit|5|||
129656179|NCT01744483|466700204|FG001|Overall Study|No ICU Admit|1|||
129656180|NCT01744483|466700205|FG002|Overall Study|No ICU Admit|2|||
129656181|NCT01744483|466700203|FG000|Overall Study|Routed to OSH|2|||
129656182|NCT01744483|466700204|FG001|Overall Study|Routed to OSH|0|||
129656183|NCT01744483|466700205|FG002|Overall Study|Routed to OSH|1|||
129656184|NCT03041467|466700206|FG000|Overall Study|Death|46|||
129656185|NCT03041467|466700207|FG001|Overall Study|Death|39|||
129656186|NCT03041467|466700206|FG000|Overall Study|Withdrawal by Subject|36|||
129656187|NCT03041467|466700207|FG001|Overall Study|Withdrawal by Subject|37|||
129656188|NCT03041467|466700206|FG000|Overall Study|Lost to Follow-up|6|||
129656189|NCT03041467|466700207|FG001|Overall Study|Lost to Follow-up|8|||
129656190|NCT03041467|466700206|FG000|Overall Study|Declined consent for study extension|21|||
129656191|NCT03041467|466700207|FG001|Overall Study|Declined consent for study extension|33|||
129656192|NCT03041467|466700206|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
129656193|NCT03041467|466700207|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
129656194|NCT01190189|466700208|FG000|Overall Study|Lost to Follow-up|4|||
129656195|NCT01190189|466700208|FG000|Overall Study|Withdrawal by Subject|1|||
129656196|NCT01190189|466700208|FG000|Overall Study|Migrated/moved from study area|1|||
129883433|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129883434|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
129883435|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
129883436|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
129883437|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129883438|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129883439|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129656197|NCT02732015|466700209|FG000|Overall Study|Lost to Follow-up|0|||
129883440|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129656198|NCT02732015|466700210|FG001|Overall Study|Lost to Follow-up|1|||
129656199|NCT01980628|466700211|FG000|Overall Study|Adverse Event|12|||
129656200|NCT01980628|466700211|FG000|Overall Study|Physician Decision|5|||
129656201|NCT01980628|466700211|FG000|Overall Study|Withdrawal by Subject|4|||
129656202|NCT01980628|466700211|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
129656203|NCT02469168|466700213|FG000|Overall Study|Trial closed|1|||
129656204|NCT02469168|466700214|FG001|Overall Study|Trial closed|0|||
129656205|NCT01760447|466700217|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
129656206|NCT01760447|466700218|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
129656207|NCT01760447|466700219|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
129656208|NCT01760447|466700220|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
129656209|NCT01760447|466700217|FG000|Weeks 0-20|Withdrawal by Subject|2|||
129656210|NCT01760447|466700218|FG001|Weeks 0-20|Withdrawal by Subject|0|||
129656211|NCT01760447|466700219|FG002|Weeks 0-20|Withdrawal by Subject|1|||
129656212|NCT01760447|466700220|FG003|Weeks 0-20|Withdrawal by Subject|0|||
129656213|NCT01760447|466700217|FG000|Weeks 0-20|Lost to Follow-up|1|||
129656214|NCT01760447|466700218|FG001|Weeks 0-20|Lost to Follow-up|0|||
129656215|NCT01760447|466700219|FG002|Weeks 0-20|Lost to Follow-up|1|||
129656216|NCT01760447|466700220|FG003|Weeks 0-20|Lost to Follow-up|1|||
129656217|NCT01760447|466700217|FG000|Weeks 0-20|Randomized but not treated|0|||
129883441|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883442|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
129883443|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
129883444|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883445|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883446|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883447|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
129883448|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883449|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883450|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
129883451|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883452|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883453|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883454|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
129883455|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
129883456|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
129883457|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
129883458|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883459|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883460|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883461|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129883462|NCT04921969|467532430|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
129883463|NCT04921969|467532431|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
129883464|NCT04921969|467532432|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883465|NCT04921969|467532433|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883466|NCT04921969|467532434|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883467|NCT04921969|467532435|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883468|NCT04921969|467532436|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
129883469|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883470|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883471|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883472|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883473|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883474|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
129883475|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
129883476|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883477|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883478|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883479|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
129883480|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129883481|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
129883482|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129883483|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129883484|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129883485|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129883486|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
129883487|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
129656218|NCT01760447|466700218|FG001|Weeks 0-20|Randomized but not treated|0|||
129883488|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
129883489|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
129656219|NCT01760447|466700219|FG002|Weeks 0-20|Randomized but not treated|2|||
129656220|NCT01760447|466700220|FG003|Weeks 0-20|Randomized but not treated|0|||
129656221|NCT01760447|466700217|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
129656222|NCT01760447|466700218|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
129656223|NCT01760447|466700219|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
129656224|NCT01760447|466700220|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
129656225|NCT01760447|466700217|FG000|Weeks 20-54|Withdrawal by Subject|2|||
129656226|NCT01760447|466700218|FG001|Weeks 20-54|Withdrawal by Subject|1|||
129656227|NCT01760447|466700219|FG002|Weeks 20-54|Withdrawal by Subject|1|||
129656228|NCT01760447|466700220|FG003|Weeks 20-54|Withdrawal by Subject|2|||
129656229|NCT01760447|466700217|FG000|Weeks 20-54|Lost to Follow-up|0|||
129656230|NCT01760447|466700218|FG001|Weeks 20-54|Lost to Follow-up|0|||
129656231|NCT01760447|466700219|FG002|Weeks 20-54|Lost to Follow-up|1|||
129656232|NCT01760447|466700220|FG003|Weeks 20-54|Lost to Follow-up|2|||
129656233|NCT00255840|466700223|FG000|Overall Study|Lost to Follow-up|10|||
129656234|NCT00255840|466700224|FG001|Overall Study|Lost to Follow-up|14|||
129656235|NCT00255840|466700223|FG000|Overall Study|Discontinued intervention|53|||
129656236|NCT00255840|466700224|FG001|Overall Study|Discontinued intervention|56|||
129656237|NCT04278924|466700226|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
129656238|NCT04278924|466700227|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
129656239|NCT04278924|466700228|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129656240|NCT04278924|466700229|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
129656241|NCT04278924|466700230|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129656242|NCT04278924|466700231|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129656243|NCT04278924|466700232|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
129656244|NCT04278924|466700226|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
129656245|NCT04278924|466700227|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
129656246|NCT04278924|466700228|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
129656247|NCT04278924|466700229|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
129656248|NCT04278924|466700230|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
129656249|NCT04278924|466700231|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
129656250|NCT04278924|466700232|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
129656251|NCT06226649|466700233|FG000|Overall Study|Withdrawal by Subject|4|||
129656252|NCT06226649|466700234|FG001|Overall Study|Withdrawal by Subject|1|||
129656253|NCT04847232|466700235|FG000|Overall Study|Death|123|||
129656254|NCT04847232|466700236|FG001|Overall Study|Death|115|||
129656255|NCT04847232|466700235|FG000|Overall Study|Lost to Follow-up|3|||
129656256|NCT04847232|466700236|FG001|Overall Study|Lost to Follow-up|10|||
129656257|NCT04847232|466700235|FG000|Overall Study|Withdrawal by Subject|73|||
129656258|NCT04847232|466700236|FG001|Overall Study|Withdrawal by Subject|101|||
129656259|NCT04847232|466700235|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
129656260|NCT04847232|466700236|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
129656261|NCT00631163|466700237|FG000|Number of Participants in Year 1|Adverse Event|12|||
129656262|NCT00631163|466700237|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
129656263|NCT00631163|466700237|FG000|Number of Participants in Year 1|Death|6|||
129656264|NCT00631163|466700237|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
129656265|NCT00631163|466700237|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
129656266|NCT00631163|466700237|FG000|Number of Participants in Year 1|Administrative problems|6|||
129656267|NCT00631163|466700237|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
129656268|NCT00631163|466700237|FG000|Number of Participants in Year 2|Adverse Event|1|||
129656269|NCT00631163|466700237|FG000|Number of Participants in Year 2|Protocol Violation|1|||
129656270|NCT00631163|466700237|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
129656271|NCT04348500|466700240|FG000|Overall Study|Death|2|||
129656272|NCT04348500|466700241|FG001|Overall Study|Death|2|||
129656273|NCT04348500|466700240|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
129656274|NCT04348500|466700241|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
129656275|NCT03699540|466700242|FG000|Overall Study|Lost to Follow-up|1|||
129656276|NCT00624832|466700245|FG000|Overall Study|Adverse Event|0|||
129656277|NCT00624832|466700246|FG001|Overall Study|Adverse Event|1|||
129656278|NCT00624832|466700247|FG002|Overall Study|Adverse Event|0|||
129656279|NCT00624832|466700248|FG003|Overall Study|Adverse Event|1|||
129656280|NCT00624832|466700245|FG000|Overall Study|Abnormal Laboratory Value|2|||
129656281|NCT00624832|466700246|FG001|Overall Study|Abnormal Laboratory Value|0|||
129656282|NCT00624832|466700247|FG002|Overall Study|Abnormal Laboratory Value|0|||
129656283|NCT00624832|466700248|FG003|Overall Study|Abnormal Laboratory Value|0|||
129656284|NCT02700698|466700249|FG000|Overall Study|Withdrawal by Subject|1|||
129656285|NCT02700698|466700250|FG001|Overall Study|Withdrawal by Subject|0|||
129656286|NCT03517449|466700257|FG000|Overall Study|Death|184|||
129656287|NCT03517449|466700258|FG001|Overall Study|Death|236|||
129656288|NCT03517449|466700257|FG000|Overall Study|Lost to Follow-up|0|||
129656289|NCT03517449|466700258|FG001|Overall Study|Lost to Follow-up|2|||
129656290|NCT03517449|466700257|FG000|Overall Study|Withdrawal by Subject|7|||
129656291|NCT03517449|466700258|FG001|Overall Study|Withdrawal by Subject|26|||
129656292|NCT03517449|466700257|FG000|Overall Study|Participants Ongoing|220|||
129656293|NCT03517449|466700258|FG001|Overall Study|Participants Ongoing|152|||
129883490|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
129545752|NCT00902486|466289830|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
129545753|NCT00902486|466289831|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
129545754|NCT00902486|466289832|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
129545755|NCT00902486|466289833|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
129545756|NCT00902486|466289828|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
129545757|NCT00902486|466289829|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
129545758|NCT00902486|466289830|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
129545759|NCT00902486|466289831|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
129545760|NCT00902486|466289832|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
129545761|NCT00902486|466289833|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
129545762|NCT00902486|466289828|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
129545763|NCT00902486|466289829|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
129545764|NCT00902486|466289830|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
129545765|NCT00902486|466289831|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
129545766|NCT00902486|466289832|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
129545767|NCT00902486|466289833|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
129545768|NCT00902486|466289828|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
129545769|NCT00902486|466289829|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
129545770|NCT00902486|466289830|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
129545771|NCT00902486|466289831|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
129545772|NCT00902486|466289832|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
129545773|NCT00902486|466289833|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
129545774|NCT00902486|466289828|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
129545775|NCT00902486|466289829|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
129545776|NCT00902486|466289830|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
129545777|NCT00902486|466289831|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
129545778|NCT00902486|466289832|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
129545779|NCT00902486|466289833|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
129545780|NCT00902486|466289828|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
129545781|NCT00902486|466289829|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
129545782|NCT00902486|466289830|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
129545783|NCT00902486|466289831|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
129545784|NCT00902486|466289832|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
129545785|NCT00902486|466289833|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
129545786|NCT00902486|466289828|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
129545787|NCT00902486|466289829|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
129545788|NCT00902486|466289830|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
129545789|NCT00902486|466289831|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
129545790|NCT00902486|466289832|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
129545791|NCT00902486|466289833|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
129545792|NCT00902486|466289828|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
129545793|NCT00902486|466289829|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
129545794|NCT00902486|466289830|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
129545795|NCT00902486|466289831|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
129545796|NCT00902486|466289832|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
129545797|NCT00902486|466289833|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
129545798|NCT00902486|466289828|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
129545799|NCT00902486|466289829|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
129545800|NCT00902486|466289830|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
129545801|NCT00902486|466289831|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
129545802|NCT00902486|466289832|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
129545803|NCT00902486|466289833|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
129545804|NCT02332655|466289834|FG000|Overall Study|Lack of Efficacy|1|||
129545805|NCT01298661|466289835|FG000|Overall Study|Withdrawal by Subject|2|||
129545806|NCT01298661|466289836|FG001|Overall Study|Withdrawal by Subject|0|||
129545807|NCT01298661|466289837|FG002|Overall Study|Withdrawal by Subject|2|||
129545808|NCT01808508|466292265|FG000|Overall Study|Lost to Follow-up|1|||
129545809|NCT01808508|466292266|FG001|Overall Study|Lost to Follow-up|0|||
129545810|NCT01808508|466292267|FG002|Overall Study|Lost to Follow-up|0|||
129545811|NCT01017731|466292268|FG000|Overall Study|Lost to Follow-up|2|||
129545812|NCT01017731|466292268|FG000|Overall Study|Withdrawal by Subject|3|||
129545813|NCT01017731|466292268|FG000|Overall Study|Physician Decision|2|||
129545814|NCT01017731|466292268|FG000|Overall Study|Adverse Event|1|||
129545815|NCT05378269|466292269|FG000|Overall Study|Protocol Violation|1|||
129883491|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
129656294|NCT02005627|466700263|FG000|Overall Study|Lost to Follow-up|1|||
129656295|NCT02005627|466700264|FG001|Overall Study|Lost to Follow-up|2|||
129656296|NCT02005627|466700263|FG000|Overall Study|Withdrawal by Subject|1|||
129656297|NCT02005627|466700264|FG001|Overall Study|Withdrawal by Subject|2|||
129656298|NCT00548249|466700265|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
129656299|NCT00548249|466700266|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
129656300|NCT00548249|466700267|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
129656301|NCT00548249|466700268|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
129656302|NCT00548249|466700269|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
129883492|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
129883493|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
129883494|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
129883495|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
129883496|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
129883497|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129883498|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129883499|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129883500|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
129988090|NCT01034163|467918838|FG000|Overall Study|Administrative problems|0|||
129988091|NCT01034163|467918839|FG001|Overall Study|Administrative problems|1|||
129988092|NCT01034163|467918838|FG000|Overall Study|Abnormal laboratory value|1|||
129988093|NCT01034163|467918839|FG001|Overall Study|Abnormal laboratory value|0|||
129988094|NCT00528645|467918840|FG000|Overall Study|Adverse Event|3|||
129545816|NCT05378269|466292270|FG001|Overall Study|Protocol Violation|0|||
129545817|NCT05378269|466292271|FG002|Overall Study|Protocol Violation|2|||
129545818|NCT05378269|466292272|FG003|Overall Study|Protocol Violation|0|||
129545819|NCT05378269|466292273|FG004|Overall Study|Protocol Violation|0|||
129545820|NCT01721200|466292276|FG000|Overall Study|Lost to Follow-up|3|||
129545821|NCT01721200|466292277|FG001|Overall Study|Lost to Follow-up|5|||
129545822|NCT03926728|466292278|FG000|Overall Study|Withdrawal by Subject|0|||
129545823|NCT03926728|466292279|FG001|Overall Study|Withdrawal by Subject|1|||
129545824|NCT03926728|466292280|FG002|Overall Study|Withdrawal by Subject|1|||
129545825|NCT03926728|466292281|FG003|Overall Study|Withdrawal by Subject|0|||
129545826|NCT03926728|466292282|FG004|Overall Study|Withdrawal by Subject|0|||
129545827|NCT03926728|466292283|FG005|Overall Study|Withdrawal by Subject|1|||
129545828|NCT03926728|466292284|FG006|Overall Study|Withdrawal by Subject|1|||
129545829|NCT03926728|466292285|FG007|Overall Study|Withdrawal by Subject|0|||
129545830|NCT03926728|466292286|FG008|Overall Study|Withdrawal by Subject|0|||
129545831|NCT03926728|466292287|FG009|Overall Study|Withdrawal by Subject|1|||
129545832|NCT03926728|466292288|FG010|Overall Study|Withdrawal by Subject|0|||
129545833|NCT03926728|466292289|FG011|Overall Study|Withdrawal by Subject|0|||
129545834|NCT00398632|466292290|FG000|Overall Study|Withdrawal by Subject|1|||
129545835|NCT00398632|466292290|FG000|Overall Study|Lack of Efficacy|1|||
129545836|NCT00366678|466292293|FG000|Infant Series|Withdrawal by Subject|8|||
129545837|NCT00366678|466292294|FG001|Infant Series|Withdrawal by Subject|6|||
129545838|NCT00366678|466292295|FG002|Infant Series|Withdrawal by Subject|0|||
129545839|NCT00366678|466292293|FG000|Infant Series|Protocol Violation|4|||
129545840|NCT00366678|466292294|FG001|Infant Series|Protocol Violation|3|||
129545841|NCT00366678|466292295|FG002|Infant Series|Protocol Violation|0|||
129545842|NCT00366678|466292293|FG000|Infant Series|Failed to return|1|||
129545843|NCT00366678|466292294|FG001|Infant Series|Failed to return|1|||
129545844|NCT00366678|466292295|FG002|Infant Series|Failed to return|0|||
129545845|NCT00366678|466292293|FG000|Infant Series|Adverse Event|1|||
129545846|NCT00366678|466292294|FG001|Infant Series|Adverse Event|0|||
129545847|NCT00366678|466292295|FG002|Infant Series|Adverse Event|0|||
129545848|NCT00366678|466292293|FG000|After Infant|Withdrawal by Subject|8|||
129545849|NCT00366678|466292294|FG001|After Infant|Withdrawal by Subject|4|||
129545850|NCT00366678|466292295|FG002|After Infant|Withdrawal by Subject|0|||
129545851|NCT00366678|466292293|FG000|After Infant|Lost to Follow-up|2|||
129545852|NCT00366678|466292294|FG001|After Infant|Lost to Follow-up|1|||
129545853|NCT00366678|466292295|FG002|After Infant|Lost to Follow-up|0|||
129545854|NCT00366678|466292293|FG000|After Infant|Failed to return|5|||
129545855|NCT00366678|466292294|FG001|After Infant|Failed to return|5|||
129545856|NCT00366678|466292295|FG002|After Infant|Failed to return|0|||
129545857|NCT00366678|466292293|FG000|After Infant|Adverse Event|1|||
129545858|NCT00366678|466292294|FG001|After Infant|Adverse Event|0|||
129545859|NCT00366678|466292295|FG002|After Infant|Adverse Event|0|||
129545860|NCT00366678|466292293|FG000|After Infant|Protocol Violation|1|||
129545861|NCT00366678|466292294|FG001|After Infant|Protocol Violation|0|||
129545862|NCT00366678|466292295|FG002|After Infant|Protocol Violation|0|||
129545863|NCT00366678|466292293|FG000|Toddler Dose|Protocol Violation|2|||
129545864|NCT00366678|466292294|FG001|Toddler Dose|Protocol Violation|1|||
129545865|NCT00366678|466292295|FG002|Toddler Dose|Protocol Violation|0|||
129988095|NCT02150343|467918841|FG000|Overall Study|Adverse Event|2|||
129545866|NCT00366678|466292293|FG000|Toddler Dose|Failed to return|1|||
129545867|NCT00366678|466292294|FG001|Toddler Dose|Failed to return|0|||
129988096|NCT02150343|467918842|FG001|Overall Study|Adverse Event|0|||
129656303|NCT00548249|466700265|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
129656304|NCT00548249|466700266|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
129656305|NCT00548249|466700267|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
129656306|NCT00548249|466700268|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
129656307|NCT00548249|466700269|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
129656308|NCT00548249|466700265|FG000|Overall Study|Protocol Violation|1|||
129656309|NCT00548249|466700266|FG001|Overall Study|Protocol Violation|1|||
129656310|NCT00548249|466700267|FG002|Overall Study|Protocol Violation|4|||
129656311|NCT00548249|466700268|FG003|Overall Study|Protocol Violation|0|||
129656312|NCT00548249|466700269|FG004|Overall Study|Protocol Violation|3|||
129656313|NCT00548249|466700265|FG000|Overall Study|Miscellaneous|2|||
129656314|NCT00548249|466700266|FG001|Overall Study|Miscellaneous|3|||
129656315|NCT00548249|466700267|FG002|Overall Study|Miscellaneous|2|||
129656316|NCT00548249|466700268|FG003|Overall Study|Miscellaneous|0|||
129656317|NCT00548249|466700269|FG004|Overall Study|Miscellaneous|2|||
129656318|NCT00548249|466700265|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
129656319|NCT00548249|466700266|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
129656320|NCT00548249|466700267|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
129656321|NCT00548249|466700268|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
129656322|NCT00548249|466700269|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
129656323|NCT00548249|466700265|FG000|Overall Study|Adverse Event|2|||
129656324|NCT00548249|466700266|FG001|Overall Study|Adverse Event|2|||
129656325|NCT00548249|466700267|FG002|Overall Study|Adverse Event|0|||
129656326|NCT00548249|466700268|FG003|Overall Study|Adverse Event|1|||
129656327|NCT00548249|466700269|FG004|Overall Study|Adverse Event|1|||
129656328|NCT00548249|466700265|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
129656329|NCT00548249|466700266|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
129656330|NCT00548249|466700267|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
129656331|NCT00548249|466700268|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
129656332|NCT00548249|466700269|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
129656333|NCT00548249|466700265|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
129656334|NCT00548249|466700266|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
129656335|NCT00548249|466700267|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
129656336|NCT00548249|466700268|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
129656337|NCT00548249|466700269|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
129656338|NCT00548249|466700265|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
129656339|NCT00548249|466700266|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
129656340|NCT00548249|466700267|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
129656341|NCT00548249|466700268|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
129656342|NCT00548249|466700269|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
129656343|NCT00548249|466700265|FG000|Overall Study|Prolonged hospitalization|0|||
129656344|NCT00548249|466700266|FG001|Overall Study|Prolonged hospitalization|0|||
129656345|NCT00548249|466700267|FG002|Overall Study|Prolonged hospitalization|2|||
129656346|NCT00548249|466700268|FG003|Overall Study|Prolonged hospitalization|1|||
129656347|NCT00548249|466700269|FG004|Overall Study|Prolonged hospitalization|0|||
129656348|NCT00548249|466700265|FG000|Overall Study|Withdrawal by Subject|2|||
129656349|NCT00548249|466700266|FG001|Overall Study|Withdrawal by Subject|0|||
129656350|NCT00548249|466700267|FG002|Overall Study|Withdrawal by Subject|0|||
129656351|NCT00548249|466700268|FG003|Overall Study|Withdrawal by Subject|0|||
129656352|NCT00548249|466700269|FG004|Overall Study|Withdrawal by Subject|0|||
129656353|NCT00548249|466700265|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
129656354|NCT00548249|466700266|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
129656355|NCT00548249|466700267|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
129656356|NCT00548249|466700268|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
129883501|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
129883502|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
129883503|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
129883504|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
129656357|NCT00548249|466700269|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
129656358|NCT00548249|466700265|FG000|Overall Study|Sponsor's request|0|||
129883505|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
129656359|NCT00548249|466700266|FG001|Overall Study|Sponsor's request|0|||
129656360|NCT00548249|466700267|FG002|Overall Study|Sponsor's request|0|||
129656361|NCT00548249|466700268|FG003|Overall Study|Sponsor's request|1|||
129883506|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
129656362|NCT00548249|466700269|FG004|Overall Study|Sponsor's request|0|||
129656363|NCT03003000|466700270|FG000|Overall Study|Adverse Event|1|||
129656364|NCT03003000|466700271|FG001|Overall Study|Adverse Event|2|||
129656365|NCT03003000|466700272|FG002|Overall Study|Adverse Event|3|||
129656366|NCT03003000|466700270|FG000|Overall Study|Lack of Efficacy|1|||
129656367|NCT03003000|466700271|FG001|Overall Study|Lack of Efficacy|0|||
129656368|NCT03003000|466700272|FG002|Overall Study|Lack of Efficacy|0|||
129883507|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
129545868|NCT00366678|466292295|FG002|Toddler Dose|Failed to return|0|||
129545869|NCT00366678|466292293|FG000|Toddler Dose|Withdrawal by Subject|1|||
129545870|NCT00366678|466292294|FG001|Toddler Dose|Withdrawal by Subject|0|||
129545871|NCT00366678|466292295|FG002|Toddler Dose|Withdrawal by Subject|0|||
129545872|NCT00366678|466292293|FG000|Toddler Dose|protocol deviation|1|||
129545873|NCT00366678|466292294|FG001|Toddler Dose|protocol deviation|0|||
129545874|NCT00366678|466292295|FG002|Toddler Dose|protocol deviation|0|||
129545875|NCT04292171|466292296|FG000|Overall Study|Pharmacy error|2|||
129545876|NCT04292171|466292297|FG001|Overall Study|Pharmacy error|0|||
129545877|NCT04292171|466292296|FG000|Overall Study|Delivered prior to procedure|0|||
129545878|NCT04292171|466292297|FG001|Overall Study|Delivered prior to procedure|1|||
129545879|NCT01803464|466292300|FG000|Overall Study|Incomplete data|0|||
129545880|NCT01803464|466292301|FG001|Overall Study|Incomplete data|0|||
129545881|NCT01803464|466292302|FG002|Overall Study|Incomplete data|4|||
129545882|NCT01803464|466292303|FG003|Overall Study|Incomplete data|0|||
129545883|NCT01803464|466292300|FG000|Overall Study|Withdrawal by Subject|1|||
129545884|NCT01803464|466292301|FG001|Overall Study|Withdrawal by Subject|0|||
129545885|NCT01803464|466292302|FG002|Overall Study|Withdrawal by Subject|0|||
129545886|NCT01803464|466292303|FG003|Overall Study|Withdrawal by Subject|0|||
129545887|NCT02860039|466292309|FG000|Overall Study|Death|4|||
129545888|NCT02860039|466292310|FG001|Overall Study|Death|0|||
129545889|NCT02860039|466292309|FG000|Overall Study|Lost to Follow-up|2|||
129545890|NCT02860039|466292310|FG001|Overall Study|Lost to Follow-up|2|||
129545891|NCT02860039|466292309|FG000|Overall Study|Protocol Violation|3|||
129545892|NCT02860039|466292310|FG001|Overall Study|Protocol Violation|1|||
129545893|NCT02860039|466292309|FG000|Overall Study|Withdrawal by Subject|1|||
129545894|NCT02860039|466292310|FG001|Overall Study|Withdrawal by Subject|0|||
129545895|NCT02860039|466292309|FG000|Overall Study|Not otherwise eligible|1|||
129545896|NCT02860039|466292310|FG001|Overall Study|Not otherwise eligible|1|||
129545897|NCT01360021|466292311|FG000|Overall Study|Eligibility criteria + other|2|||
129545898|NCT01360021|466292312|FG001|Overall Study|Eligibility criteria + other|1|||
129545899|NCT01360021|466292313|FG002|Overall Study|Eligibility criteria + other|1|||
129545900|NCT01360021|466292311|FG000|Overall Study|Protocol Violation|0|||
129545901|NCT01360021|466292312|FG001|Overall Study|Protocol Violation|0|||
129545902|NCT01360021|466292313|FG002|Overall Study|Protocol Violation|1|||
129545903|NCT01360021|466292311|FG000|Overall Study|Withdrawal by Subject|4|||
129545904|NCT01360021|466292312|FG001|Overall Study|Withdrawal by Subject|0|||
129545905|NCT01360021|466292313|FG002|Overall Study|Withdrawal by Subject|2|||
129545906|NCT01360021|466292311|FG000|Overall Study|Adverse Event|2|||
129545907|NCT01360021|466292312|FG001|Overall Study|Adverse Event|3|||
129545908|NCT01360021|466292313|FG002|Overall Study|Adverse Event|3|||
129545909|NCT01257737|466292315|FG000|Overall Study|Lost to Follow-up|1|||
129545910|NCT01257737|466292316|FG001|Overall Study|Lost to Follow-up|2|||
129545911|NCT01257737|466292315|FG000|Overall Study|Liver transplant|1|||
129545912|NCT01257737|466292316|FG001|Overall Study|Liver transplant|0|||
129545913|NCT01257737|466292315|FG000|Overall Study|Relocation out of the country|0|||
129545914|NCT01257737|466292316|FG001|Overall Study|Relocation out of the country|1|||
129545915|NCT01257737|466292315|FG000|Overall Study|Withdrew from study|0|||
129545916|NCT01257737|466292316|FG001|Overall Study|Withdrew from study|1|||
129545917|NCT03170271|466292320|FG000|Overall Study|Adverse Event|7|||
129545918|NCT03170271|466292321|FG001|Overall Study|Adverse Event|2|||
129545919|NCT03170271|466292320|FG000|Overall Study|Lost to Follow-up|0|||
129545920|NCT03170271|466292321|FG001|Overall Study|Lost to Follow-up|1|||
129545921|NCT03170271|466292320|FG000|Overall Study|Physician Decision|1|||
129545922|NCT03170271|466292321|FG001|Overall Study|Physician Decision|0|||
129545923|NCT03170271|466292320|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
129545924|NCT03170271|466292321|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
129545925|NCT03170271|466292320|FG000|Overall Study|Withdrawal by Subject|17|||
129545926|NCT03170271|466292321|FG001|Overall Study|Withdrawal by Subject|5|||
129545927|NCT03170271|466292320|FG000|Overall Study|Other|2|||
129545928|NCT03170271|466292321|FG001|Overall Study|Other|2|||
129545929|NCT03170271|466292320|FG000|Overall Study|Randomized in error|4|||
129545930|NCT03170271|466292321|FG001|Overall Study|Randomized in error|0|||
129545931|NCT03123120|466292323|FG000|Overall Study|Lost to Follow-up|0|||
129545932|NCT03123120|466292324|FG001|Overall Study|Lost to Follow-up|1|||
129545933|NCT03123120|466292323|FG000|Overall Study|Withdrawal by Subject|0|||
129545934|NCT03123120|466292324|FG001|Overall Study|Withdrawal by Subject|1|||
129545935|NCT00806416|466292327|FG000|Period 1 - Part I|Adverse Event|0|||
129545936|NCT00806416|466292328|FG001|Period 1 - Part I|Adverse Event|1|||
129545937|NCT00806416|466292329|FG002|Period 1 - Part I|Adverse Event|0|||
129545938|NCT00806416|466292330|FG003|Period 1 - Part I|Adverse Event|0|||
129545939|NCT00806416|466292327|FG000|Period 1 - Part I|Lost to Follow-up|0|||
129545940|NCT00806416|466292328|FG001|Period 1 - Part I|Lost to Follow-up|2|||
129545941|NCT00806416|466292329|FG002|Period 1 - Part I|Lost to Follow-up|0|||
129545942|NCT00806416|466292330|FG003|Period 1 - Part I|Lost to Follow-up|0|||
129545943|NCT00806416|466292327|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
129545944|NCT00806416|466292328|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
129545945|NCT00806416|466292329|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
129656369|NCT03003000|466700270|FG000|Overall Study|Non-compliant with protocol|0|||
129656370|NCT03003000|466700271|FG001|Overall Study|Non-compliant with protocol|1|||
129656371|NCT03003000|466700272|FG002|Overall Study|Non-compliant with protocol|1|||
129656372|NCT03003000|466700270|FG000|Overall Study|Refused to continue medication|2|||
129656373|NCT03003000|466700271|FG001|Overall Study|Refused to continue medication|0|||
129656374|NCT03003000|466700272|FG002|Overall Study|Refused to continue medication|0|||
129656375|NCT03003000|466700270|FG000|Overall Study|Other than listed|1|||
129656376|NCT03003000|466700271|FG001|Overall Study|Other than listed|1|||
129656377|NCT03003000|466700272|FG002|Overall Study|Other than listed|1|||
129656378|NCT04933617|466700274|FG000|Dose Escalation|Early closure of study|0|||
129656379|NCT04933617|466700275|FG001|Dose Escalation|Early closure of study|3|||
129656380|NCT04933617|466700276|FG002|Dose Escalation|Early closure of study|0|||
129656381|NCT04933617|466700277|FG003|Dose Escalation|Early closure of study|0|||
129656382|NCT04933617|466700278|FG004|Dose Escalation|Early closure of study|0|||
129656383|NCT02191046|466700280|FG000|Overall Study|low compliance|5|||
129656384|NCT02191046|466700281|FG001|Overall Study|low compliance|1|||
129656385|NCT03760458|466700282|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
129656386|NCT03760458|466700283|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
129656387|NCT03760458|466700284|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
129656388|NCT03760458|466700285|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
129656389|NCT03760458|466700286|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
129656390|NCT02007278|466700300|FG000|Overall Study|Failure to comply with an eligibility|0|||
129656391|NCT02007278|466700301|FG001|Overall Study|Failure to comply with an eligibility|1|||
129656392|NCT02007278|466700300|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
129656393|NCT02007278|466700301|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
129656394|NCT02007278|466700300|FG000|Overall Study|Incorrect medication administration|1|||
129656395|NCT02007278|466700301|FG001|Overall Study|Incorrect medication administration|0|||
129656396|NCT02007278|466700300|FG000|Overall Study|Mis-randomization|1|||
129656397|NCT02007278|466700301|FG001|Overall Study|Mis-randomization|1|||
129656398|NCT00002525|466700302|FG000|Overall Study|Adverse Event|36|||
129656399|NCT00002525|466700303|FG001|Overall Study|Adverse Event|0|||
129656400|NCT00002525|466700302|FG000|Overall Study|Death|5|||
129656401|NCT00002525|466700303|FG001|Overall Study|Death|0|||
129656402|NCT00002525|466700302|FG000|Overall Study|Withdrawal by Subject|11|||
129656403|NCT00002525|466700303|FG001|Overall Study|Withdrawal by Subject|0|||
129656404|NCT00002525|466700302|FG000|Overall Study|Start non-protocol therapy|1|||
129656405|NCT00002525|466700303|FG001|Overall Study|Start non-protocol therapy|0|||
129656406|NCT00002525|466700302|FG000|Overall Study|Other complicating disease|1|||
129656407|NCT00002525|466700303|FG001|Overall Study|Other complicating disease|0|||
129656408|NCT00002525|466700302|FG000|Overall Study|Duke's A, B1, D disease|92|||
129656409|NCT00002525|466700303|FG001|Overall Study|Duke's A, B1, D disease|0|||
129656410|NCT00002525|466700302|FG000|Overall Study|Error|6|||
129656411|NCT00002525|466700303|FG001|Overall Study|Error|0|||
129656412|NCT00002525|466700302|FG000|Overall Study|Other|26|||
129656413|NCT00002525|466700303|FG001|Overall Study|Other|0|||
129656414|NCT00002525|466700302|FG000|Overall Study|Never start protocol therapy|8|||
129656415|NCT00002525|466700303|FG001|Overall Study|Never start protocol therapy|0|||
129656416|NCT03230838|466700305|FG000|Overall Study|Withdrawal by Subject|3|||
129656417|NCT03230838|466700306|FG001|Overall Study|Withdrawal by Subject|0|||
129656418|NCT03230838|466700305|FG000|Overall Study|Temperature excursion|1|||
129656419|NCT03230838|466700306|FG001|Overall Study|Temperature excursion|0|||
129656420|NCT02886884|466700307|FG000|Follow-up|Withdrawal by Subject|0|||
129656421|NCT02886884|466700308|FG001|Follow-up|Withdrawal by Subject|0|||
129656422|NCT02886884|466700309|FG002|Follow-up|Withdrawal by Subject|0|||
129656423|NCT02886884|466700310|FG003|Follow-up|Withdrawal by Subject|1|||
129656424|NCT00435188|466700313|FG000|Overall Study|Death|1|||
129656425|NCT00435188|466700314|FG001|Overall Study|Death|6|||
129656426|NCT00435188|466700313|FG000|Overall Study|Withdrawal by Subject|16|||
129656427|NCT00435188|466700314|FG001|Overall Study|Withdrawal by Subject|11|||
129656428|NCT00435188|466700313|FG000|Overall Study|Lost to Follow-up|5|||
129656429|NCT00435188|466700314|FG001|Overall Study|Lost to Follow-up|6|||
129656430|NCT01915771|466700317|FG000|Day 1|Withdrawal by Subject|1|||
129883508|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
129656431|NCT01915771|466700317|FG000|Day 15|Withdrawal by Subject|1|||
129656432|NCT03420222|466700320|FG000|Overall Study|Withdrawal by Subject|5|||
129656433|NCT03420222|466700321|FG001|Overall Study|Withdrawal by Subject|0|||
129656434|NCT03420222|466700320|FG000|Overall Study|Physician Decision|0|||
129656435|NCT03420222|466700321|FG001|Overall Study|Physician Decision|1|||
129656436|NCT02334384|466700322|FG000|Overall Study|Lost to Follow-up|1|||
129656437|NCT02334384|466700323|FG001|Overall Study|Lost to Follow-up|1|||
129656438|NCT00055497|466700324|FG000|Overall Study|Adverse Event|1|||
129656439|NCT00055497|466700325|FG001|Overall Study|Adverse Event|1|||
129656440|NCT00055497|466700326|FG002|Overall Study|Adverse Event|1|||
129656441|NCT00055497|466700327|FG003|Overall Study|Adverse Event|28|||
129656442|NCT00055497|466700324|FG000|Overall Study|Withdrawal by Subject|3|||
129656443|NCT00055497|466700325|FG001|Overall Study|Withdrawal by Subject|1|||
129656444|NCT00055497|466700326|FG002|Overall Study|Withdrawal by Subject|1|||
129656445|NCT00055497|466700327|FG003|Overall Study|Withdrawal by Subject|15|||
129656446|NCT00055497|466700324|FG000|Overall Study|Lost to Follow-up|0|||
129656447|NCT00055497|466700325|FG001|Overall Study|Lost to Follow-up|1|||
129656448|NCT00055497|466700326|FG002|Overall Study|Lost to Follow-up|0|||
129656449|NCT00055497|466700327|FG003|Overall Study|Lost to Follow-up|5|||
129656450|NCT00055497|466700324|FG000|Overall Study|Protocol Violation|0|||
129656451|NCT00055497|466700325|FG001|Overall Study|Protocol Violation|0|||
129656452|NCT00055497|466700326|FG002|Overall Study|Protocol Violation|0|||
129656453|NCT00055497|466700327|FG003|Overall Study|Protocol Violation|3|||
129656454|NCT00055497|466700324|FG000|Overall Study|Lack of Efficacy|1|||
129656455|NCT00055497|466700325|FG001|Overall Study|Lack of Efficacy|0|||
129656456|NCT00055497|466700326|FG002|Overall Study|Lack of Efficacy|0|||
129656457|NCT00055497|466700327|FG003|Overall Study|Lack of Efficacy|27|||
129656458|NCT00055497|466700324|FG000|Overall Study|Administrative Reasons|0|||
129656459|NCT00055497|466700325|FG001|Overall Study|Administrative Reasons|0|||
129656460|NCT00055497|466700326|FG002|Overall Study|Administrative Reasons|0|||
129656461|NCT00055497|466700327|FG003|Overall Study|Administrative Reasons|1|||
129656462|NCT00055497|466700324|FG000|Overall Study|Other|0|||
129656463|NCT00055497|466700325|FG001|Overall Study|Other|0|||
129656464|NCT00055497|466700326|FG002|Overall Study|Other|0|||
129656465|NCT00055497|466700327|FG003|Overall Study|Other|11|||
129656466|NCT00048165|466700328|FG000|Completed 6 Months Study|Administration/Other|8|||
129656467|NCT00048165|466700329|FG001|Completed 6 Months Study|Administration/Other|8|||
129656468|NCT00048165|466700328|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
129656469|NCT00048165|466700329|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
129656470|NCT00048165|466700328|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
129656471|NCT00048165|466700329|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
129656472|NCT00048165|466700328|FG000|Completed 6 Months Study|Death|12|||
129656473|NCT00048165|466700329|FG001|Completed 6 Months Study|Death|6|||
129656474|NCT00048165|466700328|FG000|Completed 6 Months Study|Insufficient therapy|1|||
129656475|NCT00048165|466700329|FG001|Completed 6 Months Study|Insufficient therapy|4|||
129656476|NCT00048165|466700328|FG000|Completed 6 Months Study|Other violation|4|||
129656477|NCT00048165|466700329|FG001|Completed 6 Months Study|Other violation|6|||
129656478|NCT00048165|466700328|FG000|Completed 6 Months Study|Refused treatment|5|||
129656479|NCT00048165|466700329|FG001|Completed 6 Months Study|Refused treatment|5|||
129656480|NCT00048165|466700328|FG000|Completed 6 Months Study|Violation criteria|0|||
129656481|NCT00048165|466700329|FG001|Completed 6 Months Study|Violation criteria|2|||
129656482|NCT00048165|466700328|FG000|Completed 6 Months Study|Did not receive study drug|6|||
129656483|NCT00048165|466700329|FG001|Completed 6 Months Study|Did not receive study drug|6|||
129656484|NCT00048165|466700328|FG000|Completed 12 Months Study|Administration/Other|0|||
129656485|NCT00048165|466700329|FG001|Completed 12 Months Study|Administration/Other|2|||
129656486|NCT00048165|466700328|FG000|Completed 12 Months Study|Death|2|||
129656487|NCT00048165|466700329|FG001|Completed 12 Months Study|Death|1|||
129656488|NCT00048165|466700328|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
129656489|NCT00048165|466700329|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
129656490|NCT02112877|466700330|FG000|Overall Study|Withdrawal by Subject|1|||
129656491|NCT02112877|466700331|FG001|Overall Study|Withdrawal by Subject|7|||
129656492|NCT02112877|466700330|FG000|Overall Study|Visit Missed|1|||
129656493|NCT02112877|466700331|FG001|Overall Study|Visit Missed|6|||
129656494|NCT00621517|466700342|FG000|Overall Study|Lost to Follow-up|3|||
129656495|NCT00621517|466700343|FG001|Overall Study|Lost to Follow-up|3|||
129656496|NCT00621517|466700342|FG000|Overall Study|Withdrawal by Subject|3|||
129656497|NCT00621517|466700343|FG001|Overall Study|Withdrawal by Subject|4|||
129656498|NCT00621517|466700342|FG000|Overall Study|Adverse Event|1|||
129656499|NCT00621517|466700343|FG001|Overall Study|Adverse Event|0|||
129656500|NCT00073008|466700344|FG000|Overall Study|Missing|6|||
129656501|NCT00073008|466700345|FG001|Overall Study|Missing|6|||
129656502|NCT00073008|466700344|FG000|Overall Study|Withdrawal by Subject|2|||
129656503|NCT00073008|466700345|FG001|Overall Study|Withdrawal by Subject|2|||
129545946|NCT00806416|466292330|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
129545947|NCT00806416|466292327|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
129545948|NCT00806416|466292328|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
129545949|NCT00806416|466292329|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
129545950|NCT00806416|466292330|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
129545951|NCT01244516|466292335|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
129545952|NCT01244516|466292336|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
129545953|NCT01244516|466292337|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
129545954|NCT01244516|466292335|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
129545955|NCT01244516|466292336|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
129545956|NCT01244516|466292337|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
129656504|NCT00073008|466700344|FG000|Overall Study|Lost to Follow-up|1|||
129656505|NCT00073008|466700345|FG001|Overall Study|Lost to Follow-up|3|||
129656506|NCT00073008|466700344|FG000|Overall Study|Death|46|||
129656507|NCT00073008|466700345|FG001|Overall Study|Death|47|||
129656508|NCT00073008|466700344|FG000|Overall Study|"Other selected on Case Report Form"|7|||
129656509|NCT00073008|466700345|FG001|Overall Study|"Other selected on Case Report Form"|5|||
129656510|NCT02669667|466700346|FG000|Overall Study|Lost to Follow-up|0|||
129656511|NCT02669667|466700347|FG001|Overall Study|Lost to Follow-up|0|||
129656512|NCT02669667|466700348|FG002|Overall Study|Lost to Follow-up|0|||
129656513|NCT02669667|466700349|FG003|Overall Study|Lost to Follow-up|0|||
129656514|NCT02669667|466700350|FG004|Overall Study|Lost to Follow-up|0|||
129656515|NCT02669667|466700351|FG005|Overall Study|Lost to Follow-up|1|||
129656516|NCT02669667|466700352|FG006|Overall Study|Lost to Follow-up|0|||
129656517|NCT01156051|466700355|FG000|Overall Study|Lost to Follow-up|1|||
129656518|NCT01156051|466700356|FG001|Overall Study|Lost to Follow-up|0|||
129656519|NCT01156051|466700355|FG000|Overall Study|patient not compliant with protocol|0|||
129656520|NCT01156051|466700356|FG001|Overall Study|patient not compliant with protocol|1|||
129656521|NCT02071082|466700363|FG000|Overall Study|Enrolled and Never Treated|1|||
129656522|NCT02071082|466700364|FG001|Overall Study|Enrolled and Never Treated|1|||
129656523|NCT02071082|466700363|FG000|Overall Study|Adverse Event|0|||
129656524|NCT02071082|466700364|FG001|Overall Study|Adverse Event|1|||
129656525|NCT02071082|466700363|FG000|Overall Study|Withdrew Consent|0|||
129656526|NCT02071082|466700364|FG001|Overall Study|Withdrew Consent|4|||
129656527|NCT02071082|466700363|FG000|Overall Study|Lost to Follow-up|1|||
129656528|NCT02071082|466700364|FG001|Overall Study|Lost to Follow-up|1|||
129656529|NCT00958412|466700368|FG000|Overall Study|Study prematurely terminated|18|||
129656530|NCT02227368|466702176|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
129656531|NCT02227368|466702177|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
129656532|NCT02227368|466702176|FG000|Overall Study|Lost to Follow-up|1|||
129656533|NCT02227368|466702177|FG001|Overall Study|Lost to Follow-up|0|||
129656534|NCT02227368|466702176|FG000|Overall Study|Adverse Event|1|||
129656535|NCT02227368|466702177|FG001|Overall Study|Adverse Event|0|||
129656536|NCT02510820|466702181|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129656537|NCT02510820|466702182|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129656538|NCT02510820|466702181|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129656539|NCT02510820|466702182|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129656540|NCT03046056|466702183|FG000|Overall Study|Non-responder at Week 10|6|||
129656541|NCT03046056|466702184|FG001|Overall Study|Non-responder at Week 10|6|||
129656542|NCT03046056|466702185|FG002|Overall Study|Non-responder at Week 10|4|||
129656543|NCT03046056|466702183|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
129656544|NCT03046056|466702184|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
129656545|NCT03046056|466702185|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
129656546|NCT03046056|466702183|FG000|Overall Study|Adverse Event|1|||
129656547|NCT03046056|466702184|FG001|Overall Study|Adverse Event|5|||
129656548|NCT03046056|466702185|FG002|Overall Study|Adverse Event|0|||
129656549|NCT03046056|466702183|FG000|Overall Study|Non-compliance With Study Drug|0|||
129656550|NCT03046056|466702184|FG001|Overall Study|Non-compliance With Study Drug|0|||
129656551|NCT03046056|466702185|FG002|Overall Study|Non-compliance With Study Drug|2|||
129656552|NCT03046056|466702183|FG000|Overall Study|Protocol Violation|1|||
129545957|NCT01244516|466292335|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
129545958|NCT01244516|466292336|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
129545959|NCT01244516|466292337|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
129545960|NCT01244516|466292335|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
129545961|NCT01244516|466292336|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
129545962|NCT01244516|466292337|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
129545963|NCT01244516|466292335|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
129545964|NCT01244516|466292336|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
129545965|NCT01244516|466292337|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
129545966|NCT01244516|466292335|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
129545967|NCT01244516|466292336|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
129545968|NCT01244516|466292337|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
129545969|NCT01244516|466292335|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
129545970|NCT01244516|466292336|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
129545971|NCT01244516|466292337|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
129545972|NCT03345485|466292340|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
129545973|NCT03345485|466292341|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
129545974|NCT03345485|466292342|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
129545975|NCT03345485|466292343|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
129545976|NCT03345485|466292344|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
129545977|NCT03345485|466292345|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
129545978|NCT03345485|466292346|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
129545979|NCT03345485|466292347|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
129545980|NCT03345485|466292348|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
129656553|NCT03046056|466702184|FG001|Overall Study|Protocol Violation|1|||
129656554|NCT03046056|466702185|FG002|Overall Study|Protocol Violation|0|||
129656555|NCT03046056|466702183|FG000|Overall Study|Investigator's Discretion|0|||
129656556|NCT03046056|466702184|FG001|Overall Study|Investigator's Discretion|1|||
129656557|NCT03046056|466702185|FG002|Overall Study|Investigator's Discretion|0|||
129656558|NCT03046056|466702183|FG000|Overall Study|Withdrew Consent|1|||
129656559|NCT03046056|466702184|FG001|Overall Study|Withdrew Consent|0|||
129656560|NCT03046056|466702185|FG002|Overall Study|Withdrew Consent|0|||
129656561|NCT02913105|466702186|FG000|Overall Study|Adverse Event|11|||
129656562|NCT02913105|466702187|FG001|Overall Study|Adverse Event|0|||
129656563|NCT02913105|466702188|FG002|Overall Study|Adverse Event|4|||
129656564|NCT02913105|466702186|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129656565|NCT02913105|466702187|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129656566|NCT02913105|466702188|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129656567|NCT02913105|466702186|FG000|Overall Study|Reason Not Specified|3|||
129656568|NCT02913105|466702187|FG001|Overall Study|Reason Not Specified|1|||
129656569|NCT02913105|466702188|FG002|Overall Study|Reason Not Specified|1|||
129656570|NCT02913105|466702186|FG000|Overall Study|Physician Decision|1|||
129656571|NCT02913105|466702187|FG001|Overall Study|Physician Decision|1|||
129656572|NCT02913105|466702188|FG002|Overall Study|Physician Decision|0|||
129656573|NCT02913105|466702186|FG000|Overall Study|Withdrawal by Subject|0|||
129656574|NCT02913105|466702187|FG001|Overall Study|Withdrawal by Subject|3|||
129656575|NCT02913105|466702188|FG002|Overall Study|Withdrawal by Subject|1|||
129656576|NCT01317004|466702189|FG000|Overall Study|Withdrawal by Subject|1|||
129656577|NCT01317004|466702190|FG001|Overall Study|Withdrawal by Subject|4|||
129656578|NCT01317004|466702189|FG000|Overall Study|Protocol Violation|0|||
129656579|NCT01317004|466702190|FG001|Overall Study|Protocol Violation|2|||
129656580|NCT01317004|466702189|FG000|Overall Study|Adverse Event|3|||
129656581|NCT01317004|466702190|FG001|Overall Study|Adverse Event|3|||
129656582|NCT01859949|466702196|FG000|Overall Study|Family Matters|0|||
129656583|NCT01859949|466702197|FG001|Overall Study|Family Matters|1|||
129656584|NCT01859949|466702196|FG000|Overall Study|Physician Decision|2|||
129656585|NCT01859949|466702197|FG001|Overall Study|Physician Decision|4|||
129656586|NCT01859949|466702196|FG000|Overall Study|Withdrawal by Subject|11|||
129656587|NCT01859949|466702197|FG001|Overall Study|Withdrawal by Subject|10|||
129656588|NCT01859949|466702196|FG000|Overall Study|Protocol Violation|1|||
129656589|NCT01859949|466702197|FG001|Overall Study|Protocol Violation|1|||
129656590|NCT01859949|466702196|FG000|Overall Study|Adverse Event|0|||
129656591|NCT01859949|466702197|FG001|Overall Study|Adverse Event|1|||
129656592|NCT01344759|466702198|FG000|Overall Study|Patients failed to reach sedation level|0|||
129656593|NCT01344759|466702199|FG001|Overall Study|Patients failed to reach sedation level|2|||
129656594|NCT01890759|466702200|FG000|Overall Study|Protocol Violation|0|||
129656595|NCT01890759|466702201|FG001|Overall Study|Protocol Violation|2|||
129988097|NCT02150343|467918843|FG002|Overall Study|Adverse Event|1|||
129545981|NCT03345485|466292349|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
129545982|NCT03345485|466292350|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
129545983|NCT03345485|466292351|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
129545984|NCT03345485|466292352|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
129545985|NCT03359473|466292353|FG000|Overall Study|Adverse Event|0|||
129545986|NCT03359473|466292354|FG001|Overall Study|Adverse Event|2|||
129545987|NCT03359473|466292355|FG002|Overall Study|Adverse Event|5|||
129545988|NCT03359473|466292356|FG003|Overall Study|Adverse Event|3|||
129545989|NCT03359473|466292353|FG000|Overall Study|Lost to Follow-up|0|||
129545990|NCT03359473|466292354|FG001|Overall Study|Lost to Follow-up|1|||
129545991|NCT03359473|466292355|FG002|Overall Study|Lost to Follow-up|0|||
129545992|NCT03359473|466292356|FG003|Overall Study|Lost to Follow-up|0|||
129545993|NCT03359473|466292353|FG000|Overall Study|Physician Decision|0|||
129545994|NCT03359473|466292354|FG001|Overall Study|Physician Decision|1|||
129545995|NCT03359473|466292355|FG002|Overall Study|Physician Decision|0|||
129545996|NCT03359473|466292356|FG003|Overall Study|Physician Decision|1|||
129545997|NCT03359473|466292353|FG000|Overall Study|Withdrawal by Subject|1|||
129545998|NCT03359473|466292354|FG001|Overall Study|Withdrawal by Subject|2|||
129545999|NCT03359473|466292355|FG002|Overall Study|Withdrawal by Subject|1|||
129546000|NCT03359473|466292356|FG003|Overall Study|Withdrawal by Subject|0|||
129546001|NCT03359473|466292353|FG000|Overall Study|Protocol-defined stopping criteria|1|||
129546002|NCT03359473|466292354|FG001|Overall Study|Protocol-defined stopping criteria|0|||
129546003|NCT03359473|466292355|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129546004|NCT03359473|466292356|FG003|Overall Study|Protocol-defined stopping criteria|1|||
129546005|NCT05302414|466292357|FG000|Pretest to Posttest|Lost to Follow-up|12|||
129546006|NCT05302414|466292358|FG001|Pretest to Posttest|Lost to Follow-up|8|||
129546007|NCT05302414|466292359|FG002|Pretest to Posttest|Lost to Follow-up|8|||
129546008|NCT05302414|466292357|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
129546009|NCT05302414|466292358|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
129656596|NCT01890759|466702200|FG000|Overall Study|Lost to Follow-up|0|||
129656597|NCT01890759|466702201|FG001|Overall Study|Lost to Follow-up|2|||
129656598|NCT01890759|466702200|FG000|Overall Study|Withdrawal by Subject|2|||
129546010|NCT05302414|466292359|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
129546011|NCT01610284|466292360|FG000|Randomization Phase|Adverse Event|1|||
129656599|NCT01890759|466702201|FG001|Overall Study|Withdrawal by Subject|8|||
129656600|NCT01153009|466702202|FG000|Overall Study|Adverse Event|4|||
129656601|NCT01153009|466702203|FG001|Overall Study|Adverse Event|14|||
129656602|NCT01153009|466702204|FG002|Overall Study|Adverse Event|14|||
129656603|NCT01153009|466702205|FG003|Overall Study|Adverse Event|10|||
129988098|NCT02150343|467918844|FG003|Overall Study|Adverse Event|1|||
129988099|NCT02150343|467918841|FG000|Overall Study|Withdrawal by Subject|13|||
129988100|NCT02150343|467918842|FG001|Overall Study|Withdrawal by Subject|10|||
129988101|NCT02150343|467918843|FG002|Overall Study|Withdrawal by Subject|9|||
129988102|NCT02150343|467918844|FG003|Overall Study|Withdrawal by Subject|4|||
129988103|NCT02150343|467918841|FG000|Overall Study|Lost to Follow-up|4|||
129988104|NCT02150343|467918842|FG001|Overall Study|Lost to Follow-up|4|||
129988105|NCT02150343|467918843|FG002|Overall Study|Lost to Follow-up|2|||
129988106|NCT02150343|467918844|FG003|Overall Study|Lost to Follow-up|3|||
129988107|NCT02150343|467918841|FG000|Overall Study|Other|2|||
129988108|NCT02150343|467918842|FG001|Overall Study|Other|6|||
129988109|NCT02150343|467918843|FG002|Overall Study|Other|0|||
129988110|NCT02150343|467918844|FG003|Overall Study|Other|2|||
129988111|NCT00190749|467918845|FG000|Overall Study|Lost to Follow-up|8|||
129988112|NCT00190749|467918846|FG001|Overall Study|Lost to Follow-up|11|||
129988113|NCT00190749|467918845|FG000|Overall Study|Withdrawal by Subject|10|||
129988114|NCT00190749|467918846|FG001|Overall Study|Withdrawal by Subject|6|||
129988115|NCT00190749|467918845|FG000|Overall Study|Protocol Violation|5|||
129988116|NCT00190749|467918846|FG001|Overall Study|Protocol Violation|4|||
129988117|NCT00190749|467918845|FG000|Overall Study|Adverse Event|0|||
129656604|NCT01153009|466702202|FG000|Overall Study|Lack of Efficacy|9|||
129656605|NCT01153009|466702203|FG001|Overall Study|Lack of Efficacy|0|||
129656606|NCT01153009|466702204|FG002|Overall Study|Lack of Efficacy|2|||
129656607|NCT01153009|466702205|FG003|Overall Study|Lack of Efficacy|1|||
129656608|NCT01153009|466702202|FG000|Overall Study|Noncompliance with Study Medication|1|||
129656609|NCT01153009|466702203|FG001|Overall Study|Noncompliance with Study Medication|3|||
129656610|NCT01153009|466702204|FG002|Overall Study|Noncompliance with Study Medication|4|||
129656611|NCT01153009|466702205|FG003|Overall Study|Noncompliance with Study Medication|1|||
129656612|NCT01153009|466702202|FG000|Overall Study|Protocol Deviations|4|||
129656613|NCT01153009|466702203|FG001|Overall Study|Protocol Deviations|3|||
129656614|NCT01153009|466702204|FG002|Overall Study|Protocol Deviations|3|||
129656615|NCT01153009|466702205|FG003|Overall Study|Protocol Deviations|2|||
129656616|NCT01153009|466702202|FG000|Overall Study|Withdrawal of Consent|5|||
129656617|NCT01153009|466702203|FG001|Overall Study|Withdrawal of Consent|5|||
129656618|NCT01153009|466702204|FG002|Overall Study|Withdrawal of Consent|4|||
129656619|NCT01153009|466702205|FG003|Overall Study|Withdrawal of Consent|6|||
129656620|NCT01153009|466702202|FG000|Overall Study|Lost to Follow-up|8|||
129656621|NCT01153009|466702203|FG001|Overall Study|Lost to Follow-up|8|||
129656622|NCT01153009|466702204|FG002|Overall Study|Lost to Follow-up|11|||
129656623|NCT01153009|466702205|FG003|Overall Study|Lost to Follow-up|15|||
129656624|NCT01153009|466702202|FG000|Overall Study|Other|1|||
129656625|NCT01153009|466702203|FG001|Overall Study|Other|1|||
129656626|NCT01153009|466702204|FG002|Overall Study|Other|3|||
129656627|NCT01153009|466702205|FG003|Overall Study|Other|2|||
129656628|NCT04494425|466702210|FG000|Overall Study|Death|160|||
129656629|NCT04494425|466702211|FG001|Overall Study|Death|166|||
129656630|NCT04494425|466702210|FG000|Overall Study|Withdrawal by Subject|10|||
129656631|NCT04494425|466702211|FG001|Overall Study|Withdrawal by Subject|40|||
129656632|NCT04494425|466702210|FG000|Overall Study|Other|1|||
129656633|NCT04494425|466702211|FG001|Overall Study|Other|1|||
129656634|NCT04494425|466702210|FG000|Overall Study|Ongoing at the time of PCD|265|||
129656635|NCT04494425|466702211|FG001|Overall Study|Ongoing at the time of PCD|223|||
129656636|NCT01270321|466702213|FG000|Overall Study|Death|3|||
129656637|NCT01270321|466702214|FG001|Overall Study|Death|1|||
129656638|NCT01270321|466702215|FG002|Overall Study|Death|4|||
129656639|NCT01270321|466702213|FG000|Overall Study|Adverse Event|7|||
129656640|NCT01270321|466702214|FG001|Overall Study|Adverse Event|9|||
129656641|NCT01270321|466702215|FG002|Overall Study|Adverse Event|5|||
129656642|NCT04003623|466702219|FG000|Overall Study|Withdrawal by Subject|1|||
129656643|NCT04003623|466702220|FG001|Overall Study|Withdrawal by Subject|0|||
129656644|NCT00703326|466702222|FG000|Overall Study|Lost to Follow-up|47|||
129656645|NCT00703326|466702223|FG001|Overall Study|Lost to Follow-up|18|||
129656646|NCT00703326|466702222|FG000|Overall Study|Withdrawal by Subject|54|||
129656647|NCT00703326|466702223|FG001|Overall Study|Withdrawal by Subject|20|||
129656648|NCT00703326|466702222|FG000|Overall Study|Adverse Event|1|||
129656649|NCT00703326|466702223|FG001|Overall Study|Adverse Event|0|||
129988118|NCT00190749|467918846|FG001|Overall Study|Adverse Event|5|||
129988119|NCT00190749|467918845|FG000|Overall Study|Lack of Efficacy|2|||
129656650|NCT01393106|466702226|FG000|Overall Study|Adverse Event|3|||
129988120|NCT00190749|467918846|FG001|Overall Study|Lack of Efficacy|3|||
129656651|NCT01393106|466702226|FG000|Overall Study|Withdrawal by Subject|1|||
129656652|NCT01393106|466702226|FG000|Overall Study|Lack of Efficacy|1|||
129656653|NCT03214679|466702230|FG000|Overall Study|Lost to Follow-up|12|||
129656654|NCT03214679|466702231|FG001|Overall Study|Lost to Follow-up|14|||
129656655|NCT03214679|466702230|FG000|Overall Study|not eligible|2|||
129656656|NCT03214679|466702231|FG001|Overall Study|not eligible|0|||
129656657|NCT01754766|466702237|FG000|Overall Study|Personal reasons|1|||
129656658|NCT01754766|466702238|FG001|Overall Study|Personal reasons|1|||
129656659|NCT01754766|466702239|FG002|Overall Study|Personal reasons|0|||
129656660|NCT01709409|466702242|FG000|Overall Study|Protocol Violation|1|||
129656661|NCT01709409|466702243|FG001|Overall Study|Protocol Violation|0|||
129656662|NCT02412878|466702244|FG000|Overall Study|Withdrawal by Subject|19|||
129656663|NCT02412878|466702245|FG001|Overall Study|Withdrawal by Subject|10|||
129656664|NCT02412878|466702244|FG000|Overall Study|Lost to Follow-up|2|||
129656665|NCT02412878|466702245|FG001|Overall Study|Lost to Follow-up|3|||
129656666|NCT04571385|466702246|FG000|Overall Study|Participant non-compliance|1|||
129656667|NCT04571385|466702247|FG001|Overall Study|Participant non-compliance|0|||
129656668|NCT04571385|466702248|FG002|Overall Study|Participant non-compliance|0|||
129656669|NCT04571385|466702246|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
129656670|NCT04571385|466702247|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
129656671|NCT04571385|466702248|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
129656672|NCT04571385|466702246|FG000|Overall Study|Screen failure|0|||
129656673|NCT04571385|466702247|FG001|Overall Study|Screen failure|0|||
129656674|NCT04571385|466702248|FG002|Overall Study|Screen failure|1|||
129656675|NCT02263729|466702249|FG000|Overall Study|Lost to Follow-up|1|||
129656676|NCT02263729|466702250|FG001|Overall Study|Lost to Follow-up|1|||
129656677|NCT01212159|466702251|FG000|Overall Study|Withdrawal by Subject|12|||
129656678|NCT01212159|466702252|FG001|Overall Study|Withdrawal by Subject|12|||
129656679|NCT01306214|466702253|FG000|Overall Study|Death|0|||
129656680|NCT01306214|466702254|FG001|Overall Study|Death|0|||
129656681|NCT01306214|466702255|FG002|Overall Study|Death|1|||
129656682|NCT01306214|466702253|FG000|Overall Study|Lost to Follow-up|3|||
129656683|NCT01306214|466702254|FG001|Overall Study|Lost to Follow-up|5|||
129656684|NCT01306214|466702255|FG002|Overall Study|Lost to Follow-up|4|||
129656685|NCT01306214|466702253|FG000|Overall Study|Withdrawal by Subject|24|||
129656686|NCT01306214|466702254|FG001|Overall Study|Withdrawal by Subject|22|||
129656687|NCT01306214|466702255|FG002|Overall Study|Withdrawal by Subject|16|||
129656688|NCT01306214|466702253|FG000|Overall Study|Not treated|1|||
129656689|NCT01306214|466702254|FG001|Overall Study|Not treated|1|||
129656690|NCT01306214|466702255|FG002|Overall Study|Not treated|1|||
129656691|NCT03959488|466702256|FG000|Season 1|Other|6|||
129656692|NCT03959488|466702257|FG001|Season 1|Other|7|||
129656693|NCT03959488|466702258|FG002|Season 1|Other|0|||
129656694|NCT03959488|466702259|FG003|Season 1|Other|0|||
129656695|NCT03959488|466702260|FG004|Season 1|Other|0|||
129656696|NCT03959488|466702256|FG000|Season 1|Withdrawal by parent/guardian|43|||
129656697|NCT03959488|466702257|FG001|Season 1|Withdrawal by parent/guardian|28|||
129656698|NCT03959488|466702258|FG002|Season 1|Withdrawal by parent/guardian|0|||
129656699|NCT03959488|466702259|FG003|Season 1|Withdrawal by parent/guardian|0|||
129656700|NCT03959488|466702260|FG004|Season 1|Withdrawal by parent/guardian|0|||
129656701|NCT03959488|466702256|FG000|Season 1|Due to COVID-19 pandemic|2|||
129656702|NCT03959488|466702257|FG001|Season 1|Due to COVID-19 pandemic|3|||
129656703|NCT03959488|466702258|FG002|Season 1|Due to COVID-19 pandemic|0|||
129656704|NCT03959488|466702259|FG003|Season 1|Due to COVID-19 pandemic|0|||
129656705|NCT03959488|466702260|FG004|Season 1|Due to COVID-19 pandemic|0|||
129656706|NCT03959488|466702256|FG000|Season 1|Lost to Follow-up|17|||
129656707|NCT03959488|466702257|FG001|Season 1|Lost to Follow-up|7|||
129656708|NCT03959488|466702258|FG002|Season 1|Lost to Follow-up|0|||
129656709|NCT03959488|466702259|FG003|Season 1|Lost to Follow-up|0|||
129656710|NCT03959488|466702260|FG004|Season 1|Lost to Follow-up|0|||
129656711|NCT03959488|466702256|FG000|Season 1|Death|5|||
129656712|NCT03959488|466702257|FG001|Season 1|Death|1|||
129656713|NCT03959488|466702258|FG002|Season 1|Death|0|||
129656714|NCT03959488|466702259|FG003|Season 1|Death|0|||
129656715|NCT03959488|466702260|FG004|Season 1|Death|0|||
129656716|NCT03959488|466702256|FG000|Season 2|Other|0|||
129656717|NCT03959488|466702257|FG001|Season 2|Other|0|||
129656718|NCT03959488|466702258|FG002|Season 2|Other|2|||
129656719|NCT03959488|466702259|FG003|Season 2|Other|0|||
129656720|NCT03959488|466702260|FG004|Season 2|Other|0|||
129656721|NCT03959488|466702256|FG000|Season 2|Withdrawal by parent/guardian|0|||
129656722|NCT03959488|466702257|FG001|Season 2|Withdrawal by parent/guardian|0|||
129656723|NCT03959488|466702258|FG002|Season 2|Withdrawal by parent/guardian|3|||
129656724|NCT03959488|466702259|FG003|Season 2|Withdrawal by parent/guardian|1|||
129656725|NCT03959488|466702260|FG004|Season 2|Withdrawal by parent/guardian|1|||
129656726|NCT03959488|466702256|FG000|Season 2|Lost to Follow-up|0|||
129656727|NCT03959488|466702257|FG001|Season 2|Lost to Follow-up|0|||
129656728|NCT03959488|466702258|FG002|Season 2|Lost to Follow-up|1|||
129656729|NCT03959488|466702259|FG003|Season 2|Lost to Follow-up|0|||
129656730|NCT03959488|466702260|FG004|Season 2|Lost to Follow-up|1|||
129656731|NCT01026818|466702261|FG000|Screening Period|Entry Criteria Not Met|105|||
129656732|NCT01026818|466702262|FG001|Screening Period|Entry Criteria Not Met|0|||
129656733|NCT01026818|466702263|FG002|Screening Period|Entry Criteria Not Met|0|||
129656734|NCT01026818|466702264|FG003|Screening Period|Entry Criteria Not Met|0|||
129656735|NCT01026818|466702261|FG000|Screening Period|Withdrawal by Subject|49|||
129656736|NCT01026818|466702262|FG001|Screening Period|Withdrawal by Subject|0|||
129656737|NCT01026818|466702263|FG002|Screening Period|Withdrawal by Subject|0|||
129988121|NCT00190749|467918845|FG000|Overall Study|Reason Not Specified|0|||
129988122|NCT00190749|467918846|FG001|Overall Study|Reason Not Specified|2|||
129988123|NCT00190749|467918845|FG000|Overall Study|Sponsor Decision|1|||
129988124|NCT00190749|467918846|FG001|Overall Study|Sponsor Decision|0|||
129988125|NCT02729753|467918847|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
129656738|NCT01026818|466702264|FG003|Screening Period|Withdrawal by Subject|0|||
129656739|NCT01026818|466702261|FG000|Screening Period|Protocol Deviation|3|||
129656740|NCT01026818|466702262|FG001|Screening Period|Protocol Deviation|0|||
129656741|NCT01026818|466702263|FG002|Screening Period|Protocol Deviation|0|||
129656742|NCT01026818|466702264|FG003|Screening Period|Protocol Deviation|0|||
129988126|NCT02729753|467918848|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
129546012|NCT01610284|466292361|FG001|Randomization Phase|Adverse Event|0|||
129546013|NCT01610284|466292360|FG000|Randomization Phase|Physician Decision|1|||
129546014|NCT01610284|466292361|FG001|Randomization Phase|Physician Decision|1|||
129546015|NCT01610284|466292360|FG000|Randomization Phase|Death|0|||
129546016|NCT01610284|466292361|FG001|Randomization Phase|Death|1|||
129546017|NCT01610284|466292360|FG000|Treatment Phase|Adverse Event|80|||
129546018|NCT01610284|466292361|FG001|Treatment Phase|Adverse Event|12|||
129546019|NCT01610284|466292360|FG000|Treatment Phase|Lost to Follow-up|1|||
129546020|NCT01610284|466292361|FG001|Treatment Phase|Lost to Follow-up|0|||
129546021|NCT01610284|466292360|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
129546022|NCT01610284|466292361|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
129546023|NCT01610284|466292360|FG000|Treatment Phase|Physician Decision|27|||
129546024|NCT01610284|466292361|FG001|Treatment Phase|Physician Decision|24|||
129546025|NCT01610284|466292360|FG000|Treatment Phase|Progressive Disease|377|||
129546026|NCT01610284|466292361|FG001|Treatment Phase|Progressive Disease|486|||
129546027|NCT01610284|466292360|FG000|Treatment Phase|Protocol Deviation|2|||
129546028|NCT01610284|466292361|FG001|Treatment Phase|Protocol Deviation|3|||
129546029|NCT01610284|466292360|FG000|Treatment Phase|Study terminated by Sponsor|18|||
129546030|NCT01610284|466292361|FG001|Treatment Phase|Study terminated by Sponsor|15|||
129546031|NCT01610284|466292360|FG000|Treatment Phase|Subject/Guardian Decision|55|||
129546032|NCT01610284|466292361|FG001|Treatment Phase|Subject/Guardian Decision|23|||
129546033|NCT01610284|466292360|FG000|Treatment Phase|Death|6|||
129546034|NCT01610284|466292361|FG001|Treatment Phase|Death|5|||
129546035|NCT01610284|466292360|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
129546036|NCT01610284|466292361|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129546037|NCT01610284|466292360|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
129546038|NCT01610284|466292361|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
129546039|NCT01610284|466292360|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
129546040|NCT01610284|466292361|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
129546041|NCT01610284|466292360|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
129546042|NCT01610284|466292361|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
129546043|NCT01610284|466292360|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
129546044|NCT01610284|466292361|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
129546045|NCT01610284|466292360|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
129546046|NCT01610284|466292361|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
129546047|NCT01102972|466292364|FG000|Overall Study|Adverse Event|8|||
129546048|NCT01102972|466292365|FG001|Overall Study|Adverse Event|2|||
129546049|NCT01102972|466292364|FG000|Overall Study|Lack of Efficacy|2|||
129546050|NCT01102972|466292365|FG001|Overall Study|Lack of Efficacy|1|||
129546051|NCT01102972|466292364|FG000|Overall Study|Protocol Violation|1|||
129546052|NCT01102972|466292365|FG001|Overall Study|Protocol Violation|0|||
129546053|NCT01102972|466292364|FG000|Overall Study|Lost to Follow-up|10|||
129546054|NCT01102972|466292365|FG001|Overall Study|Lost to Follow-up|5|||
129546055|NCT01102972|466292364|FG000|Overall Study|Investigator Discretion|2|||
129546056|NCT01102972|466292365|FG001|Overall Study|Investigator Discretion|0|||
129546057|NCT01102972|466292364|FG000|Overall Study|Withdrawal by Subject|6|||
129546058|NCT01102972|466292365|FG001|Overall Study|Withdrawal by Subject|6|||
129546059|NCT01856257|466292366|FG000|Overall Study|Death|2|||
129546060|NCT01856257|466292367|FG001|Overall Study|Death|0|||
129546061|NCT01856257|466292368|FG002|Overall Study|Death|0|||
129546062|NCT01856257|466292369|FG003|Overall Study|Death|0|||
129546063|NCT01856257|466292366|FG000|Overall Study|Physician Decision|0|||
129546064|NCT01856257|466292367|FG001|Overall Study|Physician Decision|0|||
129656743|NCT01026818|466702261|FG000|Screening Period|Adverse Event|2|||
129656744|NCT01026818|466702262|FG001|Screening Period|Adverse Event|0|||
129546065|NCT01856257|466292368|FG002|Overall Study|Physician Decision|0|||
129546066|NCT01856257|466292369|FG003|Overall Study|Physician Decision|1|||
129546067|NCT01856257|466292366|FG000|Overall Study|Withdrawal by Subject|1|||
129546068|NCT01856257|466292367|FG001|Overall Study|Withdrawal by Subject|1|||
129546069|NCT01856257|466292368|FG002|Overall Study|Withdrawal by Subject|0|||
129546070|NCT01856257|466292369|FG003|Overall Study|Withdrawal by Subject|0|||
129546071|NCT01856257|466292366|FG000|Overall Study|Donor complication|0|||
129546072|NCT01856257|466292367|FG001|Overall Study|Donor complication|0|||
129656745|NCT01026818|466702263|FG002|Screening Period|Adverse Event|0|||
129656746|NCT01026818|466702264|FG003|Screening Period|Adverse Event|0|||
129656747|NCT01026818|466702261|FG000|Screening Period|Physician Decision|1|||
129656748|NCT01026818|466702262|FG001|Screening Period|Physician Decision|0|||
129656749|NCT01026818|466702263|FG002|Screening Period|Physician Decision|0|||
129656750|NCT01026818|466702264|FG003|Screening Period|Physician Decision|0|||
129656751|NCT01026818|466702261|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
129656752|NCT01026818|466702262|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
129656753|NCT01026818|466702263|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
129656754|NCT01026818|466702264|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
129656755|NCT01026818|466702261|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
129656756|NCT01026818|466702262|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
129656757|NCT01026818|466702263|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
129656758|NCT01026818|466702264|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
129656759|NCT01026818|466702261|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
129656760|NCT01026818|466702262|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
129656761|NCT01026818|466702263|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
129656762|NCT01026818|466702264|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
129656763|NCT01026818|466702261|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
129656764|NCT01026818|466702262|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
129656765|NCT01026818|466702263|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
129656766|NCT01026818|466702264|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
129656767|NCT01026818|466702261|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
129656768|NCT01026818|466702262|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
129656769|NCT01026818|466702263|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
129656770|NCT01026818|466702264|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
129656771|NCT01026818|466702261|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
129656772|NCT01026818|466702262|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
129656773|NCT01026818|466702263|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
129656774|NCT01026818|466702264|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
129656775|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
129656776|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
129656777|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
129656778|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
129656779|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
129656780|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
129656781|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
129656782|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
129656783|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
129656784|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
129656785|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
129656786|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
129656787|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
129656788|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
129656789|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
129656790|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
129656791|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
129656792|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
129656793|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
129656794|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
129656795|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
129656796|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
129656797|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
129656798|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
129656799|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
129656800|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
129656801|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
129656802|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
129656803|NCT01026818|466702261|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
129656804|NCT01026818|466702262|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
129656805|NCT01026818|466702263|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
129656806|NCT01026818|466702264|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
129656807|NCT01026818|466702261|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
129656808|NCT01026818|466702262|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
129656809|NCT01026818|466702263|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
129656810|NCT01026818|466702264|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
129988127|NCT01090427|467918849|FG000|After Controlled Period|Death|0|||
129988128|NCT01090427|467918850|FG001|After Controlled Period|Death|0|||
129988129|NCT01090427|467918851|FG002|After Controlled Period|Death|0|||
129988130|NCT01090427|467918852|FG003|After Controlled Period|Death|0|||
129988131|NCT01090427|467918853|FG004|After Controlled Period|Death|0|||
129988132|NCT01090427|467918854|FG005|After Controlled Period|Death|1|||
129988133|NCT01090427|467918855|FG006|After Controlled Period|Death|0|||
129988134|NCT01090427|467918849|FG000|After Controlled Period|Lack of Efficacy|0|||
129988135|NCT01090427|467918850|FG001|After Controlled Period|Lack of Efficacy|0|||
129988136|NCT01090427|467918851|FG002|After Controlled Period|Lack of Efficacy|0|||
129988137|NCT01090427|467918852|FG003|After Controlled Period|Lack of Efficacy|0|||
129988138|NCT01090427|467918853|FG004|After Controlled Period|Lack of Efficacy|0|||
129988139|NCT01090427|467918854|FG005|After Controlled Period|Lack of Efficacy|3|||
129988140|NCT01090427|467918855|FG006|After Controlled Period|Lack of Efficacy|2|||
129988141|NCT01090427|467918849|FG000|After Controlled Period|Adverse Event|0|||
129988142|NCT01090427|467918850|FG001|After Controlled Period|Adverse Event|0|||
129988143|NCT01090427|467918851|FG002|After Controlled Period|Adverse Event|0|||
129988144|NCT01090427|467918852|FG003|After Controlled Period|Adverse Event|2|||
129988145|NCT01090427|467918853|FG004|After Controlled Period|Adverse Event|0|||
129988146|NCT01090427|467918854|FG005|After Controlled Period|Adverse Event|1|||
129988147|NCT01090427|467918855|FG006|After Controlled Period|Adverse Event|0|||
129988148|NCT01200589|467918856|FG000|Overall Study|Withdrawal by Subject|13|||
129988149|NCT01200589|467918857|FG001|Overall Study|Withdrawal by Subject|11|||
129988150|NCT01200589|467918856|FG000|Overall Study|Physician Decision|2|||
129988151|NCT01200589|467918857|FG001|Overall Study|Physician Decision|2|||
129988152|NCT01200589|467918856|FG000|Overall Study|Lost to Follow-up|5|||
129988153|NCT01200589|467918857|FG001|Overall Study|Lost to Follow-up|4|||
129988154|NCT01200589|467918856|FG000|Overall Study|Study terminated|170|||
129988155|NCT01200589|467918857|FG001|Overall Study|Study terminated|172|||
129988156|NCT01154010|467918858|FG000|Overall Study|Lost to Follow-up|0|||
129988157|NCT01154010|467918859|FG001|Overall Study|Lost to Follow-up|1|||
129988158|NCT00439231|467918860|FG000|Overall Study|Lack of Efficacy|28|||
129988159|NCT02689518|467918861|FG000|Overall Study|Withdrawal by Subject|3|||
129988160|NCT00825825|467918864|FG000|First Medication Period (14 Days)|Adverse Event|1|||
129988161|NCT00825825|467918865|FG001|First Medication Period (14 Days)|Adverse Event|0|||
129988162|NCT00825825|467918866|FG002|First Medication Period (14 Days)|Adverse Event|0|||
129988163|NCT00825825|467918867|FG003|First Medication Period (14 Days)|Adverse Event|0|||
129988164|NCT00825825|467918868|FG004|First Medication Period (14 Days)|Adverse Event|0|||
129988165|NCT00825825|467918869|FG005|First Medication Period (14 Days)|Adverse Event|1|||
129988166|NCT00825825|467918864|FG000|First Medication Period (14 Days)|Physician Decision|2|||
129988167|NCT00825825|467918865|FG001|First Medication Period (14 Days)|Physician Decision|0|||
129988168|NCT00825825|467918866|FG002|First Medication Period (14 Days)|Physician Decision|1|||
129988169|NCT00825825|467918867|FG003|First Medication Period (14 Days)|Physician Decision|0|||
129988170|NCT00825825|467918868|FG004|First Medication Period (14 Days)|Physician Decision|0|||
129988171|NCT00825825|467918869|FG005|First Medication Period (14 Days)|Physician Decision|1|||
129988172|NCT00825825|467918864|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
129988173|NCT00825825|467918865|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
129988174|NCT00825825|467918866|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
129988175|NCT00825825|467918867|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
129988176|NCT00825825|467918868|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
129988177|NCT00825825|467918869|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
129988178|NCT00825825|467918864|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
129988179|NCT00825825|467918865|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
129988180|NCT00825825|467918866|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
129988181|NCT00825825|467918867|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
129988182|NCT00825825|467918868|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
129988183|NCT00825825|467918869|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
129988184|NCT00825825|467918864|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
129988185|NCT00825825|467918865|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
129988186|NCT00825825|467918866|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
129656811|NCT01026818|466702261|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
129988187|NCT00825825|467918867|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
129988188|NCT00825825|467918868|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
129988189|NCT00825825|467918869|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
129988190|NCT00825825|467918864|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
129656812|NCT01026818|466702262|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
129988191|NCT00825825|467918865|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
129988192|NCT00825825|467918866|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
129988193|NCT00825825|467918867|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
129988194|NCT00825825|467918868|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
129988195|NCT00825825|467918869|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
129988196|NCT00825825|467918864|FG000|Third Medication Period (14 Days)|poor data quality|0|||
129656813|NCT01026818|466702263|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
129656814|NCT01026818|466702264|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
129656815|NCT01026818|466702261|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
129656816|NCT01026818|466702262|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
129656817|NCT01026818|466702263|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
129656818|NCT01026818|466702264|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
129656819|NCT01026818|466702261|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
129656820|NCT01026818|466702262|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
129656821|NCT01026818|466702263|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
129656822|NCT01026818|466702264|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
129656823|NCT01026818|466702261|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
129656824|NCT01026818|466702262|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
129656825|NCT01026818|466702263|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
129656826|NCT01026818|466702264|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
129656827|NCT01031004|466702265|FG000|Overall Study|Protocol Violation|0|||
129656828|NCT01031004|466702266|FG001|Overall Study|Protocol Violation|1|||
129656829|NCT01031004|466702265|FG000|Overall Study|Lost to Follow-up|1|||
129656830|NCT01031004|466702266|FG001|Overall Study|Lost to Follow-up|0|||
129656831|NCT01641471|466702267|FG000|Overall Study|Withdrawal by Subject|19|||
129656832|NCT01641471|466702268|FG001|Overall Study|Withdrawal by Subject|19|||
129656833|NCT01641471|466702267|FG000|Overall Study|Lost to Follow-up|2|||
129656834|NCT01641471|466702268|FG001|Overall Study|Lost to Follow-up|4|||
129656835|NCT01641471|466702267|FG000|Overall Study|Protocol Violation|2|||
129656836|NCT01641471|466702268|FG001|Overall Study|Protocol Violation|4|||
129656837|NCT04575584|466702272|FG000|Overall Study|Death|6|||
129656838|NCT04575584|466702273|FG001|Overall Study|Death|4|||
129656839|NCT04575584|466702274|FG002|Overall Study|Death|6|||
129656840|NCT04575584|466702275|FG003|Overall Study|Death|2|||
129656841|NCT04575584|466702276|FG004|Overall Study|Death|0|||
129988197|NCT00825825|467918865|FG001|Third Medication Period (14 Days)|poor data quality|1|||
129988198|NCT00825825|467918866|FG002|Third Medication Period (14 Days)|poor data quality|0|||
129988199|NCT00825825|467918867|FG003|Third Medication Period (14 Days)|poor data quality|0|||
129656842|NCT04575584|466702277|FG005|Overall Study|Death|0|||
129656843|NCT04575584|466702272|FG000|Overall Study|Lost to Follow-up|1|||
129656844|NCT04575584|466702273|FG001|Overall Study|Lost to Follow-up|1|||
129656845|NCT04575584|466702274|FG002|Overall Study|Lost to Follow-up|1|||
129656846|NCT04575584|466702275|FG003|Overall Study|Lost to Follow-up|1|||
129656847|NCT04575584|466702276|FG004|Overall Study|Lost to Follow-up|0|||
129656848|NCT04575584|466702277|FG005|Overall Study|Lost to Follow-up|0|||
129656849|NCT04575584|466702272|FG000|Overall Study|Physician Decision|0|||
129656850|NCT04575584|466702273|FG001|Overall Study|Physician Decision|1|||
129656851|NCT04575584|466702274|FG002|Overall Study|Physician Decision|1|||
129988200|NCT00825825|467918868|FG004|Third Medication Period (14 Days)|poor data quality|0|||
129988201|NCT00825825|467918869|FG005|Third Medication Period (14 Days)|poor data quality|0|||
129988202|NCT01920854|467918872|FG000|Overall Study|Withdrawal by Subject|1|||
129988203|NCT01920854|467918873|FG001|Overall Study|Withdrawal by Subject|0|||
129546073|NCT01856257|466292368|FG002|Overall Study|Donor complication|0|||
129546074|NCT01856257|466292369|FG003|Overall Study|Donor complication|1|||
129546075|NCT01125358|466292376|FG000|Overall Study|Adverse Event|3|||
129546076|NCT01125358|466292377|FG001|Overall Study|Adverse Event|0|||
129546077|NCT01125358|466292378|FG002|Overall Study|Adverse Event|0|||
129546078|NCT01125358|466292379|FG003|Overall Study|Adverse Event|2|||
129546079|NCT01125358|466292376|FG000|Overall Study|Perceived Lack of Efficacy|6|||
129546080|NCT01125358|466292377|FG001|Overall Study|Perceived Lack of Efficacy|3|||
129546081|NCT01125358|466292378|FG002|Overall Study|Perceived Lack of Efficacy|7|||
129546082|NCT01125358|466292379|FG003|Overall Study|Perceived Lack of Efficacy|4|||
129546083|NCT01125358|466292376|FG000|Overall Study|Protocol Violation|1|||
129546084|NCT01125358|466292377|FG001|Overall Study|Protocol Violation|0|||
129546085|NCT01125358|466292378|FG002|Overall Study|Protocol Violation|0|||
129546086|NCT01125358|466292379|FG003|Overall Study|Protocol Violation|0|||
129546087|NCT01125358|466292376|FG000|Overall Study|Sponsor Decision|0|||
129546088|NCT01125358|466292377|FG001|Overall Study|Sponsor Decision|0|||
129546089|NCT01125358|466292378|FG002|Overall Study|Sponsor Decision|1|||
129546090|NCT01125358|466292379|FG003|Overall Study|Sponsor Decision|1|||
129546091|NCT01125358|466292376|FG000|Overall Study|Withdrawal by Subject|2|||
129546092|NCT01125358|466292377|FG001|Overall Study|Withdrawal by Subject|1|||
129546093|NCT01125358|466292378|FG002|Overall Study|Withdrawal by Subject|1|||
129546094|NCT01125358|466292379|FG003|Overall Study|Withdrawal by Subject|1|||
129546095|NCT01157065|466292380|FG000|Overall Study|Death|0|||
129546096|NCT01157065|466292381|FG001|Overall Study|Death|1|||
129546097|NCT01060007|466292384|FG000|Overall Study|Withdrawal by Subject|1|||
129546098|NCT01060007|466292384|FG000|Overall Study|Inevaluable for response at surgery|3|||
129546099|NCT05168657|466292385|FG000|Overall Study|Adverse Event|0|||
129546100|NCT05168657|466292386|FG001|Overall Study|Adverse Event|0|||
129546101|NCT05168657|466292387|FG002|Overall Study|Adverse Event|1|||
129546102|NCT05168657|466292388|FG003|Overall Study|Adverse Event|0|||
129656852|NCT04575584|466702275|FG003|Overall Study|Physician Decision|1|||
129656853|NCT04575584|466702276|FG004|Overall Study|Physician Decision|0|||
129656854|NCT04575584|466702277|FG005|Overall Study|Physician Decision|0|||
129656855|NCT04575584|466702272|FG000|Overall Study|Withdrawal by Subject|7|||
129656856|NCT04575584|466702273|FG001|Overall Study|Withdrawal by Subject|9|||
129656857|NCT04575584|466702274|FG002|Overall Study|Withdrawal by Subject|5|||
129656858|NCT04575584|466702275|FG003|Overall Study|Withdrawal by Subject|3|||
129656859|NCT04575584|466702276|FG004|Overall Study|Withdrawal by Subject|0|||
129656860|NCT04575584|466702277|FG005|Overall Study|Withdrawal by Subject|0|||
129656861|NCT04575584|466702272|FG000|Overall Study|Not recorded|0|||
129656862|NCT04575584|466702273|FG001|Overall Study|Not recorded|0|||
129656863|NCT04575584|466702274|FG002|Overall Study|Not recorded|0|||
129656864|NCT04575584|466702275|FG003|Overall Study|Not recorded|1|||
129656865|NCT04575584|466702276|FG004|Overall Study|Not recorded|0|||
129656866|NCT04575584|466702277|FG005|Overall Study|Not recorded|0|||
129656867|NCT03488563|466702278|FG000|Overall Study|Lost to Follow-up|7|||
129656868|NCT03488563|466702279|FG001|Overall Study|Lost to Follow-up|6|||
129656869|NCT03488563|466702280|FG002|Overall Study|Lost to Follow-up|7|||
129656870|NCT03488563|466702278|FG000|Overall Study|Withdrawal by Subject|8|||
129656871|NCT03488563|466702279|FG001|Overall Study|Withdrawal by Subject|7|||
129656872|NCT03488563|466702280|FG002|Overall Study|Withdrawal by Subject|7|||
129656873|NCT03488563|466702278|FG000|Overall Study|Physician Decision|0|||
129656874|NCT03488563|466702279|FG001|Overall Study|Physician Decision|0|||
129656875|NCT03488563|466702280|FG002|Overall Study|Physician Decision|1|||
129656876|NCT03488563|466702278|FG000|Overall Study|Protocol Violation|3|||
129656877|NCT03488563|466702279|FG001|Overall Study|Protocol Violation|2|||
129656878|NCT03488563|466702280|FG002|Overall Study|Protocol Violation|6|||
129656879|NCT03488563|466702278|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
129656880|NCT03488563|466702279|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
129656881|NCT03488563|466702280|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
129656882|NCT03488563|466702278|FG000|Overall Study|Use of prohibited medication|2|||
129656883|NCT03488563|466702279|FG001|Overall Study|Use of prohibited medication|0|||
129656884|NCT03488563|466702280|FG002|Overall Study|Use of prohibited medication|0|||
129656885|NCT03488563|466702278|FG000|Overall Study|Adverse Event|1|||
129656886|NCT03488563|466702279|FG001|Overall Study|Adverse Event|0|||
129656887|NCT03488563|466702280|FG002|Overall Study|Adverse Event|1|||
129656888|NCT03488563|466702278|FG000|Overall Study|Subject returned for ET visit|0|||
129656889|NCT03488563|466702279|FG001|Overall Study|Subject returned for ET visit|1|||
129656890|NCT03488563|466702280|FG002|Overall Study|Subject returned for ET visit|0|||
129656891|NCT03488563|466702278|FG000|Overall Study|Sponsor's decision|0|||
129656892|NCT03488563|466702279|FG001|Overall Study|Sponsor's decision|0|||
129656893|NCT03488563|466702280|FG002|Overall Study|Sponsor's decision|1|||
129656894|NCT02769312|466702293|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
129656895|NCT02769312|466702294|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
129656896|NCT02769312|466702293|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
129656897|NCT02769312|466702294|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
129656898|NCT02769312|466702293|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
129656899|NCT02769312|466702294|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
129656900|NCT02769312|466702293|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
129656901|NCT02769312|466702294|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
129656902|NCT02769312|466702293|FG000|Follow-up|Lost to Follow-up|1|||
129656903|NCT02769312|466702294|FG001|Follow-up|Lost to Follow-up|1|||
129656904|NCT02815267|466702295|FG000|Double-Blind Phase|Adverse Event|0|||
129656905|NCT02815267|466702296|FG001|Double-Blind Phase|Adverse Event|3|||
129656906|NCT02815267|466702295|FG000|Double-Blind Phase|Lost to Follow-up|17|||
129656907|NCT02815267|466702296|FG001|Double-Blind Phase|Lost to Follow-up|9|||
129656908|NCT02815267|466702295|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
129656909|NCT02815267|466702296|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
129656910|NCT02815267|466702295|FG000|Double-Blind Phase|Protocol Violation|3|||
129656911|NCT02815267|466702296|FG001|Double-Blind Phase|Protocol Violation|2|||
129656912|NCT02815267|466702295|FG000|Double-Blind Phase|Site withdrawal|1|||
129656913|NCT02815267|466702296|FG001|Double-Blind Phase|Site withdrawal|6|||
129656914|NCT02815267|466702295|FG000|Double-Blind Phase|Received a disallowed medication|1|||
129656915|NCT02815267|466702296|FG001|Double-Blind Phase|Received a disallowed medication|1|||
129656916|NCT02815267|466702295|FG000|Open-Label Phase|Adverse Event|1|||
129656917|NCT02815267|466702296|FG001|Open-Label Phase|Adverse Event|1|||
129656918|NCT02815267|466702295|FG000|Open-Label Phase|Lost to Follow-up|23|||
129656919|NCT02815267|466702296|FG001|Open-Label Phase|Lost to Follow-up|9|||
129656920|NCT02815267|466702295|FG000|Open-Label Phase|Withdrawal by Subject|24|||
129656921|NCT02815267|466702296|FG001|Open-Label Phase|Withdrawal by Subject|13|||
129883509|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
129883510|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
129656922|NCT02815267|466702295|FG000|Open-Label Phase|Protocol Violation|0|||
129656923|NCT02815267|466702296|FG001|Open-Label Phase|Protocol Violation|1|||
129656924|NCT02815267|466702295|FG000|Open-Label Phase|Administrative|21|||
129656925|NCT02815267|466702296|FG001|Open-Label Phase|Administrative|12|||
129656926|NCT02815267|466702295|FG000|Open-Label Phase|Other|2|||
129656927|NCT02815267|466702296|FG001|Open-Label Phase|Other|5|||
129656928|NCT03594955|466702297|FG000|Overall Study|Adverse Event|1|||
129656929|NCT03594955|466702297|FG000|Overall Study|Progressive disease|5|||
129656930|NCT03594955|466702297|FG000|Overall Study|Sponsor's decision|1|||
129656931|NCT05600036|466702300|FG000|Overall Study|Adverse Event|0|||
129656932|NCT05600036|466702301|FG001|Overall Study|Adverse Event|2|||
129656933|NCT05600036|466702302|FG002|Overall Study|Adverse Event|1|||
129656934|NCT05600036|466702303|FG003|Overall Study|Adverse Event|0|||
129656935|NCT05600036|466702304|FG004|Overall Study|Adverse Event|1|||
129656936|NCT05600036|466702305|FG005|Overall Study|Adverse Event|0|||
129656937|NCT05600036|466702300|FG000|Overall Study|Lost to Follow-up|0|||
129656938|NCT05600036|466702301|FG001|Overall Study|Lost to Follow-up|2|||
129656939|NCT05600036|466702302|FG002|Overall Study|Lost to Follow-up|1|||
129656940|NCT05600036|466702303|FG003|Overall Study|Lost to Follow-up|1|||
129656941|NCT05600036|466702304|FG004|Overall Study|Lost to Follow-up|0|||
129656942|NCT05600036|466702305|FG005|Overall Study|Lost to Follow-up|0|||
129656943|NCT05600036|466702300|FG000|Overall Study|Protocol Violation|0|||
129656944|NCT05600036|466702301|FG001|Overall Study|Protocol Violation|0|||
129656945|NCT05600036|466702302|FG002|Overall Study|Protocol Violation|2|||
129656946|NCT05600036|466702303|FG003|Overall Study|Protocol Violation|0|||
129656947|NCT05600036|466702304|FG004|Overall Study|Protocol Violation|0|||
129656948|NCT05600036|466702305|FG005|Overall Study|Protocol Violation|0|||
129656949|NCT05600036|466702300|FG000|Overall Study|Withdrawal by Subject|0|||
129656950|NCT05600036|466702301|FG001|Overall Study|Withdrawal by Subject|1|||
129656951|NCT05600036|466702302|FG002|Overall Study|Withdrawal by Subject|2|||
129656952|NCT05600036|466702303|FG003|Overall Study|Withdrawal by Subject|0|||
129656953|NCT05600036|466702304|FG004|Overall Study|Withdrawal by Subject|3|||
129656954|NCT05600036|466702305|FG005|Overall Study|Withdrawal by Subject|5|||
129656955|NCT05600036|466702300|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129656956|NCT05600036|466702301|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129656957|NCT05600036|466702302|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129656958|NCT05600036|466702303|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
129656959|NCT05600036|466702304|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129656960|NCT05600036|466702305|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
129656961|NCT05600036|466702300|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129656962|NCT05600036|466702301|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
129656963|NCT05600036|466702302|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129656964|NCT05600036|466702303|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129656965|NCT05600036|466702304|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129656966|NCT05600036|466702305|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
129656967|NCT05600036|466702300|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129656968|NCT05600036|466702301|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129656969|NCT05600036|466702302|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129656970|NCT05600036|466702303|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
129656971|NCT05600036|466702304|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129656972|NCT05600036|466702305|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
129656973|NCT02714036|466702306|FG000|Overall Study|Adverse Event|9|||
129656974|NCT02714036|466702307|FG001|Overall Study|Adverse Event|2|||
129656975|NCT02714036|466702306|FG000|Overall Study|Withdrawal by Subject|3|||
129656976|NCT02714036|466702307|FG001|Overall Study|Withdrawal by Subject|2|||
129656977|NCT01006590|466702308|FG000|Overall Study|Adverse Event|2|||
129656978|NCT01006590|466702309|FG001|Overall Study|Adverse Event|3|||
129656979|NCT01006590|466702308|FG000|Overall Study|Death|1|||
129656980|NCT01006590|466702309|FG001|Overall Study|Death|1|||
129656981|NCT01006590|466702308|FG000|Overall Study|Lost to Follow-up|1|||
129656982|NCT01006590|466702309|FG001|Overall Study|Lost to Follow-up|1|||
129656983|NCT01006590|466702308|FG000|Overall Study|Protocol Violation|1|||
129656984|NCT01006590|466702309|FG001|Overall Study|Protocol Violation|0|||
129656985|NCT01006590|466702308|FG000|Overall Study|Withdrawal by Subject|4|||
129656986|NCT01006590|466702309|FG001|Overall Study|Withdrawal by Subject|2|||
129656987|NCT01006590|466702308|FG000|Overall Study|Study specific discontinuation criteria|16|||
129656988|NCT01006590|466702309|FG001|Overall Study|Study specific discontinuation criteria|23|||
129656989|NCT01006590|466702308|FG000|Overall Study|Other|3|||
129656990|NCT01006590|466702309|FG001|Overall Study|Other|2|||
129656991|NCT03332095|466702310|FG000|Overall Study|Lost to Follow-up|1|||
129656992|NCT03332095|466702311|FG001|Overall Study|Lost to Follow-up|0|||
129656993|NCT03332095|466702310|FG000|Overall Study|Pregnancy|0|||
129988204|NCT01920854|467918874|FG002|Overall Study|Withdrawal by Subject|0|||
129988205|NCT01920854|467918875|FG003|Overall Study|Withdrawal by Subject|0|||
129988206|NCT01920854|467918876|FG004|Overall Study|Withdrawal by Subject|1|||
129656994|NCT03332095|466702311|FG001|Overall Study|Pregnancy|1|||
129656995|NCT00703118|466702312|FG000|Overall Study|Adverse Event|1|||
129656996|NCT00703118|466702313|FG001|Overall Study|Adverse Event|2|||
129656997|NCT00703118|466702314|FG002|Overall Study|Adverse Event|2|||
129656998|NCT00703118|466702312|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
129656999|NCT00703118|466702313|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
129657000|NCT00703118|466702314|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
129657001|NCT00703118|466702312|FG000|Overall Study|Lost to Follow-up|6|||
129657002|NCT00703118|466702313|FG001|Overall Study|Lost to Follow-up|4|||
129657003|NCT00703118|466702314|FG002|Overall Study|Lost to Follow-up|4|||
129657004|NCT00703118|466702312|FG000|Overall Study|Withdrawal by Subject|8|||
129657005|NCT00703118|466702313|FG001|Overall Study|Withdrawal by Subject|7|||
129657006|NCT00703118|466702314|FG002|Overall Study|Withdrawal by Subject|13|||
129657007|NCT00703118|466702312|FG000|Overall Study|Other|0|||
129657008|NCT00703118|466702313|FG001|Overall Study|Other|0|||
129657009|NCT00703118|466702314|FG002|Overall Study|Other|1|||
129657010|NCT00431067|466702315|FG000|Overall Study|Other Adverse Event|9|||
129657011|NCT00431067|466702315|FG000|Overall Study|Progressive disease|30|||
129657012|NCT00431067|466702315|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
129657013|NCT00830518|466702325|FG000|Overall Study|Progressive Disease|18|||
129657014|NCT00830518|466702326|FG001|Overall Study|Progressive Disease|8|||
129657015|NCT00830518|466702325|FG000|Overall Study|Symptomatic Deterioration|4|||
129657016|NCT00830518|466702326|FG001|Overall Study|Symptomatic Deterioration|1|||
129657017|NCT00830518|466702325|FG000|Overall Study|Adverse Event|14|||
129657018|NCT00830518|466702326|FG001|Overall Study|Adverse Event|1|||
129657019|NCT00830518|466702325|FG000|Overall Study|Withdrawal by Patient|2|||
129657020|NCT00830518|466702326|FG001|Overall Study|Withdrawal by Patient|0|||
129657021|NCT00830518|466702325|FG000|Overall Study|Reason not Specified|8|||
129657022|NCT00830518|466702326|FG001|Overall Study|Reason not Specified|1|||
129657023|NCT02155322|466702331|FG000|Overall Study|Adverse Event|1|||
129657024|NCT02155322|466702331|FG000|Overall Study|Physician Decision|1|||
129657025|NCT02155322|466702331|FG000|Overall Study|Relapse/Recurrence|8|||
129657026|NCT02155322|466702331|FG000|Overall Study|Withdrawal by Subject|4|||
129657027|NCT03337048|466702335|FG000|Overall Study|Withdrawal by Subject|2|||
129657028|NCT03337048|466702336|FG001|Overall Study|Withdrawal by Subject|0|||
129657029|NCT03337048|466702337|FG002|Overall Study|Withdrawal by Subject|0|||
129657030|NCT02791438|466702338|FG000|Treatment Period|Adverse Event|1|||
129657031|NCT02791438|466702339|FG001|Treatment Period|Adverse Event|0|||
129657032|NCT02791438|466702338|FG000|Treatment Period|Withdrawal by Subject|0|||
129657033|NCT02791438|466702339|FG001|Treatment Period|Withdrawal by Subject|1|||
129657034|NCT02791438|466702338|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
129657035|NCT02791438|466702339|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
129657036|NCT00394771|466702340|FG000|Overall Study|Did not meet protocol requirements|1|||
129657037|NCT00394771|466702341|FG001|Overall Study|Did not meet protocol requirements|0|||
129657038|NCT00394771|466702342|FG002|Overall Study|Did not meet protocol requirements|2|||
129657039|NCT00394771|466702343|FG003|Overall Study|Did not meet protocol requirements|0|||
129657040|NCT00394771|466702340|FG000|Overall Study|Protocol Violation|2|||
129657041|NCT00394771|466702341|FG001|Overall Study|Protocol Violation|4|||
129657042|NCT00394771|466702342|FG002|Overall Study|Protocol Violation|9|||
129657043|NCT00394771|466702343|FG003|Overall Study|Protocol Violation|7|||
129657044|NCT00394771|466702340|FG000|Overall Study|Withdrawal by Subject|10|||
129657045|NCT00394771|466702341|FG001|Overall Study|Withdrawal by Subject|6|||
129657046|NCT00394771|466702342|FG002|Overall Study|Withdrawal by Subject|8|||
129657047|NCT00394771|466702343|FG003|Overall Study|Withdrawal by Subject|12|||
129657048|NCT00394771|466702340|FG000|Overall Study|Adverse Event|10|||
129657049|NCT00394771|466702341|FG001|Overall Study|Adverse Event|5|||
129657050|NCT00394771|466702342|FG002|Overall Study|Adverse Event|12|||
129657051|NCT00394771|466702343|FG003|Overall Study|Adverse Event|8|||
129657052|NCT00394771|466702340|FG000|Overall Study|Participant pregnant|0|||
129657053|NCT00394771|466702341|FG001|Overall Study|Participant pregnant|1|||
129657054|NCT00394771|466702342|FG002|Overall Study|Participant pregnant|2|||
129657055|NCT00394771|466702343|FG003|Overall Study|Participant pregnant|2|||
129657056|NCT00394771|466702340|FG000|Overall Study|Lost to Follow-up|15|||
129657057|NCT00394771|466702341|FG001|Overall Study|Lost to Follow-up|15|||
129657058|NCT00394771|466702342|FG002|Overall Study|Lost to Follow-up|13|||
129657059|NCT00394771|466702343|FG003|Overall Study|Lost to Follow-up|10|||
129657060|NCT00394771|466702340|FG000|Overall Study|Other|3|||
129657061|NCT00394771|466702341|FG001|Overall Study|Other|3|||
129657062|NCT00394771|466702342|FG002|Overall Study|Other|1|||
129657063|NCT00394771|466702343|FG003|Overall Study|Other|0|||
129657064|NCT02839876|466702344|FG000|Overall Study|Protocol Violation|10|||
129657065|NCT02839876|466702345|FG001|Overall Study|Protocol Violation|11|||
129657066|NCT00586898|466702350|FG000|Overall Study|Adverse Event|1|||
129657067|NCT00586898|466702350|FG000|Overall Study|Patiemt Non-compliance|1|||
129657068|NCT00586898|466702350|FG000|Overall Study|Evaluable for Toxicity Only|5|||
129657069|NCT02494401|466702352|FG000|Overall Study|Lost to Follow-up|22|||
129657070|NCT02494401|466702353|FG001|Overall Study|Lost to Follow-up|25|||
129988207|NCT01920854|467918877|FG005|Overall Study|Withdrawal by Subject|0|||
129546103|NCT05168657|466292389|FG004|Overall Study|Adverse Event|0|||
129546104|NCT05168657|466292390|FG005|Overall Study|Adverse Event|0|||
129988208|NCT01920854|467918878|FG006|Overall Study|Withdrawal by Subject|1|||
129546105|NCT05168657|466292391|FG006|Overall Study|Adverse Event|0|||
129546106|NCT05168657|466292392|FG007|Overall Study|Adverse Event|0|||
129546107|NCT04935931|466292393|FG000|Overall Study|Withdrawal by Subject|1|||
129546108|NCT00962013|466292396|FG000|Overall Study|Did not have surgery|1|||
129546109|NCT00962013|466292396|FG000|Overall Study|Death|8|||
129546110|NCT00962013|466292396|FG000|Overall Study|Lost to Follow-up|12|||
129546111|NCT00962013|466292396|FG000|Overall Study|Unable/Unwilling to return|6|||
129546112|NCT00962013|466292396|FG000|Overall Study|Withdrawal by Subject|8|||
129546113|NCT00962013|466292396|FG000|Overall Study|Removal of study device|3|||
129546114|NCT00962013|466292396|FG000|Overall Study|Site Termination|24|||
129546115|NCT00962013|466292396|FG000|Overall Study|No 5 year evaluation|6|||
129546116|NCT04527549|466292397|FG000|Overall Study|Withdrawal by Subject|1|||
129546117|NCT04527549|466292398|FG001|Overall Study|Withdrawal by Subject|1|||
129546118|NCT00424632|466292399|FG000|Overall Study|Death|0|||
129546119|NCT00424632|466292400|FG001|Overall Study|Death|0|||
129546120|NCT00424632|466292401|FG002|Overall Study|Death|0|||
129546121|NCT00424632|466292402|FG003|Overall Study|Death|0|||
129546122|NCT00424632|466292403|FG004|Overall Study|Death|0|||
129546123|NCT00424632|466292404|FG005|Overall Study|Death|2|||
129546124|NCT00424632|466292405|FG006|Overall Study|Death|0|||
129546125|NCT00424632|466292406|FG007|Overall Study|Death|0|||
129546126|NCT00424632|466292407|FG008|Overall Study|Death|0|||
129546127|NCT00424632|466292408|FG009|Overall Study|Death|0|||
129546128|NCT00424632|466292399|FG000|Overall Study|Adverse Event|0|||
129546129|NCT00424632|466292400|FG001|Overall Study|Adverse Event|0|||
129546130|NCT00424632|466292401|FG002|Overall Study|Adverse Event|0|||
129546131|NCT00424632|466292402|FG003|Overall Study|Adverse Event|0|||
129546132|NCT00424632|466292403|FG004|Overall Study|Adverse Event|0|||
129546133|NCT00424632|466292404|FG005|Overall Study|Adverse Event|0|||
129546134|NCT00424632|466292405|FG006|Overall Study|Adverse Event|0|||
129546135|NCT00424632|466292406|FG007|Overall Study|Adverse Event|0|||
129546136|NCT00424632|466292407|FG008|Overall Study|Adverse Event|3|||
129546137|NCT00424632|466292408|FG009|Overall Study|Adverse Event|2|||
129546138|NCT00424632|466292399|FG000|Overall Study|Global deterioration of health status|0|||
129546139|NCT00424632|466292400|FG001|Overall Study|Global deterioration of health status|0|||
129546140|NCT00424632|466292401|FG002|Overall Study|Global deterioration of health status|0|||
129546141|NCT00424632|466292402|FG003|Overall Study|Global deterioration of health status|1|||
129546142|NCT00424632|466292403|FG004|Overall Study|Global deterioration of health status|1|||
129546143|NCT00424632|466292404|FG005|Overall Study|Global deterioration of health status|0|||
129546144|NCT00424632|466292405|FG006|Overall Study|Global deterioration of health status|0|||
129546145|NCT00424632|466292406|FG007|Overall Study|Global deterioration of health status|0|||
129546146|NCT00424632|466292407|FG008|Overall Study|Global deterioration of health status|0|||
129546147|NCT00424632|466292408|FG009|Overall Study|Global deterioration of health status|0|||
129546148|NCT00424632|466292399|FG000|Overall Study|Objective progression or relapse|1|||
129546149|NCT00424632|466292400|FG001|Overall Study|Objective progression or relapse|1|||
129546150|NCT00424632|466292401|FG002|Overall Study|Objective progression or relapse|1|||
129546151|NCT00424632|466292402|FG003|Overall Study|Objective progression or relapse|2|||
129546152|NCT00424632|466292403|FG004|Overall Study|Objective progression or relapse|2|||
129546153|NCT00424632|466292404|FG005|Overall Study|Objective progression or relapse|13|||
129546154|NCT00424632|466292405|FG006|Overall Study|Objective progression or relapse|7|||
129546155|NCT00424632|466292406|FG007|Overall Study|Objective progression or relapse|3|||
129546156|NCT00424632|466292407|FG008|Overall Study|Objective progression or relapse|12|||
129546157|NCT00424632|466292408|FG009|Overall Study|Objective progression or relapse|4|||
129546158|NCT00424632|466292399|FG000|Overall Study|Other|0|||
129546159|NCT00424632|466292400|FG001|Overall Study|Other|0|||
129546160|NCT00424632|466292401|FG002|Overall Study|Other|0|||
129546161|NCT00424632|466292402|FG003|Overall Study|Other|1|||
129546162|NCT00424632|466292403|FG004|Overall Study|Other|0|||
129546163|NCT00424632|466292404|FG005|Overall Study|Other|0|||
129546164|NCT00424632|466292405|FG006|Overall Study|Other|0|||
129546165|NCT00424632|466292406|FG007|Overall Study|Other|0|||
129546166|NCT00424632|466292407|FG008|Overall Study|Other|1|||
129546167|NCT00424632|466292408|FG009|Overall Study|Other|0|||
129546168|NCT00445458|466292413|FG000|Overall Study|Disease Progression|3|||
129546169|NCT00445458|466292414|FG001|Overall Study|Disease Progression|4|||
129546170|NCT00445458|466292415|FG002|Overall Study|Disease Progression|54|||
129546171|NCT00445458|466292416|FG003|Overall Study|Disease Progression|27|||
129546172|NCT00445458|466292413|FG000|Overall Study|Withdrawal by Subject|0|||
129546173|NCT00445458|466292414|FG001|Overall Study|Withdrawal by Subject|0|||
129546174|NCT00445458|466292415|FG002|Overall Study|Withdrawal by Subject|7|||
129546175|NCT00445458|466292416|FG003|Overall Study|Withdrawal by Subject|0|||
129546176|NCT00445458|466292413|FG000|Overall Study|Adverse Event|0|||
129546177|NCT00445458|466292414|FG001|Overall Study|Adverse Event|0|||
129546178|NCT00445458|466292415|FG002|Overall Study|Adverse Event|3|||
129657071|NCT02494401|466702352|FG000|Overall Study|Withdrawal by Subject|3|||
129657072|NCT02494401|466702353|FG001|Overall Study|Withdrawal by Subject|2|||
129657073|NCT00385827|466703923|FG000|Part 1|Adverse Event|1|||
129657074|NCT00385827|466703924|FG001|Part 1|Adverse Event|0|||
129657075|NCT00385827|466703925|FG002|Part 1|Adverse Event|0|||
129657076|NCT00385827|466703923|FG000|Part 1|Death|2|||
129657077|NCT00385827|466703924|FG001|Part 1|Death|0|||
129657078|NCT00385827|466703925|FG002|Part 1|Death|0|||
129657079|NCT00385827|466703923|FG000|Part 1|Lack of Efficacy|5|||
129657080|NCT00385827|466703924|FG001|Part 1|Lack of Efficacy|0|||
129657081|NCT00385827|466703925|FG002|Part 1|Lack of Efficacy|0|||
129657082|NCT00385827|466703923|FG000|Part 1|Other|1|||
129657083|NCT00385827|466703924|FG001|Part 1|Other|0|||
129657084|NCT00385827|466703925|FG002|Part 1|Other|0|||
129657085|NCT00385827|466703923|FG000|Part 2|Adverse Event|0|||
129657086|NCT00385827|466703924|FG001|Part 2|Adverse Event|6|||
129657087|NCT00385827|466703925|FG002|Part 2|Adverse Event|10|||
129657088|NCT00385827|466703923|FG000|Part 2|Death|0|||
129657089|NCT00385827|466703924|FG001|Part 2|Death|0|||
129657090|NCT00385827|466703925|FG002|Part 2|Death|2|||
129657091|NCT00385827|466703923|FG000|Part 2|Lack of Efficacy|0|||
129657092|NCT00385827|466703924|FG001|Part 2|Lack of Efficacy|14|||
129657093|NCT00385827|466703925|FG002|Part 2|Lack of Efficacy|13|||
129657094|NCT00385827|466703923|FG000|Part 2|Randomized but not treated|0|||
129657095|NCT00385827|466703924|FG001|Part 2|Randomized but not treated|2|||
129657096|NCT00385827|466703925|FG002|Part 2|Randomized but not treated|2|||
129657097|NCT00385827|466703923|FG000|Part 2|Other|0|||
129657098|NCT00385827|466703924|FG001|Part 2|Other|11|||
129657099|NCT00385827|466703925|FG002|Part 2|Other|21|||
129657100|NCT03307837|466703926|FG000|Overall Study|Withdrawal by Subject|0|||
129657101|NCT03307837|466703927|FG001|Overall Study|Withdrawal by Subject|0|||
129657102|NCT03307837|466703928|FG002|Overall Study|Withdrawal by Subject|1|||
129657103|NCT03307837|466703929|FG003|Overall Study|Withdrawal by Subject|0|||
129657104|NCT03307837|466703930|FG004|Overall Study|Withdrawal by Subject|0|||
129657105|NCT03307837|466703931|FG005|Overall Study|Withdrawal by Subject|1|||
129657106|NCT03307837|466703926|FG000|Overall Study|Lost to Follow-up|1|||
129657107|NCT03307837|466703927|FG001|Overall Study|Lost to Follow-up|1|||
129657108|NCT03307837|466703928|FG002|Overall Study|Lost to Follow-up|0|||
129657109|NCT03307837|466703929|FG003|Overall Study|Lost to Follow-up|0|||
129657110|NCT03307837|466703930|FG004|Overall Study|Lost to Follow-up|0|||
129657111|NCT03307837|466703931|FG005|Overall Study|Lost to Follow-up|1|||
129657112|NCT05437640|466703932|FG000|Washout (1 Week)|Adverse Event|1|||
129657113|NCT05437640|466703933|FG001|Washout (1 Week)|Adverse Event|0|||
129657114|NCT00904917|466703934|FG000|Overall Study|Lost to Follow-up|2|||
129657115|NCT00904917|466703935|FG001|Overall Study|Lost to Follow-up|2|||
129657116|NCT00904917|466703936|FG002|Overall Study|Lost to Follow-up|2|||
129657117|NCT00904917|466703937|FG003|Overall Study|Lost to Follow-up|2|||
129657118|NCT04228965|466703940|FG000|Overall Study|Lost to Follow-up|26|||
129657119|NCT04228965|466703941|FG001|Overall Study|Lost to Follow-up|11|||
129657120|NCT04228965|466703940|FG000|Overall Study|Withdrawal by Subject|18|||
129657121|NCT04228965|466703941|FG001|Overall Study|Withdrawal by Subject|5|||
129657122|NCT00734656|466703944|FG000|Lab Session 1|Withdrawal by Subject|2|||
129657123|NCT00734656|466703945|FG001|Lab Session 1|Withdrawal by Subject|0|||
129657124|NCT00734656|466703946|FG002|Lab Session 1|Withdrawal by Subject|0|||
129988209|NCT00757783|467918879|FG000|Overall Study|Adverse Event|0|||
129988210|NCT00757783|467918880|FG001|Overall Study|Adverse Event|2|||
129657125|NCT00734656|466703947|FG003|Lab Session 1|Withdrawal by Subject|0|||
129657126|NCT00734656|466703944|FG000|Washout 1|Withdrawal by Subject|1|||
129657127|NCT00734656|466703945|FG001|Washout 1|Withdrawal by Subject|5|||
129657128|NCT00734656|466703946|FG002|Washout 1|Withdrawal by Subject|2|||
129657129|NCT00734656|466703947|FG003|Washout 1|Withdrawal by Subject|3|||
129657130|NCT00734656|466703944|FG000|Lab Session 2|Withdrawal by Subject|1|||
129657131|NCT00734656|466703945|FG001|Lab Session 2|Withdrawal by Subject|0|||
129657132|NCT00734656|466703946|FG002|Lab Session 2|Withdrawal by Subject|0|||
129657133|NCT00734656|466703947|FG003|Lab Session 2|Withdrawal by Subject|1|||
129657134|NCT00734656|466703944|FG000|Washout 2|Withdrawal by Subject|1|||
129657135|NCT00734656|466703945|FG001|Washout 2|Withdrawal by Subject|1|||
129657136|NCT00734656|466703946|FG002|Washout 2|Withdrawal by Subject|1|||
129657137|NCT00734656|466703947|FG003|Washout 2|Withdrawal by Subject|0|||
129988211|NCT00757783|467918879|FG000|Overall Study|Lost to Follow-up|1|||
129657138|NCT00734656|466703944|FG000|Washout 3|Withdrawal by Subject|1|||
129657139|NCT00734656|466703945|FG001|Washout 3|Withdrawal by Subject|0|||
129657140|NCT00734656|466703946|FG002|Washout 3|Withdrawal by Subject|0|||
129657141|NCT00734656|466703947|FG003|Washout 3|Withdrawal by Subject|1|||
129657142|NCT00734656|466703944|FG000|Lab Session 4|Withdrawal by Subject|0|||
129657143|NCT00734656|466703945|FG001|Lab Session 4|Withdrawal by Subject|0|||
129657144|NCT00734656|466703946|FG002|Lab Session 4|Withdrawal by Subject|0|||
129657145|NCT00734656|466703947|FG003|Lab Session 4|Withdrawal by Subject|1|||
129657146|NCT03915626|466703948|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
129657147|NCT02190721|466703956|FG000|Overall Study|Patient was out of the city|0|||
129988212|NCT00757783|467918880|FG001|Overall Study|Lost to Follow-up|1|||
129988213|NCT00757783|467918879|FG000|Overall Study|Protocol Violation|1|||
129657148|NCT02190721|466703957|FG001|Overall Study|Patient was out of the city|1|||
129657149|NCT02190721|466703958|FG002|Overall Study|Patient was out of the city|0|||
129657150|NCT05025332|466703960|FG000|Screening|Screen failure|12|||
129657151|NCT05025332|466703960|FG000|Treatment & Follow Up|Protocol Violation|1|||
129657152|NCT05025332|466703960|FG000|Treatment & Follow Up|Adverse Event|4|||
129657153|NCT01928199|466703961|FG000|Overall Study|Lost to Follow-up|2|||
129657154|NCT01928199|466703962|FG001|Overall Study|Lost to Follow-up|1|||
129657155|NCT01928199|466703961|FG000|Overall Study|Withdrawal by Subject|3|||
129657156|NCT01928199|466703962|FG001|Overall Study|Withdrawal by Subject|5|||
129657157|NCT01502956|466703963|FG000|Overall Study|Death|0|||
129657158|NCT01502956|466703964|FG001|Overall Study|Death|2|||
129657159|NCT01502956|466703963|FG000|Overall Study|Lost to Follow-up|14|||
129657160|NCT01502956|466703964|FG001|Overall Study|Lost to Follow-up|11|||
129657161|NCT01502956|466703963|FG000|Overall Study|Physician Decision|2|||
129657162|NCT01502956|466703964|FG001|Overall Study|Physician Decision|3|||
129657163|NCT01502956|466703963|FG000|Overall Study|Withdrawal by Subject|8|||
129657164|NCT01502956|466703964|FG001|Overall Study|Withdrawal by Subject|10|||
129657165|NCT02634801|466703967|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
129657166|NCT02634801|466703968|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
129657167|NCT02634801|466703969|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
129657168|NCT02634801|466703967|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
129657169|NCT02634801|466703968|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
129657170|NCT02634801|466703969|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
129657171|NCT02634801|466703967|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
129657172|NCT02634801|466703968|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
129657173|NCT02634801|466703969|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
129657174|NCT02634801|466703967|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
129657175|NCT02634801|466703968|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
129657176|NCT02634801|466703969|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
129657177|NCT02634801|466703967|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
129657178|NCT02634801|466703968|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
129657179|NCT02634801|466703969|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
129657180|NCT02634801|466703967|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
129657181|NCT02634801|466703968|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
129657182|NCT02634801|466703969|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
129657183|NCT02634801|466703967|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
129657184|NCT02634801|466703968|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
129657185|NCT02634801|466703969|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
129657186|NCT02634801|466703967|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
129657187|NCT02634801|466703968|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
129657188|NCT02634801|466703969|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
129657189|NCT02634801|466703967|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
129657190|NCT02634801|466703968|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
129657191|NCT02634801|466703969|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
129657192|NCT02634801|466703967|FG000|Follow-up Period|Lost to Follow-up|3|||
129657193|NCT02634801|466703968|FG001|Follow-up Period|Lost to Follow-up|1|||
129988214|NCT00757783|467918880|FG001|Overall Study|Protocol Violation|0|||
129988215|NCT00757783|467918879|FG000|Overall Study|Withdrawal by Subject|2|||
129988216|NCT00757783|467918880|FG001|Overall Study|Withdrawal by Subject|1|||
129988217|NCT00757783|467918879|FG000|Overall Study|Other|1|||
129988218|NCT00757783|467918880|FG001|Overall Study|Other|2|||
129988219|NCT02008877|467918881|FG000|Overall Study|Inevaluable|0|||
129988220|NCT02008877|467918882|FG001|Overall Study|Inevaluable|1|||
129988221|NCT02008877|467918883|FG002|Overall Study|Inevaluable|0|||
129988222|NCT02412371|467918884|FG000|Overall Study|Withdrawal by Subject|0|||
129988223|NCT02412371|467918885|FG001|Overall Study|Withdrawal by Subject|2|||
129546179|NCT00445458|466292416|FG003|Overall Study|Adverse Event|0|||
129546180|NCT00445458|466292413|FG000|Overall Study|Death|0|||
129546181|NCT00445458|466292414|FG001|Overall Study|Death|1|||
129546182|NCT00445458|466292415|FG002|Overall Study|Death|2|||
129546183|NCT00445458|466292416|FG003|Overall Study|Death|0|||
129546184|NCT00445458|466292413|FG000|Overall Study|Physician Decision|0|||
129546185|NCT00445458|466292414|FG001|Overall Study|Physician Decision|0|||
129546186|NCT00445458|466292415|FG002|Overall Study|Physician Decision|1|||
129546187|NCT00445458|466292416|FG003|Overall Study|Physician Decision|1|||
129546188|NCT00445458|466292413|FG000|Overall Study|Surgery|0|||
129546189|NCT00445458|466292414|FG001|Overall Study|Surgery|0|||
129546190|NCT00445458|466292415|FG002|Overall Study|Surgery|1|||
129546191|NCT00445458|466292416|FG003|Overall Study|Surgery|0|||
129546192|NCT00728988|466292419|FG000|Overall Study|Not Treated|2|||
129546193|NCT00728988|466292420|FG001|Overall Study|Not Treated|2|||
129546194|NCT00728988|466292419|FG000|Overall Study|Death|1|||
129546195|NCT00728988|466292420|FG001|Overall Study|Death|1|||
129546196|NCT00728988|466292419|FG000|Overall Study|Adverse Event|3|||
129546197|NCT00728988|466292420|FG001|Overall Study|Adverse Event|2|||
129546198|NCT00728988|466292419|FG000|Overall Study|Other|85|||
129657194|NCT02634801|466703969|FG002|Follow-up Period|Lost to Follow-up|2|||
129657195|NCT02634801|466703967|FG000|Follow-up Period|Physician Decision|0|||
129657196|NCT02634801|466703968|FG001|Follow-up Period|Physician Decision|0|||
129657197|NCT02634801|466703969|FG002|Follow-up Period|Physician Decision|1|||
129657198|NCT02634801|466703967|FG000|Follow-up Period|Withdrawal by Subject|1|||
129657199|NCT02634801|466703968|FG001|Follow-up Period|Withdrawal by Subject|2|||
129657200|NCT02634801|466703969|FG002|Follow-up Period|Withdrawal by Subject|5|||
129657201|NCT02634801|466703967|FG000|Follow-up Period|Adverse Event|1|||
129657202|NCT02634801|466703968|FG001|Follow-up Period|Adverse Event|5|||
129657203|NCT02634801|466703969|FG002|Follow-up Period|Adverse Event|0|||
129657204|NCT02626000|466703970|FG000|Overall Study|Decision by Sponsor|1|||
129657205|NCT02626000|466703970|FG000|Overall Study|Death|29|||
129657206|NCT03539484|466703971|FG000|Overall Study|Death|1|||
129657207|NCT03539484|466703972|FG001|Overall Study|Death|0|||
129657208|NCT03539484|466703973|FG002|Overall Study|Death|0|||
129657209|NCT03539484|466703974|FG003|Overall Study|Death|2|||
129657210|NCT03539484|466703975|FG004|Overall Study|Death|8|||
129657211|NCT03539484|466703976|FG005|Overall Study|Death|3|||
129657212|NCT03539484|466703977|FG006|Overall Study|Death|0|||
129657213|NCT03539484|466703971|FG000|Overall Study|Lost to Follow-up|0|||
129657214|NCT03539484|466703972|FG001|Overall Study|Lost to Follow-up|1|||
129657215|NCT03539484|466703973|FG002|Overall Study|Lost to Follow-up|0|||
129657216|NCT03539484|466703974|FG003|Overall Study|Lost to Follow-up|0|||
129657217|NCT03539484|466703975|FG004|Overall Study|Lost to Follow-up|1|||
129657218|NCT03539484|466703976|FG005|Overall Study|Lost to Follow-up|0|||
129657219|NCT03539484|466703977|FG006|Overall Study|Lost to Follow-up|0|||
129657220|NCT03539484|466703971|FG000|Overall Study|Withdrawal by Subject|0|||
129657221|NCT03539484|466703972|FG001|Overall Study|Withdrawal by Subject|0|||
129657222|NCT03539484|466703973|FG002|Overall Study|Withdrawal by Subject|0|||
129657223|NCT03539484|466703974|FG003|Overall Study|Withdrawal by Subject|0|||
129657224|NCT03539484|466703975|FG004|Overall Study|Withdrawal by Subject|2|||
129657225|NCT03539484|466703976|FG005|Overall Study|Withdrawal by Subject|0|||
129657226|NCT03539484|466703977|FG006|Overall Study|Withdrawal by Subject|1|||
129657227|NCT03539484|466703971|FG000|Overall Study|Study Terminated by Sponsor|0|||
129657228|NCT03539484|466703972|FG001|Overall Study|Study Terminated by Sponsor|0|||
129657229|NCT03539484|466703973|FG002|Overall Study|Study Terminated by Sponsor|1|||
129657230|NCT03539484|466703974|FG003|Overall Study|Study Terminated by Sponsor|1|||
129657231|NCT03539484|466703975|FG004|Overall Study|Study Terminated by Sponsor|2|||
129657232|NCT03539484|466703976|FG005|Overall Study|Study Terminated by Sponsor|2|||
129657233|NCT03539484|466703977|FG006|Overall Study|Study Terminated by Sponsor|1|||
129657234|NCT02476916|466703978|FG000|Core Period|Adverse Event|2|||
129657235|NCT02476916|466703979|FG001|Core Period|Adverse Event|2|||
129657236|NCT02476916|466703978|FG000|Core Period|Investigator decision|1|||
129657237|NCT02476916|466703979|FG001|Core Period|Investigator decision|1|||
129657238|NCT02476916|466703978|FG000|Core Period|Withdrawal by Subject|3|||
129657239|NCT02476916|466703979|FG001|Core Period|Withdrawal by Subject|0|||
129657240|NCT02476916|466703978|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
129657241|NCT02476916|466703979|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
129657242|NCT02476916|466703978|FG000|Extension Period|On Treatment|12|||
129657243|NCT02476916|466703979|FG001|Extension Period|On Treatment|17|||
129657244|NCT06010732|466703980|FG000|Crossover Period 1|Protocol Violation|0|||
129657245|NCT06010732|466703981|FG001|Crossover Period 1|Protocol Violation|0|||
129657246|NCT06010732|466703982|FG002|Crossover Period 1|Protocol Violation|1|||
129657247|NCT06010732|466703983|FG003|Crossover Period 1|Protocol Violation|0|||
129657248|NCT06010732|466703984|FG004|Crossover Period 1|Protocol Violation|1|||
129657249|NCT06010732|466703985|FG005|Crossover Period 1|Protocol Violation|0|||
129657250|NCT06010732|466703980|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129657251|NCT06010732|466703981|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
129657252|NCT06010732|466703982|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129657253|NCT06010732|466703983|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129657254|NCT06010732|466703984|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129657255|NCT06010732|466703985|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
129657256|NCT06010732|466703980|FG000|Crossover Period 2|Adverse Event|0|||
129657257|NCT06010732|466703981|FG001|Crossover Period 2|Adverse Event|1|||
129657258|NCT06010732|466703982|FG002|Crossover Period 2|Adverse Event|0|||
129657259|NCT06010732|466703983|FG003|Crossover Period 2|Adverse Event|0|||
129657260|NCT06010732|466703984|FG004|Crossover Period 2|Adverse Event|0|||
129657261|NCT06010732|466703985|FG005|Crossover Period 2|Adverse Event|0|||
129657262|NCT06010732|466703980|FG000|Crossover Period 2|broken denture|0|||
129657263|NCT06010732|466703981|FG001|Crossover Period 2|broken denture|0|||
129657264|NCT06010732|466703982|FG002|Crossover Period 2|broken denture|1|||
129657265|NCT06010732|466703983|FG003|Crossover Period 2|broken denture|0|||
129657266|NCT06010732|466703984|FG004|Crossover Period 2|broken denture|0|||
129657267|NCT06010732|466703985|FG005|Crossover Period 2|broken denture|0|||
129657268|NCT04401202|466703986|FG000|Overall Study|Lost to Follow-up|2|||
129657269|NCT04401202|466703987|FG001|Overall Study|Lost to Follow-up|2|||
129657270|NCT04401202|466703986|FG000|Overall Study|Adverse Event|0|||
129657271|NCT04401202|466703987|FG001|Overall Study|Adverse Event|1|||
129657272|NCT04401202|466703986|FG000|Overall Study|Hospitalized|4|||
129657273|NCT04401202|466703987|FG001|Overall Study|Hospitalized|1|||
129657274|NCT00329745|466703990|FG000|Overall Study|Protocol Violation|1|||
129657275|NCT00329745|466703991|FG001|Overall Study|Protocol Violation|0|||
129657276|NCT00329745|466703990|FG000|Overall Study|Withdrawal by Subject|0|||
129657277|NCT00329745|466703991|FG001|Overall Study|Withdrawal by Subject|1|||
129657278|NCT00329745|466703990|FG000|Overall Study|Lost to Follow-up|86|||
129657279|NCT00329745|466703991|FG001|Overall Study|Lost to Follow-up|101|||
129657280|NCT01597492|466703992|FG000|Overall Study|Withdrawal by Subject|1|||
129657281|NCT01597492|466703993|FG001|Overall Study|Withdrawal by Subject|2|||
129657282|NCT01597492|466703992|FG000|Overall Study|Adverse Event|3|||
129657283|NCT01597492|466703993|FG001|Overall Study|Adverse Event|0|||
129657284|NCT01597492|466703992|FG000|Overall Study|Lost to Follow-up|0|||
129657285|NCT01597492|466703993|FG001|Overall Study|Lost to Follow-up|2|||
129657286|NCT01597492|466703992|FG000|Overall Study|Other Reason|2|||
129657287|NCT01597492|466703993|FG001|Overall Study|Other Reason|0|||
129657288|NCT01939223|466703997|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
129657289|NCT01939223|466703998|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
129657290|NCT01939223|466703997|FG000|Overall Study|Disease recurrence (radiological)|1|||
129657291|NCT01939223|466703998|FG001|Overall Study|Disease recurrence (radiological)|3|||
129657292|NCT01939223|466703997|FG000|Overall Study|Study stopped by Sponsor|5|||
129657293|NCT01939223|466703998|FG001|Overall Study|Study stopped by Sponsor|7|||
129657294|NCT01939223|466703997|FG000|Overall Study|Withdrawal by Subject|6|||
129657295|NCT01939223|466703998|FG001|Overall Study|Withdrawal by Subject|0|||
129657296|NCT03624569|466703999|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129657297|NCT03624569|466704000|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
129657298|NCT03624569|466703999|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
129657299|NCT03624569|466704000|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
129657300|NCT01557517|466704001|FG000|Overall Study|Death|1|||
129657301|NCT01557517|466704002|FG001|Overall Study|Death|0|||
129657302|NCT01557517|466704001|FG000|Overall Study|Refused further treatment|0|||
129657303|NCT01557517|466704002|FG001|Overall Study|Refused further treatment|2|||
129546199|NCT00728988|466292420|FG001|Overall Study|Other|77|||
129546200|NCT00728988|466292419|FG000|Overall Study|Withdrawal by Subject|2|||
129546201|NCT00728988|466292420|FG001|Overall Study|Withdrawal by Subject|6|||
129546202|NCT01984229|466292423|FG000|Safety Follow-up Period|Adverse Event|1|||
129546203|NCT01984229|466292424|FG001|Safety Follow-up Period|Adverse Event|1|||
129546204|NCT01984229|466292423|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
129546205|NCT01984229|466292424|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
129546206|NCT03186794|466292426|FG000|Overall Study|Physician Decision|2|||
129546207|NCT03186794|466292426|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
129546208|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
129546209|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
129546210|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Death|5|||
129546211|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Death|2|||
129546212|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
129546213|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
129546214|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
129546215|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
129546216|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
129546217|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
129546218|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Relapse|1|||
129546219|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Relapse|0|||
129546220|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
129546221|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
129546222|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
129546223|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
129546224|NCT00111007|466292428|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
129546225|NCT00111007|466292429|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
129546226|NCT00111007|466292428|FG000|Active Follow-up|Adverse Event|1|||
129546227|NCT00111007|466292429|FG001|Active Follow-up|Adverse Event|0|||
129546228|NCT00111007|466292428|FG000|Active Follow-up|Death|2|||
129546229|NCT00111007|466292429|FG001|Active Follow-up|Death|0|||
129546230|NCT00111007|466292428|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
129546231|NCT00111007|466292429|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
129546232|NCT00111007|466292428|FG000|Long Term Follow-up|Death|34|||
129546233|NCT00111007|466292429|FG001|Long Term Follow-up|Death|39|||
129546234|NCT00111007|466292428|FG000|Long Term Follow-up|Lost to Follow-up|1|||
129546235|NCT00111007|466292429|FG001|Long Term Follow-up|Lost to Follow-up|1|||
129546236|NCT00111007|466292428|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
129546237|NCT00111007|466292429|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
129546238|NCT00111007|466292428|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
129657304|NCT01557517|466704001|FG000|Overall Study|Adverse Event|0|||
129657305|NCT01557517|466704002|FG001|Overall Study|Adverse Event|2|||
129657306|NCT01557517|466704001|FG000|Overall Study|Pt declined before treatment started|1|||
129657307|NCT01557517|466704002|FG001|Overall Study|Pt declined before treatment started|0|||
129657308|NCT01204918|466704013|FG000|Overall Study|Withdrawal by Subject|4|||
129657309|NCT01204918|466704014|FG001|Overall Study|Withdrawal by Subject|10|||
129657310|NCT01204918|466704015|FG002|Overall Study|Withdrawal by Subject|5|||
129657311|NCT01853696|466704018|FG000|Overall Study|Withdrawal by Subject|1|||
129657312|NCT01853696|466704019|FG001|Overall Study|Withdrawal by Subject|1|||
129657313|NCT01853696|466704018|FG000|Overall Study|Lost to Follow-up|5|||
129657314|NCT01853696|466704019|FG001|Overall Study|Lost to Follow-up|4|||
129657315|NCT00849290|466704022|FG000|Overall Study|Adverse Event|3|||
129657316|NCT00849290|466704022|FG000|Overall Study|Death|14|||
129657317|NCT00849290|466704022|FG000|Overall Study|Withdrawal by Subject|11|||
129657318|NCT00849290|466704022|FG000|Overall Study|Lost to Follow-up|2|||
129657319|NCT00849290|466704022|FG000|Overall Study|Protocol Violation|5|||
129657320|NCT00849290|466704022|FG000|Overall Study|Disease Progression|20|||
129657321|NCT01119846|466704027|FG000|Overall Study|Adverse Event|1|||
129657322|NCT01119846|466704028|FG001|Overall Study|Adverse Event|0|||
129657323|NCT01119846|466704029|FG002|Overall Study|Adverse Event|6|||
129657324|NCT01119846|466704027|FG000|Overall Study|Physician Decision|1|||
129657325|NCT01119846|466704028|FG001|Overall Study|Physician Decision|0|||
129657326|NCT01119846|466704029|FG002|Overall Study|Physician Decision|0|||
129657327|NCT01119846|466704027|FG000|Overall Study|Protocol Violation|0|||
129657328|NCT01119846|466704028|FG001|Overall Study|Protocol Violation|0|||
129657329|NCT01119846|466704029|FG002|Overall Study|Protocol Violation|1|||
129988224|NCT02412371|467918886|FG002|Overall Study|Withdrawal by Subject|0|||
129657330|NCT01119846|466704027|FG000|Overall Study|Withdrawal by Subject|0|||
129657331|NCT01119846|466704028|FG001|Overall Study|Withdrawal by Subject|0|||
129657332|NCT01119846|466704029|FG002|Overall Study|Withdrawal by Subject|4|||
129657333|NCT03304184|466704034|FG000|Overall Study|Withdrawal by Subject|1|||
129657334|NCT03304184|466704035|FG001|Overall Study|Withdrawal by Subject|2|||
129657335|NCT01605825|466704040|FG000|Overall Study|Adverse Event|4|||
129657336|NCT01605825|466704041|FG001|Overall Study|Adverse Event|2|||
129657337|NCT01605825|466704040|FG000|Overall Study|Withdrawal by Subject|0|||
129657338|NCT01605825|466704041|FG001|Overall Study|Withdrawal by Subject|1|||
129657339|NCT01605825|466704040|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
129657340|NCT01605825|466704041|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
129657341|NCT01605825|466704040|FG000|Overall Study|Non-Compliance with Protocol|3|||
129657342|NCT01605825|466704041|FG001|Overall Study|Non-Compliance with Protocol|0|||
129657343|NCT03244618|466704046|FG000|Overall Study|Lost to Follow-up|3|||
129657344|NCT03244618|466704047|FG001|Overall Study|Lost to Follow-up|4|||
129657345|NCT03244618|466704046|FG000|Overall Study|Protocol Violation|4|||
129657346|NCT03244618|466704047|FG001|Overall Study|Protocol Violation|3|||
129657347|NCT03244618|466704046|FG000|Overall Study|Withdrawal by Subject|0|||
129657348|NCT03244618|466704047|FG001|Overall Study|Withdrawal by Subject|2|||
129657349|NCT00913770|466704049|FG000|Overall Study|Unable to contact|24|||
129657350|NCT00913770|466704050|FG001|Overall Study|Unable to contact|19|||
129657351|NCT00913770|466704051|FG002|Overall Study|Unable to contact|13|||
129657352|NCT00913770|466704049|FG000|Overall Study|Refused|11|||
129657353|NCT00913770|466704050|FG001|Overall Study|Refused|10|||
129657354|NCT00913770|466704051|FG002|Overall Study|Refused|8|||
129657355|NCT03816007|466704054|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
129657356|NCT03816007|466704055|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
129657357|NCT03816007|466704054|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
129657358|NCT03816007|466704055|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
129988225|NCT02412371|467918887|FG003|Overall Study|Withdrawal by Subject|1|||
129657359|NCT03816007|466704054|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
129657360|NCT03816007|466704055|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
129657361|NCT01926197|466704056|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
129657362|NCT01926197|466704057|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
129657363|NCT01926197|466704056|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
129988226|NCT02412371|467918888|FG004|Overall Study|Withdrawal by Subject|1|||
129657364|NCT01926197|466704057|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
129657365|NCT01428115|466704059|FG000|Overall Study|Lack of Efficacy|3|||
129657366|NCT01428115|466704059|FG000|Overall Study|Lost to Follow-up|10|||
129657367|NCT01428115|466704059|FG000|Overall Study|Pregnancy|1|||
129657368|NCT01428115|466704059|FG000|Overall Study|Protocol Violation|3|||
129657369|NCT01428115|466704059|FG000|Overall Study|Withdrawal by Subject|4|||
129657370|NCT02620384|466704060|FG000|Overall Study|Adverse Event|2|||
129657371|NCT02620384|466704061|FG001|Overall Study|Adverse Event|1|||
129657372|NCT02620384|466704060|FG000|Overall Study|Discharged prior to 2nd dose|2|||
129657373|NCT02620384|466704061|FG001|Overall Study|Discharged prior to 2nd dose|5|||
129657374|NCT02620384|466704060|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
129657375|NCT02620384|466704061|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
129657376|NCT02101359|466704062|FG000|Overall Study|Not included|23|||
129657377|NCT02101359|466704063|FG001|Overall Study|Not included|13|||
129657378|NCT02101359|466704062|FG000|Overall Study|Withdrawal by Subject|5|||
129657379|NCT02101359|466704063|FG001|Overall Study|Withdrawal by Subject|4|||
129657380|NCT02101359|466704062|FG000|Overall Study|Lost to Follow-up|1|||
129657381|NCT02101359|466704063|FG001|Overall Study|Lost to Follow-up|0|||
129657382|NCT02101359|466704062|FG000|Overall Study|Protocol Violation|0|||
129657383|NCT02101359|466704063|FG001|Overall Study|Protocol Violation|2|||
129657384|NCT01483599|466704065|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
129657385|NCT01483599|466704066|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657386|NCT01483599|466704067|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657387|NCT01483599|466704068|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
129657388|NCT01483599|466704069|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
129657389|NCT01483599|466704070|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
129657390|NCT01483599|466704071|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
129657391|NCT01483599|466704072|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657392|NCT01483599|466704073|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657393|NCT01483599|466704074|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657394|NCT01483599|466704075|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657395|NCT01483599|466704076|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657396|NCT01483599|466704077|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657397|NCT01483599|466704078|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
129657398|NCT01483599|466704065|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657399|NCT01483599|466704066|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
129657400|NCT01483599|466704067|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657401|NCT01483599|466704068|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
129657402|NCT01483599|466704069|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657403|NCT01483599|466704070|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657404|NCT01483599|466704071|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
129657405|NCT01483599|466704072|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657406|NCT01483599|466704073|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657407|NCT01483599|466704074|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657408|NCT01483599|466704075|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657409|NCT01483599|466704076|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657410|NCT01483599|466704077|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657411|NCT01483599|466704078|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
129657412|NCT01483599|466704065|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
129657413|NCT01483599|466704066|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657414|NCT01483599|466704067|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657415|NCT01483599|466704068|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657416|NCT01483599|466704069|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657417|NCT01483599|466704070|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657418|NCT01483599|466704071|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657419|NCT01483599|466704072|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657420|NCT01483599|466704073|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657421|NCT01483599|466704074|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657422|NCT01483599|466704075|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657423|NCT01483599|466704076|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657424|NCT01483599|466704077|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657425|NCT01483599|466704078|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
129657426|NCT01483599|466704065|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
129657427|NCT01483599|466704066|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
129657428|NCT01483599|466704067|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
129657429|NCT01483599|466704068|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
129657430|NCT01483599|466704069|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
129657431|NCT01483599|466704070|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
129657432|NCT01483599|466704071|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
129657433|NCT01483599|466704072|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
129988227|NCT02412371|467918889|FG005|Overall Study|Withdrawal by Subject|0|||
129988228|NCT02412371|467918884|FG000|Overall Study|Sponsor Discontinued Study|1|||
129988229|NCT02412371|467918885|FG001|Overall Study|Sponsor Discontinued Study|4|||
129988230|NCT02412371|467918886|FG002|Overall Study|Sponsor Discontinued Study|6|||
129988231|NCT02412371|467918887|FG003|Overall Study|Sponsor Discontinued Study|4|||
129988232|NCT02412371|467918888|FG004|Overall Study|Sponsor Discontinued Study|5|||
129988233|NCT02412371|467918889|FG005|Overall Study|Sponsor Discontinued Study|0|||
129988234|NCT02412371|467918884|FG000|Overall Study|Death|4|||
129988235|NCT02412371|467918885|FG001|Overall Study|Death|2|||
129657434|NCT01483599|466704073|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
129657435|NCT01483599|466704074|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
129657436|NCT01483599|466704075|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
129657437|NCT01483599|466704076|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
129657438|NCT01483599|466704077|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
129657439|NCT01483599|466704078|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
129657440|NCT01483599|466704065|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
129657441|NCT01483599|466704066|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
129657442|NCT01483599|466704067|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
129657443|NCT01483599|466704068|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
129657444|NCT01483599|466704069|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
129657445|NCT01483599|466704070|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
129657446|NCT01483599|466704071|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
129657447|NCT01483599|466704072|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
129657448|NCT01483599|466704073|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
129657449|NCT01483599|466704074|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
129657450|NCT01483599|466704075|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
129657451|NCT01483599|466704076|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
129657452|NCT01483599|466704077|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
129657453|NCT01483599|466704078|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
129657454|NCT01483599|466704065|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657455|NCT01483599|466704066|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657456|NCT01483599|466704067|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657457|NCT01483599|466704068|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657458|NCT01483599|466704069|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657459|NCT01483599|466704070|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657460|NCT01483599|466704071|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657461|NCT01483599|466704072|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129657462|NCT01483599|466704073|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129657463|NCT01483599|466704074|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657464|NCT01483599|466704075|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657465|NCT01483599|466704076|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
129657466|NCT01483599|466704077|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129657467|NCT01483599|466704078|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
129657468|NCT01483599|466704065|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657469|NCT01483599|466704066|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657470|NCT01483599|466704067|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657471|NCT01483599|466704068|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657472|NCT01483599|466704069|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657473|NCT01483599|466704070|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657474|NCT01483599|466704071|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657475|NCT01483599|466704072|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657476|NCT01483599|466704073|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
129657477|NCT01483599|466704074|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657478|NCT01483599|466704075|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657479|NCT01483599|466704076|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
129657480|NCT01483599|466704077|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
129657481|NCT01483599|466704078|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
129657482|NCT01483599|466704065|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657483|NCT01483599|466704066|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657484|NCT01483599|466704067|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657485|NCT01483599|466704068|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657486|NCT01483599|466704069|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657487|NCT01483599|466704070|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657488|NCT01483599|466704071|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657489|NCT01483599|466704072|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657490|NCT01483599|466704073|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
129657491|NCT01483599|466704074|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657492|NCT01483599|466704075|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
129657493|NCT01483599|466704076|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129657494|NCT01483599|466704077|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
129988236|NCT02412371|467918886|FG002|Overall Study|Death|1|||
129657495|NCT01483599|466704078|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
129657496|NCT01483599|466704065|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657497|NCT01483599|466704066|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657498|NCT01483599|466704067|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129988237|NCT02412371|467918887|FG003|Overall Study|Death|3|||
129988238|NCT02412371|467918888|FG004|Overall Study|Death|5|||
129988239|NCT02412371|467918889|FG005|Overall Study|Death|2|||
129657499|NCT01483599|466704068|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657500|NCT01483599|466704069|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657501|NCT01483599|466704070|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657502|NCT01483599|466704071|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657503|NCT01483599|466704072|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657504|NCT01483599|466704073|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
129657505|NCT01483599|466704074|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657506|NCT01483599|466704075|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657507|NCT01483599|466704076|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
129657508|NCT01483599|466704077|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
129657509|NCT01483599|466704078|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
129657510|NCT01483599|466704065|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
129657511|NCT01483599|466704066|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
129657512|NCT01483599|466704067|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
129657513|NCT01483599|466704068|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
129657514|NCT01483599|466704069|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
129657515|NCT01483599|466704070|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
129657516|NCT01483599|466704071|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
129657517|NCT01483599|466704072|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
129657518|NCT01483599|466704073|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
129657519|NCT01483599|466704074|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
129657520|NCT01483599|466704075|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
129657521|NCT01483599|466704076|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
129657522|NCT01483599|466704077|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
129657523|NCT01483599|466704078|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
129657524|NCT00966355|466704079|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
129657525|NCT00966355|466704080|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
129657526|NCT00966355|466704081|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
129657527|NCT00966355|466704079|FG000|Overall Study|newly diagnosed advanced HCC|11|||
129657528|NCT00966355|466704080|FG001|Overall Study|newly diagnosed advanced HCC|12|||
129657529|NCT00966355|466704081|FG002|Overall Study|newly diagnosed advanced HCC|10|||
129657530|NCT00966355|466704079|FG000|Overall Study|Lost to Follow-up|5|||
129657531|NCT00966355|466704080|FG001|Overall Study|Lost to Follow-up|4|||
129657532|NCT00966355|466704081|FG002|Overall Study|Lost to Follow-up|3|||
129657533|NCT00410072|466705595|FG000|Day 1 to Week 48|Adverse Event|1|||
129657534|NCT00410072|466705596|FG001|Day 1 to Week 48|Adverse Event|2|||
129657535|NCT00410072|466705595|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
129657536|NCT00410072|466705596|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
129657537|NCT00410072|466705595|FG000|Day 1 to Week 48|Other|0|||
129657538|NCT00410072|466705596|FG001|Day 1 to Week 48|Other|1|||
129657539|NCT00410072|466705595|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
129657540|NCT00410072|466705596|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
129657541|NCT00410072|466705595|FG000|Day 1 to Week 48|Pregnancy|0|||
129657542|NCT00410072|466705596|FG001|Day 1 to Week 48|Pregnancy|2|||
129657543|NCT00410072|466705595|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
129657544|NCT00410072|466705596|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
129657545|NCT00410072|466705595|FG000|After Week 48 to Week 96|Adverse Event|1|||
129657546|NCT00410072|466705596|FG001|After Week 48 to Week 96|Adverse Event|2|||
129657547|NCT00410072|466705595|FG000|After Week 48 to Week 96|Death|0|||
129657548|NCT00410072|466705596|FG001|After Week 48 to Week 96|Death|1|||
129657549|NCT00410072|466705595|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
129657550|NCT00410072|466705596|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
129657551|NCT00410072|466705595|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
129657552|NCT00410072|466705596|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
129657553|NCT00410072|466705595|FG000|After Week 48 to Week 96|Other|2|||
129657554|NCT00410072|466705596|FG001|After Week 48 to Week 96|Other|0|||
129657555|NCT00410072|466705595|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
129657556|NCT00410072|466705596|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
129657557|NCT00410072|466705595|FG000|After Week 48 to Week 96|Pregnancy|0|||
129657558|NCT00410072|466705596|FG001|After Week 48 to Week 96|Pregnancy|2|||
129657559|NCT00410072|466705595|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
129657560|NCT00410072|466705596|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
129657561|NCT01421147|466705597|FG000|Treatment Period|Adverse Event|2|||
129657562|NCT01421147|466705598|FG001|Treatment Period|Adverse Event|3|||
129657563|NCT01421147|466705597|FG000|Treatment Period|Lost to Follow-up|2|||
129546239|NCT00111007|466292429|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
129657564|NCT01421147|466705598|FG001|Treatment Period|Lost to Follow-up|1|||
129657565|NCT01421147|466705597|FG000|Treatment Period|Physician Decision|2|||
129657566|NCT01421147|466705598|FG001|Treatment Period|Physician Decision|2|||
129657567|NCT01421147|466705597|FG000|Treatment Period|Withdrawal by Subject|10|||
129657568|NCT01421147|466705598|FG001|Treatment Period|Withdrawal by Subject|5|||
129657569|NCT01421147|466705597|FG000|Extension Period|Adverse Event|0|||
129657570|NCT01421147|466705598|FG001|Extension Period|Adverse Event|2|||
129657571|NCT01421147|466705597|FG000|Extension Period|Death|0|||
129657572|NCT01421147|466705598|FG001|Extension Period|Death|1|||
129657573|NCT01421147|466705597|FG000|Extension Period|Lost to Follow-up|2|||
129657574|NCT01421147|466705598|FG001|Extension Period|Lost to Follow-up|5|||
129657575|NCT01421147|466705597|FG000|Extension Period|Physician Decision|1|||
129657576|NCT01421147|466705598|FG001|Extension Period|Physician Decision|0|||
129657577|NCT01421147|466705597|FG000|Extension Period|Withdrawal by Subject|5|||
129657578|NCT01421147|466705598|FG001|Extension Period|Withdrawal by Subject|3|||
129657579|NCT02155309|466705602|FG000|Overall Study|Protocol Violation|0|||
129657580|NCT02155309|466705603|FG001|Overall Study|Protocol Violation|0|||
129657581|NCT02155309|466705604|FG002|Overall Study|Protocol Violation|1|||
129657582|NCT04676152|466705605|FG000|Overall Study|screen fail|9|||
129657583|NCT00662311|466705617|FG000|Overall Study|Respiratory Infection|1|||
129657584|NCT00662311|466705618|FG001|Overall Study|Respiratory Infection|0|||
129657585|NCT00662311|466705619|FG002|Overall Study|Respiratory Infection|0|||
129657586|NCT01467271|466705620|FG000|Overall Study|Death|84|||
129657587|NCT01467271|466705620|FG000|Overall Study|Lost to Follow-up|83|||
129657588|NCT01467271|466705620|FG000|Overall Study|Retraction of patient's consent|21|||
129657589|NCT01467271|466705620|FG000|Overall Study|Other reason|14|||
129657590|NCT02335346|466705639|FG000|Overall Study|Adverse Event|11|||
129657591|NCT02335346|466705639|FG000|Overall Study|Withdrawal by Subject|1|||
129657592|NCT01548768|466705640|FG000|Overall Study|Withdrawal by Subject|0|||
129657593|NCT01548768|466705641|FG001|Overall Study|Withdrawal by Subject|2|||
129657594|NCT01548768|466705642|FG002|Overall Study|Withdrawal by Subject|1|||
129657595|NCT01548768|466705643|FG003|Overall Study|Withdrawal by Subject|0|||
129657596|NCT01548768|466705640|FG000|Overall Study|Physician Decision|1|||
129657597|NCT01548768|466705641|FG001|Overall Study|Physician Decision|0|||
129657598|NCT01548768|466705642|FG002|Overall Study|Physician Decision|0|||
129657599|NCT01548768|466705643|FG003|Overall Study|Physician Decision|0|||
129657600|NCT01548768|466705640|FG000|Overall Study|Adverse Event|0|||
129657601|NCT01548768|466705641|FG001|Overall Study|Adverse Event|0|||
129657602|NCT01548768|466705642|FG002|Overall Study|Adverse Event|0|||
129657603|NCT01548768|466705643|FG003|Overall Study|Adverse Event|1|||
129657604|NCT01548768|466705640|FG000|Overall Study|Non-Compliance|0|||
129657605|NCT01548768|466705641|FG001|Overall Study|Non-Compliance|0|||
129657606|NCT01548768|466705642|FG002|Overall Study|Non-Compliance|0|||
129657607|NCT01548768|466705643|FG003|Overall Study|Non-Compliance|3|||
129657608|NCT03300050|466705644|FG000|Overall Study|Lost to Follow-up|2|||
129657609|NCT03300050|466705645|FG001|Overall Study|Lost to Follow-up|1|||
129657610|NCT03300050|466705646|FG002|Overall Study|Lost to Follow-up|0|||
129657611|NCT03300050|466705647|FG003|Overall Study|Lost to Follow-up|0|||
129657612|NCT03300050|466705648|FG004|Overall Study|Lost to Follow-up|1|||
129657613|NCT03300050|466705644|FG000|Overall Study|Withdrawal by Subject|1|||
129657614|NCT03300050|466705645|FG001|Overall Study|Withdrawal by Subject|1|||
129657615|NCT03300050|466705646|FG002|Overall Study|Withdrawal by Subject|1|||
129657616|NCT03300050|466705647|FG003|Overall Study|Withdrawal by Subject|0|||
129657617|NCT03300050|466705648|FG004|Overall Study|Withdrawal by Subject|0|||
129657618|NCT03300050|466705644|FG000|Overall Study|Death|0|||
129657619|NCT03300050|466705645|FG001|Overall Study|Death|0|||
129657620|NCT03300050|466705646|FG002|Overall Study|Death|1|||
129657621|NCT03300050|466705647|FG003|Overall Study|Death|0|||
129657622|NCT03300050|466705648|FG004|Overall Study|Death|0|||
129657623|NCT03300050|466705644|FG000|Overall Study|Not Eligible at Randomization|0|||
129657624|NCT03300050|466705645|FG001|Overall Study|Not Eligible at Randomization|0|||
129657625|NCT03300050|466705646|FG002|Overall Study|Not Eligible at Randomization|1|||
129657626|NCT03300050|466705647|FG003|Overall Study|Not Eligible at Randomization|1|||
129657627|NCT03300050|466705648|FG004|Overall Study|Not Eligible at Randomization|0|||
129657628|NCT02178358|466705662|FG000|Overall Study|Withdrawal by Subject|0|||
129657629|NCT02178358|466705663|FG001|Overall Study|Withdrawal by Subject|2|||
129657630|NCT02178358|466705664|FG002|Overall Study|Withdrawal by Subject|2|||
129657631|NCT02178358|466705662|FG000|Overall Study|Lost to Follow-up|1|||
129657632|NCT02178358|466705663|FG001|Overall Study|Lost to Follow-up|0|||
129657633|NCT02178358|466705664|FG002|Overall Study|Lost to Follow-up|0|||
129657634|NCT01066663|466705665|FG000|Overall Study|Adverse Event|0|||
129657635|NCT01066663|466705666|FG001|Overall Study|Adverse Event|0|||
129657636|NCT01066663|466705667|FG002|Overall Study|Adverse Event|1|||
129657637|NCT02985021|466705668|FG000|Overall Study|Inability to comply with study procedures|1|||
129657638|NCT01090050|466705669|FG000|Overall Study|Lost to Follow-up|0|||
129657639|NCT01090050|466705670|FG001|Overall Study|Lost to Follow-up|1|||
129657640|NCT01090050|466705669|FG000|Overall Study|Lack of Efficacy|1|||
129657641|NCT01090050|466705670|FG001|Overall Study|Lack of Efficacy|5|||
129657642|NCT01090050|466705669|FG000|Overall Study|Physician Decision|0|||
129657643|NCT01090050|466705670|FG001|Overall Study|Physician Decision|1|||
129657644|NCT02232061|466705671|FG000|Overall Study|Administrative problems|1|||
129657645|NCT02232061|466705671|FG000|Overall Study|Withdrawal by Subject|1|||
129657646|NCT00560703|466705673|FG000|Overall Study|Adverse Event|0|||
129657647|NCT00560703|466705674|FG001|Overall Study|Adverse Event|2|||
129657648|NCT00560703|466705673|FG000|Overall Study|Protocol Violation|0|||
129657649|NCT00560703|466705674|FG001|Overall Study|Protocol Violation|2|||
129657650|NCT00560703|466705673|FG000|Overall Study|Withdrawal by Subject|0|||
129657651|NCT00560703|466705674|FG001|Overall Study|Withdrawal by Subject|1|||
129657652|NCT00560703|466705673|FG000|Overall Study|non-compliance|0|||
129657653|NCT00560703|466705674|FG001|Overall Study|non-compliance|1|||
129657654|NCT00790556|466705676|FG000|Treatment Period 1|Physician Decision|1|||
129657655|NCT00790556|466705677|FG001|Treatment Period 1|Physician Decision|0|||
129657656|NCT00790556|466705676|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129657657|NCT00790556|466705677|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129657658|NCT00339833|466705680|FG000|Overall Study|Withdrawal by Subject|1|||
129657659|NCT00339833|466705681|FG001|Overall Study|Withdrawal by Subject|2|||
129657660|NCT00339833|466705680|FG000|Overall Study|toothache|0|||
129657661|NCT00339833|466705681|FG001|Overall Study|toothache|1|||
129657662|NCT00339833|466705680|FG000|Overall Study|indigestion|0|||
129657663|NCT00339833|466705681|FG001|Overall Study|indigestion|1|||
129657664|NCT00339833|466705680|FG000|Overall Study|Chest pain|0|||
129657665|NCT00339833|466705681|FG001|Overall Study|Chest pain|1|||
129657666|NCT00339833|466705680|FG000|Overall Study|minor infection|0|||
129657667|NCT00339833|466705681|FG001|Overall Study|minor infection|1|||
129657668|NCT00339833|466705680|FG000|Overall Study|Poor venous access|2|||
129657669|NCT00339833|466705681|FG001|Overall Study|Poor venous access|2|||
129657670|NCT00339833|466705680|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
129657671|NCT00339833|466705681|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
129657672|NCT00339833|466705680|FG000|Overall Study|Error in data records|1|||
129657673|NCT00339833|466705681|FG001|Overall Study|Error in data records|0|||
129657674|NCT03585712|466705688|FG000|Treatment Period 1|Protocol Violation|1|||
129657675|NCT03585712|466705689|FG001|Treatment Period 1|Protocol Violation|0|||
129657676|NCT03585712|466705690|FG002|Treatment Period 1|Protocol Violation|0|||
129657677|NCT03585712|466705688|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
129657678|NCT03585712|466705689|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
129657679|NCT03585712|466705690|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
129657680|NCT03585712|466705688|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
129657681|NCT03585712|466705689|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
129657682|NCT03585712|466705690|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
129657683|NCT03585712|466705688|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
129657684|NCT03585712|466705689|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
129657685|NCT03585712|466705690|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
129657686|NCT03004924|466705695|FG000|Overall Study|Adverse Event|6|||
129657687|NCT03004924|466705696|FG001|Overall Study|Adverse Event|5|||
129657688|NCT03004924|466705697|FG002|Overall Study|Adverse Event|10|||
129657689|NCT03004924|466705695|FG000|Overall Study|Protocol Violation|4|||
129657690|NCT03004924|466705696|FG001|Overall Study|Protocol Violation|0|||
129657691|NCT03004924|466705697|FG002|Overall Study|Protocol Violation|1|||
129657692|NCT03004924|466705695|FG000|Overall Study|Withdrawal by Subject|5|||
129657693|NCT03004924|466705696|FG001|Overall Study|Withdrawal by Subject|3|||
129657694|NCT03004924|466705697|FG002|Overall Study|Withdrawal by Subject|5|||
129657695|NCT03004924|466705695|FG000|Overall Study|Lost to Follow-up|6|||
129657696|NCT03004924|466705696|FG001|Overall Study|Lost to Follow-up|1|||
129657697|NCT03004924|466705697|FG002|Overall Study|Lost to Follow-up|4|||
129657698|NCT03004924|466705695|FG000|Overall Study|Lack of Efficacy|2|||
129657699|NCT03004924|466705696|FG001|Overall Study|Lack of Efficacy|4|||
129657700|NCT03004924|466705697|FG002|Overall Study|Lack of Efficacy|2|||
129657701|NCT03004924|466705695|FG000|Overall Study|Physician Decision|1|||
129657702|NCT03004924|466705696|FG001|Overall Study|Physician Decision|0|||
129657703|NCT03004924|466705697|FG002|Overall Study|Physician Decision|1|||
129657704|NCT03004924|466705695|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129657705|NCT03004924|466705696|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129657706|NCT03004924|466705697|FG002|Overall Study|Withdrawal by parent/guardian|2|||
129657707|NCT03004924|466705695|FG000|Overall Study|Screen Failure|1|||
129657708|NCT03004924|466705696|FG001|Overall Study|Screen Failure|0|||
129657709|NCT03004924|466705697|FG002|Overall Study|Screen Failure|0|||
129657710|NCT03004924|466705695|FG000|Overall Study|Pregnancy|0|||
129657711|NCT03004924|466705696|FG001|Overall Study|Pregnancy|1|||
129657712|NCT03004924|466705697|FG002|Overall Study|Pregnancy|0|||
129657713|NCT03004924|466705695|FG000|Overall Study|Terminated by Sponsor|0|||
129657714|NCT03004924|466705696|FG001|Overall Study|Terminated by Sponsor|0|||
129657715|NCT03004924|466705697|FG002|Overall Study|Terminated by Sponsor|1|||
129657716|NCT03004924|466705695|FG000|Overall Study|Missed Study Visit|0|||
129657717|NCT03004924|466705696|FG001|Overall Study|Missed Study Visit|0|||
129657718|NCT03004924|466705697|FG002|Overall Study|Missed Study Visit|2|||
129657719|NCT03004924|466705695|FG000|Overall Study|HSV1 Positive|1|||
129657720|NCT03004924|466705696|FG001|Overall Study|HSV1 Positive|0|||
129883511|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129546240|NCT00111007|466292428|FG000|Long Term Follow-up|Missing|10|||
129657721|NCT03004924|466705697|FG002|Overall Study|HSV1 Positive|0|||
129657722|NCT01280682|466705698|FG000|Overall Study|Lost to Follow-up|0|||
129657723|NCT01280682|466705699|FG001|Overall Study|Lost to Follow-up|6|||
129657724|NCT01280682|466705698|FG000|Overall Study|Withdrawal by Subject|0|||
129657725|NCT01280682|466705699|FG001|Overall Study|Withdrawal by Subject|7|||
129657726|NCT00269477|466705702|FG000|Overall Study|Protocol Violation|5|||
129657727|NCT00269477|466705703|FG001|Overall Study|Protocol Violation|5|||
129657728|NCT00269477|466705704|FG002|Overall Study|Protocol Violation|1|||
129657729|NCT00269477|466705705|FG003|Overall Study|Protocol Violation|0|||
129657730|NCT00269477|466705702|FG000|Overall Study|Missed post-vaccination blood draw|0|||
129657731|NCT00269477|466705703|FG001|Overall Study|Missed post-vaccination blood draw|1|||
129657732|NCT00269477|466705704|FG002|Overall Study|Missed post-vaccination blood draw|0|||
129657733|NCT00269477|466705705|FG003|Overall Study|Missed post-vaccination blood draw|0|||
129657734|NCT01964716|466705712|FG000|Overall Study|Withdrawal by Subject|2|||
129657735|NCT01964716|466705713|FG001|Overall Study|Withdrawal by Subject|3|||
129657736|NCT01964716|466705712|FG000|Overall Study|Lost to Follow-up|1|||
129657737|NCT01964716|466705713|FG001|Overall Study|Lost to Follow-up|2|||
129657738|NCT01964716|466705712|FG000|Overall Study|No longer met eligibility criteria|1|||
129657739|NCT01964716|466705713|FG001|Overall Study|No longer met eligibility criteria|1|||
129657740|NCT01964716|466705712|FG000|Overall Study|Death|1|||
129657741|NCT01964716|466705713|FG001|Overall Study|Death|0|||
129657742|NCT01464619|466705714|FG000|Overall Study|Lost to Follow-up|3|||
129657743|NCT01464619|466705715|FG001|Overall Study|Lost to Follow-up|4|||
129657744|NCT00080483|466705720|FG000|Overall Study|Lost to Follow-up|1|||
129657745|NCT00080483|466705721|FG001|Overall Study|Lost to Follow-up|1|||
129657746|NCT00080483|466705720|FG000|Overall Study|Physician Decision|1|||
129657747|NCT00080483|466705721|FG001|Overall Study|Physician Decision|1|||
129657748|NCT04527978|466705722|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
129657749|NCT04527978|466705723|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
129657750|NCT01370616|466705724|FG000|Overall Study|Adverse Event|11|||
129657751|NCT01370616|466705725|FG001|Overall Study|Adverse Event|16|||
129657752|NCT01370616|466705724|FG000|Overall Study|Death|1|||
129657753|NCT01370616|466705725|FG001|Overall Study|Death|0|||
129657754|NCT01370616|466705724|FG000|Overall Study|Lack of Efficacy|6|||
129657755|NCT01370616|466705725|FG001|Overall Study|Lack of Efficacy|2|||
129657756|NCT01370616|466705724|FG000|Overall Study|Lost to Follow-up|0|||
129657757|NCT01370616|466705725|FG001|Overall Study|Lost to Follow-up|3|||
129657758|NCT01370616|466705724|FG000|Overall Study|Physician Decision|6|||
129657759|NCT01370616|466705725|FG001|Overall Study|Physician Decision|6|||
129657760|NCT01370616|466705724|FG000|Overall Study|Progressive Disease|0|||
129657761|NCT01370616|466705725|FG001|Overall Study|Progressive Disease|1|||
129657762|NCT01370616|466705724|FG000|Overall Study|Recovery|1|||
129657763|NCT01370616|466705725|FG001|Overall Study|Recovery|0|||
129657764|NCT01370616|466705724|FG000|Overall Study|Technical Problems|3|||
129657765|NCT01370616|466705725|FG001|Overall Study|Technical Problems|5|||
129657766|NCT01370616|466705724|FG000|Overall Study|Withdrawal by Subject|34|||
129657767|NCT01370616|466705725|FG001|Overall Study|Withdrawal by Subject|34|||
129657768|NCT02324699|466705726|FG000|Overall Study|study terminated|1|||
129657769|NCT01578499|466705729|FG000|Overall Study|Reason not Specified|0|||
129657770|NCT01578499|466705730|FG001|Overall Study|Reason not Specified|1|||
129657771|NCT01578499|466705729|FG000|Overall Study|Lost to Follow-up|2|||
129657772|NCT01578499|466705730|FG001|Overall Study|Lost to Follow-up|1|||
129657773|NCT01578499|466705729|FG000|Overall Study|Withdrawal by Subject|10|||
129657774|NCT01578499|466705730|FG001|Overall Study|Withdrawal by Subject|16|||
129657775|NCT01578499|466705729|FG000|Overall Study|Death|20|||
129657776|NCT01578499|466705730|FG001|Overall Study|Death|25|||
129657777|NCT01578499|466705729|FG000|Overall Study|Died and End of Study Page not Completed|2|||
129657778|NCT01578499|466705730|FG001|Overall Study|Died and End of Study Page not Completed|0|||
129657779|NCT02670382|466705731|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
129657780|NCT02670382|466705732|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
129657781|NCT03469999|466705735|FG000|Overall Study|Lost to Follow-up|2|||
129657782|NCT01863732|466705736|FG000|Overall Study|Adverse Event|2|||
129657783|NCT01863732|466705737|FG001|Overall Study|Adverse Event|0|||
129657784|NCT01863732|466705738|FG002|Overall Study|Adverse Event|3|||
129657785|NCT01863732|466705739|FG003|Overall Study|Adverse Event|3|||
129657786|NCT01863732|466705736|FG000|Overall Study|Lack of Efficacy|1|||
129657787|NCT01863732|466705737|FG001|Overall Study|Lack of Efficacy|0|||
129657788|NCT01863732|466705738|FG002|Overall Study|Lack of Efficacy|2|||
129988240|NCT02412371|467918884|FG000|Overall Study|Other|2|||
129988241|NCT02412371|467918885|FG001|Overall Study|Other|1|||
129657789|NCT01863732|466705739|FG003|Overall Study|Lack of Efficacy|1|||
129657790|NCT01863732|466705736|FG000|Overall Study|Lost to Follow-up|2|||
129657791|NCT01863732|466705737|FG001|Overall Study|Lost to Follow-up|2|||
129657792|NCT01863732|466705738|FG002|Overall Study|Lost to Follow-up|1|||
129657793|NCT01863732|466705739|FG003|Overall Study|Lost to Follow-up|1|||
129657794|NCT01863732|466705736|FG000|Overall Study|Physician Decision|1|||
129657795|NCT01863732|466705737|FG001|Overall Study|Physician Decision|0|||
129657796|NCT01863732|466705738|FG002|Overall Study|Physician Decision|1|||
129657797|NCT01863732|466705739|FG003|Overall Study|Physician Decision|0|||
129657798|NCT01863732|466705736|FG000|Overall Study|Pregnancy|0|||
129657799|NCT01863732|466705737|FG001|Overall Study|Pregnancy|0|||
129657800|NCT01863732|466705738|FG002|Overall Study|Pregnancy|0|||
129657801|NCT01863732|466705739|FG003|Overall Study|Pregnancy|1|||
129988242|NCT02412371|467918886|FG002|Overall Study|Other|0|||
129657802|NCT01863732|466705736|FG000|Overall Study|Technical problems|0|||
129657803|NCT01863732|466705737|FG001|Overall Study|Technical problems|1|||
129657804|NCT01863732|466705738|FG002|Overall Study|Technical problems|1|||
129657805|NCT01863732|466705739|FG003|Overall Study|Technical problems|0|||
129657806|NCT01863732|466705736|FG000|Overall Study|Subject/guardian decision|6|||
129657807|NCT01863732|466705737|FG001|Overall Study|Subject/guardian decision|9|||
129657808|NCT01863732|466705738|FG002|Overall Study|Subject/guardian decision|3|||
129657809|NCT01863732|466705739|FG003|Overall Study|Subject/guardian decision|1|||
129657810|NCT01863732|466705736|FG000|Overall Study|Death|1|||
129657811|NCT01863732|466705737|FG001|Overall Study|Death|0|||
129657812|NCT01863732|466705738|FG002|Overall Study|Death|0|||
129657813|NCT01863732|466705739|FG003|Overall Study|Death|1|||
129657814|NCT00460746|466705740|FG000|Overall Study|Adverse Event|1|||
129657815|NCT00460746|466705740|FG000|Overall Study|Lost to Follow-up|1|||
129657816|NCT00636961|466705746|FG000|Period 1|Administrative problems|1|||
129657817|NCT00636961|466705747|FG001|Period 1|Administrative problems|1|||
129657818|NCT00636961|466705746|FG000|Period 2|Adverse Event|1|||
129657819|NCT00636961|466705747|FG001|Period 2|Adverse Event|0|||
129657820|NCT02223364|466705748|FG000|Overall Study|Protocol Violation|3|||
129657821|NCT02223364|466705749|FG001|Overall Study|Protocol Violation|0|||
129657822|NCT02223364|466705750|FG002|Overall Study|Protocol Violation|3|||
129657823|NCT02223364|466705748|FG000|Overall Study|subject expired before surgery|1|||
129657824|NCT02223364|466705749|FG001|Overall Study|subject expired before surgery|0|||
129657825|NCT02223364|466705750|FG002|Overall Study|subject expired before surgery|0|||
129657826|NCT02223364|466705748|FG000|Overall Study|Physician Decision|1|||
129657827|NCT02223364|466705749|FG001|Overall Study|Physician Decision|0|||
129657828|NCT02223364|466705750|FG002|Overall Study|Physician Decision|0|||
129657829|NCT00742027|466705751|FG000|Overall Study|Disease Progression|76|||
129657830|NCT00742027|466705751|FG000|Overall Study|New Cancer Therapy|19|||
129657831|NCT00742027|466705751|FG000|Overall Study|Withdrawal by Subject|18|||
129657832|NCT00742027|466705751|FG000|Overall Study|Death|7|||
129657833|NCT00742027|466705751|FG000|Overall Study|Lost to Follow-up|4|||
129657834|NCT00742027|466705751|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
129657835|NCT00742027|466705751|FG000|Overall Study|Missing|2|||
129657836|NCT00742027|466705751|FG000|Overall Study|Administrative Problems|1|||
129657837|NCT00171158|466707361|FG000|Core Study|Death|27|||
129657838|NCT00171158|466707361|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
129657839|NCT00171158|466707361|FG000|Core Study|Protocol Violation|4|||
129657840|NCT00171158|466707361|FG000|Core Study|Administrative problems|1|||
129657841|NCT00171158|466707361|FG000|Core Study|Adverse event, non-fatal|21|||
129657842|NCT00171158|466707361|FG000|Core Study|Consent withdrawn by subject|6|||
129657843|NCT00171158|466707361|FG000|Core Study|No longer required drug (BMT)|14|||
129657844|NCT00171158|466707361|FG000|Core Study|Abnormal Laboratory Values|2|||
129657845|NCT00171158|466707361|FG000|Core Study|Lost to Follow-up|1|||
129657846|NCT00171158|466707361|FG000|E2 Extension|Other|7|||
129657847|NCT03536663|466707364|FG000|Endexo|Protocol Violation|1|||
129657848|NCT00762034|466707365|FG000|Induction Period|Protocol Violation|1|||
129657849|NCT00762034|466707366|FG001|Induction Period|Protocol Violation|2|||
129657850|NCT00762034|466707365|FG000|Induction Period|Entry Criterion Not Met|12|||
129657851|NCT00762034|466707366|FG001|Induction Period|Entry Criterion Not Met|11|||
129657852|NCT00762034|466707365|FG000|Induction Period|Adverse Event|27|||
129657853|NCT00762034|466707366|FG001|Induction Period|Adverse Event|38|||
129657854|NCT00762034|466707365|FG000|Induction Period|Lost to Follow-up|1|||
129657855|NCT00762034|466707366|FG001|Induction Period|Lost to Follow-up|1|||
129657856|NCT00762034|466707365|FG000|Induction Period|Progressive Disease|73|||
129657857|NCT00762034|466707366|FG001|Induction Period|Progressive Disease|55|||
129657858|NCT00762034|466707365|FG000|Induction Period|Physician Decision|21|||
129657859|NCT00762034|466707366|FG001|Induction Period|Physician Decision|20|||
129657860|NCT00762034|466707365|FG000|Induction Period|Withdrawal by Subject|15|||
129657861|NCT00762034|466707366|FG001|Induction Period|Withdrawal by Subject|19|||
129657862|NCT00762034|466707365|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
129657863|NCT00762034|466707366|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
129657864|NCT00762034|466707365|FG000|Induction Period|Deaths Due to Study Disease|9|||
129657865|NCT00762034|466707366|FG001|Induction Period|Deaths Due to Study Disease|9|||
129657866|NCT00762034|466707365|FG000|Maintenance Period|Protocol Violation|1|||
129657867|NCT00762034|466707366|FG001|Maintenance Period|Protocol Violation|3|||
129657868|NCT00762034|466707365|FG000|Maintenance Period|Entry Criterion Not Met|0|||
129657869|NCT00762034|466707366|FG001|Maintenance Period|Entry Criterion Not Met|2|||
129657870|NCT00762034|466707365|FG000|Maintenance Period|Adverse Event|42|||
129657871|NCT00762034|466707366|FG001|Maintenance Period|Adverse Event|26|||
129657872|NCT00762034|466707365|FG000|Maintenance Period|Progressive Disease|186|||
129883512|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129883513|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129883514|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
129883515|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129883516|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
129657873|NCT00762034|466707366|FG001|Maintenance Period|Progressive Disease|224|||
129657874|NCT00762034|466707365|FG000|Maintenance Period|Physician Decision|25|||
129657875|NCT00762034|466707366|FG001|Maintenance Period|Physician Decision|20|||
129657876|NCT00762034|466707365|FG000|Maintenance Period|Withdrawal by Subject|34|||
129657877|NCT00762034|466707366|FG001|Maintenance Period|Withdrawal by Subject|14|||
129657878|NCT00762034|466707365|FG000|Maintenance Period|Death not due to study disease|2|||
129657879|NCT00762034|466707366|FG001|Maintenance Period|Death not due to study disease|5|||
129657880|NCT00762034|466707365|FG000|Maintenance Period|Death due to study disease|3|||
129657881|NCT00762034|466707366|FG001|Maintenance Period|Death due to study disease|3|||
129657882|NCT00762034|466707365|FG000|Maintenance Period|Other|1|||
129657883|NCT00762034|466707366|FG001|Maintenance Period|Other|1|||
129657884|NCT02442206|466707367|FG000|Period 1|Adverse Event|1|||
129657885|NCT02442206|466707368|FG001|Period 1|Adverse Event|1|||
129657886|NCT02442206|466707367|FG000|Period 1|withdrew consent|0|||
129657887|NCT02442206|466707368|FG001|Period 1|withdrew consent|1|||
129657888|NCT02442206|466707367|FG000|Period 1|COPD exacerbation|0|||
129657889|NCT02442206|466707368|FG001|Period 1|COPD exacerbation|1|||
129657890|NCT02442206|466707367|FG000|Period 2|Adverse Event|1|||
129657891|NCT02442206|466707368|FG001|Period 2|Adverse Event|0|||
129657892|NCT00497146|466707369|FG000|Treatment Period|Adverse Event|6|||
129657893|NCT00497146|466707370|FG001|Treatment Period|Adverse Event|2|||
129657894|NCT00497146|466707369|FG000|Treatment Period|Withdrawal by Subject|5|||
129657895|NCT00497146|466707370|FG001|Treatment Period|Withdrawal by Subject|9|||
129657896|NCT00497146|466707369|FG000|Treatment Period|Lost to Follow-up|1|||
129657897|NCT00497146|466707370|FG001|Treatment Period|Lost to Follow-up|3|||
129657898|NCT00497146|466707369|FG000|Treatment Period|Required dialysis|4|||
129657899|NCT00497146|466707370|FG001|Treatment Period|Required dialysis|1|||
129657900|NCT00497146|466707369|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
129657901|NCT00497146|466707370|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
129657902|NCT00497146|466707369|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
129657903|NCT00497146|466707370|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
129657904|NCT00497146|466707369|FG000|Treatment Period|Other Reason|2|||
129657905|NCT00497146|466707370|FG001|Treatment Period|Other Reason|3|||
129657906|NCT00497146|466707369|FG000|Long-term Follow-up Period|Adverse Event|2|||
129657907|NCT00497146|466707370|FG001|Long-term Follow-up Period|Adverse Event|2|||
129657908|NCT00497146|466707369|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
129657909|NCT00497146|466707370|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
129657910|NCT00497146|466707369|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
129657911|NCT00497146|466707370|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
129657912|NCT00497146|466707369|FG000|Long-term Follow-up Period|Other|0|||
129657913|NCT00497146|466707370|FG001|Long-term Follow-up Period|Other|1|||
129657914|NCT01471444|466707371|FG000|Overall Study|Physician Decision|3|||
129657915|NCT01471444|466707372|FG001|Overall Study|Physician Decision|2|||
129657916|NCT01471444|466707371|FG000|Overall Study|Withdrawal by Subject|0|||
129657917|NCT01471444|466707372|FG001|Overall Study|Withdrawal by Subject|1|||
129657918|NCT01299896|466707375|FG000|Overall Study|Withdrawal by Subject|1|||
129657919|NCT01299896|466707376|FG001|Overall Study|Withdrawal by Subject|7|||
129657920|NCT01299896|466707375|FG000|Overall Study|Lost to Follow-up|0|||
129657921|NCT01299896|466707376|FG001|Overall Study|Lost to Follow-up|11|||
129657922|NCT02107313|466707377|FG000|Overall Study|One participant did not do the FED cohor|0|||
129657923|NCT02107313|466707378|FG001|Overall Study|One participant did not do the FED cohor|1|||
129657924|NCT00582426|466707389|FG000|Overall Study|Lost to Follow-up|0|||
129657925|NCT00582426|466707390|FG001|Overall Study|Lost to Follow-up|2|||
129657926|NCT00582426|466707389|FG000|Overall Study|Adverse Event|4|||
129657927|NCT00582426|466707390|FG001|Overall Study|Adverse Event|2|||
129657928|NCT00582426|466707389|FG000|Overall Study|Protocol Violation|6|||
129657929|NCT00582426|466707390|FG001|Overall Study|Protocol Violation|2|||
129657930|NCT00582426|466707389|FG000|Overall Study|Death|4|||
129657931|NCT00582426|466707390|FG001|Overall Study|Death|3|||
129657932|NCT00582426|466707389|FG000|Overall Study|Withdrawal by Subject|3|||
129657933|NCT00582426|466707390|FG001|Overall Study|Withdrawal by Subject|2|||
129657934|NCT00582426|466707389|FG000|Overall Study|Disease Progression|2|||
129657935|NCT00582426|466707390|FG001|Overall Study|Disease Progression|2|||
129657936|NCT00582426|466707389|FG000|Overall Study|Use of illicit drugs|1|||
129657937|NCT00582426|466707390|FG001|Overall Study|Use of illicit drugs|0|||
129657938|NCT04126317|466707394|FG000|Overall Study|Adverse Event|0|||
129657939|NCT04126317|466707395|FG001|Overall Study|Adverse Event|1|||
129657940|NCT04126317|466707394|FG000|Overall Study|Withdrawal by Subject|4|||
129657941|NCT04126317|466707395|FG001|Overall Study|Withdrawal by Subject|1|||
129657942|NCT03297021|466707397|FG000|Overall Study|Incomplete/illegible data sheet|4|||
129657943|NCT03297021|466707398|FG001|Overall Study|Incomplete/illegible data sheet|2|||
129657944|NCT03297021|466707399|FG002|Overall Study|Incomplete/illegible data sheet|3|||
129657945|NCT03297021|466707397|FG000|Overall Study|Missing Post-Op Data|1|||
129657946|NCT03297021|466707398|FG001|Overall Study|Missing Post-Op Data|2|||
129657947|NCT03297021|466707399|FG002|Overall Study|Missing Post-Op Data|1|||
129657948|NCT00948922|466707401|FG000|Overall Study|Did not start study treatment|2|||
129657949|NCT00948922|466707402|FG001|Overall Study|Did not start study treatment|5|||
129988243|NCT02412371|467918887|FG003|Overall Study|Other|0|||
129988244|NCT02412371|467918888|FG004|Overall Study|Other|1|||
129988245|NCT02412371|467918889|FG005|Overall Study|Other|3|||
129988246|NCT02053792|467918890|FG000|Overall Study|Physician Decision|0|||
129988247|NCT02053792|467918891|FG001|Overall Study|Physician Decision|1|||
129988248|NCT02053792|467918890|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
129546241|NCT00111007|466292429|FG001|Long Term Follow-up|Missing|3|||
129546242|NCT02380248|466292431|FG000|Overall Study|Lost to Follow-up|11|||
129546243|NCT02380248|466292431|FG000|Overall Study|Withdrawal by Subject|3|||
129546244|NCT01275170|466292432|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
129546245|NCT01275170|466292433|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546246|NCT01275170|466292434|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546247|NCT01275170|466292435|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546248|NCT01275170|466292436|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546249|NCT01275170|466292437|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546250|NCT01275170|466292438|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546251|NCT01275170|466292439|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
129546252|NCT00621309|466292440|FG000|Overall Study|Withdrawal by Subject|2|||
129546253|NCT00621309|466292441|FG001|Overall Study|Withdrawal by Subject|0|||
129546254|NCT00621309|466292442|FG002|Overall Study|Withdrawal by Subject|1|||
129546255|NCT00621309|466292443|FG003|Overall Study|Withdrawal by Subject|1|||
129546256|NCT00621309|466292444|FG004|Overall Study|Withdrawal by Subject|1|||
129546257|NCT00621309|466292445|FG005|Overall Study|Withdrawal by Subject|1|||
129546258|NCT02949219|466292447|FG000|Overall Study|Withdrawal by Subject|1|||
129546259|NCT00314262|466292458|FG000|Overall Study|Adverse Event|2|||
129546260|NCT00314262|466292458|FG000|Overall Study|Withdrawal by Subject|2|||
129546261|NCT00314262|466292458|FG000|Overall Study|Physician Decision|1|||
129546262|NCT00083226|466292459|FG000|Overall Study|Lack of Efficacy|19|||
129546263|NCT00083226|466292459|FG000|Overall Study|Adverse Event|9|||
129546264|NCT00083226|466292459|FG000|Overall Study|Death|4|||
129546265|NCT00083226|466292459|FG000|Overall Study|Withdrawal by Subject|4|||
129546266|NCT00083226|466292459|FG000|Overall Study|Other|2|||
129546267|NCT00083226|466292459|FG000|Overall Study|ineligible or not receiving treatment|4|||
129546268|NCT00909857|466292460|FG000|Overall Study|Withdrawal by Subject|6|||
129546269|NCT00909857|466292461|FG001|Overall Study|Withdrawal by Subject|10|||
129546270|NCT00909857|466292460|FG000|Overall Study|Adverse Event|5|||
129546271|NCT00909857|466292461|FG001|Overall Study|Adverse Event|5|||
129546272|NCT00909857|466292460|FG000|Overall Study|Lost to Follow-up|2|||
129546273|NCT00909857|466292461|FG001|Overall Study|Lost to Follow-up|5|||
129546274|NCT00909857|466292460|FG000|Overall Study|Protocol Violation|2|||
129546275|NCT00909857|466292461|FG001|Overall Study|Protocol Violation|1|||
129546276|NCT00909857|466292460|FG000|Overall Study|Pregnancy|1|||
129546277|NCT00909857|466292461|FG001|Overall Study|Pregnancy|0|||
129546278|NCT00909857|466292460|FG000|Overall Study|Other|1|||
129546279|NCT00909857|466292461|FG001|Overall Study|Other|0|||
129546280|NCT00909857|466292460|FG000|Overall Study|Did not receive study medication|19|||
129546281|NCT00909857|466292461|FG001|Overall Study|Did not receive study medication|24|||
129546282|NCT00604175|466292468|FG000|Entry Through Week 28|Death|2|||
129546283|NCT00604175|466292469|FG001|Entry Through Week 28|Death|0|||
129546284|NCT00604175|466292470|FG002|Entry Through Week 28|Death|0|||
129546285|NCT00604175|466292468|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
129546286|NCT00604175|466292469|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
129546287|NCT00604175|466292470|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
129546288|NCT00604175|466292468|FG000|Entry Through Week 28|Lost to Follow-up|4|||
129546289|NCT00604175|466292469|FG001|Entry Through Week 28|Lost to Follow-up|3|||
129546290|NCT00604175|466292470|FG002|Entry Through Week 28|Lost to Follow-up|0|||
129546291|NCT00604175|466292468|FG000|Entry Through Week 28|Ineligible|1|||
129546292|NCT00604175|466292469|FG001|Entry Through Week 28|Ineligible|0|||
129546293|NCT00604175|466292470|FG002|Entry Through Week 28|Ineligible|0|||
129546294|NCT00604175|466292468|FG000|Entry Through Week 28|Did not start intervention|2|||
129546295|NCT00604175|466292469|FG001|Entry Through Week 28|Did not start intervention|0|||
129546296|NCT00604175|466292470|FG002|Entry Through Week 28|Did not start intervention|1|||
129546297|NCT00604175|466292468|FG000|Week 29 Through Week 72|Death|0|||
129546298|NCT00604175|466292469|FG001|Week 29 Through Week 72|Death|0|||
129546299|NCT00604175|466292470|FG002|Week 29 Through Week 72|Death|1|||
129546300|NCT00604175|466292468|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
129546301|NCT00604175|466292469|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
129546302|NCT00604175|466292470|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
129657950|NCT00948922|466707403|FG002|Overall Study|Did not start study treatment|0|||
129546303|NCT00604175|466292468|FG000|Week 29 Through Week 72|Site closure|0|||
129546304|NCT00604175|466292469|FG001|Week 29 Through Week 72|Site closure|1|||
129546305|NCT00604175|466292470|FG002|Week 29 Through Week 72|Site closure|0|||
129546306|NCT00604175|466292468|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
129657951|NCT00948922|466707401|FG000|Overall Study|Withdrawal by Subject|0|||
129657952|NCT00948922|466707402|FG001|Overall Study|Withdrawal by Subject|2|||
129988249|NCT02053792|467918891|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
129988250|NCT02053792|467918890|FG000|Overall Study|Lack of Efficacy|1|||
129657953|NCT00948922|466707403|FG002|Overall Study|Withdrawal by Subject|1|||
129657954|NCT00948922|466707401|FG000|Overall Study|Death|3|||
129657955|NCT00948922|466707402|FG001|Overall Study|Death|0|||
129657956|NCT00948922|466707403|FG002|Overall Study|Death|0|||
129657957|NCT00948922|466707401|FG000|Overall Study|Disease progression|0|||
129657958|NCT00948922|466707402|FG001|Overall Study|Disease progression|1|||
129657959|NCT00948922|466707403|FG002|Overall Study|Disease progression|0|||
129657960|NCT00948922|466707401|FG000|Overall Study|Insurance issues|1|||
129657961|NCT00948922|466707402|FG001|Overall Study|Insurance issues|0|||
129657962|NCT00948922|466707403|FG002|Overall Study|Insurance issues|0|||
129657963|NCT00948922|466707401|FG000|Overall Study|Transplant eligibility issues|2|||
129657964|NCT00948922|466707402|FG001|Overall Study|Transplant eligibility issues|3|||
129657965|NCT00948922|466707403|FG002|Overall Study|Transplant eligibility issues|0|||
129657966|NCT00948922|466707401|FG000|Overall Study|Not evaluable at time of analysis|0|||
129657967|NCT00948922|466707402|FG001|Overall Study|Not evaluable at time of analysis|3|||
129657968|NCT00948922|466707403|FG002|Overall Study|Not evaluable at time of analysis|0|||
129657969|NCT02095197|466707404|FG000|Overall Study|Lost to Follow-up|0|||
129657970|NCT02095197|466707405|FG001|Overall Study|Lost to Follow-up|3|||
129657971|NCT02829047|466707409|FG000|Overall Study|Withdrawal by Subject|1|||
129657972|NCT03077607|466707411|FG000|Period 1 (15 Days)|Adverse Event|1|||
129657973|NCT03077607|466707412|FG001|Period 1 (15 Days)|Adverse Event|0|||
129657974|NCT03077607|466707411|FG000|Period 1 (15 Days)|Death|1|||
129657975|NCT03077607|466707412|FG001|Period 1 (15 Days)|Death|0|||
129657976|NCT03077607|466707411|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
129657977|NCT03077607|466707412|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
129657978|NCT03077607|466707411|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
129657979|NCT03077607|466707412|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
129657980|NCT00482170|466707414|FG000|Overall Study|Adverse Event|5|||
129657981|NCT00482170|466707415|FG001|Overall Study|Adverse Event|14|||
129657982|NCT00482170|466707414|FG000|Overall Study|Withdrawal by Subject|6|||
129657983|NCT00482170|466707415|FG001|Overall Study|Withdrawal by Subject|1|||
129657984|NCT00482170|466707414|FG000|Overall Study|Protocol Violation|2|||
129657985|NCT00482170|466707415|FG001|Overall Study|Protocol Violation|3|||
129657986|NCT00482170|466707414|FG000|Overall Study|Lost to Follow-up|2|||
129657987|NCT00482170|466707415|FG001|Overall Study|Lost to Follow-up|0|||
129657988|NCT00482170|466707414|FG000|Overall Study|Unspecified reason|0|||
129657989|NCT00482170|466707415|FG001|Overall Study|Unspecified reason|2|||
129657990|NCT00162097|466707416|FG000|Overall Study|Participant no longer met study criteria|0|||
129657991|NCT00162097|466707417|FG001|Overall Study|Participant no longer met study criteria|0|||
129657992|NCT00162097|466707418|FG002|Overall Study|Participant no longer met study criteria|0|||
129657993|NCT00162097|466707419|FG003|Overall Study|Participant no longer met study criteria|1|||
129657994|NCT01658904|466707420|FG000|Overall Study|Principal Investigator discretion|2|||
129657995|NCT01658904|466707421|FG001|Overall Study|Principal Investigator discretion|0|||
129657996|NCT01658904|466707422|FG002|Overall Study|Principal Investigator discretion|0|||
129657997|NCT01603394|466707432|FG000|Overall Study|Adverse Event|1|||
129657998|NCT00840034|466707434|FG000|Acute Treatment Phase|Adverse Event|6|||
129657999|NCT00840034|466707435|FG001|Acute Treatment Phase|Adverse Event|8|||
129658000|NCT00840034|466707434|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
129658001|NCT00840034|466707435|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
129658002|NCT00840034|466707434|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
129658003|NCT00840034|466707435|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
129658004|NCT00840034|466707434|FG000|Acute Treatment Phase|Physician Decision|0|||
129658005|NCT00840034|466707435|FG001|Acute Treatment Phase|Physician Decision|1|||
129988251|NCT02053792|467918891|FG001|Overall Study|Lack of Efficacy|0|||
129988252|NCT02053792|467918890|FG000|Overall Study|Adverse Event|1|||
129988253|NCT02053792|467918891|FG001|Overall Study|Adverse Event|0|||
129988254|NCT02053792|467918890|FG000|Overall Study|Withdrawal by Subject|2|||
129988255|NCT02053792|467918891|FG001|Overall Study|Withdrawal by Subject|2|||
129988256|NCT02053792|467918890|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
129988257|NCT02053792|467918891|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
129988258|NCT02053792|467918890|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
129988259|NCT02053792|467918891|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
129988260|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Death|0|||
129988261|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Death|0|||
129988262|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Death|0|||
129988263|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Death|1|||
129988264|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Death|2|||
129988265|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Death|1|||
129988266|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Death|1|||
129658006|NCT00840034|466707434|FG000|Acute Treatment Phase|Protocol Violation|2|||
129658007|NCT00840034|466707435|FG001|Acute Treatment Phase|Protocol Violation|4|||
129658008|NCT00840034|466707434|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
129658009|NCT00840034|466707435|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
129658010|NCT00840034|466707434|FG000|Taper Phase|Adverse Event|1|||
129658011|NCT00840034|466707435|FG001|Taper Phase|Adverse Event|0|||
129658012|NCT00840034|466707434|FG000|Taper Phase|Lost to Follow-up|1|||
129658013|NCT00840034|466707435|FG001|Taper Phase|Lost to Follow-up|1|||
129658014|NCT00840034|466707434|FG000|Taper Phase|Withdrawal by Subject|1|||
129658015|NCT00840034|466707435|FG001|Taper Phase|Withdrawal by Subject|1|||
129658016|NCT04399538|466707436|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
129658017|NCT04399538|466707437|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
129658018|NCT04399538|466707438|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
129658019|NCT04399538|466707439|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
129658020|NCT04399538|466707440|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
129658021|NCT04399538|466707436|FG000|Double-Blind Treatment|Adverse Event|0|||
129658022|NCT04399538|466707437|FG001|Double-Blind Treatment|Adverse Event|0|||
129658023|NCT04399538|466707438|FG002|Double-Blind Treatment|Adverse Event|0|||
129658024|NCT04399538|466707439|FG003|Double-Blind Treatment|Adverse Event|0|||
129658025|NCT04399538|466707440|FG004|Double-Blind Treatment|Adverse Event|1|||
129658026|NCT04399538|466707436|FG000|Follow-Up|Adverse Event|0|||
129658027|NCT04399538|466707437|FG001|Follow-Up|Adverse Event|0|||
129658028|NCT04399538|466707438|FG002|Follow-Up|Adverse Event|0|||
129658029|NCT04399538|466707439|FG003|Follow-Up|Adverse Event|0|||
129658030|NCT04399538|466707440|FG004|Follow-Up|Adverse Event|1|||
129658031|NCT04399538|466707436|FG000|Follow-Up|Withdrawal by Subject|0|||
129658032|NCT04399538|466707437|FG001|Follow-Up|Withdrawal by Subject|0|||
129658033|NCT04399538|466707438|FG002|Follow-Up|Withdrawal by Subject|0|||
129658034|NCT04399538|466707439|FG003|Follow-Up|Withdrawal by Subject|2|||
129658035|NCT04399538|466707440|FG004|Follow-Up|Withdrawal by Subject|0|||
129658036|NCT01215435|466707441|FG000|Overall Study|Adverse Event|1|||
129658037|NCT01215435|466707442|FG001|Overall Study|Adverse Event|0|||
129658038|NCT01215435|466707441|FG000|Overall Study|Protocol Violation|2|||
129658039|NCT01215435|466707442|FG001|Overall Study|Protocol Violation|0|||
129658040|NCT01215435|466707441|FG000|Overall Study|Withdrawal Criteria|8|||
129658041|NCT01215435|466707442|FG001|Overall Study|Withdrawal Criteria|11|||
129658042|NCT01215435|466707441|FG000|Overall Study|Lost to Follow-up|3|||
129658043|NCT01215435|466707442|FG001|Overall Study|Lost to Follow-up|0|||
129658044|NCT01215435|466707441|FG000|Overall Study|Unclassified|5|||
129658045|NCT01215435|466707442|FG001|Overall Study|Unclassified|5|||
129658046|NCT02179749|466707454|FG000|Overall Study|Adverse Event|0|||
129658047|NCT02179749|466707455|FG001|Overall Study|Adverse Event|0|||
129658048|NCT02179749|466707456|FG002|Overall Study|Adverse Event|1|||
129658049|NCT02179749|466707454|FG000|Overall Study|Withdrawal by Subject|0|||
129658050|NCT02179749|466707455|FG001|Overall Study|Withdrawal by Subject|0|||
129658051|NCT02179749|466707456|FG002|Overall Study|Withdrawal by Subject|1|||
129658052|NCT02756364|466707458|FG000|Overall Study|Site Terminated by Sponsor|24|||
129658053|NCT02756364|466707459|FG001|Overall Study|Site Terminated by Sponsor|30|||
129658054|NCT02756364|466707460|FG002|Overall Study|Site Terminated by Sponsor|21|||
129658055|NCT02756364|466707458|FG000|Overall Study|Death|20|||
129658056|NCT02756364|466707459|FG001|Overall Study|Death|15|||
129658057|NCT02756364|466707460|FG002|Overall Study|Death|18|||
129658058|NCT02756364|466707458|FG000|Overall Study|Withdrawal by Patient|2|||
129658059|NCT02756364|466707459|FG001|Overall Study|Withdrawal by Patient|1|||
129658060|NCT02756364|466707460|FG002|Overall Study|Withdrawal by Patient|8|||
129658061|NCT02756364|466707458|FG000|Overall Study|Lost to Follow-up|0|||
129658062|NCT02756364|466707459|FG001|Overall Study|Lost to Follow-up|1|||
129658063|NCT02756364|466707460|FG002|Overall Study|Lost to Follow-up|1|||
129658064|NCT00793546|466707461|FG000|Overall Study|Death|3|||
129658065|NCT00793546|466707462|FG001|Overall Study|Death|0|||
129658066|NCT00793546|466707461|FG000|Overall Study|Lost to Follow-up|1|||
129658067|NCT00793546|466707462|FG001|Overall Study|Lost to Follow-up|0|||
129988267|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Death|2|||
129988268|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Death|4|||
129988269|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Death|1|||
129988270|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Death|0|||
129988271|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Death|0|||
129988272|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Death|1|||
129658068|NCT00793546|466707461|FG000|Overall Study|Withdrawal by Subject|1|||
129658069|NCT00793546|466707462|FG001|Overall Study|Withdrawal by Subject|1|||
129658070|NCT00793546|466707461|FG000|Overall Study|Study Terminated by Sponsor|8|||
129658071|NCT00793546|466707462|FG001|Overall Study|Study Terminated by Sponsor|27|||
129658072|NCT00793546|466707461|FG000|Overall Study|Other|1|||
129658073|NCT00793546|466707462|FG001|Overall Study|Other|0|||
129658074|NCT01841567|466707463|FG000|Overall Study|Adverse Event|3|||
129658075|NCT01416155|466707464|FG000|Overall Study|Adverse Event|8|||
129658076|NCT01416155|466707464|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
129658077|NCT01416155|466707464|FG000|Overall Study|Withdrawal by Subject|33|||
129658078|NCT01416155|466707464|FG000|Overall Study|Investigator decision|8|||
129658079|NCT01416155|466707464|FG000|Overall Study|Other|7|||
129658080|NCT02984267|466707469|FG000|Overall Study|Protocol Violation|1|||
129658081|NCT02984267|466707470|FG001|Overall Study|Protocol Violation|0|||
129658082|NCT02984267|466707469|FG000|Overall Study|Withdrawal by Subject|0|||
129658083|NCT02984267|466707470|FG001|Overall Study|Withdrawal by Subject|1|||
129658084|NCT03597139|466707471|FG000|Overall Study|Adverse Event|3|||
129658085|NCT03597139|466707472|FG001|Overall Study|Adverse Event|0|||
129658086|NCT03597139|466707471|FG000|Overall Study|Protocol Non-compliance|1|||
129658087|NCT03597139|466707472|FG001|Overall Study|Protocol Non-compliance|0|||
129658088|NCT00520767|466707473|FG000|Overall Study|Death|2|||
129658089|NCT00382109|466707476|FG000|Overall Study|Adverse Event|3|||
129658090|NCT00382109|466707477|FG001|Overall Study|Adverse Event|0|||
129658091|NCT00382109|466707476|FG000|Overall Study|Physician Decision|6|||
129658092|NCT00382109|466707477|FG001|Overall Study|Physician Decision|1|||
129658093|NCT00382109|466707476|FG000|Overall Study|Withdrawal by Subject|1|||
129658094|NCT00382109|466707477|FG001|Overall Study|Withdrawal by Subject|0|||
129658095|NCT00382109|466707476|FG000|Overall Study|ineligible|2|||
129658096|NCT00382109|466707477|FG001|Overall Study|ineligible|0|||
129658097|NCT00382109|466707476|FG000|Overall Study|Other|0|||
129658098|NCT00382109|466707477|FG001|Overall Study|Other|2|||
129658099|NCT00382109|466707476|FG000|Overall Study|consent withdrawal|0|||
129658100|NCT00382109|466707477|FG001|Overall Study|consent withdrawal|1|||
129658101|NCT01249833|466707478|FG000|Overall Study|Lost to Follow-up|0|||
129658102|NCT01249833|466707479|FG001|Overall Study|Lost to Follow-up|1|||
129658103|NCT03796676|466707480|FG000|Overall Study|Adverse Event|2|||
129658104|NCT03796676|466707481|FG001|Overall Study|Adverse Event|1|||
129658105|NCT03796676|466707482|FG002|Overall Study|Adverse Event|2|||
129658106|NCT03796676|466707480|FG000|Overall Study|Lost to Follow-up|2|||
129658107|NCT03796676|466707481|FG001|Overall Study|Lost to Follow-up|1|||
129658108|NCT03796676|466707482|FG002|Overall Study|Lost to Follow-up|0|||
129988273|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988274|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988275|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988276|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988277|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988278|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988279|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988280|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
129988281|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129658109|NCT03796676|466707480|FG000|Overall Study|Protocol Violation|0|||
129658110|NCT03796676|466707481|FG001|Overall Study|Protocol Violation|0|||
129658111|NCT03796676|466707482|FG002|Overall Study|Protocol Violation|1|||
129658112|NCT03796676|466707480|FG000|Overall Study|Withdrawal by Subject|1|||
129658113|NCT03796676|466707481|FG001|Overall Study|Withdrawal by Subject|1|||
129658114|NCT03796676|466707482|FG002|Overall Study|Withdrawal by Subject|0|||
129883517|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
129883518|NCT04921969|467532430|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883519|NCT04921969|467532431|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883520|NCT04921969|467532432|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883521|NCT04921969|467532433|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883522|NCT04921969|467532434|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
129883523|NCT04921969|467532435|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
129883524|NCT04921969|467532436|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
129883525|NCT03884231|467534325|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
129883526|NCT03884231|467534325|FG000|Overall Study|Subject Withdrew Consent|1|||
129883527|NCT03884231|467534325|FG000|Overall Study|MRI Scan Not Performed|1|||
129883528|NCT01853254|467534326|FG000|Overall Study|Abnormal Laboratory Test|1|||
129883529|NCT01853254|467534326|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
129883530|NCT01853254|467534326|FG000|Overall Study|Death|1|||
129883531|NCT01853254|467534326|FG000|Overall Study|Failure to Return|43|||
129883532|NCT01853254|467534326|FG000|Overall Study|Insufficient Therapeutic Response|22|||
129883533|NCT01853254|467534326|FG000|Overall Study|Refusal of Treatment|1|||
129883534|NCT01853254|467534326|FG000|Overall Study|Other Protocol Violation|1|||
129883535|NCT01853254|467534326|FG000|Overall Study|Withdrawal of Consent|16|||
129883536|NCT01853254|467534326|FG000|Overall Study|Administrative/Other|16|||
129883537|NCT01017120|467534332|FG000|Overall Study|Adverse Event|9|||
129883538|NCT01017120|467534333|FG001|Overall Study|Adverse Event|0|||
129883539|NCT01017120|467534332|FG000|Overall Study|Lost to Follow-up|13|||
129883540|NCT01017120|467534333|FG001|Overall Study|Lost to Follow-up|11|||
129883541|NCT01017120|467534332|FG000|Overall Study|Lack of Efficacy|1|||
129883542|NCT01017120|467534333|FG001|Overall Study|Lack of Efficacy|0|||
129883543|NCT01017120|467534332|FG000|Overall Study|Withdrawal by Subject|39|||
129883544|NCT01017120|467534333|FG001|Overall Study|Withdrawal by Subject|21|||
129883545|NCT01017120|467534332|FG000|Overall Study|Pregnancy|1|||
129883546|NCT01017120|467534333|FG001|Overall Study|Pregnancy|1|||
129883547|NCT01017120|467534332|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129883548|NCT01017120|467534333|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
129658115|NCT03796676|466707480|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
129658116|NCT03796676|466707481|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
129658117|NCT03796676|466707482|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
129658118|NCT01900899|466707486|FG000|Overall Study|Withdrawal by Subject|7|||
129658119|NCT01900899|466707487|FG001|Overall Study|Withdrawal by Subject|1|||
129658120|NCT01900899|466707486|FG000|Overall Study|Migrated from study area|2|||
129658121|NCT01900899|466707487|FG001|Overall Study|Migrated from study area|0|||
129658122|NCT00248833|466707488|FG000|Overall Study|Adverse Event|2|||
129658123|NCT00248833|466707489|FG001|Overall Study|Adverse Event|0|||
129658124|NCT00248833|466707490|FG002|Overall Study|Adverse Event|0|||
129658125|NCT00248833|466707488|FG000|Overall Study|Withdrawal by Subject|0|||
129658126|NCT00248833|466707489|FG001|Overall Study|Withdrawal by Subject|1|||
129658127|NCT00248833|466707490|FG002|Overall Study|Withdrawal by Subject|1|||
129658128|NCT00248833|466707488|FG000|Overall Study|Lost to Follow-up|1|||
129658129|NCT00248833|466707489|FG001|Overall Study|Lost to Follow-up|1|||
129658130|NCT00248833|466707490|FG002|Overall Study|Lost to Follow-up|1|||
129658131|NCT00248833|466707488|FG000|Overall Study|Other|0|||
129658132|NCT00248833|466707489|FG001|Overall Study|Other|1|||
129658133|NCT00248833|466707490|FG002|Overall Study|Other|0|||
129658134|NCT00723697|466707493|FG000|Overall Study|Physician questionnaires not received|2|||
129658135|NCT00723697|466707493|FG000|Overall Study|Missing Informed Consent Form|10|||
129658136|NCT00723697|466707493|FG000|Overall Study|Other exclusion criteria applied|6|||
129658137|NCT00467558|466707496|FG000|Overall Study|Lost to Follow-up|2|||
129658138|NCT00467558|466707497|FG001|Overall Study|Lost to Follow-up|0|||
129658139|NCT05188729|466707498|FG000|Overall Study|Withdrawal by Subject|0|||
129658140|NCT05188729|466707499|FG001|Overall Study|Withdrawal by Subject|0|||
129658141|NCT05188729|466707500|FG002|Overall Study|Withdrawal by Subject|0|||
129658142|NCT05188729|466707501|FG003|Overall Study|Withdrawal by Subject|0|||
129988282|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988283|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988284|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
129988285|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
129988286|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129658143|NCT05188729|466707502|FG004|Overall Study|Withdrawal by Subject|0|||
129658144|NCT05188729|466707503|FG005|Overall Study|Withdrawal by Subject|0|||
129658145|NCT05188729|466707504|FG006|Overall Study|Withdrawal by Subject|0|||
129658146|NCT05188729|466707505|FG007|Overall Study|Withdrawal by Subject|0|||
129658147|NCT05188729|466707506|FG008|Overall Study|Withdrawal by Subject|0|||
129658148|NCT05188729|466707507|FG009|Overall Study|Withdrawal by Subject|1|||
129658149|NCT05188729|466707508|FG010|Overall Study|Withdrawal by Subject|0|||
129658150|NCT05188729|466707509|FG011|Overall Study|Withdrawal by Subject|0|||
129658151|NCT05188729|466707510|FG012|Overall Study|Withdrawal by Subject|0|||
129658152|NCT05188729|466707498|FG000|Overall Study|Lost to Follow-up|0|||
129658153|NCT05188729|466707499|FG001|Overall Study|Lost to Follow-up|0|||
129658154|NCT05188729|466707500|FG002|Overall Study|Lost to Follow-up|0|||
129658155|NCT05188729|466707501|FG003|Overall Study|Lost to Follow-up|0|||
129658156|NCT05188729|466707502|FG004|Overall Study|Lost to Follow-up|0|||
129658157|NCT05188729|466707503|FG005|Overall Study|Lost to Follow-up|0|||
129658158|NCT05188729|466707504|FG006|Overall Study|Lost to Follow-up|0|||
129988287|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988288|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988289|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
129988290|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
129988291|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
129988292|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
129988293|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988294|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
129988295|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988296|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988297|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988298|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
129988299|NCT03149549|467918892|FG000|Study Discontinuation--Treatment Period|Other|0|||
129988300|NCT03149549|467918893|FG001|Study Discontinuation--Treatment Period|Other|0|||
129988301|NCT03149549|467918894|FG002|Study Discontinuation--Treatment Period|Other|0|||
129988302|NCT03149549|467918895|FG003|Study Discontinuation--Treatment Period|Other|0|||
129988303|NCT03149549|467918896|FG004|Study Discontinuation--Treatment Period|Other|0|||
129658159|NCT05188729|466707505|FG007|Overall Study|Lost to Follow-up|0|||
129658160|NCT05188729|466707506|FG008|Overall Study|Lost to Follow-up|0|||
129658161|NCT05188729|466707507|FG009|Overall Study|Lost to Follow-up|0|||
129658162|NCT05188729|466707508|FG010|Overall Study|Lost to Follow-up|1|||
129658163|NCT05188729|466707509|FG011|Overall Study|Lost to Follow-up|1|||
129658164|NCT05188729|466707510|FG012|Overall Study|Lost to Follow-up|0|||
129658165|NCT02164318|466709572|FG000|Overall Study|Withdrawal by Subject|0|||
129988304|NCT03149549|467918897|FG005|Study Discontinuation--Treatment Period|Other|0|||
129988305|NCT03149549|467918898|FG006|Study Discontinuation--Treatment Period|Other|0|||
129988306|NCT03149549|467918899|FG007|Study Discontinuation--Treatment Period|Other|1|||
129988307|NCT03149549|467918900|FG008|Study Discontinuation--Treatment Period|Other|0|||
129988308|NCT03149549|467918901|FG009|Study Discontinuation--Treatment Period|Other|1|||
129988309|NCT03149549|467918902|FG010|Study Discontinuation--Treatment Period|Other|0|||
129988310|NCT03149549|467918903|FG011|Study Discontinuation--Treatment Period|Other|0|||
129988311|NCT03149549|467918904|FG012|Study Discontinuation--Treatment Period|Other|0|||
129988312|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988313|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988314|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988315|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988316|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988317|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
129988318|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
129988319|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988320|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
129988321|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988322|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988323|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988324|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
129988325|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988326|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988327|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988328|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988329|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
129988330|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988331|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988332|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
129988333|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
129988334|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988335|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
129988336|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
129988337|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
129988338|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988339|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988340|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988341|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988342|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988343|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988344|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988345|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
129988346|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988347|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988348|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
129988349|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
129988350|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
129988351|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
129988352|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
129988353|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
129988354|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
129988355|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
129988356|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
129988357|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
129988358|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
129988359|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
129988360|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
129988361|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
129988362|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
129658166|NCT02164318|466709573|FG001|Overall Study|Withdrawal by Subject|1|||
129658167|NCT02164318|466709574|FG002|Overall Study|Withdrawal by Subject|0|||
129658168|NCT02164318|466709575|FG003|Overall Study|Withdrawal by Subject|1|||
129658169|NCT03084302|466709580|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
129658170|NCT03084302|466709580|FG000|Overall Study|No valid objective monitor data|6|||
129658171|NCT00929994|466709581|FG000|Overall Study|Withdrawal by Subject|1|||
129658172|NCT00929994|466709581|FG000|Overall Study|medical issue unrelated to intervention|4|||
129658173|NCT00929994|466709581|FG000|Overall Study|employment|1|||
129658174|NCT01214668|466709582|FG000|Overall Study|Adverse Event|0|||
129658175|NCT01214668|466709583|FG001|Overall Study|Adverse Event|1|||
129658176|NCT01214668|466709584|FG002|Overall Study|Adverse Event|0|||
129658177|NCT01214668|466709585|FG003|Overall Study|Adverse Event|2|||
129658178|NCT01214668|466709586|FG004|Overall Study|Adverse Event|1|||
129658179|NCT01214668|466709587|FG005|Overall Study|Adverse Event|1|||
129658180|NCT01214668|466709582|FG000|Overall Study|Death|0|||
129658181|NCT01214668|466709583|FG001|Overall Study|Death|0|||
129658182|NCT01214668|466709584|FG002|Overall Study|Death|1|||
129658183|NCT01214668|466709585|FG003|Overall Study|Death|0|||
129658184|NCT01214668|466709586|FG004|Overall Study|Death|0|||
129658185|NCT01214668|466709587|FG005|Overall Study|Death|0|||
129658186|NCT01214668|466709582|FG000|Overall Study|Progressive Disease|4|||
129658187|NCT01214668|466709583|FG001|Overall Study|Progressive Disease|2|||
129658188|NCT01214668|466709584|FG002|Overall Study|Progressive Disease|5|||
129658189|NCT01214668|466709585|FG003|Overall Study|Progressive Disease|4|||
129658190|NCT01214668|466709586|FG004|Overall Study|Progressive Disease|4|||
129658191|NCT01214668|466709587|FG005|Overall Study|Progressive Disease|5|||
129658192|NCT01214668|466709582|FG000|Overall Study|Withdrawal by Subject|0|||
129658193|NCT01214668|466709583|FG001|Overall Study|Withdrawal by Subject|0|||
129658194|NCT01214668|466709584|FG002|Overall Study|Withdrawal by Subject|0|||
129658195|NCT01214668|466709585|FG003|Overall Study|Withdrawal by Subject|0|||
129658196|NCT01214668|466709586|FG004|Overall Study|Withdrawal by Subject|1|||
129658197|NCT01214668|466709587|FG005|Overall Study|Withdrawal by Subject|0|||
129658198|NCT01964989|466709588|FG000|Overall Study|Protocol Violation|3|||
129658199|NCT01964989|466709589|FG001|Overall Study|Protocol Violation|4|||
129658200|NCT01964989|466709588|FG000|Overall Study|Administrative Reason|103|||
129658201|NCT01964989|466709589|FG001|Overall Study|Administrative Reason|95|||
129658202|NCT01964989|466709588|FG000|Overall Study|Adverse Event|0|||
129658203|NCT01964989|466709589|FG001|Overall Study|Adverse Event|1|||
129658204|NCT01964989|466709588|FG000|Overall Study|Death|1|||
129658205|NCT01964989|466709589|FG001|Overall Study|Death|3|||
129658206|NCT01964989|466709588|FG000|Overall Study|Withdrawal by Subject|156|||
129658207|NCT01964989|466709589|FG001|Overall Study|Withdrawal by Subject|160|||
129658208|NCT01964989|466709588|FG000|Overall Study|Lost to Follow-up|254|||
129658209|NCT01964989|466709589|FG001|Overall Study|Lost to Follow-up|232|||
129658210|NCT01964989|466709588|FG000|Overall Study|Other|267|||
129658211|NCT01964989|466709589|FG001|Overall Study|Other|252|||
129658212|NCT00424593|466709590|FG000|Acute Double-Blind Period|Adverse Event|16|||
129658213|NCT00424593|466709591|FG001|Acute Double-Blind Period|Adverse Event|7|||
129658214|NCT00424593|466709590|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
129658215|NCT00424593|466709591|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
129658216|NCT00424593|466709590|FG000|Acute Double-Blind Period|Protocol Violation|2|||
129658217|NCT00424593|466709591|FG001|Acute Double-Blind Period|Protocol Violation|2|||
129658218|NCT00424593|466709590|FG000|Acute Double-Blind Period|Physician Decision|1|||
129658219|NCT00424593|466709591|FG001|Acute Double-Blind Period|Physician Decision|2|||
129658220|NCT00424593|466709590|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
129658221|NCT00424593|466709591|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
129658222|NCT00424593|466709590|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
129658223|NCT00424593|466709591|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
129658224|NCT00424593|466709590|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
129658225|NCT00424593|466709591|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
129658226|NCT00424593|466709590|FG000|Dose-Blind Extension Period|Adverse Event|18|||
129658227|NCT00424593|466709591|FG001|Dose-Blind Extension Period|Adverse Event|0|||
129658228|NCT00424593|466709590|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
129658229|NCT00424593|466709591|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
129658230|NCT00424593|466709590|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
129658231|NCT00424593|466709591|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
129658232|NCT00424593|466709590|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
129658233|NCT00424593|466709591|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
129988363|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
129988364|NCT03149549|467918892|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
129658234|NCT00424593|466709590|FG000|Dose-Blind Extension Period|Physician Decision|3|||
129658235|NCT00424593|466709591|FG001|Dose-Blind Extension Period|Physician Decision|0|||
129988365|NCT03149549|467918893|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
129546307|NCT00604175|466292469|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
129658236|NCT01796301|466709592|FG000|Overall Study|Withdrawal by Subject|15|||
129658237|NCT01796301|466709593|FG001|Overall Study|Withdrawal by Subject|15|||
129658238|NCT01796301|466709592|FG000|Overall Study|Lost to Follow-up|3|||
129658239|NCT01796301|466709593|FG001|Overall Study|Lost to Follow-up|3|||
129658240|NCT01796301|466709592|FG000|Overall Study|Death|0|||
129658241|NCT01796301|466709593|FG001|Overall Study|Death|1|||
129658242|NCT01796301|466709592|FG000|Overall Study|Decision by Sponsor|0|||
129658243|NCT01796301|466709593|FG001|Overall Study|Decision by Sponsor|1|||
129658244|NCT00667563|466709594|FG000|Overall Study|Protocol Violation|24|||
129988366|NCT03149549|467918894|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
129988367|NCT03149549|467918895|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
129988368|NCT03149549|467918896|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
129988369|NCT03149549|467918897|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
129988370|NCT03149549|467918898|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
129988371|NCT03149549|467918899|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
129988372|NCT03149549|467918900|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
129988373|NCT03149549|467918901|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
129988374|NCT03149549|467918902|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
129988375|NCT03149549|467918903|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
129988376|NCT03149549|467918904|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
129988377|NCT00812331|467920994|FG000|Overall Study|Adverse Event|1|||
129988378|NCT00812331|467920995|FG001|Overall Study|Adverse Event|0|||
129988379|NCT00812331|467920996|FG002|Overall Study|Adverse Event|0|||
129988380|NCT00812331|467920997|FG003|Overall Study|Adverse Event|0|||
129988381|NCT00812331|467920998|FG004|Overall Study|Adverse Event|0|||
129988382|NCT01506453|467920999|FG000|Overall Study|Withdrawal prior to treatment|0|||
129988383|NCT01506453|467921000|FG001|Overall Study|Withdrawal prior to treatment|2|||
129988384|NCT00910689|467921008|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
129658245|NCT02187029|466709595|FG000|Overall Study|Adverse Event|0|||
129658246|NCT02187029|466709596|FG001|Overall Study|Adverse Event|1|||
129658247|NCT02187029|466709597|FG002|Overall Study|Adverse Event|1|||
129658248|NCT02187029|466709598|FG003|Overall Study|Adverse Event|0|||
129658249|NCT02187029|466709595|FG000|Overall Study|Study Terminated by Sponsor|0|||
129658250|NCT02187029|466709596|FG001|Overall Study|Study Terminated by Sponsor|0|||
129658251|NCT02187029|466709597|FG002|Overall Study|Study Terminated by Sponsor|10|||
129988385|NCT00910689|467921009|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
129988386|NCT00910689|467921010|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
129658252|NCT02187029|466709598|FG003|Overall Study|Study Terminated by Sponsor|3|||
129988387|NCT00910689|467921011|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
129988388|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
129988389|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
129988390|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
129988391|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
129988392|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
129988393|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
129988394|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
129988395|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
129988396|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
129988397|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
129988398|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
129988399|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
129988400|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
129658253|NCT02187029|466709595|FG000|Overall Study|Withdrawal by Subject|1|||
129658254|NCT02187029|466709596|FG001|Overall Study|Withdrawal by Subject|0|||
129658255|NCT02187029|466709597|FG002|Overall Study|Withdrawal by Subject|0|||
129658256|NCT02187029|466709598|FG003|Overall Study|Withdrawal by Subject|0|||
129658257|NCT03042910|466709600|FG000|Overall Study|Adverse Event|1|||
129658258|NCT03042910|466709600|FG000|Overall Study|Disease Progression|2|||
129658259|NCT03042910|466709600|FG000|Overall Study|Withdrawal by Subject|3|||
129658260|NCT03042910|466709600|FG000|Overall Study|Enrolled but not treated|1|||
129658261|NCT02756819|466709604|FG000|Overall Study|Lost for observation|23|||
129658262|NCT02756819|466709604|FG000|Overall Study|Patient's unwillingness|16|||
129658263|NCT02756819|466709604|FG000|Overall Study|Insufficient efficacy|2|||
129658264|NCT02756819|466709604|FG000|Overall Study|Adverse Event|2|||
129658265|NCT02756819|466709604|FG000|Overall Study|Reason not Specified|9|||
129658266|NCT01491841|466709606|FG000|Overall Study|Screen Failure|10|||
129658267|NCT01491841|466709606|FG000|Overall Study|Withdrawal by Subject|1|||
129658268|NCT02933528|466709607|FG000|Overall Study|Lost to Follow-up|2|||
129658269|NCT01301079|466709608|FG000|Overall Study|Lost to Follow-up|2|||
129988401|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
129988402|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
129988403|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
129988404|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
129988405|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
129988406|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
129988407|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
129658270|NCT01301079|466709609|FG001|Overall Study|Lost to Follow-up|2|||
129658271|NCT00264290|466709613|FG000|Intervention (8 Weeks)|Adverse Event|1|||
129658272|NCT00264290|466709614|FG001|Intervention (8 Weeks)|Adverse Event|0|||
129658273|NCT02496039|466709615|FG000|Overall Study|Adverse Event|3|||
129658274|NCT02496039|466709615|FG000|Overall Study|Protocol Violation|1|||
129658275|NCT04472494|466709616|FG000|Pre-treatment|Other reasons|2|||
129658276|NCT04472494|466709617|FG001|Pre-treatment|Other reasons|0|||
129658277|NCT04472494|466709616|FG000|Treatment|Death|5|||
129658278|NCT04472494|466709617|FG001|Treatment|Death|2|||
129658279|NCT04472494|466709616|FG000|Treatment|Hospital discharge|1|||
129658280|NCT04472494|466709617|FG001|Treatment|Hospital discharge|1|||
129658281|NCT00571103|466709618|FG000|Overall Study|Withdrawal by Subject|1|||
129658282|NCT00571103|466709618|FG000|Overall Study|Lost to Follow-up|1|||
129658283|NCT01308463|466709619|FG000|Overall Study|Study Discontinued|23|||
129658284|NCT01308463|466709619|FG000|Overall Study|Death|4|||
129658285|NCT01308463|466709619|FG000|Overall Study|Revision|2|||
129658286|NCT02784288|466709620|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
129658287|NCT02734862|466709621|FG000|Part A|Death|3|||
129658288|NCT02734862|466709622|FG001|Part A|Death|4|||
129658289|NCT02734862|466709623|FG002|Part A|Death|6|||
129658290|NCT02734862|466709621|FG000|Part A|Lost to Follow-up|2|||
129658291|NCT02734862|466709622|FG001|Part A|Lost to Follow-up|1|||
129658292|NCT02734862|466709623|FG002|Part A|Lost to Follow-up|1|||
129658293|NCT02734862|466709621|FG000|Part A|Withdrawal by Subject|1|||
129658294|NCT02734862|466709622|FG001|Part A|Withdrawal by Subject|1|||
129658295|NCT02734862|466709623|FG002|Part A|Withdrawal by Subject|2|||
129658296|NCT02734862|466709621|FG000|Part A|Physician Decision|2|||
129658297|NCT02734862|466709622|FG001|Part A|Physician Decision|0|||
129658298|NCT02734862|466709623|FG002|Part A|Physician Decision|1|||
129658299|NCT02734862|466709621|FG000|Part A|Adverse Event|2|||
129658300|NCT02734862|466709622|FG001|Part A|Adverse Event|0|||
129658301|NCT02734862|466709623|FG002|Part A|Adverse Event|1|||
129658302|NCT02734862|466709621|FG000|Part A|Noncompliance|1|||
129658303|NCT02734862|466709622|FG001|Part A|Noncompliance|1|||
129658304|NCT02734862|466709623|FG002|Part A|Noncompliance|0|||
129658305|NCT02734862|466709621|FG000|Part A|Other|1|||
129658306|NCT02734862|466709622|FG001|Part A|Other|1|||
129658307|NCT02734862|466709623|FG002|Part A|Other|3|||
129658308|NCT02734862|466709621|FG000|Part B|Death|8|||
129658309|NCT02734862|466709622|FG001|Part B|Death|3|||
129658310|NCT02734862|466709623|FG002|Part B|Death|5|||
129658311|NCT02734862|466709621|FG000|Part B|Lost to Follow-up|2|||
129658312|NCT02734862|466709622|FG001|Part B|Lost to Follow-up|2|||
129658313|NCT02734862|466709623|FG002|Part B|Lost to Follow-up|0|||
129658314|NCT02734862|466709621|FG000|Part B|Withdrawal by Subject|3|||
129658315|NCT02734862|466709622|FG001|Part B|Withdrawal by Subject|1|||
129658316|NCT02734862|466709623|FG002|Part B|Withdrawal by Subject|0|||
129658317|NCT02734862|466709621|FG000|Part B|Other|0|||
129658318|NCT02734862|466709622|FG001|Part B|Other|1|||
129658319|NCT02734862|466709623|FG002|Part B|Other|0|||
129658320|NCT02131233|466709624|FG000|Overall Study|Not Treated|2|||
129658321|NCT02131233|466709625|FG001|Overall Study|Not Treated|3|||
129658322|NCT02131233|466709624|FG000|Overall Study|Adverse Event|7|||
129658323|NCT02131233|466709625|FG001|Overall Study|Adverse Event|6|||
129658324|NCT02131233|466709624|FG000|Overall Study|Death|0|||
129658325|NCT02131233|466709625|FG001|Overall Study|Death|1|||
129658326|NCT02131233|466709624|FG000|Overall Study|Lack of Efficacy|6|||
129658327|NCT02131233|466709625|FG001|Overall Study|Lack of Efficacy|3|||
129658328|NCT02131233|466709624|FG000|Overall Study|Lost to Follow-up|14|||
129658329|NCT02131233|466709625|FG001|Overall Study|Lost to Follow-up|13|||
129658330|NCT02131233|466709624|FG000|Overall Study|Non-Compliance With Study Drug|8|||
129658331|NCT02131233|466709625|FG001|Overall Study|Non-Compliance With Study Drug|5|||
129658332|NCT02131233|466709624|FG000|Overall Study|Physician Decision|7|||
129883549|NCT01017120|467534332|FG000|Overall Study|Relocated Out of Town|0|||
129883550|NCT01017120|467534333|FG001|Overall Study|Relocated Out of Town|2|||
129883551|NCT01017120|467534332|FG000|Overall Study|Protocol Violation|1|||
129883552|NCT01017120|467534333|FG001|Overall Study|Protocol Violation|0|||
129883553|NCT01017120|467534332|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
129883554|NCT01017120|467534333|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
129883555|NCT01087723|467534334|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
129883556|NCT01087723|467534335|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
129883557|NCT01087723|467534334|FG000|Overall Study|Withdrawal by Subject|10|||
129988408|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
129658333|NCT02131233|466709625|FG001|Overall Study|Physician Decision|0|||
129658334|NCT02131233|466709624|FG000|Overall Study|Pregnancy|4|||
129883558|NCT01087723|467534335|FG001|Overall Study|Withdrawal by Subject|13|||
129658335|NCT02131233|466709625|FG001|Overall Study|Pregnancy|0|||
129658336|NCT02131233|466709624|FG000|Overall Study|Withdrawal by Subject|18|||
129658337|NCT02131233|466709625|FG001|Overall Study|Withdrawal by Subject|11|||
129658338|NCT00217581|466709634|FG000|Overall Study|Withdrawal by Subject|1|||
129658339|NCT04399889|466709635|FG000|Overall Study|Death|5|||
129658340|NCT04399889|466709636|FG001|Overall Study|Death|1|||
129658341|NCT04399889|466709637|FG002|Overall Study|Death|1|||
129658342|NCT01005901|466709638|FG000|Overall Study|Withdrawal by Subject|38|||
129658343|NCT01005901|466709639|FG001|Overall Study|Withdrawal by Subject|14|||
129658344|NCT01005901|466709638|FG000|Overall Study|Adverse Event|30|||
129658345|NCT01005901|466709639|FG001|Overall Study|Adverse Event|16|||
129658346|NCT01005901|466709638|FG000|Overall Study|Administrative problems|21|||
129883559|NCT01087723|467534334|FG000|Overall Study|Physician Decision|2|||
129658347|NCT01005901|466709639|FG001|Overall Study|Administrative problems|13|||
129658348|NCT01005901|466709638|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129658349|NCT01005901|466709639|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
129658350|NCT01005901|466709638|FG000|Overall Study|Protocol Violation|4|||
129658351|NCT01005901|466709639|FG001|Overall Study|Protocol Violation|3|||
129658352|NCT01005901|466709638|FG000|Overall Study|Death|2|||
129658353|NCT01005901|466709639|FG001|Overall Study|Death|3|||
129658354|NCT01005901|466709638|FG000|Overall Study|Lost to Follow-up|1|||
129658355|NCT01005901|466709639|FG001|Overall Study|Lost to Follow-up|2|||
129658356|NCT01005901|466709638|FG000|Overall Study|Patient's inability to use the device|1|||
129658357|NCT01005901|466709639|FG001|Overall Study|Patient's inability to use the device|1|||
129658358|NCT01005901|466709638|FG000|Overall Study|No longer requires study drug|0|||
129658359|NCT01005901|466709639|FG001|Overall Study|No longer requires study drug|1|||
129658360|NCT00760487|466709640|FG000|Overall Study|Unilateral implantation|3|||
129658361|NCT06360588|466709641|FG000|Overall Study|Adverse Event|3|||
129658362|NCT06360588|466709641|FG000|Overall Study|Death|2|||
129658363|NCT06360588|466709641|FG000|Overall Study|Disease Progression|14|||
129658364|NCT06360588|466709641|FG000|Overall Study|Withdrawal by Subject|1|||
129658365|NCT06360588|466709641|FG000|Overall Study|Lack of Efficacy|1|||
129658366|NCT06360588|466709641|FG000|Overall Study|Ineligible|1|||
129658367|NCT02087943|466709643|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
129658368|NCT02087943|466709644|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
129658369|NCT02087943|466709645|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
129658370|NCT02087943|466709646|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
129658371|NCT02087943|466709647|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
129988409|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
129988410|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
129988411|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
129988412|NCT00910689|467921008|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
129988413|NCT00910689|467921009|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
129658372|NCT02087943|466709643|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
129658373|NCT02087943|466709644|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
129658374|NCT02087943|466709645|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
129658375|NCT02087943|466709646|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
129658376|NCT02087943|466709647|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
129658377|NCT02087943|466709643|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
129658378|NCT02087943|466709644|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
129658379|NCT02087943|466709645|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
129658380|NCT02087943|466709646|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
129658381|NCT02087943|466709647|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
129658382|NCT02087943|466709643|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
129658383|NCT02087943|466709644|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
129658384|NCT02087943|466709645|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
129988414|NCT00910689|467921010|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
129988415|NCT00910689|467921011|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
129988416|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
129988417|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
129988418|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
129988419|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
129988420|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
129988421|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
129988422|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
129988423|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
129988424|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
129988425|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
129988426|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
129988427|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
129988428|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
129988429|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
129658385|NCT02087943|466709646|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
129658386|NCT02087943|466709647|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
129658387|NCT02087943|466709643|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129658388|NCT02087943|466709644|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
129658389|NCT02087943|466709645|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129658390|NCT02087943|466709646|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129546308|NCT00604175|466292470|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
129658391|NCT02087943|466709647|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
129658392|NCT02087943|466709643|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
129988430|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
129988431|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
129658393|NCT02087943|466709644|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
129658394|NCT02087943|466709645|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
129658395|NCT02087943|466709646|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
129658396|NCT02087943|466709647|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
129658397|NCT02087943|466709643|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
129658398|NCT02087943|466709644|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
129988432|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
129988433|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
129988434|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
129988435|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
129988436|NCT00910689|467921008|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
129988437|NCT00910689|467921009|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
129988438|NCT00910689|467921010|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
129988439|NCT00910689|467921011|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
129988440|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
129988441|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
129988442|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
129988443|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
129658399|NCT02087943|466709645|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
129658400|NCT02087943|466709646|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
129658401|NCT02087943|466709647|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
129658402|NCT02087943|466709643|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129658403|NCT02087943|466709644|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129658404|NCT02087943|466709645|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
129883560|NCT01087723|467534335|FG001|Overall Study|Physician Decision|0|||
129883561|NCT01087723|467534334|FG000|Overall Study|Lost to Follow-up|1|||
129883562|NCT01087723|467534335|FG001|Overall Study|Lost to Follow-up|4|||
129883563|NCT01087723|467534334|FG000|Overall Study|Reason Not Specified|1|||
129883564|NCT01087723|467534335|FG001|Overall Study|Reason Not Specified|2|||
129883565|NCT00806624|467534336|FG000|Overall Study|Adverse Event|2|||
129883566|NCT00806624|467534337|FG001|Overall Study|Adverse Event|8|||
129883567|NCT00806624|467534338|FG002|Overall Study|Adverse Event|0|||
129883568|NCT00806624|467534336|FG000|Overall Study|Death|0|||
129883569|NCT00806624|467534337|FG001|Overall Study|Death|1|||
129883570|NCT00806624|467534338|FG002|Overall Study|Death|1|||
129883571|NCT00806624|467534336|FG000|Overall Study|Lost to Follow-up|1|||
129883572|NCT00806624|467534337|FG001|Overall Study|Lost to Follow-up|0|||
129883573|NCT00806624|467534338|FG002|Overall Study|Lost to Follow-up|1|||
129883574|NCT00806624|467534336|FG000|Overall Study|Withdrawal by Subject|6|||
129883575|NCT00806624|467534337|FG001|Overall Study|Withdrawal by Subject|3|||
129883576|NCT00806624|467534338|FG002|Overall Study|Withdrawal by Subject|3|||
129883577|NCT00806624|467534336|FG000|Overall Study|discontinued before start of treatment|0|||
129883578|NCT00806624|467534337|FG001|Overall Study|discontinued before start of treatment|0|||
129883579|NCT00806624|467534338|FG002|Overall Study|discontinued before start of treatment|1|||
129883580|NCT01702428|467534340|FG000|Overall Study|Adverse Event|2|||
129883581|NCT01702428|467534341|FG001|Overall Study|Adverse Event|0|||
129883582|NCT01702428|467534342|FG002|Overall Study|Adverse Event|0|||
129883583|NCT01702428|467534343|FG003|Overall Study|Adverse Event|0|||
129883584|NCT01702428|467534340|FG000|Overall Study|Lost to Follow-up|33|||
129883585|NCT01702428|467534341|FG001|Overall Study|Lost to Follow-up|41|||
129883586|NCT01702428|467534342|FG002|Overall Study|Lost to Follow-up|37|||
129883587|NCT01702428|467534343|FG003|Overall Study|Lost to Follow-up|44|||
129883588|NCT01702428|467534340|FG000|Overall Study|Parents cannot assist to site|1|||
129883589|NCT01702428|467534341|FG001|Overall Study|Parents cannot assist to site|0|||
129883590|NCT01702428|467534342|FG002|Overall Study|Parents cannot assist to site|1|||
129883591|NCT01702428|467534343|FG003|Overall Study|Parents cannot assist to site|0|||
129883592|NCT01702428|467534340|FG000|Overall Study|Lost Coverage|0|||
129883593|NCT01702428|467534341|FG001|Overall Study|Lost Coverage|0|||
129883594|NCT01702428|467534342|FG002|Overall Study|Lost Coverage|0|||
129883595|NCT01702428|467534343|FG003|Overall Study|Lost Coverage|1|||
129883596|NCT01702428|467534340|FG000|Overall Study|Lost Health Plan|3|||
129883597|NCT01702428|467534341|FG001|Overall Study|Lost Health Plan|5|||
129883598|NCT01702428|467534342|FG002|Overall Study|Lost Health Plan|0|||
129883599|NCT01702428|467534343|FG003|Overall Study|Lost Health Plan|2|||
129883600|NCT01702428|467534340|FG000|Overall Study|Mother transferred care|0|||
129883601|NCT01702428|467534341|FG001|Overall Study|Mother transferred care|1|||
129883602|NCT01702428|467534342|FG002|Overall Study|Mother transferred care|0|||
129883603|NCT01702428|467534343|FG003|Overall Study|Mother transferred care|0|||
129883604|NCT01702428|467534340|FG000|Overall Study|Parents too busy|1|||
129883605|NCT01702428|467534341|FG001|Overall Study|Parents too busy|0|||
129883606|NCT01702428|467534342|FG002|Overall Study|Parents too busy|0|||
129883607|NCT01702428|467534343|FG003|Overall Study|Parents too busy|0|||
129883608|NCT01702428|467534340|FG000|Overall Study|Protocol Violation|3|||
129883609|NCT01702428|467534341|FG001|Overall Study|Protocol Violation|0|||
129988444|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
129988445|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
129988446|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
129988447|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
129988448|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
129988449|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
129988450|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
129988451|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
129988452|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
129988453|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
129988454|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
129988455|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
129988456|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
129988457|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
129988458|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
129988459|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
129988460|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
129988461|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
129988462|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
129988463|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
129988464|NCT00910689|467921008|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
129988465|NCT00910689|467921009|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
129988466|NCT00910689|467921010|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
129988467|NCT00910689|467921011|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
129988468|NCT00484289|467921017|FG000|Long Term Phase|Adverse Event|1|||
129988469|NCT00484289|467921018|FG001|Long Term Phase|Adverse Event|17|||
129883610|NCT01702428|467534342|FG002|Overall Study|Protocol Violation|1|||
129883611|NCT01702428|467534343|FG003|Overall Study|Protocol Violation|0|||
129883612|NCT01702428|467534340|FG000|Overall Study|Withdrawal by Subject|21|||
129883613|NCT01702428|467534341|FG001|Overall Study|Withdrawal by Subject|23|||
129883614|NCT01702428|467534342|FG002|Overall Study|Withdrawal by Subject|14|||
129883615|NCT01702428|467534343|FG003|Overall Study|Withdrawal by Subject|10|||
129883616|NCT00154063|467534346|FG000|Overall Study|Adverse Event|4|||
129883617|NCT00154063|467534347|FG001|Overall Study|Adverse Event|8|||
129883618|NCT00154063|467534346|FG000|Overall Study|Protocol Violation|1|||
129883619|NCT00154063|467534347|FG001|Overall Study|Protocol Violation|1|||
129883620|NCT00154063|467534346|FG000|Overall Study|Investigator or Sponsor Request|0|||
129883621|NCT00154063|467534347|FG001|Overall Study|Investigator or Sponsor Request|1|||
129883622|NCT00154063|467534346|FG000|Overall Study|Withdrawal by Subject|4|||
129883623|NCT00154063|467534347|FG001|Overall Study|Withdrawal by Subject|9|||
129883624|NCT00154063|467534346|FG000|Overall Study|Other|3|||
129883625|NCT00154063|467534347|FG001|Overall Study|Other|3|||
129883626|NCT02091869|467534348|FG000|Overall Study|Withdrawal by Subject|0|||
129883627|NCT02091869|467534349|FG001|Overall Study|Withdrawal by Subject|3|||
129883628|NCT00451217|467534358|FG000|Overall Study|Lost to Follow-up|0|||
129883629|NCT00451217|467534359|FG001|Overall Study|Lost to Follow-up|1|||
129883630|NCT00451217|467534360|FG002|Overall Study|Lost to Follow-up|1|||
129883631|NCT00451217|467534361|FG003|Overall Study|Lost to Follow-up|1|||
129883632|NCT00451217|467534358|FG000|Overall Study|Withdrawal by Subject|1|||
129883633|NCT00451217|467534359|FG001|Overall Study|Withdrawal by Subject|0|||
129883634|NCT00451217|467534360|FG002|Overall Study|Withdrawal by Subject|0|||
129883635|NCT00451217|467534361|FG003|Overall Study|Withdrawal by Subject|0|||
129883636|NCT00451217|467534358|FG000|Overall Study|Not Treated|1|||
129883637|NCT00451217|467534359|FG001|Overall Study|Not Treated|1|||
129883638|NCT00451217|467534360|FG002|Overall Study|Not Treated|3|||
129883639|NCT00451217|467534361|FG003|Overall Study|Not Treated|4|||
129883640|NCT00467142|467534363|FG000|Overall Study|Withdrawal by Subject|1|||
129883641|NCT00467142|467534363|FG000|Overall Study|Adverse Event|1|||
129883642|NCT00467142|467534363|FG000|Overall Study|Protocol Violation|1|||
129883643|NCT02406261|467534364|FG000|Period 1|Lost to Follow-up|2|||
129883644|NCT02406261|467534365|FG001|Period 1|Lost to Follow-up|0|||
129883645|NCT02406261|467534364|FG000|Period 1|Adverse Event|1|||
129883646|NCT02406261|467534365|FG001|Period 1|Adverse Event|0|||
129883647|NCT02406261|467534364|FG000|Period 2|Physician Decision|0|||
129883648|NCT02406261|467534365|FG001|Period 2|Physician Decision|1|||
129883649|NCT02406261|467534364|FG000|Period 2|Protocol Violation|0|||
129883650|NCT02406261|467534365|FG001|Period 2|Protocol Violation|1|||
129883651|NCT02406261|467534364|FG000|Period 2|Withdrawal by Subject|0|||
129883652|NCT02406261|467534365|FG001|Period 2|Withdrawal by Subject|1|||
129883653|NCT02761629|467534372|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
129883654|NCT02761629|467534373|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
129883655|NCT02761629|467534372|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129883656|NCT02761629|467534373|FG001|Overall Study|Insufficient Therapeutic Response|7|||
129658405|NCT02087943|466709646|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129658406|NCT02087943|466709647|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
129658407|NCT02087943|466709643|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129658408|NCT02087943|466709644|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129658409|NCT02087943|466709645|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129658410|NCT02087943|466709646|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
129658411|NCT02087943|466709647|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
129658412|NCT02087943|466709643|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
129658413|NCT02087943|466709644|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
129658414|NCT02087943|466709645|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
129658415|NCT02087943|466709646|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
129658416|NCT02087943|466709647|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
129658417|NCT01690299|466709648|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
129658418|NCT01690299|466709649|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
129658419|NCT01690299|466709650|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
129658420|NCT01690299|466709651|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
129658421|NCT01690299|466709652|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
129658422|NCT01690299|466709653|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
129658423|NCT01690299|466709648|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
129658424|NCT01690299|466709649|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129658425|NCT01690299|466709650|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129658426|NCT01690299|466709651|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129658427|NCT01690299|466709652|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129658428|NCT01690299|466709653|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129658429|NCT01690299|466709648|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
129658430|NCT01690299|466709649|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
129658431|NCT01690299|466709650|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129658432|NCT01690299|466709651|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129658433|NCT01690299|466709652|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129658434|NCT01690299|466709653|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129658435|NCT01690299|466709648|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
129658436|NCT01690299|466709649|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
129658437|NCT01690299|466709650|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
129658438|NCT01690299|466709651|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
129658439|NCT01690299|466709652|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
129658440|NCT01690299|466709653|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
129658441|NCT01690299|466709648|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
129658442|NCT01690299|466709649|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
129658443|NCT01690299|466709650|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
129658444|NCT01690299|466709651|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
129658445|NCT01690299|466709652|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
129658446|NCT01690299|466709653|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
129658447|NCT01690299|466709648|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
129658448|NCT01690299|466709649|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
129658449|NCT01690299|466709650|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
129658450|NCT01690299|466709651|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
129658451|NCT01690299|466709652|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
129658452|NCT01690299|466709653|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
129658453|NCT01690299|466709648|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129883657|NCT02761629|467534372|FG000|Overall Study|Failure to Return|2|||
129883658|NCT02761629|467534373|FG001|Overall Study|Failure to Return|4|||
129883659|NCT02761629|467534372|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
129883660|NCT02761629|467534373|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
129883661|NCT02761629|467534372|FG000|Overall Study|Protocol Violation|2|||
129883662|NCT02761629|467534373|FG001|Overall Study|Protocol Violation|2|||
129883663|NCT02761629|467534372|FG000|Overall Study|Withdrawal by Subject|0|||
129883664|NCT02761629|467534373|FG001|Overall Study|Withdrawal by Subject|3|||
129883665|NCT02761629|467534372|FG000|Overall Study|Other|0|||
129883666|NCT02761629|467534373|FG001|Overall Study|Other|2|||
129883667|NCT02761629|467534372|FG000|Overall Study|Lost to Follow-up|4|||
129883668|NCT02761629|467534373|FG001|Overall Study|Lost to Follow-up|1|||
129883669|NCT02761629|467534372|FG000|Overall Study|Randomized But Not Treated|8|||
129883670|NCT02761629|467534373|FG001|Overall Study|Randomized But Not Treated|4|||
129883671|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
129883672|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
129883673|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
129988470|NCT00484289|467921019|FG002|Long Term Phase|Adverse Event|5|||
129883674|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
129988471|NCT00484289|467921017|FG000|Long Term Phase|Withdrawal by Subject|0|||
129988472|NCT00484289|467921018|FG001|Long Term Phase|Withdrawal by Subject|7|||
129988473|NCT00484289|467921019|FG002|Long Term Phase|Withdrawal by Subject|6|||
129988474|NCT00484289|467921017|FG000|Long Term Phase|Inadequate response|2|||
129988475|NCT00484289|467921018|FG001|Long Term Phase|Inadequate response|7|||
129988476|NCT00484289|467921019|FG002|Long Term Phase|Inadequate response|4|||
129988477|NCT00484289|467921017|FG000|Long Term Phase|Other Reason|0|||
129988478|NCT00484289|467921018|FG001|Long Term Phase|Other Reason|5|||
129988479|NCT00484289|467921019|FG002|Long Term Phase|Other Reason|1|||
129988480|NCT00484289|467921017|FG000|Post Marketing Phase|Adverse Event|0|||
129988481|NCT00484289|467921018|FG001|Post Marketing Phase|Adverse Event|1|||
129988482|NCT00484289|467921019|FG002|Post Marketing Phase|Adverse Event|0|||
129988483|NCT02349425|467921020|FG000|Period 1|Adverse Event|1|||
129988484|NCT02349425|467921021|FG001|Period 1|Adverse Event|1|||
129988485|NCT02349425|467921022|FG002|Period 1|Adverse Event|0|||
129988486|NCT02349425|467921023|FG003|Period 1|Adverse Event|0|||
129988487|NCT02349425|467921020|FG000|Period 2|Adverse Event|0|||
129988488|NCT02349425|467921021|FG001|Period 2|Adverse Event|1|||
129988489|NCT02349425|467921022|FG002|Period 2|Adverse Event|1|||
129988490|NCT02349425|467921023|FG003|Period 2|Adverse Event|0|||
129988491|NCT03064035|467921028|FG000|Overall Study|Did not receive allocated intervention|4|||
129988492|NCT03064035|467921029|FG001|Overall Study|Did not receive allocated intervention|2|||
129988493|NCT03064035|467921028|FG000|Overall Study|Lost to Follow-up|1|||
129988494|NCT03064035|467921029|FG001|Overall Study|Lost to Follow-up|1|||
129988495|NCT03103763|467921030|FG000|Overall Study|Death|15|||
129988496|NCT03103763|467921031|FG001|Overall Study|Death|5|||
129988497|NCT03103763|467921032|FG002|Overall Study|Death|5|||
129988498|NCT03103763|467921030|FG000|Overall Study|Withdrawal by Subject|0|||
129988499|NCT03103763|467921031|FG001|Overall Study|Withdrawal by Subject|3|||
129988500|NCT03103763|467921032|FG002|Overall Study|Withdrawal by Subject|2|||
129988501|NCT01143038|467921033|FG000|Overall Study|Withdrawal by Subject|4|||
129988502|NCT01143038|467921033|FG000|Overall Study|Requirement for alternative therapy|5|||
129988503|NCT01143038|467921033|FG000|Overall Study|Adverse Event|3|||
129988504|NCT01143038|467921033|FG000|Overall Study|Lost to Follow-up|2|||
129988505|NCT01143038|467921033|FG000|Overall Study|Protocol Deviation|1|||
129988506|NCT01143038|467921033|FG000|Overall Study|Death|1|||
129988507|NCT01346475|467921037|FG000|First Intervention|Lost to Follow-up|4|||
129988508|NCT01346475|467921038|FG001|First Intervention|Lost to Follow-up|3|||
129988509|NCT04279392|467921039|FG000|Overall Study|Physician Decision|1|||
129988510|NCT04279392|467921040|FG001|Overall Study|Physician Decision|0|||
129988511|NCT01171807|467921041|FG000|Overall Study|Treatment failure|2|||
129988512|NCT01171807|467921042|FG001|Overall Study|Treatment failure|4|||
129988513|NCT01171807|467921041|FG000|Overall Study|Non compliance|1|||
129988514|NCT01171807|467921042|FG001|Overall Study|Non compliance|0|||
129988515|NCT01171807|467921041|FG000|Overall Study|Lost to Follow-up|3|||
129988516|NCT01171807|467921042|FG001|Overall Study|Lost to Follow-up|0|||
129988517|NCT04101318|467921049|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
129988518|NCT04101318|467921050|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
129988519|NCT04101318|467921049|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
129988520|NCT04101318|467921050|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
129988521|NCT04101318|467921049|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
129988522|NCT04101318|467921050|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
129988523|NCT00558259|467921051|FG000|Overall Study|Adverse Event|50|||
129988524|NCT00558259|467921052|FG001|Overall Study|Adverse Event|81|||
129988525|NCT00558259|467921051|FG000|Overall Study|Protocol Violation|9|||
129988526|NCT00558259|467921052|FG001|Overall Study|Protocol Violation|5|||
129988527|NCT00558259|467921051|FG000|Overall Study|Withdrawal by Subject|12|||
129988528|NCT00558259|467921052|FG001|Overall Study|Withdrawal by Subject|13|||
129988529|NCT04289051|467921053|FG000|Overall Study|Lost to Follow-up|0|||
129988530|NCT04289051|467921054|FG001|Overall Study|Lost to Follow-up|0|||
129988531|NCT04289051|467921055|FG002|Overall Study|Lost to Follow-up|2|||
129988532|NCT01901341|467921056|FG000|Overall Study|Adverse Event|4|||
129988533|NCT01901341|467921057|FG001|Overall Study|Adverse Event|2|||
129988534|NCT01901341|467921056|FG000|Overall Study|Lack of Efficacy|0|||
129988535|NCT01901341|467921057|FG001|Overall Study|Lack of Efficacy|2|||
129988536|NCT01901341|467921056|FG000|Overall Study|Lost to Follow-up|0|||
129988537|NCT01901341|467921057|FG001|Overall Study|Lost to Follow-up|1|||
129988538|NCT01901341|467921056|FG000|Overall Study|Protocol Violation|2|||
129988539|NCT01901341|467921057|FG001|Overall Study|Protocol Violation|0|||
129988540|NCT01901341|467921056|FG000|Overall Study|Study Terminated by Sponsor|13|||
129988541|NCT01901341|467921057|FG001|Overall Study|Study Terminated by Sponsor|15|||
129988542|NCT01901341|467921056|FG000|Overall Study|Withdrawal by Subject|1|||
129988543|NCT01901341|467921057|FG001|Overall Study|Withdrawal by Subject|1|||
129988544|NCT02966301|467921058|FG000|Overall Study|Death|2|||
129988545|NCT02966301|467921058|FG000|Overall Study|Withdrawal by Subject|1|||
129988546|NCT00370331|467921060|FG000|Overall Study|Adverse Event|4|||
129988547|NCT00370331|467921061|FG001|Overall Study|Adverse Event|13|||
129988548|NCT00370331|467921060|FG000|Overall Study|Withdrawal by Subject|2|||
129658454|NCT01690299|466709649|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129658455|NCT01690299|466709650|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129658456|NCT01690299|466709651|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
129658457|NCT01690299|466709652|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
129658458|NCT01690299|466709653|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
129658459|NCT01690299|466709648|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
129658460|NCT01690299|466709649|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
129658461|NCT01690299|466709650|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
129658462|NCT01690299|466709651|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
129658463|NCT01690299|466709652|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
129658464|NCT01690299|466709653|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
129658465|NCT01690299|466709648|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
129658466|NCT01690299|466709649|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
129658467|NCT01690299|466709650|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
129658468|NCT01690299|466709651|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
129658469|NCT01690299|466709652|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
129658470|NCT01690299|466709653|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
129658471|NCT01690299|466709648|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129658472|NCT01690299|466709649|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129658473|NCT01690299|466709650|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129658474|NCT01690299|466709651|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129658475|NCT01690299|466709652|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
129658476|NCT01690299|466709653|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
129658477|NCT03836209|466709654|FG000|Overall Study|Adverse Event|5|||
129658478|NCT03836209|466709655|FG001|Overall Study|Adverse Event|2|||
129658479|NCT03836209|466709654|FG000|Overall Study|Death|4|||
129658480|NCT03836209|466709655|FG001|Overall Study|Death|1|||
129658481|NCT03836209|466709654|FG000|Overall Study|Lack of Efficacy|7|||
129658482|NCT03836209|466709655|FG001|Overall Study|Lack of Efficacy|10|||
129658483|NCT03836209|466709654|FG000|Overall Study|Physician Decision|7|||
129658484|NCT03836209|466709655|FG001|Overall Study|Physician Decision|11|||
129658485|NCT03836209|466709654|FG000|Overall Study|Protocol Violation|0|||
129658486|NCT03836209|466709655|FG001|Overall Study|Protocol Violation|3|||
129658487|NCT03836209|466709654|FG000|Overall Study|Withdrawal by Subject|2|||
129658488|NCT03836209|466709655|FG001|Overall Study|Withdrawal by Subject|10|||
129658489|NCT03836209|466709654|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
129658490|NCT03836209|466709655|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
129658491|NCT03739710|466709656|FG000|Overall Study|Screen Failed|81|||
129658492|NCT01753115|466709657|FG000|Overall Study|Lost to Follow-up|3|||
129658493|NCT01753115|466709658|FG001|Overall Study|Lost to Follow-up|6|||
129658494|NCT01753115|466709659|FG002|Overall Study|Lost to Follow-up|8|||
129658495|NCT01753115|466709657|FG000|Overall Study|Withdrawal by Subject|6|||
129658496|NCT01753115|466709658|FG001|Overall Study|Withdrawal by Subject|5|||
129658497|NCT01753115|466709659|FG002|Overall Study|Withdrawal by Subject|6|||
129658498|NCT01753115|466709657|FG000|Overall Study|Subject non-compliant|3|||
129658499|NCT01753115|466709658|FG001|Overall Study|Subject non-compliant|3|||
129658500|NCT01753115|466709659|FG002|Overall Study|Subject non-compliant|0|||
129658501|NCT01753115|466709657|FG000|Overall Study|Used excluded drug|0|||
129658502|NCT01753115|466709658|FG001|Overall Study|Used excluded drug|1|||
129658503|NCT01753115|466709659|FG002|Overall Study|Used excluded drug|0|||
129658504|NCT01424241|466709662|FG000|Overall Study|Withdrawal by Subject|1|||
129658505|NCT01424241|466709662|FG000|Overall Study|Time constraints|2|||
129658506|NCT00496587|466709663|FG000|Overall Study|Adverse Event|2|||
129658507|NCT00496587|466709663|FG000|Overall Study|Progressive Disease|24|||
129658508|NCT00496587|466709663|FG000|Overall Study|Withdrawal by Subject|2|||
129658509|NCT00496587|466709663|FG000|Overall Study|Death|1|||
129658510|NCT00496587|466709663|FG000|Overall Study|Complications unrelated|2|||
129988549|NCT00370331|467921061|FG001|Overall Study|Withdrawal by Subject|4|||
129988550|NCT00370331|467921060|FG000|Overall Study|Lost to Follow-up|0|||
129988551|NCT00370331|467921061|FG001|Overall Study|Lost to Follow-up|3|||
129988552|NCT00370331|467921060|FG000|Overall Study|Lack of Efficacy|0|||
129988553|NCT00370331|467921061|FG001|Overall Study|Lack of Efficacy|1|||
129988554|NCT00370331|467921060|FG000|Overall Study|Non-compliance|0|||
129658511|NCT05259917|466709669|FG000|Overall Study|Protocol Violation|0|||
129658512|NCT05259917|466709670|FG001|Overall Study|Protocol Violation|0|||
129658513|NCT05259917|466709671|FG002|Overall Study|Protocol Violation|1|||
129658514|NCT05259917|466709672|FG003|Overall Study|Protocol Violation|0|||
129658515|NCT05259917|466709673|FG004|Overall Study|Protocol Violation|0|||
129658516|NCT05259917|466709674|FG005|Overall Study|Protocol Violation|0|||
129988555|NCT00370331|467921061|FG001|Overall Study|Non-compliance|1|||
129988556|NCT00370331|467921060|FG000|Overall Study|Protocol Violation|1|||
129658517|NCT05259917|466709669|FG000|Overall Study|Lost to Follow-up|0|||
129658518|NCT05259917|466709670|FG001|Overall Study|Lost to Follow-up|0|||
129658519|NCT05259917|466709671|FG002|Overall Study|Lost to Follow-up|1|||
129658520|NCT05259917|466709672|FG003|Overall Study|Lost to Follow-up|0|||
129658521|NCT05259917|466709673|FG004|Overall Study|Lost to Follow-up|0|||
129658522|NCT05259917|466709674|FG005|Overall Study|Lost to Follow-up|1|||
129658523|NCT05259917|466709669|FG000|Overall Study|Physician Decision|0|||
129658524|NCT05259917|466709670|FG001|Overall Study|Physician Decision|1|||
129658525|NCT05259917|466709671|FG002|Overall Study|Physician Decision|0|||
129658526|NCT05259917|466709672|FG003|Overall Study|Physician Decision|0|||
129658527|NCT05259917|466709673|FG004|Overall Study|Physician Decision|0|||
129658528|NCT05259917|466709674|FG005|Overall Study|Physician Decision|0|||
129658529|NCT05259917|466709669|FG000|Overall Study|Withdrawal by Subject|0|||
129658530|NCT05259917|466709670|FG001|Overall Study|Withdrawal by Subject|1|||
129658531|NCT05259917|466709671|FG002|Overall Study|Withdrawal by Subject|0|||
129658532|NCT05259917|466709672|FG003|Overall Study|Withdrawal by Subject|0|||
129658533|NCT05259917|466709673|FG004|Overall Study|Withdrawal by Subject|1|||
129658534|NCT05259917|466709674|FG005|Overall Study|Withdrawal by Subject|1|||
129658535|NCT05259917|466709669|FG000|Overall Study|Trial Termination by Sponsor|7|||
129658536|NCT05259917|466709670|FG001|Overall Study|Trial Termination by Sponsor|2|||
129658537|NCT05259917|466709671|FG002|Overall Study|Trial Termination by Sponsor|3|||
129658538|NCT05259917|466709672|FG003|Overall Study|Trial Termination by Sponsor|5|||
129658539|NCT05259917|466709673|FG004|Overall Study|Trial Termination by Sponsor|11|||
129658540|NCT05259917|466709674|FG005|Overall Study|Trial Termination by Sponsor|4|||
129658541|NCT05259917|466709669|FG000|Overall Study|Other|1|||
129658542|NCT05259917|466709670|FG001|Overall Study|Other|0|||
129658543|NCT05259917|466709671|FG002|Overall Study|Other|2|||
129658544|NCT05259917|466709672|FG003|Overall Study|Other|0|||
129658545|NCT05259917|466709673|FG004|Overall Study|Other|0|||
129658546|NCT05259917|466709674|FG005|Overall Study|Other|0|||
129658547|NCT02383355|466709677|FG000|Overall Study|Adverse Event|2|||
129658548|NCT02383355|466709678|FG001|Overall Study|Adverse Event|0|||
129658549|NCT01146561|466709680|FG000|Overall Study|Withdrawal by Subject|1|||
129658550|NCT01146561|466709680|FG000|Overall Study|Lost to Follow-up|1|||
129658551|NCT03628716|466709681|FG000|Overall Study|Adverse Event|1|||
129658552|NCT03628716|466709682|FG001|Overall Study|Adverse Event|1|||
129658553|NCT03628716|466709681|FG000|Overall Study|Death|1|||
129658554|NCT03628716|466709682|FG001|Overall Study|Death|0|||
129658555|NCT03628716|466709681|FG000|Overall Study|Lack of Efficacy|15|||
129658556|NCT03628716|466709682|FG001|Overall Study|Lack of Efficacy|20|||
129658557|NCT03628716|466709681|FG000|Overall Study|Withdrawal by Subject|1|||
129658558|NCT03628716|466709682|FG001|Overall Study|Withdrawal by Subject|2|||
129658559|NCT03628716|466709681|FG000|Overall Study|Study Terminated by Sponsor|1|||
129658560|NCT03628716|466709682|FG001|Overall Study|Study Terminated by Sponsor|0|||
129658561|NCT00856843|466709683|FG000|Overall Study|Withdrawal by Subject|1|||
129658562|NCT00856843|466709684|FG001|Overall Study|Withdrawal by Subject|5|||
129658563|NCT00856843|466709683|FG000|Overall Study|Lack of Efficacy|1|||
129658564|NCT00856843|466709684|FG001|Overall Study|Lack of Efficacy|0|||
129658565|NCT01573754|466709685|FG000|Overall Study|Noncompliance or remission not achieved|3|||
129658566|NCT01573754|466709686|FG001|Overall Study|Noncompliance or remission not achieved|15|||
129658567|NCT00829829|466709688|FG000|Overall Study|Protocol Violation|0|||
129658568|NCT00829829|466709689|FG001|Overall Study|Protocol Violation|3|||
129658569|NCT00829829|466709690|FG002|Overall Study|Protocol Violation|0|||
129658570|NCT00829829|466709688|FG000|Overall Study|Adverse Event|4|||
129658571|NCT00829829|466709689|FG001|Overall Study|Adverse Event|4|||
129658572|NCT00829829|466709690|FG002|Overall Study|Adverse Event|3|||
129658573|NCT00829829|466709688|FG000|Overall Study|Withdrawal by Subject|8|||
129658574|NCT00829829|466709689|FG001|Overall Study|Withdrawal by Subject|4|||
129658575|NCT00829829|466709690|FG002|Overall Study|Withdrawal by Subject|2|||
129658576|NCT00829829|466709688|FG000|Overall Study|Decision by the Sponsor|1|||
129658577|NCT00829829|466709689|FG001|Overall Study|Decision by the Sponsor|0|||
129658578|NCT00829829|466709690|FG002|Overall Study|Decision by the Sponsor|2|||
129658579|NCT00829829|466709688|FG000|Overall Study|Lost to Follow-up|7|||
129988557|NCT00370331|467921061|FG001|Overall Study|Protocol Violation|1|||
129988558|NCT01874431|467921062|FG000|Overall Study|Physician Decision|0|||
129658580|NCT00829829|466709689|FG001|Overall Study|Lost to Follow-up|3|||
129658581|NCT00829829|466709690|FG002|Overall Study|Lost to Follow-up|3|||
129658582|NCT00829829|466709688|FG000|Overall Study|Other than specified above|2|||
129658583|NCT00829829|466709689|FG001|Overall Study|Other than specified above|2|||
129658584|NCT00829829|466709690|FG002|Overall Study|Other than specified above|1|||
129658585|NCT01994902|466709691|FG000|Test Period 1|Withdrawal by Subject|3|||
129658586|NCT01994902|466709692|FG001|Test Period 1|Withdrawal by Subject|0|||
129658587|NCT01994902|466709691|FG000|Test Period 1|device deficiency with adverse event|0|||
129988559|NCT01874431|467921063|FG001|Overall Study|Physician Decision|0|||
129988560|NCT01874431|467921064|FG002|Overall Study|Physician Decision|1|||
129658588|NCT01994902|466709692|FG001|Test Period 1|device deficiency with adverse event|1|||
129658589|NCT01994902|466709691|FG000|Test Period 1|Adverse Event|2|||
129658590|NCT01994902|466709692|FG001|Test Period 1|Adverse Event|1|||
129658591|NCT01994902|466709691|FG000|Test Period 1|Lack of Efficacy|0|||
129658592|NCT01994902|466709692|FG001|Test Period 1|Lack of Efficacy|1|||
129658593|NCT01994902|466709691|FG000|Test Period 1|bag too small|1|||
129658594|NCT01994902|466709692|FG001|Test Period 1|bag too small|0|||
129658595|NCT01994902|466709691|FG000|Test Period 2|Withdrawal by Subject|0|||
129658596|NCT01994902|466709692|FG001|Test Period 2|Withdrawal by Subject|2|||
129658597|NCT01994902|466709691|FG000|Test Period 2|Lack of Efficacy|0|||
129658598|NCT01994902|466709692|FG001|Test Period 2|Lack of Efficacy|1|||
129658599|NCT01994902|466709691|FG000|Test Period 2|Other|0|||
129658600|NCT01994902|466709692|FG001|Test Period 2|Other|3|||
129658601|NCT02717442|466709694|FG000|Overall Study|Study Terminated by Sponsor|31|||
129658602|NCT02717442|466709695|FG001|Overall Study|Study Terminated by Sponsor|29|||
129988561|NCT01874431|467921065|FG003|Overall Study|Physician Decision|0|||
129988562|NCT01874431|467921066|FG004|Overall Study|Physician Decision|0|||
129988563|NCT01874431|467921067|FG005|Overall Study|Physician Decision|0|||
129988564|NCT01874431|467921068|FG006|Overall Study|Physician Decision|0|||
129988565|NCT01874431|467921069|FG007|Overall Study|Physician Decision|0|||
129988566|NCT01874431|467921062|FG000|Overall Study|Adverse Event|5|||
129988567|NCT01874431|467921063|FG001|Overall Study|Adverse Event|4|||
129988568|NCT01874431|467921064|FG002|Overall Study|Adverse Event|6|||
129988569|NCT01874431|467921065|FG003|Overall Study|Adverse Event|5|||
129988570|NCT01874431|467921066|FG004|Overall Study|Adverse Event|2|||
129988571|NCT01874431|467921067|FG005|Overall Study|Adverse Event|8|||
129988572|NCT01874431|467921068|FG006|Overall Study|Adverse Event|2|||
129988573|NCT01874431|467921069|FG007|Overall Study|Adverse Event|3|||
129988574|NCT01874431|467921062|FG000|Overall Study|Protocol Violation|1|||
129988575|NCT01874431|467921063|FG001|Overall Study|Protocol Violation|1|||
129988576|NCT01874431|467921064|FG002|Overall Study|Protocol Violation|1|||
129988577|NCT01874431|467921065|FG003|Overall Study|Protocol Violation|0|||
129988578|NCT01874431|467921066|FG004|Overall Study|Protocol Violation|3|||
129988579|NCT01874431|467921067|FG005|Overall Study|Protocol Violation|2|||
129988580|NCT01874431|467921068|FG006|Overall Study|Protocol Violation|1|||
129988581|NCT01874431|467921069|FG007|Overall Study|Protocol Violation|1|||
129988582|NCT01874431|467921062|FG000|Overall Study|Non-compliance|0|||
129988583|NCT01874431|467921063|FG001|Overall Study|Non-compliance|0|||
129988584|NCT01874431|467921064|FG002|Overall Study|Non-compliance|0|||
129988585|NCT01874431|467921065|FG003|Overall Study|Non-compliance|0|||
129988586|NCT01874431|467921066|FG004|Overall Study|Non-compliance|1|||
129988587|NCT01874431|467921067|FG005|Overall Study|Non-compliance|0|||
129988588|NCT01874431|467921068|FG006|Overall Study|Non-compliance|1|||
129988589|NCT01874431|467921069|FG007|Overall Study|Non-compliance|0|||
129988590|NCT01874431|467921062|FG000|Overall Study|Logistical difficulties|0|||
129988591|NCT01874431|467921063|FG001|Overall Study|Logistical difficulties|0|||
129988592|NCT01874431|467921064|FG002|Overall Study|Logistical difficulties|0|||
129988593|NCT01874431|467921065|FG003|Overall Study|Logistical difficulties|0|||
129988594|NCT01874431|467921066|FG004|Overall Study|Logistical difficulties|0|||
129988595|NCT01874431|467921067|FG005|Overall Study|Logistical difficulties|0|||
129988596|NCT01874431|467921068|FG006|Overall Study|Logistical difficulties|1|||
129988597|NCT01874431|467921069|FG007|Overall Study|Logistical difficulties|0|||
129988598|NCT01874431|467921062|FG000|Overall Study|Withdrawal by Subject|0|||
129988599|NCT01874431|467921063|FG001|Overall Study|Withdrawal by Subject|0|||
129988600|NCT01874431|467921064|FG002|Overall Study|Withdrawal by Subject|1|||
129988601|NCT01874431|467921065|FG003|Overall Study|Withdrawal by Subject|2|||
129988602|NCT01874431|467921066|FG004|Overall Study|Withdrawal by Subject|1|||
129988603|NCT01874431|467921067|FG005|Overall Study|Withdrawal by Subject|1|||
129988604|NCT01874431|467921068|FG006|Overall Study|Withdrawal by Subject|3|||
129988605|NCT01874431|467921069|FG007|Overall Study|Withdrawal by Subject|0|||
129988606|NCT01874431|467921062|FG000|Overall Study|Sponsor decision|0|||
129988607|NCT01874431|467921063|FG001|Overall Study|Sponsor decision|0|||
129988608|NCT01874431|467921064|FG002|Overall Study|Sponsor decision|0|||
129988609|NCT01874431|467921065|FG003|Overall Study|Sponsor decision|0|||
129988610|NCT01874431|467921066|FG004|Overall Study|Sponsor decision|1|||
129658603|NCT02717442|466709694|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
129658604|NCT02717442|466709695|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
129658605|NCT02717442|466709694|FG000|Overall Study|Other - Not Specified|2|||
129658606|NCT02717442|466709695|FG001|Overall Study|Other - Not Specified|0|||
129988611|NCT01874431|467921067|FG005|Overall Study|Sponsor decision|0|||
129988612|NCT01874431|467921068|FG006|Overall Study|Sponsor decision|0|||
129988613|NCT01874431|467921069|FG007|Overall Study|Sponsor decision|0|||
129658607|NCT02772809|466709699|FG000|Overall Study|not completed some tasks|6|||
129658608|NCT02774005|466709702|FG000|Overall Study|Adverse Event|8|||
129658609|NCT02774005|466709702|FG000|Overall Study|Withdrawal by Subject|23|||
129658610|NCT02774005|466709702|FG000|Overall Study|Lost to Follow-up|7|||
129658611|NCT02774005|466709702|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
129988614|NCT01874431|467921062|FG000|Overall Study|Lost to Follow-up|0|||
129988615|NCT01874431|467921063|FG001|Overall Study|Lost to Follow-up|0|||
129988616|NCT01874431|467921064|FG002|Overall Study|Lost to Follow-up|1|||
129988617|NCT01874431|467921065|FG003|Overall Study|Lost to Follow-up|0|||
129658612|NCT02774005|466709702|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
129988618|NCT01874431|467921066|FG004|Overall Study|Lost to Follow-up|0|||
129988619|NCT01874431|467921067|FG005|Overall Study|Lost to Follow-up|0|||
129988620|NCT01874431|467921068|FG006|Overall Study|Lost to Follow-up|0|||
129988621|NCT01874431|467921069|FG007|Overall Study|Lost to Follow-up|0|||
129988622|NCT01981473|467921070|FG000|Overall Study|Incorrect diagnosis of RA|0|||
129988623|NCT01981473|467921071|FG001|Overall Study|Incorrect diagnosis of RA|0|||
129988624|NCT01981473|467921072|FG002|Overall Study|Incorrect diagnosis of RA|1|||
129988625|NCT01981473|467921070|FG000|Overall Study|Received treatment for < 6 months|0|||
129988626|NCT01981473|467921071|FG001|Overall Study|Received treatment for < 6 months|0|||
129988627|NCT01981473|467921072|FG002|Overall Study|Received treatment for < 6 months|1|||
129988628|NCT01981473|467921070|FG000|Overall Study|Received treatment for >24 months|2|||
129988629|NCT01981473|467921071|FG001|Overall Study|Received treatment for >24 months|0|||
129658613|NCT02774005|466709702|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
129658614|NCT02774005|466709702|FG000|Overall Study|Death|1|||
129658615|NCT02774005|466709702|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
129658616|NCT02774005|466709702|FG000|Overall Study|Lack of compliance with study medication|4|||
129658617|NCT02774005|466709702|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
129658618|NCT02774005|466709702|FG000|Overall Study|another study|1|||
129658619|NCT02774005|466709702|FG000|Overall Study|cardiologist imposed travel restriction|1|||
129658620|NCT00534105|466709703|FG000|Overall Study|Lost to Follow-up|23|||
129658621|NCT00534105|466709704|FG001|Overall Study|Lost to Follow-up|39|||
129658622|NCT03275389|466709708|FG000|Overall Study|Lost to Follow-up|10|||
129658623|NCT03275389|466709709|FG001|Overall Study|Lost to Follow-up|10|||
129658624|NCT03275389|466709710|FG002|Overall Study|Lost to Follow-up|19|||
129658625|NCT03275389|466709711|FG003|Overall Study|Lost to Follow-up|12|||
129658626|NCT03275389|466709712|FG004|Overall Study|Lost to Follow-up|11|||
129658627|NCT03275389|466709713|FG005|Overall Study|Lost to Follow-up|12|||
129658628|NCT03275389|466709714|FG006|Overall Study|Lost to Follow-up|21|||
129658629|NCT03275389|466709715|FG007|Overall Study|Lost to Follow-up|15|||
129658630|NCT03275389|466709716|FG008|Overall Study|Lost to Follow-up|12|||
129658631|NCT03275389|466709717|FG009|Overall Study|Lost to Follow-up|14|||
129658632|NCT03275389|466709708|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658633|NCT03275389|466709709|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658634|NCT03275389|466709710|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658635|NCT03275389|466709711|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658636|NCT03275389|466709712|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658637|NCT03275389|466709713|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
129658638|NCT03275389|466709714|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658639|NCT03275389|466709715|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658640|NCT03275389|466709716|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
129658641|NCT03275389|466709717|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
129658642|NCT03275389|466709708|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
129658643|NCT03275389|466709709|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129658644|NCT03275389|466709710|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129658645|NCT03275389|466709711|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
129658646|NCT03275389|466709712|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129658647|NCT03275389|466709713|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129658648|NCT03275389|466709714|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129658649|NCT03275389|466709715|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
129658650|NCT03275389|466709716|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129658651|NCT03275389|466709717|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129658652|NCT03275389|466709708|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658653|NCT03275389|466709709|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129658654|NCT03275389|466709710|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658655|NCT03275389|466709711|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
129658656|NCT03275389|466709712|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658657|NCT03275389|466709713|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658658|NCT03275389|466709714|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129658659|NCT03275389|466709715|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658660|NCT03275389|466709716|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658661|NCT03275389|466709717|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129658662|NCT03275389|466709708|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658663|NCT03275389|466709709|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658664|NCT03275389|466709710|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129658665|NCT03275389|466709711|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658666|NCT03275389|466709712|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658667|NCT03275389|466709713|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129988630|NCT01981473|467921072|FG002|Overall Study|Received treatment for >24 months|6|||
129988631|NCT00545051|467921076|FG000|Overall Study|Adverse Event|7|||
129658668|NCT03275389|466709714|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658669|NCT03275389|466709715|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658670|NCT03275389|466709716|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129658671|NCT03275389|466709717|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129658672|NCT03275389|466709708|FG000|Overall Study|Other|0|||
129658673|NCT03275389|466709709|FG001|Overall Study|Other|4|||
129658674|NCT03275389|466709710|FG002|Overall Study|Other|3|||
129658675|NCT03275389|466709711|FG003|Overall Study|Other|2|||
129658676|NCT03275389|466709712|FG004|Overall Study|Other|2|||
129658677|NCT03275389|466709713|FG005|Overall Study|Other|2|||
129658678|NCT03275389|466709714|FG006|Overall Study|Other|0|||
129658679|NCT03275389|466709715|FG007|Overall Study|Other|0|||
129658680|NCT03275389|466709716|FG008|Overall Study|Other|1|||
129658681|NCT03275389|466709717|FG009|Overall Study|Other|0|||
129658682|NCT00978341|466709718|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
129658683|NCT00978341|466709719|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
129658684|NCT00448812|466709720|FG000|Year 2|Missed visit but remained in study|4|||
129658685|NCT00448812|466709721|FG001|Year 2|Missed visit but remained in study|1|||
129658686|NCT00448812|466709720|FG000|Year 3|Withdrawal by Subject|1|||
129658687|NCT00448812|466709721|FG001|Year 3|Withdrawal by Subject|3|||
129658688|NCT00448812|466709720|FG000|Year 3|Lost to Follow-up|1|||
129658689|NCT00448812|466709721|FG001|Year 3|Lost to Follow-up|0|||
129658690|NCT00448812|466709720|FG000|Year 3|Missed visit but remained in study|2|||
129658691|NCT00448812|466709721|FG001|Year 3|Missed visit but remained in study|0|||
129658692|NCT00448812|466709720|FG000|Year 5|Missed visit but remained in study|1|||
129658693|NCT00448812|466709721|FG001|Year 5|Missed visit but remained in study|0|||
129658694|NCT03035916|466709722|FG000|Overall Study|Puncture failed|0|||
129658695|NCT03035916|466709723|FG001|Overall Study|Puncture failed|2|||
129658696|NCT03035916|466709724|FG002|Overall Study|Puncture failed|0|||
129658697|NCT03885999|466709725|FG000|Overall Study|Adverse Event|1|||
129658698|NCT02452554|466709726|FG000|Overall Study|Death|2|||
129658699|NCT02452554|466709727|FG001|Overall Study|Death|1|||
129658700|NCT02452554|466709728|FG002|Overall Study|Death|0|||
129658701|NCT02452554|466709729|FG003|Overall Study|Death|0|||
129658702|NCT02452554|466709730|FG004|Overall Study|Death|0|||
129658703|NCT02452554|466709731|FG005|Overall Study|Death|0|||
129658704|NCT02452554|466709726|FG000|Overall Study|Lack of Efficacy|13|||
129658705|NCT02452554|466709727|FG001|Overall Study|Lack of Efficacy|14|||
129658706|NCT02452554|466709728|FG002|Overall Study|Lack of Efficacy|9|||
129658707|NCT02452554|466709729|FG003|Overall Study|Lack of Efficacy|1|||
129658708|NCT02452554|466709730|FG004|Overall Study|Lack of Efficacy|5|||
129658709|NCT02452554|466709731|FG005|Overall Study|Lack of Efficacy|8|||
129658710|NCT02452554|466709726|FG000|Overall Study|Physician Decision|0|||
129658711|NCT02452554|466709727|FG001|Overall Study|Physician Decision|1|||
129658712|NCT02452554|466709728|FG002|Overall Study|Physician Decision|0|||
129658713|NCT02452554|466709729|FG003|Overall Study|Physician Decision|0|||
129658714|NCT02452554|466709730|FG004|Overall Study|Physician Decision|0|||
129658715|NCT02452554|466709731|FG005|Overall Study|Physician Decision|0|||
129658716|NCT02452554|466709726|FG000|Overall Study|Withdrawal by Subject|1|||
129658717|NCT02452554|466709727|FG001|Overall Study|Withdrawal by Subject|0|||
129658718|NCT02452554|466709728|FG002|Overall Study|Withdrawal by Subject|2|||
129658719|NCT02452554|466709729|FG003|Overall Study|Withdrawal by Subject|0|||
129658720|NCT02452554|466709730|FG004|Overall Study|Withdrawal by Subject|0|||
129658721|NCT02452554|466709731|FG005|Overall Study|Withdrawal by Subject|1|||
129658722|NCT02452554|466709726|FG000|Overall Study|Ineligible|0|||
129658723|NCT02452554|466709727|FG001|Overall Study|Ineligible|1|||
129658724|NCT02452554|466709728|FG002|Overall Study|Ineligible|0|||
129658725|NCT02452554|466709729|FG003|Overall Study|Ineligible|0|||
129658726|NCT02452554|466709730|FG004|Overall Study|Ineligible|0|||
129658727|NCT02452554|466709731|FG005|Overall Study|Ineligible|0|||
129658728|NCT02452554|466709726|FG000|Overall Study|Never Received Treatment|1|||
129988632|NCT00545051|467921077|FG001|Overall Study|Adverse Event|3|||
129658729|NCT02452554|466709727|FG001|Overall Study|Never Received Treatment|0|||
129988633|NCT00545051|467921076|FG000|Overall Study|Death|1|||
129988634|NCT00545051|467921077|FG001|Overall Study|Death|0|||
129658730|NCT02452554|466709728|FG002|Overall Study|Never Received Treatment|0|||
129988635|NCT00545051|467921076|FG000|Overall Study|Violation of inclusion/exclusion|0|||
129988636|NCT00545051|467921077|FG001|Overall Study|Violation of inclusion/exclusion|2|||
129658731|NCT02452554|466709729|FG003|Overall Study|Never Received Treatment|0|||
129658732|NCT02452554|466709730|FG004|Overall Study|Never Received Treatment|0|||
129658733|NCT02452554|466709731|FG005|Overall Study|Never Received Treatment|0|||
129658734|NCT02749799|466709732|FG000|Overall Study|Adverse Event|2|||
129658735|NCT02749799|466709732|FG000|Overall Study|Lost to Follow-up|4|||
129988637|NCT00545051|467921076|FG000|Overall Study|Protocol Violation|1|||
129658736|NCT02749799|466709732|FG000|Overall Study|Protocol Violation|1|||
129658737|NCT02749799|466709732|FG000|Overall Study|Withdrawal by Subject|1|||
129658738|NCT03749109|466709733|FG000|Overall Study|Adverse Event|2|||
129658739|NCT03749109|466709734|FG001|Overall Study|Adverse Event|0|||
129658740|NCT02636439|466709737|FG000|Overall Study|Adverse Event|2|||
129658741|NCT02636439|466709738|FG001|Overall Study|Adverse Event|2|||
129658742|NCT02636439|466709737|FG000|Overall Study|Lost to Follow-up|1|||
129658743|NCT02636439|466709738|FG001|Overall Study|Lost to Follow-up|0|||
129658744|NCT02636439|466709737|FG000|Overall Study|Non-compliance|1|||
129658745|NCT02636439|466709738|FG001|Overall Study|Non-compliance|1|||
129658746|NCT02636439|466709737|FG000|Overall Study|Personal reasons|2|||
129658747|NCT02636439|466709738|FG001|Overall Study|Personal reasons|0|||
129658748|NCT02075008|466711632|FG000|Overall Study|Technical problems|1|||
129658749|NCT02075008|466711632|FG000|Overall Study|Pregnancy|1|||
129658750|NCT02075008|466711632|FG000|Overall Study|Physician Decision|1|||
129658751|NCT02075008|466711632|FG000|Overall Study|Lost to Follow-up|1|||
129658752|NCT02075008|466711632|FG000|Overall Study|Lack of Efficacy|1|||
129658753|NCT02075008|466711632|FG000|Overall Study|Death|1|||
129658754|NCT02075008|466711632|FG000|Overall Study|Adverse Event|5|||
129658755|NCT02075008|466711632|FG000|Overall Study|Withdrawal by Subject|6|||
129658756|NCT02075008|466711632|FG000|Overall Study|Study terminated by Sponsor|159|||
129658757|NCT00660595|466711633|FG000|Overall Study|Lost to Follow-up|0|||
129658758|NCT00660595|466711634|FG001|Overall Study|Lost to Follow-up|1|||
129658759|NCT00660595|466711633|FG000|Overall Study|Did not consent to participate in study|12|||
129658760|NCT00660595|466711634|FG001|Overall Study|Did not consent to participate in study|8|||
129658761|NCT00660595|466711633|FG000|Overall Study|Participant left hospital|1|||
129658762|NCT00660595|466711634|FG001|Overall Study|Participant left hospital|0|||
129658763|NCT00660595|466711633|FG000|Overall Study|Non Specified reasons|5|||
129658764|NCT00660595|466711634|FG001|Overall Study|Non Specified reasons|0|||
129658765|NCT05205005|466711635|FG000|Overall Study|Withdrawal by Subject|1|||
129658766|NCT05205005|466711636|FG001|Overall Study|Withdrawal by Subject|0|||
129658767|NCT05205005|466711635|FG000|Overall Study|Adverse Event|1|||
129658768|NCT05205005|466711636|FG001|Overall Study|Adverse Event|0|||
129658769|NCT02757625|466711640|FG000|Overall Study|Investigator's discretion|0|||
129658770|NCT02757625|466711641|FG001|Overall Study|Investigator's discretion|0|||
129658771|NCT02757625|466711642|FG002|Overall Study|Investigator's discretion|1|||
129658772|NCT02757625|466711643|FG003|Overall Study|Investigator's discretion|0|||
129658773|NCT02757625|466711640|FG000|Overall Study|Adverse Event|0|||
129658774|NCT02757625|466711641|FG001|Overall Study|Adverse Event|0|||
129658775|NCT02757625|466711642|FG002|Overall Study|Adverse Event|1|||
129658776|NCT02757625|466711643|FG003|Overall Study|Adverse Event|0|||
129658777|NCT04854057|466711644|FG000|Overall Study|Adverse Event|0|||
129658778|NCT04854057|466711645|FG001|Overall Study|Adverse Event|1|||
129658779|NCT03519919|466711646|FG000|Overall Study|Withdrawal by Subject|1|||
129658780|NCT03519919|466711646|FG000|Overall Study|Lack of Efficacy|1|||
129658781|NCT03519919|466711646|FG000|Overall Study|Screen Failure|1|||
129658782|NCT00645671|466711647|FG000|Overall Study|Protocol Violation|1|||
129658783|NCT00645671|466711648|FG001|Overall Study|Protocol Violation|0|||
129658784|NCT00645671|466711647|FG000|Overall Study|Withdrawal by Subject|0|||
129658785|NCT00645671|466711648|FG001|Overall Study|Withdrawal by Subject|4|||
129658786|NCT00645671|466711647|FG000|Overall Study|Adverse Event|0|||
129658787|NCT00645671|466711648|FG001|Overall Study|Adverse Event|1|||
129658788|NCT00645671|466711647|FG000|Overall Study|Physician Decision|0|||
129658789|NCT00645671|466711648|FG001|Overall Study|Physician Decision|1|||
129658790|NCT05114564|466711649|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
129658791|NCT05114564|466711650|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
129658792|NCT05114564|466711649|FG000|First Intervention|Adverse Event|0|||
129883675|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
129883676|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
129883677|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
129883678|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
129883679|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
129883680|NCT02001974|467534374|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
129883681|NCT02001974|467534375|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
129658793|NCT05114564|466711650|FG001|First Intervention|Adverse Event|1|||
129658794|NCT00493311|466711651|FG000|Overall Study|Need for rescue medication|2|||
129658795|NCT00493311|466711652|FG001|Overall Study|Need for rescue medication|2|||
129658796|NCT02779075|466711653|FG000|Overall Study|Withdrawal by Subject|1|||
129658797|NCT02779075|466711654|FG001|Overall Study|Withdrawal by Subject|3|||
129658798|NCT02779075|466711653|FG000|Overall Study|IV lost during 2nd study|1|||
129658799|NCT02779075|466711654|FG001|Overall Study|IV lost during 2nd study|0|||
129658800|NCT01951573|466711655|FG000|Washout Period|Adverse Event|0|||
129658801|NCT01951573|466711656|FG001|Washout Period|Adverse Event|1|||
129658802|NCT00707980|466711657|FG000|Overall Study|Adverse Event|49|||
129658803|NCT00707980|466711657|FG000|Overall Study|Lack of Efficacy|35|||
129658804|NCT00707980|466711657|FG000|Overall Study|Non-Compliance with Study Drug|28|||
129658805|NCT00707980|466711657|FG000|Overall Study|Protocol Deviations|19|||
129658806|NCT00707980|466711657|FG000|Overall Study|Withdrawal of Consent|81|||
129658807|NCT00707980|466711657|FG000|Overall Study|Lost to Follow-up|59|||
129658808|NCT00707980|466711657|FG000|Overall Study|Other|39|||
129658809|NCT01909973|466711658|FG000|Overall Study|Lost to Follow-up|1|||
129658810|NCT01909973|466711659|FG001|Overall Study|Lost to Follow-up|0|||
129658811|NCT00460239|466711660|FG000|Overall Study|Physician Decision|0|||
129658812|NCT00460239|466711661|FG001|Overall Study|Physician Decision|1|||
129658813|NCT00460239|466711662|FG002|Overall Study|Physician Decision|0|||
129658814|NCT00460239|466711663|FG003|Overall Study|Physician Decision|0|||
129658815|NCT00460239|466711664|FG004|Overall Study|Physician Decision|0|||
129658816|NCT00460239|466711665|FG005|Overall Study|Physician Decision|2|||
129658817|NCT00460239|466711666|FG006|Overall Study|Physician Decision|0|||
129658818|NCT00460239|466711667|FG007|Overall Study|Physician Decision|0|||
129658819|NCT00460239|466711668|FG008|Overall Study|Physician Decision|0|||
129658820|NCT00460239|466711660|FG000|Overall Study|Withdrawal by Subject|0|||
129658821|NCT00460239|466711661|FG001|Overall Study|Withdrawal by Subject|0|||
129658822|NCT00460239|466711662|FG002|Overall Study|Withdrawal by Subject|0|||
129658823|NCT00460239|466711663|FG003|Overall Study|Withdrawal by Subject|0|||
129658824|NCT00460239|466711664|FG004|Overall Study|Withdrawal by Subject|0|||
129988638|NCT00545051|467921077|FG001|Overall Study|Protocol Violation|0|||
129988639|NCT00545051|467921076|FG000|Overall Study|Withdrawal by Subject|0|||
129988640|NCT00545051|467921077|FG001|Overall Study|Withdrawal by Subject|1|||
129988641|NCT00545051|467921076|FG000|Overall Study|Administrative reasons|0|||
129988642|NCT00545051|467921077|FG001|Overall Study|Administrative reasons|1|||
129988643|NCT01888900|467921078|FG000|Overall Study|failed treatment|0|||
129988644|NCT01888900|467921079|FG001|Overall Study|failed treatment|2|||
129988645|NCT03271021|467921083|FG000|Overall Study|Adverse Event|3|||
129988646|NCT03271021|467921084|FG001|Overall Study|Adverse Event|2|||
129988647|NCT03271021|467921083|FG000|Overall Study|Withdrawal by Subject|36|||
129988648|NCT03271021|467921084|FG001|Overall Study|Withdrawal by Subject|53|||
129988649|NCT03271021|467921083|FG000|Overall Study|Lost to Follow-up|34|||
129988650|NCT03271021|467921084|FG001|Overall Study|Lost to Follow-up|39|||
129988651|NCT03271021|467921083|FG000|Overall Study|Protocol Violation|6|||
129988652|NCT03271021|467921084|FG001|Overall Study|Protocol Violation|4|||
129988653|NCT03271021|467921083|FG000|Overall Study|Abnormal Lab Results|1|||
129988654|NCT03271021|467921084|FG001|Overall Study|Abnormal Lab Results|0|||
129988655|NCT03271021|467921083|FG000|Overall Study|Miscellaneous|9|||
129988656|NCT03271021|467921084|FG001|Overall Study|Miscellaneous|8|||
129988657|NCT02257567|467921091|FG000|Overall Study|Adverse Event|0|||
129988658|NCT02257567|467921092|FG001|Overall Study|Adverse Event|0|||
129988659|NCT02257567|467921093|FG002|Overall Study|Adverse Event|0|||
129988660|NCT02257567|467921094|FG003|Overall Study|Adverse Event|1|||
129988661|NCT02257567|467921095|FG004|Overall Study|Adverse Event|1|||
129988662|NCT02257567|467921096|FG005|Overall Study|Adverse Event|0|||
129988663|NCT02257567|467921097|FG006|Overall Study|Adverse Event|0|||
129988664|NCT02257567|467921098|FG007|Overall Study|Adverse Event|0|||
129988665|NCT02257567|467921099|FG008|Overall Study|Adverse Event|1|||
129988666|NCT02257567|467921100|FG009|Overall Study|Adverse Event|0|||
129988667|NCT02257567|467921101|FG010|Overall Study|Adverse Event|0|||
129988668|NCT02257567|467921091|FG000|Overall Study|Death|2|||
129988669|NCT02257567|467921092|FG001|Overall Study|Death|2|||
129988670|NCT02257567|467921093|FG002|Overall Study|Death|2|||
129988671|NCT02257567|467921094|FG003|Overall Study|Death|4|||
129988672|NCT02257567|467921095|FG004|Overall Study|Death|15|||
129988673|NCT02257567|467921096|FG005|Overall Study|Death|11|||
129988674|NCT02257567|467921097|FG006|Overall Study|Death|26|||
129988675|NCT02257567|467921098|FG007|Overall Study|Death|30|||
129988676|NCT02257567|467921099|FG008|Overall Study|Death|2|||
129988677|NCT02257567|467921100|FG009|Overall Study|Death|18|||
129988678|NCT02257567|467921101|FG010|Overall Study|Death|65|||
129988679|NCT02257567|467921091|FG000|Overall Study|Lost to Follow-up|0|||
129988680|NCT02257567|467921092|FG001|Overall Study|Lost to Follow-up|0|||
129988681|NCT02257567|467921093|FG002|Overall Study|Lost to Follow-up|0|||
129988682|NCT02257567|467921094|FG003|Overall Study|Lost to Follow-up|0|||
129988683|NCT02257567|467921095|FG004|Overall Study|Lost to Follow-up|2|||
129988684|NCT02257567|467921096|FG005|Overall Study|Lost to Follow-up|2|||
129988685|NCT02257567|467921097|FG006|Overall Study|Lost to Follow-up|0|||
129988686|NCT02257567|467921098|FG007|Overall Study|Lost to Follow-up|0|||
129988687|NCT02257567|467921099|FG008|Overall Study|Lost to Follow-up|0|||
129988688|NCT02257567|467921100|FG009|Overall Study|Lost to Follow-up|1|||
129988689|NCT02257567|467921101|FG010|Overall Study|Lost to Follow-up|1|||
129658825|NCT00460239|466711665|FG005|Overall Study|Withdrawal by Subject|1|||
129988690|NCT02257567|467921091|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988691|NCT02257567|467921092|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988692|NCT02257567|467921093|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129658826|NCT00460239|466711666|FG006|Overall Study|Withdrawal by Subject|0|||
129658827|NCT00460239|466711667|FG007|Overall Study|Withdrawal by Subject|0|||
129658828|NCT00460239|466711668|FG008|Overall Study|Withdrawal by Subject|0|||
129988693|NCT02257567|467921094|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988694|NCT02257567|467921095|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
129658829|NCT04217317|466711696|FG000|Overall Study|Lack of Efficacy|4|||
129658830|NCT04217317|466711696|FG000|Overall Study|Physician Decision|1|||
129658831|NCT04313400|466711700|FG000|Overall Study|Withdrawal by Subject|0|||
129658832|NCT04313400|466711701|FG001|Overall Study|Withdrawal by Subject|0|||
129658833|NCT04313400|466711702|FG002|Overall Study|Withdrawal by Subject|0|||
129658834|NCT04313400|466711703|FG003|Overall Study|Withdrawal by Subject|0|||
129658835|NCT04313400|466711704|FG004|Overall Study|Withdrawal by Subject|0|||
129658836|NCT04313400|466711705|FG005|Overall Study|Withdrawal by Subject|4|||
129658837|NCT04313400|466711706|FG006|Overall Study|Withdrawal by Subject|1|||
129658838|NCT04313400|466711700|FG000|Overall Study|Adverse Event|0|||
129658839|NCT04313400|466711701|FG001|Overall Study|Adverse Event|0|||
129658840|NCT04313400|466711702|FG002|Overall Study|Adverse Event|0|||
129658841|NCT04313400|466711703|FG003|Overall Study|Adverse Event|0|||
129658842|NCT04313400|466711704|FG004|Overall Study|Adverse Event|0|||
129658843|NCT04313400|466711705|FG005|Overall Study|Adverse Event|1|||
129658844|NCT04313400|466711706|FG006|Overall Study|Adverse Event|0|||
129658845|NCT04313400|466711700|FG000|Overall Study|Lost to Follow-up|0|||
129658846|NCT04313400|466711701|FG001|Overall Study|Lost to Follow-up|0|||
129658847|NCT04313400|466711702|FG002|Overall Study|Lost to Follow-up|0|||
129658848|NCT04313400|466711703|FG003|Overall Study|Lost to Follow-up|0|||
129658849|NCT04313400|466711704|FG004|Overall Study|Lost to Follow-up|0|||
129658850|NCT04313400|466711705|FG005|Overall Study|Lost to Follow-up|1|||
129658851|NCT04313400|466711706|FG006|Overall Study|Lost to Follow-up|0|||
129658852|NCT00770913|466711709|FG000|Overall Study|Adverse Event|1|||
129658853|NCT00770913|466711710|FG001|Overall Study|Adverse Event|3|||
129658854|NCT00770913|466711711|FG002|Overall Study|Adverse Event|6|||
129658855|NCT00770913|466711709|FG000|Overall Study|Refusal to continue participation|6|||
129658856|NCT00770913|466711710|FG001|Overall Study|Refusal to continue participation|4|||
129658857|NCT00770913|466711711|FG002|Overall Study|Refusal to continue participation|5|||
129658858|NCT00770913|466711709|FG000|Overall Study|Physician Decision|0|||
129658859|NCT00770913|466711710|FG001|Overall Study|Physician Decision|1|||
129658860|NCT00770913|466711711|FG002|Overall Study|Physician Decision|1|||
129658861|NCT00770913|466711709|FG000|Overall Study|Protocol Violation|3|||
129658862|NCT00770913|466711710|FG001|Overall Study|Protocol Violation|0|||
129658863|NCT00770913|466711711|FG002|Overall Study|Protocol Violation|1|||
129658864|NCT00770913|466711709|FG000|Overall Study|Incorrect drug was allocated|1|||
129658865|NCT00770913|466711710|FG001|Overall Study|Incorrect drug was allocated|0|||
129658866|NCT00770913|466711711|FG002|Overall Study|Incorrect drug was allocated|0|||
129658867|NCT00359294|466711712|FG000|Overall Study|Progressive disease|1|||
129658868|NCT00359294|466711713|FG001|Overall Study|Progressive disease|1|||
129658869|NCT00359294|466711714|FG002|Overall Study|Progressive disease|2|||
129658870|NCT00359294|466711715|FG003|Overall Study|Progressive disease|3|||
129658871|NCT00359294|466711716|FG004|Overall Study|Progressive disease|2|||
129658872|NCT00359294|466711712|FG000|Overall Study|Withdrawal by Subject|0|||
129658873|NCT00359294|466711713|FG001|Overall Study|Withdrawal by Subject|0|||
129658874|NCT00359294|466711714|FG002|Overall Study|Withdrawal by Subject|0|||
129658875|NCT00359294|466711715|FG003|Overall Study|Withdrawal by Subject|0|||
129658876|NCT00359294|466711716|FG004|Overall Study|Withdrawal by Subject|1|||
129658877|NCT00359294|466711712|FG000|Overall Study|Not treated|0|||
129658878|NCT00359294|466711713|FG001|Overall Study|Not treated|0|||
129658879|NCT00359294|466711714|FG002|Overall Study|Not treated|0|||
129658880|NCT00359294|466711715|FG003|Overall Study|Not treated|1|||
129658881|NCT00359294|466711716|FG004|Overall Study|Not treated|0|||
129658882|NCT00359294|466711712|FG000|Overall Study|Physician Decision|0|||
129658883|NCT00359294|466711713|FG001|Overall Study|Physician Decision|0|||
129658884|NCT00359294|466711714|FG002|Overall Study|Physician Decision|1|||
129658885|NCT00359294|466711715|FG003|Overall Study|Physician Decision|0|||
129658886|NCT00359294|466711716|FG004|Overall Study|Physician Decision|0|||
129658887|NCT01808222|466711717|FG000|Overall Study|mpMR scan was not performed|1|||
129658888|NCT00524680|466711720|FG000|Overall Study|progression|0|||
129658889|NCT00524680|466711721|FG001|Overall Study|progression|0|||
129658890|NCT00524680|466711722|FG002|Overall Study|progression|0|||
129658891|NCT00524680|466711723|FG003|Overall Study|progression|1|||
129658892|NCT00524680|466711720|FG000|Overall Study|Adverse Event|2|||
129658893|NCT00524680|466711721|FG001|Overall Study|Adverse Event|0|||
129658894|NCT00524680|466711722|FG002|Overall Study|Adverse Event|0|||
129658895|NCT00524680|466711723|FG003|Overall Study|Adverse Event|1|||
129658896|NCT00524680|466711720|FG000|Overall Study|Other|0|||
129658897|NCT00524680|466711721|FG001|Overall Study|Other|1|||
129658898|NCT00524680|466711722|FG002|Overall Study|Other|2|||
129658899|NCT00524680|466711723|FG003|Overall Study|Other|3|||
129658900|NCT00524680|466711720|FG000|Overall Study|Withdrawal by Subject|1|||
129658901|NCT00524680|466711721|FG001|Overall Study|Withdrawal by Subject|0|||
129658902|NCT00524680|466711722|FG002|Overall Study|Withdrawal by Subject|1|||
129658903|NCT00524680|466711723|FG003|Overall Study|Withdrawal by Subject|1|||
129658904|NCT03124537|466711724|FG000|Overall Study|Lost to Follow-up|3|||
129658905|NCT03124537|466711725|FG001|Overall Study|Lost to Follow-up|5|||
129658906|NCT03124537|466711724|FG000|Overall Study|App Crash, Incomplete Data|7|||
129658907|NCT03124537|466711725|FG001|Overall Study|App Crash, Incomplete Data|8|||
129658908|NCT03681184|466711726|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
129658909|NCT03681184|466711727|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
129658910|NCT01607346|466711730|FG000|Overall Study|Adverse Event|3|||
129658911|NCT01098162|466711731|FG000|Overall Study|Adverse Event|37|||
129658912|NCT01098162|466711731|FG000|Overall Study|Lack of Efficacy|4|||
129658913|NCT01098162|466711731|FG000|Overall Study|Wish of Patient|7|||
129658914|NCT01098162|466711731|FG000|Overall Study|Lost to Follow-up|9|||
129658915|NCT01098162|466711731|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
129658916|NCT01098162|466711731|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
129658917|NCT01098162|466711731|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
129658918|NCT01098162|466711731|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
129658919|NCT01098162|466711731|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
129658920|NCT01098162|466711731|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
129658921|NCT01098162|466711731|FG000|Overall Study|Other Reason|1|||
129658922|NCT01098162|466711731|FG000|Overall Study|Reason Unknown|26|||
129658923|NCT00625183|466711732|FG000|Overall Study|Disease Progression|1|||
129658924|NCT04318132|466711733|FG000|Overall Study|Protocol Violation|0|||
129658925|NCT04318132|466711734|FG001|Overall Study|Protocol Violation|0|||
129658926|NCT04318132|466711735|FG002|Overall Study|Protocol Violation|3|||
129658927|NCT04318132|466711736|FG003|Overall Study|Protocol Violation|0|||
129658928|NCT04424914|466711737|FG000|Overall Study|Other|0|||
129658929|NCT04424914|466711738|FG001|Overall Study|Other|0|||
129658930|NCT04424914|466711739|FG002|Overall Study|Other|28|||
129658931|NCT04424914|466711737|FG000|Overall Study|Withdrawal by Subject|3|||
129658932|NCT04424914|466711738|FG001|Overall Study|Withdrawal by Subject|0|||
129658933|NCT04424914|466711739|FG002|Overall Study|Withdrawal by Subject|0|||
129658934|NCT04424914|466711737|FG000|Overall Study|Study terminated by sponsor|23|||
129658935|NCT04424914|466711738|FG001|Overall Study|Study terminated by sponsor|7|||
129658936|NCT04424914|466711739|FG002|Overall Study|Study terminated by sponsor|0|||
129658937|NCT04424914|466711737|FG000|Overall Study|Lost to Follow-up|0|||
129658938|NCT04424914|466711738|FG001|Overall Study|Lost to Follow-up|0|||
129658939|NCT04424914|466711739|FG002|Overall Study|Lost to Follow-up|1|||
129658940|NCT04424914|466711737|FG000|Overall Study|Death|3|||
129658941|NCT04424914|466711738|FG001|Overall Study|Death|1|||
129658942|NCT04424914|466711739|FG002|Overall Study|Death|0|||
129658943|NCT01778751|466711744|FG000|Overall Study|Lost to Follow-up|1|||
129658944|NCT01778751|466711745|FG001|Overall Study|Lost to Follow-up|0|||
129658945|NCT01778751|466711744|FG000|Overall Study|Withdrawal by Subject|0|||
129658946|NCT01778751|466711745|FG001|Overall Study|Withdrawal by Subject|2|||
129658947|NCT01778751|466711744|FG000|Overall Study|Transfered care|1|||
129658948|NCT01778751|466711745|FG001|Overall Study|Transfered care|0|||
129658949|NCT02685072|466711753|FG000|Treatment Period|Lost to Follow-up|12|||
129658950|NCT02685072|466711754|FG001|Treatment Period|Lost to Follow-up|6|||
129658951|NCT02685072|466711753|FG000|Treatment Period|Withdrawal by Subject|1|||
129658952|NCT02685072|466711754|FG001|Treatment Period|Withdrawal by Subject|3|||
129658953|NCT02685072|466711753|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
129658954|NCT02685072|466711754|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
129658955|NCT02634710|466711755|FG000|Overall Study|Death|4|||
129658956|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
129658957|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658958|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658959|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658960|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658961|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658962|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658963|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658964|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
129658965|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129658966|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
129658967|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
129658968|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
129658969|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129658970|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
129658971|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
129658972|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129658973|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
129658974|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
129658975|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
129658976|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
129658977|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
129658978|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
129988695|NCT02257567|467921096|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129658979|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
129658980|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
129988696|NCT02257567|467921097|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
129988697|NCT02257567|467921098|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988698|NCT02257567|467921099|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988699|NCT02257567|467921100|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988700|NCT02257567|467921101|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
129988701|NCT02257567|467921091|FG000|Overall Study|Physician Decision|0|||
129988702|NCT02257567|467921092|FG001|Overall Study|Physician Decision|0|||
129988703|NCT02257567|467921093|FG002|Overall Study|Physician Decision|0|||
129988704|NCT02257567|467921094|FG003|Overall Study|Physician Decision|0|||
129988705|NCT02257567|467921095|FG004|Overall Study|Physician Decision|0|||
129988706|NCT02257567|467921096|FG005|Overall Study|Physician Decision|0|||
129988707|NCT02257567|467921097|FG006|Overall Study|Physician Decision|0|||
129988708|NCT02257567|467921098|FG007|Overall Study|Physician Decision|2|||
129988709|NCT02257567|467921099|FG008|Overall Study|Physician Decision|0|||
129988710|NCT02257567|467921100|FG009|Overall Study|Physician Decision|1|||
129988711|NCT02257567|467921101|FG010|Overall Study|Physician Decision|0|||
129988712|NCT02257567|467921091|FG000|Overall Study|Withdrawal by Subject|0|||
129988713|NCT02257567|467921092|FG001|Overall Study|Withdrawal by Subject|0|||
129988714|NCT02257567|467921093|FG002|Overall Study|Withdrawal by Subject|2|||
129988715|NCT02257567|467921094|FG003|Overall Study|Withdrawal by Subject|0|||
129988716|NCT02257567|467921095|FG004|Overall Study|Withdrawal by Subject|0|||
129988717|NCT02257567|467921096|FG005|Overall Study|Withdrawal by Subject|6|||
129988718|NCT02257567|467921097|FG006|Overall Study|Withdrawal by Subject|6|||
129988719|NCT02257567|467921098|FG007|Overall Study|Withdrawal by Subject|6|||
129988720|NCT02257567|467921099|FG008|Overall Study|Withdrawal by Subject|1|||
129988721|NCT02257567|467921100|FG009|Overall Study|Withdrawal by Subject|1|||
129988722|NCT02257567|467921101|FG010|Overall Study|Withdrawal by Subject|10|||
129988723|NCT01065844|467921108|FG000|Overall Study|Adverse Event|5|||
129988724|NCT00577473|467921111|FG000|Overall Study|Protocol Violation|1|||
129988725|NCT00577473|467921112|FG001|Overall Study|Protocol Violation|4|||
129988726|NCT00577473|467921111|FG000|Overall Study|Adverse Event|8|||
129988727|NCT00577473|467921112|FG001|Overall Study|Adverse Event|5|||
129988728|NCT00577473|467921111|FG000|Overall Study|Withdrawal by Subject|2|||
129988729|NCT00577473|467921112|FG001|Overall Study|Withdrawal by Subject|6|||
129988730|NCT00577473|467921111|FG000|Overall Study|Physician Decision|2|||
129988731|NCT00577473|467921112|FG001|Overall Study|Physician Decision|2|||
129988732|NCT00577473|467921111|FG000|Overall Study|Lack of Efficacy|8|||
129988733|NCT00577473|467921112|FG001|Overall Study|Lack of Efficacy|7|||
129988734|NCT02884908|467921115|FG000|Overall Study|Lost to Follow-up|13|||
129988735|NCT02884908|467921116|FG001|Overall Study|Lost to Follow-up|18|||
129988736|NCT02084056|467921127|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
129988737|NCT02084056|467921128|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129988738|NCT02084056|467921129|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129988739|NCT02084056|467921130|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129988740|NCT02084056|467921127|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
129988741|NCT02084056|467921128|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129988742|NCT02084056|467921129|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129988743|NCT02084056|467921130|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129988744|NCT02413333|467921132|FG000|Period 1|Adverse Event|1|||
129988745|NCT02413333|467921133|FG001|Period 1|Adverse Event|0|||
129988746|NCT02413333|467921132|FG000|Period 1|Reason Not Specified|0|||
129988747|NCT02413333|467921133|FG001|Period 1|Reason Not Specified|1|||
129988748|NCT02413333|467921132|FG000|Period 2|Protocol Deviation|1|||
129988749|NCT02413333|467921133|FG001|Period 2|Protocol Deviation|0|||
129988750|NCT00709852|467921134|FG000|Period 1|Adverse Event|2|||
129988751|NCT00709852|467921135|FG001|Period 1|Adverse Event|0|||
129988752|NCT00709852|467921134|FG000|Period 1|Withdrawal by Subject|4|||
129988753|NCT00709852|467921135|FG001|Period 1|Withdrawal by Subject|2|||
129988754|NCT00709852|467921134|FG000|Period 1|Protocol Violation|1|||
129988755|NCT00709852|467921135|FG001|Period 1|Protocol Violation|0|||
129988756|NCT00709852|467921134|FG000|Period 1|Defective scanner|0|||
129988757|NCT00709852|467921135|FG001|Period 1|Defective scanner|1|||
129988758|NCT00709852|467921134|FG000|Period 1|Lost to Follow-up|1|||
129988759|NCT00709852|467921135|FG001|Period 1|Lost to Follow-up|0|||
129988760|NCT00709852|467921134|FG000|Period 2|Protocol Violation|4|||
129988761|NCT00709852|467921135|FG001|Period 2|Protocol Violation|1|||
129988762|NCT00709852|467921134|FG000|Period 2|Adverse Event|1|||
129988763|NCT00709852|467921135|FG001|Period 2|Adverse Event|1|||
129988764|NCT00709852|467921134|FG000|Period 2|Lost to Follow-up|1|||
129988765|NCT00709852|467921135|FG001|Period 2|Lost to Follow-up|0|||
129988766|NCT00709852|467921134|FG000|Period 2|No 72-hour follow-up|3|||
129988767|NCT00709852|467921135|FG001|Period 2|No 72-hour follow-up|0|||
129988768|NCT02951767|467921136|FG000|Overall Study|Study Terminated By Sponsor|9|||
129658981|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
129658982|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
129658983|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
129658984|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
129658985|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
129658986|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
129658987|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
129658988|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
129658989|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
129658990|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
129658991|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
129658992|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129658993|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129658994|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129658995|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
129658996|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129658997|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
129658998|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129658999|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129659000|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
129659001|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129659002|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129659003|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129988769|NCT02951767|467921136|FG000|Overall Study|Withdrawal by Subject|11|||
129659004|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129659005|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129659006|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
129659007|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129659008|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129659009|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
129659010|NCT00528372|466711756|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
129659011|NCT00528372|466711757|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129659012|NCT00528372|466711758|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129659013|NCT00528372|466711759|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
129659014|NCT00528372|466711760|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129659015|NCT00528372|466711761|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129659016|NCT00528372|466711762|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129659017|NCT00528372|466711763|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
129659018|NCT00528372|466711764|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
129659019|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
129659020|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
129988770|NCT02951767|467921136|FG000|Overall Study|Death|96|||
129988771|NCT02951767|467921136|FG000|Overall Study|Lost to Follow-up|2|||
129988772|NCT02951767|467921136|FG000|Overall Study|Physician Decision|1|||
129988773|NCT01048671|467921137|FG000|Overall Study|Protocol Violation|0|||
129988774|NCT01048671|467921138|FG001|Overall Study|Protocol Violation|1|||
129988775|NCT01048671|467921139|FG002|Overall Study|Protocol Violation|1|||
129988776|NCT03814187|467921140|FG000|Overall Study|Sponsor's Administrative Decision|0|||
129988777|NCT03814187|467921141|FG001|Overall Study|Sponsor's Administrative Decision|0|||
129988778|NCT03814187|467921142|FG002|Overall Study|Sponsor's Administrative Decision|272|||
129988779|NCT03814187|467921140|FG000|Overall Study|Death|80|||
129988780|NCT03814187|467921141|FG001|Overall Study|Death|81|||
129988781|NCT03814187|467921142|FG002|Overall Study|Death|4|||
129988782|NCT03814187|467921140|FG000|Overall Study|Withdrew Consent|77|||
129988783|NCT03814187|467921141|FG001|Overall Study|Withdrew Consent|78|||
129988784|NCT03814187|467921142|FG002|Overall Study|Withdrew Consent|2|||
129988785|NCT03814187|467921140|FG000|Overall Study|Lost to Follow-up|47|||
129988786|NCT03814187|467921141|FG001|Overall Study|Lost to Follow-up|52|||
129988787|NCT03814187|467921142|FG002|Overall Study|Lost to Follow-up|1|||
129988788|NCT03814187|467921140|FG000|Overall Study|Adverse Event|22|||
129988789|NCT03814187|467921141|FG001|Overall Study|Adverse Event|23|||
129988790|NCT03814187|467921142|FG002|Overall Study|Adverse Event|0|||
129988791|NCT03814187|467921140|FG000|Overall Study|Physician Decision|7|||
129659021|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
129988792|NCT03814187|467921141|FG001|Overall Study|Physician Decision|4|||
129988793|NCT03814187|467921142|FG002|Overall Study|Physician Decision|2|||
129988794|NCT03814187|467921140|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
129988795|NCT03814187|467921141|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
129659022|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129659023|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129659024|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
129659025|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
129659026|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
129659027|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
129659028|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
129659029|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
129659030|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
129659031|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
129659032|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
129659033|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
129659034|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
129659035|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
129659036|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
129659037|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
129659038|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
129659039|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
129659040|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
129659041|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
129659042|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
129659043|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
129659044|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
129659045|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
129659046|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
129659047|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
129659048|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
129659049|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
129659050|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
129659051|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
129659052|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
129659053|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
129659054|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
129659055|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129659056|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129659057|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129659058|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129659059|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129659060|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129659061|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
129659062|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129659063|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
129659064|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659065|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659066|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659067|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659068|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
129659069|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
129659070|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659071|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659072|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
129659073|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129659074|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
129659075|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129659076|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129659077|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129659078|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129659079|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
129659080|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
129659081|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
129546309|NCT02044094|466292471|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
129659082|NCT00528372|466711756|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
129659083|NCT00528372|466711757|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
129659084|NCT00528372|466711758|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
129659085|NCT00528372|466711759|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
129659086|NCT00528372|466711760|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
129659087|NCT00528372|466711761|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
129659088|NCT00528372|466711762|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
129659089|NCT00528372|466711763|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
129659090|NCT00528372|466711764|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
129659091|NCT02432144|466711768|FG000|Overall Study|Participant Non-Compliance|1|||
129659092|NCT01451554|466711769|FG000|Overall Study|Withdrawal by Subject|14|||
129659093|NCT01451554|466711770|FG001|Overall Study|Withdrawal by Subject|9|||
129659094|NCT01402986|466711771|FG000|Overall Study|Withdrawal by Subject|7|||
129659095|NCT01402986|466711772|FG001|Overall Study|Withdrawal by Subject|10|||
129659096|NCT01402986|466711773|FG002|Overall Study|Withdrawal by Subject|7|||
129659097|NCT01402986|466711774|FG003|Overall Study|Withdrawal by Subject|13|||
129659098|NCT01402986|466711771|FG000|Overall Study|Death|0|||
129659099|NCT01402986|466711772|FG001|Overall Study|Death|0|||
129659100|NCT01402986|466711773|FG002|Overall Study|Death|0|||
129659101|NCT01402986|466711774|FG003|Overall Study|Death|2|||
129659102|NCT01402986|466711771|FG000|Overall Study|Lost to Follow-up|0|||
129659103|NCT01402986|466711772|FG001|Overall Study|Lost to Follow-up|0|||
129659104|NCT01402986|466711773|FG002|Overall Study|Lost to Follow-up|0|||
129659105|NCT01402986|466711774|FG003|Overall Study|Lost to Follow-up|1|||
129659106|NCT01402986|466711771|FG000|Overall Study|Other|2|||
129988796|NCT03814187|467921142|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
129659107|NCT01402986|466711772|FG001|Overall Study|Other|5|||
129659108|NCT01402986|466711773|FG002|Overall Study|Other|1|||
129659109|NCT01402986|466711774|FG003|Overall Study|Other|6|||
129659110|NCT02427802|466711775|FG000|Overall Study|Adverse Event|11|||
129659111|NCT02427802|466711776|FG001|Overall Study|Adverse Event|3|||
129659112|NCT02427802|466711777|FG002|Overall Study|Adverse Event|7|||
129659113|NCT02427802|466711775|FG000|Overall Study|Death|0|||
129659114|NCT02427802|466711776|FG001|Overall Study|Death|4|||
129659115|NCT02427802|466711777|FG002|Overall Study|Death|1|||
129659116|NCT02427802|466711775|FG000|Overall Study|Lost to Follow-up|13|||
129659117|NCT02427802|466711776|FG001|Overall Study|Lost to Follow-up|8|||
129659118|NCT02427802|466711777|FG002|Overall Study|Lost to Follow-up|8|||
129659119|NCT02427802|466711775|FG000|Overall Study|Physician Decision|4|||
129659120|NCT02427802|466711776|FG001|Overall Study|Physician Decision|2|||
129659121|NCT02427802|466711777|FG002|Overall Study|Physician Decision|4|||
129659122|NCT02427802|466711775|FG000|Overall Study|Withdrawal by Subject|10|||
129659123|NCT02427802|466711776|FG001|Overall Study|Withdrawal by Subject|5|||
129659124|NCT02427802|466711777|FG002|Overall Study|Withdrawal by Subject|11|||
129659125|NCT02427802|466711775|FG000|Overall Study|Protocol Violation|3|||
129659126|NCT02427802|466711776|FG001|Overall Study|Protocol Violation|1|||
129659127|NCT02427802|466711777|FG002|Overall Study|Protocol Violation|1|||
129659128|NCT02427802|466711775|FG000|Overall Study|protocol specific treatment unrelated|18|||
129659129|NCT02427802|466711776|FG001|Overall Study|protocol specific treatment unrelated|11|||
129659130|NCT02427802|466711777|FG002|Overall Study|protocol specific treatment unrelated|11|||
129988797|NCT03814187|467921140|FG000|Overall Study|Other reasons|34|||
129988798|NCT03814187|467921141|FG001|Overall Study|Other reasons|40|||
129988799|NCT03814187|467921142|FG002|Overall Study|Other reasons|2|||
129988800|NCT00196976|467921143|FG000|Primary Study|Migrated from study area|0|||
129988801|NCT00196976|467921144|FG001|Primary Study|Migrated from study area|0|||
129988802|NCT00196976|467921145|FG002|Primary Study|Migrated from study area|0|||
129988803|NCT00196976|467921146|FG003|Primary Study|Migrated from study area|0|||
129988804|NCT00196976|467921147|FG004|Primary Study|Migrated from study area|0|||
129988805|NCT00196976|467921148|FG005|Primary Study|Migrated from study area|0|||
129988806|NCT00196976|467921149|FG006|Primary Study|Migrated from study area|0|||
129988807|NCT00196976|467921150|FG007|Primary Study|Migrated from study area|1|||
129988808|NCT00196976|467921151|FG008|Primary Study|Migrated from study area|0|||
129988809|NCT00196976|467921152|FG009|Primary Study|Migrated from study area|0|||
129988810|NCT00196976|467921153|FG010|Primary Study|Migrated from study area|0|||
129988811|NCT00196976|467921154|FG011|Primary Study|Migrated from study area|0|||
129988812|NCT00196976|467921155|FG012|Primary Study|Migrated from study area|0|||
129988813|NCT00196976|467921156|FG013|Primary Study|Migrated from study area|0|||
129988814|NCT00196976|467921143|FG000|Primary Study|Protocol Violation|0|||
129988815|NCT00196976|467921144|FG001|Primary Study|Protocol Violation|1|||
129659131|NCT01085084|466711778|FG000|Overall Study|Withdrawal by Subject|1|||
129659132|NCT01085084|466711779|FG001|Overall Study|Withdrawal by Subject|0|||
129659133|NCT01085084|466711780|FG002|Overall Study|Withdrawal by Subject|0|||
129659134|NCT01085084|466711778|FG000|Overall Study|Lost to Follow-up|2|||
129659135|NCT01085084|466711779|FG001|Overall Study|Lost to Follow-up|1|||
129659136|NCT01085084|466711780|FG002|Overall Study|Lost to Follow-up|1|||
129659137|NCT01085084|466711778|FG000|Overall Study|Adverse Event|4|||
129659138|NCT01085084|466711779|FG001|Overall Study|Adverse Event|3|||
129659139|NCT01085084|466711780|FG002|Overall Study|Adverse Event|6|||
129659140|NCT01085084|466711778|FG000|Overall Study|Treatment Failure|0|||
129659141|NCT01085084|466711779|FG001|Overall Study|Treatment Failure|1|||
129659142|NCT01085084|466711780|FG002|Overall Study|Treatment Failure|2|||
129659143|NCT02070978|466711781|FG000|Overall Study|Adverse Event|6|||
129659144|NCT02070978|466711782|FG001|Overall Study|Adverse Event|2|||
129659145|NCT02070978|466711783|FG002|Overall Study|Adverse Event|0|||
129659146|NCT02070978|466711781|FG000|Overall Study|Lost to Follow-up|1|||
129659147|NCT02070978|466711782|FG001|Overall Study|Lost to Follow-up|3|||
129659148|NCT02070978|466711783|FG002|Overall Study|Lost to Follow-up|4|||
129659149|NCT02070978|466711781|FG000|Overall Study|Withdrawal by Subject|3|||
129659150|NCT02070978|466711782|FG001|Overall Study|Withdrawal by Subject|5|||
129659151|NCT02070978|466711783|FG002|Overall Study|Withdrawal by Subject|3|||
129659152|NCT02070978|466711781|FG000|Overall Study|Protocol Violation|1|||
129659153|NCT02070978|466711782|FG001|Overall Study|Protocol Violation|0|||
129659154|NCT02070978|466711783|FG002|Overall Study|Protocol Violation|3|||
129659155|NCT02070978|466711781|FG000|Overall Study|Lack of Efficacy|0|||
129659156|NCT02070978|466711782|FG001|Overall Study|Lack of Efficacy|1|||
129659157|NCT02070978|466711783|FG002|Overall Study|Lack of Efficacy|0|||
129659158|NCT02070978|466711781|FG000|Overall Study|Death|0|||
129659159|NCT02070978|466711782|FG001|Overall Study|Death|0|||
129659160|NCT02070978|466711783|FG002|Overall Study|Death|2|||
129659161|NCT02070978|466711781|FG000|Overall Study|Un-specified|3|||
129659162|NCT02070978|466711782|FG001|Overall Study|Un-specified|2|||
129659163|NCT02070978|466711783|FG002|Overall Study|Un-specified|2|||
129659164|NCT02070978|466711781|FG000|Overall Study|Terminated by Sponsor|33|||
129659165|NCT02070978|466711782|FG001|Overall Study|Terminated by Sponsor|40|||
129659166|NCT02070978|466711783|FG002|Overall Study|Terminated by Sponsor|39|||
129659167|NCT02634983|466711784|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
129659168|NCT02634983|466711785|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
129659169|NCT03951753|466711786|FG000|Overall Study|Adverse Event|1|||
129659170|NCT03951753|466711787|FG001|Overall Study|Adverse Event|0|||
129659171|NCT03951753|466711788|FG002|Overall Study|Adverse Event|3|||
129659172|NCT03951753|466711786|FG000|Overall Study|Withdrawal by Subject|3|||
129659173|NCT03951753|466711787|FG001|Overall Study|Withdrawal by Subject|1|||
129659174|NCT03951753|466711788|FG002|Overall Study|Withdrawal by Subject|0|||
129659175|NCT03951753|466711786|FG000|Overall Study|Lost to Follow-up|0|||
129659176|NCT03951753|466711787|FG001|Overall Study|Lost to Follow-up|0|||
129659177|NCT03951753|466711788|FG002|Overall Study|Lost to Follow-up|1|||
129659178|NCT03178851|466711789|FG000|Overall Study|Death|48|||
129659179|NCT03178851|466711790|FG001|Overall Study|Death|2|||
129659180|NCT03178851|466711791|FG002|Overall Study|Death|25|||
129659181|NCT03178851|466711789|FG000|Overall Study|Withdrawal by Subject|8|||
129659182|NCT03178851|466711790|FG001|Overall Study|Withdrawal by Subject|0|||
129659183|NCT03178851|466711791|FG002|Overall Study|Withdrawal by Subject|0|||
129659184|NCT03178851|466711789|FG000|Overall Study|Lost to Follow-up|5|||
129659185|NCT03178851|466711790|FG001|Overall Study|Lost to Follow-up|2|||
129659186|NCT03178851|466711791|FG002|Overall Study|Lost to Follow-up|0|||
129659187|NCT03178851|466711789|FG000|Overall Study|Adverse Event|0|||
129659188|NCT03178851|466711790|FG001|Overall Study|Adverse Event|0|||
129659189|NCT03178851|466711791|FG002|Overall Study|Adverse Event|1|||
129659190|NCT03178851|466711789|FG000|Overall Study|Study Termination by Sponsor|31|||
129659191|NCT03178851|466711790|FG001|Overall Study|Study Termination by Sponsor|7|||
129659192|NCT03178851|466711791|FG002|Overall Study|Study Termination by Sponsor|26|||
129659193|NCT02669043|466711796|FG000|Overall Study|Didn't meet I/E criteria|4|||
129659194|NCT02552888|466711799|FG000|Overall Study|Lost to Follow-up|1|||
129659195|NCT02552888|466711800|FG001|Overall Study|Lost to Follow-up|1|||
129659196|NCT00401193|466714379|FG000|Overall Study|Adverse Event|1|||
129659197|NCT00401193|466714380|FG001|Overall Study|Adverse Event|3|||
129659198|NCT00401193|466714381|FG002|Overall Study|Adverse Event|1|||
129988816|NCT00196976|467921145|FG002|Primary Study|Protocol Violation|1|||
129988817|NCT00196976|467921146|FG003|Primary Study|Protocol Violation|0|||
129659199|NCT00401193|466714379|FG000|Overall Study|Protocol Violation|3|||
129988818|NCT00196976|467921147|FG004|Primary Study|Protocol Violation|0|||
129659200|NCT00401193|466714380|FG001|Overall Study|Protocol Violation|1|||
129988819|NCT00196976|467921148|FG005|Primary Study|Protocol Violation|0|||
129659201|NCT00401193|466714381|FG002|Overall Study|Protocol Violation|1|||
129659202|NCT00401193|466714379|FG000|Overall Study|Lost to Follow-up|6|||
129659203|NCT00401193|466714380|FG001|Overall Study|Lost to Follow-up|5|||
129659204|NCT00401193|466714381|FG002|Overall Study|Lost to Follow-up|1|||
129659205|NCT00401193|466714379|FG000|Overall Study|Withdrawal by Subject|2|||
129988820|NCT00196976|467921149|FG006|Primary Study|Protocol Violation|0|||
129988821|NCT00196976|467921150|FG007|Primary Study|Protocol Violation|0|||
129659206|NCT00401193|466714380|FG001|Overall Study|Withdrawal by Subject|0|||
129659207|NCT00401193|466714381|FG002|Overall Study|Withdrawal by Subject|1|||
129659208|NCT00401193|466714379|FG000|Overall Study|Other Event|3|||
129659209|NCT00401193|466714380|FG001|Overall Study|Other Event|2|||
129659210|NCT00401193|466714381|FG002|Overall Study|Other Event|2|||
129659211|NCT00398216|466714382|FG000|Overall Study|Adverse Event|4|||
129988822|NCT00196976|467921151|FG008|Primary Study|Protocol Violation|0|||
129659212|NCT00398216|466714383|FG001|Overall Study|Adverse Event|2|||
129659213|NCT00398216|466714384|FG002|Overall Study|Adverse Event|5|||
129659214|NCT00398216|466714385|FG003|Overall Study|Adverse Event|7|||
129659215|NCT00398216|466714386|FG004|Overall Study|Adverse Event|2|||
129659216|NCT00398216|466714382|FG000|Overall Study|Protocol Violation|2|||
129659217|NCT00398216|466714383|FG001|Overall Study|Protocol Violation|4|||
129659218|NCT00398216|466714384|FG002|Overall Study|Protocol Violation|5|||
129659219|NCT00398216|466714385|FG003|Overall Study|Protocol Violation|7|||
129659220|NCT00398216|466714386|FG004|Overall Study|Protocol Violation|5|||
129659221|NCT00398216|466714382|FG000|Overall Study|Lost to Follow-up|1|||
129659222|NCT00398216|466714383|FG001|Overall Study|Lost to Follow-up|6|||
129659223|NCT00398216|466714384|FG002|Overall Study|Lost to Follow-up|4|||
129659224|NCT00398216|466714385|FG003|Overall Study|Lost to Follow-up|4|||
129659225|NCT00398216|466714386|FG004|Overall Study|Lost to Follow-up|1|||
129659226|NCT00398216|466714382|FG000|Overall Study|Death|0|||
129659227|NCT00398216|466714383|FG001|Overall Study|Death|3|||
129659228|NCT00398216|466714384|FG002|Overall Study|Death|0|||
129659229|NCT00398216|466714385|FG003|Overall Study|Death|0|||
129659230|NCT00398216|466714386|FG004|Overall Study|Death|0|||
129659231|NCT00398216|466714382|FG000|Overall Study|Withdrawal by Subject|1|||
129659232|NCT00398216|466714383|FG001|Overall Study|Withdrawal by Subject|0|||
129659233|NCT00398216|466714384|FG002|Overall Study|Withdrawal by Subject|3|||
129659234|NCT00398216|466714385|FG003|Overall Study|Withdrawal by Subject|1|||
129659235|NCT00398216|466714386|FG004|Overall Study|Withdrawal by Subject|2|||
129659236|NCT00398216|466714382|FG000|Overall Study|administrative reasons|3|||
129659237|NCT00398216|466714383|FG001|Overall Study|administrative reasons|4|||
129659238|NCT00398216|466714384|FG002|Overall Study|administrative reasons|4|||
129659239|NCT00398216|466714385|FG003|Overall Study|administrative reasons|3|||
129659240|NCT00398216|466714386|FG004|Overall Study|administrative reasons|3|||
129659241|NCT00398216|466714382|FG000|Overall Study|entrance criteria|0|||
129659242|NCT00398216|466714383|FG001|Overall Study|entrance criteria|0|||
129659243|NCT00398216|466714384|FG002|Overall Study|entrance criteria|0|||
129659244|NCT00398216|466714385|FG003|Overall Study|entrance criteria|0|||
129659245|NCT00398216|466714386|FG004|Overall Study|entrance criteria|2|||
129659246|NCT00376532|466714387|FG000|Overall Study|Lack sufficient blood sample|6|||
129659247|NCT00376532|466714388|FG001|Overall Study|Lack sufficient blood sample|6|||
129659248|NCT04227405|466714389|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
129659249|NCT04227405|466714390|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
129659250|NCT04227405|466714389|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
129659251|NCT04227405|466714390|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
129659252|NCT04227405|466714389|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
129659253|NCT04227405|466714390|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
129659254|NCT02207400|466714391|FG000|Overall Study|Adverse Event|1|||
129659255|NCT02207400|466714392|FG001|Overall Study|Adverse Event|1|||
129659256|NCT02207400|466714391|FG000|Overall Study|Lost to Follow-up|6|||
129659257|NCT02207400|466714392|FG001|Overall Study|Lost to Follow-up|7|||
129659258|NCT02207400|466714391|FG000|Overall Study|Protocol Violation|1|||
129659259|NCT02207400|466714392|FG001|Overall Study|Protocol Violation|1|||
129659260|NCT02207400|466714391|FG000|Overall Study|Withdrawal by Subject|8|||
129659261|NCT02207400|466714392|FG001|Overall Study|Withdrawal by Subject|4|||
129659262|NCT02207400|466714391|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
129659263|NCT02207400|466714392|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
129659264|NCT02757352|466714395|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
129659265|NCT02757352|466714396|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659266|NCT02757352|466714397|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
129659267|NCT02757352|466714398|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659268|NCT02757352|466714399|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129988823|NCT00196976|467921152|FG009|Primary Study|Protocol Violation|0|||
129988824|NCT00196976|467921153|FG010|Primary Study|Protocol Violation|0|||
129988825|NCT00196976|467921154|FG011|Primary Study|Protocol Violation|0|||
129988826|NCT00196976|467921155|FG012|Primary Study|Protocol Violation|0|||
129659269|NCT02757352|466714400|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659270|NCT02757352|466714401|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659271|NCT02757352|466714402|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659272|NCT02757352|466714403|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659273|NCT02757352|466714404|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
129659274|NCT02757352|466714395|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659275|NCT02757352|466714396|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659276|NCT02757352|466714397|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
129659277|NCT02757352|466714398|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659278|NCT02757352|466714399|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129988827|NCT00196976|467921156|FG013|Primary Study|Protocol Violation|0|||
129988828|NCT00196976|467921143|FG000|Primary Study|Withdrawal by Subject|1|||
129546310|NCT02044094|466292471|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
129659279|NCT02757352|466714400|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659280|NCT02757352|466714401|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659281|NCT02757352|466714402|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659282|NCT02757352|466714403|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659283|NCT02757352|466714404|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
129659284|NCT02757352|466714395|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
129659285|NCT02757352|466714396|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
129659286|NCT02757352|466714397|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
129659287|NCT02757352|466714398|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659288|NCT02757352|466714399|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659289|NCT02757352|466714400|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659290|NCT02757352|466714401|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659291|NCT02757352|466714402|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659292|NCT02757352|466714403|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659293|NCT02757352|466714404|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
129659294|NCT02757352|466714395|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659295|NCT02757352|466714396|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
129659296|NCT02757352|466714397|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659297|NCT02757352|466714398|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659298|NCT02757352|466714399|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659299|NCT02757352|466714400|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659300|NCT02757352|466714401|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659301|NCT02757352|466714402|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659302|NCT02757352|466714403|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659303|NCT02757352|466714404|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
129659304|NCT02757352|466714395|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659305|NCT02757352|466714396|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129659306|NCT02757352|466714397|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659307|NCT02757352|466714398|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659308|NCT02757352|466714399|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659309|NCT02757352|466714400|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659310|NCT02757352|466714401|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659311|NCT02757352|466714402|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659312|NCT02757352|466714403|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659313|NCT02757352|466714404|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659314|NCT02757352|466714395|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129659315|NCT02757352|466714396|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129659316|NCT02757352|466714397|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
129659317|NCT02757352|466714398|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659318|NCT02757352|466714399|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659319|NCT02757352|466714400|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659320|NCT02757352|466714401|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659321|NCT02757352|466714402|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659322|NCT02757352|466714403|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659323|NCT02757352|466714404|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659324|NCT02757352|466714395|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
129659325|NCT02757352|466714396|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
129659326|NCT02757352|466714397|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
129659327|NCT02757352|466714398|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659328|NCT02757352|466714399|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659329|NCT02757352|466714400|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659330|NCT02757352|466714401|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659331|NCT02757352|466714402|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659332|NCT02757352|466714403|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659333|NCT02757352|466714404|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
129659334|NCT02757352|466714395|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659335|NCT02757352|466714396|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659336|NCT02757352|466714397|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659337|NCT02757352|466714398|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
129659338|NCT02757352|466714399|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659339|NCT02757352|466714400|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
129988829|NCT00196976|467921144|FG001|Primary Study|Withdrawal by Subject|0|||
129659340|NCT02757352|466714401|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659341|NCT02757352|466714402|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659342|NCT02757352|466714403|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659343|NCT02757352|466714404|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
129659344|NCT02757352|466714395|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659345|NCT02757352|466714396|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659346|NCT02757352|466714397|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659347|NCT02757352|466714398|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
129659348|NCT02757352|466714399|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129659349|NCT02757352|466714400|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
129659350|NCT02757352|466714401|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659351|NCT02757352|466714402|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659352|NCT02757352|466714403|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659353|NCT02757352|466714404|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129659354|NCT02757352|466714395|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659355|NCT02757352|466714396|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659356|NCT02757352|466714397|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659357|NCT02757352|466714398|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659358|NCT02757352|466714399|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
129659359|NCT02757352|466714400|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659360|NCT02757352|466714401|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659361|NCT02757352|466714402|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659362|NCT02757352|466714403|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659363|NCT02757352|466714404|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
129659364|NCT02757352|466714395|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659365|NCT02757352|466714396|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659366|NCT02757352|466714397|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659367|NCT02757352|466714398|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659368|NCT02757352|466714399|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659369|NCT02757352|466714400|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
129659370|NCT02757352|466714401|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659371|NCT02757352|466714402|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659372|NCT02757352|466714403|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659373|NCT02757352|466714404|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
129659374|NCT02757352|466714395|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659375|NCT02757352|466714396|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659376|NCT02757352|466714397|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659377|NCT02757352|466714398|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
129659378|NCT02757352|466714399|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129659379|NCT02757352|466714400|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
129659380|NCT02757352|466714401|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659381|NCT02757352|466714402|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659382|NCT02757352|466714403|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659383|NCT02757352|466714404|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129659384|NCT02757352|466714395|FG000|Follow-Up Period|Adverse Event|0|||
129659385|NCT02757352|466714396|FG001|Follow-Up Period|Adverse Event|0|||
129659386|NCT02757352|466714397|FG002|Follow-Up Period|Adverse Event|0|||
129659387|NCT02757352|466714398|FG003|Follow-Up Period|Adverse Event|0|||
129659388|NCT02757352|466714399|FG004|Follow-Up Period|Adverse Event|0|||
129659389|NCT02757352|466714400|FG005|Follow-Up Period|Adverse Event|0|||
129659390|NCT02757352|466714401|FG006|Follow-Up Period|Adverse Event|1|||
129659391|NCT02757352|466714402|FG007|Follow-Up Period|Adverse Event|0|||
129659392|NCT02757352|466714403|FG008|Follow-Up Period|Adverse Event|2|||
129659393|NCT02757352|466714404|FG009|Follow-Up Period|Adverse Event|0|||
129659394|NCT02757352|466714395|FG000|Follow-Up Period|Lost to Follow-up|0|||
129659395|NCT02757352|466714396|FG001|Follow-Up Period|Lost to Follow-up|0|||
129659396|NCT02757352|466714397|FG002|Follow-Up Period|Lost to Follow-up|0|||
129659397|NCT02757352|466714398|FG003|Follow-Up Period|Lost to Follow-up|0|||
129659398|NCT02757352|466714399|FG004|Follow-Up Period|Lost to Follow-up|0|||
129659399|NCT02757352|466714400|FG005|Follow-Up Period|Lost to Follow-up|0|||
129659400|NCT02757352|466714401|FG006|Follow-Up Period|Lost to Follow-up|0|||
129659401|NCT02757352|466714402|FG007|Follow-Up Period|Lost to Follow-up|0|||
129659402|NCT02757352|466714403|FG008|Follow-Up Period|Lost to Follow-up|1|||
129659403|NCT02757352|466714404|FG009|Follow-Up Period|Lost to Follow-up|0|||
129659404|NCT02757352|466714395|FG000|Follow-Up Period|Lack of Efficacy|0|||
129659405|NCT02757352|466714396|FG001|Follow-Up Period|Lack of Efficacy|0|||
129659406|NCT02757352|466714397|FG002|Follow-Up Period|Lack of Efficacy|0|||
129546311|NCT02044094|466292471|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
129988830|NCT00196976|467921145|FG002|Primary Study|Withdrawal by Subject|1|||
129659407|NCT02757352|466714398|FG003|Follow-Up Period|Lack of Efficacy|0|||
129659408|NCT02757352|466714399|FG004|Follow-Up Period|Lack of Efficacy|0|||
129659409|NCT02757352|466714400|FG005|Follow-Up Period|Lack of Efficacy|0|||
129659410|NCT02757352|466714401|FG006|Follow-Up Period|Lack of Efficacy|0|||
129659411|NCT02757352|466714402|FG007|Follow-Up Period|Lack of Efficacy|0|||
129659412|NCT02757352|466714403|FG008|Follow-Up Period|Lack of Efficacy|1|||
129659413|NCT02757352|466714404|FG009|Follow-Up Period|Lack of Efficacy|1|||
129659414|NCT02757352|466714395|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129659415|NCT02757352|466714396|FG001|Follow-Up Period|Withdrawal by Subject|0|||
129659416|NCT02757352|466714397|FG002|Follow-Up Period|Withdrawal by Subject|0|||
129659417|NCT02757352|466714398|FG003|Follow-Up Period|Withdrawal by Subject|0|||
129659418|NCT02757352|466714399|FG004|Follow-Up Period|Withdrawal by Subject|0|||
129659419|NCT02757352|466714400|FG005|Follow-Up Period|Withdrawal by Subject|0|||
129659420|NCT02757352|466714401|FG006|Follow-Up Period|Withdrawal by Subject|0|||
129659421|NCT02757352|466714402|FG007|Follow-Up Period|Withdrawal by Subject|1|||
129659422|NCT02757352|466714403|FG008|Follow-Up Period|Withdrawal by Subject|6|||
129659423|NCT02757352|466714404|FG009|Follow-Up Period|Withdrawal by Subject|2|||
129659424|NCT02362425|466714405|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
129659425|NCT02362425|466714406|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
129659426|NCT02362425|466714407|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
129659427|NCT02362425|466714408|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
129659428|NCT02362425|466714405|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
129659429|NCT02362425|466714406|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
129659430|NCT02362425|466714407|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
129659431|NCT02362425|466714408|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
129659432|NCT02362425|466714405|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
129659433|NCT02362425|466714406|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
129659434|NCT02362425|466714407|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
129659435|NCT02362425|466714408|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
129659436|NCT02362425|466714405|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
129659437|NCT02362425|466714406|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
129659438|NCT02362425|466714407|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
129659439|NCT02362425|466714408|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
129659440|NCT02362425|466714405|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
129659441|NCT02362425|466714406|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
129659442|NCT02362425|466714407|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
129659443|NCT02362425|466714408|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
129659444|NCT02362425|466714405|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
129659445|NCT02362425|466714406|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
129659446|NCT02362425|466714407|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
129659447|NCT02362425|466714408|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
129659448|NCT02362425|466714405|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
129659449|NCT02362425|466714406|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
129659450|NCT02362425|466714407|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
129659451|NCT02362425|466714408|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
129659452|NCT02362425|466714405|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
129659453|NCT02362425|466714406|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
129659454|NCT02362425|466714407|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
129659455|NCT02362425|466714408|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
129659456|NCT00802672|466714415|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
129659457|NCT00802672|466714416|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
129659458|NCT00802672|466714417|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
129659459|NCT00802672|466714415|FG000|Overall Study|Adverse Event|1|||
129659460|NCT00802672|466714416|FG001|Overall Study|Adverse Event|1|||
129659461|NCT00802672|466714417|FG002|Overall Study|Adverse Event|1|||
129659462|NCT00802672|466714415|FG000|Overall Study|Protocol Violation|2|||
129659463|NCT00802672|466714416|FG001|Overall Study|Protocol Violation|1|||
129659464|NCT00802672|466714417|FG002|Overall Study|Protocol Violation|1|||
129659465|NCT00802672|466714415|FG000|Overall Study|Lost to Follow-up|5|||
129988831|NCT00196976|467921146|FG003|Primary Study|Withdrawal by Subject|1|||
129988832|NCT00196976|467921147|FG004|Primary Study|Withdrawal by Subject|2|||
129988833|NCT00196976|467921148|FG005|Primary Study|Withdrawal by Subject|1|||
129659466|NCT00802672|466714416|FG001|Overall Study|Lost to Follow-up|5|||
129659467|NCT00802672|466714417|FG002|Overall Study|Lost to Follow-up|3|||
129659468|NCT00802672|466714415|FG000|Overall Study|Withdrawal by Subject|1|||
129659469|NCT00802672|466714416|FG001|Overall Study|Withdrawal by Subject|1|||
129659470|NCT00802672|466714417|FG002|Overall Study|Withdrawal by Subject|2|||
129659471|NCT00802672|466714415|FG000|Overall Study|other|3|||
129659472|NCT00802672|466714416|FG001|Overall Study|other|1|||
129988834|NCT00196976|467921149|FG006|Primary Study|Withdrawal by Subject|0|||
129659473|NCT00802672|466714417|FG002|Overall Study|other|2|||
129659474|NCT01616758|466714419|FG000|Overall Study|Adverse Event|1|||
129659475|NCT01616758|466714419|FG000|Overall Study|Withdrawal by Subject|2|||
129659476|NCT01616758|466714419|FG000|Overall Study|Disease progression|18|||
129659477|NCT01616758|466714419|FG000|Overall Study|Study termination by Sponsor|1|||
129659478|NCT03026283|466714420|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
129988835|NCT00196976|467921150|FG007|Primary Study|Withdrawal by Subject|0|||
129988836|NCT00196976|467921151|FG008|Primary Study|Withdrawal by Subject|0|||
129988837|NCT00196976|467921152|FG009|Primary Study|Withdrawal by Subject|1|||
129988838|NCT00196976|467921153|FG010|Primary Study|Withdrawal by Subject|0|||
129988839|NCT00196976|467921154|FG011|Primary Study|Withdrawal by Subject|0|||
129988840|NCT00196976|467921155|FG012|Primary Study|Withdrawal by Subject|0|||
129659479|NCT03026283|466714421|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
129659480|NCT03026283|466714422|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
129659481|NCT03026283|466714423|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
129659482|NCT03026283|466714424|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
129659483|NCT03026283|466714425|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
129659484|NCT03026283|466714426|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
129659485|NCT03026283|466714427|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
129659486|NCT03026283|466714420|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
129659487|NCT03026283|466714421|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
129659488|NCT03026283|466714422|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
129659489|NCT03026283|466714423|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
129659490|NCT03026283|466714424|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
129659491|NCT03026283|466714425|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
129659492|NCT03026283|466714426|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
129659493|NCT03026283|466714427|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
129659494|NCT03026283|466714420|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659495|NCT03026283|466714421|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
129659496|NCT03026283|466714422|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659497|NCT03026283|466714423|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659498|NCT03026283|466714424|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659499|NCT03026283|466714425|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659500|NCT03026283|466714426|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659501|NCT03026283|466714427|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
129659502|NCT03026283|466714420|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659503|NCT03026283|466714421|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659504|NCT03026283|466714422|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
129988841|NCT00196976|467921156|FG013|Primary Study|Withdrawal by Subject|0|||
129988842|NCT00196976|467921143|FG000|Primary Study|Lost to Follow-up|0|||
129988843|NCT00196976|467921144|FG001|Primary Study|Lost to Follow-up|0|||
129988844|NCT00196976|467921145|FG002|Primary Study|Lost to Follow-up|0|||
129988845|NCT00196976|467921146|FG003|Primary Study|Lost to Follow-up|0|||
129988846|NCT00196976|467921147|FG004|Primary Study|Lost to Follow-up|1|||
129988847|NCT00196976|467921148|FG005|Primary Study|Lost to Follow-up|1|||
129988848|NCT00196976|467921149|FG006|Primary Study|Lost to Follow-up|0|||
129988849|NCT00196976|467921150|FG007|Primary Study|Lost to Follow-up|2|||
129988850|NCT00196976|467921151|FG008|Primary Study|Lost to Follow-up|0|||
129988851|NCT00196976|467921152|FG009|Primary Study|Lost to Follow-up|0|||
129988852|NCT00196976|467921153|FG010|Primary Study|Lost to Follow-up|0|||
129988853|NCT00196976|467921154|FG011|Primary Study|Lost to Follow-up|0|||
129988854|NCT00196976|467921155|FG012|Primary Study|Lost to Follow-up|0|||
129988855|NCT00196976|467921156|FG013|Primary Study|Lost to Follow-up|0|||
129988856|NCT00196976|467921143|FG000|Primary Study|Other|0|||
129988857|NCT00196976|467921144|FG001|Primary Study|Other|0|||
129988858|NCT00196976|467921145|FG002|Primary Study|Other|2|||
129546312|NCT02044094|466292471|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
129546313|NCT02044094|466292471|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
129546314|NCT02044094|466292471|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
129659505|NCT03026283|466714423|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659506|NCT03026283|466714424|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659507|NCT03026283|466714425|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659508|NCT03026283|466714426|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659509|NCT03026283|466714427|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
129659510|NCT03026283|466714420|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129659511|NCT03026283|466714421|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129988859|NCT00196976|467921146|FG003|Primary Study|Other|0|||
129988860|NCT00196976|467921147|FG004|Primary Study|Other|0|||
129988861|NCT00196976|467921148|FG005|Primary Study|Other|0|||
129988862|NCT00196976|467921149|FG006|Primary Study|Other|0|||
129988863|NCT00196976|467921150|FG007|Primary Study|Other|0|||
129546315|NCT02044094|466292471|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
129988864|NCT00196976|467921151|FG008|Primary Study|Other|0|||
129988865|NCT00196976|467921152|FG009|Primary Study|Other|0|||
129988866|NCT00196976|467921153|FG010|Primary Study|Other|0|||
129988867|NCT00196976|467921154|FG011|Primary Study|Other|0|||
129659512|NCT03026283|466714422|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129659513|NCT03026283|466714423|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
129659514|NCT03026283|466714424|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
129659515|NCT03026283|466714425|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129659516|NCT03026283|466714426|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129659517|NCT03026283|466714427|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
129659518|NCT03026283|466714420|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129659519|NCT03026283|466714421|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129659520|NCT03026283|466714422|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129659521|NCT03026283|466714423|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
129659522|NCT03026283|466714424|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
129659523|NCT03026283|466714425|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
129659524|NCT03026283|466714426|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129659525|NCT03026283|466714427|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
129659526|NCT03026283|466714420|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129659527|NCT03026283|466714421|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129659528|NCT03026283|466714422|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129659529|NCT03026283|466714423|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
129659530|NCT03026283|466714424|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129659531|NCT03026283|466714425|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
129659532|NCT03026283|466714426|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129659533|NCT03026283|466714427|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
129659534|NCT03026283|466714420|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659535|NCT03026283|466714421|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659536|NCT03026283|466714422|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659537|NCT03026283|466714423|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
129659538|NCT03026283|466714424|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659539|NCT03026283|466714425|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659540|NCT03026283|466714426|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659541|NCT03026283|466714427|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
129659542|NCT03026283|466714420|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129659543|NCT03026283|466714421|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129659544|NCT03026283|466714422|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129659545|NCT03026283|466714423|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129659546|NCT03026283|466714424|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
129659547|NCT03026283|466714425|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
129659548|NCT03026283|466714426|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129659549|NCT03026283|466714427|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
129659550|NCT03782571|466714428|FG000|Period 1|Withdrawal by Subject|1|||
129659551|NCT03782571|466714429|FG001|Period 1|Withdrawal by Subject|0|||
129659552|NCT03782571|466714430|FG002|Period 1|Withdrawal by Subject|0|||
129988868|NCT00196976|467921155|FG012|Primary Study|Other|0|||
129988869|NCT00196976|467921156|FG013|Primary Study|Other|0|||
129988870|NCT00196976|467921143|FG000|Booster Study|Withdrawal by Subject|0|||
129988871|NCT00196976|467921144|FG001|Booster Study|Withdrawal by Subject|0|||
129988872|NCT00196976|467921145|FG002|Booster Study|Withdrawal by Subject|0|||
129988873|NCT00196976|467921146|FG003|Booster Study|Withdrawal by Subject|0|||
129988874|NCT00196976|467921147|FG004|Booster Study|Withdrawal by Subject|0|||
129988875|NCT00196976|467921148|FG005|Booster Study|Withdrawal by Subject|0|||
129988876|NCT00196976|467921149|FG006|Booster Study|Withdrawal by Subject|0|||
129988877|NCT00196976|467921150|FG007|Booster Study|Withdrawal by Subject|0|||
129988878|NCT00196976|467921151|FG008|Booster Study|Withdrawal by Subject|0|||
129988879|NCT00196976|467921152|FG009|Booster Study|Withdrawal by Subject|0|||
129988880|NCT00196976|467921153|FG010|Booster Study|Withdrawal by Subject|1|||
129988881|NCT00196976|467921154|FG011|Booster Study|Withdrawal by Subject|0|||
129988882|NCT00196976|467921155|FG012|Booster Study|Withdrawal by Subject|0|||
129988883|NCT00196976|467921156|FG013|Booster Study|Withdrawal by Subject|0|||
129659553|NCT03782571|466714431|FG003|Period 1|Withdrawal by Subject|0|||
129659554|NCT03782571|466714428|FG000|Period 3|Subject Unable to Attend V5|1|||
129659555|NCT03782571|466714429|FG001|Period 3|Subject Unable to Attend V5|0|||
129988884|NCT00196976|467921143|FG000|Booster Study|Lost to Follow-up|0|||
129988885|NCT00196976|467921144|FG001|Booster Study|Lost to Follow-up|0|||
129988886|NCT00196976|467921145|FG002|Booster Study|Lost to Follow-up|0|||
129988887|NCT00196976|467921146|FG003|Booster Study|Lost to Follow-up|0|||
129988888|NCT00196976|467921147|FG004|Booster Study|Lost to Follow-up|0|||
129988889|NCT00196976|467921148|FG005|Booster Study|Lost to Follow-up|0|||
129988890|NCT00196976|467921149|FG006|Booster Study|Lost to Follow-up|0|||
129988891|NCT00196976|467921150|FG007|Booster Study|Lost to Follow-up|0|||
129988892|NCT00196976|467921151|FG008|Booster Study|Lost to Follow-up|0|||
129988893|NCT00196976|467921152|FG009|Booster Study|Lost to Follow-up|0|||
129988894|NCT00196976|467921153|FG010|Booster Study|Lost to Follow-up|1|||
129988895|NCT00196976|467921154|FG011|Booster Study|Lost to Follow-up|2|||
129988896|NCT00196976|467921155|FG012|Booster Study|Lost to Follow-up|0|||
129988897|NCT00196976|467921156|FG013|Booster Study|Lost to Follow-up|0|||
129988898|NCT01049217|467921164|FG000|Overall Study|Adverse Event|2|||
129988899|NCT01049217|467921165|FG001|Overall Study|Adverse Event|1|||
129988900|NCT01049217|467921164|FG000|Overall Study|Lack of Efficacy|1|||
129988901|NCT01049217|467921165|FG001|Overall Study|Lack of Efficacy|1|||
129988902|NCT01049217|467921164|FG000|Overall Study|Lost to Follow-up|3|||
129988903|NCT01049217|467921165|FG001|Overall Study|Lost to Follow-up|8|||
129988904|NCT01049217|467921164|FG000|Overall Study|Withdrawal by Subject|4|||
129988905|NCT01049217|467921165|FG001|Overall Study|Withdrawal by Subject|3|||
129988906|NCT01049217|467921164|FG000|Overall Study|Protocol Violation|1|||
129988907|NCT01049217|467921165|FG001|Overall Study|Protocol Violation|3|||
129988908|NCT01049217|467921164|FG000|Overall Study|Pregnancy|1|||
129988909|NCT01049217|467921165|FG001|Overall Study|Pregnancy|0|||
129988910|NCT01049217|467921164|FG000|Overall Study|Study Terminated by Sponsor|43|||
129988911|NCT01049217|467921165|FG001|Overall Study|Study Terminated by Sponsor|43|||
129988912|NCT01049217|467921164|FG000|Overall Study|Other|1|||
129988913|NCT01049217|467921165|FG001|Overall Study|Other|2|||
129659556|NCT03782571|466714430|FG002|Period 3|Subject Unable to Attend V5|0|||
129659557|NCT03782571|466714431|FG003|Period 3|Subject Unable to Attend V5|0|||
129659558|NCT03782571|466714428|FG000|Period 3|Adverse Event|1|||
129659559|NCT03782571|466714429|FG001|Period 3|Adverse Event|0|||
129659560|NCT03782571|466714430|FG002|Period 3|Adverse Event|0|||
129659561|NCT03782571|466714431|FG003|Period 3|Adverse Event|0|||
129659562|NCT02090283|466714441|FG000|Overall Study|Withdrawal by Subject|6|||
129659563|NCT02090283|466714442|FG001|Overall Study|Withdrawal by Subject|6|||
129659564|NCT02090283|466714443|FG002|Overall Study|Withdrawal by Subject|6|||
129659565|NCT02090283|466714441|FG000|Overall Study|Sponsor Terminated Study|6|||
129659566|NCT02090283|466714442|FG001|Overall Study|Sponsor Terminated Study|6|||
129659567|NCT02090283|466714443|FG002|Overall Study|Sponsor Terminated Study|1|||
129659568|NCT02090283|466714441|FG000|Overall Study|Lost to Follow-up|2|||
129659569|NCT02090283|466714442|FG001|Overall Study|Lost to Follow-up|2|||
129659570|NCT02090283|466714443|FG002|Overall Study|Lost to Follow-up|3|||
129659571|NCT02090283|466714441|FG000|Overall Study|Adverse Event|1|||
129659572|NCT02090283|466714442|FG001|Overall Study|Adverse Event|1|||
129659573|NCT02090283|466714443|FG002|Overall Study|Adverse Event|0|||
129659574|NCT02090283|466714441|FG000|Overall Study|Protocol Violation|2|||
129659575|NCT02090283|466714442|FG001|Overall Study|Protocol Violation|0|||
129659576|NCT02090283|466714443|FG002|Overall Study|Protocol Violation|0|||
129659577|NCT01411319|466714451|FG000|Overall Study|Lost to Follow-up|1|||
129659578|NCT02499263|466714452|FG000|Overall Study|Lost to Follow-up|9|||
129659579|NCT02499263|466714452|FG000|Overall Study|Participant's withdrawal of consent|4|||
129659580|NCT02499263|466714452|FG000|Overall Study|Lack of Efficacy|22|||
129659581|NCT02499263|466714452|FG000|Overall Study|investigator's judgment|12|||
129659582|NCT02499263|466714452|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
129659583|NCT02499263|466714452|FG000|Overall Study|Participant's decision|3|||
129659584|NCT02499263|466714452|FG000|Overall Study|Pregnancy|1|||
129659585|NCT01148459|466714471|FG000|Overall Study|Serious Adverse Event|5|||
129659586|NCT01148459|466714472|FG001|Overall Study|Serious Adverse Event|4|||
129659587|NCT01148459|466714471|FG000|Overall Study|Withdrawal by Subject|1|||
129659588|NCT01148459|466714472|FG001|Overall Study|Withdrawal by Subject|0|||
129659589|NCT01148459|466714471|FG000|Overall Study|Migrated/moved from study area|3|||
129659590|NCT01148459|466714472|FG001|Overall Study|Migrated/moved from study area|6|||
129659591|NCT01148459|466714471|FG000|Overall Study|Lost to Follow-up|2|||
129659592|NCT01148459|466714472|FG001|Overall Study|Lost to Follow-up|0|||
129659593|NCT01148459|466714471|FG000|Overall Study|Refusal|1|||
129659594|NCT01148459|466714472|FG001|Overall Study|Refusal|0|||
129659595|NCT01148459|466714471|FG000|Overall Study|Failure to comply with study procedures|0|||
129988914|NCT01049217|467921164|FG000|Overall Study|Randomized but not Treated|0|||
129988915|NCT01049217|467921165|FG001|Overall Study|Randomized but not Treated|2|||
129988916|NCT00903682|467921166|FG000|Overall Study|Adverse Event|6|||
129988917|NCT00903682|467921167|FG001|Overall Study|Adverse Event|13|||
129659596|NCT01148459|466714472|FG001|Overall Study|Failure to comply with study procedures|1|||
129659597|NCT00694356|466714473|FG000|Overall Study|Adverse Event|1|||
129659598|NCT00694356|466714474|FG001|Overall Study|Adverse Event|0|||
129659599|NCT00694356|466714475|FG002|Overall Study|Adverse Event|0|||
129659600|NCT00694356|466714473|FG000|Overall Study|Progressive Disease|2|||
129659601|NCT00694356|466714474|FG001|Overall Study|Progressive Disease|6|||
129988918|NCT00903682|467921166|FG000|Overall Study|Lost to Follow-up|1|||
129988919|NCT00903682|467921167|FG001|Overall Study|Lost to Follow-up|0|||
129988920|NCT00903682|467921166|FG000|Overall Study|Withdrawal by Subject|5|||
129988921|NCT00903682|467921167|FG001|Overall Study|Withdrawal by Subject|0|||
129659602|NCT00694356|466714475|FG002|Overall Study|Progressive Disease|6|||
129659603|NCT01763203|466714480|FG000|Overall Study|Death|4|||
129659604|NCT01763203|466714481|FG001|Overall Study|Death|7|||
129659605|NCT01763203|466714480|FG000|Overall Study|Lost to Follow-up|12|||
129659606|NCT01763203|466714481|FG001|Overall Study|Lost to Follow-up|12|||
129659607|NCT01763203|466714480|FG000|Overall Study|Withdrawal by Subject|8|||
129659608|NCT01763203|466714481|FG001|Overall Study|Withdrawal by Subject|12|||
129659609|NCT01763203|466714480|FG000|Overall Study|Moved out of study region|7|||
129659610|NCT01763203|466714481|FG001|Overall Study|Moved out of study region|10|||
129659611|NCT01763203|466714480|FG000|Overall Study|Physician Decision|2|||
129659612|NCT01763203|466714481|FG001|Overall Study|Physician Decision|1|||
129659613|NCT02187861|466714482|FG000|Overall Study|Adverse Event|2|||
129659614|NCT02187861|466714483|FG001|Overall Study|Adverse Event|1|||
129659615|NCT02187861|466714484|FG002|Overall Study|Adverse Event|2|||
129659616|NCT02187861|466714485|FG003|Overall Study|Adverse Event|1|||
129659617|NCT02187861|466714482|FG000|Overall Study|Death|0|||
129659618|NCT02187861|466714483|FG001|Overall Study|Death|3|||
129659619|NCT02187861|466714484|FG002|Overall Study|Death|1|||
129659620|NCT02187861|466714485|FG003|Overall Study|Death|2|||
129659621|NCT02187861|466714482|FG000|Overall Study|Physician Decision|0|||
129659622|NCT02187861|466714483|FG001|Overall Study|Physician Decision|1|||
129659623|NCT02187861|466714484|FG002|Overall Study|Physician Decision|0|||
129659624|NCT02187861|466714485|FG003|Overall Study|Physician Decision|3|||
129659625|NCT02187861|466714482|FG000|Overall Study|Progressive Disease|4|||
129659626|NCT02187861|466714483|FG001|Overall Study|Progressive Disease|42|||
129659627|NCT02187861|466714484|FG002|Overall Study|Progressive Disease|19|||
129659628|NCT02187861|466714485|FG003|Overall Study|Progressive Disease|22|||
129659629|NCT02187861|466714482|FG000|Overall Study|Withdrawal by Subject|0|||
129659630|NCT02187861|466714483|FG001|Overall Study|Withdrawal by Subject|0|||
129659631|NCT02187861|466714484|FG002|Overall Study|Withdrawal by Subject|3|||
129659632|NCT02187861|466714485|FG003|Overall Study|Withdrawal by Subject|3|||
129659633|NCT02187861|466714482|FG000|Overall Study|Other|0|||
129659634|NCT02187861|466714483|FG001|Overall Study|Other|1|||
129659635|NCT02187861|466714484|FG002|Overall Study|Other|7|||
129659636|NCT02187861|466714485|FG003|Overall Study|Other|1|||
129659637|NCT01152996|466714486|FG000|Overall Study|Withdrawal by Subject|142|||
129659638|NCT01152996|466714486|FG000|Overall Study|Adverse Event|115|||
129659639|NCT01152996|466714486|FG000|Overall Study|Lost to Follow-up|112|||
129659640|NCT01152996|466714486|FG000|Overall Study|Lack of Efficacy|68|||
129659641|NCT01152996|466714486|FG000|Overall Study|Noncompliance|41|||
129659642|NCT01152996|466714486|FG000|Overall Study|Other|36|||
129659643|NCT01152996|466714486|FG000|Overall Study|Protocol Violation|22|||
129659644|NCT01152996|466714486|FG000|Overall Study|Elevated liver enzymes|1|||
129659645|NCT02072941|466714487|FG000|Overall Study|Withdrawal by Subject|29|||
129659646|NCT02072941|466714488|FG001|Overall Study|Withdrawal by Subject|21|||
129659647|NCT02072941|466714487|FG000|Overall Study|Lost to Follow-up|4|||
129659648|NCT02072941|466714488|FG001|Overall Study|Lost to Follow-up|4|||
129659649|NCT02072941|466714487|FG000|Overall Study|Death|3|||
129659650|NCT02072941|466714488|FG001|Overall Study|Death|2|||
129659651|NCT02072941|466714487|FG000|Overall Study|Removed by Study Staff|2|||
129659652|NCT02072941|466714488|FG001|Overall Study|Removed by Study Staff|2|||
129659653|NCT03224624|466714497|FG000|Overall Study|Lost to Follow-up|9|||
129659654|NCT03224624|466714498|FG001|Overall Study|Lost to Follow-up|4|||
129659655|NCT03224624|466714497|FG000|Overall Study|Death|1|||
129659656|NCT03224624|466714498|FG001|Overall Study|Death|0|||
129659657|NCT01884545|466714499|FG000|Overall Study|Lost to Follow-up|6|||
129659658|NCT01884545|466714500|FG001|Overall Study|Lost to Follow-up|4|||
129659659|NCT01884545|466714501|FG002|Overall Study|Lost to Follow-up|9|||
129659660|NCT01884545|466714502|FG003|Overall Study|Lost to Follow-up|4|||
129659661|NCT01884545|466714499|FG000|Overall Study|Patient withdrawn|7|||
129659662|NCT01884545|466714500|FG001|Overall Study|Patient withdrawn|12|||
129659663|NCT01884545|466714501|FG002|Overall Study|Patient withdrawn|5|||
129659664|NCT01884545|466714502|FG003|Overall Study|Patient withdrawn|5|||
129659665|NCT01884545|466714499|FG000|Overall Study|Non-adherence|0|||
129659666|NCT01884545|466714500|FG001|Overall Study|Non-adherence|2|||
129659667|NCT01884545|466714501|FG002|Overall Study|Non-adherence|0|||
129659668|NCT01884545|466714502|FG003|Overall Study|Non-adherence|0|||
129659669|NCT02782377|466714503|FG000|Overall Study|Physician Decision|5|||
129659670|NCT02521792|466714504|FG000|Overall Study|Study Terminated|6|||
129659671|NCT00303472|466714505|FG000|Treatment Period|Adverse Event|0|||
129659672|NCT00303472|466714506|FG001|Treatment Period|Adverse Event|0|||
129659673|NCT00303472|466714507|FG002|Treatment Period|Adverse Event|0|||
129659674|NCT00303472|466714508|FG003|Treatment Period|Adverse Event|0|||
129659675|NCT00303472|466714509|FG004|Treatment Period|Adverse Event|1|||
129659676|NCT00303472|466714510|FG005|Treatment Period|Adverse Event|0|||
129659677|NCT00303472|466714511|FG006|Treatment Period|Adverse Event|0|||
129659678|NCT00303472|466714505|FG000|Treatment Period|Death|0|||
129659679|NCT00303472|466714506|FG001|Treatment Period|Death|0|||
129659680|NCT00303472|466714507|FG002|Treatment Period|Death|0|||
129659681|NCT00303472|466714508|FG003|Treatment Period|Death|1|||
129659682|NCT00303472|466714509|FG004|Treatment Period|Death|0|||
129659683|NCT00303472|466714510|FG005|Treatment Period|Death|0|||
129659684|NCT00303472|466714511|FG006|Treatment Period|Death|1|||
129659685|NCT00303472|466714505|FG000|Treatment Period|Withdrawal by Subject|0|||
129659686|NCT00303472|466714506|FG001|Treatment Period|Withdrawal by Subject|0|||
129659687|NCT00303472|466714507|FG002|Treatment Period|Withdrawal by Subject|0|||
129659688|NCT00303472|466714508|FG003|Treatment Period|Withdrawal by Subject|1|||
129659689|NCT00303472|466714509|FG004|Treatment Period|Withdrawal by Subject|0|||
129659690|NCT00303472|466714510|FG005|Treatment Period|Withdrawal by Subject|1|||
129659691|NCT00303472|466714511|FG006|Treatment Period|Withdrawal by Subject|0|||
129659692|NCT00303472|466714505|FG000|Treatment Period|Other|0|||
129659693|NCT00303472|466714506|FG001|Treatment Period|Other|0|||
129659694|NCT00303472|466714507|FG002|Treatment Period|Other|0|||
129659695|NCT00303472|466714508|FG003|Treatment Period|Other|0|||
129659696|NCT00303472|466714509|FG004|Treatment Period|Other|1|||
129659697|NCT00303472|466714510|FG005|Treatment Period|Other|0|||
129659698|NCT00303472|466714511|FG006|Treatment Period|Other|1|||
129659699|NCT00303472|466714505|FG000|Treatment Period|Disease Progression (to AML)|0|||
129659700|NCT00303472|466714506|FG001|Treatment Period|Disease Progression (to AML)|0|||
129659701|NCT00303472|466714507|FG002|Treatment Period|Disease Progression (to AML)|0|||
129659702|NCT00303472|466714508|FG003|Treatment Period|Disease Progression (to AML)|0|||
129659703|NCT00303472|466714509|FG004|Treatment Period|Disease Progression (to AML)|1|||
129659704|NCT00303472|466714510|FG005|Treatment Period|Disease Progression (to AML)|0|||
129659705|NCT00303472|466714511|FG006|Treatment Period|Disease Progression (to AML)|0|||
129659706|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Adverse Event|1|||
129659707|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Adverse Event|0|||
129659708|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Adverse Event|1|||
129659709|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Adverse Event|0|||
129659710|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Adverse Event|0|||
129659711|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Adverse Event|0|||
129659712|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Adverse Event|0|||
129659713|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Death|2|||
129659714|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Death|0|||
129659715|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Death|1|||
129659716|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Death|0|||
129659717|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Death|0|||
129659718|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Death|0|||
129659719|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Death|0|||
129659720|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
129659721|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
129659722|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
129659723|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
129659724|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
129659725|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
129659726|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
129659727|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Physician Decision|0|||
129659728|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Physician Decision|4|||
129659729|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Physician Decision|2|||
129659730|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Physician Decision|3|||
129659731|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Physician Decision|2|||
129659732|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Physician Decision|0|||
129659733|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Physician Decision|0|||
129659734|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
129659735|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
129659736|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
129659737|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
129546316|NCT02044094|466292471|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
129546317|NCT02545868|466293989|FG000|Overall Study|Lack of Efficacy|1|||
129546318|NCT02545868|466293990|FG001|Overall Study|Lack of Efficacy|1|||
129546319|NCT02545868|466293991|FG002|Overall Study|Lack of Efficacy|0|||
129546320|NCT02545868|466293989|FG000|Overall Study|Lost to Follow-up|1|||
129546321|NCT02545868|466293990|FG001|Overall Study|Lost to Follow-up|5|||
129546322|NCT02545868|466293991|FG002|Overall Study|Lost to Follow-up|1|||
129546323|NCT02545868|466293989|FG000|Overall Study|Non-compliance|1|||
129659738|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
129659739|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
129659740|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
129659741|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Other|0|||
129659742|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Other|2|||
129659743|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Other|4|||
129659744|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Other|2|||
129659745|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Other|1|||
129659746|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Other|0|||
129659747|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Other|0|||
129659748|NCT00303472|466714505|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
129659749|NCT00303472|466714506|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129659750|NCT00303472|466714507|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129659751|NCT00303472|466714508|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129659752|NCT00303472|466714509|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129659753|NCT00303472|466714510|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
129659754|NCT00303472|466714511|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
129659755|NCT02937636|466714512|FG000|Overall Study|Other (Not specified)|3|||
129659756|NCT02937636|466714513|FG001|Overall Study|Other (Not specified)|2|||
129659757|NCT03383692|466714522|FG000|Overall Study|Progressive disease as per RECIST|3|||
129659758|NCT03383692|466714523|FG001|Overall Study|Progressive disease as per RECIST|3|||
129659759|NCT03383692|466714522|FG000|Overall Study|Clinical progression|0|||
129659760|NCT03383692|466714523|FG001|Overall Study|Clinical progression|1|||
129659761|NCT03383692|466714522|FG000|Overall Study|Adverse Event|3|||
129659762|NCT03383692|466714523|FG001|Overall Study|Adverse Event|0|||
129659763|NCT00893971|466714528|FG000|Overall Study|Physician Decision|3|||
129659764|NCT02453256|466714529|FG000|Double Blind Period|Death|1|||
129659765|NCT02453256|466714530|FG001|Double Blind Period|Death|1|||
129659766|NCT02453256|466714529|FG000|Double Blind Period|Adverse Event|3|||
129659767|NCT02453256|466714530|FG001|Double Blind Period|Adverse Event|2|||
129659768|NCT02453256|466714529|FG000|Double Blind Period|Withdrawal by Subject|9|||
129659769|NCT02453256|466714530|FG001|Double Blind Period|Withdrawal by Subject|5|||
129659770|NCT02453256|466714529|FG000|Double Blind Period|Other|0|||
129659771|NCT02453256|466714530|FG001|Double Blind Period|Other|1|||
129659772|NCT02453256|466714529|FG000|Open Label Period|Adverse Event|1|||
129659773|NCT02453256|466714530|FG001|Open Label Period|Adverse Event|3|||
129659774|NCT02453256|466714529|FG000|Open Label Period|Death|0|||
129659775|NCT02453256|466714530|FG001|Open Label Period|Death|1|||
129659776|NCT02453256|466714529|FG000|Open Label Period|Lost to Follow-up|1|||
129988922|NCT00903682|467921166|FG000|Overall Study|Pregnancy|0|||
129988923|NCT00903682|467921167|FG001|Overall Study|Pregnancy|1|||
129988924|NCT00903682|467921166|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
129988925|NCT00903682|467921167|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
129988926|NCT00903682|467921166|FG000|Overall Study|Subject Non-Compliant|1|||
129988927|NCT00903682|467921167|FG001|Overall Study|Subject Non-Compliant|0|||
129988928|NCT00903682|467921166|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
129988929|NCT00903682|467921167|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
129988930|NCT00903682|467921166|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
129988931|NCT00903682|467921167|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
129988932|NCT02495792|467921168|FG000|Overall Study|Lost to Follow-up|5|||
129988933|NCT02495792|467921169|FG001|Overall Study|Lost to Follow-up|9|||
129988934|NCT02495792|467921168|FG000|Overall Study|Protocol Violation|32|||
129988935|NCT02495792|467921169|FG001|Overall Study|Protocol Violation|31|||
129988936|NCT01028027|467921170|FG000|Overall Study|Lost to Follow-up|4|||
129988937|NCT01028027|467921171|FG001|Overall Study|Lost to Follow-up|1|||
129988938|NCT01028027|467921170|FG000|Overall Study|Withdrawal by Subject|5|||
129988939|NCT01028027|467921171|FG001|Overall Study|Withdrawal by Subject|3|||
129988940|NCT01028027|467921170|FG000|Overall Study|Adverse Event|4|||
129988941|NCT01028027|467921171|FG001|Overall Study|Adverse Event|7|||
129988942|NCT01028027|467921170|FG000|Overall Study|Protocol Violation|3|||
129988943|NCT01028027|467921171|FG001|Overall Study|Protocol Violation|1|||
129988944|NCT01028027|467921170|FG000|Overall Study|Lack of Efficacy|0|||
129988945|NCT01028027|467921171|FG001|Overall Study|Lack of Efficacy|1|||
129988946|NCT00153062|467923208|FG000|Overall Study|Death|360|||
129988947|NCT00153062|467923209|FG001|Overall Study|Death|352|||
129988948|NCT00153062|467923210|FG002|Overall Study|Death|369|||
129988949|NCT00153062|467923211|FG003|Overall Study|Death|365|||
129988950|NCT00153062|467923208|FG000|Overall Study|Withdrawal by Subject|14|||
129988951|NCT00153062|467923209|FG001|Overall Study|Withdrawal by Subject|30|||
129988952|NCT00153062|467923210|FG002|Overall Study|Withdrawal by Subject|27|||
129988953|NCT00153062|467923211|FG003|Overall Study|Withdrawal by Subject|28|||
129988954|NCT00153062|467923208|FG000|Overall Study|Lost to Follow-up|12|||
129988955|NCT00153062|467923209|FG001|Overall Study|Lost to Follow-up|20|||
129988956|NCT00153062|467923210|FG002|Overall Study|Lost to Follow-up|15|||
129988957|NCT00153062|467923211|FG003|Overall Study|Lost to Follow-up|16|||
129988958|NCT00153062|467923208|FG000|Overall Study|Adverse Event|0|||
129988959|NCT00153062|467923209|FG001|Overall Study|Adverse Event|1|||
129988960|NCT00153062|467923210|FG002|Overall Study|Adverse Event|1|||
129988961|NCT00153062|467923211|FG003|Overall Study|Adverse Event|0|||
129988962|NCT00153062|467923208|FG000|Overall Study|Protocol Violation|0|||
129988963|NCT00153062|467923209|FG001|Overall Study|Protocol Violation|2|||
129988964|NCT00153062|467923210|FG002|Overall Study|Protocol Violation|1|||
129988965|NCT00153062|467923211|FG003|Overall Study|Protocol Violation|1|||
129659777|NCT02453256|466714530|FG001|Open Label Period|Lost to Follow-up|0|||
129659778|NCT02453256|466714529|FG000|Open Label Period|Other|0|||
129659779|NCT02453256|466714530|FG001|Open Label Period|Other|2|||
129659780|NCT02453256|466714529|FG000|Open Label Period|Withdrawal by Subject|5|||
129659781|NCT02453256|466714530|FG001|Open Label Period|Withdrawal by Subject|1|||
129659782|NCT01366638|466714531|FG000|Overall Study|Withdrawal by Subject|0|||
129988966|NCT00153062|467923208|FG000|Overall Study|No disposition data available|1|||
129659783|NCT01366638|466714532|FG001|Overall Study|Withdrawal by Subject|0|||
129659784|NCT01366638|466714533|FG002|Overall Study|Withdrawal by Subject|6|||
129659785|NCT01366638|466714531|FG000|Overall Study|Other|1|||
129659786|NCT01366638|466714532|FG001|Overall Study|Other|0|||
129659787|NCT01366638|466714533|FG002|Overall Study|Other|0|||
129659788|NCT01237327|466714534|FG000|Overall Study|Protocol Violation: Core Study|1|||
129659789|NCT01237327|466714535|FG001|Overall Study|Protocol Violation: Core Study|0|||
129659790|NCT01237327|466714534|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
129659791|NCT01237327|466714535|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
129659792|NCT01237327|466714534|FG000|Overall Study|Progression of Disease: Core Study|18|||
129659793|NCT01237327|466714535|FG001|Overall Study|Progression of Disease: Core Study|22|||
129659794|NCT01237327|466714534|FG000|Overall Study|Progression of Disease: Extension Study|15|||
129659795|NCT01237327|466714535|FG001|Overall Study|Progression of Disease: Extension Study|13|||
129659796|NCT01237327|466714534|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
129659797|NCT01237327|466714535|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
129659798|NCT01237327|466714534|FG000|Overall Study|Withdrawal by Subject|1|||
129659799|NCT01237327|466714535|FG001|Overall Study|Withdrawal by Subject|3|||
129659800|NCT01237327|466714534|FG000|Overall Study|Lost to Follow-up|3|||
129659801|NCT01237327|466714535|FG001|Overall Study|Lost to Follow-up|0|||
129659802|NCT02483572|466714538|FG000|Overall Study|Withdrawal by Subject|1|||
129659803|NCT02483572|466714539|FG001|Overall Study|Withdrawal by Subject|0|||
129659804|NCT02483572|466714538|FG000|Overall Study|Lost to Follow-up|1|||
129659805|NCT02483572|466714539|FG001|Overall Study|Lost to Follow-up|0|||
129659806|NCT02483572|466714538|FG000|Overall Study|Physician Decision|0|||
129659807|NCT02483572|466714539|FG001|Overall Study|Physician Decision|1|||
129659808|NCT04811664|466714540|FG000|Overall Study|Lost to Follow-up|78|||
129659809|NCT04811664|466714541|FG001|Overall Study|Lost to Follow-up|125|||
129659810|NCT04811664|466714542|FG002|Overall Study|Lost to Follow-up|46|||
129659811|NCT04811664|466714540|FG000|Overall Study|Withdrawal by Subject|39|||
129659812|NCT04811664|466714541|FG001|Overall Study|Withdrawal by Subject|76|||
129659813|NCT04811664|466714542|FG002|Overall Study|Withdrawal by Subject|12|||
129659814|NCT04811664|466714540|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
129659815|NCT04811664|466714541|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
129659816|NCT04811664|466714542|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
129659817|NCT04811664|466714540|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
129659818|NCT04811664|466714541|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
129659819|NCT04811664|466714542|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
129659820|NCT04811664|466714540|FG000|Overall Study|Protocol Violation|0|||
129659821|NCT04811664|466714541|FG001|Overall Study|Protocol Violation|5|||
129659822|NCT04811664|466714542|FG002|Overall Study|Protocol Violation|11|||
129659823|NCT04811664|466714540|FG000|Overall Study|Study Terminated by Sponsor|4|||
129659824|NCT04811664|466714541|FG001|Overall Study|Study Terminated by Sponsor|3|||
129659825|NCT04811664|466714542|FG002|Overall Study|Study Terminated by Sponsor|34|||
129659826|NCT04811664|466714540|FG000|Overall Study|Early Study Closure|3|||
129659827|NCT04811664|466714541|FG001|Overall Study|Early Study Closure|7|||
129659828|NCT04811664|466714542|FG002|Overall Study|Early Study Closure|79|||
129659829|NCT04811664|466714540|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
129659830|NCT04811664|466714541|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
129659831|NCT04811664|466714542|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
129988967|NCT00153062|467923209|FG001|Overall Study|No disposition data available|1|||
129988968|NCT00153062|467923210|FG002|Overall Study|No disposition data available|1|||
129988969|NCT00153062|467923211|FG003|Overall Study|No disposition data available|1|||
129988970|NCT00153062|467923208|FG000|Overall Study|Other|0|||
129988971|NCT00153062|467923209|FG001|Overall Study|Other|0|||
129988972|NCT00153062|467923210|FG002|Overall Study|Other|1|||
129988973|NCT00153062|467923211|FG003|Overall Study|Other|0|||
129988974|NCT00275262|467923218|FG000|Overall Study|Adverse Event|2|||
129988975|NCT00275262|467923219|FG001|Overall Study|Adverse Event|0|||
129988976|NCT00275262|467923218|FG000|Overall Study|Disease progression|2|||
129988977|NCT00275262|467923219|FG001|Overall Study|Disease progression|5|||
129988978|NCT00275262|467923218|FG000|Overall Study|Lost to Follow-up|0|||
129988979|NCT00275262|467923219|FG001|Overall Study|Lost to Follow-up|2|||
129988980|NCT00275262|467923218|FG000|Overall Study|Protocol Violation|0|||
129988981|NCT00275262|467923219|FG001|Overall Study|Protocol Violation|2|||
129988982|NCT00275262|467923218|FG000|Overall Study|Death|1|||
129988983|NCT00275262|467923219|FG001|Overall Study|Death|0|||
129659832|NCT05052697|466714543|FG000|Substudy A|Lost to Follow-up|0|||
129988984|NCT00275262|467923218|FG000|Overall Study|Started Chemotherapy|1|||
129988985|NCT00275262|467923219|FG001|Overall Study|Started Chemotherapy|0|||
129659833|NCT05052697|466714544|FG001|Substudy A|Lost to Follow-up|0|||
129659834|NCT05052697|466714545|FG002|Substudy A|Lost to Follow-up|0|||
129659835|NCT05052697|466714546|FG003|Substudy A|Lost to Follow-up|0|||
129659836|NCT05052697|466714547|FG004|Substudy A|Lost to Follow-up|0|||
129988986|NCT01589237|467923232|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
129659837|NCT05052697|466714548|FG005|Substudy A|Lost to Follow-up|1|||
129659838|NCT05052697|466714549|FG006|Substudy A|Lost to Follow-up|0|||
129659839|NCT05052697|466714550|FG007|Substudy A|Lost to Follow-up|0|||
129659840|NCT05052697|466714551|FG008|Substudy A|Lost to Follow-up|0|||
129659841|NCT05052697|466714552|FG009|Substudy A|Lost to Follow-up|0|||
129659842|NCT05052697|466714553|FG010|Substudy A|Lost to Follow-up|0|||
129659843|NCT05052697|466714554|FG011|Substudy A|Lost to Follow-up|0|||
129659844|NCT05052697|466714555|FG012|Substudy A|Lost to Follow-up|0|||
129659845|NCT05052697|466714556|FG013|Substudy A|Lost to Follow-up|0|||
129659846|NCT05052697|466714557|FG014|Substudy A|Lost to Follow-up|0|||
129659847|NCT05052697|466714558|FG015|Substudy A|Lost to Follow-up|2|||
129659848|NCT05052697|466714559|FG016|Substudy A|Lost to Follow-up|0|||
129659849|NCT05052697|466714560|FG017|Substudy A|Lost to Follow-up|0|||
129659850|NCT05052697|466714561|FG018|Substudy A|Lost to Follow-up|0|||
129659851|NCT05052697|466714562|FG019|Substudy A|Lost to Follow-up|0|||
129659852|NCT05052697|466714563|FG020|Substudy A|Lost to Follow-up|0|||
129659853|NCT05052697|466714564|FG021|Substudy A|Lost to Follow-up|0|||
129659854|NCT05052697|466714565|FG022|Substudy A|Lost to Follow-up|0|||
129659855|NCT05052697|466714566|FG023|Substudy A|Lost to Follow-up|0|||
129659856|NCT05052697|466714567|FG024|Substudy A|Lost to Follow-up|0|||
129659857|NCT05052697|466714568|FG025|Substudy A|Lost to Follow-up|0|||
129659858|NCT05052697|466714569|FG026|Substudy A|Lost to Follow-up|0|||
129659859|NCT05052697|466714570|FG027|Substudy A|Lost to Follow-up|0|||
129659860|NCT05052697|466714571|FG028|Substudy A|Lost to Follow-up|0|||
129659861|NCT05052697|466714572|FG029|Substudy A|Lost to Follow-up|0|||
129659862|NCT05052697|466714573|FG030|Substudy A|Lost to Follow-up|0|||
129659863|NCT05052697|466714574|FG031|Substudy A|Lost to Follow-up|0|||
129659864|NCT05052697|466714575|FG032|Substudy A|Lost to Follow-up|0|||
129659865|NCT05052697|466714576|FG033|Substudy A|Lost to Follow-up|0|||
129659866|NCT05052697|466714543|FG000|Substudy A|No longer met eligibility criteria|0|||
129659867|NCT05052697|466714544|FG001|Substudy A|No longer met eligibility criteria|0|||
129659868|NCT05052697|466714545|FG002|Substudy A|No longer met eligibility criteria|0|||
129659869|NCT05052697|466714546|FG003|Substudy A|No longer met eligibility criteria|0|||
129659870|NCT05052697|466714547|FG004|Substudy A|No longer met eligibility criteria|0|||
129659871|NCT05052697|466714548|FG005|Substudy A|No longer met eligibility criteria|0|||
129659872|NCT05052697|466714549|FG006|Substudy A|No longer met eligibility criteria|0|||
129659873|NCT05052697|466714550|FG007|Substudy A|No longer met eligibility criteria|0|||
129659874|NCT05052697|466714551|FG008|Substudy A|No longer met eligibility criteria|0|||
129659875|NCT05052697|466714552|FG009|Substudy A|No longer met eligibility criteria|0|||
129659876|NCT05052697|466714553|FG010|Substudy A|No longer met eligibility criteria|0|||
129659877|NCT05052697|466714554|FG011|Substudy A|No longer met eligibility criteria|0|||
129659878|NCT05052697|466714555|FG012|Substudy A|No longer met eligibility criteria|0|||
129659879|NCT05052697|466714556|FG013|Substudy A|No longer met eligibility criteria|1|||
129659880|NCT05052697|466714557|FG014|Substudy A|No longer met eligibility criteria|0|||
129659881|NCT05052697|466714558|FG015|Substudy A|No longer met eligibility criteria|0|||
129659882|NCT05052697|466714559|FG016|Substudy A|No longer met eligibility criteria|0|||
129659883|NCT05052697|466714560|FG017|Substudy A|No longer met eligibility criteria|0|||
129988987|NCT01589237|467923233|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
129988988|NCT01589237|467923234|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
129988989|NCT01589237|467923235|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
129988990|NCT01589237|467923232|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129988991|NCT01589237|467923233|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
129988992|NCT01589237|467923234|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129988993|NCT01589237|467923235|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
129988994|NCT01589237|467923232|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
129988995|NCT01589237|467923233|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
129988996|NCT01589237|467923234|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
129988997|NCT01589237|467923235|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
129988998|NCT01589237|467923232|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
129988999|NCT01589237|467923233|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
129989000|NCT01589237|467923234|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
129989001|NCT01589237|467923235|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
129989002|NCT02594163|467923236|FG000|Treatment Period|Progressive disease|2|||
129659884|NCT05052697|466714561|FG018|Substudy A|No longer met eligibility criteria|0|||
129659885|NCT05052697|466714562|FG019|Substudy A|No longer met eligibility criteria|0|||
129659886|NCT05052697|466714563|FG020|Substudy A|No longer met eligibility criteria|0|||
129659887|NCT05052697|466714564|FG021|Substudy A|No longer met eligibility criteria|0|||
129659888|NCT05052697|466714565|FG022|Substudy A|No longer met eligibility criteria|0|||
129659889|NCT05052697|466714566|FG023|Substudy A|No longer met eligibility criteria|0|||
129659890|NCT05052697|466714567|FG024|Substudy A|No longer met eligibility criteria|0|||
129659891|NCT05052697|466714568|FG025|Substudy A|No longer met eligibility criteria|0|||
129659892|NCT05052697|466714569|FG026|Substudy A|No longer met eligibility criteria|0|||
129659893|NCT05052697|466714570|FG027|Substudy A|No longer met eligibility criteria|0|||
129659894|NCT05052697|466714571|FG028|Substudy A|No longer met eligibility criteria|0|||
129659895|NCT05052697|466714572|FG029|Substudy A|No longer met eligibility criteria|0|||
129659896|NCT05052697|466714573|FG030|Substudy A|No longer met eligibility criteria|0|||
129659897|NCT05052697|466714574|FG031|Substudy A|No longer met eligibility criteria|0|||
129659898|NCT05052697|466714575|FG032|Substudy A|No longer met eligibility criteria|0|||
129659899|NCT05052697|466714576|FG033|Substudy A|No longer met eligibility criteria|0|||
129659900|NCT05052697|466714543|FG000|Substudy A|Not vaccinated|0|||
129659901|NCT05052697|466714544|FG001|Substudy A|Not vaccinated|0|||
129659902|NCT05052697|466714545|FG002|Substudy A|Not vaccinated|0|||
129659903|NCT05052697|466714546|FG003|Substudy A|Not vaccinated|1|||
129659904|NCT05052697|466714547|FG004|Substudy A|Not vaccinated|0|||
129659905|NCT05052697|466714548|FG005|Substudy A|Not vaccinated|0|||
129659906|NCT05052697|466714549|FG006|Substudy A|Not vaccinated|0|||
129659907|NCT05052697|466714550|FG007|Substudy A|Not vaccinated|0|||
129659908|NCT05052697|466714551|FG008|Substudy A|Not vaccinated|1|||
129659909|NCT05052697|466714552|FG009|Substudy A|Not vaccinated|0|||
129659910|NCT05052697|466714553|FG010|Substudy A|Not vaccinated|0|||
129659911|NCT05052697|466714554|FG011|Substudy A|Not vaccinated|0|||
129659912|NCT05052697|466714555|FG012|Substudy A|Not vaccinated|0|||
129659913|NCT05052697|466714556|FG013|Substudy A|Not vaccinated|0|||
129659914|NCT05052697|466714557|FG014|Substudy A|Not vaccinated|0|||
129659915|NCT05052697|466714558|FG015|Substudy A|Not vaccinated|0|||
129659916|NCT05052697|466714559|FG016|Substudy A|Not vaccinated|0|||
129659917|NCT05052697|466714560|FG017|Substudy A|Not vaccinated|0|||
129659918|NCT05052697|466714561|FG018|Substudy A|Not vaccinated|0|||
129659919|NCT05052697|466714562|FG019|Substudy A|Not vaccinated|0|||
129659920|NCT05052697|466714563|FG020|Substudy A|Not vaccinated|0|||
129659921|NCT05052697|466714564|FG021|Substudy A|Not vaccinated|0|||
129659922|NCT05052697|466714565|FG022|Substudy A|Not vaccinated|0|||
129883682|NCT02001974|467534376|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
129883683|NCT03632434|467534377|FG000|Overall Study|Withdrawal by Subject|2|||
129883684|NCT01751113|467534380|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883685|NCT01751113|467534381|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883686|NCT01751113|467534382|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883687|NCT01751113|467534383|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
129883688|NCT01751113|467534384|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
129883689|NCT01751113|467534385|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129883690|NCT01751113|467534380|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883691|NCT01751113|467534381|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883692|NCT01751113|467534382|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883693|NCT01751113|467534383|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883694|NCT01751113|467534384|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
129883695|NCT01751113|467534385|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
129883696|NCT01551303|467534387|FG000|Overall Study|failed awareness check on vision test|4|||
129883697|NCT01551303|467534388|FG001|Overall Study|failed awareness check on vision test|7|||
129883698|NCT02743793|467534398|FG000|Overall Study|Death|1|||
129883699|NCT02743793|467534399|FG001|Overall Study|Death|1|||
129883700|NCT02743793|467534398|FG000|Overall Study|Withdrawal by Subject|0|||
129883701|NCT02743793|467534399|FG001|Overall Study|Withdrawal by Subject|1|||
129883702|NCT02743793|467534398|FG000|Overall Study|Screen Failure|4|||
129883703|NCT02743793|467534399|FG001|Overall Study|Screen Failure|0|||
129883704|NCT02743793|467534398|FG000|Overall Study|No Primary Care Physician|0|||
129883705|NCT02743793|467534399|FG001|Overall Study|No Primary Care Physician|1|||
129883706|NCT02743793|467534398|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
129883707|NCT02743793|467534399|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
129883708|NCT02743793|467534398|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
129883709|NCT02743793|467534399|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
129883710|NCT01146574|467534404|FG000|Overall Study|Death|0|||
129883711|NCT01146574|467534405|FG001|Overall Study|Death|1|||
129883712|NCT01146574|467534406|FG002|Overall Study|Death|1|||
129883713|NCT01146574|467534407|FG003|Overall Study|Death|0|||
129883714|NCT01146574|467534408|FG004|Overall Study|Death|0|||
129883715|NCT01146574|467534409|FG005|Overall Study|Death|0|||
129883716|NCT01146574|467534410|FG006|Overall Study|Death|0|||
129546324|NCT02545868|466293990|FG001|Overall Study|Non-compliance|1|||
129659923|NCT05052697|466714566|FG023|Substudy A|Not vaccinated|0|||
129659924|NCT05052697|466714567|FG024|Substudy A|Not vaccinated|0|||
129659925|NCT05052697|466714568|FG025|Substudy A|Not vaccinated|0|||
129659926|NCT05052697|466714569|FG026|Substudy A|Not vaccinated|0|||
129659927|NCT05052697|466714570|FG027|Substudy A|Not vaccinated|0|||
129659928|NCT05052697|466714571|FG028|Substudy A|Not vaccinated|0|||
129659929|NCT05052697|466714572|FG029|Substudy A|Not vaccinated|0|||
129659930|NCT05052697|466714573|FG030|Substudy A|Not vaccinated|0|||
129659931|NCT05052697|466714574|FG031|Substudy A|Not vaccinated|0|||
129883717|NCT01146574|467534404|FG000|Overall Study|Other reasons|0|||
129883718|NCT01146574|467534405|FG001|Overall Study|Other reasons|0|||
129883719|NCT01146574|467534406|FG002|Overall Study|Other reasons|3|||
129883720|NCT01146574|467534407|FG003|Overall Study|Other reasons|0|||
129659932|NCT05052697|466714575|FG032|Substudy A|Not vaccinated|0|||
129659933|NCT05052697|466714576|FG033|Substudy A|Not vaccinated|0|||
129659934|NCT05052697|466714543|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659935|NCT05052697|466714544|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659936|NCT05052697|466714545|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659937|NCT05052697|466714546|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659938|NCT05052697|466714547|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659939|NCT05052697|466714548|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659940|NCT05052697|466714549|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659941|NCT05052697|466714550|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659942|NCT05052697|466714551|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659943|NCT05052697|466714552|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659944|NCT05052697|466714553|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659945|NCT05052697|466714554|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659946|NCT05052697|466714555|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659947|NCT05052697|466714556|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659948|NCT05052697|466714557|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659949|NCT05052697|466714558|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659950|NCT05052697|466714559|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659951|NCT05052697|466714560|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659952|NCT05052697|466714561|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
129659953|NCT05052697|466714562|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
129659954|NCT05052697|466714563|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659955|NCT05052697|466714564|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
129659956|NCT05052697|466714565|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
129659957|NCT05052697|466714566|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659958|NCT05052697|466714567|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659959|NCT05052697|466714568|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659960|NCT05052697|466714569|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659961|NCT05052697|466714570|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659962|NCT05052697|466714571|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659963|NCT05052697|466714572|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659964|NCT05052697|466714573|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659965|NCT05052697|466714574|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659966|NCT05052697|466714575|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659967|NCT05052697|466714576|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
129659968|NCT05052697|466714543|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659969|NCT05052697|466714544|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659970|NCT05052697|466714545|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659971|NCT05052697|466714546|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659972|NCT05052697|466714547|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659973|NCT05052697|466714548|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659974|NCT05052697|466714549|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659975|NCT05052697|466714550|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659976|NCT05052697|466714551|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659977|NCT05052697|466714552|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659978|NCT05052697|466714553|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659979|NCT05052697|466714554|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659980|NCT05052697|466714555|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659981|NCT05052697|466714556|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659982|NCT05052697|466714557|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659983|NCT05052697|466714558|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659984|NCT05052697|466714559|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659985|NCT05052697|466714560|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
129659986|NCT05052697|466714561|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659987|NCT05052697|466714562|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659988|NCT05052697|466714563|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659989|NCT05052697|466714564|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659990|NCT05052697|466714565|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659991|NCT05052697|466714566|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659992|NCT05052697|466714567|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659993|NCT05052697|466714568|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659994|NCT05052697|466714569|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659995|NCT05052697|466714570|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659996|NCT05052697|466714571|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659997|NCT05052697|466714572|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659998|NCT05052697|466714573|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
129659999|NCT05052697|466714574|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
129660000|NCT05052697|466714575|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
129660001|NCT05052697|466714576|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
129660002|NCT05052697|466714543|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660003|NCT05052697|466714544|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660004|NCT05052697|466714545|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660005|NCT05052697|466714546|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660006|NCT05052697|466714547|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660007|NCT05052697|466714548|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660008|NCT05052697|466714549|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660009|NCT05052697|466714550|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660010|NCT05052697|466714551|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660011|NCT05052697|466714552|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660012|NCT05052697|466714553|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660013|NCT05052697|466714554|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660014|NCT05052697|466714555|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660015|NCT05052697|466714556|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660016|NCT05052697|466714557|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660017|NCT05052697|466714558|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660018|NCT05052697|466714559|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660019|NCT05052697|466714560|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660020|NCT05052697|466714561|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660021|NCT05052697|466714562|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
129660022|NCT05052697|466714563|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660023|NCT05052697|466714564|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660024|NCT05052697|466714565|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660025|NCT05052697|466714566|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660026|NCT05052697|466714567|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660027|NCT05052697|466714568|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660028|NCT05052697|466714569|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660029|NCT05052697|466714570|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660030|NCT05052697|466714571|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660031|NCT05052697|466714572|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660032|NCT05052697|466714573|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660033|NCT05052697|466714574|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660034|NCT05052697|466714575|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660035|NCT05052697|466714576|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
129660036|NCT05052697|466714543|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660037|NCT05052697|466714544|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660038|NCT05052697|466714545|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660039|NCT05052697|466714546|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660040|NCT05052697|466714547|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660041|NCT05052697|466714548|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660042|NCT05052697|466714549|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660043|NCT05052697|466714550|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660044|NCT05052697|466714551|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660045|NCT05052697|466714552|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660046|NCT05052697|466714553|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660047|NCT05052697|466714554|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660048|NCT05052697|466714555|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660049|NCT05052697|466714556|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660050|NCT05052697|466714557|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129989003|NCT02594163|467923237|FG001|Treatment Period|Progressive disease|3|||
129989004|NCT02594163|467923236|FG000|Treatment Period|Adverse Event|1|||
129989005|NCT02594163|467923237|FG001|Treatment Period|Adverse Event|5|||
129660051|NCT05052697|466714558|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660052|NCT05052697|466714559|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660053|NCT05052697|466714560|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
129660054|NCT05052697|466714561|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660055|NCT05052697|466714562|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660056|NCT05052697|466714563|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660057|NCT05052697|466714564|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660058|NCT05052697|466714565|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660059|NCT05052697|466714566|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660060|NCT05052697|466714567|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660061|NCT05052697|466714568|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
129660062|NCT05052697|466714569|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660063|NCT05052697|466714570|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
129989006|NCT02594163|467923236|FG000|Treatment Period|Physician Decision|1|||
129660064|NCT05052697|466714571|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129546325|NCT02545868|466293991|FG002|Overall Study|Non-compliance|1|||
129660065|NCT05052697|466714572|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129989007|NCT02594163|467923237|FG001|Treatment Period|Physician Decision|3|||
129989008|NCT02594163|467923236|FG000|Treatment Period|Study termination by sponsor|2|||
129989009|NCT02594163|467923237|FG001|Treatment Period|Study termination by sponsor|1|||
129989010|NCT02594163|467923236|FG000|Treatment Period|Other, Non-AE|1|||
129989011|NCT02594163|467923237|FG001|Treatment Period|Other, Non-AE|0|||
129989012|NCT02594163|467923236|FG000|Follow-up Period|Withdrawal by Subject|0|||
129989013|NCT02594163|467923237|FG001|Follow-up Period|Withdrawal by Subject|1|||
129989014|NCT02594163|467923236|FG000|Follow-up Period|Study Termination by Sponsor|6|||
129989015|NCT02594163|467923237|FG001|Follow-up Period|Study Termination by Sponsor|4|||
129989016|NCT02594163|467923236|FG000|Follow-up Period|Lost to Follow-up|1|||
129989017|NCT02594163|467923237|FG001|Follow-up Period|Lost to Follow-up|0|||
129989018|NCT02594163|467923236|FG000|Follow-up Period|Death|2|||
129989019|NCT02594163|467923237|FG001|Follow-up Period|Death|5|||
129989020|NCT02594163|467923236|FG000|Follow-up Period|Adverse Event|0|||
129989021|NCT02594163|467923237|FG001|Follow-up Period|Adverse Event|1|||
129989022|NCT02594163|467923236|FG000|Follow-up Period|Progressive Disease|2|||
129989023|NCT02594163|467923237|FG001|Follow-up Period|Progressive Disease|0|||
129989024|NCT02594163|467923236|FG000|Follow-up Period|Physician Decision|0|||
129989025|NCT02594163|467923237|FG001|Follow-up Period|Physician Decision|1|||
129989026|NCT01290029|467923240|FG000|Overall Study|Other|2|||
129989027|NCT00189488|467923241|FG000|Overall Study|Ineligibility determined|1|||
129989028|NCT00189488|467923242|FG001|Overall Study|Ineligibility determined|0|||
129989029|NCT00189488|467923241|FG000|Overall Study|Protocol deviation|2|||
129989030|NCT00189488|467923242|FG001|Overall Study|Protocol deviation|1|||
129989031|NCT00189488|467923241|FG000|Overall Study|Adverse Event|2|||
129989032|NCT00189488|467923242|FG001|Overall Study|Adverse Event|1|||
129989033|NCT00189488|467923241|FG000|Overall Study|Withdrawal by Subject|2|||
129989034|NCT00189488|467923242|FG001|Overall Study|Withdrawal by Subject|6|||
129989035|NCT00189488|467923241|FG000|Overall Study|Disease progression|2|||
129989036|NCT00189488|467923242|FG001|Overall Study|Disease progression|4|||
129989037|NCT00189488|467923241|FG000|Overall Study|Administrative Decision|0|||
129989038|NCT00189488|467923242|FG001|Overall Study|Administrative Decision|2|||
129989039|NCT00189488|467923241|FG000|Overall Study|Death|5|||
129989040|NCT00189488|467923242|FG001|Overall Study|Death|8|||
129989041|NCT00189488|467923241|FG000|Overall Study|Other|1|||
129989042|NCT00189488|467923242|FG001|Overall Study|Other|0|||
129989043|NCT01877837|467923243|FG000|Overall Study|Lost to Follow-up|1|||
129989044|NCT01877837|467923243|FG000|Overall Study|Ineligible|4|||
129989045|NCT00645801|467923245|FG000|Overall Study|unclear if patient took all the medication.|1|||
129989046|NCT00645801|467923246|FG001|Overall Study|unclear if patient took all the medication.|0|||
129989047|NCT00645801|467923245|FG000|Overall Study|Lost to Follow-up|19|||
129989048|NCT00645801|467923246|FG001|Overall Study|Lost to Follow-up|15|||
129989049|NCT00705679|467923247|FG000|Overall Study|Adverse Event|1|||
129989050|NCT00705679|467923248|FG001|Overall Study|Adverse Event|1|||
129989051|NCT00705679|467923249|FG002|Overall Study|Adverse Event|0|||
129989052|NCT00705679|467923250|FG003|Overall Study|Adverse Event|0|||
129660066|NCT05052697|466714573|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660067|NCT05052697|466714574|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660068|NCT05052697|466714575|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660069|NCT05052697|466714576|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
129660070|NCT05052697|466714543|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660071|NCT05052697|466714544|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660072|NCT05052697|466714545|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660073|NCT05052697|466714546|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660074|NCT05052697|466714547|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660075|NCT05052697|466714548|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660076|NCT05052697|466714549|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660077|NCT05052697|466714550|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660078|NCT05052697|466714551|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660079|NCT05052697|466714552|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660080|NCT05052697|466714553|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660081|NCT05052697|466714554|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129989053|NCT00705679|467923251|FG004|Overall Study|Adverse Event|0|||
129989054|NCT00705679|467923247|FG000|Overall Study|Death|0|||
129989055|NCT00705679|467923248|FG001|Overall Study|Death|0|||
129989056|NCT00705679|467923249|FG002|Overall Study|Death|3|||
129989057|NCT00705679|467923250|FG003|Overall Study|Death|2|||
129989058|NCT00705679|467923251|FG004|Overall Study|Death|1|||
129989059|NCT00705679|467923247|FG000|Overall Study|Lost to Follow-up|32|||
129989060|NCT00705679|467923248|FG001|Overall Study|Lost to Follow-up|60|||
129989061|NCT00705679|467923249|FG002|Overall Study|Lost to Follow-up|44|||
129989062|NCT00705679|467923250|FG003|Overall Study|Lost to Follow-up|30|||
129989063|NCT00705679|467923251|FG004|Overall Study|Lost to Follow-up|35|||
129989064|NCT00705679|467923247|FG000|Overall Study|Physician Decision|0|||
129989065|NCT00705679|467923248|FG001|Overall Study|Physician Decision|1|||
129989066|NCT00705679|467923249|FG002|Overall Study|Physician Decision|0|||
129989067|NCT00705679|467923250|FG003|Overall Study|Physician Decision|1|||
129989068|NCT00705679|467923251|FG004|Overall Study|Physician Decision|0|||
129989069|NCT00705679|467923247|FG000|Overall Study|Withdrawal by Subject|32|||
129989070|NCT00705679|467923248|FG001|Overall Study|Withdrawal by Subject|77|||
129989071|NCT00705679|467923249|FG002|Overall Study|Withdrawal by Subject|68|||
129989072|NCT00705679|467923250|FG003|Overall Study|Withdrawal by Subject|47|||
129989073|NCT00705679|467923251|FG004|Overall Study|Withdrawal by Subject|33|||
129989074|NCT00932113|467923252|FG000|Overall Study|Lost to Follow-up|1|||
129989075|NCT00932113|467923253|FG001|Overall Study|Lost to Follow-up|0|||
129989076|NCT01403610|467923254|FG000|Overall Study|Withdrawal by Subject|2|||
129989077|NCT01403610|467923255|FG001|Overall Study|Withdrawal by Subject|0|||
129989078|NCT01403610|467923256|FG002|Overall Study|Withdrawal by Subject|0|||
129989079|NCT01403610|467923257|FG003|Overall Study|Withdrawal by Subject|0|||
129989080|NCT01403610|467923254|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
129989081|NCT01403610|467923255|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
129989082|NCT01403610|467923256|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
129989083|NCT01403610|467923257|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
129989084|NCT02874924|467923258|FG000|Overall Study|Adverse Event|2|||
129989085|NCT02874924|467923259|FG001|Overall Study|Adverse Event|0|||
129989086|NCT02874924|467923260|FG002|Overall Study|Adverse Event|0|||
129989087|NCT02874924|467923258|FG000|Overall Study|Withdrawal by Subject|1|||
129989088|NCT02874924|467923259|FG001|Overall Study|Withdrawal by Subject|0|||
129989089|NCT02874924|467923260|FG002|Overall Study|Withdrawal by Subject|0|||
129989090|NCT02029846|467923265|FG000|Overall Study|n=1 each arm|1|||
129989091|NCT02029846|467923266|FG001|Overall Study|n=1 each arm|1|||
129989092|NCT00822172|467923270|FG000|Overall Study|Adverse Event|10|||
129989093|NCT00822172|467923271|FG001|Overall Study|Adverse Event|12|||
129989094|NCT00822172|467923270|FG000|Overall Study|Death|1|||
129989095|NCT00822172|467923271|FG001|Overall Study|Death|0|||
129989096|NCT00822172|467923270|FG000|Overall Study|Lost to Follow-up|3|||
129989097|NCT00822172|467923271|FG001|Overall Study|Lost to Follow-up|1|||
129989098|NCT00822172|467923270|FG000|Overall Study|Withdrawal by Subject|1|||
129989099|NCT00822172|467923271|FG001|Overall Study|Withdrawal by Subject|4|||
129989100|NCT00822172|467923270|FG000|Overall Study|site closed|0|||
129989101|NCT00822172|467923271|FG001|Overall Study|site closed|1|||
129989102|NCT00822172|467923270|FG000|Overall Study|Other|0|||
129989103|NCT00822172|467923271|FG001|Overall Study|Other|1|||
129989104|NCT00700258|467923272|FG000|Overall Study|Premature discontinuation of documentation|136|||
129989105|NCT00700258|467923272|FG000|Overall Study|Type of study end not documented|1|||
129989106|NCT00700258|467923272|FG000|Overall Study|Lost to Follow-up|81|||
129989107|NCT00700258|467923272|FG000|Overall Study|Premature discontinuation of therapy|1013|||
129989108|NCT00738582|467923275|FG000|Combination Therapy|Completed Combination Therapy|1|||
129989109|NCT00738582|467923276|FG001|Combination Therapy|Completed Combination Therapy|0|||
129989110|NCT00738582|467923275|FG000|Combination Therapy|Physician Decision|1|||
129989111|NCT00738582|467923276|FG001|Combination Therapy|Physician Decision|0|||
129989112|NCT00738582|467923275|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
129989113|NCT00738582|467923276|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
129989114|NCT00738582|467923275|FG000|Combination Therapy|Other|5|||
129989115|NCT00738582|467923276|FG001|Combination Therapy|Other|0|||
129989116|NCT00738582|467923275|FG000|Combination Therapy|Adverse Event|16|||
129989117|NCT00738582|467923276|FG001|Combination Therapy|Adverse Event|0|||
129989118|NCT00738582|467923275|FG000|Combination Therapy|Progressive Disease|9|||
129989119|NCT00738582|467923276|FG001|Combination Therapy|Progressive Disease|0|||
129989120|NCT00738582|467923275|FG000|Maintenance Therapy|Other|0|||
129989121|NCT00738582|467923276|FG001|Maintenance Therapy|Other|2|||
129989122|NCT00738582|467923275|FG000|Maintenance Therapy|Adverse Event|0|||
129989123|NCT00738582|467923276|FG001|Maintenance Therapy|Adverse Event|6|||
129989124|NCT00738582|467923275|FG000|Maintenance Therapy|Progressive Disease|0|||
129989125|NCT00738582|467923276|FG001|Maintenance Therapy|Progressive Disease|47|||
129989126|NCT00738582|467923275|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
129989127|NCT00738582|467923276|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
129989128|NCT00642772|467923277|FG000|Overall Study|Lost to Follow-up|3|||
129989129|NCT00642772|467923277|FG000|Overall Study|Withdrawal by Subject|7|||
129989130|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
129989131|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
129989132|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
129989133|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
129989134|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
129989135|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
129989136|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
129989137|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
129989138|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
129989139|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
129989140|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
129660082|NCT05052697|466714555|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660083|NCT05052697|466714556|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660084|NCT05052697|466714557|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660085|NCT05052697|466714558|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660086|NCT05052697|466714559|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660087|NCT05052697|466714560|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660088|NCT05052697|466714561|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660089|NCT05052697|466714562|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660090|NCT05052697|466714563|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660091|NCT05052697|466714564|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660092|NCT05052697|466714565|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660093|NCT05052697|466714566|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129989141|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
129989142|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
129989143|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
129989144|NCT00757588|467923278|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
129989145|NCT00757588|467923279|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
129989146|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
129660094|NCT05052697|466714567|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660095|NCT05052697|466714568|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660096|NCT05052697|466714569|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660097|NCT05052697|466714570|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660098|NCT05052697|466714571|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
129660099|NCT05052697|466714572|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129660100|NCT05052697|466714573|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
129660101|NCT05052697|466714574|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
129660102|NCT05052697|466714575|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
129660103|NCT05052697|466714576|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
129989147|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
129989148|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
129989149|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
129989150|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
129989151|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
129989152|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
129989153|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
129989154|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
129989155|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
129989156|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
129989157|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
129989158|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
129989159|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
129989160|NCT00757588|467923278|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
129989161|NCT00757588|467923279|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
129989162|NCT00903006|467923280|FG000|Overall Study|Withdrawal by Subject|2|||
129989163|NCT00903006|467923281|FG001|Overall Study|Withdrawal by Subject|0|||
129989164|NCT00903006|467923282|FG002|Overall Study|Withdrawal by Subject|0|||
129989165|NCT00903006|467923283|FG003|Overall Study|Withdrawal by Subject|0|||
129989166|NCT00903006|467923280|FG000|Overall Study|Progressive Disease|0|||
129989167|NCT00903006|467923281|FG001|Overall Study|Progressive Disease|3|||
129989168|NCT00903006|467923282|FG002|Overall Study|Progressive Disease|1|||
129989169|NCT00903006|467923283|FG003|Overall Study|Progressive Disease|0|||
129989170|NCT01383499|467923284|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
129989171|NCT01383499|467923285|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129989172|NCT01383499|467923286|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129660104|NCT05052697|466714543|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660105|NCT05052697|466714544|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660106|NCT05052697|466714545|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660107|NCT05052697|466714546|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660108|NCT05052697|466714547|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660109|NCT05052697|466714548|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660110|NCT05052697|466714549|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660111|NCT05052697|466714550|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660112|NCT05052697|466714551|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660113|NCT05052697|466714552|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129989173|NCT01383499|467923287|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
129989174|NCT04275089|467923290|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
129989175|NCT01079663|467923291|FG000|Overall Study|Adverse Event|0|||
129989176|NCT01079663|467923292|FG001|Overall Study|Adverse Event|2|||
129989177|NCT01079663|467923291|FG000|Overall Study|Protocol Violation|0|||
129989178|NCT01079663|467923292|FG001|Overall Study|Protocol Violation|2|||
129989179|NCT00297232|467923293|FG000|Overall Study|Lack of Efficacy|7|||
129989180|NCT00297232|467923293|FG000|Overall Study|Lost to Follow-up|10|||
129989181|NCT00297232|467923293|FG000|Overall Study|Adverse Event|63|||
129989182|NCT00297232|467923293|FG000|Overall Study|Voluntary Withdrawal|120|||
129989183|NCT00297232|467923293|FG000|Overall Study|Subject was Noncompliant|9|||
129989184|NCT00297232|467923293|FG000|Overall Study|Death|9|||
129989185|NCT00297232|467923293|FG000|Overall Study|Anti-natalizumab Positive|8|||
129989186|NCT00297232|467923293|FG000|Overall Study|Switched to Commercial Tysabri|22|||
129989187|NCT00297232|467923293|FG000|Overall Study|Disease Progression|8|||
129989188|NCT00297232|467923293|FG000|Overall Study|Fear of PML|10|||
129989189|NCT00297232|467923293|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
129989190|NCT00297232|467923293|FG000|Overall Study|Miscellaneous|5|||
129989191|NCT00297232|467923293|FG000|Overall Study|Sponsor Decision|34|||
129989192|NCT00297232|467923293|FG000|Overall Study|Subject Relocated|7|||
129989193|NCT00297232|467923293|FG000|Overall Study|Subject Withdrew Consent|37|||
129989194|NCT00297232|467923293|FG000|Overall Study|Persistently Positive Antibodies|11|||
129989195|NCT00297232|467923293|FG000|Overall Study|Investigator Withdrew From Program|19|||
129989196|NCT00297232|467923293|FG000|Overall Study|Did Not Enroll to Week 264|34|||
129989197|NCT00297232|467923293|FG000|Overall Study|Did Not Enroll to Week 480|17|||
129989198|NCT00297232|467923293|FG000|Overall Study|No data available after Week 264|161|||
129989199|NCT00297232|467923293|FG000|Overall Study|Other|1|||
129989200|NCT03038438|467923294|FG000|Overall Study|Death|3|||
129989201|NCT03038438|467923294|FG000|Overall Study|Lost to Follow-up|8|||
129989202|NCT03038438|467923294|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
129989203|NCT03038438|467923294|FG000|Overall Study|Withdrawal by Subject|5|||
129989204|NCT03038438|467923294|FG000|Overall Study|No 36-Month Follow-Up|18|||
129989205|NCT03625895|467923297|FG000|Overall Study|Protocol Violation|585|||
129989206|NCT02476279|467923298|FG000|Overall Study|Lost to Follow-up|1|||
129989207|NCT02476279|467923299|FG001|Overall Study|Lost to Follow-up|1|||
129989208|NCT01236339|467923304|FG000|Overall Study|Termination of study by sponsor|11|||
129989209|NCT01236339|467923305|FG001|Overall Study|Termination of study by sponsor|13|||
129989210|NCT02054741|467923306|FG000|Overall Study|Protocol Violation|13|||
129989211|NCT02054741|467923307|FG001|Overall Study|Protocol Violation|2|||
129989212|NCT02054741|467923306|FG000|Overall Study|Withdrawal by Subject|10|||
129989213|NCT02054741|467923307|FG001|Overall Study|Withdrawal by Subject|5|||
129989214|NCT02054741|467923306|FG000|Overall Study|Death|94|||
129989215|NCT02054741|467923307|FG001|Overall Study|Death|90|||
129989216|NCT02054741|467923306|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
129989217|NCT02054741|467923307|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
129989218|NCT01945060|467923308|FG000|Overall Study|Lost to follow up|1|||
129989219|NCT01945060|467923309|FG001|Overall Study|Lost to follow up|0|||
129989220|NCT01945060|467923308|FG000|Overall Study|Distress related to IV access|0|||
129989221|NCT01945060|467923309|FG001|Overall Study|Distress related to IV access|1|||
129989222|NCT00402597|467923310|FG000|Overall Study|Death|15|||
129989223|NCT00402597|467923311|FG001|Overall Study|Death|7|||
129989224|NCT00402597|467923312|FG002|Overall Study|Death|6|||
129989225|NCT00402597|467923313|FG003|Overall Study|Death|4|||
129989226|NCT00402597|467923314|FG004|Overall Study|Death|6|||
129989227|NCT00402597|467923310|FG000|Overall Study|Adverse Event|81|||
129989228|NCT00402597|467923311|FG001|Overall Study|Adverse Event|18|||
129989229|NCT00402597|467923312|FG002|Overall Study|Adverse Event|106|||
129989230|NCT00402597|467923313|FG003|Overall Study|Adverse Event|39|||
129989231|NCT00402597|467923314|FG004|Overall Study|Adverse Event|71|||
129989232|NCT00402597|467923310|FG000|Overall Study|Lost to Follow-up|8|||
129989233|NCT00402597|467923311|FG001|Overall Study|Lost to Follow-up|1|||
129989234|NCT00402597|467923312|FG002|Overall Study|Lost to Follow-up|8|||
129989235|NCT00402597|467923313|FG003|Overall Study|Lost to Follow-up|2|||
129989236|NCT00402597|467923314|FG004|Overall Study|Lost to Follow-up|3|||
129989237|NCT00402597|467923310|FG000|Overall Study|Withdrawal by Subject|57|||
129989238|NCT00402597|467923311|FG001|Overall Study|Withdrawal by Subject|16|||
129989239|NCT00402597|467923312|FG002|Overall Study|Withdrawal by Subject|65|||
129989240|NCT00402597|467923313|FG003|Overall Study|Withdrawal by Subject|15|||
129989241|NCT00402597|467923314|FG004|Overall Study|Withdrawal by Subject|24|||
129989242|NCT00402597|467923310|FG000|Overall Study|reason not specified|30|||
129989243|NCT00402597|467923311|FG001|Overall Study|reason not specified|4|||
129989244|NCT00402597|467923312|FG002|Overall Study|reason not specified|27|||
129989245|NCT00402597|467923313|FG003|Overall Study|reason not specified|14|||
129989246|NCT00402597|467923314|FG004|Overall Study|reason not specified|20|||
129989247|NCT02319525|467923316|FG000|Overall Study|Withdrawal by Subject|2|||
129989248|NCT02319525|467923317|FG001|Overall Study|Withdrawal by Subject|1|||
129989249|NCT00938860|467923318|FG000|Overall Study|Adverse Event|2|||
129989250|NCT00938860|467923319|FG001|Overall Study|Adverse Event|1|||
129989251|NCT00938860|467923318|FG000|Overall Study|Abnormal laboratory values|2|||
129989252|NCT00938860|467923319|FG001|Overall Study|Abnormal laboratory values|2|||
129989253|NCT00938860|467923318|FG000|Overall Study|Withdrawal by Subject|11|||
129989254|NCT00938860|467923319|FG001|Overall Study|Withdrawal by Subject|8|||
129989255|NCT00938860|467923318|FG000|Overall Study|Lost to Follow-up|4|||
129989256|NCT00938860|467923319|FG001|Overall Study|Lost to Follow-up|4|||
129989257|NCT00938860|467923318|FG000|Overall Study|Administration problems|2|||
129989258|NCT00938860|467923319|FG001|Overall Study|Administration problems|0|||
129989259|NCT00938860|467923318|FG000|Overall Study|Death|1|||
129989260|NCT00938860|467923319|FG001|Overall Study|Death|1|||
129989261|NCT00938860|467923318|FG000|Overall Study|Protocol Violation|3|||
129660114|NCT05052697|466714553|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660115|NCT05052697|466714554|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660116|NCT05052697|466714555|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660117|NCT05052697|466714556|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660118|NCT05052697|466714557|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129989262|NCT00938860|467923319|FG001|Overall Study|Protocol Violation|1|||
129989263|NCT00577577|467923321|FG000|Overall Study|Adverse Event|3|||
129989264|NCT00577577|467923322|FG001|Overall Study|Adverse Event|2|||
129989265|NCT00577577|467923321|FG000|Overall Study|Lost to Follow-up|1|||
129989266|NCT00577577|467923322|FG001|Overall Study|Lost to Follow-up|0|||
129989267|NCT00577577|467923321|FG000|Overall Study|Protocol Violation|0|||
129989268|NCT00577577|467923322|FG001|Overall Study|Protocol Violation|3|||
129989269|NCT00577577|467923321|FG000|Overall Study|Transportation|1|||
129989270|NCT00577577|467923322|FG001|Overall Study|Transportation|0|||
129989271|NCT00232544|467923327|FG000|Overall Study|Lost to Follow-up|20|||
129989272|NCT00232544|467923328|FG001|Overall Study|Lost to Follow-up|15|||
129989273|NCT00986973|467923332|FG000|Overall Study|Withdrawn by study team|1|||
129989274|NCT01465347|467923333|FG000|Overall Study|Withdrawal by Subject|1|||
129989275|NCT01465347|467923334|FG001|Overall Study|Withdrawal by Subject|1|||
129989276|NCT01465347|467923333|FG000|Overall Study|Physician Decision|0|||
129989277|NCT01465347|467923334|FG001|Overall Study|Physician Decision|1|||
129989278|NCT01465347|467923333|FG000|Overall Study|Admitted to hospice|0|||
129989279|NCT01465347|467923334|FG001|Overall Study|Admitted to hospice|1|||
129989280|NCT01590082|467923335|FG000|Overall Study|Withdrawal by Subject|1|||
129989281|NCT01590082|467923336|FG001|Overall Study|Withdrawal by Subject|0|||
129989282|NCT01590082|467923335|FG000|Overall Study|Ineligible|1|||
129989283|NCT01590082|467923336|FG001|Overall Study|Ineligible|0|||
129989284|NCT02414932|467923337|FG000|Overall Study|Withdrawal by Subject|2|||
129989285|NCT02414932|467923338|FG001|Overall Study|Withdrawal by Subject|3|||
129989286|NCT02414932|467923337|FG000|Overall Study|Adverse Event|1|||
129989287|NCT02414932|467923338|FG001|Overall Study|Adverse Event|0|||
129989288|NCT01210664|467923340|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129989289|NCT01210664|467923341|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129989290|NCT01210664|467923342|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
129660119|NCT05052697|466714558|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129989291|NCT01210664|467923343|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
129989292|NCT01210664|467923340|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989293|NCT01210664|467923341|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989294|NCT01210664|467923342|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
129989295|NCT01210664|467923343|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989296|NCT01210664|467923340|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989297|NCT01210664|467923341|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129989298|NCT01210664|467923342|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
129660120|NCT05052697|466714559|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660121|NCT05052697|466714560|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660122|NCT05052697|466714561|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660123|NCT05052697|466714562|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660124|NCT05052697|466714563|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660125|NCT05052697|466714564|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660126|NCT05052697|466714565|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660127|NCT05052697|466714566|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660128|NCT05052697|466714567|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660129|NCT05052697|466714568|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660130|NCT05052697|466714569|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660131|NCT05052697|466714570|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660132|NCT05052697|466714571|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
129660133|NCT05052697|466714572|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
129660134|NCT05052697|466714573|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
129660135|NCT05052697|466714574|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
129660136|NCT05052697|466714575|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
129660137|NCT05052697|466714576|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
129660138|NCT05052697|466714543|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129989299|NCT01210664|467923343|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
129989300|NCT01853644|467923344|FG000|Registration and Treatment Start|Did not start treatment|1|||
129989301|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
129989302|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
129989303|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
129989304|NCT01853644|467923344|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
129989305|NCT01853644|467923344|FG000|Continued Treatment After First Response|Adverse Event|2|||
129989306|NCT01853644|467923344|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
129989307|NCT02891408|467923345|FG000|Overall Study|Lost to Follow-up|0|||
129989308|NCT02891408|467923346|FG001|Overall Study|Lost to Follow-up|0|||
129989309|NCT02891408|467923347|FG002|Overall Study|Lost to Follow-up|1|||
129989310|NCT02891408|467923348|FG003|Overall Study|Lost to Follow-up|0|||
129989311|NCT02891408|467923349|FG004|Overall Study|Lost to Follow-up|0|||
129989312|NCT02891408|467923350|FG005|Overall Study|Lost to Follow-up|0|||
129989313|NCT02891408|467923351|FG006|Overall Study|Lost to Follow-up|0|||
129989314|NCT01054170|467923352|FG000|Overall Study|Protocol Violation|1|||
129989315|NCT01054170|467923353|FG001|Overall Study|Protocol Violation|0|||
129989316|NCT01054170|467923352|FG000|Overall Study|Withdrawal by Subject|3|||
129989317|NCT01054170|467923353|FG001|Overall Study|Withdrawal by Subject|2|||
129989318|NCT01054170|467923352|FG000|Overall Study|Adverse Event|0|||
129989319|NCT01054170|467923353|FG001|Overall Study|Adverse Event|4|||
129989320|NCT01442779|467923354|FG000|Overall Study|Withdrawal by Subject|3|||
129989321|NCT01442779|467923354|FG000|Overall Study|Death|3|||
129989322|NCT01442779|467923354|FG000|Overall Study|Non-compliance|1|||
129989323|NCT05249829|467923355|FG000|Overall Study|Participant Relocation|0|||
129989324|NCT05249829|467923356|FG001|Overall Study|Participant Relocation|1|||
129989325|NCT05249829|467923357|FG002|Overall Study|Participant Relocation|2|||
129989326|NCT05249829|467923358|FG003|Overall Study|Participant Relocation|2|||
129989327|NCT05249829|467923355|FG000|Overall Study|Withdrawal by Subject|9|||
129989328|NCT05249829|467923356|FG001|Overall Study|Withdrawal by Subject|17|||
129989329|NCT05249829|467923357|FG002|Overall Study|Withdrawal by Subject|40|||
129989330|NCT05249829|467923358|FG003|Overall Study|Withdrawal by Subject|35|||
129989331|NCT05249829|467923355|FG000|Overall Study|Physician Decision|1|||
129989332|NCT05249829|467923356|FG001|Overall Study|Physician Decision|0|||
129989333|NCT05249829|467923357|FG002|Overall Study|Physician Decision|0|||
129989334|NCT05249829|467923358|FG003|Overall Study|Physician Decision|0|||
129989335|NCT05249829|467923355|FG000|Overall Study|Lost to Follow-up|16|||
129989336|NCT05249829|467923356|FG001|Overall Study|Lost to Follow-up|16|||
129989337|NCT05249829|467923357|FG002|Overall Study|Lost to Follow-up|57|||
129989338|NCT05249829|467923358|FG003|Overall Study|Lost to Follow-up|60|||
129989339|NCT05249829|467923355|FG000|Overall Study|Adverse Event|2|||
129989340|NCT05249829|467923356|FG001|Overall Study|Adverse Event|2|||
129989341|NCT05249829|467923357|FG002|Overall Study|Adverse Event|2|||
129989342|NCT05249829|467923358|FG003|Overall Study|Adverse Event|2|||
129989343|NCT05249829|467923355|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
129989344|NCT05249829|467923356|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
129989345|NCT05249829|467923357|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
129989346|NCT05249829|467923358|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
129989347|NCT05249829|467923355|FG000|Overall Study|Protocol Violation|2|||
129989348|NCT05249829|467923356|FG001|Overall Study|Protocol Violation|0|||
129989349|NCT05249829|467923357|FG002|Overall Study|Protocol Violation|5|||
129989350|NCT05249829|467923358|FG003|Overall Study|Protocol Violation|3|||
129989351|NCT05249829|467923355|FG000|Overall Study|Death|0|||
129989352|NCT05249829|467923356|FG001|Overall Study|Death|1|||
129989353|NCT05249829|467923357|FG002|Overall Study|Death|2|||
129989354|NCT05249829|467923358|FG003|Overall Study|Death|4|||
129989355|NCT00513604|467923359|FG000|Overall Study|Not treated|2|||
129989356|NCT00513604|467923360|FG001|Overall Study|Not treated|0|||
129989357|NCT00513604|467923361|FG002|Overall Study|Not treated|1|||
129989358|NCT00513604|467923362|FG003|Overall Study|Not treated|0|||
129989359|NCT00513604|467923363|FG004|Overall Study|Not treated|0|||
129989360|NCT00513604|467923359|FG000|Overall Study|Death during treatment|0|||
129989361|NCT00513604|467923360|FG001|Overall Study|Death during treatment|3|||
129989362|NCT00513604|467923361|FG002|Overall Study|Death during treatment|2|||
129989363|NCT00513604|467923362|FG003|Overall Study|Death during treatment|0|||
129989364|NCT00513604|467923363|FG004|Overall Study|Death during treatment|0|||
129989365|NCT01535560|467923365|FG000|Overall Study|Adverse Event|12|||
129989366|NCT01535560|467923366|FG001|Overall Study|Adverse Event|7|||
129989367|NCT01535560|467923365|FG000|Overall Study|Lost to Follow-up|1|||
129989368|NCT01535560|467923366|FG001|Overall Study|Lost to Follow-up|3|||
129989369|NCT01535560|467923365|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
129989370|NCT01535560|467923366|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
129989371|NCT01535560|467923365|FG000|Overall Study|Treatment Failure|21|||
129989372|NCT01535560|467923366|FG001|Overall Study|Treatment Failure|83|||
129989373|NCT01535560|467923365|FG000|Overall Study|Other|0|||
129989374|NCT01535560|467923366|FG001|Overall Study|Other|1|||
129989375|NCT01535560|467923365|FG000|Overall Study|Randomized in Error|0|||
129989376|NCT01535560|467923366|FG001|Overall Study|Randomized in Error|1|||
129989377|NCT02009761|467923367|FG000|Overall Study|Adverse Event|4|||
129989378|NCT02842827|467923368|FG000|Overall Study|Adverse Event|0|||
129989379|NCT02842827|467923369|FG001|Overall Study|Adverse Event|1|||
129989380|NCT02842827|467923370|FG002|Overall Study|Adverse Event|0|||
129989381|NCT02842827|467923371|FG003|Overall Study|Adverse Event|1|||
129989382|NCT02842827|467923372|FG004|Overall Study|Adverse Event|0|||
129989383|NCT02842827|467923373|FG005|Overall Study|Adverse Event|1|||
129989384|NCT02842827|467923374|FG006|Overall Study|Adverse Event|0|||
129989385|NCT02842827|467923375|FG007|Overall Study|Adverse Event|0|||
129989386|NCT02842827|467923368|FG000|Overall Study|Death|1|||
129989387|NCT02842827|467923369|FG001|Overall Study|Death|0|||
129989388|NCT02842827|467923370|FG002|Overall Study|Death|2|||
129989389|NCT02842827|467923371|FG003|Overall Study|Death|3|||
129989390|NCT02842827|467923372|FG004|Overall Study|Death|2|||
129989391|NCT02842827|467923373|FG005|Overall Study|Death|1|||
129989392|NCT02842827|467923374|FG006|Overall Study|Death|0|||
129989393|NCT02842827|467923375|FG007|Overall Study|Death|4|||
129989394|NCT02842827|467923368|FG000|Overall Study|Physician Decision|1|||
129989395|NCT02842827|467923369|FG001|Overall Study|Physician Decision|3|||
129989396|NCT02842827|467923370|FG002|Overall Study|Physician Decision|0|||
129989397|NCT02842827|467923371|FG003|Overall Study|Physician Decision|0|||
129989398|NCT02842827|467923372|FG004|Overall Study|Physician Decision|1|||
129989399|NCT02842827|467923373|FG005|Overall Study|Physician Decision|4|||
129989400|NCT02842827|467923374|FG006|Overall Study|Physician Decision|2|||
129989401|NCT02842827|467923375|FG007|Overall Study|Physician Decision|1|||
129989402|NCT02842827|467923368|FG000|Overall Study|Protocol Defined Disease Progression|0|||
129989403|NCT02842827|467923369|FG001|Overall Study|Protocol Defined Disease Progression|0|||
129989404|NCT02842827|467923370|FG002|Overall Study|Protocol Defined Disease Progression|0|||
129989405|NCT02842827|467923371|FG003|Overall Study|Protocol Defined Disease Progression|0|||
129989406|NCT02842827|467923372|FG004|Overall Study|Protocol Defined Disease Progression|0|||
129989407|NCT02842827|467923373|FG005|Overall Study|Protocol Defined Disease Progression|1|||
129989408|NCT02842827|467923374|FG006|Overall Study|Protocol Defined Disease Progression|0|||
129989409|NCT02842827|467923375|FG007|Overall Study|Protocol Defined Disease Progression|0|||
129989410|NCT02842827|467923368|FG000|Overall Study|Participant Withdrawal of Consent|1|||
129989411|NCT02842827|467923369|FG001|Overall Study|Participant Withdrawal of Consent|2|||
129989412|NCT02842827|467923370|FG002|Overall Study|Participant Withdrawal of Consent|2|||
129989413|NCT02842827|467923371|FG003|Overall Study|Participant Withdrawal of Consent|2|||
129989414|NCT02842827|467923372|FG004|Overall Study|Participant Withdrawal of Consent|2|||
129989415|NCT02842827|467923373|FG005|Overall Study|Participant Withdrawal of Consent|1|||
129989416|NCT02842827|467923374|FG006|Overall Study|Participant Withdrawal of Consent|2|||
129989417|NCT02842827|467923375|FG007|Overall Study|Participant Withdrawal of Consent|1|||
129989418|NCT02372136|467923376|FG000|Overall Study|Death|3|||
129989419|NCT02372136|467923377|FG001|Overall Study|Death|1|||
129989420|NCT00985946|467923378|FG000|Overall Study|Lost to Follow-up|6|||
129989421|NCT00985946|467923378|FG000|Overall Study|Withdrawal by Subject|1|||
129989422|NCT02471833|467923379|FG000|Overall Study|Lost to Follow-up|1|||
129989423|NCT02471833|467923380|FG001|Overall Study|Lost to Follow-up|0|||
129989424|NCT02471833|467923381|FG002|Overall Study|Lost to Follow-up|0|||
129989425|NCT02471833|467923379|FG000|Overall Study|Withdrawal by Subject|2|||
129989426|NCT02471833|467923380|FG001|Overall Study|Withdrawal by Subject|1|||
129989427|NCT02471833|467923381|FG002|Overall Study|Withdrawal by Subject|5|||
129989428|NCT02673515|467923385|FG000|Overall Study|Lack of motivation|2|||
129989429|NCT02673515|467923386|FG001|Overall Study|Lack of motivation|1|||
129989430|NCT03965351|467923388|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129989431|NCT03965351|467923389|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
129989432|NCT03965351|467923388|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
129989433|NCT03965351|467923389|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
129989434|NCT00490724|467923390|FG000|Period I|Physician Decision|0|||
129989435|NCT00490724|467923391|FG001|Period I|Physician Decision|0|||
129989436|NCT00490724|467923392|FG002|Period I|Physician Decision|1|||
129989437|NCT00490724|467923390|FG000|Period II|Treatment Discontinuation|3|||
129989438|NCT00490724|467923391|FG001|Period II|Treatment Discontinuation|1|||
129989439|NCT00490724|467923392|FG002|Period II|Treatment Discontinuation|3|||
129989440|NCT00994682|467923393|FG000|Double Bilnd|Withdrawal by Subject|5|||
129989441|NCT00994682|467923394|FG001|Double Bilnd|Withdrawal by Subject|6|||
129989442|NCT00994682|467923393|FG000|Double Bilnd|Lost to Follow-up|3|||
129989443|NCT00994682|467923394|FG001|Double Bilnd|Lost to Follow-up|3|||
129989444|NCT00994682|467923393|FG000|Double Bilnd|Adverse Event|1|||
129989445|NCT00994682|467923394|FG001|Double Bilnd|Adverse Event|0|||
129989446|NCT00994682|467923393|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
129989447|NCT00994682|467923394|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
129989448|NCT00994682|467923393|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
129989449|NCT00994682|467923394|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
129989450|NCT00994682|467923393|FG000|Pioglitazone Open Label|Physician Decision|6|||
129989451|NCT00994682|467923394|FG001|Pioglitazone Open Label|Physician Decision|1|||
129989452|NCT00896051|467925412|FG000|Overall Study|Adverse Event|2|||
129989453|NCT00896051|467925413|FG001|Overall Study|Adverse Event|1|||
129989454|NCT00896051|467925412|FG000|Overall Study|Lost to Follow-up|3|||
129989455|NCT00896051|467925413|FG001|Overall Study|Lost to Follow-up|2|||
129989456|NCT00896051|467925412|FG000|Overall Study|Withdrawal by Subject|3|||
129989457|NCT00896051|467925413|FG001|Overall Study|Withdrawal by Subject|2|||
129989458|NCT00896051|467925412|FG000|Overall Study|Subject noncompliant|1|||
129989459|NCT00896051|467925413|FG001|Overall Study|Subject noncompliant|3|||
129989460|NCT00896051|467925412|FG000|Overall Study|Other|1|||
129989461|NCT00896051|467925413|FG001|Overall Study|Other|1|||
129989462|NCT02935452|467925414|FG000|Overall Study|work and life commintment|3|||
129989463|NCT02935452|467925415|FG001|Overall Study|work and life commintment|1|||
129989464|NCT00876928|467925416|FG000|Overall Study|Lost to Follow-up|2|||
129989465|NCT00876928|467925417|FG001|Overall Study|Lost to Follow-up|5|||
129989466|NCT00876928|467925416|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
129989467|NCT00876928|467925417|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
129989468|NCT02336178|467925423|FG000|Overall Study|Lost to Follow-up|1|||
129989469|NCT02336178|467925423|FG000|Overall Study|Protocol Violation|1|||
129989470|NCT02336178|467925423|FG000|Overall Study|Withdrawal by Subject|1|||
129989471|NCT02336178|467925423|FG000|Overall Study|Other|1|||
129989472|NCT00618982|467925424|FG000|Overall Study|Adverse Event|23|||
129989473|NCT00618982|467925424|FG000|Overall Study|Withdrawal by Subject|1|||
129989474|NCT00618982|467925424|FG000|Overall Study|Protocol Violation|1|||
129989475|NCT00618982|467925424|FG000|Overall Study|ongoing, still treated with study med.|25|||
129989476|NCT01776541|467925427|FG000|Overall Study|Administrative Reason|6|||
129989477|NCT01776541|467925428|FG001|Overall Study|Administrative Reason|2|||
129989478|NCT01776541|467925427|FG000|Overall Study|Death|4|||
129660139|NCT05052697|466714544|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660140|NCT05052697|466714545|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660141|NCT05052697|466714546|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660142|NCT05052697|466714547|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660143|NCT05052697|466714548|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660144|NCT05052697|466714549|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660145|NCT05052697|466714550|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660146|NCT05052697|466714551|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660147|NCT05052697|466714552|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660148|NCT05052697|466714553|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660149|NCT05052697|466714554|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660150|NCT05052697|466714555|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660151|NCT05052697|466714556|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660152|NCT05052697|466714557|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660153|NCT05052697|466714558|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660154|NCT05052697|466714559|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660155|NCT05052697|466714560|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660156|NCT05052697|466714561|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660157|NCT05052697|466714562|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660158|NCT05052697|466714563|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660159|NCT05052697|466714564|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660160|NCT05052697|466714565|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660161|NCT05052697|466714566|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660162|NCT05052697|466714567|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660163|NCT05052697|466714568|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660164|NCT05052697|466714569|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660165|NCT05052697|466714570|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660166|NCT05052697|466714571|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660167|NCT05052697|466714572|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660168|NCT05052697|466714573|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660169|NCT05052697|466714574|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660170|NCT05052697|466714575|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
129660171|NCT05052697|466714576|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
129660172|NCT05052697|466714543|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660173|NCT05052697|466714544|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660174|NCT05052697|466714545|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660175|NCT05052697|466714546|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660176|NCT05052697|466714547|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660177|NCT05052697|466714548|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660178|NCT05052697|466714549|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660179|NCT05052697|466714550|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129989479|NCT01776541|467925428|FG001|Overall Study|Death|0|||
129989480|NCT01776541|467925427|FG000|Overall Study|Lost to Follow-up|27|||
129989481|NCT01776541|467925428|FG001|Overall Study|Lost to Follow-up|48|||
129660180|NCT05052697|466714551|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660181|NCT05052697|466714552|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129989482|NCT01776541|467925427|FG000|Overall Study|Unclassified|5|||
129989483|NCT01776541|467925428|FG001|Overall Study|Unclassified|4|||
129989484|NCT01776541|467925427|FG000|Overall Study|Protocol Violation|2|||
129660182|NCT05052697|466714553|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660183|NCT05052697|466714554|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660184|NCT05052697|466714555|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660185|NCT05052697|466714556|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660186|NCT05052697|466714557|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129989485|NCT01776541|467925428|FG001|Overall Study|Protocol Violation|1|||
129660187|NCT05052697|466714558|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660188|NCT05052697|466714559|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660189|NCT05052697|466714560|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660190|NCT05052697|466714561|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660191|NCT05052697|466714562|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660192|NCT05052697|466714563|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660193|NCT05052697|466714564|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660194|NCT05052697|466714565|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660195|NCT05052697|466714566|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660196|NCT05052697|466714567|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660197|NCT05052697|466714568|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660198|NCT05052697|466714569|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660199|NCT05052697|466714570|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660200|NCT05052697|466714571|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
129660201|NCT05052697|466714572|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
129660202|NCT05052697|466714573|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
129660203|NCT05052697|466714574|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660204|NCT05052697|466714575|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660205|NCT05052697|466714576|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
129660206|NCT01289574|466714577|FG000|Overall Study|Lack of Efficacy|4|||
129660207|NCT01289574|466714578|FG001|Overall Study|Lack of Efficacy|0|||
129660208|NCT01289574|466714579|FG002|Overall Study|Lack of Efficacy|1|||
129660209|NCT01289574|466714577|FG000|Overall Study|Lost to Follow-up|2|||
129660210|NCT01289574|466714578|FG001|Overall Study|Lost to Follow-up|0|||
129660211|NCT01289574|466714579|FG002|Overall Study|Lost to Follow-up|1|||
129660212|NCT01289574|466714577|FG000|Overall Study|Withdrawal by Subject|1|||
129660213|NCT01289574|466714578|FG001|Overall Study|Withdrawal by Subject|1|||
129660214|NCT01289574|466714579|FG002|Overall Study|Withdrawal by Subject|1|||
129660215|NCT01289574|466714577|FG000|Overall Study|Adverse Event|0|||
129660216|NCT01289574|466714578|FG001|Overall Study|Adverse Event|1|||
129660217|NCT01289574|466714579|FG002|Overall Study|Adverse Event|0|||
129660218|NCT01289574|466714577|FG000|Overall Study|Subject wanted alternate treatment|0|||
129660219|NCT01289574|466714578|FG001|Overall Study|Subject wanted alternate treatment|1|||
129660220|NCT01289574|466714579|FG002|Overall Study|Subject wanted alternate treatment|0|||
129660221|NCT00262002|466714580|FG000|Overall Study|Adverse Event|2|||
129660222|NCT00262002|466714581|FG001|Overall Study|Adverse Event|1|||
129660223|NCT00262002|466714582|FG002|Overall Study|Adverse Event|0|||
129989486|NCT01776541|467925427|FG000|Overall Study|Withdrawal by Subject|12|||
129989487|NCT01776541|467925428|FG001|Overall Study|Withdrawal by Subject|20|||
129989488|NCT00156819|467925429|FG000|Overall Study|Lost to Follow-up|1|||
129989489|NCT00156819|467925430|FG001|Overall Study|Lost to Follow-up|1|||
129989490|NCT00156819|467925431|FG002|Overall Study|Lost to Follow-up|3|||
129989491|NCT02090959|467925432|FG000|Overall Study|Withdrawal by Subject|10|||
129989492|NCT02090959|467925432|FG000|Overall Study|Adverse Event|1|||
129989493|NCT02090959|467925432|FG000|Overall Study|Investigator decision|2|||
129989494|NCT02090959|467925432|FG000|Overall Study|Study termination|6|||
129989495|NCT02090959|467925432|FG000|Overall Study|Enrolled but not treated|1|||
129989496|NCT02090959|467925432|FG000|Overall Study|Transfer for compassionate use medicine|4|||
129989497|NCT02090959|467925432|FG000|Overall Study|Move to medical need program|3|||
129989498|NCT02090959|467925432|FG000|Overall Study|Entered in to other study|34|||
129989499|NCT02090959|467925432|FG000|Overall Study|Switched to commercial supply|88|||
129989500|NCT02090959|467925432|FG000|Overall Study|Other than specified|2|||
129989501|NCT00522873|467925435|FG000|Overall Study|Adverse Event|41|||
129660224|NCT00262002|466714583|FG003|Overall Study|Adverse Event|0|||
129660225|NCT00262002|466714584|FG004|Overall Study|Adverse Event|0|||
129660226|NCT00262002|466714585|FG005|Overall Study|Adverse Event|1|||
129660227|NCT00262002|466714586|FG006|Overall Study|Adverse Event|0|||
129660228|NCT00262002|466714580|FG000|Overall Study|Withdrawal by Subject|4|||
129660229|NCT00262002|466714581|FG001|Overall Study|Withdrawal by Subject|2|||
129660230|NCT00262002|466714582|FG002|Overall Study|Withdrawal by Subject|0|||
129660231|NCT00262002|466714583|FG003|Overall Study|Withdrawal by Subject|1|||
129660232|NCT00262002|466714584|FG004|Overall Study|Withdrawal by Subject|2|||
129660233|NCT00262002|466714585|FG005|Overall Study|Withdrawal by Subject|2|||
129989502|NCT00522873|467925436|FG001|Overall Study|Adverse Event|26|||
129989503|NCT00522873|467925435|FG000|Overall Study|Withdrawal by Subject|20|||
129989504|NCT00522873|467925436|FG001|Overall Study|Withdrawal by Subject|9|||
129989505|NCT00522873|467925435|FG000|Overall Study|Protocol Violation|14|||
129989506|NCT00522873|467925436|FG001|Overall Study|Protocol Violation|4|||
129989507|NCT00522873|467925435|FG000|Overall Study|Lost to Follow-up|11|||
129883721|NCT01146574|467534408|FG004|Overall Study|Other reasons|0|||
129883722|NCT01146574|467534409|FG005|Overall Study|Other reasons|0|||
129883723|NCT01146574|467534410|FG006|Overall Study|Other reasons|0|||
129883724|NCT01146574|467534404|FG000|Overall Study|Kidney transplant|0|||
129883725|NCT01146574|467534405|FG001|Overall Study|Kidney transplant|0|||
129883726|NCT01146574|467534406|FG002|Overall Study|Kidney transplant|1|||
129883727|NCT01146574|467534407|FG003|Overall Study|Kidney transplant|1|||
129883728|NCT01146574|467534408|FG004|Overall Study|Kidney transplant|0|||
129883729|NCT01146574|467534409|FG005|Overall Study|Kidney transplant|0|||
129883730|NCT01146574|467534410|FG006|Overall Study|Kidney transplant|0|||
129883731|NCT01146574|467534404|FG000|Overall Study|Withdrew consent|0|||
129883732|NCT01146574|467534405|FG001|Overall Study|Withdrew consent|0|||
129883733|NCT01146574|467534406|FG002|Overall Study|Withdrew consent|1|||
129883734|NCT01146574|467534407|FG003|Overall Study|Withdrew consent|1|||
129883735|NCT01146574|467534408|FG004|Overall Study|Withdrew consent|2|||
129883736|NCT01146574|467534409|FG005|Overall Study|Withdrew consent|1|||
129883737|NCT01146574|467534410|FG006|Overall Study|Withdrew consent|1|||
129883738|NCT03051659|467534411|FG000|Treatment Period|Withdrawal by Subject|0|||
129883739|NCT03051659|467534412|FG001|Treatment Period|Withdrawal by Subject|2|||
129883740|NCT03051659|467534411|FG000|Survival Follow-up|Lost to Follow-up|23|||
129883741|NCT03051659|467534412|FG001|Survival Follow-up|Lost to Follow-up|22|||
129883742|NCT01076088|467534413|FG000|Overall Study|Adverse Event|1|||
129883743|NCT01076088|467534414|FG001|Overall Study|Adverse Event|6|||
129883744|NCT01076088|467534415|FG002|Overall Study|Adverse Event|3|||
129883745|NCT01076088|467534416|FG003|Overall Study|Adverse Event|2|||
129883746|NCT01076088|467534417|FG004|Overall Study|Adverse Event|3|||
129883747|NCT01076088|467534418|FG005|Overall Study|Adverse Event|3|||
129883748|NCT01076088|467534413|FG000|Overall Study|Lost to Follow-up|1|||
129883749|NCT01076088|467534414|FG001|Overall Study|Lost to Follow-up|1|||
129883750|NCT01076088|467534415|FG002|Overall Study|Lost to Follow-up|0|||
129883751|NCT01076088|467534416|FG003|Overall Study|Lost to Follow-up|1|||
129883752|NCT01076088|467534417|FG004|Overall Study|Lost to Follow-up|1|||
129883753|NCT01076088|467534418|FG005|Overall Study|Lost to Follow-up|2|||
129883754|NCT01076088|467534413|FG000|Overall Study|Non-compliance with study drug|0|||
129883755|NCT01076088|467534414|FG001|Overall Study|Non-compliance with study drug|0|||
129883756|NCT01076088|467534415|FG002|Overall Study|Non-compliance with study drug|0|||
129883757|NCT01076088|467534416|FG003|Overall Study|Non-compliance with study drug|1|||
129883758|NCT01076088|467534417|FG004|Overall Study|Non-compliance with study drug|0|||
129883759|NCT01076088|467534418|FG005|Overall Study|Non-compliance with study drug|0|||
129883760|NCT01076088|467534413|FG000|Overall Study|Physician Decision|1|||
129883761|NCT01076088|467534414|FG001|Overall Study|Physician Decision|3|||
129883762|NCT01076088|467534415|FG002|Overall Study|Physician Decision|0|||
129883763|NCT01076088|467534416|FG003|Overall Study|Physician Decision|1|||
129883764|NCT01076088|467534417|FG004|Overall Study|Physician Decision|1|||
129883765|NCT01076088|467534418|FG005|Overall Study|Physician Decision|0|||
129883766|NCT01076088|467534413|FG000|Overall Study|Withdrawal by Subject|8|||
129883767|NCT01076088|467534414|FG001|Overall Study|Withdrawal by Subject|8|||
129883768|NCT01076088|467534415|FG002|Overall Study|Withdrawal by Subject|14|||
129883769|NCT01076088|467534416|FG003|Overall Study|Withdrawal by Subject|10|||
129883770|NCT01076088|467534417|FG004|Overall Study|Withdrawal by Subject|11|||
129883771|NCT01076088|467534418|FG005|Overall Study|Withdrawal by Subject|17|||
129883772|NCT01076088|467534413|FG000|Overall Study|Other protocol specified criteria|0|||
129883773|NCT01076088|467534414|FG001|Overall Study|Other protocol specified criteria|0|||
129883774|NCT01076088|467534415|FG002|Overall Study|Other protocol specified criteria|0|||
129883775|NCT01076088|467534416|FG003|Overall Study|Other protocol specified criteria|0|||
129883776|NCT01076088|467534417|FG004|Overall Study|Other protocol specified criteria|0|||
129883777|NCT01076088|467534418|FG005|Overall Study|Other protocol specified criteria|1|||
129883778|NCT00786474|467534419|FG000|Overall Study|Death|5|||
129883779|NCT00786474|467534420|FG001|Overall Study|Death|4|||
129883780|NCT00786474|467534419|FG000|Overall Study|Withdrawal by Subject|23|||
129883781|NCT00786474|467534420|FG001|Overall Study|Withdrawal by Subject|31|||
129883782|NCT00786474|467534419|FG000|Overall Study|Lost to Follow-up|3|||
129883783|NCT00786474|467534420|FG001|Overall Study|Lost to Follow-up|3|||
129883784|NCT00786474|467534419|FG000|Overall Study|Physician Decision|2|||
129883785|NCT00786474|467534420|FG001|Overall Study|Physician Decision|1|||
129883786|NCT00786474|467534419|FG000|Overall Study|Other|4|||
129883787|NCT00786474|467534420|FG001|Overall Study|Other|4|||
129883788|NCT03053492|467534421|FG000|Overall Study|Adverse Event|1|||
129883789|NCT03053492|467534422|FG001|Overall Study|Adverse Event|1|||
129883790|NCT03053492|467534421|FG000|Overall Study|Withdrawal by Subject|7|||
129883791|NCT03053492|467534422|FG001|Overall Study|Withdrawal by Subject|5|||
129883792|NCT01868074|467534423|FG000|Overall Study|Lost to Follow-up|3|||
129883793|NCT01868074|467534424|FG001|Overall Study|Lost to Follow-up|2|||
129883794|NCT01868074|467534423|FG000|Overall Study|Withdrawal by Subject|4|||
129883795|NCT01868074|467534424|FG001|Overall Study|Withdrawal by Subject|2|||
129883796|NCT01544491|467534425|FG000|Overall Study|Withdrawal by Subject|3|||
129883797|NCT01544491|467534426|FG001|Overall Study|Withdrawal by Subject|2|||
129883798|NCT01544491|467534425|FG000|Overall Study|Lost to Follow-up|0|||
129989508|NCT00522873|467925436|FG001|Overall Study|Lost to Follow-up|3|||
129989509|NCT00522873|467925435|FG000|Overall Study|Personal Reasons|8|||
129989510|NCT00522873|467925436|FG001|Overall Study|Personal Reasons|1|||
129989511|NCT00522873|467925435|FG000|Overall Study|Medication Errors|1|||
129989512|NCT00522873|467925436|FG001|Overall Study|Medication Errors|1|||
129989513|NCT00522873|467925435|FG000|Overall Study|Never Received Medication|1|||
129989514|NCT00522873|467925436|FG001|Overall Study|Never Received Medication|0|||
129989515|NCT01052103|467925438|FG000|Overall Study|Adverse Event|10|||
129660234|NCT00262002|466714586|FG006|Overall Study|Withdrawal by Subject|2|||
129660235|NCT00262002|466714580|FG000|Overall Study|Lost to Follow-up|2|||
129660236|NCT00262002|466714581|FG001|Overall Study|Lost to Follow-up|0|||
129660237|NCT00262002|466714582|FG002|Overall Study|Lost to Follow-up|0|||
129883799|NCT01544491|467534426|FG001|Overall Study|Lost to Follow-up|1|||
129883800|NCT01544491|467534425|FG000|Overall Study|administrative problems|2|||
129883801|NCT01544491|467534426|FG001|Overall Study|administrative problems|0|||
129883802|NCT00967018|467534427|FG000|Overall Study|Adverse Event|2|||
129883803|NCT00967018|467534427|FG000|Overall Study|Physician Decision|7|||
129883804|NCT00967018|467534427|FG000|Overall Study|Lost to Follow-up|2|||
129883805|NCT00967018|467534427|FG000|Overall Study|Withdrawal by Subject|1|||
129883806|NCT00967018|467534427|FG000|Overall Study|Miscellaneous Reasons|9|||
129883807|NCT04642469|467534433|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
129883808|NCT04642469|467534434|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
129883809|NCT04642469|467534433|FG000|Overall Study|Death|1|||
129883810|NCT04642469|467534434|FG001|Overall Study|Death|2|||
129883811|NCT04642469|467534433|FG000|Overall Study|Study/site closed following amendment 1|11|||
129883812|NCT04642469|467534434|FG001|Overall Study|Study/site closed following amendment 1|11|||
129883813|NCT04642469|467534433|FG000|Overall Study|Other|1|||
129883814|NCT04642469|467534434|FG001|Overall Study|Other|1|||
129883815|NCT04642469|467534433|FG000|Overall Study|Withdrawal by Subject|1|||
129883816|NCT04642469|467534434|FG001|Overall Study|Withdrawal by Subject|0|||
129883817|NCT01461993|467534435|FG000|Overall Study|Withdrawal by Subject|60|||
129883818|NCT01461993|467534436|FG001|Overall Study|Withdrawal by Subject|53|||
129883819|NCT01461993|467534437|FG002|Overall Study|Withdrawal by Subject|16|||
129883820|NCT01461993|467534435|FG000|Overall Study|Lost to Follow-up|44|||
129883821|NCT01461993|467534436|FG001|Overall Study|Lost to Follow-up|48|||
129883822|NCT01461993|467534437|FG002|Overall Study|Lost to Follow-up|22|||
129883823|NCT01461993|467534435|FG000|Overall Study|Protocol Violation|10|||
129883824|NCT01461993|467534436|FG001|Overall Study|Protocol Violation|9|||
129883825|NCT01461993|467534437|FG002|Overall Study|Protocol Violation|7|||
129883826|NCT01461993|467534435|FG000|Overall Study|Adverse Event|9|||
129883827|NCT01461993|467534436|FG001|Overall Study|Adverse Event|11|||
129883828|NCT01461993|467534437|FG002|Overall Study|Adverse Event|3|||
129883829|NCT01461993|467534435|FG000|Overall Study|No longer met eligibility criteria|13|||
129883830|NCT01461993|467534436|FG001|Overall Study|No longer met eligibility criteria|18|||
129883831|NCT01461993|467534437|FG002|Overall Study|No longer met eligibility criteria|10|||
129883832|NCT01461993|467534435|FG000|Overall Study|Did not meet entrance criteria|2|||
129883833|NCT01461993|467534436|FG001|Overall Study|Did not meet entrance criteria|3|||
129883834|NCT01461993|467534437|FG002|Overall Study|Did not meet entrance criteria|0|||
129883835|NCT01461993|467534435|FG000|Overall Study|Other|13|||
129883836|NCT01461993|467534436|FG001|Overall Study|Other|15|||
129883837|NCT01461993|467534437|FG002|Overall Study|Other|6|||
129883838|NCT00680056|467534439|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
129883839|NCT00680056|467534440|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
129883840|NCT00680056|467534439|FG000|Second Intervention|Protocol Violation|3|||
129883841|NCT00680056|467534440|FG001|Second Intervention|Protocol Violation|1|||
129883842|NCT02733042|467534441|FG000|Overall Study|Adverse Event|1|||
129883843|NCT02733042|467534442|FG001|Overall Study|Adverse Event|0|||
129883844|NCT02733042|467534443|FG002|Overall Study|Adverse Event|1|||
129883845|NCT02733042|467534444|FG003|Overall Study|Adverse Event|1|||
129883846|NCT02733042|467534445|FG004|Overall Study|Adverse Event|0|||
129883847|NCT02733042|467534446|FG005|Overall Study|Adverse Event|0|||
129883848|NCT02733042|467534447|FG006|Overall Study|Adverse Event|0|||
129883849|NCT02733042|467534448|FG007|Overall Study|Adverse Event|0|||
129883850|NCT02733042|467534449|FG008|Overall Study|Adverse Event|0|||
129883851|NCT02733042|467534450|FG009|Overall Study|Adverse Event|0|||
129883852|NCT02733042|467534451|FG010|Overall Study|Adverse Event|2|||
129883853|NCT02733042|467534452|FG011|Overall Study|Adverse Event|2|||
129883854|NCT02733042|467534453|FG012|Overall Study|Adverse Event|0|||
129883855|NCT02733042|467534454|FG013|Overall Study|Adverse Event|2|||
129883856|NCT02733042|467534455|FG014|Overall Study|Adverse Event|0|||
129883857|NCT02733042|467534456|FG015|Overall Study|Adverse Event|0|||
129883858|NCT02733042|467534457|FG016|Overall Study|Adverse Event|0|||
129883859|NCT02733042|467534458|FG017|Overall Study|Adverse Event|1|||
129883860|NCT02733042|467534459|FG018|Overall Study|Adverse Event|0|||
129883861|NCT02733042|467534441|FG000|Overall Study|Progressive Disease|2|||
129883862|NCT02733042|467534442|FG001|Overall Study|Progressive Disease|1|||
129883863|NCT02733042|467534443|FG002|Overall Study|Progressive Disease|3|||
129660238|NCT00262002|466714583|FG003|Overall Study|Lost to Follow-up|2|||
129989516|NCT01052103|467925439|FG001|Overall Study|Adverse Event|6|||
129989517|NCT01052103|467925438|FG000|Overall Study|Entry Criteria Not Met|3|||
129989518|NCT01052103|467925439|FG001|Overall Study|Entry Criteria Not Met|1|||
129989519|NCT01052103|467925438|FG000|Overall Study|Lost to Follow-up|3|||
129989520|NCT01052103|467925439|FG001|Overall Study|Lost to Follow-up|5|||
129989521|NCT01052103|467925438|FG000|Overall Study|Protocol Violation|10|||
129989522|NCT01052103|467925439|FG001|Overall Study|Protocol Violation|4|||
129989523|NCT01052103|467925438|FG000|Overall Study|Scheduling conflict|2|||
129989524|NCT01052103|467925439|FG001|Overall Study|Scheduling conflict|1|||
129989525|NCT01052103|467925438|FG000|Overall Study|Sponsor Decision|2|||
129989526|NCT01052103|467925439|FG001|Overall Study|Sponsor Decision|0|||
129989527|NCT01052103|467925438|FG000|Overall Study|Withdrawal by Subject|3|||
129989528|NCT01052103|467925439|FG001|Overall Study|Withdrawal by Subject|6|||
129989529|NCT01052103|467925438|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129989530|NCT01052103|467925439|FG001|Overall Study|Perceived Lack of Efficacy|0|||
129989531|NCT00799513|467925443|FG000|Overall Study|Physician Decision|1|||
129989532|NCT00799513|467925443|FG000|Overall Study|Adverse Event|1|||
129989533|NCT05398237|467925446|FG000|Overall Study|Withdrawal by Subject|1|||
129989534|NCT00666679|467925447|FG000|First Intervention|Lost to Follow-up|1|||
129989535|NCT00666679|467925448|FG001|First Intervention|Lost to Follow-up|0|||
129989536|NCT00666679|467925447|FG000|First Intervention|Protocol Violation|1|||
129989537|NCT00666679|467925448|FG001|First Intervention|Protocol Violation|0|||
129989538|NCT00666679|467925447|FG000|First Intervention|Withdrawal by Subject|1|||
129989539|NCT00666679|467925448|FG001|First Intervention|Withdrawal by Subject|0|||
129989540|NCT00666679|467925447|FG000|First Intervention|Randomized did not start treatment|1|||
129989541|NCT00666679|467925448|FG001|First Intervention|Randomized did not start treatment|1|||
129989542|NCT00666679|467925447|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
129989543|NCT00666679|467925448|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
129989544|NCT00666679|467925447|FG000|Washout Period of 1 Week|Protocol Violation|0|||
129989545|NCT00666679|467925448|FG001|Washout Period of 1 Week|Protocol Violation|1|||
129989546|NCT00666679|467925447|FG000|Second Intervention|Adverse Event|1|||
129989547|NCT00666679|467925448|FG001|Second Intervention|Adverse Event|0|||
129989548|NCT00666679|467925447|FG000|Second Intervention|Death|0|||
129989549|NCT00666679|467925448|FG001|Second Intervention|Death|1|||
129989550|NCT05062759|467925454|FG000|Overall Study|Death|0|||
129989551|NCT05062759|467925455|FG001|Overall Study|Death|1|||
129989552|NCT05062759|467925454|FG000|Overall Study|Lost to Follow-up|1|||
129989553|NCT05062759|467925455|FG001|Overall Study|Lost to Follow-up|0|||
129989554|NCT01248065|467925456|FG000|Overall Study|Lost to Follow-up|3|||
129989555|NCT01248065|467925457|FG001|Overall Study|Lost to Follow-up|5|||
129989556|NCT01248065|467925456|FG000|Overall Study|Withdrawal by Subject|14|||
129989557|NCT01248065|467925457|FG001|Overall Study|Withdrawal by Subject|11|||
129989558|NCT01248065|467925456|FG000|Overall Study|Adverse Event|3|||
129989559|NCT01248065|467925457|FG001|Overall Study|Adverse Event|0|||
129989560|NCT01248065|467925456|FG000|Overall Study|Third treatment failure event|3|||
129989561|NCT01248065|467925457|FG001|Overall Study|Third treatment failure event|1|||
129989562|NCT01248065|467925456|FG000|Overall Study|Other|3|||
129989563|NCT01248065|467925457|FG001|Overall Study|Other|5|||
129989564|NCT02781844|467925461|FG000|Treatment Period 1|Adverse Event|0|||
129989565|NCT02781844|467925462|FG001|Treatment Period 1|Adverse Event|0|||
129989566|NCT02781844|467925463|FG002|Treatment Period 1|Adverse Event|0|||
129989567|NCT02781844|467925464|FG003|Treatment Period 1|Adverse Event|0|||
129989568|NCT02781844|467925465|FG004|Treatment Period 1|Adverse Event|0|||
129989569|NCT02781844|467925466|FG005|Treatment Period 1|Adverse Event|1|||
129989570|NCT02781844|467925467|FG006|Treatment Period 1|Adverse Event|0|||
129989571|NCT02781844|467925468|FG007|Treatment Period 1|Adverse Event|0|||
129989572|NCT02518490|467925471|FG000|Overall Study|Withdrawal by Subject|1|||
129989573|NCT02518490|467925472|FG001|Overall Study|Withdrawal by Subject|1|||
129989574|NCT03010176|467925475|FG000|Overall Study|Death|21|||
129989575|NCT03010176|467925476|FG001|Overall Study|Death|35|||
129989576|NCT03010176|467925477|FG002|Overall Study|Death|19|||
129989577|NCT03010176|467925478|FG003|Overall Study|Death|19|||
129989578|NCT03010176|467925479|FG004|Overall Study|Death|14|||
129989579|NCT03010176|467925480|FG005|Overall Study|Death|0|||
129989580|NCT03010176|467925475|FG000|Overall Study|Lost to Follow-up|0|||
129989581|NCT03010176|467925476|FG001|Overall Study|Lost to Follow-up|0|||
129989582|NCT03010176|467925477|FG002|Overall Study|Lost to Follow-up|0|||
129989583|NCT03010176|467925478|FG003|Overall Study|Lost to Follow-up|0|||
129989584|NCT03010176|467925479|FG004|Overall Study|Lost to Follow-up|1|||
129989585|NCT03010176|467925480|FG005|Overall Study|Lost to Follow-up|0|||
129989586|NCT03010176|467925475|FG000|Overall Study|Physician Decision|0|||
129989587|NCT03010176|467925476|FG001|Overall Study|Physician Decision|4|||
129989588|NCT03010176|467925477|FG002|Overall Study|Physician Decision|0|||
129989589|NCT03010176|467925478|FG003|Overall Study|Physician Decision|1|||
129989590|NCT03010176|467925479|FG004|Overall Study|Physician Decision|0|||
129989591|NCT03010176|467925480|FG005|Overall Study|Physician Decision|0|||
129989592|NCT03010176|467925475|FG000|Overall Study|Sponsor Decision|0|||
129989593|NCT03010176|467925476|FG001|Overall Study|Sponsor Decision|4|||
129989594|NCT03010176|467925477|FG002|Overall Study|Sponsor Decision|4|||
129989595|NCT03010176|467925478|FG003|Overall Study|Sponsor Decision|1|||
129989596|NCT03010176|467925479|FG004|Overall Study|Sponsor Decision|6|||
129989597|NCT03010176|467925480|FG005|Overall Study|Sponsor Decision|0|||
129989598|NCT03010176|467925475|FG000|Overall Study|Withdrawal by Subject|11|||
129989599|NCT03010176|467925476|FG001|Overall Study|Withdrawal by Subject|9|||
129989600|NCT03010176|467925477|FG002|Overall Study|Withdrawal by Subject|3|||
129989601|NCT03010176|467925478|FG003|Overall Study|Withdrawal by Subject|0|||
129989602|NCT03010176|467925479|FG004|Overall Study|Withdrawal by Subject|4|||
129989603|NCT03010176|467925480|FG005|Overall Study|Withdrawal by Subject|0|||
129989604|NCT04256629|467925481|FG000|Overall Study|Adverse Event|0|||
129989605|NCT04256629|467925482|FG001|Overall Study|Adverse Event|0|||
129989606|NCT04256629|467925483|FG002|Overall Study|Adverse Event|0|||
129989607|NCT04256629|467925484|FG003|Overall Study|Adverse Event|0|||
129989608|NCT04256629|467925485|FG004|Overall Study|Adverse Event|0|||
129989609|NCT04256629|467925486|FG005|Overall Study|Adverse Event|1|||
129989610|NCT04256629|467925481|FG000|Overall Study|Protocol Violation|0|||
129989611|NCT04256629|467925482|FG001|Overall Study|Protocol Violation|1|||
129989612|NCT04256629|467925483|FG002|Overall Study|Protocol Violation|0|||
129989613|NCT04256629|467925484|FG003|Overall Study|Protocol Violation|0|||
129660239|NCT00262002|466714584|FG004|Overall Study|Lost to Follow-up|0|||
129660240|NCT00262002|466714585|FG005|Overall Study|Lost to Follow-up|1|||
129660241|NCT00262002|466714586|FG006|Overall Study|Lost to Follow-up|0|||
129660242|NCT00262002|466714580|FG000|Overall Study|Inapropriate enrollment|0|||
129660243|NCT00262002|466714581|FG001|Overall Study|Inapropriate enrollment|1|||
129660244|NCT00262002|466714582|FG002|Overall Study|Inapropriate enrollment|0|||
129660245|NCT00262002|466714583|FG003|Overall Study|Inapropriate enrollment|0|||
129660246|NCT00262002|466714584|FG004|Overall Study|Inapropriate enrollment|0|||
129660247|NCT00262002|466714585|FG005|Overall Study|Inapropriate enrollment|0|||
129660248|NCT00262002|466714586|FG006|Overall Study|Inapropriate enrollment|0|||
129660249|NCT00262002|466714580|FG000|Overall Study|Protocol Violation|3|||
129660250|NCT00262002|466714581|FG001|Overall Study|Protocol Violation|2|||
129660251|NCT00262002|466714582|FG002|Overall Study|Protocol Violation|0|||
129660252|NCT00262002|466714583|FG003|Overall Study|Protocol Violation|2|||
129660253|NCT00262002|466714584|FG004|Overall Study|Protocol Violation|5|||
129660254|NCT00262002|466714585|FG005|Overall Study|Protocol Violation|3|||
129660255|NCT00262002|466714586|FG006|Overall Study|Protocol Violation|2|||
129660256|NCT00262002|466714580|FG000|Overall Study|Unable to classify|0|||
129660257|NCT00262002|466714581|FG001|Overall Study|Unable to classify|0|||
129660258|NCT00262002|466714582|FG002|Overall Study|Unable to classify|0|||
129989614|NCT04256629|467925485|FG004|Overall Study|Protocol Violation|0|||
129989615|NCT04256629|467925486|FG005|Overall Study|Protocol Violation|0|||
129989616|NCT00321373|467925487|FG000|Overall Study|Adverse Event|0|||
129989617|NCT00321373|467925488|FG001|Overall Study|Adverse Event|0|||
129989618|NCT00321373|467925489|FG002|Overall Study|Adverse Event|1|||
129989619|NCT00321373|467925487|FG000|Overall Study|Lost to Follow-up|1|||
129989620|NCT00321373|467925488|FG001|Overall Study|Lost to Follow-up|0|||
129989621|NCT00321373|467925489|FG002|Overall Study|Lost to Follow-up|1|||
129989622|NCT00321373|467925487|FG000|Overall Study|Withdrawal by Subject|1|||
129989623|NCT00321373|467925488|FG001|Overall Study|Withdrawal by Subject|0|||
129989624|NCT00321373|467925489|FG002|Overall Study|Withdrawal by Subject|0|||
129989625|NCT00321373|467925487|FG000|Overall Study|Other|0|||
129989626|NCT00321373|467925488|FG001|Overall Study|Other|0|||
129989627|NCT00321373|467925489|FG002|Overall Study|Other|1|||
129989628|NCT01774487|467925490|FG000|Overall Study|Did not tolerate taste|4|||
129989629|NCT01774487|467925491|FG001|Overall Study|Did not tolerate taste|4|||
129989630|NCT00346632|467925492|FG000|Overall Study|Progressive Disease|2|||
129989631|NCT00346632|467925493|FG001|Overall Study|Progressive Disease|2|||
129989632|NCT00346632|467925494|FG002|Overall Study|Progressive Disease|4|||
129989633|NCT00346632|467925495|FG003|Overall Study|Progressive Disease|3|||
129989634|NCT00346632|467925496|FG004|Overall Study|Progressive Disease|3|||
129989635|NCT00346632|467925497|FG005|Overall Study|Progressive Disease|1|||
129660259|NCT00262002|466714583|FG003|Overall Study|Unable to classify|0|||
129989636|NCT00346632|467925498|FG006|Overall Study|Progressive Disease|2|||
129989637|NCT00346632|467925499|FG007|Overall Study|Progressive Disease|2|||
129989638|NCT00346632|467925500|FG008|Overall Study|Progressive Disease|2|||
129989639|NCT00346632|467925501|FG009|Overall Study|Progressive Disease|2|||
129660260|NCT00262002|466714584|FG004|Overall Study|Unable to classify|0|||
129660261|NCT00262002|466714585|FG005|Overall Study|Unable to classify|0|||
129989640|NCT00346632|467925492|FG000|Overall Study|Adverse Event|0|||
129989641|NCT00346632|467925493|FG001|Overall Study|Adverse Event|0|||
129989642|NCT00346632|467925494|FG002|Overall Study|Adverse Event|0|||
129660262|NCT00262002|466714586|FG006|Overall Study|Unable to classify|2|||
129660263|NCT01790516|466714587|FG000|Overall Study|Physician Decision|1|||
129660264|NCT01790516|466714588|FG001|Overall Study|Physician Decision|0|||
129660265|NCT01554163|466714589|FG000|Overall Study|Adverse Event|3|||
129989643|NCT00346632|467925495|FG003|Overall Study|Adverse Event|0|||
129989644|NCT00346632|467925496|FG004|Overall Study|Adverse Event|1|||
129989645|NCT00346632|467925497|FG005|Overall Study|Adverse Event|1|||
129989646|NCT00346632|467925498|FG006|Overall Study|Adverse Event|1|||
129989647|NCT00346632|467925499|FG007|Overall Study|Adverse Event|0|||
129660266|NCT01554163|466714590|FG001|Overall Study|Adverse Event|0|||
129660267|NCT01554163|466714589|FG000|Overall Study|Lack of Efficacy|1|||
129660268|NCT01554163|466714590|FG001|Overall Study|Lack of Efficacy|0|||
129660269|NCT01554163|466714589|FG000|Overall Study|Lost to Follow-up|1|||
129660270|NCT01554163|466714590|FG001|Overall Study|Lost to Follow-up|0|||
129660271|NCT01554163|466714589|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129660272|NCT01554163|466714590|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129660273|NCT01554163|466714589|FG000|Overall Study|Protocol Violation|0|||
129660274|NCT01554163|466714590|FG001|Overall Study|Protocol Violation|4|||
129660275|NCT01554163|466714589|FG000|Overall Study|Withdrawal by Subject|1|||
129660276|NCT01554163|466714590|FG001|Overall Study|Withdrawal by Subject|5|||
129660277|NCT01554163|466714589|FG000|Overall Study|Not Treated|1|||
129660278|NCT01554163|466714590|FG001|Overall Study|Not Treated|0|||
129660279|NCT02226120|466714591|FG000|Overall Study|Adverse Event|60|||
129660280|NCT02226120|466714591|FG000|Overall Study|Death|172|||
129660281|NCT02226120|466714591|FG000|Overall Study|Study terminated by sponsor|1|||
129660282|NCT02226120|466714591|FG000|Overall Study|Technical problems|4|||
129660283|NCT02226120|466714591|FG000|Overall Study|Lost to Follow-up|13|||
129660284|NCT02226120|466714591|FG000|Overall Study|Physician Decision|21|||
129660285|NCT02226120|466714591|FG000|Overall Study|Withdrawal by parent/guardian|36|||
129660286|NCT02226120|466714591|FG000|Overall Study|Non-compliance with study drug|10|||
129660287|NCT02226120|466714591|FG000|Overall Study|Protocol deviation|1|||
129660288|NCT02226120|466714591|FG000|Overall Study|missing treatment disposition pages|2|||
129660289|NCT03034135|466714592|FG000|Overall Study|Withdrawal by Subject|2|||
129660290|NCT01972464|466714596|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
129660291|NCT01972464|466714597|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
129660292|NCT01972464|466714596|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
129660293|NCT01972464|466714597|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
129660294|NCT01972464|466714596|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
129660295|NCT01972464|466714597|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
129660296|NCT01972464|466714596|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
129660297|NCT01972464|466714597|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
129660298|NCT02526160|466716660|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
129660299|NCT02526160|466716661|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
129660300|NCT02526160|466716660|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
129660301|NCT02526160|466716661|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
129660302|NCT02526160|466716660|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
129660303|NCT02526160|466716661|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
129660304|NCT02526160|466716660|FG000|Open-Label Treatment Extension Period I|Death|0|||
129660305|NCT02526160|466716661|FG001|Open-Label Treatment Extension Period I|Death|1|||
129660306|NCT02526160|466716660|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
129660307|NCT02526160|466716661|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
129660308|NCT02526160|466716660|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
129660309|NCT02526160|466716661|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
129660310|NCT02526160|466716660|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
129660311|NCT02526160|466716661|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
129660312|NCT02526160|466716660|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
129660313|NCT02526160|466716661|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
129660314|NCT01048944|466716664|FG000|Overall Study|Protocol Violation|8|||
129660315|NCT01048944|466716665|FG001|Overall Study|Protocol Violation|10|||
129660316|NCT01048944|466716666|FG002|Overall Study|Protocol Violation|10|||
129660317|NCT01048944|466716667|FG003|Overall Study|Protocol Violation|2|||
129660318|NCT01844817|466716668|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
129660319|NCT01844817|466716669|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
129660320|NCT01844817|466716668|FG000|Treatment|Progressive Disease|27|||
129660321|NCT01844817|466716669|FG001|Treatment|Progressive Disease|36|||
129660322|NCT01844817|466716668|FG000|Treatment|Adverse Event|17|||
129660323|NCT01844817|466716669|FG001|Treatment|Adverse Event|9|||
129660324|NCT01844817|466716668|FG000|Treatment|Withdrawal by Subject|10|||
129989648|NCT00346632|467925500|FG008|Overall Study|Adverse Event|0|||
129989649|NCT00346632|467925501|FG009|Overall Study|Adverse Event|0|||
129989650|NCT00346632|467925492|FG000|Overall Study|Death|0|||
129989651|NCT00346632|467925493|FG001|Overall Study|Death|0|||
129989652|NCT00346632|467925494|FG002|Overall Study|Death|1|||
129660325|NCT01844817|466716669|FG001|Treatment|Withdrawal by Subject|6|||
129660326|NCT01844817|466716668|FG000|Treatment|Death|10|||
129660327|NCT01844817|466716669|FG001|Treatment|Death|8|||
129989653|NCT00346632|467925495|FG003|Overall Study|Death|0|||
129989654|NCT00346632|467925496|FG004|Overall Study|Death|0|||
129989655|NCT00346632|467925497|FG005|Overall Study|Death|0|||
129989656|NCT00346632|467925498|FG006|Overall Study|Death|0|||
129989657|NCT00346632|467925499|FG007|Overall Study|Death|0|||
129989658|NCT00346632|467925500|FG008|Overall Study|Death|0|||
129989659|NCT00346632|467925501|FG009|Overall Study|Death|0|||
129989660|NCT00346632|467925492|FG000|Overall Study|Protocol Violation|0|||
129989661|NCT00346632|467925493|FG001|Overall Study|Protocol Violation|0|||
129989662|NCT00346632|467925494|FG002|Overall Study|Protocol Violation|0|||
129989663|NCT00346632|467925495|FG003|Overall Study|Protocol Violation|0|||
129660328|NCT01844817|466716668|FG000|Treatment|Lost to Follow-up|0|||
129660329|NCT01844817|466716669|FG001|Treatment|Lost to Follow-up|1|||
129660330|NCT01844817|466716668|FG000|Treatment|Other|0|||
129660331|NCT01844817|466716669|FG001|Treatment|Other|3|||
129660332|NCT01133704|466716670|FG000|Overall Study|Death|44|||
129660333|NCT01133704|466716671|FG001|Overall Study|Death|26|||
129660334|NCT01133704|466716670|FG000|Overall Study|Patient refused to continue|4|||
129660335|NCT01133704|466716671|FG001|Overall Study|Patient refused to continue|0|||
129660336|NCT01133704|466716670|FG000|Overall Study|Study Closure|1|||
129660337|NCT01133704|466716671|FG001|Overall Study|Study Closure|0|||
129660338|NCT03396822|466716674|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
129660339|NCT03396822|466716674|FG000|Overall Study|Physician Decision|1|||
129660340|NCT04985942|466716675|FG000|Overall Study|Adverse Event|14|||
129660341|NCT04985942|466716676|FG001|Overall Study|Adverse Event|2|||
129660342|NCT04985942|466716675|FG000|Overall Study|Lack of Efficacy|0|||
129660343|NCT04985942|466716676|FG001|Overall Study|Lack of Efficacy|3|||
129660344|NCT04985942|466716675|FG000|Overall Study|Lost to Follow-up|1|||
129660345|NCT04985942|466716676|FG001|Overall Study|Lost to Follow-up|1|||
129660346|NCT04985942|466716675|FG000|Overall Study|Protocol Violation|1|||
129660347|NCT04985942|466716676|FG001|Overall Study|Protocol Violation|1|||
129660348|NCT04985942|466716675|FG000|Overall Study|Withdrawal by Subject|5|||
129660349|NCT04985942|466716676|FG001|Overall Study|Withdrawal by Subject|4|||
129660350|NCT03630705|466716677|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
129660351|NCT03630705|466716678|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
129660352|NCT03630705|466716679|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129660353|NCT03630705|466716680|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129660354|NCT03630705|466716677|FG000|Overall Study|Lost to Follow-up|1|||
129660355|NCT03630705|466716678|FG001|Overall Study|Lost to Follow-up|2|||
129660356|NCT03630705|466716679|FG002|Overall Study|Lost to Follow-up|0|||
129660357|NCT03630705|466716680|FG003|Overall Study|Lost to Follow-up|0|||
129660358|NCT02849704|466716682|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
129660359|NCT02849704|466716683|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
129660360|NCT02849704|466716682|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
129660361|NCT02849704|466716683|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
129660362|NCT02849704|466716682|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
129660363|NCT02849704|466716683|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
129660364|NCT03638466|466716686|FG000|Overall Study|Early Termination|0|||
129660365|NCT03638466|466716687|FG001|Overall Study|Early Termination|1|||
129660366|NCT02576977|466716688|FG000|Overall Study|Adverse Event|13|||
129660367|NCT02576977|466716689|FG001|Overall Study|Adverse Event|2|||
129989664|NCT00346632|467925496|FG004|Overall Study|Protocol Violation|0|||
129989665|NCT00346632|467925497|FG005|Overall Study|Protocol Violation|0|||
129660368|NCT02576977|466716688|FG000|Overall Study|Death|73|||
129660369|NCT02576977|466716689|FG001|Overall Study|Death|60|||
129660370|NCT02576977|466716688|FG000|Overall Study|Screen failure|1|||
129660371|NCT02576977|466716689|FG001|Overall Study|Screen failure|0|||
129660372|NCT02576977|466716688|FG000|Overall Study|Study Terminated at Selected Sites|27|||
129660373|NCT02576977|466716689|FG001|Overall Study|Study Terminated at Selected Sites|50|||
129660374|NCT02576977|466716688|FG000|Overall Study|Withdrawal by Subject|11|||
129660375|NCT02576977|466716689|FG001|Overall Study|Withdrawal by Subject|11|||
129989666|NCT00346632|467925498|FG006|Overall Study|Protocol Violation|1|||
129989667|NCT00346632|467925499|FG007|Overall Study|Protocol Violation|0|||
129989668|NCT00346632|467925500|FG008|Overall Study|Protocol Violation|0|||
129989669|NCT00346632|467925501|FG009|Overall Study|Protocol Violation|0|||
129989670|NCT00346632|467925492|FG000|Overall Study|Withdrawal by Subject|0|||
129989671|NCT00346632|467925493|FG001|Overall Study|Withdrawal by Subject|0|||
129660376|NCT02576977|466716688|FG000|Overall Study|Final Disposition Unknown|0|||
129989672|NCT00346632|467925494|FG002|Overall Study|Withdrawal by Subject|0|||
129989673|NCT00346632|467925495|FG003|Overall Study|Withdrawal by Subject|0|||
129989674|NCT00346632|467925496|FG004|Overall Study|Withdrawal by Subject|0|||
129546326|NCT02545868|466293989|FG000|Overall Study|Treatment change|21|||
129546327|NCT02545868|466293990|FG001|Overall Study|Treatment change|19|||
129660377|NCT02576977|466716689|FG001|Overall Study|Final Disposition Unknown|1|||
129660378|NCT02576977|466716688|FG000|Overall Study|Lost to Follow-up|1|||
129660379|NCT02576977|466716689|FG001|Overall Study|Lost to Follow-up|0|||
129660380|NCT02576977|466716688|FG000|Overall Study|Progressive Disease|0|||
129660381|NCT02576977|466716689|FG001|Overall Study|Progressive Disease|1|||
129660382|NCT03251482|466716690|FG000|Overall Study|Withdrawal by Subject|0|||
129660383|NCT03251482|466716691|FG001|Overall Study|Withdrawal by Subject|1|||
129989675|NCT00346632|467925497|FG005|Overall Study|Withdrawal by Subject|0|||
129989676|NCT00346632|467925498|FG006|Overall Study|Withdrawal by Subject|1|||
129989677|NCT00346632|467925499|FG007|Overall Study|Withdrawal by Subject|0|||
129546328|NCT02545868|466293991|FG002|Overall Study|Treatment change|22|||
129989678|NCT00346632|467925500|FG008|Overall Study|Withdrawal by Subject|0|||
129989679|NCT00346632|467925501|FG009|Overall Study|Withdrawal by Subject|0|||
129989680|NCT00346632|467925492|FG000|Overall Study|Switched to alternative treatment|0|||
129989681|NCT00346632|467925493|FG001|Overall Study|Switched to alternative treatment|0|||
129989682|NCT00346632|467925494|FG002|Overall Study|Switched to alternative treatment|1|||
129989683|NCT00346632|467925495|FG003|Overall Study|Switched to alternative treatment|0|||
129989684|NCT00346632|467925496|FG004|Overall Study|Switched to alternative treatment|0|||
129989685|NCT00346632|467925497|FG005|Overall Study|Switched to alternative treatment|0|||
129989686|NCT00346632|467925498|FG006|Overall Study|Switched to alternative treatment|0|||
129989687|NCT00346632|467925499|FG007|Overall Study|Switched to alternative treatment|0|||
129989688|NCT00346632|467925500|FG008|Overall Study|Switched to alternative treatment|0|||
129989689|NCT00346632|467925501|FG009|Overall Study|Switched to alternative treatment|0|||
129989690|NCT00346632|467925492|FG000|Overall Study|Not Stated|1|||
129989691|NCT00346632|467925493|FG001|Overall Study|Not Stated|1|||
129989692|NCT00346632|467925494|FG002|Overall Study|Not Stated|0|||
129989693|NCT00346632|467925495|FG003|Overall Study|Not Stated|0|||
129989694|NCT00346632|467925496|FG004|Overall Study|Not Stated|0|||
129989695|NCT00346632|467925497|FG005|Overall Study|Not Stated|0|||
129989696|NCT00346632|467925498|FG006|Overall Study|Not Stated|0|||
129989697|NCT00346632|467925499|FG007|Overall Study|Not Stated|2|||
129546329|NCT02545868|466293989|FG000|Overall Study|Physician Decision|1|||
129660384|NCT03251482|466716692|FG002|Overall Study|Withdrawal by Subject|0|||
129660385|NCT03251482|466716693|FG003|Overall Study|Withdrawal by Subject|0|||
129660386|NCT03251482|466716694|FG004|Overall Study|Withdrawal by Subject|0|||
129660387|NCT02447328|466716697|FG000|Overall Study|Withdrawal by Subject|1|||
129660388|NCT01128400|466716698|FG000|Overall Study|Lost to Follow-up|1|||
129660389|NCT01128400|466716699|FG001|Overall Study|Lost to Follow-up|0|||
129660390|NCT01128400|466716700|FG002|Overall Study|Lost to Follow-up|1|||
129660391|NCT01128400|466716698|FG000|Overall Study|Screening failure|1|||
129660392|NCT01128400|466716699|FG001|Overall Study|Screening failure|0|||
129660393|NCT01128400|466716700|FG002|Overall Study|Screening failure|0|||
129660394|NCT01128400|466716698|FG000|Overall Study|were not invited to participate on taste|0|||
129660395|NCT01128400|466716699|FG001|Overall Study|were not invited to participate on taste|0|||
129660396|NCT01128400|466716700|FG002|Overall Study|were not invited to participate on taste|15|||
129660397|NCT01128400|466716698|FG000|Overall Study|Excluded due to sinus problems|0|||
129660398|NCT01128400|466716699|FG001|Overall Study|Excluded due to sinus problems|1|||
129660399|NCT01128400|466716700|FG002|Overall Study|Excluded due to sinus problems|0|||
129660400|NCT00314808|466716706|FG000|Overall Study|Disease Progression without AE|4|||
129660401|NCT00314808|466716706|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
129660402|NCT04304508|466716707|FG000|Overall Study|Subject Decision|29|||
129660403|NCT04304508|466716708|FG001|Overall Study|Subject Decision|39|||
129660404|NCT04304508|466716709|FG002|Overall Study|Subject Decision|37|||
129660405|NCT04304508|466716710|FG003|Overall Study|Subject Decision|48|||
129660406|NCT04304508|466716707|FG000|Overall Study|Death|6|||
129660407|NCT04304508|466716708|FG001|Overall Study|Death|1|||
129660408|NCT04304508|466716709|FG002|Overall Study|Death|8|||
129660409|NCT04304508|466716710|FG003|Overall Study|Death|5|||
129660410|NCT04304508|466716707|FG000|Overall Study|Non-compliance With Study Drug|3|||
129660411|NCT04304508|466716708|FG001|Overall Study|Non-compliance With Study Drug|1|||
129660412|NCT04304508|466716709|FG002|Overall Study|Non-compliance With Study Drug|2|||
129660413|NCT04304508|466716710|FG003|Overall Study|Non-compliance With Study Drug|0|||
129660414|NCT04304508|466716707|FG000|Overall Study|Switching To Other Therapy|1|||
129660415|NCT04304508|466716708|FG001|Overall Study|Switching To Other Therapy|1|||
129660416|NCT04304508|466716709|FG002|Overall Study|Switching To Other Therapy|1|||
129660417|NCT04304508|466716710|FG003|Overall Study|Switching To Other Therapy|2|||
129660418|NCT04304508|466716707|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
129660419|NCT04304508|466716708|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
129660420|NCT04304508|466716709|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
129660421|NCT04304508|466716710|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
129660422|NCT04304508|466716707|FG000|Overall Study|Withdrawal by Subject|7|||
129660423|NCT04304508|466716708|FG001|Overall Study|Withdrawal by Subject|5|||
129660424|NCT04304508|466716709|FG002|Overall Study|Withdrawal by Subject|11|||
129660425|NCT04304508|466716710|FG003|Overall Study|Withdrawal by Subject|6|||
129660426|NCT04304508|466716707|FG000|Overall Study|Logistical Difficulties|2|||
129660427|NCT04304508|466716708|FG001|Overall Study|Logistical Difficulties|2|||
129660428|NCT04304508|466716709|FG002|Overall Study|Logistical Difficulties|3|||
129660429|NCT04304508|466716710|FG003|Overall Study|Logistical Difficulties|2|||
129660430|NCT04304508|466716707|FG000|Overall Study|Missing Information|1|||
129660431|NCT04304508|466716708|FG001|Overall Study|Missing Information|2|||
129660432|NCT04304508|466716709|FG002|Overall Study|Missing Information|1|||
129660433|NCT04304508|466716710|FG003|Overall Study|Missing Information|3|||
129989698|NCT00346632|467925500|FG008|Overall Study|Not Stated|2|||
129989699|NCT00346632|467925501|FG009|Overall Study|Not Stated|1|||
129989700|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
129989701|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
129989702|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
129989703|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
129989704|NCT00918580|467925502|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
129989705|NCT00918580|467925502|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
129989706|NCT00918580|467925502|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
129989707|NCT00946101|467925503|FG000|Overall Study|Lost to Follow-up|2|||
129989708|NCT00946101|467925504|FG001|Overall Study|Lost to Follow-up|1|||
129989709|NCT00946101|467925503|FG000|Overall Study|Withdrawal of consent|2|||
129989710|NCT00946101|467925504|FG001|Overall Study|Withdrawal of consent|0|||
129989711|NCT00946101|467925503|FG000|Overall Study|Physician Decision|0|||
129989712|NCT00946101|467925504|FG001|Overall Study|Physician Decision|1|||
129989713|NCT00552240|467925508|FG000|Overall Study|Adverse Event|9|||
129989714|NCT00552240|467925509|FG001|Overall Study|Adverse Event|9|||
129989715|NCT00552240|467925508|FG000|Overall Study|Protocol Violation|1|||
129989716|NCT00552240|467925509|FG001|Overall Study|Protocol Violation|1|||
129989717|NCT00552240|467925508|FG000|Overall Study|Lost to Follow-up|5|||
129989718|NCT00552240|467925509|FG001|Overall Study|Lost to Follow-up|6|||
129989719|NCT00552240|467925508|FG000|Overall Study|Withdrawal by Subject|2|||
129989720|NCT00552240|467925509|FG001|Overall Study|Withdrawal by Subject|2|||
129989721|NCT00552240|467925508|FG000|Overall Study|Lack of Efficacy|6|||
129989722|NCT00552240|467925509|FG001|Overall Study|Lack of Efficacy|0|||
129989723|NCT00552240|467925508|FG000|Overall Study|Other|1|||
129989724|NCT00552240|467925509|FG001|Overall Study|Other|0|||
129660434|NCT04304508|466716707|FG000|Overall Study|Other|7|||
129660435|NCT04304508|466716708|FG001|Overall Study|Other|6|||
129660436|NCT04304508|466716709|FG002|Overall Study|Other|5|||
129660437|NCT04304508|466716710|FG003|Overall Study|Other|4|||
129660438|NCT04304508|466716707|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
129660439|NCT04304508|466716708|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
129660440|NCT04304508|466716709|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
129660441|NCT04304508|466716710|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
129660442|NCT04304508|466716707|FG000|Overall Study|Physician Decision|3|||
129660443|NCT04304508|466716708|FG001|Overall Study|Physician Decision|4|||
129660444|NCT04304508|466716709|FG002|Overall Study|Physician Decision|9|||
129660445|NCT04304508|466716710|FG003|Overall Study|Physician Decision|7|||
129660446|NCT04304508|466716707|FG000|Overall Study|Study drug never administered|10|||
129660447|NCT04304508|466716708|FG001|Overall Study|Study drug never administered|4|||
129660448|NCT04304508|466716709|FG002|Overall Study|Study drug never administered|4|||
129660449|NCT04304508|466716710|FG003|Overall Study|Study drug never administered|4|||
129660450|NCT04304508|466716707|FG000|Overall Study|Adverse Event|49|||
129660451|NCT04304508|466716708|FG001|Overall Study|Adverse Event|50|||
129660452|NCT04304508|466716709|FG002|Overall Study|Adverse Event|51|||
129660453|NCT04304508|466716710|FG003|Overall Study|Adverse Event|56|||
129660454|NCT04304508|466716707|FG000|Overall Study|Lost to Follow-up|1|||
129660455|NCT04304508|466716708|FG001|Overall Study|Lost to Follow-up|5|||
129660456|NCT04304508|466716709|FG002|Overall Study|Lost to Follow-up|2|||
129660457|NCT04304508|466716710|FG003|Overall Study|Lost to Follow-up|3|||
129660458|NCT02688764|466716711|FG000|Overall Study|Adverse Event|3|||
129660459|NCT02688764|466716712|FG001|Overall Study|Adverse Event|3|||
129660460|NCT02688764|466716711|FG000|Overall Study|AE/Kidney transplant|1|||
129660461|NCT02688764|466716712|FG001|Overall Study|AE/Kidney transplant|0|||
129660462|NCT02688764|466716711|FG000|Overall Study|AE/Lack of efficacy|1|||
129660463|NCT02688764|466716712|FG001|Overall Study|AE/Lack of efficacy|0|||
129660464|NCT02688764|466716711|FG000|Overall Study|AE/Non-compl.|1|||
129660465|NCT02688764|466716712|FG001|Overall Study|AE/Non-compl.|0|||
129660466|NCT02688764|466716711|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
129660467|NCT02688764|466716712|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
129660468|NCT02688764|466716711|FG000|Overall Study|AE/Other|0|||
129660469|NCT02688764|466716712|FG001|Overall Study|AE/Other|1|||
129660470|NCT02688764|466716711|FG000|Overall Study|AE/Physician decision|1|||
129660471|NCT02688764|466716712|FG001|Overall Study|AE/Physician decision|0|||
129660472|NCT02688764|466716711|FG000|Overall Study|AE/Withd. parent|3|||
129660473|NCT02688764|466716712|FG001|Overall Study|AE/Withd. parent|0|||
129660474|NCT02688764|466716711|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
129660475|NCT02688764|466716712|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
129660476|NCT02688764|466716711|FG000|Overall Study|AE/Withd. subject|1|||
129660477|NCT02688764|466716712|FG001|Overall Study|AE/Withd. subject|0|||
129660478|NCT02688764|466716711|FG000|Overall Study|Kidney transplant|10|||
129660479|NCT02688764|466716712|FG001|Overall Study|Kidney transplant|4|||
129660480|NCT02688764|466716711|FG000|Overall Study|Lack of Efficacy|3|||
129660481|NCT02688764|466716712|FG001|Overall Study|Lack of Efficacy|2|||
129660482|NCT02688764|466716711|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
129660483|NCT02688764|466716712|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
129989725|NCT02783768|467925511|FG000|Overall Study|Lost to Follow-up|1|||
129989726|NCT02783768|467925512|FG001|Overall Study|Lost to Follow-up|0|||
129989727|NCT01323647|467925513|FG000|Overall Study|Migrated/moved from study area|2|||
129989728|NCT01323647|467925514|FG001|Overall Study|Migrated/moved from study area|0|||
129989729|NCT01323647|467925513|FG000|Overall Study|Withdrawal by Subject|5|||
129660484|NCT02688764|466716711|FG000|Overall Study|Non-compliance with study drug|4|||
129660485|NCT02688764|466716712|FG001|Overall Study|Non-compliance with study drug|0|||
129660486|NCT02688764|466716711|FG000|Overall Study|Non-compl./Physician decision|2|||
129660487|NCT02688764|466716712|FG001|Overall Study|Non-compl./Physician decision|0|||
129660488|NCT02688764|466716711|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
129660489|NCT02688764|466716712|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
129660490|NCT02688764|466716711|FG000|Overall Study|Non-compl./Withd. subject|0|||
129660491|NCT02688764|466716712|FG001|Overall Study|Non-compl./Withd. subject|2|||
129660492|NCT02688764|466716711|FG000|Overall Study|Phosphorus level outside safe range|0|||
129660493|NCT02688764|466716712|FG001|Overall Study|Phosphorus level outside safe range|1|||
129660494|NCT02688764|466716711|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
129660495|NCT02688764|466716712|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
129660496|NCT02688764|466716711|FG000|Overall Study|Study drug taste/Withd. parent|1|||
129660497|NCT02688764|466716712|FG001|Overall Study|Study drug taste/Withd. parent|0|||
129660498|NCT02688764|466716711|FG000|Overall Study|Subject moving out|2|||
129660499|NCT02688764|466716712|FG001|Overall Study|Subject moving out|0|||
129660500|NCT02688764|466716711|FG000|Overall Study|Subject taken off dialysis|1|||
129660501|NCT02688764|466716712|FG001|Overall Study|Subject taken off dialysis|0|||
129660502|NCT02688764|466716711|FG000|Overall Study|Withdrawal by parent|3|||
129660503|NCT02688764|466716712|FG001|Overall Study|Withdrawal by parent|0|||
129660504|NCT02113007|466716713|FG000|Overall Study|Progressive disease|2|||
129660505|NCT00885378|466716714|FG000|Overall Study|Lack of Efficacy|2|||
129660506|NCT00885378|466716715|FG001|Overall Study|Lack of Efficacy|2|||
129660507|NCT00885378|466716714|FG000|Overall Study|Withdrawal by Subject|1|||
129660508|NCT00885378|466716715|FG001|Overall Study|Withdrawal by Subject|2|||
129660509|NCT00885378|466716714|FG000|Overall Study|Lost to Follow-up|1|||
129660510|NCT00885378|466716715|FG001|Overall Study|Lost to Follow-up|2|||
129660511|NCT00885378|466716714|FG000|Overall Study|Poor/Noncompliance|2|||
129660512|NCT00885378|466716715|FG001|Overall Study|Poor/Noncompliance|2|||
129660513|NCT00885378|466716714|FG000|Overall Study|Protocol Violation|2|||
129660514|NCT00885378|466716715|FG001|Overall Study|Protocol Violation|0|||
129660515|NCT04750278|466716716|FG000|Overall Study|Death|9|||
129660516|NCT04750278|466716717|FG001|Overall Study|Death|10|||
129660517|NCT04750278|466716718|FG002|Overall Study|Death|10|||
129660518|NCT04750278|466716716|FG000|Overall Study|Withdrawal by Subject|4|||
129660519|NCT04750278|466716717|FG001|Overall Study|Withdrawal by Subject|1|||
129660520|NCT04750278|466716718|FG002|Overall Study|Withdrawal by Subject|2|||
129660521|NCT04750278|466716716|FG000|Overall Study|Lost to Follow-up|1|||
129660522|NCT04750278|466716717|FG001|Overall Study|Lost to Follow-up|1|||
129660523|NCT04750278|466716718|FG002|Overall Study|Lost to Follow-up|1|||
129660524|NCT04750278|466716716|FG000|Overall Study|Pregnancy|1|||
129660525|NCT04750278|466716717|FG001|Overall Study|Pregnancy|0|||
129660526|NCT04750278|466716718|FG002|Overall Study|Pregnancy|0|||
129660527|NCT04750278|466716716|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
129660528|NCT04750278|466716717|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
129660529|NCT04750278|466716718|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
129660530|NCT04750278|466716716|FG000|Overall Study|Non-compliance|0|||
129660531|NCT04750278|466716717|FG001|Overall Study|Non-compliance|0|||
129660532|NCT04750278|466716718|FG002|Overall Study|Non-compliance|1|||
129660533|NCT04750278|466716716|FG000|Overall Study|Transfer to Outside Facility|0|||
129660534|NCT04750278|466716717|FG001|Overall Study|Transfer to Outside Facility|2|||
129660535|NCT04750278|466716718|FG002|Overall Study|Transfer to Outside Facility|1|||
129660536|NCT04750278|466716716|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
129660537|NCT04750278|466716717|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
129660538|NCT04750278|466716718|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
129660539|NCT04750278|466716716|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
129660540|NCT04750278|466716717|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
129989730|NCT01323647|467925514|FG001|Overall Study|Withdrawal by Subject|0|||
129989731|NCT01323647|467925513|FG000|Overall Study|Lost to Follow-up|2|||
129989732|NCT01323647|467925514|FG001|Overall Study|Lost to Follow-up|0|||
129989733|NCT00598273|467925515|FG000|Overall Study|Adverse Event|4|||
129989734|NCT00598273|467925516|FG001|Overall Study|Adverse Event|5|||
129989735|NCT00598273|467925517|FG002|Overall Study|Adverse Event|2|||
129989736|NCT00598273|467925515|FG000|Overall Study|Death|6|||
129660541|NCT04750278|466716718|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
129660542|NCT02579382|466716721|FG000|Main Study Phase|Lost to Follow-up|0|||
129660543|NCT02579382|466716722|FG001|Main Study Phase|Lost to Follow-up|0|||
129660544|NCT02579382|466716723|FG002|Main Study Phase|Lost to Follow-up|2|||
129660545|NCT02579382|466716724|FG003|Main Study Phase|Lost to Follow-up|0|||
129660546|NCT02579382|466716721|FG000|Main Study Phase|Withdrew Consent|0|||
129989737|NCT00598273|467925516|FG001|Overall Study|Death|12|||
129989738|NCT00598273|467925517|FG002|Overall Study|Death|8|||
129989739|NCT00598273|467925515|FG000|Overall Study|Lost to Follow-up|8|||
129989740|NCT00598273|467925516|FG001|Overall Study|Lost to Follow-up|3|||
129660547|NCT02579382|466716722|FG001|Main Study Phase|Withdrew Consent|0|||
129660548|NCT02579382|466716723|FG002|Main Study Phase|Withdrew Consent|0|||
129660549|NCT02579382|466716724|FG003|Main Study Phase|Withdrew Consent|2|||
129660550|NCT02579382|466716721|FG000|Main Study Phase|Lack of Efficacy|0|||
129660551|NCT02579382|466716722|FG001|Main Study Phase|Lack of Efficacy|0|||
129660552|NCT02579382|466716723|FG002|Main Study Phase|Lack of Efficacy|0|||
129660553|NCT02579382|466716724|FG003|Main Study Phase|Lack of Efficacy|1|||
129660554|NCT02579382|466716721|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
129660555|NCT02579382|466716722|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
129660556|NCT02579382|466716723|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
129660557|NCT02579382|466716724|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
129660558|NCT02579382|466716721|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
129660559|NCT02579382|466716722|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
129660560|NCT02579382|466716723|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
129660561|NCT02579382|466716724|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
129660562|NCT02579382|466716721|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
129660563|NCT02579382|466716722|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
129660564|NCT02579382|466716723|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
129660565|NCT02579382|466716724|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
129660566|NCT02579382|466716721|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
129660567|NCT02579382|466716722|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
129660568|NCT02579382|466716723|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
129660569|NCT02579382|466716724|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
129660570|NCT02579382|466716721|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
129660571|NCT02579382|466716722|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
129660572|NCT02579382|466716723|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
129660573|NCT02579382|466716724|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
129660574|NCT02579382|466716721|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
129660575|NCT02579382|466716722|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
129660576|NCT02579382|466716723|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
129660577|NCT02579382|466716724|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
129660578|NCT01775787|466716725|FG000|First 7-10 Days|Adverse Event|0|||
129660579|NCT01775787|466716726|FG001|First 7-10 Days|Adverse Event|1|||
129660580|NCT01775787|466716725|FG000|First 7-10 Days|family emergency|0|||
129660581|NCT01775787|466716726|FG001|First 7-10 Days|family emergency|1|||
129660582|NCT01775787|466716725|FG000|First 7-10 Days|time commitment|0|||
129660583|NCT01775787|466716726|FG001|First 7-10 Days|time commitment|2|||
129660584|NCT01775787|466716725|FG000|First 7-10 Days|concerns with using IV|1|||
129660585|NCT01775787|466716726|FG001|First 7-10 Days|concerns with using IV|2|||
129660586|NCT01775787|466716725|FG000|Second 7-10 Days|time commitment|0|||
129660587|NCT01775787|466716726|FG001|Second 7-10 Days|time commitment|1|||
129989741|NCT00598273|467925517|FG002|Overall Study|Lost to Follow-up|5|||
129989742|NCT00598273|467925515|FG000|Overall Study|Physician Decision|0|||
129989743|NCT00598273|467925516|FG001|Overall Study|Physician Decision|0|||
129989744|NCT00598273|467925517|FG002|Overall Study|Physician Decision|1|||
129989745|NCT00598273|467925515|FG000|Overall Study|Withdrawal by Subject|12|||
129989746|NCT00598273|467925516|FG001|Overall Study|Withdrawal by Subject|10|||
129989747|NCT00598273|467925517|FG002|Overall Study|Withdrawal by Subject|10|||
129989748|NCT00598273|467925515|FG000|Overall Study|Noncompliance|3|||
129989749|NCT00598273|467925516|FG001|Overall Study|Noncompliance|2|||
129989750|NCT00598273|467925517|FG002|Overall Study|Noncompliance|3|||
129989751|NCT00598273|467925515|FG000|Overall Study|Relocation|0|||
129989752|NCT00598273|467925516|FG001|Overall Study|Relocation|2|||
129989753|NCT00598273|467925517|FG002|Overall Study|Relocation|4|||
129989754|NCT00598273|467925515|FG000|Overall Study|Renal transplant|1|||
129989755|NCT00598273|467925516|FG001|Overall Study|Renal transplant|0|||
129989756|NCT00598273|467925517|FG002|Overall Study|Renal transplant|1|||
129989757|NCT00598273|467925515|FG000|Overall Study|Site elected to close|1|||
129989758|NCT00598273|467925516|FG001|Overall Study|Site elected to close|0|||
129989759|NCT00598273|467925517|FG002|Overall Study|Site elected to close|0|||
129989760|NCT00598273|467925515|FG000|Overall Study|Started dialysis|6|||
129989761|NCT00598273|467925516|FG001|Overall Study|Started dialysis|4|||
129989762|NCT00598273|467925517|FG002|Overall Study|Started dialysis|5|||
129546330|NCT02545868|466293990|FG001|Overall Study|Physician Decision|1|||
129989763|NCT00906945|467925518|FG000|Overall Study|Found to be not eligible|0|||
129989764|NCT00906945|467925519|FG001|Overall Study|Found to be not eligible|0|||
129546331|NCT02545868|466293991|FG002|Overall Study|Physician Decision|1|||
129989765|NCT00906945|467925520|FG002|Overall Study|Found to be not eligible|0|||
129546332|NCT02545868|466293989|FG000|Overall Study|Withdrawal by Subject|6|||
129660588|NCT01775787|466716725|FG000|Second 7-10 Days|concerns with using IV|0|||
129660589|NCT01775787|466716726|FG001|Second 7-10 Days|concerns with using IV|1|||
129660590|NCT04076319|466716736|FG000|Overall Study|Withdrawal by Subject|2|||
129660591|NCT04076319|466716737|FG001|Overall Study|Withdrawal by Subject|0|||
129989766|NCT00906945|467925521|FG003|Overall Study|Found to be not eligible|1|||
129989767|NCT00906945|467925522|FG004|Overall Study|Found to be not eligible|1|||
129989768|NCT00906945|467925523|FG005|Overall Study|Found to be not eligible|1|||
129989769|NCT00906945|467925518|FG000|Overall Study|Physician Decision|0|||
129989770|NCT00906945|467925519|FG001|Overall Study|Physician Decision|0|||
129989771|NCT00906945|467925520|FG002|Overall Study|Physician Decision|0|||
129989772|NCT00906945|467925521|FG003|Overall Study|Physician Decision|0|||
129989773|NCT00906945|467925522|FG004|Overall Study|Physician Decision|0|||
129989774|NCT00906945|467925523|FG005|Overall Study|Physician Decision|1|||
129989775|NCT00609765|467925531|FG000|Overall Study|Study ended prior to 12 months|1|||
129989776|NCT00943111|467925538|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
129989777|NCT00943111|467925539|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
129989778|NCT00943111|467925540|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
129989779|NCT00943111|467925538|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
129989780|NCT00943111|467925539|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
129989781|NCT00943111|467925540|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
129989782|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
129989783|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
129989784|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
129989785|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
129989786|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
129989787|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
129989788|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
129989789|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
129989790|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
129989791|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
129989792|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
129989793|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
129989794|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
129989795|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
129989796|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
129989797|NCT00943111|467925538|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
129989798|NCT00943111|467925539|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
129989799|NCT00943111|467925540|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
129989800|NCT01796548|467925541|FG000|Overall Study|Lost to Follow-up|1|||
129989801|NCT01796548|467925541|FG000|Overall Study|Other|2|||
129989802|NCT02859324|467925542|FG000|Overall Study|Death|4|||
129989803|NCT02859324|467925543|FG001|Overall Study|Death|6|||
129989804|NCT02859324|467925544|FG002|Overall Study|Death|5|||
129989805|NCT02859324|467925542|FG000|Overall Study|Other reasons|3|||
129989806|NCT02859324|467925543|FG001|Overall Study|Other reasons|3|||
129989807|NCT02859324|467925544|FG002|Overall Study|Other reasons|0|||
129989808|NCT00790751|467925547|FG000|Overall Study|Protocol non-compliance|16|||
129989809|NCT00790751|467925548|FG001|Overall Study|Protocol non-compliance|16|||
129989810|NCT00790751|467925549|FG002|Overall Study|Protocol non-compliance|10|||
129989811|NCT00790751|467925550|FG003|Overall Study|Protocol non-compliance|11|||
129989812|NCT00790751|467925547|FG000|Overall Study|Lost to Follow-up|4|||
129989813|NCT00790751|467925548|FG001|Overall Study|Lost to Follow-up|9|||
129989814|NCT00790751|467925549|FG002|Overall Study|Lost to Follow-up|4|||
129989815|NCT00790751|467925550|FG003|Overall Study|Lost to Follow-up|5|||
129989816|NCT00790751|467925547|FG000|Overall Study|Adverse Event|5|||
129989817|NCT00790751|467925548|FG001|Overall Study|Adverse Event|3|||
129989818|NCT00790751|467925549|FG002|Overall Study|Adverse Event|5|||
129989819|NCT00790751|467925550|FG003|Overall Study|Adverse Event|4|||
129989820|NCT00790751|467925547|FG000|Overall Study|Requirement for restricted medication|0|||
129989821|NCT00790751|467925548|FG001|Overall Study|Requirement for restricted medication|2|||
129989822|NCT00790751|467925549|FG002|Overall Study|Requirement for restricted medication|0|||
129989823|NCT00790751|467925550|FG003|Overall Study|Requirement for restricted medication|0|||
129989824|NCT00790751|467925547|FG000|Overall Study|Death|0|||
129989825|NCT00790751|467925548|FG001|Overall Study|Death|0|||
129989826|NCT00790751|467925549|FG002|Overall Study|Death|1|||
129989827|NCT00790751|467925550|FG003|Overall Study|Death|0|||
129989828|NCT00790751|467925547|FG000|Overall Study|Physician Decision|0|||
129989829|NCT00790751|467925548|FG001|Overall Study|Physician Decision|0|||
129989830|NCT00790751|467925549|FG002|Overall Study|Physician Decision|0|||
129989831|NCT00790751|467925550|FG003|Overall Study|Physician Decision|1|||
129989832|NCT04227704|467925554|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
129989833|NCT04227704|467925555|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
129989834|NCT04227704|467925556|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
129989835|NCT04227704|467925554|FG000|Overall Study|due to C/S being cancelled|1|||
129989836|NCT04227704|467925555|FG001|Overall Study|due to C/S being cancelled|0|||
129989837|NCT04227704|467925556|FG002|Overall Study|due to C/S being cancelled|0|||
129989838|NCT03432260|467925563|FG000|Overall Study|Lost to Follow-up|1|||
129989839|NCT03432260|467925564|FG001|Overall Study|Lost to Follow-up|1|||
129989840|NCT03432260|467925565|FG002|Overall Study|Lost to Follow-up|0|||
129989841|NCT03432260|467925566|FG003|Overall Study|Lost to Follow-up|0|||
129989842|NCT03432260|467925567|FG004|Overall Study|Lost to Follow-up|1|||
129989843|NCT01775124|467925569|FG000|Core Period|Disease Progression|0|||
129989844|NCT01775124|467925570|FG001|Core Period|Disease Progression|1|||
129989845|NCT01775124|467925569|FG000|Core Period|Physician Decision|1|||
129989846|NCT01775124|467925570|FG001|Core Period|Physician Decision|1|||
129989847|NCT01775124|467925569|FG000|Core Period|Death|0|||
129989848|NCT01775124|467925570|FG001|Core Period|Death|1|||
129989849|NCT01775124|467925569|FG000|Core Period|Administrative problems|1|||
129989850|NCT01775124|467925570|FG001|Core Period|Administrative problems|0|||
129989851|NCT01775124|467925569|FG000|Core Period|Withdrawal by Subject|4|||
129989852|NCT01775124|467925570|FG001|Core Period|Withdrawal by Subject|2|||
129989853|NCT01775124|467925569|FG000|Core Period|Adverse Event|5|||
129989854|NCT01775124|467925570|FG001|Core Period|Adverse Event|5|||
129989855|NCT01775124|467925569|FG000|Extension Period|Adverse Event|3|||
129989856|NCT01775124|467925570|FG001|Extension Period|Adverse Event|2|||
129989857|NCT01775124|467925569|FG000|Extension Period|Physician Decision|0|||
129989858|NCT01775124|467925570|FG001|Extension Period|Physician Decision|2|||
129989859|NCT01775124|467925569|FG000|Extension Period|Administrative problems|0|||
129989860|NCT01775124|467925570|FG001|Extension Period|Administrative problems|1|||
129989861|NCT01775124|467925569|FG000|Extension Period|Lost to Follow-up|0|||
129989862|NCT01775124|467925570|FG001|Extension Period|Lost to Follow-up|1|||
129989863|NCT01775124|467925569|FG000|Extension Period|Withdrawal by Subject|9|||
129989864|NCT01775124|467925570|FG001|Extension Period|Withdrawal by Subject|12|||
129989865|NCT00112047|467925571|FG000|Randomized Phase|Lost to Follow-up|26|||
129989866|NCT00112047|467925572|FG001|Randomized Phase|Lost to Follow-up|33|||
129989867|NCT00112047|467925571|FG000|Randomized Phase|Adverse Event|10|||
129989868|NCT00112047|467925572|FG001|Randomized Phase|Adverse Event|10|||
129989869|NCT00112047|467925571|FG000|Randomized Phase|Withrawal of consent|10|||
129989870|NCT00112047|467925572|FG001|Randomized Phase|Withrawal of consent|18|||
129660592|NCT04076319|466716736|FG000|Overall Study|Death|1|||
129660593|NCT04076319|466716737|FG001|Overall Study|Death|0|||
129660594|NCT01054222|466716738|FG000|Overall Study|Lack of Efficacy|1|||
129660595|NCT01054222|466716738|FG000|Overall Study|Lost to Follow-up|4|||
129660596|NCT01054222|466716738|FG000|Overall Study|Withdrawal by Subject|6|||
129989871|NCT00112047|467925571|FG000|Randomized Phase|Sub-optimal virological response|3|||
129989872|NCT00112047|467925572|FG001|Randomized Phase|Sub-optimal virological response|13|||
129989873|NCT00112047|467925571|FG000|Randomized Phase|Noncompliance|8|||
129989874|NCT00112047|467925572|FG001|Randomized Phase|Noncompliance|4|||
129989875|NCT00112047|467925571|FG000|Randomized Phase|Protocol Violation|2|||
129989876|NCT00112047|467925572|FG001|Randomized Phase|Protocol Violation|0|||
129989877|NCT00112047|467925571|FG000|Randomized Phase|Pregnancy|3|||
129989878|NCT00112047|467925572|FG001|Randomized Phase|Pregnancy|1|||
129989879|NCT00112047|467925571|FG000|Randomized Phase|Death|1|||
129989880|NCT00112047|467925572|FG001|Randomized Phase|Death|3|||
129989881|NCT00112047|467925571|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
129989882|NCT00112047|467925572|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
129989883|NCT00112047|467925571|FG000|Randomized Phase|Inability to swallow pills|0|||
129989884|NCT00112047|467925572|FG001|Randomized Phase|Inability to swallow pills|1|||
129989885|NCT00112047|467925571|FG000|Randomized Phase|Incarceration|3|||
129989886|NCT00112047|467925572|FG001|Randomized Phase|Incarceration|2|||
129989887|NCT00112047|467925571|FG000|Randomized Phase|Moved out of State|0|||
129989888|NCT00112047|467925572|FG001|Randomized Phase|Moved out of State|1|||
129989889|NCT00112047|467925571|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
129989890|NCT00112047|467925572|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
129989891|NCT00112047|467925571|FG000|Randomized Phase|High Hepatitis B DNA|0|||
129989892|NCT00112047|467925572|FG001|Randomized Phase|High Hepatitis B DNA|1|||
129989893|NCT00112047|467925571|FG000|Atripla Phase|Adverse Event|2|||
129989894|NCT00112047|467925572|FG001|Atripla Phase|Adverse Event|1|||
129989895|NCT00112047|467925571|FG000|Atripla Phase|Lost to Follow-up|5|||
129989896|NCT00112047|467925572|FG001|Atripla Phase|Lost to Follow-up|7|||
129989897|NCT00112047|467925571|FG000|Atripla Phase|Pregnancy|0|||
129989898|NCT00112047|467925572|FG001|Atripla Phase|Pregnancy|1|||
129989899|NCT00112047|467925571|FG000|Atripla Phase|Death|0|||
129989900|NCT00112047|467925572|FG001|Atripla Phase|Death|2|||
129989901|NCT00112047|467925571|FG000|Atripla Phase|Withdrew consent|7|||
129989902|NCT00112047|467925572|FG001|Atripla Phase|Withdrew consent|7|||
129546333|NCT02545868|466293990|FG001|Overall Study|Withdrawal by Subject|7|||
129989903|NCT00112047|467925571|FG000|Atripla Phase|Sub-optimal virological response|0|||
129660597|NCT00824655|466716739|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
129989904|NCT00112047|467925572|FG001|Atripla Phase|Sub-optimal virological response|1|||
129989905|NCT00112047|467925571|FG000|Atripla Phase|Non-compliance|1|||
129989906|NCT00112047|467925572|FG001|Atripla Phase|Non-compliance|0|||
129546334|NCT02545868|466293991|FG002|Overall Study|Withdrawal by Subject|9|||
129660598|NCT00824655|466716740|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
129989907|NCT00112047|467925571|FG000|Atripla Phase|Other|3|||
129989908|NCT00112047|467925572|FG001|Atripla Phase|Other|1|||
129989909|NCT01307579|467925573|FG000|Overall Study|Death|3|||
129989910|NCT01307579|467925574|FG001|Overall Study|Death|6|||
129546335|NCT04465916|466293996|FG000|Overall Study|Withdrawal by Subject|0|||
129546336|NCT04465916|466293997|FG001|Overall Study|Withdrawal by Subject|1|||
129546337|NCT03976076|466293999|FG000|Overall Study|Withdrawal by Subject|2|||
129546338|NCT01325701|466294000|FG000|Overall Study|Adverse Event|12|||
129546339|NCT01325701|466294001|FG001|Overall Study|Adverse Event|0|||
129546340|NCT01325701|466294000|FG000|Overall Study|Protocol Violation|1|||
129546341|NCT01325701|466294001|FG001|Overall Study|Protocol Violation|0|||
129546342|NCT01325701|466294000|FG000|Overall Study|Physician Decision|2|||
129546343|NCT01325701|466294001|FG001|Overall Study|Physician Decision|2|||
129546344|NCT01325701|466294000|FG000|Overall Study|Withdrawal by Subject|2|||
129546345|NCT01325701|466294001|FG001|Overall Study|Withdrawal by Subject|1|||
129546346|NCT01325701|466294000|FG000|Overall Study|Rollerover Extension Study|4|||
129546347|NCT01325701|466294001|FG001|Overall Study|Rollerover Extension Study|0|||
129546348|NCT00388674|466294008|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
129546349|NCT00388674|466294009|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
129546350|NCT00388674|466294008|FG000|Initial Treatment|Adverse Event|22|||
129546351|NCT00388674|466294009|FG001|Initial Treatment|Adverse Event|87|||
129546352|NCT00388674|466294008|FG000|Initial Treatment|Death|215|||
129546353|NCT00388674|466294009|FG001|Initial Treatment|Death|216|||
129546354|NCT00388674|466294008|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
129546355|NCT00388674|466294009|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
129546356|NCT00388674|466294008|FG000|Initial Treatment|HCC|12|||
129546357|NCT00388674|466294009|FG001|Initial Treatment|HCC|20|||
129546358|NCT00388674|466294008|FG000|Initial Treatment|Lost to Follow-up|526|||
129546359|NCT00388674|466294009|FG001|Initial Treatment|Lost to Follow-up|624|||
129546360|NCT00388674|466294008|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
129546361|NCT00388674|466294009|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
129546362|NCT00388674|466294008|FG000|Initial Treatment|Never Treated with Study Medication|1|||
129546363|NCT00388674|466294009|FG001|Initial Treatment|Never Treated with Study Medication|7|||
129546364|NCT00388674|466294008|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
129546365|NCT00388674|466294009|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
129546366|NCT00388674|466294008|FG000|Initial Treatment|Not Defined|125|||
129546367|NCT00388674|466294009|FG001|Initial Treatment|Not Defined|172|||
129546368|NCT00388674|466294008|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
129546369|NCT00388674|466294009|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
129546370|NCT00388674|466294008|FG000|Initial Treatment|Pregnancy|26|||
129546371|NCT00388674|466294009|FG001|Initial Treatment|Pregnancy|16|||
129546372|NCT00388674|466294008|FG000|Initial Treatment|Study Drug Toxicity|5|||
129546373|NCT00388674|466294009|FG001|Initial Treatment|Study Drug Toxicity|92|||
129546374|NCT00388674|466294008|FG000|Initial Treatment|Participant Request|501|||
129546375|NCT00388674|466294009|FG001|Initial Treatment|Participant Request|673|||
129546376|NCT00388674|466294008|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
129546377|NCT00388674|466294009|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
129546378|NCT00388674|466294008|FG000|Initial Treatment|Not Reported|10|||
129546379|NCT00388674|466294009|FG001|Initial Treatment|Not Reported|12|||
129546380|NCT00388674|466294008|FG000|End of Study|Administrative Reason By Sponsor|299|||
129546381|NCT00388674|466294009|FG001|End of Study|Administrative Reason By Sponsor|253|||
129546382|NCT00388674|466294008|FG000|End of Study|Death|239|||
129546383|NCT00388674|466294009|FG001|End of Study|Death|262|||
129546384|NCT00388674|466294008|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
129546385|NCT00388674|466294009|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
129546386|NCT00388674|466294008|FG000|End of Study|HCC|8|||
129546387|NCT00388674|466294009|FG001|End of Study|HCC|7|||
129546388|NCT00388674|466294008|FG000|End of Study|Lost to Follow-up|587|||
129546389|NCT00388674|466294009|FG001|End of Study|Lost to Follow-up|715|||
129546390|NCT00388674|466294008|FG000|End of Study|Malignancy (Non-HCC)|1|||
129546391|NCT00388674|466294009|FG001|End of Study|Malignancy (Non-HCC)|1|||
129546392|NCT00388674|466294008|FG000|End of Study|Non-Study Related Comorbidities|3|||
129546393|NCT00388674|466294009|FG001|End of Study|Non-Study Related Comorbidities|4|||
129546394|NCT00388674|466294008|FG000|End of Study|Not Defined|135|||
129546395|NCT00388674|466294009|FG001|End of Study|Not Defined|214|||
129546396|NCT00388674|466294008|FG000|End of Study|Participant Withdrew Consent|437|||
129546397|NCT00388674|466294009|FG001|End of Study|Participant Withdrew Consent|673|||
129546398|NCT00388674|466294008|FG000|End of Study|No Off-Treatment Status Data|22|||
129546399|NCT00388674|466294009|FG001|End of Study|No Off-Treatment Status Data|30|||
129546400|NCT00388674|466294008|FG000|End of Study|Not Reported|0|||
129546401|NCT00388674|466294009|FG001|End of Study|Not Reported|1|||
129546402|NCT00568776|466294010|FG000|Overall Study|Adverse Event|8|||
129546403|NCT00568776|466294011|FG001|Overall Study|Adverse Event|8|||
129546404|NCT00568776|466294012|FG002|Overall Study|Adverse Event|10|||
129546405|NCT00568776|466294013|FG003|Overall Study|Adverse Event|8|||
129546406|NCT00568776|466294010|FG000|Overall Study|Death|0|||
129546407|NCT00568776|466294011|FG001|Overall Study|Death|1|||
129546408|NCT00568776|466294012|FG002|Overall Study|Death|4|||
129989911|NCT01307579|467925573|FG000|Overall Study|Physician Decision|26|||
129989912|NCT01307579|467925574|FG001|Overall Study|Physician Decision|29|||
129989913|NCT01307579|467925573|FG000|Overall Study|Withdrawal by Subject|7|||
129989914|NCT01307579|467925574|FG001|Overall Study|Withdrawal by Subject|3|||
129989915|NCT01307579|467925573|FG000|Overall Study|Institutional diagnosis of IFD|21|||
129989916|NCT01307579|467925574|FG001|Overall Study|Institutional diagnosis of IFD|36|||
129660599|NCT00824655|466716739|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
129660600|NCT00824655|466716740|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
129660601|NCT03252145|466716741|FG000|Overall Study|Withdrawal by Subject|1|||
129660602|NCT03252145|466716742|FG001|Overall Study|Withdrawal by Subject|0|||
129660603|NCT03252145|466716741|FG000|Overall Study|Complicating Disease|1|||
129660604|NCT03252145|466716742|FG001|Overall Study|Complicating Disease|2|||
129660605|NCT03504189|466716743|FG000|Overall Study|Withdrawal by Subject|1|||
129660606|NCT03504189|466716743|FG000|Overall Study|Screening Failure|1|||
129660607|NCT03504189|466716743|FG000|Overall Study|Device Failure|2|||
129660608|NCT03091738|466716744|FG000|Overall Study|Adverse Event|1|||
129660609|NCT03091738|466716744|FG000|Overall Study|Lost to Follow-up|1|||
129660610|NCT04336475|466716745|FG000|Overall Study|pain|1|||
129660611|NCT04336475|466716746|FG001|Overall Study|pain|0|||
129660612|NCT04336475|466716745|FG000|Overall Study|upper respiratory infection|1|||
129660613|NCT04336475|466716746|FG001|Overall Study|upper respiratory infection|0|||
129660614|NCT04336475|466716745|FG000|Overall Study|Lost to Follow-up|0|||
129660615|NCT04336475|466716746|FG001|Overall Study|Lost to Follow-up|2|||
129660616|NCT00199849|466716759|FG000|Overall Study|Unrelated illness or complication|0|||
129660617|NCT00199849|466716760|FG001|Overall Study|Unrelated illness or complication|1|||
129660618|NCT00199849|466716761|FG002|Overall Study|Unrelated illness or complication|0|||
129660619|NCT00199849|466716759|FG000|Overall Study|Progressive disease requiring intervention|0|||
129660620|NCT00199849|466716760|FG001|Overall Study|Progressive disease requiring intervention|0|||
129660621|NCT00199849|466716761|FG002|Overall Study|Progressive disease requiring intervention|1|||
129660622|NCT00199849|466716759|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
129660623|NCT00199849|466716760|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
129660624|NCT00199849|466716761|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
129660625|NCT04727528|466716762|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
129660626|NCT04727528|466716763|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
129660627|NCT04727528|466716762|FG000|Open-label Period|Randomized who did not receive treatment|1|||
129660628|NCT04727528|466716763|FG001|Open-label Period|Randomized who did not receive treatment|0|||
129660629|NCT04727528|466716762|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129660630|NCT04727528|466716763|FG001|Double-blind Treatment Phase|Adverse Event|1|||
129660631|NCT04727528|466716762|FG000|Double-blind Treatment Phase|Death|0|||
129660632|NCT04727528|466716763|FG001|Double-blind Treatment Phase|Death|1|||
129660633|NCT04727528|466716762|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
129660634|NCT04727528|466716763|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
129660635|NCT04727528|466716762|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
129660636|NCT04727528|466716763|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
129660637|NCT04727528|466716762|FG000|Double-blind Treatment Phase|Physician Decision|0|||
129660638|NCT04727528|466716763|FG001|Double-blind Treatment Phase|Physician Decision|1|||
129660639|NCT04727528|466716762|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
129660640|NCT04727528|466716763|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129660641|NCT01763827|466716768|FG000|Overall Study|Withdrawal by Subject|1|||
129660642|NCT01763827|466716769|FG001|Overall Study|Withdrawal by Subject|0|||
129660643|NCT01763827|466716770|FG002|Overall Study|Withdrawal by Subject|0|||
129660644|NCT01763827|466716771|FG003|Overall Study|Withdrawal by Subject|0|||
129660645|NCT01763827|466716772|FG004|Overall Study|Withdrawal by Subject|2|||
129660646|NCT01763827|466716773|FG005|Overall Study|Withdrawal by Subject|0|||
129660647|NCT01763827|466716768|FG000|Overall Study|Decision by sponsor|2|||
129660648|NCT01763827|466716769|FG001|Overall Study|Decision by sponsor|0|||
129660649|NCT01763827|466716770|FG002|Overall Study|Decision by sponsor|3|||
129660650|NCT01763827|466716771|FG003|Overall Study|Decision by sponsor|0|||
129660651|NCT01763827|466716772|FG004|Overall Study|Decision by sponsor|2|||
129660652|NCT01763827|466716773|FG005|Overall Study|Decision by sponsor|1|||
129660653|NCT01763827|466716768|FG000|Overall Study|Lost to Follow-up|0|||
129660654|NCT01763827|466716769|FG001|Overall Study|Lost to Follow-up|1|||
129989917|NCT01307579|467925573|FG000|Overall Study|Begin conditioning for HSCT|42|||
129660655|NCT01763827|466716770|FG002|Overall Study|Lost to Follow-up|1|||
129660656|NCT01763827|466716771|FG003|Overall Study|Lost to Follow-up|1|||
129660657|NCT01763827|466716772|FG004|Overall Study|Lost to Follow-up|2|||
129660658|NCT01763827|466716773|FG005|Overall Study|Lost to Follow-up|1|||
129660659|NCT02906579|466716776|FG000|Overall Study|Adverse Event|1|||
129660660|NCT02906579|466716776|FG000|Overall Study|Physician Decision|1|||
129660661|NCT01826981|466716779|FG000|Overall Study|Lack of Efficacy|0|||
129660662|NCT01826981|466716780|FG001|Overall Study|Lack of Efficacy|1|||
129989918|NCT01307579|467925574|FG001|Overall Study|Begin conditioning for HSCT|44|||
129989919|NCT01307579|467925573|FG000|Overall Study|Refractory or relapsed AML|38|||
129660663|NCT01826981|466716781|FG002|Overall Study|Lack of Efficacy|0|||
129660664|NCT01826981|466716782|FG003|Overall Study|Lack of Efficacy|0|||
129660665|NCT01826981|466716783|FG004|Overall Study|Lack of Efficacy|5|||
129660666|NCT01826981|466716784|FG005|Overall Study|Lack of Efficacy|0|||
129660667|NCT01826981|466716785|FG006|Overall Study|Lack of Efficacy|0|||
129660668|NCT01826981|466716786|FG007|Overall Study|Lack of Efficacy|8|||
129660669|NCT01826981|466716787|FG008|Overall Study|Lack of Efficacy|7|||
129660670|NCT01826981|466716788|FG009|Overall Study|Lack of Efficacy|0|||
129660671|NCT01826981|466716789|FG010|Overall Study|Lack of Efficacy|1|||
129660672|NCT01826981|466716790|FG011|Overall Study|Lack of Efficacy|0|||
129660673|NCT01826981|466716791|FG012|Overall Study|Lack of Efficacy|0|||
129660674|NCT01826981|466716792|FG013|Overall Study|Lack of Efficacy|3|||
129660675|NCT01826981|466716793|FG014|Overall Study|Lack of Efficacy|0|||
129660676|NCT01826981|466716779|FG000|Overall Study|Lost to Follow-up|0|||
129660677|NCT01826981|466716780|FG001|Overall Study|Lost to Follow-up|0|||
129660678|NCT01826981|466716781|FG002|Overall Study|Lost to Follow-up|0|||
129660679|NCT01826981|466716782|FG003|Overall Study|Lost to Follow-up|0|||
129989920|NCT01307579|467925574|FG001|Overall Study|Refractory or relapsed AML|23|||
129989921|NCT01307579|467925573|FG000|Overall Study|Ineligible|3|||
129989922|NCT01307579|467925574|FG001|Overall Study|Ineligible|4|||
129989923|NCT00031551|467927520|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
129989924|NCT00031551|467927521|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
129989925|NCT00409773|467927522|FG000|Overall Study|Adverse Event|3|||
129989926|NCT00409773|467927523|FG001|Overall Study|Adverse Event|4|||
129989927|NCT00409773|467927524|FG002|Overall Study|Adverse Event|4|||
129989928|NCT00409773|467927525|FG003|Overall Study|Adverse Event|2|||
129989929|NCT00409773|467927526|FG004|Overall Study|Adverse Event|6|||
129989930|NCT00409773|467927522|FG000|Overall Study|Lost to Follow-up|6|||
129989931|NCT00409773|467927523|FG001|Overall Study|Lost to Follow-up|1|||
129989932|NCT00409773|467927524|FG002|Overall Study|Lost to Follow-up|2|||
129989933|NCT00409773|467927525|FG003|Overall Study|Lost to Follow-up|3|||
129989934|NCT00409773|467927526|FG004|Overall Study|Lost to Follow-up|1|||
129989935|NCT00409773|467927522|FG000|Overall Study|Physician Decision|0|||
129989936|NCT00409773|467927523|FG001|Overall Study|Physician Decision|0|||
129989937|NCT00409773|467927524|FG002|Overall Study|Physician Decision|0|||
129989938|NCT00409773|467927525|FG003|Overall Study|Physician Decision|2|||
129989939|NCT00409773|467927526|FG004|Overall Study|Physician Decision|0|||
129989940|NCT00409773|467927522|FG000|Overall Study|Protocol Violation|0|||
129989941|NCT00409773|467927523|FG001|Overall Study|Protocol Violation|2|||
129989942|NCT00409773|467927524|FG002|Overall Study|Protocol Violation|3|||
129989943|NCT00409773|467927525|FG003|Overall Study|Protocol Violation|3|||
129989944|NCT00409773|467927526|FG004|Overall Study|Protocol Violation|1|||
129989945|NCT00409773|467927522|FG000|Overall Study|Withdrawal by Subject|0|||
129989946|NCT00409773|467927523|FG001|Overall Study|Withdrawal by Subject|0|||
129989947|NCT00409773|467927524|FG002|Overall Study|Withdrawal by Subject|0|||
129989948|NCT00409773|467927525|FG003|Overall Study|Withdrawal by Subject|2|||
129989949|NCT00409773|467927526|FG004|Overall Study|Withdrawal by Subject|1|||
129989950|NCT00409773|467927522|FG000|Overall Study|Lack of Eligibility|0|||
129989951|NCT00409773|467927523|FG001|Overall Study|Lack of Eligibility|0|||
129989952|NCT00409773|467927524|FG002|Overall Study|Lack of Eligibility|0|||
129989953|NCT00409773|467927525|FG003|Overall Study|Lack of Eligibility|0|||
129989954|NCT00409773|467927526|FG004|Overall Study|Lack of Eligibility|1|||
129989955|NCT02359877|467927527|FG000|Overall Study|Withdrawal by Subject|1|||
129989956|NCT02359877|467927528|FG001|Overall Study|Withdrawal by Subject|0|||
129989957|NCT02359877|467927529|FG002|Overall Study|Withdrawal by Subject|0|||
129989958|NCT02359877|467927530|FG003|Overall Study|Withdrawal by Subject|2|||
129989959|NCT02359877|467927527|FG000|Overall Study|Adverse Event|0|||
129989960|NCT02359877|467927528|FG001|Overall Study|Adverse Event|0|||
129660680|NCT01826981|466716783|FG004|Overall Study|Lost to Follow-up|1|||
129660681|NCT01826981|466716784|FG005|Overall Study|Lost to Follow-up|1|||
129660682|NCT01826981|466716785|FG006|Overall Study|Lost to Follow-up|0|||
129660683|NCT01826981|466716786|FG007|Overall Study|Lost to Follow-up|1|||
129660684|NCT01826981|466716787|FG008|Overall Study|Lost to Follow-up|0|||
129989961|NCT02359877|467927529|FG002|Overall Study|Adverse Event|0|||
129989962|NCT02359877|467927530|FG003|Overall Study|Adverse Event|1|||
129660685|NCT01826981|466716788|FG009|Overall Study|Lost to Follow-up|1|||
129660686|NCT01826981|466716789|FG010|Overall Study|Lost to Follow-up|1|||
129660687|NCT01826981|466716790|FG011|Overall Study|Lost to Follow-up|1|||
129989963|NCT01919814|467927531|FG000|Overall Study|Adverse Event|1|||
129989964|NCT01919814|467927532|FG001|Overall Study|Adverse Event|0|||
129989965|NCT01919814|467927531|FG000|Overall Study|Protocol Violation|1|||
129989966|NCT01919814|467927532|FG001|Overall Study|Protocol Violation|0|||
129660688|NCT01826981|466716791|FG012|Overall Study|Lost to Follow-up|1|||
129660689|NCT01826981|466716792|FG013|Overall Study|Lost to Follow-up|0|||
129660690|NCT01826981|466716793|FG014|Overall Study|Lost to Follow-up|0|||
129989967|NCT01919814|467927531|FG000|Overall Study|Withdrawal by Subject|1|||
129546409|NCT00568776|466294013|FG003|Overall Study|Death|3|||
129660691|NCT01826981|466716779|FG000|Overall Study|Withdrew Consent|0|||
129660692|NCT01826981|466716780|FG001|Overall Study|Withdrew Consent|0|||
129660693|NCT01826981|466716781|FG002|Overall Study|Withdrew Consent|0|||
129660694|NCT01826981|466716782|FG003|Overall Study|Withdrew Consent|0|||
129660695|NCT01826981|466716783|FG004|Overall Study|Withdrew Consent|0|||
129660696|NCT01826981|466716784|FG005|Overall Study|Withdrew Consent|0|||
129660697|NCT01826981|466716785|FG006|Overall Study|Withdrew Consent|1|||
129660698|NCT01826981|466716786|FG007|Overall Study|Withdrew Consent|1|||
129660699|NCT01826981|466716787|FG008|Overall Study|Withdrew Consent|0|||
129660700|NCT01826981|466716788|FG009|Overall Study|Withdrew Consent|0|||
129660701|NCT01826981|466716789|FG010|Overall Study|Withdrew Consent|0|||
129660702|NCT01826981|466716790|FG011|Overall Study|Withdrew Consent|1|||
129660703|NCT01826981|466716791|FG012|Overall Study|Withdrew Consent|0|||
129660704|NCT01826981|466716792|FG013|Overall Study|Withdrew Consent|1|||
129660705|NCT01826981|466716793|FG014|Overall Study|Withdrew Consent|0|||
129660706|NCT01826981|466716779|FG000|Overall Study|Adverse Event|0|||
129660707|NCT01826981|466716780|FG001|Overall Study|Adverse Event|0|||
129660708|NCT01826981|466716781|FG002|Overall Study|Adverse Event|0|||
129660709|NCT01826981|466716782|FG003|Overall Study|Adverse Event|0|||
129989968|NCT01919814|467927532|FG001|Overall Study|Withdrawal by Subject|0|||
129989969|NCT02164383|467927533|FG000|Overall Study|Lost to Follow-up|1|||
129989970|NCT02164383|467927534|FG001|Overall Study|Lost to Follow-up|0|||
129989971|NCT02831387|467927536|FG000|Overall Study|Withdrawal by Subject|1|||
129989972|NCT02831387|467927537|FG001|Overall Study|Withdrawal by Subject|1|||
129989973|NCT02831387|467927536|FG000|Overall Study|Discontinued due to stock recovery|0|||
129989974|NCT02831387|467927537|FG001|Overall Study|Discontinued due to stock recovery|1|||
129989975|NCT00192647|467927538|FG000|Overall Study|Death|1|||
129989976|NCT00192647|467927539|FG001|Overall Study|Death|1|||
129989977|NCT00192647|467927538|FG000|Overall Study|Adverse Event|35|||
129989978|NCT00192647|467927539|FG001|Overall Study|Adverse Event|29|||
129989979|NCT00192647|467927538|FG000|Overall Study|Laboratory Test Abnormality|4|||
129989980|NCT00192647|467927539|FG001|Overall Study|Laboratory Test Abnormality|2|||
129989981|NCT00192647|467927538|FG000|Overall Study|Insufficient Therapeutic Response|53|||
129989982|NCT00192647|467927539|FG001|Overall Study|Insufficient Therapeutic Response|83|||
129989983|NCT00192647|467927538|FG000|Overall Study|Entry Criteria Violation|6|||
129989984|NCT00192647|467927539|FG001|Overall Study|Entry Criteria Violation|6|||
129989985|NCT00192647|467927538|FG000|Overall Study|Protocol Violation|3|||
129989986|NCT00192647|467927539|FG001|Overall Study|Protocol Violation|1|||
129989987|NCT00192647|467927538|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
129989988|NCT00192647|467927539|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
129989989|NCT00192647|467927538|FG000|Overall Study|Failure to Return|11|||
129989990|NCT00192647|467927539|FG001|Overall Study|Failure to Return|13|||
129989991|NCT00192647|467927538|FG000|Overall Study|Other/Administrative|5|||
129989992|NCT00192647|467927539|FG001|Overall Study|Other/Administrative|3|||
129989993|NCT01828073|467927540|FG000|Overall Study|Lost to Follow-up|1|||
129989994|NCT01828073|467927541|FG001|Overall Study|Lost to Follow-up|2|||
129989995|NCT00690443|467927542|FG000|Overall Study|Adverse Event|1|||
129989996|NCT00690443|467927543|FG001|Overall Study|Adverse Event|2|||
129989997|NCT01350336|467927544|FG000|Overall Study|Lost to Follow-up|31|||
129989998|NCT01350336|467927544|FG000|Overall Study|Withdrawal by Subject|14|||
129989999|NCT01350336|467927544|FG000|Overall Study|Physician Decision|8|||
129990000|NCT01350336|467927544|FG000|Overall Study|Death|4|||
129990001|NCT02079610|467927545|FG000|Overall Study|Withdrawal by Subject|1|||
129990002|NCT02079610|467927546|FG001|Overall Study|Withdrawal by Subject|1|||
129990003|NCT01111474|467927547|FG000|Overall Study|Lost to Follow-up|12|||
129990004|NCT01016977|467927548|FG000|Overall Study|Lost to Follow-up|1|||
129990005|NCT01016977|467927549|FG001|Overall Study|Lost to Follow-up|0|||
129990006|NCT01016977|467927548|FG000|Overall Study|Withdrawal by Subject|2|||
129990007|NCT01016977|467927549|FG001|Overall Study|Withdrawal by Subject|2|||
129990008|NCT00477334|467927550|FG000|Overall Study|Discontinued prior to taking study drug|106|||
129990009|NCT00477334|467927551|FG001|Overall Study|Discontinued prior to taking study drug|53|||
129990010|NCT00477334|467927550|FG000|Overall Study|Adverse Event|1|||
129990011|NCT00477334|467927551|FG001|Overall Study|Adverse Event|2|||
129990012|NCT00477334|467927550|FG000|Overall Study|Withdrawal by Subject|2|||
129990013|NCT00477334|467927551|FG001|Overall Study|Withdrawal by Subject|1|||
129660710|NCT01826981|466716783|FG004|Overall Study|Adverse Event|1|||
129660711|NCT01826981|466716784|FG005|Overall Study|Adverse Event|0|||
129660712|NCT01826981|466716785|FG006|Overall Study|Adverse Event|0|||
129990014|NCT00477334|467927550|FG000|Overall Study|Lost to Follow-up|15|||
129990015|NCT00477334|467927551|FG001|Overall Study|Lost to Follow-up|4|||
129990016|NCT00477334|467927550|FG000|Overall Study|Administrative Problems|39|||
129990017|NCT00477334|467927551|FG001|Overall Study|Administrative Problems|15|||
129990018|NCT00477334|467927550|FG000|Overall Study|Protocol Violation|7|||
129990019|NCT00477334|467927551|FG001|Overall Study|Protocol Violation|1|||
129990020|NCT03587974|467927552|FG000|Overall Study|caregiver demented, care recipient died|3|||
129660713|NCT01826981|466716786|FG007|Overall Study|Adverse Event|0|||
129990021|NCT03587974|467927553|FG001|Overall Study|caregiver demented, care recipient died|3|||
129990022|NCT03587974|467927552|FG000|Overall Study|Withdrawal by Subject|2|||
129990023|NCT03587974|467927553|FG001|Overall Study|Withdrawal by Subject|1|||
129660714|NCT01826981|466716787|FG008|Overall Study|Adverse Event|0|||
129990024|NCT02354508|467927555|FG000|Period 1: Core Phase|Adverse Event|1|||
129990025|NCT02354508|467927556|FG001|Period 1: Core Phase|Adverse Event|1|||
129990026|NCT02354508|467927557|FG002|Period 1: Core Phase|Adverse Event|2|||
129990027|NCT02354508|467927555|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
129990028|NCT02354508|467927556|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
129990029|NCT02354508|467927557|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
129990030|NCT02354508|467927555|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
129990031|NCT02354508|467927556|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
129660715|NCT01826981|466716788|FG009|Overall Study|Adverse Event|0|||
129660716|NCT01826981|466716789|FG010|Overall Study|Adverse Event|0|||
129660717|NCT01826981|466716790|FG011|Overall Study|Adverse Event|0|||
129660718|NCT01826981|466716791|FG012|Overall Study|Adverse Event|0|||
129660719|NCT01826981|466716792|FG013|Overall Study|Adverse Event|0|||
129660720|NCT01826981|466716793|FG014|Overall Study|Adverse Event|0|||
129660721|NCT01826981|466716779|FG000|Overall Study|Upper G-I Haemorrhage|0|||
129660722|NCT01826981|466716780|FG001|Overall Study|Upper G-I Haemorrhage|0|||
129660723|NCT01826981|466716781|FG002|Overall Study|Upper G-I Haemorrhage|0|||
129660724|NCT01826981|466716782|FG003|Overall Study|Upper G-I Haemorrhage|0|||
129660725|NCT01826981|466716783|FG004|Overall Study|Upper G-I Haemorrhage|0|||
129660726|NCT01826981|466716784|FG005|Overall Study|Upper G-I Haemorrhage|0|||
129660727|NCT01826981|466716785|FG006|Overall Study|Upper G-I Haemorrhage|0|||
129660728|NCT01826981|466716786|FG007|Overall Study|Upper G-I Haemorrhage|0|||
129660729|NCT01826981|466716787|FG008|Overall Study|Upper G-I Haemorrhage|0|||
129660730|NCT01826981|466716788|FG009|Overall Study|Upper G-I Haemorrhage|0|||
129660731|NCT01826981|466716789|FG010|Overall Study|Upper G-I Haemorrhage|0|||
129660732|NCT01826981|466716790|FG011|Overall Study|Upper G-I Haemorrhage|0|||
129660733|NCT01826981|466716791|FG012|Overall Study|Upper G-I Haemorrhage|0|||
129660734|NCT01826981|466716792|FG013|Overall Study|Upper G-I Haemorrhage|1|||
129660735|NCT01826981|466716793|FG014|Overall Study|Upper G-I Haemorrhage|0|||
129660736|NCT01826981|466716779|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660737|NCT01826981|466716780|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660738|NCT01826981|466716781|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660739|NCT01826981|466716782|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660740|NCT01826981|466716783|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660741|NCT01826981|466716784|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660742|NCT01826981|466716785|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660743|NCT01826981|466716786|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
129660744|NCT01826981|466716787|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660745|NCT01826981|466716788|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660746|NCT01826981|466716789|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660747|NCT01826981|466716790|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660748|NCT01826981|466716791|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660749|NCT01826981|466716792|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660750|NCT01826981|466716793|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
129660751|NCT02030119|466716796|FG000|Overall Study|Withdrawal by Subject|3|||
129660752|NCT02030119|466716797|FG001|Overall Study|Withdrawal by Subject|1|||
129660753|NCT02030119|466716798|FG002|Overall Study|Withdrawal by Subject|5|||
129660754|NCT02030119|466716799|FG003|Overall Study|Withdrawal by Subject|3|||
129660755|NCT02030119|466716796|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
129660756|NCT02030119|466716797|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
129660757|NCT02030119|466716798|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
129660758|NCT02030119|466716799|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
129660759|NCT00759655|466716800|FG000|Overall Study|Termination of the study by sponsor|1|||
129660760|NCT02213380|466716801|FG000|Underwent Randomization|Withdrawal by Subject|2|||
129660761|NCT02213380|466716802|FG001|Underwent Randomization|Withdrawal by Subject|0|||
129660762|NCT02213380|466716801|FG000|Underwent Randomization|Not treated|3|||
129660763|NCT02213380|466716802|FG001|Underwent Randomization|Not treated|3|||
129660764|NCT02213380|466716801|FG000|Per-protocol Analysis|Protocol Violation|32|||
129660765|NCT02213380|466716802|FG001|Per-protocol Analysis|Protocol Violation|36|||
129660766|NCT03498313|466716803|FG000|Experimental Period 1|Adverse Event|1|||
129660767|NCT03498313|466716804|FG001|Experimental Period 1|Adverse Event|0|||
129660768|NCT03498313|466716805|FG002|Experimental Period 1|Adverse Event|0|||
129990032|NCT02354508|467927557|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
129990033|NCT02354508|467927555|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
129990034|NCT02354508|467927556|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
129990035|NCT02354508|467927557|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
129990036|NCT02354508|467927555|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
129660769|NCT03498313|466716806|FG003|Experimental Period 1|Adverse Event|1|||
129660770|NCT03498313|466716807|FG004|Experimental Period 1|Adverse Event|0|||
129660771|NCT03498313|466716808|FG005|Experimental Period 1|Adverse Event|0|||
129660772|NCT03498313|466716803|FG000|Experimental Period 1|Withdrawal by Subject|0|||
129660773|NCT03498313|466716804|FG001|Experimental Period 1|Withdrawal by Subject|1|||
129990037|NCT02354508|467927556|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
129990038|NCT02354508|467927557|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
129990039|NCT02354508|467927555|FG000|Period 2: Extension Phase|Physician Decision|5|||
129990040|NCT02354508|467927556|FG001|Period 2: Extension Phase|Physician Decision|0|||
129990041|NCT02354508|467927557|FG002|Period 2: Extension Phase|Physician Decision|1|||
129990042|NCT02354508|467927555|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
129990043|NCT02354508|467927556|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
129990044|NCT02354508|467927557|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
129990045|NCT02354508|467927555|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
129990046|NCT02354508|467927556|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
129990047|NCT02354508|467927557|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
129990048|NCT02354508|467927555|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
129990049|NCT02354508|467927556|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
129990050|NCT02354508|467927557|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
129990051|NCT04447846|467927558|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
129990052|NCT00461032|467927561|FG000|Overall Study|Adverse Event|5|||
129990053|NCT00461032|467927562|FG001|Overall Study|Adverse Event|6|||
129990054|NCT00461032|467927561|FG000|Overall Study|Lack of Efficacy|5|||
129990055|NCT00461032|467927562|FG001|Overall Study|Lack of Efficacy|1|||
129990056|NCT00461032|467927561|FG000|Overall Study|Lost to Follow-up|7|||
129990057|NCT00461032|467927562|FG001|Overall Study|Lost to Follow-up|12|||
129990058|NCT00461032|467927561|FG000|Overall Study|Protocol Violation|4|||
129990059|NCT00461032|467927562|FG001|Overall Study|Protocol Violation|4|||
129990060|NCT00461032|467927561|FG000|Overall Study|Withdrawal by Subject|7|||
129990061|NCT00461032|467927562|FG001|Overall Study|Withdrawal by Subject|15|||
129990062|NCT00461032|467927561|FG000|Overall Study|Patient Moved or Relocated|2|||
129990063|NCT00461032|467927562|FG001|Overall Study|Patient Moved or Relocated|1|||
129990064|NCT00461032|467927561|FG000|Overall Study|Other|7|||
129990065|NCT00461032|467927562|FG001|Overall Study|Other|5|||
129990066|NCT03486457|467927563|FG000|Up to Month 3|Adverse Event|2|||
129990067|NCT03486457|467927564|FG001|Up to Month 3|Adverse Event|5|||
129990068|NCT03486457|467927563|FG000|Up to Month 3|Lack of Efficacy|1|||
129990069|NCT03486457|467927564|FG001|Up to Month 3|Lack of Efficacy|0|||
129990070|NCT03486457|467927563|FG000|Up to Month 3|Withdrawal by Subject|1|||
129990071|NCT03486457|467927564|FG001|Up to Month 3|Withdrawal by Subject|0|||
129990072|NCT03486457|467927563|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
129990073|NCT03486457|467927564|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
129990074|NCT03486457|467927563|FG000|Up to Month 3|Other|1|||
129990075|NCT03486457|467927564|FG001|Up to Month 3|Other|0|||
129990076|NCT03486457|467927563|FG000|Month 3 to Month 6|Adverse Event|2|||
129990077|NCT03486457|467927564|FG001|Month 3 to Month 6|Adverse Event|0|||
129990078|NCT03486457|467927563|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
129990079|NCT03486457|467927564|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
129990080|NCT03486457|467927563|FG000|Month 3 to Month 6|Pregnancy|0|||
129990081|NCT03486457|467927564|FG001|Month 3 to Month 6|Pregnancy|1|||
129990082|NCT03486457|467927563|FG000|Month 3 to Month 6|Other|1|||
129990083|NCT03486457|467927564|FG001|Month 3 to Month 6|Other|0|||
129990084|NCT00372229|467927565|FG000|Study Phase|Graft loss|0|||
129990085|NCT00372229|467927566|FG001|Study Phase|Graft loss|3|||
129990086|NCT00372229|467927565|FG000|Study Phase|Protocol Violation|3|||
129990087|NCT00372229|467927566|FG001|Study Phase|Protocol Violation|4|||
129990088|NCT00372229|467927565|FG000|Study Phase|Consent withdrawn|16|||
129990089|NCT00372229|467927566|FG001|Study Phase|Consent withdrawn|14|||
129990090|NCT00372229|467927565|FG000|Study Phase|Refused treatment/did not cooperate|3|||
129990091|NCT00372229|467927566|FG001|Study Phase|Refused treatment/did not cooperate|1|||
129990092|NCT00372229|467927565|FG000|Study Phase|Death|3|||
129990093|NCT00372229|467927566|FG001|Study Phase|Death|2|||
129990094|NCT00372229|467927565|FG000|Study Phase|Reason not specified|3|||
129990095|NCT00372229|467927566|FG001|Study Phase|Reason not specified|2|||
129546410|NCT00568776|466294010|FG000|Overall Study|Physician Decision|0|||
129546411|NCT00568776|466294011|FG001|Overall Study|Physician Decision|2|||
129546412|NCT00568776|466294012|FG002|Overall Study|Physician Decision|0|||
129546413|NCT00568776|466294013|FG003|Overall Study|Physician Decision|0|||
129546414|NCT00568776|466294010|FG000|Overall Study|Lack of Efficacy|2|||
129990096|NCT00372229|467927565|FG000|Study Phase|Lost to Follow-up|3|||
129990097|NCT00372229|467927566|FG001|Study Phase|Lost to Follow-up|3|||
129990098|NCT00372229|467927565|FG000|Follow-Up Phase|Graft loss|8|||
129990099|NCT00372229|467927566|FG001|Follow-Up Phase|Graft loss|7|||
129990100|NCT00372229|467927565|FG000|Follow-Up Phase|Consent withdrawn|13|||
129990101|NCT00372229|467927566|FG001|Follow-Up Phase|Consent withdrawn|19|||
129990102|NCT00372229|467927565|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
129990103|NCT00372229|467927566|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
129990104|NCT00372229|467927565|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
129546415|NCT00568776|466294011|FG001|Overall Study|Lack of Efficacy|2|||
129546416|NCT00568776|466294012|FG002|Overall Study|Lack of Efficacy|2|||
129546417|NCT00568776|466294013|FG003|Overall Study|Lack of Efficacy|4|||
129660774|NCT03498313|466716805|FG002|Experimental Period 1|Withdrawal by Subject|0|||
129660775|NCT03498313|466716806|FG003|Experimental Period 1|Withdrawal by Subject|0|||
129660776|NCT03498313|466716807|FG004|Experimental Period 1|Withdrawal by Subject|0|||
129660777|NCT03498313|466716808|FG005|Experimental Period 1|Withdrawal by Subject|0|||
129660778|NCT03498313|466716803|FG000|Washout Period 1|Anovulation|1|||
129660779|NCT03498313|466716804|FG001|Washout Period 1|Anovulation|0|||
129660780|NCT03498313|466716805|FG002|Washout Period 1|Anovulation|0|||
129660781|NCT03498313|466716806|FG003|Washout Period 1|Anovulation|0|||
129660782|NCT03498313|466716807|FG004|Washout Period 1|Anovulation|0|||
129660783|NCT03498313|466716808|FG005|Washout Period 1|Anovulation|0|||
129660784|NCT03498313|466716803|FG000|Washout Period 1|Withdrawal by Subject|0|||
129660785|NCT03498313|466716804|FG001|Washout Period 1|Withdrawal by Subject|3|||
129660786|NCT03498313|466716805|FG002|Washout Period 1|Withdrawal by Subject|0|||
129660787|NCT03498313|466716806|FG003|Washout Period 1|Withdrawal by Subject|1|||
129660788|NCT03498313|466716807|FG004|Washout Period 1|Withdrawal by Subject|0|||
129660789|NCT03498313|466716808|FG005|Washout Period 1|Withdrawal by Subject|1|||
129660790|NCT03498313|466716803|FG000|Experimental Period 2|Adverse Event|0|||
129660791|NCT03498313|466716804|FG001|Experimental Period 2|Adverse Event|0|||
129660792|NCT03498313|466716805|FG002|Experimental Period 2|Adverse Event|0|||
129660793|NCT03498313|466716806|FG003|Experimental Period 2|Adverse Event|0|||
129660794|NCT03498313|466716807|FG004|Experimental Period 2|Adverse Event|1|||
129660795|NCT03498313|466716808|FG005|Experimental Period 2|Adverse Event|2|||
129660796|NCT03498313|466716803|FG000|Washout Period 2|Physician Decision|1|||
129660797|NCT03498313|466716804|FG001|Washout Period 2|Physician Decision|0|||
129660798|NCT03498313|466716805|FG002|Washout Period 2|Physician Decision|0|||
129660799|NCT03498313|466716806|FG003|Washout Period 2|Physician Decision|1|||
129660800|NCT03498313|466716807|FG004|Washout Period 2|Physician Decision|0|||
129660801|NCT03498313|466716808|FG005|Washout Period 2|Physician Decision|1|||
129660802|NCT03498313|466716803|FG000|Washout Period 2|Withdrawal by Subject|3|||
129660803|NCT03498313|466716804|FG001|Washout Period 2|Withdrawal by Subject|2|||
129660804|NCT03498313|466716805|FG002|Washout Period 2|Withdrawal by Subject|0|||
129660805|NCT03498313|466716806|FG003|Washout Period 2|Withdrawal by Subject|0|||
129660806|NCT03498313|466716807|FG004|Washout Period 2|Withdrawal by Subject|2|||
129660807|NCT03498313|466716808|FG005|Washout Period 2|Withdrawal by Subject|0|||
129660808|NCT03498313|466716803|FG000|Washout Period 2|Anovulation|0|||
129660809|NCT03498313|466716804|FG001|Washout Period 2|Anovulation|0|||
129660810|NCT03498313|466716805|FG002|Washout Period 2|Anovulation|0|||
129660811|NCT03498313|466716806|FG003|Washout Period 2|Anovulation|0|||
129660812|NCT03498313|466716807|FG004|Washout Period 2|Anovulation|0|||
129660813|NCT03498313|466716808|FG005|Washout Period 2|Anovulation|1|||
129660814|NCT00184002|466716809|FG000|Overall Study|Adverse Event|9|||
129660815|NCT00184002|466716809|FG000|Overall Study|Death|3|||
129660816|NCT00184002|466716809|FG000|Overall Study|Physician Decision|1|||
129660817|NCT00184002|466716809|FG000|Overall Study|Withdrawal by Subject|4|||
129660818|NCT02171429|466716810|FG000|Overall Study|Other|0|||
129660819|NCT02171429|466716811|FG001|Overall Study|Other|1|||
129660820|NCT02171429|466716812|FG002|Overall Study|Other|1|||
129660821|NCT02171429|466716810|FG000|Overall Study|Non-Compliance|0|||
129660822|NCT02171429|466716811|FG001|Overall Study|Non-Compliance|0|||
129660823|NCT02171429|466716812|FG002|Overall Study|Non-Compliance|1|||
129660824|NCT02171429|466716810|FG000|Overall Study|Physician Decision|0|||
129660825|NCT02171429|466716811|FG001|Overall Study|Physician Decision|0|||
129660826|NCT02171429|466716812|FG002|Overall Study|Physician Decision|1|||
129660827|NCT02171429|466716810|FG000|Overall Study|Withdrawal by Subject|1|||
129660828|NCT02171429|466716811|FG001|Overall Study|Withdrawal by Subject|1|||
129660829|NCT02171429|466716812|FG002|Overall Study|Withdrawal by Subject|1|||
129660830|NCT02171429|466716810|FG000|Overall Study|Lost to Follow-up|0|||
129660831|NCT02171429|466716811|FG001|Overall Study|Lost to Follow-up|1|||
129660832|NCT02171429|466716812|FG002|Overall Study|Lost to Follow-up|0|||
129660833|NCT02171429|466716810|FG000|Overall Study|Death|0|||
129660834|NCT02171429|466716811|FG001|Overall Study|Death|0|||
129660835|NCT02171429|466716812|FG002|Overall Study|Death|1|||
129660836|NCT02020889|466716814|FG000|Overall Study|Adverse Event|0|||
129660837|NCT02020889|466716815|FG001|Overall Study|Adverse Event|1|||
129660838|NCT02020889|466716814|FG000|Overall Study|Lack of Efficacy|1|||
129660839|NCT02020889|466716815|FG001|Overall Study|Lack of Efficacy|0|||
129660840|NCT02020889|466716814|FG000|Overall Study|Lost to Follow-up|1|||
129660841|NCT02020889|466716815|FG001|Overall Study|Lost to Follow-up|0|||
129660842|NCT02020889|466716814|FG000|Overall Study|Physician Decision|2|||
129660843|NCT02020889|466716815|FG001|Overall Study|Physician Decision|0|||
129660844|NCT02020889|466716814|FG000|Overall Study|Withdrawal by Subject|3|||
129660845|NCT02020889|466716815|FG001|Overall Study|Withdrawal by Subject|2|||
129660846|NCT02768792|466716817|FG000|Overall Study|Adverse Event|1|||
129660847|NCT05980013|466716818|FG000|Overall Study|Withdrawal by Subject|0|||
129660848|NCT05980013|466716819|FG001|Overall Study|Withdrawal by Subject|1|||
129660849|NCT05980013|466716818|FG000|Overall Study|Device Error|0|||
129660850|NCT05980013|466716819|FG001|Overall Study|Device Error|1|||
129660851|NCT01768559|466716820|FG000|Overall Study|Randomized but not treated|0|||
129990105|NCT00372229|467927566|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
129990106|NCT00372229|467927565|FG000|Follow-Up Phase|Death|9|||
129990107|NCT00372229|467927566|FG001|Follow-Up Phase|Death|12|||
129660852|NCT01768559|466716821|FG001|Overall Study|Randomized but not treated|0|||
129660853|NCT01768559|466716822|FG002|Overall Study|Randomized but not treated|1|||
129660854|NCT01768559|466716820|FG000|Overall Study|Adverse Event|15|||
129660855|NCT01768559|466716821|FG001|Overall Study|Adverse Event|2|||
129660856|NCT01768559|466716822|FG002|Overall Study|Adverse Event|5|||
129660857|NCT01768559|466716820|FG000|Overall Study|Lack of Efficacy|6|||
129660858|NCT01768559|466716821|FG001|Overall Study|Lack of Efficacy|4|||
129660859|NCT01768559|466716822|FG002|Overall Study|Lack of Efficacy|0|||
129660860|NCT01768559|466716820|FG000|Overall Study|Poor compliance to protocol|0|||
129660861|NCT01768559|466716821|FG001|Overall Study|Poor compliance to protocol|3|||
129660862|NCT01768559|466716822|FG002|Overall Study|Poor compliance to protocol|2|||
129660863|NCT01768559|466716820|FG000|Overall Study|Other than specified|9|||
129660864|NCT01768559|466716821|FG001|Overall Study|Other than specified|8|||
129660865|NCT01768559|466716822|FG002|Overall Study|Other than specified|5|||
129660866|NCT00398047|466716827|FG000|Overall Study|all patient progressed before completion|3|||
129660867|NCT01188668|466716828|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
129660868|NCT01188668|466716828|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
129660869|NCT01188668|466716828|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
129660870|NCT00902746|466716829|FG000|Overall Study|Protocol Violation|7|||
129660871|NCT00902746|466716829|FG000|Overall Study|Withdrawal by Subject|16|||
129660872|NCT00902746|466716829|FG000|Overall Study|Adverse Event|8|||
129660873|NCT00902746|466716829|FG000|Overall Study|Lost to Follow-up|3|||
129660874|NCT00902746|466716829|FG000|Overall Study|Physician Decision|2|||
129660875|NCT02347072|466716831|FG000|Overall Study|Adverse Event|2|||
129660876|NCT02347072|466716831|FG000|Overall Study|Withdrawal by Subject|6|||
129660877|NCT02347072|466716831|FG000|Overall Study|Physician Decision|1|||
129660878|NCT02347072|466716831|FG000|Overall Study|Lost to Follow-up|2|||
129660879|NCT02347072|466716831|FG000|Overall Study|Protocol Violation|1|||
129660880|NCT02347072|466716831|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
129660881|NCT02793947|466718326|FG000|Overall Study|Death|1|||
129660882|NCT02793947|466718327|FG001|Overall Study|Death|0|||
129660883|NCT02793947|466718326|FG000|Overall Study|Physician Decision|1|||
129660884|NCT02793947|466718327|FG001|Overall Study|Physician Decision|5|||
129660885|NCT03746405|466718337|FG000|Overall Study|Withdrawal by Subject|3|||
129660886|NCT03746405|466718338|FG001|Overall Study|Withdrawal by Subject|0|||
129660887|NCT03746405|466718337|FG000|Overall Study|technical difficulties|0|||
129660888|NCT03746405|466718338|FG001|Overall Study|technical difficulties|2|||
129660889|NCT03479008|466718339|FG000|Overall Study|Withdrawal by Subject|3|||
129660890|NCT01310127|466718340|FG000|Overall Study|Protocol Violation|1|||
129660891|NCT01310127|466718341|FG001|Overall Study|Protocol Violation|1|||
129660892|NCT01310127|466718340|FG000|Overall Study|advanced psc cataract outlier|1|||
129660893|NCT01310127|466718341|FG001|Overall Study|advanced psc cataract outlier|0|||
129660894|NCT00412932|466718342|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
129660895|NCT00412932|466718342|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
129660896|NCT00412932|466718342|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
129660897|NCT00412932|466718342|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
129660898|NCT00412932|466718342|FG000|Olmesartan (Olm) 20 mg|Other|1|||
129660899|NCT00412932|466718342|FG000|Olmesartan 40 mg|Adverse Event|4|||
129660900|NCT00412932|466718342|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
129660901|NCT00412932|466718342|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
129660902|NCT00412932|466718342|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
129660903|NCT00412932|466718342|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
129660904|NCT00412932|466718342|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
129660905|NCT00412932|466718342|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
129660906|NCT01490840|466718346|FG000|Phase 1|Lost to Follow-up|1|||
129660907|NCT01490840|466718347|FG001|Phase 1|Lost to Follow-up|0|||
129660908|NCT01490840|466718346|FG000|Phase 1|Adverse Event|2|||
129660909|NCT01490840|466718347|FG001|Phase 1|Adverse Event|1|||
129660910|NCT01490840|466718346|FG000|Phase 1|Withdrawal by Subject|6|||
129990108|NCT00372229|467927565|FG000|Follow-Up Phase|Administrative|1|||
129660911|NCT01490840|466718347|FG001|Phase 1|Withdrawal by Subject|5|||
129660912|NCT01490840|466718346|FG000|Phase 1|Visit 6a omitted|1|||
129660913|NCT01490840|466718347|FG001|Phase 1|Visit 6a omitted|0|||
129660914|NCT01490840|466718346|FG000|Phase 2|Withdrawal by Subject|4|||
129660915|NCT01490840|466718347|FG001|Phase 2|Withdrawal by Subject|3|||
129660916|NCT01490840|466718346|FG000|Phase 2|Permanent interruption of fingolimod|0|||
129660917|NCT01490840|466718347|FG001|Phase 2|Permanent interruption of fingolimod|1|||
129660918|NCT01490840|466718346|FG000|Phase 2|Lost to Follow-up|1|||
129660919|NCT01490840|466718347|FG001|Phase 2|Lost to Follow-up|1|||
129660920|NCT01490840|466718346|FG000|Phase 2|Adverse Event|1|||
129660921|NCT01490840|466718347|FG001|Phase 2|Adverse Event|1|||
129660922|NCT01704755|466718348|FG000|Overall Study|Adverse Event|4|||
129660923|NCT01704755|466718349|FG001|Overall Study|Adverse Event|1|||
129990109|NCT00372229|467927566|FG001|Follow-Up Phase|Administrative|0|||
129660924|NCT01704755|466718348|FG000|Overall Study|Lost to Follow-up|3|||
129660925|NCT01704755|466718349|FG001|Overall Study|Lost to Follow-up|4|||
129660926|NCT01704755|466718348|FG000|Overall Study|Withdrew consent|1|||
129660927|NCT01704755|466718349|FG001|Overall Study|Withdrew consent|1|||
129660928|NCT01704755|466718348|FG000|Overall Study|Other (not specified)|3|||
129660929|NCT01704755|466718349|FG001|Overall Study|Other (not specified)|1|||
129660930|NCT01704755|466718348|FG000|Overall Study|Withdrew consent and personal issues|1|||
129660931|NCT01704755|466718349|FG001|Overall Study|Withdrew consent and personal issues|0|||
129660932|NCT04105842|466718350|FG000|Overall Study|Withdrawal by Subject|2|||
129660933|NCT01639703|466718351|FG000|Overall Study|Withdrawal by Subject|5|||
129660934|NCT01639703|466718351|FG000|Overall Study|Other reason|7|||
129660935|NCT02087670|466718352|FG000|Overall Study|Withdrawal by Subject|3|||
129660936|NCT02087670|466718353|FG001|Overall Study|Withdrawal by Subject|2|||
129660937|NCT01042392|466718354|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
129660938|NCT01042392|466718355|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
129660939|NCT01042392|466718356|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
129660940|NCT01042392|466718357|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
129660941|NCT01042392|466718354|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
129990110|NCT00372229|467927565|FG000|Follow-Up Phase|Reason not specified|2|||
129990111|NCT00372229|467927566|FG001|Follow-Up Phase|Reason not specified|3|||
129990112|NCT00372229|467927565|FG000|Follow-Up Phase|Lost to Follow-up|12|||
129990113|NCT00372229|467927566|FG001|Follow-Up Phase|Lost to Follow-up|10|||
129990114|NCT01878214|467927567|FG000|Overall Study|Withdrawal by Subject|18|||
129990115|NCT01878214|467927568|FG001|Overall Study|Withdrawal by Subject|7|||
129990116|NCT01878214|467927567|FG000|Overall Study|Death|0|||
129990117|NCT01878214|467927568|FG001|Overall Study|Death|1|||
129660942|NCT01042392|466718355|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
129660943|NCT01042392|466718356|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
129660944|NCT01042392|466718357|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
129660945|NCT01042392|466718354|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
129990118|NCT01878214|467927567|FG000|Overall Study|Lost to Follow-up|35|||
129990119|NCT01878214|467927568|FG001|Overall Study|Lost to Follow-up|36|||
129990120|NCT00093808|467927571|FG000|Overall Study|Cancel participation before receiving tx|1|||
129990121|NCT00093808|467927571|FG000|Overall Study|Protocol Violation|1|||
129990122|NCT00871780|467927572|FG000|Overall Study|Enrolled But Not Treated|6|||
129990123|NCT00871780|467927572|FG000|Overall Study|Withdrawal by Subject|9|||
129990124|NCT00871780|467927572|FG000|Overall Study|Adverse Event|6|||
129990125|NCT00871780|467927572|FG000|Overall Study|Voluntary Discontinuation|4|||
129990126|NCT00871780|467927572|FG000|Overall Study|Death|1|||
129990127|NCT00871780|467927572|FG000|Overall Study|Physician Decision|1|||
129990128|NCT03406260|467927573|FG000|Period 1|Adverse Event|0|||
129990129|NCT03406260|467927574|FG001|Period 1|Adverse Event|0|||
129990130|NCT03406260|467927575|FG002|Period 1|Adverse Event|0|||
129990131|NCT03406260|467927576|FG003|Period 1|Adverse Event|0|||
129990132|NCT03406260|467927577|FG004|Period 1|Adverse Event|1|||
129990133|NCT03406260|467927578|FG005|Period 1|Adverse Event|0|||
129990134|NCT02647866|467927579|FG000|Overall Study|Adverse Event|0|||
129990135|NCT02647866|467927580|FG001|Overall Study|Adverse Event|0|||
129990136|NCT02647866|467927581|FG002|Overall Study|Adverse Event|2|||
129990137|NCT02647866|467927582|FG003|Overall Study|Adverse Event|2|||
129990138|NCT02647866|467927583|FG004|Overall Study|Adverse Event|1|||
129990139|NCT02647866|467927579|FG000|Overall Study|Disease Worsening|3|||
129990140|NCT02647866|467927580|FG001|Overall Study|Disease Worsening|1|||
129990141|NCT02647866|467927581|FG002|Overall Study|Disease Worsening|0|||
129990142|NCT02647866|467927582|FG003|Overall Study|Disease Worsening|0|||
129990143|NCT02647866|467927583|FG004|Overall Study|Disease Worsening|1|||
129990144|NCT02647866|467927579|FG000|Overall Study|Withdrawal by Subject|1|||
129990145|NCT02647866|467927580|FG001|Overall Study|Withdrawal by Subject|1|||
129990146|NCT02647866|467927581|FG002|Overall Study|Withdrawal by Subject|2|||
129990147|NCT02647866|467927582|FG003|Overall Study|Withdrawal by Subject|4|||
129660946|NCT01042392|466718355|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
129660947|NCT01042392|466718356|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
129660948|NCT01042392|466718357|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
129660949|NCT01042392|466718354|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
129660950|NCT01042392|466718355|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
129990148|NCT02647866|467927583|FG004|Overall Study|Withdrawal by Subject|4|||
129990149|NCT02647866|467927579|FG000|Overall Study|Physician Decision|0|||
129990150|NCT02647866|467927580|FG001|Overall Study|Physician Decision|1|||
129990151|NCT02647866|467927581|FG002|Overall Study|Physician Decision|1|||
129990152|NCT02647866|467927582|FG003|Overall Study|Physician Decision|0|||
129990153|NCT02647866|467927583|FG004|Overall Study|Physician Decision|2|||
129990154|NCT02647866|467927579|FG000|Overall Study|Death|0|||
129990155|NCT02647866|467927580|FG001|Overall Study|Death|1|||
129990156|NCT02647866|467927581|FG002|Overall Study|Death|0|||
129990157|NCT02647866|467927582|FG003|Overall Study|Death|0|||
129990158|NCT02647866|467927583|FG004|Overall Study|Death|0|||
129660951|NCT01042392|466718356|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
129660952|NCT01042392|466718357|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
129660953|NCT01042392|466718354|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
129660954|NCT01042392|466718355|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
129660955|NCT01042392|466718356|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
129660956|NCT01042392|466718357|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
129660957|NCT01042392|466718354|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
129660958|NCT01042392|466718355|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
129660959|NCT01042392|466718356|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
129660960|NCT01042392|466718357|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
129660961|NCT01042392|466718354|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
129660962|NCT01042392|466718355|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
129660963|NCT01042392|466718356|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
129660964|NCT01042392|466718357|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
129660965|NCT01042392|466718354|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
129660966|NCT01042392|466718355|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
129660967|NCT01042392|466718356|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
129660968|NCT01042392|466718357|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
129660969|NCT01042392|466718354|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
129660970|NCT01042392|466718355|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
129660971|NCT01042392|466718356|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
129660972|NCT01042392|466718357|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
129660973|NCT00587795|466718358|FG000|Overall Study|Withdrawal by Subject|1|||
129660974|NCT00587795|466718359|FG001|Overall Study|Withdrawal by Subject|0|||
129660975|NCT02869893|466718364|FG000|Overall Study|participant aversion to IV|5|||
129660976|NCT02869893|466718364|FG000|Overall Study|participant fear of MRI scanner|2|||
129660977|NCT03146741|466718365|FG000|Overall Study|Txp with non-HCV+ heart|4|||
129660978|NCT03146741|466718365|FG000|Overall Study|Listeted for MOT|2|||
129660979|NCT03146741|466718365|FG000|Overall Study|Physician Decision|2|||
129660980|NCT03146741|466718365|FG000|Overall Study|Awaiting txp|2|||
129660981|NCT00837967|466718366|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
129660982|NCT00837967|466718367|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
129660983|NCT00551525|466718368|FG000|Overall Study|Protocol Violation|5|||
129660984|NCT04676724|466718369|FG000|Overall Study|Adverse Event|2|||
129660985|NCT04676724|466718370|FG001|Overall Study|Adverse Event|0|||
129660986|NCT04676724|466718369|FG000|Overall Study|Lost to Follow-up|1|||
129660987|NCT04676724|466718370|FG001|Overall Study|Lost to Follow-up|0|||
129660988|NCT04676724|466718369|FG000|Overall Study|Physician Decision|0|||
129660989|NCT04676724|466718370|FG001|Overall Study|Physician Decision|1|||
129660990|NCT04676724|466718369|FG000|Overall Study|Withdrawal by Subject|3|||
129660991|NCT04676724|466718370|FG001|Overall Study|Withdrawal by Subject|2|||
129660992|NCT02081001|466718376|FG000|Overall Study|Adverse Event|0|||
129660993|NCT02081001|466718377|FG001|Overall Study|Adverse Event|0|||
129660994|NCT02081001|466718378|FG002|Overall Study|Adverse Event|0|||
129660995|NCT02081001|466718379|FG003|Overall Study|Adverse Event|0|||
129660996|NCT02081001|466718380|FG004|Overall Study|Adverse Event|1|||
129660997|NCT02081001|466718381|FG005|Overall Study|Adverse Event|0|||
129660998|NCT02081001|466718382|FG006|Overall Study|Adverse Event|0|||
129660999|NCT02081001|466718383|FG007|Overall Study|Adverse Event|0|||
129661000|NCT02081001|466718384|FG008|Overall Study|Adverse Event|0|||
129661001|NCT02081001|466718385|FG009|Overall Study|Adverse Event|0|||
129661002|NCT02081001|466718386|FG010|Overall Study|Adverse Event|0|||
129661003|NCT02081001|466718387|FG011|Overall Study|Adverse Event|0|||
129661004|NCT02588092|466718408|FG000|Overall Study|Death|4|||
129661005|NCT02588092|466718409|FG001|Overall Study|Death|3|||
129661006|NCT02588092|466718410|FG002|Overall Study|Death|3|||
129661007|NCT02588092|466718411|FG003|Overall Study|Death|3|||
129661008|NCT02588092|466718412|FG004|Overall Study|Death|2|||
129661009|NCT02588092|466718413|FG005|Overall Study|Death|2|||
129661010|NCT02588092|466718414|FG006|Overall Study|Death|2|||
129661011|NCT02588092|466718415|FG007|Overall Study|Death|1|||
129661012|NCT02588092|466718416|FG008|Overall Study|Death|5|||
129661013|NCT02588092|466718417|FG009|Overall Study|Death|2|||
129661014|NCT02588092|466718408|FG000|Overall Study|Withdrawal by Subject|0|||
129661015|NCT02588092|466718409|FG001|Overall Study|Withdrawal by Subject|0|||
129661016|NCT02588092|466718410|FG002|Overall Study|Withdrawal by Subject|0|||
129661017|NCT02588092|466718411|FG003|Overall Study|Withdrawal by Subject|0|||
129661018|NCT02588092|466718412|FG004|Overall Study|Withdrawal by Subject|0|||
129661019|NCT02588092|466718413|FG005|Overall Study|Withdrawal by Subject|1|||
129661020|NCT02588092|466718414|FG006|Overall Study|Withdrawal by Subject|1|||
129883864|NCT02733042|467534444|FG003|Overall Study|Progressive Disease|1|||
129883865|NCT02733042|467534445|FG004|Overall Study|Progressive Disease|2|||
129883866|NCT02733042|467534446|FG005|Overall Study|Progressive Disease|3|||
129883867|NCT02733042|467534447|FG006|Overall Study|Progressive Disease|0|||
129990159|NCT02647866|467927579|FG000|Overall Study|Subject moved to different country|1|||
129990160|NCT02647866|467927580|FG001|Overall Study|Subject moved to different country|0|||
129990161|NCT02647866|467927581|FG002|Overall Study|Subject moved to different country|0|||
129990162|NCT02647866|467927582|FG003|Overall Study|Subject moved to different country|0|||
129990163|NCT02647866|467927583|FG004|Overall Study|Subject moved to different country|0|||
129990164|NCT00069108|467927587|FG000|Overall Study|Withdrawal by Subject|5|||
129990165|NCT00069108|467927588|FG001|Overall Study|Withdrawal by Subject|9|||
129990166|NCT00069108|467927587|FG000|Overall Study|Adverse Event|64|||
129990167|NCT00069108|467927588|FG001|Overall Study|Adverse Event|42|||
129990168|NCT00069108|467927587|FG000|Overall Study|Death|6|||
129990169|NCT00069108|467927588|FG001|Overall Study|Death|6|||
129990170|NCT00069108|467927587|FG000|Overall Study|Administration|15|||
129990171|NCT00069108|467927588|FG001|Overall Study|Administration|4|||
129990172|NCT00069108|467927587|FG000|Overall Study|Insufficient therapy|117|||
129990173|NCT00069108|467927588|FG001|Overall Study|Insufficient therapy|144|||
129990174|NCT00069108|467927587|FG000|Overall Study|Violation criteria|1|||
129990175|NCT00069108|467927588|FG001|Overall Study|Violation criteria|4|||
129990176|NCT00069108|467927587|FG000|Overall Study|Refused treatment|5|||
129990177|NCT00069108|467927588|FG001|Overall Study|Refused treatment|10|||
129990178|NCT01415531|467927589|FG000|Overall Study|Adverse Event|7|||
129990179|NCT01415531|467927590|FG001|Overall Study|Adverse Event|10|||
129990180|NCT01415531|467927589|FG000|Overall Study|Lack of Efficacy|3|||
129990181|NCT01415531|467927590|FG001|Overall Study|Lack of Efficacy|2|||
129990182|NCT01415531|467927589|FG000|Overall Study|Protocol Violation|0|||
129990183|NCT01415531|467927590|FG001|Overall Study|Protocol Violation|1|||
129990184|NCT01415531|467927589|FG000|Overall Study|Withdrawal by Subject|5|||
129990185|NCT01415531|467927590|FG001|Overall Study|Withdrawal by Subject|4|||
129990186|NCT01415531|467927589|FG000|Overall Study|Lost to Follow-up|6|||
129990187|NCT01415531|467927590|FG001|Overall Study|Lost to Follow-up|14|||
129990188|NCT01415531|467927589|FG000|Overall Study|Lack of Compliance|1|||
129990189|NCT01415531|467927590|FG001|Overall Study|Lack of Compliance|4|||
129990190|NCT01415531|467927589|FG000|Overall Study|Other Reasons|3|||
129990191|NCT01415531|467927590|FG001|Overall Study|Other Reasons|2|||
129990192|NCT00262951|467927591|FG000|Overall Study|Progressive disease/relapse|3|||
129990193|NCT00262951|467927591|FG000|Overall Study|Adverse Event|7|||
129990194|NCT00262951|467927591|FG000|Overall Study|Death|1|||
129990195|NCT00262951|467927591|FG000|Overall Study|Withdrawal by Subject|1|||
129990196|NCT00262951|467927591|FG000|Overall Study|Alternative treatment|3|||
129990197|NCT00262951|467927591|FG000|Overall Study|Off treatment for other disease|1|||
129990198|NCT00394082|467927594|FG000|Overall Study|Unacceptable toxicity|15|||
129990199|NCT00394082|467927594|FG000|Overall Study|Adverse Event|4|||
129990200|NCT00394082|467927594|FG000|Overall Study|Physician Decision|4|||
129990201|NCT00394082|467927594|FG000|Overall Study|Withdrawal by Subject|2|||
129990202|NCT00394082|467927594|FG000|Overall Study|Other|1|||
129990203|NCT02325557|467927596|FG000|Overall Study|Progressive disease|1|||
129990204|NCT02325557|467927597|FG001|Overall Study|Progressive disease|0|||
129990205|NCT02325557|467927598|FG002|Overall Study|Progressive disease|0|||
129990206|NCT02325557|467927599|FG003|Overall Study|Progressive disease|0|||
129990207|NCT02325557|467927596|FG000|Overall Study|Withdrawal by Subject|4|||
129990208|NCT02325557|467927597|FG001|Overall Study|Withdrawal by Subject|0|||
129990209|NCT02325557|467927598|FG002|Overall Study|Withdrawal by Subject|0|||
129990210|NCT02325557|467927599|FG003|Overall Study|Withdrawal by Subject|15|||
129990211|NCT02325557|467927596|FG000|Overall Study|Death|5|||
129990212|NCT02325557|467927597|FG001|Overall Study|Death|1|||
129661021|NCT02588092|466718415|FG007|Overall Study|Withdrawal by Subject|2|||
129661022|NCT02588092|466718416|FG008|Overall Study|Withdrawal by Subject|0|||
129661023|NCT02588092|466718417|FG009|Overall Study|Withdrawal by Subject|0|||
129661024|NCT02588092|466718408|FG000|Overall Study|Started Another Treatment|0|||
129661025|NCT02588092|466718409|FG001|Overall Study|Started Another Treatment|0|||
129661026|NCT02588092|466718410|FG002|Overall Study|Started Another Treatment|0|||
129661027|NCT02588092|466718411|FG003|Overall Study|Started Another Treatment|0|||
129661028|NCT02588092|466718412|FG004|Overall Study|Started Another Treatment|1|||
129661029|NCT02588092|466718413|FG005|Overall Study|Started Another Treatment|0|||
129661030|NCT02588092|466718414|FG006|Overall Study|Started Another Treatment|0|||
129661031|NCT02588092|466718415|FG007|Overall Study|Started Another Treatment|1|||
129661032|NCT02588092|466718416|FG008|Overall Study|Started Another Treatment|0|||
129661033|NCT02588092|466718417|FG009|Overall Study|Started Another Treatment|0|||
129661034|NCT02588092|466718408|FG000|Overall Study|Sponsor Decision|0|||
129990213|NCT02325557|467927598|FG002|Overall Study|Death|1|||
129990214|NCT02325557|467927599|FG003|Overall Study|Death|16|||
129990215|NCT02325557|467927596|FG000|Overall Study|Lost to Follow-up|0|||
129990216|NCT02325557|467927597|FG001|Overall Study|Lost to Follow-up|0|||
129661035|NCT02588092|466718409|FG001|Overall Study|Sponsor Decision|0|||
129661036|NCT02588092|466718410|FG002|Overall Study|Sponsor Decision|0|||
129661037|NCT02588092|466718411|FG003|Overall Study|Sponsor Decision|0|||
129661038|NCT02588092|466718412|FG004|Overall Study|Sponsor Decision|0|||
129990217|NCT02325557|467927598|FG002|Overall Study|Lost to Follow-up|1|||
129990218|NCT02325557|467927599|FG003|Overall Study|Lost to Follow-up|1|||
129990219|NCT02325557|467927596|FG000|Overall Study|Other|0|||
129546418|NCT00568776|466294010|FG000|Overall Study|Lost to Follow-up|1|||
129546419|NCT00568776|466294011|FG001|Overall Study|Lost to Follow-up|1|||
129546420|NCT00568776|466294012|FG002|Overall Study|Lost to Follow-up|1|||
129546421|NCT00568776|466294013|FG003|Overall Study|Lost to Follow-up|1|||
129546422|NCT00568776|466294010|FG000|Overall Study|Protocol Violation|1|||
129546423|NCT00568776|466294011|FG001|Overall Study|Protocol Violation|0|||
129546424|NCT00568776|466294012|FG002|Overall Study|Protocol Violation|1|||
129546425|NCT00568776|466294013|FG003|Overall Study|Protocol Violation|1|||
129546426|NCT00568776|466294010|FG000|Overall Study|Withdrawal by Subject|13|||
129546427|NCT00568776|466294011|FG001|Overall Study|Withdrawal by Subject|15|||
129546428|NCT00568776|466294012|FG002|Overall Study|Withdrawal by Subject|13|||
129546429|NCT00568776|466294013|FG003|Overall Study|Withdrawal by Subject|7|||
129546430|NCT00568776|466294010|FG000|Overall Study|Loss of Caregiver|0|||
129546431|NCT00568776|466294011|FG001|Overall Study|Loss of Caregiver|2|||
129546432|NCT00568776|466294012|FG002|Overall Study|Loss of Caregiver|1|||
129546433|NCT00568776|466294013|FG003|Overall Study|Loss of Caregiver|2|||
129546434|NCT00568776|466294010|FG000|Overall Study|Sponsor Decision|2|||
129546435|NCT00568776|466294011|FG001|Overall Study|Sponsor Decision|2|||
129546436|NCT00568776|466294012|FG002|Overall Study|Sponsor Decision|41|||
129546437|NCT00568776|466294013|FG003|Overall Study|Sponsor Decision|42|||
129546438|NCT00568776|466294010|FG000|Overall Study|Miscellaeneous|3|||
129546439|NCT00568776|466294011|FG001|Overall Study|Miscellaeneous|3|||
129546440|NCT00568776|466294012|FG002|Overall Study|Miscellaeneous|1|||
129546441|NCT00568776|466294013|FG003|Overall Study|Miscellaeneous|4|||
129546442|NCT02118896|466294024|FG000|Overall Study|Death|4|||
129546443|NCT02118896|466294025|FG001|Overall Study|Death|0|||
129546444|NCT02118896|466294026|FG002|Overall Study|Death|4|||
129546445|NCT02118896|466294027|FG003|Overall Study|Death|6|||
129546446|NCT02118896|466294028|FG004|Overall Study|Death|3|||
129546447|NCT02118896|466294029|FG005|Overall Study|Death|1|||
129546448|NCT02118896|466294030|FG006|Overall Study|Death|0|||
129546449|NCT02118896|466294031|FG007|Overall Study|Death|0|||
129546450|NCT02118896|466294032|FG008|Overall Study|Death|0|||
129546451|NCT02118896|466294033|FG009|Overall Study|Death|0|||
129546452|NCT02118896|466294024|FG000|Overall Study|Adverse Event|5|||
129546453|NCT02118896|466294025|FG001|Overall Study|Adverse Event|4|||
129546454|NCT02118896|466294026|FG002|Overall Study|Adverse Event|4|||
129546455|NCT02118896|466294027|FG003|Overall Study|Adverse Event|5|||
129546456|NCT02118896|466294028|FG004|Overall Study|Adverse Event|5|||
129546457|NCT02118896|466294029|FG005|Overall Study|Adverse Event|9|||
129546458|NCT02118896|466294030|FG006|Overall Study|Adverse Event|1|||
129546459|NCT02118896|466294031|FG007|Overall Study|Adverse Event|1|||
129546460|NCT02118896|466294032|FG008|Overall Study|Adverse Event|4|||
129546461|NCT02118896|466294033|FG009|Overall Study|Adverse Event|0|||
129546462|NCT02118896|466294024|FG000|Overall Study|Consent withdrawn|2|||
129546463|NCT02118896|466294025|FG001|Overall Study|Consent withdrawn|0|||
129546464|NCT02118896|466294026|FG002|Overall Study|Consent withdrawn|3|||
129546465|NCT02118896|466294027|FG003|Overall Study|Consent withdrawn|4|||
129546466|NCT02118896|466294028|FG004|Overall Study|Consent withdrawn|1|||
129546467|NCT02118896|466294029|FG005|Overall Study|Consent withdrawn|4|||
129546468|NCT02118896|466294030|FG006|Overall Study|Consent withdrawn|0|||
129546469|NCT02118896|466294031|FG007|Overall Study|Consent withdrawn|0|||
129546470|NCT02118896|466294032|FG008|Overall Study|Consent withdrawn|0|||
129546471|NCT02118896|466294033|FG009|Overall Study|Consent withdrawn|0|||
129546472|NCT02118896|466294024|FG000|Overall Study|Non-compliance|2|||
129546473|NCT02118896|466294025|FG001|Overall Study|Non-compliance|1|||
129546474|NCT02118896|466294026|FG002|Overall Study|Non-compliance|1|||
129546475|NCT02118896|466294027|FG003|Overall Study|Non-compliance|5|||
129546476|NCT02118896|466294028|FG004|Overall Study|Non-compliance|0|||
129546477|NCT02118896|466294029|FG005|Overall Study|Non-compliance|1|||
129546478|NCT02118896|466294030|FG006|Overall Study|Non-compliance|0|||
129546479|NCT02118896|466294031|FG007|Overall Study|Non-compliance|1|||
129546480|NCT02118896|466294032|FG008|Overall Study|Non-compliance|0|||
129546481|NCT02118896|466294033|FG009|Overall Study|Non-compliance|0|||
129546482|NCT02118896|466294024|FG000|Overall Study|Pregnancy|1|||
129546483|NCT02118896|466294025|FG001|Overall Study|Pregnancy|1|||
129546484|NCT02118896|466294026|FG002|Overall Study|Pregnancy|0|||
129546485|NCT02118896|466294027|FG003|Overall Study|Pregnancy|0|||
129546486|NCT02118896|466294028|FG004|Overall Study|Pregnancy|1|||
129546487|NCT02118896|466294029|FG005|Overall Study|Pregnancy|3|||
129546488|NCT02118896|466294030|FG006|Overall Study|Pregnancy|1|||
129546489|NCT02118896|466294031|FG007|Overall Study|Pregnancy|0|||
129546490|NCT02118896|466294032|FG008|Overall Study|Pregnancy|0|||
129546491|NCT02118896|466294033|FG009|Overall Study|Pregnancy|0|||
129546492|NCT02118896|466294024|FG000|Overall Study|Lost to Follow-up|1|||
129546493|NCT02118896|466294025|FG001|Overall Study|Lost to Follow-up|2|||
129546494|NCT02118896|466294026|FG002|Overall Study|Lost to Follow-up|1|||
129546495|NCT02118896|466294027|FG003|Overall Study|Lost to Follow-up|0|||
129546496|NCT02118896|466294028|FG004|Overall Study|Lost to Follow-up|2|||
129546497|NCT02118896|466294029|FG005|Overall Study|Lost to Follow-up|1|||
129546498|NCT02118896|466294030|FG006|Overall Study|Lost to Follow-up|0|||
129546499|NCT02118896|466294031|FG007|Overall Study|Lost to Follow-up|0|||
129546500|NCT02118896|466294032|FG008|Overall Study|Lost to Follow-up|0|||
129546501|NCT02118896|466294033|FG009|Overall Study|Lost to Follow-up|0|||
129546502|NCT02118896|466294024|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
129546503|NCT02118896|466294025|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
129546504|NCT02118896|466294026|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
129546505|NCT02118896|466294027|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
129546506|NCT02118896|466294028|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
129546507|NCT02118896|466294029|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
129546508|NCT02118896|466294030|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
129546509|NCT02118896|466294031|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
129546510|NCT02118896|466294032|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
129546511|NCT02118896|466294033|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
129546512|NCT02118896|466294024|FG000|Overall Study|Prohibited medication|0|||
129546513|NCT02118896|466294025|FG001|Overall Study|Prohibited medication|0|||
129546514|NCT02118896|466294026|FG002|Overall Study|Prohibited medication|0|||
129546515|NCT02118896|466294027|FG003|Overall Study|Prohibited medication|0|||
129546516|NCT02118896|466294028|FG004|Overall Study|Prohibited medication|1|||
129546517|NCT02118896|466294029|FG005|Overall Study|Prohibited medication|3|||
129546518|NCT02118896|466294030|FG006|Overall Study|Prohibited medication|0|||
129546519|NCT02118896|466294031|FG007|Overall Study|Prohibited medication|0|||
129546520|NCT02118896|466294032|FG008|Overall Study|Prohibited medication|0|||
129546521|NCT02118896|466294033|FG009|Overall Study|Prohibited medication|0|||
129546522|NCT02118896|466294024|FG000|Overall Study|Miscellaneous|1|||
129546523|NCT02118896|466294025|FG001|Overall Study|Miscellaneous|2|||
129546524|NCT02118896|466294026|FG002|Overall Study|Miscellaneous|0|||
129546525|NCT02118896|466294027|FG003|Overall Study|Miscellaneous|2|||
129546526|NCT02118896|466294028|FG004|Overall Study|Miscellaneous|0|||
129546527|NCT02118896|466294029|FG005|Overall Study|Miscellaneous|4|||
129546528|NCT02118896|466294030|FG006|Overall Study|Miscellaneous|0|||
129546529|NCT02118896|466294031|FG007|Overall Study|Miscellaneous|0|||
129546530|NCT02118896|466294032|FG008|Overall Study|Miscellaneous|0|||
129546531|NCT02118896|466294033|FG009|Overall Study|Miscellaneous|0|||
129546532|NCT03292731|466294034|FG000|Overall Study|Protocol Violation|4|||
129546533|NCT03292731|466294035|FG001|Overall Study|Protocol Violation|11|||
129546534|NCT03292731|466294036|FG002|Overall Study|Protocol Violation|1|||
129546535|NCT03901352|466294037|FG000|Double-blind Phase|Adverse Event|6|||
129546536|NCT03901352|466294038|FG001|Double-blind Phase|Adverse Event|4|||
129546537|NCT03901352|466294037|FG000|Double-blind Phase|Death|1|||
129546538|NCT03901352|466294038|FG001|Double-blind Phase|Death|0|||
129546539|NCT03901352|466294037|FG000|Double-blind Phase|Lack of Efficacy|0|||
129546540|NCT03901352|466294038|FG001|Double-blind Phase|Lack of Efficacy|1|||
129546541|NCT03901352|466294037|FG000|Double-blind Phase|Protocol Violation|0|||
129546542|NCT03901352|466294038|FG001|Double-blind Phase|Protocol Violation|1|||
129546543|NCT03901352|466294037|FG000|Double-blind Phase|Withdrawal by Subject|10|||
129546544|NCT03901352|466294038|FG001|Double-blind Phase|Withdrawal by Subject|8|||
129546545|NCT03901352|466294037|FG000|Open-label Extension Phase|Adverse Event|24|||
129546546|NCT03901352|466294038|FG001|Open-label Extension Phase|Adverse Event|0|||
129546547|NCT03901352|466294037|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
129546548|NCT03901352|466294038|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
129546549|NCT03901352|466294037|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
129546550|NCT03901352|466294038|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
129546551|NCT03901352|466294037|FG000|Open-label Extension Phase|Other|1|||
129546552|NCT03901352|466294038|FG001|Open-label Extension Phase|Other|0|||
129546553|NCT01965431|466294039|FG000|Overall Study|Adverse Event|0|||
129546554|NCT01965431|466294040|FG001|Overall Study|Adverse Event|1|||
129546555|NCT01965431|466294041|FG002|Overall Study|Adverse Event|0|||
129546556|NCT01965431|466294042|FG003|Overall Study|Adverse Event|0|||
129546557|NCT01965431|466294043|FG004|Overall Study|Adverse Event|0|||
129546558|NCT01965431|466294044|FG005|Overall Study|Adverse Event|0|||
129546559|NCT01965431|466294039|FG000|Overall Study|Other than stated above|6|||
129546560|NCT01965431|466294040|FG001|Overall Study|Other than stated above|5|||
129546561|NCT01965431|466294041|FG002|Overall Study|Other than stated above|6|||
129546562|NCT01965431|466294042|FG003|Overall Study|Other than stated above|6|||
129546563|NCT01965431|466294043|FG004|Overall Study|Other than stated above|6|||
129546564|NCT01965431|466294044|FG005|Overall Study|Other than stated above|6|||
129546565|NCT04635631|466294045|FG000|Overall Study|Adverse Event|1|||
129546566|NCT04635631|466294045|FG000|Overall Study|Progressive disease|13|||
129546567|NCT04635631|466294045|FG000|Overall Study|Withdrawal by Subject|1|||
129546568|NCT00572910|466294048|FG000|Overall Study|Adverse Event|1|||
129546569|NCT00572910|466294049|FG001|Overall Study|Adverse Event|2|||
129546570|NCT00572910|466294050|FG002|Overall Study|Adverse Event|0|||
129546571|NCT00572910|466294051|FG003|Overall Study|Adverse Event|2|||
129546572|NCT00572910|466294052|FG004|Overall Study|Adverse Event|0|||
129546573|NCT00572910|466294053|FG005|Overall Study|Adverse Event|0|||
129546574|NCT00572910|466294054|FG006|Overall Study|Adverse Event|4|||
129546575|NCT00572910|466294055|FG007|Overall Study|Adverse Event|2|||
129546576|NCT00572910|466294056|FG008|Overall Study|Adverse Event|1|||
129990220|NCT02325557|467927597|FG001|Overall Study|Other|0|||
129990221|NCT02325557|467927598|FG002|Overall Study|Other|0|||
129990222|NCT02325557|467927599|FG003|Overall Study|Other|5|||
129990223|NCT02344004|467927600|FG000|Overall Study|Adverse Event|11|||
129990224|NCT02344004|467927601|FG001|Overall Study|Adverse Event|1|||
129990225|NCT02344004|467927600|FG000|Overall Study|Death|9|||
129990226|NCT02344004|467927601|FG001|Overall Study|Death|7|||
129990227|NCT02344004|467927600|FG000|Overall Study|Physician Decision|4|||
129990228|NCT02344004|467927601|FG001|Overall Study|Physician Decision|1|||
129661039|NCT02588092|466718413|FG005|Overall Study|Sponsor Decision|0|||
129661040|NCT02588092|466718414|FG006|Overall Study|Sponsor Decision|0|||
129661041|NCT02588092|466718415|FG007|Overall Study|Sponsor Decision|0|||
129661042|NCT02588092|466718416|FG008|Overall Study|Sponsor Decision|1|||
129661043|NCT02588092|466718417|FG009|Overall Study|Sponsor Decision|1|||
129661044|NCT01030718|466718418|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
129661045|NCT01030718|466718419|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
129661046|NCT01030718|466718420|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
129661047|NCT01030718|466718418|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
129661048|NCT01030718|466718419|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
129661049|NCT01030718|466718420|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
129661050|NCT01030718|466718418|FG000|Studies CA180-031 and -036 Combined|Death|0|||
129661051|NCT01030718|466718419|FG001|Studies CA180-031 and -036 Combined|Death|1|||
129661052|NCT01030718|466718420|FG002|Studies CA180-031 and -036 Combined|Death|0|||
129661053|NCT01030718|466718418|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
129661054|NCT01030718|466718419|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
129661055|NCT01030718|466718420|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
129661056|NCT01030718|466718418|FG000|Study CA180-036 Only|insufficient effect|1|||
129661057|NCT01030718|466718419|FG001|Study CA180-036 Only|insufficient effect|1|||
129661058|NCT01030718|466718420|FG002|Study CA180-036 Only|insufficient effect|5|||
129661059|NCT01030718|466718418|FG000|Study CA180-036 Only|Adverse Event|2|||
129661060|NCT01030718|466718419|FG001|Study CA180-036 Only|Adverse Event|3|||
129661061|NCT01030718|466718420|FG002|Study CA180-036 Only|Adverse Event|0|||
129661062|NCT01030718|466718418|FG000|Study CA180-036 Only|Death|0|||
129661063|NCT01030718|466718419|FG001|Study CA180-036 Only|Death|1|||
129661064|NCT01030718|466718420|FG002|Study CA180-036 Only|Death|0|||
129661065|NCT01030718|466718418|FG000|Study CA180-036 Only|Other Reasons|0|||
129661066|NCT01030718|466718419|FG001|Study CA180-036 Only|Other Reasons|2|||
129661067|NCT01030718|466718420|FG002|Study CA180-036 Only|Other Reasons|0|||
129661068|NCT00099632|466718423|FG000|Overall Study|Lost to Follow-up|1|||
129661069|NCT00099632|466718424|FG001|Overall Study|Lost to Follow-up|0|||
129661070|NCT00099632|466718425|FG002|Overall Study|Lost to Follow-up|3|||
129661071|NCT00099632|466718426|FG003|Overall Study|Lost to Follow-up|1|||
129661072|NCT00099632|466718427|FG004|Overall Study|Lost to Follow-up|1|||
129661073|NCT00099632|466718428|FG005|Overall Study|Lost to Follow-up|0|||
129661074|NCT00099632|466718423|FG000|Overall Study|Withdrawal by Subject|0|||
129661075|NCT00099632|466718424|FG001|Overall Study|Withdrawal by Subject|1|||
129661076|NCT00099632|466718425|FG002|Overall Study|Withdrawal by Subject|0|||
129661077|NCT00099632|466718426|FG003|Overall Study|Withdrawal by Subject|0|||
129661078|NCT00099632|466718427|FG004|Overall Study|Withdrawal by Subject|0|||
129661079|NCT00099632|466718428|FG005|Overall Study|Withdrawal by Subject|1|||
129661080|NCT00099632|466718423|FG000|Overall Study|Protocol Violation|0|||
129661081|NCT00099632|466718424|FG001|Overall Study|Protocol Violation|0|||
129661082|NCT00099632|466718425|FG002|Overall Study|Protocol Violation|0|||
129661083|NCT00099632|466718426|FG003|Overall Study|Protocol Violation|0|||
129661084|NCT00099632|466718427|FG004|Overall Study|Protocol Violation|0|||
129661085|NCT00099632|466718428|FG005|Overall Study|Protocol Violation|1|||
129661086|NCT00423813|466718429|FG000|Overall Study|Adverse Event|11|||
129661087|NCT00423813|466718430|FG001|Overall Study|Adverse Event|30|||
129661088|NCT00423813|466718431|FG002|Overall Study|Adverse Event|40|||
129661089|NCT00423813|466718429|FG000|Overall Study|Withdrawal by Subject|6|||
129661090|NCT00423813|466718430|FG001|Overall Study|Withdrawal by Subject|8|||
129661091|NCT00423813|466718431|FG002|Overall Study|Withdrawal by Subject|5|||
129661092|NCT00423813|466718429|FG000|Overall Study|Lost to Follow-up|5|||
129661093|NCT00423813|466718430|FG001|Overall Study|Lost to Follow-up|4|||
129661094|NCT00423813|466718431|FG002|Overall Study|Lost to Follow-up|4|||
129661095|NCT00423813|466718429|FG000|Overall Study|Lack of Efficacy|23|||
129661096|NCT00423813|466718430|FG001|Overall Study|Lack of Efficacy|18|||
129661097|NCT00423813|466718431|FG002|Overall Study|Lack of Efficacy|19|||
129661098|NCT00423813|466718429|FG000|Overall Study|Physician Decision|2|||
129990229|NCT02344004|467927600|FG000|Overall Study|Withdrawal by Subject|22|||
129990230|NCT02344004|467927601|FG001|Overall Study|Withdrawal by Subject|5|||
129661099|NCT00423813|466718430|FG001|Overall Study|Physician Decision|0|||
129661100|NCT00423813|466718431|FG002|Overall Study|Physician Decision|0|||
129661101|NCT00423813|466718429|FG000|Overall Study|Sponsor Decision|0|||
129661102|NCT00423813|466718430|FG001|Overall Study|Sponsor Decision|1|||
129661103|NCT00423813|466718431|FG002|Overall Study|Sponsor Decision|0|||
129990231|NCT02344004|467927600|FG000|Overall Study|Rescue Medication|2|||
129990232|NCT02344004|467927601|FG001|Overall Study|Rescue Medication|0|||
129661104|NCT00423813|466718429|FG000|Overall Study|Protocol Violation|9|||
129990233|NCT02344004|467927600|FG000|Overall Study|Other Not Specified|12|||
129990234|NCT02344004|467927601|FG001|Overall Study|Other Not Specified|0|||
129661105|NCT00423813|466718430|FG001|Overall Study|Protocol Violation|4|||
129661106|NCT00423813|466718431|FG002|Overall Study|Protocol Violation|4|||
129661107|NCT00423813|466718429|FG000|Overall Study|Pregnancy|0|||
129661108|NCT00423813|466718430|FG001|Overall Study|Pregnancy|0|||
129661109|NCT00423813|466718431|FG002|Overall Study|Pregnancy|1|||
129661110|NCT00423813|466718429|FG000|Overall Study|Subject started night shift work|1|||
129661111|NCT00423813|466718430|FG001|Overall Study|Subject started night shift work|0|||
129661112|NCT00423813|466718431|FG002|Overall Study|Subject started night shift work|0|||
129661113|NCT00423813|466718429|FG000|Overall Study|Will start exclusionary medications|0|||
129661114|NCT00423813|466718430|FG001|Overall Study|Will start exclusionary medications|1|||
129661115|NCT00423813|466718431|FG002|Overall Study|Will start exclusionary medications|0|||
129661116|NCT00423813|466718429|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
129661117|NCT00423813|466718430|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
129661118|NCT00423813|466718431|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
129661119|NCT01386944|466718433|FG000|Overall Study|Adverse Event|26|||
129661120|NCT01386944|466718433|FG000|Overall Study|Lack of Efficacy|14|||
129661121|NCT01386944|466718433|FG000|Overall Study|Lost to Follow-up|8|||
129661122|NCT01386944|466718433|FG000|Overall Study|Unspecified reason|8|||
129661123|NCT03883477|466718434|FG000|Overall Study|Death|1|||
129661124|NCT03883477|466718435|FG001|Overall Study|Death|0|||
129661125|NCT03883477|466718434|FG000|Overall Study|Protocol Violation|0|||
129661126|NCT03883477|466718435|FG001|Overall Study|Protocol Violation|1|||
129661127|NCT03853291|466718436|FG000|Overall Study|Lost to Follow-up|1|||
129661128|NCT03853291|466718437|FG001|Overall Study|Lost to Follow-up|2|||
129661129|NCT03853291|466718438|FG002|Overall Study|Lost to Follow-up|0|||
129661130|NCT03853291|466718439|FG003|Overall Study|Lost to Follow-up|0|||
129661131|NCT03853291|466718440|FG004|Overall Study|Lost to Follow-up|0|||
129661132|NCT03853291|466718441|FG005|Overall Study|Lost to Follow-up|0|||
129661133|NCT03853291|466718436|FG000|Overall Study|Determined to be ineligible|1|||
129661134|NCT03853291|466718437|FG001|Overall Study|Determined to be ineligible|1|||
129661135|NCT03853291|466718438|FG002|Overall Study|Determined to be ineligible|0|||
129661136|NCT03853291|466718439|FG003|Overall Study|Determined to be ineligible|0|||
129661137|NCT03853291|466718440|FG004|Overall Study|Determined to be ineligible|0|||
129661138|NCT03853291|466718441|FG005|Overall Study|Determined to be ineligible|0|||
129661139|NCT03762681|466718447|FG000|Part 1|Withdrawal by Subject|0|||
129990235|NCT02344004|467927600|FG000|Overall Study|Protocol Violation|1|||
129990236|NCT02344004|467927601|FG001|Overall Study|Protocol Violation|0|||
129990237|NCT03881553|467927609|FG000|Overall Study|Discharged prior to participation|1|||
129990238|NCT03881553|467927610|FG001|Overall Study|Discharged prior to participation|1|||
129990239|NCT03881553|467927611|FG002|Overall Study|Discharged prior to participation|0|||
129990240|NCT03881553|467927609|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
129990241|NCT03881553|467927610|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
129990242|NCT03881553|467927611|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
129990243|NCT00336895|467927615|FG000|Overall Study|diarrhea|1|||
129990244|NCT00336895|467927615|FG000|Overall Study|nausea and upset stomach|1|||
129990245|NCT00336895|467927615|FG000|Overall Study|Physician Decision|1|||
129990246|NCT00336895|467927615|FG000|Overall Study|screen failed|1|||
129990247|NCT02481947|467927616|FG000|Overall Study|Withdrawal by Subject|24|||
129990248|NCT02481947|467927617|FG001|Overall Study|Withdrawal by Subject|10|||
129990249|NCT02481947|467927616|FG000|Overall Study|Lost to Follow-up|11|||
129990250|NCT02481947|467927617|FG001|Overall Study|Lost to Follow-up|5|||
129990251|NCT02481947|467927616|FG000|Overall Study|Adverse Event|6|||
129990252|NCT02481947|467927617|FG001|Overall Study|Adverse Event|11|||
129990253|NCT02481947|467927616|FG000|Overall Study|Physician Decision|4|||
129990254|NCT02481947|467927617|FG001|Overall Study|Physician Decision|5|||
129990255|NCT02481947|467927616|FG000|Overall Study|Protocol Violation|1|||
129990256|NCT02481947|467927617|FG001|Overall Study|Protocol Violation|5|||
129990257|NCT03426605|467927618|FG000|Overall Study|AML relapse or progression|2|||
129990258|NCT03426605|467927619|FG001|Overall Study|AML relapse or progression|1|||
129990259|NCT03426605|467927620|FG002|Overall Study|AML relapse or progression|2|||
129990260|NCT03426605|467927621|FG003|Overall Study|AML relapse or progression|2|||
129661140|NCT03762681|466718448|FG001|Part 1|Withdrawal by Subject|0|||
129661141|NCT03762681|466718449|FG002|Part 1|Withdrawal by Subject|0|||
129661142|NCT03762681|466718450|FG003|Part 1|Withdrawal by Subject|1|||
129661143|NCT03762681|466718451|FG004|Part 1|Withdrawal by Subject|0|||
129661144|NCT03762681|466718452|FG005|Part 1|Withdrawal by Subject|0|||
129661145|NCT03762681|466718453|FG006|Part 1|Withdrawal by Subject|0|||
129990261|NCT03426605|467927618|FG000|Overall Study|Treatment failure|3|||
129990262|NCT03426605|467927619|FG001|Overall Study|Treatment failure|2|||
129990263|NCT03426605|467927620|FG002|Overall Study|Treatment failure|0|||
129661146|NCT03762681|466718454|FG007|Part 1|Withdrawal by Subject|0|||
129990264|NCT03426605|467927621|FG003|Overall Study|Treatment failure|0|||
129990265|NCT03426605|467927618|FG000|Overall Study|Adverse Event|1|||
129546577|NCT00572910|466294057|FG009|Overall Study|Adverse Event|3|||
129990266|NCT03426605|467927619|FG001|Overall Study|Adverse Event|0|||
129990267|NCT03426605|467927620|FG002|Overall Study|Adverse Event|1|||
129990268|NCT03426605|467927621|FG003|Overall Study|Adverse Event|1|||
129990269|NCT03426605|467927618|FG000|Overall Study|Withdrawal by Subject|0|||
129990270|NCT03426605|467927619|FG001|Overall Study|Withdrawal by Subject|0|||
129990271|NCT03426605|467927620|FG002|Overall Study|Withdrawal by Subject|1|||
129990272|NCT03426605|467927621|FG003|Overall Study|Withdrawal by Subject|1|||
129990273|NCT01815138|467927622|FG000|Overall Study|Withdrawal by Subject|0|||
129990274|NCT01815138|467927623|FG001|Overall Study|Withdrawal by Subject|1|||
129990275|NCT01815138|467927622|FG000|Overall Study|Physician Decision|8|||
129990276|NCT01815138|467927623|FG001|Overall Study|Physician Decision|5|||
129990277|NCT03426267|467927624|FG000|Overall Study|Physician Decision|1|||
129990278|NCT03426267|467927625|FG001|Overall Study|Physician Decision|4|||
129990279|NCT03426267|467927624|FG000|Overall Study|Lost to Follow-up|1|||
129990280|NCT03426267|467927625|FG001|Overall Study|Lost to Follow-up|0|||
129990281|NCT03426267|467927624|FG000|Overall Study|Withdrawal by Subject|4|||
129990282|NCT03426267|467927625|FG001|Overall Study|Withdrawal by Subject|10|||
129990283|NCT03426267|467927624|FG000|Overall Study|Protocol Violation|1|||
129990284|NCT03426267|467927625|FG001|Overall Study|Protocol Violation|3|||
129990285|NCT03426267|467927624|FG000|Overall Study|Adverse Event|9|||
129990286|NCT03426267|467927625|FG001|Overall Study|Adverse Event|27|||
129990287|NCT03426267|467927624|FG000|Overall Study|Prohibited Treatment Intake|2|||
129990288|NCT03426267|467927625|FG001|Overall Study|Prohibited Treatment Intake|3|||
129990289|NCT03426267|467927624|FG000|Overall Study|Lack of Efficacy|0|||
129990290|NCT03426267|467927625|FG001|Overall Study|Lack of Efficacy|25|||
129990291|NCT03426267|467927624|FG000|Overall Study|other|3|||
129990292|NCT03426267|467927625|FG001|Overall Study|other|0|||
129990293|NCT02649946|467927626|FG000|Overall Study|Withdrawal by Subject|1|||
129990294|NCT02649946|467927627|FG001|Overall Study|Withdrawal by Subject|1|||
129990295|NCT02649946|467927626|FG000|Overall Study|Death|7|||
129990296|NCT02649946|467927627|FG001|Overall Study|Death|9|||
129990297|NCT02649946|467927626|FG000|Overall Study|Physician Decision|1|||
129990298|NCT02649946|467927627|FG001|Overall Study|Physician Decision|0|||
129990299|NCT02649946|467927626|FG000|Overall Study|Lost to Follow-up|2|||
129990300|NCT02649946|467927627|FG001|Overall Study|Lost to Follow-up|1|||
129990301|NCT02649946|467927626|FG000|Overall Study|Erroneously enrolled|1|||
129990302|NCT02649946|467927627|FG001|Overall Study|Erroneously enrolled|0|||
129990303|NCT02649946|467927626|FG000|Overall Study|Missed 6-month follow-up visit|0|||
129990304|NCT02649946|467927627|FG001|Overall Study|Missed 6-month follow-up visit|4|||
129990305|NCT00950950|467927628|FG000|Overall Study|Adverse Event|1|||
129990306|NCT00950950|467927629|FG001|Overall Study|Adverse Event|0|||
129990307|NCT00950950|467927628|FG000|Overall Study|Withdrawal by Subject|0|||
129990308|NCT00950950|467927629|FG001|Overall Study|Withdrawal by Subject|1|||
129990309|NCT01047293|467927635|FG000|Overall Study|DLT criteria not fulfilled|1|||
129990310|NCT01047293|467927636|FG001|Overall Study|DLT criteria not fulfilled|1|||
129990311|NCT01047293|467927637|FG002|Overall Study|DLT criteria not fulfilled|0|||
129661147|NCT03762681|466718447|FG000|Part 2a|Pandemic Travel Restrictions|0|||
129661148|NCT03762681|466718448|FG001|Part 2a|Pandemic Travel Restrictions|0|||
129661149|NCT03762681|466718449|FG002|Part 2a|Pandemic Travel Restrictions|0|||
129661150|NCT03762681|466718450|FG003|Part 2a|Pandemic Travel Restrictions|0|||
129661151|NCT03762681|466718451|FG004|Part 2a|Pandemic Travel Restrictions|0|||
129661152|NCT03762681|466718452|FG005|Part 2a|Pandemic Travel Restrictions|0|||
129661153|NCT03762681|466718453|FG006|Part 2a|Pandemic Travel Restrictions|0|||
129661154|NCT03762681|466718454|FG007|Part 2a|Pandemic Travel Restrictions|1|||
129661155|NCT02137226|466718455|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
129661156|NCT02137226|466718456|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
129661157|NCT02137226|466718457|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
129661158|NCT02137226|466718458|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
129661159|NCT02137226|466718459|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
129661160|NCT02137226|466718455|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
129661161|NCT02137226|466718456|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
129661162|NCT02137226|466718457|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
129990312|NCT01047293|467927638|FG003|Overall Study|DLT criteria not fulfilled|0|||
129661163|NCT02137226|466718458|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
129990313|NCT02054520|467927639|FG000|Overall Study|Adverse Event|1|||
129990314|NCT02054520|467927640|FG001|Overall Study|Adverse Event|4|||
129661164|NCT02137226|466718459|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
129661165|NCT02137226|466718455|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
129990315|NCT02054520|467927641|FG002|Overall Study|Adverse Event|2|||
129990316|NCT02054520|467927642|FG003|Overall Study|Adverse Event|1|||
129990317|NCT02054520|467927643|FG004|Overall Study|Adverse Event|1|||
129990318|NCT02054520|467927644|FG005|Overall Study|Adverse Event|0|||
129990319|NCT02054520|467927639|FG000|Overall Study|Lack of Efficacy|7|||
129990320|NCT02054520|467927640|FG001|Overall Study|Lack of Efficacy|0|||
129990321|NCT02054520|467927641|FG002|Overall Study|Lack of Efficacy|2|||
129990322|NCT02054520|467927642|FG003|Overall Study|Lack of Efficacy|1|||
129990323|NCT02054520|467927643|FG004|Overall Study|Lack of Efficacy|3|||
129990324|NCT02054520|467927644|FG005|Overall Study|Lack of Efficacy|2|||
129990325|NCT02054520|467927639|FG000|Overall Study|Withdrawal by Subject|1|||
129990326|NCT02054520|467927640|FG001|Overall Study|Withdrawal by Subject|0|||
129990327|NCT02054520|467927641|FG002|Overall Study|Withdrawal by Subject|0|||
129990328|NCT02054520|467927642|FG003|Overall Study|Withdrawal by Subject|2|||
129990329|NCT02054520|467927643|FG004|Overall Study|Withdrawal by Subject|1|||
129990330|NCT02054520|467927644|FG005|Overall Study|Withdrawal by Subject|0|||
129990331|NCT02054520|467927639|FG000|Overall Study|Physician Decision|0|||
129990332|NCT02054520|467927640|FG001|Overall Study|Physician Decision|1|||
129990333|NCT02054520|467927641|FG002|Overall Study|Physician Decision|0|||
129990334|NCT02054520|467927642|FG003|Overall Study|Physician Decision|1|||
129990335|NCT02054520|467927643|FG004|Overall Study|Physician Decision|0|||
129990336|NCT02054520|467927644|FG005|Overall Study|Physician Decision|1|||
129990337|NCT02054520|467927639|FG000|Overall Study|Study terminated by Sponsor|0|||
129990338|NCT02054520|467927640|FG001|Overall Study|Study terminated by Sponsor|0|||
129990339|NCT02054520|467927641|FG002|Overall Study|Study terminated by Sponsor|2|||
129990340|NCT02054520|467927642|FG003|Overall Study|Study terminated by Sponsor|1|||
129990341|NCT02054520|467927643|FG004|Overall Study|Study terminated by Sponsor|0|||
129990342|NCT02054520|467927644|FG005|Overall Study|Study terminated by Sponsor|0|||
129990343|NCT01272804|467927645|FG000|Overall Study|Adverse Event|1|||
129990344|NCT01272804|467927646|FG001|Overall Study|Adverse Event|0|||
129990345|NCT01272804|467927647|FG002|Overall Study|Adverse Event|0|||
129990346|NCT01272804|467927648|FG003|Overall Study|Adverse Event|0|||
129990347|NCT01272804|467927649|FG004|Overall Study|Adverse Event|2|||
129990348|NCT01272804|467927650|FG005|Overall Study|Adverse Event|1|||
129990349|NCT02318797|467927651|FG000|Overall Study|Death|3|||
129990350|NCT02318797|467927652|FG001|Overall Study|Death|6|||
129990351|NCT02318797|467927651|FG000|Overall Study|Lost to Follow-up|85|||
129661166|NCT02137226|466718456|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
129661167|NCT02137226|466718457|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
129661168|NCT02137226|466718458|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
129661169|NCT02137226|466718459|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
129661170|NCT02137226|466718455|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
129661171|NCT02137226|466718456|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
129661172|NCT02137226|466718457|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
129661173|NCT02137226|466718458|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
129661174|NCT02137226|466718459|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
129661175|NCT02137226|466718455|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
129661176|NCT02137226|466718456|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
129661177|NCT02137226|466718457|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
129661178|NCT02137226|466718458|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
129661179|NCT02137226|466718459|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
129661180|NCT02137226|466718455|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
129661181|NCT02137226|466718456|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
129661182|NCT02137226|466718457|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
129661183|NCT02137226|466718458|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
129661184|NCT02137226|466718459|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
129661185|NCT02137226|466718455|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
129661186|NCT02137226|466718456|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
129661187|NCT02137226|466718457|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
129661188|NCT02137226|466718458|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
129661189|NCT02137226|466718459|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
129661190|NCT02137226|466718455|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
129661191|NCT02137226|466718456|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
129661192|NCT02137226|466718457|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
129661193|NCT02137226|466718458|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
129661194|NCT02137226|466718459|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
129661195|NCT02137226|466718455|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
129661196|NCT02137226|466718456|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
129661197|NCT02137226|466718457|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
129661198|NCT02137226|466718458|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
129661199|NCT02137226|466718459|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
129661200|NCT02137226|466718455|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129661201|NCT02137226|466718456|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129661202|NCT02137226|466718457|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
129990352|NCT02318797|467927652|FG001|Overall Study|Lost to Follow-up|96|||
129990353|NCT02308020|467927655|FG000|Overall Study|Lost to Follow-up|1|||
129990354|NCT02308020|467927656|FG001|Overall Study|Lost to Follow-up|7|||
129990355|NCT02308020|467927657|FG002|Overall Study|Lost to Follow-up|0|||
129990356|NCT02308020|467927658|FG003|Overall Study|Lost to Follow-up|0|||
129990357|NCT02308020|467927659|FG004|Overall Study|Lost to Follow-up|1|||
129990358|NCT02308020|467927660|FG005|Overall Study|Lost to Follow-up|2|||
129990359|NCT02308020|467927655|FG000|Overall Study|Sponsor Decision|0|||
129990360|NCT02308020|467927656|FG001|Overall Study|Sponsor Decision|8|||
129990361|NCT02308020|467927657|FG002|Overall Study|Sponsor Decision|0|||
129990362|NCT02308020|467927658|FG003|Overall Study|Sponsor Decision|2|||
129990363|NCT02308020|467927659|FG004|Overall Study|Sponsor Decision|2|||
129990364|NCT02308020|467927660|FG005|Overall Study|Sponsor Decision|1|||
129990365|NCT02308020|467927655|FG000|Overall Study|Withdrawal by Subject|3|||
129661203|NCT02137226|466718458|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129661204|NCT02137226|466718459|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
129661205|NCT02137226|466718455|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129661206|NCT02137226|466718456|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129661207|NCT02137226|466718457|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
129661208|NCT02137226|466718458|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129661209|NCT02137226|466718459|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
129661210|NCT02137226|466718455|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
129661211|NCT02137226|466718456|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
129661212|NCT02137226|466718457|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
129661213|NCT02137226|466718458|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
129661214|NCT02137226|466718459|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
129661215|NCT03148067|466718462|FG000|Overall Study|Lost to Follow-up|3|||
129661216|NCT03148067|466718462|FG000|Overall Study|Death|1|||
129661217|NCT05305989|466718467|FG000|Overall Study|Other|3|||
129661218|NCT05305989|466718468|FG001|Overall Study|Other|2|||
129661219|NCT05305989|466718469|FG002|Overall Study|Other|0|||
129661220|NCT05305989|466718467|FG000|Overall Study|Sponsor decision|2|||
129661221|NCT05305989|466718468|FG001|Overall Study|Sponsor decision|1|||
129661222|NCT05305989|466718469|FG002|Overall Study|Sponsor decision|0|||
129661223|NCT05305989|466718467|FG000|Overall Study|Protocol Violation|0|||
129661224|NCT05305989|466718468|FG001|Overall Study|Protocol Violation|1|||
129661225|NCT05305989|466718469|FG002|Overall Study|Protocol Violation|0|||
129661226|NCT05305989|466718467|FG000|Overall Study|Investigator decision|1|||
129661227|NCT05305989|466718468|FG001|Overall Study|Investigator decision|2|||
129990366|NCT02308020|467927656|FG001|Overall Study|Withdrawal by Subject|5|||
129990367|NCT02308020|467927657|FG002|Overall Study|Withdrawal by Subject|3|||
129990368|NCT02308020|467927658|FG003|Overall Study|Withdrawal by Subject|2|||
129990369|NCT02308020|467927659|FG004|Overall Study|Withdrawal by Subject|1|||
129990370|NCT02308020|467927660|FG005|Overall Study|Withdrawal by Subject|2|||
129990371|NCT03333837|467927661|FG000|Overall Study|Adverse Event|2|||
129990372|NCT03333837|467927662|FG001|Overall Study|Adverse Event|1|||
129990373|NCT03333837|467927663|FG002|Overall Study|Adverse Event|1|||
129990374|NCT03333837|467927664|FG003|Overall Study|Adverse Event|1|||
129990375|NCT03333837|467927665|FG004|Overall Study|Adverse Event|0|||
129990376|NCT03333837|467927661|FG000|Overall Study|Caregiver withdrew|0|||
129990377|NCT03333837|467927662|FG001|Overall Study|Caregiver withdrew|2|||
129990378|NCT03333837|467927663|FG002|Overall Study|Caregiver withdrew|1|||
129990379|NCT03333837|467927664|FG003|Overall Study|Caregiver withdrew|0|||
129990380|NCT03333837|467927665|FG004|Overall Study|Caregiver withdrew|0|||
129990381|NCT03333837|467927661|FG000|Overall Study|Withdrawal by Subject|0|||
129990382|NCT03333837|467927662|FG001|Overall Study|Withdrawal by Subject|0|||
129990383|NCT03333837|467927663|FG002|Overall Study|Withdrawal by Subject|1|||
129990384|NCT03333837|467927664|FG003|Overall Study|Withdrawal by Subject|1|||
129990385|NCT03333837|467927665|FG004|Overall Study|Withdrawal by Subject|3|||
129990386|NCT03333837|467927661|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990387|NCT03333837|467927662|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990388|NCT03333837|467927663|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
129990389|NCT03333837|467927664|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990390|NCT03333837|467927665|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
129990391|NCT04217590|467927666|FG000|Overall Study|Other|1|||
129990392|NCT04217590|467927667|FG001|Overall Study|Other|1|||
129990393|NCT04217590|467927666|FG000|Overall Study|Withdrawal by Subject|3|||
129990394|NCT04217590|467927667|FG001|Overall Study|Withdrawal by Subject|1|||
129990395|NCT04217590|467927666|FG000|Overall Study|Death|0|||
129990396|NCT04217590|467927667|FG001|Overall Study|Death|1|||
129661228|NCT05305989|466718469|FG002|Overall Study|Investigator decision|0|||
129990397|NCT02232243|467927668|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
129990398|NCT02232243|467927669|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
129990399|NCT02232243|467927670|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
129661229|NCT05305989|466718467|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
129661230|NCT05305989|466718468|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
129661231|NCT05305989|466718469|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
129990400|NCT00704405|467927671|FG000|Overall Study (NC Population)|Adverse Event|1|||
129990401|NCT00704405|467927672|FG001|Overall Study (NC Population)|Adverse Event|0|||
129990402|NCT00704405|467927673|FG002|Overall Study (NC Population)|Adverse Event|0|||
129990403|NCT00704405|467927674|FG003|Overall Study (NC Population)|Adverse Event|0|||
129990404|NCT00704405|467927675|FG004|Overall Study (NC Population)|Adverse Event|0|||
129990405|NCT00704405|467927671|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
129990406|NCT00704405|467927672|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
129990407|NCT00704405|467927673|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
129990408|NCT00704405|467927674|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
129990409|NCT00704405|467927675|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
129990410|NCT00704405|467927671|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990411|NCT00704405|467927672|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
129990412|NCT00704405|467927673|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990413|NCT00704405|467927674|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990414|NCT00704405|467927675|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
129990415|NCT00704405|467927671|FG000|Overall Study (NC Population)|Other|0|||
129990416|NCT00704405|467927672|FG001|Overall Study (NC Population)|Other|0|||
129990417|NCT00704405|467927673|FG002|Overall Study (NC Population)|Other|0|||
129990418|NCT00704405|467927674|FG003|Overall Study (NC Population)|Other|0|||
129990419|NCT00704405|467927675|FG004|Overall Study (NC Population)|Other|1|||
129990420|NCT00704405|467927671|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
129990421|NCT00704405|467927672|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
129990422|NCT00704405|467927673|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
129990423|NCT00704405|467927674|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
129990424|NCT00704405|467927675|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
129990425|NCT00704405|467927671|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
129990426|NCT00704405|467927672|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
129990427|NCT00704405|467927673|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
129990428|NCT00704405|467927674|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
129990429|NCT00704405|467927675|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
129990430|NCT01395888|467927676|FG000|2-week Run-in Period|Adverse Event|2|||
129990431|NCT01395888|467927677|FG001|2-week Run-in Period|Adverse Event|0|||
129990432|NCT01395888|467927678|FG002|2-week Run-in Period|Adverse Event|0|||
129990433|NCT01395888|467927676|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
129990434|NCT01395888|467927677|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
129990435|NCT01395888|467927678|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
129990436|NCT01395888|467927676|FG000|2-week Run-in Period|Lost to Follow-up|1|||
129990437|NCT01395888|467927677|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129990438|NCT01395888|467927678|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129990439|NCT01395888|467927676|FG000|2-week Run-in Period|Protocol Violation|2|||
129990440|NCT01395888|467927677|FG001|2-week Run-in Period|Protocol Violation|0|||
129990441|NCT01395888|467927678|FG002|2-week Run-in Period|Protocol Violation|0|||
129990442|NCT01395888|467927676|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
129990443|NCT01395888|467927677|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129990444|NCT01395888|467927678|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129990445|NCT01395888|467927676|FG000|Treatment Period (TP)|Adverse Event|0|||
129990446|NCT01395888|467927677|FG001|Treatment Period (TP)|Adverse Event|7|||
129990447|NCT01395888|467927678|FG002|Treatment Period (TP)|Adverse Event|6|||
129990448|NCT01395888|467927676|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
129990449|NCT01395888|467927677|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
129990450|NCT01395888|467927678|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
129990451|NCT01395888|467927676|FG000|Treatment Period (TP)|Protocol Violation|0|||
129990452|NCT01395888|467927677|FG001|Treatment Period (TP)|Protocol Violation|1|||
129990453|NCT01395888|467927678|FG002|Treatment Period (TP)|Protocol Violation|5|||
129990454|NCT01395888|467927676|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
129990455|NCT01395888|467927677|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
129990456|NCT01395888|467927678|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
129990457|NCT01395888|467927676|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
129990458|NCT01395888|467927677|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
129990459|NCT01395888|467927678|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
129546578|NCT00572910|466294058|FG010|Overall Study|Adverse Event|2|||
129546579|NCT00572910|466294048|FG000|Overall Study|Lost to Follow-up|0|||
129546580|NCT00572910|466294049|FG001|Overall Study|Lost to Follow-up|1|||
129546581|NCT00572910|466294050|FG002|Overall Study|Lost to Follow-up|1|||
129546582|NCT00572910|466294051|FG003|Overall Study|Lost to Follow-up|2|||
129546583|NCT00572910|466294052|FG004|Overall Study|Lost to Follow-up|1|||
129546584|NCT00572910|466294053|FG005|Overall Study|Lost to Follow-up|0|||
129546585|NCT00572910|466294054|FG006|Overall Study|Lost to Follow-up|0|||
129546586|NCT00572910|466294055|FG007|Overall Study|Lost to Follow-up|0|||
129546587|NCT00572910|466294056|FG008|Overall Study|Lost to Follow-up|0|||
129546588|NCT00572910|466294057|FG009|Overall Study|Lost to Follow-up|1|||
129546589|NCT00572910|466294058|FG010|Overall Study|Lost to Follow-up|0|||
129546590|NCT00572910|466294048|FG000|Overall Study|Withdrawal by Subject|3|||
129546591|NCT00572910|466294049|FG001|Overall Study|Withdrawal by Subject|0|||
129546592|NCT00572910|466294050|FG002|Overall Study|Withdrawal by Subject|1|||
129546593|NCT00572910|466294051|FG003|Overall Study|Withdrawal by Subject|0|||
129990460|NCT03218397|467927679|FG000|Overall Study|Prior positive blood culture|8|||
129990461|NCT03218397|467927680|FG001|Overall Study|Prior positive blood culture|13|||
129990462|NCT03218397|467927679|FG000|Overall Study|Comfort care|8|||
129990463|NCT03218397|467927680|FG001|Overall Study|Comfort care|5|||
129661232|NCT05305989|466718467|FG000|Overall Study|Adverse Event|1|||
129661233|NCT05305989|466718468|FG001|Overall Study|Adverse Event|1|||
129661234|NCT05305989|466718469|FG002|Overall Study|Adverse Event|0|||
129661235|NCT05305989|466718467|FG000|Overall Study|Enrolled but never dosed|3|||
129661236|NCT05305989|466718468|FG001|Overall Study|Enrolled but never dosed|2|||
129661237|NCT05305989|466718469|FG002|Overall Study|Enrolled but never dosed|1|||
129661238|NCT03162328|466718470|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
129661239|NCT03162328|466718471|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
129661240|NCT03162328|466718472|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
129661241|NCT03162328|466718470|FG000|Screening Period|Withdrawal by Subject|1|||
129661242|NCT03162328|466718471|FG001|Screening Period|Withdrawal by Subject|0|||
129990464|NCT03218397|467927679|FG000|Overall Study|Comfort care and positive blood culture|1|||
129990465|NCT03218397|467927680|FG001|Overall Study|Comfort care and positive blood culture|0|||
129990466|NCT03218397|467927679|FG000|Overall Study|Comfort care and mixed culture|0|||
129990467|NCT03218397|467927680|FG001|Overall Study|Comfort care and mixed culture|1|||
129990468|NCT03218397|467927679|FG000|Overall Study|Mixed culture|2|||
129990469|NCT03218397|467927680|FG001|Overall Study|Mixed culture|2|||
129990470|NCT03218397|467927679|FG000|Overall Study|Inaccessible hospital records|2|||
129990471|NCT03218397|467927680|FG001|Overall Study|Inaccessible hospital records|5|||
129990472|NCT03218397|467927679|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
129990473|NCT03218397|467927680|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
129990474|NCT03218397|467927679|FG000|Overall Study|Randomized during laboratory off hours|2|||
129990475|NCT03218397|467927680|FG001|Overall Study|Randomized during laboratory off hours|1|||
129990476|NCT01946438|467927681|FG000|Overall Study|Adverse Event|0|||
129990477|NCT01946438|467927682|FG001|Overall Study|Adverse Event|0|||
129990478|NCT01946438|467927683|FG002|Overall Study|Adverse Event|0|||
129990479|NCT01946438|467927684|FG003|Overall Study|Adverse Event|1|||
129990480|NCT01946438|467927681|FG000|Overall Study|Serious Adverse event|1|||
129990481|NCT01946438|467927682|FG001|Overall Study|Serious Adverse event|0|||
129990482|NCT01946438|467927683|FG002|Overall Study|Serious Adverse event|0|||
129661243|NCT03162328|466718472|FG002|Screening Period|Withdrawal by Subject|0|||
129661244|NCT03162328|466718470|FG000|Study Period|Withdrawal by Subject|0|||
129661245|NCT03162328|466718471|FG001|Study Period|Withdrawal by Subject|0|||
129661246|NCT03162328|466718472|FG002|Study Period|Withdrawal by Subject|1|||
129661247|NCT00492232|466718473|FG000|Placebo Run-in|Adverse Event|0|||
129661248|NCT00492232|466718474|FG001|Placebo Run-in|Adverse Event|2|||
129661249|NCT00492232|466718473|FG000|Placebo Run-in|Protocol Violation|0|||
129661250|NCT00492232|466718474|FG001|Placebo Run-in|Protocol Violation|3|||
129661251|NCT00492232|466718473|FG000|Placebo Run-in|Lost to Follow-up|0|||
129661252|NCT00492232|466718474|FG001|Placebo Run-in|Lost to Follow-up|3|||
129661253|NCT00492232|466718473|FG000|Placebo Run-in|Withdrawal by Subject|0|||
129661254|NCT00492232|466718474|FG001|Placebo Run-in|Withdrawal by Subject|8|||
129661255|NCT00492232|466718473|FG000|Placebo Run-in|Pregnancy|0|||
129661256|NCT00492232|466718474|FG001|Placebo Run-in|Pregnancy|1|||
129661257|NCT00492232|466718473|FG000|Placebo Run-in|Entrance criteria not met|0|||
129661258|NCT00492232|466718474|FG001|Placebo Run-in|Entrance criteria not met|45|||
129661259|NCT00492232|466718473|FG000|Placebo Run-in|Other|0|||
129661260|NCT00492232|466718474|FG001|Placebo Run-in|Other|6|||
129661261|NCT00492232|466718473|FG000|Placebo Run-in|Missing|0|||
129661262|NCT00492232|466718474|FG001|Placebo Run-in|Missing|2|||
129661263|NCT00492232|466718473|FG000|Double-Blind Treatment|Adverse Event|1|||
129661264|NCT00492232|466718474|FG001|Double-Blind Treatment|Adverse Event|2|||
129661265|NCT00492232|466718473|FG000|Double-Blind Treatment|Protocol Violation|3|||
129661266|NCT00492232|466718474|FG001|Double-Blind Treatment|Protocol Violation|7|||
129661267|NCT00492232|466718473|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
129661268|NCT00492232|466718474|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
129661269|NCT00492232|466718473|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
129661270|NCT00492232|466718474|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
129661271|NCT00492232|466718473|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
129661272|NCT00492232|466718474|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
129661273|NCT00492232|466718473|FG000|Double-Blind Treatment|Other|6|||
129661274|NCT00492232|466718474|FG001|Double-Blind Treatment|Other|5|||
129661275|NCT00492232|466718473|FG000|Double-Blind Treatment|Randomized not treated|1|||
129661276|NCT00492232|466718474|FG001|Double-Blind Treatment|Randomized not treated|0|||
129661277|NCT00492232|466718473|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
129661278|NCT00492232|466718474|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129661279|NCT01216332|466718475|FG000|Overall Study|Withdrawal by Subject|4|||
129661280|NCT01216332|466718476|FG001|Overall Study|Withdrawal by Subject|0|||
129990483|NCT01946438|467927684|FG003|Overall Study|Serious Adverse event|0|||
129990484|NCT01946438|467927681|FG000|Overall Study|Protocol Violation|0|||
129990485|NCT01946438|467927682|FG001|Overall Study|Protocol Violation|0|||
129990486|NCT01946438|467927683|FG002|Overall Study|Protocol Violation|1|||
129990487|NCT01946438|467927684|FG003|Overall Study|Protocol Violation|0|||
129990488|NCT01946438|467927681|FG000|Overall Study|Withdrawal by Subject|1|||
129990489|NCT01946438|467927682|FG001|Overall Study|Withdrawal by Subject|0|||
129990490|NCT01946438|467927683|FG002|Overall Study|Withdrawal by Subject|0|||
129990491|NCT01946438|467927684|FG003|Overall Study|Withdrawal by Subject|0|||
129990492|NCT03169101|467927685|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
129990493|NCT03169101|467927686|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
129990494|NCT03169101|467927687|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
129990495|NCT03169101|467927688|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
129990496|NCT02641496|467927689|FG000|Overall Study|Lost to Follow-up|13|||
129990497|NCT02641496|467927690|FG001|Overall Study|Lost to Follow-up|12|||
129990498|NCT02641496|467927689|FG000|Overall Study|Withdrawal by Subject|1|||
129990499|NCT02641496|467927690|FG001|Overall Study|Withdrawal by Subject|0|||
129990500|NCT02523599|467927691|FG000|Overall Study|Adverse Event|1|||
129990501|NCT02523599|467927692|FG001|Overall Study|Adverse Event|0|||
129990502|NCT02523599|467927691|FG000|Overall Study|Physician Decision|1|||
129990503|NCT02523599|467927692|FG001|Overall Study|Physician Decision|0|||
129990504|NCT02523599|467927691|FG000|Overall Study|Lost to Follow-up|4|||
129990505|NCT02523599|467927692|FG001|Overall Study|Lost to Follow-up|1|||
129990506|NCT02523599|467927691|FG000|Overall Study|Did not return for Day 30 visit|2|||
129990507|NCT02523599|467927692|FG001|Overall Study|Did not return for Day 30 visit|0|||
129990508|NCT00346268|467929749|FG000|Overall Study|Adverse Event|1|||
129990509|NCT00346268|467929750|FG001|Overall Study|Adverse Event|0|||
129990510|NCT00346268|467929749|FG000|Overall Study|Protocol Violation|1|||
129990511|NCT00346268|467929750|FG001|Overall Study|Protocol Violation|0|||
129990512|NCT00346268|467929749|FG000|Overall Study|Participant refused|0|||
129990513|NCT00346268|467929750|FG001|Overall Study|Participant refused|3|||
129990514|NCT01036763|467929751|FG000|Overall Study|Adverse Event|25|||
129990515|NCT01036763|467929751|FG000|Overall Study|Lost to Follow-up|28|||
129990516|NCT01036763|467929751|FG000|Overall Study|Other reason (not specified)|40|||
129990517|NCT00743275|467929752|FG000|Overall Study|Protocol Violation|0|||
129990518|NCT00743275|467929753|FG001|Overall Study|Protocol Violation|1|||
129990519|NCT01672723|467929754|FG000|First Intervention|Adverse Event|3|||
129990520|NCT01672723|467929755|FG001|First Intervention|Adverse Event|0|||
129990521|NCT02502097|467929765|FG000|Period 1|Adverse Event|0|||
129990522|NCT02502097|467929766|FG001|Period 1|Adverse Event|0|||
129990523|NCT02502097|467929767|FG002|Period 1|Adverse Event|1|||
129661281|NCT00636636|466718477|FG000|Overall Study|Other reason|4|||
129661282|NCT00636636|466718478|FG001|Overall Study|Other reason|6|||
129661283|NCT00636636|466718477|FG000|Overall Study|Adverse Event|19|||
129661284|NCT00636636|466718478|FG001|Overall Study|Adverse Event|8|||
129661285|NCT00636636|466718477|FG000|Overall Study|Lack of Efficacy|7|||
129661286|NCT00636636|466718478|FG001|Overall Study|Lack of Efficacy|12|||
129661287|NCT00636636|466718477|FG000|Overall Study|Protocol Violation|2|||
129661288|NCT00636636|466718478|FG001|Overall Study|Protocol Violation|2|||
129661289|NCT00636636|466718477|FG000|Overall Study|Lost to Follow-up|0|||
129661290|NCT00636636|466718478|FG001|Overall Study|Lost to Follow-up|1|||
129661291|NCT00636636|466718477|FG000|Overall Study|Death|0|||
129661292|NCT00636636|466718478|FG001|Overall Study|Death|1|||
129661293|NCT00636636|466718477|FG000|Overall Study|Withdrawal by Subject|4|||
129661294|NCT00636636|466718478|FG001|Overall Study|Withdrawal by Subject|9|||
129661295|NCT00524173|466718479|FG000|Overall Study|Lost to Follow-up|0|||
129661296|NCT00524173|466718480|FG001|Overall Study|Lost to Follow-up|1|||
129661297|NCT00524173|466718479|FG000|Overall Study|Death|1|||
129661298|NCT00524173|466718480|FG001|Overall Study|Death|0|||
129661299|NCT00524173|466718479|FG000|Overall Study|Had not reached endpoint at study close|4|||
129661300|NCT00524173|466718480|FG001|Overall Study|Had not reached endpoint at study close|1|||
129661301|NCT01025284|466719973|FG000|Overall Study|Investigator Decision|0|||
129661302|NCT01025284|466719974|FG001|Overall Study|Investigator Decision|1|||
129661303|NCT01025284|466719975|FG002|Overall Study|Investigator Decision|0|||
129990524|NCT02502097|467929768|FG003|Period 1|Adverse Event|0|||
129661304|NCT01025284|466719973|FG000|Overall Study|Withdrawal by Subject|0|||
129661305|NCT01025284|466719974|FG001|Overall Study|Withdrawal by Subject|1|||
129990525|NCT02502097|467929765|FG000|Wash Out Period|Adverse Event|0|||
129990526|NCT02502097|467929766|FG001|Wash Out Period|Adverse Event|1|||
129990527|NCT02502097|467929767|FG002|Wash Out Period|Adverse Event|1|||
129990528|NCT02502097|467929768|FG003|Wash Out Period|Adverse Event|1|||
129990529|NCT02502097|467929765|FG000|Period 2|Adverse Event|0|||
129661306|NCT01025284|466719975|FG002|Overall Study|Withdrawal by Subject|0|||
129661307|NCT00905567|466719977|FG000|Washout|Withdrawal by Subject|0|||
129990530|NCT02502097|467929766|FG001|Period 2|Adverse Event|0|||
129990531|NCT02502097|467929767|FG002|Period 2|Adverse Event|1|||
129990532|NCT02502097|467929768|FG003|Period 2|Adverse Event|0|||
129990533|NCT02186223|467929769|FG000|Overall Study|Not eligible for device placement|6|||
129990534|NCT02186223|467929769|FG000|Overall Study|Unable to obtain femoral access|3|||
129661308|NCT00905567|466719978|FG001|Washout|Withdrawal by Subject|1|||
129661309|NCT01465230|466719979|FG000|Overall Study|Withdrawal by Subject|2|||
129990535|NCT02186223|467929769|FG000|Overall Study|Death|3|||
129990536|NCT02186223|467929769|FG000|Overall Study|Device in place less than 48 hours|9|||
129661310|NCT02753816|466719980|FG000|Overall Study|Protocol Violation|0|||
129661311|NCT02753816|466719981|FG001|Overall Study|Protocol Violation|1|||
129661312|NCT02753816|466719982|FG002|Overall Study|Protocol Violation|0|||
129661313|NCT02542397|466719983|FG000|Overall Study|Death|2|||
129661314|NCT02542397|466719983|FG000|Overall Study|Physician Decision|6|||
129661315|NCT02542397|466719983|FG000|Overall Study|Withdrawal by Subject|6|||
129661316|NCT02542397|466719983|FG000|Overall Study|Lost to Follow-up|2|||
129990537|NCT01201317|467929770|FG000|Overall Study|Withdrawal by Subject|5|||
129990538|NCT01201317|467929771|FG001|Overall Study|Withdrawal by Subject|0|||
129990539|NCT01201317|467929772|FG002|Overall Study|Withdrawal by Subject|3|||
129990540|NCT01201317|467929770|FG000|Overall Study|Adverse Event|2|||
129990541|NCT01201317|467929771|FG001|Overall Study|Adverse Event|2|||
129990542|NCT01201317|467929772|FG002|Overall Study|Adverse Event|2|||
129990543|NCT01201317|467929770|FG000|Overall Study|Screen failure|1|||
129990544|NCT01201317|467929771|FG001|Overall Study|Screen failure|1|||
129990545|NCT01201317|467929772|FG002|Overall Study|Screen failure|0|||
129990546|NCT01201317|467929770|FG000|Overall Study|Protocol Violation|0|||
129990547|NCT01201317|467929771|FG001|Overall Study|Protocol Violation|1|||
129990548|NCT01201317|467929772|FG002|Overall Study|Protocol Violation|1|||
129990549|NCT01201317|467929770|FG000|Overall Study|Death|0|||
129990550|NCT01201317|467929771|FG001|Overall Study|Death|1|||
129990551|NCT01201317|467929772|FG002|Overall Study|Death|0|||
129990552|NCT01201317|467929770|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129990553|NCT01201317|467929771|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129990554|NCT01201317|467929772|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129990555|NCT01201317|467929770|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
129990556|NCT01201317|467929771|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
129990557|NCT01201317|467929772|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
129990558|NCT01201317|467929770|FG000|Overall Study|Decrease in renal function|0|||
129990559|NCT01201317|467929771|FG001|Overall Study|Decrease in renal function|1|||
129990560|NCT01201317|467929772|FG002|Overall Study|Decrease in renal function|0|||
129990561|NCT01201317|467929770|FG000|Overall Study|Lack of Efficacy|1|||
129990562|NCT01201317|467929771|FG001|Overall Study|Lack of Efficacy|0|||
129990563|NCT01201317|467929772|FG002|Overall Study|Lack of Efficacy|0|||
129990564|NCT01201317|467929770|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
129990565|NCT01201317|467929771|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
129990566|NCT01201317|467929772|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
129990567|NCT00252733|467929773|FG000|Overall Study|Withdrawal by Subject|73|||
129990568|NCT00252733|467929774|FG001|Overall Study|Withdrawal by Subject|67|||
129990569|NCT00252733|467929773|FG000|Overall Study|Death|7|||
129990570|NCT00252733|467929774|FG001|Overall Study|Death|5|||
129990571|NCT00252733|467929773|FG000|Overall Study|Lost to Follow-up|12|||
129990572|NCT00252733|467929774|FG001|Overall Study|Lost to Follow-up|6|||
129990573|NCT00252733|467929773|FG000|Overall Study|Multiple Reasons|14|||
129990574|NCT00252733|467929774|FG001|Overall Study|Multiple Reasons|14|||
129990575|NCT01491672|467929775|FG000|Overall Study|Lost to Follow-up|0|||
129990576|NCT01491672|467929776|FG001|Overall Study|Lost to Follow-up|4|||
129990577|NCT01491672|467929777|FG002|Overall Study|Lost to Follow-up|1|||
129990578|NCT01491672|467929775|FG000|Overall Study|Withdrawal by Subject|6|||
129990579|NCT01491672|467929776|FG001|Overall Study|Withdrawal by Subject|7|||
129990580|NCT01491672|467929777|FG002|Overall Study|Withdrawal by Subject|0|||
129990581|NCT01491672|467929775|FG000|Overall Study|Adverse Event|8|||
129990582|NCT01491672|467929776|FG001|Overall Study|Adverse Event|10|||
129990583|NCT01491672|467929777|FG002|Overall Study|Adverse Event|4|||
129990584|NCT01491672|467929775|FG000|Overall Study|Disease progression|42|||
129990585|NCT01491672|467929776|FG001|Overall Study|Disease progression|34|||
129990586|NCT01491672|467929777|FG002|Overall Study|Disease progression|6|||
129990587|NCT01491672|467929775|FG000|Overall Study|Protocol deviation|0|||
129990588|NCT01491672|467929776|FG001|Overall Study|Protocol deviation|1|||
129990589|NCT01491672|467929777|FG002|Overall Study|Protocol deviation|0|||
129990590|NCT01491672|467929775|FG000|Overall Study|Death|0|||
129661317|NCT01738919|466719990|FG000|Overall Study|Lost to Follow-up|1|||
129661318|NCT01738919|466719991|FG001|Overall Study|Lost to Follow-up|0|||
129661319|NCT01738919|466719990|FG000|Overall Study|Immigrated|0|||
129990591|NCT01491672|467929776|FG001|Overall Study|Death|4|||
129990592|NCT01491672|467929777|FG002|Overall Study|Death|0|||
129661320|NCT01738919|466719991|FG001|Overall Study|Immigrated|1|||
129990593|NCT03310268|467929781|FG000|Overall Study|(Not specified)|1|||
129990594|NCT03310268|467929782|FG001|Overall Study|(Not specified)|5|||
129990595|NCT03310268|467929783|FG002|Overall Study|(Not specified)|0|||
129661321|NCT01738919|466719990|FG000|Overall Study|Withdrawal by Subject|0|||
129661322|NCT01738919|466719991|FG001|Overall Study|Withdrawal by Subject|1|||
129990596|NCT00706433|467929786|FG000|Overall Study|Lost to Follow-up|3|||
129661323|NCT01738919|466719990|FG000|Overall Study|Not treated in accordance to guidelines|0|||
129661324|NCT01738919|466719991|FG001|Overall Study|Not treated in accordance to guidelines|1|||
129990597|NCT00706433|467929787|FG001|Overall Study|Lost to Follow-up|1|||
129990598|NCT00706433|467929788|FG002|Overall Study|Lost to Follow-up|6|||
129990599|NCT00706433|467929789|FG003|Overall Study|Lost to Follow-up|0|||
129661325|NCT01473940|466719995|FG000|Induction Therapy|Death|0|||
129661326|NCT01473940|466719996|FG001|Induction Therapy|Death|0|||
129661327|NCT01473940|466719997|FG002|Induction Therapy|Death|1|||
129661328|NCT01473940|466719998|FG003|Induction Therapy|Death|1|||
129661329|NCT01473940|466719995|FG000|Induction Therapy|Progressive Disease|0|||
129661330|NCT01473940|466719996|FG001|Induction Therapy|Progressive Disease|1|||
129661331|NCT01473940|466719997|FG002|Induction Therapy|Progressive Disease|1|||
129661332|NCT01473940|466719998|FG003|Induction Therapy|Progressive Disease|0|||
129661333|NCT01473940|466719995|FG000|Maintenance Therapy|Progressive Disease|1|||
129661334|NCT01473940|466719996|FG001|Maintenance Therapy|Progressive Disease|2|||
129661335|NCT01473940|466719997|FG002|Maintenance Therapy|Progressive Disease|1|||
129661336|NCT01473940|466719998|FG003|Maintenance Therapy|Progressive Disease|4|||
129661337|NCT00547248|466719999|FG000|Overall Study|Protocol Violation|0|||
129661338|NCT00547248|466720000|FG001|Overall Study|Protocol Violation|0|||
129661339|NCT00547248|466720001|FG002|Overall Study|Protocol Violation|1|||
129661340|NCT00547248|466720002|FG003|Overall Study|Protocol Violation|1|||
129661341|NCT00547248|466719999|FG000|Overall Study|Migrated/moved from study area|0|||
129661342|NCT00547248|466720000|FG001|Overall Study|Migrated/moved from study area|0|||
129661343|NCT00547248|466720001|FG002|Overall Study|Migrated/moved from study area|2|||
129661344|NCT00547248|466720002|FG003|Overall Study|Migrated/moved from study area|0|||
129661345|NCT00547248|466719999|FG000|Overall Study|Withdrawal by Subject|0|||
129661346|NCT00547248|466720000|FG001|Overall Study|Withdrawal by Subject|0|||
129661347|NCT00547248|466720001|FG002|Overall Study|Withdrawal by Subject|7|||
129661348|NCT00547248|466720002|FG003|Overall Study|Withdrawal by Subject|1|||
129661349|NCT00534248|466720003|FG000|Overall Study|Adverse Event|19|||
129661350|NCT00534248|466720004|FG001|Overall Study|Adverse Event|29|||
129661351|NCT00534248|466720003|FG000|Overall Study|Lost to Follow-up|353|||
129661352|NCT00534248|466720004|FG001|Overall Study|Lost to Follow-up|375|||
129990600|NCT00706433|467929786|FG000|Overall Study|Withdrawal by Subject|1|||
129990601|NCT00706433|467929787|FG001|Overall Study|Withdrawal by Subject|2|||
129990602|NCT00706433|467929788|FG002|Overall Study|Withdrawal by Subject|3|||
129990603|NCT00706433|467929789|FG003|Overall Study|Withdrawal by Subject|1|||
129990604|NCT00706433|467929786|FG000|Overall Study|Adverse Event|0|||
129990605|NCT00706433|467929787|FG001|Overall Study|Adverse Event|0|||
129990606|NCT00706433|467929788|FG002|Overall Study|Adverse Event|1|||
129990607|NCT00706433|467929789|FG003|Overall Study|Adverse Event|0|||
129990608|NCT00706433|467929786|FG000|Overall Study|Protocol Violation|1|||
129990609|NCT00706433|467929787|FG001|Overall Study|Protocol Violation|0|||
129990610|NCT00706433|467929788|FG002|Overall Study|Protocol Violation|0|||
129990611|NCT00706433|467929789|FG003|Overall Study|Protocol Violation|0|||
129990612|NCT00706433|467929786|FG000|Overall Study|new job|0|||
129990613|NCT00706433|467929787|FG001|Overall Study|new job|0|||
129990614|NCT00706433|467929788|FG002|Overall Study|new job|0|||
129990615|NCT00706433|467929789|FG003|Overall Study|new job|1|||
129990616|NCT01236365|467929790|FG000|Overall Study|Lost to Follow-up|0|||
129990617|NCT01236365|467929791|FG001|Overall Study|Lost to Follow-up|2|||
129990618|NCT01236365|467929790|FG000|Overall Study|Moved Out of State|1|||
129990619|NCT01236365|467929791|FG001|Overall Study|Moved Out of State|0|||
129990620|NCT01236365|467929790|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
129990621|NCT01236365|467929791|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
129990622|NCT00717067|467929792|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990623|NCT00717067|467929793|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990624|NCT00717067|467929794|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
129990625|NCT00717067|467929795|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990626|NCT00717067|467929796|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
129990627|NCT02808143|467929797|FG000|Maintenance Phase|Disease recurrence|1|||
129990628|NCT02808143|467929798|FG001|Maintenance Phase|Disease recurrence|3|||
129661353|NCT00534248|466720003|FG000|Overall Study|Other protocol specified criteria|13|||
129661354|NCT00534248|466720004|FG001|Overall Study|Other protocol specified criteria|3|||
129661355|NCT00534248|466720003|FG000|Overall Study|Physician Decision|10|||
129661356|NCT00534248|466720004|FG001|Overall Study|Physician Decision|7|||
129661357|NCT00534248|466720003|FG000|Overall Study|Protocol Violation|3|||
129990629|NCT02808143|467929797|FG000|Maintenance Phase|Disease progression|1|||
129661358|NCT00534248|466720004|FG001|Overall Study|Protocol Violation|4|||
129661359|NCT00534248|466720003|FG000|Overall Study|Withdrawal by Subject|263|||
129990630|NCT02808143|467929798|FG001|Maintenance Phase|Disease progression|2|||
129661360|NCT00534248|466720004|FG001|Overall Study|Withdrawal by Subject|255|||
129661361|NCT02532257|466720007|FG000|Overall Study|Adverse Event|2|||
129661362|NCT02532257|466720007|FG000|Overall Study|Physician Decision|4|||
129661363|NCT02532257|466720007|FG000|Overall Study|Withdrawal by Subject|3|||
129661364|NCT02532257|466720007|FG000|Overall Study|Progressive Disease|10|||
129661365|NCT02849171|466720008|FG000|Overall Study|Withdrawal by Subject|1|||
129661366|NCT02849171|466720008|FG000|Overall Study|Not treated|1|||
129661367|NCT02259400|466720011|FG000|Overall Study|Death|0|||
129661368|NCT02259400|466720012|FG001|Overall Study|Death|2|||
129661369|NCT00697593|466720016|FG000|Overall Study|Adverse Event|3|||
129661370|NCT00697593|466720016|FG000|Overall Study|Protocol Violation|1|||
129661371|NCT00697593|466720016|FG000|Overall Study|Lack of Efficacy|3|||
129661372|NCT00697593|466720016|FG000|Overall Study|Suspension of the study by sponsor|12|||
129661373|NCT02964338|466720017|FG000|Overall Study|Sponsor terminated study for futility|12|||
129661374|NCT02964338|466720018|FG001|Overall Study|Sponsor terminated study for futility|15|||
129661375|NCT02964338|466720019|FG002|Overall Study|Sponsor terminated study for futility|14|||
129661376|NCT02964338|466720017|FG000|Overall Study|Lack of Efficacy|0|||
129661377|NCT02964338|466720018|FG001|Overall Study|Lack of Efficacy|3|||
129661378|NCT02964338|466720019|FG002|Overall Study|Lack of Efficacy|0|||
129661379|NCT02964338|466720017|FG000|Overall Study|Lost to Follow-up|1|||
129661380|NCT02964338|466720018|FG001|Overall Study|Lost to Follow-up|0|||
129661381|NCT02964338|466720019|FG002|Overall Study|Lost to Follow-up|3|||
129661382|NCT02964338|466720017|FG000|Overall Study|Protocol Violation|0|||
129661383|NCT02964338|466720018|FG001|Overall Study|Protocol Violation|1|||
129661384|NCT02964338|466720019|FG002|Overall Study|Protocol Violation|0|||
129661385|NCT02964338|466720017|FG000|Overall Study|Withdrawal by Subject|1|||
129661386|NCT02964338|466720018|FG001|Overall Study|Withdrawal by Subject|3|||
129661387|NCT02964338|466720019|FG002|Overall Study|Withdrawal by Subject|1|||
129661388|NCT02964338|466720017|FG000|Overall Study|Adverse Event|2|||
129661389|NCT02964338|466720018|FG001|Overall Study|Adverse Event|1|||
129661390|NCT02964338|466720019|FG002|Overall Study|Adverse Event|1|||
129661391|NCT02964338|466720017|FG000|Overall Study|Non-compliant with e-diary|0|||
129661392|NCT02964338|466720018|FG001|Overall Study|Non-compliant with e-diary|1|||
129661393|NCT02964338|466720019|FG002|Overall Study|Non-compliant with e-diary|0|||
129661394|NCT02964338|466720017|FG000|Overall Study|Did not meet criteria|1|||
129661395|NCT02964338|466720018|FG001|Overall Study|Did not meet criteria|0|||
129661396|NCT02964338|466720019|FG002|Overall Study|Did not meet criteria|0|||
129661397|NCT02372383|466720023|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
129661398|NCT02372383|466720024|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
129661399|NCT02372383|466720025|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
129661400|NCT02630563|466720028|FG000|Overall Study|Administrative|1|||
129661401|NCT02239640|466720029|FG000|Overall Study|Withdrawal by Subject|3|||
129661402|NCT02239640|466720029|FG000|Overall Study|Lost to Follow-up|72|||
129661403|NCT02239640|466720029|FG000|Overall Study|Death|142|||
129661404|NCT00621257|466720030|FG000|Overall Study|Lost to Follow-up|4|||
129661405|NCT00621257|466720031|FG001|Overall Study|Lost to Follow-up|0|||
129661406|NCT00621257|466720032|FG002|Overall Study|Lost to Follow-up|2|||
129661407|NCT00621257|466720033|FG003|Overall Study|Lost to Follow-up|4|||
129661408|NCT00621257|466720034|FG004|Overall Study|Lost to Follow-up|7|||
129661409|NCT00621257|466720030|FG000|Overall Study|Adverse Event|0|||
129661410|NCT00621257|466720031|FG001|Overall Study|Adverse Event|1|||
129661411|NCT00621257|466720032|FG002|Overall Study|Adverse Event|1|||
129661412|NCT00621257|466720033|FG003|Overall Study|Adverse Event|0|||
129661413|NCT00621257|466720034|FG004|Overall Study|Adverse Event|0|||
129661414|NCT00621257|466720030|FG000|Overall Study|Physician Decision|0|||
129661415|NCT00621257|466720031|FG001|Overall Study|Physician Decision|2|||
129661416|NCT00621257|466720032|FG002|Overall Study|Physician Decision|0|||
129661417|NCT00621257|466720033|FG003|Overall Study|Physician Decision|1|||
129661418|NCT00621257|466720034|FG004|Overall Study|Physician Decision|1|||
129661419|NCT00621257|466720030|FG000|Overall Study|Withdrawal by Subject|0|||
129661420|NCT00621257|466720031|FG001|Overall Study|Withdrawal by Subject|0|||
129661421|NCT00621257|466720032|FG002|Overall Study|Withdrawal by Subject|0|||
129661422|NCT00621257|466720033|FG003|Overall Study|Withdrawal by Subject|1|||
129661423|NCT00621257|466720034|FG004|Overall Study|Withdrawal by Subject|1|||
129661424|NCT01255904|466720037|FG000|Overall Study|Physician Decision|1|||
129661425|NCT01255904|466720038|FG001|Overall Study|Physician Decision|4|||
129661426|NCT02061813|466720040|FG000|Overall Study|Withdrawal by Subject|1|||
129661427|NCT02061813|466720040|FG000|Overall Study|Protocol Violation|2|||
129661428|NCT01705080|466720043|FG000|Overall Study|Missed visit|10|||
129661429|NCT01705080|466720044|FG001|Overall Study|Missed visit|4|||
129661430|NCT01705080|466720045|FG002|Overall Study|Missed visit|1|||
129661431|NCT01705080|466720043|FG000|Overall Study|Death|4|||
129661432|NCT01705080|466720044|FG001|Overall Study|Death|4|||
129661433|NCT01705080|466720045|FG002|Overall Study|Death|6|||
129661434|NCT01705080|466720043|FG000|Overall Study|Withdrawal by Subject|61|||
129661435|NCT01705080|466720044|FG001|Overall Study|Withdrawal by Subject|44|||
129661436|NCT01705080|466720045|FG002|Overall Study|Withdrawal by Subject|9|||
129661437|NCT00206427|466720047|FG000|Overall Study|Adverse Event|2|||
129990631|NCT02808143|467929797|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
129990632|NCT02808143|467929798|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
129990633|NCT02808143|467929797|FG000|Survival Follow-Up|Disease recurrence|0|||
129990634|NCT02808143|467929798|FG001|Survival Follow-Up|Disease recurrence|2|||
129990635|NCT02808143|467929797|FG000|Survival Follow-Up|Adverse Event|0|||
129990636|NCT02808143|467929798|FG001|Survival Follow-Up|Adverse Event|1|||
129990637|NCT02808143|467929797|FG000|Survival Follow-Up|Death|1|||
129990638|NCT02808143|467929798|FG001|Survival Follow-Up|Death|0|||
129990639|NCT04964388|467929799|FG000|Overall Study|Lost to Follow-up|3|||
129990640|NCT04964388|467929800|FG001|Overall Study|Lost to Follow-up|2|||
129990641|NCT01689337|467929801|FG000|Overall Study|Study Discontinuation|1|||
129990642|NCT02208999|467929807|FG000|Overall Study|Lost to Follow-up|1|||
129990643|NCT00319839|467929808|FG000|Overall Study|Adverse Event|5|||
129990644|NCT00319839|467929808|FG000|Overall Study|Withdrawal by Subject|1|||
129990645|NCT01577745|467929809|FG000|Overall Study|Withdrawal by Subject|0|||
129990646|NCT01577745|467929810|FG001|Overall Study|Withdrawal by Subject|1|||
129990647|NCT01577745|467929811|FG002|Overall Study|Withdrawal by Subject|0|||
129990648|NCT01577745|467929812|FG003|Overall Study|Withdrawal by Subject|3|||
129990649|NCT01577745|467929813|FG004|Overall Study|Withdrawal by Subject|2|||
129990650|NCT01577745|467929814|FG005|Overall Study|Withdrawal by Subject|0|||
129990651|NCT01577745|467929809|FG000|Overall Study|Death|3|||
129990652|NCT01577745|467929810|FG001|Overall Study|Death|2|||
129990653|NCT01577745|467929811|FG002|Overall Study|Death|2|||
129990654|NCT01577745|467929812|FG003|Overall Study|Death|1|||
129990655|NCT01577745|467929813|FG004|Overall Study|Death|1|||
129990656|NCT01577745|467929814|FG005|Overall Study|Death|3|||
129990657|NCT01577745|467929809|FG000|Overall Study|Physician Decision|0|||
129990658|NCT01577745|467929810|FG001|Overall Study|Physician Decision|0|||
129990659|NCT01577745|467929811|FG002|Overall Study|Physician Decision|0|||
129990660|NCT01577745|467929812|FG003|Overall Study|Physician Decision|1|||
129990661|NCT01577745|467929813|FG004|Overall Study|Physician Decision|1|||
129990662|NCT01577745|467929814|FG005|Overall Study|Physician Decision|0|||
129990663|NCT01577745|467929809|FG000|Overall Study|Lost to Follow-up|0|||
129990664|NCT01577745|467929810|FG001|Overall Study|Lost to Follow-up|0|||
129990665|NCT01577745|467929811|FG002|Overall Study|Lost to Follow-up|0|||
129990666|NCT01577745|467929812|FG003|Overall Study|Lost to Follow-up|0|||
129990667|NCT01577745|467929813|FG004|Overall Study|Lost to Follow-up|0|||
129990668|NCT01577745|467929814|FG005|Overall Study|Lost to Follow-up|1|||
129990669|NCT01577745|467929809|FG000|Overall Study|Alternative Therapy|0|||
129990670|NCT01577745|467929810|FG001|Overall Study|Alternative Therapy|0|||
129990671|NCT01577745|467929811|FG002|Overall Study|Alternative Therapy|0|||
129990672|NCT01577745|467929812|FG003|Overall Study|Alternative Therapy|1|||
129990673|NCT01577745|467929813|FG004|Overall Study|Alternative Therapy|1|||
129990674|NCT01577745|467929814|FG005|Overall Study|Alternative Therapy|0|||
129990675|NCT02483585|467929815|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
129990676|NCT02483585|467929816|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
129990677|NCT02483585|467929815|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
129990678|NCT02483585|467929816|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
129990679|NCT02483585|467929815|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
129990680|NCT02483585|467929816|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
129990681|NCT02483585|467929815|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
129990682|NCT02483585|467929816|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
129990683|NCT02483585|467929815|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
129990684|NCT02483585|467929816|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
129990685|NCT02483585|467929815|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
129990686|NCT02483585|467929816|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
129990687|NCT02483585|467929815|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
129990688|NCT02483585|467929816|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
129990689|NCT00825916|467929818|FG000|Overall Study|Lost to Follow-up|4|||
129990690|NCT00825916|467929819|FG001|Overall Study|Lost to Follow-up|2|||
129990691|NCT00825916|467929820|FG002|Overall Study|Lost to Follow-up|1|||
129990692|NCT01324440|467929824|FG000|Overall Study|Subject moved|0|||
129990693|NCT01324440|467929825|FG001|Overall Study|Subject moved|1|||
129990694|NCT00903630|467929826|FG000|Phase 2|Adverse Event|0|||
129990695|NCT00903630|467929827|FG001|Phase 2|Adverse Event|0|||
129990696|NCT00903630|467929828|FG002|Phase 2|Adverse Event|1|||
129990697|NCT01136772|467929831|FG000|Overall Study|Adverse Event|15|||
129990698|NCT01136772|467929832|FG001|Overall Study|Adverse Event|14|||
129990699|NCT01136772|467929831|FG000|Overall Study|Lack of Efficacy|42|||
129990700|NCT01136772|467929832|FG001|Overall Study|Lack of Efficacy|39|||
129990701|NCT01136772|467929831|FG000|Overall Study|Administrative|14|||
129990702|NCT01136772|467929832|FG001|Overall Study|Administrative|12|||
129990703|NCT01136772|467929831|FG000|Overall Study|Withdrawal by Subject|33|||
129990704|NCT01136772|467929832|FG001|Overall Study|Withdrawal by Subject|36|||
129990705|NCT01136772|467929831|FG000|Overall Study|Did not receive injection|10|||
129990706|NCT01136772|467929832|FG001|Overall Study|Did not receive injection|7|||
129990707|NCT01136772|467929831|FG000|Overall Study|Did not follow up after first injection|2|||
129990708|NCT01136772|467929832|FG001|Overall Study|Did not follow up after first injection|2|||
129990709|NCT01602562|467929833|FG000|Overall Study|Adverse Event|3|||
129990710|NCT01602562|467929834|FG001|Overall Study|Adverse Event|1|||
129661438|NCT00741598|466720048|FG000|Overall Study|Lost to Follow-up|3|||
129661439|NCT00741598|466720049|FG001|Overall Study|Lost to Follow-up|4|||
129661440|NCT00741598|466720048|FG000|Overall Study|Lack of Efficacy|1|||
129990711|NCT01602562|467929833|FG000|Overall Study|Physician Decision|1|||
129990712|NCT01602562|467929834|FG001|Overall Study|Physician Decision|1|||
129661441|NCT00741598|466720049|FG001|Overall Study|Lack of Efficacy|2|||
129661442|NCT00741598|466720048|FG000|Overall Study|Physician Decision|1|||
129661443|NCT00741598|466720049|FG001|Overall Study|Physician Decision|1|||
129661444|NCT00741598|466720048|FG000|Overall Study|Pregnancy|1|||
129661445|NCT00741598|466720049|FG001|Overall Study|Pregnancy|0|||
129661446|NCT00741598|466720048|FG000|Overall Study|Withdrawal by Subject|3|||
129661447|NCT00741598|466720049|FG001|Overall Study|Withdrawal by Subject|2|||
129661448|NCT00003896|466720060|FG000|Overall Study|Adverse Event|16|||
129661449|NCT00003896|466720060|FG000|Overall Study|Withdrawal by Subject|1|||
129661450|NCT00003896|466720060|FG000|Overall Study|Lack of Efficacy|1|||
129661451|NCT00003896|466720060|FG000|Overall Study|Death|3|||
129661452|NCT00003896|466720060|FG000|Overall Study|not protocol specified|3|||
129661453|NCT00003896|466720060|FG000|Overall Study|ineligible|5|||
129661454|NCT01398358|466720061|FG000|Overall Study|Lost to Follow-up|11|||
129661455|NCT01398358|466720062|FG001|Overall Study|Lost to Follow-up|21|||
129661456|NCT01398358|466720063|FG002|Overall Study|Lost to Follow-up|18|||
129661457|NCT01398358|466720061|FG000|Overall Study|Withdrawal by Subject|3|||
129661458|NCT01398358|466720062|FG001|Overall Study|Withdrawal by Subject|2|||
129661459|NCT01398358|466720063|FG002|Overall Study|Withdrawal by Subject|2|||
129661460|NCT01398358|466720061|FG000|Overall Study|no longer eligible|1|||
129661461|NCT01398358|466720062|FG001|Overall Study|no longer eligible|0|||
129661462|NCT01398358|466720063|FG002|Overall Study|no longer eligible|1|||
129661463|NCT00985686|466720065|FG000|Overall Study|Lost to Follow-up|1|||
129661464|NCT00985686|466720066|FG001|Overall Study|Lost to Follow-up|1|||
129661465|NCT00985686|466720067|FG002|Overall Study|Lost to Follow-up|0|||
129661466|NCT00985686|466720068|FG003|Overall Study|Lost to Follow-up|2|||
129661467|NCT01670045|466720069|FG000|Overall Study|Withdrawal by Subject|3|||
129661468|NCT01670045|466720069|FG000|Overall Study|Adverse Event|1|||
129661469|NCT01670045|466720069|FG000|Overall Study|Death|1|||
129661470|NCT01670045|466720069|FG000|Overall Study|Lost to Follow-up|11|||
129661471|NCT02559570|466720071|FG000|Overall Study|Adverse Event|0|||
129661472|NCT02559570|466720072|FG001|Overall Study|Adverse Event|2|||
129661473|NCT02559570|466720073|FG002|Overall Study|Adverse Event|0|||
129661474|NCT02559570|466720074|FG003|Overall Study|Adverse Event|1|||
129661475|NCT02559570|466720075|FG004|Overall Study|Adverse Event|0|||
129661476|NCT02559570|466720071|FG000|Overall Study|Withdrawal of Consent|0|||
129661477|NCT02559570|466720072|FG001|Overall Study|Withdrawal of Consent|0|||
129661478|NCT02559570|466720073|FG002|Overall Study|Withdrawal of Consent|1|||
129661479|NCT02559570|466720074|FG003|Overall Study|Withdrawal of Consent|2|||
129661480|NCT02559570|466720075|FG004|Overall Study|Withdrawal of Consent|1|||
129661481|NCT02559570|466720071|FG000|Overall Study|Lost to Follow-up|1|||
129661482|NCT02559570|466720072|FG001|Overall Study|Lost to Follow-up|0|||
129661483|NCT02559570|466720073|FG002|Overall Study|Lost to Follow-up|0|||
129661484|NCT02559570|466720074|FG003|Overall Study|Lost to Follow-up|0|||
129661485|NCT02559570|466720075|FG004|Overall Study|Lost to Follow-up|0|||
129661486|NCT02559570|466720071|FG000|Overall Study|Protocol Violation|1|||
129661487|NCT02559570|466720072|FG001|Overall Study|Protocol Violation|0|||
129661488|NCT02559570|466720073|FG002|Overall Study|Protocol Violation|0|||
129661489|NCT02559570|466720074|FG003|Overall Study|Protocol Violation|0|||
129661490|NCT02559570|466720075|FG004|Overall Study|Protocol Violation|1|||
129661491|NCT02559570|466720071|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129661492|NCT02559570|466720072|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129661493|NCT02559570|466720073|FG002|Overall Study|Other Miscellaneous Reasons|1|||
129661494|NCT02559570|466720074|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129990713|NCT01602562|467929833|FG000|Overall Study|Withdrawal by Subject|1|||
129661495|NCT02559570|466720075|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129661496|NCT00420628|466720079|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
129990714|NCT01602562|467929834|FG001|Overall Study|Withdrawal by Subject|1|||
129661497|NCT00420628|466720080|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
129990715|NCT01959516|467929835|FG000|Epoch 1|Adverse Event|4|||
129990716|NCT01959516|467929836|FG001|Epoch 1|Adverse Event|1|||
129661498|NCT00420628|466720079|FG000|Overall Study|Lost to Follow-up|3|||
129661499|NCT00420628|466720080|FG001|Overall Study|Lost to Follow-up|2|||
129661500|NCT00420628|466720079|FG000|Overall Study|Adverse Event|1|||
129661501|NCT00420628|466720080|FG001|Overall Study|Adverse Event|0|||
129661502|NCT00396383|466720087|FG000|Overall Study|Death|2|||
129661503|NCT00396383|466720087|FG000|Overall Study|Lost to Follow-up|1|||
129661504|NCT00282152|466720088|FG000|Overall Study|Withdrawal by Subject|1|||
129661505|NCT00282152|466720089|FG001|Overall Study|Withdrawal by Subject|0|||
129661506|NCT00585325|466720090|FG000|Overall Study|Withdrawal by Subject|1|||
129661507|NCT00585325|466720091|FG001|Overall Study|Withdrawal by Subject|1|||
129661508|NCT03301831|466720092|FG000|Overall Study|Lost to Follow-up|5|||
129990717|NCT01959516|467929835|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
129661509|NCT03301831|466720093|FG001|Overall Study|Lost to Follow-up|3|||
129990718|NCT01959516|467929836|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
129990719|NCT01959516|467929835|FG000|Epoch 1|Subject withdrew consent|3|||
129990720|NCT01959516|467929836|FG001|Epoch 1|Subject withdrew consent|2|||
129990721|NCT01959516|467929835|FG000|Epoch 1|Administrative problems|1|||
129990722|NCT01959516|467929836|FG001|Epoch 1|Administrative problems|0|||
129990723|NCT01959516|467929835|FG000|Epoch 1|Use of prohibited treatment|1|||
129990724|NCT01959516|467929836|FG001|Epoch 1|Use of prohibited treatment|0|||
129990725|NCT01959516|467929835|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
129990726|NCT01959516|467929836|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
129661510|NCT03301831|466720092|FG000|Overall Study|Protocol Violation|4|||
129661511|NCT03301831|466720093|FG001|Overall Study|Protocol Violation|0|||
129661512|NCT03301831|466720092|FG000|Overall Study|Withdrawal by Subject|11|||
129661513|NCT03301831|466720093|FG001|Overall Study|Withdrawal by Subject|0|||
129661514|NCT03092791|466720094|FG000|Overall Study|Lost to Follow-up|0|||
129661515|NCT03092791|466720095|FG001|Overall Study|Lost to Follow-up|0|||
129661516|NCT03092791|466720096|FG002|Overall Study|Lost to Follow-up|0|||
129661517|NCT03092791|466720097|FG003|Overall Study|Lost to Follow-up|0|||
129661518|NCT03092791|466720098|FG004|Overall Study|Lost to Follow-up|0|||
129661519|NCT03092791|466720099|FG005|Overall Study|Lost to Follow-up|0|||
129661520|NCT03092791|466720100|FG006|Overall Study|Lost to Follow-up|1|||
129661521|NCT03092791|466720101|FG007|Overall Study|Lost to Follow-up|0|||
129661522|NCT03092791|466720094|FG000|Overall Study|Withdrawal of Consent|0|||
129661523|NCT03092791|466720095|FG001|Overall Study|Withdrawal of Consent|0|||
129661524|NCT03092791|466720096|FG002|Overall Study|Withdrawal of Consent|0|||
129661525|NCT03092791|466720097|FG003|Overall Study|Withdrawal of Consent|0|||
129661526|NCT03092791|466720098|FG004|Overall Study|Withdrawal of Consent|4|||
129661527|NCT03092791|466720099|FG005|Overall Study|Withdrawal of Consent|12|||
129661528|NCT03092791|466720100|FG006|Overall Study|Withdrawal of Consent|6|||
129661529|NCT03092791|466720101|FG007|Overall Study|Withdrawal of Consent|4|||
129661530|NCT03092791|466720094|FG000|Overall Study|Study Termination|0|||
129661531|NCT03092791|466720095|FG001|Overall Study|Study Termination|0|||
129661532|NCT03092791|466720096|FG002|Overall Study|Study Termination|0|||
129661533|NCT03092791|466720097|FG003|Overall Study|Study Termination|0|||
129661534|NCT03092791|466720098|FG004|Overall Study|Study Termination|55|||
129661535|NCT03092791|466720099|FG005|Overall Study|Study Termination|46|||
129661536|NCT03092791|466720100|FG006|Overall Study|Study Termination|53|||
129661537|NCT03092791|466720101|FG007|Overall Study|Study Termination|55|||
129661538|NCT03092791|466720094|FG000|Overall Study|Death|0|||
129661539|NCT03092791|466720095|FG001|Overall Study|Death|0|||
129661540|NCT03092791|466720096|FG002|Overall Study|Death|0|||
129661541|NCT03092791|466720097|FG003|Overall Study|Death|0|||
129661542|NCT03092791|466720098|FG004|Overall Study|Death|0|||
129661543|NCT03092791|466720099|FG005|Overall Study|Death|1|||
129661544|NCT03092791|466720100|FG006|Overall Study|Death|0|||
129661545|NCT03092791|466720101|FG007|Overall Study|Death|1|||
129661546|NCT03092791|466720094|FG000|Overall Study|Reason Not Specified|0|||
129661547|NCT03092791|466720095|FG001|Overall Study|Reason Not Specified|0|||
129661548|NCT03092791|466720096|FG002|Overall Study|Reason Not Specified|0|||
129661549|NCT03092791|466720097|FG003|Overall Study|Reason Not Specified|0|||
129661550|NCT03092791|466720098|FG004|Overall Study|Reason Not Specified|1|||
129661551|NCT03092791|466720099|FG005|Overall Study|Reason Not Specified|1|||
129661552|NCT03092791|466720100|FG006|Overall Study|Reason Not Specified|0|||
129661553|NCT03092791|466720101|FG007|Overall Study|Reason Not Specified|0|||
129661554|NCT00792116|466720103|FG000|Overall Study|Lost to Follow-up|0|||
129661555|NCT00792116|466720104|FG001|Overall Study|Lost to Follow-up|1|||
129661556|NCT00792116|466720103|FG000|Overall Study|Discontnued intervention|1|||
129661557|NCT00792116|466720104|FG001|Overall Study|Discontnued intervention|0|||
129661558|NCT00980655|466720105|FG000|Overall Study|Adverse Event|13|||
129661559|NCT00980655|466720106|FG001|Overall Study|Adverse Event|31|||
129661560|NCT00980655|466720105|FG000|Overall Study|Death|0|||
129990727|NCT01959516|467929835|FG000|Epoch 1|Protocol deviation|0|||
129990728|NCT01959516|467929836|FG001|Epoch 1|Protocol deviation|1|||
129661561|NCT00980655|466720106|FG001|Overall Study|Death|7|||
129661562|NCT00980655|466720105|FG000|Overall Study|Protocol Violation|2|||
129661563|NCT00980655|466720106|FG001|Overall Study|Protocol Violation|7|||
129990729|NCT01959516|467929835|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
129661564|NCT00980655|466720105|FG000|Overall Study|Withdrawal by Subject|0|||
129661565|NCT00980655|466720106|FG001|Overall Study|Withdrawal by Subject|4|||
129661566|NCT00980655|466720105|FG000|Overall Study|Lost to Follow-up|0|||
129990730|NCT01959516|467929836|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
129661567|NCT00980655|466720106|FG001|Overall Study|Lost to Follow-up|1|||
129661568|NCT00980655|466720105|FG000|Overall Study|Parent/legal guardian request|1|||
129661569|NCT00980655|466720106|FG001|Overall Study|Parent/legal guardian request|0|||
129661570|NCT00980655|466720105|FG000|Overall Study|Other|0|||
129661571|NCT00980655|466720106|FG001|Overall Study|Other|1|||
129661572|NCT00845676|466720112|FG000|Overall Study|Virologic breakthrough at week 20|1|||
129661573|NCT00845676|466720112|FG000|Overall Study|Adverse Event|1|||
129661574|NCT00481767|466720114|FG000|Overall Study|Withdrawal by Subject|16|||
129990731|NCT01959516|467929835|FG000|Epoch 2|Subject withdrew consent|1|||
129990732|NCT01959516|467929836|FG001|Epoch 2|Subject withdrew consent|0|||
129990733|NCT01959516|467929835|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
129990734|NCT01959516|467929836|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
129990735|NCT01477333|467929837|FG000|Overall Study|Adverse Event|1|||
129990736|NCT01477333|467929837|FG000|Overall Study|Withdrawal by Subject|1|||
129990737|NCT01477333|467929837|FG000|Overall Study|Clinical Deterioration|1|||
129990738|NCT00928746|467929838|FG000|Overall Study|Adverse Event|2|||
129990739|NCT00928746|467929838|FG000|Overall Study|Protocol Violation|1|||
129990740|NCT00928746|467929838|FG000|Overall Study|Withdrawal by Subject|1|||
129990741|NCT00928746|467929838|FG000|Overall Study|Other|2|||
129990742|NCT02004353|467929844|FG000|Overall Study|Voluntary participation|1334|||
129990743|NCT02581631|467929845|FG000|Overall Study|Disease progression|29|||
129990744|NCT02581631|467929846|FG001|Overall Study|Disease progression|19|||
129990745|NCT02581631|467929847|FG002|Overall Study|Disease progression|13|||
129990746|NCT02581631|467929848|FG003|Overall Study|Disease progression|5|||
129661575|NCT00481767|466720115|FG001|Overall Study|Withdrawal by Subject|11|||
129661576|NCT00481767|466720114|FG000|Overall Study|Lost to Follow-up|16|||
129661577|NCT00481767|466720115|FG001|Overall Study|Lost to Follow-up|10|||
129661578|NCT01941537|466720116|FG000|Overall Study|Lack of Efficacy|1|||
129661579|NCT01941537|466720117|FG001|Overall Study|Lack of Efficacy|2|||
129661580|NCT01941537|466720116|FG000|Overall Study|Lost to Follow-up|1|||
129661581|NCT01941537|466720117|FG001|Overall Study|Lost to Follow-up|0|||
129661582|NCT01941537|466720116|FG000|Overall Study|Pregnancy|1|||
129661583|NCT01941537|466720117|FG001|Overall Study|Pregnancy|0|||
129661584|NCT01941537|466720116|FG000|Overall Study|Adverse Event|1|||
129661585|NCT01941537|466720117|FG001|Overall Study|Adverse Event|0|||
129661586|NCT01941537|466720116|FG000|Overall Study|Withdrawal by Subject|0|||
129661587|NCT01941537|466720117|FG001|Overall Study|Withdrawal by Subject|1|||
129661588|NCT02557516|466720119|FG000|Overall Study|Adverse Event|1|||
129661589|NCT02557516|466720120|FG001|Overall Study|Adverse Event|0|||
129661590|NCT02557516|466720121|FG002|Overall Study|Adverse Event|2|||
129661591|NCT02557516|466720122|FG003|Overall Study|Adverse Event|1|||
129661592|NCT02557516|466720119|FG000|Overall Study|Disease progression|0|||
129661593|NCT02557516|466720120|FG001|Overall Study|Disease progression|2|||
129661594|NCT02557516|466720121|FG002|Overall Study|Disease progression|0|||
129661595|NCT02557516|466720122|FG003|Overall Study|Disease progression|0|||
129661596|NCT02557516|466720119|FG000|Overall Study|Physician Decision|0|||
129661597|NCT02557516|466720120|FG001|Overall Study|Physician Decision|2|||
129661598|NCT02557516|466720121|FG002|Overall Study|Physician Decision|0|||
129661599|NCT02557516|466720122|FG003|Overall Study|Physician Decision|0|||
129661600|NCT02557516|466720119|FG000|Overall Study|Sponsor decision|0|||
129661601|NCT02557516|466720120|FG001|Overall Study|Sponsor decision|1|||
129661602|NCT02557516|466720121|FG002|Overall Study|Sponsor decision|2|||
129661603|NCT02557516|466720122|FG003|Overall Study|Sponsor decision|8|||
129661604|NCT00632125|466722270|FG000|Overall Study|Death|82|||
129661605|NCT00632125|466722270|FG000|Overall Study|Withdrawal by Subject|44|||
129661606|NCT00632125|466722270|FG000|Overall Study|Adverse Event|36|||
129661607|NCT00632125|466722270|FG000|Overall Study|Renal transplantation|17|||
129661608|NCT00632125|466722270|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
129661609|NCT00632125|466722270|FG000|Overall Study|Non-compliance|8|||
129661610|NCT00632125|466722270|FG000|Overall Study|Development of uncontrolled hypertension|5|||
129661611|NCT00632125|466722270|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
129661612|NCT03130959|466722283|FG000|Overall Study|Disease progression|19|||
129661613|NCT03130959|466722284|FG001|Overall Study|Disease progression|7|||
129661614|NCT03130959|466722285|FG002|Overall Study|Disease progression|12|||
129661615|NCT03130959|466722286|FG003|Overall Study|Disease progression|7|||
129661616|NCT03130959|466722287|FG004|Overall Study|Disease progression|12|||
129661617|NCT03130959|466722288|FG005|Overall Study|Disease progression|3|||
129661618|NCT03130959|466722289|FG006|Overall Study|Disease progression|6|||
129661619|NCT03130959|466722290|FG007|Overall Study|Disease progression|3|||
129661620|NCT03130959|466722291|FG008|Overall Study|Disease progression|15|||
129990747|NCT02581631|467929849|FG004|Overall Study|Disease progression|8|||
129990748|NCT02581631|467929845|FG000|Overall Study|Study drug toxicity|4|||
129990749|NCT02581631|467929846|FG001|Overall Study|Study drug toxicity|6|||
129990750|NCT02581631|467929847|FG002|Overall Study|Study drug toxicity|7|||
129990751|NCT02581631|467929848|FG003|Overall Study|Study drug toxicity|0|||
129990752|NCT02581631|467929849|FG004|Overall Study|Study drug toxicity|3|||
129990753|NCT02581631|467929845|FG000|Overall Study|AE unrelated to study drug|3|||
129661621|NCT03130959|466722292|FG009|Overall Study|Disease progression|8|||
129661622|NCT03130959|466722283|FG000|Overall Study|Study drug toxicity|2|||
129661623|NCT03130959|466722284|FG001|Overall Study|Study drug toxicity|2|||
129661624|NCT03130959|466722285|FG002|Overall Study|Study drug toxicity|1|||
129661625|NCT03130959|466722286|FG003|Overall Study|Study drug toxicity|2|||
129661626|NCT03130959|466722287|FG004|Overall Study|Study drug toxicity|1|||
129661627|NCT03130959|466722288|FG005|Overall Study|Study drug toxicity|1|||
129661628|NCT03130959|466722289|FG006|Overall Study|Study drug toxicity|3|||
129990754|NCT02581631|467929846|FG001|Overall Study|AE unrelated to study drug|1|||
129990755|NCT02581631|467929847|FG002|Overall Study|AE unrelated to study drug|1|||
129990756|NCT02581631|467929848|FG003|Overall Study|AE unrelated to study drug|0|||
129990757|NCT02581631|467929849|FG004|Overall Study|AE unrelated to study drug|2|||
129990758|NCT02581631|467929845|FG000|Overall Study|Request to discontinue|1|||
129990759|NCT02581631|467929846|FG001|Overall Study|Request to discontinue|0|||
129990760|NCT02581631|467929847|FG002|Overall Study|Request to discontinue|3|||
129990761|NCT02581631|467929848|FG003|Overall Study|Request to discontinue|0|||
129990762|NCT02581631|467929849|FG004|Overall Study|Request to discontinue|1|||
129661629|NCT03130959|466722290|FG007|Overall Study|Study drug toxicity|0|||
129661630|NCT03130959|466722291|FG008|Overall Study|Study drug toxicity|3|||
129661631|NCT03130959|466722292|FG009|Overall Study|Study drug toxicity|3|||
129661632|NCT03130959|466722283|FG000|Overall Study|Other reasons|0|||
129661633|NCT03130959|466722284|FG001|Overall Study|Other reasons|0|||
129661634|NCT03130959|466722285|FG002|Overall Study|Other reasons|0|||
129661635|NCT03130959|466722286|FG003|Overall Study|Other reasons|0|||
129990763|NCT02581631|467929845|FG000|Overall Study|participant withdrew consent|3|||
129661636|NCT03130959|466722287|FG004|Overall Study|Other reasons|0|||
129661637|NCT03130959|466722288|FG005|Overall Study|Other reasons|1|||
129661638|NCT03130959|466722289|FG006|Overall Study|Other reasons|1|||
129661639|NCT03130959|466722290|FG007|Overall Study|Other reasons|0|||
129661640|NCT03130959|466722291|FG008|Overall Study|Other reasons|0|||
129661641|NCT03130959|466722292|FG009|Overall Study|Other reasons|0|||
129661642|NCT03130959|466722283|FG000|Overall Study|Subject request to discontinue therapy|0|||
129661643|NCT03130959|466722284|FG001|Overall Study|Subject request to discontinue therapy|0|||
129661644|NCT03130959|466722285|FG002|Overall Study|Subject request to discontinue therapy|1|||
129661645|NCT03130959|466722286|FG003|Overall Study|Subject request to discontinue therapy|1|||
129661646|NCT03130959|466722287|FG004|Overall Study|Subject request to discontinue therapy|0|||
129661647|NCT03130959|466722288|FG005|Overall Study|Subject request to discontinue therapy|0|||
129990764|NCT02581631|467929846|FG001|Overall Study|participant withdrew consent|0|||
129661648|NCT03130959|466722289|FG006|Overall Study|Subject request to discontinue therapy|1|||
129661649|NCT03130959|466722290|FG007|Overall Study|Subject request to discontinue therapy|1|||
129661650|NCT03130959|466722291|FG008|Overall Study|Subject request to discontinue therapy|0|||
129661651|NCT03130959|466722292|FG009|Overall Study|Subject request to discontinue therapy|0|||
129661652|NCT03130959|466722283|FG000|Overall Study|Not reported|0|||
129661653|NCT03130959|466722284|FG001|Overall Study|Not reported|0|||
129661654|NCT03130959|466722285|FG002|Overall Study|Not reported|0|||
129661655|NCT03130959|466722286|FG003|Overall Study|Not reported|1|||
129661656|NCT03130959|466722287|FG004|Overall Study|Not reported|0|||
129661657|NCT03130959|466722288|FG005|Overall Study|Not reported|1|||
129661658|NCT03130959|466722289|FG006|Overall Study|Not reported|0|||
129661659|NCT03130959|466722290|FG007|Overall Study|Not reported|0|||
129661660|NCT03130959|466722291|FG008|Overall Study|Not reported|0|||
129661661|NCT03130959|466722292|FG009|Overall Study|Not reported|1|||
129661662|NCT03130959|466722283|FG000|Overall Study|Adverse Event unrelated to drug|0|||
129661663|NCT03130959|466722284|FG001|Overall Study|Adverse Event unrelated to drug|0|||
129661664|NCT03130959|466722285|FG002|Overall Study|Adverse Event unrelated to drug|1|||
129661665|NCT03130959|466722286|FG003|Overall Study|Adverse Event unrelated to drug|1|||
129661666|NCT03130959|466722287|FG004|Overall Study|Adverse Event unrelated to drug|1|||
129661667|NCT03130959|466722288|FG005|Overall Study|Adverse Event unrelated to drug|0|||
129661668|NCT03130959|466722289|FG006|Overall Study|Adverse Event unrelated to drug|1|||
129661669|NCT03130959|466722290|FG007|Overall Study|Adverse Event unrelated to drug|0|||
129661670|NCT03130959|466722291|FG008|Overall Study|Adverse Event unrelated to drug|1|||
129661671|NCT03130959|466722292|FG009|Overall Study|Adverse Event unrelated to drug|1|||
129661672|NCT03130959|466722283|FG000|Overall Study|Participant withdrew consent|0|||
129661673|NCT03130959|466722284|FG001|Overall Study|Participant withdrew consent|1|||
129661674|NCT03130959|466722285|FG002|Overall Study|Participant withdrew consent|0|||
129990765|NCT02581631|467929847|FG002|Overall Study|participant withdrew consent|1|||
129990766|NCT02581631|467929848|FG003|Overall Study|participant withdrew consent|0|||
129990767|NCT02581631|467929849|FG004|Overall Study|participant withdrew consent|0|||
129990768|NCT02581631|467929845|FG000|Overall Study|Maximum clinical benefit|1|||
129990769|NCT02581631|467929846|FG001|Overall Study|Maximum clinical benefit|7|||
129990770|NCT02581631|467929847|FG002|Overall Study|Maximum clinical benefit|1|||
129990771|NCT02581631|467929848|FG003|Overall Study|Maximum clinical benefit|3|||
129990772|NCT02581631|467929849|FG004|Overall Study|Maximum clinical benefit|13|||
129990773|NCT02581631|467929845|FG000|Overall Study|Other Reasons|1|||
129990774|NCT02581631|467929846|FG001|Overall Study|Other Reasons|0|||
129661675|NCT03130959|466722286|FG003|Overall Study|Participant withdrew consent|2|||
129661676|NCT03130959|466722287|FG004|Overall Study|Participant withdrew consent|1|||
129661677|NCT03130959|466722288|FG005|Overall Study|Participant withdrew consent|0|||
129661678|NCT03130959|466722289|FG006|Overall Study|Participant withdrew consent|0|||
129661679|NCT03130959|466722290|FG007|Overall Study|Participant withdrew consent|0|||
129661680|NCT03130959|466722291|FG008|Overall Study|Participant withdrew consent|0|||
129661681|NCT03130959|466722292|FG009|Overall Study|Participant withdrew consent|2|||
129661682|NCT03130959|466722283|FG000|Overall Study|Administrative reason by sponsor|1|||
129661683|NCT03130959|466722284|FG001|Overall Study|Administrative reason by sponsor|0|||
129990775|NCT02581631|467929847|FG002|Overall Study|Other Reasons|2|||
129990776|NCT02581631|467929848|FG003|Overall Study|Other Reasons|2|||
129661684|NCT03130959|466722285|FG002|Overall Study|Administrative reason by sponsor|1|||
129661685|NCT03130959|466722286|FG003|Overall Study|Administrative reason by sponsor|0|||
129661686|NCT03130959|466722287|FG004|Overall Study|Administrative reason by sponsor|0|||
129661687|NCT03130959|466722288|FG005|Overall Study|Administrative reason by sponsor|0|||
129661688|NCT03130959|466722289|FG006|Overall Study|Administrative reason by sponsor|0|||
129661689|NCT03130959|466722290|FG007|Overall Study|Administrative reason by sponsor|0|||
129661690|NCT03130959|466722291|FG008|Overall Study|Administrative reason by sponsor|0|||
129661691|NCT03130959|466722292|FG009|Overall Study|Administrative reason by sponsor|0|||
129661692|NCT03130959|466722283|FG000|Overall Study|Lost to Follow-up|1|||
129661693|NCT03130959|466722284|FG001|Overall Study|Lost to Follow-up|0|||
129661694|NCT03130959|466722285|FG002|Overall Study|Lost to Follow-up|0|||
129661695|NCT03130959|466722286|FG003|Overall Study|Lost to Follow-up|0|||
129661696|NCT03130959|466722287|FG004|Overall Study|Lost to Follow-up|0|||
129661697|NCT03130959|466722288|FG005|Overall Study|Lost to Follow-up|0|||
129661698|NCT03130959|466722289|FG006|Overall Study|Lost to Follow-up|0|||
129661699|NCT03130959|466722290|FG007|Overall Study|Lost to Follow-up|0|||
129661700|NCT03130959|466722291|FG008|Overall Study|Lost to Follow-up|0|||
129661701|NCT03130959|466722292|FG009|Overall Study|Lost to Follow-up|0|||
129661702|NCT02384538|466722293|FG000|Overall Study|Adverse Event|1|||
129661703|NCT02384538|466722294|FG001|Overall Study|Adverse Event|4|||
129661704|NCT02384538|466722293|FG000|Overall Study|Lack of Efficacy|4|||
129661705|NCT02384538|466722294|FG001|Overall Study|Lack of Efficacy|4|||
129661706|NCT02384538|466722293|FG000|Overall Study|Withdrew Consent|0|||
129661707|NCT02384538|466722294|FG001|Overall Study|Withdrew Consent|4|||
129661708|NCT02384538|466722293|FG000|Overall Study|Other|1|||
129661709|NCT02384538|466722294|FG001|Overall Study|Other|3|||
129661710|NCT00313586|466722297|FG000|Overall Study|Disease progression|14|||
129661711|NCT00313586|466722298|FG001|Overall Study|Disease progression|19|||
129661712|NCT00313586|466722299|FG002|Overall Study|Disease progression|10|||
129661713|NCT00313586|466722300|FG003|Overall Study|Disease progression|3|||
129661714|NCT00313586|466722297|FG000|Overall Study|Adverse Event|12|||
129661715|NCT00313586|466722298|FG001|Overall Study|Adverse Event|18|||
129661716|NCT00313586|466722299|FG002|Overall Study|Adverse Event|3|||
129661717|NCT00313586|466722300|FG003|Overall Study|Adverse Event|10|||
129661718|NCT00313586|466722297|FG000|Overall Study|Death|11|||
129661719|NCT00313586|466722298|FG001|Overall Study|Death|8|||
129661720|NCT00313586|466722299|FG002|Overall Study|Death|1|||
129661721|NCT00313586|466722300|FG003|Overall Study|Death|7|||
129661722|NCT00313586|466722297|FG000|Overall Study|Withdrawal by Subject|13|||
129990777|NCT02581631|467929849|FG004|Overall Study|Other Reasons|3|||
129990778|NCT02581631|467929845|FG000|Overall Study|Poor/Non-Compliance|0|||
129990779|NCT02581631|467929846|FG001|Overall Study|Poor/Non-Compliance|0|||
129990780|NCT02581631|467929847|FG002|Overall Study|Poor/Non-Compliance|1|||
129661723|NCT00313586|466722298|FG001|Overall Study|Withdrawal by Subject|6|||
129661724|NCT00313586|466722299|FG002|Overall Study|Withdrawal by Subject|6|||
129661725|NCT00313586|466722300|FG003|Overall Study|Withdrawal by Subject|2|||
129661726|NCT00313586|466722297|FG000|Overall Study|Alternative therapy|3|||
129661727|NCT00313586|466722298|FG001|Overall Study|Alternative therapy|6|||
129661728|NCT00313586|466722299|FG002|Overall Study|Alternative therapy|2|||
129661729|NCT00313586|466722300|FG003|Overall Study|Alternative therapy|0|||
129661730|NCT00313586|466722297|FG000|Overall Study|Other complicating disease|2|||
129661731|NCT00313586|466722298|FG001|Overall Study|Other complicating disease|2|||
129990781|NCT02581631|467929848|FG003|Overall Study|Poor/Non-Compliance|0|||
129990782|NCT02581631|467929849|FG004|Overall Study|Poor/Non-Compliance|0|||
129990783|NCT00819390|467929850|FG000|Overall Study|Lost to Follow-up|1|||
129990784|NCT00819390|467929851|FG001|Overall Study|Lost to Follow-up|1|||
129990785|NCT00819390|467929852|FG002|Overall Study|Lost to Follow-up|0|||
129990786|NCT00819390|467929853|FG003|Overall Study|Lost to Follow-up|0|||
129990787|NCT00819390|467929850|FG000|Overall Study|Withdrawal by Subject|2|||
129990788|NCT00819390|467929851|FG001|Overall Study|Withdrawal by Subject|0|||
129990789|NCT00819390|467929852|FG002|Overall Study|Withdrawal by Subject|0|||
129661732|NCT00313586|466722299|FG002|Overall Study|Other complicating disease|0|||
129661733|NCT00313586|466722300|FG003|Overall Study|Other complicating disease|0|||
129661734|NCT00313586|466722297|FG000|Overall Study|Did not achieve HI-major/better response|10|||
129661735|NCT00313586|466722298|FG001|Overall Study|Did not achieve HI-major/better response|7|||
129661736|NCT00313586|466722299|FG002|Overall Study|Did not achieve HI-major/better response|2|||
129661737|NCT00313586|466722300|FG003|Overall Study|Did not achieve HI-major/better response|1|||
129661738|NCT00313586|466722297|FG000|Overall Study|Physician Decision|2|||
129661739|NCT00313586|466722298|FG001|Overall Study|Physician Decision|1|||
129661740|NCT00313586|466722299|FG002|Overall Study|Physician Decision|0|||
129661741|NCT00313586|466722300|FG003|Overall Study|Physician Decision|0|||
129661742|NCT00313586|466722297|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
129661743|NCT00313586|466722298|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
129661744|NCT00313586|466722299|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
129990790|NCT00819390|467929853|FG003|Overall Study|Withdrawal by Subject|0|||
129990791|NCT00819390|467929850|FG000|Overall Study|Adverse Event|0|||
129990792|NCT00819390|467929851|FG001|Overall Study|Adverse Event|0|||
129661745|NCT00313586|466722300|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
129661746|NCT00313586|466722297|FG000|Overall Study|Lost insurance|0|||
129661747|NCT00313586|466722298|FG001|Overall Study|Lost insurance|1|||
129661748|NCT00313586|466722299|FG002|Overall Study|Lost insurance|0|||
129661749|NCT00313586|466722300|FG003|Overall Study|Lost insurance|0|||
129661750|NCT00313586|466722297|FG000|Overall Study|Moved|0|||
129661751|NCT00313586|466722298|FG001|Overall Study|Moved|1|||
129661752|NCT00313586|466722299|FG002|Overall Study|Moved|0|||
129661753|NCT00313586|466722300|FG003|Overall Study|Moved|0|||
129661754|NCT00313586|466722297|FG000|Overall Study|Death before starting treatment|1|||
129661755|NCT00313586|466722298|FG001|Overall Study|Death before starting treatment|0|||
129661756|NCT00313586|466722299|FG002|Overall Study|Death before starting treatment|0|||
129661757|NCT00313586|466722300|FG003|Overall Study|Death before starting treatment|0|||
129661758|NCT03076996|466722301|FG000|Overall Study|Withdrawal by Subject|2|||
129661759|NCT03076996|466722301|FG000|Overall Study|Lost to Follow-up|3|||
129661760|NCT03076996|466722301|FG000|Overall Study|Literacy precluded participation|1|||
129661761|NCT03117361|466722303|FG000|Overall Study|Progressive disease|5|||
129661762|NCT03117361|466722303|FG000|Overall Study|Death|1|||
129661763|NCT03117361|466722303|FG000|Overall Study|Physician Decision|2|||
129661764|NCT03117361|466722303|FG000|Overall Study|On study treatment at the end of study|1|||
129661765|NCT03117361|466722303|FG000|Overall Study|Treatment-related adverse event|1|||
129661766|NCT00540644|466722307|FG000|Overall Study|Adverse Event|3|||
129661767|NCT00540644|466722308|FG001|Overall Study|Adverse Event|1|||
129990793|NCT00819390|467929852|FG002|Overall Study|Adverse Event|1|||
129990794|NCT00819390|467929853|FG003|Overall Study|Adverse Event|0|||
129990795|NCT03801915|467929861|FG000|Overall Study|Screen failure|0|||
129990796|NCT03801915|467929862|FG001|Overall Study|Screen failure|0|||
129990797|NCT03801915|467929863|FG002|Overall Study|Screen failure|1|||
129990798|NCT03801915|467929861|FG000|Overall Study|Ineligible|1|||
129661768|NCT00540644|466722307|FG000|Overall Study|Disease Progression|3|||
129661769|NCT00540644|466722308|FG001|Overall Study|Disease Progression|1|||
129990799|NCT03801915|467929862|FG001|Overall Study|Ineligible|0|||
129990800|NCT03801915|467929863|FG002|Overall Study|Ineligible|0|||
129990801|NCT03801915|467929861|FG000|Overall Study|Physician Decision|2|||
129990802|NCT03801915|467929862|FG001|Overall Study|Physician Decision|1|||
129990803|NCT03801915|467929863|FG002|Overall Study|Physician Decision|0|||
129990804|NCT01211288|467929864|FG000|Overall Study|Lost to Follow-up|1|||
129990805|NCT01211288|467929865|FG001|Overall Study|Lost to Follow-up|1|||
129990806|NCT01270971|467929866|FG000|Overall Study|Withdrawal by Subject|24|||
129990807|NCT01270971|467929867|FG001|Overall Study|Withdrawal by Subject|11|||
129990808|NCT01270971|467929866|FG000|Overall Study|Lost to Follow-up|18|||
129990809|NCT01270971|467929867|FG001|Overall Study|Lost to Follow-up|5|||
129990810|NCT01270971|467929866|FG000|Overall Study|Adverse Event|1|||
129990811|NCT01270971|467929867|FG001|Overall Study|Adverse Event|2|||
129990812|NCT01270971|467929866|FG000|Overall Study|Non compliance|2|||
129990813|NCT01270971|467929867|FG001|Overall Study|Non compliance|2|||
129990814|NCT01270971|467929866|FG000|Overall Study|Non-specific|7|||
129990815|NCT01270971|467929867|FG001|Overall Study|Non-specific|3|||
129990816|NCT02003573|467929881|FG000|Overall Study|Progressive disease|2|||
129990817|NCT02003573|467929882|FG001|Overall Study|Progressive disease|0|||
129990818|NCT02003573|467929883|FG002|Overall Study|Progressive disease|1|||
129990819|NCT02003573|467929881|FG000|Overall Study|Other Adverse event|0|||
129990820|NCT02003573|467929882|FG001|Overall Study|Other Adverse event|1|||
129990821|NCT02003573|467929883|FG002|Overall Study|Other Adverse event|1|||
129990822|NCT02003573|467929881|FG000|Overall Study|Refuse to take trial medication|0|||
129990823|NCT02003573|467929882|FG001|Overall Study|Refuse to take trial medication|1|||
129990824|NCT02003573|467929883|FG002|Overall Study|Refuse to take trial medication|1|||
129990825|NCT02003573|467929881|FG000|Overall Study|Other than specified|1|||
129990826|NCT02003573|467929882|FG001|Overall Study|Other than specified|2|||
129990827|NCT02003573|467929883|FG002|Overall Study|Other than specified|3|||
129990828|NCT02112708|467929886|FG000|Baseline|Physician Decision|16|||
129990829|NCT02112708|467929887|FG001|Baseline|Physician Decision|11|||
129661770|NCT00540644|466722307|FG000|Overall Study|Physician Decision|0|||
129990830|NCT02112708|467929886|FG000|Baseline|Lost to Follow-up|12|||
129990831|NCT02112708|467929887|FG001|Baseline|Lost to Follow-up|0|||
129990832|NCT02112708|467929886|FG000|4 Month|Death|0|||
129990833|NCT02112708|467929887|FG001|4 Month|Death|1|||
129990834|NCT02112708|467929886|FG000|4 Month|Withdrawal by Subject|12|||
129990835|NCT02112708|467929887|FG001|4 Month|Withdrawal by Subject|0|||
129990836|NCT00928018|467929892|FG000|Overall Study|Withdrawal by Subject|1|||
129990837|NCT00928018|467929893|FG001|Overall Study|Withdrawal by Subject|0|||
129990838|NCT00126503|467929894|FG000|Overall Study|disease progression|23|||
129661771|NCT00540644|466722308|FG001|Overall Study|Physician Decision|5|||
129661772|NCT00540644|466722307|FG000|Overall Study|Withdrawal by Subject|2|||
129661773|NCT00540644|466722308|FG001|Overall Study|Withdrawal by Subject|2|||
129661774|NCT00540644|466722307|FG000|Overall Study|Noncomplilance|1|||
129990839|NCT00126503|467929895|FG001|Overall Study|disease progression|14|||
129990840|NCT00126503|467929894|FG000|Overall Study|Withdrawal by Subject|0|||
129990841|NCT00126503|467929895|FG001|Overall Study|Withdrawal by Subject|1|||
129990842|NCT00126503|467929894|FG000|Overall Study|alternative therapy|1|||
129990843|NCT00126503|467929895|FG001|Overall Study|alternative therapy|1|||
129990844|NCT00126503|467929894|FG000|Overall Study|other complicating disease|4|||
129990845|NCT00126503|467929895|FG001|Overall Study|other complicating disease|1|||
129990846|NCT00126503|467929894|FG000|Overall Study|Death|3|||
129990847|NCT00126503|467929895|FG001|Overall Study|Death|0|||
129990848|NCT00126503|467929894|FG000|Overall Study|Adverse Event|13|||
129990849|NCT00126503|467929895|FG001|Overall Study|Adverse Event|3|||
129990850|NCT00126503|467929894|FG000|Overall Study|non-compliant|1|||
129990851|NCT00126503|467929895|FG001|Overall Study|non-compliant|0|||
129990852|NCT00126503|467929894|FG000|Overall Study|Physician Decision|2|||
129990853|NCT00126503|467929895|FG001|Overall Study|Physician Decision|1|||
129990854|NCT02457559|467929896|FG000|Overall Study|Progressive Disease|1|||
129990855|NCT02457559|467929897|FG001|Overall Study|Progressive Disease|2|||
129661775|NCT00540644|466722308|FG001|Overall Study|Noncomplilance|0|||
129661776|NCT03280056|466722309|FG000|Overall Study|Withdrawal by Subject|12|||
129661777|NCT03280056|466722310|FG001|Overall Study|Withdrawal by Subject|14|||
129661778|NCT03280056|466722309|FG000|Overall Study|Death|9|||
129661779|NCT03280056|466722310|FG001|Overall Study|Death|2|||
129990856|NCT02457559|467929898|FG002|Overall Study|Progressive Disease|3|||
129990857|NCT02457559|467929899|FG003|Overall Study|Progressive Disease|0|||
129990858|NCT02457559|467929900|FG004|Overall Study|Progressive Disease|0|||
129990859|NCT02457559|467929901|FG005|Overall Study|Progressive Disease|2|||
129990860|NCT02457559|467929902|FG006|Overall Study|Progressive Disease|1|||
129661780|NCT03280056|466722309|FG000|Overall Study|Adverse Event|1|||
129661781|NCT03280056|466722310|FG001|Overall Study|Adverse Event|3|||
129661782|NCT03280056|466722309|FG000|Overall Study|Lost to Follow-up|1|||
129661783|NCT03280056|466722310|FG001|Overall Study|Lost to Follow-up|1|||
129661784|NCT03280056|466722309|FG000|Overall Study|Physician Decision|0|||
129661785|NCT03280056|466722310|FG001|Overall Study|Physician Decision|1|||
129661786|NCT03280056|466722309|FG000|Overall Study|Early Discontinuation|1|||
129661787|NCT03280056|466722310|FG001|Overall Study|Early Discontinuation|0|||
129661788|NCT02144077|466722311|FG000|Overall Study|Withdrawal by Subject|3|||
129661789|NCT02144077|466722312|FG001|Overall Study|Withdrawal by Subject|3|||
129661790|NCT02144077|466722311|FG000|Overall Study|Adverse Event|2|||
129661791|NCT02144077|466722312|FG001|Overall Study|Adverse Event|3|||
129661792|NCT02144077|466722311|FG000|Overall Study|Lost to Follow-up|2|||
129661793|NCT02144077|466722312|FG001|Overall Study|Lost to Follow-up|2|||
129661794|NCT02144077|466722311|FG000|Overall Study|Protocol Violation|1|||
129661795|NCT02144077|466722312|FG001|Overall Study|Protocol Violation|2|||
129661796|NCT02144077|466722311|FG000|Overall Study|Death|0|||
129661797|NCT02144077|466722312|FG001|Overall Study|Death|1|||
129661798|NCT02144077|466722311|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
129661799|NCT02144077|466722312|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
129661800|NCT00610168|466722313|FG000|Overall Study|Withdrawal by Subject|2|||
129661801|NCT00610168|466722314|FG001|Overall Study|Withdrawal by Subject|0|||
129661802|NCT00943592|466722315|FG000|Overall Study|Death|3|||
129661803|NCT01247350|466722316|FG000|Overall Study|Adverse Event|0|||
129661804|NCT01247350|466722317|FG001|Overall Study|Adverse Event|0|||
129661805|NCT01247350|466722318|FG002|Overall Study|Adverse Event|1|||
129661806|NCT01247350|466722319|FG003|Overall Study|Adverse Event|0|||
129661807|NCT01247350|466722320|FG004|Overall Study|Adverse Event|0|||
129661808|NCT01247350|466722316|FG000|Overall Study|Withdrawal by Subject|0|||
129661809|NCT01247350|466722317|FG001|Overall Study|Withdrawal by Subject|0|||
129661810|NCT01247350|466722318|FG002|Overall Study|Withdrawal by Subject|0|||
129661811|NCT01247350|466722319|FG003|Overall Study|Withdrawal by Subject|1|||
129661812|NCT01247350|466722320|FG004|Overall Study|Withdrawal by Subject|0|||
129661813|NCT01247350|466722316|FG000|Overall Study|Entry criteria not met|0|||
129661814|NCT01247350|466722317|FG001|Overall Study|Entry criteria not met|0|||
129661815|NCT01247350|466722318|FG002|Overall Study|Entry criteria not met|0|||
129661816|NCT01247350|466722319|FG003|Overall Study|Entry criteria not met|0|||
129661817|NCT01247350|466722320|FG004|Overall Study|Entry criteria not met|1|||
129661818|NCT00169104|466722321|FG000|Overall Study|Withdrawal by Subject|2|||
129661819|NCT00169104|466722322|FG001|Overall Study|Withdrawal by Subject|0|||
129661820|NCT00169104|466722321|FG000|Overall Study|Protocol Violation|0|||
129661821|NCT00169104|466722322|FG001|Overall Study|Protocol Violation|1|||
129661822|NCT00169104|466722321|FG000|Overall Study|Physician Decision|0|||
129661823|NCT00169104|466722322|FG001|Overall Study|Physician Decision|1|||
129661824|NCT01540981|466722328|FG000|Overall Study|Withdrawal by Subject|1|||
129661825|NCT01540981|466722329|FG001|Overall Study|Withdrawal by Subject|0|||
129990861|NCT02457559|467929903|FG007|Overall Study|Progressive Disease|0|||
129990862|NCT02457559|467929904|FG008|Overall Study|Progressive Disease|1|||
129990863|NCT02457559|467929905|FG009|Overall Study|Progressive Disease|1|||
129990864|NCT02457559|467929906|FG010|Overall Study|Progressive Disease|1|||
129990865|NCT02457559|467929896|FG000|Overall Study|Investigator's Discretion|0|||
129661826|NCT00809094|466722331|FG000|Overall Study|Lost to Follow-up|0|||
129990866|NCT02457559|467929897|FG001|Overall Study|Investigator's Discretion|0|||
129661827|NCT00809094|466722332|FG001|Overall Study|Lost to Follow-up|1|||
129661828|NCT00397189|466722333|FG000|3 Weeks Period|Lost to Follow-up|5|||
129990867|NCT02457559|467929898|FG002|Overall Study|Investigator's Discretion|2|||
129990868|NCT02457559|467929899|FG003|Overall Study|Investigator's Discretion|0|||
129990869|NCT02457559|467929900|FG004|Overall Study|Investigator's Discretion|1|||
129990870|NCT02457559|467929901|FG005|Overall Study|Investigator's Discretion|0|||
129990871|NCT02457559|467929902|FG006|Overall Study|Investigator's Discretion|1|||
129990872|NCT02457559|467929903|FG007|Overall Study|Investigator's Discretion|0|||
129990873|NCT02457559|467929904|FG008|Overall Study|Investigator's Discretion|1|||
129661829|NCT00397189|466722334|FG001|3 Weeks Period|Lost to Follow-up|4|||
129661830|NCT00397189|466722333|FG000|3 Weeks Period|Adverse Event|3|||
129661831|NCT00397189|466722334|FG001|3 Weeks Period|Adverse Event|2|||
129661832|NCT00397189|466722333|FG000|3 Weeks Period|Withdrawal by Subject|13|||
129661833|NCT00397189|466722334|FG001|3 Weeks Period|Withdrawal by Subject|9|||
129661834|NCT00397189|466722333|FG000|3 Weeks Period|Physician Decision|0|||
129661835|NCT00397189|466722334|FG001|3 Weeks Period|Physician Decision|2|||
129661836|NCT00397189|466722333|FG000|3 Weeks Period|Protocol Violation|0|||
129661837|NCT00397189|466722334|FG001|3 Weeks Period|Protocol Violation|3|||
129661838|NCT00397189|466722333|FG000|3 Weeks Period|Other|0|||
129661839|NCT00397189|466722334|FG001|3 Weeks Period|Other|2|||
129661840|NCT01535443|466722335|FG000|Overall Study|Physician Decision|3|||
129661841|NCT00232557|466722338|FG000|Overall Study|Lost to Follow-up|3|||
129661842|NCT00232557|466722339|FG001|Overall Study|Lost to Follow-up|5|||
129661843|NCT01059773|466722340|FG000|Overall Study|Adverse Event|2|||
129661844|NCT01059773|466722341|FG001|Overall Study|Adverse Event|2|||
129661845|NCT01059773|466722340|FG000|Overall Study|Withdrawal by Subject|1|||
129661846|NCT01059773|466722341|FG001|Overall Study|Withdrawal by Subject|5|||
129661847|NCT01059773|466722340|FG000|Overall Study|Lost to Follow-up|1|||
129661848|NCT01059773|466722341|FG001|Overall Study|Lost to Follow-up|1|||
129661849|NCT01059773|466722340|FG000|Overall Study|Pregnancy|1|||
129661850|NCT01059773|466722341|FG001|Overall Study|Pregnancy|1|||
129661851|NCT01059773|466722340|FG000|Overall Study|Protocol Violation|6|||
129661852|NCT01059773|466722341|FG001|Overall Study|Protocol Violation|2|||
129661853|NCT01059773|466722340|FG000|Overall Study|Physician Decision|5|||
129661854|NCT01059773|466722341|FG001|Overall Study|Physician Decision|4|||
129661855|NCT01059773|466722340|FG000|Overall Study|Lack of Efficacy|3|||
129661856|NCT01059773|466722341|FG001|Overall Study|Lack of Efficacy|3|||
129661857|NCT01059773|466722340|FG000|Overall Study|Death|0|||
129661858|NCT01059773|466722341|FG001|Overall Study|Death|1|||
129661859|NCT01059773|466722340|FG000|Overall Study|Malignancy including squamous cell skin|0|||
129661860|NCT01059773|466722341|FG001|Overall Study|Malignancy including squamous cell skin|1|||
129661861|NCT01059773|466722340|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
129661862|NCT01059773|466722341|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
129990874|NCT02457559|467929905|FG009|Overall Study|Investigator's Discretion|0|||
129990875|NCT02457559|467929906|FG010|Overall Study|Investigator's Discretion|1|||
129990876|NCT02457559|467929896|FG000|Overall Study|Adverse Event|0|||
129990877|NCT02457559|467929897|FG001|Overall Study|Adverse Event|1|||
129661863|NCT01059773|466722340|FG000|Overall Study|Other|1|||
129661864|NCT01059773|466722341|FG001|Overall Study|Other|3|||
129661865|NCT00141518|466722344|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
129661866|NCT00141518|466722345|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
129661867|NCT00141518|466722346|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
129661868|NCT00141518|466722344|FG000|Overall Study|Adverse Event|7|||
129661869|NCT00141518|466722345|FG001|Overall Study|Adverse Event|5|||
129661870|NCT00141518|466722346|FG002|Overall Study|Adverse Event|2|||
129661871|NCT00141518|466722344|FG000|Overall Study|Withdrawal by Subject|2|||
129661872|NCT00141518|466722345|FG001|Overall Study|Withdrawal by Subject|0|||
129661873|NCT00141518|466722346|FG002|Overall Study|Withdrawal by Subject|2|||
129661874|NCT00141518|466722344|FG000|Overall Study|Protocol Violation|1|||
129661875|NCT00141518|466722345|FG001|Overall Study|Protocol Violation|1|||
129661876|NCT00141518|466722346|FG002|Overall Study|Protocol Violation|2|||
129661877|NCT00141518|466722344|FG000|Overall Study|Lack of Efficacy|5|||
129661878|NCT00141518|466722345|FG001|Overall Study|Lack of Efficacy|0|||
129661879|NCT00141518|466722346|FG002|Overall Study|Lack of Efficacy|0|||
129990878|NCT02457559|467929898|FG002|Overall Study|Adverse Event|2|||
129990879|NCT02457559|467929899|FG003|Overall Study|Adverse Event|0|||
129990880|NCT02457559|467929900|FG004|Overall Study|Adverse Event|0|||
129661880|NCT01806168|466722347|FG000|Overall Study|Adverse Event|1|||
129661881|NCT01806168|466722348|FG001|Overall Study|Adverse Event|0|||
129661882|NCT01806168|466722349|FG002|Overall Study|Adverse Event|0|||
129661883|NCT01806168|466722347|FG000|Overall Study|Withdrawal by Subject|0|||
129661884|NCT01806168|466722348|FG001|Overall Study|Withdrawal by Subject|1|||
129990881|NCT02457559|467929901|FG005|Overall Study|Adverse Event|0|||
129990882|NCT02457559|467929902|FG006|Overall Study|Adverse Event|0|||
129990883|NCT02457559|467929903|FG007|Overall Study|Adverse Event|0|||
129990884|NCT02457559|467929904|FG008|Overall Study|Adverse Event|0|||
129661885|NCT01806168|466722349|FG002|Overall Study|Withdrawal by Subject|2|||
129661886|NCT01806168|466722347|FG000|Overall Study|Protocol Violation|0|||
129661887|NCT01806168|466722348|FG001|Overall Study|Protocol Violation|0|||
129661888|NCT01806168|466722349|FG002|Overall Study|Protocol Violation|1|||
129661889|NCT01029262|466722352|FG000|Overall Study|Adverse Event|9|||
129661890|NCT01029262|466722353|FG001|Overall Study|Adverse Event|52|||
129661891|NCT01029262|466722352|FG000|Overall Study|Lack of therapeutic effect|57|||
129661892|NCT01029262|466722353|FG001|Overall Study|Lack of therapeutic effect|76|||
129661893|NCT01029262|466722352|FG000|Overall Study|Withdrawal by Subject|10|||
129661894|NCT01029262|466722353|FG001|Overall Study|Withdrawal by Subject|17|||
129661895|NCT01029262|466722352|FG000|Overall Study|Protocol Violation|2|||
129661896|NCT01029262|466722353|FG001|Overall Study|Protocol Violation|3|||
129661897|NCT01029262|466722352|FG000|Overall Study|Miscellaneous|1|||
129661898|NCT01029262|466722353|FG001|Overall Study|Miscellaneous|9|||
129661899|NCT01029262|466722352|FG000|Overall Study|Death|0|||
129661900|NCT01029262|466722353|FG001|Overall Study|Death|3|||
129661901|NCT03410992|466722354|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661902|NCT03410992|466722355|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
129661903|NCT03410992|466722356|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661904|NCT03410992|466722357|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661905|NCT03410992|466722358|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661906|NCT03410992|466722359|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661907|NCT03410992|466722360|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661908|NCT03410992|466722361|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661909|NCT03410992|466722362|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661910|NCT03410992|466722363|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661911|NCT03410992|466722364|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
129661912|NCT03410992|466722354|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
129661913|NCT03410992|466722355|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
129661914|NCT03410992|466722356|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661915|NCT03410992|466722357|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661916|NCT03410992|466722358|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661917|NCT03410992|466722359|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661918|NCT03410992|466722360|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661919|NCT03410992|466722361|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661920|NCT03410992|466722362|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661921|NCT03410992|466722363|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661922|NCT03410992|466722364|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
129661923|NCT03410992|466722354|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
129661924|NCT03410992|466722355|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
129661925|NCT03410992|466722356|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661926|NCT03410992|466722357|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661927|NCT03410992|466722358|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661928|NCT03410992|466722359|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661929|NCT03410992|466722360|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661930|NCT03410992|466722361|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661931|NCT03410992|466722362|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661932|NCT03410992|466722363|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661933|NCT03410992|466722364|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
129661934|NCT03410992|466722354|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
129661935|NCT03410992|466722355|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661936|NCT03410992|466722356|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661937|NCT03410992|466722357|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661938|NCT03410992|466722358|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661939|NCT03410992|466722359|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661940|NCT03410992|466722360|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661941|NCT03410992|466722361|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661942|NCT03410992|466722362|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661943|NCT03410992|466722363|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661944|NCT03410992|466722364|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
129661945|NCT03410992|466722354|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
129661946|NCT03410992|466722355|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
129661947|NCT03410992|466722356|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661948|NCT03410992|466722357|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661949|NCT03410992|466722358|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661950|NCT03410992|466722359|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661951|NCT03410992|466722360|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661952|NCT03410992|466722361|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661953|NCT03410992|466722362|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129661954|NCT03410992|466722363|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129990885|NCT02457559|467929905|FG009|Overall Study|Adverse Event|0|||
129990886|NCT02457559|467929906|FG010|Overall Study|Adverse Event|0|||
129661955|NCT03410992|466722364|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
129990887|NCT02457559|467929896|FG000|Overall Study|Reason not Specified|1|||
129990888|NCT02457559|467929897|FG001|Overall Study|Reason not Specified|0|||
129990889|NCT02457559|467929898|FG002|Overall Study|Reason not Specified|0|||
129990890|NCT02457559|467929899|FG003|Overall Study|Reason not Specified|0|||
129990891|NCT02457559|467929900|FG004|Overall Study|Reason not Specified|0|||
129990892|NCT02457559|467929901|FG005|Overall Study|Reason not Specified|0|||
129990893|NCT02457559|467929902|FG006|Overall Study|Reason not Specified|0|||
129990894|NCT02457559|467929903|FG007|Overall Study|Reason not Specified|0|||
129661956|NCT03410992|466722354|FG000|Week 16 Assessment|Incorrect escapers|0|||
129661957|NCT03410992|466722355|FG001|Week 16 Assessment|Incorrect escapers|6|||
129661958|NCT03410992|466722356|FG002|Week 16 Assessment|Incorrect escapers|0|||
129661959|NCT03410992|466722357|FG003|Week 16 Assessment|Incorrect escapers|0|||
129661960|NCT03410992|466722358|FG004|Week 16 Assessment|Incorrect escapers|0|||
129661961|NCT03410992|466722359|FG005|Week 16 Assessment|Incorrect escapers|0|||
129661962|NCT03410992|466722360|FG006|Week 16 Assessment|Incorrect escapers|0|||
129661963|NCT03410992|466722361|FG007|Week 16 Assessment|Incorrect escapers|0|||
129661964|NCT03410992|466722362|FG008|Week 16 Assessment|Incorrect escapers|0|||
129990895|NCT02457559|467929904|FG008|Overall Study|Reason not Specified|0|||
129990896|NCT02457559|467929905|FG009|Overall Study|Reason not Specified|2|||
129990897|NCT02457559|467929906|FG010|Overall Study|Reason not Specified|0|||
129990898|NCT02457559|467929896|FG000|Overall Study|Death|0|||
129990899|NCT02457559|467929897|FG001|Overall Study|Death|0|||
129990900|NCT02457559|467929898|FG002|Overall Study|Death|0|||
129990901|NCT02457559|467929899|FG003|Overall Study|Death|0|||
129990902|NCT02457559|467929900|FG004|Overall Study|Death|0|||
129990903|NCT02457559|467929901|FG005|Overall Study|Death|0|||
129990904|NCT02457559|467929902|FG006|Overall Study|Death|0|||
129990905|NCT02457559|467929903|FG007|Overall Study|Death|0|||
129661965|NCT03410992|466722363|FG009|Week 16 Assessment|Incorrect escapers|0|||
129661966|NCT03410992|466722364|FG010|Week 16 Assessment|Incorrect escapers|0|||
129661967|NCT03410992|466722354|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661968|NCT03410992|466722355|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661969|NCT03410992|466722356|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661970|NCT03410992|466722357|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
129661971|NCT03410992|466722358|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
129661972|NCT03410992|466722359|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661973|NCT03410992|466722360|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661974|NCT03410992|466722361|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661975|NCT03410992|466722362|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661976|NCT03410992|466722363|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661977|NCT03410992|466722364|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
129661978|NCT03410992|466722354|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661979|NCT03410992|466722355|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661980|NCT03410992|466722356|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661981|NCT03410992|466722357|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
129661982|NCT03410992|466722358|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
129661983|NCT03410992|466722359|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
129661984|NCT03410992|466722360|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661985|NCT03410992|466722361|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661986|NCT03410992|466722362|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661987|NCT03410992|466722363|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661988|NCT03410992|466722364|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
129661989|NCT03410992|466722354|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661990|NCT03410992|466722355|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661991|NCT03410992|466722356|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661992|NCT03410992|466722357|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661993|NCT03410992|466722358|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661994|NCT03410992|466722359|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
129661995|NCT03410992|466722360|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661996|NCT03410992|466722361|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661997|NCT03410992|466722362|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129661998|NCT03410992|466722363|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129990906|NCT02457559|467929904|FG008|Overall Study|Death|1|||
129990907|NCT02457559|467929905|FG009|Overall Study|Death|1|||
129990908|NCT02457559|467929906|FG010|Overall Study|Death|0|||
129661999|NCT03410992|466722364|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
129990909|NCT00998335|467929909|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
129990910|NCT00998335|467929910|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
129990911|NCT02374671|467929911|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
129990912|NCT02374671|467929912|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
129662000|NCT03410992|466722354|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662001|NCT03410992|466722355|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662002|NCT03410992|466722356|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662003|NCT03410992|466722357|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
129662004|NCT03410992|466722358|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
129662005|NCT03410992|466722359|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
129662006|NCT03410992|466722360|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662007|NCT03410992|466722361|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662008|NCT03410992|466722362|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662009|NCT03410992|466722363|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662010|NCT03410992|466722364|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
129662011|NCT03410992|466722354|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662012|NCT03410992|466722355|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662013|NCT03410992|466722356|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662014|NCT03410992|466722357|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662015|NCT03410992|466722358|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662016|NCT03410992|466722359|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662017|NCT03410992|466722360|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662018|NCT03410992|466722361|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
129662019|NCT03410992|466722362|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662020|NCT03410992|466722363|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662021|NCT03410992|466722364|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
129662022|NCT03410992|466722354|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662023|NCT03410992|466722355|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662024|NCT03410992|466722356|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662025|NCT03410992|466722357|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662026|NCT03410992|466722358|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662027|NCT03410992|466722359|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662028|NCT03410992|466722360|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662029|NCT03410992|466722361|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662030|NCT03410992|466722362|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
129662031|NCT03410992|466722363|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662032|NCT03410992|466722364|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
129662033|NCT02438280|466722365|FG000|Overall Study|Physician Decision|1|||
129662034|NCT02438280|466722366|FG001|Overall Study|Physician Decision|0|||
129662035|NCT02260817|466722367|FG000|Overall Study|Lost to Follow-up|0|||
129662036|NCT02260817|466722368|FG001|Overall Study|Lost to Follow-up|14|||
129662037|NCT02260817|466722367|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
129662038|NCT02260817|466722368|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
129662039|NCT02260817|466722367|FG000|Overall Study|Observation, no biopsy|0|||
129662040|NCT02260817|466722368|FG001|Overall Study|Observation, no biopsy|1|||
129662041|NCT02260817|466722367|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
129662042|NCT02260817|466722368|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
129662043|NCT02260817|466722367|FG000|Overall Study|Protocol Violation|0|||
129662044|NCT02260817|466722368|FG001|Overall Study|Protocol Violation|14|||
129662045|NCT03299101|466722369|FG000|Overall Study|Lost to Follow-up|1|||
129662046|NCT03299101|466722369|FG000|Overall Study|Withdrawal by Subject|5|||
129990913|NCT02374671|467929913|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
129990914|NCT02374671|467929911|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
129990915|NCT02374671|467929912|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
129990916|NCT02374671|467929913|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
129990917|NCT02374671|467929911|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
129990918|NCT02374671|467929912|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
129990919|NCT02374671|467929913|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
129990920|NCT02374671|467929911|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
129990921|NCT02374671|467929912|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
129990922|NCT02374671|467929913|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
129990923|NCT02374671|467929911|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
129990924|NCT02374671|467929912|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
129990925|NCT02374671|467929913|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
129662047|NCT03299101|466722369|FG000|Overall Study|Surgery was changed|3|||
129662048|NCT03299101|466722369|FG000|Overall Study|Not enough time to complete prehab|1|||
129662049|NCT01882803|466722371|FG000|Overall Study|Disease Progression|1|||
129662050|NCT01882803|466722371|FG000|Overall Study|Withdrawal by Subject|9|||
129990926|NCT03866473|467929916|FG000|Phase 1|Death|1|||
129990927|NCT03866473|467929917|FG001|Phase 1|Death|0|||
129990928|NCT03866473|467929916|FG000|Phase 2|Death|0|||
129990929|NCT03866473|467929917|FG001|Phase 2|Death|2|||
129662051|NCT01882803|466722371|FG000|Overall Study|Death|68|||
129990930|NCT03866473|467929916|FG000|Phase 2|Dropped|1|||
129662052|NCT01882803|466722371|FG000|Overall Study|Physician Decision|3|||
129662053|NCT01882803|466722371|FG000|Overall Study|Lost to Follow-up|3|||
129662054|NCT01882803|466722371|FG000|Overall Study|Follow-up Completed|39|||
129662055|NCT01882803|466722371|FG000|Overall Study|Study Terminated by the Sponsor|6|||
129662056|NCT01563913|466722372|FG000|Overall Study|Physician Decision|1|||
129662057|NCT01563913|466722373|FG001|Overall Study|Physician Decision|0|||
129662058|NCT01563913|466722372|FG000|Overall Study|Spouse Passed Away|1|||
129662059|NCT01563913|466722373|FG001|Overall Study|Spouse Passed Away|0|||
129662060|NCT03066778|466722374|FG000|Overall Study|Death|195|||
129662061|NCT03066778|466722375|FG001|Overall Study|Death|205|||
129662062|NCT03066778|466722374|FG000|Overall Study|Withdrawal by Subject|5|||
129662063|NCT03066778|466722375|FG001|Overall Study|Withdrawal by Subject|7|||
129662064|NCT02091414|466722376|FG000|Overall Study|Withdrawal by Subject|2|||
129662065|NCT02091414|466722376|FG000|Overall Study|Death|2|||
129662066|NCT03665077|466722377|FG000|Overall Study|Lost to Follow-up|2|||
129662067|NCT03665077|466722377|FG000|Overall Study|Physician Decision|2|||
129662068|NCT00435461|466722380|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
129662069|NCT00435461|466722381|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
129662070|NCT00435461|466722382|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
129662071|NCT00435461|466722380|FG000|Overall Study|Protocol Violation|6|||
129662072|NCT00435461|466722381|FG001|Overall Study|Protocol Violation|9|||
129662073|NCT00435461|466722382|FG002|Overall Study|Protocol Violation|10|||
129662074|NCT00435461|466722380|FG000|Overall Study|Participant randomized(inadequate score)|1|||
129662075|NCT00435461|466722381|FG001|Overall Study|Participant randomized(inadequate score)|0|||
129662076|NCT00435461|466722382|FG002|Overall Study|Participant randomized(inadequate score)|0|||
129662077|NCT00435461|466722380|FG000|Overall Study|Compliance less than 80 percent|1|||
129662078|NCT00435461|466722381|FG001|Overall Study|Compliance less than 80 percent|0|||
129662079|NCT00435461|466722382|FG002|Overall Study|Compliance less than 80 percent|0|||
129662080|NCT00435461|466722380|FG000|Overall Study|In error, two study medications switched|1|||
129662081|NCT00435461|466722381|FG001|Overall Study|In error, two study medications switched|0|||
129662082|NCT00435461|466722382|FG002|Overall Study|In error, two study medications switched|0|||
129662083|NCT00435461|466722380|FG000|Overall Study|Lack of Efficacy|2|||
129662084|NCT00435461|466722381|FG001|Overall Study|Lack of Efficacy|1|||
129662085|NCT00435461|466722382|FG002|Overall Study|Lack of Efficacy|0|||
129662086|NCT00435461|466722380|FG000|Overall Study|Withdrawal by Subject|1|||
129990931|NCT03866473|467929917|FG001|Phase 2|Dropped|1|||
129990932|NCT03866473|467929916|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
129662087|NCT00435461|466722381|FG001|Overall Study|Withdrawal by Subject|0|||
129662088|NCT00435461|466722382|FG002|Overall Study|Withdrawal by Subject|2|||
129662089|NCT00435461|466722380|FG000|Overall Study|Randomized in error|1|||
129990933|NCT03866473|467929917|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
129990934|NCT03110185|467929918|FG000|Overall Study|Death|0|||
129990935|NCT03110185|467929919|FG001|Overall Study|Death|1|||
129990936|NCT03110185|467929918|FG000|Overall Study|Withdrawal by Subject|2|||
129990937|NCT03110185|467929919|FG001|Overall Study|Withdrawal by Subject|7|||
129990938|NCT03110185|467929918|FG000|Overall Study|Time Constraints|0|||
129990939|NCT03110185|467929919|FG001|Overall Study|Time Constraints|6|||
129990940|NCT03110185|467929918|FG000|Overall Study|Conflict with care|5|||
129990941|NCT03110185|467929919|FG001|Overall Study|Conflict with care|12|||
129990942|NCT03110185|467929918|FG000|Overall Study|Protocol Violation|1|||
129990943|NCT03110185|467929919|FG001|Overall Study|Protocol Violation|4|||
129990944|NCT03110185|467929918|FG000|Overall Study|MRI Incompatible|2|||
129990945|NCT03110185|467929919|FG001|Overall Study|MRI Incompatible|0|||
129990946|NCT03110185|467929918|FG000|Overall Study|Patient Refusal|0|||
129990947|NCT03110185|467929919|FG001|Overall Study|Patient Refusal|1|||
129990948|NCT05330312|467929922|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
129990949|NCT05330312|467929923|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
129990950|NCT05330312|467929924|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
129990951|NCT05330312|467929922|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
129990952|NCT05330312|467929923|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
129990953|NCT05330312|467929924|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
129990954|NCT05330312|467929922|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
129990955|NCT05330312|467929923|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
129990956|NCT05330312|467929924|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
129990957|NCT05330312|467929922|FG000|Pivotal Investigation - Part 2|Death|1|||
129990958|NCT05330312|467929923|FG001|Pivotal Investigation - Part 2|Death|4|||
129662090|NCT00435461|466722381|FG001|Overall Study|Randomized in error|0|||
129662091|NCT00435461|466722382|FG002|Overall Study|Randomized in error|0|||
129662092|NCT00435461|466722380|FG000|Overall Study|Participant could not tolerate symptoms|0|||
129662093|NCT00435461|466722381|FG001|Overall Study|Participant could not tolerate symptoms|0|||
129990959|NCT05330312|467929924|FG002|Pivotal Investigation - Part 2|Death|0|||
129990960|NCT01078454|467929927|FG000|Overall Study|Adverse Event|1|||
129990961|NCT01078454|467929928|FG001|Overall Study|Adverse Event|1|||
129662094|NCT00435461|466722382|FG002|Overall Study|Participant could not tolerate symptoms|1|||
129990962|NCT01078454|467929927|FG000|Overall Study|Death|0|||
129990963|NCT01078454|467929928|FG001|Overall Study|Death|1|||
129990964|NCT00824161|467931360|FG000|Overall Study|Withdrawal by Subject|1|||
129990965|NCT00824161|467931360|FG000|Overall Study|Screen Failure|1|||
129990966|NCT04882995|467931361|FG000|Overall Study|Withdrawal by Subject|1|||
129990967|NCT04882995|467931362|FG001|Overall Study|Withdrawal by Subject|2|||
129990968|NCT04882995|467931361|FG000|Overall Study|Protocol Violation|4|||
129990969|NCT04882995|467931362|FG001|Overall Study|Protocol Violation|4|||
129990970|NCT04882995|467931361|FG000|Overall Study|Surgery postponed due to COVID|1|||
129990971|NCT04882995|467931362|FG001|Overall Study|Surgery postponed due to COVID|1|||
129990972|NCT02572882|467931363|FG000|Overall Study|Withdrawal by Subject|1|||
129990973|NCT02572882|467931363|FG000|Overall Study|Participant received kidney transplant|1|||
129662095|NCT00435461|466722380|FG000|Overall Study|Participant could not swallow capsule|0|||
129662096|NCT00435461|466722381|FG001|Overall Study|Participant could not swallow capsule|0|||
129662097|NCT00435461|466722382|FG002|Overall Study|Participant could not swallow capsule|1|||
129990974|NCT04371198|467931367|FG000|Overall Study|inadequate sample|4|||
129990975|NCT03536143|467931368|FG000|Overall Study|Early termination, Sponsor decision|1|||
129990976|NCT01174160|467931369|FG000|Overall Study|Adverse Event|1|||
129990977|NCT01174160|467931370|FG001|Overall Study|Adverse Event|0|||
129990978|NCT01174160|467931369|FG000|Overall Study|Lost to Follow-up|1|||
129990979|NCT01174160|467931370|FG001|Overall Study|Lost to Follow-up|0|||
129990980|NCT01174160|467931369|FG000|Overall Study|Physician Decision|1|||
129990981|NCT01174160|467931370|FG001|Overall Study|Physician Decision|0|||
129990982|NCT01174160|467931369|FG000|Overall Study|Protocol Violation|4|||
129990983|NCT01174160|467931370|FG001|Overall Study|Protocol Violation|6|||
129990984|NCT01174160|467931369|FG000|Overall Study|Withdrawal by Subject|1|||
129990985|NCT01174160|467931370|FG001|Overall Study|Withdrawal by Subject|0|||
129990986|NCT04754477|467931371|FG000|Overall Study|Withdrawal by Subject|1|||
129990987|NCT01590017|467931372|FG000|Overall Study|Adverse Event|1|||
129990988|NCT01590017|467931372|FG000|Overall Study|Withdrawal by Subject|1|||
129990989|NCT01590017|467931372|FG000|Overall Study|Lack of Efficacy|1|||
129990990|NCT01590017|467931372|FG000|Overall Study|Physician Decision|1|||
129990991|NCT01347762|467931373|FG000|Overall Study|Lost to Follow-up|0|||
129990992|NCT01347762|467931374|FG001|Overall Study|Lost to Follow-up|1|||
129990993|NCT01347762|467931375|FG002|Overall Study|Lost to Follow-up|6|||
129990994|NCT01347762|467931376|FG003|Overall Study|Lost to Follow-up|5|||
129990995|NCT01347762|467931373|FG000|Overall Study|Withdrawal by Subject|4|||
129990996|NCT01347762|467931374|FG001|Overall Study|Withdrawal by Subject|1|||
129990997|NCT01347762|467931375|FG002|Overall Study|Withdrawal by Subject|3|||
129990998|NCT01347762|467931376|FG003|Overall Study|Withdrawal by Subject|3|||
129990999|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
129991000|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991001|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991002|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991003|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991004|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
129991005|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
129991006|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991007|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991008|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991009|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991010|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
129991011|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991012|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
129991013|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991014|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129662098|NCT00435461|466722380|FG000|Overall Study|Pregnancy|2|||
129662099|NCT00435461|466722381|FG001|Overall Study|Pregnancy|0|||
129991015|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991016|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129991017|NCT02527343|467931377|FG000|RT Period: Weeks 1 to 52|Other|4|||
129991018|NCT02527343|467931378|FG001|RT Period: Weeks 1 to 52|Other|3|||
129991019|NCT02527343|467931379|FG002|RT Period: Weeks 1 to 52|Other|0|||
129662100|NCT00435461|466722382|FG002|Overall Study|Pregnancy|0|||
129662101|NCT00435461|466722380|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
129662102|NCT00435461|466722381|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
129991020|NCT02527343|467931380|FG003|RT Period: Weeks 1 to 52|Other|0|||
129662103|NCT00435461|466722382|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
129662104|NCT00435461|466722380|FG000|Overall Study|Participant ended study one day early|1|||
129991021|NCT02527343|467931381|FG004|RT Period: Weeks 1 to 52|Other|0|||
129991022|NCT02527343|467931382|FG005|RT Period: Weeks 1 to 52|Other|0|||
129991023|NCT02527343|467931377|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991024|NCT02527343|467931378|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991025|NCT02527343|467931379|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
129991026|NCT02527343|467931380|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991027|NCT02527343|467931381|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991028|NCT02527343|467931382|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
129991029|NCT02527343|467931377|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991030|NCT02527343|467931378|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991031|NCT02527343|467931379|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991032|NCT02527343|467931380|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
129991033|NCT02527343|467931381|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991034|NCT02527343|467931382|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
129991035|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991036|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991037|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991038|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991039|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
129991040|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
129991041|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991042|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991043|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991044|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
129991045|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
129991046|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
129991047|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129991048|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129991049|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129662105|NCT00435461|466722381|FG001|Overall Study|Participant ended study one day early|0|||
129662106|NCT00435461|466722382|FG002|Overall Study|Participant ended study one day early|0|||
129662107|NCT00435461|466722380|FG000|Overall Study|Noncompliance with study requirements|1|||
129662108|NCT00435461|466722381|FG001|Overall Study|Noncompliance with study requirements|1|||
129662109|NCT00435461|466722382|FG002|Overall Study|Noncompliance with study requirements|1|||
129662110|NCT00435461|466722380|FG000|Overall Study|Adverse Event|1|||
129662111|NCT00435461|466722381|FG001|Overall Study|Adverse Event|2|||
129662112|NCT00435461|466722382|FG002|Overall Study|Adverse Event|6|||
129662113|NCT00435461|466722380|FG000|Overall Study|Non-Compliance of diary|2|||
129662114|NCT00435461|466722381|FG001|Overall Study|Non-Compliance of diary|0|||
129662115|NCT00435461|466722382|FG002|Overall Study|Non-Compliance of diary|1|||
129662116|NCT00435461|466722380|FG000|Overall Study|Lost to Follow-up|1|||
129662117|NCT00435461|466722381|FG001|Overall Study|Lost to Follow-up|1|||
129662118|NCT00435461|466722382|FG002|Overall Study|Lost to Follow-up|2|||
129662119|NCT02306850|466722385|FG000|Overall Study|Lack of Efficacy|2|||
129662120|NCT00237692|466722386|FG000|Overall Study|Lost to Follow-up|9|||
129662121|NCT00237692|466722387|FG001|Overall Study|Lost to Follow-up|3|||
129662122|NCT00237692|466722388|FG002|Overall Study|Lost to Follow-up|5|||
129662123|NCT00237692|466722389|FG003|Overall Study|Lost to Follow-up|3|||
129662124|NCT00237692|466722386|FG000|Overall Study|Death|1|||
129662125|NCT00237692|466722387|FG001|Overall Study|Death|2|||
129662126|NCT00237692|466722388|FG002|Overall Study|Death|2|||
129662127|NCT00237692|466722389|FG003|Overall Study|Death|3|||
129662128|NCT00237692|466722386|FG000|Overall Study|Excluded - did not meet criteria|4|||
129662129|NCT00237692|466722387|FG001|Overall Study|Excluded - did not meet criteria|3|||
129662130|NCT00237692|466722388|FG002|Overall Study|Excluded - did not meet criteria|5|||
129662131|NCT00237692|466722389|FG003|Overall Study|Excluded - did not meet criteria|9|||
129662132|NCT00237692|466722386|FG000|Overall Study|Withdrawal by Subject|4|||
129662133|NCT00237692|466722387|FG001|Overall Study|Withdrawal by Subject|6|||
129662134|NCT00237692|466722388|FG002|Overall Study|Withdrawal by Subject|10|||
129662135|NCT00237692|466722389|FG003|Overall Study|Withdrawal by Subject|4|||
129662136|NCT02420262|466722390|FG000|Overall Study|Adverse Event|1|||
129662137|NCT02420262|466722391|FG001|Overall Study|Adverse Event|0|||
129662138|NCT02420262|466722390|FG000|Overall Study|Withdrawal by Subject|1|||
129662139|NCT02420262|466722391|FG001|Overall Study|Withdrawal by Subject|4|||
129662140|NCT02420262|466722390|FG000|Overall Study|Unclassified|0|||
129662141|NCT02420262|466722391|FG001|Overall Study|Unclassified|1|||
129662142|NCT05446142|466722407|FG000|Period 2|Adverse Event|1|||
129662143|NCT05446142|466722408|FG001|Period 2|Adverse Event|0|||
129662144|NCT05446142|466722409|FG002|Period 2|Adverse Event|0|||
129662145|NCT05446142|466722410|FG003|Period 2|Adverse Event|0|||
129662146|NCT05446142|466722411|FG004|Period 2|Adverse Event|0|||
129662147|NCT05446142|466722412|FG005|Period 2|Adverse Event|0|||
129991050|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
129991051|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
129662148|NCT02098395|466722413|FG000|Overall Study|Protocol Violation|2|||
129662149|NCT02098395|466722414|FG001|Overall Study|Protocol Violation|2|||
129662150|NCT02098395|466722415|FG002|Overall Study|Protocol Violation|0|||
129662151|NCT02098395|466722416|FG003|Overall Study|Protocol Violation|7|||
129662152|NCT02098395|466722413|FG000|Overall Study|Withdrawal by Subject|10|||
129662153|NCT02098395|466722414|FG001|Overall Study|Withdrawal by Subject|10|||
129662154|NCT02098395|466722415|FG002|Overall Study|Withdrawal by Subject|5|||
129662155|NCT02098395|466722416|FG003|Overall Study|Withdrawal by Subject|13|||
129662156|NCT02098395|466722413|FG000|Overall Study|Adverse Event|12|||
129662157|NCT02098395|466722414|FG001|Overall Study|Adverse Event|19|||
129662158|NCT02098395|466722415|FG002|Overall Study|Adverse Event|34|||
129662159|NCT02098395|466722416|FG003|Overall Study|Adverse Event|2|||
129662160|NCT02098395|466722413|FG000|Overall Study|Lost to Follow-up|2|||
129662161|NCT02098395|466722414|FG001|Overall Study|Lost to Follow-up|1|||
129662162|NCT02098395|466722415|FG002|Overall Study|Lost to Follow-up|0|||
129662163|NCT02098395|466722416|FG003|Overall Study|Lost to Follow-up|3|||
129662164|NCT02098395|466722413|FG000|Overall Study|Unclassified|0|||
129662165|NCT02098395|466722414|FG001|Overall Study|Unclassified|0|||
129662166|NCT02098395|466722415|FG002|Overall Study|Unclassified|3|||
129662167|NCT02098395|466722416|FG003|Overall Study|Unclassified|2|||
129662168|NCT00110357|466722419|FG000|Overall Study|Deterioration without progression|2|||
129662169|NCT00110357|466722420|FG001|Overall Study|Deterioration without progression|0|||
129662170|NCT00110357|466722419|FG000|Overall Study|Disease progression/relapse|20|||
129662171|NCT00110357|466722420|FG001|Overall Study|Disease progression/relapse|15|||
129662172|NCT00110357|466722419|FG000|Overall Study|Study Closure|1|||
129662173|NCT00110357|466722420|FG001|Overall Study|Study Closure|0|||
129662174|NCT00110357|466722419|FG000|Overall Study|Study Drug Toxicity|1|||
129662175|NCT00110357|466722420|FG001|Overall Study|Study Drug Toxicity|3|||
129662176|NCT00110357|466722419|FG000|Overall Study|Withdrawal by Subject|3|||
129662177|NCT00110357|466722420|FG001|Overall Study|Withdrawal by Subject|1|||
129662178|NCT03382418|466722421|FG000|Overall Study|Withdrawal by Subject|1|||
129662179|NCT03382418|466722422|FG001|Overall Study|Withdrawal by Subject|0|||
129662180|NCT03382418|466722423|FG002|Overall Study|Withdrawal by Subject|0|||
129662181|NCT03382418|466722421|FG000|Overall Study|Lost to Follow-up|2|||
129662182|NCT03382418|466722422|FG001|Overall Study|Lost to Follow-up|3|||
129662183|NCT03382418|466722423|FG002|Overall Study|Lost to Follow-up|0|||
129662184|NCT04633226|466722424|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129662185|NCT04633226|466722424|FG000|Overall Study|Randomized by mistake without study treatment|1|||
129662186|NCT01151345|466722426|FG000|First Intervention Period|Protocol Violation|0|||
129662187|NCT01151345|466722427|FG001|First Intervention Period|Protocol Violation|1|||
129662188|NCT01348100|466722429|FG000|Overall Study|Subject Withdrew Consent|0|||
129662189|NCT01348100|466722430|FG001|Overall Study|Subject Withdrew Consent|0|||
129662190|NCT01348100|466722431|FG002|Overall Study|Subject Withdrew Consent|2|||
129662191|NCT01348100|466722432|FG003|Overall Study|Subject Withdrew Consent|0|||
129662192|NCT01348100|466722433|FG004|Overall Study|Subject Withdrew Consent|1|||
129662193|NCT01348100|466722434|FG005|Overall Study|Subject Withdrew Consent|0|||
129662194|NCT01348100|466722435|FG006|Overall Study|Subject Withdrew Consent|1|||
129662195|NCT01348100|466722429|FG000|Overall Study|Protocol Deviation|0|||
129662196|NCT01348100|466722430|FG001|Overall Study|Protocol Deviation|0|||
129662197|NCT01348100|466722431|FG002|Overall Study|Protocol Deviation|0|||
129662198|NCT01348100|466722432|FG003|Overall Study|Protocol Deviation|1|||
129662199|NCT01348100|466722433|FG004|Overall Study|Protocol Deviation|0|||
129991052|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
129991053|NCT02527343|467931377|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991054|NCT02527343|467931378|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991055|NCT02527343|467931379|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991056|NCT02527343|467931380|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
129991057|NCT02527343|467931381|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
129991058|NCT02527343|467931382|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
129991059|NCT02527343|467931377|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991060|NCT02527343|467931378|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991061|NCT02527343|467931379|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991062|NCT02527343|467931380|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
129991063|NCT02527343|467931381|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
129991064|NCT02527343|467931382|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
129662200|NCT01348100|466722434|FG005|Overall Study|Protocol Deviation|0|||
129662201|NCT01348100|466722435|FG006|Overall Study|Protocol Deviation|0|||
129662202|NCT01348100|466722429|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129662203|NCT01348100|466722430|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129662204|NCT01348100|466722431|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129662205|NCT01348100|466722432|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129662206|NCT01348100|466722433|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129991065|NCT02527343|467931377|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991066|NCT02527343|467931378|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991067|NCT02527343|467931379|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129662207|NCT01348100|466722434|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129662208|NCT01348100|466722435|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129662209|NCT01348100|466722429|FG000|Overall Study|Lost to Follow-up|0|||
129662210|NCT01348100|466722430|FG001|Overall Study|Lost to Follow-up|0|||
129662211|NCT01348100|466722431|FG002|Overall Study|Lost to Follow-up|0|||
129662212|NCT01348100|466722432|FG003|Overall Study|Lost to Follow-up|0|||
129662213|NCT01348100|466722433|FG004|Overall Study|Lost to Follow-up|0|||
129662214|NCT01348100|466722434|FG005|Overall Study|Lost to Follow-up|0|||
129662215|NCT01348100|466722435|FG006|Overall Study|Lost to Follow-up|1|||
129662216|NCT01348100|466722429|FG000|Overall Study|Administrative Problems|0|||
129662217|NCT01348100|466722430|FG001|Overall Study|Administrative Problems|0|||
129662218|NCT01348100|466722431|FG002|Overall Study|Administrative Problems|0|||
129662219|NCT01348100|466722432|FG003|Overall Study|Administrative Problems|0|||
129662220|NCT01348100|466722433|FG004|Overall Study|Administrative Problems|0|||
129662221|NCT01348100|466722434|FG005|Overall Study|Administrative Problems|1|||
129662222|NCT01348100|466722435|FG006|Overall Study|Administrative Problems|1|||
129662223|NCT03882957|466722438|FG000|Overall Study|Did not complete all three arms|1|||
129662224|NCT01134393|466722440|FG000|Overall Study|Adverse Event|18|||
129662225|NCT01134393|466722440|FG000|Overall Study|Lack of Efficacy|2|||
129662226|NCT01134393|466722440|FG000|Overall Study|Protocol Violation|12|||
129662227|NCT01134393|466722440|FG000|Overall Study|Lost to Follow-up|3|||
129662228|NCT01134393|466722440|FG000|Overall Study|Withdrawal by Subject|11|||
129662229|NCT01134393|466722440|FG000|Overall Study|Other|6|||
129662230|NCT03134911|466722441|FG000|Overall Study|Screen failure|31|||
129662231|NCT03134911|466722441|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
129662232|NCT02787083|466722447|FG000|Overall Study|Adverse Event|1|||
129662233|NCT02787083|466722448|FG001|Overall Study|Adverse Event|0|||
129662234|NCT02787083|466722447|FG000|Overall Study|Withdrawal by Subject|2|||
129662235|NCT02787083|466722448|FG001|Overall Study|Withdrawal by Subject|2|||
129662236|NCT02710084|466722449|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
129662237|NCT02710084|466722450|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
129662238|NCT02182830|466722451|FG000|Overall Study|Not Treated|1|||
129662239|NCT02182830|466722452|FG001|Overall Study|Not Treated|1|||
129662240|NCT02182830|466722451|FG000|Overall Study|Trial stopped, reason missing|3|||
129662241|NCT02182830|466722452|FG001|Overall Study|Trial stopped, reason missing|3|||
129662242|NCT02182830|466722451|FG000|Overall Study|Consent withdrawn|8|||
129662243|NCT02182830|466722452|FG001|Overall Study|Consent withdrawn|8|||
129662244|NCT02182830|466722451|FG000|Overall Study|Lost to Follow-up|3|||
129662245|NCT02182830|466722452|FG001|Overall Study|Lost to Follow-up|3|||
129662246|NCT00154375|466722453|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
129662247|NCT00154375|466722454|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
129662248|NCT00154375|466722453|FG000|Overall Study|Adverse Event|18|||
129662249|NCT00154375|466722454|FG001|Overall Study|Adverse Event|20|||
129991068|NCT02527343|467931380|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991069|NCT02527343|467931381|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
129991070|NCT02527343|467931382|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
129991071|NCT02527343|467931377|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
129991072|NCT02527343|467931378|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
129991073|NCT02527343|467931379|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
129662250|NCT00154375|466722453|FG000|Overall Study|Withdrawal by Subject|14|||
129662251|NCT00154375|466722454|FG001|Overall Study|Withdrawal by Subject|10|||
129662252|NCT00154375|466722453|FG000|Overall Study|Death|5|||
129662253|NCT00154375|466722454|FG001|Overall Study|Death|13|||
129662254|NCT00154375|466722453|FG000|Overall Study|Study drug no longer required|5|||
129662255|NCT00154375|466722454|FG001|Overall Study|Study drug no longer required|3|||
129662256|NCT00154375|466722453|FG000|Overall Study|Lost to Follow-up|2|||
129662257|NCT00154375|466722454|FG001|Overall Study|Lost to Follow-up|1|||
129662258|NCT00154375|466722453|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129662259|NCT00154375|466722454|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129662260|NCT00154375|466722453|FG000|Overall Study|Protocol Violation|0|||
129662261|NCT00154375|466722454|FG001|Overall Study|Protocol Violation|1|||
129662262|NCT00154375|466722453|FG000|Overall Study|Suspected progression of disease|44|||
129662263|NCT00154375|466722454|FG001|Overall Study|Suspected progression of disease|30|||
129662264|NCT02348008|466722455|FG000|Overall Study|Adverse Event|2|||
129662265|NCT02348008|466722456|FG001|Overall Study|Adverse Event|3|||
129662266|NCT02348008|466722457|FG002|Overall Study|Adverse Event|3|||
129662267|NCT02348008|466722455|FG000|Overall Study|Disease Progression|1|||
129662268|NCT02348008|466722456|FG001|Overall Study|Disease Progression|5|||
129662269|NCT02348008|466722457|FG002|Overall Study|Disease Progression|16|||
129662270|NCT02348008|466722455|FG000|Overall Study|Withdrawal by Subject|0|||
129662271|NCT02348008|466722456|FG001|Overall Study|Withdrawal by Subject|1|||
129662272|NCT02348008|466722457|FG002|Overall Study|Withdrawal by Subject|0|||
129662273|NCT02348008|466722455|FG000|Overall Study|Symptomatic Deterioration|0|||
129662274|NCT02348008|466722456|FG001|Overall Study|Symptomatic Deterioration|1|||
129991074|NCT02527343|467931380|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
129991075|NCT02527343|467931381|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
129662275|NCT02348008|466722457|FG002|Overall Study|Symptomatic Deterioration|0|||
129662276|NCT00334295|466722462|FG000|Overall Study|Patients received fewer than 3 injection|5|||
129662277|NCT03268005|466722463|FG000|Overall Study|Death|2|||
129662278|NCT03268005|466722464|FG001|Overall Study|Death|1|||
129991076|NCT02527343|467931382|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
129662279|NCT03268005|466722463|FG000|Overall Study|Lost to Follow-up|2|||
129662280|NCT03268005|466722464|FG001|Overall Study|Lost to Follow-up|2|||
129662281|NCT03268005|466722463|FG000|Overall Study|Withdrawal by Subject|11|||
129991077|NCT00701220|467931383|FG000|Overall Study|Withdrawal by Subject|0|||
129991078|NCT00701220|467931384|FG001|Overall Study|Withdrawal by Subject|2|||
129991079|NCT00701220|467931383|FG000|Overall Study|Protocol Violation|2|||
129991080|NCT00701220|467931384|FG001|Overall Study|Protocol Violation|0|||
129991081|NCT03235284|467931385|FG000|Overall Study|Adverse Event|1|||
129991082|NCT03235284|467931386|FG001|Overall Study|Adverse Event|2|||
129991083|NCT03235284|467931387|FG002|Overall Study|Adverse Event|1|||
129991084|NCT00440999|467931390|FG000|Overall Study|Adverse Event|0|||
129991085|NCT00440999|467931391|FG001|Overall Study|Adverse Event|2|||
129991086|NCT00440999|467931390|FG000|Overall Study|Lack of Efficacy|6|||
129991087|NCT00440999|467931391|FG001|Overall Study|Lack of Efficacy|7|||
129991088|NCT00440999|467931390|FG000|Overall Study|Lost to Follow-up|19|||
129991089|NCT00440999|467931391|FG001|Overall Study|Lost to Follow-up|12|||
129991090|NCT00440999|467931390|FG000|Overall Study|Protocol Violation|1|||
129991091|NCT00440999|467931391|FG001|Overall Study|Protocol Violation|0|||
129991092|NCT00440999|467931390|FG000|Overall Study|Withdrawal by Subject|2|||
129991093|NCT00440999|467931391|FG001|Overall Study|Withdrawal by Subject|5|||
129991094|NCT00440999|467931390|FG000|Overall Study|Subjets missed the visit|1|||
129991095|NCT00440999|467931391|FG001|Overall Study|Subjets missed the visit|0|||
129991096|NCT00440999|467931390|FG000|Overall Study|Mixed infection at entry|1|||
129991097|NCT00440999|467931391|FG001|Overall Study|Mixed infection at entry|0|||
129991098|NCT00440999|467931390|FG000|Overall Study|P. falciparum malaria|5|||
129991099|NCT00440999|467931391|FG001|Overall Study|P. falciparum malaria|14|||
129991100|NCT00440999|467931390|FG000|Overall Study|Subj left hosp without inform staff|0|||
129991101|NCT00440999|467931391|FG001|Overall Study|Subj left hosp without inform staff|1|||
129991102|NCT04745026|467931392|FG000|Overall Study|Physician Decision|1|||
129991103|NCT04745026|467931393|FG001|Overall Study|Physician Decision|0|||
129991104|NCT04745026|467931392|FG000|Overall Study|Adverse Event|2|||
129991105|NCT04745026|467931393|FG001|Overall Study|Adverse Event|2|||
129991106|NCT04745026|467931392|FG000|Overall Study|Protocol Violation|1|||
129991107|NCT04745026|467931393|FG001|Overall Study|Protocol Violation|3|||
129991108|NCT04745026|467931392|FG000|Overall Study|Lost to Follow-up|4|||
129991109|NCT04745026|467931393|FG001|Overall Study|Lost to Follow-up|3|||
129991110|NCT04745026|467931392|FG000|Overall Study|Withdrawal by Subject|5|||
129991111|NCT04745026|467931393|FG001|Overall Study|Withdrawal by Subject|5|||
129991112|NCT05041101|467931394|FG000|Overall Study|Adverse Event|1|||
129991113|NCT05041101|467931395|FG001|Overall Study|Adverse Event|0|||
129991114|NCT05041101|467931396|FG002|Overall Study|Adverse Event|0|||
129991115|NCT05041101|467931394|FG000|Overall Study|Diease Progression|5|||
129991116|NCT05041101|467931395|FG001|Overall Study|Diease Progression|0|||
129991117|NCT05041101|467931396|FG002|Overall Study|Diease Progression|0|||
129991118|NCT01205152|467931397|FG000|Overall Study|Death|1|||
129991119|NCT04426851|467931398|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
129991120|NCT04426851|467931399|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
129991121|NCT04426851|467931398|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
129991122|NCT04426851|467931399|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
129991123|NCT00249002|467931400|FG000|Overall Study|Adverse Event|2|||
129991124|NCT00249002|467931400|FG000|Overall Study|Study cancellation|3|||
129991125|NCT00249002|467931400|FG000|Overall Study|Other|2|||
129991126|NCT03256851|467931401|FG000|Overall Study|Withdrawal by Subject|1|||
129991127|NCT03256851|467931402|FG001|Overall Study|Withdrawal by Subject|0|||
129991128|NCT00986674|467931403|FG000|Overall Study|Lack of Efficacy|28|||
129991129|NCT00986674|467931404|FG001|Overall Study|Lack of Efficacy|25|||
129662282|NCT03268005|466722464|FG001|Overall Study|Withdrawal by Subject|11|||
129662283|NCT04378569|466724156|FG000|Overall Study|Adverse Event|0|||
129662284|NCT04378569|466724157|FG001|Overall Study|Adverse Event|0|||
129662285|NCT04378569|466724158|FG002|Overall Study|Adverse Event|2|||
129662286|NCT04378569|466724159|FG003|Overall Study|Adverse Event|0|||
129662287|NCT04378569|466724160|FG004|Overall Study|Adverse Event|3|||
129662288|NCT04378569|466724161|FG005|Overall Study|Adverse Event|3|||
129991130|NCT00986674|467931405|FG002|Overall Study|Lack of Efficacy|23|||
129991131|NCT00986674|467931403|FG000|Overall Study|Adverse Event|4|||
129991132|NCT00986674|467931404|FG001|Overall Study|Adverse Event|8|||
129991133|NCT00986674|467931405|FG002|Overall Study|Adverse Event|9|||
129991134|NCT00986674|467931403|FG000|Overall Study|Death|5|||
129991135|NCT00986674|467931404|FG001|Overall Study|Death|0|||
129991136|NCT00986674|467931405|FG002|Overall Study|Death|4|||
129991137|NCT00986674|467931403|FG000|Overall Study|Withdrawal by Subject|6|||
129991138|NCT00986674|467931404|FG001|Overall Study|Withdrawal by Subject|2|||
129991139|NCT00986674|467931405|FG002|Overall Study|Withdrawal by Subject|1|||
129991140|NCT00986674|467931403|FG000|Overall Study|alternative therapy|0|||
129662289|NCT04378569|466724156|FG000|Overall Study|Lost to Follow-up|0|||
129991141|NCT00986674|467931404|FG001|Overall Study|alternative therapy|0|||
129991142|NCT00986674|467931405|FG002|Overall Study|alternative therapy|1|||
129991143|NCT00986674|467931403|FG000|Overall Study|not start protocol therapy|4|||
129662290|NCT04378569|466724157|FG001|Overall Study|Lost to Follow-up|3|||
129662291|NCT04378569|466724158|FG002|Overall Study|Lost to Follow-up|1|||
129662292|NCT04378569|466724159|FG003|Overall Study|Lost to Follow-up|0|||
129662293|NCT04378569|466724160|FG004|Overall Study|Lost to Follow-up|1|||
129662294|NCT04378569|466724161|FG005|Overall Study|Lost to Follow-up|1|||
129662295|NCT04378569|466724156|FG000|Overall Study|Protocol Violation|0|||
129662296|NCT04378569|466724157|FG001|Overall Study|Protocol Violation|0|||
129662297|NCT04378569|466724158|FG002|Overall Study|Protocol Violation|0|||
129662298|NCT04378569|466724159|FG003|Overall Study|Protocol Violation|0|||
129662299|NCT04378569|466724160|FG004|Overall Study|Protocol Violation|0|||
129662300|NCT04378569|466724161|FG005|Overall Study|Protocol Violation|1|||
129662301|NCT04378569|466724156|FG000|Overall Study|Withdrawal by Subject|0|||
129662302|NCT04378569|466724157|FG001|Overall Study|Withdrawal by Subject|6|||
129662303|NCT04378569|466724158|FG002|Overall Study|Withdrawal by Subject|7|||
129662304|NCT04378569|466724159|FG003|Overall Study|Withdrawal by Subject|4|||
129662305|NCT04378569|466724160|FG004|Overall Study|Withdrawal by Subject|5|||
129662306|NCT04378569|466724161|FG005|Overall Study|Withdrawal by Subject|4|||
129662307|NCT04378569|466724156|FG000|Overall Study|Lack of response|0|||
129662308|NCT04378569|466724157|FG001|Overall Study|Lack of response|0|||
129662309|NCT04378569|466724158|FG002|Overall Study|Lack of response|1|||
129662310|NCT04378569|466724159|FG003|Overall Study|Lack of response|0|||
129662311|NCT04378569|466724160|FG004|Overall Study|Lack of response|1|||
129662312|NCT04378569|466724161|FG005|Overall Study|Lack of response|1|||
129662313|NCT01962948|466724162|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
129662314|NCT01962948|466724163|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
129662315|NCT01962948|466724164|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
129662316|NCT01962948|466724165|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
129662317|NCT00281697|466724170|FG000|Overall Study|> 60 days since last dose of study drug|4|||
129662318|NCT00281697|466724171|FG001|Overall Study|> 60 days since last dose of study drug|4|||
129662319|NCT00281697|466724170|FG000|Overall Study|Adverse Event|54|||
129662320|NCT00281697|466724171|FG001|Overall Study|Adverse Event|15|||
129662321|NCT00281697|466724170|FG000|Overall Study|Death|8|||
129662322|NCT00281697|466724171|FG001|Overall Study|Death|3|||
129662323|NCT00281697|466724170|FG000|Overall Study|Disease progression|279|||
129662324|NCT00281697|466724171|FG001|Overall Study|Disease progression|149|||
129662325|NCT00281697|466724170|FG000|Overall Study|Other|5|||
129662326|NCT00281697|466724171|FG001|Overall Study|Other|6|||
129662327|NCT00281697|466724170|FG000|Overall Study|Physician's decision to withdraw|15|||
129662328|NCT00281697|466724171|FG001|Overall Study|Physician's decision to withdraw|12|||
129662329|NCT00281697|466724170|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
129662330|NCT00281697|466724171|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
129662331|NCT00281697|466724170|FG000|Overall Study|Did not receive study drug|3|||
129662332|NCT00281697|466724171|FG001|Overall Study|Did not receive study drug|2|||
129662333|NCT04446429|466724172|FG000|Overall Study|Lost to Follow-up|6|||
129662334|NCT04446429|466724173|FG001|Overall Study|Lost to Follow-up|0|||
129662335|NCT02256917|466724174|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
129662336|NCT02256917|466724174|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
129662337|NCT02256917|466724174|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
129662338|NCT02256917|466724174|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
129662339|NCT02256917|466724174|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
129662340|NCT00715299|466724175|FG000|Overall Study|Withdrawal by Subject|1|||
129662341|NCT00715299|466724175|FG000|Overall Study|Adverse Event|3|||
129662342|NCT00715299|466724175|FG000|Overall Study|failed the pre-screen exercise test|2|||
129662343|NCT01896193|466724181|FG000|Overall Study|Lack of Efficacy|20|||
129662344|NCT01896193|466724182|FG001|Overall Study|Lack of Efficacy|11|||
129662345|NCT01896193|466724181|FG000|Overall Study|Protocol Violation|0|||
129662346|NCT01896193|466724182|FG001|Overall Study|Protocol Violation|1|||
129662347|NCT01896193|466724181|FG000|Overall Study|Withdrew Consent|1|||
129662348|NCT01896193|466724182|FG001|Overall Study|Withdrew Consent|0|||
129662349|NCT01300247|466724184|FG000|Overall Study|Death|1|||
129662350|NCT01300247|466724185|FG001|Overall Study|Death|1|||
129662351|NCT01300247|466724184|FG000|Overall Study|Lost to Follow-up|2|||
129662352|NCT01300247|466724185|FG001|Overall Study|Lost to Follow-up|0|||
129662353|NCT01300247|466724184|FG000|Overall Study|Withdrawal by Subject|1|||
129662354|NCT01300247|466724185|FG001|Overall Study|Withdrawal by Subject|0|||
129662355|NCT01300247|466724184|FG000|Overall Study|Non-Compliance|0|||
129662356|NCT01300247|466724185|FG001|Overall Study|Non-Compliance|1|||
129662357|NCT05359952|466724186|FG000|Overall Study|Lost to Follow-up|1|||
129662358|NCT05359952|466724187|FG001|Overall Study|Lost to Follow-up|0|||
129662359|NCT01556932|466724188|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
129883868|NCT02733042|467534448|FG007|Overall Study|Progressive Disease|3|||
129883869|NCT02733042|467534449|FG008|Overall Study|Progressive Disease|3|||
129883870|NCT02733042|467534450|FG009|Overall Study|Progressive Disease|2|||
129883871|NCT02733042|467534451|FG010|Overall Study|Progressive Disease|2|||
129883872|NCT02733042|467534452|FG011|Overall Study|Progressive Disease|2|||
129883873|NCT02733042|467534453|FG012|Overall Study|Progressive Disease|8|||
129662360|NCT01556932|466724189|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
129662361|NCT02328937|466724190|FG000|Period 1|Lost to Follow-up|0|||
129662362|NCT02328937|466724191|FG001|Period 1|Lost to Follow-up|0|||
129662363|NCT02328937|466724192|FG002|Period 1|Lost to Follow-up|0|||
129662364|NCT02328937|466724193|FG003|Period 1|Lost to Follow-up|1|||
129662365|NCT02328937|466724194|FG004|Period 1|Lost to Follow-up|0|||
129662366|NCT02328937|466724195|FG005|Period 1|Lost to Follow-up|0|||
129662367|NCT02328937|466724190|FG000|Period 2|Adverse Event|0|||
129662368|NCT02328937|466724191|FG001|Period 2|Adverse Event|0|||
129662369|NCT02328937|466724192|FG002|Period 2|Adverse Event|1|||
129662370|NCT02328937|466724193|FG003|Period 2|Adverse Event|0|||
129662371|NCT02328937|466724194|FG004|Period 2|Adverse Event|0|||
129662372|NCT02328937|466724195|FG005|Period 2|Adverse Event|0|||
129662373|NCT00996034|466724198|FG000|Overall Study|Lost to Follow-up|2|||
129662374|NCT00996034|466724198|FG000|Overall Study|withdrawn by PI|1|||
129662375|NCT03231306|466724199|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
129662376|NCT03231306|466724199|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
129662377|NCT03231306|466724199|FG000|Overall Study|Treatment delay > 21 days|2|||
129662378|NCT03231306|466724199|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
129662379|NCT03231306|466724199|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
129662380|NCT03231306|466724199|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
129662381|NCT03231306|466724199|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
129662382|NCT03231306|466724199|FG000|Overall Study|More than 1 Reason|2|||
129662383|NCT00685360|466724200|FG000|Overall Study|Lost to Follow-up|0|||
129662384|NCT00685360|466724201|FG001|Overall Study|Lost to Follow-up|1|||
129662385|NCT00685360|466724202|FG002|Overall Study|Lost to Follow-up|2|||
129662386|NCT00685360|466724200|FG000|Overall Study|Adverse Event|4|||
129662387|NCT00685360|466724201|FG001|Overall Study|Adverse Event|6|||
129662388|NCT00685360|466724202|FG002|Overall Study|Adverse Event|4|||
129662389|NCT00685360|466724200|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
129662390|NCT00685360|466724201|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
129662391|NCT00685360|466724202|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
129662392|NCT00685360|466724200|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
129662393|NCT00685360|466724201|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
129662394|NCT00685360|466724202|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
129662395|NCT00685360|466724200|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
129662396|NCT00685360|466724201|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
129662397|NCT00685360|466724202|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
129662398|NCT00685360|466724200|FG000|Overall Study|Protocol Deviation|0|||
129991144|NCT00986674|467931404|FG001|Overall Study|not start protocol therapy|3|||
129991145|NCT00986674|467931405|FG002|Overall Study|not start protocol therapy|1|||
129991146|NCT00986674|467931403|FG000|Overall Study|unknown/not specify|0|||
129991147|NCT00986674|467931404|FG001|Overall Study|unknown/not specify|7|||
129991148|NCT00986674|467931405|FG002|Overall Study|unknown/not specify|9|||
129991149|NCT02128542|467931406|FG000|Overall Study|Lost to Follow-up|3|||
129991150|NCT02128542|467931407|FG001|Overall Study|Lost to Follow-up|0|||
129991151|NCT02128542|467931406|FG000|Overall Study|Withdrew Consent|1|||
129991152|NCT02128542|467931407|FG001|Overall Study|Withdrew Consent|0|||
129991153|NCT01778023|467931408|FG000|Overall Study|Withdrawal by Subject|0|||
129991154|NCT01778023|467931409|FG001|Overall Study|Withdrawal by Subject|3|||
129662399|NCT00685360|466724201|FG001|Overall Study|Protocol Deviation|1|||
129662400|NCT00685360|466724202|FG002|Overall Study|Protocol Deviation|1|||
129662401|NCT04865419|466724203|FG000|Overall Study|Other|1|||
129662402|NCT04865419|466724204|FG001|Overall Study|Other|2|||
129662403|NCT04865419|466724205|FG002|Overall Study|Other|2|||
129662404|NCT04865419|466724206|FG003|Overall Study|Other|1|||
129662405|NCT04865419|466724207|FG004|Overall Study|Other|3|||
129662406|NCT04865419|466724208|FG005|Overall Study|Other|0|||
129991155|NCT01990560|467931410|FG000|Overall Study|Withdrawal by Subject|1|||
129991156|NCT01098097|467931411|FG000|Overall Study|Adverse Event|17|||
129991157|NCT01098097|467931411|FG000|Overall Study|Lost to Follow-up|18|||
129991158|NCT01098097|467931411|FG000|Overall Study|Status unknown|16|||
129991159|NCT01098097|467931411|FG000|Overall Study|No reason reported|31|||
129991160|NCT00966277|467931414|FG000|Overall Study|Withdrawal by Subject|3|||
129662407|NCT04865419|466724209|FG006|Overall Study|Other|0|||
129662408|NCT04865419|466724210|FG007|Overall Study|Other|1|||
129662409|NCT04865419|466724211|FG008|Overall Study|Other|0|||
129662410|NCT04865419|466724212|FG009|Overall Study|Other|0|||
129662411|NCT04865419|466724213|FG010|Overall Study|Other|0|||
129662412|NCT04865419|466724203|FG000|Overall Study|Withdrawal by Subject|0|||
129662413|NCT04865419|466724204|FG001|Overall Study|Withdrawal by Subject|1|||
129662414|NCT04865419|466724205|FG002|Overall Study|Withdrawal by Subject|1|||
129662415|NCT04865419|466724206|FG003|Overall Study|Withdrawal by Subject|0|||
129662416|NCT04865419|466724207|FG004|Overall Study|Withdrawal by Subject|0|||
129662417|NCT04865419|466724208|FG005|Overall Study|Withdrawal by Subject|0|||
129662418|NCT04865419|466724209|FG006|Overall Study|Withdrawal by Subject|0|||
129662419|NCT04865419|466724210|FG007|Overall Study|Withdrawal by Subject|1|||
129662420|NCT04865419|466724211|FG008|Overall Study|Withdrawal by Subject|2|||
129662421|NCT04865419|466724212|FG009|Overall Study|Withdrawal by Subject|1|||
129662422|NCT04865419|466724213|FG010|Overall Study|Withdrawal by Subject|0|||
129662423|NCT04865419|466724203|FG000|Overall Study|Study terminated by Sponsor|0|||
129662424|NCT04865419|466724204|FG001|Overall Study|Study terminated by Sponsor|0|||
129662425|NCT04865419|466724205|FG002|Overall Study|Study terminated by Sponsor|0|||
129662426|NCT04865419|466724206|FG003|Overall Study|Study terminated by Sponsor|2|||
129662427|NCT04865419|466724207|FG004|Overall Study|Study terminated by Sponsor|2|||
129662428|NCT04865419|466724208|FG005|Overall Study|Study terminated by Sponsor|0|||
129662429|NCT04865419|466724209|FG006|Overall Study|Study terminated by Sponsor|0|||
129662430|NCT04865419|466724210|FG007|Overall Study|Study terminated by Sponsor|0|||
129662431|NCT04865419|466724211|FG008|Overall Study|Study terminated by Sponsor|0|||
129662432|NCT04865419|466724212|FG009|Overall Study|Study terminated by Sponsor|0|||
129662433|NCT04865419|466724213|FG010|Overall Study|Study terminated by Sponsor|1|||
129662434|NCT04865419|466724203|FG000|Overall Study|Death|3|||
129662435|NCT04865419|466724204|FG001|Overall Study|Death|1|||
129662436|NCT04865419|466724205|FG002|Overall Study|Death|4|||
129662437|NCT04865419|466724206|FG003|Overall Study|Death|2|||
129662438|NCT04865419|466724207|FG004|Overall Study|Death|5|||
129662439|NCT04865419|466724208|FG005|Overall Study|Death|2|||
129662440|NCT04865419|466724209|FG006|Overall Study|Death|1|||
129662441|NCT04865419|466724210|FG007|Overall Study|Death|1|||
129662442|NCT04865419|466724211|FG008|Overall Study|Death|2|||
129662443|NCT04865419|466724212|FG009|Overall Study|Death|2|||
129662444|NCT04865419|466724213|FG010|Overall Study|Death|1|||
129662445|NCT04865419|466724203|FG000|Overall Study|Lost to Follow-up|0|||
129662446|NCT04865419|466724204|FG001|Overall Study|Lost to Follow-up|0|||
129662447|NCT04865419|466724205|FG002|Overall Study|Lost to Follow-up|0|||
129662448|NCT04865419|466724206|FG003|Overall Study|Lost to Follow-up|0|||
129662449|NCT04865419|466724207|FG004|Overall Study|Lost to Follow-up|0|||
129662450|NCT04865419|466724208|FG005|Overall Study|Lost to Follow-up|0|||
129662451|NCT04865419|466724209|FG006|Overall Study|Lost to Follow-up|0|||
129662452|NCT04865419|466724210|FG007|Overall Study|Lost to Follow-up|0|||
129662453|NCT04865419|466724211|FG008|Overall Study|Lost to Follow-up|0|||
129662454|NCT04865419|466724212|FG009|Overall Study|Lost to Follow-up|1|||
129662455|NCT04865419|466724213|FG010|Overall Study|Lost to Follow-up|0|||
129662456|NCT00547157|466724214|FG000|Overall Study|Other|1|||
129662457|NCT00547157|466724215|FG001|Overall Study|Other|0|||
129662458|NCT00547157|466724214|FG000|Overall Study|Death|38|||
129662459|NCT00547157|466724215|FG001|Overall Study|Death|18|||
129662460|NCT00547157|466724214|FG000|Overall Study|Withdrawal by Subject|3|||
129662461|NCT00547157|466724215|FG001|Overall Study|Withdrawal by Subject|1|||
129662462|NCT00547157|466724214|FG000|Overall Study|Administrative decision|3|||
129662463|NCT00547157|466724215|FG001|Overall Study|Administrative decision|2|||
129662464|NCT00547157|466724214|FG000|Overall Study|Lost to Follow-up|4|||
129662465|NCT00547157|466724215|FG001|Overall Study|Lost to Follow-up|2|||
129662466|NCT04208412|466724216|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
129662467|NCT04208412|466724217|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
129662468|NCT04208412|466724216|FG000|Overall Study|Withdrawal by Subject|1|||
129662469|NCT04208412|466724217|FG001|Overall Study|Withdrawal by Subject|0|||
129662470|NCT04208412|466724216|FG000|Overall Study|Lost to Follow-up|0|||
129662471|NCT04208412|466724217|FG001|Overall Study|Lost to Follow-up|1|||
129662472|NCT05415462|466724220|FG000|Overall Study|Death|18|||
129662473|NCT05415462|466724221|FG001|Overall Study|Death|10|||
129662474|NCT05415462|466724220|FG000|Overall Study|Lost to Follow-up|72|||
129662475|NCT05415462|466724221|FG001|Overall Study|Lost to Follow-up|64|||
129662476|NCT05415462|466724220|FG000|Overall Study|Physician Decision|5|||
129662477|NCT05415462|466724221|FG001|Overall Study|Physician Decision|5|||
129662478|NCT05415462|466724220|FG000|Overall Study|Protocol Deviation|1|||
129662479|NCT05415462|466724221|FG001|Overall Study|Protocol Deviation|0|||
129662480|NCT05415462|466724220|FG000|Overall Study|Withdrawal by Subject|129|||
129662481|NCT05415462|466724221|FG001|Overall Study|Withdrawal by Subject|101|||
129662482|NCT05415462|466724220|FG000|Overall Study|Other Than Specified|8|||
129662483|NCT05415462|466724221|FG001|Overall Study|Other Than Specified|8|||
129662484|NCT04186221|466724222|FG000|Overall Study|Death|1|||
129662485|NCT01904032|466724231|FG000|Overall Study|Adverse Event|3|||
129662486|NCT01904032|466724232|FG001|Overall Study|Adverse Event|1|||
129662487|NCT01904032|466724231|FG000|Overall Study|Lost to Follow-up|4|||
129662488|NCT01904032|466724232|FG001|Overall Study|Lost to Follow-up|2|||
129662489|NCT00531947|466724233|FG000|Overall Study|Adverse Event|5|||
129662490|NCT00531947|466724234|FG001|Overall Study|Adverse Event|10|||
129662491|NCT00531947|466724233|FG000|Overall Study|Lost to Follow-up|12|||
129662492|NCT00531947|466724234|FG001|Overall Study|Lost to Follow-up|9|||
129662493|NCT00531947|466724233|FG000|Overall Study|Withdrawal by Subject|14|||
129662494|NCT00531947|466724234|FG001|Overall Study|Withdrawal by Subject|19|||
129662495|NCT00531947|466724233|FG000|Overall Study|Protocol Violation|2|||
129662496|NCT00531947|466724234|FG001|Overall Study|Protocol Violation|1|||
129991161|NCT00966277|467931415|FG001|Overall Study|Withdrawal by Subject|0|||
129991162|NCT00966277|467931414|FG000|Overall Study|Ineligible|1|||
129991163|NCT00966277|467931415|FG001|Overall Study|Ineligible|3|||
129991164|NCT00966277|467931414|FG000|Overall Study|Treatment Plan Changed|0|||
129991165|NCT00966277|467931415|FG001|Overall Study|Treatment Plan Changed|1|||
129991166|NCT01488487|467931416|FG000|Overall Study|Adverse Event|6|||
129991167|NCT01488487|467931416|FG000|Overall Study|Death|1|||
129991168|NCT01488487|467931416|FG000|Overall Study|Withdrawal by Subject|2|||
129991169|NCT01588496|467931420|FG000|Overall Study|Withdrawal by Subject|0|||
129991170|NCT01588496|467931421|FG001|Overall Study|Withdrawal by Subject|1|||
129991171|NCT01588496|467931422|FG002|Overall Study|Withdrawal by Subject|0|||
129991172|NCT01551212|467931423|FG000|Overall Study|Graft loss/Retransplantation|0|||
129991173|NCT01551212|467931424|FG001|Overall Study|Graft loss/Retransplantation|1|||
129991174|NCT01551212|467931423|FG000|Overall Study|Administrative problems|1|||
129991175|NCT01551212|467931424|FG001|Overall Study|Administrative problems|2|||
129991176|NCT01551212|467931423|FG000|Overall Study|Lost to Follow-up|0|||
129991177|NCT01551212|467931424|FG001|Overall Study|Lost to Follow-up|1|||
129991178|NCT01551212|467931423|FG000|Overall Study|Protocol Violation|0|||
129991179|NCT01551212|467931424|FG001|Overall Study|Protocol Violation|1|||
129991180|NCT01551212|467931423|FG000|Overall Study|Withdrawal by Subject|0|||
129991181|NCT01551212|467931424|FG001|Overall Study|Withdrawal by Subject|7|||
129991182|NCT01551212|467931423|FG000|Overall Study|Death|2|||
129662497|NCT00531947|466724233|FG000|Overall Study|Non-Compliance|4|||
129662498|NCT00531947|466724234|FG001|Overall Study|Non-Compliance|7|||
129662499|NCT00531947|466724233|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
129662500|NCT00531947|466724234|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
129662501|NCT01087203|466724239|FG000|Overall Study|Lost to Follow-up|2|||
129662502|NCT01087203|466724240|FG001|Overall Study|Lost to Follow-up|0|||
129662503|NCT01087203|466724239|FG000|Overall Study|Withdrawal by Subject|2|||
129662504|NCT01087203|466724240|FG001|Overall Study|Withdrawal by Subject|6|||
129662505|NCT01087203|466724239|FG000|Overall Study|Lack of Efficacy|1|||
129662506|NCT01087203|466724240|FG001|Overall Study|Lack of Efficacy|2|||
129662507|NCT01087203|466724239|FG000|Overall Study|Study terminated by sponsor|27|||
129662508|NCT01087203|466724240|FG001|Overall Study|Study terminated by sponsor|27|||
129662509|NCT04074330|466724252|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
129662510|NCT04074330|466724253|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
129662511|NCT04074330|466724254|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
129662512|NCT04074330|466724255|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
129662513|NCT04074330|466724256|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
129662514|NCT04074330|466724257|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
129662515|NCT04074330|466724258|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
129662516|NCT04074330|466724259|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
129662517|NCT04074330|466724260|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
129662518|NCT04074330|466724261|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
129662519|NCT04074330|466724252|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129662520|NCT04074330|466724253|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129662521|NCT04074330|466724254|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129662522|NCT04074330|466724255|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
129662523|NCT04074330|466724256|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129662524|NCT04074330|466724257|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129546594|NCT00572910|466294052|FG004|Overall Study|Withdrawal by Subject|1|||
129546595|NCT00572910|466294053|FG005|Overall Study|Withdrawal by Subject|3|||
129546596|NCT00572910|466294054|FG006|Overall Study|Withdrawal by Subject|0|||
129546597|NCT00572910|466294055|FG007|Overall Study|Withdrawal by Subject|2|||
129546598|NCT00572910|466294056|FG008|Overall Study|Withdrawal by Subject|2|||
129546599|NCT00572910|466294057|FG009|Overall Study|Withdrawal by Subject|2|||
129546600|NCT00572910|466294058|FG010|Overall Study|Withdrawal by Subject|1|||
129662525|NCT04074330|466724258|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
129662526|NCT04074330|466724259|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
129662527|NCT04074330|466724260|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129662528|NCT04074330|466724261|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
129662529|NCT04074330|466724252|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129662530|NCT04074330|466724253|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129662531|NCT04074330|466724254|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
129662532|NCT04074330|466724255|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129991183|NCT01551212|467931424|FG001|Overall Study|Death|4|||
129546601|NCT00592007|466294063|FG000|Overall Study|Withdrawal by Subject|1|||
129991184|NCT01551212|467931423|FG000|Overall Study|Never Received Study Treatment|2|||
129991185|NCT01551212|467931424|FG001|Overall Study|Never Received Study Treatment|4|||
129991186|NCT00705523|467931425|FG000|Overall Study|Lost to Follow-up|2|||
129991187|NCT00705523|467931426|FG001|Overall Study|Lost to Follow-up|3|||
129991188|NCT01013285|467931427|FG000|Overall Study|Death|48|||
129991189|NCT01013285|467931428|FG001|Overall Study|Death|89|||
129991190|NCT01242800|467931431|FG000|Overall Study|Patient refusal|0|||
129991191|NCT01242800|467931432|FG001|Overall Study|Patient refusal|10|||
129662533|NCT04074330|466724256|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129662534|NCT04074330|466724257|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129991192|NCT01242800|467931431|FG000|Overall Study|Physician Decision|0|||
129991193|NCT01242800|467931432|FG001|Overall Study|Physician Decision|1|||
129991194|NCT01242800|467931431|FG000|Overall Study|Disease progression|0|||
129662535|NCT04074330|466724258|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129662536|NCT04074330|466724259|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129662537|NCT04074330|466724260|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129662538|NCT04074330|466724261|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
129991195|NCT01242800|467931432|FG001|Overall Study|Disease progression|3|||
129991196|NCT01242800|467931431|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
129991197|NCT01242800|467931432|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
129991198|NCT01242800|467931431|FG000|Overall Study|Reasons not reported|0|||
129991199|NCT01242800|467931432|FG001|Overall Study|Reasons not reported|4|||
129991200|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
129991201|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
129662539|NCT04074330|466724252|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662540|NCT04074330|466724253|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662541|NCT04074330|466724254|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662542|NCT04074330|466724255|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662543|NCT04074330|466724256|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662544|NCT04074330|466724257|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
129662545|NCT04074330|466724258|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662546|NCT04074330|466724259|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
129991202|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
129991203|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
129991204|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
129991205|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
129991206|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
129991207|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
129662547|NCT04074330|466724260|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662548|NCT04074330|466724261|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
129662549|NCT04074330|466724252|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129662550|NCT04074330|466724253|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129662551|NCT04074330|466724254|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129662552|NCT04074330|466724255|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129662553|NCT04074330|466724256|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
129662554|NCT04074330|466724257|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
129662555|NCT04074330|466724258|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129662556|NCT04074330|466724259|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129662557|NCT04074330|466724260|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129662558|NCT04074330|466724261|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
129662559|NCT04074330|466724252|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129662560|NCT04074330|466724253|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129662561|NCT04074330|466724254|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129662562|NCT04074330|466724255|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129662563|NCT04074330|466724256|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129662564|NCT04074330|466724257|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
129662565|NCT04074330|466724258|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129662566|NCT04074330|466724259|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129662567|NCT04074330|466724260|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129662568|NCT04074330|466724261|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
129662569|NCT04074330|466724252|FG000|Dose Expansion (up to 42 Months)|Death|0|||
129662570|NCT04074330|466724253|FG001|Dose Expansion (up to 42 Months)|Death|0|||
129662571|NCT04074330|466724254|FG002|Dose Expansion (up to 42 Months)|Death|0|||
129662572|NCT04074330|466724255|FG003|Dose Expansion (up to 42 Months)|Death|0|||
129662573|NCT04074330|466724256|FG004|Dose Expansion (up to 42 Months)|Death|0|||
129991208|NCT00953745|467931433|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
129991209|NCT00953745|467931434|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
129991210|NCT00953745|467931433|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
129991211|NCT00953745|467931434|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
129991212|NCT02640157|467931438|FG000|Overall Study|Adverse Event|2|||
129991213|NCT02640157|467931439|FG001|Overall Study|Adverse Event|2|||
129991214|NCT02640157|467931440|FG002|Overall Study|Adverse Event|1|||
129662574|NCT04074330|466724257|FG005|Dose Expansion (up to 42 Months)|Death|0|||
129662575|NCT04074330|466724258|FG006|Dose Expansion (up to 42 Months)|Death|0|||
129662576|NCT04074330|466724259|FG007|Dose Expansion (up to 42 Months)|Death|0|||
129662577|NCT04074330|466724260|FG008|Dose Expansion (up to 42 Months)|Death|1|||
129662578|NCT04074330|466724261|FG009|Dose Expansion (up to 42 Months)|Death|0|||
129662579|NCT04074330|466724252|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662580|NCT04074330|466724253|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662581|NCT04074330|466724254|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662582|NCT04074330|466724255|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662583|NCT04074330|466724256|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662584|NCT04074330|466724257|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662585|NCT04074330|466724258|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662586|NCT04074330|466724259|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
129662587|NCT04074330|466724260|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
129662588|NCT04074330|466724261|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
129662589|NCT00184093|466724264|FG000|Overall Study|Adverse Event|3|||
129662590|NCT00184093|466724264|FG000|Overall Study|Lost to Follow-up|3|||
129662591|NCT00184093|466724264|FG000|Overall Study|Physician Decision|1|||
129662592|NCT00184093|466724264|FG000|Overall Study|Withdrawal by Subject|2|||
129662593|NCT05095311|466724265|FG000|Overall Study|Lost to Follow-up|7|||
129662594|NCT05095311|466724266|FG001|Overall Study|Lost to Follow-up|0|||
129662595|NCT05095311|466724267|FG002|Overall Study|Lost to Follow-up|0|||
129662596|NCT00972283|466724269|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
129662597|NCT00972283|466724270|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
129662598|NCT00972283|466724269|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
129662599|NCT00972283|466724270|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
129662600|NCT00972283|466724269|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
129662601|NCT00972283|466724270|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
129662602|NCT00972283|466724269|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
129662603|NCT00972283|466724270|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
129662604|NCT00972283|466724269|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
129662605|NCT00972283|466724270|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
129662606|NCT00972283|466724269|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
129662607|NCT00972283|466724270|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
129662608|NCT00972283|466724269|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
129662609|NCT00972283|466724270|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
129662610|NCT00972283|466724269|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
129662611|NCT00972283|466724270|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
129662612|NCT00972283|466724269|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
129662613|NCT00972283|466724270|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
129662614|NCT00972283|466724269|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
129662615|NCT00972283|466724270|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
129662616|NCT01868165|466724274|FG000|Overall Study|Withdrawal by Subject|36|||
129662617|NCT01868165|466724274|FG000|Overall Study|Physician Decision|2|||
129662618|NCT01868165|466724274|FG000|Overall Study|Lost to Follow-up|3|||
129662619|NCT01868165|466724274|FG000|Overall Study|Death|4|||
129662620|NCT02588664|466724277|FG000|Overall Study|Death|56|||
129662621|NCT02588664|466724278|FG001|Overall Study|Death|55|||
129662622|NCT02588664|466724277|FG000|Overall Study|Lost to Follow-up|1305|||
129662623|NCT02588664|466724278|FG001|Overall Study|Lost to Follow-up|990|||
129662624|NCT01429298|466724279|FG000|Overall Study|Protocol Violation|4|||
129662625|NCT01429298|466724280|FG001|Overall Study|Protocol Violation|6|||
129662626|NCT02903420|466724281|FG000|Overall Study|Death|3|||
129662627|NCT01124292|466724285|FG000|Overall Study|Lost to Follow-up|2|||
129662628|NCT01124292|466724286|FG001|Overall Study|Lost to Follow-up|4|||
129662629|NCT01124292|466724287|FG002|Overall Study|Lost to Follow-up|3|||
129662630|NCT01124292|466724285|FG000|Overall Study|Physician Decision|0|||
129662631|NCT01124292|466724286|FG001|Overall Study|Physician Decision|3|||
129662632|NCT01124292|466724287|FG002|Overall Study|Physician Decision|2|||
129662633|NCT01124292|466724285|FG000|Overall Study|Withdrawal by Subject|0|||
129662634|NCT01124292|466724286|FG001|Overall Study|Withdrawal by Subject|6|||
129662635|NCT01124292|466724287|FG002|Overall Study|Withdrawal by Subject|2|||
129662636|NCT01124292|466724285|FG000|Overall Study|medical issue unrelated to the study|0|||
129662637|NCT01124292|466724286|FG001|Overall Study|medical issue unrelated to the study|0|||
129662638|NCT01124292|466724287|FG002|Overall Study|medical issue unrelated to the study|2|||
129662639|NCT01124292|466724285|FG000|Overall Study|piercing track closed|0|||
129662640|NCT01124292|466724286|FG001|Overall Study|piercing track closed|2|||
129662641|NCT01124292|466724287|FG002|Overall Study|piercing track closed|1|||
129662642|NCT03373461|466724288|FG000|Part 2|Adverse Event|0|||
129662643|NCT03373461|466724289|FG001|Part 2|Adverse Event|1|||
129662644|NCT03373461|466724290|FG002|Part 2|Adverse Event|0|||
129662645|NCT03373461|466724291|FG003|Part 2|Adverse Event|0|||
129662646|NCT03373461|466724292|FG004|Part 2|Adverse Event|1|||
129662647|NCT03300180|466724293|FG000|Baseline|Withdrawal by Subject|4|||
129662648|NCT03300180|466724294|FG001|Baseline|Withdrawal by Subject|6|||
129662649|NCT03300180|466724295|FG002|Baseline|Withdrawal by Subject|4|||
129662650|NCT03300180|466724293|FG000|6 Month Outcome|Withdrawal by Subject|12|||
129662651|NCT03300180|466724294|FG001|6 Month Outcome|Withdrawal by Subject|12|||
129662652|NCT03300180|466724295|FG002|6 Month Outcome|Withdrawal by Subject|19|||
129662653|NCT03300180|466724293|FG000|6 Month Outcome|Death|2|||
129662654|NCT03300180|466724294|FG001|6 Month Outcome|Death|4|||
129662655|NCT03300180|466724295|FG002|6 Month Outcome|Death|3|||
129662656|NCT03300180|466724293|FG000|6 Month Outcome|Missed Assessment|43|||
129662657|NCT03300180|466724294|FG001|6 Month Outcome|Missed Assessment|52|||
129662658|NCT03300180|466724295|FG002|6 Month Outcome|Missed Assessment|46|||
129662659|NCT03300180|466724293|FG000|12 Month Outcome|Withdrawal by Subject|3|||
129662660|NCT03300180|466724294|FG001|12 Month Outcome|Withdrawal by Subject|6|||
129662661|NCT03300180|466724295|FG002|12 Month Outcome|Withdrawal by Subject|6|||
129662662|NCT03300180|466724293|FG000|12 Month Outcome|Death|9|||
129662663|NCT03300180|466724294|FG001|12 Month Outcome|Death|6|||
129662664|NCT03300180|466724295|FG002|12 Month Outcome|Death|6|||
129662665|NCT03300180|466724293|FG000|12 Month Outcome|Missed Assessment|62|||
129662666|NCT03300180|466724294|FG001|12 Month Outcome|Missed Assessment|59|||
129662667|NCT03300180|466724295|FG002|12 Month Outcome|Missed Assessment|58|||
129662668|NCT03300180|466724293|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
129662669|NCT03300180|466724294|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
129662670|NCT03300180|466724295|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
129662671|NCT03300180|466724293|FG000|18 Month Outcome Assessment|Death|8|||
129662672|NCT03300180|466724294|FG001|18 Month Outcome Assessment|Death|5|||
129662673|NCT03300180|466724295|FG002|18 Month Outcome Assessment|Death|5|||
129662674|NCT03300180|466724293|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
129662675|NCT03300180|466724294|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
129662676|NCT03300180|466724295|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
129662677|NCT03300180|466724293|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
129662678|NCT03300180|466724294|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
129662679|NCT03300180|466724295|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
129662680|NCT03300180|466724293|FG000|24 Month Outcome Assessment|Death|13|||
129662681|NCT03300180|466724294|FG001|24 Month Outcome Assessment|Death|13|||
129662682|NCT03300180|466724295|FG002|24 Month Outcome Assessment|Death|3|||
129662683|NCT03300180|466724293|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
129662684|NCT03300180|466724294|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
129662685|NCT03300180|466724295|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
129662686|NCT03654729|466726134|FG000|Overall Study|Death|9|||
129662687|NCT03654729|466726135|FG001|Overall Study|Death|9|||
129662688|NCT03654729|466726136|FG002|Overall Study|Death|16|||
129662689|NCT03654729|466726134|FG000|Overall Study|Withdrawal by Subject|8|||
129662690|NCT03654729|466726135|FG001|Overall Study|Withdrawal by Subject|6|||
129662691|NCT03654729|466726136|FG002|Overall Study|Withdrawal by Subject|4|||
129662692|NCT03654729|466726134|FG000|Overall Study|Study terminated by Sponsor|3|||
129991215|NCT02640157|467931438|FG000|Overall Study|Withdrew consent|2|||
129991216|NCT02640157|467931439|FG001|Overall Study|Withdrew consent|0|||
129991217|NCT02640157|467931440|FG002|Overall Study|Withdrew consent|2|||
129991218|NCT02640157|467931438|FG000|Overall Study|Lost to Follow-up|9|||
129991219|NCT02640157|467931439|FG001|Overall Study|Lost to Follow-up|2|||
129991220|NCT02640157|467931440|FG002|Overall Study|Lost to Follow-up|7|||
129991221|NCT02640157|467931438|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
129991222|NCT02640157|467931439|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
129991223|NCT02640157|467931440|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
129991224|NCT01679405|467931442|FG000|Overall Study|Death|2|||
129991225|NCT01679405|467931443|FG001|Overall Study|Death|5|||
129991226|NCT04677179|467931444|FG000|Induction Treatment Period|Adverse Event|1|||
129991227|NCT04677179|467931445|FG001|Induction Treatment Period|Adverse Event|0|||
129991228|NCT04677179|467931446|FG002|Induction Treatment Period|Adverse Event|0|||
129662693|NCT03654729|466726135|FG001|Overall Study|Study terminated by Sponsor|5|||
129662694|NCT03654729|466726136|FG002|Overall Study|Study terminated by Sponsor|4|||
129662695|NCT03654729|466726134|FG000|Overall Study|Not reported|2|||
129662696|NCT03654729|466726135|FG001|Overall Study|Not reported|4|||
129662697|NCT03654729|466726136|FG002|Overall Study|Not reported|5|||
129546602|NCT00592007|466294063|FG000|Overall Study|patient ineligible (out of lab range)|1|||
129662698|NCT03654729|466726134|FG000|Overall Study|Progressive disease|3|||
129662699|NCT03654729|466726135|FG001|Overall Study|Progressive disease|0|||
129662700|NCT03654729|466726136|FG002|Overall Study|Progressive disease|0|||
129662701|NCT03654729|466726134|FG000|Overall Study|Lost to Follow-up|2|||
129662702|NCT03654729|466726135|FG001|Overall Study|Lost to Follow-up|0|||
129662703|NCT03654729|466726136|FG002|Overall Study|Lost to Follow-up|0|||
129662704|NCT03654729|466726134|FG000|Overall Study|Physician Decision|2|||
129662705|NCT03654729|466726135|FG001|Overall Study|Physician Decision|0|||
129662706|NCT03654729|466726136|FG002|Overall Study|Physician Decision|0|||
129991229|NCT04677179|467931447|FG003|Induction Treatment Period|Adverse Event|0|||
129991230|NCT04677179|467931448|FG004|Induction Treatment Period|Adverse Event|0|||
129991231|NCT04677179|467931449|FG005|Induction Treatment Period|Adverse Event|0|||
129991232|NCT04677179|467931450|FG006|Induction Treatment Period|Adverse Event|0|||
129991233|NCT04677179|467931451|FG007|Induction Treatment Period|Adverse Event|0|||
129991234|NCT04677179|467931452|FG008|Induction Treatment Period|Adverse Event|0|||
129991235|NCT04677179|467931453|FG009|Induction Treatment Period|Adverse Event|0|||
129991236|NCT04677179|467931444|FG000|Induction Treatment Period|Physician Decision|1|||
129991237|NCT04677179|467931445|FG001|Induction Treatment Period|Physician Decision|0|||
129991238|NCT04677179|467931446|FG002|Induction Treatment Period|Physician Decision|1|||
129991239|NCT04677179|467931447|FG003|Induction Treatment Period|Physician Decision|0|||
129991240|NCT04677179|467931448|FG004|Induction Treatment Period|Physician Decision|0|||
129991241|NCT04677179|467931449|FG005|Induction Treatment Period|Physician Decision|0|||
129991242|NCT04677179|467931450|FG006|Induction Treatment Period|Physician Decision|0|||
129991243|NCT04677179|467931451|FG007|Induction Treatment Period|Physician Decision|0|||
129991244|NCT04677179|467931452|FG008|Induction Treatment Period|Physician Decision|0|||
129991245|NCT04677179|467931453|FG009|Induction Treatment Period|Physician Decision|0|||
129991246|NCT04677179|467931444|FG000|Induction Treatment Period|Protocol Violation|0|||
129991247|NCT04677179|467931445|FG001|Induction Treatment Period|Protocol Violation|1|||
129991248|NCT04677179|467931446|FG002|Induction Treatment Period|Protocol Violation|0|||
129991249|NCT04677179|467931447|FG003|Induction Treatment Period|Protocol Violation|0|||
129991250|NCT04677179|467931448|FG004|Induction Treatment Period|Protocol Violation|0|||
129991251|NCT04677179|467931449|FG005|Induction Treatment Period|Protocol Violation|0|||
129991252|NCT04677179|467931450|FG006|Induction Treatment Period|Protocol Violation|0|||
129991253|NCT04677179|467931451|FG007|Induction Treatment Period|Protocol Violation|0|||
129991254|NCT04677179|467931452|FG008|Induction Treatment Period|Protocol Violation|0|||
129991255|NCT04677179|467931453|FG009|Induction Treatment Period|Protocol Violation|0|||
129991256|NCT04677179|467931444|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
129991257|NCT04677179|467931445|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
129991258|NCT04677179|467931446|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
129991259|NCT04677179|467931447|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
129991260|NCT04677179|467931448|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
129991261|NCT04677179|467931449|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
129991262|NCT04677179|467931450|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
129991263|NCT04677179|467931451|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
129991264|NCT04677179|467931452|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
129991265|NCT04677179|467931453|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
129991266|NCT04677179|467931444|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
129991267|NCT04677179|467931445|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
129991268|NCT04677179|467931446|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
129991269|NCT04677179|467931447|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
129991270|NCT04677179|467931448|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
129991271|NCT04677179|467931449|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
129991272|NCT04677179|467931450|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
129991273|NCT04677179|467931451|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
129991274|NCT04677179|467931452|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
129991275|NCT04677179|467931453|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
129991276|NCT04677179|467931444|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
129991277|NCT04677179|467931445|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
129991278|NCT04677179|467931446|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
129991279|NCT04677179|467931447|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
129991280|NCT04677179|467931448|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
129991281|NCT04677179|467931449|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
129991282|NCT04677179|467931450|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
129991283|NCT04677179|467931451|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
129991284|NCT04677179|467931452|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
129991285|NCT04677179|467931453|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
129991286|NCT04677179|467931444|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991287|NCT04677179|467931445|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991288|NCT04677179|467931446|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991289|NCT04677179|467931447|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
129991290|NCT04677179|467931448|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
129662707|NCT03654729|466726134|FG000|Overall Study|Protocol Violation|1|||
129662708|NCT03654729|466726135|FG001|Overall Study|Protocol Violation|1|||
129662709|NCT03654729|466726136|FG002|Overall Study|Protocol Violation|0|||
129662710|NCT03654729|466726134|FG000|Overall Study|Non-compliance with study drug|0|||
129991291|NCT04677179|467931449|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991292|NCT04677179|467931450|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991293|NCT04677179|467931451|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991294|NCT04677179|467931452|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991295|NCT04677179|467931453|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
129991296|NCT04677179|467931444|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991297|NCT04677179|467931445|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991298|NCT04677179|467931446|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991299|NCT04677179|467931447|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
129991300|NCT04677179|467931448|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
129991301|NCT04677179|467931449|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
129991302|NCT04677179|467931450|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991303|NCT04677179|467931451|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991304|NCT04677179|467931452|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991305|NCT04677179|467931453|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
129991306|NCT04677179|467931444|FG000|Extension Treatment Period|Lack of Efficacy|0|||
129991307|NCT04677179|467931445|FG001|Extension Treatment Period|Lack of Efficacy|0|||
129662711|NCT03654729|466726135|FG001|Overall Study|Non-compliance with study drug|1|||
129662712|NCT03654729|466726136|FG002|Overall Study|Non-compliance with study drug|0|||
129662713|NCT03654729|466726134|FG000|Overall Study|Site terminated by Sponsor|1|||
129662714|NCT03654729|466726135|FG001|Overall Study|Site terminated by Sponsor|0|||
129662715|NCT03654729|466726136|FG002|Overall Study|Site terminated by Sponsor|0|||
129662716|NCT04530838|466726137|FG000|Overall Study|Other|2|||
129991308|NCT04677179|467931446|FG002|Extension Treatment Period|Lack of Efficacy|0|||
129991309|NCT04677179|467931447|FG003|Extension Treatment Period|Lack of Efficacy|0|||
129991310|NCT04677179|467931448|FG004|Extension Treatment Period|Lack of Efficacy|0|||
129991311|NCT04677179|467931449|FG005|Extension Treatment Period|Lack of Efficacy|0|||
129991312|NCT04677179|467931450|FG006|Extension Treatment Period|Lack of Efficacy|6|||
129991313|NCT04677179|467931451|FG007|Extension Treatment Period|Lack of Efficacy|0|||
129991314|NCT04677179|467931452|FG008|Extension Treatment Period|Lack of Efficacy|0|||
129991315|NCT04677179|467931453|FG009|Extension Treatment Period|Lack of Efficacy|0|||
129662717|NCT04530838|466726138|FG001|Overall Study|Other|1|||
129662718|NCT04530838|466726139|FG002|Overall Study|Other|0|||
129662719|NCT04530838|466726137|FG000|Overall Study|Physician Decision|0|||
129662720|NCT04530838|466726138|FG001|Overall Study|Physician Decision|0|||
129662721|NCT04530838|466726139|FG002|Overall Study|Physician Decision|1|||
129662722|NCT04530838|466726137|FG000|Overall Study|Death|0|||
129662723|NCT04530838|466726138|FG001|Overall Study|Death|0|||
129662724|NCT04530838|466726139|FG002|Overall Study|Death|1|||
129662725|NCT04530838|466726137|FG000|Overall Study|Adverse Event|0|||
129662726|NCT04530838|466726138|FG001|Overall Study|Adverse Event|1|||
129662727|NCT04530838|466726139|FG002|Overall Study|Adverse Event|0|||
129662728|NCT04530838|466726137|FG000|Overall Study|No longer meets eligibility criteria|1|||
129662729|NCT04530838|466726138|FG001|Overall Study|No longer meets eligibility criteria|0|||
129662730|NCT04530838|466726139|FG002|Overall Study|No longer meets eligibility criteria|2|||
129662731|NCT04530838|466726137|FG000|Overall Study|Withdrawal by parent/guardian|5|||
129662732|NCT04530838|466726138|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129662733|NCT04530838|466726139|FG002|Overall Study|Withdrawal by parent/guardian|2|||
129662734|NCT00803712|466726140|FG000|Overall Study|Noncompliance|3|||
129662735|NCT00803712|466726141|FG001|Overall Study|Noncompliance|0|||
129662736|NCT00803712|466726140|FG000|Overall Study|Adverse Event|5|||
129662737|NCT00803712|466726141|FG001|Overall Study|Adverse Event|0|||
129662738|NCT00803712|466726140|FG000|Overall Study|Death|8|||
129662739|NCT00803712|466726141|FG001|Overall Study|Death|7|||
129662740|NCT00803712|466726140|FG000|Overall Study|Lost to Follow-up|3|||
129662741|NCT00803712|466726141|FG001|Overall Study|Lost to Follow-up|1|||
129662742|NCT00803712|466726140|FG000|Overall Study|Withdrawal by Subject|2|||
129662743|NCT00803712|466726141|FG001|Overall Study|Withdrawal by Subject|4|||
129662744|NCT00803712|466726140|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
129662745|NCT00803712|466726141|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
129662746|NCT00803712|466726140|FG000|Overall Study|Protocol criteria (other)|0|||
129662747|NCT00803712|466726141|FG001|Overall Study|Protocol criteria (other)|2|||
129662748|NCT00803712|466726140|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
129662749|NCT00803712|466726141|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
129662750|NCT00803712|466726140|FG000|Overall Study|Administrative decision|2|||
129662751|NCT00803712|466726141|FG001|Overall Study|Administrative decision|3|||
129662752|NCT00803712|466726140|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
129662753|NCT00803712|466726141|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
129662754|NCT01919164|466726152|FG000|Overall Study|Adverse Event|6|||
129662755|NCT01919164|466726153|FG001|Overall Study|Adverse Event|4|||
129991316|NCT04677179|467931444|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
129991317|NCT04677179|467931445|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129662756|NCT01919164|466726154|FG002|Overall Study|Adverse Event|9|||
129662757|NCT01919164|466726155|FG003|Overall Study|Adverse Event|3|||
129662758|NCT01919164|466726156|FG004|Overall Study|Adverse Event|2|||
129662759|NCT01919164|466726152|FG000|Overall Study|Lost to Follow-up|2|||
129662760|NCT01919164|466726153|FG001|Overall Study|Lost to Follow-up|2|||
129662761|NCT01919164|466726154|FG002|Overall Study|Lost to Follow-up|2|||
129991318|NCT04677179|467931446|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129991319|NCT04677179|467931447|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
129991320|NCT04677179|467931448|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
129991321|NCT04677179|467931449|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
129991322|NCT04677179|467931450|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
129991323|NCT04677179|467931451|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
129991324|NCT04677179|467931452|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
129991325|NCT04677179|467931453|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
129991326|NCT04677179|467931444|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
129991327|NCT04677179|467931445|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
129991328|NCT04677179|467931446|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
129991329|NCT04677179|467931447|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
129991330|NCT04677179|467931448|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
129991331|NCT04677179|467931449|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
129991332|NCT04677179|467931450|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
129991333|NCT04677179|467931451|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
129991334|NCT04677179|467931452|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
129662762|NCT01919164|466726155|FG003|Overall Study|Lost to Follow-up|0|||
129662763|NCT01919164|466726156|FG004|Overall Study|Lost to Follow-up|4|||
129662764|NCT01919164|466726152|FG000|Overall Study|Death|1|||
129662765|NCT01919164|466726153|FG001|Overall Study|Death|0|||
129662766|NCT01919164|466726154|FG002|Overall Study|Death|0|||
129991335|NCT04677179|467931453|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
129991336|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
129991337|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
129991338|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
129991339|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
129991340|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
129991341|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
129991342|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
129991343|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
129991344|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
129991345|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
129991346|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991347|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991348|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991349|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991350|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991351|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991352|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991353|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
129991354|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
129991355|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
129991356|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991357|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991358|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991359|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991360|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991361|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991362|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991363|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
129991364|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991365|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129991366|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991367|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991368|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991369|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991370|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991371|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991372|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991373|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
129991374|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
129662767|NCT01919164|466726155|FG003|Overall Study|Death|0|||
129662768|NCT01919164|466726156|FG004|Overall Study|Death|0|||
129662769|NCT01919164|466726152|FG000|Overall Study|Protocol Violation|6|||
129991375|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129991376|NCT04677179|467931444|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991377|NCT04677179|467931445|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129662770|NCT01919164|466726153|FG001|Overall Study|Protocol Violation|0|||
129991378|NCT04677179|467931446|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991379|NCT04677179|467931447|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991380|NCT04677179|467931448|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991381|NCT04677179|467931449|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991382|NCT04677179|467931450|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
129991383|NCT04677179|467931451|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
129991384|NCT04677179|467931452|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
129991385|NCT04677179|467931453|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
129991386|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
129991387|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
129991388|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
129991389|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
129991390|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
129991391|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
129991392|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
129991393|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
129991394|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
129991395|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
129991396|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
129991397|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
129991398|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
129991399|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
129991400|NCT00600886|467931456|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
129991401|NCT00600886|467931457|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
129991402|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
129991403|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
129991404|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
129991405|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
129991406|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
129991407|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
129991408|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
129991409|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
129991410|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
129991411|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
129991412|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
129991413|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
129991414|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Death|1|||
129991415|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Death|1|||
129991416|NCT00600886|467931456|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
129991417|NCT00600886|467931457|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
129991418|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
129991419|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
129991420|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
129991421|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
129546603|NCT00457418|466294064|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
129546604|NCT00457418|466294064|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
129546605|NCT00457418|466294064|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
129546606|NCT00457418|466294064|FG000|Post PK Maintenance|Adverse Event|10|||
129546607|NCT00457418|466294064|FG000|Post PK Maintenance|Progression of Disease|6|||
129546608|NCT00457418|466294064|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
129991422|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
129991423|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
129991424|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
129991425|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
129991426|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
129991427|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
129991428|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
129991429|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
129991430|NCT00600886|467931456|FG000|Extension - After Crossover (CAS)|Death|1|||
129991431|NCT00600886|467931457|FG001|Extension - After Crossover (CAS)|Death|0|||
129991432|NCT03075410|467931458|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
129991433|NCT03075410|467931459|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
129546609|NCT00457418|466294064|FG000|Post PK Maintenance|Lost to Follow-up|1|||
129546610|NCT00595127|466294065|FG000|Overall Study|Death|6|||
129546611|NCT00595127|466294065|FG000|Overall Study|Relapsed|3|||
129546612|NCT00595127|466294065|FG000|Overall Study|joined another trial|1|||
129991434|NCT03075410|467931460|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
129991435|NCT03075410|467931461|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991436|NCT03075410|467931462|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991437|NCT03075410|467931463|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991438|NCT03075410|467931464|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991439|NCT03075410|467931465|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991440|NCT03075410|467931466|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
129991441|NCT03075410|467931458|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
129991442|NCT03075410|467931459|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991443|NCT03075410|467931460|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991444|NCT03075410|467931461|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991445|NCT03075410|467931462|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991446|NCT03075410|467931463|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991447|NCT03075410|467931464|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991448|NCT03075410|467931465|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991449|NCT03075410|467931466|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
129991450|NCT01427751|467931467|FG000|Overall Study|Adverse Event|18|||
129991451|NCT01427751|467931468|FG001|Overall Study|Adverse Event|2|||
129991452|NCT01427751|467931467|FG000|Overall Study|No further treatment benefit expected|5|||
129991453|NCT01427751|467931468|FG001|Overall Study|No further treatment benefit expected|1|||
129991454|NCT01427751|467931467|FG000|Overall Study|Lost to Follow-up|3|||
129991455|NCT01427751|467931468|FG001|Overall Study|Lost to Follow-up|1|||
129991456|NCT01427751|467931467|FG000|Overall Study|Withdrawal of consent|2|||
129991457|NCT01427751|467931468|FG001|Overall Study|Withdrawal of consent|2|||
129991458|NCT01427751|467931467|FG000|Overall Study|Protocol Violation|6|||
129991459|NCT01427751|467931468|FG001|Overall Study|Protocol Violation|4|||
129991460|NCT01427751|467931467|FG000|Overall Study|Death|2|||
129991461|NCT01427751|467931468|FG001|Overall Study|Death|0|||
129991462|NCT01427751|467931467|FG000|Overall Study|Other miscellaneous reasons|6|||
129991463|NCT01427751|467931468|FG001|Overall Study|Other miscellaneous reasons|4|||
129991464|NCT03534284|467931479|FG000|Overall Study|Death|2|||
129991465|NCT03534284|467931480|FG001|Overall Study|Death|3|||
129991466|NCT03534284|467931481|FG002|Overall Study|Death|3|||
129991467|NCT03534284|467931479|FG000|Overall Study|Withdrawal by Subject|5|||
129991468|NCT03534284|467931480|FG001|Overall Study|Withdrawal by Subject|0|||
129991469|NCT03534284|467931481|FG002|Overall Study|Withdrawal by Subject|0|||
129991470|NCT04737187|467931482|FG000|Overall Study|Switched to marketed drug|32|||
129991471|NCT04737187|467931483|FG001|Overall Study|Switched to marketed drug|4|||
129991472|NCT04737187|467931482|FG000|Overall Study|Radiological Progressive Disease|145|||
129991473|NCT04737187|467931483|FG001|Overall Study|Radiological Progressive Disease|146|||
129991474|NCT04737187|467931482|FG000|Overall Study|Clinical Progressive Disease|20|||
129991475|NCT04737187|467931483|FG001|Overall Study|Clinical Progressive Disease|20|||
129991476|NCT04737187|467931482|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
129991477|NCT04737187|467931483|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
129991478|NCT04737187|467931482|FG000|Overall Study|Adverse Event|16|||
129991479|NCT04737187|467931483|FG001|Overall Study|Adverse Event|16|||
129991480|NCT04737187|467931482|FG000|Overall Study|Physician Decision|2|||
129991481|NCT04737187|467931483|FG001|Overall Study|Physician Decision|0|||
129991482|NCT04737187|467931482|FG000|Overall Study|Withdrawal by Subject|5|||
129991483|NCT04737187|467931483|FG001|Overall Study|Withdrawal by Subject|8|||
129991484|NCT03756129|467931484|FG000|Overall Study|Adverse Event|1|||
129991485|NCT03756129|467931485|FG001|Overall Study|Adverse Event|1|||
129991486|NCT03756129|467931486|FG002|Overall Study|Adverse Event|0|||
129991487|NCT03756129|467931487|FG003|Overall Study|Adverse Event|2|||
129991488|NCT03756129|467931488|FG004|Overall Study|Adverse Event|0|||
129991489|NCT03756129|467931489|FG005|Overall Study|Adverse Event|0|||
129991490|NCT03756129|467931484|FG000|Overall Study|Withdrawal by Subject|2|||
129991491|NCT03756129|467931485|FG001|Overall Study|Withdrawal by Subject|1|||
129991492|NCT03756129|467931486|FG002|Overall Study|Withdrawal by Subject|3|||
129991493|NCT03756129|467931487|FG003|Overall Study|Withdrawal by Subject|1|||
129991494|NCT03756129|467931488|FG004|Overall Study|Withdrawal by Subject|1|||
129991495|NCT03756129|467931489|FG005|Overall Study|Withdrawal by Subject|3|||
129991496|NCT03756129|467931484|FG000|Overall Study|Lost to Follow-up|0|||
129991497|NCT03756129|467931485|FG001|Overall Study|Lost to Follow-up|0|||
129991498|NCT03756129|467931486|FG002|Overall Study|Lost to Follow-up|0|||
129991499|NCT03756129|467931487|FG003|Overall Study|Lost to Follow-up|0|||
129991500|NCT03756129|467931488|FG004|Overall Study|Lost to Follow-up|0|||
129991501|NCT03756129|467931489|FG005|Overall Study|Lost to Follow-up|1|||
129991502|NCT03756129|467931484|FG000|Overall Study|Physician Decision|0|||
129991503|NCT03756129|467931485|FG001|Overall Study|Physician Decision|0|||
129991504|NCT03756129|467931486|FG002|Overall Study|Physician Decision|0|||
129991505|NCT03756129|467931487|FG003|Overall Study|Physician Decision|0|||
129991506|NCT03756129|467931488|FG004|Overall Study|Physician Decision|0|||
129991507|NCT03756129|467931489|FG005|Overall Study|Physician Decision|1|||
129991508|NCT03035201|467931490|FG000|Overall Study|Death|9|||
129991509|NCT03035201|467931491|FG001|Overall Study|Death|12|||
129991510|NCT03035201|467931492|FG002|Overall Study|Death|9|||
129991511|NCT03035201|467931493|FG003|Overall Study|Death|10|||
129991512|NCT03035201|467931490|FG000|Overall Study|Withdrawal by Subject|51|||
129991513|NCT03035201|467931491|FG001|Overall Study|Withdrawal by Subject|49|||
129991514|NCT03035201|467931492|FG002|Overall Study|Withdrawal by Subject|37|||
129991515|NCT03035201|467931493|FG003|Overall Study|Withdrawal by Subject|46|||
129991516|NCT03035201|467931490|FG000|Overall Study|Lost to Follow-up|67|||
129991517|NCT03035201|467931491|FG001|Overall Study|Lost to Follow-up|51|||
129991518|NCT03035201|467931492|FG002|Overall Study|Lost to Follow-up|64|||
129991519|NCT03035201|467931493|FG003|Overall Study|Lost to Follow-up|69|||
129991520|NCT03319849|467931494|FG000|Overall Study|Adverse Event|1|||
129991521|NCT03319849|467931495|FG001|Overall Study|Adverse Event|0|||
129991522|NCT03319849|467931494|FG000|Overall Study|Physician Decision|0|||
129991523|NCT03319849|467931495|FG001|Overall Study|Physician Decision|1|||
129991524|NCT03319849|467931494|FG000|Overall Study|Withdrawal by Subject|0|||
129991525|NCT03319849|467931495|FG001|Overall Study|Withdrawal by Subject|1|||
129991526|NCT03319849|467931494|FG000|Overall Study|COVID-19|0|||
129991527|NCT03319849|467931495|FG001|Overall Study|COVID-19|1|||
129991528|NCT03319849|467931494|FG000|Overall Study|Other|1|||
129991529|NCT03319849|467931495|FG001|Overall Study|Other|2|||
129991530|NCT03319849|467931494|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
129991531|NCT03319849|467931495|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
129991532|NCT03319849|467931494|FG000|Overall Study|Lost to Follow-up|0|||
129991533|NCT03319849|467931495|FG001|Overall Study|Lost to Follow-up|2|||
129991534|NCT03727438|467931501|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
129991535|NCT03727438|467931502|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
129991536|NCT03727438|467931501|FG000|Intervention Period|Excluded (health)|1|||
129991537|NCT03727438|467931502|FG001|Intervention Period|Excluded (health)|0|||
129991538|NCT03727438|467931501|FG000|Intervention Period|Withdrawal by Subject|3|||
129991539|NCT03727438|467931502|FG001|Intervention Period|Withdrawal by Subject|1|||
129991540|NCT03727438|467931501|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
129991541|NCT03727438|467931502|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
129991542|NCT03727438|467931501|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
129991543|NCT03727438|467931502|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
129991544|NCT03727438|467931501|FG000|8 Week Assessment|Withdrawal by Subject|6|||
129991545|NCT03727438|467931502|FG001|8 Week Assessment|Withdrawal by Subject|1|||
129991546|NCT03727438|467931501|FG000|6 mo Assessment|did not complete assessment|10|||
129991547|NCT03727438|467931502|FG001|6 mo Assessment|did not complete assessment|11|||
129991548|NCT03595124|467934057|FG000|Overall Study|Physician Decision|1|||
129991549|NCT03595124|467934058|FG001|Overall Study|Physician Decision|1|||
129991550|NCT03595124|467934059|FG002|Overall Study|Physician Decision|1|||
129991551|NCT03595124|467934057|FG000|Overall Study|Ineligible|1|||
129991552|NCT03595124|467934058|FG001|Overall Study|Ineligible|1|||
129991553|NCT03595124|467934059|FG002|Overall Study|Ineligible|0|||
129991554|NCT03595124|467934057|FG000|Overall Study|Disease Progression|4|||
129991555|NCT03595124|467934058|FG001|Overall Study|Disease Progression|1|||
129991556|NCT03595124|467934059|FG002|Overall Study|Disease Progression|4|||
129991557|NCT05195489|467934060|FG000|Overall Study|Lost to Follow-up|1|||
129991558|NCT05195489|467934061|FG001|Overall Study|Lost to Follow-up|0|||
129991559|NCT05195489|467934060|FG000|Overall Study|Protocol Violation|0|||
129991560|NCT05195489|467934061|FG001|Overall Study|Protocol Violation|2|||
129991561|NCT05195489|467934060|FG000|Overall Study|Withdrawal by Subject|1|||
129991562|NCT05195489|467934061|FG001|Overall Study|Withdrawal by Subject|1|||
129991563|NCT05195489|467934060|FG000|Overall Study|Removed|0|||
129991564|NCT05195489|467934061|FG001|Overall Study|Removed|1|||
129991565|NCT04812548|467934062|FG000|Overall Study|Adverse Event|2|||
129991566|NCT04812548|467934063|FG001|Overall Study|Adverse Event|7|||
129991567|NCT04812548|467934062|FG000|Overall Study|HSCT Planned|2|||
129991568|NCT04812548|467934063|FG001|Overall Study|HSCT Planned|3|||
129991569|NCT04812548|467934062|FG000|Overall Study|Progressive Disease|0|||
129991570|NCT04812548|467934063|FG001|Overall Study|Progressive Disease|2|||
129991571|NCT04812548|467934062|FG000|Overall Study|Death|0|||
129991572|NCT04812548|467934063|FG001|Overall Study|Death|1|||
129991573|NCT04812548|467934062|FG000|Overall Study|Post Study Access to Treatment|0|||
129991574|NCT04812548|467934063|FG001|Overall Study|Post Study Access to Treatment|1|||
129991575|NCT04812548|467934062|FG000|Overall Study|Withdrawal by Subject|0|||
129991576|NCT04812548|467934063|FG001|Overall Study|Withdrawal by Subject|1|||
129991577|NCT04812548|467934062|FG000|Overall Study|Physician Decision|1|||
129662771|NCT01919164|466726154|FG002|Overall Study|Protocol Violation|3|||
129991578|NCT04812548|467934063|FG001|Overall Study|Physician Decision|0|||
129991579|NCT03184870|467934066|FG000|Initial Treatment|Death|6|||
129991580|NCT03184870|467934067|FG001|Initial Treatment|Death|6|||
129662772|NCT01919164|466726155|FG003|Overall Study|Protocol Violation|2|||
129991581|NCT03184870|467934068|FG002|Initial Treatment|Death|8|||
129991582|NCT03184870|467934069|FG003|Initial Treatment|Death|8|||
129991583|NCT03184870|467934070|FG004|Initial Treatment|Death|6|||
129991584|NCT03184870|467934071|FG005|Initial Treatment|Death|6|||
129991585|NCT03184870|467934072|FG006|Initial Treatment|Death|6|||
129991586|NCT03184870|467934073|FG007|Initial Treatment|Death|7|||
129991587|NCT03184870|467934074|FG008|Initial Treatment|Death|1|||
129991588|NCT03184870|467934075|FG009|Initial Treatment|Death|2|||
129991589|NCT03184870|467934076|FG010|Initial Treatment|Death|26|||
129991590|NCT03184870|467934077|FG011|Initial Treatment|Death|28|||
129991591|NCT03184870|467934078|FG012|Initial Treatment|Death|10|||
129991592|NCT03184870|467934079|FG013|Initial Treatment|Death|33|||
129991593|NCT03184870|467934080|FG014|Initial Treatment|Death|34|||
129991594|NCT03184870|467934081|FG015|Initial Treatment|Death|26|||
129991595|NCT03184870|467934082|FG016|Initial Treatment|Death|20|||
129991596|NCT03184870|467934083|FG017|Initial Treatment|Death|18|||
129991597|NCT03184870|467934066|FG000|Initial Treatment|Other Reasons|2|||
129991598|NCT03184870|467934067|FG001|Initial Treatment|Other Reasons|2|||
129991599|NCT03184870|467934068|FG002|Initial Treatment|Other Reasons|0|||
129991600|NCT03184870|467934069|FG003|Initial Treatment|Other Reasons|1|||
129991601|NCT03184870|467934070|FG004|Initial Treatment|Other Reasons|0|||
129991602|NCT03184870|467934071|FG005|Initial Treatment|Other Reasons|0|||
129991603|NCT03184870|467934072|FG006|Initial Treatment|Other Reasons|0|||
129991604|NCT03184870|467934073|FG007|Initial Treatment|Other Reasons|2|||
129991605|NCT03184870|467934074|FG008|Initial Treatment|Other Reasons|0|||
129991606|NCT03184870|467934075|FG009|Initial Treatment|Other Reasons|0|||
129991607|NCT03184870|467934076|FG010|Initial Treatment|Other Reasons|4|||
129991608|NCT03184870|467934077|FG011|Initial Treatment|Other Reasons|2|||
129991609|NCT03184870|467934078|FG012|Initial Treatment|Other Reasons|2|||
129991610|NCT03184870|467934079|FG013|Initial Treatment|Other Reasons|0|||
129991611|NCT03184870|467934080|FG014|Initial Treatment|Other Reasons|0|||
129991612|NCT03184870|467934081|FG015|Initial Treatment|Other Reasons|1|||
129991613|NCT03184870|467934082|FG016|Initial Treatment|Other Reasons|0|||
129991614|NCT03184870|467934083|FG017|Initial Treatment|Other Reasons|2|||
129991615|NCT03184870|467934066|FG000|Initial Treatment|Lost to Follow-up|2|||
129991616|NCT03184870|467934067|FG001|Initial Treatment|Lost to Follow-up|0|||
129991617|NCT03184870|467934068|FG002|Initial Treatment|Lost to Follow-up|0|||
129991618|NCT03184870|467934069|FG003|Initial Treatment|Lost to Follow-up|1|||
129991619|NCT03184870|467934070|FG004|Initial Treatment|Lost to Follow-up|1|||
129991620|NCT03184870|467934071|FG005|Initial Treatment|Lost to Follow-up|1|||
129991621|NCT03184870|467934072|FG006|Initial Treatment|Lost to Follow-up|0|||
129991622|NCT03184870|467934073|FG007|Initial Treatment|Lost to Follow-up|2|||
129991623|NCT03184870|467934074|FG008|Initial Treatment|Lost to Follow-up|0|||
129991624|NCT03184870|467934075|FG009|Initial Treatment|Lost to Follow-up|0|||
129991625|NCT03184870|467934076|FG010|Initial Treatment|Lost to Follow-up|2|||
129991626|NCT03184870|467934077|FG011|Initial Treatment|Lost to Follow-up|0|||
129991627|NCT03184870|467934078|FG012|Initial Treatment|Lost to Follow-up|2|||
129991628|NCT03184870|467934079|FG013|Initial Treatment|Lost to Follow-up|2|||
129991629|NCT03184870|467934080|FG014|Initial Treatment|Lost to Follow-up|0|||
129991630|NCT03184870|467934081|FG015|Initial Treatment|Lost to Follow-up|0|||
129991631|NCT03184870|467934082|FG016|Initial Treatment|Lost to Follow-up|2|||
129991632|NCT03184870|467934083|FG017|Initial Treatment|Lost to Follow-up|2|||
129991633|NCT03184870|467934066|FG000|Initial Treatment|Withdrawal by Subject|0|||
129991634|NCT03184870|467934067|FG001|Initial Treatment|Withdrawal by Subject|0|||
129991635|NCT03184870|467934068|FG002|Initial Treatment|Withdrawal by Subject|2|||
129991636|NCT03184870|467934069|FG003|Initial Treatment|Withdrawal by Subject|1|||
129991637|NCT03184870|467934070|FG004|Initial Treatment|Withdrawal by Subject|1|||
129991638|NCT03184870|467934071|FG005|Initial Treatment|Withdrawal by Subject|0|||
129991639|NCT03184870|467934072|FG006|Initial Treatment|Withdrawal by Subject|1|||
129991640|NCT03184870|467934073|FG007|Initial Treatment|Withdrawal by Subject|0|||
129991641|NCT03184870|467934074|FG008|Initial Treatment|Withdrawal by Subject|0|||
129991642|NCT03184870|467934075|FG009|Initial Treatment|Withdrawal by Subject|0|||
129991643|NCT03184870|467934076|FG010|Initial Treatment|Withdrawal by Subject|0|||
129991644|NCT03184870|467934077|FG011|Initial Treatment|Withdrawal by Subject|2|||
129991645|NCT03184870|467934078|FG012|Initial Treatment|Withdrawal by Subject|3|||
129662773|NCT01919164|466726156|FG004|Overall Study|Protocol Violation|2|||
129662774|NCT01919164|466726152|FG000|Overall Study|Disease progression|2|||
129991646|NCT03184870|467934079|FG013|Initial Treatment|Withdrawal by Subject|0|||
129991647|NCT03184870|467934080|FG014|Initial Treatment|Withdrawal by Subject|1|||
129991648|NCT03184870|467934081|FG015|Initial Treatment|Withdrawal by Subject|5|||
129991649|NCT03184870|467934082|FG016|Initial Treatment|Withdrawal by Subject|2|||
129991650|NCT03184870|467934083|FG017|Initial Treatment|Withdrawal by Subject|2|||
129662775|NCT01919164|466726153|FG001|Overall Study|Disease progression|2|||
129991651|NCT03184870|467934066|FG000|Initial Treatment|Moved to crossover treatment|0|||
129991652|NCT03184870|467934067|FG001|Initial Treatment|Moved to crossover treatment|0|||
129991653|NCT03184870|467934068|FG002|Initial Treatment|Moved to crossover treatment|0|||
129991654|NCT03184870|467934069|FG003|Initial Treatment|Moved to crossover treatment|0|||
129991655|NCT03184870|467934070|FG004|Initial Treatment|Moved to crossover treatment|0|||
129991656|NCT03184870|467934071|FG005|Initial Treatment|Moved to crossover treatment|0|||
129662776|NCT01919164|466726154|FG002|Overall Study|Disease progression|1|||
129991657|NCT03184870|467934072|FG006|Initial Treatment|Moved to crossover treatment|0|||
129991658|NCT03184870|467934073|FG007|Initial Treatment|Moved to crossover treatment|0|||
129991659|NCT03184870|467934074|FG008|Initial Treatment|Moved to crossover treatment|0|||
129991660|NCT03184870|467934075|FG009|Initial Treatment|Moved to crossover treatment|0|||
129991661|NCT03184870|467934076|FG010|Initial Treatment|Moved to crossover treatment|0|||
129991662|NCT03184870|467934077|FG011|Initial Treatment|Moved to crossover treatment|0|||
129991663|NCT03184870|467934078|FG012|Initial Treatment|Moved to crossover treatment|9|||
129991664|NCT03184870|467934079|FG013|Initial Treatment|Moved to crossover treatment|0|||
129991665|NCT03184870|467934080|FG014|Initial Treatment|Moved to crossover treatment|0|||
129991666|NCT03184870|467934081|FG015|Initial Treatment|Moved to crossover treatment|0|||
129991667|NCT03184870|467934082|FG016|Initial Treatment|Moved to crossover treatment|0|||
129991668|NCT03184870|467934083|FG017|Initial Treatment|Moved to crossover treatment|0|||
129991669|NCT03184870|467934066|FG000|Crossover Treatment|Other reasons|0|||
129991670|NCT03184870|467934067|FG001|Crossover Treatment|Other reasons|0|||
129991671|NCT03184870|467934068|FG002|Crossover Treatment|Other reasons|0|||
129991672|NCT03184870|467934069|FG003|Crossover Treatment|Other reasons|0|||
129991673|NCT03184870|467934070|FG004|Crossover Treatment|Other reasons|0|||
129991674|NCT03184870|467934071|FG005|Crossover Treatment|Other reasons|0|||
129991675|NCT03184870|467934072|FG006|Crossover Treatment|Other reasons|0|||
129991676|NCT03184870|467934073|FG007|Crossover Treatment|Other reasons|0|||
129991677|NCT03184870|467934074|FG008|Crossover Treatment|Other reasons|0|||
129991678|NCT03184870|467934075|FG009|Crossover Treatment|Other reasons|0|||
129991679|NCT03184870|467934076|FG010|Crossover Treatment|Other reasons|0|||
129991680|NCT03184870|467934077|FG011|Crossover Treatment|Other reasons|0|||
129991681|NCT03184870|467934078|FG012|Crossover Treatment|Other reasons|0|||
129991682|NCT03184870|467934079|FG013|Crossover Treatment|Other reasons|0|||
129991683|NCT03184870|467934080|FG014|Crossover Treatment|Other reasons|0|||
129991684|NCT03184870|467934081|FG015|Crossover Treatment|Other reasons|0|||
129991685|NCT03184870|467934082|FG016|Crossover Treatment|Other reasons|0|||
129991686|NCT03184870|467934083|FG017|Crossover Treatment|Other reasons|2|||
129991687|NCT03184870|467934066|FG000|Crossover Treatment|Death|0|||
129991688|NCT03184870|467934067|FG001|Crossover Treatment|Death|0|||
129991689|NCT03184870|467934068|FG002|Crossover Treatment|Death|0|||
129991690|NCT03184870|467934069|FG003|Crossover Treatment|Death|0|||
129991691|NCT03184870|467934070|FG004|Crossover Treatment|Death|0|||
129991692|NCT03184870|467934071|FG005|Crossover Treatment|Death|0|||
129991693|NCT03184870|467934072|FG006|Crossover Treatment|Death|0|||
129991694|NCT03184870|467934073|FG007|Crossover Treatment|Death|0|||
129991695|NCT03184870|467934074|FG008|Crossover Treatment|Death|0|||
129991696|NCT03184870|467934075|FG009|Crossover Treatment|Death|0|||
129991697|NCT03184870|467934076|FG010|Crossover Treatment|Death|0|||
129991698|NCT03184870|467934077|FG011|Crossover Treatment|Death|0|||
129991699|NCT03184870|467934078|FG012|Crossover Treatment|Death|0|||
129991700|NCT03184870|467934079|FG013|Crossover Treatment|Death|0|||
129991701|NCT03184870|467934080|FG014|Crossover Treatment|Death|0|||
129991702|NCT03184870|467934081|FG015|Crossover Treatment|Death|0|||
129991703|NCT03184870|467934082|FG016|Crossover Treatment|Death|0|||
129991704|NCT03184870|467934083|FG017|Crossover Treatment|Death|7|||
129991705|NCT03404960|467934084|FG000|Overall Study|Adverse Event|0|||
129991706|NCT03404960|467934085|FG001|Overall Study|Adverse Event|2|||
129991707|NCT03404960|467934084|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
129991708|NCT03404960|467934085|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
129991709|NCT03404960|467934084|FG000|Overall Study|Bowel obstruction|0|||
129991710|NCT03404960|467934085|FG001|Overall Study|Bowel obstruction|1|||
129991711|NCT03404960|467934084|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
129991712|NCT03404960|467934085|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
129991713|NCT03786783|467934087|FG000|Overall Study|Death|1|||
129991714|NCT03786783|467934087|FG000|Overall Study|Physician Decision|6|||
129991715|NCT03786783|467934087|FG000|Overall Study|Withdrawal by Subject|2|||
129991716|NCT03786783|467934087|FG000|Overall Study|Disease Progression|7|||
129991717|NCT03786783|467934087|FG000|Overall Study|Patient/Parent Refusal|4|||
129991718|NCT04363801|467934091|FG000|Overall Study|Death|18|||
129662777|NCT01919164|466726155|FG003|Overall Study|Disease progression|2|||
129662778|NCT01919164|466726156|FG004|Overall Study|Disease progression|1|||
129991719|NCT04363801|467934092|FG001|Overall Study|Death|14|||
129991720|NCT04363801|467934093|FG002|Overall Study|Death|16|||
129991721|NCT04363801|467934094|FG003|Overall Study|Death|48|||
129991722|NCT04363801|467934095|FG004|Overall Study|Death|38|||
129991723|NCT04363801|467934091|FG000|Overall Study|Withdrawal by Subject|1|||
129991724|NCT04363801|467934092|FG001|Overall Study|Withdrawal by Subject|6|||
129991725|NCT04363801|467934093|FG002|Overall Study|Withdrawal by Subject|1|||
129991726|NCT04363801|467934094|FG003|Overall Study|Withdrawal by Subject|4|||
129662779|NCT01919164|466726152|FG000|Overall Study|Withdrew consent|13|||
129991727|NCT04363801|467934095|FG004|Overall Study|Withdrawal by Subject|14|||
129991728|NCT04363801|467934091|FG000|Overall Study|Sponsor Decision|6|||
129991729|NCT04363801|467934092|FG001|Overall Study|Sponsor Decision|4|||
129991730|NCT04363801|467934093|FG002|Overall Study|Sponsor Decision|10|||
129991731|NCT04363801|467934094|FG003|Overall Study|Sponsor Decision|33|||
129991732|NCT04363801|467934095|FG004|Overall Study|Sponsor Decision|32|||
129991733|NCT04363801|467934091|FG000|Overall Study|Lost to Follow-up|0|||
129991734|NCT04363801|467934092|FG001|Overall Study|Lost to Follow-up|0|||
129991735|NCT04363801|467934093|FG002|Overall Study|Lost to Follow-up|1|||
129991736|NCT04363801|467934094|FG003|Overall Study|Lost to Follow-up|0|||
129991737|NCT04363801|467934095|FG004|Overall Study|Lost to Follow-up|1|||
129991738|NCT06336603|467934098|FG000|Overall Study|Withdrawal by Subject|1|||
129991739|NCT06336603|467934098|FG000|Overall Study|Lost to Follow-up|2|||
129991740|NCT04395001|467934099|FG000|Overall Study|Lost to Follow-up|8|||
129991741|NCT04395001|467934100|FG001|Overall Study|Lost to Follow-up|9|||
129991742|NCT04395001|467934101|FG002|Overall Study|Lost to Follow-up|5|||
129991743|NCT04395001|467934099|FG000|Overall Study|Withdrawal by Subject|3|||
129991744|NCT04395001|467934100|FG001|Overall Study|Withdrawal by Subject|1|||
129991745|NCT04395001|467934101|FG002|Overall Study|Withdrawal by Subject|3|||
129991746|NCT04395001|467934099|FG000|Overall Study|missed appointment|7|||
129991747|NCT04395001|467934100|FG001|Overall Study|missed appointment|4|||
129991748|NCT04395001|467934101|FG002|Overall Study|missed appointment|1|||
129991749|NCT04251156|467934102|FG000|Overall Study|Lost to Follow-up|1|||
129991750|NCT04251156|467934103|FG001|Overall Study|Lost to Follow-up|1|||
129991751|NCT04251156|467934102|FG000|Overall Study|Withdrawal by Subject|4|||
129991752|NCT04251156|467934103|FG001|Overall Study|Withdrawal by Subject|4|||
129991753|NCT04776148|467934104|FG000|Overall Study|Death|249|||
129991754|NCT04776148|467934105|FG001|Overall Study|Death|260|||
129991755|NCT04776148|467934104|FG000|Overall Study|Lost to Follow-up|0|||
129991756|NCT04776148|467934105|FG001|Overall Study|Lost to Follow-up|1|||
129991757|NCT04776148|467934104|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129991758|NCT04776148|467934105|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129991759|NCT04776148|467934104|FG000|Overall Study|Withdrawal by Subject|3|||
129991760|NCT04776148|467934105|FG001|Overall Study|Withdrawal by Subject|4|||
129991761|NCT04776148|467934104|FG000|Overall Study|Sponsor Decision|30|||
129991762|NCT04776148|467934105|FG001|Overall Study|Sponsor Decision|15|||
129991763|NCT02563522|467934106|FG000|Overall Study|Adverse Event|2|||
129991764|NCT02563522|467934107|FG001|Overall Study|Adverse Event|3|||
129991765|NCT02563522|467934106|FG000|Overall Study|Lost to Follow-up|1|||
129991766|NCT02563522|467934107|FG001|Overall Study|Lost to Follow-up|0|||
129991767|NCT02563522|467934106|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
129991768|NCT02563522|467934107|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
129991769|NCT05754333|467934108|FG000|Overall Study|Miscellaneous|3|||
129991770|NCT05754333|467934109|FG001|Overall Study|Miscellaneous|0|||
129991771|NCT05754333|467934110|FG002|Overall Study|Miscellaneous|0|||
129991772|NCT05754333|467934111|FG003|Overall Study|Miscellaneous|0|||
129991773|NCT05754333|467934108|FG000|Overall Study|Lost to Follow-up|2|||
129991774|NCT05754333|467934109|FG001|Overall Study|Lost to Follow-up|1|||
129991775|NCT05754333|467934110|FG002|Overall Study|Lost to Follow-up|0|||
129991776|NCT05754333|467934111|FG003|Overall Study|Lost to Follow-up|1|||
129991777|NCT04874415|467934112|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991778|NCT04874415|467934113|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991779|NCT04874415|467934114|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991780|NCT04874415|467934115|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991781|NCT04874415|467934116|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991782|NCT04874415|467934117|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991783|NCT04874415|467934118|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991784|NCT04874415|467934119|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991785|NCT04874415|467934120|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
129991786|NCT04874415|467934121|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991787|NCT04874415|467934122|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991788|NCT04874415|467934123|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991789|NCT04874415|467934124|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991790|NCT04874415|467934125|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
129991791|NCT04874415|467934126|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
129991792|NCT04874415|467934127|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
129991793|NCT04874415|467934112|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991794|NCT04874415|467934113|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991795|NCT04874415|467934114|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991796|NCT04874415|467934115|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991797|NCT04874415|467934116|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991798|NCT04874415|467934117|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991799|NCT04874415|467934118|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991800|NCT04874415|467934119|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991801|NCT04874415|467934120|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991802|NCT04874415|467934121|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
129991803|NCT04874415|467934122|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991804|NCT04874415|467934123|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991805|NCT04874415|467934124|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991806|NCT04874415|467934125|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
129662780|NCT01919164|466726153|FG001|Overall Study|Withdrew consent|13|||
129662781|NCT01919164|466726154|FG002|Overall Study|Withdrew consent|14|||
129662782|NCT01919164|466726155|FG003|Overall Study|Withdrew consent|14|||
129662783|NCT01919164|466726156|FG004|Overall Study|Withdrew consent|9|||
129662784|NCT01919164|466726152|FG000|Overall Study|Other Un-specified|13|||
129991807|NCT04874415|467934126|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
129991808|NCT04874415|467934127|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
129991809|NCT04874415|467934112|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991810|NCT04874415|467934113|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991811|NCT04874415|467934114|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991812|NCT04874415|467934115|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991813|NCT04874415|467934116|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
129991814|NCT04874415|467934117|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991815|NCT04874415|467934118|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991816|NCT04874415|467934119|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991817|NCT04874415|467934120|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991818|NCT04874415|467934121|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991819|NCT04874415|467934122|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991820|NCT04874415|467934123|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991821|NCT04874415|467934124|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991822|NCT04874415|467934125|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991823|NCT04874415|467934126|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991824|NCT04874415|467934127|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
129991825|NCT01312857|467934128|FG000|Overall Study|Adverse Event|1|||
129991826|NCT01312857|467934129|FG001|Overall Study|Adverse Event|1|||
129991827|NCT01312857|467934128|FG000|Overall Study|Lost to Follow-up|2|||
129991828|NCT01312857|467934129|FG001|Overall Study|Lost to Follow-up|0|||
129991829|NCT01312857|467934128|FG000|Overall Study|Physician Decision|3|||
129991830|NCT01312857|467934129|FG001|Overall Study|Physician Decision|0|||
129991831|NCT01312857|467934128|FG000|Overall Study|Withdrawal by Subject|2|||
129991832|NCT01312857|467934129|FG001|Overall Study|Withdrawal by Subject|0|||
129991833|NCT02455557|467934130|FG000|Overall Study|Withdrawal by Subject|2|||
129991834|NCT00807027|467934131|FG000|Overall Study|Withdrawal by Subject|13|||
129991835|NCT00807027|467934132|FG001|Overall Study|Withdrawal by Subject|14|||
129991836|NCT00807027|467934131|FG000|Overall Study|Protocol Violation|1|||
129991837|NCT00807027|467934132|FG001|Overall Study|Protocol Violation|1|||
129991838|NCT00807027|467934131|FG000|Overall Study|Adverse Event|2|||
129991839|NCT00807027|467934132|FG001|Overall Study|Adverse Event|2|||
129991840|NCT01382706|467934133|FG000|Overall Study|Adverse Event|1|||
129991841|NCT01382706|467934133|FG000|Overall Study|Withdrawal by Subject|1|||
129991842|NCT05559099|467934134|FG000|Overall Study|Death|5|||
129991843|NCT05559099|467934135|FG001|Overall Study|Death|4|||
129991844|NCT05559099|467934134|FG000|Overall Study|Lost to Follow-up|0|||
129991845|NCT05559099|467934135|FG001|Overall Study|Lost to Follow-up|2|||
129991846|NCT05559099|467934134|FG000|Overall Study|Adverse Event|1|||
129991847|NCT05559099|467934135|FG001|Overall Study|Adverse Event|1|||
129991848|NCT04018092|467934136|FG000|Overall Study|Withdrawal by Subject|1|||
129991849|NCT04018092|467934137|FG001|Overall Study|Withdrawal by Subject|1|||
129991850|NCT04018092|467934136|FG000|Overall Study|Withdrawal by Subject|1|||
129991851|NCT04018092|467934137|FG001|Overall Study|Withdrawal by Subject|1|||
129991852|NCT05508074|467934138|FG000|Overall Study|Death|2|||
129991853|NCT05508074|467934139|FG001|Overall Study|Death|5|||
129991854|NCT05508074|467934138|FG000|Overall Study|Withdrawal by Subject|1|||
129991855|NCT05508074|467934139|FG001|Overall Study|Withdrawal by Subject|2|||
129991856|NCT05508074|467934138|FG000|Overall Study|Adverse Event|0|||
129991857|NCT05508074|467934139|FG001|Overall Study|Adverse Event|1|||
129991858|NCT05508074|467934138|FG000|Overall Study|Physician Decision|0|||
129991859|NCT05508074|467934139|FG001|Overall Study|Physician Decision|1|||
129991860|NCT05508074|467934138|FG000|Overall Study|wrongly randomized|0|||
129991861|NCT05508074|467934139|FG001|Overall Study|wrongly randomized|1|||
129991862|NCT05508074|467934138|FG000|Overall Study|non-compliance|0|||
129991863|NCT05508074|467934139|FG001|Overall Study|non-compliance|1|||
129991864|NCT05218499|467934140|FG000|Overall Study|Not treated|1|||
129991865|NCT05218499|467934141|FG001|Overall Study|Not treated|1|||
129991866|NCT05218499|467934142|FG002|Overall Study|Not treated|8|||
129991867|NCT05218499|467934140|FG000|Overall Study|Death|2|||
129991868|NCT05218499|467934141|FG001|Overall Study|Death|0|||
129991869|NCT05218499|467934142|FG002|Overall Study|Death|0|||
129991870|NCT05218499|467934140|FG000|Overall Study|Other than listed|3|||
129991871|NCT05218499|467934141|FG001|Overall Study|Other than listed|7|||
129991872|NCT05218499|467934142|FG002|Overall Study|Other than listed|10|||
129662785|NCT01919164|466726153|FG001|Overall Study|Other Un-specified|9|||
129662786|NCT01919164|466726154|FG002|Overall Study|Other Un-specified|8|||
129662787|NCT01919164|466726155|FG003|Overall Study|Other Un-specified|7|||
129991873|NCT05218499|467934140|FG000|Overall Study|Protocol deviation|5|||
129991874|NCT05218499|467934141|FG001|Overall Study|Protocol deviation|6|||
129991875|NCT05218499|467934142|FG002|Overall Study|Protocol deviation|4|||
129991876|NCT05218499|467934140|FG000|Overall Study|Technical problems|0|||
129991877|NCT05218499|467934141|FG001|Overall Study|Technical problems|1|||
129991878|NCT05218499|467934142|FG002|Overall Study|Technical problems|0|||
129991879|NCT05218499|467934140|FG000|Overall Study|Burden of trial procedures|0|||
129991880|NCT05218499|467934141|FG001|Overall Study|Burden of trial procedures|1|||
129991881|NCT05218499|467934142|FG002|Overall Study|Burden of trial procedures|2|||
129991882|NCT05218499|467934140|FG000|Overall Study|Clinical disease progression|6|||
129991883|NCT05218499|467934141|FG001|Overall Study|Clinical disease progression|6|||
129991884|NCT05218499|467934142|FG002|Overall Study|Clinical disease progression|11|||
129991885|NCT05218499|467934140|FG000|Overall Study|Objective disease progression|44|||
129991886|NCT05218499|467934141|FG001|Overall Study|Objective disease progression|61|||
129991887|NCT05218499|467934142|FG002|Overall Study|Objective disease progression|42|||
129991888|NCT05218499|467934140|FG000|Overall Study|Adverse Event|11|||
129991889|NCT05218499|467934141|FG001|Overall Study|Adverse Event|36|||
129991890|NCT05218499|467934142|FG002|Overall Study|Adverse Event|9|||
129991891|NCT05218499|467934140|FG000|Overall Study|On treatment at time of snapshot|18|||
129991892|NCT05218499|467934141|FG001|Overall Study|On treatment at time of snapshot|29|||
129991893|NCT05218499|467934142|FG002|Overall Study|On treatment at time of snapshot|0|||
129991894|NCT04055090|467934143|FG000|Overall Study|screen failure|1|||
129991895|NCT04055090|467934144|FG001|Overall Study|screen failure|0|||
129991896|NCT04055090|467934143|FG000|Overall Study|Withdrawal by Subject|1|||
129991897|NCT04055090|467934144|FG001|Overall Study|Withdrawal by Subject|0|||
129991898|NCT04572841|467934148|FG000|Overall Study|Adverse Event|1|||
129991899|NCT04572841|467934149|FG001|Overall Study|Adverse Event|1|||
129991900|NCT04572841|467934148|FG000|Overall Study|Withdrawal by Subject|2|||
129991901|NCT04572841|467934149|FG001|Overall Study|Withdrawal by Subject|1|||
129991902|NCT06469242|467934150|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
129991903|NCT06469242|467934151|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
129991904|NCT06469242|467934150|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
129991905|NCT06469242|467934151|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
129991906|NCT05040971|467934152|FG000|Overall Study|Withdrawal by Subject|0|||
129991907|NCT05040971|467934153|FG001|Overall Study|Withdrawal by Subject|2|||
129991908|NCT05040971|467934152|FG000|Overall Study|Lost to Follow-up|8|||
129991909|NCT05040971|467934153|FG001|Overall Study|Lost to Follow-up|3|||
129991910|NCT05040971|467934152|FG000|Overall Study|Death|2|||
129991911|NCT05040971|467934153|FG001|Overall Study|Death|0|||
129991912|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
129991913|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
129991914|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
129991915|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
129991916|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
129991917|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
129991918|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
129991919|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129662788|NCT01919164|466726156|FG004|Overall Study|Other Un-specified|15|||
129991920|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991921|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991922|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991923|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
129991924|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991925|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
129991926|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991927|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991928|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991929|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991930|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
129991931|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991932|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
129991933|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991934|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991935|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991936|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
129991937|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
129991938|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991939|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991940|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991941|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129991942|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991943|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991944|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
129991945|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129991946|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
129991947|NCT04494256|467934158|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991948|NCT04494256|467934159|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991949|NCT04494256|467934160|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991950|NCT04494256|467934161|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991951|NCT04494256|467934162|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
129991952|NCT04494256|467934163|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991953|NCT04494256|467934164|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
129991954|NCT04494256|467934158|FG000|Part 2: Open Label Period|Death|0|||
129991955|NCT04494256|467934159|FG001|Part 2: Open Label Period|Death|0|||
129991956|NCT04494256|467934160|FG002|Part 2: Open Label Period|Death|0|||
129991957|NCT04494256|467934161|FG003|Part 2: Open Label Period|Death|0|||
129991958|NCT04494256|467934162|FG004|Part 2: Open Label Period|Death|0|||
129991959|NCT04494256|467934163|FG005|Part 2: Open Label Period|Death|4|||
129991960|NCT04494256|467934164|FG006|Part 2: Open Label Period|Death|2|||
129991961|NCT04494256|467934158|FG000|Part 2: Open Label Period|Adverse Event|0|||
129991962|NCT04494256|467934159|FG001|Part 2: Open Label Period|Adverse Event|0|||
129991963|NCT04494256|467934160|FG002|Part 2: Open Label Period|Adverse Event|0|||
129991964|NCT04494256|467934161|FG003|Part 2: Open Label Period|Adverse Event|0|||
129991965|NCT04494256|467934162|FG004|Part 2: Open Label Period|Adverse Event|0|||
129991966|NCT04494256|467934163|FG005|Part 2: Open Label Period|Adverse Event|0|||
129991967|NCT04494256|467934164|FG006|Part 2: Open Label Period|Adverse Event|2|||
129991968|NCT04494256|467934158|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991969|NCT04494256|467934159|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991970|NCT04494256|467934160|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991971|NCT04494256|467934161|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991972|NCT04494256|467934162|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
129991973|NCT04494256|467934163|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
129991974|NCT04494256|467934164|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
129991975|NCT04494256|467934158|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129546613|NCT01785472|466294066|FG000|Overall Study|Adverse Event|5|||
129546614|NCT01785472|466294067|FG001|Overall Study|Adverse Event|4|||
129662789|NCT00588146|466726158|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
129662790|NCT00588146|466726159|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
129662791|NCT02100839|466726160|FG000|Multiple Ascending Dose|Adverse Event|2|||
129662792|NCT02100839|466726161|FG001|Multiple Ascending Dose|Adverse Event|0|||
129662793|NCT02100839|466726160|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
129662794|NCT02100839|466726161|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
129662795|NCT02823470|466726162|FG000|Overall Study|Adverse Event|1|||
129662796|NCT02823470|466726163|FG001|Overall Study|Adverse Event|0|||
129662797|NCT02823470|466726162|FG000|Overall Study|Study terminated by sponsor|8|||
129662798|NCT02823470|466726163|FG001|Overall Study|Study terminated by sponsor|15|||
129662799|NCT00463801|466726169|FG000|Overall Study|Protocol Violation|1|||
129662800|NCT00463801|466726169|FG000|Overall Study|Lack of Efficacy|2|||
129662801|NCT00463801|466726169|FG000|Overall Study|Adverse Event|4|||
129662802|NCT00463801|466726169|FG000|Overall Study|Lost to Follow-up|5|||
129662803|NCT00463801|466726169|FG000|Overall Study|No longer require therapy|1|||
129662804|NCT00669318|466726170|FG000|Overall Study|Withdrawal by Subject|2|||
129662805|NCT02315664|466726171|FG000|Overall Study|Lost to Follow-up|1|||
129662806|NCT02315664|466726172|FG001|Overall Study|Lost to Follow-up|1|||
129662807|NCT02315664|466726171|FG000|Overall Study|Withdrawal by Subject|0|||
129662808|NCT02315664|466726172|FG001|Overall Study|Withdrawal by Subject|3|||
129662809|NCT02501161|466726175|FG000|Overall Study|Adverse Event|2|||
129662810|NCT02501161|466726176|FG001|Overall Study|Adverse Event|6|||
129662811|NCT02501161|466726175|FG000|Overall Study|Lost to Follow-up|7|||
129662812|NCT02501161|466726176|FG001|Overall Study|Lost to Follow-up|4|||
129662813|NCT02501161|466726175|FG000|Overall Study|Withdrawal by Subject|10|||
129662814|NCT02501161|466726176|FG001|Overall Study|Withdrawal by Subject|15|||
129662815|NCT02501161|466726175|FG000|Overall Study|Other|3|||
129662816|NCT02501161|466726176|FG001|Overall Study|Other|0|||
129662817|NCT00667992|466726177|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
129662818|NCT00667992|466726178|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
129662819|NCT00667992|466726177|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
129662820|NCT00667992|466726178|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
129662821|NCT00667992|466726177|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
129662822|NCT00667992|466726178|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
129662823|NCT00667992|466726177|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
129662824|NCT00667992|466726178|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
129662825|NCT00667992|466726177|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
129662826|NCT00667992|466726178|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
129662827|NCT00667992|466726177|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
129662828|NCT00667992|466726178|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
129662829|NCT00667992|466726177|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
129662830|NCT00667992|466726178|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
129662831|NCT00667992|466726177|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
129662832|NCT00667992|466726178|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
129662833|NCT00667992|466726177|FG000|Wash-out|Not within one doubling dilution|4|||
129662834|NCT00667992|466726178|FG001|Wash-out|Not within one doubling dilution|3|||
129662835|NCT00667992|466726177|FG000|Wash-out|Failure to wash-out|2|||
129662836|NCT00667992|466726178|FG001|Wash-out|Failure to wash-out|2|||
129662837|NCT00667992|466726177|FG000|Wash-out|Withdrawal by Subject|1|||
129662838|NCT00667992|466726178|FG001|Wash-out|Withdrawal by Subject|0|||
129662839|NCT00667992|466726177|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
129662840|NCT00667992|466726178|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
129662841|NCT00667992|466726177|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
129662842|NCT00667992|466726178|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
129662843|NCT02748057|466726182|FG000|Overall Study|Adverse Event|1|||
129662844|NCT02748057|466726183|FG001|Overall Study|Adverse Event|0|||
129662845|NCT02748057|466726182|FG000|Overall Study|Physician Decision|0|||
129662846|NCT02748057|466726183|FG001|Overall Study|Physician Decision|1|||
129662847|NCT02748057|466726182|FG000|Overall Study|Protocol Violation|2|||
129662848|NCT02748057|466726183|FG001|Overall Study|Protocol Violation|1|||
129662849|NCT02748057|466726182|FG000|Overall Study|Participant Moved|1|||
129662850|NCT02748057|466726183|FG001|Overall Study|Participant Moved|0|||
129662851|NCT02748057|466726182|FG000|Overall Study|Withdrawal by Subject|1|||
129662852|NCT02748057|466726183|FG001|Overall Study|Withdrawal by Subject|0|||
129662853|NCT01990573|466726184|FG000|Overall Study|Physician Decision|0|||
129662854|NCT01990573|466726185|FG001|Overall Study|Physician Decision|0|||
129662855|NCT01990573|466726186|FG002|Overall Study|Physician Decision|1|||
129662856|NCT03335813|466726191|FG000|Overall Study|Withdrawal by Subject|1|||
129662857|NCT02492165|466726194|FG000|Overall Study|Withdrawal by Subject|0|||
129662858|NCT02492165|466726195|FG001|Overall Study|Withdrawal by Subject|1|||
129662859|NCT02492165|466726196|FG002|Overall Study|Withdrawal by Subject|0|||
129662860|NCT02492165|466726197|FG003|Overall Study|Withdrawal by Subject|0|||
129662861|NCT01957579|466726199|FG000|Overall Study|Withdrawal of concent|0|||
129662862|NCT01957579|466726200|FG001|Overall Study|Withdrawal of concent|1|||
129662863|NCT01957579|466726201|FG002|Overall Study|Withdrawal of concent|0|||
129662864|NCT01957579|466726202|FG003|Overall Study|Withdrawal of concent|0|||
129662865|NCT01957579|466726199|FG000|Overall Study|Death|0|||
129662866|NCT01957579|466726200|FG001|Overall Study|Death|0|||
129662867|NCT01957579|466726201|FG002|Overall Study|Death|2|||
129662868|NCT01957579|466726202|FG003|Overall Study|Death|0|||
129662869|NCT01000974|466726203|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
129662870|NCT01000974|466726204|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
129662871|NCT01000974|466726205|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
129662872|NCT01000974|466726203|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
129662873|NCT01000974|466726204|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
129662874|NCT01000974|466726205|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
129662875|NCT01000974|466726203|FG000|Primary Vaccination Phase|Protocol Violation|40|||
129546615|NCT01785472|466294068|FG002|Overall Study|Adverse Event|6|||
129546616|NCT01785472|466294066|FG000|Overall Study|Lack of Efficacy|2|||
129662876|NCT01000974|466726204|FG001|Primary Vaccination Phase|Protocol Violation|3|||
129662877|NCT01000974|466726205|FG002|Primary Vaccination Phase|Protocol Violation|2|||
129662878|NCT01000974|466726203|FG000|Primary Vaccination Phase|Adverse Event|14|||
129662879|NCT01000974|466726204|FG001|Primary Vaccination Phase|Adverse Event|2|||
129662880|NCT01000974|466726205|FG002|Primary Vaccination Phase|Adverse Event|2|||
129662881|NCT01000974|466726203|FG000|Primary Vaccination Phase|Other|4|||
129662882|NCT01000974|466726204|FG001|Primary Vaccination Phase|Other|9|||
129662883|NCT01000974|466726205|FG002|Primary Vaccination Phase|Other|12|||
129662884|NCT01000974|466726203|FG000|Booster Vaccination Phase|Protocol Violation|0|||
129662885|NCT01000974|466726204|FG001|Booster Vaccination Phase|Protocol Violation|0|||
129662886|NCT01000974|466726205|FG002|Booster Vaccination Phase|Protocol Violation|2|||
129662887|NCT01000974|466726203|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
129662888|NCT01000974|466726204|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
129662889|NCT01000974|466726205|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
129662890|NCT01000974|466726203|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
129662891|NCT01000974|466726204|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
129662892|NCT01000974|466726205|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
129662893|NCT01000974|466726203|FG000|Booster Vaccination Phase|Other|24|||
129662894|NCT01000974|466726204|FG001|Booster Vaccination Phase|Other|6|||
129662895|NCT01000974|466726205|FG002|Booster Vaccination Phase|Other|4|||
129662896|NCT01639144|466726206|FG000|Overall Study|Withdrawal by Subject|4|||
129662897|NCT01639144|466726207|FG001|Overall Study|Withdrawal by Subject|2|||
129662898|NCT01639144|466726206|FG000|Overall Study|Physician Decision|2|||
129662899|NCT01639144|466726207|FG001|Overall Study|Physician Decision|0|||
129662900|NCT01639144|466726206|FG000|Overall Study|Met postoperative exclusion criteria|4|||
129662901|NCT01639144|466726207|FG001|Overall Study|Met postoperative exclusion criteria|3|||
129662902|NCT02750332|466726210|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129662903|NCT02750332|466726211|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129662904|NCT02485483|466726216|FG000|Overall Study|Depression at baseline|15|||
129662905|NCT02485483|466726217|FG001|Overall Study|Depression at baseline|0|||
129662906|NCT02485483|466726216|FG000|Overall Study|Discontinued after baseline|39|||
129662907|NCT02485483|466726217|FG001|Overall Study|Discontinued after baseline|0|||
129662908|NCT01724177|466726219|FG000|Overall Study|Adverse Event|8|||
129662909|NCT01724177|466726219|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
129662910|NCT01724177|466726219|FG000|Overall Study|Nervous participant|1|||
129662911|NCT01724177|466726219|FG000|Overall Study|Serious Adverse Event Related|1|||
129662912|NCT02982863|466726224|FG000|Overall Study|Not eligible patients|809|||
129662913|NCT02982863|466726225|FG001|Overall Study|Not eligible patients|4261|||
129662914|NCT02982863|466726226|FG002|Overall Study|Not eligible patients|1852|||
129662915|NCT02982863|466726227|FG003|Overall Study|Not eligible patients|1400|||
129662916|NCT02982863|466726228|FG004|Overall Study|Not eligible patients|492|||
129662917|NCT02457195|466726229|FG000|Overall Study|Adverse Event|3|||
129662918|NCT02457195|466726229|FG000|Overall Study|Protocol Violation|2|||
129662919|NCT02457195|466726229|FG000|Overall Study|Withdrawal by Subject|4|||
129662920|NCT00158262|466726232|FG000|Overall Study|Lost to Follow-up|1|||
129662921|NCT00158262|466726233|FG001|Overall Study|Lost to Follow-up|1|||
129662922|NCT02959918|466726234|FG000|Overall Study|Adverse Event|1|||
129662923|NCT02959918|466726235|FG001|Overall Study|Adverse Event|1|||
129662924|NCT02959918|466726236|FG002|Overall Study|Adverse Event|2|||
129662925|NCT02959918|466726237|FG003|Overall Study|Adverse Event|0|||
129662926|NCT02959918|466726238|FG004|Overall Study|Adverse Event|0|||
129662927|NCT02959918|466726239|FG005|Overall Study|Adverse Event|2|||
129662928|NCT02959918|466726240|FG006|Overall Study|Adverse Event|2|||
129662929|NCT02959918|466726241|FG007|Overall Study|Adverse Event|1|||
129662930|NCT02959918|466726242|FG008|Overall Study|Adverse Event|2|||
129662931|NCT02959918|466726243|FG009|Overall Study|Adverse Event|1|||
129662932|NCT02959918|466726244|FG010|Overall Study|Adverse Event|1|||
129662933|NCT02959918|466726245|FG011|Overall Study|Adverse Event|3|||
129662934|NCT02959918|466726246|FG012|Overall Study|Adverse Event|2|||
129662935|NCT02959918|466726247|FG013|Overall Study|Adverse Event|4|||
129662936|NCT02959918|466726234|FG000|Overall Study|Lost to Follow-up|0|||
129662937|NCT02959918|466726235|FG001|Overall Study|Lost to Follow-up|0|||
129662938|NCT02959918|466726236|FG002|Overall Study|Lost to Follow-up|0|||
129662939|NCT02959918|466726237|FG003|Overall Study|Lost to Follow-up|0|||
129662940|NCT02959918|466726238|FG004|Overall Study|Lost to Follow-up|0|||
129662941|NCT02959918|466726239|FG005|Overall Study|Lost to Follow-up|0|||
129662942|NCT02959918|466726240|FG006|Overall Study|Lost to Follow-up|0|||
129662943|NCT02959918|466726241|FG007|Overall Study|Lost to Follow-up|0|||
129546617|NCT01785472|466294067|FG001|Overall Study|Lack of Efficacy|0|||
129662944|NCT02959918|466726242|FG008|Overall Study|Lost to Follow-up|0|||
129662945|NCT02959918|466726243|FG009|Overall Study|Lost to Follow-up|1|||
129662946|NCT02959918|466726244|FG010|Overall Study|Lost to Follow-up|0|||
129662947|NCT02959918|466726245|FG011|Overall Study|Lost to Follow-up|0|||
129662948|NCT02959918|466726246|FG012|Overall Study|Lost to Follow-up|1|||
129662949|NCT02959918|466726247|FG013|Overall Study|Lost to Follow-up|0|||
129662950|NCT02959918|466726234|FG000|Overall Study|Withdrawal by Subject|0|||
129662951|NCT02959918|466726235|FG001|Overall Study|Withdrawal by Subject|0|||
129662952|NCT02959918|466726236|FG002|Overall Study|Withdrawal by Subject|1|||
129662953|NCT02959918|466726237|FG003|Overall Study|Withdrawal by Subject|2|||
129662954|NCT02959918|466726238|FG004|Overall Study|Withdrawal by Subject|0|||
129662955|NCT02959918|466726239|FG005|Overall Study|Withdrawal by Subject|0|||
129662956|NCT02959918|466726240|FG006|Overall Study|Withdrawal by Subject|1|||
129662957|NCT02959918|466726241|FG007|Overall Study|Withdrawal by Subject|0|||
129662958|NCT02959918|466726242|FG008|Overall Study|Withdrawal by Subject|1|||
129662959|NCT02959918|466726243|FG009|Overall Study|Withdrawal by Subject|1|||
129662960|NCT02959918|466726244|FG010|Overall Study|Withdrawal by Subject|2|||
129662961|NCT02959918|466726245|FG011|Overall Study|Withdrawal by Subject|3|||
129662962|NCT02959918|466726246|FG012|Overall Study|Withdrawal by Subject|1|||
129662963|NCT02959918|466726247|FG013|Overall Study|Withdrawal by Subject|1|||
129662964|NCT02959918|466726234|FG000|Overall Study|Protocol Violation|0|||
129662965|NCT02959918|466726235|FG001|Overall Study|Protocol Violation|0|||
129662966|NCT02959918|466726236|FG002|Overall Study|Protocol Violation|1|||
129662967|NCT02959918|466726237|FG003|Overall Study|Protocol Violation|0|||
129662968|NCT02959918|466726238|FG004|Overall Study|Protocol Violation|0|||
129662969|NCT02959918|466726239|FG005|Overall Study|Protocol Violation|1|||
129662970|NCT02959918|466726240|FG006|Overall Study|Protocol Violation|0|||
129662971|NCT02959918|466726241|FG007|Overall Study|Protocol Violation|0|||
129662972|NCT02959918|466726242|FG008|Overall Study|Protocol Violation|2|||
129662973|NCT02959918|466726243|FG009|Overall Study|Protocol Violation|1|||
129662974|NCT02959918|466726244|FG010|Overall Study|Protocol Violation|0|||
129662975|NCT02959918|466726245|FG011|Overall Study|Protocol Violation|1|||
129662976|NCT02959918|466726246|FG012|Overall Study|Protocol Violation|1|||
129662977|NCT02959918|466726247|FG013|Overall Study|Protocol Violation|0|||
129662978|NCT02959918|466726234|FG000|Overall Study|Stopping Rule Met|1|||
129662979|NCT02959918|466726235|FG001|Overall Study|Stopping Rule Met|0|||
129662980|NCT02959918|466726236|FG002|Overall Study|Stopping Rule Met|3|||
129662981|NCT02959918|466726237|FG003|Overall Study|Stopping Rule Met|4|||
129662982|NCT02959918|466726238|FG004|Overall Study|Stopping Rule Met|5|||
129662983|NCT02959918|466726239|FG005|Overall Study|Stopping Rule Met|3|||
129662984|NCT02959918|466726240|FG006|Overall Study|Stopping Rule Met|2|||
129662985|NCT02959918|466726241|FG007|Overall Study|Stopping Rule Met|4|||
129662986|NCT02959918|466726242|FG008|Overall Study|Stopping Rule Met|1|||
129662987|NCT02959918|466726243|FG009|Overall Study|Stopping Rule Met|1|||
129662988|NCT02959918|466726244|FG010|Overall Study|Stopping Rule Met|3|||
129662989|NCT02959918|466726245|FG011|Overall Study|Stopping Rule Met|5|||
129662990|NCT02959918|466726246|FG012|Overall Study|Stopping Rule Met|2|||
129662991|NCT02959918|466726247|FG013|Overall Study|Stopping Rule Met|1|||
129662992|NCT02959918|466726234|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
129662993|NCT02959918|466726235|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
129662994|NCT02959918|466726236|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
129662995|NCT02959918|466726237|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
129662996|NCT02959918|466726238|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129662997|NCT02959918|466726239|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129662998|NCT02959918|466726240|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129662999|NCT02959918|466726241|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663000|NCT02959918|466726242|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663001|NCT02959918|466726243|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663002|NCT02959918|466726244|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663003|NCT02959918|466726245|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663004|NCT02959918|466726246|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663005|NCT02959918|466726247|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
129663006|NCT02959918|466726234|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663007|NCT02959918|466726235|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663008|NCT02959918|466726236|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663009|NCT02959918|466726237|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663010|NCT02959918|466726238|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663011|NCT02959918|466726239|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663012|NCT02959918|466726240|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663013|NCT02959918|466726241|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
129663014|NCT02959918|466726242|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663015|NCT02959918|466726243|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663016|NCT02959918|466726244|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663017|NCT02959918|466726245|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663018|NCT02959918|466726246|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663019|NCT02959918|466726247|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
129663020|NCT02959918|466726234|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663021|NCT02959918|466726235|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663022|NCT02959918|466726236|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663023|NCT02959918|466726237|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663024|NCT02959918|466726238|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663025|NCT02959918|466726239|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663026|NCT02959918|466726240|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663027|NCT02959918|466726241|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663028|NCT02959918|466726242|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
129663029|NCT02959918|466726243|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663030|NCT02959918|466726244|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663031|NCT02959918|466726245|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663032|NCT02959918|466726246|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663033|NCT02959918|466726247|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
129663034|NCT02959918|466726234|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663035|NCT02959918|466726235|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663036|NCT02959918|466726236|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663037|NCT02959918|466726237|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663038|NCT02959918|466726238|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663039|NCT02959918|466726239|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663040|NCT02959918|466726240|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663041|NCT02959918|466726241|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663042|NCT02959918|466726242|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663043|NCT02959918|466726243|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
129663044|NCT02959918|466726244|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663045|NCT02959918|466726245|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663046|NCT02959918|466726246|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663047|NCT02959918|466726247|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
129663048|NCT02585713|466726249|FG000|Overall Study|Withdrew prior to treatment|2|||
129663049|NCT02585713|466726250|FG001|Overall Study|Withdrew prior to treatment|7|||
129663050|NCT02585713|466726249|FG000|Overall Study|Other|3|||
129663051|NCT02585713|466726250|FG001|Overall Study|Other|1|||
129663052|NCT03173456|466726255|FG000|Baseline|Medication dispensing system malfunction'|0|||
129663053|NCT03173456|466726256|FG001|Baseline|Medication dispensing system malfunction'|1|||
129663054|NCT03173456|466726257|FG002|Baseline|Medication dispensing system malfunction'|0|||
129663055|NCT03173456|466726258|FG003|Baseline|Medication dispensing system malfunction'|0|||
129663056|NCT03173456|466726259|FG004|Baseline|Medication dispensing system malfunction'|2|||
129663057|NCT03173456|466726255|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
129663058|NCT03173456|466726256|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
129663059|NCT03173456|466726257|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
129663060|NCT03173456|466726258|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
129663061|NCT03173456|466726259|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
129663062|NCT01733121|466726260|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
129663063|NCT01733121|466726261|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
129663064|NCT01733121|466726260|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
129663065|NCT01733121|466726261|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
129663066|NCT01733121|466726260|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
129663067|NCT01733121|466726261|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
129663068|NCT01733121|466726260|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
129663069|NCT01733121|466726261|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
129663070|NCT04501952|466726270|FG000|Overall Study|Adverse Event|0|||
129663071|NCT04501952|466726271|FG001|Overall Study|Adverse Event|3|||
129663072|NCT04501952|466726270|FG000|Overall Study|Investigator's Discretion|0|||
129663073|NCT04501952|466726271|FG001|Overall Study|Investigator's Discretion|1|||
129663074|NCT04501952|466726270|FG000|Overall Study|Protocol Violation|1|||
129663075|NCT04501952|466726271|FG001|Overall Study|Protocol Violation|1|||
129663076|NCT04501952|466726270|FG000|Overall Study|Withdrew Consent|5|||
129663077|NCT04501952|466726271|FG001|Overall Study|Withdrew Consent|4|||
129663078|NCT04501952|466726270|FG000|Overall Study|Lost to Follow-up|7|||
129663079|NCT04501952|466726271|FG001|Overall Study|Lost to Follow-up|2|||
129663080|NCT04501952|466726270|FG000|Overall Study|Randomized and Never Treated|13|||
129663081|NCT04501952|466726271|FG001|Overall Study|Randomized and Never Treated|9|||
129663082|NCT00941304|466726272|FG000|Overall Study|Lost to Follow-up|1|||
129663083|NCT00941304|466726273|FG001|Overall Study|Lost to Follow-up|0|||
129663084|NCT00941304|466726274|FG002|Overall Study|Lost to Follow-up|0|||
129663085|NCT00941304|466726275|FG003|Overall Study|Lost to Follow-up|0|||
129663086|NCT00941304|466726276|FG004|Overall Study|Lost to Follow-up|0|||
129663087|NCT00784719|466726277|FG000|Overall Study|Adverse Event|0|||
129663088|NCT00784719|466726278|FG001|Overall Study|Adverse Event|2|||
129663089|NCT00784719|466726279|FG002|Overall Study|Adverse Event|0|||
129663090|NCT00784719|466726280|FG003|Overall Study|Adverse Event|0|||
129663091|NCT00784719|466726281|FG004|Overall Study|Adverse Event|1|||
129546618|NCT01785472|466294068|FG002|Overall Study|Lack of Efficacy|1|||
129663092|NCT00784719|466726282|FG005|Overall Study|Adverse Event|1|||
129663093|NCT00784719|466726283|FG006|Overall Study|Adverse Event|1|||
129663094|NCT00784719|466726277|FG000|Overall Study|Lost to Follow-up|0|||
129663095|NCT00784719|466726278|FG001|Overall Study|Lost to Follow-up|0|||
129663096|NCT00784719|466726279|FG002|Overall Study|Lost to Follow-up|0|||
129663097|NCT00784719|466726280|FG003|Overall Study|Lost to Follow-up|0|||
129663098|NCT00784719|466726281|FG004|Overall Study|Lost to Follow-up|1|||
129663099|NCT00784719|466726282|FG005|Overall Study|Lost to Follow-up|1|||
129663100|NCT00784719|466726283|FG006|Overall Study|Lost to Follow-up|0|||
129663101|NCT00784719|466726277|FG000|Overall Study|Other|2|||
129663102|NCT00784719|466726278|FG001|Overall Study|Other|1|||
129663103|NCT00784719|466726279|FG002|Overall Study|Other|1|||
129663104|NCT00784719|466726280|FG003|Overall Study|Other|0|||
129663105|NCT00784719|466726281|FG004|Overall Study|Other|2|||
129663106|NCT00784719|466726282|FG005|Overall Study|Other|1|||
129663107|NCT00784719|466726283|FG006|Overall Study|Other|3|||
129663108|NCT00784719|466726277|FG000|Overall Study|Withdrawal by Subject|1|||
129663109|NCT00784719|466726278|FG001|Overall Study|Withdrawal by Subject|0|||
129663110|NCT00784719|466726279|FG002|Overall Study|Withdrawal by Subject|0|||
129663111|NCT00784719|466726280|FG003|Overall Study|Withdrawal by Subject|0|||
129663112|NCT00784719|466726281|FG004|Overall Study|Withdrawal by Subject|2|||
129663113|NCT00784719|466726282|FG005|Overall Study|Withdrawal by Subject|0|||
129663114|NCT00784719|466726283|FG006|Overall Study|Withdrawal by Subject|1|||
129663115|NCT01408901|466726286|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
129663116|NCT01408901|466726287|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
129663117|NCT01408901|466726288|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
129663118|NCT01408901|466726289|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
129663119|NCT01408901|466726286|FG000|6-Week Follow-Up|Death|1|||
129663120|NCT01408901|466726287|FG001|6-Week Follow-Up|Death|0|||
129663121|NCT01408901|466726288|FG002|6-Week Follow-Up|Death|0|||
129663122|NCT01408901|466726289|FG003|6-Week Follow-Up|Death|0|||
129663123|NCT01408901|466726286|FG000|6-Week Follow-Up|Cancelled visit|0|||
129663124|NCT01408901|466726287|FG001|6-Week Follow-Up|Cancelled visit|1|||
129663125|NCT01408901|466726288|FG002|6-Week Follow-Up|Cancelled visit|0|||
129663126|NCT01408901|466726289|FG003|6-Week Follow-Up|Cancelled visit|2|||
129663127|NCT01408901|466726286|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
129663128|NCT01408901|466726287|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
129663129|NCT01408901|466726288|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
129663130|NCT01408901|466726289|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
129663131|NCT01408901|466726286|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
129663132|NCT01408901|466726287|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
129663133|NCT01408901|466726288|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
129663134|NCT01408901|466726289|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
129663135|NCT01408901|466726286|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
129663136|NCT01408901|466726287|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
129663137|NCT01408901|466726288|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
129663138|NCT01408901|466726289|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
129663139|NCT01408901|466726286|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
129663140|NCT01408901|466726287|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
129663141|NCT01408901|466726288|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
129663142|NCT01408901|466726289|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
129663143|NCT01408901|466726286|FG000|26-Week Follow-Up|Death|0|||
129663144|NCT01408901|466726287|FG001|26-Week Follow-Up|Death|1|||
129663145|NCT01408901|466726288|FG002|26-Week Follow-Up|Death|0|||
129663146|NCT01408901|466726289|FG003|26-Week Follow-Up|Death|0|||
129663147|NCT04004260|466726294|FG000|Overall Study|Withdrawal by Subject|7|||
129663148|NCT04004260|466726295|FG001|Overall Study|Withdrawal by Subject|3|||
129663149|NCT04004260|466726294|FG000|Overall Study|Lost to Follow-up|22|||
129663150|NCT04004260|466726295|FG001|Overall Study|Lost to Follow-up|12|||
129663151|NCT04004260|466726294|FG000|Overall Study|Did not engage in intervention|13|||
129663152|NCT04004260|466726295|FG001|Overall Study|Did not engage in intervention|17|||
129663153|NCT05464420|466726296|FG000|Overall Study|Death|0|||
129663154|NCT05464420|466726297|FG001|Overall Study|Death|0|||
129663155|NCT05464420|466726298|FG002|Overall Study|Death|0|||
129663156|NCT05464420|466726299|FG003|Overall Study|Death|1|||
129663157|NCT05464420|466726296|FG000|Overall Study|Lost to Follow-up|16|||
129663158|NCT05464420|466726297|FG001|Overall Study|Lost to Follow-up|11|||
129663159|NCT05464420|466726298|FG002|Overall Study|Lost to Follow-up|11|||
129663160|NCT05464420|466726299|FG003|Overall Study|Lost to Follow-up|11|||
129663161|NCT05464420|466726296|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
129663162|NCT05464420|466726297|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
129663163|NCT05464420|466726298|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
129663164|NCT05464420|466726299|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
129663165|NCT05464420|466726296|FG000|Overall Study|Withdrawal by Subject|4|||
129663166|NCT05464420|466726297|FG001|Overall Study|Withdrawal by Subject|8|||
129663167|NCT05464420|466726298|FG002|Overall Study|Withdrawal by Subject|3|||
129663168|NCT05464420|466726299|FG003|Overall Study|Withdrawal by Subject|1|||
129663169|NCT05464420|466726296|FG000|Overall Study|Protocol Violation|0|||
129663170|NCT05464420|466726297|FG001|Overall Study|Protocol Violation|0|||
129663171|NCT05464420|466726298|FG002|Overall Study|Protocol Violation|1|||
129663172|NCT05464420|466726299|FG003|Overall Study|Protocol Violation|1|||
129663173|NCT05464420|466726296|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
129663174|NCT05464420|466726297|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
129663175|NCT05464420|466726298|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
129663176|NCT05464420|466726299|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
129663177|NCT01383018|466726300|FG000|Overall Study|Adverse Event|14|||
129663178|NCT01383018|466726300|FG000|Overall Study|Death|10|||
129663179|NCT01383018|466726300|FG000|Overall Study|Lost to Follow-up|5|||
129663180|NCT01383018|466726300|FG000|Overall Study|Physician Decision|5|||
129663181|NCT01383018|466726300|FG000|Overall Study|Withdrawal by Subject|9|||
129663182|NCT01383018|466726300|FG000|Overall Study|Subject not implanted|76|||
129663183|NCT01383018|466726300|FG000|Overall Study|Missed Visit|247|||
129663184|NCT01383018|466726300|FG000|Overall Study|Site closed early-not compliance related|7|||
129663185|NCT01383018|466726300|FG000|Overall Study|Patient moved away from site|1|||
129663186|NCT01383018|466726300|FG000|Overall Study|Subject Incarcerated|1|||
129663187|NCT01765569|466726302|FG000|Period B|Withdrawal by Subject|1|||
129663188|NCT01765569|466726302|FG000|Period C|Death|1|||
129663189|NCT03414229|466726303|FG000|Overall Study|Adverse Event|1|||
129663190|NCT03414229|466726304|FG001|Overall Study|Adverse Event|0|||
129663191|NCT03414229|466726305|FG002|Overall Study|Adverse Event|2|||
129663192|NCT03414229|466726306|FG003|Overall Study|Adverse Event|1|||
129663193|NCT03414229|466726303|FG000|Overall Study|Lack of Efficacy|7|||
129663194|NCT03414229|466726304|FG001|Overall Study|Lack of Efficacy|4|||
129663195|NCT03414229|466726305|FG002|Overall Study|Lack of Efficacy|1|||
129663196|NCT03414229|466726306|FG003|Overall Study|Lack of Efficacy|9|||
129663197|NCT03414229|466726303|FG000|Overall Study|Change in therapy|1|||
129663198|NCT03414229|466726304|FG001|Overall Study|Change in therapy|0|||
129663199|NCT03414229|466726305|FG002|Overall Study|Change in therapy|0|||
129663200|NCT03414229|466726306|FG003|Overall Study|Change in therapy|0|||
129663201|NCT03414229|466726303|FG000|Overall Study|Pregnancy|0|||
129663202|NCT03414229|466726304|FG001|Overall Study|Pregnancy|0|||
129663203|NCT03414229|466726305|FG002|Overall Study|Pregnancy|1|||
129663204|NCT03414229|466726306|FG003|Overall Study|Pregnancy|0|||
129663205|NCT03414229|466726303|FG000|Overall Study|Withdrawal by Subject|0|||
129663206|NCT03414229|466726304|FG001|Overall Study|Withdrawal by Subject|1|||
129663207|NCT03414229|466726305|FG002|Overall Study|Withdrawal by Subject|1|||
129663208|NCT03414229|466726306|FG003|Overall Study|Withdrawal by Subject|0|||
129663209|NCT04533438|466726307|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
129663210|NCT04533438|466726308|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
129663211|NCT01903993|466726313|FG000|Overall Study|Death|118|||
129663212|NCT01903993|466726314|FG001|Overall Study|Death|121|||
129663213|NCT01903993|466726313|FG000|Overall Study|Withdrawal by Subject|15|||
129663214|NCT01903993|466726314|FG001|Overall Study|Withdrawal by Subject|4|||
129663215|NCT01903993|466726313|FG000|Overall Study|Lost to Follow-up|2|||
129663216|NCT01903993|466726314|FG001|Overall Study|Lost to Follow-up|3|||
129663217|NCT01903993|466726313|FG000|Overall Study|Study Terminated by Sponsor|8|||
129663218|NCT01903993|466726314|FG001|Overall Study|Study Terminated by Sponsor|14|||
129663219|NCT01903993|466726313|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
129663220|NCT01903993|466726314|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
129663221|NCT01243177|466726317|FG000|Overall Study|Lack of Efficacy|47|||
129663222|NCT01243177|466726318|FG001|Overall Study|Lack of Efficacy|31|||
129663223|NCT01243177|466726317|FG000|Overall Study|Protocol Violation|11|||
129663224|NCT01243177|466726318|FG001|Overall Study|Protocol Violation|10|||
129663225|NCT01243177|466726317|FG000|Overall Study|Lost to Follow-up|15|||
129663226|NCT01243177|466726318|FG001|Overall Study|Lost to Follow-up|18|||
129663227|NCT01243177|466726317|FG000|Overall Study|Withdrawal by Subject|46|||
129663228|NCT01243177|466726318|FG001|Overall Study|Withdrawal by Subject|38|||
129663229|NCT01243177|466726317|FG000|Overall Study|AE, serious fatal|0|||
129663230|NCT01243177|466726318|FG001|Overall Study|AE, serious fatal|1|||
129663231|NCT01243177|466726317|FG000|Overall Study|SAE, non-fatal|7|||
129663232|NCT01243177|466726318|FG001|Overall Study|SAE, non-fatal|9|||
129546619|NCT01785472|466294066|FG000|Overall Study|Lost to Follow-up|1|||
129546620|NCT01785472|466294067|FG001|Overall Study|Lost to Follow-up|2|||
129546621|NCT01785472|466294068|FG002|Overall Study|Lost to Follow-up|0|||
129546622|NCT01785472|466294066|FG000|Overall Study|Physician Decision|1|||
129663233|NCT01243177|466726317|FG000|Overall Study|AE, non-serious non-fatal|40|||
129663234|NCT01243177|466726318|FG001|Overall Study|AE, non-serious non-fatal|58|||
129663235|NCT01243177|466726317|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
129663236|NCT01243177|466726318|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
129663237|NCT01243177|466726317|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129663238|NCT01243177|466726318|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
129663239|NCT01243177|466726317|FG000|Overall Study|Other Reason|11|||
129663240|NCT01243177|466726318|FG001|Overall Study|Other Reason|12|||
129546623|NCT01785472|466294067|FG001|Overall Study|Physician Decision|1|||
129663241|NCT01073163|466727841|FG000|Overall Study|Adverse Event|1|||
129663242|NCT01073163|466727841|FG000|Overall Study|Disease Progression|1|||
129663243|NCT01073163|466727841|FG000|Overall Study|Early termination|1|||
129663244|NCT00703677|466727842|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
129663245|NCT00940888|466727843|FG000|Overall Study|Unsuccessful Implant|4|||
129546624|NCT01785472|466294068|FG002|Overall Study|Physician Decision|1|||
129663246|NCT00940888|466727843|FG000|Overall Study|Death|461|||
129663247|NCT00940888|466727843|FG000|Overall Study|Withdrawn - Non-Death|364|||
129663248|NCT00940888|466727843|FG000|Overall Study|Lost to Follow-up|6|||
129663249|NCT04441788|466727846|FG000|Overall Study|Voluntary Withdrawl|0|||
129663250|NCT04441788|466727847|FG001|Overall Study|Voluntary Withdrawl|1|||
129663251|NCT04441788|466727848|FG002|Overall Study|Voluntary Withdrawl|0|||
129663252|NCT04441788|466727846|FG000|Overall Study|Ineligibility|1|||
129663253|NCT04441788|466727847|FG001|Overall Study|Ineligibility|0|||
129663254|NCT04441788|466727848|FG002|Overall Study|Ineligibility|0|||
129663255|NCT04441788|466727846|FG000|Overall Study|Adverse Event|0|||
129663256|NCT04441788|466727847|FG001|Overall Study|Adverse Event|0|||
129663257|NCT04441788|466727848|FG002|Overall Study|Adverse Event|4|||
129663258|NCT04441788|466727846|FG000|Overall Study|Study Terminated by Sponsor|16|||
129663259|NCT04441788|466727847|FG001|Overall Study|Study Terminated by Sponsor|16|||
129663260|NCT04441788|466727848|FG002|Overall Study|Study Terminated by Sponsor|12|||
129663261|NCT03859648|466727853|FG000|Overall Study|Lost to Follow-up|1|||
129663262|NCT03859648|466727853|FG000|Overall Study|Adverse Event|1|||
129663263|NCT01677182|466727854|FG000|Overall Study|Adverse Event|2|||
129663264|NCT01677182|466727855|FG001|Overall Study|Adverse Event|1|||
129663265|NCT01677182|466727856|FG002|Overall Study|Adverse Event|8|||
129663266|NCT01677182|466727854|FG000|Overall Study|Protocol Violation|5|||
129663267|NCT01677182|466727855|FG001|Overall Study|Protocol Violation|1|||
129663268|NCT01677182|466727856|FG002|Overall Study|Protocol Violation|4|||
129663269|NCT01677182|466727854|FG000|Overall Study|Lost to Follow-up|4|||
129663270|NCT01677182|466727855|FG001|Overall Study|Lost to Follow-up|0|||
129663271|NCT01677182|466727856|FG002|Overall Study|Lost to Follow-up|3|||
129663272|NCT01677182|466727854|FG000|Overall Study|Withdrawal by Subject|7|||
129663273|NCT01677182|466727855|FG001|Overall Study|Withdrawal by Subject|12|||
129663274|NCT01677182|466727856|FG002|Overall Study|Withdrawal by Subject|10|||
129663275|NCT01677182|466727854|FG000|Overall Study|Study termination|12|||
129663276|NCT01677182|466727855|FG001|Overall Study|Study termination|9|||
129663277|NCT01677182|466727856|FG002|Overall Study|Study termination|11|||
129663278|NCT01677182|466727854|FG000|Overall Study|Lack of Efficacy|3|||
129663279|NCT01677182|466727855|FG001|Overall Study|Lack of Efficacy|0|||
129663280|NCT01677182|466727856|FG002|Overall Study|Lack of Efficacy|1|||
129663281|NCT01677182|466727854|FG000|Overall Study|Other reasons|1|||
129663282|NCT01677182|466727855|FG001|Overall Study|Other reasons|5|||
129663283|NCT01677182|466727856|FG002|Overall Study|Other reasons|2|||
129663284|NCT00762762|466727861|FG000|Overall Study|Did not return for appointments|6|||
129663285|NCT00762762|466727862|FG001|Overall Study|Did not return for appointments|8|||
129663286|NCT02489448|466727863|FG000|Overall Study|Death|3|||
129663287|NCT02489448|466727863|FG000|Overall Study|Withdrawal by Subject|2|||
129663288|NCT00524771|466727872|FG000|Overall Study|Protocol Violation|220|||
129663289|NCT00524771|466727873|FG001|Overall Study|Protocol Violation|585|||
129663290|NCT02781818|466727874|FG000|Overall Study|Lost to Follow-up|4|||
129663291|NCT02781818|466727875|FG001|Overall Study|Lost to Follow-up|2|||
129663292|NCT02781818|466727876|FG002|Overall Study|Lost to Follow-up|1|||
129663293|NCT01223404|466727877|FG000|First Intervention (1 Day)|Adverse Event|0|||
129663294|NCT01223404|466727878|FG001|First Intervention (1 Day)|Adverse Event|0|||
129663295|NCT01223404|466727879|FG002|First Intervention (1 Day)|Adverse Event|0|||
129663296|NCT01223404|466727880|FG003|First Intervention (1 Day)|Adverse Event|1|||
129663297|NCT01223404|466727881|FG004|First Intervention (1 Day)|Adverse Event|0|||
129663298|NCT01223404|466727882|FG005|First Intervention (1 Day)|Adverse Event|0|||
129663299|NCT01223404|466727877|FG000|Second Intervention (1 Day)|Adverse Event|1|||
129663300|NCT01223404|466727878|FG001|Second Intervention (1 Day)|Adverse Event|0|||
129663301|NCT01223404|466727879|FG002|Second Intervention (1 Day)|Adverse Event|0|||
129663302|NCT01223404|466727880|FG003|Second Intervention (1 Day)|Adverse Event|0|||
129663303|NCT01223404|466727881|FG004|Second Intervention (1 Day)|Adverse Event|0|||
129663304|NCT01223404|466727882|FG005|Second Intervention (1 Day)|Adverse Event|0|||
129663305|NCT01223404|466727877|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129663306|NCT01223404|466727878|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129663307|NCT01223404|466727879|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129663308|NCT01223404|466727880|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
129663309|NCT01223404|466727881|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129663310|NCT01223404|466727882|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
129663311|NCT00707057|466727883|FG000|Overall Study|Withdrawal by Subject|8|||
129663312|NCT00707057|466727884|FG001|Overall Study|Withdrawal by Subject|3|||
129663313|NCT00707057|466727883|FG000|Overall Study|Dosed incorrectly|0|||
129663314|NCT00707057|466727884|FG001|Overall Study|Dosed incorrectly|1|||
129663315|NCT00577772|466727890|FG000|Overall Study|Lost to Follow-up|0|||
129663316|NCT00577772|466727891|FG001|Overall Study|Lost to Follow-up|1|||
129663317|NCT00572455|466727892|FG000|Stage I (14 Days)|Adverse Event|0|||
129663318|NCT00572455|466727893|FG001|Stage I (14 Days)|Adverse Event|0|||
129663319|NCT00572455|466727894|FG002|Stage I (14 Days)|Adverse Event|0|||
129663320|NCT00572455|466727895|FG003|Stage I (14 Days)|Adverse Event|0|||
129663321|NCT00572455|466727896|FG004|Stage I (14 Days)|Adverse Event|0|||
129663322|NCT00572455|466727897|FG005|Stage I (14 Days)|Adverse Event|3|||
129663323|NCT00572455|466727898|FG006|Stage I (14 Days)|Adverse Event|0|||
129663324|NCT00572455|466727899|FG007|Stage I (14 Days)|Adverse Event|0|||
129663325|NCT00572455|466727900|FG008|Stage I (14 Days)|Adverse Event|0|||
129663326|NCT00572455|466727901|FG009|Stage I (14 Days)|Adverse Event|0|||
129663327|NCT00572455|466727902|FG010|Stage I (14 Days)|Adverse Event|0|||
129663328|NCT00572455|466727903|FG011|Stage I (14 Days)|Adverse Event|0|||
129663329|NCT00572455|466727904|FG012|Stage I (14 Days)|Adverse Event|0|||
129663330|NCT00572455|466727905|FG013|Stage I (14 Days)|Adverse Event|0|||
129663331|NCT00572455|466727892|FG000|Stage I (14 Days)|Other|0|||
129663332|NCT00572455|466727893|FG001|Stage I (14 Days)|Other|0|||
129663333|NCT00572455|466727894|FG002|Stage I (14 Days)|Other|0|||
129663334|NCT00572455|466727895|FG003|Stage I (14 Days)|Other|0|||
129663335|NCT00572455|466727896|FG004|Stage I (14 Days)|Other|1|||
129663336|NCT00572455|466727897|FG005|Stage I (14 Days)|Other|0|||
129663337|NCT00572455|466727898|FG006|Stage I (14 Days)|Other|0|||
129663338|NCT00572455|466727899|FG007|Stage I (14 Days)|Other|0|||
129663339|NCT00572455|466727900|FG008|Stage I (14 Days)|Other|0|||
129663340|NCT00572455|466727901|FG009|Stage I (14 Days)|Other|0|||
129663341|NCT00572455|466727902|FG010|Stage I (14 Days)|Other|0|||
129663342|NCT00572455|466727903|FG011|Stage I (14 Days)|Other|0|||
129991976|NCT04494256|467934159|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991977|NCT04494256|467934160|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129663343|NCT00572455|466727904|FG012|Stage I (14 Days)|Other|0|||
129663344|NCT00572455|466727905|FG013|Stage I (14 Days)|Other|0|||
129663345|NCT00572455|466727892|FG000|Stage II (28 Days)|Adverse Event|0|||
129663346|NCT00572455|466727893|FG001|Stage II (28 Days)|Adverse Event|0|||
129663347|NCT00572455|466727894|FG002|Stage II (28 Days)|Adverse Event|0|||
129663348|NCT00572455|466727895|FG003|Stage II (28 Days)|Adverse Event|0|||
129663349|NCT00572455|466727896|FG004|Stage II (28 Days)|Adverse Event|0|||
129663350|NCT00572455|466727897|FG005|Stage II (28 Days)|Adverse Event|0|||
129663351|NCT00572455|466727898|FG006|Stage II (28 Days)|Adverse Event|0|||
129991978|NCT04494256|467934161|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991979|NCT04494256|467934162|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991980|NCT04494256|467934163|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
129991981|NCT04494256|467934164|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
129991982|NCT04494256|467934158|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991983|NCT04494256|467934159|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991984|NCT04494256|467934160|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991985|NCT04494256|467934161|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991986|NCT04494256|467934162|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
129991987|NCT04494256|467934163|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
129991988|NCT04494256|467934164|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
129991989|NCT04494256|467934158|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991990|NCT04494256|467934159|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991991|NCT04494256|467934160|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991992|NCT04494256|467934161|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991993|NCT04494256|467934162|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
129991994|NCT04494256|467934163|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
129991995|NCT04494256|467934164|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
129991996|NCT04494256|467934158|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129991997|NCT04494256|467934159|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129991998|NCT04494256|467934160|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129991999|NCT04494256|467934161|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129992000|NCT04494256|467934162|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
129992001|NCT04494256|467934163|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
129992002|NCT04494256|467934164|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
129992003|NCT02513303|467934165|FG000|Overall Study|Withdrawal by Subject|9|||
129992004|NCT02513303|467934166|FG001|Overall Study|Withdrawal by Subject|7|||
129992005|NCT02513303|467934167|FG002|Overall Study|Withdrawal by Subject|2|||
129992006|NCT02513303|467934165|FG000|Overall Study|Lost to Follow-up|2|||
129992007|NCT02513303|467934166|FG001|Overall Study|Lost to Follow-up|4|||
129992008|NCT02513303|467934167|FG002|Overall Study|Lost to Follow-up|0|||
129992009|NCT02513303|467934165|FG000|Overall Study|Adverse Event|0|||
129992010|NCT02513303|467934166|FG001|Overall Study|Adverse Event|1|||
129992011|NCT02513303|467934167|FG002|Overall Study|Adverse Event|0|||
129663352|NCT00572455|466727899|FG007|Stage II (28 Days)|Adverse Event|0|||
129663353|NCT00572455|466727900|FG008|Stage II (28 Days)|Adverse Event|1|||
129663354|NCT00572455|466727901|FG009|Stage II (28 Days)|Adverse Event|3|||
129663355|NCT00572455|466727902|FG010|Stage II (28 Days)|Adverse Event|3|||
129663356|NCT00572455|466727903|FG011|Stage II (28 Days)|Adverse Event|4|||
129663357|NCT00572455|466727904|FG012|Stage II (28 Days)|Adverse Event|5|||
129663358|NCT00572455|466727905|FG013|Stage II (28 Days)|Adverse Event|1|||
129663359|NCT00572455|466727892|FG000|Stage II (28 Days)|Death|0|||
129663360|NCT00572455|466727893|FG001|Stage II (28 Days)|Death|0|||
129663361|NCT00572455|466727894|FG002|Stage II (28 Days)|Death|0|||
129663362|NCT00572455|466727895|FG003|Stage II (28 Days)|Death|0|||
129992012|NCT02513303|467934165|FG000|Overall Study|Physician Decision|1|||
129992013|NCT02513303|467934166|FG001|Overall Study|Physician Decision|1|||
129992014|NCT02513303|467934167|FG002|Overall Study|Physician Decision|0|||
129992015|NCT02513303|467934165|FG000|Overall Study|Death|8|||
129992016|NCT02513303|467934166|FG001|Overall Study|Death|4|||
129992017|NCT02513303|467934167|FG002|Overall Study|Death|2|||
129992018|NCT06338462|467934174|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
129663363|NCT00572455|466727896|FG004|Stage II (28 Days)|Death|0|||
129663364|NCT00572455|466727897|FG005|Stage II (28 Days)|Death|0|||
129663365|NCT00572455|466727898|FG006|Stage II (28 Days)|Death|0|||
129663366|NCT00572455|466727899|FG007|Stage II (28 Days)|Death|0|||
129663367|NCT00572455|466727900|FG008|Stage II (28 Days)|Death|1|||
129992019|NCT02720094|467934178|FG000|Overall Study|Ongoing|2210|||
129992020|NCT02720094|467934179|FG001|Overall Study|Ongoing|2203|||
129992021|NCT02720094|467934178|FG000|Overall Study|Scheduled exit visit/end of study|2|||
129992022|NCT02720094|467934179|FG001|Overall Study|Scheduled exit visit/end of study|1|||
129992023|NCT02720094|467934178|FG000|Overall Study|Death|4|||
129992024|NCT02720094|467934179|FG001|Overall Study|Death|7|||
129992025|NCT02720094|467934178|FG000|Overall Study|Withdrawal by Subject|55|||
129992026|NCT02720094|467934179|FG001|Overall Study|Withdrawal by Subject|56|||
129663368|NCT00572455|466727901|FG009|Stage II (28 Days)|Death|0|||
129663369|NCT00572455|466727902|FG010|Stage II (28 Days)|Death|0|||
129663370|NCT00572455|466727903|FG011|Stage II (28 Days)|Death|0|||
129663371|NCT00572455|466727904|FG012|Stage II (28 Days)|Death|0|||
129992027|NCT02720094|467934178|FG000|Overall Study|Lost to Follow-up|2|||
129992028|NCT02720094|467934179|FG001|Overall Study|Lost to Follow-up|7|||
129992029|NCT02720094|467934178|FG000|Overall Study|Physician Decision|1|||
129992030|NCT02720094|467934179|FG001|Overall Study|Physician Decision|3|||
129663372|NCT00572455|466727905|FG013|Stage II (28 Days)|Death|0|||
129663373|NCT00572455|466727892|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
129663374|NCT00572455|466727893|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
129663375|NCT00572455|466727894|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
129663376|NCT00572455|466727895|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
129992031|NCT02720094|467934178|FG000|Overall Study|Inappropriate enrollment|1|||
129992032|NCT02720094|467934179|FG001|Overall Study|Inappropriate enrollment|3|||
129663377|NCT00572455|466727896|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
129663378|NCT00572455|466727897|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
129663379|NCT00572455|466727898|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
129663380|NCT00572455|466727899|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
129663381|NCT00572455|466727900|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
129663382|NCT00572455|466727901|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
129663383|NCT00572455|466727902|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
129663384|NCT00572455|466727903|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
129663385|NCT00572455|466727904|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
129663386|NCT00572455|466727905|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
129663387|NCT00572455|466727892|FG000|Stage II (28 Days)|Other|0|||
129663388|NCT00572455|466727893|FG001|Stage II (28 Days)|Other|0|||
129663389|NCT00572455|466727894|FG002|Stage II (28 Days)|Other|0|||
129663390|NCT00572455|466727895|FG003|Stage II (28 Days)|Other|0|||
129663391|NCT00572455|466727896|FG004|Stage II (28 Days)|Other|0|||
129663392|NCT00572455|466727897|FG005|Stage II (28 Days)|Other|0|||
129663393|NCT00572455|466727898|FG006|Stage II (28 Days)|Other|0|||
129663394|NCT00572455|466727899|FG007|Stage II (28 Days)|Other|0|||
129663395|NCT00572455|466727900|FG008|Stage II (28 Days)|Other|1|||
129663396|NCT00572455|466727901|FG009|Stage II (28 Days)|Other|0|||
129663397|NCT00572455|466727902|FG010|Stage II (28 Days)|Other|0|||
129663398|NCT00572455|466727903|FG011|Stage II (28 Days)|Other|0|||
129663399|NCT00572455|466727904|FG012|Stage II (28 Days)|Other|0|||
129663400|NCT00572455|466727905|FG013|Stage II (28 Days)|Other|0|||
129663401|NCT00572455|466727892|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
129663402|NCT00572455|466727893|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
129663403|NCT00572455|466727894|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
129663404|NCT00572455|466727895|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
129663405|NCT00572455|466727896|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
129663406|NCT00572455|466727897|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
129663407|NCT00572455|466727898|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
129663408|NCT00572455|466727899|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
129663409|NCT00572455|466727900|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
129663410|NCT00572455|466727901|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
129663411|NCT00572455|466727902|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
129663412|NCT00572455|466727903|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
129663413|NCT00572455|466727904|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
129663414|NCT00572455|466727905|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
129992033|NCT02720094|467934178|FG000|Overall Study|Relocation|1|||
129992034|NCT02720094|467934179|FG001|Overall Study|Relocation|1|||
129992035|NCT01302834|467934180|FG000|Overall Study|Protocol Violation|17|||
129992036|NCT01302834|467934181|FG001|Overall Study|Protocol Violation|23|||
129663415|NCT02821416|466727908|FG000|Overall Study|Adverse Event|0|||
129663416|NCT02821416|466727909|FG001|Overall Study|Adverse Event|1|||
129663417|NCT02821416|466727908|FG000|Overall Study|Withdrawal by Subject|2|||
129663418|NCT02821416|466727909|FG001|Overall Study|Withdrawal by Subject|0|||
129663419|NCT02821416|466727908|FG000|Overall Study|Lost to Follow-up|1|||
129663420|NCT02821416|466727909|FG001|Overall Study|Lost to Follow-up|0|||
129663421|NCT04152083|466727910|FG000|Overall Study|Lost to Follow-up|2|||
129663422|NCT04152083|466727911|FG001|Overall Study|Lost to Follow-up|1|||
129663423|NCT04152083|466727910|FG000|Overall Study|Adverse Event|1|||
129663424|NCT04152083|466727911|FG001|Overall Study|Adverse Event|0|||
129663425|NCT04152083|466727910|FG000|Overall Study|Randomized but not treated|3|||
129663426|NCT04152083|466727911|FG001|Overall Study|Randomized but not treated|2|||
129663427|NCT00856999|466727912|FG000|Overall Study|Withdrawal by Subject|5|||
129663428|NCT00872521|466727913|FG000|Completed PAD Induction|Patient choice|0|||
129663429|NCT00872521|466727914|FG001|Completed PAD Induction|Patient choice|1|||
129663430|NCT00872521|466727915|FG002|Completed PAD Induction|Patient choice|0|||
129663431|NCT00872521|466727913|FG000|Completed PAD Induction|Disease progression|0|||
129663432|NCT00872521|466727914|FG001|Completed PAD Induction|Disease progression|2|||
129663433|NCT00872521|466727915|FG002|Completed PAD Induction|Disease progression|0|||
129663434|NCT00872521|466727913|FG000|Completed PAD Induction|Adverse Event|4|||
129663435|NCT00872521|466727914|FG001|Completed PAD Induction|Adverse Event|0|||
129663436|NCT00872521|466727915|FG002|Completed PAD Induction|Adverse Event|0|||
129663437|NCT00872521|466727913|FG000|Completed PAD Induction|Death|1|||
129663438|NCT00872521|466727914|FG001|Completed PAD Induction|Death|1|||
129663439|NCT00872521|466727915|FG002|Completed PAD Induction|Death|0|||
129663440|NCT00872521|466727913|FG000|Primary Endpoint Analysis|Other|1|||
129663441|NCT00872521|466727914|FG001|Primary Endpoint Analysis|Other|2|||
129663442|NCT00872521|466727915|FG002|Primary Endpoint Analysis|Other|0|||
129663443|NCT00872521|466727913|FG000|Primary Endpoint Analysis|Patient choice|0|||
129663444|NCT00872521|466727914|FG001|Primary Endpoint Analysis|Patient choice|1|||
129663445|NCT00872521|466727915|FG002|Primary Endpoint Analysis|Patient choice|0|||
129663446|NCT00872521|466727913|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
129663447|NCT00872521|466727914|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
129663448|NCT00872521|466727915|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
129663449|NCT00872521|466727913|FG000|Primary Endpoint Analysis|Patient response missing|0|||
129663450|NCT00872521|466727914|FG001|Primary Endpoint Analysis|Patient response missing|0|||
129663451|NCT00872521|466727915|FG002|Primary Endpoint Analysis|Patient response missing|1|||
129663452|NCT00872521|466727913|FG000|Completed 3-month Follow up|Other|0|||
129663453|NCT00872521|466727914|FG001|Completed 3-month Follow up|Other|2|||
129663454|NCT00872521|466727915|FG002|Completed 3-month Follow up|Other|0|||
129663455|NCT00872521|466727913|FG000|Completed 3-month Follow up|Physician Decision|0|||
129663456|NCT00872521|466727914|FG001|Completed 3-month Follow up|Physician Decision|1|||
129663457|NCT00872521|466727915|FG002|Completed 3-month Follow up|Physician Decision|0|||
129663458|NCT00872521|466727913|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
129663459|NCT00872521|466727914|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
129663460|NCT00872521|466727915|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
129663461|NCT04819438|466727916|FG000|Overall Study|Withdrawal by Subject|1|||
129663462|NCT04819438|466727917|FG001|Overall Study|Withdrawal by Subject|0|||
129663463|NCT04819438|466727916|FG000|Overall Study|Adverse Event|0|||
129663464|NCT04819438|466727917|FG001|Overall Study|Adverse Event|1|||
129663465|NCT04819438|466727916|FG000|Overall Study|Protocol Violation|0|||
129663466|NCT04819438|466727917|FG001|Overall Study|Protocol Violation|1|||
129663467|NCT03465709|466727918|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
129663468|NCT03465709|466727918|FG000|Overall Study|Withdrawal by Subject|3|||
129663469|NCT03060291|466727919|FG000|3-month Follow-up|Declined to respond|8|||
129663470|NCT03060291|466727920|FG001|3-month Follow-up|Declined to respond|10|||
129663471|NCT03060291|466727921|FG002|3-month Follow-up|Declined to respond|2|||
129663472|NCT03060291|466727919|FG000|6-month Follow-up|Declined to respond|7|||
129663473|NCT03060291|466727920|FG001|6-month Follow-up|Declined to respond|13|||
129663474|NCT03060291|466727921|FG002|6-month Follow-up|Declined to respond|4|||
129663475|NCT03060291|466727919|FG000|12-month Follow-up|Declined to respond|7|||
129663476|NCT03060291|466727920|FG001|12-month Follow-up|Declined to respond|16|||
129663477|NCT03060291|466727921|FG002|12-month Follow-up|Declined to respond|6|||
129663478|NCT01720524|466727922|FG000|Part A|Insufficient Clinical Response|2|||
129663479|NCT01720524|466727923|FG001|Part A|Insufficient Clinical Response|4|||
129663480|NCT01720524|466727922|FG000|Part A|Adverse Event|2|||
129663481|NCT01720524|466727923|FG001|Part A|Adverse Event|2|||
129663482|NCT01720524|466727922|FG000|Part A|Death|2|||
129663483|NCT01720524|466727923|FG001|Part A|Death|1|||
129663484|NCT01720524|466727922|FG000|Part A|Lost to Follow-up|0|||
129663485|NCT01720524|466727923|FG001|Part A|Lost to Follow-up|1|||
129663486|NCT01720524|466727922|FG000|Part A|Missed 28 day follow-up visit|1|||
129663487|NCT01720524|466727923|FG001|Part A|Missed 28 day follow-up visit|1|||
129663488|NCT01720524|466727922|FG000|Part A|Withdrawal by Subject|0|||
129663489|NCT01720524|466727923|FG001|Part A|Withdrawal by Subject|1|||
129663490|NCT01720524|466727922|FG000|Part A|Other|0|||
129663491|NCT01720524|466727923|FG001|Part A|Other|1|||
129663492|NCT01720524|466727922|FG000|Part A|Lost to Follow-up|0|||
129663493|NCT01720524|466727923|FG001|Part A|Lost to Follow-up|1|||
129663494|NCT01720524|466727922|FG000|Part B|No longer willing to participate in study|1|||
129663495|NCT01720524|466727923|FG001|Part B|No longer willing to participate in study|4|||
129663496|NCT01720524|466727922|FG000|Part B|Other|2|||
129663497|NCT01720524|466727923|FG001|Part B|Other|0|||
129663498|NCT01720524|466727922|FG000|Part B|Lost to Follow-up|2|||
129663499|NCT01720524|466727923|FG001|Part B|Lost to Follow-up|3|||
129663500|NCT01720524|466727922|FG000|Part B|Death|0|||
129663501|NCT01720524|466727923|FG001|Part B|Death|2|||
129663502|NCT02105285|466727929|FG000|Overall Study|Adverse Event|1|||
129663503|NCT02105285|466727930|FG001|Overall Study|Adverse Event|1|||
129663504|NCT02105285|466727931|FG002|Overall Study|Adverse Event|0|||
129663505|NCT02105285|466727929|FG000|Overall Study|Protocol Violation|0|||
129663506|NCT02105285|466727930|FG001|Overall Study|Protocol Violation|1|||
129663507|NCT02105285|466727931|FG002|Overall Study|Protocol Violation|0|||
129663508|NCT02105285|466727929|FG000|Overall Study|Withdrawal by Subject|1|||
129663509|NCT02105285|466727930|FG001|Overall Study|Withdrawal by Subject|0|||
129663510|NCT02105285|466727931|FG002|Overall Study|Withdrawal by Subject|0|||
129663511|NCT01421641|466727932|FG000|Overall Study|Protocol Violation|2|||
129663512|NCT01421641|466727933|FG001|Overall Study|Protocol Violation|2|||
129546625|NCT01785472|466294066|FG000|Overall Study|Protocol deviation|0|||
129546626|NCT01785472|466294067|FG001|Overall Study|Protocol deviation|2|||
129546627|NCT01785472|466294068|FG002|Overall Study|Protocol deviation|2|||
129546628|NCT01785472|466294066|FG000|Overall Study|Subject/guardian decision|15|||
129546629|NCT01785472|466294067|FG001|Overall Study|Subject/guardian decision|10|||
129546630|NCT01785472|466294068|FG002|Overall Study|Subject/guardian decision|11|||
129546631|NCT01785472|466294066|FG000|Overall Study|Technical problems|0|||
129546632|NCT01785472|466294067|FG001|Overall Study|Technical problems|0|||
129546633|NCT01785472|466294068|FG002|Overall Study|Technical problems|1|||
129546634|NCT02086968|466294070|FG000|Overall Study|Adverse Event|1|||
129546635|NCT02086968|466294071|FG001|Overall Study|Adverse Event|5|||
129546636|NCT02086968|466294070|FG000|Overall Study|Lost to Follow-up|2|||
129546637|NCT02086968|466294071|FG001|Overall Study|Lost to Follow-up|3|||
129546638|NCT02086968|466294070|FG000|Overall Study|Study drug received outside protocol|0|||
129546639|NCT02086968|466294071|FG001|Overall Study|Study drug received outside protocol|1|||
129546640|NCT02086968|466294070|FG000|Overall Study|Physician Decision|4|||
129546641|NCT02086968|466294071|FG001|Overall Study|Physician Decision|0|||
129546642|NCT02086968|466294070|FG000|Overall Study|Withdrawal by Subject|1|||
129546643|NCT02086968|466294071|FG001|Overall Study|Withdrawal by Subject|4|||
129546644|NCT01569074|466294072|FG000|Overall Study|Study stopped|6|||
129546645|NCT01569074|466294073|FG001|Overall Study|Study stopped|6|||
129546646|NCT01569074|466294074|FG002|Overall Study|Study stopped|8|||
129546647|NCT01569074|466294075|FG003|Overall Study|Study stopped|7|||
129546648|NCT01569074|466294076|FG004|Overall Study|Study stopped|7|||
129546649|NCT01569074|466294072|FG000|Overall Study|Study-specific discontinuation criteria|0|||
129546650|NCT01569074|466294073|FG001|Overall Study|Study-specific discontinuation criteria|1|||
129546651|NCT01569074|466294074|FG002|Overall Study|Study-specific discontinuation criteria|0|||
129546652|NCT01569074|466294075|FG003|Overall Study|Study-specific discontinuation criteria|0|||
129546653|NCT01569074|466294076|FG004|Overall Study|Study-specific discontinuation criteria|0|||
129546654|NCT01569074|466294072|FG000|Overall Study|Severe non-compliance to protocol|0|||
129546655|NCT01569074|466294073|FG001|Overall Study|Severe non-compliance to protocol|0|||
129546656|NCT01569074|466294074|FG002|Overall Study|Severe non-compliance to protocol|1|||
129546657|NCT01569074|466294075|FG003|Overall Study|Severe non-compliance to protocol|0|||
129546658|NCT01569074|466294076|FG004|Overall Study|Severe non-compliance to protocol|0|||
129546659|NCT01569074|466294072|FG000|Overall Study|eg change in circumstances|0|||
129546660|NCT01569074|466294073|FG001|Overall Study|eg change in circumstances|2|||
129546661|NCT01569074|466294074|FG002|Overall Study|eg change in circumstances|0|||
129546662|NCT01569074|466294075|FG003|Overall Study|eg change in circumstances|1|||
129546663|NCT01569074|466294076|FG004|Overall Study|eg change in circumstances|1|||
129546664|NCT01569074|466294072|FG000|Overall Study|Adverse Event|1|||
129546665|NCT01569074|466294073|FG001|Overall Study|Adverse Event|0|||
129546666|NCT01569074|466294074|FG002|Overall Study|Adverse Event|3|||
129546667|NCT01569074|466294075|FG003|Overall Study|Adverse Event|0|||
129663513|NCT03061188|466727935|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
129663514|NCT03061188|466727936|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
129663515|NCT03061188|466727937|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
129546668|NCT01569074|466294076|FG004|Overall Study|Adverse Event|0|||
129663516|NCT03061188|466727938|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
129663517|NCT03061188|466727935|FG000|On Follow-up for 3 Years|Death|0|||
129546669|NCT02723786|466294078|FG000|Overall Study|Lost to Follow-up|1|||
129546670|NCT00203892|466294079|FG000|Overall Study|Physician Decision|1|||
129546671|NCT00203892|466294080|FG001|Overall Study|Physician Decision|2|||
129546672|NCT00203892|466294081|FG002|Overall Study|Physician Decision|0|||
129546673|NCT00203892|466294079|FG000|Overall Study|Death|1|||
129546674|NCT00203892|466294080|FG001|Overall Study|Death|0|||
129663518|NCT03061188|466727936|FG001|On Follow-up for 3 Years|Death|3|||
129663519|NCT03061188|466727937|FG002|On Follow-up for 3 Years|Death|5|||
129663520|NCT03061188|466727938|FG003|On Follow-up for 3 Years|Death|4|||
129663521|NCT03061188|466727935|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
129663522|NCT03061188|466727936|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
129663523|NCT03061188|466727937|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
129663524|NCT03061188|466727938|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
129663525|NCT02609984|466727939|FG000|Overall Study|Death|29|||
129663526|NCT02609984|466727940|FG001|Overall Study|Death|26|||
129663527|NCT02609984|466727939|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
129663528|NCT02609984|466727940|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
129663529|NCT02609984|466727939|FG000|Overall Study|Lost to Follow-up|1|||
129663530|NCT02609984|466727940|FG001|Overall Study|Lost to Follow-up|2|||
129663531|NCT02609984|466727939|FG000|Overall Study|Withdrawal by Subject|0|||
129663532|NCT02609984|466727940|FG001|Overall Study|Withdrawal by Subject|1|||
129663533|NCT02609984|466727939|FG000|Overall Study|Disease Progression|2|||
129663534|NCT02609984|466727940|FG001|Overall Study|Disease Progression|0|||
129663535|NCT02504320|466727941|FG000|Treatment Period 1|Positive Drug Screen|0|||
129663536|NCT02504320|466727942|FG001|Treatment Period 1|Positive Drug Screen|0|||
129663537|NCT02504320|466727943|FG002|Treatment Period 1|Positive Drug Screen|1|||
129546675|NCT00203892|466294081|FG002|Overall Study|Death|0|||
129546676|NCT00742859|466294095|FG000|Overall Study|Adverse Event|5|||
129546677|NCT00742859|466294096|FG001|Overall Study|Adverse Event|6|||
129546678|NCT00742859|466294097|FG002|Overall Study|Adverse Event|3|||
129546679|NCT00742859|466294098|FG003|Overall Study|Adverse Event|1|||
129546680|NCT00742859|466294095|FG000|Overall Study|Death|1|||
129546681|NCT00742859|466294096|FG001|Overall Study|Death|0|||
129546682|NCT00742859|466294097|FG002|Overall Study|Death|0|||
129546683|NCT00742859|466294098|FG003|Overall Study|Death|1|||
129546684|NCT00742859|466294095|FG000|Overall Study|Physician Decision|1|||
129546685|NCT00742859|466294096|FG001|Overall Study|Physician Decision|2|||
129546686|NCT00742859|466294097|FG002|Overall Study|Physician Decision|0|||
129546687|NCT00742859|466294098|FG003|Overall Study|Physician Decision|0|||
129546688|NCT00742859|466294095|FG000|Overall Study|Withdrawal by Subject|4|||
129546689|NCT00742859|466294096|FG001|Overall Study|Withdrawal by Subject|2|||
129546690|NCT00742859|466294097|FG002|Overall Study|Withdrawal by Subject|4|||
129546691|NCT00742859|466294098|FG003|Overall Study|Withdrawal by Subject|1|||
129546692|NCT00742859|466294095|FG000|Overall Study|Endpoint|0|||
129546693|NCT00742859|466294096|FG001|Overall Study|Endpoint|1|||
129546694|NCT00742859|466294097|FG002|Overall Study|Endpoint|1|||
129546695|NCT00742859|466294098|FG003|Overall Study|Endpoint|2|||
129546696|NCT00742859|466294095|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
129546697|NCT00742859|466294096|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
129546698|NCT00742859|466294097|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
129546699|NCT00742859|466294098|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
129546700|NCT00742859|466294095|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
129546701|NCT00742859|466294096|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
129546702|NCT00742859|466294097|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
129546703|NCT00742859|466294098|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
129546704|NCT00742859|466294095|FG000|Overall Study|Sponsor request patient out of town|0|||
129546705|NCT00742859|466294096|FG001|Overall Study|Sponsor request patient out of town|0|||
129546706|NCT00742859|466294097|FG002|Overall Study|Sponsor request patient out of town|1|||
129546707|NCT00742859|466294098|FG003|Overall Study|Sponsor request patient out of town|1|||
129546708|NCT00742859|466294095|FG000|Overall Study|Site error|0|||
129546709|NCT00742859|466294096|FG001|Overall Study|Site error|0|||
129546710|NCT00742859|466294097|FG002|Overall Study|Site error|1|||
129546711|NCT00742859|466294098|FG003|Overall Study|Site error|1|||
129546712|NCT01071083|466294109|FG000|Overall Study|Adverse Event|1|||
129546713|NCT01071083|466294110|FG001|Overall Study|Adverse Event|0|||
129546714|NCT01071083|466294111|FG002|Overall Study|Adverse Event|1|||
129546715|NCT01071083|466294112|FG003|Overall Study|Adverse Event|0|||
129546716|NCT01071083|466294113|FG004|Overall Study|Adverse Event|1|||
129546717|NCT01071083|466294109|FG000|Overall Study|Withdrawal by Subject|3|||
129546718|NCT01071083|466294110|FG001|Overall Study|Withdrawal by Subject|0|||
129546719|NCT01071083|466294111|FG002|Overall Study|Withdrawal by Subject|2|||
129546720|NCT01071083|466294112|FG003|Overall Study|Withdrawal by Subject|0|||
129546721|NCT01071083|466294113|FG004|Overall Study|Withdrawal by Subject|3|||
129546722|NCT01071083|466294109|FG000|Overall Study|Physician Decision|1|||
129546723|NCT01071083|466294110|FG001|Overall Study|Physician Decision|0|||
129546724|NCT01071083|466294111|FG002|Overall Study|Physician Decision|0|||
129546725|NCT01071083|466294112|FG003|Overall Study|Physician Decision|1|||
129663538|NCT02504320|466727944|FG003|Treatment Period 1|Positive Drug Screen|0|||
129663539|NCT02504320|466727941|FG000|Treatment Period 2|Positive Drug Screen|0|||
129546726|NCT01071083|466294113|FG004|Overall Study|Physician Decision|1|||
129546727|NCT01071083|466294109|FG000|Overall Study|Early Rescue|1|||
129546728|NCT01071083|466294110|FG001|Overall Study|Early Rescue|0|||
129546729|NCT01071083|466294111|FG002|Overall Study|Early Rescue|0|||
129546730|NCT01071083|466294112|FG003|Overall Study|Early Rescue|0|||
129663540|NCT02504320|466727942|FG001|Treatment Period 2|Positive Drug Screen|1|||
129663541|NCT02504320|466727943|FG002|Treatment Period 2|Positive Drug Screen|0|||
129663542|NCT02504320|466727944|FG003|Treatment Period 2|Positive Drug Screen|0|||
129663543|NCT02504320|466727941|FG000|Treatment Period 3|Positive Drug Screen|0|||
129663544|NCT02504320|466727942|FG001|Treatment Period 3|Positive Drug Screen|0|||
129663545|NCT02504320|466727943|FG002|Treatment Period 3|Positive Drug Screen|0|||
129663546|NCT02504320|466727944|FG003|Treatment Period 3|Positive Drug Screen|1|||
129663547|NCT02504320|466727941|FG000|Treatment Period 3|Adverse Event|0|||
129663548|NCT02504320|466727942|FG001|Treatment Period 3|Adverse Event|0|||
129663549|NCT02504320|466727943|FG002|Treatment Period 3|Adverse Event|1|||
129663550|NCT02504320|466727944|FG003|Treatment Period 3|Adverse Event|0|||
129663551|NCT01210222|466727945|FG000|Overall Study|Ineligible|2|||
129663552|NCT01210222|466727945|FG000|Overall Study|Never treated|1|||
129663553|NCT03293394|466727946|FG000|Follow-up (6 Months)|Adverse Event|4|||
129663554|NCT03293394|466727947|FG001|Follow-up (6 Months)|Adverse Event|2|||
129663555|NCT00436826|466727950|FG000|Double Blind Period (DBP)|Adverse Event|2|||
129663556|NCT00436826|466727951|FG001|Double Blind Period (DBP)|Adverse Event|0|||
129663557|NCT00436826|466727952|FG002|Double Blind Period (DBP)|Adverse Event|0|||
129663558|NCT00436826|466727953|FG003|Double Blind Period (DBP)|Adverse Event|0|||
129663559|NCT00436826|466727954|FG004|Double Blind Period (DBP)|Adverse Event|0|||
129663560|NCT00436826|466727955|FG005|Double Blind Period (DBP)|Adverse Event|0|||
129663561|NCT00436826|466727950|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
129663562|NCT00436826|466727951|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
129663563|NCT00436826|466727952|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
129663564|NCT00436826|466727953|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
129663565|NCT00436826|466727954|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
129663566|NCT00436826|466727955|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
129663567|NCT00436826|466727950|FG000|Double Blind Period (DBP)|Other|10|||
129663568|NCT00436826|466727951|FG001|Double Blind Period (DBP)|Other|11|||
129663569|NCT00436826|466727952|FG002|Double Blind Period (DBP)|Other|0|||
129663570|NCT00436826|466727953|FG003|Double Blind Period (DBP)|Other|0|||
129663571|NCT00436826|466727954|FG004|Double Blind Period (DBP)|Other|0|||
129663572|NCT00436826|466727955|FG005|Double Blind Period (DBP)|Other|0|||
129663573|NCT00436826|466727950|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129663574|NCT00436826|466727951|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129663575|NCT00436826|466727952|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129663576|NCT00436826|466727953|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
129663577|NCT00436826|466727954|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129663578|NCT00436826|466727955|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
129663579|NCT00436826|466727950|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129663580|NCT00436826|466727951|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129663581|NCT00436826|466727952|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
129663582|NCT00436826|466727953|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
129663583|NCT00436826|466727954|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129663584|NCT00436826|466727955|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
129663585|NCT00436826|466727950|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129663586|NCT00436826|466727951|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129663587|NCT00436826|466727952|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129663588|NCT00436826|466727953|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
129663589|NCT00436826|466727954|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
129663590|NCT00436826|466727955|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
129663591|NCT04978337|466727956|FG000|Overall Study|Withdrawal by Subject|0|||
129663592|NCT04978337|466727957|FG001|Overall Study|Withdrawal by Subject|1|||
129663593|NCT01436227|466727959|FG000|Overall Study|Adverse Event|7|||
129663594|NCT01436227|466727959|FG000|Overall Study|Death|1|||
129663595|NCT01436227|466727959|FG000|Overall Study|Lack of Efficacy|1|||
129663596|NCT01436227|466727959|FG000|Overall Study|Lost to Follow-up|3|||
129663597|NCT01436227|466727959|FG000|Overall Study|Physician Decision|1|||
129663598|NCT01436227|466727959|FG000|Overall Study|Withdrawal by Subject|7|||
129663599|NCT01436227|466727959|FG000|Overall Study|Disease progression, relapse|6|||
129663600|NCT00869128|466727965|FG000|Overall Study|lack of Compliance|6|||
129663601|NCT00869128|466727966|FG001|Overall Study|lack of Compliance|6|||
129663602|NCT02716584|466727972|FG000|Overall Study|Lost to Follow-up|8|||
129663603|NCT02716584|466727973|FG001|Overall Study|Lost to Follow-up|5|||
129663604|NCT02282163|466727980|FG000|Overall Study|Protocol Violation|1|||
129663605|NCT01603407|466727981|FG000|Overall Study|Adverse Event|1|||
129663606|NCT01603407|466727982|FG001|Overall Study|Adverse Event|1|||
129663607|NCT01603407|466727983|FG002|Overall Study|Adverse Event|1|||
129663608|NCT01603407|466727981|FG000|Overall Study|Protocol Violation|2|||
129663609|NCT01603407|466727982|FG001|Overall Study|Protocol Violation|2|||
129663610|NCT01603407|466727983|FG002|Overall Study|Protocol Violation|0|||
129663611|NCT01603407|466727981|FG000|Overall Study|Withdrawal by Subject|8|||
129663612|NCT01603407|466727982|FG001|Overall Study|Withdrawal by Subject|5|||
129663613|NCT01603407|466727983|FG002|Overall Study|Withdrawal by Subject|7|||
129663614|NCT01603407|466727981|FG000|Overall Study|Lost to Follow-up|0|||
129663615|NCT01603407|466727982|FG001|Overall Study|Lost to Follow-up|3|||
129663616|NCT01603407|466727983|FG002|Overall Study|Lost to Follow-up|2|||
129663617|NCT02500719|466727984|FG000|Overall Study|Lost to Follow-up|2|||
129663618|NCT02500719|466727985|FG001|Overall Study|Lost to Follow-up|3|||
129663619|NCT02500719|466727984|FG000|Overall Study|Trauma history|1|||
129663620|NCT02500719|466727985|FG001|Overall Study|Trauma history|0|||
129663621|NCT02500719|466727984|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
129663622|NCT02500719|466727985|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
129663623|NCT02500719|466727984|FG000|Overall Study|Did not meet criteria for PTSD|0|||
129663624|NCT02500719|466727985|FG001|Overall Study|Did not meet criteria for PTSD|1|||
129663625|NCT02500719|466727984|FG000|Overall Study|Claustrophobia|0|||
129663626|NCT02500719|466727985|FG001|Overall Study|Claustrophobia|1|||
129663627|NCT02500719|466727984|FG000|Overall Study|History of head trauma|0|||
129663628|NCT02500719|466727985|FG001|Overall Study|History of head trauma|1|||
129663629|NCT01990768|466727986|FG000|Intervention Started|Found to be ineligible|14|||
129663630|NCT01990768|466727987|FG001|Intervention Started|Found to be ineligible|13|||
129663631|NCT01990768|466727988|FG002|Intervention Started|Found to be ineligible|11|||
129663632|NCT01990768|466727986|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
129663633|NCT01990768|466727987|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
129663634|NCT01990768|466727988|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
129663635|NCT01990768|466727986|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
129663636|NCT01990768|466727987|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
129663637|NCT01990768|466727988|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
129663638|NCT01990768|466727986|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
129663639|NCT01990768|466727987|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
129663640|NCT01990768|466727988|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
129663641|NCT01990768|466727986|FG000|Intervention Started|Patient care priority|1|||
129663642|NCT01990768|466727987|FG001|Intervention Started|Patient care priority|2|||
129663643|NCT01990768|466727988|FG002|Intervention Started|Patient care priority|3|||
129663644|NCT01990768|466727986|FG000|Intervention Started|IV lost|2|||
129663645|NCT01990768|466727987|FG001|Intervention Started|IV lost|2|||
129663646|NCT01990768|466727988|FG002|Intervention Started|IV lost|2|||
129663647|NCT01990768|466727986|FG000|Intervention Started|Required CPR|1|||
129663648|NCT01990768|466727987|FG001|Intervention Started|Required CPR|1|||
129663649|NCT01990768|466727988|FG002|Intervention Started|Required CPR|0|||
129663650|NCT01990768|466727986|FG000|Intervention Started|Seizure or hx of seizure|0|||
129663651|NCT01990768|466727987|FG001|Intervention Started|Seizure or hx of seizure|0|||
129663652|NCT01990768|466727988|FG002|Intervention Started|Seizure or hx of seizure|2|||
129663653|NCT01990768|466727986|FG000|Intervention Started|Discovered to be pregnant|0|||
129663654|NCT01990768|466727987|FG001|Intervention Started|Discovered to be pregnant|1|||
129663655|NCT01990768|466727988|FG002|Intervention Started|Discovered to be pregnant|0|||
129663656|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
129663657|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
129663658|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
129663659|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
129663660|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
129663661|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
129663662|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
129663663|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
129663664|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
129663665|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
129663666|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
129663667|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
129663668|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Death|3|||
129663669|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Death|1|||
129663670|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Death|1|||
129663671|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Discharged|2|||
129663672|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Discharged|1|||
129663673|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Discharged|0|||
129663674|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
129663675|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
129663676|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
129663677|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
129663678|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
129663679|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
129663680|NCT01990768|466727986|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
129663681|NCT01990768|466727987|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
129663682|NCT01990768|466727988|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
129663683|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
129663684|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
129663685|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
129663686|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
129663687|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
129663688|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
129663689|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
129663690|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
129663691|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
129663692|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
129663693|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
129663694|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
129663695|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
129663696|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
129663697|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
129663698|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
129663699|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
129663700|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
129663701|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
129663702|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
129663703|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
129663704|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
129663705|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
129663706|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
129663707|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
129663708|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
129663709|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
129663710|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
129663711|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
129663712|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
129663713|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
129663714|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
129663715|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
129663716|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
129663717|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
129663718|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
129663719|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
129663720|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
129663721|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
129663722|NCT01990768|466727986|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
129663723|NCT01990768|466727987|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
129663724|NCT01990768|466727988|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
129663725|NCT01990768|466727986|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
129663726|NCT01990768|466727987|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
129663727|NCT01990768|466727988|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
129663728|NCT01990768|466727986|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
129663729|NCT01990768|466727987|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
129663730|NCT01990768|466727988|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
129663731|NCT01990768|466727986|FG000|6-Month Follow-up|No contact information|5|||
129663732|NCT01990768|466727987|FG001|6-Month Follow-up|No contact information|6|||
129663733|NCT01990768|466727988|FG002|6-Month Follow-up|No contact information|5|||
129663734|NCT01990768|466727986|FG000|6-Month Follow-up|Homeless|4|||
129663735|NCT01990768|466727987|FG001|6-Month Follow-up|Homeless|3|||
129663736|NCT01990768|466727988|FG002|6-Month Follow-up|Homeless|6|||
129663737|NCT01990768|466727986|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
129663738|NCT01990768|466727987|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
129663739|NCT01990768|466727988|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
129663740|NCT01990768|466727986|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
129663741|NCT01990768|466727987|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
129663742|NCT01990768|466727988|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
129663743|NCT01990768|466727986|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
129663744|NCT01990768|466727987|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
129663745|NCT01990768|466727988|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
129663746|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
129663747|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
129883874|NCT02733042|467534454|FG013|Overall Study|Progressive Disease|1|||
129663748|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
129663749|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
129663750|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
129663751|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
129663752|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
129663753|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
129663754|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
129663755|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
129663756|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
129663757|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
129663758|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
129663759|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
129663760|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
129663761|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
129663762|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
129663763|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
129663764|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
129663765|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
129663766|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
129663767|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
129663768|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
129663769|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
129663770|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
129663771|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
129663772|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
129663773|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
129663774|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
129663775|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
129663776|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
129663777|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
129663778|NCT03538691|466727989|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
129663779|NCT03538691|466727990|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
129663780|NCT03538691|466727991|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
129663781|NCT03538691|466727992|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
129663782|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
129663783|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
129663784|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
129663785|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
129663786|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
129663787|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
129663788|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
129663789|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
129663790|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
129663791|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
129663792|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
129663793|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
129663794|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
129663795|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
129663796|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
129663797|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
129663798|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
129663799|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
129663800|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
129663801|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
129663802|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
129663803|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
129663804|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
129663805|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
129663806|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
129663807|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
129663808|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
129546731|NCT01071083|466294113|FG004|Overall Study|Early Rescue|1|||
129663809|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
129663810|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
129663811|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
129663812|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
129663813|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
129663814|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
129663815|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
129663816|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
129663817|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
129663818|NCT03538691|466727989|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129663819|NCT03538691|466727990|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
129663820|NCT03538691|466727991|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129663821|NCT03538691|466727992|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129663822|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
129663823|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
129663824|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
129663825|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
129663826|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
129663827|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
129663828|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
129663829|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
129663830|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
129663831|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
129663832|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
129663833|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
129663834|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
129663835|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
129663836|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
129663837|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
129663838|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
129663839|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
129663840|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
129663841|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
129663842|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
129663843|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
129663844|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
129663845|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
129663846|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
129663847|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
129663848|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
129663849|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
129663850|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
129663851|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
129663852|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
129663853|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
129663854|NCT03538691|466727989|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129663855|NCT03538691|466727990|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
129663856|NCT03538691|466727991|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
129663857|NCT03538691|466727992|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
129663858|NCT06597084|466727993|FG000|Overall Study|Withdrawal by Subject|4|||
129663859|NCT06597084|466727994|FG001|Overall Study|Withdrawal by Subject|9|||
129663860|NCT06597084|466727993|FG000|Overall Study|Consent was not given by the patient until V2|0|||
129663861|NCT06597084|466727994|FG001|Overall Study|Consent was not given by the patient until V2|3|||
129663862|NCT06597084|466727993|FG000|Overall Study|Physician Decision|1|||
129663863|NCT06597084|466727994|FG001|Overall Study|Physician Decision|0|||
129663864|NCT06597084|466727993|FG000|Overall Study|Adverse Event|3|||
129663865|NCT06597084|466727994|FG001|Overall Study|Adverse Event|2|||
129663866|NCT06597084|466727993|FG000|Overall Study|Death|4|||
129663867|NCT06597084|466727994|FG001|Overall Study|Death|0|||
129663868|NCT06597084|466727993|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
129663869|NCT06597084|466727994|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
129663870|NCT06597084|466727993|FG000|Overall Study|Lost to Follow-up|4|||
129663871|NCT06597084|466727994|FG001|Overall Study|Lost to Follow-up|2|||
129663872|NCT06597084|466727993|FG000|Overall Study|Other. Not specified|1|||
129663873|NCT06597084|466727994|FG001|Overall Study|Other. Not specified|0|||
129663874|NCT01588405|466727995|FG000|Overall Study|Adverse Event|1|||
129663875|NCT01588405|466727995|FG000|Overall Study|Clinical Worsening|1|||
129663876|NCT02029274|466728001|FG000|Overall Study|Adverse Event|1|||
129663877|NCT02029274|466728002|FG001|Overall Study|Adverse Event|0|||
129663878|NCT02029274|466728003|FG002|Overall Study|Adverse Event|2|||
129663879|NCT02029274|466728004|FG003|Overall Study|Adverse Event|2|||
129663880|NCT05251233|466729614|FG000|Overall Study|Disease progression - did not start treatment|0|||
129663881|NCT05251233|466729615|FG001|Overall Study|Disease progression - did not start treatment|0|||
129663882|NCT05251233|466729616|FG002|Overall Study|Disease progression - did not start treatment|5|||
129663883|NCT05251233|466729614|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
129663884|NCT05251233|466729615|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
129663885|NCT05251233|466729616|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
129663886|NCT05251233|466729614|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
129663887|NCT05251233|466729615|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
129663888|NCT05251233|466729616|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
129663889|NCT05251233|466729614|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
129663890|NCT05251233|466729615|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
129663891|NCT05251233|466729616|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
129663892|NCT05251233|466729614|FG000|Overall Study|Death - did not start treatment|3|||
129663893|NCT05251233|466729615|FG001|Overall Study|Death - did not start treatment|0|||
129663894|NCT05251233|466729616|FG002|Overall Study|Death - did not start treatment|0|||
129663895|NCT05251233|466729614|FG000|Overall Study|Withdrawal by Subject|2|||
129663896|NCT05251233|466729615|FG001|Overall Study|Withdrawal by Subject|2|||
129663897|NCT05251233|466729616|FG002|Overall Study|Withdrawal by Subject|0|||
129663898|NCT05251233|466729614|FG000|Overall Study|Other complicating disease|2|||
129663899|NCT05251233|466729615|FG001|Overall Study|Other complicating disease|1|||
129663900|NCT05251233|466729616|FG002|Overall Study|Other complicating disease|0|||
129663901|NCT05251233|466729614|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
129663902|NCT05251233|466729615|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
129663903|NCT05251233|466729616|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
129663904|NCT05251233|466729614|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
129663905|NCT05251233|466729615|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
129663906|NCT05251233|466729616|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
129663907|NCT03272347|466729621|FG000|Overall Study|Death|0|||
129663908|NCT03272347|466729622|FG001|Overall Study|Death|0|||
129663909|NCT03272347|466729623|FG002|Overall Study|Death|0|||
129663910|NCT03272347|466729624|FG003|Overall Study|Death|1|||
129663911|NCT03272347|466729621|FG000|Overall Study|Lost to Follow-up|1|||
129663912|NCT03272347|466729622|FG001|Overall Study|Lost to Follow-up|3|||
129663913|NCT03272347|466729623|FG002|Overall Study|Lost to Follow-up|5|||
129663914|NCT03272347|466729624|FG003|Overall Study|Lost to Follow-up|1|||
129663915|NCT03272347|466729621|FG000|Overall Study|Physician Decision|4|||
129663916|NCT03272347|466729622|FG001|Overall Study|Physician Decision|2|||
129663917|NCT03272347|466729623|FG002|Overall Study|Physician Decision|5|||
129663918|NCT03272347|466729624|FG003|Overall Study|Physician Decision|4|||
129663919|NCT03272347|466729621|FG000|Overall Study|Screen Failure|1|||
129663920|NCT03272347|466729622|FG001|Overall Study|Screen Failure|0|||
129663921|NCT03272347|466729623|FG002|Overall Study|Screen Failure|0|||
129663922|NCT03272347|466729624|FG003|Overall Study|Screen Failure|0|||
129663923|NCT03272347|466729621|FG000|Overall Study|Withdrawal by Subject|5|||
129663924|NCT03272347|466729622|FG001|Overall Study|Withdrawal by Subject|1|||
129663925|NCT03272347|466729623|FG002|Overall Study|Withdrawal by Subject|2|||
129663926|NCT03272347|466729624|FG003|Overall Study|Withdrawal by Subject|1|||
129663927|NCT00391872|466729627|FG000|Overall Study|Protocol Violation|7|||
129663928|NCT00391872|466729628|FG001|Overall Study|Protocol Violation|2|||
129663929|NCT00391872|466729627|FG000|Overall Study|Withdrawal by Subject|296|||
129663930|NCT00391872|466729628|FG001|Overall Study|Withdrawal by Subject|249|||
129663931|NCT00391872|466729627|FG000|Overall Study|Reason unknown|2|||
129663932|NCT00391872|466729628|FG001|Overall Study|Reason unknown|4|||
129663933|NCT00391872|466729627|FG000|Overall Study|Lost to Follow-up|2|||
129663934|NCT00391872|466729628|FG001|Overall Study|Lost to Follow-up|0|||
129663935|NCT01239394|466729630|FG000|Overall Study|Adverse Event|1|||
129663936|NCT02861664|466729631|FG000|Overall Study|Withdrawal of Consent|0|||
129663937|NCT02861664|466729632|FG001|Overall Study|Withdrawal of Consent|1|||
129663938|NCT00905632|466729634|FG000|Overall Study|Adverse Event|0|||
129663939|NCT00905632|466729635|FG001|Overall Study|Adverse Event|0|||
129546732|NCT01071083|466294109|FG000|Overall Study|Subject Moved|0|||
129663940|NCT00905632|466729636|FG002|Overall Study|Adverse Event|0|||
129663941|NCT00905632|466729637|FG003|Overall Study|Adverse Event|0|||
129663942|NCT00905632|466729638|FG004|Overall Study|Adverse Event|0|||
129663943|NCT00905632|466729639|FG005|Overall Study|Adverse Event|1|||
129663944|NCT00905632|466729640|FG006|Overall Study|Adverse Event|4|||
129663945|NCT01307891|466729642|FG000|Overall Study|Progressive Disease|3|||
129663946|NCT01307891|466729643|FG001|Overall Study|Progressive Disease|1|||
129663947|NCT02937740|466729644|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
129663948|NCT02937740|466729645|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
129663949|NCT02937740|466729644|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
129663950|NCT02937740|466729645|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
129663951|NCT02937740|466729644|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
129663952|NCT02937740|466729645|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
129663953|NCT02937740|466729644|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
129663954|NCT02937740|466729645|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
129663955|NCT02937740|466729644|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
129663956|NCT02937740|466729645|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
129663957|NCT02937740|466729644|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
129663958|NCT02937740|466729645|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
129663959|NCT00305227|466729648|FG000|Overall Study|Lost to Follow-up|7|||
129663960|NCT00305227|466729649|FG001|Overall Study|Lost to Follow-up|6|||
129663961|NCT04085601|466729650|FG000|Overall Study|Lost to Follow-up|1|||
129663962|NCT04085601|466729651|FG001|Overall Study|Lost to Follow-up|0|||
129663963|NCT04085601|466729650|FG000|Overall Study|Death|1|||
129663964|NCT04085601|466729651|FG001|Overall Study|Death|1|||
129663965|NCT03492437|466729652|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129663966|NCT03492437|466729653|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129663967|NCT02915159|466729654|FG000|Overall Study|Participant no longer meets criteria|2|||
129663968|NCT02915159|466729655|FG001|Overall Study|Participant no longer meets criteria|0|||
129663969|NCT02915159|466729654|FG000|Overall Study|poor/non-compliance|1|||
129663970|NCT02915159|466729655|FG001|Overall Study|poor/non-compliance|0|||
129663971|NCT02915159|466729654|FG000|Overall Study|Participant withdrew consent|5|||
129663972|NCT02915159|466729655|FG001|Overall Study|Participant withdrew consent|1|||
129663973|NCT02915159|466729654|FG000|Overall Study|Request to discontinue treatment|1|||
129663974|NCT02915159|466729655|FG001|Overall Study|Request to discontinue treatment|2|||
129663975|NCT02915159|466729654|FG000|Overall Study|Adverse Event|2|||
129663976|NCT02915159|466729655|FG001|Overall Study|Adverse Event|2|||
129663977|NCT02915159|466729654|FG000|Overall Study|Lack of Efficacy|0|||
129663978|NCT02915159|466729655|FG001|Overall Study|Lack of Efficacy|3|||
129663979|NCT04534517|466729657|FG000|Overall Study|Adverse Event|1|||
129663980|NCT04534517|466729657|FG000|Overall Study|Withdrawal by Subject|1|||
129546733|NCT01071083|466294110|FG001|Overall Study|Subject Moved|1|||
129546734|NCT01071083|466294111|FG002|Overall Study|Subject Moved|0|||
129546735|NCT01071083|466294112|FG003|Overall Study|Subject Moved|0|||
129546736|NCT01071083|466294113|FG004|Overall Study|Subject Moved|0|||
129546737|NCT01071083|466294109|FG000|Overall Study|Images Not Usable (Motion)|0|||
129546738|NCT01071083|466294110|FG001|Overall Study|Images Not Usable (Motion)|1|||
129546739|NCT01071083|466294111|FG002|Overall Study|Images Not Usable (Motion)|0|||
129546740|NCT01071083|466294112|FG003|Overall Study|Images Not Usable (Motion)|0|||
129546741|NCT01071083|466294113|FG004|Overall Study|Images Not Usable (Motion)|0|||
129546742|NCT01071083|466294109|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129546743|NCT01071083|466294110|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
129546744|NCT01071083|466294111|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
129546745|NCT01071083|466294112|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
129546746|NCT01071083|466294113|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
129546747|NCT01071083|466294109|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
129546748|NCT01071083|466294110|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
129546749|NCT01071083|466294111|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
129546750|NCT01071083|466294112|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
129546751|NCT01071083|466294113|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
129546752|NCT01071083|466294109|FG000|Overall Study|Subject Refused to Continue|1|||
129546753|NCT01071083|466294110|FG001|Overall Study|Subject Refused to Continue|0|||
129546754|NCT01071083|466294111|FG002|Overall Study|Subject Refused to Continue|0|||
129546755|NCT01071083|466294112|FG003|Overall Study|Subject Refused to Continue|0|||
129546756|NCT01071083|466294113|FG004|Overall Study|Subject Refused to Continue|0|||
129546757|NCT03972709|466294114|FG000|Overall Study|Withdrawal by Subject|18|||
129546758|NCT03972709|466294115|FG001|Overall Study|Withdrawal by Subject|7|||
129546759|NCT03972709|466294116|FG002|Overall Study|Withdrawal by Subject|14|||
129663981|NCT04534517|466729657|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129663982|NCT04534517|466729657|FG000|Overall Study|COVID-19 Related|1|||
129663983|NCT03872843|466729658|FG000|Overall Study|Lost to Follow-up|5|||
129663984|NCT03872843|466729659|FG001|Overall Study|Lost to Follow-up|7|||
129663985|NCT00823264|466729660|FG000|Overall Study|Protocol Violation|2|||
129663986|NCT00823264|466729661|FG001|Overall Study|Protocol Violation|0|||
129546760|NCT03972709|466294114|FG000|Overall Study|Study Terminated by Sponsor|48|||
129546761|NCT03972709|466294115|FG001|Overall Study|Study Terminated by Sponsor|25|||
129663987|NCT05133323|466729662|FG000|Overall Study|Lack of Efficacy|0|||
129663988|NCT05133323|466729663|FG001|Overall Study|Lack of Efficacy|0|||
129663989|NCT05133323|466729664|FG002|Overall Study|Lack of Efficacy|1|||
129663990|NCT05133323|466729662|FG000|Overall Study|Withdrawal by Subject|2|||
129663991|NCT05133323|466729663|FG001|Overall Study|Withdrawal by Subject|1|||
129663992|NCT05133323|466729664|FG002|Overall Study|Withdrawal by Subject|0|||
129663993|NCT00113295|466729665|FG000|Overall Study|Adverse Event|4|||
129663994|NCT00113295|466729666|FG001|Overall Study|Adverse Event|1|||
129663995|NCT00113295|466729665|FG000|Overall Study|Unrelated Medical Illness|1|||
129663996|NCT00113295|466729666|FG001|Overall Study|Unrelated Medical Illness|0|||
129663997|NCT01714544|466729667|FG000|Overall Study|Lost to Follow-up|1|||
129663998|NCT01714544|466729667|FG000|Overall Study|Physician Decision|1|||
129663999|NCT01714544|466729667|FG000|Overall Study|Withdrawal by Subject|1|||
129664000|NCT02824224|466729676|FG000|Overall Study|Discontinued, IUS expulsion|0|||
129664001|NCT02824224|466729677|FG001|Overall Study|Discontinued, IUS expulsion|1|||
129664002|NCT02824224|466729676|FG000|Overall Study|Did not show up for allocation visit|2|||
129664003|NCT02824224|466729677|FG001|Overall Study|Did not show up for allocation visit|0|||
129664004|NCT02465437|466729684|FG000|Overall Study|Physician Decision|0|||
129664005|NCT02465437|466729685|FG001|Overall Study|Physician Decision|0|||
129664006|NCT02465437|466729686|FG002|Overall Study|Physician Decision|1|||
129664007|NCT02465437|466729687|FG003|Overall Study|Physician Decision|0|||
129664008|NCT02465437|466729684|FG000|Overall Study|Withdrawal by Subject|1|||
129664009|NCT02465437|466729685|FG001|Overall Study|Withdrawal by Subject|0|||
129664010|NCT02465437|466729686|FG002|Overall Study|Withdrawal by Subject|0|||
129664011|NCT02465437|466729687|FG003|Overall Study|Withdrawal by Subject|1|||
129664012|NCT02465437|466729684|FG000|Overall Study|Adverse Event|0|||
129664013|NCT02465437|466729685|FG001|Overall Study|Adverse Event|1|||
129664014|NCT02465437|466729686|FG002|Overall Study|Adverse Event|0|||
129664015|NCT02465437|466729687|FG003|Overall Study|Adverse Event|0|||
129664016|NCT00003483|466729688|FG000|Overall Study|Not evaluable|1|||
129664017|NCT02609386|466729691|FG000|Overall Study|Withdrawal by Subject|6|||
129664018|NCT02609386|466729692|FG001|Overall Study|Withdrawal by Subject|1|||
129664019|NCT02609386|466729691|FG000|Overall Study|Lost to Follow-up|3|||
129664020|NCT02609386|466729692|FG001|Overall Study|Lost to Follow-up|5|||
129664021|NCT02609386|466729691|FG000|Overall Study|Death|19|||
129664022|NCT02609386|466729692|FG001|Overall Study|Death|9|||
129664023|NCT02609386|466729691|FG000|Overall Study|Physician Decision|0|||
129664024|NCT02609386|466729692|FG001|Overall Study|Physician Decision|2|||
129664025|NCT01001520|466729702|FG000|Medication Period 1|Withdrawal by Subject|2|||
129664026|NCT01001520|466729703|FG001|Medication Period 1|Withdrawal by Subject|2|||
129664027|NCT01001520|466729702|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
129664028|NCT01001520|466729703|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
129664029|NCT01001520|466729702|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
129664030|NCT01001520|466729703|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
129664031|NCT01001520|466729702|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
129664032|NCT01001520|466729703|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
129664033|NCT01001520|466729702|FG000|Washout Period|Withdrawal by Subject|2|||
129664034|NCT01001520|466729703|FG001|Washout Period|Withdrawal by Subject|1|||
129664035|NCT01001520|466729702|FG000|Medication Period 2|Withdrawal by Subject|0|||
129664036|NCT01001520|466729703|FG001|Medication Period 2|Withdrawal by Subject|3|||
129664037|NCT00878800|466729719|FG000|Overall Study|Adverse Event|0|||
129664038|NCT00878800|466729720|FG001|Overall Study|Adverse Event|0|||
129664039|NCT00878800|466729721|FG002|Overall Study|Adverse Event|2|||
129664040|NCT00878800|466729722|FG003|Overall Study|Adverse Event|0|||
129664041|NCT00878800|466729723|FG004|Overall Study|Adverse Event|1|||
129664042|NCT00878800|466729719|FG000|Overall Study|Progressive disease|1|||
129664043|NCT00878800|466729720|FG001|Overall Study|Progressive disease|5|||
129664044|NCT00878800|466729721|FG002|Overall Study|Progressive disease|6|||
129664045|NCT00878800|466729722|FG003|Overall Study|Progressive disease|5|||
129664046|NCT00878800|466729723|FG004|Overall Study|Progressive disease|13|||
129664047|NCT00878800|466729719|FG000|Overall Study|Withdrew consent|1|||
129664048|NCT00878800|466729720|FG001|Overall Study|Withdrew consent|1|||
129664049|NCT00878800|466729721|FG002|Overall Study|Withdrew consent|0|||
129664050|NCT00878800|466729722|FG003|Overall Study|Withdrew consent|1|||
129664051|NCT00878800|466729723|FG004|Overall Study|Withdrew consent|1|||
129664052|NCT00878800|466729719|FG000|Overall Study|Death|0|||
129664053|NCT00878800|466729720|FG001|Overall Study|Death|0|||
129664054|NCT00878800|466729721|FG002|Overall Study|Death|1|||
129664055|NCT00878800|466729722|FG003|Overall Study|Death|0|||
129664056|NCT00878800|466729723|FG004|Overall Study|Death|0|||
129664057|NCT00878800|466729719|FG000|Overall Study|Other|1|||
129664058|NCT00878800|466729720|FG001|Overall Study|Other|1|||
129664059|NCT00878800|466729721|FG002|Overall Study|Other|0|||
129664060|NCT00878800|466729722|FG003|Overall Study|Other|0|||
129664061|NCT00878800|466729723|FG004|Overall Study|Other|1|||
129664062|NCT00613821|466729724|FG000|Overall Study|Withdrawal by Subject|1|||
129664063|NCT00613821|466729725|FG001|Overall Study|Withdrawal by Subject|0|||
129664064|NCT00613821|466729724|FG000|Overall Study|Physician Decision|1|||
129664065|NCT00613821|466729725|FG001|Overall Study|Physician Decision|1|||
129664066|NCT03318003|466729726|FG000|Overall Study|Withdrawal by Subject|1|||
129664067|NCT03318003|466729727|FG001|Overall Study|Withdrawal by Subject|1|||
129664068|NCT03318003|466729726|FG000|Overall Study|fetal loss|0|||
129664069|NCT03318003|466729727|FG001|Overall Study|fetal loss|1|||
129664070|NCT02302846|466729729|FG000|Overall Study|Withdrawal by Subject|1|||
129664071|NCT01468454|466729730|FG000|Overall Study|Did not have surgery after PET|9|||
129664072|NCT04435808|466729731|FG000|Overall Study|Study stopped by DSMB|0|||
129664073|NCT04435808|466729732|FG001|Overall Study|Study stopped by DSMB|1|||
129664074|NCT02620787|466729733|FG000|Overall Study|Adverse Event|1|||
129664075|NCT02620787|466729734|FG001|Overall Study|Adverse Event|0|||
129664076|NCT02620787|466729733|FG000|Overall Study|Eligibility Criteria Not Met|1|||
129664077|NCT02620787|466729734|FG001|Overall Study|Eligibility Criteria Not Met|0|||
129664078|NCT00807612|466729737|FG000|Overall Study|Death|8|||
129664079|NCT00807612|466729737|FG000|Overall Study|Study early termination|5|||
129664080|NCT00807612|466729737|FG000|Overall Study|Withdrawal by Subject|1|||
129664081|NCT02028507|466729739|FG000|Overall Study|Progressive Disease|122|||
129664082|NCT02028507|466729740|FG001|Overall Study|Progressive Disease|90|||
129664083|NCT02028507|466729741|FG002|Overall Study|Progressive Disease|102|||
129664084|NCT02028507|466729742|FG003|Overall Study|Progressive Disease|89|||
129664085|NCT02028507|466729739|FG000|Overall Study|Adverse Event|8|||
129664086|NCT02028507|466729740|FG001|Overall Study|Adverse Event|25|||
129664087|NCT02028507|466729741|FG002|Overall Study|Adverse Event|3|||
129664088|NCT02028507|466729742|FG003|Overall Study|Adverse Event|16|||
129664089|NCT02028507|466729739|FG000|Overall Study|Withdrawal by Subject|6|||
129664090|NCT02028507|466729740|FG001|Overall Study|Withdrawal by Subject|8|||
129664091|NCT02028507|466729741|FG002|Overall Study|Withdrawal by Subject|5|||
129664092|NCT02028507|466729742|FG003|Overall Study|Withdrawal by Subject|9|||
129664093|NCT02028507|466729739|FG000|Overall Study|Protocol Violation|2|||
129664094|NCT02028507|466729740|FG001|Overall Study|Protocol Violation|4|||
129664095|NCT02028507|466729741|FG002|Overall Study|Protocol Violation|1|||
129664096|NCT02028507|466729742|FG003|Overall Study|Protocol Violation|3|||
129664097|NCT02028507|466729739|FG000|Overall Study|Physician Decision|0|||
129664098|NCT02028507|466729740|FG001|Overall Study|Physician Decision|4|||
129664099|NCT02028507|466729741|FG002|Overall Study|Physician Decision|0|||
129664100|NCT02028507|466729742|FG003|Overall Study|Physician Decision|0|||
129664101|NCT02028507|466729739|FG000|Overall Study|Death|1|||
129664102|NCT02028507|466729740|FG001|Overall Study|Death|0|||
129664103|NCT02028507|466729741|FG002|Overall Study|Death|1|||
129664104|NCT02028507|466729742|FG003|Overall Study|Death|3|||
129664105|NCT02028507|466729739|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
129664106|NCT02028507|466729740|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
129664107|NCT02028507|466729741|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
129664108|NCT02028507|466729742|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
129664109|NCT02028507|466729739|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
129664110|NCT02028507|466729740|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
129664111|NCT02028507|466729741|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
129664112|NCT02028507|466729742|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
129664113|NCT02028507|466729739|FG000|Overall Study|Randomized But Not Treated|3|||
129664114|NCT02028507|466729740|FG001|Overall Study|Randomized But Not Treated|6|||
129664115|NCT02028507|466729741|FG002|Overall Study|Randomized But Not Treated|0|||
129664116|NCT02028507|466729742|FG003|Overall Study|Randomized But Not Treated|4|||
129664117|NCT02028507|466729739|FG000|Overall Study|Enzyme defect|0|||
129664118|NCT02028507|466729740|FG001|Overall Study|Enzyme defect|0|||
129664119|NCT02028507|466729741|FG002|Overall Study|Enzyme defect|0|||
129664120|NCT02028507|466729742|FG003|Overall Study|Enzyme defect|1|||
129664121|NCT02028507|466729739|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
129664122|NCT02028507|466729740|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
129664123|NCT02028507|466729741|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
129664124|NCT02028507|466729742|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
129664125|NCT02028507|466729739|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
129664126|NCT02028507|466729740|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
129664127|NCT02028507|466729741|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
129664128|NCT02028507|466729742|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
129664129|NCT02258659|466729743|FG000|Overall Study|Withdrawal by Subject|1|||
129664130|NCT04892446|466729744|FG000|Overall Study|Death|4|||
129664131|NCT04892446|466729745|FG001|Overall Study|Death|4|||
129664132|NCT04892446|466729746|FG002|Overall Study|Death|0|||
129664133|NCT04892446|466729744|FG000|Overall Study|Withdrew consent|3|||
129664134|NCT04892446|466729745|FG001|Overall Study|Withdrew consent|0|||
129664135|NCT04892446|466729746|FG002|Overall Study|Withdrew consent|1|||
129664136|NCT04892446|466729744|FG000|Overall Study|Investigator's discretion|1|||
129664137|NCT04892446|466729745|FG001|Overall Study|Investigator's discretion|1|||
129664138|NCT04892446|466729746|FG002|Overall Study|Investigator's discretion|0|||
129664139|NCT04892446|466729744|FG000|Overall Study|Study terminated by sponsor|0|||
129664140|NCT04892446|466729745|FG001|Overall Study|Study terminated by sponsor|0|||
129664141|NCT04892446|466729746|FG002|Overall Study|Study terminated by sponsor|2|||
129664142|NCT00272844|466729747|FG000|Overall Study|Withdrawal by Subject|5|||
129664143|NCT00705341|466729751|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
129664144|NCT00705341|466729752|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
129664145|NCT00705341|466729753|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
129664146|NCT00705341|466729754|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
129664147|NCT00705341|466729751|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
129664148|NCT00705341|466729752|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
129664149|NCT00705341|466729753|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
129664150|NCT00705341|466729754|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
129664151|NCT00791700|466729755|FG000|Overall Study|Insufficient clinical response|1|||
129664152|NCT00791700|466729756|FG001|Overall Study|Insufficient clinical response|4|||
129664153|NCT00791700|466729757|FG002|Overall Study|Insufficient clinical response|1|||
129664154|NCT00791700|466729758|FG003|Overall Study|Insufficient clinical response|8|||
129664155|NCT00791700|466729755|FG000|Overall Study|No longer willing to participate|1|||
129664156|NCT00791700|466729756|FG001|Overall Study|No longer willing to participate|1|||
129664157|NCT00791700|466729757|FG002|Overall Study|No longer willing to participate|0|||
129664158|NCT00791700|466729758|FG003|Overall Study|No longer willing to participate|8|||
129664159|NCT00791700|466729755|FG000|Overall Study|Non-compliance with study treatment|0|||
129664160|NCT00791700|466729756|FG001|Overall Study|Non-compliance with study treatment|2|||
129664161|NCT00791700|466729757|FG002|Overall Study|Non-compliance with study treatment|0|||
129664162|NCT00791700|466729758|FG003|Overall Study|Non-compliance with study treatment|4|||
129664163|NCT00791700|466729755|FG000|Overall Study|Withdrawn due to pregnancy|0|||
129664164|NCT00791700|466729756|FG001|Overall Study|Withdrawn due to pregnancy|0|||
129664165|NCT00791700|466729757|FG002|Overall Study|Withdrawn due to pregnancy|0|||
129664166|NCT00791700|466729758|FG003|Overall Study|Withdrawn due to pregnancy|1|||
129664167|NCT00791700|466729755|FG000|Overall Study|Other|0|||
129664168|NCT00791700|466729756|FG001|Overall Study|Other|1|||
129664169|NCT00791700|466729757|FG002|Overall Study|Other|0|||
129664170|NCT00791700|466729758|FG003|Overall Study|Other|1|||
129664171|NCT00791700|466729755|FG000|Overall Study|Death|0|||
129664172|NCT00791700|466729756|FG001|Overall Study|Death|0|||
129664173|NCT00791700|466729757|FG002|Overall Study|Death|0|||
129664174|NCT00791700|466729758|FG003|Overall Study|Death|1|||
129664175|NCT00791700|466729755|FG000|Overall Study|Lost to Follow-up|4|||
129664176|NCT00791700|466729756|FG001|Overall Study|Lost to Follow-up|3|||
129664177|NCT00791700|466729757|FG002|Overall Study|Lost to Follow-up|4|||
129664178|NCT00791700|466729758|FG003|Overall Study|Lost to Follow-up|6|||
129664179|NCT00791700|466729755|FG000|Overall Study|Adverse Event|0|||
129664180|NCT00791700|466729756|FG001|Overall Study|Adverse Event|0|||
129664181|NCT00791700|466729757|FG002|Overall Study|Adverse Event|1|||
129664182|NCT00791700|466729758|FG003|Overall Study|Adverse Event|1|||
129664183|NCT00527826|466729761|FG000|Overall Study|Adverse Event|10|||
129664184|NCT00527826|466729762|FG001|Overall Study|Adverse Event|10|||
129664185|NCT00527826|466729761|FG000|Overall Study|Lost to Follow-up|3|||
129664186|NCT00527826|466729762|FG001|Overall Study|Lost to Follow-up|2|||
129664187|NCT00527826|466729761|FG000|Overall Study|Withdrawal by Subject|5|||
129664188|NCT00527826|466729762|FG001|Overall Study|Withdrawal by Subject|8|||
129664189|NCT00527826|466729761|FG000|Overall Study|Inclusion Criteria Not Met|3|||
129664190|NCT00527826|466729762|FG001|Overall Study|Inclusion Criteria Not Met|3|||
129664191|NCT00527826|466729761|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
129664192|NCT00527826|466729762|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
129664193|NCT00527826|466729761|FG000|Overall Study|Additional Intake of Viani forte|0|||
129664194|NCT00527826|466729762|FG001|Overall Study|Additional Intake of Viani forte|1|||
129664195|NCT00527826|466729761|FG000|Overall Study|Participant moved away|0|||
129664196|NCT00527826|466729762|FG001|Overall Study|Participant moved away|1|||
129664197|NCT05568797|466729772|FG000|Overall Study|Adverse Event|0|||
129664198|NCT05568797|466729773|FG001|Overall Study|Adverse Event|8|||
129664199|NCT05568797|466729772|FG000|Overall Study|Lost to Follow-up|2|||
129664200|NCT05568797|466729773|FG001|Overall Study|Lost to Follow-up|3|||
129664201|NCT05568797|466729772|FG000|Overall Study|Withdrawal by Subject|1|||
129664202|NCT05568797|466729773|FG001|Overall Study|Withdrawal by Subject|10|||
129664203|NCT05568797|466729772|FG000|Overall Study|Other|2|||
129664204|NCT05568797|466729773|FG001|Overall Study|Other|2|||
129664205|NCT03131687|466729774|FG000|Overall Study|Adverse Event|0|||
129664206|NCT03131687|466729775|FG001|Overall Study|Adverse Event|1|||
129664207|NCT03131687|466729776|FG002|Overall Study|Adverse Event|0|||
129664208|NCT03131687|466729777|FG003|Overall Study|Adverse Event|1|||
129664209|NCT03131687|466729778|FG004|Overall Study|Adverse Event|2|||
129664210|NCT03131687|466729779|FG005|Overall Study|Adverse Event|2|||
129664211|NCT03131687|466729774|FG000|Overall Study|Death|1|||
129664212|NCT03131687|466729775|FG001|Overall Study|Death|0|||
129664213|NCT03131687|466729776|FG002|Overall Study|Death|0|||
129664214|NCT03131687|466729777|FG003|Overall Study|Death|0|||
129664215|NCT03131687|466729778|FG004|Overall Study|Death|0|||
129664216|NCT03131687|466729779|FG005|Overall Study|Death|0|||
129664217|NCT03131687|466729774|FG000|Overall Study|Withdrawal by Subject|3|||
129664218|NCT03131687|466729775|FG001|Overall Study|Withdrawal by Subject|3|||
129664219|NCT03131687|466729776|FG002|Overall Study|Withdrawal by Subject|3|||
129664220|NCT03131687|466729777|FG003|Overall Study|Withdrawal by Subject|1|||
129664221|NCT03131687|466729778|FG004|Overall Study|Withdrawal by Subject|2|||
129664222|NCT03131687|466729779|FG005|Overall Study|Withdrawal by Subject|1|||
129664223|NCT03131687|466729774|FG000|Overall Study|Lost to Follow-up|1|||
129664224|NCT03131687|466729775|FG001|Overall Study|Lost to Follow-up|4|||
129664225|NCT03131687|466729776|FG002|Overall Study|Lost to Follow-up|0|||
129664226|NCT03131687|466729777|FG003|Overall Study|Lost to Follow-up|1|||
129664227|NCT03131687|466729778|FG004|Overall Study|Lost to Follow-up|4|||
129664228|NCT03131687|466729779|FG005|Overall Study|Lost to Follow-up|2|||
129664229|NCT03131687|466729774|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
129664230|NCT03131687|466729775|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
129664231|NCT03131687|466729776|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
129664232|NCT03131687|466729777|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
129664233|NCT03131687|466729778|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
129664234|NCT03131687|466729779|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
129664235|NCT03131687|466729774|FG000|Overall Study|Principle Investigator Decision|0|||
129664236|NCT03131687|466729775|FG001|Overall Study|Principle Investigator Decision|1|||
129664237|NCT03131687|466729776|FG002|Overall Study|Principle Investigator Decision|0|||
129664238|NCT03131687|466729777|FG003|Overall Study|Principle Investigator Decision|0|||
129664239|NCT03131687|466729778|FG004|Overall Study|Principle Investigator Decision|0|||
129664240|NCT03131687|466729779|FG005|Overall Study|Principle Investigator Decision|0|||
129664241|NCT03131687|466729774|FG000|Overall Study|Inadvertent Enrollment|0|||
129664242|NCT03131687|466729775|FG001|Overall Study|Inadvertent Enrollment|0|||
129664243|NCT03131687|466729776|FG002|Overall Study|Inadvertent Enrollment|0|||
129664244|NCT03131687|466729777|FG003|Overall Study|Inadvertent Enrollment|1|||
129664245|NCT03131687|466729778|FG004|Overall Study|Inadvertent Enrollment|0|||
129664246|NCT03131687|466729779|FG005|Overall Study|Inadvertent Enrollment|0|||
129664247|NCT02998996|466729780|FG000|Overall Study|Lost to Follow-up|0|||
129664248|NCT02998996|466729781|FG001|Overall Study|Lost to Follow-up|0|||
129664249|NCT02998996|466729782|FG002|Overall Study|Lost to Follow-up|1|||
129664250|NCT02998996|466729783|FG003|Overall Study|Lost to Follow-up|0|||
129664251|NCT02998996|466729784|FG004|Overall Study|Lost to Follow-up|0|||
129664252|NCT02998996|466729785|FG005|Overall Study|Lost to Follow-up|0|||
129664253|NCT02998996|466729780|FG000|Overall Study|Pregnancy|0|||
129664254|NCT02998996|466729781|FG001|Overall Study|Pregnancy|1|||
129664255|NCT02998996|466729782|FG002|Overall Study|Pregnancy|0|||
129664256|NCT02998996|466729783|FG003|Overall Study|Pregnancy|0|||
129664257|NCT02998996|466729784|FG004|Overall Study|Pregnancy|0|||
129664258|NCT02998996|466729785|FG005|Overall Study|Pregnancy|0|||
129664259|NCT02998996|466729780|FG000|Overall Study|Family reasons|0|||
129664260|NCT02998996|466729781|FG001|Overall Study|Family reasons|0|||
129664261|NCT02998996|466729782|FG002|Overall Study|Family reasons|0|||
129664262|NCT02998996|466729783|FG003|Overall Study|Family reasons|0|||
129664263|NCT02998996|466729784|FG004|Overall Study|Family reasons|1|||
129664264|NCT02998996|466729785|FG005|Overall Study|Family reasons|0|||
129664265|NCT01118663|466729786|FG000|Overall Study|Adverse Event|2|||
129664266|NCT01118663|466729787|FG001|Overall Study|Adverse Event|1|||
129664267|NCT01118663|466729786|FG000|Overall Study|Withdrawal by Subject|0|||
129664268|NCT01118663|466729787|FG001|Overall Study|Withdrawal by Subject|1|||
129664269|NCT05279131|466729788|FG000|Overall Study|Lost to Follow-up|1|||
129664270|NCT05279131|466729788|FG000|Overall Study|Death|1|||
129664271|NCT05279131|466729788|FG000|Overall Study|Physician Decision|1|||
129664272|NCT01066871|466729791|FG000|Overall Study|Lost to Follow-up|0|||
129664273|NCT01066871|466729792|FG001|Overall Study|Lost to Follow-up|2|||
129664274|NCT01066871|466729793|FG002|Overall Study|Lost to Follow-up|2|||
129664275|NCT01066871|466729794|FG003|Overall Study|Lost to Follow-up|0|||
129664276|NCT01066871|466729791|FG000|Overall Study|Protocol Violation|1|||
129664277|NCT01066871|466729792|FG001|Overall Study|Protocol Violation|0|||
129664278|NCT01066871|466729793|FG002|Overall Study|Protocol Violation|3|||
129664279|NCT01066871|466729794|FG003|Overall Study|Protocol Violation|2|||
129664280|NCT01066871|466729791|FG000|Overall Study|Lack of Efficacy|0|||
129664281|NCT01066871|466729792|FG001|Overall Study|Lack of Efficacy|0|||
129664282|NCT01066871|466729793|FG002|Overall Study|Lack of Efficacy|0|||
129664283|NCT01066871|466729794|FG003|Overall Study|Lack of Efficacy|1|||
129664284|NCT01066871|466729791|FG000|Overall Study|Withdrawal by Subject|3|||
129664285|NCT01066871|466729792|FG001|Overall Study|Withdrawal by Subject|1|||
129664286|NCT01066871|466729793|FG002|Overall Study|Withdrawal by Subject|0|||
129664287|NCT01066871|466729794|FG003|Overall Study|Withdrawal by Subject|0|||
129664288|NCT01066871|466729791|FG000|Overall Study|Other|0|||
129664289|NCT01066871|466729792|FG001|Overall Study|Other|2|||
129664290|NCT01066871|466729793|FG002|Overall Study|Other|1|||
129664291|NCT01066871|466729794|FG003|Overall Study|Other|2|||
129664292|NCT00954122|466731121|FG000|Overall Study|Withdrawal by Subject|5|||
129664293|NCT00954122|466731121|FG000|Overall Study|Adverse Event|1|||
129664294|NCT00954122|466731121|FG000|Overall Study|Safety Reason|1|||
129664295|NCT02121795|466731127|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
129664296|NCT02121795|466731128|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
129664297|NCT02121795|466731127|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
129664298|NCT02121795|466731128|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
129664299|NCT02121795|466731127|FG000|Double-Blind Phase|Lost to Follow-up|7|||
129664300|NCT02121795|466731128|FG001|Double-Blind Phase|Lost to Follow-up|4|||
129664301|NCT02121795|466731127|FG000|Double-Blind Phase|Physician Decision|2|||
129664302|NCT02121795|466731128|FG001|Double-Blind Phase|Physician Decision|5|||
129664303|NCT02121795|466731127|FG000|Double-Blind Phase|Adverse Event|5|||
129664304|NCT02121795|466731128|FG001|Double-Blind Phase|Adverse Event|0|||
129664305|NCT02121795|466731127|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
129664306|NCT02121795|466731128|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
129664307|NCT02121795|466731127|FG000|Double-Blind Phase|Protocol Violation|0|||
129664308|NCT02121795|466731128|FG001|Double-Blind Phase|Protocol Violation|3|||
129664309|NCT02121795|466731127|FG000|Double-Blind Phase|Death|1|||
129664310|NCT02121795|466731128|FG001|Double-Blind Phase|Death|1|||
129664311|NCT02121795|466731127|FG000|Open-Label Phase|Physician Decision|8|||
129664312|NCT02121795|466731128|FG001|Open-Label Phase|Physician Decision|8|||
129664313|NCT02121795|466731127|FG000|Open-Label Phase|Withdrawal by Subject|3|||
129664314|NCT02121795|466731128|FG001|Open-Label Phase|Withdrawal by Subject|2|||
129664315|NCT02121795|466731127|FG000|Open-Label Phase|Lost to Follow-up|1|||
129664316|NCT02121795|466731128|FG001|Open-Label Phase|Lost to Follow-up|0|||
129664317|NCT00666211|466731129|FG000|Overall Study|Withdrawal by Subject|10|||
129664318|NCT00666211|466731130|FG001|Overall Study|Withdrawal by Subject|13|||
129664319|NCT00666211|466731129|FG000|Overall Study|went off medication, no more pain|1|||
129664320|NCT00666211|466731130|FG001|Overall Study|went off medication, no more pain|0|||
129664321|NCT00666211|466731129|FG000|Overall Study|patient non-compliant|6|||
129664322|NCT00666211|466731130|FG001|Overall Study|patient non-compliant|6|||
129664323|NCT00666211|466731129|FG000|Overall Study|disease progression|1|||
129664324|NCT00666211|466731130|FG001|Overall Study|disease progression|8|||
129664325|NCT00666211|466731129|FG000|Overall Study|Lost to Follow-up|2|||
129664326|NCT00666211|466731130|FG001|Overall Study|Lost to Follow-up|0|||
129664327|NCT00666211|466731129|FG000|Overall Study|toxicity|0|||
129664328|NCT00666211|466731130|FG001|Overall Study|toxicity|2|||
129664329|NCT00666211|466731129|FG000|Overall Study|hospital admission|0|||
129664330|NCT00666211|466731130|FG001|Overall Study|hospital admission|5|||
129664331|NCT00666211|466731129|FG000|Overall Study|Death|0|||
129664332|NCT00666211|466731130|FG001|Overall Study|Death|2|||
129664333|NCT00666211|466731129|FG000|Overall Study|off tx for other complicating disease|0|||
129664334|NCT00666211|466731130|FG001|Overall Study|off tx for other complicating disease|1|||
129664335|NCT00666211|466731129|FG000|Overall Study|Physician Decision|0|||
129664336|NCT00666211|466731130|FG001|Overall Study|Physician Decision|1|||
129664337|NCT02299388|466731131|FG000|Overall Study|Withdrawal by Subject|0|||
129664338|NCT02299388|466731132|FG001|Overall Study|Withdrawal by Subject|1|||
129664339|NCT03334188|466731135|FG000|Overall Study|Withdrawal by Subject|0|||
129664340|NCT03334188|466731136|FG001|Overall Study|Withdrawal by Subject|1|||
129664341|NCT03334188|466731135|FG000|Overall Study|Death|1|||
129664342|NCT03334188|466731136|FG001|Overall Study|Death|0|||
129664343|NCT03334188|466731135|FG000|Overall Study|Never had qualifying clinic visit|7|||
129664344|NCT03334188|466731136|FG001|Overall Study|Never had qualifying clinic visit|7|||
129664345|NCT03373760|466731139|FG000|Overall Study|Adverse Event|8|||
129664346|NCT03373760|466731139|FG000|Overall Study|Disease Progression|46|||
129664347|NCT03373760|466731139|FG000|Overall Study|Death|4|||
129664348|NCT01093586|466731140|FG000|Overall Study|Failed to engraft|3|||
129664349|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
129664350|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
129664351|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
129664352|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
129664353|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
129664354|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
129664355|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
129664356|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
129664357|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
129664358|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
129664359|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
129664360|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
129664361|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
129664362|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
129664363|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Death|1|||
129664364|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Death|0|||
129664365|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
129664366|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
129664367|NCT00105989|466731141|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
129664368|NCT00105989|466731142|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
129664369|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
129664370|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
129664371|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
129664372|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
129664373|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
129664374|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
129664375|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
129664376|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
129664377|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
129546762|NCT03972709|466294116|FG002|Overall Study|Study Terminated by Sponsor|50|||
129546763|NCT03972709|466294114|FG000|Overall Study|Physician Decision|1|||
129546764|NCT03972709|466294115|FG001|Overall Study|Physician Decision|0|||
129546765|NCT03972709|466294116|FG002|Overall Study|Physician Decision|0|||
129546766|NCT03972709|466294114|FG000|Overall Study|COVID-19|0|||
129546767|NCT03972709|466294115|FG001|Overall Study|COVID-19|1|||
129546768|NCT03972709|466294116|FG002|Overall Study|COVID-19|1|||
129546769|NCT03972709|466294114|FG000|Overall Study|Lost to Follow-up|6|||
129546770|NCT03972709|466294115|FG001|Overall Study|Lost to Follow-up|1|||
129546771|NCT03972709|466294116|FG002|Overall Study|Lost to Follow-up|2|||
129546772|NCT03972709|466294114|FG000|Overall Study|Death|5|||
129546773|NCT03972709|466294115|FG001|Overall Study|Death|1|||
129546774|NCT03972709|466294116|FG002|Overall Study|Death|4|||
129546775|NCT03972709|466294114|FG000|Overall Study|Adverse Event|3|||
129546776|NCT03972709|466294115|FG001|Overall Study|Adverse Event|1|||
129546777|NCT03972709|466294116|FG002|Overall Study|Adverse Event|4|||
129546778|NCT03972709|466294114|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
129546779|NCT03972709|466294115|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
129546780|NCT03972709|466294116|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
129546781|NCT03972709|466294114|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
129546782|NCT03972709|466294115|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
129546783|NCT03972709|466294116|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
129546784|NCT03972709|466294114|FG000|Overall Study|Subject Unable to be Contacted|0|||
129546785|NCT03972709|466294115|FG001|Overall Study|Subject Unable to be Contacted|1|||
129546786|NCT03972709|466294116|FG002|Overall Study|Subject Unable to be Contacted|0|||
129546787|NCT03972709|466294114|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
129546788|NCT03972709|466294115|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
129546789|NCT03972709|466294116|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
129546790|NCT03972709|466294114|FG000|Overall Study|Subject Moved|0|||
129546791|NCT03972709|466294115|FG001|Overall Study|Subject Moved|1|||
129546792|NCT03972709|466294116|FG002|Overall Study|Subject Moved|0|||
129546793|NCT03972709|466294114|FG000|Overall Study|Missed Study Visits|1|||
129546794|NCT03972709|466294115|FG001|Overall Study|Missed Study Visits|0|||
129546795|NCT03972709|466294116|FG002|Overall Study|Missed Study Visits|0|||
129546796|NCT00834366|466294117|FG000|Treatment Period 1|Adverse Event|1|||
129546797|NCT00834366|466294118|FG001|Treatment Period 1|Adverse Event|1|||
129546798|NCT00090259|466294119|FG000|Overall Study|Lost to Follow-up|30|||
129546799|NCT00090259|466294120|FG001|Overall Study|Lost to Follow-up|26|||
129546800|NCT00090259|466294119|FG000|Overall Study|Withdrawal by Subject|21|||
129546801|NCT00090259|466294120|FG001|Overall Study|Withdrawal by Subject|15|||
129546802|NCT00090259|466294119|FG000|Overall Study|Investigator site closed|11|||
129546803|NCT00090259|466294120|FG001|Overall Study|Investigator site closed|7|||
129546804|NCT04278872|466294123|FG000|Overall Study|Adverse Event|1|||
129546805|NCT04278872|466294124|FG001|Overall Study|Adverse Event|0|||
129546806|NCT04278872|466294123|FG000|Overall Study|Protocol Violation|0|||
129546807|NCT04278872|466294124|FG001|Overall Study|Protocol Violation|1|||
129546808|NCT04278872|466294123|FG000|Overall Study|Study Termination|2|||
129546809|NCT04278872|466294124|FG001|Overall Study|Study Termination|0|||
129546810|NCT00752895|466294125|FG000|Overall Study|Withdrawal by Subject|8|||
129546811|NCT00752895|466294126|FG001|Overall Study|Withdrawal by Subject|3|||
129546812|NCT00096031|466294127|FG000|Overall Study|Adverse Event|3|||
129546813|NCT00096031|466294127|FG000|Overall Study|Lack of Efficacy|42|||
129664378|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
129883875|NCT02733042|467534455|FG014|Overall Study|Progressive Disease|4|||
129546814|NCT00096031|466294127|FG000|Overall Study|Death|4|||
129546815|NCT00096031|466294127|FG000|Overall Study|Withdrawal by Subject|1|||
129546816|NCT00096031|466294127|FG000|Overall Study|Ineligible|8|||
129546817|NCT00096031|466294127|FG000|Overall Study|Not protocol specified|5|||
129546818|NCT03353415|466294130|FG000|Masked CGM Wear|Lost to Follow-up|2|||
129546819|NCT03353415|466294130|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
129546820|NCT02392377|466294131|FG000|Overall Study|Withdrawal by Subject|0|||
129546821|NCT02392377|466294132|FG001|Overall Study|Withdrawal by Subject|1|||
129546822|NCT03205163|466294135|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
129546823|NCT03205163|466294136|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
129664379|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
129664380|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
129664381|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
129664382|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
129664383|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Death|0|||
129664384|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Death|0|||
129664385|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
129664386|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
129664387|NCT00105989|466731141|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
129664388|NCT00105989|466731142|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
129664389|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
129664390|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
129664391|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
129664392|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
129664393|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
129664394|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
129664395|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
129664396|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
129664397|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
129664398|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
129664399|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
129664400|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
129664401|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
129664402|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
129664403|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
129664404|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
129664405|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
129664406|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
129664407|NCT00105989|466731141|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
129664408|NCT00105989|466731142|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
129664409|NCT03442088|466731143|FG000|Overall Study|Adverse Event|1|||
129664410|NCT03442088|466731143|FG000|Overall Study|Lack of Efficacy|2|||
129664411|NCT03442088|466731143|FG000|Overall Study|Lost to Follow-up|2|||
129664412|NCT00357877|466731144|FG000|Overall Study|Death|2|||
129664413|NCT00357877|466731145|FG001|Overall Study|Death|1|||
129664414|NCT00357877|466731144|FG000|Overall Study|Lost to Follow-up|20|||
129664415|NCT00357877|466731145|FG001|Overall Study|Lost to Follow-up|23|||
129664416|NCT00357877|466731144|FG000|Overall Study|Withdrawal by Subject|3|||
129664417|NCT00357877|466731145|FG001|Overall Study|Withdrawal by Subject|3|||
129664418|NCT00357877|466731144|FG000|Overall Study|Administrative withdrawal|1|||
129664419|NCT00357877|466731145|FG001|Overall Study|Administrative withdrawal|1|||
129664420|NCT00357877|466731144|FG000|Overall Study|Other|0|||
129664421|NCT00357877|466731145|FG001|Overall Study|Other|2|||
129664422|NCT04668209|466731146|FG000|Overall Study|Withdrawal by Subject|2|||
129664423|NCT04668209|466731147|FG001|Overall Study|Withdrawal by Subject|2|||
129664424|NCT04668209|466731146|FG000|Overall Study|Lost to Follow-up|3|||
129664425|NCT04668209|466731147|FG001|Overall Study|Lost to Follow-up|4|||
129664426|NCT04668209|466731146|FG000|Overall Study|Subject Expired|2|||
129664427|NCT04668209|466731147|FG001|Overall Study|Subject Expired|0|||
129664428|NCT04668209|466731146|FG000|Overall Study|Withdrawn from study|0|||
129664429|NCT04668209|466731147|FG001|Overall Study|Withdrawn from study|1|||
129664430|NCT04668209|466731146|FG000|Overall Study|Adverse Event|0|||
129664431|NCT04668209|466731147|FG001|Overall Study|Adverse Event|1|||
129664432|NCT01869777|466731154|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
129664433|NCT00613366|466731157|FG000|Overall Study|Withdrawal by Subject|3|||
129664434|NCT00613366|466731158|FG001|Overall Study|Withdrawal by Subject|2|||
129664435|NCT00766597|466731159|FG000|Overall Study|Unexpected closure of study|4|||
129664436|NCT00766597|466731159|FG000|Overall Study|Without CCR5-tropic virus|5|||
129664437|NCT01135524|466731160|FG000|Overall Study|Withdrawal by Subject|14|||
129664438|NCT01135524|466731160|FG000|Overall Study|Adverse Event|20|||
129664439|NCT01135524|466731160|FG000|Overall Study|Lost to Follow-up|3|||
129664440|NCT01135524|466731160|FG000|Overall Study|Administrative|151|||
129664441|NCT01135524|466731160|FG000|Overall Study|Lack of Efficacy|8|||
129664442|NCT02907463|466731161|FG000|Overall Study|Lost to Follow-up|17|||
129664443|NCT02907463|466731161|FG000|Overall Study|Death|10|||
129664444|NCT02907463|466731161|FG000|Overall Study|Withdrawal by Subject|4|||
129664445|NCT02907463|466731161|FG000|Overall Study|MIS Approach was not used|2|||
129664446|NCT02907463|466731161|FG000|Overall Study|Not Implanted with Study Device|2|||
129664447|NCT02907463|466731161|FG000|Overall Study|Device Explanted|1|||
129664448|NCT02907463|466731161|FG000|Overall Study|Missing Exit Form|1|||
129664449|NCT01266824|466731162|FG000|Overall Study|Study terminated prior to completion|2|||
129664450|NCT01266824|466731163|FG001|Overall Study|Study terminated prior to completion|3|||
129664451|NCT00411450|466731164|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
129664452|NCT01716663|466731165|FG000|Overall Study|Withdrawn prior to procedure|4|||
129664453|NCT01716663|466731165|FG000|Overall Study|Treated with non-study catheter|2|||
129664454|NCT02254772|466731168|FG000|Overall Study|Ineligible|1|||
129664455|NCT02254772|466731168|FG000|Overall Study|Withdrawal by Subject|1|||
129664456|NCT05225558|466731169|FG000|Overall Study|Withdrawal by Subject|4|||
129664457|NCT05225558|466731170|FG001|Overall Study|Withdrawal by Subject|3|||
129664458|NCT05225558|466731169|FG000|Overall Study|Adverse Event|1|||
129664459|NCT05225558|466731170|FG001|Overall Study|Adverse Event|0|||
129664460|NCT05225558|466731169|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
129664461|NCT05225558|466731170|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
129664462|NCT05225558|466731169|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
129664463|NCT05225558|466731170|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
129664464|NCT01001910|466731171|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
129664465|NCT03006562|466731172|FG000|Overall Study|Lost to Follow-up|0|||
129664466|NCT03006562|466731173|FG001|Overall Study|Lost to Follow-up|1|||
129664467|NCT00614874|466731174|FG000|Overall Study|Protocol Violation|1|||
129664468|NCT00614874|466731174|FG000|Overall Study|Withdrawal by Subject|1|||
129664469|NCT00511810|466731176|FG000|Overall Study|Lost to Follow-up|1|||
129664470|NCT00511810|466731177|FG001|Overall Study|Lost to Follow-up|2|||
129664471|NCT00511810|466731176|FG000|Overall Study|Lack of Efficacy|0|||
129664472|NCT00511810|466731177|FG001|Overall Study|Lack of Efficacy|2|||
129664473|NCT00511810|466731176|FG000|Overall Study|Refused second scn|0|||
129664474|NCT00511810|466731177|FG001|Overall Study|Refused second scn|1|||
129664475|NCT02427841|466731178|FG000|Overall Study|Lack of Efficacy|5|||
129664476|NCT02427841|466731178|FG000|Overall Study|Physician Decision|2|||
129664477|NCT02427841|466731178|FG000|Overall Study|Withdrawal by Subject|1|||
129664478|NCT01502033|466731181|FG000|Overall Study|1 participant had scalp discomfort|1|||
129664479|NCT01502033|466731181|FG000|Overall Study|1 participant had worsening depression|1|||
129664480|NCT01502033|466731181|FG000|Overall Study|1 participant went back to school|1|||
129664481|NCT01808261|466731182|FG000|Overall Study|Physician Decision|0|||
129664482|NCT01808261|466731183|FG001|Overall Study|Physician Decision|2|||
129664483|NCT01808261|466731182|FG000|Overall Study|Study Closed/Terminated|25|||
129664484|NCT01808261|466731183|FG001|Overall Study|Study Closed/Terminated|23|||
129664485|NCT01808261|466731182|FG000|Overall Study|Adverse event, non-fatal|2|||
129664486|NCT01808261|466731183|FG001|Overall Study|Adverse event, non-fatal|0|||
129664487|NCT01808261|466731182|FG000|Overall Study|Consent withdrawn by subject|6|||
129664488|NCT01808261|466731183|FG001|Overall Study|Consent withdrawn by subject|7|||
129664489|NCT01808261|466731182|FG000|Overall Study|Lost to Follow-up|3|||
129664490|NCT01808261|466731183|FG001|Overall Study|Lost to Follow-up|1|||
129664491|NCT01737879|466731185|FG000|Overall Study|Death|1|||
129664492|NCT01737879|466731185|FG000|Overall Study|Sponsor decision|40|||
129664493|NCT02497404|466731186|FG000|Overall Study|Adverse Event|1|||
129664494|NCT05285787|466731188|FG000|Overall Study|Withdrawal by Subject|1|||
129664495|NCT02360280|466731192|FG000|Overall Study|Withdrawal by Subject|2|||
129664496|NCT02360280|466731193|FG001|Overall Study|Withdrawal by Subject|0|||
129664497|NCT02360280|466731192|FG000|Overall Study|Adverse Event|0|||
129664498|NCT02360280|466731193|FG001|Overall Study|Adverse Event|1|||
129664499|NCT02360280|466731192|FG000|Overall Study|Lost to Follow-up|1|||
129664500|NCT02360280|466731193|FG001|Overall Study|Lost to Follow-up|0|||
129664501|NCT02472886|466731194|FG000|Overall Study|Lack of Efficacy|0|||
129664502|NCT02472886|466731195|FG001|Overall Study|Lack of Efficacy|2|||
129664503|NCT02472886|466731196|FG002|Overall Study|Lack of Efficacy|1|||
129664504|NCT00320788|466731197|FG000|Overall Study|Adverse Event|0|||
129664505|NCT00320788|466731198|FG001|Overall Study|Adverse Event|0|||
129664506|NCT00320788|466731199|FG002|Overall Study|Adverse Event|0|||
129664507|NCT00320788|466731200|FG003|Overall Study|Adverse Event|1|||
129664508|NCT00320788|466731201|FG004|Overall Study|Adverse Event|0|||
129664509|NCT00320788|466731197|FG000|Overall Study|Death|0|||
129664510|NCT00320788|466731198|FG001|Overall Study|Death|0|||
129664511|NCT00320788|466731199|FG002|Overall Study|Death|1|||
129664512|NCT00320788|466731200|FG003|Overall Study|Death|0|||
129664513|NCT00320788|466731201|FG004|Overall Study|Death|1|||
129664514|NCT00320788|466731197|FG000|Overall Study|Lost to Follow-up|0|||
129664515|NCT00320788|466731198|FG001|Overall Study|Lost to Follow-up|2|||
129664516|NCT00320788|466731199|FG002|Overall Study|Lost to Follow-up|1|||
129664517|NCT00320788|466731200|FG003|Overall Study|Lost to Follow-up|0|||
129664518|NCT00320788|466731201|FG004|Overall Study|Lost to Follow-up|0|||
129664519|NCT00320788|466731197|FG000|Overall Study|Decision by the Sponsor|1|||
129664520|NCT00320788|466731198|FG001|Overall Study|Decision by the Sponsor|1|||
129664521|NCT00320788|466731199|FG002|Overall Study|Decision by the Sponsor|0|||
129664522|NCT00320788|466731200|FG003|Overall Study|Decision by the Sponsor|0|||
129664523|NCT00320788|466731201|FG004|Overall Study|Decision by the Sponsor|1|||
129664524|NCT00320788|466731197|FG000|Overall Study|Other|1|||
129664525|NCT00320788|466731198|FG001|Overall Study|Other|2|||
129664526|NCT00320788|466731199|FG002|Overall Study|Other|1|||
129664527|NCT00320788|466731200|FG003|Overall Study|Other|1|||
129664528|NCT00320788|466731201|FG004|Overall Study|Other|1|||
129664529|NCT00320788|466731197|FG000|Overall Study|Physician Decision|1|||
129664530|NCT00320788|466731198|FG001|Overall Study|Physician Decision|1|||
129664531|NCT00320788|466731199|FG002|Overall Study|Physician Decision|0|||
129664532|NCT00320788|466731200|FG003|Overall Study|Physician Decision|0|||
129664533|NCT00320788|466731201|FG004|Overall Study|Physician Decision|0|||
129664534|NCT00320788|466731197|FG000|Overall Study|Protocol Violation|0|||
129664535|NCT00320788|466731198|FG001|Overall Study|Protocol Violation|0|||
129664536|NCT00320788|466731199|FG002|Overall Study|Protocol Violation|0|||
129664537|NCT00320788|466731200|FG003|Overall Study|Protocol Violation|0|||
129664538|NCT00320788|466731201|FG004|Overall Study|Protocol Violation|1|||
129664539|NCT00320788|466731197|FG000|Overall Study|Withdrawal by Subject|3|||
129664540|NCT00320788|466731198|FG001|Overall Study|Withdrawal by Subject|0|||
129664541|NCT00320788|466731199|FG002|Overall Study|Withdrawal by Subject|0|||
129664542|NCT00320788|466731200|FG003|Overall Study|Withdrawal by Subject|3|||
129664543|NCT00320788|466731201|FG004|Overall Study|Withdrawal by Subject|1|||
129664544|NCT02797678|466731222|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
129664545|NCT02797678|466731223|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
129664546|NCT02797678|466731224|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
129664547|NCT02797678|466731225|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
129664548|NCT02797678|466731222|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
129664549|NCT02797678|466731223|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
129664550|NCT02797678|466731224|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
129664551|NCT02797678|466731225|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
129664552|NCT02797678|466731222|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
129664553|NCT02797678|466731223|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
129664554|NCT02797678|466731224|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
129664555|NCT02797678|466731225|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
129664556|NCT02401035|466731226|FG000|Overall Study|Withdrawal by Subject|1|||
129664557|NCT02401035|466731227|FG001|Overall Study|Withdrawal by Subject|0|||
129664558|NCT03046953|466731229|FG000|Overall Study|Relapse/progressive disease|21|||
129664559|NCT03046953|466731229|FG000|Overall Study|Death|2|||
129664560|NCT03046953|466731229|FG000|Overall Study|Withdrawal by Subject|3|||
129664561|NCT04039204|466731230|FG000|Overall Study|Withdrawal by Subject|0|||
129664562|NCT04039204|466731231|FG001|Overall Study|Withdrawal by Subject|2|||
129664563|NCT01189461|466731232|FG000|Overall Study|Lack of Efficacy|13|||
129664564|NCT01189461|466731232|FG000|Overall Study|Lost to Follow-up|1|||
129664565|NCT01189461|466731232|FG000|Overall Study|Withdrawal by Subject|6|||
129664566|NCT01189461|466731232|FG000|Overall Study|Protocol Violation|1|||
129664567|NCT01189461|466731232|FG000|Overall Study|Adverse Event|2|||
129664568|NCT01189461|466731232|FG000|Overall Study|Did not meet entrance criteria|3|||
129664569|NCT01189461|466731232|FG000|Overall Study|Other|8|||
129664570|NCT00656175|466731234|FG000|Overall Study|Adverse Event|1|||
129664571|NCT00656175|466731235|FG001|Overall Study|Adverse Event|0|||
129664572|NCT00656175|466731234|FG000|Overall Study|Transportation issues|0|||
129664573|NCT00656175|466731235|FG001|Overall Study|Transportation issues|1|||
129664574|NCT00534638|466731244|FG000|Overall Study|Withdrawal by Subject|3|||
129664575|NCT00534638|466731245|FG001|Overall Study|Withdrawal by Subject|4|||
129664576|NCT00534638|466731244|FG000|Overall Study|Migrated/moved from study area|13|||
129664577|NCT00534638|466731245|FG001|Overall Study|Migrated/moved from study area|11|||
129664578|NCT00534638|466731244|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
129664579|NCT00534638|466731245|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
129664580|NCT00534638|466731244|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
129664581|NCT00534638|466731245|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
129664582|NCT00534638|466731244|FG000|Overall Study|Other|1685|||
129664583|NCT00534638|466731245|FG001|Overall Study|Other|902|||
129664584|NCT04162795|466731248|FG000|Overall Study|Other|16|||
129664585|NCT04162795|466731248|FG000|Overall Study|Screen failures|10|||
129664586|NCT05259163|466732913|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
129664587|NCT05259163|466732914|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
129664588|NCT01381926|466732917|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
129664589|NCT01381926|466732918|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
129664590|NCT01381926|466732917|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
129664591|NCT01381926|466732918|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
129664592|NCT02624947|466732919|FG000|Maternal Participants|Adverse Event|5|||
129664593|NCT02624947|466732920|FG001|Maternal Participants|Adverse Event|0|||
129664594|NCT02624947|466732919|FG000|Maternal Participants|Investigator Decision|5|||
129664595|NCT02624947|466732920|FG001|Maternal Participants|Investigator Decision|3|||
129664596|NCT02624947|466732919|FG000|Maternal Participants|Lost to Follow-up|54|||
129664597|NCT02624947|466732920|FG001|Maternal Participants|Lost to Follow-up|24|||
129664598|NCT02624947|466732919|FG000|Maternal Participants|Non Compliance|8|||
129664599|NCT02624947|466732920|FG001|Maternal Participants|Non Compliance|5|||
129664600|NCT02624947|466732919|FG000|Maternal Participants|Sponsor Request|1|||
129664601|NCT02624947|466732920|FG001|Maternal Participants|Sponsor Request|1|||
129664602|NCT02624947|466732919|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
129664603|NCT02624947|466732920|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
129664604|NCT02624947|466732919|FG000|Maternal Participants|Miscellaneous|23|||
129664605|NCT02624947|466732920|FG001|Maternal Participants|Miscellaneous|15|||
129664606|NCT02624947|466732919|FG000|Infant Participants|Adverse Event|18|||
129664607|NCT02624947|466732920|FG001|Infant Participants|Adverse Event|11|||
129664608|NCT02624947|466732919|FG000|Infant Participants|Investigator Decision|5|||
129664609|NCT02624947|466732920|FG001|Infant Participants|Investigator Decision|4|||
129664610|NCT02624947|466732919|FG000|Infant Participants|Lost to Follow-up|93|||
129664611|NCT02624947|466732920|FG001|Infant Participants|Lost to Follow-up|58|||
129664612|NCT02624947|466732919|FG000|Infant Participants|Non Compliance|17|||
129664613|NCT02624947|466732920|FG001|Infant Participants|Non Compliance|7|||
129664614|NCT02624947|466732919|FG000|Infant Participants|Sponsor Request|0|||
129664615|NCT02624947|466732920|FG001|Infant Participants|Sponsor Request|1|||
129664616|NCT02624947|466732919|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
129664617|NCT02624947|466732920|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
129664618|NCT02624947|466732919|FG000|Infant Participants|Miscellaneous|50|||
129664619|NCT02624947|466732920|FG001|Infant Participants|Miscellaneous|26|||
129664620|NCT01971567|466732934|FG000|Overall Study|Withdrawal by Subject|3|||
129664621|NCT01971567|466732935|FG001|Overall Study|Withdrawal by Subject|2|||
129664622|NCT01971567|466732934|FG000|Overall Study|Lost to Follow-up|1|||
129664623|NCT01971567|466732935|FG001|Overall Study|Lost to Follow-up|0|||
129664624|NCT01409915|466732936|FG000|Overall Study|Adverse Event|0|||
129664625|NCT01409915|466732937|FG001|Overall Study|Adverse Event|2|||
129664626|NCT01409915|466732936|FG000|Overall Study|Withdrawal by Subject|0|||
129664627|NCT01409915|466732937|FG001|Overall Study|Withdrawal by Subject|1|||
129664628|NCT01409915|466732936|FG000|Overall Study|Protocol Violation|1|||
129664629|NCT01409915|466732937|FG001|Overall Study|Protocol Violation|0|||
129664630|NCT04826484|466732938|FG000|Overall Study|Lost to Follow-up|2|||
129664631|NCT04826484|466732939|FG001|Overall Study|Lost to Follow-up|0|||
129664632|NCT02250300|466732941|FG000|Expansion Phase|Death|6|||
129664633|NCT02250300|466732942|FG001|Expansion Phase|Death|7|||
129664634|NCT02250300|466732943|FG002|Expansion Phase|Death|0|||
129664635|NCT02250300|466732944|FG003|Expansion Phase|Death|0|||
129664636|NCT00215644|466732947|FG000|Overall Study|Disease Progression|28|||
129664637|NCT00215644|466732948|FG001|Overall Study|Disease Progression|10|||
129664638|NCT00215644|466732947|FG000|Overall Study|Adverse Event|2|||
129664639|NCT00215644|466732948|FG001|Overall Study|Adverse Event|9|||
129664640|NCT00215644|466732947|FG000|Overall Study|Death|1|||
129664641|NCT00215644|466732948|FG001|Overall Study|Death|2|||
129664642|NCT00215644|466732947|FG000|Overall Study|Withdrawal by Subject|1|||
129664643|NCT00215644|466732948|FG001|Overall Study|Withdrawal by Subject|0|||
129664644|NCT00215644|466732947|FG000|Overall Study|Other|3|||
129664645|NCT00215644|466732948|FG001|Overall Study|Other|15|||
129664646|NCT00215644|466732947|FG000|Overall Study|Randomized but Not Treated|1|||
129664647|NCT00215644|466732948|FG001|Overall Study|Randomized but Not Treated|0|||
129664648|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
129664649|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
129664650|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
129664651|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
129664652|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
129664653|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
129664654|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
129664655|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
129664656|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
129664657|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
129664658|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
129664659|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
129664660|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
129664661|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
129664662|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
129664663|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
129664664|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
129664665|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
129664666|NCT03569098|466732949|FG000|Double-Blind Treatment Cycle 1|Other|1|||
129664667|NCT03569098|466732950|FG001|Double-Blind Treatment Cycle 1|Other|0|||
129664668|NCT03569098|466732951|FG002|Double-Blind Treatment Cycle 1|Other|1|||
129664669|NCT03569098|466732949|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
129664670|NCT03569098|466732950|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
129664671|NCT03569098|466732951|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
129664672|NCT03569098|466732949|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
129664673|NCT03569098|466732950|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
129664674|NCT03569098|466732951|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
129664675|NCT03569098|466732949|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
129664676|NCT03569098|466732950|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
129664677|NCT03569098|466732951|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
129664678|NCT03569098|466732949|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
129664679|NCT03569098|466732950|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
129664680|NCT03569098|466732951|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
129664681|NCT03569098|466732949|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
129664682|NCT03569098|466732950|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
129664683|NCT03569098|466732951|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
129664684|NCT03569098|466732949|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
129664685|NCT03569098|466732950|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
129664686|NCT03569098|466732951|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
129664687|NCT00758498|466732952|FG000|Overall Study|Adverse Event|2|||
129664688|NCT00758498|466732953|FG001|Overall Study|Adverse Event|2|||
129664689|NCT00758498|466732954|FG002|Overall Study|Adverse Event|3|||
129664690|NCT00758498|466732952|FG000|Overall Study|Subject legally detained out of state|1|||
129664691|NCT00758498|466732953|FG001|Overall Study|Subject legally detained out of state|0|||
129664692|NCT00758498|466732954|FG002|Overall Study|Subject legally detained out of state|0|||
129664693|NCT00758498|466732952|FG000|Overall Study|Withdrawal by Subject|0|||
129664694|NCT00758498|466732953|FG001|Overall Study|Withdrawal by Subject|0|||
129664695|NCT00758498|466732954|FG002|Overall Study|Withdrawal by Subject|1|||
129664696|NCT00758498|466732952|FG000|Overall Study|Noncompliance to study procedures|0|||
129664697|NCT00758498|466732953|FG001|Overall Study|Noncompliance to study procedures|0|||
129664698|NCT00758498|466732954|FG002|Overall Study|Noncompliance to study procedures|1|||
129664699|NCT01516736|466732959|FG000|Overall Study|Withdrawal by Subject|10|||
129664700|NCT01516736|466732960|FG001|Overall Study|Withdrawal by Subject|4|||
129664701|NCT01516736|466732959|FG000|Overall Study|Adverse Event|4|||
129664702|NCT01516736|466732960|FG001|Overall Study|Adverse Event|5|||
129664703|NCT01516736|466732959|FG000|Overall Study|Death|3|||
129664704|NCT01516736|466732960|FG001|Overall Study|Death|1|||
129664705|NCT01516736|466732959|FG000|Overall Study|Physician Decision|2|||
129664706|NCT01516736|466732960|FG001|Overall Study|Physician Decision|1|||
129664707|NCT01516736|466732959|FG000|Overall Study|Lack of Efficacy|1|||
129664708|NCT01516736|466732960|FG001|Overall Study|Lack of Efficacy|0|||
129664709|NCT01516736|466732959|FG000|Overall Study|Protocol Violation|0|||
129664710|NCT01516736|466732960|FG001|Overall Study|Protocol Violation|1|||
129664711|NCT01516736|466732959|FG000|Overall Study|Other (not specified)|0|||
129664712|NCT01516736|466732960|FG001|Overall Study|Other (not specified)|1|||
129664713|NCT01697800|466732961|FG000|Overall Study|Death|0|||
129664714|NCT01697800|466732962|FG001|Overall Study|Death|1|||
129664715|NCT03365934|466732969|FG000|Overall Study|Adverse Event|1|||
129664716|NCT03365934|466732969|FG000|Overall Study|Withdrawal by Subject|1|||
129664717|NCT04194489|466732970|FG000|Overall Study|Withdrawal by Subject|5|||
129664718|NCT04194489|466732970|FG000|Overall Study|Lost to Follow-up|48|||
129664719|NCT00522548|466732974|FG000|Overall Study|Adverse Event|2|||
129664720|NCT00522548|466732975|FG001|Overall Study|Adverse Event|2|||
129664721|NCT00522548|466732974|FG000|Overall Study|Withdrawal by Subject|0|||
129664722|NCT00522548|466732975|FG001|Overall Study|Withdrawal by Subject|2|||
129664723|NCT04147247|466732976|FG000|Overall Study|Progressive disease|3|||
129664724|NCT04147247|466732977|FG001|Overall Study|Progressive disease|3|||
129664725|NCT04147247|466732978|FG002|Overall Study|Progressive disease|4|||
129664726|NCT04147247|466732979|FG003|Overall Study|Progressive disease|4|||
129664727|NCT04147247|466732980|FG004|Overall Study|Progressive disease|3|||
129664728|NCT04147247|466732976|FG000|Overall Study|Physician Decision|0|||
129664729|NCT04147247|466732977|FG001|Overall Study|Physician Decision|1|||
129664730|NCT04147247|466732978|FG002|Overall Study|Physician Decision|0|||
129664731|NCT04147247|466732979|FG003|Overall Study|Physician Decision|0|||
129664732|NCT04147247|466732980|FG004|Overall Study|Physician Decision|0|||
129664733|NCT04147247|466732976|FG000|Overall Study|Clinical Disease Progression|0|||
129664734|NCT04147247|466732977|FG001|Overall Study|Clinical Disease Progression|0|||
129664735|NCT04147247|466732978|FG002|Overall Study|Clinical Disease Progression|0|||
129664736|NCT04147247|466732979|FG003|Overall Study|Clinical Disease Progression|0|||
129664737|NCT04147247|466732980|FG004|Overall Study|Clinical Disease Progression|1|||
129664738|NCT04147247|466732976|FG000|Overall Study|Adverse Event|0|||
129664739|NCT04147247|466732977|FG001|Overall Study|Adverse Event|0|||
129664740|NCT04147247|466732978|FG002|Overall Study|Adverse Event|1|||
129664741|NCT04147247|466732979|FG003|Overall Study|Adverse Event|0|||
129664742|NCT04147247|466732980|FG004|Overall Study|Adverse Event|1|||
129664743|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
129664744|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129664745|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129664746|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129664747|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
129664748|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
129664749|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129664750|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129664751|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129664752|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
129664753|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
129664754|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129664755|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129664756|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129664757|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
129664758|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
129664759|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129664760|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129664761|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129664762|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
129664763|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
129664764|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129664765|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129664766|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129664767|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
129664768|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
129664769|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129664770|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129664771|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129664772|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
129664773|NCT01111565|466732981|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
129664774|NCT01111565|466732982|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129664775|NCT01111565|466732983|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129664776|NCT01111565|466732984|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129664777|NCT01111565|466732985|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
129664778|NCT01111565|466732981|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129664779|NCT01111565|466732982|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129664780|NCT01111565|466732983|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129664781|NCT01111565|466732984|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
129664782|NCT01111565|466732985|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129664783|NCT01111565|466732981|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129664784|NCT01111565|466732982|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129664785|NCT01111565|466732983|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
129664786|NCT01111565|466732984|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129664787|NCT01111565|466732985|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129664788|NCT01111565|466732981|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
129664789|NCT01111565|466732982|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
129664790|NCT01111565|466732983|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
129664791|NCT01111565|466732984|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
129664792|NCT01111565|466732985|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
129664793|NCT01111565|466732981|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129664794|NCT01111565|466732982|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129664795|NCT01111565|466732983|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129664796|NCT01111565|466732984|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
129664797|NCT01111565|466732985|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
129664798|NCT01111565|466732981|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129664799|NCT01111565|466732982|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129664800|NCT01111565|466732983|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129664801|NCT01111565|466732984|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
129664802|NCT01111565|466732985|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
129664803|NCT02683239|466732986|FG000|Overall Study|Protocol Violation|35|||
129664804|NCT02683239|466732987|FG001|Overall Study|Protocol Violation|23|||
129664805|NCT02683239|466732988|FG002|Overall Study|Protocol Violation|26|||
129664806|NCT02683239|466732989|FG003|Overall Study|Protocol Violation|4|||
129664807|NCT02683239|466732990|FG004|Overall Study|Protocol Violation|35|||
129664808|NCT02683239|466732991|FG005|Overall Study|Protocol Violation|4|||
129664809|NCT02683239|466732992|FG006|Overall Study|Protocol Violation|5|||
129664810|NCT02683239|466732986|FG000|Overall Study|Adverse Event|64|||
129664811|NCT02683239|466732987|FG001|Overall Study|Adverse Event|39|||
129664812|NCT02683239|466732988|FG002|Overall Study|Adverse Event|42|||
129664813|NCT02683239|466732989|FG003|Overall Study|Adverse Event|16|||
129664814|NCT02683239|466732990|FG004|Overall Study|Adverse Event|189|||
129664815|NCT02683239|466732991|FG005|Overall Study|Adverse Event|9|||
129664816|NCT02683239|466732992|FG006|Overall Study|Adverse Event|9|||
129664817|NCT02683239|466732986|FG000|Overall Study|Physician Decision|38|||
129664818|NCT02683239|466732987|FG001|Overall Study|Physician Decision|19|||
129664819|NCT02683239|466732988|FG002|Overall Study|Physician Decision|14|||
129664820|NCT02683239|466732989|FG003|Overall Study|Physician Decision|73|||
129664821|NCT02683239|466732990|FG004|Overall Study|Physician Decision|143|||
129664822|NCT02683239|466732991|FG005|Overall Study|Physician Decision|14|||
129664823|NCT02683239|466732992|FG006|Overall Study|Physician Decision|15|||
129664824|NCT02683239|466732986|FG000|Overall Study|Withdrawal by Subject|187|||
129664825|NCT02683239|466732987|FG001|Overall Study|Withdrawal by Subject|99|||
129664826|NCT02683239|466732988|FG002|Overall Study|Withdrawal by Subject|91|||
129664827|NCT02683239|466732989|FG003|Overall Study|Withdrawal by Subject|18|||
129664828|NCT02683239|466732990|FG004|Overall Study|Withdrawal by Subject|248|||
129664829|NCT02683239|466732991|FG005|Overall Study|Withdrawal by Subject|22|||
129664830|NCT02683239|466732992|FG006|Overall Study|Withdrawal by Subject|28|||
129664831|NCT02683239|466732986|FG000|Overall Study|Lost to Follow-up|77|||
129664832|NCT02683239|466732987|FG001|Overall Study|Lost to Follow-up|24|||
129664833|NCT02683239|466732988|FG002|Overall Study|Lost to Follow-up|25|||
129664834|NCT02683239|466732989|FG003|Overall Study|Lost to Follow-up|7|||
129664835|NCT02683239|466732990|FG004|Overall Study|Lost to Follow-up|88|||
129664836|NCT02683239|466732991|FG005|Overall Study|Lost to Follow-up|8|||
129664837|NCT02683239|466732992|FG006|Overall Study|Lost to Follow-up|11|||
129664838|NCT02683239|466732986|FG000|Overall Study|Death|9|||
129664839|NCT02683239|466732987|FG001|Overall Study|Death|5|||
129664840|NCT02683239|466732988|FG002|Overall Study|Death|8|||
129664841|NCT02683239|466732989|FG003|Overall Study|Death|0|||
129664842|NCT02683239|466732990|FG004|Overall Study|Death|12|||
129664843|NCT02683239|466732991|FG005|Overall Study|Death|1|||
129664844|NCT02683239|466732992|FG006|Overall Study|Death|0|||
129664845|NCT02683239|466732986|FG000|Overall Study|Lack of Efficacy|50|||
129664846|NCT02683239|466732987|FG001|Overall Study|Lack of Efficacy|23|||
129664847|NCT02683239|466732988|FG002|Overall Study|Lack of Efficacy|12|||
129664848|NCT02683239|466732989|FG003|Overall Study|Lack of Efficacy|2|||
129664849|NCT02683239|466732990|FG004|Overall Study|Lack of Efficacy|29|||
129664850|NCT02683239|466732991|FG005|Overall Study|Lack of Efficacy|2|||
129664851|NCT02683239|466732992|FG006|Overall Study|Lack of Efficacy|3|||
129664852|NCT02683239|466732986|FG000|Overall Study|Missing data|0|||
129664853|NCT02683239|466732987|FG001|Overall Study|Missing data|1|||
129664854|NCT02683239|466732988|FG002|Overall Study|Missing data|1|||
129664855|NCT02683239|466732989|FG003|Overall Study|Missing data|0|||
129664856|NCT02683239|466732990|FG004|Overall Study|Missing data|1|||
129664857|NCT02683239|466732991|FG005|Overall Study|Missing data|0|||
129664858|NCT02683239|466732992|FG006|Overall Study|Missing data|0|||
129664859|NCT04131712|466732995|FG000|Overall Study|COVID related|0|||
129664860|NCT04131712|466732996|FG001|Overall Study|COVID related|0|||
129664861|NCT04131712|466732997|FG002|Overall Study|COVID related|2|||
129664862|NCT04131712|466732998|FG003|Overall Study|COVID related|0|||
129664863|NCT04131712|466732995|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
129664864|NCT04131712|466732996|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
129664865|NCT04131712|466732997|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
129664866|NCT04131712|466732998|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
129664867|NCT00873730|466732999|FG000|Overall Study|Protocol Deviation|5|||
129664868|NCT00873730|466733000|FG001|Overall Study|Protocol Deviation|2|||
129664869|NCT00873730|466732999|FG000|Overall Study|Adverse Event|0|||
129664870|NCT00873730|466733000|FG001|Overall Study|Adverse Event|2|||
129664871|NCT00873730|466732999|FG000|Overall Study|Withdrawal by Subject|0|||
129664872|NCT00873730|466733000|FG001|Overall Study|Withdrawal by Subject|1|||
129664873|NCT00873730|466732999|FG000|Overall Study|Sponsor decision|1|||
129664874|NCT00873730|466733000|FG001|Overall Study|Sponsor decision|0|||
129664875|NCT00103662|466733001|FG000|Overall Study|Entered Rescue Procedure|0|||
129664876|NCT00103662|466733002|FG001|Overall Study|Entered Rescue Procedure|7|||
129664877|NCT00103662|466733001|FG000|Overall Study|Death|7|||
129664878|NCT00103662|466733002|FG001|Overall Study|Death|7|||
129664879|NCT00103662|466733001|FG000|Overall Study|Elective Withdrawal|5|||
129664880|NCT00103662|466733002|FG001|Overall Study|Elective Withdrawal|5|||
129664881|NCT00103662|466733001|FG000|Overall Study|Lost to Follow-up|0|||
129664882|NCT00103662|466733002|FG001|Overall Study|Lost to Follow-up|1|||
129664883|NCT00103662|466733001|FG000|Overall Study|Other|6|||
129664884|NCT00103662|466733002|FG001|Overall Study|Other|9|||
129664885|NCT00103662|466733001|FG000|Overall Study|Failed mobilization|0|||
129664886|NCT00103662|466733002|FG001|Overall Study|Failed mobilization|4|||
129664887|NCT00103662|466733001|FG000|Overall Study|Intercurrent illness|1|||
129664888|NCT00103662|466733002|FG001|Overall Study|Intercurrent illness|0|||
129664889|NCT00943397|466733003|FG000|Overall Study|Adverse Event|0|||
129664890|NCT00943397|466733004|FG001|Overall Study|Adverse Event|6|||
129664891|NCT00943397|466733003|FG000|Overall Study|Lost to Follow-up|0|||
129664892|NCT00943397|466733004|FG001|Overall Study|Lost to Follow-up|4|||
129664893|NCT00943397|466733003|FG000|Overall Study|Protocol Violation|2|||
129664894|NCT00943397|466733004|FG001|Overall Study|Protocol Violation|5|||
129664895|NCT00943397|466733003|FG000|Overall Study|Withdrawal by Subject|1|||
129664896|NCT00943397|466733004|FG001|Overall Study|Withdrawal by Subject|1|||
129664897|NCT00943397|466733003|FG000|Overall Study|Site terminated and other|12|||
129664898|NCT00943397|466733004|FG001|Overall Study|Site terminated and other|56|||
129664899|NCT04878055|466733005|FG000|Overall Study|Patient transferred in another department|0|||
129664900|NCT04878055|466733006|FG001|Overall Study|Patient transferred in another department|2|||
129664901|NCT04878055|466733005|FG000|Overall Study|Physician Decision|1|||
129664902|NCT04878055|466733006|FG001|Overall Study|Physician Decision|1|||
129664903|NCT04878055|466733005|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
129664904|NCT04878055|466733006|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
129664905|NCT04878055|466733005|FG000|Overall Study|Adverse Event|12|||
129664906|NCT04878055|466733006|FG001|Overall Study|Adverse Event|7|||
129664907|NCT04878055|466733005|FG000|Overall Study|Other|5|||
129664908|NCT04878055|466733006|FG001|Overall Study|Other|0|||
129664909|NCT04878055|466733005|FG000|Overall Study|Withdrawal by Subject|7|||
129664910|NCT04878055|466733006|FG001|Overall Study|Withdrawal by Subject|3|||
129664911|NCT04878055|466733005|FG000|Overall Study|Lost to Follow-up|10|||
129664912|NCT04878055|466733006|FG001|Overall Study|Lost to Follow-up|1|||
129664913|NCT01968811|466733007|FG000|Overall Study|Protocol Violation|4|||
129664914|NCT01968811|466733007|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
129664915|NCT03904420|466733012|FG000|Overall Study|Study terminated|2|||
129664916|NCT03904420|466733013|FG001|Overall Study|Study terminated|2|||
129664917|NCT01089127|466733018|FG000|Overall Study|Adverse Event|5|||
129664918|NCT01089127|466733019|FG001|Overall Study|Adverse Event|1|||
129664919|NCT01089127|466733020|FG002|Overall Study|Adverse Event|1|||
129664920|NCT01089127|466733021|FG003|Overall Study|Adverse Event|0|||
129664921|NCT01089127|466733022|FG004|Overall Study|Adverse Event|0|||
129664922|NCT01089127|466733023|FG005|Overall Study|Adverse Event|1|||
129664923|NCT01089127|466733018|FG000|Overall Study|Subject withdrew consent|0|||
129664924|NCT01089127|466733019|FG001|Overall Study|Subject withdrew consent|1|||
129664925|NCT01089127|466733020|FG002|Overall Study|Subject withdrew consent|1|||
129664926|NCT01089127|466733021|FG003|Overall Study|Subject withdrew consent|1|||
129664927|NCT01089127|466733022|FG004|Overall Study|Subject withdrew consent|0|||
129664928|NCT01089127|466733023|FG005|Overall Study|Subject withdrew consent|2|||
129664929|NCT01089127|466733018|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129664930|NCT01089127|466733019|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129664931|NCT01089127|466733020|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129664932|NCT01089127|466733021|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129664933|NCT01089127|466733022|FG004|Overall Study|Abnormal test procedure result(s)|0|||
129664934|NCT01089127|466733023|FG005|Overall Study|Abnormal test procedure result(s)|0|||
129664935|NCT01089127|466733018|FG000|Overall Study|Lost to Follow-up|1|||
129664936|NCT01089127|466733019|FG001|Overall Study|Lost to Follow-up|1|||
129664937|NCT01089127|466733020|FG002|Overall Study|Lost to Follow-up|0|||
129664938|NCT01089127|466733021|FG003|Overall Study|Lost to Follow-up|0|||
129664939|NCT01089127|466733022|FG004|Overall Study|Lost to Follow-up|1|||
129664940|NCT01089127|466733023|FG005|Overall Study|Lost to Follow-up|0|||
129664941|NCT01089127|466733018|FG000|Overall Study|Protocol deviation|0|||
129664942|NCT01089127|466733019|FG001|Overall Study|Protocol deviation|1|||
129664943|NCT01089127|466733020|FG002|Overall Study|Protocol deviation|0|||
129664944|NCT01089127|466733021|FG003|Overall Study|Protocol deviation|0|||
129664945|NCT01089127|466733022|FG004|Overall Study|Protocol deviation|1|||
129664946|NCT01089127|466733023|FG005|Overall Study|Protocol deviation|0|||
129664947|NCT01841970|466733026|FG000|Overall Study|Withdrawal by Subject|1|||
129664948|NCT01841970|466733026|FG000|Overall Study|Physician Decision|2|||
129664949|NCT01841970|466733026|FG000|Overall Study|Lost to Follow-up|8|||
129664950|NCT02592447|466733027|FG000|Overall Study|Lost to Follow-up|1|||
129664951|NCT02592447|466733028|FG001|Overall Study|Lost to Follow-up|0|||
129664952|NCT02592447|466733027|FG000|Overall Study|Ineligible after randomization|1|||
129664953|NCT02592447|466733028|FG001|Overall Study|Ineligible after randomization|0|||
129664954|NCT02592447|466733027|FG000|Overall Study|Withdrawal by Subject|0|||
129664955|NCT02592447|466733028|FG001|Overall Study|Withdrawal by Subject|1|||
129664956|NCT01048541|466733033|FG000|Overall Study|Withdrawal by Subject|1|||
129664957|NCT01048541|466733034|FG001|Overall Study|Withdrawal by Subject|0|||
129664958|NCT00627497|466733035|FG000|Overall Study|Lost to Follow-up|1|||
129664959|NCT00627497|466733036|FG001|Overall Study|Lost to Follow-up|1|||
129664960|NCT00627497|466733037|FG002|Overall Study|Lost to Follow-up|0|||
129664961|NCT00627497|466733038|FG003|Overall Study|Lost to Follow-up|0|||
129664962|NCT00327717|466733039|FG000|Overall Study|Adverse Event|6|||
129664963|NCT00327717|466733040|FG001|Overall Study|Adverse Event|6|||
129664964|NCT00327717|466733039|FG000|Overall Study|Lack of Efficacy|0|||
129664965|NCT00327717|466733040|FG001|Overall Study|Lack of Efficacy|1|||
129664966|NCT00327717|466733039|FG000|Overall Study|Withdrawal by Subject|3|||
129992037|NCT01302834|467934180|FG000|Overall Study|HIV positive|1|||
129664967|NCT00327717|466733040|FG001|Overall Study|Withdrawal by Subject|7|||
129664968|NCT02080364|466733041|FG000|Baseline Period|Protocol Violation|2|||
129664969|NCT02080364|466733042|FG001|Baseline Period|Protocol Violation|1|||
129664970|NCT02080364|466733043|FG002|Baseline Period|Protocol Violation|0|||
129664971|NCT02080364|466733044|FG003|Baseline Period|Protocol Violation|0|||
129664972|NCT02080364|466733041|FG000|Baseline Period|Other|0|||
129664973|NCT02080364|466733042|FG001|Baseline Period|Other|1|||
129664974|NCT02080364|466733043|FG002|Baseline Period|Other|1|||
129664975|NCT02080364|466733044|FG003|Baseline Period|Other|0|||
129664976|NCT02080364|466733041|FG000|Treatment Period|Adverse Event|10|||
129664977|NCT02080364|466733042|FG001|Treatment Period|Adverse Event|15|||
129664978|NCT02080364|466733043|FG002|Treatment Period|Adverse Event|11|||
129664979|NCT02080364|466733044|FG003|Treatment Period|Adverse Event|14|||
129664980|NCT02080364|466733041|FG000|Treatment Period|Lost to Follow-up|2|||
129664981|NCT02080364|466733042|FG001|Treatment Period|Lost to Follow-up|3|||
129664982|NCT02080364|466733043|FG002|Treatment Period|Lost to Follow-up|5|||
129664983|NCT02080364|466733044|FG003|Treatment Period|Lost to Follow-up|0|||
129664984|NCT02080364|466733041|FG000|Treatment Period|Protocol Violation|5|||
129664985|NCT02080364|466733042|FG001|Treatment Period|Protocol Violation|3|||
129664986|NCT02080364|466733043|FG002|Treatment Period|Protocol Violation|5|||
129664987|NCT02080364|466733044|FG003|Treatment Period|Protocol Violation|1|||
129664988|NCT02080364|466733041|FG000|Treatment Period|Withdrawal by Subject|16|||
129664989|NCT02080364|466733042|FG001|Treatment Period|Withdrawal by Subject|16|||
129664990|NCT02080364|466733043|FG002|Treatment Period|Withdrawal by Subject|15|||
129664991|NCT02080364|466733044|FG003|Treatment Period|Withdrawal by Subject|10|||
129664992|NCT02080364|466733041|FG000|Treatment Period|Study Terminated by Sponsor|0|||
129664993|NCT02080364|466733042|FG001|Treatment Period|Study Terminated by Sponsor|0|||
129664994|NCT02080364|466733043|FG002|Treatment Period|Study Terminated by Sponsor|180|||
129992038|NCT01302834|467934181|FG001|Overall Study|HIV positive|3|||
129992039|NCT03735238|467934182|FG000|Overall Study|Did not want to participate in research|3|||
129992040|NCT03735238|467934182|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
129992041|NCT02427464|467934183|FG000|Overall Study|Adverse Event|6|||
129664995|NCT02080364|466733044|FG003|Treatment Period|Study Terminated by Sponsor|183|||
129664996|NCT02080364|466733041|FG000|Treatment Period|Other|14|||
129664997|NCT02080364|466733042|FG001|Treatment Period|Other|12|||
129664998|NCT02080364|466733043|FG002|Treatment Period|Other|21|||
129664999|NCT02080364|466733044|FG003|Treatment Period|Other|16|||
129665000|NCT00571662|466733046|FG000|Overall Study|Withdrawal by Subject|2|||
129665001|NCT00571662|466733046|FG000|Overall Study|psychiatric instability|1|||
129665002|NCT00571662|466733046|FG000|Overall Study|Adverse Event|5|||
129665003|NCT00964028|466733047|FG000|Overall Study|Withdrawal by Subject|0|||
129665004|NCT00964028|466733048|FG001|Overall Study|Withdrawal by Subject|1|||
129665005|NCT02385110|466733049|FG000|Overall Study|Early Death|1|||
129665006|NCT02385110|466733050|FG001|Overall Study|Early Death|0|||
129665007|NCT03472521|466733051|FG000|Overall Study|Lost to Follow-up|3|||
129665008|NCT03472521|466733052|FG001|Overall Study|Lost to Follow-up|2|||
129665009|NCT03472521|466733051|FG000|Overall Study|Discontinued intervention|3|||
129665010|NCT03472521|466733052|FG001|Overall Study|Discontinued intervention|1|||
129665011|NCT00181883|466733057|FG000|Overall Study|Lack of Efficacy|2|||
129665012|NCT00181883|466733057|FG000|Overall Study|Treatment Limiting AEs|3|||
129665013|NCT00181883|466733057|FG000|Overall Study|Withdrawal by Subject|4|||
129665014|NCT00181883|466733057|FG000|Overall Study|Lost to Follow-up|1|||
129665015|NCT00765817|466733058|FG000|Overall Study|Adverse Event|13|||
129665016|NCT00765817|466733059|FG001|Overall Study|Adverse Event|1|||
129665017|NCT00765817|466733058|FG000|Overall Study|Death|0|||
129665018|NCT00765817|466733059|FG001|Overall Study|Death|1|||
129665019|NCT00765817|466733058|FG000|Overall Study|Entry criteria not met|2|||
129665020|NCT00765817|466733059|FG001|Overall Study|Entry criteria not met|2|||
129665021|NCT00765817|466733058|FG000|Overall Study|Loss of glucose control|0|||
129665022|NCT00765817|466733059|FG001|Overall Study|Loss of glucose control|2|||
129665023|NCT00765817|466733058|FG000|Overall Study|Lost to Follow-up|1|||
129665024|NCT00765817|466733059|FG001|Overall Study|Lost to Follow-up|3|||
129665025|NCT00765817|466733058|FG000|Overall Study|Physician Decision|2|||
129665026|NCT00765817|466733059|FG001|Overall Study|Physician Decision|1|||
129665027|NCT00765817|466733058|FG000|Overall Study|Protocol Violation|1|||
129665028|NCT00765817|466733059|FG001|Overall Study|Protocol Violation|1|||
129992042|NCT02427464|467934184|FG001|Overall Study|Adverse Event|1|||
129992043|NCT02427464|467934183|FG000|Overall Study|Lost to Follow-up|16|||
129665029|NCT00765817|466733058|FG000|Overall Study|Subject decision|7|||
129665030|NCT00765817|466733059|FG001|Overall Study|Subject decision|11|||
129665031|NCT01302418|466734944|FG000|Overall Study|Protocol Violation|9|||
129665032|NCT01302418|466734944|FG000|Overall Study|Non-evaluable|9|||
129665033|NCT00377637|466734945|FG000|Induction Phase|Adverse Event|12|||
129665034|NCT00377637|466734946|FG001|Induction Phase|Adverse Event|21|||
129665035|NCT00377637|466734947|FG002|Induction Phase|Adverse Event|0|||
129665036|NCT00377637|466734948|FG003|Induction Phase|Adverse Event|0|||
129665037|NCT00377637|466734945|FG000|Induction Phase|Deterioration/serum creatinine|2|||
129665038|NCT00377637|466734946|FG001|Induction Phase|Deterioration/serum creatinine|0|||
129665039|NCT00377637|466734947|FG002|Induction Phase|Deterioration/serum creatinine|0|||
129992044|NCT02427464|467934184|FG001|Overall Study|Lost to Follow-up|5|||
129665040|NCT00377637|466734948|FG003|Induction Phase|Deterioration/serum creatinine|0|||
129665041|NCT00377637|466734945|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
129665042|NCT00377637|466734946|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
129665043|NCT00377637|466734947|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
129665044|NCT00377637|466734948|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
129665045|NCT00377637|466734945|FG000|Induction Phase|Lost to Follow-up|2|||
129665046|NCT00377637|466734946|FG001|Induction Phase|Lost to Follow-up|1|||
129665047|NCT00377637|466734947|FG002|Induction Phase|Lost to Follow-up|0|||
129665048|NCT00377637|466734948|FG003|Induction Phase|Lost to Follow-up|0|||
129665049|NCT00377637|466734945|FG000|Induction Phase|Death|1|||
129665050|NCT00377637|466734946|FG001|Induction Phase|Death|3|||
129665051|NCT00377637|466734947|FG002|Induction Phase|Death|0|||
129665052|NCT00377637|466734948|FG003|Induction Phase|Death|0|||
129665053|NCT00377637|466734945|FG000|Induction Phase|Withdrawal by Subject|5|||
129665054|NCT00377637|466734946|FG001|Induction Phase|Withdrawal by Subject|6|||
129665055|NCT00377637|466734947|FG002|Induction Phase|Withdrawal by Subject|0|||
129665056|NCT00377637|466734948|FG003|Induction Phase|Withdrawal by Subject|0|||
129665057|NCT00377637|466734945|FG000|Induction Phase|Physician Decision|3|||
129665058|NCT00377637|466734946|FG001|Induction Phase|Physician Decision|1|||
129665059|NCT00377637|466734947|FG002|Induction Phase|Physician Decision|0|||
129665060|NCT00377637|466734948|FG003|Induction Phase|Physician Decision|0|||
129665061|NCT00377637|466734945|FG000|Induction Phase|Sponsor decision|1|||
129665062|NCT00377637|466734946|FG001|Induction Phase|Sponsor decision|2|||
129665063|NCT00377637|466734947|FG002|Induction Phase|Sponsor decision|0|||
129665064|NCT00377637|466734948|FG003|Induction Phase|Sponsor decision|0|||
129665065|NCT00377637|466734945|FG000|Induction Phase|Non-Compliance|1|||
129665066|NCT00377637|466734946|FG001|Induction Phase|Non-Compliance|0|||
129665067|NCT00377637|466734947|FG002|Induction Phase|Non-Compliance|0|||
129665068|NCT00377637|466734948|FG003|Induction Phase|Non-Compliance|0|||
129665069|NCT00377637|466734945|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
129665070|NCT00377637|466734946|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
129665071|NCT00377637|466734947|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
129665072|NCT00377637|466734948|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
129665073|NCT00377637|466734945|FG000|Maintenance Phase|Adverse Event|0|||
129665074|NCT00377637|466734946|FG001|Maintenance Phase|Adverse Event|0|||
129665075|NCT00377637|466734947|FG002|Maintenance Phase|Adverse Event|29|||
129665076|NCT00377637|466734948|FG003|Maintenance Phase|Adverse Event|43|||
129665077|NCT00377637|466734945|FG000|Maintenance Phase|Physician Decision|0|||
129665078|NCT00377637|466734946|FG001|Maintenance Phase|Physician Decision|0|||
129665079|NCT00377637|466734947|FG002|Maintenance Phase|Physician Decision|5|||
129992045|NCT02427464|467934183|FG000|Overall Study|Physician Decision|2|||
129992046|NCT02427464|467934184|FG001|Overall Study|Physician Decision|0|||
129992047|NCT02427464|467934183|FG000|Overall Study|Withdrawal by Subject|10|||
129992048|NCT02427464|467934184|FG001|Overall Study|Withdrawal by Subject|8|||
129992049|NCT02427464|467934183|FG000|Overall Study|Noncompliance|16|||
129992050|NCT02427464|467934184|FG001|Overall Study|Noncompliance|10|||
129992051|NCT05214573|467934187|FG000|Overall Study|Physician Decision|5924|||
129992052|NCT05214573|467934188|FG001|Overall Study|Physician Decision|0|||
129992053|NCT02486718|467934189|FG000|Enrollment Phase|Death|19|||
129992054|NCT02486718|467934190|FG001|Enrollment Phase|Death|0|||
129992055|NCT02486718|467934191|FG002|Enrollment Phase|Death|0|||
129665080|NCT00377637|466734948|FG003|Maintenance Phase|Physician Decision|4|||
129665081|NCT00377637|466734945|FG000|Maintenance Phase|Lost to Follow-up|0|||
129665082|NCT00377637|466734946|FG001|Maintenance Phase|Lost to Follow-up|0|||
129665083|NCT00377637|466734947|FG002|Maintenance Phase|Lost to Follow-up|3|||
129665084|NCT00377637|466734948|FG003|Maintenance Phase|Lost to Follow-up|1|||
129665085|NCT00377637|466734945|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129665086|NCT00377637|466734946|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129665087|NCT00377637|466734947|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129665088|NCT00377637|466734948|FG003|Maintenance Phase|Withdrawal by Subject|3|||
129665089|NCT00377637|466734945|FG000|Maintenance Phase|Sponsor decision|0|||
129665090|NCT00377637|466734946|FG001|Maintenance Phase|Sponsor decision|0|||
129665091|NCT00377637|466734947|FG002|Maintenance Phase|Sponsor decision|2|||
129665092|NCT00377637|466734948|FG003|Maintenance Phase|Sponsor decision|3|||
129665093|NCT00377637|466734945|FG000|Maintenance Phase|Non-compliance|0|||
129665094|NCT00377637|466734946|FG001|Maintenance Phase|Non-compliance|0|||
129665095|NCT00377637|466734947|FG002|Maintenance Phase|Non-compliance|1|||
129665096|NCT00377637|466734948|FG003|Maintenance Phase|Non-compliance|1|||
129992056|NCT02486718|467934189|FG000|Enrollment Phase|Symptomatic deterioration|1|||
129665097|NCT00377637|466734945|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
129665098|NCT00377637|466734946|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
129665099|NCT00377637|466734947|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
129992057|NCT02486718|467934190|FG001|Enrollment Phase|Symptomatic deterioration|0|||
129665100|NCT00377637|466734948|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
129665101|NCT00377637|466734945|FG000|Maintenance Phase|Death|0|||
129665102|NCT00377637|466734946|FG001|Maintenance Phase|Death|0|||
129665103|NCT00377637|466734947|FG002|Maintenance Phase|Death|0|||
129992058|NCT02486718|467934191|FG002|Enrollment Phase|Symptomatic deterioration|0|||
129665104|NCT00377637|466734948|FG003|Maintenance Phase|Death|1|||
129665105|NCT00994110|466734950|FG000|Overall Study|Withdrawal by Subject|9|||
129665106|NCT00994110|466734951|FG001|Overall Study|Withdrawal by Subject|9|||
129665107|NCT00994110|466734950|FG000|Overall Study|Not Treated|4|||
129665108|NCT00994110|466734951|FG001|Overall Study|Not Treated|8|||
129665109|NCT00994110|466734950|FG000|Overall Study|Adverse Event|1|||
129665110|NCT00994110|466734951|FG001|Overall Study|Adverse Event|0|||
129665111|NCT00994110|466734950|FG000|Overall Study|Patient not resected|41|||
129665112|NCT00994110|466734951|FG001|Overall Study|Patient not resected|52|||
129665113|NCT00994110|466734950|FG000|Overall Study|Pt not eligible|10|||
129665114|NCT00994110|466734951|FG001|Overall Study|Pt not eligible|5|||
129665115|NCT00368108|466734952|FG000|Overall Study|Adverse Event|38|||
129665116|NCT00368108|466734953|FG001|Overall Study|Adverse Event|26|||
129665117|NCT00368108|466734954|FG002|Overall Study|Adverse Event|44|||
129665118|NCT00368108|466734952|FG000|Overall Study|Abnormal Laboratory Value|0|||
129665119|NCT00368108|466734953|FG001|Overall Study|Abnormal Laboratory Value|0|||
129665120|NCT00368108|466734954|FG002|Overall Study|Abnormal Laboratory Value|3|||
129665121|NCT00368108|466734952|FG000|Overall Study|Protocol Violation|5|||
129665122|NCT00368108|466734953|FG001|Overall Study|Protocol Violation|9|||
129665123|NCT00368108|466734954|FG002|Overall Study|Protocol Violation|9|||
129665124|NCT00368108|466734952|FG000|Overall Study|Withdrawal by Subject|9|||
129665125|NCT00368108|466734953|FG001|Overall Study|Withdrawal by Subject|3|||
129665126|NCT00368108|466734954|FG002|Overall Study|Withdrawal by Subject|5|||
129665127|NCT00368108|466734952|FG000|Overall Study|Lack of Efficacy|7|||
129665128|NCT00368108|466734953|FG001|Overall Study|Lack of Efficacy|8|||
129665129|NCT00368108|466734954|FG002|Overall Study|Lack of Efficacy|5|||
129665130|NCT00368108|466734952|FG000|Overall Study|Physician Decision|2|||
129665131|NCT00368108|466734953|FG001|Overall Study|Physician Decision|0|||
129665132|NCT00368108|466734954|FG002|Overall Study|Physician Decision|1|||
129665133|NCT00368108|466734952|FG000|Overall Study|Other|3|||
129665134|NCT00368108|466734953|FG001|Overall Study|Other|7|||
129665135|NCT00368108|466734954|FG002|Overall Study|Other|1|||
129665136|NCT00130689|466734955|FG000|Overall Study|Progressive Disease|29|||
129665137|NCT00130689|466734955|FG000|Overall Study|Death|1|||
129665138|NCT00130689|466734955|FG000|Overall Study|Clinical Deterioration|4|||
129665139|NCT00130689|466734955|FG000|Overall Study|Withdrawal by Subject|3|||
129665140|NCT00130689|466734955|FG000|Overall Study|Ineligible|6|||
129665141|NCT01254656|466734956|FG000|Overall Study|Discontinued due to termination of study|40|||
129665142|NCT01254656|466734957|FG001|Overall Study|Discontinued due to termination of study|39|||
129665143|NCT01254656|466734958|FG002|Overall Study|Discontinued due to termination of study|13|||
129665144|NCT01254656|466734956|FG000|Overall Study|Lack of Efficacy|3|||
129665145|NCT01254656|466734957|FG001|Overall Study|Lack of Efficacy|0|||
129665146|NCT01254656|466734958|FG002|Overall Study|Lack of Efficacy|0|||
129665147|NCT01254656|466734956|FG000|Overall Study|Lost to Follow-up|1|||
129665148|NCT01254656|466734957|FG001|Overall Study|Lost to Follow-up|0|||
129665149|NCT01254656|466734958|FG002|Overall Study|Lost to Follow-up|2|||
129665150|NCT01254656|466734956|FG000|Overall Study|Withdrawal by Subject|2|||
129665151|NCT01254656|466734957|FG001|Overall Study|Withdrawal by Subject|2|||
129665152|NCT01254656|466734958|FG002|Overall Study|Withdrawal by Subject|1|||
129665153|NCT01254656|466734956|FG000|Overall Study|Pregnancy|0|||
129665154|NCT01254656|466734957|FG001|Overall Study|Pregnancy|0|||
129665155|NCT01254656|466734958|FG002|Overall Study|Pregnancy|2|||
129665156|NCT01254656|466734956|FG000|Overall Study|Adverse Event|1|||
129665157|NCT01254656|466734957|FG001|Overall Study|Adverse Event|1|||
129665158|NCT01254656|466734958|FG002|Overall Study|Adverse Event|0|||
129665159|NCT01254656|466734956|FG000|Overall Study|Death|0|||
129665160|NCT01254656|466734957|FG001|Overall Study|Death|1|||
129665161|NCT01254656|466734958|FG002|Overall Study|Death|0|||
129665162|NCT03200548|466734963|FG000|Overall Study|Withdrawal by Subject|5|||
129665163|NCT03200548|466734964|FG001|Overall Study|Withdrawal by Subject|11|||
129665164|NCT03200548|466734965|FG002|Overall Study|Withdrawal by Subject|7|||
129665165|NCT03200548|466734966|FG003|Overall Study|Withdrawal by Subject|6|||
129665166|NCT00716456|466734967|FG000|Overall Study|Adverse Event|0|||
129665167|NCT00716456|466734968|FG001|Overall Study|Adverse Event|2|||
129665168|NCT00716456|466734969|FG002|Overall Study|Adverse Event|0|||
129665169|NCT00447772|466734970|FG000|Overall Study|Lack of Efficacy|3|||
129665170|NCT00447772|466734970|FG000|Overall Study|Insufficient compliance|6|||
129665171|NCT00447772|466734970|FG000|Overall Study|Discontinuation of drug therapy|1|||
129665172|NCT00447772|466734970|FG000|Overall Study|Lost to Follow-up|9|||
129665173|NCT00447772|466734970|FG000|Overall Study|Withdrawal by Subject|1|||
129665174|NCT00447772|466734970|FG000|Overall Study|Unable to attend all study visits|2|||
129665175|NCT00447772|466734970|FG000|Overall Study|Adverse Event|1|||
129665176|NCT00447772|466734970|FG000|Overall Study|Patient relocated|1|||
129665177|NCT00447772|466734970|FG000|Overall Study|Incomplete documentation at visit 1|1|||
129665178|NCT00447772|466734970|FG000|Overall Study|Chemotherapy for lung cancer|1|||
129665179|NCT00447772|466734970|FG000|Overall Study|Premature re-injection required|1|||
129665180|NCT00875563|466734975|FG000|Overall Study|Death|4|||
129665181|NCT00875563|466734975|FG000|Overall Study|Withdrawal by Subject|7|||
129665182|NCT00875563|466734975|FG000|Overall Study|No long-term (3-5 year) consent|6|||
129665183|NCT00875563|466734975|FG000|Overall Study|Still be eligible for follow-up|7|||
129665184|NCT02896569|466734978|FG000|Overall Study|Lost to Follow-up|2|||
129665185|NCT02896569|466734979|FG001|Overall Study|Lost to Follow-up|1|||
129665186|NCT02896569|466734978|FG000|Overall Study|Physician Decision|1|||
129665187|NCT02896569|466734979|FG001|Overall Study|Physician Decision|3|||
129665188|NCT02896569|466734978|FG000|Overall Study|Adverse Event|0|||
129665189|NCT02896569|466734979|FG001|Overall Study|Adverse Event|1|||
129665190|NCT02896569|466734978|FG000|Overall Study|Withdrawal by Subject|1|||
129665191|NCT02896569|466734979|FG001|Overall Study|Withdrawal by Subject|0|||
129665192|NCT01462630|466734980|FG000|Overall Study|Did not initiate therapy|3|||
129665193|NCT01462630|466734980|FG000|Overall Study|Death|1|||
129665194|NCT01462630|466734980|FG000|Overall Study|Protocol Violation|2|||
129665195|NCT01462630|466734980|FG000|Overall Study|Adverse Event|1|||
129665196|NCT03257436|466734981|FG000|Overall Study|Withdrawal by Subject|76|||
129665197|NCT03257436|466734981|FG000|Overall Study|Death|19|||
129665198|NCT00970489|466734984|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
129665199|NCT00970489|466734985|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
129665200|NCT05417412|466734986|FG000|Overall Study|Lost to Follow-up|2|||
129665201|NCT03478371|466734989|FG000|Overall Study|non-compliance|1|||
129665202|NCT03478371|466734989|FG000|Overall Study|Lost to Follow-up|4|||
129665203|NCT02849743|466734990|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
129665204|NCT02849743|466734991|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
129665205|NCT02849743|466734990|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
129665206|NCT02849743|466734991|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129665207|NCT03874013|466734998|FG000|Overall Study|Adverse Event|0|||
129665208|NCT03874013|466734999|FG001|Overall Study|Adverse Event|1|||
129665209|NCT01096160|466735003|FG000|Overall Study|Adverse Event|0|||
129665210|NCT01096160|466735004|FG001|Overall Study|Adverse Event|0|||
129665211|NCT01096160|466735005|FG002|Overall Study|Adverse Event|1|||
129665212|NCT01096160|466735006|FG003|Overall Study|Adverse Event|0|||
129665213|NCT01096160|466735007|FG004|Overall Study|Adverse Event|0|||
129665214|NCT01096160|466735008|FG005|Overall Study|Adverse Event|0|||
129665215|NCT01096160|466735009|FG006|Overall Study|Adverse Event|0|||
129665216|NCT01096160|466735010|FG007|Overall Study|Adverse Event|0|||
129665217|NCT01096160|466735011|FG008|Overall Study|Adverse Event|0|||
129665218|NCT01096160|466735012|FG009|Overall Study|Adverse Event|1|||
129665219|NCT01096160|466735003|FG000|Overall Study|Met stopping criteria per protocol|0|||
129665220|NCT01096160|466735004|FG001|Overall Study|Met stopping criteria per protocol|0|||
129665221|NCT01096160|466735005|FG002|Overall Study|Met stopping criteria per protocol|0|||
129665222|NCT01096160|466735006|FG003|Overall Study|Met stopping criteria per protocol|0|||
129665223|NCT01096160|466735007|FG004|Overall Study|Met stopping criteria per protocol|1|||
129665224|NCT01096160|466735008|FG005|Overall Study|Met stopping criteria per protocol|0|||
129665225|NCT01096160|466735009|FG006|Overall Study|Met stopping criteria per protocol|2|||
129665226|NCT01096160|466735010|FG007|Overall Study|Met stopping criteria per protocol|0|||
129665227|NCT01096160|466735011|FG008|Overall Study|Met stopping criteria per protocol|2|||
129665228|NCT01096160|466735012|FG009|Overall Study|Met stopping criteria per protocol|0|||
129665229|NCT00922116|466735014|FG000|Overall Study|Adverse Event|4|||
129665230|NCT00922116|466735014|FG000|Overall Study|Death|1|||
129665231|NCT00922116|466735014|FG000|Overall Study|Lost to Follow-up|1|||
129665232|NCT00922116|466735014|FG000|Overall Study|Withdrawal by Subject|4|||
129665233|NCT00922116|466735014|FG000|Overall Study|Other|5|||
129665234|NCT04607135|466735015|FG000|Overall Study|Physician Decision|1|||
129665235|NCT04607135|466735015|FG000|Overall Study|Withdrawal by Subject|1|||
129665236|NCT04607135|466735015|FG000|Overall Study|Equipment not working|3|||
129665237|NCT06060496|466735016|FG000|Overall Study|Withdrawal by Subject|2|||
129665238|NCT06060496|466735016|FG000|Overall Study|Lost to Follow-up|2|||
129665239|NCT03990051|466735017|FG000|Masked Period|Lost to Follow-up|1|||
129665240|NCT03990051|466735018|FG001|Masked Period|Lost to Follow-up|0|||
129665241|NCT03990051|466735017|FG000|Long Term Period|Death|1|||
129665242|NCT03990051|466735018|FG001|Long Term Period|Death|1|||
129665243|NCT03990051|466735017|FG000|Long Term Period|Lost to Follow-up|7|||
129665244|NCT03990051|466735018|FG001|Long Term Period|Lost to Follow-up|2|||
129665245|NCT00618826|466735020|FG000|Overall Study|Adverse Event|1|||
129665246|NCT03193047|466735021|FG000|Overall Study|Physician Decision|1|||
129665247|NCT03193047|466735022|FG001|Overall Study|Physician Decision|0|||
129665248|NCT03193047|466735021|FG000|Overall Study|Participant Left State|1|||
129665249|NCT03193047|466735022|FG001|Overall Study|Participant Left State|0|||
129665250|NCT01509664|466735025|FG000|Overall Study|Lost to Follow-up|15|||
129665251|NCT01509664|466735026|FG001|Overall Study|Lost to Follow-up|21|||
129665252|NCT00149396|466735033|FG000|Overall Study|Death|15|||
129665253|NCT00149396|466735033|FG000|Overall Study|Withdrawal by Subject|1|||
129665254|NCT00149396|466735033|FG000|Overall Study|Subject noncompliance|2|||
129665255|NCT00149396|466735033|FG000|Overall Study|other treatment|5|||
129665256|NCT02364388|466735034|FG000|Overall Study|Protocol Violation|1|||
129665257|NCT02364388|466735034|FG000|Overall Study|Technical Failure|3|||
129665258|NCT02364388|466735034|FG000|Overall Study|No OA/US data|2|||
129665259|NCT02364388|466735034|FG000|Overall Study|No Biopsy|2|||
129665260|NCT00186485|466735037|FG000|Overall Study|Lost to Follow-up|3|||
129665261|NCT00905424|466735038|FG000|Overall Study|Lost to Follow-up|3|||
129665262|NCT00905424|466735039|FG001|Overall Study|Lost to Follow-up|3|||
129665263|NCT00905424|466735038|FG000|Overall Study|Withdrawal by Subject|1|||
129665264|NCT00905424|466735039|FG001|Overall Study|Withdrawal by Subject|2|||
129665265|NCT00905424|466735038|FG000|Overall Study|Adverse Event|4|||
129665266|NCT00905424|466735039|FG001|Overall Study|Adverse Event|2|||
129665267|NCT00905424|466735038|FG000|Overall Study|Non-compliance with study medication|2|||
129665268|NCT00905424|466735039|FG001|Overall Study|Non-compliance with study medication|0|||
129665269|NCT00905424|466735038|FG000|Overall Study|Sponsor decision|1|||
129665270|NCT00905424|466735039|FG001|Overall Study|Sponsor decision|0|||
129665271|NCT00905424|466735038|FG000|Overall Study|Positive urine drug screen|0|||
129665272|NCT00905424|466735039|FG001|Overall Study|Positive urine drug screen|1|||
129665273|NCT00905424|466735038|FG000|Overall Study|Non-adherence to visit schedule|0|||
129665274|NCT00905424|466735039|FG001|Overall Study|Non-adherence to visit schedule|1|||
129665275|NCT00379899|466735040|FG000|Overall Study|Adverse Event|7|||
129665276|NCT00379899|466735041|FG001|Overall Study|Adverse Event|3|||
129665277|NCT00379899|466735040|FG000|Overall Study|Death|10|||
129665278|NCT00379899|466735041|FG001|Overall Study|Death|10|||
129665279|NCT00379899|466735040|FG000|Overall Study|Lost to Follow-up|2|||
129665280|NCT00379899|466735041|FG001|Overall Study|Lost to Follow-up|4|||
129665281|NCT00379899|466735040|FG000|Overall Study|Physician Decision|3|||
129665282|NCT00379899|466735041|FG001|Overall Study|Physician Decision|4|||
129665283|NCT00379899|466735040|FG000|Overall Study|Withdrawal by Subject|5|||
129665284|NCT00379899|466735041|FG001|Overall Study|Withdrawal by Subject|5|||
129665285|NCT00379899|466735040|FG000|Overall Study|Ineligibility determined|0|||
129665286|NCT00379899|466735041|FG001|Overall Study|Ineligibility determined|1|||
129665287|NCT00379899|466735040|FG000|Overall Study|Noncompliance|1|||
129992059|NCT02486718|467934189|FG000|Enrollment Phase|Withdrawal by Subject|86|||
129992060|NCT02486718|467934190|FG001|Enrollment Phase|Withdrawal by Subject|0|||
129992061|NCT02486718|467934191|FG002|Enrollment Phase|Withdrawal by Subject|0|||
129992062|NCT02486718|467934189|FG000|Enrollment Phase|Protocol Violation|18|||
129992063|NCT02486718|467934190|FG001|Enrollment Phase|Protocol Violation|0|||
129992064|NCT02486718|467934191|FG002|Enrollment Phase|Protocol Violation|0|||
129992065|NCT02486718|467934189|FG000|Enrollment Phase|Physician Decision|18|||
129992066|NCT02486718|467934190|FG001|Enrollment Phase|Physician Decision|0|||
129992067|NCT02486718|467934191|FG002|Enrollment Phase|Physician Decision|0|||
129992068|NCT02486718|467934189|FG000|Enrollment Phase|Reason not provided|41|||
129992069|NCT02486718|467934190|FG001|Enrollment Phase|Reason not provided|0|||
129665288|NCT00379899|466735041|FG001|Overall Study|Noncompliance|1|||
129665289|NCT00379899|466735040|FG000|Overall Study|Parathyroidectomy|0|||
129665290|NCT00379899|466735041|FG001|Overall Study|Parathyroidectomy|2|||
129665291|NCT00379899|466735040|FG000|Overall Study|Renal transplantation|5|||
129665292|NCT00379899|466735041|FG001|Overall Study|Renal transplantation|4|||
129665293|NCT00379899|466735040|FG000|Overall Study|Coronary artery bypass graft|1|||
129665294|NCT00379899|466735041|FG001|Overall Study|Coronary artery bypass graft|1|||
129665295|NCT00379899|466735040|FG000|Overall Study|Other protocol-specified criteria|3|||
129665296|NCT00379899|466735041|FG001|Overall Study|Other protocol-specified criteria|4|||
129665297|NCT00379899|466735040|FG000|Overall Study|Other|3|||
129665298|NCT00379899|466735041|FG001|Overall Study|Other|1|||
129665299|NCT05225389|466735042|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
129665300|NCT03311841|466735043|FG000|14-day Wash-out|Adverse Event|0|||
129665301|NCT03311841|466735044|FG001|14-day Wash-out|Adverse Event|1|||
129665302|NCT03311841|466735045|FG002|14-day Wash-out|Adverse Event|0|||
129665303|NCT03311841|466735046|FG003|14-day Wash-out|Adverse Event|0|||
129665304|NCT03311841|466735047|FG004|14-day Wash-out|Adverse Event|0|||
129665305|NCT03311841|466735043|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
129992070|NCT02486718|467934191|FG002|Enrollment Phase|Reason not provided|0|||
129992071|NCT02486718|467934189|FG000|Enrollment Phase|Disease relapse|54|||
129992072|NCT02486718|467934190|FG001|Enrollment Phase|Disease relapse|0|||
129665306|NCT03311841|466735044|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
129992073|NCT02486718|467934191|FG002|Enrollment Phase|Disease relapse|0|||
129992074|NCT02486718|467934189|FG000|Enrollment Phase|Lost to Follow-up|4|||
129665307|NCT03311841|466735045|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
129665308|NCT03311841|466735046|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
129665309|NCT03311841|466735047|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
129665310|NCT01026948|466735048|FG000|Overall Study|Physician Decision|8|||
129665311|NCT00627926|466735049|FG000|Overall Study|Adverse Event|26|||
129665312|NCT00627926|466735050|FG001|Overall Study|Adverse Event|37|||
129665313|NCT00627926|466735051|FG002|Overall Study|Adverse Event|36|||
129665314|NCT00627926|466735049|FG000|Overall Study|Death|1|||
129665315|NCT00627926|466735050|FG001|Overall Study|Death|0|||
129665316|NCT00627926|466735051|FG002|Overall Study|Death|0|||
129665317|NCT00627926|466735049|FG000|Overall Study|Lost to Follow-up|4|||
129665318|NCT00627926|466735050|FG001|Overall Study|Lost to Follow-up|3|||
129665319|NCT00627926|466735051|FG002|Overall Study|Lost to Follow-up|4|||
129992075|NCT02486718|467934190|FG001|Enrollment Phase|Lost to Follow-up|0|||
129992076|NCT02486718|467934191|FG002|Enrollment Phase|Lost to Follow-up|0|||
129665320|NCT00627926|466735049|FG000|Overall Study|Withdrawal by Subject|2|||
129992077|NCT02486718|467934189|FG000|Enrollment Phase|Adverse Event|34|||
129992078|NCT02486718|467934190|FG001|Enrollment Phase|Adverse Event|0|||
129992079|NCT02486718|467934191|FG002|Enrollment Phase|Adverse Event|0|||
129992080|NCT02486718|467934189|FG000|Randomized Phase|Withdrawal by Subject|0|||
129992081|NCT02486718|467934190|FG001|Randomized Phase|Withdrawal by Subject|44|||
129992082|NCT02486718|467934191|FG002|Randomized Phase|Withdrawal by Subject|47|||
129992083|NCT02486718|467934189|FG000|Randomized Phase|Protocol Violation|0|||
129992084|NCT02486718|467934190|FG001|Randomized Phase|Protocol Violation|2|||
129992085|NCT02486718|467934191|FG002|Randomized Phase|Protocol Violation|0|||
129665321|NCT00627926|466735050|FG001|Overall Study|Withdrawal by Subject|1|||
129665322|NCT00627926|466735051|FG002|Overall Study|Withdrawal by Subject|0|||
129665323|NCT00627926|466735049|FG000|Overall Study|Lack of Efficacy|118|||
129665324|NCT00627926|466735050|FG001|Overall Study|Lack of Efficacy|40|||
129665325|NCT00627926|466735051|FG002|Overall Study|Lack of Efficacy|38|||
129665326|NCT00627926|466735049|FG000|Overall Study|Noncompliance/unspecified|8|||
129665327|NCT00627926|466735050|FG001|Overall Study|Noncompliance/unspecified|23|||
129665328|NCT00627926|466735051|FG002|Overall Study|Noncompliance/unspecified|17|||
129665329|NCT03360019|466735059|FG000|Overall Study|Withdrawal by Subject|2|||
129665330|NCT03360019|466735060|FG001|Overall Study|Withdrawal by Subject|0|||
129665331|NCT03360019|466735061|FG002|Overall Study|Withdrawal by Subject|0|||
129665332|NCT03360019|466735059|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
129665333|NCT03360019|466735060|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
129665334|NCT03360019|466735061|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
129665335|NCT01462110|466735062|FG000|Overall Study|Adverse Event|1|||
129665336|NCT01462110|466735063|FG001|Overall Study|Adverse Event|0|||
129665337|NCT00753675|466735064|FG000|Overall Study|other reason|11|||
129665338|NCT00753675|466735065|FG001|Overall Study|other reason|12|||
129665339|NCT00753675|466735066|FG002|Overall Study|other reason|13|||
129665340|NCT00753675|466735064|FG000|Overall Study|Death|1|||
129665341|NCT00753675|466735065|FG001|Overall Study|Death|2|||
129665342|NCT00753675|466735066|FG002|Overall Study|Death|4|||
129665343|NCT00753675|466735064|FG000|Overall Study|Adverse Event|11|||
129665344|NCT00753675|466735065|FG001|Overall Study|Adverse Event|9|||
129665345|NCT00753675|466735066|FG002|Overall Study|Adverse Event|4|||
129665346|NCT00753675|466735064|FG000|Overall Study|Objective progression of disease|35|||
129665347|NCT00753675|466735065|FG001|Overall Study|Objective progression of disease|35|||
129665348|NCT00753675|466735066|FG002|Overall Study|Objective progression of disease|35|||
129665349|NCT00753675|466735064|FG000|Overall Study|Withdrawal by Subject|0|||
129665350|NCT00753675|466735065|FG001|Overall Study|Withdrawal by Subject|1|||
129665351|NCT00753675|466735066|FG002|Overall Study|Withdrawal by Subject|0|||
129665352|NCT00753675|466735064|FG000|Overall Study|Lost to Follow-up|1|||
129665353|NCT00753675|466735065|FG001|Overall Study|Lost to Follow-up|0|||
129665354|NCT00753675|466735066|FG002|Overall Study|Lost to Follow-up|0|||
129665355|NCT02149264|466735072|FG000|Overall Study|Withdrawal by Subject|9|||
129665356|NCT02149264|466735072|FG000|Overall Study|Adverse Event|7|||
129665357|NCT02149264|466735072|FG000|Overall Study|Physician Decision|3|||
129665358|NCT02149264|466735072|FG000|Overall Study|Protocol Violation|1|||
129665359|NCT03283930|466735073|FG000|Overall Study|Scheduling conflict|8|||
129665360|NCT03283930|466735074|FG001|Overall Study|Scheduling conflict|10|||
129665361|NCT03283930|466735073|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
129665362|NCT03283930|466735074|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
129665363|NCT03283930|466735073|FG000|Overall Study|Technical software issue|2|||
129665364|NCT03283930|466735074|FG001|Overall Study|Technical software issue|2|||
129665365|NCT00805129|466735075|FG000|Overall Study|Not treated|1|||
129665366|NCT02499120|466735079|FG000|Overall Study|Death|52|||
129665367|NCT02499120|466735080|FG001|Overall Study|Death|43|||
129665368|NCT02499120|466735079|FG000|Overall Study|Lost to Follow-up|1|||
129665369|NCT02499120|466735080|FG001|Overall Study|Lost to Follow-up|2|||
129665370|NCT02499120|466735079|FG000|Overall Study|Participant refused further follow-up|1|||
129665371|NCT02499120|466735080|FG001|Overall Study|Participant refused further follow-up|0|||
129992086|NCT02486718|467934189|FG000|Randomized Phase|Physician Decision|0|||
129992087|NCT02486718|467934190|FG001|Randomized Phase|Physician Decision|0|||
129665372|NCT02499120|466735079|FG000|Overall Study|Withdrawal by Subject|2|||
129665373|NCT02499120|466735080|FG001|Overall Study|Withdrawal by Subject|5|||
129665374|NCT02499120|466735079|FG000|Overall Study|Other|9|||
129665375|NCT02499120|466735080|FG001|Overall Study|Other|10|||
129665376|NCT01839916|466735089|FG000|Overall Study|Death|9|||
129665377|NCT01839916|466735089|FG000|Overall Study|Physician Decision|17|||
129665378|NCT01839916|466735089|FG000|Overall Study|Relapse|12|||
129665379|NCT01839916|466735089|FG000|Overall Study|GVHD|2|||
129665380|NCT01839916|466735089|FG000|Overall Study|Graft Failure|1|||
129665381|NCT04235504|466735094|FG000|Study Phase|Withdrawal by Subject|5|||
129665382|NCT04235504|466735095|FG001|Study Phase|Withdrawal by Subject|2|||
129665383|NCT04235504|466735096|FG002|Study Phase|Withdrawal by Subject|0|||
129665384|NCT04235504|466735097|FG003|Study Phase|Withdrawal by Subject|0|||
129992088|NCT02486718|467934191|FG002|Randomized Phase|Physician Decision|3|||
129665385|NCT04235504|466735094|FG000|Continuation Phase|Withdrawal by Subject|0|||
129665386|NCT04235504|466735095|FG001|Continuation Phase|Withdrawal by Subject|4|||
129665387|NCT04235504|466735096|FG002|Continuation Phase|Withdrawal by Subject|0|||
129665388|NCT04235504|466735097|FG003|Continuation Phase|Withdrawal by Subject|0|||
129665389|NCT04235504|466735094|FG000|Continuation Phase|Adverse Event|0|||
129665390|NCT04235504|466735095|FG001|Continuation Phase|Adverse Event|1|||
129665391|NCT04235504|466735096|FG002|Continuation Phase|Adverse Event|0|||
129665392|NCT04235504|466735097|FG003|Continuation Phase|Adverse Event|0|||
129665393|NCT04235504|466735094|FG000|Continuation Phase|Physician Decision|1|||
129665394|NCT04235504|466735095|FG001|Continuation Phase|Physician Decision|2|||
129665395|NCT04235504|466735096|FG002|Continuation Phase|Physician Decision|1|||
129665396|NCT04235504|466735097|FG003|Continuation Phase|Physician Decision|0|||
129665397|NCT02106351|466735104|FG000|Treatment Cycle 1|Adverse Event|2|||
129665398|NCT02106351|466735105|FG001|Treatment Cycle 1|Adverse Event|0|||
129665399|NCT02106351|466735106|FG002|Treatment Cycle 1|Adverse Event|0|||
129665400|NCT02106351|466735104|FG000|Treatment Cycle 1|Consent withdrawn|1|||
129665401|NCT02106351|466735105|FG001|Treatment Cycle 1|Consent withdrawn|0|||
129665402|NCT02106351|466735106|FG002|Treatment Cycle 1|Consent withdrawn|2|||
129665403|NCT02106351|466735104|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
129665404|NCT02106351|466735105|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
129665405|NCT02106351|466735106|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
129665406|NCT02106351|466735104|FG000|Treatment Cycle 1|Other|0|||
129665407|NCT02106351|466735105|FG001|Treatment Cycle 1|Other|3|||
129665408|NCT02106351|466735106|FG002|Treatment Cycle 1|Other|1|||
129665409|NCT02106351|466735104|FG000|Treatment Cycle 1|Randomised but not treated|1|||
129665410|NCT02106351|466735105|FG001|Treatment Cycle 1|Randomised but not treated|0|||
129665411|NCT02106351|466735106|FG002|Treatment Cycle 1|Randomised but not treated|1|||
129665412|NCT02106351|466735104|FG000|Treatment Cycle 2|Adverse Event|0|||
129665413|NCT02106351|466735105|FG001|Treatment Cycle 2|Adverse Event|2|||
129665414|NCT02106351|466735106|FG002|Treatment Cycle 2|Adverse Event|0|||
129665415|NCT02106351|466735104|FG000|Treatment Cycle 2|Consent withdrawn|0|||
129665416|NCT02106351|466735105|FG001|Treatment Cycle 2|Consent withdrawn|1|||
129665417|NCT02106351|466735106|FG002|Treatment Cycle 2|Consent withdrawn|1|||
129665418|NCT02106351|466735104|FG000|Treatment Cycle 2|Other|0|||
129665419|NCT02106351|466735105|FG001|Treatment Cycle 2|Other|2|||
129665420|NCT02106351|466735106|FG002|Treatment Cycle 2|Other|2|||
129665421|NCT02106351|466735104|FG000|Treatment Cycle 3|Adverse Event|0|||
129665422|NCT02106351|466735105|FG001|Treatment Cycle 3|Adverse Event|1|||
129665423|NCT02106351|466735106|FG002|Treatment Cycle 3|Adverse Event|0|||
129665424|NCT02106351|466735104|FG000|Treatment Cycle 3|Consent withdrawn|0|||
129665425|NCT02106351|466735105|FG001|Treatment Cycle 3|Consent withdrawn|0|||
129665426|NCT02106351|466735106|FG002|Treatment Cycle 3|Consent withdrawn|2|||
129665427|NCT02106351|466735104|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
129665428|NCT02106351|466735105|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
129665429|NCT02106351|466735106|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
129665430|NCT02106351|466735104|FG000|Treatment Cycle 3|Other|0|||
129665431|NCT02106351|466735105|FG001|Treatment Cycle 3|Other|2|||
129665432|NCT02106351|466735106|FG002|Treatment Cycle 3|Other|3|||
129665433|NCT02106351|466735104|FG000|Treatment Cycle 4|Consent withdrawn|0|||
129665434|NCT02106351|466735105|FG001|Treatment Cycle 4|Consent withdrawn|0|||
129665435|NCT02106351|466735106|FG002|Treatment Cycle 4|Consent withdrawn|2|||
129665436|NCT02106351|466735104|FG000|Treatment Cycle 4|Other|0|||
129665437|NCT02106351|466735105|FG001|Treatment Cycle 4|Other|1|||
129665438|NCT02106351|466735106|FG002|Treatment Cycle 4|Other|0|||
129665439|NCT00101868|466735107|FG000|Overall Study|Death|10|||
129665440|NCT00101868|466735108|FG001|Overall Study|Death|10|||
129665441|NCT00101868|466735107|FG000|Overall Study|Withdrawal by Subject|8|||
129665442|NCT00101868|466735108|FG001|Overall Study|Withdrawal by Subject|9|||
129665443|NCT00101868|466735107|FG000|Overall Study|Protocol Violation|3|||
129665444|NCT00101868|466735108|FG001|Overall Study|Protocol Violation|0|||
129665445|NCT00101868|466735107|FG000|Overall Study|Lost to Follow-up|8|||
129665446|NCT00101868|466735108|FG001|Overall Study|Lost to Follow-up|13|||
129665447|NCT00069823|466735109|FG000|Overall Study|Did not have follow-up diary cards|6|||
129665448|NCT00069823|466735110|FG001|Overall Study|Did not have follow-up diary cards|3|||
129665449|NCT00520039|466735111|FG000|Overall Study|Exclusion criteria met at first visit|7|||
129665450|NCT00520039|466735112|FG001|Overall Study|Exclusion criteria met at first visit|5|||
129665451|NCT02329327|466735113|FG000|Overall Study|Death|78|||
129665452|NCT02329327|466735114|FG001|Overall Study|Death|0|||
129665453|NCT02329327|466735113|FG000|Overall Study|Withdrawal by Subject|3|||
129665454|NCT02329327|466735114|FG001|Overall Study|Withdrawal by Subject|0|||
129665455|NCT02329327|466735113|FG000|Overall Study|Lost to Follow-up|4|||
129665456|NCT02329327|466735114|FG001|Overall Study|Lost to Follow-up|0|||
129665457|NCT03560869|466735115|FG000|Overall Study|Withdrawal by Subject|3|||
129665458|NCT03560869|466735116|FG001|Overall Study|Withdrawal by Subject|4|||
129665459|NCT03560869|466735115|FG000|Overall Study|Screening failure|4|||
129665460|NCT03560869|466735116|FG001|Overall Study|Screening failure|4|||
129665461|NCT03560869|466735115|FG000|Overall Study|Withdrawal by PI|0|||
129665462|NCT03560869|466735116|FG001|Overall Study|Withdrawal by PI|1|||
129665463|NCT01801111|466735117|FG000|Overall Study|Adverse Event|12|||
129665464|NCT01801111|466735117|FG000|Overall Study|Death|8|||
129665465|NCT01801111|466735117|FG000|Overall Study|Physician Decision|5|||
129665466|NCT01801111|466735117|FG000|Overall Study|Other|1|||
129665467|NCT01801111|466735117|FG000|Overall Study|Withdrawal by Subject|4|||
129665468|NCT01801111|466735117|FG000|Overall Study|Study Terminated by Sponsor|27|||
129665469|NCT01801111|466735117|FG000|Overall Study|Progressive Disease|81|||
129665470|NCT01210482|466735118|FG000|Overall Study|Protocol Violation|1|||
129665471|NCT01210482|466735118|FG000|Overall Study|Case Report Forms were not collected|18|||
129665472|NCT01210482|466735118|FG000|Overall Study|Duplicated|2|||
129665473|NCT01210482|466735118|FG000|Overall Study|No Drug Administration|28|||
129665474|NCT01223937|466735119|FG000|Overall Study|Withdrawal by Subject|3|||
129665475|NCT01223937|466735120|FG001|Overall Study|Withdrawal by Subject|2|||
129665476|NCT01223937|466735119|FG000|Overall Study|Lost to Follow-up|1|||
129665477|NCT01223937|466735120|FG001|Overall Study|Lost to Follow-up|4|||
129665478|NCT01223937|466735119|FG000|Overall Study|Adverse Event|1|||
129665479|NCT01223937|466735120|FG001|Overall Study|Adverse Event|4|||
129665480|NCT01223937|466735119|FG000|Overall Study|Protocol Violation|8|||
129665481|NCT01223937|466735120|FG001|Overall Study|Protocol Violation|7|||
129665482|NCT01223937|466735119|FG000|Overall Study|Other|4|||
129665483|NCT01223937|466735120|FG001|Overall Study|Other|1|||
129665484|NCT03284853|466735122|FG000|Overall Study|Adverse Event|40|||
129665485|NCT03284853|466735123|FG001|Overall Study|Adverse Event|4|||
129665486|NCT03284853|466735122|FG000|Overall Study|Withdrawal by Subject|5|||
129665487|NCT03284853|466735123|FG001|Overall Study|Withdrawal by Subject|1|||
129665488|NCT03284853|466735122|FG000|Overall Study|Lost to Follow-up|1|||
129665489|NCT03284853|466735123|FG001|Overall Study|Lost to Follow-up|0|||
129665490|NCT03284853|466735122|FG000|Overall Study|Lack of Efficacy|1|||
129665491|NCT03284853|466735123|FG001|Overall Study|Lack of Efficacy|0|||
129665492|NCT03284853|466735122|FG000|Overall Study|Disallowed Concurrent Medication|1|||
129665493|NCT03284853|466735123|FG001|Overall Study|Disallowed Concurrent Medication|1|||
129665494|NCT03284853|466735122|FG000|Overall Study|Protocol Violation|3|||
129665495|NCT03284853|466735123|FG001|Overall Study|Protocol Violation|3|||
129665496|NCT03284853|466735122|FG000|Overall Study|Death|0|||
129665497|NCT03284853|466735123|FG001|Overall Study|Death|1|||
129665498|NCT03284853|466735122|FG000|Overall Study|Other - Reason not reported in CSR|4|||
129665499|NCT03284853|466735123|FG001|Overall Study|Other - Reason not reported in CSR|3|||
129665500|NCT05176717|466735124|FG000|Overall Study|Sponsor Decision|1|||
129665501|NCT05176717|466735125|FG001|Overall Study|Sponsor Decision|2|||
129665502|NCT05176717|466735126|FG002|Overall Study|Sponsor Decision|2|||
129665503|NCT02308228|466735128|FG000|Overall Study|Adverse Event|3|||
129665504|NCT02308228|466735129|FG001|Overall Study|Adverse Event|4|||
129665505|NCT02308228|466735128|FG000|Overall Study|Withdrawal by Subject|5|||
129665506|NCT02308228|466735129|FG001|Overall Study|Withdrawal by Subject|3|||
129665507|NCT03999749|466735132|FG000|Overall Study|Toxicity|16|||
129665508|NCT03999749|466735132|FG000|Overall Study|Withdrawal by Subject|3|||
129665509|NCT03999749|466735132|FG000|Overall Study|Disease progression|26|||
129665510|NCT03999749|466735132|FG000|Overall Study|Physician Decision|4|||
129665511|NCT03999749|466735132|FG000|Overall Study|Death|5|||
129665512|NCT03999749|466735132|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
129665513|NCT00255164|466735133|FG000|Overall Study|Adverse Event|10|||
129665514|NCT00255164|466735134|FG001|Overall Study|Adverse Event|6|||
129665515|NCT00255164|466735135|FG002|Overall Study|Adverse Event|9|||
129665516|NCT00255164|466735133|FG000|Overall Study|Lost to Follow-up|4|||
129665517|NCT00255164|466735134|FG001|Overall Study|Lost to Follow-up|3|||
129992089|NCT02486718|467934189|FG000|Randomized Phase|Lost to Follow-up|0|||
129992090|NCT02486718|467934190|FG001|Randomized Phase|Lost to Follow-up|5|||
129992091|NCT02486718|467934191|FG002|Randomized Phase|Lost to Follow-up|11|||
129665518|NCT00255164|466735135|FG002|Overall Study|Lost to Follow-up|4|||
129665519|NCT00255164|466735133|FG000|Overall Study|Withdrawal by Subject|18|||
129665520|NCT00255164|466735134|FG001|Overall Study|Withdrawal by Subject|17|||
129665521|NCT00255164|466735135|FG002|Overall Study|Withdrawal by Subject|8|||
129665522|NCT00255164|466735133|FG000|Overall Study|Noncompliance|0|||
129665523|NCT00255164|466735134|FG001|Overall Study|Noncompliance|1|||
129665524|NCT00255164|466735135|FG002|Overall Study|Noncompliance|2|||
129992092|NCT02486718|467934189|FG000|Randomized Phase|Disease Relapse|0|||
129665525|NCT00255164|466735133|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
129665526|NCT00255164|466735134|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
129665527|NCT00255164|466735135|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
129665528|NCT00255164|466735133|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
129665529|NCT00255164|466735134|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
129665530|NCT00255164|466735135|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
129665531|NCT00255164|466735133|FG000|Overall Study|Possible Barrett's Esophagus|1|||
129665532|NCT00255164|466735134|FG001|Overall Study|Possible Barrett's Esophagus|3|||
129665533|NCT00255164|466735135|FG002|Overall Study|Possible Barrett's Esophagus|8|||
129665534|NCT00255164|466735133|FG000|Overall Study|Esophageal Stricture|0|||
129665535|NCT00255164|466735134|FG001|Overall Study|Esophageal Stricture|0|||
129665536|NCT00255164|466735135|FG002|Overall Study|Esophageal Stricture|1|||
129992093|NCT02486718|467934190|FG001|Randomized Phase|Disease Relapse|1|||
129665537|NCT00255164|466735133|FG000|Overall Study|Therapeutic Failure|11|||
129665538|NCT00255164|466735134|FG001|Overall Study|Therapeutic Failure|2|||
129665539|NCT00255164|466735135|FG002|Overall Study|Therapeutic Failure|3|||
129665540|NCT05219968|466735136|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
129665541|NCT05219968|466735137|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129665542|NCT05219968|466735138|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129665543|NCT05219968|466735139|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129665544|NCT05219968|466735140|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
129665545|NCT05219968|466735136|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
129665546|NCT05219968|466735137|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
129665547|NCT05219968|466735138|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
129665548|NCT05219968|466735139|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
129665549|NCT05219968|466735140|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
129665550|NCT05219968|466735136|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
129665551|NCT05219968|466735137|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
129665552|NCT05219968|466735138|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
129665553|NCT05219968|466735139|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
129665554|NCT05219968|466735140|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
129665555|NCT05219968|466735136|FG000|Week 24 Treatment Period|Adverse Event|3|||
129665556|NCT05219968|466735137|FG001|Week 24 Treatment Period|Adverse Event|0|||
129665557|NCT05219968|466735138|FG002|Week 24 Treatment Period|Adverse Event|0|||
129665558|NCT05219968|466735139|FG003|Week 24 Treatment Period|Adverse Event|0|||
129665559|NCT05219968|466735140|FG004|Week 24 Treatment Period|Adverse Event|0|||
129665560|NCT05219968|466735136|FG000|Week 24 Treatment Period|Physician Decision|0|||
129665561|NCT05219968|466735137|FG001|Week 24 Treatment Period|Physician Decision|1|||
129665562|NCT05219968|466735138|FG002|Week 24 Treatment Period|Physician Decision|0|||
129665563|NCT05219968|466735139|FG003|Week 24 Treatment Period|Physician Decision|0|||
129665564|NCT05219968|466735140|FG004|Week 24 Treatment Period|Physician Decision|0|||
129665565|NCT05219968|466735136|FG000|Week 24 Treatment Period|Other, not specified|3|||
129665566|NCT05219968|466735137|FG001|Week 24 Treatment Period|Other, not specified|0|||
129665567|NCT05219968|466735138|FG002|Week 24 Treatment Period|Other, not specified|0|||
129665568|NCT05219968|466735139|FG003|Week 24 Treatment Period|Other, not specified|0|||
129665569|NCT05219968|466735140|FG004|Week 24 Treatment Period|Other, not specified|0|||
129665570|NCT05219968|466735136|FG000|Safety Extension Period|Treatment administration failure|0|||
129665571|NCT05219968|466735137|FG001|Safety Extension Period|Treatment administration failure|0|||
129665572|NCT05219968|466735138|FG002|Safety Extension Period|Treatment administration failure|0|||
129665573|NCT05219968|466735139|FG003|Safety Extension Period|Treatment administration failure|1|||
129665574|NCT05219968|466735140|FG004|Safety Extension Period|Treatment administration failure|4|||
129665575|NCT05219968|466735136|FG000|Safety Extension Period|Bilateral dislodgement|0|||
129665576|NCT05219968|466735137|FG001|Safety Extension Period|Bilateral dislodgement|0|||
129665577|NCT05219968|466735138|FG002|Safety Extension Period|Bilateral dislodgement|4|||
129665578|NCT05219968|466735139|FG003|Safety Extension Period|Bilateral dislodgement|0|||
129665579|NCT05219968|466735140|FG004|Safety Extension Period|Bilateral dislodgement|1|||
129665580|NCT05219968|466735136|FG000|Safety Extension Period|Withdrawal by Subject|0|||
129665581|NCT05219968|466735137|FG001|Safety Extension Period|Withdrawal by Subject|0|||
129665582|NCT05219968|466735138|FG002|Safety Extension Period|Withdrawal by Subject|2|||
129665583|NCT05219968|466735139|FG003|Safety Extension Period|Withdrawal by Subject|0|||
129665584|NCT05219968|466735140|FG004|Safety Extension Period|Withdrawal by Subject|4|||
129665585|NCT05219968|466735136|FG000|Safety Extension Period|Adverse Event|0|||
129665586|NCT05219968|466735137|FG001|Safety Extension Period|Adverse Event|0|||
129665587|NCT05219968|466735138|FG002|Safety Extension Period|Adverse Event|2|||
129665588|NCT05219968|466735139|FG003|Safety Extension Period|Adverse Event|1|||
129665589|NCT05219968|466735140|FG004|Safety Extension Period|Adverse Event|1|||
129665590|NCT05219968|466735136|FG000|Safety Extension Period|Lost to Follow-up|0|||
129665591|NCT05219968|466735137|FG001|Safety Extension Period|Lost to Follow-up|0|||
129665592|NCT05219968|466735138|FG002|Safety Extension Period|Lost to Follow-up|0|||
129665593|NCT05219968|466735139|FG003|Safety Extension Period|Lost to Follow-up|1|||
129665594|NCT05219968|466735140|FG004|Safety Extension Period|Lost to Follow-up|0|||
129665595|NCT04587336|466735141|FG000|Overall Study|Lost to Follow-up|1|||
129665596|NCT04587336|466735142|FG001|Overall Study|Lost to Follow-up|0|||
129665597|NCT00103285|466737163|FG000|Induction|Adverse Event|14|||
129665598|NCT00103285|466737164|FG001|Induction|Adverse Event|0|||
129665599|NCT00103285|466737165|FG002|Induction|Adverse Event|0|||
129665600|NCT00103285|466737166|FG003|Induction|Adverse Event|0|||
129665601|NCT00103285|466737167|FG004|Induction|Adverse Event|0|||
129665602|NCT00103285|466737168|FG005|Induction|Adverse Event|0|||
129665603|NCT00103285|466737169|FG006|Induction|Adverse Event|0|||
129665604|NCT00103285|466737170|FG007|Induction|Adverse Event|0|||
129665605|NCT00103285|466737163|FG000|Induction|Death|24|||
129665606|NCT00103285|466737164|FG001|Induction|Death|0|||
129665607|NCT00103285|466737165|FG002|Induction|Death|0|||
129665608|NCT00103285|466737166|FG003|Induction|Death|0|||
129665609|NCT00103285|466737167|FG004|Induction|Death|0|||
129665610|NCT00103285|466737168|FG005|Induction|Death|0|||
129665611|NCT00103285|466737169|FG006|Induction|Death|0|||
129665612|NCT00103285|466737170|FG007|Induction|Death|0|||
129665613|NCT00103285|466737163|FG000|Induction|Physician Decision|103|||
129665614|NCT00103285|466737164|FG001|Induction|Physician Decision|0|||
129665615|NCT00103285|466737165|FG002|Induction|Physician Decision|0|||
129665616|NCT00103285|466737166|FG003|Induction|Physician Decision|0|||
129665617|NCT00103285|466737167|FG004|Induction|Physician Decision|0|||
129665618|NCT00103285|466737168|FG005|Induction|Physician Decision|0|||
129665619|NCT00103285|466737169|FG006|Induction|Physician Decision|0|||
129665620|NCT00103285|466737170|FG007|Induction|Physician Decision|0|||
129992094|NCT02486718|467934191|FG002|Randomized Phase|Disease Relapse|0|||
129992095|NCT02486718|467934189|FG000|Randomized Phase|Death|0|||
129992096|NCT02486718|467934190|FG001|Randomized Phase|Death|154|||
129992097|NCT02486718|467934191|FG002|Randomized Phase|Death|155|||
129992098|NCT02486718|467934189|FG000|Randomized Phase|Ongoing|0|||
129992099|NCT02486718|467934190|FG001|Randomized Phase|Ongoing|301|||
129992100|NCT02486718|467934191|FG002|Randomized Phase|Ongoing|282|||
129992101|NCT03816332|467934192|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
129992102|NCT03816332|467934192|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
129992103|NCT04689828|467934195|FG000|Overall Study|Subject decision|5|||
129992104|NCT04689828|467934196|FG001|Overall Study|Subject decision|5|||
129992105|NCT04689828|467934195|FG000|Overall Study|Adverse Event|12|||
129992106|NCT04689828|467934196|FG001|Overall Study|Adverse Event|12|||
129992107|NCT04689828|467934195|FG000|Overall Study|Physician Decision|24|||
129992108|NCT04689828|467934196|FG001|Overall Study|Physician Decision|32|||
129992109|NCT04689828|467934195|FG000|Overall Study|Progressive disease|54|||
129665621|NCT00103285|466737163|FG000|Induction|Withdrawal by Subject|1|||
129665622|NCT00103285|466737164|FG001|Induction|Withdrawal by Subject|0|||
129665623|NCT00103285|466737165|FG002|Induction|Withdrawal by Subject|0|||
129665624|NCT00103285|466737166|FG003|Induction|Withdrawal by Subject|0|||
129665625|NCT00103285|466737167|FG004|Induction|Withdrawal by Subject|0|||
129665626|NCT00103285|466737168|FG005|Induction|Withdrawal by Subject|0|||
129665627|NCT00103285|466737169|FG006|Induction|Withdrawal by Subject|0|||
129665628|NCT00103285|466737170|FG007|Induction|Withdrawal by Subject|0|||
129665629|NCT00103285|466737163|FG000|Induction|Ineligible|43|||
129665630|NCT00103285|466737164|FG001|Induction|Ineligible|0|||
129665631|NCT00103285|466737165|FG002|Induction|Ineligible|0|||
129665632|NCT00103285|466737166|FG003|Induction|Ineligible|0|||
129665633|NCT00103285|466737167|FG004|Induction|Ineligible|0|||
129665634|NCT00103285|466737168|FG005|Induction|Ineligible|0|||
129665635|NCT00103285|466737169|FG006|Induction|Ineligible|0|||
129665636|NCT00103285|466737170|FG007|Induction|Ineligible|0|||
129665637|NCT00103285|466737163|FG000|Induction|Refusal|906|||
129665638|NCT00103285|466737164|FG001|Induction|Refusal|0|||
129665639|NCT00103285|466737165|FG002|Induction|Refusal|0|||
129665640|NCT00103285|466737166|FG003|Induction|Refusal|0|||
129665641|NCT00103285|466737167|FG004|Induction|Refusal|0|||
129665642|NCT00103285|466737168|FG005|Induction|Refusal|0|||
129665643|NCT00103285|466737169|FG006|Induction|Refusal|0|||
129665644|NCT00103285|466737170|FG007|Induction|Refusal|0|||
129665645|NCT00103285|466737163|FG000|Induction|Other|258|||
129665646|NCT00103285|466737164|FG001|Induction|Other|0|||
129665647|NCT00103285|466737165|FG002|Induction|Other|0|||
129665648|NCT00103285|466737166|FG003|Induction|Other|0|||
129665649|NCT00103285|466737167|FG004|Induction|Other|0|||
129665650|NCT00103285|466737168|FG005|Induction|Other|0|||
129665651|NCT00103285|466737169|FG006|Induction|Other|0|||
129665652|NCT00103285|466737170|FG007|Induction|Other|0|||
129665653|NCT00103285|466737163|FG000|Response Assignment|Adverse Event|0|||
129665654|NCT00103285|466737164|FG001|Response Assignment|Adverse Event|8|||
129665655|NCT00103285|466737165|FG002|Response Assignment|Adverse Event|3|||
129665656|NCT00103285|466737166|FG003|Response Assignment|Adverse Event|2|||
129665657|NCT00103285|466737167|FG004|Response Assignment|Adverse Event|3|||
129665658|NCT00103285|466737168|FG005|Response Assignment|Adverse Event|1|||
129665659|NCT00103285|466737169|FG006|Response Assignment|Adverse Event|1|||
129665660|NCT00103285|466737170|FG007|Response Assignment|Adverse Event|2|||
129665661|NCT00103285|466737163|FG000|Response Assignment|Death|0|||
129665662|NCT00103285|466737164|FG001|Response Assignment|Death|5|||
129665663|NCT00103285|466737165|FG002|Response Assignment|Death|2|||
129665664|NCT00103285|466737166|FG003|Response Assignment|Death|2|||
129665665|NCT00103285|466737167|FG004|Response Assignment|Death|3|||
129665666|NCT00103285|466737168|FG005|Response Assignment|Death|1|||
129665667|NCT00103285|466737169|FG006|Response Assignment|Death|0|||
129665668|NCT00103285|466737170|FG007|Response Assignment|Death|8|||
129665669|NCT00103285|466737163|FG000|Response Assignment|Lost to Follow-up|0|||
129665670|NCT00103285|466737164|FG001|Response Assignment|Lost to Follow-up|9|||
129665671|NCT00103285|466737165|FG002|Response Assignment|Lost to Follow-up|5|||
129665672|NCT00103285|466737166|FG003|Response Assignment|Lost to Follow-up|5|||
129665673|NCT00103285|466737167|FG004|Response Assignment|Lost to Follow-up|1|||
129665674|NCT00103285|466737168|FG005|Response Assignment|Lost to Follow-up|2|||
129665675|NCT00103285|466737169|FG006|Response Assignment|Lost to Follow-up|2|||
129665676|NCT00103285|466737170|FG007|Response Assignment|Lost to Follow-up|5|||
129992110|NCT04689828|467934196|FG001|Overall Study|Progressive disease|173|||
129992111|NCT04689828|467934195|FG000|Overall Study|Death|0|||
129665677|NCT00103285|466737163|FG000|Response Assignment|Physician Decision|0|||
129665678|NCT00103285|466737164|FG001|Response Assignment|Physician Decision|13|||
129665679|NCT00103285|466737165|FG002|Response Assignment|Physician Decision|14|||
129665680|NCT00103285|466737166|FG003|Response Assignment|Physician Decision|9|||
129665681|NCT00103285|466737167|FG004|Response Assignment|Physician Decision|13|||
129665682|NCT00103285|466737168|FG005|Response Assignment|Physician Decision|7|||
129665683|NCT00103285|466737169|FG006|Response Assignment|Physician Decision|4|||
129665684|NCT00103285|466737170|FG007|Response Assignment|Physician Decision|35|||
129665685|NCT00103285|466737163|FG000|Response Assignment|Protocol Violation|0|||
129665686|NCT00103285|466737164|FG001|Response Assignment|Protocol Violation|2|||
129665687|NCT00103285|466737165|FG002|Response Assignment|Protocol Violation|0|||
129665688|NCT00103285|466737166|FG003|Response Assignment|Protocol Violation|0|||
129665689|NCT00103285|466737167|FG004|Response Assignment|Protocol Violation|0|||
129665690|NCT00103285|466737168|FG005|Response Assignment|Protocol Violation|0|||
129665691|NCT00103285|466737169|FG006|Response Assignment|Protocol Violation|0|||
129665692|NCT00103285|466737170|FG007|Response Assignment|Protocol Violation|0|||
129665693|NCT00103285|466737163|FG000|Response Assignment|Withdrawal by Subject|0|||
129665694|NCT00103285|466737164|FG001|Response Assignment|Withdrawal by Subject|4|||
129665695|NCT00103285|466737165|FG002|Response Assignment|Withdrawal by Subject|1|||
129665696|NCT00103285|466737166|FG003|Response Assignment|Withdrawal by Subject|1|||
129665697|NCT00103285|466737167|FG004|Response Assignment|Withdrawal by Subject|2|||
129665698|NCT00103285|466737168|FG005|Response Assignment|Withdrawal by Subject|2|||
129665699|NCT00103285|466737169|FG006|Response Assignment|Withdrawal by Subject|0|||
129665700|NCT00103285|466737170|FG007|Response Assignment|Withdrawal by Subject|2|||
129665701|NCT00103285|466737163|FG000|Response Assignment|Ineligible|0|||
129665702|NCT00103285|466737164|FG001|Response Assignment|Ineligible|8|||
129665703|NCT00103285|466737165|FG002|Response Assignment|Ineligible|6|||
129665704|NCT00103285|466737166|FG003|Response Assignment|Ineligible|2|||
129665705|NCT00103285|466737167|FG004|Response Assignment|Ineligible|0|||
129665706|NCT00103285|466737168|FG005|Response Assignment|Ineligible|3|||
129665707|NCT00103285|466737169|FG006|Response Assignment|Ineligible|1|||
129665708|NCT00103285|466737170|FG007|Response Assignment|Ineligible|5|||
129665709|NCT00103285|466737163|FG000|Response Assignment|Refusal|0|||
129665710|NCT00103285|466737164|FG001|Response Assignment|Refusal|53|||
129665711|NCT00103285|466737165|FG002|Response Assignment|Refusal|5|||
129665712|NCT00103285|466737166|FG003|Response Assignment|Refusal|3|||
129665713|NCT00103285|466737167|FG004|Response Assignment|Refusal|25|||
129665714|NCT00103285|466737168|FG005|Response Assignment|Refusal|15|||
129665715|NCT00103285|466737169|FG006|Response Assignment|Refusal|30|||
129665716|NCT00103285|466737170|FG007|Response Assignment|Refusal|10|||
129665717|NCT00103285|466737163|FG000|Response Assignment|Other|0|||
129665718|NCT00103285|466737164|FG001|Response Assignment|Other|30|||
129665719|NCT00103285|466737165|FG002|Response Assignment|Other|48|||
129665720|NCT00103285|466737166|FG003|Response Assignment|Other|38|||
129665721|NCT00103285|466737167|FG004|Response Assignment|Other|37|||
129665722|NCT00103285|466737168|FG005|Response Assignment|Other|17|||
129665723|NCT00103285|466737169|FG006|Response Assignment|Other|11|||
129665724|NCT00103285|466737170|FG007|Response Assignment|Other|53|||
129665725|NCT00452439|466737172|FG000|Overall Study|Lost to Follow-up|1|||
129665726|NCT00452439|466737173|FG001|Overall Study|Lost to Follow-up|1|||
129665727|NCT00452439|466737172|FG000|Overall Study|Refused Treatment|4|||
129665728|NCT00452439|466737173|FG001|Overall Study|Refused Treatment|3|||
129665729|NCT00452439|466737172|FG000|Overall Study|Death|3|||
129665730|NCT00452439|466737173|FG001|Overall Study|Death|1|||
129665731|NCT00452439|466737172|FG000|Overall Study|Bone Marrow Transplant|0|||
129665732|NCT00452439|466737173|FG001|Overall Study|Bone Marrow Transplant|1|||
129665733|NCT00452439|466737172|FG000|Overall Study|Too Ill to Continue|0|||
129665734|NCT00452439|466737173|FG001|Overall Study|Too Ill to Continue|1|||
129665735|NCT00452439|466737172|FG000|Overall Study|Failed to achieve complete response|2|||
129665736|NCT00452439|466737173|FG001|Overall Study|Failed to achieve complete response|0|||
129665737|NCT00452439|466737172|FG000|Overall Study|Relapse|3|||
129665738|NCT00452439|466737173|FG001|Overall Study|Relapse|0|||
129665739|NCT00452439|466737172|FG000|Overall Study|Fracture|1|||
129992112|NCT04689828|467934196|FG001|Overall Study|Death|1|||
129665740|NCT00452439|466737173|FG001|Overall Study|Fracture|0|||
129665741|NCT03512353|466737175|FG000|Overall Study|Sponsor Decision|3|||
129665742|NCT03512353|466737175|FG000|Overall Study|Death|1|||
129665743|NCT01845597|466737176|FG000|Overall Study|Death|8|||
129665744|NCT01845597|466737176|FG000|Overall Study|Lost to Follow-up|22|||
129665745|NCT02581488|466737180|FG000|Overall Study|Adverse Event|6|||
129665746|NCT02581488|466737181|FG001|Overall Study|Adverse Event|7|||
129665747|NCT02581488|466737180|FG000|Overall Study|Lost to Follow-up|1|||
129665748|NCT02581488|466737181|FG001|Overall Study|Lost to Follow-up|0|||
129665749|NCT02581488|466737180|FG000|Overall Study|Withdrawal by Subject|1|||
129665750|NCT02581488|466737181|FG001|Overall Study|Withdrawal by Subject|0|||
129665751|NCT02581488|466737180|FG000|Overall Study|Non-Compliance|1|||
129665752|NCT02581488|466737181|FG001|Overall Study|Non-Compliance|0|||
129665753|NCT02581488|466737180|FG000|Overall Study|Protocol Violation|0|||
129665754|NCT02581488|466737181|FG001|Overall Study|Protocol Violation|4|||
129665755|NCT01877668|466737182|FG000|Overall Study|Death|0|||
129992113|NCT04689828|467934195|FG000|Overall Study|Lost to Follow-up|1|||
129992114|NCT04689828|467934196|FG001|Overall Study|Lost to Follow-up|0|||
129992115|NCT04689828|467934195|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
129992116|NCT04689828|467934196|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
129992117|NCT04689828|467934195|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
129992118|NCT04689828|467934196|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
129665756|NCT01877668|466737183|FG001|Overall Study|Death|0|||
129665757|NCT01877668|466737184|FG002|Overall Study|Death|0|||
129665758|NCT01877668|466737185|FG003|Overall Study|Death|1|||
129665759|NCT01877668|466737186|FG004|Overall Study|Death|0|||
129665760|NCT01877668|466737182|FG000|Overall Study|No longer met study criteria|1|||
129665761|NCT01877668|466737183|FG001|Overall Study|No longer met study criteria|0|||
129665762|NCT01877668|466737184|FG002|Overall Study|No longer met study criteria|1|||
129665763|NCT01877668|466737185|FG003|Overall Study|No longer met study criteria|0|||
129665764|NCT01877668|466737186|FG004|Overall Study|No longer met study criteria|0|||
129992119|NCT04689828|467934195|FG000|Overall Study|Participants not treated|7|||
129992120|NCT04689828|467934196|FG001|Overall Study|Participants not treated|2|||
129992121|NCT05182125|467934199|FG000|Overall Study|Withdrawal by Subject|0|||
129992122|NCT05182125|467934200|FG001|Overall Study|Withdrawal by Subject|0|||
129665765|NCT01877668|466737182|FG000|Overall Study|Insufficient clinical response|0|||
129665766|NCT01877668|466737183|FG001|Overall Study|Insufficient clinical response|1|||
129665767|NCT01877668|466737184|FG002|Overall Study|Insufficient clinical response|2|||
129665768|NCT01877668|466737185|FG003|Overall Study|Insufficient clinical response|2|||
129665769|NCT01877668|466737186|FG004|Overall Study|Insufficient clinical response|0|||
129665770|NCT01877668|466737182|FG000|Overall Study|Lost to Follow-up|0|||
129665771|NCT01877668|466737183|FG001|Overall Study|Lost to Follow-up|2|||
129665772|NCT01877668|466737184|FG002|Overall Study|Lost to Follow-up|1|||
129665773|NCT01877668|466737185|FG003|Overall Study|Lost to Follow-up|0|||
129665774|NCT01877668|466737186|FG004|Overall Study|Lost to Follow-up|0|||
129665775|NCT01877668|466737182|FG000|Overall Study|Withdrawal by Subject|2|||
129665776|NCT01877668|466737183|FG001|Overall Study|Withdrawal by Subject|0|||
129665777|NCT01877668|466737184|FG002|Overall Study|Withdrawal by Subject|3|||
129665778|NCT01877668|466737185|FG003|Overall Study|Withdrawal by Subject|2|||
129665779|NCT01877668|466737186|FG004|Overall Study|Withdrawal by Subject|2|||
129665780|NCT01877668|466737182|FG000|Overall Study|Other|1|||
129665781|NCT01877668|466737183|FG001|Overall Study|Other|1|||
129665782|NCT01877668|466737184|FG002|Overall Study|Other|1|||
129665783|NCT01877668|466737185|FG003|Overall Study|Other|1|||
129665784|NCT01877668|466737186|FG004|Overall Study|Other|3|||
129665785|NCT01877668|466737182|FG000|Overall Study|Protocol Violation|1|||
129665786|NCT01877668|466737183|FG001|Overall Study|Protocol Violation|1|||
129665787|NCT01877668|466737184|FG002|Overall Study|Protocol Violation|0|||
129665788|NCT01877668|466737185|FG003|Overall Study|Protocol Violation|0|||
129992123|NCT05182125|467934201|FG002|Overall Study|Withdrawal by Subject|0|||
129992124|NCT05182125|467934202|FG003|Overall Study|Withdrawal by Subject|0|||
129992125|NCT05182125|467934203|FG004|Overall Study|Withdrawal by Subject|2|||
129665789|NCT01877668|466737186|FG004|Overall Study|Protocol Violation|3|||
129665790|NCT01877668|466737182|FG000|Overall Study|Adverse event related to study drug|2|||
129665791|NCT01877668|466737183|FG001|Overall Study|Adverse event related to study drug|2|||
129665792|NCT01877668|466737184|FG002|Overall Study|Adverse event related to study drug|2|||
129665793|NCT01877668|466737185|FG003|Overall Study|Adverse event related to study drug|2|||
129665794|NCT01877668|466737186|FG004|Overall Study|Adverse event related to study drug|1|||
129665795|NCT01877668|466737182|FG000|Overall Study|Adverse event unrelated to study drug|4|||
129665796|NCT01877668|466737183|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129665797|NCT01877668|466737184|FG002|Overall Study|Adverse event unrelated to study drug|2|||
129992126|NCT05182125|467934204|FG005|Overall Study|Withdrawal by Subject|0|||
129992127|NCT05182125|467934199|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992128|NCT05182125|467934200|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992129|NCT05182125|467934201|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992130|NCT05182125|467934202|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
129992131|NCT05182125|467934203|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992132|NCT05182125|467934204|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
129992133|NCT05182125|467934199|FG000|Overall Study|Death|0|||
129992134|NCT05182125|467934200|FG001|Overall Study|Death|0|||
129992135|NCT05182125|467934201|FG002|Overall Study|Death|0|||
129665798|NCT01877668|466737185|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129665799|NCT01877668|466737186|FG004|Overall Study|Adverse event unrelated to study drug|1|||
129665800|NCT03286218|466737216|FG000|Qualification Phase Period 1|Adverse Event|1|||
129992136|NCT05182125|467934202|FG003|Overall Study|Death|0|||
129665801|NCT03286218|466737217|FG001|Qualification Phase Period 1|Adverse Event|0|||
129665802|NCT03286218|466737218|FG002|Qualification Phase Period 1|Adverse Event|0|||
129665803|NCT03286218|466737219|FG003|Qualification Phase Period 1|Adverse Event|0|||
129665804|NCT03286218|466737220|FG004|Qualification Phase Period 1|Adverse Event|0|||
129665805|NCT03286218|466737221|FG005|Qualification Phase Period 1|Adverse Event|0|||
129992137|NCT05182125|467934203|FG004|Overall Study|Death|1|||
129992138|NCT05182125|467934204|FG005|Overall Study|Death|0|||
129992139|NCT04803214|467934205|FG000|Overall Study|Adverse Event|1|||
129992140|NCT04803214|467934206|FG001|Overall Study|Adverse Event|0|||
129665806|NCT03286218|466737222|FG006|Qualification Phase Period 1|Adverse Event|0|||
129665807|NCT03286218|466737223|FG007|Qualification Phase Period 1|Adverse Event|0|||
129665808|NCT03286218|466737224|FG008|Qualification Phase Period 1|Adverse Event|0|||
129665809|NCT03286218|466737225|FG009|Qualification Phase Period 1|Adverse Event|0|||
129665810|NCT03286218|466737226|FG010|Qualification Phase Period 1|Adverse Event|0|||
129665811|NCT03286218|466737227|FG011|Qualification Phase Period 1|Adverse Event|0|||
129665812|NCT03286218|466737216|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665813|NCT03286218|466737217|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
129665814|NCT03286218|466737218|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665815|NCT03286218|466737219|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665816|NCT03286218|466737220|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665817|NCT03286218|466737221|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665818|NCT03286218|466737222|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665819|NCT03286218|466737223|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665820|NCT03286218|466737224|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665821|NCT03286218|466737225|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665822|NCT03286218|466737226|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665823|NCT03286218|466737227|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
129665824|NCT03286218|466737216|FG000|Qualification Phase Period 2|Adverse Event|0|||
129665825|NCT03286218|466737217|FG001|Qualification Phase Period 2|Adverse Event|1|||
129665826|NCT03286218|466737218|FG002|Qualification Phase Period 2|Adverse Event|0|||
129665827|NCT03286218|466737219|FG003|Qualification Phase Period 2|Adverse Event|0|||
129665828|NCT03286218|466737220|FG004|Qualification Phase Period 2|Adverse Event|0|||
129665829|NCT03286218|466737221|FG005|Qualification Phase Period 2|Adverse Event|0|||
129665830|NCT03286218|466737222|FG006|Qualification Phase Period 2|Adverse Event|0|||
129665831|NCT03286218|466737223|FG007|Qualification Phase Period 2|Adverse Event|0|||
129665832|NCT03286218|466737224|FG008|Qualification Phase Period 2|Adverse Event|0|||
129665833|NCT03286218|466737225|FG009|Qualification Phase Period 2|Adverse Event|0|||
129665834|NCT03286218|466737226|FG010|Qualification Phase Period 2|Adverse Event|0|||
129665835|NCT03286218|466737227|FG011|Qualification Phase Period 2|Adverse Event|0|||
129665836|NCT03286218|466737216|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
129665837|NCT03286218|466737217|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
129665838|NCT03286218|466737218|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665839|NCT03286218|466737219|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665840|NCT03286218|466737220|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665841|NCT03286218|466737221|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665842|NCT03286218|466737222|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665843|NCT03286218|466737223|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665844|NCT03286218|466737224|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665845|NCT03286218|466737225|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665846|NCT03286218|466737226|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665847|NCT03286218|466737227|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
129665848|NCT03286218|466737216|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
129665849|NCT03286218|466737217|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
129665850|NCT03286218|466737218|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
129665851|NCT03286218|466737219|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
129665852|NCT03286218|466737220|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
129665853|NCT03286218|466737221|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
129665854|NCT03286218|466737222|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
129665855|NCT03286218|466737223|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
129665856|NCT03286218|466737224|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
129992141|NCT04803214|467934205|FG000|Overall Study|Withdrawal by Subject|1|||
129992142|NCT04803214|467934206|FG001|Overall Study|Withdrawal by Subject|2|||
129992143|NCT04803214|467934205|FG000|Overall Study|Lost to Follow-up|2|||
129992144|NCT04803214|467934206|FG001|Overall Study|Lost to Follow-up|4|||
129992145|NCT04803214|467934205|FG000|Overall Study|Physician Decision|1|||
129992146|NCT04803214|467934206|FG001|Overall Study|Physician Decision|1|||
129992147|NCT04803214|467934205|FG000|Overall Study|Missed 12 month visit|0|||
129992148|NCT04803214|467934206|FG001|Overall Study|Missed 12 month visit|3|||
129665857|NCT03286218|466737225|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
129992149|NCT03370276|467934207|FG000|Overall Study|Death|0|||
129992150|NCT03370276|467934208|FG001|Overall Study|Death|2|||
129992151|NCT03370276|467934209|FG002|Overall Study|Death|5|||
129992152|NCT03164564|467934215|FG000|Overall Study|Death|3|||
129992153|NCT03164564|467934216|FG001|Overall Study|Death|0|||
129665858|NCT03286218|466737226|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
129665859|NCT03286218|466737227|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
129665860|NCT03286218|466737216|FG000|Qualification Phase Period 2|Protocol Violation|2|||
129665861|NCT03286218|466737217|FG001|Qualification Phase Period 2|Protocol Violation|0|||
129665862|NCT03286218|466737218|FG002|Qualification Phase Period 2|Protocol Violation|0|||
129665863|NCT03286218|466737219|FG003|Qualification Phase Period 2|Protocol Violation|0|||
129665864|NCT03286218|466737220|FG004|Qualification Phase Period 2|Protocol Violation|0|||
129665865|NCT03286218|466737221|FG005|Qualification Phase Period 2|Protocol Violation|0|||
129665866|NCT03286218|466737222|FG006|Qualification Phase Period 2|Protocol Violation|0|||
129665867|NCT03286218|466737223|FG007|Qualification Phase Period 2|Protocol Violation|0|||
129665868|NCT03286218|466737224|FG008|Qualification Phase Period 2|Protocol Violation|0|||
129665869|NCT03286218|466737225|FG009|Qualification Phase Period 2|Protocol Violation|0|||
129665870|NCT03286218|466737226|FG010|Qualification Phase Period 2|Protocol Violation|0|||
129665871|NCT03286218|466737227|FG011|Qualification Phase Period 2|Protocol Violation|0|||
129665872|NCT03286218|466737216|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
129665873|NCT03286218|466737217|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
129665874|NCT03286218|466737218|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665875|NCT03286218|466737219|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665876|NCT03286218|466737220|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665877|NCT03286218|466737221|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665878|NCT03286218|466737222|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665879|NCT03286218|466737223|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665880|NCT03286218|466737224|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665881|NCT03286218|466737225|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665882|NCT03286218|466737226|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665883|NCT03286218|466737227|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
129665884|NCT03286218|466737216|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665885|NCT03286218|466737217|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665886|NCT03286218|466737218|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
129665887|NCT03286218|466737219|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
129665888|NCT03286218|466737220|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665889|NCT03286218|466737221|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
129665890|NCT03286218|466737222|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665891|NCT03286218|466737223|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665892|NCT03286218|466737224|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665893|NCT03286218|466737225|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665894|NCT03286218|466737226|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
129665895|NCT03286218|466737227|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
129665896|NCT03286218|466737216|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665897|NCT03286218|466737217|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665898|NCT03286218|466737218|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665899|NCT03286218|466737219|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665900|NCT03286218|466737220|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665901|NCT03286218|466737221|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665902|NCT03286218|466737222|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665903|NCT03286218|466737223|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665904|NCT03286218|466737224|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665905|NCT03286218|466737225|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665906|NCT03286218|466737226|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
129665907|NCT03286218|466737227|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
129665908|NCT02532374|466737230|FG000|Overall Study|Withdrawal by Subject|1|||
129665909|NCT02532374|466737230|FG000|Overall Study|Physician Decision|1|||
129665910|NCT01348139|466737231|FG000|Period 1|Adverse Event|1|||
129665911|NCT01348139|466737232|FG001|Period 1|Adverse Event|0|||
129665912|NCT01348139|466737233|FG002|Period 1|Adverse Event|0|||
129665913|NCT01348139|466737234|FG003|Period 1|Adverse Event|0|||
129665914|NCT01348139|466737235|FG004|Period 1|Adverse Event|0|||
129665915|NCT01348139|466737236|FG005|Period 1|Adverse Event|0|||
129665916|NCT02762084|466737237|FG000|Overall Study|Withdrawal by Subject|1|||
129665917|NCT02762084|466737238|FG001|Overall Study|Withdrawal by Subject|0|||
129665918|NCT02762084|466737239|FG002|Overall Study|Withdrawal by Subject|0|||
129665919|NCT02762084|466737237|FG000|Overall Study|Adverse Event|0|||
129665920|NCT02762084|466737238|FG001|Overall Study|Adverse Event|0|||
129665921|NCT02762084|466737239|FG002|Overall Study|Adverse Event|1|||
129665922|NCT01781962|466737242|FG000|Overall Study|Other Miscellaneous Reasons|5|||
129665923|NCT01765296|466737243|FG000|Overall Study|Protocol Violation|0|||
129665924|NCT01765296|466737244|FG001|Overall Study|Protocol Violation|5|||
129665925|NCT01765296|466737245|FG002|Overall Study|Protocol Violation|4|||
129665926|NCT01765296|466737243|FG000|Overall Study|Withdrawal by Subject|4|||
129665927|NCT01765296|466737244|FG001|Overall Study|Withdrawal by Subject|2|||
129665928|NCT01765296|466737245|FG002|Overall Study|Withdrawal by Subject|2|||
129665929|NCT01765296|466737243|FG000|Overall Study|Adverse Event|1|||
129665930|NCT01765296|466737244|FG001|Overall Study|Adverse Event|13|||
129665931|NCT01765296|466737245|FG002|Overall Study|Adverse Event|5|||
129665932|NCT01765296|466737243|FG000|Overall Study|Lack of Efficacy|0|||
129665933|NCT01765296|466737244|FG001|Overall Study|Lack of Efficacy|0|||
129665934|NCT01765296|466737245|FG002|Overall Study|Lack of Efficacy|2|||
129665935|NCT01619852|466737246|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
129665936|NCT01619852|466737247|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
129665937|NCT01619852|466737246|FG000|3 Month Follow up|Lost to Follow-up|31|||
129665938|NCT01619852|466737247|FG001|3 Month Follow up|Lost to Follow-up|34|||
129665939|NCT03933449|466737248|FG000|Overall Study|Adverse Event|6|||
129665940|NCT03933449|466737249|FG001|Overall Study|Adverse Event|4|||
129665941|NCT03933449|466737248|FG000|Overall Study|Death|55|||
129665942|NCT03933449|466737249|FG001|Overall Study|Death|57|||
129665943|NCT03933449|466737248|FG000|Overall Study|Sponsor Decision|1|||
129665944|NCT03933449|466737249|FG001|Overall Study|Sponsor Decision|0|||
129665945|NCT02659943|466737250|FG000|Overall Study|Switched to alternative treatment|1|||
129665946|NCT02659943|466737251|FG001|Overall Study|Switched to alternative treatment|1|||
129665947|NCT02659943|466737252|FG002|Overall Study|Switched to alternative treatment|0|||
129665948|NCT02659943|466737253|FG003|Overall Study|Switched to alternative treatment|2|||
129992154|NCT03164564|467934215|FG000|Overall Study|Withdrawal by Subject|20|||
129992155|NCT03164564|467934216|FG001|Overall Study|Withdrawal by Subject|15|||
129992156|NCT03164564|467934215|FG000|Overall Study|Lost to Follow-up|2|||
129992157|NCT03164564|467934216|FG001|Overall Study|Lost to Follow-up|0|||
129992158|NCT03164564|467934215|FG000|Overall Study|Physician Decision|0|||
129992159|NCT03164564|467934216|FG001|Overall Study|Physician Decision|1|||
129665949|NCT02659943|466737254|FG004|Overall Study|Switched to alternative treatment|1|||
129665950|NCT02659943|466737255|FG005|Overall Study|Switched to alternative treatment|0|||
129665951|NCT02659943|466737256|FG006|Overall Study|Switched to alternative treatment|1|||
129665952|NCT02659943|466737250|FG000|Overall Study|Disease progression on study|0|||
129992160|NCT03164564|467934215|FG000|Overall Study|Adverse Event|0|||
129992161|NCT03164564|467934216|FG001|Overall Study|Adverse Event|1|||
129992162|NCT03164564|467934215|FG000|Overall Study|Ongoing|1586|||
129665953|NCT02659943|466737251|FG001|Overall Study|Disease progression on study|1|||
129665954|NCT02659943|466737252|FG002|Overall Study|Disease progression on study|1|||
129665955|NCT02659943|466737253|FG003|Overall Study|Disease progression on study|1|||
129992163|NCT03164564|467934216|FG001|Overall Study|Ongoing|1586|||
129992164|NCT03464097|467934217|FG000|Overall Study|Withdrawal by Subject|15|||
129992165|NCT03464097|467934218|FG001|Overall Study|Withdrawal by Subject|13|||
129992166|NCT03464097|467934219|FG002|Overall Study|Withdrawal by Subject|11|||
129992167|NCT03464097|467934217|FG000|Overall Study|Study terminated by sponsor|47|||
129992168|NCT03464097|467934218|FG001|Overall Study|Study terminated by sponsor|44|||
129992169|NCT03464097|467934219|FG002|Overall Study|Study terminated by sponsor|40|||
129992170|NCT03464097|467934217|FG000|Overall Study|Pregnancy|0|||
129665956|NCT02659943|466737254|FG004|Overall Study|Disease progression on study|1|||
129665957|NCT02659943|466737255|FG005|Overall Study|Disease progression on study|4|||
129665958|NCT02659943|466737256|FG006|Overall Study|Disease progression on study|0|||
129665959|NCT02659943|466737250|FG000|Overall Study|Patient's condition per principal investigator|0|||
129665960|NCT02659943|466737251|FG001|Overall Study|Patient's condition per principal investigator|0|||
129665961|NCT02659943|466737252|FG002|Overall Study|Patient's condition per principal investigator|0|||
129665962|NCT02659943|466737253|FG003|Overall Study|Patient's condition per principal investigator|0|||
129665963|NCT02659943|466737254|FG004|Overall Study|Patient's condition per principal investigator|0|||
129665964|NCT02659943|466737255|FG005|Overall Study|Patient's condition per principal investigator|1|||
129665965|NCT02659943|466737256|FG006|Overall Study|Patient's condition per principal investigator|0|||
129665966|NCT02659943|466737250|FG000|Overall Study|Ineligible|0|||
129665967|NCT02659943|466737251|FG001|Overall Study|Ineligible|0|||
129665968|NCT02659943|466737252|FG002|Overall Study|Ineligible|0|||
129665969|NCT02659943|466737253|FG003|Overall Study|Ineligible|0|||
129665970|NCT02659943|466737254|FG004|Overall Study|Ineligible|0|||
129665971|NCT02659943|466737255|FG005|Overall Study|Ineligible|0|||
129665972|NCT02659943|466737256|FG006|Overall Study|Ineligible|1|||
129665973|NCT02659943|466737250|FG000|Overall Study|No longer meets eligibility|0|||
129665974|NCT02659943|466737251|FG001|Overall Study|No longer meets eligibility|0|||
129665975|NCT02659943|466737252|FG002|Overall Study|No longer meets eligibility|0|||
129665976|NCT02659943|466737253|FG003|Overall Study|No longer meets eligibility|0|||
129665977|NCT02659943|466737254|FG004|Overall Study|No longer meets eligibility|0|||
129992171|NCT03464097|467934218|FG001|Overall Study|Pregnancy|1|||
129665978|NCT02659943|466737255|FG005|Overall Study|No longer meets eligibility|0|||
129665979|NCT02659943|466737256|FG006|Overall Study|No longer meets eligibility|1|||
129665980|NCT02659943|466737250|FG000|Overall Study|No treatment, per protocol|0|||
129665981|NCT02659943|466737251|FG001|Overall Study|No treatment, per protocol|0|||
129665982|NCT02659943|466737252|FG002|Overall Study|No treatment, per protocol|0|||
129665983|NCT02659943|466737253|FG003|Overall Study|No treatment, per protocol|0|||
129665984|NCT02659943|466737254|FG004|Overall Study|No treatment, per protocol|0|||
129665985|NCT02659943|466737255|FG005|Overall Study|No treatment, per protocol|0|||
129992172|NCT03464097|467934219|FG002|Overall Study|Pregnancy|0|||
129992173|NCT03464097|467934217|FG000|Overall Study|Other reasons|5|||
129992174|NCT03464097|467934218|FG001|Overall Study|Other reasons|12|||
129992175|NCT03464097|467934219|FG002|Overall Study|Other reasons|14|||
129992176|NCT03464097|467934217|FG000|Overall Study|Lost to Follow-up|0|||
129992177|NCT03464097|467934218|FG001|Overall Study|Lost to Follow-up|1|||
129992178|NCT03464097|467934219|FG002|Overall Study|Lost to Follow-up|1|||
129992179|NCT03464097|467934217|FG000|Overall Study|Lack of Efficacy|11|||
129665986|NCT02659943|466737256|FG006|Overall Study|No treatment, per protocol|3|||
129665987|NCT01576575|466737257|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
129992180|NCT03464097|467934218|FG001|Overall Study|Lack of Efficacy|18|||
129992181|NCT03464097|467934219|FG002|Overall Study|Lack of Efficacy|30|||
129665988|NCT01576575|466737257|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
129665989|NCT01576575|466737257|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
129665990|NCT01723072|466737258|FG000|Overall Study|Withdrawal by Subject|7|||
129665991|NCT01723072|466737259|FG001|Overall Study|Withdrawal by Subject|13|||
129665992|NCT01723072|466737258|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
129665993|NCT01723072|466737259|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
129665994|NCT01723072|466737258|FG000|Overall Study|Other|4|||
129665995|NCT01723072|466737259|FG001|Overall Study|Other|3|||
129665996|NCT03428100|466737260|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
129665997|NCT03428100|466737261|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129665998|NCT03428100|466737262|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
129665999|NCT03428100|466737263|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
129666000|NCT03428100|466737264|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666001|NCT03428100|466737265|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666002|NCT03428100|466737266|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666003|NCT03428100|466737267|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666004|NCT03428100|466737268|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666005|NCT03428100|466737269|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666006|NCT03428100|466737270|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666007|NCT03428100|466737271|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666008|NCT03428100|466737272|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666009|NCT03428100|466737273|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666010|NCT03428100|466737274|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666011|NCT03428100|466737275|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666012|NCT03428100|466737276|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666013|NCT03428100|466737277|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666014|NCT03428100|466737278|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
129666015|NCT03428100|466737260|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
129666016|NCT03428100|466737261|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
129666017|NCT03428100|466737262|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
129666018|NCT03428100|466737263|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
129666019|NCT03428100|466737264|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666020|NCT03428100|466737265|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666021|NCT03428100|466737266|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666022|NCT03428100|466737267|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666023|NCT03428100|466737268|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666024|NCT03428100|466737269|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666025|NCT03428100|466737270|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666026|NCT03428100|466737271|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666027|NCT03428100|466737272|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666028|NCT03428100|466737273|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666029|NCT03428100|466737274|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666030|NCT03428100|466737275|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666031|NCT03428100|466737276|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666032|NCT03428100|466737277|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666033|NCT03428100|466737278|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
129666034|NCT03428100|466737260|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666035|NCT03428100|466737261|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
129666036|NCT03428100|466737262|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
129666037|NCT03428100|466737263|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666038|NCT03428100|466737264|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666039|NCT03428100|466737265|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666040|NCT03428100|466737266|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666041|NCT03428100|466737267|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666042|NCT03428100|466737268|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666043|NCT03428100|466737269|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129992182|NCT03464097|467934217|FG000|Overall Study|Death|1|||
129992183|NCT03464097|467934218|FG001|Overall Study|Death|0|||
129666044|NCT03428100|466737270|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666045|NCT03428100|466737271|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666046|NCT03428100|466737272|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666047|NCT03428100|466737273|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666048|NCT03428100|466737274|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666049|NCT03428100|466737275|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666050|NCT03428100|466737276|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666051|NCT03428100|466737277|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666052|NCT03428100|466737278|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
129666053|NCT03428100|466737260|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
129666054|NCT03428100|466737261|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666055|NCT03428100|466737262|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666056|NCT03428100|466737263|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129992184|NCT03464097|467934219|FG002|Overall Study|Death|0|||
129666057|NCT03428100|466737264|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666058|NCT03428100|466737265|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129992185|NCT03464097|467934217|FG000|Overall Study|Adverse Event|13|||
129666059|NCT03428100|466737266|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666060|NCT03428100|466737267|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666061|NCT03428100|466737268|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666062|NCT03428100|466737269|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666063|NCT03428100|466737270|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666064|NCT03428100|466737271|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666065|NCT03428100|466737272|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666066|NCT03428100|466737273|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666067|NCT03428100|466737274|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666068|NCT03428100|466737275|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666069|NCT03428100|466737276|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666070|NCT03428100|466737277|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129992186|NCT03464097|467934218|FG001|Overall Study|Adverse Event|6|||
129992187|NCT03464097|467934219|FG002|Overall Study|Adverse Event|8|||
129666071|NCT03428100|466737278|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
129666072|NCT03428100|466737260|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666073|NCT03428100|466737261|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
129666074|NCT03428100|466737262|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666075|NCT03428100|466737263|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666076|NCT03428100|466737264|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666077|NCT03428100|466737265|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666078|NCT03428100|466737266|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666079|NCT03428100|466737267|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129992188|NCT04675151|467934220|FG000|Overall Study|Protocol Violation|1|||
129992189|NCT04675151|467934221|FG001|Overall Study|Protocol Violation|0|||
129992190|NCT04675151|467934222|FG002|Overall Study|Protocol Violation|0|||
129992191|NCT04675151|467934223|FG003|Overall Study|Protocol Violation|1|||
129992192|NCT04035486|467934224|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
129992193|NCT04035486|467934225|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
129992194|NCT04035486|467934226|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
129992195|NCT04035486|467934227|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
129992196|NCT04035486|467934224|FG000|Overall Study|Death|6|||
129992197|NCT04035486|467934225|FG001|Overall Study|Death|3|||
129992198|NCT04035486|467934226|FG002|Overall Study|Death|70|||
129992199|NCT04035486|467934227|FG003|Overall Study|Death|77|||
129666080|NCT03428100|466737268|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666081|NCT03428100|466737269|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666082|NCT03428100|466737270|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666083|NCT03428100|466737271|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666084|NCT03428100|466737272|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666085|NCT03428100|466737273|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666086|NCT03428100|466737274|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666087|NCT03428100|466737275|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129992200|NCT04035486|467934224|FG000|Overall Study|Screen Failure|0|||
129666088|NCT03428100|466737276|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129992201|NCT04035486|467934225|FG001|Overall Study|Screen Failure|0|||
129992202|NCT04035486|467934226|FG002|Overall Study|Screen Failure|1|||
129992203|NCT04035486|467934227|FG003|Overall Study|Screen Failure|1|||
129992204|NCT04035486|467934224|FG000|Overall Study|Withdrawal by Subject|1|||
129666089|NCT03428100|466737277|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129992205|NCT04035486|467934225|FG001|Overall Study|Withdrawal by Subject|1|||
129992206|NCT04035486|467934226|FG002|Overall Study|Withdrawal by Subject|11|||
129992207|NCT04035486|467934227|FG003|Overall Study|Withdrawal by Subject|9|||
129992208|NCT01730937|467934228|FG000|Overall Study|Protocol Violation|5|||
129992209|NCT01730937|467934229|FG001|Overall Study|Protocol Violation|11|||
129992210|NCT05445843|467934230|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
129992211|NCT05445843|467934231|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
129992212|NCT05445843|467934230|FG000|Overall Study|Progressive disease|17|||
129992213|NCT05445843|467934231|FG001|Overall Study|Progressive disease|9|||
129992214|NCT05445843|467934230|FG000|Overall Study|Physician Decision|16|||
129992215|NCT05445843|467934231|FG001|Overall Study|Physician Decision|4|||
129992216|NCT05445843|467934230|FG000|Overall Study|Death|6|||
129992217|NCT05445843|467934231|FG001|Overall Study|Death|3|||
129992218|NCT05445843|467934230|FG000|Overall Study|Subject decision|6|||
129992219|NCT05445843|467934231|FG001|Overall Study|Subject decision|2|||
129992220|NCT05445843|467934230|FG000|Overall Study|Adverse Event|2|||
129992221|NCT05445843|467934231|FG001|Overall Study|Adverse Event|0|||
129992222|NCT04469270|467934232|FG000|Overall Study|Adverse Event|2|||
129992223|NCT04469270|467934233|FG001|Overall Study|Adverse Event|0|||
129666090|NCT03428100|466737278|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
129666091|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129992224|NCT04469270|467934232|FG000|Overall Study|Lost to Follow-up|4|||
129992225|NCT04469270|467934233|FG001|Overall Study|Lost to Follow-up|3|||
129992226|NCT04469270|467934232|FG000|Overall Study|Withdrawal by Subject|7|||
129992227|NCT04469270|467934233|FG001|Overall Study|Withdrawal by Subject|3|||
129992228|NCT04469270|467934232|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
129992229|NCT04469270|467934233|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
129992230|NCT04469270|467934232|FG000|Overall Study|missing|1|||
129992231|NCT04469270|467934233|FG001|Overall Study|missing|0|||
129992232|NCT03947684|467934236|FG000|Overall Study|Lost to Follow-up|13|||
129992233|NCT03947684|467934237|FG001|Overall Study|Lost to Follow-up|5|||
129992234|NCT03947684|467934238|FG002|Overall Study|Lost to Follow-up|1|||
129992235|NCT03947684|467934236|FG000|Overall Study|Withdrawal by Subject|11|||
129992236|NCT03947684|467934237|FG001|Overall Study|Withdrawal by Subject|4|||
129992237|NCT03947684|467934238|FG002|Overall Study|Withdrawal by Subject|0|||
129992238|NCT03947684|467934236|FG000|Overall Study|Physician Decision|1|||
129992239|NCT03947684|467934237|FG001|Overall Study|Physician Decision|0|||
129992240|NCT03947684|467934238|FG002|Overall Study|Physician Decision|0|||
129992241|NCT03947684|467934236|FG000|Overall Study|Lack of adherence to study protocol|2|||
129992242|NCT03947684|467934237|FG001|Overall Study|Lack of adherence to study protocol|0|||
129992243|NCT03947684|467934238|FG002|Overall Study|Lack of adherence to study protocol|0|||
129992244|NCT04576455|467934239|FG000|Overall Study|Ongoing in the Study|48|||
129992245|NCT04576455|467934240|FG001|Overall Study|Ongoing in the Study|58|||
129992246|NCT04576455|467934239|FG000|Overall Study|Death|83|||
129992247|NCT04576455|467934240|FG001|Overall Study|Death|77|||
129992248|NCT04576455|467934239|FG000|Overall Study|Lost to Follow-up|4|||
129992249|NCT04576455|467934240|FG001|Overall Study|Lost to Follow-up|5|||
129992250|NCT04576455|467934239|FG000|Overall Study|Withdrawal by Subject|16|||
129992251|NCT04576455|467934240|FG001|Overall Study|Withdrawal by Subject|12|||
129992252|NCT02186847|467934241|FG000|Overall Study|Protocol Violation|3|||
129992253|NCT02186847|467934242|FG001|Overall Study|Protocol Violation|0|||
129992254|NCT03875235|467934243|FG000|Overall Study|Ongoing study treatment|63|||
129666092|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666093|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666094|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666095|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666096|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
129992255|NCT03875235|467934244|FG001|Overall Study|Ongoing study treatment|20|||
129992256|NCT03875235|467934243|FG000|Overall Study|Off treatment|77|||
129992257|NCT03875235|467934244|FG001|Overall Study|Off treatment|91|||
129992258|NCT03875235|467934243|FG000|Overall Study|Withdrawal by Subject|3|||
129992259|NCT03875235|467934244|FG001|Overall Study|Withdrawal by Subject|10|||
129992260|NCT03875235|467934243|FG000|Overall Study|Death|198|||
129992261|NCT03875235|467934244|FG001|Overall Study|Death|223|||
129992262|NCT02254278|467934245|FG000|Overall Study|Protocol Violation|1|||
129992263|NCT02254278|467934246|FG001|Overall Study|Protocol Violation|1|||
129992264|NCT05774197|467934247|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
129992265|NCT04526665|467934249|FG000|Overall Study|Withdrawal by Subject|6|||
129666097|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129992266|NCT04526665|467934250|FG001|Overall Study|Withdrawal by Subject|3|||
129992267|NCT04526665|467934249|FG000|Overall Study|Adverse Event|4|||
129992268|NCT04526665|467934250|FG001|Overall Study|Adverse Event|1|||
129992269|NCT04526665|467934249|FG000|Overall Study|Physician Decision|2|||
129992270|NCT04526665|467934250|FG001|Overall Study|Physician Decision|2|||
129666098|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
129666099|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129666100|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666101|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129666102|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666103|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
129666104|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129666105|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129666106|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
129666107|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
129666108|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129666109|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
129992271|NCT04526665|467934249|FG000|Overall Study|Death|2|||
129992272|NCT04526665|467934250|FG001|Overall Study|Death|0|||
129992273|NCT04526665|467934249|FG000|Overall Study|Other|0|||
129992274|NCT04526665|467934250|FG001|Overall Study|Other|1|||
129992275|NCT03587727|467934253|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
129992276|NCT03587727|467934253|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
129992277|NCT04647253|467934254|FG000|Overall Study|Death ≤ 365 Days|16|||
129992278|NCT04647253|467934255|FG001|Overall Study|Death ≤ 365 Days|7|||
129992279|NCT04647253|467934254|FG000|Overall Study|Physician Decision|0|||
129992280|NCT04647253|467934255|FG001|Overall Study|Physician Decision|1|||
129992281|NCT04647253|467934254|FG000|Overall Study|Withdrawal by Subject|7|||
129992282|NCT04647253|467934255|FG001|Overall Study|Withdrawal by Subject|2|||
129992283|NCT04647253|467934254|FG000|Overall Study|Missed 12-Month Visit|9|||
129992284|NCT04647253|467934255|FG001|Overall Study|Missed 12-Month Visit|7|||
129992285|NCT04647253|467934254|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
129992286|NCT04647253|467934255|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
129992287|NCT06729606|467934260|FG000|Overall Study|Adverse Event|0|||
129992288|NCT06729606|467934261|FG001|Overall Study|Adverse Event|2|||
129992289|NCT06729606|467934260|FG000|Overall Study|Death|1|||
129992290|NCT06729606|467934261|FG001|Overall Study|Death|0|||
129992291|NCT06729606|467934260|FG000|Overall Study|Physician Decision|0|||
129992292|NCT06729606|467934261|FG001|Overall Study|Physician Decision|1|||
129992293|NCT06729606|467934260|FG000|Overall Study|Withdrawal by Subject|2|||
129992294|NCT06729606|467934261|FG001|Overall Study|Withdrawal by Subject|4|||
129992295|NCT04102189|467934262|FG000|Overall Study|Withdrawal by Subject|1|||
129992296|NCT04102189|467934263|FG001|Overall Study|Withdrawal by Subject|2|||
129992297|NCT04102189|467934262|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129992298|NCT04102189|467934263|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129992299|NCT04102189|467934262|FG000|Overall Study|Lost to Follow-up|1|||
129992300|NCT04102189|467934263|FG001|Overall Study|Lost to Follow-up|0|||
129992301|NCT04873232|467934264|FG000|Overall Study|Lost to Follow-up|1|||
129992302|NCT04873232|467934265|FG001|Overall Study|Lost to Follow-up|4|||
129992303|NCT04873232|467934264|FG000|Overall Study|Withdrawal by Subject|1|||
129992304|NCT04873232|467934265|FG001|Overall Study|Withdrawal by Subject|0|||
129992305|NCT05437510|467934266|FG000|Overall Study|Adverse Event|2|||
129992306|NCT05437510|467934267|FG001|Overall Study|Adverse Event|1|||
129992307|NCT05437510|467934266|FG000|Overall Study|Protocol Deviation|1|||
129992308|NCT05437510|467934267|FG001|Overall Study|Protocol Deviation|6|||
129992309|NCT05437510|467934266|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
129992310|NCT05437510|467934267|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
129992311|NCT05437510|467934266|FG000|Overall Study|Lost to Follow-up|265|||
129992312|NCT05437510|467934267|FG001|Overall Study|Lost to Follow-up|358|||
129992313|NCT05959629|467934709|FG000|Overall Study|partially necrotic/technical issues|2|||
129992314|NCT05959629|467934710|FG001|Overall Study|partially necrotic/technical issues|2|||
129992315|NCT03573401|467934711|FG000|Overall Study|Withdrawal by Subject|2|||
129992316|NCT03573401|467934712|FG001|Overall Study|Withdrawal by Subject|0|||
129992317|NCT03573401|467934711|FG000|Overall Study|Subject non-compliance with study schedule|1|||
129992318|NCT03573401|467934712|FG001|Overall Study|Subject non-compliance with study schedule|0|||
129992319|NCT03573401|467934711|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
129992320|NCT03573401|467934712|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
129992321|NCT03573401|467934711|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
129992322|NCT03573401|467934712|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
129992323|NCT03576274|467934714|FG000|Overall Study|Lost to Follow-up|3|||
129992324|NCT03576274|467934715|FG001|Overall Study|Lost to Follow-up|2|||
129992325|NCT03576274|467934716|FG002|Overall Study|Lost to Follow-up|3|||
129992326|NCT03576274|467934717|FG003|Overall Study|Lost to Follow-up|1|||
129992327|NCT03576274|467934718|FG004|Overall Study|Lost to Follow-up|3|||
129992328|NCT03576274|467934714|FG000|Overall Study|Withdrawal by Subject|5|||
129992329|NCT03576274|467934715|FG001|Overall Study|Withdrawal by Subject|3|||
129666110|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
129992330|NCT03576274|467934716|FG002|Overall Study|Withdrawal by Subject|2|||
129992331|NCT03576274|467934717|FG003|Overall Study|Withdrawal by Subject|8|||
129992332|NCT03576274|467934718|FG004|Overall Study|Withdrawal by Subject|6|||
129992333|NCT03976323|467934719|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
129992334|NCT03976323|467934720|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129992335|NCT03976323|467934721|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129992336|NCT03976323|467934719|FG000|Induction Phase|Death|80|||
129992337|NCT03976323|467934720|FG001|Induction Phase|Death|0|||
129992338|NCT03976323|467934721|FG002|Induction Phase|Death|0|||
129992339|NCT03976323|467934719|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
129992340|NCT03976323|467934720|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
129992341|NCT03976323|467934721|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
129992342|NCT03976323|467934719|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129992343|NCT03976323|467934720|FG001|Maintenance Phase|Withdrawal by Subject|9|||
129992344|NCT03976323|467934721|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129992345|NCT03976323|467934719|FG000|Maintenance Phase|Physician Decision|0|||
129992346|NCT03976323|467934720|FG001|Maintenance Phase|Physician Decision|0|||
129992347|NCT03976323|467934721|FG002|Maintenance Phase|Physician Decision|1|||
129992348|NCT03976323|467934719|FG000|Maintenance Phase|Death|0|||
129992349|NCT03976323|467934720|FG001|Maintenance Phase|Death|228|||
129992350|NCT03976323|467934721|FG002|Maintenance Phase|Death|234|||
129666111|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
129666112|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
129666113|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
129666114|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
129666115|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
129666116|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
129666117|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
129666118|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
129666119|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
129666120|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
129666121|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
129666122|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
129666123|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
129666124|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
129666125|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
129666126|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
129666127|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
129666128|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
129666129|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129666130|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129666131|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129666132|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129666133|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
129666134|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
129666135|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
129666136|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129666137|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129666138|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129666139|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129666140|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
129666141|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
129666142|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
129666143|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
129666144|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
129666145|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129666146|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
129666147|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
129666148|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666149|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666150|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666151|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666152|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666153|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666154|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666155|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
129666156|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666157|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666158|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666159|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
129666160|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
129666161|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666162|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
129666163|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666164|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666165|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
129666166|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
129666167|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
129666168|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
129666169|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
129666170|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
129666171|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
129666172|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
129666173|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
129666174|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
129666175|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
129666176|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
129666177|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
129666178|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
129666179|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
129666180|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
129666181|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
129666182|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
129666183|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
129666184|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
129666185|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
129666186|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666187|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666188|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666189|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666190|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666191|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666192|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
129666193|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666194|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666195|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666196|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666197|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666198|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666199|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666200|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666201|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129546824|NCT05257109|466294137|FG000|Overall Study|Withdrawal by Subject|1|||
129546825|NCT05257109|466294138|FG001|Overall Study|Withdrawal by Subject|0|||
129546826|NCT05257109|466294139|FG002|Overall Study|Withdrawal by Subject|0|||
129546827|NCT05257109|466294140|FG003|Overall Study|Withdrawal by Subject|0|||
129546828|NCT00359073|466296016|FG000|Overall Study|Withdrawal by Subject|1|||
129666202|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666203|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
129666204|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
129546829|NCT00359073|466296017|FG001|Overall Study|Withdrawal by Subject|1|||
129546830|NCT00359073|466296016|FG000|Overall Study|Eligibility criteria no longer met|3|||
129546831|NCT00359073|466296017|FG001|Overall Study|Eligibility criteria no longer met|0|||
129546832|NCT00359073|466296016|FG000|Overall Study|developed RV16 antibody|0|||
129546833|NCT00359073|466296017|FG001|Overall Study|developed RV16 antibody|1|||
129546834|NCT03387423|466296018|FG000|Overall Study|Lost to Follow-up|16|||
129546835|NCT03387423|466296019|FG001|Overall Study|Lost to Follow-up|12|||
129546836|NCT03387423|466296020|FG002|Overall Study|Lost to Follow-up|1|||
129546837|NCT03387423|466296021|FG003|Overall Study|Lost to Follow-up|0|||
129546838|NCT03387423|466296018|FG000|Overall Study|Other|0|||
129546839|NCT03387423|466296019|FG001|Overall Study|Other|3|||
129546840|NCT03387423|466296020|FG002|Overall Study|Other|0|||
129546841|NCT03387423|466296021|FG003|Overall Study|Other|0|||
129546842|NCT03387423|466296018|FG000|Overall Study|Administrative Reason|166|||
129546843|NCT03387423|466296019|FG001|Overall Study|Administrative Reason|89|||
129546844|NCT03387423|466296020|FG002|Overall Study|Administrative Reason|17|||
129546845|NCT03387423|466296021|FG003|Overall Study|Administrative Reason|19|||
129546846|NCT03387423|466296018|FG000|Overall Study|Revocation Consent|76|||
129546847|NCT03387423|466296019|FG001|Overall Study|Revocation Consent|32|||
129666205|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129666206|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129666207|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129666208|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
129666209|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
129666210|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
129666211|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
129666212|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
129666213|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
129666214|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
129666215|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
129666216|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
129666217|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
129666218|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
129666219|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
129666220|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
129666221|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
129666222|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
129666223|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
129666224|NCT03428100|466737260|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666225|NCT03428100|466737261|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666226|NCT03428100|466737262|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666227|NCT03428100|466737263|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666228|NCT03428100|466737264|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129666229|NCT03428100|466737265|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666230|NCT03428100|466737266|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
129666231|NCT03428100|466737267|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129666232|NCT03428100|466737268|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666233|NCT03428100|466737269|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
129666234|NCT03428100|466737270|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
129666235|NCT03428100|466737271|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
129666236|NCT03428100|466737272|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129666237|NCT03428100|466737273|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
129546848|NCT03387423|466296020|FG002|Overall Study|Revocation Consent|3|||
129546849|NCT03387423|466296021|FG003|Overall Study|Revocation Consent|5|||
129546850|NCT01371006|466296022|FG000|Overall Study|Adverse Event|1|||
129666238|NCT03428100|466737274|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
129666239|NCT03428100|466737275|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666240|NCT03428100|466737276|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
129666241|NCT03428100|466737277|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
129666242|NCT03428100|466737278|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
129666243|NCT04556760|466737279|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129666244|NCT04556760|466737280|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
129666245|NCT04556760|466737281|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129666246|NCT04556760|466737282|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129666247|NCT04556760|466737283|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129666248|NCT04556760|466737284|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
129666249|NCT04556760|466737279|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129666250|NCT04556760|466737280|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129666251|NCT04556760|466737281|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129666252|NCT04556760|466737282|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
129666253|NCT04556760|466737283|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129666254|NCT04556760|466737284|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
129666255|NCT02168491|466737286|FG000|Overall Study|Withdrawal by Subject|1|||
129666256|NCT01610037|466737288|FG000|All Patients|Adverse Event|27|||
129666257|NCT01610037|466737289|FG001|All Patients|Adverse Event|22|||
129546851|NCT01371006|466296023|FG001|Overall Study|Adverse Event|0|||
129546852|NCT00915473|466296024|FG000|Screening|Withdrawal by Subject|1|||
129666258|NCT01610037|466737290|FG002|All Patients|Adverse Event|26|||
129666259|NCT01610037|466737288|FG000|All Patients|Withdrawal by Subject|12|||
129666260|NCT01610037|466737289|FG001|All Patients|Withdrawal by Subject|10|||
129666261|NCT01610037|466737290|FG002|All Patients|Withdrawal by Subject|20|||
129666262|NCT01610037|466737288|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
129666263|NCT01610037|466737289|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
129666264|NCT01610037|466737290|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
129666265|NCT01610037|466737288|FG000|All Patients|Death|4|||
129666266|NCT01610037|466737289|FG001|All Patients|Death|2|||
129666267|NCT01610037|466737290|FG002|All Patients|Death|1|||
129666268|NCT01610037|466737288|FG000|All Patients|Protocol deviation|4|||
129666269|NCT01610037|466737289|FG001|All Patients|Protocol deviation|3|||
129666270|NCT01610037|466737290|FG002|All Patients|Protocol deviation|3|||
129666271|NCT01610037|466737288|FG000|All Patients|Abnormal laboratory value|1|||
129666272|NCT01610037|466737289|FG001|All Patients|Abnormal laboratory value|1|||
129666273|NCT01610037|466737290|FG002|All Patients|Abnormal laboratory value|0|||
129666274|NCT01610037|466737288|FG000|All Patients|Administrative problems|1|||
129666275|NCT01610037|466737289|FG001|All Patients|Administrative problems|4|||
129666276|NCT01610037|466737290|FG002|All Patients|Administrative problems|4|||
129666277|NCT01610037|466737288|FG000|All Patients|Lost to Follow-up|1|||
129666278|NCT01610037|466737289|FG001|All Patients|Lost to Follow-up|0|||
129666279|NCT01610037|466737290|FG002|All Patients|Lost to Follow-up|0|||
129883876|NCT02733042|467534456|FG015|Overall Study|Progressive Disease|7|||
129883877|NCT02733042|467534457|FG016|Overall Study|Progressive Disease|2|||
129883878|NCT02733042|467534458|FG017|Overall Study|Progressive Disease|3|||
129883879|NCT02733042|467534459|FG018|Overall Study|Progressive Disease|4|||
129883880|NCT02733042|467534441|FG000|Overall Study|Withdrawal by Subject|0|||
129883881|NCT02733042|467534442|FG001|Overall Study|Withdrawal by Subject|1|||
129883882|NCT02733042|467534443|FG002|Overall Study|Withdrawal by Subject|2|||
129883883|NCT02733042|467534444|FG003|Overall Study|Withdrawal by Subject|1|||
129883884|NCT02733042|467534445|FG004|Overall Study|Withdrawal by Subject|1|||
129883885|NCT02733042|467534446|FG005|Overall Study|Withdrawal by Subject|0|||
129883886|NCT02733042|467534447|FG006|Overall Study|Withdrawal by Subject|0|||
129883887|NCT02733042|467534448|FG007|Overall Study|Withdrawal by Subject|0|||
129883888|NCT02733042|467534449|FG008|Overall Study|Withdrawal by Subject|1|||
129883889|NCT02733042|467534450|FG009|Overall Study|Withdrawal by Subject|1|||
129883890|NCT02733042|467534451|FG010|Overall Study|Withdrawal by Subject|0|||
129883891|NCT02733042|467534452|FG011|Overall Study|Withdrawal by Subject|2|||
129883892|NCT02733042|467534453|FG012|Overall Study|Withdrawal by Subject|1|||
129883893|NCT02733042|467534454|FG013|Overall Study|Withdrawal by Subject|1|||
129883894|NCT02733042|467534455|FG014|Overall Study|Withdrawal by Subject|0|||
129883895|NCT02733042|467534456|FG015|Overall Study|Withdrawal by Subject|0|||
129883896|NCT02733042|467534457|FG016|Overall Study|Withdrawal by Subject|0|||
129883897|NCT02733042|467534458|FG017|Overall Study|Withdrawal by Subject|0|||
129883898|NCT02733042|467534459|FG018|Overall Study|Withdrawal by Subject|0|||
129883899|NCT02733042|467534441|FG000|Overall Study|Other Reasons|0|||
129883900|NCT02733042|467534442|FG001|Overall Study|Other Reasons|0|||
129883901|NCT02733042|467534443|FG002|Overall Study|Other Reasons|1|||
129883902|NCT02733042|467534444|FG003|Overall Study|Other Reasons|0|||
129883903|NCT02733042|467534445|FG004|Overall Study|Other Reasons|0|||
129883904|NCT02733042|467534446|FG005|Overall Study|Other Reasons|0|||
129883905|NCT02733042|467534447|FG006|Overall Study|Other Reasons|0|||
129883906|NCT02733042|467534448|FG007|Overall Study|Other Reasons|0|||
129883907|NCT02733042|467534449|FG008|Overall Study|Other Reasons|0|||
129883908|NCT02733042|467534450|FG009|Overall Study|Other Reasons|1|||
129883909|NCT02733042|467534451|FG010|Overall Study|Other Reasons|1|||
129883910|NCT02733042|467534452|FG011|Overall Study|Other Reasons|0|||
129883911|NCT02733042|467534453|FG012|Overall Study|Other Reasons|0|||
129883912|NCT02733042|467534454|FG013|Overall Study|Other Reasons|0|||
129883913|NCT02733042|467534455|FG014|Overall Study|Other Reasons|0|||
129883914|NCT02733042|467534456|FG015|Overall Study|Other Reasons|1|||
129883915|NCT02733042|467534457|FG016|Overall Study|Other Reasons|0|||
129883916|NCT02733042|467534458|FG017|Overall Study|Other Reasons|1|||
129883917|NCT02733042|467534459|FG018|Overall Study|Other Reasons|0|||
129883918|NCT02733042|467534441|FG000|Overall Study|Death|0|||
129883919|NCT02733042|467534442|FG001|Overall Study|Death|0|||
129883920|NCT02733042|467534443|FG002|Overall Study|Death|0|||
129883921|NCT02733042|467534444|FG003|Overall Study|Death|0|||
129883922|NCT02733042|467534445|FG004|Overall Study|Death|0|||
129883923|NCT02733042|467534446|FG005|Overall Study|Death|0|||
129883924|NCT02733042|467534447|FG006|Overall Study|Death|1|||
129883925|NCT02733042|467534448|FG007|Overall Study|Death|0|||
129883926|NCT02733042|467534449|FG008|Overall Study|Death|1|||
129883927|NCT02733042|467534450|FG009|Overall Study|Death|0|||
129883928|NCT02733042|467534451|FG010|Overall Study|Death|1|||
129883929|NCT02733042|467534452|FG011|Overall Study|Death|0|||
129883930|NCT02733042|467534453|FG012|Overall Study|Death|0|||
129883931|NCT02733042|467534454|FG013|Overall Study|Death|0|||
129883932|NCT02733042|467534455|FG014|Overall Study|Death|1|||
129883933|NCT02733042|467534456|FG015|Overall Study|Death|2|||
129883934|NCT02733042|467534457|FG016|Overall Study|Death|0|||
129666280|NCT01610037|466737288|FG000|All Patients|Abnormal test procedure result(s)|0|||
129883935|NCT02733042|467534458|FG017|Overall Study|Death|0|||
129883936|NCT02733042|467534459|FG018|Overall Study|Death|0|||
129883937|NCT00219141|467534461|FG000|Overall Study|Adverse Event|4|||
129883938|NCT00219141|467534462|FG001|Overall Study|Adverse Event|10|||
129883939|NCT00219141|467534463|FG002|Overall Study|Adverse Event|5|||
129883940|NCT00219141|467534461|FG000|Overall Study|Lack of Efficacy|3|||
129883941|NCT00219141|467534462|FG001|Overall Study|Lack of Efficacy|2|||
129883942|NCT00219141|467534463|FG002|Overall Study|Lack of Efficacy|0|||
129883943|NCT00219141|467534461|FG000|Overall Study|Administrative problems|0|||
129883944|NCT00219141|467534462|FG001|Overall Study|Administrative problems|1|||
129883945|NCT00219141|467534463|FG002|Overall Study|Administrative problems|0|||
129883946|NCT00219141|467534461|FG000|Overall Study|Lost to Follow-up|2|||
129883947|NCT00219141|467534462|FG001|Overall Study|Lost to Follow-up|4|||
129883948|NCT00219141|467534463|FG002|Overall Study|Lost to Follow-up|1|||
129883949|NCT00219141|467534461|FG000|Overall Study|Protocol Violation|3|||
129883950|NCT00219141|467534462|FG001|Overall Study|Protocol Violation|1|||
129883951|NCT00219141|467534463|FG002|Overall Study|Protocol Violation|1|||
129883952|NCT00219141|467534461|FG000|Overall Study|Withdrawal by Subject|1|||
129883953|NCT00219141|467534462|FG001|Overall Study|Withdrawal by Subject|3|||
129883954|NCT00219141|467534463|FG002|Overall Study|Withdrawal by Subject|5|||
129666281|NCT01610037|466737289|FG001|All Patients|Abnormal test procedure result(s)|1|||
129666282|NCT01610037|466737290|FG002|All Patients|Abnormal test procedure result(s)|3|||
129666283|NCT01610037|466737288|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
129666284|NCT01610037|466737289|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
129666285|NCT01610037|466737290|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
129666286|NCT01610037|466737288|FG000|Treatment and Follow up Period|Death|10|||
129666287|NCT01610037|466737289|FG001|Treatment and Follow up Period|Death|5|||
129666288|NCT01610037|466737290|FG002|Treatment and Follow up Period|Death|4|||
129666289|NCT01610037|466737288|FG000|Treatment and Follow up Period|Administrative problems|1|||
129666290|NCT01610037|466737289|FG001|Treatment and Follow up Period|Administrative problems|3|||
129666291|NCT01610037|466737290|FG002|Treatment and Follow up Period|Administrative problems|2|||
129666292|NCT01610037|466737288|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
129666293|NCT01610037|466737289|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
129666294|NCT01610037|466737290|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
129666295|NCT00705757|466737291|FG000|Overall Study|Lack of Efficacy|5|||
129666296|NCT00705757|466737292|FG001|Overall Study|Lack of Efficacy|1|||
129666297|NCT00705757|466737293|FG002|Overall Study|Lack of Efficacy|3|||
129666298|NCT00705757|466737291|FG000|Overall Study|Lost to Follow-up|7|||
129666299|NCT00705757|466737292|FG001|Overall Study|Lost to Follow-up|6|||
129666300|NCT00705757|466737293|FG002|Overall Study|Lost to Follow-up|6|||
129666301|NCT00705757|466737291|FG000|Overall Study|Withdrawal by Subject|1|||
129666302|NCT00705757|466737292|FG001|Overall Study|Withdrawal by Subject|1|||
129666303|NCT00705757|466737293|FG002|Overall Study|Withdrawal by Subject|2|||
129666304|NCT01411852|466737294|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
129666305|NCT01411852|466737295|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
129666306|NCT01411852|466737294|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
129883955|NCT00219141|467534461|FG000|Overall Study|Condition no longer requires study drug|1|||
129883956|NCT00219141|467534462|FG001|Overall Study|Condition no longer requires study drug|0|||
129666307|NCT01411852|466737295|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
129666308|NCT01411852|466737294|FG000|Prehospital Intervention Phase|Found to be under age|0|||
129546853|NCT00915473|466296025|FG001|Screening|Withdrawal by Subject|0|||
129546854|NCT00915473|466296024|FG000|4-week Follow Up|Lost to Follow-up|1|||
129666309|NCT01411852|466737295|FG001|Prehospital Intervention Phase|Found to be under age|1|||
129666310|NCT01411852|466737294|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
129666311|NCT01411852|466737295|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
129666312|NCT01411852|466737294|FG000|Hospital Intervention Phase|Severe head injury|5|||
129666313|NCT01411852|466737295|FG001|Hospital Intervention Phase|Severe head injury|4|||
129883957|NCT00219141|467534463|FG002|Overall Study|Condition no longer requires study drug|0|||
129883958|NCT01088529|467534464|FG000|Overall Study|Did not receive study treatment|0|||
129883959|NCT01088529|467534465|FG001|Overall Study|Did not receive study treatment|1|||
129883960|NCT02838628|467534467|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
129883961|NCT02838628|467534468|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
129883962|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Adverse Event|1|||
129883963|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Adverse Event|0|||
129883964|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Non-compliance|0|||
129883965|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Non-compliance|1|||
129883966|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
129883967|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
129883968|NCT02838628|467534467|FG000|Recurrence Follow-up Period|Other un-specified|1|||
129883969|NCT02838628|467534468|FG001|Recurrence Follow-up Period|Other un-specified|1|||
129883970|NCT01821898|467534469|FG000|Overall Study|Withdrawal by Subject|2|||
129883971|NCT01821898|467534470|FG001|Overall Study|Withdrawal by Subject|1|||
129883972|NCT02066532|467534475|FG000|Phase II|Withdrawal by Subject|1|||
129883973|NCT02066532|467534476|FG001|Phase II|Withdrawal by Subject|0|||
129883974|NCT02066532|467534477|FG002|Phase II|Withdrawal by Subject|0|||
129883975|NCT02066532|467534478|FG003|Phase II|Withdrawal by Subject|0|||
129883976|NCT00337662|467534479|FG000|Study Period II|Lost to Follow-up|0|||
129883977|NCT00337662|467534480|FG001|Study Period II|Lost to Follow-up|0|||
129883978|NCT00337662|467534481|FG002|Study Period II|Lost to Follow-up|0|||
129883979|NCT00337662|467534482|FG003|Study Period II|Lost to Follow-up|35|||
129883980|NCT00337662|467534479|FG000|Study Period II|Withdrawal by Subject|0|||
129883981|NCT00337662|467534480|FG001|Study Period II|Withdrawal by Subject|0|||
129883982|NCT00337662|467534481|FG002|Study Period II|Withdrawal by Subject|0|||
129883983|NCT00337662|467534482|FG003|Study Period II|Withdrawal by Subject|20|||
129883984|NCT00337662|467534479|FG000|Study Period II|Adverse Event|0|||
129883985|NCT00337662|467534480|FG001|Study Period II|Adverse Event|0|||
129883986|NCT00337662|467534481|FG002|Study Period II|Adverse Event|0|||
129883987|NCT00337662|467534482|FG003|Study Period II|Adverse Event|16|||
129883988|NCT00337662|467534479|FG000|Study Period II|Physician Decision|0|||
129883989|NCT00337662|467534480|FG001|Study Period II|Physician Decision|0|||
129883990|NCT00337662|467534481|FG002|Study Period II|Physician Decision|0|||
129883991|NCT00337662|467534482|FG003|Study Period II|Physician Decision|13|||
129883992|NCT00337662|467534479|FG000|Study Period II|Entry Criteria Not Met|0|||
129883993|NCT00337662|467534480|FG001|Study Period II|Entry Criteria Not Met|0|||
129883994|NCT00337662|467534481|FG002|Study Period II|Entry Criteria Not Met|0|||
129883995|NCT00337662|467534482|FG003|Study Period II|Entry Criteria Not Met|6|||
129883996|NCT00337662|467534479|FG000|Study Period II|Protocol Violation|0|||
129883997|NCT00337662|467534480|FG001|Study Period II|Protocol Violation|0|||
129883998|NCT00337662|467534481|FG002|Study Period II|Protocol Violation|0|||
129883999|NCT00337662|467534482|FG003|Study Period II|Protocol Violation|6|||
129884000|NCT00337662|467534479|FG000|Study Period II|Lack of Efficacy|0|||
129884001|NCT00337662|467534480|FG001|Study Period II|Lack of Efficacy|0|||
129884002|NCT00337662|467534481|FG002|Study Period II|Lack of Efficacy|0|||
129884003|NCT00337662|467534482|FG003|Study Period II|Lack of Efficacy|7|||
129884004|NCT00337662|467534479|FG000|Study Period II|Sponsor Decision|0|||
129884005|NCT00337662|467534480|FG001|Study Period II|Sponsor Decision|0|||
129884006|NCT00337662|467534481|FG002|Study Period II|Sponsor Decision|0|||
129884007|NCT00337662|467534482|FG003|Study Period II|Sponsor Decision|2|||
129884008|NCT00337662|467534479|FG000|Study Period II|Parent/Caregiver Decision|0|||
129884009|NCT00337662|467534480|FG001|Study Period II|Parent/Caregiver Decision|0|||
129884010|NCT00337662|467534481|FG002|Study Period II|Parent/Caregiver Decision|0|||
129884011|NCT00337662|467534482|FG003|Study Period II|Parent/Caregiver Decision|1|||
129884012|NCT00337662|467534479|FG000|Study Period III|Lost to Follow-up|14|||
129884013|NCT00337662|467534480|FG001|Study Period III|Lost to Follow-up|16|||
129884014|NCT00337662|467534481|FG002|Study Period III|Lost to Follow-up|14|||
129884015|NCT00337662|467534482|FG003|Study Period III|Lost to Follow-up|0|||
129884016|NCT00337662|467534479|FG000|Study Period III|Withdrawal by Subject|18|||
129884017|NCT00337662|467534480|FG001|Study Period III|Withdrawal by Subject|14|||
129884018|NCT00337662|467534481|FG002|Study Period III|Withdrawal by Subject|12|||
129884019|NCT00337662|467534482|FG003|Study Period III|Withdrawal by Subject|0|||
129884020|NCT00337662|467534479|FG000|Study Period III|Adverse Event|9|||
129884021|NCT00337662|467534480|FG001|Study Period III|Adverse Event|10|||
129884022|NCT00337662|467534481|FG002|Study Period III|Adverse Event|8|||
129884023|NCT00337662|467534482|FG003|Study Period III|Adverse Event|0|||
129884024|NCT00337662|467534479|FG000|Study Period III|Protocol Violation|3|||
129884025|NCT00337662|467534480|FG001|Study Period III|Protocol Violation|8|||
129884026|NCT00337662|467534481|FG002|Study Period III|Protocol Violation|2|||
129884027|NCT00337662|467534482|FG003|Study Period III|Protocol Violation|0|||
129884028|NCT00337662|467534479|FG000|Study Period III|Physician Decision|6|||
129884029|NCT00337662|467534480|FG001|Study Period III|Physician Decision|5|||
129884030|NCT00337662|467534481|FG002|Study Period III|Physician Decision|0|||
129884031|NCT00337662|467534482|FG003|Study Period III|Physician Decision|0|||
129884032|NCT00337662|467534479|FG000|Study Period III|Entry Criteria Not Met|4|||
129884033|NCT00337662|467534480|FG001|Study Period III|Entry Criteria Not Met|1|||
129884034|NCT00337662|467534481|FG002|Study Period III|Entry Criteria Not Met|3|||
129884035|NCT00337662|467534482|FG003|Study Period III|Entry Criteria Not Met|0|||
129884036|NCT00337662|467534479|FG000|Study Period III|Lack of Efficacy|4|||
129884037|NCT00337662|467534480|FG001|Study Period III|Lack of Efficacy|4|||
129884038|NCT00337662|467534481|FG002|Study Period III|Lack of Efficacy|2|||
129884039|NCT00337662|467534482|FG003|Study Period III|Lack of Efficacy|0|||
129884040|NCT00337662|467534479|FG000|Study Period III|Parent/Caregiver Decision|0|||
129884041|NCT00337662|467534480|FG001|Study Period III|Parent/Caregiver Decision|0|||
129884042|NCT00337662|467534481|FG002|Study Period III|Parent/Caregiver Decision|2|||
129884043|NCT00337662|467534482|FG003|Study Period III|Parent/Caregiver Decision|0|||
129884044|NCT00337662|467534479|FG000|Study Period III|Sponsor Decision|1|||
129884045|NCT00337662|467534480|FG001|Study Period III|Sponsor Decision|0|||
129884046|NCT00337662|467534481|FG002|Study Period III|Sponsor Decision|1|||
129884047|NCT00337662|467534482|FG003|Study Period III|Sponsor Decision|0|||
129884048|NCT00337662|467534479|FG000|Study Period III|Clinical Relapse|1|||
129884049|NCT00337662|467534480|FG001|Study Period III|Clinical Relapse|0|||
129884050|NCT00337662|467534481|FG002|Study Period III|Clinical Relapse|0|||
129884051|NCT00337662|467534482|FG003|Study Period III|Clinical Relapse|0|||
129884052|NCT01265823|467534483|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
129884053|NCT01265823|467534483|FG000|Overall Study|Failure to Return|4|||
129884054|NCT01265823|467534483|FG000|Overall Study|Protocol Violation|1|||
129884055|NCT01265823|467534483|FG000|Overall Study|Participant Request|1|||
129884056|NCT03691948|467534485|FG000|Overall Study|Lost to Follow-up|1|||
129884057|NCT03691948|467534486|FG001|Overall Study|Lost to Follow-up|3|||
129884058|NCT01018563|467534491|FG000|Overall Study|Termination of the study by Sponsor|2|||
129884059|NCT01018563|467534492|FG001|Overall Study|Termination of the study by Sponsor|1|||
129884060|NCT02344537|467534495|FG000|Overall Study|Protocol Violation|1|||
129884061|NCT02344537|467534496|FG001|Overall Study|Protocol Violation|1|||
129884062|NCT02344537|467534495|FG000|Overall Study|Subject started another treatment after wk 6|1|||
129884063|NCT02344537|467534496|FG001|Overall Study|Subject started another treatment after wk 6|0|||
129884064|NCT02344537|467534495|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
129884065|NCT02344537|467534496|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
129884066|NCT00960752|467534498|FG000|Overall Study|Adverse Event|0|||
129884067|NCT00960752|467534499|FG001|Overall Study|Adverse Event|0|||
129666314|NCT01411852|466737294|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
129666315|NCT01411852|466737295|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
129666316|NCT01411852|466737294|FG000|Hospital Intervention Phase|Miscommunication error|1|||
129666317|NCT01411852|466737295|FG001|Hospital Intervention Phase|Miscommunication error|2|||
129666318|NCT01411852|466737294|FG000|Hospital Intervention Phase|CPR administered|3|||
129666319|NCT01411852|466737295|FG001|Hospital Intervention Phase|CPR administered|1|||
129666320|NCT01411852|466737294|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
129666321|NCT01411852|466737295|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
129666322|NCT01411852|466737294|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
129666323|NCT01411852|466737295|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
129666324|NCT01411852|466737294|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
129666325|NCT01411852|466737295|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
129666326|NCT01411852|466737294|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
129666327|NCT01411852|466737295|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
129666328|NCT01411852|466737294|FG000|Hospital Intervention Phase|Other ineligible|2|||
129666329|NCT01411852|466737295|FG001|Hospital Intervention Phase|Other ineligible|2|||
129666330|NCT01411852|466737294|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
129666331|NCT01411852|466737295|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
129666332|NCT01411852|466737294|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
129666333|NCT01411852|466737295|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
129666334|NCT01411852|466737294|FG000|Hospital Intervention Phase|Vascular access failed|1|||
129666335|NCT01411852|466737295|FG001|Hospital Intervention Phase|Vascular access failed|0|||
129666336|NCT03743025|466737296|FG000|Overall Study|Surgery was cancelled|2|||
129666337|NCT03743025|466737297|FG001|Overall Study|Surgery was cancelled|1|||
129884068|NCT00960752|467534500|FG002|Overall Study|Adverse Event|1|||
129884069|NCT00960752|467534498|FG000|Overall Study|Progression|0|||
129884070|NCT00960752|467534499|FG001|Overall Study|Progression|0|||
129884071|NCT00960752|467534500|FG002|Overall Study|Progression|1|||
129884072|NCT02180438|467534506|FG000|Overall Study|Lost to Follow-up|1|||
129884073|NCT00514046|467534511|FG000|Overall Study|transferred to another protocol|2|||
129884074|NCT00514046|467534512|FG001|Overall Study|transferred to another protocol|1|||
129884075|NCT00514046|467534513|FG002|Overall Study|transferred to another protocol|3|||
129884076|NCT00514046|467534514|FG003|Overall Study|transferred to another protocol|0|||
129884077|NCT00514046|467534515|FG004|Overall Study|transferred to another protocol|1|||
129884078|NCT00514046|467534516|FG005|Overall Study|transferred to another protocol|0|||
129884079|NCT00514046|467534517|FG006|Overall Study|transferred to another protocol|0|||
129884080|NCT00514046|467534518|FG007|Overall Study|transferred to another protocol|0|||
129884081|NCT00514046|467534519|FG008|Overall Study|transferred to another protocol|0|||
129884082|NCT00514046|467534511|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
129884083|NCT00514046|467534512|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
129884084|NCT00514046|467534513|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
129884085|NCT00514046|467534514|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
129884086|NCT00514046|467534515|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
129884087|NCT00514046|467534516|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
129884088|NCT00514046|467534517|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
129884089|NCT00514046|467534518|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
129884090|NCT00514046|467534519|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
129884091|NCT00514046|467534511|FG000|Overall Study|Disease progression on study|0|||
129884092|NCT00514046|467534512|FG001|Overall Study|Disease progression on study|0|||
129884093|NCT00514046|467534513|FG002|Overall Study|Disease progression on study|2|||
129884094|NCT00514046|467534514|FG003|Overall Study|Disease progression on study|0|||
129884095|NCT00514046|467534515|FG004|Overall Study|Disease progression on study|0|||
129884096|NCT00514046|467534516|FG005|Overall Study|Disease progression on study|1|||
129884097|NCT00514046|467534517|FG006|Overall Study|Disease progression on study|0|||
129884098|NCT00514046|467534518|FG007|Overall Study|Disease progression on study|0|||
129884099|NCT00514046|467534519|FG008|Overall Study|Disease progression on study|0|||
129884100|NCT00383240|467534521|FG000|Overall Study|Adverse Event|4|||
129884101|NCT00383240|467534522|FG001|Overall Study|Adverse Event|6|||
129884102|NCT00383240|467534523|FG002|Overall Study|Adverse Event|9|||
129884103|NCT00383240|467534524|FG003|Overall Study|Adverse Event|7|||
129884104|NCT00383240|467534521|FG000|Overall Study|Treatment Failure|8|||
129884105|NCT00383240|467534522|FG001|Overall Study|Treatment Failure|13|||
129884106|NCT00383240|467534523|FG002|Overall Study|Treatment Failure|47|||
129884107|NCT00383240|467534524|FG003|Overall Study|Treatment Failure|46|||
129884108|NCT00383240|467534521|FG000|Overall Study|Lost to Follow-up|3|||
129884109|NCT00383240|467534522|FG001|Overall Study|Lost to Follow-up|0|||
129884110|NCT00383240|467534523|FG002|Overall Study|Lost to Follow-up|0|||
129884111|NCT00383240|467534524|FG003|Overall Study|Lost to Follow-up|2|||
129884112|NCT00383240|467534521|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
129884113|NCT00383240|467534522|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
129884114|NCT00383240|467534523|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
129884115|NCT00383240|467534524|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
129884116|NCT00383240|467534521|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
129884117|NCT00383240|467534522|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
129884118|NCT00383240|467534523|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
129884119|NCT00383240|467534524|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
129884120|NCT00383240|467534521|FG000|Overall Study|Protocol Violation|4|||
129884121|NCT00383240|467534522|FG001|Overall Study|Protocol Violation|5|||
129884122|NCT00383240|467534523|FG002|Overall Study|Protocol Violation|9|||
129884123|NCT00383240|467534524|FG003|Overall Study|Protocol Violation|6|||
129884124|NCT00383240|467534521|FG000|Overall Study|Did not meet protocol eligibility|9|||
129884125|NCT00383240|467534522|FG001|Overall Study|Did not meet protocol eligibility|4|||
129546855|NCT00915473|466296025|FG001|4-week Follow Up|Lost to Follow-up|5|||
129666338|NCT02420119|466737298|FG000|Overall Study|insufficient laboratory data|5|||
129666339|NCT00807885|466737299|FG000|Overall Study|Lost to Follow-up|0|||
129666340|NCT00807885|466737300|FG001|Overall Study|Lost to Follow-up|0|||
129666341|NCT00807885|466737301|FG002|Overall Study|Lost to Follow-up|0|||
129666342|NCT00807885|466737302|FG003|Overall Study|Lost to Follow-up|0|||
129666343|NCT00807885|466737303|FG004|Overall Study|Lost to Follow-up|0|||
129666344|NCT00807885|466737304|FG005|Overall Study|Lost to Follow-up|1|||
129666345|NCT00807885|466737305|FG006|Overall Study|Lost to Follow-up|0|||
129666346|NCT00807885|466737306|FG007|Overall Study|Lost to Follow-up|0|||
129666347|NCT00807885|466737307|FG008|Overall Study|Lost to Follow-up|0|||
129666348|NCT03126786|466737308|FG000|Overall Study|Adverse Event|3|||
129666349|NCT03126786|466737309|FG001|Overall Study|Adverse Event|0|||
129666350|NCT03126786|466737308|FG000|Overall Study|Lost to Follow-up|0|||
129884126|NCT00383240|467534523|FG002|Overall Study|Did not meet protocol eligibility|9|||
129884127|NCT00383240|467534524|FG003|Overall Study|Did not meet protocol eligibility|3|||
129884128|NCT00383240|467534521|FG000|Overall Study|Administrative|1|||
129884129|NCT00383240|467534522|FG001|Overall Study|Administrative|1|||
129884130|NCT00383240|467534523|FG002|Overall Study|Administrative|0|||
129884131|NCT00383240|467534524|FG003|Overall Study|Administrative|0|||
129884132|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
129884133|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
129884134|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
129884135|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
129884136|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
129884137|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
129884138|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
129884139|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
129884140|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
129884141|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
129884142|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
129884143|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
129884144|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
129884145|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
129884146|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
129884147|NCT02023879|467534528|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
129884148|NCT02023879|467534529|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
129884149|NCT02023879|467534530|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
129884150|NCT02023879|467534528|FG000|Extension Open Label Treatment|Adverse Event|1|||
129884151|NCT02023879|467534529|FG001|Extension Open Label Treatment|Adverse Event|7|||
129884152|NCT02023879|467534530|FG002|Extension Open Label Treatment|Adverse Event|3|||
129884153|NCT02023879|467534528|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
129884154|NCT02023879|467534529|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
129884155|NCT02023879|467534530|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
129884156|NCT02023879|467534528|FG000|Extension Open Label Treatment|Participant moved|1|||
129884157|NCT02023879|467534529|FG001|Extension Open Label Treatment|Participant moved|2|||
129884158|NCT02023879|467534530|FG002|Extension Open Label Treatment|Participant moved|0|||
129884159|NCT02023879|467534528|FG000|Extension Open Label Treatment|Other than specified above|2|||
129884160|NCT02023879|467534529|FG001|Extension Open Label Treatment|Other than specified above|7|||
129884161|NCT02023879|467534530|FG002|Extension Open Label Treatment|Other than specified above|2|||
129884162|NCT02924389|467534531|FG000|Overall Study|Lost to Follow-up|1|||
129884163|NCT02924389|467534532|FG001|Overall Study|Lost to Follow-up|0|||
129884164|NCT02924389|467534531|FG000|Overall Study|Physician Decision|2|||
129884165|NCT02924389|467534532|FG001|Overall Study|Physician Decision|0|||
129884166|NCT02924389|467534531|FG000|Overall Study|Withdrawal by Subject|3|||
129884167|NCT02924389|467534532|FG001|Overall Study|Withdrawal by Subject|0|||
129884168|NCT02924389|467534531|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
129884169|NCT02924389|467534532|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
129884170|NCT01091428|467536277|FG000|Phase 1|Progressive Disease|24|||
129884171|NCT01091428|467536278|FG001|Phase 1|Progressive Disease|8|||
129884172|NCT01091428|467536279|FG002|Phase 1|Progressive Disease|0|||
129884173|NCT01091428|467536280|FG003|Phase 1|Progressive Disease|0|||
129884174|NCT01091428|467536277|FG000|Phase 1|Symptomatic Deterioration|3|||
129884175|NCT01091428|467536278|FG001|Phase 1|Symptomatic Deterioration|2|||
129884176|NCT01091428|467536279|FG002|Phase 1|Symptomatic Deterioration|0|||
129884177|NCT01091428|467536280|FG003|Phase 1|Symptomatic Deterioration|0|||
129884178|NCT01091428|467536277|FG000|Phase 1|Adverse Event|2|||
129884179|NCT01091428|467536278|FG001|Phase 1|Adverse Event|0|||
129884180|NCT01091428|467536279|FG002|Phase 1|Adverse Event|0|||
129884181|NCT01091428|467536280|FG003|Phase 1|Adverse Event|0|||
129884182|NCT01091428|467536277|FG000|Phase 1|Withdrawal by Subject|7|||
129884183|NCT01091428|467536278|FG001|Phase 1|Withdrawal by Subject|0|||
129884184|NCT01091428|467536279|FG002|Phase 1|Withdrawal by Subject|0|||
129666351|NCT03126786|466737309|FG001|Overall Study|Lost to Follow-up|1|||
129884185|NCT01091428|467536280|FG003|Phase 1|Withdrawal by Subject|0|||
129884186|NCT01091428|467536277|FG000|Phase 1|Reason not specified|0|||
129666352|NCT03126786|466737308|FG000|Overall Study|Withdrawal by Subject|3|||
129666353|NCT03126786|466737309|FG001|Overall Study|Withdrawal by Subject|1|||
129666354|NCT00227539|466737310|FG000|Overall Study|Protocol Violation|1|||
129666355|NCT00991289|466737311|FG000|Overall Study|Adverse Event|1|||
129666356|NCT00991289|466737311|FG000|Overall Study|Physician Decision|2|||
129666357|NCT00991289|466737311|FG000|Overall Study|Withdrawal by Subject|3|||
129666358|NCT00991289|466737311|FG000|Overall Study|Lost to Follow-up|4|||
129666359|NCT00991289|466737311|FG000|Overall Study|Protocol Violation|2|||
129666360|NCT00426764|466737312|FG000|Overall Study|Protocol Violation|1|||
129666361|NCT00426764|466737312|FG000|Overall Study|Withdrawal by Subject|4|||
129666362|NCT00426764|466737312|FG000|Overall Study|Physician Decision|6|||
129666363|NCT00426764|466737312|FG000|Overall Study|Compassionate Use|1|||
129666364|NCT00426764|466737312|FG000|Overall Study|Progressive Disease|83|||
129666365|NCT00426764|466737312|FG000|Overall Study|Adverse Event|24|||
129666366|NCT00426764|466737312|FG000|Overall Study|Other|1|||
129666367|NCT00426764|466737312|FG000|Overall Study|Death|1|||
129666368|NCT00426764|466737312|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
129666369|NCT03804268|466737315|FG000|Overall Study|Adverse Event|2|||
129666370|NCT03804268|466737316|FG001|Overall Study|Adverse Event|2|||
129666371|NCT03804268|466737315|FG000|Overall Study|Withdrawal by Subject|2|||
129666372|NCT03804268|466737316|FG001|Overall Study|Withdrawal by Subject|0|||
129666373|NCT03804268|466737315|FG000|Overall Study|Lost to Follow-up|1|||
129666374|NCT03804268|466737316|FG001|Overall Study|Lost to Follow-up|0|||
129666375|NCT03804268|466737315|FG000|Overall Study|Physician Decision|2|||
129666376|NCT03804268|466737316|FG001|Overall Study|Physician Decision|0|||
129666377|NCT02716779|466737317|FG000|Monotherapy|Adverse Event|0|||
129666378|NCT02716779|466737318|FG001|Monotherapy|Adverse Event|1|||
129666379|NCT02716779|466737319|FG002|Monotherapy|Adverse Event|1|||
129666380|NCT02716779|466737317|FG000|Combination Therapy|Adverse Event|0|||
129666381|NCT02716779|466737318|FG001|Combination Therapy|Adverse Event|2|||
129666382|NCT02716779|466737319|FG002|Combination Therapy|Adverse Event|1|||
129666383|NCT01843803|466737322|FG000|Overall Study|not a Veteran, did not see provider|1|||
129666384|NCT01843803|466737323|FG001|Overall Study|not a Veteran, did not see provider|3|||
129666385|NCT01051817|466737331|FG000|Overall Study|Adverse Event|0|||
129666386|NCT01051817|466737332|FG001|Overall Study|Adverse Event|2|||
129666387|NCT01051817|466737331|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
129666388|NCT01051817|466737332|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
129666389|NCT01051817|466737331|FG000|Overall Study|Withdrawal by Subject|3|||
129666390|NCT01051817|466737332|FG001|Overall Study|Withdrawal by Subject|5|||
129666391|NCT01051817|466737331|FG000|Overall Study|Protocol Violation|0|||
129666392|NCT01051817|466737332|FG001|Overall Study|Protocol Violation|1|||
129666393|NCT02989402|466737333|FG000|Overall Study|Adverse event, or serious adverse event|4|||
129666394|NCT02989402|466737333|FG000|Overall Study|Death|2|||
129666395|NCT02989402|466737333|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
129666396|NCT02989402|466737333|FG000|Overall Study|Lost to Follow-up|8|||
129666397|NCT02989402|466737333|FG000|Overall Study|Patient no longer on monotherapy|1|||
129666398|NCT02989402|466737333|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
129666399|NCT02989402|466737333|FG000|Overall Study|Withdrawal by Subject|7|||
129666400|NCT02989402|466737333|FG000|Overall Study|Other|2|||
129666401|NCT02686164|466737335|FG000|Overall Study|Adverse Event|1|||
129666402|NCT02686164|466737335|FG000|Overall Study|Withdrawal of consent|1|||
129666403|NCT02686164|466737335|FG000|Overall Study|Clinical progression|1|||
129666404|NCT00672633|466737338|FG000|Overall Study|Withdrawal by Subject|0|||
129666405|NCT00672633|466737339|FG001|Overall Study|Withdrawal by Subject|1|||
129666406|NCT02824627|466737340|FG000|Overall Study|Adverse Event|1|||
129666407|NCT02824627|466737341|FG001|Overall Study|Adverse Event|2|||
129666408|NCT02824627|466737340|FG000|Overall Study|Lost to Follow-up|2|||
129666409|NCT02824627|466737341|FG001|Overall Study|Lost to Follow-up|1|||
129666410|NCT01938846|466737342|FG000|Overall Study|Progressive disease|26|||
129666411|NCT01938846|466737343|FG001|Overall Study|Progressive disease|18|||
129666412|NCT01938846|466737344|FG002|Overall Study|Progressive disease|16|||
129666413|NCT01938846|466737342|FG000|Overall Study|Adverse Event|8|||
129666414|NCT01938846|466737343|FG001|Overall Study|Adverse Event|4|||
129666415|NCT01938846|466737344|FG002|Overall Study|Adverse Event|3|||
129666416|NCT01938846|466737342|FG000|Overall Study|Withdrawal by Subject|2|||
129666417|NCT01938846|466737343|FG001|Overall Study|Withdrawal by Subject|2|||
129666418|NCT01938846|466737344|FG002|Overall Study|Withdrawal by Subject|1|||
129666419|NCT01938846|466737342|FG000|Overall Study|Other than listed|5|||
129666420|NCT01938846|466737343|FG001|Overall Study|Other than listed|1|||
129666421|NCT01938846|466737344|FG002|Overall Study|Other than listed|4|||
129666422|NCT02324361|466737347|FG000|Overall Study|Lost to Follow-up|5|||
129666423|NCT02324361|466737348|FG001|Overall Study|Lost to Follow-up|2|||
129666424|NCT01519817|466738955|FG000|Overall Study|Withdrawal by Subject|1|||
129666425|NCT01519817|466738956|FG001|Overall Study|Withdrawal by Subject|0|||
129666426|NCT01519817|466738957|FG002|Overall Study|Withdrawal by Subject|0|||
129666427|NCT01519817|466738958|FG003|Overall Study|Withdrawal by Subject|0|||
129666428|NCT01519817|466738955|FG000|Overall Study|Off study due to infection|0|||
129666429|NCT01519817|466738956|FG001|Overall Study|Off study due to infection|0|||
129666430|NCT01519817|466738957|FG002|Overall Study|Off study due to infection|0|||
129666431|NCT01519817|466738958|FG003|Overall Study|Off study due to infection|1|||
129666432|NCT03234036|466738963|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
129666433|NCT03234036|466738964|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
129666434|NCT03234036|466738965|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
129666435|NCT03234036|466738966|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
129666436|NCT02999789|466738967|FG000|Overall Study|Withdrawal by Subject|0|||
129666437|NCT02999789|466738968|FG001|Overall Study|Withdrawal by Subject|1|||
129666438|NCT02999789|466738967|FG000|Overall Study|Became ineligible|1|||
129666439|NCT02999789|466738968|FG001|Overall Study|Became ineligible|2|||
129666440|NCT04613739|466738971|FG000|Overall Study|Lost to Follow-up|6|||
129666441|NCT04613739|466738972|FG001|Overall Study|Lost to Follow-up|9|||
129666442|NCT04613739|466738971|FG000|Overall Study|potentially duplicative/fraudulent|1|||
129666443|NCT04613739|466738972|FG001|Overall Study|potentially duplicative/fraudulent|3|||
129666444|NCT01064414|466738973|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
129666445|NCT01064414|466738974|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
129666446|NCT01064414|466738975|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
129666447|NCT01064414|466738973|FG000|Core Period: Baseline to Week 26|Death|0|||
129666448|NCT01064414|466738974|FG001|Core Period: Baseline to Week 26|Death|1|||
129666449|NCT01064414|466738975|FG002|Core Period: Baseline to Week 26|Death|0|||
129666450|NCT01064414|466738973|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
129666451|NCT01064414|466738974|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
129666452|NCT01064414|466738975|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
129666453|NCT01064414|466738973|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
129666454|NCT01064414|466738974|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
129666455|NCT01064414|466738975|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
129666456|NCT01064414|466738973|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129666457|NCT01064414|466738974|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129666458|NCT01064414|466738975|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129666459|NCT01064414|466738973|FG000|Core Period: Baseline to Week 26|Other|4|||
129666460|NCT01064414|466738974|FG001|Core Period: Baseline to Week 26|Other|7|||
129666461|NCT01064414|466738975|FG002|Core Period: Baseline to Week 26|Other|2|||
129666462|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
129666463|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129666464|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
129666465|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Death|0|||
129666466|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Death|1|||
129666467|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Death|0|||
129666468|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
129666469|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129666470|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129666471|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
129666472|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129666473|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129666474|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129666475|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129666476|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129666477|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
129666478|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129666479|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129666480|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129666481|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129666482|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129666483|NCT01064414|466738973|FG000|Extension Period: Week 26 to Week 52|Other|5|||
129666484|NCT01064414|466738974|FG001|Extension Period: Week 26 to Week 52|Other|2|||
129666485|NCT01064414|466738975|FG002|Extension Period: Week 26 to Week 52|Other|1|||
129666486|NCT00249873|466738976|FG000|Overall Study|Not treated|7|||
129666487|NCT00249873|466738977|FG001|Overall Study|Not treated|8|||
129666488|NCT00249873|466738976|FG000|Overall Study|Significant thrombocytopenia|9|||
129666489|NCT00249873|466738977|FG001|Overall Study|Significant thrombocytopenia|8|||
129666490|NCT00249873|466738976|FG000|Overall Study|Severe allergic reaction|8|||
129666491|NCT00249873|466738977|FG001|Overall Study|Severe allergic reaction|1|||
129666492|NCT00249873|466738976|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
129666493|NCT00249873|466738977|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
129666494|NCT00249873|466738976|FG000|Overall Study|Other Serious Adverse Event|86|||
129666495|NCT00249873|466738977|FG001|Overall Study|Other Serious Adverse Event|97|||
129666496|NCT00249873|466738976|FG000|Overall Study|Qualifying condition not present|20|||
129666497|NCT00249873|466738977|FG001|Overall Study|Qualifying condition not present|23|||
129666498|NCT00249873|466738976|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
129666499|NCT00249873|466738977|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
129666500|NCT00249873|466738976|FG000|Overall Study|Withdrawal by Subject|504|||
129666501|NCT00249873|466738977|FG001|Overall Study|Withdrawal by Subject|466|||
129666502|NCT00249873|466738976|FG000|Overall Study|Lost to Follow-up|4|||
129666503|NCT00249873|466738977|FG001|Overall Study|Lost to Follow-up|7|||
129666504|NCT00249873|466738976|FG000|Overall Study|Minor bleeding|99|||
129666505|NCT00249873|466738977|FG001|Overall Study|Minor bleeding|37|||
129666506|NCT00249873|466738976|FG000|Overall Study|Non-compliance|41|||
129666507|NCT00249873|466738977|FG001|Overall Study|Non-compliance|46|||
129666508|NCT00249873|466738976|FG000|Overall Study|Other non serious Adverse Event|112|||
129666509|NCT00249873|466738977|FG001|Overall Study|Other non serious Adverse Event|108|||
129666510|NCT00249873|466738976|FG000|Overall Study|Other contraindicated medication|1|||
129666511|NCT00249873|466738977|FG001|Overall Study|Other contraindicated medication|0|||
129666512|NCT00249873|466738976|FG000|Overall Study|Patient not wish to continue after May08|3|||
129666513|NCT00249873|466738977|FG001|Overall Study|Patient not wish to continue after May08|4|||
129666514|NCT00249873|466738976|FG000|Overall Study|Physician withdrew consent|59|||
129666515|NCT00249873|466738977|FG001|Overall Study|Physician withdrew consent|60|||
129666516|NCT00249873|466738976|FG000|Overall Study|Open label clopidogrel required|31|||
129666517|NCT00249873|466738977|FG001|Overall Study|Open label clopidogrel required|42|||
129666518|NCT00249873|466738976|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
129666519|NCT00249873|466738977|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
129666520|NCT00249873|466738976|FG000|Overall Study|Oral anticoagulant required|159|||
129666521|NCT00249873|466738977|FG001|Overall Study|Oral anticoagulant required|157|||
129666522|NCT00249873|466738976|FG000|Overall Study|Study drug intolerance|5|||
129666523|NCT00249873|466738977|FG001|Overall Study|Study drug intolerance|0|||
129666524|NCT00249873|466738976|FG000|Overall Study|Surgery/ procedure|9|||
129666525|NCT00249873|466738977|FG001|Overall Study|Surgery/ procedure|9|||
129666526|NCT00249873|466738976|FG000|Overall Study|Event related to cardiac condition|12|||
129666527|NCT00249873|466738977|FG001|Overall Study|Event related to cardiac condition|21|||
129666528|NCT00249873|466738976|FG000|Overall Study|Thromboembolic/outcome event|82|||
129666529|NCT00249873|466738977|FG001|Overall Study|Thromboembolic/outcome event|122|||
129666530|NCT03131167|466738978|FG000|Overall Study|Other (Unspecified)|0|||
129666531|NCT03131167|466738979|FG001|Overall Study|Other (Unspecified)|0|||
129666532|NCT03131167|466738980|FG002|Overall Study|Other (Unspecified)|0|||
129666533|NCT03131167|466738981|FG003|Overall Study|Other (Unspecified)|0|||
129666534|NCT03131167|466738982|FG004|Overall Study|Other (Unspecified)|0|||
129666535|NCT03131167|466738983|FG005|Overall Study|Other (Unspecified)|1|||
129666536|NCT03131167|466738984|FG006|Overall Study|Other (Unspecified)|0|||
129666537|NCT03131167|466738985|FG007|Overall Study|Other (Unspecified)|0|||
129666538|NCT03131167|466738986|FG008|Overall Study|Other (Unspecified)|0|||
129666539|NCT03131167|466738987|FG009|Overall Study|Other (Unspecified)|0|||
129666540|NCT03131167|466738988|FG010|Overall Study|Other (Unspecified)|0|||
129666541|NCT03131167|466738989|FG011|Overall Study|Other (Unspecified)|0|||
129666542|NCT03131167|466738990|FG012|Overall Study|Other (Unspecified)|0|||
129666543|NCT00165503|466738991|FG000|Overall Study|Death|1|||
129666544|NCT00165503|466738991|FG000|Overall Study|Lost to Follow-up|12|||
129666545|NCT00165503|466738991|FG000|Overall Study|Unresectable|3|||
129666546|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Death|20|||
129666547|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Death|26|||
129666548|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
129666549|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
129666550|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
129666551|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
129666552|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
129666553|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
129666554|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
129666555|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
129666556|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
129666557|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
129666558|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
129666559|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
129666560|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
129666561|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
129666562|NCT00643201|466738992|FG000|Randomized, Completed 6 Months of Study|Other|107|||
129666563|NCT00643201|466738993|FG001|Randomized, Completed 6 Months of Study|Other|107|||
129666564|NCT00643201|466738992|FG000|Completed Study Follow Up|Death|28|||
129666565|NCT00643201|466738993|FG001|Completed Study Follow Up|Death|34|||
129666566|NCT00643201|466738992|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
129666567|NCT00643201|466738993|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
129666568|NCT00643201|466738992|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
129666569|NCT00643201|466738993|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
129666570|NCT00643201|466738992|FG000|Completed Study Follow Up|non-specified|1|||
129666571|NCT00643201|466738993|FG001|Completed Study Follow Up|non-specified|0|||
129666572|NCT02976519|466738994|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129666573|NCT02976519|466738995|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
129666574|NCT02976519|466738996|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129666575|NCT02976519|466738997|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129666576|NCT02976519|466738998|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129666577|NCT02976519|466738999|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129666578|NCT02976519|466739000|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
129666579|NCT02976519|466738994|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129666580|NCT02976519|466738995|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129666581|NCT02976519|466738996|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129666582|NCT02976519|466738997|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
129666583|NCT02976519|466738998|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129666584|NCT02976519|466738999|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129666585|NCT02976519|466739000|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
129666586|NCT02976519|466738994|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129666587|NCT02976519|466738995|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129666588|NCT02976519|466738996|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129666589|NCT02976519|466738997|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129666590|NCT02976519|466738998|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129666591|NCT02976519|466738999|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
129666592|NCT02976519|466739000|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
129666593|NCT02976519|466738994|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129666594|NCT02976519|466738995|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129666595|NCT02976519|466738996|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129666596|NCT02976519|466738997|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129666597|NCT02976519|466738998|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129666598|NCT02976519|466738999|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
129666599|NCT02976519|466739000|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
129666600|NCT02976519|466738994|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129666601|NCT02976519|466738995|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129666602|NCT02976519|466738996|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129666603|NCT02976519|466738997|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129666604|NCT02976519|466738998|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129666605|NCT02976519|466738999|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
129666606|NCT02976519|466739000|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
129666607|NCT02346708|466739001|FG000|Overall Study|Adverse Event|2|||
129666608|NCT02346708|466739002|FG001|Overall Study|Adverse Event|0|||
129666609|NCT02346708|466739001|FG000|Overall Study|Protocol Violation|0|||
129666610|NCT02346708|466739002|FG001|Overall Study|Protocol Violation|1|||
129666611|NCT00928434|466739003|FG000|Overall Study|Adverse Event|14|||
129666612|NCT00928434|466739004|FG001|Overall Study|Adverse Event|5|||
129666613|NCT00928434|466739005|FG002|Overall Study|Adverse Event|18|||
129666614|NCT00928434|466739003|FG000|Overall Study|Protocol Violation|5|||
129666615|NCT00928434|466739004|FG001|Overall Study|Protocol Violation|0|||
129666616|NCT00928434|466739005|FG002|Overall Study|Protocol Violation|8|||
129666617|NCT00928434|466739003|FG000|Overall Study|Physician Decision|2|||
129666618|NCT00928434|466739004|FG001|Overall Study|Physician Decision|0|||
129666619|NCT00928434|466739005|FG002|Overall Study|Physician Decision|3|||
129666620|NCT00928434|466739003|FG000|Overall Study|Lost to Follow-up|1|||
129666621|NCT00928434|466739004|FG001|Overall Study|Lost to Follow-up|0|||
129666622|NCT00928434|466739005|FG002|Overall Study|Lost to Follow-up|3|||
129666623|NCT00928434|466739003|FG000|Overall Study|Withdrawal by Subject|5|||
129666624|NCT00928434|466739004|FG001|Overall Study|Withdrawal by Subject|3|||
129666625|NCT00928434|466739005|FG002|Overall Study|Withdrawal by Subject|2|||
129666626|NCT00928434|466739003|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
129666627|NCT00928434|466739004|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
129666628|NCT00928434|466739005|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
129666629|NCT00928434|466739003|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
129666630|NCT00928434|466739004|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
129666631|NCT00928434|466739005|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
129666632|NCT00928434|466739003|FG000|Overall Study|Other (not meeting above criteria)|5|||
129666633|NCT00928434|466739004|FG001|Overall Study|Other (not meeting above criteria)|1|||
129666634|NCT00928434|466739005|FG002|Overall Study|Other (not meeting above criteria)|2|||
129666635|NCT01278342|466739008|FG000|Overall Study|Physician Decision|0|||
129666636|NCT01278342|466739009|FG001|Overall Study|Physician Decision|1|||
129666637|NCT01278342|466739010|FG002|Overall Study|Physician Decision|0|||
129666638|NCT01278342|466739008|FG000|Overall Study|Lost to Follow-up|1|||
129666639|NCT01278342|466739009|FG001|Overall Study|Lost to Follow-up|0|||
129666640|NCT01278342|466739010|FG002|Overall Study|Lost to Follow-up|0|||
129666641|NCT01278342|466739008|FG000|Overall Study|Administrative problems|2|||
129666642|NCT01278342|466739009|FG001|Overall Study|Administrative problems|0|||
129666643|NCT01278342|466739010|FG002|Overall Study|Administrative problems|0|||
129666644|NCT01278342|466739008|FG000|Overall Study|Other|1|||
129666645|NCT01278342|466739009|FG001|Overall Study|Other|0|||
129666646|NCT01278342|466739010|FG002|Overall Study|Other|0|||
129666647|NCT00313846|466739016|FG000|Overall Study|Withdrawal by Subject|2|||
129666648|NCT00313846|466739017|FG001|Overall Study|Withdrawal by Subject|0|||
129666649|NCT00313846|466739016|FG000|Overall Study|Adverse Event|1|||
129666650|NCT00313846|466739017|FG001|Overall Study|Adverse Event|8|||
129666651|NCT00313846|466739016|FG000|Overall Study|Administrative|2|||
129666652|NCT00313846|466739017|FG001|Overall Study|Administrative|3|||
129666653|NCT02221648|466739021|FG000|Overall Study|Withdrawal by Subject|3|||
129666654|NCT02221648|466739022|FG001|Overall Study|Withdrawal by Subject|3|||
129666655|NCT01922258|466739028|FG000|Overall Study|Lost to Follow-up|1|||
129666656|NCT01922258|466739029|FG001|Overall Study|Lost to Follow-up|1|||
129666657|NCT01922258|466739028|FG000|Overall Study|Adverse Event|9|||
129666658|NCT01922258|466739029|FG001|Overall Study|Adverse Event|2|||
129666659|NCT01922258|466739028|FG000|Overall Study|Met Withdrawal Criteria|0|||
129666660|NCT01922258|466739029|FG001|Overall Study|Met Withdrawal Criteria|4|||
129884187|NCT01091428|467536278|FG001|Phase 1|Reason not specified|1|||
129884188|NCT01091428|467536279|FG002|Phase 1|Reason not specified|0|||
129884189|NCT01091428|467536280|FG003|Phase 1|Reason not specified|0|||
129884190|NCT01091428|467536277|FG000|Phase 1|Single-Patient IND|2|||
129884191|NCT01091428|467536278|FG001|Phase 1|Single-Patient IND|0|||
129884192|NCT01091428|467536279|FG002|Phase 1|Single-Patient IND|0|||
129884193|NCT01091428|467536280|FG003|Phase 1|Single-Patient IND|0|||
129884194|NCT01091428|467536277|FG000|Phase 2|Progressive Disease|0|||
129884195|NCT01091428|467536278|FG001|Phase 2|Progressive Disease|0|||
129884196|NCT01091428|467536279|FG002|Phase 2|Progressive Disease|44|||
129884197|NCT01091428|467536280|FG003|Phase 2|Progressive Disease|46|||
129884198|NCT01091428|467536277|FG000|Phase 2|Symptomatic Deterioration|0|||
129884199|NCT01091428|467536278|FG001|Phase 2|Symptomatic Deterioration|0|||
129884200|NCT01091428|467536279|FG002|Phase 2|Symptomatic Deterioration|1|||
129884201|NCT01091428|467536280|FG003|Phase 2|Symptomatic Deterioration|6|||
129884202|NCT01091428|467536277|FG000|Phase 2|Adverse Event|0|||
129884203|NCT01091428|467536278|FG001|Phase 2|Adverse Event|0|||
129884204|NCT01091428|467536279|FG002|Phase 2|Adverse Event|12|||
129884205|NCT01091428|467536280|FG003|Phase 2|Adverse Event|5|||
129884206|NCT01091428|467536277|FG000|Phase 2|Withdrawal by Subject|0|||
129884207|NCT01091428|467536278|FG001|Phase 2|Withdrawal by Subject|0|||
129884208|NCT01091428|467536279|FG002|Phase 2|Withdrawal by Subject|9|||
129884209|NCT01091428|467536280|FG003|Phase 2|Withdrawal by Subject|8|||
129884210|NCT01091428|467536277|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
129884211|NCT01091428|467536278|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
129884212|NCT01091428|467536279|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
129884213|NCT01091428|467536280|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
129884214|NCT01091428|467536277|FG000|Phase 2|Reason not specified|0|||
129884215|NCT01091428|467536278|FG001|Phase 2|Reason not specified|0|||
129884216|NCT01091428|467536279|FG002|Phase 2|Reason not specified|4|||
129884217|NCT01091428|467536280|FG003|Phase 2|Reason not specified|3|||
129884218|NCT01091428|467536277|FG000|Phase 2|Physician Decision|0|||
129884219|NCT01091428|467536278|FG001|Phase 2|Physician Decision|0|||
129884220|NCT01091428|467536279|FG002|Phase 2|Physician Decision|2|||
129884221|NCT01091428|467536280|FG003|Phase 2|Physician Decision|0|||
129884222|NCT03518658|467536283|FG000|Overall Study|Other|51|||
129884223|NCT03518658|467536284|FG001|Overall Study|Other|0|||
129884224|NCT02531295|467536285|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884225|NCT02531295|467536286|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884226|NCT02531295|467536287|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884227|NCT02531295|467536288|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884228|NCT02531295|467536289|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
129884229|NCT02531295|467536290|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
129884230|NCT04424290|467536292|FG000|Overall Study|Not treated|0|||
129884231|NCT04424290|467536293|FG001|Overall Study|Not treated|0|||
129884232|NCT04424290|467536294|FG002|Overall Study|Not treated|1|||
129884233|NCT04424290|467536295|FG003|Overall Study|Not treated|0|||
129884234|NCT04424290|467536296|FG004|Overall Study|Not treated|1|||
129884235|NCT04424290|467536292|FG000|Overall Study|Adverse Event|0|||
129884236|NCT04424290|467536293|FG001|Overall Study|Adverse Event|0|||
129884237|NCT04424290|467536294|FG002|Overall Study|Adverse Event|0|||
129884238|NCT04424290|467536295|FG003|Overall Study|Adverse Event|2|||
129884239|NCT04424290|467536296|FG004|Overall Study|Adverse Event|0|||
129884240|NCT04424290|467536292|FG000|Overall Study|Withdrawal by Subject|0|||
129884241|NCT04424290|467536293|FG001|Overall Study|Withdrawal by Subject|0|||
129884242|NCT04424290|467536294|FG002|Overall Study|Withdrawal by Subject|0|||
129884243|NCT04424290|467536295|FG003|Overall Study|Withdrawal by Subject|0|||
129884244|NCT04424290|467536296|FG004|Overall Study|Withdrawal by Subject|1|||
129884245|NCT04424290|467536292|FG000|Overall Study|Other than listed|0|||
129884246|NCT04424290|467536293|FG001|Overall Study|Other than listed|0|||
129884247|NCT04424290|467536294|FG002|Overall Study|Other than listed|0|||
129884248|NCT04424290|467536295|FG003|Overall Study|Other than listed|1|||
129884249|NCT04424290|467536296|FG004|Overall Study|Other than listed|0|||
129884250|NCT04249336|467536299|FG000|Overall Study|Lost to Follow-up|3|||
129884251|NCT04249336|467536300|FG001|Overall Study|Lost to Follow-up|3|||
129884252|NCT04249336|467536301|FG002|Overall Study|Lost to Follow-up|3|||
129884253|NCT04249336|467536302|FG003|Overall Study|Lost to Follow-up|3|||
129884254|NCT01242176|467536303|FG000|Washout Period of 7 Days|Adverse Event|0|||
129884255|NCT01242176|467536304|FG001|Washout Period of 7 Days|Adverse Event|2|||
129884256|NCT01242176|467536303|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
129884257|NCT01242176|467536304|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
129884258|NCT03390036|467536305|FG000|Overall Study|Lost to Follow-up|1|||
129884259|NCT03390036|467536306|FG001|Overall Study|Lost to Follow-up|0|||
129666661|NCT01922258|466739028|FG000|Overall Study|Withdrawn by the Investigator|1|||
129666662|NCT01922258|466739029|FG001|Overall Study|Withdrawn by the Investigator|4|||
129666663|NCT01922258|466739028|FG000|Overall Study|Withdrawal by participant|5|||
129666664|NCT01922258|466739029|FG001|Overall Study|Withdrawal by participant|5|||
129666665|NCT00673257|466739030|FG000|Overall Study|Withdrawal by Subject|4|||
129666666|NCT00673257|466739030|FG000|Overall Study|Unable to obtain specimen|1|||
129666667|NCT04552132|466739031|FG000|Overall Study|Lost to Follow-up|4|||
129666668|NCT04552132|466739032|FG001|Overall Study|Lost to Follow-up|3|||
129666669|NCT04552132|466739031|FG000|Overall Study|Protocol Violation|1|||
129666670|NCT04552132|466739032|FG001|Overall Study|Protocol Violation|0|||
129666671|NCT02256839|466739033|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
129666672|NCT02256839|466739034|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
129666673|NCT01951417|466739049|FG000|Overall Study|Withdrawal by Subject|1|||
129666674|NCT01951417|466739049|FG000|Overall Study|Protocol Violation|2|||
129666675|NCT01951417|466739049|FG000|Overall Study|Lost to Follow-up|6|||
129666676|NCT01497067|466739050|FG000|Overall Study|Lost to Follow-up|56|||
129666677|NCT01497067|466739050|FG000|Overall Study|Adverse Event|3|||
129666678|NCT01497067|466739050|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
129666679|NCT01497067|466739050|FG000|Overall Study|Other|13|||
129666680|NCT01598610|466739055|FG000|Overall Study|Adverse Event|1|||
129666681|NCT04346199|466739056|FG000|Overall Study|Death|8|||
129666682|NCT04346199|466739057|FG001|Overall Study|Death|9|||
129666683|NCT04346199|466739056|FG000|Overall Study|Lost to Follow-up|0|||
129666684|NCT04346199|466739057|FG001|Overall Study|Lost to Follow-up|1|||
129666685|NCT04346199|466739056|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
129666686|NCT04346199|466739057|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
129546856|NCT03515837|466296026|FG000|Overall Study|Death|219|||
129546857|NCT03515837|466296027|FG001|Overall Study|Death|227|||
129546858|NCT03515837|466296026|FG000|Overall Study|Lost to Follow-up|0|||
129546859|NCT03515837|466296027|FG001|Overall Study|Lost to Follow-up|1|||
129546860|NCT03515837|466296026|FG000|Overall Study|Withdrawal by Subject|0|||
129666687|NCT04346199|466739056|FG000|Overall Study|Withdrawal by Subject|5|||
129546861|NCT03515837|466296027|FG001|Overall Study|Withdrawal by Subject|4|||
129546862|NCT03515837|466296026|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
129546863|NCT03515837|466296027|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
129666688|NCT04346199|466739057|FG001|Overall Study|Withdrawal by Subject|1|||
129666689|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
129666690|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
129666691|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Adverse Event|57|||
129666692|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Adverse Event|49|||
129666693|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
129666694|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
129666695|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Site closure|3|||
129666696|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Site closure|2|||
129666697|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
129666698|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
129666699|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Physician Decision|48|||
129666700|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Physician Decision|38|||
129666701|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
129666702|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
129666703|NCT01705977|466739060|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
129666704|NCT01705977|466739061|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
129666705|NCT01705977|466739060|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
129666706|NCT01705977|466739061|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
129666707|NCT01705977|466739060|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
129666708|NCT01705977|466739061|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
129666709|NCT01705977|466739060|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
129666710|NCT01705977|466739061|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
129666711|NCT01705977|466739060|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
129666712|NCT01705977|466739061|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
129666713|NCT03066830|466739062|FG000|Overall Study|At the Participant's own Request|16|||
129666714|NCT03066830|466739063|FG001|Overall Study|At the Participant's own Request|17|||
129666715|NCT03066830|466739062|FG000|Overall Study|Other|3|||
129666716|NCT03066830|466739063|FG001|Overall Study|Other|0|||
129666717|NCT03066830|466739062|FG000|Overall Study|Poor Compliance to Protocol|1|||
129666718|NCT03066830|466739063|FG001|Overall Study|Poor Compliance to Protocol|0|||
129666719|NCT03066830|466739062|FG000|Overall Study|Adverse Event|2|||
129666720|NCT03066830|466739063|FG001|Overall Study|Adverse Event|2|||
129666721|NCT03066830|466739062|FG000|Overall Study|Lost to Follow-up|11|||
129666722|NCT03066830|466739063|FG001|Overall Study|Lost to Follow-up|3|||
129666723|NCT02039778|466739065|FG000|Overall Study|Death|2|||
129666724|NCT02039778|466739065|FG000|Overall Study|Withdrawal by Subject|1|||
129666725|NCT02039778|466739065|FG000|Overall Study|Never started the protocol treatment|1|||
129666726|NCT00096538|466739074|FG000|Overall Study|Withdrawal by Subject|1|||
129666727|NCT01827592|466739077|FG000|Overall Study|Adverse Event|11|||
129666728|NCT01827592|466739078|FG001|Overall Study|Adverse Event|9|||
129666729|NCT01827592|466739079|FG002|Overall Study|Adverse Event|2|||
129666730|NCT01827592|466739077|FG000|Overall Study|Physician Decision|0|||
129666731|NCT01827592|466739078|FG001|Overall Study|Physician Decision|2|||
129666732|NCT01827592|466739079|FG002|Overall Study|Physician Decision|1|||
129666733|NCT01827592|466739077|FG000|Overall Study|Protocol Violation|2|||
129666734|NCT01827592|466739078|FG001|Overall Study|Protocol Violation|1|||
129666735|NCT01827592|466739079|FG002|Overall Study|Protocol Violation|0|||
129666736|NCT01827592|466739077|FG000|Overall Study|Lost to Follow-up|1|||
129666737|NCT01827592|466739078|FG001|Overall Study|Lost to Follow-up|2|||
129666738|NCT01827592|466739079|FG002|Overall Study|Lost to Follow-up|2|||
129666739|NCT01827592|466739077|FG000|Overall Study|Withdrawal by Subject|12|||
129666740|NCT01827592|466739078|FG001|Overall Study|Withdrawal by Subject|11|||
129666741|NCT01827592|466739079|FG002|Overall Study|Withdrawal by Subject|11|||
129666742|NCT01827592|466739077|FG000|Overall Study|Patient's substantial non-compliance|1|||
129666743|NCT01827592|466739078|FG001|Overall Study|Patient's substantial non-compliance|1|||
129666744|NCT01827592|466739079|FG002|Overall Study|Patient's substantial non-compliance|6|||
129666745|NCT01827592|466739077|FG000|Overall Study|Trial terminated by Sponsor|47|||
129666746|NCT01827592|466739078|FG001|Overall Study|Trial terminated by Sponsor|53|||
129666747|NCT01827592|466739079|FG002|Overall Study|Trial terminated by Sponsor|51|||
129666748|NCT01827592|466739077|FG000|Overall Study|Others|0|||
129666749|NCT01827592|466739078|FG001|Overall Study|Others|1|||
129666750|NCT01827592|466739079|FG002|Overall Study|Others|3|||
129884260|NCT03390036|467536307|FG002|Overall Study|Lost to Follow-up|0|||
129884261|NCT03390036|467536305|FG000|Overall Study|Lack of Efficacy|1|||
129884262|NCT03390036|467536306|FG001|Overall Study|Lack of Efficacy|0|||
129666751|NCT01931397|466739088|FG000|Overall Study|Physician Decision|2|||
129666752|NCT01931397|466739088|FG000|Overall Study|Withdrawal by Subject|8|||
129666753|NCT01931397|466739088|FG000|Overall Study|moved out of state|1|||
129884263|NCT03390036|467536307|FG002|Overall Study|Lack of Efficacy|0|||
129884264|NCT00358215|467536308|FG000|Overall Study|Ineligibility determined|4|||
129884265|NCT00358215|467536309|FG001|Overall Study|Ineligibility determined|3|||
129884266|NCT00358215|467536308|FG000|Overall Study|Adverse Event|83|||
129884267|NCT00358215|467536309|FG001|Overall Study|Adverse Event|65|||
129884268|NCT00358215|467536308|FG000|Overall Study|Withdrawal by Subject|111|||
129884269|NCT00358215|467536309|FG001|Overall Study|Withdrawal by Subject|102|||
129884270|NCT00358215|467536308|FG000|Overall Study|Participant request|65|||
129884271|NCT00358215|467536309|FG001|Overall Study|Participant request|64|||
129884272|NCT00358215|467536308|FG000|Overall Study|Physician Decision|47|||
129884273|NCT00358215|467536309|FG001|Overall Study|Physician Decision|39|||
129884274|NCT00358215|467536308|FG000|Overall Study|Lost to Follow-up|16|||
129884275|NCT00358215|467536309|FG001|Overall Study|Lost to Follow-up|22|||
129884276|NCT00358215|467536308|FG000|Overall Study|Death|265|||
129884277|NCT00358215|467536309|FG001|Overall Study|Death|281|||
129884278|NCT00358215|467536308|FG000|Overall Study|Protocol Violation|64|||
129884279|NCT00358215|467536309|FG001|Overall Study|Protocol Violation|59|||
129884280|NCT00358215|467536308|FG000|Overall Study|Pregnancy|1|||
129884281|NCT00358215|467536309|FG001|Overall Study|Pregnancy|0|||
129884282|NCT00358215|467536308|FG000|Overall Study|Other|21|||
129884283|NCT00358215|467536309|FG001|Overall Study|Other|14|||
129666754|NCT02058589|466739092|FG000|Overall Study|Serious Adverse Event|1|||
129666755|NCT02058589|466739093|FG001|Overall Study|Serious Adverse Event|1|||
129666756|NCT02058589|466739092|FG000|Overall Study|Non-Serious Adverse Event|1|||
129666757|NCT02058589|466739093|FG001|Overall Study|Non-Serious Adverse Event|0|||
129666758|NCT02058589|466739092|FG000|Overall Study|Withdrawal by Subject|0|||
129666759|NCT02058589|466739093|FG001|Overall Study|Withdrawal by Subject|1|||
129666760|NCT02143024|466739094|FG000|Overall Study|Lost to Follow-up|1|||
129666761|NCT02143024|466739095|FG001|Overall Study|Lost to Follow-up|1|||
129666762|NCT02143024|466739094|FG000|Overall Study|Withdrawal by Subject|1|||
129666763|NCT02143024|466739095|FG001|Overall Study|Withdrawal by Subject|0|||
129666764|NCT01945944|466739096|FG000|Overall Study|Adverse Event|0|||
129666765|NCT01945944|466739097|FG001|Overall Study|Adverse Event|2|||
129666766|NCT01945944|466739096|FG000|Overall Study|Physician Decision|1|||
129666767|NCT01945944|466739097|FG001|Overall Study|Physician Decision|0|||
129666768|NCT01945944|466739096|FG000|Overall Study|Withdrawal by Subject|0|||
129666769|NCT01945944|466739097|FG001|Overall Study|Withdrawal by Subject|1|||
129666770|NCT01212094|466740946|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
129666771|NCT01212094|466740947|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
129884284|NCT00358215|467536308|FG000|Overall Study|Did not receive investigational product|2|||
129666772|NCT01212094|466740948|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
129666773|NCT01212094|466740946|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
129666774|NCT01212094|466740947|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
129666775|NCT01212094|466740948|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
129666776|NCT01212094|466740946|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
129666777|NCT01212094|466740947|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
129666778|NCT01212094|466740948|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
129666779|NCT01212094|466740946|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
129666780|NCT01212094|466740947|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
129666781|NCT01212094|466740948|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
129666782|NCT01212094|466740946|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
129666783|NCT01212094|466740947|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
129666784|NCT01212094|466740948|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
129666785|NCT01212094|466740946|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
129666786|NCT01212094|466740947|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
129666787|NCT01212094|466740948|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
129666788|NCT02019550|466740951|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129666789|NCT02019550|466740952|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
129666790|NCT04771013|466740955|FG000|Overall Study|Withdrawal by Subject|2|||
129666791|NCT04771013|466740956|FG001|Overall Study|Withdrawal by Subject|0|||
129666792|NCT04771013|466740955|FG000|Overall Study|Death|0|||
129666793|NCT04771013|466740956|FG001|Overall Study|Death|5|||
129666794|NCT04771013|466740955|FG000|Overall Study|Referred to another hospital before day 20|0|||
129666795|NCT04771013|466740956|FG001|Overall Study|Referred to another hospital before day 20|1|||
129666796|NCT00823134|466740958|FG000|Overall Study|Invalid measurement|1|||
129666797|NCT02291029|466740959|FG000|Overall Study|Withdrawal by Subject|0|||
129666798|NCT02291029|466740960|FG001|Overall Study|Withdrawal by Subject|0|||
129666799|NCT02291029|466740961|FG002|Overall Study|Withdrawal by Subject|1|||
129666800|NCT02291029|466740962|FG003|Overall Study|Withdrawal by Subject|0|||
129666801|NCT02291029|466740963|FG004|Overall Study|Withdrawal by Subject|0|||
129666802|NCT02291029|466740964|FG005|Overall Study|Withdrawal by Subject|0|||
129666803|NCT02291029|466740959|FG000|Overall Study|Adverse Event|0|||
129666804|NCT02291029|466740960|FG001|Overall Study|Adverse Event|1|||
129666805|NCT02291029|466740961|FG002|Overall Study|Adverse Event|0|||
129666806|NCT02291029|466740962|FG003|Overall Study|Adverse Event|0|||
129666807|NCT02291029|466740963|FG004|Overall Study|Adverse Event|0|||
129666808|NCT02291029|466740964|FG005|Overall Study|Adverse Event|0|||
129666809|NCT00493012|466740969|FG000|Overall Study|Lost to Follow-up|18|||
129666810|NCT00493012|466740970|FG001|Overall Study|Lost to Follow-up|17|||
129666811|NCT02922153|466740971|FG000|Overall Study|Death|8|||
129666812|NCT02922153|466740972|FG001|Overall Study|Death|1|||
129666813|NCT02922153|466740971|FG000|Overall Study|Lost to Follow-up|1|||
129666814|NCT02922153|466740972|FG001|Overall Study|Lost to Follow-up|0|||
129666815|NCT02922153|466740971|FG000|Overall Study|Physician Decision|1|||
129666816|NCT02922153|466740972|FG001|Overall Study|Physician Decision|1|||
129666817|NCT02692586|466740975|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
129666818|NCT02692586|466740975|FG000|Overall Study|Received adjunctive thrombolytics|2|||
129666819|NCT04547140|466740978|FG000|Overall Study|Adverse Event|0|||
129666820|NCT04547140|466740979|FG001|Overall Study|Adverse Event|1|||
129666821|NCT04547140|466740978|FG000|Overall Study|Withdrawal by Subject|0|||
129666822|NCT04547140|466740979|FG001|Overall Study|Withdrawal by Subject|1|||
129666823|NCT04547140|466740978|FG000|Overall Study|Lost to Follow-up|3|||
129666824|NCT04547140|466740979|FG001|Overall Study|Lost to Follow-up|1|||
129666825|NCT04547140|466740978|FG000|Overall Study|Death|2|||
129666826|NCT04547140|466740979|FG001|Overall Study|Death|1|||
129666827|NCT04547140|466740978|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
129666828|NCT04547140|466740979|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
129666829|NCT04547140|466740978|FG000|Overall Study|Pregnancy|1|||
129666830|NCT04547140|466740979|FG001|Overall Study|Pregnancy|0|||
129666831|NCT04547140|466740978|FG000|Overall Study|Reason Not Specified|4|||
129666832|NCT04547140|466740979|FG001|Overall Study|Reason Not Specified|1|||
129666833|NCT00003537|466740980|FG000|Overall Study|Not evalauable|1|||
129666834|NCT01051557|466740981|FG000|Overall Study|Physician Decision|1|||
129666835|NCT01051557|466740982|FG001|Overall Study|Physician Decision|0|||
129666836|NCT01051557|466740983|FG002|Overall Study|Physician Decision|0|||
129666837|NCT01051557|466740984|FG003|Overall Study|Physician Decision|0|||
129666838|NCT01051557|466740985|FG004|Overall Study|Physician Decision|0|||
129666839|NCT01051557|466740986|FG005|Overall Study|Physician Decision|0|||
129666840|NCT01051557|466740987|FG006|Overall Study|Physician Decision|0|||
129666841|NCT01051557|466740981|FG000|Overall Study|disease progression|3|||
129666842|NCT01051557|466740982|FG001|Overall Study|disease progression|3|||
129666843|NCT01051557|466740983|FG002|Overall Study|disease progression|5|||
129666844|NCT01051557|466740984|FG003|Overall Study|disease progression|2|||
129666845|NCT01051557|466740985|FG004|Overall Study|disease progression|4|||
129666846|NCT01051557|466740986|FG005|Overall Study|disease progression|3|||
129666847|NCT01051557|466740987|FG006|Overall Study|disease progression|1|||
129666848|NCT01051557|466740981|FG000|Overall Study|Withdrawal by Subject|0|||
129666849|NCT01051557|466740982|FG001|Overall Study|Withdrawal by Subject|0|||
129666850|NCT01051557|466740983|FG002|Overall Study|Withdrawal by Subject|1|||
129666851|NCT01051557|466740984|FG003|Overall Study|Withdrawal by Subject|0|||
129666852|NCT01051557|466740985|FG004|Overall Study|Withdrawal by Subject|2|||
129666853|NCT01051557|466740986|FG005|Overall Study|Withdrawal by Subject|0|||
129666854|NCT01051557|466740987|FG006|Overall Study|Withdrawal by Subject|1|||
129666855|NCT01051557|466740981|FG000|Overall Study|Adverse Event|0|||
129666856|NCT01051557|466740982|FG001|Overall Study|Adverse Event|0|||
129666857|NCT01051557|466740983|FG002|Overall Study|Adverse Event|0|||
129666858|NCT01051557|466740984|FG003|Overall Study|Adverse Event|1|||
129666859|NCT01051557|466740985|FG004|Overall Study|Adverse Event|1|||
129666860|NCT01051557|466740986|FG005|Overall Study|Adverse Event|3|||
129666861|NCT01051557|466740987|FG006|Overall Study|Adverse Event|4|||
129666862|NCT04110314|466740989|FG000|Overall Study|Did not meet inclusion criteria|35255|||
129666863|NCT04110314|466740990|FG001|Overall Study|Did not meet inclusion criteria|35104|||
129666864|NCT04110314|466740991|FG002|Overall Study|Did not meet inclusion criteria|35636|||
129666865|NCT04110314|466740992|FG003|Overall Study|Did not meet inclusion criteria|35135|||
129666866|NCT04110314|466740993|FG004|Overall Study|Did not meet inclusion criteria|35247|||
129666867|NCT04110314|466740994|FG005|Overall Study|Did not meet inclusion criteria|35727|||
129666868|NCT01178125|466741003|FG000|Overall Study|Lost to Follow-up|397|||
129666869|NCT01178125|466741003|FG000|Overall Study|Adverse Event|244|||
129666870|NCT01178125|466741003|FG000|Overall Study|Withdrawal by Subject|209|||
129666871|NCT01178125|466741003|FG000|Overall Study|Noncompliance|184|||
129666872|NCT01178125|466741003|FG000|Overall Study|Pregnancy|55|||
129666873|NCT01178125|466741003|FG000|Overall Study|Other Reason|39|||
129666874|NCT01178125|466741003|FG000|Overall Study|Sponsor Decision|28|||
129666875|NCT01178125|466741003|FG000|Overall Study|Protocol Violation|17|||
129666876|NCT01178125|466741003|FG000|Overall Study|Investigator Decision|5|||
129666877|NCT02948829|466741004|FG000|Overall Study|Lost to Follow-up|2|||
129666878|NCT02948829|466741004|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
129666879|NCT02948829|466741004|FG000|Overall Study|Pregnancy|1|||
129666880|NCT02948829|466741004|FG000|Overall Study|Other: Reason not Specified|8|||
129666881|NCT01004978|466741005|FG000|Overall Study|Disease progression|31|||
129666882|NCT01004978|466741006|FG001|Overall Study|Disease progression|48|||
129666883|NCT01004978|466741005|FG000|Overall Study|Adverse Event|42|||
129666884|NCT01004978|466741006|FG001|Overall Study|Adverse Event|22|||
129884285|NCT00358215|467536309|FG001|Overall Study|Did not receive investigational product|3|||
129546864|NCT01964898|466296028|FG000|Overall Study|ineligible post-randomization|1|||
129666885|NCT01004978|466741005|FG000|Overall Study|Death|3|||
129666886|NCT01004978|466741006|FG001|Overall Study|Death|2|||
129666887|NCT01004978|466741005|FG000|Overall Study|Withdrawal by Subject|16|||
129666888|NCT01004978|466741006|FG001|Overall Study|Withdrawal by Subject|16|||
129666889|NCT01004978|466741005|FG000|Overall Study|Alternative therapy|4|||
129666890|NCT01004978|466741006|FG001|Overall Study|Alternative therapy|8|||
129666891|NCT01004978|466741005|FG000|Overall Study|Physician Decision|6|||
129666892|NCT01004978|466741006|FG001|Overall Study|Physician Decision|3|||
129666893|NCT01004978|466741005|FG000|Overall Study|Other complicating disease|2|||
129666894|NCT01004978|466741006|FG001|Overall Study|Other complicating disease|2|||
129666895|NCT01004978|466741005|FG000|Overall Study|Protocol Violation|2|||
129666896|NCT01004978|466741006|FG001|Overall Study|Protocol Violation|3|||
129666897|NCT01004978|466741005|FG000|Overall Study|Non-compliance|3|||
129666898|NCT01004978|466741006|FG001|Overall Study|Non-compliance|2|||
129666899|NCT01004978|466741005|FG000|Overall Study|Ineligible|1|||
129666900|NCT01004978|466741006|FG001|Overall Study|Ineligible|0|||
129666901|NCT01004978|466741005|FG000|Overall Study|Unblinded|0|||
129666902|NCT01004978|466741006|FG001|Overall Study|Unblinded|1|||
129666903|NCT01004978|466741005|FG000|Overall Study|Performance status worsening|0|||
129666904|NCT01004978|466741006|FG001|Overall Study|Performance status worsening|1|||
129666905|NCT01004978|466741005|FG000|Overall Study|Never started treatment|8|||
129666906|NCT01004978|466741006|FG001|Overall Study|Never started treatment|9|||
129666907|NCT00369915|466741007|FG000|Overall Study|expected side effects|2|||
129666908|NCT00369915|466741008|FG001|Overall Study|expected side effects|1|||
129666909|NCT00369915|466741007|FG000|Overall Study|Withdrawal by Subject|4|||
129666910|NCT00369915|466741008|FG001|Overall Study|Withdrawal by Subject|1|||
129666911|NCT00369915|466741007|FG000|Overall Study|W/drawl by investigators|0|||
129666912|NCT00369915|466741008|FG001|Overall Study|W/drawl by investigators|1|||
129666913|NCT01711983|466741009|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
129666914|NCT01711983|466741009|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
129666915|NCT01711983|466741009|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
129666916|NCT01711983|466741009|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
129666917|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666918|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
129666919|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
129666920|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666921|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666922|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666923|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666924|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666925|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666926|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666927|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666928|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666929|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666930|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666931|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129666932|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
129884286|NCT04329104|467536316|FG000|Efficacy Study|Withdrawal by Subject|0|||
129666933|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
129666934|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666935|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666936|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666937|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666938|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666939|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666940|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666941|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666942|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666943|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666944|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666945|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666946|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129666947|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
129666948|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
129666949|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
129666950|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666951|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666952|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666953|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666954|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666955|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666956|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666957|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666958|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666959|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666960|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666961|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129666962|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666963|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666964|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
129666965|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666966|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666967|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666968|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666969|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666970|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666971|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666972|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666973|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666974|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666975|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666976|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
129666977|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666978|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666979|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
129666980|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666981|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666982|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666983|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666984|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666985|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666986|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666987|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666988|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666989|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666990|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666991|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
129666992|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129666993|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129666994|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
129666995|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129666996|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129666997|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129666998|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129666999|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667000|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667001|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667002|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667003|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667004|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667005|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667006|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
129667007|NCT02326272|466741010|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667008|NCT02326272|466741011|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667009|NCT02326272|466741012|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
129667010|NCT02326272|466741013|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667011|NCT02326272|466741014|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667012|NCT02326272|466741015|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667013|NCT02326272|466741016|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667014|NCT02326272|466741017|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667015|NCT02326272|466741018|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667016|NCT02326272|466741019|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667017|NCT02326272|466741020|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667018|NCT02326272|466741021|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667019|NCT02326272|466741022|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667020|NCT02326272|466741023|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667021|NCT02326272|466741024|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
129667022|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667023|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667024|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667025|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667026|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129667027|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
129667028|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
129667029|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129667030|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129884287|NCT04329104|467536317|FG001|Efficacy Study|Withdrawal by Subject|0|||
129667031|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667032|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667033|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667034|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667035|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667036|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129667037|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667038|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667039|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667040|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667041|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667042|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
129667043|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129667044|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667045|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129667046|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129667047|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667048|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667049|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667050|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667051|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129667052|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667053|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667054|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667055|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667056|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667057|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
129667058|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667059|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
129667060|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667061|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667062|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667063|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667064|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667065|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667066|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129667067|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667068|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667069|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667070|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129667071|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667072|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
129667073|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129667074|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129667075|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667076|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129667077|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667078|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667079|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667080|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667081|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129667082|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667083|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667084|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667085|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667086|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667087|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667088|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667089|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
129667090|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667091|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667092|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667093|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667094|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667095|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667096|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
129667097|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667098|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667099|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667100|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667101|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667102|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667103|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
129667104|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667105|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667106|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667107|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667108|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667109|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667110|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667111|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129667112|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667113|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667114|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667115|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667116|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667117|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667118|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667119|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667120|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
129667121|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667122|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667123|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667124|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667125|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667126|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
129667127|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667128|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667129|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667130|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667131|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667132|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
129667133|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
129667134|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
129667135|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
129667136|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667137|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667138|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667139|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667140|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667141|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129667142|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667143|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667144|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667145|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667146|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667147|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
129667148|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667149|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667150|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667151|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667152|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667153|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667154|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667155|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667156|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
129667157|NCT02326272|466741010|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667158|NCT02326272|466741011|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129707533|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
129667159|NCT02326272|466741012|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667160|NCT02326272|466741013|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667161|NCT02326272|466741014|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667162|NCT02326272|466741015|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667163|NCT02326272|466741016|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
129667164|NCT02326272|466741017|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667165|NCT02326272|466741018|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667166|NCT02326272|466741019|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667167|NCT02326272|466741020|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667168|NCT02326272|466741021|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667169|NCT02326272|466741022|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667170|NCT02326272|466741023|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667171|NCT02326272|466741024|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
129667172|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
129667173|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
129667174|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
129667175|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
129667176|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
129667177|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
129667178|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
129667179|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
129667180|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
129667181|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
129667182|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
129667183|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
129667184|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
129667185|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
129667186|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
129667187|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667188|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667189|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667190|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667191|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667192|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667193|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667194|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667195|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667196|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667197|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
129667198|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
129667199|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
129667200|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129667201|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
129667202|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667203|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667204|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667205|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667206|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667207|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667208|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667209|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667210|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667211|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667212|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129667213|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667214|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129667215|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667216|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129667217|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667218|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667219|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667220|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667221|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667222|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667223|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667224|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667225|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667226|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667227|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667228|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
129667229|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667230|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667231|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129667232|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667233|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667234|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667235|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667236|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667237|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667238|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667239|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667240|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667241|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667242|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129667243|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667244|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
129667245|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129667246|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
129667247|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667248|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667249|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667250|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667251|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667252|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667253|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667254|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667255|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667256|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667257|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667258|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
129667259|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667260|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129667261|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
129667262|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667263|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667264|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667265|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667266|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667267|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667268|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667269|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667270|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667271|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667272|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667273|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
129667274|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
129667275|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129667276|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
129667277|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667278|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667279|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667280|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667281|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667282|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667283|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667284|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667285|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667286|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667287|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667288|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
129667289|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667290|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667291|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
129667292|NCT02326272|466741010|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667293|NCT02326272|466741011|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667294|NCT02326272|466741012|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667295|NCT02326272|466741013|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667296|NCT02326272|466741014|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129884288|NCT04329104|467536318|FG002|Efficacy Study|Withdrawal by Subject|0|||
129884289|NCT04329104|467536319|FG003|Efficacy Study|Withdrawal by Subject|5|||
129884290|NCT04329104|467536320|FG004|Efficacy Study|Withdrawal by Subject|6|||
129884291|NCT04329104|467536321|FG005|Efficacy Study|Withdrawal by Subject|8|||
129884292|NCT01024959|467536325|FG000|Overall Study|ineligible|12|||
129884293|NCT01024959|467536325|FG000|Overall Study|results not evaluable|12|||
129884294|NCT01024959|467536325|FG000|Overall Study|missing results required for analysis|17|||
129884295|NCT00636792|467536326|FG000|Overall Study|Adverse Event|16|||
129884296|NCT00636792|467536326|FG000|Overall Study|Physician Decision|7|||
129667297|NCT02326272|466741015|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667298|NCT02326272|466741016|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667299|NCT02326272|466741017|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667300|NCT02326272|466741018|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667301|NCT02326272|466741019|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667302|NCT02326272|466741020|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667303|NCT02326272|466741021|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667304|NCT02326272|466741022|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
129667305|NCT02326272|466741023|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667306|NCT02326272|466741024|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
129667307|NCT00737100|466741029|FG000|Overall Study|Adverse Event|6|||
129667308|NCT00737100|466741030|FG001|Overall Study|Adverse Event|5|||
129667309|NCT00737100|466741031|FG002|Overall Study|Adverse Event|3|||
129667310|NCT00737100|466741029|FG000|Overall Study|Lost to Follow-up|0|||
129667311|NCT00737100|466741030|FG001|Overall Study|Lost to Follow-up|1|||
129667312|NCT00737100|466741031|FG002|Overall Study|Lost to Follow-up|0|||
129667313|NCT00737100|466741029|FG000|Overall Study|Withdrawal by Subject|0|||
129667314|NCT00737100|466741030|FG001|Overall Study|Withdrawal by Subject|0|||
129667315|NCT00737100|466741031|FG002|Overall Study|Withdrawal by Subject|3|||
129667316|NCT00737100|466741029|FG000|Overall Study|Reason discontinued not explained above|1|||
129667317|NCT00737100|466741030|FG001|Overall Study|Reason discontinued not explained above|1|||
129667318|NCT00737100|466741031|FG002|Overall Study|Reason discontinued not explained above|1|||
129667319|NCT01447407|466741032|FG000|Overall Study|Withdrawal by Subject|2|||
129667320|NCT01447407|466741033|FG001|Overall Study|Withdrawal by Subject|0|||
129667321|NCT01447407|466741034|FG002|Overall Study|Withdrawal by Subject|0|||
129667322|NCT01447407|466741035|FG003|Overall Study|Withdrawal by Subject|1|||
129884297|NCT00636792|467536326|FG000|Overall Study|Progressive Disease|4|||
129884298|NCT00636792|467536326|FG000|Overall Study|Withdrawal by Subject|3|||
129884299|NCT00636792|467536326|FG000|Overall Study|Other|3|||
129884300|NCT01987596|467536329|FG000|Overall Study|Physician Decision|1|||
129884301|NCT01987596|467536330|FG001|Overall Study|Physician Decision|0|||
129884302|NCT01987596|467536329|FG000|Overall Study|Progressive Disease; missing all period|0|||
129884303|NCT01987596|467536330|FG001|Overall Study|Progressive Disease; missing all period|1|||
129884304|NCT00709592|467536331|FG000|Overall Study|Unable to proceed to transplant|0|||
129884305|NCT00709592|467536332|FG001|Overall Study|Unable to proceed to transplant|1|||
129884306|NCT01129336|467536333|FG000|Overall Study|Protocol Violation|1|||
129884307|NCT01129336|467536334|FG001|Overall Study|Protocol Violation|0|||
129884308|NCT01129336|467536333|FG000|Overall Study|Disease Progression|1|||
129667323|NCT01447407|466741032|FG000|Overall Study|Physician Decision|0|||
129667324|NCT01447407|466741033|FG001|Overall Study|Physician Decision|0|||
129667325|NCT01447407|466741034|FG002|Overall Study|Physician Decision|1|||
129667326|NCT01447407|466741035|FG003|Overall Study|Physician Decision|1|||
129667327|NCT01265394|466741038|FG000|Overall Study|Subjects withdrawn|37|||
129667328|NCT00735943|466741039|FG000|Overall Study|Lost to Follow-up|1|||
129667329|NCT00735943|466741039|FG000|Overall Study|Adverse Event|1|||
129667330|NCT00268983|466741044|FG000|Overall Study|Death|3|||
129667331|NCT00268983|466741045|FG001|Overall Study|Death|0|||
129667332|NCT01719380|466741046|FG000|Overall Study|Adverse Event|0|||
129667333|NCT01719380|466741047|FG001|Overall Study|Adverse Event|0|||
129667334|NCT01719380|466741048|FG002|Overall Study|Adverse Event|1|||
129667335|NCT01719380|466741049|FG003|Overall Study|Adverse Event|2|||
129667336|NCT01719380|466741050|FG004|Overall Study|Adverse Event|0|||
129667337|NCT01719380|466741051|FG005|Overall Study|Adverse Event|1|||
129667338|NCT01719380|466741052|FG006|Overall Study|Adverse Event|0|||
129667339|NCT01719380|466741053|FG007|Overall Study|Adverse Event|1|||
129667340|NCT01719380|466741054|FG008|Overall Study|Adverse Event|4|||
129667341|NCT01719380|466741055|FG009|Overall Study|Adverse Event|3|||
129667342|NCT01719380|466741046|FG000|Overall Study|Death|0|||
129667343|NCT01719380|466741047|FG001|Overall Study|Death|1|||
129667344|NCT01719380|466741048|FG002|Overall Study|Death|0|||
129667345|NCT01719380|466741049|FG003|Overall Study|Death|0|||
129667346|NCT01719380|466741050|FG004|Overall Study|Death|0|||
129667347|NCT01719380|466741051|FG005|Overall Study|Death|0|||
129667348|NCT01719380|466741052|FG006|Overall Study|Death|0|||
129667349|NCT01719380|466741053|FG007|Overall Study|Death|0|||
129667350|NCT01719380|466741054|FG008|Overall Study|Death|3|||
129667351|NCT01719380|466741055|FG009|Overall Study|Death|3|||
129667352|NCT01719380|466741046|FG000|Overall Study|Participant/Guardian Decision|0|||
129667353|NCT01719380|466741047|FG001|Overall Study|Participant/Guardian Decision|0|||
129667354|NCT01719380|466741048|FG002|Overall Study|Participant/Guardian Decision|1|||
129667355|NCT01719380|466741049|FG003|Overall Study|Participant/Guardian Decision|0|||
129667356|NCT01719380|466741050|FG004|Overall Study|Participant/Guardian Decision|0|||
129667357|NCT01719380|466741051|FG005|Overall Study|Participant/Guardian Decision|0|||
129667358|NCT01719380|466741052|FG006|Overall Study|Participant/Guardian Decision|0|||
129667359|NCT01719380|466741053|FG007|Overall Study|Participant/Guardian Decision|0|||
129667360|NCT01719380|466741054|FG008|Overall Study|Participant/Guardian Decision|2|||
129667361|NCT01719380|466741055|FG009|Overall Study|Participant/Guardian Decision|2|||
129667362|NCT01719380|466741046|FG000|Overall Study|Physician Decision|0|||
129667363|NCT01719380|466741047|FG001|Overall Study|Physician Decision|0|||
129667364|NCT01719380|466741048|FG002|Overall Study|Physician Decision|2|||
129667365|NCT01719380|466741049|FG003|Overall Study|Physician Decision|0|||
129667366|NCT01719380|466741050|FG004|Overall Study|Physician Decision|0|||
129667367|NCT01719380|466741051|FG005|Overall Study|Physician Decision|0|||
129667368|NCT01719380|466741052|FG006|Overall Study|Physician Decision|0|||
129667369|NCT01719380|466741053|FG007|Overall Study|Physician Decision|0|||
129667370|NCT01719380|466741054|FG008|Overall Study|Physician Decision|1|||
129667371|NCT01719380|466741055|FG009|Overall Study|Physician Decision|1|||
129667372|NCT01719380|466741046|FG000|Overall Study|Lack of Efficacy|2|||
129667373|NCT01719380|466741047|FG001|Overall Study|Lack of Efficacy|6|||
129667374|NCT01719380|466741048|FG002|Overall Study|Lack of Efficacy|5|||
129667375|NCT01719380|466741049|FG003|Overall Study|Lack of Efficacy|6|||
129667376|NCT01719380|466741050|FG004|Overall Study|Lack of Efficacy|3|||
129667377|NCT01719380|466741051|FG005|Overall Study|Lack of Efficacy|7|||
129667378|NCT01719380|466741052|FG006|Overall Study|Lack of Efficacy|10|||
129667379|NCT01719380|466741053|FG007|Overall Study|Lack of Efficacy|6|||
129667380|NCT01719380|466741054|FG008|Overall Study|Lack of Efficacy|39|||
129667381|NCT01719380|466741055|FG009|Overall Study|Lack of Efficacy|42|||
129667382|NCT01719380|466741046|FG000|Overall Study|Progressive Disease|0|||
129667383|NCT01719380|466741047|FG001|Overall Study|Progressive Disease|0|||
129667384|NCT01719380|466741048|FG002|Overall Study|Progressive Disease|0|||
129667385|NCT01719380|466741049|FG003|Overall Study|Progressive Disease|0|||
129667386|NCT01719380|466741050|FG004|Overall Study|Progressive Disease|0|||
129667387|NCT01719380|466741051|FG005|Overall Study|Progressive Disease|0|||
129667388|NCT01719380|466741052|FG006|Overall Study|Progressive Disease|0|||
129667389|NCT01719380|466741053|FG007|Overall Study|Progressive Disease|0|||
129667390|NCT01719380|466741054|FG008|Overall Study|Progressive Disease|1|||
129667391|NCT01719380|466741055|FG009|Overall Study|Progressive Disease|0|||
129667392|NCT00321906|466741063|FG000|Overall Study|Adverse Event|36|||
129667393|NCT00321906|466741064|FG001|Overall Study|Adverse Event|44|||
129667394|NCT00321906|466741063|FG000|Overall Study|Death|9|||
129667395|NCT00321906|466741064|FG001|Overall Study|Death|6|||
129667396|NCT00321906|466741063|FG000|Overall Study|Lost to Follow-up|1|||
129667397|NCT00321906|466741064|FG001|Overall Study|Lost to Follow-up|2|||
129667398|NCT00321906|466741063|FG000|Overall Study|Withdrawal by Subject|0|||
129667399|NCT00321906|466741064|FG001|Overall Study|Withdrawal by Subject|4|||
129667400|NCT00838097|466741067|FG000|Overall Study|Ineligibility determined|6|||
129667401|NCT00838097|466741067|FG000|Overall Study|Adverse Event|2|||
129667402|NCT00838097|466741067|FG000|Overall Study|Withdrawal by Subject|3|||
129667403|NCT00838097|466741067|FG000|Overall Study|Requirement for alternative therapy|2|||
129667404|NCT00838097|466741067|FG000|Overall Study|Physician Decision|4|||
129667405|NCT00838097|466741067|FG000|Overall Study|Lost to Follow-up|11|||
129667406|NCT00838097|466741067|FG000|Overall Study|Death|6|||
129667407|NCT00838097|466741067|FG000|Overall Study|Protocol-specified criteria|142|||
129667408|NCT00871234|466741068|FG000|Overall Study|Adverse Event|2|||
129667409|NCT00871234|466741068|FG000|Overall Study|Lost to Follow-up|3|||
129667410|NCT03380377|466741071|FG000|Overall Study|Physician Decision|1|||
129667411|NCT03380377|466741071|FG000|Overall Study|Withdrawal by Subject|1|||
129667412|NCT02600923|466741074|FG000|Overall Study|Death|10|||
129667413|NCT02600923|466741074|FG000|Overall Study|Adverse Event|3|||
129667414|NCT02600923|466741074|FG000|Overall Study|Global deterioration of health status|2|||
129667415|NCT02600923|466741074|FG000|Overall Study|Insufficient clinical response|6|||
129667416|NCT02600923|466741074|FG000|Overall Study|Lost to Follow-up|1|||
129667417|NCT02600923|466741074|FG000|Overall Study|Withdrawal by Subject|5|||
129667418|NCT02600923|466741074|FG000|Overall Study|Objective progression or relapse|50|||
129667419|NCT02600923|466741074|FG000|Overall Study|Study terminated by Sponsor|53|||
129667420|NCT02600923|466741074|FG000|Overall Study|Not treated|1|||
129667421|NCT00792909|466741075|FG000|Overall Study|Withdrawal by Subject|0|||
129667422|NCT00792909|466741076|FG001|Overall Study|Withdrawal by Subject|1|||
129667423|NCT00792909|466741077|FG002|Overall Study|Withdrawal by Subject|0|||
129667424|NCT00128661|466741080|FG000|Overall Study|Adverse Event|14|||
129667425|NCT00128661|466741081|FG001|Overall Study|Adverse Event|11|||
129667426|NCT00128661|466741080|FG000|Overall Study|Lost to Follow-up|10|||
129667427|NCT00128661|466741081|FG001|Overall Study|Lost to Follow-up|7|||
129667428|NCT00128661|466741080|FG000|Overall Study|Withdrawal by Subject|243|||
129667429|NCT00128661|466741081|FG001|Overall Study|Withdrawal by Subject|232|||
129667430|NCT00128661|466741080|FG000|Overall Study|Other|7|||
129667431|NCT00128661|466741081|FG001|Overall Study|Other|8|||
129667432|NCT01261390|466741083|FG000|Overall Study|Significant Concurrent Illness|1|||
129667433|NCT01261390|466741084|FG001|Overall Study|Significant Concurrent Illness|0|||
129667434|NCT01261390|466741085|FG002|Overall Study|Significant Concurrent Illness|1|||
129667435|NCT01261390|466741086|FG003|Overall Study|Significant Concurrent Illness|0|||
129667436|NCT01261390|466741083|FG000|Overall Study|Dissatisfaction with Treatment|2|||
129667437|NCT01261390|466741084|FG001|Overall Study|Dissatisfaction with Treatment|1|||
129667438|NCT01261390|466741085|FG002|Overall Study|Dissatisfaction with Treatment|1|||
129667439|NCT01261390|466741086|FG003|Overall Study|Dissatisfaction with Treatment|2|||
129667440|NCT01261390|466741083|FG000|Overall Study|Relocation|0|||
129667441|NCT01261390|466741084|FG001|Overall Study|Relocation|1|||
129667442|NCT01261390|466741085|FG002|Overall Study|Relocation|0|||
129667443|NCT01261390|466741086|FG003|Overall Study|Relocation|0|||
129667444|NCT01261390|466741083|FG000|Overall Study|Loss of Interest in the Study|3|||
129667445|NCT01261390|466741084|FG001|Overall Study|Loss of Interest in the Study|1|||
129667446|NCT01261390|466741085|FG002|Overall Study|Loss of Interest in the Study|0|||
129667447|NCT01261390|466741086|FG003|Overall Study|Loss of Interest in the Study|0|||
129667448|NCT01261390|466741083|FG000|Overall Study|Lost to Follow-up|1|||
129667449|NCT01261390|466741084|FG001|Overall Study|Lost to Follow-up|6|||
129667450|NCT01261390|466741085|FG002|Overall Study|Lost to Follow-up|5|||
129667451|NCT01261390|466741086|FG003|Overall Study|Lost to Follow-up|6|||
129667452|NCT00977613|466741092|FG000|Overall Study|Lost to Follow-up|16|||
129546865|NCT01964898|466296029|FG001|Overall Study|ineligible post-randomization|1|||
129667453|NCT01691378|466741096|FG000|Overall Study|Withdrawal by Subject|2|||
129667454|NCT01691378|466741097|FG001|Overall Study|Withdrawal by Subject|0|||
129667455|NCT01691378|466741096|FG000|Overall Study|Lost to Follow-up|5|||
129667456|NCT01691378|466741097|FG001|Overall Study|Lost to Follow-up|2|||
129667457|NCT00808067|466741100|FG000|Overall Study|Major/minor bleed|30|||
129667458|NCT00808067|466741101|FG001|Overall Study|Major/minor bleed|44|||
129667459|NCT00808067|466741100|FG000|Overall Study|Outcome event - other|33|||
129667460|NCT00808067|466741101|FG001|Overall Study|Outcome event - other|25|||
129667461|NCT00808067|466741100|FG000|Overall Study|Adverse Event|111|||
129667462|NCT00808067|466741101|FG001|Overall Study|Adverse Event|121|||
129667463|NCT00808067|466741100|FG000|Overall Study|Hospitalization (not including surgery)|18|||
129667464|NCT00808067|466741101|FG001|Overall Study|Hospitalization (not including surgery)|17|||
129667465|NCT00808067|466741100|FG000|Overall Study|Hospitalization due to surgery|37|||
129667466|NCT00808067|466741101|FG001|Overall Study|Hospitalization due to surgery|40|||
129667467|NCT00808067|466741100|FG000|Overall Study|Reduced creatinine clearance|53|||
129667468|NCT00808067|466741101|FG001|Overall Study|Reduced creatinine clearance|55|||
129667469|NCT00808067|466741100|FG000|Overall Study|Elevated LFT results|7|||
129667470|NCT00808067|466741101|FG001|Overall Study|Elevated LFT results|3|||
129667471|NCT00808067|466741100|FG000|Overall Study|Patient refused to take study medication|65|||
129667472|NCT00808067|466741101|FG001|Overall Study|Patient refused to take study medication|76|||
129667473|NCT00808067|466741100|FG000|Overall Study|Missing|1|||
129667474|NCT00808067|466741101|FG001|Overall Study|Missing|0|||
129667475|NCT00808067|466741100|FG000|Overall Study|Death|1|||
129667476|NCT00808067|466741101|FG001|Overall Study|Death|1|||
129667477|NCT00808067|466741100|FG000|Overall Study|Procedure|6|||
129667478|NCT00808067|466741101|FG001|Overall Study|Procedure|7|||
129667479|NCT00808067|466741100|FG000|Overall Study|Withdrawal by Subject|21|||
129667480|NCT00808067|466741101|FG001|Overall Study|Withdrawal by Subject|25|||
129667481|NCT00808067|466741100|FG000|Overall Study|Site closed|4|||
129667482|NCT00808067|466741101|FG001|Overall Study|Site closed|3|||
129667483|NCT00808067|466741100|FG000|Overall Study|Physician Decision|47|||
129667484|NCT00808067|466741101|FG001|Overall Study|Physician Decision|38|||
129667485|NCT00808067|466741100|FG000|Overall Study|Protocol Violation|3|||
129667486|NCT00808067|466741101|FG001|Overall Study|Protocol Violation|11|||
129667487|NCT00808067|466741100|FG000|Overall Study|Patient elected|7|||
129667488|NCT00808067|466741101|FG001|Overall Study|Patient elected|9|||
129667489|NCT00808067|466741100|FG000|Overall Study|Site closed for cause|19|||
129667490|NCT00808067|466741101|FG001|Overall Study|Site closed for cause|19|||
129667491|NCT00808067|466741100|FG000|Overall Study|Other reason not defined above|5|||
129667492|NCT00808067|466741101|FG001|Overall Study|Other reason not defined above|5|||
129667493|NCT00808067|466741100|FG000|Overall Study|Excluded from analysis|13|||
129667494|NCT00808067|466741101|FG001|Overall Study|Excluded from analysis|19|||
129667495|NCT02532283|466741104|FG000|Overall Study|Adverse Event|0|||
129667496|NCT02532283|466741105|FG001|Overall Study|Adverse Event|1|||
129667497|NCT02532283|466741104|FG000|Overall Study|Death|1|||
129667498|NCT02532283|466741105|FG001|Overall Study|Death|0|||
129667499|NCT02532283|466741104|FG000|Overall Study|Lost to Follow-up|0|||
129667500|NCT02532283|466741105|FG001|Overall Study|Lost to Follow-up|1|||
129667501|NCT02532283|466741104|FG000|Overall Study|Withdrawal by Subject|8|||
129667502|NCT02532283|466741105|FG001|Overall Study|Withdrawal by Subject|3|||
129667503|NCT00490971|466741106|FG000|Acute/Continuation|Adverse Event|62|||
129667504|NCT00490971|466741107|FG001|Acute/Continuation|Adverse Event|13|||
129667505|NCT00490971|466741108|FG002|Acute/Continuation|Adverse Event|0|||
129667506|NCT00490971|466741109|FG003|Acute/Continuation|Adverse Event|0|||
129667507|NCT00490971|466741110|FG004|Acute/Continuation|Adverse Event|0|||
129667508|NCT00490971|466741106|FG000|Acute/Continuation|Death|2|||
129884309|NCT01129336|467536334|FG001|Overall Study|Disease Progression|4|||
129884310|NCT01129336|467536333|FG000|Overall Study|Lost to Follow-up|1|||
129884311|NCT01129336|467536334|FG001|Overall Study|Lost to Follow-up|0|||
129884312|NCT01129336|467536333|FG000|Overall Study|Withdrawal by Subject|7|||
129884313|NCT01129336|467536334|FG001|Overall Study|Withdrawal by Subject|4|||
129884314|NCT01129336|467536333|FG000|Overall Study|Adverse Event|0|||
129884315|NCT01129336|467536334|FG001|Overall Study|Adverse Event|1|||
129884316|NCT01129336|467536333|FG000|Overall Study|Missing Study Completion Status|2|||
129884317|NCT01129336|467536334|FG001|Overall Study|Missing Study Completion Status|3|||
129884318|NCT01129336|467536333|FG000|Overall Study|Death|0|||
129884319|NCT01129336|467536334|FG001|Overall Study|Death|4|||
129884320|NCT00358150|467536335|FG000|Overall Study|Adverse Event|3|||
129884321|NCT00358150|467536335|FG000|Overall Study|Withdrawal by Subject|1|||
129884322|NCT00358150|467536335|FG000|Overall Study|Undefined|3|||
129884323|NCT04668989|467536336|FG000|First Intervention|Covid-19 related self-isolation|0|||
129884324|NCT04668989|467536337|FG001|First Intervention|Covid-19 related self-isolation|1|||
129884325|NCT04668989|467536336|FG000|Second Intervention|Adverse Event|0|||
129884326|NCT04668989|467536337|FG001|Second Intervention|Adverse Event|1|||
129884327|NCT00179010|467536341|FG000|Overall Study|Muscle probe defective|1|||
129884328|NCT00179010|467536342|FG001|Overall Study|Muscle probe defective|1|||
129884329|NCT00179010|467536341|FG000|Overall Study|Failure to place arterial line|0|||
129884330|NCT00179010|467536342|FG001|Overall Study|Failure to place arterial line|1|||
129884331|NCT01622348|467536343|FG000|Overall Study|Withdrawal by Subject|1|||
129884332|NCT01622348|467536344|FG001|Overall Study|Withdrawal by Subject|0|||
129884333|NCT01622348|467536345|FG002|Overall Study|Withdrawal by Subject|1|||
129884334|NCT01592695|467536354|FG000|Overall Study|Lost to Follow-up|8|||
129884335|NCT01592695|467536355|FG001|Overall Study|Lost to Follow-up|4|||
129884336|NCT00919893|467536362|FG000|Overall Study|Protocol Violation|19|||
129884337|NCT00919893|467536363|FG001|Overall Study|Protocol Violation|9|||
129884338|NCT01375959|467536369|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
129884339|NCT01375959|467536370|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
129884340|NCT01375959|467536369|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
129884341|NCT01375959|467536370|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
129884342|NCT01375959|467536369|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129884343|NCT01375959|467536370|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
129884344|NCT00178256|467536371|FG000|Overall Study|Adverse Event|2|||
129884345|NCT00178256|467536372|FG001|Overall Study|Adverse Event|0|||
129884346|NCT00178256|467536373|FG002|Overall Study|Adverse Event|0|||
129884347|NCT00178256|467536374|FG003|Overall Study|Adverse Event|0|||
129884348|NCT00178256|467536371|FG000|Overall Study|Death|0|||
129884349|NCT00178256|467536372|FG001|Overall Study|Death|1|||
129884350|NCT00178256|467536373|FG002|Overall Study|Death|0|||
129884351|NCT00178256|467536374|FG003|Overall Study|Death|1|||
129884352|NCT00178256|467536371|FG000|Overall Study|Cancer progression|2|||
129884353|NCT00178256|467536372|FG001|Overall Study|Cancer progression|0|||
129884354|NCT00178256|467536373|FG002|Overall Study|Cancer progression|0|||
129884355|NCT00178256|467536374|FG003|Overall Study|Cancer progression|1|||
129884356|NCT01763788|467536375|FG000|Overall Study|Lost to Follow-up|0|||
129884357|NCT01763788|467536376|FG001|Overall Study|Lost to Follow-up|0|||
129884358|NCT01763788|467536377|FG002|Overall Study|Lost to Follow-up|1|||
129884359|NCT01763788|467536378|FG003|Overall Study|Lost to Follow-up|0|||
129884360|NCT03893825|467536379|FG000|Overall Study|Death|2|||
129884361|NCT03893825|467536380|FG001|Overall Study|Death|1|||
129884362|NCT03893825|467536379|FG000|Overall Study|Adverse Event|0|||
129884363|NCT03893825|467536380|FG001|Overall Study|Adverse Event|2|||
129884364|NCT03893825|467536379|FG000|Overall Study|Withdrawal by Subject|19|||
129884365|NCT03893825|467536380|FG001|Overall Study|Withdrawal by Subject|21|||
129884366|NCT03893825|467536379|FG000|Overall Study|Protocol deviation|1|||
129884367|NCT03893825|467536380|FG001|Overall Study|Protocol deviation|0|||
129884368|NCT03893825|467536379|FG000|Overall Study|Lost to Follow-up|10|||
129667509|NCT00490971|466741107|FG001|Acute/Continuation|Death|0|||
129884369|NCT03893825|467536380|FG001|Overall Study|Lost to Follow-up|10|||
129667510|NCT00490971|466741108|FG002|Acute/Continuation|Death|0|||
129667511|NCT00490971|466741109|FG003|Acute/Continuation|Death|0|||
129667512|NCT00490971|466741110|FG004|Acute/Continuation|Death|0|||
129667513|NCT00490971|466741106|FG000|Acute/Continuation|Lack of Efficacy|106|||
129667514|NCT00490971|466741107|FG001|Acute/Continuation|Lack of Efficacy|12|||
129667515|NCT00490971|466741108|FG002|Acute/Continuation|Lack of Efficacy|0|||
129667516|NCT00490971|466741109|FG003|Acute/Continuation|Lack of Efficacy|0|||
129667517|NCT00490971|466741110|FG004|Acute/Continuation|Lack of Efficacy|0|||
129667518|NCT00490971|466741106|FG000|Acute/Continuation|Lost to Follow-up|23|||
129667519|NCT00490971|466741107|FG001|Acute/Continuation|Lost to Follow-up|7|||
129667520|NCT00490971|466741108|FG002|Acute/Continuation|Lost to Follow-up|0|||
129667521|NCT00490971|466741109|FG003|Acute/Continuation|Lost to Follow-up|0|||
129667522|NCT00490971|466741110|FG004|Acute/Continuation|Lost to Follow-up|0|||
129667523|NCT00490971|466741106|FG000|Acute/Continuation|Protocol Violation|10|||
129667524|NCT00490971|466741107|FG001|Acute/Continuation|Protocol Violation|2|||
129667525|NCT00490971|466741108|FG002|Acute/Continuation|Protocol Violation|0|||
129667526|NCT00490971|466741109|FG003|Acute/Continuation|Protocol Violation|0|||
129667527|NCT00490971|466741110|FG004|Acute/Continuation|Protocol Violation|0|||
129667528|NCT00490971|466741106|FG000|Acute/Continuation|Withdrawal by Subject|92|||
129667529|NCT00490971|466741107|FG001|Acute/Continuation|Withdrawal by Subject|24|||
129667530|NCT00490971|466741108|FG002|Acute/Continuation|Withdrawal by Subject|0|||
129667531|NCT00490971|466741109|FG003|Acute/Continuation|Withdrawal by Subject|0|||
129667532|NCT00490971|466741110|FG004|Acute/Continuation|Withdrawal by Subject|0|||
129667533|NCT00490971|466741106|FG000|Acute/Continuation|Other|11|||
129667534|NCT00490971|466741107|FG001|Acute/Continuation|Other|4|||
129667535|NCT00490971|466741108|FG002|Acute/Continuation|Other|0|||
129667536|NCT00490971|466741109|FG003|Acute/Continuation|Other|0|||
129667537|NCT00490971|466741110|FG004|Acute/Continuation|Other|0|||
129667538|NCT00490971|466741106|FG000|Maintenance|Adverse Event|0|||
129667539|NCT00490971|466741107|FG001|Maintenance|Adverse Event|0|||
129667540|NCT00490971|466741108|FG002|Maintenance|Adverse Event|4|||
129667541|NCT00490971|466741109|FG003|Maintenance|Adverse Event|5|||
129667542|NCT00490971|466741110|FG004|Maintenance|Adverse Event|7|||
129667543|NCT00490971|466741106|FG000|Maintenance|Death|0|||
129667544|NCT00490971|466741107|FG001|Maintenance|Death|0|||
129667545|NCT00490971|466741108|FG002|Maintenance|Death|0|||
129667546|NCT00490971|466741109|FG003|Maintenance|Death|2|||
129667547|NCT00490971|466741110|FG004|Maintenance|Death|0|||
129667548|NCT00490971|466741106|FG000|Maintenance|Lost to Follow-up|0|||
129667549|NCT00490971|466741107|FG001|Maintenance|Lost to Follow-up|0|||
129667550|NCT00490971|466741108|FG002|Maintenance|Lost to Follow-up|5|||
129667551|NCT00490971|466741109|FG003|Maintenance|Lost to Follow-up|8|||
129667552|NCT00490971|466741110|FG004|Maintenance|Lost to Follow-up|10|||
129667553|NCT00490971|466741106|FG000|Maintenance|Pregnancy|0|||
129667554|NCT00490971|466741107|FG001|Maintenance|Pregnancy|0|||
129667555|NCT00490971|466741108|FG002|Maintenance|Pregnancy|1|||
129884370|NCT03893825|467536379|FG000|Overall Study|Other than specified|7|||
129667556|NCT00490971|466741109|FG003|Maintenance|Pregnancy|0|||
129667557|NCT00490971|466741110|FG004|Maintenance|Pregnancy|0|||
129667558|NCT00490971|466741106|FG000|Maintenance|Protocol Violation|0|||
129667559|NCT00490971|466741107|FG001|Maintenance|Protocol Violation|0|||
129667560|NCT00490971|466741108|FG002|Maintenance|Protocol Violation|4|||
129667561|NCT00490971|466741109|FG003|Maintenance|Protocol Violation|1|||
129667562|NCT00490971|466741110|FG004|Maintenance|Protocol Violation|1|||
129667563|NCT00490971|466741106|FG000|Maintenance|Withdrawal by Subject|0|||
129667564|NCT00490971|466741107|FG001|Maintenance|Withdrawal by Subject|0|||
129667565|NCT00490971|466741108|FG002|Maintenance|Withdrawal by Subject|26|||
129667566|NCT00490971|466741109|FG003|Maintenance|Withdrawal by Subject|28|||
129667567|NCT00490971|466741110|FG004|Maintenance|Withdrawal by Subject|18|||
129667568|NCT00490971|466741106|FG000|Maintenance|Other|0|||
129667569|NCT00490971|466741107|FG001|Maintenance|Other|0|||
129667570|NCT00490971|466741108|FG002|Maintenance|Other|11|||
129546866|NCT01964898|466296028|FG000|Overall Study|did not receive the allocated interventi|2|||
129667571|NCT00490971|466741109|FG003|Maintenance|Other|9|||
129667572|NCT00490971|466741110|FG004|Maintenance|Other|3|||
129667573|NCT04888494|466741112|FG000|Overall Study|Lost to Follow-up|2|||
129667574|NCT04888494|466741113|FG001|Overall Study|Lost to Follow-up|3|||
129667575|NCT04888494|466741112|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
129667576|NCT04888494|466741113|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
129667577|NCT00565604|466741119|FG000|Overall Study|Failure to treat|2|||
129667578|NCT00565604|466741119|FG000|Overall Study|Lost to Follow-up|2|||
129667579|NCT04754542|466741120|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
129667580|NCT04754542|466741121|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
129667581|NCT02317991|466742633|FG000|Overall Study|Adverse Event|12|||
129667582|NCT02317991|466742633|FG000|Overall Study|Death|4|||
129667583|NCT02317991|466742633|FG000|Overall Study|Withdrawal by Subject|8|||
129667584|NCT02317991|466742633|FG000|Overall Study|Progressive Disease|41|||
129667585|NCT00419757|466742634|FG000|Overall Study|Adverse Event|1|||
129667586|NCT00419757|466742635|FG001|Overall Study|Adverse Event|4|||
129667587|NCT00419757|466742634|FG000|Overall Study|Lost to Follow-up|1|||
129667588|NCT00419757|466742635|FG001|Overall Study|Lost to Follow-up|4|||
129667589|NCT00419757|466742634|FG000|Overall Study|Withdrawal by Subject|7|||
129667590|NCT00419757|466742635|FG001|Overall Study|Withdrawal by Subject|1|||
129884371|NCT03893825|467536380|FG001|Overall Study|Other than specified|6|||
129667591|NCT00419757|466742634|FG000|Overall Study|Protocol Violation|2|||
129884372|NCT00708305|467536383|FG000|Period 1|Protocol Violation|1|||
129667592|NCT00419757|466742635|FG001|Overall Study|Protocol Violation|3|||
129667593|NCT00419757|466742634|FG000|Overall Study|Study specific discontinuation criteria|4|||
129667594|NCT00419757|466742635|FG001|Overall Study|Study specific discontinuation criteria|8|||
129667595|NCT00419757|466742634|FG000|Overall Study|Multiple reasons|3|||
129667596|NCT00419757|466742635|FG001|Overall Study|Multiple reasons|1|||
129667597|NCT00327340|466742636|FG000|Overall Study|Withdrawal by Subject|1|||
129667598|NCT00327340|466742637|FG001|Overall Study|Withdrawal by Subject|5|||
129667599|NCT00327340|466742636|FG000|Overall Study|Physician Decision|1|||
129667600|NCT00327340|466742637|FG001|Overall Study|Physician Decision|1|||
129667601|NCT00327340|466742636|FG000|Overall Study|Disease Progression|10|||
129667602|NCT00327340|466742637|FG001|Overall Study|Disease Progression|19|||
129667603|NCT00327340|466742636|FG000|Overall Study|Symptomatic Disease|0|||
129667604|NCT00327340|466742637|FG001|Overall Study|Symptomatic Disease|2|||
129667605|NCT00327340|466742636|FG000|Overall Study|Adverse Event|3|||
129667606|NCT00327340|466742637|FG001|Overall Study|Adverse Event|3|||
129667607|NCT01716806|466742642|FG000|Overall Study|Patient withdrawal of consent|4|||
129667608|NCT01716806|466742643|FG001|Overall Study|Patient withdrawal of consent|2|||
129667609|NCT01716806|466742644|FG002|Overall Study|Patient withdrawal of consent|4|||
129667610|NCT01716806|466742645|FG003|Overall Study|Patient withdrawal of consent|3|||
129667611|NCT01716806|466742646|FG004|Overall Study|Patient withdrawal of consent|2|||
129667612|NCT01716806|466742647|FG005|Overall Study|Patient withdrawal of consent|0|||
129667613|NCT01716806|466742642|FG000|Overall Study|Lost to Follow-up|3|||
129667614|NCT01716806|466742643|FG001|Overall Study|Lost to Follow-up|3|||
129667615|NCT01716806|466742644|FG002|Overall Study|Lost to Follow-up|0|||
129667616|NCT01716806|466742645|FG003|Overall Study|Lost to Follow-up|2|||
129667617|NCT01716806|466742646|FG004|Overall Study|Lost to Follow-up|1|||
129667618|NCT01716806|466742647|FG005|Overall Study|Lost to Follow-up|0|||
129667619|NCT01716806|466742642|FG000|Overall Study|Death|13|||
129667620|NCT01716806|466742643|FG001|Overall Study|Death|9|||
129667621|NCT01716806|466742644|FG002|Overall Study|Death|12|||
129667622|NCT01716806|466742645|FG003|Overall Study|Death|4|||
129667623|NCT01716806|466742646|FG004|Overall Study|Death|10|||
129667624|NCT01716806|466742647|FG005|Overall Study|Death|5|||
129667625|NCT01716806|466742642|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129667626|NCT01716806|466742643|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129667627|NCT01716806|466742644|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129667628|NCT01716806|466742645|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
129667629|NCT01716806|466742646|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
129667630|NCT01716806|466742647|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
129667631|NCT01716806|466742642|FG000|Overall Study|PI decision|0|||
129667632|NCT01716806|466742643|FG001|Overall Study|PI decision|0|||
129667633|NCT01716806|466742644|FG002|Overall Study|PI decision|0|||
129667634|NCT01716806|466742645|FG003|Overall Study|PI decision|0|||
129667635|NCT01716806|466742646|FG004|Overall Study|PI decision|1|||
129667636|NCT01716806|466742647|FG005|Overall Study|PI decision|0|||
129667637|NCT01716806|466742642|FG000|Overall Study|Change in performance status|1|||
129667638|NCT01716806|466742643|FG001|Overall Study|Change in performance status|0|||
129667639|NCT01716806|466742644|FG002|Overall Study|Change in performance status|0|||
129667640|NCT01716806|466742645|FG003|Overall Study|Change in performance status|0|||
129667641|NCT01716806|466742646|FG004|Overall Study|Change in performance status|0|||
129667642|NCT01716806|466742647|FG005|Overall Study|Change in performance status|0|||
129667643|NCT01716806|466742642|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
129667644|NCT01716806|466742643|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
129667645|NCT01716806|466742644|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
129667646|NCT01716806|466742645|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
129667647|NCT01716806|466742646|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
129667648|NCT01716806|466742647|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
129667649|NCT01716806|466742642|FG000|Overall Study|Sponsor direction|7|||
129667650|NCT01716806|466742643|FG001|Overall Study|Sponsor direction|8|||
129667651|NCT01716806|466742644|FG002|Overall Study|Sponsor direction|5|||
129667652|NCT01716806|466742645|FG003|Overall Study|Sponsor direction|12|||
129667653|NCT01716806|466742646|FG004|Overall Study|Sponsor direction|16|||
129667654|NCT01716806|466742647|FG005|Overall Study|Sponsor direction|1|||
129667655|NCT03506438|466742648|FG000|Overall Study|Lost to Follow-up|8|||
129667656|NCT03506438|466742649|FG001|Overall Study|Lost to Follow-up|7|||
129667657|NCT03506438|466742650|FG002|Overall Study|Lost to Follow-up|8|||
129667658|NCT03506438|466742651|FG003|Overall Study|Lost to Follow-up|7|||
129667659|NCT03506438|466742652|FG004|Overall Study|Lost to Follow-up|0|||
129667660|NCT03506438|466742653|FG005|Overall Study|Lost to Follow-up|0|||
129667661|NCT03527277|466742654|FG000|Overall Study|Withdrawal by Subject|5|||
129667662|NCT03527277|466742655|FG001|Overall Study|Withdrawal by Subject|0|||
129667663|NCT03527277|466742654|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
129667664|NCT03527277|466742655|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
129667665|NCT03527277|466742654|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
129667666|NCT03527277|466742655|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
129667667|NCT01128296|466742656|FG000|Overall Study|Physician Decision|0|||
129667668|NCT01128296|466742657|FG001|Overall Study|Physician Decision|0|||
129667669|NCT01128296|466742658|FG002|Overall Study|Physician Decision|0|||
129667670|NCT01128296|466742659|FG003|Overall Study|Physician Decision|0|||
129667671|NCT01128296|466742660|FG004|Overall Study|Physician Decision|0|||
129667672|NCT01128296|466742661|FG005|Overall Study|Physician Decision|3|||
129667673|NCT01128296|466742656|FG000|Overall Study|Withdrawal by Subject|0|||
129667674|NCT01128296|466742657|FG001|Overall Study|Withdrawal by Subject|0|||
129667675|NCT01128296|466742658|FG002|Overall Study|Withdrawal by Subject|0|||
129667676|NCT01128296|466742659|FG003|Overall Study|Withdrawal by Subject|0|||
129667677|NCT01128296|466742660|FG004|Overall Study|Withdrawal by Subject|0|||
129884373|NCT00708305|467536384|FG001|Period 1|Protocol Violation|0|||
129667678|NCT01128296|466742661|FG005|Overall Study|Withdrawal by Subject|2|||
129667679|NCT04155463|466742664|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
129667680|NCT04155463|466742665|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
129667681|NCT03316586|466742666|FG000|Overall Study|Adverse Event|2|||
129667682|NCT03316586|466742666|FG000|Overall Study|Physician Decision|3|||
129667683|NCT03316586|466742666|FG000|Overall Study|Lack of Efficacy|10|||
129667684|NCT03316586|466742666|FG000|Overall Study|still on treatment|1|||
129667685|NCT03316586|466742666|FG000|Overall Study|Patient needed radiation therapy|1|||
129667686|NCT03316586|466742666|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
129667687|NCT03934216|466742669|FG000|Overall Study|Other Reasons|5|||
129667688|NCT03934216|466742670|FG001|Overall Study|Other Reasons|5|||
129667689|NCT03934216|466742669|FG000|Overall Study|Adverse Event|22|||
129667690|NCT03934216|466742670|FG001|Overall Study|Adverse Event|11|||
129667691|NCT03934216|466742669|FG000|Overall Study|Lack of Efficacy|8|||
129667692|NCT03934216|466742670|FG001|Overall Study|Lack of Efficacy|7|||
129667693|NCT03934216|466742669|FG000|Overall Study|Lost to Follow-up|2|||
129667694|NCT03934216|466742670|FG001|Overall Study|Lost to Follow-up|0|||
129667695|NCT03934216|466742669|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129667696|NCT03934216|466742670|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129667697|NCT03934216|466742669|FG000|Overall Study|Pregnancy|1|||
129667698|NCT03934216|466742670|FG001|Overall Study|Pregnancy|0|||
129667699|NCT03934216|466742669|FG000|Overall Study|Withdrawal by Subject|18|||
129667700|NCT03934216|466742670|FG001|Overall Study|Withdrawal by Subject|6|||
129667701|NCT03934216|466742669|FG000|Overall Study|Randomized but not treated|1|||
129667702|NCT03934216|466742670|FG001|Overall Study|Randomized but not treated|1|||
129667703|NCT01914393|466742673|FG000|Overall Study|Protocol Violation|11|||
129667704|NCT01914393|466742674|FG001|Overall Study|Protocol Violation|3|||
129667705|NCT01914393|466742675|FG002|Overall Study|Protocol Violation|19|||
129667706|NCT01914393|466742673|FG000|Overall Study|Lack of Efficacy|11|||
129667707|NCT01914393|466742674|FG001|Overall Study|Lack of Efficacy|16|||
129667708|NCT01914393|466742675|FG002|Overall Study|Lack of Efficacy|5|||
129667709|NCT01914393|466742673|FG000|Overall Study|no reason given|14|||
129667710|NCT01914393|466742674|FG001|Overall Study|no reason given|8|||
129667711|NCT01914393|466742675|FG002|Overall Study|no reason given|16|||
129667712|NCT01914393|466742673|FG000|Overall Study|Adverse Event|29|||
129667713|NCT01914393|466742674|FG001|Overall Study|Adverse Event|18|||
129667714|NCT01914393|466742675|FG002|Overall Study|Adverse Event|31|||
129667715|NCT01914393|466742673|FG000|Overall Study|Withdrawal by Subject|38|||
129667716|NCT01914393|466742674|FG001|Overall Study|Withdrawal by Subject|20|||
129667717|NCT01914393|466742675|FG002|Overall Study|Withdrawal by Subject|47|||
129667718|NCT01914393|466742673|FG000|Overall Study|Lost to Follow-up|12|||
129667719|NCT01914393|466742674|FG001|Overall Study|Lost to Follow-up|6|||
129667720|NCT01914393|466742675|FG002|Overall Study|Lost to Follow-up|19|||
129667721|NCT01914393|466742673|FG000|Overall Study|subject never dosed|0|||
129667722|NCT01914393|466742674|FG001|Overall Study|subject never dosed|0|||
129667723|NCT01914393|466742675|FG002|Overall Study|subject never dosed|1|||
129667724|NCT01396083|466742676|FG000|Overall Study|Adverse Event|2|||
129667725|NCT01396083|466742677|FG001|Overall Study|Adverse Event|28|||
129667726|NCT01396083|466742676|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129667727|NCT01396083|466742677|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
129667728|NCT01396083|466742676|FG000|Overall Study|Consent withdrawn|4|||
129667729|NCT01396083|466742677|FG001|Overall Study|Consent withdrawn|5|||
129667730|NCT01396083|466742676|FG000|Overall Study|Protocol deviation(s)|0|||
129667731|NCT01396083|466742677|FG001|Overall Study|Protocol deviation(s)|1|||
129667732|NCT01396083|466742676|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129667733|NCT01396083|466742677|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129667734|NCT01396083|466742676|FG000|Overall Study|Administrative problems|1|||
129884374|NCT00708305|467536385|FG002|Period 1|Protocol Violation|1|||
129667735|NCT01396083|466742677|FG001|Overall Study|Administrative problems|0|||
129667736|NCT01396083|466742676|FG000|Overall Study|Lost to Follow-up|1|||
129667737|NCT01396083|466742677|FG001|Overall Study|Lost to Follow-up|0|||
129667738|NCT02806713|466742678|FG000|Overall Study|Urethral injury during procedure|1|||
129667739|NCT02806713|466742679|FG001|Overall Study|Urethral injury during procedure|0|||
129667740|NCT02806713|466742678|FG000|Overall Study|cancelled surgery|1|||
129667741|NCT02806713|466742679|FG001|Overall Study|cancelled surgery|2|||
129667742|NCT00735709|466742680|FG000|Overall Study|Adverse Event|2|||
129667743|NCT00735709|466742681|FG001|Overall Study|Adverse Event|3|||
129667744|NCT00735709|466742682|FG002|Overall Study|Adverse Event|1|||
129667745|NCT00735709|466742683|FG003|Overall Study|Adverse Event|5|||
129667746|NCT00735709|466742680|FG000|Overall Study|Lack of Efficacy|8|||
129667747|NCT00735709|466742681|FG001|Overall Study|Lack of Efficacy|4|||
129667748|NCT00735709|466742682|FG002|Overall Study|Lack of Efficacy|2|||
129667749|NCT00735709|466742683|FG003|Overall Study|Lack of Efficacy|3|||
129667750|NCT00735709|466742680|FG000|Overall Study|Noncompliance|0|||
129667751|NCT00735709|466742681|FG001|Overall Study|Noncompliance|0|||
129667752|NCT00735709|466742682|FG002|Overall Study|Noncompliance|1|||
129667753|NCT00735709|466742683|FG003|Overall Study|Noncompliance|0|||
129667754|NCT00735709|466742680|FG000|Overall Study|Protocol deviations|1|||
129667755|NCT00735709|466742681|FG001|Overall Study|Protocol deviations|2|||
129667756|NCT00735709|466742682|FG002|Overall Study|Protocol deviations|1|||
129667757|NCT00735709|466742683|FG003|Overall Study|Protocol deviations|1|||
129667758|NCT00735709|466742680|FG000|Overall Study|Voluntary Withdrawal|1|||
129667759|NCT00735709|466742681|FG001|Overall Study|Voluntary Withdrawal|3|||
129667760|NCT00735709|466742682|FG002|Overall Study|Voluntary Withdrawal|5|||
129667761|NCT00735709|466742683|FG003|Overall Study|Voluntary Withdrawal|7|||
129667762|NCT00735709|466742680|FG000|Overall Study|Lost to Follow-up|0|||
129667763|NCT00735709|466742681|FG001|Overall Study|Lost to Follow-up|1|||
129667764|NCT00735709|466742682|FG002|Overall Study|Lost to Follow-up|1|||
129667765|NCT00735709|466742683|FG003|Overall Study|Lost to Follow-up|1|||
129667766|NCT00735709|466742680|FG000|Overall Study|Excluded medication|1|||
129667767|NCT00735709|466742681|FG001|Overall Study|Excluded medication|0|||
129667768|NCT00735709|466742682|FG002|Overall Study|Excluded medication|0|||
129667769|NCT00735709|466742683|FG003|Overall Study|Excluded medication|1|||
129667770|NCT01165307|466742685|FG000|Overall Study|Lost to Follow-up|11|||
129667771|NCT01165307|466742686|FG001|Overall Study|Lost to Follow-up|3|||
129667772|NCT01165307|466742685|FG000|Overall Study|Withdrawal by Subject|2|||
129667773|NCT01165307|466742686|FG001|Overall Study|Withdrawal by Subject|0|||
129667774|NCT01165307|466742685|FG000|Overall Study|Subject not available for contact|1|||
129667775|NCT01165307|466742686|FG001|Overall Study|Subject not available for contact|0|||
129667776|NCT03113968|466742697|FG000|Overall Study|Withdrawal by Subject|31|||
129667777|NCT03113968|466742698|FG001|Overall Study|Withdrawal by Subject|4|||
129667778|NCT04805671|466742699|FG000|Overall Study|Death|2|||
129667779|NCT04805671|466742700|FG001|Overall Study|Death|7|||
129667780|NCT04805671|466742699|FG000|Overall Study|Lost to Follow-up|1|||
129884375|NCT00708305|467536386|FG003|Period 1|Protocol Violation|0|||
129667781|NCT04805671|466742700|FG001|Overall Study|Lost to Follow-up|0|||
129884376|NCT00708305|467536383|FG000|Period 1|Other Reason|0|||
129667782|NCT04805671|466742699|FG000|Overall Study|Withdrawal by Subject|9|||
129667783|NCT04805671|466742700|FG001|Overall Study|Withdrawal by Subject|7|||
129667784|NCT04805671|466742699|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
129667785|NCT04805671|466742700|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
129667786|NCT02111174|466742707|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
129667787|NCT02111174|466742708|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
129667788|NCT02111174|466742707|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
129667789|NCT02111174|466742708|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
129667790|NCT02111174|466742707|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
129667791|NCT02111174|466742708|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
129667792|NCT02111174|466742707|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
129667793|NCT02111174|466742708|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
129667794|NCT01657162|466742709|FG000|Overall Study|Adverse Event|26|||
129667795|NCT01657162|466742710|FG001|Overall Study|Adverse Event|36|||
129667796|NCT01657162|466742709|FG000|Overall Study|Withdrawal by Subject|13|||
129667797|NCT01657162|466742710|FG001|Overall Study|Withdrawal by Subject|13|||
129667798|NCT01657162|466742709|FG000|Overall Study|Continuing Significant Deterioration|9|||
129667799|NCT01657162|466742710|FG001|Overall Study|Continuing Significant Deterioration|3|||
129667800|NCT01657162|466742709|FG000|Overall Study|Refusal of Treatment|4|||
129667801|NCT01657162|466742710|FG001|Overall Study|Refusal of Treatment|6|||
129667802|NCT01657162|466742709|FG000|Overall Study|Lost to Follow-up|3|||
129667803|NCT01657162|466742710|FG001|Overall Study|Lost to Follow-up|4|||
129667804|NCT01657162|466742709|FG000|Overall Study|Death|2|||
129667805|NCT01657162|466742710|FG001|Overall Study|Death|3|||
129667806|NCT01657162|466742709|FG000|Overall Study|Inability to Complete Study Procedures|1|||
129667807|NCT01657162|466742710|FG001|Overall Study|Inability to Complete Study Procedures|7|||
129667808|NCT01657162|466742709|FG000|Overall Study|Protocol Violation|1|||
129667809|NCT01657162|466742710|FG001|Overall Study|Protocol Violation|0|||
129667810|NCT01657162|466742709|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
129667811|NCT01657162|466742710|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
129667812|NCT01657162|466742709|FG000|Overall Study|Other than Specified|0|||
129667813|NCT01657162|466742710|FG001|Overall Study|Other than Specified|2|||
129667814|NCT00901342|466742711|FG000|Overall Study|Adverse Event|1|||
129667815|NCT00901342|466742711|FG000|Overall Study|Death|4|||
129667816|NCT00901342|466742711|FG000|Overall Study|Disease progression|1|||
129667817|NCT00901342|466742711|FG000|Overall Study|Withdrawal by Subject|9|||
129667818|NCT00751140|466742720|FG000|Overall Study|benign angioma excluded from analysis|1|||
129667819|NCT04001803|466742721|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
129667820|NCT04001803|466742721|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
129667821|NCT04001803|466742721|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
129667822|NCT04001803|466742721|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
129667823|NCT04001803|466742721|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
129884377|NCT00708305|467536384|FG001|Period 1|Other Reason|0|||
129667824|NCT04001803|466742721|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
129667825|NCT04001803|466742721|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
129667826|NCT04001803|466742721|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
129667827|NCT04001803|466742721|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
129667828|NCT04001803|466742721|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
129667829|NCT02493517|466742722|FG000|Overall Study|Protocol Violation|1|||
129667830|NCT02493517|466742723|FG001|Overall Study|Protocol Violation|2|||
129667831|NCT02493517|466742722|FG000|Overall Study|Withdrawal by Subject|1|||
129667832|NCT02493517|466742723|FG001|Overall Study|Withdrawal by Subject|2|||
129667833|NCT02493517|466742722|FG000|Overall Study|Adverse Event|0|||
129667834|NCT02493517|466742723|FG001|Overall Study|Adverse Event|2|||
129667835|NCT02493517|466742722|FG000|Overall Study|Missed study visit|0|||
129667836|NCT02493517|466742723|FG001|Overall Study|Missed study visit|1|||
129667837|NCT03718429|466742725|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
129667838|NCT03718429|466742726|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
129667839|NCT03718429|466742727|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
129667840|NCT03718429|466742728|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
129667841|NCT05404711|466742730|FG000|Completed Study Visit|Withdrawal by Subject|1|||
129667842|NCT05404711|466742730|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
129667843|NCT05404711|466742730|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
129667844|NCT05404711|466742730|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
129667845|NCT05404711|466742730|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
129667846|NCT05404711|466742730|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
129667847|NCT00325819|466742731|FG000|Overall Study|Study product lost in mail|2|||
129667848|NCT00325819|466742732|FG001|Overall Study|Study product lost in mail|1|||
129667849|NCT00325819|466742731|FG000|Overall Study|Did not take a dose of study product|4|||
129667850|NCT00325819|466742732|FG001|Overall Study|Did not take a dose of study product|9|||
129667851|NCT00325819|466742731|FG000|Overall Study|Lost to Follow-up|3|||
129667852|NCT00325819|466742732|FG001|Overall Study|Lost to Follow-up|3|||
129667853|NCT02346877|466742733|FG000|Overall Study|Adverse Event|1|||
129667854|NCT02346877|466742734|FG001|Overall Study|Adverse Event|0|||
129667855|NCT02346877|466742733|FG000|Overall Study|Administrative Decision|1|||
129667856|NCT02346877|466742734|FG001|Overall Study|Administrative Decision|0|||
129667857|NCT02346877|466742733|FG000|Overall Study|Sponsor Decision|12|||
129667858|NCT02346877|466742734|FG001|Overall Study|Sponsor Decision|0|||
129667859|NCT02346877|466742733|FG000|Overall Study|Missing|5|||
129667860|NCT02346877|466742734|FG001|Overall Study|Missing|0|||
129667861|NCT04376515|466742737|FG000|Overall Study|Found to have been vaccinated before study start|6|||
129667862|NCT04376515|466742738|FG001|Overall Study|Found to have been vaccinated before study start|6|||
129667863|NCT03811821|466742739|FG000|Overall Study|Adverse Event|1|||
129667864|NCT03811821|466742740|FG001|Overall Study|Adverse Event|1|||
129667865|NCT03811821|466742739|FG000|Overall Study|Withdrawal by Subject|5|||
129667866|NCT03811821|466742740|FG001|Overall Study|Withdrawal by Subject|4|||
129667867|NCT03811821|466742739|FG000|Overall Study|Lost to Follow-up|2|||
129667868|NCT03811821|466742740|FG001|Overall Study|Lost to Follow-up|2|||
129667869|NCT03811821|466742739|FG000|Overall Study|Contraindication for treatment|0|||
129667870|NCT03811821|466742740|FG001|Overall Study|Contraindication for treatment|1|||
129667871|NCT03811821|466742739|FG000|Overall Study|Tolerability|0|||
129667872|NCT03811821|466742740|FG001|Overall Study|Tolerability|3|||
129667873|NCT03811821|466742739|FG000|Overall Study|Comorbidities|0|||
129667874|NCT03811821|466742740|FG001|Overall Study|Comorbidities|2|||
129667875|NCT01683604|466742742|FG000|Overall Study|Adverse Event|2|||
129667876|NCT01683604|466742742|FG000|Overall Study|Lack of Efficacy|1|||
129667877|NCT01683604|466742742|FG000|Overall Study|Other|2|||
129667878|NCT03430856|466742746|FG000|Overall Study|Adverse Event|0|||
129667879|NCT03430856|466742747|FG001|Overall Study|Adverse Event|1|||
129667880|NCT03430856|466742748|FG002|Overall Study|Adverse Event|0|||
129667881|NCT03430856|466742746|FG000|Overall Study|Rescue criteria|1|||
129667882|NCT03430856|466742747|FG001|Overall Study|Rescue criteria|1|||
129667883|NCT03430856|466742748|FG002|Overall Study|Rescue criteria|0|||
129667884|NCT03430856|466742746|FG000|Overall Study|Voluntary withdrawal of consent|1|||
129667885|NCT03430856|466742747|FG001|Overall Study|Voluntary withdrawal of consent|1|||
129667886|NCT03430856|466742748|FG002|Overall Study|Voluntary withdrawal of consent|1|||
129667887|NCT01949142|466742749|FG000|Overall Study|Withdrawal of consent|1|||
129667888|NCT01949142|466742750|FG001|Overall Study|Withdrawal of consent|0|||
129667889|NCT01949142|466742749|FG000|Overall Study|Lost to Follow-up|1|||
129667890|NCT01949142|466742750|FG001|Overall Study|Lost to Follow-up|1|||
129667891|NCT01949142|466742749|FG000|Overall Study|Parent changed their mind|1|||
129667892|NCT01949142|466742750|FG001|Overall Study|Parent changed their mind|0|||
129667893|NCT01395810|466742751|FG000|Overall Study|Adverse Event|0|||
129667894|NCT01395810|466742752|FG001|Overall Study|Adverse Event|1|||
129667895|NCT01395810|466742753|FG002|Overall Study|Adverse Event|0|||
129667896|NCT01395810|466742754|FG003|Overall Study|Adverse Event|0|||
129667897|NCT01395810|466742751|FG000|Overall Study|Lack of Efficacy|0|||
129667898|NCT01395810|466742752|FG001|Overall Study|Lack of Efficacy|1|||
129667899|NCT01395810|466742753|FG002|Overall Study|Lack of Efficacy|0|||
129667900|NCT01395810|466742754|FG003|Overall Study|Lack of Efficacy|0|||
129667901|NCT01395810|466742751|FG000|Overall Study|Withdrawal criteria|0|||
129667902|NCT01395810|466742752|FG001|Overall Study|Withdrawal criteria|2|||
129667903|NCT01395810|466742753|FG002|Overall Study|Withdrawal criteria|0|||
129667904|NCT01395810|466742754|FG003|Overall Study|Withdrawal criteria|0|||
129667905|NCT01395810|466742751|FG000|Overall Study|Unclassified|2|||
129667906|NCT01395810|466742752|FG001|Overall Study|Unclassified|0|||
129667907|NCT01395810|466742753|FG002|Overall Study|Unclassified|0|||
129667908|NCT01395810|466742754|FG003|Overall Study|Unclassified|0|||
129667909|NCT05027815|466742757|FG000|Overall Study|Death|2|||
129667910|NCT05027815|466742758|FG001|Overall Study|Death|1|||
129667911|NCT03677869|466742762|FG000|Overall Study|Withdrawal by Subject|1|||
129667912|NCT04265261|466742764|FG000|Overall Study|Adverse Event|2|||
129667913|NCT04265261|466742765|FG001|Overall Study|Adverse Event|0|||
129667914|NCT04265261|466742766|FG002|Overall Study|Adverse Event|0|||
129667915|NCT04265261|466742764|FG000|Overall Study|Death|1|||
129667916|NCT04265261|466742765|FG001|Overall Study|Death|0|||
129667917|NCT04265261|466742766|FG002|Overall Study|Death|0|||
129667918|NCT04265261|466742764|FG000|Overall Study|Lost to Follow-up|4|||
129667919|NCT04265261|466742765|FG001|Overall Study|Lost to Follow-up|1|||
129667920|NCT04265261|466742766|FG002|Overall Study|Lost to Follow-up|3|||
129667921|NCT04265261|466742764|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129667922|NCT04265261|466742765|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129667923|NCT04265261|466742766|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129667924|NCT04265261|466742764|FG000|Overall Study|Physician Decision|0|||
129667925|NCT04265261|466742765|FG001|Overall Study|Physician Decision|0|||
129667926|NCT04265261|466742766|FG002|Overall Study|Physician Decision|1|||
129667927|NCT04265261|466742764|FG000|Overall Study|Protocol Deviation|0|||
129667928|NCT04265261|466742765|FG001|Overall Study|Protocol Deviation|2|||
129667929|NCT04265261|466742766|FG002|Overall Study|Protocol Deviation|0|||
129667930|NCT04265261|466742764|FG000|Overall Study|Withdrawal by Subject|2|||
129667931|NCT04265261|466742765|FG001|Overall Study|Withdrawal by Subject|1|||
129667932|NCT04265261|466742766|FG002|Overall Study|Withdrawal by Subject|4|||
129667933|NCT03877224|466742767|FG000|Overall Study|Death|3|||
129667934|NCT03877224|466742768|FG001|Overall Study|Death|2|||
129667935|NCT03877224|466742767|FG000|Overall Study|Withdrawal by Subject|1|||
129667936|NCT03877224|466742768|FG001|Overall Study|Withdrawal by Subject|6|||
129667937|NCT03877224|466742767|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
129667938|NCT03877224|466742768|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
129667939|NCT00447902|466742769|FG000|Overall Study|Adverse Event|0|||
129667940|NCT00447902|466742770|FG001|Overall Study|Adverse Event|3|||
129667941|NCT00447902|466742769|FG000|Overall Study|Protocol Violation|1|||
129667942|NCT00447902|466742770|FG001|Overall Study|Protocol Violation|0|||
129667943|NCT00447902|466742769|FG000|Overall Study|Withdrawal by Subject|0|||
129667944|NCT00447902|466742770|FG001|Overall Study|Withdrawal by Subject|1|||
129667945|NCT00447902|466742769|FG000|Overall Study|included patients who discontinued|1|||
129667946|NCT00447902|466742770|FG001|Overall Study|included patients who discontinued|1|||
129667947|NCT00447902|466742769|FG000|Overall Study|Lack of Efficacy|2|||
129667948|NCT00447902|466742770|FG001|Overall Study|Lack of Efficacy|1|||
129667949|NCT02163395|466744420|FG000|Overall Study|Withdrawal by Subject|1|||
129667950|NCT02163395|466744420|FG000|Overall Study|Lost to Follow-up|3|||
129667951|NCT02163395|466744420|FG000|Overall Study|Adverse Event|1|||
129667952|NCT00521365|466744424|FG000|Overall Study|Adverse Event|3|||
129667953|NCT00521365|466744424|FG000|Overall Study|Lost to Follow-up|6|||
129667954|NCT00521365|466744424|FG000|Overall Study|Protocol deviation|2|||
129667955|NCT00521365|466744424|FG000|Overall Study|Drug compliance|3|||
129667956|NCT00521365|466744424|FG000|Overall Study|Usage of not allowed drugs|6|||
129667957|NCT03627832|466744425|FG000|Overall Study|Withdrawal by Subject|10|||
129667958|NCT03627832|466744426|FG001|Overall Study|Withdrawal by Subject|1|||
129667959|NCT03150082|466744427|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
129667960|NCT03150082|466744428|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
129667961|NCT01718483|466744429|FG000|Overall Study|Withdrawal by Subject|14|||
129667962|NCT01718483|466744430|FG001|Overall Study|Withdrawal by Subject|12|||
129667963|NCT01718483|466744429|FG000|Overall Study|Adverse Event|5|||
129667964|NCT01718483|466744430|FG001|Overall Study|Adverse Event|12|||
129667965|NCT01718483|466744429|FG000|Overall Study|Lost to Follow-up|8|||
129667966|NCT01718483|466744430|FG001|Overall Study|Lost to Follow-up|3|||
129667967|NCT01718483|466744429|FG000|Overall Study|Protocol Violation|4|||
129667968|NCT01718483|466744430|FG001|Overall Study|Protocol Violation|2|||
129667969|NCT01718483|466744429|FG000|Overall Study|Other|1|||
129667970|NCT01718483|466744430|FG001|Overall Study|Other|4|||
129667971|NCT01718483|466744429|FG000|Overall Study|Pregnancy|1|||
129667972|NCT01718483|466744430|FG001|Overall Study|Pregnancy|1|||
129667973|NCT01718483|466744429|FG000|Overall Study|Lack of Efficacy|1|||
129667974|NCT01718483|466744430|FG001|Overall Study|Lack of Efficacy|0|||
129667975|NCT01831427|466744434|FG000|Overall Study|Adverse Event|0|||
129667976|NCT01831427|466744435|FG001|Overall Study|Adverse Event|1|||
129667977|NCT01831427|466744436|FG002|Overall Study|Adverse Event|0|||
129667978|NCT01831427|466744437|FG003|Overall Study|Adverse Event|0|||
129667979|NCT01831427|466744438|FG004|Overall Study|Adverse Event|0|||
129667980|NCT01831427|466744439|FG005|Overall Study|Adverse Event|1|||
129667981|NCT01831427|466744440|FG006|Overall Study|Adverse Event|0|||
129667982|NCT01831427|466744441|FG007|Overall Study|Adverse Event|1|||
129667983|NCT01831427|466744442|FG008|Overall Study|Adverse Event|0|||
129667984|NCT01831427|466744443|FG009|Overall Study|Adverse Event|0|||
129667985|NCT01831427|466744444|FG010|Overall Study|Adverse Event|2|||
129667986|NCT01831427|466744434|FG000|Overall Study|Investigator's Discretion|0|||
129667987|NCT01831427|466744435|FG001|Overall Study|Investigator's Discretion|0|||
129667988|NCT01831427|466744436|FG002|Overall Study|Investigator's Discretion|0|||
129667989|NCT01831427|466744437|FG003|Overall Study|Investigator's Discretion|1|||
129667990|NCT01831427|466744438|FG004|Overall Study|Investigator's Discretion|0|||
129667991|NCT01831427|466744439|FG005|Overall Study|Investigator's Discretion|0|||
129667992|NCT01831427|466744440|FG006|Overall Study|Investigator's Discretion|0|||
129667993|NCT01831427|466744441|FG007|Overall Study|Investigator's Discretion|0|||
129667994|NCT01831427|466744442|FG008|Overall Study|Investigator's Discretion|0|||
129667995|NCT01831427|466744443|FG009|Overall Study|Investigator's Discretion|0|||
129667996|NCT01831427|466744444|FG010|Overall Study|Investigator's Discretion|0|||
129667997|NCT01831427|466744434|FG000|Overall Study|Withdrew Consent|0|||
129667998|NCT01831427|466744435|FG001|Overall Study|Withdrew Consent|0|||
129667999|NCT01831427|466744436|FG002|Overall Study|Withdrew Consent|0|||
129668000|NCT01831427|466744437|FG003|Overall Study|Withdrew Consent|0|||
129668001|NCT01831427|466744438|FG004|Overall Study|Withdrew Consent|0|||
129668002|NCT01831427|466744439|FG005|Overall Study|Withdrew Consent|0|||
129668003|NCT01831427|466744440|FG006|Overall Study|Withdrew Consent|2|||
129668004|NCT01831427|466744441|FG007|Overall Study|Withdrew Consent|0|||
129668005|NCT01831427|466744442|FG008|Overall Study|Withdrew Consent|0|||
129668006|NCT01831427|466744443|FG009|Overall Study|Withdrew Consent|1|||
129668007|NCT01831427|466744444|FG010|Overall Study|Withdrew Consent|1|||
129668008|NCT00536510|466744445|FG000|Overall Study|Adverse Event|27|||
129668009|NCT00536510|466744446|FG001|Overall Study|Adverse Event|4|||
129668010|NCT00536510|466744445|FG000|Overall Study|Lost to Follow-up|11|||
129668011|NCT00536510|466744446|FG001|Overall Study|Lost to Follow-up|8|||
129668012|NCT00536510|466744445|FG000|Overall Study|Protocol Violation|4|||
129668013|NCT00536510|466744446|FG001|Overall Study|Protocol Violation|5|||
129668014|NCT00536510|466744445|FG000|Overall Study|Withdrawal by Subject|16|||
129668015|NCT00536510|466744446|FG001|Overall Study|Withdrawal by Subject|9|||
129668016|NCT00536510|466744445|FG000|Overall Study|Flushing with Product|20|||
129668017|NCT00536510|466744446|FG001|Overall Study|Flushing with Product|0|||
129668018|NCT00536510|466744445|FG000|Overall Study|Laboratory Adverse Event|2|||
129668019|NCT00536510|466744446|FG001|Overall Study|Laboratory Adverse Event|1|||
129668020|NCT00536510|466744445|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
129884378|NCT00708305|467536385|FG002|Period 1|Other Reason|0|||
129668021|NCT00536510|466744446|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
129668022|NCT02169505|466744447|FG000|Overall Study|Withdrawal by Subject|1|||
129668023|NCT00048035|466744448|FG000|Core Period|Early Withdrawals|4|||
129668024|NCT00048035|466744449|FG001|Core Period|Early Withdrawals|2|||
129668025|NCT00048035|466744450|FG002|Core Period|Early Withdrawals|1|||
129668026|NCT00048035|466744451|FG003|Core Period|Early Withdrawals|1|||
129668027|NCT00048035|466744452|FG004|Core Period|Early Withdrawals|1|||
129668028|NCT00048035|466744453|FG005|Core Period|Early Withdrawals|1|||
129668029|NCT00048035|466744454|FG006|Core Period|Early Withdrawals|0|||
129668030|NCT00048035|466744455|FG007|Core Period|Early Withdrawals|0|||
129668031|NCT00048035|466744448|FG000|Extension Year 1|Early Withdrawals|0|||
129668032|NCT00048035|466744449|FG001|Extension Year 1|Early Withdrawals|0|||
129668033|NCT00048035|466744450|FG002|Extension Year 1|Early Withdrawals|0|||
129668034|NCT00048035|466744451|FG003|Extension Year 1|Early Withdrawals|0|||
129668035|NCT00048035|466744452|FG004|Extension Year 1|Early Withdrawals|0|||
129668036|NCT00048035|466744453|FG005|Extension Year 1|Early Withdrawals|0|||
129668037|NCT00048035|466744454|FG006|Extension Year 1|Early Withdrawals|11|||
129668038|NCT00048035|466744455|FG007|Extension Year 1|Early Withdrawals|11|||
129668039|NCT00048035|466744448|FG000|Extension Year 2|Early Withdrawals|0|||
129668040|NCT00048035|466744449|FG001|Extension Year 2|Early Withdrawals|0|||
129668041|NCT00048035|466744450|FG002|Extension Year 2|Early Withdrawals|0|||
129668042|NCT00048035|466744451|FG003|Extension Year 2|Early Withdrawals|0|||
129668043|NCT00048035|466744452|FG004|Extension Year 2|Early Withdrawals|0|||
129668044|NCT00048035|466744453|FG005|Extension Year 2|Early Withdrawals|0|||
129668045|NCT00048035|466744454|FG006|Extension Year 2|Early Withdrawals|3|||
129668046|NCT00048035|466744455|FG007|Extension Year 2|Early Withdrawals|3|||
129668047|NCT05137717|466744456|FG000|Overall Study|Death|2|||
129668048|NCT05137717|466744456|FG000|Overall Study|Withdrawal by Subject|6|||
129668049|NCT02035553|466744457|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
129668050|NCT02035553|466744458|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
129668051|NCT02035553|466744457|FG000|Overall Study|Adverse Event|10|||
129668052|NCT02035553|466744458|FG001|Overall Study|Adverse Event|6|||
129668053|NCT02035553|466744457|FG000|Overall Study|Physician Decision|3|||
129668054|NCT02035553|466744458|FG001|Overall Study|Physician Decision|2|||
129668055|NCT02035553|466744457|FG000|Overall Study|Lack of Efficacy|1|||
129668056|NCT02035553|466744458|FG001|Overall Study|Lack of Efficacy|1|||
129668057|NCT02035553|466744457|FG000|Overall Study|Withdrawal by Subject|4|||
129668058|NCT02035553|466744458|FG001|Overall Study|Withdrawal by Subject|7|||
129668059|NCT02035553|466744457|FG000|Overall Study|Non-compliance with Study Drug|0|||
129668060|NCT02035553|466744458|FG001|Overall Study|Non-compliance with Study Drug|1|||
129668061|NCT02035553|466744457|FG000|Overall Study|Lost to Follow-up|0|||
129668062|NCT02035553|466744458|FG001|Overall Study|Lost to Follow-up|1|||
129668063|NCT02035553|466744457|FG000|Overall Study|Other Reason|0|||
129668064|NCT02035553|466744458|FG001|Overall Study|Other Reason|4|||
129668065|NCT02735980|466744460|FG000|Overall Study|Adverse Event|0|||
129668066|NCT02735980|466744461|FG001|Overall Study|Adverse Event|4|||
129668067|NCT02735980|466744462|FG002|Overall Study|Adverse Event|1|||
129668068|NCT02735980|466744460|FG000|Overall Study|Death|5|||
129668069|NCT02735980|466744461|FG001|Overall Study|Death|4|||
129668070|NCT02735980|466744462|FG002|Overall Study|Death|0|||
129668071|NCT02735980|466744460|FG000|Overall Study|Physician Decision|3|||
129668072|NCT02735980|466744461|FG001|Overall Study|Physician Decision|1|||
129668073|NCT02735980|466744462|FG002|Overall Study|Physician Decision|0|||
129668074|NCT02735980|466744460|FG000|Overall Study|Screen failure|1|||
129668075|NCT02735980|466744461|FG001|Overall Study|Screen failure|0|||
129668076|NCT02735980|466744462|FG002|Overall Study|Screen failure|0|||
129668077|NCT02735980|466744460|FG000|Overall Study|Withdrawal by Subject|1|||
129668078|NCT02735980|466744461|FG001|Overall Study|Withdrawal by Subject|2|||
129668079|NCT02735980|466744462|FG002|Overall Study|Withdrawal by Subject|0|||
129668080|NCT00509899|466744463|FG000|Overall Study|Progressive disease|1|||
129668081|NCT00509899|466744464|FG001|Overall Study|Progressive disease|3|||
129668082|NCT00509899|466744465|FG002|Overall Study|Progressive disease|5|||
129668083|NCT00509899|466744466|FG003|Overall Study|Progressive disease|1|||
129668084|NCT00509899|466744467|FG004|Overall Study|Progressive disease|0|||
129668085|NCT00509899|466744468|FG005|Overall Study|Progressive disease|1|||
129668086|NCT00509899|466744469|FG006|Overall Study|Progressive disease|0|||
129668087|NCT00509899|466744470|FG007|Overall Study|Progressive disease|0|||
129668088|NCT00509899|466744463|FG000|Overall Study|Unacceptable Toxicity|1|||
129668089|NCT00509899|466744464|FG001|Overall Study|Unacceptable Toxicity|0|||
129668090|NCT00509899|466744465|FG002|Overall Study|Unacceptable Toxicity|0|||
129668091|NCT00509899|466744466|FG003|Overall Study|Unacceptable Toxicity|2|||
129668092|NCT00509899|466744467|FG004|Overall Study|Unacceptable Toxicity|0|||
129668093|NCT00509899|466744468|FG005|Overall Study|Unacceptable Toxicity|0|||
129668094|NCT00509899|466744469|FG006|Overall Study|Unacceptable Toxicity|0|||
129668095|NCT00509899|466744470|FG007|Overall Study|Unacceptable Toxicity|0|||
129668096|NCT00509899|466744463|FG000|Overall Study|Withdrawal by Subject|6|||
129668097|NCT00509899|466744464|FG001|Overall Study|Withdrawal by Subject|2|||
129668098|NCT00509899|466744465|FG002|Overall Study|Withdrawal by Subject|3|||
129668099|NCT00509899|466744466|FG003|Overall Study|Withdrawal by Subject|0|||
129668100|NCT00509899|466744467|FG004|Overall Study|Withdrawal by Subject|3|||
129668101|NCT00509899|466744468|FG005|Overall Study|Withdrawal by Subject|2|||
129668102|NCT00509899|466744469|FG006|Overall Study|Withdrawal by Subject|0|||
129668103|NCT00509899|466744470|FG007|Overall Study|Withdrawal by Subject|0|||
129668104|NCT00509899|466744463|FG000|Overall Study|Physician Decision|4|||
129668105|NCT00509899|466744464|FG001|Overall Study|Physician Decision|2|||
129668106|NCT00509899|466744465|FG002|Overall Study|Physician Decision|7|||
129668107|NCT00509899|466744466|FG003|Overall Study|Physician Decision|0|||
129668108|NCT00509899|466744467|FG004|Overall Study|Physician Decision|1|||
129668109|NCT00509899|466744468|FG005|Overall Study|Physician Decision|4|||
129668110|NCT00509899|466744469|FG006|Overall Study|Physician Decision|0|||
129668111|NCT00509899|466744470|FG007|Overall Study|Physician Decision|0|||
129668112|NCT00509899|466744463|FG000|Overall Study|Intercurrent Illness|1|||
129668113|NCT00509899|466744464|FG001|Overall Study|Intercurrent Illness|0|||
129668114|NCT00509899|466744465|FG002|Overall Study|Intercurrent Illness|0|||
129668115|NCT00509899|466744466|FG003|Overall Study|Intercurrent Illness|1|||
129668116|NCT00509899|466744467|FG004|Overall Study|Intercurrent Illness|0|||
129668117|NCT00509899|466744468|FG005|Overall Study|Intercurrent Illness|1|||
129668118|NCT00509899|466744469|FG006|Overall Study|Intercurrent Illness|0|||
129668119|NCT00509899|466744470|FG007|Overall Study|Intercurrent Illness|0|||
129668120|NCT00509899|466744463|FG000|Overall Study|Death|2|||
129668121|NCT00509899|466744464|FG001|Overall Study|Death|2|||
129668122|NCT00509899|466744465|FG002|Overall Study|Death|3|||
129668123|NCT00509899|466744466|FG003|Overall Study|Death|0|||
129668124|NCT00509899|466744467|FG004|Overall Study|Death|1|||
129668125|NCT00509899|466744468|FG005|Overall Study|Death|1|||
129668126|NCT00509899|466744469|FG006|Overall Study|Death|1|||
129668127|NCT00509899|466744470|FG007|Overall Study|Death|1|||
129668128|NCT00509899|466744463|FG000|Overall Study|Lack of Efficacy|1|||
129668129|NCT00509899|466744464|FG001|Overall Study|Lack of Efficacy|0|||
129668130|NCT00509899|466744465|FG002|Overall Study|Lack of Efficacy|2|||
129668131|NCT00509899|466744466|FG003|Overall Study|Lack of Efficacy|0|||
129668132|NCT00509899|466744467|FG004|Overall Study|Lack of Efficacy|0|||
129668133|NCT00509899|466744468|FG005|Overall Study|Lack of Efficacy|1|||
129668134|NCT00509899|466744469|FG006|Overall Study|Lack of Efficacy|0|||
129668135|NCT00509899|466744470|FG007|Overall Study|Lack of Efficacy|0|||
129668136|NCT03713684|466744471|FG000|Overall Study|Adverse Event|1|||
129668137|NCT03713684|466744472|FG001|Overall Study|Adverse Event|3|||
129668138|NCT03713684|466744473|FG002|Overall Study|Adverse Event|1|||
129668139|NCT03713684|466744474|FG003|Overall Study|Adverse Event|0|||
129668140|NCT03713684|466744471|FG000|Overall Study|Poor compliance to protocol|2|||
129668141|NCT03713684|466744472|FG001|Overall Study|Poor compliance to protocol|1|||
129668142|NCT03713684|466744473|FG002|Overall Study|Poor compliance to protocol|0|||
129668143|NCT03713684|466744474|FG003|Overall Study|Poor compliance to protocol|1|||
129668144|NCT03713684|466744471|FG000|Overall Study|Withdrawal by Subject|14|||
129668145|NCT03713684|466744472|FG001|Overall Study|Withdrawal by Subject|6|||
129668146|NCT03713684|466744473|FG002|Overall Study|Withdrawal by Subject|14|||
129668147|NCT03713684|466744474|FG003|Overall Study|Withdrawal by Subject|16|||
129668148|NCT03713684|466744471|FG000|Overall Study|Other than specified|69|||
129668149|NCT03713684|466744472|FG001|Overall Study|Other than specified|77|||
129668150|NCT03713684|466744473|FG002|Overall Study|Other than specified|73|||
129668151|NCT03713684|466744474|FG003|Overall Study|Other than specified|70|||
129668152|NCT02185417|466744475|FG000|Overall Study|Death|448|||
129668153|NCT02185417|466744476|FG001|Overall Study|Death|446|||
129668154|NCT02185417|466744477|FG002|Overall Study|Death|0|||
129668155|NCT02185417|466744475|FG000|Overall Study|Withdrawal by Subject|7|||
129668156|NCT02185417|466744476|FG001|Overall Study|Withdrawal by Subject|12|||
129668157|NCT02185417|466744477|FG002|Overall Study|Withdrawal by Subject|0|||
129668158|NCT02595502|466744478|FG000|Period 1|Adverse Event|0|||
129668159|NCT02595502|466744479|FG001|Period 1|Adverse Event|1|||
129668160|NCT02595502|466744478|FG000|Period 1|Withdrawal by Subject|1|||
129668161|NCT02595502|466744479|FG001|Period 1|Withdrawal by Subject|0|||
129668162|NCT02595502|466744478|FG000|Period 1|Lost to Follow-up|0|||
129668163|NCT02595502|466744479|FG001|Period 1|Lost to Follow-up|1|||
129668164|NCT02595502|466744478|FG000|Period 2|Adverse Event|1|||
129668165|NCT02595502|466744479|FG001|Period 2|Adverse Event|1|||
129668166|NCT02595502|466744478|FG000|Period 2|Received incorrect lens at Period 1|0|||
129668167|NCT02595502|466744479|FG001|Period 2|Received incorrect lens at Period 1|1|||
129668168|NCT02595502|466744478|FG000|Period 3|Protocol Violation|0|||
129668169|NCT02595502|466744479|FG001|Period 3|Protocol Violation|1|||
129668170|NCT02595502|466744478|FG000|Period 3|Lost to Follow-up|1|||
129668171|NCT02595502|466744479|FG001|Period 3|Lost to Follow-up|0|||
129668172|NCT02595502|466744478|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
129668173|NCT02595502|466744479|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
129668174|NCT00974311|466744480|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
129668175|NCT00974311|466744481|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
129668176|NCT00974311|466744480|FG000|DB Phase (up to 24 Months)|Death|561|||
129668177|NCT00974311|466744481|FG001|DB Phase (up to 24 Months)|Death|298|||
129668178|NCT00974311|466744480|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
129668179|NCT00974311|466744481|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
129668180|NCT00974311|466744480|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
129668181|NCT00974311|466744481|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
129668182|NCT00974311|466744480|FG000|DB Phase (up to 24 Months)|Other|1|||
129668183|NCT00974311|466744481|FG001|DB Phase (up to 24 Months)|Other|0|||
129668184|NCT00974311|466744480|FG000|OLE Phase (up to 77 Months)|Death|14|||
129668185|NCT00974311|466744481|FG001|OLE Phase (up to 77 Months)|Death|21|||
129668186|NCT00974311|466744480|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
129668187|NCT00974311|466744481|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
129668188|NCT00974311|466744480|FG000|OLE Phase (up to 77 Months)|Other|15|||
129668189|NCT00974311|466744481|FG001|OLE Phase (up to 77 Months)|Other|2|||
129668190|NCT00974311|466744480|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
129668191|NCT00974311|466744481|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
129668192|NCT05556148|466744482|FG000|Overall Study|Early Termination|29|||
129668193|NCT05556148|466744482|FG000|Overall Study|Baseline Tasks Expired|4|||
129668194|NCT05556148|466744482|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
129668195|NCT05556148|466744482|FG000|Overall Study|No Longer Wished to Participate|1|||
129668196|NCT05556148|466744482|FG000|Overall Study|Bacterial Conjunctivitis|1|||
129668197|NCT00458003|466744483|FG000|Overall Study|Non protocol spinal anesthesia|1|||
129668198|NCT00458003|466744484|FG001|Overall Study|Non protocol spinal anesthesia|1|||
129668199|NCT00809445|466744485|FG000|1 Month Follow-up|Lost contact|1|||
129668200|NCT00809445|466744486|FG001|1 Month Follow-up|Lost contact|2|||
129668201|NCT00809445|466744487|FG002|1 Month Follow-up|Lost contact|1|||
129668202|NCT00809445|466744485|FG000|1 Month Follow-up|Withdrew consent|1|||
129668203|NCT00809445|466744486|FG001|1 Month Follow-up|Withdrew consent|1|||
129668204|NCT00809445|466744487|FG002|1 Month Follow-up|Withdrew consent|1|||
129668205|NCT00809445|466744485|FG000|1 Month Follow-up|Death|0|||
129668206|NCT00809445|466744486|FG001|1 Month Follow-up|Death|1|||
129668207|NCT00809445|466744487|FG002|1 Month Follow-up|Death|1|||
129668208|NCT00809445|466744485|FG000|1 Month Follow-up|Incarcerated|0|||
129668209|NCT00809445|466744486|FG001|1 Month Follow-up|Incarcerated|0|||
129668210|NCT00809445|466744487|FG002|1 Month Follow-up|Incarcerated|1|||
129668211|NCT00809445|466744485|FG000|6 Month Follow-up|Lost contact|16|||
129668212|NCT00809445|466744486|FG001|6 Month Follow-up|Lost contact|14|||
129668213|NCT00809445|466744487|FG002|6 Month Follow-up|Lost contact|14|||
129668214|NCT00809445|466744485|FG000|6 Month Follow-up|Death|2|||
129668215|NCT00809445|466744486|FG001|6 Month Follow-up|Death|1|||
129668216|NCT00809445|466744487|FG002|6 Month Follow-up|Death|1|||
129668217|NCT00809445|466744485|FG000|6 Month Follow-up|Incarcerated|6|||
129668218|NCT00809445|466744486|FG001|6 Month Follow-up|Incarcerated|8|||
129668219|NCT00809445|466744487|FG002|6 Month Follow-up|Incarcerated|8|||
129668220|NCT00809445|466744485|FG000|6 Month Follow-up|Withdrew consent|0|||
129668221|NCT00809445|466744486|FG001|6 Month Follow-up|Withdrew consent|0|||
129668222|NCT00809445|466744487|FG002|6 Month Follow-up|Withdrew consent|1|||
129668223|NCT02048722|466744488|FG000|2 Cycles of Treatment|Adverse Event|2|||
129668224|NCT02048722|466744488|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
129668225|NCT02048722|466744488|FG000|2 Cycles of Treatment|Progressive Disease|2|||
129668226|NCT02048722|466744488|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
129668227|NCT02048722|466744488|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
129668228|NCT02048722|466744488|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
129668229|NCT04144322|466744489|FG000|Overall Study|Lack of Efficacy|2|||
129668230|NCT04144322|466744490|FG001|Overall Study|Lack of Efficacy|2|||
129668231|NCT01272908|466744494|FG000|Initial Treatment Period|Adverse Event|1|||
129668232|NCT01272908|466744494|FG000|Initial Treatment Period|Lack of Efficacy|5|||
129668233|NCT01272908|466744494|FG000|Initial Treatment Period|Protocol Violation|1|||
129668234|NCT01272908|466744494|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
129668235|NCT01272908|466744494|FG000|Re-Treatment Period|Adverse Event|2|||
129668236|NCT01272908|466744494|FG000|Re-Treatment Period|Lack of Efficacy|3|||
129668237|NCT01272908|466744494|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
129668238|NCT02131064|466744497|FG000|Overall Study|Death|5|||
129668239|NCT02131064|466744498|FG001|Overall Study|Death|6|||
129668240|NCT02131064|466744497|FG000|Overall Study|Lost to Follow-up|4|||
129668241|NCT02131064|466744498|FG001|Overall Study|Lost to Follow-up|8|||
129668242|NCT02131064|466744497|FG000|Overall Study|Withdrawal by Subject|14|||
129668243|NCT02131064|466744498|FG001|Overall Study|Withdrawal by Subject|18|||
129668244|NCT02131064|466744497|FG000|Overall Study|Other|2|||
129668245|NCT02131064|466744498|FG001|Overall Study|Other|2|||
129668246|NCT03489343|466744499|FG000|Overall Study|Documented progressive disease|1|||
129668247|NCT03489343|466744500|FG001|Overall Study|Documented progressive disease|0|||
129668248|NCT03489343|466744501|FG002|Overall Study|Documented progressive disease|3|||
129668249|NCT03489343|466744502|FG003|Overall Study|Documented progressive disease|1|||
129668250|NCT03489343|466744503|FG004|Overall Study|Documented progressive disease|3|||
129668251|NCT03489343|466744504|FG005|Overall Study|Documented progressive disease|5|||
129668252|NCT03489343|466744505|FG006|Overall Study|Documented progressive disease|4|||
129668253|NCT03489343|466744499|FG000|Overall Study|Adverse Event|0|||
129668254|NCT03489343|466744500|FG001|Overall Study|Adverse Event|1|||
129668255|NCT03489343|466744501|FG002|Overall Study|Adverse Event|0|||
129668256|NCT03489343|466744502|FG003|Overall Study|Adverse Event|0|||
129668257|NCT03489343|466744503|FG004|Overall Study|Adverse Event|0|||
129668258|NCT03489343|466744504|FG005|Overall Study|Adverse Event|1|||
129668259|NCT03489343|466744505|FG006|Overall Study|Adverse Event|0|||
129668260|NCT03489343|466744499|FG000|Overall Study|Withdrawal by Subject|0|||
129668261|NCT03489343|466744500|FG001|Overall Study|Withdrawal by Subject|0|||
129668262|NCT03489343|466744501|FG002|Overall Study|Withdrawal by Subject|0|||
129668263|NCT03489343|466744502|FG003|Overall Study|Withdrawal by Subject|1|||
129668264|NCT03489343|466744503|FG004|Overall Study|Withdrawal by Subject|0|||
129668265|NCT03489343|466744504|FG005|Overall Study|Withdrawal by Subject|1|||
129668266|NCT03489343|466744505|FG006|Overall Study|Withdrawal by Subject|1|||
129668267|NCT03489343|466744499|FG000|Overall Study|Clinical progression|0|||
129668268|NCT03489343|466744500|FG001|Overall Study|Clinical progression|0|||
129668269|NCT03489343|466744501|FG002|Overall Study|Clinical progression|0|||
129668270|NCT03489343|466744502|FG003|Overall Study|Clinical progression|1|||
129668271|NCT03489343|466744503|FG004|Overall Study|Clinical progression|0|||
129668272|NCT03489343|466744504|FG005|Overall Study|Clinical progression|0|||
129668273|NCT03489343|466744505|FG006|Overall Study|Clinical progression|1|||
129668274|NCT01158261|466744506|FG000|Overall Study|Lost to Follow-up|9|||
129668275|NCT01158261|466744506|FG000|Overall Study|Death|7|||
129668276|NCT01158261|466744506|FG000|Overall Study|Withdrawal by Subject|1|||
129668277|NCT03143101|466744507|FG000|Overall Study|Withdrawal by Subject|0|||
129668278|NCT03143101|466744508|FG001|Overall Study|Withdrawal by Subject|1|||
129668279|NCT03143101|466744509|FG002|Overall Study|Withdrawal by Subject|0|||
129668280|NCT03143101|466744507|FG000|Overall Study|Lost to Follow-up|2|||
129668281|NCT03143101|466744508|FG001|Overall Study|Lost to Follow-up|2|||
129668282|NCT03143101|466744509|FG002|Overall Study|Lost to Follow-up|0|||
129668283|NCT01630135|466744514|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
129668284|NCT01630135|466744515|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
129668285|NCT02899065|466744516|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
129668286|NCT02899065|466744517|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
129668287|NCT02899065|466744516|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
129668288|NCT02899065|466744517|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
129668289|NCT02899065|466744516|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
129668290|NCT02899065|466744517|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
129668291|NCT00971867|466744518|FG000|Overall Study|Adverse Event|4|||
129668292|NCT00971867|466744518|FG000|Overall Study|Participant Withdrew Consent|1|||
129668293|NCT00971867|466744518|FG000|Overall Study|Disease Progression|6|||
129668294|NCT05227118|466744522|FG000|Overall Study|Adverse Event|0|||
129668295|NCT05227118|466744523|FG001|Overall Study|Adverse Event|0|||
129668296|NCT05227118|466744524|FG002|Overall Study|Adverse Event|1|||
129668297|NCT05227118|466744525|FG003|Overall Study|Adverse Event|0|||
129668298|NCT05227118|466744522|FG000|Overall Study|Withdrawal by Subject|0|||
129668299|NCT05227118|466744523|FG001|Overall Study|Withdrawal by Subject|0|||
129668300|NCT05227118|466744524|FG002|Overall Study|Withdrawal by Subject|2|||
129668301|NCT05227118|466744525|FG003|Overall Study|Withdrawal by Subject|0|||
129668302|NCT03727841|466744531|FG000|Overall Study|Physician Decision|3|||
129668303|NCT03727841|466744532|FG001|Overall Study|Physician Decision|1|||
129668304|NCT01601496|466744533|FG000|Overall Study|Physician Decision|1|||
129668305|NCT01601496|466744533|FG000|Overall Study|Withdrawal by Subject|1|||
129668306|NCT01601496|466744533|FG000|Overall Study|Lost to Follow-up|6|||
129668307|NCT01601496|466744533|FG000|Overall Study|Death|4|||
129668308|NCT01601496|466744533|FG000|Overall Study|Other: patient refusal to continue|3|||
129668309|NCT03243305|466744534|FG000|Overall Study|Lost to Follow-up|250|||
129668310|NCT03243305|466744534|FG000|Overall Study|Withdrawal by Subject|170|||
129668311|NCT03243305|466744534|FG000|Overall Study|Pregnancy|104|||
129668312|NCT03243305|466744534|FG000|Overall Study|Non-Compliance with Study Drug|38|||
129668313|NCT03243305|466744534|FG000|Overall Study|Adverse Event|23|||
129668314|NCT03243305|466744534|FG000|Overall Study|No sexually active|26|||
129668315|NCT03243305|466744534|FG000|Overall Study|Physician Decision|22|||
129668316|NCT03243305|466744534|FG000|Overall Study|Protocol Violation|22|||
129668317|NCT03243305|466744534|FG000|Overall Study|Study method no longer primary method|12|||
129668318|NCT03243305|466744534|FG000|Overall Study|Study Terminated by Sponsor|1|||
129668319|NCT03243305|466744534|FG000|Overall Study|Early terminations|267|||
129668320|NCT02689804|466744535|FG000|Overall Study|Withdrawal by Subject|2|||
129668321|NCT02689804|466744536|FG001|Overall Study|Withdrawal by Subject|0|||
129668322|NCT01166750|466744544|FG000|Overall Study|Lost to Follow-up|1|||
129668323|NCT01166750|466744545|FG001|Overall Study|Lost to Follow-up|0|||
129668324|NCT01585246|466744546|FG000|Overall Study|Lost to Follow-up|0|||
129668325|NCT01585246|466744547|FG001|Overall Study|Lost to Follow-up|0|||
129668326|NCT01585246|466744548|FG002|Overall Study|Lost to Follow-up|2|||
129668327|NCT01585246|466744549|FG003|Overall Study|Lost to Follow-up|1|||
129668328|NCT01585246|466744550|FG004|Overall Study|Lost to Follow-up|0|||
129668329|NCT01585246|466744546|FG000|Overall Study|Protocol Violation|0|||
129668330|NCT01585246|466744547|FG001|Overall Study|Protocol Violation|0|||
129668331|NCT01585246|466744548|FG002|Overall Study|Protocol Violation|0|||
129668332|NCT01585246|466744549|FG003|Overall Study|Protocol Violation|0|||
129668333|NCT01585246|466744550|FG004|Overall Study|Protocol Violation|1|||
129668334|NCT01585246|466744546|FG000|Overall Study|Withdrawal by Subject|0|||
129668335|NCT01585246|466744547|FG001|Overall Study|Withdrawal by Subject|0|||
129668336|NCT01585246|466744548|FG002|Overall Study|Withdrawal by Subject|1|||
129668337|NCT01585246|466744549|FG003|Overall Study|Withdrawal by Subject|2|||
129668338|NCT01585246|466744550|FG004|Overall Study|Withdrawal by Subject|1|||
129668339|NCT01585246|466744546|FG000|Overall Study|Other|0|||
129668340|NCT01585246|466744547|FG001|Overall Study|Other|1|||
129668341|NCT01585246|466744548|FG002|Overall Study|Other|1|||
129668342|NCT01585246|466744549|FG003|Overall Study|Other|1|||
129668343|NCT01585246|466744550|FG004|Overall Study|Other|0|||
129668344|NCT04396626|466744551|FG000|Overall Study|Premature termination of study|975|||
129668345|NCT02417753|466744552|FG000|Overall Study|Death|1|||
129668346|NCT03771963|466744555|FG000|Overall Study|Lost to Follow-up|22|||
129668347|NCT03771963|466744555|FG000|Overall Study|Withdrawal of Consent|10|||
129668348|NCT03014206|466744556|FG000|Overall Study|Registration Violation|12|||
129668349|NCT02998151|466744561|FG000|Overall Study|Withdrawal by Subject|3|||
129668350|NCT02998151|466744561|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
129668351|NCT02998151|466744561|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
129668352|NCT02155985|466744562|FG000|Overall Study|Withdrawal by Subject|0|||
129668353|NCT02155985|466744563|FG001|Overall Study|Withdrawal by Subject|0|||
129668354|NCT02155985|466744564|FG002|Overall Study|Withdrawal by Subject|1|||
129668355|NCT02155985|466744562|FG000|Overall Study|Lost to Follow-up|1|||
129668356|NCT02155985|466744563|FG001|Overall Study|Lost to Follow-up|0|||
129668357|NCT02155985|466744564|FG002|Overall Study|Lost to Follow-up|0|||
129668358|NCT02573259|466744565|FG000|Overall Study|Death|1|||
129668359|NCT02573259|466744566|FG001|Overall Study|Death|6|||
129668360|NCT02573259|466744567|FG002|Overall Study|Death|5|||
129668361|NCT02573259|466744568|FG003|Overall Study|Death|6|||
129668362|NCT02573259|466744569|FG004|Overall Study|Death|9|||
129668363|NCT02573259|466744570|FG005|Overall Study|Death|32|||
129668364|NCT02573259|466744571|FG006|Overall Study|Death|21|||
129668365|NCT02573259|466744565|FG000|Overall Study|Lost to Follow-up|0|||
129668366|NCT02573259|466744566|FG001|Overall Study|Lost to Follow-up|0|||
129668367|NCT02573259|466744567|FG002|Overall Study|Lost to Follow-up|0|||
129668368|NCT02573259|466744568|FG003|Overall Study|Lost to Follow-up|0|||
129668369|NCT02573259|466744569|FG004|Overall Study|Lost to Follow-up|0|||
129668370|NCT02573259|466744570|FG005|Overall Study|Lost to Follow-up|2|||
129668371|NCT02573259|466744571|FG006|Overall Study|Lost to Follow-up|1|||
129668372|NCT02573259|466744565|FG000|Overall Study|Participant refused further follow-up|0|||
129668373|NCT02573259|466744566|FG001|Overall Study|Participant refused further follow-up|2|||
129668374|NCT02573259|466744567|FG002|Overall Study|Participant refused further follow-up|1|||
129668375|NCT02573259|466744568|FG003|Overall Study|Participant refused further follow-up|0|||
129668376|NCT02573259|466744569|FG004|Overall Study|Participant refused further follow-up|3|||
129668377|NCT02573259|466744570|FG005|Overall Study|Participant refused further follow-up|20|||
129668378|NCT02573259|466744571|FG006|Overall Study|Participant refused further follow-up|7|||
129668379|NCT02573259|466744565|FG000|Overall Study|Other|0|||
129668380|NCT02573259|466744566|FG001|Overall Study|Other|0|||
129668381|NCT02573259|466744567|FG002|Overall Study|Other|0|||
129668382|NCT02573259|466744568|FG003|Overall Study|Other|0|||
129668383|NCT02573259|466744569|FG004|Overall Study|Other|1|||
129668384|NCT02573259|466744570|FG005|Overall Study|Other|4|||
129668385|NCT02573259|466744571|FG006|Overall Study|Other|5|||
129668386|NCT01367249|466744577|FG000|Overall Study|Withdrawal by Subject|6|||
129668387|NCT01367249|466744578|FG001|Overall Study|Withdrawal by Subject|6|||
129668388|NCT01367249|466744577|FG000|Overall Study|Other|3|||
129668389|NCT01367249|466744578|FG001|Overall Study|Other|10|||
129668390|NCT01817075|466744579|FG000|Overall Study|Adverse Event|7|||
129668391|NCT01817075|466744580|FG001|Overall Study|Adverse Event|5|||
129668392|NCT01817075|466744579|FG000|Overall Study|Physician Decision|9|||
129668393|NCT01817075|466744580|FG001|Overall Study|Physician Decision|12|||
129668394|NCT01817075|466744579|FG000|Overall Study|Withdrawal by Subject|31|||
129668395|NCT01817075|466744580|FG001|Overall Study|Withdrawal by Subject|15|||
129668396|NCT01817075|466744579|FG000|Overall Study|Received Sorafenib after enrollment|0|||
129668397|NCT01817075|466744580|FG001|Overall Study|Received Sorafenib after enrollment|1|||
129668398|NCT01817075|466744579|FG000|Overall Study|Ineligible|0|||
129668399|NCT01817075|466744580|FG001|Overall Study|Ineligible|2|||
129668400|NCT05212168|466744581|FG000|Overall Study|Lost to Follow-up|0|||
129668401|NCT05212168|466744582|FG001|Overall Study|Lost to Follow-up|3|||
129668402|NCT05212168|466744581|FG000|Overall Study|Study terminated by sponsor|30|||
129668403|NCT05212168|466744582|FG001|Overall Study|Study terminated by sponsor|27|||
129668404|NCT05212168|466744581|FG000|Overall Study|Other|4|||
129668405|NCT05212168|466744582|FG001|Overall Study|Other|7|||
129668406|NCT02787304|466747013|FG000|Overall Study|Adverse Event|9|||
129668407|NCT02787304|466747014|FG001|Overall Study|Adverse Event|3|||
129668408|NCT02787304|466747015|FG002|Overall Study|Adverse Event|8|||
129668409|NCT02787304|466747016|FG003|Overall Study|Adverse Event|1|||
129668410|NCT02787304|466747013|FG000|Overall Study|Withdrawal by Subject|1|||
129668411|NCT02787304|466747014|FG001|Overall Study|Withdrawal by Subject|4|||
129668412|NCT02787304|466747015|FG002|Overall Study|Withdrawal by Subject|0|||
129668413|NCT02787304|466747016|FG003|Overall Study|Withdrawal by Subject|0|||
129668414|NCT02787304|466747013|FG000|Overall Study|Lost to Follow-up|1|||
129668415|NCT02787304|466747014|FG001|Overall Study|Lost to Follow-up|0|||
129668416|NCT02787304|466747015|FG002|Overall Study|Lost to Follow-up|0|||
129668417|NCT02787304|466747016|FG003|Overall Study|Lost to Follow-up|1|||
129668418|NCT02787304|466747013|FG000|Overall Study|Noncompliance with study drug|0|||
129668419|NCT02787304|466747014|FG001|Overall Study|Noncompliance with study drug|0|||
129668420|NCT02787304|466747015|FG002|Overall Study|Noncompliance with study drug|1|||
129668421|NCT02787304|466747016|FG003|Overall Study|Noncompliance with study drug|0|||
129668422|NCT02787304|466747013|FG000|Overall Study|Physician Decision|0|||
129668423|NCT02787304|466747014|FG001|Overall Study|Physician Decision|0|||
129668424|NCT02787304|466747015|FG002|Overall Study|Physician Decision|1|||
129668425|NCT02787304|466747016|FG003|Overall Study|Physician Decision|0|||
129668426|NCT02787304|466747013|FG000|Overall Study|Study terminated by sponsor|25|||
129668427|NCT02787304|466747014|FG001|Overall Study|Study terminated by sponsor|31|||
129668428|NCT02787304|466747015|FG002|Overall Study|Study terminated by sponsor|31|||
129668429|NCT02787304|466747016|FG003|Overall Study|Study terminated by sponsor|32|||
129668430|NCT01051921|466747017|FG000|Overall Study|Physician Decision|9|||
129668431|NCT01051921|466747017|FG000|Overall Study|Adverse Event|8|||
129668432|NCT01051921|466747017|FG000|Overall Study|Withdrawal by Subject|7|||
129668433|NCT01051921|466747017|FG000|Overall Study|Lost to Follow-up|4|||
129668434|NCT01051921|466747017|FG000|Overall Study|virological failure|1|||
129668435|NCT01051921|466747017|FG000|Overall Study|patient moved|1|||
129668436|NCT00379834|466747020|FG000|Overall Study|Time constraints|2|||
129668437|NCT01325350|466747021|FG000|Overall Study|Adverse Event|3|||
129668438|NCT01325350|466747022|FG001|Overall Study|Adverse Event|3|||
129668439|NCT01325350|466747023|FG002|Overall Study|Adverse Event|3|||
129668440|NCT01325350|466747024|FG003|Overall Study|Adverse Event|1|||
129668441|NCT01325350|466747025|FG004|Overall Study|Adverse Event|2|||
129668442|NCT01325350|466747021|FG000|Overall Study|Pregnancy|0|||
129668443|NCT01325350|466747022|FG001|Overall Study|Pregnancy|0|||
129668444|NCT01325350|466747023|FG002|Overall Study|Pregnancy|1|||
129668445|NCT01325350|466747024|FG003|Overall Study|Pregnancy|0|||
129668446|NCT01325350|466747025|FG004|Overall Study|Pregnancy|1|||
129668447|NCT01325350|466747021|FG000|Overall Study|Lost to Follow-up|1|||
129668448|NCT01325350|466747022|FG001|Overall Study|Lost to Follow-up|0|||
129668449|NCT01325350|466747023|FG002|Overall Study|Lost to Follow-up|5|||
129668450|NCT01325350|466747024|FG003|Overall Study|Lost to Follow-up|1|||
129668451|NCT01325350|466747025|FG004|Overall Study|Lost to Follow-up|5|||
129668452|NCT01325350|466747021|FG000|Overall Study|Personal Reasons|2|||
129668453|NCT01325350|466747022|FG001|Overall Study|Personal Reasons|1|||
129668454|NCT01325350|466747023|FG002|Overall Study|Personal Reasons|6|||
129668455|NCT01325350|466747024|FG003|Overall Study|Personal Reasons|5|||
129668456|NCT01325350|466747025|FG004|Overall Study|Personal Reasons|3|||
129668457|NCT01325350|466747021|FG000|Overall Study|Protocol Violation|0|||
129668458|NCT01325350|466747022|FG001|Overall Study|Protocol Violation|0|||
129668459|NCT01325350|466747023|FG002|Overall Study|Protocol Violation|0|||
129668460|NCT01325350|466747024|FG003|Overall Study|Protocol Violation|1|||
129668461|NCT01325350|466747025|FG004|Overall Study|Protocol Violation|0|||
129668462|NCT01325350|466747021|FG000|Overall Study|Withdrawal by Subject|0|||
129668463|NCT01325350|466747022|FG001|Overall Study|Withdrawal by Subject|0|||
129668464|NCT01325350|466747023|FG002|Overall Study|Withdrawal by Subject|1|||
129668465|NCT01325350|466747024|FG003|Overall Study|Withdrawal by Subject|1|||
129668466|NCT01325350|466747025|FG004|Overall Study|Withdrawal by Subject|0|||
129668467|NCT01325350|466747021|FG000|Overall Study|Did Not Receive Treatment|0|||
129668468|NCT01325350|466747022|FG001|Overall Study|Did Not Receive Treatment|1|||
129668469|NCT01325350|466747023|FG002|Overall Study|Did Not Receive Treatment|1|||
129668470|NCT01325350|466747024|FG003|Overall Study|Did Not Receive Treatment|0|||
129668471|NCT01325350|466747025|FG004|Overall Study|Did Not Receive Treatment|1|||
129668472|NCT00956839|466747026|FG000|Overall Study|Lost to Follow-up|3|||
129668473|NCT00956839|466747027|FG001|Overall Study|Lost to Follow-up|0|||
129668474|NCT00956839|466747028|FG002|Overall Study|Lost to Follow-up|3|||
129668475|NCT01001429|466747029|FG000|Overall Study|surgery cancelled|0|||
129668476|NCT01001429|466747030|FG001|Overall Study|surgery cancelled|1|||
129668477|NCT01053741|466747035|FG000|2nd Study Intervention|Physician Decision|0|||
129668478|NCT01053741|466747036|FG001|2nd Study Intervention|Physician Decision|1|||
129668479|NCT00619827|466747038|FG000|Overall Study|Adverse Event|1|||
129668480|NCT00619827|466747039|FG001|Overall Study|Adverse Event|2|||
129668481|NCT00619827|466747038|FG000|Overall Study|Withdrawal by Subject|2|||
129668482|NCT00619827|466747039|FG001|Overall Study|Withdrawal by Subject|2|||
129668483|NCT01063855|466747040|FG000|Overall Study|Adverse Event|4|||
129668484|NCT01063855|466747041|FG001|Overall Study|Adverse Event|4|||
129668485|NCT01063855|466747040|FG000|Overall Study|Death|0|||
129668486|NCT01063855|466747041|FG001|Overall Study|Death|1|||
129668487|NCT01063855|466747040|FG000|Overall Study|Lost to Follow-up|8|||
129668488|NCT01063855|466747041|FG001|Overall Study|Lost to Follow-up|4|||
129668489|NCT01063855|466747040|FG000|Overall Study|Pregnancy|1|||
129668490|NCT01063855|466747041|FG001|Overall Study|Pregnancy|0|||
129668491|NCT01063855|466747040|FG000|Overall Study|Lack of Efficacy|0|||
129668492|NCT01063855|466747041|FG001|Overall Study|Lack of Efficacy|1|||
129668493|NCT01063855|466747040|FG000|Overall Study|Withdrawal by Subject|11|||
129668494|NCT01063855|466747041|FG001|Overall Study|Withdrawal by Subject|8|||
129668495|NCT01063855|466747040|FG000|Overall Study|Reason not specified|13|||
129668496|NCT01063855|466747041|FG001|Overall Study|Reason not specified|11|||
129668497|NCT02619617|466747063|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
129668498|NCT02619617|466747064|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
129668499|NCT02619617|466747063|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
129668500|NCT02619617|466747064|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
129668501|NCT01854697|466747065|FG000|Overall Study|Adverse Event|1|||
129668502|NCT01854697|466747066|FG001|Overall Study|Adverse Event|0|||
129668503|NCT01854697|466747067|FG002|Overall Study|Adverse Event|0|||
129668504|NCT01854697|466747068|FG003|Overall Study|Adverse Event|0|||
129668505|NCT01854697|466747069|FG004|Overall Study|Adverse Event|1|||
129668506|NCT01854697|466747065|FG000|Overall Study|Lost to Follow-up|4|||
129668507|NCT01854697|466747066|FG001|Overall Study|Lost to Follow-up|1|||
129668508|NCT01854697|466747067|FG002|Overall Study|Lost to Follow-up|1|||
129668509|NCT01854697|466747068|FG003|Overall Study|Lost to Follow-up|2|||
129668510|NCT01854697|466747069|FG004|Overall Study|Lost to Follow-up|0|||
129668511|NCT01854697|466747065|FG000|Overall Study|To enter another AbbVie study|1|||
129668512|NCT01854697|466747066|FG001|Overall Study|To enter another AbbVie study|0|||
129668513|NCT01854697|466747067|FG002|Overall Study|To enter another AbbVie study|0|||
129668514|NCT01854697|466747068|FG003|Overall Study|To enter another AbbVie study|0|||
129668515|NCT01854697|466747069|FG004|Overall Study|To enter another AbbVie study|1|||
129668516|NCT01854697|466747065|FG000|Overall Study|Withdrew Consent|0|||
129668517|NCT01854697|466747066|FG001|Overall Study|Withdrew Consent|1|||
129668518|NCT01854697|466747067|FG002|Overall Study|Withdrew Consent|0|||
129668519|NCT01854697|466747068|FG003|Overall Study|Withdrew Consent|1|||
129668520|NCT01854697|466747069|FG004|Overall Study|Withdrew Consent|0|||
129668521|NCT01854697|466747065|FG000|Overall Study|Other|0|||
129668522|NCT01854697|466747066|FG001|Overall Study|Other|1|||
129668523|NCT01854697|466747067|FG002|Overall Study|Other|1|||
129668524|NCT01854697|466747068|FG003|Overall Study|Other|0|||
129668525|NCT01854697|466747069|FG004|Overall Study|Other|0|||
129668526|NCT00115778|466747073|FG000|Overall Study|Withdrawal by Subject|0|||
129668527|NCT00115778|466747074|FG001|Overall Study|Withdrawal by Subject|1|||
129668528|NCT00528424|466747077|FG000|Overall Study|Lost to Follow-up|13|||
129668529|NCT00528424|466747077|FG000|Overall Study|Withdrew consent|2|||
129668530|NCT00528424|466747077|FG000|Overall Study|Administrative reason|2|||
129668531|NCT00528424|466747077|FG000|Overall Study|Other|12|||
129668532|NCT02515630|466747078|FG000|Overall Study|Withdrawal by Subject|5|||
129668533|NCT02515630|466747078|FG000|Overall Study|Adverse Event|4|||
129668534|NCT02515630|466747078|FG000|Overall Study|Physician Decision|4|||
129668535|NCT02515630|466747078|FG000|Overall Study|Death|2|||
129668536|NCT02515630|466747078|FG000|Overall Study|Disease Progression|1|||
129668537|NCT00483652|466747079|FG000|Double-blind Treatment Period|Protocol Violation|2|||
129668538|NCT00483652|466747080|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129668539|NCT00483652|466747079|FG000|Double-blind Treatment Period|Adverse Event|3|||
129668540|NCT00483652|466747080|FG001|Double-blind Treatment Period|Adverse Event|4|||
129668541|NCT00483652|466747079|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
129668542|NCT00483652|466747080|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
129668543|NCT00483652|466747079|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
129668544|NCT00483652|466747080|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
129668545|NCT00468585|466747081|FG000|Overall Study|Patient not treated|1|||
129668546|NCT00468585|466747082|FG001|Overall Study|Patient not treated|0|||
129668547|NCT00468585|466747083|FG002|Overall Study|Patient not treated|1|||
129668548|NCT00468585|466747084|FG003|Overall Study|Patient not treated|0|||
129668549|NCT00468585|466747081|FG000|Overall Study|Patient found to be ineligible|0|||
129668550|NCT00468585|466747082|FG001|Overall Study|Patient found to be ineligible|0|||
129668551|NCT00468585|466747083|FG002|Overall Study|Patient found to be ineligible|1|||
129668552|NCT00468585|466747084|FG003|Overall Study|Patient found to be ineligible|0|||
129668553|NCT00468585|466747081|FG000|Overall Study|Adverse Event|0|||
129668554|NCT00468585|466747082|FG001|Overall Study|Adverse Event|0|||
129668555|NCT00468585|466747083|FG002|Overall Study|Adverse Event|1|||
129668556|NCT00468585|466747084|FG003|Overall Study|Adverse Event|0|||
129668557|NCT00468585|466747081|FG000|Overall Study|Withdrawal by Subject|0|||
129668558|NCT00468585|466747082|FG001|Overall Study|Withdrawal by Subject|0|||
129668559|NCT00468585|466747083|FG002|Overall Study|Withdrawal by Subject|2|||
129668560|NCT00468585|466747084|FG003|Overall Study|Withdrawal by Subject|1|||
129668561|NCT02154139|466747089|FG000|Overall Study|Injection not administered|2|||
129668562|NCT02154139|466747089|FG000|Overall Study|Other|2|||
129668563|NCT02154139|466747089|FG000|Overall Study|Investigator transferred|3|||
129668564|NCT02087774|466747090|FG000|Overall Study|Were absent day of data collection|8|||
129668565|NCT02087774|466747091|FG001|Overall Study|Were absent day of data collection|20|||
129668566|NCT02157519|466747099|FG000|Overall Study|Death|3|||
129668567|NCT02157519|466747100|FG001|Overall Study|Death|1|||
129668568|NCT02157519|466747099|FG000|Overall Study|Withdrawal by Subject|7|||
129668569|NCT02157519|466747100|FG001|Overall Study|Withdrawal by Subject|0|||
129668570|NCT02157519|466747099|FG000|Overall Study|Lost to Follow-up|1|||
129668571|NCT02157519|466747100|FG001|Overall Study|Lost to Follow-up|0|||
129668572|NCT01656395|466747101|FG000|Overall Study|Adverse Event|1|||
129668573|NCT01656395|466747102|FG001|Overall Study|Adverse Event|14|||
129668574|NCT01656395|466747103|FG002|Overall Study|Adverse Event|5|||
129668575|NCT01656395|466747104|FG003|Overall Study|Adverse Event|4|||
129668576|NCT01656395|466747105|FG004|Overall Study|Adverse Event|5|||
129668577|NCT01656395|466747106|FG005|Overall Study|Adverse Event|7|||
129668578|NCT01656395|466747107|FG006|Overall Study|Adverse Event|0|||
129668579|NCT01656395|466747108|FG007|Overall Study|Adverse Event|0|||
129668580|NCT01656395|466747101|FG000|Overall Study|Lack of Efficacy|1|||
129668581|NCT01656395|466747102|FG001|Overall Study|Lack of Efficacy|8|||
129668582|NCT01656395|466747103|FG002|Overall Study|Lack of Efficacy|6|||
129668583|NCT01656395|466747104|FG003|Overall Study|Lack of Efficacy|1|||
129668584|NCT01656395|466747105|FG004|Overall Study|Lack of Efficacy|1|||
129668585|NCT01656395|466747106|FG005|Overall Study|Lack of Efficacy|6|||
129668586|NCT01656395|466747107|FG006|Overall Study|Lack of Efficacy|0|||
129668587|NCT01656395|466747108|FG007|Overall Study|Lack of Efficacy|0|||
129668588|NCT01656395|466747101|FG000|Overall Study|Lost to Follow-up|1|||
129668589|NCT01656395|466747102|FG001|Overall Study|Lost to Follow-up|0|||
129668590|NCT01656395|466747103|FG002|Overall Study|Lost to Follow-up|0|||
129668591|NCT01656395|466747104|FG003|Overall Study|Lost to Follow-up|0|||
129668592|NCT01656395|466747105|FG004|Overall Study|Lost to Follow-up|0|||
129668593|NCT01656395|466747106|FG005|Overall Study|Lost to Follow-up|0|||
129668594|NCT01656395|466747107|FG006|Overall Study|Lost to Follow-up|0|||
129668595|NCT01656395|466747108|FG007|Overall Study|Lost to Follow-up|0|||
129668596|NCT01656395|466747101|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129668597|NCT01656395|466747102|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129668598|NCT01656395|466747103|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129668599|NCT01656395|466747104|FG003|Overall Study|Non-Compliance with Study Drug|0|||
129668600|NCT01656395|466747105|FG004|Overall Study|Non-Compliance with Study Drug|1|||
129668601|NCT01656395|466747106|FG005|Overall Study|Non-Compliance with Study Drug|1|||
129668602|NCT01656395|466747107|FG006|Overall Study|Non-Compliance with Study Drug|0|||
129668603|NCT01656395|466747108|FG007|Overall Study|Non-Compliance with Study Drug|0|||
129668604|NCT01656395|466747101|FG000|Overall Study|Other|0|||
129668605|NCT01656395|466747102|FG001|Overall Study|Other|0|||
129668606|NCT01656395|466747103|FG002|Overall Study|Other|1|||
129668607|NCT01656395|466747104|FG003|Overall Study|Other|0|||
129668608|NCT01656395|466747105|FG004|Overall Study|Other|0|||
129668609|NCT01656395|466747106|FG005|Overall Study|Other|1|||
129668610|NCT01656395|466747107|FG006|Overall Study|Other|0|||
129668611|NCT01656395|466747108|FG007|Overall Study|Other|0|||
129668612|NCT01656395|466747101|FG000|Overall Study|Physician Decision|2|||
129668613|NCT01656395|466747102|FG001|Overall Study|Physician Decision|3|||
129668614|NCT01656395|466747103|FG002|Overall Study|Physician Decision|3|||
129668615|NCT01656395|466747104|FG003|Overall Study|Physician Decision|2|||
129668616|NCT01656395|466747105|FG004|Overall Study|Physician Decision|3|||
129668617|NCT01656395|466747106|FG005|Overall Study|Physician Decision|3|||
129668618|NCT01656395|466747107|FG006|Overall Study|Physician Decision|0|||
129668619|NCT01656395|466747108|FG007|Overall Study|Physician Decision|0|||
129668620|NCT01656395|466747101|FG000|Overall Study|Pregnancy|0|||
129668621|NCT01656395|466747102|FG001|Overall Study|Pregnancy|0|||
129668622|NCT01656395|466747103|FG002|Overall Study|Pregnancy|1|||
129668623|NCT01656395|466747104|FG003|Overall Study|Pregnancy|0|||
129668624|NCT01656395|466747105|FG004|Overall Study|Pregnancy|0|||
129668625|NCT01656395|466747106|FG005|Overall Study|Pregnancy|0|||
129668626|NCT01656395|466747107|FG006|Overall Study|Pregnancy|0|||
129668627|NCT01656395|466747108|FG007|Overall Study|Pregnancy|0|||
129668628|NCT01656395|466747101|FG000|Overall Study|Progressive Disease|0|||
129668629|NCT01656395|466747102|FG001|Overall Study|Progressive Disease|0|||
129668630|NCT01656395|466747103|FG002|Overall Study|Progressive Disease|0|||
129668631|NCT01656395|466747104|FG003|Overall Study|Progressive Disease|0|||
129668632|NCT01656395|466747105|FG004|Overall Study|Progressive Disease|0|||
129668633|NCT01656395|466747106|FG005|Overall Study|Progressive Disease|1|||
129668634|NCT01656395|466747107|FG006|Overall Study|Progressive Disease|0|||
129668635|NCT01656395|466747108|FG007|Overall Study|Progressive Disease|0|||
129668636|NCT01656395|466747101|FG000|Overall Study|Protocol Violation|6|||
129668637|NCT01656395|466747102|FG001|Overall Study|Protocol Violation|6|||
129668638|NCT01656395|466747103|FG002|Overall Study|Protocol Violation|9|||
129668639|NCT01656395|466747104|FG003|Overall Study|Protocol Violation|2|||
129668640|NCT01656395|466747105|FG004|Overall Study|Protocol Violation|4|||
129668641|NCT01656395|466747106|FG005|Overall Study|Protocol Violation|10|||
129668642|NCT01656395|466747107|FG006|Overall Study|Protocol Violation|0|||
129668643|NCT01656395|466747108|FG007|Overall Study|Protocol Violation|0|||
129668644|NCT01656395|466747101|FG000|Overall Study|Screen Failure|2|||
129668645|NCT01656395|466747102|FG001|Overall Study|Screen Failure|1|||
129668646|NCT01656395|466747103|FG002|Overall Study|Screen Failure|7|||
129668647|NCT01656395|466747104|FG003|Overall Study|Screen Failure|1|||
129668648|NCT01656395|466747105|FG004|Overall Study|Screen Failure|0|||
129668649|NCT01656395|466747106|FG005|Overall Study|Screen Failure|8|||
129668650|NCT01656395|466747107|FG006|Overall Study|Screen Failure|0|||
129668651|NCT01656395|466747108|FG007|Overall Study|Screen Failure|0|||
129668652|NCT01656395|466747101|FG000|Overall Study|Withdrawal by Subject|3|||
129668653|NCT01656395|466747102|FG001|Overall Study|Withdrawal by Subject|1|||
129668654|NCT01656395|466747103|FG002|Overall Study|Withdrawal by Subject|4|||
129668655|NCT01656395|466747104|FG003|Overall Study|Withdrawal by Subject|2|||
129668656|NCT01656395|466747105|FG004|Overall Study|Withdrawal by Subject|0|||
129668657|NCT01656395|466747106|FG005|Overall Study|Withdrawal by Subject|3|||
129668658|NCT01656395|466747107|FG006|Overall Study|Withdrawal by Subject|0|||
129668659|NCT01656395|466747108|FG007|Overall Study|Withdrawal by Subject|0|||
129668660|NCT03075267|466747109|FG000|Overall Study|Protocol Violation|1|||
129668661|NCT03075267|466747110|FG001|Overall Study|Protocol Violation|0|||
129668662|NCT03075267|466747111|FG002|Overall Study|Protocol Violation|0|||
129668663|NCT00676403|466747112|FG000|Overall Study|Adverse Event|1|||
129668664|NCT00676403|466747113|FG001|Overall Study|Adverse Event|2|||
129668665|NCT00676403|466747114|FG002|Overall Study|Adverse Event|0|||
129668666|NCT00676403|466747115|FG003|Overall Study|Adverse Event|5|||
129668667|NCT00676403|466747116|FG004|Overall Study|Adverse Event|1|||
129668668|NCT00676403|466747117|FG005|Overall Study|Adverse Event|2|||
129668669|NCT00676403|466747112|FG000|Overall Study|Lost to Follow-up|0|||
129668670|NCT00676403|466747113|FG001|Overall Study|Lost to Follow-up|0|||
129668671|NCT00676403|466747114|FG002|Overall Study|Lost to Follow-up|0|||
129668672|NCT00676403|466747115|FG003|Overall Study|Lost to Follow-up|0|||
129668673|NCT00676403|466747116|FG004|Overall Study|Lost to Follow-up|0|||
129668674|NCT00676403|466747117|FG005|Overall Study|Lost to Follow-up|1|||
129668675|NCT00676403|466747112|FG000|Overall Study|Reason Unspecified|1|||
129668676|NCT00676403|466747113|FG001|Overall Study|Reason Unspecified|0|||
129668677|NCT00676403|466747114|FG002|Overall Study|Reason Unspecified|1|||
129668678|NCT00676403|466747115|FG003|Overall Study|Reason Unspecified|0|||
129668679|NCT00676403|466747116|FG004|Overall Study|Reason Unspecified|0|||
129668680|NCT00676403|466747117|FG005|Overall Study|Reason Unspecified|1|||
129668681|NCT00676403|466747112|FG000|Overall Study|Withdrawal by Subject|0|||
129668682|NCT00676403|466747113|FG001|Overall Study|Withdrawal by Subject|0|||
129668683|NCT00676403|466747114|FG002|Overall Study|Withdrawal by Subject|0|||
129668684|NCT00676403|466747115|FG003|Overall Study|Withdrawal by Subject|0|||
129668685|NCT00676403|466747116|FG004|Overall Study|Withdrawal by Subject|0|||
129668686|NCT00676403|466747117|FG005|Overall Study|Withdrawal by Subject|1|||
129668687|NCT01746862|466747121|FG000|Overall Study|Withdrawal by Subject|1|||
129668688|NCT01746862|466747122|FG001|Overall Study|Withdrawal by Subject|1|||
129668689|NCT01746862|466747121|FG000|Overall Study|Protocol Violation|1|||
129668690|NCT01746862|466747122|FG001|Overall Study|Protocol Violation|0|||
129668691|NCT01746862|466747121|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
129668692|NCT01746862|466747122|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
129668693|NCT01746862|466747121|FG000|Overall Study|Entered puberty during the study|1|||
129668694|NCT01746862|466747122|FG001|Overall Study|Entered puberty during the study|0|||
129668695|NCT04742673|466747123|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
129668696|NCT04742673|466747124|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
129668697|NCT06058390|466747126|FG000|Overall Study|Lost to Follow-up|0|||
129668698|NCT06058390|466747127|FG001|Overall Study|Lost to Follow-up|0|||
129668699|NCT06058390|466747128|FG002|Overall Study|Lost to Follow-up|2|||
129668700|NCT06058390|466747129|FG003|Overall Study|Lost to Follow-up|1|||
129668701|NCT06058390|466747126|FG000|Overall Study|Physician Decision|0|||
129668702|NCT06058390|466747127|FG001|Overall Study|Physician Decision|0|||
129668703|NCT06058390|466747128|FG002|Overall Study|Physician Decision|0|||
129668704|NCT06058390|466747129|FG003|Overall Study|Physician Decision|1|||
129668705|NCT06058390|466747126|FG000|Overall Study|Participants did not receive any study intervention|0|||
129668706|NCT06058390|466747127|FG001|Overall Study|Participants did not receive any study intervention|0|||
129668707|NCT06058390|466747128|FG002|Overall Study|Participants did not receive any study intervention|0|||
129668708|NCT06058390|466747129|FG003|Overall Study|Participants did not receive any study intervention|1|||
129668709|NCT03361306|466747130|FG000|Overall Study|Death|6|||
129668710|NCT04073303|466747131|FG000|Overall Study|Adverse Event|0|||
129668711|NCT04073303|466747132|FG001|Overall Study|Adverse Event|2|||
129668712|NCT04073303|466747131|FG000|Overall Study|Withdrawal by Subject|16|||
129668713|NCT04073303|466747132|FG001|Overall Study|Withdrawal by Subject|36|||
129668714|NCT04073303|466747131|FG000|Overall Study|Lost to Follow-up|6|||
129668715|NCT04073303|466747132|FG001|Overall Study|Lost to Follow-up|1|||
129668716|NCT04073303|466747131|FG000|Overall Study|Protocol Deviation|0|||
129668717|NCT04073303|466747132|FG001|Overall Study|Protocol Deviation|4|||
129668718|NCT04073303|466747131|FG000|Overall Study|Other|1|||
129668719|NCT04073303|466747132|FG001|Overall Study|Other|1|||
129668720|NCT03589807|466747140|FG000|Overall Study|Lost to Follow-up|0|||
129668721|NCT03589807|466747141|FG001|Overall Study|Lost to Follow-up|2|||
129668722|NCT03589807|466747142|FG002|Overall Study|Lost to Follow-up|2|||
129668723|NCT03589807|466747143|FG003|Overall Study|Lost to Follow-up|3|||
129668724|NCT03589807|466747144|FG004|Overall Study|Lost to Follow-up|1|||
129668725|NCT03589807|466747145|FG005|Overall Study|Lost to Follow-up|1|||
129668726|NCT03589807|466747140|FG000|Overall Study|Withdrawal by Subject|0|||
129668727|NCT03589807|466747141|FG001|Overall Study|Withdrawal by Subject|5|||
129668728|NCT03589807|466747142|FG002|Overall Study|Withdrawal by Subject|0|||
129668729|NCT03589807|466747143|FG003|Overall Study|Withdrawal by Subject|0|||
129668730|NCT03589807|466747144|FG004|Overall Study|Withdrawal by Subject|0|||
129668731|NCT03589807|466747145|FG005|Overall Study|Withdrawal by Subject|0|||
129668732|NCT03589807|466747140|FG000|Overall Study|Protocol Violation|0|||
129668733|NCT03589807|466747141|FG001|Overall Study|Protocol Violation|0|||
129668734|NCT03589807|466747142|FG002|Overall Study|Protocol Violation|0|||
129668735|NCT03589807|466747143|FG003|Overall Study|Protocol Violation|1|||
129668736|NCT03589807|466747144|FG004|Overall Study|Protocol Violation|0|||
129668737|NCT03589807|466747145|FG005|Overall Study|Protocol Violation|0|||
129668738|NCT03589807|466747140|FG000|Overall Study|Enrolled but treatment not administered|0|||
129668739|NCT03589807|466747141|FG001|Overall Study|Enrolled but treatment not administered|0|||
129668740|NCT03589807|466747142|FG002|Overall Study|Enrolled but treatment not administered|0|||
129668741|NCT03589807|466747143|FG003|Overall Study|Enrolled but treatment not administered|0|||
129668742|NCT03589807|466747144|FG004|Overall Study|Enrolled but treatment not administered|1|||
129668743|NCT03589807|466747145|FG005|Overall Study|Enrolled but treatment not administered|0|||
129668744|NCT00810069|466747146|FG000|Lead-in Period I|Adverse Event|43|||
129668745|NCT00810069|466747147|FG001|Lead-in Period I|Adverse Event|0|||
129668746|NCT00810069|466747148|FG002|Lead-in Period I|Adverse Event|0|||
129668747|NCT00810069|466747146|FG000|Lead-in Period I|Lack of Efficacy|1|||
129668748|NCT00810069|466747147|FG001|Lead-in Period I|Lack of Efficacy|0|||
129668749|NCT00810069|466747148|FG002|Lead-in Period I|Lack of Efficacy|0|||
129668750|NCT00810069|466747146|FG000|Lead-in Period I|Lost to Follow-up|19|||
129668751|NCT00810069|466747147|FG001|Lead-in Period I|Lost to Follow-up|0|||
129668752|NCT00810069|466747148|FG002|Lead-in Period I|Lost to Follow-up|0|||
129668753|NCT00810069|466747146|FG000|Lead-in Period I|Physician Decision|1|||
129668754|NCT00810069|466747147|FG001|Lead-in Period I|Physician Decision|0|||
129668755|NCT00810069|466747148|FG002|Lead-in Period I|Physician Decision|0|||
129668756|NCT00810069|466747146|FG000|Lead-in Period I|Protocol Violation|1|||
129668757|NCT00810069|466747147|FG001|Lead-in Period I|Protocol Violation|0|||
129668758|NCT00810069|466747148|FG002|Lead-in Period I|Protocol Violation|0|||
129668759|NCT00810069|466747146|FG000|Lead-in Period I|Withdrawal by Subject|46|||
129668760|NCT00810069|466747147|FG001|Lead-in Period I|Withdrawal by Subject|0|||
129668761|NCT00810069|466747148|FG002|Lead-in Period I|Withdrawal by Subject|0|||
129668762|NCT00810069|466747146|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
129668763|NCT00810069|466747147|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
129668764|NCT00810069|466747148|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
129668765|NCT00810069|466747146|FG000|Lead-in Period I|Randomization criteria not met|158|||
129668766|NCT00810069|466747147|FG001|Lead-in Period I|Randomization criteria not met|0|||
129668767|NCT00810069|466747148|FG002|Lead-in Period I|Randomization criteria not met|0|||
129668768|NCT00810069|466747146|FG000|Double-Blind Period II|Adverse Event|0|||
129668769|NCT00810069|466747147|FG001|Double-Blind Period II|Adverse Event|9|||
129668770|NCT00810069|466747148|FG002|Double-Blind Period II|Adverse Event|8|||
129668771|NCT00810069|466747146|FG000|Double-Blind Period II|Lack of Efficacy|0|||
129668772|NCT00810069|466747147|FG001|Double-Blind Period II|Lack of Efficacy|7|||
129668773|NCT00810069|466747148|FG002|Double-Blind Period II|Lack of Efficacy|12|||
129668774|NCT00810069|466747146|FG000|Double-Blind Period II|Lost to Follow-up|0|||
129668775|NCT00810069|466747147|FG001|Double-Blind Period II|Lost to Follow-up|9|||
129668776|NCT00810069|466747148|FG002|Double-Blind Period II|Lost to Follow-up|9|||
129668777|NCT00810069|466747146|FG000|Double-Blind Period II|Physician Decision|0|||
129668778|NCT00810069|466747147|FG001|Double-Blind Period II|Physician Decision|0|||
129668779|NCT00810069|466747148|FG002|Double-Blind Period II|Physician Decision|1|||
129668780|NCT00810069|466747146|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
129668781|NCT00810069|466747147|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
129668782|NCT00810069|466747148|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
129668783|NCT00810069|466747146|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
129668784|NCT00810069|466747147|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
129668785|NCT00810069|466747148|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
129668786|NCT00810069|466747146|FG000|Double-Blind Period II|Clinical relapse|0|||
129668787|NCT00810069|466747147|FG001|Double-Blind Period II|Clinical relapse|3|||
129668788|NCT00810069|466747148|FG002|Double-Blind Period II|Clinical relapse|0|||
129668789|NCT00810069|466747146|FG000|Double-Blind Period II|Protocol Violation|0|||
129668790|NCT00810069|466747147|FG001|Double-Blind Period II|Protocol Violation|7|||
129668791|NCT00810069|466747148|FG002|Double-Blind Period II|Protocol Violation|6|||
129668792|NCT04767373|466747151|FG000|Overall Study|Death|6|||
129668793|NCT04767373|466747152|FG001|Overall Study|Death|3|||
129668794|NCT04767373|466747151|FG000|Overall Study|Lost to Follow-up|67|||
129668795|NCT04767373|466747152|FG001|Overall Study|Lost to Follow-up|35|||
129668796|NCT04767373|466747151|FG000|Overall Study|Physician Decision|15|||
129668797|NCT04767373|466747152|FG001|Overall Study|Physician Decision|4|||
129668798|NCT04767373|466747151|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129668799|NCT04767373|466747152|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129668800|NCT04767373|466747151|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
129668801|NCT04767373|466747152|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
129668802|NCT04767373|466747151|FG000|Overall Study|Other|1|||
129668803|NCT04767373|466747152|FG001|Overall Study|Other|2|||
129668804|NCT02983045|466747153|FG000|Overall Study|Withdrawal by Subject|0|||
129668805|NCT02983045|466747154|FG001|Overall Study|Withdrawal by Subject|1|||
129668806|NCT02983045|466747155|FG002|Overall Study|Withdrawal by Subject|0|||
129668807|NCT02983045|466747156|FG003|Overall Study|Withdrawal by Subject|5|||
129668808|NCT02983045|466747157|FG004|Overall Study|Withdrawal by Subject|0|||
129668809|NCT02983045|466747158|FG005|Overall Study|Withdrawal by Subject|72|||
129668810|NCT02983045|466747159|FG006|Overall Study|Withdrawal by Subject|0|||
129668811|NCT02983045|466747160|FG007|Overall Study|Withdrawal by Subject|0|||
129668812|NCT02983045|466747161|FG008|Overall Study|Withdrawal by Subject|0|||
129668813|NCT02983045|466747162|FG009|Overall Study|Withdrawal by Subject|2|||
129668814|NCT02983045|466747153|FG000|Overall Study|Lost to Follow-up|0|||
129668815|NCT02983045|466747154|FG001|Overall Study|Lost to Follow-up|0|||
129668816|NCT02983045|466747155|FG002|Overall Study|Lost to Follow-up|0|||
129668817|NCT02983045|466747156|FG003|Overall Study|Lost to Follow-up|0|||
129668818|NCT02983045|466747157|FG004|Overall Study|Lost to Follow-up|0|||
129668819|NCT02983045|466747158|FG005|Overall Study|Lost to Follow-up|10|||
129668820|NCT02983045|466747159|FG006|Overall Study|Lost to Follow-up|0|||
129668821|NCT02983045|466747160|FG007|Overall Study|Lost to Follow-up|0|||
129668822|NCT02983045|466747161|FG008|Overall Study|Lost to Follow-up|0|||
129668823|NCT02983045|466747162|FG009|Overall Study|Lost to Follow-up|0|||
129668824|NCT00593918|466747163|FG000|Overall Study|Withdrawal by Subject|5|||
129668825|NCT00593918|466747164|FG001|Overall Study|Withdrawal by Subject|24|||
129668826|NCT02658669|466747165|FG000|Overall Study|Lost to Follow-up|7|||
129668827|NCT02658669|466747166|FG001|Overall Study|Lost to Follow-up|5|||
129668828|NCT03421379|466747168|FG000|Period 1|Withdrawal by Subject|0|||
129668829|NCT03421379|466747169|FG001|Period 1|Withdrawal by Subject|1|||
129668830|NCT03421379|466747168|FG000|Period 1|Physician Decision|1|||
129668831|NCT03421379|466747169|FG001|Period 1|Physician Decision|1|||
129668832|NCT03421379|466747168|FG000|Period 1|Did not receive treatment|1|||
129668833|NCT03421379|466747169|FG001|Period 1|Did not receive treatment|2|||
129668834|NCT02782741|466747170|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
129668835|NCT02782741|466747171|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
129668836|NCT02782741|466747172|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
129668837|NCT02782741|466747170|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
129668838|NCT02782741|466747171|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
129668839|NCT02782741|466747172|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
129668840|NCT02782741|466747170|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
129668841|NCT02782741|466747171|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
129668842|NCT02782741|466747172|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
129668843|NCT02782741|466747170|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
129668844|NCT02782741|466747171|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
129668845|NCT02782741|466747172|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
129668846|NCT02782741|466747170|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
129668847|NCT02782741|466747171|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
129668848|NCT02782741|466747172|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
129668849|NCT04157088|466747173|FG000|Overall Study|Study terminated by sponsor|23|||
129668850|NCT04157088|466747173|FG000|Overall Study|Withdrawal by Subject|4|||
129668851|NCT04157088|466747173|FG000|Overall Study|Lost to Follow-up|2|||
129668852|NCT04157088|466747173|FG000|Overall Study|Death|1|||
129668853|NCT00196105|466747176|FG000|Overall Study|Lost to Follow-up|4|||
129668854|NCT00196105|466747177|FG001|Overall Study|Lost to Follow-up|5|||
129668855|NCT00196105|466747178|FG002|Overall Study|Lost to Follow-up|7|||
129668856|NCT04863872|466747179|FG000|Overall Study|Withdrawal by Subject|4|||
129668857|NCT04863872|466747180|FG001|Overall Study|Withdrawal by Subject|15|||
129668858|NCT04863872|466747179|FG000|Overall Study|Death|5|||
129668859|NCT04863872|466747180|FG001|Overall Study|Death|2|||
129668860|NCT04863872|466747179|FG000|Overall Study|Lost to Follow-up|2|||
129668861|NCT04863872|466747180|FG001|Overall Study|Lost to Follow-up|1|||
129668862|NCT04058028|466747181|FG000|Overall Study|Withdrawal of Consent from Study|12|||
129668863|NCT04058028|466747182|FG001|Overall Study|Withdrawal of Consent from Study|8|||
129668864|NCT04058028|466747183|FG002|Overall Study|Withdrawal of Consent from Study|6|||
129668865|NCT04058028|466747184|FG003|Overall Study|Withdrawal of Consent from Study|7|||
129668866|NCT04058028|466747181|FG000|Overall Study|Decision by Sponsor|13|||
129668867|NCT04058028|466747182|FG001|Overall Study|Decision by Sponsor|4|||
129668868|NCT04058028|466747183|FG002|Overall Study|Decision by Sponsor|1|||
129668869|NCT04058028|466747184|FG003|Overall Study|Decision by Sponsor|35|||
129668870|NCT04058028|466747181|FG000|Overall Study|Lost to Follow-up|1|||
129668871|NCT04058028|466747182|FG001|Overall Study|Lost to Follow-up|1|||
129668872|NCT04058028|466747183|FG002|Overall Study|Lost to Follow-up|1|||
129668873|NCT04058028|466747184|FG003|Overall Study|Lost to Follow-up|0|||
129668874|NCT04058028|466747181|FG000|Overall Study|Death|0|||
129668875|NCT04058028|466747182|FG001|Overall Study|Death|1|||
129668876|NCT04058028|466747183|FG002|Overall Study|Death|0|||
129668877|NCT04058028|466747184|FG003|Overall Study|Death|0|||
129668878|NCT00485069|466747185|FG000|Overall Study|Adverse Event|10|||
129668879|NCT00485069|466747186|FG001|Overall Study|Adverse Event|4|||
129668880|NCT00485069|466747185|FG000|Overall Study|Lack of Efficacy|2|||
129668881|NCT00485069|466747186|FG001|Overall Study|Lack of Efficacy|1|||
129668882|NCT00485069|466747185|FG000|Overall Study|Protocol Violation|0|||
129668883|NCT00485069|466747186|FG001|Overall Study|Protocol Violation|1|||
129668884|NCT00485069|466747185|FG000|Overall Study|Withdrawal by Subject|6|||
129668885|NCT00485069|466747186|FG001|Overall Study|Withdrawal by Subject|6|||
129668886|NCT00992017|466747188|FG000|Overall Study|Lost to Follow-up|2|||
129668887|NCT00992017|466747188|FG000|Overall Study|Withdrawal by Subject|2|||
129668888|NCT00992017|466747188|FG000|Overall Study|Unable to get to clinic|5|||
129668889|NCT00992017|466747188|FG000|Overall Study|Not adhere to study requirements|1|||
129668890|NCT02864407|466747189|FG000|Overall Study|Protocol Violation|3|||
129668891|NCT02864407|466747189|FG000|Overall Study|Lost to Follow-up|115|||
129668892|NCT02864407|466747189|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
129668893|NCT02864407|466747189|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
129668894|NCT02864407|466747189|FG000|Overall Study|Consent prior to the contract date|1|||
129668895|NCT04577794|466747197|FG000|Overall Study|Adverse Event|1|||
129668896|NCT04577794|466747198|FG001|Overall Study|Adverse Event|1|||
129668897|NCT02849080|466747199|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
129668898|NCT02849080|466747200|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
129668899|NCT02849080|466747201|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
129668900|NCT02849080|466747202|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
129668901|NCT02849080|466747199|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
129668902|NCT02849080|466747200|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
129668903|NCT02849080|466747201|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
129668904|NCT02849080|466747202|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
129668905|NCT02849080|466747199|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
129668906|NCT02849080|466747200|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
129668907|NCT02849080|466747201|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
129668908|NCT02849080|466747202|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
129668909|NCT02849080|466747199|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
129668910|NCT02849080|466747200|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
129668911|NCT02849080|466747201|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
129668912|NCT02849080|466747202|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
129668913|NCT02849080|466747199|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
129668914|NCT02849080|466747200|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
129668915|NCT02849080|466747201|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
129668916|NCT02849080|466747202|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
129668917|NCT02849080|466747199|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
129668918|NCT02849080|466747200|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
129668919|NCT02849080|466747201|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
129668920|NCT02849080|466747202|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
129668921|NCT01819727|466747203|FG000|Overall Study|Adverse Event|8|||
129668922|NCT01819727|466747204|FG001|Overall Study|Adverse Event|9|||
129668923|NCT01819727|466747203|FG000|Overall Study|Death|1|||
129668924|NCT01819727|466747204|FG001|Overall Study|Death|0|||
129668925|NCT01819727|466747203|FG000|Overall Study|Lost to Follow-up|1|||
129668926|NCT01819727|466747204|FG001|Overall Study|Lost to Follow-up|1|||
129668927|NCT01819727|466747203|FG000|Overall Study|Physician Decision|3|||
129668928|NCT01819727|466747204|FG001|Overall Study|Physician Decision|2|||
129668929|NCT01819727|466747203|FG000|Overall Study|Pregnancy|1|||
129668930|NCT01819727|466747204|FG001|Overall Study|Pregnancy|0|||
129668931|NCT01819727|466747203|FG000|Overall Study|Protocol Violation|0|||
129668932|NCT01819727|466747204|FG001|Overall Study|Protocol Violation|2|||
129668933|NCT01819727|466747203|FG000|Overall Study|Study Terminated by Sponsor|0|||
129668934|NCT01819727|466747204|FG001|Overall Study|Study Terminated by Sponsor|1|||
129668935|NCT01819727|466747203|FG000|Overall Study|Withdrawal by Subject|6|||
129668936|NCT01819727|466747204|FG001|Overall Study|Withdrawal by Subject|11|||
129668937|NCT01819727|466747203|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
129668938|NCT01819727|466747204|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
129668939|NCT01819727|466747203|FG000|Overall Study|Quit due to lack of health benifits|0|||
129668940|NCT01819727|466747204|FG001|Overall Study|Quit due to lack of health benifits|1|||
129668941|NCT03839394|466747208|FG000|Overall Study|Lost to Follow-up|6|||
129668942|NCT03839394|466747209|FG001|Overall Study|Lost to Follow-up|8|||
129668943|NCT03839394|466747208|FG000|Overall Study|Withdrawal by Subject|0|||
129668944|NCT03839394|466747209|FG001|Overall Study|Withdrawal by Subject|2|||
129668945|NCT02358031|466748618|FG000|Overall Study|Death|253|||
129668946|NCT02358031|466748619|FG001|Overall Study|Death|237|||
129668947|NCT02358031|466748620|FG002|Overall Study|Death|266|||
129668948|NCT02358031|466748618|FG000|Overall Study|Lost to Follow-up|1|||
129668949|NCT02358031|466748619|FG001|Overall Study|Lost to Follow-up|1|||
129668950|NCT02358031|466748620|FG002|Overall Study|Lost to Follow-up|0|||
129668951|NCT02358031|466748618|FG000|Overall Study|Withdrawal by Subject|19|||
129668952|NCT02358031|466748619|FG001|Overall Study|Withdrawal by Subject|14|||
129668953|NCT02358031|466748620|FG002|Overall Study|Withdrawal by Subject|18|||
129668954|NCT02358031|466748618|FG000|Overall Study|Sponsor Decision|26|||
129668955|NCT02358031|466748619|FG001|Overall Study|Sponsor Decision|28|||
129668956|NCT02358031|466748620|FG002|Overall Study|Sponsor Decision|16|||
129668957|NCT05664581|466748621|FG000|Overall Study|Withdrawal by Subject|2|||
129668958|NCT03101150|466748622|FG000|Overall Study|Lost to Follow-up|2|||
129668959|NCT03101150|466748623|FG001|Overall Study|Lost to Follow-up|4|||
129668960|NCT03101150|466748622|FG000|Overall Study|Miscarriage|3|||
129668961|NCT03101150|466748623|FG001|Overall Study|Miscarriage|6|||
129668962|NCT00611806|466748624|FG000|Overall Study|Withdrawal by Subject|8|||
129668963|NCT00611806|466748625|FG001|Overall Study|Withdrawal by Subject|2|||
129668964|NCT00611806|466748624|FG000|Overall Study|Adverse Event|2|||
129668965|NCT00611806|466748625|FG001|Overall Study|Adverse Event|1|||
129668966|NCT00611806|466748624|FG000|Overall Study|Lost to Follow-up|6|||
129668967|NCT00611806|466748625|FG001|Overall Study|Lost to Follow-up|0|||
129668968|NCT00715559|466748626|FG000|Overall Study|medication not tolerated - nausea|1|||
129668969|NCT02063672|466748629|FG000|Overall Study|Ongoing Follow-up|27|||
129668970|NCT02063672|466748630|FG001|Overall Study|Ongoing Follow-up|14|||
129668971|NCT02063672|466748629|FG000|Overall Study|Death|5|||
129668972|NCT02063672|466748630|FG001|Overall Study|Death|3|||
129668973|NCT02063672|466748629|FG000|Overall Study|Lost to Follow-up|1|||
129668974|NCT02063672|466748630|FG001|Overall Study|Lost to Follow-up|3|||
129668975|NCT02063672|466748629|FG000|Overall Study|Withdrawal by Subject|2|||
129668976|NCT02063672|466748630|FG001|Overall Study|Withdrawal by Subject|2|||
129668977|NCT02498678|466748631|FG000|Overall Study|interference from the surgical team|0|||
129668978|NCT02498678|466748632|FG001|Overall Study|interference from the surgical team|2|||
129668979|NCT00230048|466748637|FG000|Overall Study|Lost to Follow-up|13|||
129668980|NCT00230048|466748638|FG001|Overall Study|Lost to Follow-up|18|||
129668981|NCT01566604|466748639|FG000|Overall Study|Patient's inability to use the device|1|||
129668982|NCT01566604|466748640|FG001|Overall Study|Patient's inability to use the device|0|||
129668983|NCT01566604|466748639|FG000|Overall Study|Administrative problems|1|||
129668984|NCT01566604|466748640|FG001|Overall Study|Administrative problems|0|||
129668985|NCT01566604|466748639|FG000|Overall Study|Lack of Efficacy|1|||
129668986|NCT01566604|466748640|FG001|Overall Study|Lack of Efficacy|2|||
129668987|NCT01566604|466748639|FG000|Overall Study|Protocol deviation|2|||
129668988|NCT01566604|466748640|FG001|Overall Study|Protocol deviation|0|||
129668989|NCT01566604|466748639|FG000|Overall Study|Abnormal laboratory value|2|||
129668990|NCT01566604|466748640|FG001|Overall Study|Abnormal laboratory value|0|||
129668991|NCT01566604|466748639|FG000|Overall Study|Death|4|||
129668992|NCT01566604|466748640|FG001|Overall Study|Death|1|||
129668993|NCT01566604|466748639|FG000|Overall Study|Adverse Event|4|||
129668994|NCT01566604|466748640|FG001|Overall Study|Adverse Event|2|||
129668995|NCT01566604|466748639|FG000|Overall Study|Withdrawal by Subject|9|||
129668996|NCT01566604|466748640|FG001|Overall Study|Withdrawal by Subject|6|||
129668997|NCT03225170|466748641|FG000|Overall Study|Lost to Follow-up|4|||
129668998|NCT03225170|466748642|FG001|Overall Study|Lost to Follow-up|4|||
129668999|NCT03225170|466748643|FG002|Overall Study|Lost to Follow-up|0|||
129669000|NCT03225170|466748641|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
129669001|NCT03225170|466748642|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
129669002|NCT03225170|466748643|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
129669003|NCT00661089|466748650|FG000|Overall Study|1 subject withdrawal|0|||
129669004|NCT00661089|466748651|FG001|Overall Study|1 subject withdrawal|1|||
129669005|NCT00661089|466748650|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
129669006|NCT00661089|466748651|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
129669007|NCT00274742|466748652|FG000|Overall Study|Adverse Event|0|||
129669008|NCT00274742|466748653|FG001|Overall Study|Adverse Event|4|||
129669009|NCT00274742|466748654|FG002|Overall Study|Adverse Event|1|||
129669010|NCT00274742|466748655|FG003|Overall Study|Adverse Event|4|||
129669011|NCT00274742|466748656|FG004|Overall Study|Adverse Event|12|||
129669012|NCT00274742|466748657|FG005|Overall Study|Adverse Event|3|||
129669013|NCT00274742|466748652|FG000|Overall Study|Lost to Follow-up|0|||
129669014|NCT00274742|466748653|FG001|Overall Study|Lost to Follow-up|0|||
129669015|NCT00274742|466748654|FG002|Overall Study|Lost to Follow-up|0|||
129669016|NCT00274742|466748655|FG003|Overall Study|Lost to Follow-up|0|||
129669017|NCT00274742|466748656|FG004|Overall Study|Lost to Follow-up|1|||
129669018|NCT00274742|466748657|FG005|Overall Study|Lost to Follow-up|0|||
129669019|NCT00274742|466748652|FG000|Overall Study|End of Study|0|||
129669020|NCT00274742|466748653|FG001|Overall Study|End of Study|0|||
129669021|NCT00274742|466748654|FG002|Overall Study|End of Study|0|||
129669022|NCT00274742|466748655|FG003|Overall Study|End of Study|1|||
129669023|NCT00274742|466748656|FG004|Overall Study|End of Study|0|||
129669024|NCT00274742|466748657|FG005|Overall Study|End of Study|0|||
129669025|NCT00274742|466748652|FG000|Overall Study|Disease Progression|0|||
129669026|NCT00274742|466748653|FG001|Overall Study|Disease Progression|1|||
129669027|NCT00274742|466748654|FG002|Overall Study|Disease Progression|1|||
129669028|NCT00274742|466748655|FG003|Overall Study|Disease Progression|0|||
129669029|NCT00274742|466748656|FG004|Overall Study|Disease Progression|1|||
129669030|NCT00274742|466748657|FG005|Overall Study|Disease Progression|0|||
129669031|NCT00274742|466748652|FG000|Overall Study|Other|0|||
129669032|NCT00274742|466748653|FG001|Overall Study|Other|3|||
129669033|NCT00274742|466748654|FG002|Overall Study|Other|0|||
129669034|NCT00274742|466748655|FG003|Overall Study|Other|0|||
129669035|NCT00274742|466748656|FG004|Overall Study|Other|2|||
129669036|NCT00274742|466748657|FG005|Overall Study|Other|0|||
129669037|NCT01529606|466748661|FG000|Overall Study|Lost to Follow-up|21|||
129669038|NCT01529606|466748662|FG001|Overall Study|Lost to Follow-up|18|||
129669039|NCT01900444|466748666|FG000|Overall Study|Protocol Violation|2|||
129669040|NCT01900444|466748666|FG000|Overall Study|Lost to Follow-up|1|||
129669041|NCT00072384|466748669|FG000|Overall Study|Physician Decision|1|||
129669042|NCT00072384|466748669|FG000|Overall Study|Ineligible|8|||
129669043|NCT01825200|466748670|FG000|Overall Study|Lost to Follow-up|5|||
129669044|NCT01825200|466748671|FG001|Overall Study|Lost to Follow-up|6|||
129669045|NCT01825200|466748670|FG000|Overall Study|Withdrawal by Subject|0|||
129669046|NCT01825200|466748671|FG001|Overall Study|Withdrawal by Subject|1|||
129669047|NCT00490035|466748672|FG000|Overall Study|AE, non-serious non-fatal|3|||
129669048|NCT00490035|466748673|FG001|Overall Study|AE, non-serious non-fatal|4|||
129669049|NCT00490035|466748674|FG002|Overall Study|AE, non-serious non-fatal|4|||
129669050|NCT00490035|466748675|FG003|Overall Study|AE, non-serious non-fatal|5|||
129669051|NCT00490035|466748672|FG000|Overall Study|Lost to Follow-up|2|||
129669052|NCT00490035|466748673|FG001|Overall Study|Lost to Follow-up|0|||
129669053|NCT00490035|466748674|FG002|Overall Study|Lost to Follow-up|1|||
129669054|NCT00490035|466748675|FG003|Overall Study|Lost to Follow-up|0|||
129669055|NCT00490035|466748672|FG000|Overall Study|Withdrawal by Subject|2|||
129669056|NCT00490035|466748673|FG001|Overall Study|Withdrawal by Subject|1|||
129669057|NCT00490035|466748674|FG002|Overall Study|Withdrawal by Subject|1|||
129669058|NCT00490035|466748675|FG003|Overall Study|Withdrawal by Subject|0|||
129669059|NCT00490035|466748672|FG000|Overall Study|Other reason|0|||
129669060|NCT00490035|466748673|FG001|Overall Study|Other reason|1|||
129669061|NCT00490035|466748674|FG002|Overall Study|Other reason|3|||
129669062|NCT00490035|466748675|FG003|Overall Study|Other reason|1|||
129669063|NCT00490035|466748672|FG000|Overall Study|AE, serious fatal|1|||
129669064|NCT00490035|466748673|FG001|Overall Study|AE, serious fatal|0|||
129669065|NCT00490035|466748674|FG002|Overall Study|AE, serious fatal|0|||
129669066|NCT00490035|466748675|FG003|Overall Study|AE, serious fatal|0|||
129669067|NCT00490035|466748672|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
129669068|NCT00490035|466748673|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
129669069|NCT00490035|466748674|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
129669070|NCT00490035|466748675|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
129669071|NCT00490035|466748672|FG000|Overall Study|AE of unknown type|0|||
129669072|NCT00490035|466748673|FG001|Overall Study|AE of unknown type|0|||
129669073|NCT00490035|466748674|FG002|Overall Study|AE of unknown type|2|||
129669074|NCT00490035|466748675|FG003|Overall Study|AE of unknown type|0|||
129669075|NCT00731822|466748676|FG000|Overall Study|Adverse Event|2|||
129669076|NCT00731822|466748677|FG001|Overall Study|Adverse Event|1|||
129669077|NCT00731822|466748676|FG000|Overall Study|Protocol Violation|1|||
129669078|NCT00731822|466748677|FG001|Overall Study|Protocol Violation|0|||
129669079|NCT00731822|466748676|FG000|Overall Study|Lost to Follow-up|1|||
129669080|NCT00731822|466748677|FG001|Overall Study|Lost to Follow-up|0|||
129669081|NCT05209880|466748687|FG000|1-Month Follow-up|Spoke with Doctor|5|||
129669082|NCT05209880|466748688|FG001|1-Month Follow-up|Spoke with Doctor|5|||
129669083|NCT05209880|466748687|FG000|1-Month Follow-up|Lost to Follow-up|7|||
129669084|NCT05209880|466748688|FG001|1-Month Follow-up|Lost to Follow-up|9|||
129669085|NCT05209880|466748687|FG000|1-Month Follow-up|Discontinued|0|||
129669086|NCT05209880|466748688|FG001|1-Month Follow-up|Discontinued|1|||
129669087|NCT05209880|466748687|FG000|3-Month Follow-up|Spoke with Doctor|17|||
129669088|NCT05209880|466748688|FG001|3-Month Follow-up|Spoke with Doctor|7|||
129669089|NCT05209880|466748687|FG000|3-Month Follow-up|Lost to Follow-up|8|||
129669090|NCT05209880|466748688|FG001|3-Month Follow-up|Lost to Follow-up|10|||
129669091|NCT05209880|466748687|FG000|3-Month Follow-up|Discontinued|1|||
129669092|NCT05209880|466748688|FG001|3-Month Follow-up|Discontinued|3|||
129669093|NCT05209880|466748687|FG000|6-Month Follow-up|Spoke with Doctor|25|||
129669094|NCT05209880|466748688|FG001|6-Month Follow-up|Spoke with Doctor|14|||
129669095|NCT05209880|466748687|FG000|6-Month Follow-up|Lost to Follow-up|9|||
129669096|NCT05209880|466748688|FG001|6-Month Follow-up|Lost to Follow-up|14|||
129669097|NCT05209880|466748687|FG000|6-Month Follow-up|Discontinued|1|||
129669098|NCT05209880|466748688|FG001|6-Month Follow-up|Discontinued|3|||
129669099|NCT04817332|466748689|FG000|Overall Study|Lost to Follow-up|3|||
129669100|NCT04817332|466748690|FG001|Overall Study|Lost to Follow-up|3|||
129669101|NCT04817332|466748689|FG000|Overall Study|Protocol Violation|2|||
129669102|NCT04817332|466748690|FG001|Overall Study|Protocol Violation|0|||
129669103|NCT04795466|466748696|FG000|Overall Study|Adverse Event|3|||
129669104|NCT04795466|466748697|FG001|Overall Study|Adverse Event|1|||
129669105|NCT04795466|466748696|FG000|Overall Study|Physician Decision|1|||
129669106|NCT04795466|466748697|FG001|Overall Study|Physician Decision|0|||
129669107|NCT04795466|466748696|FG000|Overall Study|Withdrawal by Subject|2|||
129669108|NCT04795466|466748697|FG001|Overall Study|Withdrawal by Subject|1|||
129669109|NCT05635045|466748698|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
129669110|NCT05635045|466748699|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
129669111|NCT05635045|466748700|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
129669112|NCT05635045|466748701|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
129669113|NCT01435759|466748705|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
129669114|NCT01435759|466748706|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
129669115|NCT01435759|466748707|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
129669116|NCT01435759|466748708|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
129669117|NCT01435759|466748709|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
129669118|NCT01435759|466748710|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
129669119|NCT01435759|466748705|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
129669120|NCT01435759|466748706|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
129669121|NCT01435759|466748707|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
129669122|NCT01435759|466748708|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
129669123|NCT01435759|466748709|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
129669124|NCT01435759|466748710|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
129669125|NCT01435759|466748705|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
129669126|NCT01435759|466748706|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129669127|NCT01435759|466748707|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129669128|NCT01435759|466748708|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129669129|NCT01435759|466748709|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129669130|NCT01435759|466748710|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129669131|NCT01435759|466748705|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
129669132|NCT01435759|466748706|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129669133|NCT01435759|466748707|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129669134|NCT01435759|466748708|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129669135|NCT01435759|466748709|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129669136|NCT01435759|466748710|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129669137|NCT01435759|466748705|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
129669138|NCT01435759|466748706|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669139|NCT01435759|466748707|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669140|NCT01435759|466748708|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669141|NCT01435759|466748709|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669142|NCT01435759|466748710|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669143|NCT01435759|466748705|FG000|Antidepressant Lead-in Phase|Other|119|||
129669144|NCT01435759|466748706|FG001|Antidepressant Lead-in Phase|Other|0|||
129669145|NCT01435759|466748707|FG002|Antidepressant Lead-in Phase|Other|0|||
129669146|NCT01435759|466748708|FG003|Antidepressant Lead-in Phase|Other|0|||
129669147|NCT01435759|466748709|FG004|Antidepressant Lead-in Phase|Other|0|||
129669148|NCT01435759|466748710|FG005|Antidepressant Lead-in Phase|Other|0|||
129669149|NCT01435759|466748705|FG000|Double-blind Phase|Adverse Event|7|||
129669150|NCT01435759|466748706|FG001|Double-blind Phase|Adverse Event|0|||
129669151|NCT01435759|466748707|FG002|Double-blind Phase|Adverse Event|1|||
129669152|NCT01435759|466748708|FG003|Double-blind Phase|Adverse Event|1|||
129669153|NCT01435759|466748709|FG004|Double-blind Phase|Adverse Event|1|||
129669154|NCT01435759|466748710|FG005|Double-blind Phase|Adverse Event|3|||
129669155|NCT01435759|466748705|FG000|Double-blind Phase|Protocol Violation|2|||
129669156|NCT01435759|466748706|FG001|Double-blind Phase|Protocol Violation|0|||
129669157|NCT01435759|466748707|FG002|Double-blind Phase|Protocol Violation|1|||
129669158|NCT01435759|466748708|FG003|Double-blind Phase|Protocol Violation|2|||
129669159|NCT01435759|466748709|FG004|Double-blind Phase|Protocol Violation|0|||
129669160|NCT01435759|466748710|FG005|Double-blind Phase|Protocol Violation|1|||
129669161|NCT01435759|466748705|FG000|Double-blind Phase|Withdrawal by Subject|17|||
129669162|NCT01435759|466748706|FG001|Double-blind Phase|Withdrawal by Subject|4|||
129669163|NCT01435759|466748707|FG002|Double-blind Phase|Withdrawal by Subject|3|||
129669164|NCT01435759|466748708|FG003|Double-blind Phase|Withdrawal by Subject|4|||
129669165|NCT01435759|466748709|FG004|Double-blind Phase|Withdrawal by Subject|2|||
129669166|NCT01435759|466748710|FG005|Double-blind Phase|Withdrawal by Subject|2|||
129669167|NCT01435759|466748705|FG000|Double-blind Phase|Lost to Follow-up|31|||
129669168|NCT01435759|466748706|FG001|Double-blind Phase|Lost to Follow-up|1|||
129669169|NCT01435759|466748707|FG002|Double-blind Phase|Lost to Follow-up|2|||
129669170|NCT01435759|466748708|FG003|Double-blind Phase|Lost to Follow-up|0|||
129669171|NCT01435759|466748709|FG004|Double-blind Phase|Lost to Follow-up|3|||
129669172|NCT01435759|466748710|FG005|Double-blind Phase|Lost to Follow-up|3|||
129669173|NCT01435759|466748705|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
129669174|NCT01435759|466748706|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669175|NCT01435759|466748707|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669176|NCT01435759|466748708|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669177|NCT01435759|466748709|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
129669178|NCT01435759|466748710|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
129669179|NCT01435759|466748705|FG000|Double-blind Phase|Other|8|||
129669180|NCT01435759|466748706|FG001|Double-blind Phase|Other|2|||
129669181|NCT01435759|466748707|FG002|Double-blind Phase|Other|0|||
129669182|NCT01435759|466748708|FG003|Double-blind Phase|Other|2|||
129669183|NCT01435759|466748709|FG004|Double-blind Phase|Other|0|||
129669184|NCT01435759|466748710|FG005|Double-blind Phase|Other|0|||
129669185|NCT02849587|466748713|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
129669186|NCT02849587|466748714|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
129669187|NCT02849587|466748715|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
129669188|NCT02849587|466748713|FG000|Overall Study|Withdrawal by Subject|0|||
129669189|NCT02849587|466748714|FG001|Overall Study|Withdrawal by Subject|1|||
129669190|NCT02849587|466748715|FG002|Overall Study|Withdrawal by Subject|0|||
129669191|NCT02421419|466748717|FG000|Overall Study|Physician Decision|0|||
129669192|NCT02421419|466748718|FG001|Overall Study|Physician Decision|0|||
129669193|NCT02421419|466748719|FG002|Overall Study|Physician Decision|1|||
129669194|NCT01365130|466748723|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
129669195|NCT00810199|466748725|FG000|Overall Study|Adverse Event|24|||
129669196|NCT00810199|466748726|FG001|Overall Study|Adverse Event|26|||
129669197|NCT00810199|466748725|FG000|Overall Study|Death|4|||
129669198|NCT00810199|466748726|FG001|Overall Study|Death|6|||
129669199|NCT00810199|466748725|FG000|Overall Study|Withdrew consent|9|||
129669200|NCT00810199|466748726|FG001|Overall Study|Withdrew consent|12|||
129669201|NCT00810199|466748725|FG000|Overall Study|Insufficient therapeutic response|5|||
129669202|NCT00810199|466748726|FG001|Overall Study|Insufficient therapeutic response|14|||
129669203|NCT00810199|466748725|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
129669204|NCT00810199|466748726|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
129669205|NCT00810199|466748725|FG000|Overall Study|Administrative/Other|5|||
129669206|NCT00810199|466748726|FG001|Overall Study|Administrative/Other|6|||
129669207|NCT00810199|466748725|FG000|Overall Study|Protocol Violation|2|||
129669208|NCT00810199|466748726|FG001|Overall Study|Protocol Violation|6|||
129669209|NCT00810199|466748725|FG000|Overall Study|Failure to return|1|||
129669210|NCT00810199|466748726|FG001|Overall Study|Failure to return|4|||
129669211|NCT00810199|466748725|FG000|Overall Study|Did not receive study drug|2|||
129669212|NCT00810199|466748726|FG001|Overall Study|Did not receive study drug|1|||
129669213|NCT05502302|466748727|FG000|Overall Study|Lost to Follow-up|6|||
129669214|NCT05502302|466748727|FG000|Overall Study|Death|2|||
129669215|NCT01628848|466748731|FG000|Overall Study|Adverse Event|9|||
129669216|NCT01628848|466748732|FG001|Overall Study|Adverse Event|7|||
129669217|NCT01628848|466748731|FG000|Overall Study|Lack of Efficacy|0|||
129669218|NCT01628848|466748732|FG001|Overall Study|Lack of Efficacy|4|||
129669219|NCT01628848|466748731|FG000|Overall Study|Withdrawal by Subject|0|||
129669220|NCT01628848|466748732|FG001|Overall Study|Withdrawal by Subject|2|||
129669221|NCT01628848|466748731|FG000|Overall Study|Physician Decision|3|||
129669222|NCT01628848|466748732|FG001|Overall Study|Physician Decision|1|||
129669223|NCT00003471|466748733|FG000|Overall Study|Not evaluable|4|||
129669224|NCT02104895|466748734|FG000|Overall Study|Withdrawal by Subject|0|||
129669225|NCT02104895|466748735|FG001|Overall Study|Withdrawal by Subject|14|||
129669226|NCT03311945|466748737|FG000|Overall Study|Adverse Event|2|||
129669227|NCT03311945|466748737|FG000|Overall Study|Lack of Efficacy|1|||
129669228|NCT01619878|466748738|FG000|6 Week Follow-up Phase|Adverse Event|1|||
129669229|NCT01619878|466748738|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
129669230|NCT01619878|466748738|FG000|Follow-up at 12 Months of Age|Death|2|||
129669231|NCT02895295|466748741|FG000|Overall Study|Survey Non-response|71|||
129669232|NCT02895295|466748742|FG001|Overall Study|Survey Non-response|94|||
129669233|NCT02895295|466748743|FG002|Overall Study|Survey Non-response|92|||
129669234|NCT04821830|466748744|FG000|Overall Study|Withdrawal by Subject|1|||
129669235|NCT04821830|466748745|FG001|Overall Study|Withdrawal by Subject|0|||
129669236|NCT00960804|466748746|FG000|Overall Study|Adverse Event|1|||
129669237|NCT00960804|466748747|FG001|Overall Study|Adverse Event|0|||
129669238|NCT00960804|466748748|FG002|Overall Study|Adverse Event|0|||
129669239|NCT00960804|466748746|FG000|Overall Study|Withdrawal by Subject|1|||
129669240|NCT00960804|466748747|FG001|Overall Study|Withdrawal by Subject|0|||
129669241|NCT00960804|466748748|FG002|Overall Study|Withdrawal by Subject|0|||
129669242|NCT00960804|466748746|FG000|Overall Study|Study terminated by the sponsor|5|||
129669243|NCT00960804|466748747|FG001|Overall Study|Study terminated by the sponsor|4|||
129669244|NCT00960804|466748748|FG002|Overall Study|Study terminated by the sponsor|10|||
129669245|NCT03810456|466748749|FG000|Treatment|Urgent Family Matters|3|||
129669246|NCT03810456|466748750|FG001|Treatment|Urgent Family Matters|0|||
129669247|NCT03810456|466748751|FG002|Treatment|Urgent Family Matters|0|||
129669248|NCT03810456|466748749|FG000|Treatment|Scheduling Conflicts|0|||
129669249|NCT03810456|466748750|FG001|Treatment|Scheduling Conflicts|11|||
129669250|NCT03810456|466748751|FG002|Treatment|Scheduling Conflicts|0|||
129669251|NCT03810456|466748749|FG000|Treatment|No Longer Interested|0|||
129669252|NCT03810456|466748750|FG001|Treatment|No Longer Interested|12|||
129669253|NCT03810456|466748751|FG002|Treatment|No Longer Interested|0|||
129669254|NCT03810456|466748749|FG000|Treatment|Transportation Issues|0|||
129669255|NCT03810456|466748750|FG001|Treatment|Transportation Issues|1|||
129669256|NCT03810456|466748751|FG002|Treatment|Transportation Issues|0|||
129669257|NCT03810456|466748749|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
129669258|NCT03810456|466748750|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
129669259|NCT03810456|466748751|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
129669260|NCT03810456|466748749|FG000|1 Month Follow-Up|Relocated to Different State|1|||
129669261|NCT03810456|466748750|FG001|1 Month Follow-Up|Relocated to Different State|0|||
129669262|NCT03810456|466748751|FG002|1 Month Follow-Up|Relocated to Different State|1|||
129669263|NCT03810456|466748749|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
129669264|NCT03810456|466748750|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
129669265|NCT03810456|466748751|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
129669266|NCT03810456|466748749|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
129669267|NCT03810456|466748750|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
129669268|NCT03810456|466748751|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
129669269|NCT03810456|466748749|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
129669270|NCT03810456|466748750|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
129669271|NCT03810456|466748751|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
129669272|NCT03810456|466748749|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
129669273|NCT03810456|466748750|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
129669274|NCT03810456|466748751|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
129669275|NCT03810456|466748749|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
129669276|NCT03810456|466748750|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
129669277|NCT03810456|466748751|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
129669278|NCT00490919|466748752|FG000|Open-label Run-in Period|Adverse Event|239|||
129669279|NCT00490919|466748753|FG001|Open-label Run-in Period|Adverse Event|0|||
129669280|NCT00490919|466748754|FG002|Open-label Run-in Period|Adverse Event|0|||
129669281|NCT00490919|466748752|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
129669282|NCT00490919|466748753|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
129669283|NCT00490919|466748754|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
129669284|NCT00490919|466748752|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
129669285|NCT00490919|466748753|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
129669286|NCT00490919|466748754|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
129669287|NCT00490919|466748752|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
129669288|NCT00490919|466748753|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
129669289|NCT00490919|466748754|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
129669290|NCT00490919|466748752|FG000|Open-label Run-in Period|Administrative|40|||
129669291|NCT00490919|466748753|FG001|Open-label Run-in Period|Administrative|0|||
129669292|NCT00490919|466748754|FG002|Open-label Run-in Period|Administrative|0|||
129669293|NCT00490919|466748752|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
129669294|NCT00490919|466748753|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
129669295|NCT00490919|466748754|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
129669296|NCT00490919|466748752|FG000|Double-blind Phase|Adverse Event|0|||
129669297|NCT00490919|466748753|FG001|Double-blind Phase|Adverse Event|40|||
129669298|NCT00490919|466748754|FG002|Double-blind Phase|Adverse Event|20|||
129669299|NCT00490919|466748752|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129669300|NCT00490919|466748753|FG001|Double-blind Phase|Withdrawal by Subject|10|||
129669301|NCT00490919|466748754|FG002|Double-blind Phase|Withdrawal by Subject|11|||
129669302|NCT00490919|466748752|FG000|Double-blind Phase|Lost to Follow-up|0|||
129669303|NCT00490919|466748753|FG001|Double-blind Phase|Lost to Follow-up|8|||
129669304|NCT00490919|466748754|FG002|Double-blind Phase|Lost to Follow-up|11|||
129669305|NCT00490919|466748752|FG000|Double-blind Phase|Lack of Efficacy|0|||
129669306|NCT00490919|466748753|FG001|Double-blind Phase|Lack of Efficacy|22|||
129669307|NCT00490919|466748754|FG002|Double-blind Phase|Lack of Efficacy|36|||
129669308|NCT00490919|466748752|FG000|Double-blind Phase|Administrative|0|||
129669309|NCT00490919|466748753|FG001|Double-blind Phase|Administrative|6|||
129669310|NCT00490919|466748754|FG002|Double-blind Phase|Administrative|6|||
129669311|NCT03163446|466750764|FG000|Overall Study|Unable to return for Day 180 visit|2|||
129669312|NCT03163446|466750765|FG001|Overall Study|Unable to return for Day 180 visit|0|||
129669313|NCT03163446|466750764|FG000|Overall Study|Withdrawal by Subject|2|||
129669314|NCT03163446|466750765|FG001|Overall Study|Withdrawal by Subject|6|||
129669315|NCT03163446|466750764|FG000|Overall Study|Death|16|||
129669316|NCT03163446|466750765|FG001|Overall Study|Death|5|||
129669317|NCT03163446|466750764|FG000|Overall Study|Lost to Follow-up|6|||
129669318|NCT03163446|466750765|FG001|Overall Study|Lost to Follow-up|5|||
129669319|NCT03163446|466750764|FG000|Overall Study|Physician Decision|1|||
129669320|NCT03163446|466750765|FG001|Overall Study|Physician Decision|1|||
129669321|NCT03163446|466750764|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
129669322|NCT03163446|466750765|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
129669323|NCT01317641|466750766|FG000|Overall Study|Not treated|0|||
129669324|NCT01317641|466750767|FG001|Overall Study|Not treated|0|||
129669325|NCT01317641|466750768|FG002|Overall Study|Not treated|0|||
129669326|NCT01317641|466750769|FG003|Overall Study|Not treated|0|||
129669327|NCT01317641|466750770|FG004|Overall Study|Not treated|0|||
129669328|NCT01317641|466750771|FG005|Overall Study|Not treated|0|||
129669329|NCT01317641|466750772|FG006|Overall Study|Not treated|0|||
129669330|NCT01317641|466750773|FG007|Overall Study|Not treated|1|||
129669331|NCT01317641|466750774|FG008|Overall Study|Not treated|1|||
129669332|NCT01317641|466750766|FG000|Overall Study|Adverse Event|0|||
129669333|NCT01317641|466750767|FG001|Overall Study|Adverse Event|1|||
129669334|NCT01317641|466750768|FG002|Overall Study|Adverse Event|0|||
129669335|NCT01317641|466750769|FG003|Overall Study|Adverse Event|1|||
129669336|NCT01317641|466750770|FG004|Overall Study|Adverse Event|0|||
129669337|NCT01317641|466750771|FG005|Overall Study|Adverse Event|0|||
129669338|NCT01317641|466750772|FG006|Overall Study|Adverse Event|2|||
129669339|NCT01317641|466750773|FG007|Overall Study|Adverse Event|1|||
129669340|NCT01317641|466750774|FG008|Overall Study|Adverse Event|0|||
129669341|NCT01317641|466750766|FG000|Overall Study|Protocol Violation|1|||
129669342|NCT01317641|466750767|FG001|Overall Study|Protocol Violation|0|||
129669343|NCT01317641|466750768|FG002|Overall Study|Protocol Violation|0|||
129669344|NCT01317641|466750769|FG003|Overall Study|Protocol Violation|0|||
129669345|NCT01317641|466750770|FG004|Overall Study|Protocol Violation|0|||
129669346|NCT01317641|466750771|FG005|Overall Study|Protocol Violation|0|||
129669347|NCT01317641|466750772|FG006|Overall Study|Protocol Violation|0|||
129669348|NCT01317641|466750773|FG007|Overall Study|Protocol Violation|0|||
129669349|NCT01317641|466750774|FG008|Overall Study|Protocol Violation|0|||
129669350|NCT01317641|466750766|FG000|Overall Study|Disease progression|0|||
129669351|NCT01317641|466750767|FG001|Overall Study|Disease progression|0|||
129669352|NCT01317641|466750768|FG002|Overall Study|Disease progression|0|||
129669353|NCT01317641|466750769|FG003|Overall Study|Disease progression|0|||
129669354|NCT01317641|466750770|FG004|Overall Study|Disease progression|0|||
129669355|NCT01317641|466750771|FG005|Overall Study|Disease progression|0|||
129669356|NCT01317641|466750772|FG006|Overall Study|Disease progression|0|||
129669357|NCT01317641|466750773|FG007|Overall Study|Disease progression|3|||
129669358|NCT01317641|466750774|FG008|Overall Study|Disease progression|4|||
129669359|NCT01317641|466750766|FG000|Overall Study|Withdrawal by Subject|0|||
129669360|NCT01317641|466750767|FG001|Overall Study|Withdrawal by Subject|0|||
129669361|NCT01317641|466750768|FG002|Overall Study|Withdrawal by Subject|0|||
129669362|NCT01317641|466750769|FG003|Overall Study|Withdrawal by Subject|0|||
129669363|NCT01317641|466750770|FG004|Overall Study|Withdrawal by Subject|0|||
129669364|NCT01317641|466750771|FG005|Overall Study|Withdrawal by Subject|0|||
129669365|NCT01317641|466750772|FG006|Overall Study|Withdrawal by Subject|1|||
129669366|NCT01317641|466750773|FG007|Overall Study|Withdrawal by Subject|0|||
129669367|NCT01317641|466750774|FG008|Overall Study|Withdrawal by Subject|0|||
129669368|NCT01228591|466750775|FG000|Baseline|Lack of Efficacy|1|||
129669369|NCT01228591|466750776|FG001|Baseline|Lack of Efficacy|2|||
129669370|NCT01921517|466750777|FG000|Overall Study|Lost to Follow-up|5|||
129669371|NCT01921517|466750778|FG001|Overall Study|Lost to Follow-up|0|||
129669372|NCT01921517|466750777|FG000|Overall Study|Newly diagnosed health concern|2|||
129669373|NCT01921517|466750778|FG001|Overall Study|Newly diagnosed health concern|0|||
129669374|NCT01921517|466750777|FG000|Overall Study|Physician Decision|0|||
129669375|NCT01921517|466750778|FG001|Overall Study|Physician Decision|2|||
129669376|NCT01921517|466750777|FG000|Overall Study|Withdrawal by Subject|7|||
129669377|NCT01921517|466750778|FG001|Overall Study|Withdrawal by Subject|3|||
129669378|NCT01921517|466750777|FG000|Overall Study|Subject missed final imaging|1|||
129669379|NCT01921517|466750778|FG001|Overall Study|Subject missed final imaging|4|||
129669380|NCT03110354|466750784|FG000|Overall Study|Death|1|||
129669381|NCT03110354|466750785|FG001|Overall Study|Death|0|||
129669382|NCT03110354|466750786|FG002|Overall Study|Death|0|||
129669383|NCT03110354|466750787|FG003|Overall Study|Death|1|||
129669384|NCT03110354|466750788|FG004|Overall Study|Death|0|||
129669385|NCT03110354|466750784|FG000|Overall Study|Start of new therapy|0|||
129669386|NCT03110354|466750785|FG001|Overall Study|Start of new therapy|0|||
129669387|NCT03110354|466750786|FG002|Overall Study|Start of new therapy|0|||
129669388|NCT03110354|466750787|FG003|Overall Study|Start of new therapy|0|||
129669389|NCT03110354|466750788|FG004|Overall Study|Start of new therapy|1|||
129669390|NCT03110354|466750784|FG000|Overall Study|Failure to achieve response|2|||
129669391|NCT03110354|466750785|FG001|Overall Study|Failure to achieve response|3|||
129669392|NCT03110354|466750786|FG002|Overall Study|Failure to achieve response|0|||
129669393|NCT03110354|466750787|FG003|Overall Study|Failure to achieve response|2|||
129669394|NCT03110354|466750788|FG004|Overall Study|Failure to achieve response|1|||
129669395|NCT03110354|466750784|FG000|Overall Study|Progressive disease|1|||
129669396|NCT03110354|466750785|FG001|Overall Study|Progressive disease|1|||
129669397|NCT03110354|466750786|FG002|Overall Study|Progressive disease|3|||
129669398|NCT03110354|466750787|FG003|Overall Study|Progressive disease|4|||
129669399|NCT03110354|466750788|FG004|Overall Study|Progressive disease|2|||
129669400|NCT03110354|466750784|FG000|Overall Study|Adverse Event|0|||
129669401|NCT03110354|466750785|FG001|Overall Study|Adverse Event|0|||
129669402|NCT03110354|466750786|FG002|Overall Study|Adverse Event|0|||
129669403|NCT03110354|466750787|FG003|Overall Study|Adverse Event|2|||
129669404|NCT03110354|466750788|FG004|Overall Study|Adverse Event|2|||
129669405|NCT03110354|466750784|FG000|Overall Study|Other|0|||
129669406|NCT03110354|466750785|FG001|Overall Study|Other|0|||
129669407|NCT03110354|466750786|FG002|Overall Study|Other|0|||
129669408|NCT03110354|466750787|FG003|Overall Study|Other|1|||
129669409|NCT03110354|466750788|FG004|Overall Study|Other|1|||
129669410|NCT00116688|466750793|FG000|Overall Study|Protocol deviation|1|||
129669411|NCT00116688|466750794|FG001|Overall Study|Protocol deviation|0|||
129669412|NCT00116688|466750793|FG000|Overall Study|Noncompliance|3|||
129669413|NCT00116688|466750794|FG001|Overall Study|Noncompliance|1|||
129669414|NCT00116688|466750793|FG000|Overall Study|Adverse Event|11|||
129669415|NCT00116688|466750794|FG001|Overall Study|Adverse Event|0|||
129669416|NCT00116688|466750793|FG000|Overall Study|Withdrawal by Subject|26|||
129669417|NCT00116688|466750794|FG001|Overall Study|Withdrawal by Subject|2|||
129669418|NCT00116688|466750793|FG000|Overall Study|Requirement for alternative therapy|11|||
129669419|NCT00116688|466750794|FG001|Overall Study|Requirement for alternative therapy|1|||
129669420|NCT00116688|466750793|FG000|Overall Study|Physician Decision|7|||
129669421|NCT00116688|466750794|FG001|Overall Study|Physician Decision|0|||
129669422|NCT00116688|466750793|FG000|Overall Study|Lost to Follow-up|3|||
129669423|NCT00116688|466750794|FG001|Overall Study|Lost to Follow-up|0|||
129669424|NCT00116688|466750793|FG000|Overall Study|Death|15|||
129669425|NCT00116688|466750794|FG001|Overall Study|Death|0|||
129669426|NCT00116688|466750793|FG000|Overall Study|Protocol-specified criteria|3|||
129669427|NCT00116688|466750794|FG001|Overall Study|Protocol-specified criteria|0|||
129669428|NCT00116688|466750793|FG000|Overall Study|Pregnancy|1|||
129669429|NCT00116688|466750794|FG001|Overall Study|Pregnancy|0|||
129669430|NCT00116688|466750793|FG000|Overall Study|Other|11|||
129669431|NCT00116688|466750794|FG001|Overall Study|Other|0|||
129669432|NCT01775670|466750799|FG000|Overall Study|Lost to Follow-up|1|||
129669433|NCT01775670|466750800|FG001|Overall Study|Lost to Follow-up|1|||
129669434|NCT01298700|466750802|FG000|Overall Study|Adverse Event|50|||
129669435|NCT01298700|466750803|FG001|Overall Study|Adverse Event|51|||
129669436|NCT01298700|466750802|FG000|Overall Study|Lack of Efficacy|9|||
129669437|NCT01298700|466750803|FG001|Overall Study|Lack of Efficacy|14|||
129669438|NCT01298700|466750802|FG000|Overall Study|Lost to Follow-up|5|||
129669439|NCT01298700|466750803|FG001|Overall Study|Lost to Follow-up|2|||
129669440|NCT01298700|466750802|FG000|Overall Study|Withdrawal by Subject|12|||
129669441|NCT01298700|466750803|FG001|Overall Study|Withdrawal by Subject|9|||
129669442|NCT01298700|466750802|FG000|Overall Study|Protocol Violation|6|||
129669443|NCT01298700|466750803|FG001|Overall Study|Protocol Violation|4|||
129669444|NCT01298700|466750802|FG000|Overall Study|Other Miscellaneous Reasons|16|||
129669445|NCT01298700|466750803|FG001|Overall Study|Other Miscellaneous Reasons|15|||
129669446|NCT01298700|466750802|FG000|Overall Study|Did not Receive Study Drug|3|||
129669447|NCT01298700|466750803|FG001|Overall Study|Did not Receive Study Drug|5|||
129669448|NCT04006145|466750806|FG000|Overall Study|Lost to Follow-up|0|||
129669449|NCT04006145|466750807|FG001|Overall Study|Lost to Follow-up|1|||
129669450|NCT04006145|466750806|FG000|Overall Study|Other|1|||
129669451|NCT04006145|466750807|FG001|Overall Study|Other|2|||
129669452|NCT00010257|466750810|FG000|Overall Study|Withdrawal by Subject|1|||
129669453|NCT00010257|466750811|FG001|Overall Study|Withdrawal by Subject|0|||
129669454|NCT00643760|466750812|FG000|Overall Study|Adverse Event|11|||
129669455|NCT00643760|466750813|FG001|Overall Study|Adverse Event|5|||
129669456|NCT00643760|466750814|FG002|Overall Study|Adverse Event|12|||
129669457|NCT00643760|466750815|FG003|Overall Study|Adverse Event|21|||
129669458|NCT00643760|466750816|FG004|Overall Study|Adverse Event|6|||
129669459|NCT00643760|466750812|FG000|Overall Study|Lack of Efficacy|3|||
129669460|NCT00643760|466750813|FG001|Overall Study|Lack of Efficacy|1|||
129669461|NCT00643760|466750814|FG002|Overall Study|Lack of Efficacy|0|||
129669462|NCT00643760|466750815|FG003|Overall Study|Lack of Efficacy|4|||
129669463|NCT00643760|466750816|FG004|Overall Study|Lack of Efficacy|3|||
129669464|NCT00643760|466750812|FG000|Overall Study|Protocol Violation|7|||
129669465|NCT00643760|466750813|FG001|Overall Study|Protocol Violation|6|||
129669466|NCT00643760|466750814|FG002|Overall Study|Protocol Violation|4|||
129669467|NCT00643760|466750815|FG003|Overall Study|Protocol Violation|4|||
129669468|NCT00643760|466750816|FG004|Overall Study|Protocol Violation|6|||
129669469|NCT00643760|466750812|FG000|Overall Study|Lost to Follow-up|6|||
129669470|NCT00643760|466750813|FG001|Overall Study|Lost to Follow-up|2|||
129669471|NCT00643760|466750814|FG002|Overall Study|Lost to Follow-up|1|||
129669472|NCT00643760|466750815|FG003|Overall Study|Lost to Follow-up|3|||
129669473|NCT00643760|466750816|FG004|Overall Study|Lost to Follow-up|3|||
129669474|NCT00643760|466750812|FG000|Overall Study|Investigator Discretion|0|||
129669475|NCT00643760|466750813|FG001|Overall Study|Investigator Discretion|0|||
129669476|NCT00643760|466750814|FG002|Overall Study|Investigator Discretion|0|||
129669477|NCT00643760|466750815|FG003|Overall Study|Investigator Discretion|2|||
129669478|NCT00643760|466750816|FG004|Overall Study|Investigator Discretion|0|||
129669479|NCT00643760|466750812|FG000|Overall Study|Withdrawal by Subject|3|||
129669480|NCT00643760|466750813|FG001|Overall Study|Withdrawal by Subject|1|||
129669481|NCT00643760|466750814|FG002|Overall Study|Withdrawal by Subject|2|||
129669482|NCT00643760|466750815|FG003|Overall Study|Withdrawal by Subject|4|||
129669483|NCT00643760|466750816|FG004|Overall Study|Withdrawal by Subject|1|||
129669484|NCT00104052|466750820|FG000|Overall Study|Adverse Event|1|||
129669485|NCT00104052|466750820|FG000|Overall Study|Lack of Efficacy|26|||
129669486|NCT00104052|466750820|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
129669487|NCT01241279|466750825|FG000|Overall Study|Lost to Follow-up|0|||
129669488|NCT01241279|466750826|FG001|Overall Study|Lost to Follow-up|1|||
129669489|NCT00239720|466750827|FG000|Overall Study|Adverse Event|1|||
129669490|NCT00239720|466750828|FG001|Overall Study|Adverse Event|0|||
129669491|NCT00239720|466750827|FG000|Overall Study|Lost to Follow-up|0|||
129669492|NCT00239720|466750828|FG001|Overall Study|Lost to Follow-up|1|||
129669493|NCT01145482|466750829|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129669494|NCT01145482|466750830|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129669495|NCT01405560|466750833|FG000|Overall Study|Physician Decision|1|||
129669496|NCT01699750|466750835|FG000|Overall Study|Withdrew Consent|0|||
129669497|NCT01699750|466750836|FG001|Overall Study|Withdrew Consent|1|||
129669498|NCT01699750|466750835|FG000|Overall Study|Other|0|||
129669499|NCT01699750|466750836|FG001|Overall Study|Other|2|||
129669500|NCT01484951|466750837|FG000|Overall Study|Adverse Event|3|||
129669501|NCT01484951|466750837|FG000|Overall Study|Personal Reasons|1|||
129669502|NCT01484951|466750837|FG000|Overall Study|Non-Compliance|1|||
129669503|NCT02119299|466750838|FG000|Overall Study|Withdrawal by Subject|7|||
129669504|NCT02119299|466750838|FG000|Overall Study|Lack of Efficacy|1|||
129669505|NCT02119299|466750838|FG000|Overall Study|Pregnancy|1|||
129669506|NCT02452047|466750839|FG000|Overall Study|Adverse Event|0|||
129669507|NCT02452047|466750840|FG001|Overall Study|Adverse Event|1|||
129669508|NCT02452047|466750841|FG002|Overall Study|Adverse Event|1|||
129669509|NCT02452047|466750839|FG000|Overall Study|Death|1|||
129669510|NCT02452047|466750840|FG001|Overall Study|Death|3|||
129669511|NCT02452047|466750841|FG002|Overall Study|Death|1|||
129669512|NCT02452047|466750839|FG000|Overall Study|Physician Decision|1|||
129669513|NCT02452047|466750840|FG001|Overall Study|Physician Decision|0|||
129669514|NCT02452047|466750841|FG002|Overall Study|Physician Decision|0|||
129669515|NCT02452047|466750839|FG000|Overall Study|Lost to Follow-up|1|||
129669516|NCT02452047|466750840|FG001|Overall Study|Lost to Follow-up|1|||
129669517|NCT02452047|466750841|FG002|Overall Study|Lost to Follow-up|0|||
129669518|NCT02452047|466750839|FG000|Overall Study|Withdrawal by Subject|1|||
129669519|NCT02452047|466750840|FG001|Overall Study|Withdrawal by Subject|0|||
129669520|NCT02452047|466750841|FG002|Overall Study|Withdrawal by Subject|0|||
129669521|NCT01249417|466750842|FG000|Randomised Population|Study treatment not received|0|||
129669522|NCT01249417|466750843|FG001|Randomised Population|Study treatment not received|0|||
129669523|NCT01249417|466750844|FG002|Randomised Population|Study treatment not received|2|||
129669524|NCT01249417|466750842|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
129669525|NCT01249417|466750843|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
129669526|NCT01249417|466750844|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
129669527|NCT01249417|466750842|FG000|Treatment Phase - ITT Population|Other|0|||
129669528|NCT01249417|466750843|FG001|Treatment Phase - ITT Population|Other|0|||
129669529|NCT01249417|466750844|FG002|Treatment Phase - ITT Population|Other|1|||
129669530|NCT01249417|466750842|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
129669531|NCT01249417|466750843|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
129546867|NCT01964898|466296029|FG001|Overall Study|did not receive the allocated interventi|1|||
129546868|NCT01964898|466296028|FG000|Overall Study|Lost to Follow-up|3|||
129546869|NCT01964898|466296029|FG001|Overall Study|Lost to Follow-up|5|||
129546870|NCT01964898|466296028|FG000|Overall Study|Withdrawal by Subject|1|||
129546871|NCT01964898|466296029|FG001|Overall Study|Withdrawal by Subject|0|||
129546872|NCT02325401|466296032|FG000|Overall Study|Withdrawal by Subject|0|||
129546873|NCT02325401|466296033|FG001|Overall Study|Withdrawal by Subject|1|||
129546874|NCT02325401|466296034|FG002|Overall Study|Withdrawal by Subject|1|||
129546875|NCT03526679|466296035|FG000|Overall Study|still under treatment|2|||
129546876|NCT03443973|466296036|FG000|Double-blind Treatment Period|Adverse Event|5|||
129546877|NCT03443973|466296037|FG001|Double-blind Treatment Period|Adverse Event|19|||
129546878|NCT03443973|466296038|FG002|Double-blind Treatment Period|Adverse Event|0|||
129546879|NCT03443973|466296039|FG003|Double-blind Treatment Period|Adverse Event|0|||
129546880|NCT03443973|466296036|FG000|Double-blind Treatment Period|Death|5|||
129546881|NCT03443973|466296037|FG001|Double-blind Treatment Period|Death|7|||
129546882|NCT03443973|466296038|FG002|Double-blind Treatment Period|Death|0|||
129546883|NCT03443973|466296039|FG003|Double-blind Treatment Period|Death|0|||
129546884|NCT03443973|466296036|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
129546885|NCT03443973|466296037|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
129546886|NCT03443973|466296038|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129546887|NCT03443973|466296039|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
129546888|NCT03443973|466296036|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129546889|NCT03443973|466296037|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
129546890|NCT03443973|466296038|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129546891|NCT03443973|466296039|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129546892|NCT03443973|466296036|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
129546893|NCT03443973|466296037|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
129546894|NCT03443973|466296038|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
129546895|NCT03443973|466296039|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
129546896|NCT03443973|466296036|FG000|Double-blind Treatment Period|Physician Decision|5|||
129546897|NCT03443973|466296037|FG001|Double-blind Treatment Period|Physician Decision|6|||
129546898|NCT03443973|466296038|FG002|Double-blind Treatment Period|Physician Decision|0|||
129546899|NCT03443973|466296039|FG003|Double-blind Treatment Period|Physician Decision|0|||
129546900|NCT03443973|466296036|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
129546901|NCT03443973|466296037|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
129546902|NCT03443973|466296038|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
129546903|NCT03443973|466296039|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
129546904|NCT03443973|466296036|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
129546905|NCT03443973|466296037|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
129546906|NCT03443973|466296038|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129546907|NCT03443973|466296039|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
129546908|NCT03443973|466296036|FG000|Open-label Extension Period|Reason Not Specified|0|||
129546909|NCT03443973|466296037|FG001|Open-label Extension Period|Reason Not Specified|0|||
129546910|NCT03443973|466296038|FG002|Open-label Extension Period|Reason Not Specified|3|||
129546911|NCT03443973|466296039|FG003|Open-label Extension Period|Reason Not Specified|0|||
129546912|NCT03443973|466296036|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129546913|NCT03443973|466296037|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129546914|NCT03443973|466296038|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
129546915|NCT03443973|466296039|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
129546916|NCT01956123|466296040|FG000|COS Cycle 2|Protocol Violation|8|||
129546917|NCT01956123|466296041|FG001|COS Cycle 2|Protocol Violation|3|||
129546918|NCT01956123|466296042|FG002|COS Cycle 2|Protocol Violation|0|||
129546919|NCT01956123|466296043|FG003|COS Cycle 2|Protocol Violation|0|||
129546920|NCT01956123|466296040|FG000|COS Cycle 2|Adverse Event|3|||
129546921|NCT01956123|466296041|FG001|COS Cycle 2|Adverse Event|4|||
129546922|NCT01956123|466296042|FG002|COS Cycle 2|Adverse Event|0|||
129546923|NCT01956123|466296043|FG003|COS Cycle 2|Adverse Event|0|||
129546924|NCT01956123|466296040|FG000|COS Cycle 2|Personal Reasons|2|||
129546925|NCT01956123|466296041|FG001|COS Cycle 2|Personal Reasons|0|||
129669532|NCT01249417|466750844|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
129546926|NCT01956123|466296042|FG002|COS Cycle 2|Personal Reasons|0|||
129546927|NCT01956123|466296043|FG003|COS Cycle 2|Personal Reasons|0|||
129546928|NCT01956123|466296040|FG000|COS Cycle 2|Withdrawal by Subject|1|||
129546929|NCT01956123|466296041|FG001|COS Cycle 2|Withdrawal by Subject|0|||
129669533|NCT01249417|466750842|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
129669534|NCT01249417|466750843|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
129669535|NCT01249417|466750844|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
129669536|NCT01249417|466750842|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
129669537|NCT01249417|466750843|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
129669538|NCT01249417|466750844|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
129669539|NCT00917124|466750845|FG000|Overall Study|Protocol Violation|4|||
129669540|NCT00917124|466750846|FG001|Overall Study|Protocol Violation|6|||
129669541|NCT00126594|466750848|FG000|Overall Study|Ineligible|2|||
129669542|NCT00126594|466750849|FG001|Overall Study|Ineligible|0|||
129669543|NCT00126594|466750848|FG000|Overall Study|Withdrawal by Subject|0|||
129669544|NCT00126594|466750849|FG001|Overall Study|Withdrawal by Subject|4|||
129669545|NCT00126594|466750848|FG000|Overall Study|Physician Decision|1|||
129669546|NCT00126594|466750849|FG001|Overall Study|Physician Decision|3|||
129669547|NCT00126594|466750848|FG000|Overall Study|Adverse Event|7|||
129669548|NCT00126594|466750849|FG001|Overall Study|Adverse Event|5|||
129669549|NCT00126594|466750848|FG000|Overall Study|Non-compliance|0|||
129669550|NCT00126594|466750849|FG001|Overall Study|Non-compliance|1|||
129669551|NCT00126594|466750848|FG000|Overall Study|Disease Progression|29|||
129669552|NCT00126594|466750849|FG001|Overall Study|Disease Progression|24|||
129669553|NCT03769649|466750850|FG000|Overall Study|Lost to Follow-up|4|||
129669554|NCT01290718|466750853|FG000|Overall Study|Early termination of the study|4|||
129669555|NCT00473655|466750854|FG000|Overall Study|Lost to Follow-up|9|||
129669556|NCT00473655|466750855|FG001|Overall Study|Lost to Follow-up|5|||
129669557|NCT00473655|466750856|FG002|Overall Study|Lost to Follow-up|8|||
129669558|NCT00243919|466750857|FG000|Overall Study|Death|3|||
129669559|NCT00243919|466750858|FG001|Overall Study|Death|4|||
129669560|NCT00243919|466750859|FG002|Overall Study|Death|6|||
129669561|NCT00243919|466750857|FG000|Overall Study|Withdrawal by Subject|6|||
129669562|NCT00243919|466750858|FG001|Overall Study|Withdrawal by Subject|6|||
129669563|NCT00243919|466750859|FG002|Overall Study|Withdrawal by Subject|2|||
129669564|NCT00243919|466750857|FG000|Overall Study|Lost to Follow-up|6|||
129669565|NCT00243919|466750858|FG001|Overall Study|Lost to Follow-up|7|||
129669566|NCT00243919|466750859|FG002|Overall Study|Lost to Follow-up|3|||
129669567|NCT00243919|466750857|FG000|Overall Study|Administrative Error|1|||
129669568|NCT00243919|466750858|FG001|Overall Study|Administrative Error|0|||
129669569|NCT00243919|466750859|FG002|Overall Study|Administrative Error|0|||
129669570|NCT00243919|466750857|FG000|Overall Study|Physician Decision|1|||
129669571|NCT00243919|466750858|FG001|Overall Study|Physician Decision|1|||
129669572|NCT00243919|466750859|FG002|Overall Study|Physician Decision|0|||
129669573|NCT01268267|466750860|FG000|Overall Study|Protocol Violation|1|||
129669574|NCT04176939|466750861|FG000|Overall Study|Withdrawal by Subject|5|||
129669575|NCT04176939|466750861|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
129669576|NCT04176939|466750861|FG000|Overall Study|Lost to Follow-up|2|||
129669577|NCT04176939|466750861|FG000|Overall Study|Unspecified reason|4|||
129669578|NCT04176939|466750861|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
129669579|NCT04919317|466750868|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
129669580|NCT04919317|466750869|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
129669581|NCT04919317|466750868|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
129669582|NCT04919317|466750869|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
129669583|NCT02869789|466750870|FG000|Overall Study|Disease progression|184|||
129669584|NCT02869789|466750871|FG001|Overall Study|Disease progression|109|||
129669585|NCT02869789|466750872|FG002|Overall Study|Disease progression|260|||
129669586|NCT02869789|466750873|FG003|Overall Study|Disease progression|19|||
129669587|NCT02869789|466750870|FG000|Overall Study|Study drug toxicity|90|||
129669588|NCT02869789|466750871|FG001|Overall Study|Study drug toxicity|32|||
129669589|NCT02869789|466750872|FG002|Overall Study|Study drug toxicity|55|||
129669590|NCT02869789|466750873|FG003|Overall Study|Study drug toxicity|14|||
129669591|NCT02869789|466750870|FG000|Overall Study|Death|7|||
129669592|NCT02869789|466750871|FG001|Overall Study|Death|3|||
129669593|NCT02869789|466750872|FG002|Overall Study|Death|5|||
129669594|NCT02869789|466750873|FG003|Overall Study|Death|1|||
129669595|NCT02869789|466750870|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
129669596|NCT02869789|466750871|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
129669597|NCT02869789|466750872|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
129669598|NCT02869789|466750873|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
129669599|NCT02869789|466750870|FG000|Overall Study|Participant request to discontinue study treatment|10|||
129669600|NCT02869789|466750871|FG001|Overall Study|Participant request to discontinue study treatment|5|||
129669601|NCT02869789|466750872|FG002|Overall Study|Participant request to discontinue study treatment|5|||
129669602|NCT02869789|466750873|FG003|Overall Study|Participant request to discontinue study treatment|3|||
129669603|NCT02869789|466750870|FG000|Overall Study|Withdrawal by Subject|5|||
129669604|NCT02869789|466750871|FG001|Overall Study|Withdrawal by Subject|2|||
129669605|NCT02869789|466750872|FG002|Overall Study|Withdrawal by Subject|7|||
129669606|NCT02869789|466750873|FG003|Overall Study|Withdrawal by Subject|2|||
129669607|NCT02869789|466750870|FG000|Overall Study|Lost to Follow-up|0|||
129669608|NCT02869789|466750871|FG001|Overall Study|Lost to Follow-up|0|||
129669609|NCT02869789|466750872|FG002|Overall Study|Lost to Follow-up|2|||
129669610|NCT02869789|466750873|FG003|Overall Study|Lost to Follow-up|0|||
129669611|NCT02869789|466750870|FG000|Overall Study|Maximum clinical benefit|5|||
129669612|NCT02869789|466750871|FG001|Overall Study|Maximum clinical benefit|2|||
129669613|NCT02869789|466750872|FG002|Overall Study|Maximum clinical benefit|1|||
129669614|NCT02869789|466750873|FG003|Overall Study|Maximum clinical benefit|0|||
129669615|NCT02869789|466750870|FG000|Overall Study|Poor/Non-compliance|0|||
129669616|NCT02869789|466750871|FG001|Overall Study|Poor/Non-compliance|2|||
129669617|NCT02869789|466750872|FG002|Overall Study|Poor/Non-compliance|1|||
129669618|NCT02869789|466750873|FG003|Overall Study|Poor/Non-compliance|0|||
129669619|NCT02869789|466750870|FG000|Overall Study|Participant no longer meets study criteria|0|||
129669620|NCT02869789|466750871|FG001|Overall Study|Participant no longer meets study criteria|1|||
129669621|NCT02869789|466750872|FG002|Overall Study|Participant no longer meets study criteria|1|||
129669622|NCT02869789|466750873|FG003|Overall Study|Participant no longer meets study criteria|0|||
129669623|NCT02869789|466750870|FG000|Overall Study|Administrative reason by sponsor|0|||
129669624|NCT02869789|466750871|FG001|Overall Study|Administrative reason by sponsor|0|||
129669625|NCT02869789|466750872|FG002|Overall Study|Administrative reason by sponsor|1|||
129669626|NCT02869789|466750873|FG003|Overall Study|Administrative reason by sponsor|0|||
129669627|NCT02869789|466750870|FG000|Overall Study|Other reasons|4|||
129669628|NCT02869789|466750871|FG001|Overall Study|Other reasons|8|||
129669629|NCT02869789|466750872|FG002|Overall Study|Other reasons|6|||
129669630|NCT02869789|466750873|FG003|Overall Study|Other reasons|0|||
129669631|NCT02127658|466750888|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
129669632|NCT02127658|466750889|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
129669633|NCT02127658|466750888|FG000|Overall Study|Withdrawal by Subject|0|||
129669634|NCT02127658|466750889|FG001|Overall Study|Withdrawal by Subject|2|||
129669635|NCT02127658|466750888|FG000|Overall Study|Physician Decision|0|||
129669636|NCT02127658|466750889|FG001|Overall Study|Physician Decision|1|||
129669637|NCT01443858|466750890|FG000|Overall Study|Withdrawal by Subject|9|||
129669638|NCT01443858|466750891|FG001|Overall Study|Withdrawal by Subject|8|||
129669639|NCT01443858|466750892|FG002|Overall Study|Withdrawal by Subject|5|||
129669640|NCT01443858|466750890|FG000|Overall Study|Lack of Efficacy|1|||
129669641|NCT01443858|466750891|FG001|Overall Study|Lack of Efficacy|0|||
129669642|NCT01443858|466750892|FG002|Overall Study|Lack of Efficacy|0|||
129546930|NCT01956123|466296042|FG002|COS Cycle 2|Withdrawal by Subject|0|||
129669643|NCT01443858|466750890|FG000|Overall Study|Lost to Follow-up|5|||
129669644|NCT01443858|466750891|FG001|Overall Study|Lost to Follow-up|5|||
129669645|NCT01443858|466750892|FG002|Overall Study|Lost to Follow-up|2|||
129669646|NCT01867008|466750893|FG000|Overall Study|Withdrawal by Subject|1|||
129669647|NCT01534273|466750894|FG000|Period 1|Physician Decision|0|||
129669648|NCT01534273|466750895|FG001|Period 1|Physician Decision|0|||
129669649|NCT01534273|466750896|FG002|Period 1|Physician Decision|0|||
129669650|NCT01534273|466750897|FG003|Period 1|Physician Decision|1|||
129669651|NCT01534273|466750898|FG004|Period 1|Physician Decision|0|||
129669652|NCT01534273|466750899|FG005|Period 1|Physician Decision|0|||
129669653|NCT01534273|466750900|FG006|Period 1|Physician Decision|0|||
129669654|NCT03586050|466750901|FG000|Overall Study|Death|3|||
129669655|NCT03586050|466750901|FG000|Overall Study|Withdrawal by Subject|2|||
129669656|NCT01211145|466750902|FG000|Overall Study|Reason not specified|3|||
129669657|NCT01211145|466750903|FG001|Overall Study|Reason not specified|2|||
129669658|NCT01211145|466750904|FG002|Overall Study|Reason not specified|2|||
129669659|NCT01211145|466750905|FG003|Overall Study|Reason not specified|1|||
129669660|NCT01211145|466750902|FG000|Overall Study|Lost to Follow-up|3|||
129669661|NCT01211145|466750903|FG001|Overall Study|Lost to Follow-up|2|||
129669662|NCT01211145|466750904|FG002|Overall Study|Lost to Follow-up|1|||
129669663|NCT01211145|466750905|FG003|Overall Study|Lost to Follow-up|2|||
129669664|NCT01211145|466750902|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129669665|NCT01211145|466750903|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129669666|NCT01211145|466750904|FG002|Overall Study|Study-specific withdrawal criteria|0|||
129669667|NCT01211145|466750905|FG003|Overall Study|Study-specific withdrawal criteria|0|||
129669668|NCT01211145|466750902|FG000|Overall Study|Severe noncompliance to protocol|1|||
129669669|NCT01211145|466750903|FG001|Overall Study|Severe noncompliance to protocol|0|||
129669670|NCT01211145|466750904|FG002|Overall Study|Severe noncompliance to protocol|0|||
129669671|NCT01211145|466750905|FG003|Overall Study|Severe noncompliance to protocol|0|||
129669672|NCT01211145|466750902|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
129669673|NCT01211145|466750903|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
129669674|NCT01211145|466750904|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
129669675|NCT01211145|466750905|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
129669676|NCT01211145|466750902|FG000|Overall Study|Patient decision|2|||
129669677|NCT01211145|466750903|FG001|Overall Study|Patient decision|1|||
129669678|NCT01211145|466750904|FG002|Overall Study|Patient decision|0|||
129669679|NCT01211145|466750905|FG003|Overall Study|Patient decision|2|||
129669680|NCT00570401|466750906|FG000|Overall Study|Adverse Event|2|||
129669681|NCT00385918|466750911|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
129669682|NCT00385918|466750912|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
129669683|NCT00385918|466750913|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
129669684|NCT00385918|466750911|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
129669685|NCT00385918|466750912|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
129669686|NCT00385918|466750913|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
129669687|NCT00385918|466750911|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
129669688|NCT00385918|466750912|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
129669689|NCT00385918|466750913|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
129669690|NCT00385918|466750911|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
129669691|NCT00385918|466750912|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
129669692|NCT00385918|466750913|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
129669693|NCT00385918|466750911|FG000|Intervention Phase After Randomization|Physician Decision|1|||
129669694|NCT00385918|466750912|FG001|Intervention Phase After Randomization|Physician Decision|0|||
129669695|NCT00385918|466750913|FG002|Intervention Phase After Randomization|Physician Decision|0|||
129669696|NCT00385918|466750911|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
129669697|NCT00385918|466750912|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
129669698|NCT00385918|466750913|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
129669699|NCT01676701|466750914|FG000|Overall Study|Protocol Violation|1|||
129669700|NCT01676701|466750915|FG001|Overall Study|Protocol Violation|0|||
129669701|NCT01676701|466750914|FG000|Overall Study|Sponsor Decision|3|||
129669702|NCT01676701|466750915|FG001|Overall Study|Sponsor Decision|4|||
129669703|NCT00549549|466750925|FG000|Overall Study|Adverse Event|5|||
129669704|NCT00549549|466750926|FG001|Overall Study|Adverse Event|3|||
129669705|NCT00549549|466750927|FG002|Overall Study|Adverse Event|1|||
129669706|NCT00549549|466750928|FG003|Overall Study|Adverse Event|9|||
129669707|NCT00549549|466750925|FG000|Overall Study|Lack of Efficacy|9|||
129669708|NCT00549549|466750926|FG001|Overall Study|Lack of Efficacy|6|||
129669709|NCT00549549|466750927|FG002|Overall Study|Lack of Efficacy|4|||
129669710|NCT00549549|466750928|FG003|Overall Study|Lack of Efficacy|2|||
129669711|NCT00549549|466750925|FG000|Overall Study|Lost to Follow-up|1|||
129669712|NCT00549549|466750926|FG001|Overall Study|Lost to Follow-up|0|||
129669713|NCT00549549|466750927|FG002|Overall Study|Lost to Follow-up|1|||
129669714|NCT00549549|466750928|FG003|Overall Study|Lost to Follow-up|2|||
129669715|NCT00549549|466750925|FG000|Overall Study|Withdrawal by Subject|0|||
129669716|NCT00549549|466750926|FG001|Overall Study|Withdrawal by Subject|4|||
129669717|NCT00549549|466750927|FG002|Overall Study|Withdrawal by Subject|1|||
129669718|NCT00549549|466750928|FG003|Overall Study|Withdrawal by Subject|0|||
129669719|NCT00549549|466750925|FG000|Overall Study|Other|9|||
129669720|NCT00549549|466750926|FG001|Overall Study|Other|9|||
129669721|NCT00549549|466750927|FG002|Overall Study|Other|9|||
129669722|NCT00549549|466750928|FG003|Overall Study|Other|11|||
129669723|NCT00549549|466750925|FG000|Overall Study|Randomized but not treated|0|||
129669724|NCT00549549|466750926|FG001|Overall Study|Randomized but not treated|0|||
129669725|NCT00549549|466750927|FG002|Overall Study|Randomized but not treated|1|||
129669726|NCT00549549|466750928|FG003|Overall Study|Randomized but not treated|1|||
129669727|NCT02227784|466750929|FG000|Double-Blind Phase|Adverse Event|3|||
129669728|NCT02227784|466750930|FG001|Double-Blind Phase|Adverse Event|2|||
129669729|NCT02227784|466750931|FG002|Double-Blind Phase|Adverse Event|1|||
129669730|NCT02227784|466750932|FG003|Double-Blind Phase|Adverse Event|3|||
129669731|NCT02227784|466750933|FG004|Double-Blind Phase|Adverse Event|0|||
129669732|NCT02227784|466750929|FG000|Double-Blind Phase|Physician Decision|1|||
129669733|NCT02227784|466750930|FG001|Double-Blind Phase|Physician Decision|0|||
129669734|NCT02227784|466750931|FG002|Double-Blind Phase|Physician Decision|0|||
129669735|NCT02227784|466750932|FG003|Double-Blind Phase|Physician Decision|1|||
129669736|NCT02227784|466750933|FG004|Double-Blind Phase|Physician Decision|0|||
129669737|NCT02227784|466750929|FG000|Double-Blind Phase|Protocol Violation|0|||
129546931|NCT01956123|466296043|FG003|COS Cycle 2|Withdrawal by Subject|0|||
129669738|NCT02227784|466750930|FG001|Double-Blind Phase|Protocol Violation|0|||
129669739|NCT02227784|466750931|FG002|Double-Blind Phase|Protocol Violation|1|||
129669740|NCT02227784|466750932|FG003|Double-Blind Phase|Protocol Violation|1|||
129669741|NCT02227784|466750933|FG004|Double-Blind Phase|Protocol Violation|0|||
129669742|NCT02227784|466750929|FG000|Double-Blind Phase|Sponsor Decision|34|||
129669743|NCT02227784|466750930|FG001|Double-Blind Phase|Sponsor Decision|15|||
129669744|NCT02227784|466750931|FG002|Double-Blind Phase|Sponsor Decision|14|||
129669745|NCT02227784|466750932|FG003|Double-Blind Phase|Sponsor Decision|32|||
129669746|NCT02227784|466750933|FG004|Double-Blind Phase|Sponsor Decision|0|||
129669747|NCT02227784|466750929|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129669748|NCT02227784|466750930|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
129669749|NCT02227784|466750931|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
129669750|NCT02227784|466750932|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
129669751|NCT02227784|466750933|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129669752|NCT02227784|466750929|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129669753|NCT02227784|466750930|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129669754|NCT02227784|466750931|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129669755|NCT02227784|466750932|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
129669756|NCT02227784|466750933|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
129669757|NCT02227784|466750929|FG000|Open-Label Extension Phase (OLE)|Death|0|||
129669758|NCT02227784|466750930|FG001|Open-Label Extension Phase (OLE)|Death|0|||
129669759|NCT02227784|466750931|FG002|Open-Label Extension Phase (OLE)|Death|0|||
129669760|NCT02227784|466750932|FG003|Open-Label Extension Phase (OLE)|Death|0|||
129669761|NCT02227784|466750933|FG004|Open-Label Extension Phase (OLE)|Death|1|||
129669762|NCT02227784|466750929|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129669763|NCT02227784|466750930|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129669764|NCT02227784|466750931|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129669765|NCT02227784|466750932|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129669766|NCT02227784|466750933|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
129669767|NCT02227784|466750929|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129669768|NCT02227784|466750930|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129669769|NCT02227784|466750931|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129669770|NCT02227784|466750932|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
129669771|NCT02227784|466750933|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
129669772|NCT02155699|466750934|FG000|Overall Study|Withdrawal by Subject|0|||
129669773|NCT02155699|466750935|FG001|Overall Study|Withdrawal by Subject|3|||
129669774|NCT02155699|466750936|FG002|Overall Study|Withdrawal by Subject|6|||
129669775|NCT02155699|466750937|FG003|Overall Study|Withdrawal by Subject|1|||
129669776|NCT02155699|466750934|FG000|Overall Study|Lost to Follow-up|0|||
129669777|NCT02155699|466750935|FG001|Overall Study|Lost to Follow-up|0|||
129669778|NCT02155699|466750936|FG002|Overall Study|Lost to Follow-up|0|||
129669779|NCT02155699|466750937|FG003|Overall Study|Lost to Follow-up|3|||
129669780|NCT02155699|466750934|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
129669781|NCT02155699|466750935|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
129669782|NCT02155699|466750936|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
129669783|NCT02155699|466750937|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
129669784|NCT00248651|466750940|FG000|Overall Study|Withdrawal by Subject|28|||
129669785|NCT00248651|466750941|FG001|Overall Study|Withdrawal by Subject|40|||
129669786|NCT00248651|466750942|FG002|Overall Study|Withdrawal by Subject|32|||
129669787|NCT02688933|466750943|FG000|Overall Study|Adverse Event|3|||
129669788|NCT02688933|466750944|FG001|Overall Study|Adverse Event|1|||
129669789|NCT02688933|466750943|FG000|Overall Study|Lack of Efficacy|2|||
129669790|NCT02688933|466750944|FG001|Overall Study|Lack of Efficacy|2|||
129669791|NCT02688933|466750943|FG000|Overall Study|Poor compliance to protocol|7|||
129669792|NCT02688933|466750944|FG001|Overall Study|Poor compliance to protocol|4|||
129546932|NCT01956123|466296040|FG000|COS Cycle 3|Protocol Violation|0|||
129546933|NCT01956123|466296041|FG001|COS Cycle 3|Protocol Violation|0|||
129546934|NCT01956123|466296042|FG002|COS Cycle 3|Protocol Violation|2|||
129546935|NCT01956123|466296043|FG003|COS Cycle 3|Protocol Violation|1|||
129546936|NCT01956123|466296040|FG000|COS Cycle 3|Adverse Event|0|||
129546937|NCT01956123|466296041|FG001|COS Cycle 3|Adverse Event|0|||
129546938|NCT01956123|466296042|FG002|COS Cycle 3|Adverse Event|3|||
129546939|NCT01956123|466296043|FG003|COS Cycle 3|Adverse Event|0|||
129546940|NCT01956123|466296040|FG000|COS Cycle 3|Personal Reasons|0|||
129546941|NCT01956123|466296041|FG001|COS Cycle 3|Personal Reasons|0|||
129546942|NCT01956123|466296042|FG002|COS Cycle 3|Personal Reasons|1|||
129546943|NCT01956123|466296043|FG003|COS Cycle 3|Personal Reasons|0|||
129546944|NCT01956123|466296040|FG000|COS Cycle 3|Withdrawal by Subject|0|||
129546945|NCT01956123|466296041|FG001|COS Cycle 3|Withdrawal by Subject|0|||
129546946|NCT01956123|466296042|FG002|COS Cycle 3|Withdrawal by Subject|0|||
129546947|NCT01956123|466296043|FG003|COS Cycle 3|Withdrawal by Subject|1|||
129546948|NCT02209454|466296049|FG000|Second Period|Adverse Event|1|||
129546949|NCT02209454|466296050|FG001|Second Period|Adverse Event|0|||
129546950|NCT01777191|466296053|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
129546951|NCT01777191|466296054|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
129546952|NCT01777191|466296053|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
129546953|NCT01777191|466296054|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
129546954|NCT01777191|466296053|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
129546955|NCT01777191|466296054|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
129546956|NCT01777191|466296053|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
129546957|NCT01777191|466296054|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
129546958|NCT01777191|466296053|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
129546959|NCT01777191|466296054|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
129546960|NCT01777191|466296053|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
129546961|NCT01777191|466296054|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
129546962|NCT01777191|466296053|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
129546963|NCT01777191|466296054|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
129546964|NCT01777191|466296053|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
129546965|NCT01777191|466296054|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
129546966|NCT01777191|466296053|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
129546967|NCT01777191|466296054|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
129546968|NCT01777191|466296053|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
129546969|NCT01777191|466296054|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
129546970|NCT01777191|466296053|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
129546971|NCT01777191|466296054|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
129546972|NCT00468312|466296059|FG000|Overall Study|Adverse Event|2|||
129546973|NCT00468312|466296060|FG001|Overall Study|Adverse Event|1|||
129546974|NCT00468312|466296059|FG000|Overall Study|Lack of Efficacy|0|||
129546975|NCT00468312|466296060|FG001|Overall Study|Lack of Efficacy|1|||
129546976|NCT00468312|466296059|FG000|Overall Study|Withdrawal by Subject|0|||
129546977|NCT00468312|466296060|FG001|Overall Study|Withdrawal by Subject|1|||
129546978|NCT00468312|466296059|FG000|Overall Study|Protocol Violation|2|||
129546979|NCT00468312|466296060|FG001|Overall Study|Protocol Violation|1|||
129546980|NCT00468312|466296059|FG000|Overall Study|Did not meet protocol eligibility|0|||
129546981|NCT00468312|466296060|FG001|Overall Study|Did not meet protocol eligibility|1|||
129546982|NCT01052038|466296061|FG000|Overall Study|Lost to Follow-up|2|||
129546983|NCT01052038|466296062|FG001|Overall Study|Lost to Follow-up|3|||
129546984|NCT01052038|466296063|FG002|Overall Study|Lost to Follow-up|1|||
129546985|NCT01052038|466296061|FG000|Overall Study|Protocol Violation|2|||
129546986|NCT01052038|466296062|FG001|Overall Study|Protocol Violation|3|||
129546987|NCT01052038|466296063|FG002|Overall Study|Protocol Violation|3|||
129546988|NCT00734617|466296064|FG000|Overall Study|Adverse Event|4|||
129546989|NCT00734617|466296065|FG001|Overall Study|Adverse Event|7|||
129546990|NCT00734617|466296064|FG000|Overall Study|Withdrawal by Subject|103|||
129546991|NCT00734617|466296065|FG001|Overall Study|Withdrawal by Subject|95|||
129546992|NCT02367729|466296069|FG000|Overall Study|Organic disorder diagnosed|2|||
129546993|NCT02367729|466296070|FG001|Overall Study|Organic disorder diagnosed|1|||
129546994|NCT02367729|466296069|FG000|Overall Study|Adverse Event|1|||
129546995|NCT02367729|466296070|FG001|Overall Study|Adverse Event|2|||
129546996|NCT02367729|466296069|FG000|Overall Study|Withdrawal by Subject|0|||
129546997|NCT02367729|466296070|FG001|Overall Study|Withdrawal by Subject|5|||
129546998|NCT00759174|466296075|FG000|Overall Study|Other|0|||
129546999|NCT00759174|466296076|FG001|Overall Study|Other|2|||
129547000|NCT01890109|466296077|FG000|Overall Study|Withdrawal by Subject|0|||
129547001|NCT01890109|466296078|FG001|Overall Study|Withdrawal by Subject|3|||
129547002|NCT01890109|466296077|FG000|Overall Study|Lost to Follow-up|1|||
129669793|NCT02688933|466750943|FG000|Overall Study|Hypoglycemia|2|||
129669794|NCT02688933|466750944|FG001|Overall Study|Hypoglycemia|0|||
129547003|NCT01890109|466296078|FG001|Overall Study|Lost to Follow-up|2|||
129669795|NCT02688933|466750943|FG000|Overall Study|Other than Specified|14|||
129669796|NCT02688933|466750944|FG001|Overall Study|Other than Specified|25|||
129669797|NCT02688933|466750943|FG000|Overall Study|Lost to Follow-up|1|||
129669798|NCT02688933|466750944|FG001|Overall Study|Lost to Follow-up|5|||
129669799|NCT01275144|466750947|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
129669800|NCT01275144|466750948|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
129669801|NCT00828113|466750949|FG000|Overall Study|Withdrawal by Subject|27|||
129669802|NCT00828113|466750950|FG001|Overall Study|Withdrawal by Subject|26|||
129669803|NCT00828113|466750949|FG000|Overall Study|Lost to Follow-up|3|||
129669804|NCT00828113|466750950|FG001|Overall Study|Lost to Follow-up|5|||
129669805|NCT05607576|466750951|FG000|Overall Study|immediate sensor error|2|||
129669806|NCT05607576|466750951|FG000|Overall Study|Physician Decision|2|||
129669807|NCT01091246|466750952|FG000|Overall Study|Lost to Follow-up|23|||
129669808|NCT01091246|466750953|FG001|Overall Study|Lost to Follow-up|11|||
129669809|NCT01091246|466750954|FG002|Overall Study|Lost to Follow-up|7|||
129669810|NCT01091246|466750952|FG000|Overall Study|Adverse Event|1|||
129669811|NCT01091246|466750953|FG001|Overall Study|Adverse Event|0|||
129669812|NCT01091246|466750954|FG002|Overall Study|Adverse Event|1|||
129669813|NCT01091246|466750952|FG000|Overall Study|Withdrawal by Subject|9|||
129669814|NCT01091246|466750953|FG001|Overall Study|Withdrawal by Subject|5|||
129669815|NCT01091246|466750954|FG002|Overall Study|Withdrawal by Subject|4|||
129669816|NCT01091246|466750952|FG000|Overall Study|Subject not dosed|2|||
129669817|NCT01091246|466750953|FG001|Overall Study|Subject not dosed|0|||
129669818|NCT01091246|466750954|FG002|Overall Study|Subject not dosed|1|||
129669819|NCT02700048|466750955|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
129669820|NCT02700048|466750956|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
129669821|NCT02175225|466750957|FG000|Overall Study|Withdrawal by Subject|1|||
129669822|NCT02175225|466750958|FG001|Overall Study|Withdrawal by Subject|2|||
129669823|NCT02175225|466750957|FG000|Overall Study|Lost to Follow-up|6|||
129669824|NCT02175225|466750958|FG001|Overall Study|Lost to Follow-up|7|||
129669825|NCT02175225|466750957|FG000|Overall Study|Study drug not administered|1|||
129669826|NCT02175225|466750958|FG001|Overall Study|Study drug not administered|2|||
129669827|NCT02668640|466750959|FG000|Overall Study|Lost to Follow-up|13|||
129669828|NCT02668640|466750959|FG000|Overall Study|Other, not specified|1|||
129669829|NCT01107925|466750960|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
129669830|NCT01107925|466750961|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
129669831|NCT01107925|466750962|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
129669832|NCT01107925|466750963|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
129669833|NCT01107925|466750964|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
129669834|NCT01107925|466750965|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
129669835|NCT01107925|466750960|FG000|Period 2|Withdrawal by Subject|0|||
129669836|NCT01107925|466750961|FG001|Period 2|Withdrawal by Subject|1|||
129669837|NCT01107925|466750962|FG002|Period 2|Withdrawal by Subject|0|||
129669838|NCT01107925|466750963|FG003|Period 2|Withdrawal by Subject|0|||
129669839|NCT01107925|466750964|FG004|Period 2|Withdrawal by Subject|0|||
129669840|NCT01107925|466750965|FG005|Period 2|Withdrawal by Subject|1|||
129669841|NCT04877990|466750966|FG000|Treatment|Other reasons|3|||
129669842|NCT04877990|466750967|FG001|Treatment|Other reasons|1|||
129669843|NCT04877990|466750966|FG000|Treatment|Administrative reasons by sponsor|17|||
129669844|NCT04877990|466750967|FG001|Treatment|Administrative reasons by sponsor|33|||
129669845|NCT04877990|466750966|FG000|Treatment|Withdrawal by Subject|2|||
129669846|NCT04877990|466750967|FG001|Treatment|Withdrawal by Subject|6|||
129669847|NCT04877990|466750966|FG000|Treatment|Adverse Event|2|||
129669848|NCT04877990|466750967|FG001|Treatment|Adverse Event|1|||
129669849|NCT01121263|466750968|FG000|Overall Study|Death|3|||
129669850|NCT01121263|466750969|FG001|Overall Study|Death|2|||
129669851|NCT01121263|466750968|FG000|Overall Study|Lost to Follow-up|22|||
129669852|NCT01121263|466750969|FG001|Overall Study|Lost to Follow-up|12|||
129669853|NCT01121263|466750968|FG000|Overall Study|Withdrawal by Subject|0|||
129669854|NCT01121263|466750969|FG001|Overall Study|Withdrawal by Subject|1|||
129669855|NCT02007720|466750970|FG000|Overall Study|Withdrawal by Subject|9|||
129669856|NCT02007720|466750971|FG001|Overall Study|Withdrawal by Subject|11|||
129669857|NCT02007720|466750970|FG000|Overall Study|study terminated by sponsor|58|||
129669858|NCT02007720|466750971|FG001|Overall Study|study terminated by sponsor|54|||
129669859|NCT02007720|466750970|FG000|Overall Study|technical problem|4|||
129669860|NCT02007720|466750971|FG001|Overall Study|technical problem|2|||
129669861|NCT02007720|466750970|FG000|Overall Study|patient followd less than 165 days|11|||
129669862|NCT02007720|466750971|FG001|Overall Study|patient followd less than 165 days|5|||
129669863|NCT01386606|466752716|FG000|Overall Study|Adverse Event|0|||
129669864|NCT01386606|466752717|FG001|Overall Study|Adverse Event|1|||
129669865|NCT01386606|466752718|FG002|Overall Study|Adverse Event|0|||
129669866|NCT01386606|466752719|FG003|Overall Study|Adverse Event|0|||
129669867|NCT01386606|466752716|FG000|Overall Study|Withdrawal by Subject|0|||
129669868|NCT01386606|466752717|FG001|Overall Study|Withdrawal by Subject|1|||
129669869|NCT01386606|466752718|FG002|Overall Study|Withdrawal by Subject|1|||
129669870|NCT01386606|466752719|FG003|Overall Study|Withdrawal by Subject|0|||
129669871|NCT01386606|466752716|FG000|Overall Study|Protocol Violation|1|||
129669872|NCT01386606|466752717|FG001|Overall Study|Protocol Violation|0|||
129669873|NCT01386606|466752718|FG002|Overall Study|Protocol Violation|1|||
129669874|NCT01386606|466752719|FG003|Overall Study|Protocol Violation|1|||
129669875|NCT01386606|466752716|FG000|Overall Study|Lost to Follow-up|2|||
129669876|NCT01386606|466752717|FG001|Overall Study|Lost to Follow-up|0|||
129669877|NCT01386606|466752718|FG002|Overall Study|Lost to Follow-up|0|||
129669878|NCT01386606|466752719|FG003|Overall Study|Lost to Follow-up|0|||
129669879|NCT01386606|466752716|FG000|Overall Study|Subject incarcerated|0|||
129669880|NCT01386606|466752717|FG001|Overall Study|Subject incarcerated|1|||
129669881|NCT01386606|466752718|FG002|Overall Study|Subject incarcerated|0|||
129669882|NCT01386606|466752719|FG003|Overall Study|Subject incarcerated|0|||
129669883|NCT01386606|466752716|FG000|Overall Study|Unable to draw PK|1|||
129669884|NCT01386606|466752717|FG001|Overall Study|Unable to draw PK|0|||
129669885|NCT01386606|466752718|FG002|Overall Study|Unable to draw PK|0|||
129669886|NCT01386606|466752719|FG003|Overall Study|Unable to draw PK|0|||
129669887|NCT01386606|466752716|FG000|Overall Study|T levels too high|0|||
129669888|NCT01386606|466752717|FG001|Overall Study|T levels too high|1|||
129669889|NCT01386606|466752718|FG002|Overall Study|T levels too high|1|||
129669890|NCT01386606|466752719|FG003|Overall Study|T levels too high|0|||
129669891|NCT04980014|466752720|FG000|Overall Study|Participants who are Duplicated|1|||
129669892|NCT04980014|466752720|FG000|Overall Study|Follow-up Failure|13|||
129669893|NCT04980014|466752720|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
129669894|NCT04980014|466752720|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
129669895|NCT04980014|466752720|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
129669896|NCT03964207|466752722|FG000|First Treatment|Withdrawal by Subject|1|||
129669897|NCT03964207|466752723|FG001|First Treatment|Withdrawal by Subject|2|||
129669898|NCT03964207|466752722|FG000|First Treatment|Protocol Violation|1|||
129669899|NCT03964207|466752723|FG001|First Treatment|Protocol Violation|0|||
129669900|NCT03964207|466752722|FG000|First Treatment|Lost to Follow-up|1|||
129669901|NCT03964207|466752723|FG001|First Treatment|Lost to Follow-up|0|||
129669902|NCT03964207|466752722|FG000|Second Treatment|Lost to Follow-up|0|||
129669903|NCT03964207|466752723|FG001|Second Treatment|Lost to Follow-up|1|||
129669904|NCT03964207|466752722|FG000|Second Treatment|Adverse Event|1|||
129669905|NCT03964207|466752723|FG001|Second Treatment|Adverse Event|2|||
129669906|NCT01294423|466752724|FG000|Overall Study|Adverse Event|1|||
129669907|NCT01294423|466752725|FG001|Overall Study|Adverse Event|2|||
129669908|NCT01294423|466752726|FG002|Overall Study|Adverse Event|3|||
129669909|NCT01294423|466752724|FG000|Overall Study|Withdrawal by Subject|1|||
129669910|NCT01294423|466752725|FG001|Overall Study|Withdrawal by Subject|2|||
129669911|NCT01294423|466752726|FG002|Overall Study|Withdrawal by Subject|2|||
129669912|NCT01294423|466752724|FG000|Overall Study|subject no longer meets study criteria|2|||
129669913|NCT01294423|466752725|FG001|Overall Study|subject no longer meets study criteria|5|||
129669914|NCT01294423|466752726|FG002|Overall Study|subject no longer meets study criteria|2|||
129669915|NCT01294423|466752724|FG000|Overall Study|poor/non-compliance|1|||
129669916|NCT01294423|466752725|FG001|Overall Study|poor/non-compliance|0|||
129669917|NCT01294423|466752726|FG002|Overall Study|poor/non-compliance|1|||
129669918|NCT00301834|466752729|FG000|Overall Study|Death|1|||
129669919|NCT02026141|466752731|FG000|Overall Study|Protocol Violation|0|||
129669920|NCT02026141|466752732|FG001|Overall Study|Protocol Violation|1|||
129669921|NCT05081388|466752733|FG000|Overall Study|Adverse Event|1|||
129669922|NCT05081388|466752734|FG001|Overall Study|Adverse Event|0|||
129669923|NCT05081388|466752735|FG002|Overall Study|Adverse Event|0|||
129669924|NCT05081388|466752736|FG003|Overall Study|Adverse Event|0|||
129669925|NCT05081388|466752737|FG004|Overall Study|Adverse Event|0|||
129669926|NCT05081388|466752733|FG000|Overall Study|Lost to Follow-up|0|||
129669927|NCT05081388|466752734|FG001|Overall Study|Lost to Follow-up|1|||
129669928|NCT05081388|466752735|FG002|Overall Study|Lost to Follow-up|0|||
129669929|NCT05081388|466752736|FG003|Overall Study|Lost to Follow-up|0|||
129669930|NCT05081388|466752737|FG004|Overall Study|Lost to Follow-up|0|||
129669931|NCT05081388|466752733|FG000|Overall Study|Subject decision|0|||
129669932|NCT05081388|466752734|FG001|Overall Study|Subject decision|0|||
129669933|NCT05081388|466752735|FG002|Overall Study|Subject decision|0|||
129669934|NCT05081388|466752736|FG003|Overall Study|Subject decision|1|||
129669935|NCT05081388|466752737|FG004|Overall Study|Subject decision|0|||
129669936|NCT02059239|466752738|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
129669937|NCT02059239|466752739|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
129669938|NCT02059239|466752738|FG000|Overall Study|Physician Decision|1|||
129669939|NCT02059239|466752739|FG001|Overall Study|Physician Decision|0|||
129669940|NCT02219685|466752740|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
129669941|NCT02219685|466752741|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
129669942|NCT02219685|466752740|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
129669943|NCT02219685|466752741|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
129669944|NCT04202497|466752742|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
129669945|NCT04202497|466752743|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
129669946|NCT04202497|466752744|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
129669947|NCT04202497|466752745|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
129669948|NCT02115607|466752752|FG000|Overall Study|Withdrawal by Subject|1|||
129669949|NCT00102596|466752756|FG000|Part A|Screen failures|6|||
129669950|NCT00102596|466752757|FG001|Part A|Screen failures|0|||
129669951|NCT00102596|466752756|FG000|Part A|Adverse Event|1|||
129669952|NCT00102596|466752757|FG001|Part A|Adverse Event|0|||
129669953|NCT00069264|466752759|FG000|Overall Study|Adverse Event|3|||
129669954|NCT00069264|466752759|FG000|Overall Study|Progressive Disease|23|||
129669955|NCT00069264|466752759|FG000|Overall Study|Withdrawal by Subject|3|||
129669956|NCT00069264|466752759|FG000|Overall Study|Discon Therapy|3|||
129669957|NCT05547386|466752760|FG000|Overall Study|Withdrawal by Subject|7|||
129669958|NCT04622969|466752761|FG000|Overall Study|Withdrawal by Subject|2|||
129669959|NCT04622969|466752762|FG001|Overall Study|Withdrawal by Subject|3|||
129669960|NCT04467515|466752763|FG000|Overall Study|Lost to Follow-up|1|||
129669961|NCT04467515|466752764|FG001|Overall Study|Lost to Follow-up|0|||
129669962|NCT04467515|466752765|FG002|Overall Study|Lost to Follow-up|0|||
129669963|NCT04467515|466752763|FG000|Overall Study|Withdrawal by Subject|1|||
129669964|NCT04467515|466752764|FG001|Overall Study|Withdrawal by Subject|0|||
129669965|NCT04467515|466752765|FG002|Overall Study|Withdrawal by Subject|1|||
129669966|NCT04467515|466752763|FG000|Overall Study|Progressive Disease|0|||
129669967|NCT04467515|466752764|FG001|Overall Study|Progressive Disease|1|||
129669968|NCT04467515|466752765|FG002|Overall Study|Progressive Disease|3|||
129669969|NCT04467515|466752763|FG000|Overall Study|Death|0|||
129669970|NCT04467515|466752764|FG001|Overall Study|Death|1|||
129669971|NCT04467515|466752765|FG002|Overall Study|Death|0|||
129669972|NCT05616013|466752768|FG000|Overall Study|Adverse Event|6|||
129669973|NCT05616013|466752769|FG001|Overall Study|Adverse Event|12|||
129669974|NCT05616013|466752770|FG002|Overall Study|Adverse Event|8|||
129669975|NCT05616013|466752771|FG003|Overall Study|Adverse Event|4|||
129669976|NCT05616013|466752772|FG004|Overall Study|Adverse Event|6|||
129669977|NCT05616013|466752773|FG005|Overall Study|Adverse Event|8|||
129669978|NCT05616013|466752774|FG006|Overall Study|Adverse Event|3|||
129669979|NCT05616013|466752775|FG007|Overall Study|Adverse Event|6|||
129669980|NCT05616013|466752776|FG008|Overall Study|Adverse Event|1|||
129669981|NCT05616013|466752768|FG000|Overall Study|Lost to Follow-up|5|||
129669982|NCT05616013|466752769|FG001|Overall Study|Lost to Follow-up|4|||
129669983|NCT05616013|466752770|FG002|Overall Study|Lost to Follow-up|3|||
129669984|NCT05616013|466752771|FG003|Overall Study|Lost to Follow-up|2|||
129669985|NCT05616013|466752772|FG004|Overall Study|Lost to Follow-up|0|||
129669986|NCT05616013|466752773|FG005|Overall Study|Lost to Follow-up|5|||
129669987|NCT05616013|466752774|FG006|Overall Study|Lost to Follow-up|2|||
129669988|NCT05616013|466752775|FG007|Overall Study|Lost to Follow-up|1|||
129669989|NCT05616013|466752776|FG008|Overall Study|Lost to Follow-up|2|||
129669990|NCT05616013|466752768|FG000|Overall Study|Non-compliance with study requirements|2|||
129669991|NCT05616013|466752769|FG001|Overall Study|Non-compliance with study requirements|2|||
129669992|NCT05616013|466752770|FG002|Overall Study|Non-compliance with study requirements|2|||
129669993|NCT05616013|466752771|FG003|Overall Study|Non-compliance with study requirements|3|||
129669994|NCT05616013|466752772|FG004|Overall Study|Non-compliance with study requirements|0|||
129669995|NCT05616013|466752773|FG005|Overall Study|Non-compliance with study requirements|2|||
129669996|NCT05616013|466752774|FG006|Overall Study|Non-compliance with study requirements|1|||
129669997|NCT05616013|466752775|FG007|Overall Study|Non-compliance with study requirements|1|||
129669998|NCT05616013|466752776|FG008|Overall Study|Non-compliance with study requirements|4|||
129669999|NCT05616013|466752768|FG000|Overall Study|Withdrawal by Subject|11|||
129670000|NCT05616013|466752769|FG001|Overall Study|Withdrawal by Subject|9|||
129670001|NCT05616013|466752770|FG002|Overall Study|Withdrawal by Subject|8|||
129670002|NCT05616013|466752771|FG003|Overall Study|Withdrawal by Subject|6|||
129670003|NCT05616013|466752772|FG004|Overall Study|Withdrawal by Subject|3|||
129670004|NCT05616013|466752773|FG005|Overall Study|Withdrawal by Subject|4|||
129670005|NCT05616013|466752774|FG006|Overall Study|Withdrawal by Subject|6|||
129670006|NCT05616013|466752775|FG007|Overall Study|Withdrawal by Subject|5|||
129670007|NCT05616013|466752776|FG008|Overall Study|Withdrawal by Subject|4|||
129670008|NCT05616013|466752768|FG000|Overall Study|Physician Decision|0|||
129670009|NCT05616013|466752769|FG001|Overall Study|Physician Decision|0|||
129670010|NCT05616013|466752770|FG002|Overall Study|Physician Decision|1|||
129670011|NCT05616013|466752771|FG003|Overall Study|Physician Decision|0|||
129670012|NCT05616013|466752772|FG004|Overall Study|Physician Decision|0|||
129670013|NCT05616013|466752773|FG005|Overall Study|Physician Decision|1|||
129670014|NCT05616013|466752774|FG006|Overall Study|Physician Decision|3|||
129670015|NCT05616013|466752775|FG007|Overall Study|Physician Decision|0|||
129670016|NCT05616013|466752776|FG008|Overall Study|Physician Decision|0|||
129670017|NCT05616013|466752768|FG000|Overall Study|Protocol Violation|0|||
129670018|NCT05616013|466752769|FG001|Overall Study|Protocol Violation|0|||
129670019|NCT05616013|466752770|FG002|Overall Study|Protocol Violation|0|||
129670020|NCT05616013|466752771|FG003|Overall Study|Protocol Violation|0|||
129670021|NCT05616013|466752772|FG004|Overall Study|Protocol Violation|0|||
129670022|NCT05616013|466752773|FG005|Overall Study|Protocol Violation|0|||
129670023|NCT05616013|466752774|FG006|Overall Study|Protocol Violation|1|||
129670024|NCT05616013|466752775|FG007|Overall Study|Protocol Violation|0|||
129670025|NCT05616013|466752776|FG008|Overall Study|Protocol Violation|2|||
129670026|NCT05616013|466752768|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
129670027|NCT05616013|466752769|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670028|NCT05616013|466752770|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670029|NCT05616013|466752771|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670030|NCT05616013|466752772|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670031|NCT05616013|466752773|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670032|NCT05616013|466752774|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670033|NCT05616013|466752775|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670034|NCT05616013|466752776|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
129670035|NCT05616013|466752768|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
129547004|NCT01643928|466296081|FG000|Overall Study|Lost to Follow-up|1|||
129547005|NCT01643928|466296082|FG001|Overall Study|Lost to Follow-up|0|||
129547006|NCT01643928|466296083|FG002|Overall Study|Lost to Follow-up|2|||
129547007|NCT01643928|466296084|FG003|Overall Study|Lost to Follow-up|0|||
129547008|NCT01643928|466296085|FG004|Overall Study|Lost to Follow-up|0|||
129547009|NCT01643928|466296081|FG000|Overall Study|Withdrawal by Subject|2|||
129547010|NCT01643928|466296082|FG001|Overall Study|Withdrawal by Subject|0|||
129547011|NCT01643928|466296083|FG002|Overall Study|Withdrawal by Subject|0|||
129547012|NCT01643928|466296084|FG003|Overall Study|Withdrawal by Subject|1|||
129547013|NCT01643928|466296085|FG004|Overall Study|Withdrawal by Subject|0|||
129547014|NCT01643928|466296081|FG000|Overall Study|Pregnancy|0|||
129547015|NCT01643928|466296082|FG001|Overall Study|Pregnancy|0|||
129547016|NCT01643928|466296083|FG002|Overall Study|Pregnancy|0|||
129547017|NCT01643928|466296084|FG003|Overall Study|Pregnancy|1|||
129547018|NCT01643928|466296085|FG004|Overall Study|Pregnancy|0|||
129547019|NCT01643928|466296081|FG000|Overall Study|Other|5|||
129547020|NCT01643928|466296082|FG001|Overall Study|Other|1|||
129547021|NCT01643928|466296083|FG002|Overall Study|Other|1|||
129547022|NCT01643928|466296084|FG003|Overall Study|Other|0|||
129547023|NCT01643928|466296085|FG004|Overall Study|Other|0|||
129547024|NCT01643928|466296081|FG000|Overall Study|Adverse Event|2|||
129547025|NCT01643928|466296082|FG001|Overall Study|Adverse Event|1|||
129547026|NCT01643928|466296083|FG002|Overall Study|Adverse Event|0|||
129547027|NCT01643928|466296084|FG003|Overall Study|Adverse Event|1|||
129547028|NCT01643928|466296085|FG004|Overall Study|Adverse Event|2|||
129547029|NCT01005680|466296086|FG000|Overall Study|Lost to Follow-up|4|||
129547030|NCT01005680|466296087|FG001|Overall Study|Lost to Follow-up|6|||
129547031|NCT01005680|466296086|FG000|Overall Study|Withdrawal by Subject|1|||
129547032|NCT01005680|466296087|FG001|Overall Study|Withdrawal by Subject|4|||
129547033|NCT01005680|466296086|FG000|Overall Study|Physician Decision|1|||
129547034|NCT01005680|466296087|FG001|Overall Study|Physician Decision|1|||
129547035|NCT03576131|466296088|FG000|Overall Study|Investigator decision|0|||
129547036|NCT03576131|466296089|FG001|Overall Study|Investigator decision|0|||
129547037|NCT03576131|466296090|FG002|Overall Study|Investigator decision|0|||
129547038|NCT03576131|466296091|FG003|Overall Study|Investigator decision|1|||
129547039|NCT03576131|466296092|FG004|Overall Study|Investigator decision|0|||
129547040|NCT03576131|466296093|FG005|Overall Study|Investigator decision|1|||
129547041|NCT03576131|466296094|FG006|Overall Study|Investigator decision|0|||
129547042|NCT03576131|466296095|FG007|Overall Study|Investigator decision|0|||
129547043|NCT03576131|466296088|FG000|Overall Study|Withdrawal by Subject|1|||
129547044|NCT03576131|466296089|FG001|Overall Study|Withdrawal by Subject|1|||
129547045|NCT03576131|466296090|FG002|Overall Study|Withdrawal by Subject|0|||
129547046|NCT03576131|466296091|FG003|Overall Study|Withdrawal by Subject|1|||
129547047|NCT03576131|466296092|FG004|Overall Study|Withdrawal by Subject|2|||
129547048|NCT03576131|466296093|FG005|Overall Study|Withdrawal by Subject|3|||
129547049|NCT03576131|466296094|FG006|Overall Study|Withdrawal by Subject|1|||
129547050|NCT03576131|466296095|FG007|Overall Study|Withdrawal by Subject|0|||
129547051|NCT03576131|466296088|FG000|Overall Study|Death|3|||
129547052|NCT03576131|466296089|FG001|Overall Study|Death|3|||
129547053|NCT03576131|466296090|FG002|Overall Study|Death|1|||
129547054|NCT03576131|466296091|FG003|Overall Study|Death|5|||
129547055|NCT03576131|466296092|FG004|Overall Study|Death|4|||
129547056|NCT03576131|466296093|FG005|Overall Study|Death|1|||
129547057|NCT03576131|466296094|FG006|Overall Study|Death|0|||
129547058|NCT03576131|466296095|FG007|Overall Study|Death|1|||
129547059|NCT03576131|466296088|FG000|Overall Study|New anti-cancer treatment|5|||
129547060|NCT03576131|466296089|FG001|Overall Study|New anti-cancer treatment|1|||
129547061|NCT03576131|466296090|FG002|Overall Study|New anti-cancer treatment|2|||
129547062|NCT03576131|466296091|FG003|Overall Study|New anti-cancer treatment|3|||
129547063|NCT03576131|466296092|FG004|Overall Study|New anti-cancer treatment|0|||
129547064|NCT03576131|466296093|FG005|Overall Study|New anti-cancer treatment|0|||
129547065|NCT03576131|466296094|FG006|Overall Study|New anti-cancer treatment|0|||
129547066|NCT03576131|466296095|FG007|Overall Study|New anti-cancer treatment|0|||
129547067|NCT03576131|466296088|FG000|Overall Study|Unspecified reason|0|||
129547068|NCT03576131|466296089|FG001|Overall Study|Unspecified reason|0|||
129547069|NCT03576131|466296090|FG002|Overall Study|Unspecified reason|1|||
129547070|NCT03576131|466296091|FG003|Overall Study|Unspecified reason|1|||
129547071|NCT03576131|466296092|FG004|Overall Study|Unspecified reason|1|||
129547072|NCT03576131|466296093|FG005|Overall Study|Unspecified reason|1|||
129547073|NCT03576131|466296094|FG006|Overall Study|Unspecified reason|0|||
129547074|NCT03576131|466296095|FG007|Overall Study|Unspecified reason|0|||
129547075|NCT03576131|466296088|FG000|Overall Study|Subject non-compliance|0|||
129547076|NCT03576131|466296089|FG001|Overall Study|Subject non-compliance|0|||
129547077|NCT03576131|466296090|FG002|Overall Study|Subject non-compliance|0|||
129547078|NCT03576131|466296091|FG003|Overall Study|Subject non-compliance|0|||
129547079|NCT03576131|466296092|FG004|Overall Study|Subject non-compliance|0|||
129547080|NCT03576131|466296093|FG005|Overall Study|Subject non-compliance|1|||
129670036|NCT05616013|466752769|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670037|NCT05616013|466752770|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670038|NCT05616013|466752771|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670039|NCT05616013|466752772|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670040|NCT05616013|466752773|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670041|NCT05616013|466752774|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670042|NCT05616013|466752775|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670043|NCT05616013|466752776|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
129670044|NCT05616013|466752768|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
129670045|NCT05616013|466752769|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670046|NCT05616013|466752770|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670047|NCT05616013|466752771|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670048|NCT05616013|466752772|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670049|NCT05616013|466752773|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670050|NCT05616013|466752774|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670051|NCT05616013|466752775|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670052|NCT05616013|466752776|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
129670053|NCT05616013|466752768|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670054|NCT05616013|466752769|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
129670055|NCT05616013|466752770|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670056|NCT05616013|466752771|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670057|NCT05616013|466752772|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670058|NCT05616013|466752773|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670059|NCT05616013|466752774|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670060|NCT05616013|466752775|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670061|NCT05616013|466752776|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
129670062|NCT05616013|466752768|FG000|Overall Study|Participant Decision, Time Constraints|0|||
129670063|NCT05616013|466752769|FG001|Overall Study|Participant Decision, Time Constraints|1|||
129670064|NCT05616013|466752770|FG002|Overall Study|Participant Decision, Time Constraints|0|||
129670065|NCT05616013|466752771|FG003|Overall Study|Participant Decision, Time Constraints|0|||
129670066|NCT05616013|466752772|FG004|Overall Study|Participant Decision, Time Constraints|0|||
129670067|NCT05616013|466752773|FG005|Overall Study|Participant Decision, Time Constraints|0|||
129670068|NCT05616013|466752774|FG006|Overall Study|Participant Decision, Time Constraints|0|||
129670069|NCT05616013|466752775|FG007|Overall Study|Participant Decision, Time Constraints|0|||
129670070|NCT05616013|466752776|FG008|Overall Study|Participant Decision, Time Constraints|0|||
129670071|NCT05616013|466752768|FG000|Overall Study|Prohibited Concomitant Medication|0|||
129670072|NCT05616013|466752769|FG001|Overall Study|Prohibited Concomitant Medication|0|||
129670073|NCT05616013|466752770|FG002|Overall Study|Prohibited Concomitant Medication|1|||
129670074|NCT05616013|466752771|FG003|Overall Study|Prohibited Concomitant Medication|0|||
129670075|NCT05616013|466752772|FG004|Overall Study|Prohibited Concomitant Medication|0|||
129670076|NCT05616013|466752773|FG005|Overall Study|Prohibited Concomitant Medication|0|||
129670077|NCT05616013|466752774|FG006|Overall Study|Prohibited Concomitant Medication|0|||
129670078|NCT05616013|466752775|FG007|Overall Study|Prohibited Concomitant Medication|0|||
129670079|NCT05616013|466752776|FG008|Overall Study|Prohibited Concomitant Medication|0|||
129670080|NCT05616013|466752768|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670081|NCT05616013|466752769|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670082|NCT05616013|466752770|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
129670083|NCT05616013|466752771|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670084|NCT05616013|466752772|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670085|NCT05616013|466752773|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670086|NCT05616013|466752774|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670087|NCT05616013|466752775|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670088|NCT05616013|466752776|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
129670089|NCT05616013|466752768|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670090|NCT05616013|466752769|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670091|NCT05616013|466752770|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129707534|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
129670092|NCT05616013|466752771|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
129670093|NCT05616013|466752772|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670094|NCT05616013|466752773|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670095|NCT05616013|466752774|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670096|NCT05616013|466752775|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670097|NCT05616013|466752776|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
129670098|NCT05616013|466752768|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670099|NCT05616013|466752769|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670100|NCT05616013|466752770|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670101|NCT05616013|466752771|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670102|NCT05616013|466752772|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670103|NCT05616013|466752773|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670104|NCT05616013|466752774|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
129670105|NCT05616013|466752775|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670106|NCT05616013|466752776|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
129670107|NCT05616013|466752768|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670108|NCT05616013|466752769|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670109|NCT05616013|466752770|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670110|NCT05616013|466752771|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670111|NCT05616013|466752772|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670112|NCT05616013|466752773|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670113|NCT05616013|466752774|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670114|NCT05616013|466752775|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
129670115|NCT05616013|466752776|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
129670116|NCT05616013|466752768|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670117|NCT05616013|466752769|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670118|NCT05616013|466752770|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670119|NCT05616013|466752771|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670120|NCT05616013|466752772|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670121|NCT05616013|466752773|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670122|NCT05616013|466752774|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670123|NCT05616013|466752775|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
129670124|NCT05616013|466752776|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
129670125|NCT05116202|466752777|FG000|Overall Study|Study Terminated by Sponsor|21|||
129670126|NCT05116202|466752778|FG001|Overall Study|Study Terminated by Sponsor|38|||
129670127|NCT05116202|466752779|FG002|Overall Study|Study Terminated by Sponsor|17|||
129670128|NCT05116202|466752780|FG003|Overall Study|Study Terminated by Sponsor|18|||
129670129|NCT05116202|466752781|FG004|Overall Study|Study Terminated by Sponsor|0|||
129670130|NCT05116202|466752777|FG000|Overall Study|Withdrawal by Subject|0|||
129670131|NCT05116202|466752778|FG001|Overall Study|Withdrawal by Subject|1|||
129670132|NCT05116202|466752779|FG002|Overall Study|Withdrawal by Subject|1|||
129670133|NCT05116202|466752780|FG003|Overall Study|Withdrawal by Subject|1|||
129670134|NCT05116202|466752781|FG004|Overall Study|Withdrawal by Subject|1|||
129670135|NCT05116202|466752777|FG000|Overall Study|Lost to Follow-up|0|||
129670136|NCT05116202|466752778|FG001|Overall Study|Lost to Follow-up|0|||
129670137|NCT05116202|466752779|FG002|Overall Study|Lost to Follow-up|0|||
129670138|NCT05116202|466752780|FG003|Overall Study|Lost to Follow-up|0|||
129670139|NCT05116202|466752781|FG004|Overall Study|Lost to Follow-up|2|||
129670140|NCT05116202|466752777|FG000|Overall Study|Death|1|||
129670141|NCT05116202|466752778|FG001|Overall Study|Death|1|||
129670142|NCT05116202|466752779|FG002|Overall Study|Death|2|||
129670143|NCT05116202|466752780|FG003|Overall Study|Death|1|||
129670144|NCT05116202|466752781|FG004|Overall Study|Death|5|||
129670145|NCT03834506|466752782|FG000|Overall Study|Death|336|||
129670146|NCT03834506|466752783|FG001|Overall Study|Death|326|||
129670147|NCT03834506|466752782|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129670148|NCT03834506|466752783|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129670149|NCT03834506|466752782|FG000|Overall Study|Withdrawal by Subject|10|||
129670150|NCT03834506|466752783|FG001|Overall Study|Withdrawal by Subject|8|||
129670151|NCT03834506|466752782|FG000|Overall Study|Sponsor decision|165|||
129670152|NCT03834506|466752783|FG001|Overall Study|Sponsor decision|178|||
129670153|NCT03834506|466752782|FG000|Overall Study|Physician Decision|3|||
129670154|NCT03834506|466752783|FG001|Overall Study|Physician Decision|1|||
129670155|NCT03834506|466752782|FG000|Overall Study|Lost to Follow-up|0|||
129670156|NCT03834506|466752783|FG001|Overall Study|Lost to Follow-up|1|||
129670157|NCT05067972|466752784|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
129670158|NCT05067972|466752785|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
129670159|NCT05067972|466752786|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
129884379|NCT00708305|467536386|FG003|Period 1|Other Reason|2|||
129670160|NCT05067972|466752787|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
129670161|NCT05067972|466752788|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
129670162|NCT05067972|466752789|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
129670163|NCT05067972|466752790|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
129670164|NCT05067972|466752784|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
129670165|NCT05067972|466752785|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
129670166|NCT05067972|466752786|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
129670167|NCT05067972|466752787|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
129670168|NCT05067972|466752788|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
129670169|NCT05067972|466752789|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
129670170|NCT05067972|466752790|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
129670171|NCT05067972|466752784|FG000|Part 1: Treatment|Progressive Disease|3|||
129670172|NCT05067972|466752785|FG001|Part 1: Treatment|Progressive Disease|3|||
129670173|NCT05067972|466752786|FG002|Part 1: Treatment|Progressive Disease|4|||
129670174|NCT05067972|466752787|FG003|Part 1: Treatment|Progressive Disease|2|||
129670175|NCT05067972|466752788|FG004|Part 1: Treatment|Progressive Disease|3|||
129670176|NCT05067972|466752789|FG005|Part 1: Treatment|Progressive Disease|0|||
129670177|NCT05067972|466752790|FG006|Part 1: Treatment|Progressive Disease|2|||
129670178|NCT05067972|466752784|FG000|Part 1: Treatment|Physician Decision|0|||
129670179|NCT05067972|466752785|FG001|Part 1: Treatment|Physician Decision|0|||
129670180|NCT05067972|466752786|FG002|Part 1: Treatment|Physician Decision|0|||
129670181|NCT05067972|466752787|FG003|Part 1: Treatment|Physician Decision|1|||
129670182|NCT05067972|466752788|FG004|Part 1: Treatment|Physician Decision|0|||
129670183|NCT05067972|466752789|FG005|Part 1: Treatment|Physician Decision|0|||
129670184|NCT05067972|466752790|FG006|Part 1: Treatment|Physician Decision|0|||
129670185|NCT05067972|466752784|FG000|Part 1: Treatment|Death|0|||
129670186|NCT05067972|466752785|FG001|Part 1: Treatment|Death|0|||
129670187|NCT05067972|466752786|FG002|Part 1: Treatment|Death|0|||
129670188|NCT05067972|466752787|FG003|Part 1: Treatment|Death|2|||
129670189|NCT05067972|466752788|FG004|Part 1: Treatment|Death|0|||
129670190|NCT05067972|466752789|FG005|Part 1: Treatment|Death|0|||
129670191|NCT05067972|466752790|FG006|Part 1: Treatment|Death|0|||
129670192|NCT05067972|466752784|FG000|Part 1: Treatment|Adverse Event|0|||
129670193|NCT05067972|466752785|FG001|Part 1: Treatment|Adverse Event|0|||
129670194|NCT05067972|466752786|FG002|Part 1: Treatment|Adverse Event|0|||
129670195|NCT05067972|466752787|FG003|Part 1: Treatment|Adverse Event|0|||
129670196|NCT05067972|466752788|FG004|Part 1: Treatment|Adverse Event|0|||
129670197|NCT05067972|466752789|FG005|Part 1: Treatment|Adverse Event|2|||
129670198|NCT05067972|466752790|FG006|Part 1: Treatment|Adverse Event|1|||
129670199|NCT05067972|466752784|FG000|Part 1: Follow-up|Adverse Event|0|||
129670200|NCT05067972|466752785|FG001|Part 1: Follow-up|Adverse Event|0|||
129670201|NCT05067972|466752786|FG002|Part 1: Follow-up|Adverse Event|0|||
129670202|NCT05067972|466752787|FG003|Part 1: Follow-up|Adverse Event|0|||
129670203|NCT05067972|466752788|FG004|Part 1: Follow-up|Adverse Event|0|||
129670204|NCT05067972|466752789|FG005|Part 1: Follow-up|Adverse Event|1|||
129670205|NCT05067972|466752790|FG006|Part 1: Follow-up|Adverse Event|0|||
129670206|NCT05067972|466752784|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
129670207|NCT05067972|466752785|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
129670208|NCT05067972|466752786|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
129670209|NCT05067972|466752787|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
129670210|NCT05067972|466752788|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
129670211|NCT05067972|466752789|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
129670212|NCT05067972|466752790|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
129670213|NCT05067972|466752784|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129670214|NCT05067972|466752785|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129670215|NCT05067972|466752786|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129670216|NCT05067972|466752787|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129670217|NCT05067972|466752788|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129670218|NCT05067972|466752789|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
129670219|NCT05067972|466752790|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
129670220|NCT05067972|466752784|FG000|Part 1: Follow-up|Physician Decision|0|||
129670221|NCT05067972|466752785|FG001|Part 1: Follow-up|Physician Decision|0|||
129670222|NCT05067972|466752786|FG002|Part 1: Follow-up|Physician Decision|0|||
129670223|NCT05067972|466752787|FG003|Part 1: Follow-up|Physician Decision|1|||
129670224|NCT05067972|466752788|FG004|Part 1: Follow-up|Physician Decision|0|||
129670225|NCT05067972|466752789|FG005|Part 1: Follow-up|Physician Decision|0|||
129670226|NCT05067972|466752790|FG006|Part 1: Follow-up|Physician Decision|0|||
129670227|NCT05067972|466752784|FG000|Part 1: Follow-up|Death|1|||
129670228|NCT05067972|466752785|FG001|Part 1: Follow-up|Death|2|||
129670229|NCT05067972|466752786|FG002|Part 1: Follow-up|Death|1|||
129670230|NCT05067972|466752787|FG003|Part 1: Follow-up|Death|0|||
129670231|NCT05067972|466752788|FG004|Part 1: Follow-up|Death|1|||
129670232|NCT05067972|466752789|FG005|Part 1: Follow-up|Death|0|||
129670233|NCT05067972|466752790|FG006|Part 1: Follow-up|Death|1|||
129670234|NCT04391842|466752791|FG000|Overall Study|Withdrawal by Subject|2|||
129670235|NCT02287038|466752792|FG000|Overall Study|Stopped attending appointments|3|||
129670236|NCT02287038|466752793|FG001|Overall Study|Stopped attending appointments|2|||
129670237|NCT02287038|466752792|FG000|Overall Study|Anxiety after starting medication|0|||
129670238|NCT02287038|466752793|FG001|Overall Study|Anxiety after starting medication|1|||
129670239|NCT02287038|466752792|FG000|Overall Study|Nausea after starting medication|1|||
129670240|NCT02287038|466752793|FG001|Overall Study|Nausea after starting medication|0|||
129670241|NCT02287038|466752792|FG000|Overall Study|Abnormal ECG after starting medication|1|||
129670242|NCT02287038|466752793|FG001|Overall Study|Abnormal ECG after starting medication|0|||
129670243|NCT01676012|466752799|FG000|Overall Study|Adverse Event|2|||
129670244|NCT01676012|466752799|FG000|Overall Study|incomplete set of videos|1|||
129670245|NCT02667301|466752822|FG000|Overall Study|Adverse Event|1|||
129670246|NCT02667301|466752822|FG000|Overall Study|Lack of Efficacy|1|||
129670247|NCT02283658|466752823|FG000|Overall Study|Withdrawal by Subject|1|||
129670248|NCT03528551|466752825|FG000|Overall Study|Lost to Follow-up|0|||
129670249|NCT03528551|466752826|FG001|Overall Study|Lost to Follow-up|1|||
129670250|NCT03528551|466752827|FG002|Overall Study|Lost to Follow-up|0|||
129670251|NCT03528551|466752825|FG000|Overall Study|Transferred to other arm/group|2|||
129670252|NCT03528551|466752826|FG001|Overall Study|Transferred to other arm/group|3|||
129670253|NCT03528551|466752827|FG002|Overall Study|Transferred to other arm/group|0|||
129670254|NCT03528551|466752825|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129670255|NCT03528551|466752826|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129670256|NCT03528551|466752827|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129670257|NCT03528551|466752825|FG000|Overall Study|Protocol Violation|0|||
129670258|NCT03528551|466752826|FG001|Overall Study|Protocol Violation|3|||
129670259|NCT03528551|466752827|FG002|Overall Study|Protocol Violation|0|||
129670260|NCT03528551|466752825|FG000|Overall Study|Withdrawal by Subject|0|||
129670261|NCT03528551|466752826|FG001|Overall Study|Withdrawal by Subject|7|||
129670262|NCT03528551|466752827|FG002|Overall Study|Withdrawal by Subject|0|||
129670263|NCT00846586|466752828|FG000|Overall Study|Adverse Event|20|||
129670264|NCT00846586|466752829|FG001|Overall Study|Adverse Event|10|||
129670265|NCT00846586|466752828|FG000|Overall Study|Subject withdrew consent|8|||
129670266|NCT00846586|466752829|FG001|Overall Study|Subject withdrew consent|10|||
129670267|NCT00846586|466752828|FG000|Overall Study|Administrative problems|5|||
129670268|NCT00846586|466752829|FG001|Overall Study|Administrative problems|4|||
129670269|NCT00846586|466752828|FG000|Overall Study|Death|2|||
129670270|NCT00846586|466752829|FG001|Overall Study|Death|0|||
129670271|NCT00846586|466752828|FG000|Overall Study|Protocol deviation|2|||
129670272|NCT00846586|466752829|FG001|Overall Study|Protocol deviation|6|||
129670273|NCT00846586|466752828|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129670274|NCT00846586|466752829|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129670275|NCT00846586|466752828|FG000|Overall Study|Lost to Follow-up|1|||
129670276|NCT00846586|466752829|FG001|Overall Study|Lost to Follow-up|4|||
129670277|NCT00846586|466752828|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129670278|NCT00846586|466752829|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129670279|NCT00689338|466752830|FG000|Overall Study|Death|65|||
129670280|NCT00689338|466752830|FG000|Overall Study|Adverse Event|13|||
129670281|NCT00689338|466752830|FG000|Overall Study|Insufficient Clinical Response|1|||
129670282|NCT00689338|466752830|FG000|Overall Study|Lack of Efficacy|6|||
129670283|NCT00689338|466752830|FG000|Overall Study|Other|8|||
129670284|NCT00689338|466752830|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
129670285|NCT00689338|466752830|FG000|Overall Study|Lost to Follow-up|5|||
129670286|NCT00689338|466752830|FG000|Overall Study|Withdrawal by Subject|3|||
129670287|NCT00689338|466752830|FG000|Overall Study|Protocol Violation|15|||
129670288|NCT01061606|466752831|FG000|Overall Study|Adverse Event|1|||
129670289|NCT01061606|466752831|FG000|Overall Study|Death|1|||
129670290|NCT01061606|466752831|FG000|Overall Study|Disease Progression|4|||
129670291|NCT01061606|466752831|FG000|Overall Study|alternative therapy|2|||
129670292|NCT00735007|466752832|FG000|Overall Study|Adverse Event|4|||
129670293|NCT00735007|466752832|FG000|Overall Study|Protocol Violation|1|||
129670294|NCT01789047|466752833|FG000|Overall Study|Adverse Event|3|||
129670295|NCT01789047|466752834|FG001|Overall Study|Adverse Event|2|||
129670296|NCT01789047|466752833|FG000|Overall Study|Withdrawal by Subject|1|||
129670297|NCT01789047|466752834|FG001|Overall Study|Withdrawal by Subject|2|||
129670298|NCT00715403|466752835|FG000|Overall Study|Progressive disease|0|||
129670299|NCT00715403|466752836|FG001|Overall Study|Progressive disease|1|||
129670300|NCT00715403|466752837|FG002|Overall Study|Progressive disease|3|||
129670301|NCT00715403|466752838|FG003|Overall Study|Progressive disease|9|||
129670302|NCT00715403|466752839|FG004|Overall Study|Progressive disease|5|||
129670303|NCT00715403|466752840|FG005|Overall Study|Progressive disease|14|||
129670304|NCT00715403|466752841|FG006|Overall Study|Progressive disease|1|||
129670305|NCT00715403|466752835|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
129670306|NCT00715403|466752836|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
129670307|NCT00715403|466752837|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
129670308|NCT00715403|466752838|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
129670309|NCT00715403|466752839|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
129670310|NCT00715403|466752840|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
129670311|NCT00715403|466752841|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
129884380|NCT00708305|467536383|FG000|Period 2|Lost to Follow-up|0|||
129670312|NCT00715403|466752835|FG000|Overall Study|Other Adverse Event than DLT|1|||
129670313|NCT00715403|466752836|FG001|Overall Study|Other Adverse Event than DLT|0|||
129670314|NCT00715403|466752837|FG002|Overall Study|Other Adverse Event than DLT|0|||
129670315|NCT00715403|466752838|FG003|Overall Study|Other Adverse Event than DLT|0|||
129670316|NCT00715403|466752839|FG004|Overall Study|Other Adverse Event than DLT|0|||
129670317|NCT00715403|466752840|FG005|Overall Study|Other Adverse Event than DLT|2|||
129670318|NCT00715403|466752841|FG006|Overall Study|Other Adverse Event than DLT|0|||
129670319|NCT00715403|466752835|FG000|Overall Study|Protocol Violation|0|||
129670320|NCT00715403|466752836|FG001|Overall Study|Protocol Violation|0|||
129670321|NCT00715403|466752837|FG002|Overall Study|Protocol Violation|0|||
129670322|NCT00715403|466752838|FG003|Overall Study|Protocol Violation|0|||
129670323|NCT00715403|466752839|FG004|Overall Study|Protocol Violation|0|||
129670324|NCT00715403|466752840|FG005|Overall Study|Protocol Violation|1|||
129670325|NCT00715403|466752841|FG006|Overall Study|Protocol Violation|0|||
129670326|NCT00715403|466752835|FG000|Overall Study|Other reason not defined above|0|||
129670327|NCT00715403|466752836|FG001|Overall Study|Other reason not defined above|0|||
129670328|NCT00715403|466752837|FG002|Overall Study|Other reason not defined above|1|||
129670329|NCT00715403|466752838|FG003|Overall Study|Other reason not defined above|0|||
129670330|NCT00715403|466752839|FG004|Overall Study|Other reason not defined above|1|||
129670331|NCT00715403|466752840|FG005|Overall Study|Other reason not defined above|1|||
129670332|NCT00715403|466752841|FG006|Overall Study|Other reason not defined above|0|||
129670333|NCT03644017|466752842|FG000|Overall Study|Access Abandonment|5|||
129670334|NCT03644017|466752842|FG000|Overall Study|Kidney Transplant|2|||
129670335|NCT02340000|466752845|FG000|Time Period 1|Withdrawal by Subject|6|||
129670336|NCT02340000|466752846|FG001|Time Period 1|Withdrawal by Subject|8|||
129670337|NCT02340000|466752845|FG000|Time Period 1|Lost to Follow-up|6|||
129670338|NCT02340000|466752846|FG001|Time Period 1|Lost to Follow-up|7|||
129670339|NCT02340000|466752845|FG000|Time Period 2|Withdrawal by Subject|9|||
129670340|NCT02340000|466752846|FG001|Time Period 2|Withdrawal by Subject|7|||
129670341|NCT02340000|466752845|FG000|Time Period 2|Lost to Follow-up|10|||
129670342|NCT02340000|466752846|FG001|Time Period 2|Lost to Follow-up|8|||
129670343|NCT01883895|466752851|FG000|Overall Study|Lost to Follow-up|2|||
129670344|NCT00073918|466752852|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
129670345|NCT00073918|466752852|FG000|Overall Study|Rapid disease progression|2|||
129670346|NCT00073918|466752852|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
129670347|NCT00919633|466752855|FG000|Overall Study|Adverse Event|1|||
129670348|NCT00919633|466752856|FG001|Overall Study|Adverse Event|9|||
129670349|NCT00919633|466752857|FG002|Overall Study|Adverse Event|12|||
129670350|NCT00919633|466752858|FG003|Overall Study|Adverse Event|10|||
129670351|NCT00919633|466752855|FG000|Overall Study|Death|0|||
129670352|NCT00919633|466752856|FG001|Overall Study|Death|0|||
129670353|NCT00919633|466752857|FG002|Overall Study|Death|2|||
129670354|NCT00919633|466752858|FG003|Overall Study|Death|0|||
129670355|NCT00919633|466752855|FG000|Overall Study|Lack of Efficacy|17|||
129670356|NCT00919633|466752856|FG001|Overall Study|Lack of Efficacy|3|||
129670357|NCT00919633|466752857|FG002|Overall Study|Lack of Efficacy|2|||
129670358|NCT00919633|466752858|FG003|Overall Study|Lack of Efficacy|3|||
129670359|NCT00919633|466752855|FG000|Overall Study|Withdrawal by Subject|1|||
129670360|NCT00919633|466752856|FG001|Overall Study|Withdrawal by Subject|2|||
129670361|NCT00919633|466752857|FG002|Overall Study|Withdrawal by Subject|4|||
129670362|NCT00919633|466752858|FG003|Overall Study|Withdrawal by Subject|3|||
129670363|NCT00919633|466752855|FG000|Overall Study|Lost to Follow-up|3|||
129670364|NCT00919633|466752856|FG001|Overall Study|Lost to Follow-up|1|||
129670365|NCT00919633|466752857|FG002|Overall Study|Lost to Follow-up|0|||
129670366|NCT00919633|466752858|FG003|Overall Study|Lost to Follow-up|2|||
129670367|NCT00919633|466752855|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
129670368|NCT00919633|466752856|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
129670369|NCT00919633|466752857|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
129670370|NCT00919633|466752858|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
129670371|NCT00919633|466752855|FG000|Overall Study|Protocol Violation|0|||
129670372|NCT00919633|466752856|FG001|Overall Study|Protocol Violation|0|||
129670373|NCT00919633|466752857|FG002|Overall Study|Protocol Violation|0|||
129670374|NCT00919633|466752858|FG003|Overall Study|Protocol Violation|1|||
129670375|NCT00919633|466752855|FG000|Overall Study|Physician Decision|0|||
129670376|NCT00919633|466752856|FG001|Overall Study|Physician Decision|0|||
129670377|NCT00919633|466752857|FG002|Overall Study|Physician Decision|0|||
129670378|NCT00919633|466752858|FG003|Overall Study|Physician Decision|1|||
129670379|NCT00919633|466752855|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
129670380|NCT00919633|466752856|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
129670381|NCT00919633|466752857|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
129670382|NCT00919633|466752858|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
129670383|NCT00919633|466752855|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
129670384|NCT00919633|466752856|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
129670385|NCT00919633|466752857|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
129670386|NCT00919633|466752858|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
129884381|NCT00708305|467536384|FG001|Period 2|Lost to Follow-up|1|||
129670387|NCT02481050|466754496|FG000|Overall Study|Adverse Event|1|||
129670388|NCT02481050|466754496|FG000|Overall Study|Disease Progression|47|||
129670389|NCT02481050|466754496|FG000|Overall Study|Withdrawal by Subject|7|||
129670390|NCT02481050|466754496|FG000|Overall Study|Other|3|||
129670391|NCT03246347|466754499|FG000|Overall Study|On Study|23|||
129670392|NCT02188160|466754500|FG000|Overall Study|Adverse Event|1|||
129670393|NCT02188160|466754501|FG001|Overall Study|Adverse Event|0|||
129670394|NCT02188160|466754500|FG000|Overall Study|Use of an excluded medication|0|||
129670395|NCT02188160|466754501|FG001|Overall Study|Use of an excluded medication|1|||
129670396|NCT04113694|466754502|FG000|Overall Study|Adverse Event|2|||
129670397|NCT04113694|466754502|FG000|Overall Study|Lost to Follow-up|2|||
129670398|NCT04113694|466754502|FG000|Overall Study|Withdrawal by Subject|6|||
129670399|NCT04113694|466754502|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
129670400|NCT01022203|466754509|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
129670401|NCT01022203|466754510|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
129670402|NCT01022203|466754509|FG000|Post Treatment Assessment|Physician Decision|2|||
129670403|NCT01022203|466754510|FG001|Post Treatment Assessment|Physician Decision|0|||
129670404|NCT01022203|466754509|FG000|Post Treatment Assessment|Adverse Event|0|||
129670405|NCT01022203|466754510|FG001|Post Treatment Assessment|Adverse Event|2|||
129670406|NCT01022203|466754509|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
129670407|NCT01022203|466754510|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
129670408|NCT03638128|466754513|FG000|Overall Study|Withdrawal by Subject|1|||
129670409|NCT03638128|466754514|FG001|Overall Study|Withdrawal by Subject|7|||
129670410|NCT03638128|466754515|FG002|Overall Study|Withdrawal by Subject|6|||
129670411|NCT03638128|466754513|FG000|Overall Study|Sponsor Decision|15|||
129670412|NCT03638128|466754514|FG001|Overall Study|Sponsor Decision|12|||
129670413|NCT03638128|466754515|FG002|Overall Study|Sponsor Decision|19|||
129670414|NCT03638128|466754513|FG000|Overall Study|Lost to Follow-up|0|||
129670415|NCT03638128|466754514|FG001|Overall Study|Lost to Follow-up|0|||
129670416|NCT03638128|466754515|FG002|Overall Study|Lost to Follow-up|1|||
129670417|NCT00329108|466754517|FG000|Overall Study|Adverse Event|2|||
129670418|NCT00329108|466754518|FG001|Overall Study|Adverse Event|2|||
129670419|NCT00329108|466754517|FG000|Overall Study|Lack of Efficacy|3|||
129670420|NCT00329108|466754518|FG001|Overall Study|Lack of Efficacy|3|||
129670421|NCT00329108|466754517|FG000|Overall Study|Withdrawal by Subject|0|||
129670422|NCT00329108|466754518|FG001|Overall Study|Withdrawal by Subject|2|||
129670423|NCT00329108|466754517|FG000|Overall Study|symptomatic deterioration|1|||
129670424|NCT00329108|466754518|FG001|Overall Study|symptomatic deterioration|1|||
129670425|NCT00329108|466754517|FG000|Overall Study|Subject no longer willing to participate|2|||
129670426|NCT00329108|466754518|FG001|Overall Study|Subject no longer willing to participate|2|||
129670427|NCT00329108|466754517|FG000|Overall Study|study terminated by sponsor|1|||
129670428|NCT00329108|466754518|FG001|Overall Study|study terminated by sponsor|0|||
129670429|NCT00329108|466754517|FG000|Overall Study|withdrew patient after SAE resolved|1|||
129670430|NCT00329108|466754518|FG001|Overall Study|withdrew patient after SAE resolved|0|||
129670431|NCT00329108|466754517|FG000|Overall Study|Protocol Violation|0|||
129670432|NCT00329108|466754518|FG001|Overall Study|Protocol Violation|2|||
129670433|NCT00903201|466754519|FG000|Overall Study|Adverse Event|1|||
129670434|NCT00903201|466754520|FG001|Overall Study|Adverse Event|4|||
129670435|NCT00903201|466754521|FG002|Overall Study|Adverse Event|0|||
129670436|NCT00903201|466754519|FG000|Overall Study|Protocol Violation|2|||
129670437|NCT00903201|466754520|FG001|Overall Study|Protocol Violation|1|||
129670438|NCT00903201|466754521|FG002|Overall Study|Protocol Violation|0|||
129670439|NCT00903201|466754519|FG000|Overall Study|Lost to Follow-up|0|||
129670440|NCT00903201|466754520|FG001|Overall Study|Lost to Follow-up|1|||
129670441|NCT00903201|466754521|FG002|Overall Study|Lost to Follow-up|0|||
129670442|NCT00903201|466754519|FG000|Overall Study|Physician Decision|1|||
129670443|NCT00903201|466754520|FG001|Overall Study|Physician Decision|0|||
129670444|NCT00903201|466754521|FG002|Overall Study|Physician Decision|1|||
129547081|NCT03576131|466296094|FG006|Overall Study|Subject non-compliance|0|||
129547082|NCT03576131|466296095|FG007|Overall Study|Subject non-compliance|0|||
129670445|NCT00903201|466754519|FG000|Overall Study|Withdrawal by Subject|1|||
129670446|NCT00903201|466754520|FG001|Overall Study|Withdrawal by Subject|0|||
129670447|NCT00903201|466754521|FG002|Overall Study|Withdrawal by Subject|1|||
129670448|NCT01094288|466754522|FG000|Overall Study|Adverse Event|0|||
129670449|NCT01094288|466754523|FG001|Overall Study|Adverse Event|3|||
129670450|NCT01094288|466754524|FG002|Overall Study|Adverse Event|1|||
129670451|NCT01094288|466754525|FG003|Overall Study|Adverse Event|1|||
129670452|NCT01094288|466754526|FG004|Overall Study|Adverse Event|0|||
129670453|NCT01094288|466754527|FG005|Overall Study|Adverse Event|0|||
129670454|NCT01094288|466754528|FG006|Overall Study|Adverse Event|0|||
129670455|NCT01094288|466754529|FG007|Overall Study|Adverse Event|0|||
129670456|NCT01094288|466754522|FG000|Overall Study|Withdrawal by Subject|0|||
129670457|NCT01094288|466754523|FG001|Overall Study|Withdrawal by Subject|1|||
129670458|NCT01094288|466754524|FG002|Overall Study|Withdrawal by Subject|2|||
129670459|NCT01094288|466754525|FG003|Overall Study|Withdrawal by Subject|0|||
129670460|NCT01094288|466754526|FG004|Overall Study|Withdrawal by Subject|0|||
129547083|NCT00996632|466296100|FG000|Overall Study|Physician Decision|0|||
129547084|NCT00996632|466296101|FG001|Overall Study|Physician Decision|0|||
129547085|NCT03069365|466296108|FG000|Overall Study|Adverse Event|1|||
129547086|NCT02050373|466296109|FG000|Overall Study|Adverse Event|4|||
129547087|NCT02050373|466296110|FG001|Overall Study|Adverse Event|7|||
129547088|NCT02050373|466296109|FG000|Overall Study|Death|3|||
129547089|NCT02050373|466296110|FG001|Overall Study|Death|3|||
129547090|NCT03901339|466296112|FG000|Overall Study|Death|220|||
129547091|NCT03901339|466296113|FG001|Overall Study|Death|192|||
129547092|NCT03901339|466296112|FG000|Overall Study|Informed consent withdrawn|13|||
129547093|NCT03901339|466296113|FG001|Overall Study|Informed consent withdrawn|40|||
129547094|NCT03901339|466296112|FG000|Overall Study|Sponsor request|30|||
129547095|NCT03901339|466296113|FG001|Overall Study|Sponsor request|23|||
129547096|NCT03901339|466296112|FG000|Overall Study|Reason not specified|5|||
129547097|NCT03901339|466296113|FG001|Overall Study|Reason not specified|7|||
129547098|NCT03901339|466296112|FG000|Overall Study|Lost to Follow-up|4|||
129547099|NCT03901339|466296113|FG001|Overall Study|Lost to Follow-up|7|||
129547100|NCT03901339|466296112|FG000|Overall Study|Covid19|0|||
129547101|NCT03901339|466296113|FG001|Overall Study|Covid19|2|||
129547102|NCT02886494|466296114|FG000|Overall Study|Adverse Event|1|||
129547103|NCT02886494|466296115|FG001|Overall Study|Adverse Event|0|||
129547104|NCT02886494|466296114|FG000|Overall Study|Withdrawal by Subject|12|||
129547105|NCT02886494|466296115|FG001|Overall Study|Withdrawal by Subject|3|||
129547106|NCT02886494|466296114|FG000|Overall Study|Protocol Violation|4|||
129547107|NCT02886494|466296115|FG001|Overall Study|Protocol Violation|1|||
129547108|NCT02780115|466296116|FG000|Overall Study|Withdrawal by Subject|0|||
129547109|NCT02780115|466296117|FG001|Overall Study|Withdrawal by Subject|1|||
129547110|NCT02780115|466296118|FG002|Overall Study|Withdrawal by Subject|1|||
129547111|NCT02780115|466296119|FG003|Overall Study|Withdrawal by Subject|0|||
129547112|NCT02780115|466296120|FG004|Overall Study|Withdrawal by Subject|0|||
129547113|NCT02780115|466296116|FG000|Overall Study|Adverse Event|0|||
129547114|NCT02780115|466296117|FG001|Overall Study|Adverse Event|0|||
129547115|NCT02780115|466296118|FG002|Overall Study|Adverse Event|0|||
129547116|NCT02780115|466296119|FG003|Overall Study|Adverse Event|1|||
129547117|NCT02780115|466296120|FG004|Overall Study|Adverse Event|1|||
129547118|NCT01179191|466296121|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
129547119|NCT01179191|466296121|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
129547120|NCT01179191|466296121|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
129547121|NCT01179191|466296121|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
129547122|NCT01179191|466296121|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
129547123|NCT01179191|466296121|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
129547124|NCT01179191|466296121|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
129547125|NCT01179191|466296121|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
129547126|NCT01179191|466296121|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
129547127|NCT01179191|466296121|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
129547128|NCT01179191|466296121|FG000|Maintenance Phase (8 Weeks)|Other|66|||
129547129|NCT02742818|466296125|FG000|Overall Study|Adverse Event|0|||
129547130|NCT02742818|466296126|FG001|Overall Study|Adverse Event|1|||
129547131|NCT02742818|466296125|FG000|Overall Study|Protocol Violation|0|||
129547132|NCT02742818|466296126|FG001|Overall Study|Protocol Violation|1|||
129547133|NCT03099161|466296132|FG000|Overall Study|Adverse Event|0|||
129547134|NCT03099161|466296133|FG001|Overall Study|Adverse Event|0|||
129547135|NCT03099161|466296134|FG002|Overall Study|Adverse Event|2|||
129547136|NCT03099161|466296132|FG000|Overall Study|Physician Decision|2|||
129547137|NCT03099161|466296133|FG001|Overall Study|Physician Decision|0|||
129547138|NCT03099161|466296134|FG002|Overall Study|Physician Decision|0|||
129547139|NCT03099161|466296132|FG000|Overall Study|Progressive Disease|1|||
129547140|NCT03099161|466296133|FG001|Overall Study|Progressive Disease|4|||
129547141|NCT03099161|466296134|FG002|Overall Study|Progressive Disease|1|||
129547142|NCT00556166|466296137|FG000|Overall Study|Withdrawal by Subject|1|||
129547143|NCT02985515|466296140|FG000|Olfaction Testing|Lost to Follow-up|0|||
129547144|NCT02985515|466296141|FG001|Olfaction Testing|Lost to Follow-up|5|||
129547145|NCT02985515|466296140|FG000|Olfaction Testing|Protocol Violation|0|||
129547146|NCT02985515|466296141|FG001|Olfaction Testing|Protocol Violation|3|||
129670461|NCT01094288|466754527|FG005|Overall Study|Withdrawal by Subject|0|||
129670462|NCT01094288|466754528|FG006|Overall Study|Withdrawal by Subject|0|||
129670463|NCT01094288|466754529|FG007|Overall Study|Withdrawal by Subject|2|||
129670464|NCT01094288|466754522|FG000|Overall Study|Initiation of Alternative Therapy|0|||
129670465|NCT01094288|466754523|FG001|Overall Study|Initiation of Alternative Therapy|0|||
129670466|NCT01094288|466754524|FG002|Overall Study|Initiation of Alternative Therapy|1|||
129670467|NCT01094288|466754525|FG003|Overall Study|Initiation of Alternative Therapy|0|||
129670468|NCT01094288|466754526|FG004|Overall Study|Initiation of Alternative Therapy|0|||
129670469|NCT01094288|466754527|FG005|Overall Study|Initiation of Alternative Therapy|0|||
129670470|NCT01094288|466754528|FG006|Overall Study|Initiation of Alternative Therapy|0|||
129670471|NCT01094288|466754529|FG007|Overall Study|Initiation of Alternative Therapy|0|||
129670472|NCT01094288|466754522|FG000|Overall Study|Reason not Specified|2|||
129670473|NCT01094288|466754523|FG001|Overall Study|Reason not Specified|3|||
129670474|NCT01094288|466754524|FG002|Overall Study|Reason not Specified|0|||
129670475|NCT01094288|466754525|FG003|Overall Study|Reason not Specified|1|||
129670476|NCT01094288|466754526|FG004|Overall Study|Reason not Specified|0|||
129670477|NCT01094288|466754527|FG005|Overall Study|Reason not Specified|0|||
129670478|NCT01094288|466754528|FG006|Overall Study|Reason not Specified|0|||
129670479|NCT01094288|466754529|FG007|Overall Study|Reason not Specified|0|||
129670480|NCT01094288|466754522|FG000|Overall Study|Ongoing Participants|0|||
129670481|NCT01094288|466754523|FG001|Overall Study|Ongoing Participants|3|||
129670482|NCT01094288|466754524|FG002|Overall Study|Ongoing Participants|0|||
129670483|NCT01094288|466754525|FG003|Overall Study|Ongoing Participants|0|||
129670484|NCT01094288|466754526|FG004|Overall Study|Ongoing Participants|0|||
129670485|NCT01094288|466754527|FG005|Overall Study|Ongoing Participants|0|||
129670486|NCT01094288|466754528|FG006|Overall Study|Ongoing Participants|0|||
129670487|NCT01094288|466754529|FG007|Overall Study|Ongoing Participants|0|||
129670488|NCT02611882|466754532|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
129670489|NCT02611882|466754533|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
129670490|NCT02611882|466754534|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
129670491|NCT01389232|466754535|FG000|Overall Study|Had scaffold removed|15|||
129670492|NCT01389232|466754535|FG000|Overall Study|Personal reasons|2|||
129670493|NCT01389232|466754535|FG000|Overall Study|Adverse Event|1|||
129670494|NCT01389232|466754535|FG000|Overall Study|Death|1|||
129670495|NCT01317940|466754536|FG000|Overall Study|Death|1|||
129670496|NCT01317940|466754537|FG001|Overall Study|Death|0|||
129670497|NCT01317940|466754538|FG002|Overall Study|Death|1|||
129670498|NCT01317940|466754539|FG003|Overall Study|Death|0|||
129670499|NCT01317940|466754540|FG004|Overall Study|Death|0|||
129670500|NCT01317940|466754541|FG005|Overall Study|Death|0|||
129670501|NCT01317940|466754536|FG000|Overall Study|Lost to Follow-up|0|||
129670502|NCT01317940|466754537|FG001|Overall Study|Lost to Follow-up|0|||
129670503|NCT01317940|466754538|FG002|Overall Study|Lost to Follow-up|1|||
129670504|NCT01317940|466754539|FG003|Overall Study|Lost to Follow-up|1|||
129670505|NCT01317940|466754540|FG004|Overall Study|Lost to Follow-up|1|||
129670506|NCT01317940|466754541|FG005|Overall Study|Lost to Follow-up|0|||
129670507|NCT01317940|466754536|FG000|Overall Study|Change in therapy plan|0|||
129670508|NCT01317940|466754537|FG001|Overall Study|Change in therapy plan|0|||
129670509|NCT01317940|466754538|FG002|Overall Study|Change in therapy plan|3|||
129670510|NCT01317940|466754539|FG003|Overall Study|Change in therapy plan|0|||
129670511|NCT01317940|466754540|FG004|Overall Study|Change in therapy plan|0|||
129670512|NCT01317940|466754541|FG005|Overall Study|Change in therapy plan|0|||
129670513|NCT02371616|466754543|FG000|Overall Study|Protocol Violation|2|||
129670514|NCT02371616|466754544|FG001|Overall Study|Protocol Violation|1|||
129670515|NCT02371616|466754543|FG000|Overall Study|Adverse Event|0|||
129670516|NCT02371616|466754544|FG001|Overall Study|Adverse Event|1|||
129670517|NCT02371616|466754543|FG000|Overall Study|Withdrawal of Consent|1|||
129670518|NCT02371616|466754544|FG001|Overall Study|Withdrawal of Consent|0|||
129670519|NCT02371616|466754543|FG000|Overall Study|Other (Not specified)|1|||
129670520|NCT02371616|466754544|FG001|Overall Study|Other (Not specified)|5|||
129670521|NCT00754741|466754545|FG000|Overall Study|Died or disenrolled|57|||
129670522|NCT00754741|466754546|FG001|Overall Study|Died or disenrolled|69|||
129670523|NCT00754741|466754547|FG002|Overall Study|Died or disenrolled|54|||
129670524|NCT04152200|466754549|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
129670525|NCT04152200|466754550|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
129670526|NCT00593814|466754551|FG000|Overall Study|Death|7|||
129670527|NCT00593814|466754552|FG001|Overall Study|Death|0|||
129670528|NCT00593814|466754551|FG000|Overall Study|Withdrawal by Subject|7|||
129670529|NCT00593814|466754552|FG001|Overall Study|Withdrawal by Subject|0|||
129670530|NCT00593814|466754551|FG000|Overall Study|Lost to Follow-up|7|||
129670531|NCT00593814|466754552|FG001|Overall Study|Lost to Follow-up|0|||
129670532|NCT00593814|466754551|FG000|Overall Study|Physician Decision|3|||
129670533|NCT00593814|466754552|FG001|Overall Study|Physician Decision|0|||
129670534|NCT02699996|466754553|FG000|Overall Study|Withdrawal by Subject|5|||
129670535|NCT02699996|466754554|FG001|Overall Study|Withdrawal by Subject|2|||
129670536|NCT04069715|466754555|FG000|Overall Study|Lost to Follow-up|1|||
129670537|NCT04069715|466754556|FG001|Overall Study|Lost to Follow-up|1|||
129670538|NCT04069715|466754555|FG000|Overall Study|Physician Decision|1|||
129670539|NCT04069715|466754556|FG001|Overall Study|Physician Decision|1|||
129670540|NCT04069715|466754555|FG000|Overall Study|Withdrawal by Subject|3|||
129670541|NCT04069715|466754556|FG001|Overall Study|Withdrawal by Subject|3|||
129670542|NCT03205150|466754557|FG000|Overall Study|Protocol deviation|1|||
129670543|NCT03205150|466754558|FG001|Overall Study|Protocol deviation|3|||
129670544|NCT03205150|466754559|FG002|Overall Study|Protocol deviation|0|||
129670545|NCT03205150|466754557|FG000|Overall Study|Patient/guardian decision|0|||
129670546|NCT03205150|466754558|FG001|Overall Study|Patient/guardian decision|3|||
129670547|NCT03205150|466754559|FG002|Overall Study|Patient/guardian decision|0|||
129670548|NCT03205150|466754557|FG000|Overall Study|Adverse Event|1|||
129670549|NCT03205150|466754558|FG001|Overall Study|Adverse Event|1|||
129670550|NCT03205150|466754559|FG002|Overall Study|Adverse Event|1|||
129670551|NCT03205150|466754557|FG000|Overall Study|Lost to Follow-up|0|||
129670552|NCT03205150|466754558|FG001|Overall Study|Lost to Follow-up|0|||
129670553|NCT03205150|466754559|FG002|Overall Study|Lost to Follow-up|1|||
129670554|NCT02723188|466754560|FG000|Overall Study|Withdrawal by Subject|1|||
129670555|NCT02723188|466754561|FG001|Overall Study|Withdrawal by Subject|0|||
129670556|NCT02723188|466754562|FG002|Overall Study|Withdrawal by Subject|0|||
129670557|NCT01095835|466754563|FG000|Overall Study|Adverse Event|8|||
129670558|NCT01095835|466754564|FG001|Overall Study|Adverse Event|6|||
129670559|NCT01095835|466754565|FG002|Overall Study|Adverse Event|6|||
129670560|NCT01095835|466754563|FG000|Overall Study|Lack of Efficacy|0|||
129670561|NCT01095835|466754564|FG001|Overall Study|Lack of Efficacy|1|||
129670562|NCT01095835|466754565|FG002|Overall Study|Lack of Efficacy|0|||
129670563|NCT01095835|466754563|FG000|Overall Study|Physician Decision|0|||
129670564|NCT01095835|466754564|FG001|Overall Study|Physician Decision|0|||
129670565|NCT01095835|466754565|FG002|Overall Study|Physician Decision|1|||
129670566|NCT01095835|466754563|FG000|Overall Study|Withdrawal by Subject|1|||
129670567|NCT01095835|466754564|FG001|Overall Study|Withdrawal by Subject|3|||
129670568|NCT01095835|466754565|FG002|Overall Study|Withdrawal by Subject|0|||
129670569|NCT01095835|466754563|FG000|Overall Study|Non study compliance|0|||
129670570|NCT01095835|466754564|FG001|Overall Study|Non study compliance|0|||
129670571|NCT01095835|466754565|FG002|Overall Study|Non study compliance|1|||
129670572|NCT01095835|466754563|FG000|Overall Study|Protocol Violation|1|||
129670573|NCT01095835|466754564|FG001|Overall Study|Protocol Violation|2|||
129670574|NCT01095835|466754565|FG002|Overall Study|Protocol Violation|0|||
129547147|NCT05013749|466296146|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
129647098|NCT00785213|466663788|FG000|Quinine Sulfate Alone|Adverse Event|4|||
129647099|NCT00785213|466663788|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
129647100|NCT00525902|466663789|FG000|Overall Study|Lack of Efficacy|1|||
129647101|NCT00985959|466663790|FG000|Overall Study|Adverse Event|0|||
129647102|NCT00985959|466663791|FG001|Overall Study|Adverse Event|0|||
129647103|NCT00985959|466663792|FG002|Overall Study|Adverse Event|19|||
129647104|NCT00985959|466663790|FG000|Overall Study|Withdrawal by Subject|0|||
129647105|NCT00985959|466663791|FG001|Overall Study|Withdrawal by Subject|0|||
129647106|NCT00985959|466663792|FG002|Overall Study|Withdrawal by Subject|8|||
129647107|NCT00985959|466663790|FG000|Overall Study|Progressive disease|1|||
129647108|NCT00985959|466663791|FG001|Overall Study|Progressive disease|2|||
129647109|NCT00985959|466663792|FG002|Overall Study|Progressive disease|8|||
129647110|NCT00985959|466663790|FG000|Overall Study|Unrecovered toxicity|0|||
129647111|NCT00985959|466663791|FG001|Overall Study|Unrecovered toxicity|0|||
129647112|NCT00985959|466663792|FG002|Overall Study|Unrecovered toxicity|7|||
129647113|NCT00985959|466663790|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
129647114|NCT00985959|466663791|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
129647115|NCT00985959|466663792|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
129647116|NCT00985959|466663790|FG000|Overall Study|Complete response observed over 2 cycles|0|||
129647117|NCT00985959|466663791|FG001|Overall Study|Complete response observed over 2 cycles|1|||
129647118|NCT00985959|466663792|FG002|Overall Study|Complete response observed over 2 cycles|4|||
129647119|NCT00985959|466663790|FG000|Overall Study|Other|0|||
129647120|NCT00985959|466663791|FG001|Overall Study|Other|0|||
129647121|NCT00985959|466663792|FG002|Overall Study|Other|11|||
129647122|NCT02858180|466663799|FG000|Overall Study|Lost to Follow-up|0|||
129647123|NCT02858180|466663800|FG001|Overall Study|Lost to Follow-up|2|||
129647124|NCT00844480|466663801|FG000|Overall Study|Withdrawal by Subject|2|||
129647125|NCT00844480|466663802|FG001|Overall Study|Withdrawal by Subject|3|||
129647126|NCT00526331|466663803|FG000|Overall Study|Sponsor Termination|55|||
129647127|NCT00979420|466663804|FG000|Overall Study|Adverse Event|1|||
129647128|NCT00979420|466663805|FG001|Overall Study|Adverse Event|0|||
129647129|NCT00979420|466663806|FG002|Overall Study|Adverse Event|0|||
129647130|NCT00979420|466663807|FG003|Overall Study|Adverse Event|0|||
129647131|NCT00979420|466663804|FG000|Overall Study|Lack of Efficacy|3|||
129647132|NCT00979420|466663805|FG001|Overall Study|Lack of Efficacy|0|||
129647133|NCT00979420|466663806|FG002|Overall Study|Lack of Efficacy|1|||
129647134|NCT00979420|466663807|FG003|Overall Study|Lack of Efficacy|1|||
129647135|NCT00979420|466663804|FG000|Overall Study|Other reasons not related to Viramune|3|||
129647136|NCT00979420|466663805|FG001|Overall Study|Other reasons not related to Viramune|0|||
129647137|NCT00979420|466663806|FG002|Overall Study|Other reasons not related to Viramune|0|||
129647138|NCT00979420|466663807|FG003|Overall Study|Other reasons not related to Viramune|1|||
129647139|NCT00574249|466663808|FG000|Overall Study|Adverse Event|6|||
129647140|NCT00574249|466663809|FG001|Overall Study|Adverse Event|18|||
129647141|NCT00574249|466663808|FG000|Overall Study|Lack of Efficacy|5|||
129647142|NCT00574249|466663809|FG001|Overall Study|Lack of Efficacy|3|||
129647143|NCT00574249|466663808|FG000|Overall Study|Lost to Follow-up|4|||
129647144|NCT00574249|466663809|FG001|Overall Study|Lost to Follow-up|3|||
129647145|NCT00574249|466663808|FG000|Overall Study|Protocol Violation|5|||
129647146|NCT00574249|466663809|FG001|Overall Study|Protocol Violation|2|||
129647147|NCT00574249|466663808|FG000|Overall Study|History of carcinoma|1|||
129647148|NCT00574249|466663809|FG001|Overall Study|History of carcinoma|0|||
129647149|NCT00574249|466663808|FG000|Overall Study|Withdrawal by Subject|3|||
129647150|NCT00574249|466663809|FG001|Overall Study|Withdrawal by Subject|0|||
129647151|NCT00574249|466663808|FG000|Overall Study|Physician Decision|1|||
129647152|NCT00574249|466663809|FG001|Overall Study|Physician Decision|0|||
129647153|NCT00574249|466663808|FG000|Overall Study|Pregnancy|1|||
129647154|NCT00574249|466663809|FG001|Overall Study|Pregnancy|0|||
129647155|NCT00574249|466663808|FG000|Overall Study|Excluded by company|0|||
129647156|NCT00574249|466663809|FG001|Overall Study|Excluded by company|1|||
129647157|NCT00574249|466663808|FG000|Overall Study|PPD test taken twice|0|||
129647158|NCT00574249|466663809|FG001|Overall Study|PPD test taken twice|1|||
129647159|NCT00347919|466663812|FG000|Overall Study|Lost to Follow-up|11|||
129647160|NCT00347919|466663813|FG001|Overall Study|Lost to Follow-up|13|||
129647161|NCT00347919|466663814|FG002|Overall Study|Lost to Follow-up|0|||
129647162|NCT00347919|466663812|FG000|Overall Study|Withdrawal by Subject|6|||
129647163|NCT00347919|466663813|FG001|Overall Study|Withdrawal by Subject|8|||
129647164|NCT00347919|466663814|FG002|Overall Study|Withdrawal by Subject|0|||
129647165|NCT00347919|466663812|FG000|Overall Study|Physician Decision|1|||
129647166|NCT00347919|466663813|FG001|Overall Study|Physician Decision|1|||
129647167|NCT00347919|466663814|FG002|Overall Study|Physician Decision|0|||
129647168|NCT00347919|466663812|FG000|Overall Study|Sponsor terminated study|15|||
129647169|NCT00347919|466663813|FG001|Overall Study|Sponsor terminated study|10|||
129647170|NCT00347919|466663814|FG002|Overall Study|Sponsor terminated study|16|||
129670575|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
129670576|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
129670577|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
129670578|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
129670579|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
129670580|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
129670581|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
129670582|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
129670583|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
129670584|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
129670585|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
129670586|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
129670587|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
129670588|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
129670589|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
129670590|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
129670591|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
129670592|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
129670593|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
129670594|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
129670595|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
129670596|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
129670597|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
129670598|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
129670599|NCT01198002|466754568|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
129670600|NCT01198002|466754569|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
129670601|NCT01198002|466754570|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
129670602|NCT01198002|466754568|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
129670603|NCT01198002|466754569|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
129670604|NCT01198002|466754570|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
129670605|NCT01198002|466754568|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
129670606|NCT01198002|466754569|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
129670607|NCT01198002|466754570|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
129670608|NCT01198002|466754568|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
129670609|NCT01198002|466754569|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
129670610|NCT01198002|466754570|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
129670611|NCT01198002|466754568|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
129670612|NCT01198002|466754569|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
129670613|NCT01198002|466754570|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
129670614|NCT01198002|466754568|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
129670615|NCT01198002|466754569|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
129670616|NCT01198002|466754570|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
129670617|NCT01198002|466754568|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
129670618|NCT01198002|466754569|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
129670619|NCT01198002|466754570|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
129670620|NCT00789321|466754578|FG000|Overall Study|Adverse Event|0|||
129670621|NCT00789321|466754579|FG001|Overall Study|Adverse Event|1|||
129670622|NCT01965327|466754580|FG000|Overall Study|Physician Decision|2|||
129670623|NCT03652818|466754584|FG000|Overall Study|Adverse Event|1|||
129670624|NCT03652818|466754585|FG001|Overall Study|Adverse Event|0|||
129670625|NCT03652818|466754586|FG002|Overall Study|Adverse Event|0|||
129670626|NCT03652818|466754587|FG003|Overall Study|Adverse Event|0|||
129670627|NCT03652818|466754588|FG004|Overall Study|Adverse Event|0|||
129670628|NCT03652818|466754584|FG000|Overall Study|Physician Decision|1|||
129670629|NCT03652818|466754585|FG001|Overall Study|Physician Decision|0|||
129670630|NCT03652818|466754586|FG002|Overall Study|Physician Decision|0|||
129670631|NCT03652818|466754587|FG003|Overall Study|Physician Decision|0|||
129670632|NCT03652818|466754588|FG004|Overall Study|Physician Decision|0|||
129670633|NCT03652818|466754584|FG000|Overall Study|Lost to Follow-up|0|||
129670634|NCT03652818|466754585|FG001|Overall Study|Lost to Follow-up|1|||
129670635|NCT03652818|466754586|FG002|Overall Study|Lost to Follow-up|2|||
129670636|NCT03652818|466754587|FG003|Overall Study|Lost to Follow-up|1|||
129670637|NCT03652818|466754588|FG004|Overall Study|Lost to Follow-up|1|||
129670638|NCT01930539|466754593|FG000|Overall Study|Withdrawal by Subject|2|||
129670639|NCT01930539|466754594|FG001|Overall Study|Withdrawal by Subject|2|||
129670640|NCT00830219|466754595|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129670641|NCT00830219|466754596|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129670642|NCT01811732|466754597|FG000|Overall Study|Lost to Follow-up|24|||
129670643|NCT01811732|466754598|FG001|Overall Study|Lost to Follow-up|30|||
129670644|NCT01811732|466754597|FG000|Overall Study|Withdrawal by Subject|16|||
129670645|NCT01811732|466754598|FG001|Overall Study|Withdrawal by Subject|10|||
129670646|NCT01811732|466754597|FG000|Overall Study|Adverse Event|3|||
129670647|NCT01811732|466754598|FG001|Overall Study|Adverse Event|9|||
129670648|NCT01811732|466754597|FG000|Overall Study|Lack of Efficacy|3|||
129670649|NCT01811732|466754598|FG001|Overall Study|Lack of Efficacy|1|||
129670650|NCT01811732|466754597|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
129670651|NCT01811732|466754598|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
129670652|NCT01811732|466754597|FG000|Overall Study|Physician Decision|2|||
129670653|NCT01811732|466754598|FG001|Overall Study|Physician Decision|0|||
129670654|NCT01811732|466754597|FG000|Overall Study|Death|1|||
129670655|NCT01811732|466754598|FG001|Overall Study|Death|1|||
129670656|NCT01811732|466754597|FG000|Overall Study|Insufficient venous access|0|||
129670657|NCT01811732|466754598|FG001|Overall Study|Insufficient venous access|1|||
129670658|NCT01811732|466754597|FG000|Overall Study|Protocol Violation|0|||
129670659|NCT01811732|466754598|FG001|Overall Study|Protocol Violation|1|||
129670660|NCT01811732|466754597|FG000|Overall Study|Subject incarcerated|1|||
129670661|NCT01811732|466754598|FG001|Overall Study|Subject incarcerated|2|||
129670662|NCT01811732|466754597|FG000|Overall Study|Admitted to another facility|1|||
129670663|NCT01811732|466754598|FG001|Overall Study|Admitted to another facility|0|||
129670664|NCT01811732|466754597|FG000|Overall Study|Correct study drug not available on site|1|||
129670665|NCT01811732|466754598|FG001|Overall Study|Correct study drug not available on site|0|||
129670666|NCT00288912|466754601|FG000|Overall Study|Developed exclusion criterion|4|||
129670667|NCT00288912|466754602|FG001|Overall Study|Developed exclusion criterion|6|||
129670668|NCT00288912|466754603|FG002|Overall Study|Developed exclusion criterion|7|||
129670669|NCT00288912|466754601|FG000|Overall Study|Lost to Follow-up|9|||
129670670|NCT00288912|466754602|FG001|Overall Study|Lost to Follow-up|6|||
129670671|NCT00288912|466754603|FG002|Overall Study|Lost to Follow-up|9|||
129670672|NCT00288912|466754601|FG000|Overall Study|Withdrawal by Subject|4|||
129670673|NCT00288912|466754602|FG001|Overall Study|Withdrawal by Subject|5|||
129670674|NCT00288912|466754603|FG002|Overall Study|Withdrawal by Subject|12|||
129670675|NCT01868646|466754604|FG000|Overall Study|Do not meet inclusion criteria|3|||
129670676|NCT01868646|466754605|FG001|Overall Study|Do not meet inclusion criteria|5|||
129670677|NCT01783743|466754610|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
129670678|NCT01783743|466754611|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
129670679|NCT01783743|466754610|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
129670680|NCT01783743|466754611|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
129670681|NCT01783743|466754610|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
129670682|NCT01783743|466754611|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
129670683|NCT01607593|466754612|FG000|Overall Study|Adverse Event|15|||
129670684|NCT01607593|466754612|FG000|Overall Study|Lack of Efficacy|16|||
129670685|NCT01607593|466754612|FG000|Overall Study|Lost to Follow-up|25|||
129670686|NCT01607593|466754612|FG000|Overall Study|Continuation|33|||
129670687|NCT01607593|466754612|FG000|Overall Study|Other|4|||
129670688|NCT02771275|466754613|FG000|Overall Study|Reoperation|3|||
129670689|NCT02771275|466754613|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
129670690|NCT00728494|466754626|FG000|Overall Study|Adverse Event|7|||
129670691|NCT00728494|466754627|FG001|Overall Study|Adverse Event|0|||
129670692|NCT00728494|466754626|FG000|Overall Study|Withdrawal by Subject|0|||
129670693|NCT00728494|466754627|FG001|Overall Study|Withdrawal by Subject|2|||
129670694|NCT00728494|466754626|FG000|Overall Study|Lack of Efficacy|2|||
129670695|NCT00728494|466754627|FG001|Overall Study|Lack of Efficacy|4|||
129670696|NCT00728494|466754626|FG000|Overall Study|No data available|0|||
129670697|NCT00728494|466754627|FG001|Overall Study|No data available|1|||
129670698|NCT03439137|466754628|FG000|Overall Study|Adverse Event|16|||
129670699|NCT03439137|466754629|FG001|Overall Study|Adverse Event|12|||
129670700|NCT03439137|466754628|FG000|Overall Study|Physician Decision|0|||
129670701|NCT03439137|466754629|FG001|Overall Study|Physician Decision|5|||
129670702|NCT03439137|466754628|FG000|Overall Study|Withdrawal by Subject|14|||
129670703|NCT03439137|466754629|FG001|Overall Study|Withdrawal by Subject|4|||
129670704|NCT03439137|466754628|FG000|Overall Study|Conducting rescue therapy|2|||
129670705|NCT03439137|466754629|FG001|Overall Study|Conducting rescue therapy|1|||
129670706|NCT03439137|466754628|FG000|Overall Study|Difficult to control Hb|10|||
129670707|NCT03439137|466754629|FG001|Overall Study|Difficult to control Hb|2|||
129670708|NCT03439137|466754628|FG000|Overall Study|Initiation of a renal transplant|0|||
129670709|NCT03439137|466754629|FG001|Overall Study|Initiation of a renal transplant|2|||
129670710|NCT01240382|466754631|FG000|Overall Study|Adverse Event|2|||
129670711|NCT01240382|466754632|FG001|Overall Study|Adverse Event|1|||
129670712|NCT01240382|466754631|FG000|Overall Study|Lack of Efficacy|0|||
129547148|NCT05013749|466296147|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
129670713|NCT01240382|466754632|FG001|Overall Study|Lack of Efficacy|2|||
129670714|NCT01240382|466754631|FG000|Overall Study|Fear of adverse events|0|||
129670715|NCT01240382|466754632|FG001|Overall Study|Fear of adverse events|1|||
129670716|NCT02456727|466754633|FG000|Overall Study|Lost to Follow-up|63|||
129670717|NCT02456727|466754634|FG001|Overall Study|Lost to Follow-up|65|||
129670718|NCT02456727|466754633|FG000|Overall Study|Death|2|||
129670719|NCT02456727|466754634|FG001|Overall Study|Death|1|||
129670720|NCT02456727|466754633|FG000|Overall Study|Withdrawal by Subject|1|||
129670721|NCT02456727|466754634|FG001|Overall Study|Withdrawal by Subject|10|||
129670722|NCT02456727|466754633|FG000|Overall Study|Never Initiated Treatment|43|||
129670723|NCT02456727|466754634|FG001|Overall Study|Never Initiated Treatment|30|||
129670724|NCT02643693|466754635|FG000|Overall Study|Physician Decision|0|||
129670725|NCT02643693|466754636|FG001|Overall Study|Physician Decision|1|||
129670726|NCT02643693|466754637|FG002|Overall Study|Physician Decision|0|||
129670727|NCT02643693|466754638|FG003|Overall Study|Physician Decision|0|||
129670728|NCT02643693|466754639|FG004|Overall Study|Physician Decision|0|||
129670729|NCT02643693|466754640|FG005|Overall Study|Physician Decision|0|||
129670730|NCT02643693|466754635|FG000|Overall Study|Withdrawal by Subject|0|||
129670731|NCT02643693|466754636|FG001|Overall Study|Withdrawal by Subject|1|||
129670732|NCT02643693|466754637|FG002|Overall Study|Withdrawal by Subject|0|||
129670733|NCT02643693|466754638|FG003|Overall Study|Withdrawal by Subject|0|||
129670734|NCT02643693|466754639|FG004|Overall Study|Withdrawal by Subject|0|||
129670735|NCT02643693|466754640|FG005|Overall Study|Withdrawal by Subject|0|||
129670736|NCT02643693|466754635|FG000|Overall Study|Protocol Adherence Issues|2|||
129670737|NCT02643693|466754636|FG001|Overall Study|Protocol Adherence Issues|0|||
129670738|NCT02643693|466754637|FG002|Overall Study|Protocol Adherence Issues|1|||
129670739|NCT02643693|466754638|FG003|Overall Study|Protocol Adherence Issues|0|||
129670740|NCT02643693|466754639|FG004|Overall Study|Protocol Adherence Issues|0|||
129670741|NCT02643693|466754640|FG005|Overall Study|Protocol Adherence Issues|1|||
129670742|NCT00888654|466754641|FG000|Overall Study|Problems swallowing oral meds.|1|||
129670743|NCT00888654|466754641|FG000|Overall Study|Not enough oral meds before surgery|3|||
129670744|NCT00888654|466754641|FG000|Overall Study|Surgery aborted|2|||
129670745|NCT00888654|466754641|FG000|Overall Study|Withdrawal by Subject|1|||
129670746|NCT00888654|466754641|FG000|Overall Study|Inelig. due to contraindication of med|1|||
129670747|NCT00888654|466754641|FG000|Overall Study|Change in surg date|1|||
129670748|NCT00888654|466754641|FG000|Overall Study|Stopped meds due to headaches|1|||
129670749|NCT00791999|466754642|FG000|Overall Study|Protocol planed withdrawal|14|||
129670750|NCT00791999|466754643|FG001|Overall Study|Protocol planed withdrawal|11|||
129670751|NCT00791999|466754644|FG002|Overall Study|Protocol planed withdrawal|11|||
129670752|NCT00791999|466754645|FG003|Overall Study|Protocol planed withdrawal|45|||
129670753|NCT00791999|466754642|FG000|Overall Study|Withdrawal by Subject|0|||
129670754|NCT00791999|466754643|FG001|Overall Study|Withdrawal by Subject|1|||
129670755|NCT00791999|466754644|FG002|Overall Study|Withdrawal by Subject|0|||
129670756|NCT00791999|466754645|FG003|Overall Study|Withdrawal by Subject|2|||
129670757|NCT00791999|466754642|FG000|Overall Study|Protocol Violation|3|||
129670758|NCT00791999|466754643|FG001|Overall Study|Protocol Violation|0|||
129670759|NCT00791999|466754644|FG002|Overall Study|Protocol Violation|1|||
129670760|NCT00791999|466754645|FG003|Overall Study|Protocol Violation|0|||
129670761|NCT00791999|466754642|FG000|Overall Study|Adverse Event|3|||
129670762|NCT00791999|466754643|FG001|Overall Study|Adverse Event|3|||
129670763|NCT00791999|466754644|FG002|Overall Study|Adverse Event|7|||
129670764|NCT00791999|466754645|FG003|Overall Study|Adverse Event|3|||
129670765|NCT00791999|466754642|FG000|Overall Study|Lack of Efficacy|0|||
129670766|NCT00791999|466754643|FG001|Overall Study|Lack of Efficacy|1|||
129670767|NCT00791999|466754644|FG002|Overall Study|Lack of Efficacy|0|||
129670768|NCT00791999|466754645|FG003|Overall Study|Lack of Efficacy|2|||
129670769|NCT00791999|466754642|FG000|Overall Study|Reason other than those above|1|||
129670770|NCT00791999|466754643|FG001|Overall Study|Reason other than those above|0|||
129670771|NCT00791999|466754644|FG002|Overall Study|Reason other than those above|1|||
129670772|NCT00791999|466754645|FG003|Overall Study|Reason other than those above|0|||
129670773|NCT00427908|466754646|FG000|Primary Phase|Lost to Follow-up|4|||
129670774|NCT00427908|466754647|FG001|Primary Phase|Lost to Follow-up|0|||
129670775|NCT00427908|466754648|FG002|Primary Phase|Lost to Follow-up|2|||
129670776|NCT00427908|466754649|FG003|Primary Phase|Lost to Follow-up|0|||
129670777|NCT00427908|466754646|FG000|Primary Phase|Withdrawal by Subject|1|||
129670778|NCT00427908|466754647|FG001|Primary Phase|Withdrawal by Subject|2|||
129670779|NCT00427908|466754648|FG002|Primary Phase|Withdrawal by Subject|1|||
129670780|NCT00427908|466754649|FG003|Primary Phase|Withdrawal by Subject|0|||
129670781|NCT00427908|466754646|FG000|Primary Phase|Adverse Event|0|||
129670782|NCT00427908|466754647|FG001|Primary Phase|Adverse Event|1|||
129670783|NCT00427908|466754648|FG002|Primary Phase|Adverse Event|0|||
129670784|NCT00427908|466754649|FG003|Primary Phase|Adverse Event|0|||
129670785|NCT01710020|466754650|FG000|Period 1|Protocol Violation|1|||
129670786|NCT01190813|466754651|FG000|Overall Study|Lost to Follow-up|1|||
129670787|NCT01190813|466754652|FG001|Overall Study|Lost to Follow-up|2|||
129670788|NCT01190813|466754651|FG000|Overall Study|Withdrawal by Subject|2|||
129670789|NCT01190813|466754652|FG001|Overall Study|Withdrawal by Subject|1|||
129670790|NCT01190813|466754651|FG000|Overall Study|Refused study treatment after randomized|1|||
129670791|NCT01190813|466754652|FG001|Overall Study|Refused study treatment after randomized|0|||
129670792|NCT01190813|466754651|FG000|Overall Study|Adverse Event|0|||
129670793|NCT01190813|466754652|FG001|Overall Study|Adverse Event|1|||
129670794|NCT04194814|466754653|FG000|Overall Study|Physician Decision|3|||
129670795|NCT04194814|466754654|FG001|Overall Study|Physician Decision|0|||
129670796|NCT04194814|466754653|FG000|Overall Study|Withdrawal by Subject|0|||
129670797|NCT04194814|466754654|FG001|Overall Study|Withdrawal by Subject|2|||
129670798|NCT03191799|466756376|FG000|Overall Study|Withdrawal by Subject|4|||
129670799|NCT03191799|466756376|FG000|Overall Study|Physician Decision|2|||
129670800|NCT03191799|466756376|FG000|Overall Study|Lost to Follow-up|1|||
129670801|NCT03191799|466756376|FG000|Overall Study|Death|2|||
129670802|NCT00748241|466756382|FG000|Overall Study|Implant failure|1|||
129670803|NCT00748241|466756382|FG000|Overall Study|Lost to Follow-up|5|||
129670804|NCT00748241|466756382|FG000|Overall Study|Death|2|||
129670805|NCT02974868|466756392|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
129670806|NCT02974868|466756393|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
129670807|NCT02974868|466756394|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
129670808|NCT02974868|466756395|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
129670809|NCT02974868|466756392|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
129670810|NCT02974868|466756393|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
129670811|NCT02974868|466756394|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
129670812|NCT02974868|466756395|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
129670813|NCT02974868|466756392|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
129670814|NCT02974868|466756393|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
129670815|NCT02974868|466756394|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
129670816|NCT02974868|466756395|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
129670817|NCT02974868|466756392|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
129670818|NCT02974868|466756393|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
129670819|NCT02974868|466756394|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
129670820|NCT02974868|466756395|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
129670821|NCT00297648|466756398|FG000|Overall Study|Adverse Event|13|||
129670822|NCT00297648|466756398|FG000|Overall Study|Lack of Efficacy|18|||
129670823|NCT00297648|466756398|FG000|Overall Study|Lost to Follow-up|1|||
129670824|NCT00297648|466756398|FG000|Overall Study|Withdrawal by Subject|3|||
129670825|NCT00297648|466756398|FG000|Overall Study|Other: Incompliance|1|||
129670826|NCT03575702|466756399|FG000|Overall Study|Withdrawal by Subject|1|||
129670827|NCT03575702|466756400|FG001|Overall Study|Withdrawal by Subject|1|||
129670828|NCT03575702|466756399|FG000|Overall Study|Lost to Follow-up|1|||
129670829|NCT03575702|466756400|FG001|Overall Study|Lost to Follow-up|2|||
129670830|NCT03575702|466756399|FG000|Overall Study|Protocol Violation|0|||
129670831|NCT03575702|466756400|FG001|Overall Study|Protocol Violation|1|||
129670832|NCT03575702|466756399|FG000|Overall Study|Patient non compliance|4|||
129670833|NCT03575702|466756400|FG001|Overall Study|Patient non compliance|0|||
129670834|NCT03903172|466756401|FG000|Overall Study|screen fail|4|||
129670835|NCT03903172|466756402|FG001|Overall Study|screen fail|1|||
129670836|NCT01545388|466756403|FG000|Overall Study|Adverse Event|2|||
129670837|NCT01545388|466756404|FG001|Overall Study|Adverse Event|4|||
129670838|NCT01545388|466756405|FG002|Overall Study|Adverse Event|1|||
129670839|NCT01545388|466756403|FG000|Overall Study|Lack of Efficacy|3|||
129670840|NCT01545388|466756404|FG001|Overall Study|Lack of Efficacy|2|||
129670841|NCT01545388|466756405|FG002|Overall Study|Lack of Efficacy|5|||
129670842|NCT01545388|466756403|FG000|Overall Study|Participant moved or relocated|1|||
129670843|NCT01545388|466756404|FG001|Overall Study|Participant moved or relocated|0|||
129670844|NCT01545388|466756405|FG002|Overall Study|Participant moved or relocated|0|||
129670845|NCT01545388|466756403|FG000|Overall Study|Withdrawal by Subject|1|||
129670846|NCT01545388|466756404|FG001|Overall Study|Withdrawal by Subject|4|||
129670847|NCT01545388|466756405|FG002|Overall Study|Withdrawal by Subject|2|||
129670848|NCT01545388|466756403|FG000|Overall Study|Other|1|||
129670849|NCT01545388|466756404|FG001|Overall Study|Other|1|||
129670850|NCT01545388|466756405|FG002|Overall Study|Other|0|||
129670851|NCT01255163|466756406|FG000|Overall Study|Withdrawal by Subject|1|||
129670852|NCT01255163|466756407|FG001|Overall Study|Withdrawal by Subject|0|||
129670853|NCT01255163|466756406|FG000|Overall Study|Lost to Follow-up|2|||
129670854|NCT01255163|466756407|FG001|Overall Study|Lost to Follow-up|0|||
129670855|NCT01255163|466756406|FG000|Overall Study|Adverse Event|0|||
129670856|NCT01255163|466756407|FG001|Overall Study|Adverse Event|2|||
129670857|NCT01255163|466756406|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
129670858|NCT01255163|466756407|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
129670859|NCT02495389|466756408|FG000|Overall Study|Withdrawal by Subject|40|||
129670860|NCT01802385|466756412|FG000|Overall Study|Death|106|||
129670861|NCT01802385|466756413|FG001|Overall Study|Death|120|||
129670862|NCT03834493|466756414|FG000|Overall Study|Participants Ongoing|311|||
129670863|NCT03834493|466756415|FG001|Overall Study|Participants Ongoing|324|||
129670864|NCT03834493|466756414|FG000|Overall Study|Withdrawal by Subject|20|||
129670865|NCT03834493|466756415|FG001|Overall Study|Withdrawal by Subject|17|||
129670866|NCT03834493|466756414|FG000|Overall Study|Physician Decision|1|||
129670867|NCT03834493|466756415|FG001|Overall Study|Physician Decision|0|||
129670868|NCT03834493|466756414|FG000|Overall Study|Death|289|||
129670869|NCT03834493|466756415|FG001|Overall Study|Death|282|||
129670870|NCT05559905|466756416|FG000|Overall Study|Withdrawal by Subject|1|||
129670871|NCT05559905|466756417|FG001|Overall Study|Withdrawal by Subject|0|||
129670872|NCT05559905|466756418|FG002|Overall Study|Withdrawal by Subject|0|||
129670873|NCT05559905|466756416|FG000|Overall Study|Not Reported|1|||
129670874|NCT05559905|466756417|FG001|Overall Study|Not Reported|0|||
129670875|NCT05559905|466756418|FG002|Overall Study|Not Reported|0|||
129670876|NCT04003103|466756419|FG000|Overall Study|Death|1|||
129670877|NCT04003103|466756420|FG001|Overall Study|Death|0|||
129670878|NCT04003103|466756421|FG002|Overall Study|Death|0|||
129670879|NCT04003103|466756419|FG000|Overall Study|Lost to Follow-up|4|||
129670880|NCT04003103|466756420|FG001|Overall Study|Lost to Follow-up|3|||
129670881|NCT04003103|466756421|FG002|Overall Study|Lost to Follow-up|2|||
129670882|NCT04003103|466756419|FG000|Overall Study|Withdrawal by Subject|10|||
129670883|NCT04003103|466756420|FG001|Overall Study|Withdrawal by Subject|1|||
129670884|NCT04003103|466756421|FG002|Overall Study|Withdrawal by Subject|1|||
129670885|NCT04003103|466756419|FG000|Overall Study|Status not recorded|0|||
129670886|NCT04003103|466756420|FG001|Overall Study|Status not recorded|2|||
129670887|NCT04003103|466756421|FG002|Overall Study|Status not recorded|0|||
129670888|NCT03829462|466756426|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
129670889|NCT03829462|466756427|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
129670890|NCT03829462|466756426|FG000|Overall Study|No treatment due to progression disease|0|||
129670891|NCT03829462|466756427|FG001|Overall Study|No treatment due to progression disease|1|||
129670892|NCT02277028|466756429|FG000|Overall Study|Lost to Follow-up|1|||
129670893|NCT02277028|466756430|FG001|Overall Study|Lost to Follow-up|0|||
129670894|NCT02277028|466756429|FG000|Overall Study|Withdrawal by Subject|0|||
129670895|NCT02277028|466756430|FG001|Overall Study|Withdrawal by Subject|1|||
129670896|NCT02718911|466756431|FG000|Overall Study|Adverse Event|0|||
129670897|NCT02718911|466756432|FG001|Overall Study|Adverse Event|0|||
129670898|NCT02718911|466756433|FG002|Overall Study|Adverse Event|0|||
129670899|NCT02718911|466756434|FG003|Overall Study|Adverse Event|0|||
129670900|NCT02718911|466756435|FG004|Overall Study|Adverse Event|0|||
129670901|NCT02718911|466756436|FG005|Overall Study|Adverse Event|0|||
129670902|NCT02718911|466756437|FG006|Overall Study|Adverse Event|0|||
129670903|NCT02718911|466756438|FG007|Overall Study|Adverse Event|0|||
129670904|NCT02718911|466756439|FG008|Overall Study|Adverse Event|0|||
129670905|NCT02718911|466756440|FG009|Overall Study|Adverse Event|2|||
129670906|NCT02718911|466756431|FG000|Overall Study|Death|2|||
129670907|NCT02718911|466756432|FG001|Overall Study|Death|3|||
129670908|NCT02718911|466756433|FG002|Overall Study|Death|1|||
129547149|NCT05013749|466296146|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
129670909|NCT02718911|466756434|FG003|Overall Study|Death|0|||
129670910|NCT02718911|466756435|FG004|Overall Study|Death|1|||
129670911|NCT02718911|466756436|FG005|Overall Study|Death|3|||
129670912|NCT02718911|466756437|FG006|Overall Study|Death|1|||
129670913|NCT02718911|466756438|FG007|Overall Study|Death|1|||
129670914|NCT02718911|466756439|FG008|Overall Study|Death|4|||
129670915|NCT02718911|466756440|FG009|Overall Study|Death|3|||
129670916|NCT02718911|466756431|FG000|Overall Study|Lost to Follow-up|0|||
129670917|NCT02718911|466756432|FG001|Overall Study|Lost to Follow-up|0|||
129670918|NCT02718911|466756433|FG002|Overall Study|Lost to Follow-up|0|||
129670919|NCT02718911|466756434|FG003|Overall Study|Lost to Follow-up|0|||
129670920|NCT02718911|466756435|FG004|Overall Study|Lost to Follow-up|0|||
129670921|NCT02718911|466756436|FG005|Overall Study|Lost to Follow-up|0|||
129670922|NCT02718911|466756437|FG006|Overall Study|Lost to Follow-up|0|||
129670923|NCT02718911|466756438|FG007|Overall Study|Lost to Follow-up|0|||
129670924|NCT02718911|466756439|FG008|Overall Study|Lost to Follow-up|1|||
129670925|NCT02718911|466756440|FG009|Overall Study|Lost to Follow-up|0|||
129670926|NCT02718911|466756431|FG000|Overall Study|Physician Decision|2|||
129670927|NCT02718911|466756432|FG001|Overall Study|Physician Decision|0|||
129670928|NCT02718911|466756433|FG002|Overall Study|Physician Decision|1|||
129670929|NCT02718911|466756434|FG003|Overall Study|Physician Decision|1|||
129670930|NCT02718911|466756435|FG004|Overall Study|Physician Decision|0|||
129670931|NCT02718911|466756436|FG005|Overall Study|Physician Decision|0|||
129670932|NCT02718911|466756437|FG006|Overall Study|Physician Decision|0|||
129670933|NCT02718911|466756438|FG007|Overall Study|Physician Decision|1|||
129670934|NCT02718911|466756439|FG008|Overall Study|Physician Decision|2|||
129670935|NCT02718911|466756440|FG009|Overall Study|Physician Decision|1|||
129670936|NCT02718911|466756431|FG000|Overall Study|Withdrawal by Subject|0|||
129670937|NCT02718911|466756432|FG001|Overall Study|Withdrawal by Subject|0|||
129670938|NCT02718911|466756433|FG002|Overall Study|Withdrawal by Subject|0|||
129670939|NCT02718911|466756434|FG003|Overall Study|Withdrawal by Subject|0|||
129670940|NCT02718911|466756435|FG004|Overall Study|Withdrawal by Subject|1|||
129670941|NCT02718911|466756436|FG005|Overall Study|Withdrawal by Subject|0|||
129670942|NCT02718911|466756437|FG006|Overall Study|Withdrawal by Subject|0|||
129670943|NCT02718911|466756438|FG007|Overall Study|Withdrawal by Subject|0|||
129670944|NCT02718911|466756439|FG008|Overall Study|Withdrawal by Subject|1|||
129670945|NCT02718911|466756440|FG009|Overall Study|Withdrawal by Subject|4|||
129670946|NCT02718911|466756431|FG000|Overall Study|Reason Not Collected|0|||
129670947|NCT02718911|466756432|FG001|Overall Study|Reason Not Collected|0|||
129670948|NCT02718911|466756433|FG002|Overall Study|Reason Not Collected|1|||
129670949|NCT02718911|466756434|FG003|Overall Study|Reason Not Collected|0|||
129670950|NCT02718911|466756435|FG004|Overall Study|Reason Not Collected|0|||
129670951|NCT02718911|466756436|FG005|Overall Study|Reason Not Collected|0|||
129670952|NCT02718911|466756437|FG006|Overall Study|Reason Not Collected|2|||
129670953|NCT02718911|466756438|FG007|Overall Study|Reason Not Collected|1|||
129670954|NCT02718911|466756439|FG008|Overall Study|Reason Not Collected|4|||
129670955|NCT02718911|466756440|FG009|Overall Study|Reason Not Collected|9|||
129670956|NCT05002972|466756441|FG000|Overall Study|Withdrawal by Subject|2|||
129670957|NCT01172873|466756445|FG000|Overall Study|Withdrawal by Subject|3|||
129670958|NCT01172873|466756446|FG001|Overall Study|Withdrawal by Subject|2|||
129670959|NCT00983372|466756447|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
129670960|NCT00983372|466756447|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
129670961|NCT00983372|466756447|FG000|Diltiazem ER Alone|Adverse Event|1|||
129670962|NCT05518539|466756450|FG000|Overall Study|Lost to Follow-up|6|||
129670963|NCT02053493|466756455|FG000|Overall Study|Withdrawal by Subject|1|||
129670964|NCT02053493|466756456|FG001|Overall Study|Withdrawal by Subject|1|||
129670965|NCT04613518|466756459|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
129670966|NCT04613518|466756460|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
129670967|NCT04613518|466756461|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
129670968|NCT04613518|466756459|FG000|Double-Blind Treatment Period|Adverse Event|2|||
129670969|NCT04613518|466756460|FG001|Double-Blind Treatment Period|Adverse Event|0|||
129670970|NCT04613518|466756461|FG002|Double-Blind Treatment Period|Adverse Event|1|||
129670971|NCT04613518|466756459|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
129670972|NCT04613518|466756460|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
129670973|NCT04613518|466756461|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
129670974|NCT04613518|466756459|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
129670975|NCT04613518|466756460|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
129670976|NCT04613518|466756461|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
129670977|NCT04613518|466756459|FG000|Double-Blind Treatment Period|Other Reasons|2|||
129670978|NCT04613518|466756460|FG001|Double-Blind Treatment Period|Other Reasons|0|||
129670979|NCT04613518|466756461|FG002|Double-Blind Treatment Period|Other Reasons|0|||
129670980|NCT04613518|466756459|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
129670981|NCT04613518|466756460|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
129670982|NCT04613518|466756461|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129670983|NCT04613518|466756459|FG000|Open-Label Treatment Period|Adverse Event|1|||
129670984|NCT04613518|466756460|FG001|Open-Label Treatment Period|Adverse Event|0|||
129670985|NCT04613518|466756461|FG002|Open-Label Treatment Period|Adverse Event|3|||
129670986|NCT04613518|466756459|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
129670987|NCT04613518|466756460|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
129670988|NCT04613518|466756461|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
129670989|NCT04613518|466756459|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
129670990|NCT04613518|466756460|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
129670991|NCT04613518|466756461|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
129670992|NCT04613518|466756459|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
129670993|NCT04613518|466756460|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
129670994|NCT04613518|466756461|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
129670995|NCT04613518|466756459|FG000|Open-Label Treatment Period|Other reasons|1|||
129670996|NCT04613518|466756460|FG001|Open-Label Treatment Period|Other reasons|0|||
129670997|NCT04613518|466756461|FG002|Open-Label Treatment Period|Other reasons|0|||
129670998|NCT01619865|466756462|FG000|Overall Study|Adverse Event|1|||
129670999|NCT01619865|466756462|FG000|Overall Study|Death|2|||
129671000|NCT01619865|466756462|FG000|Overall Study|subject not able to comply|1|||
129671001|NCT01494818|466756463|FG000|Overall Study|Relocation|1|||
129671002|NCT01494818|466756464|FG001|Overall Study|Relocation|2|||
129671003|NCT01494818|466756463|FG000|Overall Study|Lost to Follow-up|1|||
129671004|NCT01494818|466756464|FG001|Overall Study|Lost to Follow-up|0|||
129671005|NCT01077323|466756465|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
129671006|NCT01077323|466756466|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
129671007|NCT01077323|466756467|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
129671008|NCT01077323|466756465|FG000|Overall Study|Dispensing of drug in baseline period|0|||
129671009|NCT01077323|466756466|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
129671010|NCT01077323|466756467|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
129671011|NCT01077323|466756465|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
129671012|NCT01077323|466756466|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
129671013|NCT01077323|466756467|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
129671014|NCT00617357|466756468|FG000|Overall Study|Lost to Follow-up|7|||
129671015|NCT00617357|466756468|FG000|Overall Study|Death|5|||
129671016|NCT00617357|466756468|FG000|Overall Study|insurance concerns|2|||
129671017|NCT00617357|466756468|FG000|Overall Study|Withdrawal by Subject|1|||
129671018|NCT00617357|466756468|FG000|Overall Study|Physician Decision|1|||
129671019|NCT02153918|466756469|FG000|Overall Study|Refused further treatment|1|||
129671020|NCT01764841|466756470|FG000|Overall Study|Logistical Difficulties|0|||
129671021|NCT01764841|466756471|FG001|Overall Study|Logistical Difficulties|1|||
129671022|NCT01764841|466756472|FG002|Overall Study|Logistical Difficulties|0|||
129671023|NCT01764841|466756473|FG003|Overall Study|Logistical Difficulties|0|||
129671024|NCT01764841|466756470|FG000|Overall Study|Death|3|||
129671025|NCT01764841|466756471|FG001|Overall Study|Death|0|||
129671026|NCT01764841|466756472|FG002|Overall Study|Death|1|||
129671027|NCT01764841|466756473|FG003|Overall Study|Death|4|||
129671028|NCT01764841|466756470|FG000|Overall Study|No Follow Up|1|||
129671029|NCT01764841|466756471|FG001|Overall Study|No Follow Up|0|||
129671030|NCT01764841|466756472|FG002|Overall Study|No Follow Up|1|||
129671031|NCT01764841|466756473|FG003|Overall Study|No Follow Up|0|||
129671032|NCT01764841|466756470|FG000|Overall Study|Protocol Violation|0|||
129671033|NCT01764841|466756471|FG001|Overall Study|Protocol Violation|1|||
129671034|NCT01764841|466756472|FG002|Overall Study|Protocol Violation|0|||
129671035|NCT01764841|466756473|FG003|Overall Study|Protocol Violation|0|||
129671036|NCT01764841|466756470|FG000|Overall Study|Withdrawal by Subject|16|||
129671037|NCT01764841|466756471|FG001|Overall Study|Withdrawal by Subject|24|||
129671038|NCT01764841|466756472|FG002|Overall Study|Withdrawal by Subject|11|||
129671039|NCT01764841|466756473|FG003|Overall Study|Withdrawal by Subject|15|||
129671040|NCT01764841|466756470|FG000|Overall Study|Lost to Follow-up|3|||
129671041|NCT01764841|466756471|FG001|Overall Study|Lost to Follow-up|0|||
129671042|NCT01764841|466756472|FG002|Overall Study|Lost to Follow-up|1|||
129671043|NCT01764841|466756473|FG003|Overall Study|Lost to Follow-up|0|||
129671044|NCT02616783|466756474|FG000|Overall Study|Randomized but Not Treated|1|||
129671045|NCT02616783|466756475|FG001|Overall Study|Randomized but Not Treated|0|||
129671046|NCT02616783|466756474|FG000|Overall Study|Adverse Event|1|||
129671047|NCT02616783|466756475|FG001|Overall Study|Adverse Event|0|||
129671048|NCT02616783|466756474|FG000|Overall Study|Death|1|||
129671049|NCT02616783|466756475|FG001|Overall Study|Death|0|||
129671050|NCT02616783|466756474|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129671051|NCT02616783|466756475|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129671052|NCT02616783|466756474|FG000|Overall Study|Protocol Violation|1|||
129671053|NCT02616783|466756475|FG001|Overall Study|Protocol Violation|1|||
129671054|NCT02616783|466756474|FG000|Overall Study|Withdrew Consent|1|||
129671055|NCT02616783|466756475|FG001|Overall Study|Withdrew Consent|1|||
129671056|NCT04344301|466756476|FG000|Overall Study|Withdrawal by Subject|1|||
129671057|NCT04344301|466756477|FG001|Overall Study|Withdrawal by Subject|0|||
129671058|NCT04344301|466756476|FG000|Overall Study|Death|0|||
129671059|NCT04344301|466756477|FG001|Overall Study|Death|1|||
129671060|NCT05214118|466756480|FG000|Overall Study|Lost to Follow-up|0|||
129671061|NCT05214118|466756481|FG001|Overall Study|Lost to Follow-up|2|||
129671062|NCT05214118|466756480|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
129671063|NCT05214118|466756481|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
129671064|NCT05214118|466756480|FG000|Overall Study|moved|1|||
129671065|NCT05214118|466756481|FG001|Overall Study|moved|0|||
129671066|NCT04010461|466756482|FG000|Overall Study|COVID based withdrawal|5|||
129671067|NCT04010461|466756482|FG000|Overall Study|Withdrawal by Subject|5|||
129671068|NCT04010461|466756482|FG000|Overall Study|Adverse Event|1|||
129671069|NCT04010461|466756482|FG000|Overall Study|No Motor Threshold obtainable|1|||
129671070|NCT04010461|466756482|FG000|Overall Study|Physician Decision|1|||
129671071|NCT03797898|466756483|FG000|Overall Study|Lost to Follow-up|60|||
129671072|NCT03797898|466756484|FG001|Overall Study|Lost to Follow-up|69|||
129671073|NCT03797898|466756483|FG000|Overall Study|Withdrawal by Subject|9|||
129671074|NCT03797898|466756484|FG001|Overall Study|Withdrawal by Subject|7|||
129671075|NCT03797898|466756483|FG000|Overall Study|Became ineligible|5|||
129671076|NCT03797898|466756484|FG001|Overall Study|Became ineligible|2|||
129671077|NCT00086190|466756485|FG000|Overall Study|Adverse Event|6|||
129671078|NCT00086190|466756486|FG001|Overall Study|Adverse Event|2|||
129671079|NCT00086190|466756487|FG002|Overall Study|Adverse Event|2|||
129671080|NCT00086190|466756485|FG000|Overall Study|Withdrawal by Subject|0|||
129671081|NCT00086190|466756486|FG001|Overall Study|Withdrawal by Subject|2|||
129671082|NCT00086190|466756487|FG002|Overall Study|Withdrawal by Subject|2|||
129671083|NCT00086190|466756485|FG000|Overall Study|Protocol Violation|1|||
129671084|NCT00086190|466756486|FG001|Overall Study|Protocol Violation|0|||
129671085|NCT00086190|466756487|FG002|Overall Study|Protocol Violation|0|||
129671086|NCT00086190|466756485|FG000|Overall Study|Moved|1|||
129671087|NCT00086190|466756486|FG001|Overall Study|Moved|0|||
129671088|NCT00086190|466756487|FG002|Overall Study|Moved|0|||
129671089|NCT00086190|466756485|FG000|Overall Study|Worsening depression|0|||
129671090|NCT00086190|466756486|FG001|Overall Study|Worsening depression|0|||
129671091|NCT00086190|466756487|FG002|Overall Study|Worsening depression|2|||
129671092|NCT03902613|466756491|FG000|Overall Study|Physician Decision|1|||
129671093|NCT02027025|466756492|FG000|Overall Study|Adverse Event|0|||
129671094|NCT02027025|466756493|FG001|Overall Study|Adverse Event|1|||
129671095|NCT02027025|466756494|FG002|Overall Study|Adverse Event|1|||
129671096|NCT02027025|466756492|FG000|Overall Study|Protocol Violation|1|||
129671097|NCT02027025|466756493|FG001|Overall Study|Protocol Violation|0|||
129671098|NCT02027025|466756494|FG002|Overall Study|Protocol Violation|0|||
129671099|NCT02027025|466756492|FG000|Overall Study|Lost to Follow-up|0|||
129671100|NCT02027025|466756493|FG001|Overall Study|Lost to Follow-up|2|||
129671101|NCT02027025|466756494|FG002|Overall Study|Lost to Follow-up|0|||
129671102|NCT02027025|466756492|FG000|Overall Study|Withdrawal by Subject|0|||
129671103|NCT02027025|466756493|FG001|Overall Study|Withdrawal by Subject|1|||
129671104|NCT02027025|466756494|FG002|Overall Study|Withdrawal by Subject|0|||
129671105|NCT02027025|466756492|FG000|Overall Study|Sponsor's decision|0|||
129671106|NCT02027025|466756493|FG001|Overall Study|Sponsor's decision|1|||
129671107|NCT02027025|466756494|FG002|Overall Study|Sponsor's decision|0|||
129671108|NCT00732069|466756495|FG000|Washout After First Study Drug|Adverse Event|1|||
129671109|NCT00732069|466756496|FG001|Washout After First Study Drug|Adverse Event|0|||
129671110|NCT00732069|466756497|FG002|Washout After First Study Drug|Adverse Event|0|||
129671111|NCT00732069|466756498|FG003|Washout After First Study Drug|Adverse Event|0|||
129671112|NCT00732069|466756499|FG004|Washout After First Study Drug|Adverse Event|0|||
129671113|NCT00732069|466756500|FG005|Washout After First Study Drug|Adverse Event|0|||
129671114|NCT04460326|466756501|FG000|Completed at Least 4 Meals|Early discharge|5|||
129671115|NCT04460326|466756502|FG001|Completed at Least 4 Meals|Early discharge|5|||
129671116|NCT04460326|466756501|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
129671117|NCT04460326|466756502|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
129884382|NCT00708305|467536385|FG002|Period 2|Lost to Follow-up|0|||
129671118|NCT04460326|466756501|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
129671119|NCT04460326|466756502|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
129671120|NCT04460326|466756501|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
129671121|NCT04460326|466756502|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
129671122|NCT04460326|466756501|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
129671123|NCT04460326|466756502|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
129671124|NCT04460326|466756501|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
129671125|NCT04460326|466756502|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
129671126|NCT00577317|466756503|FG000|Overall Study|Study Terminated|0|||
129671127|NCT00577317|466756504|FG001|Overall Study|Study Terminated|2|||
129671128|NCT04794751|466756507|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
129671129|NCT04794751|466756508|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
129671130|NCT04794751|466756507|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
129671131|NCT04794751|466756508|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
129671132|NCT04794751|466756507|FG000|Period 1|Protocol Violation|0|||
129671133|NCT04794751|466756508|FG001|Period 1|Protocol Violation|2|||
129671134|NCT04794751|466756507|FG000|Period 1|Withdrawal by Subject|0|||
129671135|NCT04794751|466756508|FG001|Period 1|Withdrawal by Subject|1|||
129671136|NCT04794751|466756507|FG000|Period 2|Withdrawal by Subject|0|||
129671137|NCT04794751|466756508|FG001|Period 2|Withdrawal by Subject|1|||
129671138|NCT04794751|466756507|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
129671139|NCT04794751|466756508|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
129671140|NCT04794751|466756507|FG000|Period 2|Protocol Violation|1|||
129671141|NCT04794751|466756508|FG001|Period 2|Protocol Violation|0|||
129671142|NCT03669588|466756509|FG000|Overall Study|Adverse Event|1|||
129671143|NCT03669588|466756510|FG001|Overall Study|Adverse Event|0|||
129671144|NCT03669588|466756509|FG000|Overall Study|Physician Decision|0|||
129671145|NCT03669588|466756510|FG001|Overall Study|Physician Decision|1|||
129671146|NCT03669588|466756509|FG000|Overall Study|Protocol Violation|1|||
129671147|NCT03669588|466756510|FG001|Overall Study|Protocol Violation|0|||
129671148|NCT03669588|466756509|FG000|Overall Study|Sponsor Decision|1|||
129671149|NCT03669588|466756510|FG001|Overall Study|Sponsor Decision|1|||
129671150|NCT03669588|466756509|FG000|Overall Study|Withdrawal by Subject|1|||
129671151|NCT03669588|466756510|FG001|Overall Study|Withdrawal by Subject|4|||
129671152|NCT03669588|466756509|FG000|Overall Study|Rescue Therapy Needed|0|||
129671153|NCT03669588|466756510|FG001|Overall Study|Rescue Therapy Needed|1|||
129671154|NCT00369343|466756513|FG000|Double-blind Phase|Adverse Event|19|||
129671155|NCT00369343|466756514|FG001|Double-blind Phase|Adverse Event|4|||
129671156|NCT00369343|466756513|FG000|Double-blind Phase|Failed to return|2|||
129671157|NCT00369343|466756514|FG001|Double-blind Phase|Failed to return|0|||
129671158|NCT00369343|466756513|FG000|Double-blind Phase|Lost to Follow-up|9|||
129671159|NCT00369343|466756514|FG001|Double-blind Phase|Lost to Follow-up|2|||
129671160|NCT00369343|466756513|FG000|Double-blind Phase|Protocol Violation|2|||
129671161|NCT00369343|466756514|FG001|Double-blind Phase|Protocol Violation|0|||
129671162|NCT00369343|466756513|FG000|Double-blind Phase|Withdrawal by Subject|8|||
129671163|NCT00369343|466756514|FG001|Double-blind Phase|Withdrawal by Subject|6|||
129671164|NCT00369343|466756513|FG000|Double-blind Phase|Lack of Efficacy|0|||
129671165|NCT00369343|466756514|FG001|Double-blind Phase|Lack of Efficacy|4|||
129671166|NCT00369343|466756513|FG000|Double-blind Phase|Protocol deviation|4|||
129671167|NCT00369343|466756514|FG001|Double-blind Phase|Protocol deviation|0|||
129671168|NCT00369343|466756513|FG000|Open-label Phase|Adverse Event|19|||
129671169|NCT00369343|466756514|FG001|Open-label Phase|Adverse Event|7|||
129671170|NCT00369343|466756513|FG000|Open-label Phase|Failed to return|4|||
129671171|NCT00369343|466756514|FG001|Open-label Phase|Failed to return|0|||
129671172|NCT00369343|466756513|FG000|Open-label Phase|Physician Decision|2|||
129671173|NCT00369343|466756514|FG001|Open-label Phase|Physician Decision|0|||
129671174|NCT00369343|466756513|FG000|Open-label Phase|Lost to Follow-up|5|||
129671175|NCT00369343|466756514|FG001|Open-label Phase|Lost to Follow-up|3|||
129671176|NCT00369343|466756513|FG000|Open-label Phase|inadvertently reported study completers|3|||
129671177|NCT00369343|466756514|FG001|Open-label Phase|inadvertently reported study completers|2|||
129671178|NCT00369343|466756513|FG000|Open-label Phase|Protocol Violation|1|||
129671179|NCT00369343|466756514|FG001|Open-label Phase|Protocol Violation|3|||
129671180|NCT00369343|466756513|FG000|Open-label Phase|Withdrawal by Subject|15|||
129671181|NCT00369343|466756514|FG001|Open-label Phase|Withdrawal by Subject|6|||
129671182|NCT00369343|466756513|FG000|Open-label Phase|Lack of Efficacy|4|||
129671183|NCT00369343|466756514|FG001|Open-label Phase|Lack of Efficacy|3|||
129671184|NCT00369343|466756513|FG000|Open-label Phase|Lack of continuance tolerability|3|||
129671185|NCT00369343|466756514|FG001|Open-label Phase|Lack of continuance tolerability|4|||
129671186|NCT00369343|466756513|FG000|Open-label Phase|did not take study drug|1|||
129671187|NCT00369343|466756514|FG001|Open-label Phase|did not take study drug|2|||
129671188|NCT01100502|466756515|FG000|Overall Study|Withdrawal by Subject|18|||
129671189|NCT01100502|466756516|FG001|Overall Study|Withdrawal by Subject|25|||
129671190|NCT01100502|466756515|FG000|Overall Study|Lost to Follow-up|13|||
129671191|NCT01100502|466756516|FG001|Overall Study|Lost to Follow-up|28|||
129671192|NCT01100502|466756515|FG000|Overall Study|Site request to end participation in study|0|||
129671193|NCT01100502|466756516|FG001|Overall Study|Site request to end participation in study|1|||
129671194|NCT01100502|466756515|FG000|Overall Study|Death|45|||
129671195|NCT01100502|466756516|FG001|Overall Study|Death|40|||
129671196|NCT02322749|466756517|FG000|Period 2|Adverse Event|0|||
129671197|NCT02322749|466756518|FG001|Period 2|Adverse Event|0|||
129671198|NCT02322749|466756519|FG002|Period 2|Adverse Event|0|||
129671199|NCT02322749|466756520|FG003|Period 2|Adverse Event|1|||
129671200|NCT02322749|466756521|FG004|Period 2|Adverse Event|0|||
129671201|NCT02322749|466756522|FG005|Period 2|Adverse Event|0|||
129671202|NCT02322749|466756517|FG000|Period 2|Withdrawal by Subject|0|||
129671203|NCT02322749|466756518|FG001|Period 2|Withdrawal by Subject|0|||
129671204|NCT02322749|466756519|FG002|Period 2|Withdrawal by Subject|0|||
129671205|NCT02322749|466756520|FG003|Period 2|Withdrawal by Subject|1|||
129671206|NCT02322749|466756521|FG004|Period 2|Withdrawal by Subject|0|||
129671207|NCT02322749|466756522|FG005|Period 2|Withdrawal by Subject|0|||
129671208|NCT02322749|466756517|FG000|Period 3|Withdrawal by Subject|0|||
129671209|NCT02322749|466756518|FG001|Period 3|Withdrawal by Subject|0|||
129671210|NCT02322749|466756519|FG002|Period 3|Withdrawal by Subject|1|||
129671211|NCT02322749|466756520|FG003|Period 3|Withdrawal by Subject|0|||
129671212|NCT02322749|466756521|FG004|Period 3|Withdrawal by Subject|0|||
129671213|NCT02322749|466756522|FG005|Period 3|Withdrawal by Subject|0|||
129671214|NCT05158140|466756533|FG000|Overall Study|Death|0|||
129671215|NCT05158140|466756534|FG001|Overall Study|Death|0|||
129671216|NCT05158140|466756535|FG002|Overall Study|Death|0|||
129671217|NCT05158140|466756536|FG003|Overall Study|Death|1|||
129671218|NCT05158140|466756533|FG000|Overall Study|Lost to Follow-up|3|||
129671219|NCT05158140|466756534|FG001|Overall Study|Lost to Follow-up|6|||
129671220|NCT05158140|466756535|FG002|Overall Study|Lost to Follow-up|4|||
129671221|NCT05158140|466756536|FG003|Overall Study|Lost to Follow-up|3|||
129671222|NCT05158140|466756533|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129671223|NCT05158140|466756534|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129671224|NCT05158140|466756535|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
129671225|NCT05158140|466756536|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129671226|NCT05158140|466756533|FG000|Overall Study|Withdrawal by Subject|3|||
129671227|NCT05158140|466756534|FG001|Overall Study|Withdrawal by Subject|7|||
129671228|NCT05158140|466756535|FG002|Overall Study|Withdrawal by Subject|3|||
129671229|NCT05158140|466756536|FG003|Overall Study|Withdrawal by Subject|7|||
129671230|NCT04414787|466756541|FG000|Overall Study|Patient Death|18|||
129671231|NCT04414787|466756542|FG001|Overall Study|Patient Death|18|||
129671232|NCT04414787|466756543|FG002|Overall Study|Patient Death|15|||
129671233|NCT04414787|466756544|FG003|Overall Study|Patient Death|15|||
129671234|NCT04414787|466756541|FG000|Overall Study|Patient Hospitalization|1|||
129671235|NCT04414787|466756542|FG001|Overall Study|Patient Hospitalization|1|||
129671236|NCT04414787|466756543|FG002|Overall Study|Patient Hospitalization|2|||
129671237|NCT04414787|466756544|FG003|Overall Study|Patient Hospitalization|2|||
129671238|NCT04414787|466756541|FG000|Overall Study|Lost to Follow-up|7|||
129671239|NCT04414787|466756542|FG001|Overall Study|Lost to Follow-up|7|||
129671240|NCT04414787|466756543|FG002|Overall Study|Lost to Follow-up|5|||
129671241|NCT04414787|466756544|FG003|Overall Study|Lost to Follow-up|5|||
129671242|NCT04414787|466756541|FG000|Overall Study|Residence in post-acute care facility|3|||
129671243|NCT04414787|466756542|FG001|Overall Study|Residence in post-acute care facility|3|||
129671244|NCT04414787|466756543|FG002|Overall Study|Residence in post-acute care facility|5|||
129671245|NCT04414787|466756544|FG003|Overall Study|Residence in post-acute care facility|5|||
129671246|NCT00807365|466756545|FG000|Overall Study|Study Terminated|5|||
129671247|NCT01526785|466756546|FG000|Overall Study|Study Terminated by Sponsor|8|||
129671248|NCT01526785|466756546|FG000|Overall Study|Death|2|||
129671249|NCT01526785|466756546|FG000|Overall Study|Physician Decision|1|||
129671250|NCT01526785|466756546|FG000|Overall Study|Withdrawal by Subject|2|||
129671251|NCT04350827|466756553|FG000|Overall Study|Lost to Follow-up|1|||
129671252|NCT04350827|466756554|FG001|Overall Study|Lost to Follow-up|2|||
129671253|NCT00916578|466758259|FG000|Overall Study|Physician Decision|2|||
129671254|NCT00916578|466758259|FG000|Overall Study|Withdrawal by Subject|3|||
129671255|NCT00916578|466758259|FG000|Overall Study|Insurance Denial|2|||
129671256|NCT00945243|466758264|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
129671257|NCT03256578|466758265|FG000|Overall Study|Excluded Post Randomization|66|||
129671258|NCT03256578|466758266|FG001|Overall Study|Excluded Post Randomization|56|||
129671259|NCT03028142|466758267|FG000|Overall Study|Adverse Event|1|||
129671260|NCT03028142|466758268|FG001|Overall Study|Adverse Event|1|||
129671261|NCT03028142|466758269|FG002|Overall Study|Adverse Event|0|||
129671262|NCT03028142|466758270|FG003|Overall Study|Adverse Event|0|||
129671263|NCT03028142|466758271|FG004|Overall Study|Adverse Event|0|||
129671264|NCT03028142|466758272|FG005|Overall Study|Adverse Event|1|||
129671265|NCT03028142|466758267|FG000|Overall Study|Withdrawal by Subject|0|||
129671266|NCT03028142|466758268|FG001|Overall Study|Withdrawal by Subject|0|||
129671267|NCT03028142|466758269|FG002|Overall Study|Withdrawal by Subject|0|||
129671268|NCT03028142|466758270|FG003|Overall Study|Withdrawal by Subject|0|||
129671269|NCT03028142|466758271|FG004|Overall Study|Withdrawal by Subject|1|||
129671270|NCT03028142|466758272|FG005|Overall Study|Withdrawal by Subject|0|||
129671271|NCT02810418|466758273|FG000|Arm A Dose Escalation|Adverse Event|2|||
129671272|NCT02810418|466758274|FG001|Arm A Dose Escalation|Adverse Event|1|||
129671273|NCT02810418|466758275|FG002|Arm A Dose Escalation|Adverse Event|0|||
129671274|NCT02810418|466758276|FG003|Arm A Dose Escalation|Adverse Event|0|||
129671275|NCT02810418|466758277|FG004|Arm A Dose Escalation|Adverse Event|0|||
129671276|NCT02810418|466758278|FG005|Arm A Dose Escalation|Adverse Event|0|||
129671277|NCT02810418|466758279|FG006|Arm A Dose Escalation|Adverse Event|0|||
129671278|NCT02810418|466758273|FG000|Dose Expansion|Adverse Event|0|||
129671279|NCT02810418|466758274|FG001|Dose Expansion|Adverse Event|1|||
129671280|NCT02810418|466758275|FG002|Dose Expansion|Adverse Event|1|||
129671281|NCT02810418|466758276|FG003|Dose Expansion|Adverse Event|0|||
129671282|NCT02810418|466758277|FG004|Dose Expansion|Adverse Event|0|||
129671283|NCT02810418|466758278|FG005|Dose Expansion|Adverse Event|0|||
129671284|NCT02810418|466758279|FG006|Dose Expansion|Adverse Event|0|||
129671285|NCT02810418|466758273|FG000|Dose Expansion|Physician Decision|0|||
129671286|NCT02810418|466758274|FG001|Dose Expansion|Physician Decision|0|||
129671287|NCT02810418|466758275|FG002|Dose Expansion|Physician Decision|2|||
129671288|NCT02810418|466758276|FG003|Dose Expansion|Physician Decision|0|||
129671289|NCT02810418|466758277|FG004|Dose Expansion|Physician Decision|0|||
129671290|NCT02810418|466758278|FG005|Dose Expansion|Physician Decision|0|||
129671291|NCT02810418|466758279|FG006|Dose Expansion|Physician Decision|0|||
129671292|NCT02810418|466758273|FG000|Arm B Dose Escalation|Adverse Event|0|||
129671293|NCT02810418|466758274|FG001|Arm B Dose Escalation|Adverse Event|0|||
129671294|NCT02810418|466758275|FG002|Arm B Dose Escalation|Adverse Event|0|||
129671295|NCT02810418|466758276|FG003|Arm B Dose Escalation|Adverse Event|0|||
129671296|NCT02810418|466758277|FG004|Arm B Dose Escalation|Adverse Event|1|||
129671297|NCT02810418|466758278|FG005|Arm B Dose Escalation|Adverse Event|2|||
129671298|NCT02810418|466758279|FG006|Arm B Dose Escalation|Adverse Event|0|||
129671299|NCT01162343|466758283|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
129671300|NCT01162343|466758283|FG000|Overall Study|Refused psychiatrist assessment|12|||
129671301|NCT04635839|466758297|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
129671302|NCT04635839|466758298|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
129671303|NCT02737358|466758299|FG000|Overall Study|Withdrawal by Subject|7|||
129671304|NCT02737358|466758300|FG001|Overall Study|Withdrawal by Subject|12|||
129671305|NCT02737358|466758299|FG000|Overall Study|Lost to Follow-up|2|||
129671306|NCT02737358|466758300|FG001|Overall Study|Lost to Follow-up|3|||
129671307|NCT02870868|466758301|FG000|Overall Study|Withdrawal by Subject|2|||
129671308|NCT02870868|466758302|FG001|Overall Study|Withdrawal by Subject|1|||
129671309|NCT00744939|466758303|FG000|Overall Study|Withdrawal by Subject|9|||
129671310|NCT00744939|466758303|FG000|Overall Study|Protocol Violation|13|||
129671311|NCT00744939|466758303|FG000|Overall Study|Death|24|||
129671312|NCT00744939|466758303|FG000|Overall Study|distance|4|||
129671313|NCT00744939|466758303|FG000|Overall Study|Lost to Follow-up|12|||
129671314|NCT00744939|466758303|FG000|Overall Study|Medical history exclusionary|1|||
129671315|NCT00744939|466758303|FG000|Overall Study|Did not receive Magnevist|7|||
129671316|NCT00744939|466758303|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
129671317|NCT00744939|466758303|FG000|Overall Study|coma|1|||
129671318|NCT00744939|466758303|FG000|Overall Study|incorrect race|1|||
129671319|NCT01674725|466758305|FG000|Overall Study|Adverse Event|1|||
129671320|NCT01674725|466758306|FG001|Overall Study|Adverse Event|0|||
129671321|NCT01674725|466758305|FG000|Overall Study|Did not receive study drug|1|||
129671322|NCT01674725|466758306|FG001|Overall Study|Did not receive study drug|0|||
129671323|NCT01674725|466758305|FG000|Overall Study|Withdrawal by Subject|1|||
129671324|NCT01674725|466758306|FG001|Overall Study|Withdrawal by Subject|0|||
129671325|NCT01674725|466758305|FG000|Overall Study|Lost to Follow-up|0|||
129671326|NCT01674725|466758306|FG001|Overall Study|Lost to Follow-up|1|||
129671327|NCT02900352|466758307|FG000|Overall Study|Lost to Follow-up|28|||
129671328|NCT02900352|466758308|FG001|Overall Study|Lost to Follow-up|17|||
129671329|NCT03074695|466758309|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
129671330|NCT03074695|466758310|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
129671331|NCT03074695|466758309|FG000|Overall Study|Research staff not available|1|||
129671332|NCT03074695|466758310|FG001|Overall Study|Research staff not available|2|||
129671333|NCT03074695|466758309|FG000|Overall Study|Did not receive neuraxial block|2|||
129671334|NCT03074695|466758310|FG001|Overall Study|Did not receive neuraxial block|2|||
129671335|NCT01774981|466758311|FG000|Overall Study|Adverse Event|0|||
129671336|NCT01774981|466758312|FG001|Overall Study|Adverse Event|0|||
129671337|NCT01774981|466758313|FG002|Overall Study|Adverse Event|0|||
129671338|NCT01774981|466758314|FG003|Overall Study|Adverse Event|0|||
129671339|NCT01774981|466758315|FG004|Overall Study|Adverse Event|0|||
129671340|NCT01774981|466758316|FG005|Overall Study|Adverse Event|1|||
129671341|NCT01774981|466758317|FG006|Overall Study|Adverse Event|0|||
129671342|NCT01774981|466758318|FG007|Overall Study|Adverse Event|0|||
129671343|NCT01774981|466758311|FG000|Overall Study|Withdrawal by Subject|0|||
129671344|NCT01774981|466758312|FG001|Overall Study|Withdrawal by Subject|0|||
129671345|NCT01774981|466758313|FG002|Overall Study|Withdrawal by Subject|0|||
129671346|NCT01774981|466758314|FG003|Overall Study|Withdrawal by Subject|0|||
129671347|NCT01774981|466758315|FG004|Overall Study|Withdrawal by Subject|0|||
129671348|NCT01774981|466758316|FG005|Overall Study|Withdrawal by Subject|0|||
129671349|NCT01774981|466758317|FG006|Overall Study|Withdrawal by Subject|0|||
129671350|NCT01774981|466758318|FG007|Overall Study|Withdrawal by Subject|1|||
129671351|NCT01774981|466758311|FG000|Overall Study|Death|0|||
129671352|NCT01774981|466758312|FG001|Overall Study|Death|0|||
129671353|NCT01774981|466758313|FG002|Overall Study|Death|0|||
129671354|NCT01774981|466758314|FG003|Overall Study|Death|0|||
129671355|NCT01774981|466758315|FG004|Overall Study|Death|1|||
129671356|NCT01774981|466758316|FG005|Overall Study|Death|0|||
129671357|NCT01774981|466758317|FG006|Overall Study|Death|0|||
129671358|NCT01774981|466758318|FG007|Overall Study|Death|0|||
129671359|NCT00960193|466758319|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
129671360|NCT01239797|466758320|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
129671361|NCT01239797|466758321|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
129671362|NCT01239797|466758320|FG000|Randomized Participants|Participant withdrew consent|1|||
129671363|NCT01239797|466758321|FG001|Randomized Participants|Participant withdrew consent|7|||
129671364|NCT01239797|466758320|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
129671365|NCT01239797|466758321|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
129671366|NCT01239797|466758320|FG000|Treated Participants|Disease progression|185|||
129671367|NCT01239797|466758321|FG001|Treated Participants|Disease progression|185|||
129671368|NCT01239797|466758320|FG000|Treated Participants|Study drug toxicity|39|||
129671369|NCT01239797|466758321|FG001|Treated Participants|Study drug toxicity|45|||
129671370|NCT01239797|466758320|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
129671371|NCT01239797|466758321|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
129671372|NCT01239797|466758320|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
129671373|NCT01239797|466758321|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
129671374|NCT01239797|466758320|FG000|Treated Participants|Administrative reason by sponsor|13|||
129671375|NCT01239797|466758321|FG001|Treated Participants|Administrative reason by sponsor|4|||
129671376|NCT01239797|466758320|FG000|Treated Participants|Other reasons|14|||
129671377|NCT01239797|466758321|FG001|Treated Participants|Other reasons|14|||
129884383|NCT00708305|467536386|FG003|Period 2|Lost to Follow-up|0|||
129884384|NCT00708305|467536383|FG000|Period 2|Protocol Violation|0|||
129671378|NCT01239797|466758320|FG000|Treated Participants|Participant withdrew consent|6|||
129671379|NCT01239797|466758321|FG001|Treated Participants|Participant withdrew consent|11|||
129671380|NCT01239797|466758320|FG000|Treated Participants|Death|1|||
129671381|NCT01239797|466758321|FG001|Treated Participants|Death|1|||
129671382|NCT01239797|466758320|FG000|Treated Participants|Participant no longer meets study criteria|1|||
129671383|NCT01239797|466758321|FG001|Treated Participants|Participant no longer meets study criteria|1|||
129671384|NCT01239797|466758320|FG000|Treated Participants|Poor/non-compliance|0|||
129671385|NCT01239797|466758321|FG001|Treated Participants|Poor/non-compliance|1|||
129671386|NCT02631941|466758326|FG000|Overall Study|Physician Decision|0|||
129671387|NCT02631941|466758327|FG001|Overall Study|Physician Decision|1|||
129671388|NCT02631941|466758328|FG002|Overall Study|Physician Decision|0|||
129671389|NCT02631941|466758329|FG003|Overall Study|Physician Decision|0|||
129671390|NCT02631941|466758330|FG004|Overall Study|Physician Decision|0|||
129671391|NCT02631941|466758331|FG005|Overall Study|Physician Decision|0|||
129671392|NCT02631941|466758332|FG006|Overall Study|Physician Decision|0|||
129671393|NCT02631941|466758333|FG007|Overall Study|Physician Decision|0|||
129671394|NCT02631941|466758334|FG008|Overall Study|Physician Decision|0|||
129671395|NCT02631941|466758335|FG009|Overall Study|Physician Decision|0|||
129671396|NCT02631941|466758326|FG000|Overall Study|Adverse Event|0|||
129671397|NCT02631941|466758327|FG001|Overall Study|Adverse Event|1|||
129671398|NCT02631941|466758328|FG002|Overall Study|Adverse Event|0|||
129671399|NCT02631941|466758329|FG003|Overall Study|Adverse Event|0|||
129671400|NCT02631941|466758330|FG004|Overall Study|Adverse Event|0|||
129671401|NCT02631941|466758331|FG005|Overall Study|Adverse Event|0|||
129671402|NCT02631941|466758332|FG006|Overall Study|Adverse Event|0|||
129671403|NCT02631941|466758333|FG007|Overall Study|Adverse Event|0|||
129671404|NCT02631941|466758334|FG008|Overall Study|Adverse Event|0|||
129671405|NCT02631941|466758335|FG009|Overall Study|Adverse Event|0|||
129671406|NCT02631941|466758326|FG000|Overall Study|Withdrawal by Subject|0|||
129671407|NCT02631941|466758327|FG001|Overall Study|Withdrawal by Subject|0|||
129671408|NCT02631941|466758328|FG002|Overall Study|Withdrawal by Subject|0|||
129671409|NCT02631941|466758329|FG003|Overall Study|Withdrawal by Subject|0|||
129671410|NCT02631941|466758330|FG004|Overall Study|Withdrawal by Subject|1|||
129671411|NCT02631941|466758331|FG005|Overall Study|Withdrawal by Subject|0|||
129671412|NCT02631941|466758332|FG006|Overall Study|Withdrawal by Subject|0|||
129671413|NCT02631941|466758333|FG007|Overall Study|Withdrawal by Subject|1|||
129671414|NCT02631941|466758334|FG008|Overall Study|Withdrawal by Subject|0|||
129671415|NCT02631941|466758335|FG009|Overall Study|Withdrawal by Subject|0|||
129671416|NCT02631941|466758326|FG000|Overall Study|Lost to Follow-up|0|||
129671417|NCT02631941|466758327|FG001|Overall Study|Lost to Follow-up|0|||
129671418|NCT02631941|466758328|FG002|Overall Study|Lost to Follow-up|0|||
129671419|NCT02631941|466758329|FG003|Overall Study|Lost to Follow-up|0|||
129671420|NCT02631941|466758330|FG004|Overall Study|Lost to Follow-up|0|||
129671421|NCT02631941|466758331|FG005|Overall Study|Lost to Follow-up|0|||
129671422|NCT02631941|466758332|FG006|Overall Study|Lost to Follow-up|0|||
129671423|NCT02631941|466758333|FG007|Overall Study|Lost to Follow-up|0|||
129671424|NCT02631941|466758334|FG008|Overall Study|Lost to Follow-up|1|||
129671425|NCT02631941|466758335|FG009|Overall Study|Lost to Follow-up|0|||
129671426|NCT02915835|466758336|FG000|Overall Study|Physician Decision|1|||
129671427|NCT02915835|466758337|FG001|Overall Study|Physician Decision|0|||
129671428|NCT02915835|466758336|FG000|Overall Study|Withdrawal by Subject|0|||
129671429|NCT02915835|466758337|FG001|Overall Study|Withdrawal by Subject|1|||
129671430|NCT03722576|466758338|FG000|Overall Study|Withdrawal by Subject|3|||
129671431|NCT03722576|466758338|FG000|Overall Study|Adverse Event|2|||
129671432|NCT03722576|466758338|FG000|Overall Study|Physician Decision|1|||
129671433|NCT03722576|466758338|FG000|Overall Study|Lost to Follow-up|1|||
129671434|NCT02513550|466758341|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
129671435|NCT02513550|466758342|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
129671436|NCT02513550|466758343|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
129671437|NCT02513550|466758344|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
129671438|NCT02513550|466758345|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
129671439|NCT02513550|466758346|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
129671440|NCT02513550|466758341|FG000|Double Blind Treatment Period|Adverse Event|5|||
129671441|NCT02513550|466758342|FG001|Double Blind Treatment Period|Adverse Event|13|||
129671442|NCT02513550|466758343|FG002|Double Blind Treatment Period|Adverse Event|17|||
129671443|NCT02513550|466758344|FG003|Double Blind Treatment Period|Adverse Event|0|||
129671444|NCT02513550|466758345|FG004|Double Blind Treatment Period|Adverse Event|1|||
129671445|NCT02513550|466758346|FG005|Double Blind Treatment Period|Adverse Event|0|||
129671446|NCT02513550|466758341|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
129671447|NCT02513550|466758342|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
129671448|NCT02513550|466758343|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
129671449|NCT02513550|466758344|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
129671450|NCT02513550|466758345|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
129884385|NCT00708305|467536384|FG001|Period 2|Protocol Violation|1|||
129671451|NCT02513550|466758346|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
129671452|NCT02513550|466758341|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
129671453|NCT02513550|466758342|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
129671454|NCT02513550|466758343|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
129671455|NCT02513550|466758344|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
129671456|NCT02513550|466758345|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
129671457|NCT02513550|466758346|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
129671458|NCT02513550|466758341|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129671459|NCT02513550|466758342|FG001|Double Blind Treatment Period|Protocol Violation|1|||
129671460|NCT02513550|466758343|FG002|Double Blind Treatment Period|Protocol Violation|4|||
129671461|NCT02513550|466758344|FG003|Double Blind Treatment Period|Protocol Violation|0|||
129671462|NCT02513550|466758345|FG004|Double Blind Treatment Period|Protocol Violation|0|||
129671463|NCT02513550|466758346|FG005|Double Blind Treatment Period|Protocol Violation|0|||
129671464|NCT02513550|466758341|FG000|Double Blind Treatment Period|Physician Decision|2|||
129671465|NCT02513550|466758342|FG001|Double Blind Treatment Period|Physician Decision|0|||
129671466|NCT02513550|466758343|FG002|Double Blind Treatment Period|Physician Decision|4|||
129671467|NCT02513550|466758344|FG003|Double Blind Treatment Period|Physician Decision|0|||
129671468|NCT02513550|466758345|FG004|Double Blind Treatment Period|Physician Decision|0|||
129671469|NCT02513550|466758346|FG005|Double Blind Treatment Period|Physician Decision|0|||
129671470|NCT02513550|466758341|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
129671471|NCT02513550|466758342|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
129671472|NCT02513550|466758343|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
129671473|NCT02513550|466758344|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
129671474|NCT02513550|466758345|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
129671475|NCT02513550|466758346|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
129671476|NCT02513550|466758341|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129671477|NCT02513550|466758342|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129671478|NCT02513550|466758343|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
129671479|NCT02513550|466758344|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129671480|NCT02513550|466758345|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129671481|NCT02513550|466758346|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
129671482|NCT02513550|466758341|FG000|Double Blind Treatment Period|Due to personal business|2|||
129671483|NCT02513550|466758342|FG001|Double Blind Treatment Period|Due to personal business|0|||
129671484|NCT02513550|466758343|FG002|Double Blind Treatment Period|Due to personal business|1|||
129671485|NCT02513550|466758344|FG003|Double Blind Treatment Period|Due to personal business|0|||
129671486|NCT02513550|466758345|FG004|Double Blind Treatment Period|Due to personal business|0|||
129671487|NCT02513550|466758346|FG005|Double Blind Treatment Period|Due to personal business|0|||
129671488|NCT02513550|466758341|FG000|Double Blind Treatment Period|Death|1|||
129671489|NCT02513550|466758342|FG001|Double Blind Treatment Period|Death|0|||
129671490|NCT02513550|466758343|FG002|Double Blind Treatment Period|Death|2|||
129671491|NCT02513550|466758344|FG003|Double Blind Treatment Period|Death|0|||
129671492|NCT02513550|466758345|FG004|Double Blind Treatment Period|Death|0|||
129671493|NCT02513550|466758346|FG005|Double Blind Treatment Period|Death|0|||
129671494|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
129671495|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
129671496|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
129671497|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129671498|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129671499|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
129671500|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
129671501|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
129671502|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
129671503|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
129671504|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
129671505|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
129671506|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
129671507|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
129671508|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
129671509|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129671510|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129671511|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
129671512|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
129671513|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
129671514|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
129671515|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
129671516|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
129671517|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
129671518|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
129671519|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
129671520|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
129671521|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
129671522|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
129671523|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
129671524|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Death|0|||
129671525|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Death|0|||
129671526|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Death|1|||
129671527|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Death|0|||
129671528|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Death|0|||
129671529|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Death|0|||
129671530|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
129671531|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
129671532|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
129671533|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
129671534|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
129671535|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
129671536|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129671537|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129671538|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
129671539|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129671540|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129671541|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
129671542|NCT02513550|466758341|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
129671543|NCT02513550|466758342|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
129671544|NCT02513550|466758343|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
129671545|NCT02513550|466758344|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
129671546|NCT02513550|466758345|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
129671547|NCT02513550|466758346|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
129671548|NCT00192114|466758350|FG000|Overall Study|Objective Tumor Progression|19|||
129671549|NCT00192114|466758350|FG000|Overall Study|Adverse Event|2|||
129671550|NCT00192114|466758350|FG000|Overall Study|Clinical Progression|2|||
129671551|NCT00192114|466758350|FG000|Overall Study|Death|1|||
129671552|NCT00492297|466758351|FG000|Treatment|Death|2|||
129671553|NCT00492297|466758351|FG000|Treatment|Study terminated by sponsor|3|||
129671554|NCT00492297|466758351|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
129671555|NCT00492297|466758351|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
129671556|NCT00492297|466758351|FG000|Survival Only Follow-up|Death|46|||
129671557|NCT00492297|466758351|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
129671558|NCT00492297|466758351|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
129671559|NCT01408706|466758353|FG000|Overall Study|Physician Decision|1|||
129671560|NCT01408706|466758354|FG001|Overall Study|Physician Decision|0|||
129671561|NCT00113607|466758355|FG000|Overall Study|Adverse Event|40|||
129671562|NCT00113607|466758356|FG001|Overall Study|Adverse Event|71|||
129671563|NCT00113607|466758355|FG000|Overall Study|Death|8|||
129671564|NCT00113607|466758356|FG001|Overall Study|Death|8|||
129671565|NCT00113607|466758355|FG000|Overall Study|Withdrawal by Subject|50|||
129671566|NCT00113607|466758356|FG001|Overall Study|Withdrawal by Subject|58|||
129671567|NCT00113607|466758355|FG000|Overall Study|Lost to Follow-up|0|||
129671568|NCT00113607|466758356|FG001|Overall Study|Lost to Follow-up|2|||
129671569|NCT00113607|466758355|FG000|Overall Study|Disease Progression|180|||
129671570|NCT00113607|466758356|FG001|Overall Study|Disease Progression|142|||
129671571|NCT00113607|466758355|FG000|Overall Study|Complete Response (Confirmed)|14|||
129671572|NCT00113607|466758356|FG001|Overall Study|Complete Response (Confirmed)|24|||
129671573|NCT00113607|466758355|FG000|Overall Study|Other|43|||
129671574|NCT00113607|466758356|FG001|Overall Study|Other|32|||
129671575|NCT01222104|466758357|FG000|Overall Study|Lost to Follow-up|37|||
129671576|NCT01222104|466758357|FG000|Overall Study|Death|10|||
129671577|NCT01418339|466758359|FG000|Overall Study|Adverse Event|5|||
129671578|NCT01418339|466758360|FG001|Overall Study|Adverse Event|2|||
129671579|NCT01418339|466758359|FG000|Overall Study|Subject Withdrew Consent|1|||
129671580|NCT01418339|466758360|FG001|Overall Study|Subject Withdrew Consent|2|||
129671581|NCT01418339|466758359|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
129671582|NCT01418339|466758360|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
129671583|NCT03885908|466758361|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
129671584|NCT03885908|466758362|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
129671585|NCT03885908|466758361|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
129671586|NCT03885908|466758362|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
129671587|NCT03885908|466758361|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
129671588|NCT03885908|466758362|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
129671589|NCT03885908|466758361|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
129671590|NCT03885908|466758362|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
129671591|NCT02204917|466758363|FG000|Overall Study|Protocol Violation|1|||
129671592|NCT03669549|466758364|FG000|Overall Study|Adverse Event|4|||
129671593|NCT03669549|466758364|FG000|Overall Study|Withdrawal by Subject|1|||
129671594|NCT03669549|466758364|FG000|Overall Study|Study terminated by the Sponsor|1|||
129671595|NCT00909844|466758365|FG000|Overall Study|Adverse Event|1|||
129671596|NCT00909844|466758365|FG000|Overall Study|Withdrawal by Subject|1|||
129671597|NCT00909844|466758365|FG000|Overall Study|Lost to Follow-up|2|||
129671598|NCT00698815|466758366|FG000|Overall Study|Death|1|||
129671599|NCT00698815|466758367|FG001|Overall Study|Death|2|||
129671600|NCT00698815|466758368|FG002|Overall Study|Death|4|||
129671601|NCT00698815|466758366|FG000|Overall Study|Withdrawal by Subject|6|||
129671602|NCT00698815|466758367|FG001|Overall Study|Withdrawal by Subject|3|||
129671603|NCT00698815|466758368|FG002|Overall Study|Withdrawal by Subject|2|||
129671604|NCT00698815|466758366|FG000|Overall Study|MD discretion|2|||
129671605|NCT00698815|466758367|FG001|Overall Study|MD discretion|7|||
129671606|NCT00698815|466758368|FG002|Overall Study|MD discretion|2|||
129671607|NCT00698815|466758366|FG000|Overall Study|Did not receive protocol treatment|1|||
129671608|NCT00698815|466758367|FG001|Overall Study|Did not receive protocol treatment|2|||
129671609|NCT00698815|466758368|FG002|Overall Study|Did not receive protocol treatment|2|||
129671610|NCT00706004|466758369|FG000|Overall Study|Did not meet eligibility criteria|2|||
129671611|NCT01064479|466758370|FG000|Overall Study|Death|10|||
129671612|NCT01064479|466758371|FG001|Overall Study|Death|11|||
129671613|NCT01064479|466758370|FG000|Overall Study|Withdrawal by Subject|2|||
129671614|NCT01064479|466758371|FG001|Overall Study|Withdrawal by Subject|2|||
129671615|NCT01064479|466758370|FG000|Overall Study|Disease progression|1|||
129671616|NCT01064479|466758371|FG001|Overall Study|Disease progression|1|||
129671617|NCT01064479|466758370|FG000|Overall Study|Toxicity|1|||
129671618|NCT01064479|466758371|FG001|Overall Study|Toxicity|1|||
129671619|NCT01064479|466758370|FG000|Overall Study|Other|1|||
129671620|NCT01064479|466758371|FG001|Overall Study|Other|2|||
129671621|NCT01663402|466758376|FG000|Overall Study|Randomized but not treated|19|||
129671622|NCT01663402|466758377|FG001|Overall Study|Randomized but not treated|11|||
129671623|NCT01663402|466758376|FG000|Overall Study|Adverse Event|347|||
129671624|NCT01663402|466758377|FG001|Overall Study|Adverse Event|362|||
129671625|NCT01663402|466758376|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
129671626|NCT01663402|466758377|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
129671627|NCT01663402|466758376|FG000|Overall Study|Poor compliance to protocol|529|||
129671628|NCT01663402|466758377|FG001|Overall Study|Poor compliance to protocol|454|||
129671629|NCT01663402|466758376|FG000|Overall Study|Physician Decision|77|||
129671630|NCT01663402|466758377|FG001|Overall Study|Physician Decision|62|||
129671631|NCT01663402|466758376|FG000|Overall Study|Site terminated by sponsor|1|||
129671632|NCT01663402|466758377|FG001|Overall Study|Site terminated by sponsor|3|||
129671633|NCT01663402|466758376|FG000|Overall Study|Participant moved|139|||
129671634|NCT01663402|466758377|FG001|Overall Study|Participant moved|104|||
129671635|NCT01663402|466758376|FG000|Overall Study|Withdrawal by Subject|118|||
129671636|NCT01663402|466758377|FG001|Overall Study|Withdrawal by Subject|91|||
129671637|NCT01663402|466758376|FG000|Overall Study|Related to study drug administration|96|||
129671638|NCT01663402|466758377|FG001|Overall Study|Related to study drug administration|105|||
129671639|NCT01663402|466758376|FG000|Overall Study|Lost to Follow-up|17|||
129671640|NCT01663402|466758377|FG001|Overall Study|Lost to Follow-up|15|||
129671641|NCT01663402|466758376|FG000|Overall Study|Other than specified above|172|||
129671642|NCT01663402|466758377|FG001|Overall Study|Other than specified above|147|||
129671643|NCT02984982|466758391|FG000|Overall Study|Adverse Event|2|||
129671644|NCT02984982|466758392|FG001|Overall Study|Adverse Event|5|||
129671645|NCT02984982|466758391|FG000|Overall Study|Poor Compliance to Protocol|4|||
129671646|NCT02984982|466758392|FG001|Overall Study|Poor Compliance to Protocol|4|||
129671647|NCT02984982|466758391|FG000|Overall Study|Withdrawal by Subject|2|||
129671648|NCT02984982|466758392|FG001|Overall Study|Withdrawal by Subject|0|||
129671649|NCT02984982|466758391|FG000|Overall Study|Randomized but not treated|0|||
129671650|NCT02984982|466758392|FG001|Overall Study|Randomized but not treated|1|||
129671651|NCT01747499|466758394|FG000|Overall Study|Steroid refractory aGvHD|1|||
129671652|NCT01747499|466758395|FG001|Overall Study|Steroid refractory aGvHD|0|||
129671653|NCT01747499|466758396|FG002|Overall Study|Steroid refractory aGvHD|0|||
129671654|NCT01747499|466758397|FG003|Overall Study|Steroid refractory aGvHD|1|||
129671655|NCT01747499|466758398|FG004|Overall Study|Steroid refractory aGvHD|4|||
129671656|NCT01747499|466758394|FG000|Overall Study|Physician Decision|0|||
129671657|NCT01747499|466758395|FG001|Overall Study|Physician Decision|1|||
129671658|NCT01747499|466758396|FG002|Overall Study|Physician Decision|0|||
129671659|NCT01747499|466758397|FG003|Overall Study|Physician Decision|0|||
129671660|NCT01747499|466758398|FG004|Overall Study|Physician Decision|2|||
129671661|NCT01747499|466758394|FG000|Overall Study|Death|0|||
129671662|NCT01747499|466758395|FG001|Overall Study|Death|0|||
129671663|NCT01747499|466758396|FG002|Overall Study|Death|0|||
129671664|NCT01747499|466758397|FG003|Overall Study|Death|1|||
129671665|NCT01747499|466758398|FG004|Overall Study|Death|1|||
129671666|NCT01747499|466758394|FG000|Overall Study|Withdrawal by Subject|0|||
129671667|NCT01747499|466758395|FG001|Overall Study|Withdrawal by Subject|0|||
129671668|NCT01747499|466758396|FG002|Overall Study|Withdrawal by Subject|0|||
129671669|NCT01747499|466758397|FG003|Overall Study|Withdrawal by Subject|0|||
129671670|NCT01747499|466758398|FG004|Overall Study|Withdrawal by Subject|6|||
129671671|NCT01747499|466758394|FG000|Overall Study|Developed AML and death|0|||
129671672|NCT01747499|466758395|FG001|Overall Study|Developed AML and death|0|||
129671673|NCT01747499|466758396|FG002|Overall Study|Developed AML and death|0|||
129671674|NCT01747499|466758397|FG003|Overall Study|Developed AML and death|0|||
129671675|NCT01747499|466758398|FG004|Overall Study|Developed AML and death|1|||
129671676|NCT01747499|466758394|FG000|Overall Study|Determined not to be eligible|0|||
129671677|NCT01747499|466758395|FG001|Overall Study|Determined not to be eligible|0|||
129671678|NCT01747499|466758396|FG002|Overall Study|Determined not to be eligible|0|||
129671679|NCT01747499|466758397|FG003|Overall Study|Determined not to be eligible|0|||
129671680|NCT01747499|466758398|FG004|Overall Study|Determined not to be eligible|1|||
129671681|NCT01103323|466758399|FG000|Without/Before Drug Switch|Adverse Event|50|||
129671682|NCT01103323|466758400|FG001|Without/Before Drug Switch|Adverse Event|7|||
129671683|NCT01103323|466758399|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
129671684|NCT01103323|466758400|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
129671685|NCT01103323|466758399|FG000|Without/Before Drug Switch|Protocol Violation|2|||
129671686|NCT01103323|466758400|FG001|Without/Before Drug Switch|Protocol Violation|0|||
129671687|NCT01103323|466758399|FG000|Without/Before Drug Switch|Physician Decision|2|||
129671688|NCT01103323|466758400|FG001|Without/Before Drug Switch|Physician Decision|0|||
129671689|NCT01103323|466758399|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
129671690|NCT01103323|466758400|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
129671691|NCT01103323|466758399|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
129671692|NCT01103323|466758400|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
129671693|NCT01103323|466758399|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
129671694|NCT01103323|466758400|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
129671695|NCT03160716|466758402|FG000|Overall Study|Lost to Follow-up|1|||
129671696|NCT00875810|466758406|FG000|Overall Study|Withdrawal by Subject|1|||
129671697|NCT00875810|466758406|FG000|Overall Study|Physician Decision|3|||
129671698|NCT00875810|466758406|FG000|Overall Study|Lost to Follow-up|39|||
129671699|NCT00875810|466758406|FG000|Overall Study|Patient enroled but not implanted|2|||
129671700|NCT00875810|466758406|FG000|Overall Study|Device explanted|1|||
129671701|NCT00780975|466758409|FG000|Overall Study|Progressive disease|3|||
129671702|NCT00780975|466758409|FG000|Overall Study|Toxicity|5|||
129671703|NCT01939314|466758410|FG000|Overall Study|Withdrawal by Subject|3|||
129671704|NCT01939314|466758411|FG001|Overall Study|Withdrawal by Subject|1|||
129671705|NCT01939314|466758410|FG000|Overall Study|Protocol Violation|1|||
129671706|NCT01939314|466758411|FG001|Overall Study|Protocol Violation|0|||
129671707|NCT01939314|466758410|FG000|Overall Study|Pregnancy|0|||
129671708|NCT01939314|466758411|FG001|Overall Study|Pregnancy|1|||
129671709|NCT01939314|466758410|FG000|Overall Study|Lost to Follow-up|5|||
129671710|NCT01939314|466758411|FG001|Overall Study|Lost to Follow-up|6|||
129671711|NCT00969228|466758415|FG000|Overall Study|Adverse Event|1|||
129671712|NCT00969228|466758416|FG001|Overall Study|Adverse Event|0|||
129671713|NCT00969228|466758415|FG000|Overall Study|Withdrawal by Subject|4|||
129671714|NCT00969228|466758416|FG001|Overall Study|Withdrawal by Subject|0|||
129671715|NCT00969228|466758415|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
129671716|NCT00969228|466758416|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
129671717|NCT02563899|466758417|FG000|Overall Study|Protocol Violation|1|||
129671718|NCT02563899|466758418|FG001|Overall Study|Protocol Violation|0|||
129671719|NCT02563899|466758419|FG002|Overall Study|Protocol Violation|0|||
129671720|NCT02563899|466758420|FG003|Overall Study|Protocol Violation|0|||
129671721|NCT02563899|466758417|FG000|Overall Study|Withdrawal by Subject|0|||
129671722|NCT02563899|466758418|FG001|Overall Study|Withdrawal by Subject|0|||
129671723|NCT02563899|466758419|FG002|Overall Study|Withdrawal by Subject|1|||
129671724|NCT02563899|466758420|FG003|Overall Study|Withdrawal by Subject|0|||
129671725|NCT00794664|466758421|FG000|Treatment Period|Withdrawal by Subject|0|||
129671726|NCT00794664|466758422|FG001|Treatment Period|Withdrawal by Subject|2|||
129671727|NCT00794664|466758421|FG000|Treatment Period|Protocol non-compliance|0|||
129671728|NCT00794664|466758422|FG001|Treatment Period|Protocol non-compliance|1|||
129671729|NCT00794664|466758421|FG000|Treatment Period|Other|0|||
129671730|NCT00794664|466758422|FG001|Treatment Period|Other|1|||
129671731|NCT00794664|466758421|FG000|Treatment Period|Adverse Event|1|||
129671732|NCT00794664|466758422|FG001|Treatment Period|Adverse Event|8|||
129671733|NCT00794664|466758421|FG000|Follow-up Period|Other|1|||
129671734|NCT00794664|466758422|FG001|Follow-up Period|Other|2|||
129671735|NCT00794664|466758421|FG000|Follow-up Period|Withdrawal by Subject|0|||
129671736|NCT00794664|466758422|FG001|Follow-up Period|Withdrawal by Subject|2|||
129671737|NCT00794664|466758421|FG000|Follow-up Period|Protocol non-compliance|0|||
129671738|NCT00794664|466758422|FG001|Follow-up Period|Protocol non-compliance|1|||
129671739|NCT01305564|466758425|FG000|Overall Study|Death|21|||
129671740|NCT01305564|466758425|FG000|Overall Study|Lost to Follow-up|12|||
129671741|NCT01305564|466758425|FG000|Overall Study|Withdrawal by Subject|1|||
129671742|NCT01305564|466758425|FG000|Overall Study|Physician Decision|3|||
129671743|NCT01814007|466758432|FG000|Overall Study|Withdrawal by Subject|1|||
129671744|NCT01655901|466760810|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129671745|NCT01655901|466760811|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129671746|NCT01655901|466760812|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129671747|NCT01655901|466760813|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
129671748|NCT01655901|466760814|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
129671749|NCT01655901|466760815|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
129671750|NCT00922636|466760818|FG000|Overall Study|Adverse Event|3|||
129671751|NCT00922636|466760819|FG001|Overall Study|Adverse Event|3|||
129671752|NCT00922636|466760820|FG002|Overall Study|Adverse Event|2|||
129671753|NCT00922636|466760821|FG003|Overall Study|Adverse Event|3|||
129671754|NCT00922636|466760822|FG004|Overall Study|Adverse Event|2|||
129671755|NCT00922636|466760818|FG000|Overall Study|Lack of Efficacy|1|||
129671756|NCT00922636|466760819|FG001|Overall Study|Lack of Efficacy|7|||
129671757|NCT00922636|466760820|FG002|Overall Study|Lack of Efficacy|3|||
129671758|NCT00922636|466760821|FG003|Overall Study|Lack of Efficacy|2|||
129671759|NCT00922636|466760822|FG004|Overall Study|Lack of Efficacy|4|||
129671760|NCT00922636|466760818|FG000|Overall Study|Sponsor Decision|0|||
129671761|NCT00922636|466760819|FG001|Overall Study|Sponsor Decision|0|||
129671762|NCT00922636|466760820|FG002|Overall Study|Sponsor Decision|2|||
129671763|NCT00922636|466760821|FG003|Overall Study|Sponsor Decision|0|||
129647171|NCT00347919|466663812|FG000|Overall Study|Death|35|||
129647172|NCT00347919|466663813|FG001|Overall Study|Death|42|||
129647173|NCT00347919|466663814|FG002|Overall Study|Death|19|||
129647174|NCT00347919|466663812|FG000|Overall Study|Par. Started Other Treatment|1|||
129647175|NCT00347919|466663813|FG001|Overall Study|Par. Started Other Treatment|1|||
129647176|NCT00347919|466663814|FG002|Overall Study|Par. Started Other Treatment|1|||
129647177|NCT00347919|466663812|FG000|Overall Study|Missing|2|||
129647178|NCT00347919|466663813|FG001|Overall Study|Missing|1|||
129647179|NCT00347919|466663814|FG002|Overall Study|Missing|2|||
129647180|NCT01382225|466663824|FG000|Overall Study|Adverse Event|3|||
129647181|NCT01382225|466663825|FG001|Overall Study|Adverse Event|2|||
129647182|NCT01382225|466663824|FG000|Overall Study|Protocol Violation|2|||
129647183|NCT01382225|466663825|FG001|Overall Study|Protocol Violation|1|||
129647184|NCT01382225|466663824|FG000|Overall Study|Subject Withdrew Consent|5|||
129647185|NCT01382225|466663825|FG001|Overall Study|Subject Withdrew Consent|2|||
129647186|NCT01382225|466663824|FG000|Overall Study|Other|4|||
129647187|NCT01382225|466663825|FG001|Overall Study|Other|2|||
129647188|NCT02294175|466663834|FG000|Overall Study|Withdrawal by Subject|1|||
129647189|NCT02294175|466663835|FG001|Overall Study|Withdrawal by Subject|2|||
129647190|NCT02294175|466663834|FG000|Overall Study|pt taking excluded medication|3|||
129647191|NCT02294175|466663835|FG001|Overall Study|pt taking excluded medication|1|||
129647192|NCT02294175|466663834|FG000|Overall Study|Protocol Violation|1|||
129647193|NCT02294175|466663835|FG001|Overall Study|Protocol Violation|0|||
129647194|NCT02294175|466663834|FG000|Overall Study|Lost to Follow-up|0|||
129671764|NCT00922636|466760822|FG004|Overall Study|Sponsor Decision|0|||
129671765|NCT00922636|466760818|FG000|Overall Study|Withdrawal by Subject|0|||
129671766|NCT00922636|466760819|FG001|Overall Study|Withdrawal by Subject|0|||
129671767|NCT00922636|466760820|FG002|Overall Study|Withdrawal by Subject|5|||
129671768|NCT00922636|466760821|FG003|Overall Study|Withdrawal by Subject|2|||
129671769|NCT00922636|466760822|FG004|Overall Study|Withdrawal by Subject|4|||
129671770|NCT00922636|466760818|FG000|Overall Study|Protocol Violation|0|||
129671771|NCT00922636|466760819|FG001|Overall Study|Protocol Violation|0|||
129671772|NCT00922636|466760820|FG002|Overall Study|Protocol Violation|2|||
129671773|NCT00922636|466760821|FG003|Overall Study|Protocol Violation|2|||
129671774|NCT00922636|466760822|FG004|Overall Study|Protocol Violation|0|||
129671775|NCT00922636|466760818|FG000|Overall Study|Entry Criteria Not Met|0|||
129671776|NCT00922636|466760819|FG001|Overall Study|Entry Criteria Not Met|0|||
129671777|NCT00922636|466760820|FG002|Overall Study|Entry Criteria Not Met|1|||
129671778|NCT00922636|466760821|FG003|Overall Study|Entry Criteria Not Met|1|||
129671779|NCT00922636|466760822|FG004|Overall Study|Entry Criteria Not Met|0|||
129671780|NCT00922636|466760818|FG000|Overall Study|Parent/Caregiver Decision|2|||
129671781|NCT00922636|466760819|FG001|Overall Study|Parent/Caregiver Decision|4|||
129671782|NCT00922636|466760820|FG002|Overall Study|Parent/Caregiver Decision|3|||
129671783|NCT00922636|466760821|FG003|Overall Study|Parent/Caregiver Decision|5|||
129671784|NCT00922636|466760822|FG004|Overall Study|Parent/Caregiver Decision|2|||
129671785|NCT00922636|466760818|FG000|Overall Study|Lost to Follow-up|1|||
129671786|NCT00922636|466760819|FG001|Overall Study|Lost to Follow-up|2|||
129671787|NCT00922636|466760820|FG002|Overall Study|Lost to Follow-up|2|||
129671788|NCT00922636|466760821|FG003|Overall Study|Lost to Follow-up|2|||
129671789|NCT00922636|466760822|FG004|Overall Study|Lost to Follow-up|4|||
129671790|NCT04969289|466760823|FG000|Overall Study|Lost to Follow-up|13|||
129671791|NCT04969289|466760824|FG001|Overall Study|Lost to Follow-up|9|||
129671792|NCT00557466|466760825|FG000|Overall Study|Adverse Event|3|||
129671793|NCT00557466|466760826|FG001|Overall Study|Adverse Event|1|||
129671794|NCT00557466|466760827|FG002|Overall Study|Adverse Event|4|||
129671795|NCT00557466|466760828|FG003|Overall Study|Adverse Event|1|||
129671796|NCT00557466|466760829|FG004|Overall Study|Adverse Event|2|||
129671797|NCT00557466|466760830|FG005|Overall Study|Adverse Event|4|||
129671798|NCT00557466|466760825|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129671799|NCT00557466|466760826|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129671800|NCT00557466|466760827|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129671801|NCT00557466|466760828|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129671802|NCT00557466|466760829|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129671803|NCT00557466|466760830|FG005|Overall Study|Abnormal laboratory value(s)|0|||
129671804|NCT00557466|466760825|FG000|Overall Study|Protocol deviation|0|||
129671805|NCT00557466|466760826|FG001|Overall Study|Protocol deviation|1|||
129671806|NCT00557466|466760827|FG002|Overall Study|Protocol deviation|0|||
129671807|NCT00557466|466760828|FG003|Overall Study|Protocol deviation|2|||
129671808|NCT00557466|466760829|FG004|Overall Study|Protocol deviation|0|||
129671809|NCT00557466|466760830|FG005|Overall Study|Protocol deviation|0|||
129671810|NCT00557466|466760825|FG000|Overall Study|Subject withdrew consent|0|||
129671811|NCT00557466|466760826|FG001|Overall Study|Subject withdrew consent|0|||
129671812|NCT00557466|466760827|FG002|Overall Study|Subject withdrew consent|0|||
129671813|NCT00557466|466760828|FG003|Overall Study|Subject withdrew consent|0|||
129671814|NCT00557466|466760829|FG004|Overall Study|Subject withdrew consent|1|||
129671815|NCT00557466|466760830|FG005|Overall Study|Subject withdrew consent|2|||
129671816|NCT00557466|466760825|FG000|Overall Study|Administrative problems|0|||
129671817|NCT00557466|466760826|FG001|Overall Study|Administrative problems|1|||
129671818|NCT00557466|466760827|FG002|Overall Study|Administrative problems|1|||
129671819|NCT00557466|466760828|FG003|Overall Study|Administrative problems|0|||
129671820|NCT00557466|466760829|FG004|Overall Study|Administrative problems|0|||
129671821|NCT00557466|466760830|FG005|Overall Study|Administrative problems|0|||
129671822|NCT00557466|466760825|FG000|Overall Study|Abnormal test procedure results|0|||
129671823|NCT00557466|466760826|FG001|Overall Study|Abnormal test procedure results|0|||
129671824|NCT00557466|466760827|FG002|Overall Study|Abnormal test procedure results|1|||
129671825|NCT00557466|466760828|FG003|Overall Study|Abnormal test procedure results|0|||
129671826|NCT00557466|466760829|FG004|Overall Study|Abnormal test procedure results|0|||
129671827|NCT00557466|466760830|FG005|Overall Study|Abnormal test procedure results|0|||
129671828|NCT00557466|466760825|FG000|Overall Study|Lost to Follow-up|0|||
129671829|NCT00557466|466760826|FG001|Overall Study|Lost to Follow-up|0|||
129671830|NCT00557466|466760827|FG002|Overall Study|Lost to Follow-up|0|||
129671831|NCT00557466|466760828|FG003|Overall Study|Lost to Follow-up|1|||
129671832|NCT00557466|466760829|FG004|Overall Study|Lost to Follow-up|0|||
129671833|NCT00557466|466760830|FG005|Overall Study|Lost to Follow-up|0|||
129671834|NCT01251952|466760833|FG000|Overall Study|Adverse Event|1|||
129671835|NCT00496769|466760834|FG000|Double Blind|>=1 reason assigned per patient|558|||
129671836|NCT00496769|466760835|FG001|Double Blind|>=1 reason assigned per patient|649|||
129671837|NCT00496769|466760836|FG002|Double Blind|>=1 reason assigned per patient|0|||
129671838|NCT00496769|466760834|FG000|Open Label|>=1 reason assigned per patient|0|||
129671839|NCT00496769|466760835|FG001|Open Label|>=1 reason assigned per patient|0|||
129671840|NCT00496769|466760836|FG002|Open Label|>=1 reason assigned per patient|1011|||
129671841|NCT02486692|466760837|FG000|Overall Study|did not login for randomization|4|||
129671842|NCT02486692|466760838|FG001|Overall Study|did not login for randomization|7|||
129671843|NCT02224625|466760841|FG000|Irritation|Adverse Event|6|||
129671844|NCT02224625|466760841|FG000|Sensitization|Adverse Event|55|||
129671845|NCT02812186|466760842|FG000|Period 1|Post randomization screen failure|5|||
129671846|NCT02812186|466760843|FG001|Period 1|Post randomization screen failure|9|||
129671847|NCT02812186|466760842|FG000|Period 1|nonevaluable data sets|6|||
129671848|NCT02812186|466760843|FG001|Period 1|nonevaluable data sets|6|||
129671849|NCT01307787|466760846|FG000|Overall Study|Withdrawal by Subject|2|||
129671850|NCT01307787|466760847|FG001|Overall Study|Withdrawal by Subject|0|||
129671851|NCT01573000|466760848|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
129671852|NCT01573000|466760849|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
129671853|NCT01573000|466760848|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
129671854|NCT01573000|466760849|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
129671855|NCT01573000|466760848|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
129671856|NCT01573000|466760849|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
129671857|NCT01573000|466760848|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
129671858|NCT01573000|466760849|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
129671859|NCT01573000|466760848|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
129671860|NCT01573000|466760849|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
129671861|NCT01573000|466760848|FG000|Crossover Phase|Lack of Efficacy|0|||
129671862|NCT01573000|466760849|FG001|Crossover Phase|Lack of Efficacy|13|||
129671863|NCT01573000|466760848|FG000|Crossover Phase|Lost to Follow-up|0|||
129671864|NCT01573000|466760849|FG001|Crossover Phase|Lost to Follow-up|2|||
129671865|NCT01573000|466760848|FG000|Crossover Phase|Death|0|||
129671866|NCT01573000|466760849|FG001|Crossover Phase|Death|3|||
129671867|NCT01573000|466760848|FG000|Long-Term Follow-Up|Death|3|||
129671868|NCT01573000|466760849|FG001|Long-Term Follow-Up|Death|0|||
129671869|NCT01573000|466760848|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
129671870|NCT01573000|466760849|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
129671871|NCT03353792|466760850|FG000|Overall Study|Lost to Follow-up|1|||
129671872|NCT03353792|466760851|FG001|Overall Study|Lost to Follow-up|0|||
129671873|NCT03353792|466760850|FG000|Overall Study|Participant Unable to Manage Device|1|||
129671874|NCT03353792|466760851|FG001|Overall Study|Participant Unable to Manage Device|0|||
129671875|NCT03342001|466760857|FG000|Overall Study|Adverse Event|1|||
129671876|NCT03342001|466760857|FG000|Overall Study|Lost to Follow-up|1|||
129671877|NCT01433159|466760859|FG000|Overall Study|Adverse Event|1|||
129671878|NCT01433159|466760860|FG001|Overall Study|Adverse Event|0|||
129671879|NCT01433159|466760859|FG000|Overall Study|Physician Decision|1|||
129671880|NCT01433159|466760860|FG001|Overall Study|Physician Decision|0|||
129671881|NCT01433159|466760859|FG000|Overall Study|Protocol Violation|0|||
129671882|NCT01433159|466760860|FG001|Overall Study|Protocol Violation|1|||
129671883|NCT01100853|466760861|FG000|Overall Study|Lost to Follow-up|11|||
129671884|NCT01100853|466760862|FG001|Overall Study|Lost to Follow-up|6|||
129671885|NCT01100853|466760861|FG000|Overall Study|Received <4 study injections|10|||
129671886|NCT01100853|466760862|FG001|Overall Study|Received <4 study injections|13|||
129671887|NCT01100853|466760861|FG000|Overall Study|Withdrawal by Subject|6|||
129671888|NCT01100853|466760862|FG001|Overall Study|Withdrawal by Subject|4|||
129671889|NCT04161391|466760865|FG000|Overall Study|Adverse Event|0|||
129671890|NCT04161391|466760866|FG001|Overall Study|Adverse Event|1|||
129671891|NCT04161391|466760867|FG002|Overall Study|Adverse Event|0|||
129671892|NCT04161391|466760868|FG003|Overall Study|Adverse Event|1|||
129671893|NCT04161391|466760869|FG004|Overall Study|Adverse Event|0|||
129671894|NCT04161391|466760870|FG005|Overall Study|Adverse Event|0|||
129671895|NCT04161391|466760871|FG006|Overall Study|Adverse Event|0|||
129671896|NCT04161391|466760872|FG007|Overall Study|Adverse Event|3|||
129671897|NCT04161391|466760873|FG008|Overall Study|Adverse Event|0|||
129671898|NCT04161391|466760865|FG000|Overall Study|Death|0|||
129671899|NCT04161391|466760866|FG001|Overall Study|Death|0|||
129671900|NCT04161391|466760867|FG002|Overall Study|Death|0|||
129671901|NCT04161391|466760868|FG003|Overall Study|Death|0|||
129671902|NCT04161391|466760869|FG004|Overall Study|Death|0|||
129671903|NCT04161391|466760870|FG005|Overall Study|Death|0|||
129671904|NCT04161391|466760871|FG006|Overall Study|Death|0|||
129671905|NCT04161391|466760872|FG007|Overall Study|Death|1|||
129671906|NCT04161391|466760873|FG008|Overall Study|Death|0|||
129671907|NCT04161391|466760865|FG000|Overall Study|Physician Decision|0|||
129671908|NCT04161391|466760866|FG001|Overall Study|Physician Decision|0|||
129671909|NCT04161391|466760867|FG002|Overall Study|Physician Decision|1|||
129671910|NCT04161391|466760868|FG003|Overall Study|Physician Decision|2|||
129671911|NCT04161391|466760869|FG004|Overall Study|Physician Decision|0|||
129671912|NCT04161391|466760870|FG005|Overall Study|Physician Decision|0|||
129671913|NCT04161391|466760871|FG006|Overall Study|Physician Decision|2|||
129671914|NCT04161391|466760872|FG007|Overall Study|Physician Decision|0|||
129671915|NCT04161391|466760873|FG008|Overall Study|Physician Decision|0|||
129671916|NCT04161391|466760865|FG000|Overall Study|Progressive Disease|4|||
129671917|NCT04161391|466760866|FG001|Overall Study|Progressive Disease|3|||
129671918|NCT04161391|466760867|FG002|Overall Study|Progressive Disease|3|||
129671919|NCT04161391|466760868|FG003|Overall Study|Progressive Disease|5|||
129671920|NCT04161391|466760869|FG004|Overall Study|Progressive Disease|3|||
129671921|NCT04161391|466760870|FG005|Overall Study|Progressive Disease|3|||
129671922|NCT04161391|466760871|FG006|Overall Study|Progressive Disease|5|||
129671923|NCT04161391|466760872|FG007|Overall Study|Progressive Disease|2|||
129671924|NCT04161391|466760873|FG008|Overall Study|Progressive Disease|2|||
129671925|NCT02579629|466760876|FG000|Overall Study|Withdrawal by Subject|0|||
129671926|NCT02579629|466760877|FG001|Overall Study|Withdrawal by Subject|1|||
129671927|NCT02579629|466760878|FG002|Overall Study|Withdrawal by Subject|0|||
129671928|NCT02579629|466760876|FG000|Overall Study|Screen Failure|2|||
129671929|NCT02579629|466760877|FG001|Overall Study|Screen Failure|0|||
129671930|NCT02579629|466760878|FG002|Overall Study|Screen Failure|2|||
129671931|NCT01190891|466760879|FG000|Overall Study|Protocol Violation|1|||
129671932|NCT01190891|466760880|FG001|Overall Study|Protocol Violation|0|||
129671933|NCT01190891|466760879|FG000|Overall Study|Withdrawal by Subject|5|||
129671934|NCT01190891|466760880|FG001|Overall Study|Withdrawal by Subject|0|||
129671935|NCT00266708|466760881|FG000|Overall Study|No renal function|1|||
129671936|NCT00266708|466760882|FG001|Overall Study|No renal function|1|||
129671937|NCT00266708|466760881|FG000|Overall Study|Refused biopsy|3|||
129671938|NCT00266708|466760882|FG001|Overall Study|Refused biopsy|6|||
129671939|NCT00266708|466760881|FG000|Overall Study|Asthma|0|||
129671940|NCT00266708|466760882|FG001|Overall Study|Asthma|2|||
129671941|NCT01926028|466760883|FG000|Overall Study|Lost to Follow-up|7|||
129671942|NCT01926028|466760884|FG001|Overall Study|Lost to Follow-up|6|||
129671943|NCT01926028|466760885|FG002|Overall Study|Lost to Follow-up|0|||
129671944|NCT01926028|466760883|FG000|Overall Study|Physician Decision|1|||
129671945|NCT01926028|466760884|FG001|Overall Study|Physician Decision|5|||
129671946|NCT01926028|466760885|FG002|Overall Study|Physician Decision|0|||
129671947|NCT01926028|466760883|FG000|Overall Study|Withdrawal by Subject|9|||
129671948|NCT01926028|466760884|FG001|Overall Study|Withdrawal by Subject|9|||
129671949|NCT01926028|466760885|FG002|Overall Study|Withdrawal by Subject|2|||
129671950|NCT01926028|466760883|FG000|Overall Study|Non compliance or other reasons|4|||
129671951|NCT01926028|466760884|FG001|Overall Study|Non compliance or other reasons|2|||
129671952|NCT01926028|466760885|FG002|Overall Study|Non compliance or other reasons|0|||
129671953|NCT01130272|466760886|FG000|Overall Study|Adverse Event|2|||
129671954|NCT01130272|466760887|FG001|Overall Study|Adverse Event|5|||
129671955|NCT01130272|466760888|FG002|Overall Study|Adverse Event|6|||
129671956|NCT01130272|466760889|FG003|Overall Study|Adverse Event|22|||
129671957|NCT01130272|466760890|FG004|Overall Study|Adverse Event|7|||
129671958|NCT01130272|466760886|FG000|Overall Study|IVRS-confirmed constipation|0|||
129671959|NCT01130272|466760887|FG001|Overall Study|IVRS-confirmed constipation|1|||
129671960|NCT01130272|466760888|FG002|Overall Study|IVRS-confirmed constipation|1|||
129671961|NCT01130272|466760889|FG003|Overall Study|IVRS-confirmed constipation|2|||
129671962|NCT01130272|466760890|FG004|Overall Study|IVRS-confirmed constipation|0|||
129671963|NCT01130272|466760886|FG000|Overall Study|Rescue medications due to diarrhea|3|||
129671964|NCT01130272|466760887|FG001|Overall Study|Rescue medications due to diarrhea|5|||
129671965|NCT01130272|466760888|FG002|Overall Study|Rescue medications due to diarrhea|8|||
129671966|NCT01130272|466760889|FG003|Overall Study|Rescue medications due to diarrhea|8|||
129671967|NCT01130272|466760890|FG004|Overall Study|Rescue medications due to diarrhea|6|||
129671968|NCT01130272|466760886|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
129671969|NCT01130272|466760887|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
129671970|NCT01130272|466760888|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
129671971|NCT01130272|466760889|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
129671972|NCT01130272|466760890|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
129671973|NCT01130272|466760886|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129884386|NCT00708305|467536385|FG002|Period 2|Protocol Violation|0|||
129671974|NCT01130272|466760887|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129671975|NCT01130272|466760888|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129671976|NCT01130272|466760889|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
129671977|NCT01130272|466760890|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
129671978|NCT01130272|466760886|FG000|Overall Study|Protocol Violation|0|||
129671979|NCT01130272|466760887|FG001|Overall Study|Protocol Violation|0|||
129671980|NCT01130272|466760888|FG002|Overall Study|Protocol Violation|3|||
129671981|NCT01130272|466760889|FG003|Overall Study|Protocol Violation|5|||
129671982|NCT01130272|466760890|FG004|Overall Study|Protocol Violation|5|||
129671983|NCT01130272|466760886|FG000|Overall Study|Lost to Follow-up|4|||
129671984|NCT01130272|466760887|FG001|Overall Study|Lost to Follow-up|3|||
129671985|NCT01130272|466760888|FG002|Overall Study|Lost to Follow-up|4|||
129671986|NCT01130272|466760889|FG003|Overall Study|Lost to Follow-up|7|||
129671987|NCT01130272|466760890|FG004|Overall Study|Lost to Follow-up|6|||
129671988|NCT01130272|466760886|FG000|Overall Study|Withdrawal by Subject|4|||
129671989|NCT01130272|466760887|FG001|Overall Study|Withdrawal by Subject|11|||
129671990|NCT01130272|466760888|FG002|Overall Study|Withdrawal by Subject|10|||
129671991|NCT01130272|466760889|FG003|Overall Study|Withdrawal by Subject|9|||
129671992|NCT01130272|466760890|FG004|Overall Study|Withdrawal by Subject|8|||
129671993|NCT01130272|466760886|FG000|Overall Study|Physician Decision|1|||
129671994|NCT01130272|466760887|FG001|Overall Study|Physician Decision|1|||
129671995|NCT01130272|466760888|FG002|Overall Study|Physician Decision|0|||
129671996|NCT01130272|466760889|FG003|Overall Study|Physician Decision|1|||
129671997|NCT01130272|466760890|FG004|Overall Study|Physician Decision|2|||
129671998|NCT01130272|466760886|FG000|Overall Study|Sponsor decision|6|||
129671999|NCT01130272|466760887|FG001|Overall Study|Sponsor decision|15|||
129672000|NCT01130272|466760888|FG002|Overall Study|Sponsor decision|16|||
129672001|NCT01130272|466760889|FG003|Overall Study|Sponsor decision|13|||
129672002|NCT01130272|466760890|FG004|Overall Study|Sponsor decision|16|||
129672003|NCT01130272|466760886|FG000|Overall Study|Study arm discontinued|38|||
129672004|NCT01130272|466760887|FG001|Overall Study|Study arm discontinued|0|||
129672005|NCT01130272|466760888|FG002|Overall Study|Study arm discontinued|0|||
129672006|NCT01130272|466760889|FG003|Overall Study|Study arm discontinued|0|||
129672007|NCT01130272|466760890|FG004|Overall Study|Study arm discontinued|0|||
129672008|NCT01548404|466760891|FG000|Overall Study|Adverse Event|3|||
129672009|NCT01548404|466760892|FG001|Overall Study|Adverse Event|1|||
129672010|NCT01548404|466760891|FG000|Overall Study|Physician Decision|2|||
129672011|NCT01548404|466760892|FG001|Overall Study|Physician Decision|1|||
129672012|NCT01548404|466760891|FG000|Overall Study|Inadequate response to study treatment|23|||
129672013|NCT01548404|466760892|FG001|Overall Study|Inadequate response to study treatment|7|||
129672014|NCT01548404|466760891|FG000|Overall Study|Lost to Follow-up|2|||
129672015|NCT01548404|466760892|FG001|Overall Study|Lost to Follow-up|0|||
129672016|NCT01548404|466760891|FG000|Overall Study|Withdrawal by Subject|0|||
129672017|NCT01548404|466760892|FG001|Overall Study|Withdrawal by Subject|3|||
129672018|NCT01548404|466760891|FG000|Overall Study|Other than specified above|0|||
129672019|NCT01548404|466760892|FG001|Overall Study|Other than specified above|2|||
129672020|NCT00737048|466760893|FG000|Overall Study|Physician Decision|0|||
129672021|NCT00737048|466760894|FG001|Overall Study|Physician Decision|0|||
129672022|NCT00737048|466760895|FG002|Overall Study|Physician Decision|1|||
129672023|NCT00737048|466760893|FG000|Overall Study|Adverse Event|0|||
129672024|NCT00737048|466760894|FG001|Overall Study|Adverse Event|1|||
129672025|NCT00737048|466760895|FG002|Overall Study|Adverse Event|0|||
129672026|NCT00737048|466760893|FG000|Overall Study|Worsening of the symptoms|3|||
129672027|NCT00737048|466760894|FG001|Overall Study|Worsening of the symptoms|5|||
129672028|NCT00737048|466760895|FG002|Overall Study|Worsening of the symptoms|3|||
129672029|NCT00641056|466760896|FG000|Overall Study|Adverse Event|12|||
129672030|NCT00641056|466760897|FG001|Overall Study|Adverse Event|2|||
129672031|NCT00641056|466760896|FG000|Overall Study|Lost to Follow-up|2|||
129672032|NCT00641056|466760897|FG001|Overall Study|Lost to Follow-up|1|||
129672033|NCT00641056|466760896|FG000|Overall Study|Physician Decision|3|||
129672034|NCT00641056|466760897|FG001|Overall Study|Physician Decision|1|||
129672035|NCT00641056|466760896|FG000|Overall Study|Protocol Violation|2|||
129672036|NCT00641056|466760897|FG001|Overall Study|Protocol Violation|0|||
129672037|NCT00641056|466760896|FG000|Overall Study|Entry Criteria Not Met|3|||
129672038|NCT00641056|466760897|FG001|Overall Study|Entry Criteria Not Met|0|||
129672039|NCT00641056|466760896|FG000|Overall Study|Subject Decision|6|||
129672040|NCT00641056|466760897|FG001|Overall Study|Subject Decision|19|||
129672041|NCT00641056|466760896|FG000|Overall Study|Sponsor Decision|1|||
129672042|NCT00641056|466760897|FG001|Overall Study|Sponsor Decision|2|||
129672043|NCT02351934|466760898|FG000|Allocation|POD weight<pre-op weight|3|||
129672044|NCT02351934|466760899|FG001|Allocation|POD weight<pre-op weight|0|||
129547150|NCT05013749|466296147|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
129672045|NCT02351934|466760898|FG000|Allocation|Hypotension preventing administration|2|||
129672046|NCT02351934|466760899|FG001|Allocation|Hypotension preventing administration|0|||
129672047|NCT02351934|466760898|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
129672048|NCT02351934|466760899|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
129672049|NCT02351934|466760898|FG000|Follow-Up|POD weight<pre-op weight|3|||
129672050|NCT02351934|466760899|FG001|Follow-Up|POD weight<pre-op weight|0|||
129672051|NCT02351934|466760898|FG000|Follow-Up|Acute Kidney Injury|1|||
129672052|NCT02351934|466760899|FG001|Follow-Up|Acute Kidney Injury|0|||
129672053|NCT02351934|466760898|FG000|Follow-Up|Early dismissal|3|||
129672054|NCT02351934|466760899|FG001|Follow-Up|Early dismissal|0|||
129672055|NCT02351934|466760898|FG000|Follow-Up|Hypotension|3|||
129672056|NCT02351934|466760899|FG001|Follow-Up|Hypotension|0|||
129672057|NCT02351934|466760898|FG000|Follow-Up|No documentation|2|||
129672058|NCT02351934|466760899|FG001|Follow-Up|No documentation|0|||
129672059|NCT02351934|466760898|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
129672060|NCT02351934|466760899|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
129672061|NCT02351934|466760898|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
129672062|NCT02351934|466760899|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
129672063|NCT00896493|466760900|FG000|Overall Study|Early disease relapse|3|||
129672064|NCT01739335|466760902|FG000|Overall Study|Lost to Follow-up|7|||
129672065|NCT01739335|466760903|FG001|Overall Study|Lost to Follow-up|4|||
129672066|NCT01739335|466760902|FG000|Overall Study|Ineligible patient randomized|0|||
129672067|NCT01739335|466760903|FG001|Overall Study|Ineligible patient randomized|1|||
129672068|NCT04040439|466760909|FG000|Overall Study|Invalid registration|11|||
129672069|NCT04040439|466760909|FG000|Overall Study|No IC* on publication of study results|2|||
129672070|NCT01309386|466760910|FG000|Overall Study|Other|2|||
129672071|NCT01309386|466760911|FG001|Overall Study|Other|0|||
129672072|NCT01309386|466760910|FG000|Overall Study|Withdrawal by Subject|2|||
129672073|NCT01309386|466760911|FG001|Overall Study|Withdrawal by Subject|0|||
129672074|NCT01309386|466760910|FG000|Overall Study|Progressive disease|9|||
129672075|NCT01309386|466760911|FG001|Overall Study|Progressive disease|11|||
129672076|NCT01309386|466760910|FG000|Overall Study|Physician Decision|1|||
129672077|NCT01309386|466760911|FG001|Overall Study|Physician Decision|1|||
129672078|NCT01309386|466760910|FG000|Overall Study|Lack of Efficacy|3|||
129672079|NCT01309386|466760911|FG001|Overall Study|Lack of Efficacy|1|||
129672080|NCT01309386|466760910|FG000|Overall Study|Adverse Event|5|||
129672081|NCT01309386|466760911|FG001|Overall Study|Adverse Event|8|||
129672082|NCT02062437|466760912|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
129672083|NCT02062437|466760912|FG000|Overall Study|Patient not available for the 2y visit|18|||
129672084|NCT02062437|466760912|FG000|Overall Study|Death|2|||
129672085|NCT02062437|466760912|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
129672086|NCT00752089|466760913|FG000|Overall Study|Adverse Event|1|||
129672087|NCT00752089|466760913|FG000|Overall Study|Protocol Deviation|2|||
129672088|NCT00752089|466760913|FG000|Overall Study|Could not attend visit 9|1|||
129672089|NCT00752089|466760913|FG000|Overall Study|Not capable of wearing partial denture|1|||
129672090|NCT00752089|466760913|FG000|Overall Study|Cannot continue the study|1|||
129672091|NCT01324102|466760914|FG000|Overall Study|illness|1|||
129672092|NCT01324102|466760915|FG001|Overall Study|illness|6|||
129672093|NCT00386334|466760920|FG000|Double Blind Period|Adverse Event|9|||
129672094|NCT00386334|466760921|FG001|Double Blind Period|Adverse Event|14|||
129672095|NCT00386334|466760920|FG000|Double Blind Period|Protocol Violation|1|||
129672096|NCT00386334|466760921|FG001|Double Blind Period|Protocol Violation|1|||
129672097|NCT00386334|466760920|FG000|Double Blind Period|Withdrawal by Subject|9|||
129672098|NCT00386334|466760921|FG001|Double Blind Period|Withdrawal by Subject|13|||
129672099|NCT00386334|466760920|FG000|Double Blind Period|Lack of Efficacy|20|||
129672100|NCT00386334|466760921|FG001|Double Blind Period|Lack of Efficacy|11|||
129672101|NCT00386334|466760920|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
129672102|NCT00386334|466760921|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
129672103|NCT00386334|466760920|FG000|Double Blind Period|Other|3|||
129672104|NCT00386334|466760921|FG001|Double Blind Period|Other|3|||
129672105|NCT00386334|466760920|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
129672106|NCT00386334|466760921|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
129672107|NCT00902577|466760924|FG000|Overall Study|Withdrawal by Subject|6|||
129672108|NCT00902577|466760924|FG000|Overall Study|FMISO production failure|2|||
129672109|NCT00785356|466760927|FG000|Overall Study|Study prematurely terminated|8|||
129672110|NCT01232790|466760929|FG000|Randomization|Withdrawal by Subject|2|||
129672111|NCT01232790|466760930|FG001|Randomization|Withdrawal by Subject|0|||
129672112|NCT01232790|466760929|FG000|Randomization|Protocol Violation|0|||
129672113|NCT01232790|466760930|FG001|Randomization|Protocol Violation|1|||
129672114|NCT01232790|466760929|FG000|Randomization|Physician Decision|0|||
129672115|NCT01232790|466760930|FG001|Randomization|Physician Decision|1|||
129672116|NCT01232790|466760929|FG000|Initial Assessment|Withdrawal by Subject|0|||
129672117|NCT01232790|466760930|FG001|Initial Assessment|Withdrawal by Subject|1|||
129672118|NCT01232790|466760929|FG000|First Crossover|Withdrawal by Subject|1|||
129672119|NCT01232790|466760930|FG001|First Crossover|Withdrawal by Subject|0|||
129672120|NCT01232790|466760929|FG000|Second Crossover|Withdrawal by Subject|1|||
129672121|NCT01232790|466760930|FG001|Second Crossover|Withdrawal by Subject|2|||
129672122|NCT03238417|466760931|FG000|Overall|non-response|955|||
129672123|NCT03238417|466760932|FG001|Overall|non-response|1920|||
129672124|NCT03238417|466760931|FG000|Overall|partial completion|48|||
129672125|NCT03238417|466760932|FG001|Overall|partial completion|68|||
129672126|NCT03238417|466760931|FG000|Baseline|Partial completion|17|||
129672127|NCT03238417|466760932|FG001|Baseline|Partial completion|48|||
129672128|NCT03238417|466760931|FG000|Baseline|non-response|372|||
129672129|NCT03238417|466760932|FG001|Baseline|non-response|669|||
129672130|NCT03238417|466760931|FG000|12-month|non-response|296|||
129672131|NCT03238417|466760932|FG001|12-month|non-response|669|||
129672132|NCT03238417|466760931|FG000|12-month|partial completion|23|||
129672133|NCT03238417|466760932|FG001|12-month|partial completion|37|||
129672134|NCT03238417|466760931|FG000|24-month|non-response|287|||
129672135|NCT03238417|466760932|FG001|24-month|non-response|594|||
129672136|NCT03238417|466760931|FG000|24-month|partial completion|8|||
129672137|NCT03238417|466760932|FG001|24-month|partial completion|31|||
129672138|NCT00083915|466760933|FG000|Overall Study|Death|6|||
129672139|NCT00083915|466760934|FG001|Overall Study|Death|3|||
129672140|NCT00083915|466760933|FG000|Overall Study|Physician Decision|11|||
129672141|NCT00083915|466760934|FG001|Overall Study|Physician Decision|6|||
129672142|NCT00083915|466760933|FG000|Overall Study|Withdrawal by Subject|8|||
129672143|NCT00083915|466760934|FG001|Overall Study|Withdrawal by Subject|3|||
129672144|NCT00083915|466760933|FG000|Overall Study|disease progression|18|||
129672145|NCT00083915|466760934|FG001|Overall Study|disease progression|23|||
129672146|NCT00083915|466760933|FG000|Overall Study|Failure to collect|3|||
129672147|NCT00083915|466760934|FG001|Overall Study|Failure to collect|0|||
129672148|NCT00083915|466760933|FG000|Overall Study|No response|3|||
129672149|NCT00083915|466760934|FG001|Overall Study|No response|1|||
129672150|NCT00083915|466760933|FG000|Overall Study|Insurance issues|1|||
129672151|NCT00083915|466760934|FG001|Overall Study|Insurance issues|1|||
129672152|NCT00853762|466760938|FG000|Overall Study|Premature Termination|16|||
129672153|NCT00853762|466760939|FG001|Overall Study|Premature Termination|15|||
129672154|NCT00853762|466760940|FG002|Overall Study|Premature Termination|14|||
129672155|NCT00853762|466760941|FG003|Overall Study|Premature Termination|21|||
129672156|NCT00853762|466760938|FG000|Overall Study|Protocol Violation|0|||
129672157|NCT00853762|466760939|FG001|Overall Study|Protocol Violation|0|||
129672158|NCT00853762|466760940|FG002|Overall Study|Protocol Violation|0|||
129672159|NCT00853762|466760941|FG003|Overall Study|Protocol Violation|1|||
129672160|NCT00853762|466760938|FG000|Overall Study|Withdrawal by Subject|0|||
129672161|NCT00853762|466760939|FG001|Overall Study|Withdrawal by Subject|0|||
129672162|NCT00853762|466760940|FG002|Overall Study|Withdrawal by Subject|1|||
129672163|NCT00853762|466760941|FG003|Overall Study|Withdrawal by Subject|0|||
129672164|NCT00853762|466760938|FG000|Overall Study|Other|0|||
129672165|NCT00853762|466760939|FG001|Overall Study|Other|2|||
129672166|NCT00853762|466760940|FG002|Overall Study|Other|0|||
129672167|NCT00853762|466760941|FG003|Overall Study|Other|0|||
129672168|NCT00853762|466760938|FG000|Overall Study|Randomised but not Treated|0|||
129672169|NCT00853762|466760939|FG001|Overall Study|Randomised but not Treated|2|||
129672170|NCT00853762|466760940|FG002|Overall Study|Randomised but not Treated|2|||
129672171|NCT00853762|466760941|FG003|Overall Study|Randomised but not Treated|0|||
129672172|NCT02000921|466760944|FG000|Overall Study|Withdrawal by Subject|3|||
129672173|NCT02000921|466760945|FG001|Overall Study|Withdrawal by Subject|10|||
129672174|NCT02000921|466760946|FG002|Overall Study|Withdrawal by Subject|5|||
129672175|NCT02000921|466760944|FG000|Overall Study|Lost to Follow-up|2|||
129672176|NCT02000921|466760945|FG001|Overall Study|Lost to Follow-up|4|||
129672177|NCT02000921|466760946|FG002|Overall Study|Lost to Follow-up|5|||
129672178|NCT02000921|466760944|FG000|Overall Study|Physician Decision|0|||
129672179|NCT02000921|466760945|FG001|Overall Study|Physician Decision|2|||
129672180|NCT02000921|466760946|FG002|Overall Study|Physician Decision|0|||
129672181|NCT02051296|466760947|FG000|Overall Study|Lost to Follow-up|1|||
129672182|NCT02051296|466760948|FG001|Overall Study|Lost to Follow-up|2|||
129672183|NCT02051296|466760947|FG000|Overall Study|withdraw prior to treatment|7|||
129672184|NCT02051296|466760948|FG001|Overall Study|withdraw prior to treatment|7|||
129672185|NCT00106002|466760949|FG000|Overall Study|Did not take any study drug|1|||
129672186|NCT00106002|466760949|FG000|Overall Study|Ineligible after Registration|1|||
129672187|NCT01245101|466760952|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
129672188|NCT01245101|466760953|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
129672189|NCT01245101|466760952|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
129672190|NCT01245101|466760953|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
129672191|NCT01245101|466760952|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
129672192|NCT01245101|466760953|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
129672193|NCT01225549|466760954|FG000|Period 4 - Washout|Disallowed medication|0|||
129672194|NCT01225549|466760955|FG001|Period 4 - Washout|Disallowed medication|1|||
129672195|NCT01225549|466760956|FG002|Period 4 - Washout|Disallowed medication|0|||
129672196|NCT01225549|466760957|FG003|Period 4 - Washout|Disallowed medication|0|||
129672197|NCT01225549|466760958|FG004|Period 4 - Washout|Disallowed medication|0|||
129672198|NCT01225549|466760959|FG005|Period 4 - Washout|Disallowed medication|0|||
129672199|NCT01225549|466760960|FG006|Period 4 - Washout|Disallowed medication|0|||
129672200|NCT01225549|466760961|FG007|Period 4 - Washout|Disallowed medication|0|||
129672201|NCT01225549|466760962|FG008|Period 4 - Washout|Disallowed medication|0|||
129672202|NCT01225549|466760963|FG009|Period 4 - Washout|Disallowed medication|0|||
129672203|NCT01225549|466760954|FG000|Period 6 - Washout|Disallowed medication|0|||
129672204|NCT01225549|466760955|FG001|Period 6 - Washout|Disallowed medication|0|||
129672205|NCT01225549|466760956|FG002|Period 6 - Washout|Disallowed medication|0|||
129672206|NCT01225549|466760957|FG003|Period 6 - Washout|Disallowed medication|1|||
129672207|NCT01225549|466760958|FG004|Period 6 - Washout|Disallowed medication|0|||
129672208|NCT01225549|466760959|FG005|Period 6 - Washout|Disallowed medication|0|||
129672209|NCT01225549|466760960|FG006|Period 6 - Washout|Disallowed medication|0|||
129672210|NCT01225549|466760961|FG007|Period 6 - Washout|Disallowed medication|0|||
129672211|NCT01225549|466760962|FG008|Period 6 - Washout|Disallowed medication|0|||
129672212|NCT01225549|466760963|FG009|Period 6 - Washout|Disallowed medication|0|||
129672213|NCT04456686|466760964|FG000|Overall Study|Adverse Event|2|||
129672214|NCT04456686|466760965|FG001|Overall Study|Adverse Event|1|||
129672215|NCT04456686|466760964|FG000|Overall Study|Lack of Efficacy|3|||
129672216|NCT04456686|466760965|FG001|Overall Study|Lack of Efficacy|1|||
129672217|NCT04456686|466760964|FG000|Overall Study|Withdrew consent|3|||
129672218|NCT04456686|466760965|FG001|Overall Study|Withdrew consent|1|||
129672219|NCT04456686|466760964|FG000|Overall Study|Physician Decision|2|||
129672220|NCT04456686|466760965|FG001|Overall Study|Physician Decision|2|||
129672221|NCT04456686|466760964|FG000|Overall Study|Withdrawal by Subject|5|||
129672222|NCT04456686|466760965|FG001|Overall Study|Withdrawal by Subject|1|||
129672223|NCT04456686|466760964|FG000|Overall Study|Protocol Violation|0|||
129672224|NCT04456686|466760965|FG001|Overall Study|Protocol Violation|1|||
129672225|NCT00891813|466760969|FG000|Overall Study|Adverse Event|3|||
129672226|NCT00891813|466760969|FG000|Overall Study|Withdrawal by Subject|1|||
129672227|NCT00891813|466760969|FG000|Overall Study|Patient Noncompliance|6|||
129672228|NCT00891813|466760969|FG000|Overall Study|Protocol Violation|2|||
129672229|NCT00473083|466760974|FG000|Overall Study|Adverse Event|1|||
129672230|NCT00473083|466760975|FG001|Overall Study|Adverse Event|0|||
129672231|NCT00473083|466760976|FG002|Overall Study|Adverse Event|0|||
129672232|NCT02858401|466760977|FG000|Overall Study|Withdrew Consent|0|||
129672233|NCT02858401|466760978|FG001|Overall Study|Withdrew Consent|0|||
129672234|NCT02858401|466760979|FG002|Overall Study|Withdrew Consent|0|||
129672235|NCT02858401|466760980|FG003|Overall Study|Withdrew Consent|0|||
129672236|NCT02858401|466760981|FG004|Overall Study|Withdrew Consent|0|||
129672237|NCT02858401|466760982|FG005|Overall Study|Withdrew Consent|1|||
129672238|NCT02858401|466760983|FG006|Overall Study|Withdrew Consent|0|||
129672239|NCT02858401|466760977|FG000|Overall Study|Lost to Follow-up|0|||
129672240|NCT02858401|466760978|FG001|Overall Study|Lost to Follow-up|1|||
129672241|NCT02858401|466760979|FG002|Overall Study|Lost to Follow-up|0|||
129672242|NCT02858401|466760980|FG003|Overall Study|Lost to Follow-up|0|||
129672243|NCT02858401|466760981|FG004|Overall Study|Lost to Follow-up|0|||
129672244|NCT02858401|466760982|FG005|Overall Study|Lost to Follow-up|0|||
129672245|NCT02858401|466760983|FG006|Overall Study|Lost to Follow-up|0|||
129672246|NCT00749398|466760984|FG000|Overall Study|Lack of Efficacy|7|||
129672247|NCT00749398|466760984|FG000|Overall Study|Adverse Event|4|||
129672248|NCT00749398|466760984|FG000|Overall Study|Serious adverse event|11|||
129672249|NCT00749398|466760984|FG000|Overall Study|Withdrawal by Subject|17|||
129672250|NCT00749398|466760984|FG000|Overall Study|Lost to Follow-up|11|||
129672251|NCT00749398|466760984|FG000|Overall Study|Reason not specified|2|||
129672252|NCT00749398|466760984|FG000|Overall Study|Unknown reason|1|||
129672253|NCT03093181|466760985|FG000|Overall Study|Withdrawal by Subject|2|||
129672254|NCT03093181|466760986|FG001|Overall Study|Withdrawal by Subject|1|||
129672255|NCT03093181|466760987|FG002|Overall Study|Withdrawal by Subject|2|||
129672256|NCT03093181|466760985|FG000|Overall Study|Other (Not specified)|1|||
129672257|NCT03093181|466760986|FG001|Overall Study|Other (Not specified)|0|||
129672258|NCT03093181|466760987|FG002|Overall Study|Other (Not specified)|0|||
129672259|NCT03093181|466760985|FG000|Overall Study|Adverse Event|0|||
129672260|NCT03093181|466760986|FG001|Overall Study|Adverse Event|1|||
129672261|NCT03093181|466760987|FG002|Overall Study|Adverse Event|0|||
129672262|NCT03093181|466760985|FG000|Overall Study|Other (Protocol violation)|0|||
129672263|NCT03093181|466760986|FG001|Overall Study|Other (Protocol violation)|0|||
129672264|NCT03093181|466760987|FG002|Overall Study|Other (Protocol violation)|1|||
129672265|NCT04210986|466760988|FG000|Overall Study|Lost to Follow-up|5|||
129672266|NCT04210986|466760989|FG001|Overall Study|Lost to Follow-up|2|||
129672267|NCT04210986|466760988|FG000|Overall Study|Withdrawal by Subject|3|||
129672268|NCT04210986|466760989|FG001|Overall Study|Withdrawal by Subject|1|||
129672269|NCT04210986|466760988|FG000|Overall Study|Protocol Violation|1|||
129672270|NCT04210986|466760989|FG001|Overall Study|Protocol Violation|1|||
129672271|NCT04210986|466760988|FG000|Overall Study|Physician Decision|0|||
129672272|NCT04210986|466760989|FG001|Overall Study|Physician Decision|1|||
129672273|NCT01076543|466760990|FG000|Overall Study|Withdrawal by Subject|2|||
129672274|NCT01076543|466760991|FG001|Overall Study|Withdrawal by Subject|0|||
129672275|NCT01076543|466760992|FG002|Overall Study|Withdrawal by Subject|0|||
129672276|NCT01076543|466760993|FG003|Overall Study|Withdrawal by Subject|0|||
129672277|NCT01076543|466760994|FG004|Overall Study|Withdrawal by Subject|0|||
129672278|NCT01076543|466760995|FG005|Overall Study|Withdrawal by Subject|0|||
129672279|NCT05222880|466760996|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129672280|NCT05222880|466760996|FG000|Overall Study|Withdrew Consent during Study|1|||
129672281|NCT05222880|466760996|FG000|Overall Study|COVID-19 Related|1|||
129672282|NCT01791985|466760997|FG000|Overall Study|Adverse Event|7|||
129672283|NCT01791985|466760997|FG000|Overall Study|Withdrawal by Subject|1|||
129672284|NCT00072410|466760998|FG000|Overall Study|Progressive disease|0|||
129672285|NCT00072410|466760999|FG001|Overall Study|Progressive disease|3|||
129672286|NCT00372424|466761000|FG000|Overall Study|Adverse Event|2|||
129672287|NCT00372424|466761000|FG000|Overall Study|Withdrawal by Subject|1|||
129672288|NCT00372424|466761000|FG000|Overall Study|Death|1|||
129672289|NCT00372424|466761000|FG000|Overall Study|Objective Progression or Relapse|14|||
129672290|NCT00372424|466761000|FG000|Overall Study|Other|7|||
129672291|NCT00372424|466761000|FG000|Overall Study|Enrolled, Not Treated|1|||
129672292|NCT03217591|466761006|FG000|Overall Study|Adverse Event|1|||
129672293|NCT03217591|466761007|FG001|Overall Study|Adverse Event|2|||
129672294|NCT03217591|466761008|FG002|Overall Study|Adverse Event|6|||
129672295|NCT03217591|466761006|FG000|Overall Study|Withdrawal by Subject|0|||
129672296|NCT03217591|466761007|FG001|Overall Study|Withdrawal by Subject|1|||
129672297|NCT03217591|466761008|FG002|Overall Study|Withdrawal by Subject|3|||
129672298|NCT03217591|466761006|FG000|Overall Study|Lost to Follow-up|1|||
129672299|NCT03217591|466761007|FG001|Overall Study|Lost to Follow-up|0|||
129672300|NCT03217591|466761008|FG002|Overall Study|Lost to Follow-up|0|||
129672301|NCT03217591|466761006|FG000|Overall Study|Protocol Violation|1|||
129672302|NCT03217591|466761007|FG001|Overall Study|Protocol Violation|0|||
129672303|NCT03217591|466761008|FG002|Overall Study|Protocol Violation|1|||
129672304|NCT02357459|466762743|FG000|Overall Study|Adverse Event|0|||
129672305|NCT02357459|466762744|FG001|Overall Study|Adverse Event|1|||
129672306|NCT02357459|466762745|FG002|Overall Study|Adverse Event|1|||
129672307|NCT02357459|466762743|FG000|Overall Study|Withdrawal by Subject|5|||
129672308|NCT02357459|466762744|FG001|Overall Study|Withdrawal by Subject|3|||
129672309|NCT02357459|466762745|FG002|Overall Study|Withdrawal by Subject|3|||
129672310|NCT02357459|466762743|FG000|Overall Study|Physician Decision|0|||
129672311|NCT02357459|466762744|FG001|Overall Study|Physician Decision|2|||
129672312|NCT02357459|466762745|FG002|Overall Study|Physician Decision|0|||
129672313|NCT02357459|466762743|FG000|Overall Study|Protocol Violation|1|||
129672314|NCT02357459|466762744|FG001|Overall Study|Protocol Violation|1|||
129672315|NCT02357459|466762745|FG002|Overall Study|Protocol Violation|0|||
129672316|NCT02357459|466762743|FG000|Overall Study|Lost to Follow-up|1|||
129672317|NCT02357459|466762744|FG001|Overall Study|Lost to Follow-up|3|||
129672318|NCT02357459|466762745|FG002|Overall Study|Lost to Follow-up|0|||
129672319|NCT02357459|466762743|FG000|Overall Study|Lack of Efficacy|7|||
129672320|NCT02357459|466762744|FG001|Overall Study|Lack of Efficacy|4|||
129672321|NCT02357459|466762745|FG002|Overall Study|Lack of Efficacy|4|||
129672322|NCT02357459|466762743|FG000|Overall Study|Patient Relocated|2|||
129672323|NCT02357459|466762744|FG001|Overall Study|Patient Relocated|0|||
129672324|NCT02357459|466762745|FG002|Overall Study|Patient Relocated|0|||
129672325|NCT02357459|466762743|FG000|Overall Study|Instruction from PCP|1|||
129672326|NCT02357459|466762744|FG001|Overall Study|Instruction from PCP|0|||
129672327|NCT02357459|466762745|FG002|Overall Study|Instruction from PCP|0|||
129672328|NCT02357459|466762743|FG000|Overall Study|Incarceration|0|||
129672329|NCT02357459|466762744|FG001|Overall Study|Incarceration|0|||
129672330|NCT02357459|466762745|FG002|Overall Study|Incarceration|1|||
129672331|NCT02357459|466762743|FG000|Overall Study|Pre-planned Knee surgery|0|||
129672332|NCT02357459|466762744|FG001|Overall Study|Pre-planned Knee surgery|0|||
129672333|NCT02357459|466762745|FG002|Overall Study|Pre-planned Knee surgery|2|||
129672334|NCT02357459|466762743|FG000|Overall Study|Job Commitments|0|||
129672335|NCT02357459|466762744|FG001|Overall Study|Job Commitments|0|||
129672336|NCT02357459|466762745|FG002|Overall Study|Job Commitments|1|||
129672337|NCT01548599|466762746|FG000|Overall Study|Lost to Follow-up|0|||
129672338|NCT01548599|466762747|FG001|Overall Study|Lost to Follow-up|1|||
129672339|NCT01548599|466762746|FG000|Overall Study|Withdrawal by Subject|4|||
129672340|NCT01548599|466762747|FG001|Overall Study|Withdrawal by Subject|0|||
129672341|NCT01548599|466762746|FG000|Overall Study|Death|2|||
129672342|NCT01548599|466762747|FG001|Overall Study|Death|1|||
129672343|NCT05630196|466762748|FG000|Overall Study|Adverse Event|2|||
129672344|NCT05630196|466762749|FG001|Overall Study|Adverse Event|1|||
129672345|NCT05630196|466762748|FG000|Overall Study|Lost to Follow-up|1|||
129672346|NCT05630196|466762749|FG001|Overall Study|Lost to Follow-up|1|||
129672347|NCT05630196|466762748|FG000|Overall Study|Protocol Violation|2|||
129672348|NCT05630196|466762749|FG001|Overall Study|Protocol Violation|3|||
129672349|NCT05630196|466762748|FG000|Overall Study|Physician Decision|1|||
129672350|NCT05630196|466762749|FG001|Overall Study|Physician Decision|0|||
129672351|NCT05630196|466762748|FG000|Overall Study|Withdrawal by Subject|3|||
129672352|NCT05630196|466762749|FG001|Overall Study|Withdrawal by Subject|4|||
129672353|NCT00352118|466762751|FG000|Overall Study|Physician Decision|4|||
129672354|NCT02990000|466762752|FG000|Overall Study|Failed to provide data beyond baseline|36|||
129672355|NCT02990000|466762753|FG001|Overall Study|Failed to provide data beyond baseline|34|||
129672356|NCT02308046|466762754|FG000|Overall Study|Negative yeast culture at Baseline|32|||
129672357|NCT02308046|466762755|FG001|Overall Study|Negative yeast culture at Baseline|33|||
129672358|NCT02308046|466762754|FG000|Overall Study|Positive for STD at Baseline|1|||
129672359|NCT02308046|466762755|FG001|Overall Study|Positive for STD at Baseline|2|||
129672360|NCT02308046|466762754|FG000|Overall Study|Lost to Follow-up|1|||
129672361|NCT02308046|466762755|FG001|Overall Study|Lost to Follow-up|3|||
129672362|NCT00883181|466762756|FG000|Overall Study|Hematological Adverse Event|26|||
129672363|NCT00883181|466762756|FG000|Overall Study|Non-hematological Adverse Event|55|||
129672364|NCT00883181|466762756|FG000|Overall Study|Disease Progression|94|||
129672365|NCT00883181|466762756|FG000|Overall Study|Administrative Reason|24|||
129672366|NCT00883181|466762756|FG000|Overall Study|Withdrawal by Subject|4|||
129672367|NCT00883181|466762756|FG000|Overall Study|Death|31|||
129672368|NCT00883181|466762756|FG000|Overall Study|Other|38|||
129672369|NCT00883181|466762756|FG000|Overall Study|Protocol Deviation|3|||
129672370|NCT00883181|466762756|FG000|Overall Study|Noncompliance|3|||
129672371|NCT01587885|466762759|FG000|Treatment Period 1|Failure to Return|0|||
129672372|NCT01587885|466762760|FG001|Treatment Period 1|Failure to Return|1|||
129884387|NCT00708305|467536386|FG003|Period 2|Protocol Violation|0|||
129672373|NCT01587885|466762759|FG000|Treatment Period 1|Protocol Violation|0|||
129672374|NCT01587885|466762760|FG001|Treatment Period 1|Protocol Violation|2|||
129672375|NCT00001566|466762765|FG000|Overall Study|patients' choice to discontinue protocol|3|||
129672376|NCT00001566|466762765|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
129672377|NCT00001566|466762765|FG000|Overall Study|Death|13|||
129672378|NCT00001566|466762765|FG000|Overall Study|Lost to Follow-up|1|||
129672379|NCT00001566|466762765|FG000|Overall Study|unable to complete initial apheresis|1|||
129672380|NCT02914834|466762766|FG000|Overall Study|Study halted due to COVID|1|||
129672381|NCT02914834|466762767|FG001|Overall Study|Study halted due to COVID|1|||
129672382|NCT02914834|466762766|FG000|Overall Study|1 subject withdrew|0|||
129672383|NCT02914834|466762767|FG001|Overall Study|1 subject withdrew|1|||
129672384|NCT00975416|466762770|FG000|Overall Study|early discharge from tx|3|||
129672385|NCT00975416|466762771|FG001|Overall Study|early discharge from tx|5|||
129672386|NCT01249131|466762776|FG000|Washout Period of 10 Days|Adverse Event|0|||
129672387|NCT01249131|466762777|FG001|Washout Period of 10 Days|Adverse Event|0|||
129672388|NCT01249131|466762778|FG002|Washout Period of 10 Days|Adverse Event|0|||
129672389|NCT01249131|466762779|FG003|Washout Period of 10 Days|Adverse Event|0|||
129672390|NCT01249131|466762780|FG004|Washout Period of 10 Days|Adverse Event|1|||
129672391|NCT01249131|466762781|FG005|Washout Period of 10 Days|Adverse Event|0|||
129672392|NCT02378662|466762782|FG000|Overall Study|Early Discontinuation|2|||
129672393|NCT02378662|466762783|FG001|Overall Study|Early Discontinuation|0|||
129672394|NCT01774591|466762784|FG000|Overall Study|Physician Decision|1|||
129672395|NCT01774591|466762785|FG001|Overall Study|Physician Decision|1|||
129672396|NCT01774591|466762784|FG000|Overall Study|Withdrawal by Subject|0|||
129672397|NCT01774591|466762785|FG001|Overall Study|Withdrawal by Subject|1|||
129672398|NCT01774591|466762784|FG000|Overall Study|Adverse Event|0|||
129672399|NCT01774591|466762785|FG001|Overall Study|Adverse Event|2|||
129672400|NCT01701245|466762786|FG000|Overall Study|Protocol Violation|1|||
129672401|NCT01701245|466762787|FG001|Overall Study|Protocol Violation|3|||
129672402|NCT01701245|466762786|FG000|Overall Study|Did not complete the open label period|11|||
129672403|NCT01701245|466762787|FG001|Overall Study|Did not complete the open label period|12|||
129672404|NCT01159574|466762788|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
129672405|NCT01159574|466762788|FG000|Treatment Phase|Adverse Event|3|||
129672406|NCT01159574|466762788|FG000|Treatment Phase|Death|6|||
129672407|NCT01159574|466762788|FG000|Treatment Phase|Physician Decision|2|||
129672408|NCT01159574|466762788|FG000|Treatment Phase|Withdrawal by Subject|7|||
129672409|NCT01159574|466762788|FG000|Treatment Phase|still on treatment|2|||
129672410|NCT01159574|466762788|FG000|Follow Up Phase|Lost to Follow-up|2|||
129672411|NCT01159574|466762788|FG000|Follow Up Phase|still being followed for overall surviva|18|||
129672412|NCT03555149|466762793|FG000|Overall Study|Death|18|||
129672413|NCT03555149|466762794|FG001|Overall Study|Death|15|||
129672414|NCT03555149|466762795|FG002|Overall Study|Death|15|||
129672415|NCT03555149|466762796|FG003|Overall Study|Death|4|||
129672416|NCT03555149|466762797|FG004|Overall Study|Death|4|||
129672417|NCT03555149|466762798|FG005|Overall Study|Death|11|||
129672418|NCT03555149|466762799|FG006|Overall Study|Death|12|||
129672419|NCT03555149|466762800|FG007|Overall Study|Death|1|||
129672420|NCT03555149|466762793|FG000|Overall Study|Lost to Follow-up|1|||
129672421|NCT03555149|466762794|FG001|Overall Study|Lost to Follow-up|0|||
129672422|NCT03555149|466762795|FG002|Overall Study|Lost to Follow-up|0|||
129672423|NCT03555149|466762796|FG003|Overall Study|Lost to Follow-up|0|||
129672424|NCT03555149|466762797|FG004|Overall Study|Lost to Follow-up|0|||
129672425|NCT03555149|466762798|FG005|Overall Study|Lost to Follow-up|1|||
129672426|NCT03555149|466762799|FG006|Overall Study|Lost to Follow-up|0|||
129672427|NCT03555149|466762800|FG007|Overall Study|Lost to Follow-up|0|||
129672428|NCT03555149|466762793|FG000|Overall Study|Physician Decision|1|||
129672429|NCT03555149|466762794|FG001|Overall Study|Physician Decision|0|||
129672430|NCT03555149|466762795|FG002|Overall Study|Physician Decision|0|||
129672431|NCT03555149|466762796|FG003|Overall Study|Physician Decision|0|||
129672432|NCT03555149|466762797|FG004|Overall Study|Physician Decision|0|||
129672433|NCT03555149|466762798|FG005|Overall Study|Physician Decision|0|||
129672434|NCT03555149|466762799|FG006|Overall Study|Physician Decision|0|||
129672435|NCT03555149|466762800|FG007|Overall Study|Physician Decision|0|||
129672436|NCT03555149|466762793|FG000|Overall Study|Study Terminated By Sponsor|1|||
129672437|NCT03555149|466762794|FG001|Overall Study|Study Terminated By Sponsor|0|||
129672438|NCT03555149|466762795|FG002|Overall Study|Study Terminated By Sponsor|0|||
129672439|NCT03555149|466762796|FG003|Overall Study|Study Terminated By Sponsor|0|||
129672440|NCT03555149|466762797|FG004|Overall Study|Study Terminated By Sponsor|0|||
129672441|NCT03555149|466762798|FG005|Overall Study|Study Terminated By Sponsor|2|||
129672442|NCT03555149|466762799|FG006|Overall Study|Study Terminated By Sponsor|3|||
129672443|NCT03555149|466762800|FG007|Overall Study|Study Terminated By Sponsor|1|||
129672444|NCT03555149|466762793|FG000|Overall Study|Withdrawal by Subject|3|||
129672445|NCT03555149|466762794|FG001|Overall Study|Withdrawal by Subject|0|||
129672446|NCT03555149|466762795|FG002|Overall Study|Withdrawal by Subject|0|||
129672447|NCT03555149|466762796|FG003|Overall Study|Withdrawal by Subject|2|||
129672448|NCT03555149|466762797|FG004|Overall Study|Withdrawal by Subject|0|||
129672449|NCT03555149|466762798|FG005|Overall Study|Withdrawal by Subject|1|||
129672450|NCT03555149|466762799|FG006|Overall Study|Withdrawal by Subject|0|||
129672451|NCT03555149|466762800|FG007|Overall Study|Withdrawal by Subject|0|||
129672452|NCT02666222|466762802|FG000|Overall Study|Death|2|||
129672453|NCT01474486|466762804|FG000|Overall Study|Death|2|||
129672454|NCT01474486|466762804|FG000|Overall Study|Withdrawal by Subject|4|||
129672455|NCT01474486|466762804|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
129672456|NCT03504917|466762808|FG000|Blinded Treatment Period|Protocol Violation|1|||
129672457|NCT03504917|466762809|FG001|Blinded Treatment Period|Protocol Violation|0|||
129672458|NCT03504917|466762808|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
129672459|NCT03504917|466762809|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
129672460|NCT03504917|466762808|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
129672461|NCT03504917|466762809|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
129672462|NCT03504917|466762808|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
129672463|NCT03504917|466762809|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
129672464|NCT03504917|466762808|FG000|Blinded Treatment Period|Adverse Event|4|||
129672465|NCT03504917|466762809|FG001|Blinded Treatment Period|Adverse Event|4|||
129672466|NCT03504917|466762808|FG000|Blinded Treatment Period|Physician Decision|1|||
129672467|NCT03504917|466762809|FG001|Blinded Treatment Period|Physician Decision|0|||
129672468|NCT03504917|466762808|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
129672469|NCT03504917|466762809|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
129672470|NCT03504917|466762808|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
129672471|NCT03504917|466762809|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
129672472|NCT03504917|466762808|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
129672473|NCT03504917|466762809|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
129672474|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
129672475|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
129672476|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
129672477|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
129672478|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
129672479|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
129672480|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
129672481|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
129672482|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
129672483|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
129672484|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
129672485|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
129672486|NCT03504917|466762808|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
129672487|NCT03504917|466762809|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
129672488|NCT04219189|466762810|FG000|Overall Study|Withdrawal by Subject|1|||
129672489|NCT04219189|466762811|FG001|Overall Study|Withdrawal by Subject|2|||
129672490|NCT04219189|466762810|FG000|Overall Study|Protocol Violation|0|||
129672491|NCT04219189|466762811|FG001|Overall Study|Protocol Violation|1|||
129672492|NCT04219189|466762810|FG000|Overall Study|Lost to Follow-up|0|||
129672493|NCT04219189|466762811|FG001|Overall Study|Lost to Follow-up|1|||
129672494|NCT04219189|466762810|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
129672495|NCT04219189|466762811|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
129672496|NCT03101020|466762812|FG000|Overall Study|Lack of time to participate|1|||
129672497|NCT03101020|466762813|FG001|Overall Study|Lack of time to participate|0|||
129672498|NCT03101020|466762812|FG000|Overall Study|Ran over by a car|0|||
129672499|NCT03101020|466762813|FG001|Overall Study|Ran over by a car|1|||
129672500|NCT03101020|466762812|FG000|Overall Study|Withdrawal by Subject|0|||
129672501|NCT03101020|466762813|FG001|Overall Study|Withdrawal by Subject|2|||
129672502|NCT05817669|466762814|FG000|Overall Study|Prohibited medication used|1|||
129672503|NCT05817669|466762815|FG001|Overall Study|Prohibited medication used|2|||
129672504|NCT05817669|466762814|FG000|Overall Study|Adverse Event|1|||
129672505|NCT05817669|466762815|FG001|Overall Study|Adverse Event|0|||
129672506|NCT05817669|466762814|FG000|Overall Study|Withdrawal by Subject|1|||
129672507|NCT05817669|466762815|FG001|Overall Study|Withdrawal by Subject|2|||
129672508|NCT04233879|466762816|FG000|Overall Study|Death|2|||
129672509|NCT04233879|466762817|FG001|Overall Study|Death|0|||
129672510|NCT04233879|466762816|FG000|Overall Study|Lost to Follow-up|3|||
129672511|NCT04233879|466762817|FG001|Overall Study|Lost to Follow-up|8|||
129672512|NCT04233879|466762816|FG000|Overall Study|Physician Decision|4|||
129672513|NCT04233879|466762817|FG001|Overall Study|Physician Decision|4|||
129672514|NCT04233879|466762816|FG000|Overall Study|Withdrawal by Subject|7|||
129672515|NCT04233879|466762817|FG001|Overall Study|Withdrawal by Subject|10|||
129672516|NCT04233879|466762816|FG000|Overall Study|Other|281|||
129672517|NCT04233879|466762817|FG001|Overall Study|Other|279|||
129672518|NCT03585270|466762820|FG000|Overall Study|Withdrawal by Subject|2|||
129672519|NCT03585270|466762821|FG001|Overall Study|Withdrawal by Subject|6|||
129672520|NCT03585270|466762820|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
129672521|NCT03585270|466762821|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
129672522|NCT03585270|466762820|FG000|Overall Study|Adverse Event|5|||
129672523|NCT03585270|466762821|FG001|Overall Study|Adverse Event|2|||
129672524|NCT03585270|466762820|FG000|Overall Study|Lost to Follow-up|1|||
129672525|NCT03585270|466762821|FG001|Overall Study|Lost to Follow-up|4|||
129672526|NCT03585270|466762820|FG000|Overall Study|Death|5|||
129672527|NCT03585270|466762821|FG001|Overall Study|Death|3|||
129672528|NCT03585270|466762820|FG000|Overall Study|Other reasons|2|||
129672529|NCT03585270|466762821|FG001|Overall Study|Other reasons|2|||
129672530|NCT03292016|466762822|FG000|Second Washout|Adverse Event|0|||
129672531|NCT03292016|466762823|FG001|Second Washout|Adverse Event|1|||
129672532|NCT03292016|466762824|FG002|Second Washout|Adverse Event|0|||
129672533|NCT03292016|466762825|FG003|Second Washout|Adverse Event|0|||
129672534|NCT03292016|466762826|FG004|Second Washout|Adverse Event|0|||
129672535|NCT03292016|466762827|FG005|Second Washout|Adverse Event|0|||
129672536|NCT03786380|466762828|FG000|Overall Study|Adverse Event|1|||
129672537|NCT03786380|466762829|FG001|Overall Study|Adverse Event|0|||
129672538|NCT03786380|466762830|FG002|Overall Study|Adverse Event|0|||
129672539|NCT03786380|466762831|FG003|Overall Study|Adverse Event|3|||
129672540|NCT03786380|466762832|FG004|Overall Study|Adverse Event|1|||
129672541|NCT03786380|466762828|FG000|Overall Study|Lack of Efficacy|0|||
129672542|NCT03786380|466762829|FG001|Overall Study|Lack of Efficacy|0|||
129672543|NCT03786380|466762830|FG002|Overall Study|Lack of Efficacy|0|||
129672544|NCT03786380|466762831|FG003|Overall Study|Lack of Efficacy|0|||
129672545|NCT03786380|466762832|FG004|Overall Study|Lack of Efficacy|1|||
129672546|NCT03786380|466762828|FG000|Overall Study|Withdrawal by Subject|1|||
129672547|NCT03786380|466762829|FG001|Overall Study|Withdrawal by Subject|2|||
129672548|NCT03786380|466762830|FG002|Overall Study|Withdrawal by Subject|2|||
129672549|NCT03786380|466762831|FG003|Overall Study|Withdrawal by Subject|1|||
129672550|NCT03786380|466762832|FG004|Overall Study|Withdrawal by Subject|2|||
129672551|NCT03786380|466762828|FG000|Overall Study|Lost to Follow-up|3|||
129672552|NCT03786380|466762829|FG001|Overall Study|Lost to Follow-up|0|||
129672553|NCT03786380|466762830|FG002|Overall Study|Lost to Follow-up|1|||
129672554|NCT03786380|466762831|FG003|Overall Study|Lost to Follow-up|2|||
129672555|NCT03786380|466762832|FG004|Overall Study|Lost to Follow-up|0|||
129672556|NCT03786380|466762828|FG000|Overall Study|Physician Decision|0|||
129672557|NCT03786380|466762829|FG001|Overall Study|Physician Decision|0|||
129672558|NCT03786380|466762830|FG002|Overall Study|Physician Decision|1|||
129672559|NCT03786380|466762831|FG003|Overall Study|Physician Decision|0|||
129672560|NCT03786380|466762832|FG004|Overall Study|Physician Decision|0|||
129672561|NCT03786380|466762828|FG000|Overall Study|Study Terminated by the Sponsor|30|||
129672562|NCT03786380|466762829|FG001|Overall Study|Study Terminated by the Sponsor|20|||
129672563|NCT03786380|466762830|FG002|Overall Study|Study Terminated by the Sponsor|50|||
129672564|NCT03786380|466762831|FG003|Overall Study|Study Terminated by the Sponsor|57|||
129672565|NCT03786380|466762832|FG004|Overall Study|Study Terminated by the Sponsor|23|||
129672566|NCT03786380|466762828|FG000|Overall Study|Reason Not Specified|0|||
129672567|NCT03786380|466762829|FG001|Overall Study|Reason Not Specified|0|||
129672568|NCT03786380|466762830|FG002|Overall Study|Reason Not Specified|0|||
129672569|NCT03786380|466762831|FG003|Overall Study|Reason Not Specified|0|||
129672570|NCT03786380|466762832|FG004|Overall Study|Reason Not Specified|1|||
129672571|NCT01664091|466762835|FG000|Overall Study|Death|1|||
129672572|NCT01664091|466762835|FG000|Overall Study|Disease Progression|2|||
129672573|NCT01664091|466762835|FG000|Overall Study|Lost to Follow-up|2|||
129672574|NCT01664091|466762835|FG000|Overall Study|Withdrawal by Subject|1|||
129672575|NCT01909804|466762840|FG000|Overall Study|Randomized but Never Treated|0|||
129672576|NCT01909804|466762841|FG001|Overall Study|Randomized but Never Treated|0|||
129672577|NCT01909804|466762842|FG002|Overall Study|Randomized but Never Treated|0|||
129672578|NCT01909804|466762843|FG003|Overall Study|Randomized but Never Treated|0|||
129672579|NCT01909804|466762844|FG004|Overall Study|Randomized but Never Treated|0|||
129672580|NCT01909804|466762845|FG005|Overall Study|Randomized but Never Treated|0|||
129672581|NCT01909804|466762846|FG006|Overall Study|Randomized but Never Treated|1|||
129672582|NCT01909804|466762847|FG007|Overall Study|Randomized but Never Treated|0|||
129672583|NCT01909804|466762848|FG008|Overall Study|Randomized but Never Treated|0|||
129672584|NCT01909804|466762849|FG009|Overall Study|Randomized but Never Treated|0|||
129672585|NCT01909804|466762850|FG010|Overall Study|Randomized but Never Treated|0|||
129672586|NCT01909804|466762851|FG011|Overall Study|Randomized but Never Treated|1|||
129672587|NCT01909804|466762840|FG000|Overall Study|Death|0|||
129672588|NCT01909804|466762841|FG001|Overall Study|Death|0|||
129672589|NCT01909804|466762842|FG002|Overall Study|Death|0|||
129672590|NCT01909804|466762843|FG003|Overall Study|Death|0|||
129672591|NCT01909804|466762844|FG004|Overall Study|Death|0|||
129672592|NCT01909804|466762845|FG005|Overall Study|Death|0|||
129672593|NCT01909804|466762846|FG006|Overall Study|Death|0|||
129672594|NCT01909804|466762847|FG007|Overall Study|Death|0|||
129672595|NCT01909804|466762848|FG008|Overall Study|Death|0|||
129672596|NCT01909804|466762849|FG009|Overall Study|Death|0|||
129672597|NCT01909804|466762850|FG010|Overall Study|Death|1|||
129672598|NCT01909804|466762851|FG011|Overall Study|Death|0|||
129672599|NCT01909804|466762840|FG000|Overall Study|Lack of Efficacy|4|||
129672600|NCT01909804|466762841|FG001|Overall Study|Lack of Efficacy|1|||
129672601|NCT01909804|466762842|FG002|Overall Study|Lack of Efficacy|0|||
129672602|NCT01909804|466762843|FG003|Overall Study|Lack of Efficacy|0|||
129672603|NCT01909804|466762844|FG004|Overall Study|Lack of Efficacy|7|||
129672604|NCT01909804|466762845|FG005|Overall Study|Lack of Efficacy|3|||
129672605|NCT01909804|466762846|FG006|Overall Study|Lack of Efficacy|1|||
129672606|NCT01909804|466762847|FG007|Overall Study|Lack of Efficacy|1|||
129672607|NCT01909804|466762848|FG008|Overall Study|Lack of Efficacy|0|||
129672608|NCT01909804|466762849|FG009|Overall Study|Lack of Efficacy|1|||
129672609|NCT01909804|466762850|FG010|Overall Study|Lack of Efficacy|0|||
129672610|NCT01909804|466762851|FG011|Overall Study|Lack of Efficacy|1|||
129672611|NCT01909804|466762840|FG000|Overall Study|Withdrew Consent|0|||
129672612|NCT01909804|466762841|FG001|Overall Study|Withdrew Consent|0|||
129672613|NCT01909804|466762842|FG002|Overall Study|Withdrew Consent|0|||
129672614|NCT01909804|466762843|FG003|Overall Study|Withdrew Consent|0|||
129672615|NCT01909804|466762844|FG004|Overall Study|Withdrew Consent|1|||
129672616|NCT01909804|466762845|FG005|Overall Study|Withdrew Consent|1|||
129672617|NCT01909804|466762846|FG006|Overall Study|Withdrew Consent|0|||
129672618|NCT01909804|466762847|FG007|Overall Study|Withdrew Consent|0|||
129672619|NCT01909804|466762848|FG008|Overall Study|Withdrew Consent|0|||
129672620|NCT01909804|466762849|FG009|Overall Study|Withdrew Consent|0|||
129672621|NCT01909804|466762850|FG010|Overall Study|Withdrew Consent|0|||
129672622|NCT01909804|466762851|FG011|Overall Study|Withdrew Consent|0|||
129672623|NCT01909804|466762840|FG000|Overall Study|Protocol Violation|0|||
129672624|NCT01909804|466762841|FG001|Overall Study|Protocol Violation|0|||
129672625|NCT01909804|466762842|FG002|Overall Study|Protocol Violation|0|||
129672626|NCT01909804|466762843|FG003|Overall Study|Protocol Violation|0|||
129672627|NCT01909804|466762844|FG004|Overall Study|Protocol Violation|0|||
129672628|NCT01909804|466762845|FG005|Overall Study|Protocol Violation|0|||
129672629|NCT01909804|466762846|FG006|Overall Study|Protocol Violation|0|||
129672630|NCT01909804|466762847|FG007|Overall Study|Protocol Violation|0|||
129672631|NCT01909804|466762848|FG008|Overall Study|Protocol Violation|0|||
129672632|NCT01909804|466762849|FG009|Overall Study|Protocol Violation|0|||
129672633|NCT01909804|466762850|FG010|Overall Study|Protocol Violation|0|||
129672634|NCT01909804|466762851|FG011|Overall Study|Protocol Violation|1|||
129672635|NCT01038687|466762852|FG000|Overall Study|Adverse Event|0|||
129672636|NCT01038687|466762853|FG001|Overall Study|Adverse Event|2|||
129672637|NCT01038687|466762854|FG002|Overall Study|Adverse Event|1|||
129672638|NCT00338741|466762856|FG000|Overall Study|Lost to Follow-up|2|||
129672639|NCT00338741|466762857|FG001|Overall Study|Lost to Follow-up|0|||
129672640|NCT02144701|466762858|FG000|Overall Study|development of relapse, GVHD or death|9|||
129672641|NCT02144701|466762859|FG001|Overall Study|development of relapse, GVHD or death|3|||
129672642|NCT01218802|466762861|FG000|Overall Study|Lost to Follow-up|5|||
129672643|NCT01218802|466762862|FG001|Overall Study|Lost to Follow-up|6|||
129672644|NCT01218802|466762861|FG000|Overall Study|Withdrawal by Subject|3|||
129672645|NCT01218802|466762862|FG001|Overall Study|Withdrawal by Subject|10|||
129672646|NCT01218802|466762861|FG000|Overall Study|Adverse Event|0|||
129672647|NCT01218802|466762862|FG001|Overall Study|Adverse Event|2|||
129672648|NCT01218802|466762861|FG000|Overall Study|Incarcerated|2|||
129672649|NCT01218802|466762862|FG001|Overall Study|Incarcerated|0|||
129672650|NCT03327324|466762863|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672651|NCT03327324|466762864|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129672652|NCT03327324|466762865|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672653|NCT03327324|466762866|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129672654|NCT03327324|466762867|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672655|NCT03327324|466762868|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
129672656|NCT03327324|466762863|FG000|Baseline (Month 0-Month 3)|Refused|0|||
129672657|NCT03327324|466762864|FG001|Baseline (Month 0-Month 3)|Refused|0|||
129672658|NCT03327324|466762865|FG002|Baseline (Month 0-Month 3)|Refused|0|||
129672659|NCT03327324|466762866|FG003|Baseline (Month 0-Month 3)|Refused|0|||
129672660|NCT03327324|466762867|FG004|Baseline (Month 0-Month 3)|Refused|1|||
129672661|NCT03327324|466762868|FG005|Baseline (Month 0-Month 3)|Refused|0|||
129672662|NCT03327324|466762863|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129672663|NCT03327324|466762864|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
129672664|NCT03327324|466762865|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129672665|NCT03327324|466762866|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129672666|NCT03327324|466762867|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129672667|NCT03327324|466762868|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
129672668|NCT03327324|466762863|FG000|Baseline (Month 0-Month 3)|Death|0|||
129672669|NCT03327324|466762864|FG001|Baseline (Month 0-Month 3)|Death|0|||
129672670|NCT03327324|466762865|FG002|Baseline (Month 0-Month 3)|Death|0|||
129672671|NCT03327324|466762866|FG003|Baseline (Month 0-Month 3)|Death|0|||
129672672|NCT03327324|466762867|FG004|Baseline (Month 0-Month 3)|Death|1|||
129672673|NCT03327324|466762868|FG005|Baseline (Month 0-Month 3)|Death|0|||
129672674|NCT03327324|466762863|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672675|NCT03327324|466762864|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672676|NCT03327324|466762865|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672677|NCT03327324|466762866|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672678|NCT03327324|466762867|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672679|NCT03327324|466762868|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
129672680|NCT03327324|466762863|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672681|NCT03327324|466762864|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672682|NCT03327324|466762865|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129672683|NCT03327324|466762866|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672684|NCT03327324|466762867|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672685|NCT03327324|466762868|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672686|NCT03327324|466762863|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
129672687|NCT03327324|466762864|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
129672688|NCT03327324|466762865|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
129672689|NCT03327324|466762866|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
129672690|NCT03327324|466762867|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
129672691|NCT03327324|466762868|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
129672692|NCT03327324|466762863|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
129672693|NCT03327324|466762864|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129672694|NCT03327324|466762865|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129672695|NCT03327324|466762866|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129672696|NCT03327324|466762867|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129672697|NCT03327324|466762868|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
129672698|NCT03327324|466762863|FG000|Intervention (Month 3-Month 6)|Death|1|||
129672699|NCT03327324|466762864|FG001|Intervention (Month 3-Month 6)|Death|0|||
129672700|NCT03327324|466762865|FG002|Intervention (Month 3-Month 6)|Death|1|||
129672701|NCT03327324|466762866|FG003|Intervention (Month 3-Month 6)|Death|1|||
129672702|NCT03327324|466762867|FG004|Intervention (Month 3-Month 6)|Death|1|||
129672703|NCT03327324|466762868|FG005|Intervention (Month 3-Month 6)|Death|0|||
129672704|NCT03327324|466762863|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672705|NCT03327324|466762864|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672706|NCT03327324|466762865|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672707|NCT03327324|466762866|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672708|NCT03327324|466762867|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672709|NCT03327324|466762868|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
129672710|NCT03327324|466762863|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
129672711|NCT03327324|466762864|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672712|NCT03327324|466762865|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672713|NCT03327324|466762866|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672714|NCT03327324|466762867|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672715|NCT03327324|466762868|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
129672716|NCT03327324|466762863|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
129672717|NCT03327324|466762864|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
129672718|NCT03327324|466762865|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129672719|NCT03327324|466762866|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129672720|NCT03327324|466762867|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129672721|NCT03327324|466762868|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
129672722|NCT03327324|466762863|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
129672723|NCT03327324|466762864|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
129672724|NCT03327324|466762865|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
129672725|NCT03327324|466762866|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
129672726|NCT03327324|466762867|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
129672727|NCT03327324|466762868|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
129672728|NCT03327324|466762863|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672729|NCT03327324|466762864|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672730|NCT03327324|466762865|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672731|NCT03327324|466762866|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
129672732|NCT03327324|466762867|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
129672733|NCT03327324|466762868|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
129672734|NCT03327324|466762863|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
129672735|NCT03327324|466762864|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129672736|NCT03327324|466762865|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129672737|NCT03327324|466762866|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129672738|NCT03327324|466762867|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129672739|NCT03327324|466762868|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
129672740|NCT03327324|466762863|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
129672741|NCT03327324|466762864|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129672742|NCT03327324|466762865|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129672743|NCT03327324|466762866|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129672744|NCT03327324|466762867|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129672745|NCT03327324|466762868|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
129672746|NCT02314728|466762872|FG000|Overall Study|Protocol Violation|1|||
129672747|NCT02314728|466762873|FG001|Overall Study|Protocol Violation|0|||
129672748|NCT02314728|466762872|FG000|Overall Study|Lost to Follow-up|0|||
129672749|NCT02314728|466762873|FG001|Overall Study|Lost to Follow-up|1|||
129672750|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
129672751|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129672752|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129672753|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129672754|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129672755|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129672756|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
129672757|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
129672758|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129672759|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129672760|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129672761|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129672762|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129672763|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
129672764|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129672765|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
129672766|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129672767|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129672768|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129672769|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129672770|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
129672771|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129672772|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129672773|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
129672774|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129672775|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129672776|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129672777|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
129672778|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129672779|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129672780|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
129672781|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129672782|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129672783|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129672784|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
129672785|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129672786|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129672787|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
129672788|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129672789|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129672790|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129672791|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
129672792|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129672793|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129672794|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129672795|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
129672796|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129672797|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129672798|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
129672799|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129672800|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129672801|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129672802|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
129672803|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129672804|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129672805|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
129672806|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129672807|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129672808|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129672809|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129672810|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
129672811|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129672812|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
129672813|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129672814|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129672815|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129672816|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129672817|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
129672818|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129672819|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
129672820|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129672821|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129672822|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129672823|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129672824|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
129672825|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129672826|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
129672827|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129672828|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129672829|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129672830|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129672831|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
129672832|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129672833|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
129672834|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129672835|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129672836|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129672837|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129672838|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129672839|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
129672840|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
129672841|NCT01791595|466762874|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129672842|NCT01791595|466762875|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129672843|NCT01791595|466762876|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129672844|NCT01791595|466762877|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129672845|NCT01791595|466762878|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129672846|NCT01791595|466762879|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
129672847|NCT01791595|466762880|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
129672848|NCT01791595|466762874|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129672849|NCT01791595|466762875|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129672850|NCT01791595|466762876|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129672851|NCT01791595|466762877|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129672852|NCT01791595|466762878|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129672853|NCT01791595|466762879|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
129672854|NCT01791595|466762880|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
129672855|NCT01791595|466762874|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129672856|NCT01791595|466762875|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129672857|NCT01791595|466762876|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129672858|NCT01791595|466762877|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129672859|NCT01791595|466762878|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129672860|NCT01791595|466762879|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
129672861|NCT01791595|466762880|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
129672862|NCT01791595|466762874|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129672863|NCT01791595|466762875|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129672864|NCT01791595|466762876|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129672865|NCT01791595|466762877|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129672866|NCT01791595|466762878|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129672867|NCT01791595|466762879|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
129672868|NCT01791595|466762880|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
129672869|NCT01791595|466762874|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129672870|NCT01791595|466762875|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129672871|NCT01791595|466762876|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129672872|NCT01791595|466762877|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129672873|NCT01791595|466762878|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129672874|NCT01791595|466762879|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
129672875|NCT01791595|466762880|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
129672876|NCT03118934|466762881|FG000|Overall Study|Adverse Event|0|||
129672877|NCT03118934|466762882|FG001|Overall Study|Adverse Event|0|||
129672878|NCT03118934|466762883|FG002|Overall Study|Adverse Event|0|||
129672879|NCT03118934|466762884|FG003|Overall Study|Adverse Event|0|||
129672880|NCT03118934|466762885|FG004|Overall Study|Adverse Event|0|||
129672881|NCT03118934|466762886|FG005|Overall Study|Adverse Event|1|||
129672882|NCT03118934|466762881|FG000|Overall Study|Physician Decision|0|||
129672883|NCT03118934|466762882|FG001|Overall Study|Physician Decision|0|||
129672884|NCT03118934|466762883|FG002|Overall Study|Physician Decision|0|||
129672885|NCT03118934|466762884|FG003|Overall Study|Physician Decision|0|||
129672886|NCT03118934|466762885|FG004|Overall Study|Physician Decision|0|||
129672887|NCT03118934|466762886|FG005|Overall Study|Physician Decision|1|||
129672888|NCT03118934|466762881|FG000|Overall Study|Discontinued prior to exposure|0|||
129672889|NCT03118934|466762882|FG001|Overall Study|Discontinued prior to exposure|1|||
129672890|NCT03118934|466762883|FG002|Overall Study|Discontinued prior to exposure|1|||
129672891|NCT03118934|466762884|FG003|Overall Study|Discontinued prior to exposure|1|||
129672892|NCT03118934|466762885|FG004|Overall Study|Discontinued prior to exposure|2|||
129672893|NCT03118934|466762886|FG005|Overall Study|Discontinued prior to exposure|0|||
129672894|NCT01614470|466762887|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
129672895|NCT01614470|466762888|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129672896|NCT01614470|466762889|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129672897|NCT01614470|466762887|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
129672898|NCT01614470|466762888|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
129672899|NCT01614470|466762889|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
129672900|NCT00249834|466762890|FG000|Overall Study|Ovarian stimulation failed|1|||
129672901|NCT00249834|466762891|FG001|Overall Study|Ovarian stimulation failed|0|||
129672902|NCT00249834|466762892|FG002|Overall Study|Ovarian stimulation failed|0|||
129672903|NCT00249834|466762893|FG003|Overall Study|Ovarian stimulation failed|0|||
129672904|NCT00249834|466762894|FG004|Overall Study|Ovarian stimulation failed|0|||
129672905|NCT00249834|466762895|FG005|Overall Study|Ovarian stimulation failed|0|||
129672906|NCT00249834|466762896|FG006|Overall Study|Ovarian stimulation failed|0|||
129672907|NCT00249834|466762897|FG007|Overall Study|Ovarian stimulation failed|0|||
129672908|NCT00249834|466762890|FG000|Overall Study|Failure of down-regulation|0|||
129672909|NCT00249834|466762891|FG001|Overall Study|Failure of down-regulation|0|||
129672910|NCT00249834|466762892|FG002|Overall Study|Failure of down-regulation|0|||
129672911|NCT00249834|466762893|FG003|Overall Study|Failure of down-regulation|0|||
129672912|NCT00249834|466762894|FG004|Overall Study|Failure of down-regulation|0|||
129672913|NCT00249834|466762895|FG005|Overall Study|Failure of down-regulation|0|||
129672914|NCT00249834|466762896|FG006|Overall Study|Failure of down-regulation|1|||
129672915|NCT00249834|466762897|FG007|Overall Study|Failure of down-regulation|0|||
129672916|NCT00249834|466762890|FG000|Overall Study|Protocol Violation|0|||
129672917|NCT00249834|466762891|FG001|Overall Study|Protocol Violation|19|||
129672918|NCT00249834|466762892|FG002|Overall Study|Protocol Violation|14|||
129672919|NCT00249834|466762893|FG003|Overall Study|Protocol Violation|8|||
129672920|NCT00249834|466762894|FG004|Overall Study|Protocol Violation|5|||
129672921|NCT00249834|466762895|FG005|Overall Study|Protocol Violation|2|||
129672922|NCT00249834|466762896|FG006|Overall Study|Protocol Violation|0|||
129672923|NCT00249834|466762897|FG007|Overall Study|Protocol Violation|0|||
129672924|NCT02895347|466762898|FG000|Overall Study|Withdrawal by Subject|3|||
129672925|NCT02895347|466762899|FG001|Overall Study|Withdrawal by Subject|1|||
129672926|NCT03177148|466762903|FG000|Overall Study|Lost to Follow-up|50|||
129672927|NCT03177148|466762904|FG001|Overall Study|Lost to Follow-up|1|||
129672928|NCT03177148|466762903|FG000|Overall Study|Death|1|||
129672929|NCT03177148|466762904|FG001|Overall Study|Death|0|||
129672930|NCT02848664|466762907|FG000|Overall Study|Withdrawal by Subject|2|||
129672931|NCT02848664|466762907|FG000|Overall Study|Adverse Event|1|||
129672932|NCT02848664|466762907|FG000|Overall Study|no assistance for device training|1|||
129672933|NCT01204671|466762908|FG000|Overall Study|Adverse Event|4|||
129672934|NCT01204671|466762909|FG001|Overall Study|Adverse Event|3|||
129672935|NCT01204671|466762910|FG002|Overall Study|Adverse Event|3|||
129672936|NCT01204671|466762911|FG003|Overall Study|Adverse Event|3|||
129672937|NCT01204671|466762912|FG004|Overall Study|Adverse Event|1|||
129672938|NCT01204671|466762908|FG000|Overall Study|Withdrawal by Subject|2|||
129672939|NCT01204671|466762909|FG001|Overall Study|Withdrawal by Subject|3|||
129672940|NCT01204671|466762910|FG002|Overall Study|Withdrawal by Subject|4|||
129672941|NCT01204671|466762911|FG003|Overall Study|Withdrawal by Subject|5|||
129672942|NCT01204671|466762912|FG004|Overall Study|Withdrawal by Subject|3|||
129672943|NCT01204671|466762908|FG000|Overall Study|Lost to Follow-up|7|||
129672944|NCT01204671|466762909|FG001|Overall Study|Lost to Follow-up|8|||
129672945|NCT01204671|466762910|FG002|Overall Study|Lost to Follow-up|6|||
129672946|NCT01204671|466762911|FG003|Overall Study|Lost to Follow-up|4|||
129672947|NCT01204671|466762912|FG004|Overall Study|Lost to Follow-up|0|||
129672948|NCT01204671|466762908|FG000|Overall Study|Unknown Completion Status|1|||
129672949|NCT01204671|466762909|FG001|Overall Study|Unknown Completion Status|1|||
129672950|NCT01204671|466762910|FG002|Overall Study|Unknown Completion Status|0|||
129672951|NCT01204671|466762911|FG003|Overall Study|Unknown Completion Status|0|||
129672952|NCT01204671|466762912|FG004|Overall Study|Unknown Completion Status|0|||
129672953|NCT01204671|466762908|FG000|Overall Study|Physician Decision|0|||
129672954|NCT01204671|466762909|FG001|Overall Study|Physician Decision|0|||
129672955|NCT01204671|466762910|FG002|Overall Study|Physician Decision|0|||
129672956|NCT01204671|466762911|FG003|Overall Study|Physician Decision|1|||
129672957|NCT01204671|466762912|FG004|Overall Study|Physician Decision|0|||
129672958|NCT00492726|466762917|FG000|Overall Study|Adverse Event|10|||
129672959|NCT00492726|466762918|FG001|Overall Study|Adverse Event|6|||
129672960|NCT00492726|466762917|FG000|Overall Study|Death|7|||
129672961|NCT00492726|466762918|FG001|Overall Study|Death|2|||
129672962|NCT00492726|466762917|FG000|Overall Study|Lack of Efficacy|0|||
129672963|NCT00492726|466762918|FG001|Overall Study|Lack of Efficacy|2|||
129672964|NCT00492726|466762917|FG000|Overall Study|Lost to Follow-up|27|||
129672965|NCT00492726|466762918|FG001|Overall Study|Lost to Follow-up|19|||
129672966|NCT00492726|466762917|FG000|Overall Study|Physician Decision|0|||
129672967|NCT00492726|466762918|FG001|Overall Study|Physician Decision|1|||
129672968|NCT00492726|466762917|FG000|Overall Study|Withdrawal by Subject|6|||
129672969|NCT00492726|466762918|FG001|Overall Study|Withdrawal by Subject|3|||
129672970|NCT00492726|466762917|FG000|Overall Study|Non compliant with study medication|0|||
129672971|NCT00492726|466762918|FG001|Overall Study|Non compliant with study medication|3|||
129672972|NCT04386902|466762919|FG000|Overall Study|Withdrawal by Subject|5|||
129672973|NCT04386902|466762919|FG000|Overall Study|Technical problems in the recording|5|||
129672974|NCT02404545|466762920|FG000|Overall Study|Sponsor Termination|6|||
129672975|NCT02404545|466762921|FG001|Overall Study|Sponsor Termination|6|||
129672976|NCT01712516|466764353|FG000|Overall Study|Technical problems|0|||
129672977|NCT01712516|466764354|FG001|Overall Study|Technical problems|0|||
129672978|NCT01712516|466764355|FG002|Overall Study|Technical problems|0|||
129672979|NCT01712516|466764356|FG003|Overall Study|Technical problems|2|||
129672980|NCT01712516|466764353|FG000|Overall Study|Lost to Follow-up|0|||
129672981|NCT01712516|466764354|FG001|Overall Study|Lost to Follow-up|0|||
129672982|NCT01712516|466764355|FG002|Overall Study|Lost to Follow-up|2|||
129672983|NCT01712516|466764356|FG003|Overall Study|Lost to Follow-up|1|||
129672984|NCT01712516|466764353|FG000|Overall Study|Death|0|||
129672985|NCT01712516|466764354|FG001|Overall Study|Death|1|||
129672986|NCT01712516|466764355|FG002|Overall Study|Death|0|||
129672987|NCT01712516|466764356|FG003|Overall Study|Death|0|||
129672988|NCT01712516|466764353|FG000|Overall Study|Protocol deviation|1|||
129672989|NCT01712516|466764354|FG001|Overall Study|Protocol deviation|0|||
129672990|NCT01712516|466764355|FG002|Overall Study|Protocol deviation|1|||
129672991|NCT01712516|466764356|FG003|Overall Study|Protocol deviation|0|||
129672992|NCT01712516|466764353|FG000|Overall Study|Physician Decision|2|||
129672993|NCT01712516|466764354|FG001|Overall Study|Physician Decision|0|||
129672994|NCT01712516|466764355|FG002|Overall Study|Physician Decision|0|||
129672995|NCT01712516|466764356|FG003|Overall Study|Physician Decision|1|||
129672996|NCT01712516|466764353|FG000|Overall Study|Withdrawal by Subject|3|||
129672997|NCT01712516|466764354|FG001|Overall Study|Withdrawal by Subject|9|||
129672998|NCT01712516|466764355|FG002|Overall Study|Withdrawal by Subject|3|||
129672999|NCT01712516|466764356|FG003|Overall Study|Withdrawal by Subject|9|||
129673000|NCT01181167|466764357|FG000|Overall Study|Adverse Event|11|||
129673001|NCT01181167|466764358|FG001|Overall Study|Adverse Event|21|||
129673002|NCT01181167|466764357|FG000|Overall Study|Lost to Follow-up|1|||
129673003|NCT01181167|466764358|FG001|Overall Study|Lost to Follow-up|0|||
129673004|NCT01181167|466764357|FG000|Overall Study|Physician Decision|2|||
129673005|NCT01181167|466764358|FG001|Overall Study|Physician Decision|3|||
129673006|NCT01181167|466764357|FG000|Overall Study|Protocol Violation|3|||
129673007|NCT01181167|466764358|FG001|Overall Study|Protocol Violation|0|||
129673008|NCT01181167|466764357|FG000|Overall Study|Withdrawal by Subject|6|||
129673009|NCT01181167|466764358|FG001|Overall Study|Withdrawal by Subject|8|||
129673010|NCT00161213|466764359|FG000|Overall Study|Withdrawal by Subject|1|||
129673011|NCT00161213|466764359|FG000|Overall Study|Evaluable for toxicity but not response|1|||
129673012|NCT03103503|466764360|FG000|Overall Study|Death|64|||
129673013|NCT03103503|466764360|FG000|Overall Study|Physician Decision|57|||
129673014|NCT03103503|466764360|FG000|Overall Study|Withdrawal by Subject|10|||
129673015|NCT03103503|466764360|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
129673016|NCT03103503|466764360|FG000|Overall Study|Lost to Follow-up|3|||
129547151|NCT02017535|466296150|FG000|Overall Study|Withdrawal by Subject|1|||
129547152|NCT02017535|466296151|FG001|Overall Study|Withdrawal by Subject|0|||
129547153|NCT02017535|466296152|FG002|Overall Study|Withdrawal by Subject|0|||
129547154|NCT02017535|466296153|FG003|Overall Study|Withdrawal by Subject|0|||
129547155|NCT01393626|466296154|FG000|Overall Study|Adverse Event|2|||
129547156|NCT01393626|466296155|FG001|Overall Study|Adverse Event|1|||
129547157|NCT01393626|466296156|FG002|Overall Study|Adverse Event|5|||
129547158|NCT01393626|466296157|FG003|Overall Study|Adverse Event|0|||
129547159|NCT01393626|466296154|FG000|Overall Study|Did not meet entrance criteria|1|||
129547160|NCT01393626|466296155|FG001|Overall Study|Did not meet entrance criteria|0|||
129547161|NCT01393626|466296156|FG002|Overall Study|Did not meet entrance criteria|0|||
129547162|NCT01393626|466296157|FG003|Overall Study|Did not meet entrance criteria|0|||
129547163|NCT01393626|466296154|FG000|Overall Study|Lack of Efficacy|6|||
129547164|NCT01393626|466296155|FG001|Overall Study|Lack of Efficacy|6|||
129547165|NCT01393626|466296156|FG002|Overall Study|Lack of Efficacy|4|||
129547166|NCT01393626|466296157|FG003|Overall Study|Lack of Efficacy|1|||
129547167|NCT01393626|466296154|FG000|Overall Study|Lost to Follow-up|1|||
129547168|NCT01393626|466296155|FG001|Overall Study|Lost to Follow-up|1|||
129547169|NCT01393626|466296156|FG002|Overall Study|Lost to Follow-up|1|||
129547170|NCT01393626|466296157|FG003|Overall Study|Lost to Follow-up|0|||
129547171|NCT01393626|466296154|FG000|Overall Study|Withdrawal by Subject|6|||
129547172|NCT01393626|466296155|FG001|Overall Study|Withdrawal by Subject|4|||
129673017|NCT03103503|466764360|FG000|Overall Study|Study Closure|757|||
129673018|NCT02683109|466764362|FG000|Overall Study|Adverse Event|1|||
129673019|NCT02683109|466764363|FG001|Overall Study|Adverse Event|0|||
129673020|NCT00183430|466764364|FG000|Overall Study|Adverse Event|1|||
129673021|NCT00183430|466764365|FG001|Overall Study|Adverse Event|0|||
129673022|NCT00183430|466764364|FG000|Overall Study|Lost to Follow-up|3|||
129673023|NCT00183430|466764365|FG001|Overall Study|Lost to Follow-up|0|||
129673024|NCT00183430|466764364|FG000|Overall Study|did not meet inclusion criteria|1|||
129673025|NCT00183430|466764365|FG001|Overall Study|did not meet inclusion criteria|0|||
129673026|NCT00183430|466764364|FG000|Overall Study|Withdrawal by Subject|1|||
129673027|NCT00183430|466764365|FG001|Overall Study|Withdrawal by Subject|0|||
129673028|NCT00719901|466764368|FG000|Overall Study|Adverse Event|5|||
129673029|NCT00719901|466764368|FG000|Overall Study|Withdrawal by Subject|1|||
129673030|NCT00719901|466764368|FG000|Overall Study|Alternate Treatment|1|||
129673031|NCT00719901|466764368|FG000|Overall Study|Disease Progression|3|||
129673032|NCT00719901|466764368|FG000|Overall Study|Availability of Study Drug|1|||
129673033|NCT01122173|466764369|FG000|Overall Study|Lost to Follow-up|3|||
129673034|NCT01122173|466764369|FG000|Overall Study|Withdrawal by Subject|3|||
129673035|NCT01122173|466764369|FG000|Overall Study|Left study for other reasons|3|||
129673036|NCT01184872|466764370|FG000|Overall Study|Adverse Event|3|||
129673037|NCT01184872|466764371|FG001|Overall Study|Adverse Event|4|||
129673038|NCT01184872|466764370|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129673039|NCT01184872|466764371|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129673040|NCT01184872|466764370|FG000|Overall Study|Withdrawal by Subject|2|||
129673041|NCT01184872|466764371|FG001|Overall Study|Withdrawal by Subject|0|||
129673042|NCT01184872|466764370|FG000|Overall Study|Lost to Follow-up|0|||
129673043|NCT01184872|466764371|FG001|Overall Study|Lost to Follow-up|1|||
129673044|NCT01184872|466764370|FG000|Overall Study|Administrative problems|1|||
129673045|NCT01184872|466764371|FG001|Overall Study|Administrative problems|1|||
129673046|NCT01184872|466764370|FG000|Overall Study|Protocol deviation|1|||
129673047|NCT01184872|466764371|FG001|Overall Study|Protocol deviation|0|||
129673048|NCT02674516|466764372|FG000|Overall Study|Lost to Follow-up|3|||
129673049|NCT02674516|466764373|FG001|Overall Study|Lost to Follow-up|0|||
129673050|NCT02674516|466764372|FG000|Overall Study|Protocol Violation|0|||
129673051|NCT02674516|466764373|FG001|Overall Study|Protocol Violation|4|||
129673052|NCT02674516|466764372|FG000|Overall Study|Knowledge of study hypothesis|1|||
129547173|NCT01393626|466296156|FG002|Overall Study|Withdrawal by Subject|0|||
129673053|NCT02674516|466764373|FG001|Overall Study|Knowledge of study hypothesis|0|||
129673054|NCT02662569|466764375|FG000|Overall Study|Withdrawal by Subject|6|||
129673055|NCT02662569|466764376|FG001|Overall Study|Withdrawal by Subject|1|||
129673056|NCT02662569|466764377|FG002|Overall Study|Withdrawal by Subject|6|||
129673057|NCT02662569|466764378|FG003|Overall Study|Withdrawal by Subject|4|||
129673058|NCT02662569|466764375|FG000|Overall Study|Lost to Follow-up|1|||
129673059|NCT02662569|466764376|FG001|Overall Study|Lost to Follow-up|0|||
129673060|NCT02662569|466764377|FG002|Overall Study|Lost to Follow-up|0|||
129673061|NCT02662569|466764378|FG003|Overall Study|Lost to Follow-up|0|||
129673062|NCT04076917|466764379|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
129673063|NCT04076917|466764379|FG000|Overall Study|Study closure|13|||
129673064|NCT04076917|466764379|FG000|Overall Study|Physician Decision|3|||
129673065|NCT04076917|466764379|FG000|Overall Study|Death|1|||
129673066|NCT04076917|466764379|FG000|Overall Study|Lost to Follow-up|1|||
129673067|NCT04076917|466764379|FG000|Overall Study|Withdrawal by Subject|1|||
129673068|NCT04076917|466764379|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
129673069|NCT03863353|466764383|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
129673070|NCT03863353|466764384|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
129673071|NCT01299584|466764385|FG000|Overall Study|Protocol Violation|9|||
129673072|NCT02747927|466764386|FG000|Overall Study|Adverse Event|5|||
129673073|NCT02747927|466764387|FG001|Overall Study|Adverse Event|14|||
129673074|NCT02747927|466764386|FG000|Overall Study|Lost to Follow-up|22|||
129673075|NCT02747927|466764387|FG001|Overall Study|Lost to Follow-up|43|||
129673076|NCT02747927|466764386|FG000|Overall Study|Pregnancy|34|||
129673077|NCT02747927|466764387|FG001|Overall Study|Pregnancy|66|||
129673078|NCT02747927|466764386|FG000|Overall Study|Protocol Violation|2|||
129673079|NCT02747927|466764387|FG001|Overall Study|Protocol Violation|4|||
129673080|NCT02747927|466764386|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
129673081|NCT02747927|466764387|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
129673082|NCT02747927|466764386|FG000|Overall Study|Reason not Specified|11|||
129673083|NCT02747927|466764387|FG001|Overall Study|Reason not Specified|27|||
129673084|NCT03810183|466764390|FG000|Overall Study|Study terminated by Sponsor|2|||
129673085|NCT03810183|466764391|FG001|Overall Study|Study terminated by Sponsor|1|||
129673086|NCT00323063|466764393|FG000|Overall Study|Adverse Event|1|||
129673087|NCT00323063|466764394|FG001|Overall Study|Adverse Event|0|||
129673088|NCT00323063|466764393|FG000|Overall Study|brain mets discovered prior to treatment|1|||
129673089|NCT00323063|466764394|FG001|Overall Study|brain mets discovered prior to treatment|0|||
129673090|NCT00423046|466764395|FG000|Overall Study|Other|340|||
129673091|NCT00423046|466764396|FG001|Overall Study|Other|345|||
129673092|NCT00830128|466764397|FG000|Overall Study|Adverse Event|5|||
129673093|NCT00830128|466764397|FG000|Overall Study|Lack of Efficacy|7|||
129673094|NCT00830128|466764397|FG000|Overall Study|Protocol Violation|1|||
129673095|NCT00830128|466764397|FG000|Overall Study|Withdrawal by Subject|2|||
129673096|NCT00830128|466764397|FG000|Overall Study|Family obligation|1|||
129673097|NCT00830128|466764397|FG000|Overall Study|Relocation|1|||
129673098|NCT00830128|466764397|FG000|Overall Study|Work obligation|1|||
129673099|NCT00830128|466764397|FG000|Overall Study|Operating a vehicle|1|||
129673100|NCT04249427|466764402|FG000|Overall Study|Adverse Event|3|||
129673101|NCT04249427|466764403|FG001|Overall Study|Adverse Event|1|||
129673102|NCT04249427|466764402|FG000|Overall Study|Lack of Efficacy|0|||
129673103|NCT04249427|466764403|FG001|Overall Study|Lack of Efficacy|1|||
129673104|NCT04249427|466764402|FG000|Overall Study|Withdrawal by Subject|1|||
129673105|NCT04249427|466764403|FG001|Overall Study|Withdrawal by Subject|2|||
129673106|NCT01673178|466764404|FG000|Overall Study|Lost to Follow-up|0|||
129673107|NCT01673178|466764405|FG001|Overall Study|Lost to Follow-up|1|||
129673108|NCT01673178|466764406|FG002|Overall Study|Lost to Follow-up|0|||
129673109|NCT01673178|466764407|FG003|Overall Study|Lost to Follow-up|0|||
129673110|NCT01673178|466764408|FG004|Overall Study|Lost to Follow-up|0|||
129673111|NCT01673178|466764404|FG000|Overall Study|Withdrawal by Subject|0|||
129673112|NCT01673178|466764405|FG001|Overall Study|Withdrawal by Subject|0|||
129673113|NCT01673178|466764406|FG002|Overall Study|Withdrawal by Subject|1|||
129673114|NCT01673178|466764407|FG003|Overall Study|Withdrawal by Subject|4|||
129673115|NCT01673178|466764408|FG004|Overall Study|Withdrawal by Subject|2|||
129673116|NCT01673178|466764404|FG000|Overall Study|Protocol Violation|1|||
129673117|NCT01673178|466764405|FG001|Overall Study|Protocol Violation|1|||
129673118|NCT01673178|466764406|FG002|Overall Study|Protocol Violation|0|||
129673119|NCT01673178|466764407|FG003|Overall Study|Protocol Violation|1|||
129673120|NCT01673178|466764408|FG004|Overall Study|Protocol Violation|0|||
129673121|NCT01673178|466764404|FG000|Overall Study|Adverse Event|1|||
129673122|NCT01673178|466764405|FG001|Overall Study|Adverse Event|0|||
129673123|NCT01673178|466764406|FG002|Overall Study|Adverse Event|0|||
129673124|NCT01673178|466764407|FG003|Overall Study|Adverse Event|2|||
129673125|NCT01673178|466764408|FG004|Overall Study|Adverse Event|0|||
129673126|NCT01673178|466764404|FG000|Overall Study|Other|1|||
129673127|NCT01673178|466764405|FG001|Overall Study|Other|0|||
129673128|NCT01673178|466764406|FG002|Overall Study|Other|2|||
129673129|NCT01673178|466764407|FG003|Overall Study|Other|1|||
129673130|NCT01673178|466764408|FG004|Overall Study|Other|0|||
129673131|NCT01419314|466764410|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
129673132|NCT01419314|466764411|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
129673133|NCT01419314|466764410|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
129673134|NCT01419314|466764411|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
129673135|NCT01419314|466764410|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
129673136|NCT01419314|466764411|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
129673137|NCT00402727|466764414|FG000|Overall Study|Adverse Event|10|||
129673138|NCT00402727|466764415|FG001|Overall Study|Adverse Event|6|||
129673139|NCT00402727|466764414|FG000|Overall Study|Death|1|||
129673140|NCT00402727|466764415|FG001|Overall Study|Death|0|||
129673141|NCT00402727|466764414|FG000|Overall Study|Lack of Efficacy|1|||
129673142|NCT00402727|466764415|FG001|Overall Study|Lack of Efficacy|3|||
129673143|NCT00402727|466764414|FG000|Overall Study|Lost to Follow-up|24|||
129673144|NCT00402727|466764415|FG001|Overall Study|Lost to Follow-up|11|||
129673145|NCT00402727|466764414|FG000|Overall Study|Physician Decision|1|||
129673146|NCT00402727|466764415|FG001|Overall Study|Physician Decision|1|||
129647195|NCT02294175|466663835|FG001|Overall Study|Lost to Follow-up|1|||
129647196|NCT02294175|466663834|FG000|Overall Study|wound healed|0|||
129647197|NCT02294175|466663835|FG001|Overall Study|wound healed|2|||
129647198|NCT02548351|466663836|FG000|Overall Study|Withdrawal by Subject|149|||
129647199|NCT02548351|466663837|FG001|Overall Study|Withdrawal by Subject|154|||
129647200|NCT02548351|466663838|FG002|Overall Study|Withdrawal by Subject|152|||
129647201|NCT02548351|466663836|FG000|Overall Study|Death|11|||
129647202|NCT02548351|466663837|FG001|Overall Study|Death|15|||
129647203|NCT02548351|466663838|FG002|Overall Study|Death|12|||
129647204|NCT02548351|466663836|FG000|Overall Study|Adverse Event|22|||
129647205|NCT02548351|466663837|FG001|Overall Study|Adverse Event|56|||
129647206|NCT02548351|466663838|FG002|Overall Study|Adverse Event|36|||
129647207|NCT02548351|466663836|FG000|Overall Study|Study Terminated by Sponsor|549|||
129647208|NCT02548351|466663837|FG001|Overall Study|Study Terminated by Sponsor|509|||
129647209|NCT02548351|466663838|FG002|Overall Study|Study Terminated by Sponsor|528|||
129647210|NCT02548351|466663836|FG000|Overall Study|Site Closure|14|||
129647211|NCT02548351|466663837|FG001|Overall Study|Site Closure|5|||
129647212|NCT02548351|466663838|FG002|Overall Study|Site Closure|7|||
129647213|NCT02548351|466663836|FG000|Overall Study|Non-compliance with Study Drug|4|||
129647214|NCT02548351|466663837|FG001|Overall Study|Non-compliance with Study Drug|2|||
129647215|NCT02548351|466663838|FG002|Overall Study|Non-compliance with Study Drug|0|||
129647216|NCT02548351|466663836|FG000|Overall Study|Protocol Violation|2|||
129647217|NCT02548351|466663837|FG001|Overall Study|Protocol Violation|1|||
129647218|NCT02548351|466663838|FG002|Overall Study|Protocol Violation|2|||
129647219|NCT02548351|466663836|FG000|Overall Study|Physician Decision|11|||
129647220|NCT02548351|466663837|FG001|Overall Study|Physician Decision|18|||
129647221|NCT02548351|466663838|FG002|Overall Study|Physician Decision|11|||
129647222|NCT02548351|466663836|FG000|Overall Study|Lost to Follow-up|43|||
129647223|NCT02548351|466663837|FG001|Overall Study|Lost to Follow-up|50|||
129647224|NCT02548351|466663838|FG002|Overall Study|Lost to Follow-up|57|||
129647225|NCT02548351|466663836|FG000|Overall Study|Other|19|||
129647226|NCT02548351|466663837|FG001|Overall Study|Other|16|||
129647227|NCT02548351|466663838|FG002|Overall Study|Other|20|||
129647228|NCT02548351|466663836|FG000|Overall Study|Missing|1|||
129647229|NCT02548351|466663837|FG001|Overall Study|Missing|1|||
129647230|NCT02548351|466663838|FG002|Overall Study|Missing|0|||
129647231|NCT00125242|466663839|FG000|Overall Study|did not qualify|7|||
129647232|NCT00125242|466663840|FG001|Overall Study|did not qualify|2|||
129647233|NCT01664949|466663843|FG000|Overall Study|Adverse Event|11|||
129647234|NCT01664949|466663844|FG001|Overall Study|Adverse Event|12|||
129647235|NCT01664949|466663843|FG000|Overall Study|Lack of Efficacy|1|||
129647236|NCT01664949|466663844|FG001|Overall Study|Lack of Efficacy|1|||
129647237|NCT01664949|466663843|FG000|Overall Study|Lost to Follow-up|1|||
129647238|NCT01664949|466663844|FG001|Overall Study|Lost to Follow-up|2|||
129647239|NCT01664949|466663843|FG000|Overall Study|Personal Reasons|3|||
129647240|NCT01664949|466663844|FG001|Overall Study|Personal Reasons|4|||
129647241|NCT01664949|466663843|FG000|Overall Study|Protocol Violation|5|||
129647242|NCT01664949|466663844|FG001|Overall Study|Protocol Violation|5|||
129647243|NCT01664949|466663843|FG000|Overall Study|Other Miscellaneous Reasons|3|||
129647244|NCT01664949|466663844|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129647245|NCT03003494|466663846|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
129647246|NCT05238025|466663849|FG000|Overall Study|Adverse Event|2|||
129647247|NCT05238025|466663850|FG001|Overall Study|Adverse Event|2|||
129673147|NCT00402727|466764414|FG000|Overall Study|Protocol Violation|0|||
129673148|NCT00402727|466764415|FG001|Overall Study|Protocol Violation|4|||
129673149|NCT00402727|466764414|FG000|Overall Study|Withdrawal by Subject|3|||
129673150|NCT00402727|466764415|FG001|Overall Study|Withdrawal by Subject|7|||
129673151|NCT00402727|466764414|FG000|Overall Study|supply problems|2|||
129673152|NCT00402727|466764415|FG001|Overall Study|supply problems|1|||
129673153|NCT00402727|466764414|FG000|Overall Study|non-compliance|0|||
129673154|NCT00402727|466764415|FG001|Overall Study|non-compliance|1|||
129673155|NCT03188055|466764416|FG000|Overall Study|Unavailable for training|0|||
129673156|NCT03188055|466764417|FG001|Overall Study|Unavailable for training|0|||
129673157|NCT03188055|466764418|FG002|Overall Study|Unavailable for training|19|||
129673158|NCT03188055|466764419|FG003|Overall Study|Unavailable for training|0|||
129673159|NCT03188055|466764420|FG004|Overall Study|Unavailable for training|0|||
129673160|NCT03188055|466764421|FG005|Overall Study|Unavailable for training|0|||
129673161|NCT03188055|466764416|FG000|Overall Study|Lost to Follow-up|0|||
129673162|NCT03188055|466764417|FG001|Overall Study|Lost to Follow-up|18|||
129673163|NCT03188055|466764418|FG002|Overall Study|Lost to Follow-up|0|||
129673164|NCT03188055|466764419|FG003|Overall Study|Lost to Follow-up|11|||
129673165|NCT03188055|466764420|FG004|Overall Study|Lost to Follow-up|0|||
129673166|NCT03188055|466764421|FG005|Overall Study|Lost to Follow-up|0|||
129673167|NCT03188055|466764416|FG000|Overall Study|Withdrawal by Subject|0|||
129673168|NCT03188055|466764417|FG001|Overall Study|Withdrawal by Subject|1|||
129673169|NCT03188055|466764418|FG002|Overall Study|Withdrawal by Subject|0|||
129673170|NCT03188055|466764419|FG003|Overall Study|Withdrawal by Subject|1|||
129673171|NCT03188055|466764420|FG004|Overall Study|Withdrawal by Subject|0|||
129673172|NCT03188055|466764421|FG005|Overall Study|Withdrawal by Subject|0|||
129673173|NCT01405898|466764422|FG000|Overall Study|Withdrawal by Subject|2|||
129673174|NCT01405898|466764423|FG001|Overall Study|Withdrawal by Subject|2|||
129673175|NCT00887484|466764436|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
129673176|NCT00887484|466764436|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
129673177|NCT00887484|466764436|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
129673178|NCT03044314|466764437|FG000|Overall Study|Physician Decision|2|||
129673179|NCT03044314|466764437|FG000|Overall Study|Withdrawal by Subject|1|||
129673180|NCT03044314|466764437|FG000|Overall Study|Connector tubing not available|1|||
129673181|NCT00264147|466764438|FG000|Treatment I Period|Adverse Event|3|||
129673182|NCT00264147|466764439|FG001|Treatment I Period|Adverse Event|6|||
129673183|NCT00264147|466764440|FG002|Treatment I Period|Adverse Event|3|||
129673184|NCT00264147|466764441|FG003|Treatment I Period|Adverse Event|5|||
129673185|NCT00264147|466764442|FG004|Treatment I Period|Adverse Event|7|||
129673186|NCT00264147|466764443|FG005|Treatment I Period|Adverse Event|0|||
129673187|NCT00264147|466764438|FG000|Treatment I Period|Laboratory Adverse Event|0|||
129673188|NCT00264147|466764439|FG001|Treatment I Period|Laboratory Adverse Event|0|||
129673189|NCT00264147|466764440|FG002|Treatment I Period|Laboratory Adverse Event|0|||
129673190|NCT00264147|466764441|FG003|Treatment I Period|Laboratory Adverse Event|1|||
129673191|NCT00264147|466764442|FG004|Treatment I Period|Laboratory Adverse Event|0|||
129673192|NCT00264147|466764443|FG005|Treatment I Period|Laboratory Adverse Event|0|||
129647248|NCT05238025|466663849|FG000|Overall Study|Lost to Follow-up|334|||
129647249|NCT05238025|466663850|FG001|Overall Study|Lost to Follow-up|339|||
129673193|NCT00264147|466764438|FG000|Treatment I Period|Lack of Efficacy|6|||
129673194|NCT00264147|466764439|FG001|Treatment I Period|Lack of Efficacy|2|||
129673195|NCT00264147|466764440|FG002|Treatment I Period|Lack of Efficacy|8|||
129673196|NCT00264147|466764441|FG003|Treatment I Period|Lack of Efficacy|0|||
129673197|NCT00264147|466764442|FG004|Treatment I Period|Lack of Efficacy|1|||
129673198|NCT00264147|466764443|FG005|Treatment I Period|Lack of Efficacy|0|||
129673199|NCT00264147|466764438|FG000|Treatment I Period|Lost to Follow-up|1|||
129673200|NCT00264147|466764439|FG001|Treatment I Period|Lost to Follow-up|0|||
129673201|NCT00264147|466764440|FG002|Treatment I Period|Lost to Follow-up|0|||
129673202|NCT00264147|466764441|FG003|Treatment I Period|Lost to Follow-up|1|||
129673203|NCT00264147|466764442|FG004|Treatment I Period|Lost to Follow-up|1|||
129673204|NCT00264147|466764443|FG005|Treatment I Period|Lost to Follow-up|0|||
129673205|NCT00264147|466764438|FG000|Treatment I Period|Protocol Violation|2|||
129673206|NCT00264147|466764439|FG001|Treatment I Period|Protocol Violation|2|||
129673207|NCT00264147|466764440|FG002|Treatment I Period|Protocol Violation|0|||
129673208|NCT00264147|466764441|FG003|Treatment I Period|Protocol Violation|0|||
129673209|NCT00264147|466764442|FG004|Treatment I Period|Protocol Violation|0|||
129673210|NCT00264147|466764443|FG005|Treatment I Period|Protocol Violation|0|||
129673211|NCT00264147|466764438|FG000|Treatment I Period|Withdrawal by Subject|2|||
129673212|NCT00264147|466764439|FG001|Treatment I Period|Withdrawal by Subject|0|||
129673213|NCT00264147|466764440|FG002|Treatment I Period|Withdrawal by Subject|0|||
129673214|NCT00264147|466764441|FG003|Treatment I Period|Withdrawal by Subject|2|||
129673215|NCT00264147|466764442|FG004|Treatment I Period|Withdrawal by Subject|2|||
129673216|NCT00264147|466764443|FG005|Treatment I Period|Withdrawal by Subject|0|||
129673217|NCT00264147|466764438|FG000|Treatment I Period|Patient out of town for an extended time|0|||
129673218|NCT00264147|466764439|FG001|Treatment I Period|Patient out of town for an extended time|1|||
129673219|NCT00264147|466764440|FG002|Treatment I Period|Patient out of town for an extended time|0|||
129884388|NCT00708305|467536383|FG000|Period 2|Other Reason|1|||
129673220|NCT00264147|466764441|FG003|Treatment I Period|Patient out of town for an extended time|0|||
129673221|NCT00264147|466764442|FG004|Treatment I Period|Patient out of town for an extended time|0|||
129673222|NCT00264147|466764443|FG005|Treatment I Period|Patient out of town for an extended time|0|||
129673223|NCT00264147|466764438|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129673224|NCT00264147|466764439|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129673225|NCT00264147|466764440|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
129673226|NCT00264147|466764441|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129673227|NCT00264147|466764442|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129673228|NCT00264147|466764443|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
129673229|NCT00264147|466764438|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
129673230|NCT00264147|466764439|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
129673231|NCT00264147|466764440|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
129673232|NCT00264147|466764441|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
129673233|NCT00264147|466764442|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
129673234|NCT00264147|466764443|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
129673235|NCT00264147|466764438|FG000|Treatment II Period|Adverse Event|0|||
129673236|NCT00264147|466764439|FG001|Treatment II Period|Adverse Event|0|||
129673237|NCT00264147|466764440|FG002|Treatment II Period|Adverse Event|0|||
129673238|NCT00264147|466764441|FG003|Treatment II Period|Adverse Event|0|||
129673239|NCT00264147|466764442|FG004|Treatment II Period|Adverse Event|9|||
129673240|NCT00264147|466764443|FG005|Treatment II Period|Adverse Event|9|||
129673241|NCT00264147|466764438|FG000|Treatment II Period|Laboratory Adverse Event|0|||
129673242|NCT00264147|466764439|FG001|Treatment II Period|Laboratory Adverse Event|0|||
129673243|NCT00264147|466764440|FG002|Treatment II Period|Laboratory Adverse Event|0|||
129673244|NCT00264147|466764441|FG003|Treatment II Period|Laboratory Adverse Event|0|||
129673245|NCT00264147|466764442|FG004|Treatment II Period|Laboratory Adverse Event|0|||
129673246|NCT00264147|466764443|FG005|Treatment II Period|Laboratory Adverse Event|1|||
129673247|NCT00264147|466764438|FG000|Treatment II Period|Lack of Efficacy|0|||
129673248|NCT00264147|466764439|FG001|Treatment II Period|Lack of Efficacy|0|||
129673249|NCT00264147|466764440|FG002|Treatment II Period|Lack of Efficacy|0|||
129673250|NCT00264147|466764441|FG003|Treatment II Period|Lack of Efficacy|0|||
129673251|NCT00264147|466764442|FG004|Treatment II Period|Lack of Efficacy|20|||
129673252|NCT00264147|466764443|FG005|Treatment II Period|Lack of Efficacy|19|||
129673253|NCT00264147|466764438|FG000|Treatment II Period|Lost to Follow-up|0|||
129673254|NCT00264147|466764439|FG001|Treatment II Period|Lost to Follow-up|0|||
129673255|NCT00264147|466764440|FG002|Treatment II Period|Lost to Follow-up|0|||
129673256|NCT00264147|466764441|FG003|Treatment II Period|Lost to Follow-up|0|||
129673257|NCT00264147|466764442|FG004|Treatment II Period|Lost to Follow-up|1|||
129673258|NCT00264147|466764443|FG005|Treatment II Period|Lost to Follow-up|1|||
129673259|NCT00264147|466764438|FG000|Treatment II Period|Withdrawal by Subject|0|||
129673260|NCT00264147|466764439|FG001|Treatment II Period|Withdrawal by Subject|0|||
129673261|NCT00264147|466764440|FG002|Treatment II Period|Withdrawal by Subject|0|||
129673262|NCT00264147|466764441|FG003|Treatment II Period|Withdrawal by Subject|0|||
129673263|NCT00264147|466764442|FG004|Treatment II Period|Withdrawal by Subject|3|||
129673264|NCT00264147|466764443|FG005|Treatment II Period|Withdrawal by Subject|2|||
129673265|NCT00264147|466764438|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
129673266|NCT00264147|466764439|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
129673267|NCT00264147|466764440|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
129673268|NCT00264147|466764441|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
129673269|NCT00264147|466764442|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
129673270|NCT00264147|466764443|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
129673271|NCT01316224|466764444|FG000|Overall Study|Protocol Violation|3|||
129673272|NCT01316224|466764444|FG000|Overall Study|Adverse Event|3|||
129673273|NCT01316224|466764444|FG000|Overall Study|Lack of Efficacy|1|||
129673274|NCT01316224|466764444|FG000|Overall Study|Withdrawal by Subject|1|||
129673275|NCT01316224|466764444|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
129673276|NCT01316224|466764444|FG000|Overall Study|Other|1|||
129673277|NCT03234465|466764445|FG000|Overall Study|Adverse Event|4|||
129673278|NCT03234465|466764446|FG001|Overall Study|Adverse Event|2|||
129673279|NCT03234465|466764445|FG000|Overall Study|Death|0|||
129673280|NCT03234465|466764446|FG001|Overall Study|Death|1|||
129673281|NCT03234465|466764445|FG000|Overall Study|Lost to Follow-up|1|||
129673282|NCT03234465|466764446|FG001|Overall Study|Lost to Follow-up|1|||
129673283|NCT03234465|466764445|FG000|Overall Study|Withdrawal by Subject|12|||
129673284|NCT03234465|466764446|FG001|Overall Study|Withdrawal by Subject|27|||
129673285|NCT03234465|466764445|FG000|Overall Study|Symptomatic deterioration|0|||
129673286|NCT03234465|466764446|FG001|Overall Study|Symptomatic deterioration|1|||
129547174|NCT01393626|466296157|FG003|Overall Study|Withdrawal by Subject|0|||
129673287|NCT03234465|466764445|FG000|Overall Study|Non-compliance|2|||
129673288|NCT03234465|466764446|FG001|Overall Study|Non-compliance|0|||
129673289|NCT03234465|466764445|FG000|Overall Study|Other|14|||
129547175|NCT01393626|466296154|FG000|Overall Study|Other|1|||
129673290|NCT03234465|466764446|FG001|Overall Study|Other|8|||
129673291|NCT03106077|466764447|FG000|Overall Study|Screen Failure|94|||
129673292|NCT03106077|466764448|FG001|Overall Study|Screen Failure|0|||
129673293|NCT00449163|466764449|FG000|Overall Study|Physician Decision|3|||
129673294|NCT00606307|466764452|FG000|Overall Study|Adverse Event|2|||
129673295|NCT00606307|466764452|FG000|Overall Study|Withdrawal by Subject|2|||
129884389|NCT00708305|467536384|FG001|Period 2|Other Reason|0|||
129547176|NCT01393626|466296155|FG001|Overall Study|Other|0|||
129673296|NCT00606307|466764452|FG000|Overall Study|Disease progression|6|||
129673297|NCT00606307|466764452|FG000|Overall Study|QTc prolongation|1|||
129673298|NCT01274533|466764453|FG000|Overall Study|Withdrawal by Subject|1|||
129673299|NCT01274533|466764453|FG000|Overall Study|Non-compliance|1|||
129673300|NCT01274533|466764453|FG000|Overall Study|Disease progression|2|||
129673301|NCT02008526|466764463|FG000|Overall Study|Death|0|||
129673302|NCT02008526|466764464|FG001|Overall Study|Death|2|||
129673303|NCT02008526|466764465|FG002|Overall Study|Death|1|||
129673304|NCT02008526|466764463|FG000|Overall Study|Withdrawal by Subject|3|||
129673305|NCT02008526|466764464|FG001|Overall Study|Withdrawal by Subject|3|||
129673306|NCT02008526|466764465|FG002|Overall Study|Withdrawal by Subject|2|||
129673307|NCT02008526|466764463|FG000|Overall Study|Lost to Follow-up|5|||
129673308|NCT02008526|466764464|FG001|Overall Study|Lost to Follow-up|9|||
129673309|NCT02008526|466764465|FG002|Overall Study|Lost to Follow-up|6|||
129673310|NCT01118052|466764466|FG000|Overall Study|Never treated|2|||
129673311|NCT02949947|466764467|FG000|Overall Study|Non Compliance|0|||
129673312|NCT02949947|466764468|FG001|Overall Study|Non Compliance|1|||
129673313|NCT02949947|466764467|FG000|Overall Study|Insurance change|1|||
129673314|NCT02949947|466764468|FG001|Overall Study|Insurance change|0|||
129673315|NCT00828711|466764470|FG000|Overall Study|Lost to Follow-up|1|||
129673316|NCT00828711|466764471|FG001|Overall Study|Lost to Follow-up|0|||
129673317|NCT00828711|466764472|FG002|Overall Study|Lost to Follow-up|0|||
129673318|NCT01618968|466764473|FG000|Overall Study|Adverse Event|1|||
129673319|NCT01618968|466764474|FG001|Overall Study|Adverse Event|0|||
129673320|NCT01618968|466764475|FG002|Overall Study|Adverse Event|0|||
129673321|NCT01618968|466764476|FG003|Overall Study|Adverse Event|0|||
129673322|NCT01618968|466764473|FG000|Overall Study|Death|0|||
129673323|NCT01618968|466764474|FG001|Overall Study|Death|0|||
129673324|NCT01618968|466764475|FG002|Overall Study|Death|0|||
129673325|NCT01618968|466764476|FG003|Overall Study|Death|1|||
129673326|NCT02230891|466764477|FG000|Baseline|Did not meet inclusion|0|||
129673327|NCT02230891|466764478|FG001|Baseline|Did not meet inclusion|1|||
129673328|NCT02230891|466764479|FG002|Baseline|Did not meet inclusion|1|||
129673329|NCT02230891|466764477|FG000|2 Week|Withdrawal by Subject|2|||
129673330|NCT02230891|466764478|FG001|2 Week|Withdrawal by Subject|2|||
129673331|NCT02230891|466764479|FG002|2 Week|Withdrawal by Subject|0|||
129673332|NCT02230891|466764477|FG000|2 Week|Consent withdrawn|1|||
129673333|NCT02230891|466764478|FG001|2 Week|Consent withdrawn|0|||
129673334|NCT02230891|466764479|FG002|2 Week|Consent withdrawn|0|||
129673335|NCT02230891|466764477|FG000|6 Month|Withdrawal by Subject|1|||
129673336|NCT02230891|466764478|FG001|6 Month|Withdrawal by Subject|1|||
129673337|NCT02230891|466764479|FG002|6 Month|Withdrawal by Subject|1|||
129673338|NCT02230891|466764477|FG000|6 Month|Physician Decision|0|||
129673339|NCT02230891|466764478|FG001|6 Month|Physician Decision|2|||
129673340|NCT02230891|466764479|FG002|6 Month|Physician Decision|0|||
129673341|NCT02230891|466764477|FG000|12 Month|Death|1|||
129673342|NCT02230891|466764478|FG001|12 Month|Death|0|||
129673343|NCT02230891|466764479|FG002|12 Month|Death|0|||
129673344|NCT02230891|466764477|FG000|12 Month|Lost to Follow-up|0|||
129673345|NCT02230891|466764478|FG001|12 Month|Lost to Follow-up|1|||
129673346|NCT02230891|466764479|FG002|12 Month|Lost to Follow-up|0|||
129673347|NCT02230891|466764477|FG000|12 Month|Withdrawal by Subject|0|||
129673348|NCT02230891|466764478|FG001|12 Month|Withdrawal by Subject|2|||
129673349|NCT02230891|466764479|FG002|12 Month|Withdrawal by Subject|0|||
129673350|NCT02230891|466764477|FG000|18 Month End of Study|Death|0|||
129673351|NCT02230891|466764478|FG001|18 Month End of Study|Death|0|||
129673352|NCT02230891|466764479|FG002|18 Month End of Study|Death|1|||
129673353|NCT02230891|466764477|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
129673354|NCT02230891|466764478|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
129673355|NCT02230891|466764479|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
129673356|NCT02370511|466764482|FG000|Overall Study|Death|10|||
129673357|NCT02370511|466764483|FG001|Overall Study|Death|7|||
129673358|NCT02370511|466764484|FG002|Overall Study|Death|1|||
129673359|NCT02370511|466764482|FG000|Overall Study|Withdrawal by Subject|2|||
129673360|NCT02370511|466764483|FG001|Overall Study|Withdrawal by Subject|0|||
129673361|NCT02370511|466764484|FG002|Overall Study|Withdrawal by Subject|0|||
129673362|NCT02370511|466764482|FG000|Overall Study|Lost to Follow-up|0|||
129673363|NCT02370511|466764483|FG001|Overall Study|Lost to Follow-up|4|||
129673364|NCT02370511|466764484|FG002|Overall Study|Lost to Follow-up|0|||
129673365|NCT03882918|466764492|FG000|Overall Study|Study terminated by sponsor|98|||
129673366|NCT03882918|466764492|FG000|Overall Study|Protocol Violation|1|||
129673367|NCT03882918|466764492|FG000|Overall Study|Other|9|||
129673368|NCT03882918|466764492|FG000|Overall Study|Lack of Efficacy|14|||
129673369|NCT03882918|466764492|FG000|Overall Study|Adverse Event|13|||
129673370|NCT03882918|466764492|FG000|Overall Study|Withdrawal by Subject|5|||
129673371|NCT02100124|466764498|FG000|Overall Study|Lost to Follow-up|5|||
129673372|NCT02100124|466764499|FG001|Overall Study|Lost to Follow-up|11|||
129673373|NCT02100124|466764500|FG002|Overall Study|Lost to Follow-up|3|||
129673374|NCT02100124|466764498|FG000|Overall Study|Withdrawal by Subject|1|||
129673375|NCT02100124|466764499|FG001|Overall Study|Withdrawal by Subject|0|||
129673376|NCT02100124|466764500|FG002|Overall Study|Withdrawal by Subject|0|||
129673377|NCT00870727|466766369|FG000|Overall Study|Lost to Follow-up|0|||
129673378|NCT00870727|466766370|FG001|Overall Study|Lost to Follow-up|1|||
129673379|NCT00870727|466766369|FG000|Overall Study|Lack of Efficacy|1|||
129673380|NCT00870727|466766370|FG001|Overall Study|Lack of Efficacy|3|||
129673381|NCT00870727|466766369|FG000|Overall Study|Adverse Event|0|||
129673382|NCT00870727|466766370|FG001|Overall Study|Adverse Event|1|||
129673383|NCT01384877|466766374|FG000|Treatment 2|Lost to Follow-up|2|||
129673384|NCT01384877|466766375|FG001|Treatment 2|Lost to Follow-up|2|||
129673385|NCT03630393|466766376|FG000|Overall Study|Death|1|||
129673386|NCT03630393|466766377|FG001|Overall Study|Death|0|||
129673387|NCT00408499|466766378|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129673388|NCT00408499|466766379|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129673389|NCT00408499|466766380|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
129673390|NCT00408499|466766381|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129673391|NCT00408499|466766382|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
129673392|NCT00408499|466766378|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
129673393|NCT00408499|466766379|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
129673394|NCT00408499|466766380|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
129673395|NCT00408499|466766381|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
129673396|NCT00408499|466766382|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
129673397|NCT00408499|466766378|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
129673398|NCT00408499|466766379|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
129673399|NCT00408499|466766380|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
129673400|NCT00408499|466766381|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
129673401|NCT00408499|466766382|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
129673402|NCT00408499|466766378|FG000|Phase II- MTD Expansion|Adverse Event|0|||
129673403|NCT00408499|466766379|FG001|Phase II- MTD Expansion|Adverse Event|0|||
129673404|NCT00408499|466766380|FG002|Phase II- MTD Expansion|Adverse Event|0|||
129673405|NCT00408499|466766381|FG003|Phase II- MTD Expansion|Adverse Event|0|||
129673406|NCT00408499|466766382|FG004|Phase II- MTD Expansion|Adverse Event|9|||
129673407|NCT00408499|466766378|FG000|Phase II- MTD Expansion|Death|0|||
129673408|NCT00408499|466766379|FG001|Phase II- MTD Expansion|Death|0|||
129673409|NCT00408499|466766380|FG002|Phase II- MTD Expansion|Death|0|||
129673410|NCT00408499|466766381|FG003|Phase II- MTD Expansion|Death|0|||
129673411|NCT00408499|466766382|FG004|Phase II- MTD Expansion|Death|2|||
129673412|NCT00408499|466766378|FG000|Phase II- MTD Expansion|Physician Decision|0|||
129673413|NCT00408499|466766379|FG001|Phase II- MTD Expansion|Physician Decision|0|||
129673414|NCT00408499|466766380|FG002|Phase II- MTD Expansion|Physician Decision|0|||
129673415|NCT00408499|466766381|FG003|Phase II- MTD Expansion|Physician Decision|0|||
129673416|NCT00408499|466766382|FG004|Phase II- MTD Expansion|Physician Decision|1|||
129673417|NCT00408499|466766378|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129673418|NCT00408499|466766379|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129673419|NCT00408499|466766380|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129673420|NCT00408499|466766381|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
129673421|NCT00408499|466766382|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
129673422|NCT00408499|466766378|FG000|Phase II- MTD Expansion|treatment delay|0|||
129673423|NCT00408499|466766379|FG001|Phase II- MTD Expansion|treatment delay|0|||
129673424|NCT00408499|466766380|FG002|Phase II- MTD Expansion|treatment delay|0|||
129673425|NCT00408499|466766381|FG003|Phase II- MTD Expansion|treatment delay|0|||
129673426|NCT00408499|466766382|FG004|Phase II- MTD Expansion|treatment delay|3|||
129673427|NCT01586195|466766383|FG000|Overall Study|Death|11|||
129673428|NCT01586195|466766383|FG000|Overall Study|Withdrawal of Consent|5|||
129884390|NCT00708305|467536385|FG002|Period 2|Other Reason|0|||
129673429|NCT01586195|466766383|FG000|Overall Study|Started new anti-melanoma therapy|1|||
129673430|NCT01586195|466766383|FG000|Overall Study|Reason not specified|9|||
129673431|NCT00997334|466766384|FG000|Overall Study|still on therapy|12|||
129673432|NCT00997334|466766384|FG000|Overall Study|Adverse Event|3|||
129673433|NCT00997334|466766384|FG000|Overall Study|Patient non-compliance|1|||
129673434|NCT00997334|466766384|FG000|Overall Study|Withdrawal by Subject|3|||
129673435|NCT00997334|466766384|FG000|Overall Study|Death|2|||
129673436|NCT00997334|466766384|FG000|Overall Study|Urgent Palliative Care|2|||
129673437|NCT00997334|466766384|FG000|Overall Study|No lesion amenable|1|||
129673438|NCT00997334|466766384|FG000|Overall Study|Ineligible|1|||
129673439|NCT04745351|466766396|FG000|Overall Study|Death|51|||
129673440|NCT04745351|466766397|FG001|Overall Study|Death|25|||
129673441|NCT04745351|466766396|FG000|Overall Study|Lost to Follow-up|9|||
129673442|NCT04745351|466766397|FG001|Overall Study|Lost to Follow-up|3|||
129673443|NCT04745351|466766396|FG000|Overall Study|Randomized but Never Treated|3|||
129673444|NCT04745351|466766397|FG001|Overall Study|Randomized but Never Treated|3|||
129673445|NCT04745351|466766396|FG000|Overall Study|Adverse Event|4|||
129673446|NCT04745351|466766397|FG001|Overall Study|Adverse Event|0|||
129673447|NCT04745351|466766396|FG000|Overall Study|Withdrew Consent|1|||
129673448|NCT04745351|466766397|FG001|Overall Study|Withdrew Consent|2|||
129673449|NCT04745351|466766396|FG000|Overall Study|Investigator's Discretion|2|||
129673450|NCT04745351|466766397|FG001|Overall Study|Investigator's Discretion|0|||
129673451|NCT04745351|466766396|FG000|Overall Study|Protocol Violation|1|||
129673452|NCT04745351|466766397|FG001|Overall Study|Protocol Violation|0|||
129673453|NCT01863771|466766400|FG000|Induction Phase|Adverse Event|9|||
129673454|NCT01863771|466766401|FG001|Induction Phase|Adverse Event|0|||
129673455|NCT01863771|466766402|FG002|Induction Phase|Adverse Event|0|||
129673456|NCT01863771|466766403|FG003|Induction Phase|Adverse Event|0|||
129673457|NCT01863771|466766400|FG000|Induction Phase|Lack of Efficacy|10|||
129673458|NCT01863771|466766401|FG001|Induction Phase|Lack of Efficacy|0|||
129673459|NCT01863771|466766402|FG002|Induction Phase|Lack of Efficacy|0|||
129673460|NCT01863771|466766403|FG003|Induction Phase|Lack of Efficacy|0|||
129673461|NCT01863771|466766400|FG000|Induction Phase|Withdrawal by Subject|2|||
129673462|NCT01863771|466766401|FG001|Induction Phase|Withdrawal by Subject|0|||
129673463|NCT01863771|466766402|FG002|Induction Phase|Withdrawal by Subject|0|||
129673464|NCT01863771|466766403|FG003|Induction Phase|Withdrawal by Subject|0|||
129673465|NCT01863771|466766400|FG000|Maintenance Phase|Adverse Event|0|||
129673466|NCT01863771|466766401|FG001|Maintenance Phase|Adverse Event|0|||
129673467|NCT01863771|466766402|FG002|Maintenance Phase|Adverse Event|1|||
129673468|NCT01863771|466766403|FG003|Maintenance Phase|Adverse Event|1|||
129673469|NCT01863771|466766400|FG000|Maintenance Phase|Lack of Efficacy|0|||
129673470|NCT01863771|466766401|FG001|Maintenance Phase|Lack of Efficacy|3|||
129673471|NCT01863771|466766402|FG002|Maintenance Phase|Lack of Efficacy|7|||
129673472|NCT01863771|466766403|FG003|Maintenance Phase|Lack of Efficacy|38|||
129673473|NCT01863771|466766400|FG000|Maintenance Phase|Physician Decision|0|||
129673474|NCT01863771|466766401|FG001|Maintenance Phase|Physician Decision|0|||
129673475|NCT01863771|466766402|FG002|Maintenance Phase|Physician Decision|2|||
129673476|NCT01863771|466766403|FG003|Maintenance Phase|Physician Decision|1|||
129673477|NCT01863771|466766400|FG000|Maintenance Phase|Pregnancy|0|||
129673478|NCT01863771|466766401|FG001|Maintenance Phase|Pregnancy|1|||
129673479|NCT01863771|466766402|FG002|Maintenance Phase|Pregnancy|0|||
129673480|NCT01863771|466766403|FG003|Maintenance Phase|Pregnancy|0|||
129673481|NCT01863771|466766400|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129673482|NCT01863771|466766401|FG001|Maintenance Phase|Withdrawal by Subject|1|||
129673483|NCT01863771|466766402|FG002|Maintenance Phase|Withdrawal by Subject|2|||
129673484|NCT01863771|466766403|FG003|Maintenance Phase|Withdrawal by Subject|3|||
129673485|NCT01248455|466766408|FG000|Overall Study|switched to alternate treatment|1|||
129673486|NCT00426270|466766409|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
129673487|NCT00426270|466766409|FG000|Overall Study|Adverse Event|5|||
129673488|NCT01117870|466766411|FG000|Overall Study|Inability to place needle|1|||
129673489|NCT01117870|466766412|FG001|Overall Study|Inability to place needle|0|||
129673490|NCT00958074|466766413|FG000|Overall Study|Withdrawal by Subject|0|||
129673491|NCT00958074|466766414|FG001|Overall Study|Withdrawal by Subject|1|||
129673492|NCT03102762|466766415|FG000|Overall Study|Lost to Follow-up|1|||
129673493|NCT03102762|466766416|FG001|Overall Study|Lost to Follow-up|0|||
129673494|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
129673495|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129673496|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129673497|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129673498|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
129673499|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
129673500|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129673501|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129673502|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129673503|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
129673504|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
129673505|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129673506|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129884391|NCT00708305|467536386|FG003|Period 2|Other Reason|1|||
129884392|NCT00708305|467536383|FG000|Period 3|Protocol Violation|0|||
129673507|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129673508|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
129673509|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
129673510|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129673511|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129673512|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129673513|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
129673514|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
129673515|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129673516|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129673517|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129673518|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
129673519|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
129673520|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129673521|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129673522|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129673523|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
129673524|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
129673525|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129673526|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129673527|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129673528|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
129673529|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
129673530|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129547177|NCT01393626|466296156|FG002|Overall Study|Other|0|||
129884393|NCT00708305|467536384|FG001|Period 3|Protocol Violation|2|||
129673531|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129673532|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129673533|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
129884394|NCT00708305|467536385|FG002|Period 3|Protocol Violation|0|||
129673534|NCT02709746|466766417|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
129673535|NCT02709746|466766418|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129673536|NCT02709746|466766419|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129673537|NCT02709746|466766420|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129673538|NCT02709746|466766421|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
129673539|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
129673540|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
129673541|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
129673542|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
129673543|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
129673544|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
129673545|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
129673546|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
129673547|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
129673548|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
129673549|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
129673550|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
129673551|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
129673552|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
129673553|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
129673554|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
129673555|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
129673556|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
129673557|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
129673558|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
129673559|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
129673560|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
129673561|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
129673562|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
129673563|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
129673564|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
129673565|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
129673566|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
129673567|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
129673568|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
129673569|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129673570|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129673571|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
129884395|NCT00708305|467536386|FG003|Period 3|Protocol Violation|0|||
129673572|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129673573|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
129673574|NCT02709746|466766417|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
129673575|NCT02709746|466766418|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
129673576|NCT02709746|466766419|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
129673577|NCT02709746|466766420|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
129673578|NCT02709746|466766421|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
129673579|NCT03322293|466766427|FG000|Overall Study|Lost to Follow-up|0|||
129673580|NCT03322293|466766428|FG001|Overall Study|Lost to Follow-up|0|||
129673581|NCT03322293|466766429|FG002|Overall Study|Lost to Follow-up|1|||
129673582|NCT01178294|466766430|FG000|Overall Study|Adverse Event|4|||
129673583|NCT01178294|466766430|FG000|Overall Study|Lost to Follow-up|2|||
129673584|NCT01178294|466766430|FG000|Overall Study|Lack of Efficacy|1|||
129673585|NCT01178294|466766430|FG000|Overall Study|Death|1|||
129673586|NCT01178294|466766430|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
129673587|NCT01178294|466766430|FG000|Overall Study|Subject status is terminal|1|||
129673588|NCT01178294|466766430|FG000|Overall Study|Completion status could not be verified|1|||
129673589|NCT02089347|466766431|FG000|Overall Study|Protocol Violation|1|||
129673590|NCT02089347|466766432|FG001|Overall Study|Protocol Violation|0|||
129673591|NCT00551369|466766433|FG000|Overall Study|Protocol Violation|5|||
129673592|NCT00551369|466766433|FG000|Overall Study|Withdrawal by Subject|1|||
129673593|NCT00551369|466766433|FG000|Overall Study|Not treated per protocol and re|1|||
129673594|NCT03426345|466766434|FG000|Overall Study|Adverse Event|4|||
129673595|NCT03426345|466766435|FG001|Overall Study|Adverse Event|4|||
129673596|NCT03426345|466766434|FG000|Overall Study|Lack of Efficacy|1|||
129673597|NCT03426345|466766435|FG001|Overall Study|Lack of Efficacy|0|||
129673598|NCT03426345|466766434|FG000|Overall Study|Withdrawal by Subject|5|||
129673599|NCT03426345|466766435|FG001|Overall Study|Withdrawal by Subject|6|||
129673600|NCT03426345|466766434|FG000|Overall Study|Lost to Follow-up|3|||
129673601|NCT03426345|466766435|FG001|Overall Study|Lost to Follow-up|1|||
129673602|NCT03426345|466766434|FG000|Overall Study|Protocol Deviation|3|||
129673603|NCT03426345|466766435|FG001|Overall Study|Protocol Deviation|4|||
129673604|NCT03426345|466766434|FG000|Overall Study|Reason Not Specified|1|||
129673605|NCT03426345|466766435|FG001|Overall Study|Reason Not Specified|2|||
129673606|NCT03426345|466766434|FG000|Overall Study|Missing Completion Status|1|||
129673607|NCT03426345|466766435|FG001|Overall Study|Missing Completion Status|0|||
129673608|NCT02446691|466766436|FG000|Overall Study|Withdrawal by Subject|2|||
129673609|NCT02446691|466766436|FG000|Overall Study|Lost to Follow-up|8|||
129673610|NCT02446691|466766436|FG000|Overall Study|Protocol Violation|1|||
129673611|NCT02497469|466766437|FG000|Overall Study|Randomized but not Treated|0|||
129673612|NCT02497469|466766438|FG001|Overall Study|Randomized but not Treated|2|||
129673613|NCT02497469|466766437|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
129673614|NCT02497469|466766438|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
129673615|NCT02497469|466766437|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
129673616|NCT02497469|466766438|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
129673617|NCT02497469|466766437|FG000|Overall Study|Significant Protocol Deviation|4|||
129673618|NCT02497469|466766438|FG001|Overall Study|Significant Protocol Deviation|5|||
129673619|NCT02497469|466766437|FG000|Overall Study|Lost to Follow-up|14|||
129673620|NCT02497469|466766438|FG001|Overall Study|Lost to Follow-up|4|||
129673621|NCT02497469|466766437|FG000|Overall Study|Voluntary Withdrawal|39|||
129673622|NCT02497469|466766438|FG001|Overall Study|Voluntary Withdrawal|41|||
129673623|NCT02497469|466766437|FG000|Overall Study|Pregnancy|1|||
129673624|NCT02497469|466766438|FG001|Overall Study|Pregnancy|1|||
129673625|NCT02497469|466766437|FG000|Overall Study|Lack of Efficacy|86|||
129673626|NCT02497469|466766438|FG001|Overall Study|Lack of Efficacy|40|||
129673627|NCT02497469|466766437|FG000|Overall Study|Reason not Specified|6|||
129673628|NCT02497469|466766438|FG001|Overall Study|Reason not Specified|6|||
129673629|NCT01026493|466766440|FG000|Overall Study|Protocol Violation|0|||
129673630|NCT01026493|466766441|FG001|Overall Study|Protocol Violation|1|||
129673631|NCT01026493|466766442|FG002|Overall Study|Protocol Violation|0|||
129673632|NCT01026493|466766443|FG003|Overall Study|Protocol Violation|0|||
129673633|NCT01026493|466766444|FG004|Overall Study|Protocol Violation|2|||
129673634|NCT01026493|466766445|FG005|Overall Study|Protocol Violation|3|||
129673635|NCT01026493|466766446|FG006|Overall Study|Protocol Violation|4|||
129673636|NCT01026493|466766447|FG007|Overall Study|Protocol Violation|1|||
129673637|NCT00630916|466766451|FG000|Overall Study|Death|110|||
129673638|NCT00630916|466766451|FG000|Overall Study|Explant|8|||
129673639|NCT00630916|466766451|FG000|Overall Study|Lost to Follow-up|5|||
129673640|NCT00630916|466766451|FG000|Overall Study|Withdrawal by Subject|30|||
129673641|NCT00630916|466766451|FG000|Overall Study|Protocol Violation|7|||
129673642|NCT00630916|466766451|FG000|Overall Study|Physician Decision|47|||
129673643|NCT00630916|466766451|FG000|Overall Study|Lack of Efficacy|3|||
129673644|NCT05412134|466766458|FG000|Overall Study|Lost to Follow-up|2|||
129673645|NCT05412134|466766459|FG001|Overall Study|Lost to Follow-up|0|||
129673646|NCT03167242|466766460|FG000|Overall Study|Patient/Guardian Decision|0|||
129673647|NCT03167242|466766461|FG001|Overall Study|Patient/Guardian Decision|1|||
129673648|NCT03167242|466766462|FG002|Overall Study|Patient/Guardian Decision|2|||
129673649|NCT03167242|466766463|FG003|Overall Study|Patient/Guardian Decision|1|||
129673650|NCT03167242|466766464|FG004|Overall Study|Patient/Guardian Decision|1|||
129673651|NCT03167242|466766465|FG005|Overall Study|Patient/Guardian Decision|1|||
129673652|NCT03167242|466766466|FG006|Overall Study|Patient/Guardian Decision|0|||
129673653|NCT03167242|466766467|FG007|Overall Study|Patient/Guardian Decision|0|||
129673654|NCT03167242|466766468|FG008|Overall Study|Patient/Guardian Decision|0|||
129673655|NCT03167242|466766469|FG009|Overall Study|Patient/Guardian Decision|0|||
129673656|NCT03167242|466766470|FG010|Overall Study|Patient/Guardian Decision|1|||
129547178|NCT01393626|466296157|FG003|Overall Study|Other|0|||
129673657|NCT03167242|466766471|FG011|Overall Study|Patient/Guardian Decision|0|||
129673658|NCT03167242|466766460|FG000|Overall Study|Lost to Follow-up|0|||
129673659|NCT03167242|466766461|FG001|Overall Study|Lost to Follow-up|0|||
129673660|NCT03167242|466766462|FG002|Overall Study|Lost to Follow-up|1|||
129673661|NCT03167242|466766463|FG003|Overall Study|Lost to Follow-up|0|||
129673662|NCT03167242|466766464|FG004|Overall Study|Lost to Follow-up|0|||
129673663|NCT03167242|466766465|FG005|Overall Study|Lost to Follow-up|1|||
129673664|NCT03167242|466766466|FG006|Overall Study|Lost to Follow-up|2|||
129673665|NCT03167242|466766467|FG007|Overall Study|Lost to Follow-up|1|||
129547179|NCT01393626|466296154|FG000|Overall Study|Protocol Violation|1|||
129673666|NCT03167242|466766468|FG008|Overall Study|Lost to Follow-up|0|||
129673667|NCT03167242|466766469|FG009|Overall Study|Lost to Follow-up|0|||
129673668|NCT03167242|466766470|FG010|Overall Study|Lost to Follow-up|1|||
129673669|NCT03167242|466766471|FG011|Overall Study|Lost to Follow-up|1|||
129673670|NCT03167242|466766460|FG000|Overall Study|Reason not provided|0|||
129673671|NCT03167242|466766461|FG001|Overall Study|Reason not provided|0|||
129673672|NCT03167242|466766462|FG002|Overall Study|Reason not provided|0|||
129673673|NCT03167242|466766463|FG003|Overall Study|Reason not provided|0|||
129673674|NCT03167242|466766464|FG004|Overall Study|Reason not provided|0|||
129673675|NCT03167242|466766465|FG005|Overall Study|Reason not provided|0|||
129673676|NCT03167242|466766466|FG006|Overall Study|Reason not provided|0|||
129673677|NCT03167242|466766467|FG007|Overall Study|Reason not provided|0|||
129673678|NCT03167242|466766468|FG008|Overall Study|Reason not provided|1|||
129673679|NCT03167242|466766469|FG009|Overall Study|Reason not provided|0|||
129673680|NCT03167242|466766470|FG010|Overall Study|Reason not provided|0|||
129673681|NCT03167242|466766471|FG011|Overall Study|Reason not provided|0|||
129673682|NCT05401565|466766476|FG000|Overall Study|Lost to Follow-up|1|||
129884396|NCT00708305|467536383|FG000|Period 3|Other Reason|1|||
129673683|NCT05401565|466766477|FG001|Overall Study|Lost to Follow-up|0|||
129673684|NCT05401565|466766476|FG000|Overall Study|Adverse Event|2|||
129673685|NCT05401565|466766477|FG001|Overall Study|Adverse Event|0|||
129673686|NCT00726609|466766480|FG000|Overall Study|Adverse Event|10|||
129673687|NCT00726609|466766480|FG000|Overall Study|Withdrawal by Subject|2|||
129673688|NCT00726609|466766480|FG000|Overall Study|Lack of Efficacy|25|||
129673689|NCT00726609|466766480|FG000|Overall Study|Other|16|||
129673690|NCT00726609|466766480|FG000|Overall Study|Missing|42|||
129673691|NCT00726609|466766480|FG000|Overall Study|Other|3|||
129884397|NCT00708305|467536384|FG001|Period 3|Other Reason|0|||
129673692|NCT03080935|466766490|FG000|Overall Study|Death|34|||
129673693|NCT03080935|466766491|FG001|Overall Study|Death|50|||
129673694|NCT03080935|466766490|FG000|Overall Study|Lost to Follow-up|5|||
129884398|NCT00708305|467536385|FG002|Period 3|Other Reason|0|||
129673695|NCT03080935|466766491|FG001|Overall Study|Lost to Follow-up|4|||
129673696|NCT03080935|466766490|FG000|Overall Study|Withdrawal by Subject|11|||
129673697|NCT03080935|466766491|FG001|Overall Study|Withdrawal by Subject|15|||
129673698|NCT02175121|466766492|FG000|Overall Study|Lack of Efficacy|1|||
129673699|NCT02175121|466766493|FG001|Overall Study|Lack of Efficacy|0|||
129673700|NCT02175121|466766494|FG002|Overall Study|Lack of Efficacy|0|||
129673701|NCT02175121|466766495|FG003|Overall Study|Lack of Efficacy|0|||
129673702|NCT02175121|466766496|FG004|Overall Study|Lack of Efficacy|0|||
129673703|NCT02175121|466766492|FG000|Overall Study|Lost to Follow-up|0|||
129673704|NCT02175121|466766493|FG001|Overall Study|Lost to Follow-up|1|||
129673705|NCT02175121|466766494|FG002|Overall Study|Lost to Follow-up|0|||
129673706|NCT02175121|466766495|FG003|Overall Study|Lost to Follow-up|1|||
129673707|NCT02175121|466766496|FG004|Overall Study|Lost to Follow-up|0|||
129673708|NCT02175121|466766492|FG000|Overall Study|Personal emergency|0|||
129673709|NCT02175121|466766493|FG001|Overall Study|Personal emergency|0|||
129673710|NCT02175121|466766494|FG002|Overall Study|Personal emergency|0|||
129673711|NCT02175121|466766495|FG003|Overall Study|Personal emergency|0|||
129673712|NCT02175121|466766496|FG004|Overall Study|Personal emergency|1|||
129673713|NCT02175121|466766492|FG000|Overall Study|Schedule conflict|0|||
129673714|NCT02175121|466766493|FG001|Overall Study|Schedule conflict|0|||
129673715|NCT02175121|466766494|FG002|Overall Study|Schedule conflict|1|||
129673716|NCT02175121|466766495|FG003|Overall Study|Schedule conflict|0|||
129673717|NCT02175121|466766496|FG004|Overall Study|Schedule conflict|0|||
129673718|NCT02175121|466766492|FG000|Overall Study|Time issues|0|||
129673719|NCT02175121|466766493|FG001|Overall Study|Time issues|0|||
129673720|NCT02175121|466766494|FG002|Overall Study|Time issues|1|||
129673721|NCT02175121|466766495|FG003|Overall Study|Time issues|0|||
129673722|NCT02175121|466766496|FG004|Overall Study|Time issues|0|||
129673723|NCT03329885|466766497|FG000|Overall Study|Sponsor discontinued the study early|0|||
129673724|NCT03329885|466766498|FG001|Overall Study|Sponsor discontinued the study early|0|||
129673725|NCT03329885|466766499|FG002|Overall Study|Sponsor discontinued the study early|0|||
129673726|NCT03329885|466766500|FG003|Overall Study|Sponsor discontinued the study early|0|||
129673727|NCT03329885|466766501|FG004|Overall Study|Sponsor discontinued the study early|0|||
129673728|NCT03329885|466766502|FG005|Overall Study|Sponsor discontinued the study early|0|||
129673729|NCT03329885|466766503|FG006|Overall Study|Sponsor discontinued the study early|1|||
129673730|NCT03329885|466766504|FG007|Overall Study|Sponsor discontinued the study early|1|||
129673731|NCT03329885|466766505|FG008|Overall Study|Sponsor discontinued the study early|0|||
129673732|NCT00269152|466766512|FG000|Overall Study|Adverse Event|9|||
129673733|NCT00269152|466766513|FG001|Overall Study|Adverse Event|3|||
129673734|NCT00269152|466766512|FG000|Overall Study|Withdrawal by Subject|7|||
129673735|NCT00269152|466766513|FG001|Overall Study|Withdrawal by Subject|3|||
129673736|NCT00269152|466766512|FG000|Overall Study|Physician Decision|2|||
129673737|NCT00269152|466766513|FG001|Overall Study|Physician Decision|3|||
129673738|NCT00269152|466766512|FG000|Overall Study|Protocol Violation|0|||
129673739|NCT00269152|466766513|FG001|Overall Study|Protocol Violation|1|||
129673740|NCT03886272|466766514|FG000|Period 1|Withdrawal by Subject|0|||
129673741|NCT03886272|466766515|FG001|Period 1|Withdrawal by Subject|0|||
129673742|NCT03886272|466766516|FG002|Period 1|Withdrawal by Subject|0|||
129673743|NCT03886272|466766517|FG003|Period 1|Withdrawal by Subject|0|||
129673744|NCT03886272|466766518|FG004|Period 1|Withdrawal by Subject|0|||
129673745|NCT03886272|466766519|FG005|Period 1|Withdrawal by Subject|1|||
129673746|NCT03886272|466766520|FG006|Period 1|Withdrawal by Subject|0|||
129673747|NCT02557399|466766521|FG000|Overall Study|Adverse Event|6|||
129673748|NCT02557399|466766522|FG001|Overall Study|Adverse Event|5|||
129673749|NCT02557399|466766521|FG000|Overall Study|Protocol Violation|0|||
129673750|NCT02557399|466766522|FG001|Overall Study|Protocol Violation|1|||
129673751|NCT02557399|466766521|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129673752|NCT02557399|466766522|FG001|Overall Study|Protocol-defined stopping criteria|1|||
129673753|NCT02557399|466766521|FG000|Overall Study|Withdrawal by Subject|1|||
129673754|NCT02557399|466766522|FG001|Overall Study|Withdrawal by Subject|1|||
129673755|NCT00931632|466766523|FG000|Overall Study|Withdrawal by Subject|2|||
129673756|NCT00931632|466766524|FG001|Overall Study|Withdrawal by Subject|3|||
129673757|NCT00931632|466766523|FG000|Overall Study|Adverse Event|19|||
129673758|NCT00931632|466766524|FG001|Overall Study|Adverse Event|15|||
129673759|NCT01687218|466766528|FG000|Overall Study|Withdrawal by Subject|2|||
129673760|NCT01687218|466766529|FG001|Overall Study|Withdrawal by Subject|3|||
129673761|NCT01687218|466766530|FG002|Overall Study|Withdrawal by Subject|0|||
129673762|NCT01687218|466766531|FG003|Overall Study|Withdrawal by Subject|1|||
129673763|NCT01687218|466766532|FG004|Overall Study|Withdrawal by Subject|1|||
129673764|NCT01687218|466766533|FG005|Overall Study|Withdrawal by Subject|0|||
129673765|NCT01687218|466766528|FG000|Overall Study|Relocated, no follow-up planned|1|||
129673766|NCT01687218|466766529|FG001|Overall Study|Relocated, no follow-up planned|0|||
129673767|NCT01687218|466766530|FG002|Overall Study|Relocated, no follow-up planned|1|||
129673768|NCT01687218|466766531|FG003|Overall Study|Relocated, no follow-up planned|1|||
129673769|NCT01687218|466766532|FG004|Overall Study|Relocated, no follow-up planned|0|||
129673770|NCT01687218|466766533|FG005|Overall Study|Relocated, no follow-up planned|0|||
129673771|NCT03139552|466766538|FG000|Overall Study|unable to attend tasting due to schedule|3|||
129673772|NCT03368807|466766547|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
129673773|NCT03368807|466766547|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
129673774|NCT03368807|466766547|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
129673775|NCT03368807|466766547|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
129673776|NCT01973218|466766548|FG000|Overall Study|Adverse Event|1|||
129673777|NCT01973218|466766549|FG001|Overall Study|Adverse Event|0|||
129673778|NCT01973218|466766548|FG000|Overall Study|Withdrawal by Subject|1|||
129673779|NCT01973218|466766549|FG001|Overall Study|Withdrawal by Subject|0|||
129673780|NCT02247466|466766550|FG000|Overall Study|Procedure changed to open surgery|0|||
129673781|NCT02247466|466766551|FG001|Overall Study|Procedure changed to open surgery|3|||
129673782|NCT02033759|466766554|FG000|Overall Study|Withdrawal by Subject|2|||
129673783|NCT02033759|466766555|FG001|Overall Study|Withdrawal by Subject|1|||
129673784|NCT02033759|466766554|FG000|Overall Study|Protocol Violation|1|||
129673785|NCT02033759|466766555|FG001|Overall Study|Protocol Violation|1|||
129673786|NCT04356937|466766558|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
129673787|NCT04356937|466766559|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
129673788|NCT03533751|466766560|FG000|Overall Study|Withdrawal by Subject|12|||
129673789|NCT03533751|466766561|FG001|Overall Study|Withdrawal by Subject|6|||
129673790|NCT03533751|466766562|FG002|Overall Study|Withdrawal by Subject|11|||
129673791|NCT03533751|466766563|FG003|Overall Study|Withdrawal by Subject|9|||
129673792|NCT03533751|466766564|FG004|Overall Study|Withdrawal by Subject|10|||
129673793|NCT03533751|466766560|FG000|Overall Study|Adverse Event|4|||
129673794|NCT03533751|466766561|FG001|Overall Study|Adverse Event|7|||
129673795|NCT03533751|466766562|FG002|Overall Study|Adverse Event|2|||
129673796|NCT03533751|466766563|FG003|Overall Study|Adverse Event|4|||
129673797|NCT03533751|466766564|FG004|Overall Study|Adverse Event|5|||
129673798|NCT03533751|466766560|FG000|Overall Study|Physician Decision|0|||
129673799|NCT03533751|466766561|FG001|Overall Study|Physician Decision|2|||
129673800|NCT03533751|466766562|FG002|Overall Study|Physician Decision|1|||
129673801|NCT03533751|466766563|FG003|Overall Study|Physician Decision|2|||
129673802|NCT03533751|466766564|FG004|Overall Study|Physician Decision|1|||
129673803|NCT03533751|466766560|FG000|Overall Study|Sponsor Decision|0|||
129673804|NCT03533751|466766561|FG001|Overall Study|Sponsor Decision|0|||
129673805|NCT03533751|466766562|FG002|Overall Study|Sponsor Decision|1|||
129673806|NCT03533751|466766563|FG003|Overall Study|Sponsor Decision|1|||
129673807|NCT03533751|466766564|FG004|Overall Study|Sponsor Decision|0|||
129673808|NCT03533751|466766560|FG000|Overall Study|Lost to Follow-up|3|||
129673809|NCT03533751|466766561|FG001|Overall Study|Lost to Follow-up|7|||
129673810|NCT03533751|466766562|FG002|Overall Study|Lost to Follow-up|6|||
129673811|NCT03533751|466766563|FG003|Overall Study|Lost to Follow-up|4|||
129673812|NCT03533751|466766564|FG004|Overall Study|Lost to Follow-up|3|||
129673813|NCT03533751|466766560|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
129673814|NCT03533751|466766561|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
129673815|NCT03533751|466766562|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
129673816|NCT03533751|466766563|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
129673817|NCT03533751|466766564|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
129673818|NCT03533751|466766560|FG000|Overall Study|Other|0|||
129673819|NCT03533751|466766561|FG001|Overall Study|Other|2|||
129673820|NCT03533751|466766562|FG002|Overall Study|Other|1|||
129673821|NCT03533751|466766563|FG003|Overall Study|Other|0|||
129673822|NCT03533751|466766564|FG004|Overall Study|Other|3|||
129673823|NCT05117060|466766565|FG000|Overall Study|Adverse Event|3|||
129673824|NCT05117060|466766566|FG001|Overall Study|Adverse Event|5|||
129673825|NCT05117060|466766567|FG002|Overall Study|Adverse Event|6|||
129673826|NCT05117060|466766568|FG003|Overall Study|Adverse Event|1|||
129673827|NCT05117060|466766565|FG000|Overall Study|Lost to Follow-up|0|||
129673828|NCT05117060|466766566|FG001|Overall Study|Lost to Follow-up|0|||
129673829|NCT05117060|466766567|FG002|Overall Study|Lost to Follow-up|0|||
129673830|NCT05117060|466766568|FG003|Overall Study|Lost to Follow-up|1|||
129673831|NCT05117060|466766565|FG000|Overall Study|Lack of Efficacy|4|||
129673832|NCT05117060|466766566|FG001|Overall Study|Lack of Efficacy|5|||
129673833|NCT05117060|466766567|FG002|Overall Study|Lack of Efficacy|2|||
129673834|NCT05117060|466766568|FG003|Overall Study|Lack of Efficacy|6|||
129673835|NCT05117060|466766565|FG000|Overall Study|Withdrawal by Subject|8|||
129673836|NCT05117060|466766566|FG001|Overall Study|Withdrawal by Subject|5|||
129673837|NCT05117060|466766567|FG002|Overall Study|Withdrawal by Subject|5|||
129673838|NCT05117060|466766568|FG003|Overall Study|Withdrawal by Subject|6|||
129673839|NCT05117060|466766565|FG000|Overall Study|Other|2|||
129673840|NCT05117060|466766566|FG001|Overall Study|Other|1|||
129673841|NCT05117060|466766567|FG002|Overall Study|Other|3|||
129673842|NCT05117060|466766568|FG003|Overall Study|Other|1|||
129673843|NCT01419535|466766569|FG000|Overall Study|could not maintain iv line|1|||
129673844|NCT01419535|466766570|FG001|Overall Study|could not maintain iv line|1|||
129673845|NCT01419535|466766569|FG000|Overall Study|Withdrawal by Subject|0|||
129673846|NCT01419535|466766570|FG001|Overall Study|Withdrawal by Subject|1|||
129673847|NCT00350545|466768664|FG000|Overall Study|Withdrawal by Subject|2|||
129673848|NCT00720278|466768666|FG000|Overall Study|Adverse Event|5|||
129673849|NCT00720278|466768667|FG001|Overall Study|Adverse Event|3|||
129673850|NCT00720278|466768668|FG002|Overall Study|Adverse Event|4|||
129673851|NCT00720278|466768666|FG000|Overall Study|Withdrawal by Subject|0|||
129673852|NCT00720278|466768667|FG001|Overall Study|Withdrawal by Subject|1|||
129673853|NCT00720278|466768668|FG002|Overall Study|Withdrawal by Subject|0|||
129673854|NCT00720278|466768666|FG000|Overall Study|Lost to Follow-up|0|||
129673855|NCT00720278|466768667|FG001|Overall Study|Lost to Follow-up|0|||
129673856|NCT00720278|466768668|FG002|Overall Study|Lost to Follow-up|1|||
129673857|NCT00720278|466768666|FG000|Overall Study|Non-compliance|1|||
129673858|NCT00720278|466768667|FG001|Overall Study|Non-compliance|0|||
129673859|NCT00720278|466768668|FG002|Overall Study|Non-compliance|0|||
129673860|NCT00720278|466768666|FG000|Overall Study|eligibility criteria violation|1|||
129673861|NCT00720278|466768667|FG001|Overall Study|eligibility criteria violation|0|||
129673862|NCT00720278|466768668|FG002|Overall Study|eligibility criteria violation|1|||
129673863|NCT00368251|466768671|FG000|Overall Study|SAE, non-fatal|1|||
129673864|NCT00368251|466768672|FG001|Overall Study|SAE, non-fatal|0|||
129673865|NCT00368251|466768673|FG002|Overall Study|SAE, non-fatal|0|||
129673866|NCT00368251|466768671|FG000|Overall Study|AE, non-serious non-fatal|0|||
129673867|NCT00368251|466768672|FG001|Overall Study|AE, non-serious non-fatal|0|||
129673868|NCT00368251|466768673|FG002|Overall Study|AE, non-serious non-fatal|1|||
129673869|NCT03312738|466768674|FG000|Overall Study|Progressive disease|58|||
129673870|NCT03312738|466768675|FG001|Overall Study|Progressive disease|67|||
129673871|NCT03312738|466768674|FG000|Overall Study|Patient/guardian decision|13|||
129673872|NCT03312738|466768675|FG001|Overall Study|Patient/guardian decision|5|||
129673873|NCT03312738|466768674|FG000|Overall Study|Adverse Event|5|||
129673874|NCT03312738|466768675|FG001|Overall Study|Adverse Event|3|||
129673875|NCT03312738|466768674|FG000|Overall Study|Protocol deviation|2|||
129673876|NCT03312738|466768675|FG001|Overall Study|Protocol deviation|0|||
129673877|NCT03312738|466768674|FG000|Overall Study|Technical problems|0|||
129673878|NCT03312738|466768675|FG001|Overall Study|Technical problems|1|||
129673879|NCT03312738|466768674|FG000|Overall Study|Physician Decision|2|||
129673880|NCT03312738|466768675|FG001|Overall Study|Physician Decision|3|||
129673881|NCT02466399|466768679|FG000|Overall Study|Adverse Event|1|||
129673882|NCT02466399|466768680|FG001|Overall Study|Adverse Event|0|||
129673883|NCT02466399|466768679|FG000|Overall Study|Early exit due to family emergency|1|||
129673884|NCT02466399|466768680|FG001|Overall Study|Early exit due to family emergency|0|||
129673885|NCT00607893|466768681|FG000|Overall Study|Lost to Follow-up|4|||
129673886|NCT00607893|466768682|FG001|Overall Study|Lost to Follow-up|0|||
129673887|NCT00607893|466768681|FG000|Overall Study|withdrew due to loss of interest|0|||
129673888|NCT00607893|466768682|FG001|Overall Study|withdrew due to loss of interest|1|||
129673889|NCT00607893|466768681|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
129673890|NCT00607893|466768682|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
129673891|NCT00607893|466768681|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
129673892|NCT00607893|466768682|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
129673893|NCT00607893|466768681|FG000|Overall Study|Declined to be treated|1|||
129673894|NCT00607893|466768682|FG001|Overall Study|Declined to be treated|0|||
129673895|NCT00607893|466768681|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
129673896|NCT00607893|466768682|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
129673897|NCT02669849|466768683|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129673898|NCT02669849|466768684|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129673899|NCT02669849|466768685|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
129673900|NCT02669849|466768683|FG000|Overall Study|Lost to Follow-up|1|||
129673901|NCT02669849|466768684|FG001|Overall Study|Lost to Follow-up|0|||
129673902|NCT02669849|466768685|FG002|Overall Study|Lost to Follow-up|3|||
129673903|NCT02669849|466768683|FG000|Overall Study|Death|1|||
129673904|NCT02669849|466768684|FG001|Overall Study|Death|1|||
129673905|NCT02669849|466768685|FG002|Overall Study|Death|2|||
129673906|NCT02669849|466768683|FG000|Overall Study|Study terminated by sponsor|16|||
129673907|NCT02669849|466768684|FG001|Overall Study|Study terminated by sponsor|1|||
129673908|NCT02669849|466768685|FG002|Overall Study|Study terminated by sponsor|14|||
129673909|NCT02669849|466768683|FG000|Overall Study|Other|0|||
129673910|NCT02669849|466768684|FG001|Overall Study|Other|0|||
129673911|NCT02669849|466768685|FG002|Overall Study|Other|2|||
129673912|NCT03408899|466768686|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
129673913|NCT00606008|466768687|FG000|Overall Study|Adverse Event|1|||
129673914|NCT00606008|466768687|FG000|Overall Study|Withdrawal by Subject|4|||
129673915|NCT02014272|466768691|FG000|Intervention Period 1|Withdrawal by Subject|1|||
129673916|NCT02014272|466768692|FG001|Intervention Period 1|Withdrawal by Subject|0|||
129673917|NCT02014272|466768691|FG000|Intervention Period 1|Adverse Event|0|||
129673918|NCT02014272|466768692|FG001|Intervention Period 1|Adverse Event|1|||
129673919|NCT03499795|466768693|FG000|Overall Study|Adverse Event|1|||
129673920|NCT03499795|466768693|FG000|Overall Study|Lost to Follow-up|1|||
129673921|NCT03636256|466768694|FG000|Overall Study|Lost to Follow-up|3|||
129673922|NCT03636256|466768695|FG001|Overall Study|Lost to Follow-up|0|||
129673923|NCT03636256|466768696|FG002|Overall Study|Lost to Follow-up|2|||
129673924|NCT03636256|466768697|FG003|Overall Study|Lost to Follow-up|1|||
129673925|NCT03636256|466768698|FG004|Overall Study|Lost to Follow-up|0|||
129673926|NCT03636256|466768699|FG005|Overall Study|Lost to Follow-up|4|||
129673927|NCT03636256|466768700|FG006|Overall Study|Lost to Follow-up|2|||
129673928|NCT03636256|466768701|FG007|Overall Study|Lost to Follow-up|0|||
129673929|NCT03636256|466768702|FG008|Overall Study|Lost to Follow-up|4|||
129673930|NCT03636256|466768694|FG000|Overall Study|Withdrawal by Subject|0|||
129673931|NCT03636256|466768695|FG001|Overall Study|Withdrawal by Subject|0|||
129673932|NCT03636256|466768696|FG002|Overall Study|Withdrawal by Subject|0|||
129673933|NCT03636256|466768697|FG003|Overall Study|Withdrawal by Subject|0|||
129673934|NCT03636256|466768698|FG004|Overall Study|Withdrawal by Subject|0|||
129673935|NCT03636256|466768699|FG005|Overall Study|Withdrawal by Subject|0|||
129673936|NCT03636256|466768700|FG006|Overall Study|Withdrawal by Subject|0|||
129673937|NCT03636256|466768701|FG007|Overall Study|Withdrawal by Subject|0|||
129673938|NCT03636256|466768702|FG008|Overall Study|Withdrawal by Subject|1|||
129673939|NCT01218308|466768705|FG000|Overall Study|Adverse Event|1|||
129673940|NCT01218308|466768706|FG001|Overall Study|Adverse Event|2|||
129673941|NCT01218308|466768705|FG000|Overall Study|Protocol Violation|0|||
129673942|NCT01218308|466768706|FG001|Overall Study|Protocol Violation|2|||
129673943|NCT01218308|466768705|FG000|Overall Study|Withdrawal by Subject|61|||
129673944|NCT01218308|466768706|FG001|Overall Study|Withdrawal by Subject|64|||
129673945|NCT01218308|466768705|FG000|Overall Study|Lost to Follow-up|27|||
129673946|NCT01218308|466768706|FG001|Overall Study|Lost to Follow-up|31|||
129673947|NCT01218308|466768705|FG000|Overall Study|Other|14|||
129673948|NCT01218308|466768706|FG001|Overall Study|Other|21|||
129673949|NCT00547339|466768709|FG000|Overall Study|Physician Decision|0|||
129673950|NCT00547339|466768710|FG001|Overall Study|Physician Decision|0|||
129673951|NCT00547339|466768711|FG002|Overall Study|Physician Decision|1|||
129673952|NCT00547339|466768712|FG003|Overall Study|Physician Decision|0|||
129673953|NCT01516216|466768713|FG000|Overall Study|Adverse Event|2|||
129673954|NCT01516216|466768714|FG001|Overall Study|Adverse Event|4|||
129673955|NCT01516216|466768713|FG000|Overall Study|Disease Progression|38|||
129673956|NCT01516216|466768714|FG001|Overall Study|Disease Progression|34|||
129673957|NCT01516216|466768713|FG000|Overall Study|Withdrawal by Subject|9|||
129673958|NCT01516216|466768714|FG001|Overall Study|Withdrawal by Subject|11|||
129673959|NCT01516216|466768713|FG000|Overall Study|Potentially Curative Resection|6|||
129673960|NCT01516216|466768714|FG001|Overall Study|Potentially Curative Resection|12|||
129673961|NCT01516216|466768713|FG000|Overall Study|Nonadherence|2|||
129673962|NCT01516216|466768714|FG001|Overall Study|Nonadherence|3|||
129673963|NCT01516216|466768713|FG000|Overall Study|Physician Decision|6|||
129673964|NCT01516216|466768714|FG001|Overall Study|Physician Decision|3|||
129673965|NCT01516216|466768713|FG000|Overall Study|Prolonged Treatment Delay|5|||
129673966|NCT01516216|466768714|FG001|Overall Study|Prolonged Treatment Delay|1|||
129673967|NCT01516216|466768713|FG000|Overall Study|Intercurrent Illness|1|||
129673968|NCT01516216|466768714|FG001|Overall Study|Intercurrent Illness|0|||
129673969|NCT01516216|466768713|FG000|Overall Study|Death|1|||
129673970|NCT01516216|466768714|FG001|Overall Study|Death|1|||
129673971|NCT01458587|466768715|FG000|Overall Study|Withdrawal by Subject|1|||
129673972|NCT01458587|466768716|FG001|Overall Study|Withdrawal by Subject|0|||
129673973|NCT01603602|466768717|FG000|Overall Study|Adverse Event|1|||
129673974|NCT01603602|466768718|FG001|Overall Study|Adverse Event|0|||
129673975|NCT01603602|466768719|FG002|Overall Study|Adverse Event|0|||
129547180|NCT01393626|466296155|FG001|Overall Study|Protocol Violation|0|||
129673976|NCT01603602|466768717|FG000|Overall Study|Personal Reasons|1|||
129673977|NCT01603602|466768718|FG001|Overall Study|Personal Reasons|0|||
129673978|NCT01603602|466768719|FG002|Overall Study|Personal Reasons|1|||
129673979|NCT01079780|466768720|FG000|Overall Study|Disease progression|43|||
129673980|NCT01079780|466768721|FG001|Overall Study|Disease progression|7|||
129673981|NCT01079780|466768722|FG002|Overall Study|Disease progression|31|||
129673982|NCT01079780|466768720|FG000|Overall Study|Adverse Event|13|||
129673983|NCT01079780|466768721|FG001|Overall Study|Adverse Event|5|||
129673984|NCT01079780|466768722|FG002|Overall Study|Adverse Event|7|||
129673985|NCT01079780|466768720|FG000|Overall Study|Death|2|||
129673986|NCT01079780|466768721|FG001|Overall Study|Death|0|||
129673987|NCT01079780|466768722|FG002|Overall Study|Death|2|||
129673988|NCT01079780|466768720|FG000|Overall Study|Withdrawal by Subject|6|||
129673989|NCT01079780|466768721|FG001|Overall Study|Withdrawal by Subject|4|||
129673990|NCT01079780|466768722|FG002|Overall Study|Withdrawal by Subject|4|||
129673991|NCT01079780|466768720|FG000|Overall Study|Alternative therapy|2|||
129673992|NCT01079780|466768721|FG001|Overall Study|Alternative therapy|0|||
129673993|NCT01079780|466768722|FG002|Overall Study|Alternative therapy|2|||
129673994|NCT01079780|466768720|FG000|Overall Study|Physician Decision|1|||
129673995|NCT01079780|466768721|FG001|Overall Study|Physician Decision|0|||
129673996|NCT01079780|466768722|FG002|Overall Study|Physician Decision|1|||
129673997|NCT01079780|466768720|FG000|Overall Study|Error made in lesion measurement|1|||
129673998|NCT01079780|466768721|FG001|Overall Study|Error made in lesion measurement|0|||
129673999|NCT01079780|466768722|FG002|Overall Study|Error made in lesion measurement|0|||
129674000|NCT01079780|466768720|FG000|Overall Study|Patient had surgery|1|||
129674001|NCT01079780|466768721|FG001|Overall Study|Patient had surgery|0|||
129674002|NCT01079780|466768722|FG002|Overall Study|Patient had surgery|0|||
129674003|NCT01079780|466768720|FG000|Overall Study|Treatment cycle delay|0|||
129674004|NCT01079780|466768721|FG001|Overall Study|Treatment cycle delay|0|||
129674005|NCT01079780|466768722|FG002|Overall Study|Treatment cycle delay|1|||
129674006|NCT01079780|466768720|FG000|Overall Study|Never started treatment|1|||
129674007|NCT01079780|466768721|FG001|Overall Study|Never started treatment|0|||
129674008|NCT01079780|466768722|FG002|Overall Study|Never started treatment|2|||
129674009|NCT02783066|466768723|FG000|Overall Study|Withdrawal by Subject|13|||
129674010|NCT05379920|466768732|FG000|Overall Study|Lost to Follow-up|0|||
129674011|NCT05379920|466768733|FG001|Overall Study|Lost to Follow-up|5|||
129674012|NCT05379920|466768734|FG002|Overall Study|Lost to Follow-up|0|||
129674013|NCT05379920|466768735|FG003|Overall Study|Lost to Follow-up|0|||
129674014|NCT03176771|466768736|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
129884399|NCT00708305|467536386|FG003|Period 3|Other Reason|0|||
129674015|NCT03176771|466768737|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
129674016|NCT03176771|466768738|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
129674017|NCT03176771|466768739|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
129674018|NCT03176771|466768740|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
129674019|NCT03176771|466768736|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129674020|NCT03176771|466768737|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
129884400|NCT02771210|467536387|FG000|Period 1|Adverse Event|5|||
129547181|NCT01393626|466296156|FG002|Overall Study|Protocol Violation|2|||
129884401|NCT02771210|467536388|FG001|Period 1|Adverse Event|3|||
129547182|NCT01393626|466296157|FG003|Overall Study|Protocol Violation|0|||
129674021|NCT03176771|466768738|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129674022|NCT03176771|466768739|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129674023|NCT03176771|466768740|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
129674024|NCT03176771|466768736|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
129674025|NCT03176771|466768737|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
129674026|NCT03176771|466768738|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
129674027|NCT03176771|466768739|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
129674028|NCT03176771|466768740|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
129674029|NCT03176771|466768736|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129674030|NCT03176771|466768737|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129674031|NCT03176771|466768738|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
129674032|NCT03176771|466768739|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129674033|NCT03176771|466768740|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
129674034|NCT03176771|466768736|FG000|Double-Blind Extension Period|Adverse Event|0|||
129674035|NCT03176771|466768737|FG001|Double-Blind Extension Period|Adverse Event|0|||
129674036|NCT03176771|466768738|FG002|Double-Blind Extension Period|Adverse Event|0|||
129674037|NCT03176771|466768739|FG003|Double-Blind Extension Period|Adverse Event|15|||
129674038|NCT03176771|466768740|FG004|Double-Blind Extension Period|Adverse Event|18|||
129674039|NCT03176771|466768736|FG000|Double-Blind Extension Period|Death|0|||
129674040|NCT03176771|466768737|FG001|Double-Blind Extension Period|Death|0|||
129674041|NCT03176771|466768738|FG002|Double-Blind Extension Period|Death|0|||
129674042|NCT03176771|466768739|FG003|Double-Blind Extension Period|Death|3|||
129674043|NCT03176771|466768740|FG004|Double-Blind Extension Period|Death|4|||
129674044|NCT03176771|466768736|FG000|Double-Blind Extension Period|Physician Decision|0|||
129674045|NCT03176771|466768737|FG001|Double-Blind Extension Period|Physician Decision|0|||
129674046|NCT03176771|466768738|FG002|Double-Blind Extension Period|Physician Decision|0|||
129674047|NCT03176771|466768739|FG003|Double-Blind Extension Period|Physician Decision|3|||
129674048|NCT03176771|466768740|FG004|Double-Blind Extension Period|Physician Decision|1|||
129674049|NCT03176771|466768736|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
129674050|NCT03176771|466768737|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
129674051|NCT03176771|466768738|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
129674052|NCT03176771|466768739|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
129674053|NCT03176771|466768740|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
129674054|NCT03530293|466768741|FG000|Pre-randomization|Adverse Event|12|||
129674055|NCT03530293|466768742|FG001|Pre-randomization|Adverse Event|0|||
129674056|NCT03530293|466768743|FG002|Pre-randomization|Adverse Event|0|||
129674057|NCT03530293|466768741|FG000|Pre-randomization|Protocol Violation|2|||
129674058|NCT03530293|466768742|FG001|Pre-randomization|Protocol Violation|0|||
129674059|NCT03530293|466768743|FG002|Pre-randomization|Protocol Violation|0|||
129674060|NCT03530293|466768741|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
129674061|NCT03530293|466768742|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
129674062|NCT03530293|466768743|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
129674063|NCT03530293|466768741|FG000|Pre-randomization|Withdrawal by Subject|5|||
129674064|NCT03530293|466768742|FG001|Pre-randomization|Withdrawal by Subject|0|||
129674065|NCT03530293|466768743|FG002|Pre-randomization|Withdrawal by Subject|0|||
129674066|NCT03530293|466768741|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
129674067|NCT03530293|466768742|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
129674068|NCT03530293|466768743|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
129674069|NCT03530293|466768741|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
129674070|NCT03530293|466768742|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
129674071|NCT03530293|466768743|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
129674072|NCT03530293|466768741|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
129674073|NCT03530293|466768742|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
129674074|NCT03530293|466768743|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
129674075|NCT03530293|466768741|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
129674076|NCT03530293|466768742|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
129674077|NCT03530293|466768743|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
129674078|NCT03530293|466768741|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
129674079|NCT03530293|466768742|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
129674080|NCT03530293|466768743|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
129674081|NCT02732639|466768745|FG000|Overall Study|Lost to Follow-up|1|||
129674082|NCT02265510|466768748|FG000|Overall Study|Withdrawal by Subject|1|||
129674083|NCT02265510|466768749|FG001|Overall Study|Withdrawal by Subject|1|||
129674084|NCT02265510|466768750|FG002|Overall Study|Withdrawal by Subject|2|||
129674085|NCT02265510|466768751|FG003|Overall Study|Withdrawal by Subject|1|||
129674086|NCT02265510|466768752|FG004|Overall Study|Withdrawal by Subject|0|||
129674087|NCT02265510|466768753|FG005|Overall Study|Withdrawal by Subject|2|||
129674088|NCT02265510|466768754|FG006|Overall Study|Withdrawal by Subject|0|||
129674089|NCT02265510|466768755|FG007|Overall Study|Withdrawal by Subject|2|||
129674090|NCT02265510|466768756|FG008|Overall Study|Withdrawal by Subject|0|||
129674091|NCT02265510|466768757|FG009|Overall Study|Withdrawal by Subject|0|||
129674092|NCT02265510|466768758|FG010|Overall Study|Withdrawal by Subject|0|||
129674093|NCT02265510|466768759|FG011|Overall Study|Withdrawal by Subject|0|||
129674094|NCT02265510|466768760|FG012|Overall Study|Withdrawal by Subject|1|||
129674095|NCT02265510|466768761|FG013|Overall Study|Withdrawal by Subject|0|||
129674096|NCT02265510|466768748|FG000|Overall Study|Disease Progression|0|||
129674097|NCT02265510|466768749|FG001|Overall Study|Disease Progression|1|||
129674098|NCT02265510|466768750|FG002|Overall Study|Disease Progression|2|||
129674099|NCT02265510|466768751|FG003|Overall Study|Disease Progression|1|||
129674100|NCT02265510|466768752|FG004|Overall Study|Disease Progression|1|||
129674101|NCT02265510|466768753|FG005|Overall Study|Disease Progression|0|||
129674102|NCT02265510|466768754|FG006|Overall Study|Disease Progression|0|||
129674103|NCT02265510|466768755|FG007|Overall Study|Disease Progression|0|||
129674104|NCT02265510|466768756|FG008|Overall Study|Disease Progression|0|||
129674105|NCT02265510|466768757|FG009|Overall Study|Disease Progression|0|||
129674106|NCT02265510|466768758|FG010|Overall Study|Disease Progression|0|||
129674107|NCT02265510|466768759|FG011|Overall Study|Disease Progression|0|||
129674108|NCT02265510|466768760|FG012|Overall Study|Disease Progression|0|||
129674109|NCT02265510|466768761|FG013|Overall Study|Disease Progression|0|||
129674110|NCT02265510|466768748|FG000|Overall Study|Death|2|||
129674111|NCT02265510|466768749|FG001|Overall Study|Death|0|||
129674112|NCT02265510|466768750|FG002|Overall Study|Death|2|||
129674113|NCT02265510|466768751|FG003|Overall Study|Death|2|||
129674114|NCT02265510|466768752|FG004|Overall Study|Death|1|||
129674115|NCT02265510|466768753|FG005|Overall Study|Death|3|||
129674116|NCT02265510|466768754|FG006|Overall Study|Death|2|||
129674117|NCT02265510|466768755|FG007|Overall Study|Death|1|||
129674118|NCT02265510|466768756|FG008|Overall Study|Death|3|||
129674119|NCT02265510|466768757|FG009|Overall Study|Death|3|||
129674120|NCT02265510|466768758|FG010|Overall Study|Death|4|||
129674121|NCT02265510|466768759|FG011|Overall Study|Death|12|||
129674122|NCT02265510|466768760|FG012|Overall Study|Death|7|||
129674123|NCT02265510|466768761|FG013|Overall Study|Death|6|||
129674124|NCT02265510|466768748|FG000|Overall Study|Lost to Follow-up|0|||
129674125|NCT02265510|466768749|FG001|Overall Study|Lost to Follow-up|0|||
129674126|NCT02265510|466768750|FG002|Overall Study|Lost to Follow-up|0|||
129674127|NCT02265510|466768751|FG003|Overall Study|Lost to Follow-up|0|||
129674128|NCT02265510|466768752|FG004|Overall Study|Lost to Follow-up|1|||
129674129|NCT02265510|466768753|FG005|Overall Study|Lost to Follow-up|0|||
129674130|NCT02265510|466768754|FG006|Overall Study|Lost to Follow-up|0|||
129674131|NCT02265510|466768755|FG007|Overall Study|Lost to Follow-up|0|||
129674132|NCT02265510|466768756|FG008|Overall Study|Lost to Follow-up|0|||
129674133|NCT02265510|466768757|FG009|Overall Study|Lost to Follow-up|2|||
129674134|NCT02265510|466768758|FG010|Overall Study|Lost to Follow-up|0|||
129674135|NCT02265510|466768759|FG011|Overall Study|Lost to Follow-up|0|||
129674136|NCT02265510|466768760|FG012|Overall Study|Lost to Follow-up|0|||
129674137|NCT02265510|466768761|FG013|Overall Study|Lost to Follow-up|2|||
129674138|NCT02265510|466768748|FG000|Overall Study|Other|0|||
129674139|NCT02265510|466768749|FG001|Overall Study|Other|1|||
129674140|NCT02265510|466768750|FG002|Overall Study|Other|0|||
129674141|NCT02265510|466768751|FG003|Overall Study|Other|0|||
129674142|NCT02265510|466768752|FG004|Overall Study|Other|0|||
129674143|NCT02265510|466768753|FG005|Overall Study|Other|0|||
129674144|NCT02265510|466768754|FG006|Overall Study|Other|0|||
129674145|NCT02265510|466768755|FG007|Overall Study|Other|0|||
129674146|NCT02265510|466768756|FG008|Overall Study|Other|0|||
129674147|NCT02265510|466768757|FG009|Overall Study|Other|0|||
129674148|NCT02265510|466768758|FG010|Overall Study|Other|0|||
129674149|NCT02265510|466768759|FG011|Overall Study|Other|0|||
129674150|NCT02265510|466768760|FG012|Overall Study|Other|0|||
129674151|NCT02265510|466768761|FG013|Overall Study|Other|0|||
129674152|NCT02265510|466768748|FG000|Overall Study|Study Terminated by Sponsor|0|||
129674153|NCT02265510|466768749|FG001|Overall Study|Study Terminated by Sponsor|0|||
129674154|NCT02265510|466768750|FG002|Overall Study|Study Terminated by Sponsor|0|||
129674155|NCT02265510|466768751|FG003|Overall Study|Study Terminated by Sponsor|0|||
129674156|NCT02265510|466768752|FG004|Overall Study|Study Terminated by Sponsor|0|||
129674157|NCT02265510|466768753|FG005|Overall Study|Study Terminated by Sponsor|1|||
129674158|NCT02265510|466768754|FG006|Overall Study|Study Terminated by Sponsor|1|||
129674159|NCT02265510|466768755|FG007|Overall Study|Study Terminated by Sponsor|1|||
129674160|NCT02265510|466768756|FG008|Overall Study|Study Terminated by Sponsor|1|||
129674161|NCT02265510|466768757|FG009|Overall Study|Study Terminated by Sponsor|2|||
129674162|NCT02265510|466768758|FG010|Overall Study|Study Terminated by Sponsor|1|||
129674163|NCT02265510|466768759|FG011|Overall Study|Study Terminated by Sponsor|4|||
129674164|NCT02265510|466768760|FG012|Overall Study|Study Terminated by Sponsor|1|||
129674165|NCT02265510|466768761|FG013|Overall Study|Study Terminated by Sponsor|2|||
129674166|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
129674167|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
129674168|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
129674169|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
129674170|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
129674171|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
129674172|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
129674173|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
129674174|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
129674175|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
129674176|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
129674177|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
129674178|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
129674179|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
129674180|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
129674181|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
129674182|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
129674183|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
129674184|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
129674185|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
129674186|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
129674187|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
129674188|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
129674189|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
129674190|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
129674191|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
129674192|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
129674193|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
129674194|NCT01668797|466768762|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
129674195|NCT01668797|466768763|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
129674196|NCT01668797|466768764|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
129674197|NCT01668797|466768765|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
129674198|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
129547183|NCT02858076|466296158|FG000|Overall Study|Death|6|||
129674199|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
129674200|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
129674201|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
129674202|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
129674203|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
129674204|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
129674205|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
129674206|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
129674207|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
129674208|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
129674209|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
129674210|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
129674211|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
129674212|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
129674213|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
129674214|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
129674215|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
129674216|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
129674217|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
129674218|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
129674219|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
129674220|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
129674221|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
129674222|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
129674223|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
129674224|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
129674225|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
129674226|NCT01668797|466768762|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
129674227|NCT01668797|466768763|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
129674228|NCT01668797|466768764|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
129674229|NCT01668797|466768765|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
129674230|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
129674231|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
129674232|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
129674233|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
129674234|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
129674235|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
129674236|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
129674237|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
129674238|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
129674239|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
129674240|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
129674241|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
129674242|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
129674243|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
129674244|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
129674245|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
129674246|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
129674247|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
129674248|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
129674249|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
129674250|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
129674251|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
129674252|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
129674253|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
129674254|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
129674255|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
129674256|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
129674257|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
129674258|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
129674259|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
129674260|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
129674261|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
129674262|NCT01668797|466768762|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
129674263|NCT01668797|466768763|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
129674264|NCT01668797|466768764|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
129674265|NCT01668797|466768765|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
129674266|NCT01004614|466768766|FG000|Washout|Withdrawal by Subject|0|||
129674267|NCT01004614|466768767|FG001|Washout|Withdrawal by Subject|1|||
129674268|NCT01004614|466768768|FG002|Washout|Withdrawal by Subject|0|||
129674269|NCT01004614|466768769|FG003|Washout|Withdrawal by Subject|0|||
129674270|NCT02530385|466768770|FG000|Overall Study|Withdrawal by Subject|0|||
129674271|NCT02530385|466768771|FG001|Overall Study|Withdrawal by Subject|1|||
129674272|NCT01569022|466768773|FG000|First Intervention|Lost to Follow-up|2|||
129674273|NCT01569022|466768774|FG001|First Intervention|Lost to Follow-up|1|||
129674274|NCT01569022|466768773|FG000|Second Intervention|Lost to Follow-up|2|||
129674275|NCT01569022|466768774|FG001|Second Intervention|Lost to Follow-up|2|||
129674276|NCT02111083|466768779|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
129674277|NCT02111083|466768780|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
129674278|NCT00116142|466768781|FG000|Overall Study|Adverse Event|8|||
129674279|NCT00116142|466768782|FG001|Overall Study|Adverse Event|7|||
129674280|NCT00116142|466768781|FG000|Overall Study|Protocol Violation|2|||
129674281|NCT00116142|466768782|FG001|Overall Study|Protocol Violation|1|||
129674282|NCT00116142|466768781|FG000|Overall Study|Withdrawal by Subject|5|||
129674283|NCT00116142|466768782|FG001|Overall Study|Withdrawal by Subject|5|||
129674284|NCT00116142|466768781|FG000|Overall Study|Physician Decision|3|||
129674285|NCT00116142|466768782|FG001|Overall Study|Physician Decision|1|||
129674286|NCT00116142|466768781|FG000|Overall Study|Delayed Radiation Therapy|1|||
129674287|NCT00116142|466768782|FG001|Overall Study|Delayed Radiation Therapy|0|||
129674288|NCT00116142|466768781|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
129674289|NCT00116142|466768782|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
129674290|NCT00116142|466768781|FG000|Overall Study|Patient stopped due to depression|0|||
129674291|NCT00116142|466768782|FG001|Overall Study|Patient stopped due to depression|1|||
129674292|NCT00116142|466768781|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
129674293|NCT00116142|466768782|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
129674294|NCT00116142|466768781|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
129674295|NCT00116142|466768782|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
129674296|NCT00116142|466768781|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
129674297|NCT00116142|466768782|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
129674298|NCT00433836|466768783|FG000|Overall Study|Adverse Event|7|||
129674299|NCT00433836|466768784|FG001|Overall Study|Adverse Event|0|||
129674300|NCT00433836|466768783|FG000|Overall Study|Lost to Follow-up|3|||
129674301|NCT00433836|466768784|FG001|Overall Study|Lost to Follow-up|0|||
129674302|NCT00433836|466768783|FG000|Overall Study|Withdrawal by Subject|2|||
129674303|NCT00433836|466768784|FG001|Overall Study|Withdrawal by Subject|1|||
129674304|NCT00433836|466768783|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129674305|NCT00433836|466768784|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129674306|NCT00433836|466768783|FG000|Overall Study|Protocol Violation|0|||
129674307|NCT00433836|466768784|FG001|Overall Study|Protocol Violation|2|||
129674308|NCT00433836|466768783|FG000|Overall Study|Condition no longer requires study drug|0|||
129674309|NCT00433836|466768784|FG001|Overall Study|Condition no longer requires study drug|1|||
129674310|NCT00433836|466768783|FG000|Overall Study|Abnormal laboratory values|0|||
129674311|NCT00433836|466768784|FG001|Overall Study|Abnormal laboratory values|1|||
129674312|NCT00644059|466768785|FG000|Overall Study|Lost to Follow-up|37|||
129674313|NCT00644059|466768786|FG001|Overall Study|Lost to Follow-up|34|||
129674314|NCT00644059|466768787|FG002|Overall Study|Lost to Follow-up|16|||
129674315|NCT00644059|466768785|FG000|Overall Study|Withdrawal by Subject|52|||
129674316|NCT00644059|466768786|FG001|Overall Study|Withdrawal by Subject|60|||
129674317|NCT00644059|466768787|FG002|Overall Study|Withdrawal by Subject|30|||
129674318|NCT00644059|466768785|FG000|Overall Study|Adverse Event|8|||
129674319|NCT00644059|466768786|FG001|Overall Study|Adverse Event|5|||
129674320|NCT00644059|466768787|FG002|Overall Study|Adverse Event|1|||
129674321|NCT00644059|466768785|FG000|Overall Study|Inappropriate Enrollment|1|||
129674322|NCT00644059|466768786|FG001|Overall Study|Inappropriate Enrollment|3|||
129674323|NCT00644059|466768787|FG002|Overall Study|Inappropriate Enrollment|0|||
129674324|NCT00644059|466768785|FG000|Overall Study|Protocol Deviation/violation|20|||
129674325|NCT00644059|466768786|FG001|Overall Study|Protocol Deviation/violation|19|||
129674326|NCT00644059|466768787|FG002|Overall Study|Protocol Deviation/violation|15|||
129674327|NCT00644059|466768785|FG000|Overall Study|Unable to classify|6|||
129674328|NCT00644059|466768786|FG001|Overall Study|Unable to classify|2|||
129674329|NCT00644059|466768787|FG002|Overall Study|Unable to classify|3|||
129674330|NCT02133508|466768788|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
129674331|NCT02133508|466768788|FG000|Overall Study|Death|12|||
129674332|NCT02133508|466768788|FG000|Overall Study|Lost to Follow-up|2|||
129674333|NCT00472420|466768795|FG000|Induction Treatment Period|Physician Decision|9|||
129547184|NCT02858076|466296159|FG001|Overall Study|Death|3|||
129674334|NCT00472420|466768795|FG000|Induction Treatment Period|Adverse Event|3|||
129674335|NCT00472420|466768795|FG000|Induction Treatment Period|Non-compliance|1|||
129674336|NCT00472420|466768795|FG000|Induction Treatment Period|Death|3|||
129674337|NCT00472420|466768795|FG000|Follow-up Period|Death|5|||
129674338|NCT00472420|466768795|FG000|Follow-up Period|Physician Decision|9|||
129674339|NCT00472420|466768795|FG000|Follow-up Period|Lost to Follow-up|2|||
129674340|NCT00472420|466768795|FG000|Follow-up Period|Protocol Violation|1|||
129674341|NCT01787552|466768801|FG000|Overall Study|Withdrawal by Subject|2|||
129674342|NCT01787552|466768802|FG001|Overall Study|Withdrawal by Subject|0|||
129674343|NCT01787552|466768803|FG002|Overall Study|Withdrawal by Subject|0|||
129674344|NCT01787552|466768804|FG003|Overall Study|Withdrawal by Subject|4|||
129674345|NCT01787552|466768801|FG000|Overall Study|Physician Decision|2|||
129674346|NCT01787552|466768802|FG001|Overall Study|Physician Decision|2|||
129674347|NCT01787552|466768803|FG002|Overall Study|Physician Decision|1|||
129674348|NCT01787552|466768804|FG003|Overall Study|Physician Decision|2|||
129674349|NCT01787552|466768801|FG000|Overall Study|Death|0|||
129674350|NCT01787552|466768802|FG001|Overall Study|Death|0|||
129674351|NCT01787552|466768803|FG002|Overall Study|Death|0|||
129674352|NCT01787552|466768804|FG003|Overall Study|Death|1|||
129674353|NCT01787552|466768801|FG000|Overall Study|Adverse Event|2|||
129674354|NCT01787552|466768802|FG001|Overall Study|Adverse Event|5|||
129674355|NCT01787552|466768803|FG002|Overall Study|Adverse Event|2|||
129674356|NCT01787552|466768804|FG003|Overall Study|Adverse Event|16|||
129674357|NCT01787552|466768801|FG000|Overall Study|Study terminated by Sponsor|0|||
129674358|NCT01787552|466768802|FG001|Overall Study|Study terminated by Sponsor|0|||
129674359|NCT01787552|466768803|FG002|Overall Study|Study terminated by Sponsor|1|||
129674360|NCT01787552|466768804|FG003|Overall Study|Study terminated by Sponsor|3|||
129674361|NCT01787552|466768801|FG000|Overall Study|Progressive Disease|2|||
129674362|NCT01787552|466768802|FG001|Overall Study|Progressive Disease|2|||
129674363|NCT01787552|466768803|FG002|Overall Study|Progressive Disease|1|||
129674364|NCT01787552|466768804|FG003|Overall Study|Progressive Disease|1|||
129674365|NCT02295644|466768805|FG000|Overall Study|Did not meet inclusion criterion|0|||
129674366|NCT02295644|466768806|FG001|Overall Study|Did not meet inclusion criterion|0|||
129674367|NCT02295644|466768807|FG002|Overall Study|Did not meet inclusion criterion|1|||
129674368|NCT02295644|466768808|FG003|Overall Study|Did not meet inclusion criterion|2|||
129674369|NCT04079790|466768810|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
129674370|NCT04079790|466768811|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
129674371|NCT04079790|466768812|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
129674372|NCT04079790|466768813|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
129674373|NCT04079790|466768810|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
129674374|NCT04079790|466768811|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
129674375|NCT04079790|466768812|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
129674376|NCT04079790|466768813|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
129674377|NCT04079790|466768810|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
129674378|NCT04079790|466768811|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
129674379|NCT04079790|466768812|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
129674380|NCT04079790|466768813|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
129674381|NCT00324155|466768814|FG000|Enrolled and Randomized|No longer met study criteria|3|||
129674382|NCT00324155|466768815|FG001|Enrolled and Randomized|No longer met study criteria|0|||
129674383|NCT00324155|466768814|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
129674384|NCT00324155|466768815|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
129674385|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
129674386|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
129674387|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
129674388|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
129674389|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Death|8|||
129674390|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Death|15|||
129674391|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
129674392|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
129674393|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
129674394|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
129674395|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
129674396|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
129674397|NCT00324155|466768814|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
129674398|NCT00324155|466768815|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
129674399|NCT00324155|466768814|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
129674400|NCT00324155|466768815|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
129674401|NCT00324155|466768814|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
129674402|NCT00324155|466768815|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
129674403|NCT00324155|466768814|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
129674404|NCT00324155|466768815|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
129674405|NCT00324155|466768814|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
129674406|NCT00324155|466768815|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
129674407|NCT00324155|466768814|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
129674408|NCT00324155|466768815|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
129674409|NCT00324155|466768814|FG000|Follow-up Phase|On-going participants still on drug|11|||
129674410|NCT00324155|466768815|FG001|Follow-up Phase|On-going participants still on drug|6|||
129674411|NCT00390689|466768816|FG000|Overall Study|Adverse Event|2|||
129674412|NCT00390689|466768817|FG001|Overall Study|Adverse Event|5|||
129674413|NCT00390689|466768818|FG002|Overall Study|Adverse Event|2|||
129674414|NCT00390689|466768816|FG000|Overall Study|Lack of Efficacy|0|||
129674415|NCT00390689|466768817|FG001|Overall Study|Lack of Efficacy|0|||
129674416|NCT00390689|466768818|FG002|Overall Study|Lack of Efficacy|1|||
129674417|NCT00390689|466768816|FG000|Overall Study|Protocol Violation|1|||
129674418|NCT00390689|466768817|FG001|Overall Study|Protocol Violation|0|||
129674419|NCT00390689|466768818|FG002|Overall Study|Protocol Violation|0|||
129674420|NCT00390689|466768816|FG000|Overall Study|Investigator's judgement|2|||
129674421|NCT00390689|466768817|FG001|Overall Study|Investigator's judgement|0|||
129674422|NCT00390689|466768818|FG002|Overall Study|Investigator's judgement|0|||
129674423|NCT01253161|466768819|FG000|Overall Study|Adverse Event|1|||
129674424|NCT01924533|466768821|FG000|Overall Study|Death|181|||
129674425|NCT01924533|466768822|FG001|Overall Study|Death|200|||
129674426|NCT01924533|466768821|FG000|Overall Study|Lost to Follow-up|0|||
129674427|NCT01924533|466768822|FG001|Overall Study|Lost to Follow-up|1|||
129674428|NCT01924533|466768821|FG000|Overall Study|Withdrawal by Subject|7|||
129674429|NCT01924533|466768822|FG001|Overall Study|Withdrawal by Subject|3|||
129674430|NCT01924533|466768821|FG000|Overall Study|Other Eligibility criteria|1|||
129674431|NCT01924533|466768822|FG001|Overall Study|Other Eligibility criteria|1|||
129674432|NCT03307174|466768824|FG000|Overall Study|Unplanned ICU Administrion|5|||
129674433|NCT03307174|466768825|FG001|Overall Study|Unplanned ICU Administrion|3|||
129674434|NCT03307174|466768824|FG000|Overall Study|Aborted Surgery|1|||
129674435|NCT03307174|466768825|FG001|Overall Study|Aborted Surgery|2|||
129674436|NCT03307174|466768824|FG000|Overall Study|Hypotension|6|||
129674437|NCT03307174|466768825|FG001|Overall Study|Hypotension|0|||
129674438|NCT03307174|466768824|FG000|Overall Study|Nonfunctional epidural|1|||
129674439|NCT03307174|466768825|FG001|Overall Study|Nonfunctional epidural|1|||
129674440|NCT03307174|466768824|FG000|Overall Study|Planned epidural removal|1|||
129674441|NCT03307174|466768825|FG001|Overall Study|Planned epidural removal|0|||
129674442|NCT03307174|466768824|FG000|Overall Study|Intrathecal catheter placement|0|||
129674443|NCT03307174|466768825|FG001|Overall Study|Intrathecal catheter placement|1|||
129674444|NCT04275336|466768826|FG000|Overall Study|First venipuncture failed|4|||
129674445|NCT04275336|466768827|FG001|Overall Study|First venipuncture failed|6|||
129674446|NCT04275336|466768828|FG002|Overall Study|First venipuncture failed|5|||
129674447|NCT04275336|466768826|FG000|Overall Study|Unscheduled venipuncture|9|||
129674448|NCT04275336|466768827|FG001|Overall Study|Unscheduled venipuncture|13|||
129674449|NCT04275336|466768828|FG002|Overall Study|Unscheduled venipuncture|7|||
129674450|NCT04275336|466768826|FG000|Overall Study|Failed specimen of saliva|4|||
129674451|NCT04275336|466768827|FG001|Overall Study|Failed specimen of saliva|3|||
129674452|NCT04275336|466768828|FG002|Overall Study|Failed specimen of saliva|4|||
129674453|NCT03055936|466768829|FG000|Overall Study|Adverse Event|0|||
129674454|NCT03055936|466768830|FG001|Overall Study|Adverse Event|1|||
129674455|NCT03055936|466768831|FG002|Overall Study|Adverse Event|1|||
129674456|NCT03055936|466768832|FG003|Overall Study|Adverse Event|1|||
129674457|NCT03055936|466768829|FG000|Overall Study|Personal reason|2|||
129674458|NCT03055936|466768830|FG001|Overall Study|Personal reason|0|||
129674459|NCT03055936|466768831|FG002|Overall Study|Personal reason|1|||
129674460|NCT03055936|466768832|FG003|Overall Study|Personal reason|0|||
129674461|NCT03372798|466768841|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
129674462|NCT03372798|466768842|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
129674463|NCT03372798|466768841|FG000|Overall Study|Failure of imaging probe|0|||
129674464|NCT03372798|466768842|FG001|Overall Study|Failure of imaging probe|1|||
129674465|NCT00721799|466768861|FG000|Overall Study|Withdrawal by Subject|7|||
129674466|NCT00721799|466768861|FG000|Overall Study|withdraw by subject after scan 1|1|||
129674467|NCT03141359|466768862|FG000|Overall Study|Death|32|||
129674468|NCT03141359|466768862|FG000|Overall Study|Still On Study (in follow up)|29|||
129674469|NCT01081626|466768863|FG000|Overall Study|Dosing error|1|||
129674470|NCT01081626|466768864|FG001|Overall Study|Dosing error|1|||
129674471|NCT01081626|466768863|FG000|Overall Study|Missing Estradiol|25|||
129674472|NCT01081626|466768864|FG001|Overall Study|Missing Estradiol|28|||
129674473|NCT01081626|466768863|FG000|Overall Study|Low antral follicle count|1|||
129674474|NCT01081626|466768864|FG001|Overall Study|Low antral follicle count|0|||
129674475|NCT01081626|466768863|FG000|Overall Study|Overstimulation|0|||
129674476|NCT01081626|466768864|FG001|Overall Study|Overstimulation|1|||
129674477|NCT01081626|466768863|FG000|Overall Study|Lost to Follow-up|0|||
129674478|NCT01081626|466768864|FG001|Overall Study|Lost to Follow-up|1|||
129674479|NCT01081626|466768863|FG000|Overall Study|Other|33|||
129674480|NCT01081626|466768864|FG001|Overall Study|Other|30|||
129674481|NCT04158219|466768865|FG000|Overall Study|Lost to Follow-up|1|||
129674482|NCT02074514|466768866|FG000|Overall Study|Lack of Efficacy|3|||
129674483|NCT02074514|466768867|FG001|Overall Study|Lack of Efficacy|2|||
129674484|NCT02074514|466768866|FG000|Overall Study|Lost to Follow-up|0|||
129674485|NCT02074514|466768867|FG001|Overall Study|Lost to Follow-up|1|||
129674486|NCT02074514|466768866|FG000|Overall Study|Withdrew Consent|0|||
129674487|NCT02074514|466768867|FG001|Overall Study|Withdrew Consent|1|||
129674488|NCT02873689|466770170|FG000|Overall Study|Lack of Efficacy|1|||
129674489|NCT02873689|466770171|FG001|Overall Study|Lack of Efficacy|0|||
129674490|NCT02873689|466770170|FG000|Overall Study|Withdrawal by Subject|2|||
129674491|NCT02873689|466770171|FG001|Overall Study|Withdrawal by Subject|2|||
129674492|NCT02873689|466770170|FG000|Overall Study|Protocol Violation|1|||
129674493|NCT02873689|466770171|FG001|Overall Study|Protocol Violation|0|||
129674494|NCT02873689|466770170|FG000|Overall Study|Adverse Event|2|||
129674495|NCT02873689|466770171|FG001|Overall Study|Adverse Event|2|||
129674496|NCT02873689|466770170|FG000|Overall Study|Randomized but not Treated|1|||
129674497|NCT02873689|466770171|FG001|Overall Study|Randomized but not Treated|1|||
129674498|NCT04748718|466770183|FG000|Overall Study|Lost to Follow-up|50|||
129674499|NCT01065818|466770184|FG000|Overall Study|Withdrawal by Subject|1|||
129674500|NCT01065818|466770184|FG000|Overall Study|Not a candidate for surgery|1|||
129674501|NCT01450813|466770185|FG000|Overall Study|Physician Decision|1|||
129674502|NCT01450813|466770186|FG001|Overall Study|Physician Decision|1|||
129674503|NCT01450813|466770187|FG002|Overall Study|Physician Decision|0|||
129674504|NCT01450813|466770188|FG003|Overall Study|Physician Decision|3|||
129674505|NCT01935089|466770190|FG000|Overall Study|Adverse Event|2|||
129674506|NCT01935089|466770190|FG000|Overall Study|Withdrawal by Subject|1|||
129674507|NCT02337491|466770194|FG000|Overall Study|Death|1|||
129674508|NCT02337491|466770195|FG001|Overall Study|Death|1|||
129674509|NCT02337491|466770194|FG000|Overall Study|Adverse Event|0|||
129674510|NCT02337491|466770195|FG001|Overall Study|Adverse Event|1|||
129674511|NCT02337491|466770194|FG000|Overall Study|Withdrawal by Subject|3|||
129674512|NCT02337491|466770195|FG001|Overall Study|Withdrawal by Subject|0|||
129674513|NCT02337491|466770194|FG000|Overall Study|Progressive Disease|44|||
129674514|NCT02337491|466770195|FG001|Overall Study|Progressive Disease|28|||
129674515|NCT02337491|466770194|FG000|Overall Study|On Treatment|2|||
129674516|NCT02337491|466770195|FG001|Overall Study|On Treatment|0|||
129674517|NCT00723229|466770196|FG000|First Intervention|Lost to Follow-up|7|||
129674518|NCT00723229|466770197|FG001|First Intervention|Lost to Follow-up|3|||
129674519|NCT01483118|466770202|FG000|Overall Study|Lost to Follow-up|12|||
129674520|NCT01483118|466770203|FG001|Overall Study|Lost to Follow-up|16|||
129674521|NCT03435055|466770205|FG000|Screening|Physician Decision|2|||
129674522|NCT03435055|466770205|FG000|Received Intervention|Did not complete nitrous administration|3|||
129674523|NCT03712280|466770206|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
129674524|NCT03712280|466770207|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
129674525|NCT03712280|466770208|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
129674526|NCT03712280|466770209|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
129674527|NCT03712280|466770206|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
129674528|NCT03712280|466770207|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
129674529|NCT03712280|466770208|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
129674530|NCT03712280|466770209|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
129674531|NCT03712280|466770206|FG000|Overall Study|Adverse Event|0|||
129674532|NCT03712280|466770207|FG001|Overall Study|Adverse Event|0|||
129674533|NCT03712280|466770208|FG002|Overall Study|Adverse Event|1|||
129674534|NCT03712280|466770209|FG003|Overall Study|Adverse Event|0|||
129674535|NCT01302899|466770212|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
129674536|NCT01302899|466770213|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
129674537|NCT01302899|466770212|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
129674538|NCT01302899|466770213|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
129674539|NCT02834975|466770214|FG000|Overall Study|Physician Decision|2|||
129674540|NCT02834975|466770214|FG000|Overall Study|Adverse Event|1|||
129674541|NCT02834975|466770214|FG000|Overall Study|Withdrawal by Subject|1|||
129674542|NCT02834975|466770214|FG000|Overall Study|Lack of Efficacy|1|||
129674543|NCT03558516|466770215|FG000|Overall Study|Protocol Violation|2|||
129674544|NCT03558516|466770216|FG001|Overall Study|Protocol Violation|2|||
129674545|NCT00929669|466770217|FG000|Overall Study|elevated glucose levels|1|||
129674546|NCT04494646|466770222|FG000|Overall Study|Adverse Event|0|||
129674547|NCT04494646|466770223|FG001|Overall Study|Adverse Event|1|||
129674548|NCT04494646|466770222|FG000|Overall Study|Withdrawal by Subject|0|||
129674549|NCT04494646|466770223|FG001|Overall Study|Withdrawal by Subject|1|||
129674550|NCT02785939|466770226|FG000|Overall Study|Progression|25|||
129674551|NCT02785939|466770227|FG001|Overall Study|Progression|8|||
129674552|NCT02785939|466770226|FG000|Overall Study|Adverse Event|3|||
129674553|NCT02785939|466770227|FG001|Overall Study|Adverse Event|1|||
129674554|NCT02785939|466770226|FG000|Overall Study|Death|1|||
129674555|NCT02785939|466770227|FG001|Overall Study|Death|0|||
129674556|NCT02785939|466770226|FG000|Overall Study|Refusal|1|||
129674557|NCT02785939|466770227|FG001|Overall Study|Refusal|0|||
129674558|NCT02785939|466770226|FG000|Overall Study|Deteriorating health|1|||
129674559|NCT02785939|466770227|FG001|Overall Study|Deteriorating health|0|||
129674560|NCT02785939|466770226|FG000|Overall Study|Not protocol specified|0|||
129674561|NCT02785939|466770227|FG001|Overall Study|Not protocol specified|1|||
129674562|NCT02147626|466770230|FG000|Overall Study|Lost to Follow-up|4|||
129674563|NCT02147626|466770231|FG001|Overall Study|Lost to Follow-up|4|||
129674564|NCT02147626|466770230|FG000|Overall Study|Pregnancy|1|||
129674565|NCT02147626|466770231|FG001|Overall Study|Pregnancy|2|||
129674566|NCT02147626|466770230|FG000|Overall Study|Withdrawal by Subject|0|||
129674567|NCT02147626|466770231|FG001|Overall Study|Withdrawal by Subject|1|||
129674568|NCT00572832|466770232|FG000|Overall Study|Lost to Follow-up|0|||
129674569|NCT00572832|466770233|FG001|Overall Study|Lost to Follow-up|11|||
129674570|NCT00572832|466770232|FG000|Overall Study|Pregnancy|0|||
129674571|NCT00572832|466770233|FG001|Overall Study|Pregnancy|1|||
129674572|NCT01704261|466770237|FG000|Overall Study|Withdrawal by Subject|12|||
129674573|NCT01704261|466770238|FG001|Overall Study|Withdrawal by Subject|15|||
129674574|NCT01704261|466770237|FG000|Overall Study|Lost to Follow-up|1|||
129674575|NCT01704261|466770238|FG001|Overall Study|Lost to Follow-up|0|||
129674576|NCT02722967|466770239|FG000|Overall Study|Adverse Event|1|||
129674577|NCT02722967|466770240|FG001|Overall Study|Adverse Event|0|||
129674578|NCT02722967|466770241|FG002|Overall Study|Adverse Event|0|||
129674579|NCT02722967|466770239|FG000|Overall Study|Lost to Follow-up|0|||
129674580|NCT02722967|466770240|FG001|Overall Study|Lost to Follow-up|1|||
129674581|NCT02722967|466770241|FG002|Overall Study|Lost to Follow-up|0|||
129674582|NCT02722967|466770239|FG000|Overall Study|Non-compliance with patch wearing|2|||
129674583|NCT02722967|466770240|FG001|Overall Study|Non-compliance with patch wearing|1|||
129674584|NCT02722967|466770241|FG002|Overall Study|Non-compliance with patch wearing|1|||
129674585|NCT02722967|466770239|FG000|Overall Study|Withdrawal by Subject|1|||
129674586|NCT02722967|466770240|FG001|Overall Study|Withdrawal by Subject|0|||
129674587|NCT02722967|466770241|FG002|Overall Study|Withdrawal by Subject|1|||
129674588|NCT02722967|466770239|FG000|Overall Study|Physician Decision|1|||
129674589|NCT02722967|466770240|FG001|Overall Study|Physician Decision|0|||
129674590|NCT02722967|466770241|FG002|Overall Study|Physician Decision|0|||
129674591|NCT02722967|466770239|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
129674592|NCT02722967|466770240|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
129674593|NCT02722967|466770241|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
129674594|NCT00846053|466770244|FG000|Overall Study|Physician Decision|3|||
129674595|NCT00846053|466770245|FG001|Overall Study|Physician Decision|0|||
129674596|NCT00111761|466770246|FG000|Part 1|Physician Decision|0|||
129674597|NCT00111761|466770247|FG001|Part 1|Physician Decision|1|||
129674598|NCT00111761|466770246|FG000|Part 1|Death|0|||
129674599|NCT00111761|466770247|FG001|Part 1|Death|2|||
129674600|NCT00111761|466770246|FG000|Part 1|Other|0|||
129674601|NCT00111761|466770247|FG001|Part 1|Other|1|||
129674602|NCT00111761|466770246|FG000|Part 1|Withdrawal by Subject|0|||
129674603|NCT00111761|466770247|FG001|Part 1|Withdrawal by Subject|1|||
129674604|NCT00111761|466770246|FG000|Part 2|Adverse Event|1|||
129674605|NCT00111761|466770247|FG001|Part 2|Adverse Event|0|||
129674606|NCT00111761|466770246|FG000|Part 2|Physician Decision|1|||
129674607|NCT00111761|466770247|FG001|Part 2|Physician Decision|0|||
129674608|NCT00111761|466770246|FG000|Part 2|Death|1|||
129674609|NCT00111761|466770247|FG001|Part 2|Death|0|||
129674610|NCT00111761|466770246|FG000|Part 2|Disease progression|3|||
129674611|NCT00111761|466770247|FG001|Part 2|Disease progression|0|||
129674612|NCT00111761|466770246|FG000|Part 2|Protocol-specified criteria|1|||
129674613|NCT00111761|466770247|FG001|Part 2|Protocol-specified criteria|0|||
129674614|NCT00111761|466770246|FG000|Part 2|Other|1|||
129674615|NCT00111761|466770247|FG001|Part 2|Other|0|||
129674616|NCT00467519|466770251|FG000|Overall Study|Protocol Violation|8|||
129674617|NCT00467519|466770252|FG001|Overall Study|Protocol Violation|4|||
129674618|NCT00467519|466770251|FG000|Overall Study|Lost to Follow-up|2|||
129674619|NCT00467519|466770252|FG001|Overall Study|Lost to Follow-up|9|||
129674620|NCT00467519|466770251|FG000|Overall Study|Withdrawal by Subject|4|||
129674621|NCT00467519|466770252|FG001|Overall Study|Withdrawal by Subject|10|||
129674622|NCT00843492|466770259|FG000|Overall Study|Adverse Event|0|||
129674623|NCT00843492|466770260|FG001|Overall Study|Adverse Event|3|||
129674624|NCT00843492|466770259|FG000|Overall Study|Lost to Follow-up|4|||
129674625|NCT00843492|466770260|FG001|Overall Study|Lost to Follow-up|4|||
129674626|NCT00843492|466770259|FG000|Overall Study|Withdrawal by Subject|0|||
129674627|NCT00843492|466770260|FG001|Overall Study|Withdrawal by Subject|4|||
129674628|NCT00843492|466770259|FG000|Overall Study|Immobilization Stopped|1|||
129674629|NCT00843492|466770260|FG001|Overall Study|Immobilization Stopped|0|||
129674630|NCT00843492|466770259|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
129674631|NCT00843492|466770260|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
129674632|NCT00843492|466770259|FG000|Overall Study|Orthopedic Surgery|0|||
129674633|NCT00843492|466770260|FG001|Overall Study|Orthopedic Surgery|2|||
129674634|NCT00843492|466770259|FG000|Overall Study|Visit Not Performed|1|||
129674635|NCT00843492|466770260|FG001|Overall Study|Visit Not Performed|0|||
129674636|NCT00843492|466770259|FG000|Overall Study|Deep-vein Thrombosis|1|||
129674637|NCT00843492|466770260|FG001|Overall Study|Deep-vein Thrombosis|0|||
129674638|NCT01677741|466770261|FG000|Overall Study|Death|0|||
129674639|NCT01677741|466770262|FG001|Overall Study|Death|0|||
129674640|NCT01677741|466770263|FG002|Overall Study|Death|0|||
129674641|NCT01677741|466770264|FG003|Overall Study|Death|1|||
129674642|NCT01677741|466770265|FG004|Overall Study|Death|0|||
129674643|NCT01677741|466770266|FG005|Overall Study|Death|1|||
129674644|NCT01677741|466770267|FG006|Overall Study|Death|0|||
129674645|NCT01677741|466770268|FG007|Overall Study|Death|0|||
129674646|NCT01677741|466770261|FG000|Overall Study|Withdrawal by Subject|2|||
129674647|NCT01677741|466770262|FG001|Overall Study|Withdrawal by Subject|7|||
129674648|NCT01677741|466770263|FG002|Overall Study|Withdrawal by Subject|5|||
129674649|NCT01677741|466770264|FG003|Overall Study|Withdrawal by Subject|4|||
129674650|NCT01677741|466770265|FG004|Overall Study|Withdrawal by Subject|11|||
129674651|NCT01677741|466770266|FG005|Overall Study|Withdrawal by Subject|20|||
129674652|NCT01677741|466770267|FG006|Overall Study|Withdrawal by Subject|4|||
129674653|NCT01677741|466770268|FG007|Overall Study|Withdrawal by Subject|2|||
129674654|NCT01677741|466770261|FG000|Overall Study|Enrolled in a rollover study|0|||
129674655|NCT01677741|466770262|FG001|Overall Study|Enrolled in a rollover study|3|||
129674656|NCT01677741|466770263|FG002|Overall Study|Enrolled in a rollover study|2|||
129674657|NCT01677741|466770264|FG003|Overall Study|Enrolled in a rollover study|1|||
129674658|NCT01677741|466770265|FG004|Overall Study|Enrolled in a rollover study|6|||
129674659|NCT01677741|466770266|FG005|Overall Study|Enrolled in a rollover study|6|||
129674660|NCT01677741|466770267|FG006|Overall Study|Enrolled in a rollover study|7|||
129674661|NCT01677741|466770268|FG007|Overall Study|Enrolled in a rollover study|0|||
129674662|NCT01677741|466770261|FG000|Overall Study|Progressive disease|1|||
129674663|NCT01677741|466770262|FG001|Overall Study|Progressive disease|0|||
129674664|NCT01677741|466770263|FG002|Overall Study|Progressive disease|1|||
129674665|NCT01677741|466770264|FG003|Overall Study|Progressive disease|0|||
129674666|NCT01677741|466770265|FG004|Overall Study|Progressive disease|0|||
129674667|NCT01677741|466770266|FG005|Overall Study|Progressive disease|1|||
129674668|NCT01677741|466770267|FG006|Overall Study|Progressive disease|0|||
129674669|NCT01677741|466770268|FG007|Overall Study|Progressive disease|0|||
129674670|NCT00720499|466770269|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
129674671|NCT00720499|466770270|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
129674672|NCT00720499|466770269|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
129674673|NCT00720499|466770270|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
129674674|NCT00720499|466770269|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
129674675|NCT00720499|466770270|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
129674676|NCT03641508|466770282|FG000|First Injection|Lost to Follow-up|2|||
129674677|NCT03641508|466770283|FG001|First Injection|Lost to Follow-up|0|||
129674678|NCT03642990|466770284|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
129674679|NCT03642990|466770284|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
129674680|NCT00855218|466770285|FG000|Overall Study|Adverse Event|43|||
129674681|NCT00855218|466770286|FG001|Overall Study|Adverse Event|27|||
129674682|NCT00855218|466770285|FG000|Overall Study|Withdrawal by Subject|10|||
129674683|NCT00855218|466770286|FG001|Overall Study|Withdrawal by Subject|6|||
129674684|NCT00855218|466770285|FG000|Overall Study|Physician Decision|18|||
129674685|NCT00855218|466770286|FG001|Overall Study|Physician Decision|11|||
129674686|NCT00855218|466770285|FG000|Overall Study|Lost to Follow-up|0|||
129674687|NCT00855218|466770286|FG001|Overall Study|Lost to Follow-up|1|||
129674688|NCT00855218|466770285|FG000|Overall Study|Protocol Violation|5|||
129674689|NCT00855218|466770286|FG001|Overall Study|Protocol Violation|9|||
129674690|NCT00855218|466770285|FG000|Overall Study|non-compliant with study drug|3|||
129674691|NCT00855218|466770286|FG001|Overall Study|non-compliant with study drug|1|||
129674692|NCT00855218|466770285|FG000|Overall Study|patient convenience|2|||
129674693|NCT00855218|466770286|FG001|Overall Study|patient convenience|0|||
129674694|NCT00855218|466770285|FG000|Overall Study|technical problems|2|||
129674695|NCT00855218|466770286|FG001|Overall Study|technical problems|1|||
129674696|NCT00855218|466770285|FG000|Overall Study|Still treated with study medication|0|||
129674697|NCT00855218|466770286|FG001|Overall Study|Still treated with study medication|1|||
129674698|NCT00855218|466770285|FG000|Overall Study|Untreatable disease progression|54|||
129674699|NCT00855218|466770286|FG001|Overall Study|Untreatable disease progression|67|||
129674700|NCT00855218|466770285|FG000|Overall Study|Second malignancy|0|||
129674701|NCT00855218|466770286|FG001|Overall Study|Second malignancy|1|||
129674702|NCT00855218|466770285|FG000|Overall Study|Progression measurement proven|7|||
129674703|NCT00855218|466770286|FG001|Overall Study|Progression measurement proven|15|||
129674704|NCT00855218|466770285|FG000|Overall Study|Clinical endpoint reached|10|||
129674705|NCT00855218|466770286|FG001|Overall Study|Clinical endpoint reached|13|||
129674706|NCT00764790|466770287|FG000|Overall Study|Protocol Violation|0|||
129674707|NCT00764790|466770288|FG001|Overall Study|Protocol Violation|0|||
129674708|NCT00764790|466770289|FG002|Overall Study|Protocol Violation|1|||
129674709|NCT00764790|466770287|FG000|Overall Study|Withdrawal by Subject|10|||
129674710|NCT00764790|466770288|FG001|Overall Study|Withdrawal by Subject|12|||
129674711|NCT00764790|466770289|FG002|Overall Study|Withdrawal by Subject|6|||
129674712|NCT00764790|466770287|FG000|Overall Study|Lost to Follow-up|28|||
129674713|NCT00764790|466770288|FG001|Overall Study|Lost to Follow-up|29|||
129674714|NCT00764790|466770289|FG002|Overall Study|Lost to Follow-up|23|||
129674715|NCT03191552|466770290|FG000|Overall Study|Lost to Follow-up|1|||
129674716|NCT03191552|466770291|FG001|Overall Study|Lost to Follow-up|0|||
129674717|NCT03191552|466770292|FG002|Overall Study|Lost to Follow-up|0|||
129674718|NCT03191552|466770290|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
129674719|NCT03191552|466770291|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
129674720|NCT03191552|466770292|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
129674721|NCT01441973|466770293|FG000|Overall Study|Disease progression|8|||
129674722|NCT01441973|466770294|FG001|Overall Study|Disease progression|6|||
129674723|NCT01441973|466770293|FG000|Overall Study|Adverse event unrelated to study drug|3|||
129674724|NCT01441973|466770294|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129674725|NCT01441973|466770293|FG000|Overall Study|Participant request to discontinue|1|||
129674726|NCT01441973|466770294|FG001|Overall Study|Participant request to discontinue|1|||
129674727|NCT01441973|466770293|FG000|Overall Study|Poor compliance/noncompliance|0|||
129674728|NCT01441973|466770294|FG001|Overall Study|Poor compliance/noncompliance|1|||
129674729|NCT01441973|466770293|FG000|Overall Study|Administrative reason by sponsor|3|||
129674730|NCT01441973|466770294|FG001|Overall Study|Administrative reason by sponsor|5|||
129674731|NCT01441973|466770293|FG000|Overall Study|Participant withdrew consent|0|||
129674732|NCT01441973|466770294|FG001|Overall Study|Participant withdrew consent|1|||
129674733|NCT01149655|466770295|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
129674734|NCT01149655|466770296|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
129674735|NCT01149655|466770297|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
129674736|NCT01149655|466770298|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
129674737|NCT01149655|466770295|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
129766252|NCT01231984|467110332|FG003|Study Period 1|Non-compliance with study requirements|1|||
129766253|NCT01231984|467110329|FG000|Study Period 1|Protocol Violation|3|||
129766254|NCT01231984|467110330|FG001|Study Period 1|Protocol Violation|4|||
129766255|NCT01231984|467110331|FG002|Study Period 1|Protocol Violation|2|||
129766256|NCT01231984|467110332|FG003|Study Period 1|Protocol Violation|3|||
129766257|NCT01231984|467110329|FG000|Study Period 1|Adverse Event|1|||
129766258|NCT01231984|467110330|FG001|Study Period 1|Adverse Event|0|||
129766259|NCT01231984|467110331|FG002|Study Period 1|Adverse Event|0|||
129766260|NCT01231984|467110332|FG003|Study Period 1|Adverse Event|0|||
129766261|NCT01231984|467110329|FG000|Study Period 1|Other|0|||
129766262|NCT01231984|467110330|FG001|Study Period 1|Other|0|||
129766263|NCT01231984|467110331|FG002|Study Period 1|Other|0|||
129766264|NCT01231984|467110332|FG003|Study Period 1|Other|1|||
129766265|NCT01231984|467110329|FG000|Study Period 2|Withdrawal by Subject|1|||
129766266|NCT01231984|467110330|FG001|Study Period 2|Withdrawal by Subject|1|||
129766267|NCT01231984|467110331|FG002|Study Period 2|Withdrawal by Subject|0|||
129766268|NCT01231984|467110332|FG003|Study Period 2|Withdrawal by Subject|0|||
129766269|NCT01231984|467110329|FG000|Study Period 2|Lost to Follow-up|1|||
129766270|NCT01231984|467110330|FG001|Study Period 2|Lost to Follow-up|0|||
129766271|NCT01231984|467110331|FG002|Study Period 2|Lost to Follow-up|0|||
129766272|NCT01231984|467110332|FG003|Study Period 2|Lost to Follow-up|3|||
129766273|NCT01231984|467110329|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
129766274|NCT01231984|467110330|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
129766275|NCT01231984|467110331|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
129766276|NCT01231984|467110332|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
129766277|NCT02923726|467110337|FG000|Overall Study|Death|196|||
129674738|NCT01149655|466770296|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
129674739|NCT01149655|466770297|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
129674740|NCT01149655|466770298|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
129674741|NCT01149655|466770295|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
129674742|NCT01149655|466770296|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129674743|NCT01149655|466770297|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129674744|NCT01149655|466770298|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129674745|NCT01149655|466770295|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
129674746|NCT01149655|466770296|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
129674747|NCT01149655|466770297|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
129674748|NCT01149655|466770298|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
129674749|NCT01149655|466770295|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
129766278|NCT02923726|467110338|FG001|Overall Study|Death|175|||
129674750|NCT01149655|466770296|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129674751|NCT01149655|466770297|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129674752|NCT01149655|466770298|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129674753|NCT01149655|466770295|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
129674754|NCT01149655|466770296|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
129674755|NCT01149655|466770297|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
129674756|NCT01149655|466770298|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
129674757|NCT01149655|466770295|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
129766279|NCT02923726|467110337|FG000|Overall Study|Withdrawal by Subject|337|||
129766280|NCT02923726|467110338|FG001|Overall Study|Withdrawal by Subject|307|||
129674758|NCT01149655|466770296|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
129674759|NCT01149655|466770297|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
129674760|NCT01149655|466770298|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
129674761|NCT01149655|466770295|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
129674762|NCT01149655|466770296|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
129674763|NCT01149655|466770297|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
129674764|NCT01149655|466770298|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
129674765|NCT01149655|466770295|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
129674766|NCT01149655|466770296|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
129674767|NCT01149655|466770297|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
129674768|NCT01149655|466770298|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
129674769|NCT01149655|466770295|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
129674770|NCT01149655|466770296|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
129674771|NCT01149655|466770297|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
129674772|NCT01149655|466770298|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
129674773|NCT01149655|466770295|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
129674774|NCT01149655|466770296|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
129674775|NCT01149655|466770297|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
129674776|NCT01149655|466770298|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
129674777|NCT01149655|466770295|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
129674778|NCT01149655|466770296|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
129674779|NCT01149655|466770297|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
129674780|NCT01149655|466770298|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
129674781|NCT01149655|466770295|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
129674782|NCT01149655|466770296|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
129674783|NCT01149655|466770297|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
129674784|NCT01149655|466770298|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
129674785|NCT01149655|466770295|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
129674786|NCT01149655|466770296|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
129674787|NCT01149655|466770297|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
129674788|NCT01149655|466770298|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
129674789|NCT01149655|466770295|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
129674790|NCT01149655|466770296|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
129674791|NCT01149655|466770297|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
129674792|NCT01149655|466770298|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
129674793|NCT01149655|466770295|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
129674794|NCT01149655|466770296|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
129674795|NCT01149655|466770297|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
129674796|NCT01149655|466770298|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
129674797|NCT05079321|466770299|FG000|Overall Study|Withdrawal by Subject|2|||
129674798|NCT05079321|466770300|FG001|Overall Study|Withdrawal by Subject|2|||
129674799|NCT05079321|466770299|FG000|Overall Study|Lost to Follow-up|0|||
129674800|NCT05079321|466770300|FG001|Overall Study|Lost to Follow-up|1|||
129674801|NCT02003144|466770301|FG000|Open Label Maintenance Phase|Other than specified|2|||
129674802|NCT02003144|466770302|FG001|Open Label Maintenance Phase|Other than specified|4|||
129674803|NCT02003144|466770301|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
129674804|NCT02003144|466770302|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
129674805|NCT02003144|466770301|FG000|Open Label Maintenance Phase|Pregnancy|0|||
129674806|NCT02003144|466770302|FG001|Open Label Maintenance Phase|Pregnancy|2|||
129674807|NCT02003144|466770301|FG000|Open Label Maintenance Phase|Physician Decision|1|||
129674808|NCT02003144|466770302|FG001|Open Label Maintenance Phase|Physician Decision|1|||
129674809|NCT02003144|466770301|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
129674810|NCT02003144|466770302|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
129674811|NCT02003144|466770301|FG000|Open Label Maintenance Phase|Adverse Event|2|||
129674812|NCT02003144|466770302|FG001|Open Label Maintenance Phase|Adverse Event|1|||
129674813|NCT05965752|466770303|FG000|Overall Study|Adverse Event|0|||
129674814|NCT05965752|466770304|FG001|Overall Study|Adverse Event|1|||
129674815|NCT05965752|466770305|FG002|Overall Study|Adverse Event|0|||
129766281|NCT01680341|467110341|FG000|Overall Study|Adverse Event|3|||
129766282|NCT01680341|467110342|FG001|Overall Study|Adverse Event|2|||
129766283|NCT01680341|467110341|FG000|Overall Study|Unclassified|18|||
129766284|NCT01680341|467110342|FG001|Overall Study|Unclassified|15|||
129766285|NCT00481832|467110343|FG000|Enrollment|Physician Decision|8|||
129766286|NCT00481832|467110343|FG000|Enrollment|Unable to collect enough stem cells|2|||
129766287|NCT00481832|467110343|FG000|Inter-transplant Period|Adverse Event|4|||
129766288|NCT00481832|467110343|FG000|Inter-transplant Period|Death|3|||
129766289|NCT00481832|467110343|FG000|Inter-transplant Period|Physician Decision|4|||
129766290|NCT00481832|467110343|FG000|Inter-transplant Period|Disease relapse|11|||
129766291|NCT00481832|467110343|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
129766292|NCT02558894|467110346|FG000|Overall Study|Death; any cause, entire study duration|28|||
129766293|NCT02558894|467110347|FG001|Overall Study|Death; any cause, entire study duration|31|||
129766294|NCT02558894|467110346|FG000|Overall Study|Withdrawal by Subject|2|||
129766295|NCT02558894|467110347|FG001|Overall Study|Withdrawal by Subject|1|||
129766296|NCT02558894|467110346|FG000|Overall Study|Closure of Part A|2|||
129766297|NCT02558894|467110347|FG001|Overall Study|Closure of Part A|1|||
129766298|NCT02992288|467110348|FG000|Overall Study|Adverse Event|8|||
129766299|NCT02992288|467110349|FG001|Overall Study|Adverse Event|2|||
129766300|NCT02992288|467110350|FG002|Overall Study|Adverse Event|2|||
129766301|NCT02992288|467110351|FG003|Overall Study|Adverse Event|2|||
129766302|NCT02992288|467110352|FG004|Overall Study|Adverse Event|2|||
129766303|NCT02992288|467110353|FG005|Overall Study|Adverse Event|7|||
129766304|NCT02992288|467110348|FG000|Overall Study|Non-compliance with study drug|0|||
129766305|NCT02992288|467110349|FG001|Overall Study|Non-compliance with study drug|1|||
129766306|NCT02992288|467110350|FG002|Overall Study|Non-compliance with study drug|1|||
129766307|NCT02992288|467110351|FG003|Overall Study|Non-compliance with study drug|0|||
129766308|NCT02992288|467110352|FG004|Overall Study|Non-compliance with study drug|1|||
129766309|NCT02992288|467110353|FG005|Overall Study|Non-compliance with study drug|0|||
129766310|NCT02992288|467110348|FG000|Overall Study|Physician Decision|3|||
129766311|NCT02992288|467110349|FG001|Overall Study|Physician Decision|0|||
129766312|NCT02992288|467110350|FG002|Overall Study|Physician Decision|1|||
129674816|NCT05965752|466770306|FG003|Overall Study|Adverse Event|1|||
129674817|NCT05965752|466770307|FG004|Overall Study|Adverse Event|3|||
129674818|NCT05965752|466770303|FG000|Overall Study|Lost to Follow-up|2|||
129674819|NCT05965752|466770304|FG001|Overall Study|Lost to Follow-up|0|||
129674820|NCT05965752|466770305|FG002|Overall Study|Lost to Follow-up|1|||
129674821|NCT05965752|466770306|FG003|Overall Study|Lost to Follow-up|1|||
129674822|NCT05965752|466770307|FG004|Overall Study|Lost to Follow-up|1|||
129674823|NCT05965752|466770303|FG000|Overall Study|Withdrawal by Subject|2|||
129674824|NCT05965752|466770304|FG001|Overall Study|Withdrawal by Subject|2|||
129674825|NCT05965752|466770305|FG002|Overall Study|Withdrawal by Subject|1|||
129674826|NCT05965752|466770306|FG003|Overall Study|Withdrawal by Subject|5|||
129674827|NCT05965752|466770307|FG004|Overall Study|Withdrawal by Subject|0|||
129674828|NCT05965752|466770303|FG000|Overall Study|Disease Relapse|1|||
129674829|NCT05965752|466770304|FG001|Overall Study|Disease Relapse|0|||
129674830|NCT05965752|466770305|FG002|Overall Study|Disease Relapse|1|||
129674831|NCT05965752|466770306|FG003|Overall Study|Disease Relapse|0|||
129674832|NCT05965752|466770307|FG004|Overall Study|Disease Relapse|0|||
129674833|NCT05965752|466770303|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129674834|NCT05965752|466770304|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
129674835|NCT05965752|466770305|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129674836|NCT05965752|466770306|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
129674837|NCT05965752|466770307|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
129674838|NCT05965752|466770303|FG000|Overall Study|Unable to Return for Study Visits|0|||
129674839|NCT05965752|466770304|FG001|Overall Study|Unable to Return for Study Visits|1|||
129674840|NCT05965752|466770305|FG002|Overall Study|Unable to Return for Study Visits|0|||
129674841|NCT05965752|466770306|FG003|Overall Study|Unable to Return for Study Visits|3|||
129674842|NCT05965752|466770307|FG004|Overall Study|Unable to Return for Study Visits|1|||
129674843|NCT05965752|466770303|FG000|Overall Study|Early Termination|0|||
129674844|NCT05965752|466770304|FG001|Overall Study|Early Termination|0|||
129674845|NCT05965752|466770305|FG002|Overall Study|Early Termination|1|||
129674846|NCT05965752|466770306|FG003|Overall Study|Early Termination|0|||
129674847|NCT05965752|466770307|FG004|Overall Study|Early Termination|0|||
129674848|NCT05965752|466770303|FG000|Overall Study|Reported Unwanted Symptoms|0|||
129674849|NCT05965752|466770304|FG001|Overall Study|Reported Unwanted Symptoms|0|||
129674850|NCT05965752|466770305|FG002|Overall Study|Reported Unwanted Symptoms|0|||
129674851|NCT05965752|466770306|FG003|Overall Study|Reported Unwanted Symptoms|0|||
129674852|NCT05965752|466770307|FG004|Overall Study|Reported Unwanted Symptoms|1|||
129674853|NCT05965752|466770303|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129674854|NCT05965752|466770304|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129674855|NCT05965752|466770305|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129674856|NCT05965752|466770306|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
129674857|NCT05965752|466770307|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
129674858|NCT01324947|466770308|FG000|Overall Study|Adverse Event|7|||
129674859|NCT01324947|466770308|FG000|Overall Study|Death|10|||
129674860|NCT01324947|466770308|FG000|Overall Study|Other|3|||
129674861|NCT01324947|466770308|FG000|Overall Study|Progressive Disease|50|||
129674862|NCT01324947|466770308|FG000|Overall Study|Withdrawal by Subject|3|||
129674863|NCT01324947|466770308|FG000|Overall Study|1 discontinued before starting drug|1|||
129674864|NCT01274351|466770309|FG000|Overall Study|Lost to Follow-up|1|||
129674865|NCT01274351|466770309|FG000|Overall Study|patient not compliant with the protocol|1|||
129674866|NCT01274351|466770309|FG000|Overall Study|Pregnancy|1|||
129674867|NCT01274351|466770309|FG000|Overall Study|Death|2|||
129674868|NCT01274351|466770309|FG000|Overall Study|Withdrawal by Subject|3|||
129674869|NCT01274351|466770309|FG000|Overall Study|Adverse Event|8|||
129674870|NCT01274351|466770309|FG000|Overall Study|progression of disease|3|||
129674871|NCT01274351|466770309|FG000|Overall Study|hospitalization|1|||
129674872|NCT01296412|466770312|FG000|Overall Study|Adverse Event|8|||
129674873|NCT01296412|466770313|FG001|Overall Study|Adverse Event|29|||
129674874|NCT01296412|466770312|FG000|Overall Study|Lack of Efficacy|1|||
129674875|NCT01296412|466770313|FG001|Overall Study|Lack of Efficacy|0|||
129674876|NCT01296412|466770312|FG000|Overall Study|Lost to Follow-up|10|||
129674877|NCT01296412|466770313|FG001|Overall Study|Lost to Follow-up|7|||
129674878|NCT01296412|466770312|FG000|Overall Study|Non-compliance with study drug|1|||
129674879|NCT01296412|466770313|FG001|Overall Study|Non-compliance with study drug|2|||
129674880|NCT01296412|466770312|FG000|Overall Study|Other reason not specified|20|||
129674881|NCT01296412|466770313|FG001|Overall Study|Other reason not specified|15|||
129674882|NCT01296412|466770312|FG000|Overall Study|Physician Decision|1|||
129674883|NCT01296412|466770313|FG001|Overall Study|Physician Decision|3|||
129674884|NCT01296412|466770312|FG000|Overall Study|Pregnancy|0|||
129674885|NCT01296412|466770313|FG001|Overall Study|Pregnancy|1|||
129674886|NCT01296412|466770312|FG000|Overall Study|Withdrawal by Subject|10|||
129674887|NCT01296412|466770313|FG001|Overall Study|Withdrawal by Subject|13|||
129674888|NCT02160626|466770315|FG000|Overall Study|Adverse Event|1|||
129674889|NCT02160626|466770316|FG001|Overall Study|Adverse Event|0|||
129674890|NCT02160626|466770317|FG002|Overall Study|Adverse Event|0|||
129674891|NCT02160626|466770315|FG000|Overall Study|Schedule not conducive to study visits|0|||
129674892|NCT02160626|466770316|FG001|Overall Study|Schedule not conducive to study visits|0|||
129674893|NCT02160626|466770317|FG002|Overall Study|Schedule not conducive to study visits|1|||
129674894|NCT02160626|466770315|FG000|Overall Study|Withdrawal by Subject|0|||
129674895|NCT02160626|466770316|FG001|Overall Study|Withdrawal by Subject|1|||
129674896|NCT02160626|466770317|FG002|Overall Study|Withdrawal by Subject|0|||
129674897|NCT04239924|466770318|FG000|Overall Study|Lost to Follow-up|2|||
129674898|NCT00434252|466772453|FG000|Overall Study|Lack of Efficacy|50|||
129674899|NCT00434252|466772454|FG001|Overall Study|Lack of Efficacy|100|||
129674900|NCT00434252|466772453|FG000|Overall Study|Adverse Event|6|||
129674901|NCT00434252|466772454|FG001|Overall Study|Adverse Event|13|||
129674902|NCT00434252|466772453|FG000|Overall Study|Death|1|||
129674903|NCT00434252|466772454|FG001|Overall Study|Death|2|||
129674904|NCT00434252|466772453|FG000|Overall Study|Lost to Follow-up|0|||
129674905|NCT00434252|466772454|FG001|Overall Study|Lost to Follow-up|1|||
129674906|NCT00434252|466772453|FG000|Overall Study|Physician Decision|4|||
129674907|NCT00434252|466772454|FG001|Overall Study|Physician Decision|8|||
129674908|NCT00434252|466772453|FG000|Overall Study|Withdrawal by Subject|3|||
129674909|NCT00434252|466772454|FG001|Overall Study|Withdrawal by Subject|7|||
129674910|NCT02997163|466772456|FG000|Overall Study|Adverse Event|1|||
129674911|NCT02997163|466772457|FG001|Overall Study|Adverse Event|0|||
129674912|NCT02997163|466772458|FG002|Overall Study|Adverse Event|0|||
129674913|NCT02997163|466772459|FG003|Overall Study|Adverse Event|1|||
129674914|NCT02337764|466772460|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
129674915|NCT02337764|466772460|FG000|Overall Study|Voluntary Withdrawal|12|||
129674916|NCT02337764|466772460|FG000|Overall Study|Lack of Efficacy|2|||
129674917|NCT01855958|466772475|FG000|Overall Study|Withdrawal by Subject|1|||
129674918|NCT01855958|466772476|FG001|Overall Study|Withdrawal by Subject|0|||
129674919|NCT00296244|466772477|FG000|Overall Study|Underwent retransplant|0|||
129674920|NCT00296244|466772478|FG001|Overall Study|Underwent retransplant|1|||
129674921|NCT00427934|466772479|FG000|Overall Study|Adverse Event|1|||
129674922|NCT00427934|466772480|FG001|Overall Study|Adverse Event|0|||
129674923|NCT00427934|466772481|FG002|Overall Study|Adverse Event|5|||
129674924|NCT00427934|466772482|FG003|Overall Study|Adverse Event|4|||
129674925|NCT00427934|466772479|FG000|Overall Study|Lack of Efficacy|0|||
129674926|NCT00427934|466772480|FG001|Overall Study|Lack of Efficacy|0|||
129674927|NCT00427934|466772481|FG002|Overall Study|Lack of Efficacy|5|||
129674928|NCT00427934|466772482|FG003|Overall Study|Lack of Efficacy|2|||
129674929|NCT00427934|466772479|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
129674930|NCT00427934|466772480|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
129674931|NCT00427934|466772481|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
129674932|NCT00427934|466772482|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
129674933|NCT00427934|466772479|FG000|Overall Study|Other|0|||
129674934|NCT00427934|466772480|FG001|Overall Study|Other|0|||
129674935|NCT00427934|466772481|FG002|Overall Study|Other|11|||
129674936|NCT00427934|466772482|FG003|Overall Study|Other|5|||
129674937|NCT00427934|466772479|FG000|Overall Study|Withdrawal by Subject|0|||
129674938|NCT00427934|466772480|FG001|Overall Study|Withdrawal by Subject|0|||
129674939|NCT00427934|466772481|FG002|Overall Study|Withdrawal by Subject|1|||
129674940|NCT00427934|466772482|FG003|Overall Study|Withdrawal by Subject|3|||
129674941|NCT00499122|466772483|FG000|Overall Study|Withdrawal by Subject|2|||
129674942|NCT04539275|466772486|FG000|Overall Study|Death|2|||
129674943|NCT04539275|466772487|FG001|Overall Study|Death|4|||
129766313|NCT02992288|467110351|FG003|Overall Study|Physician Decision|0|||
129674944|NCT04539275|466772486|FG000|Overall Study|Lost to Follow-up|1|||
129674945|NCT04539275|466772487|FG001|Overall Study|Lost to Follow-up|1|||
129674946|NCT04539275|466772486|FG000|Overall Study|Withdrawal by Subject|3|||
129674947|NCT04539275|466772487|FG001|Overall Study|Withdrawal by Subject|0|||
129674948|NCT00903968|466772488|FG000|Overall Study|Adverse Event|0|||
129674949|NCT00903968|466772489|FG001|Overall Study|Adverse Event|0|||
129674950|NCT00903968|466772490|FG002|Overall Study|Adverse Event|0|||
129674951|NCT00903968|466772491|FG003|Overall Study|Adverse Event|0|||
129674952|NCT00903968|466772492|FG004|Overall Study|Adverse Event|0|||
129674953|NCT00903968|466772493|FG005|Overall Study|Adverse Event|0|||
129766314|NCT02992288|467110352|FG004|Overall Study|Physician Decision|0|||
129766315|NCT02992288|467110353|FG005|Overall Study|Physician Decision|1|||
129766316|NCT02992288|467110348|FG000|Overall Study|Death|2|||
129766317|NCT02992288|467110349|FG001|Overall Study|Death|0|||
129674954|NCT00903968|466772494|FG006|Overall Study|Adverse Event|1|||
129674955|NCT00903968|466772495|FG007|Overall Study|Adverse Event|8|||
129674956|NCT00903968|466772488|FG000|Overall Study|DLT|0|||
129674957|NCT00903968|466772489|FG001|Overall Study|DLT|0|||
129674958|NCT00903968|466772490|FG002|Overall Study|DLT|0|||
129674959|NCT00903968|466772491|FG003|Overall Study|DLT|0|||
129674960|NCT00903968|466772492|FG004|Overall Study|DLT|0|||
129674961|NCT00903968|466772493|FG005|Overall Study|DLT|0|||
129674962|NCT00903968|466772494|FG006|Overall Study|DLT|2|||
129674963|NCT00903968|466772495|FG007|Overall Study|DLT|0|||
129674964|NCT00903968|466772488|FG000|Overall Study|Withdrawal by Subject|1|||
129674965|NCT00903968|466772489|FG001|Overall Study|Withdrawal by Subject|0|||
129674966|NCT00903968|466772490|FG002|Overall Study|Withdrawal by Subject|1|||
129674967|NCT00903968|466772491|FG003|Overall Study|Withdrawal by Subject|0|||
129674968|NCT00903968|466772492|FG004|Overall Study|Withdrawal by Subject|1|||
129674969|NCT00903968|466772493|FG005|Overall Study|Withdrawal by Subject|1|||
129674970|NCT00903968|466772494|FG006|Overall Study|Withdrawal by Subject|0|||
129674971|NCT00903968|466772495|FG007|Overall Study|Withdrawal by Subject|4|||
129674972|NCT00903968|466772488|FG000|Overall Study|Non-Compliance|0|||
129674973|NCT00903968|466772489|FG001|Overall Study|Non-Compliance|0|||
129674974|NCT00903968|466772490|FG002|Overall Study|Non-Compliance|0|||
129674975|NCT00903968|466772491|FG003|Overall Study|Non-Compliance|0|||
129674976|NCT00903968|466772492|FG004|Overall Study|Non-Compliance|0|||
129674977|NCT00903968|466772493|FG005|Overall Study|Non-Compliance|1|||
129674978|NCT00903968|466772494|FG006|Overall Study|Non-Compliance|0|||
129674979|NCT00903968|466772495|FG007|Overall Study|Non-Compliance|0|||
129674980|NCT00903968|466772488|FG000|Overall Study|Physician Decision|0|||
129674981|NCT00903968|466772489|FG001|Overall Study|Physician Decision|0|||
129674982|NCT00903968|466772490|FG002|Overall Study|Physician Decision|0|||
129674983|NCT00903968|466772491|FG003|Overall Study|Physician Decision|0|||
129674984|NCT00903968|466772492|FG004|Overall Study|Physician Decision|0|||
129674985|NCT00903968|466772493|FG005|Overall Study|Physician Decision|1|||
129674986|NCT00903968|466772494|FG006|Overall Study|Physician Decision|0|||
129674987|NCT00903968|466772495|FG007|Overall Study|Physician Decision|0|||
129674988|NCT00903968|466772488|FG000|Overall Study|Progressive Disease|2|||
129674989|NCT00903968|466772489|FG001|Overall Study|Progressive Disease|3|||
129674990|NCT00903968|466772490|FG002|Overall Study|Progressive Disease|2|||
129674991|NCT00903968|466772491|FG003|Overall Study|Progressive Disease|3|||
129674992|NCT00903968|466772492|FG004|Overall Study|Progressive Disease|3|||
129674993|NCT00903968|466772493|FG005|Overall Study|Progressive Disease|3|||
129674994|NCT00903968|466772494|FG006|Overall Study|Progressive Disease|0|||
129674995|NCT00903968|466772495|FG007|Overall Study|Progressive Disease|18|||
129766318|NCT02992288|467110350|FG002|Overall Study|Death|2|||
129766319|NCT02992288|467110351|FG003|Overall Study|Death|1|||
129766320|NCT02992288|467110352|FG004|Overall Study|Death|2|||
129766321|NCT02992288|467110353|FG005|Overall Study|Death|0|||
129766322|NCT02992288|467110348|FG000|Overall Study|Lost to Follow-up|0|||
129766323|NCT02992288|467110349|FG001|Overall Study|Lost to Follow-up|0|||
129766324|NCT02992288|467110350|FG002|Overall Study|Lost to Follow-up|0|||
129766325|NCT02992288|467110351|FG003|Overall Study|Lost to Follow-up|1|||
129766326|NCT02992288|467110352|FG004|Overall Study|Lost to Follow-up|0|||
129766327|NCT02992288|467110353|FG005|Overall Study|Lost to Follow-up|0|||
129766328|NCT02992288|467110348|FG000|Overall Study|Protocol Violation|0|||
129766329|NCT02992288|467110349|FG001|Overall Study|Protocol Violation|0|||
129766330|NCT02992288|467110350|FG002|Overall Study|Protocol Violation|0|||
129674996|NCT00903968|466772488|FG000|Overall Study|Lack of Efficacy|0|||
129674997|NCT00903968|466772489|FG001|Overall Study|Lack of Efficacy|0|||
129674998|NCT00903968|466772490|FG002|Overall Study|Lack of Efficacy|0|||
129674999|NCT00903968|466772491|FG003|Overall Study|Lack of Efficacy|0|||
129675000|NCT00903968|466772492|FG004|Overall Study|Lack of Efficacy|0|||
129675001|NCT00903968|466772493|FG005|Overall Study|Lack of Efficacy|0|||
129766331|NCT02992288|467110351|FG003|Overall Study|Protocol Violation|0|||
129675002|NCT00903968|466772494|FG006|Overall Study|Lack of Efficacy|0|||
129675003|NCT00903968|466772495|FG007|Overall Study|Lack of Efficacy|3|||
129675004|NCT01373164|466772500|FG000|Overall Study|Lost to Follow-up|0|||
129675005|NCT01373164|466772501|FG001|Overall Study|Lost to Follow-up|0|||
129675006|NCT01373164|466772502|FG002|Overall Study|Lost to Follow-up|1|||
129675007|NCT01373164|466772503|FG003|Overall Study|Lost to Follow-up|2|||
129675008|NCT01373164|466772504|FG004|Overall Study|Lost to Follow-up|0|||
129675009|NCT01373164|466772500|FG000|Overall Study|Withdrawal by Subject|0|||
129766332|NCT02992288|467110352|FG004|Overall Study|Protocol Violation|0|||
129675010|NCT01373164|466772501|FG001|Overall Study|Withdrawal by Subject|1|||
129675011|NCT01373164|466772502|FG002|Overall Study|Withdrawal by Subject|0|||
129675012|NCT01373164|466772503|FG003|Overall Study|Withdrawal by Subject|10|||
129675013|NCT01373164|466772504|FG004|Overall Study|Withdrawal by Subject|2|||
129675014|NCT01799941|466772505|FG000|Overall Study|Adverse Event|34|||
129675015|NCT01799941|466772505|FG000|Overall Study|Withdrawal by Subject|21|||
129675016|NCT01799941|466772505|FG000|Overall Study|Death|2|||
129675017|NCT01799941|466772505|FG000|Overall Study|Investigator Decision|4|||
129675018|NCT01799941|466772505|FG000|Overall Study|Lack of Efficacy|3|||
129675019|NCT01799941|466772505|FG000|Overall Study|Lost to Follow-up|17|||
129675020|NCT01799941|466772505|FG000|Overall Study|Other|15|||
129675021|NCT03736967|466772521|FG000|Overall Study|Withdrawal by Subject|26|||
129675022|NCT03736967|466772522|FG001|Overall Study|Withdrawal by Subject|25|||
129675023|NCT03736967|466772523|FG002|Overall Study|Withdrawal by Subject|23|||
129675024|NCT03736967|466772524|FG003|Overall Study|Withdrawal by Subject|26|||
129675025|NCT03736967|466772521|FG000|Overall Study|Lost to Follow-up|3|||
129675026|NCT03736967|466772522|FG001|Overall Study|Lost to Follow-up|2|||
129675027|NCT03736967|466772523|FG002|Overall Study|Lost to Follow-up|1|||
129675028|NCT03736967|466772524|FG003|Overall Study|Lost to Follow-up|1|||
129675029|NCT03736967|466772521|FG000|Overall Study|Physician Decision|1|||
129675030|NCT03736967|466772522|FG001|Overall Study|Physician Decision|0|||
129547185|NCT02858076|466296158|FG000|Overall Study|Withdrawal by Subject|1|||
129675031|NCT03736967|466772523|FG002|Overall Study|Physician Decision|0|||
129675032|NCT03736967|466772524|FG003|Overall Study|Physician Decision|1|||
129675033|NCT03736967|466772521|FG000|Overall Study|Adverse Event|0|||
129675034|NCT03736967|466772522|FG001|Overall Study|Adverse Event|1|||
129675035|NCT03736967|466772523|FG002|Overall Study|Adverse Event|0|||
129675036|NCT03736967|466772524|FG003|Overall Study|Adverse Event|1|||
129675037|NCT03736967|466772521|FG000|Overall Study|Death|0|||
129675038|NCT03736967|466772522|FG001|Overall Study|Death|0|||
129675039|NCT03736967|466772523|FG002|Overall Study|Death|0|||
129675040|NCT03736967|466772524|FG003|Overall Study|Death|1|||
129675041|NCT03736967|466772521|FG000|Overall Study|Randomized but never treated|1|||
129675042|NCT03736967|466772522|FG001|Overall Study|Randomized but never treated|0|||
129675043|NCT03736967|466772523|FG002|Overall Study|Randomized but never treated|0|||
129675044|NCT03736967|466772524|FG003|Overall Study|Randomized but never treated|0|||
129675045|NCT02419807|466772525|FG000|Overall Study|Withdrawal by Subject|4|||
129675046|NCT02419807|466772525|FG000|Overall Study|Physician Decision|1|||
129675047|NCT02419807|466772525|FG000|Overall Study|Protocol Violation|5|||
129675048|NCT01006629|466772526|FG000|Overall Study|Adverse Event|1|||
129675049|NCT01006629|466772526|FG000|Overall Study|Parent refused to continue participation|1|||
129675050|NCT01006629|466772526|FG000|Overall Study|Parent unable to perform site visit|4|||
129675051|NCT03157089|466772527|FG000|Overall Study|Treated only with pembrolizumab|1|||
129675052|NCT03157089|466772528|FG001|Overall Study|Treated only with pembrolizumab|0|||
129675053|NCT03157089|466772527|FG000|Overall Study|Adverse Event|5|||
129675054|NCT03157089|466772528|FG001|Overall Study|Adverse Event|4|||
129675055|NCT03157089|466772527|FG000|Overall Study|Progressive disease|6|||
129675056|NCT03157089|466772528|FG001|Overall Study|Progressive disease|8|||
129675057|NCT02932943|466772529|FG000|Overall Study|Lost to Follow-up|0|||
129675058|NCT02932943|466772530|FG001|Overall Study|Lost to Follow-up|2|||
129675059|NCT02932943|466772529|FG000|Overall Study|Adverse Event|2|||
129675060|NCT02932943|466772530|FG001|Overall Study|Adverse Event|2|||
129675061|NCT02932943|466772529|FG000|Overall Study|Withdrawal by Subject|3|||
129675062|NCT02932943|466772530|FG001|Overall Study|Withdrawal by Subject|3|||
129675063|NCT02300610|466772533|FG000|Overall Study|Withdrawal by Subject|1|||
129675064|NCT02300610|466772534|FG001|Overall Study|Withdrawal by Subject|0|||
129675065|NCT02300610|466772535|FG002|Overall Study|Withdrawal by Subject|1|||
129675066|NCT00095979|466772536|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
129675067|NCT01663623|466772539|FG000|Overall Study|Adverse Event|3|||
129675068|NCT01663623|466772540|FG001|Overall Study|Adverse Event|7|||
129675069|NCT01663623|466772539|FG000|Overall Study|Lack of Efficacy|5|||
129675070|NCT01663623|466772540|FG001|Overall Study|Lack of Efficacy|6|||
129675071|NCT01663623|466772539|FG000|Overall Study|Protocol Violation|0|||
129675072|NCT01663623|466772540|FG001|Overall Study|Protocol Violation|1|||
129675073|NCT01663623|466772539|FG000|Overall Study|Other-Study closed/terminated|1|||
129675074|NCT01663623|466772540|FG001|Overall Study|Other-Study closed/terminated|1|||
129675075|NCT01663623|466772539|FG000|Overall Study|Physician Decision|1|||
129675076|NCT01663623|466772540|FG001|Overall Study|Physician Decision|4|||
129675077|NCT01663623|466772539|FG000|Overall Study|Withdrawal by Subject|2|||
129675078|NCT01663623|466772540|FG001|Overall Study|Withdrawal by Subject|1|||
129675079|NCT02251275|466772541|FG000|Overall Study|Adverse Event|23|||
129675080|NCT02251275|466772542|FG001|Overall Study|Adverse Event|60|||
129675081|NCT02251275|466772543|FG002|Overall Study|Adverse Event|28|||
129675082|NCT02251275|466772544|FG003|Overall Study|Adverse Event|0|||
129675083|NCT02251275|466772545|FG004|Overall Study|Adverse Event|0|||
129675084|NCT02251275|466772541|FG000|Overall Study|Lost to Follow-up|5|||
129675085|NCT02251275|466772542|FG001|Overall Study|Lost to Follow-up|6|||
129675086|NCT02251275|466772543|FG002|Overall Study|Lost to Follow-up|4|||
129675087|NCT02251275|466772544|FG003|Overall Study|Lost to Follow-up|0|||
129675088|NCT02251275|466772545|FG004|Overall Study|Lost to Follow-up|0|||
129675089|NCT02251275|466772541|FG000|Overall Study|Physician Decision|19|||
129675090|NCT02251275|466772542|FG001|Overall Study|Physician Decision|30|||
129675091|NCT02251275|466772543|FG002|Overall Study|Physician Decision|26|||
129675092|NCT02251275|466772544|FG003|Overall Study|Physician Decision|0|||
129675093|NCT02251275|466772545|FG004|Overall Study|Physician Decision|1|||
129675094|NCT02251275|466772541|FG000|Overall Study|Protocol Deviation|0|||
129675095|NCT02251275|466772542|FG001|Overall Study|Protocol Deviation|0|||
129675096|NCT02251275|466772543|FG002|Overall Study|Protocol Deviation|1|||
129675097|NCT02251275|466772544|FG003|Overall Study|Protocol Deviation|0|||
129675098|NCT02251275|466772545|FG004|Overall Study|Protocol Deviation|0|||
129675099|NCT02251275|466772541|FG000|Overall Study|Withdrawal by Subject|25|||
129675100|NCT02251275|466772542|FG001|Overall Study|Withdrawal by Subject|51|||
129675101|NCT02251275|466772543|FG002|Overall Study|Withdrawal by Subject|35|||
129675102|NCT02251275|466772544|FG003|Overall Study|Withdrawal by Subject|1|||
129675103|NCT02251275|466772545|FG004|Overall Study|Withdrawal by Subject|0|||
129675104|NCT00856180|466772549|FG000|Overall Study|Adverse Event|4|||
129675105|NCT00856180|466772549|FG000|Overall Study|Progressive Disease|16|||
129675106|NCT00686972|466772550|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
129675107|NCT01462942|466772553|FG000|Overall Study|Adverse Event|7|||
129675108|NCT01462942|466772554|FG001|Overall Study|Adverse Event|12|||
129675109|NCT01462942|466772555|FG002|Overall Study|Adverse Event|10|||
129675110|NCT01462942|466772556|FG003|Overall Study|Adverse Event|11|||
129675111|NCT01462942|466772557|FG004|Overall Study|Adverse Event|11|||
129675112|NCT01462942|466772553|FG000|Overall Study|Other, including COPD exacerbation|3|||
129675113|NCT01462942|466772554|FG001|Overall Study|Other, including COPD exacerbation|5|||
129675114|NCT01462942|466772555|FG002|Overall Study|Other, including COPD exacerbation|2|||
129675115|NCT01462942|466772556|FG003|Overall Study|Other, including COPD exacerbation|8|||
129675116|NCT01462942|466772557|FG004|Overall Study|Other, including COPD exacerbation|5|||
129675117|NCT01462942|466772553|FG000|Overall Study|Withdrawal by Subject|14|||
129675118|NCT01462942|466772554|FG001|Overall Study|Withdrawal by Subject|10|||
129675119|NCT01462942|466772555|FG002|Overall Study|Withdrawal by Subject|14|||
129675120|NCT01462942|466772556|FG003|Overall Study|Withdrawal by Subject|16|||
129675121|NCT01462942|466772557|FG004|Overall Study|Withdrawal by Subject|19|||
129675122|NCT01462942|466772553|FG000|Overall Study|Lack of Efficacy|6|||
129675123|NCT01462942|466772554|FG001|Overall Study|Lack of Efficacy|0|||
129675124|NCT01462942|466772555|FG002|Overall Study|Lack of Efficacy|4|||
129675125|NCT01462942|466772556|FG003|Overall Study|Lack of Efficacy|5|||
129675126|NCT01462942|466772557|FG004|Overall Study|Lack of Efficacy|3|||
129675127|NCT01462942|466772553|FG000|Overall Study|Lost to Follow-up|0|||
129675128|NCT01462942|466772554|FG001|Overall Study|Lost to Follow-up|1|||
129675129|NCT01462942|466772555|FG002|Overall Study|Lost to Follow-up|1|||
129675130|NCT01462942|466772556|FG003|Overall Study|Lost to Follow-up|1|||
129675131|NCT01462942|466772557|FG004|Overall Study|Lost to Follow-up|1|||
129675132|NCT01462942|466772553|FG000|Overall Study|Protocol Violation|4|||
129766333|NCT02992288|467110353|FG005|Overall Study|Protocol Violation|1|||
129766334|NCT02992288|467110348|FG000|Overall Study|Withdrawal by Subject|4|||
129766335|NCT02992288|467110349|FG001|Overall Study|Withdrawal by Subject|2|||
129766336|NCT02992288|467110350|FG002|Overall Study|Withdrawal by Subject|1|||
129766337|NCT02992288|467110351|FG003|Overall Study|Withdrawal by Subject|5|||
129766338|NCT02992288|467110352|FG004|Overall Study|Withdrawal by Subject|3|||
129766339|NCT02992288|467110353|FG005|Overall Study|Withdrawal by Subject|4|||
129766340|NCT02006472|467110357|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
129766341|NCT02006472|467110358|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
129766342|NCT02006472|467110359|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
129766343|NCT02006472|467110360|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
129766344|NCT02006472|467110361|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
129766345|NCT02006472|467110357|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129766346|NCT02006472|467110358|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129766347|NCT02006472|467110359|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
129766348|NCT02006472|467110360|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129766349|NCT02006472|467110361|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
129766350|NCT02006472|467110357|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
129766351|NCT02006472|467110358|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
129884402|NCT02771210|467536387|FG000|Period 1|Lack of Efficacy|3|||
129675133|NCT01462942|466772554|FG001|Overall Study|Protocol Violation|6|||
129675134|NCT01462942|466772555|FG002|Overall Study|Protocol Violation|9|||
129675135|NCT01462942|466772556|FG003|Overall Study|Protocol Violation|9|||
129675136|NCT01462942|466772557|FG004|Overall Study|Protocol Violation|6|||
129675137|NCT01027845|466772558|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
129675138|NCT01027845|466772559|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
129675139|NCT01027845|466772560|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
129675140|NCT01027845|466772561|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
129675141|NCT01027845|466772558|FG000|Primary Vaccination Phase|Adverse Event|1|||
129675142|NCT01027845|466772559|FG001|Primary Vaccination Phase|Adverse Event|0|||
129766352|NCT02006472|467110359|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
129766353|NCT02006472|467110360|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
129766354|NCT02006472|467110361|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
129766355|NCT02006472|467110357|FG000|Period 1 (Through Week 26)|Other|1|||
129766356|NCT02006472|467110358|FG001|Period 1 (Through Week 26)|Other|5|||
129766357|NCT02006472|467110359|FG002|Period 1 (Through Week 26)|Other|0|||
129766358|NCT02006472|467110360|FG003|Period 1 (Through Week 26)|Other|2|||
129766359|NCT02006472|467110361|FG004|Period 1 (Through Week 26)|Other|3|||
129766360|NCT02006472|467110357|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
129766361|NCT02006472|467110358|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
129766362|NCT02006472|467110359|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
129766363|NCT02006472|467110360|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
129766364|NCT02006472|467110361|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
129766365|NCT02006472|467110357|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
129766366|NCT02006472|467110358|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
129766367|NCT02006472|467110359|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
129766368|NCT02006472|467110360|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
129766369|NCT02006472|467110361|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
129766370|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
129766371|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
129766372|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
129766373|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
129766374|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
129766375|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
129766376|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
129766377|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
129766378|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
129766379|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
129766380|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
129766381|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
129766382|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
129766383|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
129766384|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
129766385|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Other|0|||
129766386|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Other|1|||
129766387|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Other|0|||
129766388|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Other|1|||
129766389|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Other|0|||
129766390|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Not treated|0|||
129766391|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Not treated|0|||
129766392|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Not treated|2|||
129766393|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Not treated|0|||
129766394|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Not treated|0|||
129766395|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
129766396|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
129766397|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
129766398|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
129766399|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
129766400|NCT02006472|467110357|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
129766401|NCT02006472|467110358|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
129766402|NCT02006472|467110359|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
129766403|NCT02006472|467110360|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
129766404|NCT02006472|467110361|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
129766405|NCT00499486|467110362|FG000|Overall Study|Withdrawal by Subject|16|||
129766406|NCT00087152|467110363|FG000|Overall Study|Ineligible|6|||
129766407|NCT01436149|467110365|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
129766408|NCT01436149|467110366|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
129766409|NCT01436149|467110367|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
129766410|NCT01436149|467110365|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
129766411|NCT01436149|467110366|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
129766412|NCT01436149|467110367|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
129766413|NCT01436149|467110365|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
129766414|NCT01436149|467110366|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129766415|NCT01436149|467110367|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
129766416|NCT01436149|467110365|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
129766417|NCT01436149|467110366|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129766418|NCT01436149|467110367|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
129766419|NCT01436149|467110365|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
129766420|NCT01436149|467110366|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
129766421|NCT01436149|467110367|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
129766422|NCT01436149|467110365|FG000|Antidepressant Lead-in Phase|Other|119|||
129766423|NCT01436149|467110366|FG001|Antidepressant Lead-in Phase|Other|0|||
129766424|NCT01436149|467110367|FG002|Antidepressant Lead-in Phase|Other|0|||
129675143|NCT01027845|466772560|FG002|Primary Vaccination Phase|Adverse Event|0|||
129766425|NCT01436149|467110365|FG000|Randomized Phase|Adverse Event|9|||
129766426|NCT01436149|467110366|FG001|Randomized Phase|Adverse Event|10|||
129766427|NCT01436149|467110367|FG002|Randomized Phase|Adverse Event|11|||
129766428|NCT01436149|467110365|FG000|Randomized Phase|Protocol Violation|4|||
129766429|NCT01436149|467110366|FG001|Randomized Phase|Protocol Violation|5|||
129766430|NCT01436149|467110367|FG002|Randomized Phase|Protocol Violation|0|||
129766431|NCT01436149|467110365|FG000|Randomized Phase|Withdrawal by Subject|16|||
129766432|NCT01436149|467110366|FG001|Randomized Phase|Withdrawal by Subject|10|||
129766433|NCT01436149|467110367|FG002|Randomized Phase|Withdrawal by Subject|10|||
129766434|NCT01436149|467110365|FG000|Randomized Phase|Lost to Follow-up|34|||
129766435|NCT01436149|467110366|FG001|Randomized Phase|Lost to Follow-up|5|||
129766436|NCT01436149|467110367|FG002|Randomized Phase|Lost to Follow-up|6|||
129766437|NCT01436149|467110365|FG000|Randomized Phase|Lack of Efficacy|0|||
129766438|NCT01436149|467110366|FG001|Randomized Phase|Lack of Efficacy|0|||
129766439|NCT01436149|467110367|FG002|Randomized Phase|Lack of Efficacy|1|||
129766440|NCT01436149|467110365|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
129766441|NCT01436149|467110366|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
129766442|NCT01436149|467110367|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
129766443|NCT01436149|467110365|FG000|Randomized Phase|Other|12|||
129766444|NCT01436149|467110366|FG001|Randomized Phase|Other|5|||
129766445|NCT01436149|467110367|FG002|Randomized Phase|Other|11|||
129766446|NCT01643668|467110371|FG000|Overall Study|Death|1|||
129766447|NCT00322881|467110372|FG000|Overall Study|Death|2|||
129766448|NCT00322881|467110372|FG000|Overall Study|Adverse Event|1|||
129766449|NCT00322881|467110372|FG000|Overall Study|Disease Progression|2|||
129766450|NCT00561652|467110373|FG000|Overall Study|Withdrawal by Subject|0|||
129766451|NCT00561652|467110374|FG001|Overall Study|Withdrawal by Subject|1|||
129766452|NCT02285855|467110377|FG000|Overall Study|Withdrawal by Subject|2|||
129766453|NCT02285855|467110378|FG001|Overall Study|Withdrawal by Subject|1|||
129766454|NCT02718898|467110379|FG000|Blinded Treatment Period|Adverse Event|5|||
129766455|NCT02718898|467110380|FG001|Blinded Treatment Period|Adverse Event|1|||
129766456|NCT02718898|467110381|FG002|Blinded Treatment Period|Adverse Event|0|||
129766457|NCT02718898|467110382|FG003|Blinded Treatment Period|Adverse Event|0|||
129766458|NCT02718898|467110383|FG004|Blinded Treatment Period|Adverse Event|0|||
129766459|NCT02718898|467110384|FG005|Blinded Treatment Period|Adverse Event|0|||
129766460|NCT02718898|467110385|FG006|Blinded Treatment Period|Adverse Event|0|||
129766461|NCT02718898|467110379|FG000|Blinded Treatment Period|Physician Decision|1|||
129766462|NCT02718898|467110380|FG001|Blinded Treatment Period|Physician Decision|0|||
129766463|NCT02718898|467110381|FG002|Blinded Treatment Period|Physician Decision|0|||
129766464|NCT02718898|467110382|FG003|Blinded Treatment Period|Physician Decision|0|||
129766465|NCT02718898|467110383|FG004|Blinded Treatment Period|Physician Decision|0|||
129766466|NCT02718898|467110384|FG005|Blinded Treatment Period|Physician Decision|0|||
129766467|NCT02718898|467110385|FG006|Blinded Treatment Period|Physician Decision|0|||
129766468|NCT02718898|467110379|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
129766469|NCT02718898|467110380|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
129766470|NCT02718898|467110381|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
129766471|NCT02718898|467110382|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
129766472|NCT02718898|467110383|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
129766473|NCT02718898|467110384|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
129766474|NCT02718898|467110385|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
129766475|NCT02718898|467110379|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
129766476|NCT02718898|467110380|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
129766477|NCT02718898|467110381|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
129766478|NCT02718898|467110382|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
129766479|NCT02718898|467110383|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
129766480|NCT02718898|467110384|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
129766481|NCT02718898|467110385|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
129766482|NCT02718898|467110379|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129766483|NCT02718898|467110380|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129766484|NCT02718898|467110381|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
129766485|NCT02718898|467110382|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
129675144|NCT01027845|466772561|FG003|Primary Vaccination Phase|Adverse Event|0|||
129675145|NCT01027845|466772558|FG000|Primary Vaccination Phase|Protocol Violation|1|||
129675146|NCT01027845|466772559|FG001|Primary Vaccination Phase|Protocol Violation|0|||
129675147|NCT01027845|466772560|FG002|Primary Vaccination Phase|Protocol Violation|0|||
129675148|NCT01027845|466772561|FG003|Primary Vaccination Phase|Protocol Violation|0|||
129675149|NCT01027845|466772558|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
129675150|NCT01027845|466772559|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
129766486|NCT02718898|467110383|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129766487|NCT02718898|467110384|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129766488|NCT02718898|467110385|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
129766489|NCT02718898|467110379|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129766490|NCT02718898|467110380|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129675151|NCT01027845|466772560|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
129675152|NCT01027845|466772561|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
129675153|NCT01027845|466772558|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
129675154|NCT01027845|466772559|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129675155|NCT01027845|466772560|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
129675156|NCT01027845|466772561|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
129675157|NCT01027845|466772558|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
129675158|NCT01027845|466772559|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
129675159|NCT01027845|466772560|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
129675160|NCT01027845|466772561|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
129675161|NCT00368550|466772562|FG000|Overall Study|Adverse Event|7|||
129675162|NCT00368550|466772563|FG001|Overall Study|Adverse Event|4|||
129675163|NCT00368550|466772562|FG000|Overall Study|Lack of Efficacy|4|||
129675164|NCT00368550|466772563|FG001|Overall Study|Lack of Efficacy|9|||
129675165|NCT00368550|466772562|FG000|Overall Study|Withdrawal by Subject|17|||
129675166|NCT00368550|466772563|FG001|Overall Study|Withdrawal by Subject|10|||
129675167|NCT00486044|466772564|FG000|Overall Study|Withdrawal by Subject|2|||
129675168|NCT00486044|466772565|FG001|Overall Study|Withdrawal by Subject|1|||
129675169|NCT00486044|466772564|FG000|Overall Study|Adverse Event|0|||
129675170|NCT00486044|466772565|FG001|Overall Study|Adverse Event|1|||
129675171|NCT00486044|466772564|FG000|Overall Study|Lost to Follow-up|0|||
129675172|NCT00486044|466772565|FG001|Overall Study|Lost to Follow-up|1|||
129675173|NCT01670292|466772569|FG000|Overall Study|Lost to Follow-up|14|||
129766491|NCT02718898|467110381|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129766492|NCT02718898|467110382|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
129766493|NCT02718898|467110383|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129766494|NCT02718898|467110384|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129547186|NCT02858076|466296159|FG001|Overall Study|Withdrawal by Subject|5|||
129675174|NCT03154086|466772575|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675175|NCT03154086|466772576|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129766495|NCT02718898|467110385|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
129766496|NCT02718898|467110379|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129675176|NCT03154086|466772577|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675177|NCT03154086|466772578|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
129675178|NCT03154086|466772579|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675179|NCT03154086|466772580|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675180|NCT03154086|466772581|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675181|NCT03154086|466772582|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675182|NCT03154086|466772583|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675183|NCT03154086|466772584|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675184|NCT03154086|466772585|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675185|NCT03154086|466772586|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129884403|NCT02771210|467536388|FG001|Period 1|Lack of Efficacy|6|||
129675186|NCT03154086|466772587|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675187|NCT03154086|466772588|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675188|NCT03154086|466772589|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
129675189|NCT03154086|466772575|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675190|NCT03154086|466772576|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
129675191|NCT03154086|466772577|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675192|NCT03154086|466772578|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675193|NCT03154086|466772579|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675194|NCT03154086|466772580|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675195|NCT03154086|466772581|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675196|NCT03154086|466772582|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675197|NCT03154086|466772583|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675198|NCT03154086|466772584|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129766497|NCT02718898|467110380|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129766498|NCT02718898|467110381|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
129766499|NCT02718898|467110382|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
129766500|NCT02718898|467110383|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129766501|NCT02718898|467110384|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129766502|NCT02718898|467110385|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129766503|NCT02718898|467110379|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129766504|NCT02718898|467110380|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129766505|NCT02718898|467110381|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
129766506|NCT02718898|467110382|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
129766507|NCT02718898|467110383|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129766508|NCT02718898|467110384|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129766509|NCT02718898|467110385|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
129766510|NCT02718898|467110379|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129766511|NCT02718898|467110380|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129766512|NCT02718898|467110381|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129766513|NCT02718898|467110382|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
129884404|NCT02771210|467536387|FG000|Period 1|Lost to Follow-up|2|||
129884405|NCT02771210|467536388|FG001|Period 1|Lost to Follow-up|0|||
129675199|NCT03154086|466772585|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675200|NCT03154086|466772586|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675201|NCT03154086|466772587|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675202|NCT03154086|466772588|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675203|NCT03154086|466772589|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
129675204|NCT03154086|466772575|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675205|NCT03154086|466772576|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675206|NCT03154086|466772577|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
129675207|NCT03154086|466772578|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675208|NCT03154086|466772579|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675209|NCT03154086|466772580|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675210|NCT03154086|466772581|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675211|NCT03154086|466772582|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675212|NCT03154086|466772583|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675213|NCT03154086|466772584|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675214|NCT03154086|466772585|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675215|NCT03154086|466772586|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675216|NCT03154086|466772587|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675217|NCT03154086|466772588|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675218|NCT03154086|466772589|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
129675219|NCT03154086|466772575|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
129675220|NCT03154086|466772576|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675221|NCT03154086|466772577|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675222|NCT03154086|466772578|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675223|NCT03154086|466772579|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675224|NCT03154086|466772580|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675225|NCT03154086|466772581|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675226|NCT03154086|466772582|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675227|NCT03154086|466772583|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675228|NCT03154086|466772584|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675229|NCT03154086|466772585|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675230|NCT03154086|466772586|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675231|NCT03154086|466772587|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675232|NCT03154086|466772588|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675233|NCT03154086|466772589|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
129675234|NCT03154086|466772575|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675235|NCT03154086|466772576|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675236|NCT03154086|466772577|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675237|NCT03154086|466772578|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675238|NCT03154086|466772579|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675239|NCT03154086|466772580|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675240|NCT03154086|466772581|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675241|NCT03154086|466772582|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675242|NCT03154086|466772583|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
129675243|NCT03154086|466772584|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675244|NCT03154086|466772585|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675245|NCT03154086|466772586|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675246|NCT03154086|466772587|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675247|NCT03154086|466772588|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675248|NCT03154086|466772589|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
129675249|NCT03154086|466772575|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675250|NCT03154086|466772576|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675251|NCT03154086|466772577|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675252|NCT03154086|466772578|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675253|NCT03154086|466772579|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675254|NCT03154086|466772580|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129766514|NCT02718898|467110383|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129766515|NCT02718898|467110384|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129766516|NCT02718898|467110385|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
129766517|NCT02718898|467110379|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129766518|NCT02718898|467110380|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129766519|NCT02718898|467110381|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129884406|NCT02771210|467536387|FG000|Period 1|Physician Decision|0|||
129547187|NCT02858076|466296158|FG000|Overall Study|Lost to Follow-up|2|||
129675255|NCT03154086|466772581|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675256|NCT03154086|466772582|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
129675257|NCT03154086|466772583|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675258|NCT03154086|466772584|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675259|NCT03154086|466772585|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675260|NCT03154086|466772586|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675261|NCT03154086|466772587|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675262|NCT03154086|466772588|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675263|NCT03154086|466772589|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
129675264|NCT03154086|466772575|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
129675265|NCT03154086|466772576|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
129675266|NCT03154086|466772577|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
129675267|NCT03154086|466772578|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
129675268|NCT03154086|466772579|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
129675269|NCT03154086|466772580|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
129675270|NCT03154086|466772581|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
129675271|NCT03154086|466772582|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
129675272|NCT03154086|466772583|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
129675273|NCT03154086|466772584|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
129675274|NCT03154086|466772585|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
129675275|NCT03154086|466772586|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
129675276|NCT03154086|466772587|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
129675277|NCT03154086|466772588|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
129675278|NCT03154086|466772589|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
129675279|NCT01603277|466772590|FG000|Overall Study|Adverse Event|1|||
129675280|NCT01603277|466772591|FG001|Overall Study|Adverse Event|2|||
129675281|NCT01603277|466772590|FG000|Overall Study|Physician Decision|0|||
129675282|NCT01603277|466772591|FG001|Overall Study|Physician Decision|1|||
129675283|NCT01603277|466772590|FG000|Overall Study|Protocol Violation|6|||
129675284|NCT01603277|466772591|FG001|Overall Study|Protocol Violation|10|||
129675285|NCT01603277|466772590|FG000|Overall Study|Withdrawal by Subject|5|||
129675286|NCT01603277|466772591|FG001|Overall Study|Withdrawal by Subject|4|||
129675287|NCT01603277|466772590|FG000|Overall Study|Non-Compliance|2|||
129675288|NCT01603277|466772591|FG001|Overall Study|Non-Compliance|1|||
129675289|NCT04465422|466772594|FG000|Overall Study|Lost to Follow-up|0|||
129675290|NCT04465422|466772595|FG001|Overall Study|Lost to Follow-up|2|||
129675291|NCT02391337|466772596|FG000|6 Months Follow-up|Death|5|||
129675292|NCT02391337|466772597|FG001|6 Months Follow-up|Death|4|||
129675293|NCT02391337|466772596|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
129675294|NCT02391337|466772597|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
129675295|NCT02391337|466772596|FG000|12 Months Follow-up|Death|2|||
129675296|NCT02391337|466772597|FG001|12 Months Follow-up|Death|0|||
129675297|NCT02391337|466772596|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
129675298|NCT02391337|466772597|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
129675299|NCT02391337|466772596|FG000|12 Months Follow-up|Lost to Follow-up|0|||
129675300|NCT02391337|466772597|FG001|12 Months Follow-up|Lost to Follow-up|2|||
129675301|NCT00746551|466772598|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
129675302|NCT00746551|466772599|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
129675303|NCT00746551|466772598|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
129675304|NCT00746551|466772599|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
129675305|NCT00746551|466772598|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
129884407|NCT02771210|467536388|FG001|Period 1|Physician Decision|1|||
129675306|NCT00746551|466772599|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
129675307|NCT00062166|466772600|FG000|Overall Study|Withdrawal by Subject|6|||
129675308|NCT00833755|466772601|FG000|Overall Study|Physician Decision|4|||
129675309|NCT00833755|466772602|FG001|Overall Study|Physician Decision|4|||
129675310|NCT00833755|466772603|FG002|Overall Study|Physician Decision|2|||
129675311|NCT00833755|466772604|FG003|Overall Study|Physician Decision|6|||
129675312|NCT00833755|466772601|FG000|Overall Study|Subject had scheduling issues|0|||
129675313|NCT00833755|466772602|FG001|Overall Study|Subject had scheduling issues|1|||
129675314|NCT00833755|466772603|FG002|Overall Study|Subject had scheduling issues|0|||
129766520|NCT02718898|467110382|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
129766521|NCT02718898|467110383|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129766522|NCT02718898|467110384|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129766523|NCT02718898|467110385|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
129766524|NCT02718898|467110379|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
129766525|NCT02718898|467110380|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
129766526|NCT02718898|467110381|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
129766527|NCT02718898|467110382|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
129766528|NCT02718898|467110383|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
129766529|NCT02718898|467110384|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
129766530|NCT02718898|467110385|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
129766531|NCT02718898|467110379|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129766532|NCT02718898|467110380|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129766533|NCT02718898|467110381|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129766534|NCT02718898|467110382|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
129766535|NCT02718898|467110383|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
129766536|NCT02718898|467110384|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
129766537|NCT02718898|467110385|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
129675315|NCT00833755|466772604|FG003|Overall Study|Subject had scheduling issues|0|||
129675316|NCT01776554|466772607|FG000|Overall Study|Adverse Event|1|||
129675317|NCT01776554|466772608|FG001|Overall Study|Adverse Event|0|||
129675318|NCT01776554|466772607|FG000|Overall Study|Withdrawal by Subject|3|||
129675319|NCT01776554|466772608|FG001|Overall Study|Withdrawal by Subject|8|||
129675320|NCT01776554|466772607|FG000|Overall Study|Lost to Follow-up|6|||
129766538|NCT02718898|467110379|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129766539|NCT02718898|467110380|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129766540|NCT02718898|467110381|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129766541|NCT02718898|467110382|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129766542|NCT02718898|467110383|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129766543|NCT02718898|467110384|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
129766544|NCT02718898|467110385|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
129766545|NCT04484961|467110386|FG000|Overall Study|Lost to Follow-up|9|||
129766546|NCT04484961|467110387|FG001|Overall Study|Lost to Follow-up|9|||
129766547|NCT01667900|467110388|FG000|Part B|Death|0|||
129766548|NCT01667900|467110389|FG001|Part B|Death|0|||
129766549|NCT01667900|467110390|FG002|Part B|Death|0|||
129675321|NCT01776554|466772608|FG001|Overall Study|Lost to Follow-up|9|||
129675322|NCT01776554|466772607|FG000|Overall Study|Administrative Reason|2|||
129675323|NCT01776554|466772608|FG001|Overall Study|Administrative Reason|5|||
129675324|NCT01776554|466772607|FG000|Overall Study|Protocol Violation|1|||
129675325|NCT01776554|466772608|FG001|Overall Study|Protocol Violation|0|||
129675326|NCT01776554|466772607|FG000|Overall Study|Unclassified|4|||
129675327|NCT01776554|466772608|FG001|Overall Study|Unclassified|1|||
129675328|NCT02475369|466772609|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
129675329|NCT02475369|466772610|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
129675330|NCT03608826|466772612|FG000|Overall Study|Death|3|||
129675331|NCT03608826|466772612|FG000|Overall Study|Heart Transplant|3|||
129675332|NCT03608826|466772612|FG000|Overall Study|Physician Decision|4|||
129675333|NCT03122171|466772613|FG000|Overall Study|Withdrawal by Subject|1|||
129675334|NCT00617279|466772625|FG000|Overall Study|Study terminated by Sponsor|10|||
129675335|NCT00617279|466772626|FG001|Overall Study|Study terminated by Sponsor|15|||
129675336|NCT00617279|466772625|FG000|Overall Study|Graft abandonment|2|||
129675337|NCT00617279|466772626|FG001|Overall Study|Graft abandonment|0|||
129675338|NCT00617279|466772625|FG000|Overall Study|Lost to Follow-up|1|||
129675339|NCT00617279|466772626|FG001|Overall Study|Lost to Follow-up|0|||
129675340|NCT00617279|466772625|FG000|Overall Study|Death|1|||
129675341|NCT00617279|466772626|FG001|Overall Study|Death|2|||
129675342|NCT00921024|466772629|FG000|Overall Study|Lost to Follow-up|2|||
129675343|NCT00921024|466772630|FG001|Overall Study|Lost to Follow-up|0|||
129675344|NCT00921024|466772629|FG000|Overall Study|Received concomittant therapy|2|||
129675345|NCT00921024|466772630|FG001|Overall Study|Received concomittant therapy|0|||
129675346|NCT00921024|466772629|FG000|Overall Study|Withdrawal by Subject|0|||
129675347|NCT00921024|466772630|FG001|Overall Study|Withdrawal by Subject|3|||
129675348|NCT03415178|466772632|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
129675349|NCT03415178|466772633|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
129675350|NCT03415178|466772632|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
129675351|NCT03415178|466772633|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
129675352|NCT00753519|466774288|FG000|Overall Study|Withdrawal by Subject|0|||
129675353|NCT00753519|466774289|FG001|Overall Study|Withdrawal by Subject|2|||
129675354|NCT02807259|466774290|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
129675355|NCT02807259|466774291|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
129675356|NCT02807259|466774290|FG000|Midline (3 Months)|migration, refusal, not available|30|||
129675357|NCT02807259|466774291|FG001|Midline (3 Months)|migration, refusal, not available|34|||
129675358|NCT02807259|466774290|FG000|Endline (3 Months)|migration, refusal, not available|35|||
129675359|NCT02807259|466774291|FG001|Endline (3 Months)|migration, refusal, not available|87|||
129675360|NCT03861039|466774292|FG000|Overall Study|Adverse Event|2|||
129675361|NCT03861039|466774293|FG001|Overall Study|Adverse Event|5|||
129675362|NCT03861039|466774294|FG002|Overall Study|Adverse Event|11|||
129675363|NCT03861039|466774292|FG000|Overall Study|Withdrawal by Subject|1|||
129675364|NCT03861039|466774293|FG001|Overall Study|Withdrawal by Subject|3|||
129675365|NCT03861039|466774294|FG002|Overall Study|Withdrawal by Subject|4|||
129675366|NCT02791269|466774310|FG000|Overall Study|Lost to Follow-up|0|||
129675367|NCT02791269|466774311|FG001|Overall Study|Lost to Follow-up|1|||
129675368|NCT00420745|466774312|FG000|Overall Study|Adverse Event|2|||
129675369|NCT00420745|466774313|FG001|Overall Study|Adverse Event|2|||
129675370|NCT00420745|466774312|FG000|Overall Study|Lost to Follow-up|10|||
129675371|NCT00420745|466774313|FG001|Overall Study|Lost to Follow-up|2|||
129675372|NCT00420745|466774312|FG000|Overall Study|Protocol Violation|1|||
129675373|NCT00420745|466774313|FG001|Overall Study|Protocol Violation|0|||
129675374|NCT00420745|466774312|FG000|Overall Study|Physician Decision|1|||
129675375|NCT00420745|466774313|FG001|Overall Study|Physician Decision|1|||
129675376|NCT00420745|466774312|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
129675377|NCT00420745|466774313|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
129675378|NCT00420745|466774312|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
129675379|NCT00420745|466774313|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
129675380|NCT01125930|466774314|FG000|Overall Study|Adverse Event|0|||
129675381|NCT01125930|466774315|FG001|Overall Study|Adverse Event|1|||
129675382|NCT01125930|466774314|FG000|Overall Study|Withdrawal by Subject|1|||
129675383|NCT01125930|466774315|FG001|Overall Study|Withdrawal by Subject|6|||
129675384|NCT01125930|466774314|FG000|Overall Study|Protocol Violation|0|||
129675385|NCT01125930|466774315|FG001|Overall Study|Protocol Violation|1|||
129675386|NCT01125930|466774314|FG000|Overall Study|Lost to Follow-up|0|||
129675387|NCT01125930|466774315|FG001|Overall Study|Lost to Follow-up|2|||
129675388|NCT03098979|466774316|FG000|Overall Study|Adverse Event|1|||
129675389|NCT03098979|466774317|FG001|Overall Study|Adverse Event|0|||
129675390|NCT03098979|466774318|FG002|Overall Study|Adverse Event|1|||
129675391|NCT03098979|466774319|FG003|Overall Study|Adverse Event|4|||
129675392|NCT03098979|466774320|FG004|Overall Study|Adverse Event|6|||
129675393|NCT03098979|466774321|FG005|Overall Study|Adverse Event|1|||
129675394|NCT03098979|466774316|FG000|Overall Study|Withdrawal by Subject|2|||
129675395|NCT03098979|466774317|FG001|Overall Study|Withdrawal by Subject|1|||
129675396|NCT03098979|466774318|FG002|Overall Study|Withdrawal by Subject|1|||
129675397|NCT03098979|466774319|FG003|Overall Study|Withdrawal by Subject|1|||
129675398|NCT03098979|466774320|FG004|Overall Study|Withdrawal by Subject|2|||
129675399|NCT03098979|466774321|FG005|Overall Study|Withdrawal by Subject|1|||
129675400|NCT03098979|466774316|FG000|Overall Study|Death|1|||
129675401|NCT03098979|466774317|FG001|Overall Study|Death|0|||
129675402|NCT03098979|466774318|FG002|Overall Study|Death|2|||
129675403|NCT03098979|466774319|FG003|Overall Study|Death|0|||
129675404|NCT03098979|466774320|FG004|Overall Study|Death|1|||
129675405|NCT03098979|466774321|FG005|Overall Study|Death|0|||
129675406|NCT03098979|466774316|FG000|Overall Study|Physician Decision|2|||
129675407|NCT03098979|466774317|FG001|Overall Study|Physician Decision|1|||
129675408|NCT03098979|466774318|FG002|Overall Study|Physician Decision|0|||
129675409|NCT03098979|466774319|FG003|Overall Study|Physician Decision|0|||
129675410|NCT03098979|466774320|FG004|Overall Study|Physician Decision|0|||
129675411|NCT03098979|466774321|FG005|Overall Study|Physician Decision|0|||
129675412|NCT03098979|466774316|FG000|Overall Study|Non-compliance|0|||
129675413|NCT03098979|466774317|FG001|Overall Study|Non-compliance|0|||
129675414|NCT03098979|466774318|FG002|Overall Study|Non-compliance|0|||
129675415|NCT03098979|466774319|FG003|Overall Study|Non-compliance|0|||
129675416|NCT03098979|466774320|FG004|Overall Study|Non-compliance|0|||
129675417|NCT03098979|466774321|FG005|Overall Study|Non-compliance|1|||
129675418|NCT03098979|466774316|FG000|Overall Study|Protocol Violation|0|||
129675419|NCT03098979|466774317|FG001|Overall Study|Protocol Violation|0|||
129675420|NCT03098979|466774318|FG002|Overall Study|Protocol Violation|0|||
129675421|NCT03098979|466774319|FG003|Overall Study|Protocol Violation|0|||
129675422|NCT03098979|466774320|FG004|Overall Study|Protocol Violation|0|||
129675423|NCT03098979|466774321|FG005|Overall Study|Protocol Violation|1|||
129675424|NCT02369653|466774322|FG000|Overall Study|Lost to Follow-up|0|||
129675425|NCT02369653|466774323|FG001|Overall Study|Lost to Follow-up|1|||
129675426|NCT02369653|466774322|FG000|Overall Study|Administrative reason by sponsor|0|||
129675427|NCT02369653|466774323|FG001|Overall Study|Administrative reason by sponsor|1|||
129675428|NCT02369653|466774322|FG000|Overall Study|Death|1|||
129675429|NCT02369653|466774323|FG001|Overall Study|Death|2|||
129675430|NCT02369653|466774322|FG000|Overall Study|Participant withdrew consent|13|||
129675431|NCT02369653|466774323|FG001|Overall Study|Participant withdrew consent|3|||
129675432|NCT03248037|466774324|FG000|Overall Study|Withdrawal by Subject|6|||
129675433|NCT03248037|466774325|FG001|Overall Study|Withdrawal by Subject|9|||
129675434|NCT03248037|466774324|FG000|Overall Study|Adverse Event|15|||
129675435|NCT03248037|466774325|FG001|Overall Study|Adverse Event|0|||
129675436|NCT02897349|466774326|FG000|Overall Study|Lost to Follow-up|2|||
129675437|NCT02897349|466774327|FG001|Overall Study|Lost to Follow-up|2|||
129675438|NCT02897349|466774326|FG000|Overall Study|Adverse Event|3|||
129675439|NCT02897349|466774327|FG001|Overall Study|Adverse Event|3|||
129675440|NCT02897349|466774326|FG000|Overall Study|Other than listed above|0|||
129675441|NCT02897349|466774327|FG001|Overall Study|Other than listed above|1|||
129675442|NCT00671749|466774334|FG000|Overall Study|Adverse Event|2|||
129675443|NCT00671749|466774334|FG000|Overall Study|Withdrawal by Subject|4|||
129675444|NCT00671749|466774334|FG000|Overall Study|Protocol Violation|1|||
129675445|NCT00671749|466774334|FG000|Overall Study|Lost to Follow-up|1|||
129675446|NCT02515227|466774335|FG000|Overall Study|Adverse Event|0|||
129675447|NCT02515227|466774336|FG001|Overall Study|Adverse Event|2|||
129675448|NCT02515227|466774335|FG000|Overall Study|Progressive disease|2|||
129675449|NCT02515227|466774336|FG001|Overall Study|Progressive disease|9|||
129766550|NCT01667900|467110391|FG003|Part B|Death|0|||
129675450|NCT01259245|466774337|FG000|Overall Study|Withdrawal by Subject|27|||
129675451|NCT01259245|466774338|FG001|Overall Study|Withdrawal by Subject|24|||
129675452|NCT01259245|466774337|FG000|Overall Study|Death|1|||
129675453|NCT01259245|466774338|FG001|Overall Study|Death|2|||
129675454|NCT03363906|466774348|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
129675455|NCT03363906|466774349|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
129766551|NCT01667900|467110392|FG004|Part B|Death|0|||
129766552|NCT01667900|467110393|FG005|Part B|Death|0|||
129766553|NCT01667900|467110394|FG006|Part B|Death|0|||
129766554|NCT01667900|467110395|FG007|Part B|Death|0|||
129766555|NCT01667900|467110396|FG008|Part B|Death|0|||
129766556|NCT01667900|467110397|FG009|Part B|Death|0|||
129766557|NCT01667900|467110398|FG010|Part B|Death|0|||
129766558|NCT01667900|467110399|FG011|Part B|Death|0|||
129766559|NCT01667900|467110400|FG012|Part B|Death|0|||
129766560|NCT01667900|467110401|FG013|Part B|Death|0|||
129766561|NCT01667900|467110402|FG014|Part B|Death|0|||
129766562|NCT01667900|467110403|FG015|Part B|Death|0|||
129766563|NCT01667900|467110404|FG016|Part B|Death|1|||
129766564|NCT01667900|467110405|FG017|Part B|Death|0|||
129766565|NCT01667900|467110406|FG018|Part B|Death|0|||
129766566|NCT01667900|467110407|FG019|Part B|Death|0|||
129766567|NCT00976274|467110409|FG000|Overall Study|Lost to Follow-up|5|||
129766568|NCT00976274|467110410|FG001|Overall Study|Lost to Follow-up|5|||
129766569|NCT00976274|467110409|FG000|Overall Study|Withdrawal by Subject|1|||
129766570|NCT00976274|467110410|FG001|Overall Study|Withdrawal by Subject|1|||
129766571|NCT00976274|467110409|FG000|Overall Study|Physician Decision|1|||
129766572|NCT00976274|467110410|FG001|Overall Study|Physician Decision|2|||
129766573|NCT00627393|467110413|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
129766574|NCT00627393|467110414|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
129766575|NCT00627393|467110413|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
129766576|NCT00627393|467110414|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
129766577|NCT00627393|467110413|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
129766578|NCT00627393|467110414|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
129766579|NCT00627393|467110413|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
129766580|NCT00627393|467110414|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
129766581|NCT00004563|467110415|FG000|Overall Study|Withdrawal by Subject|20|||
129766582|NCT00004563|467110416|FG001|Overall Study|Withdrawal by Subject|16|||
129766583|NCT00004563|467110415|FG000|Overall Study|Lack of Efficacy|3|||
129766584|NCT00004563|467110416|FG001|Overall Study|Lack of Efficacy|5|||
129766585|NCT00004563|467110415|FG000|Overall Study|Death|2|||
129766586|NCT00004563|467110416|FG001|Overall Study|Death|3|||
129766587|NCT03337308|467110417|FG000|Overall Study|Adverse Event|2|||
129766588|NCT03337308|467110418|FG001|Overall Study|Adverse Event|3|||
129766589|NCT03337308|467110419|FG002|Overall Study|Adverse Event|3|||
129766590|NCT03337308|467110420|FG003|Overall Study|Adverse Event|1|||
129766591|NCT03337308|467110417|FG000|Overall Study|Lost to Follow-up|1|||
129766592|NCT03337308|467110418|FG001|Overall Study|Lost to Follow-up|2|||
129766593|NCT03337308|467110419|FG002|Overall Study|Lost to Follow-up|0|||
129766594|NCT03337308|467110420|FG003|Overall Study|Lost to Follow-up|0|||
129766595|NCT03337308|467110417|FG000|Overall Study|Withdrawal by Subject|2|||
129766596|NCT03337308|467110418|FG001|Overall Study|Withdrawal by Subject|1|||
129766597|NCT03337308|467110419|FG002|Overall Study|Withdrawal by Subject|2|||
129766598|NCT03337308|467110420|FG003|Overall Study|Withdrawal by Subject|1|||
129766599|NCT03337308|467110417|FG000|Overall Study|Protocol Violation|0|||
129766600|NCT03337308|467110418|FG001|Overall Study|Protocol Violation|1|||
129766601|NCT03337308|467110419|FG002|Overall Study|Protocol Violation|0|||
129766602|NCT03337308|467110420|FG003|Overall Study|Protocol Violation|0|||
129766603|NCT01056822|467110421|FG000|Overall Study|Adverse Event|0|||
129766604|NCT01056822|467110422|FG001|Overall Study|Adverse Event|1|||
129766605|NCT01056822|467110421|FG000|Overall Study|Protocol Violation|6|||
129766606|NCT01056822|467110422|FG001|Overall Study|Protocol Violation|5|||
129766607|NCT01056822|467110421|FG000|Overall Study|Withdrawal by Subject|1|||
129766608|NCT01056822|467110422|FG001|Overall Study|Withdrawal by Subject|1|||
129766609|NCT01056822|467110421|FG000|Overall Study|Lost to Follow-up|1|||
129675456|NCT03363906|466774348|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
129675457|NCT03363906|466774349|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
129675458|NCT03363906|466774348|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
129675459|NCT03363906|466774349|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
129675460|NCT03363906|466774348|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
129675461|NCT03363906|466774349|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
129675462|NCT02714153|466774351|FG000|Overall Study|Death|1|||
129675463|NCT00087178|466774354|FG000|Overall Study|No follow up data|5|||
129675464|NCT00087178|466774355|FG001|Overall Study|No follow up data|15|||
129675465|NCT00087178|466774354|FG000|Overall Study|No clinical assessment|1|||
129675466|NCT00087178|466774355|FG001|Overall Study|No clinical assessment|2|||
129675467|NCT00087178|466774354|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
129675468|NCT00087178|466774355|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
129675469|NCT01692119|466774370|FG000|Overall Study|Protocol Violation|3|||
129675470|NCT01692119|466774371|FG001|Overall Study|Protocol Violation|1|||
129675471|NCT01692119|466774370|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
129675472|NCT01692119|466774371|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
129675473|NCT00997893|466774372|FG000|Overall Study|Adverse Event|1|||
129675474|NCT00997893|466774373|FG001|Overall Study|Adverse Event|0|||
129675475|NCT00997893|466774374|FG002|Overall Study|Adverse Event|0|||
129675476|NCT00997893|466774372|FG000|Overall Study|Unable to meet study timelines|1|||
129675477|NCT00997893|466774373|FG001|Overall Study|Unable to meet study timelines|0|||
129675478|NCT00997893|466774374|FG002|Overall Study|Unable to meet study timelines|0|||
129675479|NCT00997893|466774372|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
129675480|NCT00997893|466774373|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
129675481|NCT00997893|466774374|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
129675482|NCT01142336|466774375|FG000|Overall Study|Adverse Event|1|||
129675483|NCT01142336|466774376|FG001|Overall Study|Adverse Event|1|||
129675484|NCT01142336|466774375|FG000|Overall Study|Lost to Follow-up|0|||
129675485|NCT01142336|466774376|FG001|Overall Study|Lost to Follow-up|1|||
129675486|NCT02029417|466774377|FG000|Overall Study|Death|1|||
129675487|NCT02029417|466774377|FG000|Overall Study|Adverse Event|1|||
129675488|NCT05219162|466774380|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
129675489|NCT05219162|466774380|FG000|Overall Study|Withdrawal by Subject|23|||
129675490|NCT00171249|466774383|FG000|Overall Study|Withdrawal by Subject|2|||
129675491|NCT00171249|466774384|FG001|Overall Study|Withdrawal by Subject|0|||
129675492|NCT00171249|466774385|FG002|Overall Study|Withdrawal by Subject|0|||
129675493|NCT00171249|466774386|FG003|Overall Study|Withdrawal by Subject|6|||
129675494|NCT00171249|466774387|FG004|Overall Study|Withdrawal by Subject|0|||
129675495|NCT00171249|466774388|FG005|Overall Study|Withdrawal by Subject|0|||
129675496|NCT00171249|466774389|FG006|Overall Study|Withdrawal by Subject|0|||
129675497|NCT00171249|466774383|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
129675498|NCT00171249|466774384|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129675499|NCT00171249|466774385|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
129675500|NCT00171249|466774386|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
129675501|NCT00171249|466774387|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129675502|NCT00171249|466774388|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
129675503|NCT00171249|466774389|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129675504|NCT00171249|466774383|FG000|Overall Study|Death|7|||
129675505|NCT00171249|466774384|FG001|Overall Study|Death|1|||
129675506|NCT00171249|466774385|FG002|Overall Study|Death|0|||
129675507|NCT00171249|466774386|FG003|Overall Study|Death|4|||
129675508|NCT00171249|466774387|FG004|Overall Study|Death|0|||
129675509|NCT00171249|466774388|FG005|Overall Study|Death|3|||
129675510|NCT00171249|466774389|FG006|Overall Study|Death|1|||
129675511|NCT00171249|466774383|FG000|Overall Study|Other|10|||
129675512|NCT00171249|466774384|FG001|Overall Study|Other|0|||
129675513|NCT00171249|466774385|FG002|Overall Study|Other|0|||
129675514|NCT00171249|466774386|FG003|Overall Study|Other|43|||
129675515|NCT00171249|466774387|FG004|Overall Study|Other|0|||
129675516|NCT00171249|466774388|FG005|Overall Study|Other|2|||
129675517|NCT00171249|466774389|FG006|Overall Study|Other|0|||
129675518|NCT00171249|466774383|FG000|Overall Study|No Longer Requires Study Drug|4|||
129675519|NCT00171249|466774384|FG001|Overall Study|No Longer Requires Study Drug|0|||
129675520|NCT00171249|466774385|FG002|Overall Study|No Longer Requires Study Drug|0|||
129675521|NCT00171249|466774386|FG003|Overall Study|No Longer Requires Study Drug|3|||
129675522|NCT00171249|466774387|FG004|Overall Study|No Longer Requires Study Drug|0|||
129675523|NCT00171249|466774388|FG005|Overall Study|No Longer Requires Study Drug|5|||
129675524|NCT00171249|466774389|FG006|Overall Study|No Longer Requires Study Drug|0|||
129675525|NCT00171249|466774383|FG000|Overall Study|Administrative Problems|1|||
129675526|NCT00171249|466774384|FG001|Overall Study|Administrative Problems|0|||
129675527|NCT00171249|466774385|FG002|Overall Study|Administrative Problems|0|||
129675528|NCT00171249|466774386|FG003|Overall Study|Administrative Problems|2|||
129675529|NCT00171249|466774387|FG004|Overall Study|Administrative Problems|0|||
129675530|NCT00171249|466774388|FG005|Overall Study|Administrative Problems|0|||
129675531|NCT00171249|466774389|FG006|Overall Study|Administrative Problems|0|||
129675532|NCT00171249|466774383|FG000|Overall Study|Adverse Event|3|||
129675533|NCT00171249|466774384|FG001|Overall Study|Adverse Event|1|||
129675534|NCT00171249|466774385|FG002|Overall Study|Adverse Event|0|||
129675535|NCT00171249|466774386|FG003|Overall Study|Adverse Event|15|||
129675536|NCT00171249|466774387|FG004|Overall Study|Adverse Event|0|||
129675537|NCT00171249|466774388|FG005|Overall Study|Adverse Event|2|||
129675538|NCT00171249|466774389|FG006|Overall Study|Adverse Event|0|||
129675539|NCT00171249|466774383|FG000|Overall Study|Lost to Follow-up|5|||
129675540|NCT00171249|466774384|FG001|Overall Study|Lost to Follow-up|0|||
129675541|NCT00171249|466774385|FG002|Overall Study|Lost to Follow-up|0|||
129675542|NCT00171249|466774386|FG003|Overall Study|Lost to Follow-up|9|||
129675543|NCT00171249|466774387|FG004|Overall Study|Lost to Follow-up|0|||
129675544|NCT00171249|466774388|FG005|Overall Study|Lost to Follow-up|0|||
129675545|NCT00171249|466774389|FG006|Overall Study|Lost to Follow-up|0|||
129675546|NCT01041859|466774390|FG000|Open-Label Titration|Adverse Event|69|||
129675547|NCT01041859|466774391|FG001|Open-Label Titration|Adverse Event|0|||
129675548|NCT01041859|466774392|FG002|Open-Label Titration|Adverse Event|0|||
129675549|NCT01041859|466774390|FG000|Open-Label Titration|Lack of Efficacy|3|||
129675550|NCT01041859|466774391|FG001|Open-Label Titration|Lack of Efficacy|0|||
129675551|NCT01041859|466774392|FG002|Open-Label Titration|Lack of Efficacy|0|||
129675552|NCT01041859|466774390|FG000|Open-Label Titration|Lost to Follow-up|1|||
129675553|NCT01041859|466774391|FG001|Open-Label Titration|Lost to Follow-up|0|||
129675554|NCT01041859|466774392|FG002|Open-Label Titration|Lost to Follow-up|0|||
129675555|NCT01041859|466774390|FG000|Open-Label Titration|Physician Decision|1|||
129675556|NCT01041859|466774391|FG001|Open-Label Titration|Physician Decision|0|||
129675557|NCT01041859|466774392|FG002|Open-Label Titration|Physician Decision|0|||
129675558|NCT01041859|466774390|FG000|Open-Label Titration|Protocol Violation|1|||
129675559|NCT01041859|466774391|FG001|Open-Label Titration|Protocol Violation|0|||
129675560|NCT01041859|466774392|FG002|Open-Label Titration|Protocol Violation|0|||
129675561|NCT01041859|466774390|FG000|Open-Label Titration|Other|7|||
129675562|NCT01041859|466774391|FG001|Open-Label Titration|Other|0|||
129675563|NCT01041859|466774392|FG002|Open-Label Titration|Other|0|||
129675564|NCT01041859|466774390|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
129675565|NCT01041859|466774391|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
129675566|NCT01041859|466774392|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
129675567|NCT01041859|466774390|FG000|Open-Label Titration|Withdrawal by Subject|11|||
129675568|NCT01041859|466774391|FG001|Open-Label Titration|Withdrawal by Subject|0|||
129675569|NCT01041859|466774392|FG002|Open-Label Titration|Withdrawal by Subject|0|||
129675570|NCT01041859|466774390|FG000|Double-Blind Maintenance|Adverse Event|0|||
129675571|NCT01041859|466774391|FG001|Double-Blind Maintenance|Adverse Event|23|||
129675572|NCT01041859|466774392|FG002|Double-Blind Maintenance|Adverse Event|13|||
129675573|NCT01041859|466774390|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
129675574|NCT01041859|466774391|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
129675575|NCT01041859|466774392|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
129675576|NCT01041859|466774390|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
129675577|NCT01041859|466774391|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
129675578|NCT01041859|466774392|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
129675579|NCT01041859|466774390|FG000|Double-Blind Maintenance|Physician Decision|0|||
129675580|NCT01041859|466774391|FG001|Double-Blind Maintenance|Physician Decision|2|||
129675581|NCT01041859|466774392|FG002|Double-Blind Maintenance|Physician Decision|1|||
129675582|NCT01041859|466774390|FG000|Double-Blind Maintenance|Protocol Violation|0|||
129675583|NCT01041859|466774391|FG001|Double-Blind Maintenance|Protocol Violation|1|||
129675584|NCT01041859|466774392|FG002|Double-Blind Maintenance|Protocol Violation|3|||
129675585|NCT01041859|466774390|FG000|Double-Blind Maintenance|Other|0|||
129675586|NCT01041859|466774391|FG001|Double-Blind Maintenance|Other|6|||
129675587|NCT01041859|466774392|FG002|Double-Blind Maintenance|Other|2|||
129675588|NCT01041859|466774390|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
129675589|NCT01041859|466774391|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
129675590|NCT01041859|466774392|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
129675591|NCT01041859|466774390|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
129675592|NCT01041859|466774391|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
129675593|NCT01041859|466774392|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
129675594|NCT02908347|466774398|FG000|Overall Study|Adverse Event|0|||
129675595|NCT02908347|466774399|FG001|Overall Study|Adverse Event|1|||
129675596|NCT02908347|466774398|FG000|Overall Study|Lost to Follow-up|1|||
129675597|NCT02908347|466774399|FG001|Overall Study|Lost to Follow-up|0|||
129675598|NCT01326871|466774400|FG000|Overall Study|Major surgery|0|||
129675599|NCT01326871|466774401|FG001|Overall Study|Major surgery|1|||
129675600|NCT01326871|466774402|FG002|Overall Study|Major surgery|0|||
129675601|NCT01326871|466774400|FG000|Overall Study|SAE and death|0|||
129675602|NCT01326871|466774401|FG001|Overall Study|SAE and death|2|||
129675603|NCT01326871|466774402|FG002|Overall Study|SAE and death|0|||
129675604|NCT01326871|466774400|FG000|Overall Study|Physician decision and decreased performance status|0|||
129675605|NCT01326871|466774401|FG001|Overall Study|Physician decision and decreased performance status|1|||
129675606|NCT01326871|466774402|FG002|Overall Study|Physician decision and decreased performance status|0|||
129675607|NCT01326871|466774400|FG000|Overall Study|Disease progression|0|||
129675608|NCT01326871|466774401|FG001|Overall Study|Disease progression|11|||
129675609|NCT01326871|466774402|FG002|Overall Study|Disease progression|5|||
129675610|NCT01326871|466774400|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
129675611|NCT01326871|466774401|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
129675612|NCT01326871|466774402|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
129547188|NCT02858076|466296159|FG001|Overall Study|Lost to Follow-up|7|||
129675613|NCT01326871|466774400|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
129675614|NCT01326871|466774401|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
129675615|NCT01326871|466774402|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
129675616|NCT01326871|466774400|FG000|Overall Study|Withdrawal by Subject|0|||
129675617|NCT01326871|466774401|FG001|Overall Study|Withdrawal by Subject|1|||
129675618|NCT01326871|466774402|FG002|Overall Study|Withdrawal by Subject|0|||
129675619|NCT01326871|466774400|FG000|Overall Study|DLT|0|||
129675620|NCT01326871|466774401|FG001|Overall Study|DLT|2|||
129675621|NCT01326871|466774402|FG002|Overall Study|DLT|0|||
129675622|NCT01326871|466774400|FG000|Overall Study|SAE, disease progression and subject decision|0|||
129675623|NCT01326871|466774401|FG001|Overall Study|SAE, disease progression and subject decision|1|||
129675624|NCT01326871|466774402|FG002|Overall Study|SAE, disease progression and subject decision|0|||
129675625|NCT01326871|466774400|FG000|Overall Study|Death|0|||
129675626|NCT01326871|466774401|FG001|Overall Study|Death|1|||
129675627|NCT01326871|466774402|FG002|Overall Study|Death|0|||
129675628|NCT01326871|466774400|FG000|Overall Study|Other|0|||
129675629|NCT01326871|466774401|FG001|Overall Study|Other|3|||
129675630|NCT01326871|466774402|FG002|Overall Study|Other|0|||
129675631|NCT01326871|466774400|FG000|Overall Study|SAE and disease progression|0|||
129675632|NCT01326871|466774401|FG001|Overall Study|SAE and disease progression|0|||
129675633|NCT01326871|466774402|FG002|Overall Study|SAE and disease progression|1|||
129675634|NCT01326871|466774400|FG000|Overall Study|SAE and physician decision|0|||
129675635|NCT01326871|466774401|FG001|Overall Study|SAE and physician decision|0|||
129675636|NCT01326871|466774402|FG002|Overall Study|SAE and physician decision|1|||
129675637|NCT01326871|466774400|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
129547189|NCT02858076|466296158|FG000|Overall Study|Completed Out of Window|1|||
129675638|NCT01326871|466774401|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
129675639|NCT01326871|466774402|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
129675640|NCT01326871|466774400|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
129766610|NCT01056822|467110422|FG001|Overall Study|Lost to Follow-up|0|||
129675641|NCT01326871|466774401|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
129766611|NCT04528641|467110425|FG000|Overall Study|Withdrawal by Subject|0|||
129766612|NCT04528641|467110426|FG001|Overall Study|Withdrawal by Subject|0|||
129766613|NCT04528641|467110427|FG002|Overall Study|Withdrawal by Subject|0|||
129766614|NCT04528641|467110428|FG003|Overall Study|Withdrawal by Subject|1|||
129766615|NCT04528641|467110429|FG004|Overall Study|Withdrawal by Subject|0|||
129766616|NCT04528641|467110430|FG005|Overall Study|Withdrawal by Subject|1|||
129766617|NCT04366349|467110431|FG000|Overall Study|Withdrawal by Subject|1|||
129766618|NCT04366349|467110432|FG001|Overall Study|Withdrawal by Subject|0|||
129766619|NCT04366349|467110433|FG002|Overall Study|Withdrawal by Subject|0|||
129766620|NCT04366349|467110434|FG003|Overall Study|Withdrawal by Subject|0|||
129766621|NCT04366349|467110435|FG004|Overall Study|Withdrawal by Subject|0|||
129766622|NCT04366349|467110436|FG005|Overall Study|Withdrawal by Subject|0|||
129766623|NCT02783690|467110442|FG000|Overall Study|Withdrawal by Subject|3|||
129766624|NCT02783690|467110443|FG001|Overall Study|Withdrawal by Subject|3|||
129766625|NCT03474588|467110444|FG000|Overall Study|Withdrawal by Subject|4|||
129766626|NCT03474588|467110445|FG001|Overall Study|Withdrawal by Subject|3|||
129766627|NCT03474588|467110444|FG000|Overall Study|Death|0|||
129766628|NCT03474588|467110445|FG001|Overall Study|Death|1|||
129766629|NCT00626106|467110451|FG000|Overall Study|Withdrawal by Subject|2|||
129766630|NCT00626106|467110452|FG001|Overall Study|Withdrawal by Subject|1|||
129766631|NCT00626106|467110451|FG000|Overall Study|Lost to Follow-up|1|||
129766632|NCT00626106|467110452|FG001|Overall Study|Lost to Follow-up|4|||
129766633|NCT00626106|467110451|FG000|Overall Study|Death|64|||
129766634|NCT00626106|467110452|FG001|Overall Study|Death|19|||
129766635|NCT05417438|467110453|FG000|Overall Study|Withdrawal by Subject|3|||
129766636|NCT02702492|467110456|FG000|Overall Study|Disease progression|3|||
129766637|NCT02702492|467110457|FG001|Overall Study|Disease progression|3|||
129766638|NCT02702492|467110458|FG002|Overall Study|Disease progression|2|||
129766639|NCT02702492|467110459|FG003|Overall Study|Disease progression|4|||
129766640|NCT02702492|467110460|FG004|Overall Study|Disease progression|4|||
129675642|NCT01326871|466774402|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
129675643|NCT01326871|466774400|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
129675644|NCT01326871|466774401|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
129675645|NCT01326871|466774402|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
129675646|NCT01326871|466774400|FG000|Overall Study|Physician Decision|0|||
129675647|NCT01326871|466774401|FG001|Overall Study|Physician Decision|0|||
129675648|NCT01326871|466774402|FG002|Overall Study|Physician Decision|1|||
129675649|NCT01326871|466774400|FG000|Overall Study|SAE|0|||
129675650|NCT01326871|466774401|FG001|Overall Study|SAE|0|||
129675651|NCT01326871|466774402|FG002|Overall Study|SAE|1|||
129675652|NCT01326871|466774400|FG000|Overall Study|Disease progression and death|0|||
129675653|NCT01326871|466774401|FG001|Overall Study|Disease progression and death|0|||
129675654|NCT01326871|466774402|FG002|Overall Study|Disease progression and death|1|||
129675655|NCT01326871|466774400|FG000|Overall Study|Subject decision|0|||
129675656|NCT01326871|466774401|FG001|Overall Study|Subject decision|0|||
129675657|NCT01326871|466774402|FG002|Overall Study|Subject decision|1|||
129675658|NCT01200329|466774403|FG000|Overall Study|Lack of financial coverage|2|||
129675659|NCT01200329|466774403|FG000|Overall Study|Progressive disease|1|||
129766641|NCT02702492|467110461|FG005|Overall Study|Disease progression|1|||
129766642|NCT02702492|467110462|FG006|Overall Study|Disease progression|2|||
129766643|NCT02702492|467110463|FG007|Overall Study|Disease progression|8|||
129766644|NCT02702492|467110464|FG008|Overall Study|Disease progression|5|||
129766645|NCT02702492|467110465|FG009|Overall Study|Disease progression|1|||
129766646|NCT02702492|467110466|FG010|Overall Study|Disease progression|0|||
129675660|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
129675661|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
129675662|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
129766647|NCT02702492|467110467|FG011|Overall Study|Disease progression|3|||
129766648|NCT02702492|467110468|FG012|Overall Study|Disease progression|2|||
129884408|NCT02771210|467536387|FG000|Period 1|Withdrawal by Subject|0|||
129675663|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
129675664|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
129675665|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
129675666|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
129675667|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129675668|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129675669|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129675670|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
129675671|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
129675672|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
129675673|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
129675674|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
129675675|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
129675676|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
129675677|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129675678|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129675679|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129675680|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
129675681|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
129675682|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129675683|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129675684|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129675685|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
129675686|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
129675687|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
129675688|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
129675689|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
129675690|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
129675691|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
129675692|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
129675693|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
129675694|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
129675695|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
129675696|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
129675697|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
129675698|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
129675699|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
129675700|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
129675701|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129675702|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129675703|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129675704|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
129675705|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
129675706|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
129675707|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
129675708|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
129675709|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
129675710|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
129675711|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
129675712|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
129675713|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
129675714|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
129675715|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
129675716|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129675717|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129675718|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129675719|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
129675720|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
129675721|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129675722|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129675723|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129766649|NCT02702492|467110456|FG000|Overall Study|Clinical progression|0|||
129675724|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
129675725|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129675726|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
129675727|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129675728|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129675729|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
129675730|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
129675731|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
129675732|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
129675733|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
129675734|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
129675735|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129675736|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
129675737|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129675738|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129675739|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
129675740|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
129675741|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129675742|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129675743|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129675744|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
129675745|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129675746|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
129675747|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129675748|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129675749|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
129675750|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
129675751|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129675752|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129675753|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129675754|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
129675755|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129675756|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
129675757|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129675758|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129675759|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
129675760|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
129675761|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129675762|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129675763|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129675764|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
129675765|NCT02717195|466774406|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
129675766|NCT02717195|466774407|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129675767|NCT02717195|466774408|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129675768|NCT02717195|466774409|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129675769|NCT02717195|466774410|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
129675770|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
129675771|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
129766650|NCT02702492|467110457|FG001|Overall Study|Clinical progression|0|||
129766651|NCT02702492|467110458|FG002|Overall Study|Clinical progression|2|||
129766652|NCT02702492|467110459|FG003|Overall Study|Clinical progression|1|||
129766653|NCT02702492|467110460|FG004|Overall Study|Clinical progression|0|||
129766654|NCT02702492|467110461|FG005|Overall Study|Clinical progression|2|||
129766655|NCT02702492|467110462|FG006|Overall Study|Clinical progression|1|||
129766656|NCT02702492|467110463|FG007|Overall Study|Clinical progression|4|||
129766657|NCT02702492|467110464|FG008|Overall Study|Clinical progression|0|||
129766658|NCT02702492|467110465|FG009|Overall Study|Clinical progression|0|||
129766659|NCT02702492|467110466|FG010|Overall Study|Clinical progression|1|||
129766660|NCT02702492|467110467|FG011|Overall Study|Clinical progression|2|||
129766661|NCT02702492|467110468|FG012|Overall Study|Clinical progression|0|||
129766662|NCT02702492|467110456|FG000|Overall Study|Adverse Event|0|||
129766663|NCT02702492|467110457|FG001|Overall Study|Adverse Event|0|||
129766664|NCT02702492|467110458|FG002|Overall Study|Adverse Event|1|||
129766665|NCT02702492|467110459|FG003|Overall Study|Adverse Event|2|||
129766666|NCT02702492|467110460|FG004|Overall Study|Adverse Event|1|||
129766667|NCT02702492|467110461|FG005|Overall Study|Adverse Event|0|||
129766668|NCT02702492|467110462|FG006|Overall Study|Adverse Event|1|||
129766669|NCT02702492|467110463|FG007|Overall Study|Adverse Event|0|||
129766670|NCT02702492|467110464|FG008|Overall Study|Adverse Event|2|||
129766671|NCT02702492|467110465|FG009|Overall Study|Adverse Event|0|||
129766672|NCT02702492|467110466|FG010|Overall Study|Adverse Event|0|||
129766673|NCT02702492|467110467|FG011|Overall Study|Adverse Event|0|||
129766674|NCT02702492|467110468|FG012|Overall Study|Adverse Event|1|||
129766675|NCT02702492|467110456|FG000|Overall Study|Other|0|||
129766676|NCT02702492|467110457|FG001|Overall Study|Other|0|||
129766677|NCT02702492|467110458|FG002|Overall Study|Other|0|||
129766678|NCT02702492|467110459|FG003|Overall Study|Other|0|||
129766679|NCT02702492|467110460|FG004|Overall Study|Other|0|||
129766680|NCT02702492|467110461|FG005|Overall Study|Other|0|||
129766681|NCT02702492|467110462|FG006|Overall Study|Other|0|||
129766682|NCT02702492|467110463|FG007|Overall Study|Other|0|||
129766683|NCT02702492|467110464|FG008|Overall Study|Other|0|||
129766684|NCT02702492|467110465|FG009|Overall Study|Other|0|||
129766685|NCT02702492|467110466|FG010|Overall Study|Other|0|||
129766686|NCT02702492|467110467|FG011|Overall Study|Other|0|||
129766687|NCT02702492|467110468|FG012|Overall Study|Other|1|||
129766688|NCT00781768|467111813|FG000|Overall Study|Not transplanted.|0|||
129766689|NCT00781768|467111814|FG001|Overall Study|Not transplanted.|2|||
129766690|NCT00079417|467111823|FG000|Overall Study|Physician Decision|2|||
129766691|NCT00079417|467111823|FG000|Overall Study|Ineligible|7|||
129766692|NCT02458313|467111824|FG000|Overall Study|Withdrawal by Subject|6|||
129766693|NCT02458313|467111825|FG001|Overall Study|Withdrawal by Subject|8|||
129766694|NCT02458313|467111824|FG000|Overall Study|Excluded for motion during MRI|1|||
129766695|NCT02458313|467111825|FG001|Overall Study|Excluded for motion during MRI|2|||
129766696|NCT00904969|467111826|FG000|Overall Study|Lost to Follow-up|4|||
129766697|NCT00904969|467111826|FG000|Overall Study|Withdrawal by Subject|3|||
129766698|NCT00904969|467111826|FG000|Overall Study|Additional Treatments|11|||
129766699|NCT00904969|467111826|FG000|Overall Study|Case Aborted; Subject Exited|1|||
129766700|NCT00199381|467111833|FG000|Overall Study|Withdrawal by Subject|38|||
129766701|NCT00199381|467111833|FG000|Overall Study|Adverse Event|73|||
129766702|NCT00199381|467111833|FG000|Overall Study|Protocol Violation|6|||
129766703|NCT00199381|467111833|FG000|Overall Study|Lack of Efficacy|27|||
129766704|NCT00199381|467111833|FG000|Overall Study|Not including due to early termination|37|||
129766705|NCT00199381|467111833|FG000|Overall Study|Study termination by Sponsor|323|||
129766706|NCT00385671|467111835|FG000|Overall Study|Adverse Event|14|||
129766707|NCT00385671|467111836|FG001|Overall Study|Adverse Event|27|||
129766708|NCT00385671|467111837|FG002|Overall Study|Adverse Event|18|||
129766709|NCT00385671|467111835|FG000|Overall Study|Lack of Efficacy|5|||
129766710|NCT00385671|467111836|FG001|Overall Study|Lack of Efficacy|9|||
129766711|NCT00385671|467111837|FG002|Overall Study|Lack of Efficacy|5|||
129766712|NCT00385671|467111835|FG000|Overall Study|Lost to Follow-up|6|||
129766713|NCT00385671|467111836|FG001|Overall Study|Lost to Follow-up|6|||
129766714|NCT00385671|467111837|FG002|Overall Study|Lost to Follow-up|5|||
129766715|NCT00385671|467111835|FG000|Overall Study|Physician Decision|2|||
129766716|NCT00385671|467111836|FG001|Overall Study|Physician Decision|1|||
129766717|NCT00385671|467111837|FG002|Overall Study|Physician Decision|2|||
129766718|NCT00385671|467111835|FG000|Overall Study|Protocol Violation|5|||
129766719|NCT00385671|467111836|FG001|Overall Study|Protocol Violation|2|||
129766720|NCT00385671|467111837|FG002|Overall Study|Protocol Violation|1|||
129766721|NCT00385671|467111835|FG000|Overall Study|Sponsor Decision|2|||
129766722|NCT00385671|467111836|FG001|Overall Study|Sponsor Decision|2|||
129766723|NCT00385671|467111837|FG002|Overall Study|Sponsor Decision|1|||
129766724|NCT00385671|467111835|FG000|Overall Study|Withdrawal by Subject|4|||
129766725|NCT00385671|467111836|FG001|Overall Study|Withdrawal by Subject|4|||
129675772|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
129766726|NCT00385671|467111837|FG002|Overall Study|Withdrawal by Subject|4|||
129675773|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
129675774|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
129675775|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
129675776|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
129675777|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
129675778|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
129675779|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
129675780|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
129675781|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
129675782|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
129675783|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
129675784|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
129675785|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
129675786|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
129675787|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
129675788|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
129675789|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
129675790|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129675791|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129675792|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
129675793|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
129675794|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
129675795|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
129675796|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
129675797|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
129675798|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
129675799|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
129675800|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129675801|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129675802|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
129675803|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129675804|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
129675805|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
129675806|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
129675807|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
129675808|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
129675809|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
129675810|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
129675811|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
129675812|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
129675813|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
129675814|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
129766727|NCT01775501|467111838|FG000|Overall Study|Discontinued prior to treatment|1|||
129884409|NCT02771210|467536388|FG001|Period 1|Withdrawal by Subject|3|||
129675815|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129675816|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129675817|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129675818|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
129675819|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
129675820|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
129675821|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
129675822|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
129675823|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
129675824|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
129675825|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129675826|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129675827|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129675828|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
129675829|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
129675830|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129675831|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129675832|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
129675833|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129675834|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
129675835|NCT02717195|466774406|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
129675836|NCT02717195|466774407|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
129675837|NCT02717195|466774408|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
129675838|NCT02717195|466774409|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
129675839|NCT02717195|466774410|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
129675840|NCT03087058|466774411|FG000|Overall Study|Withdrawal by Subject|2|||
129675841|NCT03087058|466774412|FG001|Overall Study|Withdrawal by Subject|0|||
129675842|NCT03087058|466774413|FG002|Overall Study|Withdrawal by Subject|0|||
129675843|NCT02577029|466774414|FG000|Overall Study|Adverse Event|1|||
129675844|NCT02577029|466774415|FG001|Overall Study|Adverse Event|0|||
129675845|NCT02577029|466774416|FG002|Overall Study|Adverse Event|2|||
129675846|NCT02577029|466774417|FG003|Overall Study|Adverse Event|0|||
129675847|NCT02577029|466774418|FG004|Overall Study|Adverse Event|1|||
129675848|NCT02577029|466774419|FG005|Overall Study|Adverse Event|0|||
129675849|NCT02577029|466774420|FG006|Overall Study|Adverse Event|0|||
129675850|NCT02577029|466774421|FG007|Overall Study|Adverse Event|0|||
129675851|NCT02577029|466774414|FG000|Overall Study|Withdrawal by Subject|0|||
129675852|NCT02577029|466774415|FG001|Overall Study|Withdrawal by Subject|0|||
129675853|NCT02577029|466774416|FG002|Overall Study|Withdrawal by Subject|0|||
129675854|NCT02577029|466774417|FG003|Overall Study|Withdrawal by Subject|0|||
129675855|NCT02577029|466774418|FG004|Overall Study|Withdrawal by Subject|0|||
129675856|NCT02577029|466774419|FG005|Overall Study|Withdrawal by Subject|1|||
129675857|NCT02577029|466774420|FG006|Overall Study|Withdrawal by Subject|0|||
129675858|NCT02577029|466774421|FG007|Overall Study|Withdrawal by Subject|0|||
129675859|NCT02577029|466774414|FG000|Overall Study|Sponsor Termination of the Study|9|||
129675860|NCT02577029|466774415|FG001|Overall Study|Sponsor Termination of the Study|2|||
129675861|NCT02577029|466774416|FG002|Overall Study|Sponsor Termination of the Study|5|||
129675862|NCT02577029|466774417|FG003|Overall Study|Sponsor Termination of the Study|12|||
129675863|NCT02577029|466774418|FG004|Overall Study|Sponsor Termination of the Study|10|||
129675864|NCT02577029|466774419|FG005|Overall Study|Sponsor Termination of the Study|12|||
129675865|NCT02577029|466774420|FG006|Overall Study|Sponsor Termination of the Study|12|||
129675866|NCT02577029|466774421|FG007|Overall Study|Sponsor Termination of the Study|12|||
129675867|NCT02078817|466774422|FG000|Overall Study|Withdrawal by Subject|1|||
129675868|NCT01420536|466774423|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
129675869|NCT01420536|466774424|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
129675870|NCT01265498|466774429|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
129675871|NCT01265498|466774430|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
129675872|NCT01652690|466774432|FG000|Overall Study|Withdrawal by Subject|16|||
129675873|NCT01652690|466774433|FG001|Overall Study|Withdrawal by Subject|4|||
129675874|NCT01652690|466774432|FG000|Overall Study|Other|8|||
129675875|NCT01652690|466774433|FG001|Overall Study|Other|9|||
129675876|NCT01652690|466774432|FG000|Overall Study|Lost to Follow-up|6|||
129675877|NCT01652690|466774433|FG001|Overall Study|Lost to Follow-up|6|||
129675878|NCT01652690|466774432|FG000|Overall Study|Death|5|||
129766728|NCT01280903|467111842|FG000|Overall Study|Lost to Follow-up|23|||
129766729|NCT01280903|467111843|FG001|Overall Study|Lost to Follow-up|16|||
129766730|NCT03453164|467111844|FG000|Overall Study|Lack of Efficacy|16|||
129766731|NCT03453164|467111844|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
129766732|NCT03007966|467111847|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
129766733|NCT03007966|467111848|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
129766734|NCT03459079|467111849|FG000|Overall Study|Adverse Event|4|||
129766735|NCT03459079|467111850|FG001|Overall Study|Adverse Event|2|||
129766736|NCT03459079|467111851|FG002|Overall Study|Adverse Event|0|||
129766737|NCT03459079|467111849|FG000|Overall Study|Withdrawal by Subject|2|||
129766738|NCT03459079|467111850|FG001|Overall Study|Withdrawal by Subject|2|||
129766739|NCT03459079|467111851|FG002|Overall Study|Withdrawal by Subject|0|||
129766740|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
129766741|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
129766742|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
129766743|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Death|9|||
129766744|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Death|0|||
129766745|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Death|0|||
129675879|NCT01652690|466774433|FG001|Overall Study|Death|2|||
129675880|NCT03225287|466774434|FG000|Overall Study|Adverse Event|0|||
129675881|NCT03225287|466774435|FG001|Overall Study|Adverse Event|0|||
129675882|NCT03225287|466774436|FG002|Overall Study|Adverse Event|1|||
129675883|NCT03225287|466774434|FG000|Overall Study|Protocol non-compliance|0|||
129675884|NCT03225287|466774435|FG001|Overall Study|Protocol non-compliance|0|||
129675885|NCT03225287|466774436|FG002|Overall Study|Protocol non-compliance|1|||
129675886|NCT03225287|466774434|FG000|Overall Study|Subject withdraws consent|3|||
129675887|NCT03225287|466774435|FG001|Overall Study|Subject withdraws consent|0|||
129675888|NCT03225287|466774436|FG002|Overall Study|Subject withdraws consent|0|||
129675889|NCT03225287|466774434|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
129675890|NCT03225287|466774435|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
129675891|NCT03225287|466774436|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
129675892|NCT03225287|466774434|FG000|Overall Study|Trial drug not effective|0|||
129675893|NCT03225287|466774435|FG001|Overall Study|Trial drug not effective|1|||
129675894|NCT03225287|466774436|FG002|Overall Study|Trial drug not effective|0|||
129675895|NCT03225287|466774434|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
129675896|NCT03225287|466774435|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
129675897|NCT03225287|466774436|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
129675898|NCT03225287|466774434|FG000|Overall Study|Stem cell transplantation|0|||
129675899|NCT03225287|466774435|FG001|Overall Study|Stem cell transplantation|1|||
129675900|NCT03225287|466774436|FG002|Overall Study|Stem cell transplantation|0|||
129675901|NCT06996301|466774438|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
129675902|NCT06996301|466774439|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
129675903|NCT06996301|466774438|FG000|Overall Study|Patients with discordant diagnostic results|107|||
129675904|NCT06996301|466774439|FG001|Overall Study|Patients with discordant diagnostic results|90|||
129675905|NCT06996301|466774438|FG000|Overall Study|Lost to Follow-up|31|||
129675906|NCT06996301|466774439|FG001|Overall Study|Lost to Follow-up|56|||
129675907|NCT06996301|466774438|FG000|Overall Study|Withdrawal by Subject|12|||
129675908|NCT06996301|466774439|FG001|Overall Study|Withdrawal by Subject|7|||
129675909|NCT04030598|466774440|FG000|Overall Study|Voluntary Withdrawal|0|||
129675910|NCT04030598|466774441|FG001|Overall Study|Voluntary Withdrawal|1|||
129675911|NCT04030598|466774442|FG002|Overall Study|Voluntary Withdrawal|0|||
129675912|NCT02097823|466774445|FG000|Overall Study|Withdrawal by Subject|1|||
129675913|NCT02097823|466774446|FG001|Overall Study|Withdrawal by Subject|1|||
129675914|NCT00959751|466776311|FG000|Overall Study|Lost to Follow-up|2|||
129675915|NCT00959751|466776312|FG001|Overall Study|Lost to Follow-up|3|||
129675916|NCT00959751|466776311|FG000|Overall Study|Consent Withdrawn|0|||
129675917|NCT00959751|466776312|FG001|Overall Study|Consent Withdrawn|1|||
129675918|NCT00959751|466776311|FG000|Overall Study|Non-compliance to Study Procedures|0|||
129675919|NCT00959751|466776312|FG001|Overall Study|Non-compliance to Study Procedures|1|||
129675920|NCT00959751|466776311|FG000|Overall Study|No migraine headache without aura|7|||
129675921|NCT00959751|466776312|FG001|Overall Study|No migraine headache without aura|7|||
129766746|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
129766747|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129675922|NCT00900562|466776315|FG000|Overall Study|Progressive disease|9|||
129675923|NCT00900562|466776316|FG001|Overall Study|Progressive disease|5|||
129675924|NCT00900562|466776315|FG000|Overall Study|Toxicity|1|||
129675925|NCT00900562|466776316|FG001|Overall Study|Toxicity|0|||
129675926|NCT00900562|466776315|FG000|Overall Study|Death|1|||
129766748|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129766749|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
129766750|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
129766751|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
129766752|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Other|135|||
129766753|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Other|0|||
129766754|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Other|0|||
129766755|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
129766756|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
129766757|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
129766758|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
129766759|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
129766760|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
129766761|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
129766762|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
129766763|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
129766764|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Other|3|||
129766765|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Other|0|||
129766766|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Other|0|||
129766767|NCT02118584|467111853|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
129766768|NCT02118584|467111854|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129766769|NCT02118584|467111855|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129766770|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129766771|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
129766772|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129766773|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
129766774|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
129766775|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
129766776|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
129766777|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
129766778|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
129766779|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129766780|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129766781|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
129766782|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129766783|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
129766784|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129766785|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
129766786|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
129766787|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
129766788|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129766789|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
129766790|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129766791|NCT02118584|467111853|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
129766792|NCT02118584|467111854|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
129766793|NCT02118584|467111855|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
129766794|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
129766795|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
129766796|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129766797|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
129766798|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
129766799|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
129766800|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129766801|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
129766802|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
129766803|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129766804|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129766805|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129766806|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
129766807|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
129766808|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
129766809|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
129766810|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
129675927|NCT00900562|466776316|FG001|Overall Study|Death|1|||
129675928|NCT00900562|466776315|FG000|Overall Study|Withdrawal by Subject|0|||
129675929|NCT00900562|466776316|FG001|Overall Study|Withdrawal by Subject|1|||
129675930|NCT00900562|466776315|FG000|Overall Study|Unrelated adverse event|1|||
129675931|NCT00900562|466776316|FG001|Overall Study|Unrelated adverse event|0|||
129675932|NCT02426684|466776317|FG000|Overall Study|Physician Decision|1|||
129675933|NCT03587636|466776318|FG000|Overall Study|Lost to Follow-up|2|||
129675934|NCT03587636|466776319|FG001|Overall Study|Lost to Follow-up|5|||
129675935|NCT04459338|466776320|FG000|Overall Study|Loss of IV during study|1|||
129675936|NCT04459338|466776321|FG001|Overall Study|Loss of IV during study|0|||
129675937|NCT01454284|466776322|FG000|Overall Study|Adverse Event|20|||
129675938|NCT01454284|466776323|FG001|Overall Study|Adverse Event|7|||
129675939|NCT01454284|466776322|FG000|Overall Study|Death|0|||
129675940|NCT01454284|466776323|FG001|Overall Study|Death|3|||
129675941|NCT01454284|466776322|FG000|Overall Study|Lost to Follow-up|13|||
129675942|NCT01454284|466776323|FG001|Overall Study|Lost to Follow-up|8|||
129675943|NCT01454284|466776322|FG000|Overall Study|Protocol Violation|9|||
129675944|NCT01454284|466776323|FG001|Overall Study|Protocol Violation|6|||
129675945|NCT01454284|466776322|FG000|Overall Study|Withdrawal by Subject|58|||
129675946|NCT01454284|466776323|FG001|Overall Study|Withdrawal by Subject|36|||
129675947|NCT01454284|466776322|FG000|Overall Study|Physician Decision|16|||
129675948|NCT01454284|466776323|FG001|Overall Study|Physician Decision|11|||
129675949|NCT01454284|466776322|FG000|Overall Study|Sponsor Decision|0|||
129675950|NCT01454284|466776323|FG001|Overall Study|Sponsor Decision|2|||
129675951|NCT02665117|466776324|FG000|Overall Study|Physician Decision|1|||
129675952|NCT02665117|466776325|FG001|Overall Study|Physician Decision|0|||
129675953|NCT03451071|466776335|FG000|First Vaccine|Withdrawal by Subject|1|||
129675954|NCT03451071|466776335|FG000|Second Vaccine|Lost to Follow-up|19|||
129675955|NCT03451071|466776335|FG000|Third Vaccine|Lost to Follow-up|22|||
129675956|NCT03451071|466776335|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
129675957|NCT02065557|466776336|FG000|Induction Period|Withdrawal by Subject|2|||
129675958|NCT02065557|466776337|FG001|Induction Period|Withdrawal by Subject|1|||
129675959|NCT02065557|466776338|FG002|Induction Period|Withdrawal by Subject|0|||
129675960|NCT02065557|466776339|FG003|Induction Period|Withdrawal by Subject|0|||
129675961|NCT02065557|466776340|FG004|Induction Period|Withdrawal by Subject|0|||
129675962|NCT02065557|466776341|FG005|Induction Period|Withdrawal by Subject|0|||
129675963|NCT02065557|466776336|FG000|Induction Period|Lack of Efficacy|2|||
129675964|NCT02065557|466776337|FG001|Induction Period|Lack of Efficacy|1|||
129675965|NCT02065557|466776338|FG002|Induction Period|Lack of Efficacy|1|||
129675966|NCT02065557|466776339|FG003|Induction Period|Lack of Efficacy|0|||
129675967|NCT02065557|466776340|FG004|Induction Period|Lack of Efficacy|0|||
129675968|NCT02065557|466776341|FG005|Induction Period|Lack of Efficacy|0|||
129675969|NCT02065557|466776336|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
129675970|NCT02065557|466776337|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
129675971|NCT02065557|466776338|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
129675972|NCT02065557|466776339|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
129675973|NCT02065557|466776340|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
129675974|NCT02065557|466776341|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
129675975|NCT02065557|466776336|FG000|Induction Period|Non-Responder at Week 8|4|||
129675976|NCT02065557|466776337|FG001|Induction Period|Non-Responder at Week 8|4|||
129675977|NCT02065557|466776338|FG002|Induction Period|Non-Responder at Week 8|0|||
129675978|NCT02065557|466776339|FG003|Induction Period|Non-Responder at Week 8|0|||
129675979|NCT02065557|466776340|FG004|Induction Period|Non-Responder at Week 8|0|||
129675980|NCT02065557|466776341|FG005|Induction Period|Non-Responder at Week 8|0|||
129675981|NCT02065557|466776336|FG000|Induction Period|Adverse Event|1|||
129675982|NCT02065557|466776337|FG001|Induction Period|Adverse Event|1|||
129675983|NCT02065557|466776338|FG002|Induction Period|Adverse Event|0|||
129675984|NCT02065557|466776339|FG003|Induction Period|Adverse Event|0|||
129675985|NCT02065557|466776340|FG004|Induction Period|Adverse Event|0|||
129675986|NCT02065557|466776341|FG005|Induction Period|Adverse Event|0|||
129675987|NCT02065557|466776336|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
129675988|NCT02065557|466776337|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
129675989|NCT02065557|466776338|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
129675990|NCT02065557|466776339|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
129675991|NCT02065557|466776340|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
129675992|NCT02065557|466776341|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
129675993|NCT02065557|466776336|FG000|Maintenance Period|Withdrawal by Subject|0|||
129675994|NCT02065557|466776337|FG001|Maintenance Period|Withdrawal by Subject|0|||
129675995|NCT02065557|466776338|FG002|Maintenance Period|Withdrawal by Subject|0|||
129675996|NCT02065557|466776339|FG003|Maintenance Period|Withdrawal by Subject|0|||
129675997|NCT02065557|466776340|FG004|Maintenance Period|Withdrawal by Subject|2|||
129675998|NCT02065557|466776341|FG005|Maintenance Period|Withdrawal by Subject|1|||
129766811|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
129766812|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
129766813|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
129766814|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
129675999|NCT02065557|466776336|FG000|Maintenance Period|Lack of Efficacy|0|||
129676000|NCT02065557|466776337|FG001|Maintenance Period|Lack of Efficacy|0|||
129676001|NCT02065557|466776338|FG002|Maintenance Period|Lack of Efficacy|0|||
129676002|NCT02065557|466776339|FG003|Maintenance Period|Lack of Efficacy|0|||
129676003|NCT02065557|466776340|FG004|Maintenance Period|Lack of Efficacy|5|||
129676004|NCT02065557|466776341|FG005|Maintenance Period|Lack of Efficacy|2|||
129676005|NCT02065557|466776336|FG000|Maintenance Period|Subject Non-Compliance|0|||
129676006|NCT02065557|466776337|FG001|Maintenance Period|Subject Non-Compliance|0|||
129676007|NCT02065557|466776338|FG002|Maintenance Period|Subject Non-Compliance|0|||
129676008|NCT02065557|466776339|FG003|Maintenance Period|Subject Non-Compliance|0|||
129676009|NCT02065557|466776340|FG004|Maintenance Period|Subject Non-Compliance|0|||
129676010|NCT02065557|466776341|FG005|Maintenance Period|Subject Non-Compliance|1|||
129676011|NCT00250588|466776342|FG000|Overall Study|Withdrawal by Subject|3|||
129676012|NCT00250588|466776343|FG001|Overall Study|Withdrawal by Subject|6|||
129676013|NCT00250588|466776344|FG002|Overall Study|Withdrawal by Subject|0|||
129676014|NCT00250588|466776342|FG000|Overall Study|Lost to Follow-up|6|||
129676015|NCT00250588|466776343|FG001|Overall Study|Lost to Follow-up|13|||
129676016|NCT00250588|466776344|FG002|Overall Study|Lost to Follow-up|13|||
129676017|NCT03502798|466776345|FG000|Overall Study|equipment failure|0|||
129676018|NCT03502798|466776346|FG001|Overall Study|equipment failure|7|||
129676019|NCT00485303|466776348|FG000|Overall Study|Adverse Event|5|||
129676020|NCT00485303|466776348|FG000|Overall Study|Progressive Disease|44|||
129676021|NCT00485303|466776348|FG000|Overall Study|Other|3|||
129676022|NCT00485303|466776348|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
129676023|NCT00485303|466776348|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
129676024|NCT00296335|466776350|FG000|Overall Study|Recurrence|3|||
129676025|NCT00296335|466776351|FG001|Overall Study|Recurrence|51|||
129676026|NCT00296335|466776350|FG000|Overall Study|Adverse Event|17|||
129676027|NCT00296335|466776351|FG001|Overall Study|Adverse Event|27|||
129676028|NCT00296335|466776350|FG000|Overall Study|Lost to Follow-up|7|||
129676029|NCT00296335|466776351|FG001|Overall Study|Lost to Follow-up|33|||
129676030|NCT00296335|466776350|FG000|Overall Study|Physician Decision|3|||
129676031|NCT00296335|466776351|FG001|Overall Study|Physician Decision|11|||
129676032|NCT01401322|466776352|FG000|Overall Study|Withdrawal by Subject|1|||
129676033|NCT01401322|466776352|FG000|Overall Study|Physician Decision|1|||
129676034|NCT02737722|466776353|FG000|Overall Study|Physician Decision|0|||
129676035|NCT02737722|466776354|FG001|Overall Study|Physician Decision|0|||
129676036|NCT02737722|466776355|FG002|Overall Study|Physician Decision|1|||
129676037|NCT02737722|466776356|FG003|Overall Study|Physician Decision|0|||
129676038|NCT00112957|466776363|FG000|Overall Study|Progressive disease|18|||
129676039|NCT00112957|466776363|FG000|Overall Study|Physician Decision|1|||
129676040|NCT03444584|466776373|FG000|Overall Study|Withdrawal by Subject|0|||
129676041|NCT03444584|466776374|FG001|Overall Study|Withdrawal by Subject|1|||
129676042|NCT03444584|466776373|FG000|Overall Study|Other|0|||
129676043|NCT03444584|466776374|FG001|Overall Study|Other|1|||
129676044|NCT03451045|466776375|FG000|Overall Study|Lack of Efficacy|3|||
129676045|NCT03451045|466776376|FG001|Overall Study|Lack of Efficacy|2|||
129676046|NCT03451045|466776377|FG002|Overall Study|Lack of Efficacy|2|||
129676047|NCT03451045|466776375|FG000|Overall Study|Physician Decision|1|||
129676048|NCT03451045|466776376|FG001|Overall Study|Physician Decision|1|||
129676049|NCT03451045|466776377|FG002|Overall Study|Physician Decision|1|||
129676050|NCT03451045|466776375|FG000|Overall Study|Withdrawal by Subject|4|||
129676051|NCT03451045|466776376|FG001|Overall Study|Withdrawal by Subject|0|||
129676052|NCT03451045|466776377|FG002|Overall Study|Withdrawal by Subject|5|||
129676053|NCT03451045|466776375|FG000|Overall Study|Pregnancy|0|||
129676054|NCT03451045|466776376|FG001|Overall Study|Pregnancy|0|||
129676055|NCT03451045|466776377|FG002|Overall Study|Pregnancy|2|||
129676056|NCT03451045|466776375|FG000|Overall Study|Adverse Event|7|||
129676057|NCT03451045|466776376|FG001|Overall Study|Adverse Event|1|||
129676058|NCT03451045|466776377|FG002|Overall Study|Adverse Event|3|||
129547190|NCT02858076|466296159|FG001|Overall Study|Completed Out of Window|3|||
129547191|NCT03506425|466296160|FG000|Overall Study|Adverse Event|1|||
129547192|NCT03506425|466296161|FG001|Overall Study|Adverse Event|3|||
129547193|NCT03506425|466296162|FG002|Overall Study|Adverse Event|0|||
129676059|NCT03451045|466776375|FG000|Overall Study|Non-compliance with study|2|||
129676060|NCT03451045|466776376|FG001|Overall Study|Non-compliance with study|0|||
129676061|NCT03451045|466776377|FG002|Overall Study|Non-compliance with study|1|||
129676062|NCT03451045|466776375|FG000|Overall Study|any other reason|10|||
129676063|NCT03451045|466776376|FG001|Overall Study|any other reason|2|||
129676064|NCT03451045|466776377|FG002|Overall Study|any other reason|13|||
129676065|NCT00863707|466776378|FG000|Overall Study|Randomized, but drug not received|4|||
129676066|NCT00863707|466776379|FG001|Overall Study|Randomized, but drug not received|3|||
129676067|NCT03704064|466776380|FG000|Overall Study|Lost to Follow-up|8|||
129676068|NCT03704064|466776381|FG001|Overall Study|Lost to Follow-up|4|||
129676069|NCT03704064|466776380|FG000|Overall Study|Withdrawal by Subject|1|||
129676070|NCT03704064|466776381|FG001|Overall Study|Withdrawal by Subject|1|||
129676071|NCT03704064|466776380|FG000|Overall Study|No longer available for study visits|0|||
129676072|NCT03704064|466776381|FG001|Overall Study|No longer available for study visits|1|||
129676073|NCT03704064|466776380|FG000|Overall Study|Censoring event|1|||
129676074|NCT03704064|466776381|FG001|Overall Study|Censoring event|0|||
129676075|NCT04142242|466776382|FG000|Stage I|Non-compliance with the protocol|1|||
129676076|NCT04142242|466776383|FG001|Stage I|Non-compliance with the protocol|0|||
129676077|NCT04142242|466776384|FG002|Stage I|Non-compliance with the protocol|0|||
129676078|NCT04142242|466776385|FG003|Stage I|Non-compliance with the protocol|0|||
129676079|NCT04142242|466776386|FG004|Stage I|Non-compliance with the protocol|0|||
129676080|NCT04142242|466776387|FG005|Stage I|Non-compliance with the protocol|1|||
129676081|NCT04142242|466776382|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129676082|NCT04142242|466776383|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
129676083|NCT04142242|466776384|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129676084|NCT04142242|466776385|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129676085|NCT04142242|466776386|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129676086|NCT04142242|466776387|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
129676087|NCT04142242|466776382|FG000|Stage II|Non-compliance with the protocol|0|||
129676088|NCT04142242|466776383|FG001|Stage II|Non-compliance with the protocol|0|||
129676089|NCT04142242|466776384|FG002|Stage II|Non-compliance with the protocol|0|||
129676090|NCT04142242|466776385|FG003|Stage II|Non-compliance with the protocol|2|||
129676091|NCT04142242|466776386|FG004|Stage II|Non-compliance with the protocol|0|||
129676092|NCT04142242|466776387|FG005|Stage II|Non-compliance with the protocol|0|||
129676093|NCT04142242|466776382|FG000|Stage II|Lost to Follow-up|0|||
129676094|NCT04142242|466776383|FG001|Stage II|Lost to Follow-up|0|||
129676095|NCT04142242|466776384|FG002|Stage II|Lost to Follow-up|1|||
129676096|NCT04142242|466776385|FG003|Stage II|Lost to Follow-up|2|||
129676097|NCT04142242|466776386|FG004|Stage II|Lost to Follow-up|0|||
129676098|NCT04142242|466776387|FG005|Stage II|Lost to Follow-up|0|||
129676099|NCT04142242|466776382|FG000|Stage II|Withdrawal by Subject|0|||
129676100|NCT04142242|466776383|FG001|Stage II|Withdrawal by Subject|0|||
129676101|NCT04142242|466776384|FG002|Stage II|Withdrawal by Subject|5|||
129676102|NCT04142242|466776385|FG003|Stage II|Withdrawal by Subject|9|||
129676103|NCT04142242|466776386|FG004|Stage II|Withdrawal by Subject|0|||
129676104|NCT04142242|466776387|FG005|Stage II|Withdrawal by Subject|0|||
129676105|NCT00289276|466776390|FG000|Second Part of FAST Study (Expansion)|Death|0|||
129676106|NCT00289276|466776391|FG001|Second Part of FAST Study (Expansion)|Death|2|||
129676107|NCT00289276|466776390|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
129676108|NCT00289276|466776391|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
129676109|NCT03040726|466776392|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
129676110|NCT03040726|466776393|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
129676111|NCT03040726|466776392|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
129676112|NCT03040726|466776393|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
129676113|NCT03040726|466776392|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
129676114|NCT03040726|466776393|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
129676115|NCT03040726|466776392|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
129676116|NCT03040726|466776393|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
129676117|NCT03040726|466776392|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
129676118|NCT03040726|466776393|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
129676119|NCT02783911|466776394|FG000|Overall Study|Lost to Follow-up|3|||
129676120|NCT02783911|466776395|FG001|Overall Study|Lost to Follow-up|32|||
129676121|NCT00071981|466776396|FG000|Overall Study|Lack of Efficacy|37|||
129676122|NCT00071981|466776397|FG001|Overall Study|Lack of Efficacy|29|||
129676123|NCT00071981|466776398|FG002|Overall Study|Lack of Efficacy|30|||
129676124|NCT00071981|466776399|FG003|Overall Study|Lack of Efficacy|43|||
129676125|NCT00071981|466776396|FG000|Overall Study|Adverse Event|4|||
129547194|NCT03506425|466296160|FG000|Overall Study|Death|1|||
129547195|NCT03506425|466296161|FG001|Overall Study|Death|0|||
129547196|NCT03506425|466296162|FG002|Overall Study|Death|0|||
129676126|NCT00071981|466776397|FG001|Overall Study|Adverse Event|4|||
129766815|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
129766816|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129766817|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129766818|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
129766819|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
129766820|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
129766821|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
129766822|NCT04026113|467111859|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129766823|NCT04026113|467111860|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
129766824|NCT04026113|467111861|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129766825|NCT04026113|467111862|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129766826|NCT04026113|467111859|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
129766827|NCT04026113|467111860|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
129766828|NCT04026113|467111861|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
129766829|NCT04026113|467111862|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
129766830|NCT04613362|467111863|FG000|3 Month Follow-up|Lost to Follow-up|1|||
129766831|NCT04613362|467111864|FG001|3 Month Follow-up|Lost to Follow-up|2|||
129766832|NCT04613362|467111863|FG000|6 Month Follow-up|Lost to Follow-up|0|||
129766833|NCT04613362|467111864|FG001|6 Month Follow-up|Lost to Follow-up|1|||
129766834|NCT02218372|467111865|FG000|Overall Study|Adverse Event|1|||
129766835|NCT02218372|467111866|FG001|Overall Study|Adverse Event|1|||
129766836|NCT02218372|467111865|FG000|Overall Study|Miscellaneous|2|||
129766837|NCT02218372|467111866|FG001|Overall Study|Miscellaneous|1|||
129766838|NCT02218372|467111865|FG000|Overall Study|Randomized but did not receive treatment|2|||
129766839|NCT02218372|467111866|FG001|Overall Study|Randomized but did not receive treatment|3|||
129766840|NCT02218372|467111865|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129766841|NCT02218372|467111866|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129766842|NCT00074711|467111875|FG000|Overall Study|Withdrawal by Subject|1|||
129766843|NCT00074711|467111876|FG001|Overall Study|Withdrawal by Subject|1|||
129766844|NCT00074711|467111875|FG000|Overall Study|Lost to Follow-up|10|||
129766845|NCT00074711|467111876|FG001|Overall Study|Lost to Follow-up|8|||
129766846|NCT00074711|467111875|FG000|Overall Study|Participant stopped study drug|4|||
129766847|NCT00074711|467111876|FG001|Overall Study|Participant stopped study drug|6|||
129766848|NCT00671658|467111877|FG000|Overall Study|Physician Decision|5|||
129766849|NCT01921205|467111878|FG000|Overall Study|Adverse Event|12|||
129766850|NCT01921205|467111879|FG001|Overall Study|Adverse Event|7|||
129766851|NCT01921205|467111878|FG000|Overall Study|Lack of Efficacy|1|||
129766852|NCT01921205|467111879|FG001|Overall Study|Lack of Efficacy|0|||
129766853|NCT01921205|467111878|FG000|Overall Study|Protocol Violation|1|||
129766854|NCT01921205|467111879|FG001|Overall Study|Protocol Violation|3|||
129766855|NCT01921205|467111878|FG000|Overall Study|Lost to Follow-up|1|||
129766856|NCT01921205|467111879|FG001|Overall Study|Lost to Follow-up|1|||
129766857|NCT01921205|467111878|FG000|Overall Study|Withdrawal by Subject|6|||
129766858|NCT01921205|467111879|FG001|Overall Study|Withdrawal by Subject|5|||
129766859|NCT01921205|467111878|FG000|Overall Study|Use Of Prohibited Medication|0|||
129766860|NCT01921205|467111879|FG001|Overall Study|Use Of Prohibited Medication|1|||
129766861|NCT01921205|467111878|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
129766862|NCT01921205|467111879|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
129766863|NCT01921205|467111878|FG000|Overall Study|Non Compliance Of The Parent|0|||
129766864|NCT01921205|467111879|FG001|Overall Study|Non Compliance Of The Parent|1|||
129766865|NCT01921205|467111878|FG000|Overall Study|Non Compliance Of Child|0|||
129676127|NCT00071981|466776398|FG002|Overall Study|Adverse Event|3|||
129676128|NCT00071981|466776399|FG003|Overall Study|Adverse Event|1|||
129676129|NCT00071981|466776396|FG000|Overall Study|Death|0|||
129676130|NCT00071981|466776397|FG001|Overall Study|Death|0|||
129676131|NCT00071981|466776398|FG002|Overall Study|Death|1|||
129676132|NCT00071981|466776399|FG003|Overall Study|Death|1|||
129676133|NCT00071981|466776396|FG000|Overall Study|Withdrawal by Subject|3|||
129676134|NCT00071981|466776397|FG001|Overall Study|Withdrawal by Subject|1|||
129676135|NCT00071981|466776398|FG002|Overall Study|Withdrawal by Subject|0|||
129766866|NCT01921205|467111879|FG001|Overall Study|Non Compliance Of Child|1|||
129676136|NCT00071981|466776399|FG003|Overall Study|Withdrawal by Subject|0|||
129676137|NCT00071981|466776396|FG000|Overall Study|No protocol therapy|2|||
129766867|NCT01527149|467111881|FG000|Overall Study|Death|2|||
129766868|NCT03125395|467111882|FG000|Overall Study|Adverse Event|2|||
129766869|NCT03125395|467111882|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129766870|NCT03125395|467111882|FG000|Overall Study|Physician Decision|2|||
129766871|NCT03125395|467111882|FG000|Overall Study|Commercial drug is available|5|||
129547197|NCT03506425|466296160|FG000|Overall Study|Withdrawal by Subject|0|||
129766872|NCT01780506|467111883|FG000|Double-Blind Phase|Randomized but not Treated|3|||
129766873|NCT01780506|467111884|FG001|Double-Blind Phase|Randomized but not Treated|2|||
129766874|NCT01780506|467111883|FG000|Double-Blind Phase|Adverse Event|4|||
129766875|NCT01780506|467111884|FG001|Double-Blind Phase|Adverse Event|14|||
129766876|NCT01780506|467111883|FG000|Double-Blind Phase|Death|1|||
129766877|NCT01780506|467111884|FG001|Double-Blind Phase|Death|2|||
129766878|NCT01780506|467111883|FG000|Double-Blind Phase|Pregnancy|2|||
129766879|NCT01780506|467111884|FG001|Double-Blind Phase|Pregnancy|1|||
129766880|NCT01780506|467111883|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129766881|NCT01780506|467111884|FG001|Double-Blind Phase|Lack of Efficacy|1|||
129766882|NCT01780506|467111883|FG000|Double-Blind Phase|Investigator's Discretion|5|||
129766883|NCT01780506|467111884|FG001|Double-Blind Phase|Investigator's Discretion|2|||
129766884|NCT01780506|467111883|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
129766885|NCT01780506|467111884|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
129766886|NCT01780506|467111883|FG000|Double-Blind Phase|Protocol Violation|4|||
129766887|NCT01780506|467111884|FG001|Double-Blind Phase|Protocol Violation|3|||
129766888|NCT01780506|467111883|FG000|Double-Blind Phase|Withdrew Consent|23|||
129766889|NCT01780506|467111884|FG001|Double-Blind Phase|Withdrew Consent|24|||
129766890|NCT01780506|467111883|FG000|Double-Blind Phase|Lost to Follow-up|23|||
129766891|NCT01780506|467111884|FG001|Double-Blind Phase|Lost to Follow-up|26|||
129766892|NCT01780506|467111883|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
129766893|NCT01780506|467111884|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
129766894|NCT05236270|467111885|FG000|Overall Study|Lost to Follow-up|3|||
129766895|NCT05236270|467111886|FG001|Overall Study|Lost to Follow-up|2|||
129766896|NCT05236270|467111887|FG002|Overall Study|Lost to Follow-up|0|||
129766897|NCT05236270|467111888|FG003|Overall Study|Lost to Follow-up|0|||
129766898|NCT05236270|467111889|FG004|Overall Study|Lost to Follow-up|2|||
129766899|NCT05236270|467111890|FG005|Overall Study|Lost to Follow-up|0|||
129766900|NCT05236270|467111891|FG006|Overall Study|Lost to Follow-up|1|||
129766901|NCT05236270|467111892|FG007|Overall Study|Lost to Follow-up|3|||
129766902|NCT01499940|467111893|FG000|Overall Study|Study was withdrawn before completion.|9|||
129766903|NCT03279081|467111895|FG000|Overall Study|Withdrawal by Subject|12|||
129766904|NCT03279081|467111896|FG001|Overall Study|Withdrawal by Subject|20|||
129766905|NCT03279081|467111895|FG000|Overall Study|Physician Decision|4|||
129766906|NCT03279081|467111896|FG001|Overall Study|Physician Decision|1|||
129766907|NCT03279081|467111895|FG000|Overall Study|Lost to Follow-up|8|||
129766908|NCT03279081|467111896|FG001|Overall Study|Lost to Follow-up|8|||
129766909|NCT03279081|467111895|FG000|Overall Study|Death|0|||
129766910|NCT03279081|467111896|FG001|Overall Study|Death|1|||
129766911|NCT03279081|467111895|FG000|Overall Study|Adverse Event|1|||
129766912|NCT03279081|467111896|FG001|Overall Study|Adverse Event|0|||
129766913|NCT03279081|467111895|FG000|Overall Study|Reason not Specified|14|||
129766914|NCT03279081|467111896|FG001|Overall Study|Reason not Specified|4|||
129766915|NCT03521570|467111897|FG000|Overall Study|Not eligible|11|||
129766916|NCT03253796|467111908|FG000|Period 1: Run-In|Adverse Event|4|||
129766917|NCT03253796|467111909|FG001|Period 1: Run-In|Adverse Event|0|||
129766918|NCT03253796|467111910|FG002|Period 1: Run-In|Adverse Event|0|||
129766919|NCT03253796|467111911|FG003|Period 1: Run-In|Adverse Event|0|||
129766920|NCT03253796|467111912|FG004|Period 1: Run-In|Adverse Event|0|||
129766921|NCT03253796|467111908|FG000|Period 1: Run-In|Lack of Efficacy|1|||
129766922|NCT03253796|467111909|FG001|Period 1: Run-In|Lack of Efficacy|0|||
129766923|NCT03253796|467111910|FG002|Period 1: Run-In|Lack of Efficacy|0|||
129766924|NCT03253796|467111911|FG003|Period 1: Run-In|Lack of Efficacy|0|||
129766925|NCT03253796|467111912|FG004|Period 1: Run-In|Lack of Efficacy|0|||
129766926|NCT03253796|467111908|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
129766927|NCT03253796|467111909|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
129766928|NCT03253796|467111910|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
129766929|NCT03253796|467111911|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
129766930|NCT03253796|467111912|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
129766931|NCT03253796|467111908|FG000|Period 1: Run-In|Protocol Violation|5|||
129766932|NCT03253796|467111909|FG001|Period 1: Run-In|Protocol Violation|0|||
129766933|NCT03253796|467111910|FG002|Period 1: Run-In|Protocol Violation|0|||
129766934|NCT03253796|467111911|FG003|Period 1: Run-In|Protocol Violation|0|||
129766935|NCT03253796|467111912|FG004|Period 1: Run-In|Protocol Violation|0|||
129766936|NCT03253796|467111908|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
129766937|NCT03253796|467111909|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
129766938|NCT03253796|467111910|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
129766939|NCT03253796|467111911|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
129766940|NCT03253796|467111912|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
129766941|NCT03253796|467111908|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129766942|NCT03253796|467111909|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129766943|NCT03253796|467111910|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
129766944|NCT03253796|467111911|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129766945|NCT03253796|467111912|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
129766946|NCT03253796|467111908|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129766947|NCT03253796|467111909|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129766948|NCT03253796|467111910|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
129766949|NCT03253796|467111911|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129766950|NCT03253796|467111912|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
129766951|NCT03253796|467111908|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129766952|NCT03253796|467111909|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129766953|NCT03253796|467111910|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
129766954|NCT03253796|467111911|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
129766955|NCT03253796|467111912|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
129766956|NCT03253796|467111908|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129766957|NCT03253796|467111909|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129766958|NCT03253796|467111910|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
129766959|NCT03253796|467111911|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129766960|NCT03253796|467111912|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
129766961|NCT03253796|467111908|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
129766962|NCT03253796|467111909|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
129766963|NCT03253796|467111910|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
129766964|NCT03253796|467111911|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
129766965|NCT03253796|467111912|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
129766966|NCT03253796|467111908|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129766967|NCT03253796|467111909|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129766968|NCT03253796|467111910|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129766969|NCT03253796|467111911|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
129766970|NCT03253796|467111912|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
129766971|NCT01075243|467111916|FG000|Overall Study|Lost to Follow-up|5|||
129766972|NCT01075243|467111917|FG001|Overall Study|Lost to Follow-up|2|||
129766973|NCT01075243|467111918|FG002|Overall Study|Lost to Follow-up|0|||
129766974|NCT01075243|467111916|FG000|Overall Study|Withdrawal by Subject|1|||
129766975|NCT01075243|467111917|FG001|Overall Study|Withdrawal by Subject|1|||
129766976|NCT01075243|467111918|FG002|Overall Study|Withdrawal by Subject|0|||
129766977|NCT03094416|467111921|FG000|Run-in|Screening failure|8|||
129766978|NCT03094416|467111921|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
129766979|NCT03094416|467111921|FG000|Run-in|Withdrawal by Subject|3|||
129766980|NCT03094416|467111921|FG000|Treatment Period|Withdrawal by Subject|2|||
129766981|NCT01668784|467111922|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
129766982|NCT01668784|467111923|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
129766983|NCT01668784|467111922|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
129766984|NCT01668784|467111923|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
129766985|NCT01668784|467111922|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
129766986|NCT01668784|467111923|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
129766987|NCT01668784|467111922|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
129766988|NCT01668784|467111923|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
129766989|NCT01668784|467111922|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
129766990|NCT01668784|467111923|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
129766991|NCT01668784|467111922|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
129766992|NCT01668784|467111923|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
129766993|NCT01668784|467111922|FG000|Treatment Period|Disease Progression|316|||
129766994|NCT01668784|467111923|FG001|Treatment Period|Disease Progression|293|||
129766995|NCT01668784|467111922|FG000|Treatment Period|Study Drug Toxicity|46|||
129766996|NCT01668784|467111923|FG001|Treatment Period|Study Drug Toxicity|53|||
129766997|NCT01668784|467111922|FG000|Treatment Period|Death|1|||
129676138|NCT00071981|466776397|FG001|Overall Study|No protocol therapy|5|||
129676139|NCT00071981|466776398|FG002|Overall Study|No protocol therapy|1|||
129676140|NCT00071981|466776399|FG003|Overall Study|No protocol therapy|0|||
129676141|NCT00071981|466776396|FG000|Overall Study|others (not specified in the study)|0|||
129676142|NCT00071981|466776397|FG001|Overall Study|others (not specified in the study)|2|||
129676143|NCT00071981|466776398|FG002|Overall Study|others (not specified in the study)|2|||
129676144|NCT00071981|466776399|FG003|Overall Study|others (not specified in the study)|0|||
129676145|NCT01123655|466776400|FG000|Overall Study|Medication for RA had to be changed|1|||
129676146|NCT01123655|466776401|FG001|Overall Study|Medication for RA had to be changed|0|||
129676147|NCT01123655|466776402|FG002|Overall Study|Medication for RA had to be changed|0|||
129676148|NCT01123655|466776400|FG000|Overall Study|new illness|0|||
129676149|NCT01123655|466776401|FG001|Overall Study|new illness|1|||
129676150|NCT01123655|466776402|FG002|Overall Study|new illness|0|||
129676151|NCT01123655|466776400|FG000|Overall Study|began prohibitive drug|0|||
129676152|NCT01123655|466776401|FG001|Overall Study|began prohibitive drug|0|||
129676153|NCT01123655|466776402|FG002|Overall Study|began prohibitive drug|1|||
129676154|NCT00885118|466776405|FG000|Overall Study|Adverse Event|1|||
129676155|NCT00885118|466776406|FG001|Overall Study|Adverse Event|0|||
129676156|NCT00885118|466776407|FG002|Overall Study|Adverse Event|0|||
129676157|NCT00885118|466776408|FG003|Overall Study|Adverse Event|0|||
129676158|NCT00885118|466776409|FG004|Overall Study|Adverse Event|0|||
129676159|NCT00885118|466776405|FG000|Overall Study|Withdrawal by Subject|0|||
129676160|NCT00885118|466776406|FG001|Overall Study|Withdrawal by Subject|0|||
129676161|NCT00885118|466776407|FG002|Overall Study|Withdrawal by Subject|0|||
129676162|NCT00885118|466776408|FG003|Overall Study|Withdrawal by Subject|0|||
129676163|NCT00885118|466776409|FG004|Overall Study|Withdrawal by Subject|1|||
129676164|NCT00885118|466776405|FG000|Overall Study|Other reason not defined above|0|||
129676165|NCT00885118|466776406|FG001|Overall Study|Other reason not defined above|0|||
129676166|NCT00885118|466776407|FG002|Overall Study|Other reason not defined above|1|||
129676167|NCT00885118|466776408|FG003|Overall Study|Other reason not defined above|0|||
129676168|NCT00885118|466776409|FG004|Overall Study|Other reason not defined above|0|||
129676169|NCT02814526|466776414|FG000|Overall Study|Adverse Event|4|||
129676170|NCT02814526|466776415|FG001|Overall Study|Adverse Event|3|||
129676171|NCT02814526|466776414|FG000|Overall Study|Death|1|||
129676172|NCT02814526|466776415|FG001|Overall Study|Death|1|||
129676173|NCT02814526|466776414|FG000|Overall Study|Lost to Follow-up|3|||
129676174|NCT02814526|466776415|FG001|Overall Study|Lost to Follow-up|4|||
129676175|NCT02814526|466776414|FG000|Overall Study|non site physician decision|1|||
129676176|NCT02814526|466776415|FG001|Overall Study|non site physician decision|0|||
129676177|NCT02814526|466776414|FG000|Overall Study|participant noncompliance|1|||
129676178|NCT02814526|466776415|FG001|Overall Study|participant noncompliance|1|||
129676179|NCT02814526|466776414|FG000|Overall Study|Withdrawal by Subject|20|||
129676180|NCT02814526|466776415|FG001|Overall Study|Withdrawal by Subject|14|||
129676181|NCT02814526|466776414|FG000|Overall Study|safety risk|2|||
129676182|NCT02814526|466776415|FG001|Overall Study|safety risk|1|||
129676183|NCT02814526|466776414|FG000|Overall Study|early termination-study terminated|1|||
129676184|NCT02814526|466776415|FG001|Overall Study|early termination-study terminated|2|||
129676185|NCT02814526|466776414|FG000|Overall Study|Other|0|||
129676186|NCT02814526|466776415|FG001|Overall Study|Other|4|||
129676187|NCT03883386|466776416|FG000|First Assignment|Lost to Follow-up|1|||
129676188|NCT03883386|466776417|FG001|First Assignment|Lost to Follow-up|0|||
129676189|NCT03883386|466776416|FG000|First Assignment|Withdrawal by Subject|1|||
129676190|NCT03883386|466776417|FG001|First Assignment|Withdrawal by Subject|1|||
129676191|NCT00251758|466776418|FG000|Overall Study|Adverse Event|7|||
129676192|NCT00251758|466776419|FG001|Overall Study|Adverse Event|9|||
129676193|NCT00251758|466776420|FG002|Overall Study|Adverse Event|11|||
129676194|NCT00251758|466776418|FG000|Overall Study|Lost to Follow-up|4|||
129676195|NCT00251758|466776419|FG001|Overall Study|Lost to Follow-up|2|||
129676196|NCT00251758|466776420|FG002|Overall Study|Lost to Follow-up|5|||
129676197|NCT00251758|466776418|FG000|Overall Study|Withdrawal by Subject|13|||
129676198|NCT00251758|466776419|FG001|Overall Study|Withdrawal by Subject|7|||
129676199|NCT00251758|466776420|FG002|Overall Study|Withdrawal by Subject|3|||
129676200|NCT00251758|466776418|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129676201|NCT00251758|466776419|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
129676202|NCT00251758|466776420|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
129766998|NCT01668784|467111923|FG001|Treatment Period|Death|1|||
129766999|NCT01668784|467111922|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
129767000|NCT01668784|467111923|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
129676203|NCT00251758|466776418|FG000|Overall Study|Lack of Efficacy|3|||
129676204|NCT00251758|466776419|FG001|Overall Study|Lack of Efficacy|0|||
129676205|NCT00251758|466776420|FG002|Overall Study|Lack of Efficacy|0|||
129676206|NCT00251758|466776418|FG000|Overall Study|Noncompliant|0|||
129676207|NCT00251758|466776419|FG001|Overall Study|Noncompliant|2|||
129676208|NCT00251758|466776420|FG002|Overall Study|Noncompliant|2|||
129676209|NCT00251758|466776418|FG000|Overall Study|Pregnancy|0|||
129676210|NCT00251758|466776419|FG001|Overall Study|Pregnancy|1|||
129676211|NCT00251758|466776420|FG002|Overall Study|Pregnancy|0|||
129676212|NCT00251758|466776418|FG000|Overall Study|Per Subject Request|0|||
129676213|NCT00251758|466776419|FG001|Overall Study|Per Subject Request|0|||
129676214|NCT00251758|466776420|FG002|Overall Study|Per Subject Request|1|||
129676215|NCT00251758|466776418|FG000|Overall Study|Per Investigator Request|1|||
129676216|NCT00251758|466776419|FG001|Overall Study|Per Investigator Request|0|||
129676217|NCT00251758|466776420|FG002|Overall Study|Per Investigator Request|0|||
129676218|NCT01387269|466776423|FG000|Overall Study|Death|38|||
129676219|NCT01387269|466776424|FG001|Overall Study|Death|20|||
129676220|NCT01387269|466776423|FG000|Overall Study|Other|8|||
129676221|NCT01387269|466776424|FG001|Overall Study|Other|7|||
129676222|NCT01387269|466776423|FG000|Overall Study|Unrelated AE|12|||
129676223|NCT01387269|466776424|FG001|Overall Study|Unrelated AE|3|||
129676224|NCT01387269|466776423|FG000|Overall Study|Withdrawal by patient|32|||
129676225|NCT01387269|466776424|FG001|Overall Study|Withdrawal by patient|10|||
129676226|NCT01387269|466776423|FG000|Overall Study|Study drug-related AE|1|||
129676227|NCT01387269|466776424|FG001|Overall Study|Study drug-related AE|0|||
129676228|NCT01387269|466776423|FG000|Overall Study|Lost to Follow-up|1|||
129676229|NCT01387269|466776424|FG001|Overall Study|Lost to Follow-up|0|||
129676230|NCT03054428|466776425|FG000|Overall Study|Physician Decision|0|||
129676231|NCT03054428|466776426|FG001|Overall Study|Physician Decision|1|||
129676232|NCT03054428|466776427|FG002|Overall Study|Physician Decision|1|||
129676233|NCT03054428|466776425|FG000|Overall Study|Lack of Efficacy|3|||
129676234|NCT03054428|466776426|FG001|Overall Study|Lack of Efficacy|1|||
129676235|NCT03054428|466776427|FG002|Overall Study|Lack of Efficacy|0|||
129676236|NCT03054428|466776425|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
129676237|NCT03054428|466776426|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
129676238|NCT03054428|466776427|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
129676239|NCT03054428|466776425|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
129676240|NCT03054428|466776426|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
129676241|NCT03054428|466776427|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
129676242|NCT03054428|466776425|FG000|Overall Study|Transitioned to OLE study|76|||
129676243|NCT03054428|466776426|FG001|Overall Study|Transitioned to OLE study|76|||
129676244|NCT03054428|466776427|FG002|Overall Study|Transitioned to OLE study|73|||
129676245|NCT03054428|466776425|FG000|Overall Study|Withdrawal by Subject|3|||
129676246|NCT03054428|466776426|FG001|Overall Study|Withdrawal by Subject|2|||
129676247|NCT03054428|466776427|FG002|Overall Study|Withdrawal by Subject|3|||
129676248|NCT03054428|466776425|FG000|Overall Study|Lost to Follow-up|0|||
129676249|NCT03054428|466776426|FG001|Overall Study|Lost to Follow-up|0|||
129676250|NCT03054428|466776427|FG002|Overall Study|Lost to Follow-up|1|||
129676251|NCT03092752|466776428|FG000|Overall Study|Aged <40 years|14209|||
129676252|NCT03092752|466776428|FG000|Overall Study|At least one claim with T2DM|61299|||
129676253|NCT03092752|466776428|FG000|Overall Study|Having no claim of study drugs|29282|||
129676254|NCT03092752|466776428|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
129676255|NCT03092752|466776428|FG000|Overall Study|<6 month history|245900|||
129676256|NCT01499810|466776436|FG000|Overall Study|Lost to Follow-up|10|||
129676257|NCT01499810|466776436|FG000|Overall Study|Protocol Violation|1|||
129676258|NCT01499810|466776436|FG000|Overall Study|Withdrawal by Subject|1|||
129676259|NCT01884597|466776437|FG000|Overall Study|Adverse Event|0|||
129676260|NCT01884597|466776438|FG001|Overall Study|Adverse Event|0|||
129676261|NCT01884597|466776439|FG002|Overall Study|Adverse Event|1|||
129676262|NCT01884597|466776437|FG000|Overall Study|Lack of Efficacy|1|||
129676263|NCT01884597|466776438|FG001|Overall Study|Lack of Efficacy|0|||
129676264|NCT01884597|466776439|FG002|Overall Study|Lack of Efficacy|0|||
129676265|NCT01884597|466776437|FG000|Overall Study|Death|0|||
129676266|NCT01884597|466776438|FG001|Overall Study|Death|1|||
129676267|NCT01884597|466776439|FG002|Overall Study|Death|0|||
129676268|NCT03082729|466776440|FG000|Overall Study|Lost to Follow-up|7|||
129676269|NCT03082729|466776440|FG000|Overall Study|Physician Decision|2|||
129676270|NCT03082729|466776440|FG000|Overall Study|Withdrawal by Subject|1|||
129676271|NCT03082729|466776440|FG000|Overall Study|Lack of Efficacy|9|||
129676272|NCT03082729|466776440|FG000|Overall Study|Adverse Event|4|||
129676273|NCT03082729|466776440|FG000|Overall Study|Protocol Violation|6|||
129676274|NCT03082729|466776440|FG000|Overall Study|Fear of study procedure|1|||
129676275|NCT03082729|466776440|FG000|Overall Study|Scheduling conflict|1|||
129676276|NCT01093846|466776441|FG000|Overall Study|Adverse Event|0|||
129676277|NCT01093846|466776442|FG001|Overall Study|Adverse Event|0|||
129676278|NCT01093846|466776443|FG002|Overall Study|Adverse Event|1|||
129676279|NCT01093846|466776441|FG000|Overall Study|Lack of Efficacy|0|||
129676280|NCT01093846|466776442|FG001|Overall Study|Lack of Efficacy|0|||
129676281|NCT01093846|466776443|FG002|Overall Study|Lack of Efficacy|4|||
129676282|NCT01093846|466776441|FG000|Overall Study|Condition no longer required study drug|1|||
129676283|NCT01093846|466776442|FG001|Overall Study|Condition no longer required study drug|1|||
129676284|NCT01093846|466776443|FG002|Overall Study|Condition no longer required study drug|1|||
129676285|NCT01093846|466776441|FG000|Overall Study|Administrative Problems|18|||
129676286|NCT01093846|466776442|FG001|Overall Study|Administrative Problems|17|||
129676287|NCT01093846|466776443|FG002|Overall Study|Administrative Problems|15|||
129676288|NCT00666237|466776446|FG000|Overall Study|Death|5|||
129676289|NCT00666237|466776447|FG001|Overall Study|Death|5|||
129676290|NCT00666237|466776446|FG000|Overall Study|Lost to Follow-up|29|||
129676291|NCT00666237|466776447|FG001|Overall Study|Lost to Follow-up|25|||
129676292|NCT03321721|466776448|FG000|Overall Study|Lost to Follow-up|4|||
129676293|NCT03321721|466776449|FG001|Overall Study|Lost to Follow-up|8|||
129676294|NCT03321721|466776450|FG002|Overall Study|Lost to Follow-up|11|||
129676295|NCT01416571|466776451|FG000|Overall Study|Lost to Follow-up|2|||
129676296|NCT03353220|466776452|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
129676297|NCT03353220|466776453|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
129676298|NCT01673386|466778173|FG000|Overall Study|Study terminated by sponsor|16|||
129676299|NCT01673386|466778174|FG001|Overall Study|Study terminated by sponsor|22|||
129676300|NCT01673386|466778173|FG000|Overall Study|Adverse Event|5|||
129676301|NCT01673386|466778174|FG001|Overall Study|Adverse Event|2|||
129676302|NCT01673386|466778173|FG000|Overall Study|Progressive disease|4|||
129676303|NCT01673386|466778174|FG001|Overall Study|Progressive disease|1|||
129676304|NCT01673386|466778173|FG000|Overall Study|Withdrawal by Subject|0|||
129676305|NCT01673386|466778174|FG001|Overall Study|Withdrawal by Subject|2|||
129676306|NCT00336544|466778178|FG000|Overall Study|Lack of Efficacy|8|||
129676307|NCT00336544|466778179|FG001|Overall Study|Lack of Efficacy|5|||
129676308|NCT00336544|466778178|FG000|Overall Study|Adverse Event|4|||
129676309|NCT00336544|466778179|FG001|Overall Study|Adverse Event|9|||
129676310|NCT00336544|466778178|FG000|Overall Study|Withdrawal by Subject|4|||
129676311|NCT00336544|466778179|FG001|Overall Study|Withdrawal by Subject|3|||
129676312|NCT00336544|466778178|FG000|Overall Study|Other|3|||
129676313|NCT00336544|466778179|FG001|Overall Study|Other|5|||
129676314|NCT01649765|466778180|FG000|Overall Study|Adverse Event|5|||
129676315|NCT01649765|466778181|FG001|Overall Study|Adverse Event|3|||
129676316|NCT01649765|466778180|FG000|Overall Study|Lack of Efficacy|1|||
129676317|NCT01649765|466778181|FG001|Overall Study|Lack of Efficacy|1|||
129676318|NCT01649765|466778180|FG000|Overall Study|Physician Decision|0|||
129676319|NCT01649765|466778181|FG001|Overall Study|Physician Decision|3|||
129676320|NCT01649765|466778180|FG000|Overall Study|Protocol Violation|1|||
129676321|NCT01649765|466778181|FG001|Overall Study|Protocol Violation|0|||
129676322|NCT01649765|466778180|FG000|Overall Study|Withdrawal by Subject|2|||
129676323|NCT01649765|466778181|FG001|Overall Study|Withdrawal by Subject|1|||
129676324|NCT00715208|466778182|FG000|Overall Study|Withdrawal by Subject|1|||
129676325|NCT00715208|466778183|FG001|Overall Study|Withdrawal by Subject|1|||
129676326|NCT00715208|466778182|FG000|Overall Study|Adverse Event|0|||
129676327|NCT00715208|466778183|FG001|Overall Study|Adverse Event|6|||
129676328|NCT00715208|466778182|FG000|Overall Study|Lack of Efficacy|0|||
129676329|NCT00715208|466778183|FG001|Overall Study|Lack of Efficacy|2|||
129676330|NCT01648764|466778184|FG000|Overall Study|Progressive Disease|0|||
129676331|NCT01648764|466778185|FG001|Overall Study|Progressive Disease|1|||
129676332|NCT01648764|466778186|FG002|Overall Study|Progressive Disease|0|||
129676333|NCT01648764|466778187|FG003|Overall Study|Progressive Disease|0|||
129676334|NCT01648764|466778188|FG004|Overall Study|Progressive Disease|0|||
129676335|NCT01648764|466778189|FG005|Overall Study|Progressive Disease|1|||
129676336|NCT01648764|466778190|FG006|Overall Study|Progressive Disease|1|||
129676337|NCT01648764|466778191|FG007|Overall Study|Progressive Disease|0|||
129676338|NCT01648764|466778192|FG008|Overall Study|Progressive Disease|0|||
129676339|NCT01648764|466778193|FG009|Overall Study|Progressive Disease|2|||
129767001|NCT01668784|467111922|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
129767002|NCT01668784|467111923|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
129676340|NCT01648764|466778194|FG010|Overall Study|Progressive Disease|0|||
129676341|NCT01648764|466778195|FG011|Overall Study|Progressive Disease|1|||
129676342|NCT01648764|466778196|FG012|Overall Study|Progressive Disease|2|||
129676343|NCT01648764|466778197|FG013|Overall Study|Progressive Disease|1|||
129676344|NCT01648764|466778184|FG000|Overall Study|Adverse Event|0|||
129676345|NCT01648764|466778185|FG001|Overall Study|Adverse Event|0|||
129676346|NCT01648764|466778186|FG002|Overall Study|Adverse Event|0|||
129676347|NCT01648764|466778187|FG003|Overall Study|Adverse Event|0|||
129676348|NCT01648764|466778188|FG004|Overall Study|Adverse Event|0|||
129676349|NCT01648764|466778189|FG005|Overall Study|Adverse Event|1|||
129767003|NCT01668784|467111922|FG000|Treatment Period|Withdrawal by Subject|5|||
129767004|NCT01668784|467111923|FG001|Treatment Period|Withdrawal by Subject|3|||
129767005|NCT01668784|467111922|FG000|Treatment Period|Maximal Clinical Benefit|3|||
129767006|NCT01668784|467111923|FG001|Treatment Period|Maximal Clinical Benefit|3|||
129767007|NCT01668784|467111922|FG000|Treatment Period|Other|2|||
129767008|NCT01668784|467111923|FG001|Treatment Period|Other|8|||
129767009|NCT01668784|467111922|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
129767010|NCT01668784|467111923|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
129767011|NCT03804528|467111931|FG000|Overall Study|Time Commitment|18|||
129767012|NCT03804528|467111931|FG000|Overall Study|Health Reasons|5|||
129767013|NCT04607005|467111932|FG000|Overall Study|Adverse Event|0|||
129767014|NCT04607005|467111933|FG001|Overall Study|Adverse Event|1|||
129767015|NCT04607005|467111932|FG000|Overall Study|Lack of Efficacy|1|||
129767016|NCT04607005|467111933|FG001|Overall Study|Lack of Efficacy|6|||
129767017|NCT04607005|467111932|FG000|Overall Study|Withdrawal by Subject|4|||
129767018|NCT04607005|467111933|FG001|Overall Study|Withdrawal by Subject|9|||
129767019|NCT04607005|467111932|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
129767020|NCT04607005|467111933|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
129767021|NCT02331134|467111934|FG000|Overall Study|Withdrawal by Subject|1|||
129767022|NCT04825574|467111936|FG000|Overall Study|Commercial treatment became available|1|||
129767023|NCT04825574|467111936|FG000|Overall Study|Disease progression|1|||
129767024|NCT04272242|467111939|FG000|Overall Study|Withdrawal by Subject|3|||
129767025|NCT04272242|467111939|FG000|Overall Study|Lost to Follow-up|1|||
129767026|NCT04272242|467111939|FG000|Overall Study|Adverse Event|1|||
129767027|NCT04944992|467113981|FG000|Overall Study|Lost to Follow-up|1|||
129767028|NCT04944992|467113982|FG001|Overall Study|Lost to Follow-up|1|||
129767029|NCT04944992|467113981|FG000|Overall Study|Physician Decision|1|||
129767030|NCT04944992|467113982|FG001|Overall Study|Physician Decision|0|||
129767031|NCT04944992|467113981|FG000|Overall Study|Withdrawal by Subject|6|||
129767032|NCT04944992|467113982|FG001|Overall Study|Withdrawal by Subject|1|||
129767033|NCT01295814|467113983|FG000|Overall Study|Lack of Efficacy|0|||
129767034|NCT01295814|467113984|FG001|Overall Study|Lack of Efficacy|2|||
129767035|NCT01295814|467113983|FG000|Overall Study|Withdrawal by Subject|2|||
129767036|NCT01295814|467113984|FG001|Overall Study|Withdrawal by Subject|0|||
129767037|NCT03414983|467113985|FG000|Pre-Treatment|Other reasons|1|||
129767038|NCT03414983|467113986|FG001|Pre-Treatment|Other reasons|0|||
129767039|NCT03414983|467113985|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129767040|NCT03414983|467113986|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
129767041|NCT03414983|467113985|FG000|Pre-Treatment|Participant withdrew consent|1|||
129767042|NCT03414983|467113986|FG001|Pre-Treatment|Participant withdrew consent|3|||
129767043|NCT03414983|467113985|FG000|Treatment|Participant withdrew consent|4|||
129767044|NCT03414983|467113986|FG001|Treatment|Participant withdrew consent|3|||
129767045|NCT03414983|467113985|FG000|Treatment|Participant request to discontinue study treatment|8|||
129767046|NCT03414983|467113986|FG001|Treatment|Participant request to discontinue study treatment|10|||
129767047|NCT03414983|467113985|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
129767048|NCT03414983|467113986|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
129767049|NCT03414983|467113985|FG000|Treatment|Death|0|||
129767050|NCT03414983|467113986|FG001|Treatment|Death|1|||
129767051|NCT03414983|467113985|FG000|Treatment|Study Drug Toxicity|10|||
129767052|NCT03414983|467113986|FG001|Treatment|Study Drug Toxicity|5|||
129767053|NCT03414983|467113985|FG000|Treatment|Disease Progression|75|||
129767054|NCT03414983|467113986|FG001|Treatment|Disease Progression|29|||
129767055|NCT03414983|467113985|FG000|Treatment|Not reported|1|||
129767056|NCT03414983|467113986|FG001|Treatment|Not reported|0|||
129767057|NCT03414983|467113985|FG000|Treatment|Other reasons|3|||
129767058|NCT03414983|467113986|FG001|Treatment|Other reasons|2|||
129767059|NCT03414983|467113985|FG000|Treatment|Poor/non-compliance|2|||
129767060|NCT03414983|467113986|FG001|Treatment|Poor/non-compliance|0|||
129767061|NCT03414983|467113985|FG000|Treatment|Maximum clinical benefit|5|||
129767062|NCT03414983|467113986|FG001|Treatment|Maximum clinical benefit|9|||
129767063|NCT03414983|467113985|FG000|Treatment|Lost to Follow-up|0|||
129767064|NCT03414983|467113986|FG001|Treatment|Lost to Follow-up|1|||
129767065|NCT03414983|467113985|FG000|Treatment|Administrative reasons by sponsor|1|||
129767066|NCT03414983|467113986|FG001|Treatment|Administrative reasons by sponsor|0|||
129767067|NCT00303069|467113987|FG000|Overall Study|Lost to Follow-up|1|||
129767068|NCT00303069|467113988|FG001|Overall Study|Lost to Follow-up|0|||
129767069|NCT00303069|467113989|FG002|Overall Study|Lost to Follow-up|0|||
129767070|NCT00303069|467113990|FG003|Overall Study|Lost to Follow-up|2|||
129767071|NCT00303069|467113987|FG000|Overall Study|subject moved|1|||
129767072|NCT00303069|467113988|FG001|Overall Study|subject moved|0|||
129767073|NCT00303069|467113989|FG002|Overall Study|subject moved|0|||
129767074|NCT00303069|467113990|FG003|Overall Study|subject moved|0|||
129767075|NCT00303069|467113987|FG000|Overall Study|Recruitment into Army Reserves|0|||
129767076|NCT00303069|467113988|FG001|Overall Study|Recruitment into Army Reserves|0|||
129767077|NCT00303069|467113989|FG002|Overall Study|Recruitment into Army Reserves|1|||
129676350|NCT01648764|466778190|FG006|Overall Study|Adverse Event|0|||
129676351|NCT01648764|466778191|FG007|Overall Study|Adverse Event|0|||
129676352|NCT01648764|466778192|FG008|Overall Study|Adverse Event|0|||
129676353|NCT01648764|466778193|FG009|Overall Study|Adverse Event|1|||
129676354|NCT01648764|466778194|FG010|Overall Study|Adverse Event|0|||
129676355|NCT01648764|466778195|FG011|Overall Study|Adverse Event|3|||
129676356|NCT01648764|466778196|FG012|Overall Study|Adverse Event|1|||
129676357|NCT01648764|466778197|FG013|Overall Study|Adverse Event|1|||
129676358|NCT01648764|466778184|FG000|Overall Study|Death|0|||
129676359|NCT01648764|466778185|FG001|Overall Study|Death|0|||
129676360|NCT01648764|466778186|FG002|Overall Study|Death|0|||
129676361|NCT01648764|466778187|FG003|Overall Study|Death|0|||
129676362|NCT01648764|466778188|FG004|Overall Study|Death|0|||
129676363|NCT01648764|466778189|FG005|Overall Study|Death|0|||
129676364|NCT01648764|466778190|FG006|Overall Study|Death|1|||
129676365|NCT01648764|466778191|FG007|Overall Study|Death|0|||
129676366|NCT01648764|466778192|FG008|Overall Study|Death|0|||
129676367|NCT01648764|466778193|FG009|Overall Study|Death|0|||
129676368|NCT01648764|466778194|FG010|Overall Study|Death|0|||
129676369|NCT01648764|466778195|FG011|Overall Study|Death|0|||
129676370|NCT01648764|466778196|FG012|Overall Study|Death|0|||
129676371|NCT01648764|466778197|FG013|Overall Study|Death|1|||
129676372|NCT01648764|466778184|FG000|Overall Study|Withdrawal by Subject|0|||
129676373|NCT01648764|466778185|FG001|Overall Study|Withdrawal by Subject|0|||
129676374|NCT01648764|466778186|FG002|Overall Study|Withdrawal by Subject|0|||
129676375|NCT01648764|466778187|FG003|Overall Study|Withdrawal by Subject|0|||
129676376|NCT01648764|466778188|FG004|Overall Study|Withdrawal by Subject|0|||
129676377|NCT01648764|466778189|FG005|Overall Study|Withdrawal by Subject|0|||
129676378|NCT01648764|466778190|FG006|Overall Study|Withdrawal by Subject|2|||
129676379|NCT01648764|466778191|FG007|Overall Study|Withdrawal by Subject|0|||
129676380|NCT01648764|466778192|FG008|Overall Study|Withdrawal by Subject|0|||
129676381|NCT01648764|466778193|FG009|Overall Study|Withdrawal by Subject|0|||
129676382|NCT01648764|466778194|FG010|Overall Study|Withdrawal by Subject|0|||
129676383|NCT01648764|466778195|FG011|Overall Study|Withdrawal by Subject|0|||
129676384|NCT01648764|466778196|FG012|Overall Study|Withdrawal by Subject|1|||
129676385|NCT01648764|466778197|FG013|Overall Study|Withdrawal by Subject|0|||
129676386|NCT01648764|466778184|FG000|Overall Study|Investigator Decision|0|||
129676387|NCT01648764|466778185|FG001|Overall Study|Investigator Decision|0|||
129676388|NCT01648764|466778186|FG002|Overall Study|Investigator Decision|0|||
129676389|NCT01648764|466778187|FG003|Overall Study|Investigator Decision|0|||
129676390|NCT01648764|466778188|FG004|Overall Study|Investigator Decision|0|||
129676391|NCT01648764|466778189|FG005|Overall Study|Investigator Decision|0|||
129676392|NCT01648764|466778190|FG006|Overall Study|Investigator Decision|1|||
129676393|NCT01648764|466778191|FG007|Overall Study|Investigator Decision|0|||
129676394|NCT01648764|466778192|FG008|Overall Study|Investigator Decision|0|||
129676395|NCT01648764|466778193|FG009|Overall Study|Investigator Decision|0|||
129676396|NCT01648764|466778194|FG010|Overall Study|Investigator Decision|0|||
129676397|NCT01648764|466778195|FG011|Overall Study|Investigator Decision|1|||
129547198|NCT03506425|466296161|FG001|Overall Study|Withdrawal by Subject|0|||
129676398|NCT01648764|466778196|FG012|Overall Study|Investigator Decision|0|||
129676399|NCT01648764|466778197|FG013|Overall Study|Investigator Decision|0|||
129676400|NCT01715831|466778198|FG000|Overall Study|Adverse Event|1|||
129676401|NCT00316004|466778199|FG000|Overall Study|Subject was not given study fluid.|14|||
129676402|NCT00316004|466778200|FG001|Overall Study|Subject was not given study fluid.|14|||
129676403|NCT00316004|466778201|FG002|Overall Study|Subject was not given study fluid.|21|||
129676404|NCT01118299|466778204|FG000|Overall Study|Death|7|||
129676405|NCT01118299|466778205|FG001|Overall Study|Death|5|||
129676406|NCT01118299|466778204|FG000|Overall Study|Withdrawal by Subject|8|||
129676407|NCT01118299|466778205|FG001|Overall Study|Withdrawal by Subject|8|||
129676408|NCT01118299|466778204|FG000|Overall Study|Lost to Follow-up|2|||
129767078|NCT00303069|467113990|FG003|Overall Study|Recruitment into Army Reserves|0|||
129767079|NCT00092417|467113991|FG000|Overall Study|Lost to Follow-up|2|||
129767080|NCT00092417|467113992|FG001|Overall Study|Lost to Follow-up|0|||
129767081|NCT00092417|467113991|FG000|Overall Study|Withdrawal by Subject|2|||
129767082|NCT00092417|467113992|FG001|Overall Study|Withdrawal by Subject|1|||
129767083|NCT00092417|467113991|FG000|Overall Study|Other|1|||
129767084|NCT00092417|467113992|FG001|Overall Study|Other|0|||
129767085|NCT00751296|467113994|FG000|Overall Study|Adverse Event|2|||
129767086|NCT03780244|467114004|FG000|Overall Study|Lost to Follow-up|1|||
129767087|NCT03780244|467114005|FG001|Overall Study|Lost to Follow-up|0|||
129767088|NCT00804908|467114008|FG000|Overall Study|Other|115|||
129767089|NCT00804908|467114009|FG001|Overall Study|Other|116|||
129767090|NCT00804908|467114010|FG002|Overall Study|Other|114|||
129767091|NCT03181932|467114011|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
129767092|NCT03181932|467114012|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
129767093|NCT03181932|467114011|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
129767094|NCT03181932|467114012|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
129767095|NCT03181932|467114011|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
129767096|NCT03181932|467114012|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
129767097|NCT03181932|467114011|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
129767098|NCT03181932|467114012|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
129767099|NCT03181932|467114011|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
129767100|NCT03181932|467114012|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
129767101|NCT03181932|467114011|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
129767102|NCT03181932|467114012|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
129767103|NCT03181932|467114011|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
129767104|NCT03181932|467114012|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
129767105|NCT03181932|467114011|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
129767106|NCT03181932|467114012|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
129767107|NCT03181932|467114011|FG000|Period 2 (Open-label Period)|Reason missing|2|||
129767108|NCT03181932|467114012|FG001|Period 2 (Open-label Period)|Reason missing|0|||
129767109|NCT02220920|467114014|FG000|Overall Study|Adverse Event|1|||
129767110|NCT02220920|467114015|FG001|Overall Study|Adverse Event|0|||
129767111|NCT02220920|467114014|FG000|Overall Study|Lack of Efficacy|0|||
129767112|NCT02220920|467114015|FG001|Overall Study|Lack of Efficacy|1|||
129767113|NCT02220920|467114014|FG000|Overall Study|Withdrawal by Subject|1|||
129767114|NCT02220920|467114015|FG001|Overall Study|Withdrawal by Subject|0|||
129767115|NCT02220920|467114014|FG000|Overall Study|Conflict with the stopping criteria|1|||
129767116|NCT02220920|467114015|FG001|Overall Study|Conflict with the stopping criteria|2|||
129767117|NCT01112917|467114016|FG000|Overall Study|Death|2|||
129767118|NCT01112917|467114017|FG001|Overall Study|Death|11|||
129767119|NCT01112917|467114016|FG000|Overall Study|Lost to Follow-up|1|||
129676409|NCT01118299|466778205|FG001|Overall Study|Lost to Follow-up|1|||
129676410|NCT01118299|466778204|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
129676411|NCT01118299|466778205|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
129676412|NCT00784875|466778206|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
129676413|NCT00784875|466778207|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
129676414|NCT00784875|466778208|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
129676415|NCT00784875|466778209|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
129676416|NCT00784875|466778206|FG000|Period A - Baseline|Adverse Event|0|||
129676417|NCT00784875|466778207|FG001|Period A - Baseline|Adverse Event|0|||
129676418|NCT00784875|466778208|FG002|Period A - Baseline|Adverse Event|0|||
129676419|NCT00784875|466778209|FG003|Period A - Baseline|Adverse Event|8|||
129676420|NCT00784875|466778206|FG000|Period A - Baseline|Protocol Violation|0|||
129676421|NCT00784875|466778207|FG001|Period A - Baseline|Protocol Violation|0|||
129676422|NCT00784875|466778208|FG002|Period A - Baseline|Protocol Violation|0|||
129676423|NCT00784875|466778209|FG003|Period A - Baseline|Protocol Violation|25|||
129676424|NCT00784875|466778206|FG000|Period A - Baseline|Withdrawal by Subject|0|||
129676425|NCT00784875|466778207|FG001|Period A - Baseline|Withdrawal by Subject|0|||
129676426|NCT00784875|466778208|FG002|Period A - Baseline|Withdrawal by Subject|0|||
129676427|NCT00784875|466778209|FG003|Period A - Baseline|Withdrawal by Subject|27|||
129676428|NCT00784875|466778206|FG000|Period A - Baseline|Physician Decision|0|||
129676429|NCT00784875|466778207|FG001|Period A - Baseline|Physician Decision|0|||
129676430|NCT00784875|466778208|FG002|Period A - Baseline|Physician Decision|0|||
129676431|NCT00784875|466778209|FG003|Period A - Baseline|Physician Decision|2|||
129676432|NCT00784875|466778206|FG000|Period A - Baseline|Sponsor Decision|0|||
129676433|NCT00784875|466778207|FG001|Period A - Baseline|Sponsor Decision|0|||
129676434|NCT00784875|466778208|FG002|Period A - Baseline|Sponsor Decision|0|||
129676435|NCT00784875|466778209|FG003|Period A - Baseline|Sponsor Decision|113|||
129676436|NCT00784875|466778206|FG000|Period A - Baseline|Lost to Follow-up|0|||
129676437|NCT00784875|466778207|FG001|Period A - Baseline|Lost to Follow-up|0|||
129676438|NCT00784875|466778208|FG002|Period A - Baseline|Lost to Follow-up|0|||
129676439|NCT00784875|466778209|FG003|Period A - Baseline|Lost to Follow-up|2|||
129676440|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
129676441|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
129676442|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
129676443|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
129676444|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
129676445|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
129676446|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
129676447|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
129676448|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
129676449|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
129676450|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
129676451|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
129676452|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
129676453|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
129676454|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
129676455|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
129676456|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
129676457|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
129676458|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
129676459|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
129676460|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
129676461|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
129676462|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
129676463|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
129676464|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
129676465|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
129676466|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
129767120|NCT01112917|467114017|FG001|Overall Study|Lost to Follow-up|1|||
129767121|NCT01112917|467114016|FG000|Overall Study|Withdrawal by Subject|1|||
129767122|NCT01112917|467114017|FG001|Overall Study|Withdrawal by Subject|3|||
129767123|NCT01112917|467114016|FG000|Overall Study|Unable to Convert Filter|3|||
129767124|NCT01112917|467114017|FG001|Overall Study|Unable to Convert Filter|0|||
129767125|NCT02177123|467114018|FG000|Overall Study|Lost to Follow-up|6|||
129767126|NCT02177123|467114018|FG000|Overall Study|Withdrawal by Subject|4|||
129767127|NCT02177123|467114018|FG000|Overall Study|Adverse Event|4|||
129767128|NCT02177123|467114018|FG000|Overall Study|Physician Decision|3|||
129767129|NCT02177123|467114018|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
129767130|NCT02177123|467114018|FG000|Overall Study|Excluded for medical reasons|2|||
129767131|NCT02177123|467114018|FG000|Overall Study|Death|1|||
129767132|NCT02177123|467114018|FG000|Overall Study|Other|1|||
129767133|NCT02177123|467114018|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
129767134|NCT06271993|467114025|FG000|Overall Study|Not reactive to histamine|5|||
129767135|NCT06271993|467114026|FG001|Overall Study|Not reactive to histamine|5|||
129767136|NCT06271993|467114027|FG002|Overall Study|Not reactive to histamine|5|||
129767137|NCT03566511|467114028|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
129767138|NCT03566511|467114029|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
129767139|NCT02939287|467114035|FG000|Overall Study|met exclusion criteria|1|||
129767140|NCT02939287|467114036|FG001|Overall Study|met exclusion criteria|1|||
129767141|NCT02939287|467114037|FG002|Overall Study|met exclusion criteria|1|||
129767142|NCT02939287|467114035|FG000|Overall Study|Did not complete survey|2|||
129767143|NCT02939287|467114036|FG001|Overall Study|Did not complete survey|2|||
129767144|NCT02939287|467114037|FG002|Overall Study|Did not complete survey|0|||
129767145|NCT02939287|467114035|FG000|Overall Study|Withdrawal by Subject|1|||
129767146|NCT02939287|467114036|FG001|Overall Study|Withdrawal by Subject|1|||
129767147|NCT02939287|467114037|FG002|Overall Study|Withdrawal by Subject|0|||
129767148|NCT00981656|467114038|FG000|Overall Study|Protocol Violation|1|||
129767149|NCT00981656|467114038|FG000|Overall Study|Did not start protocol treatment|2|||
129547199|NCT03506425|466296162|FG002|Overall Study|Withdrawal by Subject|1|||
129767150|NCT00687596|467114039|FG000|Overall Study|Adverse Event (AE)|10|||
129767151|NCT00687596|467114040|FG001|Overall Study|Adverse Event (AE)|3|||
129767152|NCT00687596|467114039|FG000|Overall Study|Radiological Disease Progression|6|||
129767153|NCT00687596|467114040|FG001|Overall Study|Radiological Disease Progression|2|||
129767154|NCT00687596|467114039|FG000|Overall Study|Clinical Disease Progression|1|||
129767155|NCT00687596|467114040|FG001|Overall Study|Clinical Disease Progression|3|||
129767156|NCT00687596|467114039|FG000|Overall Study|Investigator Discretion|3|||
129767157|NCT00687596|467114040|FG001|Overall Study|Investigator Discretion|1|||
129767158|NCT00687596|467114039|FG000|Overall Study|Sponsor Terminated Study|6|||
129767159|NCT00687596|467114040|FG001|Overall Study|Sponsor Terminated Study|17|||
129767160|NCT03466658|467114043|FG000|Overall Study|Withdrawal by Subject|3|||
129767161|NCT00129402|467114044|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129767162|NCT00129402|467114045|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
129767163|NCT00129402|467114046|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
129767164|NCT00129402|467114047|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129767165|NCT00129402|467114048|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129767166|NCT00129402|467114049|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
129767167|NCT00129402|467114050|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
129767168|NCT00129402|467114044|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129767169|NCT00129402|467114045|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129767170|NCT00129402|467114046|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129767171|NCT00129402|467114047|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129767172|NCT00129402|467114048|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129767173|NCT00129402|467114049|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
129767174|NCT00129402|467114050|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
129767175|NCT00129402|467114044|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129767176|NCT00129402|467114045|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129767177|NCT00129402|467114046|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129767178|NCT00129402|467114047|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
129767179|NCT00129402|467114048|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129767180|NCT00129402|467114049|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129767181|NCT00129402|467114050|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
129767182|NCT00129402|467114044|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129767183|NCT00129402|467114045|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129767184|NCT00129402|467114046|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
129767185|NCT00129402|467114047|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129676467|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
129676468|NCT00784875|466778206|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
129676469|NCT00784875|466778207|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
129676470|NCT00784875|466778208|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
129676471|NCT00784875|466778209|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
129676472|NCT00784875|466778206|FG000|Period C|Adverse Event|1|||
129676473|NCT00784875|466778207|FG001|Period C|Adverse Event|0|||
129676474|NCT00784875|466778208|FG002|Period C|Adverse Event|4|||
129676475|NCT00784875|466778209|FG003|Period C|Adverse Event|2|||
129676476|NCT00784875|466778206|FG000|Period C|Protocol Violation|0|||
129676477|NCT00784875|466778207|FG001|Period C|Protocol Violation|0|||
129676478|NCT00784875|466778208|FG002|Period C|Protocol Violation|1|||
129676479|NCT00784875|466778209|FG003|Period C|Protocol Violation|2|||
129676480|NCT00784875|466778206|FG000|Period C|Lack of Efficacy|0|||
129676481|NCT00784875|466778207|FG001|Period C|Lack of Efficacy|0|||
129676482|NCT00784875|466778208|FG002|Period C|Lack of Efficacy|1|||
129676483|NCT00784875|466778209|FG003|Period C|Lack of Efficacy|0|||
129676484|NCT00784875|466778206|FG000|Period C|Withdrawal by Subject|1|||
129676485|NCT00784875|466778207|FG001|Period C|Withdrawal by Subject|1|||
129676486|NCT00784875|466778208|FG002|Period C|Withdrawal by Subject|2|||
129676487|NCT00784875|466778209|FG003|Period C|Withdrawal by Subject|0|||
129676488|NCT00784875|466778206|FG000|Period C|Physician Decision|0|||
129676489|NCT00784875|466778207|FG001|Period C|Physician Decision|0|||
129676490|NCT00784875|466778208|FG002|Period C|Physician Decision|1|||
129676491|NCT00784875|466778209|FG003|Period C|Physician Decision|1|||
129676492|NCT00784875|466778206|FG000|Period C|Sponsor Decision|5|||
129676493|NCT00784875|466778207|FG001|Period C|Sponsor Decision|5|||
129676494|NCT00784875|466778208|FG002|Period C|Sponsor Decision|4|||
129676495|NCT00784875|466778209|FG003|Period C|Sponsor Decision|2|||
129676496|NCT00784875|466778206|FG000|Period D|Adverse Event|0|||
129676497|NCT00784875|466778207|FG001|Period D|Adverse Event|2|||
129767186|NCT00129402|467114048|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
129767187|NCT00129402|467114049|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129767188|NCT00129402|467114050|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
129676498|NCT00784875|466778208|FG002|Period D|Adverse Event|2|||
129676499|NCT00784875|466778209|FG003|Period D|Adverse Event|0|||
129676500|NCT00784875|466778206|FG000|Period D|Protocol Violation|1|||
129676501|NCT00784875|466778207|FG001|Period D|Protocol Violation|0|||
129676502|NCT00784875|466778208|FG002|Period D|Protocol Violation|0|||
129676503|NCT00784875|466778209|FG003|Period D|Protocol Violation|0|||
129676504|NCT00784875|466778206|FG000|Period D|Withdrawal by Subject|2|||
129676505|NCT00784875|466778207|FG001|Period D|Withdrawal by Subject|0|||
129676506|NCT00784875|466778208|FG002|Period D|Withdrawal by Subject|2|||
129676507|NCT00784875|466778209|FG003|Period D|Withdrawal by Subject|0|||
129676508|NCT00784875|466778206|FG000|Period D|Physician Decision|0|||
129676509|NCT00784875|466778207|FG001|Period D|Physician Decision|1|||
129676510|NCT00784875|466778208|FG002|Period D|Physician Decision|0|||
129676511|NCT00784875|466778209|FG003|Period D|Physician Decision|0|||
129676512|NCT00784875|466778206|FG000|Period D|Sponsor Decision|1|||
129676513|NCT00784875|466778207|FG001|Period D|Sponsor Decision|1|||
129676514|NCT00784875|466778208|FG002|Period D|Sponsor Decision|1|||
129676515|NCT00784875|466778209|FG003|Period D|Sponsor Decision|0|||
129676516|NCT00784875|466778206|FG000|Period D|Lost to Follow-up|1|||
129676517|NCT00784875|466778207|FG001|Period D|Lost to Follow-up|0|||
129676518|NCT00784875|466778208|FG002|Period D|Lost to Follow-up|1|||
129676519|NCT00784875|466778209|FG003|Period D|Lost to Follow-up|1|||
129676520|NCT03743194|466778210|FG000|Overall Study|Protocol Violation|7|||
129676521|NCT03743194|466778211|FG001|Overall Study|Protocol Violation|7|||
129676522|NCT03743194|466778210|FG000|Overall Study|Physician Decision|0|||
129676523|NCT03743194|466778211|FG001|Overall Study|Physician Decision|2|||
129676524|NCT01829347|466778214|FG000|VTI-210|Death|5|||
129676525|NCT01829347|466778215|FG001|VTI-210|Death|3|||
129676526|NCT01829347|466778214|FG000|VTI-210|Withdrawal by Subject|1|||
129676527|NCT01829347|466778215|FG001|VTI-210|Withdrawal by Subject|0|||
129676528|NCT01829347|466778214|FG000|VTI-210E|Death|2|||
129676529|NCT01829347|466778215|FG001|VTI-210E|Death|1|||
129676530|NCT01829347|466778214|FG000|VTI-210E|Study terminated prematurely|1|||
129676531|NCT01829347|466778215|FG001|VTI-210E|Study terminated prematurely|5|||
129676532|NCT04018066|466778216|FG000|Overall Study|participants started taking medications during the study period|3|||
129676533|NCT04018066|466778216|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
129676534|NCT03817528|466778217|FG000|Overall Study|Withdrawal by Subject|1|||
129676535|NCT03817528|466778217|FG000|Overall Study|Adverse Event|2|||
129676536|NCT01027949|466778219|FG000|Overall Study|Death|174|||
129676537|NCT01027949|466778219|FG000|Overall Study|Progressive Disease|163|||
129676538|NCT01027949|466778219|FG000|Overall Study|Adverse Event|172|||
129676539|NCT01027949|466778219|FG000|Overall Study|Withdrawal by Subject|113|||
129676540|NCT01027949|466778219|FG000|Overall Study|Lost to Follow-up|17|||
129676541|NCT01027949|466778219|FG000|Overall Study|Protocol Violation|13|||
129676542|NCT01027949|466778219|FG000|Overall Study|PI Decision|8|||
129676543|NCT01027949|466778219|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
129676544|NCT01027949|466778219|FG000|Overall Study|Non-compliance with Study Procedures|7|||
129676545|NCT01027949|466778219|FG000|Overall Study|Lung Transplant|5|||
129676546|NCT01027949|466778219|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
129676547|NCT01027949|466778219|FG000|Overall Study|Use of Excluded Medication|2|||
129676548|NCT01027949|466778219|FG000|Overall Study|Patient Self-discontinuation|1|||
129676549|NCT01027949|466778219|FG000|Overall Study|Pregnancy|1|||
129676550|NCT01027949|466778219|FG000|Overall Study|Surgery|1|||
129676551|NCT02152007|466778231|FG000|Overall Study|Withdrawal by Subject|1|||
129767189|NCT00129402|467114044|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129767190|NCT00129402|467114045|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129767191|NCT00129402|467114046|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
129767192|NCT00129402|467114047|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129767193|NCT00129402|467114048|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129767194|NCT00129402|467114049|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129767195|NCT00129402|467114050|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
129767196|NCT00129402|467114044|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129767197|NCT00129402|467114045|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129767198|NCT00129402|467114046|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
129767199|NCT00129402|467114047|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129767200|NCT00129402|467114048|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129767201|NCT00129402|467114049|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
129767202|NCT00129402|467114050|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
129767203|NCT00129402|467114044|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129767204|NCT00129402|467114045|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129767205|NCT00129402|467114046|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
129767206|NCT00129402|467114047|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129767207|NCT00129402|467114048|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129767208|NCT00129402|467114049|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129767209|NCT00129402|467114050|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
129767210|NCT00129402|467114044|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129767211|NCT00129402|467114045|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129767212|NCT00129402|467114046|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
129767213|NCT00129402|467114047|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129767214|NCT00129402|467114048|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129767215|NCT00129402|467114049|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
129767216|NCT00129402|467114050|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
129767217|NCT00129402|467114044|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129767218|NCT00129402|467114045|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129767219|NCT00129402|467114046|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
129547200|NCT00358670|466296165|FG000|Overall Study|Adverse Event|26|||
129547201|NCT00358670|466296166|FG001|Overall Study|Adverse Event|29|||
129547202|NCT00358670|466296165|FG000|Overall Study|Lack of Efficacy|20|||
129676552|NCT00706797|466778234|FG000|Overall Study|Lack of Efficacy|3|||
129676553|NCT00706797|466778235|FG001|Overall Study|Lack of Efficacy|0|||
129676554|NCT00706797|466778234|FG000|Overall Study|Adverse Event|0|||
129676555|NCT00706797|466778235|FG001|Overall Study|Adverse Event|3|||
129676556|NCT00706797|466778234|FG000|Overall Study|Withdrawal by Subject|8|||
129676557|NCT00706797|466778235|FG001|Overall Study|Withdrawal by Subject|1|||
129676558|NCT00706797|466778234|FG000|Overall Study|Death|1|||
129676559|NCT00706797|466778235|FG001|Overall Study|Death|0|||
129676560|NCT00706797|466778234|FG000|Overall Study|Discontinuation of study by sponsor|52|||
129676561|NCT00706797|466778235|FG001|Overall Study|Discontinuation of study by sponsor|63|||
129676562|NCT00706797|466778234|FG000|Overall Study|Protocol Violation|3|||
129676563|NCT00706797|466778235|FG001|Overall Study|Protocol Violation|2|||
129676564|NCT00706797|466778234|FG000|Overall Study|Lost to Follow-up|1|||
129676565|NCT00706797|466778235|FG001|Overall Study|Lost to Follow-up|2|||
129676566|NCT00706797|466778234|FG000|Overall Study|Other|1|||
129676567|NCT00706797|466778235|FG001|Overall Study|Other|0|||
129676568|NCT05144945|466778239|FG000|Overall Study|Withdrawal by Subject|1|||
129676569|NCT05144945|466778240|FG001|Overall Study|Withdrawal by Subject|0|||
129676570|NCT00284856|466778241|FG000|Overall Study|Adverse Event|3|||
129676571|NCT00284856|466778242|FG001|Overall Study|Adverse Event|3|||
129676572|NCT00284856|466778243|FG002|Overall Study|Adverse Event|3|||
129676573|NCT00284856|466778241|FG000|Overall Study|Lack of Efficacy|2|||
129676574|NCT00284856|466778242|FG001|Overall Study|Lack of Efficacy|1|||
129676575|NCT00284856|466778243|FG002|Overall Study|Lack of Efficacy|8|||
129676576|NCT00284856|466778241|FG000|Overall Study|Lost to Follow-up|25|||
129676577|NCT00284856|466778242|FG001|Overall Study|Lost to Follow-up|21|||
129676578|NCT00284856|466778243|FG002|Overall Study|Lost to Follow-up|22|||
129676579|NCT00284856|466778241|FG000|Overall Study|Protocol Violation|5|||
129676580|NCT00284856|466778242|FG001|Overall Study|Protocol Violation|4|||
129676581|NCT00284856|466778243|FG002|Overall Study|Protocol Violation|5|||
129676582|NCT00284856|466778241|FG000|Overall Study|Withdrawal by Subject|12|||
129676583|NCT00284856|466778242|FG001|Overall Study|Withdrawal by Subject|16|||
129676584|NCT00284856|466778243|FG002|Overall Study|Withdrawal by Subject|18|||
129676585|NCT00284856|466778241|FG000|Overall Study|Other|4|||
129676586|NCT00284856|466778242|FG001|Overall Study|Other|5|||
129676587|NCT00284856|466778243|FG002|Overall Study|Other|4|||
129676588|NCT01192815|466778244|FG000|Overall Study|Withdrawal by Subject|1|||
129676589|NCT01192815|466778244|FG000|Overall Study|Lack of Efficacy|1|||
129676590|NCT01394276|466778245|FG000|Overall Study|Related Adverse event (AEs)|15|||
129676591|NCT01394276|466778245|FG000|Overall Study|Not related AEs|9|||
129676592|NCT01394276|466778245|FG000|Overall Study|Remission of disease|2|||
129676593|NCT01394276|466778245|FG000|Overall Study|Insufficient therapeutic effect|17|||
129676594|NCT01394276|466778245|FG000|Overall Study|Insufficient compliance|9|||
129676595|NCT01394276|466778245|FG000|Overall Study|Lost to Follow-up|5|||
129676596|NCT01394276|466778245|FG000|Overall Study|Participant moved to another site|1|||
129676597|NCT01394276|466778245|FG000|Overall Study|Pregnancy|1|||
129676598|NCT01394276|466778245|FG000|Overall Study|unavailability of drug at the Hospital|2|||
129676599|NCT01394276|466778245|FG000|Overall Study|Symptoms of concurrent diseases|1|||
129676600|NCT00465179|466778246|FG000|Overall Study|Adverse Event|4|||
129676601|NCT00465179|466778246|FG000|Overall Study|Withdrawal by Subject|2|||
129676602|NCT00465179|466778246|FG000|Overall Study|Progression of Disease|47|||
129676603|NCT00262925|466778249|FG000|Overall Study|Lack of Efficacy|3|||
129676604|NCT00262925|466778249|FG000|Overall Study|Adverse Event|4|||
129676605|NCT00262925|466778249|FG000|Overall Study|Death|2|||
129676606|NCT00262925|466778249|FG000|Overall Study|alternative therapy|1|||
129676607|NCT00262925|466778249|FG000|Overall Study|Other|1|||
129676608|NCT04682301|466778250|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
129676609|NCT04682301|466778250|FG000|Overall Study|Death|2|||
129676610|NCT00560404|466778251|FG000|Overall Study|Adverse Event|2|||
129676611|NCT00560404|466778252|FG001|Overall Study|Adverse Event|3|||
129676612|NCT00560404|466778251|FG000|Overall Study|Death|3|||
129676613|NCT00560404|466778252|FG001|Overall Study|Death|3|||
129676614|NCT00560404|466778251|FG000|Overall Study|Protocol Violation|12|||
129676615|NCT00560404|466778252|FG001|Overall Study|Protocol Violation|7|||
129676616|NCT00560404|466778251|FG000|Overall Study|Administrative Reasons|1|||
129676617|NCT00560404|466778252|FG001|Overall Study|Administrative Reasons|1|||
129676618|NCT00560404|466778251|FG000|Overall Study|Withdrew Consent|4|||
129676619|NCT00560404|466778252|FG001|Overall Study|Withdrew Consent|0|||
129676620|NCT00560404|466778251|FG000|Overall Study|Failure to return|1|||
129676621|NCT00560404|466778252|FG001|Overall Study|Failure to return|2|||
129676622|NCT00560404|466778251|FG000|Overall Study|Other withdrawal reason|13|||
129676623|NCT00560404|466778252|FG001|Overall Study|Other withdrawal reason|5|||
129676624|NCT02187783|466778253|FG000|Overall Study|Adverse Event|8|||
129676625|NCT02187783|466778253|FG000|Overall Study|Death|3|||
129676626|NCT02187783|466778253|FG000|Overall Study|Progressive disease|80|||
129676627|NCT02187783|466778253|FG000|Overall Study|Protocol Violation|3|||
129676628|NCT02187783|466778253|FG000|Overall Study|Physician Decision|2|||
129767220|NCT00129402|467114047|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129767221|NCT00129402|467114048|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129767222|NCT00129402|467114049|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
129767223|NCT00129402|467114050|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
129767224|NCT00129402|467114044|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129767225|NCT00129402|467114045|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129767226|NCT00129402|467114046|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129767227|NCT00129402|467114047|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129767228|NCT00129402|467114048|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129767229|NCT00129402|467114049|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
129767230|NCT00129402|467114050|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
129767231|NCT00129402|467114044|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129767232|NCT00129402|467114045|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129767233|NCT00129402|467114046|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129767234|NCT00129402|467114047|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129767235|NCT00129402|467114048|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129767236|NCT00129402|467114049|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
129767237|NCT00129402|467114050|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
129767238|NCT00129402|467114044|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129767239|NCT00129402|467114045|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129767240|NCT00129402|467114046|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129767241|NCT00129402|467114047|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129767242|NCT00129402|467114048|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129767243|NCT00129402|467114049|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
129767244|NCT00129402|467114050|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
129767245|NCT00129402|467114044|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129767246|NCT00129402|467114045|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129767247|NCT00129402|467114046|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129767248|NCT00129402|467114047|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129767249|NCT00129402|467114048|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129767250|NCT00129402|467114049|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
129767251|NCT00129402|467114050|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
129767252|NCT00456846|467114051|FG000|Overall Study|Adverse Event|2|||
129767253|NCT00456846|467114052|FG001|Overall Study|Adverse Event|15|||
129767254|NCT00456846|467114051|FG000|Overall Study|Physician Decision|11|||
129767255|NCT00456846|467114052|FG001|Overall Study|Physician Decision|6|||
129767256|NCT00456846|467114051|FG000|Overall Study|Protocol Deviation|2|||
129767257|NCT00456846|467114052|FG001|Overall Study|Protocol Deviation|0|||
129767258|NCT00456846|467114051|FG000|Overall Study|Participant Discretion|1|||
129767259|NCT00456846|467114052|FG001|Overall Study|Participant Discretion|5|||
129767260|NCT00456846|467114051|FG000|Overall Study|Other|0|||
129767261|NCT00456846|467114052|FG001|Overall Study|Other|2|||
129767262|NCT03379818|467114053|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
129767263|NCT03379818|467114054|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
129767264|NCT03379818|467114053|FG000|Overall Study|Withdrawal by Subject|2|||
129767265|NCT03379818|467114054|FG001|Overall Study|Withdrawal by Subject|3|||
129767266|NCT03379818|467114053|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
129767267|NCT03379818|467114054|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
129767268|NCT03199976|467114056|FG000|Overall Study|Lack of Efficacy|3|||
129767269|NCT03199976|467114057|FG001|Overall Study|Lack of Efficacy|6|||
129767270|NCT03199976|467114058|FG002|Overall Study|Lack of Efficacy|13|||
129767271|NCT03199976|467114056|FG000|Overall Study|Withdrawal by Subject|1|||
129767272|NCT03199976|467114057|FG001|Overall Study|Withdrawal by Subject|0|||
129767273|NCT03199976|467114058|FG002|Overall Study|Withdrawal by Subject|0|||
129767274|NCT03199976|467114056|FG000|Overall Study|Lost to Follow-up|0|||
129676629|NCT02187783|466778253|FG000|Overall Study|Withdrawal by Subject|9|||
129676630|NCT02187783|466778253|FG000|Overall Study|Study terminated by sponsor|1|||
129676631|NCT00471497|466778254|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
129676632|NCT00471497|466778255|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
129676633|NCT00471497|466778256|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
129676634|NCT00471497|466778254|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
129676635|NCT00471497|466778255|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
129676636|NCT00471497|466778256|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
129676637|NCT00471497|466778254|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
129676638|NCT00471497|466778255|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
129676639|NCT00471497|466778256|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
129676640|NCT00471497|466778254|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
129676641|NCT00471497|466778255|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
129676642|NCT00471497|466778256|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
129676643|NCT00471497|466778254|FG000|Core Treatment Phase|Lost to Follow-up|6|||
129676644|NCT00471497|466778255|FG001|Core Treatment Phase|Lost to Follow-up|6|||
129676645|NCT00471497|466778256|FG002|Core Treatment Phase|Lost to Follow-up|3|||
129676646|NCT00471497|466778254|FG000|Core Treatment Phase|Death|3|||
129676647|NCT00471497|466778255|FG001|Core Treatment Phase|Death|9|||
129676648|NCT00471497|466778256|FG002|Core Treatment Phase|Death|3|||
129676649|NCT00471497|466778254|FG000|Core Treatment Phase|Disease Progression|10|||
129676650|NCT00471497|466778255|FG001|Core Treatment Phase|Disease Progression|2|||
129676651|NCT00471497|466778256|FG002|Core Treatment Phase|Disease Progression|4|||
129676652|NCT00471497|466778254|FG000|Core Treatment Phase|Protocol Violation|6|||
129676653|NCT00471497|466778255|FG001|Core Treatment Phase|Protocol Violation|15|||
129676654|NCT00471497|466778256|FG002|Core Treatment Phase|Protocol Violation|11|||
129676655|NCT00471497|466778254|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
129676656|NCT00471497|466778255|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
129676657|NCT00471497|466778256|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
129676658|NCT00471497|466778254|FG000|Core Treatment Phase|Administrative problems|14|||
129676659|NCT00471497|466778255|FG001|Core Treatment Phase|Administrative problems|14|||
129676660|NCT00471497|466778256|FG002|Core Treatment Phase|Administrative problems|12|||
129676661|NCT00471497|466778254|FG000|Core Treatment Phase|Adverse Event|43|||
129676662|NCT00471497|466778255|FG001|Core Treatment Phase|Adverse Event|53|||
129676663|NCT00471497|466778256|FG002|Core Treatment Phase|Adverse Event|89|||
129676664|NCT00471497|466778254|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
129676665|NCT00471497|466778255|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
129676666|NCT00471497|466778256|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
129676667|NCT00471497|466778254|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
129676668|NCT00471497|466778255|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
129676669|NCT00471497|466778256|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
129676670|NCT00471497|466778254|FG000|Extension Phase|Adverse Event|9|||
129676671|NCT00471497|466778255|FG001|Extension Phase|Adverse Event|5|||
129676672|NCT00471497|466778256|FG002|Extension Phase|Adverse Event|1|||
129676673|NCT00471497|466778254|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
129676674|NCT00471497|466778255|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
129676675|NCT00471497|466778256|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
129676676|NCT00471497|466778254|FG000|Extension Phase|Withdrawal by Subject|3|||
129676677|NCT00471497|466778255|FG001|Extension Phase|Withdrawal by Subject|1|||
129676678|NCT00471497|466778256|FG002|Extension Phase|Withdrawal by Subject|0|||
129676679|NCT00471497|466778254|FG000|Extension Phase|Lost to Follow-up|2|||
129676680|NCT00471497|466778255|FG001|Extension Phase|Lost to Follow-up|0|||
129676681|NCT00471497|466778256|FG002|Extension Phase|Lost to Follow-up|0|||
129676682|NCT00471497|466778254|FG000|Extension Phase|Death|1|||
129676683|NCT00471497|466778255|FG001|Extension Phase|Death|0|||
129676684|NCT00471497|466778256|FG002|Extension Phase|Death|0|||
129676685|NCT00471497|466778254|FG000|Extension Phase|Disease progression|2|||
129676686|NCT00471497|466778255|FG001|Extension Phase|Disease progression|0|||
129676687|NCT00471497|466778256|FG002|Extension Phase|Disease progression|0|||
129676688|NCT00471497|466778254|FG000|Extension Phase|Protocol Violation|2|||
129676689|NCT00471497|466778255|FG001|Extension Phase|Protocol Violation|2|||
129676690|NCT00471497|466778256|FG002|Extension Phase|Protocol Violation|0|||
129676691|NCT00392223|466778257|FG000|Overall Study|Adverse Event|5|||
129676692|NCT00392223|466778258|FG001|Overall Study|Adverse Event|4|||
129676693|NCT00392223|466778257|FG000|Overall Study|Lost to Follow-up|1|||
129676694|NCT00392223|466778258|FG001|Overall Study|Lost to Follow-up|4|||
129767275|NCT03199976|467114057|FG001|Overall Study|Lost to Follow-up|1|||
129767276|NCT03199976|467114058|FG002|Overall Study|Lost to Follow-up|1|||
129767277|NCT04030143|467114066|FG000|Overall Study|Adverse Event|5|||
129767278|NCT04030143|467114067|FG001|Overall Study|Adverse Event|10|||
129767279|NCT04030143|467114066|FG000|Overall Study|Lost to Follow-up|3|||
129767280|NCT04030143|467114067|FG001|Overall Study|Lost to Follow-up|7|||
129767281|NCT04030143|467114066|FG000|Overall Study|Protocol Deviation|2|||
129767282|NCT04030143|467114067|FG001|Overall Study|Protocol Deviation|2|||
129767283|NCT04030143|467114066|FG000|Overall Study|Withdrawal by Subject|16|||
129767284|NCT04030143|467114067|FG001|Overall Study|Withdrawal by Subject|18|||
129767285|NCT04030143|467114066|FG000|Overall Study|Physician Decision|1|||
129767286|NCT04030143|467114067|FG001|Overall Study|Physician Decision|1|||
129767287|NCT04030143|467114066|FG000|Overall Study|Due to Covid-19|2|||
129767288|NCT04030143|467114067|FG001|Overall Study|Due to Covid-19|3|||
129767289|NCT04030143|467114066|FG000|Overall Study|Not Due to Covid-19|1|||
129767290|NCT04030143|467114067|FG001|Overall Study|Not Due to Covid-19|1|||
129767291|NCT00412984|467114069|FG000|Overall Study|Death|331|||
129767292|NCT00412984|467114070|FG001|Overall Study|Death|349|||
129767293|NCT00412984|467114069|FG000|Overall Study|Adverse Event|679|||
129767294|NCT00412984|467114070|FG001|Overall Study|Adverse Event|738|||
129767295|NCT00412984|467114069|FG000|Overall Study|Withdrawal by Subject|921|||
129767296|NCT00412984|467114070|FG001|Overall Study|Withdrawal by Subject|989|||
129767297|NCT00412984|467114069|FG000|Overall Study|Lost to Follow-up|51|||
129767298|NCT00412984|467114070|FG001|Overall Study|Lost to Follow-up|39|||
129767299|NCT00412984|467114069|FG000|Overall Study|Poor/Noncompliance|57|||
129767300|NCT00412984|467114070|FG001|Overall Study|Poor/Noncompliance|77|||
129767301|NCT00412984|467114069|FG000|Overall Study|Pregnancy|1|||
129767302|NCT00412984|467114070|FG001|Overall Study|Pregnancy|0|||
129767303|NCT00412984|467114069|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
129767304|NCT00412984|467114070|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
129767305|NCT00412984|467114069|FG000|Overall Study|Administrative Reason by Sponsor|11|||
129767306|NCT00412984|467114070|FG001|Overall Study|Administrative Reason by Sponsor|8|||
129767307|NCT00412984|467114069|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
129767308|NCT00412984|467114070|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
129767309|NCT00412984|467114069|FG000|Overall Study|Other Reason|80|||
129767310|NCT00412984|467114070|FG001|Overall Study|Other Reason|92|||
129767311|NCT00412984|467114069|FG000|Overall Study|Not Reported|11|||
129767312|NCT00412984|467114070|FG001|Overall Study|Not Reported|12|||
129767313|NCT02383576|467114071|FG000|Overall Study|Death|53|||
129767314|NCT02383576|467114072|FG001|Overall Study|Death|33|||
129767315|NCT02383576|467114071|FG000|Overall Study|Lost to Follow-up|7|||
129767316|NCT02383576|467114072|FG001|Overall Study|Lost to Follow-up|1|||
129767317|NCT02383576|467114071|FG000|Overall Study|Withdrew Consent|1|||
129767318|NCT02383576|467114072|FG001|Overall Study|Withdrew Consent|6|||
129767319|NCT02383576|467114071|FG000|Overall Study|Investigator's Decision|0|||
129767320|NCT02383576|467114072|FG001|Overall Study|Investigator's Decision|1|||
129767321|NCT02383576|467114071|FG000|Overall Study|Administrative/Other|2|||
129767322|NCT02383576|467114072|FG001|Overall Study|Administrative/Other|4|||
129767323|NCT04218240|467114073|FG000|Overall Study|Withdrawal by Subject|6|||
129767324|NCT04218240|467114074|FG001|Overall Study|Withdrawal by Subject|0|||
129767325|NCT04218240|467114073|FG000|Overall Study|Lack of Efficacy|24|||
129767326|NCT04218240|467114074|FG001|Overall Study|Lack of Efficacy|19|||
129767327|NCT04218240|467114073|FG000|Overall Study|Physician Decision|0|||
129767328|NCT04218240|467114074|FG001|Overall Study|Physician Decision|1|||
129767329|NCT04218240|467114073|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
129767330|NCT04218240|467114074|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
129767331|NCT04914364|467114075|FG000|Overall Study|No longer eligible for study|1|||
129767332|NCT04914364|467114075|FG000|Overall Study|Lost to Follow-up|2|||
129767333|NCT04097678|467114076|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
129767334|NCT04097678|467114077|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
129767335|NCT03694678|467114078|FG000|Overall Study|Withdrawal by Subject|2|||
129767336|NCT03694678|467114079|FG001|Overall Study|Withdrawal by Subject|0|||
129767337|NCT03694678|467114078|FG000|Overall Study|Lost to Follow-up|2|||
129767338|NCT03694678|467114079|FG001|Overall Study|Lost to Follow-up|3|||
129767339|NCT02435212|467114080|FG000|Core Phase|Adverse Event|8|||
129767340|NCT02435212|467114081|FG001|Core Phase|Adverse Event|5|||
129767341|NCT02435212|467114080|FG000|Core Phase|Withdrawal by Subject|3|||
129767342|NCT02435212|467114081|FG001|Core Phase|Withdrawal by Subject|0|||
129767343|NCT02435212|467114080|FG000|Core Phase|Withdrawal by parent/guardian|9|||
129767344|NCT02435212|467114081|FG001|Core Phase|Withdrawal by parent/guardian|4|||
129767345|NCT02435212|467114080|FG000|Core Phase|Protocol Violation|1|||
129767346|NCT02435212|467114081|FG001|Core Phase|Protocol Violation|2|||
129767347|NCT02435212|467114080|FG000|Core Phase|Physician Decision|3|||
129767348|NCT02435212|467114081|FG001|Core Phase|Physician Decision|0|||
129767349|NCT02435212|467114080|FG000|Core Phase|Lost to Follow-up|0|||
129676695|NCT00392223|466778257|FG000|Overall Study|Protocol Violation|0|||
129676696|NCT00392223|466778258|FG001|Overall Study|Protocol Violation|3|||
129676697|NCT00392223|466778257|FG000|Overall Study|Withdrawal by Subject|3|||
129676698|NCT00392223|466778258|FG001|Overall Study|Withdrawal by Subject|2|||
129676699|NCT00402831|466778261|FG000|Overall Study|Lost to Follow-up|1|||
129676700|NCT00402831|466778262|FG001|Overall Study|Lost to Follow-up|2|||
129676701|NCT00402831|466778261|FG000|Overall Study|Non-compliance with protocol|0|||
129676702|NCT00402831|466778262|FG001|Overall Study|Non-compliance with protocol|1|||
129676703|NCT01114724|466778265|FG000|Overall Study|Death|8|||
129676704|NCT01114724|466778265|FG000|Overall Study|Lost to Follow-up|1|||
129676705|NCT01114724|466778265|FG000|Overall Study|Withdrawal by Subject|1|||
129676706|NCT01981616|466778274|FG000|Overall Study|Adverse Event|0|||
129676707|NCT01981616|466778275|FG001|Overall Study|Adverse Event|1|||
129676708|NCT01981616|466778274|FG000|Overall Study|Protocol Violation|1|||
129676709|NCT01981616|466778275|FG001|Overall Study|Protocol Violation|0|||
129676710|NCT01020123|466778276|FG000|Main Period|Withdrawal by Subject|6|||
129676711|NCT01020123|466778277|FG001|Main Period|Withdrawal by Subject|5|||
129676712|NCT01020123|466778278|FG002|Main Period|Withdrawal by Subject|3|||
129676713|NCT01020123|466778279|FG003|Main Period|Withdrawal by Subject|1|||
129676714|NCT01020123|466778280|FG004|Main Period|Withdrawal by Subject|6|||
129676715|NCT01020123|466778281|FG005|Main Period|Withdrawal by Subject|3|||
129676716|NCT01020123|466778282|FG006|Main Period|Withdrawal by Subject|2|||
129676717|NCT01020123|466778276|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
129676718|NCT01020123|466778277|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
129676719|NCT01020123|466778278|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
129676720|NCT01020123|466778279|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
129676721|NCT01020123|466778280|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
129676722|NCT01020123|466778281|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
129676723|NCT01020123|466778282|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
129676724|NCT01020123|466778276|FG000|Main Period|Adverse Event|5|||
129676725|NCT01020123|466778277|FG001|Main Period|Adverse Event|2|||
129676726|NCT01020123|466778278|FG002|Main Period|Adverse Event|2|||
129676727|NCT01020123|466778279|FG003|Main Period|Adverse Event|1|||
129676728|NCT01020123|466778280|FG004|Main Period|Adverse Event|1|||
129676729|NCT01020123|466778281|FG005|Main Period|Adverse Event|2|||
129676730|NCT01020123|466778282|FG006|Main Period|Adverse Event|1|||
129676731|NCT01020123|466778276|FG000|Main Period|Protocol Violation|4|||
129676732|NCT01020123|466778277|FG001|Main Period|Protocol Violation|4|||
129676733|NCT01020123|466778278|FG002|Main Period|Protocol Violation|2|||
129676734|NCT01020123|466778279|FG003|Main Period|Protocol Violation|5|||
129676735|NCT01020123|466778280|FG004|Main Period|Protocol Violation|2|||
129676736|NCT01020123|466778281|FG005|Main Period|Protocol Violation|3|||
129676737|NCT01020123|466778282|FG006|Main Period|Protocol Violation|2|||
129676738|NCT01020123|466778276|FG000|Main Period|Lost to Follow-up|0|||
129676739|NCT01020123|466778277|FG001|Main Period|Lost to Follow-up|2|||
129676740|NCT01020123|466778278|FG002|Main Period|Lost to Follow-up|0|||
129676741|NCT01020123|466778279|FG003|Main Period|Lost to Follow-up|0|||
129676742|NCT01020123|466778280|FG004|Main Period|Lost to Follow-up|0|||
129676743|NCT01020123|466778281|FG005|Main Period|Lost to Follow-up|0|||
129676744|NCT01020123|466778282|FG006|Main Period|Lost to Follow-up|0|||
129676745|NCT01020123|466778276|FG000|Main Period|Unclasified|2|||
129676746|NCT01020123|466778277|FG001|Main Period|Unclasified|0|||
129676747|NCT01020123|466778278|FG002|Main Period|Unclasified|1|||
129676748|NCT01020123|466778279|FG003|Main Period|Unclasified|0|||
129676749|NCT01020123|466778280|FG004|Main Period|Unclasified|1|||
129676750|NCT01020123|466778281|FG005|Main Period|Unclasified|3|||
129676751|NCT01020123|466778282|FG006|Main Period|Unclasified|6|||
129676752|NCT01020123|466778276|FG000|Extention Period|Withdrawal by Subject|2|||
129676753|NCT01020123|466778277|FG001|Extention Period|Withdrawal by Subject|1|||
129676754|NCT01020123|466778278|FG002|Extention Period|Withdrawal by Subject|1|||
129676755|NCT01020123|466778279|FG003|Extention Period|Withdrawal by Subject|0|||
129676756|NCT01020123|466778280|FG004|Extention Period|Withdrawal by Subject|0|||
129676757|NCT01020123|466778281|FG005|Extention Period|Withdrawal by Subject|0|||
129676758|NCT01020123|466778282|FG006|Extention Period|Withdrawal by Subject|0|||
129676759|NCT01020123|466778276|FG000|Extention Period|Adverse Event|0|||
129676760|NCT01020123|466778277|FG001|Extention Period|Adverse Event|0|||
129676761|NCT01020123|466778278|FG002|Extention Period|Adverse Event|0|||
129676762|NCT01020123|466778279|FG003|Extention Period|Adverse Event|1|||
129676763|NCT01020123|466778280|FG004|Extention Period|Adverse Event|0|||
129676764|NCT01020123|466778281|FG005|Extention Period|Adverse Event|0|||
129676765|NCT01020123|466778282|FG006|Extention Period|Adverse Event|0|||
129676766|NCT01020123|466778276|FG000|Extention Period|Protocol Violation|1|||
129676767|NCT01020123|466778277|FG001|Extention Period|Protocol Violation|1|||
129676768|NCT01020123|466778278|FG002|Extention Period|Protocol Violation|1|||
129767350|NCT02435212|467114081|FG001|Core Phase|Lost to Follow-up|1|||
129767351|NCT02435212|467114080|FG000|Core Phase|Lack of Efficacy|0|||
129767352|NCT02435212|467114081|FG001|Core Phase|Lack of Efficacy|1|||
129767353|NCT02435212|467114080|FG000|Core Phase|Recovery|1|||
129767354|NCT02435212|467114081|FG001|Core Phase|Recovery|0|||
129767355|NCT02435212|467114080|FG000|Optional Extension Phase|Adverse Event|3|||
129767356|NCT02435212|467114081|FG001|Optional Extension Phase|Adverse Event|9|||
129767357|NCT02435212|467114080|FG000|Optional Extension Phase|Physician Decision|6|||
129767358|NCT02435212|467114081|FG001|Optional Extension Phase|Physician Decision|8|||
129767359|NCT02435212|467114080|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
129767360|NCT02435212|467114081|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
129767361|NCT02435212|467114080|FG000|Optional Extension Phase|Lack of Efficacy|2|||
129767362|NCT02435212|467114081|FG001|Optional Extension Phase|Lack of Efficacy|3|||
129767363|NCT02435212|467114080|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
129767364|NCT02435212|467114081|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
129767365|NCT02435212|467114080|FG000|Optional Extension Phase|Protocol Violation|0|||
129767366|NCT02435212|467114081|FG001|Optional Extension Phase|Protocol Violation|1|||
129767367|NCT02435212|467114080|FG000|Optional Extension Phase|Recovery|1|||
129767368|NCT02435212|467114081|FG001|Optional Extension Phase|Recovery|1|||
129767369|NCT02435212|467114080|FG000|Optional Extension Phase|Death|1|||
129767370|NCT02435212|467114081|FG001|Optional Extension Phase|Death|0|||
129767371|NCT02435212|467114080|FG000|Optional Extension Phase|Technical problems|2|||
129767372|NCT02435212|467114081|FG001|Optional Extension Phase|Technical problems|0|||
129767373|NCT05966142|467114091|FG000|Overall Study|Death|3|||
129767374|NCT05966142|467114092|FG001|Overall Study|Death|3|||
129767375|NCT05966142|467114091|FG000|Overall Study|Lost to Follow-up|55|||
129676769|NCT01020123|466778279|FG003|Extention Period|Protocol Violation|0|||
129676770|NCT01020123|466778280|FG004|Extention Period|Protocol Violation|0|||
129676771|NCT01020123|466778281|FG005|Extention Period|Protocol Violation|0|||
129676772|NCT01020123|466778282|FG006|Extention Period|Protocol Violation|1|||
129676773|NCT01020123|466778276|FG000|Extention Period|Lost to Follow-up|0|||
129676774|NCT01020123|466778277|FG001|Extention Period|Lost to Follow-up|0|||
129676775|NCT01020123|466778278|FG002|Extention Period|Lost to Follow-up|0|||
129676776|NCT01020123|466778279|FG003|Extention Period|Lost to Follow-up|0|||
129676777|NCT01020123|466778280|FG004|Extention Period|Lost to Follow-up|0|||
129676778|NCT01020123|466778281|FG005|Extention Period|Lost to Follow-up|2|||
129676779|NCT01020123|466778282|FG006|Extention Period|Lost to Follow-up|0|||
129676780|NCT00094445|466778283|FG000|Overall Study|Withdrawal by Subject|3|||
129676781|NCT00094445|466778283|FG000|Overall Study|Lost to Follow-up|1|||
129676782|NCT00094445|466778283|FG000|Overall Study|Progressive Disease|2|||
129676783|NCT00769561|466778288|FG000|Overall Study|Withdrawal by Subject|2|||
129676784|NCT00769561|466778289|FG001|Overall Study|Withdrawal by Subject|2|||
129676785|NCT00769561|466778288|FG000|Overall Study|Lost to Follow-up|1|||
129676786|NCT00769561|466778289|FG001|Overall Study|Lost to Follow-up|3|||
129676787|NCT04711005|466778290|FG000|Overall Study|Withdrawal by Subject|0|||
129676788|NCT04711005|466778291|FG001|Overall Study|Withdrawal by Subject|0|||
129676789|NCT04711005|466778292|FG002|Overall Study|Withdrawal by Subject|0|||
129676790|NCT04711005|466778293|FG003|Overall Study|Withdrawal by Subject|0|||
129676791|NCT04711005|466778294|FG004|Overall Study|Withdrawal by Subject|0|||
129676792|NCT04711005|466778295|FG005|Overall Study|Withdrawal by Subject|0|||
129676793|NCT04711005|466778296|FG006|Overall Study|Withdrawal by Subject|0|||
129676794|NCT04711005|466778297|FG007|Overall Study|Withdrawal by Subject|1|||
129676795|NCT04711005|466778298|FG008|Overall Study|Withdrawal by Subject|0|||
129676796|NCT04711005|466778299|FG009|Overall Study|Withdrawal by Subject|0|||
129676797|NCT04711005|466778290|FG000|Overall Study|Physician Decision|0|||
129676798|NCT04711005|466778291|FG001|Overall Study|Physician Decision|0|||
129676799|NCT04711005|466778292|FG002|Overall Study|Physician Decision|0|||
129676800|NCT04711005|466778293|FG003|Overall Study|Physician Decision|0|||
129676801|NCT04711005|466778294|FG004|Overall Study|Physician Decision|0|||
129676802|NCT04711005|466778295|FG005|Overall Study|Physician Decision|0|||
129676803|NCT04711005|466778296|FG006|Overall Study|Physician Decision|0|||
129676804|NCT04711005|466778297|FG007|Overall Study|Physician Decision|2|||
129767376|NCT05966142|467114092|FG001|Overall Study|Lost to Follow-up|52|||
129767377|NCT05966142|467114091|FG000|Overall Study|Physician Decision|1|||
129676805|NCT04711005|466778298|FG008|Overall Study|Physician Decision|1|||
129676806|NCT04711005|466778299|FG009|Overall Study|Physician Decision|0|||
129676807|NCT03824561|466778307|FG000|Overall Study|Protocol Violation|19|||
129767378|NCT05966142|467114092|FG001|Overall Study|Physician Decision|0|||
129767379|NCT05966142|467114091|FG000|Overall Study|Withdrawal by Subject|9|||
129547203|NCT00358670|466296166|FG001|Overall Study|Lack of Efficacy|23|||
129676808|NCT01773928|466778308|FG000|Overall Study|Adverse Event|0|||
129676809|NCT01773928|466778309|FG001|Overall Study|Adverse Event|0|||
129767380|NCT05966142|467114092|FG001|Overall Study|Withdrawal by Subject|8|||
129767381|NCT05966142|467114091|FG000|Overall Study|Duplicate Enrollment|1|||
129767382|NCT05966142|467114092|FG001|Overall Study|Duplicate Enrollment|0|||
129767383|NCT05966142|467114091|FG000|Overall Study|Study Logistical Reason|1|||
129767384|NCT05966142|467114092|FG001|Overall Study|Study Logistical Reason|0|||
129767385|NCT05966142|467114091|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
129767386|NCT05966142|467114092|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
129767387|NCT04852302|467114098|FG000|Overall Study|Withdrawal by Subject|2|||
129767388|NCT04852302|467114098|FG000|Overall Study|Did not complete CALM therapy.|2|||
129767389|NCT04711850|467114099|FG000|Overall Study|Graft loss|2|||
129767390|NCT04711850|467114100|FG001|Overall Study|Graft loss|1|||
129767391|NCT04711850|467114099|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
129767392|NCT04711850|467114100|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
129767393|NCT04711850|467114099|FG000|Overall Study|Study terminated by sponsor|5|||
129767394|NCT04711850|467114100|FG001|Overall Study|Study terminated by sponsor|3|||
129767395|NCT04711850|467114099|FG000|Overall Study|Sponsor decision|0|||
129676810|NCT01773928|466778310|FG002|Overall Study|Adverse Event|0|||
129676811|NCT01773928|466778311|FG003|Overall Study|Adverse Event|0|||
129676812|NCT01773928|466778312|FG004|Overall Study|Adverse Event|0|||
129676813|NCT01773928|466778313|FG005|Overall Study|Adverse Event|0|||
129676814|NCT01773928|466778314|FG006|Overall Study|Adverse Event|0|||
129676815|NCT01773928|466778315|FG007|Overall Study|Adverse Event|1|||
129676816|NCT01773928|466778316|FG008|Overall Study|Adverse Event|0|||
129676817|NCT01773928|466778308|FG000|Overall Study|Physician Decision|0|||
129676818|NCT01773928|466778309|FG001|Overall Study|Physician Decision|0|||
129676819|NCT01773928|466778310|FG002|Overall Study|Physician Decision|0|||
129676820|NCT01773928|466778311|FG003|Overall Study|Physician Decision|1|||
129676821|NCT01773928|466778312|FG004|Overall Study|Physician Decision|0|||
129676822|NCT01773928|466778313|FG005|Overall Study|Physician Decision|0|||
129676823|NCT01773928|466778314|FG006|Overall Study|Physician Decision|0|||
129676824|NCT01773928|466778315|FG007|Overall Study|Physician Decision|0|||
129676825|NCT01773928|466778316|FG008|Overall Study|Physician Decision|0|||
129676826|NCT01773928|466778308|FG000|Overall Study|Withdrawal by Subject|5|||
129676827|NCT01773928|466778309|FG001|Overall Study|Withdrawal by Subject|4|||
129676828|NCT01773928|466778310|FG002|Overall Study|Withdrawal by Subject|4|||
129676829|NCT01773928|466778311|FG003|Overall Study|Withdrawal by Subject|4|||
129676830|NCT01773928|466778312|FG004|Overall Study|Withdrawal by Subject|7|||
129676831|NCT01773928|466778313|FG005|Overall Study|Withdrawal by Subject|1|||
129676832|NCT01773928|466778314|FG006|Overall Study|Withdrawal by Subject|0|||
129676833|NCT01773928|466778315|FG007|Overall Study|Withdrawal by Subject|0|||
129676834|NCT01773928|466778316|FG008|Overall Study|Withdrawal by Subject|1|||
129676835|NCT01773928|466778308|FG000|Overall Study|Lost to Follow-up|0|||
129676836|NCT01773928|466778309|FG001|Overall Study|Lost to Follow-up|0|||
129676837|NCT01773928|466778310|FG002|Overall Study|Lost to Follow-up|0|||
129676838|NCT01773928|466778311|FG003|Overall Study|Lost to Follow-up|0|||
129676839|NCT01773928|466778312|FG004|Overall Study|Lost to Follow-up|0|||
129676840|NCT01773928|466778313|FG005|Overall Study|Lost to Follow-up|1|||
129676841|NCT01773928|466778314|FG006|Overall Study|Lost to Follow-up|0|||
129676842|NCT01773928|466778315|FG007|Overall Study|Lost to Follow-up|0|||
129676843|NCT01773928|466778316|FG008|Overall Study|Lost to Follow-up|0|||
129676844|NCT01773928|466778308|FG000|Overall Study|Subject misrepresented age|0|||
129676845|NCT01773928|466778309|FG001|Overall Study|Subject misrepresented age|1|||
129676846|NCT01773928|466778310|FG002|Overall Study|Subject misrepresented age|0|||
129676847|NCT01773928|466778311|FG003|Overall Study|Subject misrepresented age|0|||
129676848|NCT01773928|466778312|FG004|Overall Study|Subject misrepresented age|0|||
129676849|NCT01773928|466778313|FG005|Overall Study|Subject misrepresented age|0|||
129676850|NCT01773928|466778314|FG006|Overall Study|Subject misrepresented age|0|||
129676851|NCT01773928|466778315|FG007|Overall Study|Subject misrepresented age|0|||
129676852|NCT01773928|466778316|FG008|Overall Study|Subject misrepresented age|0|||
129676853|NCT01773928|466778308|FG000|Overall Study|Subject met exclusion criteria|0|||
129767396|NCT04711850|467114100|FG001|Overall Study|Sponsor decision|2|||
129676854|NCT01773928|466778309|FG001|Overall Study|Subject met exclusion criteria|0|||
129676855|NCT01773928|466778310|FG002|Overall Study|Subject met exclusion criteria|0|||
129676856|NCT01773928|466778311|FG003|Overall Study|Subject met exclusion criteria|0|||
129676857|NCT01773928|466778312|FG004|Overall Study|Subject met exclusion criteria|0|||
129676858|NCT01773928|466778313|FG005|Overall Study|Subject met exclusion criteria|0|||
129676859|NCT01773928|466778314|FG006|Overall Study|Subject met exclusion criteria|0|||
129676860|NCT01773928|466778315|FG007|Overall Study|Subject met exclusion criteria|0|||
129767397|NCT03267277|467114101|FG000|Overall Study|Withdrawal by Subject|1|||
129767398|NCT04849364|467114102|FG000|Overall Study|Eligibility criteria not meet|0|||
129767399|NCT04849364|467114103|FG001|Overall Study|Eligibility criteria not meet|1|||
129767400|NCT04849364|467114104|FG002|Overall Study|Eligibility criteria not meet|0|||
129767401|NCT04531176|467114115|FG000|Overall Study|Study was stopped early|24|||
129767402|NCT04531176|467114116|FG001|Overall Study|Study was stopped early|26|||
129767403|NCT04531176|467114117|FG002|Overall Study|Study was stopped early|24|||
129767404|NCT00528112|467114118|FG000|Treatment up to 3 Years|Adverse Event|313|||
129767405|NCT00528112|467114119|FG001|Treatment up to 3 Years|Adverse Event|278|||
129767406|NCT00528112|467114118|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
129767407|NCT00528112|467114119|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
129767408|NCT00528112|467114118|FG000|Treatment up to 3 Years|Protocol Violation|16|||
129767409|NCT00528112|467114119|FG001|Treatment up to 3 Years|Protocol Violation|16|||
129767410|NCT00528112|467114118|FG000|Treatment up to 3 Years|Death|0|||
129767411|NCT00528112|467114119|FG001|Treatment up to 3 Years|Death|1|||
129767412|NCT00528112|467114118|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
129767413|NCT00528112|467114119|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
129767414|NCT00528112|467114118|FG000|Treatment up to 3 Years|Pregnancy|9|||
129767415|NCT00528112|467114119|FG001|Treatment up to 3 Years|Pregnancy|10|||
129767416|NCT00528112|467114118|FG000|Treatment up to 3 Years|Other reasons|186|||
129767417|NCT00528112|467114119|FG001|Treatment up to 3 Years|Other reasons|186|||
129767418|NCT00528112|467114118|FG000|Extension Phase|Withdrawal by Subject|0|||
129767419|NCT00528112|467114119|FG001|Extension Phase|Withdrawal by Subject|3|||
129767420|NCT00528112|467114118|FG000|Extension Phase|Other reasons|0|||
129767421|NCT00528112|467114119|FG001|Extension Phase|Other reasons|100|||
129767422|NCT00528112|467114118|FG000|Extension Phase|Pregnancy|0|||
129767423|NCT00528112|467114119|FG001|Extension Phase|Pregnancy|3|||
129767424|NCT00528112|467114118|FG000|Extension Phase|Lost to Follow-up|0|||
129767425|NCT00528112|467114119|FG001|Extension Phase|Lost to Follow-up|12|||
129767426|NCT00528112|467114118|FG000|Extension Phase|Death|0|||
129767427|NCT00528112|467114119|FG001|Extension Phase|Death|1|||
129767428|NCT00528112|467114118|FG000|Extension Phase|Adverse Event|0|||
129767429|NCT00528112|467114119|FG001|Extension Phase|Adverse Event|36|||
129767430|NCT00528112|467114118|FG000|Extension Phase|Protocol Violation|0|||
129767431|NCT00528112|467114119|FG001|Extension Phase|Protocol Violation|2|||
129767432|NCT00894803|467114120|FG000|Overall Study|Death|20|||
129767433|NCT00894803|467114121|FG001|Overall Study|Death|4|||
129767434|NCT00894803|467114120|FG000|Overall Study|Lost to Follow-up|0|||
129767435|NCT00894803|467114121|FG001|Overall Study|Lost to Follow-up|1|||
129767436|NCT01345240|467114123|FG000|Overall Study|Adverse Event|3|||
129767437|NCT01345240|467114124|FG001|Overall Study|Adverse Event|5|||
129767438|NCT01345240|467114125|FG002|Overall Study|Adverse Event|4|||
129767439|NCT01345240|467114126|FG003|Overall Study|Adverse Event|2|||
129767440|NCT01345240|467114127|FG004|Overall Study|Adverse Event|1|||
129767441|NCT01345240|467114123|FG000|Overall Study|Lost to Follow-up|8|||
129767442|NCT01345240|467114124|FG001|Overall Study|Lost to Follow-up|9|||
129767443|NCT01345240|467114125|FG002|Overall Study|Lost to Follow-up|14|||
129767444|NCT01345240|467114126|FG003|Overall Study|Lost to Follow-up|7|||
129767445|NCT01345240|467114127|FG004|Overall Study|Lost to Follow-up|9|||
129767446|NCT01502293|467114128|FG000|Overall Study|Progressive Disease|20|||
129767447|NCT01502293|467114129|FG001|Overall Study|Progressive Disease|12|||
129767448|NCT01502293|467114130|FG002|Overall Study|Progressive Disease|2|||
129767449|NCT01502293|467114128|FG000|Overall Study|Withdrawal by Subject|3|||
129767450|NCT01502293|467114129|FG001|Overall Study|Withdrawal by Subject|3|||
129767451|NCT01502293|467114130|FG002|Overall Study|Withdrawal by Subject|1|||
129767452|NCT01502293|467114128|FG000|Overall Study|Adverse Event|0|||
129767453|NCT01502293|467114129|FG001|Overall Study|Adverse Event|2|||
129767454|NCT01502293|467114130|FG002|Overall Study|Adverse Event|0|||
129767455|NCT01502293|467114128|FG000|Overall Study|Reason Not Specified|2|||
129767456|NCT01502293|467114129|FG001|Overall Study|Reason Not Specified|0|||
129767457|NCT01502293|467114130|FG002|Overall Study|Reason Not Specified|0|||
129767458|NCT01502293|467114128|FG000|Overall Study|Physician Decision|0|||
129767459|NCT01502293|467114129|FG001|Overall Study|Physician Decision|0|||
129767460|NCT01502293|467114130|FG002|Overall Study|Physician Decision|1|||
129767461|NCT00774046|467114133|FG000|Screening|Not eligible|56|||
129767462|NCT00774046|467114133|FG000|Enrollment|Desired other therapy/refused|28|||
129767463|NCT00774046|467114133|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
129767464|NCT02246530|467114135|FG000|Overall Study|Lost to Follow-up|4|||
129767465|NCT02246530|467114136|FG001|Overall Study|Lost to Follow-up|0|||
129767466|NCT05138653|467114137|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
129767467|NCT05138653|467114138|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767468|NCT05138653|467114139|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767469|NCT05138653|467114140|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767470|NCT05138653|467114141|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767471|NCT05138653|467114142|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767472|NCT05138653|467114143|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767473|NCT05138653|467114144|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767474|NCT05138653|467114145|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767475|NCT05138653|467114146|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767476|NCT05138653|467114147|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767477|NCT05138653|467114148|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767478|NCT05138653|467114149|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767479|NCT05138653|467114150|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767480|NCT05138653|467114151|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767481|NCT05138653|467114152|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
129767482|NCT05138653|467114137|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767483|NCT05138653|467114138|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
129767484|NCT05138653|467114139|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767485|NCT05138653|467114140|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767486|NCT05138653|467114141|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767487|NCT05138653|467114142|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767488|NCT05138653|467114143|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767489|NCT05138653|467114144|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767490|NCT05138653|467114145|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
129767491|NCT05138653|467114146|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767492|NCT05138653|467114147|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767493|NCT05138653|467114148|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767494|NCT05138653|467114149|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767495|NCT05138653|467114150|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767496|NCT05138653|467114151|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767497|NCT05138653|467114152|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
129767498|NCT05138653|467114137|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767499|NCT05138653|467114138|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
129767500|NCT05138653|467114139|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767501|NCT05138653|467114140|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767502|NCT05138653|467114141|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
129767503|NCT05138653|467114142|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767504|NCT05138653|467114143|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767505|NCT05138653|467114144|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767506|NCT05138653|467114145|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767507|NCT05138653|467114146|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767508|NCT05138653|467114147|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767509|NCT05138653|467114148|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767510|NCT05138653|467114149|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767511|NCT05138653|467114150|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767512|NCT05138653|467114151|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767513|NCT05138653|467114152|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
129767514|NCT05138653|467114137|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767515|NCT05138653|467114138|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767516|NCT05138653|467114139|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767517|NCT05138653|467114140|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767518|NCT05138653|467114141|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767519|NCT05138653|467114142|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767520|NCT05138653|467114143|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
129767521|NCT05138653|467114144|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767522|NCT05138653|467114145|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767523|NCT05138653|467114146|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767524|NCT05138653|467114147|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767525|NCT05138653|467114148|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767526|NCT05138653|467114149|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767527|NCT05138653|467114150|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767528|NCT05138653|467114151|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767529|NCT05138653|467114152|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
129767530|NCT05138653|467114137|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767531|NCT05138653|467114138|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767532|NCT05138653|467114139|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767533|NCT05138653|467114140|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767534|NCT05138653|467114141|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767535|NCT05138653|467114142|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767536|NCT05138653|467114143|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767537|NCT05138653|467114144|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767538|NCT05138653|467114145|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767539|NCT05138653|467114146|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767540|NCT05138653|467114147|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129767541|NCT05138653|467114148|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767542|NCT05138653|467114149|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129767543|NCT05138653|467114150|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767544|NCT05138653|467114151|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
129767545|NCT05138653|467114152|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
129767546|NCT05138653|467114137|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767547|NCT05138653|467114138|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767548|NCT05138653|467114139|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767549|NCT05138653|467114140|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767550|NCT05138653|467114141|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767551|NCT05138653|467114142|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767552|NCT05138653|467114143|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767553|NCT05138653|467114144|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767554|NCT05138653|467114145|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767555|NCT05138653|467114146|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767556|NCT05138653|467114147|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767557|NCT05138653|467114148|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767558|NCT05138653|467114149|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767559|NCT05138653|467114150|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767560|NCT05138653|467114151|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
129767561|NCT05138653|467114152|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
129767562|NCT05138653|467114137|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767563|NCT05138653|467114138|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767564|NCT05138653|467114139|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767565|NCT05138653|467114140|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767566|NCT05138653|467114141|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767567|NCT05138653|467114142|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767568|NCT05138653|467114143|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767569|NCT05138653|467114144|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129676861|NCT01773928|466778316|FG008|Overall Study|Subject met exclusion criteria|1|||
129676862|NCT01773928|466778308|FG000|Overall Study|Randomized, had to leave, never returned|0|||
129676863|NCT01773928|466778309|FG001|Overall Study|Randomized, had to leave, never returned|0|||
129676864|NCT01773928|466778310|FG002|Overall Study|Randomized, had to leave, never returned|0|||
129676865|NCT01773928|466778311|FG003|Overall Study|Randomized, had to leave, never returned|1|||
129676866|NCT01773928|466778312|FG004|Overall Study|Randomized, had to leave, never returned|0|||
129676867|NCT01773928|466778313|FG005|Overall Study|Randomized, had to leave, never returned|0|||
129676868|NCT01773928|466778314|FG006|Overall Study|Randomized, had to leave, never returned|0|||
129676869|NCT01773928|466778315|FG007|Overall Study|Randomized, had to leave, never returned|0|||
129676870|NCT01773928|466778316|FG008|Overall Study|Randomized, had to leave, never returned|0|||
129676871|NCT01773928|466778308|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
129676872|NCT01773928|466778309|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
129676873|NCT01773928|466778310|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
129676874|NCT01773928|466778311|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
129676875|NCT01773928|466778312|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
129676876|NCT01773928|466778313|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
129676877|NCT01773928|466778314|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
129676878|NCT01773928|466778315|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
129676879|NCT01773928|466778316|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
129676880|NCT03573297|466778318|FG000|Open Label Treatment Period|Adverse Event|67|||
129676881|NCT03573297|466778319|FG001|Open Label Treatment Period|Adverse Event|0|||
129676882|NCT03573297|466778320|FG002|Open Label Treatment Period|Adverse Event|0|||
129676883|NCT03573297|466778321|FG003|Open Label Treatment Period|Adverse Event|0|||
129676884|NCT03573297|466778318|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
129676885|NCT03573297|466778319|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
129676886|NCT03573297|466778320|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
129676887|NCT03573297|466778321|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
129676888|NCT03573297|466778318|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
129676889|NCT03573297|466778319|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
129676890|NCT03573297|466778320|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
129676891|NCT03573297|466778321|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
129676892|NCT03573297|466778318|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
129676893|NCT03573297|466778319|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
129676894|NCT03573297|466778320|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
129676895|NCT03573297|466778321|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
129676896|NCT03573297|466778318|FG000|Open Label Treatment Period|Pregnancy|1|||
129676897|NCT03573297|466778319|FG001|Open Label Treatment Period|Pregnancy|0|||
129676898|NCT03573297|466778320|FG002|Open Label Treatment Period|Pregnancy|0|||
129676899|NCT03573297|466778321|FG003|Open Label Treatment Period|Pregnancy|0|||
129676900|NCT03573297|466778318|FG000|Open Label Treatment Period|Protocol Violation|17|||
129676901|NCT03573297|466778319|FG001|Open Label Treatment Period|Protocol Violation|0|||
129676902|NCT03573297|466778320|FG002|Open Label Treatment Period|Protocol Violation|0|||
129676903|NCT03573297|466778321|FG003|Open Label Treatment Period|Protocol Violation|0|||
129676904|NCT03573297|466778318|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
129676905|NCT03573297|466778319|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
129676906|NCT03573297|466778320|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
129676907|NCT03573297|466778321|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
129676908|NCT03573297|466778318|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
129676909|NCT03573297|466778319|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
129676910|NCT03573297|466778320|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
129676911|NCT03573297|466778321|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
129676912|NCT03573297|466778318|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
129676913|NCT03573297|466778319|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
129676914|NCT03573297|466778320|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
129676915|NCT03573297|466778321|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
129676916|NCT03573297|466778318|FG000|Open Label Treatment Period|Other, Not Specified|7|||
129676917|NCT03573297|466778319|FG001|Open Label Treatment Period|Other, Not Specified|0|||
129676918|NCT03573297|466778320|FG002|Open Label Treatment Period|Other, Not Specified|0|||
129676919|NCT03573297|466778321|FG003|Open Label Treatment Period|Other, Not Specified|0|||
129676920|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
129676921|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
129676922|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
129676923|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
129676924|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129676925|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129676926|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Adverse Event|5|||
129676927|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Adverse Event|1|||
129676928|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129676929|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
129676930|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
129676931|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
129676932|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129676933|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
129676934|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
129676935|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
129676936|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129676937|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
129676938|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
129676939|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
129676940|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129676941|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
129676942|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
129676943|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
129676944|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
129676945|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
129676946|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
129676947|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
129676948|NCT03573297|466778318|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
129676949|NCT03573297|466778319|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
129676950|NCT03573297|466778320|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
129676951|NCT03573297|466778321|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
129676952|NCT02273167|466778324|FG000|Overall Study|Adverse Event|1|||
129676953|NCT02273167|466778325|FG001|Overall Study|Adverse Event|0|||
129676954|NCT02273167|466778326|FG002|Overall Study|Adverse Event|0|||
129676955|NCT02273167|466778324|FG000|Overall Study|Protocol Violation|3|||
129676956|NCT02273167|466778325|FG001|Overall Study|Protocol Violation|1|||
129676957|NCT02273167|466778326|FG002|Overall Study|Protocol Violation|1|||
129676958|NCT02273167|466778324|FG000|Overall Study|Lost to Follow-up|0|||
129676959|NCT02273167|466778325|FG001|Overall Study|Lost to Follow-up|1|||
129676960|NCT02273167|466778326|FG002|Overall Study|Lost to Follow-up|1|||
129676961|NCT02273167|466778324|FG000|Overall Study|Withdrawal by Subject|10|||
129676962|NCT02273167|466778325|FG001|Overall Study|Withdrawal by Subject|12|||
129676963|NCT02273167|466778326|FG002|Overall Study|Withdrawal by Subject|11|||
129676964|NCT02273167|466778324|FG000|Overall Study|Various|10|||
129676965|NCT02273167|466778325|FG001|Overall Study|Various|9|||
129676966|NCT02273167|466778326|FG002|Overall Study|Various|8|||
129676967|NCT02781324|466778327|FG000|Overall Study|Withdrawal by Subject|1|||
129676968|NCT02781324|466778328|FG001|Overall Study|Withdrawal by Subject|0|||
129676969|NCT02781324|466778327|FG000|Overall Study|Physician Decision|1|||
129676970|NCT02781324|466778328|FG001|Overall Study|Physician Decision|2|||
129767570|NCT05138653|467114145|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767571|NCT05138653|467114146|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767572|NCT05138653|467114147|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767573|NCT05138653|467114148|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767574|NCT05138653|467114149|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767575|NCT05138653|467114150|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
129767576|NCT05138653|467114151|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767577|NCT05138653|467114152|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
129767578|NCT01824836|467114153|FG000|Overall Study|Adverse Event|48|||
129767579|NCT01824836|467114153|FG000|Overall Study|Withdrawal by Subject|63|||
129767580|NCT01824836|467114153|FG000|Overall Study|Other complicating disease|116|||
129767581|NCT01824836|467114153|FG000|Overall Study|Disease progression|5|||
129767582|NCT01824836|467114153|FG000|Overall Study|Alternative therapy|2|||
129767583|NCT01824836|467114153|FG000|Overall Study|Depression|1|||
129767584|NCT01824836|467114153|FG000|Overall Study|Non-compliance|3|||
129767585|NCT01824836|467114153|FG000|Overall Study|Patient regained ovarian function|3|||
129767586|NCT01824836|467114153|FG000|Overall Study|Lost to Follow-up|8|||
129767587|NCT01824836|467114153|FG000|Overall Study|Physician Decision|2|||
129767588|NCT01824836|467114153|FG000|Overall Study|Research office was closed|3|||
129767589|NCT01824836|467114153|FG000|Overall Study|Relocation|3|||
129767590|NCT01824836|467114153|FG000|Overall Study|Insurance-related issue|1|||
129767591|NCT01824836|467114153|FG000|Overall Study|Transportation issue|1|||
129767592|NCT01824836|467114153|FG000|Overall Study|Patient transferred care|1|||
129767593|NCT01824836|467114153|FG000|Overall Study|Unknown reasons|4|||
129767594|NCT01824836|467114153|FG000|Overall Study|Never started treatment|16|||
129767595|NCT02608684|467116177|FG000|Overall Study|Physician Decision|2|||
129767596|NCT02608684|467116177|FG000|Overall Study|Withdrawal by Subject|1|||
129767597|NCT01972217|467116178|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129767598|NCT01972217|467116179|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
129767599|NCT01972217|467116180|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129767600|NCT01972217|467116181|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
129767601|NCT01972217|467116178|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
129767602|NCT01972217|467116179|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
129767603|NCT01972217|467116180|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
129767604|NCT01972217|467116181|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
129767605|NCT01972217|467116178|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129767606|NCT01972217|467116179|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
129767607|NCT01972217|467116180|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129767608|NCT01972217|467116181|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
129676971|NCT00661388|466778332|FG000|Overall Study|Adverse Event|14|||
129676972|NCT00661388|466778332|FG000|Overall Study|Protocol Violation|7|||
129676973|NCT00661388|466778332|FG000|Overall Study|Renal transplantation|1|||
129676974|NCT00661388|466778332|FG000|Overall Study|Dialysis initiation|1|||
129676975|NCT00661388|466778332|FG000|Overall Study|Administrative reasons|1|||
129676976|NCT03370172|466780606|FG000|Overall Study|Withdrawal by Subject|0|||
129676977|NCT03370172|466780607|FG001|Overall Study|Withdrawal by Subject|1|||
129676978|NCT01171534|466780614|FG000|Overall Study|Lost to Follow-up|0|||
129676979|NCT01171534|466780615|FG001|Overall Study|Lost to Follow-up|2|||
129676980|NCT01171534|466780614|FG000|Overall Study|screen failure|0|||
129676981|NCT01171534|466780615|FG001|Overall Study|screen failure|1|||
129676982|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
129676983|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
129676984|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
129676985|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
129676986|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
129676987|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
129676988|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
129676989|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
129676990|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
129676991|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
129676992|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
129676993|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
129767609|NCT01972217|467116178|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
129767610|NCT01972217|467116179|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
129767611|NCT01972217|467116180|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
129767612|NCT01972217|467116181|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
129767613|NCT01972217|467116178|FG000|Part B Double-blind, Randomised Period|Death|0|||
129767614|NCT01972217|467116179|FG001|Part B Double-blind, Randomised Period|Death|0|||
129767615|NCT01972217|467116180|FG002|Part B Double-blind, Randomised Period|Death|43|||
129767616|NCT01972217|467116181|FG003|Part B Double-blind, Randomised Period|Death|44|||
129767617|NCT01972217|467116178|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129767618|NCT01972217|467116179|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129767619|NCT01972217|467116180|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
129767620|NCT01972217|467116181|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
129767621|NCT01972217|467116178|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
129767622|NCT01972217|467116179|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
129767623|NCT01972217|467116180|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
129767624|NCT01972217|467116181|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
129767625|NCT01972217|467116178|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
129767626|NCT01972217|467116179|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
129767627|NCT01972217|467116180|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
129767628|NCT01972217|467116181|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
129767629|NCT01972217|467116178|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
129767630|NCT01972217|467116179|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
129767631|NCT01972217|467116180|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
129767632|NCT01972217|467116181|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
129767633|NCT02318706|467116182|FG000|Double-blind Phase|Adverse Event|7|||
129767634|NCT02318706|467116183|FG001|Double-blind Phase|Adverse Event|4|||
129767635|NCT02318706|467116184|FG002|Double-blind Phase|Adverse Event|3|||
129767636|NCT02318706|467116185|FG003|Double-blind Phase|Adverse Event|10|||
129767637|NCT02318706|467116186|FG004|Double-blind Phase|Adverse Event|0|||
129767638|NCT02318706|467116182|FG000|Double-blind Phase|Lost to Follow-up|1|||
129767639|NCT02318706|467116183|FG001|Double-blind Phase|Lost to Follow-up|0|||
129767640|NCT02318706|467116184|FG002|Double-blind Phase|Lost to Follow-up|0|||
129767641|NCT02318706|467116185|FG003|Double-blind Phase|Lost to Follow-up|0|||
129767642|NCT02318706|467116186|FG004|Double-blind Phase|Lost to Follow-up|0|||
129767643|NCT02318706|467116182|FG000|Double-blind Phase|Protocol Violation|4|||
129767644|NCT02318706|467116183|FG001|Double-blind Phase|Protocol Violation|2|||
129767645|NCT02318706|467116184|FG002|Double-blind Phase|Protocol Violation|4|||
129767646|NCT02318706|467116185|FG003|Double-blind Phase|Protocol Violation|3|||
129767647|NCT02318706|467116186|FG004|Double-blind Phase|Protocol Violation|0|||
129767648|NCT02318706|467116182|FG000|Double-blind Phase|Withdrawal by Subject|9|||
129767649|NCT02318706|467116183|FG001|Double-blind Phase|Withdrawal by Subject|5|||
129767650|NCT02318706|467116184|FG002|Double-blind Phase|Withdrawal by Subject|7|||
129767651|NCT02318706|467116185|FG003|Double-blind Phase|Withdrawal by Subject|10|||
129767652|NCT02318706|467116186|FG004|Double-blind Phase|Withdrawal by Subject|0|||
129767653|NCT02318706|467116182|FG000|Double-blind Phase|Other|4|||
129767654|NCT02318706|467116183|FG001|Double-blind Phase|Other|1|||
129767655|NCT02318706|467116184|FG002|Double-blind Phase|Other|2|||
129767656|NCT02318706|467116185|FG003|Double-blind Phase|Other|1|||
129767657|NCT02318706|467116186|FG004|Double-blind Phase|Other|0|||
129767658|NCT02318706|467116182|FG000|Double-blind Phase|Death|0|||
129767659|NCT02318706|467116183|FG001|Double-blind Phase|Death|0|||
129767660|NCT02318706|467116184|FG002|Double-blind Phase|Death|2|||
129767661|NCT02318706|467116185|FG003|Double-blind Phase|Death|0|||
129767662|NCT02318706|467116186|FG004|Double-blind Phase|Death|0|||
129767663|NCT02318706|467116182|FG000|Open-label Extension Phase|Adverse Event|0|||
129767664|NCT02318706|467116183|FG001|Open-label Extension Phase|Adverse Event|0|||
129767665|NCT02318706|467116184|FG002|Open-label Extension Phase|Adverse Event|0|||
129767666|NCT02318706|467116185|FG003|Open-label Extension Phase|Adverse Event|0|||
129767667|NCT02318706|467116186|FG004|Open-label Extension Phase|Adverse Event|21|||
129767668|NCT02318706|467116182|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
129767669|NCT02318706|467116183|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
129767670|NCT02318706|467116184|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
129767671|NCT02318706|467116185|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
129767672|NCT02318706|467116186|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
129767673|NCT02318706|467116182|FG000|Open-label Extension Phase|Death|0|||
129767674|NCT02318706|467116183|FG001|Open-label Extension Phase|Death|0|||
129767675|NCT02318706|467116184|FG002|Open-label Extension Phase|Death|0|||
129767676|NCT02318706|467116185|FG003|Open-label Extension Phase|Death|0|||
129767677|NCT02318706|467116186|FG004|Open-label Extension Phase|Death|1|||
129767678|NCT02318706|467116182|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
129767679|NCT02318706|467116183|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
129767680|NCT02318706|467116184|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
129767681|NCT02318706|467116185|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
129547204|NCT00358670|466296165|FG000|Overall Study|Protocol Violation|6|||
129676994|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
129676995|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
129676996|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
129676997|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
129676998|NCT00849056|466780616|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
129676999|NCT00849056|466780617|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
129677000|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
129677001|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
129677002|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
129677003|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
129677004|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
129677005|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
129677006|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
129677007|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
129677008|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
129677009|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
129677010|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
129677011|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
129677012|NCT00849056|466780616|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
129677013|NCT00849056|466780617|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
129677014|NCT02934178|466780621|FG000|Received Vaccination 2|Death|0|||
129677015|NCT02934178|466780622|FG001|Received Vaccination 2|Death|1|||
129677016|NCT02934178|466780621|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
129677017|NCT02934178|466780622|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
129677018|NCT01898078|466780626|FG000|Overall Study|Progressive Disease|1|||
129677019|NCT01898078|466780627|FG001|Overall Study|Progressive Disease|5|||
129677020|NCT01898078|466780626|FG000|Overall Study|Adverse Event|2|||
129677021|NCT01898078|466780627|FG001|Overall Study|Adverse Event|1|||
129677022|NCT01898078|466780626|FG000|Overall Study|Withdrawal by Subject|1|||
129677023|NCT01898078|466780627|FG001|Overall Study|Withdrawal by Subject|1|||
129677024|NCT01898078|466780626|FG000|Overall Study|Symptomatic Deterioration|2|||
129677025|NCT01898078|466780627|FG001|Overall Study|Symptomatic Deterioration|0|||
129677026|NCT01898078|466780626|FG000|Overall Study|Reason not Specified|0|||
129677027|NCT01898078|466780627|FG001|Overall Study|Reason not Specified|1|||
129677028|NCT01075048|466780628|FG000|Overall Study|Death|4|||
129677029|NCT01075048|466780629|FG001|Overall Study|Death|17|||
129677030|NCT01075048|466780630|FG002|Overall Study|Death|12|||
129677031|NCT01075048|466780628|FG000|Overall Study|Start of other or new therapy|4|||
129677032|NCT01075048|466780629|FG001|Overall Study|Start of other or new therapy|36|||
129677033|NCT01075048|466780630|FG002|Overall Study|Start of other or new therapy|46|||
129677034|NCT01075048|466780628|FG000|Overall Study|Withdrawal by Subject|1|||
129677035|NCT01075048|466780629|FG001|Overall Study|Withdrawal by Subject|6|||
129677036|NCT01075048|466780630|FG002|Overall Study|Withdrawal by Subject|3|||
129677037|NCT01075048|466780628|FG000|Overall Study|Lost to Follow-up|0|||
129677038|NCT01075048|466780629|FG001|Overall Study|Lost to Follow-up|1|||
129677039|NCT01075048|466780630|FG002|Overall Study|Lost to Follow-up|1|||
129677040|NCT01287936|466780631|FG000|Overall Study|Lost to Follow-up|0|||
129677041|NCT01287936|466780632|FG001|Overall Study|Lost to Follow-up|1|||
129677042|NCT01287936|466780633|FG002|Overall Study|Lost to Follow-up|1|||
129677043|NCT01140906|466780634|FG000|Overall Study|Adverse Event|7|||
129677044|NCT01140906|466780635|FG001|Overall Study|Adverse Event|10|||
129677045|NCT01140906|466780636|FG002|Overall Study|Adverse Event|17|||
129677046|NCT01140906|466780637|FG003|Overall Study|Adverse Event|7|||
129677047|NCT01140906|466780634|FG000|Overall Study|Lack of Efficacy|6|||
129677048|NCT01140906|466780635|FG001|Overall Study|Lack of Efficacy|8|||
129677049|NCT01140906|466780636|FG002|Overall Study|Lack of Efficacy|2|||
129677050|NCT01140906|466780637|FG003|Overall Study|Lack of Efficacy|1|||
129677051|NCT01140906|466780634|FG000|Overall Study|Non-compliance|0|||
129677052|NCT01140906|466780635|FG001|Overall Study|Non-compliance|1|||
129547205|NCT00358670|466296166|FG001|Overall Study|Protocol Violation|9|||
129677053|NCT01140906|466780636|FG002|Overall Study|Non-compliance|0|||
129677054|NCT01140906|466780637|FG003|Overall Study|Non-compliance|1|||
129677055|NCT01140906|466780634|FG000|Overall Study|Protocol Violation|5|||
129677056|NCT01140906|466780635|FG001|Overall Study|Protocol Violation|3|||
129677057|NCT01140906|466780636|FG002|Overall Study|Protocol Violation|2|||
129677058|NCT01140906|466780637|FG003|Overall Study|Protocol Violation|1|||
129677059|NCT01140906|466780634|FG000|Overall Study|Withdrawal of consent|6|||
129677060|NCT01140906|466780635|FG001|Overall Study|Withdrawal of consent|6|||
129677061|NCT01140906|466780636|FG002|Overall Study|Withdrawal of consent|2|||
129677062|NCT01140906|466780637|FG003|Overall Study|Withdrawal of consent|2|||
129677063|NCT01140906|466780634|FG000|Overall Study|Lost to Follow-up|1|||
129677064|NCT01140906|466780635|FG001|Overall Study|Lost to Follow-up|1|||
129677065|NCT01140906|466780636|FG002|Overall Study|Lost to Follow-up|0|||
129677066|NCT01140906|466780637|FG003|Overall Study|Lost to Follow-up|2|||
129677067|NCT01140906|466780634|FG000|Overall Study|Administrative or other reason|0|||
129677068|NCT01140906|466780635|FG001|Overall Study|Administrative or other reason|5|||
129677069|NCT01140906|466780636|FG002|Overall Study|Administrative or other reason|3|||
129677070|NCT01140906|466780637|FG003|Overall Study|Administrative or other reason|2|||
129677071|NCT00703534|466780638|FG000|Overall Study|Adverse Event|14|||
129677072|NCT00703534|466780639|FG001|Overall Study|Adverse Event|3|||
129677073|NCT00703534|466780638|FG000|Overall Study|Withdrawal by Subject|8|||
129677074|NCT00703534|466780639|FG001|Overall Study|Withdrawal by Subject|7|||
129677075|NCT00703534|466780638|FG000|Overall Study|Incorrect Enrollment|6|||
129677076|NCT00703534|466780639|FG001|Overall Study|Incorrect Enrollment|6|||
129677077|NCT00703534|466780638|FG000|Overall Study|Lost to Follow-up|1|||
129677078|NCT00703534|466780639|FG001|Overall Study|Lost to Follow-up|4|||
129677079|NCT00703534|466780638|FG000|Overall Study|Severe Non Compliance|1|||
129677080|NCT00703534|466780639|FG001|Overall Study|Severe Non Compliance|5|||
129677081|NCT01316614|466780640|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
129677082|NCT01316614|466780640|FG000|Overall Study|Cytology slides not available for review|4|||
129677083|NCT01316614|466780640|FG000|Overall Study|Cystic lesion|5|||
129677084|NCT01316614|466780640|FG000|Overall Study|Inadequate number of passes|2|||
129677085|NCT01316614|466780640|FG000|Overall Study|Medically unstable|1|||
129677086|NCT03427411|466780641|FG000|Overall Study|Screen failure - platelets too low|0|||
129677087|NCT03427411|466780642|FG001|Overall Study|Screen failure - platelets too low|1|||
129677088|NCT00076570|466780643|FG000|Overall Study|Drug intolerance|8|||
129677089|NCT00076570|466780644|FG001|Overall Study|Drug intolerance|8|||
129677090|NCT04889040|466780645|FG000|Overall Study|Withdrawal by Subject|3|||
129677091|NCT04889040|466780646|FG001|Overall Study|Withdrawal by Subject|3|||
129677092|NCT04889040|466780645|FG000|Overall Study|Lost to Follow-up|0|||
129677093|NCT04889040|466780646|FG001|Overall Study|Lost to Follow-up|1|||
129677094|NCT04889040|466780645|FG000|Overall Study|Adverse Event|2|||
129677095|NCT04889040|466780646|FG001|Overall Study|Adverse Event|1|||
129677096|NCT02058095|466780647|FG000|Overall Study|Adverse Event|1|||
129677097|NCT02058095|466780648|FG001|Overall Study|Adverse Event|0|||
129677098|NCT00998946|466780649|FG000|Overall Study|Lost to Follow-up|1|||
129677099|NCT00998946|466780649|FG000|Overall Study|Withdrawal by Subject|1|||
129677100|NCT00998946|466780649|FG000|Overall Study|Death|2|||
129677101|NCT00998946|466780649|FG000|Overall Study|Reason Unspecified|3|||
129677102|NCT00998946|466780649|FG000|Overall Study|Enrolled but not Dosed|2|||
129677103|NCT00977197|466780652|FG000|Overall Study|Withdrawal by Subject|3|||
129677104|NCT00977197|466780653|FG001|Overall Study|Withdrawal by Subject|4|||
129677105|NCT00977197|466780652|FG000|Overall Study|Adverse Event|3|||
129677106|NCT00977197|466780653|FG001|Overall Study|Adverse Event|1|||
129677107|NCT00977197|466780652|FG000|Overall Study|Lack of Efficacy|1|||
129677108|NCT00977197|466780653|FG001|Overall Study|Lack of Efficacy|0|||
129677109|NCT00977197|466780652|FG000|Overall Study|Lost to Follow-up|1|||
129677110|NCT00977197|466780653|FG001|Overall Study|Lost to Follow-up|3|||
129677111|NCT00977197|466780652|FG000|Overall Study|Nonadherence|1|||
129677112|NCT00977197|466780653|FG001|Overall Study|Nonadherence|1|||
129677113|NCT01432951|466780654|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
129677114|NCT00853385|466780655|FG000|Overall Study|Death|0|||
129677115|NCT00853385|466780656|FG001|Overall Study|Death|0|||
129677116|NCT00853385|466780657|FG002|Overall Study|Death|0|||
129677117|NCT00853385|466780658|FG003|Overall Study|Death|0|||
129677118|NCT00853385|466780659|FG004|Overall Study|Death|1|||
129677119|NCT00853385|466780655|FG000|Overall Study|Adverse Event|24|||
129677120|NCT00853385|466780656|FG001|Overall Study|Adverse Event|24|||
129767682|NCT02318706|467116186|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
129767683|NCT00992108|467116192|FG000|Overall Study|Lost to Follow-up|0|||
129767684|NCT00992108|467116193|FG001|Overall Study|Lost to Follow-up|1|||
129767685|NCT04639245|467116198|FG000|Overall Study|Death|1|||
129767686|NCT01702311|467116199|FG000|Overall Study|Withdrawal by Subject|3|||
129767687|NCT01702311|467116200|FG001|Overall Study|Withdrawal by Subject|2|||
129767688|NCT01702311|467116199|FG000|Overall Study|Discharge less than 24 hours|10|||
129767689|NCT01702311|467116200|FG001|Overall Study|Discharge less than 24 hours|7|||
129767690|NCT01702311|467116199|FG000|Overall Study|Physician Decision|3|||
129767691|NCT01702311|467116200|FG001|Overall Study|Physician Decision|4|||
129767692|NCT04106557|467116204|FG000|Overall Study|Physician Decision|0|||
129767693|NCT04106557|467116205|FG001|Overall Study|Physician Decision|1|||
129767694|NCT04106557|467116206|FG002|Overall Study|Physician Decision|0|||
129767695|NCT04106557|467116204|FG000|Overall Study|Protocol Violation|0|||
129767696|NCT04106557|467116205|FG001|Overall Study|Protocol Violation|1|||
129767697|NCT04106557|467116206|FG002|Overall Study|Protocol Violation|0|||
129767698|NCT01209689|467116207|FG000|Overall Study|Insufficient Therapeutic Response|7|||
129767699|NCT01209689|467116208|FG001|Overall Study|Insufficient Therapeutic Response|2|||
129767700|NCT01209689|467116207|FG000|Overall Study|Refused Treatment|8|||
129767701|NCT01209689|467116208|FG001|Overall Study|Refused Treatment|3|||
129767702|NCT01209689|467116207|FG000|Overall Study|Adverse Event|4|||
129767703|NCT01209689|467116208|FG001|Overall Study|Adverse Event|0|||
129767704|NCT01209689|467116207|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129767705|NCT01209689|467116208|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
129767706|NCT01209689|467116207|FG000|Overall Study|Failure to Return|3|||
129767707|NCT01209689|467116208|FG001|Overall Study|Failure to Return|0|||
129767708|NCT01209689|467116207|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
129767709|NCT01209689|467116208|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
129767710|NCT03175367|467116209|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129767711|NCT03175367|467116210|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129767712|NCT03175367|467116211|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
129767713|NCT03175367|467116212|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
129767714|NCT03175367|467116213|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129767715|NCT03175367|467116214|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
129767716|NCT03175367|467116215|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
129767717|NCT03175367|467116209|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129767718|NCT03175367|467116210|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129767719|NCT03175367|467116211|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129767720|NCT03175367|467116212|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129767721|NCT03175367|467116213|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
129767722|NCT03175367|467116214|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129767723|NCT03175367|467116215|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129767724|NCT03175367|467116209|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129767725|NCT03175367|467116210|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129767726|NCT03175367|467116211|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
129767727|NCT03175367|467116212|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
129767728|NCT03175367|467116213|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129767729|NCT03175367|467116214|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129767730|NCT03175367|467116215|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129767731|NCT03175367|467116209|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
129767732|NCT03175367|467116210|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
129767733|NCT03175367|467116211|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
129767734|NCT03175367|467116212|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
129767735|NCT03175367|467116213|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129767736|NCT03175367|467116214|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129767737|NCT03175367|467116215|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129767738|NCT03175367|467116209|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129767739|NCT03175367|467116210|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129767740|NCT03175367|467116211|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
129767741|NCT03175367|467116212|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129767742|NCT03175367|467116213|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
129767743|NCT03175367|467116214|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129767744|NCT03175367|467116215|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129767745|NCT03175367|467116209|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129767746|NCT03175367|467116210|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129767747|NCT03175367|467116211|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129767748|NCT03175367|467116212|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129767749|NCT03175367|467116213|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129767750|NCT03175367|467116214|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
129767751|NCT03175367|467116215|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
129767752|NCT03175367|467116209|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129767753|NCT03175367|467116210|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129767754|NCT03175367|467116211|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129767755|NCT03175367|467116212|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129767756|NCT03175367|467116213|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129767757|NCT03175367|467116214|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
129767758|NCT03175367|467116215|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
129767759|NCT02151058|467116217|FG000|Overall Study|Withdrawal by Subject|1|||
129767760|NCT02151058|467116218|FG001|Overall Study|Withdrawal by Subject|1|||
129767761|NCT02151058|467116219|FG002|Overall Study|Withdrawal by Subject|3|||
129767762|NCT02151058|467116217|FG000|Overall Study|Lost to Follow-up|1|||
129767763|NCT02151058|467116218|FG001|Overall Study|Lost to Follow-up|0|||
129767764|NCT02151058|467116219|FG002|Overall Study|Lost to Follow-up|2|||
129767765|NCT03829228|467116220|FG000|Overall Study|Protocol Violation|1|||
129767766|NCT03337477|467116221|FG000|Overall Study|not categorized into the listed ones|11|||
129767767|NCT03337477|467116222|FG001|Overall Study|not categorized into the listed ones|9|||
129767768|NCT03337477|467116221|FG000|Overall Study|Withdrawal by Subject|0|||
129767769|NCT03337477|467116222|FG001|Overall Study|Withdrawal by Subject|1|||
129767770|NCT03337477|467116221|FG000|Overall Study|Death|0|||
129767771|NCT03337477|467116222|FG001|Overall Study|Death|1|||
129767772|NCT03337477|467116221|FG000|Overall Study|Lost to Follow-up|0|||
129767773|NCT03337477|467116222|FG001|Overall Study|Lost to Follow-up|2|||
129767774|NCT01462370|467116229|FG000|Overall Study|Lack of Qualifying Event|1|||
129767775|NCT01462370|467116230|FG001|Overall Study|Lack of Qualifying Event|1|||
129767776|NCT01462370|467116229|FG000|Overall Study|Physician Decision|0|||
129767777|NCT01462370|467116230|FG001|Overall Study|Physician Decision|1|||
129767778|NCT01462370|467116229|FG000|Overall Study|Withdrawal by Subject|0|||
129767779|NCT01462370|467116230|FG001|Overall Study|Withdrawal by Subject|3|||
129767780|NCT00853307|467116231|FG000|Overall Study|Adverse Event|1|||
129767781|NCT00853307|467116232|FG001|Overall Study|Adverse Event|2|||
129767782|NCT00853307|467116231|FG000|Overall Study|Withdrawal by Subject|1|||
129767783|NCT00853307|467116232|FG001|Overall Study|Withdrawal by Subject|2|||
129767784|NCT00853307|467116231|FG000|Overall Study|Reason Not Specified|0|||
129767785|NCT00853307|467116232|FG001|Overall Study|Reason Not Specified|1|||
129767786|NCT00473564|467116233|FG000|Overall Study|robot surgery aborted in OR|23|||
129767787|NCT00674817|467116234|FG000|Period 1|Withdrawal by Subject|2|||
129767788|NCT00674817|467116234|FG000|Period 1|Protocol Violation|1|||
129767789|NCT00674817|467116234|FG000|Period 3|Adverse Event|1|||
129767790|NCT00674817|467116234|FG000|Period 3|Protocol Violation|1|||
129767791|NCT00674817|467116234|FG000|Period 4|Adverse Event|1|||
129767792|NCT03103542|467116236|FG000|Overall Study|Physician Decision|2|||
129767793|NCT03103542|467116236|FG000|Overall Study|Adverse Event|2|||
129767794|NCT03103542|467116236|FG000|Overall Study|Other|2|||
129767795|NCT03103542|467116236|FG000|Overall Study|Withdrawal by Subject|1|||
129767796|NCT03406780|467116237|FG000|Overall Study|Withdrawal by Subject|1|||
129767797|NCT03406780|467116238|FG001|Overall Study|Withdrawal by Subject|1|||
129767798|NCT03406780|467116237|FG000|Overall Study|Other|0|||
129767799|NCT03406780|467116238|FG001|Overall Study|Other|2|||
129767800|NCT03044106|467116239|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
129767801|NCT03044106|467116240|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
129767802|NCT01748292|467116241|FG000|Overall Study|Adverse Event|2|||
129767803|NCT01748292|467116242|FG001|Overall Study|Adverse Event|4|||
129767804|NCT01748292|467116241|FG000|Overall Study|Lost to Follow-up|0|||
129767805|NCT01748292|467116242|FG001|Overall Study|Lost to Follow-up|3|||
129767806|NCT01748292|467116241|FG000|Overall Study|Death|0|||
129767807|NCT01748292|467116242|FG001|Overall Study|Death|3|||
129767808|NCT01748292|467116241|FG000|Overall Study|Withdrawal by Subject|0|||
129767809|NCT01748292|467116242|FG001|Overall Study|Withdrawal by Subject|2|||
129767810|NCT03697252|467116245|FG000|Overall Study|Adverse Event|3|||
129767811|NCT03697252|467116246|FG001|Overall Study|Adverse Event|2|||
129767812|NCT03697252|467116245|FG000|Overall Study|Withdrawal by Subject|14|||
129767813|NCT03697252|467116246|FG001|Overall Study|Withdrawal by Subject|14|||
129767814|NCT03697252|467116245|FG000|Overall Study|Lost to Follow-up|0|||
129767815|NCT03697252|467116246|FG001|Overall Study|Lost to Follow-up|1|||
129767816|NCT03697252|467116245|FG000|Overall Study|Physician Decision|1|||
129767817|NCT03697252|467116246|FG001|Overall Study|Physician Decision|1|||
129767818|NCT03697252|467116245|FG000|Overall Study|Other|0|||
129767819|NCT03697252|467116246|FG001|Overall Study|Other|1|||
129767820|NCT02340026|467116247|FG000|Treatment Phase|Withdrawal by Subject|2|||
129767821|NCT02340026|467116248|FG001|Treatment Phase|Withdrawal by Subject|2|||
129767822|NCT02340026|467116247|FG000|Follow-up Phase|Lost to Follow-up|1|||
129767823|NCT02340026|467116248|FG001|Follow-up Phase|Lost to Follow-up|0|||
129767824|NCT02738801|467116260|FG000|Overall Study|Adverse Event|1|||
129767825|NCT02738801|467116261|FG001|Overall Study|Adverse Event|1|||
129767826|NCT02738801|467116260|FG000|Overall Study|Withdrawal by Subject|0|||
129767827|NCT02738801|467116261|FG001|Overall Study|Withdrawal by Subject|1|||
129767828|NCT00888134|467116276|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
129767829|NCT00888134|467116276|FG000|Follow-up|being followed for long-term survival|1|||
129767830|NCT01488890|467116279|FG000|Overall Study|Serious adverse event|2|||
129767831|NCT01488890|467116280|FG001|Overall Study|Serious adverse event|0|||
129767832|NCT01488890|467116281|FG002|Overall Study|Serious adverse event|0|||
129767833|NCT01488890|467116282|FG003|Overall Study|Serious adverse event|0|||
129767834|NCT01488890|467116279|FG000|Overall Study|Protocol Violation|3|||
129767835|NCT01488890|467116280|FG001|Overall Study|Protocol Violation|0|||
129767836|NCT01488890|467116281|FG002|Overall Study|Protocol Violation|4|||
129767837|NCT01488890|467116282|FG003|Overall Study|Protocol Violation|0|||
129767838|NCT01488890|467116279|FG000|Overall Study|Lost to Follow-up|13|||
129767839|NCT01488890|467116280|FG001|Overall Study|Lost to Follow-up|10|||
129767840|NCT01488890|467116281|FG002|Overall Study|Lost to Follow-up|20|||
129767841|NCT01488890|467116282|FG003|Overall Study|Lost to Follow-up|3|||
129767842|NCT01488890|467116279|FG000|Overall Study|Withdrawal by Subject|14|||
129767843|NCT01488890|467116280|FG001|Overall Study|Withdrawal by Subject|10|||
129767844|NCT01488890|467116281|FG002|Overall Study|Withdrawal by Subject|11|||
129767845|NCT01488890|467116282|FG003|Overall Study|Withdrawal by Subject|2|||
129767846|NCT05712460|467116283|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767847|NCT05712460|467116284|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767848|NCT05712460|467116285|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767849|NCT05712460|467116286|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767850|NCT05712460|467116287|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767851|NCT05712460|467116288|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767852|NCT05712460|467116289|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767853|NCT05712460|467116290|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
129767854|NCT05712460|467116291|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767855|NCT05712460|467116292|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767856|NCT05712460|467116293|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767857|NCT05712460|467116294|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
129767858|NCT00829426|467116299|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129767859|NCT00829426|467116300|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129767860|NCT05135767|467116303|FG000|Baseline|Lost to Follow-up|1|||
129767861|NCT05135767|467116304|FG001|Baseline|Lost to Follow-up|1|||
129767862|NCT05135767|467116303|FG000|Baseline|Withdrawal by Subject|0|||
129767863|NCT05135767|467116304|FG001|Baseline|Withdrawal by Subject|2|||
129767864|NCT05135767|467116303|FG000|Active Study Phase|Lost to Follow-up|2|||
129767865|NCT05135767|467116304|FG001|Active Study Phase|Lost to Follow-up|0|||
129767866|NCT02260934|467116310|FG000|Overall Study|Lost to Follow-up|2|||
129767867|NCT02260934|467116311|FG001|Overall Study|Lost to Follow-up|1|||
129767868|NCT02260934|467116310|FG000|Overall Study|Withdrawal by Subject|0|||
129767869|NCT02260934|467116311|FG001|Overall Study|Withdrawal by Subject|2|||
129767870|NCT02260934|467116310|FG000|Overall Study|Participant Relocated|1|||
129767871|NCT02260934|467116311|FG001|Overall Study|Participant Relocated|0|||
129767872|NCT02260934|467116310|FG000|Overall Study|Site error|0|||
129767873|NCT02260934|467116311|FG001|Overall Study|Site error|1|||
129677121|NCT00853385|466780657|FG002|Overall Study|Adverse Event|2|||
129677122|NCT00853385|466780658|FG003|Overall Study|Adverse Event|5|||
129677123|NCT00853385|466780659|FG004|Overall Study|Adverse Event|22|||
129677124|NCT00853385|466780655|FG000|Overall Study|Lack of Efficacy|6|||
129677125|NCT00853385|466780656|FG001|Overall Study|Lack of Efficacy|7|||
129677126|NCT00853385|466780657|FG002|Overall Study|Lack of Efficacy|3|||
129767874|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
129767875|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
129767876|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
129767877|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
129767878|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
129767879|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
129767880|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
129767881|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
129767882|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
129767883|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
129767884|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
129767885|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
129767886|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
129767887|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
129767888|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
129767889|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
129767890|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
129767891|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
129767892|NCT03605667|467116314|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
129767893|NCT03605667|467116315|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
129767894|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
129767895|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
129767896|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Other|6|||
129767897|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Other|8|||
129767898|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
129767899|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
129767900|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
129767901|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
129767902|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
129767903|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
129767904|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
129767905|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
129767906|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
129767907|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
129767908|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
129767909|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
129767910|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Death|0|||
129767911|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Death|2|||
129767912|NCT03605667|467116314|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
129767913|NCT03605667|467116315|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
129767914|NCT03597347|467116318|FG000|Overall Study|Withdrawal by Subject|1|||
129767915|NCT03597347|467116319|FG001|Overall Study|Withdrawal by Subject|1|||
129767916|NCT03597347|467116320|FG002|Overall Study|Withdrawal by Subject|0|||
129767917|NCT03597347|467116318|FG000|Overall Study|Withdrawal due to Covid-19|3|||
129767918|NCT03597347|467116319|FG001|Overall Study|Withdrawal due to Covid-19|0|||
129767919|NCT03597347|467116320|FG002|Overall Study|Withdrawal due to Covid-19|0|||
129767920|NCT03597347|467116318|FG000|Overall Study|Sponsor decision to terminate study|3|||
129767921|NCT03597347|467116319|FG001|Overall Study|Sponsor decision to terminate study|2|||
129767922|NCT03597347|467116320|FG002|Overall Study|Sponsor decision to terminate study|4|||
129767923|NCT00107653|467116321|FG000|Overall Study|Adverse Event|24|||
129767924|NCT00107653|467116322|FG001|Overall Study|Adverse Event|43|||
129767925|NCT00107653|467116321|FG000|Overall Study|Insufficient Therapeutic Response|25|||
129767926|NCT00107653|467116322|FG001|Overall Study|Insufficient Therapeutic Response|11|||
129767927|NCT00107653|467116321|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129767928|NCT00107653|467116322|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129767929|NCT00107653|467116321|FG000|Overall Study|Protocol Violation|1|||
129767930|NCT00107653|467116322|FG001|Overall Study|Protocol Violation|0|||
129767931|NCT00107653|467116321|FG000|Overall Study|Withdrawal by Subject|12|||
129767932|NCT00107653|467116322|FG001|Overall Study|Withdrawal by Subject|13|||
129767933|NCT00107653|467116321|FG000|Overall Study|Lost to Follow-up|13|||
129767934|NCT00107653|467116322|FG001|Overall Study|Lost to Follow-up|5|||
129767935|NCT00107653|467116321|FG000|Overall Study|Administrative Reasons|3|||
129767936|NCT00107653|467116322|FG001|Overall Study|Administrative Reasons|3|||
129767937|NCT02532517|467116326|FG000|Overall Study|Did not complete 24-Month visit|4|||
129767938|NCT02532517|467116326|FG000|Overall Study|Failed Angiographic eligibility|1|||
129767939|NCT02532517|467116326|FG000|Overall Study|Lost to Follow-up|4|||
129767940|NCT02532517|467116326|FG000|Overall Study|Withdrawal by Subject|4|||
129767941|NCT02532517|467116326|FG000|Overall Study|Death|4|||
129767942|NCT03312231|467116327|FG000|Overall Study|Lost to Follow-up|2|||
129767943|NCT03312231|467116328|FG001|Overall Study|Lost to Follow-up|6|||
129767944|NCT03312231|467116329|FG002|Overall Study|Lost to Follow-up|1|||
129767945|NCT03312231|467116330|FG003|Overall Study|Lost to Follow-up|3|||
129767946|NCT03312231|467116331|FG004|Overall Study|Lost to Follow-up|1|||
129767947|NCT03312231|467116327|FG000|Overall Study|Withdrawal by Subject|0|||
129767948|NCT03312231|467116328|FG001|Overall Study|Withdrawal by Subject|3|||
129767949|NCT03312231|467116329|FG002|Overall Study|Withdrawal by Subject|1|||
129767950|NCT03312231|467116330|FG003|Overall Study|Withdrawal by Subject|0|||
129767951|NCT03312231|467116331|FG004|Overall Study|Withdrawal by Subject|0|||
129767952|NCT03312231|467116327|FG000|Overall Study|Death|0|||
129767953|NCT03312231|467116328|FG001|Overall Study|Death|1|||
129767954|NCT03312231|467116329|FG002|Overall Study|Death|1|||
129767955|NCT03312231|467116330|FG003|Overall Study|Death|0|||
129767956|NCT03312231|467116331|FG004|Overall Study|Death|0|||
129767957|NCT03312231|467116327|FG000|Overall Study|Study Vaccination not Received|1|||
129767958|NCT03312231|467116328|FG001|Overall Study|Study Vaccination not Received|1|||
129767959|NCT03312231|467116329|FG002|Overall Study|Study Vaccination not Received|1|||
129767960|NCT03312231|467116330|FG003|Overall Study|Study Vaccination not Received|0|||
129767961|NCT03312231|467116331|FG004|Overall Study|Study Vaccination not Received|0|||
129547206|NCT00358670|466296165|FG000|Overall Study|Lost to Follow-up|4|||
129677127|NCT00853385|466780658|FG003|Overall Study|Lack of Efficacy|3|||
129677128|NCT00853385|466780659|FG004|Overall Study|Lack of Efficacy|6|||
129677129|NCT00853385|466780655|FG000|Overall Study|Lost to Follow-up|2|||
129677130|NCT00853385|466780656|FG001|Overall Study|Lost to Follow-up|1|||
129677131|NCT00853385|466780657|FG002|Overall Study|Lost to Follow-up|0|||
129677132|NCT00853385|466780658|FG003|Overall Study|Lost to Follow-up|0|||
129677133|NCT00853385|466780659|FG004|Overall Study|Lost to Follow-up|0|||
129677134|NCT00853385|466780655|FG000|Overall Study|Withdrawal by Subject|4|||
129677135|NCT00853385|466780656|FG001|Overall Study|Withdrawal by Subject|2|||
129677136|NCT00853385|466780657|FG002|Overall Study|Withdrawal by Subject|0|||
129677137|NCT00853385|466780658|FG003|Overall Study|Withdrawal by Subject|1|||
129677138|NCT00853385|466780659|FG004|Overall Study|Withdrawal by Subject|1|||
129677139|NCT00853385|466780655|FG000|Overall Study|Other|18|||
129677140|NCT00853385|466780656|FG001|Overall Study|Other|9|||
129677141|NCT00853385|466780657|FG002|Overall Study|Other|4|||
129677142|NCT00853385|466780658|FG003|Overall Study|Other|4|||
129677143|NCT00853385|466780659|FG004|Overall Study|Other|12|||
129677144|NCT02842866|466780662|FG000|Overall Study|Serious Adverse Event|0|||
129677145|NCT02842866|466780663|FG001|Overall Study|Serious Adverse Event|1|||
129677146|NCT02842866|466780662|FG000|Overall Study|Protocol Violation|4|||
129677147|NCT02842866|466780663|FG001|Overall Study|Protocol Violation|2|||
129677148|NCT02842866|466780662|FG000|Overall Study|Lost to Follow-up|2|||
129677149|NCT02842866|466780663|FG001|Overall Study|Lost to Follow-up|0|||
129677150|NCT02842866|466780662|FG000|Overall Study|Withdrawal by Subject|1|||
129677151|NCT02842866|466780663|FG001|Overall Study|Withdrawal by Subject|0|||
129677152|NCT00577408|466780664|FG000|Overall Study|Stopped attending study visits|9|||
129677153|NCT00577408|466780665|FG001|Overall Study|Stopped attending study visits|11|||
129677154|NCT00577408|466780664|FG000|Overall Study|Continued opioid use|3|||
129677155|NCT00577408|466780665|FG001|Overall Study|Continued opioid use|2|||
129677156|NCT00577408|466780664|FG000|Overall Study|Non-compliance with study meds|0|||
129677157|NCT00577408|466780665|FG001|Overall Study|Non-compliance with study meds|3|||
129677158|NCT00577408|466780664|FG000|Overall Study|Refused Oral Naltrexone|0|||
129677159|NCT00577408|466780665|FG001|Overall Study|Refused Oral Naltrexone|1|||
129677160|NCT00577408|466780664|FG000|Overall Study|Moved out of state|0|||
129677161|NCT00577408|466780665|FG001|Overall Study|Moved out of state|1|||
129677162|NCT00577408|466780664|FG000|Overall Study|Scheduling Issues|0|||
129677163|NCT00577408|466780665|FG001|Overall Study|Scheduling Issues|3|||
129677164|NCT00577408|466780664|FG000|Overall Study|Death|0|||
129677165|NCT00577408|466780665|FG001|Overall Study|Death|1|||
129677166|NCT00577408|466780664|FG000|Overall Study|Psychiatric hospitalization|0|||
129677167|NCT00577408|466780665|FG001|Overall Study|Psychiatric hospitalization|1|||
129677168|NCT00656617|466780666|FG000|Overall Study|Adverse Event|1|||
129677169|NCT00656617|466780666|FG000|Overall Study|Death|2|||
129677170|NCT00656617|466780666|FG000|Overall Study|Insurance Issues|2|||
129677171|NCT00656617|466780666|FG000|Overall Study|Move to different clinical trial|2|||
129677172|NCT02349386|466780675|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
129677173|NCT02349386|466780676|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
129677174|NCT02349386|466780677|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
129677175|NCT02349386|466780678|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
129677176|NCT02349386|466780675|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
129677177|NCT02349386|466780676|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
129677178|NCT02349386|466780677|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
129677179|NCT02349386|466780678|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
129677180|NCT02349386|466780675|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
129677181|NCT02349386|466780676|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
129677182|NCT02349386|466780677|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
129677183|NCT02349386|466780678|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
129767962|NCT03157830|467116332|FG000|Overall Study|Lost to Follow-up|1|||
129767963|NCT03157830|467116332|FG000|Overall Study|Withdrawal by Subject|1|||
129677184|NCT02349386|466780675|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
129677185|NCT02349386|466780676|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
129677186|NCT02349386|466780677|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
129677187|NCT02349386|466780678|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
129677188|NCT02349386|466780675|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
129677189|NCT02349386|466780676|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
129677190|NCT02349386|466780677|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
129677191|NCT02349386|466780678|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
129677192|NCT02349386|466780675|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
129677193|NCT02349386|466780676|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
129677194|NCT02349386|466780677|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
129677195|NCT02349386|466780678|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
129677196|NCT00676143|466780679|FG000|Overall Study|Adverse Event|34|||
129677197|NCT00676143|466780680|FG001|Overall Study|Adverse Event|60|||
129677198|NCT00676143|466780679|FG000|Overall Study|Death|4|||
129677199|NCT00676143|466780680|FG001|Overall Study|Death|4|||
129677200|NCT00676143|466780679|FG000|Overall Study|Lack of Efficacy|0|||
129677201|NCT00676143|466780680|FG001|Overall Study|Lack of Efficacy|6|||
129677202|NCT00676143|466780679|FG000|Overall Study|Lost to Follow-up|0|||
129677203|NCT00676143|466780680|FG001|Overall Study|Lost to Follow-up|13|||
129677204|NCT00676143|466780679|FG000|Overall Study|Physician Decision|5|||
129677205|NCT00676143|466780680|FG001|Overall Study|Physician Decision|8|||
129677206|NCT00676143|466780679|FG000|Overall Study|Protocol Violation|4|||
129677207|NCT00676143|466780680|FG001|Overall Study|Protocol Violation|8|||
129677208|NCT00676143|466780679|FG000|Overall Study|Withdrawal by Subject|24|||
129677209|NCT00676143|466780680|FG001|Overall Study|Withdrawal by Subject|42|||
129677210|NCT00676143|466780679|FG000|Overall Study|Discontinuation of study by sponsor|65|||
129677211|NCT00676143|466780680|FG001|Overall Study|Discontinuation of study by sponsor|88|||
129677212|NCT00676143|466780679|FG000|Overall Study|Failed to return|2|||
129677213|NCT00676143|466780680|FG001|Overall Study|Failed to return|1|||
129677214|NCT00676143|466780679|FG000|Overall Study|Loss of caregiver|5|||
129677215|NCT00676143|466780680|FG001|Overall Study|Loss of caregiver|3|||
129677216|NCT00676143|466780679|FG000|Overall Study|Other|11|||
129677217|NCT00676143|466780680|FG001|Overall Study|Other|20|||
129677218|NCT00676143|466780679|FG000|Overall Study|Participant participation unknown|1|||
129677219|NCT00676143|466780680|FG001|Overall Study|Participant participation unknown|4|||
129677220|NCT00676143|466780679|FG000|Overall Study|Vasogenic edema recurrence|1|||
129677221|NCT00676143|466780680|FG001|Overall Study|Vasogenic edema recurrence|3|||
129677222|NCT01901185|466780681|FG000|Overall Study|Withdrawal by Subject|2|||
129677223|NCT02309359|466780684|FG000|Overall Study|Adverse Event|4|||
129677224|NCT02309359|466780685|FG001|Overall Study|Adverse Event|5|||
129677225|NCT02309359|466780686|FG002|Overall Study|Adverse Event|5|||
129677226|NCT02309359|466780687|FG003|Overall Study|Adverse Event|4|||
129677227|NCT02309359|466780688|FG004|Overall Study|Adverse Event|4|||
129677228|NCT02309359|466780684|FG000|Overall Study|Death|1|||
129677229|NCT02309359|466780685|FG001|Overall Study|Death|0|||
129677230|NCT02309359|466780686|FG002|Overall Study|Death|0|||
129677231|NCT02309359|466780687|FG003|Overall Study|Death|0|||
129677232|NCT02309359|466780688|FG004|Overall Study|Death|0|||
129677233|NCT02309359|466780684|FG000|Overall Study|Withdrawal by Subject|2|||
129677234|NCT02309359|466780685|FG001|Overall Study|Withdrawal by Subject|2|||
129677235|NCT02309359|466780686|FG002|Overall Study|Withdrawal by Subject|4|||
129677236|NCT02309359|466780687|FG003|Overall Study|Withdrawal by Subject|4|||
129677237|NCT02309359|466780688|FG004|Overall Study|Withdrawal by Subject|0|||
129677238|NCT02309359|466780684|FG000|Overall Study|Lack of Efficacy|3|||
129677239|NCT02309359|466780685|FG001|Overall Study|Lack of Efficacy|1|||
129677240|NCT02309359|466780686|FG002|Overall Study|Lack of Efficacy|0|||
129677241|NCT02309359|466780687|FG003|Overall Study|Lack of Efficacy|0|||
129677242|NCT02309359|466780688|FG004|Overall Study|Lack of Efficacy|3|||
129677243|NCT02309359|466780684|FG000|Overall Study|Lost to Follow-up|0|||
129677244|NCT02309359|466780685|FG001|Overall Study|Lost to Follow-up|0|||
129677245|NCT02309359|466780686|FG002|Overall Study|Lost to Follow-up|0|||
129677246|NCT02309359|466780687|FG003|Overall Study|Lost to Follow-up|1|||
129677247|NCT02309359|466780688|FG004|Overall Study|Lost to Follow-up|0|||
129677248|NCT02309359|466780684|FG000|Overall Study|Other|2|||
129677249|NCT02309359|466780685|FG001|Overall Study|Other|0|||
129677250|NCT02309359|466780686|FG002|Overall Study|Other|2|||
129677251|NCT02309359|466780687|FG003|Overall Study|Other|3|||
129767964|NCT03694353|467116334|FG000|Overall Study|Withdrawal by Subject|1|||
129677252|NCT02309359|466780688|FG004|Overall Study|Other|2|||
129677253|NCT00701363|466780689|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
129677254|NCT00701363|466780690|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
129677255|NCT00701363|466780691|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
129677256|NCT00701363|466780692|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
129767965|NCT03694353|467116334|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
129767966|NCT05720897|467116335|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
129767967|NCT05720897|467116336|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
129767968|NCT00400179|467116337|FG000|Overall Study|Adverse Event|2|||
129767969|NCT00400179|467116338|FG001|Overall Study|Adverse Event|2|||
129767970|NCT00400179|467116337|FG000|Overall Study|Death|1|||
129767971|NCT00400179|467116338|FG001|Overall Study|Death|2|||
129767972|NCT00400179|467116337|FG000|Overall Study|Withdrew Consent|1|||
129767973|NCT00400179|467116338|FG001|Overall Study|Withdrew Consent|5|||
129767974|NCT00400179|467116337|FG000|Overall Study|Disease progression|1|||
129767975|NCT00400179|467116338|FG001|Overall Study|Disease progression|1|||
129767976|NCT00400179|467116337|FG000|Overall Study|Intercurrent illness|0|||
129767977|NCT00400179|467116338|FG001|Overall Study|Intercurrent illness|1|||
129767978|NCT00400179|467116337|FG000|Overall Study|Investigator judgment|0|||
129767979|NCT00400179|467116338|FG001|Overall Study|Investigator judgment|1|||
129767980|NCT00400179|467116337|FG000|Overall Study|Randomization error/patient ineligible|1|||
129767981|NCT00400179|467116338|FG001|Overall Study|Randomization error/patient ineligible|6|||
129767982|NCT04780061|467116339|FG000|Overall Study|Withdrawal by Subject|5|||
129767983|NCT04780061|467116340|FG001|Overall Study|Withdrawal by Subject|8|||
129767984|NCT04780061|467116339|FG000|Overall Study|Adverse Event|2|||
129767985|NCT04780061|467116340|FG001|Overall Study|Adverse Event|2|||
129767986|NCT04780061|467116339|FG000|Overall Study|Lost to Follow-up|1|||
129767987|NCT04780061|467116340|FG001|Overall Study|Lost to Follow-up|5|||
129767988|NCT05523089|467116341|FG000|Overall Study|Withdrawal by Subject|1|||
129767989|NCT05523089|467116342|FG001|Overall Study|Withdrawal by Subject|0|||
129767990|NCT05523089|467116343|FG002|Overall Study|Withdrawal by Subject|0|||
129767991|NCT05523089|467116341|FG000|Overall Study|Lost to Follow-up|1|||
129767992|NCT05523089|467116342|FG001|Overall Study|Lost to Follow-up|0|||
129767993|NCT05523089|467116343|FG002|Overall Study|Lost to Follow-up|0|||
129767994|NCT02681523|467116344|FG000|Overall Study|Adverse Event|1|||
129767995|NCT02681523|467116344|FG000|Overall Study|Patient Non-compliance|1|||
129767996|NCT01456039|467118233|FG000|Phase 1 (First Step)|Disease Progression|1|||
129767997|NCT01456039|467118234|FG001|Phase 1 (First Step)|Disease Progression|1|||
129767998|NCT01456039|467118235|FG002|Phase 1 (First Step)|Disease Progression|0|||
129767999|NCT01456039|467118233|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
129768000|NCT01456039|467118234|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
129768001|NCT01456039|467118235|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
129768002|NCT01456039|467118233|FG000|Phase 1 (First Step)|Adverse Event|0|||
129768003|NCT01456039|467118234|FG001|Phase 1 (First Step)|Adverse Event|3|||
129768004|NCT01456039|467118235|FG002|Phase 1 (First Step)|Adverse Event|0|||
129768005|NCT01456039|467118233|FG000|Phase 1 (First Step)|Other|0|||
129768006|NCT01456039|467118234|FG001|Phase 1 (First Step)|Other|1|||
129768007|NCT01456039|467118235|FG002|Phase 1 (First Step)|Other|0|||
129768008|NCT01456039|467118233|FG000|Phase 2 (Second Step)|Disease Progression|0|||
129768009|NCT01456039|467118234|FG001|Phase 2 (Second Step)|Disease Progression|0|||
129768010|NCT01456039|467118235|FG002|Phase 2 (Second Step)|Disease Progression|17|||
129768011|NCT01456039|467118233|FG000|Phase 2 (Second Step)|Adverse Event|0|||
129768012|NCT01456039|467118234|FG001|Phase 2 (Second Step)|Adverse Event|0|||
129768013|NCT01456039|467118235|FG002|Phase 2 (Second Step)|Adverse Event|10|||
129768014|NCT01456039|467118233|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
129768015|NCT01456039|467118234|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
129768016|NCT01456039|467118235|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
129768017|NCT01456039|467118233|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
129768018|NCT01456039|467118234|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
129768019|NCT01456039|467118235|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
129768020|NCT01456039|467118233|FG000|Phase 2 (Second Step)|Other|0|||
129768021|NCT01456039|467118234|FG001|Phase 2 (Second Step)|Other|0|||
129768022|NCT01456039|467118235|FG002|Phase 2 (Second Step)|Other|1|||
129768023|NCT00755183|467118236|FG000|Overall Study|Adverse Event|5|||
129768024|NCT00755183|467118237|FG001|Overall Study|Adverse Event|2|||
129768025|NCT00755183|467118236|FG000|Overall Study|Protocol Violation|0|||
129768026|NCT00755183|467118237|FG001|Overall Study|Protocol Violation|1|||
129768027|NCT00755183|467118236|FG000|Overall Study|Withdrawal by Subject|0|||
129768028|NCT00755183|467118237|FG001|Overall Study|Withdrawal by Subject|2|||
129768029|NCT00755183|467118236|FG000|Overall Study|Administrative|2|||
129768030|NCT00755183|467118237|FG001|Overall Study|Administrative|1|||
129768031|NCT00148317|467118238|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
129768032|NCT00148317|467118238|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
129768033|NCT00148317|467118238|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
129768034|NCT00335777|467118239|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
129768035|NCT00335777|467118239|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
129768036|NCT00335777|467118239|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
129768037|NCT00335777|467118239|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
129768038|NCT00335777|467118239|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
129768039|NCT00371150|467118242|FG000|Overall Study|Lost to Follow-up|3|||
129768040|NCT00371150|467118243|FG001|Overall Study|Lost to Follow-up|2|||
129768041|NCT00124943|467118246|FG000|Phase II|Adverse Event|0|||
129768042|NCT00124943|467118247|FG001|Phase II|Adverse Event|2|||
129768043|NCT00124943|467118248|FG002|Phase II|Adverse Event|0|||
129768044|NCT00124943|467118249|FG003|Phase II|Adverse Event|1|||
129768045|NCT00124943|467118246|FG000|Phase II|Protocol Violation|0|||
129768046|NCT00124943|467118247|FG001|Phase II|Protocol Violation|0|||
129768047|NCT00124943|467118248|FG002|Phase II|Protocol Violation|0|||
129768048|NCT00124943|467118249|FG003|Phase II|Protocol Violation|1|||
129768049|NCT00124943|467118246|FG000|Phase II|Lost to Follow-up|0|||
129768050|NCT00124943|467118247|FG001|Phase II|Lost to Follow-up|0|||
129768051|NCT00124943|467118248|FG002|Phase II|Lost to Follow-up|0|||
129768052|NCT00124943|467118249|FG003|Phase II|Lost to Follow-up|1|||
129768053|NCT00124943|467118246|FG000|Phase II|Withdrawal by Subject|0|||
129768054|NCT00124943|467118247|FG001|Phase II|Withdrawal by Subject|0|||
129768055|NCT00124943|467118248|FG002|Phase II|Withdrawal by Subject|0|||
129768056|NCT00124943|467118249|FG003|Phase II|Withdrawal by Subject|2|||
129768057|NCT00321620|467118250|FG000|Overall Study|Death|269|||
129768058|NCT00321620|467118251|FG001|Overall Study|Death|294|||
129768059|NCT00321620|467118250|FG000|Overall Study|Withdrawal by Subject|164|||
129768060|NCT00321620|467118251|FG001|Overall Study|Withdrawal by Subject|147|||
129768061|NCT00321620|467118250|FG000|Overall Study|Disease progression|113|||
129768062|NCT00321620|467118251|FG001|Overall Study|Disease progression|117|||
129768063|NCT00321620|467118250|FG000|Overall Study|Adverse Event|43|||
129768064|NCT00321620|467118251|FG001|Overall Study|Adverse Event|56|||
129768065|NCT00321620|467118250|FG000|Overall Study|Lost to Follow-up|13|||
129768066|NCT00321620|467118251|FG001|Overall Study|Lost to Follow-up|9|||
129768067|NCT00321620|467118250|FG000|Overall Study|Physician Decision|4|||
129768068|NCT00321620|467118251|FG001|Overall Study|Physician Decision|1|||
129768069|NCT00321620|467118250|FG000|Overall Study|Noncompliance|14|||
129768070|NCT00321620|467118251|FG001|Overall Study|Noncompliance|7|||
129768071|NCT00321620|467118250|FG000|Overall Study|Protocol deviation|4|||
129768072|NCT00321620|467118251|FG001|Overall Study|Protocol deviation|3|||
129768073|NCT00321620|467118250|FG000|Overall Study|Ineligibility determined|2|||
129768074|NCT00321620|467118251|FG001|Overall Study|Ineligibility determined|3|||
129768075|NCT00321620|467118250|FG000|Overall Study|Participant request|75|||
129768076|NCT00321620|467118251|FG001|Overall Study|Participant request|52|||
129768077|NCT00321620|467118250|FG000|Overall Study|Other|42|||
129768078|NCT00321620|467118251|FG001|Overall Study|Other|33|||
129768079|NCT03304626|467118254|FG000|Overall Study|Adverse Event|1|||
129768080|NCT03304626|467118255|FG001|Overall Study|Adverse Event|0|||
129768081|NCT03304626|467118254|FG000|Overall Study|Lack of Efficacy|1|||
129768082|NCT03304626|467118255|FG001|Overall Study|Lack of Efficacy|1|||
129768083|NCT04385277|467118256|FG000|Overall Study|Physician Decision|2|||
129768084|NCT04385277|467118256|FG000|Overall Study|Ineligible|1|||
129768085|NCT04385277|467118256|FG000|Overall Study|Patient/Parent Refusal|2|||
129768086|NCT02903771|467118261|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
129768087|NCT02903771|467118262|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
129768088|NCT02903771|467118263|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
129768089|NCT02903771|467118264|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
129768090|NCT02903771|467118265|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
129768091|NCT02903771|467118266|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
129768092|NCT02903771|467118267|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
129768093|NCT02903771|467118261|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
129768094|NCT02903771|467118262|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
129768095|NCT02903771|467118263|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
129768096|NCT02903771|467118264|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
129768097|NCT02903771|467118265|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
129768098|NCT02903771|467118266|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
129768099|NCT02903771|467118267|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
129768100|NCT02903771|467118261|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129768101|NCT02903771|467118262|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129768102|NCT02903771|467118263|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
129768103|NCT02903771|467118264|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129768104|NCT02903771|467118265|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129768105|NCT02903771|467118266|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
129768106|NCT02903771|467118267|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
129768107|NCT02903771|467118261|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129768108|NCT02903771|467118262|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129768109|NCT02903771|467118263|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129768110|NCT02903771|467118264|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129768111|NCT02903771|467118265|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
129768112|NCT02903771|467118266|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129768113|NCT02903771|467118267|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
129768114|NCT02903771|467118261|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
129768115|NCT02903771|467118262|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
129768116|NCT02903771|467118263|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
129768117|NCT02903771|467118264|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
129768118|NCT02903771|467118265|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
129768119|NCT02903771|467118266|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
129768120|NCT02903771|467118267|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
129768121|NCT02903771|467118261|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129768122|NCT02903771|467118262|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129768123|NCT02903771|467118263|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129768124|NCT02903771|467118264|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129768125|NCT02903771|467118265|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
129768126|NCT02903771|467118266|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129768127|NCT02903771|467118267|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
129768128|NCT02903771|467118261|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129768129|NCT02903771|467118262|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129768130|NCT02903771|467118263|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129768131|NCT02903771|467118264|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129768132|NCT02903771|467118265|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
129768133|NCT02903771|467118266|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129768134|NCT02903771|467118267|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
129768135|NCT02903771|467118261|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129768136|NCT02903771|467118262|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129768137|NCT02903771|467118263|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129768138|NCT02903771|467118264|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129768139|NCT02903771|467118265|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
129768140|NCT02903771|467118266|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129768141|NCT02903771|467118267|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
129768142|NCT02903771|467118261|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129768143|NCT02903771|467118262|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129768144|NCT02903771|467118263|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129768145|NCT02903771|467118264|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129768146|NCT02903771|467118265|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
129768147|NCT02903771|467118266|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129768148|NCT02903771|467118267|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
129768149|NCT02903771|467118261|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129768150|NCT02903771|467118262|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129768151|NCT02903771|467118263|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129768152|NCT02903771|467118264|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129768153|NCT02903771|467118265|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
129768154|NCT02903771|467118266|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129768155|NCT02903771|467118267|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
129768156|NCT02903771|467118261|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129768157|NCT02903771|467118262|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129768158|NCT02903771|467118263|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129768159|NCT02903771|467118264|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129768160|NCT02903771|467118265|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
129768161|NCT02903771|467118266|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129768162|NCT02903771|467118267|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
129768163|NCT00837434|467118271|FG000|Overall Study|Physician Decision|3|||
129768164|NCT00837434|467118272|FG001|Overall Study|Physician Decision|0|||
129768165|NCT00837434|467118271|FG000|Overall Study|Lost to Follow-up|1|||
129768166|NCT00837434|467118272|FG001|Overall Study|Lost to Follow-up|1|||
129768167|NCT00837434|467118271|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
129768168|NCT00837434|467118272|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
129768169|NCT00837434|467118271|FG000|Overall Study|Noncompliant|2|||
129768170|NCT00837434|467118272|FG001|Overall Study|Noncompliant|0|||
129768171|NCT00837434|467118271|FG000|Overall Study|Baseline assessments not done in time|1|||
129768172|NCT00837434|467118272|FG001|Overall Study|Baseline assessments not done in time|0|||
129768173|NCT00837434|467118271|FG000|Overall Study|Unable to obtain study drug|1|||
129677257|NCT00701363|466780689|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
129677258|NCT00701363|466780690|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
129677259|NCT00701363|466780691|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
129677260|NCT00701363|466780692|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
129677261|NCT00701363|466780689|FG000|Treatment Phase 1|Adverse Event|7|||
129677262|NCT00701363|466780690|FG001|Treatment Phase 1|Adverse Event|0|||
129677263|NCT00701363|466780691|FG002|Treatment Phase 1|Adverse Event|0|||
129677264|NCT00701363|466780692|FG003|Treatment Phase 1|Adverse Event|0|||
129677265|NCT00701363|466780689|FG000|Treatment Phase 1|Protocol Violation|1|||
129677266|NCT00701363|466780690|FG001|Treatment Phase 1|Protocol Violation|0|||
129677267|NCT00701363|466780691|FG002|Treatment Phase 1|Protocol Violation|0|||
129677268|NCT00701363|466780692|FG003|Treatment Phase 1|Protocol Violation|0|||
129677269|NCT00701363|466780689|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
129677270|NCT00701363|466780690|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
129677271|NCT00701363|466780691|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
129677272|NCT00701363|466780692|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
129677273|NCT00701363|466780689|FG000|Treatment Phase 1|Lack of Efficacy|1|||
129677274|NCT00701363|466780690|FG001|Treatment Phase 1|Lack of Efficacy|0|||
129677275|NCT00701363|466780691|FG002|Treatment Phase 1|Lack of Efficacy|0|||
129677276|NCT00701363|466780692|FG003|Treatment Phase 1|Lack of Efficacy|0|||
129677277|NCT00701363|466780689|FG000|Treatment Phase 2|Adverse Event|0|||
129677278|NCT00701363|466780690|FG001|Treatment Phase 2|Adverse Event|0|||
129677279|NCT00701363|466780691|FG002|Treatment Phase 2|Adverse Event|1|||
129677280|NCT00701363|466780692|FG003|Treatment Phase 2|Adverse Event|0|||
129677281|NCT00701363|466780689|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
129677282|NCT00701363|466780690|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
129677283|NCT00701363|466780691|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
129677284|NCT00701363|466780692|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
129677285|NCT04759131|466780693|FG000|Overall Study|Investigator's discretion|1|||
129677286|NCT04759131|466780694|FG001|Overall Study|Investigator's discretion|0|||
129677287|NCT04759131|466780693|FG000|Overall Study|Subject withdrawal|1|||
129677288|NCT04759131|466780694|FG001|Overall Study|Subject withdrawal|0|||
129677289|NCT03692949|466780695|FG000|Overall Study|Lost to Follow-up|0|||
129677290|NCT03692949|466780696|FG001|Overall Study|Lost to Follow-up|0|||
129677291|NCT03692949|466780697|FG002|Overall Study|Lost to Follow-up|0|||
129677292|NCT03692949|466780698|FG003|Overall Study|Lost to Follow-up|0|||
129677293|NCT03692949|466780699|FG004|Overall Study|Lost to Follow-up|0|||
129677294|NCT03692949|466780700|FG005|Overall Study|Lost to Follow-up|0|||
129677295|NCT03692949|466780701|FG006|Overall Study|Lost to Follow-up|0|||
129677296|NCT03692949|466780702|FG007|Overall Study|Lost to Follow-up|1|||
129677297|NCT02592824|466780710|FG000|Overall Study|Protocol Violation|5|||
129677298|NCT02592824|466780711|FG001|Overall Study|Protocol Violation|3|||
129677299|NCT02592824|466780710|FG000|Overall Study|Lost to Follow-up|2|||
129677300|NCT02592824|466780711|FG001|Overall Study|Lost to Follow-up|1|||
129677301|NCT03426878|466780712|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
129677302|NCT03426878|466780712|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
129677303|NCT03426878|466780712|FG000|Overall Study|Declined to receive results|3|||
129677304|NCT03426878|466780712|FG000|Overall Study|Received negative results by mailed letter|65|||
129677305|NCT03426878|466780712|FG000|Overall Study|Lost to Follow-up|177|||
129677306|NCT01286129|466780713|FG000|Overall Study|Withdrawal by Subject|4|||
129677307|NCT01286129|466780714|FG001|Overall Study|Withdrawal by Subject|1|||
129677308|NCT01286129|466780713|FG000|Overall Study|Could not comply with study requirements|4|||
129677309|NCT01286129|466780714|FG001|Overall Study|Could not comply with study requirements|4|||
129677310|NCT05233761|466780719|FG000|Treatment Period A|Withdrawal by Subject|12|||
129677311|NCT05233761|466780720|FG001|Treatment Period A|Withdrawal by Subject|10|||
129677312|NCT05233761|466780719|FG000|Treatment Period A|Lost to Follow-up|6|||
129677313|NCT05233761|466780720|FG001|Treatment Period A|Lost to Follow-up|12|||
129677314|NCT05233761|466780719|FG000|Treatment Period A|Protocol Violation|8|||
129677315|NCT05233761|466780720|FG001|Treatment Period A|Protocol Violation|15|||
129677316|NCT01604785|466780721|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
129677317|NCT01604785|466780722|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
129677318|NCT00869960|466780723|FG000|Overall Study|Lost to Follow-up|2|||
129768174|NCT00837434|467118272|FG001|Overall Study|Unable to obtain study drug|0|||
129768175|NCT03041038|467118293|FG000|Overall Study|Withdrawal by Subject|4|||
129768176|NCT03041038|467118294|FG001|Overall Study|Withdrawal by Subject|0|||
129768177|NCT03041038|467118293|FG000|Overall Study|Lost to Follow-up|1|||
129768178|NCT03041038|467118294|FG001|Overall Study|Lost to Follow-up|1|||
129768179|NCT03041038|467118293|FG000|Overall Study|Protocol Violation|1|||
129768180|NCT03041038|467118294|FG001|Overall Study|Protocol Violation|1|||
129768181|NCT03331315|467118295|FG000|Overall Study|Physician Decision|18|||
129768182|NCT03331315|467118296|FG001|Overall Study|Physician Decision|14|||
129768183|NCT01709721|467118297|FG000|Open Label Phase|Withdrawal by Subject|0|||
129768184|NCT01709721|467118298|FG001|Open Label Phase|Withdrawal by Subject|0|||
129768185|NCT01709721|467118299|FG002|Open Label Phase|Withdrawal by Subject|5|||
129768186|NCT01709721|467118297|FG000|Open Label Phase|Adverse Event|0|||
129768187|NCT01709721|467118298|FG001|Open Label Phase|Adverse Event|0|||
129677319|NCT01654276|466780733|FG000|Overall Study|Lack of Efficacy|1|||
129677320|NCT01654276|466780733|FG000|Overall Study|Lost to Follow-up|4|||
129677321|NCT01654276|466780733|FG000|Overall Study|Withdrawal by Subject|1|||
129677322|NCT01991795|466780734|FG000|Overall Study|Lost to Follow-up|6|||
129677323|NCT01991795|466780735|FG001|Overall Study|Lost to Follow-up|4|||
129677324|NCT01991795|466780734|FG000|Overall Study|Withdrawal by Subject|117|||
129677325|NCT01991795|466780735|FG001|Overall Study|Withdrawal by Subject|94|||
129677326|NCT01991795|466780734|FG000|Overall Study|Site prematurely closed by sponsor|26|||
129677327|NCT01991795|466780735|FG001|Overall Study|Site prematurely closed by sponsor|25|||
129677328|NCT03344757|466780736|FG000|Overall Study|Withdrawal by Subject|18|||
129677329|NCT03344757|466780737|FG001|Overall Study|Withdrawal by Subject|16|||
129677330|NCT03344757|466780736|FG000|Overall Study|Lost to Follow-up|0|||
129677331|NCT03344757|466780737|FG001|Overall Study|Lost to Follow-up|2|||
129677332|NCT04798027|466780743|FG000|Overall Study|Protocol Violation|0|||
129677333|NCT04798027|466780744|FG001|Overall Study|Protocol Violation|0|||
129677334|NCT04798027|466780745|FG002|Overall Study|Protocol Violation|0|||
129677335|NCT04798027|466780746|FG003|Overall Study|Protocol Violation|0|||
129677336|NCT04798027|466780747|FG004|Overall Study|Protocol Violation|1|||
129677337|NCT04798027|466780748|FG005|Overall Study|Protocol Violation|0|||
129677338|NCT04798027|466780749|FG006|Overall Study|Protocol Violation|0|||
129677339|NCT04798027|466780750|FG007|Overall Study|Protocol Violation|1|||
129677340|NCT04798027|466780751|FG008|Overall Study|Protocol Violation|0|||
129677341|NCT04798027|466780743|FG000|Overall Study|Withdrawal by Subject|1|||
129677342|NCT04798027|466780744|FG001|Overall Study|Withdrawal by Subject|0|||
129677343|NCT04798027|466780745|FG002|Overall Study|Withdrawal by Subject|1|||
129677344|NCT04798027|466780746|FG003|Overall Study|Withdrawal by Subject|1|||
129677345|NCT04798027|466780747|FG004|Overall Study|Withdrawal by Subject|1|||
129677346|NCT04798027|466780748|FG005|Overall Study|Withdrawal by Subject|1|||
129677347|NCT04798027|466780749|FG006|Overall Study|Withdrawal by Subject|3|||
129677348|NCT04798027|466780750|FG007|Overall Study|Withdrawal by Subject|2|||
129677349|NCT04798027|466780751|FG008|Overall Study|Withdrawal by Subject|2|||
129677350|NCT04798027|466780743|FG000|Overall Study|Lost to Follow-up|1|||
129677351|NCT04798027|466780744|FG001|Overall Study|Lost to Follow-up|3|||
129677352|NCT04798027|466780745|FG002|Overall Study|Lost to Follow-up|0|||
129677353|NCT04798027|466780746|FG003|Overall Study|Lost to Follow-up|0|||
129677354|NCT04798027|466780747|FG004|Overall Study|Lost to Follow-up|0|||
129677355|NCT04798027|466780748|FG005|Overall Study|Lost to Follow-up|1|||
129677356|NCT04798027|466780749|FG006|Overall Study|Lost to Follow-up|0|||
129677357|NCT04798027|466780750|FG007|Overall Study|Lost to Follow-up|0|||
129677358|NCT04798027|466780751|FG008|Overall Study|Lost to Follow-up|1|||
129677359|NCT04798027|466780743|FG000|Overall Study|Withdrawal by Sponsor|8|||
129677360|NCT04798027|466780744|FG001|Overall Study|Withdrawal by Sponsor|22|||
129677361|NCT04798027|466780745|FG002|Overall Study|Withdrawal by Sponsor|9|||
129677362|NCT04798027|466780746|FG003|Overall Study|Withdrawal by Sponsor|26|||
129677363|NCT04798027|466780747|FG004|Overall Study|Withdrawal by Sponsor|24|||
129677364|NCT04798027|466780748|FG005|Overall Study|Withdrawal by Sponsor|11|||
129677365|NCT04798027|466780749|FG006|Overall Study|Withdrawal by Sponsor|25|||
129677366|NCT04798027|466780750|FG007|Overall Study|Withdrawal by Sponsor|26|||
129677367|NCT04798027|466780751|FG008|Overall Study|Withdrawal by Sponsor|11|||
129677368|NCT03104374|466780752|FG000|Period 1|Adverse Event|7|||
129677369|NCT03104374|466780753|FG001|Period 1|Adverse Event|7|||
129677370|NCT03104374|466780754|FG002|Period 1|Adverse Event|12|||
129677371|NCT03104374|466780755|FG003|Period 1|Adverse Event|14|||
129677372|NCT03104374|466780752|FG000|Period 1|Withdrawal by Subject|18|||
129677373|NCT03104374|466780753|FG001|Period 1|Withdrawal by Subject|9|||
129677374|NCT03104374|466780754|FG002|Period 1|Withdrawal by Subject|10|||
129677375|NCT03104374|466780755|FG003|Period 1|Withdrawal by Subject|17|||
129768188|NCT01709721|467118299|FG002|Open Label Phase|Adverse Event|8|||
129768189|NCT01709721|467118297|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
129768190|NCT01709721|467118298|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
129677376|NCT03104374|466780752|FG000|Period 1|Lost to Follow-up|4|||
129677377|NCT03104374|466780753|FG001|Period 1|Lost to Follow-up|4|||
129677378|NCT03104374|466780754|FG002|Period 1|Lost to Follow-up|6|||
129677379|NCT03104374|466780755|FG003|Period 1|Lost to Follow-up|8|||
129768191|NCT01709721|467118299|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
129768192|NCT01709721|467118297|FG000|Open Label Phase|Investigator Decision|0|||
129768193|NCT01709721|467118298|FG001|Open Label Phase|Investigator Decision|0|||
129768194|NCT01709721|467118299|FG002|Open Label Phase|Investigator Decision|1|||
129768195|NCT01709721|467118297|FG000|Open Label Phase|Sponsor Decision|0|||
129768196|NCT01709721|467118298|FG001|Open Label Phase|Sponsor Decision|0|||
129768197|NCT01709721|467118299|FG002|Open Label Phase|Sponsor Decision|2|||
129768198|NCT01709721|467118297|FG000|Open Label Phase|Protocol Violation|0|||
129768199|NCT01709721|467118298|FG001|Open Label Phase|Protocol Violation|0|||
129768200|NCT01709721|467118299|FG002|Open Label Phase|Protocol Violation|1|||
129768201|NCT01709721|467118297|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
129768202|NCT01709721|467118298|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
129768203|NCT01709721|467118299|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
129768204|NCT01709721|467118297|FG000|Open Label Phase|Inadequate Pain Control|0|||
129768205|NCT01709721|467118298|FG001|Open Label Phase|Inadequate Pain Control|0|||
129768206|NCT01709721|467118299|FG002|Open Label Phase|Inadequate Pain Control|37|||
129768207|NCT01709721|467118297|FG000|Open Label Phase|Other, Specify in text field in database|0|||
129768208|NCT01709721|467118298|FG001|Open Label Phase|Other, Specify in text field in database|0|||
129768209|NCT01709721|467118299|FG002|Open Label Phase|Other, Specify in text field in database|14|||
129768210|NCT01709721|467118297|FG000|Randomized Phase|Adverse Event|0|||
129768211|NCT01709721|467118298|FG001|Randomized Phase|Adverse Event|1|||
129768212|NCT01709721|467118299|FG002|Randomized Phase|Adverse Event|0|||
129768213|NCT01709721|467118297|FG000|Randomized Phase|Lost to Follow-up|1|||
129768214|NCT01709721|467118298|FG001|Randomized Phase|Lost to Follow-up|0|||
129768215|NCT01709721|467118299|FG002|Randomized Phase|Lost to Follow-up|0|||
129768216|NCT01709721|467118297|FG000|Randomized Phase|Inadequate Pain Control|1|||
129768217|NCT01709721|467118298|FG001|Randomized Phase|Inadequate Pain Control|2|||
129768218|NCT01709721|467118299|FG002|Randomized Phase|Inadequate Pain Control|0|||
129768219|NCT01709721|467118297|FG000|Randomized Phase|Other, Specify text field in database|1|||
129768220|NCT01709721|467118298|FG001|Randomized Phase|Other, Specify text field in database|3|||
129768221|NCT01709721|467118299|FG002|Randomized Phase|Other, Specify text field in database|0|||
129768222|NCT00360230|467118302|FG000|Overall Study|Withdrawal by Subject|1|||
129768223|NCT00360230|467118303|FG001|Overall Study|Withdrawal by Subject|1|||
129768224|NCT00360230|467118304|FG002|Overall Study|Withdrawal by Subject|0|||
129768225|NCT00360230|467118305|FG003|Overall Study|Withdrawal by Subject|1|||
129768226|NCT00360230|467118306|FG004|Overall Study|Withdrawal by Subject|1|||
129768227|NCT00360230|467118307|FG005|Overall Study|Withdrawal by Subject|1|||
129768228|NCT00360230|467118308|FG006|Overall Study|Withdrawal by Subject|0|||
129768229|NCT00360230|467118302|FG000|Overall Study|Migrated|4|||
129768230|NCT00360230|467118303|FG001|Overall Study|Migrated|1|||
129768231|NCT00360230|467118304|FG002|Overall Study|Migrated|3|||
129768232|NCT00360230|467118305|FG003|Overall Study|Migrated|1|||
129768233|NCT00360230|467118306|FG004|Overall Study|Migrated|4|||
129768234|NCT00360230|467118307|FG005|Overall Study|Migrated|1|||
129768235|NCT00360230|467118308|FG006|Overall Study|Migrated|1|||
129768236|NCT00360230|467118302|FG000|Overall Study|Other|1|||
129768237|NCT00360230|467118303|FG001|Overall Study|Other|0|||
129768238|NCT00360230|467118304|FG002|Overall Study|Other|0|||
129768239|NCT00360230|467118305|FG003|Overall Study|Other|0|||
129768240|NCT00360230|467118306|FG004|Overall Study|Other|0|||
129768241|NCT00360230|467118307|FG005|Overall Study|Other|0|||
129768242|NCT00360230|467118308|FG006|Overall Study|Other|0|||
129768243|NCT00360230|467118302|FG000|Overall Study|Protocol Violation|0|||
129768244|NCT00360230|467118303|FG001|Overall Study|Protocol Violation|0|||
129768245|NCT00360230|467118304|FG002|Overall Study|Protocol Violation|0|||
129768246|NCT00360230|467118305|FG003|Overall Study|Protocol Violation|0|||
129768247|NCT00360230|467118306|FG004|Overall Study|Protocol Violation|0|||
129768248|NCT00360230|467118307|FG005|Overall Study|Protocol Violation|1|||
129768249|NCT00360230|467118308|FG006|Overall Study|Protocol Violation|0|||
129768250|NCT00360230|467118302|FG000|Overall Study|Death|0|||
129768251|NCT00360230|467118303|FG001|Overall Study|Death|1|||
129768252|NCT00360230|467118304|FG002|Overall Study|Death|0|||
129768253|NCT00360230|467118305|FG003|Overall Study|Death|0|||
129768254|NCT00360230|467118306|FG004|Overall Study|Death|0|||
129768255|NCT00360230|467118307|FG005|Overall Study|Death|1|||
129768256|NCT00360230|467118308|FG006|Overall Study|Death|1|||
129768257|NCT00581308|467118309|FG000|Pre Discharge|Lost to Follow-up|1|||
129768258|NCT00581308|467118309|FG000|Pre Discharge|Device Removed|1|||
129768259|NCT00581308|467118309|FG000|Month 1|Lost to Follow-up|3|||
129768260|NCT00581308|467118309|FG000|Month 1|Withdrawal by Subject|2|||
129768261|NCT00581308|467118309|FG000|Month 1|Device Removed|2|||
129768262|NCT00581308|467118309|FG000|Month 1|Uknown|1|||
129677380|NCT03104374|466780752|FG000|Period 1|Lack of Efficacy|6|||
129677381|NCT03104374|466780753|FG001|Period 1|Lack of Efficacy|7|||
129677382|NCT03104374|466780754|FG002|Period 1|Lack of Efficacy|12|||
129677383|NCT03104374|466780755|FG003|Period 1|Lack of Efficacy|6|||
129677384|NCT03104374|466780752|FG000|Period 1|Other|2|||
129677385|NCT03104374|466780753|FG001|Period 1|Other|2|||
129677386|NCT03104374|466780754|FG002|Period 1|Other|4|||
129677387|NCT03104374|466780755|FG003|Period 1|Other|7|||
129677388|NCT03104374|466780752|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
129677389|NCT03104374|466780753|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
129677390|NCT03104374|466780754|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
129677391|NCT03104374|466780755|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
129677392|NCT03104374|466780752|FG000|Period 2|Adverse Event|4|||
129677393|NCT03104374|466780753|FG001|Period 2|Adverse Event|7|||
129677394|NCT03104374|466780754|FG002|Period 2|Adverse Event|10|||
129677395|NCT03104374|466780755|FG003|Period 2|Adverse Event|10|||
129677396|NCT03104374|466780752|FG000|Period 2|Withdrawal by Subject|3|||
129677397|NCT03104374|466780753|FG001|Period 2|Withdrawal by Subject|7|||
129677398|NCT03104374|466780754|FG002|Period 2|Withdrawal by Subject|13|||
129677399|NCT03104374|466780755|FG003|Period 2|Withdrawal by Subject|16|||
129677400|NCT03104374|466780752|FG000|Period 2|Lost to Follow-up|2|||
129677401|NCT03104374|466780753|FG001|Period 2|Lost to Follow-up|2|||
129677402|NCT03104374|466780754|FG002|Period 2|Lost to Follow-up|3|||
129677403|NCT03104374|466780755|FG003|Period 2|Lost to Follow-up|5|||
129677404|NCT03104374|466780752|FG000|Period 2|Lack of Efficacy|2|||
129677405|NCT03104374|466780753|FG001|Period 2|Lack of Efficacy|4|||
129677406|NCT03104374|466780754|FG002|Period 2|Lack of Efficacy|7|||
129677407|NCT03104374|466780755|FG003|Period 2|Lack of Efficacy|4|||
129677408|NCT03104374|466780752|FG000|Period 2|COVID-19 Infection|0|||
129677409|NCT03104374|466780753|FG001|Period 2|COVID-19 Infection|0|||
129677410|NCT03104374|466780754|FG002|Period 2|COVID-19 Infection|1|||
129677411|NCT03104374|466780755|FG003|Period 2|COVID-19 Infection|0|||
129677412|NCT03104374|466780752|FG000|Period 2|Other|3|||
129677413|NCT03104374|466780753|FG001|Period 2|Other|2|||
129677414|NCT03104374|466780754|FG002|Period 2|Other|2|||
129677415|NCT03104374|466780755|FG003|Period 2|Other|4|||
129677416|NCT02121210|466780758|FG000|Overall Study|Adverse Event|5|||
129677417|NCT02121210|466780759|FG001|Overall Study|Adverse Event|7|||
129677418|NCT02121210|466780758|FG000|Overall Study|Lack of Efficacy|2|||
129677419|NCT02121210|466780759|FG001|Overall Study|Lack of Efficacy|0|||
129677420|NCT02121210|466780758|FG000|Overall Study|Other than specified above|0|||
129677421|NCT02121210|466780759|FG001|Overall Study|Other than specified above|2|||
129677422|NCT04609514|466780760|FG000|Overall Study|Lost to Follow-up|5|||
129677423|NCT04609514|466780761|FG001|Overall Study|Lost to Follow-up|4|||
129677424|NCT04609514|466780760|FG000|Overall Study|Withdrawal by PI|0|||
129677425|NCT04609514|466780761|FG001|Overall Study|Withdrawal by PI|2|||
129677426|NCT00909870|466780762|FG000|Overall Study|Adverse Event|13|||
129677427|NCT00909870|466780763|FG001|Overall Study|Adverse Event|7|||
129677428|NCT00909870|466780762|FG000|Overall Study|Protocol Violation|1|||
129677429|NCT00909870|466780763|FG001|Overall Study|Protocol Violation|2|||
129677430|NCT00909870|466780762|FG000|Overall Study|Withdrawal by Subject|5|||
129677431|NCT00909870|466780763|FG001|Overall Study|Withdrawal by Subject|8|||
129677432|NCT00909870|466780762|FG000|Overall Study|Lost to Follow-up|3|||
129677433|NCT00909870|466780763|FG001|Overall Study|Lost to Follow-up|3|||
129677434|NCT00909870|466780762|FG000|Overall Study|Physician Decision|0|||
129677435|NCT00909870|466780763|FG001|Overall Study|Physician Decision|2|||
129677436|NCT00909870|466780762|FG000|Overall Study|Other|1|||
129677437|NCT00909870|466780763|FG001|Overall Study|Other|5|||
129677438|NCT01316575|466780764|FG000|Overall Study|Withdrawal by Subject|2|||
129677439|NCT01316575|466780765|FG001|Overall Study|Withdrawal by Subject|0|||
129677440|NCT01316575|466780764|FG000|Overall Study|Required alternate treatment|0|||
129677441|NCT01316575|466780765|FG001|Overall Study|Required alternate treatment|1|||
129677442|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
129677443|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
129677444|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677445|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677446|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677447|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677448|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677449|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677450|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677451|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
129677452|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
129677453|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
129677454|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677455|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677456|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677457|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677458|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677459|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677460|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677461|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
129677462|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
129677463|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677464|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677465|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677466|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677467|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677468|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677469|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677470|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677471|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
129677472|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
129677473|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
129677474|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677475|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677476|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677477|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677478|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677479|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129768263|NCT00581308|467118309|FG000|Month 6|Lost to Follow-up|1|||
129768264|NCT00581308|467118309|FG000|Month 6|Withdrawal by Subject|2|||
129768265|NCT00581308|467118309|FG000|Month 12|Death|1|||
129768266|NCT00581308|467118309|FG000|Month 12|Lost to Follow-up|14|||
129768267|NCT00581308|467118309|FG000|Month 12|Withdrawal by Subject|3|||
129768268|NCT00581308|467118309|FG000|Month 12|Device Removed|1|||
129768269|NCT00581308|467118309|FG000|Month 12|Other|1|||
129768270|NCT03219723|467118310|FG000|Overall Study|Case Report Forms Uncollected|6|||
129768271|NCT03219723|467118310|FG000|Overall Study|Protocol Deviation|4|||
129768272|NCT00459316|467118311|FG000|Steps 1 & 2|Other eligibility failure|1|||
129768273|NCT00459316|467118312|FG001|Steps 1 & 2|Other eligibility failure|1|||
129768274|NCT00459316|467118313|FG002|Steps 1 & 2|Other eligibility failure|0|||
129768275|NCT00459316|467118311|FG000|Steps 1 & 2|Death|1|||
129768276|NCT00459316|467118312|FG001|Steps 1 & 2|Death|1|||
129768277|NCT00459316|467118313|FG002|Steps 1 & 2|Death|0|||
129768278|NCT00459316|467118311|FG000|Steps 1 & 2|Not able to get to clinic|7|||
129768279|NCT00459316|467118312|FG001|Steps 1 & 2|Not able to get to clinic|4|||
129768280|NCT00459316|467118313|FG002|Steps 1 & 2|Not able to get to clinic|0|||
129768281|NCT00459316|467118311|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
129768282|NCT00459316|467118312|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
129768283|NCT00459316|467118313|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
129768284|NCT00459316|467118311|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
129768285|NCT00459316|467118312|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
129768286|NCT00459316|467118313|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
129768287|NCT00459316|467118311|FG000|Steps 1 & 2|Lost to Follow-up|5|||
129768288|NCT00459316|467118312|FG001|Steps 1 & 2|Lost to Follow-up|0|||
129768289|NCT00459316|467118313|FG002|Steps 1 & 2|Lost to Follow-up|2|||
129768290|NCT00459316|467118311|FG000|Step 3|Withdrawal by Subject|3|||
129768291|NCT00459316|467118312|FG001|Step 3|Withdrawal by Subject|0|||
129768292|NCT00459316|467118313|FG002|Step 3|Withdrawal by Subject|1|||
129768293|NCT01614886|467118314|FG000|Overall Study|Adverse Event|15|||
129768294|NCT01614886|467118315|FG001|Overall Study|Adverse Event|20|||
129768295|NCT01614886|467118314|FG000|Overall Study|Withdrawal by Subject|4|||
129768296|NCT01614886|467118315|FG001|Overall Study|Withdrawal by Subject|4|||
129768297|NCT01614886|467118314|FG000|Overall Study|Death|1|||
129768298|NCT01614886|467118315|FG001|Overall Study|Death|0|||
129768299|NCT01614886|467118314|FG000|Overall Study|Protocol deviation|0|||
129768300|NCT01614886|467118315|FG001|Overall Study|Protocol deviation|2|||
129768301|NCT01207414|467118317|FG000|Overall Study|Adverse Event|25|||
129768302|NCT01207414|467118318|FG001|Overall Study|Adverse Event|39|||
129768303|NCT01207414|467118317|FG000|Overall Study|Abnormal test procedure results|0|||
129768304|NCT01207414|467118318|FG001|Overall Study|Abnormal test procedure results|1|||
129768305|NCT01207414|467118317|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129677480|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677481|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
129677482|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
129677483|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
129677484|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677485|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677486|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129884410|NCT02771210|467536387|FG000|Period 1|Withdrawal of informed consent|1|||
129884411|NCT02771210|467536388|FG001|Period 1|Withdrawal of informed consent|5|||
129677487|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677488|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677489|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677490|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677491|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
129677492|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
129677493|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
129677494|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677495|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677496|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677497|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677498|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677499|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677500|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677501|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
129677502|NCT01232283|466780766|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
129677503|NCT01232283|466780767|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
129677504|NCT01232283|466780768|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677505|NCT01232283|466780769|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677506|NCT01232283|466780770|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677507|NCT01232283|466780771|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677508|NCT01232283|466780772|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677509|NCT01232283|466780773|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677510|NCT01232283|466780774|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677511|NCT01232283|466780775|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
129677512|NCT01232283|466780766|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677513|NCT01232283|466780767|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677514|NCT01232283|466780768|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
129677515|NCT01232283|466780769|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
129677516|NCT01232283|466780770|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677517|NCT01232283|466780771|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677518|NCT01232283|466780772|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677519|NCT01232283|466780773|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677520|NCT01232283|466780774|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677521|NCT01232283|466780775|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
129677522|NCT01232283|466780766|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677523|NCT01232283|466780767|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677524|NCT01232283|466780768|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
129677525|NCT01232283|466780769|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
129677526|NCT01232283|466780770|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677527|NCT01232283|466780771|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677528|NCT01232283|466780772|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677529|NCT01232283|466780773|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677530|NCT01232283|466780774|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677531|NCT01232283|466780775|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
129677532|NCT01232283|466780766|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677533|NCT01232283|466780767|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677534|NCT01232283|466780768|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
129677535|NCT01232283|466780769|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677536|NCT01232283|466780770|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677537|NCT01232283|466780771|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677538|NCT01232283|466780772|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129547207|NCT00358670|466296166|FG001|Overall Study|Lost to Follow-up|5|||
129768306|NCT01207414|467118318|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129768307|NCT01207414|467118317|FG000|Overall Study|Patient withdrew consent|14|||
129768308|NCT01207414|467118318|FG001|Overall Study|Patient withdrew consent|11|||
129768309|NCT01207414|467118317|FG000|Overall Study|Lost to Follow-up|15|||
129768310|NCT01207414|467118318|FG001|Overall Study|Lost to Follow-up|17|||
129768311|NCT01207414|467118317|FG000|Overall Study|Administrative problems|1|||
129768312|NCT01207414|467118318|FG001|Overall Study|Administrative problems|1|||
129768313|NCT01207414|467118317|FG000|Overall Study|Protocol deviation|12|||
129768314|NCT01207414|467118318|FG001|Overall Study|Protocol deviation|9|||
129768315|NCT01207414|467118317|FG000|Overall Study|Randomized in error|1|||
129768316|NCT01207414|467118318|FG001|Overall Study|Randomized in error|0|||
129768317|NCT01527370|467118319|FG000|Overall Study|Withdrawal by Subject|4|||
129768318|NCT01527370|467118319|FG000|Overall Study|Physician Decision|1|||
129768319|NCT01527370|467118319|FG000|Overall Study|Death|1|||
129768320|NCT02057250|467118322|FG000|AID Assessment Phase|Adverse Event|3|||
129768321|NCT02057250|467118323|FG001|AID Assessment Phase|Adverse Event|2|||
129768322|NCT02057250|467118324|FG002|AID Assessment Phase|Adverse Event|6|||
129768323|NCT02057250|467118325|FG003|AID Assessment Phase|Adverse Event|1|||
129768324|NCT02057250|467118326|FG004|AID Assessment Phase|Adverse Event|0|||
129768325|NCT02057250|467118322|FG000|AID Assessment Phase|Other than specified above|1|||
129768326|NCT02057250|467118323|FG001|AID Assessment Phase|Other than specified above|1|||
129768327|NCT02057250|467118324|FG002|AID Assessment Phase|Other than specified above|1|||
129768328|NCT02057250|467118325|FG003|AID Assessment Phase|Other than specified above|1|||
129768329|NCT02057250|467118326|FG004|AID Assessment Phase|Other than specified above|0|||
129768330|NCT02057250|467118322|FG000|Extension Phase|Adverse Event|0|||
129768331|NCT02057250|467118323|FG001|Extension Phase|Adverse Event|0|||
129768332|NCT02057250|467118324|FG002|Extension Phase|Adverse Event|0|||
129768333|NCT02057250|467118325|FG003|Extension Phase|Adverse Event|0|||
129768334|NCT02057250|467118326|FG004|Extension Phase|Adverse Event|15|||
129768335|NCT02057250|467118322|FG000|Extension Phase|Lack of Efficacy|0|||
129768336|NCT02057250|467118323|FG001|Extension Phase|Lack of Efficacy|0|||
129768337|NCT02057250|467118324|FG002|Extension Phase|Lack of Efficacy|0|||
129768338|NCT02057250|467118325|FG003|Extension Phase|Lack of Efficacy|0|||
129768339|NCT02057250|467118326|FG004|Extension Phase|Lack of Efficacy|10|||
129768340|NCT02057250|467118322|FG000|Extension Phase|Entered in this period but not treated|0|||
129768341|NCT02057250|467118323|FG001|Extension Phase|Entered in this period but not treated|0|||
129768342|NCT02057250|467118324|FG002|Extension Phase|Entered in this period but not treated|0|||
129768343|NCT02057250|467118325|FG003|Extension Phase|Entered in this period but not treated|0|||
129768344|NCT02057250|467118326|FG004|Extension Phase|Entered in this period but not treated|4|||
129768345|NCT02057250|467118322|FG000|Extension Phase|Other than specified above|0|||
129768346|NCT02057250|467118323|FG001|Extension Phase|Other than specified above|0|||
129768347|NCT02057250|467118324|FG002|Extension Phase|Other than specified above|0|||
129768348|NCT02057250|467118325|FG003|Extension Phase|Other than specified above|0|||
129768349|NCT02057250|467118326|FG004|Extension Phase|Other than specified above|7|||
129768350|NCT01435382|467118328|FG000|Overall Study|Lost to Follow-up|1|||
129768351|NCT01435382|467118329|FG001|Overall Study|Lost to Follow-up|0|||
129768352|NCT01435382|467118330|FG002|Overall Study|Lost to Follow-up|1|||
129768353|NCT01435382|467118331|FG003|Overall Study|Lost to Follow-up|0|||
129768354|NCT01435382|467118328|FG000|Overall Study|Withdrawal by Subject|0|||
129768355|NCT01435382|467118329|FG001|Overall Study|Withdrawal by Subject|2|||
129768356|NCT01435382|467118330|FG002|Overall Study|Withdrawal by Subject|0|||
129768357|NCT01435382|467118331|FG003|Overall Study|Withdrawal by Subject|1|||
129768358|NCT02435992|467118332|FG000|Overall Study|non compliance with protocol|2|||
129768359|NCT02435992|467118333|FG001|Overall Study|non compliance with protocol|0|||
129768360|NCT02435992|467118334|FG002|Overall Study|non compliance with protocol|1|||
129768361|NCT02435992|467118335|FG003|Overall Study|non compliance with protocol|0|||
129768362|NCT02435992|467118336|FG004|Overall Study|non compliance with protocol|0|||
129768363|NCT02435992|467118332|FG000|Overall Study|Adverse Event|11|||
129768364|NCT02435992|467118333|FG001|Overall Study|Adverse Event|6|||
129768365|NCT02435992|467118334|FG002|Overall Study|Adverse Event|12|||
129768366|NCT02435992|467118335|FG003|Overall Study|Adverse Event|0|||
129768367|NCT02435992|467118336|FG004|Overall Study|Adverse Event|0|||
129768368|NCT02435992|467118332|FG000|Overall Study|Lack of Efficacy|4|||
129768369|NCT02435992|467118333|FG001|Overall Study|Lack of Efficacy|10|||
129768370|NCT02435992|467118334|FG002|Overall Study|Lack of Efficacy|9|||
129768371|NCT02435992|467118335|FG003|Overall Study|Lack of Efficacy|0|||
129768372|NCT02435992|467118336|FG004|Overall Study|Lack of Efficacy|0|||
129768373|NCT02435992|467118332|FG000|Overall Study|Withdrawal by Subject|10|||
129768374|NCT02435992|467118333|FG001|Overall Study|Withdrawal by Subject|8|||
129768375|NCT02435992|467118334|FG002|Overall Study|Withdrawal by Subject|20|||
129768376|NCT02435992|467118335|FG003|Overall Study|Withdrawal by Subject|0|||
129768377|NCT02435992|467118336|FG004|Overall Study|Withdrawal by Subject|0|||
129768378|NCT02435992|467118332|FG000|Overall Study|Other Reason|1|||
129768379|NCT02435992|467118333|FG001|Overall Study|Other Reason|0|||
129768380|NCT02435992|467118334|FG002|Overall Study|Other Reason|0|||
129768381|NCT02435992|467118335|FG003|Overall Study|Other Reason|0|||
129768382|NCT02435992|467118336|FG004|Overall Study|Other Reason|0|||
129768383|NCT02435992|467118332|FG000|Overall Study|Physician Decision|0|||
129768384|NCT02435992|467118333|FG001|Overall Study|Physician Decision|0|||
129768385|NCT02435992|467118334|FG002|Overall Study|Physician Decision|1|||
129768386|NCT02435992|467118335|FG003|Overall Study|Physician Decision|0|||
129768387|NCT02435992|467118336|FG004|Overall Study|Physician Decision|0|||
129768388|NCT00260533|467118337|FG000|Overall Study|Other|3|||
129768389|NCT00260533|467118338|FG001|Overall Study|Other|3|||
129768390|NCT01761877|467118339|FG000|Overall Study|Adverse Event|7|||
129768391|NCT01761877|467118340|FG001|Overall Study|Adverse Event|0|||
129768392|NCT01761877|467118339|FG000|Overall Study|Withdrawal by Subject|6|||
129768393|NCT01761877|467118340|FG001|Overall Study|Withdrawal by Subject|4|||
129768394|NCT01761877|467118339|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
129768395|NCT01761877|467118340|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
129768396|NCT01761877|467118339|FG000|Overall Study|Death|0|||
129768397|NCT01761877|467118340|FG001|Overall Study|Death|1|||
129768398|NCT01761877|467118339|FG000|Overall Study|MRI intolerant|1|||
129768399|NCT01761877|467118340|FG001|Overall Study|MRI intolerant|6|||
129768400|NCT01310777|467118342|FG000|Overall Study|Adverse Event|23|||
129768401|NCT01310777|467118343|FG001|Overall Study|Adverse Event|1|||
129768402|NCT01310777|467118344|FG002|Overall Study|Adverse Event|15|||
129768403|NCT01310777|467118342|FG000|Overall Study|Lost to Follow-up|0|||
129768404|NCT01310777|467118343|FG001|Overall Study|Lost to Follow-up|4|||
129768405|NCT01310777|467118344|FG002|Overall Study|Lost to Follow-up|1|||
129768406|NCT01310777|467118342|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
129768407|NCT01310777|467118343|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
129768408|NCT01310777|467118344|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
129768409|NCT01310777|467118342|FG000|Overall Study|Inadequate Control of IOP|5|||
129768410|NCT01310777|467118343|FG001|Overall Study|Inadequate Control of IOP|7|||
129768411|NCT01310777|467118344|FG002|Overall Study|Inadequate Control of IOP|10|||
129768412|NCT01310777|467118342|FG000|Overall Study|Other|4|||
129768413|NCT01310777|467118343|FG001|Overall Study|Other|1|||
129768414|NCT01310777|467118344|FG002|Overall Study|Other|2|||
129768415|NCT02461758|467118346|FG000|Overall Study|Lost to Follow-up|0|||
129768416|NCT02461758|467118347|FG001|Overall Study|Lost to Follow-up|1|||
129768417|NCT02461758|467118348|FG002|Overall Study|Lost to Follow-up|1|||
129768418|NCT02461758|467118349|FG003|Overall Study|Lost to Follow-up|0|||
129768419|NCT01210313|467118355|FG000|Overall Study|Withdrawal by Subject|3|||
129768420|NCT01210313|467118355|FG000|Overall Study|Adverse Event|2|||
129768421|NCT01210313|467118355|FG000|Overall Study|Distant recurrence|4|||
129768422|NCT01210313|467118355|FG000|Overall Study|Non-compliance|7|||
129768423|NCT01710345|467118364|FG000|Overall Study|Adverse Event|0|||
129768424|NCT01710345|467118365|FG001|Overall Study|Adverse Event|2|||
129768425|NCT01710345|467118366|FG002|Overall Study|Adverse Event|0|||
129768426|NCT01710345|467118364|FG000|Overall Study|Lack of Efficacy|2|||
129768427|NCT01710345|467118365|FG001|Overall Study|Lack of Efficacy|3|||
129768428|NCT01710345|467118366|FG002|Overall Study|Lack of Efficacy|1|||
129768429|NCT01710345|467118364|FG000|Overall Study|Drug Dosing Error|1|||
129768430|NCT01710345|467118365|FG001|Overall Study|Drug Dosing Error|0|||
129768431|NCT01710345|467118366|FG002|Overall Study|Drug Dosing Error|0|||
129768432|NCT04298697|467118370|FG000|Overall Study|Lost to Follow-up|5|||
129768433|NCT04298697|467118371|FG001|Overall Study|Lost to Follow-up|5|||
129768434|NCT04298697|467118372|FG002|Overall Study|Lost to Follow-up|1|||
129768435|NCT04298697|467118373|FG003|Overall Study|Lost to Follow-up|0|||
129768436|NCT04298697|467118370|FG000|Overall Study|Withdrawal by Subject|0|||
129768437|NCT04298697|467118371|FG001|Overall Study|Withdrawal by Subject|3|||
129768438|NCT04298697|467118372|FG002|Overall Study|Withdrawal by Subject|2|||
129768439|NCT04298697|467118373|FG003|Overall Study|Withdrawal by Subject|3|||
129768440|NCT00449696|467118374|FG000|Overall Study|Other Treatment Required|6|||
129768441|NCT00449696|467118375|FG001|Overall Study|Other Treatment Required|1|||
129768442|NCT00449696|467118374|FG000|Overall Study|Withdrawal by Subject|5|||
129768443|NCT00449696|467118375|FG001|Overall Study|Withdrawal by Subject|5|||
129768444|NCT00449696|467118374|FG000|Overall Study|Lost to Follow-up|2|||
129768445|NCT00449696|467118375|FG001|Overall Study|Lost to Follow-up|3|||
129768446|NCT00449696|467118374|FG000|Overall Study|Others|7|||
129768447|NCT00449696|467118375|FG001|Overall Study|Others|0|||
129677539|NCT01232283|466780773|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677540|NCT01232283|466780774|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677541|NCT01232283|466780775|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
129677542|NCT01232283|466780766|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677543|NCT01232283|466780767|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677544|NCT01232283|466780768|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
129677545|NCT01232283|466780769|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
129677546|NCT01232283|466780770|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677547|NCT01232283|466780771|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677548|NCT01232283|466780772|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677549|NCT01232283|466780773|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677550|NCT01232283|466780774|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677551|NCT01232283|466780775|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
129677552|NCT01232283|466780766|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677553|NCT01232283|466780767|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677554|NCT01232283|466780768|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
129677555|NCT01232283|466780769|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
129677556|NCT01232283|466780770|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677557|NCT01232283|466780771|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677558|NCT01232283|466780772|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677559|NCT01232283|466780773|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677560|NCT01232283|466780774|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677561|NCT01232283|466780775|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
129677562|NCT01232283|466780766|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
129677563|NCT01232283|466780767|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
129677564|NCT01232283|466780768|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
129677565|NCT01232283|466780769|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
129677566|NCT01232283|466780770|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
129677567|NCT01232283|466780771|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
129677568|NCT01232283|466780772|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
129677569|NCT01232283|466780773|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
129677570|NCT01232283|466780774|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
129677571|NCT01232283|466780775|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
129677572|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677573|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677574|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677575|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677576|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
129677577|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
129768448|NCT01903460|467118376|FG000|Overall Study|Adverse Event|0|||
129768449|NCT01903460|467118377|FG001|Overall Study|Adverse Event|0|||
129768450|NCT01903460|467118378|FG002|Overall Study|Adverse Event|0|||
129768451|NCT01903460|467118379|FG003|Overall Study|Adverse Event|1|||
129768452|NCT04973449|467118380|FG000|Overall Study|Withdrawal by Subject|3|||
129768453|NCT04973449|467118381|FG001|Overall Study|Withdrawal by Subject|3|||
129768454|NCT04973449|467118382|FG002|Overall Study|Withdrawal by Subject|2|||
129768455|NCT04973449|467118383|FG003|Overall Study|Withdrawal by Subject|5|||
129768456|NCT04973449|467118384|FG004|Overall Study|Withdrawal by Subject|5|||
129768457|NCT04973449|467118385|FG005|Overall Study|Withdrawal by Subject|4|||
129677578|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677579|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
129677580|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677581|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
129677582|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677583|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677584|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677585|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677586|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
129677587|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677588|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
129677589|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
129677590|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677591|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
129677592|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129768458|NCT04973449|467118386|FG006|Overall Study|Withdrawal by Subject|7|||
129768459|NCT04973449|467118387|FG007|Overall Study|Withdrawal by Subject|5|||
129768460|NCT04973449|467118380|FG000|Overall Study|Lost to Follow-up|15|||
129768461|NCT04973449|467118381|FG001|Overall Study|Lost to Follow-up|16|||
129768462|NCT04973449|467118382|FG002|Overall Study|Lost to Follow-up|16|||
129768463|NCT04973449|467118383|FG003|Overall Study|Lost to Follow-up|13|||
129768464|NCT04973449|467118384|FG004|Overall Study|Lost to Follow-up|5|||
129768465|NCT04973449|467118385|FG005|Overall Study|Lost to Follow-up|6|||
129768466|NCT04973449|467118386|FG006|Overall Study|Lost to Follow-up|10|||
129768467|NCT04973449|467118387|FG007|Overall Study|Lost to Follow-up|6|||
129768468|NCT04973449|467118380|FG000|Overall Study|Death|1|||
129768469|NCT04973449|467118381|FG001|Overall Study|Death|0|||
129768470|NCT04973449|467118382|FG002|Overall Study|Death|0|||
129768471|NCT04973449|467118383|FG003|Overall Study|Death|0|||
129768472|NCT04973449|467118384|FG004|Overall Study|Death|0|||
129768473|NCT04973449|467118385|FG005|Overall Study|Death|1|||
129768474|NCT04973449|467118386|FG006|Overall Study|Death|0|||
129768475|NCT04973449|467118387|FG007|Overall Study|Death|0|||
129768476|NCT04973449|467118380|FG000|Overall Study|Other|1|||
129768477|NCT04973449|467118381|FG001|Overall Study|Other|1|||
129768478|NCT04973449|467118382|FG002|Overall Study|Other|2|||
129768479|NCT04973449|467118383|FG003|Overall Study|Other|1|||
129768480|NCT04973449|467118384|FG004|Overall Study|Other|4|||
129768481|NCT04973449|467118385|FG005|Overall Study|Other|0|||
129768482|NCT04973449|467118386|FG006|Overall Study|Other|2|||
129768483|NCT04973449|467118387|FG007|Overall Study|Other|2|||
129768484|NCT00521079|467118388|FG000|Overall Study|Adverse Event|7|||
129768485|NCT00521079|467118389|FG001|Overall Study|Adverse Event|1|||
129768486|NCT00521079|467118388|FG000|Overall Study|Lost to Follow-up|2|||
129768487|NCT00521079|467118389|FG001|Overall Study|Lost to Follow-up|1|||
129768488|NCT00521079|467118388|FG000|Overall Study|Withdrawal by Subject|5|||
129768489|NCT00521079|467118389|FG001|Overall Study|Withdrawal by Subject|3|||
129768490|NCT01506596|467118391|FG000|Overall Study|ineligible pathology|1|||
129768491|NCT00888173|467118392|FG000|Overall Study|Wrong Primary|1|||
129768492|NCT00888173|467118392|FG000|Overall Study|Ineligible: required test not done|1|||
129768493|NCT00651742|467118400|FG000|Overall Study|Objective Disease Progression|22|||
129768494|NCT00651742|467118400|FG000|Overall Study|Toxicity|3|||
129768495|NCT00651742|467118400|FG000|Overall Study|Investigator Judgment|1|||
129768496|NCT00651742|467118400|FG000|Overall Study|Withdrawal of Consent|1|||
129768497|NCT00651742|467118400|FG000|Overall Study|Enrolled but not treated|1|||
129768498|NCT02638220|467118401|FG000|Overall Study|Lost to Follow-up|6|||
129768499|NCT02638220|467118401|FG000|Overall Study|Withdrawal by Subject|3|||
129768500|NCT02638220|467118401|FG000|Overall Study|Physician Decision|1|||
129768501|NCT02638220|467118401|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
129768502|NCT04323124|467118406|FG000|Overall Study|Adverse Event|0|||
129768503|NCT04323124|467118407|FG001|Overall Study|Adverse Event|0|||
129768504|NCT04323124|467118408|FG002|Overall Study|Adverse Event|0|||
129768505|NCT04323124|467118409|FG003|Overall Study|Adverse Event|0|||
129768506|NCT04323124|467118410|FG004|Overall Study|Adverse Event|0|||
129768507|NCT04323124|467118411|FG005|Overall Study|Adverse Event|1|||
129768508|NCT04323124|467118412|FG006|Overall Study|Adverse Event|0|||
129768509|NCT04323124|467118413|FG007|Overall Study|Adverse Event|1|||
129768510|NCT04323124|467118414|FG008|Overall Study|Adverse Event|1|||
129768511|NCT04323124|467118415|FG009|Overall Study|Adverse Event|0|||
129768512|NCT04323124|467118416|FG010|Overall Study|Adverse Event|0|||
129768513|NCT04323124|467118417|FG011|Overall Study|Adverse Event|0|||
129768514|NCT04323124|467118418|FG012|Overall Study|Adverse Event|0|||
129768515|NCT04323124|467118419|FG013|Overall Study|Adverse Event|0|||
129768516|NCT04323124|467118420|FG014|Overall Study|Adverse Event|0|||
129768517|NCT04323124|467118406|FG000|Overall Study|Other|0|||
129768518|NCT04323124|467118407|FG001|Overall Study|Other|0|||
129768519|NCT04323124|467118408|FG002|Overall Study|Other|0|||
129768520|NCT04323124|467118409|FG003|Overall Study|Other|0|||
129768521|NCT04323124|467118410|FG004|Overall Study|Other|1|||
129768522|NCT04323124|467118411|FG005|Overall Study|Other|0|||
129768523|NCT04323124|467118412|FG006|Overall Study|Other|0|||
129768524|NCT04323124|467118413|FG007|Overall Study|Other|0|||
129768525|NCT04323124|467118414|FG008|Overall Study|Other|1|||
129768526|NCT04323124|467118415|FG009|Overall Study|Other|0|||
129768527|NCT04323124|467118416|FG010|Overall Study|Other|0|||
129768528|NCT04323124|467118417|FG011|Overall Study|Other|0|||
129768529|NCT04323124|467118418|FG012|Overall Study|Other|0|||
129768530|NCT04323124|467118419|FG013|Overall Study|Other|0|||
129768531|NCT04323124|467118420|FG014|Overall Study|Other|0|||
129768532|NCT04323124|467118406|FG000|Overall Study|Coming from a red zone (COVID)|0|||
129768533|NCT04323124|467118407|FG001|Overall Study|Coming from a red zone (COVID)|0|||
129768534|NCT04323124|467118408|FG002|Overall Study|Coming from a red zone (COVID)|0|||
129768535|NCT04323124|467118409|FG003|Overall Study|Coming from a red zone (COVID)|0|||
129768536|NCT04323124|467118410|FG004|Overall Study|Coming from a red zone (COVID)|1|||
129768537|NCT04323124|467118411|FG005|Overall Study|Coming from a red zone (COVID)|1|||
129768538|NCT04323124|467118412|FG006|Overall Study|Coming from a red zone (COVID)|0|||
129768539|NCT04323124|467118413|FG007|Overall Study|Coming from a red zone (COVID)|0|||
129768540|NCT04323124|467118414|FG008|Overall Study|Coming from a red zone (COVID)|0|||
129677593|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129677594|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129677595|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129677596|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
129677597|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
129677598|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
129677599|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
129677600|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129677601|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
129677602|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677603|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677604|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677605|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677606|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
129677607|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677608|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677609|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677610|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677611|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
129677612|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677613|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677614|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677615|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677616|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
129677617|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677618|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
129677619|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
129677620|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677621|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
129677622|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677623|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677624|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677625|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677626|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677627|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677628|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677629|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
129677630|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677631|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
129677632|NCT01232283|466780766|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677633|NCT01232283|466780767|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677634|NCT01232283|466780768|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677635|NCT01232283|466780769|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677636|NCT01232283|466780770|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677637|NCT01232283|466780771|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
129677638|NCT01232283|466780772|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677639|NCT01232283|466780773|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677640|NCT01232283|466780774|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677641|NCT01232283|466780775|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
129677642|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677643|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677644|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677645|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677646|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677647|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677648|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677649|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
129677650|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
129677651|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
129677652|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677653|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677654|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677655|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677656|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677657|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677658|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677659|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
129677660|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
129677661|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
129677662|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677663|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677664|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677665|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677666|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677667|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677668|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677669|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
129677670|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
129677671|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
129677672|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677673|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677674|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677675|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677676|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677677|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677678|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677679|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
129677680|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
129677681|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
129677682|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677683|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677684|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677685|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677686|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677687|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677688|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677689|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
129677690|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
129677691|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
129677692|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677693|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677694|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677695|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677696|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677697|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677698|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677699|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677700|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
129677701|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
129677702|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677703|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677704|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677705|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677706|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677707|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677708|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677709|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677710|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
129677711|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
129677712|NCT01232283|466780766|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677713|NCT01232283|466780767|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677714|NCT01232283|466780768|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677715|NCT01232283|466780769|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677716|NCT01232283|466780770|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677717|NCT01232283|466780771|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677718|NCT01232283|466780772|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677719|NCT01232283|466780773|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
129677720|NCT01232283|466780774|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
129677721|NCT01232283|466780775|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
129677722|NCT02792504|466780778|FG000|Overall Study|Lost to Follow-up|24|||
129677723|NCT02792504|466780778|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
129677724|NCT00848497|466780785|FG000|Overall Study|Screen failure|2|||
129677725|NCT00848497|466780786|FG001|Overall Study|Screen failure|0|||
129677726|NCT00848497|466780785|FG000|Overall Study|Withdrawal by Subject|0|||
129677727|NCT00848497|466780786|FG001|Overall Study|Withdrawal by Subject|1|||
129677728|NCT02966834|466780787|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129677729|NCT02966834|466780788|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129677730|NCT02966834|466780789|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129677731|NCT02966834|466780790|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129677732|NCT02966834|466780791|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
129677733|NCT02966834|466780792|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
129677734|NCT02966834|466780787|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
129677735|NCT02966834|466780788|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129677736|NCT02966834|466780789|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129677737|NCT02966834|466780790|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129677738|NCT02966834|466780791|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129677739|NCT02966834|466780792|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129677740|NCT02966834|466780787|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
129677741|NCT02966834|466780788|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
129677742|NCT02966834|466780789|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
129677743|NCT02966834|466780790|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
129677744|NCT02966834|466780791|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
129677745|NCT02966834|466780792|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
129677746|NCT02966834|466780787|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
129677747|NCT02966834|466780788|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
129677748|NCT02966834|466780789|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
129677749|NCT02966834|466780790|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
129677750|NCT02966834|466780791|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
129677751|NCT02966834|466780792|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
129677752|NCT02966834|466780787|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129677753|NCT02966834|466780788|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129677754|NCT02966834|466780789|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129677755|NCT02966834|466780790|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
129677756|NCT02966834|466780791|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129677757|NCT02966834|466780792|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129677758|NCT02966834|466780787|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129677759|NCT02966834|466780788|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129677760|NCT02966834|466780789|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129677761|NCT02966834|466780790|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
129677762|NCT02966834|466780791|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129677763|NCT02966834|466780792|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
129677764|NCT03729362|466782281|FG000|Overall Study|Withdrawal by Subject|2|||
129677765|NCT03729362|466782282|FG001|Overall Study|Withdrawal by Subject|0|||
129677766|NCT03729362|466782281|FG000|Overall Study|Physician Decision|1|||
129677767|NCT03729362|466782282|FG001|Overall Study|Physician Decision|0|||
129677768|NCT03729362|466782281|FG000|Overall Study|COVID-19 Pandemic|1|||
129677769|NCT03729362|466782282|FG001|Overall Study|COVID-19 Pandemic|0|||
129677770|NCT03729362|466782281|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
129677771|NCT03729362|466782282|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
129677772|NCT03729362|466782281|FG000|Overall Study|Adverse Event|0|||
129677773|NCT03729362|466782282|FG001|Overall Study|Adverse Event|1|||
129677774|NCT03729362|466782281|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
129677775|NCT03729362|466782282|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
129677776|NCT02711137|466782283|FG000|Overall Study|Death|1|||
129677777|NCT02711137|466782284|FG001|Overall Study|Death|4|||
129677778|NCT02711137|466782285|FG002|Overall Study|Death|5|||
129677779|NCT02711137|466782286|FG003|Overall Study|Death|5|||
129677780|NCT02711137|466782287|FG004|Overall Study|Death|3|||
129677781|NCT02711137|466782288|FG005|Overall Study|Death|1|||
129677782|NCT02711137|466782289|FG006|Overall Study|Death|61|||
129677783|NCT02711137|466782290|FG007|Overall Study|Death|3|||
129677784|NCT02711137|466782291|FG008|Overall Study|Death|0|||
129677785|NCT02711137|466782292|FG009|Overall Study|Death|1|||
129677786|NCT02711137|466782293|FG010|Overall Study|Death|1|||
129677787|NCT02711137|466782294|FG011|Overall Study|Death|1|||
129677788|NCT02711137|466782295|FG012|Overall Study|Death|0|||
129677789|NCT02711137|466782296|FG013|Overall Study|Death|0|||
129677790|NCT02711137|466782297|FG014|Overall Study|Death|0|||
129677791|NCT02711137|466782283|FG000|Overall Study|Study Terminated by Sponsor|0|||
129677792|NCT02711137|466782284|FG001|Overall Study|Study Terminated by Sponsor|0|||
129677793|NCT02711137|466782285|FG002|Overall Study|Study Terminated by Sponsor|1|||
129768541|NCT04323124|467118415|FG009|Overall Study|Coming from a red zone (COVID)|0|||
129768542|NCT04323124|467118416|FG010|Overall Study|Coming from a red zone (COVID)|0|||
129768543|NCT04323124|467118417|FG011|Overall Study|Coming from a red zone (COVID)|0|||
129677794|NCT02711137|466782286|FG003|Overall Study|Study Terminated by Sponsor|0|||
129677795|NCT02711137|466782287|FG004|Overall Study|Study Terminated by Sponsor|0|||
129677796|NCT02711137|466782288|FG005|Overall Study|Study Terminated by Sponsor|0|||
129677797|NCT02711137|466782289|FG006|Overall Study|Study Terminated by Sponsor|1|||
129677798|NCT02711137|466782290|FG007|Overall Study|Study Terminated by Sponsor|0|||
129677799|NCT02711137|466782291|FG008|Overall Study|Study Terminated by Sponsor|0|||
129677800|NCT02711137|466782292|FG009|Overall Study|Study Terminated by Sponsor|0|||
129677801|NCT02711137|466782293|FG010|Overall Study|Study Terminated by Sponsor|0|||
129677802|NCT02711137|466782294|FG011|Overall Study|Study Terminated by Sponsor|0|||
129677803|NCT02711137|466782295|FG012|Overall Study|Study Terminated by Sponsor|0|||
129677804|NCT02711137|466782296|FG013|Overall Study|Study Terminated by Sponsor|0|||
129677805|NCT02711137|466782297|FG014|Overall Study|Study Terminated by Sponsor|0|||
129677806|NCT02711137|466782283|FG000|Overall Study|Physician Decision|1|||
129677807|NCT02711137|466782284|FG001|Overall Study|Physician Decision|0|||
129677808|NCT02711137|466782285|FG002|Overall Study|Physician Decision|2|||
129677809|NCT02711137|466782286|FG003|Overall Study|Physician Decision|1|||
129677810|NCT02711137|466782287|FG004|Overall Study|Physician Decision|1|||
129677811|NCT02711137|466782288|FG005|Overall Study|Physician Decision|0|||
129677812|NCT02711137|466782289|FG006|Overall Study|Physician Decision|12|||
129677813|NCT02711137|466782290|FG007|Overall Study|Physician Decision|2|||
129677814|NCT02711137|466782291|FG008|Overall Study|Physician Decision|1|||
129677815|NCT02711137|466782292|FG009|Overall Study|Physician Decision|1|||
129677816|NCT02711137|466782293|FG010|Overall Study|Physician Decision|3|||
129677817|NCT02711137|466782294|FG011|Overall Study|Physician Decision|2|||
129677818|NCT02711137|466782295|FG012|Overall Study|Physician Decision|1|||
129677819|NCT02711137|466782296|FG013|Overall Study|Physician Decision|1|||
129677820|NCT02711137|466782297|FG014|Overall Study|Physician Decision|2|||
129677821|NCT02711137|466782283|FG000|Overall Study|Other|0|||
129677822|NCT02711137|466782284|FG001|Overall Study|Other|1|||
129677823|NCT02711137|466782285|FG002|Overall Study|Other|0|||
129677824|NCT02711137|466782286|FG003|Overall Study|Other|0|||
129677825|NCT02711137|466782287|FG004|Overall Study|Other|0|||
129677826|NCT02711137|466782288|FG005|Overall Study|Other|0|||
129677827|NCT02711137|466782289|FG006|Overall Study|Other|3|||
129677828|NCT02711137|466782290|FG007|Overall Study|Other|0|||
129677829|NCT02711137|466782291|FG008|Overall Study|Other|0|||
129677830|NCT02711137|466782292|FG009|Overall Study|Other|0|||
129677831|NCT02711137|466782293|FG010|Overall Study|Other|0|||
129677832|NCT02711137|466782294|FG011|Overall Study|Other|0|||
129677833|NCT02711137|466782295|FG012|Overall Study|Other|0|||
129677834|NCT02711137|466782296|FG013|Overall Study|Other|0|||
129677835|NCT02711137|466782297|FG014|Overall Study|Other|1|||
129677836|NCT02711137|466782283|FG000|Overall Study|Withdrawal by Subject|1|||
129677837|NCT02711137|466782284|FG001|Overall Study|Withdrawal by Subject|0|||
129677838|NCT02711137|466782285|FG002|Overall Study|Withdrawal by Subject|0|||
129677839|NCT02711137|466782286|FG003|Overall Study|Withdrawal by Subject|1|||
129677840|NCT02711137|466782287|FG004|Overall Study|Withdrawal by Subject|1|||
129677841|NCT02711137|466782288|FG005|Overall Study|Withdrawal by Subject|0|||
129677842|NCT02711137|466782289|FG006|Overall Study|Withdrawal by Subject|7|||
129677843|NCT02711137|466782290|FG007|Overall Study|Withdrawal by Subject|0|||
129677844|NCT02711137|466782291|FG008|Overall Study|Withdrawal by Subject|0|||
129677845|NCT02711137|466782292|FG009|Overall Study|Withdrawal by Subject|0|||
129677846|NCT02711137|466782293|FG010|Overall Study|Withdrawal by Subject|0|||
129768544|NCT04323124|467118418|FG012|Overall Study|Coming from a red zone (COVID)|0|||
129768545|NCT04323124|467118419|FG013|Overall Study|Coming from a red zone (COVID)|0|||
129768546|NCT04323124|467118420|FG014|Overall Study|Coming from a red zone (COVID)|0|||
129768547|NCT04323124|467118406|FG000|Overall Study|No longer meets eligibility criteria|0|||
129768548|NCT04323124|467118407|FG001|Overall Study|No longer meets eligibility criteria|0|||
129768549|NCT04323124|467118408|FG002|Overall Study|No longer meets eligibility criteria|0|||
129768550|NCT04323124|467118409|FG003|Overall Study|No longer meets eligibility criteria|0|||
129768551|NCT04323124|467118410|FG004|Overall Study|No longer meets eligibility criteria|0|||
129768552|NCT04323124|467118411|FG005|Overall Study|No longer meets eligibility criteria|0|||
129768553|NCT04323124|467118412|FG006|Overall Study|No longer meets eligibility criteria|0|||
129768554|NCT04323124|467118413|FG007|Overall Study|No longer meets eligibility criteria|1|||
129768555|NCT04323124|467118414|FG008|Overall Study|No longer meets eligibility criteria|0|||
129768556|NCT04323124|467118415|FG009|Overall Study|No longer meets eligibility criteria|0|||
129768557|NCT04323124|467118416|FG010|Overall Study|No longer meets eligibility criteria|0|||
129768558|NCT04323124|467118417|FG011|Overall Study|No longer meets eligibility criteria|0|||
129768559|NCT04323124|467118418|FG012|Overall Study|No longer meets eligibility criteria|0|||
129768560|NCT04323124|467118419|FG013|Overall Study|No longer meets eligibility criteria|1|||
129768561|NCT04323124|467118420|FG014|Overall Study|No longer meets eligibility criteria|1|||
129768562|NCT04323124|467118406|FG000|Overall Study|Study terminated by sponsor|0|||
129768563|NCT04323124|467118407|FG001|Overall Study|Study terminated by sponsor|0|||
129768564|NCT04323124|467118408|FG002|Overall Study|Study terminated by sponsor|0|||
129768565|NCT04323124|467118409|FG003|Overall Study|Study terminated by sponsor|0|||
129768566|NCT04323124|467118410|FG004|Overall Study|Study terminated by sponsor|0|||
129768567|NCT04323124|467118411|FG005|Overall Study|Study terminated by sponsor|0|||
129768568|NCT04323124|467118412|FG006|Overall Study|Study terminated by sponsor|0|||
129768569|NCT04323124|467118413|FG007|Overall Study|Study terminated by sponsor|0|||
129768570|NCT04323124|467118414|FG008|Overall Study|Study terminated by sponsor|0|||
129768571|NCT04323124|467118415|FG009|Overall Study|Study terminated by sponsor|0|||
129768572|NCT04323124|467118416|FG010|Overall Study|Study terminated by sponsor|0|||
129768573|NCT04323124|467118417|FG011|Overall Study|Study terminated by sponsor|2|||
129677847|NCT02711137|466782294|FG011|Overall Study|Withdrawal by Subject|0|||
129677848|NCT02711137|466782295|FG012|Overall Study|Withdrawal by Subject|0|||
129677849|NCT02711137|466782296|FG013|Overall Study|Withdrawal by Subject|1|||
129677850|NCT02711137|466782297|FG014|Overall Study|Withdrawal by Subject|0|||
129677851|NCT02711137|466782283|FG000|Overall Study|Lost to Follow-up|1|||
129677852|NCT02711137|466782284|FG001|Overall Study|Lost to Follow-up|0|||
129677853|NCT02711137|466782285|FG002|Overall Study|Lost to Follow-up|0|||
129677854|NCT02711137|466782286|FG003|Overall Study|Lost to Follow-up|0|||
129677855|NCT02711137|466782287|FG004|Overall Study|Lost to Follow-up|0|||
129677856|NCT02711137|466782288|FG005|Overall Study|Lost to Follow-up|0|||
129677857|NCT02711137|466782289|FG006|Overall Study|Lost to Follow-up|2|||
129677858|NCT02711137|466782290|FG007|Overall Study|Lost to Follow-up|0|||
129677859|NCT02711137|466782291|FG008|Overall Study|Lost to Follow-up|0|||
129677860|NCT02711137|466782292|FG009|Overall Study|Lost to Follow-up|0|||
129677861|NCT02711137|466782293|FG010|Overall Study|Lost to Follow-up|0|||
129677862|NCT02711137|466782294|FG011|Overall Study|Lost to Follow-up|0|||
129677863|NCT02711137|466782295|FG012|Overall Study|Lost to Follow-up|0|||
129677864|NCT02711137|466782296|FG013|Overall Study|Lost to Follow-up|0|||
129677865|NCT02711137|466782297|FG014|Overall Study|Lost to Follow-up|0|||
129677866|NCT01113749|466782298|FG000|Overall Study|Lost to Follow-up|1|||
129677867|NCT01113749|466782299|FG001|Overall Study|Lost to Follow-up|2|||
129677868|NCT03427892|466782300|FG000|Overall Study|Lost to Follow-up|2|||
129677869|NCT00548327|466782301|FG000|Overall Study|Adverse Event|0|||
129677870|NCT00548327|466782302|FG001|Overall Study|Adverse Event|1|||
129677871|NCT00274456|466782306|FG000|Overall Study|Still on treatment|2|||
129677872|NCT00274456|466782307|FG001|Overall Study|Still on treatment|3|||
129677873|NCT00274456|466782308|FG002|Overall Study|Still on treatment|5|||
129677874|NCT00274456|466782309|FG003|Overall Study|Still on treatment|1|||
129677875|NCT00274456|466782306|FG000|Overall Study|Unacceptable toxicity|10|||
129677876|NCT00274456|466782307|FG001|Overall Study|Unacceptable toxicity|5|||
129677877|NCT00274456|466782308|FG002|Overall Study|Unacceptable toxicity|12|||
129677878|NCT00274456|466782309|FG003|Overall Study|Unacceptable toxicity|16|||
129677879|NCT00274456|466782306|FG000|Overall Study|Adverse Event|0|||
129677880|NCT00274456|466782307|FG001|Overall Study|Adverse Event|1|||
129677881|NCT00274456|466782308|FG002|Overall Study|Adverse Event|2|||
129677882|NCT00274456|466782309|FG003|Overall Study|Adverse Event|2|||
129677883|NCT00274456|466782306|FG000|Overall Study|Physician Decision|7|||
129677884|NCT00274456|466782307|FG001|Overall Study|Physician Decision|5|||
129677885|NCT00274456|466782308|FG002|Overall Study|Physician Decision|6|||
129677886|NCT00274456|466782309|FG003|Overall Study|Physician Decision|13|||
129677887|NCT00274456|466782306|FG000|Overall Study|Lost to Follow-up|0|||
129677888|NCT00274456|466782307|FG001|Overall Study|Lost to Follow-up|0|||
129677889|NCT00274456|466782308|FG002|Overall Study|Lost to Follow-up|1|||
129677890|NCT00274456|466782309|FG003|Overall Study|Lost to Follow-up|0|||
129677891|NCT00274456|466782306|FG000|Overall Study|Withdrawal by Subject|18|||
129677892|NCT00274456|466782307|FG001|Overall Study|Withdrawal by Subject|13|||
129677893|NCT00274456|466782308|FG002|Overall Study|Withdrawal by Subject|9|||
129677894|NCT00274456|466782309|FG003|Overall Study|Withdrawal by Subject|13|||
129677895|NCT03255187|466782310|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
129677896|NCT03255187|466782311|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
129677897|NCT03255187|466782310|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
129677898|NCT03255187|466782311|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
129677899|NCT00375752|466782312|FG000|Overall Study|Lack of Efficacy|4|||
129677900|NCT00375752|466782313|FG001|Overall Study|Lack of Efficacy|4|||
129677901|NCT00375752|466782312|FG000|Overall Study|Adverse Event|1|||
129677902|NCT00375752|466782313|FG001|Overall Study|Adverse Event|6|||
129677903|NCT00375752|466782312|FG000|Overall Study|Withdrawal by Subject|6|||
129677904|NCT00375752|466782313|FG001|Overall Study|Withdrawal by Subject|1|||
129677905|NCT00375752|466782312|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129677906|NCT00375752|466782313|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
129677907|NCT00375752|466782312|FG000|Overall Study|Protocol Violation|0|||
129677908|NCT00375752|466782313|FG001|Overall Study|Protocol Violation|2|||
129677909|NCT00375752|466782312|FG000|Overall Study|Administrative Problems|0|||
129677910|NCT00375752|466782313|FG001|Overall Study|Administrative Problems|1|||
129677911|NCT02034006|466782314|FG000|Overall Study|Withdrawal by Subject|7|||
129677912|NCT02034006|466782314|FG000|Overall Study|Lost to Follow-up|5|||
129677913|NCT02034006|466782314|FG000|Overall Study|Death|1|||
129677914|NCT02034006|466782314|FG000|Overall Study|Pregnancy|1|||
129677915|NCT00109343|466782315|FG000|Overall Study|Adverse Event|1|||
129677916|NCT00109343|466782316|FG001|Overall Study|Adverse Event|0|||
129677917|NCT00109343|466782317|FG002|Overall Study|Adverse Event|2|||
129677918|NCT00109343|466782315|FG000|Overall Study|Lack of Efficacy|1|||
129677919|NCT00109343|466782316|FG001|Overall Study|Lack of Efficacy|0|||
129677920|NCT00109343|466782317|FG002|Overall Study|Lack of Efficacy|0|||
129677921|NCT00109343|466782315|FG000|Overall Study|Lost to Follow-up|35|||
129677922|NCT00109343|466782316|FG001|Overall Study|Lost to Follow-up|20|||
129677923|NCT00109343|466782317|FG002|Overall Study|Lost to Follow-up|14|||
129677924|NCT00109343|466782315|FG000|Overall Study|Protocol Violation|1|||
129677925|NCT00109343|466782316|FG001|Overall Study|Protocol Violation|2|||
129677926|NCT00109343|466782317|FG002|Overall Study|Protocol Violation|2|||
129677927|NCT00109343|466782315|FG000|Overall Study|Withdrawal by Subject|15|||
129677928|NCT00109343|466782316|FG001|Overall Study|Withdrawal by Subject|11|||
129677929|NCT00109343|466782317|FG002|Overall Study|Withdrawal by Subject|10|||
129677930|NCT00109343|466782315|FG000|Overall Study|Subject Moved|6|||
129677931|NCT00109343|466782316|FG001|Overall Study|Subject Moved|2|||
129677932|NCT00109343|466782317|FG002|Overall Study|Subject Moved|1|||
129677933|NCT00109343|466782315|FG000|Overall Study|Other|5|||
129677934|NCT00109343|466782316|FG001|Overall Study|Other|2|||
129677935|NCT00109343|466782317|FG002|Overall Study|Other|1|||
129677936|NCT00750269|466782318|FG000|Overall Study|Protocol Violation|0|||
129768574|NCT04323124|467118418|FG012|Overall Study|Study terminated by sponsor|1|||
129768575|NCT04323124|467118419|FG013|Overall Study|Study terminated by sponsor|0|||
129768576|NCT04323124|467118420|FG014|Overall Study|Study terminated by sponsor|0|||
129768577|NCT00489307|467118421|FG000|Overall Study|Death|1|||
129768578|NCT00489307|467118422|FG001|Overall Study|Death|1|||
129768579|NCT00489307|467118421|FG000|Overall Study|Lost to Follow-up|2|||
129768580|NCT00489307|467118422|FG001|Overall Study|Lost to Follow-up|2|||
129768581|NCT00489307|467118421|FG000|Overall Study|Physician Decision|1|||
129768582|NCT00489307|467118422|FG001|Overall Study|Physician Decision|0|||
129768583|NCT00489307|467118421|FG000|Overall Study|Withdrawal by Subject|2|||
129768584|NCT00489307|467118422|FG001|Overall Study|Withdrawal by Subject|4|||
129768585|NCT00489307|467118421|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
129768586|NCT00489307|467118422|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
129768587|NCT00489307|467118421|FG000|Overall Study|Surgery after assignment|1|||
129768588|NCT00489307|467118422|FG001|Overall Study|Surgery after assignment|0|||
129768589|NCT00489307|467118421|FG000|Overall Study|Did not fill up the forms|2|||
129768590|NCT00489307|467118422|FG001|Overall Study|Did not fill up the forms|1|||
129768591|NCT00489307|467118421|FG000|Overall Study|Patient or family refusal|5|||
129768592|NCT00489307|467118422|FG001|Overall Study|Patient or family refusal|9|||
129768593|NCT03204188|467118425|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
129768594|NCT03204188|467118425|FG000|Immunotherapy Phase (1 Year)|Death|1|||
129768595|NCT03204188|467118425|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
129768596|NCT03204188|467118425|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
129768597|NCT01520506|467119720|FG000|Overall Study|Missed Visit|4|||
129768598|NCT01520506|467119720|FG000|Overall Study|Lost to Follow-up|1|||
129768599|NCT01520506|467119720|FG000|Overall Study|Withdrawal by Subject|1|||
129768600|NCT00425269|467119721|FG000|Overall Study|Pregnancy|5|||
129768601|NCT00425269|467119722|FG001|Overall Study|Pregnancy|7|||
129768602|NCT00425269|467119721|FG000|Overall Study|Lost to Follow-up|9|||
129768603|NCT00425269|467119722|FG001|Overall Study|Lost to Follow-up|9|||
129768604|NCT00425269|467119721|FG000|Overall Study|moved or medical reason|5|||
129768605|NCT00425269|467119722|FG001|Overall Study|moved or medical reason|4|||
129768606|NCT01084655|467119727|FG000|Overall Study|Radiographic disease progression|3|||
129768607|NCT01084655|467119728|FG001|Overall Study|Radiographic disease progression|2|||
129768608|NCT01084655|467119729|FG002|Overall Study|Radiographic disease progression|8|||
129768609|NCT01084655|467119727|FG000|Overall Study|Withdrawal by Subject|1|||
129768610|NCT01084655|467119728|FG001|Overall Study|Withdrawal by Subject|0|||
129768611|NCT01084655|467119729|FG002|Overall Study|Withdrawal by Subject|4|||
129768612|NCT01084655|467119727|FG000|Overall Study|Adverse Event|2|||
129768613|NCT01084655|467119728|FG001|Overall Study|Adverse Event|1|||
129768614|NCT01084655|467119729|FG002|Overall Study|Adverse Event|2|||
129768615|NCT01084655|467119727|FG000|Overall Study|Other|0|||
129768616|NCT01084655|467119728|FG001|Overall Study|Other|3|||
129768617|NCT01084655|467119729|FG002|Overall Study|Other|2|||
129768618|NCT01084655|467119727|FG000|Overall Study|Symptomatic deterioration|0|||
129768619|NCT01084655|467119728|FG001|Overall Study|Symptomatic deterioration|0|||
129768620|NCT01084655|467119729|FG002|Overall Study|Symptomatic deterioration|2|||
129768621|NCT01084655|467119727|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
129768622|NCT01084655|467119728|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
129768623|NCT01084655|467119729|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
129768624|NCT00535496|467119730|FG000|Overall Study|Lost to Follow-up|0|||
129768625|NCT00535496|467119731|FG001|Overall Study|Lost to Follow-up|1|||
129768626|NCT00535496|467119732|FG002|Overall Study|Lost to Follow-up|0|||
129768627|NCT00535496|467119733|FG003|Overall Study|Lost to Follow-up|0|||
129768628|NCT00535496|467119730|FG000|Overall Study|Not treated with sugammadex|0|||
129768629|NCT00535496|467119731|FG001|Overall Study|Not treated with sugammadex|1|||
129768630|NCT00535496|467119732|FG002|Overall Study|Not treated with sugammadex|0|||
129768631|NCT00535496|467119733|FG003|Overall Study|Not treated with sugammadex|0|||
129768632|NCT02326155|467119734|FG000|Overall Study|Adverse Event|21|||
129768633|NCT02326155|467119735|FG001|Overall Study|Adverse Event|5|||
129768634|NCT02326155|467119734|FG000|Overall Study|Death|3|||
129768635|NCT02326155|467119735|FG001|Overall Study|Death|0|||
129768636|NCT02326155|467119734|FG000|Overall Study|Lack of Efficacy|49|||
129768637|NCT02326155|467119735|FG001|Overall Study|Lack of Efficacy|5|||
129768638|NCT02326155|467119734|FG000|Overall Study|Lost to Follow-up|14|||
129768639|NCT02326155|467119735|FG001|Overall Study|Lost to Follow-up|3|||
129768640|NCT02326155|467119734|FG000|Overall Study|Protocol Violation|2|||
129768641|NCT02326155|467119735|FG001|Overall Study|Protocol Violation|0|||
129768642|NCT02326155|467119734|FG000|Overall Study|Withdrawal by Subject|34|||
129768643|NCT02326155|467119735|FG001|Overall Study|Withdrawal by Subject|11|||
129768644|NCT02326155|467119734|FG000|Overall Study|Disease progression|37|||
129768645|NCT02326155|467119735|FG001|Overall Study|Disease progression|4|||
129768646|NCT02326155|467119734|FG000|Overall Study|Study close|188|||
129768647|NCT02326155|467119735|FG001|Overall Study|Study close|21|||
129768648|NCT02326155|467119734|FG000|Overall Study|except for study close|46|||
129768649|NCT02326155|467119735|FG001|Overall Study|except for study close|13|||
129768650|NCT05024032|467119736|FG000|Overall Study|Withdrawal by Subject|0|||
129768651|NCT05024032|467119737|FG001|Overall Study|Withdrawal by Subject|3|||
129768652|NCT05024032|467119738|FG002|Overall Study|Withdrawal by Subject|4|||
129768653|NCT05024032|467119736|FG000|Overall Study|Adverse Event|0|||
129768654|NCT05024032|467119737|FG001|Overall Study|Adverse Event|1|||
129768655|NCT05024032|467119738|FG002|Overall Study|Adverse Event|0|||
129768656|NCT05024032|467119736|FG000|Overall Study|Protocol Deviation|1|||
129768657|NCT05024032|467119737|FG001|Overall Study|Protocol Deviation|0|||
129768658|NCT05024032|467119738|FG002|Overall Study|Protocol Deviation|0|||
129768659|NCT03714672|467119741|FG000|Overall Study|Adverse Event|0|||
129768660|NCT03714672|467119742|FG001|Overall Study|Adverse Event|0|||
129768661|NCT03714672|467119743|FG002|Overall Study|Adverse Event|3|||
129768662|NCT03714672|467119744|FG003|Overall Study|Adverse Event|0|||
129768663|NCT03714672|467119741|FG000|Overall Study|Physician Decision|0|||
129768664|NCT03714672|467119742|FG001|Overall Study|Physician Decision|1|||
129768665|NCT03714672|467119743|FG002|Overall Study|Physician Decision|0|||
129768666|NCT03714672|467119744|FG003|Overall Study|Physician Decision|0|||
129768667|NCT03714672|467119741|FG000|Overall Study|Other Reason|1|||
129768668|NCT03714672|467119742|FG001|Overall Study|Other Reason|2|||
129768669|NCT03714672|467119743|FG002|Overall Study|Other Reason|1|||
129768670|NCT03714672|467119744|FG003|Overall Study|Other Reason|1|||
129768671|NCT03714672|467119741|FG000|Overall Study|Lost to Follow-up|1|||
129768672|NCT03714672|467119742|FG001|Overall Study|Lost to Follow-up|1|||
129768673|NCT03714672|467119743|FG002|Overall Study|Lost to Follow-up|0|||
129768674|NCT03714672|467119744|FG003|Overall Study|Lost to Follow-up|0|||
129768675|NCT02345070|467119745|FG000|Overall Study|Adverse Event|12|||
129768676|NCT02345070|467119746|FG001|Overall Study|Adverse Event|8|||
129768677|NCT02345070|467119747|FG002|Overall Study|Adverse Event|16|||
129768678|NCT02345070|467119745|FG000|Overall Study|Poor compliance to protocol|2|||
129768679|NCT02345070|467119746|FG001|Overall Study|Poor compliance to protocol|0|||
129768680|NCT02345070|467119747|FG002|Overall Study|Poor compliance to protocol|0|||
129768681|NCT02345070|467119745|FG000|Overall Study|Other than specified above|6|||
129768682|NCT02345070|467119746|FG001|Overall Study|Other than specified above|3|||
129768683|NCT02345070|467119747|FG002|Overall Study|Other than specified above|7|||
129768684|NCT05101122|467119748|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
129768685|NCT05101122|467119748|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
129768686|NCT05101122|467119748|FG000|AD313 80/5|Withdrawal by Subject|1|||
129768687|NCT05101122|467119748|FG000|AD313 80/10|Physician Decision|1|||
129768688|NCT04945733|467119749|FG000|Overall Study|Physician Decision|1|||
129768689|NCT04945733|467119750|FG001|Overall Study|Physician Decision|3|||
129768690|NCT04945733|467119751|FG002|Overall Study|Physician Decision|0|||
129768691|NCT04945733|467119749|FG000|Overall Study|Withdrawal by Subject|3|||
129768692|NCT04945733|467119750|FG001|Overall Study|Withdrawal by Subject|3|||
129768693|NCT04945733|467119751|FG002|Overall Study|Withdrawal by Subject|0|||
129768694|NCT05660577|467119754|FG000|Overall Study|Discontinued|9|||
129768695|NCT03363841|467119757|FG000|Overall Study|Adverse Event|1|||
129768696|NCT03363841|467119757|FG000|Overall Study|Withdrawal by Subject|1|||
129768697|NCT03363841|467119757|FG000|Overall Study|Death|7|||
129768698|NCT03363841|467119757|FG000|Overall Study|Physician Decision|1|||
129768699|NCT00886379|467119760|FG000|Overall Study|Transferred Schools|0|||
129768700|NCT00886379|467119761|FG001|Overall Study|Transferred Schools|0|||
129768701|NCT00886379|467119762|FG002|Overall Study|Transferred Schools|2|||
129768702|NCT00886379|467119763|FG003|Overall Study|Transferred Schools|1|||
129768703|NCT00886379|467119764|FG004|Overall Study|Transferred Schools|1|||
129768704|NCT00886379|467119760|FG000|Overall Study|Final blood draw not obtained|3|||
129768705|NCT00886379|467119761|FG001|Overall Study|Final blood draw not obtained|3|||
129768706|NCT00886379|467119762|FG002|Overall Study|Final blood draw not obtained|4|||
129768707|NCT00886379|467119763|FG003|Overall Study|Final blood draw not obtained|2|||
129768708|NCT00886379|467119764|FG004|Overall Study|Final blood draw not obtained|2|||
129768709|NCT04558125|467119765|FG000|Overall Study|Death|1|||
129768710|NCT03137381|467119766|FG000|Overall Study|Adverse Event|3|||
129768711|NCT03137381|467119767|FG001|Overall Study|Adverse Event|0|||
129768712|NCT03137381|467119768|FG002|Overall Study|Adverse Event|2|||
129768713|NCT03137381|467119769|FG003|Overall Study|Adverse Event|0|||
129768714|NCT03137381|467119766|FG000|Overall Study|Lost to Follow-up|2|||
129768715|NCT03137381|467119767|FG001|Overall Study|Lost to Follow-up|1|||
129768716|NCT03137381|467119768|FG002|Overall Study|Lost to Follow-up|1|||
129768717|NCT03137381|467119769|FG003|Overall Study|Lost to Follow-up|0|||
129768718|NCT03137381|467119766|FG000|Overall Study|Protocol deviation|1|||
129768719|NCT03137381|467119767|FG001|Overall Study|Protocol deviation|1|||
129677937|NCT00750269|466782319|FG001|Overall Study|Protocol Violation|1|||
129677938|NCT00750269|466782320|FG002|Overall Study|Protocol Violation|1|||
129677939|NCT00750269|466782321|FG003|Overall Study|Protocol Violation|2|||
129677940|NCT00750269|466782322|FG004|Overall Study|Protocol Violation|4|||
129677941|NCT00750269|466782318|FG000|Overall Study|Withdrawal by Subject|0|||
129677942|NCT00750269|466782319|FG001|Overall Study|Withdrawal by Subject|0|||
129677943|NCT00750269|466782320|FG002|Overall Study|Withdrawal by Subject|2|||
129677944|NCT00750269|466782321|FG003|Overall Study|Withdrawal by Subject|2|||
129677945|NCT00750269|466782322|FG004|Overall Study|Withdrawal by Subject|2|||
129677946|NCT00750269|466782318|FG000|Overall Study|Physician Decision|0|||
129677947|NCT00750269|466782319|FG001|Overall Study|Physician Decision|0|||
129677948|NCT00750269|466782320|FG002|Overall Study|Physician Decision|0|||
129677949|NCT00750269|466782321|FG003|Overall Study|Physician Decision|0|||
129677950|NCT00750269|466782322|FG004|Overall Study|Physician Decision|2|||
129677951|NCT00750269|466782318|FG000|Overall Study|Patient too large for positioning|0|||
129677952|NCT00750269|466782319|FG001|Overall Study|Patient too large for positioning|0|||
129677953|NCT00750269|466782320|FG002|Overall Study|Patient too large for positioning|1|||
129677954|NCT00750269|466782321|FG003|Overall Study|Patient too large for positioning|0|||
129677955|NCT00750269|466782322|FG004|Overall Study|Patient too large for positioning|0|||
129677956|NCT00750269|466782318|FG000|Overall Study|Site error|0|||
129677957|NCT00750269|466782319|FG001|Overall Study|Site error|0|||
129677958|NCT00750269|466782320|FG002|Overall Study|Site error|0|||
129677959|NCT00750269|466782321|FG003|Overall Study|Site error|1|||
129677960|NCT00750269|466782322|FG004|Overall Study|Site error|0|||
129677961|NCT00750269|466782318|FG000|Overall Study|SBRT plan could not be drawn|0|||
129677962|NCT00750269|466782319|FG001|Overall Study|SBRT plan could not be drawn|0|||
129677963|NCT00750269|466782320|FG002|Overall Study|SBRT plan could not be drawn|0|||
129677964|NCT00750269|466782321|FG003|Overall Study|SBRT plan could not be drawn|0|||
129677965|NCT00750269|466782322|FG004|Overall Study|SBRT plan could not be drawn|1|||
129677966|NCT00750269|466782318|FG000|Overall Study|Fiducials could not be placed|0|||
129677967|NCT00750269|466782319|FG001|Overall Study|Fiducials could not be placed|0|||
129677968|NCT00750269|466782320|FG002|Overall Study|Fiducials could not be placed|0|||
129677969|NCT00750269|466782321|FG003|Overall Study|Fiducials could not be placed|0|||
129677970|NCT00750269|466782322|FG004|Overall Study|Fiducials could not be placed|1|||
129677971|NCT02100631|466782324|FG000|Overall Study|Withdrawal by Subject|1|||
129677972|NCT02100631|466782325|FG001|Overall Study|Withdrawal by Subject|0|||
129677973|NCT02100631|466782326|FG002|Overall Study|Withdrawal by Subject|0|||
129677974|NCT02100631|466782324|FG000|Overall Study|Lost to Follow-up|3|||
129677975|NCT02100631|466782325|FG001|Overall Study|Lost to Follow-up|4|||
129677976|NCT02100631|466782326|FG002|Overall Study|Lost to Follow-up|0|||
129677977|NCT02100631|466782324|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
129677978|NCT02100631|466782325|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
129677979|NCT02100631|466782326|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
129677980|NCT03944616|466782328|FG000|Overall Study|Lost to Follow-up|0|||
129677981|NCT03944616|466782329|FG001|Overall Study|Lost to Follow-up|2|||
129677982|NCT01721798|466782330|FG000|Overall Study|Death|0|||
129677983|NCT01721798|466782331|FG001|Overall Study|Death|0|||
129677984|NCT01721798|466782332|FG002|Overall Study|Death|1|||
129677985|NCT01721798|466782333|FG003|Overall Study|Death|1|||
129677986|NCT01721798|466782330|FG000|Overall Study|Lost to Follow-up|2|||
129677987|NCT01721798|466782331|FG001|Overall Study|Lost to Follow-up|2|||
129677988|NCT01721798|466782332|FG002|Overall Study|Lost to Follow-up|9|||
129677989|NCT01721798|466782333|FG003|Overall Study|Lost to Follow-up|9|||
129677990|NCT01721798|466782330|FG000|Overall Study|Pregnancy|0|||
129677991|NCT01721798|466782331|FG001|Overall Study|Pregnancy|0|||
129677992|NCT01721798|466782332|FG002|Overall Study|Pregnancy|1|||
129677993|NCT01721798|466782333|FG003|Overall Study|Pregnancy|1|||
129768720|NCT03137381|467119768|FG002|Overall Study|Protocol deviation|0|||
129768721|NCT03137381|467119769|FG003|Overall Study|Protocol deviation|1|||
129677994|NCT01721798|466782330|FG000|Overall Study|Withdrawal by Subject|1|||
129677995|NCT01721798|466782331|FG001|Overall Study|Withdrawal by Subject|0|||
129677996|NCT01721798|466782332|FG002|Overall Study|Withdrawal by Subject|2|||
129677997|NCT01721798|466782333|FG003|Overall Study|Withdrawal by Subject|1|||
129677998|NCT01721798|466782330|FG000|Overall Study|Not eligible for 24 month visit|1|||
129677999|NCT01721798|466782331|FG001|Overall Study|Not eligible for 24 month visit|0|||
129678000|NCT01721798|466782332|FG002|Overall Study|Not eligible for 24 month visit|8|||
129678001|NCT01721798|466782333|FG003|Overall Study|Not eligible for 24 month visit|7|||
129678002|NCT00961064|466782334|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
129678003|NCT00961064|466782334|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
129678004|NCT00961064|466782334|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
129678005|NCT00961064|466782334|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
129678006|NCT00961064|466782334|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
129678007|NCT00961064|466782334|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
129768722|NCT03137381|467119766|FG000|Overall Study|Withdrawal by Investigator|0|||
129768723|NCT03137381|467119767|FG001|Overall Study|Withdrawal by Investigator|1|||
129768724|NCT03137381|467119768|FG002|Overall Study|Withdrawal by Investigator|1|||
129768725|NCT03137381|467119769|FG003|Overall Study|Withdrawal by Investigator|0|||
129768726|NCT03137381|467119766|FG000|Overall Study|Withdrawal by Subject|3|||
129768727|NCT03137381|467119767|FG001|Overall Study|Withdrawal by Subject|4|||
129768728|NCT03137381|467119768|FG002|Overall Study|Withdrawal by Subject|3|||
129768729|NCT03137381|467119769|FG003|Overall Study|Withdrawal by Subject|0|||
129768730|NCT03137381|467119766|FG000|Overall Study|Pregnancy|0|||
129768731|NCT03137381|467119767|FG001|Overall Study|Pregnancy|0|||
129768732|NCT03137381|467119768|FG002|Overall Study|Pregnancy|1|||
129768733|NCT03137381|467119769|FG003|Overall Study|Pregnancy|0|||
129768734|NCT01980017|467119774|FG000|Overall Study|Lost to Follow-up|30|||
129768735|NCT01980017|467119775|FG001|Overall Study|Lost to Follow-up|21|||
129768736|NCT01980017|467119774|FG000|Overall Study|Death|0|||
129768737|NCT01980017|467119775|FG001|Overall Study|Death|1|||
129768738|NCT00910650|467119776|FG000|Overall Study|Death|2|||
129768739|NCT03367793|467119777|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129768740|NCT03367793|467119778|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129768741|NCT03367793|467119779|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
129768742|NCT03367793|467119780|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129768743|NCT03367793|467119781|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129768744|NCT03367793|467119782|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
129768745|NCT00423579|467119783|FG000|Overall Study|Lost to Follow-up|3|||
129768746|NCT00423579|467119784|FG001|Overall Study|Lost to Follow-up|0|||
129768747|NCT00423579|467119783|FG000|Overall Study|Protocol Violation|1|||
129768748|NCT00423579|467119784|FG001|Overall Study|Protocol Violation|3|||
129768749|NCT00423579|467119783|FG000|Overall Study|Diagnosis of diabetes|0|||
129768750|NCT00423579|467119784|FG001|Overall Study|Diagnosis of diabetes|1|||
129768751|NCT00106704|467119787|FG000|Overall Study|Adverse Event|10|||
129768752|NCT00106704|467119788|FG001|Overall Study|Adverse Event|7|||
129768753|NCT00106704|467119787|FG000|Overall Study|Death|2|||
129768754|NCT00106704|467119788|FG001|Overall Study|Death|1|||
129768755|NCT00106704|467119787|FG000|Overall Study|Lack of Efficacy|67|||
129768756|NCT00106704|467119788|FG001|Overall Study|Lack of Efficacy|69|||
129768757|NCT00106704|467119787|FG000|Overall Study|Lost to Follow-up|7|||
129768758|NCT00106704|467119788|FG001|Overall Study|Lost to Follow-up|3|||
129768759|NCT00106704|467119787|FG000|Overall Study|Pregnancy|1|||
129768760|NCT00106704|467119788|FG001|Overall Study|Pregnancy|0|||
129768761|NCT00106704|467119787|FG000|Overall Study|Protocol Violation|4|||
129768762|NCT00106704|467119788|FG001|Overall Study|Protocol Violation|7|||
129768763|NCT00106704|467119787|FG000|Overall Study|Withdrawal by Subject|14|||
129768764|NCT00106704|467119788|FG001|Overall Study|Withdrawal by Subject|21|||
129768765|NCT00106704|467119787|FG000|Overall Study|Patient moved|1|||
129768766|NCT00106704|467119788|FG001|Overall Study|Patient moved|0|||
129768767|NCT00106704|467119787|FG000|Overall Study|Site terminated|0|||
129768768|NCT00106704|467119788|FG001|Overall Study|Site terminated|1|||
129768769|NCT00106704|467119787|FG000|Overall Study|Planned major surgery|1|||
129768770|NCT00106704|467119788|FG001|Overall Study|Planned major surgery|0|||
129768771|NCT00106704|467119787|FG000|Overall Study|Patient Received Glycemic Medication|22|||
129768772|NCT00106704|467119788|FG001|Overall Study|Patient Received Glycemic Medication|41|||
129768773|NCT00106704|467119787|FG000|Overall Study|Unable to re-enter US|1|||
129768774|NCT00106704|467119788|FG001|Overall Study|Unable to re-enter US|0|||
129768775|NCT00106704|467119787|FG000|Overall Study|Laboratory test|1|||
129768776|NCT00106704|467119788|FG001|Overall Study|Laboratory test|1|||
129768777|NCT02224560|467119789|FG000|Overall Study|Protocol Deviation|1|||
129768778|NCT02224560|467119790|FG001|Overall Study|Protocol Deviation|0|||
129768779|NCT02224560|467119791|FG002|Overall Study|Protocol Deviation|0|||
129768780|NCT02224560|467119789|FG000|Overall Study|Withdrawal by Subject|2|||
129678008|NCT00961064|466782334|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
129678009|NCT00961064|466782334|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
129678010|NCT01294046|466782335|FG000|Overall Study|Infection and surgical explant|1|||
129678011|NCT01294046|466782335|FG000|Overall Study|Eligibility criteria expanded|1|||
129678012|NCT01294046|466782335|FG000|Overall Study|Stimulation response inadqequate|1|||
129678013|NCT00761319|466782336|FG000|Overall Study|Protocol Violation|21|||
129678014|NCT00761319|466782337|FG001|Overall Study|Protocol Violation|14|||
129678015|NCT00761319|466782336|FG000|Overall Study|Adverse Event|11|||
129678016|NCT00761319|466782337|FG001|Overall Study|Adverse Event|7|||
129678017|NCT00761319|466782336|FG000|Overall Study|Withdrawal by Subject|8|||
129678018|NCT00761319|466782337|FG001|Overall Study|Withdrawal by Subject|7|||
129678019|NCT00761319|466782336|FG000|Overall Study|Noncompliance|4|||
129678020|NCT00761319|466782337|FG001|Overall Study|Noncompliance|3|||
129678021|NCT00761319|466782336|FG000|Overall Study|Lost to Follow-up|1|||
129678022|NCT00761319|466782337|FG001|Overall Study|Lost to Follow-up|1|||
129678023|NCT00761319|466782336|FG000|Overall Study|Nonspecified|2|||
129678024|NCT00761319|466782337|FG001|Overall Study|Nonspecified|2|||
129678025|NCT00761319|466782336|FG000|Overall Study|Missing|1|||
129678026|NCT00761319|466782337|FG001|Overall Study|Missing|0|||
129678027|NCT00915525|466782338|FG000|Overall Study|Protocol Violation|9|||
129678028|NCT00915525|466782339|FG001|Overall Study|Protocol Violation|4|||
129678029|NCT00915525|466782338|FG000|Overall Study|Withdrawal by Subject|59|||
129678030|NCT00915525|466782339|FG001|Overall Study|Withdrawal by Subject|21|||
129678031|NCT00915525|466782338|FG000|Overall Study|Lost to Follow-up|27|||
129678032|NCT00915525|466782339|FG001|Overall Study|Lost to Follow-up|16|||
129678033|NCT00915525|466782338|FG000|Overall Study|Pregnancy|2|||
129678034|NCT00915525|466782339|FG001|Overall Study|Pregnancy|0|||
129678035|NCT00915525|466782338|FG000|Overall Study|Lack of Efficacy|15|||
129678036|NCT00915525|466782339|FG001|Overall Study|Lack of Efficacy|32|||
129678037|NCT00915525|466782338|FG000|Overall Study|Adverse Event|29|||
129678038|NCT00915525|466782339|FG001|Overall Study|Adverse Event|13|||
129678039|NCT00915525|466782338|FG000|Overall Study|Missing|12|||
129678040|NCT00915525|466782339|FG001|Overall Study|Missing|1|||
129678041|NCT00915525|466782338|FG000|Overall Study|Other Reason|35|||
129678042|NCT00915525|466782339|FG001|Overall Study|Other Reason|12|||
129678043|NCT00915525|466782338|FG000|Overall Study|Site Closed|27|||
129678044|NCT00915525|466782339|FG001|Overall Study|Site Closed|9|||
129678045|NCT00915525|466782338|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
129678046|NCT00915525|466782339|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
129678047|NCT00915525|466782338|FG000|Overall Study|Study Burden|28|||
129678048|NCT00915525|466782339|FG001|Overall Study|Study Burden|12|||
129678049|NCT00915525|466782338|FG000|Overall Study|Non-Compliance|3|||
129678050|NCT00915525|466782339|FG001|Overall Study|Non-Compliance|1|||
129678051|NCT00915525|466782338|FG000|Overall Study|Patient Moved|15|||
129678052|NCT00915525|466782339|FG001|Overall Study|Patient Moved|9|||
129678053|NCT02765035|466782340|FG000|First Intervention (90 Days)|Adverse Event|1|||
129678054|NCT02765035|466782341|FG001|First Intervention (90 Days)|Adverse Event|1|||
129678055|NCT02765035|466782340|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
129678056|NCT02765035|466782341|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
129678057|NCT01712178|466782350|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
129678058|NCT01712178|466782351|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
129678059|NCT01712178|466782350|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
129678060|NCT01712178|466782351|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
129678061|NCT01712178|466782350|FG000|Overall Study|Lost to Follow-up|0|||
129678062|NCT01712178|466782351|FG001|Overall Study|Lost to Follow-up|1|||
129678063|NCT00091819|466782352|FG000|Overall Study|Adverse Event|1|||
129678064|NCT00091819|466782353|FG001|Overall Study|Adverse Event|1|||
129678065|NCT00091819|466782352|FG000|Overall Study|Death|4|||
129678066|NCT00091819|466782353|FG001|Overall Study|Death|5|||
129678067|NCT00091819|466782352|FG000|Overall Study|Lost to Follow-up|26|||
129678068|NCT00091819|466782353|FG001|Overall Study|Lost to Follow-up|23|||
129678069|NCT00091819|466782352|FG000|Overall Study|Withdrawal by Subject|5|||
129678070|NCT00091819|466782353|FG001|Overall Study|Withdrawal by Subject|8|||
129678071|NCT00091819|466782352|FG000|Overall Study|Protocol Violation|1|||
129678072|NCT00091819|466782353|FG001|Overall Study|Protocol Violation|2|||
129678073|NCT00091819|466782352|FG000|Overall Study|Other|2|||
129678074|NCT00091819|466782353|FG001|Overall Study|Other|3|||
129678075|NCT00091819|466782352|FG000|Overall Study|Never received study treatment|3|||
129678076|NCT00091819|466782353|FG001|Overall Study|Never received study treatment|4|||
129678077|NCT00984867|466782354|FG000|Overall Study|Adverse Event|3|||
129678078|NCT00984867|466782355|FG001|Overall Study|Adverse Event|7|||
129678079|NCT00984867|466782354|FG000|Overall Study|Death|1|||
129678080|NCT00984867|466782355|FG001|Overall Study|Death|0|||
129678081|NCT00984867|466782354|FG000|Overall Study|Withdrawal by Subject|13|||
129678082|NCT00984867|466782355|FG001|Overall Study|Withdrawal by Subject|4|||
129678083|NCT00984867|466782354|FG000|Overall Study|Lost to Follow-up|3|||
129678084|NCT00984867|466782355|FG001|Overall Study|Lost to Follow-up|4|||
129678085|NCT00984867|466782354|FG000|Overall Study|Poor/non-compliance|0|||
129678086|NCT00984867|466782355|FG001|Overall Study|Poor/non-compliance|1|||
129678087|NCT00984867|466782354|FG000|Overall Study|Subject no longer meets study criteria|1|||
129884412|NCT02771210|467536387|FG000|Period 2|Adverse Event|1|||
129768781|NCT02224560|467119790|FG001|Overall Study|Withdrawal by Subject|0|||
129768782|NCT02224560|467119791|FG002|Overall Study|Withdrawal by Subject|1|||
129768783|NCT02224560|467119789|FG000|Overall Study|Met Withdrawal Criteria|1|||
129768784|NCT02224560|467119790|FG001|Overall Study|Met Withdrawal Criteria|0|||
129768785|NCT02224560|467119791|FG002|Overall Study|Met Withdrawal Criteria|0|||
129768786|NCT02224560|467119789|FG000|Overall Study|Adverse Event|4|||
129768787|NCT02224560|467119790|FG001|Overall Study|Adverse Event|1|||
129768788|NCT02224560|467119791|FG002|Overall Study|Adverse Event|1|||
129768789|NCT02224560|467119789|FG000|Overall Study|Withdrawn by Investigator|1|||
129768790|NCT02224560|467119790|FG001|Overall Study|Withdrawn by Investigator|1|||
129768791|NCT02224560|467119791|FG002|Overall Study|Withdrawn by Investigator|0|||
129768792|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
129768793|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
129768794|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
129884413|NCT02771210|467536388|FG001|Period 2|Adverse Event|0|||
129678088|NCT00984867|466782355|FG001|Overall Study|Subject no longer meets study criteria|1|||
129678089|NCT00984867|466782354|FG000|Overall Study|site closing|1|||
129678090|NCT00984867|466782355|FG001|Overall Study|site closing|0|||
129678091|NCT00984867|466782354|FG000|Overall Study|lack of efficacy and subject compliance|1|||
129678092|NCT00984867|466782355|FG001|Overall Study|lack of efficacy and subject compliance|0|||
129678093|NCT00634504|466782360|FG000|Overall Study|Protocol Violation|1|||
129678094|NCT00634504|466782361|FG001|Overall Study|Protocol Violation|0|||
129678095|NCT05001620|466782364|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
129678096|NCT05001620|466782365|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
129678097|NCT00481676|466782366|FG000|Overall Study|Adverse Event|0|||
129678098|NCT00481676|466782367|FG001|Overall Study|Adverse Event|1|||
129678099|NCT00481676|466782366|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129678100|NCT00481676|466782367|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129678101|NCT00481676|466782366|FG000|Overall Study|Administrative problem|1|||
129678102|NCT00481676|466782367|FG001|Overall Study|Administrative problem|0|||
129678103|NCT03937778|466782368|FG000|Overall Study|Withdrawal by Subject|1|||
129678104|NCT03937778|466782368|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
129678105|NCT00819039|466782369|FG000|Overall Study|Physician Decision|1|||
129678106|NCT00819039|466782370|FG001|Overall Study|Physician Decision|0|||
129678107|NCT00819039|466782371|FG002|Overall Study|Physician Decision|1|||
129678108|NCT00819039|466782369|FG000|Overall Study|Protocol Violation|1|||
129678109|NCT00819039|466782370|FG001|Overall Study|Protocol Violation|0|||
129678110|NCT00819039|466782371|FG002|Overall Study|Protocol Violation|0|||
129678111|NCT01513590|466782372|FG000|Overall Study|Adverse Event|2|||
129678112|NCT01513590|466782373|FG001|Overall Study|Adverse Event|3|||
129678113|NCT01513590|466782372|FG000|Overall Study|Withdrawal Criteria|3|||
129678114|NCT01513590|466782373|FG001|Overall Study|Withdrawal Criteria|0|||
129678115|NCT01513590|466782372|FG000|Overall Study|Unclassified|5|||
129678116|NCT01513590|466782373|FG001|Overall Study|Unclassified|10|||
129678117|NCT01240694|466782374|FG000|Overall Study|Adverse Event|9|||
129678118|NCT01240694|466782374|FG000|Overall Study|Lack of Efficacy|6|||
129678119|NCT01240694|466782374|FG000|Overall Study|Withdrawal by Subject|6|||
129678120|NCT01240694|466782374|FG000|Overall Study|Protocol Violation|2|||
129678121|NCT01240694|466782374|FG000|Overall Study|Lost to Follow-up|2|||
129678122|NCT01240694|466782374|FG000|Overall Study|Other than specified|3|||
129678123|NCT01240694|466782374|FG000|Overall Study|Withdrawn due to early study termination|107|||
129678124|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
129678125|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
129678126|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
129678127|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
129678128|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
129678129|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
129678130|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
129678131|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
129678132|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
129678133|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
129678134|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Death|3|||
129678135|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Death|1|||
129678136|NCT01056276|466782375|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
129678137|NCT01056276|466782376|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
129678138|NCT01056276|466782375|FG000|Maintenance Therapy|Toxicity|0|||
129678139|NCT01056276|466782376|FG001|Maintenance Therapy|Toxicity|2|||
129678140|NCT01056276|466782375|FG000|Maintenance Therapy|Progressive Disease|0|||
129678141|NCT01056276|466782376|FG001|Maintenance Therapy|Progressive Disease|9|||
129678142|NCT01056276|466782375|FG000|Maintenance Therapy|Physician Decision|0|||
129678143|NCT01056276|466782376|FG001|Maintenance Therapy|Physician Decision|1|||
129678144|NCT01056276|466782375|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
129678145|NCT01056276|466782376|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
129678146|NCT01056276|466782375|FG000|Maintenance Therapy|Intercurrent Illness|0|||
129678147|NCT01056276|466782376|FG001|Maintenance Therapy|Intercurrent Illness|1|||
129678148|NCT01056276|466782375|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
129678149|NCT01056276|466782376|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
129678150|NCT01881425|466782377|FG000|Overall Study|Death|5|||
129678151|NCT01881425|466782378|FG001|Overall Study|Death|1|||
129678152|NCT01881425|466782377|FG000|Overall Study|Withdrawal by Subject|8|||
129678153|NCT01881425|466782378|FG001|Overall Study|Withdrawal by Subject|3|||
129678154|NCT01881425|466782377|FG000|Overall Study|Physician Decision|2|||
129678155|NCT01881425|466782378|FG001|Overall Study|Physician Decision|1|||
129678156|NCT01881425|466782377|FG000|Overall Study|Adverse Event|3|||
129678157|NCT01881425|466782378|FG001|Overall Study|Adverse Event|0|||
129678158|NCT01881425|466782377|FG000|Overall Study|General Anesthesia panic attack|0|||
129678159|NCT01881425|466782378|FG001|Overall Study|General Anesthesia panic attack|1|||
129678160|NCT01881425|466782377|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
129678161|NCT01881425|466782378|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
129678162|NCT01881425|466782377|FG000|Overall Study|Lost to Follow-up|7|||
129678163|NCT01881425|466782378|FG001|Overall Study|Lost to Follow-up|2|||
129678164|NCT01200355|466782379|FG000|Overall Study|Death|7|||
129678165|NCT01200355|466782380|FG001|Overall Study|Death|2|||
129678166|NCT04424901|466782381|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
129678167|NCT04424901|466782382|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
129678168|NCT01206764|466782383|FG000|Overall Study|Adverse Event|20|||
129678169|NCT01206764|466782383|FG000|Overall Study|Abnormal laboratory value|2|||
129678170|NCT01206764|466782383|FG000|Overall Study|Abnormal test procedure result|1|||
129678171|NCT01206764|466782383|FG000|Overall Study|Patient withdrew consent|5|||
129678172|NCT01206764|466782383|FG000|Overall Study|Lost to Follow-up|6|||
129678173|NCT01206764|466782383|FG000|Overall Study|Death|11|||
129678174|NCT01206764|466782383|FG000|Overall Study|New cancer therapy|2|||
129678175|NCT01206764|466782383|FG000|Overall Study|Disease progression|88|||
129678176|NCT01206764|466782383|FG000|Overall Study|Protocol deviation|3|||
129678177|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
129678178|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
129678179|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
129678180|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
129678181|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
129678182|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
129678183|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
129678184|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
129678185|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
129678186|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
129678187|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
129678188|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
129678189|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
129678190|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
129678191|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
129678192|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
129678193|NCT00410163|466782385|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
129678194|NCT00410163|466782386|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
129678195|NCT00410163|466782385|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
129678196|NCT00410163|466782386|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
129678197|NCT00410163|466782385|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
129678198|NCT00410163|466782386|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
129678199|NCT00410163|466782385|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
129678200|NCT00410163|466782386|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
129678201|NCT00410163|466782385|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
129678202|NCT00410163|466782386|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
129678203|NCT00410163|466782385|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
129678204|NCT00410163|466782386|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
129678205|NCT00797563|466782388|FG000|Overall Study|Adverse Event|1|||
129678206|NCT00688597|466782389|FG000|Overall Study|Adverse Event|2|||
129678207|NCT00688597|466782390|FG001|Overall Study|Adverse Event|0|||
129678208|NCT00688597|466782391|FG002|Overall Study|Adverse Event|0|||
129678209|NCT00688597|466782389|FG000|Overall Study|Physician Decision|1|||
129678210|NCT00688597|466782390|FG001|Overall Study|Physician Decision|0|||
129678211|NCT00688597|466782391|FG002|Overall Study|Physician Decision|0|||
129678212|NCT05853120|466782392|FG000|Overall Study|Lost to Follow-up|4|||
129678213|NCT05853120|466782393|FG001|Overall Study|Lost to Follow-up|4|||
129678214|NCT05853120|466782392|FG000|Overall Study|Physician Decision|3|||
129678215|NCT05853120|466782393|FG001|Overall Study|Physician Decision|0|||
129678216|NCT05853120|466782392|FG000|Overall Study|Withdrawal by Subject|5|||
129678217|NCT05853120|466782393|FG001|Overall Study|Withdrawal by Subject|2|||
129678218|NCT02855268|466782394|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
129678219|NCT02855268|466782395|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
129678220|NCT02855268|466782394|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
129678221|NCT02855268|466782395|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
129678222|NCT02855268|466782394|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
129678223|NCT02855268|466782395|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
129678224|NCT02855268|466782394|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
129678225|NCT02855268|466782395|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
129678226|NCT02855268|466782394|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
129678227|NCT02855268|466782395|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
129678228|NCT02855268|466782394|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
129678229|NCT02855268|466782395|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
129678230|NCT00465517|466782396|FG000|Overall Study|Adverse Event|7|||
129678231|NCT00465517|466782397|FG001|Overall Study|Adverse Event|3|||
129678232|NCT00465517|466782396|FG000|Overall Study|Lost to Follow-up|1|||
129678233|NCT00465517|466782397|FG001|Overall Study|Lost to Follow-up|0|||
129678234|NCT00465517|466782396|FG000|Overall Study|Withdrawal by Subject|4|||
129678235|NCT00465517|466782397|FG001|Overall Study|Withdrawal by Subject|1|||
129678236|NCT00834041|466782405|FG000|Overall Study|Withdrawal by Subject|1|||
129678237|NCT00834041|466782406|FG001|Overall Study|Withdrawal by Subject|0|||
129678238|NCT00834041|466782405|FG000|Overall Study|Lost to Follow-up|0|||
129678239|NCT00834041|466782406|FG001|Overall Study|Lost to Follow-up|1|||
129678240|NCT01408641|466783842|FG000|Overall Study|Physician Decision|1|||
129678241|NCT01408641|466783843|FG001|Overall Study|Physician Decision|0|||
129678242|NCT00576758|466783844|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
129678243|NCT00576758|466783845|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
129678244|NCT00576758|466783844|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
129678245|NCT00576758|466783845|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
129678246|NCT00576758|466783844|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
129678247|NCT00576758|466783845|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
129678248|NCT00576758|466783844|FG000|Induction Treatment Period|Death|1|||
129678249|NCT00576758|466783845|FG001|Induction Treatment Period|Death|0|||
129678250|NCT00576758|466783844|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
129678251|NCT00576758|466783845|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
129678252|NCT00576758|466783844|FG000|Induction Treatment Period|Withdrew consent|1|||
129678253|NCT00576758|466783845|FG001|Induction Treatment Period|Withdrew consent|0|||
129678254|NCT00576758|466783844|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
129678255|NCT00576758|466783845|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
129678256|NCT00576758|466783844|FG000|Extension Treatment Period|Death|1|||
129678257|NCT00576758|466783845|FG001|Extension Treatment Period|Death|1|||
129678258|NCT00576758|466783844|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
129678259|NCT00576758|466783845|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
129678260|NCT00576758|466783844|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
129678261|NCT00576758|466783845|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
129678262|NCT00576758|466783844|FG000|Extension Treatment Period|Administrative/Other|3|||
129678263|NCT00576758|466783845|FG001|Extension Treatment Period|Administrative/Other|1|||
129678264|NCT00576758|466783844|FG000|Follow-up Period|Administrative/Other|6|||
129678265|NCT00576758|466783845|FG001|Follow-up Period|Administrative/Other|8|||
129678266|NCT00576758|466783844|FG000|Follow-up Period|Death|3|||
129678267|NCT00576758|466783845|FG001|Follow-up Period|Death|3|||
129678268|NCT00576758|466783844|FG000|Follow-up Period|Insufficient therapeutic response|16|||
129678269|NCT00576758|466783845|FG001|Follow-up Period|Insufficient therapeutic response|5|||
129678270|NCT00576758|466783844|FG000|Follow-up Period|Withdrew consent|2|||
129768795|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
129768796|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
129768797|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
129768798|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
129768799|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
129768800|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
129678271|NCT00576758|466783845|FG001|Follow-up Period|Withdrew consent|1|||
129678272|NCT00089648|466783846|FG000|Overall Study|Adverse Event|7|||
129678273|NCT00089648|466783846|FG000|Overall Study|Withdrawal by Subject|1|||
129678274|NCT00089648|466783846|FG000|Overall Study|Lack of Efficacy|33|||
129678275|NCT00423605|466783847|FG000|Overall Study|Adverse Event|129|||
129678276|NCT00423605|466783847|FG000|Overall Study|Withdrawal by Subject|36|||
129678277|NCT00423605|466783847|FG000|Overall Study|Lost to Follow-up|15|||
129678278|NCT00423605|466783847|FG000|Overall Study|Lack of Efficacy|38|||
129678279|NCT00423605|466783847|FG000|Overall Study|Sponsor Decision|3|||
129678280|NCT00423605|466783847|FG000|Overall Study|Physician Decision|8|||
129678281|NCT00423605|466783847|FG000|Overall Study|Protocol Violation|7|||
129678282|NCT00423605|466783847|FG000|Overall Study|Not one of the pre-specified options|5|||
129678283|NCT03183908|466783850|FG000|Overall Study|Missing Symptom Diary Data|0|||
129678284|NCT03183908|466783851|FG001|Overall Study|Missing Symptom Diary Data|2|||
129678285|NCT03738696|466783852|FG000|Overall Study|Withdrawal by Subject|0|||
129678286|NCT03738696|466783853|FG001|Overall Study|Withdrawal by Subject|1|||
129678287|NCT03738696|466783852|FG000|Overall Study|Lost to Follow-up|8|||
129678288|NCT03738696|466783853|FG001|Overall Study|Lost to Follow-up|14|||
129678289|NCT02566005|466783856|FG000|Overall Study|vaginal bleeding|0|||
129678290|NCT02566005|466783857|FG001|Overall Study|vaginal bleeding|1|||
129678291|NCT02566005|466783856|FG000|Overall Study|received foley|8|||
129678292|NCT02566005|466783857|FG001|Overall Study|received foley|0|||
129678293|NCT02566005|466783856|FG000|Overall Study|did not receive foley|0|||
129678294|NCT02566005|466783857|FG001|Overall Study|did not receive foley|1|||
129678295|NCT02566005|466783856|FG000|Overall Study|labor after randomization|0|||
129678296|NCT02566005|466783857|FG001|Overall Study|labor after randomization|4|||
129678297|NCT03617588|466783858|FG000|Overall Study|Withdrawal by Subject|1|||
129678298|NCT03617588|466783859|FG001|Overall Study|Withdrawal by Subject|0|||
129678299|NCT03261401|466783860|FG000|Overall Study|Withdrawal by Subject|0|||
129678300|NCT03261401|466783861|FG001|Overall Study|Withdrawal by Subject|0|||
129678301|NCT03261401|466783862|FG002|Overall Study|Withdrawal by Subject|0|||
129678302|NCT03261401|466783863|FG003|Overall Study|Withdrawal by Subject|0|||
129678303|NCT03261401|466783864|FG004|Overall Study|Withdrawal by Subject|0|||
129768801|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
129768802|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
129768803|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
129768804|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
129768805|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
129768806|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
129768807|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
129768808|NCT03773978|467119794|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
129768809|NCT03773978|467119795|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
129768810|NCT03773978|467119794|FG000|DBW Period|Adverse Event|2|||
129768811|NCT03773978|467119795|FG001|DBW Period|Adverse Event|2|||
129768812|NCT03773978|467119794|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
129768813|NCT03773978|467119795|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
129768814|NCT03773978|467119794|FG000|DBW Period|Withdrawal by Subject|2|||
129768815|NCT03773978|467119795|FG001|DBW Period|Withdrawal by Subject|1|||
129768816|NCT03773978|467119794|FG000|DBW Period|Due to epidemic or pandemic|5|||
129768817|NCT03773978|467119795|FG001|DBW Period|Due to epidemic or pandemic|6|||
129768818|NCT03773978|467119794|FG000|DBW Period|Study team decision|1|||
129768819|NCT03773978|467119795|FG001|DBW Period|Study team decision|0|||
129768820|NCT01033019|467119799|FG000|Overall Study|Withdrawal by Subject|1|||
129768821|NCT01033019|467119800|FG001|Overall Study|Withdrawal by Subject|0|||
129768822|NCT03224819|467119803|FG000|Overall Study|Withdrawal by Subject|0|||
129768823|NCT03224819|467119804|FG001|Overall Study|Withdrawal by Subject|0|||
129768824|NCT03224819|467119805|FG002|Overall Study|Withdrawal by Subject|0|||
129768825|NCT03224819|467119806|FG003|Overall Study|Withdrawal by Subject|0|||
129768826|NCT03224819|467119807|FG004|Overall Study|Withdrawal by Subject|0|||
129768827|NCT03224819|467119808|FG005|Overall Study|Withdrawal by Subject|0|||
129768828|NCT03224819|467119809|FG006|Overall Study|Withdrawal by Subject|0|||
129768829|NCT03224819|467119810|FG007|Overall Study|Withdrawal by Subject|0|||
129768830|NCT03224819|467119811|FG008|Overall Study|Withdrawal by Subject|0|||
129768831|NCT03224819|467119812|FG009|Overall Study|Withdrawal by Subject|0|||
129768832|NCT03224819|467119813|FG010|Overall Study|Withdrawal by Subject|0|||
129768833|NCT03224819|467119814|FG011|Overall Study|Withdrawal by Subject|0|||
129768834|NCT03224819|467119815|FG012|Overall Study|Withdrawal by Subject|1|||
129768835|NCT03224819|467119816|FG013|Overall Study|Withdrawal by Subject|0|||
129768836|NCT03224819|467119803|FG000|Overall Study|Sponsor Decision|0|||
129768837|NCT03224819|467119804|FG001|Overall Study|Sponsor Decision|0|||
129768838|NCT03224819|467119805|FG002|Overall Study|Sponsor Decision|0|||
129768839|NCT03224819|467119806|FG003|Overall Study|Sponsor Decision|1|||
129768840|NCT03224819|467119807|FG004|Overall Study|Sponsor Decision|1|||
129768841|NCT03224819|467119808|FG005|Overall Study|Sponsor Decision|2|||
129768842|NCT03224819|467119809|FG006|Overall Study|Sponsor Decision|1|||
129768843|NCT03224819|467119810|FG007|Overall Study|Sponsor Decision|1|||
129768844|NCT03224819|467119811|FG008|Overall Study|Sponsor Decision|1|||
129768845|NCT03224819|467119812|FG009|Overall Study|Sponsor Decision|2|||
129768846|NCT03224819|467119813|FG010|Overall Study|Sponsor Decision|1|||
129768847|NCT03224819|467119814|FG011|Overall Study|Sponsor Decision|1|||
129768848|NCT03224819|467119815|FG012|Overall Study|Sponsor Decision|1|||
129768849|NCT03224819|467119816|FG013|Overall Study|Sponsor Decision|0|||
129678304|NCT03261401|466783865|FG005|Overall Study|Withdrawal by Subject|1|||
129678305|NCT03261401|466783866|FG006|Overall Study|Withdrawal by Subject|0|||
129678306|NCT03261401|466783867|FG007|Overall Study|Withdrawal by Subject|0|||
129678307|NCT03261401|466783868|FG008|Overall Study|Withdrawal by Subject|0|||
129678308|NCT03261401|466783869|FG009|Overall Study|Withdrawal by Subject|0|||
129678309|NCT03261401|466783870|FG010|Overall Study|Withdrawal by Subject|0|||
129678310|NCT03261401|466783871|FG011|Overall Study|Withdrawal by Subject|0|||
129678311|NCT03261401|466783872|FG012|Overall Study|Withdrawal by Subject|0|||
129678312|NCT03261401|466783860|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
129678313|NCT03261401|466783861|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
129678314|NCT03261401|466783862|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
129678315|NCT03261401|466783863|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
129678316|NCT03261401|466783864|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
129678317|NCT03261401|466783865|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
129678318|NCT03261401|466783866|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
129678319|NCT03261401|466783867|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
129678320|NCT03261401|466783868|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
129678321|NCT03261401|466783869|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
129678322|NCT03261401|466783870|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
129678323|NCT03261401|466783871|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
129678324|NCT03261401|466783872|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
129678325|NCT01294514|466783873|FG000|Overall Study|Excluded due to Arrhythmia|1|||
129678326|NCT01715298|466783874|FG000|Overall Study|Lost to Follow-up|0|||
129678327|NCT01715298|466783875|FG001|Overall Study|Lost to Follow-up|2|||
129678328|NCT01715298|466783874|FG000|Overall Study|Patient/guardian decision|7|||
129678329|NCT01715298|466783875|FG001|Overall Study|Patient/guardian decision|9|||
129678330|NCT01499511|466783880|FG000|Overall Study|Death|1|||
129678331|NCT01499511|466783881|FG001|Overall Study|Death|0|||
129678332|NCT00726453|466783883|FG000|Primary Enrollment Group|Death|18|||
129678333|NCT00726453|466783884|FG001|Primary Enrollment Group|Death|0|||
129678334|NCT00726453|466783883|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
129678335|NCT00726453|466783884|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
129678336|NCT00726453|466783883|FG000|38 mm Length Group|Death|0|||
129678337|NCT00726453|466783884|FG001|38 mm Length Group|Death|3|||
129678338|NCT00941928|466783886|FG000|Overall Study|Withdrawal by Subject|1|||
129678339|NCT00941928|466783886|FG000|Overall Study|Disease Progression|1|||
129678340|NCT03482024|466783893|FG000|Overall Study|Physician Decision|1|||
129678341|NCT03482024|466783894|FG001|Overall Study|Physician Decision|0|||
129678342|NCT03482024|466783895|FG002|Overall Study|Physician Decision|0|||
129678343|NCT03482024|466783896|FG003|Overall Study|Physician Decision|0|||
129678344|NCT03482024|466783897|FG004|Overall Study|Physician Decision|0|||
129678345|NCT04796415|466783898|FG000|Overall Study|not interested|12|||
129678346|NCT04796415|466783898|FG000|Overall Study|health issue|8|||
129678347|NCT04796415|466783898|FG000|Overall Study|Other|4|||
129678348|NCT04796415|466783898|FG000|Overall Study|discharged from home health service|3|||
129678349|NCT04796415|466783898|FG000|Overall Study|re-hospitalization|2|||
129678350|NCT04796415|466783898|FG000|Overall Study|moving to nursing home|1|||
129678351|NCT04796415|466783898|FG000|Overall Study|lost contact|1|||
129678352|NCT00147238|466783905|FG000|Overall Study|Inevaluable|8|||
129768850|NCT03224819|467119803|FG000|Overall Study|Lost to Follow-up|0|||
129768851|NCT03224819|467119804|FG001|Overall Study|Lost to Follow-up|0|||
129768852|NCT03224819|467119805|FG002|Overall Study|Lost to Follow-up|0|||
129768853|NCT03224819|467119806|FG003|Overall Study|Lost to Follow-up|0|||
129768854|NCT03224819|467119807|FG004|Overall Study|Lost to Follow-up|0|||
129768855|NCT03224819|467119808|FG005|Overall Study|Lost to Follow-up|0|||
129768856|NCT03224819|467119809|FG006|Overall Study|Lost to Follow-up|0|||
129768857|NCT03224819|467119810|FG007|Overall Study|Lost to Follow-up|0|||
129768858|NCT03224819|467119811|FG008|Overall Study|Lost to Follow-up|1|||
129768859|NCT03224819|467119812|FG009|Overall Study|Lost to Follow-up|0|||
129768860|NCT03224819|467119813|FG010|Overall Study|Lost to Follow-up|0|||
129768861|NCT03224819|467119814|FG011|Overall Study|Lost to Follow-up|0|||
129768862|NCT03224819|467119815|FG012|Overall Study|Lost to Follow-up|0|||
129768863|NCT03224819|467119816|FG013|Overall Study|Lost to Follow-up|0|||
129768864|NCT03224819|467119803|FG000|Overall Study|Death|0|||
129768865|NCT03224819|467119804|FG001|Overall Study|Death|1|||
129768866|NCT03224819|467119805|FG002|Overall Study|Death|0|||
129768867|NCT03224819|467119806|FG003|Overall Study|Death|0|||
129768868|NCT03224819|467119807|FG004|Overall Study|Death|0|||
129678353|NCT00297167|466783906|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
129678354|NCT00297167|466783907|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
129678355|NCT00297167|466783908|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
129678356|NCT00297167|466783906|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
129678357|NCT00297167|466783907|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
129678358|NCT00297167|466783908|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
129678359|NCT03185208|466783911|FG000|Overall Study|Did not start study medication|0|||
129678360|NCT03185208|466783912|FG001|Overall Study|Did not start study medication|3|||
129678361|NCT03834350|466783913|FG000|Overall Study|Withdrawal by Subject|1|||
129678362|NCT02410629|466783914|FG000|Overall Study|Family cannot commit to the study|2|||
129678363|NCT02410629|466783915|FG001|Overall Study|Family cannot commit to the study|1|||
129678364|NCT02410629|466783914|FG000|Overall Study|Subject returned to work|1|||
129678365|NCT02410629|466783915|FG001|Overall Study|Subject returned to work|0|||
129678366|NCT02410629|466783914|FG000|Overall Study|Subject moved back to home country|0|||
129678367|NCT02410629|466783915|FG001|Overall Study|Subject moved back to home country|1|||
129678368|NCT02410629|466783914|FG000|Overall Study|Subject underwent heart surgery|0|||
129678369|NCT02410629|466783915|FG001|Overall Study|Subject underwent heart surgery|1|||
129678370|NCT02765165|466783916|FG000|Treatment Period|Progressive disease|3|||
129678371|NCT02765165|466783917|FG001|Treatment Period|Progressive disease|2|||
129678372|NCT02765165|466783918|FG002|Treatment Period|Progressive disease|3|||
129678373|NCT02765165|466783919|FG003|Treatment Period|Progressive disease|3|||
129678374|NCT02765165|466783920|FG004|Treatment Period|Progressive disease|4|||
129678375|NCT02765165|466783921|FG005|Treatment Period|Progressive disease|2|||
129678376|NCT02765165|466783922|FG006|Treatment Period|Progressive disease|2|||
129678377|NCT02765165|466783916|FG000|Treatment Period|Physician Decision|0|||
129678378|NCT02765165|466783917|FG001|Treatment Period|Physician Decision|1|||
129678379|NCT02765165|466783918|FG002|Treatment Period|Physician Decision|0|||
129678380|NCT02765165|466783919|FG003|Treatment Period|Physician Decision|0|||
129678381|NCT02765165|466783920|FG004|Treatment Period|Physician Decision|0|||
129678382|NCT02765165|466783921|FG005|Treatment Period|Physician Decision|0|||
129678383|NCT02765165|466783922|FG006|Treatment Period|Physician Decision|0|||
129678384|NCT02765165|466783916|FG000|Treatment Period|Adverse Event|0|||
129678385|NCT02765165|466783917|FG001|Treatment Period|Adverse Event|1|||
129678386|NCT02765165|466783918|FG002|Treatment Period|Adverse Event|0|||
129678387|NCT02765165|466783919|FG003|Treatment Period|Adverse Event|0|||
129678388|NCT02765165|466783920|FG004|Treatment Period|Adverse Event|0|||
129678389|NCT02765165|466783921|FG005|Treatment Period|Adverse Event|0|||
129678390|NCT02765165|466783922|FG006|Treatment Period|Adverse Event|0|||
129678391|NCT02765165|466783916|FG000|Treatment Period|Withdrawal by Subject|0|||
129678392|NCT02765165|466783917|FG001|Treatment Period|Withdrawal by Subject|0|||
129678393|NCT02765165|466783918|FG002|Treatment Period|Withdrawal by Subject|0|||
129678394|NCT02765165|466783919|FG003|Treatment Period|Withdrawal by Subject|0|||
129768869|NCT03224819|467119808|FG005|Overall Study|Death|0|||
129768870|NCT03224819|467119809|FG006|Overall Study|Death|0|||
129768871|NCT03224819|467119810|FG007|Overall Study|Death|1|||
129768872|NCT03224819|467119811|FG008|Overall Study|Death|0|||
129678395|NCT02765165|466783920|FG004|Treatment Period|Withdrawal by Subject|2|||
129678396|NCT02765165|466783921|FG005|Treatment Period|Withdrawal by Subject|0|||
129678397|NCT02765165|466783922|FG006|Treatment Period|Withdrawal by Subject|0|||
129678398|NCT02765165|466783916|FG000|Treatment Period|Study terminated|0|||
129768873|NCT03224819|467119812|FG009|Overall Study|Death|0|||
129768874|NCT03224819|467119813|FG010|Overall Study|Death|0|||
129768875|NCT03224819|467119814|FG011|Overall Study|Death|1|||
129768876|NCT03224819|467119815|FG012|Overall Study|Death|0|||
129768877|NCT03224819|467119816|FG013|Overall Study|Death|0|||
129768878|NCT04050553|467119829|FG000|Period 1|Physician Decision|2|||
129768879|NCT04050553|467119830|FG001|Period 1|Physician Decision|2|||
129768880|NCT04050553|467119829|FG000|Period 1|Adverse Event|1|||
129768881|NCT04050553|467119830|FG001|Period 1|Adverse Event|1|||
129768882|NCT04050553|467119829|FG000|Period 1|Withdrawal by Subject|0|||
129768883|NCT04050553|467119830|FG001|Period 1|Withdrawal by Subject|1|||
129768884|NCT04050553|467119829|FG000|Wash-out|Adverse Event|0|||
129768885|NCT04050553|467119830|FG001|Wash-out|Adverse Event|1|||
129768886|NCT04050553|467119829|FG000|Wash-out|Withdrawal by Subject|0|||
129768887|NCT04050553|467119830|FG001|Wash-out|Withdrawal by Subject|1|||
129768888|NCT01535040|467119831|FG000|Overall Study|Physician Decision|0|||
129768889|NCT01535040|467119832|FG001|Overall Study|Physician Decision|1|||
129768890|NCT01535040|467119831|FG000|Overall Study|Withdrawal by Subject|13|||
129768891|NCT01535040|467119832|FG001|Overall Study|Withdrawal by Subject|10|||
129768892|NCT01535040|467119831|FG000|Overall Study|Never Started|9|||
129768893|NCT01535040|467119832|FG001|Overall Study|Never Started|4|||
129768894|NCT01535040|467119831|FG000|Overall Study|Toxicity|7|||
129768895|NCT01535040|467119832|FG001|Overall Study|Toxicity|5|||
129768896|NCT01535040|467119831|FG000|Overall Study|Multiple Reasons|1|||
129768897|NCT01535040|467119832|FG001|Overall Study|Multiple Reasons|1|||
129768898|NCT01074970|467119834|FG000|Overall Study|Never Treated|0|||
129768899|NCT01074970|467119835|FG001|Overall Study|Never Treated|0|||
129768900|NCT01074970|467119836|FG002|Overall Study|Never Treated|8|||
129768901|NCT01074970|467119837|FG003|Overall Study|Never Treated|1|||
129768902|NCT01074970|467119834|FG000|Overall Study|Adverse Event|1|||
129768903|NCT01074970|467119835|FG001|Overall Study|Adverse Event|0|||
129768904|NCT01074970|467119836|FG002|Overall Study|Adverse Event|4|||
129768905|NCT01074970|467119837|FG003|Overall Study|Adverse Event|3|||
129768906|NCT01074970|467119834|FG000|Overall Study|Disease progression during treatment|3|||
129768907|NCT01074970|467119835|FG001|Overall Study|Disease progression during treatment|1|||
129768908|NCT01074970|467119836|FG002|Overall Study|Disease progression during treatment|2|||
129768909|NCT01074970|467119837|FG003|Overall Study|Disease progression during treatment|9|||
129768910|NCT01074970|467119834|FG000|Overall Study|Lost to Follow-up|0|||
129768911|NCT01074970|467119835|FG001|Overall Study|Lost to Follow-up|0|||
129768912|NCT01074970|467119836|FG002|Overall Study|Lost to Follow-up|1|||
129768913|NCT01074970|467119837|FG003|Overall Study|Lost to Follow-up|0|||
129768914|NCT01074970|467119834|FG000|Overall Study|Withdrawal by Subject|0|||
129768915|NCT01074970|467119835|FG001|Overall Study|Withdrawal by Subject|0|||
129768916|NCT01074970|467119836|FG002|Overall Study|Withdrawal by Subject|6|||
129768917|NCT01074970|467119837|FG003|Overall Study|Withdrawal by Subject|4|||
129768918|NCT05430854|467119838|FG000|Overall Study|Trial terminated by Sponsor|39|||
129768919|NCT05430854|467119839|FG001|Overall Study|Trial terminated by Sponsor|50|||
129768920|NCT05430854|467119840|FG002|Overall Study|Trial terminated by Sponsor|46|||
129768921|NCT05430854|467119838|FG000|Overall Study|Withdrawal by Subject|0|||
129768922|NCT05430854|467119839|FG001|Overall Study|Withdrawal by Subject|3|||
129768923|NCT05430854|467119840|FG002|Overall Study|Withdrawal by Subject|0|||
129768924|NCT00734149|467119841|FG000|Overall Study|Withdrawal by Subject|1|||
129768925|NCT04314284|467119842|FG000|Overall Study|Withdrawal by Subject|4|||
129768926|NCT04314284|467119843|FG001|Overall Study|Withdrawal by Subject|7|||
129768927|NCT04314284|467119842|FG000|Overall Study|Consented but did not complete survey|0|||
129768928|NCT04314284|467119843|FG001|Overall Study|Consented but did not complete survey|6|||
129768929|NCT01652235|467119846|FG000|Overall Study|Death|9|||
129768930|NCT01652235|467119846|FG000|Overall Study|Lost to Follow-up|5|||
129768931|NCT01652235|467119846|FG000|Overall Study|Withdrawal by Subject|2|||
129768932|NCT02023086|467119849|FG000|Overall Study|Withdrawal by Subject|2|||
129768933|NCT02023086|467119850|FG001|Overall Study|Withdrawal by Subject|0|||
129768934|NCT03472885|467119851|FG000|24-Week Treatment Period|Adverse Event|1|||
129768935|NCT02201953|467119852|FG000|Overall Study|Randomized but Never Treated|1|||
129768936|NCT02201953|467119853|FG001|Overall Study|Randomized but Never Treated|5|||
129768937|NCT02201953|467119852|FG000|Overall Study|Lack of Efficacy|9|||
129768938|NCT02201953|467119853|FG001|Overall Study|Lack of Efficacy|30|||
129768939|NCT02201953|467119852|FG000|Overall Study|Lost to Follow-up|8|||
129768940|NCT02201953|467119853|FG001|Overall Study|Lost to Follow-up|8|||
129768941|NCT02201953|467119852|FG000|Overall Study|Withdrew Consent|2|||
129768942|NCT02201953|467119853|FG001|Overall Study|Withdrew Consent|5|||
129768943|NCT02201953|467119852|FG000|Overall Study|Adverse Event|0|||
129768944|NCT02201953|467119853|FG001|Overall Study|Adverse Event|5|||
129768945|NCT02201953|467119852|FG000|Overall Study|Death|0|||
129768946|NCT02201953|467119853|FG001|Overall Study|Death|3|||
129768947|NCT01615939|467121372|FG000|Overall Study|Lost to Follow-up|5|||
129768948|NCT01615939|467121373|FG001|Overall Study|Lost to Follow-up|0|||
129768949|NCT02892344|467121377|FG000|Overall Study|Protocol deviation|3|||
129768950|NCT02892344|467121378|FG001|Overall Study|Protocol deviation|4|||
129768951|NCT02892344|467121377|FG000|Overall Study|Adverse Event|1|||
129768952|NCT02892344|467121378|FG001|Overall Study|Adverse Event|8|||
129768953|NCT02892344|467121377|FG000|Overall Study|Lost to Follow-up|0|||
129678399|NCT02765165|466783917|FG001|Treatment Period|Study terminated|0|||
129678400|NCT02765165|466783918|FG002|Treatment Period|Study terminated|0|||
129678401|NCT02765165|466783919|FG003|Treatment Period|Study terminated|0|||
129678402|NCT02765165|466783920|FG004|Treatment Period|Study terminated|0|||
129678403|NCT02765165|466783921|FG005|Treatment Period|Study terminated|1|||
129678404|NCT02765165|466783922|FG006|Treatment Period|Study terminated|2|||
129678405|NCT02765165|466783916|FG000|Post-treatment Follow-up|Death|1|||
129678406|NCT02765165|466783917|FG001|Post-treatment Follow-up|Death|2|||
129678407|NCT02765165|466783918|FG002|Post-treatment Follow-up|Death|1|||
129678408|NCT02765165|466783919|FG003|Post-treatment Follow-up|Death|1|||
129678409|NCT02765165|466783920|FG004|Post-treatment Follow-up|Death|1|||
129678410|NCT02765165|466783921|FG005|Post-treatment Follow-up|Death|1|||
129678411|NCT02765165|466783922|FG006|Post-treatment Follow-up|Death|0|||
129678412|NCT02765165|466783916|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
129678413|NCT02765165|466783917|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
129678414|NCT02765165|466783918|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
129678415|NCT02765165|466783919|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
129678416|NCT02765165|466783920|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
129678417|NCT02765165|466783921|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
129678418|NCT02765165|466783922|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
129678419|NCT02765165|466783916|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
129678420|NCT02765165|466783917|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
129678421|NCT02765165|466783918|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
129678422|NCT02765165|466783919|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
129678423|NCT02765165|466783920|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
129678424|NCT02765165|466783921|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
129678425|NCT02765165|466783922|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
129678426|NCT02765165|466783916|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129678427|NCT02765165|466783917|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129678428|NCT02765165|466783918|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
129678429|NCT02765165|466783919|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
129678430|NCT02765165|466783920|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129678431|NCT02765165|466783921|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129678432|NCT02765165|466783922|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
129678433|NCT02765165|466783916|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
129678434|NCT02765165|466783917|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
129678435|NCT02765165|466783918|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
129678436|NCT02765165|466783919|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
129678437|NCT02765165|466783920|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
129678438|NCT02765165|466783921|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
129678439|NCT02765165|466783922|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
129678440|NCT02765165|466783916|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
129678441|NCT02765165|466783917|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
129678442|NCT02765165|466783918|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
129678443|NCT02765165|466783919|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
129678444|NCT02765165|466783920|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
129678445|NCT02765165|466783921|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
129678446|NCT02765165|466783922|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
129678447|NCT01186770|466783923|FG000|Overall Study|Ineligibility|0|||
129678448|NCT01186770|466783924|FG001|Overall Study|Ineligibility|0|||
129678449|NCT01186770|466783925|FG002|Overall Study|Ineligibility|2|||
129678450|NCT01186770|466783926|FG003|Overall Study|Ineligibility|0|||
129678451|NCT01186770|466783923|FG000|Overall Study|Protocol Violation|7|||
129678452|NCT01186770|466783924|FG001|Overall Study|Protocol Violation|9|||
129678453|NCT01186770|466783925|FG002|Overall Study|Protocol Violation|12|||
129678454|NCT01186770|466783926|FG003|Overall Study|Protocol Violation|14|||
129678455|NCT01186770|466783923|FG000|Overall Study|Adverse Event|2|||
129678456|NCT01186770|466783924|FG001|Overall Study|Adverse Event|9|||
129678457|NCT01186770|466783925|FG002|Overall Study|Adverse Event|7|||
129678458|NCT01186770|466783926|FG003|Overall Study|Adverse Event|9|||
129678459|NCT01186770|466783923|FG000|Overall Study|Withdrawal by Subject|15|||
129678460|NCT01186770|466783924|FG001|Overall Study|Withdrawal by Subject|13|||
129678461|NCT01186770|466783925|FG002|Overall Study|Withdrawal by Subject|11|||
129678462|NCT01186770|466783926|FG003|Overall Study|Withdrawal by Subject|17|||
129678463|NCT01186770|466783923|FG000|Overall Study|Lost to Follow-up|10|||
129678464|NCT01186770|466783924|FG001|Overall Study|Lost to Follow-up|6|||
129678465|NCT01186770|466783925|FG002|Overall Study|Lost to Follow-up|14|||
129678466|NCT01186770|466783926|FG003|Overall Study|Lost to Follow-up|9|||
129678467|NCT01186770|466783923|FG000|Overall Study|Insufficient response to treatment|7|||
129678468|NCT01186770|466783924|FG001|Overall Study|Insufficient response to treatment|8|||
129678469|NCT01186770|466783925|FG002|Overall Study|Insufficient response to treatment|5|||
129678470|NCT01186770|466783926|FG003|Overall Study|Insufficient response to treatment|7|||
129678471|NCT01186770|466783923|FG000|Overall Study|Other than specified|0|||
129678472|NCT01186770|466783924|FG001|Overall Study|Other than specified|1|||
129678473|NCT01186770|466783925|FG002|Overall Study|Other than specified|1|||
129678474|NCT01186770|466783926|FG003|Overall Study|Other than specified|2|||
129678475|NCT02567188|466783927|FG000|Overall Study|Death|10|||
129678476|NCT02567188|466783927|FG000|Overall Study|Terminated Mircera Treatment|9|||
129678477|NCT02567188|466783927|FG000|Overall Study|Lost to Follow-up|5|||
129678478|NCT02567188|466783927|FG000|Overall Study|Adverse Event|1|||
129678479|NCT02567188|466783927|FG000|Overall Study|Withdrawal by Subject|1|||
129678480|NCT02567188|466783927|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
129678481|NCT02567188|466783927|FG000|Overall Study|Moved and Changed Clinic|1|||
129678482|NCT02567188|466783927|FG000|Overall Study|Started Hemodialysis|2|||
129678483|NCT02567188|466783927|FG000|Overall Study|Protocol Violation|5|||
129678484|NCT00321763|466783928|FG000|Overall Study|Adverse Event|1|||
129678485|NCT00321763|466783929|FG001|Overall Study|Adverse Event|1|||
129678486|NCT00321763|466783930|FG002|Overall Study|Adverse Event|0|||
129678487|NCT00321763|466783931|FG003|Overall Study|Adverse Event|1|||
129678488|NCT00321763|466783928|FG000|Overall Study|Withdrawal by Subject|2|||
129678489|NCT00321763|466783929|FG001|Overall Study|Withdrawal by Subject|0|||
129678490|NCT00321763|466783930|FG002|Overall Study|Withdrawal by Subject|1|||
129678491|NCT00321763|466783931|FG003|Overall Study|Withdrawal by Subject|0|||
129678492|NCT00321763|466783928|FG000|Overall Study|Lost to Follow-up|3|||
129678493|NCT00321763|466783929|FG001|Overall Study|Lost to Follow-up|1|||
129678494|NCT00321763|466783930|FG002|Overall Study|Lost to Follow-up|5|||
129678495|NCT00321763|466783931|FG003|Overall Study|Lost to Follow-up|4|||
129678496|NCT01572792|466783932|FG000|Lead-in Study|Lost to Follow-up|5|||
129678497|NCT01572792|466783933|FG001|Lead-in Study|Lost to Follow-up|9|||
129678498|NCT01572792|466783934|FG002|Lead-in Study|Lost to Follow-up|4|||
129768954|NCT02892344|467121378|FG001|Overall Study|Lost to Follow-up|1|||
129768955|NCT02892344|467121377|FG000|Overall Study|Non-compliance with study treatment|0|||
129768956|NCT02892344|467121378|FG001|Overall Study|Non-compliance with study treatment|1|||
129768957|NCT02892344|467121377|FG000|Overall Study|Physician Decision|0|||
129768958|NCT02892344|467121378|FG001|Overall Study|Physician Decision|2|||
129768959|NCT02892344|467121377|FG000|Overall Study|Subject/guardian decision|0|||
129768960|NCT02892344|467121378|FG001|Overall Study|Subject/guardian decision|4|||
129768961|NCT02892344|467121377|FG000|Overall Study|Technical problems|0|||
129768962|NCT02892344|467121378|FG001|Overall Study|Technical problems|1|||
129768963|NCT03591406|467121380|FG000|Overall Study|Adverse Event|5|||
129768964|NCT03591406|467121381|FG001|Overall Study|Adverse Event|3|||
129768965|NCT03591406|467121380|FG000|Overall Study|Protocol Violation|2|||
129768966|NCT03591406|467121381|FG001|Overall Study|Protocol Violation|1|||
129768967|NCT03591406|467121380|FG000|Overall Study|Withdrawal by Subject|0|||
129768968|NCT03591406|467121381|FG001|Overall Study|Withdrawal by Subject|5|||
129768969|NCT02066181|467121382|FG000|Overall Study|Withdrawal by Subject|1|||
129768970|NCT02066181|467121383|FG001|Overall Study|Withdrawal by Subject|1|||
129768971|NCT01083771|467121384|FG000|Overall Study|non-compliant|2|||
129768972|NCT01083771|467121384|FG000|Overall Study|Withdrawal by Subject|3|||
129768973|NCT00939393|467121387|FG000|Overall Study|Withdrawal by Subject|1|||
129768974|NCT00939393|467121388|FG001|Overall Study|Withdrawal by Subject|0|||
129768975|NCT00939393|467121387|FG000|Overall Study|Lost to Follow-up|3|||
129768976|NCT00939393|467121388|FG001|Overall Study|Lost to Follow-up|0|||
129768977|NCT02851615|467121389|FG000|Overall Study|Cognitive Issue|1|||
129768978|NCT02851615|467121390|FG001|Overall Study|Cognitive Issue|0|||
129768979|NCT02851615|467121389|FG000|Overall Study|Lost to Follow-up|0|||
129678499|NCT01572792|466783935|FG003|Lead-in Study|Lost to Follow-up|2|||
129678500|NCT01572792|466783936|FG004|Lead-in Study|Lost to Follow-up|4|||
129678501|NCT01572792|466783932|FG000|Lead-in Study|Withdrawal by Subject|22|||
129678502|NCT01572792|466783933|FG001|Lead-in Study|Withdrawal by Subject|11|||
129678503|NCT01572792|466783934|FG002|Lead-in Study|Withdrawal by Subject|12|||
129678504|NCT01572792|466783935|FG003|Lead-in Study|Withdrawal by Subject|24|||
129678505|NCT01572792|466783936|FG004|Lead-in Study|Withdrawal by Subject|11|||
129678506|NCT01572792|466783932|FG000|Lead-in Study|Protocol Violation|19|||
129678507|NCT01572792|466783933|FG001|Lead-in Study|Protocol Violation|10|||
129678508|NCT01572792|466783934|FG002|Lead-in Study|Protocol Violation|12|||
129678509|NCT01572792|466783935|FG003|Lead-in Study|Protocol Violation|13|||
129678510|NCT01572792|466783936|FG004|Lead-in Study|Protocol Violation|21|||
129678511|NCT01572792|466783932|FG000|Lead-in Study|Lack of Efficacy|20|||
129678512|NCT01572792|466783933|FG001|Lead-in Study|Lack of Efficacy|5|||
129678513|NCT01572792|466783934|FG002|Lead-in Study|Lack of Efficacy|4|||
129678514|NCT01572792|466783935|FG003|Lead-in Study|Lack of Efficacy|8|||
129678515|NCT01572792|466783936|FG004|Lead-in Study|Lack of Efficacy|10|||
129678516|NCT01572792|466783932|FG000|Lead-in Study|Adverse Event|21|||
129678517|NCT01572792|466783933|FG001|Lead-in Study|Adverse Event|21|||
129678518|NCT01572792|466783934|FG002|Lead-in Study|Adverse Event|22|||
129678519|NCT01572792|466783935|FG003|Lead-in Study|Adverse Event|16|||
129678520|NCT01572792|466783936|FG004|Lead-in Study|Adverse Event|14|||
129678521|NCT01572792|466783932|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
129678522|NCT01572792|466783933|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
129678523|NCT01572792|466783934|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
129678524|NCT01572792|466783935|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
129678525|NCT01572792|466783936|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
129678526|NCT01572792|466783932|FG000|Extension Study|Lost to Follow-up|6|||
129678527|NCT01572792|466783933|FG001|Extension Study|Lost to Follow-up|2|||
129678528|NCT01572792|466783934|FG002|Extension Study|Lost to Follow-up|0|||
129678529|NCT01572792|466783935|FG003|Extension Study|Lost to Follow-up|3|||
129678530|NCT01572792|466783936|FG004|Extension Study|Lost to Follow-up|3|||
129678531|NCT01572792|466783932|FG000|Extension Study|Withdrawal by Subject|7|||
129678532|NCT01572792|466783933|FG001|Extension Study|Withdrawal by Subject|6|||
129768980|NCT02851615|467121390|FG001|Overall Study|Lost to Follow-up|4|||
129768981|NCT01747876|467121400|FG000|Overall Study|Adverse Event|1|||
129768982|NCT01747876|467121401|FG001|Overall Study|Adverse Event|0|||
129768983|NCT01747876|467121402|FG002|Overall Study|Adverse Event|2|||
129768984|NCT01747876|467121400|FG000|Overall Study|Withdrawal by Subject|0|||
129768985|NCT01747876|467121401|FG001|Overall Study|Withdrawal by Subject|1|||
129768986|NCT01747876|467121402|FG002|Overall Study|Withdrawal by Subject|1|||
129678533|NCT01572792|466783934|FG002|Extension Study|Withdrawal by Subject|11|||
129768987|NCT01747876|467121400|FG000|Overall Study|Disease progression|4|||
129768988|NCT01747876|467121401|FG001|Overall Study|Disease progression|13|||
129768989|NCT01747876|467121402|FG002|Overall Study|Disease progression|8|||
129768990|NCT01747876|467121400|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
129768991|NCT01747876|467121401|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
129768992|NCT01747876|467121402|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
129768993|NCT02379728|467121405|FG000|Overall Study|Lost to Follow-up|1|||
129768994|NCT02379728|467121406|FG001|Overall Study|Lost to Follow-up|0|||
129768995|NCT02379728|467121407|FG002|Overall Study|Lost to Follow-up|3|||
129768996|NCT02379728|467121408|FG003|Overall Study|Lost to Follow-up|0|||
129768997|NCT02379728|467121405|FG000|Overall Study|Withdrawal by Subject|5|||
129768998|NCT02379728|467121406|FG001|Overall Study|Withdrawal by Subject|0|||
129678534|NCT01572792|466783935|FG003|Extension Study|Withdrawal by Subject|8|||
129678535|NCT01572792|466783936|FG004|Extension Study|Withdrawal by Subject|14|||
129678536|NCT01572792|466783932|FG000|Extension Study|Protocol Violation|0|||
129678537|NCT01572792|466783933|FG001|Extension Study|Protocol Violation|4|||
129678538|NCT01572792|466783934|FG002|Extension Study|Protocol Violation|3|||
129678539|NCT01572792|466783935|FG003|Extension Study|Protocol Violation|4|||
129678540|NCT01572792|466783936|FG004|Extension Study|Protocol Violation|3|||
129678541|NCT01572792|466783932|FG000|Extension Study|Lack of Efficacy|2|||
129678542|NCT01572792|466783933|FG001|Extension Study|Lack of Efficacy|3|||
129678543|NCT01572792|466783934|FG002|Extension Study|Lack of Efficacy|3|||
129768999|NCT02379728|467121407|FG002|Overall Study|Withdrawal by Subject|5|||
129769000|NCT02379728|467121408|FG003|Overall Study|Withdrawal by Subject|3|||
129769001|NCT02379728|467121405|FG000|Overall Study|Protocol Violation|0|||
129769002|NCT02379728|467121406|FG001|Overall Study|Protocol Violation|0|||
129769003|NCT02379728|467121407|FG002|Overall Study|Protocol Violation|2|||
129769004|NCT02379728|467121408|FG003|Overall Study|Protocol Violation|0|||
129769005|NCT03131219|467121410|FG000|Initial Evaluation Period|Adverse Event|2|||
129769006|NCT03131219|467121411|FG001|Initial Evaluation Period|Adverse Event|0|||
129769007|NCT03131219|467121410|FG000|Initial Evaluation Period|Protocol Violation|1|||
129769008|NCT03131219|467121411|FG001|Initial Evaluation Period|Protocol Violation|0|||
129769009|NCT03131219|467121410|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
129769010|NCT03131219|467121411|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
129769011|NCT03131219|467121410|FG000|Initial Evaluation Period|Physician Decision|1|||
129769012|NCT03131219|467121411|FG001|Initial Evaluation Period|Physician Decision|0|||
129769013|NCT03131219|467121410|FG000|Extension Period|Physician Decision|1|||
129769014|NCT03131219|467121411|FG001|Extension Period|Physician Decision|0|||
129769015|NCT01391546|467121415|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
129769016|NCT01391546|467121416|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
129678544|NCT01572792|466783935|FG003|Extension Study|Lack of Efficacy|2|||
129678545|NCT01572792|466783936|FG004|Extension Study|Lack of Efficacy|2|||
129678546|NCT01572792|466783932|FG000|Extension Study|Adverse Event|7|||
129678547|NCT01572792|466783933|FG001|Extension Study|Adverse Event|6|||
129678548|NCT01572792|466783934|FG002|Extension Study|Adverse Event|5|||
129678549|NCT01572792|466783935|FG003|Extension Study|Adverse Event|6|||
129678550|NCT01572792|466783936|FG004|Extension Study|Adverse Event|4|||
129678551|NCT01572792|466783932|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
129678552|NCT01572792|466783933|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
129678553|NCT01572792|466783934|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
129678554|NCT01572792|466783935|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
129678555|NCT01572792|466783936|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
129678556|NCT01129128|466783937|FG000|Overall Study|Lost to Follow-up|2|||
129678557|NCT01129128|466783938|FG001|Overall Study|Lost to Follow-up|2|||
129678558|NCT01129128|466783939|FG002|Overall Study|Lost to Follow-up|1|||
129678559|NCT01129128|466783937|FG000|Overall Study|Protocol Violation|0|||
129678560|NCT01129128|466783938|FG001|Overall Study|Protocol Violation|1|||
129678561|NCT01129128|466783939|FG002|Overall Study|Protocol Violation|0|||
129769017|NCT02156076|467121417|FG000|Treatment Period|no longer meets study criteria|0|||
129678562|NCT01129128|466783937|FG000|Overall Study|Withdrawal by Subject|0|||
129678563|NCT01129128|466783938|FG001|Overall Study|Withdrawal by Subject|1|||
129678564|NCT01129128|466783939|FG002|Overall Study|Withdrawal by Subject|3|||
129678565|NCT01129128|466783937|FG000|Overall Study|Physician Decision|1|||
129769018|NCT02156076|467121418|FG001|Treatment Period|no longer meets study criteria|0|||
129769019|NCT02156076|467121419|FG002|Treatment Period|no longer meets study criteria|1|||
129769020|NCT02156076|467121420|FG003|Treatment Period|no longer meets study criteria|0|||
129769021|NCT02156076|467121417|FG000|Treatment Period|Poor/non-compliance|0|||
129678566|NCT01129128|466783938|FG001|Overall Study|Physician Decision|0|||
129678567|NCT01129128|466783939|FG002|Overall Study|Physician Decision|0|||
129678568|NCT00961415|466783940|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
129678569|NCT00961415|466783941|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
129678570|NCT00961415|466783942|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
129678571|NCT00961415|466783940|FG000|Induction Treatment Phase|Death|77|||
129678572|NCT00961415|466783941|FG001|Induction Treatment Phase|Death|0|||
129678573|NCT00961415|466783942|FG002|Induction Treatment Phase|Death|0|||
129678574|NCT00961415|466783940|FG000|Induction Treatment Phase|Protocol Violation|1|||
129678575|NCT00961415|466783941|FG001|Induction Treatment Phase|Protocol Violation|0|||
129678576|NCT00961415|466783942|FG002|Induction Treatment Phase|Protocol Violation|0|||
129678577|NCT00961415|466783940|FG000|Induction Treatment Phase|Physician Decision|2|||
129678578|NCT00961415|466783941|FG001|Induction Treatment Phase|Physician Decision|0|||
129678579|NCT00961415|466783942|FG002|Induction Treatment Phase|Physician Decision|0|||
129678580|NCT00961415|466783940|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
129678581|NCT00961415|466783941|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
129678582|NCT00961415|466783942|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
129678583|NCT00961415|466783940|FG000|Induction Treatment Phase|Other Reason|5|||
129678584|NCT00961415|466783941|FG001|Induction Treatment Phase|Other Reason|0|||
129678585|NCT00961415|466783942|FG002|Induction Treatment Phase|Other Reason|0|||
129678586|NCT00961415|466783940|FG000|Maintenance Treatment Phase|Death|0|||
129678587|NCT00961415|466783941|FG001|Maintenance Treatment Phase|Death|42|||
129678588|NCT00961415|466783942|FG002|Maintenance Treatment Phase|Death|34|||
129678589|NCT00961415|466783940|FG000|Maintenance Treatment Phase|Investigators decision|0|||
129678590|NCT00961415|466783941|FG001|Maintenance Treatment Phase|Investigators decision|2|||
129769022|NCT02156076|467121418|FG001|Treatment Period|Poor/non-compliance|1|||
129769023|NCT02156076|467121419|FG002|Treatment Period|Poor/non-compliance|0|||
129769024|NCT02156076|467121420|FG003|Treatment Period|Poor/non-compliance|0|||
129769025|NCT02156076|467121417|FG000|Treatment Period|Lost to Follow-up|0|||
129769026|NCT02156076|467121418|FG001|Treatment Period|Lost to Follow-up|0|||
129769027|NCT02156076|467121419|FG002|Treatment Period|Lost to Follow-up|0|||
129769028|NCT02156076|467121420|FG003|Treatment Period|Lost to Follow-up|1|||
129769029|NCT02156076|467121417|FG000|Treatment Period|Withdrawal by Subject|0|||
129769030|NCT02156076|467121418|FG001|Treatment Period|Withdrawal by Subject|0|||
129769031|NCT02156076|467121419|FG002|Treatment Period|Withdrawal by Subject|1|||
129769032|NCT02156076|467121420|FG003|Treatment Period|Withdrawal by Subject|0|||
129769033|NCT02156076|467121417|FG000|Treatment Period|Subject request to discontinue treatment|0|||
129769034|NCT02156076|467121418|FG001|Treatment Period|Subject request to discontinue treatment|1|||
129769035|NCT02156076|467121419|FG002|Treatment Period|Subject request to discontinue treatment|0|||
129769036|NCT02156076|467121420|FG003|Treatment Period|Subject request to discontinue treatment|0|||
129769037|NCT02156076|467121417|FG000|Treatment Period|Adverse Event|0|||
129769038|NCT02156076|467121418|FG001|Treatment Period|Adverse Event|0|||
129769039|NCT02156076|467121419|FG002|Treatment Period|Adverse Event|0|||
129769040|NCT02156076|467121420|FG003|Treatment Period|Adverse Event|1|||
129769041|NCT02156076|467121417|FG000|Follow-up Period|Withdrawal by Subject|1|||
129769042|NCT02156076|467121418|FG001|Follow-up Period|Withdrawal by Subject|0|||
129769043|NCT02156076|467121419|FG002|Follow-up Period|Withdrawal by Subject|0|||
129769044|NCT02156076|467121420|FG003|Follow-up Period|Withdrawal by Subject|0|||
129769045|NCT00003475|467121421|FG000|Overall Study|Not evaluable|13|||
129769046|NCT01498068|467121425|FG000|Overall Study|Withdrawal by Subject|1|||
129769047|NCT01498068|467121426|FG001|Overall Study|Withdrawal by Subject|1|||
129769048|NCT01353898|467121428|FG000|Overall Study|Study site terminated|0|||
129769049|NCT01353898|467121429|FG001|Overall Study|Study site terminated|0|||
129769050|NCT01353898|467121430|FG002|Overall Study|Study site terminated|0|||
129769051|NCT01353898|467121431|FG003|Overall Study|Study site terminated|0|||
129769052|NCT01353898|467121432|FG004|Overall Study|Study site terminated|0|||
129769053|NCT01353898|467121433|FG005|Overall Study|Study site terminated|1|||
129769054|NCT03558737|467121434|FG000|Overall Study|Death|1|||
129769055|NCT03558737|467121435|FG001|Overall Study|Death|1|||
129769056|NCT01318915|467121436|FG000|Overall Study|Lost to Follow-up|1|||
129769057|NCT00453206|467121438|FG000|Overall Study|Death|1|||
129769058|NCT05386329|467121439|FG000|Overall Study|Lost to Follow-up|3|||
129769059|NCT03041181|467121441|FG000|Overall Study|Disease Progression|1|||
129769060|NCT03041181|467121442|FG001|Overall Study|Disease Progression|2|||
129769061|NCT03104868|467121443|FG000|6 Week Follow up|Lost to Follow-up|5|||
129769062|NCT03104868|467121444|FG001|6 Week Follow up|Lost to Follow-up|8|||
129769063|NCT03104868|467121443|FG000|6 Week Follow up|Death|1|||
129769064|NCT03104868|467121444|FG001|6 Week Follow up|Death|1|||
129769065|NCT03104868|467121443|FG000|6 Week Follow up|Withdrawal by Subject|7|||
129769066|NCT03104868|467121444|FG001|6 Week Follow up|Withdrawal by Subject|6|||
129769067|NCT03104868|467121443|FG000|6 Week Follow up|Completed Later Timepoint|24|||
129547208|NCT00358670|466296165|FG000|Overall Study|Withdrawal by Subject|13|||
129547209|NCT00358670|466296166|FG001|Overall Study|Withdrawal by Subject|24|||
129769068|NCT03104868|467121444|FG001|6 Week Follow up|Completed Later Timepoint|22|||
129769069|NCT03104868|467121443|FG000|6 Month Follow up|Lost to Follow-up|2|||
129769070|NCT03104868|467121444|FG001|6 Month Follow up|Lost to Follow-up|2|||
129769071|NCT03104868|467121443|FG000|6 Month Follow up|Death|0|||
129769072|NCT03104868|467121444|FG001|6 Month Follow up|Death|1|||
129769073|NCT03104868|467121443|FG000|6 Month Follow up|Completed Later Timepoint|22|||
129769074|NCT03104868|467121444|FG001|6 Month Follow up|Completed Later Timepoint|32|||
129769075|NCT03104868|467121443|FG000|12 Month Follow up|Lost to Follow-up|1|||
129769076|NCT03104868|467121444|FG001|12 Month Follow up|Lost to Follow-up|2|||
129769077|NCT03104868|467121443|FG000|12 Month Follow up|Death|0|||
129678591|NCT00961415|466783942|FG002|Maintenance Treatment Phase|Investigators decision|0|||
129678592|NCT00961415|466783940|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129678593|NCT00961415|466783941|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
129678594|NCT00961415|466783942|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
129678595|NCT00961415|466783940|FG000|Maintenance Treatment Phase|Other reason|0|||
129678596|NCT00961415|466783941|FG001|Maintenance Treatment Phase|Other reason|1|||
129678597|NCT00961415|466783942|FG002|Maintenance Treatment Phase|Other reason|3|||
129678598|NCT00639509|466783953|FG000|Overall Study|Death|1|||
129678599|NCT01933594|466783954|FG000|Overall Study|Lost to Follow-up|1|||
129678600|NCT01933594|466783955|FG001|Overall Study|Lost to Follow-up|0|||
129678601|NCT01933594|466783956|FG002|Overall Study|Lost to Follow-up|0|||
129678602|NCT01933594|466783957|FG003|Overall Study|Lost to Follow-up|0|||
129678603|NCT01933594|466783958|FG004|Overall Study|Lost to Follow-up|1|||
129678604|NCT01933594|466783959|FG005|Overall Study|Lost to Follow-up|0|||
129678605|NCT01933594|466783954|FG000|Overall Study|Ineligible for subsequent study step|0|||
129678606|NCT01933594|466783955|FG001|Overall Study|Ineligible for subsequent study step|0|||
129678607|NCT01933594|466783956|FG002|Overall Study|Ineligible for subsequent study step|0|||
129678608|NCT01933594|466783957|FG003|Overall Study|Ineligible for subsequent study step|0|||
129678609|NCT01933594|466783958|FG004|Overall Study|Ineligible for subsequent study step|1|||
129678610|NCT01933594|466783959|FG005|Overall Study|Ineligible for subsequent study step|0|||
129678611|NCT05049122|466783960|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
129678612|NCT05049122|466783960|FG000|Overall Study|Participant moved|1|||
129678613|NCT05049122|466783960|FG000|Overall Study|At the direction of the doctor|1|||
129678614|NCT05722015|466783961|FG000|Overall Study|Death|57|||
129678615|NCT05722015|466783962|FG001|Overall Study|Death|37|||
129678616|NCT05722015|466783961|FG000|Overall Study|Lost to Follow-up|1|||
129678617|NCT05722015|466783962|FG001|Overall Study|Lost to Follow-up|0|||
129678618|NCT05722015|466783961|FG000|Overall Study|Withdrawal by Subject|5|||
129678619|NCT05722015|466783962|FG001|Overall Study|Withdrawal by Subject|1|||
129678620|NCT05722015|466783961|FG000|Overall Study|Participants Ongoing|188|||
129678621|NCT05722015|466783962|FG001|Overall Study|Participants Ongoing|88|||
129678622|NCT04513366|466783963|FG000|Treatment Phase|Withdrawal by Subject|6|||
129678623|NCT04513366|466783964|FG001|Treatment Phase|Withdrawal by Subject|8|||
129678624|NCT04513366|466783965|FG002|Treatment Phase|Withdrawal by Subject|3|||
129678625|NCT04513366|466783963|FG000|Treatment Phase|Lost to Follow-up|1|||
129678626|NCT04513366|466783964|FG001|Treatment Phase|Lost to Follow-up|2|||
129678627|NCT04513366|466783965|FG002|Treatment Phase|Lost to Follow-up|5|||
129678628|NCT04513366|466783963|FG000|Treatment Phase|Other than Specified|1|||
129678629|NCT04513366|466783964|FG001|Treatment Phase|Other than Specified|0|||
129678630|NCT04513366|466783965|FG002|Treatment Phase|Other than Specified|2|||
129678631|NCT04513366|466783963|FG000|Treatment Phase|Physician Decision|2|||
129678632|NCT04513366|466783964|FG001|Treatment Phase|Physician Decision|0|||
129678633|NCT04513366|466783965|FG002|Treatment Phase|Physician Decision|0|||
129678634|NCT04513366|466783963|FG000|Treatment Phase|Adverse Event|0|||
129678635|NCT04513366|466783964|FG001|Treatment Phase|Adverse Event|1|||
129678636|NCT04513366|466783965|FG002|Treatment Phase|Adverse Event|1|||
129678637|NCT04513366|466783963|FG000|Extension Phase|Withdrawal by Subject|3|||
129678638|NCT04513366|466783964|FG001|Extension Phase|Withdrawal by Subject|1|||
129678639|NCT04513366|466783965|FG002|Extension Phase|Withdrawal by Subject|1|||
129678640|NCT04513366|466783963|FG000|Extension Phase|Other than Specified|4|||
129678641|NCT04513366|466783964|FG001|Extension Phase|Other than Specified|0|||
129678642|NCT04513366|466783965|FG002|Extension Phase|Other than Specified|1|||
129678643|NCT04513366|466783963|FG000|Extension Phase|Lost to Follow-up|1|||
129678644|NCT04513366|466783964|FG001|Extension Phase|Lost to Follow-up|1|||
129678645|NCT04513366|466783965|FG002|Extension Phase|Lost to Follow-up|1|||
129678646|NCT04513366|466783963|FG000|Extension Phase|Sponsor Decision|0|||
129678647|NCT04513366|466783964|FG001|Extension Phase|Sponsor Decision|1|||
129678648|NCT04513366|466783965|FG002|Extension Phase|Sponsor Decision|0|||
129678649|NCT04513366|466783963|FG000|Extension Phase|Death|0|||
129678650|NCT04513366|466783964|FG001|Extension Phase|Death|1|||
129678651|NCT04513366|466783965|FG002|Extension Phase|Death|0|||
129678652|NCT04513366|466783963|FG000|Extension Phase|Adverse Event|0|||
129547210|NCT00358670|466296165|FG000|Overall Study|Protocol Defined Clinical Event|0|||
129547211|NCT00358670|466296166|FG001|Overall Study|Protocol Defined Clinical Event|1|||
129678653|NCT04513366|466783964|FG001|Extension Phase|Adverse Event|0|||
129678654|NCT04513366|466783965|FG002|Extension Phase|Adverse Event|1|||
129678655|NCT04478266|466783969|FG000|Overall Study|Adverse Event|20|||
129678656|NCT04478266|466783970|FG001|Overall Study|Adverse Event|21|||
129678657|NCT04478266|466783969|FG000|Overall Study|Progressive disease|146|||
129678658|NCT04478266|466783970|FG001|Overall Study|Progressive disease|168|||
129678659|NCT04478266|466783969|FG000|Overall Study|Poor compliance to protocol|1|||
129678660|NCT04478266|466783970|FG001|Overall Study|Poor compliance to protocol|0|||
129678661|NCT04478266|466783969|FG000|Overall Study|Withdrawal by Subject|19|||
129678662|NCT04478266|466783970|FG001|Overall Study|Withdrawal by Subject|16|||
129678663|NCT04478266|466783969|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
129678664|NCT04478266|466783970|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
129678665|NCT04478266|466783969|FG000|Overall Study|Study terminated by sponsor|33|||
129678666|NCT04478266|466783970|FG001|Overall Study|Study terminated by sponsor|35|||
129678667|NCT04478266|466783969|FG000|Overall Study|Other: unspecified|5|||
129678668|NCT04478266|466783970|FG001|Overall Study|Other: unspecified|7|||
129678669|NCT04478266|466783969|FG000|Overall Study|Randomized but not treated|1|||
129678670|NCT04478266|466783970|FG001|Overall Study|Randomized but not treated|1|||
129678671|NCT04058717|466783971|FG000|Randomization Period|Lost to Follow-up|2|||
129678672|NCT04058717|466783972|FG001|Randomization Period|Lost to Follow-up|3|||
129678673|NCT04058717|466783973|FG002|Randomization Period|Lost to Follow-up|4|||
129678674|NCT04058717|466783974|FG003|Randomization Period|Lost to Follow-up|4|||
129678675|NCT04058717|466783971|FG000|Randomization Period|Withdrawal by Subject|1|||
129678676|NCT04058717|466783972|FG001|Randomization Period|Withdrawal by Subject|3|||
129678677|NCT04058717|466783973|FG002|Randomization Period|Withdrawal by Subject|3|||
129678678|NCT04058717|466783974|FG003|Randomization Period|Withdrawal by Subject|3|||
129678679|NCT04058717|466783971|FG000|Randomization Period|PI decision|0|||
129678680|NCT04058717|466783972|FG001|Randomization Period|PI decision|1|||
129678681|NCT04058717|466783973|FG002|Randomization Period|PI decision|0|||
129678682|NCT04058717|466783974|FG003|Randomization Period|PI decision|0|||
129678683|NCT00671788|466783975|FG000|Overall Study|Adverse Event|8|||
129678684|NCT00671788|466783975|FG000|Overall Study|Refused further treatment|3|||
129678685|NCT00671788|466783975|FG000|Overall Study|Ineligible|1|||
129678686|NCT00671788|466783975|FG000|Overall Study|MD Decision|1|||
129678687|NCT00671788|466783975|FG000|Overall Study|Other|1|||
129678688|NCT01832766|466783976|FG000|Washout|Lost to Follow-up|0|||
129678689|NCT01832766|466783977|FG001|Washout|Lost to Follow-up|1|||
129678690|NCT03074500|466783982|FG000|Overall Study|Lost to Follow-up|1|||
129678691|NCT03074500|466783983|FG001|Overall Study|Lost to Follow-up|0|||
129678692|NCT03074500|466783984|FG002|Overall Study|Lost to Follow-up|0|||
129678693|NCT03074500|466783982|FG000|Overall Study|Lack of Efficacy|0|||
129678694|NCT03074500|466783983|FG001|Overall Study|Lack of Efficacy|1|||
129678695|NCT03074500|466783984|FG002|Overall Study|Lack of Efficacy|0|||
129678696|NCT03074500|466783982|FG000|Overall Study|Adverse Event|0|||
129678697|NCT03074500|466783983|FG001|Overall Study|Adverse Event|0|||
129678698|NCT03074500|466783984|FG002|Overall Study|Adverse Event|1|||
129707535|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
129707536|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
129707537|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129707538|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129707539|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
129707540|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
129707541|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
129707542|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
129707543|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
129707544|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
129707545|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
129707546|NCT03338400|466892027|FG000|Overall Study|Lost to Follow-up|1|||
129707547|NCT03338400|466892028|FG001|Overall Study|Lost to Follow-up|2|||
129707548|NCT01627691|466892029|FG000|Overall Study|Death|11|||
129707549|NCT01627691|466892029|FG000|Overall Study|Lost to Follow-up|3|||
129707550|NCT01627691|466892029|FG000|Overall Study|Withdrawal by Subject|1|||
129707551|NCT01627691|466892029|FG000|Overall Study|Missed the visit|3|||
129707552|NCT00186628|466892036|FG000|Overall Study|Death|2|||
129707553|NCT00186628|466892036|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
129707554|NCT02927795|466892037|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
129707555|NCT02927795|466892037|FG000|Overall Study|Not Treated|4|||
129707556|NCT01076010|466892038|FG000|Overall Study|Death|15|||
129769078|NCT03104868|467121444|FG001|12 Month Follow up|Death|1|||
129884414|NCT02771210|467536387|FG000|Period 2|Lack of Efficacy|0|||
129547212|NCT00358670|466296165|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
129547213|NCT00358670|466296166|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
129547214|NCT00358670|466296165|FG000|Overall Study|Administrative|153|||
129547215|NCT00358670|466296166|FG001|Overall Study|Administrative|125|||
129547216|NCT00981019|466296167|FG000|Overall Study|Did not respond|65|||
129547217|NCT00981019|466296167|FG000|Overall Study|Did not match target population|94|||
129547218|NCT00981019|466296167|FG000|Overall Study|Inadvertent exclusion|239|||
129547219|NCT00981019|466296167|FG000|Overall Study|Hit the survey after closure|79|||
129547220|NCT00960687|466296168|FG000|Washout Period of 7 Days|Adverse Event|3|||
129547221|NCT00960687|466296169|FG001|Washout Period of 7 Days|Adverse Event|2|||
129547222|NCT00960687|466296168|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
129547223|NCT00960687|466296169|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129547224|NCT02704130|466296170|FG000|Overall Study|Physician Decision|5|||
129547225|NCT02704130|466296171|FG001|Overall Study|Physician Decision|3|||
129547226|NCT02666768|466296172|FG000|Overall Study|Withdrawal by Subject|4|||
129547227|NCT00285012|466296175|FG000|Assigned to Study Treatment (Tx)|Other|2|||
129547228|NCT00285012|466296176|FG001|Assigned to Study Treatment (Tx)|Other|3|||
129547229|NCT00285012|466296175|FG000|Received Study Tx|Death|2|||
129547230|NCT00285012|466296176|FG001|Received Study Tx|Death|1|||
129547231|NCT00285012|466296175|FG000|Received Study Tx|Adverse Event|5|||
129547232|NCT00285012|466296176|FG001|Received Study Tx|Adverse Event|11|||
129547233|NCT00285012|466296175|FG000|Received Study Tx|Lack of Efficacy|0|||
129547234|NCT00285012|466296176|FG001|Received Study Tx|Lack of Efficacy|3|||
129547235|NCT00285012|466296175|FG000|Received Study Tx|Lost to Follow-up|29|||
129547236|NCT00285012|466296176|FG001|Received Study Tx|Lost to Follow-up|31|||
129547237|NCT00285012|466296175|FG000|Received Study Tx|Withdrawal by Subject|31|||
129547238|NCT00285012|466296176|FG001|Received Study Tx|Withdrawal by Subject|43|||
129547239|NCT00285012|466296175|FG000|Received Study Tx|Other|5|||
129769079|NCT03104868|467121443|FG000|12 Month Follow up|Withdrawal by Subject|0|||
129769080|NCT03104868|467121444|FG001|12 Month Follow up|Withdrawal by Subject|3|||
129769081|NCT03104868|467121443|FG000|12 Month Follow up|Completed Later Timepoint|32|||
129769082|NCT03104868|467121444|FG001|12 Month Follow up|Completed Later Timepoint|29|||
129769083|NCT03104868|467121443|FG000|18 Month Follow up|Lost to Follow-up|7|||
129769084|NCT03104868|467121444|FG001|18 Month Follow up|Lost to Follow-up|11|||
129769085|NCT03104868|467121443|FG000|18 Month Follow up|Death|2|||
129769086|NCT03104868|467121444|FG001|18 Month Follow up|Death|1|||
129769087|NCT03104868|467121443|FG000|18 Month Follow up|Withdrawal by Subject|1|||
129769088|NCT03104868|467121444|FG001|18 Month Follow up|Withdrawal by Subject|2|||
129769089|NCT03104868|467121443|FG000|18 Month Follow up|Graft Loss|1|||
129769090|NCT03104868|467121444|FG001|18 Month Follow up|Graft Loss|1|||
129769091|NCT03104868|467121443|FG000|18 Month Follow up|Completed Later Timepoint|19|||
129769092|NCT03104868|467121444|FG001|18 Month Follow up|Completed Later Timepoint|20|||
129769093|NCT03104868|467121443|FG000|24 Month Follow up|Lost to Follow-up|15|||
129769094|NCT03104868|467121444|FG001|24 Month Follow up|Lost to Follow-up|16|||
129769095|NCT03104868|467121443|FG000|24 Month Follow up|Death|3|||
129769096|NCT03104868|467121444|FG001|24 Month Follow up|Death|2|||
129769097|NCT03104868|467121443|FG000|24 Month Follow up|Withdrawal by Subject|1|||
129769098|NCT03104868|467121444|FG001|24 Month Follow up|Withdrawal by Subject|0|||
129769099|NCT03104868|467121443|FG000|24 Month Follow up|Graft Loss|2|||
129769100|NCT03104868|467121444|FG001|24 Month Follow up|Graft Loss|0|||
129769101|NCT03050801|467121447|FG000|Experiment 1|Lost to Follow-up|0|||
129769102|NCT03050801|467121448|FG001|Experiment 1|Lost to Follow-up|1|||
129769103|NCT03050801|467121449|FG002|Experiment 1|Lost to Follow-up|0|||
129769104|NCT03050801|467121450|FG003|Experiment 1|Lost to Follow-up|0|||
129769105|NCT03050801|467121451|FG004|Experiment 1|Lost to Follow-up|0|||
129769106|NCT03050801|467121452|FG005|Experiment 1|Lost to Follow-up|0|||
129769107|NCT03050801|467121447|FG000|Experiment 1|Physician Decision|0|||
129769108|NCT03050801|467121448|FG001|Experiment 1|Physician Decision|3|||
129769109|NCT03050801|467121449|FG002|Experiment 1|Physician Decision|0|||
129769110|NCT03050801|467121450|FG003|Experiment 1|Physician Decision|0|||
129769111|NCT03050801|467121451|FG004|Experiment 1|Physician Decision|0|||
129769112|NCT03050801|467121452|FG005|Experiment 1|Physician Decision|0|||
129769113|NCT03050801|467121447|FG000|Experiment 1|Change of experimental design|0|||
129769114|NCT03050801|467121448|FG001|Experiment 1|Change of experimental design|3|||
129769115|NCT03050801|467121449|FG002|Experiment 1|Change of experimental design|0|||
129769116|NCT03050801|467121450|FG003|Experiment 1|Change of experimental design|0|||
129769117|NCT03050801|467121451|FG004|Experiment 1|Change of experimental design|0|||
129769118|NCT03050801|467121452|FG005|Experiment 1|Change of experimental design|0|||
129769119|NCT03050801|467121447|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
129769120|NCT03050801|467121448|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
129769121|NCT03050801|467121449|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
129769122|NCT03050801|467121450|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
129769123|NCT03050801|467121451|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
129769124|NCT03050801|467121452|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
129769125|NCT03050801|467121447|FG000|Experiment 2|Lost to Follow-up|0|||
129769126|NCT03050801|467121448|FG001|Experiment 2|Lost to Follow-up|0|||
129769127|NCT03050801|467121449|FG002|Experiment 2|Lost to Follow-up|0|||
129769128|NCT03050801|467121450|FG003|Experiment 2|Lost to Follow-up|1|||
129769129|NCT03050801|467121451|FG004|Experiment 2|Lost to Follow-up|1|||
129769130|NCT03050801|467121452|FG005|Experiment 2|Lost to Follow-up|0|||
129769131|NCT03050801|467121447|FG000|Experiment 2|Physician Decision|0|||
129769132|NCT03050801|467121448|FG001|Experiment 2|Physician Decision|0|||
129769133|NCT03050801|467121449|FG002|Experiment 2|Physician Decision|0|||
129769134|NCT03050801|467121450|FG003|Experiment 2|Physician Decision|0|||
129769135|NCT03050801|467121451|FG004|Experiment 2|Physician Decision|1|||
129769136|NCT03050801|467121452|FG005|Experiment 2|Physician Decision|0|||
129769137|NCT03050801|467121447|FG000|Experiment 2|Pregnancy|0|||
129769138|NCT03050801|467121448|FG001|Experiment 2|Pregnancy|0|||
129769139|NCT03050801|467121449|FG002|Experiment 2|Pregnancy|0|||
129769140|NCT03050801|467121450|FG003|Experiment 2|Pregnancy|0|||
129769141|NCT03050801|467121451|FG004|Experiment 2|Pregnancy|1|||
129769142|NCT03050801|467121452|FG005|Experiment 2|Pregnancy|0|||
129547240|NCT00285012|466296176|FG001|Received Study Tx|Other|5|||
129769143|NCT03050801|467121447|FG000|Experiment 2|Withdrawal by Subject|0|||
129769144|NCT03050801|467121448|FG001|Experiment 2|Withdrawal by Subject|0|||
129769145|NCT03050801|467121449|FG002|Experiment 2|Withdrawal by Subject|0|||
129769146|NCT03050801|467121450|FG003|Experiment 2|Withdrawal by Subject|1|||
129769147|NCT03050801|467121451|FG004|Experiment 2|Withdrawal by Subject|0|||
129769148|NCT03050801|467121452|FG005|Experiment 2|Withdrawal by Subject|0|||
129769149|NCT03050801|467121447|FG000|Experiment 2|Poor data quality|0|||
129769150|NCT03050801|467121448|FG001|Experiment 2|Poor data quality|0|||
129769151|NCT03050801|467121449|FG002|Experiment 2|Poor data quality|0|||
129769152|NCT03050801|467121450|FG003|Experiment 2|Poor data quality|4|||
129769153|NCT03050801|467121451|FG004|Experiment 2|Poor data quality|1|||
129769154|NCT03050801|467121452|FG005|Experiment 2|Poor data quality|0|||
129547241|NCT02873195|466296179|FG000|Overall Study|Ineligible|5|||
129678699|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
129678700|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
129678701|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Death|1|||
129678702|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Death|3|||
129678703|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
129678704|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
129678705|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
129678706|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
129678707|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
129678708|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
129678709|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
129678710|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
129678711|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
129678712|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
129678713|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
129678714|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
129678715|NCT00362232|466785212|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
129678716|NCT00362232|466785213|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
129678717|NCT00362232|466785212|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
129678718|NCT00362232|466785213|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
129678719|NCT00362232|466785212|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
129678720|NCT00362232|466785213|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
129678721|NCT00362232|466785212|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
129678722|NCT00362232|466785213|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
129678723|NCT00362232|466785212|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
129678724|NCT00362232|466785213|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
129678725|NCT02233413|466785216|FG000|Overall Study|Lost to Follow-up|7|||
129678726|NCT02233413|466785217|FG001|Overall Study|Lost to Follow-up|9|||
129678727|NCT02233413|466785216|FG000|Overall Study|Withdrawal by Subject|4|||
129678728|NCT02233413|466785217|FG001|Overall Study|Withdrawal by Subject|5|||
129678729|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
129678730|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
129678731|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
129678732|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
129678733|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
129678734|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
129678735|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
129678736|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
129678737|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
129678738|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
129678739|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
129678740|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
129678741|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
129678742|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
129678743|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
129678744|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
129678745|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
129678746|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
129678747|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
129678748|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
129678749|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
129547242|NCT02873195|466296180|FG001|Overall Study|Ineligible|0|||
129769155|NCT03050801|467121447|FG000|Experiment 2|Discomfort during stimulation|0|||
129769156|NCT03050801|467121448|FG001|Experiment 2|Discomfort during stimulation|0|||
129769157|NCT03050801|467121449|FG002|Experiment 2|Discomfort during stimulation|0|||
129769158|NCT03050801|467121450|FG003|Experiment 2|Discomfort during stimulation|0|||
129769159|NCT03050801|467121451|FG004|Experiment 2|Discomfort during stimulation|0|||
129769160|NCT03050801|467121452|FG005|Experiment 2|Discomfort during stimulation|2|||
129769161|NCT00005780|467121453|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
129769162|NCT03600909|467121454|FG000|Overall Study|Not treated|0|||
129769163|NCT03600909|467121455|FG001|Overall Study|Not treated|3|||
129769164|NCT03600909|467121456|FG002|Overall Study|Not treated|0|||
129769165|NCT02651675|467121457|FG000|Overall Study|Death|0|||
129769166|NCT02651675|467121458|FG001|Overall Study|Death|0|||
129769167|NCT02651675|467121459|FG002|Overall Study|Death|1|||
129769168|NCT03674411|467121460|FG000|Overall Study|Non-treatment|4|||
129769169|NCT04408989|467121461|FG000|Overall Study|Lost to Follow-up|0|||
129769170|NCT04408989|467121462|FG001|Overall Study|Lost to Follow-up|0|||
129769171|NCT04408989|467121463|FG002|Overall Study|Lost to Follow-up|1|||
129769172|NCT04408989|467121461|FG000|Overall Study|Withdrawal by Subject|0|||
129769173|NCT04408989|467121462|FG001|Overall Study|Withdrawal by Subject|0|||
129769174|NCT04408989|467121463|FG002|Overall Study|Withdrawal by Subject|2|||
129769175|NCT05082857|467121464|FG000|Overall Study|participants relocated and could not continue|2|||
129769176|NCT05082857|467121465|FG001|Overall Study|participants relocated and could not continue|1|||
129678750|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
129678751|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
129678752|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
129769177|NCT05082857|467121464|FG000|Overall Study|Lost to Follow-up|1|||
129769178|NCT05082857|467121465|FG001|Overall Study|Lost to Follow-up|3|||
129769179|NCT04672239|467121466|FG000|Week 2 Survey|Failed survey check items|1|||
129769180|NCT04672239|467121467|FG001|Week 2 Survey|Failed survey check items|2|||
129769181|NCT04672239|467121468|FG002|Week 2 Survey|Failed survey check items|3|||
129769182|NCT04672239|467121466|FG000|Week 2 Survey|Partially completed survey|7|||
129769183|NCT04672239|467121467|FG001|Week 2 Survey|Partially completed survey|1|||
129769184|NCT04672239|467121468|FG002|Week 2 Survey|Partially completed survey|4|||
129769185|NCT04672239|467121466|FG000|Week 2 Survey|Withdrawal by Subject|0|||
129769186|NCT04672239|467121467|FG001|Week 2 Survey|Withdrawal by Subject|1|||
129769187|NCT04672239|467121468|FG002|Week 2 Survey|Withdrawal by Subject|0|||
129769188|NCT04672239|467121466|FG000|Week 2 Survey|Lost to Follow-up|3|||
129769189|NCT04672239|467121467|FG001|Week 2 Survey|Lost to Follow-up|2|||
129769190|NCT04672239|467121468|FG002|Week 2 Survey|Lost to Follow-up|5|||
129769191|NCT04672239|467121466|FG000|Week 6 Survey|Failed survey check items|2|||
129547243|NCT05004181|466296181|FG000|Overall Study|Withdrawal of consent|0|||
129547244|NCT05004181|466296182|FG001|Overall Study|Withdrawal of consent|0|||
129547245|NCT05004181|466296183|FG002|Overall Study|Withdrawal of consent|1|||
129547246|NCT05004181|466296184|FG003|Overall Study|Withdrawal of consent|3|||
129547247|NCT05004181|466296185|FG004|Overall Study|Withdrawal of consent|3|||
129547248|NCT05004181|466296186|FG005|Overall Study|Withdrawal of consent|0|||
129547249|NCT05004181|466296187|FG006|Overall Study|Withdrawal of consent|30|||
129547250|NCT05004181|466296188|FG007|Overall Study|Withdrawal of consent|9|||
129547251|NCT05004181|466296189|FG008|Overall Study|Withdrawal of consent|3|||
129547252|NCT05004181|466296190|FG009|Overall Study|Withdrawal of consent|2|||
129547253|NCT05004181|466296191|FG010|Overall Study|Withdrawal of consent|5|||
129769192|NCT04672239|467121467|FG001|Week 6 Survey|Failed survey check items|2|||
129769193|NCT04672239|467121468|FG002|Week 6 Survey|Failed survey check items|2|||
129769194|NCT04672239|467121466|FG000|Week 6 Survey|Partially completed survey|3|||
129769195|NCT04672239|467121467|FG001|Week 6 Survey|Partially completed survey|3|||
129547254|NCT05004181|466296192|FG011|Overall Study|Withdrawal of consent|1|||
129547255|NCT05004181|466296181|FG000|Overall Study|Lost to Follow-up|2|||
129547256|NCT05004181|466296182|FG001|Overall Study|Lost to Follow-up|4|||
129547257|NCT05004181|466296183|FG002|Overall Study|Lost to Follow-up|2|||
129547258|NCT05004181|466296184|FG003|Overall Study|Lost to Follow-up|3|||
129547259|NCT05004181|466296185|FG004|Overall Study|Lost to Follow-up|5|||
129547260|NCT05004181|466296186|FG005|Overall Study|Lost to Follow-up|2|||
129547261|NCT05004181|466296187|FG006|Overall Study|Lost to Follow-up|15|||
129547262|NCT05004181|466296188|FG007|Overall Study|Lost to Follow-up|12|||
129547263|NCT05004181|466296189|FG008|Overall Study|Lost to Follow-up|38|||
129547264|NCT05004181|466296190|FG009|Overall Study|Lost to Follow-up|6|||
129547265|NCT05004181|466296191|FG010|Overall Study|Lost to Follow-up|6|||
129547266|NCT05004181|466296192|FG011|Overall Study|Lost to Follow-up|0|||
129547267|NCT05004181|466296181|FG000|Overall Study|Death|0|||
129547268|NCT05004181|466296182|FG001|Overall Study|Death|0|||
129547269|NCT05004181|466296183|FG002|Overall Study|Death|0|||
129547270|NCT05004181|466296184|FG003|Overall Study|Death|0|||
129547271|NCT05004181|466296185|FG004|Overall Study|Death|0|||
129547272|NCT05004181|466296186|FG005|Overall Study|Death|0|||
129547273|NCT05004181|466296187|FG006|Overall Study|Death|1|||
129547274|NCT05004181|466296188|FG007|Overall Study|Death|0|||
129547275|NCT05004181|466296189|FG008|Overall Study|Death|2|||
129547276|NCT05004181|466296190|FG009|Overall Study|Death|0|||
129547277|NCT05004181|466296191|FG010|Overall Study|Death|0|||
129547278|NCT05004181|466296192|FG011|Overall Study|Death|0|||
129547279|NCT05004181|466296181|FG000|Overall Study|Physician Decision|0|||
129547280|NCT05004181|466296182|FG001|Overall Study|Physician Decision|0|||
129547281|NCT05004181|466296183|FG002|Overall Study|Physician Decision|0|||
129547282|NCT05004181|466296184|FG003|Overall Study|Physician Decision|0|||
129547283|NCT05004181|466296185|FG004|Overall Study|Physician Decision|0|||
129547284|NCT05004181|466296186|FG005|Overall Study|Physician Decision|0|||
129547285|NCT05004181|466296187|FG006|Overall Study|Physician Decision|2|||
129547286|NCT05004181|466296188|FG007|Overall Study|Physician Decision|0|||
129547287|NCT05004181|466296189|FG008|Overall Study|Physician Decision|7|||
129547288|NCT05004181|466296190|FG009|Overall Study|Physician Decision|0|||
129547289|NCT05004181|466296191|FG010|Overall Study|Physician Decision|0|||
129547290|NCT05004181|466296192|FG011|Overall Study|Physician Decision|0|||
129547291|NCT05004181|466296181|FG000|Overall Study|Withdrawal by Subject|2|||
129547292|NCT05004181|466296182|FG001|Overall Study|Withdrawal by Subject|3|||
129547293|NCT05004181|466296183|FG002|Overall Study|Withdrawal by Subject|2|||
129547294|NCT05004181|466296184|FG003|Overall Study|Withdrawal by Subject|2|||
129547295|NCT05004181|466296185|FG004|Overall Study|Withdrawal by Subject|4|||
129547296|NCT05004181|466296186|FG005|Overall Study|Withdrawal by Subject|2|||
129547297|NCT05004181|466296187|FG006|Overall Study|Withdrawal by Subject|4|||
129547298|NCT05004181|466296188|FG007|Overall Study|Withdrawal by Subject|22|||
129547299|NCT05004181|466296189|FG008|Overall Study|Withdrawal by Subject|8|||
129547300|NCT05004181|466296190|FG009|Overall Study|Withdrawal by Subject|1|||
129547301|NCT05004181|466296191|FG010|Overall Study|Withdrawal by Subject|3|||
129547302|NCT05004181|466296192|FG011|Overall Study|Withdrawal by Subject|2|||
129547303|NCT05004181|466296181|FG000|Overall Study|Protocol Violation|2|||
129547304|NCT05004181|466296182|FG001|Overall Study|Protocol Violation|3|||
129678753|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
129547305|NCT05004181|466296183|FG002|Overall Study|Protocol Violation|0|||
129547306|NCT05004181|466296184|FG003|Overall Study|Protocol Violation|0|||
129547307|NCT05004181|466296185|FG004|Overall Study|Protocol Violation|1|||
129547308|NCT05004181|466296186|FG005|Overall Study|Protocol Violation|0|||
129547309|NCT05004181|466296187|FG006|Overall Study|Protocol Violation|16|||
129547310|NCT05004181|466296188|FG007|Overall Study|Protocol Violation|18|||
129547311|NCT05004181|466296189|FG008|Overall Study|Protocol Violation|2|||
129547312|NCT05004181|466296190|FG009|Overall Study|Protocol Violation|2|||
129547313|NCT05004181|466296191|FG010|Overall Study|Protocol Violation|2|||
129547314|NCT05004181|466296192|FG011|Overall Study|Protocol Violation|1|||
129547315|NCT05004181|466296181|FG000|Overall Study|Not further specified|1|||
129547316|NCT05004181|466296182|FG001|Overall Study|Not further specified|0|||
129547317|NCT05004181|466296183|FG002|Overall Study|Not further specified|0|||
129547318|NCT05004181|466296184|FG003|Overall Study|Not further specified|0|||
129547319|NCT05004181|466296185|FG004|Overall Study|Not further specified|0|||
129547320|NCT05004181|466296186|FG005|Overall Study|Not further specified|0|||
129547321|NCT05004181|466296187|FG006|Overall Study|Not further specified|1|||
129547322|NCT05004181|466296188|FG007|Overall Study|Not further specified|0|||
129547323|NCT05004181|466296189|FG008|Overall Study|Not further specified|2|||
129547324|NCT05004181|466296190|FG009|Overall Study|Not further specified|1|||
129547325|NCT05004181|466296191|FG010|Overall Study|Not further specified|0|||
129547326|NCT05004181|466296192|FG011|Overall Study|Not further specified|1|||
129547327|NCT03993288|466297649|FG000|Overall Study|Lost to Follow-up|2|||
129547328|NCT03993288|466297650|FG001|Overall Study|Lost to Follow-up|1|||
129547329|NCT03993288|466297649|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
129547330|NCT03993288|466297650|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
129547331|NCT03993288|466297649|FG000|Overall Study|wrong randomization|0|||
129547332|NCT03993288|466297650|FG001|Overall Study|wrong randomization|1|||
129547333|NCT03993288|466297649|FG000|Overall Study|improper enrollment|0|||
129547334|NCT03993288|466297650|FG001|Overall Study|improper enrollment|1|||
129547335|NCT03993288|466297649|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
129547336|NCT03993288|466297650|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
129547337|NCT03993288|466297649|FG000|Overall Study|developed SAE|2|||
129547338|NCT03993288|466297650|FG001|Overall Study|developed SAE|0|||
129547339|NCT03993288|466297649|FG000|Overall Study|consent withdrawal|1|||
129547340|NCT03993288|466297650|FG001|Overall Study|consent withdrawal|0|||
129547341|NCT03993288|466297649|FG000|Overall Study|did not follow the treatment schedule|1|||
129547342|NCT03993288|466297650|FG001|Overall Study|did not follow the treatment schedule|0|||
129547343|NCT03993288|466297649|FG000|Overall Study|did not follow the treatment regimen|1|||
129547344|NCT03993288|466297650|FG001|Overall Study|did not follow the treatment regimen|0|||
129547345|NCT03993288|466297649|FG000|Overall Study|Adverse Event|1|||
129547346|NCT03993288|466297650|FG001|Overall Study|Adverse Event|0|||
129547347|NCT03993288|466297649|FG000|Overall Study|Withdrawal by Subject|1|||
129547348|NCT03993288|466297650|FG001|Overall Study|Withdrawal by Subject|1|||
129547349|NCT03349437|466297654|FG000|Screening|Screen Fail|4|||
129547350|NCT03349437|466297655|FG001|Screening|Screen Fail|0|||
129547351|NCT03349437|466297656|FG002|Screening|Screen Fail|0|||
129547352|NCT03349437|466297654|FG000|Screening|Withdrawn|1|||
129547353|NCT03349437|466297655|FG001|Screening|Withdrawn|0|||
129547354|NCT03349437|466297656|FG002|Screening|Withdrawn|0|||
129547355|NCT01461369|466297657|FG000|Overall Study|Lack of Efficacy|2|||
129547356|NCT01461369|466297658|FG001|Overall Study|Lack of Efficacy|0|||
129547357|NCT01461369|466297659|FG002|Overall Study|Lack of Efficacy|6|||
129547358|NCT01461369|466297657|FG000|Overall Study|Lost to Follow-up|0|||
129547359|NCT01461369|466297658|FG001|Overall Study|Lost to Follow-up|0|||
129547360|NCT01461369|466297659|FG002|Overall Study|Lost to Follow-up|3|||
129547361|NCT01461369|466297657|FG000|Overall Study|Adverse Event|9|||
129547362|NCT01461369|466297658|FG001|Overall Study|Adverse Event|12|||
129547363|NCT01461369|466297659|FG002|Overall Study|Adverse Event|4|||
129547364|NCT01461369|466297657|FG000|Overall Study|Protocol Violation|1|||
129547365|NCT01461369|466297658|FG001|Overall Study|Protocol Violation|2|||
129547366|NCT01461369|466297659|FG002|Overall Study|Protocol Violation|2|||
129547367|NCT01461369|466297657|FG000|Overall Study|Withdrawal by Subject|1|||
129547368|NCT01461369|466297658|FG001|Overall Study|Withdrawal by Subject|3|||
129547369|NCT01461369|466297659|FG002|Overall Study|Withdrawal by Subject|2|||
129547370|NCT02962739|466297662|FG000|Overall Study|Withdrawal by Subject|0|||
129547371|NCT02962739|466297663|FG001|Overall Study|Withdrawal by Subject|1|||
129547372|NCT02962739|466297664|FG002|Overall Study|Withdrawal by Subject|0|||
129547373|NCT02962739|466297665|FG003|Overall Study|Withdrawal by Subject|0|||
129547374|NCT02962739|466297666|FG004|Overall Study|Withdrawal by Subject|0|||
129547375|NCT02962739|466297667|FG005|Overall Study|Withdrawal by Subject|0|||
129547376|NCT02962739|466297662|FG000|Overall Study|Protocol Violation|0|||
129547377|NCT02962739|466297663|FG001|Overall Study|Protocol Violation|0|||
129547378|NCT02962739|466297664|FG002|Overall Study|Protocol Violation|1|||
129547379|NCT02962739|466297665|FG003|Overall Study|Protocol Violation|0|||
129678754|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
129678755|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
129678756|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
129678757|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
129678758|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
129678759|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
129678760|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
129678761|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
129547380|NCT02962739|466297666|FG004|Overall Study|Protocol Violation|1|||
129547381|NCT02962739|466297667|FG005|Overall Study|Protocol Violation|0|||
129547382|NCT02406742|466297668|FG000|Overall Study|Progression of Disease|5|||
129547383|NCT02406742|466297669|FG001|Overall Study|Progression of Disease|1|||
129547384|NCT02406742|466297670|FG002|Overall Study|Progression of Disease|6|||
129547385|NCT02406742|466297668|FG000|Overall Study|Adverse Event|3|||
129547386|NCT02406742|466297669|FG001|Overall Study|Adverse Event|0|||
129547387|NCT02406742|466297670|FG002|Overall Study|Adverse Event|2|||
129547388|NCT02406742|466297668|FG000|Overall Study|Death|1|||
129547389|NCT02406742|466297669|FG001|Overall Study|Death|0|||
129547390|NCT02406742|466297670|FG002|Overall Study|Death|0|||
129547391|NCT02406742|466297668|FG000|Overall Study|Lack of Efficacy|0|||
129678762|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
129678763|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
129678764|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
129678765|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
129678766|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
129678767|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
129678768|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
129678769|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
129678770|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
129678771|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
129678772|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
129678773|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
129678774|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
129678775|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
129678776|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
129678777|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
129678778|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
129678779|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
129678780|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
129678781|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
129678782|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
129678783|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
129678784|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
129678785|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
129678786|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
129678787|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
129678788|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
129678789|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
129678790|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
129678791|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
129678792|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
129678793|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
129678794|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
129678795|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
129678796|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
129678797|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
129678798|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
129678799|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
129678800|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
129678801|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
129678802|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
129678803|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
129678804|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
129678805|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
129678806|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
129678807|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
129678808|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
129678809|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
129678810|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
129678811|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
129678812|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
129678813|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
129678814|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
129678815|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
129678816|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
129678817|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
129678818|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
129678819|NCT00090103|466785218|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
129678820|NCT00090103|466785219|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
129678821|NCT00090103|466785220|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
129678822|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
129678823|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
129678824|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
129678825|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
129678826|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
129678827|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
129678828|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
129678829|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
129678830|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
129678831|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
129678832|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
129678833|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
129678834|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
129678835|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
129678836|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
129678837|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
129678838|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
129678839|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
129678840|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
129678841|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
129678842|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
129678843|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
129678844|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
129678845|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
129678846|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
129678847|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
129678848|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
129678849|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
129678850|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
129678851|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
129678852|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
129678853|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
129678854|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
129678855|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
129678856|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
129678857|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
129678858|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
129678859|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
129678860|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
129678861|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
129678862|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
129678863|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
129678864|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
129678865|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
129678866|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
129678867|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
129678868|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
129678869|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
129678870|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Death|1|||
129678871|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Death|0|||
129678872|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Death|1|||
129678873|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
129678874|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
129678875|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
129678876|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
129678877|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
129678878|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
129678879|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
129678880|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
129678881|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
129678882|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
129678883|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
129678884|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
129678885|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
129678886|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
129678887|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
129678888|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
129678889|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
129678890|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
129678891|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
129678892|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
129678893|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
129678894|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Depression|0|||
129678895|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Depression|1|||
129678896|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Depression|0|||
129678897|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
129678898|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
129678899|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
129678900|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Jailed|0|||
129678901|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Jailed|1|||
129678902|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Jailed|0|||
129678903|NCT00090103|466785218|FG000|16-Week Safety Follow-up Period|Other|0|||
129678904|NCT00090103|466785219|FG001|16-Week Safety Follow-up Period|Other|1|||
129678905|NCT00090103|466785220|FG002|16-Week Safety Follow-up Period|Other|0|||
129678906|NCT01799889|466785221|FG000|Overall Study|Adverse Event|4|||
129678907|NCT01799889|466785222|FG001|Overall Study|Adverse Event|4|||
129678908|NCT01799889|466785223|FG002|Overall Study|Adverse Event|5|||
129678909|NCT01799889|466785224|FG003|Overall Study|Adverse Event|1|||
129884415|NCT02771210|467536388|FG001|Period 2|Lack of Efficacy|1|||
129769196|NCT04672239|467121468|FG002|Week 6 Survey|Partially completed survey|2|||
129769197|NCT04672239|467121466|FG000|Week 6 Survey|Withdrawal by Subject|1|||
129769198|NCT04672239|467121467|FG001|Week 6 Survey|Withdrawal by Subject|1|||
129769199|NCT04672239|467121468|FG002|Week 6 Survey|Withdrawal by Subject|1|||
129547392|NCT02406742|466297669|FG001|Overall Study|Lack of Efficacy|0|||
129547393|NCT02406742|466297670|FG002|Overall Study|Lack of Efficacy|1|||
129547394|NCT02406742|466297668|FG000|Overall Study|Withdrawal by Participant|1|||
129547395|NCT02406742|466297669|FG001|Overall Study|Withdrawal by Participant|2|||
129547396|NCT02406742|466297670|FG002|Overall Study|Withdrawal by Participant|0|||
129547397|NCT02406742|466297668|FG000|Overall Study|Physician Decision|1|||
129547398|NCT02406742|466297669|FG001|Overall Study|Physician Decision|2|||
129547399|NCT02406742|466297670|FG002|Overall Study|Physician Decision|1|||
129547400|NCT02406742|466297668|FG000|Overall Study|Transition to other treatment|2|||
129547401|NCT02406742|466297669|FG001|Overall Study|Transition to other treatment|0|||
129547402|NCT02406742|466297670|FG002|Overall Study|Transition to other treatment|1|||
129547403|NCT02406742|466297668|FG000|Overall Study|Other Reasons|1|||
129547404|NCT02406742|466297669|FG001|Overall Study|Other Reasons|11|||
129547405|NCT02406742|466297670|FG002|Overall Study|Other Reasons|5|||
129769200|NCT04672239|467121466|FG000|Week 6 Survey|Withdrawn by PI|0|||
129547406|NCT03692078|466297671|FG000|Overall Study|Adverse Event|0|||
129547407|NCT03692078|466297672|FG001|Overall Study|Adverse Event|0|||
129547408|NCT03692078|466297673|FG002|Overall Study|Adverse Event|0|||
129547409|NCT03692078|466297674|FG003|Overall Study|Adverse Event|0|||
129547410|NCT03692078|466297675|FG004|Overall Study|Adverse Event|0|||
129547411|NCT03692078|466297676|FG005|Overall Study|Adverse Event|1|||
129547412|NCT03692078|466297677|FG006|Overall Study|Adverse Event|0|||
129547413|NCT03692078|466297671|FG000|Overall Study|Enrollment Closed|5|||
129547414|NCT03692078|466297672|FG001|Overall Study|Enrollment Closed|0|||
129547415|NCT03692078|466297673|FG002|Overall Study|Enrollment Closed|0|||
129547416|NCT03692078|466297674|FG003|Overall Study|Enrollment Closed|0|||
129547417|NCT03692078|466297675|FG004|Overall Study|Enrollment Closed|0|||
129547418|NCT03692078|466297676|FG005|Overall Study|Enrollment Closed|0|||
129547419|NCT03692078|466297677|FG006|Overall Study|Enrollment Closed|0|||
129547420|NCT03692078|466297671|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
129547421|NCT03692078|466297672|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
129547422|NCT03692078|466297673|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
129547423|NCT03692078|466297674|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
129769201|NCT04672239|467121467|FG001|Week 6 Survey|Withdrawn by PI|1|||
129547424|NCT03692078|466297675|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
129769202|NCT04672239|467121468|FG002|Week 6 Survey|Withdrawn by PI|0|||
129547425|NCT03692078|466297676|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
129547426|NCT03692078|466297677|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
129547427|NCT03692078|466297671|FG000|Overall Study|Withdrawal by Subject|0|||
129547428|NCT03692078|466297672|FG001|Overall Study|Withdrawal by Subject|2|||
129547429|NCT03692078|466297673|FG002|Overall Study|Withdrawal by Subject|0|||
129547430|NCT03692078|466297674|FG003|Overall Study|Withdrawal by Subject|1|||
129547431|NCT03692078|466297675|FG004|Overall Study|Withdrawal by Subject|5|||
129547432|NCT03692078|466297676|FG005|Overall Study|Withdrawal by Subject|3|||
129547433|NCT03692078|466297677|FG006|Overall Study|Withdrawal by Subject|3|||
129547434|NCT01563029|466297678|FG000|Overall Study|Adverse Event|1|||
129547435|NCT01563029|466297679|FG001|Overall Study|Adverse Event|0|||
129547436|NCT01563029|466297680|FG002|Overall Study|Adverse Event|1|||
129547437|NCT01563029|466297681|FG003|Overall Study|Adverse Event|2|||
129547438|NCT01563029|466297682|FG004|Overall Study|Adverse Event|1|||
129547439|NCT01563029|466297678|FG000|Overall Study|Lack of Efficacy|42|||
129547440|NCT01563029|466297679|FG001|Overall Study|Lack of Efficacy|16|||
129547441|NCT01563029|466297680|FG002|Overall Study|Lack of Efficacy|23|||
129547442|NCT01563029|466297681|FG003|Overall Study|Lack of Efficacy|21|||
129547443|NCT01563029|466297682|FG004|Overall Study|Lack of Efficacy|19|||
129547444|NCT01563029|466297678|FG000|Overall Study|Protocol Violation|1|||
129547445|NCT01563029|466297679|FG001|Overall Study|Protocol Violation|2|||
129547446|NCT01563029|466297680|FG002|Overall Study|Protocol Violation|3|||
129547447|NCT01563029|466297681|FG003|Overall Study|Protocol Violation|1|||
129547448|NCT01563029|466297682|FG004|Overall Study|Protocol Violation|3|||
129547449|NCT01563029|466297678|FG000|Overall Study|Protocol defined stopping criteria|1|||
129547450|NCT01563029|466297679|FG001|Overall Study|Protocol defined stopping criteria|0|||
129547451|NCT01563029|466297680|FG002|Overall Study|Protocol defined stopping criteria|0|||
129547452|NCT01563029|466297681|FG003|Overall Study|Protocol defined stopping criteria|0|||
129547453|NCT01563029|466297682|FG004|Overall Study|Protocol defined stopping criteria|0|||
129547454|NCT01563029|466297678|FG000|Overall Study|Lost to Follow-up|1|||
129547455|NCT01563029|466297679|FG001|Overall Study|Lost to Follow-up|0|||
129547456|NCT01563029|466297680|FG002|Overall Study|Lost to Follow-up|1|||
129547457|NCT01563029|466297681|FG003|Overall Study|Lost to Follow-up|1|||
129547458|NCT01563029|466297682|FG004|Overall Study|Lost to Follow-up|1|||
129547459|NCT01563029|466297678|FG000|Overall Study|Physician Decision|3|||
129547460|NCT01563029|466297679|FG001|Overall Study|Physician Decision|5|||
129547461|NCT01563029|466297680|FG002|Overall Study|Physician Decision|2|||
129547462|NCT01563029|466297681|FG003|Overall Study|Physician Decision|4|||
129547463|NCT01563029|466297682|FG004|Overall Study|Physician Decision|2|||
129547464|NCT01563029|466297678|FG000|Overall Study|Withdrawal by Subject|4|||
129547465|NCT01563029|466297679|FG001|Overall Study|Withdrawal by Subject|1|||
129547466|NCT01563029|466297680|FG002|Overall Study|Withdrawal by Subject|3|||
129547467|NCT01563029|466297681|FG003|Overall Study|Withdrawal by Subject|4|||
129547468|NCT01563029|466297682|FG004|Overall Study|Withdrawal by Subject|3|||
129547469|NCT01569594|466297683|FG000|Overall Study|Physician Decision|4|||
129547470|NCT01569594|466297683|FG000|Overall Study|Death|13|||
129547471|NCT01569594|466297683|FG000|Overall Study|Lost to Follow-up|22|||
129547472|NCT01569594|466297683|FG000|Overall Study|Adverse Event|2|||
129547473|NCT01569594|466297683|FG000|Overall Study|Withdrawal by Subject|13|||
129547474|NCT01569594|466297683|FG000|Overall Study|Other|4|||
129547475|NCT01569594|466297683|FG000|Overall Study|No ECM used|9|||
129547476|NCT01826201|466297686|FG000|Overall Study|Non compliance with protocol|4|||
129547477|NCT01615822|466297687|FG000|Period 1|Withdrawal by Subject|0|||
129547478|NCT01615822|466297688|FG001|Period 1|Withdrawal by Subject|1|||
129547479|NCT01615822|466297689|FG002|Period 1|Withdrawal by Subject|0|||
129547480|NCT01615822|466297687|FG000|Period 1|Adverse Event|1|||
129547481|NCT01615822|466297688|FG001|Period 1|Adverse Event|1|||
129547482|NCT01615822|466297689|FG002|Period 1|Adverse Event|0|||
129547483|NCT01615822|466297687|FG000|Period 2|Lost to Follow-up|0|||
129547484|NCT01615822|466297688|FG001|Period 2|Lost to Follow-up|1|||
129547485|NCT01615822|466297689|FG002|Period 2|Lost to Follow-up|2|||
129547486|NCT02861534|466297690|FG000|Overall Study|Death|541|||
129547487|NCT02861534|466297691|FG001|Overall Study|Death|552|||
129547488|NCT02861534|466297690|FG000|Overall Study|Lost to Follow-up|14|||
129547489|NCT02861534|466297691|FG001|Overall Study|Lost to Follow-up|14|||
129547490|NCT02861534|466297690|FG000|Overall Study|Site Terminated by Sponsor|4|||
129547491|NCT02861534|466297691|FG001|Overall Study|Site Terminated by Sponsor|3|||
129547492|NCT02861534|466297690|FG000|Overall Study|Withdrawal by Subject|15|||
129547493|NCT02861534|466297691|FG001|Overall Study|Withdrawal by Subject|18|||
129547494|NCT00916617|466297694|FG000|Overall Study|Adverse Event|3|||
129547495|NCT00916617|466297695|FG001|Overall Study|Adverse Event|2|||
129547496|NCT00916617|466297696|FG002|Overall Study|Adverse Event|6|||
129547497|NCT00916617|466297697|FG003|Overall Study|Adverse Event|3|||
129547498|NCT00916617|466297694|FG000|Overall Study|Withdrawal by Subject|3|||
129547499|NCT00916617|466297695|FG001|Overall Study|Withdrawal by Subject|2|||
129547500|NCT00916617|466297696|FG002|Overall Study|Withdrawal by Subject|0|||
129547501|NCT00916617|466297697|FG003|Overall Study|Withdrawal by Subject|1|||
129547502|NCT00916617|466297694|FG000|Overall Study|Caregiver Request|3|||
129547503|NCT00916617|466297695|FG001|Overall Study|Caregiver Request|2|||
129547504|NCT00916617|466297696|FG002|Overall Study|Caregiver Request|1|||
129547505|NCT00916617|466297697|FG003|Overall Study|Caregiver Request|0|||
129547506|NCT00916617|466297694|FG000|Overall Study|Physician Decision|1|||
129547507|NCT00916617|466297695|FG001|Overall Study|Physician Decision|1|||
129547508|NCT00916617|466297696|FG002|Overall Study|Physician Decision|0|||
129547509|NCT00916617|466297697|FG003|Overall Study|Physician Decision|0|||
129547510|NCT00916617|466297694|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
129547511|NCT00916617|466297695|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
129678910|NCT01799889|466785225|FG004|Overall Study|Adverse Event|11|||
129678911|NCT01799889|466785226|FG005|Overall Study|Adverse Event|1|||
129678912|NCT01799889|466785227|FG006|Overall Study|Adverse Event|5|||
129678913|NCT01799889|466785228|FG007|Overall Study|Adverse Event|2|||
129678914|NCT01799889|466785229|FG008|Overall Study|Adverse Event|3|||
129678915|NCT01799889|466785230|FG009|Overall Study|Adverse Event|1|||
129547512|NCT00916617|466297696|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
129547513|NCT00916617|466297697|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
129547514|NCT00916617|466297694|FG000|Overall Study|Lost to Follow-up|2|||
129547515|NCT00916617|466297695|FG001|Overall Study|Lost to Follow-up|1|||
129547516|NCT00916617|466297696|FG002|Overall Study|Lost to Follow-up|0|||
129547517|NCT00916617|466297697|FG003|Overall Study|Lost to Follow-up|0|||
129547518|NCT00916617|466297694|FG000|Overall Study|Lack of Efficacy|1|||
129547519|NCT00916617|466297695|FG001|Overall Study|Lack of Efficacy|0|||
129547520|NCT00916617|466297696|FG002|Overall Study|Lack of Efficacy|0|||
129547521|NCT00916617|466297697|FG003|Overall Study|Lack of Efficacy|0|||
129547522|NCT00916617|466297694|FG000|Overall Study|Other|2|||
129547523|NCT00916617|466297695|FG001|Overall Study|Other|0|||
129547524|NCT00916617|466297696|FG002|Overall Study|Other|0|||
129547525|NCT00916617|466297697|FG003|Overall Study|Other|2|||
129547526|NCT01988337|466297700|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
129547527|NCT01260194|466297701|FG000|Overall Study|Withdrawal of Consent|1|||
129547528|NCT04854707|466297704|FG000|Overall Study|Lack of Efficacy|78|||
129547529|NCT04854707|466297705|FG001|Overall Study|Lack of Efficacy|59|||
129547530|NCT04854707|466297706|FG002|Overall Study|Lack of Efficacy|30|||
129547531|NCT03466060|466297712|FG000|Period 1|Test Lens Damage|0|||
129547532|NCT03466060|466297713|FG001|Period 1|Test Lens Damage|2|||
129547533|NCT03466060|466297714|FG002|Period 1|Test Lens Damage|0|||
129547534|NCT03466060|466297715|FG003|Period 1|Test Lens Damage|0|||
129547535|NCT03466060|466297716|FG004|Period 1|Test Lens Damage|0|||
129547536|NCT03466060|466297717|FG005|Period 1|Test Lens Damage|0|||
129547537|NCT03466060|466297712|FG000|Period 1|Withdrawal by Subject|0|||
129547538|NCT03466060|466297713|FG001|Period 1|Withdrawal by Subject|0|||
129547539|NCT03466060|466297714|FG002|Period 1|Withdrawal by Subject|2|||
129547540|NCT03466060|466297715|FG003|Period 1|Withdrawal by Subject|0|||
129547541|NCT03466060|466297716|FG004|Period 1|Withdrawal by Subject|0|||
129547542|NCT03466060|466297717|FG005|Period 1|Withdrawal by Subject|0|||
129547543|NCT03466060|466297712|FG000|Period 1|Lost to Follow-up|0|||
129547544|NCT03466060|466297713|FG001|Period 1|Lost to Follow-up|0|||
129547545|NCT03466060|466297714|FG002|Period 1|Lost to Follow-up|0|||
129547546|NCT03466060|466297715|FG003|Period 1|Lost to Follow-up|1|||
129547547|NCT03466060|466297716|FG004|Period 1|Lost to Follow-up|0|||
129547548|NCT03466060|466297717|FG005|Period 1|Lost to Follow-up|0|||
129547549|NCT03466060|466297712|FG000|Period 1|Grade 2 Conjunctivitis|0|||
129547550|NCT03466060|466297713|FG001|Period 1|Grade 2 Conjunctivitis|0|||
129547551|NCT03466060|466297714|FG002|Period 1|Grade 2 Conjunctivitis|1|||
129547552|NCT03466060|466297715|FG003|Period 1|Grade 2 Conjunctivitis|0|||
129547553|NCT03466060|466297716|FG004|Period 1|Grade 2 Conjunctivitis|0|||
129547554|NCT03466060|466297717|FG005|Period 1|Grade 2 Conjunctivitis|0|||
129547555|NCT03466060|466297712|FG000|Period 2|Lens Handling Difficulties|0|||
129547556|NCT03466060|466297713|FG001|Period 2|Lens Handling Difficulties|0|||
129547557|NCT03466060|466297714|FG002|Period 2|Lens Handling Difficulties|1|||
129547558|NCT03466060|466297715|FG003|Period 2|Lens Handling Difficulties|0|||
129547559|NCT03466060|466297716|FG004|Period 2|Lens Handling Difficulties|0|||
129547560|NCT03466060|466297717|FG005|Period 2|Lens Handling Difficulties|0|||
129547561|NCT01612780|466297718|FG000|Overall Study|Treatment not completed|1|||
129547562|NCT01612780|466297718|FG000|Overall Study|Withdrawal by Subject|5|||
129547563|NCT04732728|466297722|FG000|Overall Study|Death|12|||
129547564|NCT04732728|466297722|FG000|Overall Study|Withdrawn|136|||
129547565|NCT01339000|466297725|FG000|Overall Study|study closed due to lack of drug supply|1|||
129547566|NCT01339000|466297726|FG001|Overall Study|study closed due to lack of drug supply|0|||
129547567|NCT02072174|466297727|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
129547568|NCT02072174|466297728|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
129547569|NCT02072174|466297727|FG000|Overall Study|Protocol Violation|16|||
129547570|NCT02072174|466297728|FG001|Overall Study|Protocol Violation|23|||
129547571|NCT02072174|466297727|FG000|Overall Study|Physician Decision|0|||
129547572|NCT02072174|466297728|FG001|Overall Study|Physician Decision|1|||
129547573|NCT02072174|466297727|FG000|Overall Study|Non-compliance with protocol requirement|2|||
129547574|NCT02072174|466297728|FG001|Overall Study|Non-compliance with protocol requirement|0|||
129547575|NCT05674721|466297730|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
129547576|NCT05674721|466297731|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
129547577|NCT05674721|466297730|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
129547578|NCT05674721|466297731|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
129547579|NCT02426125|466297743|FG000|Overall Study|Lost to Follow-up|14|||
129547580|NCT02426125|466297744|FG001|Overall Study|Lost to Follow-up|12|||
129547581|NCT02426125|466297743|FG000|Overall Study|Withdrawal by Subject|13|||
129547582|NCT02426125|466297744|FG001|Overall Study|Withdrawal by Subject|14|||
129547583|NCT02426125|466297743|FG000|Overall Study|Death|185|||
129547584|NCT02426125|466297744|FG001|Overall Study|Death|200|||
129547585|NCT02426125|466297743|FG000|Overall Study|Randomized, But Never Treated|5|||
129547586|NCT02426125|466297744|FG001|Overall Study|Randomized, But Never Treated|2|||
129678916|NCT01799889|466785231|FG010|Overall Study|Adverse Event|1|||
129678917|NCT01799889|466785232|FG011|Overall Study|Adverse Event|0|||
129678918|NCT01799889|466785221|FG000|Overall Study|Death|1|||
129678919|NCT01799889|466785222|FG001|Overall Study|Death|0|||
129678920|NCT01799889|466785223|FG002|Overall Study|Death|5|||
129678921|NCT01799889|466785224|FG003|Overall Study|Death|3|||
129678922|NCT01799889|466785225|FG004|Overall Study|Death|1|||
129678923|NCT01799889|466785226|FG005|Overall Study|Death|0|||
129678924|NCT01799889|466785227|FG006|Overall Study|Death|0|||
129678925|NCT01799889|466785228|FG007|Overall Study|Death|0|||
129678926|NCT01799889|466785229|FG008|Overall Study|Death|1|||
129678927|NCT01799889|466785230|FG009|Overall Study|Death|0|||
129678928|NCT01799889|466785231|FG010|Overall Study|Death|1|||
129678929|NCT01799889|466785232|FG011|Overall Study|Death|0|||
129678930|NCT01799889|466785221|FG000|Overall Study|Lack of Efficacy|1|||
129678931|NCT01799889|466785222|FG001|Overall Study|Lack of Efficacy|1|||
129678932|NCT01799889|466785223|FG002|Overall Study|Lack of Efficacy|0|||
129678933|NCT01799889|466785224|FG003|Overall Study|Lack of Efficacy|1|||
129678934|NCT01799889|466785225|FG004|Overall Study|Lack of Efficacy|2|||
129678935|NCT01799889|466785226|FG005|Overall Study|Lack of Efficacy|2|||
129678936|NCT01799889|466785227|FG006|Overall Study|Lack of Efficacy|0|||
129678937|NCT01799889|466785228|FG007|Overall Study|Lack of Efficacy|0|||
129678938|NCT01799889|466785229|FG008|Overall Study|Lack of Efficacy|2|||
129678939|NCT01799889|466785230|FG009|Overall Study|Lack of Efficacy|0|||
129678940|NCT01799889|466785231|FG010|Overall Study|Lack of Efficacy|1|||
129678941|NCT01799889|466785232|FG011|Overall Study|Lack of Efficacy|0|||
129678942|NCT01799889|466785221|FG000|Overall Study|Lost to Follow-up|0|||
129678943|NCT01799889|466785222|FG001|Overall Study|Lost to Follow-up|1|||
129678944|NCT01799889|466785223|FG002|Overall Study|Lost to Follow-up|0|||
129678945|NCT01799889|466785224|FG003|Overall Study|Lost to Follow-up|0|||
129678946|NCT01799889|466785225|FG004|Overall Study|Lost to Follow-up|0|||
129678947|NCT01799889|466785226|FG005|Overall Study|Lost to Follow-up|0|||
129678948|NCT01799889|466785227|FG006|Overall Study|Lost to Follow-up|0|||
129678949|NCT01799889|466785228|FG007|Overall Study|Lost to Follow-up|0|||
129678950|NCT01799889|466785229|FG008|Overall Study|Lost to Follow-up|0|||
129678951|NCT01799889|466785230|FG009|Overall Study|Lost to Follow-up|0|||
129678952|NCT01799889|466785231|FG010|Overall Study|Lost to Follow-up|0|||
129678953|NCT01799889|466785232|FG011|Overall Study|Lost to Follow-up|0|||
129678954|NCT01799889|466785221|FG000|Overall Study|Physician Decision|3|||
129678955|NCT01799889|466785222|FG001|Overall Study|Physician Decision|2|||
129678956|NCT01799889|466785223|FG002|Overall Study|Physician Decision|4|||
129678957|NCT01799889|466785224|FG003|Overall Study|Physician Decision|4|||
129678958|NCT01799889|466785225|FG004|Overall Study|Physician Decision|5|||
129678959|NCT01799889|466785226|FG005|Overall Study|Physician Decision|5|||
129678960|NCT01799889|466785227|FG006|Overall Study|Physician Decision|5|||
129678961|NCT01799889|466785228|FG007|Overall Study|Physician Decision|2|||
129678962|NCT01799889|466785229|FG008|Overall Study|Physician Decision|6|||
129678963|NCT01799889|466785230|FG009|Overall Study|Physician Decision|0|||
129678964|NCT01799889|466785231|FG010|Overall Study|Physician Decision|0|||
129678965|NCT01799889|466785232|FG011|Overall Study|Physician Decision|1|||
129678966|NCT01799889|466785221|FG000|Overall Study|Progressive Disease|30|||
129678967|NCT01799889|466785222|FG001|Overall Study|Progressive Disease|26|||
129678968|NCT01799889|466785223|FG002|Overall Study|Progressive Disease|25|||
129678969|NCT01799889|466785224|FG003|Overall Study|Progressive Disease|30|||
129678970|NCT01799889|466785225|FG004|Overall Study|Progressive Disease|23|||
129678971|NCT01799889|466785226|FG005|Overall Study|Progressive Disease|9|||
129678972|NCT01799889|466785227|FG006|Overall Study|Progressive Disease|8|||
129678973|NCT01799889|466785228|FG007|Overall Study|Progressive Disease|13|||
129678974|NCT01799889|466785229|FG008|Overall Study|Progressive Disease|18|||
129678975|NCT01799889|466785230|FG009|Overall Study|Progressive Disease|5|||
129678976|NCT01799889|466785231|FG010|Overall Study|Progressive Disease|3|||
129678977|NCT01799889|466785232|FG011|Overall Study|Progressive Disease|1|||
129678978|NCT01799889|466785221|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
129678979|NCT01799889|466785222|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
129678980|NCT01799889|466785223|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
129678981|NCT01799889|466785224|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
129678982|NCT01799889|466785225|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
129678983|NCT01799889|466785226|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
129678984|NCT01799889|466785227|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
129678985|NCT01799889|466785228|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
129678986|NCT01799889|466785229|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
129678987|NCT01799889|466785230|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
129678988|NCT01799889|466785231|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
129678989|NCT01799889|466785232|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
129678990|NCT01799889|466785221|FG000|Overall Study|Study Terminated By Sponsor|1|||
129678991|NCT01799889|466785222|FG001|Overall Study|Study Terminated By Sponsor|0|||
129678992|NCT01799889|466785223|FG002|Overall Study|Study Terminated By Sponsor|0|||
129678993|NCT01799889|466785224|FG003|Overall Study|Study Terminated By Sponsor|0|||
129678994|NCT01799889|466785225|FG004|Overall Study|Study Terminated By Sponsor|2|||
129547587|NCT02643394|466297745|FG000|Overall Study|Protocol Violation|4|||
129547588|NCT02643394|466297746|FG001|Overall Study|Protocol Violation|5|||
129547589|NCT04088734|466297747|FG000|Overall Study|Other, Not Specified|5|||
129547590|NCT00096200|466297748|FG000|Overall Study|Adverse Event|0|||
129547591|NCT00096200|466297749|FG001|Overall Study|Adverse Event|4|||
129547592|NCT00096200|466297750|FG002|Overall Study|Adverse Event|0|||
129547593|NCT00096200|466297748|FG000|Overall Study|Withdrawal by Subject|1|||
129547594|NCT00096200|466297749|FG001|Overall Study|Withdrawal by Subject|2|||
129547595|NCT00096200|466297750|FG002|Overall Study|Withdrawal by Subject|0|||
129547596|NCT00096200|466297748|FG000|Overall Study|Ineligible pathology|0|||
129547597|NCT00096200|466297749|FG001|Overall Study|Ineligible pathology|1|||
129678995|NCT01799889|466785226|FG005|Overall Study|Study Terminated By Sponsor|1|||
129678996|NCT01799889|466785227|FG006|Overall Study|Study Terminated By Sponsor|0|||
129678997|NCT01799889|466785228|FG007|Overall Study|Study Terminated By Sponsor|2|||
129678998|NCT01799889|466785229|FG008|Overall Study|Study Terminated By Sponsor|1|||
129678999|NCT01799889|466785230|FG009|Overall Study|Study Terminated By Sponsor|1|||
129679000|NCT01799889|466785231|FG010|Overall Study|Study Terminated By Sponsor|0|||
129679001|NCT01799889|466785232|FG011|Overall Study|Study Terminated By Sponsor|0|||
129679002|NCT01799889|466785221|FG000|Overall Study|Withdrawal by Subject|1|||
129679003|NCT01799889|466785222|FG001|Overall Study|Withdrawal by Subject|6|||
129679004|NCT01799889|466785223|FG002|Overall Study|Withdrawal by Subject|4|||
129679005|NCT01799889|466785224|FG003|Overall Study|Withdrawal by Subject|0|||
129679006|NCT01799889|466785225|FG004|Overall Study|Withdrawal by Subject|5|||
129679007|NCT01799889|466785226|FG005|Overall Study|Withdrawal by Subject|1|||
129679008|NCT01799889|466785227|FG006|Overall Study|Withdrawal by Subject|3|||
129679009|NCT01799889|466785228|FG007|Overall Study|Withdrawal by Subject|1|||
129547598|NCT00096200|466297750|FG002|Overall Study|Ineligible pathology|0|||
129679010|NCT01799889|466785229|FG008|Overall Study|Withdrawal by Subject|2|||
129679011|NCT01799889|466785230|FG009|Overall Study|Withdrawal by Subject|1|||
129679012|NCT01799889|466785231|FG010|Overall Study|Withdrawal by Subject|1|||
129679013|NCT01799889|466785232|FG011|Overall Study|Withdrawal by Subject|1|||
129679014|NCT01799889|466785221|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129679015|NCT01799889|466785222|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129679016|NCT01799889|466785223|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129679017|NCT01799889|466785224|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129679018|NCT01799889|466785225|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129679019|NCT01799889|466785226|FG005|Overall Study|Non-Compliance With Study Drug|1|||
129679020|NCT01799889|466785227|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129679021|NCT01799889|466785228|FG007|Overall Study|Non-Compliance With Study Drug|0|||
129679022|NCT01799889|466785229|FG008|Overall Study|Non-Compliance With Study Drug|0|||
129679023|NCT01799889|466785230|FG009|Overall Study|Non-Compliance With Study Drug|0|||
129679024|NCT01799889|466785231|FG010|Overall Study|Non-Compliance With Study Drug|0|||
129679025|NCT01799889|466785232|FG011|Overall Study|Non-Compliance With Study Drug|0|||
129679026|NCT02194465|466785235|FG000|Overall Study|Adverse Event|6|||
129679027|NCT02194465|466785236|FG001|Overall Study|Adverse Event|1|||
129679028|NCT02194465|466785237|FG002|Overall Study|Adverse Event|4|||
129679029|NCT02194465|466785238|FG003|Overall Study|Adverse Event|4|||
129679030|NCT02194465|466785239|FG004|Overall Study|Adverse Event|4|||
129679031|NCT02194465|466785240|FG005|Overall Study|Adverse Event|2|||
129679032|NCT02194465|466785241|FG006|Overall Study|Adverse Event|0|||
129679033|NCT02194465|466785235|FG000|Overall Study|Lost to Follow-up|0|||
129679034|NCT02194465|466785236|FG001|Overall Study|Lost to Follow-up|0|||
129679035|NCT02194465|466785237|FG002|Overall Study|Lost to Follow-up|0|||
129679036|NCT02194465|466785238|FG003|Overall Study|Lost to Follow-up|1|||
129679037|NCT02194465|466785239|FG004|Overall Study|Lost to Follow-up|0|||
129679038|NCT02194465|466785240|FG005|Overall Study|Lost to Follow-up|1|||
129679039|NCT02194465|466785241|FG006|Overall Study|Lost to Follow-up|0|||
129679040|NCT02194465|466785235|FG000|Overall Study|Physician Decision|1|||
129679041|NCT02194465|466785236|FG001|Overall Study|Physician Decision|0|||
129679042|NCT02194465|466785237|FG002|Overall Study|Physician Decision|0|||
129679043|NCT02194465|466785238|FG003|Overall Study|Physician Decision|0|||
129679044|NCT02194465|466785239|FG004|Overall Study|Physician Decision|0|||
129679045|NCT02194465|466785240|FG005|Overall Study|Physician Decision|0|||
129679046|NCT02194465|466785241|FG006|Overall Study|Physician Decision|0|||
129679047|NCT02194465|466785235|FG000|Overall Study|Protocol Violation|1|||
129679048|NCT02194465|466785236|FG001|Overall Study|Protocol Violation|1|||
129679049|NCT02194465|466785237|FG002|Overall Study|Protocol Violation|2|||
129679050|NCT02194465|466785238|FG003|Overall Study|Protocol Violation|1|||
129679051|NCT02194465|466785239|FG004|Overall Study|Protocol Violation|1|||
129679052|NCT02194465|466785240|FG005|Overall Study|Protocol Violation|0|||
129679053|NCT02194465|466785241|FG006|Overall Study|Protocol Violation|0|||
129679054|NCT02194465|466785235|FG000|Overall Study|Withdrawal by Subject|1|||
129679055|NCT02194465|466785236|FG001|Overall Study|Withdrawal by Subject|3|||
129679056|NCT02194465|466785237|FG002|Overall Study|Withdrawal by Subject|1|||
129679057|NCT02194465|466785238|FG003|Overall Study|Withdrawal by Subject|2|||
129679058|NCT02194465|466785239|FG004|Overall Study|Withdrawal by Subject|2|||
129679059|NCT02194465|466785240|FG005|Overall Study|Withdrawal by Subject|1|||
129679060|NCT02194465|466785241|FG006|Overall Study|Withdrawal by Subject|2|||
129679061|NCT02194465|466785235|FG000|Overall Study|Discontinued follow-up period|0|||
129679062|NCT02194465|466785236|FG001|Overall Study|Discontinued follow-up period|2|||
129679063|NCT02194465|466785237|FG002|Overall Study|Discontinued follow-up period|1|||
129679064|NCT02194465|466785238|FG003|Overall Study|Discontinued follow-up period|0|||
129679065|NCT02194465|466785239|FG004|Overall Study|Discontinued follow-up period|2|||
129679066|NCT02194465|466785240|FG005|Overall Study|Discontinued follow-up period|0|||
129679067|NCT02194465|466785241|FG006|Overall Study|Discontinued follow-up period|0|||
129547599|NCT00938015|466297754|FG000|Overall Study|Death|2|||
129547600|NCT00938015|466297754|FG000|Overall Study|Lost to Follow-up|32|||
129547601|NCT00938015|466297754|FG000|Overall Study|Adverse Event|32|||
129547602|NCT00938015|466297754|FG000|Overall Study|Non-responder|52|||
129547603|NCT00938015|466297754|FG000|Overall Study|Reason not related to Etanercept|29|||
129547604|NCT02341482|466297755|FG000|Overall Study|Adverse Event|1|||
129769203|NCT04672239|467121466|FG000|Week 6 Survey|Lost to Follow-up|12|||
129769204|NCT04672239|467121467|FG001|Week 6 Survey|Lost to Follow-up|2|||
129769205|NCT04672239|467121468|FG002|Week 6 Survey|Lost to Follow-up|5|||
129769206|NCT04672239|467121466|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
129547605|NCT00664066|466297761|FG000|Overall Study|Study terminated|3|||
129547606|NCT03701516|466297762|FG000|Period 1|Lost to Follow-up|0|||
129547607|NCT03701516|466297763|FG001|Period 1|Lost to Follow-up|1|||
129547608|NCT03701516|466297762|FG000|Period 1|Adverse Event|0|||
129547609|NCT03701516|466297763|FG001|Period 1|Adverse Event|2|||
129547610|NCT03701516|466297762|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
129547611|NCT03701516|466297763|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
129547612|NCT03701516|466297762|FG000|Period 1|Non Compliance to Protocol|2|||
129547613|NCT03701516|466297763|FG001|Period 1|Non Compliance to Protocol|1|||
129547614|NCT03701516|466297762|FG000|Period 1|Withdrawal by Subject|0|||
129547615|NCT03701516|466297763|FG001|Period 1|Withdrawal by Subject|1|||
129547616|NCT03701516|466297762|FG000|Period 2|failed to meet all eligibility creiteria|1|||
129547617|NCT03701516|466297763|FG001|Period 2|failed to meet all eligibility creiteria|0|||
129547618|NCT03701516|466297762|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
129547619|NCT03701516|466297763|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
129547620|NCT03083639|466297764|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
129547621|NCT03083639|466297765|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
129547622|NCT03083639|466297764|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
129547623|NCT03083639|466297765|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
129547624|NCT01591499|466297766|FG000|Baseline Visit|Withdrawal by Subject|0|||
129547625|NCT01591499|466297767|FG001|Baseline Visit|Withdrawal by Subject|2|||
129547626|NCT01591499|466297768|FG002|Baseline Visit|Withdrawal by Subject|0|||
129547627|NCT01591499|466297769|FG003|Baseline Visit|Withdrawal by Subject|2|||
129547628|NCT01591499|466297766|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
129547629|NCT01591499|466297767|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
129547630|NCT01591499|466297768|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
129547631|NCT01591499|466297769|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
129547632|NCT01591499|466297766|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
129547633|NCT01591499|466297767|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
129547634|NCT01591499|466297768|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
129547635|NCT01591499|466297769|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
129547636|NCT05083559|466297770|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
129547637|NCT05083559|466297771|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
129547638|NCT05083559|466297770|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
129547639|NCT05083559|466297771|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
129547640|NCT05083559|466297770|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
129547641|NCT05083559|466297771|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
129547642|NCT03940742|466297773|FG000|Overall Study|Lost to Follow-up|0|||
129547643|NCT03940742|466297774|FG001|Overall Study|Lost to Follow-up|0|||
129547644|NCT03940742|466297775|FG002|Overall Study|Lost to Follow-up|0|||
129547645|NCT03940742|466297776|FG003|Overall Study|Lost to Follow-up|1|||
129547646|NCT02032823|466297777|FG000|Overall Study|Death|75|||
129547647|NCT02032823|466297778|FG001|Overall Study|Death|109|||
129547648|NCT02032823|466297777|FG000|Overall Study|Lost to Follow-up|18|||
129547649|NCT02032823|466297778|FG001|Overall Study|Lost to Follow-up|17|||
129547650|NCT02032823|466297777|FG000|Overall Study|Withdrawal by Subject|70|||
129547651|NCT02032823|466297778|FG001|Overall Study|Withdrawal by Subject|53|||
129547652|NCT02032823|466297777|FG000|Overall Study|Ongoing study at data cut-off|755|||
129547653|NCT02032823|466297778|FG001|Overall Study|Ongoing study at data cut-off|731|||
129547654|NCT02032823|466297777|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
129547655|NCT02032823|466297778|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
129547656|NCT03428217|466297779|FG000|Overall Study|Death|89|||
129547657|NCT03428217|466297780|FG001|Overall Study|Death|93|||
129769207|NCT04672239|467121467|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
129547658|NCT03428217|466297779|FG000|Overall Study|Withdrawal by Subject|8|||
129547659|NCT03428217|466297780|FG001|Overall Study|Withdrawal by Subject|7|||
129547660|NCT03428217|466297779|FG000|Overall Study|Lost to Follow-up|1|||
129547661|NCT03428217|466297780|FG001|Overall Study|Lost to Follow-up|3|||
129547662|NCT03428217|466297779|FG000|Overall Study|Study terminated by sponsor|124|||
129547663|NCT03428217|466297780|FG001|Overall Study|Study terminated by sponsor|118|||
129547664|NCT03428217|466297779|FG000|Overall Study|Other, Not Specified|1|||
129547665|NCT03428217|466297780|FG001|Overall Study|Other, Not Specified|0|||
129547666|NCT03889197|466297781|FG000|Overall Study|Withdrawal by Subject|1|||
129547667|NCT03889197|466297782|FG001|Overall Study|Withdrawal by Subject|0|||
129547668|NCT03889197|466297781|FG000|Overall Study|Physician Decision|0|||
129547669|NCT03889197|466297782|FG001|Overall Study|Physician Decision|1|||
129547670|NCT03889197|466297781|FG000|Overall Study|met exclusion criteria|0|||
129547671|NCT03889197|466297782|FG001|Overall Study|met exclusion criteria|1|||
129547672|NCT03889197|466297781|FG000|Overall Study|Protocol Violation|1|||
129547673|NCT03889197|466297782|FG001|Overall Study|Protocol Violation|0|||
129547674|NCT05899218|466297783|FG000|Overall Study|Lost to Follow-up|2|||
129547675|NCT05899218|466297784|FG001|Overall Study|Lost to Follow-up|2|||
129547676|NCT05899218|466297783|FG000|Overall Study|deemed ineligible out of country|1|||
129547677|NCT05899218|466297784|FG001|Overall Study|deemed ineligible out of country|0|||
129547678|NCT05246111|466297785|FG000|Period 01|NOT ELIGIBLE IC5|1|||
129547679|NCT05246111|466297786|FG001|Period 01|NOT ELIGIBLE IC5|0|||
129547680|NCT03151226|466297787|FG000|Overall Study|Withdrawal by Subject|2|||
129547681|NCT03151226|466297787|FG000|Overall Study|not wear device correctly|1|||
129547682|NCT05022121|466297792|FG000|Overall Study|Lack of Efficacy|1|||
129769208|NCT04672239|467121468|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
129769209|NCT04672239|467121466|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
129769210|NCT04672239|467121467|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
129769211|NCT04672239|467121468|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
129769212|NCT04672239|467121466|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
129769213|NCT04672239|467121467|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
129769214|NCT04672239|467121468|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
129769215|NCT04672239|467121466|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
129769216|NCT04672239|467121467|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
129769217|NCT04672239|467121468|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
129769218|NCT04672239|467121466|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
129769219|NCT04672239|467121467|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
129769220|NCT04672239|467121468|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
129547683|NCT05022121|466297793|FG001|Overall Study|Lack of Efficacy|0|||
129547684|NCT05022121|466297792|FG000|Overall Study|Lost to Follow-up|0|||
129547685|NCT05022121|466297793|FG001|Overall Study|Lost to Follow-up|2|||
129547686|NCT00891527|466300422|FG000|Overall Study|Withdrawal by Subject|2|||
129547687|NCT01186744|466300423|FG000|Overall Study|Lack of Efficacy|156|||
129547688|NCT01186744|466300424|FG001|Overall Study|Lack of Efficacy|99|||
129547689|NCT01186744|466300425|FG002|Overall Study|Lack of Efficacy|0|||
129547690|NCT01186744|466300426|FG003|Overall Study|Lack of Efficacy|2|||
129547691|NCT01186744|466300427|FG004|Overall Study|Lack of Efficacy|2|||
129547692|NCT01186744|466300428|FG005|Overall Study|Lack of Efficacy|5|||
129547693|NCT01186744|466300423|FG000|Overall Study|Protocol Violation|1|||
129547694|NCT01186744|466300424|FG001|Overall Study|Protocol Violation|2|||
129547695|NCT01186744|466300425|FG002|Overall Study|Protocol Violation|0|||
129547696|NCT01186744|466300426|FG003|Overall Study|Protocol Violation|1|||
129547697|NCT01186744|466300427|FG004|Overall Study|Protocol Violation|1|||
129547698|NCT01186744|466300428|FG005|Overall Study|Protocol Violation|2|||
129547699|NCT01186744|466300423|FG000|Overall Study|Lost to Follow-up|15|||
129547700|NCT01186744|466300424|FG001|Overall Study|Lost to Follow-up|16|||
129547701|NCT01186744|466300425|FG002|Overall Study|Lost to Follow-up|2|||
129547702|NCT01186744|466300426|FG003|Overall Study|Lost to Follow-up|1|||
129547703|NCT01186744|466300427|FG004|Overall Study|Lost to Follow-up|1|||
129547704|NCT01186744|466300428|FG005|Overall Study|Lost to Follow-up|4|||
129547705|NCT01186744|466300423|FG000|Overall Study|Screen failure|1|||
129547706|NCT01186744|466300424|FG001|Overall Study|Screen failure|1|||
129547707|NCT01186744|466300425|FG002|Overall Study|Screen failure|0|||
129769221|NCT04672239|467121466|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
129547708|NCT01186744|466300426|FG003|Overall Study|Screen failure|1|||
129547709|NCT01186744|466300427|FG004|Overall Study|Screen failure|0|||
129547710|NCT01186744|466300428|FG005|Overall Study|Screen failure|0|||
129547711|NCT01186744|466300423|FG000|Overall Study|Withdrawal by Subject|14|||
129547712|NCT01186744|466300424|FG001|Overall Study|Withdrawal by Subject|10|||
129547713|NCT01186744|466300425|FG002|Overall Study|Withdrawal by Subject|2|||
129547714|NCT01186744|466300426|FG003|Overall Study|Withdrawal by Subject|5|||
129547715|NCT01186744|466300427|FG004|Overall Study|Withdrawal by Subject|0|||
129547716|NCT01186744|466300428|FG005|Overall Study|Withdrawal by Subject|6|||
129547717|NCT01186744|466300423|FG000|Overall Study|Study terminated by Sponsor|1|||
129547718|NCT01186744|466300424|FG001|Overall Study|Study terminated by Sponsor|0|||
129547719|NCT01186744|466300425|FG002|Overall Study|Study terminated by Sponsor|0|||
129547720|NCT01186744|466300426|FG003|Overall Study|Study terminated by Sponsor|0|||
129547721|NCT01186744|466300427|FG004|Overall Study|Study terminated by Sponsor|0|||
129547722|NCT01186744|466300428|FG005|Overall Study|Study terminated by Sponsor|0|||
129547723|NCT01186744|466300423|FG000|Overall Study|Other|9|||
129547724|NCT01186744|466300424|FG001|Overall Study|Other|10|||
129547725|NCT01186744|466300425|FG002|Overall Study|Other|1|||
129547726|NCT01186744|466300426|FG003|Overall Study|Other|2|||
129547727|NCT01186744|466300427|FG004|Overall Study|Other|1|||
129547728|NCT01186744|466300428|FG005|Overall Study|Other|5|||
129547729|NCT01186744|466300423|FG000|Overall Study|Adverse Event|10|||
129547730|NCT01186744|466300424|FG001|Overall Study|Adverse Event|14|||
129547731|NCT01186744|466300425|FG002|Overall Study|Adverse Event|1|||
129547732|NCT01186744|466300426|FG003|Overall Study|Adverse Event|0|||
129547733|NCT01186744|466300427|FG004|Overall Study|Adverse Event|1|||
129547734|NCT01186744|466300428|FG005|Overall Study|Adverse Event|4|||
129547735|NCT01186744|466300423|FG000|Overall Study|Death|1|||
129547736|NCT01186744|466300424|FG001|Overall Study|Death|0|||
129547737|NCT01186744|466300425|FG002|Overall Study|Death|0|||
129547738|NCT01186744|466300426|FG003|Overall Study|Death|0|||
129547739|NCT01186744|466300427|FG004|Overall Study|Death|0|||
129547740|NCT01186744|466300428|FG005|Overall Study|Death|0|||
129547741|NCT01020773|466300431|FG000|Overall Study|Withdrawal by Subject|4|||
129547742|NCT01020773|466300432|FG001|Overall Study|Withdrawal by Subject|3|||
129547743|NCT01389024|466300433|FG000|Overall Study|Withdrawal by Subject|0|||
129547744|NCT01389024|466300434|FG001|Overall Study|Withdrawal by Subject|1|||
129547745|NCT01389024|466300433|FG000|Overall Study|Lost to Follow-up|1|||
129547746|NCT01389024|466300434|FG001|Overall Study|Lost to Follow-up|0|||
129547747|NCT00819091|466300435|FG000|Overall Study|Adverse Event|3|||
129547748|NCT00819091|466300436|FG001|Overall Study|Adverse Event|5|||
129547749|NCT00819091|466300435|FG000|Overall Study|Protocol Violation|0|||
129547750|NCT00819091|466300436|FG001|Overall Study|Protocol Violation|1|||
129547751|NCT00819091|466300435|FG000|Overall Study|Lost to Follow-up|2|||
129547752|NCT00819091|466300436|FG001|Overall Study|Lost to Follow-up|0|||
129547753|NCT00819091|466300435|FG000|Overall Study|Withdrawal by Subject|1|||
129547754|NCT00819091|466300436|FG001|Overall Study|Withdrawal by Subject|2|||
129547755|NCT00819091|466300435|FG000|Overall Study|Other|1|||
129547756|NCT00819091|466300436|FG001|Overall Study|Other|2|||
129547757|NCT02675426|466300440|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
129547758|NCT02675426|466300441|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
129547759|NCT02675426|466300442|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
129547760|NCT02675426|466300443|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
129547761|NCT02675426|466300440|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
129547762|NCT02675426|466300441|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
129547763|NCT02675426|466300442|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
129547764|NCT02675426|466300443|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
129547765|NCT02675426|466300440|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
129547766|NCT02675426|466300441|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
129547767|NCT02675426|466300442|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
129547768|NCT02675426|466300443|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
129547769|NCT02675426|466300440|FG000|Period 1: Week 1 to Week 12|Other|2|||
129547770|NCT02675426|466300441|FG001|Period 1: Week 1 to Week 12|Other|1|||
129547771|NCT02675426|466300442|FG002|Period 1: Week 1 to Week 12|Other|0|||
129547772|NCT02675426|466300443|FG003|Period 1: Week 1 to Week 12|Other|2|||
129547773|NCT02675426|466300440|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
129547774|NCT02675426|466300441|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
129547775|NCT02675426|466300442|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
129547776|NCT02675426|466300443|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
129547777|NCT02675426|466300440|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
129547778|NCT02675426|466300441|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
129547779|NCT02675426|466300442|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
129547780|NCT02675426|466300443|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
129547781|NCT02675426|466300440|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
129547782|NCT02675426|466300441|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
129547783|NCT02675426|466300442|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
129547784|NCT02675426|466300443|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
129547785|NCT02675426|466300440|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
129547786|NCT02675426|466300441|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
129547787|NCT02675426|466300442|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
129547788|NCT02675426|466300443|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
129547789|NCT02675426|466300440|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
129547790|NCT02675426|466300441|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
129547791|NCT02675426|466300442|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
129547792|NCT02675426|466300443|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
129547793|NCT02675426|466300440|FG000|Period 2: Week 12 to Week 260|Other|8|||
129547794|NCT02675426|466300441|FG001|Period 2: Week 12 to Week 260|Other|12|||
129547795|NCT02675426|466300442|FG002|Period 2: Week 12 to Week 260|Other|23|||
129547796|NCT02675426|466300443|FG003|Period 2: Week 12 to Week 260|Other|15|||
129547797|NCT02156466|466300444|FG000|Overall Study|Adverse Event|0|||
129547798|NCT02156466|466300445|FG001|Overall Study|Adverse Event|0|||
129547799|NCT02156466|466300446|FG002|Overall Study|Adverse Event|1|||
129547800|NCT02156466|466300447|FG003|Overall Study|Adverse Event|1|||
129547801|NCT02156466|466300448|FG004|Overall Study|Adverse Event|0|||
129547802|NCT02156466|466300444|FG000|Overall Study|Quantiferon Positivity|0|||
129547803|NCT02156466|466300445|FG001|Overall Study|Quantiferon Positivity|0|||
129547804|NCT02156466|466300446|FG002|Overall Study|Quantiferon Positivity|0|||
129547805|NCT02156466|466300447|FG003|Overall Study|Quantiferon Positivity|1|||
129547806|NCT02156466|466300448|FG004|Overall Study|Quantiferon Positivity|0|||
129547807|NCT02237118|466300449|FG000|Overall Study|Protocol Violation|0|||
129547808|NCT02237118|466300450|FG001|Overall Study|Protocol Violation|1|||
129547809|NCT02237118|466300449|FG000|Overall Study|consent withdrawn|1|||
129547810|NCT02237118|466300450|FG001|Overall Study|consent withdrawn|0|||
129547811|NCT02953262|466300451|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
129547812|NCT02953262|466300452|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
129547813|NCT02953262|466300453|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
129547814|NCT02953262|466300454|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
129547815|NCT01652573|466300455|FG000|Overall Study|Adverse Event|0|||
129547816|NCT01652573|466300456|FG001|Overall Study|Adverse Event|1|||
129547817|NCT00740480|466300457|FG000|Overall Study|Adverse Event|1|||
129547818|NCT00740480|466300457|FG000|Overall Study|Physician Decision|1|||
129547819|NCT00934622|466300458|FG000|Overall Study|Lost to Follow-up|7|||
129547820|NCT00934622|466300458|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
129547821|NCT01856686|466300462|FG000|Overall Study|Lost to Follow-up|5|||
129547822|NCT01856686|466300463|FG001|Overall Study|Lost to Follow-up|11|||
129547823|NCT00602979|466300466|FG000|Overall Study|Lost to Follow-up|3|||
129547824|NCT00602979|466300467|FG001|Overall Study|Lost to Follow-up|2|||
129547825|NCT00602979|466300468|FG002|Overall Study|Lost to Follow-up|3|||
129547826|NCT00602979|466300469|FG003|Overall Study|Lost to Follow-up|2|||
129547827|NCT00602979|466300470|FG004|Overall Study|Lost to Follow-up|3|||
129547828|NCT00602979|466300466|FG000|Overall Study|Failed Intubation|0|||
129547829|NCT00602979|466300467|FG001|Overall Study|Failed Intubation|1|||
129547830|NCT00602979|466300468|FG002|Overall Study|Failed Intubation|0|||
129547831|NCT00602979|466300469|FG003|Overall Study|Failed Intubation|1|||
129547832|NCT00602979|466300470|FG004|Overall Study|Failed Intubation|0|||
129547833|NCT03891875|466300478|FG000|Overall Study|Withdrawal by Subject|20|||
129547834|NCT03891875|466300479|FG001|Overall Study|Withdrawal by Subject|3|||
129547835|NCT03891875|466300478|FG000|Overall Study|Adverse Event|10|||
129547836|NCT03891875|466300479|FG001|Overall Study|Adverse Event|4|||
129547837|NCT03891875|466300478|FG000|Overall Study|Physician Decision|1|||
129547838|NCT03891875|466300479|FG001|Overall Study|Physician Decision|1|||
129547839|NCT03891875|466300478|FG000|Overall Study|Protocol Violation|1|||
129547840|NCT03891875|466300479|FG001|Overall Study|Protocol Violation|0|||
129547841|NCT03891875|466300478|FG000|Overall Study|Lost to Follow-up|1|||
129547842|NCT03891875|466300479|FG001|Overall Study|Lost to Follow-up|0|||
129547843|NCT03891875|466300478|FG000|Overall Study|COVID-19 infection|1|||
129547844|NCT03891875|466300479|FG001|Overall Study|COVID-19 infection|0|||
129547845|NCT00835068|466300482|FG000|Overall Study|Death|1|||
129547846|NCT00835068|466300483|FG001|Overall Study|Death|0|||
129547847|NCT00835068|466300482|FG000|Overall Study|Adverse Event|0|||
129547848|NCT00835068|466300483|FG001|Overall Study|Adverse Event|1|||
129547849|NCT00835068|466300482|FG000|Overall Study|Other|8|||
129547850|NCT00835068|466300483|FG001|Overall Study|Other|0|||
129547851|NCT00835068|466300482|FG000|Overall Study|Withdrawal by Subject|1|||
129547852|NCT00835068|466300483|FG001|Overall Study|Withdrawal by Subject|0|||
129547853|NCT02575807|466300484|FG000|Overall Study|Death|8|||
129547854|NCT02575807|466300485|FG001|Overall Study|Death|3|||
129547855|NCT02575807|466300486|FG002|Overall Study|Death|7|||
129547856|NCT02575807|466300487|FG003|Overall Study|Death|0|||
129547857|NCT02575807|466300488|FG004|Overall Study|Death|1|||
129547858|NCT02575807|466300484|FG000|Overall Study|Study terminated by Sponsor|0|||
129547859|NCT02575807|466300485|FG001|Overall Study|Study terminated by Sponsor|1|||
129547860|NCT02575807|466300486|FG002|Overall Study|Study terminated by Sponsor|7|||
129547861|NCT02575807|466300487|FG003|Overall Study|Study terminated by Sponsor|0|||
129547862|NCT02575807|466300488|FG004|Overall Study|Study terminated by Sponsor|1|||
129547863|NCT02575807|466300484|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
129547864|NCT02575807|466300485|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
129547865|NCT02575807|466300486|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
129547866|NCT02575807|466300487|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
129547867|NCT02575807|466300488|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
129547868|NCT02575807|466300484|FG000|Overall Study|Terminated due to physician decision|0|||
129547869|NCT02575807|466300485|FG001|Overall Study|Terminated due to physician decision|0|||
129547870|NCT02575807|466300486|FG002|Overall Study|Terminated due to physician decision|1|||
129547871|NCT02575807|466300487|FG003|Overall Study|Terminated due to physician decision|0|||
129547872|NCT02575807|466300488|FG004|Overall Study|Terminated due to physician decision|0|||
129547873|NCT02575807|466300484|FG000|Overall Study|Subject ineligible - medical implant|0|||
129547874|NCT02575807|466300485|FG001|Overall Study|Subject ineligible - medical implant|0|||
129547875|NCT02575807|466300486|FG002|Overall Study|Subject ineligible - medical implant|0|||
129547876|NCT02575807|466300487|FG003|Overall Study|Subject ineligible - medical implant|1|||
129547877|NCT02575807|466300488|FG004|Overall Study|Subject ineligible - medical implant|0|||
129547878|NCT02575807|466300484|FG000|Overall Study|Withdrawal by Subject|0|||
129547879|NCT02575807|466300485|FG001|Overall Study|Withdrawal by Subject|0|||
129547880|NCT02575807|466300486|FG002|Overall Study|Withdrawal by Subject|1|||
129547881|NCT02575807|466300487|FG003|Overall Study|Withdrawal by Subject|1|||
129547882|NCT02575807|466300488|FG004|Overall Study|Withdrawal by Subject|2|||
129547883|NCT02180659|466300489|FG000|Overall Study|Adverse Event|1|||
129547884|NCT02180659|466300490|FG001|Overall Study|Adverse Event|0|||
129547885|NCT02180659|466300489|FG000|Overall Study|Lost to Follow-up|4|||
129547886|NCT02180659|466300490|FG001|Overall Study|Lost to Follow-up|2|||
129707557|NCT01076010|466892039|FG001|Overall Study|Death|1|||
129547887|NCT02180659|466300489|FG000|Overall Study|Subject incarcerated during conduct|1|||
129547888|NCT02180659|466300490|FG001|Overall Study|Subject incarcerated during conduct|0|||
129547889|NCT02180659|466300489|FG000|Overall Study|Withdrawal by Subject|0|||
129547890|NCT02180659|466300490|FG001|Overall Study|Withdrawal by Subject|2|||
129547891|NCT02180659|466300489|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
129547892|NCT02180659|466300490|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
129547893|NCT01495793|466300491|FG000|Overall Study|Lost to Follow-up|1|||
129547894|NCT01495793|466300491|FG000|Overall Study|Violation of inclusion criteria|1|||
129547895|NCT03014570|466300494|FG000|Overall Study|COVID-19 Restrictions|38|||
129547896|NCT03014570|466300495|FG001|Overall Study|COVID-19 Restrictions|24|||
129547897|NCT03014570|466300494|FG000|Overall Study|Death|70|||
129547898|NCT03014570|466300495|FG001|Overall Study|Death|79|||
129547899|NCT03014570|466300494|FG000|Overall Study|Transfer from facility|11|||
129547900|NCT03014570|466300495|FG001|Overall Study|Transfer from facility|14|||
129547901|NCT03014570|466300494|FG000|Overall Study|Hospitalized|5|||
129547902|NCT03014570|466300495|FG001|Overall Study|Hospitalized|3|||
129547903|NCT03014570|466300494|FG000|Overall Study|Transfer within facility|1|||
129547904|NCT03014570|466300495|FG001|Overall Study|Transfer within facility|0|||
129547905|NCT03014570|466300494|FG000|Overall Study|Site refusal|0|||
129547906|NCT03014570|466300495|FG001|Overall Study|Site refusal|11|||
129547907|NCT00478673|466300501|FG000|30-Days Post-Procedure|Death|2|||
129547908|NCT00478673|466300501|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
129547909|NCT00478673|466300501|FG000|30-Days Post-Procedure|Missed Visit|7|||
129547910|NCT00478673|466300501|FG000|12-Months Post-Procedure|Death|23|||
129547911|NCT00478673|466300501|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
129547912|NCT00478673|466300501|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
129769222|NCT04672239|467121467|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
129769223|NCT04672239|467121468|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
129769224|NCT04672239|467121466|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
129769225|NCT04672239|467121467|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
129547913|NCT00478673|466300501|FG000|12-Months Post-Procedure|Missed Visit|25|||
129547914|NCT00478673|466300501|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
129547915|NCT00481871|466300502|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
129547916|NCT00481871|466300503|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
129547917|NCT00481871|466300504|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
129547918|NCT00481871|466300505|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
129547919|NCT00481871|466300506|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
129547920|NCT03332212|466300507|FG000|Overall Study|Not treated|0|||
129547921|NCT03332212|466300508|FG001|Overall Study|Not treated|1|||
129547922|NCT03332212|466300509|FG002|Overall Study|Not treated|0|||
129547923|NCT03332212|466300510|FG003|Overall Study|Not treated|0|||
129547924|NCT03332212|466300507|FG000|Overall Study|Adverse Event|0|||
129547925|NCT03332212|466300508|FG001|Overall Study|Adverse Event|0|||
129547926|NCT03332212|466300509|FG002|Overall Study|Adverse Event|0|||
129547927|NCT03332212|466300510|FG003|Overall Study|Adverse Event|1|||
129547928|NCT03332212|466300507|FG000|Overall Study|worsening of disease under study|1|||
129547929|NCT03332212|466300508|FG001|Overall Study|worsening of disease under study|1|||
129547930|NCT03332212|466300509|FG002|Overall Study|worsening of disease under study|0|||
129547931|NCT03332212|466300510|FG003|Overall Study|worsening of disease under study|0|||
129547932|NCT02125734|466300514|FG000|Period 2|Adverse Event|0|||
129547933|NCT02125734|466300515|FG001|Period 2|Adverse Event|1|||
129547934|NCT01308762|466300516|FG000|Overall Study|Protocol Violation|0|||
129547935|NCT01308762|466300517|FG001|Overall Study|Protocol Violation|1|||
129547936|NCT01308762|466300518|FG002|Overall Study|Protocol Violation|0|||
129547937|NCT02304302|466300529|FG000|Overall Study|Adverse Event|2|||
129547938|NCT02304302|466300530|FG001|Overall Study|Adverse Event|3|||
129547939|NCT02304302|466300529|FG000|Overall Study|Lost to Follow-up|1|||
129547940|NCT02304302|466300530|FG001|Overall Study|Lost to Follow-up|4|||
129547941|NCT02304302|466300529|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
129547942|NCT02304302|466300530|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
129547943|NCT00391118|466300531|FG000|Overall Study|Adverse Event|3|||
129547944|NCT00391118|466300532|FG001|Overall Study|Adverse Event|10|||
129547945|NCT00391118|466300533|FG002|Overall Study|Adverse Event|7|||
129547946|NCT00391118|466300531|FG000|Overall Study|Lost to Follow-up|0|||
129547947|NCT00391118|466300532|FG001|Overall Study|Lost to Follow-up|2|||
129547948|NCT00391118|466300533|FG002|Overall Study|Lost to Follow-up|3|||
129547949|NCT00391118|466300531|FG000|Overall Study|Withdrawal by Subject|0|||
129547950|NCT00391118|466300532|FG001|Overall Study|Withdrawal by Subject|9|||
129547951|NCT00391118|466300533|FG002|Overall Study|Withdrawal by Subject|1|||
129547952|NCT00391118|466300531|FG000|Overall Study|Death|0|||
129547953|NCT00391118|466300532|FG001|Overall Study|Death|1|||
129547954|NCT00391118|466300533|FG002|Overall Study|Death|0|||
129547955|NCT00391118|466300531|FG000|Overall Study|Physician Decision|0|||
129547956|NCT00391118|466300532|FG001|Overall Study|Physician Decision|3|||
129547957|NCT00391118|466300533|FG002|Overall Study|Physician Decision|0|||
129547958|NCT00391118|466300531|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
129547959|NCT00391118|466300532|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
129547960|NCT00391118|466300533|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
129547961|NCT00391118|466300531|FG000|Overall Study|Progressive Disease|7|||
129547962|NCT00391118|466300532|FG001|Overall Study|Progressive Disease|26|||
129547963|NCT00391118|466300533|FG002|Overall Study|Progressive Disease|43|||
129547964|NCT00391118|466300531|FG000|Overall Study|Sponsor Decision|0|||
129547965|NCT00391118|466300532|FG001|Overall Study|Sponsor Decision|1|||
129547966|NCT00391118|466300533|FG002|Overall Study|Sponsor Decision|3|||
129547967|NCT00391118|466300531|FG000|Overall Study|Protocol Violation|1|||
129547968|NCT00391118|466300532|FG001|Overall Study|Protocol Violation|0|||
129547969|NCT00391118|466300533|FG002|Overall Study|Protocol Violation|0|||
129547970|NCT03078192|466300535|FG000|Overall Study|Withdrawal by Subject|2|||
129547971|NCT03078192|466300536|FG001|Overall Study|Withdrawal by Subject|1|||
129547972|NCT03078192|466300535|FG000|Overall Study|screen failure|0|||
129547973|NCT03078192|466300536|FG001|Overall Study|screen failure|3|||
129547974|NCT03107715|466300539|FG000|Overall Study|did not deliver at the home hospital|4|||
129547975|NCT03107715|466300540|FG001|Overall Study|did not deliver at the home hospital|6|||
129547976|NCT03107715|466300539|FG000|Overall Study|infant stillborn|0|||
129547977|NCT03107715|466300540|FG001|Overall Study|infant stillborn|1|||
129547978|NCT02508649|466300541|FG000|Overall Study|Withdrawal by Subject|4|||
129547979|NCT02508649|466300542|FG001|Overall Study|Withdrawal by Subject|6|||
129547980|NCT02508649|466300543|FG002|Overall Study|Withdrawal by Subject|5|||
129547981|NCT02508649|466300544|FG003|Overall Study|Withdrawal by Subject|6|||
129547982|NCT02508649|466300541|FG000|Overall Study|Investigator withdrew the subject|1|||
129547983|NCT02508649|466300542|FG001|Overall Study|Investigator withdrew the subject|2|||
129547984|NCT02508649|466300543|FG002|Overall Study|Investigator withdrew the subject|1|||
129547985|NCT02508649|466300544|FG003|Overall Study|Investigator withdrew the subject|0|||
129547986|NCT02508649|466300541|FG000|Overall Study|Post randomization screening failure|12|||
129547987|NCT02508649|466300542|FG001|Overall Study|Post randomization screening failure|4|||
129547988|NCT02508649|466300543|FG002|Overall Study|Post randomization screening failure|9|||
129547989|NCT02508649|466300544|FG003|Overall Study|Post randomization screening failure|3|||
129547990|NCT02508649|466300541|FG000|Overall Study|Lost to Follow-up|1|||
129547991|NCT02508649|466300542|FG001|Overall Study|Lost to Follow-up|1|||
129547992|NCT02508649|466300543|FG002|Overall Study|Lost to Follow-up|0|||
129547993|NCT02508649|466300544|FG003|Overall Study|Lost to Follow-up|1|||
129547994|NCT03594175|466300552|FG000|Overall Study|Not treated|8|||
129547995|NCT03594175|466300553|FG001|Overall Study|Not treated|1|||
129547996|NCT03594175|466300554|FG002|Overall Study|Not treated|5|||
129547997|NCT03594175|466300552|FG000|Overall Study|Adverse Event|3|||
129547998|NCT03594175|466300553|FG001|Overall Study|Adverse Event|0|||
129547999|NCT03594175|466300554|FG002|Overall Study|Adverse Event|0|||
129679068|NCT03979313|466785242|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
129679069|NCT03979313|466785243|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
129679070|NCT03979313|466785242|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
129679071|NCT03979313|466785243|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
129679072|NCT03979313|466785242|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
129679073|NCT03979313|466785243|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
129679074|NCT03979313|466785242|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
129679075|NCT03979313|466785243|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
129679076|NCT03979313|466785242|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
129679077|NCT03979313|466785243|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
129679078|NCT03979313|466785242|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
129679079|NCT03979313|466785243|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
129679080|NCT03979313|466785242|FG000|All Subjects|Any Other Reason|16|||
129679081|NCT03979313|466785243|FG001|All Subjects|Any Other Reason|23|||
129679082|NCT03979313|466785242|FG000|All Subjects|Covid-19|1|||
129679083|NCT03979313|466785243|FG001|All Subjects|Covid-19|3|||
129679084|NCT03979313|466785242|FG000|All Subjects|Withdrawal by Subject|35|||
129679085|NCT03979313|466785243|FG001|All Subjects|Withdrawal by Subject|44|||
129679086|NCT03979313|466785242|FG000|All Subjects|Death|0|||
129679087|NCT03979313|466785243|FG001|All Subjects|Death|5|||
129679088|NCT03979313|466785242|FG000|All Subjects|Lost to Follow-up|28|||
129679089|NCT03979313|466785243|FG001|All Subjects|Lost to Follow-up|61|||
129679090|NCT00300053|466785244|FG000|Overall Study|Patient/Caregiver Preference|2|||
129679091|NCT00300053|466785245|FG001|Overall Study|Patient/Caregiver Preference|2|||
129679092|NCT00300053|466785246|FG002|Overall Study|Patient/Caregiver Preference|3|||
129679093|NCT00300053|466785244|FG000|Overall Study|Death|0|||
129679094|NCT00300053|466785245|FG001|Overall Study|Death|0|||
129679095|NCT00300053|466785246|FG002|Overall Study|Death|3|||
129679096|NCT00300053|466785244|FG000|Overall Study|Lost to Follow-up|0|||
129679097|NCT00300053|466785245|FG001|Overall Study|Lost to Follow-up|1|||
129679098|NCT00300053|466785246|FG002|Overall Study|Lost to Follow-up|0|||
129679099|NCT02472405|466785250|FG000|Overall Study|Lost to Follow-up|9|||
129679100|NCT02472405|466785250|FG000|Overall Study|Adverse Event|1|||
129679101|NCT02736617|466785253|FG000|Treatment|Adverse Event|1|||
129679102|NCT02736617|466785253|FG000|Treatment|Lack of Efficacy|1|||
129679103|NCT02736617|466785253|FG000|Treatment|Withdrawal by Subject|1|||
129679104|NCT02736617|466785253|FG000|Maintenance|Lack of Efficacy|4|||
129679105|NCT02736617|466785253|FG000|Maintenance|Physician Decision|1|||
129679106|NCT02911116|466785258|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129679107|NCT02911116|466785259|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129679108|NCT02911116|466785258|FG000|Overall Study|Lost to Follow-up|0|||
129679109|NCT02911116|466785259|FG001|Overall Study|Lost to Follow-up|1|||
129679110|NCT02469857|466785260|FG000|Overall Study|Death|24|||
129679111|NCT02469857|466785261|FG001|Overall Study|Death|29|||
129679112|NCT02469857|466785260|FG000|Overall Study|Discontinuation|1|||
129679113|NCT02469857|466785261|FG001|Overall Study|Discontinuation|3|||
129679114|NCT02110693|466785262|FG000|Overall Study|Withdrawal by Subject|6|||
129679115|NCT02110693|466785263|FG001|Overall Study|Withdrawal by Subject|7|||
129679116|NCT02110693|466785262|FG000|Overall Study|skipped assessment|15|||
129679117|NCT02110693|466785263|FG001|Overall Study|skipped assessment|18|||
129679118|NCT02110693|466785262|FG000|Overall Study|technical difficulties|6|||
129679119|NCT02110693|466785263|FG001|Overall Study|technical difficulties|4|||
129679120|NCT02110693|466785262|FG000|Overall Study|Other|1|||
129679121|NCT02110693|466785263|FG001|Overall Study|Other|0|||
129679122|NCT04810962|466785264|FG000|Overall Study|Adverse Event|0|||
129679123|NCT04810962|466785265|FG001|Overall Study|Adverse Event|1|||
129679124|NCT04810962|466785264|FG000|Overall Study|Lost to Follow-up|2|||
129679125|NCT04810962|466785265|FG001|Overall Study|Lost to Follow-up|1|||
129679126|NCT04810962|466785264|FG000|Overall Study|Physician Decision|1|||
129679127|NCT04810962|466785265|FG001|Overall Study|Physician Decision|0|||
129679128|NCT04810962|466785264|FG000|Overall Study|Withdrawal by Subject|1|||
129679129|NCT04810962|466785265|FG001|Overall Study|Withdrawal by Subject|3|||
129679130|NCT04810962|466785264|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
129679131|NCT04810962|466785265|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
129679132|NCT00805532|466785266|FG000|Overall Study|invalid data|0|||
129679133|NCT00805532|466785267|FG001|Overall Study|invalid data|1|||
129679134|NCT02701634|466785269|FG000|Overall Study|Adverse Event|2|||
129679135|NCT02701634|466785270|FG001|Overall Study|Adverse Event|3|||
129679136|NCT02701634|466785269|FG000|Overall Study|Death|1|||
129679137|NCT02701634|466785270|FG001|Overall Study|Death|0|||
129679138|NCT02701634|466785269|FG000|Overall Study|Investigator's Discretion|7|||
129679139|NCT02701634|466785270|FG001|Overall Study|Investigator's Discretion|4|||
129679140|NCT02701634|466785269|FG000|Overall Study|Study terminated by Sponsor|15|||
129679141|NCT02701634|466785270|FG001|Overall Study|Study terminated by Sponsor|17|||
129679142|NCT02701634|466785269|FG000|Overall Study|Withdrew Consent|6|||
129769226|NCT04672239|467121468|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
129548000|NCT03594175|466300552|FG000|Overall Study|Withdrawal by Subject|3|||
129548001|NCT03594175|466300553|FG001|Overall Study|Withdrawal by Subject|0|||
129548002|NCT03594175|466300554|FG002|Overall Study|Withdrawal by Subject|0|||
129548003|NCT03594175|466300552|FG000|Overall Study|Protocol Violation|2|||
129548004|NCT03594175|466300553|FG001|Overall Study|Protocol Violation|2|||
129548005|NCT03594175|466300554|FG002|Overall Study|Protocol Violation|2|||
129548006|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548007|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548008|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548009|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
129548010|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
129548011|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548012|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548013|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548014|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548015|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
129548016|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548017|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548018|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
129548019|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
129548020|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
129548021|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
129548022|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
129548023|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
129548024|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
129548025|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548026|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548027|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548028|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548029|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548030|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
129548031|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548032|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548033|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548034|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
129548035|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548036|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548037|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548038|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
129884416|NCT02771210|467536387|FG000|Period 2|Withdrawal by Subject|1|||
129884417|NCT02771210|467536388|FG001|Period 2|Withdrawal by Subject|0|||
129884418|NCT02771210|467536387|FG000|Period 2|Withdrawal of informed consent|0|||
129884419|NCT02771210|467536388|FG001|Period 2|Withdrawal of informed consent|2|||
129679143|NCT02701634|466785270|FG001|Overall Study|Withdrew Consent|7|||
129679144|NCT02701634|466785269|FG000|Overall Study|Randomized but not treated|1|||
129679145|NCT02701634|466785270|FG001|Overall Study|Randomized but not treated|0|||
129679146|NCT01033136|466785273|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
129679147|NCT01033136|466785274|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
129884420|NCT04012814|467536391|FG000|Overall Study|Lost to Follow-up|4|||
129548039|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
129548040|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
129548041|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
129679148|NCT00630292|466785275|FG000|Overall Study|Withdrawal by Subject|1|||
129679149|NCT00142415|466785278|FG000|Overall Study|Physician Decision|0|||
129679150|NCT00142415|466785279|FG001|Overall Study|Physician Decision|0|||
129679151|NCT00142415|466785280|FG002|Overall Study|Physician Decision|0|||
129884421|NCT04012814|467536391|FG000|Overall Study|Withdrawal by Subject|2|||
129548042|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
129548043|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
129548044|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
129548045|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548046|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548047|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548048|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548049|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
129548050|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548051|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548052|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548053|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548054|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548055|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548056|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548057|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548058|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
129548059|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548060|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548061|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
129548062|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
129548063|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548064|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548065|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548066|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548067|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548068|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548069|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548070|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548071|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548072|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548073|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
129548074|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548075|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548076|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
129548077|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548078|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548079|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
129548080|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
129548081|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
129548082|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
129548083|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
129548084|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548085|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
129548086|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548087|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548088|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
129548089|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548090|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548091|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548092|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
129548093|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548094|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
129548095|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
129548096|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
129548097|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
129548098|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
129548099|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
129548100|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
129548101|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548102|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548103|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
129548104|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548105|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548106|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548107|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548108|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548109|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548110|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548111|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548112|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548113|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548114|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548115|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548116|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
129548117|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
129548118|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
129548119|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
129548120|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548121|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548122|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548123|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548124|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
129548125|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548126|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548127|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548128|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548129|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
129548130|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548131|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548132|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548133|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548134|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548135|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548136|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548137|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548138|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
129548139|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
129548140|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
129548141|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
129548142|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
129679152|NCT00142415|466785281|FG003|Overall Study|Physician Decision|0|||
129679153|NCT00142415|466785282|FG004|Overall Study|Physician Decision|1|||
129679154|NCT00142415|466785283|FG005|Overall Study|Physician Decision|2|||
129679155|NCT01189266|466785286|FG000|Overall Study|Adverse Event|1|||
129679156|NCT01189266|466785287|FG001|Overall Study|Adverse Event|0|||
129679157|NCT01189266|466785288|FG002|Overall Study|Adverse Event|5|||
129679158|NCT01189266|466785286|FG000|Overall Study|Death|0|||
129679159|NCT01189266|466785287|FG001|Overall Study|Death|0|||
129679160|NCT01189266|466785288|FG002|Overall Study|Death|5|||
129679161|NCT01189266|466785286|FG000|Overall Study|Lack of Efficacy|4|||
129679162|NCT01189266|466785287|FG001|Overall Study|Lack of Efficacy|5|||
129679163|NCT01189266|466785288|FG002|Overall Study|Lack of Efficacy|44|||
129679164|NCT01189266|466785286|FG000|Overall Study|Physician Decision|0|||
129679165|NCT01189266|466785287|FG001|Overall Study|Physician Decision|0|||
129679166|NCT01189266|466785288|FG002|Overall Study|Physician Decision|1|||
129679167|NCT01189266|466785286|FG000|Overall Study|Protocol Violation|0|||
129679168|NCT01189266|466785287|FG001|Overall Study|Protocol Violation|1|||
129679169|NCT01189266|466785288|FG002|Overall Study|Protocol Violation|1|||
129679170|NCT01189266|466785286|FG000|Overall Study|Withdrawal by Subject|0|||
129679171|NCT01189266|466785287|FG001|Overall Study|Withdrawal by Subject|0|||
129679172|NCT01189266|466785288|FG002|Overall Study|Withdrawal by Subject|1|||
129679173|NCT01189266|466785286|FG000|Overall Study|Patient refuses further therapy|1|||
129548143|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
129548144|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
129548145|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
129548146|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
129548147|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
129548148|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
129548149|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
129548150|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
129548151|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
129548152|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
129548153|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
129548154|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
129548155|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
129548156|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
129548157|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
129548158|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548159|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548160|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548161|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548162|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548163|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548164|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129679174|NCT01189266|466785287|FG001|Overall Study|Patient refuses further therapy|0|||
129679175|NCT01189266|466785288|FG002|Overall Study|Patient refuses further therapy|7|||
129769227|NCT04606134|467121469|FG000|Overall Study|Adverse Event|0|||
129769228|NCT04606134|467121470|FG001|Overall Study|Adverse Event|1|||
129769229|NCT01099267|467121472|FG000|MDS-003 Study|Adverse Event|37|||
129769230|NCT01099267|467121472|FG000|MDS-003 Study|Lack of Efficacy|52|||
129769231|NCT01099267|467121472|FG000|MDS-003 Study|Withdrawal by Subject|8|||
129769232|NCT01099267|467121472|FG000|MDS-003 Study|Lost to Follow-up|1|||
129769233|NCT01099267|467121472|FG000|MDS-003 Study|Death|11|||
129769234|NCT01099267|467121472|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
129769235|NCT01099267|467121472|FG000|MDS-003 Study|Disease Progression|7|||
129769236|NCT01099267|467121472|FG000|MDS-003 Study|Investigator Decision|2|||
129769237|NCT01099267|467121472|FG000|MDS-003 Study|Non-Compliance|2|||
129769238|NCT01099267|467121472|FG000|MDS-003 Study|Loss of Response|1|||
129769239|NCT01099267|467121472|FG000|MDS-003 Study|Secondary Malign Disease|1|||
129679176|NCT01189266|466785286|FG000|Overall Study|No treatment|0|||
129679177|NCT01189266|466785287|FG001|Overall Study|No treatment|0|||
129679178|NCT01189266|466785288|FG002|Overall Study|No treatment|1|||
129679179|NCT04009837|466785289|FG000|Overall Study|Withdrawal by Subject|5|||
129679180|NCT04009837|466785290|FG001|Overall Study|Withdrawal by Subject|4|||
129679181|NCT04009837|466785289|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
129769240|NCT01838395|467121480|FG000|Overall Study|Withdrawal by Subject|0|||
129769241|NCT01838395|467121481|FG001|Overall Study|Withdrawal by Subject|0|||
129769242|NCT01838395|467121482|FG002|Overall Study|Withdrawal by Subject|0|||
129548165|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548166|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548167|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548168|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
129548169|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548170|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548171|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548172|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548173|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548174|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548175|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548176|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
129548177|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
129548178|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
129548179|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548180|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548181|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
129548182|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
129548183|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548184|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
129548185|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548186|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
129548187|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548188|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548189|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
129548190|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
129548191|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
129548192|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
129548193|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
129548194|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
129548195|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
129548196|NCT01915498|466300555|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
129548197|NCT01915498|466300556|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
129548198|NCT01915498|466300557|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
129548199|NCT01915498|466300558|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
129548200|NCT01915498|466300559|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
129548201|NCT01915498|466300560|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
129548202|NCT01915498|466300561|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
129548203|NCT01915498|466300562|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
129769243|NCT01838395|467121483|FG003|Overall Study|Withdrawal by Subject|0|||
129769244|NCT01838395|467121484|FG004|Overall Study|Withdrawal by Subject|1|||
129769245|NCT01838395|467121485|FG005|Overall Study|Withdrawal by Subject|0|||
129769246|NCT01838395|467121480|FG000|Overall Study|Death|0|||
129548204|NCT01915498|466300563|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
129548205|NCT01915498|466300564|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
129548206|NCT01915498|466300565|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
129548207|NCT01915498|466300566|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
129548208|NCT01915498|466300567|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
129548209|NCT01915498|466300568|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
129548210|NCT01915498|466300569|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
129769247|NCT01838395|467121481|FG001|Overall Study|Death|0|||
129769248|NCT01838395|467121482|FG002|Overall Study|Death|1|||
129769249|NCT01838395|467121483|FG003|Overall Study|Death|0|||
129769250|NCT01838395|467121484|FG004|Overall Study|Death|0|||
129769251|NCT01838395|467121485|FG005|Overall Study|Death|0|||
129769252|NCT01838395|467121480|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129769253|NCT01838395|467121481|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
129769254|NCT01838395|467121482|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129769255|NCT01838395|467121483|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129769256|NCT01838395|467121484|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129769257|NCT01838395|467121485|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
129769258|NCT03866577|467121486|FG000|Overall Study|Protocol Violation|0|||
129769259|NCT03866577|467121487|FG001|Overall Study|Protocol Violation|0|||
129769260|NCT03866577|467121488|FG002|Overall Study|Protocol Violation|0|||
129769261|NCT03866577|467121489|FG003|Overall Study|Protocol Violation|0|||
129769262|NCT03866577|467121490|FG004|Overall Study|Protocol Violation|0|||
129769263|NCT03866577|467121491|FG005|Overall Study|Protocol Violation|0|||
129769264|NCT03866577|467121492|FG006|Overall Study|Protocol Violation|0|||
129769265|NCT03866577|467121493|FG007|Overall Study|Protocol Violation|0|||
129769266|NCT03866577|467121494|FG008|Overall Study|Protocol Violation|0|||
129769267|NCT03866577|467121495|FG009|Overall Study|Protocol Violation|0|||
129769268|NCT03866577|467121496|FG010|Overall Study|Protocol Violation|0|||
129769269|NCT03866577|467121497|FG011|Overall Study|Protocol Violation|1|||
129548211|NCT01915498|466300570|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
129548212|NCT01915498|466300571|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
129548213|NCT01915498|466300572|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
129548214|NCT01915498|466300573|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
129548215|NCT01915498|466300555|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548216|NCT01915498|466300556|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548217|NCT01915498|466300557|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548218|NCT01915498|466300558|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548219|NCT01915498|466300559|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548220|NCT01915498|466300560|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548221|NCT01915498|466300561|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548222|NCT01915498|466300562|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548223|NCT01915498|466300563|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548224|NCT01915498|466300564|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548225|NCT01915498|466300565|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548226|NCT01915498|466300566|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548227|NCT01915498|466300567|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548228|NCT01915498|466300568|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548229|NCT01915498|466300569|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548230|NCT01915498|466300570|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548231|NCT01915498|466300571|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548232|NCT01915498|466300572|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
129548233|NCT01915498|466300573|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
129548234|NCT01915498|466300555|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548235|NCT01915498|466300556|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548236|NCT01915498|466300557|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548237|NCT01915498|466300558|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548238|NCT01915498|466300559|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548239|NCT01915498|466300560|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548240|NCT01915498|466300561|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548241|NCT01915498|466300562|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548242|NCT01915498|466300563|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548243|NCT01915498|466300564|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548244|NCT01915498|466300565|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548245|NCT01915498|466300566|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548246|NCT01915498|466300567|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548247|NCT01915498|466300568|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548248|NCT01915498|466300569|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129769270|NCT03866577|467121498|FG012|Overall Study|Protocol Violation|0|||
129769271|NCT03866577|467121486|FG000|Overall Study|Withdrawal by Subject|0|||
129769272|NCT03866577|467121487|FG001|Overall Study|Withdrawal by Subject|0|||
129769273|NCT03866577|467121488|FG002|Overall Study|Withdrawal by Subject|0|||
129769274|NCT03866577|467121489|FG003|Overall Study|Withdrawal by Subject|0|||
129769275|NCT03866577|467121490|FG004|Overall Study|Withdrawal by Subject|0|||
129769276|NCT03866577|467121491|FG005|Overall Study|Withdrawal by Subject|0|||
129769277|NCT03866577|467121492|FG006|Overall Study|Withdrawal by Subject|0|||
129769278|NCT03866577|467121493|FG007|Overall Study|Withdrawal by Subject|0|||
129548249|NCT01915498|466300570|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129548250|NCT01915498|466300571|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129769279|NCT03866577|467121494|FG008|Overall Study|Withdrawal by Subject|1|||
129548251|NCT01915498|466300572|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
129769280|NCT03866577|467121495|FG009|Overall Study|Withdrawal by Subject|1|||
129769281|NCT03866577|467121496|FG010|Overall Study|Withdrawal by Subject|0|||
129769282|NCT03866577|467121497|FG011|Overall Study|Withdrawal by Subject|0|||
129769283|NCT03866577|467121498|FG012|Overall Study|Withdrawal by Subject|0|||
129769284|NCT03866577|467121486|FG000|Overall Study|Not qualified for IVIg infusion|0|||
129769285|NCT03866577|467121487|FG001|Overall Study|Not qualified for IVIg infusion|0|||
129769286|NCT03866577|467121488|FG002|Overall Study|Not qualified for IVIg infusion|0|||
129769287|NCT03866577|467121489|FG003|Overall Study|Not qualified for IVIg infusion|0|||
129769288|NCT03866577|467121490|FG004|Overall Study|Not qualified for IVIg infusion|0|||
129769289|NCT03866577|467121491|FG005|Overall Study|Not qualified for IVIg infusion|0|||
129769290|NCT03866577|467121492|FG006|Overall Study|Not qualified for IVIg infusion|0|||
129769291|NCT03866577|467121493|FG007|Overall Study|Not qualified for IVIg infusion|0|||
129769292|NCT03866577|467121494|FG008|Overall Study|Not qualified for IVIg infusion|0|||
129769293|NCT03866577|467121495|FG009|Overall Study|Not qualified for IVIg infusion|1|||
129769294|NCT03866577|467121496|FG010|Overall Study|Not qualified for IVIg infusion|0|||
129769295|NCT03866577|467121497|FG011|Overall Study|Not qualified for IVIg infusion|0|||
129769296|NCT03866577|467121498|FG012|Overall Study|Not qualified for IVIg infusion|0|||
129769297|NCT04825678|467121499|FG000|Overall Study|Decision by Sponsor|2|||
129769298|NCT04825678|467121500|FG001|Overall Study|Decision by Sponsor|3|||
129548252|NCT01915498|466300573|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
129548253|NCT01915498|466300555|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548254|NCT01915498|466300556|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548255|NCT01915498|466300557|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548256|NCT01915498|466300558|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548257|NCT01915498|466300559|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548258|NCT01915498|466300560|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548259|NCT01915498|466300561|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548260|NCT01915498|466300562|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548261|NCT01915498|466300563|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548262|NCT01915498|466300564|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548263|NCT01915498|466300565|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548264|NCT01915498|466300566|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129769299|NCT04825678|467121499|FG000|Overall Study|Withdrawal of Consent From Study|7|||
129769300|NCT04825678|467121500|FG001|Overall Study|Withdrawal of Consent From Study|9|||
129769301|NCT04825678|467121499|FG000|Overall Study|Lost to Follow-up|3|||
129769302|NCT04825678|467121500|FG001|Overall Study|Lost to Follow-up|4|||
129769303|NCT04825678|467121499|FG000|Overall Study|Never Received Investigational Product|1|||
129769304|NCT04825678|467121500|FG001|Overall Study|Never Received Investigational Product|1|||
129769305|NCT05530252|467121501|FG000|Overall Study|Lost to Follow-up|1|||
129769306|NCT05530252|467121502|FG001|Overall Study|Lost to Follow-up|1|||
129769307|NCT05530252|467121503|FG002|Overall Study|Lost to Follow-up|1|||
129769308|NCT03043794|467121509|FG000|Overall Study|Lost to Follow-up|1|||
129769309|NCT05565742|467121510|FG000|Overall Study|Withdrawal by Subject|0|||
129769310|NCT05565742|467121511|FG001|Overall Study|Withdrawal by Subject|0|||
129769311|NCT05565742|467121512|FG002|Overall Study|Withdrawal by Subject|2|||
129769312|NCT05565742|467121513|FG003|Overall Study|Withdrawal by Subject|2|||
129769313|NCT05565742|467121514|FG004|Overall Study|Withdrawal by Subject|2|||
129769314|NCT05565742|467121510|FG000|Overall Study|Death|1|||
129769315|NCT05565742|467121511|FG001|Overall Study|Death|0|||
129769316|NCT05565742|467121512|FG002|Overall Study|Death|0|||
129769317|NCT05565742|467121513|FG003|Overall Study|Death|0|||
129769318|NCT05565742|467121514|FG004|Overall Study|Death|0|||
129769319|NCT05565742|467121510|FG000|Overall Study|Participant Travelled Abroad|0|||
129769320|NCT05565742|467121511|FG001|Overall Study|Participant Travelled Abroad|0|||
129769321|NCT05565742|467121512|FG002|Overall Study|Participant Travelled Abroad|0|||
129769322|NCT05565742|467121513|FG003|Overall Study|Participant Travelled Abroad|0|||
129769323|NCT05565742|467121514|FG004|Overall Study|Participant Travelled Abroad|1|||
129769324|NCT04163341|467121515|FG000|Overall Study|Withdrawal by Subject|2|||
129548265|NCT01915498|466300567|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548266|NCT01915498|466300568|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548267|NCT01915498|466300569|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548268|NCT01915498|466300570|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548269|NCT01915498|466300571|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548270|NCT01915498|466300572|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
129548271|NCT01915498|466300573|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
129548272|NCT01907516|466300574|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
129548273|NCT01907516|466300575|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
129548274|NCT01907516|466300574|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
129548275|NCT01907516|466300575|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
129548276|NCT01907516|466300574|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
129548277|NCT01907516|466300575|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
129548278|NCT01907516|466300574|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
129548279|NCT01907516|466300575|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
129548280|NCT00633217|466300578|FG000|Overall Study|Adverse Event|5|||
129548281|NCT00633217|466300579|FG001|Overall Study|Adverse Event|9|||
129548282|NCT00633217|466300578|FG000|Overall Study|Lack of Efficacy|0|||
129548283|NCT00633217|466300579|FG001|Overall Study|Lack of Efficacy|2|||
129548284|NCT00633217|466300578|FG000|Overall Study|Protocol Violation|3|||
129548285|NCT00633217|466300579|FG001|Overall Study|Protocol Violation|7|||
129548286|NCT00633217|466300578|FG000|Overall Study|Lost to Follow-up|2|||
129548287|NCT00633217|466300579|FG001|Overall Study|Lost to Follow-up|2|||
129548288|NCT00633217|466300578|FG000|Overall Study|Investigator Discretion|2|||
129548289|NCT00633217|466300579|FG001|Overall Study|Investigator Discretion|0|||
129548290|NCT00633217|466300578|FG000|Overall Study|Withdrew Consent|3|||
129548291|NCT00633217|466300579|FG001|Overall Study|Withdrew Consent|3|||
129548292|NCT04881448|466300580|FG000|Overall Study|Study cancelled by sponsor|220|||
129548293|NCT04881448|466300580|FG000|Overall Study|Withdrawal by Subject|2|||
129548294|NCT04881448|466300580|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
129548295|NCT00005879|466300581|FG000|Overall Study|Withdrawal by Subject|8|||
129548296|NCT00005879|466300582|FG001|Overall Study|Withdrawal by Subject|10|||
129679182|NCT04009837|466785290|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
129679183|NCT03530696|466785293|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
129679184|NCT03530696|466785294|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
129679185|NCT02472353|466785295|FG000|Overall Study|Lost to Follow-up|1|||
129679186|NCT02472353|466785296|FG001|Overall Study|Lost to Follow-up|1|||
129679187|NCT02472353|466785295|FG000|Overall Study|Withdrawal by Subject|2|||
129679188|NCT02472353|466785296|FG001|Overall Study|Withdrawal by Subject|1|||
129679189|NCT02472353|466785295|FG000|Overall Study|Study Termination|1|||
129679190|NCT02472353|466785296|FG001|Overall Study|Study Termination|4|||
129679191|NCT03416179|466785297|FG000|Overall Study|Death|90|||
129679192|NCT03416179|466785298|FG001|Overall Study|Death|87|||
129679193|NCT03416179|466785299|FG002|Overall Study|Death|117|||
129679194|NCT03416179|466785300|FG003|Overall Study|Death|113|||
129679195|NCT03416179|466785297|FG000|Overall Study|Withdrawal by Subject|15|||
129679196|NCT03416179|466785298|FG001|Overall Study|Withdrawal by Subject|20|||
129679197|NCT03416179|466785299|FG002|Overall Study|Withdrawal by Subject|6|||
129679198|NCT03416179|466785300|FG003|Overall Study|Withdrawal by Subject|9|||
129679199|NCT03416179|466785297|FG000|Overall Study|Lost to Follow-up|1|||
129679200|NCT03416179|466785298|FG001|Overall Study|Lost to Follow-up|1|||
129679201|NCT03416179|466785299|FG002|Overall Study|Lost to Follow-up|0|||
129679202|NCT03416179|466785300|FG003|Overall Study|Lost to Follow-up|3|||
129679203|NCT03416179|466785297|FG000|Overall Study|Study participation terminated by Sponsor|93|||
129679204|NCT03416179|466785298|FG001|Overall Study|Study participation terminated by Sponsor|91|||
129679205|NCT03416179|466785299|FG002|Overall Study|Study participation terminated by Sponsor|26|||
129679206|NCT03416179|466785300|FG003|Overall Study|Study participation terminated by Sponsor|31|||
129679207|NCT03416179|466785297|FG000|Overall Study|Other|2|||
129679208|NCT03416179|466785298|FG001|Overall Study|Other|3|||
129679209|NCT03416179|466785299|FG002|Overall Study|Other|1|||
129679210|NCT03416179|466785300|FG003|Overall Study|Other|0|||
129679211|NCT02657551|466785320|FG000|Overall Study|Adverse Event|2|||
129679212|NCT02657551|466785320|FG000|Overall Study|Withdrawal by Subject|1|||
129679213|NCT02657551|466785320|FG000|Overall Study|Non-Compliance|1|||
129679214|NCT02657551|466785320|FG000|Overall Study|Progression / Relapse|4|||
129679215|NCT01035138|466785321|FG000|Overall Study|Adverse Event|4|||
129679216|NCT01035138|466785322|FG001|Overall Study|Adverse Event|0|||
129679217|NCT01035138|466785323|FG002|Overall Study|Adverse Event|2|||
129679218|NCT01035138|466785321|FG000|Overall Study|Caregiver Decision|2|||
129679219|NCT01035138|466785322|FG001|Overall Study|Caregiver Decision|0|||
129679220|NCT01035138|466785323|FG002|Overall Study|Caregiver Decision|1|||
129548297|NCT00689273|466300583|FG000|Overall Study|Adverse Event|3|||
129884422|NCT04012814|467536391|FG000|Overall Study|Protocol Violation|1|||
129679221|NCT01035138|466785321|FG000|Overall Study|Withdrawal by Subject|1|||
129679222|NCT01035138|466785322|FG001|Overall Study|Withdrawal by Subject|0|||
129679223|NCT01035138|466785323|FG002|Overall Study|Withdrawal by Subject|0|||
129679224|NCT01035138|466785321|FG000|Overall Study|Physician Decision|0|||
129679225|NCT01035138|466785322|FG001|Overall Study|Physician Decision|0|||
129679226|NCT01035138|466785323|FG002|Overall Study|Physician Decision|1|||
129679227|NCT01035138|466785321|FG000|Overall Study|Sponsor Decision|66|||
129679228|NCT01035138|466785322|FG001|Overall Study|Sponsor Decision|60|||
129679229|NCT01035138|466785323|FG002|Overall Study|Sponsor Decision|42|||
129679230|NCT01035138|466785321|FG000|Overall Study|Lost to Follow-up|0|||
129679231|NCT01035138|466785322|FG001|Overall Study|Lost to Follow-up|0|||
129679232|NCT01035138|466785323|FG002|Overall Study|Lost to Follow-up|1|||
129679233|NCT02916927|466785324|FG000|Overall Study|Discharged prior to study drug receipt|0|||
129679234|NCT02916927|466785325|FG001|Overall Study|Discharged prior to study drug receipt|2|||
129679235|NCT02916927|466785324|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
129679236|NCT02916927|466785325|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
129679237|NCT02916927|466785324|FG000|Overall Study|Withdrawal before first time point|1|||
129679238|NCT02916927|466785325|FG001|Overall Study|Withdrawal before first time point|0|||
129679239|NCT00655889|466785326|FG000|Overall Study|Inadequate cell growth|1|||
129679240|NCT00655889|466785326|FG000|Overall Study|Protocol Violation|1|||
129679241|NCT04585893|466785329|FG000|Overall Study|Death|1|||
129679242|NCT04585893|466785330|FG001|Overall Study|Death|0|||
129679243|NCT01366092|466785331|FG000|Overall Study|Progressive cGVHD|2|||
129679244|NCT01366092|466785331|FG000|Overall Study|Physician Decision|1|||
129679245|NCT01366092|466785331|FG000|Overall Study|Withdrawal by Subject|1|||
129679246|NCT03608163|466785332|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
129679247|NCT03608163|466785333|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
129679248|NCT05399680|466786713|FG000|Overall Study|Lost to Follow-up|1|||
129679249|NCT05399680|466786714|FG001|Overall Study|Lost to Follow-up|0|||
129679250|NCT05399680|466786713|FG000|Overall Study|Death|0|||
129679251|NCT05399680|466786714|FG001|Overall Study|Death|1|||
129679252|NCT02659865|466786715|FG000|Period 1|Withdrawal by Subject|1|||
129679253|NCT02659865|466786716|FG001|Period 1|Withdrawal by Subject|0|||
129679254|NCT02659865|466786717|FG002|Period 1|Withdrawal by Subject|0|||
129679255|NCT02659865|466786718|FG003|Period 1|Withdrawal by Subject|0|||
129679256|NCT02659865|466786719|FG004|Period 1|Withdrawal by Subject|0|||
129679257|NCT02659865|466786715|FG000|Period 1|Adverse Event|0|||
129548298|NCT00689273|466300584|FG001|Overall Study|Adverse Event|1|||
129548299|NCT00689273|466300583|FG000|Overall Study|Lack of Efficacy|3|||
129548300|NCT00689273|466300584|FG001|Overall Study|Lack of Efficacy|0|||
129548301|NCT00689273|466300583|FG000|Overall Study|Lost to Follow-up|0|||
129548302|NCT00689273|466300584|FG001|Overall Study|Lost to Follow-up|2|||
129548303|NCT00689273|466300583|FG000|Overall Study|Other|6|||
129548304|NCT00689273|466300584|FG001|Overall Study|Other|2|||
129548305|NCT00689273|466300583|FG000|Overall Study|Randomized but not Treated|1|||
129548306|NCT00689273|466300584|FG001|Overall Study|Randomized but not Treated|0|||
129548307|NCT01238172|466300586|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
129548308|NCT01238172|466300587|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
129548309|NCT01238172|466300586|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
129548310|NCT01238172|466300587|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
129548311|NCT02531698|466300590|FG000|Overall Study|Adverse Event|2|||
129548312|NCT02531698|466300591|FG001|Overall Study|Adverse Event|1|||
129548313|NCT02531698|466300590|FG000|Overall Study|Withdrawal by Subject|6|||
129548314|NCT02531698|466300591|FG001|Overall Study|Withdrawal by Subject|1|||
129548315|NCT02531698|466300590|FG000|Overall Study|Protocol Violation|2|||
129548316|NCT02531698|466300591|FG001|Overall Study|Protocol Violation|0|||
129548317|NCT02531698|466300590|FG000|Overall Study|Lost to Follow-up|1|||
129548318|NCT02531698|466300591|FG001|Overall Study|Lost to Follow-up|0|||
129548319|NCT02395536|466300592|FG000|Overall Study|Lost to Follow-up|4|||
129548320|NCT02395536|466300593|FG001|Overall Study|Lost to Follow-up|4|||
129548321|NCT02395536|466300592|FG000|Overall Study|Death|2|||
129548322|NCT02395536|466300593|FG001|Overall Study|Death|0|||
129548323|NCT02395536|466300592|FG000|Overall Study|Physician Decision|4|||
129679258|NCT02659865|466786716|FG001|Period 1|Adverse Event|0|||
129548324|NCT02395536|466300593|FG001|Overall Study|Physician Decision|6|||
129548325|NCT02395536|466300592|FG000|Overall Study|Withdrawal by Subject|9|||
129548326|NCT02395536|466300593|FG001|Overall Study|Withdrawal by Subject|17|||
129548327|NCT02395536|466300592|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
129548328|NCT02395536|466300593|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
129548329|NCT02395536|466300592|FG000|Overall Study|Insurance issue|0|||
129548330|NCT02395536|466300593|FG001|Overall Study|Insurance issue|1|||
129548331|NCT02038959|466302646|FG000|Overall Study|Withdrawal by Subject|6|||
129548332|NCT02038959|466302647|FG001|Overall Study|Withdrawal by Subject|8|||
129548333|NCT01788163|466302655|FG000|Overall Study|Other|53|||
129548334|NCT01788163|466302656|FG001|Overall Study|Other|0|||
129548335|NCT01788163|466302657|FG002|Overall Study|Other|0|||
129548336|NCT01788163|466302658|FG003|Overall Study|Other|0|||
129548337|NCT01788163|466302659|FG004|Overall Study|Other|0|||
129548338|NCT01788163|466302660|FG005|Overall Study|Other|7|||
129548339|NCT01788163|466302661|FG006|Overall Study|Other|1|||
129548340|NCT01788163|466302662|FG007|Overall Study|Other|48|||
129548341|NCT01788163|466302663|FG008|Overall Study|Other|15|||
129548342|NCT01788163|466302655|FG000|Overall Study|Withdrawal by Subject|2|||
129548343|NCT01788163|466302656|FG001|Overall Study|Withdrawal by Subject|0|||
129548344|NCT01788163|466302657|FG002|Overall Study|Withdrawal by Subject|0|||
129548345|NCT01788163|466302658|FG003|Overall Study|Withdrawal by Subject|0|||
129548346|NCT01788163|466302659|FG004|Overall Study|Withdrawal by Subject|0|||
129548347|NCT01788163|466302660|FG005|Overall Study|Withdrawal by Subject|0|||
129548348|NCT01788163|466302661|FG006|Overall Study|Withdrawal by Subject|0|||
129548349|NCT01788163|466302662|FG007|Overall Study|Withdrawal by Subject|0|||
129548350|NCT01788163|466302663|FG008|Overall Study|Withdrawal by Subject|1|||
129548351|NCT00545441|466302664|FG000|Overall Study|Fistula draining at 6 months|2|||
129548352|NCT00545441|466302665|FG001|Overall Study|Fistula draining at 6 months|4|||
129548353|NCT00545441|466302664|FG000|Overall Study|Lost to Follow-up|9|||
129679259|NCT02659865|466786717|FG002|Period 1|Adverse Event|0|||
129679260|NCT02659865|466786718|FG003|Period 1|Adverse Event|0|||
129679261|NCT02659865|466786719|FG004|Period 1|Adverse Event|1|||
129679262|NCT01288430|466786721|FG000|Part 1|Progressive disease|2|||
129679263|NCT01288430|466786722|FG001|Part 1|Progressive disease|1|||
129679264|NCT01288430|466786723|FG002|Part 1|Progressive disease|1|||
129679265|NCT01288430|466786724|FG003|Part 1|Progressive disease|6|||
129679266|NCT01288430|466786725|FG004|Part 1|Progressive disease|2|||
129679267|NCT01288430|466786726|FG005|Part 1|Progressive disease|4|||
129679268|NCT01288430|466786727|FG006|Part 1|Progressive disease|2|||
129679269|NCT01288430|466786728|FG007|Part 1|Progressive disease|0|||
129679270|NCT01288430|466786729|FG008|Part 1|Progressive disease|0|||
129679271|NCT01288430|466786730|FG009|Part 1|Progressive disease|0|||
129679272|NCT01288430|466786721|FG000|Part 1|Clinical disease progression|0|||
129679273|NCT01288430|466786722|FG001|Part 1|Clinical disease progression|0|||
129679274|NCT01288430|466786723|FG002|Part 1|Clinical disease progression|1|||
129679275|NCT01288430|466786724|FG003|Part 1|Clinical disease progression|0|||
129679276|NCT01288430|466786725|FG004|Part 1|Clinical disease progression|0|||
129679277|NCT01288430|466786726|FG005|Part 1|Clinical disease progression|2|||
129769325|NCT04163341|467121516|FG001|Overall Study|Withdrawal by Subject|0|||
129769326|NCT04163341|467121515|FG000|Overall Study|Lost to Follow-up|3|||
129769327|NCT04163341|467121516|FG001|Overall Study|Lost to Follow-up|4|||
129769328|NCT02855125|467121517|FG000|Overall Study|Withdrawal by Subject|2|||
129769329|NCT02855125|467121518|FG001|Overall Study|Withdrawal by Subject|2|||
129769330|NCT02855125|467121517|FG000|Overall Study|Clinical Disease Progression|5|||
129769331|NCT02855125|467121518|FG001|Overall Study|Clinical Disease Progression|4|||
129769332|NCT02855125|467121517|FG000|Overall Study|Radiologic Disease Progression|36|||
129769333|NCT02855125|467121518|FG001|Overall Study|Radiologic Disease Progression|39|||
129769334|NCT02855125|467121517|FG000|Overall Study|Adverse Event|11|||
129769335|NCT02855125|467121518|FG001|Overall Study|Adverse Event|7|||
129769336|NCT02855125|467121517|FG000|Overall Study|Physician Decision|1|||
129769337|NCT02855125|467121518|FG001|Overall Study|Physician Decision|0|||
129769338|NCT02855125|467121517|FG000|Overall Study|On Treatment|9|||
129769339|NCT02855125|467121518|FG001|Overall Study|On Treatment|11|||
129769340|NCT02855125|467121517|FG000|Overall Study|Randomized but not treated|0|||
129769341|NCT02855125|467121518|FG001|Overall Study|Randomized but not treated|1|||
129769342|NCT04467905|467121519|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
129769343|NCT04467905|467121520|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
129769344|NCT04467905|467121521|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
129769345|NCT04467905|467121519|FG000|Overall Study|Conversion to SR|0|||
129769346|NCT04467905|467121520|FG001|Overall Study|Conversion to SR|0|||
129769347|NCT04467905|467121521|FG002|Overall Study|Conversion to SR|3|||
129769348|NCT04467905|467121519|FG000|Overall Study|Technical issue with Holter ECG|0|||
129769349|NCT04467905|467121520|FG001|Overall Study|Technical issue with Holter ECG|0|||
129769350|NCT04467905|467121521|FG002|Overall Study|Technical issue with Holter ECG|3|||
129769351|NCT04467905|467121519|FG000|Overall Study|Hemodynamic instability|0|||
129769352|NCT04467905|467121520|FG001|Overall Study|Hemodynamic instability|0|||
129769353|NCT04467905|467121521|FG002|Overall Study|Hemodynamic instability|1|||
129769354|NCT04467905|467121519|FG000|Overall Study|Site misinterpretation of protocol|0|||
129769355|NCT04467905|467121520|FG001|Overall Study|Site misinterpretation of protocol|0|||
129769356|NCT04467905|467121521|FG002|Overall Study|Site misinterpretation of protocol|1|||
129769357|NCT04586205|467121526|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
129769358|NCT04586205|467121527|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
129769359|NCT01586364|467123441|FG000|Overall Study|Withdrawal by Subject|40|||
129769360|NCT01586364|467123441|FG000|Overall Study|Adverse Event|37|||
129769361|NCT01586364|467123441|FG000|Overall Study|Lost to Follow-up|17|||
129769362|NCT01586364|467123441|FG000|Overall Study|Protocol Violation|16|||
129769363|NCT01586364|467123441|FG000|Overall Study|Lack of Efficacy|1|||
129769364|NCT01586364|467123441|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
129769365|NCT01586364|467123441|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
129769366|NCT01586364|467123441|FG000|Overall Study|Other-Site closure due to PI illness|1|||
129769367|NCT01586364|467123441|FG000|Overall Study|Other-PI discretion, site closing|2|||
129769368|NCT01586364|467123441|FG000|Overall Study|Other-Not specified|1|||
129769369|NCT02121535|467123442|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
129769370|NCT02121535|467123443|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
129769371|NCT02121535|467123442|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
129769372|NCT02121535|467123443|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
129769373|NCT00091949|467123444|FG000|Overall Study|Withdrawal by Subject|117|||
129769374|NCT00091949|467123445|FG001|Overall Study|Withdrawal by Subject|110|||
129769375|NCT00091949|467123444|FG000|Overall Study|Lost to Follow-up|58|||
129769376|NCT00091949|467123445|FG001|Overall Study|Lost to Follow-up|41|||
129769377|NCT02083354|467123446|FG000|Overall Study|Withdrawal by Subject|9|||
129769378|NCT02083354|467123446|FG000|Overall Study|Lost to Follow-up|1|||
129769379|NCT02083354|467123446|FG000|Overall Study|Adverse Event|3|||
129769380|NCT02083354|467123446|FG000|Overall Study|Disease progression|46|||
129769381|NCT02083354|467123446|FG000|Overall Study|Study closed/terminated|5|||
129769382|NCT04328077|467123447|FG000|Overall Study|Lost to Follow-up|0|||
129769383|NCT04328077|467123448|FG001|Overall Study|Lost to Follow-up|1|||
129548354|NCT00545441|466302665|FG001|Overall Study|Lost to Follow-up|5|||
129679278|NCT01288430|466786727|FG006|Part 1|Clinical disease progression|2|||
129679279|NCT01288430|466786728|FG007|Part 1|Clinical disease progression|0|||
129679280|NCT01288430|466786729|FG008|Part 1|Clinical disease progression|0|||
129679281|NCT01288430|466786730|FG009|Part 1|Clinical disease progression|0|||
129679282|NCT01288430|466786721|FG000|Part 1|Death due to disease progression|0|||
129679283|NCT01288430|466786722|FG001|Part 1|Death due to disease progression|0|||
129679284|NCT01288430|466786723|FG002|Part 1|Death due to disease progression|0|||
129679285|NCT01288430|466786724|FG003|Part 1|Death due to disease progression|0|||
129679286|NCT01288430|466786725|FG004|Part 1|Death due to disease progression|1|||
129679287|NCT01288430|466786726|FG005|Part 1|Death due to disease progression|0|||
129679288|NCT01288430|466786727|FG006|Part 1|Death due to disease progression|0|||
129679289|NCT01288430|466786728|FG007|Part 1|Death due to disease progression|0|||
129679290|NCT01288430|466786729|FG008|Part 1|Death due to disease progression|0|||
129679291|NCT01288430|466786730|FG009|Part 1|Death due to disease progression|0|||
129679292|NCT01288430|466786721|FG000|Part 1|Adverse Event|0|||
129679293|NCT01288430|466786722|FG001|Part 1|Adverse Event|0|||
129679294|NCT01288430|466786723|FG002|Part 1|Adverse Event|3|||
129679295|NCT01288430|466786724|FG003|Part 1|Adverse Event|1|||
129679296|NCT01288430|466786725|FG004|Part 1|Adverse Event|0|||
129679297|NCT01288430|466786726|FG005|Part 1|Adverse Event|0|||
129679298|NCT01288430|466786727|FG006|Part 1|Adverse Event|2|||
129679299|NCT01288430|466786728|FG007|Part 1|Adverse Event|0|||
129679300|NCT01288430|466786729|FG008|Part 1|Adverse Event|0|||
129679301|NCT01288430|466786730|FG009|Part 1|Adverse Event|0|||
129679302|NCT01288430|466786721|FG000|Part 1|Other|0|||
129679303|NCT01288430|466786722|FG001|Part 1|Other|2|||
129679304|NCT01288430|466786723|FG002|Part 1|Other|0|||
129679305|NCT01288430|466786724|FG003|Part 1|Other|0|||
129679306|NCT01288430|466786725|FG004|Part 1|Other|0|||
129679307|NCT01288430|466786726|FG005|Part 1|Other|0|||
129679308|NCT01288430|466786727|FG006|Part 1|Other|1|||
129679309|NCT01288430|466786728|FG007|Part 1|Other|0|||
129679310|NCT01288430|466786729|FG008|Part 1|Other|0|||
129769384|NCT04328077|467123449|FG002|Overall Study|Lost to Follow-up|0|||
129769385|NCT04328077|467123450|FG003|Overall Study|Lost to Follow-up|0|||
129769386|NCT04328077|467123447|FG000|Overall Study|Withdrawal by Subject|0|||
129769387|NCT04328077|467123448|FG001|Overall Study|Withdrawal by Subject|1|||
129769388|NCT04328077|467123449|FG002|Overall Study|Withdrawal by Subject|1|||
129769389|NCT04328077|467123450|FG003|Overall Study|Withdrawal by Subject|3|||
129769390|NCT02419001|467123461|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
129548355|NCT00545441|466302664|FG000|Overall Study|Technical failure|0|||
129679311|NCT01288430|466786730|FG009|Part 1|Other|0|||
129679312|NCT01288430|466786721|FG000|Part 2|Progressive disease|0|||
129679313|NCT01288430|466786722|FG001|Part 2|Progressive disease|0|||
129679314|NCT01288430|466786723|FG002|Part 2|Progressive disease|0|||
129679315|NCT01288430|466786724|FG003|Part 2|Progressive disease|0|||
129679316|NCT01288430|466786725|FG004|Part 2|Progressive disease|0|||
129679317|NCT01288430|466786726|FG005|Part 2|Progressive disease|0|||
129679318|NCT01288430|466786727|FG006|Part 2|Progressive disease|0|||
129679319|NCT01288430|466786728|FG007|Part 2|Progressive disease|8|||
129679320|NCT01288430|466786729|FG008|Part 2|Progressive disease|7|||
129679321|NCT01288430|466786730|FG009|Part 2|Progressive disease|2|||
129679322|NCT01288430|466786721|FG000|Part 2|Clinical disease progression|0|||
129679323|NCT01288430|466786722|FG001|Part 2|Clinical disease progression|0|||
129679324|NCT01288430|466786723|FG002|Part 2|Clinical disease progression|0|||
129679325|NCT01288430|466786724|FG003|Part 2|Clinical disease progression|0|||
129679326|NCT01288430|466786725|FG004|Part 2|Clinical disease progression|0|||
129679327|NCT01288430|466786726|FG005|Part 2|Clinical disease progression|0|||
129679328|NCT01288430|466786727|FG006|Part 2|Clinical disease progression|0|||
129679329|NCT01288430|466786728|FG007|Part 2|Clinical disease progression|2|||
129679330|NCT01288430|466786729|FG008|Part 2|Clinical disease progression|0|||
129679331|NCT01288430|466786730|FG009|Part 2|Clinical disease progression|0|||
129679332|NCT01288430|466786721|FG000|Part 2|Withdrawal by Subject|0|||
129679333|NCT01288430|466786722|FG001|Part 2|Withdrawal by Subject|0|||
129679334|NCT01288430|466786723|FG002|Part 2|Withdrawal by Subject|0|||
129679335|NCT01288430|466786724|FG003|Part 2|Withdrawal by Subject|0|||
129679336|NCT01288430|466786725|FG004|Part 2|Withdrawal by Subject|0|||
129679337|NCT01288430|466786726|FG005|Part 2|Withdrawal by Subject|0|||
129679338|NCT01288430|466786727|FG006|Part 2|Withdrawal by Subject|0|||
129679339|NCT01288430|466786728|FG007|Part 2|Withdrawal by Subject|1|||
129679340|NCT01288430|466786729|FG008|Part 2|Withdrawal by Subject|4|||
129679341|NCT01288430|466786730|FG009|Part 2|Withdrawal by Subject|0|||
129679342|NCT01288430|466786721|FG000|Part 2|Adverse Event|0|||
129679343|NCT01288430|466786722|FG001|Part 2|Adverse Event|0|||
129679344|NCT01288430|466786723|FG002|Part 2|Adverse Event|0|||
129679345|NCT01288430|466786724|FG003|Part 2|Adverse Event|0|||
129679346|NCT01288430|466786725|FG004|Part 2|Adverse Event|0|||
129679347|NCT01288430|466786726|FG005|Part 2|Adverse Event|0|||
129679348|NCT01288430|466786727|FG006|Part 2|Adverse Event|0|||
129679349|NCT01288430|466786728|FG007|Part 2|Adverse Event|1|||
129679350|NCT01288430|466786729|FG008|Part 2|Adverse Event|1|||
129679351|NCT01288430|466786730|FG009|Part 2|Adverse Event|0|||
129679352|NCT01288430|466786721|FG000|Part 2|Other|0|||
129679353|NCT01288430|466786722|FG001|Part 2|Other|0|||
129769391|NCT02419001|467123462|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
129769392|NCT00313014|467123463|FG000|Overall Study|Withdrawal by Subject|11|||
129769393|NCT00313014|467123464|FG001|Overall Study|Withdrawal by Subject|7|||
129769394|NCT00313014|467123465|FG002|Overall Study|Withdrawal by Subject|5|||
129769395|NCT00313014|467123463|FG000|Overall Study|Adverse Event|14|||
129769396|NCT00313014|467123464|FG001|Overall Study|Adverse Event|29|||
129769397|NCT00313014|467123465|FG002|Overall Study|Adverse Event|16|||
129769398|NCT00313014|467123463|FG000|Overall Study|Lost to Follow-up|7|||
129769399|NCT00313014|467123464|FG001|Overall Study|Lost to Follow-up|6|||
129769400|NCT00313014|467123465|FG002|Overall Study|Lost to Follow-up|10|||
129769401|NCT00313014|467123463|FG000|Overall Study|Administrative|9|||
129769402|NCT00313014|467123464|FG001|Overall Study|Administrative|6|||
129769403|NCT00313014|467123465|FG002|Overall Study|Administrative|14|||
129769404|NCT00313014|467123463|FG000|Overall Study|Lack of Efficacy|52|||
129769405|NCT00313014|467123464|FG001|Overall Study|Lack of Efficacy|25|||
129769406|NCT00313014|467123465|FG002|Overall Study|Lack of Efficacy|16|||
129769407|NCT01198795|467123468|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
129769408|NCT01198795|467123468|FG000|Overall Study|Withdrawal by Subject|17|||
129769409|NCT01198795|467123468|FG000|Overall Study|Lost to Follow-up|15|||
129769410|NCT01198795|467123468|FG000|Overall Study|Adverse Event|9|||
129769411|NCT01198795|467123468|FG000|Overall Study|Lack of Efficacy|5|||
129769412|NCT01198795|467123468|FG000|Overall Study|Protocol Violation|2|||
129769413|NCT01198795|467123468|FG000|Overall Study|Other Reason|4|||
129769414|NCT00744497|467123469|FG000|Overall Study|Withdrawal by Subject|21|||
129769415|NCT00744497|467123470|FG001|Overall Study|Withdrawal by Subject|18|||
129769416|NCT00744497|467123469|FG000|Overall Study|Death|11|||
129769417|NCT00744497|467123470|FG001|Overall Study|Death|9|||
129769418|NCT00744497|467123469|FG000|Overall Study|Lost to Follow-up|4|||
129769419|NCT00744497|467123470|FG001|Overall Study|Lost to Follow-up|2|||
129769420|NCT00744497|467123469|FG000|Overall Study|Poor compliance/noncompliance|9|||
129769421|NCT00744497|467123470|FG001|Overall Study|Poor compliance/noncompliance|5|||
129769422|NCT00744497|467123469|FG000|Overall Study|No longer meets study criteria|7|||
129769423|NCT00744497|467123470|FG001|Overall Study|No longer meets study criteria|3|||
129769424|NCT00744497|467123469|FG000|Overall Study|Administrative Reason By Sponsor|25|||
129769425|NCT00744497|467123470|FG001|Overall Study|Administrative Reason By Sponsor|8|||
129769426|NCT00744497|467123469|FG000|Overall Study|Disease progression|312|||
129769427|NCT00744497|467123470|FG001|Overall Study|Disease progression|219|||
129769428|NCT00744497|467123469|FG000|Overall Study|Study drug toxicity|68|||
129769429|NCT00744497|467123470|FG001|Overall Study|Study drug toxicity|141|||
129769430|NCT00744497|467123469|FG000|Overall Study|Adverse event unrelated to study drug|78|||
129769431|NCT00744497|467123470|FG001|Overall Study|Adverse event unrelated to study drug|122|||
129769432|NCT00744497|467123469|FG000|Overall Study|Patient requested to stop study drug|65|||
129769433|NCT00744497|467123470|FG001|Overall Study|Patient requested to stop study drug|80|||
129769434|NCT00744497|467123469|FG000|Overall Study|Maximum clinical benefit|141|||
129769435|NCT00744497|467123470|FG001|Overall Study|Maximum clinical benefit|142|||
129769436|NCT00744497|467123469|FG000|Overall Study|Not defined|19|||
129769437|NCT00744497|467123470|FG001|Overall Study|Not defined|13|||
129769438|NCT03819114|467123505|FG000|Overall Study|Protocol Violation|0|||
129769439|NCT03819114|467123506|FG001|Overall Study|Protocol Violation|1|||
129769440|NCT03819114|467123507|FG002|Overall Study|Protocol Violation|1|||
129769441|NCT03819114|467123508|FG003|Overall Study|Protocol Violation|0|||
129769442|NCT03819114|467123505|FG000|Overall Study|Lost to Follow-up|0|||
129769443|NCT03819114|467123506|FG001|Overall Study|Lost to Follow-up|0|||
129769444|NCT03819114|467123507|FG002|Overall Study|Lost to Follow-up|1|||
129769445|NCT03819114|467123508|FG003|Overall Study|Lost to Follow-up|0|||
129679354|NCT01288430|466786723|FG002|Part 2|Other|0|||
129679355|NCT01288430|466786724|FG003|Part 2|Other|0|||
129679356|NCT01288430|466786725|FG004|Part 2|Other|0|||
129679357|NCT01288430|466786726|FG005|Part 2|Other|0|||
129679358|NCT01288430|466786727|FG006|Part 2|Other|0|||
129679359|NCT01288430|466786728|FG007|Part 2|Other|0|||
129679360|NCT01288430|466786729|FG008|Part 2|Other|0|||
129679361|NCT01288430|466786730|FG009|Part 2|Other|1|||
129679362|NCT03836053|466786736|FG000|Overall Study|Protocol-specified criteria|0|||
129679363|NCT03836053|466786737|FG001|Overall Study|Protocol-specified criteria|2|||
129679364|NCT03836053|466786738|FG002|Overall Study|Protocol-specified criteria|1|||
129769446|NCT01744977|467123509|FG000|Overall Study|Withdrawal by Subject|1|||
129769447|NCT01744977|467123510|FG001|Overall Study|Withdrawal by Subject|2|||
129769448|NCT01744977|467123509|FG000|Overall Study|Death|2|||
129769449|NCT01744977|467123510|FG001|Overall Study|Death|3|||
129769450|NCT01744977|467123509|FG000|Overall Study|Lost to Follow-up|2|||
129769451|NCT01744977|467123510|FG001|Overall Study|Lost to Follow-up|0|||
129769452|NCT01744977|467123509|FG000|Overall Study|No longer meets inclusion|6|||
129769453|NCT01744977|467123510|FG001|Overall Study|No longer meets inclusion|0|||
129769454|NCT04225897|467123518|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129884423|NCT04012814|467536391|FG000|Overall Study|Adverse Event|1|||
129769455|NCT04225897|467123519|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
129769456|NCT04225897|467123520|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769457|NCT04225897|467123521|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769458|NCT04225897|467123522|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769459|NCT04225897|467123523|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769460|NCT04225897|467123524|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769461|NCT04225897|467123525|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769462|NCT04225897|467123526|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769463|NCT04225897|467123527|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769464|NCT04225897|467123528|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769465|NCT04225897|467123529|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
129769466|NCT04225897|467123518|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769467|NCT04225897|467123519|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769468|NCT04225897|467123520|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
129769469|NCT04225897|467123521|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769470|NCT04225897|467123522|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769471|NCT04225897|467123523|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769472|NCT04225897|467123524|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769473|NCT04225897|467123525|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769474|NCT04225897|467123526|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769475|NCT04225897|467123527|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769476|NCT04225897|467123528|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769477|NCT04225897|467123529|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
129769478|NCT04225897|467123518|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769479|NCT04225897|467123519|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769480|NCT04225897|467123520|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
129769481|NCT04225897|467123521|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769482|NCT04225897|467123522|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769483|NCT04225897|467123523|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769484|NCT04225897|467123524|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769485|NCT04225897|467123525|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769486|NCT04225897|467123526|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769487|NCT04225897|467123527|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769488|NCT04225897|467123528|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769489|NCT04225897|467123529|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
129769490|NCT04225897|467123518|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769491|NCT04225897|467123519|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769492|NCT04225897|467123520|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769493|NCT04225897|467123521|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769494|NCT04225897|467123522|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769495|NCT04225897|467123523|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769496|NCT04225897|467123524|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769497|NCT04225897|467123525|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
129769498|NCT04225897|467123526|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769499|NCT04225897|467123527|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769500|NCT04225897|467123528|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769501|NCT04225897|467123529|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
129769502|NCT02703597|467123530|FG000|Assignment to Baseline|Lost to Follow-up|17|||
129769503|NCT02703597|467123531|FG001|Assignment to Baseline|Lost to Follow-up|16|||
129769504|NCT02703597|467123530|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
129769505|NCT02703597|467123531|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
129769506|NCT02703597|467123530|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
129769507|NCT02703597|467123531|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
129769508|NCT02703597|467123530|FG000|First Post-test to First Follow-up|Site drop out|0|||
129769509|NCT02703597|467123531|FG001|First Post-test to First Follow-up|Site drop out|58|||
129769510|NCT02703597|467123530|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
129769511|NCT02703597|467123531|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
129769512|NCT02703597|467123530|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
129769513|NCT02703597|467123531|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
129769514|NCT02703597|467123530|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
129769515|NCT02703597|467123531|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
129769516|NCT02131259|467123532|FG000|Overall Study|Progressive disease|751|||
129769517|NCT02131259|467123532|FG000|Overall Study|Adverse Event|341|||
129769518|NCT02131259|467123532|FG000|Overall Study|Lost to Follow-up|7|||
129769519|NCT02131259|467123532|FG000|Overall Study|Relocation|32|||
129679365|NCT03836053|466786736|FG000|Overall Study|Death|1|||
129679366|NCT03836053|466786737|FG001|Overall Study|Death|6|||
129679367|NCT03836053|466786738|FG002|Overall Study|Death|4|||
129679368|NCT03836053|466786736|FG000|Overall Study|Withdrawal of consent from study|0|||
129679369|NCT03836053|466786737|FG001|Overall Study|Withdrawal of consent from study|0|||
129679370|NCT03836053|466786738|FG002|Overall Study|Withdrawal of consent from study|1|||
129679371|NCT03836053|466786736|FG000|Overall Study|Decision by sponsor|0|||
129679372|NCT03836053|466786737|FG001|Overall Study|Decision by sponsor|2|||
129679373|NCT03836053|466786738|FG002|Overall Study|Decision by sponsor|4|||
129679374|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
129679375|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
129679376|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
129679377|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Death|1|||
129679378|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Death|1|||
129679379|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Death|0|||
129679380|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
129679381|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
129679382|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
129679383|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
129679384|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
129679385|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
129679386|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
129679387|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
129679388|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
129679389|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
129679390|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
129679391|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
129679392|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
129679393|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
129679394|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
129679395|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
129679396|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
129679397|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
129679398|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
129679399|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
129679400|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
129679401|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
129679402|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
129679403|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
129679404|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Other|10|||
129679405|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Other|4|||
129679406|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Other|0|||
129679407|NCT04006457|466786739|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
129679408|NCT04006457|466786740|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
129679409|NCT04006457|466786741|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
129679410|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
129679411|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
129679412|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
129679413|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
129679414|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
129679415|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
129679416|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
129679417|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
129679418|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
129679419|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
129679420|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
129679421|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
129679422|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
129679423|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
129679424|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
129679425|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Other|2|||
129679426|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Other|3|||
129679427|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Other|0|||
129707558|NCT01076010|466892040|FG002|Overall Study|Death|0|||
129707559|NCT01076010|466892038|FG000|Overall Study|Adverse Event|7|||
129769520|NCT02131259|467123532|FG000|Overall Study|Other|63|||
129769521|NCT02131259|467123532|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
129769522|NCT02131259|467123532|FG000|Overall Study|Progressive disease/relocation|1|||
129769523|NCT02131259|467123532|FG000|Overall Study|Progressive disease/other|2|||
129769524|NCT02131259|467123532|FG000|Overall Study|AE/lost to follow-up|1|||
129769525|NCT02131259|467123532|FG000|Overall Study|AE/other|1|||
129769526|NCT02131259|467123532|FG000|Overall Study|Progressive disease/AE/other|1|||
129769527|NCT02131259|467123532|FG000|Overall Study|Missing|3|||
129769528|NCT02796170|467123533|FG000|Overall Study|Lost to Follow-up|3|||
129769529|NCT02796170|467123534|FG001|Overall Study|Lost to Follow-up|0|||
129769530|NCT03818321|467123537|FG000|Overall Study|Withdrawal by Subject|1|||
129769531|NCT03818321|467123538|FG001|Overall Study|Withdrawal by Subject|2|||
129769532|NCT01867671|467123539|FG000|Overall Study|Adverse Event|5|||
129769533|NCT01867671|467123540|FG001|Overall Study|Adverse Event|3|||
129769534|NCT01867671|467123539|FG000|Overall Study|Anaphylaxis|0|||
129769535|NCT01867671|467123540|FG001|Overall Study|Anaphylaxis|1|||
129769536|NCT01867671|467123539|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
129769537|NCT01867671|467123540|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
129769538|NCT01867671|467123539|FG000|Overall Study|Lost to Follow-up|0|||
129769539|NCT01867671|467123540|FG001|Overall Study|Lost to Follow-up|1|||
129769540|NCT01867671|467123539|FG000|Overall Study|Non-compliance with Study Drug|1|||
129769541|NCT01867671|467123540|FG001|Overall Study|Non-compliance with Study Drug|2|||
129769542|NCT01867671|467123539|FG000|Overall Study|Withdrawal by Subject|21|||
129769543|NCT01867671|467123540|FG001|Overall Study|Withdrawal by Subject|21|||
129769544|NCT01523366|467123541|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129769545|NCT01523366|467123542|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129769546|NCT01523366|467123541|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
129769547|NCT01523366|467123542|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
129769548|NCT04543279|467123547|FG000|Overall Study|Withdrawal by Subject|1|||
129769549|NCT04543279|467123548|FG001|Overall Study|Withdrawal by Subject|0|||
129769550|NCT04543279|467123547|FG000|Overall Study|Adverse Event|1|||
129769551|NCT04543279|467123548|FG001|Overall Study|Adverse Event|0|||
129769552|NCT04543279|467123547|FG000|Overall Study|Physician Decision|1|||
129769553|NCT04543279|467123548|FG001|Overall Study|Physician Decision|0|||
129769554|NCT05249582|467123552|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
129769555|NCT05249582|467123553|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
129769556|NCT05249582|467123552|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
129769557|NCT05249582|467123553|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
129769558|NCT05249582|467123552|FG000|Overall Study|Declined to use virtual reality headset|1|||
129769559|NCT05249582|467123553|FG001|Overall Study|Declined to use virtual reality headset|0|||
129769560|NCT03675126|467123554|FG000|Overall Study|Study Terminated by Sponsor|9|||
129769561|NCT03675126|467123554|FG000|Overall Study|Death|2|||
129769562|NCT03675126|467123554|FG000|Overall Study|Withdrawal by Subject|4|||
129769563|NCT00001959|467123555|FG000|Overall Study|newly diagnosed colon cancer|1|||
129769564|NCT00001959|467123555|FG000|Overall Study|disabling sedation|1|||
129769565|NCT00001959|467123555|FG000|Overall Study|non-compliance|1|||
129769566|NCT04189952|467123557|FG000|Follow-up Period|Death|1|||
129769567|NCT04189952|467123557|FG000|Follow-up Period|Withdrawal by Subject|1|||
129769568|NCT01052493|467123558|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
129769569|NCT01052493|467123559|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
129769570|NCT01052493|467123560|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
129769571|NCT00283296|467123562|FG000|Overall Study|in-home trial not completed|5|||
129769572|NCT02158442|467123565|FG000|Overall Study|Withdrawal by Subject|1|||
129769573|NCT02158442|467123566|FG001|Overall Study|Withdrawal by Subject|0|||
129769574|NCT02158442|467123565|FG000|Overall Study|Perfusion staff not available|1|||
129769575|NCT02158442|467123566|FG001|Overall Study|Perfusion staff not available|0|||
129769576|NCT00632229|467123574|FG000|Overall Study|Adverse Event|6|||
129769577|NCT00632229|467123575|FG001|Overall Study|Adverse Event|0|||
129769578|NCT00632229|467123574|FG000|Overall Study|Lost to Follow-up|0|||
129769579|NCT00632229|467123575|FG001|Overall Study|Lost to Follow-up|3|||
129769580|NCT00632229|467123574|FG000|Overall Study|Lack of Efficacy|0|||
129769581|NCT00632229|467123575|FG001|Overall Study|Lack of Efficacy|2|||
129769582|NCT00632229|467123574|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
129769583|NCT00632229|467123575|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
129769584|NCT00474812|467123582|FG000|Overall Study|Withdrawal by Subject|5|||
129769585|NCT00474812|467123582|FG000|Overall Study|No Initiation of treatment|2|||
129769586|NCT00737672|467123589|FG000|Overall Study|Graft Abandonment|48|||
129769587|NCT00737672|467123590|FG001|Overall Study|Graft Abandonment|56|||
129769588|NCT00737672|467123589|FG000|Overall Study|Death|23|||
129769589|NCT00737672|467123590|FG001|Overall Study|Death|22|||
129769590|NCT00737672|467123589|FG000|Overall Study|Withdrawal by Subject|1|||
129769591|NCT00737672|467123590|FG001|Overall Study|Withdrawal by Subject|2|||
129769592|NCT00737672|467123589|FG000|Overall Study|Lost to Follow-up|1|||
129769593|NCT00737672|467123590|FG001|Overall Study|Lost to Follow-up|0|||
129769594|NCT00737672|467123589|FG000|Overall Study|Miscellaneous|7|||
129769595|NCT00737672|467123590|FG001|Overall Study|Miscellaneous|1|||
129769596|NCT00737672|467123589|FG000|Overall Study|Physician Decision|0|||
129769597|NCT00737672|467123590|FG001|Overall Study|Physician Decision|2|||
129769598|NCT02694185|467123592|FG000|Overall Study|Withdrawal by Subject|45|||
129769599|NCT02694185|467123593|FG001|Overall Study|Withdrawal by Subject|0|||
129769600|NCT04363320|467123594|FG000|Overall Study|Lost to Follow-up|43|||
129769601|NCT04363320|467123595|FG001|Overall Study|Lost to Follow-up|42|||
129769602|NCT04363320|467123596|FG002|Overall Study|Lost to Follow-up|24|||
129769603|NCT04363320|467123597|FG003|Overall Study|Lost to Follow-up|29|||
129769604|NCT04363320|467123594|FG000|Overall Study|Death|0|||
129769605|NCT04363320|467123595|FG001|Overall Study|Death|0|||
129769606|NCT04363320|467123596|FG002|Overall Study|Death|1|||
129769607|NCT04363320|467123597|FG003|Overall Study|Death|0|||
129769608|NCT05632211|467123598|FG000|Overall Study|Withdrawal by Subject|2|||
129769609|NCT05632211|467123599|FG001|Overall Study|Withdrawal by Subject|0|||
129769610|NCT05632211|467123600|FG002|Overall Study|Withdrawal by Subject|2|||
129769611|NCT05632211|467123598|FG000|Overall Study|Other reasons|1|||
129769612|NCT05632211|467123599|FG001|Overall Study|Other reasons|1|||
129769613|NCT05632211|467123600|FG002|Overall Study|Other reasons|1|||
129769614|NCT04123470|467123601|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
129769615|NCT04123470|467123602|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
129769616|NCT04123470|467123601|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
129769617|NCT04123470|467123602|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
129769618|NCT04123470|467123601|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
129769619|NCT04123470|467123602|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
129769620|NCT04123470|467123601|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
129769621|NCT04123470|467123602|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
129769622|NCT05408429|467123614|FG000|Overall Study|Lost to Follow-up|1|||
129769623|NCT05408429|467123615|FG001|Overall Study|Lost to Follow-up|1|||
129769624|NCT05408429|467123616|FG002|Overall Study|Lost to Follow-up|0|||
129769625|NCT05408429|467123614|FG000|Overall Study|Withdrawal by Subject|5|||
129769626|NCT05408429|467123615|FG001|Overall Study|Withdrawal by Subject|0|||
129769627|NCT05408429|467123616|FG002|Overall Study|Withdrawal by Subject|1|||
129769628|NCT05972993|467123618|FG000|Overall Study|Lost to Follow-up|2|||
129769629|NCT05972993|467123619|FG001|Overall Study|Lost to Follow-up|0|||
129769630|NCT05972993|467123620|FG002|Overall Study|Lost to Follow-up|1|||
129769631|NCT05972993|467123621|FG003|Overall Study|Lost to Follow-up|0|||
129769632|NCT05972993|467123622|FG004|Overall Study|Lost to Follow-up|0|||
129769633|NCT05972993|467123623|FG005|Overall Study|Lost to Follow-up|0|||
129769634|NCT05972993|467123624|FG006|Overall Study|Lost to Follow-up|0|||
129769635|NCT05972993|467123625|FG007|Overall Study|Lost to Follow-up|2|||
129769636|NCT05972993|467123626|FG008|Overall Study|Lost to Follow-up|0|||
129769637|NCT03818256|467123629|FG000|Overall Study|Withdrawal by Subject|2|||
129769638|NCT03818256|467123630|FG001|Overall Study|Withdrawal by Subject|2|||
129679428|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
129679429|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
129679430|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
129679431|NCT04006457|466786739|FG000|Main Study: Treatment Period 2|Ongoing|86|||
129679432|NCT04006457|466786740|FG001|Main Study: Treatment Period 2|Ongoing|96|||
129679433|NCT04006457|466786741|FG002|Main Study: Treatment Period 2|Ongoing|0|||
129679434|NCT04006457|466786739|FG000|Main Study Observation Period|Adverse Event|1|||
129679435|NCT04006457|466786740|FG001|Main Study Observation Period|Adverse Event|1|||
129679436|NCT04006457|466786741|FG002|Main Study Observation Period|Adverse Event|0|||
129679437|NCT04006457|466786739|FG000|Main Study Observation Period|Lost to Follow-up|0|||
129679438|NCT04006457|466786740|FG001|Main Study Observation Period|Lost to Follow-up|1|||
129679439|NCT04006457|466786741|FG002|Main Study Observation Period|Lost to Follow-up|0|||
129679440|NCT04006457|466786739|FG000|Main Study Observation Period|Pregnancy|1|||
129679441|NCT04006457|466786740|FG001|Main Study Observation Period|Pregnancy|0|||
129679442|NCT04006457|466786741|FG002|Main Study Observation Period|Pregnancy|0|||
129679443|NCT04006457|466786739|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
129679444|NCT04006457|466786740|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
129679445|NCT04006457|466786741|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
129679446|NCT04006457|466786739|FG000|Main Study Observation Period|Other|8|||
129679447|NCT04006457|466786740|FG001|Main Study Observation Period|Other|16|||
129679448|NCT04006457|466786741|FG002|Main Study Observation Period|Other|0|||
129679449|NCT04006457|466786739|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
129679450|NCT04006457|466786740|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
129679451|NCT04006457|466786741|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
129679452|NCT04006457|466786739|FG000|Main Study Observation Period|Ongoing|2|||
129679453|NCT04006457|466786740|FG001|Main Study Observation Period|Ongoing|1|||
129679454|NCT04006457|466786741|FG002|Main Study Observation Period|Ongoing|0|||
129679455|NCT04006457|466786739|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
129679456|NCT04006457|466786740|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
129679457|NCT04006457|466786741|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
129679458|NCT04486716|466786742|FG000|Core Phase|Subject decision|6|||
129679459|NCT04486716|466786742|FG000|Core Phase|Adverse Event|5|||
129679460|NCT04486716|466786742|FG000|Core Phase|Lost to Follow-up|1|||
129679461|NCT04486716|466786742|FG000|Core Phase|Physician Decision|1|||
129679462|NCT04486716|466786742|FG000|Core Phase|Enrolled subjects not treated|9|||
129679463|NCT02332707|466786743|FG000|Overall Study|Adverse Event|0|||
129679464|NCT02332707|466786744|FG001|Overall Study|Adverse Event|0|||
129679465|NCT02332707|466786745|FG002|Overall Study|Adverse Event|0|||
129679466|NCT02332707|466786746|FG003|Overall Study|Adverse Event|0|||
129679467|NCT02332707|466786747|FG004|Overall Study|Adverse Event|0|||
129679468|NCT02332707|466786748|FG005|Overall Study|Adverse Event|0|||
129679469|NCT02332707|466786749|FG006|Overall Study|Adverse Event|0|||
129679470|NCT02332707|466786750|FG007|Overall Study|Adverse Event|0|||
129679471|NCT02332707|466786751|FG008|Overall Study|Adverse Event|0|||
129679472|NCT02332707|466786752|FG009|Overall Study|Adverse Event|0|||
129679473|NCT02332707|466786753|FG010|Overall Study|Adverse Event|0|||
129679474|NCT02332707|466786754|FG011|Overall Study|Adverse Event|0|||
129679475|NCT02332707|466786755|FG012|Overall Study|Adverse Event|1|||
129679476|NCT02332707|466786756|FG013|Overall Study|Adverse Event|0|||
129679477|NCT02332707|466786757|FG014|Overall Study|Adverse Event|0|||
129679478|NCT02332707|466786758|FG015|Overall Study|Adverse Event|0|||
129679479|NCT02332707|466786759|FG016|Overall Study|Adverse Event|0|||
129679480|NCT02332707|466786760|FG017|Overall Study|Adverse Event|0|||
129679481|NCT02332707|466786743|FG000|Overall Study|Lost to Follow-up|0|||
129679482|NCT02332707|466786744|FG001|Overall Study|Lost to Follow-up|0|||
129679483|NCT02332707|466786745|FG002|Overall Study|Lost to Follow-up|0|||
129679484|NCT02332707|466786746|FG003|Overall Study|Lost to Follow-up|0|||
129679485|NCT02332707|466786747|FG004|Overall Study|Lost to Follow-up|0|||
129679486|NCT02332707|466786748|FG005|Overall Study|Lost to Follow-up|1|||
129679487|NCT02332707|466786749|FG006|Overall Study|Lost to Follow-up|0|||
129679488|NCT02332707|466786750|FG007|Overall Study|Lost to Follow-up|0|||
129679489|NCT02332707|466786751|FG008|Overall Study|Lost to Follow-up|0|||
129679490|NCT02332707|466786752|FG009|Overall Study|Lost to Follow-up|0|||
129679491|NCT02332707|466786753|FG010|Overall Study|Lost to Follow-up|2|||
129679492|NCT02332707|466786754|FG011|Overall Study|Lost to Follow-up|0|||
129679493|NCT02332707|466786755|FG012|Overall Study|Lost to Follow-up|3|||
129679494|NCT02332707|466786756|FG013|Overall Study|Lost to Follow-up|0|||
129679495|NCT02332707|466786757|FG014|Overall Study|Lost to Follow-up|0|||
129679496|NCT02332707|466786758|FG015|Overall Study|Lost to Follow-up|0|||
129679497|NCT02332707|466786759|FG016|Overall Study|Lost to Follow-up|0|||
129679498|NCT02332707|466786760|FG017|Overall Study|Lost to Follow-up|0|||
129679499|NCT02332707|466786743|FG000|Overall Study|Physician Decision|0|||
129679500|NCT02332707|466786744|FG001|Overall Study|Physician Decision|0|||
129679501|NCT02332707|466786745|FG002|Overall Study|Physician Decision|0|||
129679502|NCT02332707|466786746|FG003|Overall Study|Physician Decision|1|||
129679503|NCT02332707|466786747|FG004|Overall Study|Physician Decision|0|||
129769639|NCT03818256|467123629|FG000|Overall Study|Adverse Event|3|||
129769640|NCT03818256|467123630|FG001|Overall Study|Adverse Event|1|||
129769641|NCT03818256|467123629|FG000|Overall Study|Lost to Follow-up|0|||
129769642|NCT03818256|467123630|FG001|Overall Study|Lost to Follow-up|5|||
129769643|NCT03818256|467123629|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
129769644|NCT03818256|467123630|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
129769645|NCT03818256|467123629|FG000|Overall Study|Not reporting for scheduled visits|1|||
129769646|NCT03818256|467123630|FG001|Overall Study|Not reporting for scheduled visits|0|||
129769647|NCT03818256|467123629|FG000|Overall Study|Non-compliant with investigational product|1|||
129769648|NCT03818256|467123630|FG001|Overall Study|Non-compliant with investigational product|0|||
129769649|NCT00911170|467123631|FG000|Treatment Period|Randomized in error|1|||
129769650|NCT00911170|467123632|FG001|Treatment Period|Randomized in error|1|||
129769651|NCT00911170|467123631|FG000|Treatment Period|Ineligibility determined|1|||
129769652|NCT00911170|467123632|FG001|Treatment Period|Ineligibility determined|3|||
129769653|NCT00911170|467123631|FG000|Treatment Period|Protocol deviation|1|||
129769654|NCT00911170|467123632|FG001|Treatment Period|Protocol deviation|2|||
129769655|NCT00911170|467123631|FG000|Treatment Period|Adverse Event|9|||
129769656|NCT00911170|467123632|FG001|Treatment Period|Adverse Event|10|||
129769657|NCT00911170|467123631|FG000|Treatment Period|Withdrawal by Subject|4|||
129769658|NCT00911170|467123632|FG001|Treatment Period|Withdrawal by Subject|4|||
129769659|NCT00911170|467123631|FG000|Treatment Period|Disease progression|0|||
129769660|NCT00911170|467123632|FG001|Treatment Period|Disease progression|2|||
129769661|NCT00911170|467123631|FG000|Treatment Period|Physician Decision|5|||
129769662|NCT00911170|467123632|FG001|Treatment Period|Physician Decision|5|||
129769663|NCT00911170|467123631|FG000|Treatment Period|Lost to Follow-up|0|||
129769664|NCT00911170|467123632|FG001|Treatment Period|Lost to Follow-up|1|||
129769665|NCT00911170|467123631|FG000|Treatment Period|Death|6|||
129769666|NCT00911170|467123632|FG001|Treatment Period|Death|9|||
129769667|NCT00911170|467123631|FG000|Long Term Follow-Up|Continuing in study|274|||
129769668|NCT00911170|467123632|FG001|Long Term Follow-Up|Continuing in study|269|||
129769669|NCT00911170|467123631|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
129769670|NCT00911170|467123632|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
129769671|NCT00911170|467123631|FG000|Long Term Follow-Up|Physician Decision|5|||
129769672|NCT00911170|467123632|FG001|Long Term Follow-Up|Physician Decision|4|||
129769673|NCT00911170|467123631|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
129769674|NCT00911170|467123632|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
129769675|NCT00911170|467123631|FG000|Long Term Follow-Up|Death|116|||
129769676|NCT00911170|467123632|FG001|Long Term Follow-Up|Death|121|||
129769677|NCT02514083|467123633|FG000|Overall Study|Adverse Event|1|||
129769678|NCT04154904|467126394|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
129769679|NCT04154904|467126395|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
129769680|NCT04154904|467126396|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
129769681|NCT00936715|467126397|FG000|Overall Study|Investigators Discretion|1|||
129769682|NCT00936715|467126397|FG000|Overall Study|Protocol Violation|1|||
129769683|NCT00936715|467126397|FG000|Overall Study|Safety or Tolerability Reasons|4|||
129769684|NCT04226742|467126398|FG000|Overall Study|Lost to Follow-up|16|||
129769685|NCT04226742|467126399|FG001|Overall Study|Lost to Follow-up|13|||
129769686|NCT04226742|467126398|FG000|Overall Study|Withdrawal by Subject|5|||
129769687|NCT04226742|467126399|FG001|Overall Study|Withdrawal by Subject|3|||
129769688|NCT02492763|467126400|FG000|Overall Study|Withdrawal by Subject|0|||
129769689|NCT02492763|467126401|FG001|Overall Study|Withdrawal by Subject|2|||
129769690|NCT02492763|467126402|FG002|Overall Study|Withdrawal by Subject|1|||
129769691|NCT02492763|467126403|FG003|Overall Study|Withdrawal by Subject|0|||
129769692|NCT02492763|467126400|FG000|Overall Study|Adverse Event|3|||
129769693|NCT02492763|467126401|FG001|Overall Study|Adverse Event|1|||
129769694|NCT02492763|467126402|FG002|Overall Study|Adverse Event|1|||
129769695|NCT02492763|467126403|FG003|Overall Study|Adverse Event|2|||
129769696|NCT02492763|467126400|FG000|Overall Study|Death|0|||
129769697|NCT02492763|467126401|FG001|Overall Study|Death|0|||
129769698|NCT02492763|467126402|FG002|Overall Study|Death|1|||
129769699|NCT02492763|467126403|FG003|Overall Study|Death|0|||
129769700|NCT02492763|467126400|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
129769701|NCT02492763|467126401|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
129769702|NCT02492763|467126402|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
129769703|NCT02492763|467126403|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
129769704|NCT02492763|467126400|FG000|Overall Study|Lost to Follow-up|0|||
129769705|NCT02492763|467126401|FG001|Overall Study|Lost to Follow-up|0|||
129679504|NCT02332707|466786748|FG005|Overall Study|Physician Decision|0|||
129679505|NCT02332707|466786749|FG006|Overall Study|Physician Decision|0|||
129679506|NCT02332707|466786750|FG007|Overall Study|Physician Decision|0|||
129679507|NCT02332707|466786751|FG008|Overall Study|Physician Decision|0|||
129679508|NCT02332707|466786752|FG009|Overall Study|Physician Decision|0|||
129679509|NCT02332707|466786753|FG010|Overall Study|Physician Decision|0|||
129679510|NCT02332707|466786754|FG011|Overall Study|Physician Decision|0|||
129679511|NCT02332707|466786755|FG012|Overall Study|Physician Decision|1|||
129679512|NCT02332707|466786756|FG013|Overall Study|Physician Decision|0|||
129679513|NCT02332707|466786757|FG014|Overall Study|Physician Decision|0|||
129679514|NCT02332707|466786758|FG015|Overall Study|Physician Decision|0|||
129679515|NCT02332707|466786759|FG016|Overall Study|Physician Decision|0|||
129679516|NCT02332707|466786760|FG017|Overall Study|Physician Decision|0|||
129679517|NCT02332707|466786743|FG000|Overall Study|Withdrawal by Subject|0|||
129679518|NCT02332707|466786744|FG001|Overall Study|Withdrawal by Subject|0|||
129679519|NCT02332707|466786745|FG002|Overall Study|Withdrawal by Subject|1|||
129679520|NCT02332707|466786746|FG003|Overall Study|Withdrawal by Subject|0|||
129679521|NCT02332707|466786747|FG004|Overall Study|Withdrawal by Subject|0|||
129679522|NCT02332707|466786748|FG005|Overall Study|Withdrawal by Subject|0|||
129679523|NCT02332707|466786749|FG006|Overall Study|Withdrawal by Subject|0|||
129679524|NCT02332707|466786750|FG007|Overall Study|Withdrawal by Subject|0|||
129679525|NCT02332707|466786751|FG008|Overall Study|Withdrawal by Subject|0|||
129679526|NCT02332707|466786752|FG009|Overall Study|Withdrawal by Subject|3|||
129679527|NCT02332707|466786753|FG010|Overall Study|Withdrawal by Subject|0|||
129679528|NCT02332707|466786754|FG011|Overall Study|Withdrawal by Subject|0|||
129679529|NCT02332707|466786755|FG012|Overall Study|Withdrawal by Subject|0|||
129679530|NCT02332707|466786756|FG013|Overall Study|Withdrawal by Subject|0|||
129679531|NCT02332707|466786757|FG014|Overall Study|Withdrawal by Subject|0|||
129679532|NCT02332707|466786758|FG015|Overall Study|Withdrawal by Subject|0|||
129679533|NCT02332707|466786759|FG016|Overall Study|Withdrawal by Subject|0|||
129679534|NCT02332707|466786760|FG017|Overall Study|Withdrawal by Subject|0|||
129679535|NCT00947544|466786765|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
129679536|NCT00947544|466786766|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
129679537|NCT01240746|466786767|FG000|Overall Study|Adverse Event|2|||
129679538|NCT01240746|466786768|FG001|Overall Study|Adverse Event|0|||
129679539|NCT01240746|466786769|FG002|Overall Study|Adverse Event|10|||
129679540|NCT01240746|466786767|FG000|Overall Study|Lost to Follow-up|23|||
129679541|NCT01240746|466786768|FG001|Overall Study|Lost to Follow-up|20|||
129679542|NCT01240746|466786769|FG002|Overall Study|Lost to Follow-up|102|||
129679543|NCT01240746|466786767|FG000|Overall Study|Protocol Violation|24|||
129679544|NCT01240746|466786768|FG001|Overall Study|Protocol Violation|15|||
129679545|NCT01240746|466786769|FG002|Overall Study|Protocol Violation|72|||
129679546|NCT01240746|466786767|FG000|Overall Study|Withdrawal by Subject|10|||
129679547|NCT01240746|466786768|FG001|Overall Study|Withdrawal by Subject|13|||
129679548|NCT01240746|466786769|FG002|Overall Study|Withdrawal by Subject|59|||
129679549|NCT02471183|466786773|FG000|Main Treatment Period|Adverse Event|1|||
129679550|NCT02471183|466786773|FG000|Main Treatment Period|Withdrawal by Subject|1|||
129679551|NCT02471183|466786773|FG000|Extended Treatment Period|Lack of Efficacy|1|||
129679552|NCT02690727|466786774|FG000|Overall Study|Adverse Event|2|||
129679553|NCT02690727|466786775|FG001|Overall Study|Adverse Event|2|||
129679554|NCT01461551|466786781|FG000|Overall Study|Physician Decision|2|||
129548356|NCT00545441|466302665|FG001|Overall Study|Technical failure|1|||
129679555|NCT01461551|466786782|FG001|Overall Study|Physician Decision|1|||
129679556|NCT01461551|466786783|FG002|Overall Study|Physician Decision|2|||
129679557|NCT00827567|466786784|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
129679558|NCT01155141|466786785|FG000|Overall Study|Withdrawal by Subject|1|||
129679559|NCT01155141|466786785|FG000|Overall Study|Screen Failure|1|||
129679560|NCT03473197|466786786|FG000|Overall Study|Adverse Event|4|||
129679561|NCT03473197|466786786|FG000|Overall Study|Lost to Follow-up|1|||
129679562|NCT03473197|466786786|FG000|Overall Study|Withdrawal by Subject|5|||
129679563|NCT00785629|466786787|FG000|Overall Study|Adverse Event|2|||
129679564|NCT00785629|466786788|FG001|Overall Study|Adverse Event|1|||
129679565|NCT00785629|466786789|FG002|Overall Study|Adverse Event|1|||
129679566|NCT00785629|466786790|FG003|Overall Study|Adverse Event|5|||
129769706|NCT02492763|467126402|FG002|Overall Study|Lost to Follow-up|1|||
129769707|NCT02492763|467126403|FG003|Overall Study|Lost to Follow-up|0|||
129769708|NCT02492763|467126400|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129769709|NCT02492763|467126401|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129769710|NCT02492763|467126402|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129769711|NCT02492763|467126403|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129769712|NCT02492763|467126400|FG000|Overall Study|Screen Failure|0|||
129769713|NCT02492763|467126401|FG001|Overall Study|Screen Failure|0|||
129769714|NCT02492763|467126402|FG002|Overall Study|Screen Failure|0|||
129769715|NCT02492763|467126403|FG003|Overall Study|Screen Failure|1|||
129769716|NCT02492763|467126400|FG000|Overall Study|Study Terminated by Sponsor|13|||
129769717|NCT02492763|467126401|FG001|Overall Study|Study Terminated by Sponsor|10|||
129769718|NCT02492763|467126402|FG002|Overall Study|Study Terminated by Sponsor|6|||
129769719|NCT02492763|467126403|FG003|Overall Study|Study Terminated by Sponsor|10|||
129769720|NCT00914316|467126407|FG000|Phase 1|Physician Decision|4|||
129769721|NCT00914316|467126408|FG001|Phase 1|Physician Decision|0|||
129769722|NCT00914316|467126409|FG002|Phase 1|Physician Decision|1|||
129769723|NCT00914316|467126410|FG003|Phase 1|Physician Decision|2|||
129769724|NCT00914316|467126407|FG000|Phase 1|Withdrawal by Subject|0|||
129769725|NCT00914316|467126408|FG001|Phase 1|Withdrawal by Subject|2|||
129769726|NCT00914316|467126409|FG002|Phase 1|Withdrawal by Subject|4|||
129769727|NCT00914316|467126410|FG003|Phase 1|Withdrawal by Subject|0|||
129769728|NCT00914316|467126407|FG000|Phase 1|Adverse Event|1|||
129769729|NCT00914316|467126408|FG001|Phase 1|Adverse Event|0|||
129769730|NCT00914316|467126409|FG002|Phase 1|Adverse Event|0|||
129769731|NCT00914316|467126410|FG003|Phase 1|Adverse Event|0|||
129769732|NCT00914316|467126407|FG000|Phase 2|Withdrawal by Subject|1|||
129769733|NCT00914316|467126408|FG001|Phase 2|Withdrawal by Subject|0|||
129769734|NCT00914316|467126409|FG002|Phase 2|Withdrawal by Subject|1|||
129769735|NCT00914316|467126410|FG003|Phase 2|Withdrawal by Subject|0|||
129769736|NCT01759446|467126412|FG000|Overall Study|Protocol Violation|1|||
129769737|NCT01759446|467126413|FG001|Overall Study|Protocol Violation|0|||
129769738|NCT01759446|467126414|FG002|Overall Study|Protocol Violation|1|||
129769739|NCT01759446|467126415|FG003|Overall Study|Protocol Violation|0|||
129769740|NCT01759446|467126416|FG004|Overall Study|Protocol Violation|0|||
129769741|NCT01759446|467126412|FG000|Overall Study|Withdrawal by Subject|0|||
129769742|NCT01759446|467126413|FG001|Overall Study|Withdrawal by Subject|1|||
129769743|NCT01759446|467126414|FG002|Overall Study|Withdrawal by Subject|0|||
129769744|NCT01759446|467126415|FG003|Overall Study|Withdrawal by Subject|1|||
129769745|NCT01759446|467126416|FG004|Overall Study|Withdrawal by Subject|0|||
129679567|NCT00785629|466786787|FG000|Overall Study|Protocol Violation|1|||
129679568|NCT00785629|466786788|FG001|Overall Study|Protocol Violation|2|||
129679569|NCT00785629|466786789|FG002|Overall Study|Protocol Violation|4|||
129679570|NCT00785629|466786790|FG003|Overall Study|Protocol Violation|5|||
129679571|NCT00785629|466786787|FG000|Overall Study|administrative decision|5|||
129679572|NCT00785629|466786788|FG001|Overall Study|administrative decision|1|||
129679573|NCT00785629|466786789|FG002|Overall Study|administrative decision|3|||
129679574|NCT00785629|466786790|FG003|Overall Study|administrative decision|4|||
129679575|NCT00785629|466786787|FG000|Overall Study|Withdrawal by Subject|0|||
129679576|NCT00785629|466786788|FG001|Overall Study|Withdrawal by Subject|1|||
129679577|NCT00785629|466786789|FG002|Overall Study|Withdrawal by Subject|2|||
129679578|NCT00785629|466786790|FG003|Overall Study|Withdrawal by Subject|2|||
129679579|NCT00851591|466786793|FG000|Overall Study|Withdrawal by Subject|2|||
129679580|NCT00851591|466786794|FG001|Overall Study|Withdrawal by Subject|0|||
129679581|NCT02326883|466786796|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
129679582|NCT02326883|466786797|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
129679583|NCT02326883|466786798|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
129679584|NCT04154956|466786799|FG000|Overall Study|Death|109|||
129679585|NCT04154956|466786800|FG001|Overall Study|Death|110|||
129679586|NCT04154956|466786799|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
129679587|NCT04154956|466786800|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
129679588|NCT04154956|466786799|FG000|Overall Study|Withdrawal by Subject|1|||
129679589|NCT04154956|466786800|FG001|Overall Study|Withdrawal by Subject|7|||
129679590|NCT04154956|466786799|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
129679591|NCT04154956|466786800|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
129679592|NCT01859741|466786801|FG000|Overall Study|Death|3|||
129679593|NCT01859741|466786802|FG001|Overall Study|Death|2|||
129679594|NCT01859741|466786803|FG002|Overall Study|Death|4|||
129679595|NCT01859741|466786804|FG003|Overall Study|Death|3|||
129679596|NCT01859741|466786805|FG004|Overall Study|Death|5|||
129679597|NCT01859741|466786806|FG005|Overall Study|Death|4|||
129679598|NCT01859741|466786807|FG006|Overall Study|Death|51|||
129679599|NCT01859741|466786808|FG007|Overall Study|Death|51|||
129679600|NCT01859741|466786801|FG000|Overall Study|Lost to Follow-up|0|||
129679601|NCT01859741|466786802|FG001|Overall Study|Lost to Follow-up|0|||
129679602|NCT01859741|466786803|FG002|Overall Study|Lost to Follow-up|0|||
129679603|NCT01859741|466786804|FG003|Overall Study|Lost to Follow-up|0|||
129679604|NCT01859741|466786805|FG004|Overall Study|Lost to Follow-up|0|||
129679605|NCT01859741|466786806|FG005|Overall Study|Lost to Follow-up|1|||
129679606|NCT01859741|466786807|FG006|Overall Study|Lost to Follow-up|0|||
129679607|NCT01859741|466786808|FG007|Overall Study|Lost to Follow-up|4|||
129679608|NCT01859741|466786801|FG000|Overall Study|Withdrawal by Subject|0|||
129679609|NCT01859741|466786802|FG001|Overall Study|Withdrawal by Subject|1|||
129679610|NCT01859741|466786803|FG002|Overall Study|Withdrawal by Subject|2|||
129679611|NCT01859741|466786804|FG003|Overall Study|Withdrawal by Subject|0|||
129679612|NCT01859741|466786805|FG004|Overall Study|Withdrawal by Subject|0|||
129679613|NCT01859741|466786806|FG005|Overall Study|Withdrawal by Subject|1|||
129679614|NCT01859741|466786807|FG006|Overall Study|Withdrawal by Subject|1|||
129679615|NCT01859741|466786808|FG007|Overall Study|Withdrawal by Subject|1|||
129679616|NCT01859741|466786801|FG000|Overall Study|Study Terminated by Sponsor|0|||
129679617|NCT01859741|466786802|FG001|Overall Study|Study Terminated by Sponsor|0|||
129679618|NCT01859741|466786803|FG002|Overall Study|Study Terminated by Sponsor|0|||
129679619|NCT01859741|466786804|FG003|Overall Study|Study Terminated by Sponsor|0|||
129679620|NCT01859741|466786805|FG004|Overall Study|Study Terminated by Sponsor|1|||
129679621|NCT01859741|466786806|FG005|Overall Study|Study Terminated by Sponsor|0|||
129679622|NCT01859741|466786807|FG006|Overall Study|Study Terminated by Sponsor|16|||
129679623|NCT01859741|466786808|FG007|Overall Study|Study Terminated by Sponsor|14|||
129679624|NCT01859741|466786801|FG000|Overall Study|Other|0|||
129679625|NCT01859741|466786802|FG001|Overall Study|Other|0|||
129679626|NCT01859741|466786803|FG002|Overall Study|Other|0|||
129679627|NCT01859741|466786804|FG003|Overall Study|Other|0|||
129679628|NCT01859741|466786805|FG004|Overall Study|Other|0|||
129679629|NCT01859741|466786806|FG005|Overall Study|Other|0|||
129679630|NCT01859741|466786807|FG006|Overall Study|Other|2|||
129679631|NCT01859741|466786808|FG007|Overall Study|Other|0|||
129679632|NCT02412657|466786812|FG000|Overall Study|Lost to Follow-up|1|||
129679633|NCT02412657|466786813|FG001|Overall Study|Lost to Follow-up|0|||
129679634|NCT02412657|466786814|FG002|Overall Study|Lost to Follow-up|0|||
129679635|NCT02412657|466786812|FG000|Overall Study|Protocol Violation|0|||
129679636|NCT02412657|466786813|FG001|Overall Study|Protocol Violation|2|||
129679637|NCT02412657|466786814|FG002|Overall Study|Protocol Violation|3|||
129769746|NCT01213472|467126424|FG000|Overall Study|Recurrence/Progressive disease|25|||
129769747|NCT01213472|467126424|FG000|Overall Study|Withdrawal by Subject|1|||
129769748|NCT01213472|467126424|FG000|Overall Study|Physician Decision|1|||
129769749|NCT02085460|467126425|FG000|Overall Study|Adverse Event|2|||
129769750|NCT02085460|467126426|FG001|Overall Study|Adverse Event|2|||
129769751|NCT02085460|467126427|FG002|Overall Study|Adverse Event|1|||
129769752|NCT02085460|467126425|FG000|Overall Study|Physician Decision|1|||
129769753|NCT02085460|467126426|FG001|Overall Study|Physician Decision|1|||
129769754|NCT02085460|467126427|FG002|Overall Study|Physician Decision|2|||
129769755|NCT02085460|467126425|FG000|Overall Study|Withdrawal by Subject|11|||
129769756|NCT02085460|467126426|FG001|Overall Study|Withdrawal by Subject|5|||
129769757|NCT02085460|467126427|FG002|Overall Study|Withdrawal by Subject|7|||
129769758|NCT01285323|467126428|FG000|Overall Study|Adverse Event|9|||
129769759|NCT01285323|467126429|FG001|Overall Study|Adverse Event|8|||
129769760|NCT01285323|467126428|FG000|Overall Study|Lack of Efficacy|4|||
129769761|NCT01285323|467126429|FG001|Overall Study|Lack of Efficacy|2|||
129769762|NCT01285323|467126428|FG000|Overall Study|Withdrawal by Subject|15|||
129769763|NCT01285323|467126429|FG001|Overall Study|Withdrawal by Subject|11|||
129769764|NCT01285323|467126428|FG000|Overall Study|Protocol Violation|1|||
129769765|NCT01285323|467126429|FG001|Overall Study|Protocol Violation|2|||
129769766|NCT01285323|467126428|FG000|Overall Study|Non-compliance with study procedures|2|||
129769767|NCT01285323|467126429|FG001|Overall Study|Non-compliance with study procedures|3|||
129769768|NCT01285323|467126428|FG000|Overall Study|Lost to Follow-up|1|||
129769769|NCT01285323|467126429|FG001|Overall Study|Lost to Follow-up|1|||
129769770|NCT01285323|467126428|FG000|Overall Study|Other|1|||
129769771|NCT01285323|467126429|FG001|Overall Study|Other|3|||
129769772|NCT00763035|467126430|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
129769773|NCT00763035|467126431|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
129769774|NCT00763035|467126430|FG000|First Intervention|Adverse Event|0|||
129769775|NCT00763035|467126431|FG001|First Intervention|Adverse Event|1|||
129769776|NCT00763035|467126430|FG000|Second Intervention|Adverse Event|1|||
129769777|NCT00763035|467126431|FG001|Second Intervention|Adverse Event|0|||
129769778|NCT00763035|467126430|FG000|Second Intervention|Physician Decision|2|||
129769779|NCT00763035|467126431|FG001|Second Intervention|Physician Decision|0|||
129769780|NCT02606643|467126432|FG000|Overall Study|did not meet inclusion criteria|1|||
129769781|NCT02606643|467126433|FG001|Overall Study|did not meet inclusion criteria|3|||
129769782|NCT04313244|467126439|FG000|Overall Study|Withdrawal of Consent|3|||
129769783|NCT04313244|467126440|FG001|Overall Study|Withdrawal of Consent|3|||
129769784|NCT04313244|467126439|FG000|Overall Study|Met Exclusion Criteria|1|||
129769785|NCT04313244|467126440|FG001|Overall Study|Met Exclusion Criteria|0|||
129769786|NCT04313244|467126439|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
129769787|NCT04313244|467126440|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
129769788|NCT01472289|467126443|FG000|Overall Study|Death|2|||
129769789|NCT00907335|467126444|FG000|Overall Study|Withdrawal by Subject|2|||
129769790|NCT00907335|467126445|FG001|Overall Study|Withdrawal by Subject|0|||
129769791|NCT00907335|467126444|FG000|Overall Study|Adverse Event|4|||
129769792|NCT00907335|467126445|FG001|Overall Study|Adverse Event|1|||
129769793|NCT00907335|467126444|FG000|Overall Study|Lost to Follow-up|2|||
129769794|NCT00907335|467126445|FG001|Overall Study|Lost to Follow-up|0|||
129769795|NCT03879772|467126446|FG000|Overall Study|Adverse Event|2|||
129769796|NCT03879772|467126447|FG001|Overall Study|Adverse Event|2|||
129769797|NCT03879772|467126448|FG002|Overall Study|Adverse Event|3|||
129769798|NCT03879772|467126449|FG003|Overall Study|Adverse Event|4|||
129769799|NCT03879772|467126450|FG004|Overall Study|Adverse Event|3|||
129769800|NCT03879772|467126446|FG000|Overall Study|Treatment Failure|1|||
129769801|NCT03879772|467126447|FG001|Overall Study|Treatment Failure|0|||
129769802|NCT03879772|467126448|FG002|Overall Study|Treatment Failure|0|||
129769803|NCT03879772|467126449|FG003|Overall Study|Treatment Failure|2|||
129679638|NCT03620162|466786818|FG000|Overall Study|Physician Decision|4|||
129679639|NCT03620162|466786819|FG001|Overall Study|Physician Decision|0|||
129679640|NCT03620162|466786820|FG002|Overall Study|Physician Decision|1|||
129679641|NCT03620162|466786821|FG003|Overall Study|Physician Decision|0|||
129679642|NCT03620162|466786822|FG004|Overall Study|Physician Decision|2|||
129679643|NCT03620162|466786818|FG000|Overall Study|Lost to Follow-up|2|||
129679644|NCT03620162|466786819|FG001|Overall Study|Lost to Follow-up|6|||
129679645|NCT03620162|466786820|FG002|Overall Study|Lost to Follow-up|7|||
129679646|NCT03620162|466786821|FG003|Overall Study|Lost to Follow-up|3|||
129679647|NCT03620162|466786822|FG004|Overall Study|Lost to Follow-up|2|||
129679648|NCT03620162|466786818|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
129679649|NCT03620162|466786819|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
129679650|NCT03620162|466786820|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
129679651|NCT03620162|466786821|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
129679652|NCT03620162|466786822|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
129679653|NCT01682031|466786825|FG000|Overall Study|Withdrawal by Subject|0|||
129679654|NCT01682031|466786826|FG001|Overall Study|Withdrawal by Subject|1|||
129679655|NCT01682031|466786825|FG000|Overall Study|Adverse Event|0|||
129679656|NCT01682031|466786826|FG001|Overall Study|Adverse Event|2|||
129679657|NCT01682031|466786825|FG000|Overall Study|MRI results indicate increased nodul|0|||
129679658|NCT01682031|466786826|FG001|Overall Study|MRI results indicate increased nodul|1|||
129679659|NCT01682031|466786825|FG000|Overall Study|Patient could not swallow tablets|1|||
129679660|NCT01682031|466786826|FG001|Overall Study|Patient could not swallow tablets|0|||
129679661|NCT01682031|466786825|FG000|Overall Study|Patient stopped selenium on his own|0|||
129679662|NCT01682031|466786826|FG001|Overall Study|Patient stopped selenium on his own|1|||
129679663|NCT01056536|466786828|FG000|Overall Study|Lost to Follow-up|202|||
129679664|NCT01056536|466786829|FG001|Overall Study|Lost to Follow-up|116|||
129679665|NCT01056536|466786830|FG002|Overall Study|Lost to Follow-up|248|||
129679666|NCT02763566|466786831|FG000|Overall Study|Lost to Follow-up|1|||
129679667|NCT02763566|466786832|FG001|Overall Study|Lost to Follow-up|4|||
129679668|NCT02763566|466786833|FG002|Overall Study|Lost to Follow-up|0|||
129679669|NCT02763566|466786834|FG003|Overall Study|Lost to Follow-up|1|||
129679670|NCT02763566|466786831|FG000|Overall Study|On study treatment at study conclusion|114|||
129679671|NCT02763566|466786832|FG001|Overall Study|On study treatment at study conclusion|34|||
129679672|NCT02763566|466786833|FG002|Overall Study|On study treatment at study conclusion|54|||
129679673|NCT02763566|466786834|FG003|Overall Study|On study treatment at study conclusion|13|||
129679674|NCT02763566|466786831|FG000|Overall Study|Withdrawal by Subject|3|||
129679675|NCT02763566|466786832|FG001|Overall Study|Withdrawal by Subject|1|||
129679676|NCT02763566|466786833|FG002|Overall Study|Withdrawal by Subject|0|||
129679677|NCT02763566|466786834|FG003|Overall Study|Withdrawal by Subject|0|||
129679678|NCT00315445|466786835|FG000|Overall Study|Adverse Event|7|||
129679679|NCT00315445|466786836|FG001|Overall Study|Adverse Event|12|||
129679680|NCT00315445|466786837|FG002|Overall Study|Adverse Event|15|||
129679681|NCT00315445|466786835|FG000|Overall Study|Lack of Efficacy|16|||
129679682|NCT00315445|466786836|FG001|Overall Study|Lack of Efficacy|1|||
129679683|NCT00315445|466786837|FG002|Overall Study|Lack of Efficacy|7|||
129679684|NCT00315445|466786835|FG000|Overall Study|Lost to Follow-up|1|||
129679685|NCT00315445|466786836|FG001|Overall Study|Lost to Follow-up|0|||
129769804|NCT03879772|467126450|FG004|Overall Study|Treatment Failure|1|||
129679686|NCT00315445|466786837|FG002|Overall Study|Lost to Follow-up|1|||
129679687|NCT00315445|466786835|FG000|Overall Study|Protocol Violation|2|||
129679688|NCT00315445|466786836|FG001|Overall Study|Protocol Violation|0|||
129679689|NCT00315445|466786837|FG002|Overall Study|Protocol Violation|1|||
129679690|NCT00315445|466786835|FG000|Overall Study|Other|1|||
129679691|NCT00315445|466786836|FG001|Overall Study|Other|3|||
129769805|NCT03879772|467126446|FG000|Overall Study|Lost to Follow-up|0|||
129769806|NCT03879772|467126447|FG001|Overall Study|Lost to Follow-up|0|||
129769807|NCT03879772|467126448|FG002|Overall Study|Lost to Follow-up|0|||
129769808|NCT03879772|467126449|FG003|Overall Study|Lost to Follow-up|0|||
129769809|NCT03879772|467126450|FG004|Overall Study|Lost to Follow-up|1|||
129769810|NCT03879772|467126446|FG000|Overall Study|Withdrawal by Subject|0|||
129769811|NCT03879772|467126447|FG001|Overall Study|Withdrawal by Subject|1|||
129769812|NCT03879772|467126448|FG002|Overall Study|Withdrawal by Subject|3|||
129769813|NCT03879772|467126449|FG003|Overall Study|Withdrawal by Subject|1|||
129769814|NCT03879772|467126450|FG004|Overall Study|Withdrawal by Subject|1|||
129769815|NCT03879772|467126446|FG000|Overall Study|Protocol Violation|0|||
129769816|NCT03879772|467126447|FG001|Overall Study|Protocol Violation|0|||
129769817|NCT03879772|467126448|FG002|Overall Study|Protocol Violation|3|||
129769818|NCT03879772|467126449|FG003|Overall Study|Protocol Violation|1|||
129769819|NCT03879772|467126450|FG004|Overall Study|Protocol Violation|2|||
129769820|NCT03879772|467126446|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
129769821|NCT03879772|467126447|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
129769822|NCT03879772|467126448|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
129769823|NCT03879772|467126449|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
129769824|NCT03879772|467126450|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
129769825|NCT00930046|467126451|FG000|Overall Study|Wound catheter malfunctioned|1|||
129769826|NCT00930046|467126452|FG001|Overall Study|Wound catheter malfunctioned|2|||
129769827|NCT02161016|467126453|FG000|Overall Study|withdrawn by IRB|1|||
129769828|NCT02531802|467126454|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
129769829|NCT02531802|467126455|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
129769830|NCT02531802|467126456|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
129769831|NCT02531802|467126457|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
129769832|NCT02531802|467126458|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
129769833|NCT02531802|467126459|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
129884424|NCT01275196|467536392|FG000|Overall Study|Adverse Event|3|||
129679692|NCT00315445|466786837|FG002|Overall Study|Other|0|||
129679693|NCT01101178|466786840|FG000|Period 1|Withdrawal by Subject|1|||
129679694|NCT01101178|466786841|FG001|Period 1|Withdrawal by Subject|2|||
129679695|NCT01101178|466786840|FG000|Period 1|Positive drug screen|1|||
129679696|NCT01101178|466786841|FG001|Period 1|Positive drug screen|1|||
129679697|NCT01101178|466786840|FG000|Period 1|Adverse Event|2|||
129679698|NCT01101178|466786841|FG001|Period 1|Adverse Event|1|||
129679699|NCT01101178|466786840|FG000|Period 2|Withdrawal by Subject|0|||
129679700|NCT01101178|466786841|FG001|Period 2|Withdrawal by Subject|1|||
129679701|NCT01850641|466786842|FG000|Overall Study|Physician Decision|1|||
129679702|NCT01850641|466786842|FG000|Overall Study|Decrease in serum phosphorus|1|||
129679703|NCT01850641|466786842|FG000|Overall Study|Decrease in serum calcium|2|||
129679704|NCT01850641|466786842|FG000|Overall Study|Increase in serum ferritin|1|||
129679705|NCT00141817|466786843|FG000|Overall Study|Protocol Violation|0|||
129679706|NCT00141817|466786844|FG001|Overall Study|Protocol Violation|0|||
129679707|NCT00141817|466786845|FG002|Overall Study|Protocol Violation|1|||
129679708|NCT00141817|466786846|FG003|Overall Study|Protocol Violation|0|||
129679709|NCT00141817|466786843|FG000|Overall Study|Parent request|1|||
129679710|NCT00141817|466786844|FG001|Overall Study|Parent request|0|||
129679711|NCT00141817|466786845|FG002|Overall Study|Parent request|0|||
129679712|NCT00141817|466786846|FG003|Overall Study|Parent request|0|||
129679713|NCT00846365|466786853|FG000|Overall Study|Adverse Event|20|||
129679714|NCT00846365|466786854|FG001|Overall Study|Adverse Event|30|||
129679715|NCT00846365|466786855|FG002|Overall Study|Adverse Event|11|||
129679716|NCT00846365|466786853|FG000|Overall Study|Protocol Violation|5|||
129679717|NCT00846365|466786854|FG001|Overall Study|Protocol Violation|4|||
129679718|NCT00846365|466786855|FG002|Overall Study|Protocol Violation|0|||
129679719|NCT00846365|466786853|FG000|Overall Study|Lost to Follow-up|8|||
129679720|NCT00846365|466786854|FG001|Overall Study|Lost to Follow-up|2|||
129679721|NCT00846365|466786855|FG002|Overall Study|Lost to Follow-up|5|||
129679722|NCT00846365|466786853|FG000|Overall Study|Withdrawal by Subject|11|||
129679723|NCT00846365|466786854|FG001|Overall Study|Withdrawal by Subject|11|||
129679724|NCT00846365|466786855|FG002|Overall Study|Withdrawal by Subject|9|||
129679725|NCT00846365|466786853|FG000|Overall Study|Pregnancy|1|||
129679726|NCT00846365|466786854|FG001|Overall Study|Pregnancy|0|||
129679727|NCT00846365|466786855|FG002|Overall Study|Pregnancy|0|||
129679728|NCT00846365|466786853|FG000|Overall Study|Lack of Efficacy|1|||
129679729|NCT00846365|466786854|FG001|Overall Study|Lack of Efficacy|1|||
129679730|NCT00846365|466786855|FG002|Overall Study|Lack of Efficacy|2|||
129679731|NCT00846365|466786853|FG000|Overall Study|Other|9|||
129679732|NCT00846365|466786854|FG001|Overall Study|Other|1|||
129679733|NCT00846365|466786855|FG002|Overall Study|Other|6|||
129679734|NCT03479905|466786856|FG000|Overall Study|Other airway method used|4|||
129679735|NCT03479905|466786857|FG001|Overall Study|Other airway method used|5|||
129679736|NCT03479905|466786858|FG002|Overall Study|Other airway method used|5|||
129679737|NCT00862992|466786859|FG000|Overall Study|Adverse Event|2|||
129679738|NCT00862992|466786860|FG001|Overall Study|Adverse Event|1|||
129679739|NCT00862992|466786861|FG002|Overall Study|Adverse Event|1|||
129679740|NCT00862992|466786859|FG000|Overall Study|Physician Decision|1|||
129679741|NCT00862992|466786860|FG001|Overall Study|Physician Decision|0|||
129679742|NCT00862992|466786861|FG002|Overall Study|Physician Decision|0|||
129679743|NCT00862992|466786859|FG000|Overall Study|Withdrawal by Subject|0|||
129679744|NCT00862992|466786860|FG001|Overall Study|Withdrawal by Subject|0|||
129679745|NCT00862992|466786861|FG002|Overall Study|Withdrawal by Subject|2|||
129679746|NCT00720759|466786862|FG000|Overall Study|Lost to Follow-up|0|||
129679747|NCT00720759|466786863|FG001|Overall Study|Lost to Follow-up|1|||
129679748|NCT00720759|466786864|FG002|Overall Study|Lost to Follow-up|1|||
129679749|NCT00720759|466786865|FG003|Overall Study|Lost to Follow-up|0|||
129679750|NCT01047319|466786866|FG000|Overall Study|Teva requested participant withdrawal|3|||
129769834|NCT02531802|467126460|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
129769835|NCT02531802|467126461|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
129769836|NCT02531802|467126462|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
129769837|NCT02531802|467126463|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
129769838|NCT02531802|467126464|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
129769839|NCT02531802|467126465|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
129769840|NCT02531802|467126466|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
129769841|NCT02531802|467126467|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
129769842|NCT02531802|467126468|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
129769843|NCT02531802|467126469|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
129769844|NCT02531802|467126470|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
129769845|NCT02531802|467126471|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
129769846|NCT02531802|467126472|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
129769847|NCT02531802|467126473|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
129769848|NCT02531802|467126474|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
129769849|NCT02531802|467126454|FG000|Received Vaccination 2|Physician Decision|0|||
129769850|NCT02531802|467126455|FG001|Received Vaccination 2|Physician Decision|0|||
129769851|NCT02531802|467126456|FG002|Received Vaccination 2|Physician Decision|0|||
129769852|NCT02531802|467126457|FG003|Received Vaccination 2|Physician Decision|0|||
129769853|NCT02531802|467126458|FG004|Received Vaccination 2|Physician Decision|0|||
129769854|NCT02531802|467126459|FG005|Received Vaccination 2|Physician Decision|1|||
129769855|NCT02531802|467126460|FG006|Received Vaccination 2|Physician Decision|0|||
129769856|NCT02531802|467126461|FG007|Received Vaccination 2|Physician Decision|0|||
129769857|NCT02531802|467126462|FG008|Received Vaccination 2|Physician Decision|0|||
129769858|NCT02531802|467126463|FG009|Received Vaccination 2|Physician Decision|2|||
129769859|NCT02531802|467126464|FG010|Received Vaccination 2|Physician Decision|0|||
129769860|NCT02531802|467126465|FG011|Received Vaccination 2|Physician Decision|0|||
129769861|NCT02531802|467126466|FG012|Received Vaccination 2|Physician Decision|0|||
129769862|NCT02531802|467126467|FG013|Received Vaccination 2|Physician Decision|1|||
129769863|NCT02531802|467126468|FG014|Received Vaccination 2|Physician Decision|0|||
129769864|NCT02531802|467126469|FG015|Received Vaccination 2|Physician Decision|0|||
129769865|NCT02531802|467126470|FG016|Received Vaccination 2|Physician Decision|0|||
129769866|NCT02531802|467126471|FG017|Received Vaccination 2|Physician Decision|1|||
129769867|NCT02531802|467126472|FG018|Received Vaccination 2|Physician Decision|0|||
129769868|NCT02531802|467126473|FG019|Received Vaccination 2|Physician Decision|0|||
129769869|NCT02531802|467126474|FG020|Received Vaccination 2|Physician Decision|0|||
129769870|NCT02531802|467126454|FG000|Received Vaccination 2|Adverse Event|0|||
129769871|NCT02531802|467126455|FG001|Received Vaccination 2|Adverse Event|0|||
129769872|NCT02531802|467126456|FG002|Received Vaccination 2|Adverse Event|0|||
129769873|NCT02531802|467126457|FG003|Received Vaccination 2|Adverse Event|0|||
129769874|NCT02531802|467126458|FG004|Received Vaccination 2|Adverse Event|0|||
129769875|NCT02531802|467126459|FG005|Received Vaccination 2|Adverse Event|2|||
129769876|NCT02531802|467126460|FG006|Received Vaccination 2|Adverse Event|0|||
129769877|NCT02531802|467126461|FG007|Received Vaccination 2|Adverse Event|0|||
129769878|NCT02531802|467126462|FG008|Received Vaccination 2|Adverse Event|0|||
129769879|NCT02531802|467126463|FG009|Received Vaccination 2|Adverse Event|0|||
129769880|NCT02531802|467126464|FG010|Received Vaccination 2|Adverse Event|0|||
129769881|NCT02531802|467126465|FG011|Received Vaccination 2|Adverse Event|0|||
129769882|NCT02531802|467126466|FG012|Received Vaccination 2|Adverse Event|0|||
129769883|NCT02531802|467126467|FG013|Received Vaccination 2|Adverse Event|0|||
129769884|NCT02531802|467126468|FG014|Received Vaccination 2|Adverse Event|0|||
129769885|NCT02531802|467126469|FG015|Received Vaccination 2|Adverse Event|0|||
129769886|NCT02531802|467126470|FG016|Received Vaccination 2|Adverse Event|0|||
129769887|NCT02531802|467126471|FG017|Received Vaccination 2|Adverse Event|2|||
129769888|NCT02531802|467126472|FG018|Received Vaccination 2|Adverse Event|1|||
129769889|NCT02531802|467126473|FG019|Received Vaccination 2|Adverse Event|0|||
129769890|NCT02531802|467126474|FG020|Received Vaccination 2|Adverse Event|1|||
129769891|NCT02531802|467126454|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
129769892|NCT02531802|467126455|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
129769893|NCT02531802|467126456|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
129769894|NCT02531802|467126457|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
129679751|NCT01047319|466786867|FG001|Overall Study|Teva requested participant withdrawal|0|||
129679752|NCT01047319|466786868|FG002|Overall Study|Teva requested participant withdrawal|1|||
129679753|NCT01047319|466786866|FG000|Overall Study|Protocol Violation|3|||
129679754|NCT01047319|466786867|FG001|Overall Study|Protocol Violation|2|||
129679755|NCT01047319|466786868|FG002|Overall Study|Protocol Violation|4|||
129679756|NCT01047319|466786866|FG000|Overall Study|Lack of Efficacy|4|||
129679757|NCT01047319|466786867|FG001|Overall Study|Lack of Efficacy|3|||
129679758|NCT01047319|466786868|FG002|Overall Study|Lack of Efficacy|3|||
129679759|NCT01047319|466786866|FG000|Overall Study|Death|5|||
129679760|NCT01047319|466786867|FG001|Overall Study|Death|1|||
129679761|NCT01047319|466786868|FG002|Overall Study|Death|5|||
129679762|NCT01047319|466786866|FG000|Overall Study|Pregnancy|13|||
129679763|NCT01047319|466786867|FG001|Overall Study|Pregnancy|8|||
129679764|NCT01047319|466786868|FG002|Overall Study|Pregnancy|8|||
129679765|NCT01047319|466786866|FG000|Overall Study|Physician Decision|12|||
129679766|NCT01047319|466786867|FG001|Overall Study|Physician Decision|9|||
129679767|NCT01047319|466786868|FG002|Overall Study|Physician Decision|10|||
129679768|NCT01047319|466786866|FG000|Overall Study|Lost to Follow-up|14|||
129679769|NCT01047319|466786867|FG001|Overall Study|Lost to Follow-up|10|||
129679770|NCT01047319|466786868|FG002|Overall Study|Lost to Follow-up|10|||
129679771|NCT01047319|466786866|FG000|Overall Study|Adverse Event|16|||
129679772|NCT01047319|466786867|FG001|Overall Study|Adverse Event|27|||
129679773|NCT01047319|466786868|FG002|Overall Study|Adverse Event|21|||
129679774|NCT01047319|466786866|FG000|Overall Study|Withdrawal by Subject|77|||
129679775|NCT01047319|466786867|FG001|Overall Study|Withdrawal by Subject|75|||
129679776|NCT01047319|466786868|FG002|Overall Study|Withdrawal by Subject|87|||
129679777|NCT01047319|466786866|FG000|Overall Study|Study terminated by Sponsor|198|||
129679778|NCT01047319|466786867|FG001|Overall Study|Study terminated by Sponsor|215|||
129679779|NCT01047319|466786868|FG002|Overall Study|Study terminated by Sponsor|203|||
129679780|NCT02318940|466786869|FG000|Overall Study|lost the record|1|||
129679781|NCT02318940|466786870|FG001|Overall Study|lost the record|0|||
129679782|NCT01277861|466786873|FG000|Overall Study|Physician Decision|2|||
129679783|NCT01277861|466786874|FG001|Overall Study|Physician Decision|2|||
129679784|NCT02696798|466786875|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
129679785|NCT02696798|466786876|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
129679786|NCT02696798|466786877|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
129679787|NCT02696798|466786875|FG000|Blinded Treatment Dosing Period|Death|0|||
129679788|NCT02696798|466786876|FG001|Blinded Treatment Dosing Period|Death|0|||
129679789|NCT02696798|466786877|FG002|Blinded Treatment Dosing Period|Death|1|||
129679790|NCT02696798|466786875|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
129679791|NCT02696798|466786876|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
129679792|NCT02696798|466786877|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
129679793|NCT02696798|466786875|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
129679794|NCT02696798|466786876|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
129679795|NCT02696798|466786877|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
129679796|NCT02696798|466786875|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
129679797|NCT02696798|466786876|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
129679798|NCT02696798|466786877|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
129679799|NCT02696798|466786875|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
129679800|NCT02696798|466786876|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
129679801|NCT02696798|466786877|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
129679802|NCT02696798|466786875|FG000|Extended Treatment Period|Adverse Event|1|||
129679803|NCT02696798|466786876|FG001|Extended Treatment Period|Adverse Event|4|||
129679804|NCT02696798|466786877|FG002|Extended Treatment Period|Adverse Event|5|||
129679805|NCT02696798|466786875|FG000|Extended Treatment Period|Lack of Efficacy|7|||
129679806|NCT02696798|466786876|FG001|Extended Treatment Period|Lack of Efficacy|2|||
129679807|NCT02696798|466786877|FG002|Extended Treatment Period|Lack of Efficacy|2|||
129679808|NCT02696798|466786875|FG000|Extended Treatment Period|Lost to Follow-up|1|||
129679809|NCT02696798|466786876|FG001|Extended Treatment Period|Lost to Follow-up|0|||
129679810|NCT02696798|466786877|FG002|Extended Treatment Period|Lost to Follow-up|0|||
129679811|NCT02696798|466786875|FG000|Extended Treatment Period|Physician Decision|0|||
129679812|NCT02696798|466786876|FG001|Extended Treatment Period|Physician Decision|1|||
129679813|NCT02696798|466786877|FG002|Extended Treatment Period|Physician Decision|0|||
129679814|NCT02696798|466786875|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
129679815|NCT02696798|466786876|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
129679816|NCT02696798|466786877|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
129679817|NCT02696798|466786875|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
129679818|NCT02696798|466786876|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
129679819|NCT02696798|466786877|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
129769895|NCT02531802|467126458|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
129769896|NCT02531802|467126459|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
129769897|NCT02531802|467126460|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
129769898|NCT02531802|467126461|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
129769899|NCT02531802|467126462|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
129769900|NCT02531802|467126463|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
129769901|NCT02531802|467126464|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
129769902|NCT02531802|467126465|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
129769903|NCT02531802|467126466|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
129769904|NCT02531802|467126467|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
129769905|NCT02531802|467126468|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
129769906|NCT02531802|467126469|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
129769907|NCT02531802|467126470|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
129769908|NCT02531802|467126471|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
129769909|NCT02531802|467126472|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
129769910|NCT02531802|467126473|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
129769911|NCT02531802|467126474|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
129769912|NCT03345784|467126477|FG000|Overall Study|Withdrawal by Subject|2|||
129769913|NCT03345784|467126478|FG001|Overall Study|Withdrawal by Subject|1|||
129769914|NCT04798196|467126479|FG000|Overall Study|Lost to Follow-up|3|||
129769915|NCT04798196|467126480|FG001|Overall Study|Lost to Follow-up|1|||
129769916|NCT04798196|467126481|FG002|Overall Study|Lost to Follow-up|3|||
129769917|NCT00728689|467126490|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
129769918|NCT00728689|467126491|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
129769919|NCT00929695|467126492|FG000|Overall Study|Death|2|||
129769920|NCT00929695|467126493|FG001|Overall Study|Death|1|||
129769921|NCT00929695|467126492|FG000|Overall Study|Withdrawal by Subject|0|||
129769922|NCT00929695|467126493|FG001|Overall Study|Withdrawal by Subject|2|||
129769923|NCT00929695|467126492|FG000|Overall Study|discharge home|4|||
129769924|NCT00929695|467126493|FG001|Overall Study|discharge home|3|||
129769925|NCT00929695|467126492|FG000|Overall Study|incorrect stratification|2|||
129769926|NCT00929695|467126493|FG001|Overall Study|incorrect stratification|0|||
129769927|NCT03216226|467126494|FG000|Overall Study|Adverse Event|3|||
129769928|NCT03216226|467126495|FG001|Overall Study|Adverse Event|0|||
129769929|NCT03216226|467126494|FG000|Overall Study|Protocol Violation|1|||
129769930|NCT03216226|467126495|FG001|Overall Study|Protocol Violation|3|||
129769931|NCT03216226|467126494|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
129769932|NCT03216226|467126495|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
129769933|NCT03216226|467126494|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
129769934|NCT03216226|467126495|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
129769935|NCT03216226|467126494|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
129769936|NCT03216226|467126495|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
129769937|NCT00887809|467126496|FG000|Overall Study|Patient Not Treated|3|||
129769938|NCT00887809|467126497|FG001|Overall Study|Patient Not Treated|0|||
129769939|NCT00887809|467126496|FG000|Overall Study|Death|1|||
129769940|NCT00887809|467126497|FG001|Overall Study|Death|0|||
129769941|NCT01352715|467126500|FG000|Overall Study|Death|3|||
129769942|NCT01352715|467126501|FG001|Overall Study|Death|3|||
129769943|NCT01352715|467126500|FG000|Overall Study|Lost to Follow-up|5|||
129769944|NCT01352715|467126501|FG001|Overall Study|Lost to Follow-up|7|||
129769945|NCT01352715|467126500|FG000|Overall Study|Withdrawal by Subject|4|||
129769946|NCT01352715|467126501|FG001|Overall Study|Withdrawal by Subject|8|||
129769947|NCT01352715|467126500|FG000|Overall Study|site closure|16|||
129769948|NCT01352715|467126501|FG001|Overall Study|site closure|15|||
129769949|NCT01352715|467126500|FG000|Overall Study|no final visit in closeout period|15|||
129769950|NCT01352715|467126501|FG001|Overall Study|no final visit in closeout period|12|||
129769951|NCT01352715|467126500|FG000|Overall Study|major ineligibility|2|||
129769952|NCT01352715|467126501|FG001|Overall Study|major ineligibility|1|||
129769953|NCT04596267|467126502|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
129769954|NCT04596267|467126503|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
129769955|NCT04596267|467126502|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
129769956|NCT04596267|467126503|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
129769957|NCT00071058|467126504|FG000|Overall Study|brain tumor-removed from study|1|||
129769958|NCT04109547|467126505|FG000|Overall Study|Withdrawal by Subject|3|||
129769959|NCT04109547|467126506|FG001|Overall Study|Withdrawal by Subject|2|||
129769960|NCT04109547|467126507|FG002|Overall Study|Withdrawal by Subject|6|||
129769961|NCT04109547|467126508|FG003|Overall Study|Withdrawal by Subject|6|||
129769962|NCT04109547|467126505|FG000|Overall Study|Lost to Follow-up|0|||
129769963|NCT04109547|467126506|FG001|Overall Study|Lost to Follow-up|0|||
129769964|NCT04109547|467126507|FG002|Overall Study|Lost to Follow-up|0|||
129769965|NCT04109547|467126508|FG003|Overall Study|Lost to Follow-up|1|||
129769966|NCT04109547|467126505|FG000|Overall Study|Physician Decision|1|||
129769967|NCT04109547|467126506|FG001|Overall Study|Physician Decision|2|||
129769968|NCT04109547|467126507|FG002|Overall Study|Physician Decision|0|||
129769969|NCT04109547|467126508|FG003|Overall Study|Physician Decision|0|||
129769970|NCT01550003|467126509|FG000|Overall Study|Adverse Event|0|||
129769971|NCT01550003|467126510|FG001|Overall Study|Adverse Event|9|||
129769972|NCT01550003|467126511|FG002|Overall Study|Adverse Event|15|||
129769973|NCT01550003|467126509|FG000|Overall Study|Lack of Efficacy|4|||
129769974|NCT01550003|467126510|FG001|Overall Study|Lack of Efficacy|11|||
129769975|NCT01550003|467126511|FG002|Overall Study|Lack of Efficacy|15|||
129769976|NCT01550003|467126509|FG000|Overall Study|Protocol Violation|0|||
129769977|NCT01550003|467126510|FG001|Overall Study|Protocol Violation|3|||
129769978|NCT01550003|467126511|FG002|Overall Study|Protocol Violation|2|||
129769979|NCT01550003|467126509|FG000|Overall Study|Lost to Follow-up|1|||
129769980|NCT01550003|467126510|FG001|Overall Study|Lost to Follow-up|4|||
129769981|NCT01550003|467126511|FG002|Overall Study|Lost to Follow-up|8|||
129769982|NCT01550003|467126509|FG000|Overall Study|Consent withdrawn|2|||
129769983|NCT01550003|467126510|FG001|Overall Study|Consent withdrawn|11|||
129769984|NCT01550003|467126511|FG002|Overall Study|Consent withdrawn|23|||
129769985|NCT01550003|467126509|FG000|Overall Study|Missing|1|||
129769986|NCT01550003|467126510|FG001|Overall Study|Missing|0|||
129769987|NCT01550003|467126511|FG002|Overall Study|Missing|2|||
129769988|NCT01550003|467126509|FG000|Overall Study|Study closure as announced by sponsor|7|||
129769989|NCT01550003|467126510|FG001|Overall Study|Study closure as announced by sponsor|6|||
129769990|NCT01550003|467126511|FG002|Overall Study|Study closure as announced by sponsor|24|||
129769991|NCT01550003|467126509|FG000|Overall Study|Protocol Noncompliance|1|||
129769992|NCT01550003|467126510|FG001|Overall Study|Protocol Noncompliance|0|||
129769993|NCT01550003|467126511|FG002|Overall Study|Protocol Noncompliance|0|||
129769994|NCT01550003|467126509|FG000|Overall Study|Study closure|0|||
129769995|NCT01550003|467126510|FG001|Overall Study|Study closure|1|||
129769996|NCT01550003|467126511|FG002|Overall Study|Study closure|1|||
129769997|NCT01550003|467126509|FG000|Overall Study|Patient reached adulthood|0|||
129769998|NCT01550003|467126510|FG001|Overall Study|Patient reached adulthood|1|||
129769999|NCT01550003|467126511|FG002|Overall Study|Patient reached adulthood|0|||
129770000|NCT01550003|467126509|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
129770001|NCT01550003|467126510|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
129770002|NCT01550003|467126511|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
129770003|NCT01550003|467126509|FG000|Overall Study|Sponsor's order|0|||
129770004|NCT01550003|467126510|FG001|Overall Study|Sponsor's order|3|||
129770005|NCT01550003|467126511|FG002|Overall Study|Sponsor's order|3|||
129770006|NCT01550003|467126509|FG000|Overall Study|Sponsor's decision|1|||
129770007|NCT01550003|467126510|FG001|Overall Study|Sponsor's decision|5|||
129770008|NCT01550003|467126511|FG002|Overall Study|Sponsor's decision|4|||
129770009|NCT01550003|467126509|FG000|Overall Study|Subject mother passed away|0|||
129770010|NCT01550003|467126510|FG001|Overall Study|Subject mother passed away|1|||
129770011|NCT01550003|467126511|FG002|Overall Study|Subject mother passed away|0|||
129770012|NCT01550003|467126509|FG000|Overall Study|Discontinuation|0|||
129770013|NCT01550003|467126510|FG001|Overall Study|Discontinuation|1|||
129770014|NCT01550003|467126511|FG002|Overall Study|Discontinuation|0|||
129770015|NCT01550003|467126509|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
129770016|NCT01550003|467126510|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
129770017|NCT01550003|467126511|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
129770018|NCT01550003|467126509|FG000|Overall Study|Site closure|0|||
129770019|NCT01550003|467126510|FG001|Overall Study|Site closure|2|||
129770020|NCT01550003|467126511|FG002|Overall Study|Site closure|0|||
129770021|NCT01550003|467126509|FG000|Overall Study|Pregnancy|0|||
129770022|NCT01550003|467126510|FG001|Overall Study|Pregnancy|1|||
129770023|NCT01550003|467126511|FG002|Overall Study|Pregnancy|0|||
129770024|NCT01550003|467126509|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
129770025|NCT01550003|467126510|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
129770026|NCT01550003|467126511|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
129770027|NCT01550003|467126509|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
129770028|NCT01550003|467126510|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
129770029|NCT01550003|467126511|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
129770030|NCT01550003|467126509|FG000|Overall Study|Switching to adult rheumatologist|0|||
129770031|NCT01550003|467126510|FG001|Overall Study|Switching to adult rheumatologist|0|||
129770032|NCT01550003|467126511|FG002|Overall Study|Switching to adult rheumatologist|1|||
129770033|NCT01550003|467126509|FG000|Overall Study|Patient transition to adult care|0|||
129770034|NCT01550003|467126510|FG001|Overall Study|Patient transition to adult care|0|||
129770035|NCT01550003|467126511|FG002|Overall Study|Patient transition to adult care|1|||
129679820|NCT02696798|466786875|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
129679821|NCT02696798|466786876|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
129679822|NCT02696798|466786877|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
129679823|NCT02696798|466786875|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
129679824|NCT02696798|466786876|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
129679825|NCT02696798|466786877|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
129679826|NCT02696798|466786875|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
129679827|NCT02696798|466786876|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
129679828|NCT02696798|466786877|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
129679829|NCT02696798|466786875|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
129679830|NCT02696798|466786876|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
129679831|NCT02696798|466786877|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
129679832|NCT02696798|466786875|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
129679833|NCT02696798|466786876|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
129679834|NCT02696798|466786877|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
129679835|NCT00857389|466786878|FG000|Overall Study|Did not proceed to transplant|2|||
129679836|NCT01157845|466786879|FG000|Overall Study|Lost to Follow-up|5|||
129679837|NCT01157845|466786879|FG000|Overall Study|Withdrawal by Subject|12|||
129679838|NCT01157845|466786879|FG000|Overall Study|Physician Decision|3|||
129679839|NCT01157845|466786879|FG000|Overall Study|Protocol Violation|13|||
129679840|NCT01157845|466786879|FG000|Overall Study|Study was ended|1|||
129679841|NCT01157845|466786879|FG000|Overall Study|Device malfunction|1|||
129679842|NCT03311555|466786880|FG000|Overall Study|Adverse Event|1|||
129679843|NCT04530630|466788258|FG000|Overall Study|Physician Decision|1|||
129679844|NCT03675308|466788261|FG000|Overall Study|Adverse Event|3|||
129679845|NCT03675308|466788262|FG001|Overall Study|Adverse Event|2|||
129679846|NCT03675308|466788261|FG000|Overall Study|Withdrawal by Subject|6|||
129679847|NCT03675308|466788262|FG001|Overall Study|Withdrawal by Subject|4|||
129679848|NCT03675308|466788261|FG000|Overall Study|Lost to Follow-up|3|||
129679849|NCT03675308|466788262|FG001|Overall Study|Lost to Follow-up|0|||
129679850|NCT03675308|466788261|FG000|Overall Study|Lack of Efficacy|1|||
129679851|NCT03675308|466788262|FG001|Overall Study|Lack of Efficacy|1|||
129679852|NCT03675308|466788261|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
129679853|NCT03675308|466788262|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
129679854|NCT03675308|466788261|FG000|Overall Study|Other|0|||
129679855|NCT03675308|466788262|FG001|Overall Study|Other|1|||
129679856|NCT00788671|466788266|FG000|Overall Study|Death|2|||
129679857|NCT00788671|466788266|FG000|Overall Study|Unable to biopsy|1|||
129679858|NCT00788671|466788266|FG000|Overall Study|Withdrawal by Subject|4|||
129679859|NCT00788671|466788266|FG000|Overall Study|IUD expulsed|1|||
129679860|NCT00788671|466788266|FG000|Overall Study|Lost to follow up|2|||
129679861|NCT04761822|466788267|FG000|Overall Study|Adverse Event|3|||
129679862|NCT04761822|466788268|FG001|Overall Study|Adverse Event|1|||
129679863|NCT04761822|466788269|FG002|Overall Study|Adverse Event|1|||
129679864|NCT04761822|466788270|FG003|Overall Study|Adverse Event|3|||
129679865|NCT04761822|466788267|FG000|Overall Study|Lost to Follow-up|1|||
129679866|NCT04761822|466788268|FG001|Overall Study|Lost to Follow-up|0|||
129679867|NCT04761822|466788269|FG002|Overall Study|Lost to Follow-up|2|||
129679868|NCT04761822|466788270|FG003|Overall Study|Lost to Follow-up|3|||
129679869|NCT04761822|466788267|FG000|Overall Study|Physician Decision|0|||
129679870|NCT04761822|466788268|FG001|Overall Study|Physician Decision|1|||
129548357|NCT00545441|466302664|FG000|Overall Study|Withdrawal by Subject|1|||
129679871|NCT04761822|466788269|FG002|Overall Study|Physician Decision|0|||
129679872|NCT04761822|466788270|FG003|Overall Study|Physician Decision|0|||
129679873|NCT04761822|466788267|FG000|Overall Study|Withdrawal by Subject|3|||
129679874|NCT04761822|466788268|FG001|Overall Study|Withdrawal by Subject|8|||
129679875|NCT04761822|466788269|FG002|Overall Study|Withdrawal by Subject|1|||
129679876|NCT04761822|466788270|FG003|Overall Study|Withdrawal by Subject|11|||
129679877|NCT04761822|466788267|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
129679878|NCT04761822|466788268|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
129679879|NCT04761822|466788269|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
129770036|NCT01550003|467126509|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
129770037|NCT01550003|467126510|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
129770038|NCT01550003|467126511|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
129770039|NCT01550003|467126509|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
129770040|NCT01550003|467126510|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
129770041|NCT01550003|467126511|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
129770042|NCT01550003|467126509|FG000|Overall Study|Per Sponsor request|1|||
129770043|NCT01550003|467126510|FG001|Overall Study|Per Sponsor request|0|||
129770044|NCT01550003|467126511|FG002|Overall Study|Per Sponsor request|1|||
129770045|NCT01550003|467126509|FG000|Overall Study|Patient not compliance|0|||
129770046|NCT01550003|467126510|FG001|Overall Study|Patient not compliance|0|||
129770047|NCT01550003|467126511|FG002|Overall Study|Patient not compliance|1|||
129770048|NCT01550003|467126509|FG000|Overall Study|Non-compliance|0|||
129770049|NCT01550003|467126510|FG001|Overall Study|Non-compliance|0|||
129770050|NCT01550003|467126511|FG002|Overall Study|Non-compliance|1|||
129770051|NCT01550003|467126509|FG000|Overall Study|Study closed|0|||
129770052|NCT01550003|467126510|FG001|Overall Study|Study closed|1|||
129770053|NCT01550003|467126511|FG002|Overall Study|Study closed|0|||
129770054|NCT01550003|467126509|FG000|Overall Study|Transitioned to adult rheumatology|0|||
129770055|NCT01550003|467126510|FG001|Overall Study|Transitioned to adult rheumatology|0|||
129770056|NCT01550003|467126511|FG002|Overall Study|Transitioned to adult rheumatology|1|||
129770057|NCT01656408|467126512|FG000|Overall Study|Adverse Event|0|||
129770058|NCT01656408|467126513|FG001|Overall Study|Adverse Event|0|||
129770059|NCT01656408|467126514|FG002|Overall Study|Adverse Event|1|||
129770060|NCT01656408|467126515|FG003|Overall Study|Adverse Event|0|||
129770061|NCT01656408|467126516|FG004|Overall Study|Adverse Event|0|||
129770062|NCT01656408|467126517|FG005|Overall Study|Adverse Event|1|||
129770063|NCT01656408|467126518|FG006|Overall Study|Adverse Event|1|||
129770064|NCT01656408|467126519|FG007|Overall Study|Adverse Event|0|||
129770065|NCT01656408|467126520|FG008|Overall Study|Adverse Event|1|||
129770066|NCT01656408|467126521|FG009|Overall Study|Adverse Event|0|||
129770067|NCT01656408|467126512|FG000|Overall Study|Physician Decision|1|||
129770068|NCT01656408|467126513|FG001|Overall Study|Physician Decision|0|||
129770069|NCT01656408|467126514|FG002|Overall Study|Physician Decision|1|||
129770070|NCT01656408|467126515|FG003|Overall Study|Physician Decision|0|||
129770071|NCT01656408|467126516|FG004|Overall Study|Physician Decision|1|||
129770072|NCT01656408|467126517|FG005|Overall Study|Physician Decision|1|||
129770073|NCT01656408|467126518|FG006|Overall Study|Physician Decision|0|||
129770074|NCT01656408|467126519|FG007|Overall Study|Physician Decision|1|||
129770075|NCT01656408|467126520|FG008|Overall Study|Physician Decision|1|||
129770076|NCT01656408|467126521|FG009|Overall Study|Physician Decision|3|||
129770077|NCT00871975|467126522|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
129770078|NCT00871975|467126522|FG000|Overall Study|Catheters could not be inserted|1|||
129770079|NCT00871975|467126522|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
129770080|NCT00871975|467126522|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
129770081|NCT00870740|467126523|FG000|Overall Study|Adverse Event|2|||
129770082|NCT00870740|467126524|FG001|Overall Study|Adverse Event|1|||
129770083|NCT00870740|467126525|FG002|Overall Study|Adverse Event|3|||
129770084|NCT00870740|467126526|FG003|Overall Study|Adverse Event|2|||
129770085|NCT00870740|467126527|FG004|Overall Study|Adverse Event|1|||
129770086|NCT00870740|467126528|FG005|Overall Study|Adverse Event|6|||
129770087|NCT00870740|467126523|FG000|Overall Study|Consent Withdrawn|6|||
129770088|NCT00870740|467126524|FG001|Overall Study|Consent Withdrawn|3|||
129770089|NCT00870740|467126525|FG002|Overall Study|Consent Withdrawn|4|||
129770090|NCT00870740|467126526|FG003|Overall Study|Consent Withdrawn|6|||
129770091|NCT00870740|467126527|FG004|Overall Study|Consent Withdrawn|6|||
129770092|NCT00870740|467126528|FG005|Overall Study|Consent Withdrawn|5|||
129770093|NCT00870740|467126523|FG000|Overall Study|Investigator Decision|2|||
129770094|NCT00870740|467126524|FG001|Overall Study|Investigator Decision|0|||
129770095|NCT00870740|467126525|FG002|Overall Study|Investigator Decision|1|||
129770096|NCT00870740|467126526|FG003|Overall Study|Investigator Decision|0|||
129770097|NCT00870740|467126527|FG004|Overall Study|Investigator Decision|0|||
129770098|NCT00870740|467126528|FG005|Overall Study|Investigator Decision|0|||
129679880|NCT04761822|466788270|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
129679881|NCT04761822|466788267|FG000|Overall Study|Participant requested unblinding|0|||
129679882|NCT04761822|466788268|FG001|Overall Study|Participant requested unblinding|0|||
129679883|NCT04761822|466788269|FG002|Overall Study|Participant requested unblinding|0|||
129679884|NCT04761822|466788270|FG003|Overall Study|Participant requested unblinding|1|||
129679885|NCT04476043|466788273|FG000|Overall Study|Withdrawal by Subject|1|||
129679886|NCT04476043|466788274|FG001|Overall Study|Withdrawal by Subject|3|||
129679887|NCT04476043|466788275|FG002|Overall Study|Withdrawal by Subject|4|||
129679888|NCT04476043|466788276|FG003|Overall Study|Withdrawal by Subject|1|||
129679889|NCT04476043|466788273|FG000|Overall Study|Lost to Follow-up|1|||
129679890|NCT04476043|466788274|FG001|Overall Study|Lost to Follow-up|1|||
129679891|NCT04476043|466788275|FG002|Overall Study|Lost to Follow-up|2|||
129679892|NCT04476043|466788276|FG003|Overall Study|Lost to Follow-up|1|||
129679893|NCT04476043|466788273|FG000|Overall Study|Adverse Event|2|||
129679894|NCT04476043|466788274|FG001|Overall Study|Adverse Event|0|||
129679895|NCT04476043|466788275|FG002|Overall Study|Adverse Event|1|||
129679896|NCT04476043|466788276|FG003|Overall Study|Adverse Event|0|||
129679897|NCT04476043|466788273|FG000|Overall Study|Protocol Violation|0|||
129679898|NCT04476043|466788274|FG001|Overall Study|Protocol Violation|1|||
129679899|NCT04476043|466788275|FG002|Overall Study|Protocol Violation|0|||
129679900|NCT04476043|466788276|FG003|Overall Study|Protocol Violation|0|||
129679901|NCT06217380|466788277|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
129679902|NCT06217380|466788277|FG000|Overall Study|Physician Decision|1|||
129679903|NCT06217380|466788277|FG000|Overall Study|Withdrawal by Subject|2|||
129679904|NCT06633965|466788278|FG000|Overall Study|Withdrawal by Subject|0|||
129679905|NCT06633965|466788279|FG001|Overall Study|Withdrawal by Subject|1|||
129679906|NCT01963611|466788286|FG000|Overall Study|Adverse Event|1|||
129770099|NCT00870740|467126523|FG000|Overall Study|Subject Non-compliance|0|||
129770100|NCT00870740|467126524|FG001|Overall Study|Subject Non-compliance|0|||
129770101|NCT00870740|467126525|FG002|Overall Study|Subject Non-compliance|0|||
129770102|NCT00870740|467126526|FG003|Overall Study|Subject Non-compliance|0|||
129770103|NCT00870740|467126527|FG004|Overall Study|Subject Non-compliance|0|||
129770104|NCT00870740|467126528|FG005|Overall Study|Subject Non-compliance|1|||
129770105|NCT00870740|467126523|FG000|Overall Study|Death|0|||
129770106|NCT00870740|467126524|FG001|Overall Study|Death|0|||
129770107|NCT00870740|467126525|FG002|Overall Study|Death|0|||
129770108|NCT00870740|467126526|FG003|Overall Study|Death|0|||
129770109|NCT00870740|467126527|FG004|Overall Study|Death|1|||
129770110|NCT00870740|467126528|FG005|Overall Study|Death|0|||
129770111|NCT00870740|467126523|FG000|Overall Study|Other|2|||
129770112|NCT00870740|467126524|FG001|Overall Study|Other|5|||
129770113|NCT00870740|467126525|FG002|Overall Study|Other|2|||
129770114|NCT00870740|467126526|FG003|Overall Study|Other|4|||
129770115|NCT00870740|467126527|FG004|Overall Study|Other|3|||
129770116|NCT00870740|467126528|FG005|Overall Study|Other|5|||
129770117|NCT03592186|467126529|FG000|Overall Study|Withdrawal by Subject|1|||
129770118|NCT03592186|467126530|FG001|Overall Study|Withdrawal by Subject|0|||
129770119|NCT03592186|467126529|FG000|Overall Study|Lost to Follow-up|16|||
129770120|NCT03592186|467126530|FG001|Overall Study|Lost to Follow-up|11|||
129770121|NCT00307801|467126533|FG000|Overall Study|Adverse Event|12|||
129770122|NCT00307801|467126534|FG001|Overall Study|Adverse Event|4|||
129770123|NCT00307801|467126533|FG000|Overall Study|Withdrawal by Subject|9|||
129770124|NCT00307801|467126534|FG001|Overall Study|Withdrawal by Subject|4|||
129770125|NCT00307801|467126533|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
129770126|NCT00307801|467126534|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
129770127|NCT00307801|467126533|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
129770128|NCT00307801|467126534|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
129770129|NCT00307801|467126533|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
129770130|NCT00307801|467126534|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
129770131|NCT00307801|467126533|FG000|Overall Study|Wrong Randomization|1|||
129770132|NCT00307801|467126534|FG001|Overall Study|Wrong Randomization|0|||
129770133|NCT00307801|467126533|FG000|Overall Study|Lack of Efficacy|0|||
129770134|NCT00307801|467126534|FG001|Overall Study|Lack of Efficacy|2|||
129770135|NCT00307801|467126533|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
129770136|NCT00307801|467126534|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
129770137|NCT00307801|467126533|FG000|Overall Study|Frustration with e-diary|1|||
129770138|NCT00307801|467126534|FG001|Overall Study|Frustration with e-diary|0|||
129770139|NCT00307801|467126533|FG000|Overall Study|Protocol Violation|3|||
129770140|NCT00307801|467126534|FG001|Overall Study|Protocol Violation|2|||
129770141|NCT00307801|467126533|FG000|Overall Study|No reason specified|2|||
129770142|NCT00307801|467126534|FG001|Overall Study|No reason specified|0|||
129770143|NCT00307801|467126533|FG000|Overall Study|Pregnancy|0|||
129770144|NCT00307801|467126534|FG001|Overall Study|Pregnancy|1|||
129770145|NCT00551642|467126537|FG000|Treatment Period|Protocol Deviation|6|||
129770146|NCT00551642|467126538|FG001|Treatment Period|Protocol Deviation|11|||
129770147|NCT00551642|467126537|FG000|Treatment Period|Delivery device failure|1|||
129770148|NCT00551642|467126538|FG001|Treatment Period|Delivery device failure|3|||
129770149|NCT00551642|467126537|FG000|Treatment Period|Physician Decision|0|||
129770150|NCT00551642|467126538|FG001|Treatment Period|Physician Decision|1|||
129770151|NCT00551642|467126537|FG000|Treatment Period|Death|33|||
129770152|NCT00551642|467126538|FG001|Treatment Period|Death|31|||
129770153|NCT00551642|467126537|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
129770154|NCT00551642|467126538|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
129770155|NCT00551642|467126537|FG000|Treatment Period|Adverse Event|15|||
129770156|NCT00551642|467126538|FG001|Treatment Period|Adverse Event|12|||
129770157|NCT00551642|467126537|FG000|Treatment Period|Withdrawal by Subject|2|||
129770158|NCT00551642|467126538|FG001|Treatment Period|Withdrawal by Subject|1|||
129679907|NCT01963611|466788287|FG001|Overall Study|Adverse Event|1|||
129679908|NCT01963611|466788288|FG002|Overall Study|Adverse Event|3|||
129679909|NCT01963611|466788289|FG003|Overall Study|Adverse Event|4|||
129679910|NCT01963611|466788290|FG004|Overall Study|Adverse Event|3|||
129679911|NCT01963611|466788286|FG000|Overall Study|Protocol Violation|0|||
129679912|NCT01963611|466788287|FG001|Overall Study|Protocol Violation|0|||
129679913|NCT01963611|466788288|FG002|Overall Study|Protocol Violation|0|||
129679914|NCT01963611|466788289|FG003|Overall Study|Protocol Violation|1|||
129679915|NCT01963611|466788290|FG004|Overall Study|Protocol Violation|0|||
129679916|NCT01963611|466788286|FG000|Overall Study|Lack of Efficacy|0|||
129679917|NCT01963611|466788287|FG001|Overall Study|Lack of Efficacy|0|||
129679918|NCT01963611|466788288|FG002|Overall Study|Lack of Efficacy|0|||
129679919|NCT01963611|466788289|FG003|Overall Study|Lack of Efficacy|1|||
129679920|NCT01963611|466788290|FG004|Overall Study|Lack of Efficacy|0|||
129679921|NCT01963611|466788286|FG000|Overall Study|Withdrawal by Subject|3|||
129679922|NCT01963611|466788287|FG001|Overall Study|Withdrawal by Subject|2|||
129679923|NCT01963611|466788288|FG002|Overall Study|Withdrawal by Subject|1|||
129679924|NCT01963611|466788289|FG003|Overall Study|Withdrawal by Subject|1|||
129679925|NCT01963611|466788290|FG004|Overall Study|Withdrawal by Subject|3|||
129679926|NCT01963611|466788286|FG000|Overall Study|Other|47|||
129679927|NCT01963611|466788287|FG001|Overall Study|Other|46|||
129679928|NCT01963611|466788288|FG002|Overall Study|Other|48|||
129679929|NCT01963611|466788289|FG003|Overall Study|Other|45|||
129679930|NCT01963611|466788290|FG004|Overall Study|Other|45|||
129679931|NCT01126424|466788291|FG000|Overall Study|Adverse Event|0|||
129679932|NCT01126424|466788292|FG001|Overall Study|Adverse Event|0|||
129679933|NCT01126424|466788293|FG002|Overall Study|Adverse Event|0|||
129679934|NCT01126424|466788294|FG003|Overall Study|Adverse Event|0|||
129679935|NCT01126424|466788295|FG004|Overall Study|Adverse Event|1|||
129679936|NCT01126424|466788296|FG005|Overall Study|Adverse Event|0|||
129679937|NCT01126424|466788291|FG000|Overall Study|Withdrawal by Subject|0|||
129679938|NCT01126424|466788292|FG001|Overall Study|Withdrawal by Subject|0|||
129679939|NCT01126424|466788293|FG002|Overall Study|Withdrawal by Subject|1|||
129679940|NCT01126424|466788294|FG003|Overall Study|Withdrawal by Subject|3|||
129679941|NCT01126424|466788295|FG004|Overall Study|Withdrawal by Subject|1|||
129679942|NCT01126424|466788296|FG005|Overall Study|Withdrawal by Subject|0|||
129679943|NCT03801252|466788298|FG000|Overall Study|Protocol Violation|1|||
129679944|NCT03801252|466788299|FG001|Overall Study|Protocol Violation|2|||
129679945|NCT01134042|466788300|FG000|Overall Study|Adverse Event|3|||
129679946|NCT01134042|466788301|FG001|Overall Study|Adverse Event|7|||
129679947|NCT01134042|466788302|FG002|Overall Study|Adverse Event|2|||
129679948|NCT01134042|466788300|FG000|Overall Study|Lack of Efficacy|21|||
129679949|NCT01134042|466788301|FG001|Overall Study|Lack of Efficacy|6|||
129679950|NCT01134042|466788302|FG002|Overall Study|Lack of Efficacy|18|||
129679951|NCT01134042|466788300|FG000|Overall Study|Protocol Violation|5|||
129679952|NCT01134042|466788301|FG001|Overall Study|Protocol Violation|3|||
129679953|NCT01134042|466788302|FG002|Overall Study|Protocol Violation|5|||
129679954|NCT01134042|466788300|FG000|Overall Study|Lost to Follow-up|2|||
129679955|NCT01134042|466788301|FG001|Overall Study|Lost to Follow-up|0|||
129679956|NCT01134042|466788302|FG002|Overall Study|Lost to Follow-up|1|||
129679957|NCT01134042|466788300|FG000|Overall Study|Physician Decision|4|||
129679958|NCT01134042|466788301|FG001|Overall Study|Physician Decision|8|||
129679959|NCT01134042|466788302|FG002|Overall Study|Physician Decision|1|||
129679960|NCT01134042|466788300|FG000|Overall Study|Withdrawal by Subject|13|||
129679961|NCT01134042|466788301|FG001|Overall Study|Withdrawal by Subject|4|||
129679962|NCT01134042|466788302|FG002|Overall Study|Withdrawal by Subject|7|||
129679963|NCT02328105|466788303|FG000|Overall Study|Death|6|||
129679964|NCT02328105|466788303|FG000|Overall Study|Withdrawal by Subject|1|||
129679965|NCT02328105|466788303|FG000|Overall Study|Still On Study in Follow-Up|4|||
129679966|NCT01588509|466788307|FG000|Overall Study|Lost to Follow-up|1|||
129679967|NCT01588509|466788308|FG001|Overall Study|Lost to Follow-up|0|||
129679968|NCT01983930|466788309|FG000|Overall Study|Withdrawal by Subject|9|||
129679969|NCT01983930|466788310|FG001|Overall Study|Withdrawal by Subject|8|||
129679970|NCT01983930|466788309|FG000|Overall Study|Adverse Event|0|||
129679971|NCT01983930|466788310|FG001|Overall Study|Adverse Event|1|||
129679972|NCT00393367|466788311|FG000|Overall Study|Protocol Violation|2|||
129679973|NCT00393367|466788312|FG001|Overall Study|Protocol Violation|5|||
129679974|NCT00393367|466788311|FG000|Overall Study|Withdrawal by Subject|0|||
129679975|NCT00393367|466788312|FG001|Overall Study|Withdrawal by Subject|2|||
129679976|NCT03286504|466788313|FG000|Overall Study|Lost to Follow-up|19|||
129679977|NCT03286504|466788314|FG001|Overall Study|Lost to Follow-up|16|||
129679978|NCT01432327|466788315|FG000|Posttest 3 Months|depression|3|||
129679979|NCT01432327|466788316|FG001|Posttest 3 Months|depression|0|||
129679980|NCT01432327|466788317|FG002|Posttest 3 Months|depression|0|||
129679981|NCT01432327|466788318|FG003|Posttest 3 Months|depression|0|||
129679982|NCT01432327|466788315|FG000|Posttest 3 Months|Lost to Follow-up|1|||
129679983|NCT01432327|466788316|FG001|Posttest 3 Months|Lost to Follow-up|0|||
129679984|NCT01432327|466788317|FG002|Posttest 3 Months|Lost to Follow-up|2|||
129679985|NCT01432327|466788318|FG003|Posttest 3 Months|Lost to Follow-up|1|||
129679986|NCT01432327|466788315|FG000|Posttest 3 Months|Allergic reaction|0|||
129679987|NCT01432327|466788316|FG001|Posttest 3 Months|Allergic reaction|2|||
129679988|NCT01432327|466788317|FG002|Posttest 3 Months|Allergic reaction|0|||
129679989|NCT01432327|466788318|FG003|Posttest 3 Months|Allergic reaction|0|||
129679990|NCT01432327|466788315|FG000|Posttest 6 Months|Lost to Follow-up|0|||
129679991|NCT01432327|466788316|FG001|Posttest 6 Months|Lost to Follow-up|0|||
129679992|NCT01432327|466788317|FG002|Posttest 6 Months|Lost to Follow-up|3|||
129770159|NCT03011099|467126542|FG000|Overall Study|Withdrawal by Subject|0|||
129770160|NCT03011099|467126543|FG001|Overall Study|Withdrawal by Subject|2|||
129770161|NCT02668653|467126546|FG000|Overall Study|Refractory disease|41|||
129770162|NCT02668653|467126547|FG001|Overall Study|Refractory disease|70|||
129770163|NCT02668653|467126546|FG000|Overall Study|Relapse|44|||
129770164|NCT02668653|467126547|FG001|Overall Study|Relapse|65|||
129770165|NCT02668653|467126546|FG000|Overall Study|Adverse Event|58|||
129770166|NCT02668653|467126547|FG001|Overall Study|Adverse Event|23|||
129770167|NCT02668653|467126546|FG000|Overall Study|Subject decision to stop study drug|25|||
129770168|NCT02668653|467126547|FG001|Overall Study|Subject decision to stop study drug|23|||
129770169|NCT02668653|467126546|FG000|Overall Study|Other reasons not specified|16|||
129679993|NCT01432327|466788318|FG003|Posttest 6 Months|Lost to Follow-up|2|||
129679994|NCT01432327|466788315|FG000|Posttest 6 Months|Allergic reaction|0|||
129679995|NCT01432327|466788316|FG001|Posttest 6 Months|Allergic reaction|0|||
129679996|NCT01432327|466788317|FG002|Posttest 6 Months|Allergic reaction|1|||
129679997|NCT01432327|466788318|FG003|Posttest 6 Months|Allergic reaction|0|||
129679998|NCT01432327|466788315|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
129679999|NCT01432327|466788316|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
129680000|NCT01432327|466788317|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
129680001|NCT01432327|466788318|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
129680002|NCT01432327|466788315|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
129680003|NCT01432327|466788316|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
129680004|NCT01432327|466788317|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
129680005|NCT01432327|466788318|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
129680006|NCT01432327|466788315|FG000|Posttest 1 Year|Lost to Follow-up|0|||
129680007|NCT01432327|466788316|FG001|Posttest 1 Year|Lost to Follow-up|0|||
129680008|NCT01432327|466788317|FG002|Posttest 1 Year|Lost to Follow-up|4|||
129680009|NCT01432327|466788318|FG003|Posttest 1 Year|Lost to Follow-up|2|||
129680010|NCT01432327|466788315|FG000|Posttest 1 Year|Allergic reaction|0|||
129680011|NCT01432327|466788316|FG001|Posttest 1 Year|Allergic reaction|0|||
129680012|NCT01432327|466788317|FG002|Posttest 1 Year|Allergic reaction|1|||
129680013|NCT01432327|466788318|FG003|Posttest 1 Year|Allergic reaction|1|||
129680014|NCT00141921|466788321|FG000|Overall Study|Remain on Study|28|||
129680015|NCT00141921|466788321|FG000|Overall Study|Withdrawal by Subject|42|||
129680016|NCT00141921|466788321|FG000|Overall Study|Lost to Follow-up|19|||
129680017|NCT00141921|466788321|FG000|Overall Study|Noncompliance|17|||
129680018|NCT00141921|466788321|FG000|Overall Study|Disease Progression|7|||
129680019|NCT00141921|466788321|FG000|Overall Study|Protocol Deviation|7|||
129680020|NCT00141921|466788321|FG000|Overall Study|Adverse Event|5|||
129680021|NCT00141921|466788321|FG000|Overall Study|Administrative Decision|2|||
129680022|NCT00141921|466788321|FG000|Overall Study|Pregnancy|4|||
129680023|NCT00141921|466788321|FG000|Overall Study|Ineligibility Determined|2|||
129680024|NCT00141921|466788321|FG000|Overall Study|Other|8|||
129680025|NCT02030600|466788324|FG000|Treatment Period 1|Adverse Event|5|||
129680026|NCT02030600|466788325|FG001|Treatment Period 1|Adverse Event|7|||
129680027|NCT02030600|466788324|FG000|Treatment Period 1|Lack of Efficacy|0|||
129680028|NCT02030600|466788325|FG001|Treatment Period 1|Lack of Efficacy|1|||
129680029|NCT02030600|466788324|FG000|Treatment Period 1|Lost to Follow-up|11|||
129680030|NCT02030600|466788325|FG001|Treatment Period 1|Lost to Follow-up|3|||
129680031|NCT02030600|466788324|FG000|Treatment Period 1|Protocol Violation|22|||
129680032|NCT02030600|466788325|FG001|Treatment Period 1|Protocol Violation|17|||
129680033|NCT02030600|466788324|FG000|Treatment Period 1|Withdrawal by Subject|13|||
129680034|NCT02030600|466788325|FG001|Treatment Period 1|Withdrawal by Subject|17|||
129680035|NCT02030600|466788324|FG000|Treatment Period 1|Casebook Unsigned|1|||
129680036|NCT02030600|466788325|FG001|Treatment Period 1|Casebook Unsigned|0|||
129680037|NCT02030600|466788324|FG000|Treatment Period 1|Unclassified|1|||
129680038|NCT02030600|466788325|FG001|Treatment Period 1|Unclassified|0|||
129680039|NCT02030600|466788324|FG000|Treatment Period 2|Adverse Event|4|||
129680040|NCT02030600|466788325|FG001|Treatment Period 2|Adverse Event|4|||
129680041|NCT02030600|466788324|FG000|Treatment Period 2|Lack of Efficacy|2|||
129680042|NCT02030600|466788325|FG001|Treatment Period 2|Lack of Efficacy|1|||
129680043|NCT02030600|466788324|FG000|Treatment Period 2|Lost to Follow-up|4|||
129770170|NCT02668653|467126547|FG001|Overall Study|Other reasons not specified|11|||
129770171|NCT02668653|467126546|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
129680044|NCT02030600|466788325|FG001|Treatment Period 2|Lost to Follow-up|2|||
129770172|NCT02668653|467126547|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
129770173|NCT02668653|467126546|FG000|Overall Study|Investigator decision|10|||
129770174|NCT02668653|467126547|FG001|Overall Study|Investigator decision|7|||
129770175|NCT02668653|467126546|FG000|Overall Study|Failure to meet continuation criteria|5|||
129770176|NCT02668653|467126547|FG001|Overall Study|Failure to meet continuation criteria|12|||
129770177|NCT02668653|467126546|FG000|Overall Study|Lost to Follow-up|1|||
129770178|NCT02668653|467126547|FG001|Overall Study|Lost to Follow-up|0|||
129770179|NCT02668653|467126546|FG000|Overall Study|Pregnancy|0|||
129770180|NCT02668653|467126547|FG001|Overall Study|Pregnancy|1|||
129770181|NCT02668653|467126546|FG000|Overall Study|Death|0|||
129770182|NCT02668653|467126547|FG001|Overall Study|Death|1|||
129770183|NCT01294553|467126548|FG000|Overall Study|Duplicated Participants|1|||
129770184|NCT01294553|467126548|FG000|Overall Study|Protocol Violation|268|||
129770185|NCT01217229|467126549|FG000|Overall Study|Adverse Event|1|||
129770186|NCT01217229|467126549|FG000|Overall Study|Disease progression, deterioration|2|||
129770187|NCT01217229|467126549|FG000|Overall Study|Disease progression, Cheson criteria|14|||
129770188|NCT01217229|467126549|FG000|Overall Study|Protocol Violation|1|||
129770189|NCT01217229|467126549|FG000|Overall Study|Disease progression not confirmed|2|||
129770190|NCT00926237|467126550|FG000|Overall Study|Withdrawal by Subject|2|||
129770191|NCT00926237|467126551|FG001|Overall Study|Withdrawal by Subject|1|||
129770192|NCT00577889|467126552|FG000|Overall Study|Withdrawal by Subject|1|||
129770193|NCT00577889|467126553|FG001|Overall Study|Withdrawal by Subject|0|||
129770194|NCT00577889|467126554|FG002|Overall Study|Withdrawal by Subject|0|||
129770195|NCT02667119|467126555|FG000|Overall Study|Lost to Follow-up|3|||
129770196|NCT02667119|467126556|FG001|Overall Study|Lost to Follow-up|0|||
129770197|NCT03783078|467126559|FG000|Overall Study|Death|31|||
129770198|NCT03783078|467126559|FG000|Overall Study|Sponsor Decision|23|||
129770199|NCT03783078|467126559|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129770200|NCT02059278|467126561|FG000|Overall Study|Adverse Event|1|||
129770201|NCT02059278|467126562|FG001|Overall Study|Adverse Event|1|||
129770202|NCT02059278|467126561|FG000|Overall Study|Lost to Follow-up|1|||
129770203|NCT02059278|467126562|FG001|Overall Study|Lost to Follow-up|0|||
129770204|NCT02059278|467126561|FG000|Overall Study|Withdrawal by Subject|0|||
129770205|NCT02059278|467126562|FG001|Overall Study|Withdrawal by Subject|3|||
129770206|NCT02059278|467126561|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
129770207|NCT02059278|467126562|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
129770208|NCT00541658|467126563|FG000|Overall Study|Adverse Event|28|||
129770209|NCT00541658|467126564|FG001|Overall Study|Adverse Event|37|||
129770210|NCT00541658|467126565|FG002|Overall Study|Adverse Event|25|||
129770211|NCT00541658|467126563|FG000|Overall Study|Physician Decision|0|||
129770212|NCT00541658|467126564|FG001|Overall Study|Physician Decision|0|||
129770213|NCT00541658|467126565|FG002|Overall Study|Physician Decision|4|||
129770214|NCT00541658|467126563|FG000|Overall Study|Lost to Follow-up|3|||
129770215|NCT00541658|467126564|FG001|Overall Study|Lost to Follow-up|3|||
129770216|NCT00541658|467126565|FG002|Overall Study|Lost to Follow-up|6|||
129770217|NCT00541658|467126563|FG000|Overall Study|Protocol Violation|0|||
129770218|NCT00541658|467126564|FG001|Overall Study|Protocol Violation|1|||
129770219|NCT00541658|467126565|FG002|Overall Study|Protocol Violation|1|||
129770220|NCT00541658|467126563|FG000|Overall Study|Withdrawal by Subject|28|||
129770221|NCT00541658|467126564|FG001|Overall Study|Withdrawal by Subject|32|||
129770222|NCT00541658|467126565|FG002|Overall Study|Withdrawal by Subject|32|||
129770223|NCT00541658|467126563|FG000|Overall Study|Took No Study Drug|1|||
129770224|NCT00541658|467126564|FG001|Overall Study|Took No Study Drug|0|||
129770225|NCT00541658|467126565|FG002|Overall Study|Took No Study Drug|0|||
129770226|NCT04482647|467126571|FG000|Overall Study|Time constraints|2|||
129770227|NCT04482647|467126571|FG000|Overall Study|Health issues|1|||
129770228|NCT04482647|467126571|FG000|Overall Study|Death in the family|1|||
129770229|NCT04482647|467126571|FG000|Overall Study|Disliked the intervention|1|||
129770230|NCT04482647|467126571|FG000|Overall Study|No reasons specified|7|||
129770231|NCT02484391|467126572|FG000|Overall Study|Lack of Efficacy|15|||
129770232|NCT02484391|467126573|FG001|Overall Study|Lack of Efficacy|14|||
129770233|NCT02484391|467126574|FG002|Overall Study|Lack of Efficacy|3|||
129770234|NCT02484391|467126572|FG000|Overall Study|Lost to Follow-up|0|||
129770235|NCT02484391|467126573|FG001|Overall Study|Lost to Follow-up|0|||
129770236|NCT02484391|467126574|FG002|Overall Study|Lost to Follow-up|2|||
129770237|NCT02484391|467126572|FG000|Overall Study|Physician Decision|1|||
129770238|NCT02484391|467126573|FG001|Overall Study|Physician Decision|3|||
129770239|NCT02484391|467126574|FG002|Overall Study|Physician Decision|0|||
129770240|NCT02484391|467126572|FG000|Overall Study|Went to Transplant|5|||
129770241|NCT02484391|467126573|FG001|Overall Study|Went to Transplant|3|||
129770242|NCT02484391|467126574|FG002|Overall Study|Went to Transplant|2|||
129770243|NCT02594124|467126575|FG000|Overall Study|Adverse Event|0|||
129680045|NCT02030600|466788324|FG000|Treatment Period 2|Protocol Violation|1|||
129680046|NCT02030600|466788325|FG001|Treatment Period 2|Protocol Violation|2|||
129680047|NCT02030600|466788324|FG000|Treatment Period 2|Withdrawal by Subject|13|||
129680048|NCT02030600|466788325|FG001|Treatment Period 2|Withdrawal by Subject|9|||
129680049|NCT02030600|466788324|FG000|Treatment Period 2|Unclassified|1|||
129680050|NCT02030600|466788325|FG001|Treatment Period 2|Unclassified|0|||
129680051|NCT01155323|466788326|FG000|First Intervention|exclusion criteria|1|||
129680052|NCT01155323|466788327|FG001|First Intervention|exclusion criteria|1|||
129680053|NCT01155323|466788326|FG000|Second Intervention|Lost to Follow-up|1|||
129680054|NCT01155323|466788327|FG001|Second Intervention|Lost to Follow-up|1|||
129680055|NCT02471339|466788331|FG000|Overall Study|Did not provide follow-up data|2|||
129680056|NCT02471339|466788332|FG001|Overall Study|Did not provide follow-up data|0|||
129680057|NCT00626639|466788340|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
129680058|NCT00626639|466788341|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
129680059|NCT00303186|466788342|FG000|Overall Study|Other|52|||
129680060|NCT00937950|466788344|FG000|Overall Study|Withdrawal by Subject|23|||
129680061|NCT00937950|466788344|FG000|Overall Study|Migrated/moved from study area|27|||
129680062|NCT00937950|466788344|FG000|Overall Study|Lost to Follow-up|144|||
129680063|NCT00937950|466788344|FG000|Overall Study|Missing confirmed|4|||
129680064|NCT00937950|466788344|FG000|Overall Study|Other|18|||
129680065|NCT01137786|466788345|FG000|Overall Study|Lost to Follow-up|0|||
129680066|NCT01137786|466788346|FG001|Overall Study|Lost to Follow-up|2|||
129680067|NCT01137786|466788345|FG000|Overall Study|Withdrawal by Subject|1|||
129680068|NCT01137786|466788346|FG001|Overall Study|Withdrawal by Subject|1|||
129680069|NCT00460798|466788348|FG000|Overall Study|Death|59|||
129680070|NCT00460798|466788348|FG000|Overall Study|Adverse Event|27|||
129680071|NCT00460798|466788348|FG000|Overall Study|Lost to Follow-up|19|||
129680072|NCT00460798|466788348|FG000|Overall Study|Progressive Disease|99|||
129680073|NCT00460798|466788348|FG000|Overall Study|Other|27|||
129680074|NCT00460798|466788348|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
129680075|NCT00460798|466788348|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
129680076|NCT01898130|466788349|FG000|Treatment|Withdrawal by Subject|2|||
129680077|NCT01898130|466788349|FG000|Treatment|Progressive Disease|4|||
129680078|NCT01898130|466788349|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
129680079|NCT02320396|466788353|FG000|Overall Study|Adverse Event|2|||
129680080|NCT02320396|466788354|FG001|Overall Study|Adverse Event|2|||
129680081|NCT02320396|466788353|FG000|Overall Study|Pregnancy|0|||
129680082|NCT02320396|466788354|FG001|Overall Study|Pregnancy|1|||
129680083|NCT02320396|466788353|FG000|Overall Study|Protocol Violation|0|||
129680084|NCT02320396|466788354|FG001|Overall Study|Protocol Violation|1|||
129680085|NCT02320396|466788353|FG000|Overall Study|Withdrawal by Subject|2|||
129680086|NCT02320396|466788354|FG001|Overall Study|Withdrawal by Subject|0|||
129680087|NCT04666298|466788359|FG000|Overall Study|Subject decision|1|||
129680088|NCT04666298|466788360|FG001|Overall Study|Subject decision|0|||
129680089|NCT04666298|466788361|FG002|Overall Study|Subject decision|0|||
129680090|NCT04666298|466788362|FG003|Overall Study|Subject decision|2|||
129680091|NCT04666298|466788359|FG000|Overall Study|Death|1|||
129680092|NCT04666298|466788360|FG001|Overall Study|Death|0|||
129680093|NCT04666298|466788361|FG002|Overall Study|Death|0|||
129680094|NCT04666298|466788362|FG003|Overall Study|Death|0|||
129680095|NCT04666298|466788359|FG000|Overall Study|Lost to Follow-up|0|||
129680096|NCT04666298|466788360|FG001|Overall Study|Lost to Follow-up|0|||
129680097|NCT04666298|466788361|FG002|Overall Study|Lost to Follow-up|0|||
129680098|NCT04666298|466788362|FG003|Overall Study|Lost to Follow-up|1|||
129680099|NCT04666298|466788359|FG000|Overall Study|Physician Decision|0|||
129680100|NCT04666298|466788360|FG001|Overall Study|Physician Decision|0|||
129680101|NCT04666298|466788361|FG002|Overall Study|Physician Decision|0|||
129680102|NCT04666298|466788362|FG003|Overall Study|Physician Decision|1|||
129680103|NCT04666298|466788359|FG000|Overall Study|Protocol deviation|0|||
129680104|NCT04666298|466788360|FG001|Overall Study|Protocol deviation|0|||
129680105|NCT04666298|466788361|FG002|Overall Study|Protocol deviation|1|||
129680106|NCT04666298|466788362|FG003|Overall Study|Protocol deviation|0|||
129680107|NCT00844519|466788363|FG000|Overall Study|Withdrawal by Subject|1|||
129680108|NCT00844519|466788364|FG001|Overall Study|Withdrawal by Subject|1|||
129680109|NCT00844519|466788363|FG000|Overall Study|Adverse Event|1|||
129680110|NCT00844519|466788364|FG001|Overall Study|Adverse Event|0|||
129680111|NCT00226655|466788365|FG000|Overall Study|Death|13|||
129680112|NCT00226655|466788365|FG000|Overall Study|Withdrawal by Subject|15|||
129680113|NCT00226655|466788365|FG000|Overall Study|Adverse Event|35|||
129680114|NCT00226655|466788365|FG000|Overall Study|Physician Decision|6|||
129680115|NCT00226655|466788365|FG000|Overall Study|Clinical deterioration|10|||
129680116|NCT06438601|466788366|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
129680117|NCT06438601|466788367|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
129680118|NCT06438601|466788366|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
129680119|NCT06438601|466788367|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
129680120|NCT01311661|466788370|FG000|Overall Study|Adverse Event|2|||
129680121|NCT01311661|466788370|FG000|Overall Study|Protocol Violation|3|||
129680122|NCT01311661|466788370|FG000|Overall Study|Withdrawal by Subject|2|||
129770244|NCT02594124|467126576|FG001|Overall Study|Adverse Event|5|||
129770245|NCT02594124|467126577|FG002|Overall Study|Adverse Event|8|||
129770246|NCT02594124|467126578|FG003|Overall Study|Adverse Event|1|||
129770247|NCT02594124|467126579|FG004|Overall Study|Adverse Event|0|||
129770248|NCT02594124|467126580|FG005|Overall Study|Adverse Event|0|||
129770249|NCT02594124|467126581|FG006|Overall Study|Adverse Event|2|||
129770250|NCT02594124|467126582|FG007|Overall Study|Adverse Event|2|||
129770251|NCT02594124|467126583|FG008|Overall Study|Adverse Event|0|||
129770252|NCT02594124|467126575|FG000|Overall Study|Withdrawal by Subject|2|||
129770253|NCT02594124|467126576|FG001|Overall Study|Withdrawal by Subject|3|||
129770254|NCT02594124|467126577|FG002|Overall Study|Withdrawal by Subject|5|||
129770255|NCT02594124|467126578|FG003|Overall Study|Withdrawal by Subject|1|||
129770256|NCT02594124|467126579|FG004|Overall Study|Withdrawal by Subject|8|||
129770257|NCT02594124|467126580|FG005|Overall Study|Withdrawal by Subject|4|||
129770258|NCT02594124|467126581|FG006|Overall Study|Withdrawal by Subject|13|||
129770259|NCT02594124|467126582|FG007|Overall Study|Withdrawal by Subject|19|||
129770260|NCT02594124|467126583|FG008|Overall Study|Withdrawal by Subject|0|||
129770261|NCT02594124|467126575|FG000|Overall Study|Physician Decision|0|||
129770262|NCT02594124|467126576|FG001|Overall Study|Physician Decision|2|||
129770263|NCT02594124|467126577|FG002|Overall Study|Physician Decision|0|||
129770264|NCT02594124|467126578|FG003|Overall Study|Physician Decision|0|||
129770265|NCT02594124|467126579|FG004|Overall Study|Physician Decision|0|||
129770266|NCT02594124|467126580|FG005|Overall Study|Physician Decision|0|||
129770267|NCT02594124|467126581|FG006|Overall Study|Physician Decision|0|||
129770268|NCT02594124|467126582|FG007|Overall Study|Physician Decision|1|||
129770269|NCT02594124|467126583|FG008|Overall Study|Physician Decision|0|||
129770270|NCT02594124|467126575|FG000|Overall Study|Commercial drug|0|||
129770271|NCT02594124|467126576|FG001|Overall Study|Commercial drug|1|||
129770272|NCT02594124|467126577|FG002|Overall Study|Commercial drug|6|||
129770273|NCT02594124|467126578|FG003|Overall Study|Commercial drug|3|||
129770274|NCT02594124|467126579|FG004|Overall Study|Commercial drug|0|||
129770275|NCT02594124|467126580|FG005|Overall Study|Commercial drug|0|||
129770276|NCT02594124|467126581|FG006|Overall Study|Commercial drug|7|||
129770277|NCT02594124|467126582|FG007|Overall Study|Commercial drug|11|||
129770278|NCT02594124|467126583|FG008|Overall Study|Commercial drug|2|||
129770279|NCT02594124|467126575|FG000|Overall Study|Reason Not Specified|1|||
129770280|NCT02594124|467126576|FG001|Overall Study|Reason Not Specified|3|||
129770281|NCT02594124|467126577|FG002|Overall Study|Reason Not Specified|4|||
129770282|NCT02594124|467126578|FG003|Overall Study|Reason Not Specified|0|||
129770283|NCT02594124|467126579|FG004|Overall Study|Reason Not Specified|0|||
129770284|NCT02594124|467126580|FG005|Overall Study|Reason Not Specified|1|||
129770285|NCT02594124|467126581|FG006|Overall Study|Reason Not Specified|1|||
129770286|NCT02594124|467126582|FG007|Overall Study|Reason Not Specified|6|||
129770287|NCT02594124|467126583|FG008|Overall Study|Reason Not Specified|1|||
129770288|NCT01899040|467126588|FG000|Overall Study|Randomized in error|0|||
129770289|NCT01899040|467126589|FG001|Overall Study|Randomized in error|1|||
129770290|NCT01899040|467126590|FG002|Overall Study|Randomized in error|1|||
129770291|NCT01899040|467126588|FG000|Overall Study|Adverse Event|3|||
129770292|NCT01899040|467126589|FG001|Overall Study|Adverse Event|1|||
129770293|NCT01899040|467126590|FG002|Overall Study|Adverse Event|2|||
129770294|NCT01899040|467126588|FG000|Overall Study|Unspecified reasons|4|||
129770295|NCT01899040|467126589|FG001|Overall Study|Unspecified reasons|4|||
129770296|NCT01899040|467126590|FG002|Overall Study|Unspecified reasons|0|||
129770297|NCT01899040|467126588|FG000|Overall Study|Compliance issues|1|||
129770298|NCT01899040|467126589|FG001|Overall Study|Compliance issues|2|||
129770299|NCT01899040|467126590|FG002|Overall Study|Compliance issues|0|||
129770300|NCT00905164|467126596|FG000|Period 1|Protocol Violation|0|||
129770301|NCT00905164|467126597|FG001|Period 1|Protocol Violation|1|||
129770302|NCT01256788|467128520|FG000|Overall Study|Lost to Follow-up|5|||
129770303|NCT01256788|467128521|FG001|Overall Study|Lost to Follow-up|8|||
129770304|NCT01256788|467128522|FG002|Overall Study|Lost to Follow-up|3|||
129770305|NCT03312634|467128523|FG000|Overall Study|Adverse Event|11|||
129770306|NCT03312634|467128524|FG001|Overall Study|Adverse Event|0|||
129770307|NCT03312634|467128523|FG000|Overall Study|Sponsor request|2|||
129770308|NCT03312634|467128524|FG001|Overall Study|Sponsor request|0|||
129770309|NCT03312634|467128523|FG000|Overall Study|Withdrawal by Subject|31|||
129770310|NCT03312634|467128524|FG001|Overall Study|Withdrawal by Subject|9|||
129770311|NCT03312634|467128523|FG000|Overall Study|Enrolled in an interventional study|0|||
129770312|NCT03312634|467128524|FG001|Overall Study|Enrolled in an interventional study|52|||
129770313|NCT03312634|467128523|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
129770314|NCT03312634|467128524|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
129770315|NCT03312634|467128523|FG000|Overall Study|Death|0|||
129770316|NCT03312634|467128524|FG001|Overall Study|Death|1|||
129770317|NCT03312634|467128523|FG000|Overall Study|Non-compliance|0|||
129770318|NCT03312634|467128524|FG001|Overall Study|Non-compliance|2|||
129770319|NCT03312634|467128523|FG000|Overall Study|Lost to Follow-up|0|||
129770320|NCT03312634|467128524|FG001|Overall Study|Lost to Follow-up|1|||
129884425|NCT01275196|467536393|FG001|Overall Study|Adverse Event|5|||
129770321|NCT03312634|467128523|FG000|Overall Study|Enrolled into non-interventional study|0|||
129770322|NCT03312634|467128524|FG001|Overall Study|Enrolled into non-interventional study|5|||
129770323|NCT03312634|467128523|FG000|Overall Study|Worsening clinical condition|0|||
129770324|NCT03312634|467128524|FG001|Overall Study|Worsening clinical condition|1|||
129770325|NCT03312634|467128523|FG000|Overall Study|Participant did not want to travel|0|||
129770326|NCT03312634|467128524|FG001|Overall Study|Participant did not want to travel|1|||
129770327|NCT03312634|467128523|FG000|Overall Study|Physician Decision|1|||
129770328|NCT03312634|467128524|FG001|Overall Study|Physician Decision|0|||
129770329|NCT03312634|467128523|FG000|Overall Study|Other|13|||
129770330|NCT03312634|467128524|FG001|Overall Study|Other|0|||
129770331|NCT05366738|467128525|FG000|Overall Study|Adverse Event|0|||
129770332|NCT05366738|467128526|FG001|Overall Study|Adverse Event|1|||
129770333|NCT05366738|467128527|FG002|Overall Study|Adverse Event|0|||
129770334|NCT00906204|467128530|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
129770335|NCT00906204|467128531|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
129770336|NCT00906204|467128530|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
129770337|NCT00906204|467128531|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
129770338|NCT00906204|467128530|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
129770339|NCT00906204|467128531|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
129770340|NCT00906204|467128530|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
129770341|NCT00906204|467128531|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
129770342|NCT00906204|467128530|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
129770343|NCT00906204|467128531|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
129770344|NCT05291520|467128532|FG000|Overall Study|Lost to Follow-up|0|||
129770345|NCT05291520|467128533|FG001|Overall Study|Lost to Follow-up|0|||
129770346|NCT05291520|467128534|FG002|Overall Study|Lost to Follow-up|1|||
129770347|NCT01347112|467128535|FG000|Overall Study|Withdrawal by Subject|1|||
129770348|NCT01347112|467128536|FG001|Overall Study|Withdrawal by Subject|7|||
129770349|NCT01347112|467128535|FG000|Overall Study|Lost to Follow-up|3|||
129770350|NCT01347112|467128536|FG001|Overall Study|Lost to Follow-up|5|||
129770351|NCT00696072|467128539|FG000|Overall Study|continuing active treatment|10|||
129770352|NCT00696072|467128540|FG001|Overall Study|continuing active treatment|13|||
129770353|NCT00696072|467128539|FG000|Overall Study|Adverse Event|10|||
129770354|NCT00696072|467128540|FG001|Overall Study|Adverse Event|6|||
129770355|NCT00696072|467128539|FG000|Overall Study|Patient Request|3|||
129770356|NCT00696072|467128540|FG001|Overall Study|Patient Request|7|||
129770357|NCT00696072|467128539|FG000|Overall Study|Investigator Request|1|||
129770358|NCT00696072|467128540|FG001|Overall Study|Investigator Request|4|||
129770359|NCT00696072|467128539|FG000|Overall Study|Sponsor Request|0|||
129770360|NCT00696072|467128540|FG001|Overall Study|Sponsor Request|1|||
129770361|NCT00696072|467128539|FG000|Overall Study|Disease Progression|32|||
129770362|NCT00696072|467128540|FG001|Overall Study|Disease Progression|30|||
129770363|NCT00696072|467128539|FG000|Overall Study|Non-specified|1|||
129770364|NCT00696072|467128540|FG001|Overall Study|Non-specified|2|||
129770365|NCT01597596|467128541|FG000|Overall Study|Study terminated by sponsor|1|||
129770366|NCT01597596|467128542|FG001|Overall Study|Study terminated by sponsor|0|||
129770367|NCT01597596|467128541|FG000|Overall Study|Physician Decision|0|||
129770368|NCT01597596|467128542|FG001|Overall Study|Physician Decision|1|||
129770369|NCT02141295|467128557|FG000|Overall Study|Adverse Event|1|||
129770370|NCT02141295|467128558|FG001|Overall Study|Adverse Event|18|||
129770371|NCT02141295|467128559|FG002|Overall Study|Adverse Event|11|||
129770372|NCT02141295|467128557|FG000|Overall Study|Physician Decision|2|||
129770373|NCT02141295|467128558|FG001|Overall Study|Physician Decision|19|||
129770374|NCT02141295|467128559|FG002|Overall Study|Physician Decision|14|||
129770375|NCT02141295|467128557|FG000|Overall Study|Study terminated by sponsor|0|||
129770376|NCT02141295|467128558|FG001|Overall Study|Study terminated by sponsor|6|||
129770377|NCT02141295|467128559|FG002|Overall Study|Study terminated by sponsor|6|||
129770378|NCT02141295|467128557|FG000|Overall Study|Non-compliance|0|||
129770379|NCT02141295|467128558|FG001|Overall Study|Non-compliance|1|||
129770380|NCT02141295|467128559|FG002|Overall Study|Non-compliance|0|||
129770381|NCT02141295|467128557|FG000|Overall Study|Progressive disease|3|||
129770382|NCT02141295|467128558|FG001|Overall Study|Progressive disease|32|||
129770383|NCT02141295|467128559|FG002|Overall Study|Progressive disease|50|||
129770384|NCT02141295|467128557|FG000|Overall Study|Reason not specified|0|||
129770385|NCT02141295|467128558|FG001|Overall Study|Reason not specified|9|||
129770386|NCT02141295|467128559|FG002|Overall Study|Reason not specified|10|||
129770387|NCT02141295|467128557|FG000|Overall Study|Withdrawal by Subject|0|||
129680123|NCT03188822|466788371|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
129680124|NCT03188822|466788371|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
129680125|NCT03805841|466788372|FG000|Overall Study|Clinical Progression|2|||
129680126|NCT03805841|466788373|FG001|Overall Study|Clinical Progression|0|||
129680127|NCT03805841|466788374|FG002|Overall Study|Clinical Progression|0|||
129680128|NCT03805841|466788372|FG000|Overall Study|Death|0|||
129680129|NCT03805841|466788373|FG001|Overall Study|Death|3|||
129680130|NCT03805841|466788374|FG002|Overall Study|Death|1|||
129680131|NCT03805841|466788372|FG000|Overall Study|Lost to Follow-up|0|||
129680132|NCT03805841|466788373|FG001|Overall Study|Lost to Follow-up|0|||
129680133|NCT03805841|466788374|FG002|Overall Study|Lost to Follow-up|1|||
129680134|NCT03805841|466788372|FG000|Overall Study|Withdrawal by Subject|2|||
129680135|NCT03805841|466788373|FG001|Overall Study|Withdrawal by Subject|3|||
129680136|NCT03805841|466788374|FG002|Overall Study|Withdrawal by Subject|0|||
129680137|NCT03805841|466788372|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
129680138|NCT03805841|466788373|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
129680139|NCT03805841|466788374|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
129680140|NCT02460289|466788377|FG000|Overall Study|Adverse Event|1|||
129680141|NCT02460289|466788377|FG000|Overall Study|Withdrawal by Subject|8|||
129680142|NCT02460289|466788377|FG000|Overall Study|Lost to Follow-up|1|||
129680143|NCT01977846|466788378|FG000|Total Study - Prospective|Death|0|||
129680144|NCT01977846|466788379|FG001|Total Study - Prospective|Death|1|||
129680145|NCT01977846|466788378|FG000|Total Study - Prospective|Lost to Follow-up|0|||
129680146|NCT01977846|466788379|FG001|Total Study - Prospective|Lost to Follow-up|8|||
129680147|NCT01977846|466788378|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
129680148|NCT01977846|466788379|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
129680149|NCT01977846|466788378|FG000|Total Study - Prospective|Not available at time of visit|0|||
129680150|NCT01977846|466788379|FG001|Total Study - Prospective|Not available at time of visit|5|||
129680151|NCT01977846|466788378|FG000|Total Study - Prospective|No show|0|||
129680152|NCT01977846|466788379|FG001|Total Study - Prospective|No show|1|||
129680153|NCT01977846|466788378|FG000|Total Study - Prospective|Protocol Violation|0|||
129680154|NCT01977846|466788379|FG001|Total Study - Prospective|Protocol Violation|1|||
129680155|NCT02164916|466788380|FG000|Overall Study|Adverse Event|3|||
129680156|NCT02164916|466788381|FG001|Overall Study|Adverse Event|8|||
129680157|NCT02164916|466788380|FG000|Overall Study|Death|1|||
129680158|NCT02164916|466788381|FG001|Overall Study|Death|1|||
129680159|NCT02164916|466788380|FG000|Overall Study|Refusal unrelated to adverse event|3|||
129680160|NCT02164916|466788381|FG001|Overall Study|Refusal unrelated to adverse event|7|||
129680161|NCT02164916|466788380|FG000|Overall Study|Progression|37|||
129680162|NCT02164916|466788381|FG001|Overall Study|Progression|26|||
129680163|NCT02164916|466788380|FG000|Overall Study|Not protocol specified|5|||
129680164|NCT02164916|466788381|FG001|Overall Study|Not protocol specified|1|||
129680165|NCT02164916|466788380|FG000|Overall Study|Reason under review|1|||
129680166|NCT02164916|466788381|FG001|Overall Study|Reason under review|6|||
129680167|NCT02164916|466788380|FG000|Overall Study|Not eligible|2|||
129680168|NCT02164916|466788381|FG001|Overall Study|Not eligible|5|||
129680169|NCT00596635|466788387|FG000|Overall Study|Lost to Follow-up|0|||
129680170|NCT00596635|466788388|FG001|Overall Study|Lost to Follow-up|2|||
129680171|NCT00596635|466788389|FG002|Overall Study|Lost to Follow-up|0|||
129680172|NCT00596635|466788387|FG000|Overall Study|Treatment for symptomatic UTI|4|||
129680173|NCT00596635|466788388|FG001|Overall Study|Treatment for symptomatic UTI|6|||
129680174|NCT00596635|466788389|FG002|Overall Study|Treatment for symptomatic UTI|3|||
129680175|NCT00596635|466788387|FG000|Overall Study|Hip fracture|2|||
129680176|NCT00596635|466788388|FG001|Overall Study|Hip fracture|3|||
129680177|NCT00596635|466788389|FG002|Overall Study|Hip fracture|3|||
129680178|NCT00596635|466788387|FG000|Overall Study|Could not provide urine specimen|1|||
129680179|NCT00596635|466788388|FG001|Overall Study|Could not provide urine specimen|2|||
129680180|NCT00596635|466788389|FG002|Overall Study|Could not provide urine specimen|2|||
129680181|NCT00127803|466788390|FG000|Overall Study|Adverse Event|2|||
129680182|NCT00127803|466788391|FG001|Overall Study|Adverse Event|0|||
129680183|NCT00127803|466788392|FG002|Overall Study|Adverse Event|0|||
129680184|NCT00127803|466788393|FG003|Overall Study|Adverse Event|0|||
129680185|NCT00127803|466788390|FG000|Overall Study|Withdrawal by Subject|1|||
129680186|NCT00127803|466788391|FG001|Overall Study|Withdrawal by Subject|0|||
129770388|NCT02141295|467128558|FG001|Overall Study|Withdrawal by Subject|9|||
129770389|NCT02141295|467128559|FG002|Overall Study|Withdrawal by Subject|4|||
129770390|NCT01710501|467128560|FG000|Overall Study|Lost to Follow-up|2|||
129770391|NCT01710501|467128561|FG001|Overall Study|Lost to Follow-up|0|||
129770392|NCT01710501|467128562|FG002|Overall Study|Lost to Follow-up|0|||
129770393|NCT02536976|467128563|FG000|Overall Study|Physician Decision|0|||
129770394|NCT02536976|467128564|FG001|Overall Study|Physician Decision|1|||
129770395|NCT01389596|467128567|FG000|Overall Study|Protocol Violation|3|||
129770396|NCT01389596|467128568|FG001|Overall Study|Protocol Violation|4|||
129770397|NCT01389596|467128569|FG002|Overall Study|Protocol Violation|3|||
129770398|NCT01389596|467128567|FG000|Overall Study|Withdrawal by Subject|1|||
129770399|NCT01389596|467128568|FG001|Overall Study|Withdrawal by Subject|2|||
129770400|NCT01389596|467128569|FG002|Overall Study|Withdrawal by Subject|2|||
129770401|NCT01389596|467128567|FG000|Overall Study|Insufficient Clinical Response|3|||
129770402|NCT01389596|467128568|FG001|Overall Study|Insufficient Clinical Response|4|||
129770403|NCT01389596|467128569|FG002|Overall Study|Insufficient Clinical Response|5|||
129770404|NCT01389596|467128567|FG000|Overall Study|Adverse Event|1|||
129770405|NCT01389596|467128568|FG001|Overall Study|Adverse Event|4|||
129770406|NCT01389596|467128569|FG002|Overall Study|Adverse Event|0|||
129770407|NCT01389596|467128567|FG000|Overall Study|Death|0|||
129770408|NCT01389596|467128568|FG001|Overall Study|Death|1|||
129770409|NCT01389596|467128569|FG002|Overall Study|Death|0|||
129770410|NCT01389596|467128567|FG000|Overall Study|Other Unspecified|2|||
129770411|NCT01389596|467128568|FG001|Overall Study|Other Unspecified|1|||
129770412|NCT01389596|467128569|FG002|Overall Study|Other Unspecified|0|||
129770413|NCT01671319|467128570|FG000|Overall Study|Withdrawal by Subject|1|||
129770414|NCT01709084|467128571|FG000|Overall Study|Lost to Follow-up|4|||
129770415|NCT01709084|467128572|FG001|Overall Study|Lost to Follow-up|7|||
129770416|NCT01709084|467128571|FG000|Overall Study|Withdrawal by Subject|2|||
129770417|NCT01709084|467128572|FG001|Overall Study|Withdrawal by Subject|2|||
129770418|NCT01709084|467128571|FG000|Overall Study|Adverse Event|5|||
129770419|NCT01709084|467128572|FG001|Overall Study|Adverse Event|0|||
129770420|NCT01709084|467128571|FG000|Overall Study|Other|5|||
129770421|NCT01709084|467128572|FG001|Overall Study|Other|3|||
129770422|NCT01709084|467128571|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
129770423|NCT01709084|467128572|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
129770424|NCT01709084|467128571|FG000|Overall Study|Not Treated|0|||
129770425|NCT01709084|467128572|FG001|Overall Study|Not Treated|2|||
129770426|NCT02144610|467128573|FG000|Overall Study|Physician Decision|1|||
129770427|NCT02144610|467128574|FG001|Overall Study|Physician Decision|0|||
129770428|NCT02144610|467128573|FG000|Overall Study|Withdrawal by Subject|1|||
129770429|NCT02144610|467128574|FG001|Overall Study|Withdrawal by Subject|5|||
129770430|NCT02144610|467128573|FG000|Overall Study|Death|2|||
129770431|NCT02144610|467128574|FG001|Overall Study|Death|2|||
129770432|NCT02144610|467128573|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
129770433|NCT02144610|467128574|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
129770434|NCT02144610|467128573|FG000|Overall Study|Other|0|||
129770435|NCT02144610|467128574|FG001|Overall Study|Other|1|||
129770436|NCT01054885|467128575|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
129770437|NCT01054885|467128576|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129770438|NCT01054885|467128577|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129770439|NCT01054885|467128578|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129770440|NCT01054885|467128579|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129770441|NCT01054885|467128580|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129770442|NCT01054885|467128581|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129770443|NCT01054885|467128575|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
129770444|NCT01054885|467128576|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
129770445|NCT01054885|467128577|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
129770446|NCT01054885|467128578|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
129770447|NCT01054885|467128579|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
129770448|NCT01054885|467128580|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
129770449|NCT01054885|467128581|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
129770450|NCT01054885|467128575|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
129770451|NCT01054885|467128576|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129770452|NCT01054885|467128577|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129770453|NCT01054885|467128578|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129770454|NCT01054885|467128579|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129770455|NCT01054885|467128580|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129770456|NCT01054885|467128581|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129770457|NCT01054885|467128575|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
129770458|NCT01054885|467128576|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129770459|NCT01054885|467128577|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129680187|NCT00127803|466788392|FG002|Overall Study|Withdrawal by Subject|0|||
129680188|NCT00127803|466788393|FG003|Overall Study|Withdrawal by Subject|0|||
129680189|NCT00127803|466788390|FG000|Overall Study|Lost to Follow-up|0|||
129680190|NCT00127803|466788391|FG001|Overall Study|Lost to Follow-up|0|||
129680191|NCT00127803|466788392|FG002|Overall Study|Lost to Follow-up|0|||
129680192|NCT00127803|466788393|FG003|Overall Study|Lost to Follow-up|1|||
129680193|NCT01925417|466788398|FG000|Overall Study|Withdrawal by Subject|2|||
129680194|NCT01925417|466788398|FG000|Overall Study|Death|1|||
129680195|NCT03454555|466790671|FG000|Overall Study|Death|6|||
129680196|NCT03454555|466790672|FG001|Overall Study|Death|6|||
129680197|NCT03454555|466790671|FG000|Overall Study|Lost to Follow-up|31|||
129680198|NCT03454555|466790672|FG001|Overall Study|Lost to Follow-up|12|||
129680199|NCT03454555|466790671|FG000|Overall Study|Physician Decision|2|||
129680200|NCT03454555|466790672|FG001|Overall Study|Physician Decision|6|||
129680201|NCT03454555|466790671|FG000|Overall Study|Withdrawal by Subject|34|||
129680202|NCT03454555|466790672|FG001|Overall Study|Withdrawal by Subject|5|||
129680203|NCT03454555|466790671|FG000|Overall Study|Ineligible|1|||
129680204|NCT03454555|466790672|FG001|Overall Study|Ineligible|5|||
129680205|NCT01386385|466790673|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
129680206|NCT01386385|466790674|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680207|NCT01386385|466790675|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680208|NCT01386385|466790676|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680209|NCT01386385|466790677|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680210|NCT01386385|466790678|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680211|NCT01386385|466790679|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680212|NCT01386385|466790680|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
129680213|NCT01386385|466790673|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
129680214|NCT01386385|466790674|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680215|NCT01386385|466790675|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680216|NCT01386385|466790676|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680217|NCT01386385|466790677|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680218|NCT01386385|466790678|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680219|NCT01386385|466790679|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680220|NCT01386385|466790680|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
129680221|NCT01386385|466790673|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680222|NCT01386385|466790674|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680223|NCT01386385|466790675|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
129680224|NCT01386385|466790676|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680225|NCT01386385|466790677|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680226|NCT01386385|466790678|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680227|NCT01386385|466790679|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680228|NCT01386385|466790680|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
129680229|NCT01386385|466790673|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680230|NCT01386385|466790674|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680231|NCT01386385|466790675|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680232|NCT01386385|466790676|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680233|NCT01386385|466790677|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
129680234|NCT01386385|466790678|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680235|NCT01386385|466790679|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680236|NCT01386385|466790680|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
129680237|NCT01386385|466790673|FG000|Phase II Concurrent CRT|Adverse Event|0|||
129680238|NCT01386385|466790674|FG001|Phase II Concurrent CRT|Adverse Event|0|||
129680239|NCT01386385|466790675|FG002|Phase II Concurrent CRT|Adverse Event|0|||
129680240|NCT01386385|466790676|FG003|Phase II Concurrent CRT|Adverse Event|0|||
129680241|NCT01386385|466790677|FG004|Phase II Concurrent CRT|Adverse Event|0|||
129680242|NCT01386385|466790678|FG005|Phase II Concurrent CRT|Adverse Event|0|||
129680243|NCT01386385|466790679|FG006|Phase II Concurrent CRT|Adverse Event|3|||
129680244|NCT01386385|466790680|FG007|Phase II Concurrent CRT|Adverse Event|3|||
129680245|NCT01386385|466790673|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680246|NCT01386385|466790674|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680247|NCT01386385|466790675|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680248|NCT01386385|466790676|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680249|NCT01386385|466790677|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680250|NCT01386385|466790678|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680251|NCT01386385|466790679|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
129680252|NCT01386385|466790680|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
129680253|NCT01386385|466790673|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
129680254|NCT01386385|466790674|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
129680255|NCT01386385|466790675|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
129680256|NCT01386385|466790676|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
129680257|NCT01386385|466790677|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
129680258|NCT01386385|466790678|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
129707560|NCT01076010|466892039|FG001|Overall Study|Adverse Event|2|||
129770460|NCT01054885|467128578|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129770461|NCT01054885|467128579|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129770462|NCT01054885|467128580|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129770463|NCT01054885|467128581|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129770464|NCT01054885|467128575|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
129770465|NCT01054885|467128576|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
129770466|NCT01054885|467128577|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
129770467|NCT01054885|467128578|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
129770468|NCT01054885|467128579|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
129770469|NCT01054885|467128580|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
129770470|NCT01054885|467128581|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
129680259|NCT01386385|466790679|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
129680260|NCT01386385|466790680|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
129680261|NCT01386385|466790673|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680262|NCT01386385|466790674|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680263|NCT01386385|466790675|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680264|NCT01386385|466790676|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680265|NCT01386385|466790677|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680266|NCT01386385|466790678|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680267|NCT01386385|466790679|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
129680268|NCT01386385|466790680|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
129680269|NCT01386385|466790673|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
129680270|NCT01386385|466790674|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
129680271|NCT01386385|466790675|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
129680272|NCT01386385|466790676|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
129680273|NCT01386385|466790677|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
129680274|NCT01386385|466790678|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
129680275|NCT01386385|466790679|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
129680276|NCT01386385|466790680|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
129680277|NCT05399485|466790681|FG000|DBT Phase|Other|6|||
129680278|NCT05399485|466790682|FG001|DBT Phase|Other|5|||
129680279|NCT05399485|466790681|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
129680280|NCT05399485|466790682|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
129680281|NCT05399485|466790681|FG000|DBT Phase|Withdrawal by Subject|3|||
129680282|NCT05399485|466790682|FG001|DBT Phase|Withdrawal by Subject|2|||
129680283|NCT05399485|466790681|FG000|DBT Phase|Protocol Violation|2|||
129680284|NCT05399485|466790682|FG001|DBT Phase|Protocol Violation|1|||
129680285|NCT05399485|466790681|FG000|DBT Phase|Physician Decision|0|||
129680286|NCT05399485|466790682|FG001|DBT Phase|Physician Decision|1|||
129680287|NCT05399485|466790681|FG000|DBT Phase|Adverse Event|2|||
129680288|NCT05399485|466790682|FG001|DBT Phase|Adverse Event|1|||
129680289|NCT05399485|466790681|FG000|OLE Phase|Not reported|0|||
129680290|NCT05399485|466790682|FG001|OLE Phase|Not reported|1|||
129680291|NCT05399485|466790681|FG000|OLE Phase|Other|3|||
129680292|NCT05399485|466790682|FG001|OLE Phase|Other|3|||
129680293|NCT05399485|466790681|FG000|OLE Phase|Withdrawal by Subject|8|||
129680294|NCT05399485|466790682|FG001|OLE Phase|Withdrawal by Subject|5|||
129680295|NCT05399485|466790681|FG000|OLE Phase|Pregnancy|0|||
129680296|NCT05399485|466790682|FG001|OLE Phase|Pregnancy|1|||
129680297|NCT05399485|466790681|FG000|OLE Phase|Physician Decision|2|||
129680298|NCT05399485|466790682|FG001|OLE Phase|Physician Decision|0|||
129680299|NCT05399485|466790681|FG000|OLE Phase|Adverse Event|0|||
129680300|NCT05399485|466790682|FG001|OLE Phase|Adverse Event|1|||
129680301|NCT05399485|466790681|FG000|OLE Phase|Ongoing in the OLE Phase|141|||
129680302|NCT05399485|466790682|FG001|OLE Phase|Ongoing in the OLE Phase|140|||
129680303|NCT03405870|466790683|FG000|Overall Study|Withdrawal|1|||
129680304|NCT03405870|466790684|FG001|Overall Study|Withdrawal|0|||
129680305|NCT03405870|466790685|FG002|Overall Study|Withdrawal|1|||
129770471|NCT01054885|467128575|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
129770472|NCT01054885|467128576|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129680306|NCT03405870|466790686|FG003|Overall Study|Withdrawal|0|||
129680307|NCT03405870|466790687|FG004|Overall Study|Withdrawal|0|||
129680308|NCT03405870|466790688|FG005|Overall Study|Withdrawal|0|||
129680309|NCT03405870|466790689|FG006|Overall Study|Withdrawal|1|||
129680310|NCT03405870|466790690|FG007|Overall Study|Withdrawal|0|||
129680311|NCT05172609|466790691|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
129680312|NCT05172609|466790692|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
129680313|NCT05172609|466790691|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
129680314|NCT05172609|466790692|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
129680315|NCT05172609|466790691|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
129680316|NCT05172609|466790692|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
129680317|NCT03737994|466790693|FG000|Overall Study|Withdrawal by Subject|0|||
129680318|NCT03737994|466790694|FG001|Overall Study|Withdrawal by Subject|0|||
129680319|NCT03737994|466790695|FG002|Overall Study|Withdrawal by Subject|0|||
129680320|NCT03737994|466790696|FG003|Overall Study|Withdrawal by Subject|0|||
129680321|NCT03737994|466790697|FG004|Overall Study|Withdrawal by Subject|0|||
129680322|NCT03737994|466790698|FG005|Overall Study|Withdrawal by Subject|0|||
129680323|NCT03737994|466790699|FG006|Overall Study|Withdrawal by Subject|1|||
129680324|NCT03846479|466790700|FG000|Overall Study|Death|8|||
129680325|NCT03846479|466790700|FG000|Overall Study|Lost to Follow-up|1|||
129680326|NCT01473134|466790701|FG000|Overall Study|Lost to Follow-up|21|||
129680327|NCT01473134|466790702|FG001|Overall Study|Lost to Follow-up|13|||
129680328|NCT01473134|466790701|FG000|Overall Study|Protocol Violation|32|||
129680329|NCT01473134|466790702|FG001|Overall Study|Protocol Violation|19|||
129680330|NCT01473134|466790701|FG000|Overall Study|Withdrawal by Subject|1|||
129680331|NCT01473134|466790702|FG001|Overall Study|Withdrawal by Subject|2|||
129680332|NCT01473134|466790701|FG000|Overall Study|Death|0|||
129680333|NCT01473134|466790702|FG001|Overall Study|Death|1|||
129680334|NCT01473134|466790701|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
129680335|NCT01473134|466790702|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
129680336|NCT05020015|466790705|FG000|Overall Study|Ongoing on study|1|||
129680337|NCT05020015|466790706|FG001|Overall Study|Ongoing on study|3|||
129680338|NCT05020015|466790707|FG002|Overall Study|Ongoing on study|4|||
129680339|NCT05020015|466790708|FG003|Overall Study|Ongoing on study|7|||
129680340|NCT05020015|466790705|FG000|Overall Study|Death|2|||
129680341|NCT05020015|466790706|FG001|Overall Study|Death|3|||
129680342|NCT05020015|466790707|FG002|Overall Study|Death|4|||
129680343|NCT05020015|466790708|FG003|Overall Study|Death|0|||
129680344|NCT05020015|466790705|FG000|Overall Study|Withdrawal by Subject|0|||
129680345|NCT05020015|466790706|FG001|Overall Study|Withdrawal by Subject|0|||
129680346|NCT05020015|466790707|FG002|Overall Study|Withdrawal by Subject|1|||
129680347|NCT05020015|466790708|FG003|Overall Study|Withdrawal by Subject|0|||
129680348|NCT05020015|466790705|FG000|Overall Study|Reason Not Specified|0|||
129680349|NCT05020015|466790706|FG001|Overall Study|Reason Not Specified|0|||
129680350|NCT05020015|466790707|FG002|Overall Study|Reason Not Specified|2|||
129680351|NCT05020015|466790708|FG003|Overall Study|Reason Not Specified|0|||
129680352|NCT00614393|466790715|FG000|Overall Study|Adverse Event|20|||
129680353|NCT00614393|466790716|FG001|Overall Study|Adverse Event|2|||
129680354|NCT00614393|466790717|FG002|Overall Study|Adverse Event|3|||
129680355|NCT00614393|466790718|FG003|Overall Study|Adverse Event|13|||
129680356|NCT00614393|466790719|FG004|Overall Study|Adverse Event|21|||
129680357|NCT00614393|466790715|FG000|Overall Study|Lost to Follow-up|0|||
129680358|NCT00614393|466790716|FG001|Overall Study|Lost to Follow-up|0|||
129680359|NCT00614393|466790717|FG002|Overall Study|Lost to Follow-up|0|||
129680360|NCT00614393|466790718|FG003|Overall Study|Lost to Follow-up|1|||
129680361|NCT00614393|466790719|FG004|Overall Study|Lost to Follow-up|2|||
129680362|NCT00614393|466790715|FG000|Overall Study|Physician Decision|17|||
129680363|NCT00614393|466790716|FG001|Overall Study|Physician Decision|0|||
129680364|NCT00614393|466790717|FG002|Overall Study|Physician Decision|1|||
129680365|NCT00614393|466790718|FG003|Overall Study|Physician Decision|8|||
129680366|NCT00614393|466790719|FG004|Overall Study|Physician Decision|9|||
129680367|NCT00614393|466790715|FG000|Overall Study|Progressive Disease|118|||
129680368|NCT00614393|466790716|FG001|Overall Study|Progressive Disease|5|||
129680369|NCT00614393|466790717|FG002|Overall Study|Progressive Disease|5|||
129680370|NCT00614393|466790718|FG003|Overall Study|Progressive Disease|138|||
129680371|NCT00614393|466790719|FG004|Overall Study|Progressive Disease|130|||
129680372|NCT00614393|466790715|FG000|Overall Study|Protocol Violation|1|||
129680373|NCT00614393|466790716|FG001|Overall Study|Protocol Violation|0|||
129680374|NCT00614393|466790717|FG002|Overall Study|Protocol Violation|0|||
129680375|NCT00614393|466790718|FG003|Overall Study|Protocol Violation|0|||
129680376|NCT00614393|466790719|FG004|Overall Study|Protocol Violation|0|||
129680377|NCT00614393|466790715|FG000|Overall Study|Terminated by Sponsor|0|||
129680378|NCT00614393|466790716|FG001|Overall Study|Terminated by Sponsor|0|||
129680379|NCT00614393|466790717|FG002|Overall Study|Terminated by Sponsor|0|||
129680380|NCT00614393|466790718|FG003|Overall Study|Terminated by Sponsor|0|||
129680381|NCT00614393|466790719|FG004|Overall Study|Terminated by Sponsor|1|||
129680382|NCT00614393|466790715|FG000|Overall Study|Withdrawal by Subject|20|||
129680383|NCT00614393|466790716|FG001|Overall Study|Withdrawal by Subject|1|||
129680384|NCT00614393|466790717|FG002|Overall Study|Withdrawal by Subject|1|||
129680385|NCT00614393|466790718|FG003|Overall Study|Withdrawal by Subject|16|||
129680386|NCT00614393|466790719|FG004|Overall Study|Withdrawal by Subject|13|||
129680387|NCT00614393|466790715|FG000|Overall Study|Other|4|||
129680388|NCT00614393|466790716|FG001|Overall Study|Other|0|||
129680389|NCT00614393|466790717|FG002|Overall Study|Other|0|||
129680390|NCT00614393|466790718|FG003|Overall Study|Other|4|||
129680391|NCT00614393|466790719|FG004|Overall Study|Other|2|||
129680392|NCT00614393|466790715|FG000|Overall Study|Not Treated|0|||
129680393|NCT00614393|466790716|FG001|Overall Study|Not Treated|0|||
129680394|NCT00614393|466790717|FG002|Overall Study|Not Treated|0|||
129680395|NCT00614393|466790718|FG003|Overall Study|Not Treated|0|||
129680396|NCT00614393|466790719|FG004|Overall Study|Not Treated|2|||
129680397|NCT00855582|466790720|FG000|Overall Study|Adverse Event|2|||
129680398|NCT00855582|466790721|FG001|Overall Study|Adverse Event|6|||
129680399|NCT00855582|466790722|FG002|Overall Study|Adverse Event|3|||
129680400|NCT00855582|466790720|FG000|Overall Study|Death|1|||
129680401|NCT00855582|466790721|FG001|Overall Study|Death|0|||
129680402|NCT00855582|466790722|FG002|Overall Study|Death|0|||
129680403|NCT00855582|466790720|FG000|Overall Study|Lack of Efficacy|1|||
129680404|NCT00855582|466790721|FG001|Overall Study|Lack of Efficacy|3|||
129680405|NCT00855582|466790722|FG002|Overall Study|Lack of Efficacy|8|||
129680406|NCT00855582|466790720|FG000|Overall Study|Lost to Follow-up|1|||
129680407|NCT00855582|466790721|FG001|Overall Study|Lost to Follow-up|3|||
129680408|NCT00855582|466790722|FG002|Overall Study|Lost to Follow-up|1|||
129680409|NCT00855582|466790720|FG000|Overall Study|Physician Decision|0|||
129680410|NCT00855582|466790721|FG001|Overall Study|Physician Decision|0|||
129680411|NCT00855582|466790722|FG002|Overall Study|Physician Decision|1|||
129680412|NCT00855582|466790720|FG000|Overall Study|Protocol Violation|6|||
129680413|NCT00855582|466790721|FG001|Overall Study|Protocol Violation|2|||
129680414|NCT00855582|466790722|FG002|Overall Study|Protocol Violation|6|||
129680415|NCT00855582|466790720|FG000|Overall Study|Entry Criteria Not Met|8|||
129680416|NCT00855582|466790721|FG001|Overall Study|Entry Criteria Not Met|6|||
129680417|NCT00855582|466790722|FG002|Overall Study|Entry Criteria Not Met|3|||
129680418|NCT00855582|466790720|FG000|Overall Study|Withdrawal by Subject|7|||
129680419|NCT00855582|466790721|FG001|Overall Study|Withdrawal by Subject|4|||
129680420|NCT00855582|466790722|FG002|Overall Study|Withdrawal by Subject|8|||
129680421|NCT03345004|466790723|FG000|Overall Study|Physician Decision|1|||
129680422|NCT03345004|466790724|FG001|Overall Study|Physician Decision|0|||
129680423|NCT03345004|466790723|FG000|Overall Study|Withdrawal by Subject|0|||
129680424|NCT03345004|466790724|FG001|Overall Study|Withdrawal by Subject|1|||
129680425|NCT01013753|466790725|FG000|Overall Study|Adverse Event|8|||
129680426|NCT01013753|466790725|FG000|Overall Study|Protocol Violation|3|||
129680427|NCT01013753|466790725|FG000|Overall Study|Lost to Follow-up|1|||
129680428|NCT01013753|466790725|FG000|Overall Study|Withdrawal by Subject|2|||
129680429|NCT01013753|466790725|FG000|Overall Study|Other|2|||
129680430|NCT03320369|466790728|FG000|Overall Study|Adverse Event|1|||
129680431|NCT03320369|466790728|FG000|Overall Study|Withdrawal by Subject|2|||
129680432|NCT01732692|466790729|FG000|Overall Study|Adverse Event|0|||
129680433|NCT01732692|466790730|FG001|Overall Study|Adverse Event|1|||
129680434|NCT01281306|466790731|FG000|Overall Study|Lack of Efficacy|0|||
129680435|NCT01281306|466790732|FG001|Overall Study|Lack of Efficacy|1|||
129680436|NCT01281306|466790733|FG002|Overall Study|Lack of Efficacy|3|||
129680437|NCT01281306|466790734|FG003|Overall Study|Lack of Efficacy|0|||
129680438|NCT01281306|466790735|FG004|Overall Study|Lack of Efficacy|2|||
129680439|NCT01281306|466790736|FG005|Overall Study|Lack of Efficacy|0|||
129680440|NCT01281306|466790737|FG006|Overall Study|Lack of Efficacy|1|||
129680441|NCT01281306|466790731|FG000|Overall Study|Withdrawal by Subject|1|||
129680442|NCT01281306|466790732|FG001|Overall Study|Withdrawal by Subject|0|||
129680443|NCT01281306|466790733|FG002|Overall Study|Withdrawal by Subject|2|||
129680444|NCT01281306|466790734|FG003|Overall Study|Withdrawal by Subject|4|||
129680445|NCT01281306|466790735|FG004|Overall Study|Withdrawal by Subject|1|||
129680446|NCT01281306|466790736|FG005|Overall Study|Withdrawal by Subject|3|||
129680447|NCT01281306|466790737|FG006|Overall Study|Withdrawal by Subject|1|||
129680448|NCT01281306|466790731|FG000|Overall Study|Protocol deviation|0|||
129680449|NCT01281306|466790732|FG001|Overall Study|Protocol deviation|1|||
129680450|NCT01281306|466790733|FG002|Overall Study|Protocol deviation|1|||
129680451|NCT01281306|466790734|FG003|Overall Study|Protocol deviation|1|||
129680452|NCT01281306|466790735|FG004|Overall Study|Protocol deviation|1|||
129680453|NCT01281306|466790736|FG005|Overall Study|Protocol deviation|0|||
129680454|NCT01281306|466790737|FG006|Overall Study|Protocol deviation|0|||
129680455|NCT01281306|466790731|FG000|Overall Study|Condition no longer requires study drug|1|||
129680456|NCT01281306|466790732|FG001|Overall Study|Condition no longer requires study drug|0|||
129680457|NCT01281306|466790733|FG002|Overall Study|Condition no longer requires study drug|0|||
129770473|NCT01054885|467128577|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129770474|NCT01054885|467128578|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129770475|NCT01054885|467128579|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129770476|NCT01054885|467128580|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129770477|NCT01054885|467128581|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129770478|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
129770479|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
129770480|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
129770481|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
129770482|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
129770483|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
129680458|NCT01281306|466790734|FG003|Overall Study|Condition no longer requires study drug|0|||
129680459|NCT01281306|466790735|FG004|Overall Study|Condition no longer requires study drug|0|||
129680460|NCT01281306|466790736|FG005|Overall Study|Condition no longer requires study drug|1|||
129680461|NCT01281306|466790737|FG006|Overall Study|Condition no longer requires study drug|1|||
129680462|NCT01281306|466790731|FG000|Overall Study|Lost to Follow-up|1|||
129770484|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
129770485|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129770486|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129770487|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
129770488|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
129770489|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129770490|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
129770491|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129770492|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
129770493|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
129770494|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
129770495|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
129770496|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
129770497|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
129770498|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
129770499|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129770500|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
129770501|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
129770502|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
129770503|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
129770504|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
129770505|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129770506|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
129770507|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
129770508|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
129770509|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
129680463|NCT01281306|466790732|FG001|Overall Study|Lost to Follow-up|0|||
129680464|NCT01281306|466790733|FG002|Overall Study|Lost to Follow-up|0|||
129680465|NCT01281306|466790734|FG003|Overall Study|Lost to Follow-up|2|||
129680466|NCT01281306|466790735|FG004|Overall Study|Lost to Follow-up|0|||
129680467|NCT01281306|466790736|FG005|Overall Study|Lost to Follow-up|0|||
129680468|NCT01281306|466790737|FG006|Overall Study|Lost to Follow-up|1|||
129680469|NCT01281306|466790731|FG000|Overall Study|Death|1|||
129680470|NCT01281306|466790732|FG001|Overall Study|Death|0|||
129680471|NCT01281306|466790733|FG002|Overall Study|Death|0|||
129680472|NCT01281306|466790734|FG003|Overall Study|Death|0|||
129680473|NCT01281306|466790735|FG004|Overall Study|Death|0|||
129680474|NCT01281306|466790736|FG005|Overall Study|Death|0|||
129680475|NCT01281306|466790737|FG006|Overall Study|Death|0|||
129680476|NCT01281306|466790731|FG000|Overall Study|Adverse Event|3|||
129680477|NCT01281306|466790732|FG001|Overall Study|Adverse Event|2|||
129680478|NCT01281306|466790733|FG002|Overall Study|Adverse Event|2|||
129680479|NCT01281306|466790734|FG003|Overall Study|Adverse Event|3|||
129680480|NCT01281306|466790735|FG004|Overall Study|Adverse Event|5|||
129680481|NCT01281306|466790736|FG005|Overall Study|Adverse Event|3|||
129680482|NCT01281306|466790737|FG006|Overall Study|Adverse Event|3|||
129680483|NCT01281306|466790731|FG000|Overall Study|Randomized in error|1|||
129680484|NCT01281306|466790732|FG001|Overall Study|Randomized in error|0|||
129680485|NCT01281306|466790733|FG002|Overall Study|Randomized in error|0|||
129680486|NCT01281306|466790734|FG003|Overall Study|Randomized in error|1|||
129680487|NCT01281306|466790735|FG004|Overall Study|Randomized in error|0|||
129680488|NCT01281306|466790736|FG005|Overall Study|Randomized in error|0|||
129680489|NCT01281306|466790737|FG006|Overall Study|Randomized in error|0|||
129680490|NCT02606253|466790738|FG000|Overall Study|Adverse Event|2|||
129680491|NCT02606253|466790739|FG001|Overall Study|Adverse Event|0|||
129680492|NCT02606253|466790740|FG002|Overall Study|Adverse Event|0|||
129680493|NCT02606253|466790738|FG000|Overall Study|Protocol Violation|2|||
129680494|NCT02606253|466790739|FG001|Overall Study|Protocol Violation|1|||
129680495|NCT02606253|466790740|FG002|Overall Study|Protocol Violation|0|||
129680496|NCT02606253|466790738|FG000|Overall Study|Physician Decision|1|||
129680497|NCT02606253|466790739|FG001|Overall Study|Physician Decision|1|||
129680498|NCT02606253|466790740|FG002|Overall Study|Physician Decision|0|||
129680499|NCT03331562|466790743|FG000|Overall Study|Adverse Event|2|||
129680500|NCT03331562|466790744|FG001|Overall Study|Adverse Event|0|||
129680501|NCT03331562|466790743|FG000|Overall Study|Death|1|||
129680502|NCT03331562|466790744|FG001|Overall Study|Death|0|||
129680503|NCT03718000|466790745|FG000|Overall Study|Relocation|2|||
129680504|NCT03718000|466790746|FG001|Overall Study|Relocation|4|||
129680505|NCT03718000|466790745|FG000|Overall Study|Pregnancy|0|||
129680506|NCT03718000|466790746|FG001|Overall Study|Pregnancy|1|||
129680507|NCT05522751|466790749|FG000|Overall Study|Adverse Event|1|||
129680508|NCT02475213|466790750|FG000|Overall Study|Adverse Event|2|||
129680509|NCT02475213|466790751|FG001|Overall Study|Adverse Event|0|||
129680510|NCT02475213|466790752|FG002|Overall Study|Adverse Event|0|||
129680511|NCT02475213|466790753|FG003|Overall Study|Adverse Event|1|||
129680512|NCT02475213|466790754|FG004|Overall Study|Adverse Event|1|||
129680513|NCT02475213|466790755|FG005|Overall Study|Adverse Event|4|||
129680514|NCT02475213|466790756|FG006|Overall Study|Adverse Event|6|||
129680515|NCT02475213|466790757|FG007|Overall Study|Adverse Event|2|||
129680516|NCT02475213|466790750|FG000|Overall Study|Physician Decision|1|||
129680517|NCT02475213|466790751|FG001|Overall Study|Physician Decision|1|||
129680518|NCT02475213|466790752|FG002|Overall Study|Physician Decision|1|||
129680519|NCT02475213|466790753|FG003|Overall Study|Physician Decision|0|||
129680520|NCT02475213|466790754|FG004|Overall Study|Physician Decision|0|||
129680521|NCT02475213|466790755|FG005|Overall Study|Physician Decision|1|||
129680522|NCT02475213|466790756|FG006|Overall Study|Physician Decision|4|||
129680523|NCT02475213|466790757|FG007|Overall Study|Physician Decision|0|||
129680524|NCT02475213|466790750|FG000|Overall Study|Progressive Disease|3|||
129680525|NCT02475213|466790751|FG001|Overall Study|Progressive Disease|2|||
129680526|NCT02475213|466790752|FG002|Overall Study|Progressive Disease|2|||
129680527|NCT02475213|466790753|FG003|Overall Study|Progressive Disease|13|||
129680528|NCT02475213|466790754|FG004|Overall Study|Progressive Disease|15|||
129680529|NCT02475213|466790755|FG005|Overall Study|Progressive Disease|25|||
129680530|NCT02475213|466790756|FG006|Overall Study|Progressive Disease|30|||
129680531|NCT02475213|466790757|FG007|Overall Study|Progressive Disease|10|||
129680532|NCT02475213|466790750|FG000|Overall Study|Death|0|||
129680533|NCT02475213|466790751|FG001|Overall Study|Death|0|||
129680534|NCT02475213|466790752|FG002|Overall Study|Death|0|||
129680535|NCT02475213|466790753|FG003|Overall Study|Death|0|||
129680536|NCT02475213|466790754|FG004|Overall Study|Death|0|||
129680537|NCT02475213|466790755|FG005|Overall Study|Death|4|||
129680538|NCT02475213|466790756|FG006|Overall Study|Death|1|||
129680539|NCT02475213|466790757|FG007|Overall Study|Death|0|||
129680540|NCT02475213|466790750|FG000|Overall Study|Protocol Violation|0|||
129680541|NCT02475213|466790751|FG001|Overall Study|Protocol Violation|0|||
129680542|NCT02475213|466790752|FG002|Overall Study|Protocol Violation|0|||
129680543|NCT02475213|466790753|FG003|Overall Study|Protocol Violation|0|||
129680544|NCT02475213|466790754|FG004|Overall Study|Protocol Violation|1|||
129680545|NCT02475213|466790755|FG005|Overall Study|Protocol Violation|0|||
129680546|NCT02475213|466790756|FG006|Overall Study|Protocol Violation|0|||
129680547|NCT02475213|466790757|FG007|Overall Study|Protocol Violation|0|||
129680548|NCT02475213|466790750|FG000|Overall Study|Withdrawal by Subject|0|||
129680549|NCT02475213|466790751|FG001|Overall Study|Withdrawal by Subject|0|||
129680550|NCT02475213|466790752|FG002|Overall Study|Withdrawal by Subject|0|||
129680551|NCT02475213|466790753|FG003|Overall Study|Withdrawal by Subject|1|||
129680552|NCT02475213|466790754|FG004|Overall Study|Withdrawal by Subject|0|||
129680553|NCT02475213|466790755|FG005|Overall Study|Withdrawal by Subject|2|||
129680554|NCT02475213|466790756|FG006|Overall Study|Withdrawal by Subject|2|||
129680555|NCT02475213|466790757|FG007|Overall Study|Withdrawal by Subject|0|||
129680556|NCT02475213|466790750|FG000|Overall Study|Other|0|||
129680557|NCT02475213|466790751|FG001|Overall Study|Other|0|||
129680558|NCT02475213|466790752|FG002|Overall Study|Other|0|||
129680559|NCT02475213|466790753|FG003|Overall Study|Other|1|||
129680560|NCT02475213|466790754|FG004|Overall Study|Other|3|||
129680561|NCT02475213|466790755|FG005|Overall Study|Other|1|||
129680562|NCT02475213|466790756|FG006|Overall Study|Other|0|||
129680563|NCT02475213|466790757|FG007|Overall Study|Other|0|||
129680564|NCT00505921|466790758|FG000|Overall Study|Ineligible|1|||
129680565|NCT00505921|466790758|FG000|Overall Study|Failed to Mobilize|8|||
129680566|NCT02441283|466790759|FG000|Overall Study|Withdrew consent|15|||
129680567|NCT02441283|466790759|FG000|Overall Study|Lost to Follow-up|42|||
129680568|NCT02441283|466790759|FG000|Overall Study|Death|1|||
129680569|NCT02441283|466790759|FG000|Overall Study|Other, not specified|32|||
129680570|NCT02382939|466790765|FG000|Overall Study|Adverse Event|1|||
129680571|NCT02382939|466790766|FG001|Overall Study|Adverse Event|1|||
129680572|NCT02382939|466790765|FG000|Overall Study|Withdrawal by Subject|2|||
129680573|NCT02382939|466790766|FG001|Overall Study|Withdrawal by Subject|2|||
129680574|NCT00537277|466790769|FG000|Overall Study|Adverse Event|1|||
129680575|NCT00537277|466790769|FG000|Overall Study|Lack of Efficacy|2|||
129680576|NCT00537277|466790769|FG000|Overall Study|Lost to Follow-up|12|||
129680577|NCT00537277|466790769|FG000|Overall Study|Protocol Violation|11|||
129680578|NCT00537277|466790769|FG000|Overall Study|Unclassified|4|||
129680579|NCT00537277|466790769|FG000|Overall Study|Inability to tolerate trial medication|4|||
129680580|NCT00537277|466790769|FG000|Overall Study|Non-compliance with trial procedures|15|||
129680581|NCT05383209|466790770|FG000|Overall Study|Adverse Event: Non-ocular|0|||
129680582|NCT05383209|466790771|FG001|Overall Study|Adverse Event: Non-ocular|1|||
129680583|NCT05383209|466790772|FG002|Overall Study|Adverse Event: Non-ocular|0|||
129680584|NCT05383209|466790770|FG000|Overall Study|Lost to Follow-up|2|||
129680585|NCT05383209|466790771|FG001|Overall Study|Lost to Follow-up|1|||
129680586|NCT05383209|466790772|FG002|Overall Study|Lost to Follow-up|4|||
129680587|NCT05383209|466790770|FG000|Overall Study|Withdrawal by Subject|2|||
129680588|NCT05383209|466790771|FG001|Overall Study|Withdrawal by Subject|0|||
129680589|NCT05383209|466790772|FG002|Overall Study|Withdrawal by Subject|1|||
129680590|NCT05383209|466790770|FG000|Overall Study|Death|1|||
129680591|NCT05383209|466790771|FG001|Overall Study|Death|0|||
129680592|NCT05383209|466790772|FG002|Overall Study|Death|0|||
129680593|NCT05383209|466790770|FG000|Overall Study|Other|0|||
129680594|NCT05383209|466790771|FG001|Overall Study|Other|1|||
129680595|NCT05383209|466790772|FG002|Overall Study|Other|0|||
129680596|NCT00717886|466790773|FG000|Overall Study|Withdrawal by Subject|3|||
129680597|NCT00717886|466790773|FG000|Overall Study|Treatment Failure|1|||
129680598|NCT00716417|466790774|FG000|Overall Study|Adverse Event|0|||
129680599|NCT00716417|466790775|FG001|Overall Study|Adverse Event|0|||
129680600|NCT00716417|466790776|FG002|Overall Study|Adverse Event|2|||
129680601|NCT00716417|466790777|FG003|Overall Study|Adverse Event|1|||
129680602|NCT00716417|466790778|FG004|Overall Study|Adverse Event|0|||
129680603|NCT00716417|466790779|FG005|Overall Study|Adverse Event|0|||
129680604|NCT00716417|466790780|FG006|Overall Study|Adverse Event|3|||
129680605|NCT00716417|466790781|FG007|Overall Study|Adverse Event|1|||
129680606|NCT00716417|466790782|FG008|Overall Study|Adverse Event|0|||
129680607|NCT00716417|466790783|FG009|Overall Study|Adverse Event|3|||
129680608|NCT00716417|466790774|FG000|Overall Study|Withdrawal by Subject|0|||
129680609|NCT00716417|466790775|FG001|Overall Study|Withdrawal by Subject|1|||
129680610|NCT00716417|466790776|FG002|Overall Study|Withdrawal by Subject|0|||
129680611|NCT00716417|466790777|FG003|Overall Study|Withdrawal by Subject|2|||
129680612|NCT00716417|466790778|FG004|Overall Study|Withdrawal by Subject|0|||
129680613|NCT00716417|466790779|FG005|Overall Study|Withdrawal by Subject|0|||
129680614|NCT00716417|466790780|FG006|Overall Study|Withdrawal by Subject|1|||
129680615|NCT00716417|466790781|FG007|Overall Study|Withdrawal by Subject|0|||
129680616|NCT00716417|466790782|FG008|Overall Study|Withdrawal by Subject|0|||
129680617|NCT00716417|466790783|FG009|Overall Study|Withdrawal by Subject|0|||
129680618|NCT00716417|466790774|FG000|Overall Study|Progressive disease|3|||
129680619|NCT00716417|466790775|FG001|Overall Study|Progressive disease|5|||
129680620|NCT00716417|466790776|FG002|Overall Study|Progressive disease|3|||
129680621|NCT00716417|466790777|FG003|Overall Study|Progressive disease|8|||
129680622|NCT00716417|466790778|FG004|Overall Study|Progressive disease|0|||
129680623|NCT00716417|466790779|FG005|Overall Study|Progressive disease|3|||
129680624|NCT00716417|466790780|FG006|Overall Study|Progressive disease|3|||
129680625|NCT00716417|466790781|FG007|Overall Study|Progressive disease|1|||
129680626|NCT00716417|466790782|FG008|Overall Study|Progressive disease|5|||
129680627|NCT00716417|466790783|FG009|Overall Study|Progressive disease|0|||
129680628|NCT00716417|466790774|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
129680629|NCT00716417|466790775|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
129680630|NCT00716417|466790776|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
129680631|NCT00716417|466790777|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
129680632|NCT00716417|466790778|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
129680633|NCT00716417|466790779|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
129680634|NCT00716417|466790780|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
129680635|NCT00716417|466790781|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
129680636|NCT00716417|466790782|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
129680637|NCT00716417|466790783|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
129680638|NCT00716417|466790774|FG000|Overall Study|On patient request due to toxicities|0|||
129680639|NCT00716417|466790775|FG001|Overall Study|On patient request due to toxicities|0|||
129680640|NCT00716417|466790776|FG002|Overall Study|On patient request due to toxicities|0|||
129680641|NCT00716417|466790777|FG003|Overall Study|On patient request due to toxicities|0|||
129680642|NCT00716417|466790778|FG004|Overall Study|On patient request due to toxicities|0|||
129680643|NCT00716417|466790779|FG005|Overall Study|On patient request due to toxicities|0|||
129680644|NCT00716417|466790780|FG006|Overall Study|On patient request due to toxicities|0|||
129680645|NCT00716417|466790781|FG007|Overall Study|On patient request due to toxicities|1|||
129680646|NCT00716417|466790782|FG008|Overall Study|On patient request due to toxicities|0|||
129680647|NCT00716417|466790783|FG009|Overall Study|On patient request due to toxicities|0|||
129680648|NCT01553851|466790784|FG000|Overall Study|Adverse Event|2|||
129680649|NCT01553851|466790784|FG000|Overall Study|constipation|1|||
129680650|NCT01369433|466790785|FG000|Overall Study|Adverse Event|31|||
129680651|NCT01369433|466790786|FG001|Overall Study|Adverse Event|1|||
129680652|NCT01369433|466790785|FG000|Overall Study|Required significant surgical procedure|1|||
129680653|NCT01369433|466790786|FG001|Overall Study|Required significant surgical procedure|0|||
129680654|NCT01369433|466790785|FG000|Overall Study|Non-compliance|1|||
129680655|NCT01369433|466790786|FG001|Overall Study|Non-compliance|0|||
129680656|NCT01369433|466790785|FG000|Overall Study|Withdrawal by Subject|5|||
129680657|NCT01369433|466790786|FG001|Overall Study|Withdrawal by Subject|2|||
129770510|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
129548358|NCT00545441|466302665|FG001|Overall Study|Withdrawal by Subject|1|||
129680658|NCT01369433|466790785|FG000|Overall Study|Study terminated by Sponsor|67|||
129680659|NCT01369433|466790786|FG001|Overall Study|Study terminated by Sponsor|0|||
129680660|NCT01369433|466790785|FG000|Overall Study|Lost to Follow-up|1|||
129680661|NCT01369433|466790786|FG001|Overall Study|Lost to Follow-up|0|||
129680662|NCT01369433|466790785|FG000|Overall Study|Death|5|||
129680663|NCT01369433|466790786|FG001|Overall Study|Death|0|||
129680664|NCT01369433|466790785|FG000|Overall Study|Investigator discretion|6|||
129770511|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
129770512|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
129770513|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129770514|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129770515|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
129770516|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129680665|NCT01369433|466790786|FG001|Overall Study|Investigator discretion|1|||
129680666|NCT01369433|466790785|FG000|Overall Study|Progressive Disease|92|||
129680667|NCT01369433|466790786|FG001|Overall Study|Progressive Disease|12|||
129680668|NCT01838876|466790788|FG000|Overall Study|Adverse Event|49|||
129680669|NCT01838876|466790788|FG000|Overall Study|Insufficient Therapeutic Response|10|||
129680670|NCT01838876|466790788|FG000|Overall Study|Protocol Violation|34|||
129680671|NCT01838876|466790788|FG000|Overall Study|Withdrawal of Consent|33|||
129680672|NCT01838876|466790788|FG000|Overall Study|Lost to Follow-up|21|||
129680673|NCT01838876|466790788|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
129680674|NCT01838876|466790788|FG000|Overall Study|Reason not Specified|7|||
129680675|NCT01838876|466790788|FG000|Overall Study|Did not meet eligibility criteria|78|||
129680676|NCT02101294|466790789|FG000|Overall Study|Withdrawal by Subject|5|||
129680677|NCT02101294|466790789|FG000|Overall Study|Lost to Follow-up|6|||
129680678|NCT02755090|466790795|FG000|Overall Study|equipment malfunction|1|||
129680679|NCT02755090|466790796|FG001|Overall Study|equipment malfunction|0|||
129680680|NCT00207740|466790800|FG000|Overall Study|Adverse Event|4|||
129680681|NCT00207740|466790801|FG001|Overall Study|Adverse Event|14|||
129680682|NCT00207740|466790802|FG002|Overall Study|Adverse Event|14|||
129680683|NCT00207740|466790803|FG003|Overall Study|Adverse Event|11|||
129680684|NCT00207740|466790800|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129680685|NCT00207740|466790801|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129680686|NCT00207740|466790802|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129680687|NCT00207740|466790803|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
129680688|NCT00207740|466790800|FG000|Overall Study|Lost to Follow-up|0|||
129680689|NCT00207740|466790801|FG001|Overall Study|Lost to Follow-up|2|||
129680690|NCT00207740|466790802|FG002|Overall Study|Lost to Follow-up|1|||
129680691|NCT00207740|466790803|FG003|Overall Study|Lost to Follow-up|1|||
129680692|NCT00207740|466790800|FG000|Overall Study|Death|0|||
129680693|NCT00207740|466790801|FG001|Overall Study|Death|0|||
129680694|NCT00207740|466790802|FG002|Overall Study|Death|0|||
129680695|NCT00207740|466790803|FG003|Overall Study|Death|1|||
129680696|NCT00207740|466790800|FG000|Overall Study|Sponsor Directive|22|||
129680697|NCT00207740|466790801|FG001|Overall Study|Sponsor Directive|15|||
129680698|NCT00207740|466790802|FG002|Overall Study|Sponsor Directive|16|||
129680699|NCT00207740|466790803|FG003|Overall Study|Sponsor Directive|21|||
129548359|NCT00545441|466302664|FG000|Overall Study|Persistence or recurrence of fistula|5|||
129680700|NCT00207740|466790800|FG000|Overall Study|Other|2|||
129680701|NCT00207740|466790801|FG001|Overall Study|Other|10|||
129680702|NCT00207740|466790802|FG002|Overall Study|Other|7|||
129680703|NCT00207740|466790803|FG003|Overall Study|Other|5|||
129680704|NCT00390013|466790804|FG000|Phase 1|tired|0|||
129680705|NCT00390013|466790805|FG001|Phase 1|tired|0|||
129680706|NCT00390013|466790806|FG002|Phase 1|tired|0|||
129680707|NCT00390013|466790807|FG003|Phase 1|tired|1|||
129680708|NCT00390013|466790804|FG000|Phase 2 First Treatment|tired|1|||
129680709|NCT00390013|466790805|FG001|Phase 2 First Treatment|tired|0|||
129680710|NCT00390013|466790806|FG002|Phase 2 First Treatment|tired|0|||
129770517|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129770518|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
129770519|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
129770520|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129770521|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
129770522|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129770523|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129770524|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129770525|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129770526|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129770527|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129770528|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
129770529|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
129770530|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
129770531|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
129770532|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
129770533|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
129770534|NCT01054885|467128575|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129770535|NCT01054885|467128576|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
129770536|NCT01054885|467128577|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129770537|NCT01054885|467128578|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
129680711|NCT00390013|466790807|FG003|Phase 2 First Treatment|tired|0|||
129680712|NCT00390013|466790804|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
129680713|NCT00390013|466790805|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
129680714|NCT00390013|466790806|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
129680715|NCT00390013|466790807|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
129680716|NCT00924898|466790813|FG000|Overall Study|Withdrawal by Subject|2|||
129680717|NCT01285518|466790814|FG000|Overall Study|Lost to Follow-up|0|||
129680718|NCT01285518|466790815|FG001|Overall Study|Lost to Follow-up|0|||
129680719|NCT01285518|466790816|FG002|Overall Study|Lost to Follow-up|0|||
129680720|NCT01285518|466790817|FG003|Overall Study|Lost to Follow-up|0|||
129680721|NCT01285518|466790818|FG004|Overall Study|Lost to Follow-up|0|||
129680722|NCT01285518|466790819|FG005|Overall Study|Lost to Follow-up|1|||
129680723|NCT01285518|466790820|FG006|Overall Study|Lost to Follow-up|0|||
129680724|NCT01285518|466790821|FG007|Overall Study|Lost to Follow-up|0|||
129680725|NCT00294658|466790822|FG000|Overall Study|Death|0|||
129680726|NCT00294658|466790823|FG001|Overall Study|Death|1|||
129680727|NCT00294658|466790822|FG000|Overall Study|Lost to Follow-up|4|||
129680728|NCT00294658|466790823|FG001|Overall Study|Lost to Follow-up|0|||
129680729|NCT00294658|466790822|FG000|Overall Study|Physician Decision|1|||
129680730|NCT00294658|466790823|FG001|Overall Study|Physician Decision|2|||
129680731|NCT00294658|466790822|FG000|Overall Study|Pregnancy|0|||
129680732|NCT00294658|466790823|FG001|Overall Study|Pregnancy|1|||
129680733|NCT00294658|466790822|FG000|Overall Study|Withdrawal by Subject|0|||
129680734|NCT00294658|466790823|FG001|Overall Study|Withdrawal by Subject|4|||
129680735|NCT00294658|466790822|FG000|Overall Study|Found to have invasive thymoma|1|||
129680736|NCT00294658|466790823|FG001|Overall Study|Found to have invasive thymoma|0|||
129680737|NCT00294658|466790822|FG000|Overall Study|Patient and family were not satisfied|0|||
129680738|NCT00294658|466790823|FG001|Overall Study|Patient and family were not satisfied|1|||
129680739|NCT01910441|466790829|FG000|Overall Study|Sponsor decision|0|||
129680740|NCT01910441|466790830|FG001|Overall Study|Sponsor decision|2|||
129680741|NCT01910441|466790829|FG000|Overall Study|Lost to Follow-up|6|||
129680742|NCT01910441|466790830|FG001|Overall Study|Lost to Follow-up|5|||
129680743|NCT01910441|466790829|FG000|Overall Study|Withdrawal by Subject|0|||
129680744|NCT01910441|466790830|FG001|Overall Study|Withdrawal by Subject|1|||
129680745|NCT01910441|466790829|FG000|Overall Study|Non-compliance|0|||
129680746|NCT01910441|466790830|FG001|Overall Study|Non-compliance|1|||
129680747|NCT01910441|466790829|FG000|Overall Study|Adverse Event|1|||
129680748|NCT01910441|466790830|FG001|Overall Study|Adverse Event|0|||
129680749|NCT01910441|466790829|FG000|Overall Study|Physician Decision|0|||
129680750|NCT01910441|466790830|FG001|Overall Study|Physician Decision|1|||
129680751|NCT01811238|466790831|FG000|Overall Study|Withdrawal by Subject|42|||
129680752|NCT01811238|466790831|FG000|Overall Study|Adverse Event|25|||
129680753|NCT01811238|466790831|FG000|Overall Study|Protocol Violation|4|||
129680754|NCT01811238|466790831|FG000|Overall Study|Lack of Efficacy|4|||
129680755|NCT01811238|466790831|FG000|Overall Study|subject refused study medication|6|||
129680756|NCT02340949|466790832|FG000|Overall Study|Adverse Event|4|||
129680757|NCT02340949|466790833|FG001|Overall Study|Adverse Event|2|||
129680758|NCT02340949|466790832|FG000|Overall Study|Withdrawal by Subject|2|||
129680759|NCT02340949|466790833|FG001|Overall Study|Withdrawal by Subject|0|||
129680760|NCT02340949|466790832|FG000|Overall Study|Progression disease|6|||
129680761|NCT02340949|466790833|FG001|Overall Study|Progression disease|2|||
129680762|NCT02340949|466790832|FG000|Overall Study|Death|3|||
129770538|NCT01054885|467128579|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
129770539|NCT01054885|467128580|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129770540|NCT01054885|467128581|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
129770541|NCT00214201|467128583|FG000|Overall Study|Withdrawal by Subject|2|||
129770542|NCT00214201|467128584|FG001|Overall Study|Withdrawal by Subject|0|||
129770543|NCT00214201|467128583|FG000|Overall Study|Death|0|||
129770544|NCT00214201|467128584|FG001|Overall Study|Death|2|||
129770545|NCT01399372|467128588|FG000|Overall Study|Protocol Violation|3|||
129770546|NCT01399372|467128589|FG001|Overall Study|Protocol Violation|1|||
129770547|NCT01432730|467128590|FG000|Period 1|Adverse Event|2|||
129770548|NCT01432730|467128591|FG001|Period 1|Adverse Event|0|||
129770549|NCT01432730|467128590|FG000|Period 2|Adverse Event|0|||
129770550|NCT01432730|467128591|FG001|Period 2|Adverse Event|4|||
129770551|NCT01421719|467128596|FG000|Overall Study|Withdrawal by Subject|4|||
129770552|NCT01124006|467128597|FG000|Overall Study|Withdrawal by Subject|2|||
129770553|NCT01124006|467128598|FG001|Overall Study|Withdrawal by Subject|2|||
129770554|NCT01124006|467128599|FG002|Overall Study|Withdrawal by Subject|0|||
129770555|NCT01124006|467128597|FG000|Overall Study|Lost to Follow-up|1|||
129770556|NCT01124006|467128598|FG001|Overall Study|Lost to Follow-up|0|||
129770557|NCT01124006|467128599|FG002|Overall Study|Lost to Follow-up|1|||
129770558|NCT01124006|467128597|FG000|Overall Study|Other|0|||
129770559|NCT01124006|467128598|FG001|Overall Study|Other|0|||
129770560|NCT01124006|467128599|FG002|Overall Study|Other|1|||
129770561|NCT01712399|467128605|FG000|Overall Study|Lost to Follow-up|1|||
129770562|NCT01712399|467128605|FG000|Overall Study|Withdrawal by Subject|39|||
129770563|NCT01712399|467128605|FG000|Overall Study|Death|1|||
129770564|NCT01712399|467128605|FG000|Overall Study|Adverse Event|11|||
129770565|NCT01712399|467128605|FG000|Overall Study|Study closure|345|||
129770566|NCT01942837|467128606|FG000|Overall Study|Death|1|||
129770567|NCT01942837|467128606|FG000|Overall Study|Symptomatic or radiographic progression|49|||
129680763|NCT02340949|466790833|FG001|Overall Study|Death|0|||
129680764|NCT02340949|466790832|FG000|Overall Study|Physician Decision|1|||
129680765|NCT02340949|466790833|FG001|Overall Study|Physician Decision|0|||
129680766|NCT01192178|466790834|FG000|Overall Study|Withdrawal by Subject|6|||
129680767|NCT01192178|466790835|FG001|Overall Study|Withdrawal by Subject|10|||
129680768|NCT01192178|466790834|FG000|Overall Study|Protocol Violation|10|||
129680769|NCT01192178|466790835|FG001|Overall Study|Protocol Violation|3|||
129680770|NCT01192178|466790834|FG000|Overall Study|Physician Decision|2|||
129680771|NCT01192178|466790835|FG001|Overall Study|Physician Decision|4|||
129770568|NCT01942837|467128606|FG000|Overall Study|Adverse Event|6|||
129680772|NCT01192178|466790834|FG000|Overall Study|Lost to Follow-up|3|||
129680773|NCT01192178|466790835|FG001|Overall Study|Lost to Follow-up|3|||
129680774|NCT01192178|466790834|FG000|Overall Study|Adverse Event|2|||
129680775|NCT01192178|466790835|FG001|Overall Study|Adverse Event|1|||
129770569|NCT01942837|467128606|FG000|Overall Study|Physician Decision|3|||
129770570|NCT01942837|467128606|FG000|Overall Study|Withdrawal by Subject|2|||
129770571|NCT01942837|467128606|FG000|Overall Study|Intercurrent Illness|1|||
129770572|NCT01942837|467128606|FG000|Overall Study|On treatment|3|||
129770573|NCT01942837|467128606|FG000|Overall Study|Never initiate the treatment|2|||
129680776|NCT01192178|466790834|FG000|Overall Study|Lack of Efficacy|1|||
129680777|NCT01192178|466790835|FG001|Overall Study|Lack of Efficacy|2|||
129680778|NCT00296517|466790836|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
129680779|NCT00296517|466790837|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
129680780|NCT00296517|466790836|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
129680781|NCT00296517|466790837|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
129680782|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
129680783|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
129680784|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
129680785|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
129680786|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
129680787|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
129680788|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
129680789|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
129680790|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
129680791|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
129680792|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
129707561|NCT01076010|466892040|FG002|Overall Study|Adverse Event|0|||
129707562|NCT01076010|466892038|FG000|Overall Study|Progressive disease|90|||
129707563|NCT01076010|466892039|FG001|Overall Study|Progressive disease|30|||
129707564|NCT01076010|466892040|FG002|Overall Study|Progressive disease|1|||
129707565|NCT01076010|466892038|FG000|Overall Study|Lack of Efficacy|4|||
129707566|NCT01076010|466892039|FG001|Overall Study|Lack of Efficacy|0|||
129707567|NCT01076010|466892040|FG002|Overall Study|Lack of Efficacy|0|||
129707568|NCT01076010|466892038|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
129707569|NCT01076010|466892039|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
129707570|NCT01076010|466892040|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
129707571|NCT01076010|466892038|FG000|Overall Study|Significant Surgical Procedure|0|||
129707572|NCT01076010|466892039|FG001|Overall Study|Significant Surgical Procedure|1|||
129707573|NCT01076010|466892040|FG002|Overall Study|Significant Surgical Procedure|0|||
129707574|NCT01076010|466892038|FG000|Overall Study|Protocol Violation|0|||
129707575|NCT01076010|466892039|FG001|Overall Study|Protocol Violation|1|||
129707576|NCT01076010|466892040|FG002|Overall Study|Protocol Violation|0|||
129707577|NCT01076010|466892038|FG000|Overall Study|Noncompliance|1|||
129707578|NCT01076010|466892039|FG001|Overall Study|Noncompliance|1|||
129707579|NCT01076010|466892040|FG002|Overall Study|Noncompliance|0|||
129707580|NCT01076010|466892038|FG000|Overall Study|Withdrawal by Subject|3|||
129707581|NCT01076010|466892039|FG001|Overall Study|Withdrawal by Subject|0|||
129707582|NCT01076010|466892040|FG002|Overall Study|Withdrawal by Subject|1|||
129707583|NCT01076010|466892038|FG000|Overall Study|Other|5|||
129707584|NCT01076010|466892039|FG001|Overall Study|Other|2|||
129707585|NCT01076010|466892040|FG002|Overall Study|Other|0|||
129707586|NCT00760552|466892062|FG000|Overall Study|Death|2|||
129707587|NCT00760552|466892063|FG001|Overall Study|Death|0|||
129707588|NCT00760552|466892062|FG000|Overall Study|Lost to Follow-up|11|||
129707589|NCT00760552|466892063|FG001|Overall Study|Lost to Follow-up|10|||
129707590|NCT02536664|466892071|FG000|Overall Study|Inadequate completion of documentation|2|||
129707591|NCT02536664|466892072|FG001|Overall Study|Inadequate completion of documentation|4|||
129707592|NCT02536664|466892071|FG000|Overall Study|Progression|13|||
129707593|NCT02536664|466892072|FG001|Overall Study|Progression|18|||
129707594|NCT02536664|466892071|FG000|Overall Study|Death due to lymphoma|2|||
129707595|NCT02536664|466892072|FG001|Overall Study|Death due to lymphoma|1|||
129707596|NCT02536664|466892071|FG000|Overall Study|Death due to other reason|3|||
129707597|NCT02536664|466892072|FG001|Overall Study|Death due to other reason|2|||
129707598|NCT02536664|466892071|FG000|Overall Study|Intolerability|8|||
129770574|NCT01298648|467128607|FG000|Overall Study|Withdrawal by Subject|2|||
129770575|NCT01298648|467128607|FG000|Overall Study|Lost to Follow-up|21|||
129770576|NCT01803607|467128610|FG000|Overall Study|Adverse Event|5|||
129770577|NCT01803607|467128611|FG001|Overall Study|Adverse Event|3|||
129770578|NCT01803607|467128610|FG000|Overall Study|Lack of Efficacy|0|||
129770579|NCT01803607|467128611|FG001|Overall Study|Lack of Efficacy|1|||
129770580|NCT01803607|467128610|FG000|Overall Study|Protocol Violation|3|||
129770581|NCT01803607|467128611|FG001|Overall Study|Protocol Violation|2|||
129770582|NCT01803607|467128610|FG000|Overall Study|Study terminated by sponsor|54|||
129680793|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
129680794|NCT00296517|466790836|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
129680795|NCT00296517|466790837|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
129680796|NCT01155570|466790838|FG000|Overall Study|Adverse Event|39|||
129680797|NCT01155570|466790838|FG000|Overall Study|Lack of Efficacy|46|||
129680798|NCT01155570|466790838|FG000|Overall Study|Participant's Economic Reasons|17|||
129680799|NCT01155570|466790838|FG000|Overall Study|No Hospital Visits|7|||
129680800|NCT01155570|466790838|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
129680801|NCT01155570|466790838|FG000|Overall Study|Adverse Event + Other Reasons|7|||
129680802|NCT01155570|466790838|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
129680803|NCT01155570|466790838|FG000|Overall Study|Other Reasons|23|||
129680804|NCT04584788|466790857|FG000|Overall Study|Physician Decision|8|||
129680805|NCT04584788|466790857|FG000|Overall Study|Withdrawal by Subject|1|||
129680806|NCT04584788|466790857|FG000|Overall Study|Adverse Event|3|||
129680807|NCT03095287|466792569|FG000|Overall Study|Treatment Failure|1|||
129680808|NCT03095287|466792569|FG000|Overall Study|Adverse Event|1|||
129680809|NCT02394275|466792572|FG000|Overall Study|Adverse Event|22|||
129770583|NCT01803607|467128611|FG001|Overall Study|Study terminated by sponsor|56|||
129770584|NCT01803607|467128610|FG000|Overall Study|Withdrawal by Subject|6|||
129770585|NCT01803607|467128611|FG001|Overall Study|Withdrawal by Subject|5|||
129770586|NCT02038933|467128625|FG000|Overall Study|Disease progression|104|||
129770587|NCT02038933|467128625|FG000|Overall Study|Study drug toxicity|6|||
129770588|NCT02038933|467128625|FG000|Overall Study|Adverse event unrelated to study drug|6|||
129770589|NCT02038933|467128625|FG000|Overall Study|Participant request to discontinue treatment|2|||
129770590|NCT02038933|467128625|FG000|Overall Study|Lost to Follow-up|1|||
129770591|NCT02038933|467128625|FG000|Overall Study|Other reasons|2|||
129770592|NCT03250273|467128626|FG000|Overall Study|Disease Progression|2|||
129770593|NCT03250273|467128627|FG001|Overall Study|Disease Progression|11|||
129770594|NCT03250273|467128626|FG000|Overall Study|Death|0|||
129770595|NCT03250273|467128627|FG001|Overall Study|Death|1|||
129770596|NCT01337960|467128628|FG000|Overall Study|Lost to Follow-up|1|||
129770597|NCT01337960|467128629|FG001|Overall Study|Lost to Follow-up|0|||
129770598|NCT01337960|467128630|FG002|Overall Study|Lost to Follow-up|0|||
129770599|NCT01337960|467128628|FG000|Overall Study|Withdrawal by Subject|1|||
129770600|NCT01337960|467128629|FG001|Overall Study|Withdrawal by Subject|0|||
129770601|NCT01337960|467128630|FG002|Overall Study|Withdrawal by Subject|0|||
129770602|NCT01772316|467128631|FG000|Overall Study|Serious adverse event|1|||
129770603|NCT01772316|467128631|FG000|Overall Study|Inform consent withdrawn|1|||
129770604|NCT01772316|467128631|FG000|Overall Study|Withdrawn by sponsor decision|5|||
129770605|NCT01774721|467128634|FG000|Overall Study|Death|133|||
129770606|NCT01774721|467128635|FG001|Overall Study|Death|152|||
129770607|NCT01774721|467128634|FG000|Overall Study|Withdrawal by Subject|20|||
129770608|NCT01774721|467128635|FG001|Overall Study|Withdrawal by Subject|14|||
129770609|NCT01774721|467128634|FG000|Overall Study|Lost to Follow-up|6|||
129770610|NCT01774721|467128635|FG001|Overall Study|Lost to Follow-up|7|||
129770611|NCT01774721|467128634|FG000|Overall Study|Did not meet eligibility criteria|0|||
129770612|NCT01774721|467128635|FG001|Overall Study|Did not meet eligibility criteria|3|||
129770613|NCT01774721|467128634|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
129770614|NCT01774721|467128635|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
129770615|NCT01774721|467128634|FG000|Overall Study|Study terminated by sponsor|5|||
129770616|NCT01774721|467128635|FG001|Overall Study|Study terminated by sponsor|0|||
129770617|NCT01774721|467128634|FG000|Overall Study|Disease progression|5|||
129770618|NCT01774721|467128635|FG001|Overall Study|Disease progression|0|||
129770619|NCT02399163|467128637|FG000|Overall Study|Adverse Event|2|||
129770620|NCT02399163|467128637|FG000|Overall Study|Protocol Deviation|2|||
129770621|NCT02399163|467128637|FG000|Overall Study|Withdrawal by Participant|5|||
129770622|NCT04646044|467128639|FG000|Overall Study|Lost to Follow-up|0|||
129770623|NCT04646044|467128640|FG001|Overall Study|Lost to Follow-up|0|||
129770624|NCT04646044|467128641|FG002|Overall Study|Lost to Follow-up|1|||
129770625|NCT04646044|467128642|FG003|Overall Study|Lost to Follow-up|0|||
129770626|NCT04646044|467128639|FG000|Overall Study|Withdrawal by Subject|0|||
129770627|NCT04646044|467128640|FG001|Overall Study|Withdrawal by Subject|1|||
129770628|NCT04646044|467128641|FG002|Overall Study|Withdrawal by Subject|0|||
129770629|NCT04646044|467128642|FG003|Overall Study|Withdrawal by Subject|0|||
129680810|NCT02394275|466792572|FG000|Overall Study|Lost to Follow-up|7|||
129680811|NCT04757636|466792578|FG000|Overall Study|Adverse Event|25|||
129680812|NCT04757636|466792579|FG001|Overall Study|Adverse Event|8|||
129680813|NCT04757636|466792580|FG002|Overall Study|Adverse Event|11|||
129680814|NCT04757636|466792578|FG000|Overall Study|Death|9|||
129680815|NCT04757636|466792579|FG001|Overall Study|Death|12|||
129680816|NCT04757636|466792580|FG002|Overall Study|Death|6|||
129680817|NCT04757636|466792578|FG000|Overall Study|Lack of Efficacy|2|||
129680818|NCT04757636|466792579|FG001|Overall Study|Lack of Efficacy|0|||
129680819|NCT04757636|466792580|FG002|Overall Study|Lack of Efficacy|0|||
129680820|NCT04757636|466792578|FG000|Overall Study|Lost to Follow-up|1|||
129680821|NCT04757636|466792579|FG001|Overall Study|Lost to Follow-up|6|||
129770630|NCT01907854|467128643|FG000|Overall Study|Protocol Violation|1|||
129770631|NCT01907854|467128644|FG001|Overall Study|Protocol Violation|1|||
129770632|NCT01907854|467128643|FG000|Overall Study|Withdrawal by Subject|9|||
129770633|NCT01907854|467128644|FG001|Overall Study|Withdrawal by Subject|7|||
129770634|NCT01907854|467128643|FG000|Overall Study|Lost to Follow-up|2|||
129770635|NCT01907854|467128644|FG001|Overall Study|Lost to Follow-up|2|||
129770636|NCT01907854|467128643|FG000|Overall Study|Unclassified|4|||
129680822|NCT04757636|466792580|FG002|Overall Study|Lost to Follow-up|7|||
129680823|NCT04757636|466792578|FG000|Overall Study|Physician Decision|1|||
129680824|NCT04757636|466792579|FG001|Overall Study|Physician Decision|3|||
129680825|NCT04757636|466792580|FG002|Overall Study|Physician Decision|4|||
129680826|NCT04757636|466792578|FG000|Overall Study|Withdrawal by Subject|20|||
129680827|NCT04757636|466792579|FG001|Overall Study|Withdrawal by Subject|23|||
129680828|NCT04757636|466792580|FG002|Overall Study|Withdrawal by Subject|18|||
129680829|NCT04757636|466792578|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
129680830|NCT04757636|466792579|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
129680831|NCT04757636|466792580|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
129680832|NCT04757636|466792578|FG000|Overall Study|Study Terminated by Sponsor|103|||
129770637|NCT01907854|467128644|FG001|Overall Study|Unclassified|3|||
129770638|NCT02215252|467128645|FG000|Overall Study|Adverse Event|1|||
129680833|NCT04757636|466792579|FG001|Overall Study|Study Terminated by Sponsor|104|||
129680834|NCT04757636|466792580|FG002|Overall Study|Study Terminated by Sponsor|114|||
129680835|NCT04757636|466792578|FG000|Overall Study|Sponsor Decision|0|||
129680836|NCT04757636|466792579|FG001|Overall Study|Sponsor Decision|0|||
129680837|NCT04757636|466792580|FG002|Overall Study|Sponsor Decision|1|||
129680838|NCT04757636|466792578|FG000|Overall Study|Randomized in Error|0|||
129680839|NCT04757636|466792579|FG001|Overall Study|Randomized in Error|0|||
129680840|NCT04757636|466792580|FG002|Overall Study|Randomized in Error|2|||
129680841|NCT05350423|466792586|FG000|Overall Study|Lost to Follow-up|3|||
129680842|NCT05350423|466792587|FG001|Overall Study|Lost to Follow-up|3|||
129680843|NCT05350423|466792586|FG000|Overall Study|screen failure|5|||
129680844|NCT05350423|466792587|FG001|Overall Study|screen failure|6|||
129680845|NCT02097277|466792588|FG000|Overall Study|Subject no longer meets study criteria|0|||
129680846|NCT02097277|466792589|FG001|Overall Study|Subject no longer meets study criteria|1|||
129680847|NCT02097277|466792590|FG002|Overall Study|Subject no longer meets study criteria|0|||
129680848|NCT02097277|466792591|FG003|Overall Study|Subject no longer meets study criteria|1|||
129680849|NCT02097277|466792592|FG004|Overall Study|Subject no longer meets study criteria|0|||
129707599|NCT02536664|466892072|FG001|Overall Study|Intolerability|6|||
129707600|NCT02536664|466892071|FG000|Overall Study|Withdrawal by Subject|8|||
129707601|NCT02536664|466892072|FG001|Overall Study|Withdrawal by Subject|5|||
129707602|NCT02536664|466892071|FG000|Overall Study|Other|18|||
129707603|NCT02536664|466892072|FG001|Overall Study|Other|24|||
129707604|NCT02536664|466892071|FG000|Overall Study|Missing|53|||
129707605|NCT02536664|466892072|FG001|Overall Study|Missing|20|||
129707606|NCT03507127|466892081|FG000|Overall Study|Withdrawal by Subject|1|||
129707607|NCT03507127|466892082|FG001|Overall Study|Withdrawal by Subject|0|||
129707608|NCT03507127|466892081|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
129707609|NCT03507127|466892082|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
129707610|NCT03508050|466892083|FG000|Overall Study|Pleural adhesions|1|||
129707611|NCT03508050|466892084|FG001|Overall Study|Pleural adhesions|0|||
129707612|NCT03508050|466892083|FG000|Overall Study|Mucus plug|1|||
129707613|NCT03508050|466892084|FG001|Overall Study|Mucus plug|0|||
129707614|NCT03508050|466892083|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
129707615|NCT03508050|466892084|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
129707616|NCT03508050|466892083|FG000|Overall Study|Sustained desaturation|0|||
129707617|NCT03508050|466892084|FG001|Overall Study|Sustained desaturation|1|||
129707618|NCT01240863|466892085|FG000|Open-label Titration Period|Adverse Event|47|||
129707619|NCT01240863|466892086|FG001|Open-label Titration Period|Adverse Event|0|||
129707620|NCT01240863|466892087|FG002|Open-label Titration Period|Adverse Event|0|||
129707621|NCT01240863|466892085|FG000|Open-label Titration Period|Lack of Efficacy|19|||
129707622|NCT01240863|466892086|FG001|Open-label Titration Period|Lack of Efficacy|0|||
129707623|NCT01240863|466892087|FG002|Open-label Titration Period|Lack of Efficacy|0|||
129707624|NCT01240863|466892085|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
129707625|NCT01240863|466892086|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
129707626|NCT01240863|466892087|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
129707627|NCT01240863|466892085|FG000|Open-label Titration Period|Protocol Violation|7|||
129707628|NCT01240863|466892086|FG001|Open-label Titration Period|Protocol Violation|0|||
129707629|NCT01240863|466892087|FG002|Open-label Titration Period|Protocol Violation|0|||
129707630|NCT01240863|466892085|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
129707631|NCT01240863|466892086|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
129707632|NCT01240863|466892087|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
129707633|NCT01240863|466892085|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
129707634|NCT01240863|466892086|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
129707635|NCT01240863|466892087|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
129707636|NCT01240863|466892085|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
129707637|NCT01240863|466892086|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
129707638|NCT01240863|466892087|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
129707639|NCT01240863|466892085|FG000|Open-label Titration Period|Other|7|||
129707640|NCT01240863|466892086|FG001|Open-label Titration Period|Other|0|||
129707641|NCT01240863|466892087|FG002|Open-label Titration Period|Other|0|||
129707642|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
129707643|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
129707644|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
129707645|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129707646|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
129707647|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
129707648|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129707649|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
129707650|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
129707651|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129770639|NCT02215252|467128646|FG001|Overall Study|Adverse Event|5|||
129770640|NCT02215252|467128647|FG002|Overall Study|Adverse Event|2|||
129770641|NCT02215252|467128645|FG000|Overall Study|Lost to Follow-up|0|||
129770642|NCT02215252|467128646|FG001|Overall Study|Lost to Follow-up|0|||
129770643|NCT02215252|467128647|FG002|Overall Study|Lost to Follow-up|1|||
129770644|NCT02215252|467128645|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
129770645|NCT02215252|467128646|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
129770646|NCT02215252|467128647|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
129770647|NCT02215252|467128645|FG000|Overall Study|Protocol Violation|0|||
129770648|NCT02215252|467128646|FG001|Overall Study|Protocol Violation|1|||
129770649|NCT02215252|467128647|FG002|Overall Study|Protocol Violation|0|||
129770650|NCT02215252|467128645|FG000|Overall Study|Withdrawal by Subject|1|||
129770651|NCT02215252|467128646|FG001|Overall Study|Withdrawal by Subject|0|||
129770652|NCT02215252|467128647|FG002|Overall Study|Withdrawal by Subject|0|||
129770653|NCT02215252|467128645|FG000|Overall Study|Other|0|||
129770654|NCT02215252|467128646|FG001|Overall Study|Other|1|||
129770655|NCT02215252|467128647|FG002|Overall Study|Other|1|||
129770656|NCT02633306|467128648|FG000|Overall Study|Withdrawal by Subject|3|||
129770657|NCT03910244|467128649|FG000|Overall Study|Adverse Event|14|||
129770658|NCT03910244|467128650|FG001|Overall Study|Adverse Event|0|||
129770659|NCT03910244|467128649|FG000|Overall Study|Death|1|||
129770660|NCT03910244|467128650|FG001|Overall Study|Death|0|||
129770661|NCT03910244|467128649|FG000|Overall Study|Lost to Follow-up|0|||
129770662|NCT03910244|467128650|FG001|Overall Study|Lost to Follow-up|2|||
129770663|NCT03910244|467128649|FG000|Overall Study|Joint withdrawal decision|1|||
129770664|NCT03910244|467128650|FG001|Overall Study|Joint withdrawal decision|0|||
129770665|NCT03910244|467128649|FG000|Overall Study|Study Terminated by Sponsor|7|||
129770666|NCT03910244|467128650|FG001|Overall Study|Study Terminated by Sponsor|4|||
129770667|NCT03910244|467128649|FG000|Overall Study|Physician Decision|1|||
129770668|NCT03910244|467128650|FG001|Overall Study|Physician Decision|0|||
129770669|NCT03910244|467128649|FG000|Overall Study|Protocol Violation|1|||
129770670|NCT03910244|467128650|FG001|Overall Study|Protocol Violation|0|||
129770671|NCT03910244|467128649|FG000|Overall Study|Withdrawal by Subject|7|||
129770672|NCT03910244|467128650|FG001|Overall Study|Withdrawal by Subject|2|||
129770673|NCT00803569|467128652|FG000|Overall Study|Progressive Disease|3|||
129770674|NCT00803569|467128652|FG000|Overall Study|Noncompliance|1|||
129770675|NCT04004988|467128653|FG000|Period 1|Physician Decision|2|||
129770676|NCT04004988|467128654|FG001|Period 1|Physician Decision|0|||
129770677|NCT04004988|467128653|FG000|Period 1|Withdrawal by Subject|0|||
129770678|NCT04004988|467128654|FG001|Period 1|Withdrawal by Subject|1|||
129770679|NCT04004988|467128653|FG000|Period 1|Adverse Event|1|||
129770680|NCT04004988|467128654|FG001|Period 1|Adverse Event|2|||
129770681|NCT01598532|467128655|FG000|Overall Study|Lost to Follow-up|3|||
129770682|NCT01598532|467128655|FG000|Overall Study|Did not meet inclusion criteria|8|||
129770683|NCT00912808|467128656|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
129770684|NCT00912808|467128657|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129770685|NCT00912808|467128656|FG000|Washout|Withdrawal by Subject|0|||
129770686|NCT00912808|467128657|FG001|Washout|Withdrawal by Subject|1|||
129770687|NCT00912808|467128656|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129770688|NCT00912808|467128657|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
129770689|NCT00912808|467128656|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
129770690|NCT00912808|467128657|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
129770691|NCT03873116|467128658|FG000|Part 1|Study drug discontinuation due to rash|0|||
129770692|NCT03873116|467128659|FG001|Part 1|Study drug discontinuation due to rash|0|||
129770693|NCT03873116|467128660|FG002|Part 1|Study drug discontinuation due to rash|0|||
129770694|NCT03873116|467128661|FG003|Part 1|Study drug discontinuation due to rash|0|||
129770695|NCT03873116|467128662|FG004|Part 1|Study drug discontinuation due to rash|0|||
129770696|NCT03873116|467128663|FG005|Part 1|Study drug discontinuation due to rash|1|||
129770697|NCT03873116|467128658|FG000|Part 2|Withdrawal by Subject|0|||
129770698|NCT03873116|467128659|FG001|Part 2|Withdrawal by Subject|0|||
129770699|NCT03873116|467128660|FG002|Part 2|Withdrawal by Subject|1|||
129770700|NCT03873116|467128661|FG003|Part 2|Withdrawal by Subject|0|||
129770701|NCT03873116|467128662|FG004|Part 2|Withdrawal by Subject|0|||
129770702|NCT03873116|467128663|FG005|Part 2|Withdrawal by Subject|0|||
129770703|NCT03873116|467128658|FG000|Part 2|Lab abnormality or AE|0|||
129770704|NCT03873116|467128659|FG001|Part 2|Lab abnormality or AE|0|||
129770705|NCT03873116|467128660|FG002|Part 2|Lab abnormality or AE|0|||
129770706|NCT03873116|467128661|FG003|Part 2|Lab abnormality or AE|0|||
129770707|NCT03873116|467128662|FG004|Part 2|Lab abnormality or AE|1|||
129770708|NCT03873116|467128663|FG005|Part 2|Lab abnormality or AE|0|||
129770709|NCT03873116|467128658|FG000|Part 3|Withdrawal by Subject|0|||
129770710|NCT03873116|467128659|FG001|Part 3|Withdrawal by Subject|0|||
129770711|NCT03873116|467128660|FG002|Part 3|Withdrawal by Subject|0|||
129770712|NCT03873116|467128661|FG003|Part 3|Withdrawal by Subject|0|||
129770713|NCT03873116|467128662|FG004|Part 3|Withdrawal by Subject|1|||
129770714|NCT03873116|467128663|FG005|Part 3|Withdrawal by Subject|0|||
129680850|NCT02097277|466792588|FG000|Overall Study|Subject request to discontinue treatment|0|||
129680851|NCT02097277|466792589|FG001|Overall Study|Subject request to discontinue treatment|0|||
129680852|NCT02097277|466792590|FG002|Overall Study|Subject request to discontinue treatment|0|||
129680853|NCT02097277|466792591|FG003|Overall Study|Subject request to discontinue treatment|0|||
129680854|NCT02097277|466792592|FG004|Overall Study|Subject request to discontinue treatment|1|||
129680855|NCT02097277|466792588|FG000|Overall Study|Lost to Follow-up|0|||
129680856|NCT02097277|466792589|FG001|Overall Study|Lost to Follow-up|1|||
129680857|NCT02097277|466792590|FG002|Overall Study|Lost to Follow-up|1|||
129680858|NCT02097277|466792591|FG003|Overall Study|Lost to Follow-up|0|||
129680859|NCT02097277|466792592|FG004|Overall Study|Lost to Follow-up|0|||
129680860|NCT02097277|466792588|FG000|Overall Study|Withdrawal by Subject|2|||
129680861|NCT02097277|466792589|FG001|Overall Study|Withdrawal by Subject|1|||
129680862|NCT02097277|466792590|FG002|Overall Study|Withdrawal by Subject|0|||
129680863|NCT02097277|466792591|FG003|Overall Study|Withdrawal by Subject|1|||
129680864|NCT02097277|466792592|FG004|Overall Study|Withdrawal by Subject|0|||
129680865|NCT02097277|466792588|FG000|Overall Study|Adverse Event|0|||
129680866|NCT02097277|466792589|FG001|Overall Study|Adverse Event|0|||
129680867|NCT02097277|466792590|FG002|Overall Study|Adverse Event|1|||
129680868|NCT02097277|466792591|FG003|Overall Study|Adverse Event|2|||
129680869|NCT02097277|466792592|FG004|Overall Study|Adverse Event|0|||
129680870|NCT01091259|466792595|FG000|Overall Study|Adverse Event|3|||
129680871|NCT01091259|466792595|FG000|Overall Study|Lack of Efficacy|2|||
129680872|NCT00671060|466792598|FG000|Overall Study|Protocol Violation|1|||
129680873|NCT00671060|466792599|FG001|Overall Study|Protocol Violation|0|||
129680874|NCT00671060|466792598|FG000|Overall Study|Physician Decision|0|||
129680875|NCT00671060|466792599|FG001|Overall Study|Physician Decision|1|||
129680876|NCT06057064|466792600|FG000|Overall Study|Death|2|||
129680877|NCT06057064|466792601|FG001|Overall Study|Death|0|||
129680878|NCT06057064|466792600|FG000|Overall Study|Physician Decision|1|||
129680879|NCT06057064|466792601|FG001|Overall Study|Physician Decision|0|||
129680880|NCT06057064|466792600|FG000|Overall Study|Withdrawal by Subject|1|||
129680881|NCT06057064|466792601|FG001|Overall Study|Withdrawal by Subject|1|||
129680882|NCT01541748|466792602|FG000|Overall Study|Lost to Follow-up|17|||
129680883|NCT01541748|466792602|FG000|Overall Study|Moved out of state|1|||
129680884|NCT01541748|466792602|FG000|Overall Study|Withdrawal by Subject|7|||
129680885|NCT01541748|466792602|FG000|Overall Study|Screen failure|5|||
129680886|NCT01541748|466792602|FG000|Overall Study|Did not receive study device|1|||
129680887|NCT02832037|466792603|FG000|Overall Study|Administrative reasons|0|||
129680888|NCT02832037|466792604|FG001|Overall Study|Administrative reasons|0|||
129680889|NCT02832037|466792605|FG002|Overall Study|Administrative reasons|1|||
129680890|NCT02832037|466792606|FG003|Overall Study|Administrative reasons|0|||
129680891|NCT02832037|466792607|FG004|Overall Study|Administrative reasons|0|||
129680892|NCT02832037|466792603|FG000|Overall Study|Protocol Violation|3|||
129680893|NCT02832037|466792604|FG001|Overall Study|Protocol Violation|0|||
129680894|NCT02832037|466792605|FG002|Overall Study|Protocol Violation|4|||
129680895|NCT02832037|466792606|FG003|Overall Study|Protocol Violation|1|||
129680896|NCT02832037|466792607|FG004|Overall Study|Protocol Violation|2|||
129680897|NCT02832037|466792603|FG000|Overall Study|Lost to Follow-up|2|||
129680898|NCT02832037|466792604|FG001|Overall Study|Lost to Follow-up|0|||
129680899|NCT02832037|466792605|FG002|Overall Study|Lost to Follow-up|3|||
129680900|NCT02832037|466792606|FG003|Overall Study|Lost to Follow-up|0|||
129680901|NCT02832037|466792607|FG004|Overall Study|Lost to Follow-up|5|||
129680902|NCT02832037|466792603|FG000|Overall Study|Withdrawal by Subject|9|||
129680903|NCT02832037|466792604|FG001|Overall Study|Withdrawal by Subject|8|||
129680904|NCT02832037|466792605|FG002|Overall Study|Withdrawal by Subject|0|||
129680905|NCT02832037|466792606|FG003|Overall Study|Withdrawal by Subject|4|||
129680906|NCT02832037|466792607|FG004|Overall Study|Withdrawal by Subject|8|||
129680907|NCT02832037|466792603|FG000|Overall Study|Adverse Event|5|||
129680908|NCT02832037|466792604|FG001|Overall Study|Adverse Event|4|||
129680909|NCT02832037|466792605|FG002|Overall Study|Adverse Event|0|||
129680910|NCT02832037|466792606|FG003|Overall Study|Adverse Event|2|||
129680911|NCT02832037|466792607|FG004|Overall Study|Adverse Event|4|||
129680912|NCT03329989|466792608|FG000|Overall Study|Withdrawal by Subject|9|||
129680913|NCT03329989|466792608|FG000|Overall Study|Lost to Follow-up|8|||
129770715|NCT04682366|467128664|FG000|Overall Study|Lost to Follow-up|1|||
129770716|NCT04682366|467128665|FG001|Overall Study|Lost to Follow-up|1|||
129770717|NCT00702221|467128666|FG000|Overall Study|Adverse Event|4|||
129770718|NCT00702221|467128667|FG001|Overall Study|Adverse Event|3|||
129770719|NCT02000440|467128672|FG000|Overall Study|Adverse Event|3|||
129770720|NCT02000440|467128672|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
129770721|NCT03995368|467128673|FG000|Overall Study|Lost to Follow-up|1|||
129770722|NCT03995368|467128674|FG001|Overall Study|Lost to Follow-up|4|||
129770723|NCT03995368|467128675|FG002|Overall Study|Lost to Follow-up|1|||
129770724|NCT03995368|467128673|FG000|Overall Study|Did not meet inclusion criteria|1|||
129770725|NCT03995368|467128674|FG001|Overall Study|Did not meet inclusion criteria|6|||
129770726|NCT03995368|467128675|FG002|Overall Study|Did not meet inclusion criteria|3|||
129770727|NCT03995368|467128673|FG000|Overall Study|Withdrawal by Subject|0|||
129770728|NCT03995368|467128674|FG001|Overall Study|Withdrawal by Subject|1|||
129770729|NCT03995368|467128675|FG002|Overall Study|Withdrawal by Subject|1|||
129770730|NCT03755934|467128676|FG000|Overall Study|Adverse Event|4|||
129770731|NCT03755934|467128677|FG001|Overall Study|Adverse Event|1|||
129770732|NCT03755934|467128678|FG002|Overall Study|Adverse Event|1|||
129770733|NCT03755934|467128679|FG003|Overall Study|Adverse Event|3|||
129770734|NCT03755934|467128676|FG000|Overall Study|Physician Decision|2|||
129770735|NCT03755934|467128677|FG001|Overall Study|Physician Decision|0|||
129770736|NCT03755934|467128678|FG002|Overall Study|Physician Decision|0|||
129770737|NCT03755934|467128679|FG003|Overall Study|Physician Decision|1|||
129770738|NCT03755934|467128676|FG000|Overall Study|Withdrawal by Subject|5|||
129770739|NCT03755934|467128677|FG001|Overall Study|Withdrawal by Subject|0|||
129770740|NCT03755934|467128678|FG002|Overall Study|Withdrawal by Subject|0|||
129770741|NCT03755934|467128679|FG003|Overall Study|Withdrawal by Subject|1|||
129770742|NCT03755934|467128676|FG000|Overall Study|Other|3|||
129770743|NCT03755934|467128677|FG001|Overall Study|Other|1|||
129770744|NCT03755934|467128678|FG002|Overall Study|Other|3|||
129770745|NCT03755934|467128679|FG003|Overall Study|Other|1|||
129770746|NCT00361296|467128680|FG000|Overall Study|Physician Decision|1|||
129770747|NCT00361296|467128680|FG000|Overall Study|Lack of Efficacy|2|||
129770748|NCT04322526|467128681|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
129770749|NCT04322526|467128682|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129770750|NCT04322526|467128681|FG000|Washout (1 Week)|Lost to Follow-up|1|||
129770751|NCT04322526|467128682|FG001|Washout (1 Week)|Lost to Follow-up|2|||
129770752|NCT00993967|467128683|FG000|Overall Study|Adverse Event|8|||
129770753|NCT00993967|467128683|FG000|Overall Study|Death|1|||
129770754|NCT00993967|467128683|FG000|Overall Study|Lost to Follow-up|14|||
129770755|NCT00993967|467128683|FG000|Overall Study|Withdrawal by Subject|36|||
129770756|NCT00993967|467128683|FG000|Overall Study|Protocol Violation|2|||
129770757|NCT02760498|467128684|FG000|Overall Study|Adverse Event|3|||
129770758|NCT02760498|467128685|FG001|Overall Study|Adverse Event|3|||
129770759|NCT02760498|467128686|FG002|Overall Study|Adverse Event|1|||
129770760|NCT02760498|467128687|FG003|Overall Study|Adverse Event|1|||
129770761|NCT02760498|467128688|FG004|Overall Study|Adverse Event|0|||
129770762|NCT02760498|467128689|FG005|Overall Study|Adverse Event|6|||
129770763|NCT02760498|467128684|FG000|Overall Study|Death|7|||
129770764|NCT02760498|467128685|FG001|Overall Study|Death|5|||
129770765|NCT02760498|467128686|FG002|Overall Study|Death|5|||
129770766|NCT02760498|467128687|FG003|Overall Study|Death|7|||
129770767|NCT02760498|467128688|FG004|Overall Study|Death|0|||
129770768|NCT02760498|467128689|FG005|Overall Study|Death|23|||
129770769|NCT02760498|467128684|FG000|Overall Study|Lost to Follow-up|0|||
129770770|NCT02760498|467128685|FG001|Overall Study|Lost to Follow-up|0|||
129770771|NCT02760498|467128686|FG002|Overall Study|Lost to Follow-up|0|||
129770772|NCT02760498|467128687|FG003|Overall Study|Lost to Follow-up|0|||
129770773|NCT02760498|467128688|FG004|Overall Study|Lost to Follow-up|0|||
129770774|NCT02760498|467128689|FG005|Overall Study|Lost to Follow-up|3|||
129770775|NCT02760498|467128684|FG000|Overall Study|Non-compliance with study drug|0|||
129770776|NCT02760498|467128685|FG001|Overall Study|Non-compliance with study drug|2|||
129770777|NCT02760498|467128686|FG002|Overall Study|Non-compliance with study drug|0|||
129770778|NCT02760498|467128687|FG003|Overall Study|Non-compliance with study drug|0|||
129770779|NCT02760498|467128688|FG004|Overall Study|Non-compliance with study drug|0|||
129770780|NCT02760498|467128689|FG005|Overall Study|Non-compliance with study drug|0|||
129770781|NCT02760498|467128684|FG000|Overall Study|Participant decision|1|||
129770782|NCT02760498|467128685|FG001|Overall Study|Participant decision|4|||
129770783|NCT02760498|467128686|FG002|Overall Study|Participant decision|2|||
129770784|NCT02760498|467128687|FG003|Overall Study|Participant decision|2|||
129770785|NCT02760498|467128688|FG004|Overall Study|Participant decision|1|||
129770786|NCT02760498|467128689|FG005|Overall Study|Participant decision|6|||
129770787|NCT02760498|467128684|FG000|Overall Study|Sponsor decision|0|||
129770788|NCT02760498|467128685|FG001|Overall Study|Sponsor decision|0|||
129770789|NCT02760498|467128686|FG002|Overall Study|Sponsor decision|0|||
129770790|NCT02760498|467128687|FG003|Overall Study|Sponsor decision|3|||
129770791|NCT02760498|467128688|FG004|Overall Study|Sponsor decision|0|||
129770792|NCT02760498|467128689|FG005|Overall Study|Sponsor decision|0|||
129770793|NCT02760498|467128684|FG000|Overall Study|Physician Decision|3|||
129680914|NCT03329989|466792608|FG000|Overall Study|Adverse Event|5|||
129680915|NCT03329989|466792608|FG000|Overall Study|Protocol Violation|1|||
129680916|NCT00435942|466792611|FG000|Overall Study|Death|17|||
129680917|NCT00435942|466792612|FG001|Overall Study|Death|10|||
129680918|NCT00435942|466792611|FG000|Overall Study|Withdrawal by Subject|2|||
129680919|NCT00435942|466792612|FG001|Overall Study|Withdrawal by Subject|0|||
129680920|NCT00435942|466792611|FG000|Overall Study|Lost to Follow-up|0|||
129680921|NCT00435942|466792612|FG001|Overall Study|Lost to Follow-up|16|||
129680922|NCT00435942|466792611|FG000|Overall Study|Conversion to Open Repair|1|||
129680923|NCT00435942|466792612|FG001|Overall Study|Conversion to Open Repair|0|||
129680924|NCT00435942|466792611|FG000|Overall Study|Technical Failure|3|||
129680925|NCT00435942|466792612|FG001|Overall Study|Technical Failure|0|||
129680926|NCT00435942|466792611|FG000|Overall Study|Other|0|||
129680927|NCT00435942|466792612|FG001|Overall Study|Other|1|||
129680928|NCT04491994|466792613|FG000|Overall Study|Withdrawal by Subject|10|||
129680929|NCT04491994|466792614|FG001|Overall Study|Withdrawal by Subject|5|||
129680930|NCT04491994|466792613|FG000|Overall Study|developed fever > 3 days|4|||
129680931|NCT04491994|466792614|FG001|Overall Study|developed fever > 3 days|1|||
129680932|NCT04491994|466792613|FG000|Overall Study|Protocol Violation|11|||
129680933|NCT04491994|466792614|FG001|Overall Study|Protocol Violation|2|||
129680934|NCT04491994|466792613|FG000|Overall Study|Lost to Follow-up|4|||
129770794|NCT02760498|467128685|FG001|Overall Study|Physician Decision|4|||
129770795|NCT02760498|467128686|FG002|Overall Study|Physician Decision|1|||
129680935|NCT04491994|466792614|FG001|Overall Study|Lost to Follow-up|3|||
129680936|NCT04167462|466792622|FG000|Overall Study|Other reasons|3|||
129680937|NCT04167462|466792623|FG001|Overall Study|Other reasons|2|||
129680938|NCT04167462|466792622|FG000|Overall Study|Withdrawal by Subject|6|||
129680939|NCT04167462|466792623|FG001|Overall Study|Withdrawal by Subject|7|||
129680940|NCT04167462|466792622|FG000|Overall Study|Adverse Event|4|||
129680941|NCT04167462|466792623|FG001|Overall Study|Adverse Event|0|||
129680942|NCT04167462|466792622|FG000|Overall Study|Pregnancy|1|||
129680943|NCT04167462|466792623|FG001|Overall Study|Pregnancy|0|||
129680944|NCT04167462|466792622|FG000|Overall Study|Lack of Efficacy|0|||
129680945|NCT04167462|466792623|FG001|Overall Study|Lack of Efficacy|1|||
129680946|NCT03881371|466792628|FG000|Overall Study|Adverse Event|8|||
129680947|NCT03881371|466792629|FG001|Overall Study|Adverse Event|9|||
129680948|NCT03881371|466792628|FG000|Overall Study|Death|1|||
129680949|NCT03881371|466792629|FG001|Overall Study|Death|0|||
129680950|NCT03881371|466792628|FG000|Overall Study|Lost to Follow-up|1|||
129680951|NCT03881371|466792629|FG001|Overall Study|Lost to Follow-up|0|||
129680952|NCT03881371|466792628|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129680953|NCT03881371|466792629|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129680954|NCT03881371|466792628|FG000|Overall Study|Physician Decision|3|||
129680955|NCT03881371|466792629|FG001|Overall Study|Physician Decision|3|||
129680956|NCT03881371|466792628|FG000|Overall Study|Withdrawal by Subject|2|||
129680957|NCT03881371|466792629|FG001|Overall Study|Withdrawal by Subject|10|||
129680958|NCT03881371|466792628|FG000|Overall Study|Discontinuation from Study|1|||
129680959|NCT03881371|466792629|FG001|Overall Study|Discontinuation from Study|0|||
129680960|NCT00933933|466792633|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
129680961|NCT00933933|466792634|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
129680962|NCT00933933|466792635|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
129680963|NCT00933933|466792633|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
129680964|NCT00933933|466792634|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
129680965|NCT00933933|466792635|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
129680966|NCT01138046|466792636|FG000|Overall Study|Withdrawal due to death|6|||
129680967|NCT02178956|466792637|FG000|Overall Study|Lost to Follow-up|4|||
129680968|NCT02178956|466792638|FG001|Overall Study|Lost to Follow-up|4|||
129680969|NCT02178956|466792637|FG000|Overall Study|Sponsor terminated study|49|||
129680970|NCT02178956|466792638|FG001|Overall Study|Sponsor terminated study|58|||
129680971|NCT02178956|466792637|FG000|Overall Study|Withdrawal by Subject|15|||
129680972|NCT02178956|466792638|FG001|Overall Study|Withdrawal by Subject|11|||
129680973|NCT02178956|466792637|FG000|Overall Study|Various Reasons|3|||
129680974|NCT02178956|466792638|FG001|Overall Study|Various Reasons|5|||
129680975|NCT01900314|466792639|FG000|Overall Study|Lost to Follow-up|1|||
129680976|NCT01900314|466792640|FG001|Overall Study|Lost to Follow-up|0|||
129680977|NCT01900314|466792639|FG000|Overall Study|Protocol Violation|0|||
129680978|NCT01900314|466792640|FG001|Overall Study|Protocol Violation|1|||
129680979|NCT01900314|466792639|FG000|Overall Study|Withdrawal by Subject|3|||
129680980|NCT01900314|466792640|FG001|Overall Study|Withdrawal by Subject|3|||
129680981|NCT04225832|466792641|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
129680982|NCT04225832|466792642|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
129680983|NCT04225832|466792641|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
129680984|NCT04225832|466792642|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
129680985|NCT03282097|466792643|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
129770796|NCT02760498|467128687|FG003|Overall Study|Physician Decision|4|||
129680986|NCT03282097|466792644|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
129680987|NCT03282097|466792643|FG000|Intervention Visit Complete|Patient Death|13|||
129770797|NCT02760498|467128688|FG004|Overall Study|Physician Decision|0|||
129680988|NCT03282097|466792644|FG001|Intervention Visit Complete|Patient Death|15|||
129680989|NCT03282097|466792643|FG000|Intervention Visit Complete|Caregiver Death|0|||
129680990|NCT03282097|466792644|FG001|Intervention Visit Complete|Caregiver Death|3|||
129680991|NCT03282097|466792643|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
129680992|NCT03282097|466792644|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
129680993|NCT03282097|466792643|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
129770798|NCT02760498|467128689|FG005|Overall Study|Physician Decision|2|||
129770799|NCT02760498|467128684|FG000|Overall Study|Disease progression|21|||
129770800|NCT02760498|467128685|FG001|Overall Study|Disease progression|19|||
129770801|NCT02760498|467128686|FG002|Overall Study|Disease progression|20|||
129770802|NCT02760498|467128687|FG003|Overall Study|Disease progression|18|||
129770803|NCT02760498|467128688|FG004|Overall Study|Disease progression|4|||
129770804|NCT02760498|467128689|FG005|Overall Study|Disease progression|55|||
129770805|NCT02760498|467128684|FG000|Overall Study|Withdrawal by Subject|4|||
129770806|NCT02760498|467128685|FG001|Overall Study|Withdrawal by Subject|7|||
129770807|NCT02760498|467128686|FG002|Overall Study|Withdrawal by Subject|5|||
129770808|NCT02760498|467128687|FG003|Overall Study|Withdrawal by Subject|1|||
129770809|NCT02760498|467128688|FG004|Overall Study|Withdrawal by Subject|0|||
129770810|NCT02760498|467128689|FG005|Overall Study|Withdrawal by Subject|6|||
129770811|NCT02760498|467128684|FG000|Overall Study|Other than specified|1|||
129770812|NCT02760498|467128685|FG001|Overall Study|Other than specified|6|||
129770813|NCT02760498|467128686|FG002|Overall Study|Other than specified|0|||
129770814|NCT02760498|467128687|FG003|Overall Study|Other than specified|3|||
129680994|NCT03282097|466792644|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
129680995|NCT03282097|466792643|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
129680996|NCT03282097|466792644|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
129680997|NCT03282097|466792643|FG000|Primary Outcome Data Collection Complete|Missing|2|||
129680998|NCT03282097|466792644|FG001|Primary Outcome Data Collection Complete|Missing|3|||
129680999|NCT03282097|466792643|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
129681000|NCT03282097|466792644|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
129681001|NCT03282097|466792643|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
129681002|NCT03282097|466792644|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
129681003|NCT03282097|466792643|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
129681004|NCT03282097|466792644|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
129681005|NCT06001021|466792648|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
129681006|NCT06001021|466792649|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
129681007|NCT06001021|466792650|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
129681008|NCT06001021|466792651|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
129681009|NCT06001021|466792652|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
129681010|NCT06001021|466792653|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
129681011|NCT06001021|466792654|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
129681012|NCT06001021|466792648|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
129681013|NCT06001021|466792649|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129681014|NCT06001021|466792650|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129770815|NCT02760498|467128688|FG004|Overall Study|Other than specified|1|||
129770816|NCT02760498|467128689|FG005|Overall Study|Other than specified|0|||
129770817|NCT02760498|467128684|FG000|Overall Study|Not treated|0|||
129770818|NCT02760498|467128685|FG001|Overall Study|Not treated|0|||
129770819|NCT02760498|467128686|FG002|Overall Study|Not treated|0|||
129770820|NCT02760498|467128687|FG003|Overall Study|Not treated|0|||
129770821|NCT02760498|467128688|FG004|Overall Study|Not treated|0|||
129770822|NCT02760498|467128689|FG005|Overall Study|Not treated|2|||
129770823|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
129770824|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
129770825|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
129770826|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
129770827|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Adverse Event|2|||
129770828|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Adverse Event|5|||
129770829|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Adverse Event|1|||
129770830|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Adverse Event|2|||
129770831|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Death|13|||
129770832|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Death|17|||
129770833|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Death|1|||
129770834|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Death|0|||
129770835|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
129770836|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
129770837|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
129770838|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
129770839|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Disease Progression|2|||
129770840|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Disease Progression|0|||
129770841|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Disease Progression|0|||
129770842|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Disease Progression|0|||
129770843|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
129770844|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
129770845|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
129770846|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
129770847|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
129770848|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
129770849|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
129770850|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
129770851|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
129770852|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
129770853|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
129770854|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
129770855|NCT03955146|467128692|FG000|DB Period (48 Weeks)|Participant Decision|9|||
129770856|NCT03955146|467128693|FG001|DB Period (48 Weeks)|Participant Decision|12|||
129770857|NCT03955146|467128694|FG002|DB Period (48 Weeks)|Participant Decision|1|||
129770858|NCT03955146|467128695|FG003|DB Period (48 Weeks)|Participant Decision|1|||
129681015|NCT06001021|466792651|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
129770859|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
129770860|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
129770861|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
129770862|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
129770863|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
129770864|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
129770865|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
129770866|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
129681016|NCT06001021|466792652|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
129681017|NCT06001021|466792653|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129681018|NCT06001021|466792654|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
129681019|NCT04797169|466792655|FG000|Overall Study|Lost to Follow-up|84|||
129681020|NCT04797169|466792656|FG001|Overall Study|Lost to Follow-up|67|||
129681021|NCT04797169|466792655|FG000|Overall Study|Pregnancy|1|||
129681022|NCT04797169|466792656|FG001|Overall Study|Pregnancy|3|||
129681023|NCT04797169|466792655|FG000|Overall Study|Withdrawal by Subject|27|||
129681024|NCT04797169|466792656|FG001|Overall Study|Withdrawal by Subject|35|||
129681025|NCT03839641|466792665|FG000|Overall Study|Withdrawal by Subject|1|||
129681026|NCT03839641|466792666|FG001|Overall Study|Withdrawal by Subject|1|||
129681027|NCT02550795|466792673|FG000|Overall Study|Physician Decision|0|||
129681028|NCT02550795|466792674|FG001|Overall Study|Physician Decision|1|||
129681029|NCT02550795|466792675|FG002|Overall Study|Physician Decision|0|||
129681030|NCT00879658|466792676|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129681031|NCT00879658|466792677|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129681032|NCT00879658|466792678|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129681033|NCT00879658|466792679|FG003|Overall Study|Abnormal laboratory value(s)|1|||
129681034|NCT00879658|466792680|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129681035|NCT00879658|466792681|FG005|Overall Study|Abnormal laboratory value(s)|0|||
129681036|NCT00879658|466792682|FG006|Overall Study|Abnormal laboratory value(s)|0|||
129681037|NCT00879658|466792676|FG000|Overall Study|Administrative problems|2|||
129681038|NCT00879658|466792677|FG001|Overall Study|Administrative problems|1|||
129681039|NCT00879658|466792678|FG002|Overall Study|Administrative problems|0|||
129681040|NCT00879658|466792679|FG003|Overall Study|Administrative problems|1|||
129681041|NCT00879658|466792680|FG004|Overall Study|Administrative problems|0|||
129681042|NCT00879658|466792681|FG005|Overall Study|Administrative problems|0|||
129681043|NCT00879658|466792682|FG006|Overall Study|Administrative problems|0|||
129681044|NCT00879658|466792676|FG000|Overall Study|Adverse Event|6|||
129681045|NCT00879658|466792677|FG001|Overall Study|Adverse Event|4|||
129681046|NCT00879658|466792678|FG002|Overall Study|Adverse Event|3|||
129681047|NCT00879658|466792679|FG003|Overall Study|Adverse Event|1|||
129681048|NCT00879658|466792680|FG004|Overall Study|Adverse Event|2|||
129681049|NCT00879658|466792681|FG005|Overall Study|Adverse Event|0|||
129681050|NCT00879658|466792682|FG006|Overall Study|Adverse Event|0|||
129681051|NCT00879658|466792676|FG000|Overall Study|Protocol Violation|1|||
129681052|NCT00879658|466792677|FG001|Overall Study|Protocol Violation|0|||
129681053|NCT00879658|466792678|FG002|Overall Study|Protocol Violation|0|||
129681054|NCT00879658|466792679|FG003|Overall Study|Protocol Violation|0|||
129681055|NCT00879658|466792680|FG004|Overall Study|Protocol Violation|0|||
129681056|NCT00879658|466792681|FG005|Overall Study|Protocol Violation|0|||
129681057|NCT00879658|466792682|FG006|Overall Study|Protocol Violation|0|||
129681058|NCT00879658|466792676|FG000|Overall Study|Withdrawal by Subject|3|||
129681059|NCT00879658|466792677|FG001|Overall Study|Withdrawal by Subject|0|||
129681060|NCT00879658|466792678|FG002|Overall Study|Withdrawal by Subject|2|||
129681061|NCT00879658|466792679|FG003|Overall Study|Withdrawal by Subject|0|||
129681062|NCT00879658|466792680|FG004|Overall Study|Withdrawal by Subject|0|||
129681063|NCT00879658|466792681|FG005|Overall Study|Withdrawal by Subject|1|||
129681064|NCT00879658|466792682|FG006|Overall Study|Withdrawal by Subject|0|||
129770867|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
129681065|NCT00879658|466792676|FG000|Overall Study|Lack of Efficacy|0|||
129681066|NCT00879658|466792677|FG001|Overall Study|Lack of Efficacy|0|||
129681067|NCT00879658|466792678|FG002|Overall Study|Lack of Efficacy|2|||
129681068|NCT00879658|466792679|FG003|Overall Study|Lack of Efficacy|0|||
129681069|NCT00879658|466792680|FG004|Overall Study|Lack of Efficacy|0|||
129681070|NCT00879658|466792681|FG005|Overall Study|Lack of Efficacy|0|||
129681071|NCT00879658|466792682|FG006|Overall Study|Lack of Efficacy|0|||
129681072|NCT00879658|466792676|FG000|Overall Study|misrandomized (never received study med)|0|||
129681073|NCT00879658|466792677|FG001|Overall Study|misrandomized (never received study med)|0|||
129681074|NCT00879658|466792678|FG002|Overall Study|misrandomized (never received study med)|0|||
129681075|NCT00879658|466792679|FG003|Overall Study|misrandomized (never received study med)|1|||
129681076|NCT00879658|466792680|FG004|Overall Study|misrandomized (never received study med)|0|||
129681077|NCT00879658|466792681|FG005|Overall Study|misrandomized (never received study med)|0|||
129681078|NCT00879658|466792682|FG006|Overall Study|misrandomized (never received study med)|0|||
129681079|NCT00580840|466792683|FG000|Run-in|Adverse Event|17|||
129681080|NCT00580840|466792684|FG001|Run-in|Adverse Event|0|||
129681081|NCT00580840|466792685|FG002|Run-in|Adverse Event|0|||
129681082|NCT00580840|466792686|FG003|Run-in|Adverse Event|0|||
129681083|NCT00580840|466792683|FG000|Run-in|Lack of Efficacy|93|||
129681084|NCT00580840|466792684|FG001|Run-in|Lack of Efficacy|0|||
129681085|NCT00580840|466792685|FG002|Run-in|Lack of Efficacy|0|||
129681086|NCT00580840|466792686|FG003|Run-in|Lack of Efficacy|0|||
129681087|NCT00580840|466792683|FG000|Run-in|Loss of Efficacy|1|||
129681088|NCT00580840|466792684|FG001|Run-in|Loss of Efficacy|0|||
129681089|NCT00580840|466792685|FG002|Run-in|Loss of Efficacy|0|||
129681090|NCT00580840|466792686|FG003|Run-in|Loss of Efficacy|0|||
129681091|NCT00580840|466792683|FG000|Run-in|Lost to Follow-up|4|||
129681092|NCT00580840|466792684|FG001|Run-in|Lost to Follow-up|0|||
129681093|NCT00580840|466792685|FG002|Run-in|Lost to Follow-up|0|||
129681094|NCT00580840|466792686|FG003|Run-in|Lost to Follow-up|0|||
129681095|NCT00580840|466792683|FG000|Run-in|Withdrawal by Subject|5|||
129681096|NCT00580840|466792684|FG001|Run-in|Withdrawal by Subject|0|||
129681097|NCT00580840|466792685|FG002|Run-in|Withdrawal by Subject|0|||
129681098|NCT00580840|466792686|FG003|Run-in|Withdrawal by Subject|0|||
129681099|NCT00580840|466792683|FG000|Run-in|Other: Per Sponsor Request|2|||
129681100|NCT00580840|466792684|FG001|Run-in|Other: Per Sponsor Request|0|||
129681101|NCT00580840|466792685|FG002|Run-in|Other: Per Sponsor Request|0|||
129681102|NCT00580840|466792686|FG003|Run-in|Other: Per Sponsor Request|0|||
129681103|NCT00580840|466792683|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
129681104|NCT00580840|466792684|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
129681105|NCT00580840|466792685|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
129681106|NCT00580840|466792686|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
129681107|NCT00580840|466792683|FG000|Run-in|Other: Exclusionary Lab Value|1|||
129681108|NCT00580840|466792684|FG001|Run-in|Other: Exclusionary Lab Value|0|||
129681109|NCT00580840|466792685|FG002|Run-in|Other: Exclusionary Lab Value|0|||
129681110|NCT00580840|466792686|FG003|Run-in|Other: Exclusionary Lab Value|0|||
129681111|NCT00580840|466792683|FG000|Double-Blind|Adverse Event|0|||
129681112|NCT00580840|466792684|FG001|Double-Blind|Adverse Event|3|||
129681113|NCT00580840|466792685|FG002|Double-Blind|Adverse Event|4|||
129681114|NCT00580840|466792686|FG003|Double-Blind|Adverse Event|1|||
129681115|NCT00580840|466792683|FG000|Double-Blind|Loss of Efficacy|0|||
129681116|NCT00580840|466792684|FG001|Double-Blind|Loss of Efficacy|1|||
129681117|NCT00580840|466792685|FG002|Double-Blind|Loss of Efficacy|2|||
129681118|NCT00580840|466792686|FG003|Double-Blind|Loss of Efficacy|10|||
129681119|NCT00580840|466792683|FG000|Double-Blind|Lost to Follow-up|0|||
129681120|NCT00580840|466792684|FG001|Double-Blind|Lost to Follow-up|1|||
129681121|NCT00580840|466792685|FG002|Double-Blind|Lost to Follow-up|0|||
129770868|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
129681122|NCT00580840|466792686|FG003|Double-Blind|Lost to Follow-up|2|||
129681123|NCT00580840|466792683|FG000|Double-Blind|Withdrawal by Subject|0|||
129681124|NCT00580840|466792684|FG001|Double-Blind|Withdrawal by Subject|1|||
129681125|NCT00580840|466792685|FG002|Double-Blind|Withdrawal by Subject|2|||
129681126|NCT00580840|466792686|FG003|Double-Blind|Withdrawal by Subject|2|||
129681127|NCT00580840|466792683|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
129681128|NCT00580840|466792684|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
129681129|NCT00580840|466792685|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
129681130|NCT00580840|466792686|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
129681131|NCT00580840|466792683|FG000|Double-Blind|Other: Forbidden Medication|0|||
129681132|NCT00580840|466792684|FG001|Double-Blind|Other: Forbidden Medication|0|||
129681133|NCT00580840|466792685|FG002|Double-Blind|Other: Forbidden Medication|1|||
129681134|NCT00580840|466792686|FG003|Double-Blind|Other: Forbidden Medication|0|||
129681135|NCT01551173|466792687|FG000|Overall Study|Withdrawal by Subject|11|||
129681136|NCT01551173|466792688|FG001|Overall Study|Withdrawal by Subject|16|||
129681137|NCT01551173|466792687|FG000|Overall Study|Adverse Event|7|||
129681138|NCT01551173|466792688|FG001|Overall Study|Adverse Event|6|||
129681139|NCT01551173|466792687|FG000|Overall Study|Lost to Follow-up|5|||
129681140|NCT01551173|466792688|FG001|Overall Study|Lost to Follow-up|7|||
129681141|NCT01551173|466792687|FG000|Overall Study|Other|5|||
129681142|NCT01551173|466792688|FG001|Overall Study|Other|3|||
129681143|NCT04530344|466792689|FG000|Overall Study|Lost to Follow-up|3|||
129681144|NCT04530344|466792690|FG001|Overall Study|Lost to Follow-up|3|||
129681145|NCT04530344|466792691|FG002|Overall Study|Lost to Follow-up|3|||
129681146|NCT04530344|466792692|FG003|Overall Study|Lost to Follow-up|10|||
129681147|NCT04530344|466792689|FG000|Overall Study|Withdrawal by Subject|14|||
129681148|NCT04530344|466792690|FG001|Overall Study|Withdrawal by Subject|5|||
129681149|NCT04530344|466792691|FG002|Overall Study|Withdrawal by Subject|18|||
129681150|NCT04530344|466792692|FG003|Overall Study|Withdrawal by Subject|33|||
129681151|NCT04530344|466792689|FG000|Overall Study|Adverse Event|0|||
129681152|NCT04530344|466792690|FG001|Overall Study|Adverse Event|0|||
129681153|NCT04530344|466792691|FG002|Overall Study|Adverse Event|0|||
129681154|NCT04530344|466792692|FG003|Overall Study|Adverse Event|1|||
129681155|NCT04530344|466792689|FG000|Overall Study|Lack of Efficacy|0|||
129681156|NCT04530344|466792690|FG001|Overall Study|Lack of Efficacy|0|||
129681157|NCT04530344|466792691|FG002|Overall Study|Lack of Efficacy|0|||
129681158|NCT04530344|466792692|FG003|Overall Study|Lack of Efficacy|1|||
129681159|NCT04530344|466792689|FG000|Overall Study|Physician Decision|0|||
129681160|NCT04530344|466792690|FG001|Overall Study|Physician Decision|0|||
129681161|NCT04530344|466792691|FG002|Overall Study|Physician Decision|1|||
129681162|NCT04530344|466792692|FG003|Overall Study|Physician Decision|1|||
129681163|NCT04530344|466792689|FG000|Overall Study|Pregnancy|0|||
129681164|NCT04530344|466792690|FG001|Overall Study|Pregnancy|0|||
129681165|NCT04530344|466792691|FG002|Overall Study|Pregnancy|2|||
129681166|NCT04530344|466792692|FG003|Overall Study|Pregnancy|1|||
129681167|NCT04530344|466792689|FG000|Overall Study|Protocol Violation|0|||
129681168|NCT04530344|466792690|FG001|Overall Study|Protocol Violation|0|||
129681169|NCT04530344|466792691|FG002|Overall Study|Protocol Violation|0|||
129681170|NCT04530344|466792692|FG003|Overall Study|Protocol Violation|1|||
129681171|NCT04530344|466792689|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
129681172|NCT04530344|466792690|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
129681173|NCT04530344|466792691|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
129681174|NCT04530344|466792692|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
129681175|NCT04530344|466792689|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
129681176|NCT04530344|466792690|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
129681177|NCT04530344|466792691|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
129681178|NCT04530344|466792692|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
129681179|NCT04530344|466792689|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
129681180|NCT04530344|466792690|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
129681181|NCT04530344|466792691|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
129681182|NCT04530344|466792692|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
129681183|NCT04530344|466792689|FG000|Overall Study|Personal Reasons|0|||
129681184|NCT04530344|466792690|FG001|Overall Study|Personal Reasons|0|||
129681185|NCT04530344|466792691|FG002|Overall Study|Personal Reasons|0|||
129681186|NCT04530344|466792692|FG003|Overall Study|Personal Reasons|1|||
129681187|NCT04530344|466792689|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
129681188|NCT04530344|466792690|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
129681189|NCT04530344|466792691|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
129681190|NCT04530344|466792692|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
129681191|NCT01402700|466792693|FG000|Overall Study|Death|3|||
129681192|NCT01402700|466792693|FG000|Overall Study|Withdrawal by Subject|3|||
129681193|NCT01402700|466792693|FG000|Overall Study|Missed Visit|1|||
129681194|NCT02401230|466792697|FG000|Overall Study|Adverse Event|3|||
129681195|NCT02401230|466792698|FG001|Overall Study|Adverse Event|2|||
129681196|NCT02401230|466792699|FG002|Overall Study|Adverse Event|0|||
129681197|NCT02401230|466792697|FG000|Overall Study|Withdrawal by Subject|2|||
129681198|NCT02401230|466792698|FG001|Overall Study|Withdrawal by Subject|1|||
129681199|NCT02401230|466792699|FG002|Overall Study|Withdrawal by Subject|1|||
129681200|NCT02401230|466792697|FG000|Overall Study|Lost to Follow-up|1|||
129681201|NCT02401230|466792698|FG001|Overall Study|Lost to Follow-up|3|||
129681202|NCT02401230|466792699|FG002|Overall Study|Lost to Follow-up|3|||
129681203|NCT00830765|466792700|FG000|Overall Study|Protocol Violation|3|||
129681204|NCT00830765|466792701|FG001|Overall Study|Protocol Violation|2|||
129681205|NCT01299909|466792702|FG000|Overall Study|Lost to Follow-up|22|||
129681206|NCT01299909|466792703|FG001|Overall Study|Lost to Follow-up|18|||
129681207|NCT01299909|466792704|FG002|Overall Study|Lost to Follow-up|17|||
129681208|NCT00964782|466792705|FG000|Overall Study|Lost to Follow-up|1|||
129681209|NCT00964782|466792706|FG001|Overall Study|Lost to Follow-up|0|||
129681210|NCT01143324|466792712|FG000|Overall Study|Lost to Follow-up|11|||
129681211|NCT01143324|466792712|FG000|Overall Study|Withdrawal by Subject|4|||
129681212|NCT01143324|466792712|FG000|Overall Study|Explant of the device|4|||
129681213|NCT02774889|466792722|FG000|Overall Study|Lost to Follow-up|2|||
129681214|NCT02774889|466792723|FG001|Overall Study|Lost to Follow-up|1|||
129681215|NCT00858988|466792724|FG000|Analysis|Lactulose unable to be detected in urine|2|||
129681216|NCT00858988|466792725|FG001|Analysis|Lactulose unable to be detected in urine|1|||
129681217|NCT01349595|466792726|FG000|Overall Study|Lack of funding|2|||
129681218|NCT01349595|466792727|FG001|Overall Study|Lack of funding|2|||
129681219|NCT00549055|466794611|FG000|Overall Study|Adverse Event|4|||
129681220|NCT00549055|466794611|FG000|Overall Study|Lack of Efficacy|18|||
129681221|NCT00549055|466794611|FG000|Overall Study|Stabilization|5|||
129681222|NCT00549055|466794611|FG000|Overall Study|Progression to fibrosis|2|||
129681223|NCT00549055|466794611|FG000|Overall Study|Decrease of size|1|||
129681224|NCT00549055|466794611|FG000|Overall Study|Active choroidal neovascula increased|1|||
129681225|NCT00549055|466794611|FG000|Overall Study|Vitreous hemorrhage|1|||
129681226|NCT00549055|466794611|FG000|Overall Study|Growth choroidal neovascularisation|1|||
129681227|NCT00549055|466794611|FG000|Overall Study|Choroidal neovascularization|1|||
129681228|NCT00549055|466794611|FG000|Overall Study|Very low visual acuity (VA)|1|||
129681229|NCT00770809|466794616|FG000|Overall Study|Adverse Event|9|||
129681230|NCT00770809|466794617|FG001|Overall Study|Adverse Event|1|||
129681231|NCT00770809|466794618|FG002|Overall Study|Adverse Event|12|||
129681232|NCT00770809|466794616|FG000|Overall Study|Death|1|||
129681233|NCT00770809|466794617|FG001|Overall Study|Death|0|||
129681234|NCT00770809|466794618|FG002|Overall Study|Death|0|||
129681235|NCT00770809|466794616|FG000|Overall Study|Withdrawal by Subject|3|||
129681236|NCT00770809|466794617|FG001|Overall Study|Withdrawal by Subject|3|||
129681237|NCT00770809|466794618|FG002|Overall Study|Withdrawal by Subject|7|||
129681238|NCT00770809|466794616|FG000|Overall Study|Progression|2|||
129681239|NCT00770809|466794617|FG001|Overall Study|Progression|2|||
129681240|NCT00770809|466794618|FG002|Overall Study|Progression|0|||
129681241|NCT00770809|466794616|FG000|Overall Study|Complicating illness|0|||
129681242|NCT00770809|466794617|FG001|Overall Study|Complicating illness|0|||
129681243|NCT00770809|466794618|FG002|Overall Study|Complicating illness|1|||
129681244|NCT00770809|466794616|FG000|Overall Study|Other Medical Reasons|2|||
129681245|NCT00770809|466794617|FG001|Overall Study|Other Medical Reasons|4|||
129681246|NCT00770809|466794618|FG002|Overall Study|Other Medical Reasons|3|||
129681247|NCT02469233|466794619|FG000|Overall Study|Death|1|||
129681248|NCT02469233|466794620|FG001|Overall Study|Death|1|||
129681249|NCT02469233|466794619|FG000|Overall Study|Lost to post or 6 month follow up|7|||
129681250|NCT02469233|466794620|FG001|Overall Study|Lost to post or 6 month follow up|2|||
129681251|NCT03474107|466794621|FG000|Overall Study|Adverse Event|42|||
129681252|NCT03474107|466794622|FG001|Overall Study|Adverse Event|46|||
129681253|NCT03474107|466794621|FG000|Overall Study|Death|2|||
129681254|NCT03474107|466794622|FG001|Overall Study|Death|2|||
129681255|NCT03474107|466794621|FG000|Overall Study|Lost to Follow-up|0|||
129681256|NCT03474107|466794622|FG001|Overall Study|Lost to Follow-up|1|||
129681257|NCT03474107|466794621|FG000|Overall Study|Progressive Disease|177|||
129681258|NCT03474107|466794622|FG001|Overall Study|Progressive Disease|180|||
129681259|NCT03474107|466794621|FG000|Overall Study|Protocol Violation|1|||
129681260|NCT03474107|466794622|FG001|Overall Study|Protocol Violation|1|||
129681261|NCT03474107|466794621|FG000|Overall Study|Withdrawal by Subject|15|||
129681262|NCT03474107|466794622|FG001|Overall Study|Withdrawal by Subject|27|||
129681263|NCT03474107|466794621|FG000|Overall Study|Physician Decision|7|||
129681264|NCT03474107|466794622|FG001|Overall Study|Physician Decision|22|||
129681265|NCT03474107|466794621|FG000|Overall Study|Miscellaneous|1|||
129681266|NCT03474107|466794622|FG001|Overall Study|Miscellaneous|6|||
129681267|NCT02127671|466794623|FG000|Overall Study|Death|2|||
129681268|NCT02127671|466794624|FG001|Overall Study|Death|2|||
129681269|NCT02127671|466794623|FG000|Overall Study|Lost to Follow-up|4|||
129681270|NCT02127671|466794624|FG001|Overall Study|Lost to Follow-up|2|||
129681271|NCT02127671|466794623|FG000|Overall Study|Physician Decision|1|||
129681272|NCT02127671|466794624|FG001|Overall Study|Physician Decision|0|||
129681273|NCT02127671|466794623|FG000|Overall Study|incarceration|0|||
129681274|NCT02127671|466794624|FG001|Overall Study|incarceration|1|||
129681275|NCT02127671|466794623|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
129681276|NCT02127671|466794624|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
129681277|NCT00764517|466794625|FG000|Overall Study|Adverse Event|9|||
129681278|NCT00764517|466794626|FG001|Overall Study|Adverse Event|3|||
129681279|NCT00764517|466794625|FG000|Overall Study|Death|3|||
129681280|NCT00764517|466794626|FG001|Overall Study|Death|11|||
129681281|NCT00764517|466794625|FG000|Overall Study|Physician Decision|3|||
129681282|NCT00764517|466794626|FG001|Overall Study|Physician Decision|0|||
129681283|NCT03813654|466794631|FG000|Overall Study|Protocol Violation|0|||
129681284|NCT03813654|466794632|FG001|Overall Study|Protocol Violation|1|||
129681285|NCT03813654|466794633|FG002|Overall Study|Protocol Violation|2|||
129681286|NCT03813654|466794631|FG000|Overall Study|Withdrawal by Subject|1|||
129548360|NCT00545441|466302665|FG001|Overall Study|Persistence or recurrence of fistula|2|||
129681287|NCT03813654|466794632|FG001|Overall Study|Withdrawal by Subject|0|||
129681288|NCT03813654|466794633|FG002|Overall Study|Withdrawal by Subject|0|||
129681289|NCT01208051|466794634|FG000|Total Enrollment|Withdrawal by Subject|0|||
129681290|NCT01208051|466794635|FG001|Total Enrollment|Withdrawal by Subject|1|||
129681291|NCT01208051|466794636|FG002|Total Enrollment|Withdrawal by Subject|0|||
129681292|NCT01208051|466794637|FG003|Total Enrollment|Withdrawal by Subject|0|||
129681293|NCT01208051|466794638|FG004|Total Enrollment|Withdrawal by Subject|2|||
129681294|NCT01208051|466794634|FG000|Total Enrollment|Brain metastases|0|||
129681295|NCT01208051|466794635|FG001|Total Enrollment|Brain metastases|0|||
129681296|NCT01208051|466794636|FG002|Total Enrollment|Brain metastases|1|||
129681297|NCT01208051|466794637|FG003|Total Enrollment|Brain metastases|0|||
129681298|NCT01208051|466794638|FG004|Total Enrollment|Brain metastases|0|||
129681299|NCT02107898|466794641|FG000|Overall Study|Adverse Event|4|||
129681300|NCT02107898|466794642|FG001|Overall Study|Adverse Event|7|||
129681301|NCT02107898|466794641|FG000|Overall Study|Poor compliance to protocol|0|||
129681302|NCT02107898|466794642|FG001|Overall Study|Poor compliance to protocol|1|||
129681303|NCT02107898|466794641|FG000|Overall Study|Participant moved|0|||
129681304|NCT02107898|466794642|FG001|Overall Study|Participant moved|2|||
129681305|NCT02107898|466794641|FG000|Overall Study|Consent withdrawn by participant|2|||
129681306|NCT02107898|466794642|FG001|Overall Study|Consent withdrawn by participant|1|||
129681307|NCT02107898|466794641|FG000|Overall Study|Randomized but not treated|0|||
129681308|NCT02107898|466794642|FG001|Overall Study|Randomized but not treated|1|||
129681309|NCT01283386|466794643|FG000|Overall Study|Death|2|||
129681310|NCT01283386|466794644|FG001|Overall Study|Death|0|||
129681311|NCT01283386|466794643|FG000|Overall Study|Withdrawal by Subject|2|||
129681312|NCT01283386|466794644|FG001|Overall Study|Withdrawal by Subject|1|||
129770869|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
129770870|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
129770871|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
129770872|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
129770873|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
129770874|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
129770875|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
129770876|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
129770877|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
129770878|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
129770879|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
129770880|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
129770881|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
129770882|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
129770883|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
129770884|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
129770885|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
129770886|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
129770887|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
129770888|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
129770889|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
129770890|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
129770891|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
129770892|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
129770893|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
129770894|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
129770895|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
129770896|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
129770897|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
129770898|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
129770899|NCT03955146|467128692|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
129770900|NCT03955146|467128693|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
129681313|NCT01283386|466794643|FG000|Overall Study|Relapse of underlying disease|1|||
129681314|NCT01283386|466794644|FG001|Overall Study|Relapse of underlying disease|3|||
129681315|NCT01283386|466794643|FG000|Overall Study|Progression of underlying disease|2|||
129681316|NCT01283386|466794644|FG001|Overall Study|Progression of underlying disease|7|||
129681317|NCT01283386|466794643|FG000|Overall Study|Reason not specified|1|||
129681318|NCT01283386|466794644|FG001|Overall Study|Reason not specified|0|||
129681319|NCT01283386|466794643|FG000|Overall Study|Protocol Violation|0|||
129681320|NCT01283386|466794644|FG001|Overall Study|Protocol Violation|1|||
129681321|NCT01531153|466794645|FG000|Overall Study|Withdrawal by Subject|10|||
129681322|NCT01531153|466794646|FG001|Overall Study|Withdrawal by Subject|9|||
129681323|NCT01531153|466794647|FG002|Overall Study|Withdrawal by Subject|15|||
129681324|NCT00770367|466794648|FG000|First Intervention|Withdrawal by Subject|0|||
129681325|NCT00770367|466794649|FG001|First Intervention|Withdrawal by Subject|2|||
129681326|NCT00770367|466794648|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
129681327|NCT00770367|466794649|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
129681328|NCT00770367|466794648|FG000|Second Intervention|Lost to Follow-up|2|||
129681329|NCT00770367|466794649|FG001|Second Intervention|Lost to Follow-up|0|||
129681330|NCT00920816|466794651|FG000|Overall Study|Death|116|||
129681331|NCT00920816|466794652|FG001|Overall Study|Death|63|||
129681332|NCT00920816|466794653|FG002|Overall Study|Death|8|||
129681333|NCT00920816|466794654|FG003|Overall Study|Death|3|||
129681334|NCT00920816|466794651|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
129681335|NCT00920816|466794652|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
129681336|NCT00920816|466794653|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
129681337|NCT00920816|466794654|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
129681338|NCT00920816|466794651|FG000|Overall Study|Global deterioration of health status|2|||
129681339|NCT00920816|466794652|FG001|Overall Study|Global deterioration of health status|0|||
129681340|NCT00920816|466794653|FG002|Overall Study|Global deterioration of health status|0|||
129681341|NCT00920816|466794654|FG003|Overall Study|Global deterioration of health status|0|||
129681342|NCT00920816|466794651|FG000|Overall Study|Objective progression or relapse|6|||
129681343|NCT00920816|466794652|FG001|Overall Study|Objective progression or relapse|2|||
129681344|NCT00920816|466794653|FG002|Overall Study|Objective progression or relapse|0|||
129681345|NCT00920816|466794654|FG003|Overall Study|Objective progression or relapse|0|||
129681346|NCT00920816|466794651|FG000|Overall Study|Other|26|||
129681347|NCT00920816|466794652|FG001|Overall Study|Other|15|||
129681348|NCT00920816|466794653|FG002|Overall Study|Other|1|||
129681349|NCT00920816|466794654|FG003|Overall Study|Other|2|||
129681350|NCT00920816|466794651|FG000|Overall Study|Lost to Follow-up|11|||
129681351|NCT00920816|466794652|FG001|Overall Study|Lost to Follow-up|2|||
129681352|NCT00920816|466794653|FG002|Overall Study|Lost to Follow-up|0|||
129681353|NCT00920816|466794654|FG003|Overall Study|Lost to Follow-up|0|||
129681354|NCT00920816|466794651|FG000|Overall Study|Adverse Event|1|||
129681355|NCT00920816|466794652|FG001|Overall Study|Adverse Event|1|||
129681356|NCT00920816|466794653|FG002|Overall Study|Adverse Event|1|||
129681357|NCT00920816|466794654|FG003|Overall Study|Adverse Event|0|||
129681358|NCT00920816|466794651|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
129681359|NCT00920816|466794652|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
129681360|NCT00920816|466794653|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
129770901|NCT03955146|467128694|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
129681361|NCT00920816|466794654|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
129681362|NCT00920816|466794651|FG000|Overall Study|Randomized but not treated|3|||
129681363|NCT00920816|466794652|FG001|Overall Study|Randomized but not treated|0|||
129681364|NCT00920816|466794653|FG002|Overall Study|Randomized but not treated|0|||
129681365|NCT00920816|466794654|FG003|Overall Study|Randomized but not treated|0|||
129681366|NCT01180777|466794655|FG000|Overall Study|Protocol Violation|6|||
129681367|NCT01180777|466794655|FG000|Overall Study|Poor lens fit|4|||
129681368|NCT01180777|466794655|FG000|Overall Study|Lost to Follow-up|1|||
129681369|NCT01180777|466794655|FG000|Overall Study|Adverse Event|1|||
129681370|NCT03517137|466794658|FG000|Overall Study|Lack of Efficacy|1|||
129681371|NCT03517137|466794658|FG000|Overall Study|Adverse Event|2|||
129681372|NCT03517137|466794658|FG000|Overall Study|Withdrawal by Subject|2|||
129681373|NCT03517137|466794658|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
129681374|NCT01582451|466794659|FG000|Overall Study|Adverse Event|1|||
129681375|NCT01582451|466794660|FG001|Overall Study|Adverse Event|3|||
129681376|NCT01582451|466794659|FG000|Overall Study|Death|3|||
129681377|NCT01582451|466794660|FG001|Overall Study|Death|3|||
129681378|NCT01582451|466794659|FG000|Overall Study|Lost to Follow-up|0|||
129681379|NCT01582451|466794660|FG001|Overall Study|Lost to Follow-up|2|||
129681380|NCT01582451|466794659|FG000|Overall Study|Protocol Violation|11|||
129681381|NCT01582451|466794660|FG001|Overall Study|Protocol Violation|3|||
129681382|NCT01582451|466794659|FG000|Overall Study|Withdrawal by Subject|13|||
129681383|NCT01582451|466794660|FG001|Overall Study|Withdrawal by Subject|9|||
129681384|NCT01582451|466794659|FG000|Overall Study|Physician Decision|3|||
129681385|NCT01582451|466794660|FG001|Overall Study|Physician Decision|0|||
129681386|NCT01582451|466794659|FG000|Overall Study|Sponsor Decision|1|||
129681387|NCT01582451|466794660|FG001|Overall Study|Sponsor Decision|0|||
129681388|NCT00487188|466794664|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
129681389|NCT00487188|466794665|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
129681390|NCT00487188|466794666|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
129681391|NCT00487188|466794664|FG000|Induction Phase|Adverse Event|5|||
129681392|NCT00487188|466794665|FG001|Induction Phase|Adverse Event|0|||
129681393|NCT00487188|466794666|FG002|Induction Phase|Adverse Event|0|||
129681394|NCT00487188|466794664|FG000|Induction Phase|Lack of Efficacy|0|||
129681395|NCT00487188|466794665|FG001|Induction Phase|Lack of Efficacy|1|||
129681396|NCT00487188|466794666|FG002|Induction Phase|Lack of Efficacy|0|||
129681397|NCT00487188|466794664|FG000|Induction Phase|Protocol Violation|1|||
129681398|NCT00487188|466794665|FG001|Induction Phase|Protocol Violation|0|||
129681399|NCT00487188|466794666|FG002|Induction Phase|Protocol Violation|0|||
129681400|NCT00487188|466794664|FG000|Induction Phase|Refused Treatment|1|||
129681401|NCT00487188|466794665|FG001|Induction Phase|Refused Treatment|2|||
129681402|NCT00487188|466794666|FG002|Induction Phase|Refused Treatment|0|||
129681403|NCT00487188|466794664|FG000|Induction Phase|Lost to Follow-up|2|||
129681404|NCT00487188|466794665|FG001|Induction Phase|Lost to Follow-up|2|||
129681405|NCT00487188|466794666|FG002|Induction Phase|Lost to Follow-up|0|||
129681406|NCT00487188|466794664|FG000|Induction Phase|Administrative|0|||
129681407|NCT00487188|466794665|FG001|Induction Phase|Administrative|1|||
129681408|NCT00487188|466794666|FG002|Induction Phase|Administrative|0|||
129681409|NCT00487188|466794664|FG000|Maintenance Phase|Adverse Event|1|||
129681410|NCT00487188|466794665|FG001|Maintenance Phase|Adverse Event|0|||
129681411|NCT00487188|466794666|FG002|Maintenance Phase|Adverse Event|0|||
129681412|NCT00487188|466794664|FG000|Maintenance Phase|Death|1|||
129681413|NCT00487188|466794665|FG001|Maintenance Phase|Death|0|||
129681414|NCT00487188|466794666|FG002|Maintenance Phase|Death|0|||
129681415|NCT00487188|466794664|FG000|Maintenance Phase|Lost to Follow-up|1|||
129681416|NCT00487188|466794665|FG001|Maintenance Phase|Lost to Follow-up|0|||
129681417|NCT00487188|466794666|FG002|Maintenance Phase|Lost to Follow-up|0|||
129681418|NCT00487188|466794664|FG000|Maintenance Phase|Administrative|0|||
129681419|NCT00487188|466794665|FG001|Maintenance Phase|Administrative|0|||
129681420|NCT00487188|466794666|FG002|Maintenance Phase|Administrative|1|||
129681421|NCT03822416|466794669|FG000|Overall Study|Lost to Follow-up|1|||
129681422|NCT03822416|466794670|FG001|Overall Study|Lost to Follow-up|0|||
129681423|NCT03822416|466794669|FG000|Overall Study|Withdrawal by Subject|0|||
129681424|NCT03822416|466794670|FG001|Overall Study|Withdrawal by Subject|1|||
129681425|NCT01995201|466794673|FG000|From Baseline Until Week 24|Adverse Event|4|||
129681426|NCT01995201|466794674|FG001|From Baseline Until Week 24|Adverse Event|15|||
129681427|NCT01995201|466794675|FG002|From Baseline Until Week 24|Adverse Event|0|||
129681428|NCT01995201|466794676|FG003|From Baseline Until Week 24|Adverse Event|0|||
129681429|NCT01995201|466794677|FG004|From Baseline Until Week 24|Adverse Event|0|||
129681430|NCT01995201|466794678|FG005|From Baseline Until Week 24|Adverse Event|0|||
129681431|NCT01995201|466794679|FG006|From Baseline Until Week 24|Adverse Event|0|||
129681432|NCT01995201|466794673|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129681433|NCT01995201|466794674|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
129681434|NCT01995201|466794675|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129681435|NCT01995201|466794676|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129681436|NCT01995201|466794677|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129681437|NCT01995201|466794678|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129681438|NCT01995201|466794679|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
129681439|NCT01995201|466794673|FG000|From Baseline Until Week 24|Death|0|||
129681440|NCT01995201|466794674|FG001|From Baseline Until Week 24|Death|1|||
129681441|NCT01995201|466794675|FG002|From Baseline Until Week 24|Death|0|||
129681442|NCT01995201|466794676|FG003|From Baseline Until Week 24|Death|0|||
129681443|NCT01995201|466794677|FG004|From Baseline Until Week 24|Death|0|||
129681444|NCT01995201|466794678|FG005|From Baseline Until Week 24|Death|0|||
129681445|NCT01995201|466794679|FG006|From Baseline Until Week 24|Death|0|||
129681446|NCT01995201|466794673|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
129681447|NCT01995201|466794674|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
129681448|NCT01995201|466794675|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
129681449|NCT01995201|466794676|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
129681450|NCT01995201|466794677|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
129681451|NCT01995201|466794678|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
129681452|NCT01995201|466794679|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
129681453|NCT01995201|466794673|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
129681454|NCT01995201|466794674|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
129681455|NCT01995201|466794675|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
129681456|NCT01995201|466794676|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
129681457|NCT01995201|466794677|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
129681458|NCT01995201|466794678|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
129681459|NCT01995201|466794679|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
129681460|NCT01995201|466794673|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
129681461|NCT01995201|466794674|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
129681462|NCT01995201|466794675|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
129681463|NCT01995201|466794676|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
129681464|NCT01995201|466794677|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
129681465|NCT01995201|466794678|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
129681466|NCT01995201|466794679|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
129681467|NCT01995201|466794673|FG000|From Baseline Until Week 24|Physician Decision|0|||
129681468|NCT01995201|466794674|FG001|From Baseline Until Week 24|Physician Decision|2|||
129681469|NCT01995201|466794675|FG002|From Baseline Until Week 24|Physician Decision|0|||
129681470|NCT01995201|466794676|FG003|From Baseline Until Week 24|Physician Decision|0|||
129681471|NCT01995201|466794677|FG004|From Baseline Until Week 24|Physician Decision|0|||
129681472|NCT01995201|466794678|FG005|From Baseline Until Week 24|Physician Decision|0|||
129681473|NCT01995201|466794679|FG006|From Baseline Until Week 24|Physician Decision|0|||
129681474|NCT01995201|466794673|FG000|From Baseline Until Week 24|Protocol Violation|0|||
129681475|NCT01995201|466794674|FG001|From Baseline Until Week 24|Protocol Violation|9|||
129681476|NCT01995201|466794675|FG002|From Baseline Until Week 24|Protocol Violation|0|||
129681477|NCT01995201|466794676|FG003|From Baseline Until Week 24|Protocol Violation|0|||
129681478|NCT01995201|466794677|FG004|From Baseline Until Week 24|Protocol Violation|0|||
129681479|NCT01995201|466794678|FG005|From Baseline Until Week 24|Protocol Violation|0|||
129681480|NCT01995201|466794679|FG006|From Baseline Until Week 24|Protocol Violation|0|||
129681481|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Adverse Event|0|||
129681482|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Adverse Event|0|||
129681483|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Adverse Event|2|||
129681484|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Adverse Event|1|||
129681485|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Adverse Event|1|||
129681486|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Adverse Event|3|||
129681487|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Adverse Event|1|||
129681488|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Death|0|||
129681489|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Death|0|||
129681490|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Death|0|||
129681491|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Death|0|||
129681492|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Death|0|||
129681493|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Death|2|||
129681494|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Death|0|||
129681495|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
129681496|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
129681497|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
129681498|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
129681499|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
129681500|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
129770902|NCT03955146|467128695|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
129770903|NCT02002598|467128698|FG000|Dose Level 1|Withdrawal by Subject|1|||
129770904|NCT02002598|467128699|FG001|Dose Level 1|Withdrawal by Subject|0|||
129770905|NCT02002598|467128700|FG002|Dose Level 1|Withdrawal by Subject|0|||
129770906|NCT02002598|467128701|FG003|Dose Level 1|Withdrawal by Subject|0|||
129681501|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
129681502|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
129681503|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
129681504|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
129681505|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
129681506|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
129681507|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
129681508|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
129681509|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129681510|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129681511|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
129681512|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129681513|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
129681514|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129681515|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
129681516|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Physician Decision|0|||
129681517|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Physician Decision|0|||
129681518|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Physician Decision|0|||
129681519|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Physician Decision|0|||
129681520|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Physician Decision|1|||
129681521|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Physician Decision|0|||
129681522|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Physician Decision|0|||
129681523|NCT01995201|466794673|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
129681524|NCT01995201|466794674|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
129681525|NCT01995201|466794675|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
129681526|NCT01995201|466794676|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
129681527|NCT01995201|466794677|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
129681528|NCT01995201|466794678|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
129681529|NCT01995201|466794679|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
129681530|NCT03329001|466794680|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129681531|NCT03329001|466794681|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129681532|NCT03329001|466794682|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
129681533|NCT03329001|466794683|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
129770907|NCT02002598|467128702|FG004|Dose Level 1|Withdrawal by Subject|0|||
129770908|NCT02628873|467128703|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
129770909|NCT02628873|467128704|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
129770910|NCT02628873|467128703|FG000|Second Test (1 Hour)|Physician Decision|1|||
129770911|NCT02628873|467128704|FG001|Second Test (1 Hour)|Physician Decision|0|||
129770912|NCT02195518|467128705|FG000|Overall Study|Adverse Event|1|||
129770913|NCT02195518|467128705|FG000|Overall Study|Protocol Violation|4|||
129770914|NCT02195518|467128705|FG000|Overall Study|Pregnancy|2|||
129770915|NCT02195518|467128705|FG000|Overall Study|Withdrawal by Subject|1|||
129770916|NCT02195518|467128705|FG000|Overall Study|Lost to Follow-up|1|||
129770917|NCT01281124|467130519|FG000|Overall Study|Death|1|||
129770918|NCT03038100|467130520|FG000|Overall Study|Death|289|||
129770919|NCT03038100|467130521|FG001|Overall Study|Death|272|||
129770920|NCT03038100|467130520|FG000|Overall Study|Lost to Follow-up|9|||
129770921|NCT03038100|467130521|FG001|Overall Study|Lost to Follow-up|10|||
129770922|NCT03038100|467130520|FG000|Overall Study|Protocol Deviation|1|||
129770923|NCT03038100|467130521|FG001|Overall Study|Protocol Deviation|4|||
129770924|NCT03038100|467130520|FG000|Overall Study|Withdrawal by Subject|45|||
129770925|NCT03038100|467130521|FG001|Overall Study|Withdrawal by Subject|51|||
129770926|NCT03038100|467130520|FG000|Overall Study|Study Terminated By Sponsor|305|||
129770927|NCT03038100|467130521|FG001|Overall Study|Study Terminated By Sponsor|311|||
129770928|NCT03038100|467130520|FG000|Overall Study|Physician Decision|1|||
129770929|NCT03038100|467130521|FG001|Overall Study|Physician Decision|3|||
129770930|NCT02392624|467130522|FG000|Overall Study|Withdrawal by Subject|15|||
129770931|NCT02392624|467130523|FG001|Overall Study|Withdrawal by Subject|12|||
129770932|NCT02392624|467130524|FG002|Overall Study|Withdrawal by Subject|9|||
129770933|NCT02392624|467130522|FG000|Overall Study|Adverse Event|4|||
129770934|NCT02392624|467130523|FG001|Overall Study|Adverse Event|1|||
129770935|NCT02392624|467130524|FG002|Overall Study|Adverse Event|2|||
129770936|NCT02392624|467130522|FG000|Overall Study|Pregnancy|1|||
129770937|NCT02392624|467130523|FG001|Overall Study|Pregnancy|0|||
129770938|NCT02392624|467130524|FG002|Overall Study|Pregnancy|0|||
129770939|NCT02392624|467130522|FG000|Overall Study|Protocol Violation|0|||
129770940|NCT02392624|467130523|FG001|Overall Study|Protocol Violation|0|||
129770941|NCT02392624|467130524|FG002|Overall Study|Protocol Violation|1|||
129770942|NCT02392624|467130522|FG000|Overall Study|Sponsor/Investigator Decision|2|||
129770943|NCT02392624|467130523|FG001|Overall Study|Sponsor/Investigator Decision|1|||
129770944|NCT02392624|467130524|FG002|Overall Study|Sponsor/Investigator Decision|0|||
129770945|NCT02392624|467130522|FG000|Overall Study|Other|49|||
129770946|NCT02392624|467130523|FG001|Overall Study|Other|1|||
129770947|NCT02392624|467130524|FG002|Overall Study|Other|1|||
129770948|NCT00706238|467130525|FG000|Overall Study|Disease progression|4|||
129770949|NCT00706238|467130525|FG000|Overall Study|Other|1|||
129770950|NCT03841604|467130530|FG000|Overall Study|Withdrawal by Subject|3|||
129770951|NCT03841604|467130531|FG001|Overall Study|Withdrawal by Subject|1|||
129770952|NCT03841604|467130530|FG000|Overall Study|Adverse Event|4|||
129770953|NCT03841604|467130531|FG001|Overall Study|Adverse Event|2|||
129770954|NCT03841604|467130530|FG000|Overall Study|Physician Decision|1|||
129770955|NCT03841604|467130531|FG001|Overall Study|Physician Decision|0|||
129770956|NCT03877510|467130534|FG000|Overall Study|Death|6|||
129770957|NCT03877510|467130534|FG000|Overall Study|Lost to Follow-up|2|||
129770958|NCT03877510|467130534|FG000|Overall Study|Non-compliance with study drug|2|||
129770959|NCT03877510|467130534|FG000|Overall Study|Lack of Efficacy|14|||
129770960|NCT03877510|467130534|FG000|Overall Study|Adverse Event|20|||
129770961|NCT03877510|467130534|FG000|Overall Study|Withdrawal by Subject|22|||
129770962|NCT03877510|467130534|FG000|Overall Study|Miscellaneous|1|||
129770963|NCT01417377|467130535|FG000|Overall Study|Lost to Follow-up|12|||
129770964|NCT01417377|467130535|FG000|Overall Study|Enrolled, but not treated|1|||
129770965|NCT02113982|467130536|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
129770966|NCT02113982|467130537|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
129770967|NCT02113982|467130538|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
129770968|NCT02113982|467130539|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
129770969|NCT02113982|467130540|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
129770970|NCT02113982|467130541|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
129770971|NCT02113982|467130542|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
129770972|NCT02113982|467130543|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
129770973|NCT02113982|467130544|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
129770974|NCT02113982|467130545|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
129770975|NCT02113982|467130546|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
129770976|NCT02113982|467130547|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
129770977|NCT02113982|467130548|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
129770978|NCT02113982|467130549|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
129770979|NCT02113982|467130536|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
129770980|NCT02113982|467130537|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
129770981|NCT02113982|467130538|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
129770982|NCT02113982|467130539|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
129770983|NCT02113982|467130540|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
129770984|NCT02113982|467130541|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
129770985|NCT02113982|467130542|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
129770986|NCT02113982|467130543|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
129770987|NCT02113982|467130544|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
129770988|NCT02113982|467130545|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
129770989|NCT02113982|467130546|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
129770990|NCT02113982|467130547|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
129770991|NCT02113982|467130548|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
129770992|NCT02113982|467130549|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
129770993|NCT02113982|467130536|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129770994|NCT02113982|467130537|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129770995|NCT02113982|467130538|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129770996|NCT02113982|467130539|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129770997|NCT02113982|467130540|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129770998|NCT02113982|467130541|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129770999|NCT02113982|467130542|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
129771000|NCT02113982|467130543|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771001|NCT02113982|467130544|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771002|NCT02113982|467130545|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771003|NCT02113982|467130546|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771004|NCT02113982|467130547|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771005|NCT02113982|467130548|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771006|NCT02113982|467130549|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
129771007|NCT02113982|467130536|FG000|Stage 1: Dose Escalation|Transplant|0|||
129771008|NCT02113982|467130537|FG001|Stage 1: Dose Escalation|Transplant|1|||
129771009|NCT02113982|467130538|FG002|Stage 1: Dose Escalation|Transplant|0|||
129771010|NCT02113982|467130539|FG003|Stage 1: Dose Escalation|Transplant|0|||
129771011|NCT02113982|467130540|FG004|Stage 1: Dose Escalation|Transplant|0|||
129771012|NCT02113982|467130541|FG005|Stage 1: Dose Escalation|Transplant|1|||
129771013|NCT02113982|467130542|FG006|Stage 1: Dose Escalation|Transplant|0|||
129771014|NCT02113982|467130543|FG007|Stage 1: Dose Escalation|Transplant|0|||
129771015|NCT02113982|467130544|FG008|Stage 1: Dose Escalation|Transplant|0|||
129771016|NCT02113982|467130545|FG009|Stage 1: Dose Escalation|Transplant|0|||
129771017|NCT02113982|467130546|FG010|Stage 1: Dose Escalation|Transplant|0|||
129771018|NCT02113982|467130547|FG011|Stage 1: Dose Escalation|Transplant|0|||
129771019|NCT02113982|467130548|FG012|Stage 1: Dose Escalation|Transplant|0|||
129771020|NCT02113982|467130549|FG013|Stage 1: Dose Escalation|Transplant|0|||
129771021|NCT02113982|467130536|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
129771022|NCT02113982|467130537|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
129771023|NCT02113982|467130538|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
129771024|NCT02113982|467130539|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
129771025|NCT02113982|467130540|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
129771026|NCT02113982|467130541|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
129681534|NCT03329001|466794684|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129681535|NCT03329001|466794685|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129681536|NCT03329001|466794686|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129681537|NCT03329001|466794687|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
129681538|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681539|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681540|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681541|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
129681542|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681543|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681544|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681545|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
129681546|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681547|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681548|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681549|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
129681550|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681551|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681552|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681553|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
129681554|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129681555|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129771027|NCT02113982|467130542|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
129771028|NCT02113982|467130543|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
129771029|NCT02113982|467130544|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
129771030|NCT02113982|467130545|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
129771031|NCT02113982|467130546|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
129771032|NCT02113982|467130547|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
129771033|NCT02113982|467130548|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
129771034|NCT02113982|467130549|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
129771035|NCT02113982|467130536|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
129771036|NCT02113982|467130537|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
129771037|NCT02113982|467130538|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
129771038|NCT02113982|467130539|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
129771039|NCT02113982|467130540|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
129771040|NCT02113982|467130541|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
129771041|NCT02113982|467130542|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
129771042|NCT02113982|467130543|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
129771043|NCT02113982|467130544|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
129771044|NCT02113982|467130545|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
129771045|NCT02113982|467130546|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
129771046|NCT02113982|467130547|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
129771047|NCT02113982|467130548|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
129771048|NCT02113982|467130549|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
129771049|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
129771050|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
129771051|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
129771052|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
129771053|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
129771054|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
129771055|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
129771056|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
129771057|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
129771058|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
129771059|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
129771060|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
129771061|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
129771062|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
129771063|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
129771064|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
129771065|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
129771066|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
129771067|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
129771068|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
129771069|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
129681556|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129681557|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
129681558|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129681559|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129681560|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129681561|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
129681562|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129681563|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129681564|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
129681565|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129681566|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129681567|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129771070|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
129681568|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129681569|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
129681570|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681571|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681572|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
129681573|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681574|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681575|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681576|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681577|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
129681578|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681579|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681580|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
129681581|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681582|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681583|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681584|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681585|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
129681586|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681587|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681588|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
129681589|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681590|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681591|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681592|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681593|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
129681594|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129681595|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129681596|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
129681597|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
129681598|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129681599|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129681600|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129681601|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
129681602|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129681603|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129681604|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
129681605|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129771071|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
129771072|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
129771073|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
129771074|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
129771075|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
129771076|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
129771077|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771078|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771079|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771080|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771081|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771082|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771083|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771084|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
129771085|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771086|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
129771087|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
129771088|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771089|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771090|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
129771091|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771092|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771093|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771094|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771095|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771096|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771097|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771098|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
129771099|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771100|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
129771101|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771102|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771103|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771104|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
129771105|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771106|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771107|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771108|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771109|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771110|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771111|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771112|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
129771113|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771114|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771115|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771116|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771117|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771118|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
129771119|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Transplant|0|||
129771120|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Transplant|0|||
129771121|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Transplant|0|||
129771122|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Transplant|0|||
129771123|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Transplant|0|||
129771124|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Transplant|0|||
129771125|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Transplant|0|||
129771126|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Transplant|0|||
129771127|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Transplant|0|||
129771128|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Transplant|4|||
129771129|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Transplant|2|||
129771130|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Transplant|0|||
129771131|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Transplant|0|||
129771132|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Transplant|0|||
129771133|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
129771134|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
129771135|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
129771136|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
129771137|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
129771138|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
129681606|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129681607|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129681608|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129681609|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
129681610|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129681611|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129681612|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
129681613|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
129681614|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129681615|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129681616|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129681617|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
129681618|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129681619|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129681620|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
129681621|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
129681622|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129681623|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129681624|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129681625|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
129681626|NCT03329001|466794680|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129681627|NCT03329001|466794681|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129681628|NCT03329001|466794682|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
129681629|NCT03329001|466794683|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
129681630|NCT03329001|466794684|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129681631|NCT03329001|466794685|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129681632|NCT03329001|466794686|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129681633|NCT03329001|466794687|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
129681634|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681635|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681636|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681637|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
129681638|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681639|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681640|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681641|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
129681642|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681643|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681644|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681645|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
129681646|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681647|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681648|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681649|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
129681650|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681651|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681652|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
129681653|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681654|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681655|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681656|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681657|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
129681658|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129681659|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129681660|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
129681661|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
129681662|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129681663|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129681664|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129681665|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
129681666|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129771139|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
129771140|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
129771141|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
129771142|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
129771143|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
129771144|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
129771145|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
129771146|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
129771147|NCT02113982|467130536|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
129771148|NCT02113982|467130537|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
129771149|NCT02113982|467130538|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
129771150|NCT02113982|467130539|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
129771151|NCT02113982|467130540|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
129771152|NCT02113982|467130541|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
129771153|NCT02113982|467130542|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
129771154|NCT02113982|467130543|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
129771155|NCT02113982|467130544|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
129771156|NCT02113982|467130545|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
129771157|NCT02113982|467130546|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
129771158|NCT02113982|467130547|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
129771159|NCT02113982|467130548|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
129771160|NCT02113982|467130549|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
129771161|NCT02113982|467130536|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771162|NCT02113982|467130537|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771163|NCT02113982|467130538|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771164|NCT02113982|467130539|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771165|NCT02113982|467130540|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771166|NCT02113982|467130541|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771167|NCT02113982|467130542|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771168|NCT02113982|467130543|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771169|NCT02113982|467130544|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771170|NCT02113982|467130545|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771171|NCT02113982|467130546|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771172|NCT02113982|467130547|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
129771173|NCT02113982|467130548|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771174|NCT02113982|467130549|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
129771175|NCT02113982|467130536|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771176|NCT02113982|467130537|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771177|NCT02113982|467130538|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771178|NCT02113982|467130539|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771179|NCT02113982|467130540|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771180|NCT02113982|467130541|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771181|NCT02113982|467130542|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771182|NCT02113982|467130543|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771183|NCT02113982|467130544|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771184|NCT02113982|467130545|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771185|NCT02113982|467130546|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771186|NCT02113982|467130547|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
129771187|NCT02113982|467130548|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771188|NCT02113982|467130549|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
129771189|NCT02113982|467130536|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771190|NCT02113982|467130537|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771191|NCT02113982|467130538|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771192|NCT02113982|467130539|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771193|NCT02113982|467130540|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771194|NCT02113982|467130541|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771195|NCT02113982|467130542|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771196|NCT02113982|467130543|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771197|NCT02113982|467130544|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771198|NCT02113982|467130545|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771199|NCT02113982|467130546|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771200|NCT02113982|467130547|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
129771201|NCT02113982|467130548|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771202|NCT02113982|467130549|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
129771203|NCT02113982|467130536|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
129771204|NCT02113982|467130537|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
129771205|NCT02113982|467130538|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
129771206|NCT02113982|467130539|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
129771207|NCT02113982|467130540|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
129771208|NCT02113982|467130541|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
129771209|NCT02113982|467130542|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
129771210|NCT02113982|467130543|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
129771211|NCT02113982|467130544|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
129771212|NCT02113982|467130545|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
129771213|NCT02113982|467130546|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
129771214|NCT02113982|467130547|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
129771215|NCT02113982|467130548|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
129771216|NCT02113982|467130549|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
129771217|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771218|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771219|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771220|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771221|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771222|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771223|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771224|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771225|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771226|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771227|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771228|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771229|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
129771230|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
129771231|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771232|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129681667|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129681668|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
129681669|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129681670|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129681671|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129681672|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129681673|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
129681674|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681675|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681676|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
129681677|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681678|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681679|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681680|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681681|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
129681682|NCT03329001|466794680|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681683|NCT03329001|466794681|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681684|NCT03329001|466794682|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681685|NCT03329001|466794683|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
129681686|NCT03329001|466794684|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681687|NCT03329001|466794685|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681688|NCT03329001|466794686|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681689|NCT03329001|466794687|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
129681690|NCT03329001|466794680|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681691|NCT03329001|466794681|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681692|NCT03329001|466794682|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681693|NCT03329001|466794683|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681694|NCT03329001|466794684|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681695|NCT03329001|466794685|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
129681696|NCT03329001|466794686|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681697|NCT03329001|466794687|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
129681698|NCT03329001|466794680|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681699|NCT03329001|466794681|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681700|NCT03329001|466794682|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681701|NCT03329001|466794683|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681702|NCT03329001|466794684|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
129681703|NCT03329001|466794685|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681704|NCT03329001|466794686|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681705|NCT03329001|466794687|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
129681706|NCT03329001|466794680|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129681707|NCT03329001|466794681|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129681708|NCT03329001|466794682|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129681709|NCT03329001|466794683|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129681710|NCT03329001|466794684|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
129681711|NCT03329001|466794685|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
129681712|NCT03329001|466794686|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129681713|NCT03329001|466794687|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
129681714|NCT03329001|466794680|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681715|NCT03329001|466794681|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681716|NCT03329001|466794682|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681717|NCT03329001|466794683|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681718|NCT03329001|466794684|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
129681719|NCT03329001|466794685|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681720|NCT03329001|466794686|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681721|NCT03329001|466794687|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
129681722|NCT03329001|466794680|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129681723|NCT03329001|466794681|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129681724|NCT03329001|466794682|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129681725|NCT03329001|466794683|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129707652|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
129771233|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771234|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771235|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771236|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771237|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771238|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771239|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771240|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771241|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771242|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
129771243|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
129771244|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
129771245|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771246|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771247|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771248|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771249|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771250|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771251|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771252|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771253|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771254|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771255|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771256|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
129771257|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
129771258|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
129771259|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771260|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771261|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771262|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771263|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771264|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771265|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771266|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771267|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771268|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771269|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771270|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
129771271|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
129771272|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
129771273|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771274|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771275|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771276|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771277|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771278|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771279|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771280|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771281|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771282|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771283|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771284|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771285|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
129771286|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
129771287|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771288|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771289|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771290|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771291|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771292|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771293|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771294|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771295|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771296|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771297|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771298|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771299|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
129771300|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
129771301|NCT02113982|467130536|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771302|NCT02113982|467130537|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771303|NCT02113982|467130538|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771304|NCT02113982|467130539|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771305|NCT02113982|467130540|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771306|NCT02113982|467130541|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771307|NCT02113982|467130542|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771308|NCT02113982|467130543|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771309|NCT02113982|467130544|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771310|NCT02113982|467130545|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771311|NCT02113982|467130546|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771312|NCT02113982|467130547|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771313|NCT02113982|467130548|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
129771314|NCT02113982|467130549|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
129771315|NCT02085161|467130551|FG000|Overall Study|Not Treated|1|||
129771316|NCT02085161|467130552|FG001|Overall Study|Not Treated|0|||
129771317|NCT02085161|467130553|FG002|Overall Study|Not Treated|0|||
129771318|NCT02085161|467130554|FG003|Overall Study|Not Treated|0|||
129771319|NCT02085161|467130551|FG000|Overall Study|Adverse Event|8|||
129771320|NCT02085161|467130552|FG001|Overall Study|Adverse Event|5|||
129771321|NCT02085161|467130553|FG002|Overall Study|Adverse Event|4|||
129681726|NCT03329001|466794684|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
129681727|NCT03329001|466794685|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
129681728|NCT03329001|466794686|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129681729|NCT03329001|466794687|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
129681730|NCT03329001|466794680|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129681731|NCT03329001|466794681|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129681732|NCT03329001|466794682|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129681733|NCT03329001|466794683|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129681734|NCT03329001|466794684|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129681735|NCT03329001|466794685|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
129681736|NCT03329001|466794686|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
129681737|NCT03329001|466794687|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
129681738|NCT03329001|466794680|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681739|NCT03329001|466794681|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681740|NCT03329001|466794682|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681741|NCT03329001|466794683|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681742|NCT03329001|466794684|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681743|NCT03329001|466794685|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681744|NCT03329001|466794686|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
129681745|NCT03329001|466794687|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
129681746|NCT03329001|466794680|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129681747|NCT03329001|466794681|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129681748|NCT03329001|466794682|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129681749|NCT03329001|466794683|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129771322|NCT02085161|467130554|FG003|Overall Study|Adverse Event|5|||
129771323|NCT02085161|467130551|FG000|Overall Study|Protocol Violation|0|||
129771324|NCT02085161|467130552|FG001|Overall Study|Protocol Violation|1|||
129771325|NCT02085161|467130553|FG002|Overall Study|Protocol Violation|0|||
129771326|NCT02085161|467130554|FG003|Overall Study|Protocol Violation|1|||
129771327|NCT02085161|467130551|FG000|Overall Study|Withdrawal by Subject|2|||
129771328|NCT02085161|467130552|FG001|Overall Study|Withdrawal by Subject|4|||
129771329|NCT02085161|467130553|FG002|Overall Study|Withdrawal by Subject|0|||
129771330|NCT02085161|467130554|FG003|Overall Study|Withdrawal by Subject|3|||
129771331|NCT02085161|467130551|FG000|Overall Study|Other Reason|1|||
129771332|NCT02085161|467130552|FG001|Overall Study|Other Reason|0|||
129771333|NCT02085161|467130553|FG002|Overall Study|Other Reason|1|||
129771334|NCT02085161|467130554|FG003|Overall Study|Other Reason|1|||
129771335|NCT01936870|467130557|FG000|Overall Study|No Visit After Treatment|176|||
129771336|NCT01936870|467130557|FG000|Overall Study|Protocol Violation|12|||
129771337|NCT01936870|467130557|FG000|Overall Study|No Drug Administration|1|||
129771338|NCT00628108|467130566|FG000|Overall Study|Adverse Event|0|||
129681750|NCT03329001|466794684|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129681751|NCT03329001|466794685|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
129771339|NCT00628108|467130567|FG001|Overall Study|Adverse Event|3|||
129771340|NCT00628108|467130566|FG000|Overall Study|Withdrawal by Subject|1|||
129771341|NCT00628108|467130567|FG001|Overall Study|Withdrawal by Subject|0|||
129771342|NCT03848832|467130570|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
129771343|NCT03848832|467130571|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
129771344|NCT03848832|467130572|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
129771345|NCT03848832|467130570|FG000|Overall Study|Withdrawal by Subject|0|||
129771346|NCT03848832|467130571|FG001|Overall Study|Withdrawal by Subject|0|||
129771347|NCT03848832|467130572|FG002|Overall Study|Withdrawal by Subject|1|||
129771348|NCT03848832|467130570|FG000|Overall Study|Withdrawal (Covid-19)|0|||
129771349|NCT03848832|467130571|FG001|Overall Study|Withdrawal (Covid-19)|2|||
129771350|NCT03848832|467130572|FG002|Overall Study|Withdrawal (Covid-19)|0|||
129771351|NCT03848832|467130570|FG000|Overall Study|Physician Decision|2|||
129771352|NCT03848832|467130571|FG001|Overall Study|Physician Decision|1|||
129771353|NCT03848832|467130572|FG002|Overall Study|Physician Decision|3|||
129771354|NCT03848832|467130570|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
129771355|NCT03848832|467130571|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
129771356|NCT03848832|467130572|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
129771357|NCT03848832|467130570|FG000|Overall Study|Adverse Event|1|||
129771358|NCT03848832|467130571|FG001|Overall Study|Adverse Event|0|||
129771359|NCT03848832|467130572|FG002|Overall Study|Adverse Event|0|||
129771360|NCT01760733|467130573|FG000|Waiting List|Death|18|||
129771361|NCT01760733|467130573|FG000|Waiting List|Removed from waiting list|41|||
129771362|NCT01760733|467130573|FG000|Waiting List|Not received a transplant yet|13|||
129771363|NCT01760733|467130573|FG000|Transplanted|Not reached 10 years post transplant|184|||
129771364|NCT01760733|467130573|FG000|Transplanted|Death|26|||
129771365|NCT01760733|467130573|FG000|Transplanted|Graft loss|7|||
129771366|NCT02404025|467130575|FG000|Overall Study|Adverse Event|1|||
129771367|NCT02404025|467130575|FG000|Overall Study|Lack of Efficacy|3|||
129771368|NCT03938259|467130577|FG000|Overall Study|unable to establish baseline for ventilation|1|||
129771369|NCT03938259|467130578|FG001|Overall Study|unable to establish baseline for ventilation|1|||
129771370|NCT01746901|467130581|FG000|Naloxone Challenge Phase|Adverse Event|2|||
129681752|NCT03329001|466794686|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
129681753|NCT03329001|466794687|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
129681754|NCT03329001|466794680|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129681755|NCT03329001|466794681|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129681756|NCT03329001|466794682|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129681757|NCT03329001|466794683|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129681758|NCT03329001|466794684|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129771371|NCT01746901|467130582|FG001|Naloxone Challenge Phase|Adverse Event|0|||
129771372|NCT01746901|467130583|FG002|Naloxone Challenge Phase|Adverse Event|0|||
129771373|NCT01746901|467130584|FG003|Naloxone Challenge Phase|Adverse Event|0|||
129771374|NCT01746901|467130585|FG004|Naloxone Challenge Phase|Adverse Event|0|||
129771375|NCT01746901|467130586|FG005|Naloxone Challenge Phase|Adverse Event|0|||
129771376|NCT01746901|467130587|FG006|Naloxone Challenge Phase|Adverse Event|0|||
129681759|NCT03329001|466794685|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
129681760|NCT03329001|466794686|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
129681761|NCT03329001|466794687|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
129681762|NCT02709369|466794691|FG000|Overall Study|Lost to Follow-up|15|||
129681763|NCT02709369|466794691|FG000|Overall Study|Withdrawal by Subject|10|||
129681764|NCT02709369|466794691|FG000|Overall Study|Did not received intervention|2|||
129681765|NCT00963235|466794692|FG000|Overall Study|Withdrawal by Subject|22|||
129681766|NCT00963235|466794692|FG000|Overall Study|Lost to Follow-up|14|||
129681767|NCT00963235|466794692|FG000|Overall Study|Failed to return|9|||
129681768|NCT00963235|466794692|FG000|Overall Study|Protocol Violation|7|||
129681769|NCT00963235|466794692|FG000|Overall Study|Adverse Event|5|||
129681770|NCT00963235|466794692|FG000|Overall Study|Physician Decision|2|||
129681771|NCT00963235|466794692|FG000|Overall Study|Other|1|||
129681772|NCT01104766|466794694|FG000|Overall Study|Did not meet inc/exc criteria|1|||
129681773|NCT01104766|466794695|FG001|Overall Study|Did not meet inc/exc criteria|0|||
129681774|NCT01104766|466794696|FG002|Overall Study|Did not meet inc/exc criteria|0|||
129681775|NCT01104766|466794697|FG003|Overall Study|Did not meet inc/exc criteria|0|||
129681776|NCT01104766|466794694|FG000|Overall Study|Adverse Event|17|||
129681777|NCT01104766|466794695|FG001|Overall Study|Adverse Event|15|||
129681778|NCT01104766|466794696|FG002|Overall Study|Adverse Event|20|||
129681779|NCT01104766|466794697|FG003|Overall Study|Adverse Event|14|||
129681780|NCT01104766|466794694|FG000|Overall Study|Lack of Efficacy|20|||
129681781|NCT01104766|466794695|FG001|Overall Study|Lack of Efficacy|15|||
129681782|NCT01104766|466794696|FG002|Overall Study|Lack of Efficacy|14|||
129681783|NCT01104766|466794697|FG003|Overall Study|Lack of Efficacy|8|||
129681784|NCT01104766|466794694|FG000|Overall Study|Protocol Violation|2|||
129681785|NCT01104766|466794695|FG001|Overall Study|Protocol Violation|0|||
129681786|NCT01104766|466794696|FG002|Overall Study|Protocol Violation|0|||
129681787|NCT01104766|466794697|FG003|Overall Study|Protocol Violation|0|||
129681788|NCT01104766|466794694|FG000|Overall Study|Withdrawal by Subject|17|||
129681789|NCT01104766|466794695|FG001|Overall Study|Withdrawal by Subject|19|||
129681790|NCT01104766|466794696|FG002|Overall Study|Withdrawal by Subject|25|||
129681791|NCT01104766|466794697|FG003|Overall Study|Withdrawal by Subject|15|||
129681792|NCT01104766|466794694|FG000|Overall Study|Lost to Follow-up|1|||
129681793|NCT01104766|466794695|FG001|Overall Study|Lost to Follow-up|2|||
129681794|NCT01104766|466794696|FG002|Overall Study|Lost to Follow-up|1|||
129681795|NCT01104766|466794697|FG003|Overall Study|Lost to Follow-up|1|||
129681796|NCT01341470|466794699|FG000|Overall Study|Sponsor decision|0|||
129681797|NCT01341470|466794700|FG001|Overall Study|Sponsor decision|0|||
129681798|NCT01341470|466794701|FG002|Overall Study|Sponsor decision|1|||
129681799|NCT01341470|466794702|FG003|Overall Study|Sponsor decision|1|||
129681800|NCT01341470|466794703|FG004|Overall Study|Sponsor decision|0|||
129681801|NCT01341470|466794704|FG005|Overall Study|Sponsor decision|1|||
129681802|NCT01136915|466794706|FG000|Overall Study|Lost to Follow-up|2|||
129681803|NCT01136915|466794707|FG001|Overall Study|Lost to Follow-up|0|||
129681804|NCT01136915|466794706|FG000|Overall Study|Exclusion criterion met|0|||
129681805|NCT01136915|466794707|FG001|Overall Study|Exclusion criterion met|1|||
129681806|NCT01756235|466794708|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
129681807|NCT05376358|466794709|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
129681808|NCT05376358|466794710|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
129681809|NCT05376358|466794709|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
129681810|NCT05376358|466794710|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
129681811|NCT05376358|466794709|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
129681812|NCT05376358|466794710|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
129681813|NCT05376358|466794709|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
129681814|NCT05376358|466794710|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
129681815|NCT05376358|466794709|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
129681816|NCT05376358|466794710|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
129771377|NCT01746901|467130588|FG007|Naloxone Challenge Phase|Adverse Event|0|||
129771378|NCT01746901|467130589|FG008|Naloxone Challenge Phase|Adverse Event|0|||
129771379|NCT01746901|467130581|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
129681817|NCT05376358|466794709|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
129681818|NCT05376358|466794710|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
129681819|NCT03965923|466794711|FG000|Overall Study|Withdrawal by Subject|1|||
129681820|NCT03965923|466794712|FG001|Overall Study|Withdrawal by Subject|2|||
129681821|NCT03965923|466794713|FG002|Overall Study|Withdrawal by Subject|3|||
129681822|NCT03965923|466794714|FG003|Overall Study|Withdrawal by Subject|1|||
129681823|NCT03965923|466794715|FG004|Overall Study|Withdrawal by Subject|2|||
129681824|NCT03965923|466794716|FG005|Overall Study|Withdrawal by Subject|0|||
129681825|NCT03965923|466794717|FG006|Overall Study|Withdrawal by Subject|4|||
129681826|NCT03965923|466794718|FG007|Overall Study|Withdrawal by Subject|3|||
129681827|NCT03965923|466794719|FG008|Overall Study|Withdrawal by Subject|4|||
129681828|NCT03965923|466794720|FG009|Overall Study|Withdrawal by Subject|0|||
129681829|NCT03965923|466794721|FG010|Overall Study|Withdrawal by Subject|2|||
129681830|NCT03965923|466794722|FG011|Overall Study|Withdrawal by Subject|0|||
129681831|NCT03965923|466794711|FG000|Overall Study|Lost to Follow-up|2|||
129681832|NCT03965923|466794712|FG001|Overall Study|Lost to Follow-up|1|||
129681833|NCT03965923|466794713|FG002|Overall Study|Lost to Follow-up|1|||
129681834|NCT03965923|466794714|FG003|Overall Study|Lost to Follow-up|0|||
129681835|NCT03965923|466794715|FG004|Overall Study|Lost to Follow-up|2|||
129681836|NCT03965923|466794716|FG005|Overall Study|Lost to Follow-up|1|||
129681837|NCT03965923|466794717|FG006|Overall Study|Lost to Follow-up|2|||
129681838|NCT03965923|466794718|FG007|Overall Study|Lost to Follow-up|1|||
129681839|NCT03965923|466794719|FG008|Overall Study|Lost to Follow-up|0|||
129681840|NCT03965923|466794720|FG009|Overall Study|Lost to Follow-up|2|||
129681841|NCT03965923|466794721|FG010|Overall Study|Lost to Follow-up|0|||
129681842|NCT03965923|466794722|FG011|Overall Study|Lost to Follow-up|0|||
129681843|NCT03965923|466794711|FG000|Overall Study|Death|0|||
129681844|NCT03965923|466794712|FG001|Overall Study|Death|0|||
129681845|NCT03965923|466794713|FG002|Overall Study|Death|0|||
129681846|NCT03965923|466794714|FG003|Overall Study|Death|0|||
129681847|NCT03965923|466794715|FG004|Overall Study|Death|0|||
129681848|NCT03965923|466794716|FG005|Overall Study|Death|0|||
129681849|NCT03965923|466794717|FG006|Overall Study|Death|0|||
129681850|NCT03965923|466794718|FG007|Overall Study|Death|1|||
129681851|NCT03965923|466794719|FG008|Overall Study|Death|4|||
129681852|NCT03965923|466794720|FG009|Overall Study|Death|0|||
129681853|NCT03965923|466794721|FG010|Overall Study|Death|4|||
129681854|NCT03965923|466794722|FG011|Overall Study|Death|0|||
129681855|NCT03965923|466794711|FG000|Overall Study|Other reason|0|||
129681856|NCT03965923|466794712|FG001|Overall Study|Other reason|0|||
129681857|NCT03965923|466794713|FG002|Overall Study|Other reason|0|||
129681858|NCT03965923|466794714|FG003|Overall Study|Other reason|1|||
129681859|NCT03965923|466794715|FG004|Overall Study|Other reason|0|||
129681860|NCT03965923|466794716|FG005|Overall Study|Other reason|0|||
129681861|NCT03965923|466794717|FG006|Overall Study|Other reason|0|||
129681862|NCT03965923|466794718|FG007|Overall Study|Other reason|0|||
129681863|NCT03965923|466794719|FG008|Overall Study|Other reason|0|||
129681864|NCT03965923|466794720|FG009|Overall Study|Other reason|0|||
129681865|NCT03965923|466794721|FG010|Overall Study|Other reason|2|||
129681866|NCT03965923|466794722|FG011|Overall Study|Other reason|0|||
129681867|NCT04221490|466794723|FG000|At 30 Days Follow-up|Death|7|||
129681868|NCT04221490|466794723|FG000|At 30 Days Follow-up|Missed Visit|4|||
129681869|NCT04221490|466794723|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
129681870|NCT04221490|466794723|FG000|At 6 Months Follow-up|Death|9|||
129681871|NCT04221490|466794723|FG000|At 6 Months Follow-up|Physician Decision|1|||
129681872|NCT04221490|466794723|FG000|At 6 Months Follow-up|Missed Visit|8|||
129681873|NCT04221490|466794723|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
129681874|NCT03034967|466794724|FG000|Overall Study|Withdrawal by Subject|9|||
129681875|NCT03034967|466794725|FG001|Overall Study|Withdrawal by Subject|2|||
129681876|NCT03034967|466794726|FG002|Overall Study|Withdrawal by Subject|6|||
129771380|NCT01746901|467130582|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129771381|NCT01746901|467130583|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129771382|NCT01746901|467130584|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129771383|NCT01746901|467130585|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129681877|NCT03034967|466794727|FG003|Overall Study|Withdrawal by Subject|6|||
129681878|NCT03034967|466794728|FG004|Overall Study|Withdrawal by Subject|9|||
129681879|NCT03034967|466794729|FG005|Overall Study|Withdrawal by Subject|2|||
129681880|NCT03034967|466794724|FG000|Overall Study|Physician Decision|1|||
129681881|NCT03034967|466794725|FG001|Overall Study|Physician Decision|0|||
129681882|NCT03034967|466794726|FG002|Overall Study|Physician Decision|1|||
129681883|NCT03034967|466794727|FG003|Overall Study|Physician Decision|1|||
129681884|NCT03034967|466794728|FG004|Overall Study|Physician Decision|1|||
129771384|NCT01746901|467130586|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129681885|NCT03034967|466794729|FG005|Overall Study|Physician Decision|0|||
129681886|NCT03034967|466794724|FG000|Overall Study|Lost to Follow-up|0|||
129771385|NCT01746901|467130587|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129771386|NCT01746901|467130588|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129771387|NCT01746901|467130589|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
129771388|NCT01746901|467130581|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771389|NCT01746901|467130582|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
129771390|NCT01746901|467130583|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771391|NCT01746901|467130584|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771392|NCT01746901|467130585|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771393|NCT01746901|467130586|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771394|NCT01746901|467130587|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771395|NCT01746901|467130588|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771396|NCT01746901|467130589|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129771397|NCT01746901|467130581|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771398|NCT01746901|467130582|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
129771399|NCT01746901|467130583|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
129771400|NCT01746901|467130584|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771401|NCT01746901|467130585|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771402|NCT01746901|467130586|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771403|NCT01746901|467130587|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771404|NCT01746901|467130588|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771405|NCT01746901|467130589|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
129771406|NCT01746901|467130581|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771407|NCT01746901|467130582|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
129771408|NCT01746901|467130583|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
129771409|NCT01746901|467130584|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771410|NCT01746901|467130585|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771411|NCT01746901|467130586|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771412|NCT01746901|467130587|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771413|NCT01746901|467130588|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771414|NCT01746901|467130589|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
129771415|NCT01746901|467130581|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771416|NCT01746901|467130582|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
129771417|NCT01746901|467130583|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
129771418|NCT01746901|467130584|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771419|NCT01746901|467130585|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771420|NCT01746901|467130586|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771421|NCT01746901|467130587|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771422|NCT01746901|467130588|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771423|NCT01746901|467130589|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129771424|NCT01746901|467130581|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
129771425|NCT01746901|467130582|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
129771426|NCT01746901|467130583|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
129771427|NCT01746901|467130584|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
129771428|NCT01746901|467130585|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
129771429|NCT01746901|467130586|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
129771430|NCT01746901|467130587|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
129771431|NCT01746901|467130588|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
129771432|NCT01746901|467130589|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
129771433|NCT01746901|467130581|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129771434|NCT01746901|467130582|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129771435|NCT01746901|467130583|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129681887|NCT03034967|466794725|FG001|Overall Study|Lost to Follow-up|0|||
129681888|NCT03034967|466794726|FG002|Overall Study|Lost to Follow-up|0|||
129681889|NCT03034967|466794727|FG003|Overall Study|Lost to Follow-up|1|||
129681890|NCT03034967|466794728|FG004|Overall Study|Lost to Follow-up|0|||
129681891|NCT03034967|466794729|FG005|Overall Study|Lost to Follow-up|2|||
129681892|NCT03034967|466794724|FG000|Overall Study|Liver function test abnormality|0|||
129681893|NCT03034967|466794725|FG001|Overall Study|Liver function test abnormality|0|||
129681894|NCT03034967|466794726|FG002|Overall Study|Liver function test abnormality|1|||
129681895|NCT03034967|466794727|FG003|Overall Study|Liver function test abnormality|0|||
129681896|NCT03034967|466794728|FG004|Overall Study|Liver function test abnormality|0|||
129681897|NCT03034967|466794729|FG005|Overall Study|Liver function test abnormality|0|||
129681898|NCT03034967|466794724|FG000|Overall Study|Protocol Violation|1|||
129771436|NCT01746901|467130584|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129681899|NCT03034967|466794725|FG001|Overall Study|Protocol Violation|0|||
129681900|NCT03034967|466794726|FG002|Overall Study|Protocol Violation|0|||
129681901|NCT03034967|466794727|FG003|Overall Study|Protocol Violation|0|||
129681902|NCT03034967|466794728|FG004|Overall Study|Protocol Violation|0|||
129681903|NCT03034967|466794729|FG005|Overall Study|Protocol Violation|2|||
129681904|NCT03034967|466794724|FG000|Overall Study|Lack of Efficacy|0|||
129681905|NCT03034967|466794725|FG001|Overall Study|Lack of Efficacy|1|||
129681906|NCT03034967|466794726|FG002|Overall Study|Lack of Efficacy|2|||
129681907|NCT03034967|466794727|FG003|Overall Study|Lack of Efficacy|1|||
129681908|NCT03034967|466794728|FG004|Overall Study|Lack of Efficacy|1|||
129681909|NCT03034967|466794729|FG005|Overall Study|Lack of Efficacy|0|||
129681910|NCT03034967|466794724|FG000|Overall Study|Adverse Event, non-fatal|3|||
129681911|NCT03034967|466794725|FG001|Overall Study|Adverse Event, non-fatal|1|||
129681912|NCT03034967|466794726|FG002|Overall Study|Adverse Event, non-fatal|2|||
129681913|NCT03034967|466794727|FG003|Overall Study|Adverse Event, non-fatal|0|||
129681914|NCT03034967|466794728|FG004|Overall Study|Adverse Event, non-fatal|2|||
129681915|NCT03034967|466794729|FG005|Overall Study|Adverse Event, non-fatal|8|||
129681916|NCT03034967|466794724|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
129681917|NCT03034967|466794725|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
129681918|NCT03034967|466794726|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
129681919|NCT03034967|466794727|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
129681920|NCT03034967|466794728|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
129681921|NCT03034967|466794729|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
129681922|NCT04225039|466794736|FG000|Overall Study|Withdrawal by Subject|1|||
129681923|NCT04225039|466794737|FG001|Overall Study|Withdrawal by Subject|0|||
129681924|NCT04225039|466794738|FG002|Overall Study|Withdrawal by Subject|0|||
129681925|NCT04225039|466794739|FG003|Overall Study|Withdrawal by Subject|1|||
129681926|NCT04225039|466794736|FG000|Overall Study|Currently active on study treatment|0|||
129681927|NCT04225039|466794737|FG001|Overall Study|Currently active on study treatment|1|||
129681928|NCT04225039|466794738|FG002|Overall Study|Currently active on study treatment|0|||
129681929|NCT04225039|466794739|FG003|Overall Study|Currently active on study treatment|0|||
129681930|NCT04225039|466794736|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
129681931|NCT04225039|466794737|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
129681932|NCT04225039|466794738|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
129681933|NCT04225039|466794739|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
129681934|NCT04225039|466794736|FG000|Overall Study|Ineligible for treatment|0|||
129681935|NCT04225039|466794737|FG001|Overall Study|Ineligible for treatment|0|||
129681936|NCT04225039|466794738|FG002|Overall Study|Ineligible for treatment|0|||
129681937|NCT04225039|466794739|FG003|Overall Study|Ineligible for treatment|4|||
129681938|NCT02879695|466794743|FG000|Overall Study|Did not start study treatment|2|||
129681939|NCT02879695|466794744|FG001|Overall Study|Did not start study treatment|0|||
129771437|NCT01746901|467130585|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129771438|NCT01746901|467130586|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129771439|NCT01746901|467130587|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129771440|NCT01746901|467130588|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
129771441|NCT01746901|467130589|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
129681940|NCT02879695|466794745|FG002|Overall Study|Did not start study treatment|3|||
129681941|NCT02879695|466794746|FG003|Overall Study|Did not start study treatment|0|||
129681942|NCT00157755|466794749|FG000|Overall Study|Death|2|||
129681943|NCT00157755|466794750|FG001|Overall Study|Death|3|||
129681944|NCT00157755|466794751|FG002|Overall Study|Death|3|||
129681945|NCT00157755|466794752|FG003|Overall Study|Death|2|||
129681946|NCT00157755|466794753|FG004|Overall Study|Death|0|||
129681947|NCT00157755|466794754|FG005|Overall Study|Death|0|||
129681948|NCT00157755|466794749|FG000|Overall Study|Lost to Follow-up|0|||
129681949|NCT00157755|466794750|FG001|Overall Study|Lost to Follow-up|0|||
129681950|NCT00157755|466794751|FG002|Overall Study|Lost to Follow-up|1|||
129681951|NCT00157755|466794752|FG003|Overall Study|Lost to Follow-up|0|||
129681952|NCT00157755|466794753|FG004|Overall Study|Lost to Follow-up|0|||
129681953|NCT00157755|466794754|FG005|Overall Study|Lost to Follow-up|0|||
129681954|NCT00157755|466794749|FG000|Overall Study|Withdrawal by Subject|0|||
129681955|NCT00157755|466794750|FG001|Overall Study|Withdrawal by Subject|0|||
129681956|NCT00157755|466794751|FG002|Overall Study|Withdrawal by Subject|1|||
129681957|NCT00157755|466794752|FG003|Overall Study|Withdrawal by Subject|1|||
129681958|NCT00157755|466794753|FG004|Overall Study|Withdrawal by Subject|1|||
129681959|NCT00157755|466794754|FG005|Overall Study|Withdrawal by Subject|2|||
129681960|NCT00157755|466794749|FG000|Overall Study|Explant due to infection|0|||
129681961|NCT00157755|466794750|FG001|Overall Study|Explant due to infection|0|||
129681962|NCT00157755|466794751|FG002|Overall Study|Explant due to infection|1|||
129681963|NCT00157755|466794752|FG003|Overall Study|Explant due to infection|0|||
129681964|NCT00157755|466794753|FG004|Overall Study|Explant due to infection|0|||
129681965|NCT00157755|466794754|FG005|Overall Study|Explant due to infection|0|||
129681966|NCT00157755|466794749|FG000|Overall Study|Medical reason|0|||
129681967|NCT00157755|466794750|FG001|Overall Study|Medical reason|0|||
129681968|NCT00157755|466794751|FG002|Overall Study|Medical reason|1|||
129681969|NCT00157755|466794752|FG003|Overall Study|Medical reason|1|||
129681970|NCT00157755|466794753|FG004|Overall Study|Medical reason|0|||
129681971|NCT00157755|466794754|FG005|Overall Study|Medical reason|0|||
129681972|NCT00157755|466794749|FG000|Overall Study|Study site closure|0|||
129681973|NCT00157755|466794750|FG001|Overall Study|Study site closure|1|||
129681974|NCT00157755|466794751|FG002|Overall Study|Study site closure|0|||
129681975|NCT00157755|466794752|FG003|Overall Study|Study site closure|0|||
129681976|NCT00157755|466794753|FG004|Overall Study|Study site closure|0|||
129681977|NCT00157755|466794754|FG005|Overall Study|Study site closure|0|||
129681978|NCT00157755|466794749|FG000|Overall Study|Subject non-compliance|0|||
129681979|NCT00157755|466794750|FG001|Overall Study|Subject non-compliance|0|||
129681980|NCT00157755|466794751|FG002|Overall Study|Subject non-compliance|0|||
129681981|NCT00157755|466794752|FG003|Overall Study|Subject non-compliance|0|||
129681982|NCT00157755|466794753|FG004|Overall Study|Subject non-compliance|0|||
129681983|NCT00157755|466794754|FG005|Overall Study|Subject non-compliance|1|||
129681984|NCT00157755|466794749|FG000|Overall Study|Study completion|0|||
129681985|NCT00157755|466794750|FG001|Overall Study|Study completion|0|||
129681986|NCT00157755|466794751|FG002|Overall Study|Study completion|0|||
129681987|NCT00157755|466794752|FG003|Overall Study|Study completion|0|||
129681988|NCT00157755|466794753|FG004|Overall Study|Study completion|1|||
129681989|NCT00157755|466794754|FG005|Overall Study|Study completion|2|||
129681990|NCT05523297|466794759|FG000|Overall Study|Death|7|||
129681991|NCT05523297|466794760|FG001|Overall Study|Death|8|||
129681992|NCT05523297|466794759|FG000|Overall Study|Lost to Follow-up|2|||
129681993|NCT05523297|466794760|FG001|Overall Study|Lost to Follow-up|1|||
129681994|NCT03462680|466794761|FG000|Overall Study|Withdrawal by Subject|3|||
129681995|NCT03462680|466794762|FG001|Overall Study|Withdrawal by Subject|5|||
129681996|NCT02246777|466794763|FG000|Overall Study|Adverse Event|2|||
129681997|NCT02246777|466794763|FG000|Overall Study|Change of residence|1|||
129681998|NCT04133909|466794764|FG000|Overall Study|Death|11|||
129681999|NCT04133909|466794765|FG001|Overall Study|Death|11|||
129682000|NCT04133909|466794764|FG000|Overall Study|Adverse Event|4|||
129682001|NCT04133909|466794765|FG001|Overall Study|Adverse Event|5|||
129682002|NCT04133909|466794764|FG000|Overall Study|Lost to Follow-up|3|||
129682003|NCT04133909|466794765|FG001|Overall Study|Lost to Follow-up|5|||
129682004|NCT04133909|466794764|FG000|Overall Study|Physician Decision|4|||
129682005|NCT04133909|466794765|FG001|Overall Study|Physician Decision|7|||
129682006|NCT04133909|466794764|FG000|Overall Study|Withdrawal by Subject|40|||
129682007|NCT04133909|466794765|FG001|Overall Study|Withdrawal by Subject|35|||
129682008|NCT04133909|466794764|FG000|Overall Study|Lack of Efficacy|2|||
129682009|NCT04133909|466794765|FG001|Overall Study|Lack of Efficacy|7|||
129682010|NCT04133909|466794764|FG000|Overall Study|Randomized in error|1|||
129682011|NCT04133909|466794765|FG001|Overall Study|Randomized in error|1|||
129682012|NCT04817410|466796815|FG000|Overall Study|Withdrawal by Subject|5|||
129682013|NCT04817410|466796815|FG000|Overall Study|Physician Decision|3|||
129682014|NCT03595748|466796816|FG000|Overall Study|Death|11|||
129682015|NCT03595748|466796817|FG001|Overall Study|Death|12|||
129682016|NCT03595748|466796816|FG000|Overall Study|Withdrawal by Subject|28|||
129682017|NCT03595748|466796817|FG001|Overall Study|Withdrawal by Subject|29|||
129682018|NCT03595748|466796816|FG000|Overall Study|Protocol Violation|0|||
129682019|NCT03595748|466796817|FG001|Overall Study|Protocol Violation|1|||
129682020|NCT04809974|466796819|FG000|Lead-in Phase|Withdrawal by Subject|3|||
129682021|NCT04809974|466796820|FG001|Lead-in Phase|Withdrawal by Subject|0|||
129682022|NCT04809974|466796821|FG002|Lead-in Phase|Withdrawal by Subject|0|||
129682023|NCT04809974|466796819|FG000|Lead-in Phase|No longer eligible|11|||
129682024|NCT04809974|466796820|FG001|Lead-in Phase|No longer eligible|0|||
129682025|NCT04809974|466796821|FG002|Lead-in Phase|No longer eligible|0|||
129682026|NCT04809974|466796819|FG000|Randomized Phase|Lost to Follow-up|0|||
129682027|NCT04809974|466796820|FG001|Randomized Phase|Lost to Follow-up|1|||
129682028|NCT04809974|466796821|FG002|Randomized Phase|Lost to Follow-up|5|||
129682029|NCT04809974|466796819|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
129682030|NCT04809974|466796820|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
129682031|NCT04809974|466796821|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
129682032|NCT04809974|466796819|FG000|Randomized Phase|Adverse Event|0|||
129682033|NCT04809974|466796820|FG001|Randomized Phase|Adverse Event|1|||
129682034|NCT04809974|466796821|FG002|Randomized Phase|Adverse Event|4|||
129682035|NCT04809974|466796819|FG000|Randomized Phase|Withdrawal by Subject|0|||
129682036|NCT04809974|466796820|FG001|Randomized Phase|Withdrawal by Subject|0|||
129682037|NCT04809974|466796821|FG002|Randomized Phase|Withdrawal by Subject|5|||
129682038|NCT05493111|466796822|FG000|Overall Study|Adverse Event|3|||
129682039|NCT05493111|466796823|FG001|Overall Study|Adverse Event|4|||
129682040|NCT05493111|466796822|FG000|Overall Study|Withdrawal of Consent|19|||
129682041|NCT05493111|466796823|FG001|Overall Study|Withdrawal of Consent|10|||
129682042|NCT05493111|466796822|FG000|Overall Study|Non-compliance|1|||
129682043|NCT05493111|466796823|FG001|Overall Study|Non-compliance|1|||
129682044|NCT05493111|466796822|FG000|Overall Study|Lost to Follow-up|8|||
129682045|NCT05493111|466796823|FG001|Overall Study|Lost to Follow-up|1|||
129682046|NCT05493111|466796822|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
129682047|NCT05493111|466796823|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
129682048|NCT05493111|466796822|FG000|Overall Study|Withdrawal by Subject|1|||
129682049|NCT05493111|466796823|FG001|Overall Study|Withdrawal by Subject|1|||
129682050|NCT06125964|466796824|FG000|Overall Study|Lost to Follow-up|0|||
129682051|NCT06125964|466796825|FG001|Overall Study|Lost to Follow-up|1|||
129682052|NCT06125964|466796826|FG002|Overall Study|Lost to Follow-up|0|||
129682053|NCT06125964|466796827|FG003|Overall Study|Lost to Follow-up|0|||
129682054|NCT01787838|466796828|FG000|Overall Study|refused|1413|||
129682055|NCT01431976|466796829|FG000|Overall Study|Adverse Event|6|||
129682056|NCT01431976|466796829|FG000|Overall Study|Lack of Efficacy|2|||
129682057|NCT01431976|466796829|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
129682058|NCT01431976|466796829|FG000|Overall Study|Physician Decision|1|||
129682059|NCT01431976|466796829|FG000|Overall Study|Withdrawal by Subject|1|||
129682060|NCT01136954|466796831|FG000|Overall Study|Adverse Event|3|||
129682061|NCT01136954|466796832|FG001|Overall Study|Adverse Event|2|||
129682062|NCT01136954|466796831|FG000|Overall Study|Withdrawal by Subject|6|||
129682063|NCT01136954|466796832|FG001|Overall Study|Withdrawal by Subject|2|||
129682064|NCT01136954|466796831|FG000|Overall Study|Lack of Efficacy|14|||
129771442|NCT01746901|467130581|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771443|NCT01746901|467130582|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771444|NCT01746901|467130583|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771445|NCT01746901|467130584|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771446|NCT01746901|467130585|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771447|NCT01746901|467130586|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
129771448|NCT01746901|467130587|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
129771449|NCT01746901|467130588|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771450|NCT01746901|467130589|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
129771451|NCT01746901|467130581|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771452|NCT01746901|467130582|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771453|NCT01746901|467130583|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771454|NCT01746901|467130584|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
129771455|NCT01746901|467130585|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771456|NCT01746901|467130586|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771457|NCT01746901|467130587|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771458|NCT01746901|467130588|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771459|NCT01746901|467130589|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
129771460|NCT01746901|467130581|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771461|NCT01746901|467130582|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771462|NCT01746901|467130583|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771463|NCT01746901|467130584|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771464|NCT01746901|467130585|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771465|NCT01746901|467130586|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
129771466|NCT01746901|467130587|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771467|NCT01746901|467130588|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
129771468|NCT01746901|467130589|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
129771469|NCT01746901|467130581|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771470|NCT01746901|467130582|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771471|NCT01746901|467130583|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771472|NCT01746901|467130584|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771473|NCT01746901|467130585|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771474|NCT01746901|467130586|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771475|NCT01746901|467130587|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
129771476|NCT01746901|467130588|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
129771477|NCT01746901|467130589|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
129771478|NCT03594110|467130593|FG000|Interventional Part|Participant concerned about study treatment|23|||
129771479|NCT03594110|467130594|FG001|Interventional Part|Participant concerned about study treatment|28|||
129771480|NCT03594110|467130593|FG000|Interventional Part|Doctor advice|38|||
129771481|NCT03594110|467130594|FG001|Interventional Part|Doctor advice|40|||
129771482|NCT03594110|467130593|FG000|Interventional Part|Participants' wish|89|||
129771483|NCT03594110|467130594|FG001|Interventional Part|Participants' wish|68|||
129771484|NCT03594110|467130593|FG000|Interventional Part|Adverse event-non-fatal events|119|||
129771485|NCT03594110|467130594|FG001|Interventional Part|Adverse event-non-fatal events|116|||
129771486|NCT03594110|467130593|FG000|Interventional Part|Study drug stopped, reason missing|336|||
129771487|NCT03594110|467130594|FG001|Interventional Part|Study drug stopped, reason missing|294|||
129771488|NCT03594110|467130593|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
129771489|NCT03594110|467130594|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
129771490|NCT03594110|467130593|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
129771491|NCT03594110|467130594|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
129771492|NCT03594110|467130593|FG000|Interventional Part|Contraindicated drug started|32|||
129771493|NCT03594110|467130594|FG001|Interventional Part|Contraindicated drug started|18|||
129771494|NCT03594110|467130593|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
129771495|NCT03594110|467130594|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
129771496|NCT03594110|467130593|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
129771497|NCT03594110|467130594|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
129771498|NCT03594110|467130593|FG000|Non-interventional Part|Withdrawal by Subject|3|||
129771499|NCT03594110|467130594|FG001|Non-interventional Part|Withdrawal by Subject|4|||
129771500|NCT03594110|467130593|FG000|Non-interventional Part|Lost to Follow-up|45|||
129771501|NCT03594110|467130594|FG001|Non-interventional Part|Lost to Follow-up|41|||
129771502|NCT05029362|467130595|FG000|Overall Study|Lost to Follow-up|9|||
129771503|NCT00684021|467130601|FG000|Overall Study|MRI Contraindicated|1|||
129771504|NCT00684021|467130602|FG001|Overall Study|MRI Contraindicated|1|||
129771505|NCT00684021|467130603|FG002|Overall Study|MRI Contraindicated|1|||
129771506|NCT00684021|467130604|FG003|Overall Study|MRI Contraindicated|0|||
129771507|NCT00684021|467130601|FG000|Overall Study|MRI not performed|0|||
129771508|NCT00684021|467130602|FG001|Overall Study|MRI not performed|1|||
129771509|NCT00684021|467130603|FG002|Overall Study|MRI not performed|1|||
129771510|NCT00684021|467130604|FG003|Overall Study|MRI not performed|2|||
129771511|NCT00684021|467130601|FG000|Overall Study|Death|1|||
129771512|NCT00684021|467130602|FG001|Overall Study|Death|0|||
129771513|NCT00684021|467130603|FG002|Overall Study|Death|0|||
129771514|NCT00684021|467130604|FG003|Overall Study|Death|0|||
129771515|NCT04041414|467130605|FG000|Overall Study|Lost to Follow-up|1|||
129771516|NCT04041414|467130606|FG001|Overall Study|Lost to Follow-up|2|||
129771517|NCT02900378|467130607|FG000|Randomization (Visit 2)|Adverse Event|14|||
129771518|NCT02900378|467130608|FG001|Randomization (Visit 2)|Adverse Event|11|||
129771519|NCT02900378|467130607|FG000|Randomization (Visit 2)|Death|1|||
129771520|NCT02900378|467130608|FG001|Randomization (Visit 2)|Death|4|||
129771521|NCT02900378|467130607|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
129771522|NCT02900378|467130608|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
129771523|NCT02900378|467130607|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
129771524|NCT02900378|467130608|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
129771525|NCT02900378|467130607|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
129771526|NCT02900378|467130608|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
129771527|NCT02900378|467130607|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
129771528|NCT02900378|467130608|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
129771529|NCT02900378|467130607|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
129771530|NCT02900378|467130608|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
129771531|NCT01690143|467130611|FG000|Overall Study|Withdrawal by Subject|1|||
129771532|NCT00198822|467130619|FG000|Overall Study|Lost to Follow-up|14|||
129771533|NCT00198822|467130620|FG001|Overall Study|Lost to Follow-up|20|||
129771534|NCT00198822|467130621|FG002|Overall Study|Lost to Follow-up|21|||
129771535|NCT02420821|467130627|FG000|Overall Study|Lost to Follow-up|6|||
129771536|NCT02420821|467130628|FG001|Overall Study|Lost to Follow-up|6|||
129771537|NCT02420821|467130627|FG000|Overall Study|Non-compliance|0|||
129771538|NCT02420821|467130628|FG001|Overall Study|Non-compliance|2|||
129771539|NCT02420821|467130627|FG000|Overall Study|Physician Decision|6|||
129771540|NCT02420821|467130628|FG001|Overall Study|Physician Decision|2|||
129771541|NCT02420821|467130627|FG000|Overall Study|Withdrawal by Subject|32|||
129771542|NCT02420821|467130628|FG001|Overall Study|Withdrawal by Subject|25|||
129771543|NCT02420821|467130627|FG000|Overall Study|Death|270|||
129771544|NCT02420821|467130628|FG001|Overall Study|Death|263|||
129771545|NCT02420821|467130627|FG000|Overall Study|Study Terminated By Sponsor|145|||
129771546|NCT02420821|467130628|FG001|Overall Study|Study Terminated By Sponsor|149|||
129771547|NCT02420821|467130627|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
129771548|NCT02420821|467130628|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
129771549|NCT02420821|467130627|FG000|Overall Study|Adverse Event|0|||
129771550|NCT02420821|467130628|FG001|Overall Study|Adverse Event|1|||
129771551|NCT02420821|467130627|FG000|Overall Study|Protinuria|0|||
129771552|NCT02420821|467130628|FG001|Overall Study|Protinuria|1|||
129771553|NCT02420821|467130627|FG000|Overall Study|Progressive Disease|1|||
129771554|NCT02420821|467130628|FG001|Overall Study|Progressive Disease|1|||
129771555|NCT02420821|467130627|FG000|Overall Study|Disease Progression|0|||
129771556|NCT02420821|467130628|FG001|Overall Study|Disease Progression|1|||
129771557|NCT02420821|467130627|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
129771558|NCT02420821|467130628|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
129771559|NCT01409707|467130629|FG000|Overall Study|Withdrawal by Subject|5|||
129771560|NCT01409707|467130630|FG001|Overall Study|Withdrawal by Subject|17|||
129771561|NCT01409707|467130631|FG002|Overall Study|Withdrawal by Subject|16|||
129771562|NCT01658436|467130632|FG000|Overall Study|Adverse Event|6|||
129771563|NCT01658436|467130633|FG001|Overall Study|Adverse Event|5|||
129771564|NCT01658436|467130632|FG000|Overall Study|Physician Decision|1|||
129771565|NCT01658436|467130633|FG001|Overall Study|Physician Decision|0|||
129771566|NCT01658436|467130632|FG000|Overall Study|Progressive disease|12|||
129771567|NCT01658436|467130633|FG001|Overall Study|Progressive disease|4|||
129771568|NCT01658436|467130632|FG000|Overall Study|Study terminated by sponsor|0|||
129771569|NCT01658436|467130633|FG001|Overall Study|Study terminated by sponsor|1|||
129771570|NCT01658436|467130632|FG000|Overall Study|Subject/guardian decision|0|||
129682065|NCT01136954|466796832|FG001|Overall Study|Lack of Efficacy|13|||
129682066|NCT01136954|466796831|FG000|Overall Study|Physician Decision|0|||
129682067|NCT01136954|466796832|FG001|Overall Study|Physician Decision|1|||
129682068|NCT01136954|466796831|FG000|Overall Study|Other|1|||
129682069|NCT01136954|466796832|FG001|Overall Study|Other|3|||
129682070|NCT00782067|466796833|FG000|Overall Study|Adverse Event|35|||
129682071|NCT00782067|466796833|FG000|Overall Study|Subject withdrew consent|11|||
129682072|NCT00782067|466796833|FG000|Overall Study|Lost to Follow-up|2|||
129682073|NCT00782067|466796833|FG000|Overall Study|Administrative problems|14|||
129682074|NCT00782067|466796833|FG000|Overall Study|Death|9|||
129682075|NCT00782067|466796833|FG000|Overall Study|Disease progression|43|||
129682076|NCT00782067|466796833|FG000|Overall Study|Protocol deviation|2|||
129682077|NCT00973973|466796839|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
129682078|NCT00973973|466796840|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
129682079|NCT00973973|466796839|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
129682080|NCT00973973|466796840|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
129682081|NCT00973973|466796839|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
129682082|NCT00973973|466796840|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
129682083|NCT00973973|466796839|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
129682084|NCT00973973|466796840|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
129682085|NCT00973973|466796839|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
129682086|NCT00973973|466796840|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
129682087|NCT00973973|466796839|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
129682088|NCT00973973|466796840|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
129682089|NCT00973973|466796839|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
129682090|NCT00973973|466796840|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
129682091|NCT00973973|466796839|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
129682092|NCT00973973|466796840|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
129682093|NCT00973973|466796839|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
129682094|NCT00973973|466796840|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
129682095|NCT00973973|466796839|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
129682096|NCT00973973|466796840|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
129682097|NCT00973973|466796839|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
129682098|NCT00973973|466796840|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
129682099|NCT00973973|466796839|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
129682100|NCT00973973|466796840|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
129682101|NCT02020941|466796841|FG000|Overall Study|Adverse Event|1|||
129682102|NCT02020941|466796841|FG000|Overall Study|Physician Decision|2|||
129682103|NCT02020941|466796841|FG000|Overall Study|Withdrawal by Subject|1|||
129771571|NCT01658436|467130633|FG001|Overall Study|Subject/guardian decision|1|||
129771572|NCT01658436|467130632|FG000|Overall Study|Death|1|||
129682104|NCT02020941|466796841|FG000|Overall Study|Disease Progression|4|||
129682105|NCT03483103|466796849|FG000|Pre-Treatment Phase|Other reasons|1|||
129682106|NCT03483103|466796849|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
129682107|NCT03483103|466796849|FG000|Pre-Treatment Phase|Disease-related complications|1|||
129682108|NCT03483103|466796849|FG000|Pre-Treatment Phase|Death|5|||
129682109|NCT03483103|466796849|FG000|Treatment Phase|Withdrawal by Subject|7|||
129682110|NCT03483103|466796849|FG000|Treatment Phase|Other reasons|1|||
129682111|NCT03483103|466796849|FG000|Treatment Phase|Death|23|||
129682112|NCT03483103|466796849|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
129682113|NCT03483103|466796849|FG000|Treatment Phase|Received nonconforming product|1|||
129682114|NCT02239328|466796850|FG000|Overall Study|Benign disease noted at time of surgery|6|||
129682115|NCT02239328|466796850|FG000|Overall Study|Equipment or website malfunction|2|||
129682116|NCT01481779|466796851|FG000|Overall Study|Adverse Event|23|||
129682117|NCT01481779|466796852|FG001|Overall Study|Adverse Event|5|||
129682118|NCT01481779|466796851|FG000|Overall Study|Lost to Follow-up|3|||
129682119|NCT01481779|466796852|FG001|Overall Study|Lost to Follow-up|2|||
129682120|NCT01481779|466796851|FG000|Overall Study|Protocol Violation|2|||
129682121|NCT01481779|466796852|FG001|Overall Study|Protocol Violation|3|||
129682122|NCT01481779|466796851|FG000|Overall Study|Withdrawal by Subject|26|||
129682123|NCT01481779|466796852|FG001|Overall Study|Withdrawal by Subject|13|||
129682124|NCT01481779|466796851|FG000|Overall Study|Physician Decision|13|||
129682125|NCT01481779|466796852|FG001|Overall Study|Physician Decision|4|||
129682126|NCT01481779|466796851|FG000|Overall Study|Sponsor Decision|3|||
129682127|NCT01481779|466796852|FG001|Overall Study|Sponsor Decision|1|||
129682128|NCT02378181|466796853|FG000|Overall Study|Lost to Follow-up|2|||
129682129|NCT02378181|466796854|FG001|Overall Study|Lost to Follow-up|5|||
129682130|NCT02378181|466796853|FG000|Overall Study|Withdrawal by Subject|1|||
129682131|NCT02378181|466796854|FG001|Overall Study|Withdrawal by Subject|1|||
129682132|NCT02378181|466796853|FG000|Overall Study|Incarcerated|0|||
129682133|NCT02378181|466796854|FG001|Overall Study|Incarcerated|1|||
129682134|NCT04115059|466796855|FG000|Overall Study|Withdrawal by Subject|1|||
129682135|NCT04115059|466796855|FG000|Overall Study|Lack of Efficacy|2|||
129682136|NCT06420232|466796864|FG000|Overall Study|Withdrawal by Subject|3|||
129682137|NCT00689936|466796865|FG000|Active Treatment Phase|Adverse Event|68|||
129682138|NCT00689936|466796866|FG001|Active Treatment Phase|Adverse Event|71|||
129682139|NCT00689936|466796867|FG002|Active Treatment Phase|Adverse Event|76|||
129682140|NCT00689936|466796865|FG000|Active Treatment Phase|Disease Progression|273|||
129682141|NCT00689936|466796866|FG001|Active Treatment Phase|Disease Progression|362|||
129682142|NCT00689936|466796867|FG002|Active Treatment Phase|Disease Progression|339|||
129682143|NCT00689936|466796865|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
129682144|NCT00689936|466796866|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
129682145|NCT00689936|466796867|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
129682146|NCT00689936|466796865|FG000|Active Treatment Phase|Death|60|||
129682147|NCT00689936|466796866|FG001|Active Treatment Phase|Death|28|||
129682148|NCT00689936|466796867|FG002|Active Treatment Phase|Death|37|||
129682149|NCT00689936|466796865|FG000|Active Treatment Phase|Lost to Follow-up|0|||
129682150|NCT00689936|466796866|FG001|Active Treatment Phase|Lost to Follow-up|2|||
129682151|NCT00689936|466796867|FG002|Active Treatment Phase|Lost to Follow-up|2|||
129682152|NCT00689936|466796865|FG000|Active Treatment Phase|Protocol Violation|2|||
129682153|NCT00689936|466796866|FG001|Active Treatment Phase|Protocol Violation|2|||
129682154|NCT00689936|466796867|FG002|Active Treatment Phase|Protocol Violation|4|||
129682155|NCT00689936|466796865|FG000|Active Treatment Phase|Study Close Out|64|||
129682156|NCT00689936|466796866|FG001|Active Treatment Phase|Study Close Out|26|||
129682157|NCT00689936|466796867|FG002|Active Treatment Phase|Study Close Out|21|||
129682158|NCT00689936|466796865|FG000|Active Treatment Phase|Miscellaneous|52|||
129682159|NCT00689936|466796866|FG001|Active Treatment Phase|Miscellaneous|34|||
129682160|NCT00689936|466796867|FG002|Active Treatment Phase|Miscellaneous|47|||
129682161|NCT00689936|466796865|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
129682162|NCT00689936|466796866|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
129682163|NCT00689936|466796867|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
129682164|NCT01303419|466796868|FG000|Overall Study|Discontinuation of study|60|||
129682165|NCT01303419|466796868|FG000|Overall Study|Did not complete both imaging methods|5|||
129682166|NCT01303419|466796868|FG000|Overall Study|Did not meet all I/E after screening|31|||
129682167|NCT00311168|466796871|FG000|First Intervention|Withdrawal by Subject|2|||
129682168|NCT00311168|466796872|FG001|First Intervention|Withdrawal by Subject|2|||
129682169|NCT00311168|466796871|FG000|First Intervention|Lost to Follow-up|1|||
129682170|NCT00311168|466796872|FG001|First Intervention|Lost to Follow-up|1|||
129682171|NCT00311168|466796871|FG000|First Intervention|Protocol Violation|1|||
129682172|NCT00311168|466796872|FG001|First Intervention|Protocol Violation|1|||
129682173|NCT00311168|466796871|FG000|First Intervention|Adverse Event|1|||
129682174|NCT00311168|466796872|FG001|First Intervention|Adverse Event|0|||
129682175|NCT00311168|466796871|FG000|First Intervention|Other|2|||
129682176|NCT00311168|466796872|FG001|First Intervention|Other|2|||
129682177|NCT00311168|466796871|FG000|Second Intervention|Lost to Follow-up|9|||
129682178|NCT00311168|466796872|FG001|Second Intervention|Lost to Follow-up|2|||
129682179|NCT00311168|466796871|FG000|Second Intervention|Withdrawal by Subject|0|||
129682180|NCT00311168|466796872|FG001|Second Intervention|Withdrawal by Subject|1|||
129682181|NCT00311168|466796871|FG000|Second Intervention|Other|1|||
129682182|NCT00311168|466796872|FG001|Second Intervention|Other|1|||
129771573|NCT01658436|467130633|FG001|Overall Study|Death|0|||
129682183|NCT05513950|466796879|FG000|Overall Study|Not treated due to technical reasons|0|||
129682184|NCT05513950|466796880|FG001|Overall Study|Not treated due to technical reasons|0|||
129682185|NCT05513950|466796881|FG002|Overall Study|Not treated due to technical reasons|1|||
129682186|NCT05513950|466796882|FG003|Overall Study|Not treated due to technical reasons|0|||
129682187|NCT06001866|466796883|FG000|Overall Study|Withdrawal by Subject|0|||
129682188|NCT06001866|466796884|FG001|Overall Study|Withdrawal by Subject|2|||
129682189|NCT06001866|466796883|FG000|Overall Study|Protocol Violation|0|||
129682190|NCT06001866|466796884|FG001|Overall Study|Protocol Violation|2|||
129682191|NCT02903914|466796885|FG000|Overall Study|Adverse Event|0|||
129682192|NCT02903914|466796886|FG001|Overall Study|Adverse Event|0|||
129682193|NCT02903914|466796887|FG002|Overall Study|Adverse Event|1|||
129682194|NCT02903914|466796888|FG003|Overall Study|Adverse Event|0|||
129682195|NCT02903914|466796889|FG004|Overall Study|Adverse Event|0|||
129682196|NCT02903914|466796890|FG005|Overall Study|Adverse Event|0|||
129682197|NCT02903914|466796891|FG006|Overall Study|Adverse Event|2|||
129682198|NCT02903914|466796892|FG007|Overall Study|Adverse Event|0|||
129682199|NCT02903914|466796885|FG000|Overall Study|Withdrawal by Subject|3|||
129682200|NCT02903914|466796886|FG001|Overall Study|Withdrawal by Subject|1|||
129682201|NCT02903914|466796887|FG002|Overall Study|Withdrawal by Subject|28|||
129682202|NCT02903914|466796888|FG003|Overall Study|Withdrawal by Subject|0|||
129682203|NCT02903914|466796889|FG004|Overall Study|Withdrawal by Subject|1|||
129682204|NCT02903914|466796890|FG005|Overall Study|Withdrawal by Subject|2|||
129682205|NCT02903914|466796891|FG006|Overall Study|Withdrawal by Subject|12|||
129682206|NCT02903914|466796892|FG007|Overall Study|Withdrawal by Subject|0|||
129682207|NCT02903914|466796885|FG000|Overall Study|Progressive Disease|1|||
129682208|NCT02903914|466796886|FG001|Overall Study|Progressive Disease|0|||
129682209|NCT02903914|466796887|FG002|Overall Study|Progressive Disease|4|||
129682210|NCT02903914|466796888|FG003|Overall Study|Progressive Disease|0|||
129682211|NCT02903914|466796889|FG004|Overall Study|Progressive Disease|0|||
129682212|NCT02903914|466796890|FG005|Overall Study|Progressive Disease|0|||
129682213|NCT02903914|466796891|FG006|Overall Study|Progressive Disease|2|||
129682214|NCT02903914|466796892|FG007|Overall Study|Progressive Disease|0|||
129682215|NCT02903914|466796885|FG000|Overall Study|Death|0|||
129682216|NCT02903914|466796886|FG001|Overall Study|Death|0|||
129682217|NCT02903914|466796887|FG002|Overall Study|Death|9|||
129682218|NCT02903914|466796888|FG003|Overall Study|Death|0|||
129682219|NCT02903914|466796889|FG004|Overall Study|Death|1|||
129682220|NCT02903914|466796890|FG005|Overall Study|Death|3|||
129682221|NCT02903914|466796891|FG006|Overall Study|Death|24|||
129682222|NCT02903914|466796892|FG007|Overall Study|Death|2|||
129682223|NCT02903914|466796885|FG000|Overall Study|Lost to Follow-up|0|||
129682224|NCT02903914|466796886|FG001|Overall Study|Lost to Follow-up|1|||
129682225|NCT02903914|466796887|FG002|Overall Study|Lost to Follow-up|0|||
129682226|NCT02903914|466796888|FG003|Overall Study|Lost to Follow-up|0|||
129682227|NCT02903914|466796889|FG004|Overall Study|Lost to Follow-up|2|||
129682228|NCT02903914|466796890|FG005|Overall Study|Lost to Follow-up|0|||
129682229|NCT02903914|466796891|FG006|Overall Study|Lost to Follow-up|1|||
129682230|NCT02903914|466796892|FG007|Overall Study|Lost to Follow-up|0|||
129682231|NCT02903914|466796885|FG000|Overall Study|Physician Decision|0|||
129682232|NCT02903914|466796886|FG001|Overall Study|Physician Decision|0|||
129682233|NCT02903914|466796887|FG002|Overall Study|Physician Decision|1|||
129682234|NCT02903914|466796888|FG003|Overall Study|Physician Decision|0|||
129682235|NCT02903914|466796889|FG004|Overall Study|Physician Decision|0|||
129682236|NCT02903914|466796890|FG005|Overall Study|Physician Decision|0|||
129682237|NCT02903914|466796891|FG006|Overall Study|Physician Decision|1|||
129682238|NCT02903914|466796892|FG007|Overall Study|Physician Decision|0|||
129682239|NCT02903914|466796885|FG000|Overall Study|Symptomatic Deterioration|0|||
129682240|NCT02903914|466796886|FG001|Overall Study|Symptomatic Deterioration|0|||
129682241|NCT02903914|466796887|FG002|Overall Study|Symptomatic Deterioration|1|||
129682242|NCT02903914|466796888|FG003|Overall Study|Symptomatic Deterioration|0|||
129682243|NCT02903914|466796889|FG004|Overall Study|Symptomatic Deterioration|0|||
129682244|NCT02903914|466796890|FG005|Overall Study|Symptomatic Deterioration|0|||
129682245|NCT02903914|466796891|FG006|Overall Study|Symptomatic Deterioration|0|||
129682246|NCT02903914|466796892|FG007|Overall Study|Symptomatic Deterioration|0|||
129682247|NCT02903914|466796885|FG000|Overall Study|New Cancer Therapy|2|||
129682248|NCT02903914|466796886|FG001|Overall Study|New Cancer Therapy|2|||
129682249|NCT02903914|466796887|FG002|Overall Study|New Cancer Therapy|21|||
129682250|NCT02903914|466796888|FG003|Overall Study|New Cancer Therapy|4|||
129682251|NCT02903914|466796889|FG004|Overall Study|New Cancer Therapy|3|||
129682252|NCT02903914|466796890|FG005|Overall Study|New Cancer Therapy|6|||
129682253|NCT02903914|466796891|FG006|Overall Study|New Cancer Therapy|56|||
129682254|NCT02903914|466796892|FG007|Overall Study|New Cancer Therapy|3|||
129682255|NCT02903914|466796885|FG000|Overall Study|Didn't Return to Site|1|||
129771574|NCT00686712|467130634|FG000|Overall Study|Protocol Violation|8|||
129771575|NCT00686712|467130635|FG001|Overall Study|Protocol Violation|8|||
129771576|NCT00686712|467130636|FG002|Overall Study|Protocol Violation|10|||
129771577|NCT00686712|467130634|FG000|Overall Study|Lost to Follow-up|1|||
129771578|NCT00686712|467130635|FG001|Overall Study|Lost to Follow-up|2|||
129771579|NCT00686712|467130636|FG002|Overall Study|Lost to Follow-up|3|||
129771580|NCT00686712|467130634|FG000|Overall Study|Adverse Event|1|||
129771581|NCT00686712|467130635|FG001|Overall Study|Adverse Event|1|||
129771582|NCT00686712|467130636|FG002|Overall Study|Adverse Event|0|||
129771583|NCT03987503|467130637|FG000|Overall Study|Lost to Follow-up|20|||
129771584|NCT03987503|467130637|FG000|Overall Study|Withdrawal by Subject|2|||
129771585|NCT01929317|467130639|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
129771586|NCT01929317|467130640|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
129771587|NCT01929317|467130639|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
129771588|NCT01929317|467130640|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
129771589|NCT01929317|467130639|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
129771590|NCT01929317|467130640|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
129771591|NCT01929317|467130639|FG000|Long-term Phase|Adverse Event|5|||
129771592|NCT01929317|467130640|FG001|Long-term Phase|Adverse Event|1|||
129771593|NCT01929317|467130639|FG000|Long-term Phase|Physician Decision|3|||
129771594|NCT01929317|467130640|FG001|Long-term Phase|Physician Decision|0|||
129771595|NCT01929317|467130639|FG000|Long-term Phase|Withdrawal by Subject|4|||
129771596|NCT01929317|467130640|FG001|Long-term Phase|Withdrawal by Subject|0|||
129771597|NCT01929317|467130639|FG000|Long-term Phase|Protocol Violation|1|||
129771598|NCT01929317|467130640|FG001|Long-term Phase|Protocol Violation|0|||
129771599|NCT01929317|467130639|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
129771600|NCT01929317|467130640|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
129771601|NCT01929317|467130639|FG000|Long-term Phase|Study Closed/Terminated|5|||
129771602|NCT01929317|467130640|FG001|Long-term Phase|Study Closed/Terminated|3|||
129771603|NCT01523756|467130641|FG000|Baseline Period|Adverse Event|0|||
129771604|NCT01523756|467130642|FG001|Baseline Period|Adverse Event|1|||
129771605|NCT01523756|467130641|FG000|Test Period 1|Adverse Event|1|||
129771606|NCT01523756|467130642|FG001|Test Period 1|Adverse Event|0|||
129771607|NCT01523756|467130641|FG000|Test Period 2|Withdrawal by Subject|0|||
129771608|NCT01523756|467130642|FG001|Test Period 2|Withdrawal by Subject|1|||
129771609|NCT00515619|467130643|FG000|Overall Study|Adverse Event|34|||
129771610|NCT00515619|467130643|FG000|Overall Study|Lack of Efficacy|92|||
129771611|NCT00515619|467130643|FG000|Overall Study|Withdrawal by Subject|66|||
129771612|NCT00515619|467130643|FG000|Overall Study|Protocol Violation|3|||
129771613|NCT00515619|467130643|FG000|Overall Study|Lost to Follow-up|4|||
129771614|NCT00515619|467130643|FG000|Overall Study|Unsatisfactory compliance|6|||
129682256|NCT02903914|466796886|FG001|Overall Study|Didn't Return to Site|0|||
129682257|NCT02903914|466796887|FG002|Overall Study|Didn't Return to Site|1|||
129682258|NCT02903914|466796888|FG003|Overall Study|Didn't Return to Site|1|||
129682259|NCT02903914|466796889|FG004|Overall Study|Didn't Return to Site|0|||
129682260|NCT02903914|466796890|FG005|Overall Study|Didn't Return to Site|0|||
129682261|NCT02903914|466796891|FG006|Overall Study|Didn't Return to Site|2|||
129682262|NCT02903914|466796892|FG007|Overall Study|Didn't Return to Site|0|||
129682263|NCT02903914|466796885|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
129682264|NCT02903914|466796886|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
129682265|NCT02903914|466796887|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
129682266|NCT02903914|466796888|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
129682267|NCT02903914|466796889|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
129682268|NCT02903914|466796890|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
129682269|NCT02903914|466796891|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
129682270|NCT02903914|466796892|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
129682271|NCT02903914|466796885|FG000|Overall Study|Follow-up Did Not Occur|0|||
129682272|NCT02903914|466796886|FG001|Overall Study|Follow-up Did Not Occur|1|||
129682273|NCT02903914|466796887|FG002|Overall Study|Follow-up Did Not Occur|1|||
129682274|NCT02903914|466796888|FG003|Overall Study|Follow-up Did Not Occur|0|||
129682275|NCT02903914|466796889|FG004|Overall Study|Follow-up Did Not Occur|2|||
129682276|NCT02903914|466796890|FG005|Overall Study|Follow-up Did Not Occur|0|||
129682277|NCT02903914|466796891|FG006|Overall Study|Follow-up Did Not Occur|8|||
129682278|NCT02903914|466796892|FG007|Overall Study|Follow-up Did Not Occur|0|||
129682279|NCT02903914|466796885|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
129682280|NCT02903914|466796886|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
129682281|NCT02903914|466796887|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
129682282|NCT02903914|466796888|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
129682283|NCT02903914|466796889|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
129682284|NCT02903914|466796890|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
129682285|NCT02903914|466796891|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
129682286|NCT02903914|466796892|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
129682287|NCT02903914|466796885|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
129682288|NCT02903914|466796886|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
129682289|NCT02903914|466796887|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
129682290|NCT02903914|466796888|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
129682291|NCT02903914|466796889|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
129771615|NCT00515619|467130643|FG000|Overall Study|Other: Site discontinuing trials|2|||
129771616|NCT00515619|467130643|FG000|Overall Study|Other: Subject cannot attend visits|2|||
129771617|NCT00515619|467130643|FG000|Overall Study|Other: Subject required surgery|1|||
129771618|NCT00515619|467130643|FG000|Overall Study|Other: Subject moved to another country|1|||
129771619|NCT00515619|467130643|FG000|Overall Study|Other: Investigator decision|1|||
129682292|NCT02903914|466796890|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
129682293|NCT02903914|466796891|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
129682294|NCT02903914|466796892|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
129682295|NCT02903914|466796885|FG000|Overall Study|Clinical Disease Progression|0|||
129682296|NCT02903914|466796886|FG001|Overall Study|Clinical Disease Progression|0|||
129682297|NCT02903914|466796887|FG002|Overall Study|Clinical Disease Progression|2|||
129682298|NCT02903914|466796888|FG003|Overall Study|Clinical Disease Progression|0|||
129682299|NCT02903914|466796889|FG004|Overall Study|Clinical Disease Progression|0|||
129682300|NCT02903914|466796890|FG005|Overall Study|Clinical Disease Progression|0|||
129682301|NCT02903914|466796891|FG006|Overall Study|Clinical Disease Progression|0|||
129682302|NCT02903914|466796892|FG007|Overall Study|Clinical Disease Progression|0|||
129682303|NCT02903914|466796885|FG000|Overall Study|Completed Follow-up Period|0|||
129682304|NCT02903914|466796886|FG001|Overall Study|Completed Follow-up Period|0|||
129682305|NCT02903914|466796887|FG002|Overall Study|Completed Follow-up Period|6|||
129682306|NCT02903914|466796888|FG003|Overall Study|Completed Follow-up Period|2|||
129682307|NCT02903914|466796889|FG004|Overall Study|Completed Follow-up Period|1|||
129682308|NCT02903914|466796890|FG005|Overall Study|Completed Follow-up Period|0|||
129682309|NCT02903914|466796891|FG006|Overall Study|Completed Follow-up Period|9|||
129682310|NCT02903914|466796892|FG007|Overall Study|Completed Follow-up Period|1|||
129682311|NCT02903914|466796885|FG000|Overall Study|Taken off Treatment per Protocol|0|||
129682312|NCT02903914|466796886|FG001|Overall Study|Taken off Treatment per Protocol|0|||
129682313|NCT02903914|466796887|FG002|Overall Study|Taken off Treatment per Protocol|0|||
129682314|NCT02903914|466796888|FG003|Overall Study|Taken off Treatment per Protocol|0|||
129682315|NCT02903914|466796889|FG004|Overall Study|Taken off Treatment per Protocol|0|||
129682316|NCT02903914|466796890|FG005|Overall Study|Taken off Treatment per Protocol|1|||
129682317|NCT02903914|466796891|FG006|Overall Study|Taken off Treatment per Protocol|0|||
129682318|NCT02903914|466796892|FG007|Overall Study|Taken off Treatment per Protocol|0|||
129682319|NCT02903914|466796885|FG000|Overall Study|Refused Further Treatment/Contact|0|||
129682320|NCT02903914|466796886|FG001|Overall Study|Refused Further Treatment/Contact|0|||
129682321|NCT02903914|466796887|FG002|Overall Study|Refused Further Treatment/Contact|0|||
129682322|NCT02903914|466796888|FG003|Overall Study|Refused Further Treatment/Contact|0|||
129682323|NCT02903914|466796889|FG004|Overall Study|Refused Further Treatment/Contact|0|||
129682324|NCT02903914|466796890|FG005|Overall Study|Refused Further Treatment/Contact|0|||
129682325|NCT02903914|466796891|FG006|Overall Study|Refused Further Treatment/Contact|1|||
129682326|NCT02903914|466796892|FG007|Overall Study|Refused Further Treatment/Contact|0|||
129682327|NCT02903914|466796885|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682328|NCT02903914|466796886|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682329|NCT02903914|466796887|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682330|NCT02903914|466796888|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682331|NCT02903914|466796889|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682332|NCT02903914|466796890|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682333|NCT02903914|466796891|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
129682334|NCT02903914|466796892|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
129682335|NCT03112603|466796896|FG000|End of Randomization Period|Lost to Follow-up|3|||
129682336|NCT03112603|466796897|FG001|End of Randomization Period|Lost to Follow-up|0|||
129682337|NCT03112603|466796898|FG002|End of Randomization Period|Lost to Follow-up|0|||
129682338|NCT03112603|466796896|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
129682339|NCT03112603|466796897|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
129682340|NCT03112603|466796898|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
129682341|NCT03112603|466796896|FG000|End of Randomization Period|Physician Decision|43|||
129682342|NCT03112603|466796897|FG001|End of Randomization Period|Physician Decision|18|||
129682343|NCT03112603|466796898|FG002|End of Randomization Period|Physician Decision|0|||
129682344|NCT03112603|466796896|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
129682345|NCT03112603|466796897|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
129682346|NCT03112603|466796898|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
129682347|NCT03112603|466796896|FG000|End of Randomization Period|Death|10|||
129682348|NCT03112603|466796897|FG001|End of Randomization Period|Death|7|||
129682349|NCT03112603|466796898|FG002|End of Randomization Period|Death|0|||
129682350|NCT03112603|466796896|FG000|End of Randomization Period|Disease Relapse|12|||
129682351|NCT03112603|466796897|FG001|End of Randomization Period|Disease Relapse|7|||
129682352|NCT03112603|466796898|FG002|End of Randomization Period|Disease Relapse|0|||
129682353|NCT03112603|466796896|FG000|End of Randomization Period|Lack of Efficacy|25|||
129682354|NCT03112603|466796897|FG001|End of Randomization Period|Lack of Efficacy|77|||
129682355|NCT03112603|466796898|FG002|End of Randomization Period|Lack of Efficacy|0|||
129682356|NCT03112603|466796896|FG000|End of Randomization Period|Adverse Event|32|||
129682357|NCT03112603|466796897|FG001|End of Randomization Period|Adverse Event|12|||
129682358|NCT03112603|466796898|FG002|End of Randomization Period|Adverse Event|0|||
129682359|NCT03112603|466796896|FG000|End of Cross Over Period|Death|0|||
129771620|NCT00515619|467130643|FG000|Overall Study|Other: Subject became pregnant|1|||
129771621|NCT00515619|467130643|FG000|Overall Study|Other: Request from sponsor|1|||
129771622|NCT00515619|467130643|FG000|Overall Study|Other: Drug available on license|1|||
129771623|NCT00515619|467130643|FG000|Overall Study|Other: Subject interested in other AED|1|||
129548361|NCT00545441|466302664|FG000|Overall Study|Patients were not treated|1|||
129548362|NCT00545441|466302665|FG001|Overall Study|Patients were not treated|3|||
129548363|NCT00265239|466302666|FG000|Overall Study|Adverse Event|2|||
129548364|NCT00265239|466302667|FG001|Overall Study|Adverse Event|1|||
129771624|NCT01467960|467130644|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
129771625|NCT01467960|467130645|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
129771626|NCT01467960|467130646|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
129771627|NCT01467960|467130647|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
129771628|NCT01467960|467130648|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
129771629|NCT01467960|467130649|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
129771630|NCT01588522|467130650|FG000|Overall Study|Withdrawal by Subject|1|||
129771631|NCT01588522|467130651|FG001|Overall Study|Withdrawal by Subject|5|||
129771632|NCT01588522|467130652|FG002|Overall Study|Withdrawal by Subject|3|||
129771633|NCT01588522|467130653|FG003|Overall Study|Withdrawal by Subject|1|||
129771634|NCT01588522|467130654|FG004|Overall Study|Withdrawal by Subject|2|||
129771635|NCT01588522|467130655|FG005|Overall Study|Withdrawal by Subject|0|||
129771636|NCT01588522|467130650|FG000|Overall Study|Lack of Efficacy|0|||
129771637|NCT01588522|467130651|FG001|Overall Study|Lack of Efficacy|0|||
129771638|NCT01588522|467130652|FG002|Overall Study|Lack of Efficacy|0|||
129771639|NCT01588522|467130653|FG003|Overall Study|Lack of Efficacy|0|||
129771640|NCT01588522|467130654|FG004|Overall Study|Lack of Efficacy|1|||
129771641|NCT01588522|467130655|FG005|Overall Study|Lack of Efficacy|0|||
129771642|NCT01588522|467130650|FG000|Overall Study|Adverse Event|0|||
129771643|NCT01588522|467130651|FG001|Overall Study|Adverse Event|0|||
129771644|NCT01588522|467130652|FG002|Overall Study|Adverse Event|0|||
129771645|NCT01588522|467130653|FG003|Overall Study|Adverse Event|1|||
129771646|NCT01588522|467130654|FG004|Overall Study|Adverse Event|0|||
129771647|NCT01588522|467130655|FG005|Overall Study|Adverse Event|0|||
129771648|NCT01588522|467130650|FG000|Overall Study|Grade 2 alopecia|1|||
129771649|NCT01588522|467130651|FG001|Overall Study|Grade 2 alopecia|0|||
129771650|NCT01588522|467130652|FG002|Overall Study|Grade 2 alopecia|0|||
129771651|NCT01588522|467130653|FG003|Overall Study|Grade 2 alopecia|0|||
129771652|NCT01588522|467130654|FG004|Overall Study|Grade 2 alopecia|0|||
129771653|NCT01588522|467130655|FG005|Overall Study|Grade 2 alopecia|0|||
129771654|NCT01588522|467130650|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
129771655|NCT01588522|467130651|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
129771656|NCT01588522|467130652|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
129771657|NCT01588522|467130653|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
129771658|NCT01588522|467130654|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
129771659|NCT01588522|467130655|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
129771660|NCT01588522|467130650|FG000|Overall Study|Taken off taxane-based regimen|0|||
129771661|NCT01588522|467130651|FG001|Overall Study|Taken off taxane-based regimen|0|||
129771662|NCT01588522|467130652|FG002|Overall Study|Taken off taxane-based regimen|0|||
129771663|NCT01588522|467130653|FG003|Overall Study|Taken off taxane-based regimen|1|||
129771664|NCT01588522|467130654|FG004|Overall Study|Taken off taxane-based regimen|0|||
129771665|NCT01588522|467130655|FG005|Overall Study|Taken off taxane-based regimen|0|||
129771666|NCT01588522|467130650|FG000|Overall Study|Did not initiate chemotherapy|0|||
129771667|NCT01588522|467130651|FG001|Overall Study|Did not initiate chemotherapy|0|||
129771668|NCT01588522|467130652|FG002|Overall Study|Did not initiate chemotherapy|0|||
129771669|NCT01588522|467130653|FG003|Overall Study|Did not initiate chemotherapy|0|||
129771670|NCT01588522|467130654|FG004|Overall Study|Did not initiate chemotherapy|1|||
129771671|NCT01588522|467130655|FG005|Overall Study|Did not initiate chemotherapy|0|||
129771672|NCT04949490|467130658|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129771673|NCT04949490|467130659|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129771674|NCT04949490|467130660|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129771675|NCT04949490|467130661|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
129771676|NCT04949490|467130662|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129771677|NCT04949490|467130663|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
129771678|NCT04949490|467130658|FG000|Group A and Group B|Withdrawal by Subject|0|||
129771679|NCT04949490|467130659|FG001|Group A and Group B|Withdrawal by Subject|0|||
129771680|NCT04949490|467130660|FG002|Group A and Group B|Withdrawal by Subject|1|||
129771681|NCT04949490|467130661|FG003|Group A and Group B|Withdrawal by Subject|0|||
129771682|NCT04949490|467130662|FG004|Group A and Group B|Withdrawal by Subject|0|||
129771683|NCT04949490|467130663|FG005|Group A and Group B|Withdrawal by Subject|0|||
129771684|NCT04949490|467130658|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129771685|NCT04949490|467130659|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129771686|NCT04949490|467130660|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129771687|NCT04949490|467130661|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129771688|NCT04949490|467130662|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
129771689|NCT04949490|467130663|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
129771690|NCT04949490|467130658|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129771691|NCT04949490|467130659|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129771692|NCT04949490|467130660|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129771693|NCT04949490|467130661|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129771694|NCT04949490|467130662|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
129771695|NCT04949490|467130663|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
129771696|NCT02017405|467130664|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129771697|NCT02017405|467130665|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129771698|NCT02017405|467130666|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129771699|NCT02017405|467130667|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129771700|NCT02017405|467130668|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
129771701|NCT02017405|467130669|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
129771702|NCT02017405|467130664|FG000|Open-label Phase|Adverse Event|1|||
129771703|NCT02017405|467130665|FG001|Open-label Phase|Adverse Event|1|||
129771704|NCT02017405|467130666|FG002|Open-label Phase|Adverse Event|0|||
129771705|NCT02017405|467130667|FG003|Open-label Phase|Adverse Event|0|||
129771706|NCT02017405|467130668|FG004|Open-label Phase|Adverse Event|0|||
129771707|NCT02017405|467130669|FG005|Open-label Phase|Adverse Event|0|||
129771708|NCT02864394|467130671|FG000|Overall Study|Death|184|||
129771709|NCT02864394|467130672|FG001|Overall Study|Death|189|||
129771710|NCT02864394|467130671|FG000|Overall Study|Lost to Follow-up|0|||
129771711|NCT02864394|467130672|FG001|Overall Study|Lost to Follow-up|2|||
129771712|NCT02864394|467130671|FG000|Overall Study|Sponsor Decision|26|||
129771713|NCT02864394|467130672|FG001|Overall Study|Sponsor Decision|11|||
129771714|NCT02864394|467130671|FG000|Overall Study|Withdrawal by Subject|3|||
129771715|NCT02864394|467130672|FG001|Overall Study|Withdrawal by Subject|10|||
129771716|NCT04730804|467130677|FG000|Overall Study|Physician Decision|0|||
129771717|NCT04730804|467130678|FG001|Overall Study|Physician Decision|0|||
129771718|NCT04730804|467130679|FG002|Overall Study|Physician Decision|0|||
129771719|NCT04730804|467130680|FG003|Overall Study|Physician Decision|0|||
129771720|NCT04730804|467130681|FG004|Overall Study|Physician Decision|0|||
129771721|NCT04730804|467130682|FG005|Overall Study|Physician Decision|1|||
129771722|NCT04730804|467130677|FG000|Overall Study|Withdrawal by Subject|0|||
129771723|NCT04730804|467130678|FG001|Overall Study|Withdrawal by Subject|0|||
129771724|NCT04730804|467130679|FG002|Overall Study|Withdrawal by Subject|0|||
129771725|NCT04730804|467130680|FG003|Overall Study|Withdrawal by Subject|0|||
129771726|NCT04730804|467130681|FG004|Overall Study|Withdrawal by Subject|1|||
129771727|NCT04730804|467130682|FG005|Overall Study|Withdrawal by Subject|2|||
129771728|NCT00554216|467132246|FG000|Overall Study|Lost to Follow-up|92|||
129771729|NCT00554216|467132247|FG001|Overall Study|Lost to Follow-up|31|||
129771730|NCT00554216|467132248|FG002|Overall Study|Lost to Follow-up|63|||
129771731|NCT00554216|467132246|FG000|Overall Study|Adverse Event|16|||
129771732|NCT00554216|467132247|FG001|Overall Study|Adverse Event|16|||
129771733|NCT00554216|467132248|FG002|Overall Study|Adverse Event|36|||
129771734|NCT00554216|467132246|FG000|Overall Study|Withdrawal by Subject|92|||
129771735|NCT00554216|467132247|FG001|Overall Study|Withdrawal by Subject|31|||
129771736|NCT00554216|467132248|FG002|Overall Study|Withdrawal by Subject|43|||
129771737|NCT00554216|467132246|FG000|Overall Study|Non compliance|10|||
129771738|NCT00554216|467132247|FG001|Overall Study|Non compliance|4|||
129771739|NCT00554216|467132248|FG002|Overall Study|Non compliance|5|||
129771740|NCT00554216|467132246|FG000|Overall Study|Pregnancy|2|||
129682360|NCT03112603|466796897|FG001|End of Cross Over Period|Death|0|||
129682361|NCT03112603|466796898|FG002|End of Cross Over Period|Death|2|||
129682362|NCT03112603|466796896|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
129682363|NCT03112603|466796897|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
129682364|NCT03112603|466796898|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
129682365|NCT03112603|466796896|FG000|End of Cross Over Period|Physician Decision|0|||
129682366|NCT03112603|466796897|FG001|End of Cross Over Period|Physician Decision|0|||
129682367|NCT03112603|466796898|FG002|End of Cross Over Period|Physician Decision|29|||
129682368|NCT03112603|466796896|FG000|End of Cross Over Period|Lack of Efficacy|0|||
129682369|NCT03112603|466796897|FG001|End of Cross Over Period|Lack of Efficacy|0|||
129682370|NCT03112603|466796898|FG002|End of Cross Over Period|Lack of Efficacy|8|||
129682371|NCT03112603|466796896|FG000|End of Cross Over Period|Adverse Event|0|||
129682372|NCT03112603|466796897|FG001|End of Cross Over Period|Adverse Event|0|||
129682373|NCT03112603|466796898|FG002|End of Cross Over Period|Adverse Event|6|||
129682374|NCT03112603|466796896|FG000|End of Cross Over Period|Disease Relapse|0|||
129682375|NCT03112603|466796897|FG001|End of Cross Over Period|Disease Relapse|0|||
129682376|NCT03112603|466796898|FG002|End of Cross Over Period|Disease Relapse|2|||
129682377|NCT04725188|466796899|FG000|Overall Study|Death|72|||
129682378|NCT04725188|466796900|FG001|Overall Study|Death|69|||
129682379|NCT04725188|466796901|FG002|Overall Study|Death|76|||
129682380|NCT04725188|466796899|FG000|Overall Study|Lost to Follow-up|1|||
129682381|NCT04725188|466796900|FG001|Overall Study|Lost to Follow-up|0|||
129682382|NCT04725188|466796901|FG002|Overall Study|Lost to Follow-up|1|||
129682383|NCT04725188|466796899|FG000|Overall Study|Withdrawal by Subject|2|||
129682384|NCT04725188|466796900|FG001|Overall Study|Withdrawal by Subject|2|||
129682385|NCT04725188|466796901|FG002|Overall Study|Withdrawal by Subject|1|||
129682386|NCT04725188|466796899|FG000|Overall Study|Sponsor Decision|12|||
129682387|NCT04725188|466796900|FG001|Overall Study|Sponsor Decision|12|||
129682388|NCT04725188|466796901|FG002|Overall Study|Sponsor Decision|7|||
129682389|NCT02337829|466796902|FG000|Overall Study|Death|0|||
129682390|NCT02337829|466796903|FG001|Overall Study|Death|1|||
129682391|NCT02337829|466796904|FG002|Overall Study|Death|0|||
129682392|NCT02337829|466796905|FG003|Overall Study|Death|0|||
129682393|NCT02337829|466796902|FG000|Overall Study|Study terminated by sponsor|12|||
129682394|NCT02337829|466796903|FG001|Overall Study|Study terminated by sponsor|10|||
129682395|NCT02337829|466796904|FG002|Overall Study|Study terminated by sponsor|5|||
129682396|NCT02337829|466796905|FG003|Overall Study|Study terminated by sponsor|6|||
129682397|NCT02337829|466796902|FG000|Overall Study|discontinued for other reasons|6|||
129682398|NCT02337829|466796903|FG001|Overall Study|discontinued for other reasons|3|||
129682399|NCT02337829|466796904|FG002|Overall Study|discontinued for other reasons|1|||
129682400|NCT02337829|466796905|FG003|Overall Study|discontinued for other reasons|4|||
129682401|NCT03330197|466796906|FG000|Overall Study|Adverse Event|0|||
129682402|NCT03330197|466796907|FG001|Overall Study|Adverse Event|1|||
129682403|NCT03330197|466796906|FG000|Overall Study|Withdrawal by Subject|0|||
129682404|NCT03330197|466796907|FG001|Overall Study|Withdrawal by Subject|1|||
129682405|NCT02802228|466796916|FG000|Overall Study|Withdrawal by Subject|2|||
129682406|NCT02802228|466796917|FG001|Overall Study|Withdrawal by Subject|0|||
129682407|NCT02802228|466796916|FG000|Overall Study|Lost to Follow-up|1|||
129682408|NCT02802228|466796917|FG001|Overall Study|Lost to Follow-up|0|||
129682409|NCT02802228|466796916|FG000|Overall Study|Adverse Event|1|||
129682410|NCT02802228|466796917|FG001|Overall Study|Adverse Event|0|||
129771741|NCT00554216|467132247|FG001|Overall Study|Pregnancy|1|||
129682411|NCT02802228|466796916|FG000|Overall Study|Physician Decision|1|||
129682412|NCT02802228|466796917|FG001|Overall Study|Physician Decision|0|||
129682413|NCT00695019|466796920|FG000|Overall Study|Withdrawal by Subject|8|||
129682414|NCT00695019|466796921|FG001|Overall Study|Withdrawal by Subject|6|||
129682415|NCT00695019|466796922|FG002|Overall Study|Withdrawal by Subject|4|||
129682416|NCT00695019|466796920|FG000|Overall Study|Protocol Violation|1|||
129682417|NCT00695019|466796921|FG001|Overall Study|Protocol Violation|3|||
129682418|NCT00695019|466796922|FG002|Overall Study|Protocol Violation|1|||
129682419|NCT00695019|466796920|FG000|Overall Study|Lack of Efficacy|0|||
129682420|NCT00695019|466796921|FG001|Overall Study|Lack of Efficacy|0|||
129682421|NCT00695019|466796922|FG002|Overall Study|Lack of Efficacy|1|||
129682422|NCT00695019|466796920|FG000|Overall Study|Various|4|||
129682423|NCT00695019|466796921|FG001|Overall Study|Various|5|||
129682424|NCT00695019|466796922|FG002|Overall Study|Various|4|||
129682425|NCT02225587|466796923|FG000|Overall Study|Adverse Event|5|||
129682426|NCT02225587|466796924|FG001|Overall Study|Adverse Event|5|||
129682427|NCT02225587|466796923|FG000|Overall Study|Lost to Follow-up|5|||
129682428|NCT02225587|466796924|FG001|Overall Study|Lost to Follow-up|5|||
129682429|NCT02225587|466796923|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129682430|NCT02225587|466796924|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129682431|NCT02225587|466796923|FG000|Overall Study|Physician Decision|2|||
129682432|NCT02225587|466796924|FG001|Overall Study|Physician Decision|0|||
129682433|NCT02225587|466796923|FG000|Overall Study|Protocol Violation|1|||
129682434|NCT02225587|466796924|FG001|Overall Study|Protocol Violation|0|||
129682435|NCT02225587|466796923|FG000|Overall Study|Participant Moved|1|||
129682436|NCT02225587|466796924|FG001|Overall Study|Participant Moved|0|||
129682437|NCT02225587|466796923|FG000|Overall Study|Withdrawal by Subject|13|||
129682438|NCT02225587|466796924|FG001|Overall Study|Withdrawal by Subject|28|||
129682439|NCT03197129|466796927|FG000|Overall Study|did not answer the VPT: shyness|4|||
129682440|NCT03197129|466796928|FG001|Overall Study|did not answer the VPT: shyness|5|||
129682441|NCT01564407|466796929|FG000|Overall Study|Lost to Follow-up|0|||
129682442|NCT01564407|466796930|FG001|Overall Study|Lost to Follow-up|1|||
129682443|NCT01564407|466796931|FG002|Overall Study|Lost to Follow-up|0|||
129682444|NCT01564407|466796932|FG003|Overall Study|Lost to Follow-up|0|||
129682445|NCT01564407|466796933|FG004|Overall Study|Lost to Follow-up|0|||
129682446|NCT01564407|466796929|FG000|Overall Study|Withdrawal by Subject|0|||
129682447|NCT01564407|466796930|FG001|Overall Study|Withdrawal by Subject|1|||
129548365|NCT02803138|466302670|FG000|Overall Study|Failure to return|38|||
129682448|NCT01564407|466796931|FG002|Overall Study|Withdrawal by Subject|0|||
129682449|NCT01564407|466796932|FG003|Overall Study|Withdrawal by Subject|0|||
129682450|NCT01564407|466796933|FG004|Overall Study|Withdrawal by Subject|0|||
129682451|NCT01564407|466796929|FG000|Overall Study|funding lost, study ended|0|||
129682452|NCT01564407|466796930|FG001|Overall Study|funding lost, study ended|0|||
129682453|NCT01564407|466796931|FG002|Overall Study|funding lost, study ended|0|||
129682454|NCT01564407|466796932|FG003|Overall Study|funding lost, study ended|1|||
129682455|NCT01564407|466796933|FG004|Overall Study|funding lost, study ended|0|||
129682456|NCT02442349|466796934|FG000|Overall Study|Death|95|||
129682457|NCT02442349|466796934|FG000|Overall Study|Withdrawal by Subject|27|||
129682458|NCT02442349|466796934|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
129682459|NCT02442349|466796934|FG000|Overall Study|Lost to Follow-up|1|||
129682460|NCT00314145|466796935|FG000|Overall Study|Withdrawal by Subject|8|||
129682461|NCT00314145|466796936|FG001|Overall Study|Withdrawal by Subject|10|||
129682462|NCT00314145|466796935|FG000|Overall Study|Lost to Follow-up|5|||
129682463|NCT00314145|466796936|FG001|Overall Study|Lost to Follow-up|12|||
129682464|NCT00314145|466796935|FG000|Overall Study|Physician Decision|3|||
129682465|NCT00314145|466796936|FG001|Overall Study|Physician Decision|4|||
129682466|NCT00314145|466796935|FG000|Overall Study|Adverse Event|0|||
129682467|NCT00314145|466796936|FG001|Overall Study|Adverse Event|3|||
129682468|NCT00314145|466796935|FG000|Overall Study|Protocol Violation|3|||
129682469|NCT00314145|466796936|FG001|Overall Study|Protocol Violation|0|||
129682470|NCT00314145|466796935|FG000|Overall Study|Sponsor Decision|2|||
129682471|NCT00314145|466796936|FG001|Overall Study|Sponsor Decision|0|||
129682472|NCT03507790|466796937|FG000|Overall Study|Adverse Event|0|||
129682473|NCT03507790|466796938|FG001|Overall Study|Adverse Event|11|||
129682474|NCT03507790|466796939|FG002|Overall Study|Adverse Event|3|||
129682475|NCT03507790|466796937|FG000|Overall Study|Withdrawal by Subject|2|||
129682476|NCT03507790|466796938|FG001|Overall Study|Withdrawal by Subject|0|||
129682477|NCT03507790|466796939|FG002|Overall Study|Withdrawal by Subject|0|||
129682478|NCT03507790|466796937|FG000|Overall Study|Subject moved to another location|1|||
129682479|NCT03507790|466796938|FG001|Overall Study|Subject moved to another location|2|||
129682480|NCT03507790|466796939|FG002|Overall Study|Subject moved to another location|0|||
129682481|NCT03507790|466796937|FG000|Overall Study|Non-compliance with study drug|0|||
129682482|NCT03507790|466796938|FG001|Overall Study|Non-compliance with study drug|0|||
129682483|NCT03507790|466796939|FG002|Overall Study|Non-compliance with study drug|1|||
129682484|NCT03507790|466796937|FG000|Overall Study|COVID 19 Pandemic|0|||
129682485|NCT03507790|466796938|FG001|Overall Study|COVID 19 Pandemic|1|||
129682486|NCT03507790|466796939|FG002|Overall Study|COVID 19 Pandemic|0|||
129682487|NCT03507790|466796937|FG000|Overall Study|Lost to Follow-up|0|||
129682488|NCT03507790|466796938|FG001|Overall Study|Lost to Follow-up|1|||
129682489|NCT03507790|466796939|FG002|Overall Study|Lost to Follow-up|0|||
129682490|NCT03507790|466796937|FG000|Overall Study|Discontinuation of the trial at the site|1|||
129682491|NCT03507790|466796938|FG001|Overall Study|Discontinuation of the trial at the site|1|||
129682492|NCT03507790|466796939|FG002|Overall Study|Discontinuation of the trial at the site|0|||
129682493|NCT03507790|466796937|FG000|Overall Study|Randomized in error|0|||
129682494|NCT03507790|466796938|FG001|Overall Study|Randomized in error|0|||
129682495|NCT03507790|466796939|FG002|Overall Study|Randomized in error|1|||
129682496|NCT02296125|466796942|FG000|Overall Study|Withdrawal by Subject|18|||
129682497|NCT02296125|466796943|FG001|Overall Study|Withdrawal by Subject|8|||
129682498|NCT02296125|466796944|FG002|Overall Study|Withdrawal by Subject|6|||
129682499|NCT02296125|466796945|FG003|Overall Study|Withdrawal by Subject|2|||
129682500|NCT02296125|466796942|FG000|Overall Study|Adverse Event|41|||
129682501|NCT02296125|466796943|FG001|Overall Study|Adverse Event|52|||
129682502|NCT02296125|466796944|FG002|Overall Study|Adverse Event|9|||
129682503|NCT02296125|466796945|FG003|Overall Study|Adverse Event|4|||
129682504|NCT02296125|466796942|FG000|Overall Study|Severe non-compliance to protocol|0|||
129682505|NCT02296125|466796943|FG001|Overall Study|Severe non-compliance to protocol|1|||
129682506|NCT02296125|466796944|FG002|Overall Study|Severe non-compliance to protocol|0|||
129682507|NCT02296125|466796945|FG003|Overall Study|Severe non-compliance to protocol|0|||
129682508|NCT02296125|466796942|FG000|Overall Study|Condition under investigation worsened|153|||
129682509|NCT02296125|466796943|FG001|Overall Study|Condition under investigation worsened|199|||
129682510|NCT02296125|466796944|FG002|Overall Study|Condition under investigation worsened|39|||
129682511|NCT02296125|466796945|FG003|Overall Study|Condition under investigation worsened|56|||
129682512|NCT02296125|466796942|FG000|Overall Study|Any reason not specifically recorded|6|||
129682513|NCT02296125|466796943|FG001|Overall Study|Any reason not specifically recorded|4|||
129682514|NCT02296125|466796944|FG002|Overall Study|Any reason not specifically recorded|2|||
129682515|NCT02296125|466796945|FG003|Overall Study|Any reason not specifically recorded|0|||
129682516|NCT01160614|466796946|FG000|Overall Study|Withdrawal by Subject|0|||
129682517|NCT01160614|466796947|FG001|Overall Study|Withdrawal by Subject|2|||
129682518|NCT03314935|466796948|FG000|Phase 1|Death|4|||
129682519|NCT03314935|466796949|FG001|Phase 1|Death|2|||
129682520|NCT03314935|466796950|FG002|Phase 1|Death|5|||
129682521|NCT03314935|466796951|FG003|Phase 1|Death|4|||
129771742|NCT00554216|467132248|FG002|Overall Study|Pregnancy|14|||
129771743|NCT00554216|467132246|FG000|Overall Study|Restricted med|3|||
129771744|NCT00554216|467132247|FG001|Overall Study|Restricted med|1|||
129771745|NCT00554216|467132248|FG002|Overall Study|Restricted med|1|||
129771746|NCT00554216|467132246|FG000|Overall Study|Other|12|||
129771747|NCT00554216|467132247|FG001|Overall Study|Other|7|||
129771748|NCT00554216|467132248|FG002|Overall Study|Other|10|||
129771749|NCT00554216|467132246|FG000|Overall Study|Lack of Efficacy|15|||
129771750|NCT00554216|467132247|FG001|Overall Study|Lack of Efficacy|3|||
129771751|NCT00554216|467132248|FG002|Overall Study|Lack of Efficacy|0|||
129771752|NCT00463567|467132255|FG000|Overall Study|Adverse Event|29|||
129771753|NCT00463567|467132256|FG001|Overall Study|Adverse Event|26|||
129771754|NCT00463567|467132257|FG002|Overall Study|Adverse Event|17|||
129771755|NCT00463567|467132258|FG003|Overall Study|Adverse Event|46|||
129771756|NCT00463567|467132259|FG004|Overall Study|Adverse Event|10|||
129771757|NCT00463567|467132260|FG005|Overall Study|Adverse Event|10|||
129771758|NCT00463567|467132261|FG006|Overall Study|Adverse Event|4|||
129771759|NCT00463567|467132255|FG000|Overall Study|Withdrawal by Subject|29|||
129771760|NCT00463567|467132256|FG001|Overall Study|Withdrawal by Subject|22|||
129771761|NCT00463567|467132257|FG002|Overall Study|Withdrawal by Subject|20|||
129771762|NCT00463567|467132258|FG003|Overall Study|Withdrawal by Subject|37|||
129771763|NCT00463567|467132259|FG004|Overall Study|Withdrawal by Subject|6|||
129771764|NCT00463567|467132260|FG005|Overall Study|Withdrawal by Subject|5|||
129771765|NCT00463567|467132261|FG006|Overall Study|Withdrawal by Subject|1|||
129771766|NCT00463567|467132255|FG000|Overall Study|Protocol Deviation|13|||
129771767|NCT00463567|467132256|FG001|Overall Study|Protocol Deviation|9|||
129771768|NCT00463567|467132257|FG002|Overall Study|Protocol Deviation|14|||
129771769|NCT00463567|467132258|FG003|Overall Study|Protocol Deviation|11|||
129771770|NCT00463567|467132259|FG004|Overall Study|Protocol Deviation|1|||
129771771|NCT00463567|467132260|FG005|Overall Study|Protocol Deviation|1|||
129771772|NCT00463567|467132261|FG006|Overall Study|Protocol Deviation|2|||
129771773|NCT00463567|467132255|FG000|Overall Study|Lost to Follow-up|12|||
129771774|NCT00463567|467132256|FG001|Overall Study|Lost to Follow-up|6|||
129771775|NCT00463567|467132257|FG002|Overall Study|Lost to Follow-up|13|||
129771776|NCT00463567|467132258|FG003|Overall Study|Lost to Follow-up|8|||
129771777|NCT00463567|467132259|FG004|Overall Study|Lost to Follow-up|1|||
129771778|NCT00463567|467132260|FG005|Overall Study|Lost to Follow-up|1|||
129771779|NCT00463567|467132261|FG006|Overall Study|Lost to Follow-up|1|||
129771780|NCT00463567|467132255|FG000|Overall Study|Administrative problems|5|||
129771781|NCT00463567|467132256|FG001|Overall Study|Administrative problems|3|||
129771782|NCT00463567|467132257|FG002|Overall Study|Administrative problems|6|||
129771783|NCT00463567|467132258|FG003|Overall Study|Administrative problems|9|||
129771784|NCT00463567|467132259|FG004|Overall Study|Administrative problems|3|||
129771785|NCT00463567|467132260|FG005|Overall Study|Administrative problems|2|||
129771786|NCT00463567|467132261|FG006|Overall Study|Administrative problems|2|||
129771787|NCT00463567|467132255|FG000|Overall Study|Lack of Efficacy|4|||
129771788|NCT00463567|467132256|FG001|Overall Study|Lack of Efficacy|9|||
129771789|NCT00463567|467132257|FG002|Overall Study|Lack of Efficacy|9|||
129771790|NCT00463567|467132258|FG003|Overall Study|Lack of Efficacy|17|||
129771791|NCT00463567|467132259|FG004|Overall Study|Lack of Efficacy|1|||
129771792|NCT00463567|467132260|FG005|Overall Study|Lack of Efficacy|0|||
129771793|NCT00463567|467132261|FG006|Overall Study|Lack of Efficacy|1|||
129771794|NCT00463567|467132255|FG000|Overall Study|Abnormal lab value(s)|1|||
129771795|NCT00463567|467132256|FG001|Overall Study|Abnormal lab value(s)|1|||
129771796|NCT00463567|467132257|FG002|Overall Study|Abnormal lab value(s)|2|||
129771797|NCT00463567|467132258|FG003|Overall Study|Abnormal lab value(s)|1|||
129771798|NCT00463567|467132259|FG004|Overall Study|Abnormal lab value(s)|1|||
129771799|NCT00463567|467132260|FG005|Overall Study|Abnormal lab value(s)|0|||
129771800|NCT00463567|467132261|FG006|Overall Study|Abnormal lab value(s)|0|||
129771801|NCT00463567|467132255|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129771802|NCT00463567|467132256|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129771803|NCT00463567|467132257|FG002|Overall Study|Abnormal test procedure result(s)|6|||
129771804|NCT00463567|467132258|FG003|Overall Study|Abnormal test procedure result(s)|2|||
129771805|NCT00463567|467132259|FG004|Overall Study|Abnormal test procedure result(s)|0|||
129771806|NCT00463567|467132260|FG005|Overall Study|Abnormal test procedure result(s)|2|||
129771807|NCT00463567|467132261|FG006|Overall Study|Abnormal test procedure result(s)|0|||
129771808|NCT00463567|467132255|FG000|Overall Study|Death|1|||
129771809|NCT00463567|467132256|FG001|Overall Study|Death|0|||
129771810|NCT00463567|467132257|FG002|Overall Study|Death|2|||
129771811|NCT00463567|467132258|FG003|Overall Study|Death|0|||
129771812|NCT00463567|467132259|FG004|Overall Study|Death|0|||
129771813|NCT00463567|467132260|FG005|Overall Study|Death|0|||
129771814|NCT00463567|467132261|FG006|Overall Study|Death|0|||
129771815|NCT01524796|467132263|FG000|Overall Study|Adverse Event|13|||
129771816|NCT01524796|467132263|FG000|Overall Study|Lack of Efficacy|3|||
129771817|NCT01524796|467132263|FG000|Overall Study|Lost to Follow-up|1|||
129771818|NCT01524796|467132263|FG000|Overall Study|The price|1|||
129771819|NCT01524796|467132263|FG000|Overall Study|Withdrawal by Subject|4|||
129771820|NCT01524796|467132263|FG000|Overall Study|Move|1|||
129771821|NCT01524796|467132263|FG000|Overall Study|Deterioration of pains|1|||
129771822|NCT01524796|467132263|FG000|Overall Study|Gall stone surgery|1|||
129771823|NCT01524796|467132263|FG000|Overall Study|Nervous about confidentiality|1|||
129771824|NCT01524796|467132263|FG000|Overall Study|Switch to carbamazapine|1|||
129771825|NCT01524796|467132263|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
129771826|NCT00956007|467132266|FG000|Overall Study|Protocol Violation|27|||
129771827|NCT00956007|467132267|FG001|Overall Study|Protocol Violation|23|||
129771828|NCT03774576|467132268|FG000|Period 2|Adverse Event|1|||
129771829|NCT00927953|467132269|FG000|Overall Study|Death|2|||
129771830|NCT00927953|467132270|FG001|Overall Study|Death|1|||
129771831|NCT01249261|467132284|FG000|Overall Study|Withdrawal by Subject|1|||
129771832|NCT01249261|467132285|FG001|Overall Study|Withdrawal by Subject|0|||
129771833|NCT00482053|467132289|FG000|Inter-treatment Period|Disease progression|1|||
129771834|NCT01055197|467132295|FG000|Overall Study|Protocol Violation|7|||
129771835|NCT01055197|467132296|FG001|Overall Study|Protocol Violation|2|||
129771836|NCT01055197|467132295|FG000|Overall Study|Withdrawal by Subject|2|||
129771837|NCT01055197|467132296|FG001|Overall Study|Withdrawal by Subject|0|||
129771838|NCT00538902|467132297|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
129771839|NCT00538902|467132298|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
129771840|NCT00538902|467132299|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
129771841|NCT00538902|467132297|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
129771842|NCT00538902|467132298|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
129771843|NCT00538902|467132299|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
129771844|NCT00538902|467132297|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
129771845|NCT00538902|467132298|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
129771846|NCT00538902|467132299|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
129771847|NCT00538902|467132297|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
129771848|NCT00538902|467132298|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
129771849|NCT00538902|467132299|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
129771850|NCT00538902|467132297|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
129771851|NCT00538902|467132298|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
129771852|NCT00538902|467132299|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
129771853|NCT00538902|467132297|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
129771854|NCT00538902|467132298|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
129771855|NCT00538902|467132299|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
129682522|NCT03314935|466796952|FG004|Phase 1|Death|3|||
129682523|NCT03314935|466796953|FG005|Phase 1|Death|4|||
129682524|NCT03314935|466796954|FG006|Phase 1|Death|5|||
129682525|NCT03314935|466796955|FG007|Phase 1|Death|4|||
129682526|NCT03314935|466796956|FG008|Phase 1|Death|3|||
129682527|NCT03314935|466796957|FG009|Phase 1|Death|0|||
129682528|NCT03314935|466796958|FG010|Phase 1|Death|0|||
129682529|NCT03314935|466796959|FG011|Phase 1|Death|0|||
129682530|NCT03314935|466796960|FG012|Phase 1|Death|0|||
129682531|NCT03314935|466796961|FG013|Phase 1|Death|0|||
129682532|NCT03314935|466796962|FG014|Phase 1|Death|0|||
129682533|NCT03314935|466796948|FG000|Phase 1|Withdrawal by Subject|2|||
129682534|NCT03314935|466796949|FG001|Phase 1|Withdrawal by Subject|1|||
129682535|NCT03314935|466796950|FG002|Phase 1|Withdrawal by Subject|1|||
129682536|NCT03314935|466796951|FG003|Phase 1|Withdrawal by Subject|2|||
129682537|NCT03314935|466796952|FG004|Phase 1|Withdrawal by Subject|1|||
129682538|NCT03314935|466796953|FG005|Phase 1|Withdrawal by Subject|0|||
129682539|NCT03314935|466796954|FG006|Phase 1|Withdrawal by Subject|1|||
129682540|NCT03314935|466796955|FG007|Phase 1|Withdrawal by Subject|0|||
129682541|NCT03314935|466796956|FG008|Phase 1|Withdrawal by Subject|1|||
129682542|NCT03314935|466796957|FG009|Phase 1|Withdrawal by Subject|0|||
129682543|NCT03314935|466796958|FG010|Phase 1|Withdrawal by Subject|0|||
129682544|NCT03314935|466796959|FG011|Phase 1|Withdrawal by Subject|0|||
129682545|NCT03314935|466796960|FG012|Phase 1|Withdrawal by Subject|0|||
129682546|NCT03314935|466796961|FG013|Phase 1|Withdrawal by Subject|0|||
129682547|NCT03314935|466796962|FG014|Phase 1|Withdrawal by Subject|0|||
129682548|NCT03314935|466796948|FG000|Phase 1|Progressive Disease|2|||
129682549|NCT03314935|466796949|FG001|Phase 1|Progressive Disease|0|||
129682550|NCT03314935|466796950|FG002|Phase 1|Progressive Disease|0|||
129682551|NCT03314935|466796951|FG003|Phase 1|Progressive Disease|1|||
129682552|NCT03314935|466796952|FG004|Phase 1|Progressive Disease|0|||
129682553|NCT03314935|466796953|FG005|Phase 1|Progressive Disease|0|||
129682554|NCT03314935|466796954|FG006|Phase 1|Progressive Disease|0|||
129682555|NCT03314935|466796955|FG007|Phase 1|Progressive Disease|0|||
129682556|NCT03314935|466796956|FG008|Phase 1|Progressive Disease|0|||
129682557|NCT03314935|466796957|FG009|Phase 1|Progressive Disease|0|||
129682558|NCT03314935|466796958|FG010|Phase 1|Progressive Disease|0|||
129682559|NCT03314935|466796959|FG011|Phase 1|Progressive Disease|0|||
129682560|NCT03314935|466796960|FG012|Phase 1|Progressive Disease|0|||
129682561|NCT03314935|466796961|FG013|Phase 1|Progressive Disease|0|||
129682562|NCT03314935|466796962|FG014|Phase 1|Progressive Disease|0|||
129682563|NCT03314935|466796948|FG000|Phase 1|Study Terminated by Sponsor|0|||
129682564|NCT03314935|466796949|FG001|Phase 1|Study Terminated by Sponsor|1|||
129682565|NCT03314935|466796950|FG002|Phase 1|Study Terminated by Sponsor|0|||
129682566|NCT03314935|466796951|FG003|Phase 1|Study Terminated by Sponsor|0|||
129682567|NCT03314935|466796952|FG004|Phase 1|Study Terminated by Sponsor|0|||
129682568|NCT03314935|466796953|FG005|Phase 1|Study Terminated by Sponsor|0|||
129682569|NCT03314935|466796954|FG006|Phase 1|Study Terminated by Sponsor|0|||
129682570|NCT03314935|466796955|FG007|Phase 1|Study Terminated by Sponsor|0|||
129682571|NCT03314935|466796956|FG008|Phase 1|Study Terminated by Sponsor|1|||
129682572|NCT03314935|466796957|FG009|Phase 1|Study Terminated by Sponsor|0|||
129682573|NCT03314935|466796958|FG010|Phase 1|Study Terminated by Sponsor|0|||
129682574|NCT03314935|466796959|FG011|Phase 1|Study Terminated by Sponsor|0|||
129682575|NCT03314935|466796960|FG012|Phase 1|Study Terminated by Sponsor|0|||
129682576|NCT03314935|466796961|FG013|Phase 1|Study Terminated by Sponsor|0|||
129682577|NCT03314935|466796962|FG014|Phase 1|Study Terminated by Sponsor|0|||
129682578|NCT03314935|466796948|FG000|Phase 1|"Captured as Other in Database"|0|||
129682579|NCT03314935|466796949|FG001|Phase 1|"Captured as Other in Database"|2|||
129682580|NCT03314935|466796950|FG002|Phase 1|"Captured as Other in Database"|0|||
129682581|NCT03314935|466796951|FG003|Phase 1|"Captured as Other in Database"|0|||
129682582|NCT03314935|466796952|FG004|Phase 1|"Captured as Other in Database"|0|||
129682583|NCT03314935|466796953|FG005|Phase 1|"Captured as Other in Database"|0|||
129682584|NCT03314935|466796954|FG006|Phase 1|"Captured as Other in Database"|1|||
129682585|NCT03314935|466796955|FG007|Phase 1|"Captured as Other in Database"|1|||
129682586|NCT03314935|466796956|FG008|Phase 1|"Captured as Other in Database"|1|||
129682587|NCT03314935|466796957|FG009|Phase 1|"Captured as Other in Database"|0|||
129682588|NCT03314935|466796958|FG010|Phase 1|"Captured as Other in Database"|0|||
129682589|NCT03314935|466796959|FG011|Phase 1|"Captured as Other in Database"|0|||
129682590|NCT03314935|466796960|FG012|Phase 1|"Captured as Other in Database"|0|||
129682591|NCT03314935|466796961|FG013|Phase 1|"Captured as Other in Database"|0|||
129682592|NCT03314935|466796962|FG014|Phase 1|"Captured as Other in Database"|0|||
129682593|NCT03314935|466796948|FG000|Phase 1|Lost to Follow-up|0|||
129682594|NCT03314935|466796949|FG001|Phase 1|Lost to Follow-up|0|||
129682595|NCT03314935|466796950|FG002|Phase 1|Lost to Follow-up|0|||
129771856|NCT00538902|467132297|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
129771857|NCT00538902|467132298|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
129771858|NCT00538902|467132299|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
129771859|NCT00538902|467132297|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
129771860|NCT00538902|467132298|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
129771861|NCT00538902|467132299|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
129771862|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
129771863|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
129771864|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
129771865|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
129771866|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129771867|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
129771868|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
129771869|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
129771870|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
129771871|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
129771872|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
129771873|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
129771874|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
129771875|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
129771876|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
129771877|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
129771878|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
129771879|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
129771880|NCT03739203|467132300|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
129771881|NCT03739203|467132301|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
129771882|NCT03739203|467132302|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
129771883|NCT03739203|467132300|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
129771884|NCT03739203|467132301|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
129771885|NCT03739203|467132302|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
129682596|NCT03314935|466796951|FG003|Phase 1|Lost to Follow-up|0|||
129682597|NCT03314935|466796952|FG004|Phase 1|Lost to Follow-up|0|||
129682598|NCT03314935|466796953|FG005|Phase 1|Lost to Follow-up|0|||
129682599|NCT03314935|466796954|FG006|Phase 1|Lost to Follow-up|0|||
129682600|NCT03314935|466796955|FG007|Phase 1|Lost to Follow-up|0|||
129682601|NCT03314935|466796956|FG008|Phase 1|Lost to Follow-up|1|||
129682602|NCT03314935|466796957|FG009|Phase 1|Lost to Follow-up|0|||
129682603|NCT03314935|466796958|FG010|Phase 1|Lost to Follow-up|0|||
129682604|NCT03314935|466796959|FG011|Phase 1|Lost to Follow-up|0|||
129682605|NCT03314935|466796960|FG012|Phase 1|Lost to Follow-up|0|||
129682606|NCT03314935|466796961|FG013|Phase 1|Lost to Follow-up|0|||
129682607|NCT03314935|466796962|FG014|Phase 1|Lost to Follow-up|0|||
129682608|NCT03314935|466796948|FG000|Phase 2|Death|0|||
129682609|NCT03314935|466796949|FG001|Phase 2|Death|0|||
129682610|NCT03314935|466796950|FG002|Phase 2|Death|0|||
129682611|NCT03314935|466796951|FG003|Phase 2|Death|0|||
129682612|NCT03314935|466796952|FG004|Phase 2|Death|0|||
129682613|NCT03314935|466796953|FG005|Phase 2|Death|0|||
129682614|NCT03314935|466796954|FG006|Phase 2|Death|0|||
129682615|NCT03314935|466796955|FG007|Phase 2|Death|0|||
129682616|NCT03314935|466796956|FG008|Phase 2|Death|0|||
129682617|NCT03314935|466796957|FG009|Phase 2|Death|5|||
129682618|NCT03314935|466796958|FG010|Phase 2|Death|20|||
129682619|NCT03314935|466796959|FG011|Phase 2|Death|6|||
129682620|NCT03314935|466796960|FG012|Phase 2|Death|7|||
129682621|NCT03314935|466796961|FG013|Phase 2|Death|6|||
129682622|NCT03314935|466796962|FG014|Phase 2|Death|17|||
129682623|NCT03314935|466796948|FG000|Phase 2|Withdrawal by Subject|0|||
129682624|NCT03314935|466796949|FG001|Phase 2|Withdrawal by Subject|0|||
129682625|NCT03314935|466796950|FG002|Phase 2|Withdrawal by Subject|0|||
129682626|NCT03314935|466796951|FG003|Phase 2|Withdrawal by Subject|0|||
129682627|NCT03314935|466796952|FG004|Phase 2|Withdrawal by Subject|0|||
129682628|NCT03314935|466796953|FG005|Phase 2|Withdrawal by Subject|0|||
129682629|NCT03314935|466796954|FG006|Phase 2|Withdrawal by Subject|0|||
129682630|NCT03314935|466796955|FG007|Phase 2|Withdrawal by Subject|0|||
129682631|NCT03314935|466796956|FG008|Phase 2|Withdrawal by Subject|0|||
129682632|NCT03314935|466796957|FG009|Phase 2|Withdrawal by Subject|1|||
129682633|NCT03314935|466796958|FG010|Phase 2|Withdrawal by Subject|4|||
129682634|NCT03314935|466796959|FG011|Phase 2|Withdrawal by Subject|0|||
129682635|NCT03314935|466796960|FG012|Phase 2|Withdrawal by Subject|1|||
129682636|NCT03314935|466796961|FG013|Phase 2|Withdrawal by Subject|0|||
129682637|NCT03314935|466796962|FG014|Phase 2|Withdrawal by Subject|1|||
129682638|NCT03314935|466796948|FG000|Phase 2|Progressive Disease|0|||
129682639|NCT03314935|466796949|FG001|Phase 2|Progressive Disease|0|||
129682640|NCT03314935|466796950|FG002|Phase 2|Progressive Disease|0|||
129682641|NCT03314935|466796951|FG003|Phase 2|Progressive Disease|0|||
129682642|NCT03314935|466796952|FG004|Phase 2|Progressive Disease|0|||
129682643|NCT03314935|466796953|FG005|Phase 2|Progressive Disease|0|||
129682644|NCT03314935|466796954|FG006|Phase 2|Progressive Disease|0|||
129682645|NCT03314935|466796955|FG007|Phase 2|Progressive Disease|0|||
129682646|NCT03314935|466796956|FG008|Phase 2|Progressive Disease|0|||
129682647|NCT03314935|466796957|FG009|Phase 2|Progressive Disease|1|||
129682648|NCT03314935|466796958|FG010|Phase 2|Progressive Disease|1|||
129682649|NCT03314935|466796959|FG011|Phase 2|Progressive Disease|1|||
129682650|NCT03314935|466796960|FG012|Phase 2|Progressive Disease|2|||
129682651|NCT03314935|466796961|FG013|Phase 2|Progressive Disease|0|||
129682652|NCT03314935|466796962|FG014|Phase 2|Progressive Disease|1|||
129682653|NCT03314935|466796948|FG000|Phase 2|Study Terminated by Sponsor|0|||
129682654|NCT03314935|466796949|FG001|Phase 2|Study Terminated by Sponsor|0|||
129682655|NCT03314935|466796950|FG002|Phase 2|Study Terminated by Sponsor|0|||
129682656|NCT03314935|466796951|FG003|Phase 2|Study Terminated by Sponsor|0|||
129682657|NCT03314935|466796952|FG004|Phase 2|Study Terminated by Sponsor|0|||
129682658|NCT03314935|466796953|FG005|Phase 2|Study Terminated by Sponsor|0|||
129682659|NCT03314935|466796954|FG006|Phase 2|Study Terminated by Sponsor|0|||
129682660|NCT03314935|466796955|FG007|Phase 2|Study Terminated by Sponsor|0|||
129682661|NCT03314935|466796956|FG008|Phase 2|Study Terminated by Sponsor|0|||
129682662|NCT03314935|466796957|FG009|Phase 2|Study Terminated by Sponsor|0|||
129682663|NCT03314935|466796958|FG010|Phase 2|Study Terminated by Sponsor|7|||
129682664|NCT03314935|466796959|FG011|Phase 2|Study Terminated by Sponsor|2|||
129682665|NCT03314935|466796960|FG012|Phase 2|Study Terminated by Sponsor|1|||
129682666|NCT03314935|466796961|FG013|Phase 2|Study Terminated by Sponsor|4|||
129682667|NCT03314935|466796962|FG014|Phase 2|Study Terminated by Sponsor|4|||
129682668|NCT03314935|466796948|FG000|Phase 2|Lost to Follow-up|0|||
129682669|NCT03314935|466796949|FG001|Phase 2|Lost to Follow-up|0|||
129682670|NCT03314935|466796950|FG002|Phase 2|Lost to Follow-up|0|||
129682671|NCT03314935|466796951|FG003|Phase 2|Lost to Follow-up|0|||
129682672|NCT03314935|466796952|FG004|Phase 2|Lost to Follow-up|0|||
129682673|NCT03314935|466796953|FG005|Phase 2|Lost to Follow-up|0|||
129682674|NCT03314935|466796954|FG006|Phase 2|Lost to Follow-up|0|||
129682675|NCT03314935|466796955|FG007|Phase 2|Lost to Follow-up|0|||
129682676|NCT03314935|466796956|FG008|Phase 2|Lost to Follow-up|0|||
129682677|NCT03314935|466796957|FG009|Phase 2|Lost to Follow-up|1|||
129682678|NCT03314935|466796958|FG010|Phase 2|Lost to Follow-up|0|||
129682679|NCT03314935|466796959|FG011|Phase 2|Lost to Follow-up|0|||
129682680|NCT03314935|466796960|FG012|Phase 2|Lost to Follow-up|0|||
129682681|NCT03314935|466796961|FG013|Phase 2|Lost to Follow-up|0|||
129682682|NCT03314935|466796962|FG014|Phase 2|Lost to Follow-up|1|||
129682683|NCT03314935|466796948|FG000|Phase 2|Physician Decision|0|||
129682684|NCT03314935|466796949|FG001|Phase 2|Physician Decision|0|||
129682685|NCT03314935|466796950|FG002|Phase 2|Physician Decision|0|||
129682686|NCT03314935|466796951|FG003|Phase 2|Physician Decision|0|||
129682687|NCT03314935|466796952|FG004|Phase 2|Physician Decision|0|||
129682688|NCT03314935|466796953|FG005|Phase 2|Physician Decision|0|||
129682689|NCT03314935|466796954|FG006|Phase 2|Physician Decision|0|||
129682690|NCT03314935|466796955|FG007|Phase 2|Physician Decision|0|||
129682691|NCT03314935|466796956|FG008|Phase 2|Physician Decision|0|||
129682692|NCT03314935|466796957|FG009|Phase 2|Physician Decision|0|||
129682693|NCT03314935|466796958|FG010|Phase 2|Physician Decision|1|||
129682694|NCT03314935|466796959|FG011|Phase 2|Physician Decision|0|||
129682695|NCT03314935|466796960|FG012|Phase 2|Physician Decision|0|||
129771886|NCT03739203|467132300|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
129771887|NCT03739203|467132301|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
129771888|NCT03739203|467132302|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
129682696|NCT03314935|466796961|FG013|Phase 2|Physician Decision|0|||
129682697|NCT03314935|466796962|FG014|Phase 2|Physician Decision|0|||
129682698|NCT05845619|466796963|FG000|Overall Study|duplicate enrollment|2|||
129682699|NCT05845619|466796964|FG001|Overall Study|duplicate enrollment|2|||
129548366|NCT02803138|466302670|FG000|Overall Study|Insufficient virological response|2|||
129548367|NCT02803138|466302670|FG000|Overall Study|Withdrawn consent|1|||
129548368|NCT02803138|466302670|FG000|Overall Study|Death|1|||
129548369|NCT02803138|466302670|FG000|Overall Study|Other, not specified|28|||
129548370|NCT00424515|466302671|FG000|Overall Study|Progressive Disease|10|||
129548371|NCT00424515|466302672|FG001|Overall Study|Progressive Disease|11|||
129548372|NCT00424515|466302671|FG000|Overall Study|Adverse Event|0|||
129548373|NCT00424515|466302672|FG001|Overall Study|Adverse Event|1|||
129548374|NCT00424515|466302671|FG000|Overall Study|Intercurrent Illness|0|||
129548375|NCT00424515|466302672|FG001|Overall Study|Intercurrent Illness|1|||
129548376|NCT00424515|466302671|FG000|Overall Study|Withdrawal by Subject|1|||
129548377|NCT00424515|466302672|FG001|Overall Study|Withdrawal by Subject|0|||
129548378|NCT00267020|466302673|FG000|Overall Study|Adverse Event|22|||
129548379|NCT00267020|466302674|FG001|Overall Study|Adverse Event|5|||
129548380|NCT00267020|466302673|FG000|Overall Study|Death|2|||
129548381|NCT00267020|466302674|FG001|Overall Study|Death|1|||
129548382|NCT00267020|466302673|FG000|Overall Study|Withdrawal by Subject|17|||
129548383|NCT00267020|466302674|FG001|Overall Study|Withdrawal by Subject|7|||
129548384|NCT00267020|466302673|FG000|Overall Study|Physician Decision|3|||
129771889|NCT03739203|467132300|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
129771890|NCT03739203|467132301|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
129771891|NCT03739203|467132302|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
129771892|NCT03739203|467132300|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
129771893|NCT03739203|467132301|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
129771894|NCT03739203|467132302|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
129771895|NCT01967940|467132303|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
129771896|NCT01967940|467132304|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
129771897|NCT01967940|467132305|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
129771898|NCT01967940|467132306|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
129771899|NCT01967940|467132303|FG000|Part 2|Adverse Event|0|||
129771900|NCT01967940|467132304|FG001|Part 2|Adverse Event|0|||
129771901|NCT01967940|467132305|FG002|Part 2|Adverse Event|0|||
129771902|NCT01967940|467132306|FG003|Part 2|Adverse Event|1|||
129771903|NCT01967940|467132303|FG000|Part 2|Unknown Reason|0|||
129771904|NCT01967940|467132304|FG001|Part 2|Unknown Reason|0|||
129771905|NCT01967940|467132305|FG002|Part 2|Unknown Reason|0|||
129771906|NCT01967940|467132306|FG003|Part 2|Unknown Reason|1|||
129771907|NCT01663103|467132307|FG000|Overall Study|Withdrawal by Subject|1|||
129771908|NCT01663103|467132308|FG001|Overall Study|Withdrawal by Subject|2|||
129771909|NCT01663103|467132307|FG000|Overall Study|Adverse Event|1|||
129771910|NCT01663103|467132308|FG001|Overall Study|Adverse Event|0|||
129771911|NCT01663103|467132307|FG000|Overall Study|dog bite|1|||
129771912|NCT01663103|467132308|FG001|Overall Study|dog bite|0|||
129771913|NCT03113487|467132313|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
129771914|NCT03777982|467132314|FG000|Overall Study|Physician Decision|0|||
129771915|NCT03777982|467132315|FG001|Overall Study|Physician Decision|1|||
129771916|NCT00391586|467132319|FG000|Overall Study|Progressive disease|13|||
129771917|NCT00391586|467132319|FG000|Overall Study|Adverse Event|5|||
129771918|NCT00391586|467132319|FG000|Overall Study|Physician Decision|2|||
129771919|NCT00391586|467132319|FG000|Overall Study|Death|4|||
129771920|NCT00904982|467132320|FG000|Overall Study|Withdrawal by Subject|2|||
129771921|NCT00904982|467132321|FG001|Overall Study|Withdrawal by Subject|0|||
129771922|NCT00904982|467132322|FG002|Overall Study|Withdrawal by Subject|0|||
129771923|NCT00904982|467132323|FG003|Overall Study|Withdrawal by Subject|0|||
129771924|NCT02072668|467132324|FG000|Second Intervention|Lost to Follow-up|1|||
129771925|NCT02072668|467132325|FG001|Second Intervention|Lost to Follow-up|0|||
129771926|NCT00771758|467132330|FG000|Overall Study|Adverse Event|2|||
129771927|NCT00771758|467132331|FG001|Overall Study|Adverse Event|8|||
129771928|NCT00771758|467132332|FG002|Overall Study|Adverse Event|1|||
129771929|NCT00771758|467132330|FG000|Overall Study|Lack of Efficacy|0|||
129771930|NCT00771758|467132331|FG001|Overall Study|Lack of Efficacy|2|||
129771931|NCT00771758|467132332|FG002|Overall Study|Lack of Efficacy|1|||
129771932|NCT00771758|467132330|FG000|Overall Study|Lost to Follow-up|1|||
129771933|NCT00771758|467132331|FG001|Overall Study|Lost to Follow-up|0|||
129771934|NCT00771758|467132332|FG002|Overall Study|Lost to Follow-up|0|||
129771935|NCT00771758|467132330|FG000|Overall Study|Protocol Violation|1|||
129771936|NCT00771758|467132331|FG001|Overall Study|Protocol Violation|0|||
129771937|NCT00771758|467132332|FG002|Overall Study|Protocol Violation|0|||
129771938|NCT00771758|467132330|FG000|Overall Study|Withdrawal by Subject|1|||
129771939|NCT00771758|467132331|FG001|Overall Study|Withdrawal by Subject|0|||
129771940|NCT00771758|467132332|FG002|Overall Study|Withdrawal by Subject|0|||
129771941|NCT00771758|467132330|FG000|Overall Study|Other|3|||
129771942|NCT00771758|467132331|FG001|Overall Study|Other|2|||
129771943|NCT00771758|467132332|FG002|Overall Study|Other|0|||
129548385|NCT00267020|466302674|FG001|Overall Study|Physician Decision|2|||
129548386|NCT00267020|466302673|FG000|Overall Study|Disease Progression|39|||
129548387|NCT00267020|466302674|FG001|Overall Study|Disease Progression|25|||
129548388|NCT00267020|466302673|FG000|Overall Study|Unrelated Complication|1|||
129548389|NCT00267020|466302674|FG001|Overall Study|Unrelated Complication|1|||
129548390|NCT00267020|466302673|FG000|Overall Study|Sponsor Request|1|||
129548391|NCT00267020|466302674|FG001|Overall Study|Sponsor Request|0|||
129682700|NCT05845619|466796965|FG002|Overall Study|duplicate enrollment|1|||
129682701|NCT03636477|466796969|FG000|Overall Study|Adverse Event|0|||
129682702|NCT03636477|466796970|FG001|Overall Study|Adverse Event|0|||
129682703|NCT03636477|466796971|FG002|Overall Study|Adverse Event|1|||
129682704|NCT03621592|466796972|FG000|Overall Study|Lost to Follow-up|1|||
129682705|NCT03621592|466796973|FG001|Overall Study|Lost to Follow-up|0|||
129682706|NCT03621592|466796972|FG000|Overall Study|Lack of Improvement|1|||
129682707|NCT03621592|466796973|FG001|Overall Study|Lack of Improvement|0|||
129682708|NCT03621592|466796972|FG000|Overall Study|Preference to receive wound care closer to home|1|||
129682709|NCT03621592|466796973|FG001|Overall Study|Preference to receive wound care closer to home|0|||
129682710|NCT03621592|466796972|FG000|Overall Study|Lack of healing|0|||
129682711|NCT03621592|466796973|FG001|Overall Study|Lack of healing|2|||
129682712|NCT02382380|466796975|FG000|Overall Study|Withdrawal by Subject|2|||
129682713|NCT02382380|466796976|FG001|Overall Study|Withdrawal by Subject|2|||
129682714|NCT02382380|466796975|FG000|Overall Study|Lost to Follow-up|0|||
129682715|NCT02382380|466796976|FG001|Overall Study|Lost to Follow-up|1|||
129682716|NCT05168800|466796977|FG000|Time 1 Survey|Did not start T1 survey|182|||
129682717|NCT05168800|466796978|FG001|Time 1 Survey|Did not start T1 survey|150|||
129682718|NCT05168800|466796979|FG002|Time 1 Survey|Did not start T1 survey|140|||
129682719|NCT05168800|466796977|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
129682720|NCT05168800|466796978|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
129682721|NCT05168800|466796979|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
129682722|NCT05168800|466796977|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
129682723|NCT05168800|466796978|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
129682724|NCT05168800|466796979|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
129682725|NCT05168800|466796977|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
129682726|NCT05168800|466796978|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
129682727|NCT05168800|466796979|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
129682728|NCT05168800|466796977|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
129682729|NCT05168800|466796978|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
129682730|NCT05168800|466796979|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
129682731|NCT05168800|466796977|FG000|Time 1 Survey|Withdrawal by Subject|6|||
129682732|NCT05168800|466796978|FG001|Time 1 Survey|Withdrawal by Subject|3|||
129682733|NCT05168800|466796979|FG002|Time 1 Survey|Withdrawal by Subject|2|||
129682734|NCT05168800|466796977|FG000|Time 2 Survey|Already excluded at Time 1|228|||
129682735|NCT05168800|466796978|FG001|Time 2 Survey|Already excluded at Time 1|202|||
129682736|NCT05168800|466796979|FG002|Time 2 Survey|Already excluded at Time 1|173|||
129682737|NCT05168800|466796977|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
129682738|NCT05168800|466796978|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
129682739|NCT05168800|466796979|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
129682740|NCT05168800|466796977|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
129682741|NCT05168800|466796978|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
129682742|NCT05168800|466796979|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
129682743|NCT05168800|466796977|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
129682744|NCT05168800|466796978|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
129682745|NCT05168800|466796979|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
129682746|NCT05168800|466796977|FG000|Time 2 Survey|Withdrawal by Subject|1|||
129682747|NCT05168800|466796978|FG001|Time 2 Survey|Withdrawal by Subject|0|||
129682748|NCT05168800|466796979|FG002|Time 2 Survey|Withdrawal by Subject|1|||
129682749|NCT05168800|466796977|FG000|Time 3 Survey|Already excluded at Time 1|228|||
129682750|NCT05168800|466796978|FG001|Time 3 Survey|Already excluded at Time 1|200|||
129682751|NCT05168800|466796979|FG002|Time 3 Survey|Already excluded at Time 1|173|||
129682752|NCT05168800|466796977|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
129682753|NCT05168800|466796978|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
129682754|NCT05168800|466796979|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
129682755|NCT05168800|466796977|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
129682756|NCT05168800|466796978|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
129682757|NCT05168800|466796979|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
129682758|NCT05168800|466796977|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
129682759|NCT05168800|466796978|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
129682760|NCT05168800|466796979|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
129682761|NCT04556097|466796980|FG000|Overall Study|Death|0|||
129682762|NCT04556097|466796981|FG001|Overall Study|Death|5|||
129682763|NCT04556097|466796982|FG002|Overall Study|Death|0|||
129682764|NCT04556097|466796983|FG003|Overall Study|Death|0|||
129682765|NCT04556097|466796980|FG000|Overall Study|No caregiver|43|||
129682766|NCT04556097|466796981|FG001|Overall Study|No caregiver|53|||
129682767|NCT04556097|466796982|FG002|Overall Study|No caregiver|0|||
129548392|NCT00267020|466302673|FG000|Overall Study|Other|1|||
129548393|NCT00267020|466302674|FG001|Overall Study|Other|2|||
129682768|NCT04556097|466796983|FG003|Overall Study|No caregiver|0|||
129682769|NCT04556097|466796980|FG000|Overall Study|Ineligible, SNF|2|||
129682770|NCT04556097|466796981|FG001|Overall Study|Ineligible, SNF|2|||
129682771|NCT04556097|466796982|FG002|Overall Study|Ineligible, SNF|0|||
129682772|NCT04556097|466796983|FG003|Overall Study|Ineligible, SNF|0|||
129682773|NCT04556097|466796980|FG000|Overall Study|Ineligible, health|3|||
129682774|NCT04556097|466796981|FG001|Overall Study|Ineligible, health|4|||
129682775|NCT04556097|466796982|FG002|Overall Study|Ineligible, health|0|||
129682776|NCT04556097|466796983|FG003|Overall Study|Ineligible, health|0|||
129682777|NCT04556097|466796980|FG000|Overall Study|Ineligible, language|0|||
129682778|NCT04556097|466796981|FG001|Overall Study|Ineligible, language|1|||
129682779|NCT04556097|466796982|FG002|Overall Study|Ineligible, language|0|||
129682780|NCT04556097|466796983|FG003|Overall Study|Ineligible, language|0|||
129682781|NCT04556097|466796980|FG000|Overall Study|Ineligible, no longer in care management|0|||
129682782|NCT04556097|466796981|FG001|Overall Study|Ineligible, no longer in care management|2|||
129682783|NCT04556097|466796982|FG002|Overall Study|Ineligible, no longer in care management|1|||
129682784|NCT04556097|466796983|FG003|Overall Study|Ineligible, no longer in care management|0|||
129682785|NCT04556097|466796980|FG000|Overall Study|No dementia|13|||
129682786|NCT04556097|466796981|FG001|Overall Study|No dementia|3|||
129682787|NCT04556097|466796982|FG002|Overall Study|No dementia|0|||
129682788|NCT04556097|466796983|FG003|Overall Study|No dementia|0|||
129682789|NCT04556097|466796980|FG000|Overall Study|Missing identifier|2|||
129682790|NCT04556097|466796981|FG001|Overall Study|Missing identifier|4|||
129682791|NCT04556097|466796982|FG002|Overall Study|Missing identifier|0|||
129682792|NCT04556097|466796983|FG003|Overall Study|Missing identifier|0|||
129771944|NCT03067077|467132333|FG000|Overall Study|Did not receive surgery|4|||
129682793|NCT04556097|466796980|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
129682794|NCT04556097|466796981|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
129682795|NCT04556097|466796982|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
129771945|NCT03067077|467132334|FG001|Overall Study|Did not receive surgery|5|||
129771946|NCT03067077|467132333|FG000|Overall Study|Lost to Follow-up|3|||
129771947|NCT03067077|467132334|FG001|Overall Study|Lost to Follow-up|2|||
129771948|NCT00935584|467132337|FG000|Overall Study|Withdrawal by Subject|9|||
129771949|NCT00935584|467132338|FG001|Overall Study|Withdrawal by Subject|0|||
129771950|NCT00935584|467132337|FG000|Overall Study|Death|3|||
129771951|NCT00935584|467132338|FG001|Overall Study|Death|0|||
129771952|NCT00935584|467132337|FG000|Overall Study|Lost to Follow-up|8|||
129771953|NCT00935584|467132338|FG001|Overall Study|Lost to Follow-up|0|||
129771954|NCT00935584|467132337|FG000|Overall Study|No show|9|||
129771955|NCT00935584|467132338|FG001|Overall Study|No show|0|||
129771956|NCT00935584|467132337|FG000|Overall Study|Relocated|3|||
129771957|NCT00935584|467132338|FG001|Overall Study|Relocated|0|||
129771958|NCT00935584|467132337|FG000|Overall Study|Patient changed provider|3|||
129771959|NCT00935584|467132338|FG001|Overall Study|Patient changed provider|0|||
129771960|NCT00935584|467132337|FG000|Overall Study|Provider dropped out of study|14|||
129771961|NCT00935584|467132338|FG001|Overall Study|Provider dropped out of study|4|||
129771962|NCT00687193|467132339|FG000|Overall Study|Adverse Event|0|||
129771963|NCT00687193|467132340|FG001|Overall Study|Adverse Event|1|||
129771964|NCT00687193|467132341|FG002|Overall Study|Adverse Event|2|||
129771965|NCT00687193|467132342|FG003|Overall Study|Adverse Event|3|||
129771966|NCT00687193|467132343|FG004|Overall Study|Adverse Event|0|||
129771967|NCT00687193|467132344|FG005|Overall Study|Adverse Event|2|||
129771968|NCT00687193|467132339|FG000|Overall Study|Lack of Efficacy|1|||
129771969|NCT00687193|467132340|FG001|Overall Study|Lack of Efficacy|1|||
129771970|NCT00687193|467132341|FG002|Overall Study|Lack of Efficacy|0|||
129771971|NCT00687193|467132342|FG003|Overall Study|Lack of Efficacy|0|||
129771972|NCT00687193|467132343|FG004|Overall Study|Lack of Efficacy|0|||
129771973|NCT00687193|467132344|FG005|Overall Study|Lack of Efficacy|2|||
129771974|NCT00687193|467132339|FG000|Overall Study|Protocol Violation|1|||
129771975|NCT00687193|467132340|FG001|Overall Study|Protocol Violation|2|||
129771976|NCT00687193|467132341|FG002|Overall Study|Protocol Violation|0|||
129771977|NCT00687193|467132342|FG003|Overall Study|Protocol Violation|1|||
129771978|NCT00687193|467132343|FG004|Overall Study|Protocol Violation|2|||
129771979|NCT00687193|467132344|FG005|Overall Study|Protocol Violation|0|||
129771980|NCT04986904|467132345|FG000|Overall Study|Lost to Follow-up|11|||
129771981|NCT04986904|467132345|FG000|Overall Study|Withdrawal by Subject|1|||
129771982|NCT03435211|467132346|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
129771983|NCT03863080|467132347|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
129771984|NCT03863080|467132348|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
129771985|NCT03863080|467132349|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
129771986|NCT03863080|467132350|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
129771987|NCT03863080|467132347|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
129771988|NCT03863080|467132348|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
129771989|NCT03863080|467132349|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
129771990|NCT03863080|467132350|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
129771991|NCT03863080|467132347|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
129771992|NCT03863080|467132348|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
129771993|NCT03863080|467132349|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
129548394|NCT04071366|466302675|FG000|Part 1: Open-label (29 Days)|Death|4|||
129548395|NCT04071366|466302676|FG001|Part 1: Open-label (29 Days)|Death|2|||
129548396|NCT04071366|466302677|FG002|Part 1: Open-label (29 Days)|Death|8|||
129548397|NCT04071366|466302678|FG003|Part 1: Open-label (29 Days)|Death|0|||
129548398|NCT04071366|466302679|FG004|Part 1: Open-label (29 Days)|Death|0|||
129548399|NCT04071366|466302675|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
129548400|NCT04071366|466302676|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
129548401|NCT04071366|466302677|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
129548402|NCT04071366|466302678|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
129548403|NCT04071366|466302679|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
129548404|NCT04071366|466302675|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
129548405|NCT04071366|466302676|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
129548406|NCT04071366|466302677|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
129548407|NCT04071366|466302678|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
129548408|NCT04071366|466302679|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
129548409|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Death|0|||
129548410|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Death|0|||
129548411|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Death|0|||
129548412|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Death|2|||
129548413|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Death|2|||
129548414|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
129548415|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
129548416|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
129548417|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
129548418|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
129548419|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
129548420|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
129548421|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
129548422|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
129548423|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
129548424|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
129548425|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
129548426|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
129548427|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
129548428|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
129548429|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
129548430|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
129548431|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
129548432|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
129548433|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
129548434|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
129548435|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
129548436|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
129548437|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
129682796|NCT04556097|466796983|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
129682797|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
129548438|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
129548439|NCT04071366|466302675|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
129548440|NCT04071366|466302676|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
129548441|NCT04071366|466302677|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
129548442|NCT04071366|466302678|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
129548443|NCT04071366|466302679|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
129548444|NCT00021229|466302680|FG000|Overall Study|Adverse Event|10|||
129548445|NCT00021229|466302681|FG001|Overall Study|Adverse Event|5|||
129548446|NCT00021229|466302682|FG002|Overall Study|Adverse Event|2|||
129548447|NCT00021229|466302680|FG000|Overall Study|Death|0|||
129548448|NCT00021229|466302681|FG001|Overall Study|Death|1|||
129548449|NCT00021229|466302682|FG002|Overall Study|Death|0|||
129548450|NCT00021229|466302680|FG000|Overall Study|Withdrawal by Subject|7|||
129548451|NCT00021229|466302681|FG001|Overall Study|Withdrawal by Subject|7|||
129548452|NCT00021229|466302682|FG002|Overall Study|Withdrawal by Subject|1|||
129548453|NCT00021229|466302680|FG000|Overall Study|Progressive Disease|15|||
129548454|NCT00021229|466302681|FG001|Overall Study|Progressive Disease|19|||
129548455|NCT00021229|466302682|FG002|Overall Study|Progressive Disease|12|||
129548456|NCT00021229|466302680|FG000|Overall Study|Protocol Violation|1|||
129548457|NCT00021229|466302681|FG001|Overall Study|Protocol Violation|1|||
129548458|NCT00021229|466302682|FG002|Overall Study|Protocol Violation|0|||
129548459|NCT00021229|466302680|FG000|Overall Study|Physician Decision|0|||
129548460|NCT00021229|466302681|FG001|Overall Study|Physician Decision|0|||
129548461|NCT00021229|466302682|FG002|Overall Study|Physician Decision|1|||
129548462|NCT00021229|466302680|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
129548463|NCT00021229|466302681|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
129548464|NCT00021229|466302682|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
129548465|NCT00953927|466302683|FG000|Overall Study|Lost to Follow-up|61|||
129548466|NCT00953927|466302684|FG001|Overall Study|Lost to Follow-up|65|||
129548467|NCT00953927|466302683|FG000|Overall Study|Withdrawal by Subject|36|||
129548468|NCT00953927|466302684|FG001|Overall Study|Withdrawal by Subject|25|||
129548469|NCT00953927|466302683|FG000|Overall Study|Death|7|||
129548470|NCT00953927|466302684|FG001|Overall Study|Death|4|||
129548471|NCT00953927|466302683|FG000|Overall Study|Other study discontinuation|1|||
129548472|NCT00953927|466302684|FG001|Overall Study|Other study discontinuation|1|||
129548473|NCT03284424|466302686|FG000|Overall Study|Death|70|||
129548474|NCT03284424|466302687|FG001|Overall Study|Death|24|||
129548475|NCT03284424|466302686|FG000|Overall Study|Lost to Follow-up|3|||
129548476|NCT03284424|466302687|FG001|Overall Study|Lost to Follow-up|1|||
129548477|NCT03284424|466302686|FG000|Overall Study|Physician Decision|1|||
129548478|NCT03284424|466302687|FG001|Overall Study|Physician Decision|2|||
129548479|NCT03284424|466302686|FG000|Overall Study|Withdrawal by Subject|4|||
129548480|NCT03284424|466302687|FG001|Overall Study|Withdrawal by Subject|5|||
129548481|NCT03284424|466302686|FG000|Overall Study|Sponsor's decision|27|||
129548482|NCT03284424|466302687|FG001|Overall Study|Sponsor's decision|22|||
129548483|NCT01268683|466302692|FG000|Overall Study|Lost to Follow-up|1|||
129548484|NCT01268683|466302692|FG000|Overall Study|Death|1|||
129548485|NCT02216214|466302693|FG000|Overall Study|Randomized Never Received Study Drug|1|||
129548486|NCT02216214|466302694|FG001|Overall Study|Randomized Never Received Study Drug|0|||
129548487|NCT02216214|466302693|FG000|Overall Study|Adverse Event|10|||
129548488|NCT02216214|466302694|FG001|Overall Study|Adverse Event|8|||
129548489|NCT02216214|466302693|FG000|Overall Study|Lack of Efficacy|2|||
129548490|NCT02216214|466302694|FG001|Overall Study|Lack of Efficacy|2|||
129548491|NCT02216214|466302693|FG000|Overall Study|Lost to Follow-up|3|||
129682798|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
129682799|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
129682800|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
129682801|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
129682802|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
129682803|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129682804|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129682805|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
129682806|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
129682807|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
129682808|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
129682809|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
129682810|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
129682811|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
129682812|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
129682813|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129682814|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
129682815|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129682816|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
129682817|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
129682818|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
129682819|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
129682820|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
129682821|NCT00620542|466799042|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
129682822|NCT00620542|466799043|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
129682823|NCT00620542|466799044|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
129682824|NCT00620542|466799045|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
129548492|NCT02216214|466302694|FG001|Overall Study|Lost to Follow-up|2|||
129548493|NCT02216214|466302693|FG000|Overall Study|Protocol Violation|4|||
129548494|NCT02216214|466302694|FG001|Overall Study|Protocol Violation|2|||
129548495|NCT02216214|466302693|FG000|Overall Study|Withdrawal by Subject|22|||
129548496|NCT02216214|466302694|FG001|Overall Study|Withdrawal by Subject|20|||
129548497|NCT02216214|466302693|FG000|Overall Study|Study Terminated By Sponsor|0|||
129548498|NCT02216214|466302694|FG001|Overall Study|Study Terminated By Sponsor|1|||
129548499|NCT02216214|466302693|FG000|Overall Study|Miscellaneous|1|||
129548500|NCT02216214|466302694|FG001|Overall Study|Miscellaneous|1|||
129548501|NCT00713830|466302695|FG000|Overall Study|Adverse Event|23|||
129548502|NCT00713830|466302696|FG001|Overall Study|Adverse Event|71|||
129682825|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
129682826|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
129682827|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
129682828|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
129682829|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
129682830|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
129682831|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
129682832|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
129682833|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
129682834|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
129682835|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
129682836|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
129682837|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
129682838|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
129682839|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
129682840|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
129682841|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
129682842|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
129682843|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
129682844|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
129682845|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
129682846|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
129682847|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
129682848|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
129682849|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
129682850|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
129682851|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
129682852|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
129682853|NCT00620542|466799042|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
129682854|NCT00620542|466799043|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
129682855|NCT00620542|466799044|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
129682856|NCT00620542|466799045|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
129682857|NCT01970371|466799046|FG000|Overall Study|Death|8|||
129682858|NCT01970371|466799047|FG001|Overall Study|Death|13|||
129682859|NCT01970371|466799048|FG002|Overall Study|Death|12|||
129682860|NCT01970371|466799046|FG000|Overall Study|Lost to Follow-up|0|||
129682861|NCT01970371|466799047|FG001|Overall Study|Lost to Follow-up|0|||
129682862|NCT01970371|466799048|FG002|Overall Study|Lost to Follow-up|1|||
129682863|NCT01348269|466799049|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
129682864|NCT01348269|466799050|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
129682865|NCT01348269|466799049|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
129682866|NCT01348269|466799050|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
129682867|NCT01348269|466799049|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
129682868|NCT01348269|466799050|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
129682869|NCT04727749|466799051|FG000|Overall Study|Lost to Follow-up|10|||
129682870|NCT04727749|466799052|FG001|Overall Study|Lost to Follow-up|3|||
129682871|NCT03575364|466799056|FG000|Overall Study|Death|45|||
129682872|NCT03575364|466799056|FG000|Overall Study|Lost to Follow-up|114|||
129682873|NCT03575364|466799056|FG000|Overall Study|Withdrawal by Subject|21|||
129682874|NCT03575364|466799056|FG000|Overall Study|Physician Decision|11|||
129682875|NCT03575364|466799056|FG000|Overall Study|Subject Refused Follow-up|13|||
129682876|NCT03575364|466799056|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
129682877|NCT03575364|466799056|FG000|Overall Study|Patient moved out of the state|1|||
129548503|NCT00713830|466302695|FG000|Overall Study|Lack of Efficacy|24|||
129548504|NCT00713830|466302696|FG001|Overall Study|Lack of Efficacy|16|||
129548505|NCT00713830|466302695|FG000|Overall Study|Lost to Follow-up|2|||
129548506|NCT00713830|466302696|FG001|Overall Study|Lost to Follow-up|9|||
129548507|NCT00713830|466302695|FG000|Overall Study|Withdrawal by Subject|13|||
129548508|NCT00713830|466302696|FG001|Overall Study|Withdrawal by Subject|23|||
129682878|NCT03575364|466799056|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
129682879|NCT03575364|466799056|FG000|Overall Study|Patient is lost to follow up|1|||
129682880|NCT03575364|466799056|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
129682881|NCT02313155|466799057|FG000|Overall Study|Lost to Follow-up|0|||
129682882|NCT02313155|466799058|FG001|Overall Study|Lost to Follow-up|1|||
129682883|NCT02213926|466799059|FG000|Overall Study|Death|59|||
129682884|NCT02213926|466799059|FG000|Overall Study|Withdrawal by Subject|10|||
129682885|NCT02213926|466799059|FG000|Overall Study|study terminated by sponsor|51|||
129682886|NCT02213926|466799059|FG000|Overall Study|Lost to Follow-up|3|||
129682887|NCT02213926|466799059|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
129682888|NCT01697579|466799060|FG000|Base Study-Cycle 1|Adverse Event|1|||
129682889|NCT01697579|466799061|FG001|Base Study-Cycle 1|Adverse Event|0|||
129682890|NCT01697579|466799062|FG002|Base Study-Cycle 1|Adverse Event|0|||
129682891|NCT01697579|466799063|FG003|Base Study-Cycle 1|Adverse Event|0|||
129682892|NCT01697579|466799064|FG004|Base Study-Cycle 1|Adverse Event|0|||
129682893|NCT01697579|466799065|FG005|Base Study-Cycle 1|Adverse Event|0|||
129682894|NCT01697579|466799066|FG006|Base Study-Cycle 1|Adverse Event|0|||
129682895|NCT01697579|466799060|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
129682896|NCT01697579|466799061|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129682897|NCT01697579|466799062|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129682898|NCT01697579|466799063|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129682899|NCT01697579|466799064|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129682900|NCT01697579|466799065|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129682901|NCT01697579|466799066|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
129682902|NCT01697579|466799060|FG000|Base Study-Cycle 1|Protocol Violation|0|||
129682903|NCT01697579|466799061|FG001|Base Study-Cycle 1|Protocol Violation|0|||
129682904|NCT01697579|466799062|FG002|Base Study-Cycle 1|Protocol Violation|0|||
129682905|NCT01697579|466799063|FG003|Base Study-Cycle 1|Protocol Violation|0|||
129682906|NCT01697579|466799064|FG004|Base Study-Cycle 1|Protocol Violation|3|||
129682907|NCT01697579|466799065|FG005|Base Study-Cycle 1|Protocol Violation|0|||
129682908|NCT01697579|466799066|FG006|Base Study-Cycle 1|Protocol Violation|0|||
129682909|NCT01697579|466799060|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129682910|NCT01697579|466799061|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
129682911|NCT01697579|466799062|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129682912|NCT01697579|466799063|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129682913|NCT01697579|466799064|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129682914|NCT01697579|466799065|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129682915|NCT01697579|466799066|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
129682916|NCT01697579|466799060|FG000|Base Study-Cycle 1|Technical Problems|0|||
129682917|NCT01697579|466799061|FG001|Base Study-Cycle 1|Technical Problems|0|||
129682918|NCT01697579|466799062|FG002|Base Study-Cycle 1|Technical Problems|1|||
129682919|NCT01697579|466799063|FG003|Base Study-Cycle 1|Technical Problems|1|||
129682920|NCT01697579|466799064|FG004|Base Study-Cycle 1|Technical Problems|0|||
129682921|NCT01697579|466799065|FG005|Base Study-Cycle 1|Technical Problems|0|||
129682922|NCT01697579|466799066|FG006|Base Study-Cycle 1|Technical Problems|0|||
129682923|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Death|0|||
129682924|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Death|0|||
129682925|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Death|0|||
129682926|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Death|0|||
129682927|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Death|0|||
129682928|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Death|0|||
129682929|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Death|2|||
129682930|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129682931|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129682932|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129682933|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129682934|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129682935|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
129682936|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
129682937|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
129682938|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
129682939|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
129682940|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
129682941|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
129682942|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
129548509|NCT00713830|466302695|FG000|Overall Study|Poor Compliance to Protocol|7|||
129548510|NCT00713830|466302696|FG001|Overall Study|Poor Compliance to Protocol|14|||
129548511|NCT00713830|466302695|FG000|Overall Study|Familial and Personal Reasons|9|||
129548512|NCT00713830|466302696|FG001|Overall Study|Familial and Personal Reasons|34|||
129548513|NCT00713830|466302695|FG000|Overall Study|Sponsor Decision|4|||
129548514|NCT00713830|466302696|FG001|Overall Study|Sponsor Decision|10|||
129548515|NCT03981614|466302699|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
129548516|NCT03981614|466302700|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
129548517|NCT03981614|466302701|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
129548518|NCT00499252|466302702|FG000|Overall Study|Adverse Event|3|||
129548519|NCT00499252|466302702|FG000|Overall Study|Refused further treatment|2|||
129548520|NCT00499252|466302702|FG000|Overall Study|Ineligible|4|||
129548521|NCT00499252|466302702|FG000|Overall Study|<no further label>|3|||
129548522|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
129548523|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
129548524|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
129548525|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
129548526|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
129548527|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
129548528|NCT00566631|466302703|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
129548529|NCT00566631|466302703|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
129548530|NCT00566631|466302703|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
129548531|NCT00566631|466302703|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
129548532|NCT00566631|466302703|FG000|Part 2: Extension Phase|Adverse Event|11|||
129548533|NCT00566631|466302703|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
129548534|NCT00566631|466302703|FG000|Part 2: Extension Phase|Death|1|||
129548535|NCT00566631|466302703|FG000|Part 2: Extension Phase|Other|5|||
129548536|NCT03387735|466302704|FG000|Overall Study|Lost to Follow-up|4|||
129548537|NCT03387735|466302705|FG001|Overall Study|Lost to Follow-up|8|||
129548538|NCT03387735|466302704|FG000|Overall Study|Death|4|||
129548539|NCT03387735|466302705|FG001|Overall Study|Death|8|||
129548540|NCT00537056|466302706|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
129548541|NCT03020966|466302710|FG000|Overall Study|Withdrawal by Subject|2|||
129548542|NCT03020966|466302711|FG001|Overall Study|Withdrawal by Subject|0|||
129548543|NCT02628418|466302715|FG000|Overall Study|Lost to Follow-up|1|||
129548544|NCT02628418|466302716|FG001|Overall Study|Lost to Follow-up|2|||
129548545|NCT01215955|466302717|FG000|Overall Study|Adverse Event|1|||
129682943|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
129682944|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129682945|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129682946|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129682947|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129682948|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129682949|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
129682950|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
129548546|NCT01215955|466302718|FG001|Overall Study|Adverse Event|4|||
129548547|NCT01215955|466302719|FG002|Overall Study|Adverse Event|2|||
129548548|NCT01215955|466302720|FG003|Overall Study|Adverse Event|3|||
129771994|NCT03863080|467132350|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
129771995|NCT01342211|467132351|FG000|Overall Study|Lost to Follow-up|0|||
129771996|NCT01342211|467132352|FG001|Overall Study|Lost to Follow-up|0|||
129771997|NCT01342211|467132353|FG002|Overall Study|Lost to Follow-up|0|||
129771998|NCT01342211|467132354|FG003|Overall Study|Lost to Follow-up|1|||
129771999|NCT01342211|467132355|FG004|Overall Study|Lost to Follow-up|0|||
129772000|NCT01342211|467132351|FG000|Overall Study|Adverse Event|0|||
129772001|NCT01342211|467132352|FG001|Overall Study|Adverse Event|0|||
129772002|NCT01342211|467132353|FG002|Overall Study|Adverse Event|0|||
129772003|NCT01342211|467132354|FG003|Overall Study|Adverse Event|0|||
129772004|NCT01342211|467132355|FG004|Overall Study|Adverse Event|1|||
129772005|NCT01342211|467132351|FG000|Overall Study|Withdrawal by Subject|0|||
129772006|NCT01342211|467132352|FG001|Overall Study|Withdrawal by Subject|0|||
129772007|NCT01342211|467132353|FG002|Overall Study|Withdrawal by Subject|0|||
129772008|NCT01342211|467132354|FG003|Overall Study|Withdrawal by Subject|1|||
129772009|NCT01342211|467132355|FG004|Overall Study|Withdrawal by Subject|0|||
129772010|NCT01342211|467132351|FG000|Overall Study|Randomized, but not Treated|0|||
129772011|NCT01342211|467132352|FG001|Overall Study|Randomized, but not Treated|2|||
129772012|NCT01342211|467132353|FG002|Overall Study|Randomized, but not Treated|0|||
129772013|NCT01342211|467132354|FG003|Overall Study|Randomized, but not Treated|0|||
129772014|NCT01342211|467132355|FG004|Overall Study|Randomized, but not Treated|1|||
129772015|NCT01648751|467132373|FG000|Overall Study|Withdrawal by Subject|2|||
129772016|NCT01648751|467132374|FG001|Overall Study|Withdrawal by Subject|3|||
129772017|NCT05673876|467132377|FG000|Overall Study|Death|3|||
129548549|NCT01215955|466302717|FG000|Overall Study|Death|2|||
129548550|NCT01215955|466302718|FG001|Overall Study|Death|0|||
129548551|NCT01215955|466302719|FG002|Overall Study|Death|1|||
129548552|NCT01215955|466302720|FG003|Overall Study|Death|3|||
129548553|NCT01215955|466302717|FG000|Overall Study|Entry Criteria Not Met|1|||
129548554|NCT01215955|466302718|FG001|Overall Study|Entry Criteria Not Met|3|||
129548555|NCT01215955|466302719|FG002|Overall Study|Entry Criteria Not Met|4|||
129548556|NCT01215955|466302720|FG003|Overall Study|Entry Criteria Not Met|7|||
129548557|NCT01215955|466302717|FG000|Overall Study|Lack of Efficacy|1|||
129548558|NCT01215955|466302718|FG001|Overall Study|Lack of Efficacy|2|||
129548559|NCT01215955|466302719|FG002|Overall Study|Lack of Efficacy|1|||
129548560|NCT01215955|466302720|FG003|Overall Study|Lack of Efficacy|0|||
129548561|NCT01215955|466302717|FG000|Overall Study|Lost to Follow-up|4|||
129548562|NCT01215955|466302718|FG001|Overall Study|Lost to Follow-up|4|||
129548563|NCT01215955|466302719|FG002|Overall Study|Lost to Follow-up|8|||
129548564|NCT01215955|466302720|FG003|Overall Study|Lost to Follow-up|9|||
129548565|NCT01215955|466302717|FG000|Overall Study|Physician Decision|4|||
129548566|NCT01215955|466302718|FG001|Overall Study|Physician Decision|10|||
129548567|NCT01215955|466302719|FG002|Overall Study|Physician Decision|8|||
129548568|NCT01215955|466302720|FG003|Overall Study|Physician Decision|11|||
129548569|NCT01215955|466302717|FG000|Overall Study|Protocol Violation|17|||
129548570|NCT01215955|466302718|FG001|Overall Study|Protocol Violation|13|||
129548571|NCT01215955|466302719|FG002|Overall Study|Protocol Violation|8|||
129548572|NCT01215955|466302720|FG003|Overall Study|Protocol Violation|8|||
129548573|NCT01215955|466302717|FG000|Overall Study|Sponsor Decision|1|||
129548574|NCT01215955|466302718|FG001|Overall Study|Sponsor Decision|2|||
129548575|NCT01215955|466302719|FG002|Overall Study|Sponsor Decision|0|||
129548576|NCT01215955|466302720|FG003|Overall Study|Sponsor Decision|1|||
129548577|NCT01215955|466302717|FG000|Overall Study|Withdrawal by Subject|14|||
129548578|NCT01215955|466302718|FG001|Overall Study|Withdrawal by Subject|15|||
129548579|NCT01215955|466302719|FG002|Overall Study|Withdrawal by Subject|13|||
129548580|NCT01215955|466302720|FG003|Overall Study|Withdrawal by Subject|9|||
129548581|NCT01215955|466302717|FG000|Overall Study|Quality Issues|0|||
129548582|NCT01215955|466302718|FG001|Overall Study|Quality Issues|0|||
129548583|NCT01215955|466302719|FG002|Overall Study|Quality Issues|3|||
129548584|NCT01215955|466302720|FG003|Overall Study|Quality Issues|2|||
129548585|NCT01523301|466302721|FG000|Overall Study|Adverse Event|25|||
129548586|NCT01523301|466302722|FG001|Overall Study|Adverse Event|16|||
129548587|NCT01523301|466302721|FG000|Overall Study|Lack of Efficacy|0|||
129548588|NCT01523301|466302722|FG001|Overall Study|Lack of Efficacy|2|||
129548589|NCT01523301|466302721|FG000|Overall Study|Protocol Violation|3|||
129548590|NCT01523301|466302722|FG001|Overall Study|Protocol Violation|4|||
129548591|NCT01523301|466302721|FG000|Overall Study|Lost to Follow-up|1|||
129548592|NCT01523301|466302722|FG001|Overall Study|Lost to Follow-up|0|||
129548593|NCT01523301|466302721|FG000|Overall Study|Withdrawal by Subject|6|||
129548594|NCT01523301|466302722|FG001|Overall Study|Withdrawal by Subject|8|||
129548595|NCT01523301|466302721|FG000|Overall Study|Other Reason|0|||
129548596|NCT01523301|466302722|FG001|Overall Study|Other Reason|2|||
129548597|NCT01447628|466302723|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
129548598|NCT01447628|466302724|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
129548599|NCT01447628|466302725|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
129548600|NCT01447628|466302726|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
129548601|NCT00185731|466302727|FG000|Overall Study|Withdrawal by Subject|1|||
129548602|NCT00185731|466302727|FG000|Overall Study|Not Eligible|1|||
129548603|NCT03087773|466302728|FG000|Overall Study|Withdrawal by Subject|8|||
129548604|NCT03087773|466302729|FG001|Overall Study|Withdrawal by Subject|4|||
129548605|NCT03087773|466302728|FG000|Overall Study|Lost to Follow-up|12|||
129772018|NCT05673876|467132378|FG001|Overall Study|Death|1|||
129772019|NCT05673876|467132377|FG000|Overall Study|Study Terminated by Sponsor|0|||
129548606|NCT03087773|466302729|FG001|Overall Study|Lost to Follow-up|8|||
129548607|NCT01787188|466302736|FG000|Overall Study|Adverse Event|2|||
129548608|NCT01787188|466302737|FG001|Overall Study|Adverse Event|4|||
129772020|NCT05673876|467132378|FG001|Overall Study|Study Terminated by Sponsor|1|||
129548609|NCT01787188|466302738|FG002|Overall Study|Adverse Event|6|||
129548610|NCT01787188|466302736|FG000|Overall Study|Lack of Efficacy|7|||
129548611|NCT01787188|466302737|FG001|Overall Study|Lack of Efficacy|3|||
129548612|NCT01787188|466302738|FG002|Overall Study|Lack of Efficacy|5|||
129548613|NCT01787188|466302736|FG000|Overall Study|Non-compliance with Study Drug|0|||
129548614|NCT01787188|466302737|FG001|Overall Study|Non-compliance with Study Drug|1|||
129548615|NCT01787188|466302738|FG002|Overall Study|Non-compliance with Study Drug|0|||
129548616|NCT01787188|466302736|FG000|Overall Study|Withdrawal by Subject|4|||
129548617|NCT01787188|466302737|FG001|Overall Study|Withdrawal by Subject|3|||
129548618|NCT01787188|466302738|FG002|Overall Study|Withdrawal by Subject|2|||
129548619|NCT01787188|466302736|FG000|Overall Study|Protocol Violation|3|||
129548620|NCT01787188|466302737|FG001|Overall Study|Protocol Violation|2|||
129548621|NCT01787188|466302738|FG002|Overall Study|Protocol Violation|3|||
129548622|NCT01787188|466302736|FG000|Overall Study|Lost to Follow-up|1|||
129772021|NCT05673876|467132377|FG000|Overall Study|Physician Decision|0|||
129772022|NCT05673876|467132378|FG001|Overall Study|Physician Decision|1|||
129548623|NCT01787188|466302737|FG001|Overall Study|Lost to Follow-up|2|||
129548624|NCT01787188|466302738|FG002|Overall Study|Lost to Follow-up|2|||
129548625|NCT01787188|466302736|FG000|Overall Study|Other, including patient moved|0|||
129548626|NCT01787188|466302737|FG001|Overall Study|Other, including patient moved|3|||
129548627|NCT01787188|466302738|FG002|Overall Study|Other, including patient moved|0|||
129548628|NCT05349188|466302741|FG000|Overall Study|Withdrawal by Subject|1|||
129548629|NCT05349188|466302742|FG001|Overall Study|Withdrawal by Subject|0|||
129548630|NCT02756078|466302743|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
129548631|NCT02756078|466302744|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
129548632|NCT02756078|466302743|FG000|Period 1|Lost to Follow-up|0|||
129548633|NCT02756078|466302744|FG001|Period 1|Lost to Follow-up|2|||
129548634|NCT02756078|466302743|FG000|Period 1|Protocol Violation|0|||
129548635|NCT02756078|466302744|FG001|Period 1|Protocol Violation|1|||
129548636|NCT02756078|466302743|FG000|Period 1|Adverse Event|1|||
129548637|NCT02756078|466302744|FG001|Period 1|Adverse Event|10|||
129548638|NCT02756078|466302743|FG000|Period 1|Withdrawal by Subject|6|||
129548639|NCT02756078|466302744|FG001|Period 1|Withdrawal by Subject|6|||
129548640|NCT02756078|466302743|FG000|Period 1|Lens Discomfort|2|||
129548641|NCT02756078|466302744|FG001|Period 1|Lens Discomfort|2|||
129548642|NCT02756078|466302743|FG000|Period 2|Adverse Event|3|||
129548643|NCT02756078|466302744|FG001|Period 2|Adverse Event|5|||
129548644|NCT02756078|466302743|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
129548645|NCT02756078|466302744|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
129548646|NCT02756078|466302743|FG000|Period 2|Withdrawal by Subject|3|||
129548647|NCT02756078|466302744|FG001|Period 2|Withdrawal by Subject|1|||
129548648|NCT00943384|466302745|FG000|Overall Study|Dispositioned prior to treatment|23|||
129548649|NCT00943384|466302745|FG000|Overall Study|Treated off protocol-protocol violation|5|||
129548650|NCT00943384|466302745|FG000|Overall Study|Lost to Follow-up|16|||
129548651|NCT00943384|466302745|FG000|Overall Study|Withdrawal by Subject|5|||
129548652|NCT01216319|466302746|FG000|Overall Study|Lost to Follow-up|2|||
129548653|NCT01216319|466302746|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
129548654|NCT00929864|466302747|FG000|Overall Study|Death|1|||
129548655|NCT00929864|466302748|FG001|Overall Study|Death|1|||
129548656|NCT00929864|466302747|FG000|Overall Study|Adverse Event|11|||
129548657|NCT00929864|466302748|FG001|Overall Study|Adverse Event|30|||
129548658|NCT00929864|466302747|FG000|Overall Study|Lack of Efficacy|19|||
129548659|NCT00929864|466302748|FG001|Overall Study|Lack of Efficacy|16|||
129548660|NCT00929864|466302747|FG000|Overall Study|Lost to Follow-up|7|||
129548661|NCT00929864|466302748|FG001|Overall Study|Lost to Follow-up|12|||
129548662|NCT00929864|466302747|FG000|Overall Study|Withdrawal by Subject|20|||
129548663|NCT00929864|466302748|FG001|Overall Study|Withdrawal by Subject|9|||
129548664|NCT00929864|466302747|FG000|Overall Study|No longer met criteria|2|||
129548665|NCT00929864|466302748|FG001|Overall Study|No longer met criteria|1|||
129548666|NCT00929864|466302747|FG000|Overall Study|Poor or non-compliance|3|||
129548667|NCT00929864|466302748|FG001|Overall Study|Poor or non-compliance|3|||
129548668|NCT00929864|466302747|FG000|Overall Study|Pregnancy|0|||
129548669|NCT00929864|466302748|FG001|Overall Study|Pregnancy|3|||
129548670|NCT00929864|466302747|FG000|Overall Study|Administrative reason by Sponsor|1|||
129548671|NCT00929864|466302748|FG001|Overall Study|Administrative reason by Sponsor|1|||
129548672|NCT00929864|466302747|FG000|Overall Study|Non-specified|2|||
129548673|NCT00929864|466302748|FG001|Overall Study|Non-specified|7|||
129548674|NCT03454672|466302751|FG000|Overall Study|Adverse Event|1|||
129548675|NCT03454672|466302752|FG001|Overall Study|Adverse Event|1|||
129548676|NCT03454672|466302751|FG000|Overall Study|Lost to Follow-up|1|||
129548677|NCT03454672|466302752|FG001|Overall Study|Lost to Follow-up|3|||
129772023|NCT03205423|467132381|FG000|Overall Study|Personal|1|||
129772024|NCT03205423|467132382|FG001|Overall Study|Personal|1|||
129772025|NCT03205423|467132381|FG000|Overall Study|Physician Decision|0|||
129772026|NCT03205423|467132382|FG001|Overall Study|Physician Decision|2|||
129772027|NCT02749422|467132385|FG000|Overall Study|Lost to Follow-up|0|||
129772028|NCT02749422|467132386|FG001|Overall Study|Lost to Follow-up|2|||
129548678|NCT03454672|466302751|FG000|Overall Study|painful|1|||
129548679|NCT03454672|466302752|FG001|Overall Study|painful|2|||
129548680|NCT03454672|466302751|FG000|Overall Study|Non-compliance|2|||
129548681|NCT03454672|466302752|FG001|Overall Study|Non-compliance|4|||
129548682|NCT03454672|466302751|FG000|Overall Study|personal reasons|3|||
129548683|NCT03454672|466302752|FG001|Overall Study|personal reasons|2|||
129548684|NCT03454672|466302751|FG000|Overall Study|Withdrawal by Subject|1|||
129548685|NCT03454672|466302752|FG001|Overall Study|Withdrawal by Subject|0|||
129548686|NCT05473247|466302753|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
129548687|NCT02392559|466302754|FG000|Overall Study|Withdrawal by Subject|0|||
129548688|NCT02392559|466302755|FG001|Overall Study|Withdrawal by Subject|1|||
129548689|NCT00402779|466302756|FG000|Overall Study|Screen Failure|77|||
129548690|NCT00402779|466302757|FG001|Overall Study|Screen Failure|76|||
129548691|NCT02149199|466302759|FG000|Overall Study|Study specific withdrawal criteria|4|||
129548692|NCT02149199|466302760|FG001|Overall Study|Study specific withdrawal criteria|21|||
129772029|NCT02749422|467132385|FG000|Overall Study|Ineligible|0|||
129772030|NCT02749422|467132386|FG001|Overall Study|Ineligible|1|||
129548693|NCT02149199|466302761|FG002|Overall Study|Study specific withdrawal criteria|6|||
129548694|NCT02149199|466302759|FG000|Overall Study|Other|20|||
129548695|NCT02149199|466302760|FG001|Overall Study|Other|25|||
129548696|NCT02149199|466302761|FG002|Overall Study|Other|20|||
129548697|NCT02149199|466302759|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
129548698|NCT02149199|466302760|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
129548699|NCT02149199|466302761|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
129548700|NCT02149199|466302759|FG000|Overall Study|Withdrawal by Subject|75|||
129548701|NCT02149199|466302760|FG001|Overall Study|Withdrawal by Subject|93|||
129548702|NCT02149199|466302761|FG002|Overall Study|Withdrawal by Subject|77|||
129548703|NCT02149199|466302759|FG000|Overall Study|Protocol Violation|16|||
129548704|NCT02149199|466302760|FG001|Overall Study|Protocol Violation|13|||
129548705|NCT02149199|466302761|FG002|Overall Study|Protocol Violation|15|||
129548706|NCT02149199|466302759|FG000|Overall Study|Lost to Follow-up|3|||
129548707|NCT02149199|466302760|FG001|Overall Study|Lost to Follow-up|12|||
129548708|NCT02149199|466302761|FG002|Overall Study|Lost to Follow-up|11|||
129548709|NCT02149199|466302759|FG000|Overall Study|Death|0|||
129548710|NCT02149199|466302760|FG001|Overall Study|Death|0|||
129548711|NCT02149199|466302761|FG002|Overall Study|Death|1|||
129548712|NCT02149199|466302759|FG000|Overall Study|Adverse Event|6|||
129548713|NCT02149199|466302760|FG001|Overall Study|Adverse Event|15|||
129548714|NCT02149199|466302761|FG002|Overall Study|Adverse Event|9|||
129548715|NCT03252756|466302762|FG000|Overall Study|Protocol Violation|2|||
129548716|NCT03252756|466302763|FG001|Overall Study|Protocol Violation|4|||
129548717|NCT03252756|466302762|FG000|Overall Study|COVID-19 Pandemic|1|||
129548718|NCT03252756|466302763|FG001|Overall Study|COVID-19 Pandemic|1|||
129548719|NCT03252756|466302762|FG000|Overall Study|Study Drug Expiration|0|||
129548720|NCT03252756|466302763|FG001|Overall Study|Study Drug Expiration|1|||
129548721|NCT01500434|466302766|FG000|Overall Study|Death|1|||
129548722|NCT01500434|466302766|FG000|Overall Study|Withdrawal by Subject|1|||
129548723|NCT01500434|466302766|FG000|Overall Study|Missed 12-month follow-up|5|||
129548724|NCT01966107|466302770|FG000|Overall Study|excluded from FAS|21|||
129548725|NCT01966107|466302771|FG001|Overall Study|excluded from FAS|20|||
129548726|NCT01966107|466302770|FG000|Overall Study|discontinued treatment|345|||
129548727|NCT01966107|466302771|FG001|Overall Study|discontinued treatment|372|||
129548728|NCT01966107|466302770|FG000|Overall Study|due to study closure|164|||
129548729|NCT01966107|466302771|FG001|Overall Study|due to study closure|186|||
129548730|NCT01966107|466302770|FG000|Overall Study|withdrew from the study|272|||
129548731|NCT01966107|466302771|FG001|Overall Study|withdrew from the study|303|||
129548732|NCT00532779|466302772|FG000|Overall Study|Adverse Event|122|||
129548733|NCT00532779|466302773|FG001|Overall Study|Adverse Event|112|||
129548734|NCT00532779|466302774|FG002|Overall Study|Adverse Event|56|||
129548735|NCT00532779|466302772|FG000|Overall Study|Lost to Follow-up|76|||
129548736|NCT00532779|466302773|FG001|Overall Study|Lost to Follow-up|65|||
129548737|NCT00532779|466302774|FG002|Overall Study|Lost to Follow-up|66|||
129548738|NCT00532779|466302772|FG000|Overall Study|Withdrawal by Subject|63|||
129548739|NCT00532779|466302773|FG001|Overall Study|Withdrawal by Subject|60|||
129548740|NCT00532779|466302774|FG002|Overall Study|Withdrawal by Subject|90|||
129548741|NCT00532779|466302772|FG000|Overall Study|Lack of Efficacy|12|||
129548742|NCT00532779|466302773|FG001|Overall Study|Lack of Efficacy|12|||
129548743|NCT00532779|466302774|FG002|Overall Study|Lack of Efficacy|40|||
129548744|NCT00532779|466302772|FG000|Overall Study|Protocol Violation|5|||
129548745|NCT00532779|466302773|FG001|Overall Study|Protocol Violation|9|||
129548746|NCT00532779|466302774|FG002|Overall Study|Protocol Violation|7|||
129548747|NCT00532779|466302772|FG000|Overall Study|Pregnancy|2|||
129548748|NCT00532779|466302773|FG001|Overall Study|Pregnancy|5|||
129548749|NCT00532779|466302774|FG002|Overall Study|Pregnancy|3|||
129548750|NCT00532779|466302772|FG000|Overall Study|Death|0|||
129548751|NCT00532779|466302773|FG001|Overall Study|Death|1|||
129548752|NCT00532779|466302774|FG002|Overall Study|Death|0|||
129548753|NCT00532779|466302772|FG000|Overall Study|Drug noncompliance, moved, other|14|||
129548754|NCT00532779|466302773|FG001|Overall Study|Drug noncompliance, moved, other|23|||
129548755|NCT00532779|466302774|FG002|Overall Study|Drug noncompliance, moved, other|29|||
129548756|NCT02662556|466302775|FG000|Overall Study|Adverse Event|4|||
129548757|NCT02662556|466302775|FG000|Overall Study|Lack of Efficacy|4|||
129548758|NCT01556165|466302776|FG000|Overall Study|Adverse Event|5|||
129682951|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129682952|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129682953|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129682954|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129682955|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
129682956|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
129682957|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
129682958|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129548759|NCT01556165|466302777|FG001|Overall Study|Adverse Event|3|||
129548760|NCT01556165|466302776|FG000|Overall Study|Protocol Violation|0|||
129548761|NCT01556165|466302777|FG001|Overall Study|Protocol Violation|3|||
129548762|NCT01556165|466302776|FG000|Overall Study|Withdrawal of Consent|7|||
129548763|NCT01556165|466302777|FG001|Overall Study|Withdrawal of Consent|1|||
129548764|NCT00701558|466302778|FG000|Overall Study|Death|7|||
129548765|NCT00701558|466302778|FG000|Overall Study|Lost to Follow-up|8|||
129548766|NCT00131937|466302779|FG000|Overall Study|Adverse Event|3|||
129548767|NCT00131937|466302779|FG000|Overall Study|Withdrawal by Subject|2|||
129548768|NCT00131937|466302779|FG000|Overall Study|Physician Decision|1|||
129548769|NCT00131937|466302779|FG000|Overall Study|Disease Progression|7|||
129548770|NCT00131937|466302779|FG000|Overall Study|Alternative therapy|1|||
129548771|NCT01640964|466302780|FG000|Overall Study|Lost to Follow-up|0|||
129548772|NCT01640964|466302781|FG001|Overall Study|Lost to Follow-up|0|||
129548773|NCT01640964|466302782|FG002|Overall Study|Lost to Follow-up|1|||
129548774|NCT01640964|466302780|FG000|Overall Study|Protocol Deviation|1|||
129548775|NCT01640964|466302781|FG001|Overall Study|Protocol Deviation|1|||
129548776|NCT01640964|466302782|FG002|Overall Study|Protocol Deviation|2|||
129548777|NCT02787746|466302783|FG000|Overall Study|Adverse Event|42|||
129548778|NCT02787746|466302783|FG000|Overall Study|Withdrawal by Subject|65|||
129548779|NCT02787746|466302783|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
129548780|NCT00858234|466304042|FG000|Overall Study|Adverse Event|6|||
129548781|NCT00858234|466304042|FG000|Overall Study|Progressive disease|2|||
129548782|NCT00858234|466304042|FG000|Overall Study|Status unknown|1|||
129548783|NCT01678924|466304043|FG000|Overall Study|Adverse Event|1|||
129548784|NCT01678924|466304044|FG001|Overall Study|Adverse Event|1|||
129548785|NCT01678924|466304045|FG002|Overall Study|Adverse Event|0|||
129548786|NCT01678924|466304046|FG003|Overall Study|Adverse Event|1|||
129548787|NCT01678924|466304043|FG000|Overall Study|Lack of Efficacy|7|||
129548788|NCT01678924|466304044|FG001|Overall Study|Lack of Efficacy|2|||
129548789|NCT01678924|466304045|FG002|Overall Study|Lack of Efficacy|0|||
129548790|NCT01678924|466304046|FG003|Overall Study|Lack of Efficacy|5|||
129548791|NCT01678924|466304043|FG000|Overall Study|Lost to Follow-up|0|||
129548792|NCT01678924|466304044|FG001|Overall Study|Lost to Follow-up|4|||
129548793|NCT01678924|466304045|FG002|Overall Study|Lost to Follow-up|0|||
129548794|NCT01678924|466304046|FG003|Overall Study|Lost to Follow-up|2|||
129548795|NCT01678924|466304043|FG000|Overall Study|Personal Reasons|2|||
129548796|NCT01678924|466304044|FG001|Overall Study|Personal Reasons|2|||
129548797|NCT01678924|466304045|FG002|Overall Study|Personal Reasons|2|||
129548798|NCT01678924|466304046|FG003|Overall Study|Personal Reasons|7|||
129548799|NCT01678924|466304043|FG000|Overall Study|Withdrawal by Subject|0|||
129548800|NCT01678924|466304044|FG001|Overall Study|Withdrawal by Subject|3|||
129548801|NCT01678924|466304045|FG002|Overall Study|Withdrawal by Subject|0|||
129548802|NCT01678924|466304046|FG003|Overall Study|Withdrawal by Subject|2|||
129548803|NCT01678924|466304043|FG000|Overall Study|Unable to attend scheduled visits|0|||
129548804|NCT01678924|466304044|FG001|Overall Study|Unable to attend scheduled visits|0|||
129548805|NCT01678924|466304045|FG002|Overall Study|Unable to attend scheduled visits|0|||
129548806|NCT01678924|466304046|FG003|Overall Study|Unable to attend scheduled visits|1|||
129548807|NCT00640614|466304050|FG000|Overall Study|Lost to Follow-up|1|||
129548808|NCT00640614|466304051|FG001|Overall Study|Lost to Follow-up|0|||
129548809|NCT00529802|466304052|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
129548810|NCT00529802|466304052|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
129682959|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129682960|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129682961|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129682962|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129682963|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
129682964|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
129548811|NCT00529802|466304052|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
129548812|NCT00529802|466304052|FG000|Evaluable for Primary Endpoint|Death|1|||
129548813|NCT00529802|466304052|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
129548814|NCT00529802|466304052|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
129548815|NCT00529802|466304052|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
129548816|NCT02428231|466304058|FG000|Overall Study|Other|10|||
129548817|NCT02428231|466304059|FG001|Overall Study|Other|16|||
129548818|NCT02428231|466304058|FG000|Overall Study|Required Symptomatic Therapy|0|||
129548819|NCT02428231|466304059|FG001|Overall Study|Required Symptomatic Therapy|1|||
129548820|NCT02428231|466304058|FG000|Overall Study|Adverse Event|3|||
129548821|NCT02428231|466304059|FG001|Overall Study|Adverse Event|0|||
129548822|NCT01784419|466304062|FG000|Overall Study|Adverse Event|3|||
129548823|NCT01336608|466304063|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
129548824|NCT01336608|466304064|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129548825|NCT01336608|466304065|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129548826|NCT01336608|466304066|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129548827|NCT01336608|466304063|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
129548828|NCT01336608|466304064|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129548829|NCT01336608|466304065|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129548830|NCT01336608|466304066|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129548831|NCT01336608|466304063|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
129548832|NCT01336608|466304064|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
129548833|NCT01336608|466304065|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
129548834|NCT01336608|466304066|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
129548835|NCT01336608|466304063|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
129548836|NCT01336608|466304064|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
129548837|NCT01336608|466304065|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
129548838|NCT01336608|466304066|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
129548839|NCT01336608|466304063|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
129548840|NCT01336608|466304064|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129548841|NCT01336608|466304065|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129548842|NCT01336608|466304066|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129548843|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
129548844|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
129548845|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
129548846|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
129548847|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129548848|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
129548849|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129548850|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129548851|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
129548852|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
129548853|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
129548854|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
129548855|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129548856|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129548857|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
129548858|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
129548859|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
129548860|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
129548861|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
129548862|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
129548863|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129548864|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
129548865|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129548866|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129548867|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129548868|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
129548869|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
129548870|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
129548871|NCT01336608|466304063|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129548872|NCT01336608|466304064|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
129548873|NCT01336608|466304065|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
129548874|NCT01336608|466304066|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
129548875|NCT00080288|466304067|FG000|Overall Study|Adverse Event|7|||
129548876|NCT00080288|466304068|FG001|Overall Study|Adverse Event|4|||
129682965|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129682966|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129682967|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129682968|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129682969|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
129682970|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
129548877|NCT00080288|466304067|FG000|Overall Study|Lost to Follow-up|3|||
129548878|NCT00080288|466304068|FG001|Overall Study|Lost to Follow-up|5|||
129548879|NCT00080288|466304067|FG000|Overall Study|Physician Decision|6|||
129548880|NCT00080288|466304068|FG001|Overall Study|Physician Decision|2|||
129548881|NCT00080288|466304067|FG000|Overall Study|Withdrawal by Subject|3|||
129682971|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
129548882|NCT00080288|466304068|FG001|Overall Study|Withdrawal by Subject|16|||
129548883|NCT00080288|466304067|FG000|Overall Study|Miscellaneous|11|||
129548884|NCT00080288|466304068|FG001|Overall Study|Miscellaneous|11|||
129548885|NCT02253654|466304069|FG000|Overall Study|Withdrawal by Subject|12|||
129548886|NCT02253654|466304070|FG001|Overall Study|Withdrawal by Subject|4|||
129548887|NCT02253654|466304069|FG000|Overall Study|Decision by Sponsor|1|||
129548888|NCT02253654|466304070|FG001|Overall Study|Decision by Sponsor|1|||
129548889|NCT02253654|466304069|FG000|Overall Study|Lost to Follow-up|2|||
129548890|NCT02253654|466304070|FG001|Overall Study|Lost to Follow-up|5|||
129548891|NCT02253654|466304069|FG000|Overall Study|Death|4|||
129548892|NCT02253654|466304070|FG001|Overall Study|Death|7|||
129548893|NCT02253654|466304069|FG000|Overall Study|Did Not Receive Study Treatment|4|||
129548894|NCT02253654|466304070|FG001|Overall Study|Did Not Receive Study Treatment|1|||
129548895|NCT03044431|466304073|FG000|Overall Study|Lost to Follow-up|59|||
129548896|NCT03456726|466304074|FG000|Overall Study|Disease Progression|6|||
129548897|NCT03456726|466304075|FG001|Overall Study|Disease Progression|1|||
129548898|NCT03456726|466304074|FG000|Overall Study|Adverse Event|4|||
129548899|NCT03456726|466304075|FG001|Overall Study|Adverse Event|2|||
129548900|NCT03456726|466304074|FG000|Overall Study|Withdrawal by Subject|1|||
129548901|NCT03456726|466304075|FG001|Overall Study|Withdrawal by Subject|0|||
129548902|NCT03456726|466304074|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
129548903|NCT03456726|466304075|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
129548904|NCT04470622|466304076|FG000|Overall Study|Withdrawal by Subject|0|||
129548905|NCT04470622|466304077|FG001|Overall Study|Withdrawal by Subject|1|||
129548906|NCT04470622|466304076|FG000|Overall Study|Screen Failure|0|||
129548907|NCT04470622|466304077|FG001|Overall Study|Screen Failure|1|||
129548908|NCT04470622|466304076|FG000|Overall Study|Death|0|||
129548909|NCT04470622|466304077|FG001|Overall Study|Death|1|||
129548910|NCT00399490|466304078|FG000|Overall Study|Adverse Event|19|||
129548911|NCT00399490|466304078|FG000|Overall Study|Lack of Efficacy|31|||
129548912|NCT00399490|466304078|FG000|Overall Study|Lost to Follow-up|5|||
129548913|NCT00399490|466304078|FG000|Overall Study|Withdrawal by Subject|18|||
129548914|NCT00399490|466304078|FG000|Overall Study|Other|25|||
129548915|NCT00791154|466304083|FG000|Overall Study|Noncompliance|0|||
129548916|NCT00791154|466304084|FG001|Overall Study|Noncompliance|1|||
129548917|NCT00791154|466304085|FG002|Overall Study|Noncompliance|0|||
129548918|NCT00791154|466304086|FG003|Overall Study|Noncompliance|0|||
129548919|NCT00791154|466304087|FG004|Overall Study|Noncompliance|1|||
129548920|NCT00791154|466304088|FG005|Overall Study|Noncompliance|1|||
129548921|NCT00791154|466304089|FG006|Overall Study|Noncompliance|1|||
129548922|NCT00791154|466304083|FG000|Overall Study|Adverse Event|0|||
129548923|NCT00791154|466304084|FG001|Overall Study|Adverse Event|0|||
129548924|NCT00791154|466304085|FG002|Overall Study|Adverse Event|0|||
129548925|NCT00791154|466304086|FG003|Overall Study|Adverse Event|0|||
129548926|NCT00791154|466304087|FG004|Overall Study|Adverse Event|2|||
129548927|NCT00791154|466304088|FG005|Overall Study|Adverse Event|0|||
129548928|NCT00791154|466304089|FG006|Overall Study|Adverse Event|1|||
129548929|NCT00791154|466304083|FG000|Overall Study|Full Consent withdrawn|1|||
129548930|NCT00791154|466304084|FG001|Overall Study|Full Consent withdrawn|3|||
129548931|NCT00791154|466304085|FG002|Overall Study|Full Consent withdrawn|0|||
129548932|NCT00791154|466304086|FG003|Overall Study|Full Consent withdrawn|0|||
129548933|NCT00791154|466304087|FG004|Overall Study|Full Consent withdrawn|1|||
129548934|NCT00791154|466304088|FG005|Overall Study|Full Consent withdrawn|3|||
129548935|NCT00791154|466304089|FG006|Overall Study|Full Consent withdrawn|1|||
129548936|NCT00791154|466304083|FG000|Overall Study|Lost to Follow-up|0|||
129548937|NCT00791154|466304084|FG001|Overall Study|Lost to Follow-up|0|||
129548938|NCT00791154|466304085|FG002|Overall Study|Lost to Follow-up|0|||
129548939|NCT00791154|466304086|FG003|Overall Study|Lost to Follow-up|1|||
129548940|NCT00791154|466304087|FG004|Overall Study|Lost to Follow-up|2|||
129548941|NCT00791154|466304088|FG005|Overall Study|Lost to Follow-up|0|||
129548942|NCT00791154|466304089|FG006|Overall Study|Lost to Follow-up|4|||
129548943|NCT00791154|466304083|FG000|Overall Study|Death|5|||
129548944|NCT00791154|466304084|FG001|Overall Study|Death|4|||
129548945|NCT00791154|466304085|FG002|Overall Study|Death|4|||
129548946|NCT00791154|466304086|FG003|Overall Study|Death|7|||
129548947|NCT00791154|466304087|FG004|Overall Study|Death|54|||
129548948|NCT00791154|466304088|FG005|Overall Study|Death|54|||
129548949|NCT00791154|466304089|FG006|Overall Study|Death|52|||
129548950|NCT00791154|466304083|FG000|Overall Study|Other event|0|||
129548951|NCT00791154|466304084|FG001|Overall Study|Other event|0|||
129548952|NCT00791154|466304085|FG002|Overall Study|Other event|2|||
129548953|NCT00791154|466304086|FG003|Overall Study|Other event|0|||
129548954|NCT00791154|466304087|FG004|Overall Study|Other event|2|||
129548955|NCT00791154|466304088|FG005|Overall Study|Other event|4|||
129548956|NCT00791154|466304089|FG006|Overall Study|Other event|2|||
129548957|NCT00765999|466304090|FG000|Overall Study|Adverse Event|203|||
129548958|NCT00765999|466304090|FG000|Overall Study|Insufficient Therapeutic Response|100|||
129707653|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
129548959|NCT00765999|466304090|FG000|Overall Study|Protocol Violation|95|||
129548960|NCT00765999|466304090|FG000|Overall Study|Consent Withdrawn|202|||
129548961|NCT00765999|466304090|FG000|Overall Study|Lost to Follow-up|131|||
129548962|NCT00765999|466304090|FG000|Overall Study|Study Terminated by Sponsor|2|||
129548963|NCT00765999|466304090|FG000|Overall Study|Other Miscellaneous Reasons|51|||
129548964|NCT04840901|466304093|FG000|Overall Study|Lost to Follow-up|3|||
129548965|NCT04840901|466304094|FG001|Overall Study|Lost to Follow-up|1|||
129548966|NCT04840901|466304093|FG000|Overall Study|Moved|1|||
129548967|NCT04840901|466304094|FG001|Overall Study|Moved|0|||
129548968|NCT04840901|466304093|FG000|Overall Study|Unable to comply with study schedule|0|||
129548969|NCT04840901|466304094|FG001|Overall Study|Unable to comply with study schedule|1|||
129548970|NCT04840901|466304093|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
129548971|NCT04840901|466304094|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
129548972|NCT00902265|466304095|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
129548973|NCT00902265|466304095|FG000|Overall Study|Adverse Event|2|||
129548974|NCT00902265|466304095|FG000|Overall Study|Lack of Efficacy|2|||
129548975|NCT00902265|466304095|FG000|Overall Study|Protocol Violation|1|||
129548976|NCT04701658|466304096|FG000|Overall Study|Lost to Follow-up|6|||
129548977|NCT00110084|466304097|FG000|Overall Study|Adverse Event|9|||
129548978|NCT00110084|466304097|FG000|Overall Study|Death|1|||
129548979|NCT00110084|466304097|FG000|Overall Study|Patient Refusal|10|||
129548980|NCT00110084|466304097|FG000|Overall Study|Alternate Therapy|5|||
129548981|NCT00110084|466304097|FG000|Overall Study|Intercurrent Illness|1|||
129548982|NCT00110084|466304097|FG000|Overall Study|Other|2|||
129548983|NCT05016765|466304098|FG000|Overall Study|Lost to Follow-up|4|||
129548984|NCT01346501|466304102|FG000|Overall Study|Initiated Other Biological Agents|3|||
129548985|NCT01346501|466304103|FG001|Overall Study|Initiated Other Biological Agents|1|||
129548986|NCT01346501|466304102|FG000|Overall Study|Other|8|||
129548987|NCT01346501|466304103|FG001|Overall Study|Other|12|||
129548988|NCT04101721|466304104|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
129548989|NCT04101721|466304105|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
129548990|NCT04101721|466304104|FG000|Overall Study|Death|0|||
129548991|NCT04101721|466304105|FG001|Overall Study|Death|1|||
129548992|NCT04101721|466304104|FG000|Overall Study|Lost to Follow-up|0|||
129548993|NCT04101721|466304105|FG001|Overall Study|Lost to Follow-up|3|||
129548994|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
129548995|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
129548996|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
129548997|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
129548998|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
129548999|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
129549000|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
129549001|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
129549002|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
129549003|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
129549004|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
129549005|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
129549006|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
129549007|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
129549008|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
129549009|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
129549010|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
129549011|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
129549012|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
129549013|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
129549014|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
129682972|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129682973|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129682974|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129682975|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129682976|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
129682977|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
129682978|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
129682979|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129549015|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
129549016|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
129549017|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
129549018|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
129549019|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
129549020|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
129549021|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
129549022|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
129549023|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
129549024|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
129549025|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
129549026|NCT03747939|466304106|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
129549027|NCT03747939|466304107|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
129549028|NCT03747939|466304108|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
129549029|NCT03747939|466304109|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
129549030|NCT03747939|466304106|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
129549031|NCT03747939|466304107|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
129549032|NCT03747939|466304108|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
129549033|NCT03747939|466304109|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
129549034|NCT03747939|466304106|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
129549035|NCT03747939|466304107|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
129549036|NCT03747939|466304108|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
129549037|NCT03747939|466304109|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
129549038|NCT03747939|466304106|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
129549039|NCT03747939|466304107|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
129549040|NCT03747939|466304108|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
129549041|NCT03747939|466304109|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
129549042|NCT03747939|466304106|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
129549043|NCT03747939|466304107|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
129549044|NCT03747939|466304108|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
129549045|NCT03747939|466304109|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
129549046|NCT03747939|466304106|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
129549047|NCT03747939|466304107|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
129549048|NCT03747939|466304108|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
129549049|NCT03747939|466304109|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
129549050|NCT02494583|466304112|FG000|Overall Study|Death|224|||
129549051|NCT02494583|466304113|FG001|Overall Study|Death|214|||
129549052|NCT02494583|466304114|FG002|Overall Study|Death|225|||
129549053|NCT02494583|466304112|FG000|Overall Study|Lost to Follow-up|1|||
129549054|NCT02494583|466304113|FG001|Overall Study|Lost to Follow-up|0|||
129549055|NCT02494583|466304114|FG002|Overall Study|Lost to Follow-up|0|||
129549056|NCT02494583|466304112|FG000|Overall Study|Protocol Violation|1|||
129549057|NCT02494583|466304113|FG001|Overall Study|Protocol Violation|2|||
129549058|NCT02494583|466304114|FG002|Overall Study|Protocol Violation|0|||
129549059|NCT02494583|466304112|FG000|Overall Study|Screen Failure|0|||
129549060|NCT02494583|466304113|FG001|Overall Study|Screen Failure|1|||
129549061|NCT02494583|466304114|FG002|Overall Study|Screen Failure|0|||
129549062|NCT02494583|466304112|FG000|Overall Study|Transferred to Extension Study|15|||
129549063|NCT02494583|466304113|FG001|Overall Study|Transferred to Extension Study|15|||
129549064|NCT02494583|466304114|FG002|Overall Study|Transferred to Extension Study|6|||
129549065|NCT02494583|466304112|FG000|Overall Study|Did Not Continue on Extension Study|8|||
129549066|NCT02494583|466304113|FG001|Overall Study|Did Not Continue on Extension Study|10|||
129549067|NCT02494583|466304114|FG002|Overall Study|Did Not Continue on Extension Study|4|||
129682980|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129682981|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129682982|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129682983|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129682984|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
129682985|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
129682986|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
129682987|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
129682988|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
129682989|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
129682990|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
129682991|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
129682992|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
129682993|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
129549068|NCT02494583|466304112|FG000|Overall Study|Withdrawal by Subject|7|||
129549069|NCT02494583|466304113|FG001|Overall Study|Withdrawal by Subject|15|||
129682994|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
129682995|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
129682996|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
129549070|NCT02494583|466304114|FG002|Overall Study|Withdrawal by Subject|15|||
129549071|NCT03151707|466304117|FG000|Overall Study|Lost to Follow-up|6|||
129549072|NCT02362646|466304121|FG000|Overall Study|Death|15|||
129549073|NCT02362646|466304122|FG001|Overall Study|Death|8|||
129549074|NCT02362646|466304121|FG000|Overall Study|Withdrawal by Subject|2|||
129549075|NCT02362646|466304122|FG001|Overall Study|Withdrawal by Subject|2|||
129549076|NCT02362646|466304121|FG000|Overall Study|received transplant|21|||
129549077|NCT02362646|466304122|FG001|Overall Study|received transplant|14|||
129549078|NCT00865306|466304123|FG000|Controlled Trial|Lost to Follow-up|1|||
129549079|NCT00865306|466304124|FG001|Controlled Trial|Lost to Follow-up|1|||
129549080|NCT00865306|466304123|FG000|Controlled Trial|Difficulty commuting|2|||
129549081|NCT00865306|466304124|FG001|Controlled Trial|Difficulty commuting|0|||
129549082|NCT00865306|466304123|FG000|Controlled Trial|Improved btw baseline and first session|1|||
129549083|NCT00865306|466304124|FG001|Controlled Trial|Improved btw baseline and first session|0|||
129549084|NCT00865306|466304123|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
129549085|NCT00865306|466304124|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
129549086|NCT00865306|466304123|FG000|Controlled Trial|Withdrawal by Subject|0|||
129549087|NCT00865306|466304124|FG001|Controlled Trial|Withdrawal by Subject|1|||
129549088|NCT02058368|466304126|FG000|Overall Study|Adverse Event|15|||
129549089|NCT02058368|466304127|FG001|Overall Study|Adverse Event|20|||
129549090|NCT02058368|466304126|FG000|Overall Study|Lack of Efficacy|0|||
129549091|NCT02058368|466304127|FG001|Overall Study|Lack of Efficacy|1|||
129549092|NCT02058368|466304126|FG000|Overall Study|Protocol Violation|0|||
129549093|NCT02058368|466304127|FG001|Overall Study|Protocol Violation|4|||
129549094|NCT02058368|466304126|FG000|Overall Study|Lost to Follow-up|2|||
129549095|NCT02058368|466304127|FG001|Overall Study|Lost to Follow-up|0|||
129549096|NCT02058368|466304126|FG000|Overall Study|Physician Decision|2|||
129549097|NCT02058368|466304127|FG001|Overall Study|Physician Decision|3|||
129549098|NCT02058368|466304126|FG000|Overall Study|Withdrawal by Subject|22|||
129549099|NCT02058368|466304127|FG001|Overall Study|Withdrawal by Subject|26|||
129549100|NCT02181842|466304128|FG000|Overall Study|Case Report Forms Uncollected|2|||
129549101|NCT01652872|466304129|FG000|Overall Study|Death|36|||
129549102|NCT01652872|466304130|FG001|Overall Study|Death|39|||
129549103|NCT01652872|466304129|FG000|Overall Study|Lost to Follow-up|28|||
129549104|NCT01652872|466304130|FG001|Overall Study|Lost to Follow-up|23|||
129549105|NCT01652872|466304129|FG000|Overall Study|Decision by sponsor|5|||
129549106|NCT01652872|466304130|FG001|Overall Study|Decision by sponsor|7|||
129549107|NCT01652872|466304129|FG000|Overall Study|Withdrawal by Subject|76|||
129549108|NCT01652872|466304130|FG001|Overall Study|Withdrawal by Subject|84|||
129549109|NCT04529096|466304131|FG000|Overall Study|Adverse Event|6|||
129549110|NCT04529096|466304132|FG001|Overall Study|Adverse Event|1|||
129549111|NCT04529096|466304131|FG000|Overall Study|Lack of Efficacy|1|||
129549112|NCT04529096|466304132|FG001|Overall Study|Lack of Efficacy|0|||
129549113|NCT04529096|466304131|FG000|Overall Study|Lost to Follow-up|1|||
129549114|NCT04529096|466304132|FG001|Overall Study|Lost to Follow-up|1|||
129549115|NCT04529096|466304131|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129549116|NCT04529096|466304132|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129549117|NCT04529096|466304131|FG000|Overall Study|Physician Decision|1|||
129549118|NCT04529096|466304132|FG001|Overall Study|Physician Decision|3|||
129549119|NCT04529096|466304131|FG000|Overall Study|Withdrawal by Subject|5|||
129549120|NCT04529096|466304132|FG001|Overall Study|Withdrawal by Subject|0|||
129549121|NCT03985293|466304143|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
129549122|NCT03985293|466304144|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
129549123|NCT03985293|466304145|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
129549124|NCT03985293|466304146|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
129549125|NCT03985293|466304147|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
129549126|NCT03985293|466304148|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
129549127|NCT03985293|466304143|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
129549128|NCT03985293|466304144|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
129549129|NCT03985293|466304145|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
129549130|NCT03985293|466304146|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
129549131|NCT03985293|466304147|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
129549132|NCT03985293|466304148|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
129549133|NCT03985293|466304143|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
129549134|NCT03985293|466304144|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
129549135|NCT03985293|466304145|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
129549136|NCT03985293|466304146|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
129549137|NCT03985293|466304147|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
129549138|NCT03985293|466304148|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
129549139|NCT03985293|466304143|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
129549140|NCT03985293|466304144|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
129549141|NCT03985293|466304145|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
129549142|NCT03985293|466304146|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
129549143|NCT03985293|466304147|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
129549144|NCT03985293|466304148|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
129549145|NCT03985293|466304143|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
129549146|NCT03985293|466304144|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
129549147|NCT03985293|466304145|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
129549148|NCT03985293|466304146|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
129549149|NCT03985293|466304147|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
129549150|NCT03985293|466304148|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
129549151|NCT03985293|466304143|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
129549152|NCT03985293|466304144|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
129549153|NCT03985293|466304145|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
129682997|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
129682998|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
129682999|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
129683000|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129683001|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129683002|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129683003|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129683004|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
129683005|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
129683006|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
129683007|NCT01697579|466799060|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129683008|NCT01697579|466799061|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129683009|NCT01697579|466799062|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129683010|NCT01697579|466799063|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129683011|NCT01697579|466799064|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129683012|NCT01697579|466799065|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
129683013|NCT01697579|466799066|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
129683014|NCT02452190|466799067|FG000|Overall Study|Withdrawal by Sponsor|1|||
129683015|NCT02452190|466799068|FG001|Overall Study|Withdrawal by Sponsor|3|||
129683016|NCT02452190|466799067|FG000|Overall Study|Pregnancy|1|||
129683017|NCT02452190|466799068|FG001|Overall Study|Pregnancy|0|||
129683018|NCT02452190|466799067|FG000|Overall Study|Investigator's Decision|2|||
129683019|NCT02452190|466799068|FG001|Overall Study|Investigator's Decision|0|||
129683020|NCT02452190|466799067|FG000|Overall Study|Lack of Efficacy|3|||
129683021|NCT02452190|466799068|FG001|Overall Study|Lack of Efficacy|1|||
129683022|NCT02452190|466799067|FG000|Overall Study|Lost to Follow-up|4|||
129683023|NCT02452190|466799068|FG001|Overall Study|Lost to Follow-up|3|||
129683024|NCT02452190|466799067|FG000|Overall Study|Adverse Event|2|||
129683025|NCT02452190|466799068|FG001|Overall Study|Adverse Event|5|||
129683026|NCT02452190|466799067|FG000|Overall Study|Withdrawal by Subject|20|||
129683027|NCT02452190|466799068|FG001|Overall Study|Withdrawal by Subject|11|||
129683028|NCT02452190|466799067|FG000|Overall Study|Noncompliance with study drug|1|||
129683029|NCT02452190|466799068|FG001|Overall Study|Noncompliance with study drug|0|||
129683030|NCT02452190|466799067|FG000|Overall Study|Participant traveled abroad|1|||
129683031|NCT02452190|466799068|FG001|Overall Study|Participant traveled abroad|0|||
129683032|NCT02452190|466799067|FG000|Overall Study|Death|0|||
129683033|NCT02452190|466799068|FG001|Overall Study|Death|1|||
129683034|NCT01044498|466799069|FG000|Overall Study|Withdrew consent|1|||
129683035|NCT01044498|466799070|FG001|Overall Study|Withdrew consent|1|||
129683036|NCT01044498|466799069|FG000|Overall Study|Adverse Event|1|||
129683037|NCT01044498|466799070|FG001|Overall Study|Adverse Event|1|||
129683038|NCT01044498|466799069|FG000|Overall Study|Other|1|||
129683039|NCT01044498|466799070|FG001|Overall Study|Other|0|||
129683040|NCT02327078|466799075|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
129683041|NCT02327078|466799076|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
129683042|NCT02327078|466799077|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
129683043|NCT02327078|466799078|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
129683044|NCT02327078|466799079|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
129683045|NCT02327078|466799080|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
129683046|NCT02327078|466799081|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
129683047|NCT02327078|466799082|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
129683048|NCT02327078|466799083|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
129549154|NCT03985293|466304146|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
129683049|NCT02327078|466799075|FG000|Overall Study|Death|2|||
129683050|NCT02327078|466799076|FG001|Overall Study|Death|4|||
129683051|NCT02327078|466799077|FG002|Overall Study|Death|10|||
129683052|NCT02327078|466799078|FG003|Overall Study|Death|6|||
129683053|NCT02327078|466799079|FG004|Overall Study|Death|4|||
129549155|NCT03985293|466304147|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
129683054|NCT02327078|466799080|FG005|Overall Study|Death|3|||
129683055|NCT02327078|466799081|FG006|Overall Study|Death|2|||
129683056|NCT02327078|466799082|FG007|Overall Study|Death|51|||
129683057|NCT02327078|466799083|FG008|Overall Study|Death|97|||
129772031|NCT05786651|467132389|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
129772032|NCT04390763|467132390|FG000|Safety run-in Part|Adverse Event|4|||
129772033|NCT04390763|467132391|FG001|Safety run-in Part|Adverse Event|0|||
129772034|NCT04390763|467132392|FG002|Safety run-in Part|Adverse Event|0|||
129772035|NCT04390763|467132393|FG003|Safety run-in Part|Adverse Event|0|||
129772036|NCT04390763|467132390|FG000|Safety run-in Part|Physician Decision|1|||
129772037|NCT04390763|467132391|FG001|Safety run-in Part|Physician Decision|0|||
129772038|NCT04390763|467132392|FG002|Safety run-in Part|Physician Decision|0|||
129772039|NCT04390763|467132393|FG003|Safety run-in Part|Physician Decision|0|||
129772040|NCT04390763|467132390|FG000|Safety run-in Part|Progressive Disease|6|||
129772041|NCT04390763|467132391|FG001|Safety run-in Part|Progressive Disease|0|||
129772042|NCT04390763|467132392|FG002|Safety run-in Part|Progressive Disease|0|||
129772043|NCT04390763|467132393|FG003|Safety run-in Part|Progressive Disease|0|||
129772044|NCT04390763|467132390|FG000|Randomized Part|Adverse Event|0|||
129772045|NCT04390763|467132391|FG001|Randomized Part|Adverse Event|11|||
129772046|NCT04390763|467132392|FG002|Randomized Part|Adverse Event|5|||
129772047|NCT04390763|467132393|FG003|Randomized Part|Adverse Event|5|||
129772048|NCT04390763|467132390|FG000|Randomized Part|Death|0|||
129772049|NCT04390763|467132391|FG001|Randomized Part|Death|3|||
129772050|NCT04390763|467132392|FG002|Randomized Part|Death|4|||
129772051|NCT04390763|467132393|FG003|Randomized Part|Death|2|||
129772052|NCT04390763|467132390|FG000|Randomized Part|Physician Decision|0|||
129772053|NCT04390763|467132391|FG001|Randomized Part|Physician Decision|2|||
129772054|NCT04390763|467132392|FG002|Randomized Part|Physician Decision|2|||
129772055|NCT04390763|467132393|FG003|Randomized Part|Physician Decision|9|||
129772056|NCT04390763|467132390|FG000|Randomized Part|Progressive Disease|0|||
129772057|NCT04390763|467132391|FG001|Randomized Part|Progressive Disease|24|||
129772058|NCT04390763|467132392|FG002|Randomized Part|Progressive Disease|31|||
129772059|NCT04390763|467132393|FG003|Randomized Part|Progressive Disease|23|||
129772060|NCT04390763|467132390|FG000|Randomized Part|Study terminated by sponsor|0|||
129772061|NCT04390763|467132391|FG001|Randomized Part|Study terminated by sponsor|1|||
129772062|NCT04390763|467132392|FG002|Randomized Part|Study terminated by sponsor|0|||
129772063|NCT04390763|467132393|FG003|Randomized Part|Study terminated by sponsor|0|||
129772064|NCT04390763|467132390|FG000|Randomized Part|Participant Decision|0|||
129772065|NCT04390763|467132391|FG001|Randomized Part|Participant Decision|5|||
129772066|NCT04390763|467132392|FG002|Randomized Part|Participant Decision|7|||
129772067|NCT04390763|467132393|FG003|Randomized Part|Participant Decision|6|||
129683058|NCT02327078|466799075|FG000|Overall Study|Lost to Follow-up|0|||
129683059|NCT02327078|466799076|FG001|Overall Study|Lost to Follow-up|1|||
129683060|NCT02327078|466799077|FG002|Overall Study|Lost to Follow-up|1|||
129683061|NCT02327078|466799078|FG003|Overall Study|Lost to Follow-up|0|||
129683062|NCT02327078|466799079|FG004|Overall Study|Lost to Follow-up|0|||
129683063|NCT02327078|466799080|FG005|Overall Study|Lost to Follow-up|0|||
129683064|NCT02327078|466799081|FG006|Overall Study|Lost to Follow-up|0|||
129683065|NCT02327078|466799082|FG007|Overall Study|Lost to Follow-up|2|||
129683066|NCT02327078|466799083|FG008|Overall Study|Lost to Follow-up|5|||
129683067|NCT02327078|466799075|FG000|Overall Study|Site Terminated by Sponsor|1|||
129683068|NCT02327078|466799076|FG001|Overall Study|Site Terminated by Sponsor|0|||
129683069|NCT02327078|466799077|FG002|Overall Study|Site Terminated by Sponsor|1|||
129683070|NCT02327078|466799078|FG003|Overall Study|Site Terminated by Sponsor|4|||
129683071|NCT02327078|466799079|FG004|Overall Study|Site Terminated by Sponsor|0|||
129683072|NCT02327078|466799080|FG005|Overall Study|Site Terminated by Sponsor|0|||
129683073|NCT02327078|466799081|FG006|Overall Study|Site Terminated by Sponsor|0|||
129683074|NCT02327078|466799082|FG007|Overall Study|Site Terminated by Sponsor|11|||
129683075|NCT02327078|466799083|FG008|Overall Study|Site Terminated by Sponsor|25|||
129772068|NCT04390763|467132390|FG000|Randomized Part|Not treated|0|||
129772069|NCT04390763|467132391|FG001|Randomized Part|Not treated|4|||
129772070|NCT04390763|467132392|FG002|Randomized Part|Not treated|2|||
129772071|NCT04390763|467132393|FG003|Randomized Part|Not treated|7|||
129772072|NCT04721977|467132399|FG000|Overall Study|Death|15|||
129772073|NCT04721977|467132399|FG000|Overall Study|Ongoing|51|||
129772074|NCT00777153|467134034|FG000|Overall Study|Lost to Follow-up|1|||
129772075|NCT00777153|467134035|FG001|Overall Study|Lost to Follow-up|1|||
129772076|NCT00777153|467134036|FG002|Overall Study|Lost to Follow-up|0|||
129683076|NCT02327078|466799075|FG000|Overall Study|Physician Decision|0|||
129683077|NCT02327078|466799076|FG001|Overall Study|Physician Decision|0|||
129772077|NCT00777153|467134034|FG000|Overall Study|Death|85|||
129549156|NCT03985293|466304148|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
129549157|NCT03985293|466304143|FG000|FOLLOW-UP|Lost to Follow-up|0|||
129549158|NCT03985293|466304144|FG001|FOLLOW-UP|Lost to Follow-up|0|||
129549159|NCT03985293|466304145|FG002|FOLLOW-UP|Lost to Follow-up|1|||
129549160|NCT03985293|466304146|FG003|FOLLOW-UP|Lost to Follow-up|0|||
129549161|NCT03985293|466304147|FG004|FOLLOW-UP|Lost to Follow-up|0|||
129549162|NCT03985293|466304148|FG005|FOLLOW-UP|Lost to Follow-up|0|||
129549163|NCT00390572|466304149|FG000|Overall Study|Lost to Follow-up|8|||
129549164|NCT00390572|466304150|FG001|Overall Study|Lost to Follow-up|4|||
129683078|NCT02327078|466799077|FG002|Overall Study|Physician Decision|0|||
129683079|NCT02327078|466799078|FG003|Overall Study|Physician Decision|1|||
129683080|NCT02327078|466799079|FG004|Overall Study|Physician Decision|0|||
129683081|NCT02327078|466799080|FG005|Overall Study|Physician Decision|0|||
129683082|NCT02327078|466799081|FG006|Overall Study|Physician Decision|0|||
129683083|NCT02327078|466799082|FG007|Overall Study|Physician Decision|0|||
129683084|NCT02327078|466799083|FG008|Overall Study|Physician Decision|1|||
129683085|NCT02327078|466799075|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
129683086|NCT02327078|466799076|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
129683087|NCT02327078|466799077|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
129683088|NCT02327078|466799078|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
129683089|NCT02327078|466799079|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
129683090|NCT02327078|466799080|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
129683091|NCT02327078|466799081|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
129683092|NCT02327078|466799082|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
129683093|NCT02327078|466799083|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
129683094|NCT02327078|466799075|FG000|Overall Study|Reason not Specified|0|||
129683095|NCT02327078|466799076|FG001|Overall Study|Reason not Specified|0|||
129683096|NCT02327078|466799077|FG002|Overall Study|Reason not Specified|0|||
129683097|NCT02327078|466799078|FG003|Overall Study|Reason not Specified|0|||
129549165|NCT00390572|466304149|FG000|Overall Study|health condition|0|||
129683098|NCT02327078|466799079|FG004|Overall Study|Reason not Specified|0|||
129683099|NCT02327078|466799080|FG005|Overall Study|Reason not Specified|0|||
129683100|NCT02327078|466799081|FG006|Overall Study|Reason not Specified|0|||
129683101|NCT02327078|466799082|FG007|Overall Study|Reason not Specified|5|||
129549166|NCT00390572|466304150|FG001|Overall Study|health condition|1|||
129549167|NCT01345058|466304157|FG000|Overall Study|Withdrawal by Subject|1|||
129549168|NCT01345058|466304158|FG001|Overall Study|Withdrawal by Subject|0|||
129549169|NCT01345058|466304157|FG000|Overall Study|Participant Reported Increase in Events|1|||
129549170|NCT01345058|466304158|FG001|Overall Study|Participant Reported Increase in Events|0|||
129549171|NCT01345058|466304157|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
129549172|NCT01345058|466304158|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
129549173|NCT01345058|466304157|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
129549174|NCT01345058|466304158|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
129549175|NCT01345058|466304157|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
129549176|NCT01345058|466304158|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
129549177|NCT01892020|466304165|FG000|Period 1|Adverse Event|1|||
129549178|NCT01892020|466304166|FG001|Period 1|Adverse Event|1|||
129772078|NCT00777153|467134035|FG001|Overall Study|Death|73|||
129772079|NCT00777153|467134036|FG002|Overall Study|Death|33|||
129772080|NCT00777153|467134034|FG000|Overall Study|Withdrawal by Subject|3|||
129772081|NCT00777153|467134035|FG001|Overall Study|Withdrawal by Subject|4|||
129772082|NCT00777153|467134036|FG002|Overall Study|Withdrawal by Subject|3|||
129772083|NCT00777153|467134034|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
129772084|NCT00777153|467134035|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
129772085|NCT00777153|467134036|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
129772086|NCT02079246|467134038|FG000|OLEX|Withdrawal before treatment|1|||
129772087|NCT02079246|467134039|FG001|OLEX|Withdrawal before treatment|0|||
129772088|NCT02079246|467134038|FG000|OLEX|Death|11|||
129549179|NCT01892020|466304165|FG000|Period 1|Protocol Violation|2|||
129683102|NCT02327078|466799083|FG008|Overall Study|Reason not Specified|12|||
129683103|NCT03916926|466799087|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
129683104|NCT03916926|466799088|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
129683105|NCT03916926|466799087|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
129683106|NCT03916926|466799088|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
129683107|NCT03916926|466799087|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
129683108|NCT03916926|466799088|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
129683109|NCT03916926|466799087|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
129683110|NCT03916926|466799088|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
129683111|NCT03765073|466799089|FG000|Stage 1|Lost to Follow-up|1|||
129683112|NCT03765073|466799090|FG001|Stage 1|Lost to Follow-up|0|||
129683113|NCT03765073|466799091|FG002|Stage 1|Lost to Follow-up|0|||
129683114|NCT03765073|466799092|FG003|Stage 1|Lost to Follow-up|0|||
129683115|NCT03765073|466799093|FG004|Stage 1|Lost to Follow-up|0|||
129683116|NCT03765073|466799094|FG005|Stage 1|Lost to Follow-up|0|||
129683117|NCT03765073|466799095|FG006|Stage 1|Lost to Follow-up|0|||
129683118|NCT03765073|466799096|FG007|Stage 1|Lost to Follow-up|0|||
129683119|NCT03765073|466799097|FG008|Stage 1|Lost to Follow-up|0|||
129683120|NCT03765073|466799098|FG009|Stage 1|Lost to Follow-up|0|||
129683121|NCT03765073|466799099|FG010|Stage 1|Lost to Follow-up|0|||
129683122|NCT03765073|466799100|FG011|Stage 1|Lost to Follow-up|0|||
129683123|NCT03765073|466799101|FG012|Stage 1|Lost to Follow-up|0|||
129683124|NCT03765073|466799102|FG013|Stage 1|Lost to Follow-up|0|||
129683125|NCT03765073|466799103|FG014|Stage 1|Lost to Follow-up|0|||
129683126|NCT03765073|466799104|FG015|Stage 1|Lost to Follow-up|0|||
129683127|NCT03765073|466799105|FG016|Stage 1|Lost to Follow-up|0|||
129683128|NCT03765073|466799106|FG017|Stage 1|Lost to Follow-up|0|||
129683129|NCT03765073|466799107|FG018|Stage 1|Lost to Follow-up|0|||
129683130|NCT03765073|466799108|FG019|Stage 1|Lost to Follow-up|0|||
129683131|NCT03765073|466799109|FG020|Stage 1|Lost to Follow-up|0|||
129683132|NCT03765073|466799089|FG000|Stage 1|Withdrawal by participant|0|||
129683133|NCT03765073|466799090|FG001|Stage 1|Withdrawal by participant|1|||
129683134|NCT03765073|466799091|FG002|Stage 1|Withdrawal by participant|0|||
129683135|NCT03765073|466799092|FG003|Stage 1|Withdrawal by participant|0|||
129683136|NCT03765073|466799093|FG004|Stage 1|Withdrawal by participant|0|||
129683137|NCT03765073|466799094|FG005|Stage 1|Withdrawal by participant|0|||
129683138|NCT03765073|466799095|FG006|Stage 1|Withdrawal by participant|0|||
129683139|NCT03765073|466799096|FG007|Stage 1|Withdrawal by participant|0|||
129683140|NCT03765073|466799097|FG008|Stage 1|Withdrawal by participant|0|||
129683141|NCT03765073|466799098|FG009|Stage 1|Withdrawal by participant|0|||
129683142|NCT03765073|466799099|FG010|Stage 1|Withdrawal by participant|0|||
129683143|NCT03765073|466799100|FG011|Stage 1|Withdrawal by participant|0|||
129683144|NCT03765073|466799101|FG012|Stage 1|Withdrawal by participant|0|||
129683145|NCT03765073|466799102|FG013|Stage 1|Withdrawal by participant|0|||
129683146|NCT03765073|466799103|FG014|Stage 1|Withdrawal by participant|0|||
129683147|NCT03765073|466799104|FG015|Stage 1|Withdrawal by participant|0|||
129683148|NCT03765073|466799105|FG016|Stage 1|Withdrawal by participant|0|||
129683149|NCT03765073|466799106|FG017|Stage 1|Withdrawal by participant|0|||
129683150|NCT03765073|466799107|FG018|Stage 1|Withdrawal by participant|0|||
129772089|NCT02079246|467134039|FG001|OLEX|Death|0|||
129772090|NCT02079246|467134038|FG000|OLEX|Adverse Event|66|||
129549180|NCT01892020|466304166|FG001|Period 1|Protocol Violation|4|||
129549181|NCT01892020|466304165|FG000|Period 1|Unclassified|0|||
129549182|NCT01892020|466304166|FG001|Period 1|Unclassified|1|||
129549183|NCT01892020|466304165|FG000|Period 2|Protocol Violation|1|||
129549184|NCT01892020|466304166|FG001|Period 2|Protocol Violation|0|||
129549185|NCT02328547|466305551|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
129549186|NCT02328547|466305552|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
129549187|NCT02328547|466305551|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
129549188|NCT02328547|466305552|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129549189|NCT02576054|466305553|FG000|Overall Study|Withdrawal by Subject|1|||
129549190|NCT01190098|466305557|FG000|Overall Study|Adverse Event|2|||
129549191|NCT01190098|466305558|FG001|Overall Study|Adverse Event|0|||
129549192|NCT01190098|466305557|FG000|Overall Study|Patient coomorbidity|0|||
129549193|NCT01190098|466305558|FG001|Overall Study|Patient coomorbidity|1|||
129549194|NCT01190098|466305557|FG000|Overall Study|Lack of transportation|1|||
129549195|NCT01190098|466305558|FG001|Overall Study|Lack of transportation|0|||
129549196|NCT01190098|466305557|FG000|Overall Study|Other|0|||
129549197|NCT01190098|466305558|FG001|Overall Study|Other|1|||
129549198|NCT00344305|466305559|FG000|Overall Study|Lost to Follow-up|2|||
129549199|NCT00344305|466305560|FG001|Overall Study|Lost to Follow-up|0|||
129549200|NCT00344305|466305559|FG000|Overall Study|Participant was not contacted in window|0|||
129549201|NCT00344305|466305560|FG001|Overall Study|Participant was not contacted in window|1|||
129549202|NCT02957682|466305561|FG000|Overall Study|Adverse Event|64|||
129549203|NCT02957682|466305562|FG001|Overall Study|Adverse Event|67|||
129549204|NCT02957682|466305561|FG000|Overall Study|Poor Compliance to Protocol|30|||
129549205|NCT02957682|466305562|FG001|Overall Study|Poor Compliance to Protocol|26|||
129549206|NCT02957682|466305561|FG000|Overall Study|Physician Decision|4|||
129549207|NCT02957682|466305562|FG001|Overall Study|Physician Decision|4|||
129549208|NCT02957682|466305561|FG000|Overall Study|Study Terminated by Sponsor|4|||
129549209|NCT02957682|466305562|FG001|Overall Study|Study Terminated by Sponsor|3|||
129549210|NCT02957682|466305561|FG000|Overall Study|Subject Moved|10|||
129549211|NCT02957682|466305562|FG001|Overall Study|Subject Moved|16|||
129549212|NCT02957682|466305561|FG000|Overall Study|Withdrawal by Subject|64|||
129683151|NCT03765073|466799108|FG019|Stage 1|Withdrawal by participant|0|||
129683152|NCT03765073|466799109|FG020|Stage 1|Withdrawal by participant|0|||
129683153|NCT03765073|466799089|FG000|Stage 2|Death|0|||
129683154|NCT03765073|466799090|FG001|Stage 2|Death|0|||
129683155|NCT03765073|466799091|FG002|Stage 2|Death|0|||
129683156|NCT03765073|466799092|FG003|Stage 2|Death|0|||
129683157|NCT03765073|466799093|FG004|Stage 2|Death|0|||
129683158|NCT03765073|466799094|FG005|Stage 2|Death|0|||
129683159|NCT03765073|466799095|FG006|Stage 2|Death|0|||
129683160|NCT03765073|466799096|FG007|Stage 2|Death|0|||
129683161|NCT03765073|466799097|FG008|Stage 2|Death|0|||
129683162|NCT03765073|466799098|FG009|Stage 2|Death|1|||
129683163|NCT03765073|466799099|FG010|Stage 2|Death|0|||
129683164|NCT03765073|466799100|FG011|Stage 2|Death|1|||
129683165|NCT03765073|466799101|FG012|Stage 2|Death|0|||
129683166|NCT03765073|466799102|FG013|Stage 2|Death|0|||
129683167|NCT03765073|466799103|FG014|Stage 2|Death|0|||
129683168|NCT03765073|466799104|FG015|Stage 2|Death|0|||
129683169|NCT03765073|466799105|FG016|Stage 2|Death|2|||
129683170|NCT03765073|466799106|FG017|Stage 2|Death|0|||
129683171|NCT03765073|466799107|FG018|Stage 2|Death|0|||
129683172|NCT03765073|466799108|FG019|Stage 2|Death|0|||
129683173|NCT03765073|466799109|FG020|Stage 2|Death|0|||
129683174|NCT03765073|466799089|FG000|Stage 2|Lost to Follow-up|0|||
129683175|NCT03765073|466799090|FG001|Stage 2|Lost to Follow-up|0|||
129683176|NCT03765073|466799091|FG002|Stage 2|Lost to Follow-up|0|||
129683177|NCT03765073|466799092|FG003|Stage 2|Lost to Follow-up|5|||
129683178|NCT03765073|466799093|FG004|Stage 2|Lost to Follow-up|1|||
129772091|NCT02079246|467134039|FG001|OLEX|Adverse Event|0|||
129772092|NCT02079246|467134038|FG000|OLEX|Withdrawal by Subject|60|||
129549213|NCT02957682|466305562|FG001|Overall Study|Withdrawal by Subject|33|||
129683179|NCT03765073|466799094|FG005|Stage 2|Lost to Follow-up|0|||
129683180|NCT03765073|466799095|FG006|Stage 2|Lost to Follow-up|3|||
129549214|NCT02957682|466305561|FG000|Overall Study|Related to IMP Administration|3|||
129683181|NCT03765073|466799096|FG007|Stage 2|Lost to Follow-up|3|||
129683182|NCT03765073|466799097|FG008|Stage 2|Lost to Follow-up|1|||
129772093|NCT02079246|467134039|FG001|OLEX|Withdrawal by Subject|0|||
129549215|NCT02957682|466305562|FG001|Overall Study|Related to IMP Administration|6|||
129549216|NCT02957682|466305561|FG000|Overall Study|Non-disclosed|16|||
129549217|NCT02957682|466305562|FG001|Overall Study|Non-disclosed|12|||
129549218|NCT02957682|466305561|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
129683183|NCT03765073|466799098|FG009|Stage 2|Lost to Follow-up|6|||
129683184|NCT03765073|466799099|FG010|Stage 2|Lost to Follow-up|5|||
129683185|NCT03765073|466799100|FG011|Stage 2|Lost to Follow-up|1|||
129683186|NCT03765073|466799101|FG012|Stage 2|Lost to Follow-up|1|||
129683187|NCT03765073|466799102|FG013|Stage 2|Lost to Follow-up|3|||
129683188|NCT03765073|466799103|FG014|Stage 2|Lost to Follow-up|3|||
129683189|NCT03765073|466799104|FG015|Stage 2|Lost to Follow-up|1|||
129683190|NCT03765073|466799105|FG016|Stage 2|Lost to Follow-up|6|||
129683191|NCT03765073|466799106|FG017|Stage 2|Lost to Follow-up|0|||
129772094|NCT02079246|467134038|FG000|OLEX|Lost to Follow-up|6|||
129549219|NCT02957682|466305562|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
129549220|NCT01726335|466305569|FG000|Overall Study|Lost to Follow-up|2|||
129549221|NCT01726335|466305569|FG000|Overall Study|Withdrawal by Subject|15|||
129549222|NCT01726335|466305569|FG000|Overall Study|Adverse Event|4|||
129549223|NCT01726335|466305569|FG000|Overall Study|Lost to Follow-up|2|||
129549224|NCT01726335|466305569|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
129549225|NCT01796860|466305575|FG000|Overall Study|Withdrawal by Subject|3|||
129549226|NCT02703454|466305580|FG000|Overall Study|Not treated|1|||
129549227|NCT02703454|466305581|FG001|Overall Study|Not treated|3|||
129549228|NCT02703454|466305580|FG000|Overall Study|Withdrawal by Subject|4|||
129549229|NCT02703454|466305581|FG001|Overall Study|Withdrawal by Subject|3|||
129549230|NCT02703454|466305580|FG000|Overall Study|Lost to Follow-up|1|||
129549231|NCT02703454|466305581|FG001|Overall Study|Lost to Follow-up|2|||
129549232|NCT02703454|466305580|FG000|Overall Study|Study discontinuation|5|||
129549233|NCT02703454|466305581|FG001|Overall Study|Study discontinuation|8|||
129549234|NCT02284373|466305582|FG000|Overall Study|Withdrawal by Subject|0|||
129549235|NCT02284373|466305583|FG001|Overall Study|Withdrawal by Subject|1|||
129549236|NCT02284373|466305584|FG002|Overall Study|Withdrawal by Subject|0|||
129549237|NCT02284373|466305582|FG000|Overall Study|Other|0|||
129549238|NCT02284373|466305583|FG001|Overall Study|Other|1|||
129549239|NCT02284373|466305584|FG002|Overall Study|Other|0|||
129549240|NCT02284373|466305582|FG000|Overall Study|Lost to Follow-up|0|||
129549241|NCT02284373|466305583|FG001|Overall Study|Lost to Follow-up|1|||
129549242|NCT02284373|466305584|FG002|Overall Study|Lost to Follow-up|0|||
129549243|NCT02499406|466305585|FG000|Overall Study|missed 3 treatment sessions|4|||
129549244|NCT01396161|466305586|FG000|Overall Study|Withdrawal by Subject|0|||
129549245|NCT01396161|466305587|FG001|Overall Study|Withdrawal by Subject|0|||
129549246|NCT01396161|466305588|FG002|Overall Study|Withdrawal by Subject|0|||
129549247|NCT01396161|466305589|FG003|Overall Study|Withdrawal by Subject|0|||
129549248|NCT01396161|466305590|FG004|Overall Study|Withdrawal by Subject|1|||
129549249|NCT01396161|466305591|FG005|Overall Study|Withdrawal by Subject|0|||
129549250|NCT01396161|466305592|FG006|Overall Study|Withdrawal by Subject|0|||
129549251|NCT01396161|466305586|FG000|Overall Study|Other|0|||
129549252|NCT01396161|466305587|FG001|Overall Study|Other|0|||
129549253|NCT01396161|466305588|FG002|Overall Study|Other|0|||
129549254|NCT01396161|466305589|FG003|Overall Study|Other|0|||
129549255|NCT01396161|466305590|FG004|Overall Study|Other|0|||
129549256|NCT01396161|466305591|FG005|Overall Study|Other|0|||
129549257|NCT01396161|466305592|FG006|Overall Study|Other|1|||
129549258|NCT04651218|466305593|FG000|Overall Study|Withdrawal by Subject|0|||
129549259|NCT04651218|466305594|FG001|Overall Study|Withdrawal by Subject|2|||
129549260|NCT00414011|466305595|FG000|Overall Study|Physician Decision|3|||
129549261|NCT00414011|466305595|FG000|Overall Study|Withdrawal by Subject|2|||
129549262|NCT02476851|466305596|FG000|Overall Study|Protocol Violation|1|||
129549263|NCT02476851|466305597|FG001|Overall Study|Protocol Violation|1|||
129549264|NCT01399125|466305598|FG000|Overall Study|Adverse Event|32|||
129549265|NCT01399125|466305599|FG001|Overall Study|Adverse Event|30|||
129549266|NCT01399125|466305598|FG000|Overall Study|Abnormal Lab values|0|||
129549267|NCT01399125|466305599|FG001|Overall Study|Abnormal Lab values|1|||
129549268|NCT01399125|466305598|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129549269|NCT01399125|466305599|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
129549270|NCT01399125|466305598|FG000|Overall Study|Withdrawal by Subject|5|||
129549271|NCT01399125|466305599|FG001|Overall Study|Withdrawal by Subject|8|||
129549272|NCT01399125|466305598|FG000|Overall Study|Lost to Follow-up|2|||
129549273|NCT01399125|466305599|FG001|Overall Study|Lost to Follow-up|3|||
129549274|NCT01399125|466305598|FG000|Overall Study|Administrative Problems|7|||
129549275|NCT01399125|466305599|FG001|Overall Study|Administrative Problems|11|||
129683192|NCT03765073|466799107|FG018|Stage 2|Lost to Follow-up|0|||
129683193|NCT03765073|466799108|FG019|Stage 2|Lost to Follow-up|0|||
129683194|NCT03765073|466799109|FG020|Stage 2|Lost to Follow-up|0|||
129683195|NCT03765073|466799089|FG000|Stage 2|Other|0|||
129683196|NCT03765073|466799090|FG001|Stage 2|Other|0|||
129683197|NCT03765073|466799091|FG002|Stage 2|Other|0|||
129683198|NCT03765073|466799092|FG003|Stage 2|Other|0|||
129549276|NCT01399125|466305598|FG000|Overall Study|Death|0|||
129549277|NCT01399125|466305599|FG001|Overall Study|Death|1|||
129683199|NCT03765073|466799093|FG004|Stage 2|Other|0|||
129683200|NCT03765073|466799094|FG005|Stage 2|Other|0|||
129549278|NCT01399125|466305598|FG000|Overall Study|Protocol Deviation|5|||
129549279|NCT01399125|466305599|FG001|Overall Study|Protocol Deviation|2|||
129549280|NCT00647426|466305600|FG000|Overall Study|Withdrawal by Subject|2|||
129549281|NCT03578276|466305603|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
129549282|NCT03578276|466305604|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
129549283|NCT00981409|466305605|FG000|Overall Study|Adverse Event|4|||
129549284|NCT00981409|466305606|FG001|Overall Study|Adverse Event|0|||
129549285|NCT00981409|466305605|FG000|Overall Study|Protocol Violation|0|||
129549286|NCT00981409|466305606|FG001|Overall Study|Protocol Violation|1|||
129549287|NCT00981409|466305605|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
129683201|NCT03765073|466799095|FG006|Stage 2|Other|0|||
129683202|NCT03765073|466799096|FG007|Stage 2|Other|1|||
129549288|NCT00981409|466305606|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
129549289|NCT00078312|466305615|FG000|Overall Study|Adverse Event|43|||
129549290|NCT00078312|466305615|FG000|Overall Study|Lack of Efficacy|15|||
129549291|NCT00078312|466305615|FG000|Overall Study|Lost to Follow-up|41|||
129549292|NCT00078312|466305615|FG000|Overall Study|Physician Decision|9|||
129549293|NCT00078312|466305615|FG000|Overall Study|Protocol Violation|3|||
129549294|NCT00078312|466305615|FG000|Overall Study|Withdrawal by Subject|33|||
129549295|NCT00078312|466305615|FG000|Overall Study|Miscellaneous|33|||
129549296|NCT05354206|466305616|FG000|Overall Study|Withdrawal by Subject|1|||
129549297|NCT05354206|466305617|FG001|Overall Study|Withdrawal by Subject|0|||
129549298|NCT04285983|466305618|FG000|Overall Study|Protocol Violation|6|||
129549299|NCT04936334|466305619|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
129549300|NCT00422058|466305620|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
129549301|NCT00422058|466305621|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
129549302|NCT00422058|466305622|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
129549303|NCT00422058|466305623|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
129549304|NCT00422058|466305624|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
129549305|NCT00422058|466305625|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
129549306|NCT00422058|466305620|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
129549307|NCT00422058|466305621|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
129549308|NCT00422058|466305622|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
129549309|NCT00422058|466305623|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
129549310|NCT00422058|466305624|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
129549311|NCT00422058|466305625|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
129549312|NCT00422058|466305620|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
129549313|NCT00422058|466305621|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
129549314|NCT00422058|466305622|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
129549315|NCT00422058|466305623|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
129549316|NCT00422058|466305624|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
129549317|NCT00422058|466305625|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
129549318|NCT00422058|466305620|FG000|Double-Blind, Week 0-20|Other|11|||
129549319|NCT00422058|466305621|FG001|Double-Blind, Week 0-20|Other|3|||
129549320|NCT00422058|466305622|FG002|Double-Blind, Week 0-20|Other|8|||
129549321|NCT00422058|466305623|FG003|Double-Blind, Week 0-20|Other|8|||
129549322|NCT00422058|466305624|FG004|Double-Blind, Week 0-20|Other|4|||
129549323|NCT00422058|466305625|FG005|Double-Blind, Week 0-20|Other|10|||
129549324|NCT00422058|466305620|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
129549325|NCT00422058|466305621|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
129549326|NCT00422058|466305622|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
129549327|NCT00422058|466305623|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
129549328|NCT00422058|466305624|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
129549329|NCT00422058|466305625|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
129549330|NCT00422058|466305620|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
129549331|NCT00422058|466305621|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
129549332|NCT00422058|466305622|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
129549333|NCT00422058|466305623|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
129549334|NCT00422058|466305624|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
129549335|NCT00422058|466305625|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
129549336|NCT00422058|466305620|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
129549337|NCT00422058|466305621|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
129549338|NCT00422058|466305622|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
129549339|NCT00422058|466305623|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
129549340|NCT00422058|466305624|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
129549341|NCT00422058|466305625|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
129549342|NCT00422058|466305620|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
129549343|NCT00422058|466305621|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
129549344|NCT00422058|466305622|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
129549345|NCT00422058|466305623|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
129549346|NCT00422058|466305624|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
129549347|NCT00422058|466305625|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
129549348|NCT00422058|466305620|FG000|Open-Label Extension, Week 20-104|Other|13|||
129549349|NCT00422058|466305621|FG001|Open-Label Extension, Week 20-104|Other|14|||
129549350|NCT00422058|466305622|FG002|Open-Label Extension, Week 20-104|Other|6|||
129549351|NCT00422058|466305623|FG003|Open-Label Extension, Week 20-104|Other|13|||
129549352|NCT00422058|466305624|FG004|Open-Label Extension, Week 20-104|Other|16|||
129549353|NCT00422058|466305625|FG005|Open-Label Extension, Week 20-104|Other|18|||
129549354|NCT00103259|466305631|FG000|Overall Study|Death|3|||
129549355|NCT00103259|466305632|FG001|Overall Study|Death|2|||
129549356|NCT00103259|466305631|FG000|Overall Study|Withdrawal by Subject|2|||
129549357|NCT00103259|466305632|FG001|Overall Study|Withdrawal by Subject|3|||
129549358|NCT00103259|466305631|FG000|Overall Study|alternative therapy|1|||
129549359|NCT00103259|466305632|FG001|Overall Study|alternative therapy|0|||
129549360|NCT00103259|466305631|FG000|Overall Study|other (reasons were not specified)|2|||
129549361|NCT00103259|466305632|FG001|Overall Study|other (reasons were not specified)|1|||
129549362|NCT00103259|466305631|FG000|Overall Study|ineligible/no protocol therapy|4|||
129549363|NCT00103259|466305632|FG001|Overall Study|ineligible/no protocol therapy|6|||
129549364|NCT03224234|466305637|FG000|Main Study|Lost to Follow-up|5|||
129549365|NCT03224234|466305638|FG001|Main Study|Lost to Follow-up|5|||
129549366|NCT02866695|466305639|FG000|Overall Study|Adverse Event|1|||
129549367|NCT02866695|466305639|FG000|Overall Study|Lost to Follow-up|1|||
129549368|NCT00756652|466305640|FG000|Original Phase|Withdrawal by Subject|864|||
129549369|NCT00756652|466305641|FG001|Original Phase|Withdrawal by Subject|23|||
129549370|NCT00756652|466305640|FG000|Original Phase|Lost to Follow-up|601|||
129549371|NCT00756652|466305641|FG001|Original Phase|Lost to Follow-up|0|||
129549372|NCT00756652|466305640|FG000|Original Phase|Other Discontinuation|797|||
129549373|NCT00756652|466305641|FG001|Original Phase|Other Discontinuation|5|||
129549374|NCT00756652|466305640|FG000|Original Phase|Participant Noncompliance|18622|||
129549375|NCT00756652|466305641|FG001|Original Phase|Participant Noncompliance|424|||
129549376|NCT00756652|466305640|FG000|Original Phase|Unknown Discontinuation Reason|2|||
129549377|NCT00756652|466305641|FG001|Original Phase|Unknown Discontinuation Reason|0|||
129549378|NCT00756652|466305640|FG000|Original Phase|Participants without data|3259|||
129549379|NCT00756652|466305641|FG001|Original Phase|Participants without data|466|||
129549380|NCT00756652|466305640|FG000|Original Phase|Death|168|||
129549381|NCT00756652|466305641|FG001|Original Phase|Death|1|||
129549382|NCT00756652|466305640|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
129549383|NCT00756652|466305641|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
129549384|NCT00756652|466305640|FG000|Re-Op Phase|Withdrawal by Subject|62|||
129549385|NCT00756652|466305641|FG001|Re-Op Phase|Withdrawal by Subject|0|||
129549386|NCT00756652|466305640|FG000|Re-Op Phase|Death|6|||
129683203|NCT03765073|466799097|FG008|Stage 2|Other|1|||
129683204|NCT03765073|466799098|FG009|Stage 2|Other|3|||
129683205|NCT03765073|466799099|FG010|Stage 2|Other|0|||
129683206|NCT03765073|466799100|FG011|Stage 2|Other|0|||
129683207|NCT03765073|466799101|FG012|Stage 2|Other|0|||
129683208|NCT03765073|466799102|FG013|Stage 2|Other|0|||
129683209|NCT03765073|466799103|FG014|Stage 2|Other|0|||
129683210|NCT03765073|466799104|FG015|Stage 2|Other|1|||
129683211|NCT03765073|466799105|FG016|Stage 2|Other|2|||
129683212|NCT03765073|466799106|FG017|Stage 2|Other|0|||
129683213|NCT03765073|466799107|FG018|Stage 2|Other|0|||
129683214|NCT03765073|466799108|FG019|Stage 2|Other|0|||
129683215|NCT03765073|466799109|FG020|Stage 2|Other|0|||
129683216|NCT03765073|466799089|FG000|Stage 2|Withdrawal by parent/guardian|0|||
129683217|NCT03765073|466799090|FG001|Stage 2|Withdrawal by parent/guardian|0|||
129683218|NCT03765073|466799091|FG002|Stage 2|Withdrawal by parent/guardian|0|||
129683219|NCT03765073|466799092|FG003|Stage 2|Withdrawal by parent/guardian|0|||
129683220|NCT03765073|466799093|FG004|Stage 2|Withdrawal by parent/guardian|0|||
129683221|NCT03765073|466799094|FG005|Stage 2|Withdrawal by parent/guardian|0|||
129683222|NCT03765073|466799095|FG006|Stage 2|Withdrawal by parent/guardian|0|||
129683223|NCT03765073|466799096|FG007|Stage 2|Withdrawal by parent/guardian|0|||
129683224|NCT03765073|466799097|FG008|Stage 2|Withdrawal by parent/guardian|0|||
129683225|NCT03765073|466799098|FG009|Stage 2|Withdrawal by parent/guardian|0|||
129683226|NCT03765073|466799099|FG010|Stage 2|Withdrawal by parent/guardian|3|||
129683227|NCT03765073|466799100|FG011|Stage 2|Withdrawal by parent/guardian|3|||
129683228|NCT03765073|466799101|FG012|Stage 2|Withdrawal by parent/guardian|3|||
129683229|NCT03765073|466799102|FG013|Stage 2|Withdrawal by parent/guardian|1|||
129683230|NCT03765073|466799103|FG014|Stage 2|Withdrawal by parent/guardian|1|||
129549387|NCT00756652|466305641|FG001|Re-Op Phase|Death|0|||
129549388|NCT00756652|466305640|FG000|Re-Op Phase|Lost to Follow-up|340|||
129549389|NCT00756652|466305641|FG001|Re-Op Phase|Lost to Follow-up|0|||
129683231|NCT03765073|466799104|FG015|Stage 2|Withdrawal by parent/guardian|0|||
129683232|NCT03765073|466799105|FG016|Stage 2|Withdrawal by parent/guardian|3|||
129683233|NCT03765073|466799106|FG017|Stage 2|Withdrawal by parent/guardian|0|||
129683234|NCT03765073|466799107|FG018|Stage 2|Withdrawal by parent/guardian|0|||
129683235|NCT03765073|466799108|FG019|Stage 2|Withdrawal by parent/guardian|0|||
129683236|NCT03765073|466799109|FG020|Stage 2|Withdrawal by parent/guardian|0|||
129683237|NCT03765073|466799089|FG000|Stage 2|Withdrawal by Subject|0|||
129683238|NCT03765073|466799090|FG001|Stage 2|Withdrawal by Subject|0|||
129683239|NCT03765073|466799091|FG002|Stage 2|Withdrawal by Subject|0|||
129772095|NCT02079246|467134039|FG001|OLEX|Lost to Follow-up|0|||
129549390|NCT00756652|466305640|FG000|Re-Op Phase|Site Closed|2454|||
129683240|NCT03765073|466799092|FG003|Stage 2|Withdrawal by Subject|3|||
129683241|NCT03765073|466799093|FG004|Stage 2|Withdrawal by Subject|3|||
129683242|NCT03765073|466799094|FG005|Stage 2|Withdrawal by Subject|3|||
129549391|NCT00756652|466305641|FG001|Re-Op Phase|Site Closed|0|||
129549392|NCT00756652|466305640|FG000|Re-Op Phase|Withdrawn after explant|14|||
129549393|NCT00756652|466305641|FG001|Re-Op Phase|Withdrawn after explant|0|||
129549394|NCT02564952|466305642|FG000|Overall Study|Adverse Event|6|||
129549395|NCT02564952|466305642|FG000|Overall Study|Lost to Follow-up|1|||
129683243|NCT03765073|466799095|FG006|Stage 2|Withdrawal by Subject|0|||
129683244|NCT03765073|466799096|FG007|Stage 2|Withdrawal by Subject|1|||
129549396|NCT02564952|466305642|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
129549397|NCT02564952|466305642|FG000|Overall Study|Withdrawal by Subject|1|||
129549398|NCT02564952|466305642|FG000|Overall Study|Low Efficacy|1|||
129549399|NCT02564952|466305642|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
129549400|NCT02610842|466305643|FG000|Overall Study|Lost to Follow-up|5|||
129549401|NCT00038467|466305644|FG000|Overall Study|Adverse Event|170|||
129549402|NCT00038467|466305645|FG001|Overall Study|Adverse Event|145|||
129549403|NCT00038467|466305644|FG000|Overall Study|Withdrawal by Subject|150|||
129549404|NCT00038467|466305645|FG001|Overall Study|Withdrawal by Subject|107|||
129549405|NCT00038467|466305644|FG000|Overall Study|Protocol Violation|19|||
129549406|NCT00038467|466305645|FG001|Overall Study|Protocol Violation|22|||
129549407|NCT00038467|466305644|FG000|Overall Study|Death|22|||
129549408|NCT00038467|466305645|FG001|Overall Study|Death|16|||
129549409|NCT00038467|466305644|FG000|Overall Study|Lost to Follow-up|15|||
129549410|NCT00038467|466305645|FG001|Overall Study|Lost to Follow-up|10|||
129549411|NCT00038467|466305644|FG000|Overall Study|Recurrence|109|||
129549412|NCT00038467|466305645|FG001|Overall Study|Recurrence|179|||
129549413|NCT00038467|466305644|FG000|Overall Study|Randomized, but not treated|31|||
129549414|NCT00038467|466305645|FG001|Overall Study|Randomized, but not treated|35|||
129549415|NCT00038467|466305644|FG000|Overall Study|Other|26|||
129549416|NCT00038467|466305645|FG001|Overall Study|Other|28|||
129549417|NCT01988493|466305646|FG000|Overall Study|Randomized but not treated|0|||
129549418|NCT01988493|466305647|FG001|Overall Study|Randomized but not treated|0|||
129549419|NCT01988493|466305648|FG002|Overall Study|Randomized but not treated|0|||
129549420|NCT01988493|466305649|FG003|Overall Study|Randomized but not treated|0|||
129549421|NCT01988493|466305650|FG004|Overall Study|Randomized but not treated|1|||
129549422|NCT00627458|466305651|FG000|Overall Study|Migrated from study area|1|||
129549423|NCT00627458|466305652|FG001|Overall Study|Migrated from study area|0|||
129549424|NCT00627458|466305653|FG002|Overall Study|Migrated from study area|1|||
129549425|NCT00627458|466305651|FG000|Overall Study|Withdrawal by Subject|2|||
129549426|NCT00627458|466305652|FG001|Overall Study|Withdrawal by Subject|6|||
129549427|NCT00627458|466305653|FG002|Overall Study|Withdrawal by Subject|5|||
129549428|NCT00627458|466305651|FG000|Overall Study|Lost to Follow-up|1|||
129549429|NCT00627458|466305652|FG001|Overall Study|Lost to Follow-up|1|||
129549430|NCT00627458|466305653|FG002|Overall Study|Lost to Follow-up|0|||
129549431|NCT02617446|466305657|FG000|Overall Study|Withdrawal by Subject|0|||
129549432|NCT02617446|466305658|FG001|Overall Study|Withdrawal by Subject|2|||
129549433|NCT02617446|466305659|FG002|Overall Study|Withdrawal by Subject|0|||
129549434|NCT02617446|466305657|FG000|Overall Study|Adverse Event|1|||
129549435|NCT02617446|466305658|FG001|Overall Study|Adverse Event|0|||
129549436|NCT02617446|466305659|FG002|Overall Study|Adverse Event|5|||
129549437|NCT02617446|466305657|FG000|Overall Study|Lost to Follow-up|3|||
129549438|NCT02617446|466305658|FG001|Overall Study|Lost to Follow-up|0|||
129549439|NCT02617446|466305659|FG002|Overall Study|Lost to Follow-up|0|||
129549440|NCT02617446|466305657|FG000|Overall Study|Death|0|||
129549441|NCT02617446|466305658|FG001|Overall Study|Death|0|||
129549442|NCT02617446|466305659|FG002|Overall Study|Death|2|||
129549443|NCT00530088|466305660|FG000|Overall Study|Disease Progression|4|||
129549444|NCT00530088|466305660|FG000|Overall Study|Physician Decision|4|||
129549445|NCT00530088|466305660|FG000|Overall Study|Other Not Specified|2|||
129549446|NCT00902278|466305661|FG000|Overall Study|Physician Decision|1|||
129549447|NCT00902278|466305662|FG001|Overall Study|Physician Decision|0|||
129549448|NCT00902278|466305663|FG002|Overall Study|Physician Decision|2|||
129549449|NCT00902278|466305664|FG003|Overall Study|Physician Decision|0|||
129683245|NCT03765073|466799097|FG008|Stage 2|Withdrawal by Subject|0|||
129683246|NCT03765073|466799098|FG009|Stage 2|Withdrawal by Subject|5|||
129683247|NCT03765073|466799099|FG010|Stage 2|Withdrawal by Subject|0|||
129683248|NCT03765073|466799100|FG011|Stage 2|Withdrawal by Subject|0|||
129683249|NCT03765073|466799101|FG012|Stage 2|Withdrawal by Subject|0|||
129683250|NCT03765073|466799102|FG013|Stage 2|Withdrawal by Subject|0|||
129683251|NCT03765073|466799103|FG014|Stage 2|Withdrawal by Subject|0|||
129683252|NCT03765073|466799104|FG015|Stage 2|Withdrawal by Subject|0|||
129683253|NCT03765073|466799105|FG016|Stage 2|Withdrawal by Subject|0|||
129683254|NCT03765073|466799106|FG017|Stage 2|Withdrawal by Subject|0|||
129549450|NCT00902278|466305665|FG004|Overall Study|Physician Decision|1|||
129549451|NCT00902278|466305661|FG000|Overall Study|Lost to Follow-up|3|||
129549452|NCT00902278|466305662|FG001|Overall Study|Lost to Follow-up|2|||
129549453|NCT00902278|466305663|FG002|Overall Study|Lost to Follow-up|3|||
129549454|NCT00902278|466305664|FG003|Overall Study|Lost to Follow-up|0|||
129549455|NCT00902278|466305665|FG004|Overall Study|Lost to Follow-up|1|||
129549456|NCT04822701|466305672|FG000|Overall Study|Not treated|2|||
129549457|NCT04822701|466305673|FG001|Overall Study|Not treated|0|||
129549458|NCT04822701|466305672|FG000|Overall Study|Lost to Follow-up|1|||
129549459|NCT04822701|466305673|FG001|Overall Study|Lost to Follow-up|0|||
129549460|NCT04822701|466305672|FG000|Overall Study|Withdrawal by Subject|1|||
129549461|NCT04822701|466305673|FG001|Overall Study|Withdrawal by Subject|0|||
129683255|NCT03765073|466799107|FG018|Stage 2|Withdrawal by Subject|0|||
129683256|NCT03765073|466799108|FG019|Stage 2|Withdrawal by Subject|0|||
129549462|NCT00883740|466307450|FG000|First Intervention|Lost to Follow-up|1|||
129549463|NCT00883740|466307451|FG001|First Intervention|Lost to Follow-up|0|||
129549464|NCT00883740|466307450|FG000|First Intervention|No longer willing to participate|2|||
129549465|NCT00883740|466307451|FG001|First Intervention|No longer willing to participate|0|||
129549466|NCT00883740|466307450|FG000|First Intervention|Protocol Violation|3|||
129549467|NCT00883740|466307451|FG001|First Intervention|Protocol Violation|6|||
129549468|NCT00883740|466307450|FG000|First Intervention|Adverse Event|1|||
129549469|NCT00883740|466307451|FG001|First Intervention|Adverse Event|2|||
129549470|NCT00883740|466307450|FG000|Second Intervention|Protocol Violation|1|||
129549471|NCT00883740|466307451|FG001|Second Intervention|Protocol Violation|0|||
129549472|NCT00883740|466307450|FG000|Second Intervention|No longer willing to participate|0|||
129549473|NCT00883740|466307451|FG001|Second Intervention|No longer willing to participate|1|||
129549474|NCT03543046|466307456|FG000|Overall Study|Adverse Event|1|||
129549475|NCT03543046|466307457|FG001|Overall Study|Adverse Event|1|||
129549476|NCT03543046|466307456|FG000|Overall Study|Physician Decision|1|||
129549477|NCT03543046|466307457|FG001|Overall Study|Physician Decision|1|||
129549478|NCT03543046|466307456|FG000|Overall Study|Protocol Violation|1|||
129549479|NCT03543046|466307457|FG001|Overall Study|Protocol Violation|0|||
129549480|NCT03869684|466307458|FG000|Overall Study|Adverse Event|0|||
129549481|NCT03869684|466307459|FG001|Overall Study|Adverse Event|3|||
129549482|NCT03869684|466307460|FG002|Overall Study|Adverse Event|1|||
129549483|NCT03869684|466307458|FG000|Overall Study|Withdrawal by Subject|1|||
129549484|NCT03869684|466307459|FG001|Overall Study|Withdrawal by Subject|0|||
129549485|NCT03869684|466307460|FG002|Overall Study|Withdrawal by Subject|0|||
129549486|NCT03869684|466307458|FG000|Overall Study|Lost to Follow-up|1|||
129549487|NCT03869684|466307459|FG001|Overall Study|Lost to Follow-up|0|||
129549488|NCT03869684|466307460|FG002|Overall Study|Lost to Follow-up|0|||
129549489|NCT03869684|466307458|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
129549490|NCT03869684|466307459|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
129549491|NCT03869684|466307460|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
129549492|NCT04056299|466307461|FG000|Overall Study|Sponsor discontinued study|3|||
129549493|NCT04056299|466307462|FG001|Overall Study|Sponsor discontinued study|3|||
129549494|NCT01227954|466307467|FG000|Overall Study|Protocol Violation|6|||
129549495|NCT01227954|466307467|FG000|Overall Study|No protocol treatment|7|||
129549496|NCT01296152|466307468|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
129549497|NCT01414062|466307473|FG000|Overall Study|Lost to Follow-up|3|||
129549498|NCT01414062|466307474|FG001|Overall Study|Lost to Follow-up|2|||
129549499|NCT01414062|466307473|FG000|Overall Study|Left Country|1|||
129549500|NCT01414062|466307474|FG001|Overall Study|Left Country|1|||
129683257|NCT03765073|466799109|FG020|Stage 2|Withdrawal by Subject|0|||
129549501|NCT01414062|466307473|FG000|Overall Study|Family Disapproval|1|||
129683258|NCT03765073|466799089|FG000|Stage 3|Adverse Event|0|||
129683259|NCT03765073|466799090|FG001|Stage 3|Adverse Event|0|||
129683260|NCT03765073|466799091|FG002|Stage 3|Adverse Event|0|||
129683261|NCT03765073|466799092|FG003|Stage 3|Adverse Event|0|||
129683262|NCT03765073|466799093|FG004|Stage 3|Adverse Event|0|||
129683263|NCT03765073|466799094|FG005|Stage 3|Adverse Event|0|||
129683264|NCT03765073|466799095|FG006|Stage 3|Adverse Event|0|||
129683265|NCT03765073|466799096|FG007|Stage 3|Adverse Event|0|||
129683266|NCT03765073|466799097|FG008|Stage 3|Adverse Event|0|||
129683267|NCT03765073|466799098|FG009|Stage 3|Adverse Event|0|||
129683268|NCT03765073|466799099|FG010|Stage 3|Adverse Event|0|||
129683269|NCT03765073|466799100|FG011|Stage 3|Adverse Event|0|||
129683270|NCT03765073|466799101|FG012|Stage 3|Adverse Event|0|||
129683271|NCT03765073|466799102|FG013|Stage 3|Adverse Event|0|||
129683272|NCT03765073|466799103|FG014|Stage 3|Adverse Event|0|||
129683273|NCT03765073|466799104|FG015|Stage 3|Adverse Event|0|||
129683274|NCT03765073|466799105|FG016|Stage 3|Adverse Event|0|||
129683275|NCT03765073|466799106|FG017|Stage 3|Adverse Event|0|||
129683276|NCT03765073|466799107|FG018|Stage 3|Adverse Event|1|||
129683277|NCT03765073|466799108|FG019|Stage 3|Adverse Event|0|||
129683278|NCT03765073|466799109|FG020|Stage 3|Adverse Event|0|||
129549502|NCT01414062|466307474|FG001|Overall Study|Family Disapproval|0|||
129549503|NCT01414062|466307473|FG000|Overall Study|Withdrawal by Subject|0|||
129549504|NCT01414062|466307474|FG001|Overall Study|Withdrawal by Subject|1|||
129549505|NCT02787785|466307477|FG000|Overall Study|Death|3|||
129683279|NCT03765073|466799089|FG000|Stage 3|Death|0|||
129683280|NCT03765073|466799090|FG001|Stage 3|Death|0|||
129683281|NCT03765073|466799091|FG002|Stage 3|Death|0|||
129549506|NCT02787785|466307478|FG001|Overall Study|Death|4|||
129549507|NCT02787785|466307477|FG000|Overall Study|Lost to Follow-up|1|||
129549508|NCT02787785|466307478|FG001|Overall Study|Lost to Follow-up|1|||
129549509|NCT02787785|466307477|FG000|Overall Study|Withdrawal by Subject|0|||
129683282|NCT03765073|466799092|FG003|Stage 3|Death|0|||
129683283|NCT03765073|466799093|FG004|Stage 3|Death|0|||
129683284|NCT03765073|466799094|FG005|Stage 3|Death|0|||
129683285|NCT03765073|466799095|FG006|Stage 3|Death|0|||
129683286|NCT03765073|466799096|FG007|Stage 3|Death|0|||
129683287|NCT03765073|466799097|FG008|Stage 3|Death|0|||
129683288|NCT03765073|466799098|FG009|Stage 3|Death|0|||
129683289|NCT03765073|466799099|FG010|Stage 3|Death|0|||
129683290|NCT03765073|466799100|FG011|Stage 3|Death|0|||
129772096|NCT02079246|467134038|FG000|OLEX|Protocol Violation|6|||
129772097|NCT02079246|467134039|FG001|OLEX|Protocol Violation|0|||
129772098|NCT02079246|467134038|FG000|OLEX|Lack of Efficacy|3|||
129772099|NCT02079246|467134039|FG001|OLEX|Lack of Efficacy|0|||
129772100|NCT02079246|467134038|FG000|OLEX|Results of the lead-in studies|58|||
129772101|NCT02079246|467134039|FG001|OLEX|Results of the lead-in studies|0|||
129772102|NCT02079246|467134038|FG000|OLEX|Other: Disallowed medication|8|||
129772103|NCT02079246|467134039|FG001|OLEX|Other: Disallowed medication|0|||
129772104|NCT02079246|467134038|FG000|OLEX|Other: Insufficient compliance|2|||
129772105|NCT02079246|467134039|FG001|OLEX|Other: Insufficient compliance|0|||
129772106|NCT02079246|467134038|FG000|OLEX|Other: Caregiver unavailable|3|||
129772107|NCT02079246|467134039|FG001|OLEX|Other: Caregiver unavailable|0|||
129772108|NCT02079246|467134038|FG000|OLEX|Other: Coordinator decision|1|||
129772109|NCT02079246|467134039|FG001|OLEX|Other: Coordinator decision|0|||
129772110|NCT02079246|467134038|FG000|OLEX|Other: Worsening of condition|1|||
129772111|NCT02079246|467134039|FG001|OLEX|Other: Worsening of condition|0|||
129772112|NCT02079246|467134038|FG000|OLEX|Other: Moved to nursing home|1|||
129772113|NCT02079246|467134039|FG001|OLEX|Other: Moved to nursing home|0|||
129772114|NCT02079246|467134038|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
129772115|NCT02079246|467134039|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
129772116|NCT02079246|467134038|FG000|OLEX-MEM|Adverse Event|0|||
129772117|NCT02079246|467134039|FG001|OLEX-MEM|Adverse Event|6|||
129772118|NCT02079246|467134038|FG000|OLEX-MEM|Withdrawal by Subject|0|||
129772119|NCT02079246|467134039|FG001|OLEX-MEM|Withdrawal by Subject|7|||
129772120|NCT02079246|467134038|FG000|OLEX-MEM|Protocol Violation|0|||
129772121|NCT02079246|467134039|FG001|OLEX-MEM|Protocol Violation|2|||
129772122|NCT02079246|467134038|FG000|OLEX-MEM|Lost to Follow-up|0|||
129772123|NCT02079246|467134039|FG001|OLEX-MEM|Lost to Follow-up|1|||
129772124|NCT02079246|467134038|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
129772125|NCT02079246|467134039|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
129772126|NCT03077412|467134040|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
129772127|NCT03077412|467134041|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
129772128|NCT03077412|467134042|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
129772129|NCT03077412|467134040|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
129772130|NCT03077412|467134041|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
129772131|NCT03077412|467134042|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
129772132|NCT03077412|467134040|FG000|Overall Study|Adverse Event|1|||
129772133|NCT03077412|467134041|FG001|Overall Study|Adverse Event|2|||
129772134|NCT03077412|467134042|FG002|Overall Study|Adverse Event|2|||
129772135|NCT03077412|467134040|FG000|Overall Study|Investigator's Discretion|0|||
129772136|NCT03077412|467134041|FG001|Overall Study|Investigator's Discretion|1|||
129772137|NCT03077412|467134042|FG002|Overall Study|Investigator's Discretion|1|||
129772138|NCT03077412|467134040|FG000|Overall Study|Withdrew Consent|0|||
129772139|NCT03077412|467134041|FG001|Overall Study|Withdrew Consent|2|||
129772140|NCT03077412|467134042|FG002|Overall Study|Withdrew Consent|0|||
129772141|NCT02266888|467134043|FG000|Overall Study|Death|2|||
129772142|NCT02266888|467134044|FG001|Overall Study|Death|2|||
129772143|NCT02266888|467134045|FG002|Overall Study|Death|4|||
129772144|NCT02266888|467134046|FG003|Overall Study|Death|2|||
129772145|NCT02266888|467134043|FG000|Overall Study|Physician Decision|0|||
129772146|NCT02266888|467134044|FG001|Overall Study|Physician Decision|1|||
129772147|NCT02266888|467134045|FG002|Overall Study|Physician Decision|2|||
129772148|NCT02266888|467134046|FG003|Overall Study|Physician Decision|2|||
129772149|NCT02266888|467134043|FG000|Overall Study|Study Terminated|5|||
129772150|NCT02266888|467134044|FG001|Overall Study|Study Terminated|1|||
129772151|NCT02266888|467134045|FG002|Overall Study|Study Terminated|0|||
129772152|NCT02266888|467134046|FG003|Overall Study|Study Terminated|0|||
129772153|NCT02266888|467134043|FG000|Overall Study|No Longer Eligible|0|||
129772154|NCT02266888|467134044|FG001|Overall Study|No Longer Eligible|0|||
129772155|NCT02266888|467134045|FG002|Overall Study|No Longer Eligible|0|||
129772156|NCT02266888|467134046|FG003|Overall Study|No Longer Eligible|2|||
129772157|NCT02266888|467134043|FG000|Overall Study|Randomization Closed|0|||
129772158|NCT02266888|467134044|FG001|Overall Study|Randomization Closed|0|||
129772159|NCT02266888|467134045|FG002|Overall Study|Randomization Closed|4|||
129772160|NCT02266888|467134046|FG003|Overall Study|Randomization Closed|0|||
129772161|NCT02266888|467134043|FG000|Overall Study|Personnel unavailable at transplant|0|||
129772162|NCT02266888|467134044|FG001|Overall Study|Personnel unavailable at transplant|0|||
129549510|NCT02787785|466307478|FG001|Overall Study|Withdrawal by Subject|5|||
129549511|NCT01850108|466307481|FG000|Overall Study|Lost to Follow-up|4|||
129549512|NCT01850108|466307481|FG000|Overall Study|Not eligible|1|||
129549513|NCT01850108|466307481|FG000|Overall Study|Failed engraftment|2|||
129549514|NCT01850108|466307481|FG000|Overall Study|Physician Decision|1|||
129549515|NCT04330482|466307486|FG000|Overall Study|Lost to Follow-up|2|||
129549516|NCT04330482|466307487|FG001|Overall Study|Lost to Follow-up|1|||
129549517|NCT04330482|466307486|FG000|Overall Study|Withdrawal by Subject|0|||
129549518|NCT04330482|466307487|FG001|Overall Study|Withdrawal by Subject|3|||
129549519|NCT05144477|466307489|FG000|Overall Study|Withdrawal by Subject|1|||
129549520|NCT05144477|466307490|FG001|Overall Study|Withdrawal by Subject|1|||
129549521|NCT04333199|466307493|FG000|Evaluated Patients|Lost to Follow-up|0|||
129549522|NCT04333199|466307494|FG001|Evaluated Patients|Lost to Follow-up|1|||
129549523|NCT04333199|466307495|FG002|Evaluated Patients|Lost to Follow-up|2|||
129549524|NCT01155284|466307504|FG000|Overall Study|Withdrawal by Subject|4|||
129549525|NCT01155284|466307505|FG001|Overall Study|Withdrawal by Subject|3|||
129549526|NCT01155284|466307504|FG000|Overall Study|Lost to Follow-up|1|||
129549527|NCT01155284|466307505|FG001|Overall Study|Lost to Follow-up|2|||
129549528|NCT01155284|466307504|FG000|Overall Study|Physician Decision|1|||
129549529|NCT01155284|466307505|FG001|Overall Study|Physician Decision|0|||
129549530|NCT01155284|466307504|FG000|Overall Study|Adverse Event|1|||
129549531|NCT01155284|466307505|FG001|Overall Study|Adverse Event|0|||
129549532|NCT02268045|466307506|FG000|Overall Study|Death|4|||
129549533|NCT02268045|466307507|FG001|Overall Study|Death|4|||
129549534|NCT02268045|466307506|FG000|Overall Study|Disease Progression|2|||
129549535|NCT02268045|466307507|FG001|Overall Study|Disease Progression|1|||
129549536|NCT02268045|466307506|FG000|Overall Study|Adverse Event|7|||
129549537|NCT02268045|466307507|FG001|Overall Study|Adverse Event|7|||
129549538|NCT02268045|466307506|FG000|Overall Study|Withdrawal by Subject|2|||
129549539|NCT02268045|466307507|FG001|Overall Study|Withdrawal by Subject|6|||
129549540|NCT02268045|466307506|FG000|Overall Study|Physician Decision|0|||
129549541|NCT02268045|466307507|FG001|Overall Study|Physician Decision|1|||
129549542|NCT02268045|466307506|FG000|Overall Study|Protocol Violation|1|||
129549543|NCT02268045|466307507|FG001|Overall Study|Protocol Violation|1|||
129549544|NCT01766310|466307508|FG000|Overall Study|Lost to Follow-up|1|||
129549545|NCT01766310|466307509|FG001|Overall Study|Lost to Follow-up|3|||
129549546|NCT01154673|466307510|FG000|Overall Study|Lost to Follow-up|1|||
129549547|NCT01154673|466307511|FG001|Overall Study|Lost to Follow-up|0|||
129549548|NCT01154673|466307510|FG000|Overall Study|moved out of province|1|||
129549549|NCT01154673|466307511|FG001|Overall Study|moved out of province|0|||
129549550|NCT00646282|466307512|FG000|Overall Study|Protocol terminated|4|||
129549551|NCT00646282|466307513|FG001|Overall Study|Protocol terminated|4|||
129549552|NCT01556490|466307522|FG000|Randomized Patients Summary|Protocol Violation|22|||
129549553|NCT01556490|466307523|FG001|Randomized Patients Summary|Protocol Violation|23|||
129549554|NCT01556490|466307522|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
129549555|NCT01556490|466307523|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
129549556|NCT01289990|466307527|FG000|Overall Study|Death|0|||
129549557|NCT01289990|466307528|FG001|Overall Study|Death|0|||
129549558|NCT01289990|466307529|FG002|Overall Study|Death|0|||
129549559|NCT01289990|466307530|FG003|Overall Study|Death|1|||
129549560|NCT01289990|466307531|FG004|Overall Study|Death|2|||
129549561|NCT01289990|466307532|FG005|Overall Study|Death|1|||
129549562|NCT01289990|466307533|FG006|Overall Study|Death|0|||
129549563|NCT01289990|466307534|FG007|Overall Study|Death|0|||
129549564|NCT01289990|466307535|FG008|Overall Study|Death|0|||
129549565|NCT01289990|466307536|FG009|Overall Study|Death|0|||
129549566|NCT01289990|466307537|FG010|Overall Study|Death|0|||
129549567|NCT01289990|466307538|FG011|Overall Study|Death|1|||
129549568|NCT01289990|466307539|FG012|Overall Study|Death|0|||
129549569|NCT01289990|466307527|FG000|Overall Study|Lost to Follow-up|3|||
129549570|NCT01289990|466307528|FG001|Overall Study|Lost to Follow-up|2|||
129549571|NCT01289990|466307529|FG002|Overall Study|Lost to Follow-up|5|||
129549572|NCT01289990|466307530|FG003|Overall Study|Lost to Follow-up|5|||
129549573|NCT01289990|466307531|FG004|Overall Study|Lost to Follow-up|3|||
129549574|NCT01289990|466307532|FG005|Overall Study|Lost to Follow-up|4|||
129549575|NCT01289990|466307533|FG006|Overall Study|Lost to Follow-up|2|||
129549576|NCT01289990|466307534|FG007|Overall Study|Lost to Follow-up|2|||
129549577|NCT01289990|466307535|FG008|Overall Study|Lost to Follow-up|1|||
129549578|NCT01289990|466307536|FG009|Overall Study|Lost to Follow-up|4|||
129549579|NCT01289990|466307537|FG010|Overall Study|Lost to Follow-up|2|||
129549580|NCT01289990|466307538|FG011|Overall Study|Lost to Follow-up|1|||
129549581|NCT01289990|466307539|FG012|Overall Study|Lost to Follow-up|2|||
129549582|NCT01289990|466307527|FG000|Overall Study|Withdrawal by Subject|15|||
129549583|NCT01289990|466307528|FG001|Overall Study|Withdrawal by Subject|14|||
129549584|NCT01289990|466307529|FG002|Overall Study|Withdrawal by Subject|12|||
129549585|NCT01289990|466307530|FG003|Overall Study|Withdrawal by Subject|13|||
129683291|NCT03765073|466799101|FG012|Stage 3|Death|0|||
129683292|NCT03765073|466799102|FG013|Stage 3|Death|0|||
129683293|NCT03765073|466799103|FG014|Stage 3|Death|0|||
129549586|NCT01289990|466307531|FG004|Overall Study|Withdrawal by Subject|8|||
129549587|NCT01289990|466307532|FG005|Overall Study|Withdrawal by Subject|7|||
129549588|NCT01289990|466307533|FG006|Overall Study|Withdrawal by Subject|13|||
129549589|NCT01289990|466307534|FG007|Overall Study|Withdrawal by Subject|9|||
129549590|NCT01289990|466307535|FG008|Overall Study|Withdrawal by Subject|12|||
129549591|NCT01289990|466307536|FG009|Overall Study|Withdrawal by Subject|13|||
129549592|NCT01289990|466307537|FG010|Overall Study|Withdrawal by Subject|11|||
129549593|NCT01289990|466307538|FG011|Overall Study|Withdrawal by Subject|13|||
129549594|NCT01289990|466307539|FG012|Overall Study|Withdrawal by Subject|16|||
129549595|NCT01289990|466307527|FG000|Overall Study|discontinued in preceding trial|18|||
129549596|NCT01289990|466307528|FG001|Overall Study|discontinued in preceding trial|20|||
129549597|NCT01289990|466307529|FG002|Overall Study|discontinued in preceding trial|41|||
129549598|NCT01289990|466307530|FG003|Overall Study|discontinued in preceding trial|17|||
129549599|NCT01289990|466307531|FG004|Overall Study|discontinued in preceding trial|11|||
129549600|NCT01289990|466307532|FG005|Overall Study|discontinued in preceding trial|12|||
129549601|NCT01289990|466307533|FG006|Overall Study|discontinued in preceding trial|18|||
129549602|NCT01289990|466307534|FG007|Overall Study|discontinued in preceding trial|8|||
129549603|NCT01289990|466307535|FG008|Overall Study|discontinued in preceding trial|17|||
129549604|NCT01289990|466307536|FG009|Overall Study|discontinued in preceding trial|21|||
129549605|NCT01289990|466307537|FG010|Overall Study|discontinued in preceding trial|17|||
129549606|NCT01289990|466307538|FG011|Overall Study|discontinued in preceding trial|17|||
129549607|NCT01289990|466307539|FG012|Overall Study|discontinued in preceding trial|24|||
129549608|NCT01289990|466307527|FG000|Overall Study|did not continue in extension|41|||
129549609|NCT01289990|466307528|FG001|Overall Study|did not continue in extension|45|||
129549610|NCT01289990|466307529|FG002|Overall Study|did not continue in extension|51|||
129549611|NCT01289990|466307530|FG003|Overall Study|did not continue in extension|51|||
129549612|NCT01289990|466307531|FG004|Overall Study|did not continue in extension|48|||
129549613|NCT01289990|466307532|FG005|Overall Study|did not continue in extension|50|||
129549614|NCT01289990|466307533|FG006|Overall Study|did not continue in extension|54|||
129549615|NCT01289990|466307534|FG007|Overall Study|did not continue in extension|36|||
129549616|NCT01289990|466307535|FG008|Overall Study|did not continue in extension|44|||
129549617|NCT01289990|466307536|FG009|Overall Study|did not continue in extension|48|||
129549618|NCT01289990|466307537|FG010|Overall Study|did not continue in extension|45|||
129549619|NCT01289990|466307538|FG011|Overall Study|did not continue in extension|34|||
129549620|NCT01289990|466307539|FG012|Overall Study|did not continue in extension|56|||
129549621|NCT01289990|466307527|FG000|Overall Study|Not treated|0|||
129549622|NCT01289990|466307528|FG001|Overall Study|Not treated|0|||
129549623|NCT01289990|466307529|FG002|Overall Study|Not treated|0|||
129549624|NCT01289990|466307530|FG003|Overall Study|Not treated|0|||
129549625|NCT01289990|466307531|FG004|Overall Study|Not treated|0|||
129549626|NCT01289990|466307532|FG005|Overall Study|Not treated|0|||
129549627|NCT01289990|466307533|FG006|Overall Study|Not treated|1|||
129549628|NCT01289990|466307534|FG007|Overall Study|Not treated|0|||
129549629|NCT01289990|466307535|FG008|Overall Study|Not treated|1|||
129549630|NCT01289990|466307536|FG009|Overall Study|Not treated|0|||
129549631|NCT01289990|466307537|FG010|Overall Study|Not treated|1|||
129549632|NCT01289990|466307538|FG011|Overall Study|Not treated|2|||
129549633|NCT01289990|466307539|FG012|Overall Study|Not treated|0|||
129549634|NCT04529499|466307540|FG000|Overall Study|Withdrawal by Subject|9|||
129549635|NCT04529499|466307541|FG001|Overall Study|Withdrawal by Subject|11|||
129549636|NCT04529499|466307540|FG000|Overall Study|Physician Decision|1|||
129683294|NCT03765073|466799104|FG015|Stage 3|Death|0|||
129683295|NCT03765073|466799105|FG016|Stage 3|Death|0|||
129683296|NCT03765073|466799106|FG017|Stage 3|Death|0|||
129683297|NCT03765073|466799107|FG018|Stage 3|Death|0|||
129683298|NCT03765073|466799108|FG019|Stage 3|Death|3|||
129683299|NCT03765073|466799109|FG020|Stage 3|Death|2|||
129683300|NCT03765073|466799089|FG000|Stage 3|Lost to Follow-up|0|||
129683301|NCT03765073|466799090|FG001|Stage 3|Lost to Follow-up|0|||
129683302|NCT03765073|466799091|FG002|Stage 3|Lost to Follow-up|0|||
129683303|NCT03765073|466799092|FG003|Stage 3|Lost to Follow-up|0|||
129683304|NCT03765073|466799093|FG004|Stage 3|Lost to Follow-up|0|||
129683305|NCT03765073|466799094|FG005|Stage 3|Lost to Follow-up|0|||
129683306|NCT03765073|466799095|FG006|Stage 3|Lost to Follow-up|0|||
129683307|NCT03765073|466799096|FG007|Stage 3|Lost to Follow-up|0|||
129683308|NCT03765073|466799097|FG008|Stage 3|Lost to Follow-up|0|||
129683309|NCT03765073|466799098|FG009|Stage 3|Lost to Follow-up|0|||
129683310|NCT03765073|466799099|FG010|Stage 3|Lost to Follow-up|0|||
129683311|NCT03765073|466799100|FG011|Stage 3|Lost to Follow-up|0|||
129683312|NCT03765073|466799101|FG012|Stage 3|Lost to Follow-up|0|||
129683313|NCT03765073|466799102|FG013|Stage 3|Lost to Follow-up|0|||
129683314|NCT03765073|466799103|FG014|Stage 3|Lost to Follow-up|0|||
129683315|NCT03765073|466799104|FG015|Stage 3|Lost to Follow-up|0|||
129683316|NCT03765073|466799105|FG016|Stage 3|Lost to Follow-up|0|||
129683317|NCT03765073|466799106|FG017|Stage 3|Lost to Follow-up|8|||
129683318|NCT03765073|466799107|FG018|Stage 3|Lost to Follow-up|5|||
129683319|NCT03765073|466799108|FG019|Stage 3|Lost to Follow-up|7|||
129683320|NCT03765073|466799109|FG020|Stage 3|Lost to Follow-up|4|||
129683321|NCT03765073|466799089|FG000|Stage 3|No longer meets eligibility criteria|0|||
129683322|NCT03765073|466799090|FG001|Stage 3|No longer meets eligibility criteria|0|||
129683323|NCT03765073|466799091|FG002|Stage 3|No longer meets eligibility criteria|0|||
129683324|NCT03765073|466799092|FG003|Stage 3|No longer meets eligibility criteria|0|||
129683325|NCT03765073|466799093|FG004|Stage 3|No longer meets eligibility criteria|0|||
129683326|NCT03765073|466799094|FG005|Stage 3|No longer meets eligibility criteria|0|||
129683327|NCT03765073|466799095|FG006|Stage 3|No longer meets eligibility criteria|0|||
129683328|NCT03765073|466799096|FG007|Stage 3|No longer meets eligibility criteria|0|||
129683329|NCT03765073|466799097|FG008|Stage 3|No longer meets eligibility criteria|0|||
129683330|NCT03765073|466799098|FG009|Stage 3|No longer meets eligibility criteria|0|||
129683331|NCT03765073|466799099|FG010|Stage 3|No longer meets eligibility criteria|0|||
129683332|NCT03765073|466799100|FG011|Stage 3|No longer meets eligibility criteria|0|||
129683333|NCT03765073|466799101|FG012|Stage 3|No longer meets eligibility criteria|0|||
129683334|NCT03765073|466799102|FG013|Stage 3|No longer meets eligibility criteria|0|||
129683335|NCT03765073|466799103|FG014|Stage 3|No longer meets eligibility criteria|0|||
129683336|NCT03765073|466799104|FG015|Stage 3|No longer meets eligibility criteria|0|||
129683337|NCT03765073|466799105|FG016|Stage 3|No longer meets eligibility criteria|0|||
129683338|NCT03765073|466799106|FG017|Stage 3|No longer meets eligibility criteria|0|||
129683339|NCT03765073|466799107|FG018|Stage 3|No longer meets eligibility criteria|1|||
129683340|NCT03765073|466799108|FG019|Stage 3|No longer meets eligibility criteria|0|||
129683341|NCT03765073|466799109|FG020|Stage 3|No longer meets eligibility criteria|1|||
129683342|NCT03765073|466799089|FG000|Stage 3|Other|0|||
129683343|NCT03765073|466799090|FG001|Stage 3|Other|0|||
129683344|NCT03765073|466799091|FG002|Stage 3|Other|0|||
129683345|NCT03765073|466799092|FG003|Stage 3|Other|0|||
129683346|NCT03765073|466799093|FG004|Stage 3|Other|0|||
129683347|NCT03765073|466799094|FG005|Stage 3|Other|0|||
129683348|NCT03765073|466799095|FG006|Stage 3|Other|0|||
129683349|NCT03765073|466799096|FG007|Stage 3|Other|0|||
129683350|NCT03765073|466799097|FG008|Stage 3|Other|0|||
129683351|NCT03765073|466799098|FG009|Stage 3|Other|0|||
129683352|NCT03765073|466799099|FG010|Stage 3|Other|0|||
129683353|NCT03765073|466799100|FG011|Stage 3|Other|0|||
129683354|NCT03765073|466799101|FG012|Stage 3|Other|0|||
129683355|NCT03765073|466799102|FG013|Stage 3|Other|0|||
129683356|NCT03765073|466799103|FG014|Stage 3|Other|0|||
129683357|NCT03765073|466799104|FG015|Stage 3|Other|0|||
129683358|NCT03765073|466799105|FG016|Stage 3|Other|0|||
129683359|NCT03765073|466799106|FG017|Stage 3|Other|1|||
129683360|NCT03765073|466799107|FG018|Stage 3|Other|2|||
129683361|NCT03765073|466799108|FG019|Stage 3|Other|2|||
129683362|NCT03765073|466799109|FG020|Stage 3|Other|2|||
129683363|NCT03765073|466799089|FG000|Stage 3|Withdrawal by parent/guardian|0|||
129683364|NCT03765073|466799090|FG001|Stage 3|Withdrawal by parent/guardian|0|||
129683365|NCT03765073|466799091|FG002|Stage 3|Withdrawal by parent/guardian|0|||
129683366|NCT03765073|466799092|FG003|Stage 3|Withdrawal by parent/guardian|0|||
129683367|NCT03765073|466799093|FG004|Stage 3|Withdrawal by parent/guardian|0|||
129683368|NCT03765073|466799094|FG005|Stage 3|Withdrawal by parent/guardian|0|||
129683369|NCT03765073|466799095|FG006|Stage 3|Withdrawal by parent/guardian|0|||
129683370|NCT03765073|466799096|FG007|Stage 3|Withdrawal by parent/guardian|0|||
129683371|NCT03765073|466799097|FG008|Stage 3|Withdrawal by parent/guardian|0|||
129683372|NCT03765073|466799098|FG009|Stage 3|Withdrawal by parent/guardian|0|||
129683373|NCT03765073|466799099|FG010|Stage 3|Withdrawal by parent/guardian|0|||
129683374|NCT03765073|466799100|FG011|Stage 3|Withdrawal by parent/guardian|0|||
129683375|NCT03765073|466799101|FG012|Stage 3|Withdrawal by parent/guardian|0|||
129683376|NCT03765073|466799102|FG013|Stage 3|Withdrawal by parent/guardian|0|||
129683377|NCT03765073|466799103|FG014|Stage 3|Withdrawal by parent/guardian|0|||
129683378|NCT03765073|466799104|FG015|Stage 3|Withdrawal by parent/guardian|0|||
129683379|NCT03765073|466799105|FG016|Stage 3|Withdrawal by parent/guardian|0|||
129683380|NCT03765073|466799106|FG017|Stage 3|Withdrawal by parent/guardian|0|||
129683381|NCT03765073|466799107|FG018|Stage 3|Withdrawal by parent/guardian|0|||
129683382|NCT03765073|466799108|FG019|Stage 3|Withdrawal by parent/guardian|6|||
129683383|NCT03765073|466799109|FG020|Stage 3|Withdrawal by parent/guardian|9|||
129683384|NCT03765073|466799089|FG000|Stage 3|Withdrawal by Subject|0|||
129683385|NCT03765073|466799090|FG001|Stage 3|Withdrawal by Subject|0|||
129683386|NCT03765073|466799091|FG002|Stage 3|Withdrawal by Subject|0|||
129683387|NCT03765073|466799092|FG003|Stage 3|Withdrawal by Subject|0|||
129683388|NCT03765073|466799093|FG004|Stage 3|Withdrawal by Subject|0|||
129683389|NCT03765073|466799094|FG005|Stage 3|Withdrawal by Subject|0|||
129549637|NCT04529499|466307541|FG001|Overall Study|Physician Decision|2|||
129683390|NCT03765073|466799095|FG006|Stage 3|Withdrawal by Subject|0|||
129683391|NCT03765073|466799096|FG007|Stage 3|Withdrawal by Subject|0|||
129683392|NCT03765073|466799097|FG008|Stage 3|Withdrawal by Subject|0|||
129683393|NCT03765073|466799098|FG009|Stage 3|Withdrawal by Subject|0|||
129683394|NCT03765073|466799099|FG010|Stage 3|Withdrawal by Subject|0|||
129683395|NCT03765073|466799100|FG011|Stage 3|Withdrawal by Subject|0|||
129683396|NCT03765073|466799101|FG012|Stage 3|Withdrawal by Subject|0|||
129683397|NCT03765073|466799102|FG013|Stage 3|Withdrawal by Subject|0|||
129683398|NCT03765073|466799103|FG014|Stage 3|Withdrawal by Subject|0|||
129683399|NCT03765073|466799104|FG015|Stage 3|Withdrawal by Subject|0|||
129549638|NCT04529499|466307540|FG000|Overall Study|Adverse Event|4|||
129549639|NCT04529499|466307541|FG001|Overall Study|Adverse Event|4|||
129549640|NCT04529499|466307540|FG000|Overall Study|Death|14|||
129549641|NCT04529499|466307541|FG001|Overall Study|Death|11|||
129549642|NCT04529499|466307540|FG000|Overall Study|Lost to Follow-up|1|||
129549643|NCT04529499|466307541|FG001|Overall Study|Lost to Follow-up|1|||
129549644|NCT04529499|466307540|FG000|Overall Study|Others|7|||
129549645|NCT04529499|466307541|FG001|Overall Study|Others|11|||
129683400|NCT03765073|466799105|FG016|Stage 3|Withdrawal by Subject|0|||
129683401|NCT03765073|466799106|FG017|Stage 3|Withdrawal by Subject|8|||
129683402|NCT03765073|466799107|FG018|Stage 3|Withdrawal by Subject|11|||
129683403|NCT03765073|466799108|FG019|Stage 3|Withdrawal by Subject|0|||
129683404|NCT03765073|466799109|FG020|Stage 3|Withdrawal by Subject|0|||
129683405|NCT04537299|466799110|FG000|Overall Study|Withdrawal by Subject|2|||
129683406|NCT04537299|466799111|FG001|Overall Study|Withdrawal by Subject|0|||
129683407|NCT04537299|466799110|FG000|Overall Study|Protocol Violation|1|||
129683408|NCT04537299|466799111|FG001|Overall Study|Protocol Violation|1|||
129683409|NCT03806296|466799114|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
129683410|NCT03806296|466799115|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
129683411|NCT03806296|466799116|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
129683412|NCT03806296|466799114|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
129683413|NCT03806296|466799115|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
129683414|NCT03806296|466799116|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
129683415|NCT03806296|466799114|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
129683416|NCT03806296|466799115|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
129683417|NCT03806296|466799116|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
129683418|NCT00876343|466799123|FG000|Overall Study|Adverse Event|7|||
129683419|NCT00876343|466799124|FG001|Overall Study|Adverse Event|8|||
129683420|NCT00876343|466799125|FG002|Overall Study|Adverse Event|2|||
129683421|NCT00876343|466799123|FG000|Overall Study|Withdrawal by Subject|4|||
129683422|NCT00876343|466799124|FG001|Overall Study|Withdrawal by Subject|4|||
129683423|NCT00876343|466799125|FG002|Overall Study|Withdrawal by Subject|3|||
129683424|NCT00876343|466799123|FG000|Overall Study|Lack of Efficacy|0|||
129683425|NCT00876343|466799124|FG001|Overall Study|Lack of Efficacy|0|||
129683426|NCT00876343|466799125|FG002|Overall Study|Lack of Efficacy|1|||
129683427|NCT00876343|466799123|FG000|Overall Study|Protocol Violation|4|||
129683428|NCT00876343|466799124|FG001|Overall Study|Protocol Violation|1|||
129683429|NCT00876343|466799125|FG002|Overall Study|Protocol Violation|1|||
129683430|NCT00876343|466799123|FG000|Overall Study|Physician Decision|0|||
129683431|NCT00876343|466799124|FG001|Overall Study|Physician Decision|1|||
129683432|NCT00876343|466799125|FG002|Overall Study|Physician Decision|1|||
129683433|NCT00876343|466799123|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
129683434|NCT00876343|466799124|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
129683435|NCT00876343|466799125|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
129683436|NCT00876343|466799123|FG000|Overall Study|Change of residence or other commitments|2|||
129683437|NCT00876343|466799124|FG001|Overall Study|Change of residence or other commitments|2|||
129683438|NCT00876343|466799125|FG002|Overall Study|Change of residence or other commitments|3|||
129683439|NCT01933932|466799128|FG000|Overall Study|Death|173|||
129683440|NCT01933932|466799129|FG001|Overall Study|Death|163|||
129683441|NCT01933932|466799128|FG000|Overall Study|Withdrawal by Subject|11|||
129683442|NCT01933932|466799129|FG001|Overall Study|Withdrawal by Subject|14|||
129683443|NCT01933932|466799128|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129683444|NCT01933932|466799129|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129683445|NCT01925794|466799137|FG000|180 Days|Death|2|||
129683446|NCT01925794|466799137|FG000|180 Days|Withdrawal by Subject|2|||
129683447|NCT01925794|466799137|FG000|270 Days|Death|2|||
129683448|NCT01925794|466799137|FG000|270 Days|Protocol Violation|3|||
129683449|NCT00790036|466799138|FG000|Overall Study|Abnormal lab values|3|||
129683450|NCT00790036|466799139|FG001|Overall Study|Abnormal lab values|2|||
129683451|NCT00790036|466799138|FG000|Overall Study|Administrative problems|5|||
129683452|NCT00790036|466799139|FG001|Overall Study|Administrative problems|9|||
129683453|NCT00790036|466799138|FG000|Overall Study|Adverse Event|113|||
129683454|NCT00790036|466799139|FG001|Overall Study|Adverse Event|44|||
129683455|NCT00790036|466799138|FG000|Overall Study|Death|1|||
129683456|NCT00790036|466799139|FG001|Overall Study|Death|0|||
129683457|NCT00790036|466799138|FG000|Overall Study|Disease progression|24|||
129549646|NCT00683904|466307542|FG000|Dose Level 1|Disease progression|2|||
129549647|NCT00683904|466307543|FG001|Dose Level 1|Disease progression|0|||
129549648|NCT00683904|466307542|FG000|Dose Level 1|Adverse Event|1|||
129549649|NCT00683904|466307543|FG001|Dose Level 1|Adverse Event|0|||
129683458|NCT00790036|466799139|FG001|Overall Study|Disease progression|48|||
129683459|NCT00790036|466799138|FG000|Overall Study|Lost to Follow-up|1|||
129683460|NCT00790036|466799139|FG001|Overall Study|Lost to Follow-up|2|||
129683461|NCT00790036|466799138|FG000|Overall Study|Protocol Violation|10|||
129683462|NCT00790036|466799139|FG001|Overall Study|Protocol Violation|2|||
129683463|NCT00790036|466799138|FG000|Overall Study|Withdrawal by Subject|18|||
129683464|NCT00790036|466799139|FG001|Overall Study|Withdrawal by Subject|7|||
129549650|NCT00683904|466307542|FG000|Dose Level 2|Adverse Event|0|||
129549651|NCT00683904|466307543|FG001|Dose Level 2|Adverse Event|2|||
129549652|NCT00758706|466307544|FG000|Overall Study|Adverse Event|4|||
129549653|NCT00758706|466307545|FG001|Overall Study|Adverse Event|4|||
129549654|NCT03467971|466307546|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129549655|NCT03467971|466307547|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129549656|NCT01488071|466307548|FG000|Overall Study|Adverse Event|15|||
129549657|NCT01488071|466307549|FG001|Overall Study|Adverse Event|23|||
129549658|NCT01488071|466307548|FG000|Overall Study|Lack of Efficacy|11|||
129549659|NCT01488071|466307549|FG001|Overall Study|Lack of Efficacy|17|||
129549660|NCT01488071|466307548|FG000|Overall Study|Non-compliance with study drug|2|||
129549661|NCT01488071|466307549|FG001|Overall Study|Non-compliance with study drug|0|||
129549662|NCT01488071|466307548|FG000|Overall Study|Protocol Violation|5|||
129549663|NCT01488071|466307549|FG001|Overall Study|Protocol Violation|7|||
129549664|NCT01488071|466307548|FG000|Overall Study|Withdrawal of Consent|14|||
129549665|NCT01488071|466307549|FG001|Overall Study|Withdrawal of Consent|12|||
129549666|NCT01488071|466307548|FG000|Overall Study|Lost to Follow-up|1|||
129549667|NCT01488071|466307549|FG001|Overall Study|Lost to Follow-up|0|||
129549668|NCT01488071|466307548|FG000|Overall Study|Administrative or Other Reason(s)|5|||
129549669|NCT01488071|466307549|FG001|Overall Study|Administrative or Other Reason(s)|4|||
129549670|NCT05789420|466307550|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
129549671|NCT05789420|466307550|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
129549672|NCT02587325|466307551|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
129549673|NCT02587325|466307552|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
129549674|NCT02587325|466307553|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
129549675|NCT02587325|466307554|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
129549676|NCT02587325|466307555|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
129549677|NCT02587325|466307551|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
129549678|NCT02587325|466307552|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
129549679|NCT02587325|466307553|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
129549680|NCT02587325|466307554|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
129549681|NCT02587325|466307555|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
129549682|NCT02587325|466307551|FG000|32-Week Optional Extension Part|Adverse Event|0|||
129549683|NCT02587325|466307552|FG001|32-Week Optional Extension Part|Adverse Event|0|||
129549684|NCT02587325|466307553|FG002|32-Week Optional Extension Part|Adverse Event|1|||
129549685|NCT02587325|466307554|FG003|32-Week Optional Extension Part|Adverse Event|0|||
129549686|NCT02587325|466307555|FG004|32-Week Optional Extension Part|Adverse Event|0|||
129549687|NCT02587325|466307551|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
129549688|NCT02587325|466307552|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
129549689|NCT02587325|466307553|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
129549690|NCT02587325|466307554|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
129549691|NCT02587325|466307555|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
129549692|NCT01220128|466307556|FG000|Overall Study|Progressive disease|0|||
129549693|NCT01220128|466307557|FG001|Overall Study|Progressive disease|0|||
129549694|NCT01220128|466307558|FG002|Overall Study|Progressive disease|2|||
129549695|NCT01220128|466307559|FG003|Overall Study|Progressive disease|0|||
129549696|NCT01220128|466307560|FG004|Overall Study|Progressive disease|0|||
129549697|NCT01220128|466307561|FG005|Overall Study|Progressive disease|0|||
129549698|NCT01220128|466307562|FG006|Overall Study|Progressive disease|0|||
129549699|NCT01220128|466307556|FG000|Overall Study|Sponsor study termination|0|||
129549700|NCT01220128|466307557|FG001|Overall Study|Sponsor study termination|1|||
129549701|NCT01220128|466307558|FG002|Overall Study|Sponsor study termination|0|||
129549702|NCT01220128|466307559|FG003|Overall Study|Sponsor study termination|0|||
129549703|NCT01220128|466307560|FG004|Overall Study|Sponsor study termination|0|||
129549704|NCT01220128|466307561|FG005|Overall Study|Sponsor study termination|0|||
129549705|NCT01220128|466307562|FG006|Overall Study|Sponsor study termination|1|||
129549706|NCT01220128|466307556|FG000|Overall Study|Adverse event, serious fatal|2|||
129549707|NCT01220128|466307557|FG001|Overall Study|Adverse event, serious fatal|0|||
129683465|NCT00790036|466799138|FG000|Overall Study|Subject/guardian decision|20|||
129683466|NCT00790036|466799139|FG001|Overall Study|Subject/guardian decision|7|||
129549708|NCT01220128|466307558|FG002|Overall Study|Adverse event, serious fatal|0|||
129549709|NCT01220128|466307559|FG003|Overall Study|Adverse event, serious fatal|0|||
129549710|NCT01220128|466307560|FG004|Overall Study|Adverse event, serious fatal|0|||
129549711|NCT01220128|466307561|FG005|Overall Study|Adverse event, serious fatal|0|||
129549712|NCT01220128|466307562|FG006|Overall Study|Adverse event, serious fatal|1|||
129549713|NCT01220128|466307556|FG000|Overall Study|Adverse event, non-fatal|1|||
129549714|NCT01220128|466307557|FG001|Overall Study|Adverse event, non-fatal|0|||
129549715|NCT01220128|466307558|FG002|Overall Study|Adverse event, non-fatal|0|||
129549716|NCT01220128|466307559|FG003|Overall Study|Adverse event, non-fatal|0|||
129549717|NCT01220128|466307560|FG004|Overall Study|Adverse event, non-fatal|0|||
129549718|NCT01220128|466307561|FG005|Overall Study|Adverse event, non-fatal|0|||
129549719|NCT01220128|466307562|FG006|Overall Study|Adverse event, non-fatal|3|||
129549720|NCT01220128|466307556|FG000|Overall Study|Other|0|||
129549721|NCT01220128|466307557|FG001|Overall Study|Other|0|||
129549722|NCT01220128|466307558|FG002|Overall Study|Other|1|||
129549723|NCT01220128|466307559|FG003|Overall Study|Other|0|||
129549724|NCT01220128|466307560|FG004|Overall Study|Other|0|||
129549725|NCT01220128|466307561|FG005|Overall Study|Other|0|||
129549726|NCT01220128|466307562|FG006|Overall Study|Other|0|||
129549727|NCT01220128|466307556|FG000|Overall Study|Consent withdrawn by subject|1|||
129549728|NCT01220128|466307557|FG001|Overall Study|Consent withdrawn by subject|0|||
129549729|NCT01220128|466307558|FG002|Overall Study|Consent withdrawn by subject|0|||
129549730|NCT01220128|466307559|FG003|Overall Study|Consent withdrawn by subject|0|||
129549731|NCT01220128|466307560|FG004|Overall Study|Consent withdrawn by subject|0|||
129549732|NCT01220128|466307561|FG005|Overall Study|Consent withdrawn by subject|0|||
129549733|NCT01220128|466307562|FG006|Overall Study|Consent withdrawn by subject|0|||
129549734|NCT00000135|466307563|FG000|Overall Study|Death|27|||
129549735|NCT00000135|466307564|FG001|Overall Study|Death|14|||
129549736|NCT02340078|466307565|FG000|Overall Study|Protocol Violation|1|||
129549737|NCT01831596|466307566|FG000|Overall Study|Other|8|||
129549738|NCT02524665|466307570|FG000|Overall Study|Lost to Follow-up|1|||
129549739|NCT02602080|466307571|FG000|Overall Study|Protocol Violation|6|||
129549740|NCT02602080|466307572|FG001|Overall Study|Protocol Violation|1|||
129549741|NCT02602080|466307573|FG002|Overall Study|Protocol Violation|3|||
129549742|NCT04355767|466307579|FG000|Overall Study|Withdrawal by Subject|2|||
129549743|NCT04355767|466307580|FG001|Overall Study|Withdrawal by Subject|2|||
129549744|NCT04355767|466307579|FG000|Overall Study|Death|5|||
129549745|NCT04355767|466307580|FG001|Overall Study|Death|1|||
129549746|NCT01999322|466307581|FG000|Overall Study|Adverse Event|1|||
129549747|NCT01999322|466307582|FG001|Overall Study|Adverse Event|0|||
129549748|NCT02200614|466307583|FG000|Double Blind Treatment|Adverse Event|86|||
129772163|NCT02266888|467134045|FG002|Overall Study|Personnel unavailable at transplant|0|||
129772164|NCT02266888|467134046|FG003|Overall Study|Personnel unavailable at transplant|1|||
129772165|NCT02266888|467134043|FG000|Overall Study|Transfer of care|0|||
129772166|NCT02266888|467134044|FG001|Overall Study|Transfer of care|0|||
129772167|NCT02266888|467134045|FG002|Overall Study|Transfer of care|1|||
129772168|NCT02266888|467134046|FG003|Overall Study|Transfer of care|0|||
129772169|NCT02351856|467134047|FG000|Overall Study|Adverse Event|2|||
129772170|NCT02351856|467134047|FG000|Overall Study|Physician Decision|5|||
129772171|NCT02351856|467134047|FG000|Overall Study|Study terminated by sponsor|1|||
129772172|NCT01458392|467134048|FG000|Overall Study|Death|2|||
129772173|NCT01458392|467134049|FG001|Overall Study|Death|11|||
129683467|NCT03126110|466799148|FG000|Phase 1|Death|2|||
129683468|NCT03126110|466799149|FG001|Phase 1|Death|2|||
129683469|NCT03126110|466799150|FG002|Phase 1|Death|4|||
129683470|NCT03126110|466799151|FG003|Phase 1|Death|3|||
129683471|NCT03126110|466799152|FG004|Phase 1|Death|4|||
129683472|NCT03126110|466799153|FG005|Phase 1|Death|4|||
129683473|NCT03126110|466799154|FG006|Phase 1|Death|3|||
129683474|NCT03126110|466799155|FG007|Phase 1|Death|4|||
129683475|NCT03126110|466799156|FG008|Phase 1|Death|5|||
129683476|NCT03126110|466799157|FG009|Phase 1|Death|2|||
129683477|NCT03126110|466799158|FG010|Phase 1|Death|6|||
129683478|NCT03126110|466799159|FG011|Phase 1|Death|0|||
129683479|NCT03126110|466799160|FG012|Phase 1|Death|0|||
129683480|NCT03126110|466799161|FG013|Phase 1|Death|0|||
129683481|NCT03126110|466799162|FG014|Phase 1|Death|0|||
129683482|NCT03126110|466799163|FG015|Phase 1|Death|0|||
129683483|NCT03126110|466799164|FG016|Phase 1|Death|0|||
129683484|NCT03126110|466799148|FG000|Phase 1|Lost to Follow-up|0|||
129683485|NCT03126110|466799149|FG001|Phase 1|Lost to Follow-up|1|||
129683486|NCT03126110|466799150|FG002|Phase 1|Lost to Follow-up|0|||
129683487|NCT03126110|466799151|FG003|Phase 1|Lost to Follow-up|0|||
129683488|NCT03126110|466799152|FG004|Phase 1|Lost to Follow-up|0|||
129683489|NCT03126110|466799153|FG005|Phase 1|Lost to Follow-up|0|||
129683490|NCT03126110|466799154|FG006|Phase 1|Lost to Follow-up|0|||
129683491|NCT03126110|466799155|FG007|Phase 1|Lost to Follow-up|0|||
129683492|NCT03126110|466799156|FG008|Phase 1|Lost to Follow-up|1|||
129772174|NCT01458392|467134050|FG002|Overall Study|Death|22|||
129549749|NCT02200614|466307584|FG001|Double Blind Treatment|Adverse Event|48|||
129549750|NCT02200614|466307583|FG000|Double Blind Treatment|Confirmed metastasis|120|||
129549751|NCT02200614|466307584|FG001|Double Blind Treatment|Confirmed metastasis|140|||
129549752|NCT02200614|466307583|FG000|Double Blind Treatment|Judgment of the investigator|59|||
129683493|NCT03126110|466799157|FG009|Phase 1|Lost to Follow-up|0|||
129549753|NCT02200614|466307584|FG001|Double Blind Treatment|Judgment of the investigator|99|||
129549754|NCT02200614|466307583|FG000|Double Blind Treatment|Metastasis by local reading|1|||
129683494|NCT03126110|466799158|FG010|Phase 1|Lost to Follow-up|0|||
129683495|NCT03126110|466799159|FG011|Phase 1|Lost to Follow-up|0|||
129683496|NCT03126110|466799160|FG012|Phase 1|Lost to Follow-up|0|||
129683497|NCT03126110|466799161|FG013|Phase 1|Lost to Follow-up|0|||
129772175|NCT01458392|467134048|FG000|Overall Study|At the discretion of the sponsor|0|||
129772176|NCT01458392|467134049|FG001|Overall Study|At the discretion of the sponsor|2|||
129772177|NCT01458392|467134050|FG002|Overall Study|At the discretion of the sponsor|7|||
129683498|NCT03126110|466799162|FG014|Phase 1|Lost to Follow-up|0|||
129683499|NCT03126110|466799163|FG015|Phase 1|Lost to Follow-up|0|||
129683500|NCT03126110|466799164|FG016|Phase 1|Lost to Follow-up|0|||
129683501|NCT03126110|466799148|FG000|Phase 1|Withdrawal by Subject|1|||
129549755|NCT02200614|466307584|FG001|Double Blind Treatment|Metastasis by local reading|3|||
129549756|NCT02200614|466307583|FG000|Double Blind Treatment|Other reason|6|||
129549757|NCT02200614|466307584|FG001|Double Blind Treatment|Other reason|2|||
129549758|NCT02200614|466307583|FG000|Double Blind Treatment|Personal reason|77|||
129549759|NCT02200614|466307584|FG001|Double Blind Treatment|Personal reason|85|||
129549760|NCT02200614|466307583|FG000|Double Blind Treatment|Protocol deviation|14|||
129549761|NCT02200614|466307584|FG001|Double Blind Treatment|Protocol deviation|7|||
129549762|NCT02200614|466307583|FG000|Double Blind Treatment|Not treated|1|||
129549763|NCT02200614|466307584|FG001|Double Blind Treatment|Not treated|0|||
129549764|NCT02200614|466307583|FG000|Open Label|Adverse Event|41|||
129549765|NCT02200614|466307584|FG001|Open Label|Adverse Event|11|||
129549766|NCT02200614|466307583|FG000|Open Label|Confirmed metastasis|1|||
129549767|NCT02200614|466307584|FG001|Open Label|Confirmed metastasis|0|||
129549768|NCT02200614|466307583|FG000|Open Label|Judgment of the investigator|29|||
129549769|NCT02200614|466307584|FG001|Open Label|Judgment of the investigator|2|||
129549770|NCT02200614|466307583|FG000|Open Label|Metastasis by local reading|138|||
129549771|NCT02200614|466307584|FG001|Open Label|Metastasis by local reading|27|||
129549772|NCT02200614|466307583|FG000|Open Label|Other reason|22|||
129549773|NCT02200614|466307584|FG001|Open Label|Other reason|4|||
129549774|NCT02200614|466307583|FG000|Open Label|Personal reason|60|||
129549775|NCT02200614|466307584|FG001|Open Label|Personal reason|8|||
129549776|NCT02200614|466307583|FG000|Open Label|Protocol deviation|3|||
129549777|NCT02200614|466307584|FG001|Open Label|Protocol deviation|2|||
129549778|NCT02200614|466307583|FG000|Open Label|Missing|2|||
129549779|NCT02200614|466307584|FG001|Open Label|Missing|2|||
129549780|NCT03302299|466309339|FG000|Overall Study|Protocol Violation|1|||
129549781|NCT00391092|466309340|FG000|Overall Study|Death|78|||
129549782|NCT00391092|466309341|FG001|Overall Study|Death|81|||
129549783|NCT00391092|466309340|FG000|Overall Study|Lost to Follow-up|13|||
129549784|NCT00391092|466309341|FG001|Overall Study|Lost to Follow-up|18|||
129549785|NCT00391092|466309340|FG000|Overall Study|Alive on treatment|29|||
129549786|NCT00391092|466309341|FG001|Overall Study|Alive on treatment|33|||
129549787|NCT00391092|466309340|FG000|Overall Study|Alive in follow-up|88|||
129549788|NCT00391092|466309341|FG001|Overall Study|Alive in follow-up|84|||
129549789|NCT04318535|466309342|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
129549790|NCT04318535|466309343|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
129549791|NCT04318535|466309344|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
129549792|NCT01901146|466309346|FG000|Neoadjuvant Phase|Death|1|||
129549793|NCT01901146|466309347|FG001|Neoadjuvant Phase|Death|2|||
129549794|NCT01901146|466309348|FG002|Neoadjuvant Phase|Death|0|||
129549795|NCT01901146|466309349|FG003|Neoadjuvant Phase|Death|0|||
129549796|NCT01901146|466309350|FG004|Neoadjuvant Phase|Death|0|||
129549797|NCT01901146|466309346|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
129549798|NCT01901146|466309347|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
129549799|NCT01901146|466309348|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
129549800|NCT01901146|466309349|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
129549801|NCT01901146|466309350|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
129549802|NCT01901146|466309346|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
129549803|NCT01901146|466309347|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
129549804|NCT01901146|466309348|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
129549805|NCT01901146|466309349|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
129549806|NCT01901146|466309350|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
129549807|NCT01901146|466309346|FG000|Neoadjuvant Phase|Physician Decision|1|||
129549808|NCT01901146|466309347|FG001|Neoadjuvant Phase|Physician Decision|2|||
129549809|NCT01901146|466309348|FG002|Neoadjuvant Phase|Physician Decision|0|||
129549810|NCT01901146|466309349|FG003|Neoadjuvant Phase|Physician Decision|0|||
129549811|NCT01901146|466309350|FG004|Neoadjuvant Phase|Physician Decision|0|||
129549812|NCT01901146|466309346|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
129549813|NCT01901146|466309347|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
129549814|NCT01901146|466309348|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
129549815|NCT01901146|466309349|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
129549816|NCT01901146|466309350|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
129549817|NCT01901146|466309346|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
129683502|NCT03126110|466799149|FG001|Phase 1|Withdrawal by Subject|0|||
129683503|NCT03126110|466799150|FG002|Phase 1|Withdrawal by Subject|0|||
129683504|NCT03126110|466799151|FG003|Phase 1|Withdrawal by Subject|1|||
129549818|NCT01901146|466309347|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
129683505|NCT03126110|466799152|FG004|Phase 1|Withdrawal by Subject|1|||
129549819|NCT01901146|466309348|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
129549820|NCT01901146|466309349|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
129549821|NCT01901146|466309350|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
129683506|NCT03126110|466799153|FG005|Phase 1|Withdrawal by Subject|0|||
129549822|NCT01901146|466309346|FG000|Adjuvant Phase|Other|0|||
129549823|NCT01901146|466309347|FG001|Adjuvant Phase|Other|0|||
129549824|NCT01901146|466309348|FG002|Adjuvant Phase|Other|1|||
129549825|NCT01901146|466309349|FG003|Adjuvant Phase|Other|0|||
129549826|NCT01901146|466309350|FG004|Adjuvant Phase|Other|0|||
129549827|NCT01901146|466309346|FG000|Adjuvant Phase|Death|0|||
129549828|NCT01901146|466309347|FG001|Adjuvant Phase|Death|0|||
129549829|NCT01901146|466309348|FG002|Adjuvant Phase|Death|0|||
129549830|NCT01901146|466309349|FG003|Adjuvant Phase|Death|0|||
129549831|NCT01901146|466309350|FG004|Adjuvant Phase|Death|3|||
129549832|NCT01901146|466309346|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
129549833|NCT01901146|466309347|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
129549834|NCT01901146|466309348|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
129549835|NCT01901146|466309349|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
129549836|NCT01901146|466309350|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
129549837|NCT01901146|466309346|FG000|Adjuvant Phase|Physician Decision|0|||
129549838|NCT01901146|466309347|FG001|Adjuvant Phase|Physician Decision|0|||
129549839|NCT01901146|466309348|FG002|Adjuvant Phase|Physician Decision|9|||
129549840|NCT01901146|466309349|FG003|Adjuvant Phase|Physician Decision|2|||
129549841|NCT01901146|466309350|FG004|Adjuvant Phase|Physician Decision|4|||
129549842|NCT01901146|466309346|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
129549843|NCT01901146|466309347|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
129549844|NCT01901146|466309348|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
129549845|NCT01901146|466309349|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
129549846|NCT01901146|466309350|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
129549847|NCT01614925|466309351|FG000|Overall Study|Withdrawal by Subject|1|||
129549848|NCT01614925|466309352|FG001|Overall Study|Withdrawal by Subject|0|||
129549849|NCT01614925|466309351|FG000|Overall Study|Protocol Violation|3|||
129549850|NCT01614925|466309352|FG001|Overall Study|Protocol Violation|2|||
129549851|NCT02996448|466309355|FG000|Overall Study|Study terminated due to adverse effects|3|||
129549852|NCT00606801|466309356|FG000|Intervention|Protocol Violation|3|||
129549853|NCT00606801|466309357|FG001|Intervention|Protocol Violation|3|||
129549854|NCT00303316|466309360|FG000|Overall Study|Protocol Violation|1|||
129549855|NCT00303316|466309361|FG001|Overall Study|Protocol Violation|0|||
129549856|NCT00303316|466309360|FG000|Overall Study|Lost to Follow-up|0|||
129549857|NCT00303316|466309361|FG001|Overall Study|Lost to Follow-up|1|||
129549858|NCT00303316|466309360|FG000|Overall Study|Withdrawal by Subject|1|||
129549859|NCT00303316|466309361|FG001|Overall Study|Withdrawal by Subject|2|||
129549860|NCT01586624|466309362|FG000|Overall Study|Adverse Event|3|||
129549861|NCT01586624|466309363|FG001|Overall Study|Adverse Event|0|||
129549862|NCT01586624|466309364|FG002|Overall Study|Adverse Event|2|||
129549863|NCT01586624|466309365|FG003|Overall Study|Adverse Event|1|||
129549864|NCT01586624|466309366|FG004|Overall Study|Adverse Event|3|||
129549865|NCT01586624|466309367|FG005|Overall Study|Adverse Event|3|||
129549866|NCT01586624|466309368|FG006|Overall Study|Adverse Event|2|||
129549867|NCT01586624|466309369|FG007|Overall Study|Adverse Event|3|||
129549868|NCT01586624|466309362|FG000|Overall Study|Physician Decision|0|||
129549869|NCT01586624|466309363|FG001|Overall Study|Physician Decision|1|||
129549870|NCT01586624|466309364|FG002|Overall Study|Physician Decision|1|||
129549871|NCT01586624|466309365|FG003|Overall Study|Physician Decision|0|||
129549872|NCT01586624|466309366|FG004|Overall Study|Physician Decision|2|||
129549873|NCT01586624|466309367|FG005|Overall Study|Physician Decision|0|||
129549874|NCT01586624|466309368|FG006|Overall Study|Physician Decision|1|||
129549875|NCT01586624|466309369|FG007|Overall Study|Physician Decision|1|||
129549876|NCT01586624|466309362|FG000|Overall Study|Withdrawal by Subject|0|||
129549877|NCT01586624|466309363|FG001|Overall Study|Withdrawal by Subject|0|||
129549878|NCT01586624|466309364|FG002|Overall Study|Withdrawal by Subject|0|||
129549879|NCT01586624|466309365|FG003|Overall Study|Withdrawal by Subject|1|||
129549880|NCT01586624|466309366|FG004|Overall Study|Withdrawal by Subject|0|||
129549881|NCT01586624|466309367|FG005|Overall Study|Withdrawal by Subject|0|||
129549882|NCT01586624|466309368|FG006|Overall Study|Withdrawal by Subject|0|||
129549883|NCT01586624|466309369|FG007|Overall Study|Withdrawal by Subject|0|||
129549884|NCT01586624|466309362|FG000|Overall Study|Evidence of disease progression|1|||
129549885|NCT01586624|466309363|FG001|Overall Study|Evidence of disease progression|3|||
129549886|NCT01586624|466309364|FG002|Overall Study|Evidence of disease progression|2|||
129549887|NCT01586624|466309365|FG003|Overall Study|Evidence of disease progression|5|||
129683507|NCT03126110|466799154|FG006|Phase 1|Withdrawal by Subject|0|||
129549888|NCT01586624|466309366|FG004|Overall Study|Evidence of disease progression|3|||
129683508|NCT03126110|466799155|FG007|Phase 1|Withdrawal by Subject|0|||
129549889|NCT01586624|466309367|FG005|Overall Study|Evidence of disease progression|5|||
129549890|NCT01586624|466309368|FG006|Overall Study|Evidence of disease progression|4|||
129549891|NCT01586624|466309369|FG007|Overall Study|Evidence of disease progression|6|||
129549892|NCT01586624|466309362|FG000|Overall Study|Screen failure (no treatment received)|0|||
129549893|NCT01586624|466309363|FG001|Overall Study|Screen failure (no treatment received)|0|||
129549894|NCT01586624|466309364|FG002|Overall Study|Screen failure (no treatment received)|0|||
129683509|NCT03126110|466799156|FG008|Phase 1|Withdrawal by Subject|2|||
129683510|NCT03126110|466799157|FG009|Phase 1|Withdrawal by Subject|1|||
129549895|NCT01586624|466309365|FG003|Overall Study|Screen failure (no treatment received)|0|||
129549896|NCT01586624|466309366|FG004|Overall Study|Screen failure (no treatment received)|0|||
129549897|NCT01586624|466309367|FG005|Overall Study|Screen failure (no treatment received)|0|||
129549898|NCT01586624|466309368|FG006|Overall Study|Screen failure (no treatment received)|1|||
129549899|NCT01586624|466309369|FG007|Overall Study|Screen failure (no treatment received)|0|||
129549900|NCT01160198|466309372|FG000|Overall Study|Withdrawal by Subject|2|||
129549901|NCT01160198|466309373|FG001|Overall Study|Withdrawal by Subject|1|||
129549902|NCT01160198|466309374|FG002|Overall Study|Withdrawal by Subject|0|||
129549903|NCT01160198|466309372|FG000|Overall Study|Adverse Event|0|||
129549904|NCT01160198|466309373|FG001|Overall Study|Adverse Event|1|||
129549905|NCT01160198|466309374|FG002|Overall Study|Adverse Event|0|||
129549906|NCT01160198|466309372|FG000|Overall Study|Lost to Follow-up|0|||
129549907|NCT01160198|466309373|FG001|Overall Study|Lost to Follow-up|1|||
129549908|NCT01160198|466309374|FG002|Overall Study|Lost to Follow-up|0|||
129549909|NCT01160198|466309372|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
129549910|NCT01160198|466309373|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
129549911|NCT01160198|466309374|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
129549912|NCT02016755|466309376|FG000|Overall Study|Major amputation of index limb|2|||
129549913|NCT02016755|466309376|FG000|Overall Study|Adverse Event|2|||
129549914|NCT02016755|466309376|FG000|Overall Study|Physician Decision|1|||
129549915|NCT02016755|466309376|FG000|Overall Study|Death|2|||
129549916|NCT00306852|466309380|FG000|Overall Study|Death|14|||
129549917|NCT00306852|466309381|FG001|Overall Study|Death|14|||
129549918|NCT00306852|466309380|FG000|Overall Study|Lost to Follow-up|15|||
129549919|NCT00306852|466309381|FG001|Overall Study|Lost to Follow-up|24|||
129549920|NCT03343054|466309383|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
129549921|NCT03343054|466309384|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
129549922|NCT03343054|466309385|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
129549923|NCT03343054|466309383|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
129549924|NCT03343054|466309384|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
129549925|NCT03343054|466309385|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
129549926|NCT03343054|466309383|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
129549927|NCT03343054|466309384|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
129549928|NCT03343054|466309385|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
129549929|NCT03343054|466309383|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
129549930|NCT03343054|466309384|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
129549931|NCT03343054|466309385|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
129549932|NCT01467570|466309386|FG000|Overall Study|Lost to Follow-up|8|||
129549933|NCT01467570|466309387|FG001|Overall Study|Lost to Follow-up|9|||
129549934|NCT02626182|466309388|FG000|Overall Study|Adverse Event|2|||
129549935|NCT02626182|466309389|FG001|Overall Study|Adverse Event|0|||
129549936|NCT02766088|466309392|FG000|Overall Study|Sponsor study termination|498|||
129549937|NCT02766088|466309392|FG000|Overall Study|Migrated/moved from the study area|1|||
129549938|NCT02766088|466309392|FG000|Overall Study|Lost to Follow-up|5|||
129549939|NCT02766088|466309392|FG000|Overall Study|Other|1|||
129549940|NCT02766088|466309392|FG000|Overall Study|Death|1|||
129549941|NCT01222715|466309393|FG000|Overall Study|Adverse Event|0|||
129549942|NCT01222715|466309394|FG001|Overall Study|Adverse Event|4|||
129549943|NCT01222715|466309393|FG000|Overall Study|Death|0|||
129549944|NCT01222715|466309394|FG001|Overall Study|Death|1|||
129549945|NCT01222715|466309393|FG000|Overall Study|Lack of Efficacy|22|||
129549946|NCT01222715|466309394|FG001|Overall Study|Lack of Efficacy|14|||
129549947|NCT01222715|466309393|FG000|Overall Study|Physician Decision|12|||
129549948|NCT01222715|466309394|FG001|Overall Study|Physician Decision|2|||
129549949|NCT01222715|466309393|FG000|Overall Study|Refusal of further protocol therapy|0|||
129549950|NCT01222715|466309394|FG001|Overall Study|Refusal of further protocol therapy|4|||
129549951|NCT01222715|466309393|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
129549952|NCT01222715|466309394|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
129549953|NCT01222715|466309393|FG000|Overall Study|Ineligible|0|||
129683511|NCT03126110|466799158|FG010|Phase 1|Withdrawal by Subject|0|||
129683512|NCT03126110|466799159|FG011|Phase 1|Withdrawal by Subject|0|||
129683513|NCT03126110|466799160|FG012|Phase 1|Withdrawal by Subject|0|||
129683514|NCT03126110|466799161|FG013|Phase 1|Withdrawal by Subject|0|||
129683515|NCT03126110|466799162|FG014|Phase 1|Withdrawal by Subject|0|||
129549954|NCT01222715|466309394|FG001|Overall Study|Ineligible|1|||
129549955|NCT01222715|466309393|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
129549956|NCT01222715|466309394|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
129549957|NCT03555890|466309403|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129549958|NCT03555890|466309404|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129683516|NCT03126110|466799163|FG015|Phase 1|Withdrawal by Subject|0|||
129683517|NCT03126110|466799164|FG016|Phase 1|Withdrawal by Subject|0|||
129549959|NCT03555890|466309405|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129549960|NCT03555890|466309406|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129549961|NCT03372369|466309407|FG000|Qualification Period|Withdrawal by Subject|16|||
129549962|NCT03372369|466309408|FG001|Qualification Period|Withdrawal by Subject|13|||
129549963|NCT03372369|466309407|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
129549964|NCT03372369|466309408|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
129549965|NCT03372369|466309407|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
129549966|NCT03372369|466309408|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
129549967|NCT02239601|466309409|FG000|Overall Study|Withdrawal by Subject|3|||
129549968|NCT02239601|466309410|FG001|Overall Study|Withdrawal by Subject|4|||
129549969|NCT02239601|466309409|FG000|Overall Study|Protocol Violation|4|||
129549970|NCT02239601|466309410|FG001|Overall Study|Protocol Violation|2|||
129549971|NCT01508325|466309411|FG000|Overall Study|Withdrawal by Subject|8|||
129549972|NCT01508325|466309412|FG001|Overall Study|Withdrawal by Subject|9|||
129549973|NCT01508325|466309411|FG000|Overall Study|Protocol Violation|0|||
129549974|NCT01508325|466309412|FG001|Overall Study|Protocol Violation|3|||
129549975|NCT01508325|466309411|FG000|Overall Study|Physician Decision|2|||
129549976|NCT01508325|466309412|FG001|Overall Study|Physician Decision|1|||
129549977|NCT01508325|466309411|FG000|Overall Study|Adverse Event|1|||
129549978|NCT01508325|466309412|FG001|Overall Study|Adverse Event|0|||
129549979|NCT01508325|466309411|FG000|Overall Study|Lost to Follow-up|5|||
129549980|NCT01508325|466309412|FG001|Overall Study|Lost to Follow-up|6|||
129549981|NCT01508325|466309411|FG000|Overall Study|Other|2|||
129549982|NCT01508325|466309412|FG001|Overall Study|Other|2|||
129549983|NCT04682639|466309413|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
129549984|NCT04682639|466309414|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
129549985|NCT04682639|466309415|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
129549986|NCT04682639|466309416|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
129549987|NCT04682639|466309417|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
129549988|NCT04682639|466309413|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
129549989|NCT04682639|466309414|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
129549990|NCT04682639|466309415|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
129549991|NCT04682639|466309416|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129549992|NCT04682639|466309417|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129549993|NCT04682639|466309413|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
129549994|NCT04682639|466309414|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129549995|NCT04682639|466309415|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129549996|NCT04682639|466309416|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129549997|NCT04682639|466309417|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129549998|NCT04682639|466309413|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
129549999|NCT04682639|466309414|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
129550000|NCT04682639|466309415|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
129550001|NCT04682639|466309416|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
129550002|NCT04682639|466309417|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
129550003|NCT04682639|466309413|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
129550004|NCT04682639|466309414|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
129550005|NCT04682639|466309415|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
129550006|NCT04682639|466309416|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
129550007|NCT04682639|466309417|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
129550008|NCT04682639|466309413|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
129550009|NCT04682639|466309414|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
129550010|NCT04682639|466309415|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
129550011|NCT04682639|466309416|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129550012|NCT04682639|466309417|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129550013|NCT04682639|466309413|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
129683518|NCT03126110|466799148|FG000|Phase 1|Safety follow-up no longer necessary|1|||
129683519|NCT03126110|466799149|FG001|Phase 1|Safety follow-up no longer necessary|0|||
129683520|NCT03126110|466799150|FG002|Phase 1|Safety follow-up no longer necessary|0|||
129683521|NCT03126110|466799151|FG003|Phase 1|Safety follow-up no longer necessary|0|||
129683522|NCT03126110|466799152|FG004|Phase 1|Safety follow-up no longer necessary|0|||
129683523|NCT03126110|466799153|FG005|Phase 1|Safety follow-up no longer necessary|0|||
129683524|NCT03126110|466799154|FG006|Phase 1|Safety follow-up no longer necessary|0|||
129683525|NCT03126110|466799155|FG007|Phase 1|Safety follow-up no longer necessary|0|||
129683526|NCT03126110|466799156|FG008|Phase 1|Safety follow-up no longer necessary|0|||
129683527|NCT03126110|466799157|FG009|Phase 1|Safety follow-up no longer necessary|0|||
129683528|NCT03126110|466799158|FG010|Phase 1|Safety follow-up no longer necessary|0|||
129683529|NCT03126110|466799159|FG011|Phase 1|Safety follow-up no longer necessary|0|||
129550014|NCT04682639|466309414|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
129683530|NCT03126110|466799160|FG012|Phase 1|Safety follow-up no longer necessary|0|||
129550015|NCT04682639|466309415|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
129550016|NCT04682639|466309416|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
129550017|NCT04682639|466309417|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
129550018|NCT04682639|466309413|FG000|OLE Period (28 Weeks)|Other|1|||
129550019|NCT04682639|466309414|FG001|OLE Period (28 Weeks)|Other|2|||
129550020|NCT04682639|466309415|FG002|OLE Period (28 Weeks)|Other|0|||
129550021|NCT04682639|466309416|FG003|OLE Period (28 Weeks)|Other|0|||
129550022|NCT04682639|466309417|FG004|OLE Period (28 Weeks)|Other|1|||
129550023|NCT04682639|466309413|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
129550024|NCT04682639|466309414|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
129550025|NCT04682639|466309415|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
129550026|NCT04682639|466309416|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
129550027|NCT04682639|466309417|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
129550028|NCT04682639|466309413|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
129550029|NCT04682639|466309414|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
129550030|NCT04682639|466309415|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129550031|NCT04682639|466309416|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129550032|NCT04682639|466309417|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129550033|NCT04682639|466309413|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
129550034|NCT04682639|466309414|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
129550035|NCT04682639|466309415|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129550036|NCT04682639|466309416|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129550037|NCT04682639|466309417|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129550038|NCT04682639|466309413|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
129550039|NCT04682639|466309414|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
129550040|NCT04682639|466309415|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
129550041|NCT04682639|466309416|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
129550042|NCT04682639|466309417|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
129550043|NCT01392170|466309418|FG000|Overall Study|Withdrawal by Subject|1|||
129550044|NCT01392170|466309418|FG000|Overall Study|Ineligible|1|||
129550045|NCT03174925|466309429|FG000|Overall Study|Elastographic images not retrievable|2|||
129550046|NCT03174925|466309429|FG000|Overall Study|Elastography image not interpretable|1|||
129550047|NCT04247594|466309432|FG000|Overall Study|Withdrawal by Subject|4|||
129550048|NCT02748616|466309438|FG000|Overall Study|Lost to Follow-up|1|||
129550049|NCT02748616|466309438|FG000|Overall Study|Withdrawal by Subject|2|||
129550050|NCT02748616|466309438|FG000|Overall Study|Physician Decision|2|||
129550051|NCT02748616|466309438|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
129550052|NCT04057118|466309442|FG000|Overall Study|Adverse Event|1|||
129550053|NCT04057118|466309443|FG001|Overall Study|Adverse Event|0|||
129550054|NCT04057118|466309444|FG002|Overall Study|Adverse Event|1|||
129550055|NCT04057118|466309445|FG003|Overall Study|Adverse Event|1|||
129550056|NCT04057118|466309442|FG000|Overall Study|Physician Decision|0|||
129550057|NCT04057118|466309443|FG001|Overall Study|Physician Decision|0|||
129550058|NCT04057118|466309444|FG002|Overall Study|Physician Decision|1|||
129550059|NCT04057118|466309445|FG003|Overall Study|Physician Decision|1|||
129550060|NCT04057118|466309442|FG000|Overall Study|Withdrawal by Subject|2|||
129550061|NCT04057118|466309443|FG001|Overall Study|Withdrawal by Subject|2|||
129550062|NCT04057118|466309444|FG002|Overall Study|Withdrawal by Subject|0|||
129550063|NCT04057118|466309445|FG003|Overall Study|Withdrawal by Subject|2|||
129550064|NCT04057118|466309442|FG000|Overall Study|Not Specific|0|||
129550065|NCT04057118|466309443|FG001|Overall Study|Not Specific|0|||
129550066|NCT04057118|466309444|FG002|Overall Study|Not Specific|1|||
129550067|NCT04057118|466309445|FG003|Overall Study|Not Specific|1|||
129550068|NCT04736576|466309446|FG000|Overall Study|Progressive disease|3|||
129550069|NCT04736576|466309447|FG001|Overall Study|Progressive disease|1|||
129550070|NCT04736576|466309446|FG000|Overall Study|Death|1|||
129550071|NCT04736576|466309447|FG001|Overall Study|Death|0|||
129550072|NCT03273712|466309448|FG000|Overall Study|Death|5|||
129550073|NCT03273712|466309448|FG000|Overall Study|Adverse Event|1|||
129550074|NCT03273712|466309448|FG000|Overall Study|Disease Progression|1|||
129550075|NCT00190684|466309449|FG000|Overall Study|Adverse Event|86|||
129550076|NCT00190684|466309449|FG000|Overall Study|Satisfactory response|80|||
129550077|NCT00190684|466309449|FG000|Overall Study|Lack of efficacy|204|||
129550078|NCT00190684|466309449|FG000|Overall Study|Lost to Follow-up|232|||
129550079|NCT00190684|466309449|FG000|Overall Study|Patient moved|60|||
129550080|NCT00190684|466309449|FG000|Overall Study|Patient Decision|432|||
129550081|NCT00190684|466309449|FG000|Overall Study|Clinical relapse|67|||
129550082|NCT00190684|466309449|FG000|Overall Study|Sponsor's decision|17|||
129550083|NCT00190684|466309449|FG000|Overall Study|Physician Decision|84|||
129550084|NCT00190684|466309449|FG000|Overall Study|Protocol Violation|123|||
129550085|NCT00190684|466309449|FG000|Overall Study|Study Period III Completed|103|||
129550086|NCT00190684|466309449|FG000|Overall Study|Study Period V Completed|1|||
129550087|NCT00829439|466309455|FG000|Overall Study|Adverse Event|0|||
129550088|NCT00829439|466309456|FG001|Overall Study|Adverse Event|0|||
129550089|NCT00829439|466309457|FG002|Overall Study|Adverse Event|1|||
129550090|NCT00829439|466309458|FG003|Overall Study|Adverse Event|0|||
129550091|NCT03611751|466309461|FG000|Pre-treatment|Randomized but not treated|1|||
129772178|NCT01458392|467134048|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
129683531|NCT03126110|466799161|FG013|Phase 1|Safety follow-up no longer necessary|0|||
129683532|NCT03126110|466799162|FG014|Phase 1|Safety follow-up no longer necessary|0|||
129772179|NCT01458392|467134049|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
129772180|NCT01458392|467134050|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
129772181|NCT01193244|467134053|FG000|Overall Study|Withdrawal by Subject|79|||
129772182|NCT01193244|467134054|FG001|Overall Study|Withdrawal by Subject|97|||
129772183|NCT01193244|467134053|FG000|Overall Study|Other|303|||
129772184|NCT01193244|467134054|FG001|Overall Study|Other|278|||
129772185|NCT01193244|467134053|FG000|Overall Study|Lost to Follow-up|6|||
129772186|NCT01193244|467134054|FG001|Overall Study|Lost to Follow-up|15|||
129772187|NCT03763877|467134064|FG000|Overall Study|Withdrawal by Subject|3|||
129772188|NCT03763877|467134065|FG001|Overall Study|Withdrawal by Subject|1|||
129772189|NCT03763877|467134066|FG002|Overall Study|Withdrawal by Subject|3|||
129772190|NCT03763877|467134067|FG003|Overall Study|Withdrawal by Subject|4|||
129772191|NCT03763877|467134064|FG000|Overall Study|Adverse Event|1|||
129772192|NCT03763877|467134065|FG001|Overall Study|Adverse Event|1|||
129772193|NCT03763877|467134066|FG002|Overall Study|Adverse Event|3|||
129772194|NCT03763877|467134067|FG003|Overall Study|Adverse Event|1|||
129772195|NCT03763877|467134064|FG000|Overall Study|Protocol Violation|1|||
129772196|NCT03763877|467134065|FG001|Overall Study|Protocol Violation|1|||
129772197|NCT03763877|467134066|FG002|Overall Study|Protocol Violation|0|||
129772198|NCT03763877|467134067|FG003|Overall Study|Protocol Violation|0|||
129772199|NCT03763877|467134064|FG000|Overall Study|Lost to Follow-up|0|||
129772200|NCT03763877|467134065|FG001|Overall Study|Lost to Follow-up|1|||
129772201|NCT03763877|467134066|FG002|Overall Study|Lost to Follow-up|1|||
129772202|NCT03763877|467134067|FG003|Overall Study|Lost to Follow-up|0|||
129772203|NCT03040336|467134068|FG000|Overall Study|Death|1|||
129772204|NCT03040336|467134069|FG001|Overall Study|Death|0|||
129772205|NCT03040336|467134068|FG000|Overall Study|Withdrawal by Subject|2|||
129772206|NCT03040336|467134069|FG001|Overall Study|Withdrawal by Subject|3|||
129772207|NCT00068692|467134074|FG000|Step 1: Registration|Disese progression/relapse|5|||
129772208|NCT00068692|467134075|FG001|Step 1: Registration|Disese progression/relapse|0|||
129772209|NCT00068692|467134076|FG002|Step 1: Registration|Disese progression/relapse|0|||
129772210|NCT00068692|467134077|FG003|Step 1: Registration|Disese progression/relapse|0|||
129772211|NCT00068692|467134078|FG004|Step 1: Registration|Disese progression/relapse|0|||
129772212|NCT00068692|467134079|FG005|Step 1: Registration|Disese progression/relapse|0|||
129772213|NCT00068692|467134080|FG006|Step 1: Registration|Disese progression/relapse|0|||
129772214|NCT00068692|467134081|FG007|Step 1: Registration|Disese progression/relapse|0|||
129772215|NCT00068692|467134074|FG000|Step 1: Registration|Adverse Event|7|||
129772216|NCT00068692|467134075|FG001|Step 1: Registration|Adverse Event|0|||
129772217|NCT00068692|467134076|FG002|Step 1: Registration|Adverse Event|0|||
129772218|NCT00068692|467134077|FG003|Step 1: Registration|Adverse Event|0|||
129772219|NCT00068692|467134078|FG004|Step 1: Registration|Adverse Event|0|||
129683533|NCT03126110|466799163|FG015|Phase 1|Safety follow-up no longer necessary|0|||
129683534|NCT03126110|466799164|FG016|Phase 1|Safety follow-up no longer necessary|0|||
129683535|NCT03126110|466799148|FG000|Phase 1|Survival follow-up no longer necessary|0|||
129683536|NCT03126110|466799149|FG001|Phase 1|Survival follow-up no longer necessary|0|||
129683537|NCT03126110|466799150|FG002|Phase 1|Survival follow-up no longer necessary|1|||
129683538|NCT03126110|466799151|FG003|Phase 1|Survival follow-up no longer necessary|0|||
129683539|NCT03126110|466799152|FG004|Phase 1|Survival follow-up no longer necessary|0|||
129683540|NCT03126110|466799153|FG005|Phase 1|Survival follow-up no longer necessary|0|||
129683541|NCT03126110|466799154|FG006|Phase 1|Survival follow-up no longer necessary|0|||
129683542|NCT03126110|466799155|FG007|Phase 1|Survival follow-up no longer necessary|0|||
129683543|NCT03126110|466799156|FG008|Phase 1|Survival follow-up no longer necessary|0|||
129683544|NCT03126110|466799157|FG009|Phase 1|Survival follow-up no longer necessary|0|||
129683545|NCT03126110|466799158|FG010|Phase 1|Survival follow-up no longer necessary|0|||
129683546|NCT03126110|466799159|FG011|Phase 1|Survival follow-up no longer necessary|0|||
129683547|NCT03126110|466799160|FG012|Phase 1|Survival follow-up no longer necessary|0|||
129683548|NCT03126110|466799161|FG013|Phase 1|Survival follow-up no longer necessary|0|||
129683549|NCT03126110|466799162|FG014|Phase 1|Survival follow-up no longer necessary|0|||
129772220|NCT00068692|467134079|FG005|Step 1: Registration|Adverse Event|0|||
129772221|NCT00068692|467134080|FG006|Step 1: Registration|Adverse Event|0|||
129772222|NCT00068692|467134081|FG007|Step 1: Registration|Adverse Event|0|||
129683550|NCT03126110|466799163|FG015|Phase 1|Survival follow-up no longer necessary|0|||
129683551|NCT03126110|466799164|FG016|Phase 1|Survival follow-up no longer necessary|0|||
129772223|NCT00068692|467134074|FG000|Step 1: Registration|Death|1|||
129772224|NCT00068692|467134075|FG001|Step 1: Registration|Death|0|||
129772225|NCT00068692|467134076|FG002|Step 1: Registration|Death|0|||
129772226|NCT00068692|467134077|FG003|Step 1: Registration|Death|0|||
129772227|NCT00068692|467134078|FG004|Step 1: Registration|Death|0|||
129772228|NCT00068692|467134079|FG005|Step 1: Registration|Death|0|||
129772229|NCT00068692|467134080|FG006|Step 1: Registration|Death|0|||
129772230|NCT00068692|467134081|FG007|Step 1: Registration|Death|0|||
129772231|NCT00068692|467134074|FG000|Step 1: Registration|Withdrawal by Subject|11|||
129683552|NCT03126110|466799148|FG000|Phase 2|Study terminated by the sponsor|0|||
129683553|NCT03126110|466799149|FG001|Phase 2|Study terminated by the sponsor|0|||
129683554|NCT03126110|466799150|FG002|Phase 2|Study terminated by the sponsor|0|||
129683555|NCT03126110|466799151|FG003|Phase 2|Study terminated by the sponsor|0|||
129683556|NCT03126110|466799152|FG004|Phase 2|Study terminated by the sponsor|0|||
129683557|NCT03126110|466799153|FG005|Phase 2|Study terminated by the sponsor|0|||
129683558|NCT03126110|466799154|FG006|Phase 2|Study terminated by the sponsor|0|||
129683559|NCT03126110|466799155|FG007|Phase 2|Study terminated by the sponsor|0|||
129683560|NCT03126110|466799156|FG008|Phase 2|Study terminated by the sponsor|0|||
129683561|NCT03126110|466799157|FG009|Phase 2|Study terminated by the sponsor|0|||
129683562|NCT03126110|466799158|FG010|Phase 2|Study terminated by the sponsor|0|||
129683563|NCT03126110|466799159|FG011|Phase 2|Study terminated by the sponsor|0|||
129683564|NCT03126110|466799160|FG012|Phase 2|Study terminated by the sponsor|0|||
129683565|NCT03126110|466799161|FG013|Phase 2|Study terminated by the sponsor|4|||
129683566|NCT03126110|466799162|FG014|Phase 2|Study terminated by the sponsor|0|||
129683567|NCT03126110|466799163|FG015|Phase 2|Study terminated by the sponsor|0|||
129683568|NCT03126110|466799164|FG016|Phase 2|Study terminated by the sponsor|0|||
129683569|NCT03126110|466799148|FG000|Phase 2|Withdrawal by Subject|0|||
129683570|NCT03126110|466799149|FG001|Phase 2|Withdrawal by Subject|0|||
129683571|NCT03126110|466799150|FG002|Phase 2|Withdrawal by Subject|0|||
129683572|NCT03126110|466799151|FG003|Phase 2|Withdrawal by Subject|0|||
129683573|NCT03126110|466799152|FG004|Phase 2|Withdrawal by Subject|0|||
129683574|NCT03126110|466799153|FG005|Phase 2|Withdrawal by Subject|0|||
129683575|NCT03126110|466799154|FG006|Phase 2|Withdrawal by Subject|0|||
129683576|NCT03126110|466799155|FG007|Phase 2|Withdrawal by Subject|0|||
129683577|NCT03126110|466799156|FG008|Phase 2|Withdrawal by Subject|0|||
129683578|NCT03126110|466799157|FG009|Phase 2|Withdrawal by Subject|0|||
129683579|NCT03126110|466799158|FG010|Phase 2|Withdrawal by Subject|0|||
129683580|NCT03126110|466799159|FG011|Phase 2|Withdrawal by Subject|1|||
129683581|NCT03126110|466799160|FG012|Phase 2|Withdrawal by Subject|3|||
129683582|NCT03126110|466799161|FG013|Phase 2|Withdrawal by Subject|3|||
129683583|NCT03126110|466799162|FG014|Phase 2|Withdrawal by Subject|2|||
129683584|NCT03126110|466799163|FG015|Phase 2|Withdrawal by Subject|1|||
129683585|NCT03126110|466799164|FG016|Phase 2|Withdrawal by Subject|0|||
129683586|NCT03126110|466799148|FG000|Phase 2|Lost to Follow-up|0|||
129683587|NCT03126110|466799149|FG001|Phase 2|Lost to Follow-up|0|||
129683588|NCT03126110|466799150|FG002|Phase 2|Lost to Follow-up|0|||
129683589|NCT03126110|466799151|FG003|Phase 2|Lost to Follow-up|0|||
129683590|NCT03126110|466799152|FG004|Phase 2|Lost to Follow-up|0|||
129683591|NCT03126110|466799153|FG005|Phase 2|Lost to Follow-up|0|||
129683592|NCT03126110|466799154|FG006|Phase 2|Lost to Follow-up|0|||
129683593|NCT03126110|466799155|FG007|Phase 2|Lost to Follow-up|0|||
129683594|NCT03126110|466799156|FG008|Phase 2|Lost to Follow-up|0|||
129683595|NCT03126110|466799157|FG009|Phase 2|Lost to Follow-up|0|||
129683596|NCT03126110|466799158|FG010|Phase 2|Lost to Follow-up|0|||
129683597|NCT03126110|466799159|FG011|Phase 2|Lost to Follow-up|1|||
129683598|NCT03126110|466799160|FG012|Phase 2|Lost to Follow-up|1|||
129683599|NCT03126110|466799161|FG013|Phase 2|Lost to Follow-up|1|||
129683600|NCT03126110|466799162|FG014|Phase 2|Lost to Follow-up|2|||
129683601|NCT03126110|466799163|FG015|Phase 2|Lost to Follow-up|0|||
129683602|NCT03126110|466799164|FG016|Phase 2|Lost to Follow-up|0|||
129683603|NCT03126110|466799148|FG000|Phase 2|Death|0|||
129683604|NCT03126110|466799149|FG001|Phase 2|Death|0|||
129683605|NCT03126110|466799150|FG002|Phase 2|Death|0|||
129683606|NCT03126110|466799151|FG003|Phase 2|Death|0|||
129683607|NCT03126110|466799152|FG004|Phase 2|Death|0|||
129683608|NCT03126110|466799153|FG005|Phase 2|Death|0|||
129683609|NCT03126110|466799154|FG006|Phase 2|Death|0|||
129683610|NCT03126110|466799155|FG007|Phase 2|Death|0|||
129683611|NCT03126110|466799156|FG008|Phase 2|Death|0|||
129683612|NCT03126110|466799157|FG009|Phase 2|Death|0|||
129683613|NCT03126110|466799158|FG010|Phase 2|Death|0|||
129683614|NCT03126110|466799159|FG011|Phase 2|Death|6|||
129683615|NCT03126110|466799160|FG012|Phase 2|Death|12|||
129683616|NCT03126110|466799161|FG013|Phase 2|Death|25|||
129683617|NCT03126110|466799162|FG014|Phase 2|Death|11|||
129683618|NCT03126110|466799163|FG015|Phase 2|Death|3|||
129683619|NCT03126110|466799164|FG016|Phase 2|Death|2|||
129683620|NCT03126110|466799148|FG000|Phase 2|Progressive Disease|0|||
129683621|NCT03126110|466799149|FG001|Phase 2|Progressive Disease|0|||
129683622|NCT03126110|466799150|FG002|Phase 2|Progressive Disease|0|||
129683623|NCT03126110|466799151|FG003|Phase 2|Progressive Disease|0|||
129683624|NCT03126110|466799152|FG004|Phase 2|Progressive Disease|0|||
129683625|NCT03126110|466799153|FG005|Phase 2|Progressive Disease|0|||
129683626|NCT03126110|466799154|FG006|Phase 2|Progressive Disease|0|||
129683627|NCT03126110|466799155|FG007|Phase 2|Progressive Disease|0|||
129683628|NCT03126110|466799156|FG008|Phase 2|Progressive Disease|0|||
129683629|NCT03126110|466799157|FG009|Phase 2|Progressive Disease|0|||
129683630|NCT03126110|466799158|FG010|Phase 2|Progressive Disease|0|||
129683631|NCT03126110|466799159|FG011|Phase 2|Progressive Disease|0|||
129683632|NCT03126110|466799160|FG012|Phase 2|Progressive Disease|0|||
129683633|NCT03126110|466799161|FG013|Phase 2|Progressive Disease|1|||
129683634|NCT03126110|466799162|FG014|Phase 2|Progressive Disease|0|||
129683635|NCT03126110|466799163|FG015|Phase 2|Progressive Disease|0|||
129550092|NCT03611751|466309462|FG001|Pre-treatment|Randomized but not treated|1|||
129550093|NCT03611751|466309463|FG002|Pre-treatment|Randomized but not treated|0|||
129550094|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
129550095|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
129550096|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
129550097|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
129550098|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
129550099|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
129550100|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
129550101|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
129550102|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
129550103|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
129550104|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
129550105|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
129550106|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
129550107|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
129550108|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
129550109|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
129550110|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
129550111|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
129550112|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
129550113|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
129550114|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
129550115|NCT03611751|466309461|FG000|Treatment Week 0 - Week 16|Death|0|||
129550116|NCT03611751|466309462|FG001|Treatment Week 0 - Week 16|Death|0|||
129550117|NCT03611751|466309463|FG002|Treatment Week 0 - Week 16|Death|1|||
129550118|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
129550119|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
129550120|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
129550121|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
129550122|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
129550123|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
129550124|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
129550125|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
129550126|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
129550127|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
129550128|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
129550129|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
129550130|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
129550131|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
129550132|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
129550133|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
129550134|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
129550135|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
129550136|NCT03611751|466309461|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
129550137|NCT03611751|466309462|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
129550138|NCT03611751|466309463|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
129550139|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
129550140|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
129550141|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
129550142|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
129550143|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
129550144|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
129550145|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
129550146|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
129550147|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
129550148|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
129550149|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
129550150|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
129550151|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
129550152|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
129683636|NCT03126110|466799164|FG016|Phase 2|Progressive Disease|0|||
129683637|NCT03126110|466799148|FG000|Phase 2|Started new treatment|0|||
129683638|NCT03126110|466799149|FG001|Phase 2|Started new treatment|0|||
129683639|NCT03126110|466799150|FG002|Phase 2|Started new treatment|0|||
129550153|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
129550154|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
129683640|NCT03126110|466799151|FG003|Phase 2|Started new treatment|0|||
129683641|NCT03126110|466799152|FG004|Phase 2|Started new treatment|0|||
129550155|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
129550156|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
129550157|NCT03611751|466309461|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
129550158|NCT03611751|466309462|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
129550159|NCT03611751|466309463|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
129550160|NCT02702271|466309464|FG000|Overall Study|Death|36|||
129550161|NCT02702271|466309465|FG001|Overall Study|Death|7|||
129550162|NCT02702271|466309464|FG000|Overall Study|Lost to Follow-up|12|||
129550163|NCT02702271|466309465|FG001|Overall Study|Lost to Follow-up|0|||
129550164|NCT02702271|466309464|FG000|Overall Study|Withdrawal by Subject|8|||
129550165|NCT02702271|466309465|FG001|Overall Study|Withdrawal by Subject|1|||
129550166|NCT02702271|466309464|FG000|Overall Study|Physician Decision|2|||
129550167|NCT02702271|466309465|FG001|Overall Study|Physician Decision|0|||
129550168|NCT02702271|466309464|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
129550169|NCT02702271|466309465|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
129550170|NCT01494649|466309466|FG000|Overall Study|Lost to Follow-up|0|||
129550171|NCT01494649|466309467|FG001|Overall Study|Lost to Follow-up|1|||
129550172|NCT01174368|466309470|FG000|Overall Study|Withdrawal by Subject|1|||
129550173|NCT01311505|466309495|FG000|First Intervention Period|Protocol Violation|0|||
129550174|NCT01311505|466309496|FG001|First Intervention Period|Protocol Violation|1|||
129550175|NCT00567996|466309497|FG000|Overall Study|Adverse Event|18|||
129550176|NCT00567996|466309498|FG001|Overall Study|Adverse Event|16|||
129550177|NCT00567996|466309499|FG002|Overall Study|Adverse Event|13|||
129550178|NCT00567996|466309497|FG000|Overall Study|Protocol Deviation|9|||
129550179|NCT00567996|466309498|FG001|Overall Study|Protocol Deviation|11|||
129550180|NCT00567996|466309499|FG002|Overall Study|Protocol Deviation|13|||
129550181|NCT00567996|466309497|FG000|Overall Study|Withdrawal by Subject|8|||
129550182|NCT00567996|466309498|FG001|Overall Study|Withdrawal by Subject|12|||
129550183|NCT00567996|466309499|FG002|Overall Study|Withdrawal by Subject|22|||
129550184|NCT00567996|466309497|FG000|Overall Study|Abnormal Lab value(s)|2|||
129550185|NCT00567996|466309498|FG001|Overall Study|Abnormal Lab value(s)|1|||
129550186|NCT00567996|466309499|FG002|Overall Study|Abnormal Lab value(s)|2|||
129550187|NCT00567996|466309497|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129550188|NCT00567996|466309498|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129550189|NCT00567996|466309499|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129550190|NCT00567996|466309497|FG000|Overall Study|Lost to Follow-up|2|||
129550191|NCT00567996|466309498|FG001|Overall Study|Lost to Follow-up|5|||
129550192|NCT00567996|466309499|FG002|Overall Study|Lost to Follow-up|2|||
129683642|NCT03126110|466799153|FG005|Phase 2|Started new treatment|0|||
129683643|NCT03126110|466799154|FG006|Phase 2|Started new treatment|0|||
129683644|NCT03126110|466799155|FG007|Phase 2|Started new treatment|0|||
129683645|NCT03126110|466799156|FG008|Phase 2|Started new treatment|0|||
129683646|NCT03126110|466799157|FG009|Phase 2|Started new treatment|0|||
129683647|NCT03126110|466799158|FG010|Phase 2|Started new treatment|0|||
129683648|NCT03126110|466799159|FG011|Phase 2|Started new treatment|0|||
129683649|NCT03126110|466799160|FG012|Phase 2|Started new treatment|0|||
129683650|NCT03126110|466799161|FG013|Phase 2|Started new treatment|0|||
129683651|NCT03126110|466799162|FG014|Phase 2|Started new treatment|1|||
129683652|NCT03126110|466799163|FG015|Phase 2|Started new treatment|0|||
129683653|NCT03126110|466799164|FG016|Phase 2|Started new treatment|0|||
129683654|NCT04235374|466799165|FG000|Overall Study|Death|91|||
129683655|NCT04235374|466799166|FG001|Overall Study|Death|91|||
129683656|NCT04235374|466799165|FG000|Overall Study|Refused|2|||
129683657|NCT04235374|466799166|FG001|Overall Study|Refused|2|||
129683658|NCT04235374|466799165|FG000|Overall Study|Unavailable|12|||
129683659|NCT04235374|466799166|FG001|Overall Study|Unavailable|3|||
129683660|NCT04235374|466799165|FG000|Overall Study|Withdrawal by Subject|0|||
129683661|NCT04235374|466799166|FG001|Overall Study|Withdrawal by Subject|1|||
129683662|NCT04235374|466799165|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
129683663|NCT04235374|466799166|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
129683664|NCT04967222|466799176|FG000|Randomized|Lost to Follow-up|0|||
129683665|NCT04967222|466799177|FG001|Randomized|Lost to Follow-up|1|||
129550193|NCT00567996|466309497|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129550194|NCT00567996|466309498|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129550195|NCT00567996|466309499|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
129550196|NCT00567996|466309497|FG000|Overall Study|Administrative problems|1|||
129550197|NCT00567996|466309498|FG001|Overall Study|Administrative problems|1|||
129550198|NCT00567996|466309499|FG002|Overall Study|Administrative problems|0|||
129550199|NCT00567996|466309497|FG000|Overall Study|Death|1|||
129683666|NCT04967222|466799178|FG002|Randomized|Lost to Follow-up|1|||
129683667|NCT04967222|466799176|FG000|Randomized|Physician Decision|0|||
129683668|NCT04967222|466799177|FG001|Randomized|Physician Decision|0|||
129683669|NCT04967222|466799178|FG002|Randomized|Physician Decision|1|||
129550200|NCT00567996|466309498|FG001|Overall Study|Death|0|||
129550201|NCT00567996|466309499|FG002|Overall Study|Death|2|||
129550202|NCT00567996|466309497|FG000|Overall Study|Patient's inability to use the device|0|||
129772232|NCT00068692|467134075|FG001|Step 1: Registration|Withdrawal by Subject|0|||
129683670|NCT04967222|466799176|FG000|Randomized|Withdrawal by Subject|0|||
129683671|NCT04967222|466799177|FG001|Randomized|Withdrawal by Subject|0|||
129683672|NCT04967222|466799178|FG002|Randomized|Withdrawal by Subject|2|||
129550203|NCT00567996|466309498|FG001|Overall Study|Patient's inability to use the device|1|||
129550204|NCT00567996|466309499|FG002|Overall Study|Patient's inability to use the device|0|||
129550205|NCT02956005|466309500|FG000|Overall Study|Not eligible|1|||
129550206|NCT02956005|466309500|FG000|Overall Study|Withdrawal by Subject|3|||
129550207|NCT02956005|466309500|FG000|Overall Study|Physician Decision|12|||
129550208|NCT00883129|466309503|FG000|Overall Study|Adverse Event|7|||
129550209|NCT00883129|466309504|FG001|Overall Study|Adverse Event|15|||
129550210|NCT00883129|466309503|FG000|Overall Study|Withdrawal by Subject|8|||
129550211|NCT00883129|466309504|FG001|Overall Study|Withdrawal by Subject|9|||
129550212|NCT00883129|466309503|FG000|Overall Study|Non-compliance|3|||
129550213|NCT00883129|466309504|FG001|Overall Study|Non-compliance|6|||
129550214|NCT00883129|466309503|FG000|Overall Study|Lost to Follow-up|1|||
129550215|NCT00883129|466309504|FG001|Overall Study|Lost to Follow-up|2|||
129550216|NCT00883129|466309503|FG000|Overall Study|Death|1|||
129550217|NCT00883129|466309504|FG001|Overall Study|Death|2|||
129550218|NCT00883129|466309503|FG000|Overall Study|Defined Treatment Failure|0|||
129550219|NCT00883129|466309504|FG001|Overall Study|Defined Treatment Failure|2|||
129550220|NCT03273257|466309505|FG000|Overall Study|Death|0|||
129550221|NCT03273257|466309506|FG001|Overall Study|Death|1|||
129550222|NCT03273257|466309505|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
129550223|NCT03273257|466309506|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
129550224|NCT03273257|466309505|FG000|Overall Study|Study terminated|3|||
129550225|NCT03273257|466309506|FG001|Overall Study|Study terminated|2|||
129550226|NCT01185639|466309508|FG000|Overall Study|Progressed and didn't receive therapy|2|||
129550227|NCT01898884|466309509|FG000|Multiple Dose Period|Adverse Event|0|||
129550228|NCT01898884|466309510|FG001|Multiple Dose Period|Adverse Event|0|||
129550229|NCT01898884|466309511|FG002|Multiple Dose Period|Adverse Event|0|||
129550230|NCT01898884|466309512|FG003|Multiple Dose Period|Adverse Event|0|||
129550231|NCT01898884|466309513|FG004|Multiple Dose Period|Adverse Event|0|||
129550232|NCT01898884|466309514|FG005|Multiple Dose Period|Adverse Event|0|||
129550233|NCT01898884|466309515|FG006|Multiple Dose Period|Adverse Event|1|||
129550234|NCT01898884|466309516|FG007|Multiple Dose Period|Adverse Event|0|||
129550235|NCT01898884|466309517|FG008|Multiple Dose Period|Adverse Event|0|||
129550236|NCT01898884|466309509|FG000|Multiple Dose Period|Randomized Not Treated|0|||
129550237|NCT01898884|466309510|FG001|Multiple Dose Period|Randomized Not Treated|0|||
129550238|NCT01898884|466309511|FG002|Multiple Dose Period|Randomized Not Treated|0|||
129550239|NCT01898884|466309512|FG003|Multiple Dose Period|Randomized Not Treated|0|||
129550240|NCT01898884|466309513|FG004|Multiple Dose Period|Randomized Not Treated|0|||
129550241|NCT01898884|466309514|FG005|Multiple Dose Period|Randomized Not Treated|0|||
129550242|NCT01898884|466309515|FG006|Multiple Dose Period|Randomized Not Treated|0|||
129550243|NCT01898884|466309516|FG007|Multiple Dose Period|Randomized Not Treated|0|||
129550244|NCT01898884|466309517|FG008|Multiple Dose Period|Randomized Not Treated|1|||
129550245|NCT00759759|466309518|FG000|Overall Study|didn't return for period 2|1|||
129550246|NCT00759759|466309519|FG001|Overall Study|didn't return for period 2|0|||
129550247|NCT00759759|466309518|FG000|Overall Study|Didn't receive drug in period 2|1|||
129550248|NCT00759759|466309519|FG001|Overall Study|Didn't receive drug in period 2|0|||
129550249|NCT00759759|466309518|FG000|Overall Study|Withdrawal by Subject|2|||
129550250|NCT00759759|466309519|FG001|Overall Study|Withdrawal by Subject|1|||
129550251|NCT02239692|466311053|FG000|Overall Study|Incomplete colonoscopy|1|||
129550252|NCT02239692|466311054|FG001|Overall Study|Incomplete colonoscopy|2|||
129550253|NCT02239692|466311053|FG000|Overall Study|Adverse Event|0|||
129550254|NCT02239692|466311054|FG001|Overall Study|Adverse Event|1|||
129550255|NCT02239692|466311053|FG000|Overall Study|Physician Decision|0|||
129550256|NCT02239692|466311054|FG001|Overall Study|Physician Decision|1|||
129550257|NCT02239692|466311053|FG000|Overall Study|Lost to Follow-up|1|||
129550258|NCT02239692|466311054|FG001|Overall Study|Lost to Follow-up|4|||
129550259|NCT02239692|466311053|FG000|Overall Study|Withdrawal by Subject|3|||
129550260|NCT02239692|466311054|FG001|Overall Study|Withdrawal by Subject|5|||
129550261|NCT02239692|466311053|FG000|Overall Study|Other reason|1|||
129550262|NCT02239692|466311054|FG001|Overall Study|Other reason|0|||
129550263|NCT00297492|466311055|FG000|Set Quit Date|Lost to Follow-up|7|||
129550264|NCT00297492|466311056|FG001|Set Quit Date|Lost to Follow-up|13|||
129683673|NCT04967222|466799176|FG000|Randomized|abnormal finding in MRI|0|||
129683674|NCT04967222|466799177|FG001|Randomized|abnormal finding in MRI|2|||
129683675|NCT04967222|466799178|FG002|Randomized|abnormal finding in MRI|0|||
129683676|NCT01295944|466799179|FG000|Overall Study|Switched to alternative treatment|1|||
129683677|NCT01295944|466799179|FG000|Overall Study|Ineligible|9|||
129550265|NCT00297492|466311057|FG002|Set Quit Date|Lost to Follow-up|5|||
129550266|NCT00297492|466311055|FG000|6 Month Follow-up|Lost to Follow-up|63|||
129550267|NCT00297492|466311056|FG001|6 Month Follow-up|Lost to Follow-up|49|||
129550268|NCT00297492|466311057|FG002|6 Month Follow-up|Lost to Follow-up|27|||
129550269|NCT02437890|466311058|FG000|Overall Study|Non-compliance to study drug|0|||
129683678|NCT01295944|466799179|FG000|Overall Study|Withdrawal by Subject|1|||
129683679|NCT01295944|466799179|FG000|Overall Study|Participant chose to be treated in Peru|1|||
129707763|NCT01280968|466892117|FG000|Overall Study|Scheduling Conflicts|1|||
129550270|NCT02437890|466311059|FG001|Overall Study|Non-compliance to study drug|1|||
129550271|NCT02437890|466311060|FG002|Overall Study|Non-compliance to study drug|0|||
129550272|NCT02437890|466311061|FG003|Overall Study|Non-compliance to study drug|0|||
129550273|NCT02437890|466311062|FG004|Overall Study|Non-compliance to study drug|1|||
129550274|NCT02437890|466311058|FG000|Overall Study|Sponsor's decision|1|||
129550275|NCT02437890|466311059|FG001|Overall Study|Sponsor's decision|1|||
129550276|NCT02437890|466311060|FG002|Overall Study|Sponsor's decision|4|||
129550277|NCT02437890|466311061|FG003|Overall Study|Sponsor's decision|0|||
129550278|NCT02437890|466311062|FG004|Overall Study|Sponsor's decision|2|||
129550279|NCT02437890|466311058|FG000|Overall Study|Physician Decision|0|||
129550280|NCT02437890|466311059|FG001|Overall Study|Physician Decision|0|||
129550281|NCT02437890|466311060|FG002|Overall Study|Physician Decision|0|||
129550282|NCT02437890|466311061|FG003|Overall Study|Physician Decision|1|||
129550283|NCT02437890|466311062|FG004|Overall Study|Physician Decision|0|||
129550284|NCT02437890|466311058|FG000|Overall Study|Unable to attend visit(s)|1|||
129550285|NCT02437890|466311059|FG001|Overall Study|Unable to attend visit(s)|0|||
129550286|NCT02437890|466311060|FG002|Overall Study|Unable to attend visit(s)|0|||
129550287|NCT02437890|466311061|FG003|Overall Study|Unable to attend visit(s)|0|||
129550288|NCT02437890|466311062|FG004|Overall Study|Unable to attend visit(s)|0|||
129550289|NCT02437890|466311058|FG000|Overall Study|Lack of Efficacy|1|||
129550290|NCT02437890|466311059|FG001|Overall Study|Lack of Efficacy|3|||
129550291|NCT02437890|466311060|FG002|Overall Study|Lack of Efficacy|0|||
129550292|NCT02437890|466311061|FG003|Overall Study|Lack of Efficacy|3|||
129550293|NCT02437890|466311062|FG004|Overall Study|Lack of Efficacy|1|||
129550294|NCT02437890|466311058|FG000|Overall Study|Adverse Event|4|||
129550295|NCT02437890|466311059|FG001|Overall Study|Adverse Event|9|||
129550296|NCT02437890|466311060|FG002|Overall Study|Adverse Event|5|||
129550297|NCT02437890|466311061|FG003|Overall Study|Adverse Event|11|||
129550298|NCT02437890|466311062|FG004|Overall Study|Adverse Event|7|||
129550299|NCT02437890|466311058|FG000|Overall Study|Withdrawal by Subject|1|||
129550300|NCT02437890|466311059|FG001|Overall Study|Withdrawal by Subject|2|||
129550301|NCT02437890|466311060|FG002|Overall Study|Withdrawal by Subject|6|||
129550302|NCT02437890|466311061|FG003|Overall Study|Withdrawal by Subject|5|||
129550303|NCT02437890|466311062|FG004|Overall Study|Withdrawal by Subject|5|||
129550304|NCT02437890|466311058|FG000|Overall Study|Death|0|||
129550305|NCT02437890|466311059|FG001|Overall Study|Death|0|||
129550306|NCT02437890|466311060|FG002|Overall Study|Death|0|||
129550307|NCT02437890|466311061|FG003|Overall Study|Death|2|||
129550308|NCT02437890|466311062|FG004|Overall Study|Death|0|||
129550309|NCT04723173|466311063|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
129550310|NCT01422720|466311064|FG000|Overall Study|Adverse Event|16|||
129550311|NCT01422720|466311064|FG000|Overall Study|Lack of Efficacy|1|||
129550312|NCT01422720|466311064|FG000|Overall Study|Withdrawal by Subject|4|||
129550313|NCT01422720|466311064|FG000|Overall Study|Ineligibility|1|||
129550314|NCT02082262|466311065|FG000|Overall Study|Withdrawal by Subject|3|||
129550315|NCT02082262|466311065|FG000|Overall Study|Adverse Event|48|||
129550316|NCT01074307|466311067|FG000|Overall Study|No primary endpoint evaluation|14|||
129550317|NCT01074307|466311068|FG001|Overall Study|No primary endpoint evaluation|6|||
129550318|NCT01074307|466311067|FG000|Overall Study|Exclusion criterion|0|||
129550319|NCT01074307|466311068|FG001|Overall Study|Exclusion criterion|1|||
129550320|NCT01074307|466311067|FG000|Overall Study|Protocol Violation|8|||
129550321|NCT01074307|466311068|FG001|Overall Study|Protocol Violation|5|||
129550322|NCT02162511|466311073|FG000|Overall Study|Lack of Efficacy|0|||
129550323|NCT02162511|466311074|FG001|Overall Study|Lack of Efficacy|0|||
129683680|NCT01295944|466799179|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
129683681|NCT01295944|466799179|FG000|Overall Study|Physician Decision|1|||
129683682|NCT01295944|466799179|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
129683683|NCT01295944|466799179|FG000|Overall Study|Disease progression|4|||
129550324|NCT02162511|466311075|FG002|Overall Study|Lack of Efficacy|2|||
129550325|NCT01408576|466311076|FG000|Overall Study|Lack of Efficacy|17|||
129550326|NCT01408576|466311077|FG001|Overall Study|Lack of Efficacy|30|||
129550327|NCT01408576|466311078|FG002|Overall Study|Lack of Efficacy|48|||
129550328|NCT01408576|466311076|FG000|Overall Study|Protocol Violation|1|||
129550329|NCT01408576|466311077|FG001|Overall Study|Protocol Violation|2|||
129683684|NCT01295944|466799179|FG000|Overall Study|Transferred care before starting new treatment|1|||
129683685|NCT02783274|466799187|FG000|Overall Study|Withdrawal by Subject|16|||
129683686|NCT02783274|466799187|FG000|Overall Study|Physician Decision|6|||
129550330|NCT01408576|466311078|FG002|Overall Study|Protocol Violation|2|||
129550331|NCT01408576|466311076|FG000|Overall Study|Lost to Follow-up|10|||
129550332|NCT01408576|466311077|FG001|Overall Study|Lost to Follow-up|9|||
129550333|NCT01408576|466311078|FG002|Overall Study|Lost to Follow-up|17|||
129683687|NCT02783274|466799187|FG000|Overall Study|Death|9|||
129683688|NCT02783274|466799187|FG000|Overall Study|Lost to Follow-up|22|||
129550334|NCT01408576|466311076|FG000|Overall Study|Withdrawal by Subject|34|||
129550335|NCT01408576|466311077|FG001|Overall Study|Withdrawal by Subject|60|||
129550336|NCT01408576|466311078|FG002|Overall Study|Withdrawal by Subject|66|||
129550337|NCT01408576|466311076|FG000|Overall Study|Sponsor terminated study|89|||
129550338|NCT01408576|466311077|FG001|Overall Study|Sponsor terminated study|333|||
129550339|NCT01408576|466311078|FG002|Overall Study|Sponsor terminated study|330|||
129550340|NCT01408576|466311076|FG000|Overall Study|AE, serious fatal|4|||
129550341|NCT01408576|466311077|FG001|Overall Study|AE, serious fatal|4|||
129550342|NCT01408576|466311078|FG002|Overall Study|AE, serious fatal|1|||
129550343|NCT01408576|466311076|FG000|Overall Study|SAE, non-fatal|11|||
129550344|NCT01408576|466311077|FG001|Overall Study|SAE, non-fatal|23|||
129550345|NCT01408576|466311078|FG002|Overall Study|SAE, non-fatal|14|||
129550346|NCT01408576|466311076|FG000|Overall Study|AE, non-serious non-fatal|12|||
129550347|NCT01408576|466311077|FG001|Overall Study|AE, non-serious non-fatal|19|||
129550348|NCT01408576|466311078|FG002|Overall Study|AE, non-serious non-fatal|11|||
129550349|NCT01408576|466311076|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129550350|NCT01408576|466311077|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129550351|NCT01408576|466311078|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129550352|NCT01408576|466311076|FG000|Overall Study|AE, unknown type|0|||
129550353|NCT01408576|466311077|FG001|Overall Study|AE, unknown type|1|||
129550354|NCT01408576|466311078|FG002|Overall Study|AE, unknown type|0|||
129550355|NCT01408576|466311076|FG000|Overall Study|Other|10|||
129550356|NCT01408576|466311077|FG001|Overall Study|Other|16|||
129550357|NCT01408576|466311078|FG002|Overall Study|Other|18|||
129550358|NCT00802529|466311079|FG000|Overall Study|Lost to Follow-up|0|||
129550359|NCT00802529|466311080|FG001|Overall Study|Lost to Follow-up|1|||
129550360|NCT00552617|466311082|FG000|Overall Study|Not Treated|0|||
129550361|NCT00552617|466311083|FG001|Overall Study|Not Treated|0|||
129550362|NCT00552617|466311084|FG002|Overall Study|Not Treated|1|||
129550363|NCT00552617|466311085|FG003|Overall Study|Not Treated|0|||
129550364|NCT00552617|466311086|FG004|Overall Study|Not Treated|0|||
129550365|NCT00552617|466311087|FG005|Overall Study|Not Treated|0|||
129550366|NCT00552617|466311088|FG006|Overall Study|Not Treated|0|||
129550367|NCT00552617|466311089|FG007|Overall Study|Not Treated|0|||
129550368|NCT00552617|466311090|FG008|Overall Study|Not Treated|0|||
129550369|NCT00552617|466311091|FG009|Overall Study|Not Treated|1|||
129550370|NCT00552617|466311082|FG000|Overall Study|Lost to Follow-up|0|||
129550371|NCT00552617|466311083|FG001|Overall Study|Lost to Follow-up|0|||
129550372|NCT00552617|466311084|FG002|Overall Study|Lost to Follow-up|0|||
129550373|NCT00552617|466311085|FG003|Overall Study|Lost to Follow-up|1|||
129550374|NCT00552617|466311086|FG004|Overall Study|Lost to Follow-up|0|||
129550375|NCT00552617|466311087|FG005|Overall Study|Lost to Follow-up|2|||
129550376|NCT00552617|466311088|FG006|Overall Study|Lost to Follow-up|0|||
129550377|NCT00552617|466311089|FG007|Overall Study|Lost to Follow-up|0|||
129550378|NCT00552617|466311090|FG008|Overall Study|Lost to Follow-up|2|||
129550379|NCT00552617|466311091|FG009|Overall Study|Lost to Follow-up|0|||
129550380|NCT00337129|466311099|FG000|Overall Study|Adverse Event|4|||
129550381|NCT00337129|466311099|FG000|Overall Study|Withdrawal by Subject|1|||
129550382|NCT00337129|466311099|FG000|Overall Study|Lack of Efficacy|32|||
129550383|NCT00337129|466311099|FG000|Overall Study|Death|2|||
129550384|NCT00337129|466311099|FG000|Overall Study|not protocol specified|1|||
129550385|NCT00563524|466311102|FG000|Overall Study|Adverse Event|0|||
129550386|NCT00563524|466311103|FG001|Overall Study|Adverse Event|1|||
129550387|NCT00563524|466311104|FG002|Overall Study|Adverse Event|0|||
129683689|NCT02783274|466799187|FG000|Overall Study|Other|22|||
129683690|NCT04717557|466799188|FG000|Overall Study|Withdrawal by Subject|2|||
129683691|NCT04717557|466799189|FG001|Overall Study|Withdrawal by Subject|0|||
129683692|NCT04717557|466799188|FG000|Overall Study|Death|1|||
129683693|NCT04717557|466799189|FG001|Overall Study|Death|0|||
129683694|NCT02516241|466799193|FG000|Overall Study|Death|255|||
129683695|NCT02516241|466799194|FG001|Overall Study|Death|262|||
129683696|NCT02516241|466799195|FG002|Overall Study|Death|270|||
129683697|NCT02516241|466799193|FG000|Overall Study|Lost to Follow-up|1|||
129683698|NCT02516241|466799194|FG001|Overall Study|Lost to Follow-up|1|||
129683699|NCT02516241|466799195|FG002|Overall Study|Lost to Follow-up|3|||
129683700|NCT02516241|466799193|FG000|Overall Study|Withdrawal by Subject|2|||
129772233|NCT00068692|467134076|FG002|Step 1: Registration|Withdrawal by Subject|0|||
129550388|NCT00563524|466311105|FG003|Overall Study|Adverse Event|0|||
129550389|NCT00563524|466311106|FG004|Overall Study|Adverse Event|2|||
129550390|NCT00563524|466311107|FG005|Overall Study|Adverse Event|0|||
129550391|NCT00563524|466311102|FG000|Overall Study|Lost to Follow-up|1|||
129550392|NCT00563524|466311103|FG001|Overall Study|Lost to Follow-up|0|||
129550393|NCT00563524|466311104|FG002|Overall Study|Lost to Follow-up|0|||
129683701|NCT02516241|466799194|FG001|Overall Study|Withdrawal by Subject|7|||
129683702|NCT02516241|466799195|FG002|Overall Study|Withdrawal by Subject|12|||
129683703|NCT02516241|466799193|FG000|Overall Study|participants ongoing at data cut-off|84|||
129550394|NCT00563524|466311105|FG003|Overall Study|Lost to Follow-up|0|||
129550395|NCT00563524|466311106|FG004|Overall Study|Lost to Follow-up|0|||
129550396|NCT00563524|466311107|FG005|Overall Study|Lost to Follow-up|0|||
129550397|NCT00563524|466311102|FG000|Overall Study|Protocol Violation|0|||
129550398|NCT00563524|466311103|FG001|Overall Study|Protocol Violation|1|||
129550399|NCT00563524|466311104|FG002|Overall Study|Protocol Violation|0|||
129550400|NCT00563524|466311105|FG003|Overall Study|Protocol Violation|0|||
129550401|NCT00563524|466311106|FG004|Overall Study|Protocol Violation|0|||
129550402|NCT00563524|466311107|FG005|Overall Study|Protocol Violation|0|||
129550403|NCT00563524|466311102|FG000|Overall Study|Withdrawal by Subject|1|||
129550404|NCT00563524|466311103|FG001|Overall Study|Withdrawal by Subject|1|||
129550405|NCT00563524|466311104|FG002|Overall Study|Withdrawal by Subject|3|||
129550406|NCT00563524|466311105|FG003|Overall Study|Withdrawal by Subject|0|||
129550407|NCT00563524|466311106|FG004|Overall Study|Withdrawal by Subject|0|||
129550408|NCT00563524|466311107|FG005|Overall Study|Withdrawal by Subject|1|||
129550409|NCT02360397|466311111|FG000|Overall Study|Incomplete screening|3|||
129550410|NCT02360397|466311111|FG000|Overall Study|Adverse Event|1|||
129550411|NCT01537549|466311112|FG000|Overall Study|Lost to Follow-up|1|||
129550412|NCT01537549|466311112|FG000|Overall Study|Withdrawal by Subject|2|||
129550413|NCT01286207|466311115|FG000|Overall Study|Adverse Event|27|||
129550414|NCT01286207|466311116|FG001|Overall Study|Adverse Event|41|||
129550415|NCT01286207|466311117|FG002|Overall Study|Adverse Event|8|||
129550416|NCT01286207|466311115|FG000|Overall Study|Lost to Follow-up|49|||
129550417|NCT01286207|466311116|FG001|Overall Study|Lost to Follow-up|43|||
129550418|NCT01286207|466311117|FG002|Overall Study|Lost to Follow-up|20|||
129550419|NCT01286207|466311115|FG000|Overall Study|Withdrawal by Subject|93|||
129550420|NCT01286207|466311116|FG001|Overall Study|Withdrawal by Subject|79|||
129550421|NCT01286207|466311117|FG002|Overall Study|Withdrawal by Subject|41|||
129550422|NCT01286207|466311115|FG000|Overall Study|Lack of Response|92|||
129550423|NCT01286207|466311116|FG001|Overall Study|Lack of Response|38|||
129550424|NCT01286207|466311117|FG002|Overall Study|Lack of Response|8|||
129550425|NCT01286207|466311115|FG000|Overall Study|Other|37|||
129550426|NCT01286207|466311116|FG001|Overall Study|Other|47|||
129550427|NCT01286207|466311117|FG002|Overall Study|Other|13|||
129550428|NCT01383954|466311118|FG000|Overall Study|Lack of Efficacy|2|||
129550429|NCT01383954|466311118|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
129550430|NCT01383954|466311118|FG000|Overall Study|Adverse Event|1|||
129550431|NCT01383954|466311118|FG000|Overall Study|Reason Not Specified|9|||
129550432|NCT00450177|466311119|FG000|Overall Study|Adverse Event|7|||
129550433|NCT00450177|466311120|FG001|Overall Study|Adverse Event|4|||
129550434|NCT00450177|466311119|FG000|Overall Study|Withdrawal by Subject|1|||
129550435|NCT00450177|466311120|FG001|Overall Study|Withdrawal by Subject|6|||
129550436|NCT00450177|466311119|FG000|Overall Study|Withdrawal by Primary Team|1|||
129550437|NCT00450177|466311120|FG001|Overall Study|Withdrawal by Primary Team|1|||
129550438|NCT00763269|466311123|FG000|Overall Study|Lost to Follow-up|12|||
129550439|NCT00763269|466311124|FG001|Overall Study|Lost to Follow-up|13|||
129550440|NCT01791127|466311125|FG000|Overall Study|Death|356|||
129550441|NCT01791127|466311125|FG000|Overall Study|Patient has withdrawn from study|293|||
129550442|NCT01791127|466311125|FG000|Overall Study|Lost to Follow-up|42|||
129550443|NCT01791127|466311125|FG000|Overall Study|All Siello leads are explanted|31|||
129550444|NCT01791127|466311125|FG000|Overall Study|Completion of 30 day safety registry|1|||
129550445|NCT01791127|466311125|FG000|Overall Study|Study terminated for EP Passion|749|||
129550446|NCT00589693|466311126|FG000|Overall Study|randomized in error|12|||
129550447|NCT00589693|466311127|FG001|Overall Study|randomized in error|6|||
129550448|NCT00589693|466311126|FG000|Overall Study|Adverse Event|4|||
129550449|NCT00589693|466311127|FG001|Overall Study|Adverse Event|4|||
129550450|NCT00589693|466311126|FG000|Overall Study|Death|26|||
129550451|NCT00589693|466311127|FG001|Overall Study|Death|16|||
129550452|NCT00589693|466311126|FG000|Overall Study|Lack of Efficacy|0|||
129550453|NCT00589693|466311127|FG001|Overall Study|Lack of Efficacy|1|||
129550454|NCT00589693|466311126|FG000|Overall Study|Lost to Follow-up|1|||
129550455|NCT00589693|466311127|FG001|Overall Study|Lost to Follow-up|0|||
129550456|NCT00589693|466311126|FG000|Overall Study|Physician Decision|0|||
129550457|NCT00589693|466311127|FG001|Overall Study|Physician Decision|1|||
129550458|NCT00589693|466311126|FG000|Overall Study|Protocol Violation|1|||
129550459|NCT00589693|466311127|FG001|Overall Study|Protocol Violation|1|||
129550460|NCT03231709|466311128|FG000|Treatment Period 1|Reason not Specified|0|||
129550461|NCT03231709|466311129|FG001|Treatment Period 1|Reason not Specified|1|||
129550462|NCT03231709|466311128|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
129550463|NCT03231709|466311129|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
129550464|NCT02609178|466311130|FG000|First Crown|Withdrawal by Subject|0|||
129550465|NCT02609178|466311131|FG001|First Crown|Withdrawal by Subject|0|||
129550466|NCT02609178|466311132|FG002|First Crown|Withdrawal by Subject|1|||
129550467|NCT02609178|466311133|FG003|First Crown|Withdrawal by Subject|1|||
129550468|NCT02609178|466311134|FG004|First Crown|Withdrawal by Subject|0|||
129550469|NCT02609178|466311135|FG005|First Crown|Withdrawal by Subject|0|||
129550470|NCT01128153|466311136|FG000|Overall Study|Adverse Event|1|||
129550471|NCT01128153|466311137|FG001|Overall Study|Adverse Event|3|||
129550472|NCT01128153|466311136|FG000|Overall Study|Condition under investigation worsened|8|||
129550473|NCT01128153|466311137|FG001|Overall Study|Condition under investigation worsened|7|||
129550474|NCT01128153|466311136|FG000|Overall Study|Withdrawal by Subject|2|||
129550475|NCT01128153|466311137|FG001|Overall Study|Withdrawal by Subject|3|||
129550476|NCT01128153|466311136|FG000|Overall Study|Incorrect enrolment to study|2|||
129550477|NCT01128153|466311137|FG001|Overall Study|Incorrect enrolment to study|1|||
129550478|NCT01128153|466311136|FG000|Overall Study|Protocol Violation|2|||
129550479|NCT01128153|466311137|FG001|Overall Study|Protocol Violation|0|||
129550480|NCT01128153|466311136|FG000|Overall Study|Developed discontinuation criteria|1|||
129550481|NCT01128153|466311137|FG001|Overall Study|Developed discontinuation criteria|1|||
129550482|NCT02419469|466311138|FG000|Overall Study|Withdrawal by Subject|1|||
129550483|NCT01682512|466311139|FG000|Overall Study|Adverse Event|6|||
129550484|NCT01682512|466311140|FG001|Overall Study|Adverse Event|5|||
129550485|NCT01682512|466311141|FG002|Overall Study|Adverse Event|2|||
129550486|NCT01682512|466311139|FG000|Overall Study|Withdrawal by Subject|2|||
129550487|NCT01682512|466311140|FG001|Overall Study|Withdrawal by Subject|6|||
129550488|NCT01682512|466311141|FG002|Overall Study|Withdrawal by Subject|3|||
129550489|NCT01682512|466311139|FG000|Overall Study|Physician Decision|0|||
129550490|NCT01682512|466311140|FG001|Overall Study|Physician Decision|2|||
129550491|NCT01682512|466311141|FG002|Overall Study|Physician Decision|0|||
129550492|NCT01682512|466311139|FG000|Overall Study|Study terminated by sponsor|46|||
129550493|NCT01682512|466311140|FG001|Overall Study|Study terminated by sponsor|43|||
129550494|NCT01682512|466311141|FG002|Overall Study|Study terminated by sponsor|0|||
129550495|NCT01682512|466311139|FG000|Overall Study|Lost to Follow-up|3|||
129550496|NCT01682512|466311140|FG001|Overall Study|Lost to Follow-up|0|||
129550497|NCT01682512|466311141|FG002|Overall Study|Lost to Follow-up|2|||
129550498|NCT01682512|466311139|FG000|Overall Study|Protocol Violation|2|||
129550499|NCT01682512|466311140|FG001|Overall Study|Protocol Violation|3|||
129550500|NCT01682512|466311141|FG002|Overall Study|Protocol Violation|2|||
129550501|NCT01682512|466311139|FG000|Overall Study|Primary lack of efficacy|10|||
129550502|NCT01682512|466311140|FG001|Overall Study|Primary lack of efficacy|7|||
129550503|NCT01682512|466311141|FG002|Overall Study|Primary lack of efficacy|7|||
129550504|NCT01682512|466311139|FG000|Overall Study|Secondary lack of efficacy|1|||
129550505|NCT01682512|466311140|FG001|Overall Study|Secondary lack of efficacy|1|||
129550506|NCT01682512|466311141|FG002|Overall Study|Secondary lack of efficacy|0|||
129550507|NCT01682512|466311139|FG000|Overall Study|Other than stated above|2|||
129550508|NCT01682512|466311140|FG001|Overall Study|Other than stated above|4|||
129550509|NCT01682512|466311141|FG002|Overall Study|Other than stated above|2|||
129550510|NCT00054275|466311144|FG000|Overall Study|Withdrawal by Subject|4|||
129550511|NCT00054275|466311144|FG000|Overall Study|Adverse Event|5|||
129550512|NCT00054275|466311144|FG000|Overall Study|Progressive disease in cycle 1|1|||
129550513|NCT00054275|466311144|FG000|Overall Study|Physician Decision|1|||
129550514|NCT02030834|466311152|FG000|Overall Study|Death|4|||
129550515|NCT02030834|466311153|FG001|Overall Study|Death|0|||
129550516|NCT02030834|466311154|FG002|Overall Study|Death|0|||
129550517|NCT02030834|466311152|FG000|Overall Study|Manufacturing failure|2|||
129683704|NCT02516241|466799194|FG001|Overall Study|participants ongoing at data cut-off|76|||
129683705|NCT02516241|466799195|FG002|Overall Study|participants ongoing at data cut-off|59|||
129683706|NCT00724945|466799196|FG000|Period 1|non-compliance|1|||
129683707|NCT00724945|466799197|FG001|Period 1|non-compliance|0|||
129683708|NCT00724945|466799196|FG000|Period 1|Adverse Event|1|||
129683709|NCT00724945|466799197|FG001|Period 1|Adverse Event|1|||
129683710|NCT00724945|466799196|FG000|Period 1|Lost to Follow-up|1|||
129683711|NCT00724945|466799197|FG001|Period 1|Lost to Follow-up|0|||
129683712|NCT00724945|466799196|FG000|Period 2|lens comfort issue|3|||
129683713|NCT00724945|466799197|FG001|Period 2|lens comfort issue|0|||
129683714|NCT00724945|466799196|FG000|Period 2|lens physiology issue|1|||
129683715|NCT00724945|466799197|FG001|Period 2|lens physiology issue|0|||
129683716|NCT04835441|466799198|FG000|Overall Study|Physician Decision|4|||
129683717|NCT04835441|466799199|FG001|Overall Study|Physician Decision|4|||
129683718|NCT04835441|466799198|FG000|Overall Study|Other|1|||
129683719|NCT04835441|466799199|FG001|Overall Study|Other|1|||
129683720|NCT04835441|466799198|FG000|Overall Study|Lost to Follow-up|0|||
129683721|NCT04835441|466799199|FG001|Overall Study|Lost to Follow-up|1|||
129683722|NCT03069989|466799203|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
129683723|NCT03069989|466799204|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
129683724|NCT01081951|466800307|FG000|Overall Study|Death|54|||
129683725|NCT01081951|466800308|FG001|Overall Study|Death|47|||
129683726|NCT01081951|466800307|FG000|Overall Study|Withdrawal by Subject|2|||
129683727|NCT01081951|466800308|FG001|Overall Study|Withdrawal by Subject|6|||
129683728|NCT01081951|466800307|FG000|Overall Study|Allocated treatment but did not take it|0|||
129683729|NCT01081951|466800308|FG001|Overall Study|Allocated treatment but did not take it|1|||
129683730|NCT01081951|466800307|FG000|Overall Study|Lost to Follow-up|0|||
129550518|NCT02030834|466311153|FG001|Overall Study|Manufacturing failure|0|||
129550519|NCT02030834|466311154|FG002|Overall Study|Manufacturing failure|1|||
129550520|NCT02030834|466311152|FG000|Overall Study|Disease progression|2|||
129550521|NCT02030834|466311153|FG001|Overall Study|Disease progression|0|||
129550522|NCT02030834|466311154|FG002|Overall Study|Disease progression|2|||
129550523|NCT02030834|466311152|FG000|Overall Study|Lost to Follow-up|1|||
129550524|NCT02030834|466311153|FG001|Overall Study|Lost to Follow-up|0|||
129683731|NCT01081951|466800308|FG001|Overall Study|Lost to Follow-up|1|||
129683732|NCT01901562|466800310|FG000|Overall Study|Protocol Violation|5|||
129550525|NCT02030834|466311154|FG002|Overall Study|Lost to Follow-up|0|||
129550526|NCT02030834|466311152|FG000|Overall Study|Withdrawal by Subject|1|||
129550527|NCT02030834|466311153|FG001|Overall Study|Withdrawal by Subject|0|||
129550528|NCT02030834|466311154|FG002|Overall Study|Withdrawal by Subject|0|||
129550529|NCT02030834|466311152|FG000|Overall Study|Lack of funding|1|||
129550530|NCT02030834|466311153|FG001|Overall Study|Lack of funding|0|||
129550531|NCT02030834|466311154|FG002|Overall Study|Lack of funding|0|||
129550532|NCT00996918|466311157|FG000|Overall Study|Lack of Efficacy|1|||
129550533|NCT00996918|466311158|FG001|Overall Study|Lack of Efficacy|1|||
129550534|NCT00996918|466311159|FG002|Overall Study|Lack of Efficacy|2|||
129550535|NCT00996918|466311160|FG003|Overall Study|Lack of Efficacy|2|||
129550536|NCT00996918|466311161|FG004|Overall Study|Lack of Efficacy|0|||
129550537|NCT00996918|466311157|FG000|Overall Study|Adverse Event|2|||
129550538|NCT00996918|466311158|FG001|Overall Study|Adverse Event|5|||
129550539|NCT00996918|466311159|FG002|Overall Study|Adverse Event|2|||
129550540|NCT00996918|466311160|FG003|Overall Study|Adverse Event|6|||
129550541|NCT00996918|466311161|FG004|Overall Study|Adverse Event|0|||
129550542|NCT00996918|466311157|FG000|Overall Study|Withdrawal by Subject|1|||
129550543|NCT00996918|466311158|FG001|Overall Study|Withdrawal by Subject|4|||
129550544|NCT00996918|466311159|FG002|Overall Study|Withdrawal by Subject|3|||
129550545|NCT00996918|466311160|FG003|Overall Study|Withdrawal by Subject|3|||
129550546|NCT00996918|466311161|FG004|Overall Study|Withdrawal by Subject|2|||
129550547|NCT00996918|466311157|FG000|Overall Study|Physician Decision|1|||
129550548|NCT00996918|466311158|FG001|Overall Study|Physician Decision|0|||
129550549|NCT00996918|466311159|FG002|Overall Study|Physician Decision|0|||
129550550|NCT00996918|466311160|FG003|Overall Study|Physician Decision|0|||
129550551|NCT00996918|466311161|FG004|Overall Study|Physician Decision|0|||
129550552|NCT00996918|466311157|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
129550553|NCT00996918|466311158|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
129550554|NCT00996918|466311159|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
129550555|NCT00996918|466311160|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
129550556|NCT00996918|466311161|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
129550557|NCT00996918|466311157|FG000|Overall Study|Loss of Caregiver|0|||
129550558|NCT00996918|466311158|FG001|Overall Study|Loss of Caregiver|1|||
129550559|NCT00996918|466311159|FG002|Overall Study|Loss of Caregiver|0|||
129550560|NCT00996918|466311160|FG003|Overall Study|Loss of Caregiver|0|||
129550561|NCT00996918|466311161|FG004|Overall Study|Loss of Caregiver|0|||
129550562|NCT00996918|466311157|FG000|Overall Study|Other|3|||
129550563|NCT00996918|466311158|FG001|Overall Study|Other|1|||
129550564|NCT00996918|466311159|FG002|Overall Study|Other|0|||
129550565|NCT00996918|466311160|FG003|Overall Study|Other|0|||
129550566|NCT00996918|466311161|FG004|Overall Study|Other|0|||
129550567|NCT04440007|466311166|FG000|Overall Study|Adverse Event|0|||
129550568|NCT04440007|466311167|FG001|Overall Study|Adverse Event|1|||
129550569|NCT04440007|466311166|FG000|Overall Study|Lost to Follow-up|1|||
129550570|NCT04440007|466311167|FG001|Overall Study|Lost to Follow-up|3|||
129550571|NCT04440007|466311166|FG000|Overall Study|Death|7|||
129550572|NCT04440007|466311167|FG001|Overall Study|Death|2|||
129550573|NCT04440007|466311166|FG000|Overall Study|Physician Decision|1|||
129550574|NCT04440007|466311167|FG001|Overall Study|Physician Decision|1|||
129550575|NCT04440007|466311166|FG000|Overall Study|Withdrawal by Subject|2|||
129550576|NCT04440007|466311167|FG001|Overall Study|Withdrawal by Subject|1|||
129550577|NCT04440007|466311166|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
129550578|NCT04440007|466311167|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
129550579|NCT04440007|466311166|FG000|Overall Study|Discontinued prior to dosing|0|||
129550580|NCT04440007|466311167|FG001|Overall Study|Discontinued prior to dosing|2|||
129550581|NCT01466673|466311168|FG000|Overall Study|Non-compliance with study treatment|2|||
129550582|NCT01466673|466311169|FG001|Overall Study|Non-compliance with study treatment|0|||
129550583|NCT01466673|466311168|FG000|Overall Study|Lost to Follow-up|3|||
129550584|NCT01466673|466311169|FG001|Overall Study|Lost to Follow-up|5|||
129550585|NCT01466673|466311168|FG000|Overall Study|Adverse Event|2|||
129550586|NCT01466673|466311169|FG001|Overall Study|Adverse Event|1|||
129550587|NCT00854607|466311170|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
129683733|NCT01901562|466800310|FG000|Overall Study|Excluded intraoperatively|4|||
129683734|NCT00088153|466800311|FG000|Overall Study|Physician Decision|3|||
129683735|NCT00088153|466800312|FG001|Overall Study|Physician Decision|3|||
129550588|NCT03959137|466311173|FG000|Overall Study|Protocol Violation|6|||
129550589|NCT00995488|466311174|FG000|Overall Study|Withdrawal by Subject|1|||
129550590|NCT05166512|466311177|FG000|Randomized|Lost to Follow-up|2|||
129550591|NCT05166512|466311178|FG001|Randomized|Lost to Follow-up|0|||
129550592|NCT05166512|466311177|FG000|Randomized|Withdrawal by Subject|1|||
129550593|NCT05166512|466311178|FG001|Randomized|Withdrawal by Subject|0|||
129550594|NCT05166512|466311177|FG000|Baseline Data Collection|Lost to Follow-up|0|||
129550595|NCT05166512|466311178|FG001|Baseline Data Collection|Lost to Follow-up|3|||
129550596|NCT05166512|466311177|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
129550597|NCT05166512|466311178|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
129683736|NCT00088153|466800311|FG000|Overall Study|Withdrawal by Subject|10|||
129683737|NCT00088153|466800312|FG001|Overall Study|Withdrawal by Subject|10|||
129550598|NCT05166512|466311177|FG000|Baseline Data Collection|Protocol Violation|2|||
129550599|NCT05166512|466311178|FG001|Baseline Data Collection|Protocol Violation|0|||
129550600|NCT05166512|466311177|FG000|4 Month Data Collection|Lost to Follow-up|1|||
129550601|NCT05166512|466311178|FG001|4 Month Data Collection|Lost to Follow-up|0|||
129550602|NCT05166512|466311177|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
129550603|NCT05166512|466311178|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
129550604|NCT05166512|466311177|FG000|12 Month Data Collection|Lost to Follow-up|3|||
129550605|NCT05166512|466311178|FG001|12 Month Data Collection|Lost to Follow-up|1|||
129550606|NCT05166512|466311177|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
129550607|NCT05166512|466311178|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
129550608|NCT02139306|466311179|FG000|Overall Study|Withdrawal by Subject|4|||
129550609|NCT02139306|466311180|FG001|Overall Study|Withdrawal by Subject|6|||
129550610|NCT02139306|466311179|FG000|Overall Study|Adverse Event|3|||
129550611|NCT02139306|466311180|FG001|Overall Study|Adverse Event|4|||
129550612|NCT02139306|466311179|FG000|Overall Study|Physician Decision|0|||
129550613|NCT02139306|466311180|FG001|Overall Study|Physician Decision|1|||
129550614|NCT02139306|466311179|FG000|Overall Study|Other Unspecified|2|||
129683738|NCT00088153|466800311|FG000|Overall Study|Lost to Follow-up|11|||
129683739|NCT00088153|466800312|FG001|Overall Study|Lost to Follow-up|12|||
129683740|NCT00976027|466800314|FG000|Overall Study|Serious Adverse Event|36|||
129683741|NCT00976027|466800315|FG001|Overall Study|Serious Adverse Event|17|||
129683742|NCT00976027|466800314|FG000|Overall Study|Adverse Event|0|||
129683743|NCT00976027|466800315|FG001|Overall Study|Adverse Event|2|||
129683744|NCT00976027|466800314|FG000|Overall Study|Protocol Violation|60|||
129683745|NCT00976027|466800315|FG001|Overall Study|Protocol Violation|27|||
129683746|NCT00976027|466800314|FG000|Overall Study|Lost to Follow-up|208|||
129683747|NCT00976027|466800315|FG001|Overall Study|Lost to Follow-up|103|||
129683748|NCT00976027|466800314|FG000|Overall Study|Withdrawal by Subject|107|||
129683749|NCT00976027|466800315|FG001|Overall Study|Withdrawal by Subject|66|||
129683750|NCT04435626|466800320|FG000|Overall Study|Lost to Follow-up|1|||
129683751|NCT04435626|466800321|FG001|Overall Study|Lost to Follow-up|5|||
129683752|NCT04435626|466800320|FG000|Overall Study|Withdrawal by Subject|6|||
129683753|NCT04435626|466800321|FG001|Overall Study|Withdrawal by Subject|7|||
129683754|NCT04435626|466800320|FG000|Overall Study|major GCP violations|8|||
129683755|NCT04435626|466800321|FG001|Overall Study|major GCP violations|7|||
129683756|NCT01771107|466800327|FG000|Overall Study|Adverse Event|1|||
129683757|NCT01771107|466800328|FG001|Overall Study|Adverse Event|3|||
129683758|NCT01771107|466800327|FG000|Overall Study|Withdrawal by Subject|0|||
129683759|NCT01771107|466800328|FG001|Overall Study|Withdrawal by Subject|2|||
129683760|NCT01771107|466800327|FG000|Overall Study|Lost to Follow-up|0|||
129683761|NCT01771107|466800328|FG001|Overall Study|Lost to Follow-up|1|||
129683762|NCT01771107|466800327|FG000|Overall Study|participant moved|0|||
129683763|NCT01771107|466800328|FG001|Overall Study|participant moved|1|||
129683764|NCT01771107|466800327|FG000|Overall Study|Other|0|||
129683765|NCT01771107|466800328|FG001|Overall Study|Other|1|||
129683766|NCT05248386|466800330|FG000|Overall Study|Technical problems|0|||
129683767|NCT05248386|466800331|FG001|Overall Study|Technical problems|1|||
129683768|NCT05248386|466800330|FG000|Overall Study|Withdrawal by Subject|15|||
129683769|NCT05248386|466800331|FG001|Overall Study|Withdrawal by Subject|10|||
129683770|NCT05248386|466800330|FG000|Overall Study|Physician Decision|0|||
129683771|NCT05248386|466800331|FG001|Overall Study|Physician Decision|1|||
129683772|NCT05248386|466800330|FG000|Overall Study|Adverse Event|2|||
129683773|NCT05248386|466800331|FG001|Overall Study|Adverse Event|4|||
129683774|NCT05248386|466800330|FG000|Overall Study|Other|1|||
129683775|NCT05248386|466800331|FG001|Overall Study|Other|0|||
129683776|NCT05248386|466800330|FG000|Overall Study|Lack of Efficacy|14|||
129683777|NCT05248386|466800331|FG001|Overall Study|Lack of Efficacy|12|||
129683778|NCT02864992|466800332|FG000|Overall Study|still on treatment|15|||
129683779|NCT02864992|466800333|FG001|Overall Study|still on treatment|1|||
129683780|NCT02864992|466800334|FG002|Overall Study|still on treatment|33|||
129683781|NCT03785366|466800335|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
129683782|NCT03785366|466800336|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
129683783|NCT03785366|466800335|FG000|Overall Study|Lost to Follow-up|1|||
129683784|NCT03785366|466800336|FG001|Overall Study|Lost to Follow-up|0|||
129550615|NCT02139306|466311180|FG001|Overall Study|Other Unspecified|3|||
129550616|NCT02139306|466311179|FG000|Overall Study|Protocol Violation|4|||
129550617|NCT02139306|466311180|FG001|Overall Study|Protocol Violation|0|||
129772234|NCT00068692|467134077|FG003|Step 1: Registration|Withdrawal by Subject|0|||
129772235|NCT00068692|467134078|FG004|Step 1: Registration|Withdrawal by Subject|0|||
129550618|NCT04449354|466311181|FG000|Overall Study|Withdrawal by Subject|1|||
129550619|NCT02913261|466311182|FG000|Overall Study|Technical problems|0|||
129550620|NCT02913261|466311183|FG001|Overall Study|Technical problems|1|||
129550621|NCT02913261|466311182|FG000|Overall Study|Lack of Efficacy|32|||
129683785|NCT03785366|466800335|FG000|Overall Study|Partial IUD Expulsion|0|||
129683786|NCT03785366|466800336|FG001|Overall Study|Partial IUD Expulsion|2|||
129683787|NCT03785366|466800335|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
129683788|NCT03785366|466800336|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
129683789|NCT03240874|466800337|FG000|Overall Study|Lost to Follow-up|0|||
129550622|NCT02913261|466311183|FG001|Overall Study|Lack of Efficacy|69|||
129550623|NCT02913261|466311182|FG000|Overall Study|Adverse Event|27|||
129550624|NCT02913261|466311183|FG001|Overall Study|Adverse Event|5|||
129550625|NCT02913261|466311182|FG000|Overall Study|Death|25|||
129550626|NCT02913261|466311183|FG001|Overall Study|Death|22|||
129550627|NCT02913261|466311182|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
129550628|NCT02913261|466311183|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
129550629|NCT02913261|466311182|FG000|Overall Study|Disease relapse|8|||
129550630|NCT02913261|466311183|FG001|Overall Study|Disease relapse|13|||
129550631|NCT02913261|466311182|FG000|Overall Study|Physician Decision|8|||
129550632|NCT02913261|466311183|FG001|Overall Study|Physician Decision|9|||
129550633|NCT02913261|466311182|FG000|Overall Study|Subject/guardian decision|4|||
129550634|NCT02913261|466311183|FG001|Overall Study|Subject/guardian decision|6|||
129550635|NCT02913261|466311182|FG000|Overall Study|Graft loss|2|||
129550636|NCT02913261|466311183|FG001|Overall Study|Graft loss|0|||
129550637|NCT03022799|466311184|FG000|Overall Study|Adverse Event|0|||
129550638|NCT03022799|466311185|FG001|Overall Study|Adverse Event|0|||
129550639|NCT03022799|466311186|FG002|Overall Study|Adverse Event|0|||
129550640|NCT03022799|466311187|FG003|Overall Study|Adverse Event|0|||
129550641|NCT03022799|466311188|FG004|Overall Study|Adverse Event|0|||
129550642|NCT03022799|466311189|FG005|Overall Study|Adverse Event|0|||
129550643|NCT03022799|466311190|FG006|Overall Study|Adverse Event|0|||
129550644|NCT03022799|466311191|FG007|Overall Study|Adverse Event|0|||
129550645|NCT03022799|466311192|FG008|Overall Study|Adverse Event|0|||
129550646|NCT03022799|466311193|FG009|Overall Study|Adverse Event|1|||
129550647|NCT03022799|466311194|FG010|Overall Study|Adverse Event|1|||
129550648|NCT03022799|466311195|FG011|Overall Study|Adverse Event|0|||
129550649|NCT03022799|466311196|FG012|Overall Study|Adverse Event|0|||
129550650|NCT01211613|466312817|FG000|Overall Study|Lost to Follow-up|2|||
129550651|NCT01211613|466312818|FG001|Overall Study|Lost to Follow-up|2|||
129550652|NCT01211613|466312819|FG002|Overall Study|Lost to Follow-up|2|||
129550653|NCT01211613|466312817|FG000|Overall Study|Withdrawal by Subject|1|||
129550654|NCT01211613|466312818|FG001|Overall Study|Withdrawal by Subject|0|||
129550655|NCT01211613|466312819|FG002|Overall Study|Withdrawal by Subject|0|||
129550656|NCT03853213|466312820|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
129550657|NCT03853213|466312821|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
129550658|NCT03853213|466312820|FG000|Overall Study|Other (e.g., too busy)|0|||
129550659|NCT03853213|466312821|FG001|Overall Study|Other (e.g., too busy)|2|||
129550660|NCT01458132|466312822|FG000|Overall Study|Other|15|||
129550661|NCT01458132|466312823|FG001|Overall Study|Other|3|||
129550662|NCT00833976|466312828|FG000|Overall Study|Withdrawal by Subject|5|||
129550663|NCT00833976|466312828|FG000|Overall Study|Lost to Follow-up|4|||
129683790|NCT03240874|466800338|FG001|Overall Study|Lost to Follow-up|2|||
129683791|NCT03240874|466800339|FG002|Overall Study|Lost to Follow-up|4|||
129683792|NCT03240874|466800340|FG003|Overall Study|Lost to Follow-up|1|||
129683793|NCT05252702|466800341|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
129683794|NCT05252702|466800341|FG000|Overall Study|Death|16|||
129683795|NCT05252702|466800341|FG000|Overall Study|System explant|5|||
129683796|NCT05252702|466800341|FG000|Overall Study|Lost to Follow-up|1|||
129683797|NCT05252702|466800341|FG000|Overall Study|Withdrawn by investigator|1|||
129683798|NCT05252702|466800341|FG000|Overall Study|Visit not due|306|||
129683799|NCT05252702|466800341|FG000|Overall Study|Visit within window but not completed|92|||
129683800|NCT05252702|466800341|FG000|Overall Study|Unsuccessful implant|1|||
129683801|NCT04153864|466800342|FG000|Overall Study|Withdrawal by Subject|21|||
129683802|NCT04153864|466800343|FG001|Overall Study|Withdrawal by Subject|7|||
129683803|NCT04153864|466800344|FG002|Overall Study|Withdrawal by Subject|23|||
129683804|NCT04153864|466800345|FG003|Overall Study|Withdrawal by Subject|2|||
129683805|NCT04153864|466800342|FG000|Overall Study|Lost to Follow-up|4|||
129683806|NCT04153864|466800343|FG001|Overall Study|Lost to Follow-up|0|||
129683807|NCT04153864|466800344|FG002|Overall Study|Lost to Follow-up|3|||
129683808|NCT04153864|466800345|FG003|Overall Study|Lost to Follow-up|0|||
129683809|NCT04153864|466800342|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
129772236|NCT00068692|467134079|FG005|Step 1: Registration|Withdrawal by Subject|0|||
129550664|NCT00833976|466312828|FG000|Overall Study|Did not meet eligibility criteria|41|||
129683810|NCT04153864|466800343|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
129683811|NCT04153864|466800344|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
129683812|NCT04153864|466800345|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
129683813|NCT04958707|466800346|FG000|Post Intervention|Withdrawal by Subject|1|||
129550665|NCT00833976|466312828|FG000|Overall Study|Physician Decision|1|||
129550666|NCT03911960|466312829|FG000|Overall Study|Lost to Follow-up|5|||
129550667|NCT03911960|466312830|FG001|Overall Study|Lost to Follow-up|3|||
129550668|NCT02414854|466312833|FG000|Overall Study|Adverse Event|9|||
129550669|NCT02414854|466312834|FG001|Overall Study|Adverse Event|7|||
129550670|NCT02414854|466312835|FG002|Overall Study|Adverse Event|1|||
129550671|NCT02414854|466312836|FG003|Overall Study|Adverse Event|12|||
129550672|NCT02414854|466312833|FG000|Overall Study|Poor compliance to protocol|1|||
129550673|NCT02414854|466312834|FG001|Overall Study|Poor compliance to protocol|1|||
129550674|NCT02414854|466312835|FG002|Overall Study|Poor compliance to protocol|2|||
129550675|NCT02414854|466312836|FG003|Overall Study|Poor compliance to protocol|2|||
129550676|NCT02414854|466312833|FG000|Overall Study|Other than specified above|12|||
129550677|NCT02414854|466312834|FG001|Overall Study|Other than specified above|37|||
129550678|NCT02414854|466312835|FG002|Overall Study|Other than specified above|17|||
129550679|NCT02414854|466312836|FG003|Overall Study|Other than specified above|37|||
129550680|NCT00817778|466312838|FG000|Overall Study|Adverse Event|1|||
129550681|NCT00817778|466312839|FG001|Overall Study|Adverse Event|0|||
129550682|NCT00817778|466312838|FG000|Overall Study|Withdrawal by Subject|1|||
129550683|NCT00817778|466312839|FG001|Overall Study|Withdrawal by Subject|1|||
129550684|NCT00817778|466312838|FG000|Overall Study|Protocol Violation|0|||
129550685|NCT00817778|466312839|FG001|Overall Study|Protocol Violation|1|||
129550686|NCT00817778|466312838|FG000|Overall Study|Study-specific discontinuation criteria|0|||
129550687|NCT00817778|466312839|FG001|Overall Study|Study-specific discontinuation criteria|1|||
129550688|NCT00817778|466312838|FG000|Overall Study|Poor venous access|1|||
129550689|NCT00817778|466312839|FG001|Overall Study|Poor venous access|0|||
129550690|NCT02923115|466312845|FG000|Overall Study|Lost to Follow-up|0|||
129550691|NCT02923115|466312846|FG001|Overall Study|Lost to Follow-up|0|||
129550692|NCT02923115|466312847|FG002|Overall Study|Lost to Follow-up|0|||
129550693|NCT02923115|466312848|FG003|Overall Study|Lost to Follow-up|1|||
129550694|NCT02923115|466312849|FG004|Overall Study|Lost to Follow-up|0|||
129550695|NCT02923115|466312850|FG005|Overall Study|Lost to Follow-up|0|||
129550696|NCT02923115|466312845|FG000|Overall Study|Withdrawal by Subject|0|||
129550697|NCT02923115|466312846|FG001|Overall Study|Withdrawal by Subject|1|||
129550698|NCT02923115|466312847|FG002|Overall Study|Withdrawal by Subject|0|||
129550699|NCT02923115|466312848|FG003|Overall Study|Withdrawal by Subject|0|||
129550700|NCT02923115|466312849|FG004|Overall Study|Withdrawal by Subject|0|||
129550701|NCT02923115|466312850|FG005|Overall Study|Withdrawal by Subject|0|||
129550702|NCT02923115|466312845|FG000|Overall Study|Randomized, but not dosed|0|||
129550703|NCT02923115|466312846|FG001|Overall Study|Randomized, but not dosed|0|||
129550704|NCT02923115|466312847|FG002|Overall Study|Randomized, but not dosed|3|||
129550705|NCT02923115|466312848|FG003|Overall Study|Randomized, but not dosed|1|||
129550706|NCT02923115|466312849|FG004|Overall Study|Randomized, but not dosed|5|||
129550707|NCT02923115|466312850|FG005|Overall Study|Randomized, but not dosed|0|||
129550708|NCT00520494|466312851|FG000|Overall Study|Withdrawal by Subject|1|||
129550709|NCT03471182|466312854|FG000|Overall Study|Withdrawal by Subject|1|||
129550710|NCT03471182|466312855|FG001|Overall Study|Withdrawal by Subject|1|||
129550711|NCT03471182|466312856|FG002|Overall Study|Withdrawal by Subject|0|||
129550712|NCT03471182|466312854|FG000|Overall Study|Technical failure|2|||
129550713|NCT03471182|466312855|FG001|Overall Study|Technical failure|0|||
129550714|NCT03471182|466312856|FG002|Overall Study|Technical failure|0|||
129550715|NCT00068406|466312858|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
129772237|NCT00068692|467134080|FG006|Step 1: Registration|Withdrawal by Subject|0|||
129772238|NCT00068692|467134081|FG007|Step 1: Registration|Withdrawal by Subject|0|||
129772239|NCT00068692|467134074|FG000|Step 1: Registration|Alternative therapy|2|||
129772240|NCT00068692|467134075|FG001|Step 1: Registration|Alternative therapy|0|||
129772241|NCT00068692|467134076|FG002|Step 1: Registration|Alternative therapy|0|||
129772242|NCT00068692|467134077|FG003|Step 1: Registration|Alternative therapy|0|||
129772243|NCT00068692|467134078|FG004|Step 1: Registration|Alternative therapy|0|||
129772244|NCT00068692|467134079|FG005|Step 1: Registration|Alternative therapy|0|||
129772245|NCT00068692|467134080|FG006|Step 1: Registration|Alternative therapy|0|||
129772246|NCT00068692|467134081|FG007|Step 1: Registration|Alternative therapy|0|||
129772247|NCT00068692|467134074|FG000|Step 1: Registration|Complicating disease|2|||
129772248|NCT00068692|467134075|FG001|Step 1: Registration|Complicating disease|0|||
129772249|NCT00068692|467134076|FG002|Step 1: Registration|Complicating disease|0|||
129772250|NCT00068692|467134077|FG003|Step 1: Registration|Complicating disease|0|||
129772251|NCT00068692|467134078|FG004|Step 1: Registration|Complicating disease|0|||
129772252|NCT00068692|467134079|FG005|Step 1: Registration|Complicating disease|0|||
129772253|NCT00068692|467134080|FG006|Step 1: Registration|Complicating disease|0|||
129772254|NCT00068692|467134081|FG007|Step 1: Registration|Complicating disease|0|||
129550716|NCT00068406|466312858|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
129550717|NCT03451331|466312859|FG000|Overall Study|Withdrawal by Subject|1|||
129550718|NCT03451331|466312860|FG001|Overall Study|Withdrawal by Subject|0|||
129550719|NCT03451331|466312859|FG000|Overall Study|Unable to start treatment.|1|||
129550720|NCT03451331|466312860|FG001|Overall Study|Unable to start treatment.|1|||
129550721|NCT01875991|466312861|FG000|Overall Study|Withdrawal by Subject|6|||
129550722|NCT01875991|466312862|FG001|Overall Study|Withdrawal by Subject|6|||
129550723|NCT01875991|466312861|FG000|Overall Study|Sponsor Decision|1|||
129550724|NCT01875991|466312862|FG001|Overall Study|Sponsor Decision|0|||
129550725|NCT02454972|466312863|FG000|Overall Study|Progressive disease|17|||
129772255|NCT00068692|467134074|FG000|Step 1: Registration|Protocol Violation|1|||
129772256|NCT00068692|467134075|FG001|Step 1: Registration|Protocol Violation|0|||
129772257|NCT00068692|467134076|FG002|Step 1: Registration|Protocol Violation|0|||
129772258|NCT00068692|467134077|FG003|Step 1: Registration|Protocol Violation|0|||
129683814|NCT04958707|466800347|FG001|Post Intervention|Withdrawal by Subject|0|||
129683815|NCT04958707|466800348|FG002|Post Intervention|Withdrawal by Subject|0|||
129683816|NCT04958707|466800346|FG000|3 Months Follow- up|Lost to Follow-up|0|||
129683817|NCT04958707|466800347|FG001|3 Months Follow- up|Lost to Follow-up|3|||
129683818|NCT04958707|466800348|FG002|3 Months Follow- up|Lost to Follow-up|0|||
129683819|NCT04958707|466800346|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
129683820|NCT04958707|466800347|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
129683821|NCT04958707|466800348|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
129683822|NCT04279522|466800349|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
129683823|NCT04279522|466800350|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
129683824|NCT04279522|466800349|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
129683825|NCT04279522|466800350|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
129683826|NCT04279522|466800349|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
129683827|NCT04279522|466800350|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
129683828|NCT04279522|466800349|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
129683829|NCT04279522|466800350|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
129683830|NCT04279522|466800349|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
129683831|NCT04279522|466800350|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
129683832|NCT04279522|466800349|FG000|Period 2: Open Label Phase|Physician Decision|0|||
129683833|NCT04279522|466800350|FG001|Period 2: Open Label Phase|Physician Decision|3|||
129683834|NCT04279522|466800349|FG000|Period 2: Open Label Phase|Adverse Event|0|||
129683835|NCT04279522|466800350|FG001|Period 2: Open Label Phase|Adverse Event|1|||
129683836|NCT04279522|466800349|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
129683837|NCT04279522|466800350|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
129683838|NCT02629159|466800353|FG000|Overall Study|Adverse Event|17|||
129683839|NCT02629159|466800354|FG001|Overall Study|Adverse Event|20|||
129683840|NCT02629159|466800355|FG002|Overall Study|Adverse Event|22|||
129683841|NCT02629159|466800353|FG000|Overall Study|Withdrawal by Subject|22|||
129683842|NCT02629159|466800354|FG001|Overall Study|Withdrawal by Subject|11|||
129683843|NCT02629159|466800355|FG002|Overall Study|Withdrawal by Subject|15|||
129683844|NCT02629159|466800353|FG000|Overall Study|Lost to Follow-up|7|||
129683845|NCT02629159|466800354|FG001|Overall Study|Lost to Follow-up|4|||
129683846|NCT02629159|466800355|FG002|Overall Study|Lost to Follow-up|5|||
129683847|NCT02629159|466800353|FG000|Overall Study|Lack of Efficacy|4|||
129683848|NCT02629159|466800354|FG001|Overall Study|Lack of Efficacy|0|||
129683849|NCT02629159|466800355|FG002|Overall Study|Lack of Efficacy|1|||
129683850|NCT02629159|466800353|FG000|Overall Study|Other|6|||
129683851|NCT02629159|466800354|FG001|Overall Study|Other|4|||
129683852|NCT02629159|466800355|FG002|Overall Study|Other|8|||
129683853|NCT05352399|466800368|FG000|Overall Study|Discontinued intervention|6|||
129683854|NCT01802281|466800369|FG000|Overall Study|Death|1|||
129683855|NCT01802281|466800370|FG001|Overall Study|Death|2|||
129683856|NCT01802281|466800369|FG000|Overall Study|Withdrawal by Subject|2|||
129683857|NCT01802281|466800370|FG001|Overall Study|Withdrawal by Subject|1|||
129683858|NCT01802281|466800369|FG000|Overall Study|Ineligible|5|||
129683859|NCT01802281|466800370|FG001|Overall Study|Ineligible|3|||
129683860|NCT02685735|466800371|FG000|Overall Study|Surgery Cancelled|4|||
129683861|NCT02685735|466800372|FG001|Overall Study|Surgery Cancelled|9|||
129683862|NCT02685735|466800371|FG000|Overall Study|Adverse Event|10|||
129683863|NCT02685735|466800372|FG001|Overall Study|Adverse Event|3|||
129683864|NCT02685735|466800371|FG000|Overall Study|Preop testing found to be incomplete|2|||
129683865|NCT02685735|466800372|FG001|Overall Study|Preop testing found to be incomplete|2|||
129683866|NCT02685735|466800371|FG000|Overall Study|Withdrawal by Subject|1|||
129683867|NCT02685735|466800372|FG001|Overall Study|Withdrawal by Subject|2|||
129683868|NCT02685735|466800371|FG000|Overall Study|Death|1|||
129683869|NCT02685735|466800372|FG001|Overall Study|Death|0|||
129683870|NCT00927472|466800382|FG000|Overall Study|Withdrawal by Subject|10|||
129683871|NCT00927472|466800383|FG001|Overall Study|Withdrawal by Subject|11|||
129683872|NCT00927472|466800382|FG000|Overall Study|Lost to Follow-up|1|||
129683873|NCT00927472|466800383|FG001|Overall Study|Lost to Follow-up|6|||
129683874|NCT00927472|466800382|FG000|Overall Study|Protocol Violation|0|||
129683875|NCT00927472|466800383|FG001|Overall Study|Protocol Violation|1|||
129683876|NCT00927472|466800382|FG000|Overall Study|Post treatment Assessment out of window|0|||
129683877|NCT00927472|466800383|FG001|Overall Study|Post treatment Assessment out of window|4|||
129683878|NCT05436613|466800391|FG000|Overall Study|Lost to Follow-up|9|||
129683879|NCT05436613|466800391|FG000|Overall Study|Withdrawal by Subject|3|||
129683880|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
129683881|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
129683882|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
129683883|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
129683884|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
129683885|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
129683886|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
129772259|NCT00068692|467134078|FG004|Step 1: Registration|Protocol Violation|0|||
129772260|NCT00068692|467134079|FG005|Step 1: Registration|Protocol Violation|0|||
129772261|NCT00068692|467134080|FG006|Step 1: Registration|Protocol Violation|0|||
129772262|NCT00068692|467134081|FG007|Step 1: Registration|Protocol Violation|0|||
129772263|NCT00068692|467134074|FG000|Step 1: Registration|Not eligible|6|||
129772264|NCT00068692|467134075|FG001|Step 1: Registration|Not eligible|0|||
129772265|NCT00068692|467134076|FG002|Step 1: Registration|Not eligible|0|||
129772266|NCT00068692|467134077|FG003|Step 1: Registration|Not eligible|0|||
129772267|NCT00068692|467134078|FG004|Step 1: Registration|Not eligible|0|||
129772268|NCT00068692|467134079|FG005|Step 1: Registration|Not eligible|0|||
129772269|NCT00068692|467134080|FG006|Step 1: Registration|Not eligible|0|||
129772270|NCT00068692|467134081|FG007|Step 1: Registration|Not eligible|0|||
129772271|NCT00068692|467134074|FG000|Step 1: Registration|Other|2|||
129772272|NCT00068692|467134075|FG001|Step 1: Registration|Other|0|||
129772273|NCT00068692|467134076|FG002|Step 1: Registration|Other|0|||
129772274|NCT00068692|467134077|FG003|Step 1: Registration|Other|0|||
129772275|NCT00068692|467134078|FG004|Step 1: Registration|Other|0|||
129772276|NCT00068692|467134079|FG005|Step 1: Registration|Other|0|||
129772277|NCT00068692|467134080|FG006|Step 1: Registration|Other|0|||
129772278|NCT00068692|467134081|FG007|Step 1: Registration|Other|0|||
129772279|NCT00068692|467134074|FG000|Step 1: Registration|Not start protocol therapy|3|||
129772280|NCT00068692|467134075|FG001|Step 1: Registration|Not start protocol therapy|0|||
129772281|NCT00068692|467134076|FG002|Step 1: Registration|Not start protocol therapy|0|||
129772282|NCT00068692|467134077|FG003|Step 1: Registration|Not start protocol therapy|0|||
129772283|NCT00068692|467134078|FG004|Step 1: Registration|Not start protocol therapy|0|||
129772284|NCT00068692|467134079|FG005|Step 1: Registration|Not start protocol therapy|0|||
129772285|NCT00068692|467134080|FG006|Step 1: Registration|Not start protocol therapy|0|||
129772286|NCT00068692|467134081|FG007|Step 1: Registration|Not start protocol therapy|0|||
129772287|NCT00068692|467134074|FG000|Step 1: Registration|Registered but not randomized|0|||
129772288|NCT00068692|467134075|FG001|Step 1: Registration|Registered but not randomized|1|||
129772289|NCT00068692|467134076|FG002|Step 1: Registration|Registered but not randomized|0|||
129772290|NCT00068692|467134077|FG003|Step 1: Registration|Registered but not randomized|0|||
129772291|NCT00068692|467134078|FG004|Step 1: Registration|Registered but not randomized|0|||
129772292|NCT00068692|467134079|FG005|Step 1: Registration|Registered but not randomized|0|||
129772293|NCT00068692|467134080|FG006|Step 1: Registration|Registered but not randomized|0|||
129772294|NCT00068692|467134081|FG007|Step 1: Registration|Registered but not randomized|0|||
129772295|NCT00068692|467134074|FG000|Step 2: Randomization|Disesae progression/replase|0|||
129772296|NCT00068692|467134075|FG001|Step 2: Randomization|Disesae progression/replase|0|||
129772297|NCT00068692|467134076|FG002|Step 2: Randomization|Disesae progression/replase|1|||
129772298|NCT00068692|467134077|FG003|Step 2: Randomization|Disesae progression/replase|1|||
129772299|NCT00068692|467134078|FG004|Step 2: Randomization|Disesae progression/replase|0|||
129772300|NCT00068692|467134079|FG005|Step 2: Randomization|Disesae progression/replase|0|||
129772301|NCT00068692|467134080|FG006|Step 2: Randomization|Disesae progression/replase|0|||
129772302|NCT00068692|467134081|FG007|Step 2: Randomization|Disesae progression/replase|0|||
129772303|NCT00068692|467134074|FG000|Step 2: Randomization|Adverse Event|0|||
129772304|NCT00068692|467134075|FG001|Step 2: Randomization|Adverse Event|0|||
129772305|NCT00068692|467134076|FG002|Step 2: Randomization|Adverse Event|4|||
129772306|NCT00068692|467134077|FG003|Step 2: Randomization|Adverse Event|2|||
129772307|NCT00068692|467134078|FG004|Step 2: Randomization|Adverse Event|2|||
129772308|NCT00068692|467134079|FG005|Step 2: Randomization|Adverse Event|3|||
129772309|NCT00068692|467134080|FG006|Step 2: Randomization|Adverse Event|4|||
129772310|NCT00068692|467134081|FG007|Step 2: Randomization|Adverse Event|4|||
129772311|NCT00068692|467134074|FG000|Step 2: Randomization|Death|0|||
129772312|NCT00068692|467134075|FG001|Step 2: Randomization|Death|0|||
129772313|NCT00068692|467134076|FG002|Step 2: Randomization|Death|0|||
129772314|NCT00068692|467134077|FG003|Step 2: Randomization|Death|0|||
129772315|NCT00068692|467134078|FG004|Step 2: Randomization|Death|1|||
129772316|NCT00068692|467134079|FG005|Step 2: Randomization|Death|0|||
129772317|NCT00068692|467134080|FG006|Step 2: Randomization|Death|0|||
129772318|NCT00068692|467134081|FG007|Step 2: Randomization|Death|1|||
129772319|NCT00068692|467134074|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
129772320|NCT00068692|467134075|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
129772321|NCT00068692|467134076|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
129772322|NCT00068692|467134077|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
129772323|NCT00068692|467134078|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
129772324|NCT00068692|467134079|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
129772325|NCT00068692|467134080|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
129772326|NCT00068692|467134081|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
129772327|NCT00068692|467134074|FG000|Step 2: Randomization|alternative therapy|0|||
129772328|NCT00068692|467134075|FG001|Step 2: Randomization|alternative therapy|0|||
129772329|NCT00068692|467134076|FG002|Step 2: Randomization|alternative therapy|0|||
129772330|NCT00068692|467134077|FG003|Step 2: Randomization|alternative therapy|1|||
129683887|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
129683888|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
129683889|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
129683890|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
129683891|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
129683892|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
129683893|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
129683894|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
129683895|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
129683896|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
129683897|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
129683898|NCT01069939|466800396|FG000|Randomised and Included in the Analyses|Removal|1|||
129683899|NCT01069939|466800397|FG001|Randomised and Included in the Analyses|Removal|0|||
129683900|NCT00191100|466800404|FG000|Overall Study|Adverse Event|18|||
129683901|NCT00191100|466800405|FG001|Overall Study|Adverse Event|1|||
129683902|NCT00191100|466800404|FG000|Overall Study|Lost to Follow-up|2|||
129683903|NCT00191100|466800405|FG001|Overall Study|Lost to Follow-up|0|||
129683904|NCT00191100|466800404|FG000|Overall Study|Patient Moved|0|||
129683905|NCT00191100|466800405|FG001|Overall Study|Patient Moved|1|||
129683906|NCT00191100|466800404|FG000|Overall Study|Withdrawal by Subject|9|||
129683907|NCT00191100|466800405|FG001|Overall Study|Withdrawal by Subject|3|||
129683908|NCT00191100|466800404|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
129683909|NCT00191100|466800405|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
129683910|NCT00191100|466800404|FG000|Overall Study|Clinical Relapse|2|||
129683911|NCT00191100|466800405|FG001|Overall Study|Clinical Relapse|1|||
129683912|NCT00191100|466800404|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
129683913|NCT00191100|466800405|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
129683914|NCT00191100|466800404|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
129683915|NCT00191100|466800405|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
129683916|NCT00191100|466800404|FG000|Overall Study|Physician Decision|3|||
129683917|NCT00191100|466800405|FG001|Overall Study|Physician Decision|1|||
129683918|NCT00191100|466800404|FG000|Overall Study|Death from Study Drug Toxicity|2|||
129683919|NCT00191100|466800405|FG001|Overall Study|Death from Study Drug Toxicity|0|||
129683920|NCT00191100|466800404|FG000|Overall Study|Protocol Violation|1|||
129683921|NCT00191100|466800405|FG001|Overall Study|Protocol Violation|1|||
129683922|NCT00191100|466800404|FG000|Overall Study|Death from Other Cause|1|||
129683923|NCT00191100|466800405|FG001|Overall Study|Death from Other Cause|0|||
129683924|NCT00191100|466800404|FG000|Overall Study|Reason Not Specified|0|||
129683925|NCT00191100|466800405|FG001|Overall Study|Reason Not Specified|1|||
129683926|NCT01525589|466800409|FG000|Overall Study|Non-treatment-related AE|1|||
129683927|NCT01525589|466800410|FG001|Overall Study|Non-treatment-related AE|0|||
129683928|NCT01525589|466800411|FG002|Overall Study|Non-treatment-related AE|0|||
129683929|NCT01525589|466800409|FG000|Overall Study|Progressive disease|48|||
129683930|NCT01525589|466800410|FG001|Overall Study|Progressive disease|15|||
129683931|NCT01525589|466800411|FG002|Overall Study|Progressive disease|29|||
129683932|NCT01525589|466800409|FG000|Overall Study|Never treated|2|||
129683933|NCT01525589|466800410|FG001|Overall Study|Never treated|0|||
129683934|NCT01525589|466800411|FG002|Overall Study|Never treated|0|||
129683935|NCT01525589|466800409|FG000|Overall Study|Physician Decision|4|||
129683936|NCT01525589|466800410|FG001|Overall Study|Physician Decision|2|||
129683937|NCT01525589|466800411|FG002|Overall Study|Physician Decision|2|||
129683938|NCT01525589|466800409|FG000|Overall Study|Death|0|||
129683939|NCT01525589|466800410|FG001|Overall Study|Death|0|||
129683940|NCT01525589|466800411|FG002|Overall Study|Death|2|||
129683941|NCT01525589|466800409|FG000|Overall Study|Treatment-related AE|1|||
129683942|NCT01525589|466800410|FG001|Overall Study|Treatment-related AE|1|||
129683943|NCT01525589|466800411|FG002|Overall Study|Treatment-related AE|2|||
129683944|NCT01525589|466800409|FG000|Overall Study|Other reasons|0|||
129683945|NCT01525589|466800410|FG001|Overall Study|Other reasons|1|||
129683946|NCT01525589|466800411|FG002|Overall Study|Other reasons|0|||
129683947|NCT01525589|466800409|FG000|Overall Study|Withdrawal by Subject|0|||
129683948|NCT01525589|466800410|FG001|Overall Study|Withdrawal by Subject|1|||
129683949|NCT01525589|466800411|FG002|Overall Study|Withdrawal by Subject|0|||
129683950|NCT02101853|466800412|FG000|Block 1 Induction|Adverse Event|11|||
129683951|NCT02101853|466800413|FG001|Block 1 Induction|Adverse Event|0|||
129683952|NCT02101853|466800414|FG002|Block 1 Induction|Adverse Event|0|||
129683953|NCT02101853|466800415|FG003|Block 1 Induction|Adverse Event|0|||
129683954|NCT02101853|466800416|FG004|Block 1 Induction|Adverse Event|0|||
129683955|NCT02101853|466800417|FG005|Block 1 Induction|Adverse Event|0|||
129683956|NCT02101853|466800412|FG000|Block 1 Induction|Death|20|||
129683957|NCT02101853|466800413|FG001|Block 1 Induction|Death|0|||
129683958|NCT02101853|466800414|FG002|Block 1 Induction|Death|0|||
129683959|NCT02101853|466800415|FG003|Block 1 Induction|Death|0|||
129683960|NCT02101853|466800416|FG004|Block 1 Induction|Death|0|||
129683961|NCT02101853|466800417|FG005|Block 1 Induction|Death|0|||
129772331|NCT00068692|467134078|FG004|Step 2: Randomization|alternative therapy|1|||
129772332|NCT00068692|467134079|FG005|Step 2: Randomization|alternative therapy|0|||
129772333|NCT00068692|467134080|FG006|Step 2: Randomization|alternative therapy|0|||
129772334|NCT00068692|467134081|FG007|Step 2: Randomization|alternative therapy|0|||
129772335|NCT00068692|467134074|FG000|Step 2: Randomization|Physician Decision|0|||
129772336|NCT00068692|467134075|FG001|Step 2: Randomization|Physician Decision|0|||
129772337|NCT00068692|467134076|FG002|Step 2: Randomization|Physician Decision|0|||
129772338|NCT00068692|467134077|FG003|Step 2: Randomization|Physician Decision|1|||
129772339|NCT00068692|467134078|FG004|Step 2: Randomization|Physician Decision|1|||
129772340|NCT00068692|467134079|FG005|Step 2: Randomization|Physician Decision|0|||
129772341|NCT00068692|467134080|FG006|Step 2: Randomization|Physician Decision|0|||
129772342|NCT00068692|467134081|FG007|Step 2: Randomization|Physician Decision|0|||
129772343|NCT00068692|467134074|FG000|Step 2: Randomization|Other|0|||
129772344|NCT00068692|467134075|FG001|Step 2: Randomization|Other|0|||
129772345|NCT00068692|467134076|FG002|Step 2: Randomization|Other|0|||
129772346|NCT00068692|467134077|FG003|Step 2: Randomization|Other|1|||
129772347|NCT00068692|467134078|FG004|Step 2: Randomization|Other|0|||
129772348|NCT00068692|467134079|FG005|Step 2: Randomization|Other|1|||
129772349|NCT00068692|467134080|FG006|Step 2: Randomization|Other|0|||
129772350|NCT00068692|467134081|FG007|Step 2: Randomization|Other|0|||
129772351|NCT00068692|467134074|FG000|Step 2: Randomization|never start protocol therapy|0|||
129772352|NCT00068692|467134075|FG001|Step 2: Randomization|never start protocol therapy|0|||
129772353|NCT00068692|467134076|FG002|Step 2: Randomization|never start protocol therapy|1|||
129772354|NCT00068692|467134077|FG003|Step 2: Randomization|never start protocol therapy|0|||
129772355|NCT00068692|467134078|FG004|Step 2: Randomization|never start protocol therapy|1|||
129772356|NCT00068692|467134079|FG005|Step 2: Randomization|never start protocol therapy|0|||
129772357|NCT00068692|467134080|FG006|Step 2: Randomization|never start protocol therapy|0|||
129772358|NCT00068692|467134081|FG007|Step 2: Randomization|never start protocol therapy|0|||
129772359|NCT00248040|467134086|FG000|Overall Study|transplantectomy|2|||
129772360|NCT00248040|467134087|FG001|Overall Study|transplantectomy|1|||
129772361|NCT00248040|467134088|FG002|Overall Study|transplantectomy|3|||
129772362|NCT00248040|467134086|FG000|Overall Study|transplant cancelled post treat start|1|||
129772363|NCT00248040|467134087|FG001|Overall Study|transplant cancelled post treat start|0|||
129772364|NCT00248040|467134088|FG002|Overall Study|transplant cancelled post treat start|0|||
129772365|NCT00248040|467134086|FG000|Overall Study|Death|0|||
129772366|NCT00248040|467134087|FG001|Overall Study|Death|0|||
129772367|NCT00248040|467134088|FG002|Overall Study|Death|1|||
129772368|NCT00711191|467134094|FG000|Overall Study|Adverse Event|1|||
129772369|NCT00711191|467134095|FG001|Overall Study|Adverse Event|1|||
129772370|NCT00711191|467134096|FG002|Overall Study|Adverse Event|2|||
129772371|NCT00711191|467134094|FG000|Overall Study|Objective progression or relapse|2|||
129772372|NCT00711191|467134095|FG001|Overall Study|Objective progression or relapse|3|||
129772373|NCT00711191|467134096|FG002|Overall Study|Objective progression or relapse|7|||
129772374|NCT00711191|467134094|FG000|Overall Study|Withdrawal by Subject|0|||
129772375|NCT00711191|467134095|FG001|Overall Study|Withdrawal by Subject|1|||
129772376|NCT00711191|467134096|FG002|Overall Study|Withdrawal by Subject|3|||
129772377|NCT01002339|467134097|FG000|Overall Study|Withdrawal by Subject|0|||
129772378|NCT01002339|467134098|FG001|Overall Study|Withdrawal by Subject|1|||
129772379|NCT01002339|467134099|FG002|Overall Study|Withdrawal by Subject|0|||
129772380|NCT01002339|467134097|FG000|Overall Study|Incorrect treatment assignment|0|||
129772381|NCT01002339|467134098|FG001|Overall Study|Incorrect treatment assignment|0|||
129772382|NCT01002339|467134099|FG002|Overall Study|Incorrect treatment assignment|1|||
129772383|NCT01002339|467134097|FG000|Overall Study|Protocol Violation|0|||
129772384|NCT01002339|467134098|FG001|Overall Study|Protocol Violation|0|||
129772385|NCT01002339|467134099|FG002|Overall Study|Protocol Violation|2|||
129772386|NCT01002339|467134097|FG000|Overall Study|Lung cancer detected before transplant|0|||
129772387|NCT01002339|467134098|FG001|Overall Study|Lung cancer detected before transplant|0|||
129772388|NCT01002339|467134099|FG002|Overall Study|Lung cancer detected before transplant|1|||
129772389|NCT01002339|467134097|FG000|Overall Study|Randomized. Not transplanted|0|||
129772390|NCT01002339|467134098|FG001|Overall Study|Randomized. Not transplanted|0|||
129772391|NCT01002339|467134099|FG002|Overall Study|Randomized. Not transplanted|1|||
129772392|NCT02118961|467134100|FG000|Overall Study|Withdrawal by Subject|1|||
129772393|NCT02118961|467134101|FG001|Overall Study|Withdrawal by Subject|0|||
129772394|NCT00790842|467134102|FG000|Dose Level 1|Adverse Event|1|||
129772395|NCT00790842|467134103|FG001|Dose Level 1|Adverse Event|0|||
129772396|NCT00790842|467134104|FG002|Dose Level 1|Adverse Event|0|||
129772397|NCT00790842|467134105|FG003|Dose Level 1|Adverse Event|2|||
129772398|NCT00790842|467134106|FG004|Dose Level 1|Adverse Event|0|||
129772399|NCT00790842|467134107|FG005|Dose Level 1|Adverse Event|0|||
129772400|NCT00790842|467134108|FG006|Dose Level 1|Adverse Event|0|||
129772401|NCT00790842|467134109|FG007|Dose Level 1|Adverse Event|1|||
129772402|NCT00790842|467134110|FG008|Dose Level 1|Adverse Event|0|||
129772403|NCT00790842|467134111|FG009|Dose Level 1|Adverse Event|0|||
129772404|NCT00790842|467134112|FG010|Dose Level 1|Adverse Event|0|||
129772405|NCT00790842|467134102|FG000|Dose Level 1|Physician Decision|1|||
129772406|NCT00790842|467134103|FG001|Dose Level 1|Physician Decision|0|||
129772407|NCT00790842|467134104|FG002|Dose Level 1|Physician Decision|0|||
129772408|NCT00790842|467134105|FG003|Dose Level 1|Physician Decision|0|||
129772409|NCT00790842|467134106|FG004|Dose Level 1|Physician Decision|0|||
129772410|NCT00790842|467134107|FG005|Dose Level 1|Physician Decision|0|||
129772411|NCT00790842|467134108|FG006|Dose Level 1|Physician Decision|0|||
129772412|NCT00790842|467134109|FG007|Dose Level 1|Physician Decision|1|||
129772413|NCT00790842|467134110|FG008|Dose Level 1|Physician Decision|0|||
129772414|NCT00790842|467134111|FG009|Dose Level 1|Physician Decision|0|||
129772415|NCT00790842|467134112|FG010|Dose Level 1|Physician Decision|0|||
129683962|NCT02101853|466800412|FG000|Block 1 Induction|Lack of Efficacy|6|||
129683963|NCT02101853|466800413|FG001|Block 1 Induction|Lack of Efficacy|0|||
129683964|NCT02101853|466800414|FG002|Block 1 Induction|Lack of Efficacy|0|||
129683965|NCT02101853|466800415|FG003|Block 1 Induction|Lack of Efficacy|0|||
129683966|NCT02101853|466800416|FG004|Block 1 Induction|Lack of Efficacy|0|||
129683967|NCT02101853|466800417|FG005|Block 1 Induction|Lack of Efficacy|0|||
129683968|NCT02101853|466800412|FG000|Block 1 Induction|Physician Decision|61|||
129683969|NCT02101853|466800413|FG001|Block 1 Induction|Physician Decision|0|||
129683970|NCT02101853|466800414|FG002|Block 1 Induction|Physician Decision|0|||
129683971|NCT02101853|466800415|FG003|Block 1 Induction|Physician Decision|0|||
129683972|NCT02101853|466800416|FG004|Block 1 Induction|Physician Decision|0|||
129683973|NCT02101853|466800417|FG005|Block 1 Induction|Physician Decision|0|||
129683974|NCT02101853|466800412|FG000|Block 1 Induction|Protocol Violation|2|||
129683975|NCT02101853|466800413|FG001|Block 1 Induction|Protocol Violation|0|||
129683976|NCT02101853|466800414|FG002|Block 1 Induction|Protocol Violation|0|||
129683977|NCT02101853|466800415|FG003|Block 1 Induction|Protocol Violation|0|||
129683978|NCT02101853|466800416|FG004|Block 1 Induction|Protocol Violation|0|||
129683979|NCT02101853|466800417|FG005|Block 1 Induction|Protocol Violation|0|||
129683980|NCT02101853|466800412|FG000|Block 1 Induction|Withdrawal by Subject|65|||
129683981|NCT02101853|466800413|FG001|Block 1 Induction|Withdrawal by Subject|0|||
129683982|NCT02101853|466800414|FG002|Block 1 Induction|Withdrawal by Subject|0|||
129683983|NCT02101853|466800415|FG003|Block 1 Induction|Withdrawal by Subject|0|||
129683984|NCT02101853|466800416|FG004|Block 1 Induction|Withdrawal by Subject|0|||
129683985|NCT02101853|466800417|FG005|Block 1 Induction|Withdrawal by Subject|0|||
129683986|NCT02101853|466800412|FG000|Block 1 Induction|Ineligible|8|||
129683987|NCT02101853|466800413|FG001|Block 1 Induction|Ineligible|0|||
129683988|NCT02101853|466800414|FG002|Block 1 Induction|Ineligible|0|||
129683989|NCT02101853|466800415|FG003|Block 1 Induction|Ineligible|0|||
129683990|NCT02101853|466800416|FG004|Block 1 Induction|Ineligible|0|||
129683991|NCT02101853|466800417|FG005|Block 1 Induction|Ineligible|0|||
129683992|NCT02101853|466800412|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
129683993|NCT02101853|466800413|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129683994|NCT02101853|466800414|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129683995|NCT02101853|466800415|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129683996|NCT02101853|466800416|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129683997|NCT02101853|466800417|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
129683998|NCT02101853|466800412|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
129683999|NCT02101853|466800413|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684000|NCT02101853|466800414|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684001|NCT02101853|466800415|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684002|NCT02101853|466800416|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684003|NCT02101853|466800417|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684004|NCT02101853|466800412|FG000|Post Induction Randomization|Adverse Event|0|||
129684005|NCT02101853|466800413|FG001|Post Induction Randomization|Adverse Event|3|||
129684006|NCT02101853|466800414|FG002|Post Induction Randomization|Adverse Event|8|||
129684007|NCT02101853|466800415|FG003|Post Induction Randomization|Adverse Event|4|||
129684008|NCT02101853|466800416|FG004|Post Induction Randomization|Adverse Event|4|||
129684009|NCT02101853|466800417|FG005|Post Induction Randomization|Adverse Event|0|||
129684010|NCT02101853|466800412|FG000|Post Induction Randomization|Death|0|||
129684011|NCT02101853|466800413|FG001|Post Induction Randomization|Death|9|||
129684012|NCT02101853|466800414|FG002|Post Induction Randomization|Death|2|||
129684013|NCT02101853|466800415|FG003|Post Induction Randomization|Death|2|||
129772416|NCT00790842|467134102|FG000|Dose Level 1|Withdrawal by Subject|1|||
129772417|NCT00790842|467134103|FG001|Dose Level 1|Withdrawal by Subject|0|||
129772418|NCT00790842|467134104|FG002|Dose Level 1|Withdrawal by Subject|0|||
129772419|NCT00790842|467134105|FG003|Dose Level 1|Withdrawal by Subject|0|||
129772420|NCT00790842|467134106|FG004|Dose Level 1|Withdrawal by Subject|0|||
129772421|NCT00790842|467134107|FG005|Dose Level 1|Withdrawal by Subject|0|||
129772422|NCT00790842|467134108|FG006|Dose Level 1|Withdrawal by Subject|0|||
129772423|NCT00790842|467134109|FG007|Dose Level 1|Withdrawal by Subject|0|||
129550726|NCT02454972|466312864|FG001|Overall Study|Progressive disease|16|||
129684014|NCT02101853|466800416|FG004|Post Induction Randomization|Death|0|||
129684015|NCT02101853|466800417|FG005|Post Induction Randomization|Death|0|||
129684016|NCT02101853|466800412|FG000|Post Induction Randomization|Lack of Efficacy|0|||
129684017|NCT02101853|466800413|FG001|Post Induction Randomization|Lack of Efficacy|14|||
129684018|NCT02101853|466800414|FG002|Post Induction Randomization|Lack of Efficacy|23|||
129684019|NCT02101853|466800415|FG003|Post Induction Randomization|Lack of Efficacy|18|||
129684020|NCT02101853|466800416|FG004|Post Induction Randomization|Lack of Efficacy|21|||
129684021|NCT02101853|466800417|FG005|Post Induction Randomization|Lack of Efficacy|0|||
129684022|NCT02101853|466800412|FG000|Post Induction Randomization|Physician Decision|0|||
129684023|NCT02101853|466800413|FG001|Post Induction Randomization|Physician Decision|43|||
129684024|NCT02101853|466800414|FG002|Post Induction Randomization|Physician Decision|23|||
129684025|NCT02101853|466800415|FG003|Post Induction Randomization|Physician Decision|14|||
129684026|NCT02101853|466800416|FG004|Post Induction Randomization|Physician Decision|14|||
129684027|NCT02101853|466800417|FG005|Post Induction Randomization|Physician Decision|0|||
129684028|NCT02101853|466800412|FG000|Post Induction Randomization|Protocol Violation|0|||
129684029|NCT02101853|466800413|FG001|Post Induction Randomization|Protocol Violation|3|||
129684030|NCT02101853|466800414|FG002|Post Induction Randomization|Protocol Violation|0|||
129684031|NCT02101853|466800415|FG003|Post Induction Randomization|Protocol Violation|0|||
129684032|NCT02101853|466800416|FG004|Post Induction Randomization|Protocol Violation|0|||
129684033|NCT02101853|466800417|FG005|Post Induction Randomization|Protocol Violation|0|||
129684034|NCT02101853|466800412|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
129684035|NCT02101853|466800413|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
129684036|NCT02101853|466800414|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
129684037|NCT02101853|466800415|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
129684038|NCT02101853|466800416|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
129684039|NCT02101853|466800417|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
129684040|NCT02101853|466800412|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684041|NCT02101853|466800413|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684042|NCT02101853|466800414|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684043|NCT02101853|466800415|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
129684044|NCT02101853|466800416|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684045|NCT02101853|466800417|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
129684046|NCT02101853|466800412|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129684047|NCT02101853|466800413|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
129684048|NCT02101853|466800414|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
129684049|NCT02101853|466800415|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129684050|NCT02101853|466800416|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129684051|NCT02101853|466800417|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
129684052|NCT02101853|466800412|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129684053|NCT02101853|466800413|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
129684054|NCT02101853|466800414|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129684055|NCT02101853|466800415|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129684056|NCT02101853|466800416|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129684057|NCT02101853|466800417|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
129684058|NCT02101853|466800412|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129684059|NCT02101853|466800413|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129684060|NCT02101853|466800414|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129684061|NCT02101853|466800415|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
129684062|NCT02101853|466800416|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
129684063|NCT02101853|466800417|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
129684064|NCT02101853|466800412|FG000|Blinatumomab Salvage Therapy|Death|0|||
129684065|NCT02101853|466800413|FG001|Blinatumomab Salvage Therapy|Death|0|||
129684066|NCT02101853|466800414|FG002|Blinatumomab Salvage Therapy|Death|0|||
129684067|NCT02101853|466800415|FG003|Blinatumomab Salvage Therapy|Death|0|||
129684068|NCT02101853|466800416|FG004|Blinatumomab Salvage Therapy|Death|0|||
129684069|NCT02101853|466800417|FG005|Blinatumomab Salvage Therapy|Death|2|||
129684070|NCT02101853|466800412|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129684071|NCT02101853|466800413|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129684072|NCT02101853|466800414|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129684073|NCT02101853|466800415|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129684074|NCT02101853|466800416|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
129684075|NCT02101853|466800417|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
129684076|NCT02101853|466800412|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
129684077|NCT02101853|466800413|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
129684078|NCT02101853|466800414|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
129684079|NCT02101853|466800415|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
129684080|NCT02101853|466800416|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
129684081|NCT02101853|466800417|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
129684082|NCT02101853|466800412|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129684083|NCT02101853|466800413|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129684084|NCT02101853|466800414|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129684085|NCT02101853|466800415|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129684086|NCT02101853|466800416|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
129684087|NCT02101853|466800417|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
129684088|NCT04409002|466800418|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
129684089|NCT06481579|466800419|FG000|Overall Study|Death|1|||
129684090|NCT06481579|466800420|FG001|Overall Study|Death|0|||
129684091|NCT06481579|466800419|FG000|Overall Study|Withdrawal by Subject|3|||
129684092|NCT06481579|466800420|FG001|Overall Study|Withdrawal by Subject|0|||
129684093|NCT06481579|466800419|FG000|Overall Study|Other|1|||
129684094|NCT06481579|466800420|FG001|Overall Study|Other|1|||
129684095|NCT05032196|466800421|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129684096|NCT05032196|466800422|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
129684097|NCT05032196|466800423|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129684098|NCT05032196|466800424|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129684099|NCT05032196|466800425|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129684100|NCT05032196|466800426|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
129684101|NCT05032196|466800421|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129684102|NCT05032196|466800422|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129684103|NCT05032196|466800423|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129684104|NCT05032196|466800424|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
129684105|NCT05032196|466800425|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129684106|NCT05032196|466800426|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
129684107|NCT05032196|466800421|FG000|Period 2 (Multidose)|Physician Decision|0|||
129684108|NCT05032196|466800422|FG001|Period 2 (Multidose)|Physician Decision|0|||
129684109|NCT05032196|466800423|FG002|Period 2 (Multidose)|Physician Decision|0|||
129684110|NCT05032196|466800424|FG003|Period 2 (Multidose)|Physician Decision|0|||
129684111|NCT05032196|466800425|FG004|Period 2 (Multidose)|Physician Decision|1|||
129684112|NCT05032196|466800426|FG005|Period 2 (Multidose)|Physician Decision|0|||
129684113|NCT05260008|466800427|FG000|Overall Study|Physician Decision|0|||
129684114|NCT05260008|466800428|FG001|Overall Study|Physician Decision|1|||
129684115|NCT05260008|466800429|FG002|Overall Study|Physician Decision|0|||
129684116|NCT05260008|466800430|FG003|Overall Study|Physician Decision|0|||
129684117|NCT05977868|466801500|FG000|Overall Study|Withdrawal by Subject|1|||
129684118|NCT05977868|466801501|FG001|Overall Study|Withdrawal by Subject|2|||
129684119|NCT05977868|466801500|FG000|Overall Study|Transitioned to comfort care|1|||
129684120|NCT05977868|466801501|FG001|Overall Study|Transitioned to comfort care|0|||
129684121|NCT05696847|466801510|FG000|Overall Study|Withdrawal by Subject|1|||
129684122|NCT05696847|466801511|FG001|Overall Study|Withdrawal by Subject|0|||
129684123|NCT05696847|466801512|FG002|Overall Study|Withdrawal by Subject|0|||
129684124|NCT05696847|466801513|FG003|Overall Study|Withdrawal by Subject|0|||
129684125|NCT05696847|466801514|FG004|Overall Study|Withdrawal by Subject|0|||
129684126|NCT05696847|466801515|FG005|Overall Study|Withdrawal by Subject|0|||
129684127|NCT05696847|466801510|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129684128|NCT05696847|466801511|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129684129|NCT05696847|466801512|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129684130|NCT05696847|466801513|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129684131|NCT05696847|466801514|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129684132|NCT05696847|466801515|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129684133|NCT05696847|466801510|FG000|Overall Study|Adverse Event|0|||
129684134|NCT05696847|466801511|FG001|Overall Study|Adverse Event|0|||
129684135|NCT05696847|466801512|FG002|Overall Study|Adverse Event|0|||
129684136|NCT05696847|466801513|FG003|Overall Study|Adverse Event|0|||
129684137|NCT05696847|466801514|FG004|Overall Study|Adverse Event|0|||
129684138|NCT05696847|466801515|FG005|Overall Study|Adverse Event|1|||
129684139|NCT05696847|466801510|FG000|Overall Study|Sponsor Decision|0|||
129684140|NCT05696847|466801511|FG001|Overall Study|Sponsor Decision|0|||
129684141|NCT05696847|466801512|FG002|Overall Study|Sponsor Decision|0|||
129684142|NCT05696847|466801513|FG003|Overall Study|Sponsor Decision|1|||
129684143|NCT05696847|466801514|FG004|Overall Study|Sponsor Decision|0|||
129684144|NCT05696847|466801515|FG005|Overall Study|Sponsor Decision|0|||
129684145|NCT03323502|466801516|FG000|Overall Study|Resident could not be linked to CMS data|594|||
129684146|NCT03323502|466801517|FG001|Overall Study|Resident could not be linked to CMS data|435|||
129684147|NCT03323502|466801516|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
129684148|NCT03323502|466801517|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
129772424|NCT00790842|467134110|FG008|Dose Level 1|Withdrawal by Subject|0|||
129772425|NCT00790842|467134111|FG009|Dose Level 1|Withdrawal by Subject|0|||
129772426|NCT00790842|467134112|FG010|Dose Level 1|Withdrawal by Subject|0|||
129772427|NCT00790842|467134102|FG000|Dose Level 2|Death|0|||
129772428|NCT00790842|467134103|FG001|Dose Level 2|Death|1|||
129772429|NCT00790842|467134104|FG002|Dose Level 2|Death|0|||
129772430|NCT00790842|467134105|FG003|Dose Level 2|Death|0|||
129772431|NCT00790842|467134106|FG004|Dose Level 2|Death|1|||
129772432|NCT00790842|467134107|FG005|Dose Level 2|Death|0|||
129772433|NCT00790842|467134108|FG006|Dose Level 2|Death|0|||
129772434|NCT00790842|467134109|FG007|Dose Level 2|Death|0|||
129772435|NCT00790842|467134110|FG008|Dose Level 2|Death|0|||
129772436|NCT00790842|467134111|FG009|Dose Level 2|Death|0|||
129772437|NCT00790842|467134112|FG010|Dose Level 2|Death|0|||
129772438|NCT00790842|467134102|FG000|Dose Level 2|Physician Decision|0|||
129772439|NCT00790842|467134103|FG001|Dose Level 2|Physician Decision|1|||
129772440|NCT00790842|467134104|FG002|Dose Level 2|Physician Decision|0|||
129772441|NCT00790842|467134105|FG003|Dose Level 2|Physician Decision|0|||
129772442|NCT00790842|467134106|FG004|Dose Level 2|Physician Decision|0|||
129772443|NCT00790842|467134107|FG005|Dose Level 2|Physician Decision|0|||
129772444|NCT00790842|467134108|FG006|Dose Level 2|Physician Decision|0|||
129772445|NCT00790842|467134109|FG007|Dose Level 2|Physician Decision|0|||
129772446|NCT00790842|467134110|FG008|Dose Level 2|Physician Decision|0|||
129772447|NCT00790842|467134111|FG009|Dose Level 2|Physician Decision|0|||
129772448|NCT00790842|467134112|FG010|Dose Level 2|Physician Decision|0|||
129772449|NCT00790842|467134102|FG000|Dose Level 2|Withdrawal by Subject|0|||
129772450|NCT00790842|467134103|FG001|Dose Level 2|Withdrawal by Subject|1|||
129772451|NCT00790842|467134104|FG002|Dose Level 2|Withdrawal by Subject|0|||
129772452|NCT00790842|467134105|FG003|Dose Level 2|Withdrawal by Subject|0|||
129772453|NCT00790842|467134106|FG004|Dose Level 2|Withdrawal by Subject|0|||
129772454|NCT00790842|467134107|FG005|Dose Level 2|Withdrawal by Subject|0|||
129772455|NCT00790842|467134108|FG006|Dose Level 2|Withdrawal by Subject|0|||
129772456|NCT00790842|467134109|FG007|Dose Level 2|Withdrawal by Subject|0|||
129772457|NCT00790842|467134110|FG008|Dose Level 2|Withdrawal by Subject|0|||
129772458|NCT00790842|467134111|FG009|Dose Level 2|Withdrawal by Subject|0|||
129772459|NCT00790842|467134112|FG010|Dose Level 2|Withdrawal by Subject|0|||
129772460|NCT00790842|467134102|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772461|NCT00790842|467134103|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772462|NCT00790842|467134104|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772463|NCT00790842|467134105|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772464|NCT00790842|467134106|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772465|NCT00790842|467134107|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772466|NCT00790842|467134108|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772467|NCT00790842|467134109|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772468|NCT00790842|467134110|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
129772469|NCT00790842|467134111|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772470|NCT00790842|467134112|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
129772471|NCT00790842|467134102|FG000|Dose Level 3|Adverse Event|0|||
129772472|NCT00790842|467134103|FG001|Dose Level 3|Adverse Event|0|||
129772473|NCT00790842|467134104|FG002|Dose Level 3|Adverse Event|1|||
129772474|NCT00790842|467134105|FG003|Dose Level 3|Adverse Event|0|||
129772475|NCT00790842|467134106|FG004|Dose Level 3|Adverse Event|0|||
129772476|NCT00790842|467134107|FG005|Dose Level 3|Adverse Event|0|||
129772477|NCT00790842|467134108|FG006|Dose Level 3|Adverse Event|0|||
129772478|NCT00790842|467134109|FG007|Dose Level 3|Adverse Event|0|||
129772479|NCT00790842|467134110|FG008|Dose Level 3|Adverse Event|0|||
129772480|NCT00790842|467134111|FG009|Dose Level 3|Adverse Event|0|||
129772481|NCT00790842|467134112|FG010|Dose Level 3|Adverse Event|0|||
129772482|NCT00790842|467134102|FG000|Dose Level 3|Withdrawal by Subject|0|||
129772483|NCT00790842|467134103|FG001|Dose Level 3|Withdrawal by Subject|0|||
129772484|NCT00790842|467134104|FG002|Dose Level 3|Withdrawal by Subject|3|||
129772485|NCT00790842|467134105|FG003|Dose Level 3|Withdrawal by Subject|0|||
129772486|NCT00790842|467134106|FG004|Dose Level 3|Withdrawal by Subject|0|||
129772487|NCT00790842|467134107|FG005|Dose Level 3|Withdrawal by Subject|0|||
129772488|NCT00790842|467134108|FG006|Dose Level 3|Withdrawal by Subject|0|||
129772489|NCT00790842|467134109|FG007|Dose Level 3|Withdrawal by Subject|0|||
129772490|NCT00790842|467134110|FG008|Dose Level 3|Withdrawal by Subject|0|||
129772491|NCT00790842|467134111|FG009|Dose Level 3|Withdrawal by Subject|2|||
129772492|NCT00790842|467134112|FG010|Dose Level 3|Withdrawal by Subject|0|||
129772493|NCT00790842|467134102|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772494|NCT00790842|467134103|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772495|NCT00790842|467134104|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772496|NCT00790842|467134105|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772497|NCT00790842|467134106|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772498|NCT00790842|467134107|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
129772499|NCT00790842|467134108|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772500|NCT00790842|467134109|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772501|NCT00790842|467134110|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772502|NCT00790842|467134111|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772503|NCT00790842|467134112|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
129772504|NCT00790842|467134102|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772505|NCT00790842|467134103|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772506|NCT00790842|467134104|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
129772507|NCT00790842|467134105|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772508|NCT00790842|467134106|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772509|NCT00790842|467134107|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772510|NCT00790842|467134108|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772511|NCT00790842|467134109|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772512|NCT00790842|467134110|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772513|NCT00790842|467134111|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772514|NCT00790842|467134112|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
129772515|NCT00790842|467134102|FG000|Dose Level 4|Adverse Event|0|||
129772516|NCT00790842|467134103|FG001|Dose Level 4|Adverse Event|0|||
129772517|NCT00790842|467134104|FG002|Dose Level 4|Adverse Event|0|||
129772518|NCT00790842|467134105|FG003|Dose Level 4|Adverse Event|0|||
129772519|NCT00790842|467134106|FG004|Dose Level 4|Adverse Event|0|||
129772520|NCT00790842|467134107|FG005|Dose Level 4|Adverse Event|0|||
129772521|NCT00790842|467134108|FG006|Dose Level 4|Adverse Event|1|||
129772522|NCT00790842|467134109|FG007|Dose Level 4|Adverse Event|0|||
129772523|NCT00790842|467134110|FG008|Dose Level 4|Adverse Event|0|||
129772524|NCT00790842|467134111|FG009|Dose Level 4|Adverse Event|0|||
129772525|NCT00790842|467134112|FG010|Dose Level 4|Adverse Event|0|||
129772526|NCT00790842|467134102|FG000|Dose Level 4|Physician Decision|0|||
129772527|NCT00790842|467134103|FG001|Dose Level 4|Physician Decision|0|||
129772528|NCT00790842|467134104|FG002|Dose Level 4|Physician Decision|0|||
129772529|NCT00790842|467134105|FG003|Dose Level 4|Physician Decision|0|||
129772530|NCT00790842|467134106|FG004|Dose Level 4|Physician Decision|0|||
129772531|NCT00790842|467134107|FG005|Dose Level 4|Physician Decision|0|||
129772532|NCT00790842|467134108|FG006|Dose Level 4|Physician Decision|1|||
129772533|NCT00790842|467134109|FG007|Dose Level 4|Physician Decision|0|||
129772534|NCT00790842|467134110|FG008|Dose Level 4|Physician Decision|0|||
129772535|NCT00790842|467134111|FG009|Dose Level 4|Physician Decision|0|||
129772536|NCT00790842|467134112|FG010|Dose Level 4|Physician Decision|1|||
129772537|NCT00790842|467134102|FG000|Dose Level 4|Withdrawal by Subject|0|||
129772538|NCT00790842|467134103|FG001|Dose Level 4|Withdrawal by Subject|0|||
129772539|NCT00790842|467134104|FG002|Dose Level 4|Withdrawal by Subject|0|||
129772540|NCT00790842|467134105|FG003|Dose Level 4|Withdrawal by Subject|0|||
129772541|NCT00790842|467134106|FG004|Dose Level 4|Withdrawal by Subject|0|||
129772542|NCT00790842|467134107|FG005|Dose Level 4|Withdrawal by Subject|0|||
129772543|NCT00790842|467134108|FG006|Dose Level 4|Withdrawal by Subject|0|||
129772544|NCT00790842|467134109|FG007|Dose Level 4|Withdrawal by Subject|0|||
129772545|NCT00790842|467134110|FG008|Dose Level 4|Withdrawal by Subject|0|||
129772546|NCT00790842|467134111|FG009|Dose Level 4|Withdrawal by Subject|0|||
129772547|NCT00790842|467134112|FG010|Dose Level 4|Withdrawal by Subject|1|||
129772548|NCT00790842|467134102|FG000|Expansion Cohort|Adverse Event|0|||
129772549|NCT00790842|467134103|FG001|Expansion Cohort|Adverse Event|0|||
129772550|NCT00790842|467134104|FG002|Expansion Cohort|Adverse Event|0|||
129772551|NCT00790842|467134105|FG003|Expansion Cohort|Adverse Event|0|||
129772552|NCT00790842|467134106|FG004|Expansion Cohort|Adverse Event|0|||
129772553|NCT00790842|467134107|FG005|Expansion Cohort|Adverse Event|0|||
129772554|NCT00790842|467134108|FG006|Expansion Cohort|Adverse Event|1|||
129772555|NCT00790842|467134109|FG007|Expansion Cohort|Adverse Event|0|||
129772556|NCT00790842|467134110|FG008|Expansion Cohort|Adverse Event|0|||
129772557|NCT00790842|467134111|FG009|Expansion Cohort|Adverse Event|0|||
129772558|NCT00790842|467134112|FG010|Expansion Cohort|Adverse Event|0|||
129772559|NCT00790842|467134102|FG000|Expansion Cohort|Death|0|||
129772560|NCT00790842|467134103|FG001|Expansion Cohort|Death|0|||
129772561|NCT00790842|467134104|FG002|Expansion Cohort|Death|2|||
129772562|NCT00790842|467134105|FG003|Expansion Cohort|Death|0|||
129772563|NCT00790842|467134106|FG004|Expansion Cohort|Death|0|||
129772564|NCT00790842|467134107|FG005|Expansion Cohort|Death|0|||
129772565|NCT00790842|467134108|FG006|Expansion Cohort|Death|0|||
129772566|NCT00790842|467134109|FG007|Expansion Cohort|Death|0|||
129772567|NCT00790842|467134110|FG008|Expansion Cohort|Death|0|||
129772568|NCT00790842|467134111|FG009|Expansion Cohort|Death|0|||
129772569|NCT00790842|467134112|FG010|Expansion Cohort|Death|0|||
129772570|NCT00790842|467134102|FG000|Expansion Cohort|Physician Decision|0|||
129772571|NCT00790842|467134103|FG001|Expansion Cohort|Physician Decision|0|||
129772572|NCT00790842|467134104|FG002|Expansion Cohort|Physician Decision|1|||
129772573|NCT00790842|467134105|FG003|Expansion Cohort|Physician Decision|0|||
129772574|NCT00790842|467134106|FG004|Expansion Cohort|Physician Decision|0|||
129772575|NCT00790842|467134107|FG005|Expansion Cohort|Physician Decision|0|||
129772576|NCT00790842|467134108|FG006|Expansion Cohort|Physician Decision|0|||
129550727|NCT02454972|466312865|FG002|Overall Study|Progressive disease|59|||
129550728|NCT02454972|466312866|FG003|Overall Study|Progressive disease|23|||
129550729|NCT02454972|466312867|FG004|Overall Study|Progressive disease|16|||
129684149|NCT03323502|466801516|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
129684150|NCT03323502|466801517|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
129684151|NCT03323502|466801516|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
129684152|NCT03323502|466801517|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
129684153|NCT03323502|466801516|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
129684154|NCT03323502|466801517|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
129684155|NCT04092777|466801518|FG000|Overall Study|Lost to Follow-up|28|||
129684156|NCT04092777|466801519|FG001|Overall Study|Lost to Follow-up|46|||
129684157|NCT04092777|466801518|FG000|Overall Study|Withdrawal by Subject|8|||
129684158|NCT04092777|466801519|FG001|Overall Study|Withdrawal by Subject|5|||
129684159|NCT00975923|466801524|FG000|Overall Study|Withdrawal by Subject|0|||
129684160|NCT00975923|466801525|FG001|Overall Study|Withdrawal by Subject|1|||
129684161|NCT04896385|466801526|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
129684162|NCT04896385|466801527|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
129684163|NCT04896385|466801528|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
129684164|NCT04896385|466801529|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
129684165|NCT04896385|466801526|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
129684166|NCT04896385|466801527|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
129684167|NCT04896385|466801528|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129684168|NCT04896385|466801529|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129684169|NCT04896385|466801526|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129684170|NCT04896385|466801527|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129684171|NCT04896385|466801528|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
129684172|NCT04896385|466801529|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
129684173|NCT04896385|466801526|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129684174|NCT04896385|466801527|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129684175|NCT04896385|466801528|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
129684176|NCT04896385|466801529|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
129684177|NCT04896385|466801526|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
129684178|NCT04896385|466801527|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
129684179|NCT04896385|466801528|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
129684180|NCT04896385|466801529|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
129684181|NCT04896385|466801526|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
129684182|NCT04896385|466801527|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
129684183|NCT04896385|466801528|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
129684184|NCT04896385|466801529|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
129684185|NCT05291689|466801532|FG000|Overall Study|Adverse Event|3|||
129684186|NCT05291689|466801532|FG000|Overall Study|Lack of Efficacy|10|||
129684187|NCT05291689|466801532|FG000|Overall Study|Withdrawal by Subject|4|||
129684188|NCT01931098|466801533|FG000|Overall Study|Withdrawal by Subject|0|||
129684189|NCT01931098|466801534|FG001|Overall Study|Withdrawal by Subject|1|||
129684190|NCT01931098|466801533|FG000|Overall Study|Enrolled in different protocol|0|||
129684191|NCT01931098|466801534|FG001|Overall Study|Enrolled in different protocol|1|||
129684192|NCT01931098|466801533|FG000|Overall Study|Unable to begin trmt:active infection|0|||
129684193|NCT01931098|466801534|FG001|Overall Study|Unable to begin trmt:active infection|1|||
129684194|NCT01931098|466801533|FG000|Overall Study|Refused further treatment|0|||
129684195|NCT01931098|466801534|FG001|Overall Study|Refused further treatment|1|||
129684196|NCT02278354|466801535|FG000|Overall Study|Lost to Follow-up|2|||
129684197|NCT02278354|466801536|FG001|Overall Study|Lost to Follow-up|2|||
129684198|NCT02278354|466801535|FG000|Overall Study|Withdrawal by Subject|0|||
129684199|NCT02278354|466801536|FG001|Overall Study|Withdrawal by Subject|1|||
129684200|NCT02278354|466801535|FG000|Overall Study|<10 professional fights|2|||
129684201|NCT02278354|466801536|FG001|Overall Study|<10 professional fights|0|||
129684202|NCT02612155|466801538|FG000|Overall Study|Death|1|||
129684203|NCT02612155|466801539|FG001|Overall Study|Death|1|||
129684204|NCT02612155|466801538|FG000|Overall Study|Lost to Follow-up|2|||
129684205|NCT02612155|466801539|FG001|Overall Study|Lost to Follow-up|2|||
129684206|NCT00569127|466801542|FG000|Overall Study|Adverse Event|57|||
129684207|NCT00569127|466801543|FG001|Overall Study|Adverse Event|47|||
129684208|NCT00569127|466801542|FG000|Overall Study|Withdrawal by Subject|13|||
129684209|NCT00569127|466801543|FG001|Overall Study|Withdrawal by Subject|27|||
129684210|NCT00569127|466801542|FG000|Overall Study|Progression|99|||
129684211|NCT00569127|466801543|FG001|Overall Study|Progression|100|||
129550730|NCT02454972|466312868|FG005|Overall Study|Progressive disease|12|||
129684212|NCT00569127|466801542|FG000|Overall Study|Death|4|||
129684213|NCT00569127|466801543|FG001|Overall Study|Death|3|||
129684214|NCT00569127|466801542|FG000|Overall Study|Other|20|||
129684215|NCT00569127|466801543|FG001|Overall Study|Other|19|||
129772577|NCT00790842|467134109|FG007|Expansion Cohort|Physician Decision|0|||
129772578|NCT00790842|467134110|FG008|Expansion Cohort|Physician Decision|0|||
129772579|NCT00790842|467134111|FG009|Expansion Cohort|Physician Decision|0|||
129772580|NCT00790842|467134112|FG010|Expansion Cohort|Physician Decision|0|||
129772581|NCT00790842|467134102|FG000|Expansion Cohort|Withdrawal by Subject|0|||
129772582|NCT00790842|467134103|FG001|Expansion Cohort|Withdrawal by Subject|0|||
129772583|NCT00790842|467134104|FG002|Expansion Cohort|Withdrawal by Subject|3|||
129772584|NCT00790842|467134105|FG003|Expansion Cohort|Withdrawal by Subject|0|||
129772585|NCT00790842|467134106|FG004|Expansion Cohort|Withdrawal by Subject|0|||
129772586|NCT00790842|467134107|FG005|Expansion Cohort|Withdrawal by Subject|0|||
129772587|NCT00790842|467134108|FG006|Expansion Cohort|Withdrawal by Subject|0|||
129772588|NCT00790842|467134109|FG007|Expansion Cohort|Withdrawal by Subject|0|||
129772589|NCT00790842|467134110|FG008|Expansion Cohort|Withdrawal by Subject|0|||
129772590|NCT00790842|467134111|FG009|Expansion Cohort|Withdrawal by Subject|0|||
129772591|NCT00790842|467134112|FG010|Expansion Cohort|Withdrawal by Subject|0|||
129772592|NCT00790842|467134102|FG000|Expansion Cohort|Study Closure|0|||
129772593|NCT00790842|467134103|FG001|Expansion Cohort|Study Closure|0|||
129772594|NCT00790842|467134104|FG002|Expansion Cohort|Study Closure|1|||
129772595|NCT00790842|467134105|FG003|Expansion Cohort|Study Closure|0|||
129772596|NCT00790842|467134106|FG004|Expansion Cohort|Study Closure|0|||
129772597|NCT00790842|467134107|FG005|Expansion Cohort|Study Closure|0|||
129772598|NCT00790842|467134108|FG006|Expansion Cohort|Study Closure|0|||
129772599|NCT00790842|467134109|FG007|Expansion Cohort|Study Closure|0|||
129772600|NCT00790842|467134110|FG008|Expansion Cohort|Study Closure|0|||
129772601|NCT00790842|467134111|FG009|Expansion Cohort|Study Closure|0|||
129772602|NCT00790842|467134112|FG010|Expansion Cohort|Study Closure|0|||
129772603|NCT00419952|467134113|FG000|Overall Study|Adverse Event|8|||
129772604|NCT00419952|467134114|FG001|Overall Study|Adverse Event|10|||
129772605|NCT00419952|467134113|FG000|Overall Study|Withdrawal by Subject|44|||
129772606|NCT00419952|467134114|FG001|Overall Study|Withdrawal by Subject|43|||
129772607|NCT00419952|467134113|FG000|Overall Study|Lost to Follow-up|43|||
129772608|NCT00419952|467134114|FG001|Overall Study|Lost to Follow-up|34|||
129772609|NCT00419952|467134113|FG000|Overall Study|Protocol Violation|32|||
129772610|NCT00419952|467134114|FG001|Overall Study|Protocol Violation|24|||
129772611|NCT00419952|467134113|FG000|Overall Study|Pregnancy|4|||
129772612|NCT00419952|467134114|FG001|Overall Study|Pregnancy|2|||
129772613|NCT00419952|467134113|FG000|Overall Study|Physician Decision|1|||
129772614|NCT00419952|467134114|FG001|Overall Study|Physician Decision|3|||
129772615|NCT00419952|467134113|FG000|Overall Study|Incorrectly enrolled|10|||
129772616|NCT00419952|467134114|FG001|Overall Study|Incorrectly enrolled|3|||
129772617|NCT00419952|467134113|FG000|Overall Study|Intake of prohibited medication|2|||
129772618|NCT00419952|467134114|FG001|Overall Study|Intake of prohibited medication|2|||
129772619|NCT00419952|467134113|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
129772620|NCT00419952|467134114|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
129772621|NCT00419952|467134113|FG000|Overall Study|Diary or medication non-compliance|2|||
129772622|NCT00419952|467134114|FG001|Overall Study|Diary or medication non-compliance|4|||
129772623|NCT00419952|467134113|FG000|Overall Study|Abnormal ECG|1|||
129772624|NCT00419952|467134114|FG001|Overall Study|Abnormal ECG|0|||
129772625|NCT03126591|467134115|FG000|Overall Study|Death|6|||
129772626|NCT03126591|467134116|FG001|Overall Study|Death|3|||
129772627|NCT03126591|467134117|FG002|Overall Study|Death|17|||
129772628|NCT03126591|467134115|FG000|Overall Study|Progressive Disease|0|||
129772629|NCT03126591|467134116|FG001|Overall Study|Progressive Disease|1|||
129772630|NCT03126591|467134117|FG002|Overall Study|Progressive Disease|2|||
129772631|NCT03126591|467134115|FG000|Overall Study|Terminated by Sponsor|0|||
129772632|NCT03126591|467134116|FG001|Overall Study|Terminated by Sponsor|1|||
129772633|NCT03126591|467134117|FG002|Overall Study|Terminated by Sponsor|4|||
129772634|NCT03126591|467134115|FG000|Overall Study|Withdrawal by Subject|1|||
129772635|NCT03126591|467134116|FG001|Overall Study|Withdrawal by Subject|1|||
129772636|NCT03126591|467134117|FG002|Overall Study|Withdrawal by Subject|4|||
129772637|NCT02158546|467134118|FG000|Overall Study|Physician Decision|0|||
129772638|NCT02158546|467134119|FG001|Overall Study|Physician Decision|1|||
129772639|NCT02158546|467134120|FG002|Overall Study|Physician Decision|0|||
129772640|NCT02158546|467134121|FG003|Overall Study|Physician Decision|0|||
129772641|NCT02158546|467134118|FG000|Overall Study|Non-compliance|0|||
129772642|NCT02158546|467134119|FG001|Overall Study|Non-compliance|1|||
129772643|NCT02158546|467134120|FG002|Overall Study|Non-compliance|0|||
129772644|NCT02158546|467134121|FG003|Overall Study|Non-compliance|1|||
129772645|NCT02158546|467134118|FG000|Overall Study|Failure to meet eligibility criteria|0|||
129772646|NCT02158546|467134119|FG001|Overall Study|Failure to meet eligibility criteria|1|||
129772647|NCT02158546|467134120|FG002|Overall Study|Failure to meet eligibility criteria|0|||
129772648|NCT02158546|467134121|FG003|Overall Study|Failure to meet eligibility criteria|0|||
129772649|NCT02158546|467134118|FG000|Overall Study|Lack of Efficacy|1|||
129772650|NCT02158546|467134119|FG001|Overall Study|Lack of Efficacy|1|||
129772651|NCT02158546|467134120|FG002|Overall Study|Lack of Efficacy|0|||
129772652|NCT02158546|467134121|FG003|Overall Study|Lack of Efficacy|0|||
129772653|NCT02158546|467134118|FG000|Overall Study|Adverse Event|2|||
129772654|NCT02158546|467134119|FG001|Overall Study|Adverse Event|2|||
129772655|NCT02158546|467134120|FG002|Overall Study|Adverse Event|0|||
129772656|NCT02158546|467134121|FG003|Overall Study|Adverse Event|0|||
129772657|NCT02158546|467134118|FG000|Overall Study|Withdrawal by Subject|6|||
129772658|NCT02158546|467134119|FG001|Overall Study|Withdrawal by Subject|2|||
129772659|NCT02158546|467134120|FG002|Overall Study|Withdrawal by Subject|1|||
129772660|NCT02158546|467134121|FG003|Overall Study|Withdrawal by Subject|0|||
129772661|NCT02158546|467134118|FG000|Overall Study|Lost to Follow-up|5|||
129772662|NCT02158546|467134119|FG001|Overall Study|Lost to Follow-up|4|||
129772663|NCT02158546|467134120|FG002|Overall Study|Lost to Follow-up|0|||
129772664|NCT02158546|467134121|FG003|Overall Study|Lost to Follow-up|1|||
129772665|NCT02158546|467134118|FG000|Overall Study|Site Excluded|5|||
129772666|NCT02158546|467134119|FG001|Overall Study|Site Excluded|5|||
129772667|NCT02158546|467134120|FG002|Overall Study|Site Excluded|3|||
129772668|NCT02158546|467134121|FG003|Overall Study|Site Excluded|4|||
129772669|NCT02351817|467134122|FG000|Period 1|Adverse Event|1|||
129772670|NCT02351817|467134123|FG001|Period 1|Adverse Event|2|||
129772671|NCT02351817|467134122|FG000|Period 1|Lack of Efficacy|0|||
129772672|NCT02351817|467134123|FG001|Period 1|Lack of Efficacy|1|||
129772673|NCT02351817|467134122|FG000|Period 2|Adverse Event|0|||
129772674|NCT02351817|467134123|FG001|Period 2|Adverse Event|2|||
129772675|NCT02351817|467134122|FG000|Period 2|Protocol Violation|1|||
129772676|NCT02351817|467134123|FG001|Period 2|Protocol Violation|0|||
129772677|NCT02488915|467134126|FG000|Overall Study|Death|21|||
129772678|NCT02488915|467134126|FG000|Overall Study|Lost to Follow-up|4|||
129772679|NCT02488915|467134126|FG000|Overall Study|Withdrawal by Subject|1|||
129772680|NCT02976038|467134127|FG000|Overall Study|Physician Decision|22|||
129772681|NCT02976038|467134127|FG000|Overall Study|Withdrawal by Subject|3|||
129772682|NCT02976038|467134127|FG000|Overall Study|Lost to Follow-up|2|||
129772683|NCT02976038|467134127|FG000|Overall Study|Adverse Event|1|||
129772684|NCT01046396|467134128|FG000|Overall Study|Withdrawal by Subject|5|||
129772685|NCT01208207|467134129|FG000|Part I|Adverse Event|19|||
129772686|NCT01208207|467134130|FG001|Part I|Adverse Event|2|||
129772687|NCT01208207|467134131|FG002|Part I|Adverse Event|6|||
129772688|NCT01208207|467134132|FG003|Part I|Adverse Event|0|||
129772689|NCT01208207|467134133|FG004|Part I|Adverse Event|0|||
129772690|NCT01208207|467134134|FG005|Part I|Adverse Event|0|||
129772691|NCT01208207|467134135|FG006|Part I|Adverse Event|0|||
129772692|NCT01208207|467134129|FG000|Part I|Lack of Efficacy|21|||
129772693|NCT01208207|467134130|FG001|Part I|Lack of Efficacy|3|||
129772694|NCT01208207|467134131|FG002|Part I|Lack of Efficacy|2|||
129772695|NCT01208207|467134132|FG003|Part I|Lack of Efficacy|0|||
129772696|NCT01208207|467134133|FG004|Part I|Lack of Efficacy|0|||
129772697|NCT01208207|467134134|FG005|Part I|Lack of Efficacy|0|||
129772698|NCT01208207|467134135|FG006|Part I|Lack of Efficacy|0|||
129772699|NCT01208207|467134129|FG000|Part I|Lost to Follow-up|6|||
129772700|NCT01208207|467134130|FG001|Part I|Lost to Follow-up|1|||
129772701|NCT01208207|467134131|FG002|Part I|Lost to Follow-up|0|||
129772702|NCT01208207|467134132|FG003|Part I|Lost to Follow-up|0|||
129772703|NCT01208207|467134133|FG004|Part I|Lost to Follow-up|0|||
129772704|NCT01208207|467134134|FG005|Part I|Lost to Follow-up|0|||
129772705|NCT01208207|467134135|FG006|Part I|Lost to Follow-up|0|||
129772706|NCT01208207|467134129|FG000|Part I|Non-Compliance With Study Drug|1|||
129772707|NCT01208207|467134130|FG001|Part I|Non-Compliance With Study Drug|0|||
129772708|NCT01208207|467134131|FG002|Part I|Non-Compliance With Study Drug|1|||
129772709|NCT01208207|467134132|FG003|Part I|Non-Compliance With Study Drug|0|||
129772710|NCT01208207|467134133|FG004|Part I|Non-Compliance With Study Drug|0|||
129772711|NCT01208207|467134134|FG005|Part I|Non-Compliance With Study Drug|0|||
129772712|NCT01208207|467134135|FG006|Part I|Non-Compliance With Study Drug|0|||
129772713|NCT01208207|467134129|FG000|Part I|Physician Decision|0|||
129772714|NCT01208207|467134130|FG001|Part I|Physician Decision|1|||
129772715|NCT01208207|467134131|FG002|Part I|Physician Decision|0|||
129772716|NCT01208207|467134132|FG003|Part I|Physician Decision|0|||
129772717|NCT01208207|467134133|FG004|Part I|Physician Decision|0|||
129772718|NCT01208207|467134134|FG005|Part I|Physician Decision|0|||
129772719|NCT01208207|467134135|FG006|Part I|Physician Decision|0|||
129772720|NCT01208207|467134129|FG000|Part I|Progressive Disease|1|||
129772721|NCT01208207|467134130|FG001|Part I|Progressive Disease|0|||
129772722|NCT01208207|467134131|FG002|Part I|Progressive Disease|0|||
129772723|NCT01208207|467134132|FG003|Part I|Progressive Disease|0|||
129772724|NCT01208207|467134133|FG004|Part I|Progressive Disease|0|||
129772725|NCT01208207|467134134|FG005|Part I|Progressive Disease|0|||
129772726|NCT01208207|467134135|FG006|Part I|Progressive Disease|0|||
129772727|NCT01208207|467134129|FG000|Part I|Protocol Violation|8|||
129772728|NCT01208207|467134130|FG001|Part I|Protocol Violation|0|||
129772729|NCT01208207|467134131|FG002|Part I|Protocol Violation|2|||
129772730|NCT01208207|467134132|FG003|Part I|Protocol Violation|0|||
129772731|NCT01208207|467134133|FG004|Part I|Protocol Violation|0|||
129772732|NCT01208207|467134134|FG005|Part I|Protocol Violation|0|||
129772733|NCT01208207|467134135|FG006|Part I|Protocol Violation|0|||
129772734|NCT01208207|467134129|FG000|Part I|Withdrawal by Subject|14|||
129772735|NCT01208207|467134130|FG001|Part I|Withdrawal by Subject|4|||
129772736|NCT01208207|467134131|FG002|Part I|Withdrawal by Subject|4|||
129772737|NCT01208207|467134132|FG003|Part I|Withdrawal by Subject|0|||
129772738|NCT01208207|467134133|FG004|Part I|Withdrawal by Subject|0|||
129772739|NCT01208207|467134134|FG005|Part I|Withdrawal by Subject|0|||
129772740|NCT01208207|467134135|FG006|Part I|Withdrawal by Subject|0|||
129772741|NCT01208207|467134129|FG000|Part II|Withdrawal by Subject|0|||
129772742|NCT01208207|467134130|FG001|Part II|Withdrawal by Subject|0|||
129772743|NCT01208207|467134131|FG002|Part II|Withdrawal by Subject|0|||
129772744|NCT01208207|467134132|FG003|Part II|Withdrawal by Subject|10|||
129772745|NCT01208207|467134133|FG004|Part II|Withdrawal by Subject|9|||
129772746|NCT01208207|467134134|FG005|Part II|Withdrawal by Subject|3|||
129772747|NCT01208207|467134135|FG006|Part II|Withdrawal by Subject|5|||
129772748|NCT01208207|467134129|FG000|Part II|Adverse Event|0|||
129772749|NCT01208207|467134130|FG001|Part II|Adverse Event|0|||
129772750|NCT01208207|467134131|FG002|Part II|Adverse Event|0|||
129772751|NCT01208207|467134132|FG003|Part II|Adverse Event|5|||
129772752|NCT01208207|467134133|FG004|Part II|Adverse Event|9|||
129772753|NCT01208207|467134134|FG005|Part II|Adverse Event|4|||
129772754|NCT01208207|467134135|FG006|Part II|Adverse Event|2|||
129772755|NCT01208207|467134129|FG000|Part II|Lack of Efficacy|0|||
129772756|NCT01208207|467134130|FG001|Part II|Lack of Efficacy|0|||
129772757|NCT01208207|467134131|FG002|Part II|Lack of Efficacy|0|||
129772758|NCT01208207|467134132|FG003|Part II|Lack of Efficacy|6|||
129772759|NCT01208207|467134133|FG004|Part II|Lack of Efficacy|4|||
129772760|NCT01208207|467134134|FG005|Part II|Lack of Efficacy|3|||
129772761|NCT01208207|467134135|FG006|Part II|Lack of Efficacy|3|||
129772762|NCT01208207|467134129|FG000|Part II|Lost to Follow-up|0|||
129772763|NCT01208207|467134130|FG001|Part II|Lost to Follow-up|0|||
129772764|NCT01208207|467134131|FG002|Part II|Lost to Follow-up|0|||
129772765|NCT01208207|467134132|FG003|Part II|Lost to Follow-up|4|||
129772766|NCT01208207|467134133|FG004|Part II|Lost to Follow-up|0|||
129772767|NCT01208207|467134134|FG005|Part II|Lost to Follow-up|2|||
129772768|NCT01208207|467134135|FG006|Part II|Lost to Follow-up|1|||
129772769|NCT01208207|467134129|FG000|Part II|Non-Compliance With Study Drug|0|||
129772770|NCT01208207|467134130|FG001|Part II|Non-Compliance With Study Drug|0|||
129772771|NCT01208207|467134131|FG002|Part II|Non-Compliance With Study Drug|0|||
129772772|NCT01208207|467134132|FG003|Part II|Non-Compliance With Study Drug|4|||
129772773|NCT01208207|467134133|FG004|Part II|Non-Compliance With Study Drug|1|||
129772774|NCT01208207|467134134|FG005|Part II|Non-Compliance With Study Drug|1|||
129772775|NCT01208207|467134135|FG006|Part II|Non-Compliance With Study Drug|0|||
129772776|NCT01208207|467134129|FG000|Part II|Physician Decision|0|||
129772777|NCT01208207|467134130|FG001|Part II|Physician Decision|0|||
129772778|NCT01208207|467134131|FG002|Part II|Physician Decision|0|||
129772779|NCT01208207|467134132|FG003|Part II|Physician Decision|1|||
129772780|NCT01208207|467134133|FG004|Part II|Physician Decision|0|||
129772781|NCT01208207|467134134|FG005|Part II|Physician Decision|2|||
129772782|NCT01208207|467134135|FG006|Part II|Physician Decision|0|||
129772783|NCT01208207|467134129|FG000|Part II|Protocol Violation|0|||
129772784|NCT01208207|467134130|FG001|Part II|Protocol Violation|0|||
129772785|NCT01208207|467134131|FG002|Part II|Protocol Violation|0|||
129772786|NCT01208207|467134132|FG003|Part II|Protocol Violation|1|||
129772787|NCT01208207|467134133|FG004|Part II|Protocol Violation|0|||
129772788|NCT01208207|467134134|FG005|Part II|Protocol Violation|0|||
129772789|NCT01208207|467134135|FG006|Part II|Protocol Violation|0|||
129772790|NCT01208207|467134129|FG000|Part II|Technical Problems|0|||
129772791|NCT01208207|467134130|FG001|Part II|Technical Problems|0|||
129772792|NCT01208207|467134131|FG002|Part II|Technical Problems|0|||
129772793|NCT01208207|467134132|FG003|Part II|Technical Problems|1|||
129772794|NCT01208207|467134133|FG004|Part II|Technical Problems|0|||
129772795|NCT01208207|467134134|FG005|Part II|Technical Problems|1|||
129772796|NCT01208207|467134135|FG006|Part II|Technical Problems|0|||
129772797|NCT00724698|467134136|FG000|Overall Study|Adverse Event|9|||
129772798|NCT00724698|467134136|FG000|Overall Study|Failure of Therapy|4|||
129772799|NCT00724698|467134136|FG000|Overall Study|Poor Compliance|16|||
129772800|NCT00724698|467134136|FG000|Overall Study|Lost to Follow-up|36|||
129772801|NCT00724698|467134136|FG000|Overall Study|No Info|25|||
129772802|NCT02177032|467134139|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
129550731|NCT02454972|466312869|FG006|Overall Study|Progressive disease|19|||
129772803|NCT02177032|467134140|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
129772804|NCT02177032|467134141|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
129772805|NCT02177032|467134142|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
129772806|NCT02177032|467134139|FG000|Overall Study|Lost to Follow-up|0|||
129550732|NCT02454972|466312870|FG007|Overall Study|Progressive disease|27|||
129772807|NCT02177032|467134140|FG001|Overall Study|Lost to Follow-up|2|||
129550733|NCT02454972|466312871|FG008|Overall Study|Progressive disease|0|||
129550734|NCT02454972|466312863|FG000|Overall Study|Death|0|||
129550735|NCT02454972|466312864|FG001|Overall Study|Death|0|||
129550736|NCT02454972|466312865|FG002|Overall Study|Death|5|||
129550737|NCT02454972|466312866|FG003|Overall Study|Death|1|||
129550738|NCT02454972|466312867|FG004|Overall Study|Death|0|||
129550739|NCT02454972|466312868|FG005|Overall Study|Death|0|||
129550740|NCT02454972|466312869|FG006|Overall Study|Death|0|||
129550741|NCT02454972|466312870|FG007|Overall Study|Death|0|||
129550742|NCT02454972|466312871|FG008|Overall Study|Death|95|||
129550743|NCT02454972|466312863|FG000|Overall Study|Physician Decision|0|||
129550744|NCT02454972|466312864|FG001|Overall Study|Physician Decision|1|||
129550745|NCT02454972|466312865|FG002|Overall Study|Physician Decision|2|||
129550746|NCT02454972|466312866|FG003|Overall Study|Physician Decision|1|||
129550747|NCT02454972|466312867|FG004|Overall Study|Physician Decision|2|||
129550748|NCT02454972|466312868|FG005|Overall Study|Physician Decision|0|||
129550749|NCT02454972|466312869|FG006|Overall Study|Physician Decision|0|||
129550750|NCT02454972|466312870|FG007|Overall Study|Physician Decision|1|||
129550751|NCT02454972|466312871|FG008|Overall Study|Physician Decision|0|||
129550752|NCT02454972|466312863|FG000|Overall Study|Non treatment-related adverse event|2|||
129550753|NCT02454972|466312864|FG001|Overall Study|Non treatment-related adverse event|0|||
129550754|NCT02454972|466312865|FG002|Overall Study|Non treatment-related adverse event|1|||
129550755|NCT02454972|466312866|FG003|Overall Study|Non treatment-related adverse event|0|||
129550756|NCT02454972|466312867|FG004|Overall Study|Non treatment-related adverse event|0|||
129550757|NCT02454972|466312868|FG005|Overall Study|Non treatment-related adverse event|1|||
129550758|NCT02454972|466312869|FG006|Overall Study|Non treatment-related adverse event|0|||
129550759|NCT02454972|466312870|FG007|Overall Study|Non treatment-related adverse event|1|||
129550760|NCT02454972|466312871|FG008|Overall Study|Non treatment-related adverse event|0|||
129550761|NCT02454972|466312863|FG000|Overall Study|Treatment-related adverse events|0|||
129550762|NCT02454972|466312864|FG001|Overall Study|Treatment-related adverse events|1|||
129550763|NCT02454972|466312865|FG002|Overall Study|Treatment-related adverse events|1|||
129550764|NCT02454972|466312866|FG003|Overall Study|Treatment-related adverse events|0|||
129550765|NCT02454972|466312867|FG004|Overall Study|Treatment-related adverse events|2|||
129550766|NCT02454972|466312868|FG005|Overall Study|Treatment-related adverse events|0|||
129550767|NCT02454972|466312869|FG006|Overall Study|Treatment-related adverse events|0|||
129550768|NCT02454972|466312870|FG007|Overall Study|Treatment-related adverse events|2|||
129550769|NCT02454972|466312871|FG008|Overall Study|Treatment-related adverse events|0|||
129550770|NCT02454972|466312863|FG000|Overall Study|Patient moves to compassionate use|0|||
129550771|NCT02454972|466312864|FG001|Overall Study|Patient moves to compassionate use|0|||
129550772|NCT02454972|466312865|FG002|Overall Study|Patient moves to compassionate use|0|||
129550773|NCT02454972|466312866|FG003|Overall Study|Patient moves to compassionate use|0|||
129550774|NCT02454972|466312867|FG004|Overall Study|Patient moves to compassionate use|0|||
129550775|NCT02454972|466312868|FG005|Overall Study|Patient moves to compassionate use|0|||
129550776|NCT02454972|466312869|FG006|Overall Study|Patient moves to compassionate use|2|||
129550777|NCT02454972|466312870|FG007|Overall Study|Patient moves to compassionate use|0|||
129550778|NCT02454972|466312871|FG008|Overall Study|Patient moves to compassionate use|0|||
129550779|NCT02454972|466312863|FG000|Overall Study|Withdrawal by Subject|0|||
129550780|NCT02454972|466312864|FG001|Overall Study|Withdrawal by Subject|1|||
129550781|NCT02454972|466312865|FG002|Overall Study|Withdrawal by Subject|5|||
129550782|NCT02454972|466312866|FG003|Overall Study|Withdrawal by Subject|2|||
129772808|NCT02177032|467134141|FG002|Overall Study|Lost to Follow-up|0|||
129772809|NCT02177032|467134142|FG003|Overall Study|Lost to Follow-up|0|||
129772810|NCT02177032|467134139|FG000|Overall Study|OTHER|2|||
129772811|NCT02177032|467134140|FG001|Overall Study|OTHER|0|||
129772812|NCT02177032|467134141|FG002|Overall Study|OTHER|1|||
129772813|NCT02177032|467134142|FG003|Overall Study|OTHER|0|||
129772814|NCT02177032|467134139|FG000|Overall Study|Withdrawal by Subject|1|||
129772815|NCT02177032|467134140|FG001|Overall Study|Withdrawal by Subject|0|||
129772816|NCT02177032|467134141|FG002|Overall Study|Withdrawal by Subject|1|||
129772817|NCT02177032|467134142|FG003|Overall Study|Withdrawal by Subject|0|||
129772818|NCT00665652|467134143|FG000|Overall Study|Adverse Event|4|||
129772819|NCT00665652|467134143|FG000|Overall Study|Death|1|||
129772820|NCT00665652|467134143|FG000|Overall Study|No longer met inclusion criteria.|1|||
129772821|NCT02556177|467134146|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
129772822|NCT02556177|467134147|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
129772823|NCT00389610|467134154|FG000|Overall Study|Disease Progression|0|||
129772824|NCT00389610|467134155|FG001|Overall Study|Disease Progression|19|||
129772825|NCT00389610|467134154|FG000|Overall Study|Death|0|||
129772826|NCT00389610|467134155|FG001|Overall Study|Death|1|||
129772827|NCT00389610|467134154|FG000|Overall Study|Physician Decision|0|||
129772828|NCT00389610|467134155|FG001|Overall Study|Physician Decision|1|||
129772829|NCT00389610|467134154|FG000|Overall Study|Withdrawal by Subject|0|||
129772830|NCT00389610|467134155|FG001|Overall Study|Withdrawal by Subject|1|||
129772831|NCT03131570|467134156|FG000|Overall Study|Adverse Event|1|||
129772832|NCT03131570|467134157|FG001|Overall Study|Adverse Event|0|||
129772833|NCT00830440|467134158|FG000|Overall Study|Protocol Violation|1|||
129772834|NCT00830440|467134159|FG001|Overall Study|Protocol Violation|0|||
129772835|NCT00830440|467134158|FG000|Overall Study|Withdrawal by Subject|1|||
129772836|NCT00830440|467134159|FG001|Overall Study|Withdrawal by Subject|0|||
129772837|NCT00830440|467134158|FG000|Overall Study|unsuccessful procedure|4|||
129772838|NCT00830440|467134159|FG001|Overall Study|unsuccessful procedure|0|||
129772839|NCT00830440|467134158|FG000|Overall Study|Adverse Event|2|||
129772840|NCT00830440|467134159|FG001|Overall Study|Adverse Event|0|||
129772841|NCT00942604|467134165|FG000|Overall Study|Protocol Violation|1|||
129772842|NCT00942604|467134166|FG001|Overall Study|Protocol Violation|1|||
129772843|NCT00942604|467134165|FG000|Overall Study|Adverse Event|0|||
129772844|NCT00942604|467134166|FG001|Overall Study|Adverse Event|1|||
129772845|NCT00942604|467134165|FG000|Overall Study|Withdrawal by Subject|0|||
129772846|NCT00942604|467134166|FG001|Overall Study|Withdrawal by Subject|1|||
129772847|NCT00942604|467134165|FG000|Overall Study|Patient relocation|1|||
129772848|NCT00942604|467134166|FG001|Overall Study|Patient relocation|1|||
129772849|NCT01188343|467134167|FG000|Overall Study|Not vaccinated|0|||
129772850|NCT01188343|467134168|FG001|Overall Study|Not vaccinated|2|||
129772851|NCT01188343|467134169|FG002|Overall Study|Not vaccinated|1|||
129772852|NCT01188343|467134167|FG000|Overall Study|Withdrawal by Subject|1|||
129550783|NCT02454972|466312867|FG004|Overall Study|Withdrawal by Subject|3|||
129772853|NCT01188343|467134168|FG001|Overall Study|Withdrawal by Subject|24|||
129772854|NCT01188343|467134169|FG002|Overall Study|Withdrawal by Subject|0|||
129772855|NCT01143246|467134170|FG000|Overall Study|Adverse Event|24|||
129772856|NCT01143246|467134171|FG001|Overall Study|Adverse Event|28|||
129772857|NCT01143246|467134170|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
129772858|NCT01143246|467134171|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
129772859|NCT01143246|467134170|FG000|Overall Study|Lost to Follow-up|0|||
129772860|NCT01143246|467134171|FG001|Overall Study|Lost to Follow-up|1|||
129772861|NCT01143246|467134170|FG000|Overall Study|Death|16|||
129772862|NCT01143246|467134171|FG001|Overall Study|Death|15|||
129772863|NCT01143246|467134170|FG000|Overall Study|Reason not Specified|3|||
129772864|NCT01143246|467134171|FG001|Overall Study|Reason not Specified|5|||
129772865|NCT05567783|467134172|FG000|Overall Study|Death|2|||
129772866|NCT05567783|467134173|FG001|Overall Study|Death|3|||
129550784|NCT02454972|466312868|FG005|Overall Study|Withdrawal by Subject|2|||
129550785|NCT02454972|466312869|FG006|Overall Study|Withdrawal by Subject|0|||
129772867|NCT05567783|467134174|FG002|Overall Study|Death|0|||
129772868|NCT05567783|467134172|FG000|Overall Study|Lost to Follow-up|25|||
129772869|NCT05567783|467134173|FG001|Overall Study|Lost to Follow-up|19|||
129772870|NCT05567783|467134174|FG002|Overall Study|Lost to Follow-up|17|||
129772871|NCT05567783|467134172|FG000|Overall Study|Physician Decision|10|||
129772872|NCT05567783|467134173|FG001|Overall Study|Physician Decision|7|||
129772873|NCT05567783|467134174|FG002|Overall Study|Physician Decision|9|||
129772874|NCT05567783|467134172|FG000|Overall Study|Study Terminated by Sponsor|924|||
129772875|NCT05567783|467134173|FG001|Overall Study|Study Terminated by Sponsor|937|||
129772876|NCT05567783|467134174|FG002|Overall Study|Study Terminated by Sponsor|941|||
129550786|NCT02454972|466312870|FG007|Overall Study|Withdrawal by Subject|1|||
129550787|NCT02454972|466312871|FG008|Overall Study|Withdrawal by Subject|2|||
129772877|NCT05567783|467134172|FG000|Overall Study|Withdrawal by Subject|23|||
129772878|NCT05567783|467134173|FG001|Overall Study|Withdrawal by Subject|27|||
129772879|NCT05567783|467134174|FG002|Overall Study|Withdrawal by Subject|24|||
129772880|NCT05567783|467134172|FG000|Overall Study|Incarcerated|1|||
129684216|NCT00569127|466801542|FG000|Overall Study|Lost to Follow-up|0|||
129684217|NCT00569127|466801543|FG001|Overall Study|Lost to Follow-up|3|||
129684218|NCT00569127|466801542|FG000|Overall Study|Not Eligible|14|||
129684219|NCT00569127|466801543|FG001|Overall Study|Not Eligible|11|||
129684220|NCT00569127|466801542|FG000|Overall Study|Still on Treatment|7|||
129684221|NCT00569127|466801543|FG001|Overall Study|Still on Treatment|3|||
129684222|NCT03036254|466801546|FG000|Overall Study|Adverse Event|6|||
129684223|NCT03036254|466801547|FG001|Overall Study|Adverse Event|4|||
129684224|NCT03036254|466801546|FG000|Overall Study|Death|3|||
129684225|NCT03036254|466801547|FG001|Overall Study|Death|1|||
129684226|NCT03036254|466801546|FG000|Overall Study|Lack of Efficacy|5|||
129684227|NCT03036254|466801547|FG001|Overall Study|Lack of Efficacy|1|||
129684228|NCT03036254|466801546|FG000|Overall Study|Withdrawal by Subject|3|||
129684229|NCT03036254|466801547|FG001|Overall Study|Withdrawal by Subject|5|||
129684230|NCT06354257|466801548|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129684231|NCT06354257|466801548|FG000|Treatment Period 2|Adverse Event|1|||
129684232|NCT03168672|466801549|FG000|Overall Study|Withdrawal by Subject|13|||
129684233|NCT03168672|466801549|FG000|Overall Study|Death|3|||
129684234|NCT03168672|466801549|FG000|Overall Study|Investigator's Decision|137|||
129684235|NCT03168672|466801549|FG000|Overall Study|Adverse Event|1|||
129684236|NCT03168672|466801549|FG000|Overall Study|Other|2|||
129684237|NCT03168672|466801549|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
129684238|NCT01757847|466801550|FG000|Overall Study|Withdrawal by Subject|3|||
129684239|NCT01757847|466801551|FG001|Overall Study|Withdrawal by Subject|4|||
129684240|NCT00831844|466801552|FG000|Overall Study|Adverse Event|2|||
129684241|NCT00831844|466801553|FG001|Overall Study|Adverse Event|0|||
129684242|NCT00831844|466801554|FG002|Overall Study|Adverse Event|0|||
129684243|NCT00831844|466801555|FG003|Overall Study|Adverse Event|0|||
129684244|NCT00831844|466801556|FG004|Overall Study|Adverse Event|1|||
129684245|NCT00831844|466801557|FG005|Overall Study|Adverse Event|1|||
129684246|NCT00831844|466801558|FG006|Overall Study|Adverse Event|2|||
129684247|NCT00831844|466801559|FG007|Overall Study|Adverse Event|0|||
129684248|NCT00831844|466801560|FG008|Overall Study|Adverse Event|0|||
129684249|NCT00831844|466801561|FG009|Overall Study|Adverse Event|0|||
129684250|NCT00831844|466801552|FG000|Overall Study|Death|0|||
129684251|NCT00831844|466801553|FG001|Overall Study|Death|0|||
129684252|NCT00831844|466801554|FG002|Overall Study|Death|0|||
129684253|NCT00831844|466801555|FG003|Overall Study|Death|1|||
129684254|NCT00831844|466801556|FG004|Overall Study|Death|0|||
129684255|NCT00831844|466801557|FG005|Overall Study|Death|0|||
129684256|NCT00831844|466801558|FG006|Overall Study|Death|0|||
129684257|NCT00831844|466801559|FG007|Overall Study|Death|0|||
129684258|NCT00831844|466801560|FG008|Overall Study|Death|0|||
129684259|NCT00831844|466801561|FG009|Overall Study|Death|0|||
129684260|NCT00831844|466801552|FG000|Overall Study|Lack of Efficacy|8|||
129684261|NCT00831844|466801553|FG001|Overall Study|Lack of Efficacy|10|||
129684262|NCT00831844|466801554|FG002|Overall Study|Lack of Efficacy|15|||
129684263|NCT00831844|466801555|FG003|Overall Study|Lack of Efficacy|8|||
129684264|NCT00831844|466801556|FG004|Overall Study|Lack of Efficacy|11|||
129684265|NCT00831844|466801557|FG005|Overall Study|Lack of Efficacy|17|||
129684266|NCT00831844|466801558|FG006|Overall Study|Lack of Efficacy|8|||
129684267|NCT00831844|466801559|FG007|Overall Study|Lack of Efficacy|9|||
129684268|NCT00831844|466801560|FG008|Overall Study|Lack of Efficacy|7|||
129684269|NCT00831844|466801561|FG009|Overall Study|Lack of Efficacy|0|||
129684270|NCT00831844|466801552|FG000|Overall Study|Physician Decision|0|||
129684271|NCT00831844|466801553|FG001|Overall Study|Physician Decision|1|||
129684272|NCT00831844|466801554|FG002|Overall Study|Physician Decision|3|||
129684273|NCT00831844|466801555|FG003|Overall Study|Physician Decision|1|||
129684274|NCT00831844|466801556|FG004|Overall Study|Physician Decision|1|||
129684275|NCT00831844|466801557|FG005|Overall Study|Physician Decision|1|||
129684276|NCT00831844|466801558|FG006|Overall Study|Physician Decision|0|||
129684277|NCT00831844|466801559|FG007|Overall Study|Physician Decision|0|||
129684278|NCT00831844|466801560|FG008|Overall Study|Physician Decision|1|||
129684279|NCT00831844|466801561|FG009|Overall Study|Physician Decision|0|||
129684280|NCT00831844|466801552|FG000|Overall Study|Withdrawal by Subject|0|||
129684281|NCT00831844|466801553|FG001|Overall Study|Withdrawal by Subject|0|||
129684282|NCT00831844|466801554|FG002|Overall Study|Withdrawal by Subject|1|||
129684283|NCT00831844|466801555|FG003|Overall Study|Withdrawal by Subject|0|||
129684284|NCT00831844|466801556|FG004|Overall Study|Withdrawal by Subject|0|||
129684285|NCT00831844|466801557|FG005|Overall Study|Withdrawal by Subject|0|||
129684286|NCT00831844|466801558|FG006|Overall Study|Withdrawal by Subject|0|||
129684287|NCT00831844|466801559|FG007|Overall Study|Withdrawal by Subject|1|||
129684288|NCT00831844|466801560|FG008|Overall Study|Withdrawal by Subject|1|||
129684289|NCT00831844|466801561|FG009|Overall Study|Withdrawal by Subject|0|||
129684290|NCT00831844|466801552|FG000|Overall Study|Ineligible|0|||
129684291|NCT00831844|466801553|FG001|Overall Study|Ineligible|1|||
129684292|NCT00831844|466801554|FG002|Overall Study|Ineligible|1|||
129684293|NCT00831844|466801555|FG003|Overall Study|Ineligible|0|||
129684294|NCT00831844|466801556|FG004|Overall Study|Ineligible|1|||
129684295|NCT00831844|466801557|FG005|Overall Study|Ineligible|0|||
129684296|NCT00831844|466801558|FG006|Overall Study|Ineligible|0|||
129684297|NCT00831844|466801559|FG007|Overall Study|Ineligible|0|||
129684298|NCT00831844|466801560|FG008|Overall Study|Ineligible|0|||
129684299|NCT00831844|466801561|FG009|Overall Study|Ineligible|0|||
129684300|NCT04738487|466801564|FG000|Overall Study|Participant Ongoing in Study|298|||
129684301|NCT04738487|466801565|FG001|Overall Study|Participant Ongoing in Study|297|||
129684302|NCT04738487|466801564|FG000|Overall Study|Withdrawal by Subject|7|||
129684303|NCT04738487|466801565|FG001|Overall Study|Withdrawal by Subject|9|||
129684304|NCT04738487|466801564|FG000|Overall Study|Lost to Follow-up|2|||
129684305|NCT04738487|466801565|FG001|Overall Study|Lost to Follow-up|0|||
129684306|NCT04738487|466801564|FG000|Overall Study|Death|287|||
129684307|NCT04738487|466801565|FG001|Overall Study|Death|306|||
129684308|NCT05350202|466801566|FG000|Visit 1 - Baseline|Not-treated|18|||
129684309|NCT05350202|466801567|FG001|Visit 1 - Baseline|Not-treated|0|||
129684310|NCT05350202|466801566|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
129684311|NCT05350202|466801567|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
129684312|NCT05350202|466801566|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
129684313|NCT05350202|466801567|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
129684314|NCT05350202|466801566|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
129684315|NCT05350202|466801567|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
129684316|NCT05350202|466801566|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
129684317|NCT05350202|466801567|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
129684318|NCT05350202|466801566|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
129684319|NCT05350202|466801567|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
129684320|NCT05350202|466801566|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
129684321|NCT05350202|466801567|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
129684322|NCT04635423|466801568|FG000|Overall Study|Ongoing|493|||
129684323|NCT04635423|466801569|FG001|Overall Study|Ongoing|501|||
129684324|NCT04635423|466801568|FG000|Overall Study|Withdrawal by Subject|36|||
129684325|NCT04635423|466801569|FG001|Overall Study|Withdrawal by Subject|29|||
129684326|NCT05119569|466801584|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
129684327|NCT05119569|466801585|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
129684328|NCT05119569|466801586|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129684329|NCT05119569|466801587|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129684330|NCT05119569|466801584|FG000|Double Blind Treatment Phase|Adverse Event|6|||
129684331|NCT05119569|466801585|FG001|Double Blind Treatment Phase|Adverse Event|0|||
129684332|NCT05119569|466801586|FG002|Double Blind Treatment Phase|Adverse Event|0|||
129684333|NCT05119569|466801587|FG003|Double Blind Treatment Phase|Adverse Event|0|||
129684334|NCT05119569|466801584|FG000|Open Label Extension Phase|Ongoing in the study|0|||
129684335|NCT05119569|466801585|FG001|Open Label Extension Phase|Ongoing in the study|0|||
129684336|NCT05119569|466801586|FG002|Open Label Extension Phase|Ongoing in the study|65|||
129684337|NCT05119569|466801587|FG003|Open Label Extension Phase|Ongoing in the study|34|||
129684338|NCT03683030|466801588|FG000|Overall Study|Enrolled but screen failures|12|||
129684339|NCT03683030|466801589|FG001|Overall Study|Enrolled but screen failures|7|||
129684340|NCT03683030|466801588|FG000|Overall Study|Enrolled but no catheter inserted|11|||
129684341|NCT03683030|466801589|FG001|Overall Study|Enrolled but no catheter inserted|13|||
129684342|NCT03683030|466801588|FG000|Overall Study|Withdrawal by Subject|0|||
129684343|NCT03683030|466801589|FG001|Overall Study|Withdrawal by Subject|2|||
129684344|NCT03683030|466801588|FG000|Overall Study|Early termination by subject|1|||
129684345|NCT03683030|466801589|FG001|Overall Study|Early termination by subject|0|||
129684346|NCT03683030|466801588|FG000|Overall Study|Lost to Follow-up|0|||
129684347|NCT03683030|466801589|FG001|Overall Study|Lost to Follow-up|6|||
129684348|NCT03683030|466801588|FG000|Overall Study|Death|0|||
129684349|NCT03683030|466801589|FG001|Overall Study|Death|2|||
129684350|NCT03683030|466801588|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
129684351|NCT03683030|466801589|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
129684352|NCT02390284|466801590|FG000|Overall Study|Physician Decision|0|||
129684353|NCT02390284|466801591|FG001|Overall Study|Physician Decision|0|||
129684354|NCT02390284|466801592|FG002|Overall Study|Physician Decision|9|||
129684355|NCT03980223|466801593|FG000|Overall Study|Lost to Follow-up|3|||
129684356|NCT03980223|466801594|FG001|Overall Study|Lost to Follow-up|7|||
129684357|NCT03980223|466801595|FG002|Overall Study|Lost to Follow-up|10|||
129684358|NCT03980223|466801596|FG003|Overall Study|Lost to Follow-up|8|||
129684359|NCT03980223|466801593|FG000|Overall Study|Withdrawal by Subject|0|||
129684360|NCT03980223|466801594|FG001|Overall Study|Withdrawal by Subject|0|||
129684361|NCT03980223|466801595|FG002|Overall Study|Withdrawal by Subject|1|||
129684362|NCT03980223|466801596|FG003|Overall Study|Withdrawal by Subject|2|||
129684363|NCT03980223|466801593|FG000|Overall Study|Physician Decision|0|||
129684364|NCT03980223|466801594|FG001|Overall Study|Physician Decision|0|||
129684365|NCT03980223|466801595|FG002|Overall Study|Physician Decision|1|||
129684366|NCT03980223|466801596|FG003|Overall Study|Physician Decision|0|||
129684367|NCT03980223|466801593|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
129684368|NCT03980223|466801594|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
129684369|NCT03980223|466801595|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
129684370|NCT03980223|466801596|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
129684371|NCT06239610|466801597|FG000|Overall Study|no usable migration data for minimum of one day|11|||
129684372|NCT01922934|466801601|FG000|Eligible Patients|Death|0|||
129684373|NCT01922934|466801602|FG001|Eligible Patients|Death|7|||
129684374|NCT01922934|466801601|FG000|Eligible Patients|Physician Decision|17|||
129684375|NCT01922934|466801602|FG001|Eligible Patients|Physician Decision|0|||
129684376|NCT01922934|466801601|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
129684377|NCT01922934|466801602|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
129684378|NCT01922934|466801601|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
129684379|NCT01922934|466801602|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
129684380|NCT01922934|466801601|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
129684381|NCT01922934|466801602|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
129684382|NCT01922934|466801601|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
129684383|NCT01922934|466801602|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
129684384|NCT05166876|466801605|FG000|Overall Study|Withdrawal by Subject|1|||
129684385|NCT05166876|466801606|FG001|Overall Study|Withdrawal by Subject|0|||
129684386|NCT05166876|466801607|FG002|Overall Study|Withdrawal by Subject|0|||
129684387|NCT00658528|466801608|FG000|Overall Study|Adverse Event|5|||
129684388|NCT00658528|466801609|FG001|Overall Study|Adverse Event|7|||
129684389|NCT00658528|466801608|FG000|Overall Study|Lost to Follow-up|14|||
129684390|NCT00658528|466801609|FG001|Overall Study|Lost to Follow-up|22|||
129684391|NCT00658528|466801608|FG000|Overall Study|Withdrawal by Subject|8|||
129684392|NCT00658528|466801609|FG001|Overall Study|Withdrawal by Subject|6|||
129684393|NCT00658528|466801608|FG000|Overall Study|Withdrawal of consent|5|||
129684394|NCT00658528|466801609|FG001|Overall Study|Withdrawal of consent|6|||
129684395|NCT00658528|466801608|FG000|Overall Study|Other|8|||
129684396|NCT00658528|466801609|FG001|Overall Study|Other|4|||
129684397|NCT01937299|466801610|FG000|Overall Study|Adverse Event|13|||
129684398|NCT01937299|466801611|FG001|Overall Study|Adverse Event|0|||
129684399|NCT01937299|466801610|FG000|Overall Study|Lack of Efficacy|0|||
129684400|NCT01937299|466801611|FG001|Overall Study|Lack of Efficacy|4|||
129684401|NCT01937299|466801610|FG000|Overall Study|Withdrawal by Subject|1|||
129684402|NCT01937299|466801611|FG001|Overall Study|Withdrawal by Subject|0|||
129684403|NCT00385840|466801612|FG000|Overall Study|Adverse Event|1|||
129684404|NCT00385840|466801613|FG001|Overall Study|Adverse Event|1|||
129684405|NCT00385840|466801612|FG000|Overall Study|Lost to Follow-up|3|||
129684406|NCT00385840|466801613|FG001|Overall Study|Lost to Follow-up|13|||
129684407|NCT01706328|466801621|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
129684408|NCT01706328|466801622|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129684409|NCT01706328|466801623|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129684410|NCT01706328|466801621|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
129772881|NCT05567783|467134173|FG001|Overall Study|Incarcerated|0|||
129684411|NCT01706328|466801622|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129684412|NCT01706328|466801623|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129684413|NCT01706328|466801621|FG000|2-week Run-in Period|Physician Decision|4|||
129684414|NCT01706328|466801622|FG001|2-week Run-in Period|Physician Decision|0|||
129684415|NCT01706328|466801623|FG002|2-week Run-in Period|Physician Decision|0|||
129684416|NCT01706328|466801621|FG000|2-week Run-in Period|Adverse Event|4|||
129684417|NCT01706328|466801622|FG001|2-week Run-in Period|Adverse Event|0|||
129684418|NCT01706328|466801623|FG002|2-week Run-in Period|Adverse Event|0|||
129684419|NCT01706328|466801621|FG000|2-week Run-in Period|Lost to Follow-up|2|||
129684420|NCT01706328|466801622|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129684421|NCT01706328|466801623|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129684422|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
129684423|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
129684424|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
129684425|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
129684426|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
129684427|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
129684428|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
129684429|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
129684430|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
129684431|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
129684432|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
129684433|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
129684434|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
129684435|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
129684436|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
129684437|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
129684438|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
129684439|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
129684440|NCT01706328|466801621|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129684441|NCT01706328|466801622|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
129684442|NCT01706328|466801623|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
129684443|NCT03018938|466801626|FG000|Overall Study|Death|0|||
129684444|NCT03018938|466801627|FG001|Overall Study|Death|1|||
129684445|NCT03018938|466801626|FG000|Overall Study|Lost to Follow-up|21|||
129684446|NCT03018938|466801627|FG001|Overall Study|Lost to Follow-up|32|||
129684447|NCT03018938|466801626|FG000|Overall Study|Withdrawal by Subject|38|||
129684448|NCT03018938|466801627|FG001|Overall Study|Withdrawal by Subject|45|||
129684449|NCT03018938|466801626|FG000|Overall Study|Physician Decision|3|||
129684450|NCT03018938|466801627|FG001|Overall Study|Physician Decision|2|||
129684451|NCT03018938|466801626|FG000|Overall Study|Sponsor Decision|0|||
129684452|NCT03018938|466801627|FG001|Overall Study|Sponsor Decision|1|||
129684453|NCT03018938|466801626|FG000|Overall Study|Screen failure-After randomization|4|||
129684454|NCT03018938|466801627|FG001|Overall Study|Screen failure-After randomization|2|||
129684455|NCT03018938|466801626|FG000|Overall Study|Not recorded|0|||
129684456|NCT03018938|466801627|FG001|Overall Study|Not recorded|2|||
129684457|NCT02916771|466801634|FG000|Overall Study|Withdrawal by Subject|9|||
129684458|NCT02916771|466801634|FG000|Overall Study|Physician Decision|1|||
129684459|NCT02916771|466801634|FG000|Overall Study|Began treatment for another active malignancy|1|||
129684460|NCT05759338|466801635|FG000|Overall Study|Withdrawal by Subject|3|||
129684461|NCT02924376|466801636|FG000|Overall Study|Progressive Disease|4|||
129684462|NCT02924376|466801637|FG001|Overall Study|Progressive Disease|0|||
129684463|NCT02924376|466801638|FG002|Overall Study|Progressive Disease|1|||
129684464|NCT02924376|466801639|FG003|Overall Study|Progressive Disease|0|||
129684465|NCT02924376|466801636|FG000|Overall Study|Death|73|||
129684466|NCT02924376|466801637|FG001|Overall Study|Death|18|||
129684467|NCT02924376|466801638|FG002|Overall Study|Death|15|||
129684468|NCT02924376|466801639|FG003|Overall Study|Death|2|||
129684469|NCT02924376|466801636|FG000|Overall Study|Lost to Follow-up|3|||
129684470|NCT02924376|466801637|FG001|Overall Study|Lost to Follow-up|0|||
129684471|NCT02924376|466801638|FG002|Overall Study|Lost to Follow-up|0|||
129684472|NCT02924376|466801639|FG003|Overall Study|Lost to Follow-up|0|||
129684473|NCT02924376|466801636|FG000|Overall Study|Study Terminated by Sponsor|19|||
129684474|NCT02924376|466801637|FG001|Overall Study|Study Terminated by Sponsor|0|||
129684475|NCT02924376|466801638|FG002|Overall Study|Study Terminated by Sponsor|0|||
129684476|NCT02924376|466801639|FG003|Overall Study|Study Terminated by Sponsor|0|||
129684477|NCT02924376|466801636|FG000|Overall Study|Physician Decision|1|||
129684478|NCT02924376|466801637|FG001|Overall Study|Physician Decision|0|||
129684479|NCT02924376|466801638|FG002|Overall Study|Physician Decision|0|||
129684480|NCT02924376|466801639|FG003|Overall Study|Physician Decision|0|||
129684481|NCT02924376|466801636|FG000|Overall Study|Withdrawal by Subject|7|||
129684482|NCT02924376|466801637|FG001|Overall Study|Withdrawal by Subject|2|||
129772882|NCT05567783|467134174|FG002|Overall Study|Incarcerated|0|||
129772883|NCT05567783|467134172|FG000|Overall Study|Participant randomized in error|4|||
129772884|NCT05567783|467134173|FG001|Overall Study|Participant randomized in error|2|||
129772885|NCT05567783|467134174|FG002|Overall Study|Participant randomized in error|2|||
129772886|NCT03944577|467134180|FG000|Overall Study|Adverse Event|3|||
129772887|NCT04119414|467134181|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
129772888|NCT03058146|467134182|FG000|Overall Study|Withdrawal by Subject|4|||
129772889|NCT03058146|467134183|FG001|Overall Study|Withdrawal by Subject|1|||
129772890|NCT03058146|467134182|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
129772891|NCT03058146|467134183|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
129772892|NCT01352793|467134187|FG000|Overall Study|Lost to Follow-up|289|||
129772893|NCT01352793|467134188|FG001|Overall Study|Lost to Follow-up|125|||
129772894|NCT01352793|467134187|FG000|Overall Study|Withdrawal by Subject|120|||
129772895|NCT01352793|467134188|FG001|Overall Study|Withdrawal by Subject|55|||
129684483|NCT02924376|466801638|FG002|Overall Study|Withdrawal by Subject|1|||
129684484|NCT02924376|466801639|FG003|Overall Study|Withdrawal by Subject|0|||
129684485|NCT02924376|466801636|FG000|Overall Study|Rolled Over to Another Study|1|||
129684486|NCT02924376|466801637|FG001|Overall Study|Rolled Over to Another Study|0|||
129684487|NCT02924376|466801638|FG002|Overall Study|Rolled Over to Another Study|0|||
129684488|NCT02924376|466801639|FG003|Overall Study|Rolled Over to Another Study|0|||
129684489|NCT06455111|466801641|FG000|Overall Study|Withdrawal by Subject|11|||
129684490|NCT06455111|466801642|FG001|Overall Study|Withdrawal by Subject|4|||
129684491|NCT02572167|466802937|FG000|Overall Study|Withdrawal by Subject|0|||
129684492|NCT02572167|466802938|FG001|Overall Study|Withdrawal by Subject|3|||
129684493|NCT02572167|466802939|FG002|Overall Study|Withdrawal by Subject|0|||
129684494|NCT02572167|466802937|FG000|Overall Study|Lost to Follow-up|2|||
129684495|NCT02572167|466802938|FG001|Overall Study|Lost to Follow-up|5|||
129684496|NCT02572167|466802939|FG002|Overall Study|Lost to Follow-up|3|||
129684497|NCT02572167|466802937|FG000|Overall Study|Death|0|||
129684498|NCT02572167|466802938|FG001|Overall Study|Death|8|||
129684499|NCT02572167|466802939|FG002|Overall Study|Death|3|||
129684500|NCT02572167|466802937|FG000|Overall Study|Did not meet inclusion criteria|0|||
129684501|NCT02572167|466802938|FG001|Overall Study|Did not meet inclusion criteria|0|||
129684502|NCT02572167|466802939|FG002|Overall Study|Did not meet inclusion criteria|1|||
129684503|NCT02572167|466802937|FG000|Overall Study|Study closure by Sponsor|4|||
129684504|NCT02572167|466802938|FG001|Overall Study|Study closure by Sponsor|40|||
129684505|NCT02572167|466802939|FG002|Overall Study|Study closure by Sponsor|24|||
129684506|NCT00005047|466802940|FG000|Overall Study|Withdrawal by Subject|12|||
129684507|NCT00005047|466802941|FG001|Overall Study|Withdrawal by Subject|0|||
129684508|NCT00005047|466802942|FG002|Overall Study|Withdrawal by Subject|0|||
129684509|NCT00005047|466802943|FG003|Overall Study|Withdrawal by Subject|0|||
129684510|NCT00005047|466802940|FG000|Overall Study|Adverse Event|5|||
129684511|NCT00005047|466802941|FG001|Overall Study|Adverse Event|0|||
129684512|NCT00005047|466802942|FG002|Overall Study|Adverse Event|0|||
129684513|NCT00005047|466802943|FG003|Overall Study|Adverse Event|0|||
129684514|NCT00005047|466802940|FG000|Overall Study|Lost to Follow-up|1|||
129684515|NCT00005047|466802941|FG001|Overall Study|Lost to Follow-up|0|||
129684516|NCT00005047|466802942|FG002|Overall Study|Lost to Follow-up|0|||
129684517|NCT00005047|466802943|FG003|Overall Study|Lost to Follow-up|0|||
129684518|NCT00005047|466802940|FG000|Overall Study|Lack of Efficacy|1|||
129684519|NCT00005047|466802941|FG001|Overall Study|Lack of Efficacy|0|||
129684520|NCT00005047|466802942|FG002|Overall Study|Lack of Efficacy|0|||
129684521|NCT00005047|466802943|FG003|Overall Study|Lack of Efficacy|0|||
129684522|NCT00098475|466802951|FG000|Step 1|Progressive disease|33|||
129684523|NCT00098475|466802952|FG001|Step 1|Progressive disease|35|||
129684524|NCT00098475|466802953|FG002|Step 1|Progressive disease|2|||
129684525|NCT00098475|466802954|FG003|Step 1|Progressive disease|1|||
129684526|NCT00098475|466802951|FG000|Step 1|Adverse Event|56|||
129684527|NCT00098475|466802952|FG001|Step 1|Adverse Event|37|||
129684528|NCT00098475|466802953|FG002|Step 1|Adverse Event|0|||
129684529|NCT00098475|466802954|FG003|Step 1|Adverse Event|1|||
129684530|NCT00098475|466802951|FG000|Step 1|Death|8|||
129684531|NCT00098475|466802952|FG001|Step 1|Death|5|||
129684532|NCT00098475|466802953|FG002|Step 1|Death|0|||
129684533|NCT00098475|466802954|FG003|Step 1|Death|1|||
129684534|NCT00098475|466802951|FG000|Step 1|Withdrawal by Subject|14|||
129772896|NCT01352793|467134187|FG000|Overall Study|Protocol Violation|44|||
129772897|NCT01352793|467134188|FG001|Overall Study|Protocol Violation|23|||
129772898|NCT01352793|467134187|FG000|Overall Study|Adverse Event|44|||
129684535|NCT00098475|466802952|FG001|Step 1|Withdrawal by Subject|11|||
129684536|NCT00098475|466802953|FG002|Step 1|Withdrawal by Subject|0|||
129684537|NCT00098475|466802954|FG003|Step 1|Withdrawal by Subject|0|||
129684538|NCT00098475|466802951|FG000|Step 1|Physician Decision|5|||
129684539|NCT00098475|466802952|FG001|Step 1|Physician Decision|2|||
129684540|NCT00098475|466802953|FG002|Step 1|Physician Decision|0|||
129684541|NCT00098475|466802954|FG003|Step 1|Physician Decision|0|||
129684542|NCT00098475|466802951|FG000|Step 1|Alternative therapy|31|||
129772899|NCT01352793|467134188|FG001|Overall Study|Adverse Event|10|||
129772900|NCT01352793|467134187|FG000|Overall Study|Physician Decision|1|||
129772901|NCT01352793|467134188|FG001|Overall Study|Physician Decision|0|||
129772902|NCT01352793|467134187|FG000|Overall Study|Pregnancy|26|||
129772903|NCT01352793|467134188|FG001|Overall Study|Pregnancy|8|||
129772904|NCT01352793|467134187|FG000|Overall Study|Other|25|||
129772905|NCT01352793|467134188|FG001|Overall Study|Other|7|||
129772906|NCT01352793|467134187|FG000|Overall Study|Medication error|2|||
129772907|NCT01352793|467134188|FG001|Overall Study|Medication error|2|||
129772908|NCT01352793|467134187|FG000|Overall Study|Death|1|||
129772909|NCT01352793|467134188|FG001|Overall Study|Death|0|||
129772910|NCT01352793|467134187|FG000|Overall Study|Randomized but not vaccinated|8|||
129772911|NCT01352793|467134188|FG001|Overall Study|Randomized but not vaccinated|0|||
129772912|NCT01352793|467134187|FG000|Overall Study|No longer meets eligibility criteria|25|||
129772913|NCT01352793|467134188|FG001|Overall Study|No longer meets eligibility criteria|15|||
129772914|NCT01716234|467134193|FG000|Overall Study|Protocol Violation|0|||
129772915|NCT01716234|467134194|FG001|Overall Study|Protocol Violation|0|||
129772916|NCT01716234|467134195|FG002|Overall Study|Protocol Violation|0|||
129772917|NCT01716234|467134196|FG003|Overall Study|Protocol Violation|1|||
129772918|NCT01716234|467134197|FG004|Overall Study|Protocol Violation|1|||
129772919|NCT01716234|467134198|FG005|Overall Study|Protocol Violation|1|||
129772920|NCT01716234|467134199|FG006|Overall Study|Protocol Violation|0|||
129772921|NCT01716234|467134193|FG000|Overall Study|Lack of Efficacy|0|||
129772922|NCT01716234|467134194|FG001|Overall Study|Lack of Efficacy|0|||
129772923|NCT01716234|467134195|FG002|Overall Study|Lack of Efficacy|0|||
129772924|NCT01716234|467134196|FG003|Overall Study|Lack of Efficacy|1|||
129772925|NCT01716234|467134197|FG004|Overall Study|Lack of Efficacy|0|||
129772926|NCT01716234|467134198|FG005|Overall Study|Lack of Efficacy|0|||
129772927|NCT01716234|467134199|FG006|Overall Study|Lack of Efficacy|0|||
129772928|NCT01716234|467134193|FG000|Overall Study|Did not meet protocol eligibility|0|||
129772929|NCT01716234|467134194|FG001|Overall Study|Did not meet protocol eligibility|0|||
129772930|NCT01716234|467134195|FG002|Overall Study|Did not meet protocol eligibility|1|||
129772931|NCT01716234|467134196|FG003|Overall Study|Did not meet protocol eligibility|0|||
129772932|NCT01716234|467134197|FG004|Overall Study|Did not meet protocol eligibility|0|||
129772933|NCT01716234|467134198|FG005|Overall Study|Did not meet protocol eligibility|4|||
129772934|NCT01716234|467134199|FG006|Overall Study|Did not meet protocol eligibility|0|||
129772935|NCT01716234|467134193|FG000|Overall Study|Adverse Event|7|||
129772936|NCT01716234|467134194|FG001|Overall Study|Adverse Event|10|||
129772937|NCT01716234|467134195|FG002|Overall Study|Adverse Event|2|||
129772938|NCT01716234|467134196|FG003|Overall Study|Adverse Event|8|||
129772939|NCT01716234|467134197|FG004|Overall Study|Adverse Event|3|||
129772940|NCT01716234|467134198|FG005|Overall Study|Adverse Event|6|||
129772941|NCT01716234|467134199|FG006|Overall Study|Adverse Event|0|||
129772942|NCT01716234|467134193|FG000|Overall Study|Withdrawal by Subject|3|||
129772943|NCT01716234|467134194|FG001|Overall Study|Withdrawal by Subject|0|||
129772944|NCT01716234|467134195|FG002|Overall Study|Withdrawal by Subject|2|||
129772945|NCT01716234|467134196|FG003|Overall Study|Withdrawal by Subject|2|||
129772946|NCT01716234|467134197|FG004|Overall Study|Withdrawal by Subject|1|||
129772947|NCT01716234|467134198|FG005|Overall Study|Withdrawal by Subject|3|||
129772948|NCT01716234|467134199|FG006|Overall Study|Withdrawal by Subject|0|||
129772949|NCT03326713|467134201|FG000|Overall Study|Death|2|||
129772950|NCT03326713|467134202|FG001|Overall Study|Death|1|||
129772951|NCT03326713|467134203|FG002|Overall Study|Death|0|||
129772952|NCT03326713|467134201|FG000|Overall Study|Lost to Follow-up|20|||
129772953|NCT03326713|467134202|FG001|Overall Study|Lost to Follow-up|21|||
129772954|NCT03326713|467134203|FG002|Overall Study|Lost to Follow-up|33|||
129772955|NCT03326713|467134201|FG000|Overall Study|Withdrawal by Subject|1|||
129772956|NCT03326713|467134202|FG001|Overall Study|Withdrawal by Subject|2|||
129772957|NCT03326713|467134203|FG002|Overall Study|Withdrawal by Subject|11|||
129772958|NCT03326713|467134201|FG000|Overall Study|Found Ineligible|11|||
129772959|NCT03326713|467134202|FG001|Overall Study|Found Ineligible|11|||
129772960|NCT03326713|467134203|FG002|Overall Study|Found Ineligible|8|||
129772961|NCT01394016|467134206|FG000|Overall Study|Progressive Disease|2|||
129550788|NCT02454972|466312863|FG000|Overall Study|Multiple delay/holds on treatment|0|||
129550789|NCT02454972|466312864|FG001|Overall Study|Multiple delay/holds on treatment|0|||
129772962|NCT01394016|467134207|FG001|Overall Study|Progressive Disease|0|||
129772963|NCT01394016|467134208|FG002|Overall Study|Progressive Disease|0|||
129772964|NCT01394016|467134209|FG003|Overall Study|Progressive Disease|0|||
129772965|NCT01394016|467134210|FG004|Overall Study|Progressive Disease|0|||
129772966|NCT01394016|467134211|FG005|Overall Study|Progressive Disease|0|||
129772967|NCT01394016|467134212|FG006|Overall Study|Progressive Disease|0|||
129772968|NCT01394016|467134213|FG007|Overall Study|Progressive Disease|0|||
129772969|NCT01394016|467134214|FG008|Overall Study|Progressive Disease|0|||
129772970|NCT01394016|467134215|FG009|Overall Study|Progressive Disease|0|||
129772971|NCT01394016|467134216|FG010|Overall Study|Progressive Disease|0|||
129772972|NCT01394016|467134217|FG011|Overall Study|Progressive Disease|0|||
129772973|NCT01394016|467134218|FG012|Overall Study|Progressive Disease|0|||
129772974|NCT01394016|467134219|FG013|Overall Study|Progressive Disease|0|||
129772975|NCT01394016|467134220|FG014|Overall Study|Progressive Disease|0|||
129772976|NCT01394016|467134221|FG015|Overall Study|Progressive Disease|0|||
129772977|NCT01394016|467134222|FG016|Overall Study|Progressive Disease|0|||
129772978|NCT01394016|467134223|FG017|Overall Study|Progressive Disease|0|||
129772979|NCT01394016|467134224|FG018|Overall Study|Progressive Disease|0|||
129772980|NCT01394016|467134206|FG000|Overall Study|Withdrawal by Subject|0|||
129772981|NCT01394016|467134207|FG001|Overall Study|Withdrawal by Subject|0|||
129772982|NCT01394016|467134208|FG002|Overall Study|Withdrawal by Subject|0|||
129772983|NCT01394016|467134209|FG003|Overall Study|Withdrawal by Subject|0|||
129772984|NCT01394016|467134210|FG004|Overall Study|Withdrawal by Subject|0|||
129772985|NCT01394016|467134211|FG005|Overall Study|Withdrawal by Subject|0|||
129772986|NCT01394016|467134212|FG006|Overall Study|Withdrawal by Subject|0|||
129772987|NCT01394016|467134213|FG007|Overall Study|Withdrawal by Subject|1|||
129772988|NCT01394016|467134214|FG008|Overall Study|Withdrawal by Subject|1|||
129772989|NCT01394016|467134215|FG009|Overall Study|Withdrawal by Subject|1|||
129772990|NCT01394016|467134216|FG010|Overall Study|Withdrawal by Subject|4|||
129772991|NCT01394016|467134217|FG011|Overall Study|Withdrawal by Subject|0|||
129772992|NCT01394016|467134218|FG012|Overall Study|Withdrawal by Subject|0|||
129772993|NCT01394016|467134219|FG013|Overall Study|Withdrawal by Subject|3|||
129772994|NCT01394016|467134220|FG014|Overall Study|Withdrawal by Subject|1|||
129772995|NCT01394016|467134221|FG015|Overall Study|Withdrawal by Subject|3|||
129772996|NCT01394016|467134222|FG016|Overall Study|Withdrawal by Subject|1|||
129772997|NCT01394016|467134223|FG017|Overall Study|Withdrawal by Subject|1|||
129772998|NCT01394016|467134224|FG018|Overall Study|Withdrawal by Subject|2|||
129772999|NCT01394016|467134206|FG000|Overall Study|Adverse Event|0|||
129773000|NCT01394016|467134207|FG001|Overall Study|Adverse Event|0|||
129773001|NCT01394016|467134208|FG002|Overall Study|Adverse Event|0|||
129773002|NCT01394016|467134209|FG003|Overall Study|Adverse Event|0|||
129773003|NCT01394016|467134210|FG004|Overall Study|Adverse Event|0|||
129773004|NCT01394016|467134211|FG005|Overall Study|Adverse Event|0|||
129773005|NCT01394016|467134212|FG006|Overall Study|Adverse Event|0|||
129773006|NCT01394016|467134213|FG007|Overall Study|Adverse Event|0|||
129773007|NCT01394016|467134214|FG008|Overall Study|Adverse Event|0|||
129773008|NCT01394016|467134215|FG009|Overall Study|Adverse Event|1|||
129773009|NCT01394016|467134216|FG010|Overall Study|Adverse Event|0|||
129773010|NCT01394016|467134217|FG011|Overall Study|Adverse Event|0|||
129773011|NCT01394016|467134218|FG012|Overall Study|Adverse Event|0|||
129773012|NCT01394016|467134219|FG013|Overall Study|Adverse Event|0|||
129773013|NCT01394016|467134220|FG014|Overall Study|Adverse Event|0|||
129773014|NCT01394016|467134221|FG015|Overall Study|Adverse Event|0|||
129773015|NCT01394016|467134222|FG016|Overall Study|Adverse Event|1|||
129773016|NCT01394016|467134223|FG017|Overall Study|Adverse Event|1|||
129773017|NCT01394016|467134224|FG018|Overall Study|Adverse Event|0|||
129773018|NCT01394016|467134206|FG000|Overall Study|Sponsor Decision|0|||
129773019|NCT01394016|467134207|FG001|Overall Study|Sponsor Decision|0|||
129773020|NCT01394016|467134208|FG002|Overall Study|Sponsor Decision|0|||
129773021|NCT01394016|467134209|FG003|Overall Study|Sponsor Decision|0|||
129773022|NCT01394016|467134210|FG004|Overall Study|Sponsor Decision|0|||
129773023|NCT01394016|467134211|FG005|Overall Study|Sponsor Decision|0|||
129773024|NCT01394016|467134212|FG006|Overall Study|Sponsor Decision|0|||
129773025|NCT01394016|467134213|FG007|Overall Study|Sponsor Decision|0|||
129773026|NCT01394016|467134214|FG008|Overall Study|Sponsor Decision|0|||
129773027|NCT01394016|467134215|FG009|Overall Study|Sponsor Decision|0|||
129773028|NCT01394016|467134216|FG010|Overall Study|Sponsor Decision|0|||
129773029|NCT01394016|467134217|FG011|Overall Study|Sponsor Decision|0|||
129773030|NCT01394016|467134218|FG012|Overall Study|Sponsor Decision|1|||
129773031|NCT01394016|467134219|FG013|Overall Study|Sponsor Decision|0|||
129773032|NCT01394016|467134220|FG014|Overall Study|Sponsor Decision|0|||
129773033|NCT01394016|467134221|FG015|Overall Study|Sponsor Decision|0|||
129773034|NCT01394016|467134222|FG016|Overall Study|Sponsor Decision|0|||
129773035|NCT01394016|467134223|FG017|Overall Study|Sponsor Decision|0|||
129773036|NCT01394016|467134224|FG018|Overall Study|Sponsor Decision|0|||
129773037|NCT01394016|467134206|FG000|Overall Study|Lost to Follow-up|0|||
129773038|NCT01394016|467134207|FG001|Overall Study|Lost to Follow-up|0|||
129773039|NCT01394016|467134208|FG002|Overall Study|Lost to Follow-up|0|||
129773040|NCT01394016|467134209|FG003|Overall Study|Lost to Follow-up|0|||
129773041|NCT01394016|467134210|FG004|Overall Study|Lost to Follow-up|0|||
129773042|NCT01394016|467134211|FG005|Overall Study|Lost to Follow-up|0|||
129773043|NCT01394016|467134212|FG006|Overall Study|Lost to Follow-up|0|||
129773044|NCT01394016|467134213|FG007|Overall Study|Lost to Follow-up|0|||
129773045|NCT01394016|467134214|FG008|Overall Study|Lost to Follow-up|0|||
129773046|NCT01394016|467134215|FG009|Overall Study|Lost to Follow-up|0|||
129773047|NCT01394016|467134216|FG010|Overall Study|Lost to Follow-up|0|||
129773048|NCT01394016|467134217|FG011|Overall Study|Lost to Follow-up|0|||
129773049|NCT01394016|467134218|FG012|Overall Study|Lost to Follow-up|0|||
129773050|NCT01394016|467134219|FG013|Overall Study|Lost to Follow-up|0|||
129773051|NCT01394016|467134220|FG014|Overall Study|Lost to Follow-up|0|||
129773052|NCT01394016|467134221|FG015|Overall Study|Lost to Follow-up|0|||
129773053|NCT01394016|467134222|FG016|Overall Study|Lost to Follow-up|0|||
129773054|NCT01394016|467134223|FG017|Overall Study|Lost to Follow-up|0|||
129773055|NCT01394016|467134224|FG018|Overall Study|Lost to Follow-up|1|||
129773056|NCT03534804|467134225|FG000|Overall Study|Withdrawal by Subject|1|||
129773057|NCT00174187|467134226|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
129773058|NCT00174187|467134227|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
129773059|NCT00174187|467134228|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
129773060|NCT00174187|467134226|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
129773061|NCT00174187|467134227|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
129773062|NCT00174187|467134228|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
129773063|NCT00174187|467134226|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
129773064|NCT00174187|467134227|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
129773065|NCT00174187|467134228|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
129773066|NCT00174187|467134226|FG000|Period 1 (up to 3 Years)|Other|0|||
129773067|NCT00174187|467134227|FG001|Period 1 (up to 3 Years)|Other|1|||
129773068|NCT00174187|467134228|FG002|Period 1 (up to 3 Years)|Other|0|||
129773069|NCT00174187|467134226|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
129773070|NCT00174187|467134227|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
129773071|NCT00174187|467134228|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
129773072|NCT00174187|467134226|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
129773073|NCT00174187|467134227|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
129773074|NCT00174187|467134228|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
129773075|NCT00174187|467134226|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
129773076|NCT00174187|467134227|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
129773077|NCT00174187|467134228|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
129773078|NCT00174187|467134226|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
129773079|NCT00174187|467134227|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
129773080|NCT00174187|467134228|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
129773081|NCT00174187|467134226|FG000|Period 2 (After 3 Years)|Other|0|||
129773082|NCT00174187|467134227|FG001|Period 2 (After 3 Years)|Other|0|||
129773083|NCT00174187|467134228|FG002|Period 2 (After 3 Years)|Other|5|||
129773084|NCT00759941|467134229|FG000|Overall Study|Use of medication|1|||
129773085|NCT00759941|467134230|FG001|Overall Study|Use of medication|0|||
129773086|NCT00759941|467134229|FG000|Overall Study|Adverse Event|1|||
129773087|NCT00759941|467134230|FG001|Overall Study|Adverse Event|0|||
129684543|NCT00098475|466802952|FG001|Step 1|Alternative therapy|43|||
129684544|NCT00098475|466802953|FG002|Step 1|Alternative therapy|1|||
129684545|NCT00098475|466802954|FG003|Step 1|Alternative therapy|0|||
129684546|NCT00098475|466802951|FG000|Step 1|Other disease|2|||
129684547|NCT00098475|466802952|FG001|Step 1|Other disease|1|||
129684548|NCT00098475|466802953|FG002|Step 1|Other disease|1|||
129684549|NCT00098475|466802954|FG003|Step 1|Other disease|0|||
129684550|NCT00098475|466802951|FG000|Step 1|Never started treatment|0|||
129684551|NCT00098475|466802952|FG001|Step 1|Never started treatment|2|||
129684552|NCT00098475|466802953|FG002|Step 1|Never started treatment|0|||
129684553|NCT00098475|466802954|FG003|Step 1|Never started treatment|0|||
129684554|NCT00098475|466802951|FG000|Step 1|Still on treatment as of this analysis|14|||
129684555|NCT00098475|466802952|FG001|Step 1|Still on treatment as of this analysis|27|||
129684556|NCT00098475|466802953|FG002|Step 1|Still on treatment as of this analysis|0|||
129684557|NCT00098475|466802954|FG003|Step 1|Still on treatment as of this analysis|0|||
129684558|NCT00098475|466802951|FG000|Step 1|Knee surgery|1|||
129684559|NCT00098475|466802952|FG001|Step 1|Knee surgery|0|||
129684560|NCT00098475|466802953|FG002|Step 1|Knee surgery|0|||
129684561|NCT00098475|466802954|FG003|Step 1|Knee surgery|0|||
129684562|NCT00098475|466802951|FG000|Step 1|Complications|1|||
129684563|NCT00098475|466802952|FG001|Step 1|Complications|0|||
129684564|NCT00098475|466802953|FG002|Step 1|Complications|0|||
129684565|NCT00098475|466802954|FG003|Step 1|Complications|0|||
129684566|NCT00098475|466802951|FG000|Step 1|Cannot comply due to other tx|0|||
129684567|NCT00098475|466802952|FG001|Step 1|Cannot comply due to other tx|1|||
129684568|NCT00098475|466802953|FG002|Step 1|Cannot comply due to other tx|0|||
129684569|NCT00098475|466802954|FG003|Step 1|Cannot comply due to other tx|0|||
129684570|NCT00098475|466802951|FG000|Step 1|Both patient and physician's decision|2|||
129684571|NCT00098475|466802952|FG001|Step 1|Both patient and physician's decision|1|||
129684572|NCT00098475|466802953|FG002|Step 1|Both patient and physician's decision|0|||
129684573|NCT00098475|466802954|FG003|Step 1|Both patient and physician's decision|0|||
129684574|NCT00098475|466802951|FG000|Step 1|Incorrect disease assessment|2|||
129684575|NCT00098475|466802952|FG001|Step 1|Incorrect disease assessment|0|||
129684576|NCT00098475|466802953|FG002|Step 1|Incorrect disease assessment|0|||
129684577|NCT00098475|466802954|FG003|Step 1|Incorrect disease assessment|0|||
129684578|NCT00098475|466802951|FG000|Step 1|Off treatment for > specified timeframe|1|||
129684579|NCT00098475|466802952|FG001|Step 1|Off treatment for > specified timeframe|1|||
129684580|NCT00098475|466802953|FG002|Step 1|Off treatment for > specified timeframe|0|||
129684581|NCT00098475|466802954|FG003|Step 1|Off treatment for > specified timeframe|0|||
129684582|NCT00098475|466802951|FG000|Step 1|Declining performance status|0|||
129684583|NCT00098475|466802952|FG001|Step 1|Declining performance status|1|||
129684584|NCT00098475|466802953|FG002|Step 1|Declining performance status|0|||
129773088|NCT00759941|467134229|FG000|Overall Study|Exited in error by site|1|||
129773089|NCT00759941|467134230|FG001|Overall Study|Exited in error by site|1|||
129773090|NCT06078124|467134231|FG000|Overall Study|Lost to Follow-up|14|||
129773091|NCT06078124|467134232|FG001|Overall Study|Lost to Follow-up|14|||
129773092|NCT01198977|467134233|FG000|Overall Study|Lost to Follow-up|1|||
129773093|NCT01198977|467134234|FG001|Overall Study|Lost to Follow-up|0|||
129773094|NCT01285557|467134235|FG000|Overall Study|Death|173|||
129773095|NCT01285557|467134236|FG001|Overall Study|Death|90|||
129773096|NCT01285557|467134235|FG000|Overall Study|Lost to Follow-up|6|||
129773097|NCT01285557|467134236|FG001|Overall Study|Lost to Follow-up|2|||
129773098|NCT01285557|467134235|FG000|Overall Study|Withdrew Consent|6|||
129773099|NCT01285557|467134236|FG001|Overall Study|Withdrew Consent|1|||
129773100|NCT01285557|467134235|FG000|Overall Study|Sponsor Study Termination|23|||
129773101|NCT01285557|467134236|FG001|Overall Study|Sponsor Study Termination|13|||
129773102|NCT01285557|467134235|FG000|Overall Study|Randomized but not treated|1|||
129773103|NCT01285557|467134236|FG001|Overall Study|Randomized but not treated|1|||
129773104|NCT01285557|467134235|FG000|Overall Study|Study follow-up ongoing|28|||
129773105|NCT01285557|467134236|FG001|Overall Study|Study follow-up ongoing|14|||
129773106|NCT01285557|467134235|FG000|Overall Study|Sponsor Decision|2|||
129773107|NCT01285557|467134236|FG001|Overall Study|Sponsor Decision|1|||
129773108|NCT03467750|467134237|FG000|Overall Study|Surgery canceled|1|||
129773109|NCT03467750|467134238|FG001|Overall Study|Surgery canceled|0|||
129773110|NCT03467750|467134237|FG000|Overall Study|Protocol Violation|1|||
129773111|NCT03467750|467134238|FG001|Overall Study|Protocol Violation|1|||
129773112|NCT03467750|467134237|FG000|Overall Study|Withdrawal by Subject|0|||
129773113|NCT03467750|467134238|FG001|Overall Study|Withdrawal by Subject|1|||
129773114|NCT04145349|467136005|FG000|Overall Study|Withdrawal by Subject|3|||
129773115|NCT04145349|467136006|FG001|Overall Study|Withdrawal by Subject|0|||
129773116|NCT04145349|467136005|FG000|Overall Study|Lost to Follow-up|0|||
129773117|NCT04145349|467136006|FG001|Overall Study|Lost to Follow-up|1|||
129773118|NCT04145349|467136005|FG000|Overall Study|On study treatment (Ongoing)|0|||
129773119|NCT04145349|467136006|FG001|Overall Study|On study treatment (Ongoing)|1|||
129773120|NCT01148979|467136016|FG000|Overall Study|Lost to Follow-up|0|||
129773121|NCT01148979|467136017|FG001|Overall Study|Lost to Follow-up|1|||
129773122|NCT00775190|467136018|FG000|Overall Study|Lost to Follow-up|2|||
129773123|NCT00775190|467136019|FG001|Overall Study|Lost to Follow-up|3|||
129773124|NCT00775190|467136018|FG000|Overall Study|Withdrawal by Subject|1|||
129773125|NCT00775190|467136019|FG001|Overall Study|Withdrawal by Subject|2|||
129773126|NCT00775190|467136018|FG000|Overall Study|Protocol Violation|1|||
129773127|NCT00775190|467136019|FG001|Overall Study|Protocol Violation|0|||
129773128|NCT04610281|467136024|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
129773129|NCT04610281|467136025|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
129773130|NCT00918255|467136027|FG000|Overall Study|Adverse Event|1|||
129773131|NCT00918255|467136028|FG001|Overall Study|Adverse Event|0|||
129773132|NCT00918255|467136029|FG002|Overall Study|Adverse Event|0|||
129773133|NCT00918255|467136027|FG000|Overall Study|Withdrawal by Subject|1|||
129773134|NCT00918255|467136028|FG001|Overall Study|Withdrawal by Subject|0|||
129773135|NCT00918255|467136029|FG002|Overall Study|Withdrawal by Subject|2|||
129773136|NCT00918255|467136027|FG000|Overall Study|Lack of Efficacy|1|||
129773137|NCT00918255|467136028|FG001|Overall Study|Lack of Efficacy|0|||
129773138|NCT00918255|467136029|FG002|Overall Study|Lack of Efficacy|0|||
129773139|NCT00918255|467136027|FG000|Overall Study|Lost to Follow-up|1|||
129773140|NCT00918255|467136028|FG001|Overall Study|Lost to Follow-up|0|||
129773141|NCT00918255|467136029|FG002|Overall Study|Lost to Follow-up|2|||
129773142|NCT00918255|467136027|FG000|Overall Study|Exceeded allowed number of interventions|0|||
129773143|NCT00918255|467136028|FG001|Overall Study|Exceeded allowed number of interventions|0|||
129773144|NCT00918255|467136029|FG002|Overall Study|Exceeded allowed number of interventions|1|||
129773145|NCT00918255|467136027|FG000|Overall Study|Non-compliance|1|||
129773146|NCT00918255|467136028|FG001|Overall Study|Non-compliance|0|||
129773147|NCT00918255|467136029|FG002|Overall Study|Non-compliance|0|||
129773148|NCT00918255|467136027|FG000|Overall Study|Investigator discretion|1|||
129773149|NCT00918255|467136028|FG001|Overall Study|Investigator discretion|0|||
129773150|NCT00918255|467136029|FG002|Overall Study|Investigator discretion|0|||
129773151|NCT03557034|467136030|FG000|Overall Study|Withdrawal by Subject|1|||
129773152|NCT03557034|467136031|FG001|Overall Study|Withdrawal by Subject|0|||
129773153|NCT00719472|467136032|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
129773154|NCT00719472|467136032|FG000|Enrolled in Study|Subject decision to withdraw|8|||
129773155|NCT00719472|467136032|FG000|Enrolled in Study|Various Reasons|17|||
129773156|NCT00719472|467136032|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
129773157|NCT00719472|467136032|FG000|Received Cycle 1 Treatment|Death|5|||
129773158|NCT00719472|467136032|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
129773159|NCT00719472|467136032|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
129773160|NCT00719472|467136032|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
129773161|NCT00719472|467136032|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
129773162|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
129684585|NCT00098475|466802954|FG003|Step 1|Declining performance status|0|||
129684586|NCT00098475|466802951|FG000|Step 1|Insurance issue|0|||
129684587|NCT00098475|466802952|FG001|Step 1|Insurance issue|1|||
129684588|NCT00098475|466802953|FG002|Step 1|Insurance issue|0|||
129684589|NCT00098475|466802954|FG003|Step 1|Insurance issue|0|||
129684590|NCT00098475|466802951|FG000|Step 1|Rising paraprotein|0|||
129684591|NCT00098475|466802952|FG001|Step 1|Rising paraprotein|1|||
129684592|NCT00098475|466802953|FG002|Step 1|Rising paraprotein|0|||
129684593|NCT00098475|466802954|FG003|Step 1|Rising paraprotein|0|||
129684594|NCT00098475|466802951|FG000|Step 1|Referred to other physicians|0|||
129684595|NCT00098475|466802952|FG001|Step 1|Referred to other physicians|1|||
129684596|NCT00098475|466802953|FG002|Step 1|Referred to other physicians|0|||
129684597|NCT00098475|466802954|FG003|Step 1|Referred to other physicians|0|||
129684598|NCT00098475|466802951|FG000|Step 1|Criteria to continue treatment not met|0|||
129684599|NCT00098475|466802952|FG001|Step 1|Criteria to continue treatment not met|1|||
129684600|NCT00098475|466802953|FG002|Step 1|Criteria to continue treatment not met|0|||
129684601|NCT00098475|466802954|FG003|Step 1|Criteria to continue treatment not met|0|||
129684602|NCT00098475|466802951|FG000|Step 1|Misinterpretation of lab data|0|||
129684603|NCT00098475|466802952|FG001|Step 1|Misinterpretation of lab data|1|||
129684604|NCT00098475|466802953|FG002|Step 1|Misinterpretation of lab data|0|||
129684605|NCT00098475|466802954|FG003|Step 1|Misinterpretation of lab data|0|||
129684606|NCT00098475|466802951|FG000|Step 1|Patient fell with fracture|1|||
129684607|NCT00098475|466802952|FG001|Step 1|Patient fell with fracture|0|||
129684608|NCT00098475|466802953|FG002|Step 1|Patient fell with fracture|0|||
129684609|NCT00098475|466802954|FG003|Step 1|Patient fell with fracture|0|||
129684610|NCT00098475|466802951|FG000|Step 1|Not documented|0|||
129684611|NCT00098475|466802952|FG001|Step 1|Not documented|1|||
129684612|NCT00098475|466802953|FG002|Step 1|Not documented|0|||
129684613|NCT00098475|466802954|FG003|Step 1|Not documented|0|||
129684614|NCT00098475|466802951|FG000|Step 2|Disease progression|1|||
129684615|NCT00098475|466802952|FG001|Step 2|Disease progression|4|||
129684616|NCT00098475|466802953|FG002|Step 2|Disease progression|0|||
129684617|NCT00098475|466802954|FG003|Step 2|Disease progression|0|||
129684618|NCT00098475|466802951|FG000|Step 2|Adverse Event|2|||
129684619|NCT00098475|466802952|FG001|Step 2|Adverse Event|0|||
129684620|NCT00098475|466802953|FG002|Step 2|Adverse Event|0|||
129684621|NCT00098475|466802954|FG003|Step 2|Adverse Event|0|||
129684622|NCT00098475|466802951|FG000|Step 2|Withdrawal by Subject|0|||
129684623|NCT00098475|466802952|FG001|Step 2|Withdrawal by Subject|2|||
129684624|NCT00098475|466802953|FG002|Step 2|Withdrawal by Subject|0|||
129684625|NCT00098475|466802954|FG003|Step 2|Withdrawal by Subject|0|||
129684626|NCT00098475|466802951|FG000|Step 2|Physician Decision|0|||
129684627|NCT00098475|466802952|FG001|Step 2|Physician Decision|1|||
129684628|NCT00098475|466802953|FG002|Step 2|Physician Decision|0|||
129684629|NCT00098475|466802954|FG003|Step 2|Physician Decision|0|||
129684630|NCT00098475|466802951|FG000|Step 2|Alternative therapy|1|||
129684631|NCT00098475|466802952|FG001|Step 2|Alternative therapy|2|||
129684632|NCT00098475|466802953|FG002|Step 2|Alternative therapy|0|||
129684633|NCT00098475|466802954|FG003|Step 2|Alternative therapy|0|||
129684634|NCT00098475|466802951|FG000|Step 2|Never started treatment|1|||
129684635|NCT00098475|466802952|FG001|Step 2|Never started treatment|1|||
129684636|NCT00098475|466802953|FG002|Step 2|Never started treatment|0|||
129684637|NCT00098475|466802954|FG003|Step 2|Never started treatment|0|||
129684638|NCT04132050|466802955|FG000|Period I (Double-blind Period)|Adverse Event|3|||
129684639|NCT04132050|466802956|FG001|Period I (Double-blind Period)|Adverse Event|0|||
129684640|NCT04132050|466802955|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
129684641|NCT04132050|466802956|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
129684642|NCT04132050|466802955|FG000|R788 Treatment Period|Adverse Event|5|||
129684643|NCT04132050|466802956|FG001|R788 Treatment Period|Adverse Event|0|||
129684644|NCT04132050|466802955|FG000|R788 Treatment Period|Lack of Efficacy|5|||
129684645|NCT04132050|466802956|FG001|R788 Treatment Period|Lack of Efficacy|0|||
129684646|NCT04132050|466802955|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
129684647|NCT04132050|466802956|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
129684648|NCT00433537|466802957|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
129684649|NCT00433537|466802958|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
129684650|NCT00433537|466802959|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
129684651|NCT00433537|466802957|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
129684652|NCT00433537|466802958|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
129684653|NCT00433537|466802959|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
129684654|NCT00433537|466802957|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
129684655|NCT00433537|466802958|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
129684656|NCT00433537|466802959|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
129684657|NCT00433537|466802957|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
129684658|NCT00433537|466802958|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
129684659|NCT00433537|466802959|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
129773163|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Death|6|||
129773164|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Disease progression|3|||
129773165|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
129773166|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
129773167|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
129773168|NCT00719472|467136032|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
129773169|NCT01244893|467136033|FG000|Baseline|Protocol Violation|0|||
129773170|NCT01244893|467136034|FG001|Baseline|Protocol Violation|1|||
129773171|NCT01244893|467136033|FG000|1-Week Follow Up|Lost to Follow-up|1|||
129773172|NCT01244893|467136034|FG001|1-Week Follow Up|Lost to Follow-up|0|||
129773173|NCT00357552|467136035|FG000|Screening|Did not meet eligibility criteria|84|||
129773174|NCT00357552|467136035|FG000|Weeks 0 to 24|Death|1|||
129773175|NCT00357552|467136035|FG000|Weeks 24 to 104|Death|3|||
129773176|NCT00357552|467136035|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
129773177|NCT00882557|467136038|FG000|Overall Study|Withdrawal by Subject|1|||
129773178|NCT00882557|467136039|FG001|Overall Study|Withdrawal by Subject|0|||
129773179|NCT00882557|467136038|FG000|Overall Study|Trouble with Vein Access|1|||
129773180|NCT00882557|467136039|FG001|Overall Study|Trouble with Vein Access|0|||
129773181|NCT00882557|467136038|FG000|Overall Study|Randomized Not Treated|0|||
129773182|NCT00882557|467136039|FG001|Overall Study|Randomized Not Treated|1|||
129773183|NCT03038880|467136044|FG000|Overall Study|Death|1|||
129773184|NCT03038880|467136045|FG001|Overall Study|Death|2|||
129773185|NCT03038880|467136046|FG002|Overall Study|Death|0|||
129773186|NCT03038880|467136044|FG000|Overall Study|Physician Decision|2|||
129773187|NCT03038880|467136045|FG001|Overall Study|Physician Decision|1|||
129773188|NCT03038880|467136046|FG002|Overall Study|Physician Decision|0|||
129773189|NCT00602472|467136047|FG000|Overall Study|Adverse Event|5|||
129773190|NCT00602472|467136048|FG001|Overall Study|Adverse Event|23|||
129773191|NCT00602472|467136047|FG000|Overall Study|Protocol Violation|4|||
129773192|NCT00602472|467136048|FG001|Overall Study|Protocol Violation|19|||
129773193|NCT00602472|467136047|FG000|Overall Study|Withdrawal by Subject|8|||
129773194|NCT00602472|467136048|FG001|Overall Study|Withdrawal by Subject|14|||
129773195|NCT00602472|467136047|FG000|Overall Study|Other incl. lack of efficacy|4|||
129773196|NCT00602472|467136048|FG001|Overall Study|Other incl. lack of efficacy|2|||
129773197|NCT02803580|467136049|FG000|Overall Study|Death|13|||
129773198|NCT02803580|467136049|FG000|Overall Study|Lost to Follow-up|19|||
129773199|NCT02803580|467136049|FG000|Overall Study|Withdrawal by Subject|3|||
129773200|NCT02803580|467136049|FG000|Overall Study|Inclusion in clinical trial|1|||
129773201|NCT02054104|467136054|FG000|Overall Study|Did not want to continue due to college classes|1|||
129773202|NCT02054104|467136055|FG001|Overall Study|Did not want to continue due to college classes|0|||
129773203|NCT02054104|467136054|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
129773204|NCT02054104|467136055|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
129773205|NCT02054104|467136054|FG000|Overall Study|No evidence of immunologic response|2|||
129773206|NCT02054104|467136055|FG001|Overall Study|No evidence of immunologic response|2|||
129773207|NCT02054104|467136054|FG000|Overall Study|Disease Progression On Study|4|||
129773208|NCT02054104|467136055|FG001|Overall Study|Disease Progression On Study|5|||
129773209|NCT02054104|467136054|FG000|Overall Study|Diagnosis of lymphoma|0|||
129773210|NCT02054104|467136055|FG001|Overall Study|Diagnosis of lymphoma|1|||
129773211|NCT02054104|467136054|FG000|Overall Study|Inconclusive response|0|||
129773212|NCT02054104|467136055|FG001|Overall Study|Inconclusive response|1|||
129773213|NCT00084136|467136056|FG000|PI Comparison|Death|10|||
129773214|NCT00084136|467136057|FG001|PI Comparison|Death|9|||
129773215|NCT00084136|467136058|FG002|PI Comparison|Death|0|||
129773216|NCT00084136|467136056|FG000|PI Comparison|Lost to Follow-up|11|||
129773217|NCT00084136|467136057|FG001|PI Comparison|Lost to Follow-up|8|||
129773218|NCT00084136|467136058|FG002|PI Comparison|Lost to Follow-up|0|||
129773219|NCT00084136|467136056|FG000|PI Comparison|Withdrawal by Subject|33|||
129773220|NCT00084136|467136057|FG001|PI Comparison|Withdrawal by Subject|30|||
129773221|NCT00084136|467136058|FG002|PI Comparison|Withdrawal by Subject|0|||
129773222|NCT00084136|467136056|FG000|PI Comparison|Clinic site closed|1|||
129773223|NCT00084136|467136057|FG001|PI Comparison|Clinic site closed|0|||
129773224|NCT00084136|467136058|FG002|PI Comparison|Clinic site closed|0|||
129773225|NCT00084136|467136056|FG000|NRTI Comparison|Death|20|||
129773226|NCT00084136|467136057|FG001|NRTI Comparison|Death|0|||
129773227|NCT00084136|467136058|FG002|NRTI Comparison|Death|18|||
129550790|NCT02454972|466312865|FG002|Overall Study|Multiple delay/holds on treatment|0|||
129550791|NCT02454972|466312866|FG003|Overall Study|Multiple delay/holds on treatment|1|||
129773228|NCT00084136|467136056|FG000|NRTI Comparison|Lost to Follow-up|14|||
129773229|NCT00084136|467136057|FG001|NRTI Comparison|Lost to Follow-up|0|||
129773230|NCT00084136|467136058|FG002|NRTI Comparison|Lost to Follow-up|12|||
129773231|NCT00084136|467136056|FG000|NRTI Comparison|Withdrawal by Subject|54|||
129773232|NCT00084136|467136057|FG001|NRTI Comparison|Withdrawal by Subject|0|||
129773233|NCT00084136|467136058|FG002|NRTI Comparison|Withdrawal by Subject|38|||
129773234|NCT00084136|467136056|FG000|NRTI Comparison|Clinic site closed|12|||
129773235|NCT00084136|467136057|FG001|NRTI Comparison|Clinic site closed|0|||
129773236|NCT00084136|467136058|FG002|NRTI Comparison|Clinic site closed|14|||
129773237|NCT00084136|467136056|FG000|NRTI Comparison|Not reason above|1|||
129773238|NCT00084136|467136057|FG001|NRTI Comparison|Not reason above|0|||
129773239|NCT00084136|467136058|FG002|NRTI Comparison|Not reason above|0|||
129773240|NCT00836693|467136061|FG000|Overall Study|Adverse Event|4|||
129773241|NCT00836693|467136062|FG001|Overall Study|Adverse Event|1|||
129773242|NCT00836693|467136061|FG000|Overall Study|Sponsor Decision|0|||
129773243|NCT00836693|467136062|FG001|Overall Study|Sponsor Decision|1|||
129773244|NCT00836693|467136061|FG000|Overall Study|Physician Decision|2|||
129773245|NCT00836693|467136062|FG001|Overall Study|Physician Decision|0|||
129773246|NCT00836693|467136061|FG000|Overall Study|Withdrawal by Subject|9|||
129773247|NCT00836693|467136062|FG001|Overall Study|Withdrawal by Subject|4|||
129773248|NCT00836693|467136061|FG000|Overall Study|Protocol Violation|1|||
129773249|NCT00836693|467136062|FG001|Overall Study|Protocol Violation|0|||
129773250|NCT00836693|467136061|FG000|Overall Study|Lost to Follow-up|1|||
129773251|NCT00836693|467136062|FG001|Overall Study|Lost to Follow-up|0|||
129773252|NCT02612779|467136063|FG000|Overall Study|Administrative reason by sponsor|4|||
129773253|NCT02612779|467136064|FG001|Overall Study|Administrative reason by sponsor|1|||
129773254|NCT02612779|467136063|FG000|Overall Study|No longer meet study criteria|0|||
129773255|NCT02612779|467136064|FG001|Overall Study|No longer meet study criteria|1|||
129773256|NCT02612779|467136063|FG000|Overall Study|Disease progression|29|||
129773257|NCT02612779|467136064|FG001|Overall Study|Disease progression|2|||
129773258|NCT02612779|467136063|FG000|Overall Study|Study drug toxicity|10|||
129773259|NCT02612779|467136064|FG001|Overall Study|Study drug toxicity|1|||
129773260|NCT02612779|467136063|FG000|Overall Study|Death|1|||
129773261|NCT02612779|467136064|FG001|Overall Study|Death|0|||
129773262|NCT02612779|467136063|FG000|Overall Study|Adverse event unrelated to study drug|5|||
129773263|NCT02612779|467136064|FG001|Overall Study|Adverse event unrelated to study drug|0|||
129773264|NCT02612779|467136063|FG000|Overall Study|Participant withdrew consent|4|||
129773265|NCT02612779|467136064|FG001|Overall Study|Participant withdrew consent|0|||
129773266|NCT02612779|467136063|FG000|Overall Study|Lost to Follow-up|1|||
129773267|NCT02612779|467136064|FG001|Overall Study|Lost to Follow-up|0|||
129773268|NCT02612779|467136063|FG000|Overall Study|Maximum clinical benefit|10|||
129773269|NCT02612779|467136064|FG001|Overall Study|Maximum clinical benefit|1|||
129773270|NCT02612779|467136063|FG000|Overall Study|Other reasons|4|||
129773271|NCT02612779|467136064|FG001|Overall Study|Other reasons|0|||
129773272|NCT01657019|467136065|FG000|Overall Study|Withdrawal by Subject|65|||
129773273|NCT01657019|467136065|FG000|Overall Study|Adverse Event|55|||
129773274|NCT01657019|467136065|FG000|Overall Study|Lost to Follow-up|48|||
129773275|NCT01657019|467136065|FG000|Overall Study|Protocol Violation|6|||
129773276|NCT01657019|467136065|FG000|Overall Study|Lack of Efficacy|3|||
129773277|NCT01657019|467136065|FG000|Overall Study|Other|58|||
129773278|NCT01750229|467136068|FG000|Randomized Crossover Phase|Adverse Event|1|||
129773279|NCT01750229|467136068|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
129773280|NCT01750229|467136068|FG000|Long-term Follow-up Phase|Adverse Event|2|||
129773281|NCT01750229|467136068|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
129773282|NCT02346721|467136069|FG000|Overall Study|Withdrew Consent|3|||
129773283|NCT02346721|467136069|FG000|Overall Study|Lack of Efficacy|1|||
129773284|NCT03809104|467136070|FG000|Overall Study|Withdrawal by Subject|3|||
129773285|NCT02968004|467136071|FG000|Main Study Phase|Adverse Event|1|||
129773286|NCT02968004|467136072|FG001|Main Study Phase|Adverse Event|0|||
129773287|NCT02968004|467136071|FG000|Main Study Phase|Withdrawal by Subject|0|||
129773288|NCT02968004|467136072|FG001|Main Study Phase|Withdrawal by Subject|1|||
129773289|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
129773290|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
129773291|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
129773292|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
129773293|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
129773294|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
129773295|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
129773296|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
129773297|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
129773298|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
129773299|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
129773300|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
129773301|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
129773302|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
129773303|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
129773304|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
129773305|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
129773306|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
129773307|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
129773308|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
129773309|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
129773310|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
129773311|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
129773312|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
129773313|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
129773314|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
129773315|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
129773316|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
129773317|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
129773318|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
129773319|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
129773320|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
129773321|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
129773322|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
129773323|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
129773324|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
129773325|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
129773326|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
129773327|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
129773328|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
129773329|NCT02968004|467136071|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
129773330|NCT02968004|467136072|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
129773331|NCT00885170|467136083|FG000|Overall Study|Adverse Event|12|||
129773332|NCT00885170|467136084|FG001|Overall Study|Adverse Event|4|||
129773333|NCT00885170|467136083|FG000|Overall Study|Excessive bone loss|6|||
129773334|NCT00885170|467136084|FG001|Overall Study|Excessive bone loss|3|||
129773335|NCT00885170|467136083|FG000|Overall Study|Lost to Follow-up|2|||
129773336|NCT00885170|467136084|FG001|Overall Study|Lost to Follow-up|1|||
129773337|NCT00885170|467136083|FG000|Overall Study|Physician Decision|2|||
129773338|NCT00885170|467136084|FG001|Overall Study|Physician Decision|1|||
129773339|NCT00885170|467136083|FG000|Overall Study|Protocol Violation|3|||
129773340|NCT00885170|467136084|FG001|Overall Study|Protocol Violation|1|||
129773341|NCT00885170|467136083|FG000|Overall Study|Withdrawal by Subject|13|||
129773342|NCT00885170|467136084|FG001|Overall Study|Withdrawal by Subject|13|||
129773343|NCT03771664|467136085|FG000|Overall Study|Adverse Event|1|||
129773344|NCT03771664|467136086|FG001|Overall Study|Adverse Event|0|||
129773345|NCT03771664|467136085|FG000|Overall Study|Lost to Follow-up|1|||
129773346|NCT03771664|467136086|FG001|Overall Study|Lost to Follow-up|0|||
129773347|NCT03771664|467136085|FG000|Overall Study|Withdrawal by Participant|1|||
129773348|NCT03771664|467136086|FG001|Overall Study|Withdrawal by Participant|4|||
129773349|NCT03771664|467136085|FG000|Overall Study|Randomized but not Treated|0|||
129773350|NCT03771664|467136086|FG001|Overall Study|Randomized but not Treated|1|||
129773351|NCT00561925|467136087|FG000|14 Day Lead-In Period|Adverse Event|38|||
129773352|NCT00561925|467136088|FG001|14 Day Lead-In Period|Adverse Event|0|||
129773353|NCT00561925|467136089|FG002|14 Day Lead-In Period|Adverse Event|0|||
129773354|NCT00561925|467136090|FG003|14 Day Lead-In Period|Adverse Event|0|||
129773355|NCT00561925|467136091|FG004|14 Day Lead-In Period|Adverse Event|0|||
129773356|NCT00561925|467136087|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
129773357|NCT00561925|467136088|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
129773358|NCT00561925|467136089|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
129773359|NCT00561925|467136090|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
129773360|NCT00561925|467136091|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
129773361|NCT00561925|467136087|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
129773362|NCT00561925|467136088|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
129773363|NCT00561925|467136089|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
129773364|NCT00561925|467136090|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
129773365|NCT00561925|467136091|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
129773366|NCT00561925|467136087|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
129773367|NCT00561925|467136088|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
129773368|NCT00561925|467136089|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
129773369|NCT00561925|467136090|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
129773370|NCT00561925|467136091|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
129773371|NCT00561925|467136087|FG000|14 Day Lead-In Period|Other|5|||
129773372|NCT00561925|467136088|FG001|14 Day Lead-In Period|Other|0|||
129773373|NCT00561925|467136089|FG002|14 Day Lead-In Period|Other|0|||
129773374|NCT00561925|467136090|FG003|14 Day Lead-In Period|Other|0|||
129773375|NCT00561925|467136091|FG004|14 Day Lead-In Period|Other|0|||
129773376|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
129773377|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
129773378|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
129773379|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
129773380|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
129773381|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
129773382|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
129773383|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
129773384|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
129773385|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
129773386|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
129773387|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
129773388|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
129773389|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
129773390|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
129773391|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
129773392|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
129773393|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
129773394|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
129773395|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
129773396|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
129773397|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
129773398|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
129773399|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
129773400|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
129773401|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
129773402|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
129773403|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
129773404|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
129773405|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
129773406|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Death|0|||
129773407|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Death|6|||
129773408|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Death|3|||
129773409|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Death|0|||
129773410|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Death|0|||
129773411|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
129773412|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
129773413|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
129773414|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
129773415|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
129773416|NCT00561925|467136087|FG000|144-week Double-blind, Double-dummy|Other|0|||
129773417|NCT00561925|467136088|FG001|144-week Double-blind, Double-dummy|Other|8|||
129773418|NCT00561925|467136089|FG002|144-week Double-blind, Double-dummy|Other|11|||
129773419|NCT00561925|467136090|FG003|144-week Double-blind, Double-dummy|Other|0|||
129773420|NCT00561925|467136091|FG004|144-week Double-blind, Double-dummy|Other|0|||
129773421|NCT00561925|467136087|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
129773422|NCT00561925|467136088|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
129773423|NCT00561925|467136089|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
129773424|NCT00561925|467136090|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
129773425|NCT00561925|467136091|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
129773426|NCT00891904|467136092|FG000|Overall Study|Death|1|||
129773427|NCT00891904|467136092|FG000|Overall Study|Adverse Event|1|||
129773428|NCT05021978|467136093|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
129773429|NCT05021978|467136094|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
129773430|NCT05021978|467136095|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
129773431|NCT05021978|467136096|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
129773432|NCT05021978|467136093|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
129773433|NCT05021978|467136094|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
129773434|NCT05021978|467136095|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
129773435|NCT05021978|467136096|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
129773436|NCT03096288|467136098|FG000|Overall Study|Withdrawal by Subject|0|||
129773437|NCT03096288|467136099|FG001|Overall Study|Withdrawal by Subject|1|||
129773438|NCT03096288|467136100|FG002|Overall Study|Withdrawal by Subject|0|||
129773439|NCT03096288|467136101|FG003|Overall Study|Withdrawal by Subject|1|||
129773440|NCT04639258|467136106|FG000|Overall Study|Screen failure|5|||
129773441|NCT04639258|467136106|FG000|Overall Study|Physician Decision|2|||
129773442|NCT04639258|467136106|FG000|Overall Study|Early study termination|3|||
129773443|NCT04639258|467136106|FG000|Overall Study|Withdrawal by Subject|1|||
129773444|NCT02819804|467136108|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
129773445|NCT01782378|467136109|FG000|First Series|Lost to Follow-up|7|||
129773446|NCT01782378|467136110|FG001|First Series|Lost to Follow-up|8|||
129773447|NCT01782378|467136109|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
129773448|NCT01782378|467136110|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
129773449|NCT01782378|467136109|FG000|Second Series|Lost to Follow-up|8|||
129773450|NCT01782378|467136110|FG001|Second Series|Lost to Follow-up|7|||
129773451|NCT01782378|467136109|FG000|Second Series|Did not choose to complete S2 Optional|18|||
129773452|NCT01782378|467136110|FG001|Second Series|Did not choose to complete S2 Optional|0|||
129773453|NCT03815929|467136113|FG000|Overall Study|Lost to Follow-up|2|||
129773454|NCT03815929|467136114|FG001|Overall Study|Lost to Follow-up|1|||
129773455|NCT03815929|467136115|FG002|Overall Study|Lost to Follow-up|0|||
129773456|NCT03815929|467136113|FG000|Overall Study|Physician Decision|2|||
129773457|NCT03815929|467136114|FG001|Overall Study|Physician Decision|2|||
129773458|NCT03815929|467136115|FG002|Overall Study|Physician Decision|0|||
129773459|NCT03815929|467136113|FG000|Overall Study|Withdrawal by Subject|0|||
129773460|NCT03815929|467136114|FG001|Overall Study|Withdrawal by Subject|0|||
129773461|NCT03815929|467136115|FG002|Overall Study|Withdrawal by Subject|1|||
129773462|NCT02205736|467136116|FG000|Overall Study|Lost to Follow-up|106|||
129773463|NCT05615922|467136122|FG000|Overall Study|Lost to Follow-up|1|||
129773464|NCT03173248|467136126|FG000|Overall Study|Death|28|||
129773465|NCT03173248|467136127|FG001|Overall Study|Death|46|||
129773466|NCT03173248|467136126|FG000|Overall Study|Lost to Follow-up|0|||
129773467|NCT03173248|467136127|FG001|Overall Study|Lost to Follow-up|1|||
129773468|NCT03173248|467136126|FG000|Overall Study|Withdrawal by Subject|6|||
129773469|NCT03173248|467136127|FG001|Overall Study|Withdrawal by Subject|4|||
129773470|NCT03173248|467136126|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
129773471|NCT03173248|467136127|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
129773472|NCT02991768|467136129|FG000|Overall Study|Physician Decision|4|||
129773473|NCT04500158|467136132|FG000|Overall Study|Physician Decision|17|||
129773474|NCT04500158|467136133|FG001|Overall Study|Physician Decision|11|||
129773475|NCT02807402|467136136|FG000|Overall Study|Failure to Return|1|||
129773476|NCT02807402|467136136|FG000|Overall Study|Death|3|||
129773477|NCT02807402|467136136|FG000|Overall Study|Other|2|||
129773478|NCT04922216|467136138|FG000|Overall Study|Withdrawal by Subject|0|||
129773479|NCT04922216|467136139|FG001|Overall Study|Withdrawal by Subject|1|||
129773480|NCT04922216|467136140|FG002|Overall Study|Withdrawal by Subject|0|||
129773481|NCT04922216|467136141|FG003|Overall Study|Withdrawal by Subject|0|||
129773482|NCT04922216|467136142|FG004|Overall Study|Withdrawal by Subject|0|||
129773483|NCT04922216|467136143|FG005|Overall Study|Withdrawal by Subject|0|||
129773484|NCT04922216|467136144|FG006|Overall Study|Withdrawal by Subject|0|||
129773485|NCT04922216|467136145|FG007|Overall Study|Withdrawal by Subject|2|||
129773486|NCT04922216|467136146|FG008|Overall Study|Withdrawal by Subject|0|||
129773487|NCT04922216|467136147|FG009|Overall Study|Withdrawal by Subject|0|||
129773488|NCT04922216|467136148|FG010|Overall Study|Withdrawal by Subject|0|||
129773489|NCT04922216|467136149|FG011|Overall Study|Withdrawal by Subject|0|||
129773490|NCT04922216|467136150|FG012|Overall Study|Withdrawal by Subject|1|||
129773491|NCT04922216|467136151|FG013|Overall Study|Withdrawal by Subject|1|||
129773492|NCT04922216|467136152|FG014|Overall Study|Withdrawal by Subject|1|||
129773493|NCT04922216|467136153|FG015|Overall Study|Withdrawal by Subject|0|||
129773494|NCT04922216|467136154|FG016|Overall Study|Withdrawal by Subject|0|||
129773495|NCT04922216|467136155|FG017|Overall Study|Withdrawal by Subject|1|||
129773496|NCT04922216|467136156|FG018|Overall Study|Withdrawal by Subject|1|||
129773497|NCT04922216|467136157|FG019|Overall Study|Withdrawal by Subject|1|||
129773498|NCT04922216|467136158|FG020|Overall Study|Withdrawal by Subject|1|||
129773499|NCT04922216|467136159|FG021|Overall Study|Withdrawal by Subject|0|||
129773500|NCT04922216|467136160|FG022|Overall Study|Withdrawal by Subject|0|||
129773501|NCT04922216|467136161|FG023|Overall Study|Withdrawal by Subject|2|||
129773502|NCT04922216|467136162|FG024|Overall Study|Withdrawal by Subject|0|||
129773503|NCT04922216|467136163|FG025|Overall Study|Withdrawal by Subject|0|||
129773504|NCT04922216|467136164|FG026|Overall Study|Withdrawal by Subject|1|||
129773505|NCT04922216|467136165|FG027|Overall Study|Withdrawal by Subject|0|||
129773506|NCT04922216|467136166|FG028|Overall Study|Withdrawal by Subject|0|||
129773507|NCT04922216|467136167|FG029|Overall Study|Withdrawal by Subject|0|||
129773508|NCT04922216|467136168|FG030|Overall Study|Withdrawal by Subject|1|||
129773509|NCT04922216|467136169|FG031|Overall Study|Withdrawal by Subject|0|||
129773510|NCT04922216|467136138|FG000|Overall Study|Lost to Follow-up|1|||
129773511|NCT04922216|467136139|FG001|Overall Study|Lost to Follow-up|0|||
129773512|NCT04922216|467136140|FG002|Overall Study|Lost to Follow-up|2|||
129773513|NCT04922216|467136141|FG003|Overall Study|Lost to Follow-up|0|||
129773514|NCT04922216|467136142|FG004|Overall Study|Lost to Follow-up|0|||
129773515|NCT04922216|467136143|FG005|Overall Study|Lost to Follow-up|2|||
129773516|NCT04922216|467136144|FG006|Overall Study|Lost to Follow-up|0|||
129773517|NCT04922216|467136145|FG007|Overall Study|Lost to Follow-up|1|||
129773518|NCT04922216|467136146|FG008|Overall Study|Lost to Follow-up|1|||
129773519|NCT04922216|467136147|FG009|Overall Study|Lost to Follow-up|2|||
129773520|NCT04922216|467136148|FG010|Overall Study|Lost to Follow-up|2|||
129773521|NCT04922216|467136149|FG011|Overall Study|Lost to Follow-up|1|||
129773522|NCT04922216|467136150|FG012|Overall Study|Lost to Follow-up|1|||
129773523|NCT04922216|467136151|FG013|Overall Study|Lost to Follow-up|0|||
129773524|NCT04922216|467136152|FG014|Overall Study|Lost to Follow-up|1|||
129773525|NCT04922216|467136153|FG015|Overall Study|Lost to Follow-up|0|||
129773526|NCT04922216|467136154|FG016|Overall Study|Lost to Follow-up|0|||
129773527|NCT04922216|467136155|FG017|Overall Study|Lost to Follow-up|2|||
129773528|NCT04922216|467136156|FG018|Overall Study|Lost to Follow-up|1|||
129773529|NCT04922216|467136157|FG019|Overall Study|Lost to Follow-up|0|||
129773530|NCT04922216|467136158|FG020|Overall Study|Lost to Follow-up|1|||
129773531|NCT04922216|467136159|FG021|Overall Study|Lost to Follow-up|0|||
129773532|NCT04922216|467136160|FG022|Overall Study|Lost to Follow-up|2|||
129773533|NCT04922216|467136161|FG023|Overall Study|Lost to Follow-up|1|||
129773534|NCT04922216|467136162|FG024|Overall Study|Lost to Follow-up|0|||
129773535|NCT04922216|467136163|FG025|Overall Study|Lost to Follow-up|2|||
129773536|NCT04922216|467136164|FG026|Overall Study|Lost to Follow-up|0|||
129773537|NCT04922216|467136165|FG027|Overall Study|Lost to Follow-up|0|||
129773538|NCT04922216|467136166|FG028|Overall Study|Lost to Follow-up|1|||
129773539|NCT04922216|467136167|FG029|Overall Study|Lost to Follow-up|0|||
129773540|NCT04922216|467136168|FG030|Overall Study|Lost to Follow-up|2|||
129773541|NCT04922216|467136169|FG031|Overall Study|Lost to Follow-up|1|||
129773542|NCT04801420|467136170|FG000|Overall Study|Other|1|||
129773543|NCT04801420|467136171|FG001|Overall Study|Other|2|||
129773544|NCT04801420|467136172|FG002|Overall Study|Other|1|||
129773545|NCT04801420|467136170|FG000|Overall Study|Lost to Follow-up|7|||
129773546|NCT04801420|467136171|FG001|Overall Study|Lost to Follow-up|9|||
129773547|NCT04801420|467136172|FG002|Overall Study|Lost to Follow-up|10|||
129773548|NCT04801420|467136170|FG000|Overall Study|Moved from study area|0|||
129773549|NCT04801420|467136171|FG001|Overall Study|Moved from study area|1|||
129773550|NCT04801420|467136172|FG002|Overall Study|Moved from study area|1|||
129773551|NCT04801420|467136170|FG000|Overall Study|Withdrawal by Subject|5|||
129773552|NCT04801420|467136171|FG001|Overall Study|Withdrawal by Subject|1|||
129773553|NCT04801420|467136172|FG002|Overall Study|Withdrawal by Subject|4|||
129773554|NCT04801420|467136170|FG000|Overall Study|Individual stopping criteria reached|0|||
129773555|NCT04801420|467136171|FG001|Overall Study|Individual stopping criteria reached|1|||
129773556|NCT04801420|467136172|FG002|Overall Study|Individual stopping criteria reached|0|||
129773557|NCT04801420|467136170|FG000|Overall Study|Ongoing in the study|195|||
129773558|NCT04801420|467136171|FG001|Overall Study|Ongoing in the study|195|||
129773559|NCT04801420|467136172|FG002|Overall Study|Ongoing in the study|192|||
129773560|NCT04774094|467136173|FG000|Overall Study|Other|2|||
129773561|NCT04774094|467136173|FG000|Overall Study|Withdrawal by Subject|9|||
129773562|NCT04774094|467136173|FG000|Overall Study|Lost to Follow-up|7|||
129773563|NCT04774094|467136173|FG000|Overall Study|Lack of Efficacy|5|||
129773564|NCT04774094|467136173|FG000|Overall Study|Death|17|||
129773565|NCT04774094|467136173|FG000|Overall Study|Adverse Event|4|||
129773566|NCT01646125|467138050|FG000|Overall Study|Untreated|2|||
129773567|NCT01646125|467138051|FG001|Overall Study|Untreated|5|||
129773568|NCT01646125|467138050|FG000|Overall Study|Adverse Event|2|||
129773569|NCT01646125|467138051|FG001|Overall Study|Adverse Event|1|||
129773570|NCT01646125|467138050|FG000|Overall Study|Death|1|||
129773571|NCT01646125|467138051|FG001|Overall Study|Death|1|||
129773572|NCT01646125|467138050|FG000|Overall Study|Physician Decision|1|||
129773573|NCT01646125|467138051|FG001|Overall Study|Physician Decision|3|||
129773574|NCT01646125|467138050|FG000|Overall Study|Progressive disease|22|||
129773575|NCT01646125|467138051|FG001|Overall Study|Progressive disease|16|||
129773576|NCT01646125|467138050|FG000|Overall Study|Study terminated by sponsor|2|||
129773577|NCT01646125|467138051|FG001|Overall Study|Study terminated by sponsor|1|||
129773578|NCT01646125|467138050|FG000|Overall Study|Subject/Guardian decision|1|||
129773579|NCT01646125|467138051|FG001|Overall Study|Subject/Guardian decision|1|||
129773580|NCT01376804|467138052|FG000|Treatment Period|Withdrawal by Subject|1|||
129773581|NCT01376804|467138052|FG000|Treatment Period|Adverse Event|6|||
129773582|NCT01376804|467138052|FG000|Treatment Period|Patient did not receive study drug|1|||
129773583|NCT01357850|467138053|FG000|Overall Study|Lost to Follow-up|1|||
129773584|NCT01357850|467138054|FG001|Overall Study|Lost to Follow-up|0|||
129773585|NCT01357850|467138055|FG002|Overall Study|Lost to Follow-up|0|||
129773586|NCT01357850|467138056|FG003|Overall Study|Lost to Follow-up|0|||
129773587|NCT00753506|467138059|FG000|Overall Study|Withdrawal by Subject|4|||
129773588|NCT00753506|467138060|FG001|Overall Study|Withdrawal by Subject|1|||
129773589|NCT00753506|467138059|FG000|Overall Study|Lost to Follow-up|2|||
129773590|NCT00753506|467138060|FG001|Overall Study|Lost to Follow-up|0|||
129773591|NCT00753506|467138059|FG000|Overall Study|Other reason|1|||
129773592|NCT00753506|467138060|FG001|Overall Study|Other reason|1|||
129773593|NCT01600716|467138061|FG000|Overall Study|Other Reasons|3|||
129773594|NCT01600716|467138062|FG001|Overall Study|Other Reasons|1|||
129773595|NCT01600716|467138061|FG000|Overall Study|Personal Reasons|0|||
129773596|NCT01600716|467138062|FG001|Overall Study|Personal Reasons|2|||
129773597|NCT01600716|467138061|FG000|Overall Study|Lost to Follow-up|0|||
129773598|NCT01600716|467138062|FG001|Overall Study|Lost to Follow-up|2|||
129773599|NCT01600716|467138061|FG000|Overall Study|Pregnancy|1|||
129773600|NCT01600716|467138062|FG001|Overall Study|Pregnancy|0|||
129773601|NCT01600716|467138061|FG000|Overall Study|Lack of Efficacy|2|||
129773602|NCT01600716|467138062|FG001|Overall Study|Lack of Efficacy|1|||
129773603|NCT01600716|467138061|FG000|Overall Study|Adverse Event|1|||
129773604|NCT01600716|467138062|FG001|Overall Study|Adverse Event|1|||
129773605|NCT03926611|467138066|FG000|Overall Study|Adverse Event|0|||
129773606|NCT03926611|467138067|FG001|Overall Study|Adverse Event|0|||
129773607|NCT03926611|467138068|FG002|Overall Study|Adverse Event|0|||
129684660|NCT00433537|466802957|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
129684661|NCT00433537|466802958|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
129684662|NCT00433537|466802959|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
129684663|NCT00433537|466802957|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
129684664|NCT00433537|466802958|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
129684665|NCT00433537|466802959|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
129684666|NCT00433537|466802957|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
129684667|NCT00433537|466802958|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
129684668|NCT00433537|466802959|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
129684669|NCT00433537|466802957|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
129684670|NCT00433537|466802958|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
129684671|NCT00433537|466802959|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
129684672|NCT00433537|466802957|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
129684673|NCT00433537|466802958|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
129684674|NCT00433537|466802959|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
129684675|NCT00843882|466802960|FG000|Step 1|Lack of Efficacy|14|||
129684676|NCT00843882|466802961|FG001|Step 1|Lack of Efficacy|10|||
129684677|NCT00843882|466802962|FG002|Step 1|Lack of Efficacy|21|||
129684678|NCT00843882|466802960|FG000|Step 1|Adverse Event|8|||
129684679|NCT00843882|466802961|FG001|Step 1|Adverse Event|17|||
129684680|NCT00843882|466802962|FG002|Step 1|Adverse Event|20|||
129684681|NCT00843882|466802960|FG000|Step 1|Death|1|||
129684682|NCT00843882|466802961|FG001|Step 1|Death|2|||
129684683|NCT00843882|466802962|FG002|Step 1|Death|4|||
129684684|NCT00843882|466802960|FG000|Step 1|Withdrawal by Subject|6|||
129684685|NCT00843882|466802961|FG001|Step 1|Withdrawal by Subject|12|||
129684686|NCT00843882|466802962|FG002|Step 1|Withdrawal by Subject|9|||
129684687|NCT00843882|466802960|FG000|Step 1|Physician Decision|0|||
129684688|NCT00843882|466802961|FG001|Step 1|Physician Decision|5|||
129684689|NCT00843882|466802962|FG002|Step 1|Physician Decision|1|||
129684690|NCT00843882|466802960|FG000|Step 1|Patient and physician's decision|0|||
129684691|NCT00843882|466802961|FG001|Step 1|Patient and physician's decision|0|||
129684692|NCT00843882|466802962|FG002|Step 1|Patient and physician's decision|1|||
129684693|NCT00843882|466802960|FG000|Step 1|Other complicating disease|1|||
129684694|NCT00843882|466802961|FG001|Step 1|Other complicating disease|3|||
129684695|NCT00843882|466802962|FG002|Step 1|Other complicating disease|4|||
129684696|NCT00843882|466802960|FG000|Step 1|Alternative therapy|0|||
129684697|NCT00843882|466802961|FG001|Step 1|Alternative therapy|1|||
129684698|NCT00843882|466802962|FG002|Step 1|Alternative therapy|1|||
129684699|NCT00843882|466802960|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
129684700|NCT00843882|466802961|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
129684701|NCT00843882|466802962|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
129684702|NCT00843882|466802960|FG000|Step 1|Off treatment reason unknown|0|||
129684703|NCT00843882|466802961|FG001|Step 1|Off treatment reason unknown|1|||
129684704|NCT00843882|466802962|FG002|Step 1|Off treatment reason unknown|4|||
129684705|NCT00843882|466802960|FG000|Step 1|Never started treatment|2|||
129684706|NCT00843882|466802961|FG001|Step 1|Never started treatment|0|||
129684707|NCT00843882|466802962|FG002|Step 1|Never started treatment|0|||
129684708|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
129684709|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
129684710|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
129684711|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
129684712|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
129684713|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
129684714|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
129684715|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
129684716|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
129684717|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
129684718|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
129684719|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
129684720|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
129684721|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
129684722|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
129684723|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
129684724|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
129684725|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
129684726|NCT00843882|466802960|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
129684727|NCT00843882|466802961|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
129684728|NCT00843882|466802962|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
129684729|NCT05317546|466802963|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
129684730|NCT05317546|466802964|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
129773608|NCT03926611|467138069|FG003|Overall Study|Adverse Event|3|||
129684731|NCT03331250|466802965|FG000|Overall Study|Withdrawal by Subject|1|||
129773609|NCT03926611|467138070|FG004|Overall Study|Adverse Event|1|||
129773610|NCT03926611|467138071|FG005|Overall Study|Adverse Event|3|||
129773611|NCT03926611|467138072|FG006|Overall Study|Adverse Event|0|||
129773612|NCT03926611|467138066|FG000|Overall Study|Lack of Efficacy|1|||
129773613|NCT03926611|467138067|FG001|Overall Study|Lack of Efficacy|2|||
129773614|NCT03926611|467138068|FG002|Overall Study|Lack of Efficacy|0|||
129773615|NCT03926611|467138069|FG003|Overall Study|Lack of Efficacy|0|||
129773616|NCT03926611|467138070|FG004|Overall Study|Lack of Efficacy|1|||
129773617|NCT03926611|467138071|FG005|Overall Study|Lack of Efficacy|0|||
129773618|NCT03926611|467138072|FG006|Overall Study|Lack of Efficacy|1|||
129773619|NCT03926611|467138066|FG000|Overall Study|Physician Decision|0|||
129773620|NCT03926611|467138067|FG001|Overall Study|Physician Decision|0|||
129773621|NCT03926611|467138068|FG002|Overall Study|Physician Decision|0|||
129773622|NCT03926611|467138069|FG003|Overall Study|Physician Decision|0|||
129773623|NCT03926611|467138070|FG004|Overall Study|Physician Decision|0|||
129773624|NCT03926611|467138071|FG005|Overall Study|Physician Decision|1|||
129773625|NCT03926611|467138072|FG006|Overall Study|Physician Decision|0|||
129773626|NCT03926611|467138066|FG000|Overall Study|Protocol Violation|1|||
129773627|NCT03926611|467138067|FG001|Overall Study|Protocol Violation|0|||
129773628|NCT03926611|467138068|FG002|Overall Study|Protocol Violation|0|||
129773629|NCT03926611|467138069|FG003|Overall Study|Protocol Violation|1|||
129773630|NCT03926611|467138070|FG004|Overall Study|Protocol Violation|1|||
129773631|NCT03926611|467138071|FG005|Overall Study|Protocol Violation|1|||
129773632|NCT03926611|467138072|FG006|Overall Study|Protocol Violation|1|||
129773633|NCT03926611|467138066|FG000|Overall Study|Technical problems|0|||
129773634|NCT03926611|467138067|FG001|Overall Study|Technical problems|0|||
129773635|NCT03926611|467138068|FG002|Overall Study|Technical problems|0|||
129773636|NCT03926611|467138069|FG003|Overall Study|Technical problems|0|||
129773637|NCT03926611|467138070|FG004|Overall Study|Technical problems|0|||
129773638|NCT03926611|467138071|FG005|Overall Study|Technical problems|1|||
129773639|NCT03926611|467138072|FG006|Overall Study|Technical problems|0|||
129773640|NCT03926611|467138066|FG000|Overall Study|Withdrawal by Subject|1|||
129773641|NCT03926611|467138067|FG001|Overall Study|Withdrawal by Subject|1|||
129773642|NCT03926611|467138068|FG002|Overall Study|Withdrawal by Subject|1|||
129773643|NCT03926611|467138069|FG003|Overall Study|Withdrawal by Subject|0|||
129773644|NCT03926611|467138070|FG004|Overall Study|Withdrawal by Subject|0|||
129773645|NCT03926611|467138071|FG005|Overall Study|Withdrawal by Subject|1|||
129773646|NCT03926611|467138072|FG006|Overall Study|Withdrawal by Subject|3|||
129773647|NCT03926611|467138066|FG000|Overall Study|Covid-19 pandemic|0|||
129773648|NCT03926611|467138067|FG001|Overall Study|Covid-19 pandemic|0|||
129773649|NCT03926611|467138068|FG002|Overall Study|Covid-19 pandemic|1|||
129773650|NCT03926611|467138069|FG003|Overall Study|Covid-19 pandemic|0|||
129773651|NCT03926611|467138070|FG004|Overall Study|Covid-19 pandemic|1|||
129773652|NCT03926611|467138071|FG005|Overall Study|Covid-19 pandemic|2|||
129773653|NCT03926611|467138072|FG006|Overall Study|Covid-19 pandemic|0|||
129773654|NCT02230670|467138075|FG000|Overall Study|Adverse Event|1|||
129773655|NCT02230670|467138076|FG001|Overall Study|Adverse Event|2|||
129773656|NCT02230670|467138075|FG000|Overall Study|Withdrawal by Subject|2|||
129773657|NCT02230670|467138076|FG001|Overall Study|Withdrawal by Subject|2|||
129773658|NCT02230670|467138075|FG000|Overall Study|Physician Decision|0|||
129773659|NCT02230670|467138076|FG001|Overall Study|Physician Decision|1|||
129773660|NCT02230670|467138075|FG000|Overall Study|Protocol Violation|0|||
129773661|NCT02230670|467138076|FG001|Overall Study|Protocol Violation|1|||
129773662|NCT02230670|467138075|FG000|Overall Study|Progression to Child-Pugh C|1|||
129773663|NCT02230670|467138076|FG001|Overall Study|Progression to Child-Pugh C|2|||
129773664|NCT03722238|467138077|FG000|Overall Study|Protocol Violation|1|||
129773665|NCT03722238|467138078|FG001|Overall Study|Protocol Violation|0|||
129773666|NCT03722238|467138077|FG000|Overall Study|Physician Decision|1|||
129773667|NCT03722238|467138078|FG001|Overall Study|Physician Decision|0|||
129773668|NCT03722238|467138077|FG000|Overall Study|Death|1|||
129773669|NCT03722238|467138078|FG001|Overall Study|Death|0|||
129773670|NCT03722238|467138077|FG000|Overall Study|Lost to Follow-up|6|||
129773671|NCT03722238|467138078|FG001|Overall Study|Lost to Follow-up|0|||
129773672|NCT03722238|467138077|FG000|Overall Study|Partial missing data|44|||
129773673|NCT03722238|467138078|FG001|Overall Study|Partial missing data|1|||
129773674|NCT03722238|467138077|FG000|Overall Study|Withdrawal by Subject|2|||
129773675|NCT03722238|467138078|FG001|Overall Study|Withdrawal by Subject|0|||
129773676|NCT03722238|467138077|FG000|Overall Study|Other|4|||
129773677|NCT03722238|467138078|FG001|Overall Study|Other|0|||
129773678|NCT03722238|467138077|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
129773679|NCT03722238|467138078|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
129773680|NCT03722238|467138077|FG000|Overall Study|Did not meet risk classification group criteria|90|||
129773681|NCT03722238|467138078|FG001|Overall Study|Did not meet risk classification group criteria|0|||
129773682|NCT03722238|467138077|FG000|Overall Study|Did not sign consent|17|||
129773683|NCT03722238|467138078|FG001|Overall Study|Did not sign consent|0|||
129773684|NCT03722238|467138077|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
129773685|NCT03722238|467138078|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
129684732|NCT04590963|466802966|FG000|Overall Study|Death|118|||
129684733|NCT04590963|466802967|FG001|Overall Study|Death|59|||
129684734|NCT04590963|466802966|FG000|Overall Study|Lost to Follow-up|1|||
129684735|NCT04590963|466802967|FG001|Overall Study|Lost to Follow-up|1|||
129684736|NCT04590963|466802966|FG000|Overall Study|Progressive disease|0|||
129684737|NCT04590963|466802967|FG001|Overall Study|Progressive disease|1|||
129684738|NCT04590963|466802966|FG000|Overall Study|Study terminated by sponsor|103|||
129684739|NCT04590963|466802967|FG001|Overall Study|Study terminated by sponsor|50|||
129684740|NCT04590963|466802966|FG000|Overall Study|Withdrawal by Subject|15|||
129684741|NCT04590963|466802967|FG001|Overall Study|Withdrawal by Subject|8|||
129684742|NCT04590963|466802966|FG000|Overall Study|Ongoing at data cut-off|9|||
129684743|NCT04590963|466802967|FG001|Overall Study|Ongoing at data cut-off|4|||
129684744|NCT04590963|466802966|FG000|Overall Study|Screen failure|1|||
129684745|NCT04590963|466802967|FG001|Overall Study|Screen failure|0|||
129684746|NCT04057365|466802968|FG000|Overall Study|Withdrawal by Subject|2|||
129684747|NCT04057365|466802969|FG001|Overall Study|Withdrawal by Subject|0|||
129684748|NCT03976375|466802970|FG000|Overall Study|Death|158|||
129684749|NCT03976375|466802971|FG001|Overall Study|Death|160|||
129684750|NCT03976375|466802972|FG002|Overall Study|Death|42|||
129684751|NCT03976375|466802970|FG000|Overall Study|Lost to Follow-up|2|||
129684752|NCT03976375|466802971|FG001|Overall Study|Lost to Follow-up|1|||
129684753|NCT03976375|466802972|FG002|Overall Study|Lost to Follow-up|1|||
129684754|NCT03976375|466802970|FG000|Overall Study|Withdrawal by Subject|5|||
129684755|NCT03976375|466802971|FG001|Overall Study|Withdrawal by Subject|9|||
129684756|NCT03976375|466802972|FG002|Overall Study|Withdrawal by Subject|4|||
129684757|NCT03976375|466802970|FG000|Overall Study|Sponsor decision|20|||
129684758|NCT03976375|466802971|FG001|Overall Study|Sponsor decision|19|||
129684759|NCT03976375|466802972|FG002|Overall Study|Sponsor decision|1|||
129684760|NCT01063114|466802973|FG000|Overall Study|Lost to Follow-up|1|||
129684761|NCT05556057|466802986|FG000|Overall Study|Lost to Follow-up|5|||
129684762|NCT05556057|466802987|FG001|Overall Study|Lost to Follow-up|4|||
129684763|NCT05556057|466802986|FG000|Overall Study|Withdrawal by Subject|0|||
129684764|NCT05556057|466802987|FG001|Overall Study|Withdrawal by Subject|2|||
129684765|NCT02466971|466802991|FG000|Overall Study|eligible and never treated|14|||
129684766|NCT02466971|466802992|FG001|Overall Study|eligible and never treated|20|||
129684767|NCT02466971|466802991|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
129684768|NCT02466971|466802992|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
129684769|NCT02466971|466802991|FG000|Overall Study|ineligible and treated|1|||
129684770|NCT02466971|466802992|FG001|Overall Study|ineligible and treated|0|||
129684771|NCT02466971|466802991|FG000|Overall Study|ineligible and never treated|0|||
129684772|NCT02466971|466802992|FG001|Overall Study|ineligible and never treated|1|||
129684773|NCT04818112|466802997|FG000|Overall Study|Withdrawal by Subject|54|||
129684774|NCT04818112|466802998|FG001|Overall Study|Withdrawal by Subject|12|||
129684775|NCT04818112|466802997|FG000|Overall Study|Lost to Follow-up|38|||
129684776|NCT04818112|466802998|FG001|Overall Study|Lost to Follow-up|10|||
129684777|NCT06187909|466802999|FG000|Overall Study|Withdrawal by Subject|2|||
129684778|NCT06187909|466803000|FG001|Overall Study|Withdrawal by Subject|2|||
129684779|NCT05020743|466803001|FG000|Overall Study|Enrollment in Interventional Study|2|||
129684780|NCT05020743|466803002|FG001|Overall Study|Enrollment in Interventional Study|9|||
129684781|NCT05020743|466803003|FG002|Overall Study|Enrollment in Interventional Study|0|||
129684782|NCT05020743|466803001|FG000|Overall Study|Withdrawal by Subject|0|||
129684783|NCT05020743|466803002|FG001|Overall Study|Withdrawal by Subject|3|||
129684784|NCT05020743|466803003|FG002|Overall Study|Withdrawal by Subject|1|||
129684785|NCT05020743|466803001|FG000|Overall Study|Lost to Follow-up|1|||
129684786|NCT05020743|466803002|FG001|Overall Study|Lost to Follow-up|0|||
129684787|NCT05020743|466803003|FG002|Overall Study|Lost to Follow-up|0|||
129684788|NCT05020743|466803001|FG000|Overall Study|Study Termination by Sponsor|10|||
129684789|NCT05020743|466803002|FG001|Overall Study|Study Termination by Sponsor|11|||
129684790|NCT05020743|466803003|FG002|Overall Study|Study Termination by Sponsor|10|||
129684791|NCT03488524|466803004|FG000|Overall Study|Withdrawal by Subject|51|||
129684792|NCT03488524|466803004|FG000|Overall Study|Death|19|||
129684793|NCT03488524|466803004|FG000|Overall Study|Study Sponsor|11|||
129684794|NCT03488524|466803004|FG000|Overall Study|Physician Decision|4|||
129684795|NCT03488524|466803004|FG000|Overall Study|Lost to Follow-up|3|||
129684796|NCT01913353|466803007|FG000|Overall Study|Adverse Event|2|||
129684797|NCT01913353|466803008|FG001|Overall Study|Adverse Event|0|||
129684798|NCT01913353|466803007|FG000|Overall Study|Physician Decision|0|||
129684799|NCT01913353|466803008|FG001|Overall Study|Physician Decision|2|||
129684800|NCT01913353|466803007|FG000|Overall Study|Withdrawal by Subject|20|||
129684801|NCT01913353|466803008|FG001|Overall Study|Withdrawal by Subject|6|||
129684802|NCT01913353|466803007|FG000|Overall Study|multiple reasons|10|||
129684803|NCT01913353|466803008|FG001|Overall Study|multiple reasons|7|||
129684804|NCT04017962|466803009|FG000|Overall Study|Death|2|||
129684805|NCT04017962|466803010|FG001|Overall Study|Death|0|||
129684806|NCT04017962|466803009|FG000|Overall Study|Lost to Follow-up|2|||
129684807|NCT04017962|466803010|FG001|Overall Study|Lost to Follow-up|0|||
129684808|NCT04017962|466803009|FG000|Overall Study|Physician Decision|1|||
129684809|NCT04017962|466803010|FG001|Overall Study|Physician Decision|0|||
129550792|NCT02454972|466312867|FG004|Overall Study|Multiple delay/holds on treatment|0|||
129550793|NCT02454972|466312868|FG005|Overall Study|Multiple delay/holds on treatment|0|||
129550794|NCT02454972|466312869|FG006|Overall Study|Multiple delay/holds on treatment|0|||
129550795|NCT02454972|466312870|FG007|Overall Study|Multiple delay/holds on treatment|0|||
129550796|NCT02454972|466312871|FG008|Overall Study|Multiple delay/holds on treatment|0|||
129550797|NCT02454972|466312863|FG000|Overall Study|Never treated|0|||
129550798|NCT02454972|466312864|FG001|Overall Study|Never treated|0|||
129550799|NCT02454972|466312865|FG002|Overall Study|Never treated|3|||
129550800|NCT02454972|466312866|FG003|Overall Study|Never treated|1|||
129550801|NCT02454972|466312867|FG004|Overall Study|Never treated|1|||
129684810|NCT04017962|466803009|FG000|Overall Study|Discontinued LTV|5|||
129684811|NCT04017962|466803010|FG001|Overall Study|Discontinued LTV|0|||
129684812|NCT01260948|466803012|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
129684813|NCT01260948|466803013|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
129684814|NCT01260948|466803012|FG000|Second Intervention|Emesis|0|||
129684815|NCT01260948|466803013|FG001|Second Intervention|Emesis|1|||
129684816|NCT00462462|466803014|FG000|Overall Study|Physician Decision|0|||
129684817|NCT00462462|466803015|FG001|Overall Study|Physician Decision|1|||
129684818|NCT01163617|466803016|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684819|NCT01163617|466803017|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
129684820|NCT01163617|466803018|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684821|NCT01163617|466803019|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684822|NCT01163617|466803020|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684823|NCT01163617|466803021|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684824|NCT01163617|466803022|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684825|NCT01163617|466803023|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
129684826|NCT01163617|466803016|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684827|NCT01163617|466803017|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
129684828|NCT01163617|466803018|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684829|NCT01163617|466803019|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684830|NCT01163617|466803020|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684831|NCT01163617|466803021|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684832|NCT01163617|466803022|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684833|NCT01163617|466803023|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
129684834|NCT01163617|466803016|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684835|NCT01163617|466803017|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684836|NCT01163617|466803018|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
129684837|NCT01163617|466803019|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684838|NCT01163617|466803020|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684839|NCT01163617|466803021|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684840|NCT01163617|466803022|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684841|NCT01163617|466803023|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
129684842|NCT02394756|466803024|FG000|Period 1|Lens Discomfort|0|||
129684843|NCT02394756|466803025|FG001|Period 1|Lens Discomfort|0|||
129684844|NCT02394756|466803026|FG002|Period 1|Lens Discomfort|0|||
129684845|NCT02394756|466803027|FG003|Period 1|Lens Discomfort|0|||
129684846|NCT02394756|466803028|FG004|Period 1|Lens Discomfort|0|||
129684847|NCT02394756|466803029|FG005|Period 1|Lens Discomfort|1|||
129684848|NCT02394756|466803024|FG000|Period 1|Withdrawal by Subject|0|||
129684849|NCT02394756|466803025|FG001|Period 1|Withdrawal by Subject|1|||
129684850|NCT02394756|466803026|FG002|Period 1|Withdrawal by Subject|1|||
129684851|NCT02394756|466803027|FG003|Period 1|Withdrawal by Subject|1|||
129684852|NCT02394756|466803028|FG004|Period 1|Withdrawal by Subject|0|||
129684853|NCT02394756|466803029|FG005|Period 1|Withdrawal by Subject|0|||
129684854|NCT02394756|466803024|FG000|Period 2|Unsatisfactory Visual Response|0|||
129684855|NCT02394756|466803025|FG001|Period 2|Unsatisfactory Visual Response|0|||
129684856|NCT02394756|466803026|FG002|Period 2|Unsatisfactory Visual Response|0|||
129684857|NCT02394756|466803027|FG003|Period 2|Unsatisfactory Visual Response|0|||
129684858|NCT02394756|466803028|FG004|Period 2|Unsatisfactory Visual Response|1|||
129684859|NCT02394756|466803029|FG005|Period 2|Unsatisfactory Visual Response|0|||
129684860|NCT02335944|466803030|FG000|Treatment Phase|Progressive Disease|2|||
129684861|NCT02335944|466803031|FG001|Treatment Phase|Progressive Disease|5|||
129550802|NCT02454972|466312868|FG005|Overall Study|Never treated|0|||
129550803|NCT02454972|466312869|FG006|Overall Study|Never treated|0|||
129684862|NCT02335944|466803032|FG002|Treatment Phase|Progressive Disease|2|||
129684863|NCT02335944|466803033|FG003|Treatment Phase|Progressive Disease|11|||
129684864|NCT02335944|466803034|FG004|Treatment Phase|Progressive Disease|4|||
129684865|NCT02335944|466803035|FG005|Treatment Phase|Progressive Disease|25|||
129684866|NCT02335944|466803036|FG006|Treatment Phase|Progressive Disease|2|||
129550804|NCT02454972|466312870|FG007|Overall Study|Never treated|0|||
129550805|NCT02454972|466312871|FG008|Overall Study|Never treated|5|||
129550806|NCT02454972|466312863|FG000|Overall Study|Lost to Follow-up|0|||
129550807|NCT02454972|466312864|FG001|Overall Study|Lost to Follow-up|0|||
129550808|NCT02454972|466312865|FG002|Overall Study|Lost to Follow-up|0|||
129550809|NCT02454972|466312866|FG003|Overall Study|Lost to Follow-up|0|||
129550810|NCT02454972|466312867|FG004|Overall Study|Lost to Follow-up|0|||
129550811|NCT02454972|466312868|FG005|Overall Study|Lost to Follow-up|0|||
129550812|NCT02454972|466312869|FG006|Overall Study|Lost to Follow-up|0|||
129550813|NCT02454972|466312870|FG007|Overall Study|Lost to Follow-up|0|||
129550814|NCT02454972|466312871|FG008|Overall Study|Lost to Follow-up|2|||
129550815|NCT02454972|466312863|FG000|Overall Study|Study termination|0|||
129550816|NCT02454972|466312864|FG001|Overall Study|Study termination|0|||
129550817|NCT02454972|466312865|FG002|Overall Study|Study termination|0|||
129550818|NCT02454972|466312866|FG003|Overall Study|Study termination|0|||
129550819|NCT02454972|466312867|FG004|Overall Study|Study termination|0|||
129550820|NCT02454972|466312868|FG005|Overall Study|Study termination|0|||
129684867|NCT02335944|466803037|FG007|Treatment Phase|Progressive Disease|30|||
129684868|NCT02335944|466803038|FG008|Treatment Phase|Progressive Disease|27|||
129684869|NCT02335944|466803039|FG009|Treatment Phase|Progressive Disease|0|||
129684870|NCT02335944|466803030|FG000|Treatment Phase|Adverse Event|2|||
129684871|NCT02335944|466803031|FG001|Treatment Phase|Adverse Event|0|||
129684872|NCT02335944|466803032|FG002|Treatment Phase|Adverse Event|0|||
129684873|NCT02335944|466803033|FG003|Treatment Phase|Adverse Event|2|||
129684874|NCT02335944|466803034|FG004|Treatment Phase|Adverse Event|1|||
129684875|NCT02335944|466803035|FG005|Treatment Phase|Adverse Event|15|||
129684876|NCT02335944|466803036|FG006|Treatment Phase|Adverse Event|0|||
129684877|NCT02335944|466803037|FG007|Treatment Phase|Adverse Event|5|||
129684878|NCT02335944|466803038|FG008|Treatment Phase|Adverse Event|7|||
129684879|NCT02335944|466803039|FG009|Treatment Phase|Adverse Event|0|||
129684880|NCT02335944|466803030|FG000|Treatment Phase|Physician Decision|0|||
129684881|NCT02335944|466803031|FG001|Treatment Phase|Physician Decision|0|||
129684882|NCT02335944|466803032|FG002|Treatment Phase|Physician Decision|0|||
129684883|NCT02335944|466803033|FG003|Treatment Phase|Physician Decision|1|||
129684884|NCT02335944|466803034|FG004|Treatment Phase|Physician Decision|0|||
129684885|NCT02335944|466803035|FG005|Treatment Phase|Physician Decision|6|||
129684886|NCT02335944|466803036|FG006|Treatment Phase|Physician Decision|1|||
129684887|NCT02335944|466803037|FG007|Treatment Phase|Physician Decision|2|||
129684888|NCT02335944|466803038|FG008|Treatment Phase|Physician Decision|1|||
129684889|NCT02335944|466803039|FG009|Treatment Phase|Physician Decision|0|||
129684890|NCT02335944|466803030|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
129684891|NCT02335944|466803031|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
129684892|NCT02335944|466803032|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
129684893|NCT02335944|466803033|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
129684894|NCT02335944|466803034|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
129684895|NCT02335944|466803035|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
129684896|NCT02335944|466803036|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
129684897|NCT02335944|466803037|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
129684898|NCT02335944|466803038|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
129684899|NCT02335944|466803039|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
129684900|NCT02335944|466803030|FG000|Treatment Phase|Subject/Guardian Decision|0|||
129684901|NCT02335944|466803031|FG001|Treatment Phase|Subject/Guardian Decision|0|||
129684902|NCT02335944|466803032|FG002|Treatment Phase|Subject/Guardian Decision|1|||
129684903|NCT02335944|466803033|FG003|Treatment Phase|Subject/Guardian Decision|0|||
129684904|NCT02335944|466803034|FG004|Treatment Phase|Subject/Guardian Decision|0|||
129684905|NCT02335944|466803035|FG005|Treatment Phase|Subject/Guardian Decision|1|||
129684906|NCT02335944|466803036|FG006|Treatment Phase|Subject/Guardian Decision|0|||
129684907|NCT02335944|466803037|FG007|Treatment Phase|Subject/Guardian Decision|4|||
129684908|NCT02335944|466803038|FG008|Treatment Phase|Subject/Guardian Decision|0|||
129550821|NCT02454972|466312869|FG006|Overall Study|Study termination|0|||
129550822|NCT02454972|466312870|FG007|Overall Study|Study termination|0|||
129550823|NCT02454972|466312871|FG008|Overall Study|Study termination|6|||
129684909|NCT02335944|466803039|FG009|Treatment Phase|Subject/Guardian Decision|0|||
129684910|NCT02335944|466803030|FG000|Post-treatment Follow-up|Progressive Disease|0|||
129684911|NCT02335944|466803031|FG001|Post-treatment Follow-up|Progressive Disease|0|||
129684912|NCT02335944|466803032|FG002|Post-treatment Follow-up|Progressive Disease|0|||
129684913|NCT02335944|466803033|FG003|Post-treatment Follow-up|Progressive Disease|1|||
129684914|NCT02335944|466803034|FG004|Post-treatment Follow-up|Progressive Disease|0|||
129684915|NCT02335944|466803035|FG005|Post-treatment Follow-up|Progressive Disease|9|||
129684916|NCT02335944|466803036|FG006|Post-treatment Follow-up|Progressive Disease|0|||
129684917|NCT02335944|466803037|FG007|Post-treatment Follow-up|Progressive Disease|2|||
129684918|NCT02335944|466803038|FG008|Post-treatment Follow-up|Progressive Disease|3|||
129773686|NCT03722238|467138077|FG000|Overall Study|Not willing to purchase study medication|142|||
129550824|NCT01377233|466312872|FG000|Open-label|Adverse Event|1|||
129550825|NCT01377233|466312873|FG001|Open-label|Adverse Event|0|||
129550826|NCT01377233|466312874|FG002|Open-label|Adverse Event|0|||
129550827|NCT01377233|466312875|FG003|Open-label|Adverse Event|0|||
129684919|NCT02335944|466803039|FG009|Post-treatment Follow-up|Progressive Disease|0|||
129684920|NCT02335944|466803030|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684921|NCT02335944|466803031|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684922|NCT02335944|466803032|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684923|NCT02335944|466803033|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684924|NCT02335944|466803034|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684925|NCT02335944|466803035|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
129684926|NCT02335944|466803036|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684927|NCT02335944|466803037|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684928|NCT02335944|466803038|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129684929|NCT02335944|466803039|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
129773687|NCT03722238|467138078|FG001|Overall Study|Not willing to purchase study medication|0|||
129773688|NCT03722238|467138077|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
129773689|NCT03722238|467138078|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
129773690|NCT02004093|467138079|FG000|Overall Study|Death|2|||
129773691|NCT02004093|467138080|FG001|Overall Study|Death|1|||
129773692|NCT02004093|467138079|FG000|Overall Study|Lack of Efficacy|66|||
129773693|NCT02004093|467138080|FG001|Overall Study|Lack of Efficacy|62|||
129773694|NCT02004093|467138079|FG000|Overall Study|Protocol Violation|0|||
129773695|NCT02004093|467138080|FG001|Overall Study|Protocol Violation|1|||
129773696|NCT02004093|467138079|FG000|Overall Study|Lost to Follow-up|0|||
129773697|NCT02004093|467138080|FG001|Overall Study|Lost to Follow-up|1|||
129773698|NCT02004093|467138079|FG000|Overall Study|Withdrawal by Subject|3|||
129773699|NCT02004093|467138080|FG001|Overall Study|Withdrawal by Subject|7|||
129773700|NCT02004093|467138079|FG000|Overall Study|Other|3|||
129773701|NCT02004093|467138080|FG001|Overall Study|Other|1|||
129773702|NCT01411891|467138081|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
129773703|NCT01411891|467138082|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
129773704|NCT00414596|467138083|FG000|Overall Study|Protocol Violation|2|||
129773705|NCT02558296|467138084|FG000|Completed the Study Through Week 24|Adverse Event|9|||
129773706|NCT02558296|467138085|FG001|Completed the Study Through Week 24|Adverse Event|3|||
129773707|NCT02558296|467138084|FG000|Completed the Study Through Week 24|Death|7|||
129773708|NCT02558296|467138085|FG001|Completed the Study Through Week 24|Death|7|||
129773709|NCT02558296|467138084|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
129773710|NCT02558296|467138085|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
129773711|NCT02558296|467138084|FG000|Completed the Study Through Week 24|Physician Decision|1|||
129773712|NCT02558296|467138085|FG001|Completed the Study Through Week 24|Physician Decision|0|||
129773713|NCT02558296|467138084|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
129773714|NCT02558296|467138085|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
129773715|NCT02558296|467138084|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
129773716|NCT02558296|467138085|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
129773717|NCT02558296|467138084|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
129773718|NCT02558296|467138085|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
129773719|NCT02558296|467138084|FG000|Completed the Study|Adverse Event|14|||
129773720|NCT02558296|467138085|FG001|Completed the Study|Adverse Event|5|||
129773721|NCT02558296|467138084|FG000|Completed the Study|Death|39|||
129773722|NCT02558296|467138085|FG001|Completed the Study|Death|25|||
129773723|NCT02558296|467138084|FG000|Completed the Study|Lost to Follow-up|31|||
129773724|NCT02558296|467138085|FG001|Completed the Study|Lost to Follow-up|23|||
129773725|NCT02558296|467138084|FG000|Completed the Study|Physician Decision|6|||
129773726|NCT02558296|467138085|FG001|Completed the Study|Physician Decision|0|||
129773727|NCT02558296|467138084|FG000|Completed the Study|Protocol Violation|2|||
129773728|NCT02558296|467138085|FG001|Completed the Study|Protocol Violation|1|||
129773729|NCT02558296|467138084|FG000|Completed the Study|Withdrawal by Subject|53|||
129550828|NCT01377233|466312876|FG004|Open-label|Adverse Event|0|||
129773730|NCT02558296|467138085|FG001|Completed the Study|Withdrawal by Subject|31|||
129773731|NCT02558296|467138084|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
129773732|NCT02558296|467138085|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
129773733|NCT00297258|467138086|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
129773734|NCT00297258|467138086|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
129773735|NCT00297258|467138086|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
129773736|NCT00297258|467138086|FG000|Overall Study|Intercurrent Illness|3|||
129773737|NCT00297258|467138086|FG000|Overall Study|Intercurrent Death|2|||
129773738|NCT00297258|467138086|FG000|Overall Study|Deteriorization of General Condition|1|||
129773739|NCT00297258|467138086|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
129773740|NCT00297258|467138086|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
129773741|NCT00297258|467138086|FG000|Overall Study|Switch to Commercial Treatment|1|||
129550829|NCT01377233|466312872|FG000|Open-label|Withdrawal by Subject|3|||
129550830|NCT01377233|466312873|FG001|Open-label|Withdrawal by Subject|0|||
129550831|NCT01377233|466312874|FG002|Open-label|Withdrawal by Subject|0|||
129684930|NCT02335944|466803030|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684931|NCT02335944|466803031|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684932|NCT02335944|466803032|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684933|NCT02335944|466803033|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684934|NCT02335944|466803034|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684935|NCT02335944|466803035|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684936|NCT02335944|466803036|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684937|NCT02335944|466803037|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
129684938|NCT02335944|466803038|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684939|NCT02335944|466803039|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
129684940|NCT02335944|466803030|FG000|Post-treatment Follow-up|Adverse Event|0|||
129684941|NCT02335944|466803031|FG001|Post-treatment Follow-up|Adverse Event|0|||
129684942|NCT02335944|466803032|FG002|Post-treatment Follow-up|Adverse Event|0|||
129684943|NCT02335944|466803033|FG003|Post-treatment Follow-up|Adverse Event|0|||
129684944|NCT02335944|466803034|FG004|Post-treatment Follow-up|Adverse Event|0|||
129684945|NCT02335944|466803035|FG005|Post-treatment Follow-up|Adverse Event|1|||
129684946|NCT02335944|466803036|FG006|Post-treatment Follow-up|Adverse Event|0|||
129684947|NCT02335944|466803037|FG007|Post-treatment Follow-up|Adverse Event|0|||
129684948|NCT02335944|466803038|FG008|Post-treatment Follow-up|Adverse Event|0|||
129684949|NCT02335944|466803039|FG009|Post-treatment Follow-up|Adverse Event|0|||
129684950|NCT02335944|466803030|FG000|Post-treatment Follow-up|Death|0|||
129684951|NCT02335944|466803031|FG001|Post-treatment Follow-up|Death|0|||
129684952|NCT02335944|466803032|FG002|Post-treatment Follow-up|Death|0|||
129684953|NCT02335944|466803033|FG003|Post-treatment Follow-up|Death|1|||
129684954|NCT02335944|466803034|FG004|Post-treatment Follow-up|Death|0|||
129684955|NCT02335944|466803035|FG005|Post-treatment Follow-up|Death|1|||
129684956|NCT02335944|466803036|FG006|Post-treatment Follow-up|Death|0|||
129684957|NCT02335944|466803037|FG007|Post-treatment Follow-up|Death|0|||
129684958|NCT02335944|466803038|FG008|Post-treatment Follow-up|Death|0|||
129684959|NCT02335944|466803039|FG009|Post-treatment Follow-up|Death|0|||
129684960|NCT02335944|466803030|FG000|Post-treatment Follow-up|Physician Decision|1|||
129684961|NCT02335944|466803031|FG001|Post-treatment Follow-up|Physician Decision|0|||
129684962|NCT02335944|466803032|FG002|Post-treatment Follow-up|Physician Decision|0|||
129684963|NCT02335944|466803033|FG003|Post-treatment Follow-up|Physician Decision|0|||
129684964|NCT02335944|466803034|FG004|Post-treatment Follow-up|Physician Decision|0|||
129684965|NCT02335944|466803035|FG005|Post-treatment Follow-up|Physician Decision|0|||
129684966|NCT02335944|466803036|FG006|Post-treatment Follow-up|Physician Decision|0|||
129684967|NCT02335944|466803037|FG007|Post-treatment Follow-up|Physician Decision|1|||
129684968|NCT02335944|466803038|FG008|Post-treatment Follow-up|Physician Decision|0|||
129684969|NCT02335944|466803039|FG009|Post-treatment Follow-up|Physician Decision|0|||
129684970|NCT00832975|466803040|FG000|Overall Study|Lost to Follow-up|7|||
129684971|NCT00832975|466803040|FG000|Overall Study|Protocol Violation|6|||
129684972|NCT00832975|466803040|FG000|Overall Study|Death|5|||
129684973|NCT00832975|466803040|FG000|Overall Study|Physician Decision|4|||
129684974|NCT00832975|466803040|FG000|Overall Study|Withdrawal by Subject|3|||
129684975|NCT00832975|466803040|FG000|Overall Study|Other reasons|14|||
129684976|NCT02811159|466803041|FG000|Treatment Course 1|Lost to Follow-up|1|||
129684977|NCT04603066|466803042|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
129684978|NCT04603066|466803043|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
129684979|NCT02406612|466803044|FG000|Overall Study|Screening Failure|3|||
129684980|NCT02406612|466803045|FG001|Overall Study|Screening Failure|0|||
129684981|NCT02406612|466803044|FG000|Overall Study|Intra-procedural Exclusion|1|||
129684982|NCT02406612|466803045|FG001|Overall Study|Intra-procedural Exclusion|3|||
129684983|NCT02406612|466803044|FG000|Overall Study|Guidewire Failure|0|||
129684984|NCT02406612|466803045|FG001|Overall Study|Guidewire Failure|1|||
129684985|NCT01371981|466803046|FG000|Overall Study|Adverse Event|12|||
129684986|NCT01371981|466803047|FG001|Overall Study|Adverse Event|17|||
129684987|NCT01371981|466803048|FG002|Overall Study|Adverse Event|0|||
129684988|NCT01371981|466803049|FG003|Overall Study|Adverse Event|4|||
129684989|NCT01371981|466803050|FG004|Overall Study|Adverse Event|1|||
129550832|NCT01377233|466312875|FG003|Open-label|Withdrawal by Subject|0|||
129684990|NCT01371981|466803051|FG005|Overall Study|Adverse Event|0|||
129684991|NCT01371981|466803046|FG000|Overall Study|Death|22|||
129550833|NCT01377233|466312876|FG004|Open-label|Withdrawal by Subject|0|||
129684992|NCT01371981|466803047|FG001|Overall Study|Death|16|||
129684993|NCT01371981|466803048|FG002|Overall Study|Death|0|||
129684994|NCT01371981|466803049|FG003|Overall Study|Death|0|||
129684995|NCT01371981|466803050|FG004|Overall Study|Death|2|||
129684996|NCT01371981|466803051|FG005|Overall Study|Death|2|||
129684997|NCT01371981|466803046|FG000|Overall Study|Lack of Efficacy|69|||
129684998|NCT01371981|466803047|FG001|Overall Study|Lack of Efficacy|61|||
129684999|NCT01371981|466803048|FG002|Overall Study|Lack of Efficacy|4|||
129685000|NCT01371981|466803049|FG003|Overall Study|Lack of Efficacy|8|||
129685001|NCT01371981|466803050|FG004|Overall Study|Lack of Efficacy|5|||
129685002|NCT01371981|466803051|FG005|Overall Study|Lack of Efficacy|0|||
129773742|NCT00297258|467138086|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
129773743|NCT00346697|467138089|FG000|Overall Study|Lost to Follow-up|0|||
129773744|NCT00346697|467138090|FG001|Overall Study|Lost to Follow-up|1|||
129773745|NCT00734539|467138091|FG000|Main Study|Death|33|||
129773746|NCT00734539|467138092|FG001|Main Study|Death|32|||
129773747|NCT00734539|467138091|FG000|Main Study|Physician Decision|2|||
129773748|NCT00734539|467138092|FG001|Main Study|Physician Decision|0|||
129773749|NCT00734539|467138091|FG000|Main Study|Withdrawal by Subject|1|||
129773750|NCT00734539|467138092|FG001|Main Study|Withdrawal by Subject|3|||
129773751|NCT00734539|467138091|FG000|Main Study|Enrolled in error; ineligible|1|||
129773752|NCT00734539|467138092|FG001|Main Study|Enrolled in error; ineligible|0|||
129773753|NCT02504151|467138097|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
129773754|NCT02504151|467138098|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
129773755|NCT02504151|467138097|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
129773756|NCT02504151|467138098|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
129773757|NCT02504151|467138097|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129773758|NCT02504151|467138098|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129773759|NCT02504151|467138097|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
129773760|NCT02504151|467138098|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
129773761|NCT05038982|467138099|FG000|Overall Study|Withdrawal by Subject|0|||
129773762|NCT05038982|467138100|FG001|Overall Study|Withdrawal by Subject|2|||
129773763|NCT02557139|467138106|FG000|Overall Study|Significant liver elevation|1|||
129773764|NCT02557139|467138107|FG001|Overall Study|Significant liver elevation|0|||
129773765|NCT02557139|467138108|FG002|Overall Study|Significant liver elevation|1|||
129773766|NCT02557139|467138106|FG000|Overall Study|Withdrawal by Subject|1|||
129773767|NCT02557139|467138107|FG001|Overall Study|Withdrawal by Subject|0|||
129773768|NCT02557139|467138108|FG002|Overall Study|Withdrawal by Subject|0|||
129773769|NCT02557139|467138106|FG000|Overall Study|Illness of prohibited medication|0|||
129773770|NCT02557139|467138107|FG001|Overall Study|Illness of prohibited medication|0|||
129773771|NCT02557139|467138108|FG002|Overall Study|Illness of prohibited medication|1|||
129773772|NCT01454102|467138109|FG000|Overall Study|Continuing in the treatment period|0|||
129773773|NCT01454102|467138110|FG001|Overall Study|Continuing in the treatment period|0|||
129773774|NCT01454102|467138111|FG002|Overall Study|Continuing in the treatment period|0|||
129773775|NCT01454102|467138112|FG003|Overall Study|Continuing in the treatment period|0|||
129773776|NCT01454102|467138113|FG004|Overall Study|Continuing in the treatment period|3|||
129773777|NCT01454102|467138114|FG005|Overall Study|Continuing in the treatment period|3|||
129773778|NCT01454102|467138115|FG006|Overall Study|Continuing in the treatment period|2|||
129773779|NCT01454102|467138116|FG007|Overall Study|Continuing in the treatment period|0|||
129773780|NCT01454102|467138117|FG008|Overall Study|Continuing in the treatment period|1|||
129773781|NCT01454102|467138118|FG009|Overall Study|Continuing in the treatment period|0|||
129773782|NCT01454102|467138119|FG010|Overall Study|Continuing in the treatment period|0|||
129773783|NCT01454102|467138120|FG011|Overall Study|Continuing in the treatment period|4|||
129773784|NCT01454102|467138121|FG012|Overall Study|Continuing in the treatment period|7|||
129773785|NCT01454102|467138122|FG013|Overall Study|Continuing in the treatment period|4|||
129773786|NCT01454102|467138123|FG014|Overall Study|Continuing in the treatment period|3|||
129773787|NCT01454102|467138124|FG015|Overall Study|Continuing in the treatment period|1|||
129773788|NCT02592798|467138130|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
129773789|NCT02592798|467138131|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
129773790|NCT02592798|467138130|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
129773791|NCT02592798|467138131|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
129773792|NCT02592798|467138130|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
129773793|NCT02592798|467138131|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
129773794|NCT02592798|467138130|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
129773795|NCT02592798|467138131|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
129773796|NCT02592798|467138130|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
129773797|NCT02592798|467138131|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
129773798|NCT02592798|467138130|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
129773799|NCT02592798|467138131|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
129773800|NCT02592798|467138130|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
129773801|NCT02592798|467138131|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
129773802|NCT02592798|467138130|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
129773803|NCT02592798|467138131|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
129773804|NCT02592798|467138130|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
129773805|NCT02592798|467138131|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
129773806|NCT02592798|467138130|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
129773807|NCT02592798|467138131|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
129773808|NCT02592798|467138130|FG000|Transition From DB2 to OLE|Other reasons|1|||
129773809|NCT02592798|467138131|FG001|Transition From DB2 to OLE|Other reasons|0|||
129773810|NCT02592798|467138130|FG000|Open Label Period (OLE)|Other reasons|0|||
129773811|NCT02592798|467138131|FG001|Open Label Period (OLE)|Other reasons|2|||
129773812|NCT02592798|467138130|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
129773813|NCT02592798|467138131|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
129773814|NCT02592798|467138130|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
129773815|NCT02592798|467138131|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
129773816|NCT02592798|467138130|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
129773817|NCT02592798|467138131|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
129773818|NCT02592798|467138130|FG000|Open Label Period (OLE)|Adverse Event|0|||
129773819|NCT02592798|467138131|FG001|Open Label Period (OLE)|Adverse Event|1|||
129773820|NCT00705016|467138132|FG000|Overall Study|Adverse Event|6|||
129773821|NCT00705016|467138133|FG001|Overall Study|Adverse Event|11|||
129773822|NCT00705016|467138134|FG002|Overall Study|Adverse Event|10|||
129773823|NCT00705016|467138132|FG000|Overall Study|Death|5|||
129773824|NCT00705016|467138133|FG001|Overall Study|Death|7|||
129773825|NCT00705016|467138134|FG002|Overall Study|Death|5|||
129773826|NCT00705016|467138132|FG000|Overall Study|Protocol Violation|0|||
129773827|NCT00705016|467138133|FG001|Overall Study|Protocol Violation|1|||
129773828|NCT00705016|467138134|FG002|Overall Study|Protocol Violation|1|||
129773829|NCT00705016|467138132|FG000|Overall Study|Withdrawal by Subject|4|||
129773830|NCT00705016|467138133|FG001|Overall Study|Withdrawal by Subject|3|||
129773831|NCT00705016|467138134|FG002|Overall Study|Withdrawal by Subject|2|||
129773832|NCT00705016|467138132|FG000|Overall Study|Progressive Disease|33|||
129773833|NCT00705016|467138133|FG001|Overall Study|Progressive Disease|29|||
129773834|NCT00705016|467138134|FG002|Overall Study|Progressive Disease|33|||
129773835|NCT00705016|467138132|FG000|Overall Study|Symptomatic Deterioration|3|||
129773836|NCT00705016|467138133|FG001|Overall Study|Symptomatic Deterioration|1|||
129773837|NCT00705016|467138134|FG002|Overall Study|Symptomatic Deterioration|1|||
129773838|NCT00705016|467138132|FG000|Overall Study|Other|9|||
129773839|NCT00705016|467138133|FG001|Overall Study|Other|6|||
129773840|NCT00705016|467138134|FG002|Overall Study|Other|6|||
129773841|NCT03853109|467138137|FG000|Overall Study|Withdrawal by Subject|0|||
129773842|NCT03853109|467138138|FG001|Overall Study|Withdrawal by Subject|0|||
129773843|NCT03853109|467138139|FG002|Overall Study|Withdrawal by Subject|1|||
129773844|NCT03853109|467138140|FG003|Overall Study|Withdrawal by Subject|2|||
129773845|NCT03853109|467138141|FG004|Overall Study|Withdrawal by Subject|1|||
129773846|NCT03853109|467138142|FG005|Overall Study|Withdrawal by Subject|4|||
129773847|NCT03853109|467138143|FG006|Overall Study|Withdrawal by Subject|5|||
129773848|NCT03853109|467138144|FG007|Overall Study|Withdrawal by Subject|3|||
129773849|NCT03853109|467138137|FG000|Overall Study|Decision by Sponsor|0|||
129773850|NCT03853109|467138138|FG001|Overall Study|Decision by Sponsor|0|||
129773851|NCT03853109|467138139|FG002|Overall Study|Decision by Sponsor|1|||
129773852|NCT03853109|467138140|FG003|Overall Study|Decision by Sponsor|0|||
129773853|NCT03853109|467138141|FG004|Overall Study|Decision by Sponsor|1|||
129773854|NCT03853109|467138142|FG005|Overall Study|Decision by Sponsor|1|||
129773855|NCT03853109|467138143|FG006|Overall Study|Decision by Sponsor|10|||
129773856|NCT03853109|467138144|FG007|Overall Study|Decision by Sponsor|2|||
129773857|NCT03853109|467138137|FG000|Overall Study|Lost to Follow-up|0|||
129773858|NCT03853109|467138138|FG001|Overall Study|Lost to Follow-up|0|||
129773859|NCT03853109|467138139|FG002|Overall Study|Lost to Follow-up|0|||
129773860|NCT03853109|467138140|FG003|Overall Study|Lost to Follow-up|0|||
129773861|NCT03853109|467138141|FG004|Overall Study|Lost to Follow-up|1|||
129773862|NCT03853109|467138142|FG005|Overall Study|Lost to Follow-up|3|||
129773863|NCT03853109|467138143|FG006|Overall Study|Lost to Follow-up|0|||
129773864|NCT03853109|467138144|FG007|Overall Study|Lost to Follow-up|0|||
129773865|NCT03853109|467138137|FG000|Overall Study|Death|2|||
129773866|NCT03853109|467138138|FG001|Overall Study|Death|5|||
129773867|NCT03853109|467138139|FG002|Overall Study|Death|8|||
129773868|NCT03853109|467138140|FG003|Overall Study|Death|10|||
129773869|NCT03853109|467138141|FG004|Overall Study|Death|3|||
129773870|NCT03853109|467138142|FG005|Overall Study|Death|20|||
129773871|NCT03853109|467138143|FG006|Overall Study|Death|10|||
129773872|NCT03853109|467138144|FG007|Overall Study|Death|5|||
129773873|NCT01721044|467138149|FG000|Treatment Period|Adverse Event|7|||
129773874|NCT01721044|467138150|FG001|Treatment Period|Adverse Event|7|||
129773875|NCT01721044|467138151|FG002|Treatment Period|Adverse Event|10|||
129773876|NCT01721044|467138149|FG000|Treatment Period|Death|0|||
129773877|NCT01721044|467138150|FG001|Treatment Period|Death|0|||
129773878|NCT01721044|467138151|FG002|Treatment Period|Death|1|||
129773879|NCT01721044|467138149|FG000|Treatment Period|Lack of Efficacy|16|||
129773880|NCT01721044|467138150|FG001|Treatment Period|Lack of Efficacy|4|||
129773881|NCT01721044|467138151|FG002|Treatment Period|Lack of Efficacy|4|||
129773882|NCT01721044|467138149|FG000|Treatment Period|Lost to Follow-up|0|||
129773883|NCT01721044|467138150|FG001|Treatment Period|Lost to Follow-up|0|||
129773884|NCT01721044|467138151|FG002|Treatment Period|Lost to Follow-up|1|||
129773885|NCT01721044|467138149|FG000|Treatment Period|Physician Decision|1|||
129773886|NCT01721044|467138150|FG001|Treatment Period|Physician Decision|0|||
129773887|NCT01721044|467138151|FG002|Treatment Period|Physician Decision|2|||
129773888|NCT01721044|467138149|FG000|Treatment Period|Protocol Violation|1|||
129773889|NCT01721044|467138150|FG001|Treatment Period|Protocol Violation|0|||
129773890|NCT01721044|467138151|FG002|Treatment Period|Protocol Violation|0|||
129773891|NCT01721044|467138149|FG000|Treatment Period|Withdrawal by Subject|7|||
129550834|NCT01377233|466312872|FG000|Double-blind|Adverse Event|0|||
129550835|NCT01377233|466312873|FG001|Double-blind|Adverse Event|1|||
129550836|NCT01377233|466312874|FG002|Double-blind|Adverse Event|2|||
129685003|NCT01371981|466803046|FG000|Overall Study|Physician Decision|48|||
129685004|NCT01371981|466803047|FG001|Overall Study|Physician Decision|63|||
129685005|NCT01371981|466803048|FG002|Overall Study|Physician Decision|1|||
129685006|NCT01371981|466803049|FG003|Overall Study|Physician Decision|7|||
129685007|NCT01371981|466803050|FG004|Overall Study|Physician Decision|14|||
129685008|NCT01371981|466803051|FG005|Overall Study|Physician Decision|3|||
129685009|NCT01371981|466803046|FG000|Overall Study|Withdrawal by Subject|12|||
129685010|NCT01371981|466803047|FG001|Overall Study|Withdrawal by Subject|19|||
129685011|NCT01371981|466803048|FG002|Overall Study|Withdrawal by Subject|1|||
129685012|NCT01371981|466803049|FG003|Overall Study|Withdrawal by Subject|2|||
129685013|NCT01371981|466803050|FG004|Overall Study|Withdrawal by Subject|10|||
129685014|NCT01371981|466803051|FG005|Overall Study|Withdrawal by Subject|3|||
129685015|NCT01371981|466803046|FG000|Overall Study|Ineligible|19|||
129685016|NCT01371981|466803047|FG001|Overall Study|Ineligible|13|||
129685017|NCT01371981|466803048|FG002|Overall Study|Ineligible|0|||
129685018|NCT01371981|466803049|FG003|Overall Study|Ineligible|0|||
129685019|NCT01371981|466803050|FG004|Overall Study|Ineligible|0|||
129685020|NCT01371981|466803051|FG005|Overall Study|Ineligible|4|||
129685021|NCT01371981|466803046|FG000|Overall Study|Did not start treatment|2|||
129685022|NCT01371981|466803047|FG001|Overall Study|Did not start treatment|3|||
129685023|NCT01371981|466803048|FG002|Overall Study|Did not start treatment|0|||
129685024|NCT01371981|466803049|FG003|Overall Study|Did not start treatment|0|||
129685025|NCT01371981|466803050|FG004|Overall Study|Did not start treatment|0|||
129685026|NCT01371981|466803051|FG005|Overall Study|Did not start treatment|2|||
129685027|NCT05253807|466803052|FG000|Overall Study|Death|1|||
129685028|NCT05253807|466803053|FG001|Overall Study|Death|4|||
129685029|NCT05253807|466803052|FG000|Overall Study|Withdrawal by Subject|1|||
129685030|NCT05253807|466803053|FG001|Overall Study|Withdrawal by Subject|0|||
129685031|NCT05253807|466803052|FG000|Overall Study|Study Terminated by Sponsor|1|||
129685032|NCT05253807|466803053|FG001|Overall Study|Study Terminated by Sponsor|1|||
129685033|NCT04611126|466803054|FG000|Overall Study|TIL expansion unsuccessful|1|||
129685034|NCT04611126|466803055|FG001|Overall Study|TIL expansion unsuccessful|0|||
129685035|NCT03459846|466803060|FG000|Overall Study|Death|52|||
129685036|NCT03459846|466803061|FG001|Overall Study|Death|46|||
129685037|NCT03459846|466803060|FG000|Overall Study|Study terminated by sponsor|24|||
129685038|NCT03459846|466803061|FG001|Overall Study|Study terminated by sponsor|28|||
129685039|NCT03459846|466803060|FG000|Overall Study|Withdrawal by Subject|2|||
129685040|NCT03459846|466803061|FG001|Overall Study|Withdrawal by Subject|2|||
129685041|NCT05578872|466803066|FG000|Overall Study|Withdrawal by Subject|2|||
129685042|NCT05578872|466803067|FG001|Overall Study|Withdrawal by Subject|1|||
129685043|NCT05578872|466803066|FG000|Overall Study|Adverse Event|1|||
129685044|NCT05578872|466803067|FG001|Overall Study|Adverse Event|1|||
129685045|NCT05578872|466803066|FG000|Overall Study|Physician Decision|1|||
129685046|NCT05578872|466803067|FG001|Overall Study|Physician Decision|2|||
129685047|NCT05578872|466803066|FG000|Overall Study|Progressive disease|10|||
129685048|NCT05578872|466803067|FG001|Overall Study|Progressive disease|9|||
129685049|NCT05578872|466803066|FG000|Overall Study|Sponsor decision|0|||
129685050|NCT05578872|466803067|FG001|Overall Study|Sponsor decision|1|||
129685051|NCT05578872|466803066|FG000|Overall Study|Toxicity and Patient's decision|0|||
129685052|NCT05578872|466803067|FG001|Overall Study|Toxicity and Patient's decision|1|||
129685053|NCT03506477|466803385|FG000|Overall Study|Withdrawal by Subject|1|||
129685054|NCT03506477|466803386|FG001|Overall Study|Withdrawal by Subject|0|||
129685055|NCT00632359|466803394|FG000|Overall Study|Withdrawal by Subject|2|||
129685056|NCT06717399|466803395|FG000|Overall Study|Death|1|||
129685057|NCT05763875|466803400|FG000|Overall Study|Subject decision|5|||
129685058|NCT05763875|466803401|FG001|Overall Study|Subject decision|2|||
129685059|NCT05763875|466803402|FG002|Overall Study|Subject decision|1|||
129685060|NCT05763875|466803400|FG000|Overall Study|Lost to Follow-up|4|||
129685061|NCT05763875|466803401|FG001|Overall Study|Lost to Follow-up|1|||
129685062|NCT05763875|466803402|FG002|Overall Study|Lost to Follow-up|2|||
129685063|NCT05763875|466803400|FG000|Overall Study|Adverse Event|1|||
129685064|NCT05763875|466803401|FG001|Overall Study|Adverse Event|0|||
129685065|NCT05763875|466803402|FG002|Overall Study|Adverse Event|0|||
129685066|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
129685067|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
129685068|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
129685069|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
129685070|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
129685071|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
129685072|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
129685073|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
129685074|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
129685075|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
129773892|NCT01721044|467138150|FG001|Treatment Period|Withdrawal by Subject|6|||
129773893|NCT01721044|467138151|FG002|Treatment Period|Withdrawal by Subject|1|||
129773894|NCT04032093|467138154|FG000|Overall Study|Lost to Follow-up|7|||
129773895|NCT04032093|467138155|FG001|Overall Study|Lost to Follow-up|7|||
129773896|NCT04032093|467138156|FG002|Overall Study|Lost to Follow-up|6|||
129773897|NCT04032093|467138157|FG003|Overall Study|Lost to Follow-up|10|||
129773898|NCT04032093|467138158|FG004|Overall Study|Lost to Follow-up|13|||
129773899|NCT04032093|467138159|FG005|Overall Study|Lost to Follow-up|7|||
129773900|NCT04032093|467138160|FG006|Overall Study|Lost to Follow-up|7|||
129773901|NCT04032093|467138161|FG007|Overall Study|Lost to Follow-up|5|||
129773902|NCT04032093|467138162|FG008|Overall Study|Lost to Follow-up|9|||
129773903|NCT04032093|467138163|FG009|Overall Study|Lost to Follow-up|12|||
129773904|NCT04032093|467138154|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129773905|NCT04032093|467138155|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129773906|NCT04032093|467138156|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129773907|NCT04032093|467138157|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
129773908|NCT04032093|467138158|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
129773909|NCT04032093|467138159|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129773910|NCT04032093|467138160|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
129773911|NCT04032093|467138161|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129773912|NCT04032093|467138162|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
129773913|NCT04032093|467138163|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
129773914|NCT04032093|467138154|FG000|Overall Study|Other|1|||
129773915|NCT04032093|467138155|FG001|Overall Study|Other|0|||
129773916|NCT04032093|467138156|FG002|Overall Study|Other|0|||
129773917|NCT04032093|467138157|FG003|Overall Study|Other|1|||
129773918|NCT04032093|467138158|FG004|Overall Study|Other|1|||
129773919|NCT04032093|467138159|FG005|Overall Study|Other|0|||
129773920|NCT04032093|467138160|FG006|Overall Study|Other|0|||
129773921|NCT04032093|467138161|FG007|Overall Study|Other|0|||
129773922|NCT04032093|467138162|FG008|Overall Study|Other|0|||
129773923|NCT04032093|467138163|FG009|Overall Study|Other|1|||
129773924|NCT04032093|467138154|FG000|Overall Study|Withdrawal by Subject|1|||
129773925|NCT04032093|467138155|FG001|Overall Study|Withdrawal by Subject|3|||
129773926|NCT04032093|467138156|FG002|Overall Study|Withdrawal by Subject|2|||
129773927|NCT04032093|467138157|FG003|Overall Study|Withdrawal by Subject|2|||
129773928|NCT04032093|467138158|FG004|Overall Study|Withdrawal by Subject|3|||
129773929|NCT04032093|467138159|FG005|Overall Study|Withdrawal by Subject|0|||
129773930|NCT04032093|467138160|FG006|Overall Study|Withdrawal by Subject|0|||
129773931|NCT04032093|467138161|FG007|Overall Study|Withdrawal by Subject|0|||
129773932|NCT04032093|467138162|FG008|Overall Study|Withdrawal by Subject|0|||
129773933|NCT04032093|467138163|FG009|Overall Study|Withdrawal by Subject|0|||
129773934|NCT04032093|467138154|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129773935|NCT04032093|467138155|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129773936|NCT04032093|467138156|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129773937|NCT04032093|467138157|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129773938|NCT04032093|467138158|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129773939|NCT04032093|467138159|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129773940|NCT04032093|467138160|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
129773941|NCT04032093|467138161|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
129773942|NCT04032093|467138162|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
129884426|NCT01275196|467536392|FG000|Overall Study|Withdrawal by Subject|4|||
129884427|NCT01275196|467536393|FG001|Overall Study|Withdrawal by Subject|5|||
129773943|NCT04032093|467138163|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
129773944|NCT04032093|467138154|FG000|Overall Study|Adverse Event|0|||
129773945|NCT04032093|467138155|FG001|Overall Study|Adverse Event|0|||
129773946|NCT04032093|467138156|FG002|Overall Study|Adverse Event|0|||
129773947|NCT04032093|467138157|FG003|Overall Study|Adverse Event|0|||
129773948|NCT04032093|467138158|FG004|Overall Study|Adverse Event|0|||
129773949|NCT04032093|467138159|FG005|Overall Study|Adverse Event|0|||
129773950|NCT04032093|467138160|FG006|Overall Study|Adverse Event|0|||
129773951|NCT04032093|467138161|FG007|Overall Study|Adverse Event|0|||
129773952|NCT04032093|467138162|FG008|Overall Study|Adverse Event|0|||
129773953|NCT04032093|467138163|FG009|Overall Study|Adverse Event|1|||
129773954|NCT04032093|467138154|FG000|Overall Study|Physician Decision|0|||
129773955|NCT04032093|467138155|FG001|Overall Study|Physician Decision|0|||
129773956|NCT04032093|467138156|FG002|Overall Study|Physician Decision|0|||
129773957|NCT04032093|467138157|FG003|Overall Study|Physician Decision|0|||
129884428|NCT01275196|467536392|FG000|Overall Study|Lost to Follow-up|1|||
129773958|NCT04032093|467138158|FG004|Overall Study|Physician Decision|0|||
129773959|NCT04032093|467138159|FG005|Overall Study|Physician Decision|1|||
129773960|NCT04032093|467138160|FG006|Overall Study|Physician Decision|0|||
129773961|NCT04032093|467138161|FG007|Overall Study|Physician Decision|0|||
129773962|NCT04032093|467138162|FG008|Overall Study|Physician Decision|0|||
129773963|NCT04032093|467138163|FG009|Overall Study|Physician Decision|0|||
129773964|NCT01654302|467138170|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
129884429|NCT01275196|467536393|FG001|Overall Study|Lost to Follow-up|0|||
129773965|NCT01654302|467138171|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
129773966|NCT03133793|467138175|FG000|Overall Study|Withdrawal by Subject|0|||
129773967|NCT03133793|467138176|FG001|Overall Study|Withdrawal by Subject|4|||
129773968|NCT03133793|467138177|FG002|Overall Study|Withdrawal by Subject|2|||
129773969|NCT03133793|467138178|FG003|Overall Study|Withdrawal by Subject|4|||
129773970|NCT03133793|467138175|FG000|Overall Study|Lost to Follow-up|1|||
129773971|NCT03133793|467138176|FG001|Overall Study|Lost to Follow-up|0|||
129773972|NCT03133793|467138177|FG002|Overall Study|Lost to Follow-up|2|||
129773973|NCT03133793|467138178|FG003|Overall Study|Lost to Follow-up|0|||
129773974|NCT03133793|467138175|FG000|Overall Study|Death|0|||
129773975|NCT03133793|467138176|FG001|Overall Study|Death|0|||
129773976|NCT03133793|467138177|FG002|Overall Study|Death|0|||
129773977|NCT03133793|467138178|FG003|Overall Study|Death|1|||
129773978|NCT02839200|467138179|FG000|Overall Study|Withdrawal by Subject|2|||
129773979|NCT02839200|467138180|FG001|Overall Study|Withdrawal by Subject|0|||
129773980|NCT02839200|467138181|FG002|Overall Study|Withdrawal by Subject|1|||
129773981|NCT02839200|467138182|FG003|Overall Study|Withdrawal by Subject|0|||
129773982|NCT02839200|467138183|FG004|Overall Study|Withdrawal by Subject|0|||
129773983|NCT02839200|467138184|FG005|Overall Study|Withdrawal by Subject|1|||
129773984|NCT02839200|467138179|FG000|Overall Study|Lost to Follow-up|2|||
129773985|NCT02839200|467138180|FG001|Overall Study|Lost to Follow-up|0|||
129773986|NCT02839200|467138181|FG002|Overall Study|Lost to Follow-up|0|||
129773987|NCT02839200|467138182|FG003|Overall Study|Lost to Follow-up|0|||
129773988|NCT02839200|467138183|FG004|Overall Study|Lost to Follow-up|1|||
129773989|NCT02839200|467138184|FG005|Overall Study|Lost to Follow-up|0|||
129773990|NCT02839200|467138179|FG000|Overall Study|Adverse Event|0|||
129773991|NCT02839200|467138180|FG001|Overall Study|Adverse Event|0|||
129773992|NCT02839200|467138181|FG002|Overall Study|Adverse Event|0|||
129773993|NCT02839200|467138182|FG003|Overall Study|Adverse Event|0|||
129773994|NCT02839200|467138183|FG004|Overall Study|Adverse Event|1|||
129773995|NCT02839200|467138184|FG005|Overall Study|Adverse Event|0|||
129773996|NCT02839200|467138179|FG000|Overall Study|Randomized in error|0|||
129773997|NCT02839200|467138180|FG001|Overall Study|Randomized in error|1|||
129773998|NCT02839200|467138181|FG002|Overall Study|Randomized in error|0|||
129773999|NCT02839200|467138182|FG003|Overall Study|Randomized in error|0|||
129774000|NCT02839200|467138183|FG004|Overall Study|Randomized in error|0|||
129774001|NCT02839200|467138184|FG005|Overall Study|Randomized in error|0|||
129774002|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
129774003|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
129774004|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
129774005|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
129774006|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
129774007|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
129774008|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
129774009|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
129774010|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
129774011|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
129774012|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
129774013|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
129774014|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
129774015|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
129774016|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
129774017|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
129774018|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
129774019|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
129774020|NCT02952820|467138185|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
129774021|NCT02952820|467138186|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
129774022|NCT02952820|467138187|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
129774023|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
129774024|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
129774025|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
129774026|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
129774027|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
129774028|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
129774029|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
129774030|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
129774031|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
129774032|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
129774033|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
129774034|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
129774035|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
129884430|NCT01275196|467536392|FG000|Overall Study|Disease Progression|6|||
129774036|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
129774037|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
129774038|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
129774039|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
129774040|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
129774041|NCT02952820|467138185|FG000|Active Treatment Period (6 Months)|Not treated|0|||
129774042|NCT02952820|467138186|FG001|Active Treatment Period (6 Months)|Not treated|0|||
129774043|NCT02952820|467138187|FG002|Active Treatment Period (6 Months)|Not treated|1|||
129774044|NCT04139018|467138188|FG000|Overall Study|Screen fail|1|||
129774045|NCT04139018|467138189|FG001|Overall Study|Screen fail|0|||
129774046|NCT04139018|467138188|FG000|Overall Study|Withdrawal by Subject|2|||
129774047|NCT04139018|467138189|FG001|Overall Study|Withdrawal by Subject|0|||
129774048|NCT04139018|467138188|FG000|Overall Study|Lost to Follow-up|0|||
129774049|NCT04139018|467138189|FG001|Overall Study|Lost to Follow-up|1|||
129774050|NCT04476797|467138191|FG000|Overall Study|Withdrawal by Subject|1|||
129774051|NCT04476797|467138192|FG001|Overall Study|Withdrawal by Subject|0|||
129774052|NCT04476797|467138193|FG002|Overall Study|Withdrawal by Subject|0|||
129774053|NCT04476797|467138191|FG000|Overall Study|Death|0|||
129774054|NCT04476797|467138192|FG001|Overall Study|Death|1|||
129774055|NCT04476797|467138193|FG002|Overall Study|Death|2|||
129774056|NCT04476797|467138191|FG000|Overall Study|Sponsor Terminated Study|0|||
129774057|NCT04476797|467138192|FG001|Overall Study|Sponsor Terminated Study|18|||
129774058|NCT04476797|467138193|FG002|Overall Study|Sponsor Terminated Study|17|||
129774059|NCT03486834|467138194|FG000|Overall Study|Withdrawal by Subject|46|||
129774060|NCT03486834|467138195|FG001|Overall Study|Withdrawal by Subject|46|||
129774061|NCT03486834|467138196|FG002|Overall Study|Withdrawal by Subject|52|||
129774062|NCT03486834|467138194|FG000|Overall Study|Adverse Event|8|||
129774063|NCT03486834|467138195|FG001|Overall Study|Adverse Event|7|||
129774064|NCT03486834|467138196|FG002|Overall Study|Adverse Event|0|||
129774065|NCT03486834|467138194|FG000|Overall Study|Lost to Follow-up|41|||
129774066|NCT03486834|467138195|FG001|Overall Study|Lost to Follow-up|24|||
129774067|NCT03486834|467138196|FG002|Overall Study|Lost to Follow-up|39|||
129774068|NCT03486834|467138194|FG000|Overall Study|Non-compliance with Study Drug|2|||
129774069|NCT03486834|467138195|FG001|Overall Study|Non-compliance with Study Drug|2|||
129774070|NCT03486834|467138196|FG002|Overall Study|Non-compliance with Study Drug|0|||
129774071|NCT03486834|467138194|FG000|Overall Study|Physician Decision|5|||
129774072|NCT03486834|467138195|FG001|Overall Study|Physician Decision|2|||
129774073|NCT03486834|467138196|FG002|Overall Study|Physician Decision|3|||
129774074|NCT03486834|467138194|FG000|Overall Study|Pregnancy|10|||
129774075|NCT03486834|467138195|FG001|Overall Study|Pregnancy|12|||
129774076|NCT03486834|467138196|FG002|Overall Study|Pregnancy|12|||
129774077|NCT03486834|467138194|FG000|Overall Study|Protocol Deviation|2|||
129774078|NCT03486834|467138195|FG001|Overall Study|Protocol Deviation|3|||
129774079|NCT03486834|467138196|FG002|Overall Study|Protocol Deviation|3|||
129774080|NCT03486834|467138194|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129774081|NCT03486834|467138195|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129774082|NCT03486834|467138196|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129774083|NCT03486834|467138194|FG000|Overall Study|Randomized but not treated|4|||
129774084|NCT03486834|467138195|FG001|Overall Study|Randomized but not treated|4|||
129774085|NCT03486834|467138196|FG002|Overall Study|Randomized but not treated|1|||
129774086|NCT03614156|467138213|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
129774087|NCT03614156|467138214|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
129774088|NCT03614156|467138215|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
129774089|NCT03614156|467138216|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
129774090|NCT03614156|467138213|FG000|Open-Label Treatment Period|Adverse Event|7|||
129774091|NCT03614156|467138214|FG001|Open-Label Treatment Period|Adverse Event|0|||
129774092|NCT03614156|467138215|FG002|Open-Label Treatment Period|Adverse Event|0|||
129774093|NCT03614156|467138216|FG003|Open-Label Treatment Period|Adverse Event|0|||
129774094|NCT03614156|467138213|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
129774095|NCT03614156|467138214|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129774096|NCT03614156|467138215|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129774097|NCT03614156|467138216|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
129774098|NCT03614156|467138213|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
129774099|NCT03614156|467138214|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
129774100|NCT03614156|467138215|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
129774101|NCT03614156|467138216|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
129774102|NCT03614156|467138213|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
129774103|NCT03614156|467138214|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
129774104|NCT03614156|467138215|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
129774105|NCT03614156|467138216|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
129774106|NCT03614156|467138213|FG000|Open-Label Treatment Period|Protocol Violation|2|||
129774107|NCT03614156|467138214|FG001|Open-Label Treatment Period|Protocol Violation|0|||
129884431|NCT01275196|467536393|FG001|Overall Study|Disease Progression|5|||
129884432|NCT01275196|467536392|FG000|Overall Study|Protocol Violation|1|||
129774108|NCT03614156|467138215|FG002|Open-Label Treatment Period|Protocol Violation|0|||
129774109|NCT03614156|467138216|FG003|Open-Label Treatment Period|Protocol Violation|0|||
129774110|NCT03614156|467138213|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
129774111|NCT03614156|467138214|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
129774112|NCT03614156|467138215|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
129774113|NCT03614156|467138216|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
129774114|NCT03614156|467138213|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
129774115|NCT03614156|467138214|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
129774116|NCT03614156|467138215|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
129774117|NCT03614156|467138216|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
129774118|NCT03614156|467138213|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
129774119|NCT03614156|467138214|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
129774120|NCT03614156|467138215|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
129774121|NCT03614156|467138216|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
129774122|NCT03614156|467138213|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129774123|NCT03614156|467138214|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
129774124|NCT03614156|467138215|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129774125|NCT03614156|467138216|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129774126|NCT03614156|467138213|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129774127|NCT03614156|467138214|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129774128|NCT03614156|467138215|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
129774129|NCT03614156|467138216|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
129774130|NCT03614156|467138213|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
129774131|NCT03614156|467138214|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
129774132|NCT03614156|467138215|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
129774133|NCT03614156|467138216|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
129774134|NCT03614156|467138213|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
129774135|NCT03614156|467138214|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
129774136|NCT03614156|467138215|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
129774137|NCT03614156|467138216|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
129774138|NCT03614156|467138213|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129774139|NCT03614156|467138214|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
129774140|NCT03614156|467138215|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129774141|NCT03614156|467138216|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
129774142|NCT03614156|467138213|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
129774143|NCT03614156|467138214|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
129774144|NCT03614156|467138215|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
129774145|NCT03614156|467138216|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
129774146|NCT03614156|467138213|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
129774147|NCT03614156|467138214|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
129774148|NCT03614156|467138215|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
129774149|NCT03614156|467138216|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
129774150|NCT03614156|467138213|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
129774151|NCT03614156|467138214|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
129774152|NCT03614156|467138215|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
129774153|NCT03614156|467138216|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
129774154|NCT04287517|467138221|FG000|Overall Study|Withdrawal by Subject|1|||
129774155|NCT04287517|467138222|FG001|Overall Study|Withdrawal by Subject|1|||
129774156|NCT03070964|467138223|FG000|Overall Study|Progressive disease|8|||
129774157|NCT03070964|467138223|FG000|Overall Study|Treatment-unrelated adverse event|2|||
129774158|NCT03070964|467138223|FG000|Overall Study|Never treated|1|||
129774159|NCT03070964|467138223|FG000|Overall Study|Physician Decision|1|||
129774160|NCT03070964|467138223|FG000|Overall Study|Withdrawal by Subject|1|||
129774161|NCT03070964|467138223|FG000|Overall Study|Adverse Event|1|||
129774162|NCT01094119|467138224|FG000|Overall Study|Lack of Efficacy|2|||
129774163|NCT01094119|467138225|FG001|Overall Study|Lack of Efficacy|4|||
129774164|NCT00834093|467138228|FG000|Overall Study|Progressive Disease|3|||
129774165|NCT00834093|467138228|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
129774166|NCT02745119|467138229|FG000|Overall Study|Adverse Event|1|||
129774167|NCT02745119|467138230|FG001|Overall Study|Adverse Event|0|||
129774168|NCT02745119|467138231|FG002|Overall Study|Adverse Event|1|||
129774169|NCT02745119|467138232|FG003|Overall Study|Adverse Event|3|||
129774170|NCT02745119|467138229|FG000|Overall Study|Death|3|||
129774171|NCT02745119|467138230|FG001|Overall Study|Death|3|||
129774172|NCT02745119|467138231|FG002|Overall Study|Death|0|||
129774173|NCT02745119|467138232|FG003|Overall Study|Death|4|||
129550837|NCT01377233|466312875|FG003|Double-blind|Adverse Event|2|||
129774174|NCT02745119|467138229|FG000|Overall Study|Lost to Follow-up|0|||
129774175|NCT02745119|467138230|FG001|Overall Study|Lost to Follow-up|0|||
129774176|NCT02745119|467138231|FG002|Overall Study|Lost to Follow-up|0|||
129774177|NCT02745119|467138232|FG003|Overall Study|Lost to Follow-up|1|||
129774178|NCT02745119|467138229|FG000|Overall Study|Protocol Deviation|0|||
129774179|NCT02745119|467138230|FG001|Overall Study|Protocol Deviation|0|||
129774180|NCT02745119|467138231|FG002|Overall Study|Protocol Deviation|0|||
129774181|NCT02745119|467138232|FG003|Overall Study|Protocol Deviation|1|||
129774182|NCT02745119|467138229|FG000|Overall Study|Withdrawal by Subject|7|||
129774183|NCT02745119|467138230|FG001|Overall Study|Withdrawal by Subject|15|||
129774184|NCT02745119|467138231|FG002|Overall Study|Withdrawal by Subject|8|||
129774185|NCT02745119|467138232|FG003|Overall Study|Withdrawal by Subject|14|||
129774186|NCT02745119|467138229|FG000|Overall Study|Study Terminated by Sponsor|134|||
129774187|NCT02745119|467138230|FG001|Overall Study|Study Terminated by Sponsor|252|||
129774188|NCT02745119|467138231|FG002|Overall Study|Study Terminated by Sponsor|135|||
129774189|NCT02745119|467138232|FG003|Overall Study|Study Terminated by Sponsor|251|||
129774190|NCT02745119|467138229|FG000|Overall Study|Physician Decision|0|||
129550838|NCT01377233|466312876|FG004|Double-blind|Adverse Event|0|||
129550839|NCT01377233|466312872|FG000|Double-blind|Protocol Violation|0|||
129550840|NCT01377233|466312873|FG001|Double-blind|Protocol Violation|0|||
129550841|NCT01377233|466312874|FG002|Double-blind|Protocol Violation|0|||
129550842|NCT01377233|466312875|FG003|Double-blind|Protocol Violation|0|||
129550843|NCT01377233|466312876|FG004|Double-blind|Protocol Violation|1|||
129550844|NCT01377233|466312872|FG000|Double-blind|Withdrawal by Subject|0|||
129550845|NCT01377233|466312873|FG001|Double-blind|Withdrawal by Subject|0|||
129550846|NCT01377233|466312874|FG002|Double-blind|Withdrawal by Subject|0|||
129550847|NCT01377233|466312875|FG003|Double-blind|Withdrawal by Subject|1|||
129550848|NCT01377233|466312876|FG004|Double-blind|Withdrawal by Subject|0|||
129550849|NCT01377233|466312872|FG000|Double-blind|Administrative or other|0|||
129550850|NCT01377233|466312873|FG001|Double-blind|Administrative or other|0|||
129550851|NCT01377233|466312874|FG002|Double-blind|Administrative or other|0|||
129550852|NCT01377233|466312875|FG003|Double-blind|Administrative or other|1|||
129550853|NCT01377233|466312876|FG004|Double-blind|Administrative or other|1|||
129550854|NCT01785875|466312877|FG000|Overall Study|Withdrawal by Subject|41|||
129550855|NCT01785875|466312878|FG001|Overall Study|Withdrawal by Subject|34|||
129550856|NCT01785875|466312879|FG002|Overall Study|Withdrawal by Subject|36|||
129550857|NCT01785875|466312877|FG000|Overall Study|Lost to Follow-up|19|||
129550858|NCT01785875|466312878|FG001|Overall Study|Lost to Follow-up|22|||
129550859|NCT01785875|466312879|FG002|Overall Study|Lost to Follow-up|6|||
129550860|NCT01785875|466312877|FG000|Overall Study|Death|27|||
129550861|NCT01785875|466312878|FG001|Overall Study|Death|16|||
129550862|NCT01785875|466312879|FG002|Overall Study|Death|7|||
129550863|NCT01785875|466312877|FG000|Overall Study|Sponsor Decision|0|||
129550864|NCT01785875|466312878|FG001|Overall Study|Sponsor Decision|2|||
129550865|NCT01785875|466312879|FG002|Overall Study|Sponsor Decision|0|||
129550866|NCT01785875|466312877|FG000|Overall Study|Protocol Specified Criteria|207|||
129550867|NCT01785875|466312878|FG001|Overall Study|Protocol Specified Criteria|214|||
129550868|NCT01785875|466312879|FG002|Overall Study|Protocol Specified Criteria|55|||
129550869|NCT01785875|466312877|FG000|Overall Study|Missing|0|||
129550870|NCT01785875|466312878|FG001|Overall Study|Missing|1|||
129550871|NCT01785875|466312879|FG002|Overall Study|Missing|3|||
129550872|NCT04991311|466312880|FG000|Overall Study|Adverse Event|1|||
129550873|NCT00755937|466312881|FG000|Recruitment|Unknown if infliximab received|164|||
129550874|NCT00755937|466312881|FG000|Observational Follow-up|Lost to Follow-up|148|||
129550875|NCT01440595|466312884|FG000|Overall Study|Lost to Follow-up|0|||
129550876|NCT01440595|466312885|FG001|Overall Study|Lost to Follow-up|1|||
129550877|NCT01440595|466312886|FG002|Overall Study|Lost to Follow-up|0|||
129550878|NCT01440595|466312884|FG000|Overall Study|Study terminated by sponsor.|1|||
129550879|NCT01440595|466312885|FG001|Overall Study|Study terminated by sponsor.|2|||
129550880|NCT01440595|466312886|FG002|Overall Study|Study terminated by sponsor.|1|||
129550881|NCT01347879|466312887|FG000|Overall Study|Adverse Event|0|||
129550882|NCT01347879|466312888|FG001|Overall Study|Adverse Event|12|||
129550883|NCT01347879|466312887|FG000|Overall Study|Lost to Follow-up|2|||
129550884|NCT01347879|466312888|FG001|Overall Study|Lost to Follow-up|0|||
129550885|NCT01347879|466312887|FG000|Overall Study|Withdrawal by Subject|3|||
129774191|NCT02745119|467138230|FG001|Overall Study|Physician Decision|2|||
129774192|NCT02745119|467138231|FG002|Overall Study|Physician Decision|2|||
129774193|NCT02745119|467138232|FG003|Overall Study|Physician Decision|2|||
129550886|NCT01347879|466312888|FG001|Overall Study|Withdrawal by Subject|2|||
129774194|NCT02745119|467138229|FG000|Overall Study|Reason Not Specified|0|||
129550887|NCT01347879|466312887|FG000|Overall Study|Other|2|||
129550888|NCT01347879|466312888|FG001|Overall Study|Other|3|||
129550889|NCT01223196|466312889|FG000|Overall Study|Lost to Follow-up|2|||
129550890|NCT01223196|466312890|FG001|Overall Study|Lost to Follow-up|0|||
129550891|NCT01223196|466312889|FG000|Overall Study|Physician Decision|1|||
129550892|NCT01223196|466312890|FG001|Overall Study|Physician Decision|0|||
129774195|NCT02745119|467138230|FG001|Overall Study|Reason Not Specified|2|||
129774196|NCT02745119|467138231|FG002|Overall Study|Reason Not Specified|0|||
129774197|NCT02745119|467138232|FG003|Overall Study|Reason Not Specified|1|||
129774198|NCT01587924|467138233|FG000|Overall Study|Adverse Event|0|||
129550893|NCT01223196|466312889|FG000|Overall Study|Withdrawal by Subject|1|||
129550894|NCT01223196|466312890|FG001|Overall Study|Withdrawal by Subject|0|||
129550895|NCT01238822|466312895|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
129550896|NCT02725671|466312901|FG000|Overall Study|Lost to Follow-up|1|||
129550897|NCT00965263|466312902|FG000|Overall Study|Physician Decision|2|||
129550898|NCT00965263|466312903|FG001|Overall Study|Physician Decision|0|||
129550899|NCT00965263|466312902|FG000|Overall Study|Family emergency|0|||
129550900|NCT00965263|466312903|FG001|Overall Study|Family emergency|1|||
129550901|NCT00965263|466312902|FG000|Overall Study|Protocol Violation|0|||
129550902|NCT00965263|466312903|FG001|Overall Study|Protocol Violation|2|||
129550903|NCT00123487|466312904|FG000|Randomized|Death prior to starting treatment|0|||
129550904|NCT00123487|466312905|FG001|Randomized|Death prior to starting treatment|1|||
129550905|NCT00123487|466312904|FG000|Randomized|SAE prior to starting treatment|1|||
129550906|NCT00123487|466312905|FG001|Randomized|SAE prior to starting treatment|0|||
129550907|NCT00123487|466312904|FG000|Treated With Study Drug|Adverse Event|23|||
129550908|NCT00123487|466312905|FG001|Treated With Study Drug|Adverse Event|22|||
129550909|NCT00123487|466312904|FG000|Treated With Study Drug|Disease Progression|141|||
129550910|NCT00123487|466312905|FG001|Treated With Study Drug|Disease Progression|122|||
129550911|NCT00123487|466312904|FG000|Treated With Study Drug|Physician Decision|8|||
129550912|NCT00123487|466312905|FG001|Treated With Study Drug|Physician Decision|9|||
129550913|NCT00123487|466312904|FG000|Treated With Study Drug|Other|59|||
129550914|NCT00123487|466312905|FG001|Treated With Study Drug|Other|58|||
129550915|NCT00123487|466312904|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
129550916|NCT00123487|466312905|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
129550917|NCT00123487|466312904|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
129550918|NCT00123487|466312905|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
129550919|NCT00123487|466312904|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
129550920|NCT00123487|466312905|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
129550921|NCT02643966|466312906|FG000|First Screening Round|ineligible|1|||
129550922|NCT02643966|466312906|FG000|First Screening Round|excluded from analysis|2|||
129550923|NCT02643966|466312906|FG000|First Screening Round|Lost to Follow-up|56|||
129550924|NCT02643966|466312906|FG000|First Screening Round|Withdrawal by Subject|28|||
129550925|NCT02643966|466312906|FG000|First Screening Round|Death|1|||
129550926|NCT02643966|466312906|FG000|Between First and Second Screening|Lost to Follow-up|65|||
129550927|NCT02643966|466312906|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
129550928|NCT02643966|466312906|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
129550929|NCT02643966|466312906|FG000|Second Screening Round|Withdrawal by Subject|20|||
129550930|NCT02643966|466312906|FG000|Second Screening Round|Lost to Follow-up|57|||
129550931|NCT02643966|466312906|FG000|Second Screening Round|Physician Decision|2|||
129550932|NCT02643966|466312906|FG000|Second Screening Round|Death|4|||
129550933|NCT02643966|466312906|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
129550934|NCT02643966|466312906|FG000|Between Second and Third Screening|Death|1|||
129550935|NCT02643966|466312906|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
129550936|NCT02643966|466312906|FG000|Third Screening Round|PI excluded|2|||
129550937|NCT02643966|466312906|FG000|Third Screening Round|Lost to Follow-up|241|||
129550938|NCT03835975|466312907|FG000|Overall Study|Lost to Follow-up|1|||
129550939|NCT03835975|466312908|FG001|Overall Study|Lost to Follow-up|1|||
129550940|NCT03835975|466312909|FG002|Overall Study|Lost to Follow-up|0|||
129550941|NCT03835975|466312910|FG003|Overall Study|Lost to Follow-up|0|||
129550942|NCT03835975|466312911|FG004|Overall Study|Lost to Follow-up|0|||
129550943|NCT03835975|466312907|FG000|Overall Study|No longer met eligibility criteria|0|||
129550944|NCT03835975|466312908|FG001|Overall Study|No longer met eligibility criteria|1|||
129550945|NCT03835975|466312909|FG002|Overall Study|No longer met eligibility criteria|0|||
129550946|NCT03835975|466312910|FG003|Overall Study|No longer met eligibility criteria|0|||
129550947|NCT03835975|466312911|FG004|Overall Study|No longer met eligibility criteria|0|||
129550948|NCT03835975|466312907|FG000|Overall Study|Protocol Violation|1|||
129550949|NCT03835975|466312908|FG001|Overall Study|Protocol Violation|1|||
129550950|NCT03835975|466312909|FG002|Overall Study|Protocol Violation|2|||
129550951|NCT03835975|466312910|FG003|Overall Study|Protocol Violation|0|||
129550952|NCT03835975|466312911|FG004|Overall Study|Protocol Violation|0|||
129550953|NCT03835975|466312907|FG000|Overall Study|Withdrawal by Subject|1|||
129550954|NCT03835975|466312908|FG001|Overall Study|Withdrawal by Subject|0|||
129550955|NCT03835975|466312909|FG002|Overall Study|Withdrawal by Subject|1|||
129550956|NCT03835975|466312910|FG003|Overall Study|Withdrawal by Subject|1|||
129550957|NCT03835975|466312911|FG004|Overall Study|Withdrawal by Subject|0|||
129550958|NCT00061945|466312912|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
129550959|NCT00061945|466312913|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
129550960|NCT00061945|466312912|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
129550961|NCT00061945|466312913|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
129550962|NCT00061945|466312912|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
129550963|NCT00061945|466312913|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
129550964|NCT00061945|466312912|FG000|Course IV: Alemtuzumab|Early exits|6|||
129550965|NCT00061945|466312913|FG001|Course IV: Alemtuzumab|Early exits|15|||
129550966|NCT01039584|466312914|FG000|Overall Study|Withdrawal by Subject|4|||
129774199|NCT01587924|467138234|FG001|Overall Study|Adverse Event|2|||
129550967|NCT01039584|466312915|FG001|Overall Study|Withdrawal by Subject|2|||
129550968|NCT01039584|466312916|FG002|Overall Study|Withdrawal by Subject|1|||
129550969|NCT01039584|466312914|FG000|Overall Study|Protocol Violation|10|||
129550970|NCT01039584|466312915|FG001|Overall Study|Protocol Violation|4|||
129550971|NCT01039584|466312916|FG002|Overall Study|Protocol Violation|6|||
129550972|NCT01039584|466312914|FG000|Overall Study|Lost to Follow-up|5|||
129550973|NCT01039584|466312915|FG001|Overall Study|Lost to Follow-up|3|||
129550974|NCT01039584|466312916|FG002|Overall Study|Lost to Follow-up|4|||
129550975|NCT01039584|466312914|FG000|Overall Study|Negative Baseline culture for Candida|59|||
129550976|NCT01039584|466312915|FG001|Overall Study|Negative Baseline culture for Candida|59|||
129550977|NCT01039584|466312916|FG002|Overall Study|Negative Baseline culture for Candida|24|||
129550978|NCT01039584|466312914|FG000|Overall Study|Lack of Efficacy|7|||
129550979|NCT01039584|466312915|FG001|Overall Study|Lack of Efficacy|6|||
129550980|NCT01039584|466312916|FG002|Overall Study|Lack of Efficacy|10|||
129550981|NCT01039584|466312914|FG000|Overall Study|other|1|||
129550982|NCT01039584|466312915|FG001|Overall Study|other|3|||
129550983|NCT01039584|466312916|FG002|Overall Study|other|1|||
129550984|NCT01039584|466312914|FG000|Overall Study|Pap smear with significant pathology|10|||
129550985|NCT01039584|466312915|FG001|Overall Study|Pap smear with significant pathology|10|||
129550986|NCT01039584|466312916|FG002|Overall Study|Pap smear with significant pathology|3|||
129550987|NCT01039584|466312914|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
129550988|NCT01039584|466312915|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
129550989|NCT01039584|466312916|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
129550990|NCT03672396|466312919|FG000|Overall Study|Withdrawal by Subject|4|||
129550991|NCT03672396|466312919|FG000|Overall Study|Physician Decision|1|||
129550992|NCT03672396|466312919|FG000|Overall Study|Adverse Event|1|||
129550993|NCT02441179|466312921|FG000|Overall Study|Withdrawal by Subject|1|||
129550994|NCT02441179|466312922|FG001|Overall Study|Withdrawal by Subject|1|||
129550995|NCT00975884|466312923|FG000|Overall Study|Adverse Event|1|||
129550996|NCT00975884|466312924|FG001|Overall Study|Adverse Event|0|||
129550997|NCT00975884|466312923|FG000|Overall Study|Lost to Follow-up|5|||
129550998|NCT00975884|466312924|FG001|Overall Study|Lost to Follow-up|3|||
129550999|NCT00975884|466312923|FG000|Overall Study|Withdrawal by Subject|9|||
129551000|NCT00975884|466312924|FG001|Overall Study|Withdrawal by Subject|9|||
129551001|NCT00975884|466312923|FG000|Overall Study|Other|1|||
129551002|NCT00975884|466312924|FG001|Overall Study|Other|3|||
129551003|NCT01656967|466312925|FG000|Overall Study|faulty monitor|1|||
129551004|NCT01656967|466312926|FG001|Overall Study|faulty monitor|0|||
129551005|NCT01656967|466312925|FG000|Overall Study|unsuccessful ETT insertion|3|||
129551006|NCT01656967|466312926|FG001|Overall Study|unsuccessful ETT insertion|2|||
129551007|NCT00051636|466312927|FG000|Period 1 - Core|Adverse Event|2|||
129551008|NCT00051636|466312928|FG001|Period 1 - Core|Adverse Event|2|||
129551009|NCT00051636|466312927|FG000|Period 1 - Core|Protocol Violation|1|||
129551010|NCT00051636|466312928|FG001|Period 1 - Core|Protocol Violation|0|||
129551011|NCT00051636|466312927|FG000|Period 1 - Core|Withdrawal by Subject|1|||
129551012|NCT00051636|466312928|FG001|Period 1 - Core|Withdrawal by Subject|2|||
129551013|NCT00051636|466312927|FG000|Period 1 - Core|Lost to Follow-up|0|||
129551014|NCT00051636|466312928|FG001|Period 1 - Core|Lost to Follow-up|2|||
129551015|NCT00051636|466312927|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
129551016|NCT00051636|466312928|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
129551017|NCT00051636|466312927|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
129551018|NCT00051636|466312928|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
129551019|NCT00051636|466312927|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
129551020|NCT00051636|466312928|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
129551021|NCT00051636|466312927|FG000|Period 2- Extended Observation Period|Death|4|||
129551022|NCT00051636|466312928|FG001|Period 2- Extended Observation Period|Death|5|||
129551023|NCT00051636|466312927|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
129551024|NCT00051636|466312928|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
129774200|NCT01587924|467138235|FG002|Overall Study|Adverse Event|0|||
129774201|NCT01587924|467138236|FG003|Overall Study|Adverse Event|0|||
129774202|NCT01587924|467138233|FG000|Overall Study|Protocol Violation|2|||
129551025|NCT00479765|466312929|FG000|Overall Study|study terminated|4|||
129551026|NCT00944125|466312930|FG000|3 to 6 Months|Withdrawal by Subject|0|||
129551027|NCT00944125|466312931|FG001|3 to 6 Months|Withdrawal by Subject|2|||
129551028|NCT00944125|466312930|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
129551029|NCT00944125|466312931|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
129551030|NCT00446134|466312932|FG000|Overall Study|Adverse Event|7|||
129551031|NCT00446134|466312933|FG001|Overall Study|Adverse Event|17|||
129551032|NCT00446134|466312934|FG002|Overall Study|Adverse Event|13|||
129551033|NCT00446134|466312935|FG003|Overall Study|Adverse Event|18|||
129774203|NCT01587924|467138234|FG001|Overall Study|Protocol Violation|1|||
129551034|NCT00446134|466312932|FG000|Overall Study|Lack of Efficacy|19|||
129774204|NCT01587924|467138235|FG002|Overall Study|Protocol Violation|2|||
129551035|NCT00446134|466312933|FG001|Overall Study|Lack of Efficacy|19|||
129551036|NCT00446134|466312934|FG002|Overall Study|Lack of Efficacy|24|||
129551037|NCT00446134|466312935|FG003|Overall Study|Lack of Efficacy|19|||
129551038|NCT00446134|466312932|FG000|Overall Study|Protocol Violation|0|||
129551039|NCT00446134|466312933|FG001|Overall Study|Protocol Violation|2|||
129551040|NCT00446134|466312934|FG002|Overall Study|Protocol Violation|1|||
129551041|NCT00446134|466312935|FG003|Overall Study|Protocol Violation|0|||
129551042|NCT00446134|466312932|FG000|Overall Study|Lost to Follow-up|1|||
129551043|NCT00446134|466312933|FG001|Overall Study|Lost to Follow-up|3|||
129551044|NCT00446134|466312934|FG002|Overall Study|Lost to Follow-up|1|||
129551045|NCT00446134|466312935|FG003|Overall Study|Lost to Follow-up|1|||
129551046|NCT00446134|466312932|FG000|Overall Study|Withdrawal by Subject|3|||
129551047|NCT00446134|466312933|FG001|Overall Study|Withdrawal by Subject|3|||
129551048|NCT00446134|466312934|FG002|Overall Study|Withdrawal by Subject|1|||
129551049|NCT00446134|466312935|FG003|Overall Study|Withdrawal by Subject|3|||
129685076|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
129685077|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
129685078|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
129685079|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
129685080|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
129685081|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
129685082|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
129685083|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
129685084|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
129685085|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
129685086|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
129685087|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
129685088|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
129685089|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
129685090|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
129685091|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
129685092|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
129685093|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
129685094|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
129685095|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
129685096|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
129685097|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
129685098|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
129685099|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
129685100|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
129685101|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
129685102|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
129685103|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
129685104|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
129685105|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
129685106|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
129685107|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
129685108|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
129685109|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
129685110|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
129685111|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
129685112|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
129685113|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
129685114|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
129685115|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
129685116|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
129685117|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
129685118|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
129685119|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
129685120|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
129685121|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
129685122|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
129685123|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
129685124|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
129774205|NCT01587924|467138236|FG003|Overall Study|Protocol Violation|1|||
129551050|NCT00446134|466312932|FG000|Overall Study|Physician Decision|0|||
129551051|NCT00446134|466312933|FG001|Overall Study|Physician Decision|0|||
129685125|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
129685126|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
129685127|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
129685128|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
129685129|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
129685130|NCT00217737|466803403|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
129685131|NCT00217737|466803404|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
129685132|NCT00217737|466803405|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
129685133|NCT00217737|466803406|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
129685134|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
129685135|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
129685136|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
129685137|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
129685138|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
129685139|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
129685140|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
129685141|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
129685142|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Study suspension|0|||
129685143|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Study suspension|45|||
129685144|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Study suspension|0|||
129685145|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Study suspension|0|||
129685146|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
129685147|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
129685148|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
129685149|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
129685150|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Death|2|||
129685151|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Death|3|||
129685152|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Death|0|||
129685153|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Death|0|||
129685154|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
129685155|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
129685156|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
129685157|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
129685158|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
129685159|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
129685160|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
129685161|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
129685162|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
129685163|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
129685164|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
129685165|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
129685166|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
129685167|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
129685168|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
129685169|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
129685170|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
129685171|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
129685172|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
129685173|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
129685174|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
129685175|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
129685176|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
129685177|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
129685178|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
129685179|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
129685180|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
129685181|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
129685182|NCT00217737|466803403|FG000|Step 2 Randomization/Registration|Other|1|||
129685183|NCT00217737|466803404|FG001|Step 2 Randomization/Registration|Other|2|||
129685184|NCT00217737|466803405|FG002|Step 2 Randomization/Registration|Other|0|||
129685185|NCT00217737|466803406|FG003|Step 2 Randomization/Registration|Other|0|||
129685186|NCT02145390|466803407|FG000|Overall Study|Withdrawal by Subject|1|||
129685187|NCT01732783|466804303|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
129685188|NCT01732783|466804304|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
129685189|NCT01732783|466804305|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
129884433|NCT01275196|467536393|FG001|Overall Study|Protocol Violation|0|||
129774206|NCT01587924|467138233|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
129774207|NCT01587924|467138234|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
129774208|NCT01587924|467138235|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
129774209|NCT01587924|467138236|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
129774210|NCT01587924|467138233|FG000|Overall Study|Withdrawal by Subject|0|||
129774211|NCT01587924|467138234|FG001|Overall Study|Withdrawal by Subject|1|||
129774212|NCT01587924|467138235|FG002|Overall Study|Withdrawal by Subject|1|||
129774213|NCT01587924|467138236|FG003|Overall Study|Withdrawal by Subject|0|||
129774214|NCT00432172|467138237|FG000|Overall Study|Physician Decision|0|||
129774215|NCT00432172|467138238|FG001|Overall Study|Physician Decision|0|||
129774216|NCT00432172|467138239|FG002|Overall Study|Physician Decision|2|||
129774217|NCT00432172|467138240|FG003|Overall Study|Physician Decision|0|||
129774218|NCT00432172|467138237|FG000|Overall Study|Adverse Event|4|||
129774219|NCT00432172|467138238|FG001|Overall Study|Adverse Event|2|||
129774220|NCT00432172|467138239|FG002|Overall Study|Adverse Event|4|||
129774221|NCT00432172|467138240|FG003|Overall Study|Adverse Event|3|||
129774222|NCT00432172|467138237|FG000|Overall Study|Disease progression|0|||
129774223|NCT00432172|467138238|FG001|Overall Study|Disease progression|2|||
129774224|NCT00432172|467138239|FG002|Overall Study|Disease progression|5|||
129774225|NCT00432172|467138240|FG003|Overall Study|Disease progression|1|||
129774226|NCT00432172|467138237|FG000|Overall Study|Withdrawal by Subject|0|||
129774227|NCT00432172|467138238|FG001|Overall Study|Withdrawal by Subject|1|||
129774228|NCT00432172|467138239|FG002|Overall Study|Withdrawal by Subject|0|||
129774229|NCT00432172|467138240|FG003|Overall Study|Withdrawal by Subject|2|||
129774230|NCT00432172|467138237|FG000|Overall Study|No treatment received|2|||
129774231|NCT00432172|467138238|FG001|Overall Study|No treatment received|2|||
129774232|NCT00432172|467138239|FG002|Overall Study|No treatment received|0|||
129774233|NCT00432172|467138240|FG003|Overall Study|No treatment received|1|||
129774234|NCT02425943|467138241|FG000|Overall Study|Adverse Event|3|||
129774235|NCT02425943|467138242|FG001|Overall Study|Adverse Event|1|||
129774236|NCT02425943|467138241|FG000|Overall Study|Lost to Follow-up|59|||
129774237|NCT02425943|467138242|FG001|Overall Study|Lost to Follow-up|37|||
129774238|NCT02425943|467138241|FG000|Overall Study|Protocol Violation|4|||
129774239|NCT02425943|467138242|FG001|Overall Study|Protocol Violation|1|||
129774240|NCT02425943|467138241|FG000|Overall Study|Withdrawal by Subject|64|||
129774241|NCT02425943|467138242|FG001|Overall Study|Withdrawal by Subject|31|||
129774242|NCT02425943|467138241|FG000|Overall Study|Other|6|||
129774243|NCT02425943|467138242|FG001|Overall Study|Other|0|||
129774244|NCT03313037|467138249|FG000|Overall Study|Protocol Violation|4|||
129774245|NCT03313037|467138250|FG001|Overall Study|Protocol Violation|1|||
129774246|NCT03313037|467138249|FG000|Overall Study|Other|1|||
129774247|NCT03313037|467138250|FG001|Overall Study|Other|1|||
129774248|NCT03313037|467138249|FG000|Overall Study|Withdrawal by Subject|4|||
129774249|NCT03313037|467138250|FG001|Overall Study|Withdrawal by Subject|3|||
129774250|NCT03313037|467138249|FG000|Overall Study|No longer meets eligibility criteria|1|||
129774251|NCT03313037|467138250|FG001|Overall Study|No longer meets eligibility criteria|7|||
129774252|NCT03313037|467138249|FG000|Overall Study|Lost to Follow-up|9|||
129774253|NCT03313037|467138250|FG001|Overall Study|Lost to Follow-up|8|||
129774254|NCT03313037|467138249|FG000|Overall Study|Randomized but not treated|1|||
129774255|NCT03313037|467138250|FG001|Overall Study|Randomized but not treated|0|||
129774256|NCT02379091|467138251|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129774257|NCT02379091|467138252|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129774258|NCT02379091|467138253|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129774259|NCT02379091|467138254|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129774260|NCT02379091|467138251|FG000|Overall Study|Principal Investigator Discretion|0|||
129774261|NCT02379091|467138252|FG001|Overall Study|Principal Investigator Discretion|1|||
129774262|NCT02379091|467138253|FG002|Overall Study|Principal Investigator Discretion|0|||
129774263|NCT02379091|467138254|FG003|Overall Study|Principal Investigator Discretion|0|||
129774264|NCT02379091|467138251|FG000|Overall Study|Lost to Follow-up|0|||
129774265|NCT02379091|467138252|FG001|Overall Study|Lost to Follow-up|0|||
129774266|NCT02379091|467138253|FG002|Overall Study|Lost to Follow-up|0|||
129774267|NCT02379091|467138254|FG003|Overall Study|Lost to Follow-up|1|||
129774268|NCT02379091|467138251|FG000|Overall Study|Voluntary Withdrawal|2|||
129774269|NCT02379091|467138252|FG001|Overall Study|Voluntary Withdrawal|5|||
129774270|NCT02379091|467138253|FG002|Overall Study|Voluntary Withdrawal|2|||
129884434|NCT01275196|467536392|FG000|Overall Study|Suboptimal response/treatment failure|5|||
129774271|NCT02379091|467138254|FG003|Overall Study|Voluntary Withdrawal|4|||
129774272|NCT02379091|467138251|FG000|Overall Study|Study Termination|7|||
129774273|NCT02379091|467138252|FG001|Overall Study|Study Termination|2|||
129774274|NCT02379091|467138253|FG002|Overall Study|Study Termination|5|||
129774275|NCT02379091|467138254|FG003|Overall Study|Study Termination|8|||
129774276|NCT02379091|467138251|FG000|Overall Study|Lack of Efficacy|3|||
129884435|NCT01275196|467536393|FG001|Overall Study|Suboptimal response/treatment failure|6|||
129774277|NCT02379091|467138252|FG001|Overall Study|Lack of Efficacy|0|||
129774278|NCT02379091|467138253|FG002|Overall Study|Lack of Efficacy|0|||
129774279|NCT02379091|467138254|FG003|Overall Study|Lack of Efficacy|0|||
129774280|NCT03278249|467138255|FG000|Overall Study|Withdrawal by Subject|2|||
129685190|NCT01732783|466804303|FG000|Overall Study|Death|13|||
129685191|NCT01732783|466804304|FG001|Overall Study|Death|4|||
129685192|NCT01732783|466804305|FG002|Overall Study|Death|1|||
129685193|NCT01732783|466804303|FG000|Overall Study|Lost to Follow-up|7|||
129685194|NCT01732783|466804304|FG001|Overall Study|Lost to Follow-up|1|||
129685195|NCT01732783|466804305|FG002|Overall Study|Lost to Follow-up|1|||
129685196|NCT01732783|466804303|FG000|Overall Study|Administrative Decision|8|||
129685197|NCT01732783|466804304|FG001|Overall Study|Administrative Decision|2|||
129685198|NCT01732783|466804305|FG002|Overall Study|Administrative Decision|1|||
129685199|NCT01732783|466804303|FG000|Overall Study|Withdrawal by Subject|1|||
129685200|NCT01732783|466804304|FG001|Overall Study|Withdrawal by Subject|0|||
129685201|NCT01732783|466804305|FG002|Overall Study|Withdrawal by Subject|0|||
129685202|NCT02717611|466804306|FG000|Overall Study|Death|13|||
129685203|NCT02717611|466804306|FG000|Overall Study|Withdrawal by Subject|6|||
129685204|NCT02717611|466804306|FG000|Overall Study|Active, not recruiting|40|||
129685205|NCT02717611|466804306|FG000|Overall Study|Complicating disease|1|||
129685206|NCT00325416|466804307|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
129685207|NCT00325416|466804308|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
129685208|NCT00325416|466804307|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
129685209|NCT00325416|466804308|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
129685210|NCT00325416|466804307|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
129685211|NCT00325416|466804308|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
129685212|NCT00325416|466804307|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
129685213|NCT00325416|466804308|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
129685214|NCT00325416|466804307|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
129685215|NCT00325416|466804308|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
129685216|NCT00325416|466804307|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
129685217|NCT00325416|466804308|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
129685218|NCT04589650|466804309|FG000|Overall Study|Subject decision|6|||
129685219|NCT04589650|466804310|FG001|Overall Study|Subject decision|2|||
129685220|NCT04589650|466804311|FG002|Overall Study|Subject decision|2|||
129685221|NCT04589650|466804312|FG003|Overall Study|Subject decision|0|||
129685222|NCT04589650|466804313|FG004|Overall Study|Subject decision|0|||
129685223|NCT04589650|466804314|FG005|Overall Study|Subject decision|0|||
129685224|NCT04589650|466804309|FG000|Overall Study|Adverse Event|3|||
129685225|NCT04589650|466804310|FG001|Overall Study|Adverse Event|1|||
129685226|NCT04589650|466804311|FG002|Overall Study|Adverse Event|1|||
129685227|NCT04589650|466804312|FG003|Overall Study|Adverse Event|1|||
129685228|NCT04589650|466804313|FG004|Overall Study|Adverse Event|0|||
129685229|NCT04589650|466804314|FG005|Overall Study|Adverse Event|1|||
129685230|NCT04589650|466804309|FG000|Overall Study|Physician Decision|1|||
129685231|NCT04589650|466804310|FG001|Overall Study|Physician Decision|1|||
129685232|NCT04589650|466804311|FG002|Overall Study|Physician Decision|0|||
129685233|NCT04589650|466804312|FG003|Overall Study|Physician Decision|0|||
129685234|NCT04589650|466804313|FG004|Overall Study|Physician Decision|0|||
129685235|NCT04589650|466804314|FG005|Overall Study|Physician Decision|0|||
129685236|NCT04589650|466804309|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129685237|NCT04589650|466804310|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129685238|NCT04589650|466804311|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129685239|NCT04589650|466804312|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129685240|NCT04589650|466804313|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
129685241|NCT04589650|466804314|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
129685242|NCT04589650|466804309|FG000|Overall Study|Death|0|||
129685243|NCT04589650|466804310|FG001|Overall Study|Death|0|||
129685244|NCT04589650|466804311|FG002|Overall Study|Death|0|||
129685245|NCT04589650|466804312|FG003|Overall Study|Death|1|||
129685246|NCT04589650|466804313|FG004|Overall Study|Death|0|||
129685247|NCT04589650|466804314|FG005|Overall Study|Death|0|||
129685248|NCT04589650|466804309|FG000|Overall Study|Guardian Decision|0|||
129685249|NCT04589650|466804310|FG001|Overall Study|Guardian Decision|0|||
129685250|NCT04589650|466804311|FG002|Overall Study|Guardian Decision|0|||
129685251|NCT04589650|466804312|FG003|Overall Study|Guardian Decision|1|||
129685252|NCT04589650|466804313|FG004|Overall Study|Guardian Decision|0|||
129685253|NCT04589650|466804314|FG005|Overall Study|Guardian Decision|0|||
129685254|NCT02324153|466804315|FG000|Overall Study|Withdrawal by Subject|4|||
129551052|NCT00446134|466312934|FG002|Overall Study|Physician Decision|0|||
129551053|NCT00446134|466312935|FG003|Overall Study|Physician Decision|2|||
129551054|NCT00446134|466312932|FG000|Overall Study|Adverse Event-Diarrhea|1|||
129551055|NCT00446134|466312933|FG001|Overall Study|Adverse Event-Diarrhea|1|||
129551056|NCT00446134|466312934|FG002|Overall Study|Adverse Event-Diarrhea|2|||
129551057|NCT00446134|466312935|FG003|Overall Study|Adverse Event-Diarrhea|0|||
129551058|NCT00446134|466312932|FG000|Overall Study|Reason Not Completed|3|||
129551059|NCT00446134|466312933|FG001|Overall Study|Reason Not Completed|0|||
129551060|NCT00446134|466312934|FG002|Overall Study|Reason Not Completed|1|||
129551061|NCT00446134|466312935|FG003|Overall Study|Reason Not Completed|2|||
129551062|NCT00928135|466312936|FG000|Overall Study|Withdrawal by Subject|1|||
129551063|NCT00928135|466312937|FG001|Overall Study|Withdrawal by Subject|0|||
129551064|NCT03338673|466312940|FG000|Overall Study|Lost to Follow-up|1|||
129551065|NCT03338673|466312941|FG001|Overall Study|Lost to Follow-up|1|||
129551066|NCT00434148|466312944|FG000|Overall Study|Adverse Event|18|||
129551067|NCT00434148|466312945|FG001|Overall Study|Adverse Event|18|||
129551068|NCT00434148|466312944|FG000|Overall Study|Lack of Efficacy|25|||
129551069|NCT00434148|466312945|FG001|Overall Study|Lack of Efficacy|28|||
129551070|NCT00434148|466312944|FG000|Overall Study|Withdrawal by Subject|15|||
129551071|NCT00434148|466312945|FG001|Overall Study|Withdrawal by Subject|15|||
129551072|NCT00434148|466312944|FG000|Overall Study|Protocol Violation|4|||
129551073|NCT00434148|466312945|FG001|Overall Study|Protocol Violation|0|||
129551074|NCT00434148|466312944|FG000|Overall Study|Administrative problems|6|||
129551075|NCT00434148|466312945|FG001|Overall Study|Administrative problems|10|||
129551076|NCT00434148|466312944|FG000|Overall Study|Lost to Follow-up|0|||
129551077|NCT00434148|466312945|FG001|Overall Study|Lost to Follow-up|1|||
129551078|NCT00434148|466312944|FG000|Overall Study|Condition no longer requires study drug|1|||
129551079|NCT00434148|466312945|FG001|Overall Study|Condition no longer requires study drug|0|||
129551080|NCT00434148|466312944|FG000|Overall Study|Abnormal test procedure result|0|||
129685255|NCT02324153|466804316|FG001|Overall Study|Withdrawal by Subject|1|||
129685256|NCT02324153|466804315|FG000|Overall Study|Surgery postponed after randomization|3|||
129685257|NCT02324153|466804316|FG001|Overall Study|Surgery postponed after randomization|0|||
129685258|NCT02324153|466804315|FG000|Overall Study|Developed delirium preoperatively|1|||
129685259|NCT02324153|466804316|FG001|Overall Study|Developed delirium preoperatively|0|||
129685260|NCT03122106|466804319|FG000|Overall Study|Not enough tissue|1|||
129685261|NCT03122106|466804319|FG000|Overall Study|Disease progression during screening|2|||
129685262|NCT03122106|466804319|FG000|Overall Study|Poor RNA quality for vaccine|1|||
129685263|NCT01147458|466804321|FG000|First Intervention|Study terminated by sponsor|8|||
129685264|NCT01147458|466804322|FG001|First Intervention|Study terminated by sponsor|8|||
129685265|NCT01147458|466804323|FG002|First Intervention|Study terminated by sponsor|7|||
129685266|NCT01147458|466804324|FG003|First Intervention|Study terminated by sponsor|8|||
129685267|NCT01147458|466804321|FG000|First Intervention|Protocol Violation|2|||
129685268|NCT01147458|466804322|FG001|First Intervention|Protocol Violation|3|||
129685269|NCT01147458|466804323|FG002|First Intervention|Protocol Violation|2|||
129685270|NCT01147458|466804324|FG003|First Intervention|Protocol Violation|3|||
129551081|NCT00434148|466312945|FG001|Overall Study|Abnormal test procedure result|1|||
129551082|NCT01861717|466312953|FG000|Overall Study|Lost to Follow-up|1|||
129551083|NCT01861717|466312953|FG000|Overall Study|Withdrawal by Subject|1|||
129551084|NCT03033069|466312954|FG000|Overall Study|Adverse Event|6|||
129551085|NCT03033069|466312955|FG001|Overall Study|Adverse Event|7|||
129551086|NCT03033069|466312956|FG002|Overall Study|Adverse Event|4|||
129551087|NCT03033069|466312957|FG003|Overall Study|Adverse Event|6|||
129551088|NCT03033069|466312954|FG000|Overall Study|Lack of Efficacy|0|||
129551089|NCT03033069|466312955|FG001|Overall Study|Lack of Efficacy|0|||
129551090|NCT03033069|466312956|FG002|Overall Study|Lack of Efficacy|1|||
129551091|NCT03033069|466312957|FG003|Overall Study|Lack of Efficacy|0|||
129551092|NCT03033069|466312954|FG000|Overall Study|Lost to Follow-up|6|||
129551093|NCT03033069|466312955|FG001|Overall Study|Lost to Follow-up|5|||
129551094|NCT03033069|466312956|FG002|Overall Study|Lost to Follow-up|5|||
129551095|NCT03033069|466312957|FG003|Overall Study|Lost to Follow-up|6|||
129551096|NCT03033069|466312954|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129551097|NCT03033069|466312955|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129551098|NCT03033069|466312956|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129551099|NCT03033069|466312957|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129551100|NCT03033069|466312954|FG000|Overall Study|Protocol Deviation|0|||
129551101|NCT03033069|466312955|FG001|Overall Study|Protocol Deviation|1|||
129551102|NCT03033069|466312956|FG002|Overall Study|Protocol Deviation|0|||
129551103|NCT03033069|466312957|FG003|Overall Study|Protocol Deviation|0|||
129884436|NCT02572817|467536394|FG000|Overall Study|Death|6|||
129551104|NCT03033069|466312954|FG000|Overall Study|Withdrawal by Subject|10|||
129551105|NCT03033069|466312955|FG001|Overall Study|Withdrawal by Subject|10|||
129551106|NCT03033069|466312956|FG002|Overall Study|Withdrawal by Subject|11|||
129551107|NCT03033069|466312957|FG003|Overall Study|Withdrawal by Subject|6|||
129551108|NCT03033069|466312954|FG000|Overall Study|Withdrawal By Caregiver|1|||
129551109|NCT03033069|466312955|FG001|Overall Study|Withdrawal By Caregiver|0|||
129551110|NCT03033069|466312956|FG002|Overall Study|Withdrawal By Caregiver|0|||
129551111|NCT03033069|466312957|FG003|Overall Study|Withdrawal By Caregiver|0|||
129551112|NCT03033069|466312954|FG000|Overall Study|Reason not Specified|0|||
129551113|NCT03033069|466312955|FG001|Overall Study|Reason not Specified|1|||
129551114|NCT03033069|466312956|FG002|Overall Study|Reason not Specified|0|||
129551115|NCT03033069|466312957|FG003|Overall Study|Reason not Specified|1|||
129551116|NCT02623426|466312960|FG000|Overall Study|Lost to Follow-up|0|||
129551117|NCT02623426|466312961|FG001|Overall Study|Lost to Follow-up|0|||
129551118|NCT02623426|466312962|FG002|Overall Study|Lost to Follow-up|1|||
129551119|NCT02623426|466312960|FG000|Overall Study|Withdrawal by Subject|1|||
129551120|NCT02623426|466312961|FG001|Overall Study|Withdrawal by Subject|2|||
129551121|NCT02623426|466312962|FG002|Overall Study|Withdrawal by Subject|2|||
129551122|NCT05458895|466312967|FG000|Overall Study|Withdrawal by Subject|8|||
129551123|NCT05458895|466312967|FG000|Overall Study|Lost to Follow-up|17|||
129551124|NCT05458895|466312967|FG000|Overall Study|Pregnancy|2|||
129551125|NCT05458895|466312967|FG000|Overall Study|Withdrawal by Study Team|1|||
129551126|NCT04639310|466312968|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
129551127|NCT04639310|466312969|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
129551128|NCT00700310|466314707|FG000|Overall Study|Adverse Event|6|||
129551129|NCT00700310|466314708|FG001|Overall Study|Adverse Event|10|||
129551130|NCT00700310|466314709|FG002|Overall Study|Adverse Event|5|||
129551131|NCT00700310|466314710|FG003|Overall Study|Adverse Event|11|||
129685271|NCT01147458|466804321|FG000|First Intervention|Withdrawal by Subject|3|||
129685272|NCT01147458|466804322|FG001|First Intervention|Withdrawal by Subject|0|||
129685273|NCT01147458|466804323|FG002|First Intervention|Withdrawal by Subject|1|||
129685274|NCT01147458|466804324|FG003|First Intervention|Withdrawal by Subject|0|||
129685275|NCT01147458|466804321|FG000|First Intervention|Adverse Event|0|||
129685276|NCT01147458|466804322|FG001|First Intervention|Adverse Event|3|||
129685277|NCT01147458|466804323|FG002|First Intervention|Adverse Event|2|||
129685278|NCT01147458|466804324|FG003|First Intervention|Adverse Event|3|||
129685279|NCT01147458|466804321|FG000|First Intervention|Other|1|||
129685280|NCT01147458|466804322|FG001|First Intervention|Other|2|||
129685281|NCT01147458|466804323|FG002|First Intervention|Other|0|||
129685282|NCT01147458|466804324|FG003|First Intervention|Other|0|||
129685283|NCT01147458|466804321|FG000|Second Intervention|Study terminated by sponsor|7|||
129685284|NCT01147458|466804322|FG001|Second Intervention|Study terminated by sponsor|5|||
129685285|NCT01147458|466804323|FG002|Second Intervention|Study terminated by sponsor|5|||
129685286|NCT01147458|466804324|FG003|Second Intervention|Study terminated by sponsor|3|||
129685287|NCT01147458|466804321|FG000|Second Intervention|Protocol Violation|0|||
129685288|NCT01147458|466804322|FG001|Second Intervention|Protocol Violation|1|||
129685289|NCT01147458|466804323|FG002|Second Intervention|Protocol Violation|1|||
129685290|NCT01147458|466804324|FG003|Second Intervention|Protocol Violation|0|||
129685291|NCT01147458|466804321|FG000|Second Intervention|Withdrawal by Subject|0|||
129685292|NCT01147458|466804322|FG001|Second Intervention|Withdrawal by Subject|1|||
129685293|NCT01147458|466804323|FG002|Second Intervention|Withdrawal by Subject|0|||
129685294|NCT01147458|466804324|FG003|Second Intervention|Withdrawal by Subject|0|||
129685295|NCT01147458|466804321|FG000|Second Intervention|Adverse Event|2|||
129685296|NCT01147458|466804322|FG001|Second Intervention|Adverse Event|0|||
129685297|NCT01147458|466804323|FG002|Second Intervention|Adverse Event|1|||
129685298|NCT01147458|466804324|FG003|Second Intervention|Adverse Event|1|||
129685299|NCT01147458|466804321|FG000|Second Intervention|Other|0|||
129685300|NCT01147458|466804322|FG001|Second Intervention|Other|0|||
129685301|NCT01147458|466804323|FG002|Second Intervention|Other|1|||
129685302|NCT01147458|466804324|FG003|Second Intervention|Other|0|||
129551132|NCT00700310|466314707|FG000|Overall Study|Lost to Follow-up|4|||
129551133|NCT00700310|466314708|FG001|Overall Study|Lost to Follow-up|1|||
129551134|NCT00700310|466314709|FG002|Overall Study|Lost to Follow-up|0|||
129551135|NCT00700310|466314710|FG003|Overall Study|Lost to Follow-up|1|||
129685303|NCT03550209|466804325|FG000|Overall Study|Lost to Follow-up|1|||
129685304|NCT03550209|466804326|FG001|Overall Study|Lost to Follow-up|0|||
129685305|NCT03550209|466804327|FG002|Overall Study|Lost to Follow-up|1|||
129685306|NCT03550209|466804328|FG003|Overall Study|Lost to Follow-up|0|||
129685307|NCT03550209|466804325|FG000|Overall Study|Withdrawal by Subject|0|||
129685308|NCT03550209|466804326|FG001|Overall Study|Withdrawal by Subject|3|||
129685309|NCT03550209|466804327|FG002|Overall Study|Withdrawal by Subject|1|||
129685310|NCT03550209|466804328|FG003|Overall Study|Withdrawal by Subject|2|||
129685311|NCT03550209|466804325|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
129685312|NCT03550209|466804326|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
129685313|NCT03550209|466804327|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
129685314|NCT03550209|466804328|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
129685315|NCT02555878|466804329|FG000|Overall Study|Lost to Follow-up|2|||
129685316|NCT02555878|466804330|FG001|Overall Study|Lost to Follow-up|3|||
129685317|NCT02555878|466804329|FG000|Overall Study|Withdrawal by Subject|48|||
129685318|NCT02555878|466804330|FG001|Overall Study|Withdrawal by Subject|48|||
129685319|NCT02555878|466804329|FG000|Overall Study|Adverse Event|12|||
129685320|NCT02555878|466804330|FG001|Overall Study|Adverse Event|8|||
129685321|NCT02555878|466804329|FG000|Overall Study|Death|74|||
129685322|NCT02555878|466804330|FG001|Overall Study|Death|59|||
129685323|NCT02555878|466804329|FG000|Overall Study|Protocol Violation|1|||
129685324|NCT02555878|466804330|FG001|Overall Study|Protocol Violation|2|||
129685325|NCT02555878|466804329|FG000|Overall Study|Physician Decision|12|||
129685326|NCT02555878|466804330|FG001|Overall Study|Physician Decision|13|||
129685327|NCT02555878|466804329|FG000|Overall Study|Other|17|||
129685328|NCT02555878|466804330|FG001|Overall Study|Other|17|||
129685329|NCT00765076|466804331|FG000|Overall Study|Adverse Event|1|||
129685330|NCT00765076|466804332|FG001|Overall Study|Adverse Event|0|||
129685331|NCT00765076|466804333|FG002|Overall Study|Adverse Event|0|||
129685332|NCT00765076|466804331|FG000|Overall Study|Withdrawal by Subject|0|||
129685333|NCT00765076|466804332|FG001|Overall Study|Withdrawal by Subject|0|||
129685334|NCT00765076|466804333|FG002|Overall Study|Withdrawal by Subject|1|||
129685335|NCT02875080|466804334|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
129685336|NCT02875080|466804335|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
129685337|NCT02875080|466804336|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
129685338|NCT00768053|466804337|FG000|Overall Study|Adverse Event|10|||
129685339|NCT00768053|466804337|FG000|Overall Study|Lost to Follow-up|1|||
129685340|NCT01164475|466804338|FG000|Overall Study|Lack of Efficacy|1|||
129685341|NCT01164475|466804339|FG001|Overall Study|Lack of Efficacy|0|||
129685342|NCT01164475|466804338|FG000|Overall Study|Other|0|||
129685343|NCT01164475|466804339|FG001|Overall Study|Other|1|||
129685344|NCT01164475|466804338|FG000|Overall Study|Progressive disease|0|||
129685345|NCT01164475|466804339|FG001|Overall Study|Progressive disease|1|||
129685346|NCT01164475|466804338|FG000|Overall Study|Protocol Violation|1|||
129685347|NCT01164475|466804339|FG001|Overall Study|Protocol Violation|0|||
129685348|NCT03244189|466804341|FG000|Overall Study|Death|0|||
129685349|NCT03244189|466804342|FG001|Overall Study|Death|2|||
129685350|NCT03244189|466804341|FG000|Overall Study|Lost to Follow-up|92|||
129685351|NCT03244189|466804342|FG001|Overall Study|Lost to Follow-up|107|||
129685352|NCT03244189|466804341|FG000|Overall Study|Physician Decision|4|||
129685353|NCT03244189|466804342|FG001|Overall Study|Physician Decision|2|||
129685354|NCT03244189|466804341|FG000|Overall Study|Pregnancy|7|||
129685355|NCT03244189|466804342|FG001|Overall Study|Pregnancy|5|||
129685356|NCT03244189|466804341|FG000|Overall Study|Protocol Violation|0|||
129685357|NCT03244189|466804342|FG001|Overall Study|Protocol Violation|2|||
129685358|NCT03244189|466804341|FG000|Overall Study|Withdrawal by Subject|45|||
129685359|NCT03244189|466804342|FG001|Overall Study|Withdrawal by Subject|23|||
129685360|NCT03244189|466804341|FG000|Overall Study|Technical Problems|2|||
129685361|NCT03244189|466804342|FG001|Overall Study|Technical Problems|0|||
129685362|NCT06170827|466804343|FG000|Overall Study|Withdrawal by Subject|1|||
129685363|NCT06170827|466804344|FG001|Overall Study|Withdrawal by Subject|1|||
129685364|NCT03421808|466804349|FG000|Overall Study|COVID related problems|2|||
129685365|NCT03421808|466804350|FG001|Overall Study|COVID related problems|0|||
129685366|NCT03421808|466804349|FG000|Overall Study|Withdrawal by Subject|1|||
129685367|NCT03421808|466804350|FG001|Overall Study|Withdrawal by Subject|0|||
129685368|NCT03421808|466804349|FG000|Overall Study|Protocol Violation|0|||
129685369|NCT03421808|466804350|FG001|Overall Study|Protocol Violation|1|||
129685370|NCT02180867|466804353|FG000|Overall Study|Adverse Event|3|||
129685371|NCT02180867|466804354|FG001|Overall Study|Adverse Event|4|||
129685372|NCT02180867|466804355|FG002|Overall Study|Adverse Event|1|||
129685373|NCT02180867|466804356|FG003|Overall Study|Adverse Event|5|||
129685374|NCT02180867|466804357|FG004|Overall Study|Adverse Event|0|||
129685375|NCT02180867|466804358|FG005|Overall Study|Adverse Event|0|||
129685376|NCT02180867|466804359|FG006|Overall Study|Adverse Event|0|||
129685377|NCT02180867|466804353|FG000|Overall Study|Death|0|||
129685378|NCT02180867|466804354|FG001|Overall Study|Death|0|||
129685379|NCT02180867|466804355|FG002|Overall Study|Death|0|||
129685380|NCT02180867|466804356|FG003|Overall Study|Death|0|||
129685381|NCT02180867|466804357|FG004|Overall Study|Death|1|||
129685382|NCT02180867|466804358|FG005|Overall Study|Death|0|||
129685383|NCT02180867|466804359|FG006|Overall Study|Death|0|||
129685384|NCT02180867|466804353|FG000|Overall Study|Lack of Efficacy|0|||
129685385|NCT02180867|466804354|FG001|Overall Study|Lack of Efficacy|2|||
129685386|NCT02180867|466804355|FG002|Overall Study|Lack of Efficacy|0|||
129685387|NCT02180867|466804356|FG003|Overall Study|Lack of Efficacy|1|||
129551136|NCT00700310|466314707|FG000|Overall Study|Withdrawal by Subject|8|||
129551137|NCT00700310|466314708|FG001|Overall Study|Withdrawal by Subject|9|||
129551138|NCT00700310|466314709|FG002|Overall Study|Withdrawal by Subject|8|||
129551139|NCT00700310|466314710|FG003|Overall Study|Withdrawal by Subject|8|||
129551140|NCT00700310|466314707|FG000|Overall Study|Lack of Efficacy|0|||
129551141|NCT00700310|466314708|FG001|Overall Study|Lack of Efficacy|3|||
129551142|NCT00700310|466314709|FG002|Overall Study|Lack of Efficacy|0|||
129551143|NCT00700310|466314710|FG003|Overall Study|Lack of Efficacy|1|||
129551144|NCT00700310|466314707|FG000|Overall Study|Administrative/Other|1|||
129551145|NCT00700310|466314708|FG001|Overall Study|Administrative/Other|3|||
129551146|NCT00700310|466314709|FG002|Overall Study|Administrative/Other|1|||
129551147|NCT00700310|466314710|FG003|Overall Study|Administrative/Other|3|||
129551148|NCT00700310|466314707|FG000|Overall Study|Randomized, Not Treated|2|||
129551149|NCT00700310|466314708|FG001|Overall Study|Randomized, Not Treated|0|||
129551150|NCT00700310|466314709|FG002|Overall Study|Randomized, Not Treated|2|||
129551151|NCT00700310|466314710|FG003|Overall Study|Randomized, Not Treated|2|||
129551152|NCT04575038|466314711|FG000|Overall Study|Withdrawal by Subject|1|||
129551153|NCT04575038|466314712|FG001|Overall Study|Withdrawal by Subject|1|||
129551154|NCT01084603|466314717|FG000|Baseline|Withdrawal by Subject|2|||
129551155|NCT01084603|466314717|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
129551156|NCT01084603|466314717|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
129551157|NCT01084603|466314717|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
129551158|NCT01084603|466314717|FG000|Washout Period 4|Adverse Event|1|||
129551159|NCT04388527|466314719|FG000|Overall Study|Death|14|||
129551160|NCT04388527|466314719|FG000|Overall Study|Withdrawal by Subject|2|||
129551161|NCT04388527|466314719|FG000|Overall Study|Lost to Follow-up|1|||
129551162|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
129551163|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
129551164|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
129551165|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
129551166|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
129551167|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
129551168|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
129551169|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
129551170|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
129551171|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
129551172|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
129551173|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
129551174|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
129551175|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
129551176|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
129551177|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
129551178|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
129551179|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
129551180|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
129551181|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
129551182|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
129551183|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
129551184|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
129551185|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
129551186|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
129551187|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
129551188|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
129551189|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
129551190|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
129551191|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
129551192|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
129551193|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
129551194|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
129551195|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
129551196|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
129551197|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
129551198|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
129551199|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
129551200|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
129551201|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
129551202|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
129685388|NCT02180867|466804357|FG004|Overall Study|Lack of Efficacy|6|||
129685389|NCT02180867|466804358|FG005|Overall Study|Lack of Efficacy|0|||
129685390|NCT02180867|466804359|FG006|Overall Study|Lack of Efficacy|1|||
129685391|NCT02180867|466804353|FG000|Overall Study|Physician Decision|1|||
129685392|NCT02180867|466804354|FG001|Overall Study|Physician Decision|3|||
129685393|NCT02180867|466804355|FG002|Overall Study|Physician Decision|1|||
129685394|NCT02180867|466804356|FG003|Overall Study|Physician Decision|10|||
129685395|NCT02180867|466804357|FG004|Overall Study|Physician Decision|9|||
129685396|NCT02180867|466804358|FG005|Overall Study|Physician Decision|3|||
129685397|NCT02180867|466804359|FG006|Overall Study|Physician Decision|4|||
129685398|NCT02180867|466804353|FG000|Overall Study|Withdrawal by Subject|0|||
129685399|NCT02180867|466804354|FG001|Overall Study|Withdrawal by Subject|0|||
129685400|NCT02180867|466804355|FG002|Overall Study|Withdrawal by Subject|0|||
129685401|NCT02180867|466804356|FG003|Overall Study|Withdrawal by Subject|1|||
129685402|NCT02180867|466804357|FG004|Overall Study|Withdrawal by Subject|1|||
129685403|NCT02180867|466804358|FG005|Overall Study|Withdrawal by Subject|0|||
129685404|NCT02180867|466804359|FG006|Overall Study|Withdrawal by Subject|0|||
129685405|NCT02180867|466804353|FG000|Overall Study|Ineligible|1|||
129685406|NCT02180867|466804354|FG001|Overall Study|Ineligible|2|||
129685407|NCT02180867|466804355|FG002|Overall Study|Ineligible|0|||
129685408|NCT02180867|466804356|FG003|Overall Study|Ineligible|3|||
129685409|NCT02180867|466804357|FG004|Overall Study|Ineligible|5|||
129685410|NCT02180867|466804358|FG005|Overall Study|Ineligible|0|||
129685411|NCT02180867|466804359|FG006|Overall Study|Ineligible|0|||
129685412|NCT02180867|466804353|FG000|Overall Study|Repeat Eligibility Studies|0|||
129685413|NCT02180867|466804354|FG001|Overall Study|Repeat Eligibility Studies|0|||
129685414|NCT02180867|466804355|FG002|Overall Study|Repeat Eligibility Studies|0|||
129685415|NCT02180867|466804356|FG003|Overall Study|Repeat Eligibility Studies|0|||
129685416|NCT02180867|466804357|FG004|Overall Study|Repeat Eligibility Studies|1|||
129685417|NCT02180867|466804358|FG005|Overall Study|Repeat Eligibility Studies|0|||
129685418|NCT02180867|466804359|FG006|Overall Study|Repeat Eligibility Studies|0|||
129685419|NCT02180867|466804353|FG000|Overall Study|Refusal of further protocol therapy|1|||
129685420|NCT02180867|466804354|FG001|Overall Study|Refusal of further protocol therapy|0|||
129685421|NCT02180867|466804355|FG002|Overall Study|Refusal of further protocol therapy|2|||
129685422|NCT02180867|466804356|FG003|Overall Study|Refusal of further protocol therapy|6|||
129685423|NCT02180867|466804357|FG004|Overall Study|Refusal of further protocol therapy|4|||
129685424|NCT02180867|466804358|FG005|Overall Study|Refusal of further protocol therapy|0|||
129685425|NCT02180867|466804359|FG006|Overall Study|Refusal of further protocol therapy|0|||
129685426|NCT02337686|466804360|FG000|Overall Study|Adverse Event|1|||
129685427|NCT00177671|466805251|FG000|Overall Study|Withdrawal by Subject|5|||
129685428|NCT00177671|466805252|FG001|Overall Study|Withdrawal by Subject|6|||
129685429|NCT00177671|466805251|FG000|Overall Study|medical complications|2|||
129685430|NCT00177671|466805252|FG001|Overall Study|medical complications|0|||
129685431|NCT00177671|466805251|FG000|Overall Study|Adverse Event|6|||
129685432|NCT00177671|466805252|FG001|Overall Study|Adverse Event|0|||
129685433|NCT00177671|466805251|FG000|Overall Study|Physician Decision|12|||
129685434|NCT00177671|466805252|FG001|Overall Study|Physician Decision|8|||
129685435|NCT02293499|466805253|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
129685436|NCT02293499|466805254|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
129685437|NCT02293499|466805255|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
129685438|NCT02293499|466805253|FG000|Intervention - Camp|Withdrawal by Subject|3|||
129685439|NCT02293499|466805254|FG001|Intervention - Camp|Withdrawal by Subject|6|||
129685440|NCT02293499|466805255|FG002|Intervention - Camp|Withdrawal by Subject|2|||
129685441|NCT02293499|466805253|FG000|Intervention - Camp|these are those not showing up at camp|24|||
129685442|NCT02293499|466805254|FG001|Intervention - Camp|these are those not showing up at camp|28|||
129685443|NCT02293499|466805255|FG002|Intervention - Camp|these are those not showing up at camp|4|||
129685444|NCT02293499|466805253|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
129685445|NCT02293499|466805254|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
129685446|NCT02293499|466805255|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
129685447|NCT02293499|466805253|FG000|3 Month Follow Up|Lost to Follow-up|14|||
129685448|NCT02293499|466805254|FG001|3 Month Follow Up|Lost to Follow-up|15|||
129685449|NCT02293499|466805255|FG002|3 Month Follow Up|Lost to Follow-up|6|||
129685450|NCT02293499|466805253|FG000|6 Month Follow Up|Lost to Follow-up|17|||
129685451|NCT02293499|466805254|FG001|6 Month Follow Up|Lost to Follow-up|27|||
129685452|NCT02293499|466805255|FG002|6 Month Follow Up|Lost to Follow-up|6|||
129685453|NCT02293499|466805253|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
129685454|NCT02293499|466805254|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
129685455|NCT02293499|466805255|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
129685456|NCT02293499|466805253|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
129685457|NCT02293499|466805254|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
129685458|NCT02293499|466805255|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
129685459|NCT02293499|466805253|FG000|9 Month Follow Up|Lost to Follow-up|24|||
129685460|NCT02293499|466805254|FG001|9 Month Follow Up|Lost to Follow-up|28|||
129685461|NCT02293499|466805255|FG002|9 Month Follow Up|Lost to Follow-up|4|||
129551203|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
129551204|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
129551205|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
129551206|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
129551207|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
129551208|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
129551209|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
129551210|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
129551211|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
129551212|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
129551213|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
129551214|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
129551215|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
129551216|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
129551217|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
129551218|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
129551219|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
129551220|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
129551221|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
129551222|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
129551223|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
129551224|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
129551225|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
129551226|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
129551227|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
129551228|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
129551229|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
129551230|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
129551231|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
129551232|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
129551233|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
129551234|NCT04440163|466314720|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
129551235|NCT04440163|466314721|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
129551236|NCT04440163|466314722|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
129551237|NCT04440163|466314723|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
129551238|NCT04440163|466314724|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
129551239|NCT04440163|466314725|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
129551240|NCT04440163|466314726|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
129551241|NCT04440163|466314727|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
129551242|NCT04440163|466314720|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
129551243|NCT04440163|466314721|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
129551244|NCT04440163|466314722|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
129551245|NCT04440163|466314723|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
129551246|NCT04440163|466314724|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
129551247|NCT04440163|466314725|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
129551248|NCT04440163|466314726|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
129551249|NCT04440163|466314727|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
129551250|NCT04440163|466314720|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551251|NCT04440163|466314721|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551252|NCT04440163|466314722|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551253|NCT04440163|466314723|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
129551254|NCT04440163|466314724|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551255|NCT04440163|466314725|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551256|NCT04440163|466314726|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551257|NCT04440163|466314727|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
129551258|NCT02018042|466314730|FG000|Overall Study|Withdrawal by Subject|1|||
129551259|NCT01954082|466314731|FG000|Overall Study|Study Suspension|42|||
129551260|NCT01954082|466314732|FG001|Overall Study|Study Suspension|36|||
129551261|NCT01954082|466314731|FG000|Overall Study|Adverse Event|10|||
129551262|NCT01954082|466314732|FG001|Overall Study|Adverse Event|4|||
129551263|NCT01954082|466314731|FG000|Overall Study|Intolerance|0|||
129551264|NCT01954082|466314732|FG001|Overall Study|Intolerance|1|||
129551265|NCT01954082|466314731|FG000|Overall Study|Non-compliance|6|||
129551266|NCT01954082|466314732|FG001|Overall Study|Non-compliance|4|||
129551267|NCT01954082|466314731|FG000|Overall Study|Physician Decision|2|||
129551268|NCT01954082|466314732|FG001|Overall Study|Physician Decision|0|||
129551269|NCT01954082|466314731|FG000|Overall Study|Parent Decision|1|||
129551270|NCT01954082|466314732|FG001|Overall Study|Parent Decision|0|||
129551271|NCT01954082|466314731|FG000|Overall Study|Withdrawal by Subject|0|||
129551272|NCT01954082|466314732|FG001|Overall Study|Withdrawal by Subject|1|||
129551273|NCT01954082|466314731|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
129551274|NCT01954082|466314732|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
129551275|NCT01954082|466314731|FG000|Overall Study|Redirection of Care|0|||
129551276|NCT01954082|466314732|FG001|Overall Study|Redirection of Care|2|||
129551277|NCT01954082|466314731|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
129551278|NCT01954082|466314732|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
129774281|NCT03278249|467138255|FG000|Overall Study|Lost to Follow-up|1|||
129774282|NCT04988477|467138256|FG000|Overall Study|Death|1|||
129774283|NCT04988477|467138257|FG001|Overall Study|Death|0|||
129774284|NCT04988477|467138258|FG002|Overall Study|Death|0|||
129774285|NCT04988477|467138256|FG000|Overall Study|Lost to Follow-up|5|||
129774286|NCT04988477|467138257|FG001|Overall Study|Lost to Follow-up|2|||
129774287|NCT04988477|467138258|FG002|Overall Study|Lost to Follow-up|0|||
129774288|NCT04988477|467138256|FG000|Overall Study|Withdrawal by Subject|2|||
129774289|NCT04988477|467138257|FG001|Overall Study|Withdrawal by Subject|0|||
129774290|NCT04988477|467138258|FG002|Overall Study|Withdrawal by Subject|0|||
129774291|NCT01354899|467139599|FG000|Overall Study|discharge from the hospital|2|||
129774292|NCT01354899|467139599|FG000|Overall Study|Protocol Violation|1|||
129774293|NCT01071798|467139600|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
129774294|NCT01071798|467139600|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
129774295|NCT01071798|467139600|FG000|Participants Who Received One Cycle|Patient requirement|20|||
129774296|NCT01071798|467139600|FG000|Participants Who Received One Cycle|Death|5|||
129774297|NCT01071798|467139600|FG000|Participants Who Received One Cycle|Change of therapy|6|||
129774298|NCT01071798|467139600|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
129774299|NCT01071798|467139600|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
129774300|NCT01071798|467139600|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
129774301|NCT01071798|467139600|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
129774302|NCT01071798|467139600|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
129774303|NCT00641667|467139601|FG000|Overall Study|Withdrawal by Subject|1|||
129774304|NCT00641667|467139601|FG000|Overall Study|Adverse Event|1|||
129774305|NCT00641667|467139601|FG000|Overall Study|Physician Decision|1|||
129774306|NCT00641667|467139601|FG000|Overall Study|Worsening of underlying disease|3|||
129774307|NCT03349034|467139602|FG000|Overall Study|catheters dislodged during transport|2|||
129774308|NCT03349034|467139603|FG001|Overall Study|catheters dislodged during transport|0|||
129774309|NCT03349034|467139602|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
129774310|NCT03349034|467139603|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
129774311|NCT03349034|467139602|FG000|Overall Study|soft tissue flap used|1|||
129774312|NCT03349034|467139603|FG001|Overall Study|soft tissue flap used|0|||
129774313|NCT03349034|467139602|FG000|Overall Study|Other|0|||
129774314|NCT03349034|467139603|FG001|Overall Study|Other|1|||
129774315|NCT00865566|467139604|FG000|Overall Study|Death|1|||
129774316|NCT00865566|467139605|FG001|Overall Study|Death|11|||
129774317|NCT00865566|467139604|FG000|Overall Study|Lost to Follow-up|314|||
129774318|NCT00865566|467139605|FG001|Overall Study|Lost to Follow-up|315|||
129774319|NCT00865566|467139604|FG000|Overall Study|Withdrawal by Subject|45|||
129774320|NCT00865566|467139605|FG001|Overall Study|Withdrawal by Subject|65|||
129774321|NCT00865566|467139604|FG000|Overall Study|Physician Decision|0|||
129774322|NCT00865566|467139605|FG001|Overall Study|Physician Decision|1|||
129774323|NCT00865566|467139604|FG000|Overall Study|Participant relocated|78|||
129774324|NCT00865566|467139605|FG001|Overall Study|Participant relocated|107|||
129774325|NCT00865566|467139604|FG000|Overall Study|Participant unable to adhere|27|||
129774326|NCT00865566|467139605|FG001|Overall Study|Participant unable to adhere|42|||
129774327|NCT00865566|467139604|FG000|Overall Study|Other; N=245 due to early study closure|154|||
129774328|NCT00865566|467139605|FG001|Overall Study|Other; N=245 due to early study closure|139|||
129774329|NCT00865566|467139604|FG000|Overall Study|HIV infection|5|||
129774330|NCT00865566|467139605|FG001|Overall Study|HIV infection|7|||
129774331|NCT00815659|467139606|FG000|Overall Study|Adverse Event|9|||
129551279|NCT01954082|466314731|FG000|Overall Study|Comfort Care|0|||
129551280|NCT01954082|466314732|FG001|Overall Study|Comfort Care|1|||
129551281|NCT01954082|466314731|FG000|Overall Study|Infant Moved|0|||
129774332|NCT00815659|467139606|FG000|Overall Study|Withdrawal by Subject|9|||
129774333|NCT00815659|467139606|FG000|Overall Study|Lost to Follow-up|4|||
129774334|NCT00815659|467139606|FG000|Overall Study|Protocol Violation|1|||
129774335|NCT02395471|467139607|FG000|Overall Study|Lost to Follow-up|2|||
129774336|NCT02395471|467139608|FG001|Overall Study|Lost to Follow-up|0|||
129774337|NCT02395471|467139607|FG000|Overall Study|Withdrawal by Subject|2|||
129774338|NCT02395471|467139608|FG001|Overall Study|Withdrawal by Subject|1|||
129774339|NCT02395471|467139607|FG000|Overall Study|Physician Decision|1|||
129774340|NCT02395471|467139608|FG001|Overall Study|Physician Decision|0|||
129551282|NCT01954082|466314732|FG001|Overall Study|Infant Moved|1|||
129551283|NCT01954082|466314731|FG000|Overall Study|Randomized not Treated|4|||
129551284|NCT01954082|466314732|FG001|Overall Study|Randomized not Treated|2|||
129551285|NCT00417027|466314735|FG000|Overall Study|Protocol Violation|0|||
129551286|NCT00417027|466314736|FG001|Overall Study|Protocol Violation|5|||
129551287|NCT00417027|466314737|FG002|Overall Study|Protocol Violation|5|||
129551288|NCT00707174|466314738|FG000|Overall Study|Adverse Event|1|||
129551289|NCT00707174|466314739|FG001|Overall Study|Adverse Event|6|||
129551290|NCT00707174|466314738|FG000|Overall Study|Withdrawal by Subject|4|||
129551291|NCT00707174|466314739|FG001|Overall Study|Withdrawal by Subject|1|||
129551292|NCT00618774|466314742|FG000|Overall Study|Adverse Event|5|||
129551293|NCT00618774|466314743|FG001|Overall Study|Adverse Event|3|||
129551294|NCT00618774|466314742|FG000|Overall Study|Withdrawal by Subject|1|||
129551295|NCT00618774|466314743|FG001|Overall Study|Withdrawal by Subject|0|||
129551296|NCT00572156|466314744|FG000|Overall Study|Adverse Event|3|||
129551297|NCT00572156|466314745|FG001|Overall Study|Adverse Event|1|||
129551298|NCT00572156|466314746|FG002|Overall Study|Adverse Event|5|||
129551299|NCT00572156|466314747|FG003|Overall Study|Adverse Event|1|||
129551300|NCT00572156|466314744|FG000|Overall Study|Lost to Follow-up|1|||
129551301|NCT00572156|466314745|FG001|Overall Study|Lost to Follow-up|1|||
129551302|NCT00572156|466314746|FG002|Overall Study|Lost to Follow-up|1|||
129551303|NCT00572156|466314747|FG003|Overall Study|Lost to Follow-up|0|||
129551304|NCT00572156|466314744|FG000|Overall Study|Protocol Violation|1|||
129551305|NCT00572156|466314745|FG001|Overall Study|Protocol Violation|2|||
129551306|NCT00572156|466314746|FG002|Overall Study|Protocol Violation|0|||
129551307|NCT00572156|466314747|FG003|Overall Study|Protocol Violation|2|||
129551308|NCT00572156|466314744|FG000|Overall Study|Patient/Parent Decision|1|||
129551309|NCT00572156|466314745|FG001|Overall Study|Patient/Parent Decision|6|||
129551310|NCT00572156|466314746|FG002|Overall Study|Patient/Parent Decision|4|||
129551311|NCT00572156|466314747|FG003|Overall Study|Patient/Parent Decision|3|||
129551312|NCT00572156|466314744|FG000|Overall Study|Sponsor Decision|20|||
129551313|NCT00572156|466314745|FG001|Overall Study|Sponsor Decision|16|||
129551314|NCT00572156|466314746|FG002|Overall Study|Sponsor Decision|17|||
129551315|NCT00572156|466314747|FG003|Overall Study|Sponsor Decision|19|||
129551316|NCT02261974|466314748|FG000|Overall Study|Withdrawal by Subject|3|||
129551317|NCT02261974|466314749|FG001|Overall Study|Withdrawal by Subject|2|||
129551318|NCT02261974|466314748|FG000|Overall Study|Pregnancy|0|||
129551319|NCT02261974|466314749|FG001|Overall Study|Pregnancy|1|||
129551320|NCT02261974|466314748|FG000|Overall Study|Missed treatment cut-off date|6|||
129551321|NCT02261974|466314749|FG001|Overall Study|Missed treatment cut-off date|3|||
129551322|NCT02261974|466314748|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
129551323|NCT02261974|466314749|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
129551324|NCT02261974|466314748|FG000|Overall Study|Lost to Follow-up|2|||
129551325|NCT02261974|466314749|FG001|Overall Study|Lost to Follow-up|0|||
129551326|NCT02261974|466314748|FG000|Overall Study|Adverse Event|1|||
129551327|NCT02261974|466314749|FG001|Overall Study|Adverse Event|0|||
129551328|NCT05180630|466314753|FG000|First Intervention|Physician Decision|0|||
129551329|NCT05180630|466314754|FG001|First Intervention|Physician Decision|0|||
129551330|NCT05180630|466314755|FG002|First Intervention|Physician Decision|3|||
129551331|NCT00709735|466314763|FG000|Overall Study|Lost to Follow-up|1|||
129551332|NCT00709735|466314764|FG001|Overall Study|Lost to Follow-up|1|||
129551333|NCT00709735|466314763|FG000|Overall Study|Relapse into Opioid Abuse|0|||
129551334|NCT00709735|466314764|FG001|Overall Study|Relapse into Opioid Abuse|1|||
129551335|NCT00709735|466314763|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
129551336|NCT00709735|466314764|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
129551337|NCT00666718|466314765|FG000|Overall Study|Adverse Event|0|||
129551338|NCT00666718|466314766|FG001|Overall Study|Adverse Event|1|||
129551339|NCT00666718|466314765|FG000|Overall Study|Death|1|||
129551340|NCT00666718|466314766|FG001|Overall Study|Death|0|||
129551341|NCT00666718|466314765|FG000|Overall Study|Lost to Follow-up|1|||
129551342|NCT00666718|466314766|FG001|Overall Study|Lost to Follow-up|0|||
129551343|NCT00666718|466314765|FG000|Overall Study|Entry Criteria Not Met|2|||
129551344|NCT00666718|466314766|FG001|Overall Study|Entry Criteria Not Met|0|||
129551345|NCT00666718|466314765|FG000|Overall Study|Protocol Violation|1|||
129551346|NCT00666718|466314766|FG001|Overall Study|Protocol Violation|3|||
129551347|NCT00666718|466314765|FG000|Overall Study|Withdrawal by Subject|7|||
129551348|NCT00666718|466314766|FG001|Overall Study|Withdrawal by Subject|12|||
129551349|NCT00666718|466314765|FG000|Overall Study|Physician Decision|0|||
129551350|NCT00666718|466314766|FG001|Overall Study|Physician Decision|2|||
129551351|NCT00963599|466314767|FG000|Overall Study|Adverse Event|2|||
129551352|NCT00963599|466314768|FG001|Overall Study|Adverse Event|0|||
129551353|NCT00963599|466314769|FG002|Overall Study|Adverse Event|1|||
129551354|NCT00963599|466314770|FG003|Overall Study|Adverse Event|2|||
129551355|NCT00963599|466314767|FG000|Overall Study|Lack of Efficacy|0|||
129551356|NCT00963599|466314768|FG001|Overall Study|Lack of Efficacy|2|||
129551357|NCT00963599|466314769|FG002|Overall Study|Lack of Efficacy|1|||
129551358|NCT00963599|466314770|FG003|Overall Study|Lack of Efficacy|4|||
129551359|NCT00963599|466314767|FG000|Overall Study|Lost to Follow-up|0|||
129551360|NCT00963599|466314768|FG001|Overall Study|Lost to Follow-up|1|||
129551361|NCT00963599|466314769|FG002|Overall Study|Lost to Follow-up|1|||
129551362|NCT00963599|466314770|FG003|Overall Study|Lost to Follow-up|1|||
129551363|NCT00963599|466314767|FG000|Overall Study|Protocol Violation|2|||
129551364|NCT00963599|466314768|FG001|Overall Study|Protocol Violation|2|||
129551365|NCT00963599|466314769|FG002|Overall Study|Protocol Violation|3|||
129551366|NCT00963599|466314770|FG003|Overall Study|Protocol Violation|4|||
129551367|NCT00963599|466314767|FG000|Overall Study|Withdrawal by Subject|2|||
129551368|NCT00963599|466314768|FG001|Overall Study|Withdrawal by Subject|1|||
129551369|NCT00963599|466314769|FG002|Overall Study|Withdrawal by Subject|3|||
129551370|NCT00963599|466314770|FG003|Overall Study|Withdrawal by Subject|3|||
129551371|NCT03496207|466314773|FG000|Base Study|Adverse Event|0|||
129551372|NCT03496207|466314774|FG001|Base Study|Adverse Event|0|||
129551373|NCT03496207|466314775|FG002|Base Study|Adverse Event|1|||
129551374|NCT03496207|466314776|FG003|Base Study|Adverse Event|1|||
129551375|NCT03496207|466314777|FG004|Base Study|Adverse Event|4|||
129551376|NCT03496207|466314773|FG000|Base Study|Death|0|||
129551377|NCT03496207|466314774|FG001|Base Study|Death|0|||
129551378|NCT03496207|466314775|FG002|Base Study|Death|0|||
129551379|NCT03496207|466314776|FG003|Base Study|Death|0|||
129551380|NCT03496207|466314777|FG004|Base Study|Death|1|||
129551381|NCT03496207|466314773|FG000|Base Study|Withdrawal by Subject|0|||
129551382|NCT03496207|466314774|FG001|Base Study|Withdrawal by Subject|0|||
129551383|NCT03496207|466314775|FG002|Base Study|Withdrawal by Subject|1|||
129551384|NCT03496207|466314776|FG003|Base Study|Withdrawal by Subject|0|||
129551385|NCT03496207|466314777|FG004|Base Study|Withdrawal by Subject|1|||
129551386|NCT03496207|466314773|FG000|Extension Period|Adverse Event|0|||
129551387|NCT03496207|466314774|FG001|Extension Period|Adverse Event|0|||
129551388|NCT03496207|466314775|FG002|Extension Period|Adverse Event|0|||
129551389|NCT03496207|466314776|FG003|Extension Period|Adverse Event|1|||
129551390|NCT03496207|466314777|FG004|Extension Period|Adverse Event|1|||
129551391|NCT03496207|466314773|FG000|Extension Period|Death|1|||
129551392|NCT03496207|466314774|FG001|Extension Period|Death|0|||
129551393|NCT03496207|466314775|FG002|Extension Period|Death|0|||
129551394|NCT03496207|466314776|FG003|Extension Period|Death|1|||
129551395|NCT03496207|466314777|FG004|Extension Period|Death|2|||
129551396|NCT03496207|466314773|FG000|Extension Period|Withdrawal by Subject|1|||
129551397|NCT03496207|466314774|FG001|Extension Period|Withdrawal by Subject|0|||
129551398|NCT03496207|466314775|FG002|Extension Period|Withdrawal by Subject|0|||
129551399|NCT03496207|466314776|FG003|Extension Period|Withdrawal by Subject|1|||
129551400|NCT03496207|466314777|FG004|Extension Period|Withdrawal by Subject|1|||
129551401|NCT03496207|466314773|FG000|Extension Period|Elevated hemoglobin levels|0|||
129551402|NCT03496207|466314774|FG001|Extension Period|Elevated hemoglobin levels|0|||
129551403|NCT03496207|466314775|FG002|Extension Period|Elevated hemoglobin levels|0|||
129551404|NCT03496207|466314776|FG003|Extension Period|Elevated hemoglobin levels|0|||
129551405|NCT03496207|466314777|FG004|Extension Period|Elevated hemoglobin levels|1|||
129551406|NCT00810615|466314780|FG000|Overall Study|Withdrawal by Subject|1|||
129551407|NCT00810615|466314781|FG001|Overall Study|Withdrawal by Subject|1|||
129551408|NCT02525562|466314782|FG000|Overall Study|Death|9|||
129551409|NCT02525562|466314783|FG001|Overall Study|Death|0|||
129551410|NCT02525562|466314784|FG002|Overall Study|Death|0|||
129551411|NCT02525562|466314782|FG000|Overall Study|Lost to Follow-up|19|||
129551412|NCT02525562|466314783|FG001|Overall Study|Lost to Follow-up|0|||
129551413|NCT02525562|466314784|FG002|Overall Study|Lost to Follow-up|0|||
129551414|NCT02525562|466314782|FG000|Overall Study|Withdrawal by Subject|37|||
129551415|NCT02525562|466314783|FG001|Overall Study|Withdrawal by Subject|0|||
129551416|NCT02525562|466314784|FG002|Overall Study|Withdrawal by Subject|0|||
129551417|NCT02525562|466314782|FG000|Overall Study|Revision/Removal of Study Device|4|||
129551418|NCT02525562|466314783|FG001|Overall Study|Revision/Removal of Study Device|0|||
129551419|NCT02525562|466314784|FG002|Overall Study|Revision/Removal of Study Device|0|||
129551420|NCT02525562|466314782|FG000|Overall Study|Study Closed by Sponsor|154|||
129774341|NCT02395471|467139607|FG000|Overall Study|Protocol Violation|0|||
129774342|NCT02395471|467139608|FG001|Overall Study|Protocol Violation|1|||
129774343|NCT02395471|467139607|FG000|Overall Study|Failure to swollow sponge twice|1|||
129774344|NCT02395471|467139608|FG001|Overall Study|Failure to swollow sponge twice|0|||
129774345|NCT02395471|467139607|FG000|Overall Study|Patient did not return for procedure|0|||
129774346|NCT02395471|467139608|FG001|Overall Study|Patient did not return for procedure|1|||
129774347|NCT02395471|467139607|FG000|Overall Study|Subject not eligible|1|||
129774348|NCT02395471|467139608|FG001|Overall Study|Subject not eligible|0|||
129551421|NCT02525562|466314783|FG001|Overall Study|Study Closed by Sponsor|0|||
129551422|NCT02525562|466314784|FG002|Overall Study|Study Closed by Sponsor|0|||
129551423|NCT02567266|466314785|FG000|Overall Study|Withdrawal by Subject|10|||
129551424|NCT02567266|466314786|FG001|Overall Study|Withdrawal by Subject|7|||
129551425|NCT02567266|466314787|FG002|Overall Study|Withdrawal by Subject|6|||
129774349|NCT03847896|467139609|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129551426|NCT02567266|466314785|FG000|Overall Study|Lost to Follow-up|13|||
129551427|NCT02567266|466314786|FG001|Overall Study|Lost to Follow-up|8|||
129551428|NCT02567266|466314787|FG002|Overall Study|Lost to Follow-up|10|||
129551429|NCT02164539|466314788|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
129551430|NCT02164539|466314789|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
129551431|NCT02164539|466314790|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
129551432|NCT02164539|466314791|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
129551433|NCT02164539|466314792|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
129551434|NCT02164539|466314793|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
129551435|NCT02164539|466314794|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
129551436|NCT02164539|466314788|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
129551437|NCT02164539|466314789|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
129551438|NCT02164539|466314790|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
129551439|NCT02164539|466314791|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
129551440|NCT02164539|466314792|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
129551441|NCT02164539|466314793|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
129551442|NCT02164539|466314794|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
129551443|NCT02164539|466314788|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
129551444|NCT02164539|466314789|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
129774350|NCT03847896|467139610|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129774351|NCT03847896|467139611|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
129774352|NCT03847896|467139612|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129774353|NCT03847896|467139613|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
129774354|NCT03847896|467139609|FG000|Overall Study|Withdrawal by Subject|2|||
129774355|NCT03847896|467139610|FG001|Overall Study|Withdrawal by Subject|10|||
129774356|NCT03847896|467139611|FG002|Overall Study|Withdrawal by Subject|5|||
129774357|NCT03847896|467139612|FG003|Overall Study|Withdrawal by Subject|9|||
129774358|NCT03847896|467139613|FG004|Overall Study|Withdrawal by Subject|8|||
129774359|NCT03847896|467139609|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129774360|NCT03847896|467139610|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129774361|NCT03847896|467139611|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129774362|NCT03847896|467139612|FG003|Overall Study|Withdrawal by parent/guardian|0|||
129774363|NCT03847896|467139613|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129774364|NCT03847896|467139609|FG000|Overall Study|Adverse Event|2|||
129774365|NCT03847896|467139610|FG001|Overall Study|Adverse Event|1|||
129774366|NCT03847896|467139611|FG002|Overall Study|Adverse Event|3|||
129774367|NCT03847896|467139612|FG003|Overall Study|Adverse Event|2|||
129774368|NCT03847896|467139613|FG004|Overall Study|Adverse Event|4|||
129774369|NCT03847896|467139609|FG000|Overall Study|A severe exacerbation event|0|||
129551445|NCT02164539|466314790|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
129551446|NCT02164539|466314791|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
129551447|NCT02164539|466314792|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
129551448|NCT02164539|466314793|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
129551449|NCT02164539|466314794|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
129551450|NCT02164539|466314788|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
129551451|NCT02164539|466314789|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
129551452|NCT02164539|466314790|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
129551453|NCT02164539|466314791|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
129551454|NCT02164539|466314792|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
129551455|NCT02164539|466314793|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
129551456|NCT02164539|466314794|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
129551457|NCT02164539|466314788|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
129551458|NCT02164539|466314789|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
129551459|NCT02164539|466314790|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
129551460|NCT02164539|466314791|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
129551461|NCT02164539|466314792|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
129551462|NCT02164539|466314793|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
129551463|NCT02164539|466314794|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
129551464|NCT02164539|466314788|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
129551465|NCT02164539|466314789|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
129551466|NCT02164539|466314790|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
129551467|NCT02164539|466314791|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
129551468|NCT02164539|466314792|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
129551469|NCT02164539|466314793|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
129551470|NCT02164539|466314794|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
129551471|NCT01255722|466314795|FG000|Overall Study|Adverse Event|0|||
129551472|NCT01255722|466314796|FG001|Overall Study|Adverse Event|1|||
129551473|NCT01255722|466314797|FG002|Overall Study|Adverse Event|1|||
129551474|NCT01255722|466314795|FG000|Overall Study|asymptomatic patient|1|||
129551475|NCT01255722|466314796|FG001|Overall Study|asymptomatic patient|0|||
129551476|NCT01255722|466314797|FG002|Overall Study|asymptomatic patient|0|||
129551477|NCT01255722|466314795|FG000|Overall Study|beta-blocker contraindicated|2|||
129551478|NCT01255722|466314796|FG001|Overall Study|beta-blocker contraindicated|0|||
129551479|NCT01255722|466314797|FG002|Overall Study|beta-blocker contraindicated|0|||
129551480|NCT01612702|466314800|FG000|Overall Study|Protocol Violation|11|||
129551481|NCT01612702|466314801|FG001|Overall Study|Protocol Violation|11|||
129551482|NCT01542736|466314802|FG000|Overall Study|Death|1|||
129551483|NCT02400905|466314803|FG000|Overall Study|Death|24|||
129551484|NCT02400905|466314803|FG000|Overall Study|Lost to Follow-up|18|||
129551485|NCT02400905|466314803|FG000|Overall Study|Withdrawal by Subject|16|||
129551486|NCT02400905|466314803|FG000|Overall Study|Physician Decision|4|||
129551487|NCT02400905|466314803|FG000|Overall Study|Other|1|||
129551488|NCT03091400|466314808|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
129551489|NCT03091400|466314809|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
129551490|NCT00420849|466314812|FG000|Overall Study|Lack of Efficacy|154|||
129551491|NCT00420849|466314812|FG000|Overall Study|Adverse Event|107|||
129551492|NCT00420849|466314812|FG000|Overall Study|Withdrawal by Subject|28|||
129774370|NCT03847896|467139610|FG001|Overall Study|A severe exacerbation event|0|||
129774371|NCT03847896|467139611|FG002|Overall Study|A severe exacerbation event|0|||
129774372|NCT03847896|467139612|FG003|Overall Study|A severe exacerbation event|0|||
129774373|NCT03847896|467139613|FG004|Overall Study|A severe exacerbation event|3|||
129774374|NCT03847896|467139609|FG000|Overall Study|Protocol Violation|0|||
129774375|NCT03847896|467139610|FG001|Overall Study|Protocol Violation|2|||
129774376|NCT03847896|467139611|FG002|Overall Study|Protocol Violation|1|||
129774377|NCT03847896|467139612|FG003|Overall Study|Protocol Violation|0|||
129774378|NCT03847896|467139613|FG004|Overall Study|Protocol Violation|2|||
129774379|NCT03847896|467139609|FG000|Overall Study|Lost to Follow-up|0|||
129774380|NCT03847896|467139610|FG001|Overall Study|Lost to Follow-up|0|||
129774381|NCT03847896|467139611|FG002|Overall Study|Lost to Follow-up|0|||
129774382|NCT03847896|467139612|FG003|Overall Study|Lost to Follow-up|1|||
129774383|NCT03847896|467139613|FG004|Overall Study|Lost to Follow-up|0|||
129774384|NCT03847896|467139609|FG000|Overall Study|Condition under investigation worsened|0|||
129551493|NCT00420849|466314812|FG000|Overall Study|Death|18|||
129551494|NCT00420849|466314812|FG000|Overall Study|Other|14|||
129551495|NCT00420849|466314812|FG000|Overall Study|Transplant|8|||
129551496|NCT00420849|466314812|FG000|Overall Study|Protocol Violation|1|||
129551497|NCT00420849|466314812|FG000|Overall Study|Lost to Follow-up|1|||
129551498|NCT00743119|466314815|FG000|Overall Study|unreliable|3|||
129551499|NCT00743119|466314815|FG000|Overall Study|Withdrawal by Subject|1|||
129774385|NCT03847896|467139610|FG001|Overall Study|Condition under investigation worsened|0|||
129774386|NCT03847896|467139611|FG002|Overall Study|Condition under investigation worsened|0|||
129551500|NCT04816877|466314816|FG000|Overall Study|Withdrawal by Subject|1|||
129551501|NCT04816877|466314817|FG001|Overall Study|Withdrawal by Subject|0|||
129774387|NCT03847896|467139612|FG003|Overall Study|Condition under investigation worsened|1|||
129774388|NCT03847896|467139613|FG004|Overall Study|Condition under investigation worsened|1|||
129551502|NCT02176642|466314819|FG000|Overall Study|Withdrawal by Subject|0|||
129551503|NCT02176642|466314820|FG001|Overall Study|Withdrawal by Subject|1|||
129551504|NCT01309828|466314821|FG000|Overall Study|Adverse Event|10|||
129551505|NCT01309828|466314822|FG001|Overall Study|Adverse Event|11|||
129551506|NCT01309828|466314821|FG000|Overall Study|Voluntary Withdrawal|5|||
129551507|NCT01309828|466314822|FG001|Overall Study|Voluntary Withdrawal|4|||
129551508|NCT01309828|466314821|FG000|Overall Study|Major Protocol Deviation|0|||
129551509|NCT01309828|466314822|FG001|Overall Study|Major Protocol Deviation|1|||
129551510|NCT01309828|466314821|FG000|Overall Study|Other|1|||
129551511|NCT01309828|466314822|FG001|Overall Study|Other|0|||
129551512|NCT00295620|466314823|FG000|Overall Study|Lost to Follow-up|9|||
129551513|NCT00295620|466314824|FG001|Overall Study|Lost to Follow-up|5|||
129551514|NCT00295620|466314823|FG000|Overall Study|Withdrawal by Subject|37|||
129551515|NCT00295620|466314824|FG001|Overall Study|Withdrawal by Subject|50|||
129551516|NCT00295620|466314823|FG000|Overall Study|Death|206|||
129551517|NCT00295620|466314824|FG001|Overall Study|Death|207|||
129551518|NCT00295620|466314823|FG000|Overall Study|Other reasons|10|||
129551519|NCT00295620|466314824|FG001|Overall Study|Other reasons|9|||
129551520|NCT00295620|466314823|FG000|Overall Study|Discontinuation by sponsor|580|||
129551521|NCT00295620|466314824|FG001|Overall Study|Discontinuation by sponsor|593|||
129551522|NCT00295620|466314823|FG000|Overall Study|Protocol Violation|30|||
129551523|NCT00295620|466314824|FG001|Overall Study|Protocol Violation|32|||
129551524|NCT00217971|466314825|FG000|Overall Study|Adverse Event|1|||
129551525|NCT00217971|466314826|FG001|Overall Study|Adverse Event|1|||
129551526|NCT00217971|466314825|FG000|Overall Study|Lost to Follow-up|15|||
129551527|NCT00217971|466314826|FG001|Overall Study|Lost to Follow-up|19|||
129551528|NCT00217971|466314825|FG000|Overall Study|Physician Decision|0|||
129551529|NCT00217971|466314826|FG001|Overall Study|Physician Decision|1|||
129551530|NCT00217971|466314825|FG000|Overall Study|Withdrawal by Subject|7|||
129551531|NCT00217971|466314826|FG001|Overall Study|Withdrawal by Subject|12|||
129551532|NCT00217971|466314825|FG000|Overall Study|non compliant|1|||
129551533|NCT00217971|466314826|FG001|Overall Study|non compliant|0|||
129551534|NCT02989610|466314827|FG000|Overall Study|Withdrawal by Subject|20|||
129551535|NCT02989610|466314827|FG000|Overall Study|Departure of PI from Site|8|||
129551536|NCT02989610|466314827|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
129551537|NCT02989610|466314827|FG000|Overall Study|Lost to Follow-up|3|||
129551538|NCT02989610|466314827|FG000|Overall Study|Death|3|||
129551539|NCT02989610|466314827|FG000|Overall Study|System Explant|3|||
129551540|NCT02989610|466314827|FG000|Overall Study|Subject Non-Compliance|2|||
129551541|NCT02989610|466314827|FG000|Overall Study|System Revision|2|||
129551542|NCT02989610|466314827|FG000|Overall Study|PI Left, Study Closing|1|||
129551543|NCT02989610|466314827|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
129551544|NCT02989610|466314827|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
129551545|NCT02556632|466314832|FG000|Overall Study|Lost to Follow-up|1|||
129551546|NCT02556632|466314833|FG001|Overall Study|Lost to Follow-up|0|||
129551547|NCT02556632|466314834|FG002|Overall Study|Lost to Follow-up|0|||
129551548|NCT02556632|466314832|FG000|Overall Study|Disliked Intervention|1|||
129551549|NCT02556632|466314833|FG001|Overall Study|Disliked Intervention|1|||
129551550|NCT02556632|466314834|FG002|Overall Study|Disliked Intervention|1|||
129551551|NCT02556632|466314832|FG000|Overall Study|No Reason|1|||
129551552|NCT02556632|466314833|FG001|Overall Study|No Reason|0|||
129551553|NCT02556632|466314834|FG002|Overall Study|No Reason|1|||
129551554|NCT02556632|466314832|FG000|Overall Study|Personal Issues|0|||
129551555|NCT02556632|466314833|FG001|Overall Study|Personal Issues|1|||
129551556|NCT02556632|466314834|FG002|Overall Study|Personal Issues|1|||
129551557|NCT02556632|466314832|FG000|Overall Study|Changed Mind|0|||
129551558|NCT02556632|466314833|FG001|Overall Study|Changed Mind|1|||
129551559|NCT02556632|466314834|FG002|Overall Study|Changed Mind|0|||
129551560|NCT02556632|466314832|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
129551561|NCT02556632|466314833|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
129551562|NCT02556632|466314834|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
129551563|NCT02556632|466314832|FG000|Overall Study|Unrelated Adverse Event|1|||
129551564|NCT02556632|466314833|FG001|Overall Study|Unrelated Adverse Event|0|||
129551565|NCT02556632|466314834|FG002|Overall Study|Unrelated Adverse Event|3|||
129551566|NCT02556632|466314832|FG000|Overall Study|Related Adverse Event|0|||
129551567|NCT02556632|466314833|FG001|Overall Study|Related Adverse Event|1|||
129551568|NCT02556632|466314834|FG002|Overall Study|Related Adverse Event|0|||
129551569|NCT02556632|466314832|FG000|Overall Study|Possibly Related Adverse Event|0|||
129551570|NCT02556632|466314833|FG001|Overall Study|Possibly Related Adverse Event|0|||
129551571|NCT02556632|466314834|FG002|Overall Study|Possibly Related Adverse Event|1|||
129551572|NCT02556632|466314832|FG000|Overall Study|Did Not Start RT|0|||
129551573|NCT02556632|466314833|FG001|Overall Study|Did Not Start RT|1|||
129551574|NCT02556632|466314834|FG002|Overall Study|Did Not Start RT|0|||
129551575|NCT02556632|466314832|FG000|Overall Study|Ineligible|0|||
129551576|NCT02556632|466314833|FG001|Overall Study|Ineligible|1|||
129551577|NCT02556632|466314834|FG002|Overall Study|Ineligible|0|||
129551578|NCT02556632|466314832|FG000|Overall Study|Disliked Study Procedures|0|||
129551579|NCT02556632|466314833|FG001|Overall Study|Disliked Study Procedures|0|||
129551580|NCT02556632|466314834|FG002|Overall Study|Disliked Study Procedures|1|||
129551581|NCT02556632|466314832|FG000|Overall Study|Treatment or Change Delay|0|||
129551582|NCT02556632|466314833|FG001|Overall Study|Treatment or Change Delay|0|||
129551583|NCT02556632|466314834|FG002|Overall Study|Treatment or Change Delay|1|||
129551584|NCT00808015|466314837|FG000|Overall Study|Death|1|||
129551585|NCT00808015|466314837|FG000|Overall Study|Lack of Efficacy|58|||
129551586|NCT00808015|466314837|FG000|Overall Study|Lost to Follow-up|76|||
129551587|NCT00808015|466314837|FG000|Overall Study|Participants not willing to participate|158|||
129551588|NCT00808015|466314837|FG000|Overall Study|Adverse Event|22|||
129551589|NCT00808015|466314837|FG000|Overall Study|Other|25|||
129551590|NCT00808015|466314837|FG000|Overall Study|Enrolled but not treated|4|||
129551591|NCT02574260|466314840|FG000|Overall Study|Disease Progression|1|||
129551592|NCT01066039|466314845|FG000|Overall Study|Adverse Event|6|||
129551593|NCT01066039|466314845|FG000|Overall Study|Withdrawal by Subject|17|||
129551594|NCT01066039|466314845|FG000|Overall Study|Protocol Violation|2|||
129551595|NCT01066039|466314845|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
129551596|NCT01066039|466314845|FG000|Overall Study|Investigator's Request|1|||
129551597|NCT01066039|466314845|FG000|Overall Study|Dropout due to Insulin Administration|1|||
129551598|NCT01066039|466314845|FG000|Overall Study|Additional Antihypertensive Required|4|||
129551599|NCT01066039|466314845|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
129551600|NCT01066039|466314845|FG000|Overall Study|Failure to Control Blood Pressure|1|||
129551601|NCT01066039|466314845|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
129551602|NCT04508621|466314846|FG000|Overall Study|Adverse Event|39|||
129551603|NCT04508621|466314847|FG001|Overall Study|Adverse Event|16|||
129551604|NCT04508621|466314846|FG000|Overall Study|Lack of Efficacy|2|||
129551605|NCT04508621|466314847|FG001|Overall Study|Lack of Efficacy|8|||
129551606|NCT04508621|466314846|FG000|Overall Study|Physician Decision|0|||
129551607|NCT04508621|466314847|FG001|Overall Study|Physician Decision|1|||
129551608|NCT04508621|466314846|FG000|Overall Study|Withdrawal by Subject|10|||
129551609|NCT04508621|466314847|FG001|Overall Study|Withdrawal by Subject|14|||
129551610|NCT04508621|466314846|FG000|Overall Study|Lost to Follow-up|12|||
129551611|NCT04508621|466314847|FG001|Overall Study|Lost to Follow-up|9|||
129551612|NCT04508621|466314846|FG000|Overall Study|COVID-19 related crisis|3|||
129551613|NCT04508621|466314847|FG001|Overall Study|COVID-19 related crisis|0|||
129551614|NCT04508621|466314846|FG000|Overall Study|Subject non-compliance|1|||
129551615|NCT04508621|466314847|FG001|Overall Study|Subject non-compliance|0|||
129551616|NCT00084617|466314857|FG000|Overall Study|Withdrawal by Subject|7|||
129551617|NCT00084617|466314857|FG000|Overall Study|Lack of Efficacy|1|||
129551618|NCT00084617|466314857|FG000|Overall Study|Protocol Violation|1|||
129551619|NCT01625286|466314858|FG000|Overall Study|Adverse Event|0|||
129551620|NCT01625286|466314859|FG001|Overall Study|Adverse Event|0|||
129551621|NCT01625286|466314860|FG002|Overall Study|Adverse Event|0|||
129551622|NCT01625286|466314861|FG003|Overall Study|Adverse Event|0|||
129551623|NCT01625286|466314862|FG004|Overall Study|Adverse Event|1|||
129551624|NCT01625286|466314863|FG005|Overall Study|Adverse Event|2|||
129551625|NCT01625286|466314864|FG006|Overall Study|Adverse Event|1|||
129551626|NCT01625286|466314858|FG000|Overall Study|Death|0|||
129551627|NCT01625286|466314859|FG001|Overall Study|Death|0|||
129551628|NCT01625286|466314860|FG002|Overall Study|Death|1|||
129551629|NCT01625286|466314861|FG003|Overall Study|Death|1|||
129551630|NCT01625286|466314862|FG004|Overall Study|Death|0|||
129551631|NCT01625286|466314863|FG005|Overall Study|Death|11|||
129551632|NCT01625286|466314864|FG006|Overall Study|Death|16|||
129551633|NCT01625286|466314858|FG000|Overall Study|Withdrawal by Subject|0|||
129774389|NCT03847896|467139609|FG000|Overall Study|Lack of Efficacy|0|||
129551634|NCT01625286|466314859|FG001|Overall Study|Withdrawal by Subject|1|||
129551635|NCT01625286|466314860|FG002|Overall Study|Withdrawal by Subject|0|||
129551636|NCT01625286|466314861|FG003|Overall Study|Withdrawal by Subject|1|||
129551637|NCT01625286|466314862|FG004|Overall Study|Withdrawal by Subject|0|||
129551638|NCT01625286|466314863|FG005|Overall Study|Withdrawal by Subject|0|||
129551639|NCT01625286|466314864|FG006|Overall Study|Withdrawal by Subject|1|||
129551640|NCT01625286|466314858|FG000|Overall Study|Any reason not specifically recorded|0|||
129551641|NCT01625286|466314859|FG001|Overall Study|Any reason not specifically recorded|0|||
129551642|NCT01625286|466314860|FG002|Overall Study|Any reason not specifically recorded|0|||
129685462|NCT02293499|466805253|FG000|12 Month Follow Up|Lost to Follow-up|26|||
129685463|NCT02293499|466805254|FG001|12 Month Follow Up|Lost to Follow-up|25|||
129685464|NCT02293499|466805255|FG002|12 Month Follow Up|Lost to Follow-up|6|||
129685465|NCT02293499|466805253|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
129685466|NCT02293499|466805254|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
129685467|NCT02293499|466805255|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
129685468|NCT02293499|466805253|FG000|15 Month Follow Up|Lost to Follow-up|22|||
129685469|NCT02293499|466805254|FG001|15 Month Follow Up|Lost to Follow-up|22|||
129685470|NCT02293499|466805255|FG002|15 Month Follow Up|Lost to Follow-up|7|||
129551643|NCT01625286|466314861|FG003|Overall Study|Any reason not specifically recorded|0|||
129551644|NCT01625286|466314862|FG004|Overall Study|Any reason not specifically recorded|0|||
129551645|NCT01625286|466314863|FG005|Overall Study|Any reason not specifically recorded|1|||
129551646|NCT01625286|466314864|FG006|Overall Study|Any reason not specifically recorded|0|||
129551647|NCT01625286|466314858|FG000|Overall Study|Progressive disease|6|||
129685471|NCT00690898|466805256|FG000|SCREENING|Screen failure|18|||
129685472|NCT00690898|466805256|FG000|TREATMENT|Adverse Event|3|||
129685473|NCT00690898|466805256|FG000|TREATMENT|Lack of Efficacy|18|||
129774390|NCT03847896|467139610|FG001|Overall Study|Lack of Efficacy|0|||
129774391|NCT03847896|467139611|FG002|Overall Study|Lack of Efficacy|0|||
129774392|NCT03847896|467139612|FG003|Overall Study|Lack of Efficacy|2|||
129774393|NCT03847896|467139613|FG004|Overall Study|Lack of Efficacy|2|||
129774394|NCT03847896|467139609|FG000|Overall Study|Other reasons|3|||
129774395|NCT03847896|467139610|FG001|Overall Study|Other reasons|3|||
129774396|NCT03847896|467139611|FG002|Overall Study|Other reasons|1|||
129774397|NCT03847896|467139612|FG003|Overall Study|Other reasons|2|||
129774398|NCT03847896|467139613|FG004|Overall Study|Other reasons|1|||
129774399|NCT02978781|467139614|FG000|Part A|Adverse Event|1|||
129774400|NCT02978781|467139615|FG001|Part A|Adverse Event|1|||
129774401|NCT02978781|467139616|FG002|Part A|Adverse Event|0|||
129774402|NCT02978781|467139617|FG003|Part A|Adverse Event|0|||
129774403|NCT02978781|467139618|FG004|Part A|Adverse Event|0|||
129551648|NCT01625286|466314859|FG001|Overall Study|Progressive disease|3|||
129551649|NCT01625286|466314860|FG002|Overall Study|Progressive disease|4|||
129774404|NCT02978781|467139614|FG000|Part A|Withdrawal by Subject|0|||
129774405|NCT02978781|467139615|FG001|Part A|Withdrawal by Subject|1|||
129774406|NCT02978781|467139616|FG002|Part A|Withdrawal by Subject|0|||
129774407|NCT02978781|467139617|FG003|Part A|Withdrawal by Subject|0|||
129774408|NCT02978781|467139618|FG004|Part A|Withdrawal by Subject|0|||
129774409|NCT02978781|467139614|FG000|Part B|Withdrawal by Subject|0|||
129774410|NCT02978781|467139615|FG001|Part B|Withdrawal by Subject|0|||
129774411|NCT02978781|467139616|FG002|Part B|Withdrawal by Subject|0|||
129774412|NCT02978781|467139617|FG003|Part B|Withdrawal by Subject|1|||
129551650|NCT01625286|466314861|FG003|Overall Study|Progressive disease|5|||
129774413|NCT02978781|467139618|FG004|Part B|Withdrawal by Subject|0|||
129774414|NCT02978781|467139614|FG000|Part C|Adverse Event|0|||
129774415|NCT02978781|467139615|FG001|Part C|Adverse Event|0|||
129774416|NCT02978781|467139616|FG002|Part C|Adverse Event|0|||
129774417|NCT02978781|467139617|FG003|Part C|Adverse Event|0|||
129774418|NCT02978781|467139618|FG004|Part C|Adverse Event|2|||
129551651|NCT01625286|466314862|FG004|Overall Study|Progressive disease|5|||
129551652|NCT01625286|466314863|FG005|Overall Study|Progressive disease|0|||
129551653|NCT01625286|466314864|FG006|Overall Study|Progressive disease|0|||
129551654|NCT01625286|466314858|FG000|Overall Study|Lost to Follow-up|0|||
129551655|NCT01625286|466314859|FG001|Overall Study|Lost to Follow-up|0|||
129551656|NCT01625286|466314860|FG002|Overall Study|Lost to Follow-up|0|||
129551657|NCT01625286|466314861|FG003|Overall Study|Lost to Follow-up|0|||
129551658|NCT01625286|466314862|FG004|Overall Study|Lost to Follow-up|0|||
129551659|NCT01625286|466314863|FG005|Overall Study|Lost to Follow-up|0|||
129551660|NCT01625286|466314864|FG006|Overall Study|Lost to Follow-up|1|||
129551661|NCT00828516|466314865|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
129551662|NCT03724968|466316450|FG000|Overall Study|Insurance issues|0|||
129551663|NCT03724968|466316451|FG001|Overall Study|Insurance issues|1|||
129551664|NCT03724968|466316450|FG000|Overall Study|Study closed|0|||
129551665|NCT03724968|466316451|FG001|Overall Study|Study closed|1|||
129551666|NCT01858558|466316452|FG000|Overall Study|Death|1|||
129551667|NCT01858558|466316453|FG001|Overall Study|Death|1|||
129551668|NCT01858558|466316452|FG000|Overall Study|Lost to Follow-up|1|||
129685474|NCT00690898|466805256|FG000|TREATMENT|Withdrawal by Subject|4|||
129685475|NCT00690898|466805256|FG000|TREATMENT|Other (not otherwise specified)|1|||
129551669|NCT01858558|466316453|FG001|Overall Study|Lost to Follow-up|0|||
129774419|NCT02978781|467139614|FG000|Part C|Withdrawal by Subject|0|||
129774420|NCT02978781|467139615|FG001|Part C|Withdrawal by Subject|0|||
129774421|NCT02978781|467139616|FG002|Part C|Withdrawal by Subject|0|||
129774422|NCT02978781|467139617|FG003|Part C|Withdrawal by Subject|0|||
129774423|NCT02978781|467139618|FG004|Part C|Withdrawal by Subject|1|||
129774424|NCT02978781|467139614|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
129774425|NCT02978781|467139615|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
129774426|NCT02978781|467139616|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
129774427|NCT02978781|467139617|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
129774428|NCT02978781|467139618|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
129774429|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
129774430|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
129774431|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Adverse Event|31|||
129774432|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Adverse Event|21|||
129774433|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
129774434|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
129774435|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
129774436|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
129774437|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
129774438|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
129774439|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
129774440|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
129774441|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Administrative problems|3|||
129774442|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Administrative problems|3|||
129774443|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Death|5|||
129774444|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Death|8|||
129774445|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Disease progression|139|||
129774446|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Disease progression|119|||
129774447|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
129774448|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
129551670|NCT01858558|466316452|FG000|Overall Study|Disease progression|3|||
129685476|NCT01847209|466805259|FG000|Overall Study|Withdrawal by Subject|1|||
129685477|NCT01847209|466805259|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
129685478|NCT02737618|466805281|FG000|Overall Study|Withdrawal by Subject|9|||
129685479|NCT01879852|466805285|FG000|Overall Study|Withdrawal by Subject|2|||
129685480|NCT01879852|466805286|FG001|Overall Study|Withdrawal by Subject|0|||
129685481|NCT02696616|466805287|FG000|Overall Study|Adverse Event|0|||
129685482|NCT02696616|466805288|FG001|Overall Study|Adverse Event|1|||
129774449|NCT00785785|467139619|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
129774450|NCT00785785|467139620|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
129774451|NCT00785785|467139619|FG000|Optional Extension Phase|Adverse Event|4|||
129774452|NCT00785785|467139620|FG001|Optional Extension Phase|Adverse Event|5|||
129774453|NCT00785785|467139619|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
129774454|NCT00785785|467139620|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
129774455|NCT00785785|467139619|FG000|Optional Extension Phase|Lost to Follow-up|1|||
129551671|NCT01858558|466316453|FG001|Overall Study|Disease progression|1|||
129551672|NCT01858558|466316452|FG000|Overall Study|Product contamination|2|||
129551673|NCT01858558|466316453|FG001|Overall Study|Product contamination|0|||
129551674|NCT01858558|466316452|FG000|Overall Study|Failed expansion of cell product|2|||
129551675|NCT01858558|466316453|FG001|Overall Study|Failed expansion of cell product|0|||
129551676|NCT01142466|466316454|FG000|Overall Study|Adverse Event|2|||
129685483|NCT02696616|466805289|FG002|Overall Study|Adverse Event|0|||
129685484|NCT02696616|466805290|FG003|Overall Study|Adverse Event|0|||
129551677|NCT01142466|466316455|FG001|Overall Study|Adverse Event|1|||
129551678|NCT01142466|466316454|FG000|Overall Study|Withdrawal by Subject|1|||
129551679|NCT01142466|466316455|FG001|Overall Study|Withdrawal by Subject|1|||
129551680|NCT00569231|466316460|FG000|Overall Study|Study unrelated surgery|1|||
129551681|NCT00569231|466316460|FG000|Overall Study|Airfare expense|2|||
129551682|NCT00569231|466316460|FG000|Overall Study|Withdrawal by Subject|1|||
129551683|NCT00569231|466316460|FG000|Overall Study|Car accident injury|1|||
129551684|NCT00569231|466316460|FG000|Overall Study|Non-compliance|2|||
129551685|NCT00681824|466316465|FG000|Overall Study|withdrawn by investigator|0|||
129551686|NCT00681824|466316466|FG001|Overall Study|withdrawn by investigator|0|||
129551687|NCT00681824|466316467|FG002|Overall Study|withdrawn by investigator|1|||
129551688|NCT00681824|466316465|FG000|Overall Study|scheduling conflict|1|||
129551689|NCT00681824|466316466|FG001|Overall Study|scheduling conflict|0|||
129551690|NCT00681824|466316467|FG002|Overall Study|scheduling conflict|0|||
129551691|NCT00681824|466316465|FG000|Overall Study|Death|0|||
129551692|NCT00681824|466316466|FG001|Overall Study|Death|1|||
129551693|NCT00681824|466316467|FG002|Overall Study|Death|0|||
129551694|NCT03724916|466316468|FG000|Overall Study|Withdrawal by Subject|0|||
129551695|NCT03724916|466316469|FG001|Overall Study|Withdrawal by Subject|1|||
129551696|NCT03724916|466316470|FG002|Overall Study|Withdrawal by Subject|1|||
129551697|NCT03724916|466316471|FG003|Overall Study|Withdrawal by Subject|2|||
129551698|NCT03724916|466316468|FG000|Overall Study|Randomized but not Treated|1|||
129551699|NCT03724916|466316469|FG001|Overall Study|Randomized but not Treated|0|||
129551700|NCT03724916|466316470|FG002|Overall Study|Randomized but not Treated|0|||
129551701|NCT03724916|466316471|FG003|Overall Study|Randomized but not Treated|0|||
129551702|NCT03591107|466316473|FG000|Overall Study|Same patient in both arms|1|||
129551703|NCT03591107|466316474|FG001|Overall Study|Same patient in both arms|1|||
129551704|NCT03591107|466316473|FG000|Overall Study|Sought care at other clinics|0|||
129551705|NCT03591107|466316474|FG001|Overall Study|Sought care at other clinics|2|||
129551706|NCT03591107|466316473|FG000|Overall Study|Discharged from clinic|0|||
129551707|NCT03591107|466316474|FG001|Overall Study|Discharged from clinic|1|||
129551708|NCT03591107|466316473|FG000|Overall Study|Withdrawal by Subject|0|||
129551709|NCT03591107|466316474|FG001|Overall Study|Withdrawal by Subject|1|||
129551710|NCT01902134|466316477|FG000|Overall Study|Adverse Event|3|||
129551711|NCT01902134|466316478|FG001|Overall Study|Adverse Event|1|||
129551712|NCT01902134|466316479|FG002|Overall Study|Adverse Event|2|||
129551713|NCT01902134|466316480|FG003|Overall Study|Adverse Event|1|||
129551714|NCT01902134|466316481|FG004|Overall Study|Adverse Event|1|||
129551715|NCT01902134|466316482|FG005|Overall Study|Adverse Event|3|||
129551716|NCT01902134|466316477|FG000|Overall Study|Lack of Efficacy|0|||
129551717|NCT01902134|466316478|FG001|Overall Study|Lack of Efficacy|0|||
129551718|NCT01902134|466316479|FG002|Overall Study|Lack of Efficacy|2|||
129551719|NCT01902134|466316480|FG003|Overall Study|Lack of Efficacy|0|||
129551720|NCT01902134|466316481|FG004|Overall Study|Lack of Efficacy|0|||
129551721|NCT01902134|466316482|FG005|Overall Study|Lack of Efficacy|1|||
129551722|NCT01902134|466316477|FG000|Overall Study|Physician Decision|0|||
129551723|NCT01902134|466316478|FG001|Overall Study|Physician Decision|1|||
129551724|NCT01902134|466316479|FG002|Overall Study|Physician Decision|0|||
129551725|NCT01902134|466316480|FG003|Overall Study|Physician Decision|0|||
129551726|NCT01902134|466316481|FG004|Overall Study|Physician Decision|0|||
129551727|NCT01902134|466316482|FG005|Overall Study|Physician Decision|0|||
129551728|NCT01902134|466316477|FG000|Overall Study|Protocol Violation|0|||
129551729|NCT01902134|466316478|FG001|Overall Study|Protocol Violation|0|||
129551730|NCT01902134|466316479|FG002|Overall Study|Protocol Violation|0|||
129551731|NCT01902134|466316480|FG003|Overall Study|Protocol Violation|0|||
129551732|NCT01902134|466316481|FG004|Overall Study|Protocol Violation|0|||
129551733|NCT01902134|466316482|FG005|Overall Study|Protocol Violation|1|||
129551734|NCT01902134|466316477|FG000|Overall Study|Withdrawal by Subject|4|||
129551735|NCT01902134|466316478|FG001|Overall Study|Withdrawal by Subject|8|||
129685485|NCT02696616|466805291|FG004|Overall Study|Adverse Event|0|||
129685486|NCT02696616|466805292|FG005|Overall Study|Adverse Event|0|||
129685487|NCT02696616|466805293|FG006|Overall Study|Adverse Event|0|||
129685488|NCT01500083|466805296|FG000|Overall Study|Adverse Event|4|||
129685489|NCT01500083|466805297|FG001|Overall Study|Adverse Event|17|||
129685490|NCT01500083|466805296|FG000|Overall Study|Death|0|||
129551736|NCT01902134|466316479|FG002|Overall Study|Withdrawal by Subject|9|||
129551737|NCT01902134|466316480|FG003|Overall Study|Withdrawal by Subject|1|||
129551738|NCT01902134|466316481|FG004|Overall Study|Withdrawal by Subject|5|||
129551739|NCT01902134|466316482|FG005|Overall Study|Withdrawal by Subject|4|||
129551740|NCT01902134|466316477|FG000|Overall Study|no compliance|1|||
129551741|NCT01902134|466316478|FG001|Overall Study|no compliance|0|||
129551742|NCT01902134|466316479|FG002|Overall Study|no compliance|0|||
129551743|NCT01902134|466316480|FG003|Overall Study|no compliance|0|||
129551744|NCT01902134|466316481|FG004|Overall Study|no compliance|0|||
129685491|NCT01500083|466805297|FG001|Overall Study|Death|2|||
129685492|NCT01500083|466805296|FG000|Overall Study|Lost to Follow-up|1|||
129551745|NCT01902134|466316482|FG005|Overall Study|no compliance|0|||
129551746|NCT01902134|466316477|FG000|Overall Study|Other|0|||
129685493|NCT01500083|466805297|FG001|Overall Study|Lost to Follow-up|0|||
129551747|NCT01902134|466316478|FG001|Overall Study|Other|1|||
129551748|NCT01902134|466316479|FG002|Overall Study|Other|2|||
129551749|NCT01902134|466316480|FG003|Overall Study|Other|0|||
129551750|NCT01902134|466316481|FG004|Overall Study|Other|1|||
129551751|NCT01902134|466316482|FG005|Overall Study|Other|0|||
129551752|NCT00305110|466316483|FG000|Overall Study|Missing data|29|||
129551753|NCT00678379|466316484|FG000|Overall Study|Injection performed after tonsillectomy|2|||
129551754|NCT00678379|466316485|FG001|Overall Study|Injection performed after tonsillectomy|0|||
129551755|NCT00678379|466316486|FG002|Overall Study|Injection performed after tonsillectomy|1|||
129551756|NCT00678379|466316484|FG000|Overall Study|Incomplete Data|4|||
129551757|NCT00678379|466316485|FG001|Overall Study|Incomplete Data|3|||
129551758|NCT00678379|466316486|FG002|Overall Study|Incomplete Data|3|||
129551759|NCT00350519|466316498|FG000|Overall Study|Death|0|||
129551760|NCT00350519|466316499|FG001|Overall Study|Death|1|||
129551761|NCT00350519|466316498|FG000|Overall Study|Physician Decision|0|||
129551762|NCT00350519|466316499|FG001|Overall Study|Physician Decision|1|||
129551763|NCT00350519|466316498|FG000|Overall Study|Protocol Violation|1|||
129551764|NCT00350519|466316499|FG001|Overall Study|Protocol Violation|2|||
129551765|NCT00350519|466316498|FG000|Overall Study|Withdrawal by Subject|3|||
129551766|NCT00350519|466316499|FG001|Overall Study|Withdrawal by Subject|2|||
129551767|NCT03836729|466316500|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
129551768|NCT01637961|466316501|FG000|Overall Study|Ineligible: wrong primary|1|||
129551769|NCT01637961|466316501|FG000|Overall Study|Ineligible: inadequate pathology|1|||
129551770|NCT03101293|466316505|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
129551771|NCT03101293|466316506|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
129551772|NCT03862625|466316513|FG000|Overall Study|Lost to Follow-up|0|||
129551773|NCT03862625|466316514|FG001|Overall Study|Lost to Follow-up|1|||
129551774|NCT01270841|466316515|FG000|Overall Study|Adverse Event|0|||
129551775|NCT01270841|466316516|FG001|Overall Study|Adverse Event|1|||
129551776|NCT01270841|466316517|FG002|Overall Study|Adverse Event|0|||
129685494|NCT01500083|466805296|FG000|Overall Study|Withdrawal of Consent|0|||
129685495|NCT01500083|466805297|FG001|Overall Study|Withdrawal of Consent|1|||
129685496|NCT01500083|466805296|FG000|Overall Study|Disease Progression|2|||
129685497|NCT01500083|466805297|FG001|Overall Study|Disease Progression|10|||
129685498|NCT01500083|466805296|FG000|Overall Study|Investigator Discretion|3|||
129685499|NCT01500083|466805297|FG001|Overall Study|Investigator Discretion|8|||
129685500|NCT01500083|466805296|FG000|Overall Study|Other Reasons|2|||
129685501|NCT01500083|466805297|FG001|Overall Study|Other Reasons|5|||
129685502|NCT01555931|466805298|FG000|Overall Study|Lost to Follow-up|2|||
129685503|NCT01555931|466805299|FG001|Overall Study|Lost to Follow-up|5|||
129685504|NCT02299167|466805302|FG000|Overall Study|patients were excluded from the study|11|||
129685505|NCT04615507|466805303|FG000|Period 1|Covid-19 exposure|2|||
129685506|NCT04615507|466805304|FG001|Period 1|Covid-19 exposure|1|||
129685507|NCT04615507|466805303|FG000|Period 2|Covid-19 exposure|0|||
129685508|NCT04615507|466805304|FG001|Period 2|Covid-19 exposure|1|||
129685509|NCT04615507|466805303|FG000|Period 2|Protocol Violation|1|||
129685510|NCT04615507|466805304|FG001|Period 2|Protocol Violation|0|||
129685511|NCT04615507|466805303|FG000|Period 2|Withdrawal by Subject|1|||
129685512|NCT04615507|466805304|FG001|Period 2|Withdrawal by Subject|0|||
129685513|NCT04615507|466805303|FG000|Period 2|Adverse Event|0|||
129685514|NCT04615507|466805304|FG001|Period 2|Adverse Event|1|||
129685515|NCT04615507|466805303|FG000|Period 3|Covid-19 exposure|0|||
129685516|NCT04615507|466805304|FG001|Period 3|Covid-19 exposure|1|||
129685517|NCT04598828|466805305|FG000|Overall Study|Physician Decision|1|||
129685518|NCT04598828|466805306|FG001|Overall Study|Physician Decision|0|||
129685519|NCT04598828|466805305|FG000|Overall Study|Withdrawal by Subject|0|||
129685520|NCT04598828|466805306|FG001|Overall Study|Withdrawal by Subject|1|||
129685521|NCT04598828|466805305|FG000|Overall Study|Withdrawal by Subject|0|||
129685522|NCT04598828|466805306|FG001|Overall Study|Withdrawal by Subject|1|||
129685523|NCT02676973|466805307|FG000|Overall Study|Withdrawal by Subject|9|||
129685524|NCT02676973|466805308|FG001|Overall Study|Withdrawal by Subject|8|||
129685525|NCT02676973|466805309|FG002|Overall Study|Withdrawal by Subject|11|||
129685526|NCT02676973|466805307|FG000|Overall Study|Lost to Follow-up|8|||
129685527|NCT02676973|466805308|FG001|Overall Study|Lost to Follow-up|12|||
129685528|NCT02676973|466805309|FG002|Overall Study|Lost to Follow-up|8|||
129685529|NCT02676973|466805307|FG000|Overall Study|Death|2|||
129551777|NCT01270841|466316518|FG003|Overall Study|Adverse Event|3|||
129551778|NCT01270841|466316515|FG000|Overall Study|Withdrawal by Subject|3|||
129551779|NCT01270841|466316516|FG001|Overall Study|Withdrawal by Subject|2|||
129551780|NCT01270841|466316517|FG002|Overall Study|Withdrawal by Subject|3|||
129551781|NCT01270841|466316518|FG003|Overall Study|Withdrawal by Subject|3|||
129685530|NCT02676973|466805308|FG001|Overall Study|Death|1|||
129685531|NCT02676973|466805309|FG002|Overall Study|Death|5|||
129685532|NCT01078662|466805311|FG000|Overall Study|Death|41|||
129685533|NCT01078662|466805312|FG001|Overall Study|Death|103|||
129685534|NCT01078662|466805313|FG002|Overall Study|Death|18|||
129685535|NCT01078662|466805314|FG003|Overall Study|Death|5|||
129685536|NCT01078662|466805315|FG004|Overall Study|Death|8|||
129685537|NCT01078662|466805311|FG000|Overall Study|Patients reached data cut-off|12|||
129551782|NCT01270841|466316515|FG000|Overall Study|Lost to Follow-up|3|||
129551783|NCT01270841|466316516|FG001|Overall Study|Lost to Follow-up|1|||
129551784|NCT01270841|466316517|FG002|Overall Study|Lost to Follow-up|4|||
129551785|NCT01270841|466316518|FG003|Overall Study|Lost to Follow-up|2|||
129551786|NCT01270841|466316515|FG000|Overall Study|Physician Decision|0|||
129551787|NCT01270841|466316516|FG001|Overall Study|Physician Decision|1|||
129551788|NCT01270841|466316517|FG002|Overall Study|Physician Decision|0|||
129551789|NCT01270841|466316518|FG003|Overall Study|Physician Decision|0|||
129551790|NCT01270841|466316515|FG000|Overall Study|Did not qualify|6|||
129551791|NCT01270841|466316516|FG001|Overall Study|Did not qualify|3|||
129551792|NCT01270841|466316517|FG002|Overall Study|Did not qualify|4|||
129551793|NCT01270841|466316518|FG003|Overall Study|Did not qualify|5|||
129551794|NCT01270841|466316515|FG000|Overall Study|Protocol Violation|1|||
129551795|NCT01270841|466316516|FG001|Overall Study|Protocol Violation|5|||
129551796|NCT01270841|466316517|FG002|Overall Study|Protocol Violation|0|||
129551797|NCT01270841|466316518|FG003|Overall Study|Protocol Violation|0|||
129551798|NCT01270841|466316515|FG000|Overall Study|Enrolled in error|0|||
129551799|NCT01270841|466316516|FG001|Overall Study|Enrolled in error|1|||
129551800|NCT01270841|466316517|FG002|Overall Study|Enrolled in error|0|||
129551801|NCT01270841|466316518|FG003|Overall Study|Enrolled in error|0|||
129551802|NCT02082912|466316519|FG000|Overall Study|Physician Decision|0|||
129551803|NCT02082912|466316520|FG001|Overall Study|Physician Decision|1|||
129551804|NCT01020305|466316533|FG000|Overall Study|Adverse Event|2|||
129551805|NCT01017029|466316537|FG000|Overall Study|Lost to Follow-up|1|||
129551806|NCT01017029|466316538|FG001|Overall Study|Lost to Follow-up|0|||
129551807|NCT01017029|466316537|FG000|Overall Study|Administrative problem|0|||
129551808|NCT01017029|466316538|FG001|Overall Study|Administrative problem|1|||
129551809|NCT01017029|466316537|FG000|Overall Study|Death|3|||
129551810|NCT01017029|466316538|FG001|Overall Study|Death|1|||
129551811|NCT02753400|466316540|FG000|Overall Study|Adverse Event|3|||
129551812|NCT02753400|466316541|FG001|Overall Study|Adverse Event|0|||
129551813|NCT02753400|466316540|FG000|Overall Study|Withdrawal by Subject|2|||
129551814|NCT02753400|466316541|FG001|Overall Study|Withdrawal by Subject|1|||
129551815|NCT01415921|466316542|FG000|Overall Study|Adverse Event|0|||
129551816|NCT01415921|466316543|FG001|Overall Study|Adverse Event|1|||
129551817|NCT01415921|466316542|FG000|Overall Study|Physician Decision|1|||
129551818|NCT01415921|466316543|FG001|Overall Study|Physician Decision|1|||
129551819|NCT01415921|466316542|FG000|Overall Study|Withdrawal by Subject|0|||
129551820|NCT01415921|466316543|FG001|Overall Study|Withdrawal by Subject|1|||
129551821|NCT01415921|466316542|FG000|Overall Study|Other|2|||
129551822|NCT01415921|466316543|FG001|Overall Study|Other|0|||
129551823|NCT01830920|466316548|FG000|Overall Study|Adverse Event|1|||
129551824|NCT01830920|466316549|FG001|Overall Study|Adverse Event|0|||
129551825|NCT01830920|466316550|FG002|Overall Study|Adverse Event|1|||
129551826|NCT01830920|466316551|FG003|Overall Study|Adverse Event|0|||
129551827|NCT01830920|466316552|FG004|Overall Study|Adverse Event|0|||
129551828|NCT01830920|466316548|FG000|Overall Study|Withdrawal by Subject|2|||
129551829|NCT01830920|466316549|FG001|Overall Study|Withdrawal by Subject|2|||
129551830|NCT01830920|466316550|FG002|Overall Study|Withdrawal by Subject|1|||
129551831|NCT01830920|466316551|FG003|Overall Study|Withdrawal by Subject|7|||
129685538|NCT01078662|466805312|FG001|Overall Study|Patients reached data cut-off|53|||
129685539|NCT01078662|466805313|FG002|Overall Study|Patients reached data cut-off|2|||
129685540|NCT01078662|466805314|FG003|Overall Study|Patients reached data cut-off|2|||
129685541|NCT01078662|466805315|FG004|Overall Study|Patients reached data cut-off|3|||
129685542|NCT01078662|466805311|FG000|Overall Study|Withdrawal by Subject|4|||
129685543|NCT01078662|466805312|FG001|Overall Study|Withdrawal by Subject|11|||
129685544|NCT01078662|466805313|FG002|Overall Study|Withdrawal by Subject|1|||
129685545|NCT01078662|466805314|FG003|Overall Study|Withdrawal by Subject|0|||
129685546|NCT01078662|466805315|FG004|Overall Study|Withdrawal by Subject|0|||
129685547|NCT01078662|466805311|FG000|Overall Study|Protocol Violation|0|||
129551832|NCT01830920|466316552|FG004|Overall Study|Withdrawal by Subject|1|||
129551833|NCT01830920|466316548|FG000|Overall Study|Death|3|||
129551834|NCT01830920|466316549|FG001|Overall Study|Death|3|||
129551835|NCT01830920|466316550|FG002|Overall Study|Death|5|||
129551836|NCT01830920|466316551|FG003|Overall Study|Death|4|||
129551837|NCT01830920|466316552|FG004|Overall Study|Death|4|||
129551838|NCT01830920|466316548|FG000|Overall Study|Other|15|||
129551839|NCT01830920|466316549|FG001|Overall Study|Other|1|||
129551840|NCT01830920|466316550|FG002|Overall Study|Other|1|||
129551841|NCT01830920|466316551|FG003|Overall Study|Other|5|||
129551842|NCT01830920|466316552|FG004|Overall Study|Other|3|||
129551843|NCT03876873|466316553|FG000|Overall Study|Physician Decision|0|||
129551844|NCT03876873|466316554|FG001|Overall Study|Physician Decision|1|||
129685548|NCT01078662|466805312|FG001|Overall Study|Protocol Violation|1|||
129774456|NCT00785785|467139620|FG001|Optional Extension Phase|Lost to Follow-up|0|||
129551845|NCT03402126|466316556|FG000|Overall Study|Lost to Follow-up|6|||
129551846|NCT03402126|466316556|FG000|Overall Study|Protocol Violation|10|||
129551847|NCT03402126|466316556|FG000|Overall Study|Sponsor request/Study termination|29|||
129685549|NCT01078662|466805313|FG002|Overall Study|Protocol Violation|0|||
129685550|NCT01078662|466805314|FG003|Overall Study|Protocol Violation|0|||
129551848|NCT03402126|466316556|FG000|Overall Study|Study product no longer in use|1|||
129551849|NCT03402126|466316556|FG000|Overall Study|Technical problems|1|||
129551850|NCT03402126|466316556|FG000|Overall Study|Withdrawal by Subject|6|||
129551851|NCT03402126|466316556|FG000|Overall Study|Physician Decision|2|||
129551852|NCT03402126|466316556|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
129551853|NCT03402126|466316556|FG000|Overall Study|Death|4|||
129551854|NCT02117479|466316557|FG000|Overall Study|Death|13|||
129551855|NCT02117479|466316558|FG001|Overall Study|Death|8|||
129551856|NCT02117479|466316557|FG000|Overall Study|Adverse Event|8|||
129551857|NCT02117479|466316558|FG001|Overall Study|Adverse Event|16|||
129551858|NCT02117479|466316557|FG000|Overall Study|Subject decision|8|||
129551859|NCT02117479|466316558|FG001|Overall Study|Subject decision|9|||
129551860|NCT02117479|466316557|FG000|Overall Study|Disease progression|104|||
129551861|NCT02117479|466316558|FG001|Overall Study|Disease progression|108|||
129551862|NCT02117479|466316557|FG000|Overall Study|Noncompliance with study treatment|1|||
129551863|NCT02117479|466316558|FG001|Overall Study|Noncompliance with study treatment|0|||
129551864|NCT02117479|466316557|FG000|Overall Study|Study terminated by the sponsor|4|||
129551865|NCT02117479|466316558|FG001|Overall Study|Study terminated by the sponsor|6|||
129551866|NCT02117479|466316557|FG000|Overall Study|Physician Decision|7|||
129551867|NCT02117479|466316558|FG001|Overall Study|Physician Decision|2|||
129551868|NCT02117479|466316557|FG000|Overall Study|Other unspecified|11|||
129551869|NCT02117479|466316558|FG001|Overall Study|Other unspecified|7|||
129551870|NCT01959230|466316559|FG000|Overall Study|Failure to follow study procedures|0|||
129551871|NCT01959230|466316560|FG001|Overall Study|Failure to follow study procedures|1|||
129551872|NCT01959230|466316559|FG000|Overall Study|Administrative reasons|2|||
129551873|NCT01959230|466316560|FG001|Overall Study|Administrative reasons|0|||
129551874|NCT01959230|466316559|FG000|Overall Study|Withdrawal by Subject|2|||
129551875|NCT01959230|466316560|FG001|Overall Study|Withdrawal by Subject|0|||
129551876|NCT01453374|466316561|FG000|Overall Study|Adverse Event|7|||
129685551|NCT01078662|466805315|FG004|Overall Study|Protocol Violation|0|||
129685552|NCT01078662|466805311|FG000|Overall Study|Lost to Follow-up|1|||
129685553|NCT01078662|466805312|FG001|Overall Study|Lost to Follow-up|0|||
129685554|NCT01078662|466805313|FG002|Overall Study|Lost to Follow-up|0|||
129774457|NCT00785785|467139619|FG000|Optional Extension Phase|Administrative problems|2|||
129774458|NCT00785785|467139620|FG001|Optional Extension Phase|Administrative problems|0|||
129551877|NCT01453374|466316561|FG000|Overall Study|Lack of Efficacy|1|||
129685555|NCT01078662|466805314|FG003|Overall Study|Lost to Follow-up|0|||
129685556|NCT01078662|466805315|FG004|Overall Study|Lost to Follow-up|0|||
129685557|NCT00700635|466805317|FG000|Overall Study|Adverse Event|1|||
129685558|NCT00700635|466805318|FG001|Overall Study|Adverse Event|0|||
129685559|NCT00700635|466805319|FG002|Overall Study|Adverse Event|0|||
129685560|NCT00700635|466805317|FG000|Overall Study|Lost to Follow-up|1|||
129685561|NCT00700635|466805318|FG001|Overall Study|Lost to Follow-up|3|||
129685562|NCT00700635|466805319|FG002|Overall Study|Lost to Follow-up|0|||
129685563|NCT00700635|466805317|FG000|Overall Study|Protocol Violation|2|||
129685564|NCT00700635|466805318|FG001|Overall Study|Protocol Violation|2|||
129685565|NCT00700635|466805319|FG002|Overall Study|Protocol Violation|0|||
129685566|NCT00700635|466805317|FG000|Overall Study|Withdrawal by Subject|7|||
129685567|NCT00700635|466805318|FG001|Overall Study|Withdrawal by Subject|3|||
129685568|NCT00700635|466805319|FG002|Overall Study|Withdrawal by Subject|1|||
129685569|NCT05172570|466805320|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
129685570|NCT05172570|466805321|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
129685571|NCT05172570|466805322|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
129685572|NCT05172570|466805320|FG000|Overall Study|PI Decision due to equipment shortages|0|||
129685573|NCT05172570|466805321|FG001|Overall Study|PI Decision due to equipment shortages|0|||
129685574|NCT05172570|466805322|FG002|Overall Study|PI Decision due to equipment shortages|1|||
129685575|NCT04937387|466805325|FG000|Overall Study|Adverse Event|1|||
129685576|NCT04937387|466805326|FG001|Overall Study|Adverse Event|0|||
129685577|NCT04937387|466805327|FG002|Overall Study|Adverse Event|2|||
129685578|NCT04937387|466805328|FG003|Overall Study|Adverse Event|0|||
129685579|NCT04937387|466805325|FG000|Overall Study|Lack of Efficacy|1|||
129774459|NCT00785785|467139619|FG000|Optional Extension Phase|Death|1|||
129551878|NCT01453374|466316561|FG000|Overall Study|Lost to Follow-up|3|||
129551879|NCT01453374|466316561|FG000|Overall Study|Withdrawal by Subject|5|||
129551880|NCT01453374|466316561|FG000|Overall Study|Incarcerated|2|||
129685580|NCT04937387|466805326|FG001|Overall Study|Lack of Efficacy|0|||
129774460|NCT00785785|467139620|FG001|Optional Extension Phase|Death|5|||
129551881|NCT00720304|466316562|FG000|Overall Study|Withdrawal by Subject|14|||
129551882|NCT00720304|466316563|FG001|Overall Study|Withdrawal by Subject|1|||
129551883|NCT00720304|466316562|FG000|Overall Study|Death|1|||
129685581|NCT04937387|466805327|FG002|Overall Study|Lack of Efficacy|0|||
129685582|NCT04937387|466805328|FG003|Overall Study|Lack of Efficacy|1|||
129685583|NCT04937387|466805325|FG000|Overall Study|Withdrawal by Subject|1|||
129685584|NCT04937387|466805326|FG001|Overall Study|Withdrawal by Subject|0|||
129685585|NCT04937387|466805327|FG002|Overall Study|Withdrawal by Subject|1|||
129685586|NCT04937387|466805328|FG003|Overall Study|Withdrawal by Subject|1|||
129685587|NCT04937387|466805325|FG000|Overall Study|Randomized in error|0|||
129685588|NCT04937387|466805326|FG001|Overall Study|Randomized in error|0|||
129685589|NCT04937387|466805327|FG002|Overall Study|Randomized in error|0|||
129685590|NCT04937387|466805328|FG003|Overall Study|Randomized in error|1|||
129685591|NCT02872714|466805337|FG000|Overall Study|Progressive Disease|1|||
129685592|NCT02872714|466805338|FG001|Overall Study|Progressive Disease|2|||
129685593|NCT02872714|466805339|FG002|Overall Study|Progressive Disease|0|||
129685594|NCT02872714|466805340|FG003|Overall Study|Progressive Disease|0|||
129685595|NCT02872714|466805341|FG004|Overall Study|Progressive Disease|0|||
129685596|NCT02872714|466805337|FG000|Overall Study|Death|87|||
129685597|NCT02872714|466805338|FG001|Overall Study|Death|36|||
129685598|NCT02872714|466805339|FG002|Overall Study|Death|8|||
129685599|NCT02872714|466805340|FG003|Overall Study|Death|81|||
129685600|NCT02872714|466805341|FG004|Overall Study|Death|2|||
129685601|NCT02872714|466805337|FG000|Overall Study|Lost to Follow-up|2|||
129685602|NCT02872714|466805338|FG001|Overall Study|Lost to Follow-up|1|||
129685603|NCT02872714|466805339|FG002|Overall Study|Lost to Follow-up|0|||
129685604|NCT02872714|466805340|FG003|Overall Study|Lost to Follow-up|3|||
129685605|NCT02872714|466805341|FG004|Overall Study|Lost to Follow-up|0|||
129685606|NCT02872714|466805337|FG000|Overall Study|Physician Decision|0|||
129685607|NCT02872714|466805338|FG001|Overall Study|Physician Decision|0|||
129685608|NCT02872714|466805339|FG002|Overall Study|Physician Decision|0|||
129685609|NCT02872714|466805340|FG003|Overall Study|Physician Decision|1|||
129685610|NCT02872714|466805341|FG004|Overall Study|Physician Decision|0|||
129685611|NCT02872714|466805337|FG000|Overall Study|Withdrawal by Subject|1|||
129685612|NCT02872714|466805338|FG001|Overall Study|Withdrawal by Subject|3|||
129685613|NCT02872714|466805339|FG002|Overall Study|Withdrawal by Subject|0|||
129685614|NCT02872714|466805340|FG003|Overall Study|Withdrawal by Subject|2|||
129685615|NCT02872714|466805341|FG004|Overall Study|Withdrawal by Subject|0|||
129685616|NCT02872714|466805337|FG000|Overall Study|Captured as Other|2|||
129685617|NCT02872714|466805338|FG001|Overall Study|Captured as Other|0|||
129685618|NCT02872714|466805339|FG002|Overall Study|Captured as Other|0|||
129685619|NCT02872714|466805340|FG003|Overall Study|Captured as Other|1|||
129685620|NCT02872714|466805341|FG004|Overall Study|Captured as Other|0|||
129685621|NCT02008370|466806285|FG000|Overall Study|Lost to Follow-up|7|||
129685622|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
129685623|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
129685624|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
129685625|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
129685626|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
129685627|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129685628|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
129685629|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129685630|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129685631|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
129685632|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Death|0|||
129685633|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Death|0|||
129685634|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Death|1|||
129685635|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Death|0|||
129685636|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Death|0|||
129685637|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
129685638|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
129685639|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
129685640|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
129685641|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
129685642|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Other|2|||
129685643|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Other|1|||
129685644|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Other|0|||
129685645|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Other|0|||
129685646|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Other|0|||
129685647|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129685648|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129685649|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
129685650|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129685651|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
129685652|NCT03317496|466806286|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
129685653|NCT03317496|466806287|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
129685654|NCT03317496|466806288|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
129685655|NCT03317496|466806289|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
129685656|NCT03317496|466806290|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
129685657|NCT03317496|466806286|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
129685658|NCT03317496|466806287|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
129685659|NCT03317496|466806288|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
129685660|NCT03317496|466806289|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
129685661|NCT03317496|466806290|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
129685662|NCT03317496|466806286|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
129774461|NCT00785785|467139619|FG000|Optional Extension Phase|Disease progression|22|||
129774462|NCT00785785|467139620|FG001|Optional Extension Phase|Disease progression|70|||
129774463|NCT00785785|467139619|FG000|Optional Extension Phase|Protocol deviation|0|||
129774464|NCT00785785|467139620|FG001|Optional Extension Phase|Protocol deviation|2|||
129774465|NCT00785785|467139619|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
129774466|NCT00785785|467139620|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
129774467|NCT02453321|467139621|FG000|Overall Study|Weakness|1|||
129774468|NCT02453321|467139622|FG001|Overall Study|Weakness|1|||
129774469|NCT02453321|467139623|FG002|Overall Study|Weakness|2|||
129774470|NCT02453321|467139621|FG000|Overall Study|Deep Venous Thrombosis|0|||
129774471|NCT02453321|467139622|FG001|Overall Study|Deep Venous Thrombosis|1|||
129774472|NCT02453321|467139623|FG002|Overall Study|Deep Venous Thrombosis|0|||
129774473|NCT00521404|467139624|FG000|Overall Study|Adverse Event|13|||
129774474|NCT00521404|467139624|FG000|Overall Study|Disease Progression|33|||
129774475|NCT00521404|467139624|FG000|Overall Study|Investigator decision|5|||
129774476|NCT00521404|467139624|FG000|Overall Study|Withdrawal of consent|3|||
129774477|NCT00521404|467139624|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
129774478|NCT00521404|467139624|FG000|Overall Study|Other|7|||
129774479|NCT02282605|467139625|FG000|Overall Study|negative SA result on Day -1|3|||
129774480|NCT02282605|467139626|FG001|Overall Study|negative SA result on Day -1|0|||
129774481|NCT02282605|467139627|FG002|Overall Study|negative SA result on Day -1|0|||
129774482|NCT03584789|467139630|FG000|Overall Study|refused EHR permission|19|||
129774483|NCT03584789|467139631|FG001|Overall Study|refused EHR permission|28|||
129774484|NCT03584789|467139632|FG002|Overall Study|refused EHR permission|23|||
129774485|NCT03584789|467139630|FG000|Overall Study|patients tied to a provider who retired|0|||
129774486|NCT03584789|467139631|FG001|Overall Study|patients tied to a provider who retired|0|||
129774487|NCT03584789|467139632|FG002|Overall Study|patients tied to a provider who retired|3|||
129774488|NCT02035267|467139633|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
129774489|NCT02035267|467139634|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
129774490|NCT02035267|467139635|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
129774491|NCT02035267|467139636|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
129774492|NCT02035267|467139633|FG000|Overall Study|Adverse Event|0|||
129774493|NCT02035267|467139634|FG001|Overall Study|Adverse Event|0|||
129774494|NCT02035267|467139635|FG002|Overall Study|Adverse Event|1|||
129774495|NCT02035267|467139636|FG003|Overall Study|Adverse Event|0|||
129774496|NCT02035267|467139633|FG000|Overall Study|Lost to Follow-up|0|||
129774497|NCT02035267|467139634|FG001|Overall Study|Lost to Follow-up|0|||
129774498|NCT02035267|467139635|FG002|Overall Study|Lost to Follow-up|0|||
129774499|NCT02035267|467139636|FG003|Overall Study|Lost to Follow-up|1|||
129774500|NCT02035267|467139633|FG000|Overall Study|Other unspecified|0|||
129774501|NCT02035267|467139634|FG001|Overall Study|Other unspecified|1|||
129774502|NCT02035267|467139635|FG002|Overall Study|Other unspecified|0|||
129551884|NCT00720304|466316563|FG001|Overall Study|Death|0|||
129551885|NCT00720304|466316562|FG000|Overall Study|Physician Decision|5|||
129551886|NCT00720304|466316563|FG001|Overall Study|Physician Decision|2|||
129551887|NCT00720304|466316562|FG000|Overall Study|Adverse Event|3|||
129551888|NCT00720304|466316563|FG001|Overall Study|Adverse Event|1|||
129551889|NCT00720304|466316562|FG000|Overall Study|Disease progression|6|||
129551890|NCT00720304|466316563|FG001|Overall Study|Disease progression|1|||
129551891|NCT01333475|466316564|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
129551892|NCT01333475|466316565|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
129551893|NCT01333475|466316564|FG000|Overall Study|Toxicity|1|||
129551894|NCT01333475|466316565|FG001|Overall Study|Toxicity|3|||
129551895|NCT03674827|466316568|FG000|Treatment Phase|Adverse Event|0|||
129551896|NCT03674827|466316569|FG001|Treatment Phase|Adverse Event|0|||
129551897|NCT03674827|466316570|FG002|Treatment Phase|Adverse Event|0|||
129551898|NCT03674827|466316571|FG003|Treatment Phase|Adverse Event|0|||
129551899|NCT03674827|466316572|FG004|Treatment Phase|Adverse Event|0|||
129551900|NCT03674827|466316573|FG005|Treatment Phase|Adverse Event|2|||
129551901|NCT03674827|466316568|FG000|Treatment Phase|Death|2|||
129551902|NCT03674827|466316569|FG001|Treatment Phase|Death|0|||
129551903|NCT03674827|466316570|FG002|Treatment Phase|Death|0|||
129551904|NCT03674827|466316571|FG003|Treatment Phase|Death|0|||
129551905|NCT03674827|466316572|FG004|Treatment Phase|Death|1|||
129551906|NCT03674827|466316573|FG005|Treatment Phase|Death|0|||
129774503|NCT02035267|467139636|FG003|Overall Study|Other unspecified|0|||
129774504|NCT00823615|467139645|FG000|Period 2|Lost to Follow-up|2|||
129551907|NCT03674827|466316568|FG000|Treatment Phase|Progressive Disease|0|||
129551908|NCT03674827|466316569|FG001|Treatment Phase|Progressive Disease|4|||
129551909|NCT03674827|466316570|FG002|Treatment Phase|Progressive Disease|3|||
129551910|NCT03674827|466316571|FG003|Treatment Phase|Progressive Disease|4|||
129551911|NCT03674827|466316572|FG004|Treatment Phase|Progressive Disease|4|||
129551912|NCT03674827|466316573|FG005|Treatment Phase|Progressive Disease|9|||
129551913|NCT03674827|466316568|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
129551914|NCT03674827|466316569|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
129551915|NCT03674827|466316570|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
129551916|NCT03674827|466316571|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
129551917|NCT03674827|466316572|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
129551918|NCT03674827|466316573|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
129551919|NCT03674827|466316568|FG000|Treatment Phase|Withdrawal by Subject|0|||
129551920|NCT03674827|466316569|FG001|Treatment Phase|Withdrawal by Subject|0|||
129551921|NCT03674827|466316570|FG002|Treatment Phase|Withdrawal by Subject|0|||
129551922|NCT03674827|466316571|FG003|Treatment Phase|Withdrawal by Subject|0|||
129551923|NCT03674827|466316572|FG004|Treatment Phase|Withdrawal by Subject|0|||
129551924|NCT03674827|466316573|FG005|Treatment Phase|Withdrawal by Subject|1|||
129551925|NCT03674827|466316568|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
129551926|NCT03674827|466316569|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
129551927|NCT03674827|466316570|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
129551928|NCT03674827|466316571|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
129551929|NCT03674827|466316572|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
129551930|NCT03674827|466316573|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
129551931|NCT03674827|466316568|FG000|Treatment Phase|Other|0|||
129551932|NCT03674827|466316569|FG001|Treatment Phase|Other|1|||
129551933|NCT03674827|466316570|FG002|Treatment Phase|Other|0|||
129551934|NCT03674827|466316571|FG003|Treatment Phase|Other|0|||
129551935|NCT03674827|466316572|FG004|Treatment Phase|Other|0|||
129551936|NCT03674827|466316573|FG005|Treatment Phase|Other|1|||
129551937|NCT03674827|466316568|FG000|Long-Term Follow-up Phase|Death|2|||
129774505|NCT00823615|467139646|FG001|Period 2|Lost to Follow-up|0|||
129774506|NCT00823615|467139645|FG000|Period 2|Time/Job Conflict|1|||
129774507|NCT00823615|467139646|FG001|Period 2|Time/Job Conflict|2|||
129774508|NCT00098813|467139647|FG000|Overall Study|Death|8|||
129774509|NCT00098813|467139647|FG000|Overall Study|Protocol Violation|1|||
129774510|NCT00098813|467139647|FG000|Overall Study|Withdrawal by Subject|7|||
129774511|NCT00098813|467139647|FG000|Overall Study|Progression of Disease|1|||
129774512|NCT00098813|467139647|FG000|Overall Study|Other complicating disease|1|||
129774513|NCT00098813|467139647|FG000|Overall Study|Reversal of RAI resistance|1|||
129551938|NCT03674827|466316569|FG001|Long-Term Follow-up Phase|Death|4|||
129551939|NCT03674827|466316570|FG002|Long-Term Follow-up Phase|Death|2|||
129774514|NCT00892099|467139649|FG000|Overall Study|Death|1|||
129551940|NCT03674827|466316571|FG003|Long-Term Follow-up Phase|Death|3|||
129551941|NCT03674827|466316572|FG004|Long-Term Follow-up Phase|Death|2|||
129551942|NCT03674827|466316573|FG005|Long-Term Follow-up Phase|Death|6|||
129551943|NCT03674827|466316568|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
129551944|NCT03674827|466316569|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
129551945|NCT03674827|466316570|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
129551946|NCT03674827|466316571|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
129774515|NCT00892099|467139650|FG001|Overall Study|Death|0|||
129774516|NCT00892099|467139651|FG002|Overall Study|Death|1|||
129774517|NCT00892099|467139649|FG000|Overall Study|Adverse Event|1|||
129551947|NCT03674827|466316572|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
129551948|NCT03674827|466316573|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
129551949|NCT03674827|466316568|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
129551950|NCT03674827|466316569|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
129551951|NCT03674827|466316570|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
129551952|NCT03674827|466316571|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
129551953|NCT03674827|466316572|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
129551954|NCT03674827|466316573|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
129551955|NCT01783483|466316574|FG000|Overall Study|Death|3|||
129551956|NCT01783483|466316575|FG001|Overall Study|Death|3|||
129551957|NCT01783483|466316574|FG000|Overall Study|Lost to Follow-up|14|||
129551958|NCT01783483|466316575|FG001|Overall Study|Lost to Follow-up|10|||
129551959|NCT01783483|466316574|FG000|Overall Study|Withdrawal by Subject|2|||
129551960|NCT01783483|466316575|FG001|Overall Study|Withdrawal by Subject|1|||
129551961|NCT01783483|466316574|FG000|Overall Study|Physician Decision|1|||
129551962|NCT01783483|466316575|FG001|Overall Study|Physician Decision|1|||
129551963|NCT02624518|466316578|FG000|Overall Study|Physician Decision|1|||
129551964|NCT00370396|466316579|FG000|Overall Study|Withdrawal by Subject|0|||
129551965|NCT00370396|466316580|FG001|Overall Study|Withdrawal by Subject|0|||
129551966|NCT00370396|466316581|FG002|Overall Study|Withdrawal by Subject|1|||
129551967|NCT00370396|466316579|FG000|Overall Study|Lost to Follow-up|11|||
129551968|NCT00370396|466316580|FG001|Overall Study|Lost to Follow-up|1|||
129551969|NCT00370396|466316581|FG002|Overall Study|Lost to Follow-up|0|||
129551970|NCT01462695|466316582|FG000|Overall Study|Adverse Event|1|||
129551971|NCT01462695|466316583|FG001|Overall Study|Adverse Event|1|||
129551972|NCT01462695|466316582|FG000|Overall Study|Death|2|||
129551973|NCT01462695|466316583|FG001|Overall Study|Death|0|||
129551974|NCT01462695|466316582|FG000|Overall Study|Lack of Efficacy|6|||
129551975|NCT01462695|466316583|FG001|Overall Study|Lack of Efficacy|12|||
129551976|NCT01462695|466316582|FG000|Overall Study|Physician Decision|5|||
129551977|NCT01462695|466316583|FG001|Overall Study|Physician Decision|0|||
129551978|NCT01462695|466316582|FG000|Overall Study|Withdrawal by Subject|2|||
129551979|NCT01462695|466316583|FG001|Overall Study|Withdrawal by Subject|0|||
129551980|NCT01462695|466316582|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
129551981|NCT01462695|466316583|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
129551982|NCT01364298|466316585|FG000|Overall Study|Adverse Event|3|||
129551983|NCT01364298|466316586|FG001|Overall Study|Adverse Event|4|||
129551984|NCT01364298|466316585|FG000|Overall Study|Lack of adherence to treatment|1|||
129551985|NCT01364298|466316586|FG001|Overall Study|Lack of adherence to treatment|3|||
129551986|NCT01364298|466316585|FG000|Overall Study|Lack of Efficacy|1|||
129551987|NCT01364298|466316586|FG001|Overall Study|Lack of Efficacy|0|||
129551988|NCT01364298|466316585|FG000|Overall Study|Lost to Follow-up|5|||
129551989|NCT01364298|466316586|FG001|Overall Study|Lost to Follow-up|10|||
129551990|NCT01364298|466316585|FG000|Overall Study|Withdrawal by Subject|3|||
129551991|NCT01364298|466316586|FG001|Overall Study|Withdrawal by Subject|3|||
129551992|NCT01364298|466316585|FG000|Overall Study|Other|1|||
129551993|NCT01364298|466316586|FG001|Overall Study|Other|3|||
129551994|NCT00659581|466316589|FG000|Overall Study|Adverse Event|1006|||
129551995|NCT00659581|466316589|FG000|Overall Study|Lack of Efficacy|1183|||
129551996|NCT00659581|466316589|FG000|Overall Study|Other|6393|||
129551997|NCT03125629|466316593|FG000|Overall Study|Withdrawal by Subject|2|||
129551998|NCT03125629|466316593|FG000|Overall Study|Equipment malfunction|1|||
129551999|NCT03909971|466316594|FG000|Overall Study|Other Reasons Not Specified|0|||
129552000|NCT03909971|466316595|FG001|Overall Study|Other Reasons Not Specified|1|||
129552001|NCT03909971|466316594|FG000|Overall Study|Global Deterioration of Health Status|2|||
129552002|NCT03909971|466316595|FG001|Overall Study|Global Deterioration of Health Status|1|||
129552003|NCT03909971|466316594|FG000|Overall Study|Progressive Disease|6|||
129552004|NCT03909971|466316595|FG001|Overall Study|Progressive Disease|14|||
129552005|NCT03909971|466316594|FG000|Overall Study|Death|2|||
129552006|NCT03909971|466316595|FG001|Overall Study|Death|6|||
129552007|NCT04523831|466316601|FG000|Overall Study|Lost to Follow-up|15|||
129552008|NCT04523831|466316602|FG001|Overall Study|Lost to Follow-up|17|||
129552009|NCT04523831|466316601|FG000|Overall Study|Death|0|||
129552010|NCT04523831|466316602|FG001|Overall Study|Death|3|||
129552011|NCT04523831|466316601|FG000|Overall Study|Adverse Event|2|||
129552012|NCT04523831|466316602|FG001|Overall Study|Adverse Event|0|||
129552013|NCT00430638|466316607|FG000|Overall Study|Adverse Event|15|||
129552014|NCT00430638|466316608|FG001|Overall Study|Adverse Event|15|||
129552015|NCT00430638|466316607|FG000|Overall Study|Uncontrolled blood pressure|48|||
129552016|NCT00430638|466316608|FG001|Overall Study|Uncontrolled blood pressure|13|||
129552017|NCT00430638|466316607|FG000|Overall Study|Lost to Follow-up|1|||
129552018|NCT00430638|466316608|FG001|Overall Study|Lost to Follow-up|7|||
129552019|NCT00430638|466316607|FG000|Overall Study|Protocol Violation|6|||
129552020|NCT00430638|466316608|FG001|Overall Study|Protocol Violation|4|||
129552021|NCT00430638|466316607|FG000|Overall Study|Withdrawal by Subject|4|||
129552022|NCT00430638|466316608|FG001|Overall Study|Withdrawal by Subject|6|||
129552023|NCT00430638|466316607|FG000|Overall Study|Non-compliant|2|||
129552024|NCT00430638|466316608|FG001|Overall Study|Non-compliant|1|||
129552025|NCT00430638|466316607|FG000|Overall Study|Other|2|||
129552026|NCT00430638|466316608|FG001|Overall Study|Other|2|||
129552027|NCT03185949|466316609|FG000|ITT Analysis|Withdrawal by Subject|4|||
129552028|NCT03185949|466316610|FG001|ITT Analysis|Withdrawal by Subject|3|||
129552029|NCT03185949|466316609|FG000|PP Analysis|Protocol Violation|2|||
129552030|NCT03185949|466316610|FG001|PP Analysis|Protocol Violation|2|||
129552031|NCT03185949|466316609|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
129685663|NCT03317496|466806287|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129685664|NCT03317496|466806288|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129685665|NCT03317496|466806289|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129685666|NCT03317496|466806290|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
129685667|NCT03317496|466806286|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129685668|NCT03317496|466806287|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129685669|NCT03317496|466806288|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
129685670|NCT03317496|466806289|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129685671|NCT03317496|466806290|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
129685672|NCT03317496|466806286|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
129685673|NCT03317496|466806287|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
129685674|NCT03317496|466806288|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
129685675|NCT03317496|466806289|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
129685676|NCT03317496|466806290|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
129685677|NCT03317496|466806286|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
129685678|NCT03317496|466806287|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
129685679|NCT03317496|466806288|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
129685680|NCT03317496|466806289|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
129685681|NCT03317496|466806290|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
129685682|NCT03317496|466806286|FG000|Phase 2: Treatment|Adverse Event|0|||
129685683|NCT03317496|466806287|FG001|Phase 2: Treatment|Adverse Event|0|||
129685684|NCT03317496|466806288|FG002|Phase 2: Treatment|Adverse Event|0|||
129685685|NCT03317496|466806289|FG003|Phase 2: Treatment|Adverse Event|0|||
129685686|NCT03317496|466806290|FG004|Phase 2: Treatment|Adverse Event|6|||
129685687|NCT03317496|466806286|FG000|Phase 2: Treatment|Progressive disease|0|||
129685688|NCT03317496|466806287|FG001|Phase 2: Treatment|Progressive disease|0|||
129685689|NCT03317496|466806288|FG002|Phase 2: Treatment|Progressive disease|0|||
129685690|NCT03317496|466806289|FG003|Phase 2: Treatment|Progressive disease|0|||
129685691|NCT03317496|466806290|FG004|Phase 2: Treatment|Progressive disease|22|||
129685692|NCT03317496|466806286|FG000|Phase 2: Treatment|Other|0|||
129685693|NCT03317496|466806287|FG001|Phase 2: Treatment|Other|0|||
129685694|NCT03317496|466806288|FG002|Phase 2: Treatment|Other|0|||
129685695|NCT03317496|466806289|FG003|Phase 2: Treatment|Other|0|||
129685696|NCT03317496|466806290|FG004|Phase 2: Treatment|Other|4|||
129685697|NCT03317496|466806286|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
129685698|NCT03317496|466806287|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
129685699|NCT03317496|466806288|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
129685700|NCT03317496|466806289|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
129685701|NCT03317496|466806290|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
129685702|NCT03317496|466806286|FG000|Phase 2: Treatment|Physician Decision|0|||
129685703|NCT03317496|466806287|FG001|Phase 2: Treatment|Physician Decision|0|||
129685704|NCT03317496|466806288|FG002|Phase 2: Treatment|Physician Decision|0|||
129685705|NCT03317496|466806289|FG003|Phase 2: Treatment|Physician Decision|0|||
129685706|NCT03317496|466806290|FG004|Phase 2: Treatment|Physician Decision|1|||
129685707|NCT03317496|466806286|FG000|Phase 2: Treatment|Death|0|||
129685708|NCT03317496|466806287|FG001|Phase 2: Treatment|Death|0|||
129685709|NCT03317496|466806288|FG002|Phase 2: Treatment|Death|0|||
129685710|NCT03317496|466806289|FG003|Phase 2: Treatment|Death|0|||
129685711|NCT03317496|466806290|FG004|Phase 2: Treatment|Death|1|||
129685712|NCT03317496|466806286|FG000|Phase 2: Follow-up|Death|0|||
129685713|NCT03317496|466806287|FG001|Phase 2: Follow-up|Death|0|||
129685714|NCT03317496|466806288|FG002|Phase 2: Follow-up|Death|0|||
129685715|NCT03317496|466806289|FG003|Phase 2: Follow-up|Death|0|||
129685716|NCT03317496|466806290|FG004|Phase 2: Follow-up|Death|24|||
129685717|NCT03317496|466806286|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
129685718|NCT03317496|466806287|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
129552032|NCT03185949|466316610|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
129552033|NCT05166421|466316619|FG000|Overall Study|Other|3|||
129552034|NCT05166421|466316620|FG001|Overall Study|Other|1|||
129685719|NCT03317496|466806288|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
129685720|NCT03317496|466806289|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
129685721|NCT03317496|466806290|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
129685722|NCT03317496|466806286|FG000|Phase 2: Follow-up|Other|0|||
129685723|NCT03317496|466806287|FG001|Phase 2: Follow-up|Other|0|||
129685724|NCT03317496|466806288|FG002|Phase 2: Follow-up|Other|0|||
129685725|NCT03317496|466806289|FG003|Phase 2: Follow-up|Other|0|||
129685726|NCT03317496|466806290|FG004|Phase 2: Follow-up|Other|1|||
129685727|NCT03317496|466806286|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
129685728|NCT03317496|466806287|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
129685729|NCT03317496|466806288|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
129685730|NCT03317496|466806289|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
129774518|NCT00892099|467139650|FG001|Overall Study|Adverse Event|0|||
129774519|NCT00892099|467139651|FG002|Overall Study|Adverse Event|0|||
129774520|NCT00892099|467139649|FG000|Overall Study|replocated|1|||
129774521|NCT00892099|467139650|FG001|Overall Study|replocated|0|||
129774522|NCT00892099|467139651|FG002|Overall Study|replocated|2|||
129774523|NCT00892099|467139649|FG000|Overall Study|Prolonged hospitalization|1|||
129774524|NCT00892099|467139650|FG001|Overall Study|Prolonged hospitalization|0|||
129774525|NCT00892099|467139651|FG002|Overall Study|Prolonged hospitalization|1|||
129774526|NCT00892099|467139649|FG000|Overall Study|no further details|1|||
129774527|NCT00892099|467139650|FG001|Overall Study|no further details|0|||
129774528|NCT00892099|467139651|FG002|Overall Study|no further details|1|||
129774529|NCT00892099|467139649|FG000|Overall Study|kidney function recovered|0|||
129774530|NCT00892099|467139650|FG001|Overall Study|kidney function recovered|1|||
129774531|NCT00892099|467139651|FG002|Overall Study|kidney function recovered|0|||
129774532|NCT00892099|467139649|FG000|Overall Study|investigator decision|0|||
129774533|NCT00892099|467139650|FG001|Overall Study|investigator decision|0|||
129774534|NCT00892099|467139651|FG002|Overall Study|investigator decision|1|||
129774535|NCT00892099|467139649|FG000|Overall Study|Lost to Follow-up|0|||
129774536|NCT00892099|467139650|FG001|Overall Study|Lost to Follow-up|0|||
129774537|NCT00892099|467139651|FG002|Overall Study|Lost to Follow-up|1|||
129774538|NCT04396639|467139652|FG000|Overall Study|Withdrawal by Subject|1|||
129774539|NCT04396639|467139652|FG000|Overall Study|Other|1|||
129774540|NCT01532986|467139653|FG000|Overall Study|Death|9|||
129774541|NCT01532986|467139654|FG001|Overall Study|Death|9|||
129774542|NCT01532986|467139653|FG000|Overall Study|Withdrawal by Subject|7|||
129774543|NCT01532986|467139654|FG001|Overall Study|Withdrawal by Subject|10|||
129774544|NCT01532986|467139653|FG000|Overall Study|Physician Decision|7|||
129774545|NCT01532986|467139654|FG001|Overall Study|Physician Decision|5|||
129774546|NCT00658359|467139657|FG000|Overall Study|Death|3|||
129774547|NCT00658359|467139658|FG001|Overall Study|Death|1|||
129774548|NCT00658359|467139659|FG002|Overall Study|Death|2|||
129774549|NCT00658359|467139657|FG000|Overall Study|Adverse Event|13|||
129774550|NCT00658359|467139658|FG001|Overall Study|Adverse Event|6|||
129774551|NCT00658359|467139659|FG002|Overall Study|Adverse Event|9|||
129774552|NCT00658359|467139657|FG000|Overall Study|Protocol Violation|1|||
129774553|NCT00658359|467139658|FG001|Overall Study|Protocol Violation|0|||
129774554|NCT00658359|467139659|FG002|Overall Study|Protocol Violation|0|||
129774555|NCT00658359|467139657|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
129774556|NCT00658359|467139658|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
129774557|NCT00658359|467139659|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
129774558|NCT00658359|467139657|FG000|Overall Study|Withdrawal by Subject|7|||
129774559|NCT00658359|467139658|FG001|Overall Study|Withdrawal by Subject|4|||
129774560|NCT00658359|467139659|FG002|Overall Study|Withdrawal by Subject|2|||
129774561|NCT00658359|467139657|FG000|Overall Study|Lost to Follow-up|2|||
129774562|NCT00658359|467139658|FG001|Overall Study|Lost to Follow-up|2|||
129774563|NCT00658359|467139659|FG002|Overall Study|Lost to Follow-up|4|||
129774564|NCT00658359|467139657|FG000|Overall Study|Lack of Efficacy|0|||
129774565|NCT00658359|467139658|FG001|Overall Study|Lack of Efficacy|1|||
129774566|NCT00658359|467139659|FG002|Overall Study|Lack of Efficacy|0|||
129774567|NCT02754440|467139660|FG000|Overall Study|Protocol Violation|3|||
129774568|NCT02754440|467139661|FG001|Overall Study|Protocol Violation|2|||
129774569|NCT02754440|467139662|FG002|Overall Study|Protocol Violation|2|||
129774570|NCT02754440|467139663|FG003|Overall Study|Protocol Violation|6|||
129774571|NCT02754440|467139660|FG000|Overall Study|Adverse Event|3|||
129774572|NCT02754440|467139661|FG001|Overall Study|Adverse Event|1|||
129774573|NCT02754440|467139662|FG002|Overall Study|Adverse Event|0|||
129774574|NCT02754440|467139663|FG003|Overall Study|Adverse Event|9|||
129774575|NCT02754440|467139660|FG000|Overall Study|Withdrawal by Subject|0|||
129774576|NCT02754440|467139661|FG001|Overall Study|Withdrawal by Subject|0|||
129774577|NCT02754440|467139662|FG002|Overall Study|Withdrawal by Subject|0|||
129774578|NCT02754440|467139663|FG003|Overall Study|Withdrawal by Subject|1|||
129774579|NCT02754440|467139660|FG000|Overall Study|Equipment failure|0|||
129774580|NCT02754440|467139661|FG001|Overall Study|Equipment failure|5|||
129774581|NCT02754440|467139662|FG002|Overall Study|Equipment failure|5|||
129774582|NCT02754440|467139663|FG003|Overall Study|Equipment failure|7|||
129774583|NCT02754440|467139660|FG000|Overall Study|Subject issues not resulting in AE|0|||
129774584|NCT02754440|467139661|FG001|Overall Study|Subject issues not resulting in AE|0|||
129774585|NCT02754440|467139662|FG002|Overall Study|Subject issues not resulting in AE|0|||
129774586|NCT02754440|467139663|FG003|Overall Study|Subject issues not resulting in AE|12|||
129774587|NCT01189032|467139666|FG000|Overall Study|Adverse Event|1|||
129774588|NCT01189032|467139667|FG001|Overall Study|Adverse Event|3|||
129774589|NCT01189032|467139668|FG002|Overall Study|Adverse Event|4|||
129774590|NCT01189032|467139666|FG000|Overall Study|Lack of Efficacy|2|||
129774591|NCT01189032|467139667|FG001|Overall Study|Lack of Efficacy|3|||
129774592|NCT01189032|467139668|FG002|Overall Study|Lack of Efficacy|0|||
129774593|NCT01189032|467139666|FG000|Overall Study|Withdrawal by Subject|1|||
129774594|NCT01189032|467139667|FG001|Overall Study|Withdrawal by Subject|0|||
129774595|NCT01189032|467139668|FG002|Overall Study|Withdrawal by Subject|1|||
129774596|NCT01189032|467139666|FG000|Overall Study|Protocol Violation|1|||
129552035|NCT05166421|466316621|FG002|Overall Study|Other|1|||
129552036|NCT05166421|466316619|FG000|Overall Study|Withdrawal by Subject|5|||
129552037|NCT05166421|466316620|FG001|Overall Study|Withdrawal by Subject|3|||
129552038|NCT05166421|466316621|FG002|Overall Study|Withdrawal by Subject|6|||
129552039|NCT05166421|466316619|FG000|Overall Study|Lost to Follow-up|4|||
129552040|NCT05166421|466316620|FG001|Overall Study|Lost to Follow-up|1|||
129552041|NCT05166421|466316621|FG002|Overall Study|Lost to Follow-up|7|||
129552042|NCT02598622|466318492|FG000|Overall Study|Withdrawal by Subject|3|||
129552043|NCT02598622|466318493|FG001|Overall Study|Withdrawal by Subject|0|||
129552044|NCT02598622|466318492|FG000|Overall Study|Physician Decision|3|||
129552045|NCT02598622|466318493|FG001|Overall Study|Physician Decision|0|||
129552046|NCT04335110|466318509|FG000|Overall Study|Withdrawal by Subject|1|||
129552047|NCT04335110|466318510|FG001|Overall Study|Withdrawal by Subject|1|||
129552048|NCT04335110|466318509|FG000|Overall Study|Death|0|||
129552049|NCT04335110|466318510|FG001|Overall Study|Death|1|||
129552050|NCT02595528|466318511|FG000|Overall Study|Withdrawal by Subject|1|||
129552051|NCT02595528|466318512|FG001|Overall Study|Withdrawal by Subject|2|||
129552052|NCT02595528|466318513|FG002|Overall Study|Withdrawal by Subject|1|||
129552053|NCT02595528|466318514|FG003|Overall Study|Withdrawal by Subject|3|||
129552054|NCT02595528|466318511|FG000|Overall Study|Lost to Follow-up|1|||
129552055|NCT02595528|466318512|FG001|Overall Study|Lost to Follow-up|1|||
129552056|NCT02595528|466318513|FG002|Overall Study|Lost to Follow-up|0|||
129552057|NCT02595528|466318514|FG003|Overall Study|Lost to Follow-up|1|||
129552058|NCT00948025|466318515|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
129552059|NCT00948025|466318516|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
129552060|NCT00948025|466318515|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
129552061|NCT00948025|466318516|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
129552062|NCT00948025|466318515|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
129552063|NCT00948025|466318516|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
129552064|NCT03333382|466318518|FG000|Overall Study|Lost to Follow-up|1|||
129552065|NCT03333382|466318519|FG001|Overall Study|Lost to Follow-up|0|||
129552066|NCT00550420|466318520|FG000|Overall Study|Adverse Event|28|||
129552067|NCT00550420|466318520|FG000|Overall Study|Lost to Follow-up|8|||
129552068|NCT00550420|466318520|FG000|Overall Study|Protocol Violation|11|||
129552069|NCT00550420|466318520|FG000|Overall Study|Withdrawal by Subject|30|||
129552070|NCT00550420|466318520|FG000|Overall Study|Still in study at termination|206|||
129552071|NCT00550420|466318520|FG000|Overall Study|Missing|2|||
129552072|NCT00550420|466318520|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
129552073|NCT00550420|466318520|FG000|Overall Study|Investigators opinion|1|||
129552074|NCT00550420|466318520|FG000|Overall Study|Lack of curative effect|1|||
129552075|NCT00550420|466318520|FG000|Overall Study|Unethical stop of enrollment|2|||
129552076|NCT00550420|466318520|FG000|Overall Study|Caregiver's decision to withdraw|1|||
129552077|NCT00550420|466318520|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
129552078|NCT00550420|466318520|FG000|Overall Study|Exclusion criteria|1|||
129552079|NCT00550420|466318520|FG000|Overall Study|Prohibited medicine|1|||
129552080|NCT02773446|466318526|FG000|First Admission|Withdrawal by Subject|0|||
129552081|NCT02773446|466318527|FG001|First Admission|Withdrawal by Subject|0|||
129552082|NCT02773446|466318528|FG002|First Admission|Withdrawal by Subject|0|||
129685731|NCT03317496|466806290|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
129685732|NCT01001104|466806295|FG000|Overall Study|Adverse Event|2|||
129685733|NCT01001104|466806296|FG001|Overall Study|Adverse Event|1|||
129685734|NCT01001104|466806297|FG002|Overall Study|Adverse Event|0|||
129685735|NCT01001104|466806298|FG003|Overall Study|Adverse Event|0|||
129685736|NCT01001104|466806295|FG000|Overall Study|Lost to Follow-up|0|||
129685737|NCT01001104|466806296|FG001|Overall Study|Lost to Follow-up|0|||
129685738|NCT01001104|466806297|FG002|Overall Study|Lost to Follow-up|1|||
129685739|NCT01001104|466806298|FG003|Overall Study|Lost to Follow-up|0|||
129685740|NCT01001104|466806295|FG000|Overall Study|Entry Criteria Not Met|0|||
129685741|NCT01001104|466806296|FG001|Overall Study|Entry Criteria Not Met|0|||
129685742|NCT01001104|466806297|FG002|Overall Study|Entry Criteria Not Met|0|||
129685743|NCT01001104|466806298|FG003|Overall Study|Entry Criteria Not Met|1|||
129685744|NCT01001104|466806295|FG000|Overall Study|Withdrawal by Subject|0|||
129552083|NCT02773446|466318529|FG003|First Admission|Withdrawal by Subject|1|||
129552084|NCT02773446|466318530|FG004|First Admission|Withdrawal by Subject|0|||
129552085|NCT02773446|466318531|FG005|First Admission|Withdrawal by Subject|0|||
129552086|NCT02773446|466318526|FG000|First Admission|Lost to Follow-up|1|||
129552087|NCT02773446|466318527|FG001|First Admission|Lost to Follow-up|0|||
129552088|NCT02773446|466318528|FG002|First Admission|Lost to Follow-up|0|||
129552089|NCT02773446|466318529|FG003|First Admission|Lost to Follow-up|0|||
129552090|NCT02773446|466318530|FG004|First Admission|Lost to Follow-up|0|||
129552091|NCT02773446|466318531|FG005|First Admission|Lost to Follow-up|0|||
129552092|NCT04378010|466318532|FG000|Overall Study|Adverse Event|8|||
129552093|NCT04378010|466318533|FG001|Overall Study|Adverse Event|14|||
129552094|NCT04378010|466318534|FG002|Overall Study|Adverse Event|4|||
129685745|NCT01001104|466806296|FG001|Overall Study|Withdrawal by Subject|0|||
129685746|NCT01001104|466806297|FG002|Overall Study|Withdrawal by Subject|0|||
129685747|NCT01001104|466806298|FG003|Overall Study|Withdrawal by Subject|2|||
129685748|NCT02397837|466806299|FG000|Overall Study|Withdrawal by Subject|6|||
129552095|NCT04378010|466318532|FG000|Overall Study|Withdrawal by Subject|0|||
129552096|NCT04378010|466318533|FG001|Overall Study|Withdrawal by Subject|2|||
129552097|NCT04378010|466318534|FG002|Overall Study|Withdrawal by Subject|1|||
129552098|NCT04378010|466318532|FG000|Overall Study|Protocol Violation|2|||
129552099|NCT04378010|466318533|FG001|Overall Study|Protocol Violation|1|||
129552100|NCT04378010|466318534|FG002|Overall Study|Protocol Violation|4|||
129552101|NCT04378010|466318532|FG000|Overall Study|Study terminated by Sponsor|22|||
129552102|NCT04378010|466318533|FG001|Overall Study|Study terminated by Sponsor|16|||
129552103|NCT04378010|466318534|FG002|Overall Study|Study terminated by Sponsor|22|||
129552104|NCT04378010|466318532|FG000|Overall Study|Subject inability to complete study visit|0|||
129552105|NCT04378010|466318533|FG001|Overall Study|Subject inability to complete study visit|0|||
129552106|NCT04378010|466318534|FG002|Overall Study|Subject inability to complete study visit|1|||
129552107|NCT04378010|466318532|FG000|Overall Study|Subject never dosed|0|||
129552108|NCT04378010|466318533|FG001|Overall Study|Subject never dosed|1|||
129552109|NCT04378010|466318534|FG002|Overall Study|Subject never dosed|0|||
129552110|NCT02513459|466318535|FG000|Overall Study|Adverse Event|7|||
129552111|NCT02513459|466318535|FG000|Overall Study|Withdrew consent|5|||
129552112|NCT02513459|466318535|FG000|Overall Study|Loss of efficacy|2|||
129552113|NCT02513459|466318535|FG000|Overall Study|Pregnancy|2|||
129552114|NCT02513459|466318535|FG000|Overall Study|Subject decision|2|||
129552115|NCT02513459|466318535|FG000|Overall Study|Lack of response|1|||
129552116|NCT02513459|466318535|FG000|Overall Study|Reproductive plans|1|||
129552117|NCT02513459|466318535|FG000|Overall Study|Surgery planned-- not done|1|||
129552118|NCT03237611|466318536|FG000|Overall Study|Withdrawal by Subject|1|||
129552119|NCT03237611|466318536|FG000|Overall Study|Ineligible|1|||
129552120|NCT04023994|466318537|FG000|Overall Study|Lost to Follow-up|0|||
129552121|NCT04023994|466318538|FG001|Overall Study|Lost to Follow-up|1|||
129552122|NCT04023994|466318539|FG002|Overall Study|Lost to Follow-up|2|||
129552123|NCT04023994|466318540|FG003|Overall Study|Lost to Follow-up|0|||
129552124|NCT04023994|466318541|FG004|Overall Study|Lost to Follow-up|0|||
129552125|NCT04023994|466318542|FG005|Overall Study|Lost to Follow-up|0|||
129552126|NCT04023994|466318537|FG000|Overall Study|Withdrawal by Subject|0|||
129552127|NCT04023994|466318538|FG001|Overall Study|Withdrawal by Subject|0|||
129552128|NCT04023994|466318539|FG002|Overall Study|Withdrawal by Subject|0|||
129552129|NCT04023994|466318540|FG003|Overall Study|Withdrawal by Subject|1|||
129552130|NCT04023994|466318541|FG004|Overall Study|Withdrawal by Subject|0|||
129552131|NCT04023994|466318542|FG005|Overall Study|Withdrawal by Subject|0|||
129552132|NCT00923195|466318543|FG000|Overall Study|Death|0|||
129552133|NCT00923195|466318544|FG001|Overall Study|Death|1|||
129552134|NCT01613131|466318547|FG000|Overall Study|Withdrawal by Subject|3|||
129552135|NCT01613131|466318548|FG001|Overall Study|Withdrawal by Subject|5|||
129552136|NCT00787566|466318549|FG000|Overall Study|AE related to chemotherapy|0|||
129685749|NCT02397837|466806300|FG001|Overall Study|Withdrawal by Subject|5|||
129774597|NCT01189032|467139667|FG001|Overall Study|Protocol Violation|1|||
129774598|NCT01189032|467139668|FG002|Overall Study|Protocol Violation|1|||
129774599|NCT03388164|467139673|FG000|Overall Study|Withdrawal by Subject|3|||
129685750|NCT02397837|466806299|FG000|Overall Study|Physician Decision|1|||
129685751|NCT02397837|466806300|FG001|Overall Study|Physician Decision|1|||
129685752|NCT00599313|466806302|FG000|Overall Study|Adverse Event|19|||
129685753|NCT00599313|466806302|FG000|Overall Study|Disease Progression|12|||
129685754|NCT00599313|466806302|FG000|Overall Study|Patient Request|4|||
129685755|NCT00599313|466806302|FG000|Overall Study|Ineligible|1|||
129685756|NCT02536794|466806303|FG000|Reached 1st Response Assessment|Adverse Event|2|||
129685757|NCT02536794|466806303|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
129685758|NCT02536794|466806303|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
129685759|NCT02536794|466806303|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
129685760|NCT02536794|466806303|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
129685761|NCT02536794|466806303|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
129685762|NCT00898807|466806316|FG000|Overall Study|Withdrawal by Subject|5|||
129685763|NCT00898807|466806317|FG001|Overall Study|Withdrawal by Subject|3|||
129685764|NCT00898807|466806316|FG000|Overall Study|Family pressure to discontinue|2|||
129685765|NCT00898807|466806317|FG001|Overall Study|Family pressure to discontinue|2|||
129685766|NCT00898807|466806316|FG000|Overall Study|Lost to Follow-up|1|||
129552137|NCT00787566|466318550|FG001|Overall Study|AE related to chemotherapy|1|||
129552138|NCT00787566|466318551|FG002|Overall Study|AE related to chemotherapy|0|||
129552139|NCT01814761|466318552|FG000|Overall Study|Other Reasons|1|||
129552140|NCT01814761|466318553|FG001|Overall Study|Other Reasons|10|||
129552141|NCT01814761|466318552|FG000|Overall Study|Ocular Adverse Event|6|||
129552142|NCT01814761|466318553|FG001|Overall Study|Ocular Adverse Event|15|||
129552143|NCT01814761|466318552|FG000|Overall Study|Lost to Follow-up|1|||
129552144|NCT01814761|466318553|FG001|Overall Study|Lost to Follow-up|5|||
129685767|NCT00898807|466806317|FG001|Overall Study|Lost to Follow-up|3|||
129685768|NCT00898807|466806316|FG000|Overall Study|Death|0|||
129685769|NCT00898807|466806317|FG001|Overall Study|Death|1|||
129774600|NCT03388164|467139674|FG001|Overall Study|Withdrawal by Subject|1|||
129552145|NCT03137082|466318554|FG000|Overall Study|Withdrawal by Subject|1|||
129552146|NCT03137082|466318555|FG001|Overall Study|Withdrawal by Subject|1|||
129552147|NCT03137082|466318554|FG000|Overall Study|Lost to Follow-up|1|||
129552148|NCT03137082|466318555|FG001|Overall Study|Lost to Follow-up|0|||
129552149|NCT00544557|466318556|FG000|Overall Study|Adverse Event|140|||
129552150|NCT00544557|466318556|FG000|Overall Study|Lack of Efficacy|196|||
129552151|NCT00544557|466318556|FG000|Overall Study|Other|98|||
129552152|NCT00467818|466318557|FG000|Overall Study|Adverse Event|1|||
129685770|NCT00817063|466806318|FG000|Overall Study|Adverse Event|32|||
129685771|NCT00817063|466806319|FG001|Overall Study|Adverse Event|13|||
129685772|NCT00817063|466806318|FG000|Overall Study|Death|1|||
129685773|NCT00817063|466806319|FG001|Overall Study|Death|1|||
129685774|NCT00817063|466806318|FG000|Overall Study|Lack of Efficacy|33|||
129685775|NCT00817063|466806319|FG001|Overall Study|Lack of Efficacy|86|||
129685776|NCT00817063|466806318|FG000|Overall Study|Failure to Return|13|||
129685777|NCT00817063|466806319|FG001|Overall Study|Failure to Return|12|||
129685778|NCT00817063|466806318|FG000|Overall Study|Violation of Selection at Entry|7|||
129685779|NCT00817063|466806319|FG001|Overall Study|Violation of Selection at Entry|4|||
129685780|NCT00817063|466806318|FG000|Overall Study|Protocol Violation|3|||
129685781|NCT00817063|466806319|FG001|Overall Study|Protocol Violation|8|||
129685782|NCT00817063|466806318|FG000|Overall Study|Withdrawal by Subject|17|||
129685783|NCT00817063|466806319|FG001|Overall Study|Withdrawal by Subject|37|||
129685784|NCT00817063|466806318|FG000|Overall Study|Early Improvement|19|||
129685785|NCT00817063|466806319|FG001|Overall Study|Early Improvement|4|||
129685786|NCT00817063|466806318|FG000|Overall Study|Administrative|10|||
129685787|NCT00817063|466806319|FG001|Overall Study|Administrative|4|||
129685788|NCT00817063|466806318|FG000|Overall Study|Abnormality of Laboratory Test|2|||
129685789|NCT00817063|466806319|FG001|Overall Study|Abnormality of Laboratory Test|1|||
129685790|NCT01496456|466806320|FG000|Overall Study|Protocol Violation|1|||
129685791|NCT01496456|466806320|FG000|Overall Study|Lost to Follow-up|7|||
129685792|NCT04919161|466806321|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
129685793|NCT04919161|466806322|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
129552153|NCT00467818|466318558|FG001|Overall Study|Adverse Event|0|||
129685794|NCT04919161|466806321|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
129685795|NCT04919161|466806322|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
129685796|NCT04919161|466806321|FG000|Overall Study|Acute ankle sprain after session 1|0|||
129685797|NCT04919161|466806322|FG001|Overall Study|Acute ankle sprain after session 1|1|||
129774601|NCT05375760|467139677|FG000|Overall Study|Adverse Event|1|||
129774602|NCT05375760|467139678|FG001|Overall Study|Adverse Event|0|||
129774603|NCT05375760|467139677|FG000|Overall Study|Death|0|||
129774604|NCT05375760|467139678|FG001|Overall Study|Death|1|||
129774605|NCT05375760|467139677|FG000|Overall Study|Lost to Follow-up|6|||
129774606|NCT05375760|467139678|FG001|Overall Study|Lost to Follow-up|6|||
129774607|NCT05375760|467139677|FG000|Overall Study|Withdrawal by Subject|17|||
129774608|NCT05375760|467139678|FG001|Overall Study|Withdrawal by Subject|19|||
129774609|NCT05375760|467139677|FG000|Overall Study|Dosing halted by FDA|96|||
129774610|NCT05375760|467139678|FG001|Overall Study|Dosing halted by FDA|100|||
129774611|NCT05375760|467139677|FG000|Overall Study|Not compliant with study visit|2|||
129774612|NCT05375760|467139678|FG001|Overall Study|Not compliant with study visit|0|||
129774613|NCT05375760|467139677|FG000|Overall Study|Physician Decision|1|||
129774614|NCT05375760|467139678|FG001|Overall Study|Physician Decision|0|||
129774615|NCT05375760|467139677|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
129774616|NCT05375760|467139678|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
129774617|NCT05375760|467139677|FG000|Overall Study|Participant moved|1|||
129774618|NCT05375760|467139678|FG001|Overall Study|Participant moved|0|||
129774619|NCT00363480|467139679|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
129774620|NCT00363480|467139679|FG000|Overall Study|Adverse Event|4|||
129884437|NCT02572817|467536395|FG001|Overall Study|Death|3|||
129552154|NCT00467818|466318557|FG000|Overall Study|Lost to Follow-up|2|||
129552155|NCT00467818|466318558|FG001|Overall Study|Lost to Follow-up|2|||
129774621|NCT00363480|467139679|FG000|Overall Study|Lost to Follow-up|5|||
129774622|NCT00363480|467139679|FG000|Overall Study|Withdrawal by Subject|5|||
129774623|NCT00363480|467139679|FG000|Overall Study|Non-compliance of subject|1|||
129774624|NCT00363480|467139679|FG000|Overall Study|Participant discontinued on its own|1|||
129774625|NCT01457703|467139680|FG000|Overall Study|Screen Failure|5|||
129774626|NCT01457703|467139681|FG001|Overall Study|Screen Failure|7|||
129884438|NCT02572817|467536394|FG000|Overall Study|Lost to Follow-up|3|||
129552156|NCT01313728|466318559|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
129552157|NCT03547531|466318562|FG000|Overall Study|not coming in data collection : sick|2|||
129552158|NCT03547531|466318563|FG001|Overall Study|not coming in data collection : sick|2|||
129552159|NCT03547531|466318562|FG000|Overall Study|having family occasion|0|||
129552160|NCT03547531|466318563|FG001|Overall Study|having family occasion|2|||
129552161|NCT02444182|466318571|FG000|Overall Study|non-compliance|2|||
129552162|NCT02444182|466318572|FG001|Overall Study|non-compliance|1|||
129552163|NCT02444182|466318571|FG000|Overall Study|Lost to Follow-up|0|||
129552164|NCT02444182|466318572|FG001|Overall Study|Lost to Follow-up|4|||
129552165|NCT02981602|466318575|FG000|Overall Study|Adverse Event|0|||
129552166|NCT02981602|466318576|FG001|Overall Study|Adverse Event|0|||
129552167|NCT02981602|466318577|FG002|Overall Study|Adverse Event|0|||
129552168|NCT02981602|466318578|FG003|Overall Study|Adverse Event|1|||
129552169|NCT02981602|466318579|FG004|Overall Study|Adverse Event|0|||
129552170|NCT01169987|466318580|FG000|Overall Study|Withdrawal by Subject|3|||
129552171|NCT01169987|466318580|FG000|Overall Study|Lost to Follow-up|24|||
129552172|NCT01169987|466318580|FG000|Overall Study|Other|4|||
129552173|NCT00386100|466318581|FG000|Overall Study|Did not receive study medication|6|||
129552174|NCT00386100|466318582|FG001|Overall Study|Did not receive study medication|4|||
129552175|NCT00386100|466318581|FG000|Overall Study|Adverse Event|15|||
129774627|NCT01457703|467139680|FG000|Overall Study|Withdrawal by Subject|1|||
129774628|NCT01457703|467139681|FG001|Overall Study|Withdrawal by Subject|4|||
129774629|NCT00949702|467139682|FG000|Overall Study|Death|40|||
129774630|NCT00949702|467139682|FG000|Overall Study|Disease progression|7|||
129774631|NCT00949702|467139682|FG000|Overall Study|Withdrawal of consent|1|||
129774632|NCT06042855|467139685|FG000|Overall Study|No Receipt of Study Drug|48|||
129774633|NCT06042855|467139686|FG001|Overall Study|No Receipt of Study Drug|57|||
129774634|NCT06042855|467139685|FG000|Overall Study|Administratively Withdrawn|59|||
129774635|NCT06042855|467139686|FG001|Overall Study|Administratively Withdrawn|59|||
129774636|NCT02129699|467139691|FG000|Overall Study|Did not start treatment|3|||
129774637|NCT02129699|467139692|FG001|Overall Study|Did not start treatment|2|||
129774638|NCT00525161|467139695|FG000|Overall Study|Adverse Event|1|||
129774639|NCT01076361|467139699|FG000|Overall Study|22 leads were excluded from analysis|21|||
129774640|NCT02447003|467139700|FG000|Overall Study|Other|0|||
129774641|NCT02447003|467139701|FG001|Overall Study|Other|4|||
129774642|NCT02447003|467139700|FG000|Overall Study|Site discontinued|0|||
129774643|NCT02447003|467139701|FG001|Overall Study|Site discontinued|2|||
129774644|NCT02447003|467139700|FG000|Overall Study|Physician Decision|0|||
129774645|NCT02447003|467139701|FG001|Overall Study|Physician Decision|1|||
129774646|NCT02447003|467139700|FG000|Overall Study|Withdrawal by Subject|4|||
129774647|NCT02447003|467139701|FG001|Overall Study|Withdrawal by Subject|3|||
129552176|NCT00386100|466318582|FG001|Overall Study|Adverse Event|25|||
129774648|NCT02447003|467139700|FG000|Overall Study|Sponsor Decision|6|||
129552177|NCT00386100|466318581|FG000|Overall Study|Death|0|||
129552178|NCT00386100|466318582|FG001|Overall Study|Death|1|||
129774649|NCT02447003|467139701|FG001|Overall Study|Sponsor Decision|11|||
129774650|NCT02447003|467139700|FG000|Overall Study|Progressive Disease|1|||
129774651|NCT02447003|467139701|FG001|Overall Study|Progressive Disease|0|||
129774652|NCT02447003|467139700|FG000|Overall Study|Lost to Follow-up|5|||
129774653|NCT02447003|467139701|FG001|Overall Study|Lost to Follow-up|0|||
129774654|NCT02447003|467139700|FG000|Overall Study|Death|154|||
129774655|NCT02447003|467139701|FG001|Overall Study|Death|63|||
129774656|NCT03848728|467139702|FG000|Overall Study|Death|16|||
129774657|NCT03848728|467139703|FG001|Overall Study|Death|13|||
129774658|NCT03848728|467139702|FG000|Overall Study|Outmigrated to non-study community|98|||
129774659|NCT03848728|467139703|FG001|Overall Study|Outmigrated to non-study community|106|||
129774660|NCT03848728|467139702|FG000|Overall Study|Transfered to non-study clinic|32|||
129774661|NCT03848728|467139703|FG001|Overall Study|Transfered to non-study clinic|48|||
129774662|NCT03848728|467139702|FG000|Overall Study|Withdrawal by Subject|1|||
129774663|NCT03848728|467139703|FG001|Overall Study|Withdrawal by Subject|0|||
129774664|NCT00630838|467139706|FG000|Overall Study|Death|0|||
129774665|NCT00630838|467139707|FG001|Overall Study|Death|1|||
129774666|NCT00630838|467139706|FG000|Overall Study|Lost to Follow-up|0|||
129774667|NCT00630838|467139707|FG001|Overall Study|Lost to Follow-up|1|||
129774668|NCT04161157|467139711|FG000|Overall Study|Lost to Follow-up|4|||
129774669|NCT04161157|467139711|FG000|Overall Study|Death|3|||
129774670|NCT04161157|467139711|FG000|Overall Study|Ineligible|2|||
129774671|NCT04161157|467139711|FG000|Overall Study|Withdrawal by Subject|4|||
129774672|NCT01108185|467139712|FG000|Overall Study|Non-compliance|15|||
129552179|NCT00386100|466318581|FG000|Overall Study|Insufficient therapeutic effect|30|||
129552180|NCT00386100|466318582|FG001|Overall Study|Insufficient therapeutic effect|6|||
129552181|NCT00386100|466318581|FG000|Overall Study|Lost to Follow-up|29|||
129552182|NCT00386100|466318582|FG001|Overall Study|Lost to Follow-up|29|||
129552183|NCT00386100|466318581|FG000|Overall Study|Non-compliance|18|||
129552184|NCT00386100|466318582|FG001|Overall Study|Non-compliance|19|||
129552185|NCT00386100|466318581|FG000|Overall Study|Protocol Violation|5|||
129552186|NCT00386100|466318582|FG001|Overall Study|Protocol Violation|3|||
129552187|NCT00386100|466318581|FG000|Overall Study|Withdrawal by Subject|32|||
129552188|NCT00386100|466318582|FG001|Overall Study|Withdrawal by Subject|31|||
129552189|NCT00386100|466318581|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
129552190|NCT00386100|466318582|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
129552191|NCT00386100|466318581|FG000|Overall Study|BMD <2.5|1|||
129552192|NCT00386100|466318582|FG001|Overall Study|BMD <2.5|0|||
129552193|NCT00386100|466318581|FG000|Overall Study|Consecutive elevated Hba1C|1|||
129552194|NCT00386100|466318582|FG001|Overall Study|Consecutive elevated Hba1C|0|||
129552195|NCT00386100|466318581|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
129552196|NCT00386100|466318582|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
129552197|NCT00386100|466318581|FG000|Overall Study|Laboratory findings|1|||
129552198|NCT00386100|466318582|FG001|Overall Study|Laboratory findings|0|||
129552199|NCT00386100|466318581|FG000|Overall Study|Participant's concern due to CPK levels|1|||
129552200|NCT00386100|466318582|FG001|Overall Study|Participant's concern due to CPK levels|0|||
129552201|NCT00386100|466318581|FG000|Overall Study|Participant moving out of state|2|||
129552202|NCT00386100|466318582|FG001|Overall Study|Participant moving out of state|0|||
129552203|NCT00386100|466318581|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
129552204|NCT00386100|466318582|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
129552205|NCT00386100|466318581|FG000|Overall Study|Didn't meet entry criteria|1|||
129552206|NCT00386100|466318582|FG001|Overall Study|Didn't meet entry criteria|1|||
129552207|NCT00386100|466318581|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
129552208|NCT00386100|466318582|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
129552209|NCT00386100|466318581|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
129552210|NCT00386100|466318582|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
129552211|NCT00386100|466318581|FG000|Overall Study|Bad metabolic control & patient security|1|||
129552212|NCT00386100|466318582|FG001|Overall Study|Bad metabolic control & patient security|0|||
129552213|NCT00386100|466318581|FG000|Overall Study|Bone loss by DXA bone scan|1|||
129552214|NCT00386100|466318582|FG001|Overall Study|Bone loss by DXA bone scan|0|||
129685798|NCT02489773|466806323|FG000|Overall Study|Lost to Follow-up|4|||
129685799|NCT02489773|466806324|FG001|Overall Study|Lost to Follow-up|1|||
129685800|NCT02489773|466806323|FG000|Overall Study|Physician Decision|1|||
129685801|NCT02489773|466806324|FG001|Overall Study|Physician Decision|0|||
129552215|NCT00386100|466318581|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
129685802|NCT02489773|466806323|FG000|Overall Study|Withdrawal by Subject|1|||
129552216|NCT00386100|466318582|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
129552217|NCT00386100|466318581|FG000|Overall Study|7.6% bone loss|1|||
129552218|NCT00386100|466318582|FG001|Overall Study|7.6% bone loss|0|||
129552219|NCT00386100|466318581|FG000|Overall Study|Osteoporosis|0|||
129552220|NCT00386100|466318582|FG001|Overall Study|Osteoporosis|1|||
129685803|NCT02489773|466806324|FG001|Overall Study|Withdrawal by Subject|0|||
129685804|NCT02489773|466806323|FG000|Overall Study|Leave the country or the state|1|||
129552221|NCT00386100|466318581|FG000|Overall Study|Positive pregnancy test|1|||
129552222|NCT00386100|466318582|FG001|Overall Study|Positive pregnancy test|3|||
129552223|NCT00386100|466318581|FG000|Overall Study|Out of country for 5 months|1|||
129552224|NCT00386100|466318582|FG001|Overall Study|Out of country for 5 months|0|||
129552225|NCT00386100|466318581|FG000|Overall Study|Hb1Ac >8%|0|||
129552226|NCT00386100|466318582|FG001|Overall Study|Hb1Ac >8%|1|||
129552227|NCT00386100|466318581|FG000|Overall Study|Participant randomized in error|1|||
129552228|NCT00386100|466318582|FG001|Overall Study|Participant randomized in error|0|||
129552229|NCT01706770|466318585|FG000|Overall Study|Lost to Follow-up|1|||
129552230|NCT01706770|466318586|FG001|Overall Study|Lost to Follow-up|0|||
129552231|NCT01706770|466318585|FG000|Overall Study|Physician Decision|1|||
129552232|NCT01706770|466318586|FG001|Overall Study|Physician Decision|0|||
129552233|NCT01896700|466318590|FG000|Overall Study|Adverse Event|4|||
129552234|NCT01896700|466318591|FG001|Overall Study|Adverse Event|5|||
129552235|NCT01896700|466318590|FG000|Overall Study|Withdrawal by Subject|0|||
129552236|NCT01896700|466318591|FG001|Overall Study|Withdrawal by Subject|1|||
129552237|NCT00423488|466318592|FG000|Overall Study|No evidence of study drug intake|2|||
129552238|NCT00423488|466318593|FG001|Overall Study|No evidence of study drug intake|1|||
129552239|NCT00423488|466318592|FG000|Overall Study|No post baseline data|3|||
129552240|NCT00423488|466318593|FG001|Overall Study|No post baseline data|0|||
129552241|NCT00886782|466318596|FG000|Overall Study|Disease progression|3|||
129552242|NCT00886782|466318597|FG001|Overall Study|Disease progression|3|||
129552243|NCT00886782|466318598|FG002|Overall Study|Disease progression|3|||
129552244|NCT00886782|466318596|FG000|Overall Study|Study drug toxicity|0|||
129552245|NCT00886782|466318597|FG001|Overall Study|Study drug toxicity|0|||
129552246|NCT00886782|466318598|FG002|Overall Study|Study drug toxicity|1|||
129552247|NCT00886782|466318596|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
129552248|NCT00886782|466318597|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
129552249|NCT00886782|466318598|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
129552250|NCT00849524|466318599|FG000|Overall Study|Lack of Efficacy|3|||
129552251|NCT03636542|466318602|FG000|Overall Study|Lost to Follow-up|1|||
129552252|NCT03636542|466318603|FG001|Overall Study|Lost to Follow-up|1|||
129552253|NCT03636542|466318602|FG000|Overall Study|Physician Decision|0|||
129552254|NCT03636542|466318603|FG001|Overall Study|Physician Decision|1|||
129552255|NCT03636542|466318602|FG000|Overall Study|Withdrawal by Subject|1|||
129552256|NCT03636542|466318603|FG001|Overall Study|Withdrawal by Subject|0|||
129552257|NCT00527397|466318604|FG000|Overall Study|Adverse Event|3|||
129552258|NCT00527397|466318604|FG000|Overall Study|Lack of Efficacy|1|||
129552259|NCT00527397|466318604|FG000|Overall Study|Protocol Violation|1|||
129552260|NCT00527397|466318604|FG000|Overall Study|Withdrawal by Subject|6|||
129552261|NCT00527397|466318604|FG000|Overall Study|Study terminated by sponsor|13|||
129552262|NCT04130919|466318605|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
129552263|NCT04130919|466318606|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
129552264|NCT04130919|466318607|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
129552265|NCT04130919|466318608|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
129552266|NCT04130919|466318609|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
129552267|NCT04130919|466318610|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
129552268|NCT04130919|466318605|FG000|Blinded Treatment Phase|Adverse Event|0|||
129552269|NCT04130919|466318606|FG001|Blinded Treatment Phase|Adverse Event|0|||
129552270|NCT04130919|466318607|FG002|Blinded Treatment Phase|Adverse Event|1|||
129552271|NCT04130919|466318608|FG003|Blinded Treatment Phase|Adverse Event|0|||
129552272|NCT04130919|466318609|FG004|Blinded Treatment Phase|Adverse Event|0|||
129552273|NCT04130919|466318610|FG005|Blinded Treatment Phase|Adverse Event|0|||
129552274|NCT04130919|466318605|FG000|Blinded Treatment Phase|Disease worsening|0|||
129552275|NCT04130919|466318606|FG001|Blinded Treatment Phase|Disease worsening|0|||
129552276|NCT04130919|466318607|FG002|Blinded Treatment Phase|Disease worsening|1|||
129774673|NCT01108185|467139712|FG000|Overall Study|Lost to Follow-up|12|||
129774674|NCT02581410|467139713|FG000|Vaccination Phase|Adverse Event|2|||
129774675|NCT02581410|467139714|FG001|Vaccination Phase|Adverse Event|1|||
129774676|NCT02581410|467139713|FG000|Vaccination Phase|Withdrawal by Subject|0|||
129774677|NCT02581410|467139714|FG001|Vaccination Phase|Withdrawal by Subject|1|||
129774678|NCT02581410|467139713|FG000|Vaccination Phase|Migrated/moved from study area|0|||
129774679|NCT02581410|467139714|FG001|Vaccination Phase|Migrated/moved from study area|1|||
129552277|NCT04130919|466318608|FG003|Blinded Treatment Phase|Disease worsening|0|||
129774680|NCT02581410|467139713|FG000|End of Study Phase|Adverse Event|4|||
129774681|NCT02581410|467139714|FG001|End of Study Phase|Adverse Event|3|||
129552278|NCT04130919|466318609|FG004|Blinded Treatment Phase|Disease worsening|0|||
129552279|NCT04130919|466318610|FG005|Blinded Treatment Phase|Disease worsening|0|||
129552280|NCT04130919|466318605|FG000|Blinded Treatment Phase|Investigator's decision|0|||
129552281|NCT04130919|466318606|FG001|Blinded Treatment Phase|Investigator's decision|1|||
129552282|NCT04130919|466318607|FG002|Blinded Treatment Phase|Investigator's decision|0|||
129552283|NCT04130919|466318608|FG003|Blinded Treatment Phase|Investigator's decision|0|||
129552284|NCT04130919|466318609|FG004|Blinded Treatment Phase|Investigator's decision|0|||
129774682|NCT02581410|467139713|FG000|End of Study Phase|Withdrawal by Subject|1|||
129774683|NCT02581410|467139714|FG001|End of Study Phase|Withdrawal by Subject|2|||
129552285|NCT04130919|466318610|FG005|Blinded Treatment Phase|Investigator's decision|0|||
129552286|NCT04130919|466318605|FG000|Blinded Treatment Phase|Withdrew consent|1|||
129552287|NCT04130919|466318606|FG001|Blinded Treatment Phase|Withdrew consent|0|||
129552288|NCT04130919|466318607|FG002|Blinded Treatment Phase|Withdrew consent|0|||
129552289|NCT04130919|466318608|FG003|Blinded Treatment Phase|Withdrew consent|0|||
129552290|NCT04130919|466318609|FG004|Blinded Treatment Phase|Withdrew consent|0|||
129552291|NCT04130919|466318610|FG005|Blinded Treatment Phase|Withdrew consent|0|||
129552292|NCT04130919|466318605|FG000|Open-label Treatment Phase|Withdrew consent|0|||
129552293|NCT04130919|466318606|FG001|Open-label Treatment Phase|Withdrew consent|0|||
129552294|NCT04130919|466318607|FG002|Open-label Treatment Phase|Withdrew consent|0|||
129552295|NCT04130919|466318608|FG003|Open-label Treatment Phase|Withdrew consent|1|||
129552296|NCT04130919|466318609|FG004|Open-label Treatment Phase|Withdrew consent|1|||
129552297|NCT04130919|466318610|FG005|Open-label Treatment Phase|Withdrew consent|1|||
129552298|NCT04130919|466318605|FG000|Open-label Treatment Phase|Disease worsening|0|||
129552299|NCT04130919|466318606|FG001|Open-label Treatment Phase|Disease worsening|0|||
129552300|NCT04130919|466318607|FG002|Open-label Treatment Phase|Disease worsening|0|||
129552301|NCT04130919|466318608|FG003|Open-label Treatment Phase|Disease worsening|1|||
129552302|NCT04130919|466318609|FG004|Open-label Treatment Phase|Disease worsening|0|||
129552303|NCT04130919|466318610|FG005|Open-label Treatment Phase|Disease worsening|1|||
129552304|NCT04130919|466318605|FG000|Open-label Treatment Phase|Investigator's decision|0|||
129552305|NCT04130919|466318606|FG001|Open-label Treatment Phase|Investigator's decision|0|||
129552306|NCT04130919|466318607|FG002|Open-label Treatment Phase|Investigator's decision|0|||
129552307|NCT04130919|466318608|FG003|Open-label Treatment Phase|Investigator's decision|1|||
129552308|NCT04130919|466318609|FG004|Open-label Treatment Phase|Investigator's decision|0|||
129552309|NCT04130919|466318610|FG005|Open-label Treatment Phase|Investigator's decision|0|||
129552310|NCT04130919|466318605|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
129552311|NCT04130919|466318606|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
129552312|NCT04130919|466318607|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
129552313|NCT04130919|466318608|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
129552314|NCT04130919|466318609|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
129552315|NCT04130919|466318610|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
129552316|NCT04130919|466318605|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
129552317|NCT04130919|466318606|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
129552318|NCT04130919|466318607|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
129552319|NCT04130919|466318608|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
129552320|NCT04130919|466318609|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
129552321|NCT04130919|466318610|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
129552322|NCT00068237|466318617|FG000|Overall Study|Ineligible|3|||
129552323|NCT00068237|466318617|FG000|Overall Study|No protocol treatment received|2|||
129552324|NCT01358708|466318618|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
129552325|NCT01358708|466318619|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129552326|NCT01358708|466318618|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
129552327|NCT01358708|466318619|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
129552328|NCT03056001|466318620|FG000|Overall Study|Death|24|||
129552329|NCT00363129|466318623|FG000|Overall Study|Withdrawal by Subject|11|||
129552330|NCT00363129|466318624|FG001|Overall Study|Withdrawal by Subject|18|||
129552331|NCT00363129|466318623|FG000|Overall Study|Adverse Event|8|||
129552332|NCT00363129|466318624|FG001|Overall Study|Adverse Event|3|||
129552333|NCT00363129|466318623|FG000|Overall Study|Alternate Treatment|2|||
129552334|NCT00363129|466318624|FG001|Overall Study|Alternate Treatment|4|||
129552335|NCT00363129|466318623|FG000|Overall Study|Other Medical Problems|2|||
129552336|NCT00363129|466318624|FG001|Overall Study|Other Medical Problems|4|||
129552337|NCT00363129|466318623|FG000|Overall Study|Death|0|||
129774684|NCT02581410|467139713|FG000|End of Study Phase|Migrated/moved from study area|0|||
129552338|NCT00363129|466318624|FG001|Overall Study|Death|1|||
129552339|NCT00363129|466318623|FG000|Overall Study|Other Reasons|6|||
129552340|NCT00363129|466318624|FG001|Overall Study|Other Reasons|3|||
129552341|NCT03707522|466318625|FG000|Overall Study|Lost to Follow-up|24|||
129552342|NCT03707522|466318626|FG001|Overall Study|Lost to Follow-up|27|||
129552343|NCT03707522|466318627|FG002|Overall Study|Lost to Follow-up|41|||
129552344|NCT03707522|466318628|FG003|Overall Study|Lost to Follow-up|36|||
129552345|NCT04363736|466318629|FG000|Overall Study|Withdrawal by Subject|1|||
129552346|NCT04363736|466318630|FG001|Overall Study|Withdrawal by Subject|0|||
129552347|NCT04363736|466318629|FG000|Overall Study|Lost to Follow-up|10|||
129552348|NCT04363736|466318630|FG001|Overall Study|Lost to Follow-up|7|||
129552349|NCT04363736|466318629|FG000|Overall Study|Death|8|||
129552350|NCT04363736|466318630|FG001|Overall Study|Death|6|||
129774685|NCT02581410|467139714|FG001|End of Study Phase|Migrated/moved from study area|3|||
129774686|NCT02581410|467139713|FG000|End of Study Phase|Lost to Follow-up|0|||
129774687|NCT02581410|467139714|FG001|End of Study Phase|Lost to Follow-up|2|||
129774688|NCT02581410|467139713|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
129884439|NCT02572817|467536395|FG001|Overall Study|Lost to Follow-up|3|||
129884440|NCT02111213|467536399|FG000|Overall Study|Withdrawal by Subject|3|||
129884441|NCT02111213|467536400|FG001|Overall Study|Withdrawal by Subject|2|||
129884442|NCT02111213|467536399|FG000|Overall Study|Lost to Follow-up|3|||
129884443|NCT02111213|467536400|FG001|Overall Study|Lost to Follow-up|4|||
129884444|NCT00210119|467536401|FG000|Overall Study|Protocol Violation|1|||
129884445|NCT00210119|467536401|FG000|Overall Study|Withdrawal by Subject|1|||
129884446|NCT01830881|467536402|FG000|Overall Study|Changed decision to have an abortion|0|||
129884447|NCT01830881|467536403|FG001|Overall Study|Changed decision to have an abortion|1|||
129884448|NCT00119262|467536404|FG000|Overall Study|Lack of Efficacy|0|||
129884449|NCT00119262|467536405|FG001|Overall Study|Lack of Efficacy|3|||
129552351|NCT03797222|466318631|FG000|Overall Study|Withdrawal by Subject|1|||
129552352|NCT00725725|466318632|FG000|Overall Study|Adverse Event|1|||
129552353|NCT00725725|466318633|FG001|Overall Study|Adverse Event|3|||
129552354|NCT00725725|466318634|FG002|Overall Study|Adverse Event|2|||
129552355|NCT00725725|466318632|FG000|Overall Study|Lost to Follow-up|2|||
129552356|NCT00725725|466318633|FG001|Overall Study|Lost to Follow-up|0|||
129552357|NCT00725725|466318634|FG002|Overall Study|Lost to Follow-up|2|||
129552358|NCT00725725|466318632|FG000|Overall Study|Withdrawal by Subject|1|||
129552359|NCT00725725|466318633|FG001|Overall Study|Withdrawal by Subject|0|||
129552360|NCT00725725|466318634|FG002|Overall Study|Withdrawal by Subject|1|||
129552361|NCT00725725|466318632|FG000|Overall Study|Protocol Violation|0|||
129552362|NCT00725725|466318633|FG001|Overall Study|Protocol Violation|1|||
129552363|NCT00725725|466318634|FG002|Overall Study|Protocol Violation|0|||
129552364|NCT01619085|466318635|FG000|Overall Study|Adverse Event|231|||
129552365|NCT01619085|466318635|FG000|Overall Study|Protocol Violation|4|||
129552366|NCT01619085|466318635|FG000|Overall Study|Lost to Follow-up|3|||
129552367|NCT01619085|466318635|FG000|Overall Study|Withdrawal by Subject|45|||
129552368|NCT01619085|466318635|FG000|Overall Study|Other than specified|96|||
129552369|NCT01619085|466318635|FG000|Overall Study|Not treated|1|||
129552370|NCT01619085|466318635|FG000|Overall Study|Death|145|||
129552371|NCT03125915|466318636|FG000|1 Month Follow up|Lost to Follow-up|3|||
129552372|NCT03125915|466318637|FG001|1 Month Follow up|Lost to Follow-up|3|||
129552373|NCT03125915|466318638|FG002|1 Month Follow up|Lost to Follow-up|2|||
129552374|NCT03125915|466318639|FG003|1 Month Follow up|Lost to Follow-up|3|||
129552375|NCT03125915|466318636|FG000|3 Month Follow-up|Lost to Follow-up|6|||
129552376|NCT03125915|466318637|FG001|3 Month Follow-up|Lost to Follow-up|4|||
129552377|NCT03125915|466318638|FG002|3 Month Follow-up|Lost to Follow-up|4|||
129552378|NCT03125915|466318639|FG003|3 Month Follow-up|Lost to Follow-up|2|||
129552379|NCT03125915|466318636|FG000|6 Month Follow-up|Lost to Follow-up|7|||
129552380|NCT03125915|466318637|FG001|6 Month Follow-up|Lost to Follow-up|3|||
129552381|NCT03125915|466318638|FG002|6 Month Follow-up|Lost to Follow-up|6|||
129552382|NCT03125915|466318639|FG003|6 Month Follow-up|Lost to Follow-up|3|||
129552383|NCT00990093|466318640|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
129552384|NCT00990093|466318641|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
129552385|NCT00990093|466318640|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
129552386|NCT00990093|466318641|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
129552387|NCT00990093|466318640|FG000|Test Period 1 (1-14 Days)|Other|1|||
129552388|NCT00990093|466318641|FG001|Test Period 1 (1-14 Days)|Other|0|||
129552389|NCT00990093|466318640|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
129552390|NCT00990093|466318641|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
129552391|NCT00990093|466318640|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
129552392|NCT00990093|466318641|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
129552393|NCT00990093|466318640|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
129552394|NCT00990093|466318641|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
129552395|NCT00990093|466318640|FG000|Test Period 2 (15-28 Days)|Other|0|||
129552396|NCT00990093|466318641|FG001|Test Period 2 (15-28 Days)|Other|1|||
129552397|NCT04556838|466318642|FG000|Overall Study|Withdrawal by Subject|3|||
129552398|NCT04556838|466318643|FG001|Overall Study|Withdrawal by Subject|1|||
129552399|NCT04556838|466318644|FG002|Overall Study|Withdrawal by Subject|2|||
129552400|NCT04556838|466318642|FG000|Overall Study|Adverse Event|0|||
129552401|NCT04556838|466318643|FG001|Overall Study|Adverse Event|1|||
129552402|NCT04556838|466318644|FG002|Overall Study|Adverse Event|1|||
129552403|NCT04556838|466318642|FG000|Overall Study|Lost to Follow-up|0|||
129552404|NCT04556838|466318643|FG001|Overall Study|Lost to Follow-up|0|||
129552405|NCT04556838|466318644|FG002|Overall Study|Lost to Follow-up|2|||
129552406|NCT04556838|466318642|FG000|Overall Study|Subject travel|0|||
129552407|NCT04556838|466318643|FG001|Overall Study|Subject travel|1|||
129685805|NCT02489773|466806324|FG001|Overall Study|Leave the country or the state|1|||
129552408|NCT04556838|466318644|FG002|Overall Study|Subject travel|0|||
129884450|NCT00119262|467536404|FG000|Overall Study|Withdrawal by Subject|12|||
129884451|NCT00119262|467536405|FG001|Overall Study|Withdrawal by Subject|11|||
129884452|NCT00119262|467536404|FG000|Overall Study|Adverse Event|33|||
129884453|NCT00119262|467536405|FG001|Overall Study|Adverse Event|35|||
129884454|NCT00119262|467536404|FG000|Overall Study|other disease|0|||
129884455|NCT00119262|467536405|FG001|Overall Study|other disease|2|||
129884456|NCT00119262|467536404|FG000|Overall Study|ineligble|1|||
129884457|NCT00119262|467536405|FG001|Overall Study|ineligble|2|||
129884458|NCT00119262|467536404|FG000|Overall Study|others|0|||
129774689|NCT02581410|467139714|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
129774690|NCT00670748|467139719|FG000|Overall Study|Death during treatment|1|||
129774691|NCT00670748|467139720|FG001|Overall Study|Death during treatment|1|||
129774692|NCT00670748|467139721|FG002|Overall Study|Death during treatment|1|||
129774693|NCT00670748|467139722|FG003|Overall Study|Death during treatment|0|||
129774694|NCT00670748|467139719|FG000|Overall Study|Not off study|2|||
129774695|NCT00670748|467139720|FG001|Overall Study|Not off study|1|||
129774696|NCT00670748|467139721|FG002|Overall Study|Not off study|1|||
129774697|NCT00670748|467139722|FG003|Overall Study|Not off study|1|||
129774698|NCT06083506|467139727|FG000|Overall Study|Physician Decision|2|||
129774699|NCT06083506|467139727|FG000|Overall Study|Lack of Efficacy|1|||
129884459|NCT00119262|467536405|FG001|Overall Study|others|5|||
129884460|NCT00734214|467536406|FG000|Overall Study|Withdrawal by Subject|3|||
129685806|NCT00712920|466806325|FG000|Overall Study|Adverse Event|3|||
129685807|NCT00712920|466806326|FG001|Overall Study|Adverse Event|4|||
129685808|NCT00712920|466806327|FG002|Overall Study|Adverse Event|7|||
129685809|NCT00712920|466806325|FG000|Overall Study|Withdrawal by Subject|4|||
129685810|NCT00712920|466806326|FG001|Overall Study|Withdrawal by Subject|2|||
129685811|NCT00712920|466806327|FG002|Overall Study|Withdrawal by Subject|1|||
129685812|NCT00712920|466806325|FG000|Overall Study|Lost to Follow-up|1|||
129685813|NCT00712920|466806326|FG001|Overall Study|Lost to Follow-up|4|||
129685814|NCT00712920|466806327|FG002|Overall Study|Lost to Follow-up|0|||
129685815|NCT00712920|466806325|FG000|Overall Study|Lack of Efficacy|1|||
129685816|NCT00712920|466806326|FG001|Overall Study|Lack of Efficacy|0|||
129685817|NCT00712920|466806327|FG002|Overall Study|Lack of Efficacy|1|||
129685818|NCT00712920|466806325|FG000|Overall Study|Other|5|||
129685819|NCT00712920|466806326|FG001|Overall Study|Other|7|||
129685820|NCT00712920|466806327|FG002|Overall Study|Other|3|||
129685821|NCT00712920|466806325|FG000|Overall Study|Non-compliance|3|||
129685822|NCT00712920|466806326|FG001|Overall Study|Non-compliance|0|||
129685823|NCT00712920|466806327|FG002|Overall Study|Non-compliance|0|||
129685824|NCT02362451|466806330|FG000|Overall Study|Withdrawal by Subject|0|||
129685825|NCT02362451|466806331|FG001|Overall Study|Withdrawal by Subject|1|||
129685826|NCT02362451|466806330|FG000|Overall Study|Lack of Efficacy|2|||
129685827|NCT02362451|466806331|FG001|Overall Study|Lack of Efficacy|0|||
129685828|NCT02362451|466806330|FG000|Overall Study|Progression|1|||
129685829|NCT02362451|466806331|FG001|Overall Study|Progression|0|||
129685830|NCT02362451|466806330|FG000|Overall Study|Participant chose other therapy.|1|||
129685831|NCT02362451|466806331|FG001|Overall Study|Participant chose other therapy.|0|||
129685832|NCT02115386|466806332|FG000|Overall Study|Protocol Violation|1|||
129774700|NCT03529422|467139728|FG000|Overall Study|Withdrawal by Subject|1|||
129774701|NCT03529422|467139728|FG000|Overall Study|Protocol Violation|1|||
129774702|NCT03529422|467139728|FG000|Overall Study|Disease progression|2|||
129884461|NCT00734214|467536407|FG001|Overall Study|Withdrawal by Subject|4|||
129552409|NCT04556838|466318642|FG000|Overall Study|Physician Decision|1|||
129552410|NCT04556838|466318643|FG001|Overall Study|Physician Decision|0|||
129552411|NCT04556838|466318644|FG002|Overall Study|Physician Decision|0|||
129552412|NCT00995930|466318645|FG000|Overall Study|Protocol deviation|2|||
129552413|NCT00995930|466318646|FG001|Overall Study|Protocol deviation|5|||
129552414|NCT00995930|466318645|FG000|Overall Study|Death|0|||
129552415|NCT00995930|466318646|FG001|Overall Study|Death|1|||
129552416|NCT00995930|466318645|FG000|Overall Study|Administrative problems|4|||
129552417|NCT00995930|466318646|FG001|Overall Study|Administrative problems|2|||
129552418|NCT00995930|466318645|FG000|Overall Study|Lost to Follow-up|1|||
129552419|NCT00995930|466318646|FG001|Overall Study|Lost to Follow-up|2|||
129552420|NCT00995930|466318645|FG000|Overall Study|Withdrawal by Subject|3|||
129552421|NCT00995930|466318646|FG001|Overall Study|Withdrawal by Subject|4|||
129552422|NCT00995930|466318645|FG000|Overall Study|Adverse Event|11|||
129552423|NCT00995930|466318646|FG001|Overall Study|Adverse Event|14|||
129552424|NCT01458119|466318647|FG000|Overall Study|Physician Decision|4|||
129552425|NCT01458119|466318647|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
129552426|NCT01458119|466318647|FG000|Overall Study|Pregnancy|1|||
129552427|NCT01458119|466318647|FG000|Overall Study|Death|2|||
129552428|NCT01458119|466318647|FG000|Overall Study|Adverse Event|1|||
129552429|NCT01458119|466318647|FG000|Overall Study|Consent Withdrawn by Participant|8|||
129552430|NCT01458119|466318647|FG000|Overall Study|Non-compliance With Study Drug|3|||
129552431|NCT05003167|466318648|FG000|Overall Study|Withdrawal by Subject|1|||
129552432|NCT02367781|466318649|FG000|Overall Study|Withdrawal by Subject|20|||
129552433|NCT02367781|466318650|FG001|Overall Study|Withdrawal by Subject|13|||
129552434|NCT02367781|466318649|FG000|Overall Study|Protocol Violation|0|||
129552435|NCT02367781|466318650|FG001|Overall Study|Protocol Violation|1|||
129552436|NCT02367781|466318649|FG000|Overall Study|Physician Decision|7|||
129552437|NCT02367781|466318650|FG001|Overall Study|Physician Decision|0|||
129552438|NCT02367781|466318649|FG000|Overall Study|Randomized in Error|5|||
129552439|NCT02367781|466318650|FG001|Overall Study|Randomized in Error|4|||
129552440|NCT02367781|466318649|FG000|Overall Study|Non-Compliance|1|||
129552441|NCT02367781|466318650|FG001|Overall Study|Non-Compliance|0|||
129552442|NCT02367781|466318649|FG000|Overall Study|Lost to Follow-up|1|||
129552443|NCT02367781|466318650|FG001|Overall Study|Lost to Follow-up|2|||
129552444|NCT02367781|466318649|FG000|Overall Study|Death|330|||
129552445|NCT02367781|466318650|FG001|Overall Study|Death|176|||
129552446|NCT02367781|466318649|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
129552447|NCT02367781|466318650|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
129552448|NCT02367781|466318649|FG000|Overall Study|Prolonged Hospitalization|1|||
129552449|NCT02367781|466318650|FG001|Overall Study|Prolonged Hospitalization|0|||
129552450|NCT02367781|466318649|FG000|Overall Study|Death Prior First Dose|1|||
129552451|NCT02367781|466318650|FG001|Overall Study|Death Prior First Dose|0|||
129552452|NCT02367781|466318649|FG000|Overall Study|Administrative-Change Facility|1|||
129552453|NCT02367781|466318650|FG001|Overall Study|Administrative-Change Facility|0|||
129685833|NCT02115386|466806332|FG000|Overall Study|Administrative - trial was terminated|6|||
129685834|NCT02493855|466806333|FG000|Overall Study|Non-compliance|1|||
129685835|NCT02493855|466806334|FG001|Overall Study|Non-compliance|0|||
129685836|NCT02493855|466806335|FG002|Overall Study|Non-compliance|0|||
129685837|NCT02493855|466806333|FG000|Overall Study|Adverse Event|0|||
129685838|NCT02493855|466806334|FG001|Overall Study|Adverse Event|1|||
129685839|NCT02493855|466806335|FG002|Overall Study|Adverse Event|0|||
129685840|NCT02493855|466806333|FG000|Overall Study|Withdrawal by Subject|1|||
129685841|NCT02493855|466806334|FG001|Overall Study|Withdrawal by Subject|0|||
129685842|NCT02493855|466806335|FG002|Overall Study|Withdrawal by Subject|0|||
129685843|NCT02453048|466806336|FG000|Overall Study|Only part of initial 6 mo. study|0|||
129685844|NCT02453048|466806337|FG001|Overall Study|Only part of initial 6 mo. study|0|||
129685845|NCT02453048|466806338|FG002|Overall Study|Only part of initial 6 mo. study|0|||
129685846|NCT02453048|466806339|FG003|Overall Study|Only part of initial 6 mo. study|0|||
129685847|NCT02453048|466806340|FG004|Overall Study|Only part of initial 6 mo. study|6|||
129685848|NCT02453048|466806336|FG000|Overall Study|Lost to Follow-up|0|||
129774703|NCT02000115|467139729|FG000|Overall Study|Death|56|||
129552454|NCT02367781|466318649|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
129552455|NCT02367781|466318650|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
129552456|NCT02367781|466318649|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
129552457|NCT02367781|466318650|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
129552458|NCT02367781|466318649|FG000|Overall Study|Study Terminated by Sponsor|3|||
129552459|NCT02367781|466318650|FG001|Overall Study|Study Terminated by Sponsor|1|||
129552460|NCT02367781|466318649|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
129552461|NCT02367781|466318650|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
129552462|NCT02367781|466318649|FG000|Overall Study|Sponsor Decision|2|||
129552463|NCT02367781|466318650|FG001|Overall Study|Sponsor Decision|0|||
129685849|NCT02453048|466806337|FG001|Overall Study|Lost to Follow-up|1|||
129685850|NCT02453048|466806338|FG002|Overall Study|Lost to Follow-up|2|||
129685851|NCT02453048|466806339|FG003|Overall Study|Lost to Follow-up|0|||
129774704|NCT02000115|467139730|FG001|Overall Study|Death|45|||
129552464|NCT02367781|466318649|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
129552465|NCT02367781|466318650|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
129552466|NCT01123980|466318653|FG000|Overall Study|Adverse Event|1|||
129552467|NCT01123980|466318654|FG001|Overall Study|Adverse Event|1|||
129552468|NCT01123980|466318653|FG000|Overall Study|Lack of Efficacy|1|||
129552469|NCT01123980|466318654|FG001|Overall Study|Lack of Efficacy|0|||
129552470|NCT01123980|466318653|FG000|Overall Study|Physician Decision|0|||
129552471|NCT01123980|466318654|FG001|Overall Study|Physician Decision|1|||
129552472|NCT01123980|466318653|FG000|Overall Study|Lost to Follow-up|0|||
129552473|NCT01123980|466318654|FG001|Overall Study|Lost to Follow-up|6|||
129552474|NCT01123980|466318653|FG000|Overall Study|Protocol Violation|6|||
129552475|NCT01123980|466318654|FG001|Overall Study|Protocol Violation|6|||
129552476|NCT01123980|466318653|FG000|Overall Study|Withdrawal by Subject|5|||
129552477|NCT01123980|466318654|FG001|Overall Study|Withdrawal by Subject|3|||
129552478|NCT01123980|466318653|FG000|Overall Study|Unclassified|6|||
129552479|NCT01123980|466318654|FG001|Overall Study|Unclassified|7|||
129552480|NCT01225991|466318655|FG000|Overall Study|Withdrawal by Subject|6|||
129552481|NCT02094937|466318656|FG000|8 Weeks in Period 1|Adverse Event|9|||
129552482|NCT02094937|466318657|FG001|8 Weeks in Period 1|Adverse Event|0|||
129552483|NCT02094937|466318658|FG002|8 Weeks in Period 1|Adverse Event|0|||
129552484|NCT02094937|466318659|FG003|8 Weeks in Period 1|Adverse Event|0|||
129552485|NCT02094937|466318656|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
129552486|NCT02094937|466318657|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
129552487|NCT02094937|466318658|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
129552488|NCT02094937|466318659|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
129552489|NCT02094937|466318656|FG000|8 Weeks in Period 1|Protocol Violation|2|||
129552490|NCT02094937|466318657|FG001|8 Weeks in Period 1|Protocol Violation|0|||
129552491|NCT02094937|466318658|FG002|8 Weeks in Period 1|Protocol Violation|0|||
129552492|NCT02094937|466318659|FG003|8 Weeks in Period 1|Protocol Violation|0|||
129552493|NCT02094937|466318656|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
129552494|NCT02094937|466318657|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
129552495|NCT02094937|466318658|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
129552496|NCT02094937|466318659|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
129552497|NCT02094937|466318656|FG000|8 Weeks in Period 1|Physician Decision|1|||
129552498|NCT02094937|466318657|FG001|8 Weeks in Period 1|Physician Decision|0|||
129552499|NCT02094937|466318658|FG002|8 Weeks in Period 1|Physician Decision|0|||
129552500|NCT02094937|466318659|FG003|8 Weeks in Period 1|Physician Decision|0|||
129552501|NCT02094937|466318656|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
129552502|NCT02094937|466318657|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
129552503|NCT02094937|466318658|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
129552504|NCT02094937|466318659|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
129552505|NCT02094937|466318656|FG000|12 Weeks in Period 2|Adverse Event|0|||
129552506|NCT02094937|466318657|FG001|12 Weeks in Period 2|Adverse Event|2|||
129552507|NCT02094937|466318658|FG002|12 Weeks in Period 2|Adverse Event|4|||
129552508|NCT02094937|466318659|FG003|12 Weeks in Period 2|Adverse Event|1|||
129552509|NCT02094937|466318656|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
129552510|NCT02094937|466318657|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
129552511|NCT02094937|466318658|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
129552512|NCT02094937|466318659|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
129552513|NCT02094937|466318656|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
129552514|NCT02094937|466318657|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
129552515|NCT02094937|466318658|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
129552516|NCT02094937|466318659|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
129552517|NCT02094937|466318656|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
129552518|NCT02094937|466318657|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
129552519|NCT02094937|466318658|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
129552520|NCT02094937|466318659|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
129552521|NCT02094937|466318656|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
129552522|NCT02094937|466318657|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
129552523|NCT02094937|466318658|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
129552524|NCT02094937|466318659|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
129552525|NCT01133392|466318660|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
129552526|NCT01133392|466318661|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
129552527|NCT01133392|466318660|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
129552528|NCT01133392|466318661|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
129552529|NCT03053622|466320470|FG000|Overall Study|Lost to Follow-up|0|||
129552530|NCT03053622|466320471|FG001|Overall Study|Lost to Follow-up|0|||
129552531|NCT03053622|466320472|FG002|Overall Study|Lost to Follow-up|0|||
129552532|NCT03053622|466320473|FG003|Overall Study|Lost to Follow-up|1|||
129552533|NCT01355523|466320477|FG000|Overall Study|Withdrawal by Subject|1|||
129685852|NCT02453048|466806340|FG004|Overall Study|Lost to Follow-up|0|||
129552534|NCT01355523|466320478|FG001|Overall Study|Withdrawal by Subject|4|||
129552535|NCT01355523|466320477|FG000|Overall Study|Lost to Follow-up|0|||
129552536|NCT01355523|466320478|FG001|Overall Study|Lost to Follow-up|2|||
129552537|NCT01355523|466320477|FG000|Overall Study|Protocol Violation|0|||
129552538|NCT01355523|466320478|FG001|Overall Study|Protocol Violation|2|||
129552539|NCT01355523|466320477|FG000|Overall Study|Adverse Event|0|||
129552540|NCT01355523|466320478|FG001|Overall Study|Adverse Event|2|||
129552541|NCT01835470|466320479|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
129552542|NCT01835470|466320479|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
129774705|NCT02000115|467139731|FG002|Overall Study|Death|0|||
129774706|NCT02000115|467139732|FG003|Overall Study|Death|0|||
129774707|NCT02000115|467139729|FG000|Overall Study|Missed Visit|6|||
129774708|NCT02000115|467139730|FG001|Overall Study|Missed Visit|8|||
129774709|NCT02000115|467139731|FG002|Overall Study|Missed Visit|1|||
129774710|NCT02000115|467139732|FG003|Overall Study|Missed Visit|0|||
129774711|NCT02000115|467139729|FG000|Overall Study|Protocol Violation|2|||
129774712|NCT02000115|467139730|FG001|Overall Study|Protocol Violation|1|||
129774713|NCT02000115|467139731|FG002|Overall Study|Protocol Violation|0|||
129774714|NCT02000115|467139732|FG003|Overall Study|Protocol Violation|0|||
129774715|NCT02000115|467139729|FG000|Overall Study|Physician Decision|2|||
129774716|NCT02000115|467139730|FG001|Overall Study|Physician Decision|0|||
129774717|NCT02000115|467139731|FG002|Overall Study|Physician Decision|0|||
129552543|NCT01272193|466320480|FG000|Overall Study|Adverse Event|1|||
129552544|NCT01272193|466320481|FG001|Overall Study|Adverse Event|1|||
129774718|NCT02000115|467139732|FG003|Overall Study|Physician Decision|0|||
129774719|NCT02000115|467139729|FG000|Overall Study|Withdrawal by Subject|11|||
129774720|NCT02000115|467139730|FG001|Overall Study|Withdrawal by Subject|11|||
129774721|NCT02000115|467139731|FG002|Overall Study|Withdrawal by Subject|0|||
129774722|NCT02000115|467139732|FG003|Overall Study|Withdrawal by Subject|0|||
129774723|NCT02000115|467139729|FG000|Overall Study|Lost to Follow-up|0|||
129774724|NCT02000115|467139730|FG001|Overall Study|Lost to Follow-up|1|||
129774725|NCT02000115|467139731|FG002|Overall Study|Lost to Follow-up|0|||
129774726|NCT02000115|467139732|FG003|Overall Study|Lost to Follow-up|0|||
129774727|NCT02000115|467139729|FG000|Overall Study|Non-compliance|2|||
129774728|NCT02000115|467139730|FG001|Overall Study|Non-compliance|1|||
129774729|NCT02000115|467139731|FG002|Overall Study|Non-compliance|0|||
129774730|NCT02000115|467139732|FG003|Overall Study|Non-compliance|0|||
129774731|NCT02000115|467139729|FG000|Overall Study|Withdrawn on day of randomization|0|||
129774732|NCT02000115|467139730|FG001|Overall Study|Withdrawn on day of randomization|1|||
129774733|NCT02000115|467139731|FG002|Overall Study|Withdrawn on day of randomization|0|||
129774734|NCT02000115|467139732|FG003|Overall Study|Withdrawn on day of randomization|0|||
129774735|NCT02000115|467139729|FG000|Overall Study|Still on Study|0|||
129774736|NCT02000115|467139730|FG001|Overall Study|Still on Study|0|||
129774737|NCT02000115|467139731|FG002|Overall Study|Still on Study|0|||
129552545|NCT01272193|466320480|FG000|Overall Study|Lack of Efficacy|0|||
129774738|NCT02000115|467139732|FG003|Overall Study|Still on Study|53|||
129774739|NCT05006573|467139735|FG000|Double-blind Treatment Period|Physician Decision|2|||
129774740|NCT05006573|467139736|FG001|Double-blind Treatment Period|Physician Decision|0|||
129552546|NCT01272193|466320481|FG001|Overall Study|Lack of Efficacy|3|||
129774741|NCT05006573|467139735|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
129774742|NCT05006573|467139736|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
129774743|NCT05006573|467139735|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129774744|NCT05006573|467139736|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129774745|NCT05006573|467139735|FG000|Double-blind Treatment Period|Protocol Violation|2|||
129774746|NCT05006573|467139736|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129774747|NCT05006573|467139735|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
129774748|NCT05006573|467139736|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
129774749|NCT05006573|467139735|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
129774750|NCT05006573|467139736|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
129774751|NCT03493464|467139741|FG000|Overall Study|Surgery not performed|1|||
129774752|NCT05462756|467141122|FG000|Treatment Period|Adverse Event|3|||
129774753|NCT05462756|467141123|FG001|Treatment Period|Adverse Event|0|||
129774754|NCT05462756|467141122|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
129774755|NCT05462756|467141123|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
129774756|NCT05462756|467141122|FG000|Treatment Period|Death|0|||
129774757|NCT05462756|467141123|FG001|Treatment Period|Death|1|||
129774758|NCT05462756|467141122|FG000|Treatment Period|Lost to Follow-up|2|||
129774759|NCT05462756|467141123|FG001|Treatment Period|Lost to Follow-up|1|||
129774760|NCT05462756|467141122|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
129774761|NCT05462756|467141123|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
129774762|NCT05462756|467141122|FG000|Treatment Period|Physician Decision|2|||
129774763|NCT05462756|467141123|FG001|Treatment Period|Physician Decision|0|||
129774764|NCT05462756|467141122|FG000|Treatment Period|Protocol Violation|0|||
129774765|NCT05462756|467141123|FG001|Treatment Period|Protocol Violation|1|||
129774766|NCT05462756|467141122|FG000|Treatment Period|Withdrawal by Subject|5|||
129774767|NCT05462756|467141123|FG001|Treatment Period|Withdrawal by Subject|12|||
129552547|NCT01272193|466320480|FG000|Overall Study|Withdrawal Criteria|1|||
129552548|NCT01272193|466320481|FG001|Overall Study|Withdrawal Criteria|1|||
129552549|NCT01272193|466320480|FG000|Overall Study|Unclassified|8|||
129552550|NCT01272193|466320481|FG001|Overall Study|Unclassified|7|||
129552551|NCT01440647|466320482|FG000|Overall Study|Death|2|||
129552552|NCT01440647|466320483|FG001|Overall Study|Death|3|||
129552553|NCT00096382|466320486|FG000|Overall Study|Not treated|1|||
129552554|NCT00096382|466320487|FG001|Overall Study|Not treated|0|||
129552555|NCT00096382|466320486|FG000|Overall Study|Death during treatment|1|||
129552556|NCT00096382|466320487|FG001|Overall Study|Death during treatment|0|||
129552557|NCT01326702|466320489|FG000|Overall Study|Other|1|||
129552558|NCT01326702|466320490|FG001|Overall Study|Other|0|||
129552559|NCT01326702|466320491|FG002|Overall Study|Other|0|||
129552560|NCT01326702|466320492|FG003|Overall Study|Other|0|||
129552561|NCT01326702|466320493|FG004|Overall Study|Other|0|||
129552562|NCT01326702|466320494|FG005|Overall Study|Other|1|||
129552563|NCT01326702|466320495|FG006|Overall Study|Other|0|||
129552564|NCT01326702|466320489|FG000|Overall Study|progressive disease|1|||
129552565|NCT01326702|466320490|FG001|Overall Study|progressive disease|1|||
129552566|NCT01326702|466320491|FG002|Overall Study|progressive disease|3|||
129552567|NCT01326702|466320492|FG003|Overall Study|progressive disease|1|||
129552568|NCT01326702|466320493|FG004|Overall Study|progressive disease|3|||
129552569|NCT01326702|466320494|FG005|Overall Study|progressive disease|2|||
129552570|NCT01326702|466320495|FG006|Overall Study|progressive disease|3|||
129552571|NCT01326702|466320489|FG000|Overall Study|Death|0|||
129552572|NCT01326702|466320490|FG001|Overall Study|Death|1|||
129552573|NCT01326702|466320491|FG002|Overall Study|Death|0|||
129552574|NCT01326702|466320492|FG003|Overall Study|Death|0|||
129552575|NCT01326702|466320493|FG004|Overall Study|Death|0|||
129552576|NCT01326702|466320494|FG005|Overall Study|Death|0|||
129552577|NCT01326702|466320495|FG006|Overall Study|Death|0|||
129552578|NCT01326702|466320489|FG000|Overall Study|Adverse Event|0|||
129552579|NCT01326702|466320490|FG001|Overall Study|Adverse Event|0|||
129552580|NCT01326702|466320491|FG002|Overall Study|Adverse Event|1|||
129552581|NCT01326702|466320492|FG003|Overall Study|Adverse Event|1|||
129552582|NCT01326702|466320493|FG004|Overall Study|Adverse Event|0|||
129552583|NCT01326702|466320494|FG005|Overall Study|Adverse Event|3|||
129552584|NCT01326702|466320495|FG006|Overall Study|Adverse Event|1|||
129552585|NCT01326702|466320489|FG000|Overall Study|Withdrawal by Subject|0|||
129552586|NCT01326702|466320490|FG001|Overall Study|Withdrawal by Subject|0|||
129552587|NCT01326702|466320491|FG002|Overall Study|Withdrawal by Subject|1|||
129552588|NCT01326702|466320492|FG003|Overall Study|Withdrawal by Subject|0|||
129552589|NCT01326702|466320493|FG004|Overall Study|Withdrawal by Subject|1|||
129552590|NCT01326702|466320494|FG005|Overall Study|Withdrawal by Subject|1|||
129552591|NCT01326702|466320495|FG006|Overall Study|Withdrawal by Subject|3|||
129552592|NCT01326702|466320489|FG000|Overall Study|Not Treated|0|||
129552593|NCT01326702|466320490|FG001|Overall Study|Not Treated|0|||
129552594|NCT01326702|466320491|FG002|Overall Study|Not Treated|0|||
129552595|NCT01326702|466320492|FG003|Overall Study|Not Treated|1|||
129552596|NCT01326702|466320493|FG004|Overall Study|Not Treated|0|||
129774768|NCT05462756|467141122|FG000|Follow-Up Period|Adverse Event|1|||
129774769|NCT05462756|467141123|FG001|Follow-Up Period|Adverse Event|0|||
129774770|NCT05462756|467141122|FG000|Follow-Up Period|Death|1|||
129552597|NCT01326702|466320494|FG005|Overall Study|Not Treated|1|||
129552598|NCT01326702|466320495|FG006|Overall Study|Not Treated|0|||
129552599|NCT00782275|466320508|FG000|Overall Study|Adverse Event|11|||
129552600|NCT00782275|466320508|FG000|Overall Study|Withdrawal by Subject|1|||
129774771|NCT05462756|467141123|FG001|Follow-Up Period|Death|0|||
129774772|NCT05462756|467141122|FG000|Follow-Up Period|Lost to Follow-up|3|||
129774773|NCT05462756|467141123|FG001|Follow-Up Period|Lost to Follow-up|1|||
129552601|NCT00782275|466320508|FG000|Overall Study|Progressive Disease|21|||
129552602|NCT00782275|466320508|FG000|Overall Study|Physician Decision|4|||
129552603|NCT00782275|466320508|FG000|Overall Study|Not started treatment|1|||
129552604|NCT00782275|466320508|FG000|Overall Study|Other|3|||
129552605|NCT00331773|466320511|FG000|Overall Study|Withdrawal by Subject|6|||
129552606|NCT00331773|466320512|FG001|Overall Study|Withdrawal by Subject|4|||
129552607|NCT00331773|466320511|FG000|Overall Study|Protocol Violation|10|||
129552608|NCT00331773|466320512|FG001|Overall Study|Protocol Violation|3|||
129552609|NCT00289731|466320513|FG000|Overall Study|Adverse Event|1|||
129552610|NCT00289731|466320514|FG001|Overall Study|Adverse Event|2|||
129552611|NCT00289731|466320515|FG002|Overall Study|Adverse Event|2|||
129552612|NCT00289731|466320513|FG000|Overall Study|Other|1|||
129552613|NCT00289731|466320514|FG001|Overall Study|Other|0|||
129552614|NCT00289731|466320515|FG002|Overall Study|Other|0|||
129552615|NCT02019979|466320516|FG000|Overall Study|study terminated|14|||
129552616|NCT00525031|466320524|FG000|Overall Study|Disease Progression|1|||
129552617|NCT00525031|466320525|FG001|Overall Study|Disease Progression|1|||
129552618|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
129552619|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
129552620|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
129552621|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
129552622|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
129552623|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
129552624|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
129552625|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
129552626|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
129552627|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
129552628|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
129552629|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
129552630|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
129552631|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
129552632|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
129552633|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
129552634|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
129552635|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
129552636|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
129552637|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
129552638|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
129552639|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
129552640|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
129552641|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
129552642|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
129552643|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
129552644|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
129552645|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
129552646|NCT01872689|466320526|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
129552647|NCT01872689|466320527|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
129552648|NCT01872689|466320528|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
129552649|NCT01872689|466320529|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
129552650|NCT01872689|466320526|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
129552651|NCT01872689|466320527|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
129552652|NCT01872689|466320528|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
129552653|NCT01872689|466320529|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
129552654|NCT01872689|466320526|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
129552655|NCT01872689|466320527|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
129552656|NCT01872689|466320528|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
129552657|NCT01872689|466320529|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
129552658|NCT01872689|466320526|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
129552659|NCT01872689|466320527|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
129552660|NCT01872689|466320528|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
129552661|NCT01872689|466320529|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
129552662|NCT01872689|466320526|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
129552663|NCT01872689|466320527|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
129552664|NCT01872689|466320528|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
129552665|NCT01872689|466320529|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
129552666|NCT01872689|466320526|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
129552667|NCT01872689|466320527|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
129552668|NCT01872689|466320528|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
129685853|NCT03600428|466806342|FG000|Overall Study|Not eligible|0|||
129685854|NCT03600428|466806343|FG001|Overall Study|Not eligible|1|||
129685855|NCT03600428|466806342|FG000|Overall Study|Lost to Follow-up|5|||
129685856|NCT03600428|466806343|FG001|Overall Study|Lost to Follow-up|4|||
129685857|NCT01695746|466806347|FG000|Overall Study|Adverse Event|1|||
129685858|NCT01695746|466806347|FG000|Overall Study|Non-compliance by the participant|3|||
129685859|NCT01695746|466806347|FG000|Overall Study|Protocol Violation|5|||
129685860|NCT01695746|466806347|FG000|Overall Study|Participant not willing to participate|3|||
129685861|NCT01202591|466806348|FG000|Overall Study|Adverse Event|2|||
129685862|NCT01202591|466806349|FG001|Overall Study|Adverse Event|1|||
129685863|NCT01202591|466806350|FG002|Overall Study|Adverse Event|4|||
129552669|NCT01872689|466320529|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
129552670|NCT01872689|466320526|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
129552671|NCT01872689|466320527|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
129552672|NCT01872689|466320528|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
129552673|NCT01872689|466320529|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
129552674|NCT02143947|466320534|FG000|Overall Study|Lost to Follow-up|4|||
129552675|NCT02143947|466320535|FG001|Overall Study|Lost to Follow-up|2|||
129552676|NCT01244815|466320536|FG000|Overall Study|Not Treated|0|||
129552677|NCT01244815|466320537|FG001|Overall Study|Not Treated|1|||
129552678|NCT01244815|466320538|FG002|Overall Study|Not Treated|0|||
129552679|NCT01244815|466320539|FG003|Overall Study|Not Treated|0|||
129552680|NCT01244815|466320536|FG000|Overall Study|Adverse Event|4|||
129552681|NCT01244815|466320537|FG001|Overall Study|Adverse Event|7|||
129552682|NCT01244815|466320538|FG002|Overall Study|Adverse Event|5|||
129552683|NCT01244815|466320539|FG003|Overall Study|Adverse Event|5|||
129552684|NCT01244815|466320536|FG000|Overall Study|Treatment Failure|0|||
129552685|NCT01244815|466320537|FG001|Overall Study|Treatment Failure|0|||
129552686|NCT01244815|466320538|FG002|Overall Study|Treatment Failure|0|||
129552687|NCT01244815|466320539|FG003|Overall Study|Treatment Failure|1|||
129552688|NCT01244815|466320536|FG000|Overall Study|Lost to Follow-up|3|||
129552689|NCT01244815|466320537|FG001|Overall Study|Lost to Follow-up|2|||
129552690|NCT01244815|466320538|FG002|Overall Study|Lost to Follow-up|3|||
129552691|NCT01244815|466320539|FG003|Overall Study|Lost to Follow-up|2|||
129552692|NCT01244815|466320536|FG000|Overall Study|Withdrawal by Subject|0|||
129552693|NCT01244815|466320537|FG001|Overall Study|Withdrawal by Subject|2|||
129552694|NCT01244815|466320538|FG002|Overall Study|Withdrawal by Subject|0|||
129552695|NCT01244815|466320539|FG003|Overall Study|Withdrawal by Subject|3|||
129552696|NCT01244815|466320536|FG000|Overall Study|Protocol Violation|7|||
129552697|NCT01244815|466320537|FG001|Overall Study|Protocol Violation|4|||
129552698|NCT01244815|466320538|FG002|Overall Study|Protocol Violation|3|||
129552699|NCT01244815|466320539|FG003|Overall Study|Protocol Violation|1|||
129552700|NCT01244815|466320536|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
129552701|NCT01244815|466320537|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
129552702|NCT01244815|466320538|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
129552703|NCT01244815|466320539|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
129552704|NCT00697112|466320541|FG000|Overall Study|Adverse Event|8|||
129552705|NCT00697112|466320541|FG000|Overall Study|Lost to Follow-up|1|||
129552706|NCT00697112|466320541|FG000|Overall Study|Did not meet inclusion criteria|1|||
129552707|NCT03066440|466320544|FG000|Overall Study|Physician Decision|1|||
129552708|NCT03066440|466320545|FG001|Overall Study|Physician Decision|1|||
129552709|NCT03066440|466320544|FG000|Overall Study|Protocol Violation|0|||
129552710|NCT03066440|466320545|FG001|Overall Study|Protocol Violation|2|||
129552711|NCT00736333|466320546|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
129552712|NCT00736333|466320546|FG000|Overall Study|Data Missing|2|||
129552713|NCT00736333|466320546|FG000|Overall Study|Tumor Progression|75|||
129552714|NCT00736333|466320546|FG000|Overall Study|Toxicity|6|||
129552715|NCT00736333|466320546|FG000|Overall Study|Withdrawal by Subject|10|||
129552716|NCT00736333|466320546|FG000|Overall Study|Death|7|||
129552717|NCT00736333|466320546|FG000|Overall Study|Other|4|||
129552718|NCT01106352|466320549|FG000|Overall Study|Subjects untreated|0|||
129552719|NCT01106352|466320550|FG001|Overall Study|Subjects untreated|0|||
129552720|NCT01106352|466320551|FG002|Overall Study|Subjects untreated|0|||
129552721|NCT01106352|466320552|FG003|Overall Study|Subjects untreated|3|||
129552722|NCT01106352|466320553|FG004|Overall Study|Subjects untreated|4|||
129552723|NCT01106352|466320549|FG000|Overall Study|Sponsor Decision|1|||
129552724|NCT01106352|466320550|FG001|Overall Study|Sponsor Decision|0|||
129552725|NCT01106352|466320551|FG002|Overall Study|Sponsor Decision|0|||
129552726|NCT01106352|466320552|FG003|Overall Study|Sponsor Decision|0|||
129552727|NCT01106352|466320553|FG004|Overall Study|Sponsor Decision|0|||
129552728|NCT01106352|466320549|FG000|Overall Study|Too ill to come in for the visit|0|||
129552729|NCT01106352|466320550|FG001|Overall Study|Too ill to come in for the visit|0|||
129552730|NCT01106352|466320551|FG002|Overall Study|Too ill to come in for the visit|1|||
129552731|NCT01106352|466320552|FG003|Overall Study|Too ill to come in for the visit|0|||
129774774|NCT05462756|467141122|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129774775|NCT05462756|467141123|FG001|Follow-Up Period|Withdrawal by Subject|4|||
129774776|NCT00990704|467141124|FG000|Overall Study|Adverse Event|1|||
129552732|NCT01106352|466320553|FG004|Overall Study|Too ill to come in for the visit|0|||
129552733|NCT01106352|466320549|FG000|Overall Study|Lost to Follow-up|0|||
129552734|NCT01106352|466320550|FG001|Overall Study|Lost to Follow-up|0|||
129552735|NCT01106352|466320551|FG002|Overall Study|Lost to Follow-up|0|||
129552736|NCT01106352|466320552|FG003|Overall Study|Lost to Follow-up|0|||
129552737|NCT01106352|466320553|FG004|Overall Study|Lost to Follow-up|1|||
129552738|NCT01106352|466320549|FG000|Overall Study|Death|0|||
129552739|NCT01106352|466320550|FG001|Overall Study|Death|0|||
129552740|NCT01106352|466320551|FG002|Overall Study|Death|1|||
129552741|NCT01106352|466320552|FG003|Overall Study|Death|3|||
129552742|NCT01106352|466320553|FG004|Overall Study|Death|1|||
129552743|NCT01106352|466320549|FG000|Overall Study|Disease progression|0|||
129552744|NCT01106352|466320550|FG001|Overall Study|Disease progression|0|||
129552745|NCT01106352|466320551|FG002|Overall Study|Disease progression|0|||
129552746|NCT01106352|466320552|FG003|Overall Study|Disease progression|1|||
129552747|NCT01106352|466320553|FG004|Overall Study|Disease progression|0|||
129552748|NCT01106352|466320549|FG000|Overall Study|Withdrawal by Subject|0|||
129552749|NCT01106352|466320550|FG001|Overall Study|Withdrawal by Subject|0|||
129552750|NCT01106352|466320551|FG002|Overall Study|Withdrawal by Subject|0|||
129552751|NCT01106352|466320552|FG003|Overall Study|Withdrawal by Subject|3|||
129552752|NCT01106352|466320553|FG004|Overall Study|Withdrawal by Subject|2|||
129552753|NCT01106352|466320549|FG000|Overall Study|Went on hospice|0|||
129552754|NCT01106352|466320550|FG001|Overall Study|Went on hospice|0|||
129552755|NCT01106352|466320551|FG002|Overall Study|Went on hospice|0|||
129552756|NCT01106352|466320552|FG003|Overall Study|Went on hospice|1|||
129552757|NCT01106352|466320553|FG004|Overall Study|Went on hospice|0|||
129552758|NCT01106352|466320549|FG000|Overall Study|Subject entered hospice|0|||
129552759|NCT01106352|466320550|FG001|Overall Study|Subject entered hospice|0|||
129552760|NCT01106352|466320551|FG002|Overall Study|Subject entered hospice|0|||
129552761|NCT01106352|466320552|FG003|Overall Study|Subject entered hospice|1|||
129552762|NCT01106352|466320553|FG004|Overall Study|Subject entered hospice|0|||
129552763|NCT01106352|466320549|FG000|Overall Study|Home hospice since July 2013|0|||
129552764|NCT01106352|466320550|FG001|Overall Study|Home hospice since July 2013|0|||
129552765|NCT01106352|466320551|FG002|Overall Study|Home hospice since July 2013|0|||
129552766|NCT01106352|466320552|FG003|Overall Study|Home hospice since July 2013|1|||
129552767|NCT01106352|466320553|FG004|Overall Study|Home hospice since July 2013|0|||
129552768|NCT03944707|466320554|FG000|Overall Study|Adverse Event|0|||
129552769|NCT03944707|466320555|FG001|Overall Study|Adverse Event|2|||
129552770|NCT03944707|466320554|FG000|Overall Study|Study terminated by sponsor|12|||
129552771|NCT03944707|466320555|FG001|Overall Study|Study terminated by sponsor|7|||
129552772|NCT03944707|466320554|FG000|Overall Study|Subject decision|0|||
129552773|NCT03944707|466320555|FG001|Overall Study|Subject decision|1|||
129552774|NCT04126733|466320558|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
129552775|NCT04126733|466320558|FG000|Treatment Period|Adverse Event|8|||
129552776|NCT04126733|466320558|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
129685864|NCT01202591|466806351|FG003|Overall Study|Adverse Event|4|||
129685865|NCT01202591|466806352|FG004|Overall Study|Adverse Event|0|||
129685866|NCT01202591|466806353|FG005|Overall Study|Adverse Event|0|||
129685867|NCT01202591|466806348|FG000|Overall Study|Other reason as per investigator|3|||
129685868|NCT01202591|466806349|FG001|Overall Study|Other reason as per investigator|4|||
129685869|NCT01202591|466806350|FG002|Overall Study|Other reason as per investigator|7|||
129685870|NCT01202591|466806351|FG003|Overall Study|Other reason as per investigator|3|||
129685871|NCT01202591|466806352|FG004|Overall Study|Other reason as per investigator|1|||
129685872|NCT01202591|466806353|FG005|Overall Study|Other reason as per investigator|3|||
129685873|NCT01202591|466806348|FG000|Overall Study|Withdrawal by Subject|0|||
129685874|NCT01202591|466806349|FG001|Overall Study|Withdrawal by Subject|0|||
129685875|NCT01202591|466806350|FG002|Overall Study|Withdrawal by Subject|0|||
129685876|NCT01202591|466806351|FG003|Overall Study|Withdrawal by Subject|0|||
129685877|NCT01202591|466806352|FG004|Overall Study|Withdrawal by Subject|2|||
129685878|NCT01202591|466806353|FG005|Overall Study|Withdrawal by Subject|1|||
129685879|NCT01202591|466806348|FG000|Overall Study|Objective Disease Progression|0|||
129685880|NCT01202591|466806349|FG001|Overall Study|Objective Disease Progression|0|||
129685881|NCT01202591|466806350|FG002|Overall Study|Objective Disease Progression|0|||
129685882|NCT01202591|466806351|FG003|Overall Study|Objective Disease Progression|0|||
129685883|NCT01202591|466806352|FG004|Overall Study|Objective Disease Progression|2|||
129685884|NCT01202591|466806353|FG005|Overall Study|Objective Disease Progression|0|||
129685885|NCT02830087|466806356|FG000|Overall Study|No study staff to follow-up patients|4|||
129685886|NCT02830087|466806357|FG001|Overall Study|No study staff to follow-up patients|4|||
129685887|NCT02830087|466806358|FG002|Overall Study|No study staff to follow-up patients|4|||
129685888|NCT02830087|466806359|FG003|Overall Study|No study staff to follow-up patients|3|||
129685889|NCT02830087|466806360|FG004|Overall Study|No study staff to follow-up patients|3|||
129685890|NCT02830087|466806361|FG005|Overall Study|No study staff to follow-up patients|3|||
129685891|NCT02583269|466806362|FG000|Overall Study|Patient hospitalized prior to start|1|||
129685892|NCT02583269|466806363|FG001|Overall Study|Patient hospitalized prior to start|0|||
129685893|NCT02583269|466806364|FG002|Overall Study|Patient hospitalized prior to start|0|||
129685894|NCT02583269|466806365|FG003|Overall Study|Patient hospitalized prior to start|0|||
129685895|NCT02583269|466806366|FG004|Overall Study|Patient hospitalized prior to start|0|||
129552777|NCT04126733|466320558|FG000|Treatment Period|Physician Decision|5|||
129552778|NCT04126733|466320558|FG000|Treatment Period|Death|1|||
129552779|NCT04126733|466320558|FG000|Treatment Period|Other Reasons|2|||
129552780|NCT04126733|466320558|FG000|Active Follow-up Period|Death|13|||
129552781|NCT04126733|466320558|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
129552782|NCT04126733|466320558|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
129685896|NCT03611946|466806367|FG000|Overall Study|Withdrawal by Subject|0|||
129685897|NCT03611946|466806368|FG001|Overall Study|Withdrawal by Subject|0|||
129685898|NCT03611946|466806369|FG002|Overall Study|Withdrawal by Subject|1|||
129552783|NCT04126733|466320558|FG000|Active Follow-up Period|Other Reasons|1|||
129552784|NCT04126733|466320558|FG000|Long-term Follow-up Period|Death|22|||
129552785|NCT04126733|466320558|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
129552786|NCT04126733|466320558|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
129552787|NCT02598193|466320560|FG000|Overall Study|Adverse Event|13|||
129552788|NCT02598193|466320560|FG000|Overall Study|Withdrawal by Subject|1|||
129552789|NCT02598193|466320560|FG000|Overall Study|Listed in active lung transplant list|1|||
129552790|NCT02598193|466320560|FG000|Overall Study|Does not want to take Nintedanib|1|||
129552791|NCT02487979|466320563|FG000|Overall Study|Physician Decision|2|||
129552792|NCT02487979|466320563|FG000|Overall Study|Withdrawal by Subject|2|||
129552793|NCT02487979|466320563|FG000|Overall Study|Progressive Disease|17|||
129552794|NCT00447694|466320564|FG000|Overall Study|Adverse Event|2|||
129552795|NCT00447694|466320564|FG000|Overall Study|Abnormal laboratory value|1|||
129552796|NCT00447694|466320564|FG000|Overall Study|Abnormal test procedure result|1|||
129552797|NCT00447694|466320564|FG000|Overall Study|Withdrawal by Subject|2|||
129552798|NCT02354976|466320569|FG000|Overall Study|Other - reason not specified|1|||
129552799|NCT02354976|466320570|FG001|Overall Study|Other - reason not specified|0|||
129552800|NCT02354976|466320571|FG002|Overall Study|Other - reason not specified|1|||
129552801|NCT02354976|466320569|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
129552802|NCT02354976|466320570|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
129552803|NCT02354976|466320571|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
129552804|NCT02354976|466320569|FG000|Overall Study|Adverse Event|1|||
129552805|NCT02354976|466320570|FG001|Overall Study|Adverse Event|0|||
129552806|NCT02354976|466320571|FG002|Overall Study|Adverse Event|2|||
129552807|NCT00986154|466320572|FG000|Overall Study|Death|136|||
129552808|NCT00986154|466320573|FG001|Overall Study|Death|127|||
129552809|NCT00986154|466320572|FG000|Overall Study|Lost to Follow-up|7|||
129552810|NCT00986154|466320573|FG001|Overall Study|Lost to Follow-up|4|||
129552811|NCT00986154|466320572|FG000|Overall Study|Withdrawal by Subject|32|||
129552812|NCT00986154|466320573|FG001|Overall Study|Withdrawal by Subject|33|||
129552813|NCT00986154|466320572|FG000|Overall Study|investigator/subject decide not continue|6|||
129552814|NCT00986154|466320573|FG001|Overall Study|investigator/subject decide not continue|3|||
129552815|NCT00986154|466320572|FG000|Overall Study|never received study drug|25|||
129552816|NCT00986154|466320573|FG001|Overall Study|never received study drug|27|||
129552817|NCT03726437|466320574|FG000|Overall Study|Lost to Follow-up|85|||
129552818|NCT03726437|466320575|FG001|Overall Study|Lost to Follow-up|76|||
129552819|NCT00068445|466320576|FG000|Randomization|Cancel|1|||
129552820|NCT00068445|466320577|FG001|Randomization|Cancel|3|||
129552821|NCT00068445|466320576|FG000|Randomization|Ineligible|1|||
129552822|NCT00068445|466320577|FG001|Randomization|Ineligible|1|||
129552823|NCT00068445|466320576|FG000|Treatment|Refused Further Treatment|13|||
129552824|NCT00068445|466320577|FG001|Treatment|Refused Further Treatment|10|||
129552825|NCT00068445|466320576|FG000|Treatment|Adverse Event|7|||
129552826|NCT00068445|466320577|FG001|Treatment|Adverse Event|1|||
129552827|NCT00068445|466320576|FG000|Treatment|Other (Specifics not available)|9|||
129552828|NCT00068445|466320577|FG001|Treatment|Other (Specifics not available)|5|||
129552829|NCT03118765|466320579|FG000|Overall Study|Withdrawal by Subject|0|||
129552830|NCT03118765|466320580|FG001|Overall Study|Withdrawal by Subject|0|||
129552831|NCT03118765|466320581|FG002|Overall Study|Withdrawal by Subject|1|||
129552832|NCT03118765|466320582|FG003|Overall Study|Withdrawal by Subject|0|||
129552833|NCT03118765|466320583|FG004|Overall Study|Withdrawal by Subject|0|||
129552834|NCT03118765|466320579|FG000|Overall Study|Adverse Event|1|||
129552835|NCT03118765|466320580|FG001|Overall Study|Adverse Event|1|||
129552836|NCT03118765|466320581|FG002|Overall Study|Adverse Event|1|||
129552837|NCT03118765|466320582|FG003|Overall Study|Adverse Event|1|||
129552838|NCT03118765|466320583|FG004|Overall Study|Adverse Event|1|||
129552839|NCT03118765|466320579|FG000|Overall Study|Non compliance with Study Procedures|0|||
129552840|NCT03118765|466320580|FG001|Overall Study|Non compliance with Study Procedures|0|||
129552841|NCT03118765|466320581|FG002|Overall Study|Non compliance with Study Procedures|0|||
129552842|NCT03118765|466320582|FG003|Overall Study|Non compliance with Study Procedures|1|||
129552843|NCT03118765|466320583|FG004|Overall Study|Non compliance with Study Procedures|0|||
129552844|NCT03118765|466320579|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
129552845|NCT03118765|466320580|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
129552846|NCT03118765|466320581|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
129552847|NCT03118765|466320582|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
129774777|NCT00990704|467141125|FG001|Overall Study|Adverse Event|1|||
129774778|NCT00990704|467141124|FG000|Overall Study|Physician Decision|0|||
129774779|NCT00990704|467141125|FG001|Overall Study|Physician Decision|1|||
129774780|NCT04040933|467141126|FG000|Overall Study|Protocol Violation|1|||
129774781|NCT04040933|467141126|FG000|Overall Study|Withdrawal by Subject|2|||
129774782|NCT01235741|467141130|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
129774783|NCT01235741|467141131|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
129774784|NCT01235741|467141132|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
129774785|NCT01235741|467141130|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
129774786|NCT01235741|467141131|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
129774787|NCT01235741|467141132|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
129774788|NCT01235741|467141130|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
129774789|NCT01235741|467141131|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
129774790|NCT01235741|467141132|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
129774791|NCT01235741|467141130|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
129774792|NCT01235741|467141131|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
129774793|NCT01235741|467141132|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
129774794|NCT01235741|467141130|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
129774795|NCT01235741|467141131|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
129774796|NCT01235741|467141132|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
129774797|NCT01235741|467141130|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
129774798|NCT01235741|467141131|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
129774799|NCT01235741|467141132|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
129774800|NCT01235741|467141130|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
129774801|NCT01235741|467141131|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
129774802|NCT01235741|467141132|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
129774803|NCT01235741|467141130|FG000|Randomized to Treatment|Adverse Event|0|||
129774804|NCT01235741|467141131|FG001|Randomized to Treatment|Adverse Event|1|||
129774805|NCT01235741|467141132|FG002|Randomized to Treatment|Adverse Event|1|||
129774806|NCT01235741|467141130|FG000|Randomized to Treatment|Sponsor terminated study|0|||
129774807|NCT01235741|467141131|FG001|Randomized to Treatment|Sponsor terminated study|35|||
129774808|NCT01235741|467141132|FG002|Randomized to Treatment|Sponsor terminated study|34|||
129774809|NCT01235741|467141130|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
129774810|NCT01235741|467141131|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
129774811|NCT01235741|467141132|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
129774812|NCT01235741|467141130|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
129774813|NCT01235741|467141131|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
129774814|NCT01235741|467141132|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
129774815|NCT01235741|467141130|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
129774816|NCT01235741|467141131|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
129774817|NCT01235741|467141132|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
129774818|NCT00904033|467141137|FG000|Overall Study|Withdrawal by Subject|1|||
129774819|NCT00904033|467141138|FG001|Overall Study|Withdrawal by Subject|1|||
129774820|NCT00904033|467141139|FG002|Overall Study|Withdrawal by Subject|0|||
129774821|NCT00904033|467141140|FG003|Overall Study|Withdrawal by Subject|0|||
129774822|NCT00904033|467141137|FG000|Overall Study|Physician Decision|0|||
129774823|NCT00904033|467141138|FG001|Overall Study|Physician Decision|0|||
129774824|NCT00904033|467141139|FG002|Overall Study|Physician Decision|1|||
129774825|NCT00904033|467141140|FG003|Overall Study|Physician Decision|0|||
129774826|NCT00904033|467141137|FG000|Overall Study|Unable to obtain final blood draw|0|||
129774827|NCT00904033|467141138|FG001|Overall Study|Unable to obtain final blood draw|0|||
129884462|NCT00734214|467536406|FG000|Overall Study|MD withdrawal|1|||
129552848|NCT03118765|466320583|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
129552849|NCT03118765|466320579|FG000|Overall Study|COPD Exacerbation|1|||
129552850|NCT03118765|466320580|FG001|Overall Study|COPD Exacerbation|0|||
129552851|NCT03118765|466320581|FG002|Overall Study|COPD Exacerbation|0|||
129552852|NCT03118765|466320582|FG003|Overall Study|COPD Exacerbation|1|||
129552853|NCT03118765|466320583|FG004|Overall Study|COPD Exacerbation|0|||
129552854|NCT03118765|466320579|FG000|Overall Study|Lost to Follow-up|1|||
129552855|NCT03118765|466320580|FG001|Overall Study|Lost to Follow-up|0|||
129552856|NCT03118765|466320581|FG002|Overall Study|Lost to Follow-up|1|||
129552857|NCT03118765|466320582|FG003|Overall Study|Lost to Follow-up|0|||
129552858|NCT03118765|466320583|FG004|Overall Study|Lost to Follow-up|0|||
129552859|NCT03118765|466320579|FG000|Overall Study|Sponsor Decision|1|||
129552860|NCT03118765|466320580|FG001|Overall Study|Sponsor Decision|0|||
129552861|NCT03118765|466320581|FG002|Overall Study|Sponsor Decision|1|||
129552862|NCT03118765|466320582|FG003|Overall Study|Sponsor Decision|0|||
129552863|NCT03118765|466320583|FG004|Overall Study|Sponsor Decision|1|||
129552864|NCT00879970|466320584|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
129552865|NCT00879970|466320585|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
129552866|NCT00879970|466320586|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
129552867|NCT00879970|466320587|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
129552868|NCT00879970|466320588|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
129552869|NCT00879970|466320584|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
129552870|NCT00879970|466320585|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
129552871|NCT00879970|466320586|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
129552872|NCT00879970|466320587|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
129552873|NCT00879970|466320588|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
129552874|NCT00879970|466320584|FG000|Period 1 TZD Randomization|Death|2|||
129552875|NCT00879970|466320585|FG001|Period 1 TZD Randomization|Death|1|||
129552876|NCT00879970|466320586|FG002|Period 1 TZD Randomization|Death|0|||
129552877|NCT00879970|466320587|FG003|Period 1 TZD Randomization|Death|0|||
129552878|NCT00879970|466320588|FG004|Period 1 TZD Randomization|Death|0|||
129552879|NCT00879970|466320584|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
129552880|NCT00879970|466320585|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
129552881|NCT00879970|466320586|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
129552882|NCT00879970|466320587|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
129552883|NCT00879970|466320588|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
129552884|NCT00879970|466320584|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
129552885|NCT00879970|466320585|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
129552886|NCT00879970|466320586|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
129552887|NCT00879970|466320587|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
129552888|NCT00879970|466320588|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
129552889|NCT00879970|466320584|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
129552890|NCT00879970|466320585|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
129552891|NCT00879970|466320586|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
129552892|NCT00879970|466320587|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
129552893|NCT00879970|466320588|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
129552894|NCT00879970|466320584|FG000|Period 2 Vitamin D Randomization|Death|0|||
129552895|NCT00879970|466320585|FG001|Period 2 Vitamin D Randomization|Death|0|||
129552896|NCT00879970|466320586|FG002|Period 2 Vitamin D Randomization|Death|0|||
129552897|NCT00879970|466320587|FG003|Period 2 Vitamin D Randomization|Death|2|||
129552898|NCT00879970|466320588|FG004|Period 2 Vitamin D Randomization|Death|0|||
129552899|NCT01749033|466320590|FG000|Overall Study|Did not receive allocated intervention|3|||
129774828|NCT00904033|467141139|FG002|Overall Study|Unable to obtain final blood draw|0|||
129774829|NCT00904033|467141140|FG003|Overall Study|Unable to obtain final blood draw|2|||
129774830|NCT01177397|467141141|FG000|Overall Study|Protocol Violation|0|||
129552900|NCT01749033|466320591|FG001|Overall Study|Did not receive allocated intervention|3|||
129552901|NCT01749033|466320592|FG002|Overall Study|Did not receive allocated intervention|0|||
129552902|NCT01749033|466320590|FG000|Overall Study|Lost to Follow-up|0|||
129552903|NCT01749033|466320591|FG001|Overall Study|Lost to Follow-up|2|||
129552904|NCT01749033|466320592|FG002|Overall Study|Lost to Follow-up|1|||
129552905|NCT04380701|466320593|FG000|Overall Study|Pregnancy|0|||
129552906|NCT04380701|466320594|FG001|Overall Study|Pregnancy|0|||
129552907|NCT04380701|466320595|FG002|Overall Study|Pregnancy|0|||
129552908|NCT04380701|466320596|FG003|Overall Study|Pregnancy|0|||
129552909|NCT04380701|466320597|FG004|Overall Study|Pregnancy|0|||
129552910|NCT04380701|466320598|FG005|Overall Study|Pregnancy|0|||
129552911|NCT04380701|466320599|FG006|Overall Study|Pregnancy|0|||
129552912|NCT04380701|466320600|FG007|Overall Study|Pregnancy|0|||
129774831|NCT01177397|467141142|FG001|Overall Study|Protocol Violation|0|||
129774832|NCT01177397|467141143|FG002|Overall Study|Protocol Violation|0|||
129774833|NCT01177397|467141144|FG003|Overall Study|Protocol Violation|0|||
129552913|NCT04380701|466320601|FG008|Overall Study|Pregnancy|0|||
129552914|NCT04380701|466320602|FG009|Overall Study|Pregnancy|0|||
129774834|NCT01177397|467141145|FG004|Overall Study|Protocol Violation|0|||
129552915|NCT04380701|466320603|FG010|Overall Study|Pregnancy|0|||
129552916|NCT04380701|466320604|FG011|Overall Study|Pregnancy|0|||
129552917|NCT04380701|466320605|FG012|Overall Study|Pregnancy|0|||
129552918|NCT04380701|466320606|FG013|Overall Study|Pregnancy|0|||
129552919|NCT04380701|466320607|FG014|Overall Study|Pregnancy|0|||
129552920|NCT04380701|466320608|FG015|Overall Study|Pregnancy|0|||
129552921|NCT04380701|466320609|FG016|Overall Study|Pregnancy|0|||
129552922|NCT04380701|466320610|FG017|Overall Study|Pregnancy|0|||
129552923|NCT04380701|466320611|FG018|Overall Study|Pregnancy|0|||
129552924|NCT04380701|466320612|FG019|Overall Study|Pregnancy|0|||
129552925|NCT04380701|466320613|FG020|Overall Study|Pregnancy|0|||
129552926|NCT04380701|466320614|FG021|Overall Study|Pregnancy|0|||
129552927|NCT04380701|466320615|FG022|Overall Study|Pregnancy|0|||
129552928|NCT04380701|466320616|FG023|Overall Study|Pregnancy|0|||
129552929|NCT04380701|466320617|FG024|Overall Study|Pregnancy|0|||
129552930|NCT04380701|466320618|FG025|Overall Study|Pregnancy|0|||
129552931|NCT04380701|466320619|FG026|Overall Study|Pregnancy|0|||
129552932|NCT04380701|466320620|FG027|Overall Study|Pregnancy|0|||
129552933|NCT04380701|466320621|FG028|Overall Study|Pregnancy|0|||
129552934|NCT04380701|466320622|FG029|Overall Study|Pregnancy|0|||
129552935|NCT04380701|466320623|FG030|Overall Study|Pregnancy|0|||
129552936|NCT04380701|466320624|FG031|Overall Study|Pregnancy|0|||
129552937|NCT04380701|466320625|FG032|Overall Study|Pregnancy|1|||
129552938|NCT04380701|466320626|FG033|Overall Study|Pregnancy|0|||
129552939|NCT04380701|466320593|FG000|Overall Study|Lost to Follow-up|0|||
129774835|NCT01177397|467141146|FG005|Overall Study|Protocol Violation|1|||
129774836|NCT01177397|467141147|FG006|Overall Study|Protocol Violation|0|||
129552940|NCT04380701|466320594|FG001|Overall Study|Lost to Follow-up|0|||
129774837|NCT01177397|467141148|FG007|Overall Study|Protocol Violation|0|||
129774838|NCT01177397|467141149|FG008|Overall Study|Protocol Violation|0|||
129774839|NCT01177397|467141150|FG009|Overall Study|Protocol Violation|0|||
129774840|NCT01177397|467141151|FG010|Overall Study|Protocol Violation|0|||
129774841|NCT01177397|467141152|FG011|Overall Study|Protocol Violation|0|||
129774842|NCT01177397|467141141|FG000|Overall Study|Lost to Follow-up|0|||
129774843|NCT01177397|467141142|FG001|Overall Study|Lost to Follow-up|0|||
129774844|NCT01177397|467141143|FG002|Overall Study|Lost to Follow-up|0|||
129774845|NCT01177397|467141144|FG003|Overall Study|Lost to Follow-up|0|||
129774846|NCT01177397|467141145|FG004|Overall Study|Lost to Follow-up|1|||
129774847|NCT01177397|467141146|FG005|Overall Study|Lost to Follow-up|0|||
129774848|NCT01177397|467141147|FG006|Overall Study|Lost to Follow-up|0|||
129774849|NCT01177397|467141148|FG007|Overall Study|Lost to Follow-up|2|||
129774850|NCT01177397|467141149|FG008|Overall Study|Lost to Follow-up|0|||
129774851|NCT01177397|467141150|FG009|Overall Study|Lost to Follow-up|0|||
129774852|NCT01177397|467141151|FG010|Overall Study|Lost to Follow-up|0|||
129774853|NCT01177397|467141152|FG011|Overall Study|Lost to Follow-up|0|||
129774854|NCT01177397|467141141|FG000|Overall Study|Death|0|||
129774855|NCT01177397|467141142|FG001|Overall Study|Death|0|||
129774856|NCT01177397|467141143|FG002|Overall Study|Death|1|||
129774857|NCT01177397|467141144|FG003|Overall Study|Death|1|||
129774858|NCT01177397|467141145|FG004|Overall Study|Death|0|||
129774859|NCT01177397|467141146|FG005|Overall Study|Death|0|||
129774860|NCT01177397|467141147|FG006|Overall Study|Death|0|||
129774861|NCT01177397|467141148|FG007|Overall Study|Death|5|||
129774862|NCT01177397|467141149|FG008|Overall Study|Death|2|||
129774863|NCT01177397|467141150|FG009|Overall Study|Death|1|||
129774864|NCT01177397|467141151|FG010|Overall Study|Death|0|||
129774865|NCT01177397|467141152|FG011|Overall Study|Death|0|||
129774866|NCT01177397|467141141|FG000|Overall Study|Withdrawal by Subject|0|||
129774867|NCT01177397|467141142|FG001|Overall Study|Withdrawal by Subject|0|||
129774868|NCT01177397|467141143|FG002|Overall Study|Withdrawal by Subject|1|||
129774869|NCT01177397|467141144|FG003|Overall Study|Withdrawal by Subject|1|||
129552941|NCT04380701|466320595|FG002|Overall Study|Lost to Follow-up|0|||
129774870|NCT01177397|467141145|FG004|Overall Study|Withdrawal by Subject|1|||
129774871|NCT01177397|467141146|FG005|Overall Study|Withdrawal by Subject|2|||
129774872|NCT01177397|467141147|FG006|Overall Study|Withdrawal by Subject|0|||
129552942|NCT04380701|466320596|FG003|Overall Study|Lost to Follow-up|0|||
129552943|NCT04380701|466320597|FG004|Overall Study|Lost to Follow-up|0|||
129552944|NCT04380701|466320598|FG005|Overall Study|Lost to Follow-up|0|||
129552945|NCT04380701|466320599|FG006|Overall Study|Lost to Follow-up|0|||
129552946|NCT04380701|466320600|FG007|Overall Study|Lost to Follow-up|0|||
129774873|NCT01177397|467141148|FG007|Overall Study|Withdrawal by Subject|5|||
129774874|NCT01177397|467141149|FG008|Overall Study|Withdrawal by Subject|9|||
129774875|NCT01177397|467141150|FG009|Overall Study|Withdrawal by Subject|1|||
129552947|NCT04380701|466320601|FG008|Overall Study|Lost to Follow-up|0|||
129774876|NCT01177397|467141151|FG010|Overall Study|Withdrawal by Subject|1|||
129774877|NCT01177397|467141152|FG011|Overall Study|Withdrawal by Subject|0|||
129774878|NCT01177397|467141141|FG000|Overall Study|Adverse Event|0|||
129774879|NCT01177397|467141142|FG001|Overall Study|Adverse Event|0|||
129552948|NCT04380701|466320602|FG009|Overall Study|Lost to Follow-up|0|||
129552949|NCT04380701|466320603|FG010|Overall Study|Lost to Follow-up|0|||
129552950|NCT04380701|466320604|FG011|Overall Study|Lost to Follow-up|0|||
129552951|NCT04380701|466320605|FG012|Overall Study|Lost to Follow-up|0|||
129552952|NCT04380701|466320606|FG013|Overall Study|Lost to Follow-up|0|||
129685899|NCT03611946|466806370|FG003|Overall Study|Withdrawal by Subject|0|||
129685900|NCT02207608|466806371|FG000|Overall Study|Adverse Event|1|||
129685901|NCT02207608|466806372|FG001|Overall Study|Adverse Event|0|||
129685902|NCT00980460|466806373|FG000|Overall Study|Death|0|||
129685903|NCT00980460|466806374|FG001|Overall Study|Death|0|||
129685904|NCT00980460|466806375|FG002|Overall Study|Death|1|||
129685905|NCT00980460|466806376|FG003|Overall Study|Death|2|||
129685906|NCT00980460|466806377|FG004|Overall Study|Death|1|||
129685907|NCT00980460|466806373|FG000|Overall Study|Lack of Efficacy|0|||
129685908|NCT00980460|466806374|FG001|Overall Study|Lack of Efficacy|0|||
129685909|NCT00980460|466806375|FG002|Overall Study|Lack of Efficacy|10|||
129685910|NCT00980460|466806376|FG003|Overall Study|Lack of Efficacy|6|||
129685911|NCT00980460|466806377|FG004|Overall Study|Lack of Efficacy|8|||
129685912|NCT00980460|466806373|FG000|Overall Study|Lost to Follow-up|0|||
129685913|NCT00980460|466806374|FG001|Overall Study|Lost to Follow-up|0|||
129685914|NCT00980460|466806375|FG002|Overall Study|Lost to Follow-up|0|||
129685915|NCT00980460|466806376|FG003|Overall Study|Lost to Follow-up|1|||
129685916|NCT00980460|466806377|FG004|Overall Study|Lost to Follow-up|0|||
129685917|NCT00980460|466806373|FG000|Overall Study|Physician Decision|0|||
129685918|NCT00980460|466806374|FG001|Overall Study|Physician Decision|0|||
129685919|NCT00980460|466806375|FG002|Overall Study|Physician Decision|11|||
129685920|NCT00980460|466806376|FG003|Overall Study|Physician Decision|5|||
129685921|NCT00980460|466806377|FG004|Overall Study|Physician Decision|3|||
129685922|NCT00980460|466806373|FG000|Overall Study|Withdrawal by Subject|0|||
129685923|NCT00980460|466806374|FG001|Overall Study|Withdrawal by Subject|0|||
129685924|NCT00980460|466806375|FG002|Overall Study|Withdrawal by Subject|1|||
129685925|NCT00980460|466806376|FG003|Overall Study|Withdrawal by Subject|0|||
129685926|NCT00980460|466806377|FG004|Overall Study|Withdrawal by Subject|0|||
129685927|NCT00980460|466806373|FG000|Overall Study|Ineligible|0|||
129685928|NCT00980460|466806374|FG001|Overall Study|Ineligible|2|||
129685929|NCT00980460|466806375|FG002|Overall Study|Ineligible|3|||
129685930|NCT00980460|466806376|FG003|Overall Study|Ineligible|1|||
129685931|NCT00980460|466806377|FG004|Overall Study|Ineligible|4|||
129685932|NCT00980460|466806373|FG000|Overall Study|Refusal of further therapy|0|||
129685933|NCT00980460|466806374|FG001|Overall Study|Refusal of further therapy|2|||
129685934|NCT00980460|466806375|FG002|Overall Study|Refusal of further therapy|3|||
129685935|NCT00980460|466806376|FG003|Overall Study|Refusal of further therapy|2|||
129685936|NCT00980460|466806377|FG004|Overall Study|Refusal of further therapy|0|||
129685937|NCT00980460|466806373|FG000|Overall Study|No therapy within 42 days of resection|0|||
129685938|NCT00980460|466806374|FG001|Overall Study|No therapy within 42 days of resection|0|||
129685939|NCT00980460|466806375|FG002|Overall Study|No therapy within 42 days of resection|3|||
129685940|NCT00980460|466806376|FG003|Overall Study|No therapy within 42 days of resection|1|||
129685941|NCT00980460|466806377|FG004|Overall Study|No therapy within 42 days of resection|0|||
129685942|NCT00980460|466806373|FG000|Overall Study|No transplant by protocol timepoints|0|||
129685943|NCT00980460|466806374|FG001|Overall Study|No transplant by protocol timepoints|0|||
129685944|NCT00980460|466806375|FG002|Overall Study|No transplant by protocol timepoints|3|||
129685945|NCT00980460|466806376|FG003|Overall Study|No transplant by protocol timepoints|0|||
129685946|NCT00980460|466806377|FG004|Overall Study|No transplant by protocol timepoints|0|||
129685947|NCT03599713|466806381|FG000|Overall Study|Death|38|||
129685948|NCT03599713|466806382|FG001|Overall Study|Death|3|||
129685949|NCT03599713|466806381|FG000|Overall Study|Withdrawal by Subject|17|||
129685950|NCT03599713|466806382|FG001|Overall Study|Withdrawal by Subject|0|||
129685951|NCT03599713|466806381|FG000|Overall Study|Lost to Follow-up|4|||
129685952|NCT03599713|466806382|FG001|Overall Study|Lost to Follow-up|0|||
129685953|NCT03599713|466806381|FG000|Overall Study|Discontinued Due to End of Study|42|||
129685954|NCT03599713|466806382|FG001|Overall Study|Discontinued Due to End of Study|3|||
129685955|NCT05800145|466806383|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
129685956|NCT05800145|466806384|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129685957|NCT05800145|466806385|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129685958|NCT05800145|466806386|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
129685959|NCT05800145|466806387|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129685960|NCT05800145|466806388|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129685961|NCT05800145|466806383|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
129685962|NCT05800145|466806384|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129685963|NCT05800145|466806385|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129685964|NCT05800145|466806386|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
129774880|NCT01177397|467141143|FG002|Overall Study|Adverse Event|1|||
129685965|NCT05800145|466806387|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129685966|NCT05800145|466806388|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
129685967|NCT05800145|466806383|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
129685968|NCT05800145|466806384|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
129685969|NCT05800145|466806385|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
129685970|NCT05800145|466806386|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
129685971|NCT05800145|466806387|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
129685972|NCT05800145|466806388|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
129685973|NCT02850406|466806389|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685974|NCT02850406|466806390|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685975|NCT02850406|466806391|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685976|NCT02850406|466806392|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
129685977|NCT02850406|466806393|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685978|NCT02850406|466806394|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685979|NCT02850406|466806395|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685980|NCT02850406|466806396|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
129685981|NCT02850406|466806389|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129685982|NCT02850406|466806390|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129685983|NCT02850406|466806391|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
129685984|NCT02850406|466806392|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
129685985|NCT02850406|466806393|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129685986|NCT02850406|466806394|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129685987|NCT02850406|466806395|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129685988|NCT02850406|466806396|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
129685989|NCT02850406|466806389|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685990|NCT02850406|466806390|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685991|NCT02850406|466806391|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
129685992|NCT02850406|466806392|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685993|NCT02850406|466806393|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685994|NCT02850406|466806394|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685995|NCT02850406|466806395|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685996|NCT02850406|466806396|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
129685997|NCT02850406|466806389|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
129685998|NCT02850406|466806390|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
129685999|NCT02850406|466806391|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
129686000|NCT02850406|466806392|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
129686001|NCT02850406|466806393|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
129686002|NCT02850406|466806394|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
129686003|NCT02850406|466806395|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
129686004|NCT02850406|466806396|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
129686005|NCT02850406|466806389|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
129686006|NCT02850406|466806390|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
129686007|NCT02850406|466806391|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
129686008|NCT02850406|466806392|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
129686009|NCT02850406|466806393|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
129686010|NCT02850406|466806394|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
129686011|NCT02850406|466806395|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
129686012|NCT02850406|466806396|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
129686013|NCT02850406|466806389|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686014|NCT02850406|466806390|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686015|NCT02850406|466806391|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686016|NCT02850406|466806392|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686017|NCT02850406|466806393|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
129686018|NCT02850406|466806394|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
129686019|NCT02850406|466806395|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686020|NCT02850406|466806396|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686021|NCT02850406|466806389|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686022|NCT02850406|466806390|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686023|NCT02850406|466806391|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686024|NCT02850406|466806392|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686025|NCT02850406|466806393|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
129686026|NCT02850406|466806394|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686027|NCT02850406|466806395|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686028|NCT02850406|466806396|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
129686029|NCT02850406|466806389|FG000|Part C (Up to 52 Weeks)|Other|0|||
129686030|NCT02850406|466806390|FG001|Part C (Up to 52 Weeks)|Other|0|||
129686031|NCT02850406|466806391|FG002|Part C (Up to 52 Weeks)|Other|0|||
129686032|NCT02850406|466806392|FG003|Part C (Up to 52 Weeks)|Other|0|||
129686033|NCT02850406|466806393|FG004|Part C (Up to 52 Weeks)|Other|1|||
129686034|NCT02850406|466806394|FG005|Part C (Up to 52 Weeks)|Other|3|||
129686035|NCT02850406|466806395|FG006|Part C (Up to 52 Weeks)|Other|0|||
129686036|NCT02850406|466806396|FG007|Part C (Up to 52 Weeks)|Other|0|||
129686037|NCT02850406|466806389|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
129552953|NCT04380701|466320607|FG014|Overall Study|Lost to Follow-up|0|||
129552954|NCT04380701|466320608|FG015|Overall Study|Lost to Follow-up|0|||
129552955|NCT04380701|466320609|FG016|Overall Study|Lost to Follow-up|0|||
129552956|NCT04380701|466320610|FG017|Overall Study|Lost to Follow-up|0|||
129552957|NCT04380701|466320611|FG018|Overall Study|Lost to Follow-up|0|||
129552958|NCT04380701|466320612|FG019|Overall Study|Lost to Follow-up|0|||
129552959|NCT04380701|466320613|FG020|Overall Study|Lost to Follow-up|1|||
129552960|NCT04380701|466320614|FG021|Overall Study|Lost to Follow-up|0|||
129552961|NCT04380701|466320615|FG022|Overall Study|Lost to Follow-up|0|||
129552962|NCT04380701|466320616|FG023|Overall Study|Lost to Follow-up|1|||
129552963|NCT04380701|466320617|FG024|Overall Study|Lost to Follow-up|0|||
129552964|NCT04380701|466320618|FG025|Overall Study|Lost to Follow-up|0|||
129552965|NCT04380701|466320619|FG026|Overall Study|Lost to Follow-up|0|||
129552966|NCT04380701|466320620|FG027|Overall Study|Lost to Follow-up|0|||
129552967|NCT04380701|466320621|FG028|Overall Study|Lost to Follow-up|0|||
129552968|NCT04380701|466320622|FG029|Overall Study|Lost to Follow-up|1|||
129552969|NCT04380701|466320623|FG030|Overall Study|Lost to Follow-up|0|||
129552970|NCT04380701|466320624|FG031|Overall Study|Lost to Follow-up|0|||
129552971|NCT04380701|466320625|FG032|Overall Study|Lost to Follow-up|0|||
129552972|NCT04380701|466320626|FG033|Overall Study|Lost to Follow-up|1|||
129552973|NCT04380701|466320593|FG000|Overall Study|Private reason(s)|0|||
129552974|NCT04380701|466320594|FG001|Overall Study|Private reason(s)|0|||
129552975|NCT04380701|466320595|FG002|Overall Study|Private reason(s)|0|||
129552976|NCT04380701|466320596|FG003|Overall Study|Private reason(s)|0|||
129552977|NCT04380701|466320597|FG004|Overall Study|Private reason(s)|0|||
129552978|NCT04380701|466320598|FG005|Overall Study|Private reason(s)|0|||
129552979|NCT04380701|466320599|FG006|Overall Study|Private reason(s)|1|||
129552980|NCT04380701|466320600|FG007|Overall Study|Private reason(s)|0|||
129552981|NCT04380701|466320601|FG008|Overall Study|Private reason(s)|1|||
129552982|NCT04380701|466320602|FG009|Overall Study|Private reason(s)|1|||
129552983|NCT04380701|466320603|FG010|Overall Study|Private reason(s)|0|||
129552984|NCT04380701|466320604|FG011|Overall Study|Private reason(s)|0|||
129552985|NCT04380701|466320605|FG012|Overall Study|Private reason(s)|0|||
129552986|NCT04380701|466320606|FG013|Overall Study|Private reason(s)|0|||
129552987|NCT04380701|466320607|FG014|Overall Study|Private reason(s)|0|||
129552988|NCT04380701|466320608|FG015|Overall Study|Private reason(s)|0|||
129552989|NCT04380701|466320609|FG016|Overall Study|Private reason(s)|0|||
129552990|NCT04380701|466320610|FG017|Overall Study|Private reason(s)|0|||
129552991|NCT04380701|466320611|FG018|Overall Study|Private reason(s)|0|||
129552992|NCT04380701|466320612|FG019|Overall Study|Private reason(s)|0|||
129552993|NCT04380701|466320613|FG020|Overall Study|Private reason(s)|0|||
129552994|NCT04380701|466320614|FG021|Overall Study|Private reason(s)|0|||
129552995|NCT04380701|466320615|FG022|Overall Study|Private reason(s)|0|||
129552996|NCT04380701|466320616|FG023|Overall Study|Private reason(s)|1|||
129552997|NCT04380701|466320617|FG024|Overall Study|Private reason(s)|0|||
129552998|NCT04380701|466320618|FG025|Overall Study|Private reason(s)|0|||
129552999|NCT04380701|466320619|FG026|Overall Study|Private reason(s)|0|||
129553000|NCT04380701|466320620|FG027|Overall Study|Private reason(s)|0|||
129553001|NCT04380701|466320621|FG028|Overall Study|Private reason(s)|0|||
129553002|NCT04380701|466320622|FG029|Overall Study|Private reason(s)|1|||
129553003|NCT04380701|466320623|FG030|Overall Study|Private reason(s)|0|||
129553004|NCT04380701|466320624|FG031|Overall Study|Private reason(s)|0|||
129553005|NCT04380701|466320625|FG032|Overall Study|Private reason(s)|0|||
129774881|NCT01177397|467141144|FG003|Overall Study|Adverse Event|2|||
129774882|NCT01177397|467141145|FG004|Overall Study|Adverse Event|0|||
129774883|NCT01177397|467141146|FG005|Overall Study|Adverse Event|12|||
129774884|NCT01177397|467141147|FG006|Overall Study|Adverse Event|1|||
129774885|NCT01177397|467141148|FG007|Overall Study|Adverse Event|14|||
129553006|NCT04380701|466320626|FG033|Overall Study|Private reason(s)|0|||
129553007|NCT04380701|466320593|FG000|Overall Study|Withdrawal by Subject|0|||
129553008|NCT04380701|466320594|FG001|Overall Study|Withdrawal by Subject|0|||
129553009|NCT04380701|466320595|FG002|Overall Study|Withdrawal by Subject|0|||
129553010|NCT04380701|466320596|FG003|Overall Study|Withdrawal by Subject|0|||
129553011|NCT04380701|466320597|FG004|Overall Study|Withdrawal by Subject|0|||
129553012|NCT04380701|466320598|FG005|Overall Study|Withdrawal by Subject|0|||
129553013|NCT04380701|466320599|FG006|Overall Study|Withdrawal by Subject|1|||
129553014|NCT04380701|466320600|FG007|Overall Study|Withdrawal by Subject|1|||
129774886|NCT01177397|467141149|FG008|Overall Study|Adverse Event|8|||
129774887|NCT01177397|467141150|FG009|Overall Study|Adverse Event|6|||
129774888|NCT01177397|467141151|FG010|Overall Study|Adverse Event|3|||
129774889|NCT01177397|467141152|FG011|Overall Study|Adverse Event|7|||
129774890|NCT01177397|467141141|FG000|Overall Study|Disease progression|1|||
129553015|NCT04380701|466320601|FG008|Overall Study|Withdrawal by Subject|0|||
129553016|NCT04380701|466320602|FG009|Overall Study|Withdrawal by Subject|0|||
129553017|NCT04380701|466320603|FG010|Overall Study|Withdrawal by Subject|0|||
129553018|NCT04380701|466320604|FG011|Overall Study|Withdrawal by Subject|1|||
129553019|NCT04380701|466320605|FG012|Overall Study|Withdrawal by Subject|0|||
129553020|NCT04380701|466320606|FG013|Overall Study|Withdrawal by Subject|1|||
129553021|NCT04380701|466320607|FG014|Overall Study|Withdrawal by Subject|0|||
129553022|NCT04380701|466320608|FG015|Overall Study|Withdrawal by Subject|0|||
129553023|NCT04380701|466320609|FG016|Overall Study|Withdrawal by Subject|1|||
129553024|NCT04380701|466320610|FG017|Overall Study|Withdrawal by Subject|0|||
129553025|NCT04380701|466320611|FG018|Overall Study|Withdrawal by Subject|0|||
129553026|NCT04380701|466320612|FG019|Overall Study|Withdrawal by Subject|0|||
129553027|NCT04380701|466320613|FG020|Overall Study|Withdrawal by Subject|0|||
129553028|NCT04380701|466320614|FG021|Overall Study|Withdrawal by Subject|0|||
129553029|NCT04380701|466320615|FG022|Overall Study|Withdrawal by Subject|2|||
129553030|NCT04380701|466320616|FG023|Overall Study|Withdrawal by Subject|2|||
129553031|NCT04380701|466320617|FG024|Overall Study|Withdrawal by Subject|1|||
129553032|NCT04380701|466320618|FG025|Overall Study|Withdrawal by Subject|1|||
129553033|NCT04380701|466320619|FG026|Overall Study|Withdrawal by Subject|0|||
129553034|NCT04380701|466320620|FG027|Overall Study|Withdrawal by Subject|0|||
129553035|NCT04380701|466320621|FG028|Overall Study|Withdrawal by Subject|0|||
129553036|NCT04380701|466320622|FG029|Overall Study|Withdrawal by Subject|0|||
129553037|NCT04380701|466320623|FG030|Overall Study|Withdrawal by Subject|0|||
129553038|NCT04380701|466320624|FG031|Overall Study|Withdrawal by Subject|0|||
129553039|NCT04380701|466320625|FG032|Overall Study|Withdrawal by Subject|0|||
129553040|NCT04380701|466320626|FG033|Overall Study|Withdrawal by Subject|0|||
129553041|NCT04380701|466320593|FG000|Overall Study|Adverse Event|0|||
129553042|NCT04380701|466320594|FG001|Overall Study|Adverse Event|0|||
129553043|NCT04380701|466320595|FG002|Overall Study|Adverse Event|0|||
129553044|NCT04380701|466320596|FG003|Overall Study|Adverse Event|0|||
129553045|NCT04380701|466320597|FG004|Overall Study|Adverse Event|0|||
129553046|NCT04380701|466320598|FG005|Overall Study|Adverse Event|1|||
129553047|NCT04380701|466320599|FG006|Overall Study|Adverse Event|0|||
129553048|NCT04380701|466320600|FG007|Overall Study|Adverse Event|0|||
129553049|NCT04380701|466320601|FG008|Overall Study|Adverse Event|0|||
129553050|NCT04380701|466320602|FG009|Overall Study|Adverse Event|0|||
129553051|NCT04380701|466320603|FG010|Overall Study|Adverse Event|0|||
129553052|NCT04380701|466320604|FG011|Overall Study|Adverse Event|0|||
129553053|NCT04380701|466320605|FG012|Overall Study|Adverse Event|0|||
129686038|NCT02850406|466806390|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
129686039|NCT02850406|466806391|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
129686040|NCT02850406|466806392|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
129686041|NCT02850406|466806393|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
129686042|NCT02850406|466806394|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
129686043|NCT02850406|466806395|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
129686044|NCT02850406|466806396|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
129686045|NCT02850406|466806389|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686046|NCT02850406|466806390|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686047|NCT02850406|466806391|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686048|NCT02850406|466806392|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686049|NCT02850406|466806393|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686050|NCT02850406|466806394|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686051|NCT02850406|466806395|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
129686052|NCT02850406|466806396|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
129686053|NCT02850406|466806389|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
129686054|NCT02850406|466806390|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
129686055|NCT02850406|466806391|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
129686056|NCT02850406|466806392|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
129686057|NCT02850406|466806393|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
129686058|NCT02850406|466806394|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
129686059|NCT02850406|466806395|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
129686060|NCT02850406|466806396|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
129686061|NCT02850406|466806389|FG000|Part D (Up to 52 Weeks)|Other|0|||
129686062|NCT02850406|466806390|FG001|Part D (Up to 52 Weeks)|Other|0|||
129686063|NCT02850406|466806391|FG002|Part D (Up to 52 Weeks)|Other|0|||
129686064|NCT02850406|466806392|FG003|Part D (Up to 52 Weeks)|Other|0|||
129686065|NCT02850406|466806393|FG004|Part D (Up to 52 Weeks)|Other|0|||
129553054|NCT04380701|466320606|FG013|Overall Study|Adverse Event|0|||
129553055|NCT04380701|466320607|FG014|Overall Study|Adverse Event|0|||
129553056|NCT04380701|466320608|FG015|Overall Study|Adverse Event|1|||
129553057|NCT04380701|466320609|FG016|Overall Study|Adverse Event|0|||
129553058|NCT04380701|466320610|FG017|Overall Study|Adverse Event|0|||
129553059|NCT04380701|466320611|FG018|Overall Study|Adverse Event|0|||
129553060|NCT04380701|466320612|FG019|Overall Study|Adverse Event|1|||
129553061|NCT04380701|466320613|FG020|Overall Study|Adverse Event|0|||
129553062|NCT04380701|466320614|FG021|Overall Study|Adverse Event|0|||
129553063|NCT04380701|466320615|FG022|Overall Study|Adverse Event|0|||
129686066|NCT02850406|466806394|FG005|Part D (Up to 52 Weeks)|Other|0|||
129686067|NCT02850406|466806395|FG006|Part D (Up to 52 Weeks)|Other|0|||
129686068|NCT02850406|466806396|FG007|Part D (Up to 52 Weeks)|Other|1|||
129686069|NCT00876395|466807651|FG000|Overall Study|Untreated|8|||
129686070|NCT00876395|466807652|FG001|Overall Study|Untreated|1|||
129686071|NCT00876395|466807651|FG000|Overall Study|Adverse Event|63|||
129774891|NCT01177397|467141142|FG001|Overall Study|Disease progression|2|||
129774892|NCT01177397|467141143|FG002|Overall Study|Disease progression|5|||
129774893|NCT01177397|467141144|FG003|Overall Study|Disease progression|5|||
129774894|NCT01177397|467141145|FG004|Overall Study|Disease progression|4|||
129774895|NCT01177397|467141146|FG005|Overall Study|Disease progression|10|||
129774896|NCT01177397|467141147|FG006|Overall Study|Disease progression|10|||
129774897|NCT01177397|467141148|FG007|Overall Study|Disease progression|21|||
129774898|NCT01177397|467141149|FG008|Overall Study|Disease progression|18|||
129774899|NCT01177397|467141150|FG009|Overall Study|Disease progression|12|||
129774900|NCT01177397|467141151|FG010|Overall Study|Disease progression|10|||
129774901|NCT01177397|467141152|FG011|Overall Study|Disease progression|8|||
129774902|NCT01177397|467141141|FG000|Overall Study|Other reasons|0|||
129774903|NCT01177397|467141142|FG001|Overall Study|Other reasons|0|||
129774904|NCT01177397|467141143|FG002|Overall Study|Other reasons|1|||
129774905|NCT01177397|467141144|FG003|Overall Study|Other reasons|0|||
129774906|NCT01177397|467141145|FG004|Overall Study|Other reasons|1|||
129774907|NCT01177397|467141146|FG005|Overall Study|Other reasons|1|||
129774908|NCT01177397|467141147|FG006|Overall Study|Other reasons|2|||
129774909|NCT01177397|467141148|FG007|Overall Study|Other reasons|6|||
129553064|NCT04380701|466320616|FG023|Overall Study|Adverse Event|0|||
129553065|NCT04380701|466320617|FG024|Overall Study|Adverse Event|0|||
129553066|NCT04380701|466320618|FG025|Overall Study|Adverse Event|0|||
129553067|NCT04380701|466320619|FG026|Overall Study|Adverse Event|0|||
129553068|NCT04380701|466320620|FG027|Overall Study|Adverse Event|0|||
129774910|NCT01177397|467141149|FG008|Overall Study|Other reasons|10|||
129774911|NCT01177397|467141150|FG009|Overall Study|Other reasons|8|||
129774912|NCT01177397|467141151|FG010|Overall Study|Other reasons|0|||
129774913|NCT01177397|467141152|FG011|Overall Study|Other reasons|2|||
129774914|NCT00118417|467141153|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
129774915|NCT00118417|467141154|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
129553069|NCT04380701|466320621|FG028|Overall Study|Adverse Event|0|||
129553070|NCT04380701|466320622|FG029|Overall Study|Adverse Event|0|||
129553071|NCT04380701|466320623|FG030|Overall Study|Adverse Event|0|||
129553072|NCT04380701|466320624|FG031|Overall Study|Adverse Event|0|||
129553073|NCT04380701|466320625|FG032|Overall Study|Adverse Event|0|||
129553074|NCT04380701|466320626|FG033|Overall Study|Adverse Event|0|||
129553075|NCT04380701|466320593|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
129553076|NCT04380701|466320594|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
129553077|NCT04380701|466320595|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
129553078|NCT04380701|466320596|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
129553079|NCT04380701|466320597|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
129553080|NCT04380701|466320598|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
129553081|NCT04380701|466320599|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
129553082|NCT04380701|466320600|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
129553083|NCT04380701|466320601|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
129553084|NCT04380701|466320602|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
129553085|NCT04380701|466320603|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
129553086|NCT04380701|466320604|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
129553087|NCT04380701|466320605|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
129553088|NCT04380701|466320606|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
129553089|NCT04380701|466320607|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
129553090|NCT04380701|466320608|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
129553091|NCT04380701|466320609|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
129553092|NCT04380701|466320610|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
129553093|NCT04380701|466320611|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
129553094|NCT04380701|466320612|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
129553095|NCT04380701|466320613|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
129553096|NCT04380701|466320614|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
129553097|NCT04380701|466320615|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
129553098|NCT04380701|466320616|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
129553099|NCT04380701|466320617|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
129553100|NCT04380701|466320618|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
129553101|NCT04380701|466320619|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
129553102|NCT04380701|466320620|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
129553103|NCT04380701|466320621|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
129553104|NCT04380701|466320622|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
129686072|NCT00876395|466807652|FG001|Overall Study|Adverse Event|11|||
129686073|NCT00876395|466807651|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129686074|NCT00876395|466807652|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129686075|NCT00876395|466807651|FG000|Overall Study|Disease progression|259|||
129686076|NCT00876395|466807652|FG001|Overall Study|Disease progression|162|||
129686077|NCT00876395|466807651|FG000|Overall Study|New cancer therapy|25|||
129686078|NCT00876395|466807652|FG001|Overall Study|New cancer therapy|7|||
129686079|NCT00876395|466807651|FG000|Overall Study|Protocol Violation|5|||
129686080|NCT00876395|466807652|FG001|Overall Study|Protocol Violation|2|||
129686081|NCT00876395|466807651|FG000|Overall Study|Withdrawal by Subject|66|||
129686082|NCT00876395|466807652|FG001|Overall Study|Withdrawal by Subject|33|||
129686083|NCT00876395|466807651|FG000|Overall Study|Lost to Follow-up|2|||
129686084|NCT00876395|466807652|FG001|Overall Study|Lost to Follow-up|0|||
129686085|NCT00876395|466807651|FG000|Overall Study|Administrative problems|39|||
129686086|NCT00876395|466807652|FG001|Overall Study|Administrative problems|23|||
129686087|NCT00876395|466807651|FG000|Overall Study|Death|12|||
129686088|NCT00876395|466807652|FG001|Overall Study|Death|0|||
129686089|NCT03807843|466807653|FG000|Overall Study|Lost to Follow-up|1|||
129686090|NCT03807843|466807654|FG001|Overall Study|Lost to Follow-up|0|||
129686091|NCT01312129|466807655|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
129686092|NCT01312129|466807656|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
129686093|NCT00924651|466807659|FG000|Overall Study|Chemo started too soon|2|||
129686094|NCT00924651|466807660|FG001|Overall Study|Chemo started too soon|3|||
129686095|NCT00924651|466807659|FG000|Overall Study|No Reason|3|||
129686096|NCT00924651|466807660|FG001|Overall Study|No Reason|7|||
129686097|NCT00924651|466807659|FG000|Overall Study|Overwhelmed|6|||
129686098|NCT00924651|466807660|FG001|Overall Study|Overwhelmed|6|||
129686099|NCT00924651|466807659|FG000|Overall Study|Noncompliant|1|||
129686100|NCT00924651|466807660|FG001|Overall Study|Noncompliant|4|||
129884463|NCT00734214|467536407|FG001|Overall Study|MD withdrawal|0|||
129553105|NCT04380701|466320623|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
129553106|NCT04380701|466320624|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
129553107|NCT04380701|466320625|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
129686101|NCT00924651|466807659|FG000|Overall Study|Medical|1|||
129686102|NCT00924651|466807660|FG001|Overall Study|Medical|3|||
129686103|NCT00924651|466807659|FG000|Overall Study|Changed Mind|10|||
129686104|NCT00924651|466807660|FG001|Overall Study|Changed Mind|1|||
129686105|NCT00924651|466807659|FG000|Overall Study|Incomplete Form|2|||
129686106|NCT00924651|466807660|FG001|Overall Study|Incomplete Form|1|||
129686107|NCT01991314|466807661|FG000|Overall Study|Adverse Event|5|||
129686108|NCT01991314|466807662|FG001|Overall Study|Adverse Event|1|||
129553108|NCT04380701|466320626|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
129553109|NCT04380701|466320593|FG000|Overall Study|Physician Decision|0|||
129553110|NCT04380701|466320594|FG001|Overall Study|Physician Decision|0|||
129553111|NCT04380701|466320595|FG002|Overall Study|Physician Decision|0|||
129553112|NCT04380701|466320596|FG003|Overall Study|Physician Decision|0|||
129553113|NCT04380701|466320597|FG004|Overall Study|Physician Decision|0|||
129553114|NCT04380701|466320598|FG005|Overall Study|Physician Decision|0|||
129553115|NCT04380701|466320599|FG006|Overall Study|Physician Decision|0|||
129553116|NCT04380701|466320600|FG007|Overall Study|Physician Decision|0|||
129553117|NCT04380701|466320601|FG008|Overall Study|Physician Decision|0|||
129553118|NCT04380701|466320602|FG009|Overall Study|Physician Decision|0|||
129553119|NCT04380701|466320603|FG010|Overall Study|Physician Decision|0|||
129553120|NCT04380701|466320604|FG011|Overall Study|Physician Decision|0|||
129553121|NCT04380701|466320605|FG012|Overall Study|Physician Decision|0|||
129553122|NCT04380701|466320606|FG013|Overall Study|Physician Decision|0|||
129553123|NCT04380701|466320607|FG014|Overall Study|Physician Decision|0|||
129553124|NCT04380701|466320608|FG015|Overall Study|Physician Decision|0|||
129553125|NCT04380701|466320609|FG016|Overall Study|Physician Decision|0|||
129553126|NCT04380701|466320610|FG017|Overall Study|Physician Decision|0|||
129553127|NCT04380701|466320611|FG018|Overall Study|Physician Decision|0|||
129553128|NCT04380701|466320612|FG019|Overall Study|Physician Decision|0|||
129553129|NCT04380701|466320613|FG020|Overall Study|Physician Decision|0|||
129553130|NCT04380701|466320614|FG021|Overall Study|Physician Decision|0|||
129774916|NCT00118417|467141153|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
129774917|NCT00118417|467141154|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
129553131|NCT04380701|466320615|FG022|Overall Study|Physician Decision|0|||
129774918|NCT00118417|467141153|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
129774919|NCT00118417|467141154|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
129774920|NCT00118417|467141153|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
129774921|NCT00118417|467141154|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
129774922|NCT00118417|467141153|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
129774923|NCT00118417|467141154|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
129774924|NCT01383356|467141157|FG000|Period 1|Adverse Event|5|||
129774925|NCT01383356|467141158|FG001|Period 1|Adverse Event|3|||
129774926|NCT01383356|467141157|FG000|Period 1|Non-compliance|3|||
129774927|NCT01383356|467141158|FG001|Period 1|Non-compliance|0|||
129774928|NCT01383356|467141157|FG000|Period 1|Out of Range Mid-study-Test|0|||
129774929|NCT01383356|467141158|FG001|Period 1|Out of Range Mid-study-Test|1|||
129774930|NCT01383356|467141157|FG000|Period 1|Personal|0|||
129774931|NCT01383356|467141158|FG001|Period 1|Personal|2|||
129774932|NCT00998296|467141159|FG000|Overall Study|Progressive disease|0|||
129774933|NCT00998296|467141160|FG001|Overall Study|Progressive disease|1|||
129774934|NCT00998296|467141161|FG002|Overall Study|Progressive disease|0|||
129774935|NCT00998296|467141162|FG003|Overall Study|Progressive disease|0|||
129774936|NCT00998296|467141163|FG004|Overall Study|Progressive disease|0|||
129774937|NCT00998296|467141164|FG005|Overall Study|Progressive disease|0|||
129774938|NCT00998296|467141165|FG006|Overall Study|Progressive disease|1|||
129774939|NCT00998296|467141166|FG007|Overall Study|Progressive disease|0|||
129774940|NCT00998296|467141167|FG008|Overall Study|Progressive disease|0|||
129774941|NCT00998296|467141168|FG009|Overall Study|Progressive disease|14|||
129774942|NCT00998296|467141169|FG010|Overall Study|Progressive disease|5|||
129774943|NCT00998296|467141159|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774944|NCT00998296|467141160|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774945|NCT00998296|467141161|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774946|NCT00998296|467141162|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774947|NCT00998296|467141163|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
129774948|NCT00998296|467141164|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774949|NCT00998296|467141165|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774950|NCT00998296|467141166|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
129774951|NCT00998296|467141167|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
129553132|NCT04380701|466320616|FG023|Overall Study|Physician Decision|0|||
129553133|NCT04380701|466320617|FG024|Overall Study|Physician Decision|2|||
129553134|NCT04380701|466320618|FG025|Overall Study|Physician Decision|0|||
129774952|NCT00998296|467141168|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774953|NCT00998296|467141169|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
129774954|NCT00998296|467141159|FG000|Overall Study|Other adverse event|0|||
129774955|NCT00998296|467141160|FG001|Overall Study|Other adverse event|0|||
129553135|NCT04380701|466320619|FG026|Overall Study|Physician Decision|0|||
129553136|NCT04380701|466320620|FG027|Overall Study|Physician Decision|0|||
129553137|NCT04380701|466320621|FG028|Overall Study|Physician Decision|0|||
129774956|NCT00998296|467141161|FG002|Overall Study|Other adverse event|0|||
129774957|NCT00998296|467141162|FG003|Overall Study|Other adverse event|0|||
129774958|NCT00998296|467141163|FG004|Overall Study|Other adverse event|1|||
129774959|NCT00998296|467141164|FG005|Overall Study|Other adverse event|0|||
129553138|NCT04380701|466320622|FG029|Overall Study|Physician Decision|0|||
129553139|NCT04380701|466320623|FG030|Overall Study|Physician Decision|0|||
129553140|NCT04380701|466320624|FG031|Overall Study|Physician Decision|0|||
129553141|NCT04380701|466320625|FG032|Overall Study|Physician Decision|0|||
129553142|NCT04380701|466320626|FG033|Overall Study|Physician Decision|0|||
129553143|NCT04380701|466320593|FG000|Overall Study|Death|0|||
129553144|NCT04380701|466320594|FG001|Overall Study|Death|0|||
129553145|NCT04380701|466320595|FG002|Overall Study|Death|0|||
129553146|NCT04380701|466320596|FG003|Overall Study|Death|0|||
129553147|NCT04380701|466320597|FG004|Overall Study|Death|0|||
129553148|NCT04380701|466320598|FG005|Overall Study|Death|0|||
129553149|NCT04380701|466320599|FG006|Overall Study|Death|0|||
129553150|NCT04380701|466320600|FG007|Overall Study|Death|0|||
129553151|NCT04380701|466320601|FG008|Overall Study|Death|0|||
129553152|NCT04380701|466320602|FG009|Overall Study|Death|0|||
129553153|NCT04380701|466320603|FG010|Overall Study|Death|0|||
129553154|NCT04380701|466320604|FG011|Overall Study|Death|0|||
129553155|NCT04380701|466320605|FG012|Overall Study|Death|0|||
129553156|NCT04380701|466320606|FG013|Overall Study|Death|0|||
129553157|NCT04380701|466320607|FG014|Overall Study|Death|0|||
129553158|NCT04380701|466320608|FG015|Overall Study|Death|0|||
129553159|NCT04380701|466320609|FG016|Overall Study|Death|0|||
129553160|NCT04380701|466320610|FG017|Overall Study|Death|0|||
129553161|NCT04380701|466320611|FG018|Overall Study|Death|0|||
129553162|NCT04380701|466320612|FG019|Overall Study|Death|0|||
129553163|NCT04380701|466320613|FG020|Overall Study|Death|0|||
129553164|NCT04380701|466320614|FG021|Overall Study|Death|0|||
129553165|NCT04380701|466320615|FG022|Overall Study|Death|0|||
129774960|NCT00998296|467141165|FG006|Overall Study|Other adverse event|0|||
129774961|NCT00998296|467141166|FG007|Overall Study|Other adverse event|0|||
129774962|NCT00998296|467141167|FG008|Overall Study|Other adverse event|0|||
129774963|NCT00998296|467141168|FG009|Overall Study|Other adverse event|1|||
129774964|NCT00998296|467141169|FG010|Overall Study|Other adverse event|2|||
129774965|NCT00998296|467141159|FG000|Overall Study|Refused to continue taking trial med.|0|||
129553166|NCT04380701|466320616|FG023|Overall Study|Death|0|||
129553167|NCT04380701|466320617|FG024|Overall Study|Death|1|||
129553168|NCT04380701|466320618|FG025|Overall Study|Death|0|||
129774966|NCT00998296|467141160|FG001|Overall Study|Refused to continue taking trial med.|0|||
129884464|NCT02038764|467536408|FG000|Overall Study|Adverse Event|0|||
129553169|NCT04380701|466320619|FG026|Overall Study|Death|0|||
129553170|NCT04380701|466320620|FG027|Overall Study|Death|0|||
129553171|NCT04380701|466320621|FG028|Overall Study|Death|0|||
129553172|NCT04380701|466320622|FG029|Overall Study|Death|0|||
129553173|NCT04380701|466320623|FG030|Overall Study|Death|0|||
129553174|NCT04380701|466320624|FG031|Overall Study|Death|0|||
129553175|NCT04380701|466320625|FG032|Overall Study|Death|0|||
129553176|NCT04380701|466320626|FG033|Overall Study|Death|0|||
129553177|NCT04380701|466320593|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553178|NCT04380701|466320594|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553179|NCT04380701|466320595|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553180|NCT04380701|466320596|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553181|NCT04380701|466320597|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553182|NCT04380701|466320598|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553183|NCT04380701|466320599|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553184|NCT04380701|466320600|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553185|NCT04380701|466320601|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553186|NCT04380701|466320602|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553187|NCT04380701|466320603|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553188|NCT04380701|466320604|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553189|NCT04380701|466320605|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553190|NCT04380701|466320606|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553191|NCT04380701|466320607|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553192|NCT04380701|466320608|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553193|NCT04380701|466320609|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553194|NCT04380701|466320610|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553195|NCT04380701|466320611|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553196|NCT04380701|466320612|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553197|NCT04380701|466320613|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553198|NCT04380701|466320614|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
129553199|NCT04380701|466320615|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
129553200|NCT04380701|466320616|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
129553201|NCT04380701|466320617|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
129553202|NCT04380701|466320618|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553203|NCT04380701|466320619|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553204|NCT04380701|466320620|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553205|NCT04380701|466320621|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553206|NCT04380701|466320622|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553207|NCT04380701|466320623|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553208|NCT04380701|466320624|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553209|NCT04380701|466320625|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553210|NCT04380701|466320626|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
129553211|NCT00383019|466320627|FG000|Overall Study|Adverse Event|5|||
129553212|NCT00383019|466320628|FG001|Overall Study|Adverse Event|1|||
129553213|NCT00383019|466320627|FG000|Overall Study|Withdrawal by Subject|0|||
129553214|NCT00383019|466320628|FG001|Overall Study|Withdrawal by Subject|1|||
129553215|NCT00789828|466320631|FG000|Core Period (48 Weeks)|Administrative problems|0|||
129553216|NCT00789828|466320632|FG001|Core Period (48 Weeks)|Administrative problems|1|||
129553217|NCT00789828|466320631|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
129553218|NCT00789828|466320632|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
129553219|NCT00789828|466320631|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
129553220|NCT00789828|466320632|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
129553221|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
129553222|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
129553223|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
129553224|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
129553225|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
129553226|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
129553227|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
129553228|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
129686109|NCT01991314|466807661|FG000|Overall Study|Lost to Follow-up|6|||
129686110|NCT01991314|466807662|FG001|Overall Study|Lost to Follow-up|10|||
129686111|NCT00970944|466807663|FG000|Overall Study|Death|1|||
129686112|NCT00970944|466807664|FG001|Overall Study|Death|0|||
129686113|NCT00970944|466807663|FG000|Overall Study|Physician Decision|0|||
129686114|NCT00970944|466807664|FG001|Overall Study|Physician Decision|2|||
129686115|NCT00662259|466807665|FG000|Overall Study|Adverse Event|2|||
129686116|NCT00662259|466807666|FG001|Overall Study|Adverse Event|0|||
129686117|NCT01033942|466807667|FG000|Overall Study|Withdrawal by Subject|1|||
129686118|NCT01033942|466807668|FG001|Overall Study|Withdrawal by Subject|1|||
129686119|NCT01033942|466807669|FG002|Overall Study|Withdrawal by Subject|1|||
129686120|NCT01033942|466807667|FG000|Overall Study|Lost to Follow-up|1|||
129774967|NCT00998296|467141161|FG002|Overall Study|Refused to continue taking trial med.|0|||
129553229|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|Death|1|||
129553230|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|Death|0|||
129553231|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
129553232|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
129553233|NCT00789828|466320631|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
129553234|NCT00789828|466320632|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
129553235|NCT05788237|466320633|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
129553236|NCT05788237|466320634|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
129553237|NCT05788237|466320635|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
129553238|NCT05788237|466320636|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
129553239|NCT05788237|466320633|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
129553240|NCT05788237|466320634|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
129553241|NCT05788237|466320635|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
129553242|NCT05788237|466320636|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
129553243|NCT05788237|466320633|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
129553244|NCT05788237|466320634|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
129553245|NCT05788237|466320635|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
129553246|NCT05788237|466320636|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
129553247|NCT05788237|466320633|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
129553248|NCT05788237|466320634|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
129553249|NCT05788237|466320635|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
129553250|NCT05788237|466320636|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
129553251|NCT05788237|466320633|FG000|SSA (Approximately 2 Months)|Death|0|||
129553252|NCT05788237|466320634|FG001|SSA (Approximately 2 Months)|Death|1|||
129553253|NCT05788237|466320635|FG002|SSA (Approximately 2 Months)|Death|0|||
129553254|NCT05788237|466320636|FG003|SSA (Approximately 2 Months)|Death|0|||
129553255|NCT05788237|466320633|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
129553256|NCT05788237|466320634|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
129553257|NCT05788237|466320635|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
129553258|NCT05788237|466320636|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
129553259|NCT05788237|466320633|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
129553260|NCT05788237|466320634|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
129553261|NCT05788237|466320635|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
129553262|NCT05788237|466320636|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
129553263|NCT05788237|466320633|FG000|SSB (Approximately 1 Month)|Other|0|||
129553264|NCT05788237|466320634|FG001|SSB (Approximately 1 Month)|Other|0|||
129553265|NCT05788237|466320635|FG002|SSB (Approximately 1 Month)|Other|0|||
129553266|NCT05788237|466320636|FG003|SSB (Approximately 1 Month)|Other|1|||
129553267|NCT02842086|466320637|FG000|Overall Study|Randomized but Never Treated|6|||
129553268|NCT02842086|466320638|FG001|Overall Study|Randomized but Never Treated|6|||
129553269|NCT02842086|466320637|FG000|Overall Study|Still in Double-Blind Phase|7|||
129553270|NCT02842086|466320638|FG001|Overall Study|Still in Double-Blind Phase|3|||
129553271|NCT02842086|466320637|FG000|Overall Study|Adverse Event|18|||
129553272|NCT02842086|466320638|FG001|Overall Study|Adverse Event|20|||
129553273|NCT02842086|466320637|FG000|Overall Study|Death|3|||
129553274|NCT02842086|466320638|FG001|Overall Study|Death|3|||
129553275|NCT02842086|466320637|FG000|Overall Study|Investigator's Discretion|9|||
129553276|NCT02842086|466320638|FG001|Overall Study|Investigator's Discretion|13|||
129553277|NCT02842086|466320637|FG000|Overall Study|Non-Compliance with Study Drug|9|||
129553278|NCT02842086|466320638|FG001|Overall Study|Non-Compliance with Study Drug|8|||
129553279|NCT02842086|466320637|FG000|Overall Study|Protocol Violation|8|||
129553280|NCT02842086|466320638|FG001|Overall Study|Protocol Violation|4|||
129553281|NCT02842086|466320637|FG000|Overall Study|Withdrew Consent|205|||
129553282|NCT02842086|466320638|FG001|Overall Study|Withdrew Consent|194|||
129553283|NCT02842086|466320637|FG000|Overall Study|Lost to Follow-up|274|||
129553284|NCT02842086|466320638|FG001|Overall Study|Lost to Follow-up|236|||
129553285|NCT02842086|466320637|FG000|Overall Study|HIV-1 Infection|5|||
129553286|NCT02842086|466320638|FG001|Overall Study|HIV-1 Infection|6|||
129553287|NCT03751124|466320639|FG000|Overall Study|Adverse Event|4|||
129553288|NCT03751124|466320640|FG001|Overall Study|Adverse Event|3|||
129553289|NCT03751124|466320639|FG000|Overall Study|Protocol Deviation|0|||
129553290|NCT03751124|466320640|FG001|Overall Study|Protocol Deviation|1|||
129553291|NCT03751124|466320639|FG000|Overall Study|Lost to Follow-up|6|||
129553292|NCT03751124|466320640|FG001|Overall Study|Lost to Follow-up|4|||
129553293|NCT03751124|466320639|FG000|Overall Study|Withdrawal by Subject|6|||
129553294|NCT03751124|466320640|FG001|Overall Study|Withdrawal by Subject|8|||
129553295|NCT03751124|466320639|FG000|Overall Study|Lack of Efficacy|1|||
129553296|NCT03751124|466320640|FG001|Overall Study|Lack of Efficacy|1|||
129553297|NCT03751124|466320639|FG000|Overall Study|Pregnancy|0|||
129553298|NCT03751124|466320640|FG001|Overall Study|Pregnancy|1|||
129553299|NCT03751124|466320639|FG000|Overall Study|Other|9|||
129553300|NCT03751124|466320640|FG001|Overall Study|Other|9|||
129553301|NCT03751124|466320639|FG000|Overall Study|Participants who did not receive any study drug|0|||
129553302|NCT03751124|466320640|FG001|Overall Study|Participants who did not receive any study drug|1|||
129553303|NCT00555399|466320643|FG000|Overall Study|Withdrawal by Subject|0|||
129553304|NCT00555399|466320644|FG001|Overall Study|Withdrawal by Subject|0|||
129553305|NCT00555399|466320645|FG002|Overall Study|Withdrawal by Subject|1|||
129553306|NCT00555399|466320646|FG003|Overall Study|Withdrawal by Subject|0|||
129553307|NCT00555399|466320647|FG004|Overall Study|Withdrawal by Subject|0|||
129553308|NCT00555399|466320648|FG005|Overall Study|Withdrawal by Subject|0|||
129553309|NCT00555399|466320649|FG006|Overall Study|Withdrawal by Subject|0|||
129553310|NCT00555399|466320650|FG007|Overall Study|Withdrawal by Subject|0|||
129553311|NCT00555399|466320651|FG008|Overall Study|Withdrawal by Subject|0|||
129553312|NCT00555399|466320652|FG009|Overall Study|Withdrawal by Subject|0|||
129553313|NCT00555399|466320653|FG010|Overall Study|Withdrawal by Subject|0|||
129553314|NCT00555399|466320654|FG011|Overall Study|Withdrawal by Subject|1|||
129553315|NCT00555399|466320643|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
129553316|NCT00555399|466320644|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
129553317|NCT00555399|466320645|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
129553318|NCT00555399|466320646|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
129553319|NCT00555399|466320647|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
129553320|NCT00555399|466320648|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
129553321|NCT00555399|466320649|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
129553322|NCT00555399|466320650|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
129553323|NCT00555399|466320651|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
129553324|NCT00555399|466320652|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
129553325|NCT00555399|466320653|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
129553326|NCT00555399|466320654|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
129553327|NCT01011907|466322038|FG000|Overall Study|Withdrawal by Subject|13|||
129553328|NCT01011907|466322039|FG001|Overall Study|Withdrawal by Subject|11|||
129553329|NCT01011907|466322038|FG000|Overall Study|Adverse Event|1|||
129553330|NCT01011907|466322039|FG001|Overall Study|Adverse Event|4|||
129553331|NCT01406873|466322050|FG000|Overall Study|Withdrawal by Subject|1|||
129553332|NCT01406873|466322051|FG001|Overall Study|Withdrawal by Subject|1|||
129553333|NCT00207714|466322052|FG000|Overall Study|Adverse Event|6|||
129553334|NCT00207714|466322053|FG001|Overall Study|Adverse Event|2|||
129553335|NCT00207714|466322054|FG002|Overall Study|Adverse Event|4|||
129553336|NCT00207714|466322055|FG003|Overall Study|Adverse Event|3|||
129553337|NCT00207714|466322056|FG004|Overall Study|Adverse Event|1|||
129553338|NCT00207714|466322052|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129553339|NCT00207714|466322053|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129553340|NCT00207714|466322054|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
129553341|NCT00207714|466322055|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
129553342|NCT00207714|466322056|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
129553343|NCT00207714|466322052|FG000|Overall Study|Other|3|||
129553344|NCT00207714|466322053|FG001|Overall Study|Other|2|||
129553345|NCT00207714|466322054|FG002|Overall Study|Other|5|||
129553346|NCT00207714|466322055|FG003|Overall Study|Other|1|||
129553347|NCT00207714|466322056|FG004|Overall Study|Other|0|||
129553348|NCT03627195|466322057|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
129553349|NCT03627195|466322058|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
129553350|NCT03627195|466322059|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
129553351|NCT03627195|466322060|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
129553352|NCT03627195|466322061|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
129553353|NCT03627195|466322062|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
129553354|NCT00736099|466322065|FG000|Overall Study|Adverse Event|61|||
129553355|NCT00736099|466322066|FG001|Overall Study|Adverse Event|18|||
129553356|NCT00736099|466322065|FG000|Overall Study|Protocol Violation|10|||
129553357|NCT00736099|466322066|FG001|Overall Study|Protocol Violation|4|||
129553358|NCT00736099|466322065|FG000|Overall Study|Lost to Follow-up|12|||
129553359|NCT00736099|466322066|FG001|Overall Study|Lost to Follow-up|5|||
129553360|NCT00736099|466322065|FG000|Overall Study|Withdrawal by Subject|42|||
129553361|NCT00736099|466322066|FG001|Overall Study|Withdrawal by Subject|13|||
129553362|NCT00736099|466322065|FG000|Overall Study|Lack of Efficacy|15|||
129553363|NCT00736099|466322066|FG001|Overall Study|Lack of Efficacy|8|||
129553364|NCT00736099|466322065|FG000|Overall Study|Other reason|43|||
129553365|NCT00736099|466322066|FG001|Overall Study|Other reason|10|||
129553366|NCT00833547|466322070|FG000|Overall Study|Withdrawal by Subject|2|||
129553367|NCT00833547|466322071|FG001|Overall Study|Withdrawal by Subject|2|||
129553368|NCT00686790|466322076|FG000|Overall Study|Adverse Event|2|||
129553369|NCT00686790|466322076|FG000|Overall Study|Withdrawal by Subject|1|||
129553370|NCT00686790|466322076|FG000|Overall Study|Death|1|||
129553371|NCT00686790|466322076|FG000|Overall Study|Lost to Follow-up|12|||
129553372|NCT01835132|466322077|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
129553373|NCT00856778|466322078|FG000|Overall Study|Adverse Event|7|||
129553374|NCT00856778|466322078|FG000|Overall Study|Withdrawal by Subject|10|||
129553375|NCT00856778|466322078|FG000|Overall Study|Study deviation|2|||
129553376|NCT00856778|466322078|FG000|Overall Study|Lost to Follow-up|5|||
129553377|NCT02140164|466322079|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
129553378|NCT00686374|466322094|FG000|Overall Study|Lack of Efficacy|10|||
129553379|NCT00686374|466322094|FG000|Overall Study|Adverse Event|8|||
129553380|NCT00686374|466322094|FG000|Overall Study|Withdrew consent|5|||
129553381|NCT00686374|466322094|FG000|Overall Study|Lost to Follow-up|1|||
129553382|NCT00686374|466322094|FG000|Overall Study|Missing reason|33|||
129553383|NCT00686374|466322094|FG000|Overall Study|Other, not specified|4|||
129553384|NCT01070966|466322095|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
129553385|NCT01070966|466322095|FG000|Participants for Safety Evaluation|Off-label use|9|||
129686121|NCT01033942|466807668|FG001|Overall Study|Lost to Follow-up|0|||
129686122|NCT01033942|466807669|FG002|Overall Study|Lost to Follow-up|0|||
129774968|NCT00998296|467141162|FG003|Overall Study|Refused to continue taking trial med.|0|||
129774969|NCT00998296|467141163|FG004|Overall Study|Refused to continue taking trial med.|0|||
129774970|NCT00998296|467141164|FG005|Overall Study|Refused to continue taking trial med.|0|||
129774971|NCT00998296|467141165|FG006|Overall Study|Refused to continue taking trial med.|0|||
129774972|NCT00998296|467141166|FG007|Overall Study|Refused to continue taking trial med.|0|||
129774973|NCT00998296|467141167|FG008|Overall Study|Refused to continue taking trial med.|0|||
129774974|NCT00998296|467141168|FG009|Overall Study|Refused to continue taking trial med.|2|||
129774975|NCT00998296|467141169|FG010|Overall Study|Refused to continue taking trial med.|0|||
129774976|NCT00998296|467141159|FG000|Overall Study|Reason other than those specified above|0|||
129774977|NCT00998296|467141160|FG001|Overall Study|Reason other than those specified above|0|||
129774978|NCT00998296|467141161|FG002|Overall Study|Reason other than those specified above|0|||
129774979|NCT00998296|467141162|FG003|Overall Study|Reason other than those specified above|0|||
129774980|NCT00998296|467141163|FG004|Overall Study|Reason other than those specified above|0|||
129774981|NCT00998296|467141164|FG005|Overall Study|Reason other than those specified above|0|||
129774982|NCT00998296|467141165|FG006|Overall Study|Reason other than those specified above|0|||
129774983|NCT00998296|467141166|FG007|Overall Study|Reason other than those specified above|0|||
129774984|NCT00998296|467141167|FG008|Overall Study|Reason other than those specified above|0|||
129774985|NCT00998296|467141168|FG009|Overall Study|Reason other than those specified above|1|||
129774986|NCT00998296|467141169|FG010|Overall Study|Reason other than those specified above|0|||
129774987|NCT01544335|467141172|FG000|Overall Study|Lost to Follow-up|27|||
129774988|NCT01544335|467141172|FG000|Overall Study|Death|4|||
129774989|NCT01544335|467141172|FG000|Overall Study|Disease progression|3|||
129774990|NCT01544335|467141172|FG000|Overall Study|Baseline Measurements not Available|19|||
129774991|NCT03219528|467141173|FG000|Overall Study|Lost to Follow-up|5|||
129774992|NCT03219528|467141174|FG001|Overall Study|Lost to Follow-up|4|||
129774993|NCT03219528|467141173|FG000|Overall Study|Withdrawal by Subject|4|||
129774994|NCT03219528|467141174|FG001|Overall Study|Withdrawal by Subject|4|||
129774995|NCT02120898|467141177|FG000|Overall Study|Withdrawal by Subject|4|||
129774996|NCT02120898|467141178|FG001|Overall Study|Withdrawal by Subject|2|||
129774997|NCT02120898|467141179|FG002|Overall Study|Withdrawal by Subject|2|||
129774998|NCT02120898|467141177|FG000|Overall Study|Non-compliance with study drug|3|||
129774999|NCT02120898|467141178|FG001|Overall Study|Non-compliance with study drug|0|||
129775000|NCT02120898|467141179|FG002|Overall Study|Non-compliance with study drug|0|||
129775001|NCT02120898|467141177|FG000|Overall Study|Adverse Event|1|||
129775002|NCT02120898|467141178|FG001|Overall Study|Adverse Event|2|||
129775003|NCT02120898|467141179|FG002|Overall Study|Adverse Event|1|||
129775004|NCT02120898|467141177|FG000|Overall Study|Protocol Violation|1|||
129775005|NCT02120898|467141178|FG001|Overall Study|Protocol Violation|2|||
129775006|NCT02120898|467141179|FG002|Overall Study|Protocol Violation|0|||
129775007|NCT02120898|467141177|FG000|Overall Study|Lost to Follow-up|0|||
129775008|NCT02120898|467141178|FG001|Overall Study|Lost to Follow-up|0|||
129775009|NCT02120898|467141179|FG002|Overall Study|Lost to Follow-up|1|||
129775010|NCT00043979|467141180|FG000|Period 1|recipient with progressive disease|7|||
129775011|NCT00043979|467141181|FG001|Period 1|recipient with progressive disease|4|||
129775012|NCT00043979|467141182|FG002|Period 1|recipient with progressive disease|3|||
129775013|NCT04085289|467141183|FG000|Overall Study|Withdrawal by Subject|0|||
129775014|NCT04085289|467141184|FG001|Overall Study|Withdrawal by Subject|0|||
129775015|NCT04085289|467141185|FG002|Overall Study|Withdrawal by Subject|1|||
129775016|NCT02919995|467141189|FG000|Overall Study|Adverse Event|0|||
129775017|NCT02919995|467141190|FG001|Overall Study|Adverse Event|0|||
129775018|NCT02919995|467141191|FG002|Overall Study|Adverse Event|0|||
129775019|NCT02919995|467141192|FG003|Overall Study|Adverse Event|0|||
129775020|NCT02919995|467141193|FG004|Overall Study|Adverse Event|0|||
129775021|NCT02919995|467141194|FG005|Overall Study|Adverse Event|1|||
129775022|NCT02560558|467141195|FG000|Overall Study|Adverse Event|1|||
129775023|NCT02560558|467141196|FG001|Overall Study|Adverse Event|0|||
129775024|NCT02560558|467141195|FG000|Overall Study|Death|0|||
129775025|NCT02560558|467141196|FG001|Overall Study|Death|2|||
129775026|NCT02560558|467141195|FG000|Overall Study|Lost to Follow-up|0|||
129775027|NCT02560558|467141196|FG001|Overall Study|Lost to Follow-up|4|||
129775028|NCT02560558|467141195|FG000|Overall Study|Protocol Violation|3|||
129775029|NCT02560558|467141196|FG001|Overall Study|Protocol Violation|0|||
129775030|NCT02560558|467141195|FG000|Overall Study|Withdrawal by Subject|3|||
129775031|NCT02560558|467141196|FG001|Overall Study|Withdrawal by Subject|0|||
129775032|NCT02454517|467141203|FG000|Overall Study|Withdrawal by Subject|3|||
129775033|NCT02454517|467141204|FG001|Overall Study|Withdrawal by Subject|0|||
129775034|NCT02454517|467141203|FG000|Overall Study|Lost to Follow-up|4|||
129775035|NCT02454517|467141204|FG001|Overall Study|Lost to Follow-up|7|||
129775036|NCT02454517|467141203|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
129775037|NCT02454517|467141204|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
129775038|NCT00473382|467141205|FG000|Core Study|Adverse Event|3|||
129775039|NCT00473382|467141206|FG001|Core Study|Adverse Event|1|||
129775040|NCT00473382|467141207|FG002|Core Study|Adverse Event|1|||
129775041|NCT00473382|467141205|FG000|Core Study|Death|3|||
129775042|NCT00473382|467141206|FG001|Core Study|Death|5|||
129775043|NCT00473382|467141207|FG002|Core Study|Death|10|||
129775044|NCT00473382|467141205|FG000|Core Study|Lost to Follow-up|3|||
129775045|NCT00473382|467141206|FG001|Core Study|Lost to Follow-up|3|||
129775046|NCT00473382|467141207|FG002|Core Study|Lost to Follow-up|3|||
129775047|NCT00473382|467141205|FG000|Core Study|Physician Decision|1|||
129775048|NCT00473382|467141206|FG001|Core Study|Physician Decision|2|||
129775049|NCT00473382|467141207|FG002|Core Study|Physician Decision|2|||
129775050|NCT00473382|467141205|FG000|Core Study|Subject non-compliance|5|||
129775051|NCT00473382|467141206|FG001|Core Study|Subject non-compliance|2|||
129775052|NCT00473382|467141207|FG002|Core Study|Subject non-compliance|1|||
129775053|NCT00473382|467141205|FG000|Core Study|Subject needed other treatment|1|||
129775054|NCT00473382|467141206|FG001|Core Study|Subject needed other treatment|3|||
129775055|NCT00473382|467141207|FG002|Core Study|Subject needed other treatment|2|||
129775056|NCT00473382|467141205|FG000|Core Study|Subject's decision|12|||
129775057|NCT00473382|467141206|FG001|Core Study|Subject's decision|11|||
129775058|NCT00473382|467141207|FG002|Core Study|Subject's decision|10|||
129775059|NCT00473382|467141205|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
129775060|NCT00473382|467141206|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
129775061|NCT00473382|467141207|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
129775062|NCT00473382|467141205|FG000|Open-label Extension Through Month 48|Death|1|||
129775063|NCT00473382|467141206|FG001|Open-label Extension Through Month 48|Death|3|||
129775064|NCT00473382|467141207|FG002|Open-label Extension Through Month 48|Death|3|||
129775065|NCT00473382|467141205|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
129775066|NCT00473382|467141206|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
129775067|NCT00473382|467141207|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
129775068|NCT00473382|467141205|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
129775069|NCT00473382|467141206|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
129775070|NCT00473382|467141207|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
129775071|NCT00473382|467141205|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
129775072|NCT00473382|467141206|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
129775073|NCT00473382|467141207|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
129775074|NCT00473382|467141205|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
129775075|NCT00473382|467141206|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
129775076|NCT00473382|467141207|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
129775077|NCT00473382|467141205|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
129775078|NCT00473382|467141206|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
129775079|NCT00473382|467141207|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
129775080|NCT00473382|467141205|FG000|Open-label Extension Through Month 60|Death|1|||
129775081|NCT00473382|467141206|FG001|Open-label Extension Through Month 60|Death|7|||
129775082|NCT00473382|467141207|FG002|Open-label Extension Through Month 60|Death|4|||
129775083|NCT00473382|467141205|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
129775084|NCT00473382|467141206|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
129775085|NCT00473382|467141207|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
129775086|NCT00473382|467141205|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
129775087|NCT00473382|467141206|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
129775088|NCT00473382|467141207|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
129775089|NCT00473382|467141205|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
129775090|NCT00473382|467141206|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
129775091|NCT00473382|467141207|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
129775092|NCT00473382|467141205|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
129775093|NCT00473382|467141206|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
129775094|NCT00473382|467141207|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
129775095|NCT01134055|467141208|FG000|Overall Study|Adverse Event|5|||
129775096|NCT01134055|467141209|FG001|Overall Study|Adverse Event|2|||
129775097|NCT01134055|467141210|FG002|Overall Study|Adverse Event|2|||
129775098|NCT01134055|467141211|FG003|Overall Study|Adverse Event|2|||
129775099|NCT01134055|467141212|FG004|Overall Study|Adverse Event|5|||
129775100|NCT01134055|467141213|FG005|Overall Study|Adverse Event|7|||
129775101|NCT01134055|467141214|FG006|Overall Study|Adverse Event|2|||
129884465|NCT02038764|467536409|FG001|Overall Study|Adverse Event|0|||
129775102|NCT01134055|467141208|FG000|Overall Study|Lost to Follow-up|0|||
129775103|NCT01134055|467141209|FG001|Overall Study|Lost to Follow-up|1|||
129884466|NCT02038764|467536410|FG002|Overall Study|Adverse Event|1|||
129884467|NCT02038764|467536411|FG003|Overall Study|Adverse Event|0|||
129553386|NCT01070966|466322095|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
129553387|NCT01070966|466322095|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
129553388|NCT01070966|466322095|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
129553389|NCT01070966|466322095|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
129553390|NCT01070966|466322095|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
129553391|NCT01070966|466322095|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
129553392|NCT02770716|466322096|FG000|Overall Study|Death|101|||
129553393|NCT02770716|466322097|FG001|Overall Study|Death|45|||
129553394|NCT02770716|466322096|FG000|Overall Study|Withdrawal by Subject|4|||
129553395|NCT02770716|466322097|FG001|Overall Study|Withdrawal by Subject|2|||
129553396|NCT02770716|466322096|FG000|Overall Study|Lost to Follow-up|1|||
129553397|NCT02770716|466322097|FG001|Overall Study|Lost to Follow-up|0|||
129553398|NCT02770716|466322096|FG000|Overall Study|Various reasons|6|||
129553399|NCT02770716|466322097|FG001|Overall Study|Various reasons|2|||
129553400|NCT01725113|466322098|FG000|Overall Study|Kidney Transplant|1|||
129553401|NCT01725113|466322099|FG001|Overall Study|Kidney Transplant|1|||
129553402|NCT01725113|466322098|FG000|Overall Study|Withdrawal by Subject|0|||
129553403|NCT01725113|466322099|FG001|Overall Study|Withdrawal by Subject|1|||
129553404|NCT03989115|466322100|FG000|Overall Study|Withdrawal by Subject|2|||
129553405|NCT03989115|466322101|FG001|Overall Study|Withdrawal by Subject|1|||
129553406|NCT03989115|466322102|FG002|Overall Study|Withdrawal by Subject|3|||
129553407|NCT03989115|466322103|FG003|Overall Study|Withdrawal by Subject|0|||
129553408|NCT03989115|466322104|FG004|Overall Study|Withdrawal by Subject|17|||
129553409|NCT03989115|466322105|FG005|Overall Study|Withdrawal by Subject|1|||
129553410|NCT03989115|466322106|FG006|Overall Study|Withdrawal by Subject|0|||
129553411|NCT03989115|466322107|FG007|Overall Study|Withdrawal by Subject|0|||
129553412|NCT03989115|466322100|FG000|Overall Study|Sponsor decision to terminate the study|1|||
129553413|NCT03989115|466322101|FG001|Overall Study|Sponsor decision to terminate the study|1|||
129553414|NCT03989115|466322102|FG002|Overall Study|Sponsor decision to terminate the study|0|||
129553415|NCT03989115|466322103|FG003|Overall Study|Sponsor decision to terminate the study|1|||
129553416|NCT03989115|466322104|FG004|Overall Study|Sponsor decision to terminate the study|11|||
129553417|NCT03989115|466322105|FG005|Overall Study|Sponsor decision to terminate the study|0|||
129553418|NCT03989115|466322106|FG006|Overall Study|Sponsor decision to terminate the study|2|||
129553419|NCT03989115|466322107|FG007|Overall Study|Sponsor decision to terminate the study|1|||
129553420|NCT03989115|466322100|FG000|Overall Study|Lost to Follow-up|2|||
129553421|NCT03989115|466322101|FG001|Overall Study|Lost to Follow-up|0|||
129553422|NCT03989115|466322102|FG002|Overall Study|Lost to Follow-up|0|||
129553423|NCT03989115|466322103|FG003|Overall Study|Lost to Follow-up|0|||
129553424|NCT03989115|466322104|FG004|Overall Study|Lost to Follow-up|1|||
129553425|NCT03989115|466322105|FG005|Overall Study|Lost to Follow-up|0|||
129553426|NCT03989115|466322106|FG006|Overall Study|Lost to Follow-up|0|||
129553427|NCT03989115|466322107|FG007|Overall Study|Lost to Follow-up|0|||
129553428|NCT03989115|466322100|FG000|Overall Study|Death|2|||
129553429|NCT03989115|466322101|FG001|Overall Study|Death|2|||
129553430|NCT03989115|466322102|FG002|Overall Study|Death|9|||
129553431|NCT03989115|466322103|FG003|Overall Study|Death|6|||
129553432|NCT03989115|466322104|FG004|Overall Study|Death|31|||
129553433|NCT03989115|466322105|FG005|Overall Study|Death|6|||
129553434|NCT03989115|466322106|FG006|Overall Study|Death|2|||
129553435|NCT03989115|466322107|FG007|Overall Study|Death|3|||
129553436|NCT03989115|466322100|FG000|Overall Study|Other|1|||
129553437|NCT03989115|466322101|FG001|Overall Study|Other|2|||
129553438|NCT03989115|466322102|FG002|Overall Study|Other|0|||
129553439|NCT03989115|466322103|FG003|Overall Study|Other|0|||
129553440|NCT03989115|466322104|FG004|Overall Study|Other|5|||
129553441|NCT03989115|466322105|FG005|Overall Study|Other|0|||
129686123|NCT01033942|466807667|FG000|Overall Study|Enrolled in Extension Study|0|||
129686124|NCT01033942|466807668|FG001|Overall Study|Enrolled in Extension Study|3|||
129686125|NCT01033942|466807669|FG002|Overall Study|Enrolled in Extension Study|0|||
129686126|NCT02693418|466807670|FG000|Overall Study|Lost to Follow-up|1|||
129686127|NCT02693418|466807671|FG001|Overall Study|Lost to Follow-up|2|||
129686128|NCT02693418|466807672|FG002|Overall Study|Lost to Follow-up|0|||
129686129|NCT02693418|466807673|FG003|Overall Study|Lost to Follow-up|0|||
129686130|NCT02693418|466807674|FG004|Overall Study|Lost to Follow-up|0|||
129686131|NCT02693418|466807670|FG000|Overall Study|Menses during study period|0|||
129686132|NCT02693418|466807671|FG001|Overall Study|Menses during study period|0|||
129553442|NCT03989115|466322106|FG006|Overall Study|Other|0|||
129553443|NCT03989115|466322107|FG007|Overall Study|Other|0|||
129553444|NCT01808209|466322108|FG000|Overall Study|Lost to Follow-up|0|||
129553445|NCT01808209|466322109|FG001|Overall Study|Lost to Follow-up|1|||
129553446|NCT02629133|466322115|FG000|Overall Study|Lost to Follow-up|3|||
129553447|NCT02629133|466322116|FG001|Overall Study|Lost to Follow-up|1|||
129553448|NCT02629133|466322115|FG000|Overall Study|Withdrawal by Subject|1|||
129686133|NCT02693418|466807672|FG002|Overall Study|Menses during study period|2|||
129686134|NCT02693418|466807673|FG003|Overall Study|Menses during study period|0|||
129553449|NCT02629133|466322116|FG001|Overall Study|Withdrawal by Subject|1|||
129553450|NCT03216954|466322117|FG000|Overall Study|Adverse Event|0|||
129553451|NCT03216954|466322118|FG001|Overall Study|Adverse Event|0|||
129553452|NCT03216954|466322119|FG002|Overall Study|Adverse Event|1|||
129553453|NCT03216954|466322120|FG003|Overall Study|Adverse Event|0|||
129553454|NCT03216954|466322121|FG004|Overall Study|Adverse Event|1|||
129553455|NCT03216954|466322117|FG000|Overall Study|Withdrawal by Subject|2|||
129553456|NCT03216954|466322118|FG001|Overall Study|Withdrawal by Subject|0|||
129553457|NCT03216954|466322119|FG002|Overall Study|Withdrawal by Subject|0|||
129553458|NCT03216954|466322120|FG003|Overall Study|Withdrawal by Subject|0|||
129553459|NCT03216954|466322121|FG004|Overall Study|Withdrawal by Subject|0|||
129553460|NCT03216954|466322117|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
129553461|NCT03216954|466322118|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
129553462|NCT03216954|466322119|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
129553463|NCT03216954|466322120|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
129553464|NCT03216954|466322121|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
129553465|NCT01507831|466322122|FG000|Overall Study|Randomized but not treated|0|||
129553466|NCT01507831|466322123|FG001|Overall Study|Randomized but not treated|3|||
129553467|NCT01507831|466322122|FG000|Overall Study|Adverse Event|48|||
129553468|NCT01507831|466322123|FG001|Overall Study|Adverse Event|113|||
129553469|NCT01507831|466322122|FG000|Overall Study|Death|6|||
129553470|NCT01507831|466322123|FG001|Overall Study|Death|2|||
129553471|NCT01507831|466322122|FG000|Overall Study|Poor compliance to protocol|38|||
129553472|NCT01507831|466322123|FG001|Overall Study|Poor compliance to protocol|60|||
129553473|NCT01507831|466322122|FG000|Overall Study|Physician Decision|0|||
129553474|NCT01507831|466322123|FG001|Overall Study|Physician Decision|4|||
129553475|NCT01507831|466322122|FG000|Overall Study|Participant moved|5|||
129553476|NCT01507831|466322123|FG001|Overall Study|Participant moved|19|||
129553477|NCT01507831|466322122|FG000|Overall Study|Consent withdrawn by participant|34|||
129553478|NCT01507831|466322123|FG001|Overall Study|Consent withdrawn by participant|72|||
129553479|NCT01507831|466322122|FG000|Overall Study|Related to study drug administration|5|||
129553480|NCT01507831|466322123|FG001|Overall Study|Related to study drug administration|14|||
129553481|NCT01507831|466322122|FG000|Overall Study|Last visit outside protocol visit window|51|||
129553482|NCT01507831|466322123|FG001|Overall Study|Last visit outside protocol visit window|143|||
129553483|NCT01507831|466322122|FG000|Overall Study|Selection criteria finally not met|0|||
129553484|NCT01507831|466322123|FG001|Overall Study|Selection criteria finally not met|1|||
129686135|NCT02693418|466807674|FG004|Overall Study|Menses during study period|0|||
129775104|NCT01134055|467141210|FG002|Overall Study|Lost to Follow-up|0|||
129775105|NCT01134055|467141211|FG003|Overall Study|Lost to Follow-up|1|||
129553485|NCT01507831|466322122|FG000|Overall Study|Site closure|0|||
129686136|NCT01750346|466807676|FG000|Overall Study|Adverse Event|1|||
129686137|NCT01750346|466807677|FG001|Overall Study|Adverse Event|0|||
129686138|NCT01750346|466807678|FG002|Overall Study|Adverse Event|0|||
129686139|NCT02260986|466807679|FG000|Overall Study|Adverse Event|24|||
129686140|NCT02260986|466807680|FG001|Overall Study|Adverse Event|0|||
129686141|NCT02260986|466807681|FG002|Overall Study|Adverse Event|11|||
129686142|NCT02260986|466807679|FG000|Overall Study|Lack of Efficacy|27|||
129686143|NCT02260986|466807680|FG001|Overall Study|Lack of Efficacy|3|||
129686144|NCT02260986|466807681|FG002|Overall Study|Lack of Efficacy|0|||
129686145|NCT02260986|466807679|FG000|Overall Study|Protocol Violation|14|||
129686146|NCT02260986|466807680|FG001|Overall Study|Protocol Violation|5|||
129686147|NCT02260986|466807681|FG002|Overall Study|Protocol Violation|16|||
129686148|NCT02260986|466807679|FG000|Overall Study|Car accident|0|||
129686149|NCT02260986|466807680|FG001|Overall Study|Car accident|0|||
129686150|NCT02260986|466807681|FG002|Overall Study|Car accident|1|||
129686151|NCT02260986|466807679|FG000|Overall Study|Withdrawal by Subject|17|||
129686152|NCT02260986|466807680|FG001|Overall Study|Withdrawal by Subject|4|||
129686153|NCT02260986|466807681|FG002|Overall Study|Withdrawal by Subject|9|||
129686154|NCT02260986|466807679|FG000|Overall Study|Incorrect randomization|0|||
129686155|NCT02260986|466807680|FG001|Overall Study|Incorrect randomization|1|||
129686156|NCT02260986|466807681|FG002|Overall Study|Incorrect randomization|0|||
129686157|NCT02260986|466807679|FG000|Overall Study|Lack of investigation product supply|2|||
129775106|NCT01134055|467141212|FG004|Overall Study|Lost to Follow-up|0|||
129775107|NCT01134055|467141213|FG005|Overall Study|Lost to Follow-up|0|||
129775108|NCT01134055|467141214|FG006|Overall Study|Lost to Follow-up|0|||
129553486|NCT01507831|466322123|FG001|Overall Study|Site closure|3|||
129553487|NCT01507831|466322122|FG000|Overall Study|Potential lost to follow-up|3|||
129553488|NCT01507831|466322123|FG001|Overall Study|Potential lost to follow-up|0|||
129553489|NCT01507831|466322122|FG000|Overall Study|Other|3|||
129553490|NCT01507831|466322123|FG001|Overall Study|Other|6|||
129686158|NCT02260986|466807680|FG001|Overall Study|Lack of investigation product supply|0|||
129686159|NCT02260986|466807681|FG002|Overall Study|Lack of investigation product supply|1|||
129686160|NCT02260986|466807679|FG000|Overall Study|Lost to Follow-up|4|||
129686161|NCT02260986|466807680|FG001|Overall Study|Lost to Follow-up|0|||
129686162|NCT02260986|466807681|FG002|Overall Study|Lost to Follow-up|3|||
129553491|NCT01610167|466322124|FG000|Overall Study|Scheduling conflict.|0|||
129553492|NCT01610167|466322125|FG001|Overall Study|Scheduling conflict.|0|||
129553493|NCT01610167|466322126|FG002|Overall Study|Scheduling conflict.|2|||
129553494|NCT03296553|466322128|FG000|Overall Study|Withdrawal by Subject|1|||
129553495|NCT03296553|466322129|FG001|Overall Study|Withdrawal by Subject|1|||
129553496|NCT03296553|466322128|FG000|Overall Study|Death|1|||
129553497|NCT03296553|466322129|FG001|Overall Study|Death|0|||
129553498|NCT02295280|466322130|FG000|Overall Study|Adverse Event|0|||
129553499|NCT02295280|466322131|FG001|Overall Study|Adverse Event|1|||
129553500|NCT02713243|466322132|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
129553501|NCT02713243|466322133|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
129553502|NCT02713243|466322132|FG000|Overall Study|Administrative problems|0|||
129553503|NCT02713243|466322133|FG001|Overall Study|Administrative problems|1|||
129553504|NCT02713243|466322132|FG000|Overall Study|Protocol deviation|0|||
129553505|NCT02713243|466322133|FG001|Overall Study|Protocol deviation|1|||
129553506|NCT00124449|466322134|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
129553507|NCT00124449|466322135|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
129553508|NCT00124449|466322134|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
129553509|NCT00124449|466322135|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
129553510|NCT00124449|466322134|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
129553511|NCT00124449|466322135|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
129553512|NCT00124449|466322134|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
129553513|NCT00124449|466322135|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
129553514|NCT00124449|466322134|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
129553515|NCT00124449|466322135|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
129553516|NCT00124449|466322134|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
129553517|NCT00124449|466322135|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
129553518|NCT00124449|466322134|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
129553519|NCT00124449|466322135|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
129553520|NCT00124449|466322134|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
129553521|NCT00124449|466322135|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
129553522|NCT00124449|466322134|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
129553523|NCT00124449|466322135|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
129553524|NCT00124449|466322134|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
129553525|NCT00124449|466322135|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
129553526|NCT00124449|466322134|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
129553527|NCT00124449|466322135|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
129553528|NCT00124449|466322134|FG000|18-Month Untreated Observation Period|Relocated|1|||
129553529|NCT00124449|466322135|FG001|18-Month Untreated Observation Period|Relocated|0|||
129553530|NCT01254045|466322136|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
129553531|NCT01254045|466322137|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
129553532|NCT01254045|466322138|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
129553533|NCT01254045|466322139|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
129553534|NCT01254045|466322140|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
129553535|NCT01254045|466322141|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
129553536|NCT02971605|466322142|FG000|Overall Study|Withdrawal by Subject|1|||
129553537|NCT01021137|466322143|FG000|Overall Study|Lost to Follow-up|9|||
129553538|NCT01021137|466322144|FG001|Overall Study|Lost to Follow-up|4|||
129553539|NCT01021137|466322145|FG002|Overall Study|Lost to Follow-up|2|||
129553540|NCT01021137|466322146|FG003|Overall Study|Lost to Follow-up|6|||
129553541|NCT01021137|466322143|FG000|Overall Study|Withdrawal by Subject|1|||
129553542|NCT01021137|466322144|FG001|Overall Study|Withdrawal by Subject|0|||
129553543|NCT01021137|466322145|FG002|Overall Study|Withdrawal by Subject|0|||
129553544|NCT01021137|466322146|FG003|Overall Study|Withdrawal by Subject|3|||
129553545|NCT03439293|466322147|FG000|Overall Study|Death|22|||
129553546|NCT03439293|466322147|FG000|Overall Study|Withdrawal by Subject|8|||
129553547|NCT03439293|466322147|FG000|Overall Study|Lost to Follow-up|2|||
129686163|NCT02260986|466807679|FG000|Overall Study|Pregnancy|2|||
129686164|NCT02260986|466807680|FG001|Overall Study|Pregnancy|0|||
129686165|NCT02260986|466807681|FG002|Overall Study|Pregnancy|0|||
129686166|NCT02782468|466807684|FG000|Overall Study|Progressive Disease|2|||
129686167|NCT02782468|466807685|FG001|Overall Study|Progressive Disease|5|||
129686168|NCT02782468|466807686|FG002|Overall Study|Progressive Disease|0|||
129686169|NCT02782468|466807687|FG003|Overall Study|Progressive Disease|4|||
129686170|NCT02782468|466807684|FG000|Overall Study|Adverse Event|0|||
129686171|NCT02782468|466807685|FG001|Overall Study|Adverse Event|2|||
129553548|NCT03439293|466322147|FG000|Overall Study|Reason Not Specified|28|||
129553549|NCT03439293|466322147|FG000|Overall Study|Missing|1|||
129686172|NCT02782468|466807686|FG002|Overall Study|Adverse Event|2|||
129686173|NCT02782468|466807687|FG003|Overall Study|Adverse Event|3|||
129686174|NCT02782468|466807684|FG000|Overall Study|Other|0|||
129553550|NCT02766400|466322150|FG000|Overall Study|Death|1|||
129553551|NCT02766400|466322151|FG001|Overall Study|Death|2|||
129553552|NCT02766400|466322150|FG000|Overall Study|Withdrawal by Subject|1|||
129553553|NCT02766400|466322151|FG001|Overall Study|Withdrawal by Subject|0|||
129553554|NCT03499249|466322158|FG000|Overall Study|Physician Decision|1|||
129553555|NCT01374906|466322161|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129553556|NCT01374906|466322162|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129553557|NCT01374906|466322161|FG000|Overall Study|Administrative problems|2|||
129553558|NCT01374906|466322162|FG001|Overall Study|Administrative problems|2|||
129553559|NCT01374906|466322161|FG000|Overall Study|Adverse Event|10|||
129553560|NCT01374906|466322162|FG001|Overall Study|Adverse Event|11|||
129553561|NCT01374906|466322161|FG000|Overall Study|Death|0|||
129553562|NCT01374906|466322162|FG001|Overall Study|Death|2|||
129553563|NCT01374906|466322161|FG000|Overall Study|Protocol Violation|2|||
129553564|NCT01374906|466322162|FG001|Overall Study|Protocol Violation|2|||
129553565|NCT01374906|466322161|FG000|Overall Study|Withdrawal by Subject|15|||
129553566|NCT01374906|466322162|FG001|Overall Study|Withdrawal by Subject|9|||
129553567|NCT01374906|466322161|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
129553568|NCT01374906|466322162|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
129553569|NCT02475980|466322165|FG000|Overall Study|Lost to Follow-up|4|||
129553570|NCT02475980|466322165|FG000|Overall Study|Withdrawal by Subject|1|||
129553571|NCT00665626|466322166|FG000|Overall Study|Lack of Efficacy|8|||
129553572|NCT00665626|466322167|FG001|Overall Study|Lack of Efficacy|5|||
129553573|NCT00665626|466322166|FG000|Overall Study|Lost to Follow-up|0|||
129553574|NCT00665626|466322167|FG001|Overall Study|Lost to Follow-up|2|||
129553575|NCT00665626|466322166|FG000|Overall Study|Withdrawal by Subject|0|||
129553576|NCT00665626|466322167|FG001|Overall Study|Withdrawal by Subject|1|||
129553577|NCT00665626|466322166|FG000|Overall Study|Protocol Violation|0|||
129553578|NCT00665626|466322167|FG001|Overall Study|Protocol Violation|2|||
129553579|NCT00665626|466322166|FG000|Overall Study|Adverse Event|1|||
129553580|NCT00665626|466322167|FG001|Overall Study|Adverse Event|9|||
129553581|NCT00665626|466322166|FG000|Overall Study|Due to exclusion criteria|0|||
129553582|NCT00665626|466322167|FG001|Overall Study|Due to exclusion criteria|1|||
129553583|NCT00665626|466322166|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
129553584|NCT00665626|466322167|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
129553585|NCT00665626|466322166|FG000|Overall Study|Unably to comply with dosing regimen|0|||
129553586|NCT00665626|466322167|FG001|Overall Study|Unably to comply with dosing regimen|1|||
129553587|NCT00665626|466322166|FG000|Overall Study|Death|1|||
129553588|NCT00665626|466322167|FG001|Overall Study|Death|0|||
129553589|NCT04147611|466322168|FG000|Overall Study|Physician Decision|0|||
129553590|NCT04147611|466322169|FG001|Overall Study|Physician Decision|1|||
129553591|NCT00435825|466322170|FG000|Overall Study|Abnormality of Laboratory Test|0|||
129553592|NCT00435825|466322171|FG001|Overall Study|Abnormality of Laboratory Test|1|||
129553593|NCT00435825|466322172|FG002|Overall Study|Abnormality of Laboratory Test|0|||
129686175|NCT02782468|466807685|FG001|Overall Study|Other|0|||
129884468|NCT02038764|467536412|FG004|Overall Study|Adverse Event|0|||
129553594|NCT00435825|466322173|FG003|Overall Study|Abnormality of Laboratory Test|0|||
129553595|NCT00435825|466322170|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129553596|NCT00435825|466322171|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129553597|NCT00435825|466322172|FG002|Overall Study|Insufficient Therapeutic Response|0|||
129553598|NCT00435825|466322173|FG003|Overall Study|Insufficient Therapeutic Response|3|||
129553599|NCT00435825|466322170|FG000|Overall Study|Other Protocol Violation|1|||
129553600|NCT00435825|466322171|FG001|Overall Study|Other Protocol Violation|0|||
129553601|NCT00435825|466322172|FG002|Overall Study|Other Protocol Violation|0|||
129553602|NCT00435825|466322173|FG003|Overall Study|Other Protocol Violation|0|||
129553603|NCT00435825|466322170|FG000|Overall Study|Refused treatment|2|||
129553604|NCT00435825|466322171|FG001|Overall Study|Refused treatment|0|||
129553605|NCT00435825|466322172|FG002|Overall Study|Refused treatment|0|||
129553606|NCT00435825|466322173|FG003|Overall Study|Refused treatment|5|||
129553607|NCT00435825|466322170|FG000|Overall Study|Failure to return|5|||
129553608|NCT00435825|466322171|FG001|Overall Study|Failure to return|0|||
129553609|NCT00435825|466322172|FG002|Overall Study|Failure to return|4|||
129553610|NCT00435825|466322173|FG003|Overall Study|Failure to return|0|||
129553611|NCT00435825|466322170|FG000|Overall Study|Did not receive study drug|1|||
129553612|NCT00435825|466322171|FG001|Overall Study|Did not receive study drug|0|||
129553613|NCT00435825|466322172|FG002|Overall Study|Did not receive study drug|2|||
129553614|NCT00435825|466322173|FG003|Overall Study|Did not receive study drug|0|||
129553615|NCT00435825|466322170|FG000|Overall Study|Did not enter follow-up|0|||
129553616|NCT00435825|466322171|FG001|Overall Study|Did not enter follow-up|4|||
129775109|NCT01134055|467141208|FG000|Overall Study|Withdrawal by Subject|3|||
129775110|NCT01134055|467141209|FG001|Overall Study|Withdrawal by Subject|3|||
129775111|NCT01134055|467141210|FG002|Overall Study|Withdrawal by Subject|1|||
129775112|NCT01134055|467141211|FG003|Overall Study|Withdrawal by Subject|2|||
129775113|NCT01134055|467141212|FG004|Overall Study|Withdrawal by Subject|0|||
129775114|NCT01134055|467141213|FG005|Overall Study|Withdrawal by Subject|0|||
129775115|NCT01134055|467141214|FG006|Overall Study|Withdrawal by Subject|8|||
129775116|NCT01134055|467141208|FG000|Overall Study|Protocol Violation|0|||
129775117|NCT01134055|467141209|FG001|Overall Study|Protocol Violation|0|||
129775118|NCT01134055|467141210|FG002|Overall Study|Protocol Violation|0|||
129775119|NCT01134055|467141211|FG003|Overall Study|Protocol Violation|1|||
129775120|NCT01134055|467141212|FG004|Overall Study|Protocol Violation|1|||
129775121|NCT01134055|467141213|FG005|Overall Study|Protocol Violation|0|||
129775122|NCT01134055|467141214|FG006|Overall Study|Protocol Violation|0|||
129775123|NCT01134055|467141208|FG000|Overall Study|Physician Decision|0|||
129775124|NCT01134055|467141209|FG001|Overall Study|Physician Decision|0|||
129775125|NCT01134055|467141210|FG002|Overall Study|Physician Decision|0|||
129775126|NCT01134055|467141211|FG003|Overall Study|Physician Decision|0|||
129553617|NCT00435825|466322172|FG002|Overall Study|Did not enter follow-up|1|||
129553618|NCT00435825|466322173|FG003|Overall Study|Did not enter follow-up|3|||
129553619|NCT00435825|466322170|FG000|Overall Study|Did not complete full follow-up period|6|||
129553620|NCT00435825|466322171|FG001|Overall Study|Did not complete full follow-up period|6|||
129553621|NCT00435825|466322172|FG002|Overall Study|Did not complete full follow-up period|4|||
129553622|NCT00435825|466322173|FG003|Overall Study|Did not complete full follow-up period|5|||
129553623|NCT00530439|466322174|FG000|Overall Study|GDM|9|||
129553624|NCT00530439|466322175|FG001|Overall Study|GDM|3|||
129553625|NCT00530439|466322174|FG000|Overall Study|Withdraw|18|||
129553626|NCT00530439|466322175|FG001|Overall Study|Withdraw|14|||
129553627|NCT00530439|466322174|FG000|Overall Study|Missed abortion|1|||
129553628|NCT00530439|466322175|FG001|Overall Study|Missed abortion|4|||
129553629|NCT00530439|466322174|FG000|Overall Study|Misclassification|2|||
129553630|NCT00530439|466322175|FG001|Overall Study|Misclassification|0|||
129553631|NCT00530439|466322174|FG000|Overall Study|Twin pregnancy|0|||
129553632|NCT00530439|466322175|FG001|Overall Study|Twin pregnancy|2|||
129553633|NCT00530439|466322174|FG000|Overall Study|Severe malformation/abortion|0|||
129553634|NCT00530439|466322175|FG001|Overall Study|Severe malformation/abortion|3|||
129553635|NCT01529749|466322176|FG000|Overall Study|Lost to Follow-up|0|||
129553636|NCT01529749|466322177|FG001|Overall Study|Lost to Follow-up|1|||
129553637|NCT01529749|466322178|FG002|Overall Study|Lost to Follow-up|1|||
129553638|NCT01529749|466322179|FG003|Overall Study|Lost to Follow-up|0|||
129553639|NCT01529749|466322176|FG000|Overall Study|Physician Decision|0|||
129553640|NCT01529749|466322177|FG001|Overall Study|Physician Decision|0|||
129553641|NCT01529749|466322178|FG002|Overall Study|Physician Decision|0|||
129553642|NCT01529749|466322179|FG003|Overall Study|Physician Decision|1|||
129553643|NCT01529749|466322176|FG000|Overall Study|Withdrawal by Subject|0|||
129553644|NCT01529749|466322177|FG001|Overall Study|Withdrawal by Subject|1|||
129553645|NCT01529749|466322178|FG002|Overall Study|Withdrawal by Subject|1|||
129553646|NCT01529749|466322179|FG003|Overall Study|Withdrawal by Subject|0|||
129553647|NCT01529749|466322176|FG000|Overall Study|Protocol Violation|0|||
129553648|NCT01529749|466322177|FG001|Overall Study|Protocol Violation|0|||
129553649|NCT01529749|466322178|FG002|Overall Study|Protocol Violation|0|||
129553650|NCT01529749|466322179|FG003|Overall Study|Protocol Violation|1|||
129553651|NCT00378482|466322180|FG000|Overall Study|Lost to Follow-up|1|||
129553652|NCT00378482|466322180|FG000|Overall Study|Lack of Efficacy|8|||
129553653|NCT00378482|466322180|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
129553654|NCT00378482|466322180|FG000|Overall Study|Withdrawal by Subject|4|||
129553655|NCT00378482|466322180|FG000|Overall Study|Adverse Event|9|||
129553656|NCT00343642|466323562|FG000|Overall Study|Lost to Follow-up|0|||
129553657|NCT00343642|466323563|FG001|Overall Study|Lost to Follow-up|1|||
129553658|NCT00343642|466323564|FG002|Overall Study|Lost to Follow-up|0|||
129553659|NCT00343642|466323562|FG000|Overall Study|Pregnancy|1|||
129553660|NCT00343642|466323563|FG001|Overall Study|Pregnancy|0|||
129553661|NCT00343642|466323564|FG002|Overall Study|Pregnancy|2|||
129553662|NCT00343642|466323562|FG000|Overall Study|Withdrawal by Subject|2|||
129553663|NCT00343642|466323563|FG001|Overall Study|Withdrawal by Subject|3|||
129553664|NCT00343642|466323564|FG002|Overall Study|Withdrawal by Subject|4|||
129553665|NCT00343642|466323562|FG000|Overall Study|Adverse Event|0|||
129553666|NCT00343642|466323563|FG001|Overall Study|Adverse Event|0|||
129553667|NCT00343642|466323564|FG002|Overall Study|Adverse Event|1|||
129553668|NCT00343642|466323562|FG000|Overall Study|Flare up|6|||
129553669|NCT00343642|466323563|FG001|Overall Study|Flare up|4|||
129686176|NCT02782468|466807686|FG002|Overall Study|Other|1|||
129686177|NCT02782468|466807687|FG003|Overall Study|Other|1|||
129686178|NCT02782468|466807684|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
129686179|NCT02782468|466807685|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
129686180|NCT02782468|466807686|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
129686181|NCT02782468|466807687|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
129686182|NCT02782468|466807684|FG000|Overall Study|Symptomatic Deterioration|0|||
129686183|NCT02782468|466807685|FG001|Overall Study|Symptomatic Deterioration|0|||
129686184|NCT02782468|466807686|FG002|Overall Study|Symptomatic Deterioration|0|||
129686185|NCT02782468|466807687|FG003|Overall Study|Symptomatic Deterioration|1|||
129686186|NCT02782468|466807684|FG000|Overall Study|Withdrawal by Subject|1|||
129686187|NCT02782468|466807685|FG001|Overall Study|Withdrawal by Subject|0|||
129553670|NCT00343642|466323564|FG002|Overall Study|Flare up|0|||
129553671|NCT00860574|466323565|FG000|Overall Study|Death|2|||
129686188|NCT02782468|466807686|FG002|Overall Study|Withdrawal by Subject|0|||
129686189|NCT02782468|466807687|FG003|Overall Study|Withdrawal by Subject|0|||
129553672|NCT00860574|466323565|FG000|Overall Study|Relapse|1|||
129553673|NCT01246986|466323566|FG000|Overall Study|Lost to Follow-up|0|||
129553674|NCT01246986|466323567|FG001|Overall Study|Lost to Follow-up|1|||
129553675|NCT01246986|466323568|FG002|Overall Study|Lost to Follow-up|3|||
129553676|NCT01246986|466323569|FG003|Overall Study|Lost to Follow-up|0|||
129553677|NCT01246986|466323570|FG004|Overall Study|Lost to Follow-up|0|||
129553678|NCT01246986|466323571|FG005|Overall Study|Lost to Follow-up|1|||
129553679|NCT01246986|466323572|FG006|Overall Study|Lost to Follow-up|0|||
129686190|NCT00356590|466807688|FG000|Overall Study|Adverse Event|54|||
129686191|NCT00356590|466807688|FG000|Overall Study|Death|10|||
129686192|NCT00356590|466807688|FG000|Overall Study|Lost to Follow-up|35|||
129686193|NCT00356590|466807688|FG000|Overall Study|Physician Decision|46|||
129686194|NCT00356590|466807688|FG000|Overall Study|Withdrawal by Subject|41|||
129686195|NCT00356590|466807688|FG000|Overall Study|Completed month 12 only|2|||
129686196|NCT00356590|466807688|FG000|Overall Study|Protocol issues|6|||
129686197|NCT00356590|466807688|FG000|Overall Study|Response status|28|||
129553680|NCT01246986|466323566|FG000|Overall Study|Withdrawal by Subject|3|||
129553681|NCT01246986|466323567|FG001|Overall Study|Withdrawal by Subject|4|||
129553682|NCT01246986|466323568|FG002|Overall Study|Withdrawal by Subject|3|||
129553683|NCT01246986|466323569|FG003|Overall Study|Withdrawal by Subject|0|||
129553684|NCT01246986|466323570|FG004|Overall Study|Withdrawal by Subject|4|||
129553685|NCT01246986|466323571|FG005|Overall Study|Withdrawal by Subject|0|||
129553686|NCT01246986|466323572|FG006|Overall Study|Withdrawal by Subject|0|||
129553687|NCT01416142|466323576|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
129553688|NCT01416142|466323577|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
129553689|NCT01416142|466323578|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
129553690|NCT01335399|466323579|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
129553691|NCT01335399|466323580|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
129553692|NCT01335399|466323579|FG000|Pre-treatment Period|Participant request to discontinue|0|||
129553693|NCT01335399|466323580|FG001|Pre-treatment Period|Participant request to discontinue|1|||
129553694|NCT01335399|466323579|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
129553695|NCT01335399|466323580|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
129775127|NCT01134055|467141212|FG004|Overall Study|Physician Decision|0|||
129775128|NCT01134055|467141213|FG005|Overall Study|Physician Decision|0|||
129775129|NCT01134055|467141214|FG006|Overall Study|Physician Decision|1|||
129775130|NCT00275509|467141215|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
129775131|NCT00275509|467141216|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
129775132|NCT00594815|467141217|FG000|Overall Study|Never Treated|3|||
129775133|NCT00594815|467141217|FG000|Overall Study|Withdrawal by Subject|2|||
129775134|NCT00594815|467141217|FG000|Overall Study|Toxicity|4|||
129775135|NCT00131248|467141218|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
129775136|NCT00131248|467141219|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
129775137|NCT03023397|467141220|FG000|Run-In|Failed screening allergen challenge|1|||
129775138|NCT03023397|467141221|FG001|Run-In|Failed screening allergen challenge|0|||
129775139|NCT03023397|467141222|FG002|Run-In|Failed screening allergen challenge|0|||
129775140|NCT03023397|467141220|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
129775141|NCT03023397|467141221|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
129775142|NCT03023397|467141222|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
129775143|NCT01146795|467141226|FG000|Overall Study|Withdrawal by Subject|4|||
129775144|NCT01146795|467141226|FG000|Overall Study|Adverse Event|6|||
129775145|NCT01146795|467141226|FG000|Overall Study|Still in treatment at study closure|10|||
129775146|NCT01599637|467141234|FG000|Overall Study|administrative problems|0|||
129775147|NCT01599637|467141235|FG001|Overall Study|administrative problems|2|||
129775148|NCT01599637|467141236|FG002|Overall Study|administrative problems|0|||
129775149|NCT01599637|467141234|FG000|Overall Study|Adverse Event|1|||
129775150|NCT01599637|467141235|FG001|Overall Study|Adverse Event|0|||
129775151|NCT01599637|467141236|FG002|Overall Study|Adverse Event|0|||
129775152|NCT02721966|467141237|FG000|Overall Study|Protocol Violation|1|||
129775153|NCT02721966|467141238|FG001|Overall Study|Protocol Violation|0|||
129775154|NCT02721966|467141239|FG002|Overall Study|Protocol Violation|0|||
129775155|NCT02721966|467141240|FG003|Overall Study|Protocol Violation|0|||
129775156|NCT02721966|467141241|FG004|Overall Study|Protocol Violation|0|||
129775157|NCT02721966|467141237|FG000|Overall Study|Withdrawal by Subject|9|||
129775158|NCT02721966|467141238|FG001|Overall Study|Withdrawal by Subject|2|||
129775159|NCT02721966|467141239|FG002|Overall Study|Withdrawal by Subject|3|||
129775160|NCT02721966|467141240|FG003|Overall Study|Withdrawal by Subject|7|||
129775161|NCT02721966|467141241|FG004|Overall Study|Withdrawal by Subject|0|||
129775162|NCT02721966|467141237|FG000|Overall Study|Adverse Event|4|||
129775163|NCT02721966|467141238|FG001|Overall Study|Adverse Event|4|||
129775164|NCT02721966|467141239|FG002|Overall Study|Adverse Event|3|||
129775165|NCT02721966|467141240|FG003|Overall Study|Adverse Event|0|||
129775166|NCT02721966|467141241|FG004|Overall Study|Adverse Event|0|||
129775167|NCT02721966|467141237|FG000|Overall Study|Death|1|||
129775168|NCT02721966|467141238|FG001|Overall Study|Death|0|||
129553696|NCT01335399|466323579|FG000|Pre-treatment Period|Consent withdrawal|3|||
129553697|NCT01335399|466323580|FG001|Pre-treatment Period|Consent withdrawal|0|||
129553698|NCT01335399|466323579|FG000|Treatment Period|Disease progression|117|||
129553699|NCT01335399|466323580|FG001|Treatment Period|Disease progression|145|||
129553700|NCT01335399|466323579|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
129553701|NCT01335399|466323580|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
129553702|NCT01335399|466323579|FG000|Treatment Period|Study drug toxicity|52|||
129553703|NCT01335399|466323580|FG001|Treatment Period|Study drug toxicity|64|||
129775169|NCT02721966|467141239|FG002|Overall Study|Death|0|||
129775170|NCT02721966|467141240|FG003|Overall Study|Death|0|||
129775171|NCT02721966|467141241|FG004|Overall Study|Death|0|||
129775172|NCT02721966|467141237|FG000|Overall Study|Lack of Efficacy|7|||
129775173|NCT02721966|467141238|FG001|Overall Study|Lack of Efficacy|4|||
129775174|NCT02721966|467141239|FG002|Overall Study|Lack of Efficacy|0|||
129775175|NCT02721966|467141240|FG003|Overall Study|Lack of Efficacy|0|||
129553704|NCT01335399|466323579|FG000|Treatment Period|Participant request to discontinue|30|||
129553705|NCT01335399|466323580|FG001|Treatment Period|Participant request to discontinue|22|||
129553706|NCT01335399|466323579|FG000|Treatment Period|Other reasons|30|||
129553707|NCT01335399|466323580|FG001|Treatment Period|Other reasons|30|||
129553708|NCT01335399|466323579|FG000|Treatment Period|Consent withdrawal|10|||
129553709|NCT01335399|466323580|FG001|Treatment Period|Consent withdrawal|7|||
129553710|NCT01335399|466323579|FG000|Treatment Period|Death|7|||
129553711|NCT01335399|466323580|FG001|Treatment Period|Death|6|||
129553712|NCT01335399|466323579|FG000|Treatment Period|Poor/Non-compliance|3|||
129553713|NCT01335399|466323580|FG001|Treatment Period|Poor/Non-compliance|4|||
129553714|NCT01335399|466323579|FG000|Treatment Period|Lost to Follow-up|2|||
129553715|NCT01335399|466323580|FG001|Treatment Period|Lost to Follow-up|2|||
129553716|NCT01335399|466323579|FG000|Treatment Period|Maximum clinical benefit|1|||
129553717|NCT01335399|466323580|FG001|Treatment Period|Maximum clinical benefit|1|||
129553718|NCT01335399|466323579|FG000|Treatment Period|No longer meet study criteria|1|||
129553719|NCT01335399|466323580|FG001|Treatment Period|No longer meet study criteria|1|||
129553720|NCT01335399|466323579|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
129553721|NCT01335399|466323580|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
129553722|NCT02464059|466323581|FG000|Overall Study|Lost to Follow-up|6|||
129553723|NCT00304954|466323584|FG000|Overall Study|Withdrawal by Subject|0|||
129553724|NCT00304954|466323585|FG001|Overall Study|Withdrawal by Subject|0|||
129553725|NCT00304954|466323586|FG002|Overall Study|Withdrawal by Subject|1|||
129553726|NCT00304954|466323587|FG003|Overall Study|Withdrawal by Subject|0|||
129553727|NCT00304954|466323584|FG000|Overall Study|Adverse Event|1|||
129553728|NCT00304954|466323585|FG001|Overall Study|Adverse Event|0|||
129553729|NCT00304954|466323586|FG002|Overall Study|Adverse Event|0|||
129553730|NCT00304954|466323587|FG003|Overall Study|Adverse Event|0|||
129553731|NCT03990389|466323590|FG000|Overall Study|Lost to Follow-up|3|||
129553732|NCT03990389|466323591|FG001|Overall Study|Lost to Follow-up|0|||
129553733|NCT02290028|466323592|FG000|Overall Study|Death|217|||
129553734|NCT02290028|466323592|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
129553735|NCT02290028|466323592|FG000|Overall Study|No longer under care of study physician|76|||
129553736|NCT02290028|466323592|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
129553737|NCT02290028|466323592|FG000|Overall Study|Withdrawal by Subject|52|||
129553738|NCT02290028|466323592|FG000|Overall Study|Study site closure|44|||
129553739|NCT02290028|466323592|FG000|Overall Study|Lost to Follow-up|34|||
129553740|NCT02290028|466323592|FG000|Overall Study|Miscellaneous|10|||
129553741|NCT02290028|466323592|FG000|Overall Study|Transition to EP PASSION|1295|||
129775176|NCT02721966|467141241|FG004|Overall Study|Lack of Efficacy|0|||
129553742|NCT02290028|466323592|FG000|Overall Study|Planned study completion at 12 months|257|||
129553743|NCT03202511|466323593|FG000|Overall Study|Withdrawal by Subject|1|||
129553744|NCT03202511|466323594|FG001|Overall Study|Withdrawal by Subject|0|||
129553745|NCT00265083|466323595|FG000|Overall Study|Adverse Event|5|||
129553746|NCT00265083|466323596|FG001|Overall Study|Adverse Event|13|||
129553747|NCT00265083|466323597|FG002|Overall Study|Adverse Event|15|||
129553748|NCT00265083|466323595|FG000|Overall Study|Lost to Follow-up|3|||
129553749|NCT00265083|466323596|FG001|Overall Study|Lost to Follow-up|4|||
129775177|NCT02721966|467141237|FG000|Overall Study|Lost to Follow-up|0|||
129775178|NCT02721966|467141238|FG001|Overall Study|Lost to Follow-up|0|||
129775179|NCT02721966|467141239|FG002|Overall Study|Lost to Follow-up|3|||
129775180|NCT02721966|467141240|FG003|Overall Study|Lost to Follow-up|0|||
129553750|NCT00265083|466323597|FG002|Overall Study|Lost to Follow-up|4|||
129553751|NCT00265083|466323595|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
129553752|NCT00265083|466323596|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
129553753|NCT00265083|466323597|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
129553754|NCT00265083|466323595|FG000|Overall Study|Other|1|||
129553755|NCT00265083|466323596|FG001|Overall Study|Other|12|||
129553756|NCT00265083|466323597|FG002|Overall Study|Other|9|||
129553757|NCT03208933|466323598|FG000|Overall Study|Death|3|||
129553758|NCT03208933|466323598|FG000|Overall Study|Withdrawal by Subject|3|||
129775181|NCT02721966|467141241|FG004|Overall Study|Lost to Follow-up|0|||
129553759|NCT03208933|466323598|FG000|Overall Study|Adverse Event|1|||
129553760|NCT03208933|466323598|FG000|Overall Study|Lost to Follow-up|2|||
129553761|NCT03208933|466323598|FG000|Overall Study|Physician Decision|3|||
129553762|NCT03208933|466323598|FG000|Overall Study|Protocol Violation|1|||
129553763|NCT04242186|466323599|FG000|Overall Study|Death|5|||
129553764|NCT00379587|466323600|FG000|Overall Study|Lost to Follow-up|2|||
129553765|NCT00534092|466323601|FG000|Overall Study|Lost to Follow-up|1|||
129553766|NCT00534092|466323602|FG001|Overall Study|Lost to Follow-up|0|||
129553767|NCT00534092|466323601|FG000|Overall Study|personal reasons/family concerns|1|||
129553768|NCT00534092|466323602|FG001|Overall Study|personal reasons/family concerns|0|||
129553769|NCT00830063|466323609|FG000|Overall Study|Adverse Event|7|||
129553770|NCT00830063|466323610|FG001|Overall Study|Adverse Event|13|||
129553771|NCT00830063|466323611|FG002|Overall Study|Adverse Event|16|||
129775182|NCT02721966|467141237|FG000|Overall Study|Physician Decision|1|||
129775183|NCT02721966|467141238|FG001|Overall Study|Physician Decision|1|||
129553772|NCT00830063|466323612|FG003|Overall Study|Adverse Event|13|||
129553773|NCT00830063|466323609|FG000|Overall Study|Death|1|||
129553774|NCT00830063|466323610|FG001|Overall Study|Death|0|||
129553775|NCT00830063|466323611|FG002|Overall Study|Death|0|||
129553776|NCT00830063|466323612|FG003|Overall Study|Death|0|||
129553777|NCT00830063|466323609|FG000|Overall Study|Lost to Follow-up|0|||
129553778|NCT00830063|466323610|FG001|Overall Study|Lost to Follow-up|0|||
129553779|NCT00830063|466323611|FG002|Overall Study|Lost to Follow-up|3|||
129553780|NCT00830063|466323612|FG003|Overall Study|Lost to Follow-up|1|||
129553781|NCT00830063|466323609|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
129553782|NCT00830063|466323610|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
129553783|NCT00830063|466323611|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
129553784|NCT00830063|466323612|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
129553785|NCT00830063|466323609|FG000|Overall Study|Lack of Efficacy|51|||
129553786|NCT00830063|466323610|FG001|Overall Study|Lack of Efficacy|23|||
129553787|NCT00830063|466323611|FG002|Overall Study|Lack of Efficacy|25|||
129553788|NCT00830063|466323612|FG003|Overall Study|Lack of Efficacy|32|||
129553789|NCT00830063|466323609|FG000|Overall Study|Other|5|||
129553790|NCT00830063|466323610|FG001|Overall Study|Other|5|||
129553791|NCT00830063|466323611|FG002|Overall Study|Other|8|||
129553792|NCT00830063|466323612|FG003|Overall Study|Other|6|||
129553793|NCT00830063|466323609|FG000|Overall Study|Withdrawal by Subject|16|||
129553794|NCT00830063|466323610|FG001|Overall Study|Withdrawal by Subject|10|||
129553795|NCT00830063|466323611|FG002|Overall Study|Withdrawal by Subject|16|||
129553796|NCT00830063|466323612|FG003|Overall Study|Withdrawal by Subject|13|||
129553797|NCT00830063|466323609|FG000|Overall Study|Protocol Violation|1|||
129553798|NCT00830063|466323610|FG001|Overall Study|Protocol Violation|0|||
129553799|NCT00830063|466323611|FG002|Overall Study|Protocol Violation|3|||
129553800|NCT00830063|466323612|FG003|Overall Study|Protocol Violation|2|||
129553801|NCT00830063|466323609|FG000|Overall Study|Randomized But Not Treated|0|||
129553802|NCT00830063|466323610|FG001|Overall Study|Randomized But Not Treated|2|||
129553803|NCT00830063|466323611|FG002|Overall Study|Randomized But Not Treated|0|||
129553804|NCT00830063|466323612|FG003|Overall Study|Randomized But Not Treated|2|||
129553805|NCT02323295|466323613|FG000|Overall Study|Adverse Event|0|||
129553806|NCT02323295|466323614|FG001|Overall Study|Adverse Event|1|||
129553807|NCT02323295|466323613|FG000|Overall Study|Withdrawal by Subject|0|||
129553808|NCT02323295|466323614|FG001|Overall Study|Withdrawal by Subject|1|||
129553809|NCT02323295|466323613|FG000|Overall Study|Patient did not have surgery as planned.|0|||
129553810|NCT02323295|466323614|FG001|Overall Study|Patient did not have surgery as planned.|1|||
129553811|NCT00775983|466323615|FG000|Overall Study|Protocol Violation|1|||
129553812|NCT00775983|466323616|FG001|Overall Study|Protocol Violation|2|||
129553813|NCT01155063|466323617|FG000|Overall Study|Adverse Event|1|||
129553814|NCT01155063|466323617|FG000|Overall Study|Withdrawal by Subject|1|||
129553815|NCT01155063|466323617|FG000|Overall Study|Study terminated by sponsor|87|||
129553816|NCT01314703|466323618|FG000|Overall Study|screen failure and closed enrollment|8|||
129553817|NCT00881959|466323621|FG000|Overall Study|Lost to Follow-up|2|||
129553818|NCT00881959|466323622|FG001|Overall Study|Lost to Follow-up|4|||
129553819|NCT01427920|466323630|FG000|Overall Study|Adverse Event|1|||
129553820|NCT01427920|466323631|FG001|Overall Study|Adverse Event|2|||
129553821|NCT01427920|466323630|FG000|Overall Study|Lack of Efficacy|1|||
129553822|NCT01427920|466323631|FG001|Overall Study|Lack of Efficacy|0|||
129553823|NCT01427920|466323630|FG000|Overall Study|Protocol Violation|1|||
129775184|NCT02721966|467141239|FG002|Overall Study|Physician Decision|0|||
129775185|NCT02721966|467141240|FG003|Overall Study|Physician Decision|0|||
129553824|NCT01427920|466323631|FG001|Overall Study|Protocol Violation|3|||
129775186|NCT02721966|467141241|FG004|Overall Study|Physician Decision|0|||
129775187|NCT02721966|467141237|FG000|Overall Study|Pregnancy|1|||
129775188|NCT02721966|467141238|FG001|Overall Study|Pregnancy|0|||
129775189|NCT02721966|467141239|FG002|Overall Study|Pregnancy|0|||
129775190|NCT02721966|467141240|FG003|Overall Study|Pregnancy|0|||
129775191|NCT02721966|467141241|FG004|Overall Study|Pregnancy|0|||
129775192|NCT02721966|467141237|FG000|Overall Study|Did not continue to period 2|5|||
129775193|NCT02721966|467141238|FG001|Overall Study|Did not continue to period 2|12|||
129553825|NCT01427920|466323630|FG000|Overall Study|Withdrawal Criteria|4|||
129553826|NCT01427920|466323631|FG001|Overall Study|Withdrawal Criteria|4|||
129553827|NCT01427920|466323630|FG000|Overall Study|Unclassified|2|||
129553828|NCT01427920|466323631|FG001|Overall Study|Unclassified|8|||
129553829|NCT00751998|466323640|FG000|Overall Study|Lost to Follow-up|7|||
129553830|NCT00751998|466323640|FG000|Overall Study|Death|11|||
129553831|NCT00751998|466323640|FG000|Overall Study|Withdrawal by Subject|2|||
129553832|NCT01965535|466323641|FG000|Overall Study|Lack of Efficacy|2|||
129775194|NCT02721966|467141239|FG002|Overall Study|Did not continue to period 2|0|||
129775195|NCT02721966|467141240|FG003|Overall Study|Did not continue to period 2|0|||
129775196|NCT02721966|467141241|FG004|Overall Study|Did not continue to period 2|5|||
129553833|NCT01965535|466323642|FG001|Overall Study|Lack of Efficacy|1|||
129553834|NCT02983227|466323643|FG000|Overall Study|Adverse Event|21|||
129553835|NCT02983227|466323644|FG001|Overall Study|Adverse Event|3|||
129553836|NCT02983227|466323643|FG000|Overall Study|Death|3|||
129553837|NCT02983227|466323644|FG001|Overall Study|Death|0|||
129553838|NCT02983227|466323643|FG000|Overall Study|Lack of Efficacy|8|||
129553839|NCT02983227|466323644|FG001|Overall Study|Lack of Efficacy|1|||
129553840|NCT02983227|466323643|FG000|Overall Study|Lost to Follow-up|3|||
129553841|NCT02983227|466323644|FG001|Overall Study|Lost to Follow-up|0|||
129553842|NCT02983227|466323643|FG000|Overall Study|Multiple Reasons|2|||
129553843|NCT02983227|466323644|FG001|Overall Study|Multiple Reasons|1|||
129553844|NCT02983227|466323643|FG000|Overall Study|Physician Decision|3|||
129553845|NCT02983227|466323644|FG001|Overall Study|Physician Decision|1|||
129553846|NCT02983227|466323643|FG000|Overall Study|Withdrawal by Subject|19|||
129553847|NCT02983227|466323644|FG001|Overall Study|Withdrawal by Subject|8|||
129553848|NCT01946282|466323647|FG000|Year 1|Did not return FIT kit|4186|||
129553849|NCT01946282|466323648|FG001|Year 1|Did not return FIT kit|608|||
129553850|NCT01946282|466323649|FG002|Year 1|Did not return FIT kit|654|||
129553851|NCT01946282|466323647|FG000|Year 2|Did not return FIT kit|803|||
129553852|NCT01946282|466323648|FG001|Year 2|Did not return FIT kit|131|||
129553853|NCT01946282|466323649|FG002|Year 2|Did not return FIT kit|115|||
129553854|NCT01946282|466323647|FG000|Year 3|Did not return FIT kit|288|||
129553855|NCT01946282|466323648|FG001|Year 3|Did not return FIT kit|43|||
129553856|NCT01946282|466323649|FG002|Year 3|Did not return FIT kit|30|||
129553857|NCT01493531|466323650|FG000|Overall Study|Adverse Event|4|||
129553858|NCT01493531|466323651|FG001|Overall Study|Adverse Event|12|||
129553859|NCT01493531|466323652|FG002|Overall Study|Adverse Event|9|||
129553860|NCT01493531|466323650|FG000|Overall Study|Gout flare|3|||
129553861|NCT01493531|466323651|FG001|Overall Study|Gout flare|0|||
129553862|NCT01493531|466323652|FG002|Overall Study|Gout flare|2|||
129553863|NCT01493531|466323650|FG000|Overall Study|Protocol Violation|8|||
129553864|NCT01493531|466323651|FG001|Overall Study|Protocol Violation|15|||
129553865|NCT01493531|466323652|FG002|Overall Study|Protocol Violation|12|||
129553866|NCT01493531|466323650|FG000|Overall Study|Sponsor terminated study|5|||
129553867|NCT01493531|466323651|FG001|Overall Study|Sponsor terminated study|2|||
129553868|NCT01493531|466323652|FG002|Overall Study|Sponsor terminated study|3|||
129553869|NCT01493531|466323650|FG000|Overall Study|Lost to Follow-up|5|||
129553870|NCT01493531|466323651|FG001|Overall Study|Lost to Follow-up|7|||
129553871|NCT01493531|466323652|FG002|Overall Study|Lost to Follow-up|11|||
129553872|NCT01493531|466323650|FG000|Overall Study|Withdrawal by Subject|16|||
129553873|NCT01493531|466323651|FG001|Overall Study|Withdrawal by Subject|13|||
129686198|NCT00356590|466807688|FG000|Overall Study|Other|52|||
129686199|NCT03086343|466807691|FG000|Period 1|Adverse Event|7|||
129686200|NCT03086343|466807692|FG001|Period 1|Adverse Event|7|||
129686201|NCT03086343|466807693|FG002|Period 1|Adverse Event|0|||
129686202|NCT03086343|466807694|FG003|Period 1|Adverse Event|1|||
129686203|NCT03086343|466807691|FG000|Period 1|Withdrawal by Subject|6|||
129686204|NCT03086343|466807692|FG001|Period 1|Withdrawal by Subject|10|||
129686205|NCT03086343|466807693|FG002|Period 1|Withdrawal by Subject|0|||
129686206|NCT03086343|466807694|FG003|Period 1|Withdrawal by Subject|0|||
129686207|NCT03086343|466807691|FG000|Period 1|Lost to Follow-up|1|||
129686208|NCT03086343|466807692|FG001|Period 1|Lost to Follow-up|3|||
129686209|NCT03086343|466807693|FG002|Period 1|Lost to Follow-up|1|||
129686210|NCT03086343|466807694|FG003|Period 1|Lost to Follow-up|0|||
129686211|NCT03086343|466807691|FG000|Period 1|Other, Not Specified|10|||
129686212|NCT03086343|466807692|FG001|Period 1|Other, Not Specified|12|||
129686213|NCT03086343|466807693|FG002|Period 1|Other, Not Specified|2|||
129686214|NCT03086343|466807694|FG003|Period 1|Other, Not Specified|1|||
129686215|NCT03086343|466807691|FG000|Period 1|Missing|1|||
129686216|NCT03086343|466807692|FG001|Period 1|Missing|0|||
129686217|NCT03086343|466807693|FG002|Period 1|Missing|0|||
129686218|NCT03086343|466807694|FG003|Period 1|Missing|0|||
129686219|NCT03086343|466807691|FG000|Period 2|Adverse Event|20|||
129686220|NCT03086343|466807692|FG001|Period 2|Adverse Event|11|||
129686221|NCT03086343|466807693|FG002|Period 2|Adverse Event|1|||
129775197|NCT03857867|467141242|FG000|Overall Study|Physician Decision|1|||
129775198|NCT01106248|467141244|FG000|Overall Study|Adverse Event|1|||
129553874|NCT01493531|466323652|FG002|Overall Study|Withdrawal by Subject|11|||
129553875|NCT01493531|466323650|FG000|Overall Study|Death|0|||
129553876|NCT01493531|466323651|FG001|Overall Study|Death|1|||
129553877|NCT01493531|466323652|FG002|Overall Study|Death|0|||
129553878|NCT00845026|466323655|FG000|Study Period III|Adverse Event|23|||
129553879|NCT00845026|466323656|FG001|Study Period III|Adverse Event|19|||
129553880|NCT00845026|466323655|FG000|Study Period III|Perceived lack of efficacy|27|||
129553881|NCT00845026|466323656|FG001|Study Period III|Perceived lack of efficacy|15|||
129686222|NCT03086343|466807694|FG003|Period 2|Adverse Event|2|||
129686223|NCT03086343|466807691|FG000|Period 2|Withdrawal by Subject|15|||
129686224|NCT03086343|466807692|FG001|Period 2|Withdrawal by Subject|25|||
129553882|NCT00845026|466323655|FG000|Study Period III|Withdrawal by Subject|19|||
129686225|NCT03086343|466807693|FG002|Period 2|Withdrawal by Subject|2|||
129686226|NCT03086343|466807694|FG003|Period 2|Withdrawal by Subject|2|||
129686227|NCT03086343|466807691|FG000|Period 2|Lost to Follow-up|6|||
129553883|NCT00845026|466323656|FG001|Study Period III|Withdrawal by Subject|15|||
129686228|NCT03086343|466807692|FG001|Period 2|Lost to Follow-up|11|||
129686229|NCT03086343|466807693|FG002|Period 2|Lost to Follow-up|1|||
129686230|NCT03086343|466807694|FG003|Period 2|Lost to Follow-up|0|||
129686231|NCT03086343|466807691|FG000|Period 2|COVID-19 Infection|5|||
129686232|NCT03086343|466807692|FG001|Period 2|COVID-19 Infection|0|||
129686233|NCT03086343|466807693|FG002|Period 2|COVID-19 Infection|0|||
129686234|NCT03086343|466807694|FG003|Period 2|COVID-19 Infection|0|||
129686235|NCT03086343|466807691|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
129686236|NCT03086343|466807692|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
129686237|NCT03086343|466807693|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
129686238|NCT03086343|466807694|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
129686239|NCT03086343|466807691|FG000|Period 2|Other, Not Specified|23|||
129686240|NCT03086343|466807692|FG001|Period 2|Other, Not Specified|22|||
129686241|NCT03086343|466807693|FG002|Period 2|Other, Not Specified|2|||
129686242|NCT03086343|466807694|FG003|Period 2|Other, Not Specified|4|||
129686243|NCT00741611|466807695|FG000|Overall Study|Death|0|||
129686244|NCT00741611|466807696|FG001|Overall Study|Death|0|||
129686245|NCT00741611|466807697|FG002|Overall Study|Death|1|||
129686246|NCT00741611|466807695|FG000|Overall Study|Withdrawal by Subject|0|||
129686247|NCT00741611|466807696|FG001|Overall Study|Withdrawal by Subject|2|||
129686248|NCT00741611|466807697|FG002|Overall Study|Withdrawal by Subject|2|||
129686249|NCT05607043|466807698|FG000|Overall Study|Lost to Follow-up|2|||
129686250|NCT00800540|466807704|FG000|Period One: 6 Weeks|Noncompliance|1|||
129686251|NCT00800540|466807705|FG001|Period One: 6 Weeks|Noncompliance|0|||
129686252|NCT00800540|466807704|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
129686253|NCT00800540|466807705|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
129686254|NCT00800540|466807704|FG000|Period 2: 6 Weeks|Adverse Event|0|||
129686255|NCT00800540|466807705|FG001|Period 2: 6 Weeks|Adverse Event|1|||
129686256|NCT01922011|466807708|FG000|Overall Study|Protocol Violation|0|||
129686257|NCT01922011|466807709|FG001|Overall Study|Protocol Violation|1|||
129686258|NCT01922011|466807708|FG000|Overall Study|Physician Decision|0|||
129686259|NCT01922011|466807709|FG001|Overall Study|Physician Decision|1|||
129686260|NCT01922011|466807708|FG000|Overall Study|Parent/Guardian Decision|3|||
129686261|NCT01922011|466807709|FG001|Overall Study|Parent/Guardian Decision|0|||
129686262|NCT01922011|466807708|FG000|Overall Study|Lost to Follow-up|0|||
129686263|NCT01922011|466807709|FG001|Overall Study|Lost to Follow-up|1|||
129686264|NCT01922011|466807708|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
129686265|NCT01922011|466807709|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
129686266|NCT01922011|466807708|FG000|Overall Study|Not Treated|1|||
129686267|NCT01922011|466807709|FG001|Overall Study|Not Treated|0|||
129686268|NCT01922011|466807708|FG000|Overall Study|Lack of willing home health agency|1|||
129686269|NCT01922011|466807709|FG001|Overall Study|Lack of willing home health agency|0|||
129686270|NCT01922011|466807708|FG000|Overall Study|Randomized in error|1|||
129686271|NCT01922011|466807709|FG001|Overall Study|Randomized in error|0|||
129686272|NCT04398134|466807710|FG000|Overall Study|Adverse Event|0|||
129686273|NCT04398134|466807711|FG001|Overall Study|Adverse Event|0|||
129686274|NCT04398134|466807712|FG002|Overall Study|Adverse Event|1|||
129686275|NCT04398134|466807713|FG003|Overall Study|Adverse Event|0|||
129686276|NCT04398134|466807710|FG000|Overall Study|Withdrawal by Subject|2|||
129686277|NCT04398134|466807711|FG001|Overall Study|Withdrawal by Subject|0|||
129686278|NCT04398134|466807712|FG002|Overall Study|Withdrawal by Subject|0|||
129884469|NCT02038764|467536408|FG000|Overall Study|Lost to Follow-up|0|||
129686279|NCT04398134|466807713|FG003|Overall Study|Withdrawal by Subject|1|||
129553884|NCT00845026|466323655|FG000|Study Period III|Entry Criteria not met|8|||
129553885|NCT00845026|466323656|FG001|Study Period III|Entry Criteria not met|11|||
129553886|NCT00845026|466323655|FG000|Study Period III|Lost to Follow-up|4|||
129553887|NCT00845026|466323656|FG001|Study Period III|Lost to Follow-up|5|||
129553888|NCT00845026|466323655|FG000|Study Period III|Protocol Violation|8|||
129553889|NCT00845026|466323656|FG001|Study Period III|Protocol Violation|1|||
129553890|NCT00845026|466323655|FG000|Study Period III|Scheduled conflict|3|||
129553891|NCT00845026|466323656|FG001|Study Period III|Scheduled conflict|1|||
129553892|NCT00845026|466323655|FG000|Study Period III|Subject is moving or has moved|2|||
129553893|NCT00845026|466323656|FG001|Study Period III|Subject is moving or has moved|4|||
129553894|NCT00845026|466323655|FG000|Study Period III|Transportation issues|1|||
129686280|NCT04398134|466807710|FG000|Overall Study|Study Terminated by Sponsor|30|||
129686281|NCT04398134|466807711|FG001|Overall Study|Study Terminated by Sponsor|11|||
129686282|NCT04398134|466807712|FG002|Overall Study|Study Terminated by Sponsor|32|||
129686283|NCT04398134|466807713|FG003|Overall Study|Study Terminated by Sponsor|11|||
129686284|NCT00153920|466807715|FG000|Overall Study|Adverse Event|9|||
129686285|NCT00153920|466807715|FG000|Overall Study|Progressive Disease|9|||
129686286|NCT00153920|466807715|FG000|Overall Study|Physician Decision|3|||
129686287|NCT00153920|466807715|FG000|Overall Study|Lack of Response|3|||
129686288|NCT00153920|466807715|FG000|Overall Study|Death|2|||
129686289|NCT00153920|466807715|FG000|Overall Study|Withdrawal by Subject|1|||
129686290|NCT00153920|466807715|FG000|Overall Study|Non-Protocol Therapy|1|||
129686291|NCT00153920|466807715|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
129686292|NCT00153920|466807715|FG000|Overall Study|Progressive Disease before Trt|1|||
129686293|NCT02202616|466807716|FG000|Overall Study|Screen failed|24|||
129686294|NCT02202616|466807716|FG000|Overall Study|Adverse Event|32|||
129686295|NCT02202616|466807716|FG000|Overall Study|Protocol deviation|18|||
129686296|NCT02202616|466807716|FG000|Overall Study|Patient withdrew consent|12|||
129686297|NCT02202616|466807716|FG000|Overall Study|Lost to Follow-up|6|||
129686298|NCT02202616|466807716|FG000|Overall Study|Administrative problems|6|||
129686299|NCT02202616|466807716|FG000|Overall Study|Abnormal test procedure result|1|||
129686300|NCT02202616|466807716|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129686301|NCT01334515|466807719|FG000|Overall Study|Adverse Event|1|||
129686302|NCT01334515|466807720|FG001|Overall Study|Adverse Event|6|||
129686303|NCT01334515|466807719|FG000|Overall Study|Death|1|||
129686304|NCT01334515|466807720|FG001|Overall Study|Death|0|||
129686305|NCT01334515|466807719|FG000|Overall Study|Lack of Efficacy|8|||
129686306|NCT01334515|466807720|FG001|Overall Study|Lack of Efficacy|21|||
129686307|NCT01334515|466807719|FG000|Overall Study|Physician Decision|1|||
129686308|NCT01334515|466807720|FG001|Overall Study|Physician Decision|1|||
129686309|NCT01334515|466807719|FG000|Overall Study|Withdrawal by Subject|1|||
129686310|NCT01334515|466807720|FG001|Overall Study|Withdrawal by Subject|1|||
129686311|NCT04327271|466807721|FG000|Overall Study|Death|1|||
129686312|NCT04327271|466807722|FG001|Overall Study|Death|0|||
129686313|NCT04327271|466807721|FG000|Overall Study|Withdrawal by Subject|1|||
129686314|NCT04327271|466807722|FG001|Overall Study|Withdrawal by Subject|0|||
129686315|NCT04327271|466807721|FG000|Overall Study|randomization error (data capture)|4|||
129686316|NCT04327271|466807722|FG001|Overall Study|randomization error (data capture)|3|||
129686317|NCT01479530|466807724|FG000|Overall Study|Adverse Event|5|||
129686318|NCT01479530|466807725|FG001|Overall Study|Adverse Event|6|||
129686319|NCT01479530|466807724|FG000|Overall Study|Lack of Efficacy|0|||
129686320|NCT01479530|466807725|FG001|Overall Study|Lack of Efficacy|1|||
129686321|NCT01479530|466807724|FG000|Overall Study|Protocol Violation|2|||
129686322|NCT01479530|466807725|FG001|Overall Study|Protocol Violation|3|||
129686323|NCT01479530|466807724|FG000|Overall Study|Withdrawal of Consent|3|||
129686324|NCT01479530|466807725|FG001|Overall Study|Withdrawal of Consent|2|||
129686325|NCT00303628|466807726|FG000|Overall Study|Disease progression|0|||
129686326|NCT00303628|466807727|FG001|Overall Study|Disease progression|1|||
129884470|NCT02038764|467536409|FG001|Overall Study|Lost to Follow-up|1|||
129686327|NCT00303628|466807726|FG000|Overall Study|Adverse Event|26|||
129686328|NCT00303628|466807727|FG001|Overall Study|Adverse Event|36|||
129686329|NCT00303628|466807726|FG000|Overall Study|Death|0|||
129686330|NCT00303628|466807727|FG001|Overall Study|Death|1|||
129686331|NCT00303628|466807726|FG000|Overall Study|Withdrawal by Subject|11|||
129686332|NCT00303628|466807727|FG001|Overall Study|Withdrawal by Subject|20|||
129553895|NCT00845026|466323656|FG001|Study Period III|Transportation issues|1|||
129553896|NCT00845026|466323655|FG000|Study Period IV|Adverse Event|4|||
129553897|NCT00845026|466323656|FG001|Study Period IV|Adverse Event|0|||
129553898|NCT00845026|466323655|FG000|Study Period IV|Perceived lack of efficacy|2|||
129553899|NCT00845026|466323656|FG001|Study Period IV|Perceived lack of efficacy|1|||
129553900|NCT00845026|466323655|FG000|Study Period IV|Protocol Violation|3|||
129553901|NCT00845026|466323656|FG001|Study Period IV|Protocol Violation|1|||
129553902|NCT00845026|466323655|FG000|Study Period IV|Lost to Follow-up|1|||
129553903|NCT00845026|466323656|FG001|Study Period IV|Lost to Follow-up|0|||
129553904|NCT00845026|466323655|FG000|Study Period IV|Withdrawal by Subject|4|||
129553905|NCT00845026|466323656|FG001|Study Period IV|Withdrawal by Subject|1|||
129553906|NCT00845026|466323655|FG000|Study Period IV|Entry Criteria Not Met|1|||
129553907|NCT00845026|466323656|FG001|Study Period IV|Entry Criteria Not Met|0|||
129553908|NCT00845026|466323655|FG000|Study Period IV|Subject is moving or has moved|0|||
129553909|NCT00845026|466323656|FG001|Study Period IV|Subject is moving or has moved|1|||
129553910|NCT00845026|466323655|FG000|Study Period IV|Scheduling conflict|1|||
129553911|NCT00845026|466323656|FG001|Study Period IV|Scheduling conflict|0|||
129553912|NCT01325532|466323657|FG000|Overall Study|Withdrawal by Subject|2|||
129553913|NCT01325532|466323658|FG001|Overall Study|Withdrawal by Subject|0|||
129553914|NCT03012815|466323659|FG000|Overall Study|Lost to Follow-up|1|||
129553915|NCT03012815|466323660|FG001|Overall Study|Lost to Follow-up|0|||
129553916|NCT03012815|466323659|FG000|Overall Study|Physician Decision|3|||
129553917|NCT03012815|466323660|FG001|Overall Study|Physician Decision|2|||
129553918|NCT03012815|466323659|FG000|Overall Study|Adverse Event|1|||
129553919|NCT03012815|466323660|FG001|Overall Study|Adverse Event|0|||
129553920|NCT01252238|466323661|FG000|Overall Study|Sponsor terminated study|4|||
129553921|NCT01252238|466323662|FG001|Overall Study|Sponsor terminated study|4|||
129553922|NCT01252238|466323663|FG002|Overall Study|Sponsor terminated study|4|||
129553923|NCT00449930|466323664|FG000|Overall Study|Adverse Event|9|||
129553924|NCT00449930|466323665|FG001|Overall Study|Adverse Event|19|||
129553925|NCT00449930|466323664|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
129553926|NCT00449930|466323665|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
129553927|NCT00449930|466323664|FG000|Overall Study|Lack of Efficacy|10|||
129553928|NCT00449930|466323665|FG001|Overall Study|Lack of Efficacy|1|||
129553929|NCT00449930|466323664|FG000|Overall Study|Lost to Follow-up|9|||
129553930|NCT00449930|466323665|FG001|Overall Study|Lost to Follow-up|14|||
129553931|NCT00449930|466323664|FG000|Overall Study|Physician Decision|1|||
129553932|NCT00449930|466323665|FG001|Overall Study|Physician Decision|2|||
129553933|NCT00449930|466323664|FG000|Overall Study|Protocol Violation|14|||
129553934|NCT00449930|466323665|FG001|Overall Study|Protocol Violation|15|||
129553935|NCT00449930|466323664|FG000|Overall Study|Withdrawal by Subject|16|||
129553936|NCT00449930|466323665|FG001|Overall Study|Withdrawal by Subject|23|||
129553937|NCT00449930|466323664|FG000|Overall Study|Glycemic discontinuation criteria|1|||
129553938|NCT00449930|466323665|FG001|Overall Study|Glycemic discontinuation criteria|1|||
129553939|NCT01864525|466323666|FG000|Overall Study|Adverse Event|1|||
129553940|NCT01864525|466323667|FG001|Overall Study|Adverse Event|0|||
129553941|NCT01890785|466323668|FG000|Third Intervention|Withdrawal by Subject|0|||
129553942|NCT01890785|466323669|FG001|Third Intervention|Withdrawal by Subject|1|||
129553943|NCT01890785|466323670|FG002|Third Intervention|Withdrawal by Subject|0|||
129553944|NCT01890785|466323671|FG003|Third Intervention|Withdrawal by Subject|0|||
129553945|NCT01890785|466323672|FG004|Third Intervention|Withdrawal by Subject|0|||
129553946|NCT01890785|466323673|FG005|Third Intervention|Withdrawal by Subject|0|||
129553947|NCT03712228|466323674|FG000|Treatment Period 1|Lack of Efficacy|0|||
129553948|NCT03712228|466323675|FG001|Treatment Period 1|Lack of Efficacy|0|||
129553949|NCT03712228|466323676|FG002|Treatment Period 1|Lack of Efficacy|0|||
129553950|NCT03712228|466323677|FG003|Treatment Period 1|Lack of Efficacy|0|||
129553951|NCT03712228|466323678|FG004|Treatment Period 1|Lack of Efficacy|0|||
129553952|NCT03712228|466323679|FG005|Treatment Period 1|Lack of Efficacy|1|||
129553953|NCT03712228|466323674|FG000|Treatment Period 2|Pregnancy|0|||
129553954|NCT03712228|466323675|FG001|Treatment Period 2|Pregnancy|0|||
129553955|NCT03712228|466323676|FG002|Treatment Period 2|Pregnancy|0|||
129553956|NCT03712228|466323677|FG003|Treatment Period 2|Pregnancy|1|||
129553957|NCT03712228|466323678|FG004|Treatment Period 2|Pregnancy|0|||
129686333|NCT00303628|466807726|FG000|Overall Study|Alternative therapy|2|||
129686334|NCT00303628|466807727|FG001|Overall Study|Alternative therapy|0|||
129686335|NCT00303628|466807726|FG000|Overall Study|Other complicating disease|0|||
129686336|NCT00303628|466807727|FG001|Overall Study|Other complicating disease|1|||
129686337|NCT00303628|466807726|FG000|Overall Study|Not start protocol therapy|3|||
129686338|NCT00303628|466807727|FG001|Overall Study|Not start protocol therapy|5|||
129686339|NCT00303628|466807726|FG000|Overall Study|Other|8|||
129686340|NCT00303628|466807727|FG001|Overall Study|Other|9|||
129686341|NCT01666652|466807728|FG000|Overall Study|Serious Adverse Event|0|||
129686342|NCT01666652|466807729|FG001|Overall Study|Serious Adverse Event|0|||
129553958|NCT03712228|466323679|FG005|Treatment Period 2|Pregnancy|0|||
129553959|NCT03712228|466323674|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129553960|NCT03712228|466323675|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129553961|NCT03712228|466323676|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129553962|NCT03712228|466323677|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129553963|NCT03712228|466323678|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129553964|NCT03712228|466323679|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129553965|NCT01964105|466323680|FG000|Overall Study|Lost to Follow-up|2|||
129553966|NCT01964105|466323681|FG001|Overall Study|Lost to Follow-up|13|||
129553967|NCT01964105|466323682|FG002|Overall Study|Lost to Follow-up|0|||
129553968|NCT00558519|466323683|FG000|Overall Study|Ph+|20|||
129553969|NCT00558519|466323683|FG000|Overall Study|Ineligible|1|||
129553970|NCT00558519|466323683|FG000|Overall Study|Insufficient data|1|||
129553971|NCT00558519|466323683|FG000|Overall Study|Never received treatment|1|||
129553972|NCT03001011|466323684|FG000|Overall Study|Adverse Event|9|||
129553973|NCT03001011|466323685|FG001|Overall Study|Adverse Event|3|||
129553974|NCT03001011|466323684|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
129553975|NCT03001011|466323685|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
129553976|NCT03001011|466323684|FG000|Overall Study|Other than specified above|3|||
129553977|NCT03001011|466323685|FG001|Overall Study|Other than specified above|8|||
129553978|NCT02875067|466323686|FG000|Overall Study|Withdrawal by Subject|1|||
129553979|NCT02875067|466323686|FG000|Overall Study|Withdrawal by Termination of Study|5|||
129553980|NCT00065065|466323687|FG000|Overall Study|Adverse Event|3|||
129553981|NCT00065065|466323688|FG001|Overall Study|Adverse Event|2|||
129553982|NCT00065065|466323687|FG000|Overall Study|Withdrawal by Subject|1|||
129553983|NCT00065065|466323688|FG001|Overall Study|Withdrawal by Subject|5|||
129553984|NCT00065065|466323687|FG000|Overall Study|Lack of Efficacy|4|||
129553985|NCT00065065|466323688|FG001|Overall Study|Lack of Efficacy|11|||
129553986|NCT00065065|466323687|FG000|Overall Study|Other|2|||
129553987|NCT00065065|466323688|FG001|Overall Study|Other|2|||
129553988|NCT01050673|466323692|FG000|Overall Study|Physician Decision|4|||
129553989|NCT01050673|466323693|FG001|Overall Study|Physician Decision|5|||
129553990|NCT05288673|466323694|FG000|Overall Study|Consent withdrawn by subject|0|||
129553991|NCT05288673|466323695|FG001|Overall Study|Consent withdrawn by subject|0|||
129553992|NCT05288673|466323696|FG002|Overall Study|Consent withdrawn by subject|1|||
129553993|NCT03056352|466323697|FG000|Overall Study|Lost to Follow-up|1|||
129553994|NCT00597207|466323702|FG000|Overall Study|Lost to Follow-up|5|||
129553995|NCT00597207|466323703|FG001|Overall Study|Lost to Follow-up|7|||
129553996|NCT00520351|466323704|FG000|First Intervention|Withdrawal by Subject|1|||
129553997|NCT00520351|466323705|FG001|First Intervention|Withdrawal by Subject|1|||
129553998|NCT02278952|466323706|FG000|Overall Study|Insufficient Sample|6|||
129553999|NCT00869089|466323713|FG000|Overall Study|Lost to Follow-up|1|||
129554000|NCT00869089|466323713|FG000|Overall Study|Withdrawal by Subject|1|||
129554001|NCT00869089|466323713|FG000|Overall Study|Screen Fail|1|||
129554002|NCT01559818|466323719|FG000|Overall Study|Physician Decision|1|||
129554003|NCT01559818|466323719|FG000|Overall Study|Pregnancy|1|||
129554004|NCT01559818|466323719|FG000|Overall Study|Study terminated by Sponsor|4|||
129554005|NCT01559818|466323719|FG000|Overall Study|Withdrawal by Subject|1|||
129554006|NCT04071626|466323720|FG000|Overall Study|Withdrawal by Subject|1|||
129554007|NCT04071626|466323721|FG001|Overall Study|Withdrawal by Subject|1|||
129554008|NCT04071626|466323720|FG000|Overall Study|Protocol Violation|0|||
129554009|NCT04071626|466323721|FG001|Overall Study|Protocol Violation|1|||
129554010|NCT02919475|466325187|FG000|Overall Study|Adverse Event|3|||
129554011|NCT02919475|466325188|FG001|Overall Study|Adverse Event|3|||
129554012|NCT02919475|466325189|FG002|Overall Study|Adverse Event|3|||
129554013|NCT02919475|466325190|FG003|Overall Study|Adverse Event|9|||
129554014|NCT02919475|466325191|FG004|Overall Study|Adverse Event|2|||
129554015|NCT02919475|466325187|FG000|Overall Study|Death|0|||
129554016|NCT02919475|466325188|FG001|Overall Study|Death|1|||
129554017|NCT02919475|466325189|FG002|Overall Study|Death|0|||
129554018|NCT02919475|466325190|FG003|Overall Study|Death|0|||
129554019|NCT02919475|466325191|FG004|Overall Study|Death|0|||
129554020|NCT02919475|466325187|FG000|Overall Study|Lost to Follow-up|0|||
129554021|NCT02919475|466325188|FG001|Overall Study|Lost to Follow-up|0|||
129554022|NCT02919475|466325189|FG002|Overall Study|Lost to Follow-up|0|||
129554023|NCT02919475|466325190|FG003|Overall Study|Lost to Follow-up|1|||
129554024|NCT02919475|466325191|FG004|Overall Study|Lost to Follow-up|0|||
129554025|NCT02919475|466325187|FG000|Overall Study|Withdrawal by Subject|2|||
129554026|NCT02919475|466325188|FG001|Overall Study|Withdrawal by Subject|3|||
129554027|NCT02919475|466325189|FG002|Overall Study|Withdrawal by Subject|1|||
129554028|NCT02919475|466325190|FG003|Overall Study|Withdrawal by Subject|2|||
129554029|NCT02919475|466325191|FG004|Overall Study|Withdrawal by Subject|2|||
129554030|NCT02919475|466325187|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129554031|NCT02919475|466325188|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129554032|NCT02919475|466325189|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129554033|NCT02919475|466325190|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129554034|NCT02919475|466325191|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129554035|NCT02791659|466325193|FG000|Overall Study|Protocol Violation|0|||
129554036|NCT02791659|466325194|FG001|Overall Study|Protocol Violation|1|||
129775199|NCT01106248|467141244|FG000|Overall Study|Administrative|2|||
129775200|NCT00357903|467141245|FG000|Overall Study|Adverse Event|87|||
129775201|NCT00357903|467141246|FG001|Overall Study|Adverse Event|4|||
129775202|NCT00357903|467141245|FG000|Overall Study|Death|33|||
129775203|NCT00357903|467141246|FG001|Overall Study|Death|0|||
129775204|NCT00357903|467141245|FG000|Overall Study|Lost to Follow-up|23|||
129775205|NCT00357903|467141246|FG001|Overall Study|Lost to Follow-up|4|||
129775206|NCT00357903|467141245|FG000|Overall Study|Physician Decision|39|||
129775207|NCT00357903|467141246|FG001|Overall Study|Physician Decision|5|||
129775208|NCT00357903|467141245|FG000|Overall Study|Withdrawal by Subject|57|||
129775209|NCT00357903|467141246|FG001|Overall Study|Withdrawal by Subject|7|||
129775210|NCT00357903|467141245|FG000|Overall Study|Completed month 12 only|0|||
129775211|NCT00357903|467141246|FG001|Overall Study|Completed month 12 only|1|||
129775212|NCT00357903|467141245|FG000|Overall Study|Protocol issues|14|||
129775213|NCT00357903|467141246|FG001|Overall Study|Protocol issues|3|||
129775214|NCT00357903|467141245|FG000|Overall Study|Response status|61|||
129775215|NCT00357903|467141246|FG001|Overall Study|Response status|9|||
129775216|NCT00357903|467141245|FG000|Overall Study|Other|49|||
129775217|NCT00357903|467141246|FG001|Overall Study|Other|10|||
129775218|NCT00606593|467141247|FG000|Overall Study|Adverse Event|0|||
129775219|NCT00606593|467141248|FG001|Overall Study|Adverse Event|0|||
129775220|NCT00606593|467141249|FG002|Overall Study|Adverse Event|0|||
129775221|NCT00606593|467141250|FG003|Overall Study|Adverse Event|1|||
129775222|NCT00606593|467141251|FG004|Overall Study|Adverse Event|1|||
129775223|NCT00606593|467141252|FG005|Overall Study|Adverse Event|0|||
129775224|NCT00606593|467141253|FG006|Overall Study|Adverse Event|1|||
129775225|NCT00606593|467141254|FG007|Overall Study|Adverse Event|2|||
129775226|NCT00606593|467141255|FG008|Overall Study|Adverse Event|1|||
129775227|NCT00606593|467141256|FG009|Overall Study|Adverse Event|0|||
129775228|NCT00606593|467141247|FG000|Overall Study|Withdrawal of consent|1|||
129775229|NCT00606593|467141248|FG001|Overall Study|Withdrawal of consent|0|||
129775230|NCT00606593|467141249|FG002|Overall Study|Withdrawal of consent|1|||
129775231|NCT00606593|467141250|FG003|Overall Study|Withdrawal of consent|0|||
129775232|NCT00606593|467141251|FG004|Overall Study|Withdrawal of consent|0|||
129775233|NCT00606593|467141252|FG005|Overall Study|Withdrawal of consent|0|||
129775234|NCT00606593|467141253|FG006|Overall Study|Withdrawal of consent|0|||
129775235|NCT00606593|467141254|FG007|Overall Study|Withdrawal of consent|0|||
129775236|NCT00606593|467141255|FG008|Overall Study|Withdrawal of consent|0|||
129775237|NCT00606593|467141256|FG009|Overall Study|Withdrawal of consent|0|||
129775238|NCT00606593|467141247|FG000|Overall Study|Administrative/Other|0|||
129775239|NCT00606593|467141248|FG001|Overall Study|Administrative/Other|0|||
129775240|NCT00606593|467141249|FG002|Overall Study|Administrative/Other|1|||
129775241|NCT00606593|467141250|FG003|Overall Study|Administrative/Other|0|||
129775242|NCT00606593|467141251|FG004|Overall Study|Administrative/Other|0|||
129775243|NCT00606593|467141252|FG005|Overall Study|Administrative/Other|0|||
129775244|NCT00606593|467141253|FG006|Overall Study|Administrative/Other|0|||
129775245|NCT00606593|467141254|FG007|Overall Study|Administrative/Other|0|||
129775246|NCT00606593|467141255|FG008|Overall Study|Administrative/Other|0|||
129775247|NCT00606593|467141256|FG009|Overall Study|Administrative/Other|0|||
129775248|NCT03181529|467141257|FG000|Overall Study|Withdrawal by Subject|1|||
129775249|NCT03181529|467141258|FG001|Overall Study|Withdrawal by Subject|1|||
129775250|NCT03181529|467141257|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
129775251|NCT03181529|467141258|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
129775252|NCT02374450|467141259|FG000|Overall Study|Protocol Violation|0|||
129775253|NCT02374450|467141260|FG001|Overall Study|Protocol Violation|1|||
129775254|NCT02374450|467141261|FG002|Overall Study|Protocol Violation|0|||
129775255|NCT02374450|467141259|FG000|Overall Study|Withdrawal by Subject|91|||
129775256|NCT02374450|467141260|FG001|Overall Study|Withdrawal by Subject|110|||
129775257|NCT02374450|467141261|FG002|Overall Study|Withdrawal by Subject|4|||
129775258|NCT02374450|467141259|FG000|Overall Study|Lost to Follow-up|168|||
129775259|NCT02374450|467141260|FG001|Overall Study|Lost to Follow-up|194|||
129775260|NCT02374450|467141261|FG002|Overall Study|Lost to Follow-up|138|||
129775261|NCT02374450|467141259|FG000|Overall Study|Death|173|||
129775262|NCT02374450|467141260|FG001|Overall Study|Death|185|||
129775263|NCT02374450|467141261|FG002|Overall Study|Death|81|||
129775264|NCT02374450|467141259|FG000|Overall Study|Migrated from the study area|538|||
129775265|NCT02374450|467141260|FG001|Overall Study|Migrated from the study area|648|||
129775266|NCT02374450|467141261|FG002|Overall Study|Migrated from the study area|181|||
129775267|NCT02374450|467141259|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
129775268|NCT02374450|467141260|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
129775269|NCT02374450|467141261|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
129775270|NCT02374450|467141259|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
129775271|NCT02374450|467141260|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
129775272|NCT02374450|467141261|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
129775273|NCT02374450|467141259|FG000|Overall Study|Other|0|||
129686343|NCT01666652|466807730|FG002|Overall Study|Serious Adverse Event|0|||
129686344|NCT01666652|466807731|FG003|Overall Study|Serious Adverse Event|1|||
129686345|NCT01666652|466807732|FG004|Overall Study|Serious Adverse Event|0|||
129686346|NCT01666652|466807728|FG000|Overall Study|Withdrawal by Subject|0|||
129686347|NCT01666652|466807729|FG001|Overall Study|Withdrawal by Subject|0|||
129686348|NCT01666652|466807730|FG002|Overall Study|Withdrawal by Subject|0|||
129686349|NCT01666652|466807731|FG003|Overall Study|Withdrawal by Subject|0|||
129686350|NCT01666652|466807732|FG004|Overall Study|Withdrawal by Subject|1|||
129686351|NCT01666652|466807728|FG000|Overall Study|Moved from study area|1|||
129686352|NCT01666652|466807729|FG001|Overall Study|Moved from study area|0|||
129686353|NCT01666652|466807730|FG002|Overall Study|Moved from study area|0|||
129686354|NCT01666652|466807731|FG003|Overall Study|Moved from study area|2|||
129686355|NCT01666652|466807732|FG004|Overall Study|Moved from study area|0|||
129686356|NCT01666652|466807728|FG000|Overall Study|Lost to Follow-up|1|||
129686357|NCT01666652|466807729|FG001|Overall Study|Lost to Follow-up|1|||
129686358|NCT01666652|466807730|FG002|Overall Study|Lost to Follow-up|1|||
129686359|NCT01666652|466807731|FG003|Overall Study|Lost to Follow-up|1|||
129686360|NCT01666652|466807732|FG004|Overall Study|Lost to Follow-up|0|||
129686361|NCT01018979|466807733|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
129686362|NCT01018979|466807734|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
129686363|NCT01018979|466807733|FG000|Overall Study|Not received at least one dose|0|||
129686364|NCT01018979|466807734|FG001|Overall Study|Not received at least one dose|1|||
129686365|NCT03010501|466807737|FG000|Study Week 1|Withdrawal by Subject|2|||
129686366|NCT03010501|466807738|FG001|Study Week 1|Withdrawal by Subject|1|||
129686367|NCT03010501|466807739|FG002|Study Week 1|Withdrawal by Subject|0|||
129686368|NCT03010501|466807740|FG003|Study Week 1|Withdrawal by Subject|2|||
129686369|NCT03010501|466807741|FG004|Study Week 1|Withdrawal by Subject|0|||
129686370|NCT03010501|466807742|FG005|Study Week 1|Withdrawal by Subject|0|||
129686371|NCT03010501|466807737|FG000|Study Week 3|Withdrawal by Subject|0|||
129686372|NCT03010501|466807738|FG001|Study Week 3|Withdrawal by Subject|0|||
129686373|NCT03010501|466807739|FG002|Study Week 3|Withdrawal by Subject|0|||
129686374|NCT03010501|466807740|FG003|Study Week 3|Withdrawal by Subject|1|||
129686375|NCT03010501|466807741|FG004|Study Week 3|Withdrawal by Subject|0|||
129686376|NCT03010501|466807742|FG005|Study Week 3|Withdrawal by Subject|0|||
129686377|NCT00640289|466807743|FG000|Overall Study|Death|3|||
129686378|NCT00640289|466807743|FG000|Overall Study|Withdrawal by Subject|1|||
129686379|NCT00640289|466807743|FG000|Overall Study|Lost to Follow-up|1|||
129686380|NCT00640289|466807743|FG000|Overall Study|Data collected under different amendment|2|||
129686381|NCT00640289|466807743|FG000|Overall Study|Transferred to another center|1|||
129686382|NCT00640289|466807743|FG000|Overall Study|Missing status|5|||
129686383|NCT00544882|466807746|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
129686384|NCT00544882|466807747|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
129686385|NCT00544882|466807748|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
129686386|NCT00544882|466807746|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
129686387|NCT00544882|466807747|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
129686388|NCT00544882|466807748|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
129686389|NCT00544882|466807746|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
129686390|NCT00544882|466807747|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
129686391|NCT00544882|466807748|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
129686392|NCT00544882|466807746|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
129686393|NCT00544882|466807747|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
129686394|NCT00544882|466807748|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
129686395|NCT00544882|466807746|FG000|Cycle 3: Follow-up|Noncompliance|0|||
129686396|NCT00544882|466807747|FG001|Cycle 3: Follow-up|Noncompliance|1|||
129686397|NCT00544882|466807748|FG002|Cycle 3: Follow-up|Noncompliance|0|||
129686398|NCT00544882|466807746|FG000|Cycle 3: Follow-up|Pregnancy|0|||
129686399|NCT00544882|466807747|FG001|Cycle 3: Follow-up|Pregnancy|1|||
129686400|NCT00544882|466807748|FG002|Cycle 3: Follow-up|Pregnancy|0|||
129686401|NCT03043573|466807749|FG000|Overall Study|Lost to Follow-up|3|||
129686402|NCT03043573|466807750|FG001|Overall Study|Lost to Follow-up|3|||
129686403|NCT03043573|466807749|FG000|Overall Study|Physician Decision|0|||
129686404|NCT03043573|466807750|FG001|Overall Study|Physician Decision|5|||
129686405|NCT03043573|466807749|FG000|Overall Study|Withdrawal by Subject|0|||
129686406|NCT03043573|466807750|FG001|Overall Study|Withdrawal by Subject|4|||
129686407|NCT01373229|466808858|FG000|Overall Study|Death|3|||
129686408|NCT01373229|466808858|FG000|Overall Study|Physician Decision|3|||
129686409|NCT00143507|466808859|FG000|Overall Study|Death|572|||
129686410|NCT00143507|466808860|FG001|Overall Study|Death|547|||
129686411|NCT00143507|466808859|FG000|Overall Study|Withdrawal by Subject|114|||
129686412|NCT00143507|466808860|FG001|Overall Study|Withdrawal by Subject|102|||
129686413|NCT00143507|466808859|FG000|Overall Study|Lost to Follow-up|1|||
129686414|NCT00143507|466808860|FG001|Overall Study|Lost to Follow-up|0|||
129686415|NCT00143507|466808859|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
129686416|NCT00143507|466808860|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
129686417|NCT00587457|466808861|FG000|Overall Study|Adverse Event|1|||
129554037|NCT01904383|466325197|FG000|Overall Study|CRF not collected|117|||
129554038|NCT01904383|466325197|FG000|Overall Study|Reason not listed|147|||
129554039|NCT01904383|466325197|FG000|Overall Study|Lost to Follow-up|674|||
129554040|NCT01904383|466325197|FG000|Overall Study|Lack of Efficacy|370|||
129554041|NCT01904383|466325197|FG000|Overall Study|Improvement|141|||
129554042|NCT01904383|466325197|FG000|Overall Study|Adverse Event|271|||
129554043|NCT01904383|466325197|FG000|Overall Study|No patient visit after entry|54|||
129554044|NCT01294592|466325198|FG000|Overall Study|Adverse Event|28|||
129554045|NCT01294592|466325199|FG001|Overall Study|Adverse Event|13|||
129554046|NCT01294592|466325198|FG000|Overall Study|Lack of Efficacy|7|||
129554047|NCT01294592|466325199|FG001|Overall Study|Lack of Efficacy|5|||
129554048|NCT01294592|466325198|FG000|Overall Study|Protocol Violation|1|||
129554049|NCT01294592|466325199|FG001|Overall Study|Protocol Violation|7|||
129554050|NCT01294592|466325198|FG000|Overall Study|Lost to Follow-up|7|||
129554051|NCT01294592|466325199|FG001|Overall Study|Lost to Follow-up|9|||
129554052|NCT01294592|466325198|FG000|Overall Study|Physician Decision|6|||
129554053|NCT01294592|466325199|FG001|Overall Study|Physician Decision|11|||
129554054|NCT01294592|466325198|FG000|Overall Study|Withdrawal by Subject|28|||
129554055|NCT01294592|466325199|FG001|Overall Study|Withdrawal by Subject|28|||
129554056|NCT02762565|466325200|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
129554057|NCT01113710|466325201|FG000|Overall Study|Adverse Event|64|||
129554058|NCT01113710|466325201|FG000|Overall Study|Lack of Efficacy|41|||
129554059|NCT01113710|466325201|FG000|Overall Study|No Information Available|40|||
129554060|NCT01113710|466325201|FG000|Overall Study|Withdrawal by Subject|28|||
129554061|NCT01113710|466325201|FG000|Overall Study|Lost to Follow-up|20|||
129554062|NCT01113710|466325201|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
129554063|NCT01113710|466325201|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
129554064|NCT01113710|466325201|FG000|Overall Study|Lack of Patient's Compliance|8|||
129554065|NCT01113710|466325201|FG000|Overall Study|Other|7|||
129554066|NCT01113710|466325201|FG000|Overall Study|Adverse Event/Other|5|||
129775274|NCT02374450|467141260|FG001|Overall Study|Other|21|||
129775275|NCT02374450|467141261|FG002|Overall Study|Other|79|||
129775276|NCT01442103|467142851|FG000|Overall Study|Lost to Follow-up|2|||
129775277|NCT02202759|467142852|FG000|Overall Study|Study Terminated by Sponsor|3|||
129775278|NCT02202759|467142853|FG001|Overall Study|Study Terminated by Sponsor|3|||
129775279|NCT02202759|467142854|FG002|Overall Study|Study Terminated by Sponsor|3|||
129775280|NCT02202759|467142852|FG000|Overall Study|Withdrawal by Subject|2|||
129775281|NCT02202759|467142853|FG001|Overall Study|Withdrawal by Subject|1|||
129554067|NCT01113710|466325201|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
129554068|NCT01113710|466325201|FG000|Overall Study|Lack of Efficacy/Other|4|||
129554069|NCT01113710|466325201|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
129554070|NCT01113710|466325201|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
129554071|NCT01113710|466325201|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
129554072|NCT01113710|466325201|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
129554073|NCT01113710|466325201|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
129554074|NCT01113710|466325201|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
129686418|NCT00587457|466808862|FG001|Overall Study|Adverse Event|2|||
129686419|NCT00587457|466808863|FG002|Overall Study|Adverse Event|1|||
129686420|NCT00587457|466808861|FG000|Overall Study|Disease progression|2|||
129686421|NCT00587457|466808862|FG001|Overall Study|Disease progression|0|||
129686422|NCT00587457|466808863|FG002|Overall Study|Disease progression|2|||
129686423|NCT00587457|466808861|FG000|Overall Study|Initiation of alternative therapy|0|||
129686424|NCT00587457|466808862|FG001|Overall Study|Initiation of alternative therapy|1|||
129686425|NCT00587457|466808863|FG002|Overall Study|Initiation of alternative therapy|0|||
129686426|NCT00587457|466808861|FG000|Overall Study|Undefined|0|||
129686427|NCT00587457|466808862|FG001|Overall Study|Undefined|0|||
129686428|NCT00587457|466808863|FG002|Overall Study|Undefined|1|||
129686429|NCT00587457|466808861|FG000|Overall Study|Development of neutralizing Abs|0|||
129686430|NCT00587457|466808862|FG001|Overall Study|Development of neutralizing Abs|0|||
129686431|NCT00587457|466808863|FG002|Overall Study|Development of neutralizing Abs|1|||
129686432|NCT03234881|466808864|FG000|Overall Study|Lost to Follow-up|9|||
129686433|NCT03234881|466808865|FG001|Overall Study|Lost to Follow-up|3|||
129686434|NCT00729586|466808866|FG000|Overall Study|Ineligible|0|||
129686435|NCT00729586|466808867|FG001|Overall Study|Ineligible|1|||
129686436|NCT00729586|466808866|FG000|Overall Study|never treated|1|||
129686437|NCT00729586|466808867|FG001|Overall Study|never treated|0|||
129686438|NCT00972738|466808869|FG000|Overall Study|Adverse Event|7|||
129686439|NCT00972738|466808870|FG001|Overall Study|Adverse Event|1|||
129686440|NCT00972738|466808871|FG002|Overall Study|Adverse Event|8|||
129686441|NCT00972738|466808869|FG000|Overall Study|Protocol Violation|2|||
129686442|NCT00972738|466808870|FG001|Overall Study|Protocol Violation|1|||
129686443|NCT00972738|466808871|FG002|Overall Study|Protocol Violation|3|||
129686444|NCT00972738|466808869|FG000|Overall Study|Lost to Follow-up|1|||
129775282|NCT02202759|467142854|FG002|Overall Study|Withdrawal by Subject|1|||
129775283|NCT02202759|467142852|FG000|Overall Study|Reason not Specified|4|||
129775284|NCT02202759|467142853|FG001|Overall Study|Reason not Specified|11|||
129884471|NCT02038764|467536410|FG002|Overall Study|Lost to Follow-up|0|||
129884472|NCT02038764|467536411|FG003|Overall Study|Lost to Follow-up|0|||
129884473|NCT02038764|467536412|FG004|Overall Study|Lost to Follow-up|0|||
129884474|NCT02038764|467536408|FG000|Overall Study|Withdrawal by Subject|0|||
129884475|NCT02038764|467536409|FG001|Overall Study|Withdrawal by Subject|0|||
129884476|NCT02038764|467536410|FG002|Overall Study|Withdrawal by Subject|0|||
129884477|NCT02038764|467536411|FG003|Overall Study|Withdrawal by Subject|0|||
129884478|NCT02038764|467536412|FG004|Overall Study|Withdrawal by Subject|1|||
129884479|NCT02038764|467536408|FG000|Overall Study|Other|1|||
129884480|NCT02038764|467536409|FG001|Overall Study|Other|0|||
129884481|NCT02038764|467536410|FG002|Overall Study|Other|1|||
129884482|NCT02038764|467536411|FG003|Overall Study|Other|0|||
129884483|NCT02038764|467536412|FG004|Overall Study|Other|0|||
129884484|NCT04844918|467536415|FG000|Overall Study|Adverse Event|7|||
129884485|NCT04844918|467536416|FG001|Overall Study|Adverse Event|8|||
129884486|NCT04844918|467536417|FG002|Overall Study|Adverse Event|5|||
129884487|NCT04844918|467536415|FG000|Overall Study|Physician Decision|0|||
129554075|NCT01113710|466325201|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
129554076|NCT01113710|466325201|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
129554077|NCT01113710|466325201|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
129554078|NCT01113710|466325201|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
129554079|NCT01113710|466325201|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
129554080|NCT01113710|466325201|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
129554081|NCT01113710|466325201|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
129554082|NCT00623623|466325202|FG000|Overall Study|Previous enrolment into this study|1|||
129554083|NCT00623623|466325203|FG001|Overall Study|Previous enrolment into this study|1|||
129554084|NCT02265952|466325205|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
129554085|NCT02265952|466325206|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
129554086|NCT02265952|466325205|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
129554087|NCT02265952|466325206|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
129554088|NCT01042977|466325207|FG000|Overall Study|Adverse Event|4|||
129554089|NCT01042977|466325208|FG001|Overall Study|Adverse Event|12|||
129554090|NCT01042977|466325207|FG000|Overall Study|Death|2|||
129554091|NCT01042977|466325208|FG001|Overall Study|Death|1|||
129554092|NCT01042977|466325207|FG000|Overall Study|Withdrawal by Subject|8|||
129554093|NCT01042977|466325208|FG001|Overall Study|Withdrawal by Subject|16|||
129554094|NCT01042977|466325207|FG000|Overall Study|Lost to Follow-up|0|||
129554095|NCT01042977|466325208|FG001|Overall Study|Lost to Follow-up|2|||
129554096|NCT01042977|466325207|FG000|Overall Study|Poor/non-compliance|3|||
129554097|NCT01042977|466325208|FG001|Overall Study|Poor/non-compliance|4|||
129554098|NCT01042977|466325207|FG000|Overall Study|Subject no longer meets study criteria|15|||
129554099|NCT01042977|466325208|FG001|Overall Study|Subject no longer meets study criteria|13|||
129554100|NCT01042977|466325207|FG000|Overall Study|Incorrect enrollment|6|||
129554101|NCT01042977|466325208|FG001|Overall Study|Incorrect enrollment|4|||
129554102|NCT01042977|466325207|FG000|Overall Study|Safety|0|||
129554103|NCT01042977|466325208|FG001|Overall Study|Safety|2|||
129554104|NCT01042977|466325207|FG000|Overall Study|Administrative reason by sponsor|0|||
129554105|NCT01042977|466325208|FG001|Overall Study|Administrative reason by sponsor|1|||
129554106|NCT01042977|466325207|FG000|Overall Study|Various|3|||
129554107|NCT01042977|466325208|FG001|Overall Study|Various|0|||
129554108|NCT02499354|466325209|FG000|Overall Study|Withdrawal by Subject|1|||
129554109|NCT02499354|466325210|FG001|Overall Study|Withdrawal by Subject|0|||
129554110|NCT02424565|466325213|FG000|Period 1 (D0)|Protocol Violation|0|||
129554111|NCT02424565|466325214|FG001|Period 1 (D0)|Protocol Violation|1|||
129554112|NCT03650400|466325215|FG000|Overall Study|Study terminated by sponsor|0|||
129554113|NCT03650400|466325216|FG001|Overall Study|Study terminated by sponsor|5|||
129554114|NCT01759381|466325217|FG000|Overall Study|Death|1|||
129554115|NCT01759381|466325218|FG001|Overall Study|Death|0|||
129554116|NCT00447603|466325220|FG000|Screening|Withdrawal by Subject|1|||
129554117|NCT00447603|466325221|FG001|Screening|Withdrawal by Subject|0|||
129554118|NCT00447603|466325222|FG002|Screening|Withdrawal by Subject|0|||
129554119|NCT00447603|466325220|FG000|Screening|Protocol Violation|1|||
129554120|NCT00447603|466325221|FG001|Screening|Protocol Violation|0|||
129554121|NCT00447603|466325222|FG002|Screening|Protocol Violation|0|||
129554122|NCT00447603|466325220|FG000|Screening|Screen Failure|4|||
129554123|NCT00447603|466325221|FG001|Screening|Screen Failure|0|||
129554124|NCT00447603|466325222|FG002|Screening|Screen Failure|0|||
129554125|NCT00447603|466325220|FG000|Screening|Study Terminated by Sponsor|15|||
129554126|NCT00447603|466325221|FG001|Screening|Study Terminated by Sponsor|0|||
129554127|NCT00447603|466325222|FG002|Screening|Study Terminated by Sponsor|0|||
129554128|NCT00447603|466325220|FG000|Filter Period|Adverse Event|0|||
129554129|NCT00447603|466325221|FG001|Filter Period|Adverse Event|0|||
129554130|NCT00447603|466325222|FG002|Filter Period|Adverse Event|1|||
129554131|NCT00447603|466325220|FG000|Filter Period|Screen Failure|0|||
129554132|NCT00447603|466325221|FG001|Filter Period|Screen Failure|3|||
129554133|NCT00447603|466325222|FG002|Filter Period|Screen Failure|4|||
129554134|NCT00447603|466325220|FG000|Filter Period|Study terminated by Sponsor|0|||
129554135|NCT00447603|466325221|FG001|Filter Period|Study terminated by Sponsor|1|||
129554136|NCT00447603|466325222|FG002|Filter Period|Study terminated by Sponsor|10|||
129554137|NCT04228302|466325226|FG000|Overall Study|Adverse Event|0|||
129686445|NCT00972738|466808870|FG001|Overall Study|Lost to Follow-up|0|||
129686446|NCT00972738|466808871|FG002|Overall Study|Lost to Follow-up|1|||
129686447|NCT00972738|466808869|FG000|Overall Study|Lack of Efficacy|5|||
129686448|NCT00972738|466808870|FG001|Overall Study|Lack of Efficacy|1|||
129686449|NCT00972738|466808871|FG002|Overall Study|Lack of Efficacy|11|||
129686450|NCT00972738|466808869|FG000|Overall Study|Withdrawal by Subject|5|||
129686451|NCT00972738|466808870|FG001|Overall Study|Withdrawal by Subject|1|||
129686452|NCT00972738|466808871|FG002|Overall Study|Withdrawal by Subject|4|||
129686453|NCT00972738|466808869|FG000|Overall Study|Moved|0|||
129554138|NCT04228302|466325227|FG001|Overall Study|Adverse Event|0|||
129554139|NCT04228302|466325228|FG002|Overall Study|Adverse Event|0|||
129554140|NCT04228302|466325229|FG003|Overall Study|Adverse Event|0|||
129554141|NCT04228302|466325230|FG004|Overall Study|Adverse Event|1|||
129554142|NCT04228302|466325231|FG005|Overall Study|Adverse Event|0|||
129554143|NCT02732561|466325233|FG000|Overall Study|Lost to Follow-up|1|||
129554144|NCT02732561|466325234|FG001|Overall Study|Lost to Follow-up|1|||
129554145|NCT02732561|466325233|FG000|Overall Study|Withdrawal by Subject|1|||
129554146|NCT02732561|466325234|FG001|Overall Study|Withdrawal by Subject|0|||
129554147|NCT02410837|466325241|FG000|Overall Study|Death|387|||
129554148|NCT02410837|466325241|FG000|Overall Study|Lost to Follow-up|50|||
129554149|NCT02410837|466325241|FG000|Overall Study|Withdrawal by Subject|44|||
129554150|NCT02410837|466325241|FG000|Overall Study|Physician Decision|6|||
129554151|NCT02410837|466325241|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
129554152|NCT00837577|466325242|FG000|Double-blind Period|Clinical Adverse Event|1|||
129554153|NCT00837577|466325243|FG001|Double-blind Period|Clinical Adverse Event|0|||
129554154|NCT00837577|466325242|FG000|Double-blind Period|Withdrawal by Subject|1|||
129554155|NCT00837577|466325243|FG001|Double-blind Period|Withdrawal by Subject|0|||
129554156|NCT00837577|466325242|FG000|Open-label Period|Clinical Adverse Event|2|||
129554157|NCT00837577|466325243|FG001|Open-label Period|Clinical Adverse Event|2|||
129554158|NCT00837577|466325242|FG000|Open-label Period|Laboratory Adverse Event|0|||
129554159|NCT00837577|466325243|FG001|Open-label Period|Laboratory Adverse Event|1|||
129554160|NCT00837577|466325242|FG000|Open-label Period|Lack of Efficacy|4|||
129554161|NCT00837577|466325243|FG001|Open-label Period|Lack of Efficacy|3|||
129554162|NCT00837577|466325242|FG000|Open-label Period|Withdrawal by Subject|1|||
129554163|NCT00837577|466325243|FG001|Open-label Period|Withdrawal by Subject|2|||
129554164|NCT00837577|466325242|FG000|Open-label Period|Other Reason|1|||
129554165|NCT00837577|466325243|FG001|Open-label Period|Other Reason|1|||
129686454|NCT00972738|466808870|FG001|Overall Study|Moved|0|||
129686455|NCT00972738|466808871|FG002|Overall Study|Moved|1|||
129686456|NCT00972738|466808869|FG000|Overall Study|Other|1|||
129686457|NCT00972738|466808870|FG001|Overall Study|Other|2|||
129686458|NCT00972738|466808871|FG002|Overall Study|Other|1|||
129686459|NCT03915067|466808872|FG000|Overall Study|Adverse Event|0|||
129686460|NCT03915067|466808873|FG001|Overall Study|Adverse Event|0|||
129686461|NCT03915067|466808874|FG002|Overall Study|Adverse Event|1|||
129686462|NCT03915067|466808872|FG000|Overall Study|Withdrawal by Subject|4|||
129686463|NCT03915067|466808873|FG001|Overall Study|Withdrawal by Subject|3|||
129686464|NCT03915067|466808874|FG002|Overall Study|Withdrawal by Subject|0|||
129686465|NCT03915067|466808872|FG000|Overall Study|Lost to Follow-up|3|||
129686466|NCT03915067|466808873|FG001|Overall Study|Lost to Follow-up|2|||
129686467|NCT03915067|466808874|FG002|Overall Study|Lost to Follow-up|0|||
129686468|NCT03915067|466808872|FG000|Overall Study|Protocol Deviation|0|||
129686469|NCT03915067|466808873|FG001|Overall Study|Protocol Deviation|0|||
129686470|NCT03915067|466808874|FG002|Overall Study|Protocol Deviation|1|||
129686471|NCT03915067|466808872|FG000|Overall Study|Covid-19 Related Issues|2|||
129686472|NCT03915067|466808873|FG001|Overall Study|Covid-19 Related Issues|4|||
129686473|NCT03915067|466808874|FG002|Overall Study|Covid-19 Related Issues|4|||
129686474|NCT03915067|466808872|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
129686475|NCT03915067|466808873|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
129686476|NCT03915067|466808874|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
129686477|NCT02034591|466808881|FG000|Overall Study|Withdrawal by Subject|0|||
129686478|NCT02034591|466808882|FG001|Overall Study|Withdrawal by Subject|0|||
129686479|NCT02034591|466808883|FG002|Overall Study|Withdrawal by Subject|0|||
129686480|NCT02034591|466808884|FG003|Overall Study|Withdrawal by Subject|0|||
129686481|NCT02034591|466808885|FG004|Overall Study|Withdrawal by Subject|1|||
129686482|NCT02034591|466808886|FG005|Overall Study|Withdrawal by Subject|0|||
129686483|NCT01793935|466808889|FG000|Overall Study|Pregnancy|1|||
129686484|NCT01793935|466808890|FG001|Overall Study|Pregnancy|0|||
129686485|NCT01793935|466808889|FG000|Overall Study|Protocol Violation|2|||
129686486|NCT01793935|466808890|FG001|Overall Study|Protocol Violation|1|||
129686487|NCT01793935|466808889|FG000|Overall Study|Adverse Event|2|||
129686488|NCT01793935|466808890|FG001|Overall Study|Adverse Event|0|||
129686489|NCT01793935|466808889|FG000|Overall Study|Patient did not take study medication|1|||
129686490|NCT01793935|466808890|FG001|Overall Study|Patient did not take study medication|1|||
129686491|NCT01793935|466808889|FG000|Overall Study|Lost to Follow-up|0|||
129554166|NCT03031431|466325248|FG000|Overall Study|Infant removed by maternal request|1|||
129554167|NCT01205529|466325249|FG000|Overall Study|Procedure Cancelled|4|||
129686492|NCT01793935|466808890|FG001|Overall Study|Lost to Follow-up|1|||
129686493|NCT01121926|466808891|FG000|First Intervention Period|Adverse Event|1|||
129686494|NCT01121926|466808892|FG001|First Intervention Period|Adverse Event|0|||
129686495|NCT01121926|466808891|FG000|Washout Period|Adverse Event|0|||
129686496|NCT01121926|466808892|FG001|Washout Period|Adverse Event|1|||
129554168|NCT01205529|466325249|FG000|Overall Study|Withdrawal by Subject|2|||
129554169|NCT01205529|466325249|FG000|Overall Study|Physician Decision|4|||
129775285|NCT02202759|467142854|FG002|Overall Study|Reason not Specified|10|||
129775286|NCT01987453|467142855|FG000|Overall Study|Death|0|||
129775287|NCT01987453|467142856|FG001|Overall Study|Death|0|||
129775288|NCT01987453|467142857|FG002|Overall Study|Death|1|||
129775289|NCT01987453|467142855|FG000|Overall Study|Lack of Efficacy|1|||
129775290|NCT01987453|467142856|FG001|Overall Study|Lack of Efficacy|12|||
129775291|NCT01987453|467142857|FG002|Overall Study|Lack of Efficacy|0|||
129775292|NCT01590888|467142859|FG000|Overall Study|Adverse Event|3|||
129775293|NCT01590888|467142860|FG001|Overall Study|Adverse Event|0|||
129775294|NCT01590888|467142861|FG002|Overall Study|Adverse Event|1|||
129775295|NCT01590888|467142859|FG000|Overall Study|Lost to Follow-up|1|||
129775296|NCT01590888|467142860|FG001|Overall Study|Lost to Follow-up|0|||
129775297|NCT01590888|467142861|FG002|Overall Study|Lost to Follow-up|0|||
129775298|NCT04953728|467142862|FG000|Overall Study|Withdrawal by Subject|3|||
129775299|NCT04953728|467142862|FG000|Overall Study|Physician Decision|1|||
129775300|NCT02105662|467142863|FG000|Overall Study|Lost to Follow-up|5|||
129775301|NCT02105662|467142863|FG000|Overall Study|Withdrawal by Subject|1|||
129775302|NCT02331277|467142866|FG000|Overall Study|Withdrawal by Subject|1|||
129775303|NCT02331277|467142867|FG001|Overall Study|Withdrawal by Subject|0|||
129775304|NCT03978117|467142868|FG000|Overall Study|Non-Compliance|26|||
129775305|NCT03978117|467142869|FG001|Overall Study|Non-Compliance|26|||
129775306|NCT03978117|467142868|FG000|Overall Study|Lost to Follow-up|4|||
129775307|NCT03978117|467142869|FG001|Overall Study|Lost to Follow-up|4|||
129775308|NCT01528969|467142876|FG000|Overall Study|absent from the school at baseline|2|||
129775309|NCT01528969|467142877|FG001|Overall Study|absent from the school at baseline|0|||
129775310|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
129775311|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
129775312|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
129775313|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
129775314|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
129775315|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129775316|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
129775317|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
129775318|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
129775319|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
129775320|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
129775321|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
129775322|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
129775323|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
129775324|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
129775325|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129775326|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129775327|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129775328|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
129775329|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129775330|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129800202|NCT00764504|467236235|FG002|Overall Study|Withdrawal by Subject|4|||
129800203|NCT00764504|467236233|FG000|Overall Study|Lost to Follow-up|40|||
129800204|NCT00764504|467236234|FG001|Overall Study|Lost to Follow-up|34|||
129800205|NCT00764504|467236235|FG002|Overall Study|Lost to Follow-up|72|||
129800206|NCT01638819|467236246|FG000|Overall Study|Lost to Follow-up|1|||
129800207|NCT01638819|467236247|FG001|Overall Study|Lost to Follow-up|0|||
129800208|NCT03538431|467236248|FG000|Overall Study|Physician Decision|0|||
129800209|NCT03538431|467236249|FG001|Overall Study|Physician Decision|1|||
129800210|NCT03538431|467236248|FG000|Overall Study|Withdrawal by Subject|1|||
129800211|NCT03538431|467236249|FG001|Overall Study|Withdrawal by Subject|0|||
129800212|NCT03911154|467236250|FG000|Overall Study|Withdrawal by Subject|1|||
129800213|NCT01278160|467236254|FG000|Overall Study|Adverse Event|1|||
129800214|NCT01278160|467236255|FG001|Overall Study|Adverse Event|1|||
129800215|NCT01278160|467236254|FG000|Overall Study|Lost to Follow-up|0|||
129800216|NCT01278160|467236255|FG001|Overall Study|Lost to Follow-up|1|||
129800217|NCT01278160|467236254|FG000|Overall Study|Withdrawal by Subject|3|||
129800218|NCT01278160|467236255|FG001|Overall Study|Withdrawal by Subject|2|||
129800219|NCT01278160|467236254|FG000|Overall Study|Unclassified|1|||
129800220|NCT01278160|467236255|FG001|Overall Study|Unclassified|2|||
129800221|NCT02898116|467236259|FG000|Overall Study|Adverse Event|1|||
129800222|NCT02898116|467236259|FG000|Overall Study|Progressive disease|1|||
129800223|NCT02891161|467236266|FG000|Study Treatment|Disease Progression|2|||
129800224|NCT02891161|467236267|FG001|Study Treatment|Disease Progression|4|||
129800225|NCT02891161|467236266|FG000|Study Treatment|AE/Side Effects/Complications|1|||
129800226|NCT02891161|467236267|FG001|Study Treatment|AE/Side Effects/Complications|5|||
129800227|NCT02891161|467236266|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
129800228|NCT02891161|467236267|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
129775331|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
129554170|NCT01205529|466325249|FG000|Overall Study|Unstable post op|15|||
129554171|NCT01205529|466325249|FG000|Overall Study|No longer met criteria|30|||
129554172|NCT01027884|466325254|FG000|Overall Study|Adverse Event|2|||
129554173|NCT01027884|466325255|FG001|Overall Study|Adverse Event|1|||
129775332|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129775333|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129775334|NCT01106690|467142878|FG000|Core Period: Baseline to Week 26|Other|10|||
129775335|NCT01106690|467142879|FG001|Core Period: Baseline to Week 26|Other|2|||
129775336|NCT01106690|467142880|FG002|Core Period: Baseline to Week 26|Other|6|||
129775337|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129775338|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129775339|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129775340|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129775341|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129775342|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129775343|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129775344|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129775345|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129775346|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129775347|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
129775348|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
129775349|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129775350|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129775351|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129775352|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Other|8|||
129775353|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Other|3|||
129775354|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Other|4|||
129775355|NCT01106690|467142878|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
129775356|NCT01106690|467142879|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129775357|NCT01106690|467142880|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129775358|NCT04614974|467142886|FG000|Overall Study|Lost to Follow-up|14|||
129775359|NCT04614974|467142887|FG001|Overall Study|Lost to Follow-up|11|||
129775360|NCT01635153|467142888|FG000|Overall Study|Lost to Follow-up|40|||
129775361|NCT01635153|467142889|FG001|Overall Study|Lost to Follow-up|43|||
129775362|NCT01263197|467142901|FG000|First Intervention (Period 1)|Adverse Event|0|||
129775363|NCT01263197|467142902|FG001|First Intervention (Period 1)|Adverse Event|0|||
129775364|NCT01263197|467142903|FG002|First Intervention (Period 1)|Adverse Event|0|||
129775365|NCT01263197|467142904|FG003|First Intervention (Period 1)|Adverse Event|0|||
129775366|NCT01263197|467142905|FG004|First Intervention (Period 1)|Adverse Event|0|||
129775367|NCT01263197|467142906|FG005|First Intervention (Period 1)|Adverse Event|1|||
129775368|NCT01263197|467142901|FG000|Washout Period 1|Protocol Violation|0|||
129775369|NCT01263197|467142902|FG001|Washout Period 1|Protocol Violation|0|||
129775370|NCT01263197|467142903|FG002|Washout Period 1|Protocol Violation|0|||
129775371|NCT01263197|467142904|FG003|Washout Period 1|Protocol Violation|0|||
129775372|NCT01263197|467142905|FG004|Washout Period 1|Protocol Violation|1|||
129775373|NCT01263197|467142906|FG005|Washout Period 1|Protocol Violation|0|||
129775374|NCT01263197|467142901|FG000|Washout Period 2|Physician Decision|0|||
129775375|NCT01263197|467142902|FG001|Washout Period 2|Physician Decision|0|||
129775376|NCT01263197|467142903|FG002|Washout Period 2|Physician Decision|0|||
129775377|NCT01263197|467142904|FG003|Washout Period 2|Physician Decision|0|||
129775378|NCT01263197|467142905|FG004|Washout Period 2|Physician Decision|0|||
129775379|NCT01263197|467142906|FG005|Washout Period 2|Physician Decision|1|||
129775380|NCT01263197|467142901|FG000|Washout Period 2|Protocol Violation|0|||
129775381|NCT01263197|467142902|FG001|Washout Period 2|Protocol Violation|0|||
129775382|NCT01263197|467142903|FG002|Washout Period 2|Protocol Violation|0|||
129775383|NCT01263197|467142904|FG003|Washout Period 2|Protocol Violation|1|||
129775384|NCT01263197|467142905|FG004|Washout Period 2|Protocol Violation|0|||
129775385|NCT01263197|467142906|FG005|Washout Period 2|Protocol Violation|0|||
129775386|NCT01263197|467142901|FG000|Third Intervention (Period 3)|Adverse Event|0|||
129775387|NCT01263197|467142902|FG001|Third Intervention (Period 3)|Adverse Event|1|||
129554174|NCT01027884|466325254|FG000|Overall Study|Protocol Violation|1|||
129775388|NCT01263197|467142903|FG002|Third Intervention (Period 3)|Adverse Event|0|||
129775389|NCT01263197|467142904|FG003|Third Intervention (Period 3)|Adverse Event|0|||
129775390|NCT01263197|467142905|FG004|Third Intervention (Period 3)|Adverse Event|0|||
129775391|NCT01263197|467142906|FG005|Third Intervention (Period 3)|Adverse Event|0|||
129775392|NCT02892448|467142907|FG000|Overall Study|Screening failure|2|||
129775393|NCT02892448|467142908|FG001|Overall Study|Screening failure|2|||
129775394|NCT02892448|467142909|FG002|Overall Study|Screening failure|1|||
129775395|NCT00499083|467142910|FG000|Overall Study|Not evaluable|3|||
129775396|NCT00686686|467142911|FG000|Overall Study|Non-compliance|1|||
129775397|NCT00686686|467142911|FG000|Overall Study|Adverse Event|2|||
129775398|NCT00686686|467142911|FG000|Overall Study|Lost to Follow-up|3|||
129775399|NCT01012440|467142912|FG000|Overall Study|Withdrawal by Subject|2|||
129775400|NCT01254422|467142916|FG000|Overall Study|Protocol Violation|1|||
129775401|NCT01254422|467142917|FG001|Overall Study|Protocol Violation|0|||
129775402|NCT01254422|467142916|FG000|Overall Study|Adverse Event|1|||
129775403|NCT01254422|467142917|FG001|Overall Study|Adverse Event|0|||
129775404|NCT01254422|467142916|FG000|Overall Study|Serious adverse event|0|||
129775405|NCT01254422|467142917|FG001|Overall Study|Serious adverse event|1|||
129775406|NCT01254422|467142916|FG000|Overall Study|Lost to Follow-up|1|||
129775407|NCT01254422|467142917|FG001|Overall Study|Lost to Follow-up|0|||
129775408|NCT00643162|467142918|FG000|Overall Study|Withdrawal by Subject|1|||
129775409|NCT00643162|467142919|FG001|Overall Study|Withdrawal by Subject|1|||
129775410|NCT02691507|467142920|FG000|Overall Study|Missed Visit 3|0|||
129775411|NCT02691507|467142921|FG001|Overall Study|Missed Visit 3|1|||
129775412|NCT00541385|467142922|FG000|Overall Study|Adverse Event|6|||
129775413|NCT00541385|467142923|FG001|Overall Study|Adverse Event|3|||
129775414|NCT00541385|467142922|FG000|Overall Study|Withdrawal by Subject|2|||
129775415|NCT00541385|467142923|FG001|Overall Study|Withdrawal by Subject|2|||
129775416|NCT00541385|467142922|FG000|Overall Study|Lost to Follow-up|6|||
129775417|NCT00541385|467142923|FG001|Overall Study|Lost to Follow-up|1|||
129775418|NCT00541385|467142922|FG000|Overall Study|Parasite reappearance/malaria|67|||
129775419|NCT00541385|467142923|FG001|Overall Study|Parasite reappearance/malaria|32|||
129775420|NCT04139798|467142925|FG000|Overall Study|Withdrawal by Subject|6|||
129775421|NCT04139798|467142926|FG001|Overall Study|Withdrawal by Subject|5|||
129775422|NCT04139798|467142925|FG000|Overall Study|Lost to Follow-up|2|||
129775423|NCT04139798|467142926|FG001|Overall Study|Lost to Follow-up|5|||
129775424|NCT04139798|467142925|FG000|Overall Study|Discontinued|4|||
129775425|NCT04139798|467142926|FG001|Overall Study|Discontinued|2|||
129775426|NCT04139798|467142925|FG000|Overall Study|Adverse Event|1|||
129775427|NCT04139798|467142926|FG001|Overall Study|Adverse Event|3|||
129775428|NCT04139798|467142925|FG000|Overall Study|Protocol Violation|1|||
129775429|NCT04139798|467142926|FG001|Overall Study|Protocol Violation|0|||
129775430|NCT03155841|467142927|FG000|Overall Study|Protocol Violation|3|||
129775431|NCT03155841|467142928|FG001|Overall Study|Protocol Violation|4|||
129775432|NCT02699749|467142931|FG000|Overall Study|Other|0|||
129775433|NCT02699749|467142932|FG001|Overall Study|Other|0|||
129775434|NCT02699749|467142933|FG002|Overall Study|Other|2|||
129775435|NCT02699749|467142934|FG003|Overall Study|Other|0|||
129775436|NCT02699749|467142935|FG004|Overall Study|Other|0|||
129775437|NCT02699749|467142936|FG005|Overall Study|Other|1|||
129775438|NCT02699749|467142937|FG006|Overall Study|Other|1|||
129775439|NCT02699749|467142938|FG007|Overall Study|Other|0|||
129775440|NCT02699749|467142939|FG008|Overall Study|Other|0|||
129775441|NCT02699749|467142940|FG009|Overall Study|Other|0|||
129775442|NCT02699749|467142941|FG010|Overall Study|Other|1|||
129775443|NCT02699749|467142942|FG011|Overall Study|Other|0|||
129775444|NCT02699749|467142943|FG012|Overall Study|Other|0|||
129775445|NCT02699749|467142944|FG013|Overall Study|Other|0|||
129775446|NCT02699749|467142931|FG000|Overall Study|Progressive Disease|3|||
129775447|NCT02699749|467142932|FG001|Overall Study|Progressive Disease|3|||
129775448|NCT02699749|467142933|FG002|Overall Study|Progressive Disease|14|||
129775449|NCT02699749|467142934|FG003|Overall Study|Progressive Disease|3|||
129775450|NCT02699749|467142935|FG004|Overall Study|Progressive Disease|3|||
129775451|NCT02699749|467142936|FG005|Overall Study|Progressive Disease|7|||
129775452|NCT02699749|467142937|FG006|Overall Study|Progressive Disease|5|||
129775453|NCT02699749|467142938|FG007|Overall Study|Progressive Disease|5|||
129775454|NCT02699749|467142939|FG008|Overall Study|Progressive Disease|6|||
129775455|NCT02699749|467142940|FG009|Overall Study|Progressive Disease|6|||
129775456|NCT02699749|467142941|FG010|Overall Study|Progressive Disease|5|||
129775457|NCT02699749|467142942|FG011|Overall Study|Progressive Disease|4|||
129775458|NCT02699749|467142943|FG012|Overall Study|Progressive Disease|3|||
129775459|NCT02699749|467142944|FG013|Overall Study|Progressive Disease|5|||
129775460|NCT02699749|467142931|FG000|Overall Study|Death|0|||
129775461|NCT02699749|467142932|FG001|Overall Study|Death|0|||
129775462|NCT02699749|467142933|FG002|Overall Study|Death|0|||
129775463|NCT02699749|467142934|FG003|Overall Study|Death|0|||
129775464|NCT02699749|467142935|FG004|Overall Study|Death|0|||
129775465|NCT02699749|467142936|FG005|Overall Study|Death|0|||
129775466|NCT02699749|467142937|FG006|Overall Study|Death|0|||
129775467|NCT02699749|467142938|FG007|Overall Study|Death|0|||
129775468|NCT02699749|467142939|FG008|Overall Study|Death|0|||
129554175|NCT01027884|466325255|FG001|Overall Study|Protocol Violation|0|||
129554176|NCT01027884|466325254|FG000|Overall Study|Non-compliance|1|||
129554177|NCT01027884|466325255|FG001|Overall Study|Non-compliance|1|||
129554178|NCT01027884|466325254|FG000|Overall Study|Withdrawal by Subject|0|||
129554179|NCT01027884|466325255|FG001|Overall Study|Withdrawal by Subject|1|||
129554180|NCT01027884|466325254|FG000|Overall Study|Lost to Follow-up|0|||
129554181|NCT01027884|466325255|FG001|Overall Study|Lost to Follow-up|1|||
129554182|NCT01027884|466325254|FG000|Overall Study|Spinal fixation surgery|0|||
129554183|NCT01027884|466325255|FG001|Overall Study|Spinal fixation surgery|3|||
129554184|NCT03670537|466325256|FG000|Overall Study|Protocol Violation|1|||
129554185|NCT02059187|466325257|FG000|Overall Study|Adverse Event|0|||
129554186|NCT02059187|466325258|FG001|Overall Study|Adverse Event|3|||
129554187|NCT02059187|466325257|FG000|Overall Study|Death|1|||
129554188|NCT02059187|466325258|FG001|Overall Study|Death|1|||
129554189|NCT02059187|466325257|FG000|Overall Study|Lost to Follow-up|9|||
129554190|NCT02059187|466325258|FG001|Overall Study|Lost to Follow-up|8|||
129554191|NCT02059187|466325257|FG000|Overall Study|Non-compliance with study drug|1|||
129554192|NCT02059187|466325258|FG001|Overall Study|Non-compliance with study drug|0|||
129554193|NCT02059187|466325257|FG000|Overall Study|Physician Decision|1|||
129554194|NCT02059187|466325258|FG001|Overall Study|Physician Decision|2|||
129554195|NCT02059187|466325257|FG000|Overall Study|Protocol Violation|1|||
129554196|NCT02059187|466325258|FG001|Overall Study|Protocol Violation|0|||
129554197|NCT02059187|466325257|FG000|Overall Study|Withdrawal by Subject|12|||
129554198|NCT02059187|466325258|FG001|Overall Study|Withdrawal by Subject|8|||
129554199|NCT03070431|466325259|FG000|Overall Study|Withdrawal by Subject|2|||
129554200|NCT03070431|466325259|FG000|Overall Study|Lost to Follow-up|2|||
129554201|NCT01889862|466325260|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
129554202|NCT01889862|466325261|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
129554203|NCT01889862|466325262|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
129554204|NCT01889862|466325263|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
129554205|NCT01889862|466325264|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
129554206|NCT01889862|466325260|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
129554207|NCT01889862|466325261|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
129554208|NCT01889862|466325262|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
129554209|NCT01889862|466325263|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
129554210|NCT01889862|466325264|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
129554211|NCT01889862|466325260|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
129554212|NCT01889862|466325261|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
129554213|NCT01889862|466325262|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
129554214|NCT01889862|466325263|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
129554215|NCT01889862|466325264|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
129554216|NCT01889862|466325260|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
129554217|NCT01889862|466325261|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
129554218|NCT01889862|466325262|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
129554219|NCT01889862|466325263|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
129554220|NCT01889862|466325264|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
129554221|NCT01889862|466325260|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
129554222|NCT01889862|466325261|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
129554223|NCT01889862|466325262|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
129554224|NCT01889862|466325263|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
129554225|NCT01889862|466325264|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
129554226|NCT01889862|466325260|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
129554227|NCT01889862|466325261|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
129554228|NCT01889862|466325262|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
129554229|NCT01889862|466325263|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
129554230|NCT01889862|466325264|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
129554231|NCT01889862|466325260|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
129686497|NCT01121926|466808891|FG000|Washout Period|Positive pregnancy test|0|||
129686498|NCT01121926|466808892|FG001|Washout Period|Positive pregnancy test|1|||
129686499|NCT00416949|466808894|FG000|Overall Study|Patients refused to participate|5|||
129686500|NCT00313170|466808895|FG000|Overall Study|Death|2|||
129686501|NCT00313170|466808896|FG001|Overall Study|Death|4|||
129686502|NCT00313170|466808897|FG002|Overall Study|Death|2|||
129686503|NCT00313170|466808895|FG000|Overall Study|Adverse Event|1|||
129686504|NCT00313170|466808896|FG001|Overall Study|Adverse Event|2|||
129686505|NCT00313170|466808897|FG002|Overall Study|Adverse Event|0|||
129686506|NCT00313170|466808895|FG000|Overall Study|Disease progression|31|||
129686507|NCT00313170|466808896|FG001|Overall Study|Disease progression|26|||
129686508|NCT00313170|466808897|FG002|Overall Study|Disease progression|27|||
129686509|NCT00313170|466808895|FG000|Overall Study|Withdrawal by Subject|1|||
129686510|NCT00313170|466808896|FG001|Overall Study|Withdrawal by Subject|0|||
129686511|NCT00313170|466808897|FG002|Overall Study|Withdrawal by Subject|1|||
129554232|NCT01889862|466325261|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
129554233|NCT01889862|466325262|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
129554234|NCT01889862|466325263|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
129554235|NCT01889862|466325264|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
129775469|NCT02699749|467142940|FG009|Overall Study|Death|0|||
129775470|NCT02699749|467142941|FG010|Overall Study|Death|0|||
129775471|NCT02699749|467142942|FG011|Overall Study|Death|0|||
129775472|NCT02699749|467142943|FG012|Overall Study|Death|0|||
129775473|NCT02699749|467142944|FG013|Overall Study|Death|1|||
129775474|NCT02699749|467142931|FG000|Overall Study|Lost to Follow-up|0|||
129775475|NCT02699749|467142932|FG001|Overall Study|Lost to Follow-up|0|||
129775476|NCT02699749|467142933|FG002|Overall Study|Lost to Follow-up|0|||
129775477|NCT02699749|467142934|FG003|Overall Study|Lost to Follow-up|0|||
129775478|NCT02699749|467142935|FG004|Overall Study|Lost to Follow-up|0|||
129775479|NCT02699749|467142936|FG005|Overall Study|Lost to Follow-up|1|||
129775480|NCT02699749|467142937|FG006|Overall Study|Lost to Follow-up|0|||
129775481|NCT02699749|467142938|FG007|Overall Study|Lost to Follow-up|1|||
129775482|NCT02699749|467142939|FG008|Overall Study|Lost to Follow-up|0|||
129775483|NCT02699749|467142940|FG009|Overall Study|Lost to Follow-up|0|||
129775484|NCT02699749|467142941|FG010|Overall Study|Lost to Follow-up|0|||
129775485|NCT02699749|467142942|FG011|Overall Study|Lost to Follow-up|0|||
129775486|NCT02699749|467142943|FG012|Overall Study|Lost to Follow-up|0|||
129775487|NCT02699749|467142944|FG013|Overall Study|Lost to Follow-up|0|||
129775488|NCT02157883|467142946|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
129775489|NCT02157883|467142946|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
129775490|NCT02157883|467142946|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
129775491|NCT02157883|467142946|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
129775492|NCT02157883|467142946|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
129775493|NCT00888940|467142947|FG000|Overall Study|Adverse Event|12|||
129775494|NCT00888940|467142948|FG001|Overall Study|Adverse Event|3|||
129775495|NCT00888940|467142947|FG000|Overall Study|Lost to Follow-up|5|||
129775496|NCT00888940|467142948|FG001|Overall Study|Lost to Follow-up|5|||
129775497|NCT00888940|467142947|FG000|Overall Study|Randomized Not Treated|11|||
129775498|NCT00888940|467142948|FG001|Overall Study|Randomized Not Treated|13|||
129775499|NCT01578486|467142949|FG000|Overall Study|Physician Decision|3|||
129775500|NCT01578486|467142949|FG000|Overall Study|Withdrawal by Subject|2|||
129775501|NCT02536963|467142950|FG000|Overall Study|Withdrawal by Subject|18|||
129775502|NCT02668393|467142952|FG000|Overall Study|Progressive disease|6|||
129775503|NCT02668393|467142953|FG001|Overall Study|Progressive disease|3|||
129775504|NCT02668393|467142952|FG000|Overall Study|Adverse Event|0|||
129775505|NCT02668393|467142953|FG001|Overall Study|Adverse Event|2|||
129775506|NCT02668393|467142952|FG000|Overall Study|Withdrawal from the trial|0|||
129775507|NCT02668393|467142953|FG001|Overall Study|Withdrawal from the trial|1|||
129775508|NCT02668393|467142952|FG000|Overall Study|Lack of benefit and side effects|1|||
129775509|NCT02668393|467142953|FG001|Overall Study|Lack of benefit and side effects|0|||
129775510|NCT02141204|467142954|FG000|Overall Study|Lost to Follow-up|2|||
129775511|NCT02141204|467142955|FG001|Overall Study|Lost to Follow-up|1|||
129775512|NCT02141204|467142954|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
129686512|NCT00313170|466808895|FG000|Overall Study|Incorrect enrollment|0|||
129686513|NCT00313170|466808896|FG001|Overall Study|Incorrect enrollment|2|||
129686514|NCT00313170|466808897|FG002|Overall Study|Incorrect enrollment|1|||
129686515|NCT00313170|466808895|FG000|Overall Study|Lost to Follow-up|0|||
129686516|NCT00313170|466808896|FG001|Overall Study|Lost to Follow-up|0|||
129686517|NCT00313170|466808897|FG002|Overall Study|Lost to Follow-up|1|||
129686518|NCT00313170|466808895|FG000|Overall Study|Progression (investigators opinion)|1|||
129686519|NCT00313170|466808896|FG001|Overall Study|Progression (investigators opinion)|0|||
129686520|NCT00313170|466808897|FG002|Overall Study|Progression (investigators opinion)|0|||
129686521|NCT01410604|466808899|FG000|Overall Study|Adverse Event|2|||
129686522|NCT01410604|466808900|FG001|Overall Study|Adverse Event|1|||
129686523|NCT01410604|466808899|FG000|Overall Study|Lost to Follow-up|1|||
129686524|NCT01410604|466808900|FG001|Overall Study|Lost to Follow-up|0|||
129775513|NCT02141204|467142955|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
129775514|NCT02141204|467142954|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
129775515|NCT02141204|467142955|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
129775516|NCT02141204|467142954|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
129775517|NCT02141204|467142955|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
129554236|NCT01889862|466325260|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
129554237|NCT01889862|466325261|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
129554238|NCT01889862|466325262|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
129554239|NCT01889862|466325263|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
129554240|NCT01889862|466325264|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
129554241|NCT01889862|466325260|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
129554242|NCT01889862|466325261|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
129554243|NCT01889862|466325262|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
129554244|NCT01889862|466325263|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
129554245|NCT01889862|466325264|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
129554246|NCT01889862|466325260|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
129554247|NCT01889862|466325261|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
129554248|NCT01889862|466325262|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
129554249|NCT01889862|466325263|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
129554250|NCT01889862|466325264|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
129554251|NCT02065791|466325265|FG000|Overall Study|Closed Site|1|||
129554252|NCT02065791|466325266|FG001|Overall Study|Closed Site|1|||
129554253|NCT02065791|466325265|FG000|Overall Study|Withdrawal by Subject|11|||
129554254|NCT02065791|466325266|FG001|Overall Study|Withdrawal by Subject|5|||
129554255|NCT02065791|466325265|FG000|Overall Study|Lost to Follow-up|13|||
129554256|NCT02065791|466325266|FG001|Overall Study|Lost to Follow-up|9|||
129554257|NCT00272961|466325267|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
129554258|NCT00272961|466325268|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
129554259|NCT00272961|466325269|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
129554260|NCT00272961|466325270|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
129554261|NCT00272961|466325271|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
129554262|NCT00272961|466325267|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
129554263|NCT00272961|466325268|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
129554264|NCT00272961|466325269|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
129554265|NCT00272961|466325270|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
129554266|NCT00272961|466325271|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
129554267|NCT00272961|466325267|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
129554268|NCT00272961|466325268|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
129554269|NCT00272961|466325269|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
129554270|NCT00272961|466325270|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
129554271|NCT00272961|466325271|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
129554272|NCT00272961|466325267|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
129554273|NCT00272961|466325268|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
129554274|NCT00272961|466325269|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
129554275|NCT00272961|466325270|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
129554276|NCT00272961|466325271|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
129554277|NCT00272961|466325267|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
129554278|NCT00272961|466325268|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
129554279|NCT00272961|466325269|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
129554280|NCT00272961|466325270|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
129554281|NCT00272961|466325271|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
129554282|NCT00272961|466325267|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
129554283|NCT00272961|466325268|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
129554284|NCT00272961|466325269|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
129554285|NCT00272961|466325270|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
129554286|NCT00272961|466325271|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
129554287|NCT00272961|466325267|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
129554288|NCT00272961|466325268|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
129554289|NCT00272961|466325269|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
129554290|NCT00272961|466325270|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
129554291|NCT00272961|466325271|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
129554292|NCT00272961|466325267|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
129554293|NCT00272961|466325268|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
129554294|NCT00272961|466325269|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
129554295|NCT00272961|466325270|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
129554296|NCT00272961|466325271|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
129554297|NCT00106028|466325281|FG000|Overall Study|Adverse Event|3|||
129554298|NCT00106028|466325282|FG001|Overall Study|Adverse Event|2|||
129686525|NCT01410604|466808899|FG000|Overall Study|Physician Decision|0|||
129686526|NCT01410604|466808900|FG001|Overall Study|Physician Decision|1|||
129686527|NCT00529035|466808902|FG000|Overall Study|Withdrawal by Subject|1|||
129686528|NCT03439514|466808903|FG000|Double-Blind Treatment Period|Other|4|||
129686529|NCT03439514|466808904|FG001|Double-Blind Treatment Period|Other|1|||
129775518|NCT00607373|467142956|FG000|Treatment Period|Adverse Event|0|||
129686530|NCT03439514|466808903|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
129686531|NCT03439514|466808904|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129686532|NCT03439514|466808903|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
129686533|NCT03439514|466808904|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
129686534|NCT03439514|466808903|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
129686535|NCT03439514|466808904|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
129686536|NCT03439514|466808903|FG000|Double-Blind Treatment Period|Death|1|||
129686537|NCT03439514|466808904|FG001|Double-Blind Treatment Period|Death|2|||
129686538|NCT02175758|466808905|FG000|Treatment Phase|Lost to Follow-up|0|||
129686539|NCT02175758|466808906|FG001|Treatment Phase|Lost to Follow-up|1|||
129686540|NCT02175758|466808907|FG002|Treatment Phase|Lost to Follow-up|0|||
129686541|NCT02175758|466808908|FG003|Treatment Phase|Lost to Follow-up|0|||
129686542|NCT02175758|466808909|FG004|Treatment Phase|Lost to Follow-up|0|||
129686543|NCT02175758|466808910|FG005|Treatment Phase|Lost to Follow-up|0|||
129686544|NCT02175758|466808905|FG000|Treatment Phase|Adverse Event|0|||
129686545|NCT02175758|466808906|FG001|Treatment Phase|Adverse Event|0|||
129686546|NCT02175758|466808907|FG002|Treatment Phase|Adverse Event|0|||
129686547|NCT02175758|466808908|FG003|Treatment Phase|Adverse Event|0|||
129686548|NCT02175758|466808909|FG004|Treatment Phase|Adverse Event|1|||
129554299|NCT00106028|466325281|FG000|Overall Study|Protocol Violation|1|||
129554300|NCT00106028|466325282|FG001|Overall Study|Protocol Violation|1|||
129554301|NCT00106028|466325281|FG000|Overall Study|Withdrawal by Subject|2|||
129554302|NCT00106028|466325282|FG001|Overall Study|Withdrawal by Subject|8|||
129554303|NCT00106028|466325281|FG000|Overall Study|Lost to Follow-up|0|||
129554304|NCT00106028|466325282|FG001|Overall Study|Lost to Follow-up|1|||
129554305|NCT01280981|466325283|FG000|Overall Study|Withdrawal by Subject|11|||
129554306|NCT01280981|466325283|FG000|Overall Study|Protocol Violation|2|||
129554307|NCT01280981|466325283|FG000|Overall Study|Lack of Efficacy|13|||
129554308|NCT01280981|466325283|FG000|Overall Study|Lost to Follow-up|3|||
129554309|NCT01280981|466325283|FG000|Overall Study|Adverse Event|6|||
129554310|NCT01280981|466325283|FG000|Overall Study|Irregular or discontinued menses|3|||
129554311|NCT01280981|466325283|FG000|Overall Study|Failed to return|45|||
129554312|NCT01280981|466325283|FG000|Overall Study|Non-compliance with protocol|3|||
129554313|NCT01280981|466325283|FG000|Overall Study|Withdrawal of consent|3|||
129554314|NCT01280981|466325283|FG000|Overall Study|Elective surgery|2|||
129554315|NCT01280981|466325283|FG000|Overall Study|Study site closure|1|||
129554316|NCT06371079|466325285|FG000|Overall Study|Missing data|88|||
129554317|NCT06371079|466325286|FG001|Overall Study|Missing data|247|||
129554318|NCT01256398|466325287|FG000|Overall Study|Withdrawal by Subject|1|||
129554319|NCT00411762|466325289|FG000|Overall Study|Withdrawal by Subject|5|||
129554320|NCT03276962|466325290|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
129554321|NCT03276962|466325291|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
129554322|NCT03276962|466325292|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
129554323|NCT03276962|466325293|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
129554324|NCT03276962|466325294|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
129554325|NCT03276962|466325290|FG000|Overall Study|Protocol Deviation|2|||
129554326|NCT03276962|466325291|FG001|Overall Study|Protocol Deviation|0|||
129554327|NCT03276962|466325292|FG002|Overall Study|Protocol Deviation|1|||
129554328|NCT03276962|466325293|FG003|Overall Study|Protocol Deviation|2|||
129554329|NCT03276962|466325294|FG004|Overall Study|Protocol Deviation|1|||
129554330|NCT03276962|466325290|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
129554331|NCT03276962|466325291|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
129554332|NCT03276962|466325292|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
129554333|NCT03276962|466325293|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
129554334|NCT03276962|466325294|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
129554335|NCT03276962|466325290|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
129554336|NCT03276962|466325291|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
129554337|NCT03276962|466325292|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
129554338|NCT03276962|466325293|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
129554339|NCT03276962|466325294|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
129554340|NCT03276962|466325290|FG000|Overall Study|Lost to Follow-up|10|||
129554341|NCT03276962|466325291|FG001|Overall Study|Lost to Follow-up|10|||
129554342|NCT03276962|466325292|FG002|Overall Study|Lost to Follow-up|4|||
129554343|NCT03276962|466325293|FG003|Overall Study|Lost to Follow-up|6|||
129554344|NCT03276962|466325294|FG004|Overall Study|Lost to Follow-up|10|||
129554345|NCT03276962|466325290|FG000|Overall Study|Other|0|||
129554346|NCT03276962|466325291|FG001|Overall Study|Other|2|||
129554347|NCT03276962|466325292|FG002|Overall Study|Other|0|||
129554348|NCT03276962|466325293|FG003|Overall Study|Other|2|||
129686549|NCT02175758|466808910|FG005|Treatment Phase|Adverse Event|0|||
129686550|NCT01482221|466808913|FG000|Overall Study|Lack of Efficacy|1|||
129686551|NCT01482221|466808914|FG001|Overall Study|Lack of Efficacy|0|||
129686552|NCT01482221|466808915|FG002|Overall Study|Lack of Efficacy|1|||
129686553|NCT01482221|466808913|FG000|Overall Study|Lost to Follow-up|3|||
129686554|NCT01482221|466808914|FG001|Overall Study|Lost to Follow-up|2|||
129686555|NCT01482221|466808915|FG002|Overall Study|Lost to Follow-up|1|||
129686556|NCT01482221|466808913|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
129686557|NCT01482221|466808914|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
129686558|NCT01482221|466808915|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
129686559|NCT01482221|466808913|FG000|Overall Study|Condition under Investigation Worsened|3|||
129686560|NCT01482221|466808914|FG001|Overall Study|Condition under Investigation Worsened|2|||
129686561|NCT01482221|466808915|FG002|Overall Study|Condition under Investigation Worsened|4|||
129686562|NCT01482221|466808913|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
129554349|NCT03276962|466325294|FG004|Overall Study|Other|1|||
129554350|NCT01238211|466325295|FG000|Overall Study|Continues active treatment|31|||
129554351|NCT01238211|466325295|FG000|Overall Study|Adverse Event|7|||
129554352|NCT01238211|466325295|FG000|Overall Study|Death|4|||
129554353|NCT01238211|466325295|FG000|Overall Study|Relapse/Progression|2|||
129554354|NCT01238211|466325295|FG000|Overall Study|Withdrawal by Subject|7|||
129554355|NCT01238211|466325295|FG000|Overall Study|Non-protocol treatment|4|||
129686563|NCT01482221|466808914|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
129554356|NCT01238211|466325295|FG000|Overall Study|Investigator/Patient Decision|3|||
129554357|NCT04428502|466325296|FG000|Overall Study|Did not meet entrance criteria|14|||
129554358|NCT03550794|466325307|FG000|Overall Study|No longer met inclusion criteria|1|||
129554359|NCT03550794|466325308|FG001|Overall Study|No longer met inclusion criteria|2|||
129554360|NCT03550794|466325307|FG000|Overall Study|Goals of care changed|1|||
129554361|NCT03550794|466325308|FG001|Overall Study|Goals of care changed|0|||
129554362|NCT03550794|466325307|FG000|Overall Study|Withdrawal by Subject|2|||
129554363|NCT03550794|466325308|FG001|Overall Study|Withdrawal by Subject|0|||
129554364|NCT03550794|466325307|FG000|Overall Study|Death|0|||
129554365|NCT03550794|466325308|FG001|Overall Study|Death|1|||
129554366|NCT01629693|466325313|FG000|Overall Study|Lost to Follow-up|2|||
129554367|NCT01629693|466325314|FG001|Overall Study|Lost to Follow-up|4|||
129554368|NCT01629693|466325313|FG000|Overall Study|Withdrawal by Subject|2|||
129554369|NCT01629693|466325314|FG001|Overall Study|Withdrawal by Subject|2|||
129554370|NCT01629693|466325313|FG000|Overall Study|Adverse Event|1|||
129554371|NCT01629693|466325314|FG001|Overall Study|Adverse Event|0|||
129554372|NCT01629693|466325313|FG000|Overall Study|Investigator decision|0|||
129554373|NCT01629693|466325314|FG001|Overall Study|Investigator decision|1|||
129554374|NCT01629693|466325313|FG000|Overall Study|Poor comfort of study lenses|0|||
129554375|NCT01629693|466325314|FG001|Overall Study|Poor comfort of study lenses|2|||
129554376|NCT01629693|466325313|FG000|Overall Study|Subject decision unrelated to AE|0|||
129554377|NCT01629693|466325314|FG001|Overall Study|Subject decision unrelated to AE|1|||
129554378|NCT04385199|466325315|FG000|Overall Study|Withdrawal by Subject|1|||
129554379|NCT04385199|466325316|FG001|Overall Study|Withdrawal by Subject|0|||
129554380|NCT00579254|466325319|FG000|Overall Study|Lost to Follow-up|39|||
129554381|NCT00579254|466325319|FG000|Overall Study|Discontinued when study terminated|73|||
129554382|NCT02557672|466325320|FG000|Overall Study|Withdrawal by Subject|4|||
129554383|NCT02557672|466325321|FG001|Overall Study|Withdrawal by Subject|2|||
129554384|NCT03705169|466325322|FG000|Overall Study|Lost to Follow-up|0|||
129554385|NCT03705169|466325323|FG001|Overall Study|Lost to Follow-up|0|||
129554386|NCT03705169|466325324|FG002|Overall Study|Lost to Follow-up|0|||
129554387|NCT03705169|466325325|FG003|Overall Study|Lost to Follow-up|2|||
129554388|NCT03705169|466325326|FG004|Overall Study|Lost to Follow-up|0|||
129554389|NCT03705169|466325327|FG005|Overall Study|Lost to Follow-up|2|||
129554390|NCT03705169|466325328|FG006|Overall Study|Lost to Follow-up|1|||
129554391|NCT03705169|466325329|FG007|Overall Study|Lost to Follow-up|0|||
129554392|NCT03705169|466325330|FG008|Overall Study|Lost to Follow-up|0|||
129554393|NCT03705169|466325331|FG009|Overall Study|Lost to Follow-up|1|||
129554394|NCT03705169|466325322|FG000|Overall Study|Adverse Event|0|||
129554395|NCT03705169|466325323|FG001|Overall Study|Adverse Event|0|||
129554396|NCT03705169|466325324|FG002|Overall Study|Adverse Event|0|||
129554397|NCT03705169|466325325|FG003|Overall Study|Adverse Event|1|||
129554398|NCT03705169|466325326|FG004|Overall Study|Adverse Event|0|||
129554399|NCT03705169|466325327|FG005|Overall Study|Adverse Event|0|||
129554400|NCT03705169|466325328|FG006|Overall Study|Adverse Event|0|||
129554401|NCT03705169|466325329|FG007|Overall Study|Adverse Event|0|||
129554402|NCT03705169|466325330|FG008|Overall Study|Adverse Event|0|||
129554403|NCT03705169|466325331|FG009|Overall Study|Adverse Event|0|||
129554404|NCT03705169|466325322|FG000|Overall Study|Site Closure|0|||
129554405|NCT03705169|466325323|FG001|Overall Study|Site Closure|0|||
129554406|NCT03705169|466325324|FG002|Overall Study|Site Closure|0|||
129554407|NCT03705169|466325325|FG003|Overall Study|Site Closure|1|||
129554408|NCT03705169|466325326|FG004|Overall Study|Site Closure|0|||
129554409|NCT03705169|466325327|FG005|Overall Study|Site Closure|0|||
129554410|NCT03705169|466325328|FG006|Overall Study|Site Closure|0|||
129686564|NCT01482221|466808915|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
129686565|NCT01482221|466808913|FG000|Overall Study|Adverse Event|1|||
129686566|NCT01482221|466808914|FG001|Overall Study|Adverse Event|7|||
129686567|NCT01482221|466808915|FG002|Overall Study|Adverse Event|3|||
129686568|NCT01482221|466808913|FG000|Overall Study|Withdrawal by Subject|10|||
129686569|NCT01482221|466808914|FG001|Overall Study|Withdrawal by Subject|7|||
129686570|NCT01482221|466808915|FG002|Overall Study|Withdrawal by Subject|12|||
129686571|NCT01482221|466808913|FG000|Overall Study|Incorrect randomization|0|||
129686572|NCT01482221|466808914|FG001|Overall Study|Incorrect randomization|1|||
129686573|NCT01482221|466808915|FG002|Overall Study|Incorrect randomization|0|||
129686574|NCT01482221|466808913|FG000|Overall Study|Physician Decision|0|||
129686575|NCT01482221|466808914|FG001|Overall Study|Physician Decision|1|||
129686576|NCT01482221|466808915|FG002|Overall Study|Physician Decision|0|||
129554411|NCT03705169|466325329|FG007|Overall Study|Site Closure|0|||
129554412|NCT03705169|466325330|FG008|Overall Study|Site Closure|0|||
129686577|NCT01047501|466808917|FG000|Overall Study|Adverse Event|7|||
129686578|NCT01047501|466808918|FG001|Overall Study|Adverse Event|8|||
129686579|NCT01047501|466808919|FG002|Overall Study|Adverse Event|5|||
129686580|NCT01047501|466808917|FG000|Overall Study|Withdrew Consent|6|||
129554413|NCT03705169|466325331|FG009|Overall Study|Site Closure|0|||
129554414|NCT03705169|466325322|FG000|Overall Study|Did not receive study treatment|0|||
129554415|NCT03705169|466325323|FG001|Overall Study|Did not receive study treatment|0|||
129554416|NCT03705169|466325324|FG002|Overall Study|Did not receive study treatment|0|||
129554417|NCT03705169|466325325|FG003|Overall Study|Did not receive study treatment|1|||
129554418|NCT03705169|466325326|FG004|Overall Study|Did not receive study treatment|0|||
129686581|NCT01047501|466808918|FG001|Overall Study|Withdrew Consent|2|||
129686582|NCT01047501|466808919|FG002|Overall Study|Withdrew Consent|4|||
129554419|NCT03705169|466325327|FG005|Overall Study|Did not receive study treatment|0|||
129554420|NCT03705169|466325328|FG006|Overall Study|Did not receive study treatment|0|||
129554421|NCT03705169|466325329|FG007|Overall Study|Did not receive study treatment|0|||
129554422|NCT03705169|466325330|FG008|Overall Study|Did not receive study treatment|0|||
129554423|NCT03705169|466325331|FG009|Overall Study|Did not receive study treatment|0|||
129554424|NCT03705169|466325322|FG000|Overall Study|Concerns about study visit compliance|0|||
129554425|NCT03705169|466325323|FG001|Overall Study|Concerns about study visit compliance|0|||
129554426|NCT03705169|466325324|FG002|Overall Study|Concerns about study visit compliance|0|||
129554427|NCT03705169|466325325|FG003|Overall Study|Concerns about study visit compliance|1|||
129554428|NCT03705169|466325326|FG004|Overall Study|Concerns about study visit compliance|0|||
129554429|NCT03705169|466325327|FG005|Overall Study|Concerns about study visit compliance|0|||
129554430|NCT03705169|466325328|FG006|Overall Study|Concerns about study visit compliance|0|||
129554431|NCT03705169|466325329|FG007|Overall Study|Concerns about study visit compliance|0|||
129554432|NCT03705169|466325330|FG008|Overall Study|Concerns about study visit compliance|0|||
129554433|NCT03705169|466325331|FG009|Overall Study|Concerns about study visit compliance|0|||
129554434|NCT00420290|466325332|FG000|Overall Study|Adverse Event|3|||
129554435|NCT00420290|466325333|FG001|Overall Study|Adverse Event|1|||
129554436|NCT00420290|466325332|FG000|Overall Study|Withdrawal by Subject|0|||
129554437|NCT00420290|466325333|FG001|Overall Study|Withdrawal by Subject|2|||
129554438|NCT00420290|466325332|FG000|Overall Study|did not meet inclusion/exclusion|1|||
129554439|NCT00420290|466325333|FG001|Overall Study|did not meet inclusion/exclusion|1|||
129554440|NCT01963676|466326981|FG000|Overall Study|Withdrawal by Subject|1|||
129554441|NCT01963676|466326982|FG001|Overall Study|Withdrawal by Subject|0|||
129554442|NCT01246973|466326983|FG000|Overall Study|Other|38|||
129554443|NCT01246973|466326984|FG001|Overall Study|Other|25|||
129554444|NCT01246973|466326983|FG000|Overall Study|Adverse Event|16|||
129554445|NCT01246973|466326984|FG001|Overall Study|Adverse Event|9|||
129554446|NCT01246973|466326983|FG000|Overall Study|Withdrawal by Subject|7|||
129554447|NCT01246973|466326984|FG001|Overall Study|Withdrawal by Subject|13|||
129554448|NCT00766506|466326985|FG000|Overall Study|Use rescue medication after 3 hours|3|||
129554449|NCT00766506|466326986|FG001|Overall Study|Use rescue medication after 3 hours|0|||
129554450|NCT00766506|466326985|FG000|Overall Study|Other|2|||
129554451|NCT00766506|466326986|FG001|Overall Study|Other|2|||
129554452|NCT02496221|466326987|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
129554453|NCT02496221|466326988|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
129554454|NCT02496221|466326987|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
129554455|NCT02496221|466326988|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
129554456|NCT02496221|466326987|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
129554457|NCT02496221|466326988|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
129554458|NCT03262233|466326989|FG000|Overall Study|Withdrawal by Subject|12|||
129554459|NCT03262233|466326990|FG001|Overall Study|Withdrawal by Subject|8|||
129554460|NCT03262233|466326991|FG002|Overall Study|Withdrawal by Subject|21|||
129554461|NCT03262233|466326992|FG003|Overall Study|Withdrawal by Subject|13|||
129554462|NCT03262233|466326989|FG000|Overall Study|Declined due to shock|1|||
129554463|NCT03262233|466326990|FG001|Overall Study|Declined due to shock|2|||
129686583|NCT01047501|466808917|FG000|Overall Study|Lost to Follow-up|0|||
129686584|NCT01047501|466808918|FG001|Overall Study|Lost to Follow-up|1|||
129686585|NCT01047501|466808919|FG002|Overall Study|Lost to Follow-up|1|||
129686586|NCT01047501|466808917|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
129686587|NCT01047501|466808918|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
129686588|NCT01047501|466808919|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
129686589|NCT01047501|466808917|FG000|Overall Study|Death|1|||
129686590|NCT01047501|466808918|FG001|Overall Study|Death|0|||
129686591|NCT01047501|466808919|FG002|Overall Study|Death|0|||
129686592|NCT01047501|466808917|FG000|Overall Study|Other discontinuation|1|||
129686593|NCT01047501|466808918|FG001|Overall Study|Other discontinuation|0|||
129686594|NCT01047501|466808919|FG002|Overall Study|Other discontinuation|1|||
129686595|NCT01047501|466808917|FG000|Overall Study|Investigator judgement|0|||
129775519|NCT00607373|467142957|FG001|Treatment Period|Adverse Event|4|||
129775520|NCT00607373|467142956|FG000|Treatment Period|Physician Decision|0|||
129554464|NCT03262233|466326991|FG002|Overall Study|Declined due to shock|2|||
129554465|NCT03262233|466326992|FG003|Overall Study|Declined due to shock|3|||
129554466|NCT03262233|466326989|FG000|Overall Study|Protocol Violation|5|||
129554467|NCT03262233|466326990|FG001|Overall Study|Protocol Violation|10|||
129554468|NCT03262233|466326991|FG002|Overall Study|Protocol Violation|2|||
129554469|NCT03262233|466326992|FG003|Overall Study|Protocol Violation|13|||
129554470|NCT03262233|466326989|FG000|Overall Study|data collection artifact|0|||
129686596|NCT01047501|466808918|FG001|Overall Study|Investigator judgement|0|||
129686597|NCT01047501|466808919|FG002|Overall Study|Investigator judgement|1|||
129686598|NCT00429299|466808922|FG000|Overall Study|Disease Progression|1|||
129686599|NCT00429299|466808923|FG001|Overall Study|Disease Progression|1|||
129554471|NCT03262233|466326990|FG001|Overall Study|data collection artifact|1|||
129554472|NCT03262233|466326991|FG002|Overall Study|data collection artifact|0|||
129554473|NCT03262233|466326992|FG003|Overall Study|data collection artifact|0|||
129554474|NCT01120600|466326995|FG000|Overall Study|Adverse Event|7|||
129554475|NCT01120600|466326996|FG001|Overall Study|Adverse Event|7|||
129554476|NCT01120600|466326995|FG000|Overall Study|Excessive Bone Loss|0|||
129554477|NCT01120600|466326996|FG001|Overall Study|Excessive Bone Loss|4|||
129554478|NCT01120600|466326995|FG000|Overall Study|Lost to Follow-up|1|||
129554479|NCT01120600|466326996|FG001|Overall Study|Lost to Follow-up|3|||
129554480|NCT01120600|466326995|FG000|Overall Study|Physician Decision|1|||
129554481|NCT01120600|466326996|FG001|Overall Study|Physician Decision|3|||
129554482|NCT01120600|466326995|FG000|Overall Study|Protocol Violation|0|||
129554483|NCT01120600|466326996|FG001|Overall Study|Protocol Violation|4|||
129554484|NCT01120600|466326995|FG000|Overall Study|Withdrawal by Subject|10|||
129554485|NCT01120600|466326996|FG001|Overall Study|Withdrawal by Subject|11|||
129554486|NCT01165242|466326997|FG000|Overall Study|Unreachable Subjects|1|||
129554487|NCT01165242|466326998|FG001|Overall Study|Unreachable Subjects|0|||
129554488|NCT01165242|466326999|FG002|Overall Study|Unreachable Subjects|0|||
129554489|NCT01165242|466326997|FG000|Overall Study|Incarcerated Subjects|0|||
129554490|NCT01165242|466326998|FG001|Overall Study|Incarcerated Subjects|1|||
129554491|NCT01165242|466326999|FG002|Overall Study|Incarcerated Subjects|0|||
129554492|NCT01165242|466326997|FG000|Overall Study|Visit 2 Declined by Subject|0|||
129554493|NCT01165242|466326998|FG001|Overall Study|Visit 2 Declined by Subject|0|||
129554494|NCT01165242|466326999|FG002|Overall Study|Visit 2 Declined by Subject|1|||
129554495|NCT01165242|466326997|FG000|Overall Study|Withdrawal by Subject|0|||
129554496|NCT01165242|466326998|FG001|Overall Study|Withdrawal by Subject|2|||
129554497|NCT01165242|466326999|FG002|Overall Study|Withdrawal by Subject|2|||
129554498|NCT01165242|466326997|FG000|Overall Study|Extended Holiday|0|||
129554499|NCT01165242|466326998|FG001|Overall Study|Extended Holiday|0|||
129554500|NCT01165242|466326999|FG002|Overall Study|Extended Holiday|1|||
129554501|NCT01165242|466326997|FG000|Overall Study|Lost to Follow-up|9|||
129554502|NCT01165242|466326998|FG001|Overall Study|Lost to Follow-up|7|||
129554503|NCT01165242|466326999|FG002|Overall Study|Lost to Follow-up|10|||
129775521|NCT00607373|467142957|FG001|Treatment Period|Physician Decision|1|||
129775522|NCT00607373|467142956|FG000|Treatment Period|Withdrawal by Subject|0|||
129775523|NCT00607373|467142957|FG001|Treatment Period|Withdrawal by Subject|1|||
129775524|NCT00607373|467142956|FG000|Follow-up Period|Other|0|||
129775525|NCT00607373|467142957|FG001|Follow-up Period|Other|1|||
129775526|NCT00607373|467142956|FG000|Follow-up Period|Protocol Violation|0|||
129775527|NCT00607373|467142957|FG001|Follow-up Period|Protocol Violation|1|||
129775528|NCT00607373|467142956|FG000|Follow-up Period|Withdrawal by Subject|1|||
129775529|NCT00607373|467142957|FG001|Follow-up Period|Withdrawal by Subject|3|||
129775530|NCT02170077|467142958|FG000|Overall Study|Withdrawal by Subject|3|||
129775531|NCT02170077|467142959|FG001|Overall Study|Withdrawal by Subject|4|||
129775532|NCT02170077|467142960|FG002|Overall Study|Withdrawal by Subject|2|||
129775533|NCT02170077|467142958|FG000|Overall Study|Adverse Event|4|||
129775534|NCT02170077|467142959|FG001|Overall Study|Adverse Event|4|||
129775535|NCT02170077|467142960|FG002|Overall Study|Adverse Event|4|||
129775536|NCT02170077|467142958|FG000|Overall Study|Lost to Follow-up|0|||
129775537|NCT02170077|467142959|FG001|Overall Study|Lost to Follow-up|1|||
129775538|NCT02170077|467142960|FG002|Overall Study|Lost to Follow-up|0|||
129775539|NCT02170077|467142958|FG000|Overall Study|Exclusion criteria|2|||
129775540|NCT02170077|467142959|FG001|Overall Study|Exclusion criteria|2|||
129775541|NCT02170077|467142960|FG002|Overall Study|Exclusion criteria|5|||
129775542|NCT02170077|467142958|FG000|Overall Study|Exacerbation of seizures|0|||
129775543|NCT02170077|467142959|FG001|Overall Study|Exacerbation of seizures|2|||
129775544|NCT02170077|467142960|FG002|Overall Study|Exacerbation of seizures|1|||
129884488|NCT04844918|467536416|FG001|Overall Study|Physician Decision|1|||
129554504|NCT03770000|466327000|FG000|Overall Study|Premature discontinuation due to PD|0|||
129554505|NCT03770000|466327001|FG001|Overall Study|Premature discontinuation due to PD|0|||
129554506|NCT03770000|466327002|FG002|Overall Study|Premature discontinuation due to PD|1|||
129554507|NCT03770000|466327003|FG003|Overall Study|Premature discontinuation due to PD|3|||
129554508|NCT03770000|466327004|FG004|Overall Study|Premature discontinuation due to PD|2|||
129554509|NCT03877237|466327005|FG000|Overall Study|Adverse Event|1|||
129554510|NCT03877237|466327006|FG001|Overall Study|Adverse Event|2|||
129554511|NCT03877237|466327005|FG000|Overall Study|Death|3|||
129554512|NCT03877237|466327006|FG001|Overall Study|Death|2|||
129554513|NCT03877237|466327005|FG000|Overall Study|Physician Decision|1|||
129554514|NCT03877237|466327006|FG001|Overall Study|Physician Decision|0|||
129775545|NCT01780974|467142963|FG000|Overall Study|Death|1|||
129775546|NCT01780974|467142964|FG001|Overall Study|Death|0|||
129775547|NCT01780974|467142963|FG000|Overall Study|Adverse Event|1|||
129775548|NCT01780974|467142964|FG001|Overall Study|Adverse Event|3|||
129554515|NCT03877237|466327005|FG000|Overall Study|Withdrawal by Subject|0|||
129554516|NCT03877237|466327006|FG001|Overall Study|Withdrawal by Subject|2|||
129775549|NCT01724346|467142965|FG000|Overall Study|Death|42|||
129554517|NCT00566098|466327009|FG000|Collection of MILs|Withdrawal by Subject|1|||
129775550|NCT01724346|467142966|FG001|Overall Study|Death|42|||
129554518|NCT00566098|466327009|FG000|Collection of MILs|Relapsed|1|||
129554519|NCT00566098|466327009|FG000|Generation of MILs Product|Relapsed|1|||
129554520|NCT00566098|466327009|FG000|Administration of ASCT+MILs|Death|10|||
129554521|NCT00566098|466327009|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
129554522|NCT01690520|466327012|FG000|Overall Study|Death|25|||
129554523|NCT01690520|466327013|FG001|Overall Study|Death|21|||
129554524|NCT01690520|466327012|FG000|Overall Study|Lost to Follow-up|2|||
129554525|NCT01690520|466327013|FG001|Overall Study|Lost to Follow-up|3|||
129554526|NCT01690520|466327012|FG000|Overall Study|Withdrawal by Subject|2|||
129554527|NCT01690520|466327013|FG001|Overall Study|Withdrawal by Subject|0|||
129554528|NCT01690520|466327012|FG000|Overall Study|Relapse|0|||
129554529|NCT01690520|466327013|FG001|Overall Study|Relapse|1|||
129554530|NCT01690520|466327012|FG000|Overall Study|Other|0|||
129554531|NCT01690520|466327013|FG001|Overall Study|Other|1|||
129554532|NCT01690520|466327012|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
129554533|NCT01690520|466327013|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
129554534|NCT02236754|466327014|FG000|Overall Study|Withdrawal by Subject|1|||
129554535|NCT02236754|466327015|FG001|Overall Study|Withdrawal by Subject|0|||
129554536|NCT04006847|466327016|FG000|Overall Study|Product issue|1|||
129554537|NCT00382291|466327017|FG000|Overall Study|Adverse Event|1|||
129554538|NCT00382291|466327018|FG001|Overall Study|Adverse Event|2|||
129554539|NCT00382291|466327019|FG002|Overall Study|Adverse Event|2|||
129554540|NCT00382291|466327017|FG000|Overall Study|Protocol Violation|1|||
129554541|NCT00382291|466327018|FG001|Overall Study|Protocol Violation|0|||
129554542|NCT00382291|466327019|FG002|Overall Study|Protocol Violation|0|||
129554543|NCT00382291|466327017|FG000|Overall Study|Temporary study suspension|2|||
129554544|NCT00382291|466327018|FG001|Overall Study|Temporary study suspension|2|||
129554545|NCT00382291|466327019|FG002|Overall Study|Temporary study suspension|5|||
129554546|NCT00382291|466327017|FG000|Overall Study|Withdrawal by Subject|0|||
129554547|NCT00382291|466327018|FG001|Overall Study|Withdrawal by Subject|2|||
129554548|NCT00382291|466327019|FG002|Overall Study|Withdrawal by Subject|0|||
129554549|NCT00382291|466327017|FG000|Overall Study|Physician Decision|0|||
129554550|NCT00382291|466327018|FG001|Overall Study|Physician Decision|1|||
129554551|NCT00382291|466327019|FG002|Overall Study|Physician Decision|0|||
129554552|NCT00382291|466327017|FG000|Overall Study|Lack of Efficacy|0|||
129554553|NCT00382291|466327018|FG001|Overall Study|Lack of Efficacy|0|||
129554554|NCT00382291|466327019|FG002|Overall Study|Lack of Efficacy|1|||
129554555|NCT01375010|466327020|FG000|Overall Study|Lost to Follow-up|8|||
129554556|NCT01375010|466327021|FG001|Overall Study|Lost to Follow-up|2|||
129554557|NCT01375010|466327020|FG000|Overall Study|Withdrawal by Subject|4|||
129554558|NCT01375010|466327021|FG001|Overall Study|Withdrawal by Subject|2|||
129554559|NCT02614703|466327022|FG000|Overall Study|Withdrawal by Subject|7|||
129554560|NCT02614703|466327023|FG001|Overall Study|Withdrawal by Subject|1|||
129554561|NCT02402933|466327024|FG000|Overall Study|Withdrawal by Subject|4|||
129554562|NCT02402933|466327024|FG000|Overall Study|Discontinued; Site Termination|10|||
129554563|NCT01681771|466327029|FG000|Overall Study|Lost to Follow-up|4|||
129554564|NCT01681771|466327030|FG001|Overall Study|Lost to Follow-up|2|||
129554565|NCT02092961|466327031|FG000|Overall Study|Not reported|1|||
129554566|NCT02092961|466327032|FG001|Overall Study|Not reported|0|||
129554567|NCT02092961|466327033|FG002|Overall Study|Not reported|1|||
129686600|NCT00429299|466808924|FG002|Overall Study|Disease Progression|0|||
129686601|NCT00429299|466808922|FG000|Overall Study|Adverse Event|2|||
129686602|NCT00429299|466808923|FG001|Overall Study|Adverse Event|5|||
129686603|NCT00429299|466808924|FG002|Overall Study|Adverse Event|1|||
129686604|NCT00429299|466808922|FG000|Overall Study|Protocol Violation|1|||
129686605|NCT00429299|466808923|FG001|Overall Study|Protocol Violation|0|||
129554568|NCT02092961|466327031|FG000|Overall Study|Study stopped|13|||
129554569|NCT02092961|466327032|FG001|Overall Study|Study stopped|9|||
129686606|NCT00429299|466808924|FG002|Overall Study|Protocol Violation|0|||
129554570|NCT02092961|466327033|FG002|Overall Study|Study stopped|12|||
129554571|NCT02092961|466327031|FG000|Overall Study|Lack of therapeutic response|2|||
129686607|NCT00429299|466808922|FG000|Overall Study|Withdrawal by Subject|0|||
129554572|NCT02092961|466327032|FG001|Overall Study|Lack of therapeutic response|1|||
129554573|NCT02092961|466327033|FG002|Overall Study|Lack of therapeutic response|3|||
129554574|NCT02092961|466327031|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
129554575|NCT02092961|466327032|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
129554576|NCT02092961|466327033|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
129554577|NCT02092961|466327031|FG000|Overall Study|Adverse Event|2|||
129554578|NCT02092961|466327032|FG001|Overall Study|Adverse Event|4|||
129554579|NCT02092961|466327033|FG002|Overall Study|Adverse Event|0|||
129554580|NCT01792284|466327040|FG000|Lead-in Period|Adverse Event|15|||
129554581|NCT01792284|466327041|FG001|Lead-in Period|Adverse Event|0|||
129554582|NCT01792284|466327042|FG002|Lead-in Period|Adverse Event|0|||
129554583|NCT01792284|466327040|FG000|Lead-in Period|Lost to Follow-up|2|||
129554584|NCT01792284|466327041|FG001|Lead-in Period|Lost to Follow-up|0|||
129554585|NCT01792284|466327042|FG002|Lead-in Period|Lost to Follow-up|0|||
129554586|NCT01792284|466327040|FG000|Lead-in Period|Protocol Violation|1|||
129554587|NCT01792284|466327041|FG001|Lead-in Period|Protocol Violation|0|||
129554588|NCT01792284|466327042|FG002|Lead-in Period|Protocol Violation|0|||
129554589|NCT01792284|466327040|FG000|Lead-in Period|Withdrawal by Subject|10|||
129554590|NCT01792284|466327041|FG001|Lead-in Period|Withdrawal by Subject|0|||
129554591|NCT01792284|466327042|FG002|Lead-in Period|Withdrawal by Subject|0|||
129554592|NCT01792284|466327040|FG000|Lead-in Period|Physician Decision|1|||
129554593|NCT01792284|466327041|FG001|Lead-in Period|Physician Decision|0|||
129554594|NCT01792284|466327042|FG002|Lead-in Period|Physician Decision|0|||
129554595|NCT01792284|466327040|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
129554596|NCT01792284|466327041|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
129554597|NCT01792284|466327042|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
129554598|NCT01792284|466327040|FG000|Randomization Period 1|Withdrawal by Subject|0|||
129554599|NCT01792284|466327041|FG001|Randomization Period 1|Withdrawal by Subject|1|||
129554600|NCT01792284|466327042|FG002|Randomization Period 1|Withdrawal by Subject|1|||
129554601|NCT01792284|466327040|FG000|Randomization Period 1|Physician Decision|0|||
129554602|NCT01792284|466327041|FG001|Randomization Period 1|Physician Decision|1|||
129554603|NCT01792284|466327042|FG002|Randomization Period 1|Physician Decision|1|||
129554604|NCT01792284|466327040|FG000|Randomization Period 1|Adverse Event|0|||
129554605|NCT01792284|466327041|FG001|Randomization Period 1|Adverse Event|0|||
129554606|NCT01792284|466327042|FG002|Randomization Period 1|Adverse Event|2|||
129554607|NCT01792284|466327040|FG000|Randomization Period 1|Lost to Follow-up|0|||
129554608|NCT01792284|466327041|FG001|Randomization Period 1|Lost to Follow-up|0|||
129554609|NCT01792284|466327042|FG002|Randomization Period 1|Lost to Follow-up|1|||
129775551|NCT01724346|467142965|FG000|Overall Study|Lost to Follow-up|5|||
129775552|NCT01724346|467142966|FG001|Overall Study|Lost to Follow-up|1|||
129775553|NCT01724346|467142965|FG000|Overall Study|Withdrawal by Subject|27|||
129775554|NCT01724346|467142966|FG001|Overall Study|Withdrawal by Subject|19|||
129775555|NCT01724346|467142965|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
129775556|NCT01724346|467142966|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
129775557|NCT01642589|467142967|FG000|Overall Study|Withdrawal by Subject|1|||
129775558|NCT01642589|467142968|FG001|Overall Study|Withdrawal by Subject|1|||
129775559|NCT02876601|467142973|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
129775560|NCT02876601|467142974|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
129775561|NCT02876601|467142975|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
129775562|NCT02876601|467142976|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
129775563|NCT00256997|467142979|FG000|Overall Study|Protocol Violation|1|||
129775564|NCT00256997|467142980|FG001|Overall Study|Protocol Violation|4|||
129775565|NCT00256997|467142979|FG000|Overall Study|Lack of Efficacy|1|||
129554610|NCT01792284|466327040|FG000|Randomization Period 2|Protocol Violation|0|||
129554611|NCT01792284|466327041|FG001|Randomization Period 2|Protocol Violation|1|||
129554612|NCT01792284|466327042|FG002|Randomization Period 2|Protocol Violation|0|||
129554613|NCT01792284|466327040|FG000|Randomization Period 2|Withdrawal by Subject|0|||
129554614|NCT01792284|466327041|FG001|Randomization Period 2|Withdrawal by Subject|2|||
129554615|NCT01792284|466327042|FG002|Randomization Period 2|Withdrawal by Subject|0|||
129554616|NCT01169649|466327043|FG000|Overall Study|Patient Not Treated|3|||
129554617|NCT01847313|466327044|FG000|Overall Study|Death|0|||
129554618|NCT01847313|466327045|FG001|Overall Study|Death|1|||
129554619|NCT01847313|466327044|FG000|Overall Study|Withdrawal by Subject|0|||
129554620|NCT01847313|466327045|FG001|Overall Study|Withdrawal by Subject|1|||
129554621|NCT02962882|466327047|FG000|Overall Study|Adverse Event|2|||
129554622|NCT02962882|466327047|FG000|Overall Study|Withdrawal by Subject|2|||
129554623|NCT02962882|466327047|FG000|Overall Study|Transfer from ICU|32|||
129554624|NCT01663714|466327048|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
129554625|NCT01663714|466327048|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
129554626|NCT01663714|466327048|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
129554627|NCT01663714|466327048|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
129554628|NCT01663714|466327048|FG000|Long-Term Follow-Up|Death|4|||
129554629|NCT01663714|466327048|FG000|Long-Term Follow-Up|Non-compliance|1|||
129554630|NCT00597584|466327049|FG000|Overall Study|Adverse Event|4|||
129775566|NCT00256997|467142980|FG001|Overall Study|Lack of Efficacy|4|||
129775567|NCT00256997|467142979|FG000|Overall Study|Death|2|||
129775568|NCT00256997|467142980|FG001|Overall Study|Death|0|||
129554631|NCT00597584|466327050|FG001|Overall Study|Adverse Event|2|||
129554632|NCT00597584|466327049|FG000|Overall Study|Death|53|||
129554633|NCT00597584|466327050|FG001|Overall Study|Death|30|||
129554634|NCT00597584|466327049|FG000|Overall Study|Lack of Efficacy|1|||
129554635|NCT00597584|466327050|FG001|Overall Study|Lack of Efficacy|0|||
129554636|NCT00597584|466327049|FG000|Overall Study|Lost to Follow-up|2|||
129775569|NCT00256997|467142979|FG000|Overall Study|Adverse Event|4|||
129775570|NCT00256997|467142980|FG001|Overall Study|Adverse Event|0|||
129775571|NCT00256997|467142979|FG000|Overall Study|Lost to Follow-up|3|||
129775572|NCT00256997|467142980|FG001|Overall Study|Lost to Follow-up|5|||
129554637|NCT00597584|466327050|FG001|Overall Study|Lost to Follow-up|4|||
129554638|NCT00597584|466327049|FG000|Overall Study|Physician Decision|3|||
129686608|NCT00429299|466808923|FG001|Overall Study|Withdrawal by Subject|1|||
129686609|NCT00429299|466808924|FG002|Overall Study|Withdrawal by Subject|3|||
129686610|NCT01510756|466808925|FG000|Overall Study|Death|1|||
129686611|NCT01510756|466808925|FG000|Overall Study|Lack of Efficacy|2|||
129686612|NCT01510756|466808925|FG000|Overall Study|Physician Decision|1|||
129686613|NCT03927157|466808926|FG000|Overall Study|Adverse Event|1|||
129686614|NCT03927157|466808927|FG001|Overall Study|Adverse Event|3|||
129686615|NCT03927157|466808926|FG000|Overall Study|Protocol Violation|1|||
129686616|NCT03927157|466808927|FG001|Overall Study|Protocol Violation|2|||
129686617|NCT03927157|466808926|FG000|Overall Study|Withdrawal by Subject|8|||
129686618|NCT03927157|466808927|FG001|Overall Study|Withdrawal by Subject|21|||
129686619|NCT03927157|466808926|FG000|Overall Study|Due to COVID-19 pandemic|5|||
129686620|NCT03927157|466808927|FG001|Overall Study|Due to COVID-19 pandemic|2|||
129686621|NCT03927157|466808926|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
129686622|NCT03927157|466808927|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
129686623|NCT03927157|466808926|FG000|Overall Study|Other than above|0|||
129686624|NCT03927157|466808927|FG001|Overall Study|Other than above|1|||
129686625|NCT04871113|466808928|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686626|NCT04871113|466808929|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686627|NCT04871113|466808930|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686628|NCT04871113|466808931|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686629|NCT04871113|466808932|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686630|NCT04871113|466808933|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
129686631|NCT04871113|466808934|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686632|NCT04871113|466808935|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686633|NCT04871113|466808936|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686634|NCT04871113|466808937|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
129686635|NCT04871113|466808928|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686636|NCT04871113|466808929|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686637|NCT04871113|466808930|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129554639|NCT00597584|466327050|FG001|Overall Study|Physician Decision|0|||
129554640|NCT00597584|466327049|FG000|Overall Study|Pregnancy|2|||
129686638|NCT04871113|466808931|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686639|NCT04871113|466808932|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686640|NCT04871113|466808933|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686641|NCT04871113|466808934|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
129775573|NCT00256997|467142979|FG000|Overall Study|Withdrawal by Subject|13|||
129800229|NCT02891161|467236266|FG000|Follow up|Death|4|||
129554641|NCT00597584|466327050|FG001|Overall Study|Pregnancy|0|||
129554642|NCT00597584|466327049|FG000|Overall Study|Withdrawal by Subject|44|||
129554643|NCT00597584|466327050|FG001|Overall Study|Withdrawal by Subject|12|||
129554644|NCT00597584|466327049|FG000|Overall Study|Discontinued Dialysis|0|||
129554645|NCT00597584|466327050|FG001|Overall Study|Discontinued Dialysis|1|||
129554646|NCT00597584|466327049|FG000|Overall Study|Lost ability to consent|1|||
129554647|NCT00597584|466327050|FG001|Overall Study|Lost ability to consent|1|||
129554648|NCT00597584|466327049|FG000|Overall Study|Never dosed|1|||
129554649|NCT00597584|466327050|FG001|Overall Study|Never dosed|0|||
129554650|NCT00597584|466327049|FG000|Overall Study|Relocation|8|||
129554651|NCT00597584|466327050|FG001|Overall Study|Relocation|6|||
129554652|NCT00597584|466327049|FG000|Overall Study|Renal transplant|9|||
129554653|NCT00597584|466327050|FG001|Overall Study|Renal transplant|7|||
129554654|NCT00515073|466327051|FG000|Overall Study|Withdrawal by Subject|1|||
129554655|NCT00515073|466327051|FG000|Overall Study|Physician Decision|1|||
129554656|NCT00660790|466327052|FG000|Baseline to 3 Months|Death|1|||
129554657|NCT00660790|466327052|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
129554658|NCT00660790|466327052|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
129554659|NCT01456052|466327053|FG000|Overall Study|Adverse Event|1|||
129554660|NCT01456052|466327054|FG001|Overall Study|Adverse Event|1|||
129554661|NCT01456052|466327055|FG002|Overall Study|Adverse Event|2|||
129554662|NCT01456052|466327053|FG000|Overall Study|Consent withdrawn|0|||
129554663|NCT01456052|466327054|FG001|Overall Study|Consent withdrawn|2|||
129554664|NCT01456052|466327055|FG002|Overall Study|Consent withdrawn|1|||
129554665|NCT01456052|466327053|FG000|Overall Study|Protocol Violation|0|||
129554666|NCT01456052|466327054|FG001|Overall Study|Protocol Violation|1|||
129554667|NCT01456052|466327055|FG002|Overall Study|Protocol Violation|0|||
129554668|NCT01456052|466327053|FG000|Overall Study|Physician Decision|1|||
129554669|NCT01456052|466327054|FG001|Overall Study|Physician Decision|0|||
129554670|NCT01456052|466327055|FG002|Overall Study|Physician Decision|1|||
129554671|NCT01456052|466327053|FG000|Overall Study|Treatment Failure|0|||
129554672|NCT01456052|466327054|FG001|Overall Study|Treatment Failure|1|||
129554673|NCT01456052|466327055|FG002|Overall Study|Treatment Failure|1|||
129554674|NCT03840811|466327056|FG000|Overall Study|Lost to Follow-up|0|||
129554675|NCT03840811|466327057|FG001|Overall Study|Lost to Follow-up|0|||
129554676|NCT03840811|466327058|FG002|Overall Study|Lost to Follow-up|1|||
129554677|NCT01625845|466327059|FG000|Overall Study|Adverse Event|1|||
129554678|NCT01625845|466327060|FG001|Overall Study|Adverse Event|2|||
129554679|NCT01625845|466327059|FG000|Overall Study|Lost to Follow-up|2|||
129554680|NCT01625845|466327060|FG001|Overall Study|Lost to Follow-up|1|||
129554681|NCT01625845|466327059|FG000|Overall Study|Withdrawal by Subject|2|||
129554682|NCT01625845|466327060|FG001|Overall Study|Withdrawal by Subject|0|||
129554683|NCT02853929|466327061|FG000|Overall Study|Lost to Follow-up|3|||
129554684|NCT02853929|466327062|FG001|Overall Study|Lost to Follow-up|0|||
129554685|NCT02853929|466327061|FG000|Overall Study|Withdrawal by Subject|1|||
129554686|NCT02853929|466327062|FG001|Overall Study|Withdrawal by Subject|0|||
129554687|NCT02853929|466327061|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
129554688|NCT02853929|466327062|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
129554689|NCT03549130|466327063|FG000|Overall Study|Adverse Event|0|||
129775574|NCT00256997|467142980|FG001|Overall Study|Withdrawal by Subject|3|||
129775575|NCT00256997|467142979|FG000|Overall Study|Started but not treated|2|||
129775576|NCT00256997|467142980|FG001|Overall Study|Started but not treated|0|||
129775577|NCT00256997|467142979|FG000|Overall Study|Other|5|||
129775578|NCT00256997|467142980|FG001|Overall Study|Other|8|||
129775579|NCT00256997|467142979|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
129775580|NCT00256997|467142980|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
129775581|NCT00256997|467142979|FG000|Overall Study|Participant Non-compliant|3|||
129775582|NCT00256997|467142980|FG001|Overall Study|Participant Non-compliant|6|||
129775583|NCT00256997|467142979|FG000|Overall Study|Investigator Withdrew Participant|2|||
129554690|NCT03549130|466327064|FG001|Overall Study|Adverse Event|1|||
129554691|NCT03549130|466327063|FG000|Overall Study|Lost to Follow-up|0|||
129554692|NCT03549130|466327064|FG001|Overall Study|Lost to Follow-up|1|||
129554693|NCT01078623|466327065|FG000|Treatment Period 1|Adverse Event|1|||
129554694|NCT01078623|466327066|FG001|Treatment Period 1|Adverse Event|1|||
129554695|NCT01078623|466327067|FG002|Treatment Period 1|Adverse Event|1|||
129554696|NCT01078623|466327068|FG003|Treatment Period 1|Adverse Event|0|||
129554697|NCT01078623|466327069|FG004|Treatment Period 1|Adverse Event|0|||
129554698|NCT01078623|466327070|FG005|Treatment Period 1|Adverse Event|0|||
129554699|NCT01078623|466327071|FG006|Treatment Period 1|Adverse Event|1|||
129554700|NCT01078623|466327072|FG007|Treatment Period 1|Adverse Event|0|||
129554701|NCT01078623|466327073|FG008|Treatment Period 1|Adverse Event|1|||
129554702|NCT01078623|466327074|FG009|Treatment Period 1|Adverse Event|1|||
129554703|NCT01078623|466327075|FG010|Treatment Period 1|Adverse Event|0|||
129554704|NCT01078623|466327076|FG011|Treatment Period 1|Adverse Event|0|||
129554705|NCT01078623|466327077|FG012|Treatment Period 1|Adverse Event|0|||
129554706|NCT01078623|466327078|FG013|Treatment Period 1|Adverse Event|0|||
129554707|NCT01078623|466327079|FG014|Treatment Period 1|Adverse Event|0|||
129554708|NCT01078623|466327080|FG015|Treatment Period 1|Adverse Event|0|||
129554709|NCT01078623|466327081|FG016|Treatment Period 1|Adverse Event|0|||
129775584|NCT00256997|467142980|FG001|Overall Study|Investigator Withdrew Participant|1|||
129554710|NCT01078623|466327082|FG017|Treatment Period 1|Adverse Event|0|||
129554711|NCT01078623|466327083|FG018|Treatment Period 1|Adverse Event|0|||
129554712|NCT01078623|466327084|FG019|Treatment Period 1|Adverse Event|0|||
129554713|NCT01078623|466327065|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129554714|NCT01078623|466327066|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129554715|NCT01078623|466327067|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129554716|NCT01078623|466327068|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129554717|NCT01078623|466327069|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129554718|NCT01078623|466327070|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129554719|NCT01078623|466327071|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129554720|NCT01078623|466327072|FG007|Treatment Period 1|Withdrawal by Subject|1|||
129554721|NCT01078623|466327073|FG008|Treatment Period 1|Withdrawal by Subject|0|||
129554722|NCT01078623|466327074|FG009|Treatment Period 1|Withdrawal by Subject|0|||
129554723|NCT01078623|466327075|FG010|Treatment Period 1|Withdrawal by Subject|1|||
129554724|NCT01078623|466327076|FG011|Treatment Period 1|Withdrawal by Subject|0|||
129554725|NCT01078623|466327077|FG012|Treatment Period 1|Withdrawal by Subject|0|||
129554726|NCT01078623|466327078|FG013|Treatment Period 1|Withdrawal by Subject|0|||
129554727|NCT01078623|466327079|FG014|Treatment Period 1|Withdrawal by Subject|0|||
129554728|NCT01078623|466327080|FG015|Treatment Period 1|Withdrawal by Subject|0|||
129554729|NCT01078623|466327081|FG016|Treatment Period 1|Withdrawal by Subject|0|||
129554730|NCT01078623|466327082|FG017|Treatment Period 1|Withdrawal by Subject|0|||
129554731|NCT01078623|466327083|FG018|Treatment Period 1|Withdrawal by Subject|0|||
129554732|NCT01078623|466327084|FG019|Treatment Period 1|Withdrawal by Subject|0|||
129554733|NCT01078623|466327065|FG000|Treatment Period 1|Protocol Violation|0|||
129554734|NCT01078623|466327066|FG001|Treatment Period 1|Protocol Violation|0|||
129554735|NCT01078623|466327067|FG002|Treatment Period 1|Protocol Violation|0|||
129554736|NCT01078623|466327068|FG003|Treatment Period 1|Protocol Violation|0|||
129554737|NCT01078623|466327069|FG004|Treatment Period 1|Protocol Violation|0|||
129554738|NCT01078623|466327070|FG005|Treatment Period 1|Protocol Violation|1|||
129686642|NCT04871113|466808935|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
129686643|NCT04871113|466808936|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686644|NCT04871113|466808937|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
129686645|NCT02447029|466808938|FG000|Overall Study|Withdrawal by Subject|3|||
129686646|NCT02447029|466808939|FG001|Overall Study|Withdrawal by Subject|2|||
129686647|NCT00726557|466808940|FG000|Overall Study|Screening failure|4|||
129686648|NCT00726557|466808940|FG000|Overall Study|No end of treatment documentation|37|||
129686649|NCT00726557|466808940|FG000|Overall Study|No follow-up documentation available|55|||
129686650|NCT00726557|466808940|FG000|Overall Study|Treatment less than 3 months|17|||
129686651|NCT00726557|466808940|FG000|Overall Study|Inclusion criteria not met|15|||
129686652|NCT01239745|466808941|FG000|Overall Study|Study terminated by sponsor|45|||
129686653|NCT01239745|466808941|FG000|Overall Study|Adverse Event|1|||
129686654|NCT01257542|466808944|FG000|Overall Study|Protocol Violation|3|||
129686655|NCT01257542|466808945|FG001|Overall Study|Protocol Violation|5|||
129686656|NCT01257542|466808944|FG000|Overall Study|Withdrawal by Subject|0|||
129686657|NCT01257542|466808945|FG001|Overall Study|Withdrawal by Subject|2|||
129686658|NCT00776997|466808951|FG000|Overall Study|Adverse Event|2|||
129686659|NCT03487445|466808952|FG000|Randomization|Not treated for administrative reasons|1|||
129686660|NCT03487445|466808953|FG001|Randomization|Not treated for administrative reasons|0|||
129686661|NCT03301714|466808954|FG000|Overall Study|Lost to Follow-up|10|||
129686662|NCT03301714|466808955|FG001|Overall Study|Lost to Follow-up|4|||
129686663|NCT03301714|466808956|FG002|Overall Study|Lost to Follow-up|4|||
129686664|NCT03301714|466808954|FG000|Overall Study|Did not receive allocated intervention|0|||
129686665|NCT03301714|466808955|FG001|Overall Study|Did not receive allocated intervention|2|||
129686666|NCT03301714|466808956|FG002|Overall Study|Did not receive allocated intervention|3|||
129686667|NCT01251861|466808959|FG000|Overall Study|Disease progression|6|||
129686668|NCT01251861|466808960|FG001|Overall Study|Disease progression|6|||
129686669|NCT01251861|466808959|FG000|Overall Study|Adverse Event|2|||
129686670|NCT01251861|466808960|FG001|Overall Study|Adverse Event|17|||
129554739|NCT01078623|466327071|FG006|Treatment Period 1|Protocol Violation|0|||
129554740|NCT01078623|466327072|FG007|Treatment Period 1|Protocol Violation|0|||
129686671|NCT01251861|466808959|FG000|Overall Study|Withdrawal by Subject|2|||
129686672|NCT01251861|466808960|FG001|Overall Study|Withdrawal by Subject|2|||
129686673|NCT01251861|466808959|FG000|Overall Study|Alternative therapy|1|||
129686674|NCT01251861|466808960|FG001|Overall Study|Alternative therapy|0|||
129686675|NCT01251861|466808959|FG000|Overall Study|Other complicating disease|0|||
129884489|NCT04844918|467536417|FG002|Overall Study|Physician Decision|0|||
129686676|NCT01251861|466808960|FG001|Overall Study|Other complicating disease|1|||
129554741|NCT01078623|466327073|FG008|Treatment Period 1|Protocol Violation|0|||
129554742|NCT01078623|466327074|FG009|Treatment Period 1|Protocol Violation|0|||
129554743|NCT01078623|466327075|FG010|Treatment Period 1|Protocol Violation|0|||
129554744|NCT01078623|466327076|FG011|Treatment Period 1|Protocol Violation|0|||
129686677|NCT01251861|466808959|FG000|Overall Study|Physician Decision|1|||
129686678|NCT01251861|466808960|FG001|Overall Study|Physician Decision|0|||
129554745|NCT01078623|466327077|FG012|Treatment Period 1|Protocol Violation|0|||
129554746|NCT01078623|466327078|FG013|Treatment Period 1|Protocol Violation|0|||
129554747|NCT01078623|466327079|FG014|Treatment Period 1|Protocol Violation|0|||
129554748|NCT01078623|466327080|FG015|Treatment Period 1|Protocol Violation|0|||
129554749|NCT01078623|466327081|FG016|Treatment Period 1|Protocol Violation|0|||
129554750|NCT01078623|466327082|FG017|Treatment Period 1|Protocol Violation|0|||
129554751|NCT01078623|466327083|FG018|Treatment Period 1|Protocol Violation|0|||
129554752|NCT01078623|466327084|FG019|Treatment Period 1|Protocol Violation|0|||
129554753|NCT01078623|466327065|FG000|Treatment Period 2|Adverse Event|0|||
129554754|NCT01078623|466327066|FG001|Treatment Period 2|Adverse Event|0|||
129554755|NCT01078623|466327067|FG002|Treatment Period 2|Adverse Event|0|||
129554756|NCT01078623|466327068|FG003|Treatment Period 2|Adverse Event|0|||
129554757|NCT01078623|466327069|FG004|Treatment Period 2|Adverse Event|0|||
129554758|NCT01078623|466327070|FG005|Treatment Period 2|Adverse Event|0|||
129554759|NCT01078623|466327071|FG006|Treatment Period 2|Adverse Event|1|||
129686679|NCT01251861|466808959|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
129686680|NCT01251861|466808960|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
129686681|NCT01251861|466808959|FG000|Overall Study|Other|1|||
129686682|NCT01251861|466808960|FG001|Overall Study|Other|0|||
129686683|NCT01251861|466808959|FG000|Overall Study|Never started therapy|4|||
129686684|NCT01251861|466808960|FG001|Overall Study|Never started therapy|1|||
129686685|NCT01251861|466808959|FG000|Overall Study|Potential interaction of drugs|0|||
129686686|NCT01251861|466808960|FG001|Overall Study|Potential interaction of drugs|1|||
129686687|NCT03580928|466808963|FG000|Overall Study|Death|0|||
129686688|NCT03580928|466808964|FG001|Overall Study|Death|3|||
129686689|NCT03580928|466808963|FG000|Overall Study|Withdrawal by Subject|2|||
129686690|NCT03580928|466808964|FG001|Overall Study|Withdrawal by Subject|1|||
129686691|NCT03580928|466808963|FG000|Overall Study|Lost to Follow-up|2|||
129686692|NCT03580928|466808964|FG001|Overall Study|Lost to Follow-up|0|||
129686693|NCT03580928|466808963|FG000|Overall Study|Progressive Disease|0|||
129686694|NCT03580928|466808964|FG001|Overall Study|Progressive Disease|1|||
129686695|NCT05643794|466809994|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
129686696|NCT05643794|466809995|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
129686697|NCT05643794|466809996|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129686698|NCT05643794|466809994|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129686699|NCT05643794|466809995|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129686700|NCT05643794|466809996|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129686701|NCT05643794|466809994|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129686702|NCT05643794|466809995|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
129686703|NCT05643794|466809996|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129686704|NCT05643794|466809994|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129686705|NCT05643794|466809995|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129686706|NCT05643794|466809996|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129686707|NCT05643794|466809994|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
129686708|NCT05643794|466809995|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129686709|NCT05643794|466809996|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
129686710|NCT05643794|466809994|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
129686711|NCT05643794|466809995|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
129686712|NCT05643794|466809996|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
129686713|NCT04167670|466809997|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
129686714|NCT04167670|466809998|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
129686715|NCT04167670|466809999|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
129686716|NCT04167670|466809997|FG000|Overall Study|Significant protocol deviation|3|||
129686717|NCT04167670|466809998|FG001|Overall Study|Significant protocol deviation|1|||
129686718|NCT04167670|466809999|FG002|Overall Study|Significant protocol deviation|0|||
129686719|NCT04167670|466809997|FG000|Overall Study|Lost to Follow-up|0|||
129686720|NCT04167670|466809998|FG001|Overall Study|Lost to Follow-up|3|||
129686721|NCT04167670|466809999|FG002|Overall Study|Lost to Follow-up|3|||
129686722|NCT04167670|466809997|FG000|Overall Study|Voluntary Withdrawal|0|||
129686723|NCT04167670|466809998|FG001|Overall Study|Voluntary Withdrawal|1|||
129686724|NCT04167670|466809999|FG002|Overall Study|Voluntary Withdrawal|1|||
129686725|NCT04167670|466809997|FG000|Overall Study|Withdrawal of Consent|4|||
129686726|NCT04167670|466809998|FG001|Overall Study|Withdrawal of Consent|1|||
129775585|NCT04163016|467142981|FG000|Enrollment|Adverse Event|1|||
129554760|NCT01078623|466327072|FG007|Treatment Period 2|Adverse Event|0|||
129554761|NCT01078623|466327073|FG008|Treatment Period 2|Adverse Event|0|||
129554762|NCT01078623|466327074|FG009|Treatment Period 2|Adverse Event|0|||
129554763|NCT01078623|466327075|FG010|Treatment Period 2|Adverse Event|0|||
129554764|NCT01078623|466327076|FG011|Treatment Period 2|Adverse Event|0|||
129775586|NCT04163016|467142982|FG001|Enrollment|Adverse Event|0|||
129775587|NCT04163016|467142983|FG002|Enrollment|Adverse Event|0|||
129775588|NCT04163016|467142984|FG003|Enrollment|Adverse Event|0|||
129775589|NCT04163016|467142981|FG000|Treatment|Adverse Event|0|||
129775590|NCT04163016|467142982|FG001|Treatment|Adverse Event|1|||
129775591|NCT04163016|467142983|FG002|Treatment|Adverse Event|0|||
129775592|NCT04163016|467142984|FG003|Treatment|Adverse Event|0|||
129775593|NCT04163016|467142981|FG000|Treatment|Withdrawal by Subject|0|||
129775594|NCT04163016|467142982|FG001|Treatment|Withdrawal by Subject|2|||
129775595|NCT04163016|467142983|FG002|Treatment|Withdrawal by Subject|0|||
129775596|NCT04163016|467142984|FG003|Treatment|Withdrawal by Subject|0|||
129775597|NCT04163016|467142981|FG000|Treatment|Indeterminate TB-test|0|||
129775598|NCT04163016|467142982|FG001|Treatment|Indeterminate TB-test|0|||
129775599|NCT04163016|467142983|FG002|Treatment|Indeterminate TB-test|0|||
129775600|NCT04163016|467142984|FG003|Treatment|Indeterminate TB-test|1|||
129775601|NCT04163016|467142981|FG000|Treatment|Participant did not want to continue in study|0|||
129775602|NCT04163016|467142982|FG001|Treatment|Participant did not want to continue in study|0|||
129775603|NCT04163016|467142983|FG002|Treatment|Participant did not want to continue in study|0|||
129775604|NCT04163016|467142984|FG003|Treatment|Participant did not want to continue in study|1|||
129775605|NCT01967238|467142985|FG000|Overall Study|Adverse Event|1|||
129775606|NCT01967238|467142986|FG001|Overall Study|Adverse Event|1|||
129775607|NCT01967238|467142987|FG002|Overall Study|Adverse Event|0|||
129775608|NCT01967238|467142985|FG000|Overall Study|Lost to Follow-up|1|||
129775609|NCT01967238|467142986|FG001|Overall Study|Lost to Follow-up|0|||
129775610|NCT01967238|467142987|FG002|Overall Study|Lost to Follow-up|1|||
129775611|NCT01967238|467142985|FG000|Overall Study|Withdrawal by Subject|0|||
129775612|NCT01967238|467142986|FG001|Overall Study|Withdrawal by Subject|0|||
129775613|NCT01967238|467142987|FG002|Overall Study|Withdrawal by Subject|1|||
129775614|NCT05232682|467142988|FG000|Overall Study|Lost to Follow-up|2|||
129775615|NCT03387085|467142989|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
129775616|NCT02015637|467144204|FG000|Overall Study|Lost to Follow-up|3|||
129775617|NCT02015637|467144205|FG001|Overall Study|Lost to Follow-up|5|||
129775618|NCT02015637|467144204|FG000|Overall Study|Adverse Event|3|||
129775619|NCT02015637|467144205|FG001|Overall Study|Adverse Event|0|||
129775620|NCT02015637|467144204|FG000|Overall Study|Did not take study drug|2|||
129775621|NCT02015637|467144205|FG001|Overall Study|Did not take study drug|0|||
129775622|NCT02223858|467144208|FG000|Overall Study|Death|1|||
129775623|NCT02223858|467144209|FG001|Overall Study|Death|1|||
129775624|NCT02223858|467144208|FG000|Overall Study|Lost to Follow-up|6|||
129775625|NCT02223858|467144209|FG001|Overall Study|Lost to Follow-up|11|||
129775626|NCT02223858|467144208|FG000|Overall Study|Withdrawal by Subject|8|||
129775627|NCT02223858|467144209|FG001|Overall Study|Withdrawal by Subject|5|||
129775628|NCT02223858|467144208|FG000|Overall Study|Refused|9|||
129775629|NCT02223858|467144209|FG001|Overall Study|Refused|9|||
129775630|NCT04455815|467144210|FG000|Randomisation Phase|Adverse Event|1|||
129775631|NCT04455815|467144211|FG001|Randomisation Phase|Adverse Event|0|||
129775632|NCT04455815|467144210|FG000|Treatment Phase|Adverse Event|0|||
129775633|NCT04455815|467144211|FG001|Treatment Phase|Adverse Event|1|||
129775634|NCT04455815|467144210|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
129775635|NCT04455815|467144211|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
129775636|NCT04455815|467144210|FG000|Treatment Phase|Withdrawal by Subject|1|||
129775637|NCT04455815|467144211|FG001|Treatment Phase|Withdrawal by Subject|1|||
129775638|NCT02106390|467144212|FG000|Overall Study|Withdrawal by Subject|15|||
129775639|NCT02106390|467144213|FG001|Overall Study|Withdrawal by Subject|16|||
129775640|NCT02106390|467144214|FG002|Overall Study|Withdrawal by Subject|15|||
129775641|NCT02106390|467144212|FG000|Overall Study|Lost to Follow-up|25|||
129775642|NCT02106390|467144213|FG001|Overall Study|Lost to Follow-up|20|||
129775643|NCT02106390|467144214|FG002|Overall Study|Lost to Follow-up|13|||
129775644|NCT02106390|467144212|FG000|Overall Study|Other: Administrative Reason|8|||
129775645|NCT02106390|467144213|FG001|Overall Study|Other: Administrative Reason|5|||
129775646|NCT02106390|467144214|FG002|Overall Study|Other: Administrative Reason|12|||
129775647|NCT02106390|467144212|FG000|Overall Study|Other: Unspecified|1|||
129775648|NCT02106390|467144213|FG001|Overall Study|Other: Unspecified|4|||
129775649|NCT02106390|467144214|FG002|Overall Study|Other: Unspecified|2|||
129775650|NCT02106390|467144212|FG000|Overall Study|Adverse Event|0|||
129775651|NCT02106390|467144213|FG001|Overall Study|Adverse Event|2|||
129775652|NCT02106390|467144214|FG002|Overall Study|Adverse Event|1|||
129775653|NCT02106390|467144212|FG000|Overall Study|Protocol Violation|0|||
129775654|NCT02106390|467144213|FG001|Overall Study|Protocol Violation|1|||
129775655|NCT02106390|467144214|FG002|Overall Study|Protocol Violation|0|||
129775656|NCT03198507|467144215|FG000|Overall Study|Withdrawal by Subject|1|||
129775657|NCT03198507|467144216|FG001|Overall Study|Withdrawal by Subject|0|||
129775658|NCT00241839|467144219|FG000|Overall Study|Withdrawal by Subject|18|||
129775659|NCT00241839|467144220|FG001|Overall Study|Withdrawal by Subject|17|||
129775660|NCT00241839|467144219|FG000|Overall Study|Adverse Event|1|||
129775661|NCT00241839|467144220|FG001|Overall Study|Adverse Event|1|||
129775662|NCT00831181|467144221|FG000|Overall Study|Adverse Event|12|||
129775663|NCT02863419|467144222|FG000|Overall Study|Lost to Follow-up|0|||
129554765|NCT01078623|466327077|FG012|Treatment Period 2|Adverse Event|0|||
129554766|NCT01078623|466327078|FG013|Treatment Period 2|Adverse Event|0|||
129554767|NCT01078623|466327079|FG014|Treatment Period 2|Adverse Event|0|||
129554768|NCT01078623|466327080|FG015|Treatment Period 2|Adverse Event|0|||
129554769|NCT01078623|466327081|FG016|Treatment Period 2|Adverse Event|0|||
129554770|NCT01078623|466327082|FG017|Treatment Period 2|Adverse Event|0|||
129554771|NCT01078623|466327083|FG018|Treatment Period 2|Adverse Event|1|||
129554772|NCT01078623|466327084|FG019|Treatment Period 2|Adverse Event|0|||
129554773|NCT01078623|466327065|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129554774|NCT01078623|466327066|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129554775|NCT01078623|466327067|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129554776|NCT01078623|466327068|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129554777|NCT01078623|466327069|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129554778|NCT01078623|466327070|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129554779|NCT01078623|466327071|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129554780|NCT01078623|466327072|FG007|Treatment Period 2|Withdrawal by Subject|0|||
129554781|NCT01078623|466327073|FG008|Treatment Period 2|Withdrawal by Subject|0|||
129554782|NCT01078623|466327074|FG009|Treatment Period 2|Withdrawal by Subject|0|||
129554783|NCT01078623|466327075|FG010|Treatment Period 2|Withdrawal by Subject|0|||
129554784|NCT01078623|466327076|FG011|Treatment Period 2|Withdrawal by Subject|0|||
129554785|NCT01078623|466327077|FG012|Treatment Period 2|Withdrawal by Subject|0|||
129554786|NCT01078623|466327078|FG013|Treatment Period 2|Withdrawal by Subject|0|||
129554787|NCT01078623|466327079|FG014|Treatment Period 2|Withdrawal by Subject|0|||
129554788|NCT01078623|466327080|FG015|Treatment Period 2|Withdrawal by Subject|0|||
129554789|NCT01078623|466327081|FG016|Treatment Period 2|Withdrawal by Subject|0|||
129554790|NCT01078623|466327082|FG017|Treatment Period 2|Withdrawal by Subject|0|||
129554791|NCT01078623|466327083|FG018|Treatment Period 2|Withdrawal by Subject|0|||
129554792|NCT01078623|466327084|FG019|Treatment Period 2|Withdrawal by Subject|0|||
129554793|NCT01078623|466327065|FG000|Treatment Period 3|Adverse Event|0|||
129554794|NCT01078623|466327066|FG001|Treatment Period 3|Adverse Event|0|||
129554795|NCT01078623|466327067|FG002|Treatment Period 3|Adverse Event|0|||
129554796|NCT01078623|466327068|FG003|Treatment Period 3|Adverse Event|0|||
129554797|NCT01078623|466327069|FG004|Treatment Period 3|Adverse Event|1|||
129554798|NCT01078623|466327070|FG005|Treatment Period 3|Adverse Event|0|||
129554799|NCT01078623|466327071|FG006|Treatment Period 3|Adverse Event|0|||
129554800|NCT01078623|466327072|FG007|Treatment Period 3|Adverse Event|0|||
129554801|NCT01078623|466327073|FG008|Treatment Period 3|Adverse Event|0|||
129554802|NCT01078623|466327074|FG009|Treatment Period 3|Adverse Event|0|||
129554803|NCT01078623|466327075|FG010|Treatment Period 3|Adverse Event|0|||
129554804|NCT01078623|466327076|FG011|Treatment Period 3|Adverse Event|0|||
129554805|NCT01078623|466327077|FG012|Treatment Period 3|Adverse Event|0|||
129554806|NCT01078623|466327078|FG013|Treatment Period 3|Adverse Event|1|||
129554807|NCT01078623|466327079|FG014|Treatment Period 3|Adverse Event|0|||
129554808|NCT01078623|466327080|FG015|Treatment Period 3|Adverse Event|0|||
129554809|NCT01078623|466327081|FG016|Treatment Period 3|Adverse Event|0|||
129554810|NCT01078623|466327082|FG017|Treatment Period 3|Adverse Event|0|||
129554811|NCT01078623|466327083|FG018|Treatment Period 3|Adverse Event|0|||
129554812|NCT01078623|466327084|FG019|Treatment Period 3|Adverse Event|0|||
129554813|NCT01078623|466327065|FG000|Treatment Period 4|Adverse Event|0|||
129554814|NCT01078623|466327066|FG001|Treatment Period 4|Adverse Event|0|||
129554815|NCT01078623|466327067|FG002|Treatment Period 4|Adverse Event|1|||
129554816|NCT01078623|466327068|FG003|Treatment Period 4|Adverse Event|0|||
129686727|NCT04167670|466809999|FG002|Overall Study|Withdrawal of Consent|3|||
129686728|NCT04167670|466809997|FG000|Overall Study|Miscellaneous|7|||
129686729|NCT04167670|466809998|FG001|Overall Study|Miscellaneous|5|||
129686730|NCT04167670|466809999|FG002|Overall Study|Miscellaneous|3|||
129686731|NCT01127061|466810002|FG000|Overall Study|Lost to Follow-up|7|||
129686732|NCT01127061|466810003|FG001|Overall Study|Lost to Follow-up|10|||
129686733|NCT01127061|466810002|FG000|Overall Study|Physician Decision|3|||
129686734|NCT01127061|466810003|FG001|Overall Study|Physician Decision|3|||
129686735|NCT00003456|466810004|FG000|Overall Study|Not evaluable|8|||
129686736|NCT00479232|466810005|FG000|Overall Study|Adverse Event|0|||
129686737|NCT00479232|466810006|FG001|Overall Study|Adverse Event|0|||
129686738|NCT00479232|466810007|FG002|Overall Study|Adverse Event|5|||
129686739|NCT00479232|466810008|FG003|Overall Study|Adverse Event|0|||
129686740|NCT00479232|466810009|FG004|Overall Study|Adverse Event|0|||
129686741|NCT00479232|466810010|FG005|Overall Study|Adverse Event|10|||
129554817|NCT01078623|466327069|FG004|Treatment Period 4|Adverse Event|0|||
129554818|NCT01078623|466327070|FG005|Treatment Period 4|Adverse Event|0|||
129554819|NCT01078623|466327071|FG006|Treatment Period 4|Adverse Event|0|||
129554820|NCT01078623|466327072|FG007|Treatment Period 4|Adverse Event|0|||
129554821|NCT01078623|466327073|FG008|Treatment Period 4|Adverse Event|0|||
129554822|NCT01078623|466327074|FG009|Treatment Period 4|Adverse Event|0|||
129554823|NCT01078623|466327075|FG010|Treatment Period 4|Adverse Event|0|||
129554824|NCT01078623|466327076|FG011|Treatment Period 4|Adverse Event|0|||
129554825|NCT01078623|466327077|FG012|Treatment Period 4|Adverse Event|0|||
129686742|NCT00479232|466810005|FG000|Overall Study|Deviation from Protocol|0|||
129554826|NCT01078623|466327078|FG013|Treatment Period 4|Adverse Event|0|||
129554827|NCT01078623|466327079|FG014|Treatment Period 4|Adverse Event|0|||
129554828|NCT01078623|466327080|FG015|Treatment Period 4|Adverse Event|0|||
129554829|NCT01078623|466327081|FG016|Treatment Period 4|Adverse Event|0|||
129554830|NCT01078623|466327082|FG017|Treatment Period 4|Adverse Event|0|||
129554831|NCT01078623|466327083|FG018|Treatment Period 4|Adverse Event|0|||
129554832|NCT01078623|466327084|FG019|Treatment Period 4|Adverse Event|0|||
129554833|NCT01078623|466327065|FG000|Treatment Period 4|Withdrawal by Subject|0|||
129554834|NCT01078623|466327066|FG001|Treatment Period 4|Withdrawal by Subject|0|||
129775664|NCT02863419|467144223|FG001|Overall Study|Lost to Follow-up|1|||
129775665|NCT02863419|467144224|FG002|Overall Study|Lost to Follow-up|4|||
129775666|NCT02863419|467144222|FG000|Overall Study|Withdrawal by Subject|5|||
129775667|NCT02863419|467144223|FG001|Overall Study|Withdrawal by Subject|5|||
129554835|NCT01078623|466327067|FG002|Treatment Period 4|Withdrawal by Subject|0|||
129554836|NCT01078623|466327068|FG003|Treatment Period 4|Withdrawal by Subject|0|||
129554837|NCT01078623|466327069|FG004|Treatment Period 4|Withdrawal by Subject|0|||
129554838|NCT01078623|466327070|FG005|Treatment Period 4|Withdrawal by Subject|0|||
129554839|NCT01078623|466327071|FG006|Treatment Period 4|Withdrawal by Subject|0|||
129554840|NCT01078623|466327072|FG007|Treatment Period 4|Withdrawal by Subject|0|||
129554841|NCT01078623|466327073|FG008|Treatment Period 4|Withdrawal by Subject|0|||
129554842|NCT01078623|466327074|FG009|Treatment Period 4|Withdrawal by Subject|0|||
129554843|NCT01078623|466327075|FG010|Treatment Period 4|Withdrawal by Subject|0|||
129554844|NCT01078623|466327076|FG011|Treatment Period 4|Withdrawal by Subject|0|||
129554845|NCT01078623|466327077|FG012|Treatment Period 4|Withdrawal by Subject|0|||
129554846|NCT01078623|466327078|FG013|Treatment Period 4|Withdrawal by Subject|0|||
129554847|NCT01078623|466327079|FG014|Treatment Period 4|Withdrawal by Subject|0|||
129554848|NCT01078623|466327080|FG015|Treatment Period 4|Withdrawal by Subject|1|||
129554849|NCT01078623|466327081|FG016|Treatment Period 4|Withdrawal by Subject|0|||
129775668|NCT02863419|467144224|FG002|Overall Study|Withdrawal by Subject|3|||
129554850|NCT01078623|466327082|FG017|Treatment Period 4|Withdrawal by Subject|0|||
129554851|NCT01078623|466327083|FG018|Treatment Period 4|Withdrawal by Subject|0|||
129554852|NCT01078623|466327084|FG019|Treatment Period 4|Withdrawal by Subject|0|||
129554853|NCT00463866|466327085|FG000|Overall Study|Adverse Event|70|||
129554854|NCT00463866|466327086|FG001|Overall Study|Adverse Event|93|||
129554855|NCT00463866|466327085|FG000|Overall Study|Withdrawal by Subject|81|||
129554856|NCT00463866|466327086|FG001|Overall Study|Withdrawal by Subject|79|||
129554857|NCT00463866|466327085|FG000|Overall Study|Lost to Follow-up|46|||
129554858|NCT00463866|466327086|FG001|Overall Study|Lost to Follow-up|55|||
129554859|NCT00463866|466327085|FG000|Overall Study|Incorrect Enrolment|64|||
129554860|NCT00463866|466327086|FG001|Overall Study|Incorrect Enrolment|66|||
129554861|NCT00463866|466327085|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
129554862|NCT00463866|466327086|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
129554863|NCT00463866|466327085|FG000|Overall Study|Safety Reason|1|||
129554864|NCT00463866|466327086|FG001|Overall Study|Safety Reason|3|||
129775669|NCT02863419|467144222|FG000|Overall Study|Died|3|||
129775670|NCT02863419|467144223|FG001|Overall Study|Died|4|||
129775671|NCT02863419|467144224|FG002|Overall Study|Died|1|||
129775672|NCT00196313|467144227|FG000|Overall Study|Protocol Violation|2|||
129775673|NCT00196313|467144228|FG001|Overall Study|Protocol Violation|3|||
129775674|NCT00196313|467144227|FG000|Overall Study|Withdrawal by Subject|3|||
129775675|NCT00196313|467144228|FG001|Overall Study|Withdrawal by Subject|1|||
129775676|NCT00196313|467144227|FG000|Overall Study|Adverse Event|3|||
129775677|NCT00196313|467144228|FG001|Overall Study|Adverse Event|1|||
129775678|NCT00196313|467144227|FG000|Overall Study|Subject Pregnant|1|||
129775679|NCT00196313|467144228|FG001|Overall Study|Subject Pregnant|1|||
129775680|NCT00196313|467144227|FG000|Overall Study|Lost to Follow-up|2|||
129775681|NCT00196313|467144228|FG001|Overall Study|Lost to Follow-up|2|||
129775682|NCT02577718|467144229|FG000|Overall Study|Death|6|||
129775683|NCT02577718|467144229|FG000|Overall Study|Withdrawal by Subject|2|||
129775684|NCT01967576|467144230|FG000|Overall Study|Withdrawal by Subject|3|||
129775685|NCT01967576|467144230|FG000|Overall Study|Progressed/Removed from treatment|1|||
129775686|NCT01967576|467144230|FG000|Overall Study|Study closing at site|1|||
129775687|NCT01967576|467144230|FG000|Overall Study|Adverse Event|1|||
129775688|NCT01967576|467144230|FG000|Overall Study|Refused further treatment|1|||
129775689|NCT03196349|467144231|FG000|Overall Study|Did not receive study drug|0|||
129554865|NCT00463866|466327085|FG000|Overall Study|Mis-Randomization of subject|0|||
129554866|NCT00463866|466327086|FG001|Overall Study|Mis-Randomization of subject|1|||
129554867|NCT00463866|466327085|FG000|Overall Study|Other|22|||
129775690|NCT03196349|467144232|FG001|Overall Study|Did not receive study drug|1|||
129775691|NCT03196349|467144233|FG002|Overall Study|Did not receive study drug|2|||
129775692|NCT03196349|467144231|FG000|Overall Study|No data entered|2|||
129554868|NCT00463866|466327086|FG001|Overall Study|Other|22|||
129554869|NCT04356573|466327087|FG000|Overall Study|Didn't Qualify|1|||
129554870|NCT04356573|466327088|FG001|Overall Study|Didn't Qualify|0|||
129554871|NCT03568500|466327089|FG000|Overall Study|Lost to Follow-up|1|||
129554872|NCT03568500|466327090|FG001|Overall Study|Lost to Follow-up|1|||
129554873|NCT03568500|466327091|FG002|Overall Study|Lost to Follow-up|2|||
129554874|NCT03568500|466327089|FG000|Overall Study|Adverse Event|1|||
129554875|NCT03568500|466327090|FG001|Overall Study|Adverse Event|1|||
129554876|NCT03568500|466327091|FG002|Overall Study|Adverse Event|2|||
129554877|NCT03568500|466327089|FG000|Overall Study|Physician Decision|1|||
129554878|NCT03568500|466327090|FG001|Overall Study|Physician Decision|0|||
129554879|NCT03568500|466327091|FG002|Overall Study|Physician Decision|0|||
129554880|NCT03568500|466327089|FG000|Overall Study|Withdrawal by Subject|4|||
129554881|NCT03568500|466327090|FG001|Overall Study|Withdrawal by Subject|2|||
129554882|NCT03568500|466327091|FG002|Overall Study|Withdrawal by Subject|0|||
129554883|NCT03568500|466327089|FG000|Overall Study|Technical Problems|2|||
129554884|NCT03568500|466327090|FG001|Overall Study|Technical Problems|1|||
129554885|NCT03568500|466327091|FG002|Overall Study|Technical Problems|0|||
129554886|NCT03568500|466327089|FG000|Overall Study|Participant Noncompliance|1|||
129554887|NCT03568500|466327090|FG001|Overall Study|Participant Noncompliance|1|||
129554888|NCT03568500|466327091|FG002|Overall Study|Participant Noncompliance|0|||
129554889|NCT04132232|466327103|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
129554890|NCT04132232|466327104|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
129554891|NCT04132232|466327103|FG000|Overall Study|Lost to Follow-up|6|||
129775693|NCT03196349|467144232|FG001|Overall Study|No data entered|4|||
129775694|NCT03196349|467144233|FG002|Overall Study|No data entered|0|||
129775695|NCT03196349|467144231|FG000|Overall Study|Study Terminated early|15|||
129775696|NCT03196349|467144232|FG001|Overall Study|Study Terminated early|9|||
129775697|NCT03196349|467144233|FG002|Overall Study|Study Terminated early|11|||
129775698|NCT03967444|467144234|FG000|Overall Study|Lost to Follow-up|1|||
129775699|NCT03967444|467144235|FG001|Overall Study|Lost to Follow-up|2|||
129775700|NCT01821118|467144242|FG000|Overall Study|Death|0|||
129775701|NCT01821118|467144243|FG001|Overall Study|Death|1|||
129775702|NCT01605799|467144244|FG000|Overall Study|Withdrawal by Subject|2|||
129775703|NCT01605799|467144245|FG001|Overall Study|Withdrawal by Subject|1|||
129775704|NCT00345358|467144246|FG000|Primary Vaccination Phase|Other|0|||
129554892|NCT04132232|466327104|FG001|Overall Study|Lost to Follow-up|7|||
129554893|NCT00368537|466327105|FG000|Randomization|No study drug dosed|13|||
129554894|NCT00368537|466327106|FG001|Randomization|No study drug dosed|6|||
129554895|NCT00368537|466327105|FG000|Baseline Participants|Lost to Follow-up|16|||
129554896|NCT00368537|466327106|FG001|Baseline Participants|Lost to Follow-up|17|||
129554897|NCT00368537|466327105|FG000|Baseline Participants|Withdrawal by Subject|6|||
129554898|NCT00368537|466327106|FG001|Baseline Participants|Withdrawal by Subject|4|||
129775705|NCT00345358|467144247|FG001|Primary Vaccination Phase|Other|1|||
129775706|NCT00345358|467144248|FG002|Primary Vaccination Phase|Other|1|||
129775707|NCT00345358|467144249|FG003|Primary Vaccination Phase|Other|0|||
129775708|NCT00345358|467144246|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
129775709|NCT00345358|467144247|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
129775710|NCT00345358|467144248|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
129554899|NCT00368537|466327105|FG000|Baseline Participants|Death|1|||
129554900|NCT00368537|466327106|FG001|Baseline Participants|Death|2|||
129554901|NCT00368537|466327105|FG000|Baseline Participants|No susceptibility|1|||
129554902|NCT00368537|466327106|FG001|Baseline Participants|No susceptibility|0|||
129554903|NCT00368537|466327105|FG000|Baseline Participants|Patient uncompliant|0|||
129554904|NCT00368537|466327106|FG001|Baseline Participants|Patient uncompliant|1|||
129554905|NCT01368276|466327118|FG000|Overall Study|Death|1|||
129554906|NCT01368276|466327119|FG001|Overall Study|Death|10|||
129554907|NCT01886300|466327126|FG000|Overall Study|Trial terminated by sponsor|16|||
129554908|NCT00373685|466327129|FG000|Overall Study|Death|2|||
129554909|NCT00373685|466327130|FG001|Overall Study|Death|1|||
129554910|NCT00373685|466327129|FG000|Overall Study|Adverse Event|278|||
129554911|NCT00373685|466327130|FG001|Overall Study|Adverse Event|253|||
129554912|NCT00373685|466327129|FG000|Overall Study|Insufficient clinical response|169|||
129554913|NCT00373685|466327130|FG001|Overall Study|Insufficient clinical response|119|||
129554914|NCT00373685|466327129|FG000|Overall Study|Did not meet entrance criteria|167|||
129554915|NCT00373685|466327130|FG001|Overall Study|Did not meet entrance criteria|184|||
129554916|NCT00373685|466327129|FG000|Overall Study|Lost to follow up|83|||
129775711|NCT00345358|467144249|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
129775712|NCT00345358|467144246|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
129775713|NCT00345358|467144247|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
129884490|NCT04844918|467536415|FG000|Overall Study|Withdrawal by Subject|6|||
129554917|NCT00373685|466327130|FG001|Overall Study|Lost to follow up|103|||
129554918|NCT00373685|466327129|FG000|Overall Study|No longer willing to participate|337|||
129554919|NCT00373685|466327130|FG001|Overall Study|No longer willing to participate|352|||
129775714|NCT00345358|467144248|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
129775715|NCT00345358|467144249|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
129554920|NCT00373685|466327129|FG000|Overall Study|Other|149|||
129554921|NCT00373685|466327130|FG001|Overall Study|Other|146|||
129554922|NCT00373685|466327129|FG000|Overall Study|Protocol Violation|191|||
129554923|NCT00373685|466327130|FG001|Overall Study|Protocol Violation|182|||
129775716|NCT00345358|467144246|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
129775717|NCT00345358|467144247|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
129775718|NCT00345358|467144248|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
129775719|NCT00345358|467144249|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
129775720|NCT00345358|467144246|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
129775721|NCT00345358|467144247|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129775722|NCT00345358|467144248|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
129775723|NCT00345358|467144249|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
129775724|NCT00345358|467144246|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
129775725|NCT00345358|467144247|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
129775726|NCT00345358|467144248|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
129775727|NCT00345358|467144249|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
129775728|NCT00477386|467144250|FG000|Overall Study|Adverse Event|4|||
129775729|NCT00477386|467144251|FG001|Overall Study|Adverse Event|8|||
129775730|NCT00477386|467144250|FG000|Overall Study|Disease progression, relapse|3|||
129775731|NCT00477386|467144251|FG001|Overall Study|Disease progression, relapse|4|||
129775732|NCT00477386|467144250|FG000|Overall Study|Disease progression, refractory|1|||
129775733|NCT00477386|467144251|FG001|Overall Study|Disease progression, refractory|3|||
129775734|NCT00477386|467144250|FG000|Overall Study|Other|1|||
129775735|NCT00477386|467144251|FG001|Overall Study|Other|2|||
129554924|NCT00373685|466327129|FG000|Overall Study|Final Status Unknown|12|||
129554925|NCT00373685|466327130|FG001|Overall Study|Final Status Unknown|4|||
129554926|NCT00373685|466327129|FG000|Overall Study|Randomized, not treated|51|||
129554927|NCT00373685|466327130|FG001|Overall Study|Randomized, not treated|77|||
129554928|NCT00575328|466327131|FG000|Overall Study|Adverse Event|1|||
129554929|NCT00575328|466327132|FG001|Overall Study|Adverse Event|1|||
129554930|NCT00575328|466327131|FG000|Overall Study|Lost to Follow-up|2|||
129554931|NCT00575328|466327132|FG001|Overall Study|Lost to Follow-up|1|||
129554932|NCT02124746|466327133|FG000|Overall Study|Adverse Event|2|||
129554933|NCT02124746|466327134|FG001|Overall Study|Adverse Event|1|||
129554934|NCT02124746|466327135|FG002|Overall Study|Adverse Event|2|||
129775736|NCT00477386|467144250|FG000|Overall Study|Physician Decision|1|||
129775737|NCT00477386|467144251|FG001|Overall Study|Physician Decision|0|||
129775738|NCT00477386|467144250|FG000|Overall Study|Withdrawal by Subject|1|||
129775739|NCT00477386|467144251|FG001|Overall Study|Withdrawal by Subject|0|||
129775740|NCT02207088|467144252|FG000|Overall Study|Adverse Event|2|||
129775741|NCT01812252|467144253|FG000|Overall Study|Persistent Disease|1|||
129775742|NCT01812252|467144254|FG001|Overall Study|Persistent Disease|0|||
129775743|NCT01812252|467144253|FG000|Overall Study|Not transplanted|11|||
129775744|NCT01812252|467144254|FG001|Overall Study|Not transplanted|11|||
129775745|NCT01812252|467144253|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
129775746|NCT01812252|467144254|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
129775747|NCT01812252|467144253|FG000|Overall Study|Withdrawal by Subject|1|||
129775748|NCT01812252|467144254|FG001|Overall Study|Withdrawal by Subject|1|||
129775749|NCT01812252|467144253|FG000|Overall Study|Screen Failure|1|||
129775750|NCT01812252|467144254|FG001|Overall Study|Screen Failure|0|||
129775751|NCT02284243|467144255|FG000|Overall Study|Lack of Efficacy|3|||
129775752|NCT02284243|467144256|FG001|Overall Study|Lack of Efficacy|3|||
129775753|NCT02284243|467144255|FG000|Overall Study|Adverse Event|1|||
129775754|NCT02284243|467144256|FG001|Overall Study|Adverse Event|0|||
129775755|NCT04269889|467144258|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
129775756|NCT04634253|467144259|FG000|Overall Study|Adverse Event|1|||
129775757|NCT04634253|467144260|FG001|Overall Study|Adverse Event|1|||
129775758|NCT04634253|467144261|FG002|Overall Study|Adverse Event|0|||
129775759|NCT04634253|467144259|FG000|Overall Study|Physician Decision|0|||
129775760|NCT04634253|467144260|FG001|Overall Study|Physician Decision|1|||
129775761|NCT04634253|467144261|FG002|Overall Study|Physician Decision|0|||
129775762|NCT04634253|467144259|FG000|Overall Study|Withdrawal by Subject|1|||
129775763|NCT04634253|467144260|FG001|Overall Study|Withdrawal by Subject|0|||
129775764|NCT04634253|467144261|FG002|Overall Study|Withdrawal by Subject|3|||
129775765|NCT01499355|467144262|FG000|Run-In Period|Study Termination|15|||
129775766|NCT01499355|467144263|FG001|Run-In Period|Study Termination|0|||
129775767|NCT01499355|467144264|FG002|Run-In Period|Study Termination|0|||
129775768|NCT01499355|467144265|FG003|Run-In Period|Study Termination|0|||
129775769|NCT01499355|467144262|FG000|Run-In Period|Other|3|||
129775770|NCT01499355|467144263|FG001|Run-In Period|Other|0|||
129775771|NCT01499355|467144264|FG002|Run-In Period|Other|0|||
129554935|NCT02124746|466327133|FG000|Overall Study|Death|2|||
129554936|NCT02124746|466327134|FG001|Overall Study|Death|1|||
129554937|NCT02124746|466327135|FG002|Overall Study|Death|3|||
129775772|NCT01499355|467144265|FG003|Run-In Period|Other|0|||
129554938|NCT02124746|466327133|FG000|Overall Study|Lack of Efficacy|3|||
129554939|NCT02124746|466327134|FG001|Overall Study|Lack of Efficacy|2|||
129775773|NCT01499355|467144262|FG000|Run-In Period|Death|2|||
129775774|NCT01499355|467144263|FG001|Run-In Period|Death|0|||
129775775|NCT01499355|467144264|FG002|Run-In Period|Death|0|||
129775776|NCT01499355|467144265|FG003|Run-In Period|Death|0|||
129775777|NCT01499355|467144262|FG000|Run-In Period|Investigator Decision|2|||
129775778|NCT01499355|467144263|FG001|Run-In Period|Investigator Decision|0|||
129775779|NCT01499355|467144264|FG002|Run-In Period|Investigator Decision|0|||
129775780|NCT01499355|467144265|FG003|Run-In Period|Investigator Decision|0|||
129775781|NCT01499355|467144262|FG000|Run-In Period|Consent Withdrawn|1|||
129775782|NCT01499355|467144263|FG001|Run-In Period|Consent Withdrawn|0|||
129775783|NCT01499355|467144264|FG002|Run-In Period|Consent Withdrawn|0|||
129775784|NCT01499355|467144265|FG003|Run-In Period|Consent Withdrawn|0|||
129775785|NCT01499355|467144262|FG000|Run-In Period|Adverse Event|8|||
129775786|NCT01499355|467144263|FG001|Run-In Period|Adverse Event|0|||
129554940|NCT02124746|466327135|FG002|Overall Study|Lack of Efficacy|2|||
129554941|NCT02124746|466327133|FG000|Overall Study|Physician Decision|6|||
129554942|NCT02124746|466327134|FG001|Overall Study|Physician Decision|4|||
129554943|NCT02124746|466327135|FG002|Overall Study|Physician Decision|5|||
129554944|NCT02124746|466327133|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129554945|NCT02124746|466327134|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129554946|NCT02124746|466327135|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129554947|NCT02124746|466327133|FG000|Overall Study|Withdrawal by Subject|3|||
129554948|NCT02124746|466327134|FG001|Overall Study|Withdrawal by Subject|3|||
129554949|NCT02124746|466327135|FG002|Overall Study|Withdrawal by Subject|0|||
129775787|NCT01499355|467144264|FG002|Run-In Period|Adverse Event|0|||
129775788|NCT01499355|467144265|FG003|Run-In Period|Adverse Event|0|||
129775789|NCT01499355|467144262|FG000|Double-Blind Period|Adverse Event|0|||
129775790|NCT01499355|467144263|FG001|Double-Blind Period|Adverse Event|2|||
129775791|NCT01499355|467144264|FG002|Double-Blind Period|Adverse Event|3|||
129775792|NCT01499355|467144265|FG003|Double-Blind Period|Adverse Event|2|||
129775793|NCT01499355|467144262|FG000|Double-Blind Period|Study Termination|0|||
129775794|NCT01499355|467144263|FG001|Double-Blind Period|Study Termination|18|||
129775795|NCT01499355|467144264|FG002|Double-Blind Period|Study Termination|16|||
129775796|NCT01499355|467144265|FG003|Double-Blind Period|Study Termination|14|||
129775797|NCT01499355|467144262|FG000|Double-Blind Period|Other|0|||
129775798|NCT01499355|467144263|FG001|Double-Blind Period|Other|1|||
129775799|NCT01499355|467144264|FG002|Double-Blind Period|Other|2|||
129775800|NCT01499355|467144265|FG003|Double-Blind Period|Other|2|||
129775801|NCT01499355|467144262|FG000|Double-Blind Period|Death|0|||
129775802|NCT01499355|467144263|FG001|Double-Blind Period|Death|1|||
129775803|NCT01499355|467144264|FG002|Double-Blind Period|Death|0|||
129775804|NCT01499355|467144265|FG003|Double-Blind Period|Death|0|||
129775805|NCT01499355|467144262|FG000|Double-Blind Period|Investigator Decision|0|||
129775806|NCT01499355|467144263|FG001|Double-Blind Period|Investigator Decision|0|||
129775807|NCT01499355|467144264|FG002|Double-Blind Period|Investigator Decision|3|||
129775808|NCT01499355|467144265|FG003|Double-Blind Period|Investigator Decision|3|||
129775809|NCT01499355|467144262|FG000|Double-Blind Period|Consent Withdrawn|0|||
129775810|NCT01499355|467144263|FG001|Double-Blind Period|Consent Withdrawn|0|||
129775811|NCT01499355|467144264|FG002|Double-Blind Period|Consent Withdrawn|1|||
129775812|NCT01499355|467144265|FG003|Double-Blind Period|Consent Withdrawn|2|||
129775813|NCT01499355|467144262|FG000|Double-Blind Period|Lost to Follow-up|0|||
129775814|NCT01499355|467144263|FG001|Double-Blind Period|Lost to Follow-up|1|||
129775815|NCT01499355|467144264|FG002|Double-Blind Period|Lost to Follow-up|0|||
129775816|NCT01499355|467144265|FG003|Double-Blind Period|Lost to Follow-up|0|||
129775817|NCT01526733|467144266|FG000|Phase 1|Protocol Violation|1|||
129775818|NCT01526733|467144267|FG001|Phase 1|Protocol Violation|0|||
129775819|NCT01526733|467144266|FG000|Phase 1|Withdrawal by Subject|1|||
129775820|NCT01526733|467144267|FG001|Phase 1|Withdrawal by Subject|1|||
129775821|NCT01310075|467144268|FG000|Overall Study|Lost to Follow-up|1|||
129775822|NCT01310075|467144269|FG001|Overall Study|Lost to Follow-up|0|||
129775823|NCT01310075|467144268|FG000|Overall Study|Physician Decision|10|||
129775824|NCT01310075|467144269|FG001|Overall Study|Physician Decision|7|||
129775825|NCT01310075|467144268|FG000|Overall Study|Protocol Violation|2|||
129775826|NCT01310075|467144269|FG001|Overall Study|Protocol Violation|2|||
129775827|NCT01310075|467144268|FG000|Overall Study|Withdrawal by Subject|1|||
129775828|NCT01310075|467144269|FG001|Overall Study|Withdrawal by Subject|1|||
129775829|NCT02395081|467144270|FG000|Overall Study|Withdrawal by Subject|1|||
129775830|NCT02395081|467144271|FG001|Overall Study|Withdrawal by Subject|1|||
129775831|NCT02395081|467144272|FG002|Overall Study|Withdrawal by Subject|0|||
129775832|NCT02395081|467144270|FG000|Overall Study|Moved where blood couldn't be collected|4|||
129775833|NCT02395081|467144271|FG001|Overall Study|Moved where blood couldn't be collected|1|||
129775834|NCT02395081|467144272|FG002|Overall Study|Moved where blood couldn't be collected|3|||
129775835|NCT02395081|467144270|FG000|Overall Study|Fetal Loss|2|||
129554950|NCT02124746|466327133|FG000|Overall Study|Study Terminated by Sponsor|0|||
129554951|NCT02124746|466327134|FG001|Overall Study|Study Terminated by Sponsor|0|||
129775836|NCT02395081|467144271|FG001|Overall Study|Fetal Loss|3|||
129775837|NCT02395081|467144272|FG002|Overall Study|Fetal Loss|1|||
129775838|NCT02991040|467144273|FG000|Overall Study|Withdrawal by Subject|2|||
129775839|NCT02991040|467144273|FG000|Overall Study|Lost to Follow-up|2|||
129775840|NCT01869764|467144274|FG000|Overall Study|Withdrawal by Subject|0|||
129775841|NCT01869764|467144275|FG001|Overall Study|Withdrawal by Subject|2|||
129775842|NCT01286480|467144276|FG000|Overall Study|Withdrawal by Subject|5|||
129775843|NCT01286480|467144277|FG001|Overall Study|Withdrawal by Subject|3|||
129775844|NCT01626872|467144278|FG000|Overall Study|Physician Decision|13|||
129775845|NCT01626872|467144279|FG001|Overall Study|Physician Decision|9|||
129775846|NCT01626872|467144280|FG002|Overall Study|Physician Decision|6|||
129775847|NCT01626872|467144278|FG000|Overall Study|Withdrawal by Subject|19|||
129775848|NCT01626872|467144279|FG001|Overall Study|Withdrawal by Subject|27|||
129775849|NCT01626872|467144280|FG002|Overall Study|Withdrawal by Subject|8|||
129775850|NCT01626872|467144278|FG000|Overall Study|Adverse Event (including Death)|20|||
129775851|NCT01626872|467144279|FG001|Overall Study|Adverse Event (including Death)|28|||
129775852|NCT01626872|467144280|FG002|Overall Study|Adverse Event (including Death)|8|||
129775853|NCT01626872|467144278|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
129775854|NCT01626872|467144279|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
129775855|NCT01626872|467144280|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
129775856|NCT01696188|467144281|FG000|Overall Study|Protocol Violation|1|||
129775857|NCT01696188|467144282|FG001|Overall Study|Protocol Violation|1|||
129775858|NCT00960999|467144283|FG000|Overall Study|Withdrawal by Subject|1|||
129775859|NCT00960999|467144284|FG001|Overall Study|Withdrawal by Subject|0|||
129775860|NCT00960999|467144283|FG000|Overall Study|Protocol Violation|5|||
129775861|NCT00960999|467144284|FG001|Overall Study|Protocol Violation|2|||
129775862|NCT00960999|467144283|FG000|Overall Study|RT dose constraints not met|2|||
129775863|NCT00960999|467144284|FG001|Overall Study|RT dose constraints not met|0|||
129775864|NCT01918306|467144285|FG000|Overall Study|progresive disease|4|||
129775865|NCT01918306|467144286|FG001|Overall Study|progresive disease|0|||
129775866|NCT01918306|467144287|FG002|Overall Study|progresive disease|1|||
129775867|NCT01918306|467144288|FG003|Overall Study|progresive disease|1|||
129775868|NCT01918306|467144285|FG000|Overall Study|Withdrawal by Subject|0|||
129775869|NCT01918306|467144286|FG001|Overall Study|Withdrawal by Subject|0|||
129775870|NCT01918306|467144287|FG002|Overall Study|Withdrawal by Subject|0|||
129775871|NCT01918306|467144288|FG003|Overall Study|Withdrawal by Subject|2|||
129775872|NCT01918306|467144285|FG000|Overall Study|neutropenia|1|||
129775873|NCT01918306|467144286|FG001|Overall Study|neutropenia|0|||
129775874|NCT01918306|467144287|FG002|Overall Study|neutropenia|0|||
129775875|NCT01918306|467144288|FG003|Overall Study|neutropenia|0|||
129775876|NCT01918306|467144285|FG000|Overall Study|Lack of Efficacy|1|||
129775877|NCT01918306|467144286|FG001|Overall Study|Lack of Efficacy|0|||
129775878|NCT01918306|467144287|FG002|Overall Study|Lack of Efficacy|0|||
129775879|NCT01918306|467144288|FG003|Overall Study|Lack of Efficacy|0|||
129775880|NCT01918306|467144285|FG000|Overall Study|progress disease, crossover|0|||
129775881|NCT01918306|467144286|FG001|Overall Study|progress disease, crossover|0|||
129775882|NCT01918306|467144287|FG002|Overall Study|progress disease, crossover|1|||
129775883|NCT01918306|467144288|FG003|Overall Study|progress disease, crossover|0|||
129775884|NCT01958164|467144290|FG000|Overall Study|Adverse Event|0|||
129775885|NCT01958164|467144291|FG001|Overall Study|Adverse Event|2|||
129775886|NCT01958164|467144290|FG000|Overall Study|Lost to Follow-up|2|||
129775887|NCT01958164|467144291|FG001|Overall Study|Lost to Follow-up|3|||
129775888|NCT02963506|467144292|FG000|Double-Blind Period|Adverse Event|0|||
129554952|NCT02124746|466327135|FG002|Overall Study|Study Terminated by Sponsor|6|||
129554953|NCT02124746|466327133|FG000|Overall Study|Disease Progression|3|||
129554954|NCT02124746|466327134|FG001|Overall Study|Disease Progression|6|||
129775889|NCT02963506|467144293|FG001|Double-Blind Period|Adverse Event|0|||
129775890|NCT02963506|467144294|FG002|Double-Blind Period|Adverse Event|1|||
129775891|NCT02963506|467144295|FG003|Double-Blind Period|Adverse Event|0|||
129775892|NCT02963506|467144296|FG004|Double-Blind Period|Adverse Event|0|||
129775893|NCT02963506|467144297|FG005|Double-Blind Period|Adverse Event|0|||
129775894|NCT02963506|467144298|FG006|Double-Blind Period|Adverse Event|0|||
129775895|NCT02963506|467144299|FG007|Double-Blind Period|Adverse Event|0|||
129775896|NCT02963506|467144300|FG008|Double-Blind Period|Adverse Event|0|||
129554955|NCT02124746|466327135|FG002|Overall Study|Disease Progression|4|||
129554956|NCT00571922|466327136|FG000|Overall Study|Completion unknown|36|||
129554957|NCT00571922|466327137|FG001|Overall Study|Completion unknown|36|||
129775897|NCT02963506|467144301|FG009|Double-Blind Period|Adverse Event|0|||
129775898|NCT02963506|467144302|FG010|Double-Blind Period|Adverse Event|0|||
129775899|NCT02963506|467144303|FG011|Double-Blind Period|Adverse Event|0|||
129775900|NCT02963506|467144304|FG012|Double-Blind Period|Adverse Event|0|||
129775901|NCT02963506|467144292|FG000|Double-Blind Period|Death|0|||
129775902|NCT02963506|467144293|FG001|Double-Blind Period|Death|0|||
129775903|NCT02963506|467144294|FG002|Double-Blind Period|Death|0|||
129775904|NCT02963506|467144295|FG003|Double-Blind Period|Death|1|||
129775905|NCT02963506|467144296|FG004|Double-Blind Period|Death|0|||
129775906|NCT02963506|467144297|FG005|Double-Blind Period|Death|0|||
129775907|NCT02963506|467144298|FG006|Double-Blind Period|Death|0|||
129775908|NCT02963506|467144299|FG007|Double-Blind Period|Death|0|||
129775909|NCT02963506|467144300|FG008|Double-Blind Period|Death|0|||
129775910|NCT02963506|467144301|FG009|Double-Blind Period|Death|0|||
129775911|NCT02963506|467144302|FG010|Double-Blind Period|Death|0|||
129686743|NCT00479232|466810006|FG001|Overall Study|Deviation from Protocol|0|||
129686744|NCT00479232|466810007|FG002|Overall Study|Deviation from Protocol|1|||
129686745|NCT00479232|466810008|FG003|Overall Study|Deviation from Protocol|0|||
129686746|NCT00479232|466810009|FG004|Overall Study|Deviation from Protocol|0|||
129686747|NCT00479232|466810010|FG005|Overall Study|Deviation from Protocol|0|||
129686748|NCT00479232|466810005|FG000|Overall Study|Lack of Efficacy|0|||
129686749|NCT00479232|466810006|FG001|Overall Study|Lack of Efficacy|0|||
129686750|NCT00479232|466810007|FG002|Overall Study|Lack of Efficacy|2|||
129686751|NCT00479232|466810008|FG003|Overall Study|Lack of Efficacy|0|||
129686752|NCT00479232|466810009|FG004|Overall Study|Lack of Efficacy|0|||
129686753|NCT00479232|466810010|FG005|Overall Study|Lack of Efficacy|4|||
129686754|NCT00479232|466810005|FG000|Overall Study|Physician Decision|0|||
129686755|NCT00479232|466810006|FG001|Overall Study|Physician Decision|0|||
129686756|NCT00479232|466810007|FG002|Overall Study|Physician Decision|2|||
129686757|NCT00479232|466810008|FG003|Overall Study|Physician Decision|0|||
129686758|NCT00479232|466810009|FG004|Overall Study|Physician Decision|0|||
129686759|NCT00479232|466810010|FG005|Overall Study|Physician Decision|1|||
129686760|NCT00479232|466810005|FG000|Overall Study|Progressive Disease|3|||
129686761|NCT00479232|466810006|FG001|Overall Study|Progressive Disease|1|||
129686762|NCT00479232|466810007|FG002|Overall Study|Progressive Disease|12|||
129686763|NCT00479232|466810008|FG003|Overall Study|Progressive Disease|3|||
129686764|NCT00479232|466810009|FG004|Overall Study|Progressive Disease|3|||
129686765|NCT00479232|466810010|FG005|Overall Study|Progressive Disease|12|||
129686766|NCT00479232|466810005|FG000|Overall Study|Withdrew Consent|0|||
129686767|NCT00479232|466810006|FG001|Overall Study|Withdrew Consent|2|||
129686768|NCT00479232|466810007|FG002|Overall Study|Withdrew Consent|6|||
129686769|NCT00479232|466810008|FG003|Overall Study|Withdrew Consent|0|||
129686770|NCT00479232|466810009|FG004|Overall Study|Withdrew Consent|1|||
129686771|NCT00479232|466810010|FG005|Overall Study|Withdrew Consent|3|||
129686772|NCT05399771|466810011|FG000|Overall Study|Physician Decision|3|||
129686773|NCT05399771|466810011|FG000|Overall Study|Adverse Event|1|||
129686774|NCT00484159|466810012|FG000|Overall Study|Lost to Follow-up|1|||
129686775|NCT00484159|466810013|FG001|Overall Study|Lost to Follow-up|1|||
129554958|NCT02191579|466327145|FG000|Treatment 1|Multiple Reasons Specified|27|||
129554959|NCT02191579|466327146|FG001|Treatment 1|Multiple Reasons Specified|58|||
129554960|NCT02191579|466327145|FG000|Treatment 2|Multiple Reasons Specified|0|||
129554961|NCT02191579|466327146|FG001|Treatment 2|Multiple Reasons Specified|25|||
129554962|NCT03940586|466327153|FG000|Overall Study|Death|3|||
129554963|NCT03940586|466327154|FG001|Overall Study|Death|2|||
129554964|NCT03940586|466327155|FG002|Overall Study|Death|0|||
129554965|NCT03940586|466327153|FG000|Overall Study|Physician Decision|1|||
129554966|NCT03940586|466327154|FG001|Overall Study|Physician Decision|0|||
129554967|NCT03940586|466327155|FG002|Overall Study|Physician Decision|1|||
129554968|NCT03940586|466327153|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
129554969|NCT03940586|466327154|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
129554970|NCT03940586|466327155|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
129554971|NCT03940586|466327153|FG000|Overall Study|Not Treated|0|||
129554972|NCT03940586|466327154|FG001|Overall Study|Not Treated|2|||
129554973|NCT03940586|466327155|FG002|Overall Study|Not Treated|0|||
129686776|NCT00484159|466810014|FG002|Overall Study|Lost to Follow-up|0|||
129686777|NCT03720847|466810015|FG000|Washout|Physician Decision|1|||
129686778|NCT03720847|466810016|FG001|Washout|Physician Decision|2|||
129686779|NCT01239680|466810017|FG000|Overall Study|Withdrawal by Subject|2|||
129686780|NCT01239680|466810018|FG001|Overall Study|Withdrawal by Subject|0|||
129686781|NCT03033901|466810019|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
129686782|NCT03033901|466810019|FG000|Overall Study|Refused PSG|23|||
129686783|NCT03033901|466810019|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
129686784|NCT03033901|466810019|FG000|Overall Study|Missing Oximetry Data|3|||
129686785|NCT02513199|466810022|FG000|Treatment|Death|1|||
129686786|NCT02513199|466810022|FG000|Treatment|Lost to Follow-up|1|||
129686787|NCT02513199|466810022|FG000|Follow-Up|Death|11|||
129686788|NCT04307394|466810029|FG000|Overall Study|Lost to Follow-up|3|||
129686789|NCT04307394|466810029|FG000|Overall Study|Withdrawal by Subject|2|||
129686790|NCT01521364|466810037|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
129686791|NCT01521364|466810037|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
129686792|NCT04900272|466810038|FG000|Overall Study|Lost to Follow-up|2|||
129686793|NCT04900272|466810038|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
129686794|NCT04900272|466810038|FG000|Overall Study|Withdrawal by Subject|1|||
129686795|NCT05059080|466810039|FG000|Overall Study|Withdrawal by Subject|3|||
129686796|NCT05059080|466810039|FG000|Overall Study|Study Terminated by Sponsor|64|||
129686797|NCT00081458|466810041|FG000|Overall Study|Adverse Event|1|||
129686798|NCT00081458|466810042|FG001|Overall Study|Adverse Event|5|||
129686799|NCT00081458|466810043|FG002|Overall Study|Adverse Event|2|||
129686800|NCT00081458|466810041|FG000|Overall Study|Withdrawal by Subject|0|||
129686801|NCT00081458|466810042|FG001|Overall Study|Withdrawal by Subject|3|||
129686802|NCT00081458|466810043|FG002|Overall Study|Withdrawal by Subject|1|||
129686803|NCT00081458|466810041|FG000|Overall Study|Randomized but not dosed|0|||
129686804|NCT00081458|466810042|FG001|Overall Study|Randomized but not dosed|0|||
129686805|NCT00081458|466810043|FG002|Overall Study|Randomized but not dosed|1|||
129686806|NCT00549328|466810044|FG000|Overall Study|Adverse Event|2|||
129686807|NCT00549328|466810044|FG000|Overall Study|Disease Progression|10|||
129686808|NCT00549328|466810044|FG000|Overall Study|Death|1|||
129686809|NCT00549328|466810044|FG000|Overall Study|Use of Prohibited Medication|1|||
129686810|NCT00770484|466810045|FG000|Overall Study|Withdrawal by Subject|1|||
129686811|NCT00770484|466810046|FG001|Overall Study|Withdrawal by Subject|0|||
129686812|NCT03097315|466810051|FG000|Overall Study|Withdrawal by Subject|1|||
129686813|NCT01946802|466810052|FG000|Overall Study|Death|1|||
129686814|NCT01946802|466810052|FG000|Overall Study|Withdrawal by Subject|2|||
129686815|NCT01946802|466810052|FG000|Overall Study|Combined septic shock|1|||
129686816|NCT01946802|466810052|FG000|Overall Study|Protocol Violation|1|||
129686817|NCT03384966|466810053|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
129686818|NCT03384966|466810054|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
129686819|NCT03384966|466810055|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
129686820|NCT03384966|466810053|FG000|Follow-up Period|Adverse Event|1|||
129686821|NCT03384966|466810054|FG001|Follow-up Period|Adverse Event|0|||
129686822|NCT03384966|466810055|FG002|Follow-up Period|Adverse Event|0|||
129686823|NCT03637374|466810056|FG000|Overall Study|Death|2|||
129554974|NCT00964223|466327156|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
129554975|NCT03077828|466327157|FG000|Treatment Cycles|Death|1|||
129554976|NCT03077828|466327157|FG000|Treatment Cycles|Withdrawal by Subject|1|||
129554977|NCT03077828|466327157|FG000|Treatment Cycles|Screen Fail|2|||
129686824|NCT03637374|466810057|FG001|Overall Study|Death|0|||
129686825|NCT02836769|466810059|FG000|Overall Study|Lost to Follow-up|10|||
129686826|NCT02836769|466810059|FG000|Overall Study|Medical withdrawal|2|||
129686827|NCT02836769|466810059|FG000|Overall Study|Withdrawal by Subject|3|||
129686828|NCT00376506|466810068|FG000|Overall Study|Death|0|||
129686829|NCT00376506|466810069|FG001|Overall Study|Death|2|||
129686830|NCT02948400|466810072|FG000|Overall Study|Withdrawal by Subject|17|||
129554978|NCT03077828|466327157|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
129554979|NCT03077828|466327157|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
129775912|NCT02963506|467144303|FG011|Double-Blind Period|Death|0|||
129775913|NCT02963506|467144304|FG012|Double-Blind Period|Death|0|||
129775914|NCT02963506|467144292|FG000|Double-Blind Period|Lost to Follow-up|0|||
129775915|NCT02963506|467144293|FG001|Double-Blind Period|Lost to Follow-up|1|||
129775916|NCT02963506|467144294|FG002|Double-Blind Period|Lost to Follow-up|0|||
129775917|NCT02963506|467144295|FG003|Double-Blind Period|Lost to Follow-up|0|||
129775918|NCT02963506|467144296|FG004|Double-Blind Period|Lost to Follow-up|0|||
129775919|NCT02963506|467144297|FG005|Double-Blind Period|Lost to Follow-up|0|||
129775920|NCT02963506|467144298|FG006|Double-Blind Period|Lost to Follow-up|0|||
129775921|NCT02963506|467144299|FG007|Double-Blind Period|Lost to Follow-up|0|||
129775922|NCT02963506|467144300|FG008|Double-Blind Period|Lost to Follow-up|0|||
129775923|NCT02963506|467144301|FG009|Double-Blind Period|Lost to Follow-up|0|||
129775924|NCT02963506|467144302|FG010|Double-Blind Period|Lost to Follow-up|0|||
129775925|NCT02963506|467144303|FG011|Double-Blind Period|Lost to Follow-up|0|||
129775926|NCT02963506|467144304|FG012|Double-Blind Period|Lost to Follow-up|0|||
129775927|NCT02963506|467144292|FG000|Double-Blind Period|Withdrawal by Subject|0|||
129775928|NCT02963506|467144293|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129775929|NCT02963506|467144294|FG002|Double-Blind Period|Withdrawal by Subject|1|||
129775930|NCT02963506|467144295|FG003|Double-Blind Period|Withdrawal by Subject|1|||
129775931|NCT02963506|467144296|FG004|Double-Blind Period|Withdrawal by Subject|0|||
129775932|NCT02963506|467144297|FG005|Double-Blind Period|Withdrawal by Subject|0|||
129775933|NCT02963506|467144298|FG006|Double-Blind Period|Withdrawal by Subject|0|||
129775934|NCT02963506|467144299|FG007|Double-Blind Period|Withdrawal by Subject|0|||
129775935|NCT02963506|467144300|FG008|Double-Blind Period|Withdrawal by Subject|0|||
129775936|NCT02963506|467144301|FG009|Double-Blind Period|Withdrawal by Subject|0|||
129775937|NCT02963506|467144302|FG010|Double-Blind Period|Withdrawal by Subject|0|||
129775938|NCT02963506|467144303|FG011|Double-Blind Period|Withdrawal by Subject|0|||
129775939|NCT02963506|467144304|FG012|Double-Blind Period|Withdrawal by Subject|0|||
129775940|NCT02963506|467144292|FG000|Double-Blind Period|No compliance|0|||
129775941|NCT02963506|467144293|FG001|Double-Blind Period|No compliance|1|||
129775942|NCT02963506|467144294|FG002|Double-Blind Period|No compliance|0|||
129775943|NCT02963506|467144295|FG003|Double-Blind Period|No compliance|0|||
129775944|NCT02963506|467144296|FG004|Double-Blind Period|No compliance|0|||
129775945|NCT02963506|467144297|FG005|Double-Blind Period|No compliance|0|||
129775946|NCT02963506|467144298|FG006|Double-Blind Period|No compliance|0|||
129775947|NCT02963506|467144299|FG007|Double-Blind Period|No compliance|0|||
129775948|NCT02963506|467144300|FG008|Double-Blind Period|No compliance|0|||
129775949|NCT02963506|467144301|FG009|Double-Blind Period|No compliance|0|||
129775950|NCT02963506|467144302|FG010|Double-Blind Period|No compliance|0|||
129775951|NCT02963506|467144303|FG011|Double-Blind Period|No compliance|0|||
129775952|NCT02963506|467144304|FG012|Double-Blind Period|No compliance|0|||
129775953|NCT02963506|467144292|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775954|NCT02963506|467144293|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
129775955|NCT02963506|467144294|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775956|NCT02963506|467144295|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775957|NCT02963506|467144296|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775958|NCT02963506|467144297|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775959|NCT02963506|467144298|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775960|NCT02963506|467144299|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775961|NCT02963506|467144300|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775962|NCT02963506|467144301|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775963|NCT02963506|467144302|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775964|NCT02963506|467144303|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775965|NCT02963506|467144304|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
129775966|NCT02963506|467144292|FG000|Dose-Blind Period|Adverse Event|0|||
129775967|NCT02963506|467144293|FG001|Dose-Blind Period|Adverse Event|0|||
129554980|NCT03077828|466327157|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
129554981|NCT03077828|466327157|FG000|Follow-up|Patients still in follow-up|15|||
129686831|NCT02948400|466810073|FG001|Overall Study|Withdrawal by Subject|10|||
129686832|NCT02948400|466810072|FG000|Overall Study|failed to attend appointments|47|||
129686833|NCT02948400|466810073|FG001|Overall Study|failed to attend appointments|34|||
129686834|NCT02948400|466810072|FG000|Overall Study|COVID-related closure|6|||
129686835|NCT02948400|466810073|FG001|Overall Study|COVID-related closure|2|||
129686836|NCT02948400|466810072|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
129686837|NCT02948400|466810073|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
129686838|NCT02948400|466810072|FG000|Overall Study|motion sickness in virtual reality|2|||
129686839|NCT02948400|466810073|FG001|Overall Study|motion sickness in virtual reality|0|||
129686840|NCT02403271|466810074|FG000|Period 1|Other varied reasons|1|||
129686841|NCT02403271|466810075|FG001|Period 1|Other varied reasons|0|||
129686842|NCT02403271|466810074|FG000|Period 2|Withdrawal by Subject|0|||
129686843|NCT02403271|466810075|FG001|Period 2|Withdrawal by Subject|14|||
129686844|NCT02403271|466810074|FG000|Period 2|Death|0|||
129686845|NCT02403271|466810075|FG001|Period 2|Death|84|||
129686846|NCT02403271|466810074|FG000|Period 2|Lost to Follow-up|0|||
129686847|NCT02403271|466810075|FG001|Period 2|Lost to Follow-up|2|||
129686848|NCT02403271|466810074|FG000|Period 2|Study Terminated by Sponsor|0|||
129686849|NCT02403271|466810075|FG001|Period 2|Study Terminated by Sponsor|14|||
129686850|NCT02403271|466810074|FG000|Period 2|Other varied reasons|0|||
129686851|NCT02403271|466810075|FG001|Period 2|Other varied reasons|10|||
129686852|NCT00221104|466810080|FG000|Overall Study|Adverse Event|1|||
129686853|NCT00221104|466810081|FG001|Overall Study|Adverse Event|0|||
129686854|NCT00221104|466810080|FG000|Overall Study|Physician Decision|1|||
129686855|NCT00221104|466810081|FG001|Overall Study|Physician Decision|0|||
129686856|NCT00221104|466810080|FG000|Overall Study|Protocol Violation|2|||
129554982|NCT00345683|466327161|FG000|Overall Study|Lost to Follow-up|19|||
129554983|NCT00345683|466327162|FG001|Overall Study|Lost to Follow-up|7|||
129554984|NCT00345683|466327161|FG000|Overall Study|Other|6|||
129554985|NCT00345683|466327162|FG001|Overall Study|Other|2|||
129554986|NCT04288115|466327163|FG000|Overall Study|Withdrawal by Subject|0|||
129554987|NCT04288115|466327164|FG001|Overall Study|Withdrawal by Subject|1|||
129554988|NCT04288115|466327163|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
129554989|NCT04288115|466327164|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
129554990|NCT00729365|466327166|FG000|Overall Study|Physician Decision|33|||
129686857|NCT00221104|466810081|FG001|Overall Study|Protocol Violation|0|||
129686858|NCT00221104|466810080|FG000|Overall Study|Withdrawal by Subject|42|||
129686859|NCT00221104|466810081|FG001|Overall Study|Withdrawal by Subject|29|||
129686860|NCT00221104|466810080|FG000|Overall Study|Others|37|||
129686861|NCT00221104|466810081|FG001|Overall Study|Others|47|||
129686862|NCT02989389|466810082|FG000|Period 1|Lost to Follow-up|0|||
129686863|NCT02989389|466810083|FG001|Period 1|Lost to Follow-up|1|||
129686864|NCT02989389|466810084|FG002|Period 1|Lost to Follow-up|0|||
129686865|NCT02989389|466810085|FG003|Period 1|Lost to Follow-up|0|||
129686866|NCT02989389|466810086|FG004|Period 1|Lost to Follow-up|0|||
129686867|NCT02989389|466810087|FG005|Period 1|Lost to Follow-up|0|||
129686868|NCT02989389|466810088|FG006|Period 1|Lost to Follow-up|0|||
129686869|NCT02989389|466810089|FG007|Period 1|Lost to Follow-up|0|||
129686870|NCT02989389|466810090|FG008|Period 1|Lost to Follow-up|0|||
129686871|NCT02989389|466810091|FG009|Period 1|Lost to Follow-up|0|||
129686872|NCT02989389|466810082|FG000|Period 1|Physician Decision|0|||
129686873|NCT02989389|466810083|FG001|Period 1|Physician Decision|0|||
129686874|NCT02989389|466810084|FG002|Period 1|Physician Decision|0|||
129686875|NCT02989389|466810085|FG003|Period 1|Physician Decision|0|||
129686876|NCT02989389|466810086|FG004|Period 1|Physician Decision|0|||
129686877|NCT02989389|466810087|FG005|Period 1|Physician Decision|0|||
129686878|NCT02989389|466810088|FG006|Period 1|Physician Decision|0|||
129686879|NCT02989389|466810089|FG007|Period 1|Physician Decision|0|||
129686880|NCT02989389|466810090|FG008|Period 1|Physician Decision|1|||
129686881|NCT02989389|466810091|FG009|Period 1|Physician Decision|0|||
129686882|NCT04470427|466810092|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
129686883|NCT04470427|466810093|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
129686884|NCT04470427|466810094|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
129686885|NCT04470427|466810095|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
129686886|NCT04470427|466810096|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
129775968|NCT02963506|467144294|FG002|Dose-Blind Period|Adverse Event|0|||
129686887|NCT04470427|466810097|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
129686888|NCT04470427|466810092|FG000|Part B :Open-label|Other than specified|0|||
129686889|NCT04470427|466810093|FG001|Part B :Open-label|Other than specified|0|||
129686890|NCT04470427|466810094|FG002|Part B :Open-label|Other than specified|788|||
129686891|NCT04470427|466810095|FG003|Part B :Open-label|Other than specified|0|||
129686892|NCT04470427|466810096|FG004|Part B :Open-label|Other than specified|523|||
129686893|NCT04470427|466810097|FG005|Part B :Open-label|Other than specified|0|||
129686894|NCT04470427|466810092|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
129775969|NCT02963506|467144295|FG003|Dose-Blind Period|Adverse Event|0|||
129554991|NCT00729365|466327167|FG001|Overall Study|Physician Decision|6|||
129554992|NCT00729365|466327168|FG002|Overall Study|Physician Decision|7|||
129554993|NCT01298596|466327171|FG000|Overall Study|Withdrawal by Subject|1|||
129554994|NCT01298596|466327172|FG001|Overall Study|Withdrawal by Subject|1|||
129554995|NCT01298596|466327171|FG000|Overall Study|Death|5|||
129554996|NCT01298596|466327172|FG001|Overall Study|Death|3|||
129554997|NCT01298596|466327171|FG000|Overall Study|Lost to Follow-up|6|||
129554998|NCT01298596|466327172|FG001|Overall Study|Lost to Follow-up|14|||
129554999|NCT01298596|466327171|FG000|Overall Study|Referred for further management|16|||
129555000|NCT01298596|466327172|FG001|Overall Study|Referred for further management|15|||
129555001|NCT04128696|466327175|FG000|Overall Study|Lost to Follow-up|3|||
129555002|NCT04128696|466327176|FG001|Overall Study|Lost to Follow-up|7|||
129555003|NCT04128696|466327175|FG000|Overall Study|Withdrawal by Subject|12|||
129555004|NCT04128696|466327176|FG001|Overall Study|Withdrawal by Subject|11|||
129555005|NCT04128696|466327175|FG000|Overall Study|Study Closed/Terminated|26|||
129555006|NCT04128696|466327176|FG001|Overall Study|Study Closed/Terminated|38|||
129555007|NCT04128696|466327175|FG000|Overall Study|Physician Decision|2|||
129555008|NCT04128696|466327176|FG001|Overall Study|Physician Decision|3|||
129555009|NCT00585039|466327177|FG000|Overall Study|medication spilled|2|||
129555010|NCT00585039|466327178|FG001|Overall Study|medication spilled|0|||
129555011|NCT01010230|466327179|FG000|Overall Study|Withdrawal by Subject|6|||
129555012|NCT01010230|466327180|FG001|Overall Study|Withdrawal by Subject|5|||
129555013|NCT01010230|466327179|FG000|Overall Study|Lost to Follow-up|4|||
129555014|NCT01010230|466327180|FG001|Overall Study|Lost to Follow-up|2|||
129555015|NCT01585831|466327187|FG000|Overall Study|Physician Decision|0|||
129555016|NCT01585831|466327188|FG001|Overall Study|Physician Decision|1|||
129775970|NCT02963506|467144296|FG004|Dose-Blind Period|Adverse Event|0|||
129775971|NCT02963506|467144297|FG005|Dose-Blind Period|Adverse Event|1|||
129775972|NCT02963506|467144298|FG006|Dose-Blind Period|Adverse Event|3|||
129775973|NCT02963506|467144299|FG007|Dose-Blind Period|Adverse Event|2|||
129775974|NCT02963506|467144300|FG008|Dose-Blind Period|Adverse Event|2|||
129775975|NCT02963506|467144301|FG009|Dose-Blind Period|Adverse Event|2|||
129775976|NCT02963506|467144302|FG010|Dose-Blind Period|Adverse Event|1|||
129775977|NCT02963506|467144303|FG011|Dose-Blind Period|Adverse Event|1|||
129775978|NCT02963506|467144304|FG012|Dose-Blind Period|Adverse Event|6|||
129775979|NCT02963506|467144292|FG000|Dose-Blind Period|Lack of Efficacy|0|||
129775980|NCT02963506|467144293|FG001|Dose-Blind Period|Lack of Efficacy|0|||
129775981|NCT02963506|467144294|FG002|Dose-Blind Period|Lack of Efficacy|0|||
129775982|NCT02963506|467144295|FG003|Dose-Blind Period|Lack of Efficacy|0|||
129775983|NCT02963506|467144296|FG004|Dose-Blind Period|Lack of Efficacy|0|||
129775984|NCT02963506|467144297|FG005|Dose-Blind Period|Lack of Efficacy|0|||
129775985|NCT02963506|467144298|FG006|Dose-Blind Period|Lack of Efficacy|0|||
129775986|NCT02963506|467144299|FG007|Dose-Blind Period|Lack of Efficacy|1|||
129775987|NCT02963506|467144300|FG008|Dose-Blind Period|Lack of Efficacy|0|||
129775988|NCT02963506|467144301|FG009|Dose-Blind Period|Lack of Efficacy|1|||
129775989|NCT02963506|467144302|FG010|Dose-Blind Period|Lack of Efficacy|0|||
129775990|NCT02963506|467144303|FG011|Dose-Blind Period|Lack of Efficacy|0|||
129775991|NCT02963506|467144304|FG012|Dose-Blind Period|Lack of Efficacy|0|||
129775992|NCT02963506|467144292|FG000|Dose-Blind Period|Lost to Follow-up|0|||
129775993|NCT02963506|467144293|FG001|Dose-Blind Period|Lost to Follow-up|0|||
129775994|NCT02963506|467144294|FG002|Dose-Blind Period|Lost to Follow-up|0|||
129775995|NCT02963506|467144295|FG003|Dose-Blind Period|Lost to Follow-up|0|||
129775996|NCT02963506|467144296|FG004|Dose-Blind Period|Lost to Follow-up|0|||
129775997|NCT02963506|467144297|FG005|Dose-Blind Period|Lost to Follow-up|1|||
129775998|NCT02963506|467144298|FG006|Dose-Blind Period|Lost to Follow-up|0|||
129775999|NCT02963506|467144299|FG007|Dose-Blind Period|Lost to Follow-up|0|||
129776000|NCT02963506|467144300|FG008|Dose-Blind Period|Lost to Follow-up|1|||
129776001|NCT02963506|467144301|FG009|Dose-Blind Period|Lost to Follow-up|0|||
129776002|NCT02963506|467144302|FG010|Dose-Blind Period|Lost to Follow-up|0|||
129555017|NCT01585831|466327187|FG000|Overall Study|Withdrawal by Subject|2|||
129555018|NCT01585831|466327188|FG001|Overall Study|Withdrawal by Subject|1|||
129555019|NCT02046369|466327189|FG000|Overall Study|Adverse Event|3|||
129555020|NCT02046369|466327190|FG001|Overall Study|Adverse Event|3|||
129776003|NCT02963506|467144303|FG011|Dose-Blind Period|Lost to Follow-up|1|||
129776004|NCT02963506|467144304|FG012|Dose-Blind Period|Lost to Follow-up|0|||
129776005|NCT02963506|467144292|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
129776006|NCT02963506|467144293|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
129776007|NCT02963506|467144294|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
129776008|NCT02963506|467144295|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
129776009|NCT02963506|467144296|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
129776010|NCT02963506|467144297|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
129776011|NCT02963506|467144298|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
129555021|NCT02046369|466327189|FG000|Overall Study|Lack of Efficacy|3|||
129555022|NCT02046369|466327190|FG001|Overall Study|Lack of Efficacy|3|||
129555023|NCT02046369|466327189|FG000|Overall Study|Lost to Follow-up|3|||
129555024|NCT02046369|466327190|FG001|Overall Study|Lost to Follow-up|3|||
129800230|NCT02891161|467236267|FG001|Follow up|Death|8|||
129555025|NCT02046369|466327189|FG000|Overall Study|Protocol Violation|1|||
129555026|NCT02046369|466327190|FG001|Overall Study|Protocol Violation|2|||
129555027|NCT02046369|466327189|FG000|Overall Study|Withdrawal by Subject|3|||
129686895|NCT04470427|466810093|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
129686896|NCT04470427|466810094|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
129686897|NCT04470427|466810095|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
129686898|NCT04470427|466810096|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
129686899|NCT04470427|466810097|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
129686900|NCT04470427|466810092|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
129686901|NCT04470427|466810093|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
129686902|NCT04470427|466810094|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
129686903|NCT04470427|466810095|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
129686904|NCT04470427|466810096|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
129686905|NCT04470427|466810097|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
129686906|NCT03412890|466810104|FG000|Overall Study|Adverse Event|5|||
129686907|NCT03412890|466810105|FG001|Overall Study|Adverse Event|5|||
129686908|NCT03412890|466810106|FG002|Overall Study|Adverse Event|9|||
129686909|NCT03412890|466810104|FG000|Overall Study|Protocol deviation|2|||
129686910|NCT03412890|466810105|FG001|Overall Study|Protocol deviation|1|||
129686911|NCT03412890|466810106|FG002|Overall Study|Protocol deviation|2|||
129686912|NCT03412890|466810104|FG000|Overall Study|Lost to Follow-up|7|||
129686913|NCT03412890|466810105|FG001|Overall Study|Lost to Follow-up|10|||
129686914|NCT03412890|466810106|FG002|Overall Study|Lost to Follow-up|10|||
129686915|NCT03412890|466810104|FG000|Overall Study|Withdrawal by Subject|9|||
129686916|NCT03412890|466810105|FG001|Overall Study|Withdrawal by Subject|12|||
129686917|NCT03412890|466810106|FG002|Overall Study|Withdrawal by Subject|11|||
129686918|NCT03412890|466810104|FG000|Overall Study|Lack of Efficacy|2|||
129686919|NCT03412890|466810105|FG001|Overall Study|Lack of Efficacy|7|||
129686920|NCT03412890|466810106|FG002|Overall Study|Lack of Efficacy|5|||
129686921|NCT03412890|466810104|FG000|Overall Study|Other|5|||
129686922|NCT03412890|466810105|FG001|Overall Study|Other|6|||
129686923|NCT03412890|466810106|FG002|Overall Study|Other|5|||
129686924|NCT03412890|466810104|FG000|Overall Study|Participants who did not receive any study drug|0|||
129686925|NCT03412890|466810105|FG001|Overall Study|Participants who did not receive any study drug|1|||
129686926|NCT03412890|466810106|FG002|Overall Study|Participants who did not receive any study drug|0|||
129686927|NCT00021255|466810107|FG000|Overall Study|Death|1|||
129686928|NCT00021255|466810108|FG001|Overall Study|Death|0|||
129686929|NCT00021255|466810109|FG002|Overall Study|Death|2|||
129686930|NCT00021255|466810107|FG000|Overall Study|Breast cancer relapse|5|||
129686931|NCT00021255|466810108|FG001|Overall Study|Breast cancer relapse|18|||
129686932|NCT00021255|466810109|FG002|Overall Study|Breast cancer relapse|11|||
129686933|NCT00021255|466810107|FG000|Overall Study|Second primary malignancy|0|||
129686934|NCT00021255|466810108|FG001|Overall Study|Second primary malignancy|4|||
129686935|NCT00021255|466810109|FG002|Overall Study|Second primary malignancy|1|||
129686936|NCT00021255|466810107|FG000|Overall Study|Withdrawal by Subject|41|||
129686937|NCT00021255|466810108|FG001|Overall Study|Withdrawal by Subject|64|||
129686938|NCT00021255|466810109|FG002|Overall Study|Withdrawal by Subject|26|||
129686939|NCT00021255|466810107|FG000|Overall Study|Lost to Follow-up|0|||
129686940|NCT00021255|466810108|FG001|Overall Study|Lost to Follow-up|2|||
129686941|NCT00021255|466810109|FG002|Overall Study|Lost to Follow-up|3|||
129686942|NCT00021255|466810107|FG000|Overall Study|Cardiac toxicity|0|||
129686943|NCT00021255|466810108|FG001|Overall Study|Cardiac toxicity|61|||
129686944|NCT00021255|466810109|FG002|Overall Study|Cardiac toxicity|32|||
129686945|NCT00021255|466810107|FG000|Overall Study|Herceptin toxicity|0|||
129686946|NCT00021255|466810108|FG001|Overall Study|Herceptin toxicity|22|||
129686947|NCT00021255|466810109|FG002|Overall Study|Herceptin toxicity|6|||
129686948|NCT00021255|466810107|FG000|Overall Study|Adverse Event|46|||
129686949|NCT00021255|466810108|FG001|Overall Study|Adverse Event|30|||
129686950|NCT00021255|466810109|FG002|Overall Study|Adverse Event|18|||
129686951|NCT00021255|466810107|FG000|Overall Study|Protocol Violation|0|||
129686952|NCT00021255|466810108|FG001|Overall Study|Protocol Violation|2|||
129686953|NCT00021255|466810109|FG002|Overall Study|Protocol Violation|0|||
129686954|NCT00021255|466810107|FG000|Overall Study|Other than specified above|0|||
129686955|NCT00021255|466810108|FG001|Overall Study|Other than specified above|38|||
129686956|NCT00021255|466810109|FG002|Overall Study|Other than specified above|19|||
129686957|NCT00021255|466810107|FG000|Overall Study|Missing|0|||
129686958|NCT00021255|466810108|FG001|Overall Study|Missing|27|||
129686959|NCT00021255|466810109|FG002|Overall Study|Missing|13|||
129686960|NCT00021255|466810107|FG000|Overall Study|Randomized but not treated|28|||
129776012|NCT02963506|467144299|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
129776013|NCT02963506|467144300|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
129776014|NCT02963506|467144301|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
129776015|NCT02963506|467144302|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
129776016|NCT02963506|467144303|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
129776017|NCT02963506|467144304|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
129776018|NCT02963506|467144292|FG000|Dose-Blind Period|Sponsor decision|0|||
129776019|NCT02963506|467144293|FG001|Dose-Blind Period|Sponsor decision|0|||
129776020|NCT02963506|467144294|FG002|Dose-Blind Period|Sponsor decision|0|||
129776021|NCT02963506|467144295|FG003|Dose-Blind Period|Sponsor decision|0|||
129776022|NCT02963506|467144296|FG004|Dose-Blind Period|Sponsor decision|0|||
129776023|NCT02963506|467144297|FG005|Dose-Blind Period|Sponsor decision|1|||
129776024|NCT02963506|467144298|FG006|Dose-Blind Period|Sponsor decision|0|||
129776025|NCT02963506|467144299|FG007|Dose-Blind Period|Sponsor decision|0|||
129776026|NCT02963506|467144300|FG008|Dose-Blind Period|Sponsor decision|0|||
129776027|NCT02963506|467144301|FG009|Dose-Blind Period|Sponsor decision|0|||
129776028|NCT02963506|467144302|FG010|Dose-Blind Period|Sponsor decision|0|||
129776029|NCT02963506|467144303|FG011|Dose-Blind Period|Sponsor decision|0|||
129776030|NCT02963506|467144304|FG012|Dose-Blind Period|Sponsor decision|0|||
129776031|NCT02963506|467144292|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776032|NCT02963506|467144293|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776033|NCT02963506|467144294|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776034|NCT02963506|467144295|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776035|NCT02963506|467144296|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776036|NCT02963506|467144297|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776037|NCT02963506|467144298|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776038|NCT02963506|467144299|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776039|NCT02963506|467144300|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776040|NCT02963506|467144301|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776041|NCT02963506|467144302|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776042|NCT02963506|467144303|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
129776043|NCT02963506|467144304|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
129776044|NCT00828204|467144307|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
129776045|NCT00828204|467144308|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
129776046|NCT00828204|467144307|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
129776047|NCT00828204|467144308|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
129776048|NCT00828204|467144307|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
129776049|NCT00828204|467144308|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
129776050|NCT00828204|467144307|FG000|Main Study: After Study Restart|Adverse Event|0|||
129776051|NCT00828204|467144308|FG001|Main Study: After Study Restart|Adverse Event|2|||
129776052|NCT00828204|467144307|FG000|Main Study: After Study Restart|Noncompliance|0|||
129776053|NCT00828204|467144308|FG001|Main Study: After Study Restart|Noncompliance|1|||
129776054|NCT00828204|467144307|FG000|Extension Study|Lost to Follow-up|0|||
129776055|NCT00828204|467144308|FG001|Extension Study|Lost to Follow-up|1|||
129776056|NCT00828204|467144307|FG000|Extension Study|Physician Decision|0|||
129555028|NCT02046369|466327190|FG001|Overall Study|Withdrawal by Subject|6|||
129555029|NCT02046369|466327189|FG000|Overall Study|never received study drug|0|||
129555030|NCT02046369|466327190|FG001|Overall Study|never received study drug|1|||
129555031|NCT02046369|466327189|FG000|Overall Study|non compliance|1|||
129555032|NCT02046369|466327190|FG001|Overall Study|non compliance|0|||
129555033|NCT03120520|466327191|FG000|Overall Study|Lost to Follow-up|1|||
129555034|NCT03120520|466327192|FG001|Overall Study|Lost to Follow-up|1|||
129776057|NCT00828204|467144308|FG001|Extension Study|Physician Decision|2|||
129776058|NCT00750438|467144311|FG000|Overall Study|Protocol Violation|4|||
129776059|NCT00750438|467144312|FG001|Overall Study|Protocol Violation|1|||
129776060|NCT00750438|467144311|FG000|Overall Study|Physician Decision|2|||
129776061|NCT00750438|467144312|FG001|Overall Study|Physician Decision|2|||
129776062|NCT00750438|467144311|FG000|Overall Study|Withdrawal by Subject|1|||
129776063|NCT00750438|467144312|FG001|Overall Study|Withdrawal by Subject|1|||
129776064|NCT00928408|467144317|FG000|Overall Study|Other|2|||
129776065|NCT00928408|467144317|FG000|Overall Study|Withdrawal by Subject|4|||
129776066|NCT00928408|467144317|FG000|Overall Study|Death|5|||
129776067|NCT00928408|467144317|FG000|Overall Study|Lost to Follow-up|12|||
129555035|NCT03120520|466327193|FG002|Overall Study|Lost to Follow-up|1|||
129555036|NCT03120520|466327194|FG003|Overall Study|Lost to Follow-up|1|||
129555037|NCT03120520|466327191|FG000|Overall Study|Withdrawal by Subject|3|||
129555038|NCT03120520|466327192|FG001|Overall Study|Withdrawal by Subject|2|||
129776068|NCT00536744|467144318|FG000|Overall Study|Adverse Event|13|||
129776069|NCT00536744|467144319|FG001|Overall Study|Adverse Event|10|||
129776070|NCT00536744|467144318|FG000|Overall Study|Death|2|||
129776071|NCT00536744|467144319|FG001|Overall Study|Death|1|||
129776072|NCT00536744|467144318|FG000|Overall Study|Physician Decision|3|||
129776073|NCT00536744|467144319|FG001|Overall Study|Physician Decision|1|||
129776074|NCT00536744|467144318|FG000|Overall Study|Lost to Follow-up|3|||
129555039|NCT03120520|466327193|FG002|Overall Study|Withdrawal by Subject|3|||
129555040|NCT03120520|466327194|FG003|Overall Study|Withdrawal by Subject|2|||
129555041|NCT03120520|466327191|FG000|Overall Study|Other|0|||
129555042|NCT03120520|466327192|FG001|Overall Study|Other|1|||
129555043|NCT03120520|466327193|FG002|Overall Study|Other|0|||
129555044|NCT03120520|466327194|FG003|Overall Study|Other|0|||
129555045|NCT02133352|466327196|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
129555046|NCT01623830|466329143|FG000|Overall Study|Withdrawal by Subject|6|||
129555047|NCT01623830|466329144|FG001|Overall Study|Withdrawal by Subject|7|||
129555048|NCT01623830|466329143|FG000|Overall Study|Exclusion from Study|1|||
129555049|NCT01623830|466329144|FG001|Overall Study|Exclusion from Study|2|||
129555050|NCT01677910|466329146|FG000|Double-Blind Treatment Period|Adverse Event|6|||
129555051|NCT01677910|466329147|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129555052|NCT01677910|466329148|FG002|Double-Blind Treatment Period|Adverse Event|3|||
129555053|NCT01677910|466329149|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129555054|NCT01677910|466329146|FG000|Double-Blind Treatment Period|Physician Decision|0|||
129555055|NCT01677910|466329147|FG001|Double-Blind Treatment Period|Physician Decision|0|||
129555056|NCT01677910|466329148|FG002|Double-Blind Treatment Period|Physician Decision|1|||
129686961|NCT00021255|466810108|FG001|Overall Study|Randomized but not treated|2|||
129686962|NCT00021255|466810109|FG002|Overall Study|Randomized but not treated|18|||
129776075|NCT00536744|467144319|FG001|Overall Study|Lost to Follow-up|5|||
129776076|NCT00536744|467144318|FG000|Overall Study|Withdrawal by Subject|7|||
129776077|NCT00536744|467144319|FG001|Overall Study|Withdrawal by Subject|8|||
129776078|NCT00536744|467144318|FG000|Overall Study|PI tried alternative treatment|1|||
129555057|NCT01677910|466329149|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129686963|NCT01132755|466810112|FG000|Overall Study|Procedure not done due to medical reason|23|||
129686964|NCT01132755|466810112|FG000|Overall Study|Protocol Violation|15|||
129686965|NCT01132755|466810112|FG000|Overall Study|Withdrawal by Subject|4|||
129686966|NCT02232698|466810113|FG000|Overall Study|Pregnancy|1|||
129686967|NCT02232698|466810114|FG001|Overall Study|Pregnancy|1|||
129686968|NCT02232698|466810113|FG000|Overall Study|Met exclusion criteria|1|||
129686969|NCT02232698|466810114|FG001|Overall Study|Met exclusion criteria|1|||
129686970|NCT02232698|466810113|FG000|Overall Study|Had device-associated symptoms|7|||
129686971|NCT02232698|466810114|FG001|Overall Study|Had device-associated symptoms|0|||
129686972|NCT02232698|466810113|FG000|Overall Study|Non-compliance with study device|1|||
129686973|NCT02232698|466810114|FG001|Overall Study|Non-compliance with study device|4|||
129686974|NCT02232698|466810113|FG000|Overall Study|Allocated to control group|0|||
129686975|NCT02232698|466810114|FG001|Overall Study|Allocated to control group|3|||
129686976|NCT02232698|466810113|FG000|Overall Study|Withdrawal by Subject|0|||
129686977|NCT02232698|466810114|FG001|Overall Study|Withdrawal by Subject|11|||
129686978|NCT02393755|466810115|FG000|Overall Study|Withdrawal by Subject|0|||
129686979|NCT02393755|466810116|FG001|Overall Study|Withdrawal by Subject|3|||
129686980|NCT02393755|466810115|FG000|Overall Study|Adverse Event|0|||
129686981|NCT02393755|466810116|FG001|Overall Study|Adverse Event|2|||
129686982|NCT02393755|466810115|FG000|Overall Study|Physician Decision|0|||
129686983|NCT02393755|466810116|FG001|Overall Study|Physician Decision|2|||
129686984|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
129686985|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
129686986|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
129686987|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
129686988|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
129686989|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
129686990|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
129686991|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
129686992|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
129686993|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
129686994|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
129686995|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
129686996|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
129686997|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
129686998|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
129686999|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
129687000|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
129687001|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
129687002|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
129555058|NCT01677910|466329146|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
129555059|NCT01677910|466329147|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
129555060|NCT01677910|466329148|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
129687003|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
129687004|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
129687005|NCT02337946|466810117|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
129776079|NCT00536744|467144319|FG001|Overall Study|PI tried alternative treatment|3|||
129776080|NCT00787644|467144320|FG000|Overall Study|Lost to Follow-up|1|||
129776081|NCT00787644|467144321|FG001|Overall Study|Lost to Follow-up|1|||
129776082|NCT00787644|467144320|FG000|Overall Study|Withdrawal by Subject|1|||
129776083|NCT00787644|467144321|FG001|Overall Study|Withdrawal by Subject|1|||
129776084|NCT02736578|467144325|FG000|Overall Study|Adverse Event|1|||
129776085|NCT02736578|467144326|FG001|Overall Study|Adverse Event|0|||
129776086|NCT00354432|467144327|FG000|Overall Study|Adverse Event|3|||
129776087|NCT00354432|467144328|FG001|Overall Study|Adverse Event|1|||
129776088|NCT00354432|467144329|FG002|Overall Study|Adverse Event|5|||
129776089|NCT00354432|467144330|FG003|Overall Study|Adverse Event|5|||
129776090|NCT00354432|467144327|FG000|Overall Study|Off/Toxicity|3|||
129776091|NCT00354432|467144328|FG001|Overall Study|Off/Toxicity|7|||
129776092|NCT00354432|467144329|FG002|Overall Study|Off/Toxicity|5|||
129776093|NCT00354432|467144330|FG003|Overall Study|Off/Toxicity|5|||
129776094|NCT02827877|467144333|FG000|Overall Study|Withdrawal by Subject|1|||
129776095|NCT00145158|467146095|FG000|Overall Study|premature withdrawal|2|||
129776096|NCT00145158|467146096|FG001|Overall Study|premature withdrawal|3|||
129776097|NCT00499616|467146097|FG000|Overall Study|Death|1|||
129776098|NCT00499616|467146098|FG001|Overall Study|Death|5|||
129776099|NCT00499616|467146099|FG002|Overall Study|Death|3|||
129776100|NCT00499616|467146100|FG003|Overall Study|Death|1|||
129776101|NCT00499616|467146097|FG000|Overall Study|Lack of Efficacy|5|||
129776102|NCT00499616|467146098|FG001|Overall Study|Lack of Efficacy|0|||
129776103|NCT00499616|467146099|FG002|Overall Study|Lack of Efficacy|19|||
129776104|NCT00499616|467146100|FG003|Overall Study|Lack of Efficacy|0|||
129776105|NCT00499616|467146097|FG000|Overall Study|Lost to Follow-up|0|||
129776106|NCT00499616|467146098|FG001|Overall Study|Lost to Follow-up|0|||
129776107|NCT00499616|467146099|FG002|Overall Study|Lost to Follow-up|1|||
129776108|NCT00499616|467146100|FG003|Overall Study|Lost to Follow-up|0|||
129776109|NCT00499616|467146097|FG000|Overall Study|Physician Decision|6|||
129776110|NCT00499616|467146098|FG001|Overall Study|Physician Decision|16|||
129776111|NCT00499616|467146099|FG002|Overall Study|Physician Decision|9|||
129776112|NCT00499616|467146100|FG003|Overall Study|Physician Decision|0|||
129776113|NCT00499616|467146097|FG000|Overall Study|Withdrawal by Subject|1|||
129776114|NCT00499616|467146098|FG001|Overall Study|Withdrawal by Subject|0|||
129776115|NCT00499616|467146099|FG002|Overall Study|Withdrawal by Subject|1|||
129776116|NCT00499616|467146100|FG003|Overall Study|Withdrawal by Subject|0|||
129776117|NCT00499616|467146097|FG000|Overall Study|Ineligible|1|||
129776118|NCT00499616|467146098|FG001|Overall Study|Ineligible|2|||
129776119|NCT00499616|467146099|FG002|Overall Study|Ineligible|0|||
129776120|NCT00499616|467146100|FG003|Overall Study|Ineligible|15|||
129776121|NCT00499616|467146097|FG000|Overall Study|Not evaluable|0|||
129776122|NCT00499616|467146098|FG001|Overall Study|Not evaluable|0|||
129776123|NCT00499616|467146099|FG002|Overall Study|Not evaluable|0|||
129776124|NCT00499616|467146100|FG003|Overall Study|Not evaluable|41|||
129776125|NCT00499616|467146097|FG000|Overall Study|Patient/Parent Refusal|1|||
129776126|NCT00499616|467146098|FG001|Overall Study|Patient/Parent Refusal|5|||
129776127|NCT00499616|467146099|FG002|Overall Study|Patient/Parent Refusal|3|||
129776128|NCT00499616|467146100|FG003|Overall Study|Patient/Parent Refusal|0|||
129776129|NCT01938716|467146101|FG000|Overall Study|Physician Decision|2|||
129776130|NCT01938716|467146101|FG000|Overall Study|Withdrawal by Subject|2|||
129776131|NCT01358721|467146102|FG000|Overall Study|Withdrawal by Subject|0|||
129776132|NCT01358721|467146103|FG001|Overall Study|Withdrawal by Subject|0|||
129776133|NCT01358721|467146104|FG002|Overall Study|Withdrawal by Subject|0|||
129776134|NCT01358721|467146105|FG003|Overall Study|Withdrawal by Subject|1|||
129776135|NCT01358721|467146102|FG000|Overall Study|Death|0|||
129776136|NCT01358721|467146103|FG001|Overall Study|Death|2|||
129776137|NCT01358721|467146104|FG002|Overall Study|Death|0|||
129776138|NCT01358721|467146105|FG003|Overall Study|Death|0|||
129776139|NCT01358721|467146102|FG000|Overall Study|Study Drug Toxicity|1|||
129776140|NCT01358721|467146103|FG001|Overall Study|Study Drug Toxicity|3|||
129776141|NCT01358721|467146104|FG002|Overall Study|Study Drug Toxicity|4|||
129776142|NCT01358721|467146105|FG003|Overall Study|Study Drug Toxicity|5|||
129776143|NCT01358721|467146102|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
129776144|NCT01358721|467146103|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
129776145|NCT01358721|467146104|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
129776146|NCT01358721|467146105|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
129776147|NCT01358721|467146102|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129776148|NCT01358721|467146103|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
129776149|NCT01358721|467146104|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
129776150|NCT01358721|467146105|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
129776151|NCT01358721|467146102|FG000|Overall Study|Adverse Event related to study drug|1|||
129776152|NCT01358721|467146103|FG001|Overall Study|Adverse Event related to study drug|0|||
129776153|NCT01358721|467146104|FG002|Overall Study|Adverse Event related to study drug|0|||
129776154|NCT01358721|467146105|FG003|Overall Study|Adverse Event related to study drug|1|||
129776155|NCT01358721|467146102|FG000|Overall Study|Disease Progression|19|||
129776156|NCT01358721|467146103|FG001|Overall Study|Disease Progression|15|||
129776157|NCT01358721|467146104|FG002|Overall Study|Disease Progression|17|||
129776158|NCT01358721|467146105|FG003|Overall Study|Disease Progression|15|||
129776159|NCT01358721|467146102|FG000|Overall Study|Out of State/Unmet Criteria|0|||
129776160|NCT01358721|467146103|FG001|Overall Study|Out of State/Unmet Criteria|0|||
129776161|NCT01358721|467146104|FG002|Overall Study|Out of State/Unmet Criteria|1|||
129776162|NCT01358721|467146105|FG003|Overall Study|Out of State/Unmet Criteria|0|||
129776163|NCT01908803|467146106|FG000|Overall Study|Adverse Event|1|||
129776164|NCT01908803|467146107|FG001|Overall Study|Adverse Event|0|||
129776165|NCT01908803|467146106|FG000|Overall Study|Physician Decision|0|||
129776166|NCT01908803|467146107|FG001|Overall Study|Physician Decision|1|||
129776167|NCT01908803|467146106|FG000|Overall Study|Withdrawal by Subject|1|||
129776168|NCT01908803|467146107|FG001|Overall Study|Withdrawal by Subject|0|||
129776169|NCT01908803|467146106|FG000|Overall Study|Randomization Error|1|||
129776170|NCT01908803|467146107|FG001|Overall Study|Randomization Error|0|||
129776171|NCT01908803|467146106|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
129776172|NCT01908803|467146107|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
129776173|NCT00867815|467146108|FG000|Overall Study|Lost to Follow-up|1|||
129776174|NCT00001213|467146109|FG000|Overall Study|Death|18|||
129776175|NCT01554241|467146110|FG000|Overall Study|Death|3|||
129776176|NCT01554241|467146111|FG001|Overall Study|Death|1|||
129776177|NCT01554241|467146112|FG002|Overall Study|Death|1|||
129776178|NCT01554241|467146113|FG003|Overall Study|Death|0|||
129776179|NCT01554241|467146110|FG000|Overall Study|protocol specified renal stone|0|||
129776180|NCT01554241|467146111|FG001|Overall Study|protocol specified renal stone|0|||
129776181|NCT01554241|467146112|FG002|Overall Study|protocol specified renal stone|0|||
129776182|NCT01554241|467146113|FG003|Overall Study|protocol specified renal stone|1|||
129776183|NCT01554241|467146110|FG000|Overall Study|protocol specified change in eGFR|0|||
129776184|NCT01554241|467146111|FG001|Overall Study|protocol specified change in eGFR|0|||
129776185|NCT01554241|467146112|FG002|Overall Study|protocol specified change in eGFR|1|||
129776186|NCT01554241|467146113|FG003|Overall Study|protocol specified change in eGFR|0|||
129555061|NCT01677910|466329149|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
129555062|NCT01677910|466329146|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
129555063|NCT01677910|466329147|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
129555064|NCT01677910|466329148|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
129776187|NCT01554241|467146110|FG000|Overall Study|Withdrawal by Subject|0|||
129776188|NCT01554241|467146111|FG001|Overall Study|Withdrawal by Subject|0|||
129776189|NCT01554241|467146112|FG002|Overall Study|Withdrawal by Subject|2|||
129776190|NCT01554241|467146113|FG003|Overall Study|Withdrawal by Subject|0|||
129776191|NCT00372593|467146120|FG000|Overall Study|Adverse Event|43|||
129555065|NCT01677910|466329149|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
129555066|NCT01677910|466329146|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
129555067|NCT01677910|466329147|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
129555068|NCT01677910|466329148|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
129555069|NCT01677910|466329149|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
129555070|NCT01677910|466329146|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129555071|NCT01677910|466329147|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129776192|NCT00372593|467146121|FG001|Overall Study|Adverse Event|45|||
129776193|NCT00372593|467146122|FG002|Overall Study|Adverse Event|0|||
129776194|NCT00372593|467146120|FG000|Overall Study|Death|16|||
129776195|NCT00372593|467146121|FG001|Overall Study|Death|20|||
129776196|NCT00372593|467146122|FG002|Overall Study|Death|1|||
129776197|NCT00372593|467146120|FG000|Overall Study|Lack of Efficacy|82|||
129776198|NCT00372593|467146121|FG001|Overall Study|Lack of Efficacy|71|||
129776199|NCT00372593|467146122|FG002|Overall Study|Lack of Efficacy|2|||
129776200|NCT00372593|467146120|FG000|Overall Study|Lost to Follow-up|1|||
129776201|NCT00372593|467146121|FG001|Overall Study|Lost to Follow-up|0|||
129776202|NCT00372593|467146122|FG002|Overall Study|Lost to Follow-up|0|||
129776203|NCT00372593|467146120|FG000|Overall Study|Physician Decision|42|||
129776204|NCT00372593|467146121|FG001|Overall Study|Physician Decision|41|||
129776205|NCT00372593|467146122|FG002|Overall Study|Physician Decision|0|||
129776206|NCT00372593|467146120|FG000|Overall Study|Ineligible|20|||
129776207|NCT00372593|467146121|FG001|Overall Study|Ineligible|21|||
129776208|NCT00372593|467146122|FG002|Overall Study|Ineligible|1|||
129776209|NCT00433004|467146123|FG000|Overall Study|Lost to Follow-up|5|||
129776210|NCT00433004|467146124|FG001|Overall Study|Lost to Follow-up|7|||
129776211|NCT03534180|467146125|FG000|Overall Study|Withdrawal by Subject|1|||
129776212|NCT00220636|467146126|FG000|Overall Study|Withdrawal by Subject|4|||
129776213|NCT00330967|467146127|FG000|Overall Study|Withdrawal by Subject|0|||
129776214|NCT00330967|467146128|FG001|Overall Study|Withdrawal by Subject|5|||
129776215|NCT00330967|467146127|FG000|Overall Study|Physician Decision|0|||
129776216|NCT00330967|467146128|FG001|Overall Study|Physician Decision|9|||
129776217|NCT00790088|467146131|FG000|Overall Study|Protocol Violation|11|||
129776218|NCT00790088|467146131|FG000|Overall Study|Withdrawal by Subject|17|||
129776219|NCT00790088|467146131|FG000|Overall Study|Lost to Follow-up|7|||
129776220|NCT00790088|467146131|FG000|Overall Study|Physician Decision|4|||
129776221|NCT05661409|467146132|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
129776222|NCT05661409|467146133|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
129776223|NCT05661409|467146134|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
129776224|NCT05661409|467146135|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
129776225|NCT05661409|467146136|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
129776226|NCT05661409|467146137|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
129776227|NCT05661409|467146132|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
129776228|NCT05661409|467146133|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
129776229|NCT05661409|467146134|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
129776230|NCT05661409|467146135|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
129776231|NCT05661409|467146136|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
129776232|NCT05661409|467146137|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
129776233|NCT05661409|467146132|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
129776234|NCT05661409|467146133|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
129776235|NCT05661409|467146134|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
129776236|NCT05661409|467146135|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
129776237|NCT05661409|467146136|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
129776238|NCT05661409|467146137|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
129776239|NCT05661409|467146132|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
129776240|NCT05661409|467146133|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
129776241|NCT05661409|467146134|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
129776242|NCT05661409|467146135|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
129776243|NCT05661409|467146136|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
129776244|NCT05661409|467146137|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
129776245|NCT05661409|467146132|FG000|Overall Study|Miscommu-nication about administration|0|||
129776246|NCT05661409|467146133|FG001|Overall Study|Miscommu-nication about administration|0|||
129776247|NCT05661409|467146134|FG002|Overall Study|Miscommu-nication about administration|0|||
129776248|NCT05661409|467146135|FG003|Overall Study|Miscommu-nication about administration|0|||
129776249|NCT05661409|467146136|FG004|Overall Study|Miscommu-nication about administration|0|||
129776250|NCT05661409|467146137|FG005|Overall Study|Miscommu-nication about administration|1|||
129776251|NCT04439136|467146138|FG000|Overall Study|Ineligible|1|||
129776252|NCT04439136|467146138|FG000|Overall Study|Never Started Treatment|2|||
129776253|NCT04439136|467146138|FG000|Overall Study|Adverse Event|4|||
129776254|NCT04439136|467146138|FG000|Overall Study|Death|3|||
129776255|NCT04439136|467146138|FG000|Overall Study|Disease Progression|27|||
129776256|NCT04439136|467146138|FG000|Overall Study|Alternative Therapy|1|||
129776257|NCT04439136|467146138|FG000|Overall Study|Increased Tumor Burden|1|||
129776258|NCT04439136|467146138|FG000|Overall Study|Symptomatic Detrioration|1|||
129776259|NCT02578706|467146141|FG000|Overall Study|Withdrawal by Subject|1|||
129776260|NCT02578706|467146142|FG001|Overall Study|Withdrawal by Subject|0|||
129776261|NCT02578706|467146143|FG002|Overall Study|Withdrawal by Subject|0|||
129776262|NCT02578706|467146141|FG000|Overall Study|Lost to Follow-up|0|||
129776263|NCT02578706|467146142|FG001|Overall Study|Lost to Follow-up|4|||
129776264|NCT02578706|467146143|FG002|Overall Study|Lost to Follow-up|0|||
129776265|NCT02578706|467146141|FG000|Overall Study|Physician Decision|0|||
129555072|NCT01677910|466329148|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129555073|NCT01677910|466329149|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
129687006|NCT02337946|466810118|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
129687007|NCT02337946|466810119|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
129687008|NCT02337946|466810117|FG000|In-between Period|Without Informed Consent|1|||
129687009|NCT02337946|466810118|FG001|In-between Period|Without Informed Consent|0|||
129687010|NCT02337946|466810119|FG002|In-between Period|Without Informed Consent|0|||
129687011|NCT02337946|466810117|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
129687012|NCT02337946|466810118|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
129687013|NCT02337946|466810119|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
129687014|NCT02337946|466810117|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
129687015|NCT02337946|466810118|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
129687016|NCT02337946|466810119|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
129687017|NCT02337946|466810117|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
129687018|NCT02337946|466810118|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
129687019|NCT02337946|466810119|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
129687020|NCT02337946|466810117|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
129687021|NCT02337946|466810118|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
129687022|NCT02337946|466810119|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
129687023|NCT02337946|466810117|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
129687024|NCT02337946|466810118|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
129687025|NCT02337946|466810119|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
129687026|NCT02337946|466810117|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
129687027|NCT02337946|466810118|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
129687028|NCT02337946|466810119|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
129687029|NCT05324371|466810121|FG000|Overall Study|Withdrawal by Subject|1|||
129687030|NCT05324371|466810121|FG000|Overall Study|Death|1|||
129687031|NCT02949934|466810123|FG000|Natural Drinking Period|Adverse Event|1|||
129687032|NCT02949934|466810124|FG001|Natural Drinking Period|Adverse Event|0|||
129555074|NCT01677910|466329146|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129555075|NCT01677910|466329147|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129555076|NCT01677910|466329148|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129555077|NCT01677910|466329149|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
129555078|NCT01677910|466329146|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129555079|NCT01677910|466329147|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129555080|NCT01677910|466329148|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129555081|NCT01677910|466329149|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
129555082|NCT01677910|466329146|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
129555083|NCT01677910|466329147|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
129555084|NCT01677910|466329148|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
129555085|NCT01677910|466329149|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
129555086|NCT01677910|466329146|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
129555087|NCT01677910|466329147|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
129555088|NCT01677910|466329148|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
129555089|NCT01677910|466329149|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
129555090|NCT03341273|466329152|FG000|Overall Study|Lost to Follow-up|7|||
129555091|NCT03341273|466329153|FG001|Overall Study|Lost to Follow-up|7|||
129555092|NCT03341273|466329152|FG000|Overall Study|Withdrawal by Subject|4|||
129555093|NCT03341273|466329153|FG001|Overall Study|Withdrawal by Subject|2|||
129555094|NCT03341273|466329152|FG000|Overall Study|Physician Decision|1|||
129555095|NCT03341273|466329153|FG001|Overall Study|Physician Decision|0|||
129555096|NCT03341273|466329152|FG000|Overall Study|Protocol Violation|0|||
129555097|NCT03341273|466329153|FG001|Overall Study|Protocol Violation|1|||
129555098|NCT03341273|466329152|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
129687033|NCT02949934|466810125|FG002|Natural Drinking Period|Adverse Event|0|||
129687034|NCT02949934|466810126|FG003|Natural Drinking Period|Adverse Event|1|||
129687035|NCT02949934|466810127|FG004|Natural Drinking Period|Adverse Event|0|||
129687036|NCT02949934|466810128|FG005|Natural Drinking Period|Adverse Event|0|||
129687037|NCT02949934|466810123|FG000|Natural Drinking Period|Lost to Follow-up|0|||
129687038|NCT02949934|466810124|FG001|Natural Drinking Period|Lost to Follow-up|0|||
129687039|NCT02949934|466810125|FG002|Natural Drinking Period|Lost to Follow-up|0|||
129687040|NCT02949934|466810126|FG003|Natural Drinking Period|Lost to Follow-up|0|||
129687041|NCT02949934|466810127|FG004|Natural Drinking Period|Lost to Follow-up|1|||
129687042|NCT02949934|466810128|FG005|Natural Drinking Period|Lost to Follow-up|0|||
129687043|NCT02949934|466810123|FG000|Neuroimaging|Protocol Violation|2|||
129687044|NCT02949934|466810124|FG001|Neuroimaging|Protocol Violation|0|||
129687045|NCT02949934|466810125|FG002|Neuroimaging|Protocol Violation|0|||
129687046|NCT02949934|466810126|FG003|Neuroimaging|Protocol Violation|0|||
129687047|NCT02949934|466810127|FG004|Neuroimaging|Protocol Violation|1|||
129687048|NCT02949934|466810128|FG005|Neuroimaging|Protocol Violation|0|||
129687049|NCT02949934|466810123|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
129687050|NCT02949934|466810124|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
129687051|NCT02949934|466810125|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
129687052|NCT02949934|466810126|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
129687053|NCT02949934|466810127|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
129687054|NCT02949934|466810128|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
129687055|NCT02949934|466810123|FG000|Neuroimaging|Not scanned|0|||
129687056|NCT02949934|466810124|FG001|Neuroimaging|Not scanned|0|||
129687057|NCT02949934|466810125|FG002|Neuroimaging|Not scanned|1|||
129687058|NCT02949934|466810126|FG003|Neuroimaging|Not scanned|0|||
129687059|NCT02949934|466810127|FG004|Neuroimaging|Not scanned|0|||
129687060|NCT02949934|466810128|FG005|Neuroimaging|Not scanned|2|||
129687061|NCT02949934|466810123|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
129687062|NCT02949934|466810124|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
129687063|NCT02949934|466810125|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
129687064|NCT02949934|466810126|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
129687065|NCT02949934|466810127|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
129687066|NCT02949934|466810128|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
129687067|NCT02949934|466810123|FG000|Bar Laboratory|Adverse Event|1|||
129687068|NCT02949934|466810124|FG001|Bar Laboratory|Adverse Event|0|||
129687069|NCT02949934|466810125|FG002|Bar Laboratory|Adverse Event|2|||
129687070|NCT02949934|466810126|FG003|Bar Laboratory|Adverse Event|0|||
129884491|NCT04844918|467536416|FG001|Overall Study|Withdrawal by Subject|3|||
129555099|NCT03341273|466329153|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
129555100|NCT03341273|466329152|FG000|Overall Study|Became ineligible after enrollment|1|||
129687071|NCT02949934|466810127|FG004|Bar Laboratory|Adverse Event|1|||
129687072|NCT02949934|466810128|FG005|Bar Laboratory|Adverse Event|0|||
129687073|NCT02949934|466810123|FG000|Bar Laboratory|Protocol Violation|0|||
129687074|NCT02949934|466810124|FG001|Bar Laboratory|Protocol Violation|0|||
129687075|NCT02949934|466810125|FG002|Bar Laboratory|Protocol Violation|0|||
129687076|NCT02949934|466810126|FG003|Bar Laboratory|Protocol Violation|1|||
129687077|NCT02949934|466810127|FG004|Bar Laboratory|Protocol Violation|0|||
129884492|NCT04844918|467536417|FG002|Overall Study|Withdrawal by Subject|3|||
129555101|NCT03341273|466329153|FG001|Overall Study|Became ineligible after enrollment|0|||
129555102|NCT03341273|466329152|FG000|Overall Study|Not Eligible at Enrollment|0|||
129555103|NCT03341273|466329153|FG001|Overall Study|Not Eligible at Enrollment|1|||
129555104|NCT03341273|466329152|FG000|Overall Study|Participant incarcerated|1|||
129555105|NCT03341273|466329153|FG001|Overall Study|Participant incarcerated|0|||
129555106|NCT00685919|466329154|FG000|Overall Study|Withdrawal by Subject|0|||
129555107|NCT00685919|466329155|FG001|Overall Study|Withdrawal by Subject|0|||
129555108|NCT00685919|466329156|FG002|Overall Study|Withdrawal by Subject|1|||
129555109|NCT00685919|466329157|FG003|Overall Study|Withdrawal by Subject|0|||
129555110|NCT00685919|466329154|FG000|Overall Study|Physician Decision|1|||
129555111|NCT00685919|466329155|FG001|Overall Study|Physician Decision|0|||
129555112|NCT00685919|466329156|FG002|Overall Study|Physician Decision|0|||
129555113|NCT00685919|466329157|FG003|Overall Study|Physician Decision|0|||
129555114|NCT01717456|466329158|FG000|End of Treatment|Physician Decision|0|||
129555115|NCT01717456|466329159|FG001|End of Treatment|Physician Decision|1|||
129555116|NCT01717456|466329158|FG000|End of Treatment|Lost to Follow-up|0|||
129555117|NCT01717456|466329159|FG001|End of Treatment|Lost to Follow-up|1|||
129555118|NCT01717456|466329158|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
129555119|NCT01717456|466329159|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
129555120|NCT02008721|466329160|FG000|Overall Study|Withdrawal by Subject|5|||
129555121|NCT02008721|466329161|FG001|Overall Study|Withdrawal by Subject|1|||
129555122|NCT02008721|466329160|FG000|Overall Study|Death|4|||
129555123|NCT02008721|466329161|FG001|Overall Study|Death|2|||
129555124|NCT02008721|466329160|FG000|Overall Study|Adverse Event|3|||
129555125|NCT02008721|466329161|FG001|Overall Study|Adverse Event|5|||
129555126|NCT02008721|466329160|FG000|Overall Study|Protocol Violation|3|||
129555127|NCT02008721|466329161|FG001|Overall Study|Protocol Violation|2|||
129555128|NCT03870997|466329164|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
129555129|NCT03870997|466329165|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
129555130|NCT03870997|466329166|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
129555131|NCT03870997|466329167|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
129555132|NCT03870997|466329168|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
129776266|NCT02578706|467146142|FG001|Overall Study|Physician Decision|1|||
129555133|NCT03870997|466329169|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
129555134|NCT00267007|466329170|FG000|Overall Study|Withdrawal by Subject|6|||
129555135|NCT00267007|466329171|FG001|Overall Study|Withdrawal by Subject|0|||
129555136|NCT00267007|466329170|FG000|Overall Study|Lost to Follow-up|1|||
129687078|NCT02949934|466810128|FG005|Bar Laboratory|Protocol Violation|0|||
129687079|NCT04827446|466810785|FG000|Overall Study|Lost to Follow-up|1|||
129687080|NCT04827446|466810786|FG001|Overall Study|Lost to Follow-up|1|||
129687081|NCT04827446|466810785|FG000|Overall Study|Death|2|||
129687082|NCT04827446|466810786|FG001|Overall Study|Death|0|||
129687083|NCT04827446|466810785|FG000|Overall Study|Withdrawal by Subject|2|||
129687084|NCT04827446|466810786|FG001|Overall Study|Withdrawal by Subject|2|||
129687085|NCT01363076|466810791|FG000|Overall Study|Withdrawal by Subject|0|||
129687086|NCT01363076|466810792|FG001|Overall Study|Withdrawal by Subject|1|||
129687087|NCT04706403|466810793|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
129687088|NCT04706403|466810794|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
129687089|NCT04706403|466810795|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
129687090|NCT04706403|466810796|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
129687091|NCT04706403|466810797|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
129687092|NCT00182637|466810798|FG000|Overall Study|Adverse Event|2|||
129687093|NCT00182637|466810798|FG000|Overall Study|Disease Progression|1|||
129687094|NCT04766333|466810801|FG000|Overall Study|Lost to Follow-up|40|||
129687095|NCT04766333|466810802|FG001|Overall Study|Lost to Follow-up|826|||
129687096|NCT00639379|466810803|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
129687097|NCT00639379|466810804|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
129687098|NCT00639379|466810803|FG000|Period 1 - 2 Weeks|lens issue|3|||
129687099|NCT00639379|466810804|FG001|Period 1 - 2 Weeks|lens issue|0|||
129687100|NCT01771913|466810812|FG000|Overall Study|Withdrawal by Subject|1|||
129687101|NCT01771913|466810813|FG001|Overall Study|Withdrawal by Subject|0|||
129687102|NCT00407511|466810814|FG000|Overall Study|Adverse Event|9|||
129687103|NCT00407511|466810814|FG000|Overall Study|Lost to Follow-up|4|||
129687104|NCT00407511|466810814|FG000|Overall Study|Other|5|||
129687105|NCT00407511|466810814|FG000|Overall Study|Withdrawal by Subject|4|||
129687106|NCT02636283|466810815|FG000|Overall Study|Adverse Event|2|||
129687107|NCT02636283|466810816|FG001|Overall Study|Adverse Event|0|||
129687108|NCT02636283|466810815|FG000|Overall Study|Trial Terminated Prematurely|0|||
129687109|NCT02636283|466810816|FG001|Overall Study|Trial Terminated Prematurely|3|||
129687110|NCT00195429|466810819|FG000|Overall Study|Adverse Event|2|||
129687111|NCT00195429|466810820|FG001|Overall Study|Adverse Event|4|||
129687112|NCT00195429|466810819|FG000|Overall Study|Lack of Efficacy|2|||
129687113|NCT00195429|466810820|FG001|Overall Study|Lack of Efficacy|1|||
129687114|NCT00195429|466810819|FG000|Overall Study|Lost to Follow-up|1|||
129687115|NCT00195429|466810820|FG001|Overall Study|Lost to Follow-up|0|||
129687116|NCT02541903|466810821|FG000|Overall Study|Death|1|||
129687117|NCT04795323|466810824|FG000|Overall Study|Did not interact with TARA|1|||
129687118|NCT04795323|466810825|FG001|Overall Study|Did not interact with TARA|0|||
129687119|NCT03142750|466810827|FG000|Overall Study|Lost to Follow-up|4|||
129687120|NCT03142750|466810828|FG001|Overall Study|Lost to Follow-up|1|||
129687121|NCT04925934|466810829|FG000|Overall Study|Adverse Event|1|||
129687122|NCT04925934|466810830|FG001|Overall Study|Adverse Event|0|||
129687123|NCT04925934|466810831|FG002|Overall Study|Adverse Event|0|||
129687124|NCT04925934|466810829|FG000|Overall Study|Lost to Follow-up|2|||
129555137|NCT00267007|466329171|FG001|Overall Study|Lost to Follow-up|0|||
129555138|NCT00267007|466329170|FG000|Overall Study|Non-compliance|0|||
129555139|NCT00267007|466329171|FG001|Overall Study|Non-compliance|1|||
129555140|NCT00267007|466329170|FG000|Overall Study|Adverse Event|1|||
129555141|NCT00267007|466329171|FG001|Overall Study|Adverse Event|0|||
129555142|NCT01825876|466329175|FG000|Period 2|Withdrawal by Subject|0|||
129555143|NCT01825876|466329176|FG001|Period 2|Withdrawal by Subject|1|||
129555144|NCT03751020|466329179|FG000|Overall Study|Withdrawal by Subject|2|||
129555145|NCT03751020|466329180|FG001|Overall Study|Withdrawal by Subject|0|||
129555146|NCT03751020|466329181|FG002|Overall Study|Withdrawal by Subject|0|||
129555147|NCT03751020|466329179|FG000|Overall Study|Lost to Follow-up|7|||
129555148|NCT03751020|466329180|FG001|Overall Study|Lost to Follow-up|4|||
129555149|NCT03751020|466329181|FG002|Overall Study|Lost to Follow-up|10|||
129555150|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
129555151|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
129555152|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
129555153|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
129555154|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
129555155|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
129555156|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
129555157|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
129555158|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
129555159|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
129555160|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
129555161|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
129555162|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
129555163|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
129555164|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
129555165|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
129555166|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
129555167|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
129555168|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
129555169|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
129555170|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
129555171|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
129555172|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
129555173|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
129555174|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
129555175|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
129555176|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
129555177|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
129555178|NCT00528879|466329182|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
129555179|NCT00528879|466329183|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
129555180|NCT00528879|466329184|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
129555181|NCT00528879|466329185|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
129555182|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
129555183|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
129555184|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
129555185|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
129555186|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
129555187|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
129555188|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
129555189|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
129555190|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
129555191|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
129555192|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
129555193|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
129555194|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
129555195|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
129555196|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
129555197|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
129555198|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
129555199|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
129555200|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
129555201|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
129555202|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
129555203|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
129555204|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
129555205|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
129555206|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
129555207|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
129555208|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
129555209|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
129555210|NCT00528879|466329182|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
129555211|NCT00528879|466329183|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
129555212|NCT00528879|466329184|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
129555213|NCT00528879|466329185|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
129555214|NCT00078819|466329188|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
129555215|NCT00078819|466329189|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
129555216|NCT00078819|466329190|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
129555217|NCT00078819|466329191|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
129555218|NCT00078819|466329188|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
129555219|NCT00078819|466329189|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
129555220|NCT00078819|466329190|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
129555221|NCT00078819|466329191|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
129555222|NCT00078819|466329188|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
129555223|NCT00078819|466329189|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
129555224|NCT00078819|466329190|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
129555225|NCT00078819|466329191|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
129555226|NCT00078819|466329188|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
129555227|NCT00078819|466329189|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
129555228|NCT00078819|466329190|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
129555229|NCT00078819|466329191|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
129555230|NCT00078819|466329188|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
129555231|NCT00078819|466329189|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
129555232|NCT00078819|466329190|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
129555233|NCT00078819|466329191|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
129555234|NCT00078819|466329188|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
129555235|NCT00078819|466329189|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
129555236|NCT00078819|466329190|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
129555237|NCT00078819|466329191|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
129555238|NCT00078819|466329188|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
129555239|NCT00078819|466329189|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
129555240|NCT00078819|466329190|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
129555241|NCT00078819|466329191|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
129555242|NCT00078819|466329188|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
129555243|NCT00078819|466329189|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
129555244|NCT00078819|466329190|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
129555245|NCT00078819|466329191|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
129555246|NCT04133519|466329192|FG000|Overall Study|Withdrawal by Subject|5|||
129555247|NCT04133519|466329193|FG001|Overall Study|Withdrawal by Subject|4|||
129555248|NCT04133519|466329192|FG000|Overall Study|Protocol Violation|0|||
129776267|NCT02578706|467146143|FG002|Overall Study|Physician Decision|0|||
129555249|NCT04133519|466329193|FG001|Overall Study|Protocol Violation|1|||
129555250|NCT04133519|466329192|FG000|Overall Study|Never started treatment|1|||
129555251|NCT04133519|466329193|FG001|Overall Study|Never started treatment|1|||
129555252|NCT00667719|466329194|FG000|Overall Study|Adverse Event|39|||
129555253|NCT00667719|466329194|FG000|Overall Study|Abnormal Test Procedure|1|||
129555254|NCT00667719|466329194|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129555255|NCT00667719|466329194|FG000|Overall Study|Protocol Violation|3|||
129555256|NCT00667719|466329194|FG000|Overall Study|Withdrawal by Subject|17|||
129555257|NCT00667719|466329194|FG000|Overall Study|Lost to Follow-up|8|||
129555258|NCT00323609|466329195|FG000|Overall Study|Death|16|||
129555259|NCT00323609|466329196|FG001|Overall Study|Death|21|||
129555260|NCT00323609|466329197|FG002|Overall Study|Death|0|||
129555261|NCT00323609|466329198|FG003|Overall Study|Death|0|||
129555262|NCT00323609|466329195|FG000|Overall Study|Lost to Follow-up|9|||
129555263|NCT00323609|466329196|FG001|Overall Study|Lost to Follow-up|10|||
129555264|NCT00323609|466329197|FG002|Overall Study|Lost to Follow-up|0|||
129555265|NCT00323609|466329198|FG003|Overall Study|Lost to Follow-up|0|||
129555266|NCT00323609|466329195|FG000|Overall Study|Physician Decision|2|||
129555267|NCT00323609|466329196|FG001|Overall Study|Physician Decision|0|||
129555268|NCT00323609|466329197|FG002|Overall Study|Physician Decision|0|||
129555269|NCT00323609|466329198|FG003|Overall Study|Physician Decision|1|||
129555270|NCT00323609|466329195|FG000|Overall Study|Withdrawal by Subject|11|||
129555271|NCT00323609|466329196|FG001|Overall Study|Withdrawal by Subject|23|||
129555272|NCT00323609|466329197|FG002|Overall Study|Withdrawal by Subject|4|||
129555273|NCT00323609|466329198|FG003|Overall Study|Withdrawal by Subject|4|||
129555274|NCT00323609|466329195|FG000|Overall Study|Other non-VCF-related medical condition|3|||
129555275|NCT00323609|466329196|FG001|Overall Study|Other non-VCF-related medical condition|2|||
129555276|NCT00323609|466329197|FG002|Overall Study|Other non-VCF-related medical condition|0|||
129555277|NCT00323609|466329198|FG003|Overall Study|Other non-VCF-related medical condition|0|||
129555278|NCT00323609|466329195|FG000|Overall Study|Sponsor discontinued trial|29|||
129555279|NCT00323609|466329196|FG001|Overall Study|Sponsor discontinued trial|29|||
129555280|NCT00323609|466329197|FG002|Overall Study|Sponsor discontinued trial|0|||
129555281|NCT00323609|466329198|FG003|Overall Study|Sponsor discontinued trial|0|||
129555282|NCT00323609|466329195|FG000|Overall Study|Unrelenting or severe back pain|1|||
129555283|NCT00323609|466329196|FG001|Overall Study|Unrelenting or severe back pain|1|||
129555284|NCT00323609|466329197|FG002|Overall Study|Unrelenting or severe back pain|0|||
129555285|NCT00323609|466329198|FG003|Overall Study|Unrelenting or severe back pain|0|||
129555286|NCT00323609|466329195|FG000|Overall Study|Logistical withdrawal|9|||
129555287|NCT00323609|466329196|FG001|Overall Study|Logistical withdrawal|5|||
129555288|NCT00323609|466329197|FG002|Overall Study|Logistical withdrawal|0|||
129555289|NCT00323609|466329198|FG003|Overall Study|Logistical withdrawal|1|||
129555290|NCT00323609|466329195|FG000|Overall Study|Other reason|11|||
129555291|NCT00323609|466329196|FG001|Overall Study|Other reason|8|||
129555292|NCT00323609|466329197|FG002|Overall Study|Other reason|4|||
129555293|NCT00323609|466329198|FG003|Overall Study|Other reason|9|||
129555294|NCT02217345|466329202|FG000|Overall Study|Lost to Follow-up|2|||
129555295|NCT02217345|466329203|FG001|Overall Study|Lost to Follow-up|1|||
129555296|NCT02217345|466329202|FG000|Overall Study|Withdrawal by Subject|3|||
129555297|NCT02217345|466329203|FG001|Overall Study|Withdrawal by Subject|2|||
129555298|NCT02217345|466329202|FG000|Overall Study|Adverse Event|2|||
129555299|NCT02217345|466329203|FG001|Overall Study|Adverse Event|1|||
129555300|NCT02217345|466329202|FG000|Overall Study|Physician Decision|0|||
129555301|NCT02217345|466329203|FG001|Overall Study|Physician Decision|1|||
129555302|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555303|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555304|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555305|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
129555306|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555307|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555308|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555309|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129687125|NCT04925934|466810830|FG001|Overall Study|Lost to Follow-up|0|||
129687126|NCT04925934|466810831|FG002|Overall Study|Lost to Follow-up|1|||
129687127|NCT04925934|466810829|FG000|Overall Study|Death|0|||
129555310|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555311|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
129555312|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129555313|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129555314|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Adverse Event|1|||
129555315|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Adverse Event|1|||
129687128|NCT04925934|466810830|FG001|Overall Study|Death|1|||
129555316|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Adverse Event|1|||
129555317|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Adverse Event|1|||
129687129|NCT04925934|466810831|FG002|Overall Study|Death|0|||
129555318|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Adverse Event|0|||
129555319|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Adverse Event|0|||
129555320|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Adverse Event|0|||
129555321|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Adverse Event|0|||
129555322|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
129555323|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
129555324|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
129555325|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
129555326|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
129555327|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
129555328|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
129555329|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
129555330|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
129555331|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
129555332|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129555333|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
129555334|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
129555335|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
129555336|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
129555337|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
129555338|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
129555339|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
129555340|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
129555341|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
129555342|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
129555343|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
129555344|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555345|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555346|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555347|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555348|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555349|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
129555350|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555351|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
129555352|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555353|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555354|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555355|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555356|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
129555357|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
129555358|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555359|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555360|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555361|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
129555362|NCT00950599|466329204|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
129555363|NCT00950599|466329205|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
129555364|NCT00950599|466329206|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
129555365|NCT00950599|466329207|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
129555366|NCT00950599|466329208|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
129555367|NCT00950599|466329209|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
129555368|NCT00950599|466329210|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
129555369|NCT00950599|466329211|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
129555370|NCT00950599|466329212|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
129555371|NCT00950599|466329213|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
129555372|NCT00950599|466329204|FG000|Follow-Up Period|Adverse Event|0|||
129555373|NCT00950599|466329205|FG001|Follow-Up Period|Adverse Event|0|||
129555374|NCT00950599|466329206|FG002|Follow-Up Period|Adverse Event|0|||
129555375|NCT00950599|466329207|FG003|Follow-Up Period|Adverse Event|0|||
129555376|NCT00950599|466329208|FG004|Follow-Up Period|Adverse Event|0|||
129555377|NCT00950599|466329209|FG005|Follow-Up Period|Adverse Event|0|||
129555378|NCT00950599|466329210|FG006|Follow-Up Period|Adverse Event|0|||
129555379|NCT00950599|466329211|FG007|Follow-Up Period|Adverse Event|0|||
129555380|NCT00950599|466329212|FG008|Follow-Up Period|Adverse Event|1|||
129555381|NCT00950599|466329213|FG009|Follow-Up Period|Adverse Event|0|||
129555382|NCT00950599|466329204|FG000|Follow-Up Period|Lack of Efficacy|0|||
129555383|NCT00950599|466329205|FG001|Follow-Up Period|Lack of Efficacy|0|||
129555384|NCT00950599|466329206|FG002|Follow-Up Period|Lack of Efficacy|0|||
129555385|NCT00950599|466329207|FG003|Follow-Up Period|Lack of Efficacy|0|||
129555386|NCT00950599|466329208|FG004|Follow-Up Period|Lack of Efficacy|0|||
129555387|NCT00950599|466329209|FG005|Follow-Up Period|Lack of Efficacy|0|||
129555388|NCT00950599|466329210|FG006|Follow-Up Period|Lack of Efficacy|0|||
129555389|NCT00950599|466329211|FG007|Follow-Up Period|Lack of Efficacy|0|||
129555390|NCT00950599|466329212|FG008|Follow-Up Period|Lack of Efficacy|3|||
129555391|NCT00950599|466329213|FG009|Follow-Up Period|Lack of Efficacy|0|||
129555392|NCT00950599|466329204|FG000|Follow-Up Period|Lost to Follow-up|0|||
129555393|NCT00950599|466329205|FG001|Follow-Up Period|Lost to Follow-up|0|||
129555394|NCT00950599|466329206|FG002|Follow-Up Period|Lost to Follow-up|0|||
129555395|NCT00950599|466329207|FG003|Follow-Up Period|Lost to Follow-up|0|||
129555396|NCT00950599|466329208|FG004|Follow-Up Period|Lost to Follow-up|0|||
129555397|NCT00950599|466329209|FG005|Follow-Up Period|Lost to Follow-up|0|||
129555398|NCT00950599|466329210|FG006|Follow-Up Period|Lost to Follow-up|0|||
129555399|NCT00950599|466329211|FG007|Follow-Up Period|Lost to Follow-up|0|||
129555400|NCT00950599|466329212|FG008|Follow-Up Period|Lost to Follow-up|5|||
129555401|NCT00950599|466329213|FG009|Follow-Up Period|Lost to Follow-up|1|||
129555402|NCT00950599|466329204|FG000|Follow-Up Period|Physician Decision|0|||
129555403|NCT00950599|466329205|FG001|Follow-Up Period|Physician Decision|0|||
129555404|NCT00950599|466329206|FG002|Follow-Up Period|Physician Decision|0|||
129555405|NCT00950599|466329207|FG003|Follow-Up Period|Physician Decision|0|||
129555406|NCT00950599|466329208|FG004|Follow-Up Period|Physician Decision|0|||
129555407|NCT00950599|466329209|FG005|Follow-Up Period|Physician Decision|0|||
129555408|NCT00950599|466329210|FG006|Follow-Up Period|Physician Decision|0|||
129555409|NCT00950599|466329211|FG007|Follow-Up Period|Physician Decision|0|||
129555410|NCT00950599|466329212|FG008|Follow-Up Period|Physician Decision|1|||
129555411|NCT00950599|466329213|FG009|Follow-Up Period|Physician Decision|0|||
129555412|NCT00950599|466329204|FG000|Follow-Up Period|Poor/Noncompliance|0|||
129555413|NCT00950599|466329205|FG001|Follow-Up Period|Poor/Noncompliance|0|||
129555414|NCT00950599|466329206|FG002|Follow-Up Period|Poor/Noncompliance|0|||
129555415|NCT00950599|466329207|FG003|Follow-Up Period|Poor/Noncompliance|0|||
129555416|NCT00950599|466329208|FG004|Follow-Up Period|Poor/Noncompliance|0|||
129555417|NCT00950599|466329209|FG005|Follow-Up Period|Poor/Noncompliance|0|||
129555418|NCT00950599|466329210|FG006|Follow-Up Period|Poor/Noncompliance|0|||
129555419|NCT00950599|466329211|FG007|Follow-Up Period|Poor/Noncompliance|0|||
129555420|NCT00950599|466329212|FG008|Follow-Up Period|Poor/Noncompliance|1|||
129555421|NCT00950599|466329213|FG009|Follow-Up Period|Poor/Noncompliance|0|||
129555422|NCT00950599|466329204|FG000|Follow-Up Period|Subject withdrew Consent|0|||
129555423|NCT00950599|466329205|FG001|Follow-Up Period|Subject withdrew Consent|0|||
129555424|NCT00950599|466329206|FG002|Follow-Up Period|Subject withdrew Consent|0|||
129555425|NCT00950599|466329207|FG003|Follow-Up Period|Subject withdrew Consent|0|||
129555426|NCT00950599|466329208|FG004|Follow-Up Period|Subject withdrew Consent|0|||
129555427|NCT00950599|466329209|FG005|Follow-Up Period|Subject withdrew Consent|0|||
129555428|NCT00950599|466329210|FG006|Follow-Up Period|Subject withdrew Consent|0|||
129555429|NCT00950599|466329211|FG007|Follow-Up Period|Subject withdrew Consent|0|||
129555430|NCT00950599|466329212|FG008|Follow-Up Period|Subject withdrew Consent|2|||
129555431|NCT00950599|466329213|FG009|Follow-Up Period|Subject withdrew Consent|1|||
129776268|NCT01662102|467146148|FG000|Overall Study|Sponsor's decision|1|||
129776269|NCT01662102|467146149|FG001|Overall Study|Sponsor's decision|0|||
129776270|NCT01995838|467146152|FG000|Overall Study|Lost to Follow-up|0|||
129776271|NCT01995838|467146153|FG001|Overall Study|Lost to Follow-up|1|||
129555432|NCT00971204|466329214|FG000|Overall Study|Did not meet all criteria-not treated|14|||
129555433|NCT00971204|466329214|FG000|Overall Study|Lost to Follow-up|10|||
129555434|NCT02436135|466329215|FG000|Overall Study|Progressive Disease|3|||
129555435|NCT02436135|466329216|FG001|Overall Study|Progressive Disease|1|||
129555436|NCT02436135|466329215|FG000|Overall Study|Investigator Discretion|1|||
129555437|NCT02436135|466329216|FG001|Overall Study|Investigator Discretion|2|||
129555438|NCT02436135|466329215|FG000|Overall Study|Adverse Event|1|||
129555439|NCT02436135|466329216|FG001|Overall Study|Adverse Event|0|||
129555440|NCT02436135|466329215|FG000|Overall Study|Withdrawal by Participant|1|||
129555441|NCT02436135|466329216|FG001|Overall Study|Withdrawal by Participant|0|||
129555442|NCT02436135|466329215|FG000|Overall Study|Study Terminated By Sponsor|0|||
129555443|NCT02436135|466329216|FG001|Overall Study|Study Terminated By Sponsor|1|||
129555444|NCT02729194|466329217|FG000|Overall Study|Withdrawal by Subject|3|||
129555445|NCT00475852|466329218|FG000|Overall Study|Death|444|||
129776272|NCT01995838|467146154|FG002|Overall Study|Lost to Follow-up|0|||
129776273|NCT01995838|467146155|FG003|Overall Study|Lost to Follow-up|0|||
129776274|NCT01995838|467146156|FG004|Overall Study|Lost to Follow-up|0|||
129555446|NCT00475852|466329219|FG001|Overall Study|Death|456|||
129555447|NCT00475852|466329218|FG000|Overall Study|Withdrawal by Subject|19|||
129555448|NCT00475852|466329219|FG001|Overall Study|Withdrawal by Subject|24|||
129555449|NCT00475852|466329218|FG000|Overall Study|Lost to Follow-up|54|||
129555450|NCT00475852|466329219|FG001|Overall Study|Lost to Follow-up|68|||
129555451|NCT00297479|466329221|FG000|Overall Study|Lost to Follow-up|37|||
129555452|NCT00297479|466329222|FG001|Overall Study|Lost to Follow-up|54|||
129555453|NCT00297479|466329223|FG002|Overall Study|Lost to Follow-up|51|||
129776275|NCT01995838|467146157|FG005|Overall Study|Lost to Follow-up|0|||
129555454|NCT01664494|466329226|FG000|Overall Study|Withdrawal by Subject|27|||
129555455|NCT01664494|466329226|FG000|Overall Study|Death|18|||
129555456|NCT01664494|466329226|FG000|Overall Study|Other|49|||
129555457|NCT01664494|466329226|FG000|Overall Study|Lost to Follow-up|99|||
129555458|NCT03196791|466329227|FG000|Overall Study|Protocol Violation|7|||
129555459|NCT03196791|466329228|FG001|Overall Study|Protocol Violation|3|||
129555460|NCT03196791|466329227|FG000|Overall Study|Withdrawal by Subject|3|||
129555461|NCT03196791|466329228|FG001|Overall Study|Withdrawal by Subject|2|||
129555462|NCT03063632|466329233|FG000|Overall Study|Death|4|||
129555463|NCT03063632|466329234|FG001|Overall Study|Death|6|||
129555464|NCT03063632|466329233|FG000|Overall Study|Lost to Follow-up|0|||
129555465|NCT03063632|466329234|FG001|Overall Study|Lost to Follow-up|1|||
129555466|NCT03063632|466329233|FG000|Overall Study|Withdrawal by Subject|0|||
129555467|NCT03063632|466329234|FG001|Overall Study|Withdrawal by Subject|2|||
129555468|NCT03063632|466329233|FG000|Overall Study|Physician Decision|2|||
129555469|NCT03063632|466329234|FG001|Overall Study|Physician Decision|0|||
129555470|NCT03063632|466329233|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
129555471|NCT03063632|466329234|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
129555472|NCT02570165|466329237|FG000|Overall Study|Adverse Event|1|||
129555473|NCT02570165|466329238|FG001|Overall Study|Adverse Event|0|||
129555474|NCT02570165|466329239|FG002|Overall Study|Adverse Event|2|||
129555475|NCT02570165|466329240|FG003|Overall Study|Adverse Event|0|||
129555476|NCT02570165|466329241|FG004|Overall Study|Adverse Event|0|||
129555477|NCT02570165|466329242|FG005|Overall Study|Adverse Event|0|||
129555478|NCT02570165|466329243|FG006|Overall Study|Adverse Event|0|||
129555479|NCT02570165|466329237|FG000|Overall Study|Lack of Efficacy|0|||
129555480|NCT02570165|466329238|FG001|Overall Study|Lack of Efficacy|1|||
129555481|NCT02570165|466329239|FG002|Overall Study|Lack of Efficacy|0|||
129555482|NCT02570165|466329240|FG003|Overall Study|Lack of Efficacy|0|||
129555483|NCT02570165|466329241|FG004|Overall Study|Lack of Efficacy|4|||
129555484|NCT02570165|466329242|FG005|Overall Study|Lack of Efficacy|0|||
129555485|NCT02570165|466329243|FG006|Overall Study|Lack of Efficacy|0|||
129555486|NCT02570165|466329237|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
129555487|NCT02570165|466329238|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
129555488|NCT02570165|466329239|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
129555489|NCT02570165|466329240|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
129555490|NCT02570165|466329241|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
129555491|NCT02570165|466329242|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
129555492|NCT02570165|466329243|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
129555493|NCT02570165|466329237|FG000|Overall Study|Lost to Follow-up|0|||
129555494|NCT02570165|466329238|FG001|Overall Study|Lost to Follow-up|0|||
129555495|NCT02570165|466329239|FG002|Overall Study|Lost to Follow-up|1|||
129555496|NCT02570165|466329240|FG003|Overall Study|Lost to Follow-up|1|||
129555497|NCT02570165|466329241|FG004|Overall Study|Lost to Follow-up|0|||
129555498|NCT02570165|466329242|FG005|Overall Study|Lost to Follow-up|0|||
129555499|NCT02570165|466329243|FG006|Overall Study|Lost to Follow-up|0|||
129555500|NCT02570165|466329237|FG000|Overall Study|Physician Decision|0|||
129555501|NCT02570165|466329238|FG001|Overall Study|Physician Decision|1|||
129555502|NCT02570165|466329239|FG002|Overall Study|Physician Decision|0|||
129555503|NCT02570165|466329240|FG003|Overall Study|Physician Decision|0|||
129555504|NCT02570165|466329241|FG004|Overall Study|Physician Decision|0|||
129555505|NCT02570165|466329242|FG005|Overall Study|Physician Decision|0|||
129555506|NCT02570165|466329243|FG006|Overall Study|Physician Decision|0|||
129555507|NCT02570165|466329237|FG000|Overall Study|Withdrawal by Subject|0|||
129555508|NCT02570165|466329238|FG001|Overall Study|Withdrawal by Subject|0|||
129555509|NCT02570165|466329239|FG002|Overall Study|Withdrawal by Subject|0|||
129776276|NCT01995838|467146158|FG006|Overall Study|Lost to Follow-up|1|||
129776277|NCT01995838|467146152|FG000|Overall Study|Participant choice|2|||
129776278|NCT01995838|467146153|FG001|Overall Study|Participant choice|0|||
129776279|NCT01995838|467146154|FG002|Overall Study|Participant choice|0|||
129776280|NCT01995838|467146155|FG003|Overall Study|Participant choice|0|||
129776281|NCT01995838|467146156|FG004|Overall Study|Participant choice|0|||
129776282|NCT01995838|467146157|FG005|Overall Study|Participant choice|1|||
129776283|NCT01995838|467146158|FG006|Overall Study|Participant choice|1|||
129776284|NCT01995838|467146152|FG000|Overall Study|Adverse Event|0|||
129776285|NCT01995838|467146153|FG001|Overall Study|Adverse Event|0|||
129555510|NCT02570165|466329240|FG003|Overall Study|Withdrawal by Subject|2|||
129555511|NCT02570165|466329241|FG004|Overall Study|Withdrawal by Subject|1|||
129555512|NCT02570165|466329242|FG005|Overall Study|Withdrawal by Subject|0|||
129555513|NCT02570165|466329243|FG006|Overall Study|Withdrawal by Subject|0|||
129555514|NCT02570165|466329237|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
129555515|NCT02570165|466329238|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
129555516|NCT02570165|466329239|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
129555517|NCT02570165|466329240|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
129555518|NCT02570165|466329241|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
129555519|NCT02570165|466329242|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
129555520|NCT02570165|466329243|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
129555521|NCT02570165|466329237|FG000|Overall Study|Withdrawal Request by GSK|0|||
129687130|NCT04925934|466810829|FG000|Overall Study|Withdrawal by Subject|8|||
129884493|NCT04844918|467536415|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
129555522|NCT02570165|466329238|FG001|Overall Study|Withdrawal Request by GSK|0|||
129555523|NCT02570165|466329239|FG002|Overall Study|Withdrawal Request by GSK|2|||
129555524|NCT02570165|466329240|FG003|Overall Study|Withdrawal Request by GSK|0|||
129555525|NCT02570165|466329241|FG004|Overall Study|Withdrawal Request by GSK|0|||
129555526|NCT02570165|466329242|FG005|Overall Study|Withdrawal Request by GSK|0|||
129555527|NCT02570165|466329243|FG006|Overall Study|Withdrawal Request by GSK|0|||
129555528|NCT01789281|466329244|FG000|Overall Study|Disease progression|15|||
129555529|NCT01789281|466329245|FG001|Overall Study|Disease progression|4|||
129555530|NCT01789281|466329244|FG000|Overall Study|Adverse Event|5|||
129555531|NCT01789281|466329245|FG001|Overall Study|Adverse Event|5|||
129555532|NCT01789281|466329244|FG000|Overall Study|Withdrawal by Subject|1|||
129555533|NCT01789281|466329245|FG001|Overall Study|Withdrawal by Subject|0|||
129555534|NCT01789281|466329244|FG000|Overall Study|Lost to Follow-up|1|||
129555535|NCT01789281|466329245|FG001|Overall Study|Lost to Follow-up|0|||
129555536|NCT01789281|466329244|FG000|Overall Study|Administrative problems|0|||
129555537|NCT01789281|466329245|FG001|Overall Study|Administrative problems|1|||
129555538|NCT02746705|466329248|FG000|Overall Study|Physician Decision|1|||
129555539|NCT02746705|466329249|FG001|Overall Study|Physician Decision|1|||
129555540|NCT02746705|466329248|FG000|Overall Study|Lost to Follow-up|1|||
129555541|NCT02746705|466329249|FG001|Overall Study|Lost to Follow-up|0|||
129555542|NCT02746705|466329248|FG000|Overall Study|outlier scores deemed not valid|0|||
129555543|NCT02746705|466329249|FG001|Overall Study|outlier scores deemed not valid|1|||
129555544|NCT04304950|466329263|FG000|Overall Study|Lost to Follow-up|1|||
129555545|NCT04304950|466329264|FG001|Overall Study|Lost to Follow-up|1|||
129555546|NCT02418910|466329265|FG000|Overall Study|Lost to Follow-up|3|||
129555547|NCT02418910|466329265|FG000|Overall Study|Withdrawal by Subject|4|||
129555548|NCT03634488|466329267|FG000|Overall Study|Death|1|||
129555549|NCT03634488|466329268|FG001|Overall Study|Death|0|||
129555550|NCT03634488|466329269|FG002|Overall Study|Death|0|||
129555551|NCT03634488|466329267|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
129555552|NCT03634488|466329268|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
129555553|NCT03634488|466329269|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
129555554|NCT03182686|466329270|FG000|Overall Study|Lost to Follow-up|2|||
129555555|NCT03182686|466329271|FG001|Overall Study|Lost to Follow-up|0|||
129555556|NCT03182686|466329270|FG000|Overall Study|Adverse Event|2|||
129555557|NCT03182686|466329271|FG001|Overall Study|Adverse Event|0|||
129555558|NCT03182686|466329270|FG000|Overall Study|Withdrawal by Subject|3|||
129555559|NCT03182686|466329271|FG001|Overall Study|Withdrawal by Subject|0|||
129555560|NCT01154127|466329272|FG000|Period 1 (21 Days)|Adverse Event|3|||
129555561|NCT01154127|466329273|FG001|Period 1 (21 Days)|Adverse Event|4|||
129555562|NCT01154127|466329272|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
129555563|NCT01154127|466329273|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
129555564|NCT01154127|466329272|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
129555565|NCT01154127|466329273|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
129555566|NCT01154127|466329272|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
129555567|NCT01154127|466329273|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
129555568|NCT01154127|466329272|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
129555569|NCT01154127|466329273|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
129555570|NCT01697449|466329274|FG000|Overall Study|Disease progression|47|||
129555571|NCT01697449|466329274|FG000|Overall Study|Adverse Event|7|||
129555572|NCT01697449|466329274|FG000|Overall Study|Lost to Follow-up|5|||
129555573|NCT01697449|466329274|FG000|Overall Study|Withdrawal by Subject|2|||
129555574|NCT01697449|466329274|FG000|Overall Study|Physician Decision|1|||
129555575|NCT01697449|466329274|FG000|Overall Study|Death|2|||
129555576|NCT01697449|466329274|FG000|Overall Study|Other|1|||
129555577|NCT01697449|466329274|FG000|Overall Study|Missing|25|||
129555578|NCT02390219|466329275|FG000|Overall Study|Death|1|||
129555579|NCT02390219|466329275|FG000|Overall Study|Physician Decision|1|||
129555580|NCT02390219|466329275|FG000|Overall Study|Adverse Event|6|||
129555581|NCT02390219|466329275|FG000|Overall Study|Withdrawal by Subject|1|||
129687131|NCT04925934|466810830|FG001|Overall Study|Withdrawal by Subject|5|||
129555582|NCT02390219|466329275|FG000|Overall Study|Lost to Follow-up|2|||
129687132|NCT04925934|466810831|FG002|Overall Study|Withdrawal by Subject|9|||
129555583|NCT02390219|466329275|FG000|Overall Study|Other|2|||
129555584|NCT01169844|466329276|FG000|Overall Study|Adverse Event|0|||
129555585|NCT01169844|466329277|FG001|Overall Study|Adverse Event|1|||
129687133|NCT04925934|466810829|FG000|Overall Study|Other|2|||
129687134|NCT04925934|466810830|FG001|Overall Study|Other|2|||
129687135|NCT04925934|466810831|FG002|Overall Study|Other|2|||
129555586|NCT01169844|466329276|FG000|Overall Study|Patient withdrew consent|4|||
129555587|NCT01169844|466329277|FG001|Overall Study|Patient withdrew consent|0|||
129555588|NCT01169844|466329276|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129555589|NCT01169844|466329277|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129687136|NCT04925934|466810829|FG000|Overall Study|Eastern European Conflict|7|||
129555590|NCT05037409|466329278|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
129687137|NCT04925934|466810830|FG001|Overall Study|Eastern European Conflict|3|||
129687138|NCT04925934|466810831|FG002|Overall Study|Eastern European Conflict|2|||
129555591|NCT05037409|466329279|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
129555592|NCT05037409|466329280|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
129555593|NCT00529568|466329281|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
129555594|NCT00529568|466329282|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
129555595|NCT00529568|466329283|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
129555596|NCT00529568|466329281|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
129555597|NCT00529568|466329282|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
129555598|NCT00529568|466329283|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
129555599|NCT00529568|466329281|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
129555600|NCT00529568|466329282|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
129555601|NCT00529568|466329283|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
129555602|NCT00529568|466329281|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
129555603|NCT00529568|466329282|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
129555604|NCT00529568|466329283|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
129555605|NCT00529568|466329281|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
129555606|NCT00529568|466329282|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
129555607|NCT00529568|466329283|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
129555608|NCT00529568|466329281|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
129555609|NCT00529568|466329282|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
129555610|NCT00529568|466329283|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
129555611|NCT00529568|466329281|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
129555612|NCT00529568|466329282|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
129555613|NCT00529568|466329283|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
129555614|NCT00529568|466329281|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
129555615|NCT00529568|466329282|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
129555616|NCT00529568|466329283|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
129555617|NCT00529568|466329281|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
129555618|NCT00529568|466329282|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
129555619|NCT00529568|466329283|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
129555620|NCT00529568|466329281|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
129555621|NCT00529568|466329282|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
129555622|NCT00529568|466329283|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
129555623|NCT00529568|466329281|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
129555624|NCT00529568|466329282|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
129555625|NCT00529568|466329283|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
129555626|NCT01201356|466329284|FG000|Overall Study|Adverse Event|170|||
129555627|NCT01201356|466329284|FG000|Overall Study|Abnormal laboratory value(s)|51|||
129555628|NCT01201356|466329284|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129555629|NCT01201356|466329284|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
129555630|NCT01201356|466329284|FG000|Overall Study|Condition no longer requires study drug|12|||
129555631|NCT01201356|466329284|FG000|Overall Study|Withdrawal by Subject|144|||
129555632|NCT01201356|466329284|FG000|Overall Study|Lost to Follow-up|50|||
129555633|NCT01201356|466329284|FG000|Overall Study|administrative problems|74|||
129555634|NCT01201356|466329284|FG000|Overall Study|Death|16|||
129555635|NCT01201356|466329284|FG000|Overall Study|Protocol Violation|12|||
129555636|NCT00931385|466329285|FG000|Overall Study|Adverse Event|2|||
129555637|NCT00931385|466329286|FG001|Overall Study|Adverse Event|1|||
129555638|NCT00931385|466329287|FG002|Overall Study|Adverse Event|0|||
129555639|NCT00931385|466329288|FG003|Overall Study|Adverse Event|3|||
129555640|NCT00931385|466329285|FG000|Overall Study|Protocol Violation|0|||
129555641|NCT00931385|466329286|FG001|Overall Study|Protocol Violation|0|||
129555642|NCT00931385|466329287|FG002|Overall Study|Protocol Violation|1|||
129555643|NCT00931385|466329288|FG003|Overall Study|Protocol Violation|0|||
129555644|NCT00931385|466329285|FG000|Overall Study|Withdrawal by Subject|0|||
129555645|NCT00931385|466329286|FG001|Overall Study|Withdrawal by Subject|1|||
129555646|NCT00931385|466329287|FG002|Overall Study|Withdrawal by Subject|0|||
129555647|NCT00931385|466329288|FG003|Overall Study|Withdrawal by Subject|1|||
129555648|NCT00931385|466329285|FG000|Overall Study|Lost to Follow-up|0|||
129555649|NCT00931385|466329286|FG001|Overall Study|Lost to Follow-up|0|||
129555650|NCT00931385|466329287|FG002|Overall Study|Lost to Follow-up|0|||
129555651|NCT00931385|466329288|FG003|Overall Study|Lost to Follow-up|1|||
129555652|NCT00811070|466329290|FG000|Overall Study|Death|0|||
129555653|NCT00811070|466329291|FG001|Overall Study|Death|0|||
129555654|NCT00811070|466329292|FG002|Overall Study|Death|0|||
129555655|NCT00811070|466329293|FG003|Overall Study|Death|2|||
129555656|NCT00811070|466329294|FG004|Overall Study|Death|5|||
129555657|NCT00811070|466329295|FG005|Overall Study|Death|0|||
129555658|NCT00811070|466329290|FG000|Overall Study|Other|1|||
129555659|NCT00811070|466329291|FG001|Overall Study|Other|0|||
129555660|NCT00811070|466329292|FG002|Overall Study|Other|0|||
129555661|NCT00811070|466329293|FG003|Overall Study|Other|0|||
129555662|NCT00811070|466329294|FG004|Overall Study|Other|0|||
129555663|NCT00811070|466329295|FG005|Overall Study|Other|0|||
129555664|NCT00811070|466329290|FG000|Overall Study|Withdrawal by Subject|0|||
129555665|NCT00811070|466329291|FG001|Overall Study|Withdrawal by Subject|1|||
129555666|NCT00811070|466329292|FG002|Overall Study|Withdrawal by Subject|0|||
129555667|NCT00811070|466329293|FG003|Overall Study|Withdrawal by Subject|0|||
129555668|NCT00811070|466329294|FG004|Overall Study|Withdrawal by Subject|0|||
129555669|NCT00811070|466329295|FG005|Overall Study|Withdrawal by Subject|0|||
129555670|NCT00811070|466329290|FG000|Overall Study|Physician Decision|0|||
129555671|NCT00811070|466329291|FG001|Overall Study|Physician Decision|0|||
129555672|NCT00811070|466329292|FG002|Overall Study|Physician Decision|0|||
129555673|NCT00811070|466329293|FG003|Overall Study|Physician Decision|0|||
129555674|NCT00811070|466329294|FG004|Overall Study|Physician Decision|0|||
129555675|NCT00811070|466329295|FG005|Overall Study|Physician Decision|1|||
129555676|NCT04444752|466329299|FG000|Overall Study|Adverse Event|1|||
129555677|NCT04444752|466329300|FG001|Overall Study|Adverse Event|0|||
129555678|NCT04444752|466329301|FG002|Overall Study|Adverse Event|0|||
129555679|NCT04444752|466329302|FG003|Overall Study|Adverse Event|2|||
129555680|NCT04444752|466329299|FG000|Overall Study|Lost to Follow-up|2|||
129555681|NCT04444752|466329300|FG001|Overall Study|Lost to Follow-up|6|||
129555682|NCT04444752|466329301|FG002|Overall Study|Lost to Follow-up|2|||
129555683|NCT04444752|466329302|FG003|Overall Study|Lost to Follow-up|5|||
129555684|NCT04444752|466329299|FG000|Overall Study|Physician Decision|0|||
129555685|NCT04444752|466329300|FG001|Overall Study|Physician Decision|0|||
129555686|NCT04444752|466329301|FG002|Overall Study|Physician Decision|0|||
129555687|NCT04444752|466329302|FG003|Overall Study|Physician Decision|2|||
129555688|NCT04444752|466329299|FG000|Overall Study|Pregnancy|0|||
129555689|NCT04444752|466329300|FG001|Overall Study|Pregnancy|0|||
129555690|NCT04444752|466329301|FG002|Overall Study|Pregnancy|0|||
129555691|NCT04444752|466329302|FG003|Overall Study|Pregnancy|1|||
129555692|NCT04444752|466329299|FG000|Overall Study|Withdrawal by Subject|6|||
129555693|NCT04444752|466329300|FG001|Overall Study|Withdrawal by Subject|5|||
129555694|NCT04444752|466329301|FG002|Overall Study|Withdrawal by Subject|3|||
129555695|NCT04444752|466329302|FG003|Overall Study|Withdrawal by Subject|4|||
129555696|NCT04444752|466329299|FG000|Overall Study|Protocol Violation|1|||
129555697|NCT04444752|466329300|FG001|Overall Study|Protocol Violation|1|||
129555698|NCT04444752|466329301|FG002|Overall Study|Protocol Violation|0|||
129555699|NCT04444752|466329302|FG003|Overall Study|Protocol Violation|0|||
129555700|NCT04444752|466329299|FG000|Overall Study|Patient moving out of town|1|||
129555701|NCT04444752|466329300|FG001|Overall Study|Patient moving out of town|0|||
129555702|NCT04444752|466329301|FG002|Overall Study|Patient moving out of town|0|||
129555703|NCT04444752|466329302|FG003|Overall Study|Patient moving out of town|1|||
129555704|NCT04444752|466329299|FG000|Overall Study|Lack of Efficacy|0|||
129555705|NCT04444752|466329300|FG001|Overall Study|Lack of Efficacy|0|||
129555706|NCT04444752|466329301|FG002|Overall Study|Lack of Efficacy|0|||
129555707|NCT04444752|466329302|FG003|Overall Study|Lack of Efficacy|1|||
129555708|NCT04444752|466329299|FG000|Overall Study|Death|0|||
129555709|NCT04444752|466329300|FG001|Overall Study|Death|0|||
129555710|NCT04444752|466329301|FG002|Overall Study|Death|1|||
129555711|NCT04444752|466329302|FG003|Overall Study|Death|0|||
129555712|NCT01759537|466329303|FG000|Overall Study|Death|1|||
129555713|NCT01759537|466329304|FG001|Overall Study|Death|1|||
129555714|NCT01759537|466329303|FG000|Overall Study|Pregnancy|1|||
129555715|NCT01759537|466329304|FG001|Overall Study|Pregnancy|1|||
129555716|NCT01759537|466329303|FG000|Overall Study|Lost to Follow-up|9|||
129555717|NCT01759537|466329304|FG001|Overall Study|Lost to Follow-up|9|||
129555718|NCT01759537|466329303|FG000|Overall Study|Accident involving jaw fracture|1|||
129555719|NCT01759537|466329304|FG001|Overall Study|Accident involving jaw fracture|1|||
129555720|NCT01759537|466329303|FG000|Overall Study|Subcrestal implant too coronal|1|||
129687139|NCT03158688|466810832|FG000|Overall Study|Withdrawal by Subject|14|||
129687140|NCT03158688|466810833|FG001|Overall Study|Withdrawal by Subject|28|||
129687141|NCT03158688|466810832|FG000|Overall Study|Decision by sponsor|13|||
129687142|NCT03158688|466810833|FG001|Overall Study|Decision by sponsor|37|||
129687143|NCT03158688|466810832|FG000|Overall Study|Lost to Follow-up|4|||
129555721|NCT01759537|466329304|FG001|Overall Study|Subcrestal implant too coronal|1|||
129555722|NCT02544633|466330635|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
129555723|NCT02544633|466330636|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
129555724|NCT02544633|466330637|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
129555725|NCT02544633|466330638|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
129555726|NCT02544633|466330635|FG000|Treatment Period|Adverse Event|7|||
129555727|NCT02544633|466330636|FG001|Treatment Period|Adverse Event|4|||
129555728|NCT02544633|466330637|FG002|Treatment Period|Adverse Event|0|||
129555729|NCT02544633|466330638|FG003|Treatment Period|Adverse Event|5|||
129555730|NCT02544633|466330635|FG000|Treatment Period|Lack of Efficacy|17|||
129555731|NCT02544633|466330636|FG001|Treatment Period|Lack of Efficacy|11|||
129555732|NCT02544633|466330637|FG002|Treatment Period|Lack of Efficacy|5|||
129555733|NCT02544633|466330638|FG003|Treatment Period|Lack of Efficacy|5|||
129555734|NCT02544633|466330635|FG000|Treatment Period|Global Deterioration of Health|3|||
129687144|NCT03158688|466810833|FG001|Overall Study|Lost to Follow-up|3|||
129687145|NCT03158688|466810832|FG000|Overall Study|Death|74|||
129687146|NCT03158688|466810833|FG001|Overall Study|Death|142|||
129687147|NCT00374868|466810837|FG000|Overall Study|Adverse Event|12|||
129687148|NCT00374868|466810837|FG000|Overall Study|Progressive Disease|7|||
129687149|NCT00374868|466810837|FG000|Overall Study|Physician Decision|13|||
129687150|NCT00374868|466810837|FG000|Overall Study|Lost to Follow-up|1|||
129687151|NCT00374868|466810837|FG000|Overall Study|Death|2|||
129687152|NCT00374868|466810837|FG000|Overall Study|Other - Not Specified|1|||
129687153|NCT03188185|466810838|FG000|Stage 1|Adverse Event|4|||
129776286|NCT01995838|467146154|FG002|Overall Study|Adverse Event|0|||
129776287|NCT01995838|467146155|FG003|Overall Study|Adverse Event|0|||
129776288|NCT01995838|467146156|FG004|Overall Study|Adverse Event|0|||
129776289|NCT01995838|467146157|FG005|Overall Study|Adverse Event|0|||
129776290|NCT01995838|467146158|FG006|Overall Study|Adverse Event|1|||
129776291|NCT01995838|467146152|FG000|Overall Study|Withdrawal by Subject|0|||
129776292|NCT01995838|467146153|FG001|Overall Study|Withdrawal by Subject|0|||
129776293|NCT01995838|467146154|FG002|Overall Study|Withdrawal by Subject|0|||
129687154|NCT03188185|466810839|FG001|Stage 1|Adverse Event|12|||
129687155|NCT03188185|466810840|FG002|Stage 1|Adverse Event|0|||
129687156|NCT03188185|466810841|FG003|Stage 1|Adverse Event|0|||
129687157|NCT03188185|466810838|FG000|Stage 1|Lack of Efficacy|0|||
129687158|NCT03188185|466810839|FG001|Stage 1|Lack of Efficacy|2|||
129687159|NCT03188185|466810840|FG002|Stage 1|Lack of Efficacy|0|||
129687160|NCT03188185|466810841|FG003|Stage 1|Lack of Efficacy|0|||
129687161|NCT03188185|466810838|FG000|Stage 1|Lost to Follow-up|6|||
129687162|NCT03188185|466810839|FG001|Stage 1|Lost to Follow-up|1|||
129687163|NCT03188185|466810840|FG002|Stage 1|Lost to Follow-up|0|||
129687164|NCT03188185|466810841|FG003|Stage 1|Lost to Follow-up|0|||
129687165|NCT03188185|466810838|FG000|Stage 1|Withdrawal by Subject|9|||
129687166|NCT03188185|466810839|FG001|Stage 1|Withdrawal by Subject|0|||
129687167|NCT03188185|466810840|FG002|Stage 1|Withdrawal by Subject|0|||
129555735|NCT02544633|466330636|FG001|Treatment Period|Global Deterioration of Health|3|||
129555736|NCT02544633|466330637|FG002|Treatment Period|Global Deterioration of Health|0|||
129555737|NCT02544633|466330638|FG003|Treatment Period|Global Deterioration of Health|1|||
129555738|NCT02544633|466330635|FG000|Treatment Period|Withdrawal by Subject|1|||
129555739|NCT02544633|466330636|FG001|Treatment Period|Withdrawal by Subject|0|||
129555740|NCT02544633|466330637|FG002|Treatment Period|Withdrawal by Subject|0|||
129687168|NCT03188185|466810841|FG003|Stage 1|Withdrawal by Subject|0|||
129776294|NCT01995838|467146155|FG003|Overall Study|Withdrawal by Subject|0|||
129776295|NCT01995838|467146156|FG004|Overall Study|Withdrawal by Subject|1|||
129776296|NCT01995838|467146157|FG005|Overall Study|Withdrawal by Subject|0|||
129776297|NCT01995838|467146158|FG006|Overall Study|Withdrawal by Subject|0|||
129776298|NCT01995838|467146152|FG000|Overall Study|Other|3|||
129776299|NCT01995838|467146153|FG001|Overall Study|Other|1|||
129776300|NCT01995838|467146154|FG002|Overall Study|Other|0|||
129776301|NCT01995838|467146155|FG003|Overall Study|Other|2|||
129776302|NCT01995838|467146156|FG004|Overall Study|Other|1|||
129776303|NCT01995838|467146157|FG005|Overall Study|Other|1|||
129776304|NCT01995838|467146158|FG006|Overall Study|Other|2|||
129776305|NCT00380367|467146161|FG000|Overall Study|Lost to Follow-up|1|||
129776306|NCT00380367|467146161|FG000|Overall Study|Withdrawal by Subject|1|||
129776307|NCT00439517|467146169|FG000|Overall Study|Subject on treatment|1|||
129776308|NCT00439517|467146170|FG001|Overall Study|Subject on treatment|0|||
129776309|NCT00439517|467146169|FG000|Overall Study|Subject in survival follow-up|1|||
129776310|NCT00439517|467146170|FG001|Overall Study|Subject in survival follow-up|0|||
129776311|NCT01519921|467146180|FG000|Overall Study|Adverse Event|10|||
129776312|NCT01519921|467146181|FG001|Overall Study|Adverse Event|9|||
129776313|NCT01519921|467146180|FG000|Overall Study|Lack of Efficacy|4|||
129776314|NCT01519921|467146181|FG001|Overall Study|Lack of Efficacy|3|||
129776315|NCT01519921|467146180|FG000|Overall Study|Withdrawal by Subject|3|||
129776316|NCT01519921|467146181|FG001|Overall Study|Withdrawal by Subject|0|||
129776317|NCT01519921|467146180|FG000|Overall Study|Lost to Follow-up|2|||
129776318|NCT01519921|467146181|FG001|Overall Study|Lost to Follow-up|1|||
129776319|NCT01519921|467146180|FG000|Overall Study|Treatment refusal|2|||
129776320|NCT01519921|467146181|FG001|Overall Study|Treatment refusal|1|||
129776321|NCT01519921|467146180|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
129776322|NCT01519921|467146181|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
129776323|NCT00060840|467146184|FG000|Overall Study|Change in surgical plan|2|||
129776324|NCT00060840|467146185|FG001|Overall Study|Change in surgical plan|6|||
129776325|NCT00060840|467146184|FG000|Overall Study|Death|0|||
129776326|NCT00060840|467146185|FG001|Overall Study|Death|1|||
129776327|NCT00060840|467146184|FG000|Overall Study|Withdrawal by Subject|0|||
129776328|NCT00060840|467146185|FG001|Overall Study|Withdrawal by Subject|1|||
129776329|NCT00060840|467146184|FG000|Overall Study|Subinvestigator unavailable|0|||
129776330|NCT00060840|467146185|FG001|Overall Study|Subinvestigator unavailable|1|||
129776331|NCT00060840|467146184|FG000|Overall Study|Physician Decision|1|||
129776332|NCT00060840|467146185|FG001|Overall Study|Physician Decision|0|||
129776333|NCT00060840|467146184|FG000|Overall Study|Other|1|||
129776334|NCT00060840|467146185|FG001|Overall Study|Other|0|||
129776335|NCT01216189|467146190|FG000|Overall Study|Lost to Follow-up|21|||
129776336|NCT01216189|467146191|FG001|Overall Study|Lost to Follow-up|3|||
129776337|NCT01216189|467146190|FG000|Overall Study|Death|4|||
129776338|NCT01216189|467146191|FG001|Overall Study|Death|2|||
129555741|NCT02544633|466330638|FG003|Treatment Period|Withdrawal by Subject|0|||
129555742|NCT02544633|466330635|FG000|Treatment Period|Lost to Follow-up|0|||
129687169|NCT03188185|466810838|FG000|Stage 1|Identified as a professional patient|0|||
129687170|NCT03188185|466810839|FG001|Stage 1|Identified as a professional patient|1|||
129687171|NCT03188185|466810840|FG002|Stage 1|Identified as a professional patient|0|||
129687172|NCT03188185|466810841|FG003|Stage 1|Identified as a professional patient|0|||
129687173|NCT03188185|466810838|FG000|Stage 2|Adverse Event|0|||
129555743|NCT02544633|466330636|FG001|Treatment Period|Lost to Follow-up|1|||
129555744|NCT02544633|466330637|FG002|Treatment Period|Lost to Follow-up|0|||
129555745|NCT02544633|466330638|FG003|Treatment Period|Lost to Follow-up|0|||
129555746|NCT02544633|466330635|FG000|Treatment Period|Death|0|||
129555747|NCT02544633|466330636|FG001|Treatment Period|Death|0|||
129555748|NCT02544633|466330637|FG002|Treatment Period|Death|1|||
129555749|NCT02544633|466330638|FG003|Treatment Period|Death|0|||
129555750|NCT02544633|466330635|FG000|Treatment Period|Non-compliance|0|||
129555751|NCT02544633|466330636|FG001|Treatment Period|Non-compliance|0|||
129555752|NCT02544633|466330637|FG002|Treatment Period|Non-compliance|1|||
129555753|NCT02544633|466330638|FG003|Treatment Period|Non-compliance|0|||
129687174|NCT03188185|466810839|FG001|Stage 2|Adverse Event|0|||
129687175|NCT03188185|466810840|FG002|Stage 2|Adverse Event|2|||
129776339|NCT00125164|467146192|FG000|Overall Study|Adverse Event|0|||
129776340|NCT00125164|467146193|FG001|Overall Study|Adverse Event|0|||
129776341|NCT00125164|467146194|FG002|Overall Study|Adverse Event|2|||
129776342|NCT00125164|467146195|FG003|Overall Study|Adverse Event|4|||
129776343|NCT00125164|467146192|FG000|Overall Study|Lost to Follow-up|0|||
129776344|NCT00125164|467146193|FG001|Overall Study|Lost to Follow-up|0|||
129776345|NCT00125164|467146194|FG002|Overall Study|Lost to Follow-up|1|||
129776346|NCT00125164|467146195|FG003|Overall Study|Lost to Follow-up|1|||
129776347|NCT00125164|467146192|FG000|Overall Study|Withdrawal by Subject|2|||
129776348|NCT00125164|467146193|FG001|Overall Study|Withdrawal by Subject|0|||
129776349|NCT00125164|467146194|FG002|Overall Study|Withdrawal by Subject|1|||
129776350|NCT00125164|467146195|FG003|Overall Study|Withdrawal by Subject|1|||
129776351|NCT01339052|467146196|FG000|Overall Study|Disease progression|13|||
129776352|NCT01339052|467146197|FG001|Overall Study|Disease progression|46|||
129776353|NCT01339052|467146196|FG000|Overall Study|Adverse Event|1|||
129776354|NCT01339052|467146197|FG001|Overall Study|Adverse Event|1|||
129776355|NCT01339052|467146196|FG000|Overall Study|Withdrawal by Subject|0|||
129776356|NCT01339052|467146197|FG001|Overall Study|Withdrawal by Subject|3|||
129776357|NCT01339052|467146196|FG000|Overall Study|Physician Decision|1|||
129776358|NCT01339052|467146197|FG001|Overall Study|Physician Decision|0|||
129776359|NCT02637037|467146198|FG000|Overall Study|Positive drug screen at admission|1|||
129776360|NCT02637037|467146199|FG001|Overall Study|Positive drug screen at admission|0|||
129776361|NCT02637037|467146198|FG000|Overall Study|Withdrawal by Subject|2|||
129776362|NCT02637037|467146199|FG001|Overall Study|Withdrawal by Subject|1|||
129776363|NCT02637037|467146198|FG000|Overall Study|Adverse Event|1|||
129776364|NCT02637037|467146199|FG001|Overall Study|Adverse Event|0|||
129776365|NCT01469377|467146202|FG000|Overall Study|Protocol Deviation|7|||
129776366|NCT01469377|467146203|FG001|Overall Study|Protocol Deviation|10|||
129776367|NCT01469377|467146204|FG002|Overall Study|Protocol Deviation|10|||
129776368|NCT01469377|467146202|FG000|Overall Study|Lost to Follow-up|3|||
129776369|NCT01469377|467146203|FG001|Overall Study|Lost to Follow-up|2|||
129776370|NCT01469377|467146204|FG002|Overall Study|Lost to Follow-up|5|||
129776371|NCT01469377|467146202|FG000|Overall Study|Withdrawal of Consent|12|||
129776372|NCT01469377|467146203|FG001|Overall Study|Withdrawal of Consent|14|||
129776373|NCT01469377|467146204|FG002|Overall Study|Withdrawal of Consent|15|||
129776374|NCT01469377|467146202|FG000|Overall Study|Adverse Event|8|||
129776375|NCT01469377|467146203|FG001|Overall Study|Adverse Event|18|||
129776376|NCT01469377|467146204|FG002|Overall Study|Adverse Event|36|||
129776377|NCT01469377|467146202|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129776378|NCT01469377|467146203|FG001|Overall Study|Insufficient Therapeutic Response|4|||
129776379|NCT01469377|467146204|FG002|Overall Study|Insufficient Therapeutic Response|0|||
129776380|NCT01469377|467146202|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129776381|NCT01469377|467146203|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129776382|NCT01469377|467146204|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129776383|NCT01733680|467146205|FG000|Overall Study|Withdrawal by Subject|0|||
129776384|NCT01733680|467146206|FG001|Overall Study|Withdrawal by Subject|1|||
129776385|NCT04308291|467146213|FG000|Run-In Phase|Withdrawal by Subject|4|||
129776386|NCT04308291|467146213|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
129776387|NCT04308291|467146213|FG000|Study Phase 6-M|Physician Decision|2|||
129776388|NCT04308291|467146213|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
129776389|NCT04308291|467146213|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
129776390|NCT04308291|467146213|FG000|Study Phase 12-M|Physician Decision|2|||
129776391|NCT04308291|467146213|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
129776392|NCT02565108|467146214|FG000|Overall Study|Adverse Event|1|||
129776393|NCT02565108|467146215|FG001|Overall Study|Adverse Event|0|||
129776394|NCT02565108|467146214|FG000|Overall Study|Withdrew Consent|1|||
129776395|NCT02565108|467146215|FG001|Overall Study|Withdrew Consent|0|||
129776396|NCT02453711|467146216|FG000|Overall Study|Withdrawal by Subject|5|||
129776397|NCT02453711|467146217|FG001|Overall Study|Withdrawal by Subject|4|||
129776398|NCT02453711|467146218|FG002|Overall Study|Withdrawal by Subject|6|||
129776399|NCT02453711|467146219|FG003|Overall Study|Withdrawal by Subject|4|||
129776400|NCT02453711|467146220|FG004|Overall Study|Withdrawal by Subject|1|||
129776401|NCT02453711|467146221|FG005|Overall Study|Withdrawal by Subject|1|||
129776402|NCT02453711|467146222|FG006|Overall Study|Withdrawal by Subject|0|||
129776403|NCT02453711|467146223|FG007|Overall Study|Withdrawal by Subject|1|||
129555754|NCT02544633|466330635|FG000|Treatment Period|Clinical Disease Progression|0|||
129555755|NCT02544633|466330636|FG001|Treatment Period|Clinical Disease Progression|0|||
129555756|NCT02544633|466330637|FG002|Treatment Period|Clinical Disease Progression|0|||
129555757|NCT02544633|466330638|FG003|Treatment Period|Clinical Disease Progression|1|||
129555758|NCT02544633|466330635|FG000|Survival Follow-up Period|Death|12|||
129555759|NCT02544633|466330636|FG001|Survival Follow-up Period|Death|14|||
129687176|NCT03188185|466810841|FG003|Stage 2|Adverse Event|4|||
129687177|NCT03188185|466810838|FG000|Stage 2|Lack of Efficacy|0|||
129687178|NCT03188185|466810839|FG001|Stage 2|Lack of Efficacy|0|||
129687179|NCT03188185|466810840|FG002|Stage 2|Lack of Efficacy|3|||
129687180|NCT03188185|466810841|FG003|Stage 2|Lack of Efficacy|0|||
129687181|NCT03188185|466810838|FG000|Stage 2|Lost to Follow-up|0|||
129687182|NCT03188185|466810839|FG001|Stage 2|Lost to Follow-up|0|||
129687183|NCT03188185|466810840|FG002|Stage 2|Lost to Follow-up|1|||
129687184|NCT03188185|466810841|FG003|Stage 2|Lost to Follow-up|0|||
129687185|NCT03188185|466810838|FG000|Stage 2|Physician Decision|0|||
129687186|NCT03188185|466810839|FG001|Stage 2|Physician Decision|0|||
129687187|NCT03188185|466810840|FG002|Stage 2|Physician Decision|0|||
129687188|NCT03188185|466810841|FG003|Stage 2|Physician Decision|1|||
129687189|NCT03188185|466810838|FG000|Stage 2|Withdrawal by Subject|0|||
129687190|NCT03188185|466810839|FG001|Stage 2|Withdrawal by Subject|0|||
129687191|NCT03188185|466810840|FG002|Stage 2|Withdrawal by Subject|3|||
129687192|NCT03188185|466810841|FG003|Stage 2|Withdrawal by Subject|1|||
129687193|NCT02315625|466810845|FG000|First Intervention|Disease Progression|1|||
129687194|NCT02315625|466810846|FG001|First Intervention|Disease Progression|0|||
129687195|NCT02315625|466810845|FG000|Second Intervention|Physician Decision|2|||
129687196|NCT02315625|466810846|FG001|Second Intervention|Physician Decision|1|||
129687197|NCT02315625|466810845|FG000|Second Intervention|Study closure|1|||
129687198|NCT02315625|466810846|FG001|Second Intervention|Study closure|0|||
129687199|NCT02315625|466810845|FG000|Second Intervention|Disease Progression|1|||
129687200|NCT02315625|466810846|FG001|Second Intervention|Disease Progression|0|||
129687201|NCT04822194|466810849|FG000|Overall Study|Withdrawal by Subject|5|||
129687202|NCT04822194|466810850|FG001|Overall Study|Withdrawal by Subject|4|||
129687203|NCT04822194|466810849|FG000|Overall Study|Technical issues with MR scanner|1|||
129687204|NCT04822194|466810850|FG001|Overall Study|Technical issues with MR scanner|0|||
129884494|NCT04844918|467536416|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
129884495|NCT04844918|467536417|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
129884496|NCT01266993|467536428|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
129884497|NCT01266993|467536429|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
129884498|NCT01266993|467536428|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
129884499|NCT01266993|467536429|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
129884500|NCT02293837|467536432|FG000|Overall Study|Lost to Follow-up|0|||
129884501|NCT02293837|467536433|FG001|Overall Study|Lost to Follow-up|2|||
129884502|NCT02293837|467536434|FG002|Overall Study|Lost to Follow-up|1|||
129687205|NCT04822194|466810849|FG000|Overall Study|Lost to Follow-up|5|||
129687206|NCT04822194|466810850|FG001|Overall Study|Lost to Follow-up|7|||
129687207|NCT03442569|466810854|FG000|Overall Study|Subject was ineligible after enrollment|1|||
129884503|NCT02293837|467536435|FG003|Overall Study|Lost to Follow-up|0|||
129776404|NCT02453711|467146224|FG008|Overall Study|Withdrawal by Subject|7|||
129776405|NCT02453711|467146216|FG000|Overall Study|Lost to Follow-up|5|||
129776406|NCT02453711|467146217|FG001|Overall Study|Lost to Follow-up|3|||
129776407|NCT02453711|467146218|FG002|Overall Study|Lost to Follow-up|2|||
129776408|NCT02453711|467146219|FG003|Overall Study|Lost to Follow-up|3|||
129776409|NCT02453711|467146220|FG004|Overall Study|Lost to Follow-up|1|||
129776410|NCT02453711|467146221|FG005|Overall Study|Lost to Follow-up|5|||
129776411|NCT02453711|467146222|FG006|Overall Study|Lost to Follow-up|2|||
129776412|NCT02453711|467146223|FG007|Overall Study|Lost to Follow-up|6|||
129776413|NCT02453711|467146224|FG008|Overall Study|Lost to Follow-up|6|||
129776414|NCT02453711|467146216|FG000|Overall Study|Death|0|||
129776415|NCT02453711|467146217|FG001|Overall Study|Death|0|||
129776416|NCT02453711|467146218|FG002|Overall Study|Death|0|||
129776417|NCT02453711|467146219|FG003|Overall Study|Death|0|||
129776418|NCT02453711|467146220|FG004|Overall Study|Death|0|||
129776419|NCT02453711|467146221|FG005|Overall Study|Death|0|||
129776420|NCT02453711|467146222|FG006|Overall Study|Death|1|||
129776421|NCT02453711|467146223|FG007|Overall Study|Death|0|||
129776422|NCT02453711|467146224|FG008|Overall Study|Death|0|||
129776423|NCT02453711|467146216|FG000|Overall Study|Unclassified|1|||
129776424|NCT02453711|467146217|FG001|Overall Study|Unclassified|0|||
129776425|NCT02453711|467146218|FG002|Overall Study|Unclassified|1|||
129776426|NCT02453711|467146219|FG003|Overall Study|Unclassified|0|||
129776427|NCT02453711|467146220|FG004|Overall Study|Unclassified|0|||
129776428|NCT02453711|467146221|FG005|Overall Study|Unclassified|0|||
129776429|NCT02453711|467146222|FG006|Overall Study|Unclassified|0|||
129776430|NCT02453711|467146223|FG007|Overall Study|Unclassified|0|||
129776431|NCT02453711|467146224|FG008|Overall Study|Unclassified|0|||
129776432|NCT01273519|467146225|FG000|Overall Study|Adverse Event|3|||
129776433|NCT01273519|467146226|FG001|Overall Study|Adverse Event|0|||
129776434|NCT01273519|467146227|FG002|Overall Study|Adverse Event|0|||
129776435|NCT01273519|467146225|FG000|Overall Study|Lost to Follow-up|2|||
129776436|NCT01273519|467146226|FG001|Overall Study|Lost to Follow-up|1|||
129776437|NCT01273519|467146227|FG002|Overall Study|Lost to Follow-up|3|||
129776438|NCT01273519|467146225|FG000|Overall Study|Lack of Efficacy|8|||
129776439|NCT01273519|467146226|FG001|Overall Study|Lack of Efficacy|3|||
129776440|NCT01273519|467146227|FG002|Overall Study|Lack of Efficacy|4|||
129776441|NCT01273519|467146225|FG000|Overall Study|Other|6|||
129776442|NCT01273519|467146226|FG001|Overall Study|Other|1|||
129776443|NCT01273519|467146227|FG002|Overall Study|Other|1|||
129776444|NCT02302339|467146228|FG000|Overall Study|Lost to Follow-up|1|||
129776445|NCT02302339|467146229|FG001|Overall Study|Lost to Follow-up|0|||
129776446|NCT02302339|467146230|FG002|Overall Study|Lost to Follow-up|0|||
129776447|NCT02302339|467146231|FG003|Overall Study|Lost to Follow-up|0|||
129776448|NCT02302339|467146228|FG000|Overall Study|Withdrawal by Subject|0|||
129776449|NCT02302339|467146229|FG001|Overall Study|Withdrawal by Subject|2|||
129776450|NCT02302339|467146230|FG002|Overall Study|Withdrawal by Subject|1|||
129776451|NCT02302339|467146231|FG003|Overall Study|Withdrawal by Subject|0|||
129776452|NCT02908672|467146232|FG000|Run-in Period|Death|12|||
129776453|NCT02908672|467146233|FG001|Run-in Period|Death|10|||
129776454|NCT02908672|467146234|FG002|Run-in Period|Death|0|||
129776455|NCT02908672|467146235|FG003|Run-in Period|Death|0|||
129776456|NCT02908672|467146232|FG000|Run-in Period|Lost to Follow-up|1|||
129776457|NCT02908672|467146233|FG001|Run-in Period|Lost to Follow-up|1|||
129776458|NCT02908672|467146234|FG002|Run-in Period|Lost to Follow-up|0|||
129776459|NCT02908672|467146235|FG003|Run-in Period|Lost to Follow-up|0|||
129776460|NCT02908672|467146232|FG000|Run-in Period|Reason Not Specified|2|||
129776461|NCT02908672|467146233|FG001|Run-in Period|Reason Not Specified|0|||
129776462|NCT02908672|467146234|FG002|Run-in Period|Reason Not Specified|0|||
129776463|NCT02908672|467146235|FG003|Run-in Period|Reason Not Specified|0|||
129776464|NCT02908672|467146232|FG000|Run-in Period|Protocol Violation|1|||
129776465|NCT02908672|467146233|FG001|Run-in Period|Protocol Violation|1|||
129776466|NCT02908672|467146234|FG002|Run-in Period|Protocol Violation|0|||
129776467|NCT02908672|467146235|FG003|Run-in Period|Protocol Violation|0|||
129776468|NCT02908672|467146232|FG000|Run-in Period|Study Ended by Sponsor|5|||
129776469|NCT02908672|467146233|FG001|Run-in Period|Study Ended by Sponsor|1|||
129776470|NCT02908672|467146234|FG002|Run-in Period|Study Ended by Sponsor|0|||
129776471|NCT02908672|467146235|FG003|Run-in Period|Study Ended by Sponsor|0|||
129776472|NCT02908672|467146232|FG000|Run-in Period|Withdrawal by Subject|3|||
129776473|NCT02908672|467146233|FG001|Run-in Period|Withdrawal by Subject|9|||
129776474|NCT02908672|467146234|FG002|Run-in Period|Withdrawal by Subject|0|||
129776475|NCT02908672|467146235|FG003|Run-in Period|Withdrawal by Subject|0|||
129776476|NCT02908672|467146232|FG000|Triple Combination Period|Death|0|||
129776477|NCT02908672|467146233|FG001|Triple Combination Period|Death|0|||
129776478|NCT02908672|467146234|FG002|Triple Combination Period|Death|150|||
129776479|NCT02908672|467146235|FG003|Triple Combination Period|Death|127|||
129776480|NCT02908672|467146232|FG000|Triple Combination Period|Lost to Follow-up|0|||
129776481|NCT02908672|467146233|FG001|Triple Combination Period|Lost to Follow-up|0|||
129776482|NCT02908672|467146234|FG002|Triple Combination Period|Lost to Follow-up|6|||
129776483|NCT02908672|467146235|FG003|Triple Combination Period|Lost to Follow-up|8|||
129776484|NCT02908672|467146232|FG000|Triple Combination Period|Reason Not Specified|0|||
129776485|NCT02908672|467146233|FG001|Triple Combination Period|Reason Not Specified|0|||
129776486|NCT02908672|467146234|FG002|Triple Combination Period|Reason Not Specified|0|||
129776487|NCT02908672|467146235|FG003|Triple Combination Period|Reason Not Specified|1|||
129776488|NCT02908672|467146232|FG000|Triple Combination Period|Physician Decision|0|||
129776489|NCT02908672|467146233|FG001|Triple Combination Period|Physician Decision|0|||
129776490|NCT02908672|467146234|FG002|Triple Combination Period|Physician Decision|1|||
129776491|NCT02908672|467146235|FG003|Triple Combination Period|Physician Decision|1|||
129776492|NCT02908672|467146232|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
129776493|NCT02908672|467146233|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
129776494|NCT02908672|467146234|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
129776495|NCT02908672|467146235|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
129776496|NCT02908672|467146232|FG000|Triple Combination Period|Withdrawal by Subject|0|||
129776497|NCT02908672|467146233|FG001|Triple Combination Period|Withdrawal by Subject|0|||
129776498|NCT02908672|467146234|FG002|Triple Combination Period|Withdrawal by Subject|13|||
129776499|NCT02908672|467146235|FG003|Triple Combination Period|Withdrawal by Subject|16|||
129776500|NCT01185080|467146236|FG000|Overall Study|Adverse Event|1|||
129776501|NCT01185080|467146237|FG001|Overall Study|Adverse Event|1|||
129776502|NCT01185080|467146238|FG002|Overall Study|Adverse Event|0|||
129776503|NCT01185080|467146236|FG000|Overall Study|Personal reasons|0|||
129776504|NCT01185080|467146237|FG001|Overall Study|Personal reasons|0|||
129776505|NCT01185080|467146238|FG002|Overall Study|Personal reasons|1|||
129776506|NCT01104311|467146239|FG000|Overall Study|Withdrawal by Subject|6|||
129776507|NCT01104311|467146240|FG001|Overall Study|Withdrawal by Subject|6|||
129776508|NCT01104311|467146239|FG000|Overall Study|Protocol Violation|0|||
129776509|NCT01104311|467146240|FG001|Overall Study|Protocol Violation|1|||
129776510|NCT01104311|467146239|FG000|Overall Study|Physician Decision|2|||
129776511|NCT01104311|467146240|FG001|Overall Study|Physician Decision|2|||
129776512|NCT01104311|467146239|FG000|Overall Study|low compliance|1|||
129776513|NCT01104311|467146240|FG001|Overall Study|low compliance|1|||
129776514|NCT01104311|467146239|FG000|Overall Study|Adverse Event|1|||
129776515|NCT01104311|467146240|FG001|Overall Study|Adverse Event|2|||
129776516|NCT01705509|467147680|FG000|Inclusion CPET|Screen Failure|5|||
129776517|NCT01705509|467147680|FG000|Inclusion CPET|Withdrawal by Subject|2|||
129776518|NCT01705509|467147680|FG000|CPET w/ Ranexa|Screen Failure|2|||
129776519|NCT01227018|467147681|FG000|Overall Study|Disease progression|9|||
129776520|NCT01227018|467147681|FG000|Overall Study|Toxicity|2|||
129776521|NCT01227018|467147681|FG000|Overall Study|Withdrew after beginning treatment|4|||
129776522|NCT01413204|467147684|FG000|Overall Study|Adverse Event|1|||
129776523|NCT01413204|467147685|FG001|Overall Study|Adverse Event|2|||
129776524|NCT01413204|467147686|FG002|Overall Study|Adverse Event|2|||
129776525|NCT01413204|467147684|FG000|Overall Study|Physician Decision|3|||
129776526|NCT01413204|467147685|FG001|Overall Study|Physician Decision|0|||
129776527|NCT01413204|467147686|FG002|Overall Study|Physician Decision|2|||
129776528|NCT01413204|467147684|FG000|Overall Study|Withdrawal by Subject|1|||
129776529|NCT01413204|467147685|FG001|Overall Study|Withdrawal by Subject|4|||
129776530|NCT01413204|467147686|FG002|Overall Study|Withdrawal by Subject|4|||
129776531|NCT01413204|467147684|FG000|Overall Study|Clearly not eligible for the study|0|||
129776532|NCT01413204|467147685|FG001|Overall Study|Clearly not eligible for the study|0|||
129776533|NCT01413204|467147686|FG002|Overall Study|Clearly not eligible for the study|1|||
129776534|NCT01413204|467147684|FG000|Overall Study|Fasting plasma glucose level increased|1|||
129776535|NCT01413204|467147685|FG001|Overall Study|Fasting plasma glucose level increased|0|||
129776536|NCT01413204|467147686|FG002|Overall Study|Fasting plasma glucose level increased|10|||
129776537|NCT01039376|467147687|FG000|Overall Study|Lost to Follow-up|5|||
129776538|NCT01039376|467147688|FG001|Overall Study|Lost to Follow-up|12|||
129776539|NCT01039376|467147687|FG000|Overall Study|Physician Decision|15|||
129776540|NCT01039376|467147688|FG001|Overall Study|Physician Decision|10|||
129776541|NCT01039376|467147687|FG000|Overall Study|Withdrawal by Subject|20|||
129776542|NCT01039376|467147688|FG001|Overall Study|Withdrawal by Subject|32|||
129776543|NCT01039376|467147687|FG000|Overall Study|Study terminated by Sponsor|90|||
129776544|NCT01039376|467147688|FG001|Overall Study|Study terminated by Sponsor|72|||
129776545|NCT00753649|467147689|FG000|Overall Study|Migrated/moved from study area|1|||
129776546|NCT00753649|467147690|FG001|Overall Study|Migrated/moved from study area|0|||
129776547|NCT00753649|467147689|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
129776548|NCT00753649|467147690|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
129776549|NCT00753649|467147689|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
129776550|NCT00753649|467147690|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
129776551|NCT00753649|467147689|FG000|Overall Study|Protocol Violation|2|||
129776552|NCT00753649|467147690|FG001|Overall Study|Protocol Violation|0|||
129776553|NCT03252925|467147691|FG000|Overall Study|Withdrawal by Subject|1|||
129776554|NCT03252925|467147692|FG001|Overall Study|Withdrawal by Subject|0|||
129776555|NCT03252925|467147691|FG000|Overall Study|Protocol Violation|6|||
129776556|NCT03252925|467147692|FG001|Overall Study|Protocol Violation|0|||
129776557|NCT03252925|467147691|FG000|Overall Study|Adverse Event|1|||
129776558|NCT03252925|467147692|FG001|Overall Study|Adverse Event|0|||
129776559|NCT03252925|467147691|FG000|Overall Study|Lost to Follow-up|6|||
129776560|NCT03252925|467147692|FG001|Overall Study|Lost to Follow-up|6|||
129776561|NCT00123422|467147693|FG000|Overall Study|Physician Decision|2|||
129776562|NCT00123422|467147694|FG001|Overall Study|Physician Decision|2|||
129776563|NCT00123422|467147695|FG002|Overall Study|Physician Decision|6|||
129776564|NCT00123422|467147693|FG000|Overall Study|Withdrawal by Subject|1|||
129776565|NCT00123422|467147694|FG001|Overall Study|Withdrawal by Subject|2|||
129776566|NCT00123422|467147695|FG002|Overall Study|Withdrawal by Subject|2|||
129776567|NCT00123422|467147693|FG000|Overall Study|Lost to Follow-up|1|||
129776568|NCT00123422|467147694|FG001|Overall Study|Lost to Follow-up|2|||
129776569|NCT00123422|467147695|FG002|Overall Study|Lost to Follow-up|2|||
129776570|NCT04555616|467147696|FG000|Overall Study|Death|1|||
129776571|NCT04555616|467147697|FG001|Overall Study|Death|0|||
129776572|NCT04555616|467147698|FG002|Overall Study|Death|1|||
129776573|NCT04555616|467147696|FG000|Overall Study|Withdrawal by Subject|2|||
129776574|NCT04555616|467147697|FG001|Overall Study|Withdrawal by Subject|1|||
129776575|NCT04555616|467147698|FG002|Overall Study|Withdrawal by Subject|0|||
129776576|NCT01255436|467147703|FG000|Overall Study|Lost to Follow-up|178|||
129776577|NCT01255436|467147704|FG001|Overall Study|Lost to Follow-up|191|||
129776578|NCT01255436|467147703|FG000|Overall Study|Death, stroke, or MI|4|||
129776579|NCT01255436|467147704|FG001|Overall Study|Death, stroke, or MI|3|||
129776580|NCT04816669|467147705|FG000|Part 1|Adverse Event|1|||
129776581|NCT04816669|467147706|FG001|Part 1|Adverse Event|1|||
129776582|NCT04816669|467147707|FG002|Part 1|Adverse Event|0|||
129776583|NCT04816669|467147708|FG003|Part 1|Adverse Event|0|||
129776584|NCT04816669|467147705|FG000|Part 1|Lost to Follow-up|2|||
129776585|NCT04816669|467147706|FG001|Part 1|Lost to Follow-up|2|||
129776586|NCT04816669|467147707|FG002|Part 1|Lost to Follow-up|0|||
129776587|NCT04816669|467147708|FG003|Part 1|Lost to Follow-up|0|||
129776588|NCT04816669|467147705|FG000|Part 1|Protocol Violation|0|||
129776589|NCT04816669|467147706|FG001|Part 1|Protocol Violation|1|||
129776590|NCT04816669|467147707|FG002|Part 1|Protocol Violation|0|||
129776591|NCT04816669|467147708|FG003|Part 1|Protocol Violation|0|||
129776592|NCT04816669|467147705|FG000|Part 1|Withdrawal by Subject|1|||
129776593|NCT04816669|467147706|FG001|Part 1|Withdrawal by Subject|2|||
129776594|NCT04816669|467147707|FG002|Part 1|Withdrawal by Subject|0|||
129776595|NCT04816669|467147708|FG003|Part 1|Withdrawal by Subject|0|||
129776596|NCT04816669|467147705|FG000|Part 2|Other|0|||
129776597|NCT04816669|467147706|FG001|Part 2|Other|0|||
129776598|NCT04816669|467147707|FG002|Part 2|Other|1|||
129776599|NCT04816669|467147708|FG003|Part 2|Other|0|||
129776600|NCT04816669|467147705|FG000|Part 2|Withdrawal by Subject|0|||
129776601|NCT04816669|467147706|FG001|Part 2|Withdrawal by Subject|0|||
129776602|NCT04816669|467147707|FG002|Part 2|Withdrawal by Subject|0|||
129776603|NCT04816669|467147708|FG003|Part 2|Withdrawal by Subject|1|||
129776604|NCT04816669|467147705|FG000|Part 2|Lost to Follow-up|0|||
129776605|NCT04816669|467147706|FG001|Part 2|Lost to Follow-up|0|||
129776606|NCT04816669|467147707|FG002|Part 2|Lost to Follow-up|1|||
129776607|NCT04816669|467147708|FG003|Part 2|Lost to Follow-up|0|||
129776608|NCT01229267|467147709|FG000|Overall Study|Adverse Event|4|||
129776609|NCT01229267|467147710|FG001|Overall Study|Adverse Event|6|||
129776610|NCT01229267|467147711|FG002|Overall Study|Adverse Event|3|||
129776611|NCT01229267|467147712|FG003|Overall Study|Adverse Event|2|||
129776612|NCT01229267|467147713|FG004|Overall Study|Adverse Event|10|||
129776613|NCT01229267|467147709|FG000|Overall Study|Death|40|||
129776614|NCT01229267|467147710|FG001|Overall Study|Death|37|||
129776615|NCT01229267|467147711|FG002|Overall Study|Death|35|||
129776616|NCT01229267|467147712|FG003|Overall Study|Death|13|||
129776617|NCT01229267|467147713|FG004|Overall Study|Death|103|||
129776618|NCT01229267|467147709|FG000|Overall Study|Withdrawal by Subject|23|||
129776619|NCT01229267|467147710|FG001|Overall Study|Withdrawal by Subject|22|||
129776620|NCT01229267|467147711|FG002|Overall Study|Withdrawal by Subject|32|||
129776621|NCT01229267|467147712|FG003|Overall Study|Withdrawal by Subject|14|||
129776622|NCT01229267|467147713|FG004|Overall Study|Withdrawal by Subject|59|||
129776623|NCT01229267|467147709|FG000|Overall Study|Protocol Violation|0|||
129776624|NCT01229267|467147710|FG001|Overall Study|Protocol Violation|1|||
129776625|NCT01229267|467147711|FG002|Overall Study|Protocol Violation|0|||
129776626|NCT01229267|467147712|FG003|Overall Study|Protocol Violation|0|||
129776627|NCT01229267|467147713|FG004|Overall Study|Protocol Violation|0|||
129776628|NCT01229267|467147709|FG000|Overall Study|Progressive disease|0|||
129776629|NCT01229267|467147710|FG001|Overall Study|Progressive disease|0|||
129776630|NCT01229267|467147711|FG002|Overall Study|Progressive disease|0|||
129776631|NCT01229267|467147712|FG003|Overall Study|Progressive disease|0|||
129776632|NCT01229267|467147713|FG004|Overall Study|Progressive disease|1|||
129776633|NCT01229267|467147709|FG000|Overall Study|Physician Decision|8|||
129776634|NCT01229267|467147710|FG001|Overall Study|Physician Decision|11|||
129776635|NCT01229267|467147711|FG002|Overall Study|Physician Decision|8|||
129776636|NCT01229267|467147712|FG003|Overall Study|Physician Decision|3|||
129776637|NCT01229267|467147713|FG004|Overall Study|Physician Decision|25|||
129776638|NCT01229267|467147709|FG000|Overall Study|Lost to Follow-up|6|||
129776639|NCT01229267|467147710|FG001|Overall Study|Lost to Follow-up|5|||
129776640|NCT01229267|467147711|FG002|Overall Study|Lost to Follow-up|8|||
129776641|NCT01229267|467147712|FG003|Overall Study|Lost to Follow-up|3|||
129776642|NCT01229267|467147713|FG004|Overall Study|Lost to Follow-up|22|||
129776643|NCT01864603|467147725|FG000|Stage 2|DSMB design modification|86056|||
129776644|NCT01864603|467147726|FG001|Stage 2|DSMB design modification|92558|||
129776645|NCT02446899|467147727|FG000|Overall Study|Adverse Event|4|||
129776646|NCT02446899|467147728|FG001|Overall Study|Adverse Event|7|||
129776647|NCT02446899|467147727|FG000|Overall Study|Condition Under Investigation Worsened|1|||
129776648|NCT02446899|467147728|FG001|Overall Study|Condition Under Investigation Worsened|4|||
129776649|NCT02446899|467147727|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
129776650|NCT02446899|467147728|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
129776651|NCT02446899|467147727|FG000|Overall Study|Lack of Efficacy|2|||
129776652|NCT02446899|467147728|FG001|Overall Study|Lack of Efficacy|8|||
129776653|NCT02446899|467147727|FG000|Overall Study|Lost to Follow-up|1|||
129776654|NCT02446899|467147728|FG001|Overall Study|Lost to Follow-up|3|||
129776655|NCT02446899|467147727|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
129776656|NCT02446899|467147728|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
129776657|NCT02446899|467147727|FG000|Overall Study|Withdrawal by Subject|11|||
129776658|NCT02446899|467147728|FG001|Overall Study|Withdrawal by Subject|19|||
129776659|NCT02446899|467147727|FG000|Overall Study|Miscellaneous|5|||
129776660|NCT02446899|467147728|FG001|Overall Study|Miscellaneous|4|||
129776661|NCT02446899|467147727|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129776662|NCT02446899|467147728|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
129776663|NCT04050202|467147729|FG000|Overall Study|Lost to Follow-up|2|||
129776664|NCT01499277|467147734|FG000|Overall Study|Adverse Event|3|||
129776665|NCT01499277|467147735|FG001|Overall Study|Adverse Event|6|||
129776666|NCT01499277|467147734|FG000|Overall Study|Death|3|||
129776667|NCT01499277|467147735|FG001|Overall Study|Death|2|||
129776668|NCT01499277|467147734|FG000|Overall Study|Lost to Follow-up|15|||
129776669|NCT01499277|467147735|FG001|Overall Study|Lost to Follow-up|8|||
129776670|NCT01499277|467147734|FG000|Overall Study|Protocol Violation|2|||
129776671|NCT01499277|467147735|FG001|Overall Study|Protocol Violation|3|||
129776672|NCT01499277|467147734|FG000|Overall Study|Withdrawal by Subject|16|||
129776673|NCT01499277|467147735|FG001|Overall Study|Withdrawal by Subject|6|||
129776674|NCT01499277|467147734|FG000|Overall Study|Lack of therapeutic response and other|8|||
129776675|NCT01499277|467147735|FG001|Overall Study|Lack of therapeutic response and other|7|||
129776676|NCT02974543|467147736|FG000|Overall Study|Withdrawal by Subject|1|||
129776677|NCT02974543|467147737|FG001|Overall Study|Withdrawal by Subject|0|||
129776678|NCT00742235|467147738|FG000|Overall Study|Lost to Follow-up|0|||
129776679|NCT00742235|467147739|FG001|Overall Study|Lost to Follow-up|31|||
129776680|NCT01237899|467147740|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
129776681|NCT01237899|467147741|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
129776682|NCT01237899|467147742|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
129776683|NCT01237899|467147743|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
129555760|NCT02544633|466330637|FG002|Survival Follow-up Period|Death|3|||
129555761|NCT02544633|466330638|FG003|Survival Follow-up Period|Death|9|||
129555762|NCT02544633|466330635|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
129555763|NCT02544633|466330636|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
129555764|NCT02544633|466330637|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
129776684|NCT01237899|467147744|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
129776685|NCT01237899|467147745|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
129776686|NCT01237899|467147746|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
129776687|NCT01237899|467147747|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
129776688|NCT01237899|467147748|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
129776689|NCT01237899|467147749|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
129776690|NCT01237899|467147750|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
129776691|NCT02141438|467147752|FG000|Overall Study|Death|1308|||
129776692|NCT02141438|467147752|FG000|Overall Study|Lost to Follow-up|84|||
129776693|NCT02141438|467147752|FG000|Overall Study|Withdrawal by Subject|52|||
129776694|NCT02141438|467147752|FG000|Overall Study|Physician Decision|1|||
129776695|NCT02141438|467147752|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
129776696|NCT04329806|467147753|FG000|Overall Study|Physician Decision|3|||
129776697|NCT04329806|467147754|FG001|Overall Study|Physician Decision|4|||
129776698|NCT02636595|467147757|FG000|Overall Study|Lost to Follow-up|1|||
129776699|NCT02636595|467147757|FG000|Overall Study|Other|1|||
129776700|NCT04730271|467147758|FG000|Overall Study|Adverse Event|0|||
129776701|NCT04730271|467147759|FG001|Overall Study|Adverse Event|2|||
129776702|NCT04730271|467147758|FG000|Overall Study|Withdrawal by Subject|1|||
129776703|NCT04730271|467147759|FG001|Overall Study|Withdrawal by Subject|1|||
129776704|NCT04730271|467147758|FG000|Overall Study|Protocol Violation|7|||
129776705|NCT04730271|467147759|FG001|Overall Study|Protocol Violation|13|||
129776706|NCT04730271|467147758|FG000|Overall Study|Lost to Follow-up|3|||
129776707|NCT04730271|467147759|FG001|Overall Study|Lost to Follow-up|3|||
129776708|NCT04730271|467147758|FG000|Overall Study|Death|1|||
129776709|NCT04730271|467147759|FG001|Overall Study|Death|0|||
129776710|NCT05782179|467147762|FG000|Overall Study|Adverse Event|0|||
129776711|NCT05782179|467147763|FG001|Overall Study|Adverse Event|0|||
129776712|NCT05782179|467147764|FG002|Overall Study|Adverse Event|2|||
129776713|NCT05782179|467147765|FG003|Overall Study|Adverse Event|0|||
129776714|NCT05782179|467147766|FG004|Overall Study|Adverse Event|0|||
129776715|NCT05782179|467147767|FG005|Overall Study|Adverse Event|0|||
129776716|NCT03682770|467147768|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129776717|NCT03682770|467147769|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
129776718|NCT03682770|467147770|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129776719|NCT03682770|467147771|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129555765|NCT02544633|466330638|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
129776720|NCT03682770|467147772|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129776721|NCT03682770|467147773|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129776722|NCT03682770|467147774|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
129776723|NCT03682770|467147768|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
129776724|NCT03682770|467147769|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
129776725|NCT03682770|467147770|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129776726|NCT03682770|467147771|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129776727|NCT03682770|467147772|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129776728|NCT03682770|467147773|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129776729|NCT03682770|467147774|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
129776730|NCT03682770|467147768|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129776731|NCT03682770|467147769|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129776732|NCT03682770|467147770|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
129776733|NCT03682770|467147771|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
129776734|NCT03682770|467147772|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129776735|NCT03682770|467147773|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129776736|NCT03682770|467147774|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
129776737|NCT03682770|467147768|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129776738|NCT03682770|467147769|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129776739|NCT03682770|467147770|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129776740|NCT03682770|467147771|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
129776741|NCT03682770|467147772|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129776742|NCT03682770|467147773|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129776743|NCT03682770|467147774|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
129776744|NCT03682770|467147768|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129776745|NCT03682770|467147769|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129776746|NCT03682770|467147770|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
129776747|NCT03682770|467147771|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
129776748|NCT03682770|467147772|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129776749|NCT03682770|467147773|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129776750|NCT03682770|467147774|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
129776751|NCT03682770|467147768|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129776752|NCT03682770|467147769|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129776753|NCT03682770|467147770|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
129776754|NCT03682770|467147771|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129776755|NCT03682770|467147772|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129776756|NCT03682770|467147773|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129776757|NCT03682770|467147774|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
129555766|NCT02544633|466330635|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
129555767|NCT02544633|466330636|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
129776758|NCT03682770|467147768|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129776759|NCT03682770|467147769|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129776760|NCT03682770|467147770|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
129776761|NCT03682770|467147771|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129776762|NCT03682770|467147772|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129776763|NCT03682770|467147773|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129776764|NCT03682770|467147774|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
129776765|NCT03682770|467147768|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129776766|NCT03682770|467147769|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129776767|NCT03682770|467147770|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129776768|NCT03682770|467147771|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
129555768|NCT02544633|466330637|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
129776769|NCT03682770|467147772|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129776770|NCT03682770|467147773|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129555769|NCT02544633|466330638|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
129555770|NCT02544633|466330635|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
129555771|NCT02544633|466330636|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
129555772|NCT02544633|466330637|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
129555773|NCT02544633|466330638|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
129555774|NCT01977352|466330639|FG000|Overall Study|Lost to Follow-up|1|||
129555775|NCT01977352|466330640|FG001|Overall Study|Lost to Follow-up|2|||
129776771|NCT03682770|467147774|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
129776772|NCT03682770|467147768|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
129776773|NCT03682770|467147769|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
129776774|NCT03682770|467147770|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
129776775|NCT03682770|467147771|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
129776776|NCT03682770|467147772|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
129776777|NCT03682770|467147773|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
129776778|NCT03682770|467147774|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
129776779|NCT03682770|467147768|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129776780|NCT03682770|467147769|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129776781|NCT03682770|467147770|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129776782|NCT03682770|467147771|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129776783|NCT03682770|467147772|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
129776784|NCT03682770|467147773|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129776785|NCT03682770|467147774|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
129776786|NCT03682770|467147768|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129776787|NCT03682770|467147769|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129776788|NCT03682770|467147770|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129776789|NCT03682770|467147771|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129776790|NCT03682770|467147772|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129776791|NCT03682770|467147773|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
129776792|NCT03682770|467147774|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
129776793|NCT03682770|467147768|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129776794|NCT03682770|467147769|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129555776|NCT02270983|466330641|FG000|Overall Study|Adverse Event|3|||
129555777|NCT02270983|466330642|FG001|Overall Study|Adverse Event|2|||
129555778|NCT02270983|466330643|FG002|Overall Study|Adverse Event|6|||
129555779|NCT02270983|466330641|FG000|Overall Study|Lack of Efficacy|2|||
129555780|NCT02270983|466330642|FG001|Overall Study|Lack of Efficacy|1|||
129555781|NCT02270983|466330643|FG002|Overall Study|Lack of Efficacy|1|||
129555782|NCT02270983|466330641|FG000|Overall Study|Withdrawal by Subject|1|||
129776795|NCT03682770|467147770|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129776796|NCT03682770|467147771|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129776797|NCT03682770|467147772|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
129776798|NCT03682770|467147773|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
129776799|NCT03682770|467147774|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
129776800|NCT02362282|467147775|FG000|Overall Study|Withdrawal by Subject|1|||
129776801|NCT02362282|467147776|FG001|Overall Study|Withdrawal by Subject|0|||
129776802|NCT01470326|467147777|FG000|Overall Study|Protocol Violation|32|||
129776803|NCT01470326|467147777|FG000|Overall Study|No Drug Administration Information|2|||
129776804|NCT01470326|467147777|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
129776805|NCT01166282|467147778|FG000|Open-label Period|Adverse Event|0|||
129776806|NCT01166282|467147779|FG001|Open-label Period|Adverse Event|0|||
129776807|NCT01166282|467147780|FG002|Open-label Period|Adverse Event|6|||
129776808|NCT01166282|467147778|FG000|Open-label Period|Withdrawal by Subject|0|||
129776809|NCT01166282|467147779|FG001|Open-label Period|Withdrawal by Subject|0|||
129776810|NCT01166282|467147780|FG002|Open-label Period|Withdrawal by Subject|4|||
129776811|NCT01166282|467147778|FG000|Open-label Period|Lack of Efficacy|0|||
129776812|NCT01166282|467147779|FG001|Open-label Period|Lack of Efficacy|0|||
129776813|NCT01166282|467147780|FG002|Open-label Period|Lack of Efficacy|2|||
129776814|NCT01166282|467147778|FG000|Open-label Period|Remission|0|||
129776815|NCT01166282|467147779|FG001|Open-label Period|Remission|0|||
129776816|NCT01166282|467147780|FG002|Open-label Period|Remission|4|||
129776817|NCT01166282|467147778|FG000|Open-label Period|Irregular Compliance|0|||
129776818|NCT01166282|467147779|FG001|Open-label Period|Irregular Compliance|0|||
129776819|NCT01166282|467147780|FG002|Open-label Period|Irregular Compliance|1|||
129776820|NCT00392769|467147787|FG000|Overall Study|Clinical Deterioration|9|||
129776821|NCT00392769|467147787|FG000|Overall Study|Adverse Event|1|||
129776822|NCT02304367|467147788|FG000|Overall Study|Lack of Response to Bruosumab|1|||
129776823|NCT02304367|467147788|FG000|Overall Study|Sponsor Decision|3|||
129776824|NCT02304367|467147788|FG000|Overall Study|Death|2|||
129776825|NCT02304367|467147788|FG000|Overall Study|Physician Decision|1|||
129776826|NCT02304367|467147788|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
129776827|NCT00318643|467147789|FG000|Overall Study|Adverse Event|0|||
129776828|NCT00318643|467147790|FG001|Overall Study|Adverse Event|0|||
129776829|NCT00318643|467147791|FG002|Overall Study|Adverse Event|0|||
129776830|NCT00318643|467147792|FG003|Overall Study|Adverse Event|0|||
129776831|NCT00318643|467147793|FG004|Overall Study|Adverse Event|1|||
129776832|NCT00318643|467147789|FG000|Overall Study|Participant's Decision|0|||
129776833|NCT00318643|467147790|FG001|Overall Study|Participant's Decision|0|||
129776834|NCT00318643|467147791|FG002|Overall Study|Participant's Decision|0|||
129776835|NCT00318643|467147792|FG003|Overall Study|Participant's Decision|0|||
129776836|NCT00318643|467147793|FG004|Overall Study|Participant's Decision|1|||
129776837|NCT00318643|467147789|FG000|Overall Study|Investigator's Decision|0|||
129776838|NCT00318643|467147790|FG001|Overall Study|Investigator's Decision|0|||
129776839|NCT00318643|467147791|FG002|Overall Study|Investigator's Decision|0|||
129776840|NCT00318643|467147792|FG003|Overall Study|Investigator's Decision|0|||
129776841|NCT00318643|467147793|FG004|Overall Study|Investigator's Decision|1|||
129776842|NCT04411667|467147796|FG000|Overall Study|Physician Decision|1|||
129776843|NCT04411667|467147797|FG001|Overall Study|Physician Decision|0|||
129776844|NCT00067002|467147798|FG000|Overall Study|Early Death|1|||
129776845|NCT00067002|467147799|FG001|Overall Study|Early Death|2|||
129776846|NCT00067002|467147798|FG000|Overall Study|Delayed|1|||
129776847|NCT00067002|467147799|FG001|Overall Study|Delayed|1|||
129776848|NCT00067002|467147798|FG000|Overall Study|Graft Failure|5|||
129776849|NCT00067002|467147799|FG001|Overall Study|Graft Failure|6|||
129776850|NCT01354314|467147804|FG000|Overall Study|Lost to Follow-up|1|||
129776851|NCT01354314|467147805|FG001|Overall Study|Lost to Follow-up|0|||
129776852|NCT01354314|467147806|FG002|Overall Study|Lost to Follow-up|1|||
129776853|NCT01354314|467147807|FG003|Overall Study|Lost to Follow-up|1|||
129776854|NCT01354314|467147804|FG000|Overall Study|Withdrawal by Subject|0|||
129776855|NCT01354314|467147805|FG001|Overall Study|Withdrawal by Subject|0|||
129776856|NCT01354314|467147806|FG002|Overall Study|Withdrawal by Subject|1|||
129776857|NCT01354314|467147807|FG003|Overall Study|Withdrawal by Subject|0|||
129776858|NCT01354314|467147804|FG000|Overall Study|Adverse Event|0|||
129776859|NCT01354314|467147805|FG001|Overall Study|Adverse Event|0|||
129776860|NCT01354314|467147806|FG002|Overall Study|Adverse Event|0|||
129776861|NCT01354314|467147807|FG003|Overall Study|Adverse Event|1|||
129776862|NCT01354314|467147804|FG000|Overall Study|Protocol Violation|1|||
129776863|NCT01354314|467147805|FG001|Overall Study|Protocol Violation|1|||
129776864|NCT01354314|467147806|FG002|Overall Study|Protocol Violation|0|||
129776865|NCT01354314|467147807|FG003|Overall Study|Protocol Violation|0|||
129776866|NCT01354314|467147804|FG000|Overall Study|Less than 90% Adherence|4|||
129776867|NCT01354314|467147805|FG001|Overall Study|Less than 90% Adherence|2|||
129776868|NCT01354314|467147806|FG002|Overall Study|Less than 90% Adherence|6|||
129776869|NCT01354314|467147807|FG003|Overall Study|Less than 90% Adherence|4|||
129776870|NCT00714870|467147809|FG000|Overall Study|Lost to Follow-up|22|||
129776871|NCT00714870|467147810|FG001|Overall Study|Lost to Follow-up|5|||
129776872|NCT00714870|467147809|FG000|Overall Study|patient unable to come b/c back pain|1|||
129776873|NCT00714870|467147810|FG001|Overall Study|patient unable to come b/c back pain|0|||
129776874|NCT00714870|467147809|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
129776875|NCT00714870|467147810|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
129776876|NCT03399552|467147811|FG000|Overall Study|No evidence of disease|1|||
129776877|NCT03399552|467147811|FG000|Overall Study|Unevaluable|1|||
129776878|NCT02357368|467147812|FG000|Overall Study|Lost to Follow-up|0|||
129776879|NCT02357368|467147813|FG001|Overall Study|Lost to Follow-up|0|||
129776880|NCT02357368|467147814|FG002|Overall Study|Lost to Follow-up|0|||
129776881|NCT02357368|467147815|FG003|Overall Study|Lost to Follow-up|1|||
129555783|NCT02270983|466330642|FG001|Overall Study|Withdrawal by Subject|0|||
129555784|NCT02270983|466330643|FG002|Overall Study|Withdrawal by Subject|2|||
129555785|NCT02270983|466330641|FG000|Overall Study|Lost to Follow-up|1|||
129555786|NCT02270983|466330642|FG001|Overall Study|Lost to Follow-up|1|||
129555787|NCT02270983|466330643|FG002|Overall Study|Lost to Follow-up|2|||
129776882|NCT02357368|467147812|FG000|Overall Study|Pregnancy|3|||
129776883|NCT02357368|467147813|FG001|Overall Study|Pregnancy|2|||
129776884|NCT02357368|467147814|FG002|Overall Study|Pregnancy|0|||
129555788|NCT02270983|466330641|FG000|Overall Study|Protocol Violation|1|||
129776885|NCT02357368|467147815|FG003|Overall Study|Pregnancy|0|||
129776886|NCT02357368|467147812|FG000|Overall Study|Withdrawal by Subject|3|||
129555789|NCT02270983|466330642|FG001|Overall Study|Protocol Violation|1|||
129555790|NCT02270983|466330643|FG002|Overall Study|Protocol Violation|1|||
129555791|NCT02270983|466330641|FG000|Overall Study|family emergency|0|||
129555792|NCT02270983|466330642|FG001|Overall Study|family emergency|1|||
129555793|NCT02270983|466330643|FG002|Overall Study|family emergency|0|||
129555794|NCT02270983|466330641|FG000|Overall Study|study procedure non-compliance|1|||
129555795|NCT02270983|466330642|FG001|Overall Study|study procedure non-compliance|0|||
129555796|NCT02270983|466330643|FG002|Overall Study|study procedure non-compliance|0|||
129555797|NCT02270983|466330641|FG000|Overall Study|moved away from study site|0|||
129555798|NCT02270983|466330642|FG001|Overall Study|moved away from study site|1|||
129884504|NCT02293837|467536432|FG000|Overall Study|Withdrawal by Subject|2|||
129555799|NCT02270983|466330643|FG002|Overall Study|moved away from study site|0|||
129555800|NCT00854620|466330646|FG000|Overall Study|Adverse Event|1|||
129776887|NCT02357368|467147813|FG001|Overall Study|Withdrawal by Subject|1|||
129776888|NCT02357368|467147814|FG002|Overall Study|Withdrawal by Subject|1|||
129776889|NCT02357368|467147815|FG003|Overall Study|Withdrawal by Subject|2|||
129776890|NCT02377817|467147816|FG000|Overall Study|Transportation/childcare barriers.|2|||
129776891|NCT02377817|467147817|FG001|Overall Study|Transportation/childcare barriers.|0|||
129776892|NCT02377817|467147816|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
129776893|NCT02377817|467147817|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
129776894|NCT03895840|467147818|FG000|Overall Study|Withdrawal by Subject|21|||
129776895|NCT01931566|467147819|FG000|Overall Study|Randomized But Not Treated|6|||
129776896|NCT01931566|467147820|FG001|Overall Study|Randomized But Not Treated|9|||
129776897|NCT01931566|467147821|FG002|Overall Study|Randomized But Not Treated|14|||
129776898|NCT01931566|467147819|FG000|Overall Study|Adverse Event|37|||
129776899|NCT01931566|467147820|FG001|Overall Study|Adverse Event|167|||
129555801|NCT00928252|466330647|FG000|Overall Study|Physician Decision|3|||
129776900|NCT01931566|467147821|FG002|Overall Study|Adverse Event|132|||
129776901|NCT01931566|467147819|FG000|Overall Study|Major Protocol Deviation|5|||
129776902|NCT01931566|467147820|FG001|Overall Study|Major Protocol Deviation|14|||
129776903|NCT01931566|467147821|FG002|Overall Study|Major Protocol Deviation|21|||
129776904|NCT01931566|467147819|FG000|Overall Study|Lost to Follow-up|3|||
129776905|NCT01931566|467147820|FG001|Overall Study|Lost to Follow-up|26|||
129776906|NCT01931566|467147821|FG002|Overall Study|Lost to Follow-up|23|||
129776907|NCT01931566|467147819|FG000|Overall Study|Voluntary Withdrawal|78|||
129776908|NCT01931566|467147820|FG001|Overall Study|Voluntary Withdrawal|245|||
129776909|NCT01931566|467147821|FG002|Overall Study|Voluntary Withdrawal|225|||
129776910|NCT01931566|467147819|FG000|Overall Study|Study Termination|289|||
129776911|NCT01931566|467147820|FG001|Overall Study|Study Termination|968|||
129776912|NCT01931566|467147821|FG002|Overall Study|Study Termination|1037|||
129776913|NCT01931566|467147819|FG000|Overall Study|Reason Not Specified|11|||
129776914|NCT01931566|467147820|FG001|Overall Study|Reason Not Specified|47|||
129776915|NCT01931566|467147821|FG002|Overall Study|Reason Not Specified|53|||
129776916|NCT01931566|467147819|FG000|Overall Study|Missing|0|||
129776917|NCT01931566|467147820|FG001|Overall Study|Missing|0|||
129776918|NCT01931566|467147821|FG002|Overall Study|Missing|1|||
129776919|NCT00760617|467147825|FG000|Overall Study|Adverse Event|5|||
129776920|NCT00760617|467147826|FG001|Overall Study|Adverse Event|2|||
129776921|NCT00760617|467147827|FG002|Overall Study|Adverse Event|0|||
129776922|NCT00760617|467147825|FG000|Overall Study|Lost to Follow-up|0|||
129776923|NCT00760617|467147826|FG001|Overall Study|Lost to Follow-up|0|||
129776924|NCT00760617|467147827|FG002|Overall Study|Lost to Follow-up|5|||
129776925|NCT04625101|467147828|FG000|Overall Study|Withdrawal by Subject|0|||
129776926|NCT04625101|467147829|FG001|Overall Study|Withdrawal by Subject|1|||
129776927|NCT04625101|467147828|FG000|Overall Study|Protocol Deviation|1|||
129776928|NCT04625101|467147829|FG001|Overall Study|Protocol Deviation|0|||
129776929|NCT02817464|467147830|FG000|Overall Study|Lost to Follow-up|1|||
129776930|NCT02817464|467147831|FG001|Overall Study|Lost to Follow-up|0|||
129776931|NCT02817464|467147830|FG000|Overall Study|Discontinued early due to personal decision|1|||
129776932|NCT02817464|467147831|FG001|Overall Study|Discontinued early due to personal decision|1|||
129776933|NCT03207763|467149343|FG000|Overall Study|Lost to Follow-up|1|||
129776934|NCT03207763|467149344|FG001|Overall Study|Lost to Follow-up|0|||
129776935|NCT02605122|467149345|FG000|Overall Study|Withdrawal by Subject|4|||
129776936|NCT02605122|467149346|FG001|Overall Study|Withdrawal by Subject|1|||
129776937|NCT02605122|467149345|FG000|Overall Study|Lost to Follow-up|1|||
129776938|NCT02605122|467149346|FG001|Overall Study|Lost to Follow-up|1|||
129776939|NCT00684060|467149347|FG000|Overall Study|Lost to Follow-up|1|||
129776940|NCT00684060|467149348|FG001|Overall Study|Lost to Follow-up|0|||
129776941|NCT00684060|467149347|FG000|Overall Study|New stenosis identified|1|||
129776942|NCT00684060|467149348|FG001|Overall Study|New stenosis identified|0|||
129776943|NCT00684060|467149347|FG000|Overall Study|Unable to collect MRI|1|||
129776944|NCT00684060|467149348|FG001|Overall Study|Unable to collect MRI|2|||
129776945|NCT00684060|467149347|FG000|Overall Study|Death|0|||
129776946|NCT00684060|467149348|FG001|Overall Study|Death|1|||
129776947|NCT00702715|467149353|FG000|Overall Study|Lost to Follow-up|1|||
129776948|NCT00702715|467149354|FG001|Overall Study|Lost to Follow-up|0|||
129776949|NCT03751657|467149355|FG000|Overall Study|Physician Decision|0|||
129776950|NCT03751657|467149356|FG001|Overall Study|Physician Decision|1|||
129776951|NCT03751657|467149355|FG000|Overall Study|Withdrawal by Subject|1|||
129776952|NCT03751657|467149356|FG001|Overall Study|Withdrawal by Subject|1|||
129776953|NCT03751657|467149355|FG000|Overall Study|Lost to Follow-up|2|||
129776954|NCT03751657|467149356|FG001|Overall Study|Lost to Follow-up|1|||
129776955|NCT00807001|467149364|FG000|Overall Study|Non-compliance|0|||
129776956|NCT00807001|467149365|FG001|Overall Study|Non-compliance|1|||
129555802|NCT01605461|466330649|FG000|Overall Study|Lost to Follow-up|3|||
129776957|NCT00807001|467149366|FG002|Overall Study|Non-compliance|0|||
129776958|NCT00807001|467149367|FG003|Overall Study|Non-compliance|0|||
129776959|NCT00807001|467149368|FG004|Overall Study|Non-compliance|0|||
129776960|NCT00854113|467149370|FG000|Overall Study|Adverse Event|0|||
129776961|NCT00854113|467149371|FG001|Overall Study|Adverse Event|0|||
129776962|NCT00854113|467149372|FG002|Overall Study|Adverse Event|0|||
129776963|NCT00854113|467149373|FG003|Overall Study|Adverse Event|0|||
129776964|NCT00854113|467149374|FG004|Overall Study|Adverse Event|0|||
129776965|NCT00854113|467149375|FG005|Overall Study|Adverse Event|0|||
129776966|NCT00854113|467149376|FG006|Overall Study|Adverse Event|0|||
129776967|NCT00854113|467149377|FG007|Overall Study|Adverse Event|2|||
129776968|NCT00854113|467149378|FG008|Overall Study|Adverse Event|0|||
129776969|NCT00854113|467149379|FG009|Overall Study|Adverse Event|0|||
129776970|NCT00854113|467149380|FG010|Overall Study|Adverse Event|0|||
129776971|NCT00854113|467149370|FG000|Overall Study|Withdrawal by Subject|0|||
129776972|NCT00854113|467149371|FG001|Overall Study|Withdrawal by Subject|0|||
129776973|NCT00854113|467149372|FG002|Overall Study|Withdrawal by Subject|0|||
129776974|NCT00854113|467149373|FG003|Overall Study|Withdrawal by Subject|0|||
129776975|NCT00854113|467149374|FG004|Overall Study|Withdrawal by Subject|0|||
129776976|NCT00854113|467149375|FG005|Overall Study|Withdrawal by Subject|0|||
129776977|NCT00854113|467149376|FG006|Overall Study|Withdrawal by Subject|0|||
129776978|NCT00854113|467149377|FG007|Overall Study|Withdrawal by Subject|1|||
129776979|NCT00854113|467149378|FG008|Overall Study|Withdrawal by Subject|1|||
129776980|NCT00854113|467149379|FG009|Overall Study|Withdrawal by Subject|0|||
129776981|NCT00854113|467149380|FG010|Overall Study|Withdrawal by Subject|0|||
129776982|NCT02273596|467149384|FG000|24-Week Treatment Period|Adverse Event|3|||
129776983|NCT02273596|467149384|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
129555803|NCT01605461|466330649|FG000|Overall Study|Withdrawal by Subject|1|||
129776984|NCT02273596|467149384|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
129776985|NCT02273596|467149384|FG000|24-Week Treatment Period|Physician Decision|1|||
129776986|NCT02273596|467149384|FG000|24-Week Treatment Period|Protocol Deviation|1|||
129776987|NCT02273596|467149384|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
129776988|NCT02273596|467149384|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
129776989|NCT02273596|467149384|FG000|Extension Period|Lost to Follow-up|1|||
129555804|NCT02024698|466330650|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
129555805|NCT02024698|466330651|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
129687208|NCT03770455|466810855|FG000|Overall Study|Screen failures|3|||
129687209|NCT02582632|466812099|FG000|Overall Study|Other|1|||
129687210|NCT03298061|466812100|FG000|Overall Study|Adverse Event|3|||
129687211|NCT03298061|466812100|FG000|Overall Study|Lack of Efficacy|6|||
129687212|NCT03298061|466812100|FG000|Overall Study|Protocol Violation|1|||
129687213|NCT03298061|466812100|FG000|Overall Study|Physician Decision|7|||
129687214|NCT03298061|466812100|FG000|Overall Study|Withdrawal by Subject|10|||
129687215|NCT02383173|466812104|FG000|Overall Study|Palliative Care Team withdrew|0|||
129687216|NCT02383173|466812105|FG001|Overall Study|Palliative Care Team withdrew|2|||
129687217|NCT01297244|466812106|FG000|Overall Study|Progressive disease|22|||
129687218|NCT01297244|466812107|FG001|Overall Study|Progressive disease|3|||
129687219|NCT01297244|466812106|FG000|Overall Study|Adverse Event|9|||
129687220|NCT01297244|466812107|FG001|Overall Study|Adverse Event|1|||
129687221|NCT01297244|466812106|FG000|Overall Study|Death|1|||
129687222|NCT01297244|466812107|FG001|Overall Study|Death|1|||
129687223|NCT01297244|466812106|FG000|Overall Study|Clinical progression|1|||
129687224|NCT01297244|466812107|FG001|Overall Study|Clinical progression|1|||
129687225|NCT01297244|466812106|FG000|Overall Study|Withdrawal by Subject|2|||
129687226|NCT01297244|466812107|FG001|Overall Study|Withdrawal by Subject|0|||
129687227|NCT03677401|466812108|FG000|Overall Study|Adverse Event|4|||
129687228|NCT03677401|466812109|FG001|Overall Study|Adverse Event|14|||
129687229|NCT03677401|466812108|FG000|Overall Study|Lack of Efficacy|3|||
129687230|NCT03677401|466812109|FG001|Overall Study|Lack of Efficacy|1|||
129687231|NCT03677401|466812108|FG000|Overall Study|Withdrawal by Subject|2|||
129687232|NCT03677401|466812109|FG001|Overall Study|Withdrawal by Subject|2|||
129687233|NCT03677401|466812108|FG000|Overall Study|Sponsor decision|0|||
129687234|NCT03677401|466812109|FG001|Overall Study|Sponsor decision|1|||
129687235|NCT03677401|466812108|FG000|Overall Study|Reason Unspecified|1|||
129687236|NCT03677401|466812109|FG001|Overall Study|Reason Unspecified|0|||
129687237|NCT01177410|466812110|FG000|Overall Study|Adverse Event|0|||
129687238|NCT01177410|466812111|FG001|Overall Study|Adverse Event|2|||
129687239|NCT01177410|466812112|FG002|Overall Study|Adverse Event|2|||
129687240|NCT01177410|466812110|FG000|Overall Study|Withdrawal by Subject|1|||
129687241|NCT01177410|466812111|FG001|Overall Study|Withdrawal by Subject|4|||
129687242|NCT01177410|466812112|FG002|Overall Study|Withdrawal by Subject|3|||
129687243|NCT01177410|466812110|FG000|Overall Study|Lost to Follow-up|0|||
129555806|NCT00331630|466330655|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
129776990|NCT02273596|467149384|FG000|Extension Period|Protocol Deviation|1|||
129776991|NCT02604160|467149385|FG000|Overall Study|Protocol Violation|0|||
129776992|NCT02604160|467149386|FG001|Overall Study|Protocol Violation|1|||
129776993|NCT02604160|467149385|FG000|Overall Study|Physician Decision|0|||
129776994|NCT02604160|467149386|FG001|Overall Study|Physician Decision|1|||
129776995|NCT01596062|467149387|FG000|Overall Study|Adverse Event|1|||
129776996|NCT01596062|467149388|FG001|Overall Study|Adverse Event|0|||
129776997|NCT01596062|467149389|FG002|Overall Study|Adverse Event|2|||
129776998|NCT01596062|467149387|FG000|Overall Study|Lack of Efficacy|0|||
129776999|NCT01596062|467149388|FG001|Overall Study|Lack of Efficacy|0|||
129777000|NCT01596062|467149389|FG002|Overall Study|Lack of Efficacy|1|||
129777001|NCT02139592|467149390|FG000|Overall Study|Case Report Forms Uncollected|8|||
129777002|NCT02687191|467149391|FG000|Overall Study|Death|0|||
129777003|NCT02687191|467149392|FG001|Overall Study|Death|1|||
129555807|NCT00331630|466330655|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
129777004|NCT02687191|467149393|FG002|Overall Study|Death|1|||
129777005|NCT02687191|467149394|FG003|Overall Study|Death|0|||
129777006|NCT02687191|467149395|FG004|Overall Study|Death|1|||
129555808|NCT00331630|466330655|FG000|Follow up for 5 Years|Death|5|||
129555809|NCT00331630|466330655|FG000|Follow up for 5 Years|Data collection was stopped|24|||
129777007|NCT02687191|467149396|FG005|Overall Study|Death|1|||
129777008|NCT02687191|467149391|FG000|Overall Study|Withdrawal by Subject|0|||
129777009|NCT02687191|467149392|FG001|Overall Study|Withdrawal by Subject|0|||
129777010|NCT02687191|467149393|FG002|Overall Study|Withdrawal by Subject|0|||
129777011|NCT02687191|467149394|FG003|Overall Study|Withdrawal by Subject|1|||
129777012|NCT02687191|467149395|FG004|Overall Study|Withdrawal by Subject|0|||
129777013|NCT02687191|467149396|FG005|Overall Study|Withdrawal by Subject|0|||
129777014|NCT03180840|467149397|FG000|Overall Study|Withdrawal by Subject|1|||
129777015|NCT01788358|467149398|FG000|Overall Study|Other|11|||
129777016|NCT01788358|467149398|FG000|Overall Study|Logistical difficulties|1|||
129777017|NCT01788358|467149398|FG000|Overall Study|Lost to Follow-up|5|||
129777018|NCT01788358|467149398|FG000|Overall Study|Protocol Violation|3|||
129884505|NCT02293837|467536433|FG001|Overall Study|Withdrawal by Subject|1|||
129884506|NCT02293837|467536434|FG002|Overall Study|Withdrawal by Subject|2|||
129777019|NCT01788358|467149398|FG000|Overall Study|Withdrawal by Subject|26|||
129777020|NCT01788358|467149398|FG000|Overall Study|Lack of Efficacy|1|||
129777021|NCT01788358|467149398|FG000|Overall Study|Adverse Event|51|||
129555810|NCT02370784|466330656|FG000|Overall Study|Patient started prohibited medication|0|||
129555811|NCT02370784|466330657|FG001|Overall Study|Patient started prohibited medication|1|||
129555812|NCT03763331|466330660|FG000|Overall Study|Lost to Follow-up|1|||
129777022|NCT02736890|467149401|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
129777023|NCT02736890|467149402|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
129777024|NCT02736890|467149401|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
129777025|NCT02736890|467149402|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
129777026|NCT02904954|467149403|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
129777027|NCT02904954|467149404|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
129777028|NCT02904954|467149403|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
129777029|NCT02904954|467149404|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
129777030|NCT02904954|467149403|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
129777031|NCT02904954|467149404|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
129777032|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Recurrence|2|||
129777033|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Recurrence|0|||
129777034|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Adverse Event|2|||
129777035|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Adverse Event|6|||
129777036|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Participant wishes|12|||
129777037|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Participant wishes|7|||
129777038|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Physician Decision|2|||
129777039|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Physician Decision|1|||
129777040|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
129777041|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
129777042|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Death|0|||
129777043|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Death|1|||
129777044|NCT02904954|467149403|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
129777045|NCT02904954|467149404|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
129777046|NCT05097963|467149405|FG000|Overall Study|Protocol Violation|13|||
129777047|NCT05097963|467149405|FG000|Overall Study|Withdrawal by Subject|21|||
129777048|NCT02873702|467149408|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
129777049|NCT02873702|467149409|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
129777050|NCT02873702|467149410|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
129777051|NCT02873702|467149411|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
129777052|NCT02873702|467149408|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
129777053|NCT02873702|467149409|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
129777054|NCT02873702|467149410|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
129777055|NCT02873702|467149411|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
129777056|NCT02873702|467149408|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
129777057|NCT02873702|467149409|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
129777058|NCT02873702|467149410|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
129777059|NCT02873702|467149411|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
129777060|NCT02873702|467149408|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
129777061|NCT02873702|467149409|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
129777062|NCT02873702|467149410|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
129777063|NCT02873702|467149411|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
129777064|NCT02873702|467149408|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
129777065|NCT02873702|467149409|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
129777066|NCT02873702|467149410|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
129777067|NCT02873702|467149411|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
129777068|NCT02948634|467149417|FG000|Overall Study|Lack of efficacy and study suspended|10|||
129777069|NCT02948634|467149418|FG001|Overall Study|Lack of efficacy and study suspended|2|||
129555813|NCT03763331|466330661|FG001|Overall Study|Lost to Follow-up|0|||
129777070|NCT03830892|467149421|FG000|Overall Study|Physician Decision|2|||
129777071|NCT03830892|467149422|FG001|Overall Study|Physician Decision|3|||
129777072|NCT03830892|467149421|FG000|Overall Study|Study terminated due to COVID|4|||
129555814|NCT03763331|466330660|FG000|Overall Study|Withdrawal by Subject|1|||
129777073|NCT03830892|467149422|FG001|Overall Study|Study terminated due to COVID|0|||
129777074|NCT03830892|467149421|FG000|Overall Study|Protocol Violation|0|||
129777075|NCT03830892|467149422|FG001|Overall Study|Protocol Violation|1|||
129687244|NCT01177410|466812111|FG001|Overall Study|Lost to Follow-up|1|||
129687245|NCT01177410|466812112|FG002|Overall Study|Lost to Follow-up|0|||
129687246|NCT00875667|466812116|FG000|Overall Study|Adverse Event|29|||
129687247|NCT00875667|466812117|FG001|Overall Study|Adverse Event|10|||
129687248|NCT00875667|466812116|FG000|Overall Study|Withdrawal by Subject|17|||
129687249|NCT00875667|466812117|FG001|Overall Study|Withdrawal by Subject|5|||
129687250|NCT00875667|466812116|FG000|Overall Study|Death|7|||
129687251|NCT00875667|466812117|FG001|Overall Study|Death|2|||
129687252|NCT00875667|466812116|FG000|Overall Study|Protocol Violation|2|||
129687253|NCT00875667|466812117|FG001|Overall Study|Protocol Violation|0|||
129687254|NCT00875667|466812116|FG000|Overall Study|Disease Progression|100|||
129687255|NCT00875667|466812117|FG001|Overall Study|Disease Progression|49|||
129687256|NCT00875667|466812116|FG000|Overall Study|Miscellaneous|12|||
129687257|NCT00875667|466812117|FG001|Overall Study|Miscellaneous|6|||
129687258|NCT00875667|466812116|FG000|Overall Study|Randomized but no Study Drug Given|3|||
129687259|NCT00875667|466812117|FG001|Overall Study|Randomized but no Study Drug Given|1|||
129687260|NCT00894647|466812118|FG000|Overall Study|Adverse Event|5|||
129687261|NCT00894647|466812119|FG001|Overall Study|Adverse Event|4|||
129687262|NCT00894647|466812118|FG000|Overall Study|Withdrawal by Subject|4|||
129687263|NCT00894647|466812119|FG001|Overall Study|Withdrawal by Subject|4|||
129687264|NCT00894647|466812118|FG000|Overall Study|Lost to Follow-up|0|||
129687265|NCT00894647|466812119|FG001|Overall Study|Lost to Follow-up|2|||
129687266|NCT00894647|466812118|FG000|Overall Study|Non-compliance with study procedures|0|||
129687267|NCT00894647|466812119|FG001|Overall Study|Non-compliance with study procedures|2|||
129687268|NCT00894647|466812118|FG000|Overall Study|Other, not due to AE|1|||
129777076|NCT03830892|467149421|FG000|Overall Study|Withdrawal by Subject|0|||
129777077|NCT03830892|467149422|FG001|Overall Study|Withdrawal by Subject|2|||
129777078|NCT02194985|467149427|FG000|Overall Study|Adverse Event|1|||
129777079|NCT02194985|467149427|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
129777080|NCT02194985|467149427|FG000|Overall Study|Physician Decision|4|||
129777081|NCT02194985|467149427|FG000|Overall Study|Lost to Follow-up|1|||
129777082|NCT02194985|467149427|FG000|Overall Study|Withdrawal by Subject|2|||
129777083|NCT02561832|467149428|FG000|Overall Study|Withdrawal by Subject|1|||
129777084|NCT02561832|467149429|FG001|Overall Study|Withdrawal by Subject|1|||
129777085|NCT02561832|467149428|FG000|Overall Study|Adverse Event|3|||
129777086|NCT02561832|467149429|FG001|Overall Study|Adverse Event|0|||
129777087|NCT02561832|467149428|FG000|Overall Study|Disease progression|3|||
129777088|NCT02561832|467149429|FG001|Overall Study|Disease progression|3|||
129777089|NCT01262989|467149430|FG000|Period 1|Lost to Follow-up|1|||
129777090|NCT01262989|467149431|FG001|Period 1|Lost to Follow-up|1|||
129777091|NCT01262989|467149430|FG000|Period 1|Intercurrent disease|0|||
129777092|NCT01262989|467149431|FG001|Period 1|Intercurrent disease|1|||
129777093|NCT01262989|467149430|FG000|Period 1|Positive answer for exclusion criteria|0|||
129777094|NCT01262989|467149431|FG001|Period 1|Positive answer for exclusion criteria|1|||
129777095|NCT01262989|467149430|FG000|Period 2|Intercurrent disease|0|||
129777096|NCT01262989|467149431|FG001|Period 2|Intercurrent disease|1|||
129777097|NCT03599089|467149432|FG000|Overall Study|Lost to Follow-up|1|||
129777098|NCT03599089|467149433|FG001|Overall Study|Lost to Follow-up|0|||
129777099|NCT03599089|467149434|FG002|Overall Study|Lost to Follow-up|0|||
129777100|NCT03599089|467149435|FG003|Overall Study|Lost to Follow-up|0|||
129777101|NCT03599089|467149432|FG000|Overall Study|Withdrawal by Subject|2|||
129777102|NCT03599089|467149433|FG001|Overall Study|Withdrawal by Subject|1|||
129777103|NCT03599089|467149434|FG002|Overall Study|Withdrawal by Subject|0|||
129777104|NCT03599089|467149435|FG003|Overall Study|Withdrawal by Subject|0|||
129777105|NCT03599089|467149432|FG000|Overall Study|Lack of Efficacy|0|||
129777106|NCT03599089|467149433|FG001|Overall Study|Lack of Efficacy|0|||
129777107|NCT03599089|467149434|FG002|Overall Study|Lack of Efficacy|1|||
129777108|NCT03599089|467149435|FG003|Overall Study|Lack of Efficacy|2|||
129777109|NCT03214666|467149436|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129777110|NCT03214666|467149437|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129777111|NCT03214666|467149438|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129777112|NCT03214666|467149439|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129777113|NCT03214666|467149440|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
129777114|NCT03214666|467149441|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
129777115|NCT00470275|467149442|FG000|Overall Study|Death|1|||
129777116|NCT00470275|467149442|FG000|Overall Study|Lack of Efficacy|7|||
129777117|NCT00470275|467149442|FG000|Overall Study|Withdrawal by Subject|2|||
129777118|NCT03048578|467149443|FG000|Overall Study|Withdrawal by Subject|5|||
129777119|NCT03048578|467149444|FG001|Overall Study|Withdrawal by Subject|6|||
129777120|NCT03048578|467149443|FG000|Overall Study|Lost to Follow-up|22|||
129777121|NCT03048578|467149444|FG001|Overall Study|Lost to Follow-up|10|||
129777122|NCT03048578|467149443|FG000|Overall Study|Adverse Event|1|||
129777123|NCT03048578|467149444|FG001|Overall Study|Adverse Event|2|||
129777124|NCT03048578|467149443|FG000|Overall Study|Terminated|3|||
129777125|NCT03048578|467149444|FG001|Overall Study|Terminated|2|||
129777126|NCT00526071|467149445|FG000|Overall Study|Adverse Event|1|||
129777127|NCT00526071|467149445|FG000|Overall Study|Withdrawal by Subject|1|||
129777128|NCT00526071|467149445|FG000|Overall Study|Lack of Response to Study Drug|4|||
129777129|NCT02500797|467149450|FG000|Overall Study|Cancel (rapid disease progression)|0|||
129777130|NCT02500797|467149451|FG001|Overall Study|Cancel (rapid disease progression)|0|||
129777131|NCT02500797|467149452|FG002|Overall Study|Cancel (rapid disease progression)|0|||
129777132|NCT02500797|467149453|FG003|Overall Study|Cancel (rapid disease progression)|0|||
129777133|NCT02500797|467149454|FG004|Overall Study|Cancel (rapid disease progression)|1|||
129777134|NCT02500797|467149455|FG005|Overall Study|Cancel (rapid disease progression)|1|||
129777135|NCT02500797|467149456|FG006|Overall Study|Cancel (rapid disease progression)|0|||
129777136|NCT02500797|467149457|FG007|Overall Study|Cancel (rapid disease progression)|0|||
129777137|NCT02500797|467149450|FG000|Overall Study|Withdrawal by Subject|1|||
129777138|NCT02500797|467149451|FG001|Overall Study|Withdrawal by Subject|0|||
129777139|NCT02500797|467149452|FG002|Overall Study|Withdrawal by Subject|0|||
129777140|NCT02500797|467149453|FG003|Overall Study|Withdrawal by Subject|0|||
129777141|NCT02500797|467149454|FG004|Overall Study|Withdrawal by Subject|0|||
129777142|NCT02500797|467149455|FG005|Overall Study|Withdrawal by Subject|0|||
129777143|NCT02500797|467149456|FG006|Overall Study|Withdrawal by Subject|0|||
129777144|NCT02500797|467149457|FG007|Overall Study|Withdrawal by Subject|0|||
129777145|NCT01415882|467149460|FG000|Overall Study|Ineligible|1|||
129777146|NCT01415882|467149461|FG001|Overall Study|Ineligible|0|||
129777147|NCT01415882|467149462|FG002|Overall Study|Ineligible|0|||
129777148|NCT01415882|467149463|FG003|Overall Study|Ineligible|3|||
129777149|NCT01415882|467149464|FG004|Overall Study|Ineligible|0|||
129777150|NCT01415882|467149460|FG000|Overall Study|Withdrawal by Subject|0|||
129777151|NCT01415882|467149461|FG001|Overall Study|Withdrawal by Subject|1|||
129777152|NCT01415882|467149462|FG002|Overall Study|Withdrawal by Subject|0|||
129777153|NCT01415882|467149463|FG003|Overall Study|Withdrawal by Subject|1|||
129777154|NCT01415882|467149464|FG004|Overall Study|Withdrawal by Subject|0|||
129884507|NCT02293837|467536435|FG003|Overall Study|Withdrawal by Subject|1|||
129777155|NCT00357006|467149465|FG000|Overall Study|Lost to Follow-up|1|||
129777156|NCT00357006|467149466|FG001|Overall Study|Lost to Follow-up|2|||
129777157|NCT00357006|467149467|FG002|Overall Study|Lost to Follow-up|1|||
129777158|NCT00357006|467149465|FG000|Overall Study|Withdrawal by Subject|1|||
129777159|NCT00357006|467149466|FG001|Overall Study|Withdrawal by Subject|3|||
129777160|NCT00357006|467149467|FG002|Overall Study|Withdrawal by Subject|2|||
129777161|NCT00976560|467149468|FG000|Overall Study|Adverse Event|5|||
129777162|NCT00976560|467149469|FG001|Overall Study|Adverse Event|5|||
129777163|NCT00976560|467149468|FG000|Overall Study|Lack of Efficacy|3|||
129777164|NCT00976560|467149469|FG001|Overall Study|Lack of Efficacy|5|||
129777165|NCT00976560|467149468|FG000|Overall Study|Protocol Violation|1|||
129777166|NCT00976560|467149469|FG001|Overall Study|Protocol Violation|0|||
129777167|NCT00976560|467149468|FG000|Overall Study|Lost to Follow-up|1|||
129777168|NCT00976560|467149469|FG001|Overall Study|Lost to Follow-up|0|||
129777169|NCT00976560|467149468|FG000|Overall Study|Physician Decision|2|||
129555815|NCT03763331|466330661|FG001|Overall Study|Withdrawal by Subject|0|||
129555816|NCT03763331|466330660|FG000|Overall Study|Non-compliance|0|||
129555817|NCT03763331|466330661|FG001|Overall Study|Non-compliance|3|||
129555818|NCT01312779|466330662|FG000|Overall Study|Withdrawal by Subject|2|||
129555819|NCT01312779|466330662|FG000|Overall Study|Death|3|||
129555820|NCT01312779|466330662|FG000|Overall Study|Not Implanted with Device|27|||
129555821|NCT04741503|466330663|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
129555822|NCT04741503|466330664|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
129555823|NCT04741503|466330665|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
129555824|NCT04741503|466330663|FG000|Initial Enrollment|Overquotas removed|0|||
129555825|NCT04741503|466330664|FG001|Initial Enrollment|Overquotas removed|0|||
129555826|NCT04741503|466330665|FG002|Initial Enrollment|Overquotas removed|186|||
129555827|NCT04741503|466330663|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
129555828|NCT04741503|466330664|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
129555829|NCT04741503|466330665|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
129555830|NCT02280421|466330668|FG000|Washout (2 Weeks)|Adverse Event|0|||
129555831|NCT02280421|466330669|FG001|Washout (2 Weeks)|Adverse Event|1|||
129555832|NCT02280421|466330668|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129555833|NCT02280421|466330669|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
129555834|NCT02764489|466330679|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
129555835|NCT02764489|466330680|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
129555836|NCT02764489|466330679|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
129555837|NCT02764489|466330680|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
129555838|NCT02764489|466330679|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
129555839|NCT02764489|466330680|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
129555840|NCT02764489|466330679|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
129555841|NCT02764489|466330680|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
129555842|NCT00693784|466330681|FG000|Overall Study|Lost to Follow-up|2|||
129555843|NCT00693784|466330681|FG000|Overall Study|Withdrawal by Subject|2|||
129555844|NCT00326885|466330685|FG000|Overall Study|Adverse Event|1|||
129555845|NCT00326885|466330685|FG000|Overall Study|Withdrawal by Subject|3|||
129555846|NCT00326885|466330685|FG000|Overall Study|Physician Decision|1|||
129555847|NCT00326885|466330685|FG000|Overall Study|Hospice withdrew consent|2|||
129555848|NCT01706198|466330686|FG000|Overall Study|Adverse Event|12|||
129555849|NCT01706198|466330687|FG001|Overall Study|Adverse Event|15|||
129555850|NCT01706198|466330686|FG000|Overall Study|Protocol Violation|7|||
129555851|NCT01706198|466330687|FG001|Overall Study|Protocol Violation|5|||
129555852|NCT01706198|466330686|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
129555853|NCT01706198|466330687|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
129555854|NCT01706198|466330686|FG000|Overall Study|Lost to Follow-up|97|||
129555855|NCT01706198|466330687|FG001|Overall Study|Lost to Follow-up|93|||
129555856|NCT01706198|466330686|FG000|Overall Study|Physician Decision|23|||
129555857|NCT01706198|466330687|FG001|Overall Study|Physician Decision|37|||
129555858|NCT01706198|466330686|FG000|Overall Study|Withdrawal by Subject|23|||
129555859|NCT01706198|466330687|FG001|Overall Study|Withdrawal by Subject|31|||
129555860|NCT04313283|466330689|FG000|Overall Study|did not complete intervention|4|||
129555861|NCT01473758|466330690|FG000|Cycle 1|Adverse Event|10|||
129555862|NCT01473758|466330691|FG001|Cycle 1|Adverse Event|2|||
129555863|NCT01473758|466330692|FG002|Cycle 1|Adverse Event|0|||
129555864|NCT01473758|466330693|FG003|Cycle 1|Adverse Event|0|||
129555865|NCT01473758|466330690|FG000|Cycle 1|Withdrawal by Subject|1|||
129555866|NCT01473758|466330691|FG001|Cycle 1|Withdrawal by Subject|1|||
129555867|NCT01473758|466330692|FG002|Cycle 1|Withdrawal by Subject|0|||
129555868|NCT01473758|466330693|FG003|Cycle 1|Withdrawal by Subject|0|||
129555869|NCT01473758|466330690|FG000|Cycle 2|Adverse Event|0|||
129555870|NCT01473758|466330691|FG001|Cycle 2|Adverse Event|0|||
129555871|NCT01473758|466330692|FG002|Cycle 2|Adverse Event|5|||
129555872|NCT01473758|466330693|FG003|Cycle 2|Adverse Event|0|||
129555873|NCT00033631|466330694|FG000|Overall Study|Protocol Violation|14|||
129555874|NCT00033631|466330695|FG001|Overall Study|Protocol Violation|11|||
129555875|NCT00033631|466330694|FG000|Overall Study|Withdrawal by Subject|4|||
129555876|NCT00033631|466330695|FG001|Overall Study|Withdrawal by Subject|4|||
129555877|NCT01827371|466330697|FG000|Overall Study|Adverse Event|0|||
129555878|NCT01827371|466330698|FG001|Overall Study|Adverse Event|0|||
129555879|NCT01827371|466330699|FG002|Overall Study|Adverse Event|4|||
129555880|NCT01827371|466330700|FG003|Overall Study|Adverse Event|2|||
129555881|NCT01827371|466330697|FG000|Overall Study|Lost to Follow-up|0|||
129555882|NCT01827371|466330698|FG001|Overall Study|Lost to Follow-up|2|||
129555883|NCT01827371|466330699|FG002|Overall Study|Lost to Follow-up|0|||
129555884|NCT01827371|466330700|FG003|Overall Study|Lost to Follow-up|4|||
129555885|NCT01827371|466330697|FG000|Overall Study|Protocol Violation|1|||
129555886|NCT01827371|466330698|FG001|Overall Study|Protocol Violation|0|||
129555887|NCT01827371|466330699|FG002|Overall Study|Protocol Violation|0|||
129555888|NCT01827371|466330700|FG003|Overall Study|Protocol Violation|0|||
129555889|NCT01827371|466330697|FG000|Overall Study|Withdrawal by Subject|1|||
129555890|NCT01827371|466330698|FG001|Overall Study|Withdrawal by Subject|2|||
129555891|NCT01827371|466330699|FG002|Overall Study|Withdrawal by Subject|2|||
129555892|NCT01827371|466330700|FG003|Overall Study|Withdrawal by Subject|3|||
129555893|NCT01827371|466330697|FG000|Overall Study|Physician Decision|0|||
129555894|NCT01827371|466330698|FG001|Overall Study|Physician Decision|1|||
129555895|NCT01827371|466330699|FG002|Overall Study|Physician Decision|0|||
129555896|NCT01827371|466330700|FG003|Overall Study|Physician Decision|1|||
129687269|NCT00894647|466812119|FG001|Overall Study|Other, not due to AE|2|||
129687270|NCT01913470|466812120|FG000|Overall Study|Lost to Follow-up|0|||
129555897|NCT01827371|466330697|FG000|Overall Study|Temporary study halt to vaccinations|11|||
129555898|NCT01827371|466330698|FG001|Overall Study|Temporary study halt to vaccinations|2|||
129555899|NCT01827371|466330699|FG002|Overall Study|Temporary study halt to vaccinations|5|||
129555900|NCT01827371|466330700|FG003|Overall Study|Temporary study halt to vaccinations|13|||
129555901|NCT01361607|466330707|FG000|Overall Study|Adverse Event|38|||
129555902|NCT01361607|466330708|FG001|Overall Study|Adverse Event|29|||
129555903|NCT01361607|466330707|FG000|Overall Study|Withdrawal by Subject|19|||
129555904|NCT01361607|466330708|FG001|Overall Study|Withdrawal by Subject|8|||
129555905|NCT01361607|466330707|FG000|Overall Study|Withdrawal by Investigator|5|||
129555906|NCT01361607|466330708|FG001|Overall Study|Withdrawal by Investigator|3|||
129555907|NCT01361607|466330707|FG000|Overall Study|Lost to Follow-up|1|||
129687271|NCT01913470|466812121|FG001|Overall Study|Lost to Follow-up|1|||
129555908|NCT01361607|466330708|FG001|Overall Study|Lost to Follow-up|0|||
129555909|NCT01361607|466330707|FG000|Overall Study|Met Withdrawal Criteria|1|||
129555910|NCT01361607|466330708|FG001|Overall Study|Met Withdrawal Criteria|1|||
129555911|NCT01401478|466330709|FG000|Overall Study|Study drug not available|6|||
129555912|NCT01401478|466330709|FG000|Overall Study|Adverse Event|5|||
129555913|NCT01401478|466330709|FG000|Overall Study|Hyperphosphatemia|5|||
129555914|NCT01401478|466330709|FG000|Overall Study|Lost to Follow-up|5|||
129555915|NCT01401478|466330709|FG000|Overall Study|Kidney transplantation|3|||
129555916|NCT01401478|466330709|FG000|Overall Study|Withdrawal by Subject|3|||
129555917|NCT01401478|466330709|FG000|Overall Study|Blood samples not available|1|||
129555918|NCT01401478|466330709|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
129555919|NCT01401478|466330709|FG000|Overall Study|Low intact parathyroid hormone|1|||
129555920|NCT01401478|466330709|FG000|Overall Study|Serious adverse event|1|||
129555921|NCT01684722|466330710|FG000|Overall Study|Lost to Follow-up|78|||
129555922|NCT01684722|466330711|FG001|Overall Study|Lost to Follow-up|56|||
129555923|NCT01684722|466330712|FG002|Overall Study|Lost to Follow-up|75|||
129555924|NCT01684722|466330713|FG003|Overall Study|Lost to Follow-up|89|||
129555925|NCT01684722|466330710|FG000|Overall Study|Death|19|||
129555926|NCT01684722|466330711|FG001|Overall Study|Death|21|||
129555927|NCT01684722|466330712|FG002|Overall Study|Death|19|||
129555928|NCT01684722|466330713|FG003|Overall Study|Death|21|||
129555929|NCT01814137|466330714|FG000|Overall Study|Adverse Event|0|||
129555930|NCT01814137|466330715|FG001|Overall Study|Adverse Event|1|||
129555931|NCT01814137|466330714|FG000|Overall Study|Withdrawal by Subject|2|||
129555932|NCT01814137|466330715|FG001|Overall Study|Withdrawal by Subject|2|||
129555933|NCT01814137|466330714|FG000|Overall Study|Physician Decision|1|||
129555934|NCT01814137|466330715|FG001|Overall Study|Physician Decision|1|||
129555935|NCT01814137|466330714|FG000|Overall Study|Unclassified|2|||
129555936|NCT01814137|466330715|FG001|Overall Study|Unclassified|1|||
129555937|NCT00219557|466330716|FG000|Phase 1|Lack of Efficacy|3|||
129555938|NCT00219557|466330717|FG001|Phase 1|Lack of Efficacy|0|||
129555939|NCT00219557|466330718|FG002|Phase 1|Lack of Efficacy|0|||
129555940|NCT00219557|466330716|FG000|Phase 1|Adverse Event|2|||
129777170|NCT00976560|467149469|FG001|Overall Study|Physician Decision|0|||
129777171|NCT00976560|467149468|FG000|Overall Study|Withdrawal by Subject|2|||
129777172|NCT00976560|467149469|FG001|Overall Study|Withdrawal by Subject|3|||
129777173|NCT03710161|467149470|FG000|Overall Study|Study halted due to COVID pandemic|3|||
129777174|NCT03710161|467149471|FG001|Overall Study|Study halted due to COVID pandemic|2|||
129777175|NCT03339219|467149479|FG000|Overall Study|Death|12|||
129777176|NCT03339219|467149479|FG000|Overall Study|Site Terminated by Sponsor|22|||
129777177|NCT03339219|467149479|FG000|Overall Study|Withdrawal by Subject|1|||
129777178|NCT01932437|467149481|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129777179|NCT01932437|467149482|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129777180|NCT01932437|467149483|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129777181|NCT01932437|467149484|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129777182|NCT01932437|467149485|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
129777183|NCT01932437|467149486|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
129777184|NCT00074490|467149487|FG000|Overall Study|Progressive malignancy|0|||
129777185|NCT00074490|467149488|FG001|Overall Study|Progressive malignancy|7|||
129777186|NCT00074490|467149489|FG002|Overall Study|Progressive malignancy|0|||
129777187|NCT00074490|467149490|FG003|Overall Study|Progressive malignancy|0|||
129777188|NCT00074490|467149491|FG004|Overall Study|Progressive malignancy|3|||
129555941|NCT00219557|466330717|FG001|Phase 1|Adverse Event|0|||
129555942|NCT00219557|466330718|FG002|Phase 1|Adverse Event|0|||
129555943|NCT00219557|466330716|FG000|Phase 1|Withdrawal by Subject|1|||
129555944|NCT00219557|466330717|FG001|Phase 1|Withdrawal by Subject|0|||
129555945|NCT00219557|466330718|FG002|Phase 1|Withdrawal by Subject|0|||
129555946|NCT00219557|466330716|FG000|Phase 1|Started chemotherapy at other institute|1|||
129555947|NCT00219557|466330717|FG001|Phase 1|Started chemotherapy at other institute|0|||
129555948|NCT00219557|466330718|FG002|Phase 1|Started chemotherapy at other institute|0|||
129777189|NCT00074490|467149492|FG005|Overall Study|Progressive malignancy|0|||
129777190|NCT00467753|467149498|FG000|Overall Study|Lost to Follow-up|1|||
129777191|NCT00467753|467149499|FG001|Overall Study|Lost to Follow-up|2|||
129555949|NCT00219557|466330716|FG000|Phase 2|Lack of Efficacy|0|||
129555950|NCT00219557|466330717|FG001|Phase 2|Lack of Efficacy|21|||
129555951|NCT00219557|466330718|FG002|Phase 2|Lack of Efficacy|15|||
129555952|NCT00219557|466330716|FG000|Phase 2|Adverse Event|0|||
129555953|NCT00219557|466330717|FG001|Phase 2|Adverse Event|22|||
129555954|NCT00219557|466330718|FG002|Phase 2|Adverse Event|2|||
129555955|NCT00219557|466330716|FG000|Phase 2|Death|0|||
129555956|NCT00219557|466330717|FG001|Phase 2|Death|8|||
129555957|NCT00219557|466330718|FG002|Phase 2|Death|2|||
129555958|NCT00219557|466330716|FG000|Phase 2|Other|0|||
129555959|NCT00219557|466330717|FG001|Phase 2|Other|8|||
129555960|NCT00219557|466330718|FG002|Phase 2|Other|6|||
129555961|NCT00219557|466330716|FG000|Phase 2|Withdrawal by Subject|0|||
129555962|NCT00219557|466330717|FG001|Phase 2|Withdrawal by Subject|9|||
129555963|NCT00219557|466330718|FG002|Phase 2|Withdrawal by Subject|5|||
129555964|NCT00219557|466330716|FG000|Phase 2|Treatment not received|0|||
129555965|NCT00219557|466330717|FG001|Phase 2|Treatment not received|1|||
129555966|NCT00219557|466330718|FG002|Phase 2|Treatment not received|3|||
129555967|NCT03412019|466330719|FG000|Overall Study|Withdrawal by Subject|1|||
129555968|NCT03412019|466330720|FG001|Overall Study|Withdrawal by Subject|1|||
129555969|NCT00479401|466330725|FG000|Overall Study|Adverse Event|24|||
129555970|NCT00479401|466330726|FG001|Overall Study|Adverse Event|20|||
129555971|NCT00479401|466330727|FG002|Overall Study|Adverse Event|4|||
129555972|NCT00479401|466330725|FG000|Overall Study|Lack of Efficacy|2|||
129555973|NCT00479401|466330726|FG001|Overall Study|Lack of Efficacy|2|||
129555974|NCT00479401|466330727|FG002|Overall Study|Lack of Efficacy|4|||
129555975|NCT00479401|466330725|FG000|Overall Study|Protocol Violation|2|||
129555976|NCT00479401|466330726|FG001|Overall Study|Protocol Violation|1|||
129555977|NCT00479401|466330727|FG002|Overall Study|Protocol Violation|1|||
129555978|NCT00479401|466330725|FG000|Overall Study|Lost to Follow-up|1|||
129555979|NCT00479401|466330726|FG001|Overall Study|Lost to Follow-up|1|||
129555980|NCT00479401|466330727|FG002|Overall Study|Lost to Follow-up|1|||
129555981|NCT00479401|466330725|FG000|Overall Study|Withdrawal by Subject|16|||
129555982|NCT00479401|466330726|FG001|Overall Study|Withdrawal by Subject|10|||
129555983|NCT00479401|466330727|FG002|Overall Study|Withdrawal by Subject|2|||
129555984|NCT00479401|466330725|FG000|Overall Study|Exclusion criteria, relocation|4|||
129555985|NCT00479401|466330726|FG001|Overall Study|Exclusion criteria, relocation|3|||
129555986|NCT00479401|466330727|FG002|Overall Study|Exclusion criteria, relocation|0|||
129555987|NCT01430104|466330730|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
129555988|NCT01571635|466330731|FG000|Overall Study|Adverse Event|3|||
129555989|NCT01571635|466330732|FG001|Overall Study|Adverse Event|0|||
129555990|NCT01571635|466330733|FG002|Overall Study|Adverse Event|2|||
129555991|NCT01571635|466330734|FG003|Overall Study|Adverse Event|3|||
129555992|NCT01571635|466330735|FG004|Overall Study|Adverse Event|5|||
129555993|NCT01571635|466330731|FG000|Overall Study|Other reasons|2|||
129555994|NCT01571635|466330732|FG001|Overall Study|Other reasons|1|||
129555995|NCT01571635|466330733|FG002|Overall Study|Other reasons|2|||
129687272|NCT01913470|466812120|FG000|Overall Study|Physician Decision|0|||
129555996|NCT01571635|466330734|FG003|Overall Study|Other reasons|2|||
129555997|NCT01571635|466330735|FG004|Overall Study|Other reasons|1|||
129555998|NCT01571635|466330731|FG000|Overall Study|Study terminated by sponsor|0|||
129555999|NCT01571635|466330732|FG001|Overall Study|Study terminated by sponsor|4|||
129687273|NCT01913470|466812121|FG001|Overall Study|Physician Decision|1|||
129687274|NCT01913470|466812120|FG000|Overall Study|Withdrawal by Subject|0|||
129687275|NCT01913470|466812121|FG001|Overall Study|Withdrawal by Subject|1|||
129687276|NCT02573467|466812127|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
129687277|NCT02573467|466812128|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
129687278|NCT02573467|466812129|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
129556000|NCT01571635|466330733|FG002|Overall Study|Study terminated by sponsor|1|||
129556001|NCT01571635|466330734|FG003|Overall Study|Study terminated by sponsor|3|||
129556002|NCT01571635|466330735|FG004|Overall Study|Study terminated by sponsor|1|||
129556003|NCT01571635|466330731|FG000|Overall Study|Withdrew consent|1|||
129556004|NCT01571635|466330732|FG001|Overall Study|Withdrew consent|1|||
129556005|NCT01571635|466330733|FG002|Overall Study|Withdrew consent|2|||
129556006|NCT01571635|466330734|FG003|Overall Study|Withdrew consent|3|||
129556007|NCT01571635|466330735|FG004|Overall Study|Withdrew consent|0|||
129556008|NCT01571635|466330731|FG000|Overall Study|Lack of Efficacy|0|||
129556009|NCT01571635|466330732|FG001|Overall Study|Lack of Efficacy|2|||
129556010|NCT01571635|466330733|FG002|Overall Study|Lack of Efficacy|0|||
129556011|NCT01571635|466330734|FG003|Overall Study|Lack of Efficacy|1|||
129556012|NCT01571635|466330735|FG004|Overall Study|Lack of Efficacy|2|||
129556013|NCT01722266|466330736|FG000|Overall Study|Withdrawal by Subject|1|||
129556014|NCT01722266|466330737|FG001|Overall Study|Withdrawal by Subject|2|||
129556015|NCT01722266|466330738|FG002|Overall Study|Withdrawal by Subject|0|||
129556016|NCT01722266|466330739|FG003|Overall Study|Withdrawal by Subject|0|||
129556017|NCT01722266|466330736|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
129777192|NCT00467753|467149498|FG000|Overall Study|Adverse Event|2|||
129556018|NCT01722266|466330737|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
129556019|NCT01722266|466330738|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
129556020|NCT01722266|466330739|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
129556021|NCT01722266|466330736|FG000|Overall Study|Dropped out due to Nausea|0|||
129556022|NCT01722266|466330737|FG001|Overall Study|Dropped out due to Nausea|0|||
129556023|NCT01722266|466330738|FG002|Overall Study|Dropped out due to Nausea|2|||
129556024|NCT01722266|466330739|FG003|Overall Study|Dropped out due to Nausea|0|||
129556025|NCT02862535|466330740|FG000|Overall Study|Death|7|||
129556026|NCT02862535|466330741|FG001|Overall Study|Death|3|||
129556027|NCT02862535|466330742|FG002|Overall Study|Death|2|||
129556028|NCT02862535|466330743|FG003|Overall Study|Death|5|||
129556029|NCT02862535|466330740|FG000|Overall Study|Study Terminated by Sponsor|1|||
129556030|NCT02862535|466330741|FG001|Overall Study|Study Terminated by Sponsor|3|||
129556031|NCT02862535|466330742|FG002|Overall Study|Study Terminated by Sponsor|8|||
129556032|NCT02862535|466330743|FG003|Overall Study|Study Terminated by Sponsor|5|||
129556033|NCT02862535|466330740|FG000|Overall Study|Enrolled, not Treated|1|||
129556034|NCT02862535|466330741|FG001|Overall Study|Enrolled, not Treated|0|||
129556035|NCT02862535|466330742|FG002|Overall Study|Enrolled, not Treated|0|||
129556036|NCT02862535|466330743|FG003|Overall Study|Enrolled, not Treated|1|||
129556037|NCT02472977|466330749|FG000|Overall Study|Disease progression|4|||
129556038|NCT02472977|466330750|FG001|Overall Study|Disease progression|25|||
129556039|NCT02472977|466330751|FG002|Overall Study|Disease progression|6|||
129556040|NCT02472977|466330749|FG000|Overall Study|Withdrawal by Subject|0|||
129556041|NCT02472977|466330750|FG001|Overall Study|Withdrawal by Subject|1|||
129556042|NCT02472977|466330751|FG002|Overall Study|Withdrawal by Subject|0|||
129556043|NCT02472977|466330749|FG000|Overall Study|Study drug toxicity|2|||
129556044|NCT02472977|466330750|FG001|Overall Study|Study drug toxicity|0|||
129556045|NCT02472977|466330751|FG002|Overall Study|Study drug toxicity|2|||
129556046|NCT02472977|466330749|FG000|Overall Study|Subject request to discontinue treatment|0|||
129556047|NCT02472977|466330750|FG001|Overall Study|Subject request to discontinue treatment|1|||
129556048|NCT02472977|466330751|FG002|Overall Study|Subject request to discontinue treatment|0|||
129556049|NCT00738920|466330758|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
129556050|NCT00738920|466330759|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
129777193|NCT00467753|467149499|FG001|Overall Study|Adverse Event|0|||
129777194|NCT02175030|467149500|FG000|Overall Study|Failed screen after consent|7|||
129777195|NCT02175030|467149501|FG001|Overall Study|Failed screen after consent|6|||
129777196|NCT02175030|467149500|FG000|Overall Study|Failed IUD Insertion|20|||
129777197|NCT02175030|467149501|FG001|Overall Study|Failed IUD Insertion|21|||
129777198|NCT02175030|467149500|FG000|Overall Study|Physician Decision|1|||
129777199|NCT02175030|467149501|FG001|Overall Study|Physician Decision|1|||
129777200|NCT02175030|467149500|FG000|Overall Study|Lost to Follow-up|6|||
129777201|NCT02175030|467149501|FG001|Overall Study|Lost to Follow-up|6|||
129777202|NCT02175030|467149500|FG000|Overall Study|Withdrawal by Subject|1|||
129777203|NCT02175030|467149501|FG001|Overall Study|Withdrawal by Subject|4|||
129777204|NCT03695367|467149504|FG000|Overall Study|Missed the Day 28 visit.|1|||
129777205|NCT03695367|467149505|FG001|Overall Study|Missed the Day 28 visit.|0|||
129777206|NCT03695367|467149504|FG000|Overall Study|Lost to Follow-up|0|||
129777207|NCT03695367|467149505|FG001|Overall Study|Lost to Follow-up|1|||
129777208|NCT03695367|467149504|FG000|Overall Study|Withdrawal by Subject|0|||
129777209|NCT03695367|467149505|FG001|Overall Study|Withdrawal by Subject|1|||
129777210|NCT03695367|467149504|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
129777211|NCT03695367|467149505|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
129777212|NCT01077050|467151252|FG000|Overall Study|Subjects signed ICF could not be located|1|||
129777213|NCT01077050|467151252|FG000|Overall Study|Screen failure|8|||
129777214|NCT03894813|467151253|FG000|Overall Study|Adverse Event|1|||
129777215|NCT03894813|467151254|FG001|Overall Study|Adverse Event|1|||
129777216|NCT03894813|467151253|FG000|Overall Study|Lack of Efficacy|3|||
129777217|NCT03894813|467151254|FG001|Overall Study|Lack of Efficacy|3|||
129777218|NCT03894813|467151253|FG000|Overall Study|Lost to Follow-up|1|||
129777219|NCT03894813|467151254|FG001|Overall Study|Lost to Follow-up|0|||
129777220|NCT03894813|467151253|FG000|Overall Study|Pregnancy|2|||
129556051|NCT00738920|466330760|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
129777221|NCT03894813|467151254|FG001|Overall Study|Pregnancy|1|||
129777222|NCT03894813|467151253|FG000|Overall Study|Protocol Violation|3|||
129777223|NCT03894813|467151254|FG001|Overall Study|Protocol Violation|7|||
129777224|NCT03894813|467151253|FG000|Overall Study|Withdrawal by Subject|1|||
129777225|NCT03894813|467151254|FG001|Overall Study|Withdrawal by Subject|3|||
129556052|NCT00738920|466330758|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
129556053|NCT00738920|466330759|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
129556054|NCT00738920|466330760|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
129556055|NCT00738920|466330758|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
129556056|NCT00738920|466330759|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
129777226|NCT03894813|467151253|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
129777227|NCT03894813|467151254|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
129556057|NCT00738920|466330760|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
129556058|NCT00738920|466330758|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
129556059|NCT00738920|466330759|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
129556060|NCT00738920|466330760|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
129556061|NCT00738920|466330758|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
129556062|NCT00738920|466330759|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
129556063|NCT00738920|466330760|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
129556064|NCT00738920|466330758|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
129556065|NCT00738920|466330759|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
129556066|NCT00738920|466330760|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
129556067|NCT00738920|466330758|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
129556068|NCT00738920|466330759|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
129556069|NCT00738920|466330760|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
129556070|NCT00738920|466330758|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
129556071|NCT00738920|466330759|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
129556072|NCT00738920|466330760|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
129556073|NCT00738920|466330758|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
129556074|NCT00738920|466330759|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
129556075|NCT00738920|466330760|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
129556076|NCT00738920|466330758|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
129556077|NCT00738920|466330759|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
129556078|NCT00738920|466330760|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
129556079|NCT01025193|466330761|FG000|Overall Study|Protocol Violation|1|||
129556080|NCT01025193|466330761|FG000|Overall Study|Adverse Event|3|||
129556081|NCT04079842|466330762|FG000|Overall Study|Request of subject|2|||
129556082|NCT04079842|466330762|FG000|Overall Study|Unable to draw Arterial samples|1|||
129556083|NCT02904200|466330763|FG000|Overall Study|Withdrawal by Subject|1|||
129556084|NCT02904200|466330764|FG001|Overall Study|Withdrawal by Subject|0|||
129556085|NCT00185211|466330765|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
129556086|NCT00185211|466330766|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
129556087|NCT00185211|466330765|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
129556088|NCT00185211|466330766|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
129777228|NCT03773796|467151255|FG000|Overall Study|Adverse Event|1|||
129777229|NCT03773796|467151255|FG000|Overall Study|Withdrawal by Subject|1|||
129777230|NCT03773796|467151255|FG000|Overall Study|Lack of Efficacy|1|||
129777231|NCT03805659|467151256|FG000|Overall Study|Withdrawal by Subject|0|||
129777232|NCT03805659|467151257|FG001|Overall Study|Withdrawal by Subject|1|||
129777233|NCT01250145|467151259|FG000|Overall Study|Adverse Event|2|||
129777234|NCT01250145|467151260|FG001|Overall Study|Adverse Event|1|||
129777235|NCT01250145|467151259|FG000|Overall Study|Withdrawal by Subject|0|||
129777236|NCT01250145|467151260|FG001|Overall Study|Withdrawal by Subject|4|||
129777237|NCT01069900|467151263|FG000|Overall Study|Technical problems|0|||
129777238|NCT01069900|467151264|FG001|Overall Study|Technical problems|1|||
129777239|NCT01069900|467151263|FG000|Overall Study|Lost to Follow-up|7|||
129777240|NCT01069900|467151264|FG001|Overall Study|Lost to Follow-up|1|||
129777241|NCT01069900|467151263|FG000|Overall Study|Withdrawal by Subject|6|||
129777242|NCT01069900|467151264|FG001|Overall Study|Withdrawal by Subject|1|||
129777243|NCT01069900|467151263|FG000|Overall Study|Protocol Violation|4|||
129777244|NCT01069900|467151264|FG001|Overall Study|Protocol Violation|1|||
129884508|NCT02293837|467536432|FG000|Overall Study|COVID-19 Related|1|||
129777245|NCT01069900|467151263|FG000|Overall Study|Insufficient Therapeutic effect|1|||
129777246|NCT01069900|467151264|FG001|Overall Study|Insufficient Therapeutic effect|0|||
129777247|NCT01675544|467151265|FG000|Overall Study|Withdrawal by Subject|2|||
129777248|NCT03675321|467151267|FG000|Overall Study|Lack of Efficacy|2|||
129556089|NCT00185211|466330765|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
129556090|NCT00185211|466330766|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
129556091|NCT00185211|466330765|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
129556092|NCT00185211|466330766|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
129556093|NCT00185211|466330765|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
129556094|NCT00185211|466330766|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
129556095|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
129556096|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
129556097|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
129556098|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
129556099|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
129556100|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
129556101|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
129556102|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
129556103|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
129556104|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
129556105|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
129556106|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
129777249|NCT03675321|467151268|FG001|Overall Study|Lack of Efficacy|2|||
129777250|NCT03675321|467151267|FG000|Overall Study|Withdrawal by Subject|1|||
129777251|NCT03675321|467151268|FG001|Overall Study|Withdrawal by Subject|3|||
129777252|NCT01491607|467151272|FG000|Overall Study|Lost to Follow-up|7|||
129777253|NCT01491607|467151272|FG000|Overall Study|Withdrawal by Subject|3|||
129777254|NCT01317277|467151273|FG000|Overall Study|Lost to Follow-up|3|||
129777255|NCT01317277|467151274|FG001|Overall Study|Lost to Follow-up|1|||
129777256|NCT01317277|467151273|FG000|Overall Study|Lost MEMS|1|||
129777257|NCT01317277|467151274|FG001|Overall Study|Lost MEMS|1|||
129777258|NCT01317277|467151273|FG000|Overall Study|Unable to comply with intervention|1|||
129777259|NCT01317277|467151274|FG001|Overall Study|Unable to comply with intervention|0|||
129777260|NCT01317277|467151273|FG000|Overall Study|Withdrawal by Subject|1|||
129777261|NCT01317277|467151274|FG001|Overall Study|Withdrawal by Subject|0|||
129777262|NCT01317277|467151273|FG000|Overall Study|Adverse Event|1|||
129777263|NCT01317277|467151274|FG001|Overall Study|Adverse Event|0|||
129777264|NCT00774566|467151275|FG000|Overall Study|Protocol Violation|18|||
129777265|NCT00774566|467151276|FG001|Overall Study|Protocol Violation|15|||
129777266|NCT02999672|467151283|FG000|Overall Study|Death|0|||
129777267|NCT02999672|467151284|FG001|Overall Study|Death|1|||
129777268|NCT02999672|467151283|FG000|Overall Study|Study Terminated by Sponsor|0|||
129777269|NCT02999672|467151284|FG001|Overall Study|Study Terminated by Sponsor|1|||
129777270|NCT02999672|467151283|FG000|Overall Study|Progressive Disease|9|||
129777271|NCT02999672|467151284|FG001|Overall Study|Progressive Disease|5|||
129777272|NCT02999672|467151283|FG000|Overall Study|Adverse Event|4|||
129556107|NCT00185211|466330765|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
129556108|NCT00185211|466330766|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
129556109|NCT03372083|466332648|FG000|Overall Study|Adverse Event|3|||
129556110|NCT03372083|466332648|FG000|Overall Study|Physician Decision|1|||
129777273|NCT02999672|467151284|FG001|Overall Study|Adverse Event|0|||
129777274|NCT03565497|467151285|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
129777275|NCT03565497|467151286|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
129556111|NCT03372083|466332648|FG000|Overall Study|Withdrawal by Subject|1|||
129556112|NCT02266706|466332649|FG000|Overall Study|Withdrawal by Subject|0|||
129556113|NCT02266706|466332650|FG001|Overall Study|Withdrawal by Subject|1|||
129556114|NCT02266706|466332651|FG002|Overall Study|Withdrawal by Subject|1|||
129556115|NCT02266706|466332652|FG003|Overall Study|Withdrawal by Subject|0|||
129556116|NCT02266706|466332653|FG004|Overall Study|Withdrawal by Subject|0|||
129556117|NCT02266706|466332654|FG005|Overall Study|Withdrawal by Subject|1|||
129556118|NCT02266706|466332655|FG006|Overall Study|Withdrawal by Subject|0|||
129556119|NCT02266706|466332656|FG007|Overall Study|Withdrawal by Subject|0|||
129556120|NCT02266706|466332657|FG008|Overall Study|Withdrawal by Subject|0|||
129556121|NCT02266706|466332649|FG000|Overall Study|Screen failure|0|||
129556122|NCT02266706|466332650|FG001|Overall Study|Screen failure|0|||
129556123|NCT02266706|466332651|FG002|Overall Study|Screen failure|0|||
129556124|NCT02266706|466332652|FG003|Overall Study|Screen failure|0|||
129556125|NCT02266706|466332653|FG004|Overall Study|Screen failure|0|||
129556126|NCT02266706|466332654|FG005|Overall Study|Screen failure|1|||
129556127|NCT02266706|466332655|FG006|Overall Study|Screen failure|1|||
129556128|NCT02266706|466332656|FG007|Overall Study|Screen failure|0|||
129556129|NCT02266706|466332657|FG008|Overall Study|Screen failure|0|||
129556130|NCT02266706|466332649|FG000|Overall Study|Enrollment in another study|0|||
129556131|NCT02266706|466332650|FG001|Overall Study|Enrollment in another study|0|||
129556132|NCT02266706|466332651|FG002|Overall Study|Enrollment in another study|0|||
129556133|NCT02266706|466332652|FG003|Overall Study|Enrollment in another study|1|||
129556134|NCT02266706|466332653|FG004|Overall Study|Enrollment in another study|0|||
129556135|NCT02266706|466332654|FG005|Overall Study|Enrollment in another study|0|||
129556136|NCT02266706|466332655|FG006|Overall Study|Enrollment in another study|0|||
129556137|NCT02266706|466332656|FG007|Overall Study|Enrollment in another study|0|||
129556138|NCT02266706|466332657|FG008|Overall Study|Enrollment in another study|0|||
129556139|NCT00409188|466332658|FG000|Overall Study|Ongoing at data cut-off|383|||
129556140|NCT00409188|466332659|FG001|Overall Study|Ongoing at data cut-off|175|||
129556141|NCT02257632|466332665|FG000|Overall Study|Withdrawal by Subject|0|||
129556142|NCT02257632|466332666|FG001|Overall Study|Withdrawal by Subject|1|||
129556143|NCT02257632|466332665|FG000|Overall Study|Adverse Event|1|||
129556144|NCT02257632|466332666|FG001|Overall Study|Adverse Event|2|||
129556145|NCT01393990|466332667|FG000|Overall Study|Adverse Event|0|||
129556146|NCT01393990|466332668|FG001|Overall Study|Adverse Event|0|||
129556147|NCT01393990|466332669|FG002|Overall Study|Adverse Event|0|||
129556148|NCT01393990|466332670|FG003|Overall Study|Adverse Event|0|||
129556149|NCT01393990|466332671|FG004|Overall Study|Adverse Event|0|||
129556150|NCT01393990|466332672|FG005|Overall Study|Adverse Event|0|||
129556151|NCT01393990|466332673|FG006|Overall Study|Adverse Event|0|||
129556152|NCT01393990|466332674|FG007|Overall Study|Adverse Event|0|||
129556153|NCT01393990|466332675|FG008|Overall Study|Adverse Event|0|||
129556154|NCT01393990|466332676|FG009|Overall Study|Adverse Event|0|||
129556155|NCT01393990|466332677|FG010|Overall Study|Adverse Event|0|||
129556156|NCT01393990|466332678|FG011|Overall Study|Adverse Event|0|||
129556157|NCT01393990|466332679|FG012|Overall Study|Adverse Event|0|||
129556158|NCT01393990|466332680|FG013|Overall Study|Adverse Event|0|||
129777276|NCT03565497|467151287|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
129777277|NCT03565497|467151285|FG000|Overall Study|Lost to Follow-up|1|||
129777278|NCT03565497|467151286|FG001|Overall Study|Lost to Follow-up|1|||
129777279|NCT03565497|467151287|FG002|Overall Study|Lost to Follow-up|2|||
129777280|NCT03565497|467151285|FG000|Overall Study|Withdrawal by Subject|1|||
129777281|NCT03565497|467151286|FG001|Overall Study|Withdrawal by Subject|1|||
129777282|NCT03565497|467151287|FG002|Overall Study|Withdrawal by Subject|1|||
129556159|NCT01393990|466332681|FG014|Overall Study|Adverse Event|1|||
129556160|NCT01393990|466332682|FG015|Overall Study|Adverse Event|1|||
129556161|NCT01393990|466332683|FG016|Overall Study|Adverse Event|0|||
129777283|NCT01075685|467151288|FG000|Overall Study|Protocol Violation|9|||
129556162|NCT01393990|466332684|FG017|Overall Study|Adverse Event|0|||
129556163|NCT01393990|466332667|FG000|Overall Study|Progressive Disease|1|||
129556164|NCT01393990|466332668|FG001|Overall Study|Progressive Disease|0|||
129556165|NCT01393990|466332669|FG002|Overall Study|Progressive Disease|0|||
129556166|NCT01393990|466332670|FG003|Overall Study|Progressive Disease|1|||
129556167|NCT01393990|466332671|FG004|Overall Study|Progressive Disease|1|||
129556168|NCT01393990|466332672|FG005|Overall Study|Progressive Disease|1|||
129777284|NCT01075685|467151289|FG001|Overall Study|Protocol Violation|1|||
129777285|NCT01075685|467151288|FG000|Overall Study|Withdrawal by Subject|20|||
129777286|NCT01075685|467151289|FG001|Overall Study|Withdrawal by Subject|5|||
129777287|NCT01075685|467151288|FG000|Overall Study|Lost to Follow-up|563|||
129777288|NCT01075685|467151289|FG001|Overall Study|Lost to Follow-up|220|||
129777289|NCT02858362|467151292|FG000|Overall Study|Protocol Violation|0|||
129777290|NCT02858362|467151293|FG001|Overall Study|Protocol Violation|1|||
129777291|NCT02858362|467151294|FG002|Overall Study|Protocol Violation|0|||
129777292|NCT02858362|467151292|FG000|Overall Study|Withdrawal by Subject|1|||
129777293|NCT02858362|467151293|FG001|Overall Study|Withdrawal by Subject|0|||
129777294|NCT02858362|467151294|FG002|Overall Study|Withdrawal by Subject|0|||
129777295|NCT02858362|467151292|FG000|Overall Study|Early Study Termination|0|||
129777296|NCT02858362|467151293|FG001|Overall Study|Early Study Termination|0|||
129556169|NCT01393990|466332673|FG006|Overall Study|Progressive Disease|1|||
129556170|NCT01393990|466332674|FG007|Overall Study|Progressive Disease|1|||
129556171|NCT01393990|466332675|FG008|Overall Study|Progressive Disease|3|||
129556172|NCT01393990|466332676|FG009|Overall Study|Progressive Disease|1|||
129556173|NCT01393990|466332677|FG010|Overall Study|Progressive Disease|0|||
129556174|NCT01393990|466332678|FG011|Overall Study|Progressive Disease|0|||
129556175|NCT01393990|466332679|FG012|Overall Study|Progressive Disease|0|||
129556176|NCT01393990|466332680|FG013|Overall Study|Progressive Disease|1|||
129556177|NCT01393990|466332681|FG014|Overall Study|Progressive Disease|6|||
129556178|NCT01393990|466332682|FG015|Overall Study|Progressive Disease|1|||
129556179|NCT01393990|466332683|FG016|Overall Study|Progressive Disease|0|||
129556180|NCT01393990|466332684|FG017|Overall Study|Progressive Disease|0|||
129556181|NCT01393990|466332667|FG000|Overall Study|Death|0|||
129556182|NCT01393990|466332668|FG001|Overall Study|Death|0|||
129556183|NCT01393990|466332669|FG002|Overall Study|Death|0|||
129556184|NCT01393990|466332670|FG003|Overall Study|Death|0|||
129556185|NCT01393990|466332671|FG004|Overall Study|Death|1|||
129556186|NCT01393990|466332672|FG005|Overall Study|Death|0|||
129556187|NCT01393990|466332673|FG006|Overall Study|Death|0|||
129556188|NCT01393990|466332674|FG007|Overall Study|Death|0|||
129556189|NCT01393990|466332675|FG008|Overall Study|Death|0|||
129556190|NCT01393990|466332676|FG009|Overall Study|Death|0|||
129556191|NCT01393990|466332677|FG010|Overall Study|Death|0|||
129556192|NCT01393990|466332678|FG011|Overall Study|Death|0|||
129556193|NCT01393990|466332679|FG012|Overall Study|Death|0|||
129556194|NCT01393990|466332680|FG013|Overall Study|Death|1|||
129556195|NCT01393990|466332681|FG014|Overall Study|Death|1|||
129556196|NCT01393990|466332682|FG015|Overall Study|Death|0|||
129556197|NCT01393990|466332683|FG016|Overall Study|Death|0|||
129556198|NCT01393990|466332684|FG017|Overall Study|Death|0|||
129556199|NCT01393990|466332667|FG000|Overall Study|Withdrawal by Subject|0|||
129556200|NCT01393990|466332668|FG001|Overall Study|Withdrawal by Subject|0|||
129556201|NCT01393990|466332669|FG002|Overall Study|Withdrawal by Subject|0|||
129556202|NCT01393990|466332670|FG003|Overall Study|Withdrawal by Subject|0|||
129556203|NCT01393990|466332671|FG004|Overall Study|Withdrawal by Subject|0|||
129556204|NCT01393990|466332672|FG005|Overall Study|Withdrawal by Subject|0|||
129556205|NCT01393990|466332673|FG006|Overall Study|Withdrawal by Subject|0|||
129556206|NCT01393990|466332674|FG007|Overall Study|Withdrawal by Subject|0|||
129556207|NCT01393990|466332675|FG008|Overall Study|Withdrawal by Subject|0|||
129556208|NCT01393990|466332676|FG009|Overall Study|Withdrawal by Subject|0|||
129556209|NCT01393990|466332677|FG010|Overall Study|Withdrawal by Subject|0|||
129556210|NCT01393990|466332678|FG011|Overall Study|Withdrawal by Subject|0|||
129556211|NCT01393990|466332679|FG012|Overall Study|Withdrawal by Subject|0|||
129556212|NCT01393990|466332680|FG013|Overall Study|Withdrawal by Subject|0|||
129556213|NCT01393990|466332681|FG014|Overall Study|Withdrawal by Subject|1|||
129556214|NCT01393990|466332682|FG015|Overall Study|Withdrawal by Subject|1|||
129556215|NCT01393990|466332683|FG016|Overall Study|Withdrawal by Subject|0|||
129556216|NCT01393990|466332684|FG017|Overall Study|Withdrawal by Subject|0|||
129556217|NCT00275028|466332685|FG000|Overall Study|Withdrew consent before treatment began|1|||
129556218|NCT00275028|466332685|FG000|Overall Study|Withdrawal by Subject|5|||
129556219|NCT00275028|466332685|FG000|Overall Study|Adverse Event|9|||
129556220|NCT00275028|466332685|FG000|Overall Study|Progressive Disease|30|||
129556221|NCT00275028|466332685|FG000|Overall Study|Physician Decision|2|||
129556222|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
129556223|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129556224|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129556225|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129556226|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129556227|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129556228|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
129556229|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
129556230|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129556231|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129556232|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129556233|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129556234|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129556235|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
129556236|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
129556237|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
129556238|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
129556239|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
129800231|NCT02891161|467236266|FG000|Follow up|Refused to Follow up|0|||
129556240|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
129556241|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
129556242|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
129687279|NCT02573467|466812130|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
129884509|NCT02293837|467536433|FG001|Overall Study|COVID-19 Related|1|||
129556243|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
129556244|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129556245|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129556246|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129556247|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129556248|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129556249|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
129556250|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
129556251|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129556252|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129556253|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129556254|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129556255|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129556256|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
129556257|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
129556258|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
129556259|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
129556260|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
129556261|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
129556262|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
129556263|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
129556264|NCT00606684|466332699|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
129556265|NCT00606684|466332700|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129556266|NCT00606684|466332701|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129556267|NCT00606684|466332702|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129556268|NCT00606684|466332703|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129556269|NCT00606684|466332704|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129556270|NCT00606684|466332705|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
129556271|NCT00606684|466332699|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129556272|NCT00606684|466332700|FG001|Double-Blind Treatment Period|Adverse Event|3|||
129556273|NCT00606684|466332701|FG002|Double-Blind Treatment Period|Adverse Event|2|||
129556274|NCT00606684|466332702|FG003|Double-Blind Treatment Period|Adverse Event|4|||
129556275|NCT00606684|466332703|FG004|Double-Blind Treatment Period|Adverse Event|2|||
129556276|NCT00606684|466332704|FG005|Double-Blind Treatment Period|Adverse Event|0|||
129556277|NCT00606684|466332705|FG006|Double-Blind Treatment Period|Adverse Event|1|||
129556278|NCT00606684|466332699|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129556279|NCT00606684|466332700|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
129556280|NCT00606684|466332701|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
129556281|NCT00606684|466332702|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
129556282|NCT00606684|466332703|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
129556283|NCT00606684|466332704|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
129556284|NCT00606684|466332705|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
129556285|NCT00606684|466332699|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129556286|NCT00606684|466332700|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
129556287|NCT00606684|466332701|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
129556288|NCT00606684|466332702|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
129556289|NCT00606684|466332703|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
129556290|NCT00606684|466332704|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
129556291|NCT00606684|466332705|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
129556292|NCT00606684|466332699|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
129556293|NCT00606684|466332700|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
129556294|NCT00606684|466332701|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
129556295|NCT00606684|466332702|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
129556296|NCT00606684|466332703|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
129556297|NCT00606684|466332704|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
129556298|NCT00606684|466332705|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
129556299|NCT00606684|466332699|FG000|Double-Blind Treatment Period|Physician Decision|0|||
129556300|NCT00606684|466332700|FG001|Double-Blind Treatment Period|Physician Decision|5|||
129556301|NCT00606684|466332701|FG002|Double-Blind Treatment Period|Physician Decision|1|||
129556302|NCT00606684|466332702|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129556303|NCT00606684|466332703|FG004|Double-Blind Treatment Period|Physician Decision|3|||
129556304|NCT00606684|466332704|FG005|Double-Blind Treatment Period|Physician Decision|1|||
129556305|NCT00606684|466332705|FG006|Double-Blind Treatment Period|Physician Decision|2|||
129556306|NCT00606684|466332699|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129556307|NCT00606684|466332700|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129556308|NCT00606684|466332701|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129556309|NCT00606684|466332702|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129556310|NCT00606684|466332703|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129556311|NCT00606684|466332704|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129556312|NCT00606684|466332705|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129556313|NCT02763579|466332706|FG000|Global Period|Death|167|||
129556314|NCT02763579|466332707|FG001|Global Period|Death|151|||
129556315|NCT02763579|466332708|FG002|Global Period|Death|0|||
129556316|NCT02763579|466332709|FG003|Global Period|Death|0|||
129556317|NCT02763579|466332706|FG000|Global Period|Lost to Follow-up|2|||
129556318|NCT02763579|466332707|FG001|Global Period|Lost to Follow-up|4|||
129556319|NCT02763579|466332708|FG002|Global Period|Lost to Follow-up|0|||
129556320|NCT02763579|466332709|FG003|Global Period|Lost to Follow-up|0|||
129556321|NCT02763579|466332706|FG000|Global Period|Physician Decision|0|||
129556322|NCT02763579|466332707|FG001|Global Period|Physician Decision|2|||
129556323|NCT02763579|466332708|FG002|Global Period|Physician Decision|0|||
129556324|NCT02763579|466332709|FG003|Global Period|Physician Decision|0|||
129556325|NCT02763579|466332706|FG000|Global Period|Study Terminated By Sponsor|21|||
129556326|NCT02763579|466332707|FG001|Global Period|Study Terminated By Sponsor|26|||
129556327|NCT02763579|466332708|FG002|Global Period|Study Terminated By Sponsor|0|||
129556328|NCT02763579|466332709|FG003|Global Period|Study Terminated By Sponsor|0|||
129556329|NCT02763579|466332706|FG000|Global Period|Withdrawal by Subject|12|||
129556330|NCT02763579|466332707|FG001|Global Period|Withdrawal by Subject|18|||
129556331|NCT02763579|466332708|FG002|Global Period|Withdrawal by Subject|0|||
129556332|NCT02763579|466332709|FG003|Global Period|Withdrawal by Subject|0|||
129556333|NCT02763579|466332706|FG000|China Period|Death|0|||
129556334|NCT02763579|466332707|FG001|China Period|Death|0|||
129556335|NCT02763579|466332708|FG002|China Period|Death|46|||
129777297|NCT02858362|467151294|FG002|Overall Study|Early Study Termination|3|||
129777298|NCT02858362|467151292|FG000|Overall Study|Lost to Follow-up|1|||
129777299|NCT02858362|467151293|FG001|Overall Study|Lost to Follow-up|0|||
129777300|NCT02858362|467151294|FG002|Overall Study|Lost to Follow-up|0|||
129777301|NCT02813577|467151296|FG000|Overall Study|Study terminated|4|||
129556336|NCT02763579|466332709|FG003|China Period|Death|48|||
129556337|NCT02763579|466332706|FG000|China Period|Lost to Follow-up|0|||
129556338|NCT02763579|466332707|FG001|China Period|Lost to Follow-up|0|||
129556339|NCT02763579|466332708|FG002|China Period|Lost to Follow-up|1|||
129556340|NCT02763579|466332709|FG003|China Period|Lost to Follow-up|1|||
129556341|NCT02763579|466332706|FG000|China Period|Physician Decision|0|||
129556342|NCT02763579|466332707|FG001|China Period|Physician Decision|0|||
129556343|NCT02763579|466332708|FG002|China Period|Physician Decision|0|||
129556344|NCT02763579|466332709|FG003|China Period|Physician Decision|1|||
129556345|NCT02763579|466332706|FG000|China Period|Study Terminated By Sponsor|0|||
129556346|NCT02763579|466332707|FG001|China Period|Study Terminated By Sponsor|0|||
129556347|NCT02763579|466332708|FG002|China Period|Study Terminated By Sponsor|3|||
129556348|NCT02763579|466332709|FG003|China Period|Study Terminated By Sponsor|4|||
129556349|NCT02763579|466332706|FG000|China Period|Withdrawal by Subject|0|||
129556350|NCT02763579|466332707|FG001|China Period|Withdrawal by Subject|0|||
129556351|NCT02763579|466332708|FG002|China Period|Withdrawal by Subject|3|||
129556352|NCT02763579|466332709|FG003|China Period|Withdrawal by Subject|3|||
129556353|NCT00910858|466332715|FG000|Pharmacokinetic Phase|Adverse Event|1|||
129556354|NCT00910858|466332716|FG001|Pharmacokinetic Phase|Adverse Event|0|||
129556355|NCT00910858|466332717|FG002|Pharmacokinetic Phase|Adverse Event|0|||
129556356|NCT00910858|466332715|FG000|Monotherapy Phase|Adverse Event|3|||
129556357|NCT00910858|466332716|FG001|Monotherapy Phase|Adverse Event|2|||
129556358|NCT00910858|466332717|FG002|Monotherapy Phase|Adverse Event|0|||
129556359|NCT00910858|466332715|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
129556360|NCT00910858|466332716|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
129556361|NCT00910858|466332717|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
129556362|NCT00910858|466332715|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
129556363|NCT00910858|466332716|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
129556364|NCT00910858|466332717|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
129556365|NCT00910858|466332715|FG000|Monotherapy Phase|Protocol Violation|1|||
129556366|NCT00910858|466332716|FG001|Monotherapy Phase|Protocol Violation|0|||
129556367|NCT00910858|466332717|FG002|Monotherapy Phase|Protocol Violation|0|||
129556368|NCT00910858|466332715|FG000|Monotherapy Phase|Other|3|||
129556369|NCT00910858|466332716|FG001|Monotherapy Phase|Other|4|||
129556370|NCT00910858|466332717|FG002|Monotherapy Phase|Other|2|||
129556371|NCT00910858|466332715|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
129556372|NCT00910858|466332716|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
129556373|NCT00910858|466332717|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
129556374|NCT00910858|466332715|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
129556375|NCT00910858|466332716|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
129556376|NCT00910858|466332717|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
129556377|NCT00910858|466332715|FG000|Combined Treatment Phase|Protocol Violation|1|||
129556378|NCT00910858|466332716|FG001|Combined Treatment Phase|Protocol Violation|0|||
129556379|NCT00910858|466332717|FG002|Combined Treatment Phase|Protocol Violation|0|||
129556380|NCT00910858|466332715|FG000|Combined Treatment Phase|Other|0|||
129556381|NCT00910858|466332716|FG001|Combined Treatment Phase|Other|2|||
129556382|NCT00910858|466332717|FG002|Combined Treatment Phase|Other|1|||
129556383|NCT01703741|466332724|FG000|Overall Study|Withdrawal by Subject|6|||
129556384|NCT01703741|466332724|FG000|Overall Study|Adverse Event|2|||
129556385|NCT01703741|466332724|FG000|Overall Study|Physician Decision|2|||
129556386|NCT01703741|466332724|FG000|Overall Study|Protocol Violation|1|||
129556387|NCT01703741|466332724|FG000|Overall Study|Lost to Follow-up|3|||
129556388|NCT01703741|466332724|FG000|Overall Study|Subject did not want to continue|2|||
129556389|NCT01703741|466332724|FG000|Overall Study|Subject cannot comply with study visits|1|||
129556390|NCT01703741|466332724|FG000|Overall Study|Subject started testosterone injections|1|||
129556391|NCT01170364|466332725|FG000|Overall Study|Protocol Violation|4|||
129556392|NCT01170364|466332726|FG001|Overall Study|Protocol Violation|1|||
129556393|NCT01381900|466332727|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
129556394|NCT01381900|466332728|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
129556395|NCT01381900|466332729|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
129556396|NCT01381900|466332727|FG000|Overall Study|Adverse Event|4|||
129556397|NCT01381900|466332728|FG001|Overall Study|Adverse Event|6|||
129556398|NCT01381900|466332729|FG002|Overall Study|Adverse Event|7|||
129556399|NCT01381900|466332727|FG000|Overall Study|Noncompliance with study drug|0|||
129777302|NCT01301027|467151297|FG000|Overall Study|Physician Decision|2|||
129777303|NCT01301027|467151298|FG001|Overall Study|Physician Decision|0|||
129777304|NCT01301027|467151297|FG000|Overall Study|Withdrawal by Subject|2|||
129777305|NCT01301027|467151298|FG001|Overall Study|Withdrawal by Subject|3|||
129777306|NCT01301027|467151297|FG000|Overall Study|Adverse Event|0|||
129777307|NCT01301027|467151298|FG001|Overall Study|Adverse Event|2|||
129777308|NCT01301027|467151297|FG000|Overall Study|Fracture|1|||
129777309|NCT01301027|467151298|FG001|Overall Study|Fracture|3|||
129777310|NCT01301027|467151297|FG000|Overall Study|Transplant|0|||
129777311|NCT01301027|467151298|FG001|Overall Study|Transplant|2|||
129777312|NCT01301027|467151297|FG000|Overall Study|Volume Overload|3|||
129777313|NCT01301027|467151298|FG001|Overall Study|Volume Overload|0|||
129556400|NCT01381900|466332728|FG001|Overall Study|Noncompliance with study drug|0|||
129556401|NCT01381900|466332729|FG002|Overall Study|Noncompliance with study drug|1|||
129556402|NCT01381900|466332727|FG000|Overall Study|Physician Decision|0|||
129556403|NCT01381900|466332728|FG001|Overall Study|Physician Decision|1|||
129777314|NCT02023697|467151299|FG000|Treatment Period|Radiological progression|13|||
129556404|NCT01381900|466332729|FG002|Overall Study|Physician Decision|1|||
129556405|NCT01381900|466332727|FG000|Overall Study|Protocol Violation|0|||
129777315|NCT02023697|467151300|FG001|Treatment Period|Radiological progression|17|||
129777316|NCT02023697|467151301|FG002|Treatment Period|Radiological progression|26|||
129777317|NCT02023697|467151299|FG000|Treatment Period|Never Treated|5|||
129777318|NCT02023697|467151300|FG001|Treatment Period|Never Treated|6|||
129777319|NCT02023697|467151301|FG002|Treatment Period|Never Treated|10|||
129777320|NCT02023697|467151299|FG000|Treatment Period|Adverse Event|13|||
129777321|NCT02023697|467151300|FG001|Treatment Period|Adverse Event|25|||
129556406|NCT01381900|466332728|FG001|Overall Study|Protocol Violation|1|||
129556407|NCT01381900|466332729|FG002|Overall Study|Protocol Violation|1|||
129556408|NCT01381900|466332727|FG000|Overall Study|Withdrawal by Subject|0|||
129556409|NCT01381900|466332728|FG001|Overall Study|Withdrawal by Subject|0|||
129556410|NCT01381900|466332729|FG002|Overall Study|Withdrawal by Subject|1|||
129556411|NCT01381900|466332727|FG000|Overall Study|Early withdraw|3|||
129556412|NCT01381900|466332728|FG001|Overall Study|Early withdraw|1|||
129556413|NCT01381900|466332729|FG002|Overall Study|Early withdraw|1|||
129556414|NCT02041494|466332730|FG000|Overall Study|Death|1|||
129556415|NCT02041494|466332731|FG001|Overall Study|Death|3|||
129556416|NCT02041494|466332730|FG000|Overall Study|Lost to Follow-up|2|||
129556417|NCT02041494|466332731|FG001|Overall Study|Lost to Follow-up|6|||
129556418|NCT02041494|466332730|FG000|Overall Study|study terminated|16|||
129556419|NCT02041494|466332731|FG001|Overall Study|study terminated|11|||
129556420|NCT02965820|466332735|FG000|Period 2, Second 30 Days|Adverse Event|1|||
129556421|NCT02965820|466332736|FG001|Period 2, Second 30 Days|Adverse Event|1|||
129556422|NCT01967888|466332737|FG000|Overall Study|Lost to Follow-up|6|||
129556423|NCT01967888|466332738|FG001|Overall Study|Lost to Follow-up|4|||
129556424|NCT01967888|466332737|FG000|Overall Study|Withdrawal by Subject|1|||
129556425|NCT01967888|466332738|FG001|Overall Study|Withdrawal by Subject|1|||
129556426|NCT01967888|466332737|FG000|Overall Study|Did Not Have Transplant|1|||
129556427|NCT01967888|466332738|FG001|Overall Study|Did Not Have Transplant|0|||
129556428|NCT01967888|466332737|FG000|Overall Study|Research visit not done, data recorded|1|||
129556429|NCT01967888|466332738|FG001|Overall Study|Research visit not done, data recorded|0|||
129556430|NCT01967888|466332737|FG000|Overall Study|Subject excluded after randomization|1|||
129556431|NCT01967888|466332738|FG001|Overall Study|Subject excluded after randomization|0|||
129556432|NCT01967888|466332737|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
129556433|NCT01967888|466332738|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
129556434|NCT01967888|466332737|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
129556435|NCT01967888|466332738|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
129556436|NCT00553540|466332739|FG000|Overall Study|discharged after first visit|2|||
129556437|NCT00553540|466332740|FG001|Overall Study|discharged after first visit|5|||
129556438|NCT02622074|466332741|FG000|Overall Study|Death|4|||
129556439|NCT02622074|466332742|FG001|Overall Study|Death|0|||
129556440|NCT02622074|466332743|FG002|Overall Study|Death|0|||
129556441|NCT02622074|466332744|FG003|Overall Study|Death|1|||
129556442|NCT02622074|466332745|FG004|Overall Study|Death|1|||
129556443|NCT02622074|466332746|FG005|Overall Study|Death|0|||
129556444|NCT02622074|466332741|FG000|Overall Study|Withdrawal by Subject|0|||
129556445|NCT02622074|466332742|FG001|Overall Study|Withdrawal by Subject|1|||
129556446|NCT02622074|466332743|FG002|Overall Study|Withdrawal by Subject|0|||
129556447|NCT02622074|466332744|FG003|Overall Study|Withdrawal by Subject|0|||
129556448|NCT02622074|466332745|FG004|Overall Study|Withdrawal by Subject|0|||
129556449|NCT02622074|466332746|FG005|Overall Study|Withdrawal by Subject|0|||
129556450|NCT02114931|466332747|FG000|Overall Study|Withdrawal by Subject|15|||
129556451|NCT02114931|466332748|FG001|Overall Study|Withdrawal by Subject|18|||
129556452|NCT02114931|466332747|FG000|Overall Study|Adverse Event|4|||
129556453|NCT02114931|466332748|FG001|Overall Study|Adverse Event|6|||
129556454|NCT02114931|466332747|FG000|Overall Study|Lost to Follow-up|3|||
129556455|NCT02114931|466332748|FG001|Overall Study|Lost to Follow-up|3|||
129556456|NCT02114931|466332747|FG000|Overall Study|Physician Decision|1|||
129556457|NCT02114931|466332748|FG001|Overall Study|Physician Decision|2|||
129556458|NCT02114931|466332747|FG000|Overall Study|Other|2|||
129556459|NCT02114931|466332748|FG001|Overall Study|Other|1|||
129556460|NCT03565211|466332750|FG000|Overall Study|Withdrawal by Subject|2|||
129777322|NCT02023697|467151301|FG002|Treatment Period|Adverse Event|23|||
129777323|NCT02023697|467151299|FG000|Treatment Period|Logistical difficulties|1|||
129556461|NCT03565211|466332750|FG000|Overall Study|Lost to Follow-up|1|||
129556462|NCT03565211|466332750|FG000|Overall Study|Adverse Event|44|||
129556463|NCT03565211|466332750|FG000|Overall Study|Personal issues|1|||
129556464|NCT01894984|466332754|FG000|Overall Study|Other|314|||
129556465|NCT01894984|466332755|FG001|Overall Study|Other|175|||
129556466|NCT03840135|466332757|FG000|Overall Study|Protocol Violation|6|||
129556467|NCT03840135|466332758|FG001|Overall Study|Protocol Violation|1|||
129556468|NCT03840135|466332757|FG000|Overall Study|Withdrawal by Subject|1|||
129777324|NCT02023697|467151300|FG001|Treatment Period|Logistical difficulties|1|||
129777325|NCT02023697|467151301|FG002|Treatment Period|Logistical difficulties|1|||
129556469|NCT03840135|466332758|FG001|Overall Study|Withdrawal by Subject|0|||
129556470|NCT01809314|466332759|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
129556471|NCT01809314|466332759|FG000|Overall Study|Adverse Event|6|||
129556472|NCT01809314|466332759|FG000|Overall Study|Insufficient Therapeutic Response|14|||
129556473|NCT01809314|466332759|FG000|Overall Study|Lost to Follow-up|724|||
129556474|NCT01427803|466332764|FG000|Overall Study|Lost to Follow-up|32|||
129556475|NCT01427803|466332765|FG001|Overall Study|Lost to Follow-up|26|||
129556476|NCT01427803|466332764|FG000|Overall Study|Withdrawal by Subject|20|||
129556477|NCT01427803|466332765|FG001|Overall Study|Withdrawal by Subject|0|||
129556478|NCT01427803|466332764|FG000|Overall Study|Unable to complete full treatment period|6|||
129556479|NCT01427803|466332765|FG001|Overall Study|Unable to complete full treatment period|0|||
129556480|NCT01427803|466332764|FG000|Overall Study|Protocol Violation|1|||
129556481|NCT01427803|466332765|FG001|Overall Study|Protocol Violation|0|||
129556482|NCT01427803|466332764|FG000|Overall Study|Physician Decision|3|||
129556483|NCT01427803|466332765|FG001|Overall Study|Physician Decision|0|||
129556484|NCT01427803|466332764|FG000|Overall Study|did not take product|1|||
129556485|NCT01427803|466332765|FG001|Overall Study|did not take product|0|||
129556486|NCT00863057|466332766|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
129556487|NCT00863057|466332767|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
129556488|NCT00863057|466332768|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
129556489|NCT00863057|466332769|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
129556490|NCT00863057|466332766|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129556491|NCT00863057|466332767|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
129556492|NCT00863057|466332768|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129556493|NCT00863057|466332769|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
129556494|NCT00863057|466332766|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
129556495|NCT00863057|466332767|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
129556496|NCT00863057|466332768|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
129556497|NCT00863057|466332769|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
129556498|NCT00863057|466332766|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
129556499|NCT00863057|466332767|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
129556500|NCT00863057|466332768|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
129556501|NCT00863057|466332769|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
129556502|NCT02741271|466332772|FG000|Overall Study|Lost to Follow-up|2|||
129556503|NCT02741271|466332773|FG001|Overall Study|Lost to Follow-up|0|||
129556504|NCT02741271|466332772|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129556505|NCT02741271|466332773|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129556506|NCT01612156|466332774|FG000|Overall Study|Protocol Violation|2|||
129556507|NCT01612156|466332775|FG001|Overall Study|Protocol Violation|0|||
129556508|NCT00410410|466332776|FG000|Induction Period (IP)|Death|1|||
129556509|NCT00410410|466332777|FG001|Induction Period (IP)|Death|0|||
129556510|NCT00410410|466332778|FG002|Induction Period (IP)|Death|0|||
129556511|NCT00410410|466332779|FG003|Induction Period (IP)|Death|0|||
129556512|NCT00410410|466332780|FG004|Induction Period (IP)|Death|0|||
129556513|NCT00410410|466332781|FG005|Induction Period (IP)|Death|0|||
129556514|NCT00410410|466332782|FG006|Induction Period (IP)|Death|0|||
129556515|NCT00410410|466332783|FG007|Induction Period (IP)|Death|0|||
129556516|NCT00410410|466332784|FG008|Induction Period (IP)|Death|0|||
129556517|NCT00410410|466332776|FG000|Induction Period (IP)|Adverse Event|3|||
129556518|NCT00410410|466332777|FG001|Induction Period (IP)|Adverse Event|4|||
129556519|NCT00410410|466332778|FG002|Induction Period (IP)|Adverse Event|2|||
129556520|NCT00410410|466332779|FG003|Induction Period (IP)|Adverse Event|4|||
129556521|NCT00410410|466332780|FG004|Induction Period (IP)|Adverse Event|1|||
129556522|NCT00410410|466332781|FG005|Induction Period (IP)|Adverse Event|0|||
129556523|NCT00410410|466332782|FG006|Induction Period (IP)|Adverse Event|0|||
129556524|NCT00410410|466332783|FG007|Induction Period (IP)|Adverse Event|0|||
129556525|NCT00410410|466332784|FG008|Induction Period (IP)|Adverse Event|0|||
129556526|NCT00410410|466332776|FG000|Induction Period (IP)|Lack of Efficacy|26|||
129556527|NCT00410410|466332777|FG001|Induction Period (IP)|Lack of Efficacy|24|||
129556528|NCT00410410|466332778|FG002|Induction Period (IP)|Lack of Efficacy|8|||
129556529|NCT00410410|466332779|FG003|Induction Period (IP)|Lack of Efficacy|8|||
129556530|NCT00410410|466332780|FG004|Induction Period (IP)|Lack of Efficacy|7|||
129556531|NCT00410410|466332781|FG005|Induction Period (IP)|Lack of Efficacy|7|||
129556532|NCT00410410|466332782|FG006|Induction Period (IP)|Lack of Efficacy|0|||
129556533|NCT00410410|466332783|FG007|Induction Period (IP)|Lack of Efficacy|0|||
129556534|NCT00410410|466332784|FG008|Induction Period (IP)|Lack of Efficacy|0|||
129556535|NCT00410410|466332776|FG000|Induction Period (IP)|Lost to Follow-up|2|||
129556536|NCT00410410|466332777|FG001|Induction Period (IP)|Lost to Follow-up|2|||
129556537|NCT00410410|466332778|FG002|Induction Period (IP)|Lost to Follow-up|2|||
129556538|NCT00410410|466332779|FG003|Induction Period (IP)|Lost to Follow-up|3|||
129556539|NCT00410410|466332780|FG004|Induction Period (IP)|Lost to Follow-up|0|||
129556540|NCT00410410|466332781|FG005|Induction Period (IP)|Lost to Follow-up|1|||
129556541|NCT00410410|466332782|FG006|Induction Period (IP)|Lost to Follow-up|0|||
129556542|NCT00410410|466332783|FG007|Induction Period (IP)|Lost to Follow-up|0|||
129556543|NCT00410410|466332784|FG008|Induction Period (IP)|Lost to Follow-up|0|||
129556544|NCT00410410|466332776|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
129556545|NCT00410410|466332777|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
129556546|NCT00410410|466332778|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
129556547|NCT00410410|466332779|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
129556548|NCT00410410|466332780|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
129556549|NCT00410410|466332781|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
129556550|NCT00410410|466332782|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
129556551|NCT00410410|466332783|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
129556552|NCT00410410|466332784|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
129556553|NCT00410410|466332776|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556554|NCT00410410|466332777|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556555|NCT00410410|466332778|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
129556556|NCT00410410|466332779|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556557|NCT00410410|466332780|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556558|NCT00410410|466332781|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556559|NCT00410410|466332782|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556560|NCT00410410|466332783|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556561|NCT00410410|466332784|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
129556562|NCT00410410|466332776|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556563|NCT00410410|466332777|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556564|NCT00410410|466332778|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556565|NCT00410410|466332779|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556566|NCT00410410|466332780|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
129556567|NCT00410410|466332781|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
129556568|NCT00410410|466332782|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556569|NCT00410410|466332783|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556570|NCT00410410|466332784|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
129556571|NCT00410410|466332776|FG000|Induction Period (IP)|Other|0|||
129556572|NCT00410410|466332777|FG001|Induction Period (IP)|Other|0|||
129556573|NCT00410410|466332778|FG002|Induction Period (IP)|Other|1|||
129556574|NCT00410410|466332779|FG003|Induction Period (IP)|Other|0|||
129556575|NCT00410410|466332780|FG004|Induction Period (IP)|Other|0|||
129556576|NCT00410410|466332781|FG005|Induction Period (IP)|Other|0|||
129556577|NCT00410410|466332782|FG006|Induction Period (IP)|Other|0|||
129556578|NCT00410410|466332783|FG007|Induction Period (IP)|Other|0|||
129556579|NCT00410410|466332784|FG008|Induction Period (IP)|Other|0|||
129556580|NCT00410410|466332776|FG000|Maintenance Period (MP)|Death|0|||
129556581|NCT00410410|466332777|FG001|Maintenance Period (MP)|Death|0|||
129556582|NCT00410410|466332778|FG002|Maintenance Period (MP)|Death|0|||
129556583|NCT00410410|466332779|FG003|Maintenance Period (MP)|Death|0|||
129556584|NCT00410410|466332780|FG004|Maintenance Period (MP)|Death|0|||
129556585|NCT00410410|466332781|FG005|Maintenance Period (MP)|Death|0|||
129556586|NCT00410410|466332782|FG006|Maintenance Period (MP)|Death|1|||
129556587|NCT00410410|466332783|FG007|Maintenance Period (MP)|Death|0|||
129556588|NCT00410410|466332784|FG008|Maintenance Period (MP)|Death|0|||
129556589|NCT00410410|466332776|FG000|Maintenance Period (MP)|Adverse Event|0|||
129556590|NCT00410410|466332777|FG001|Maintenance Period (MP)|Adverse Event|0|||
129556591|NCT00410410|466332778|FG002|Maintenance Period (MP)|Adverse Event|0|||
129556592|NCT00410410|466332779|FG003|Maintenance Period (MP)|Adverse Event|0|||
129556593|NCT00410410|466332780|FG004|Maintenance Period (MP)|Adverse Event|0|||
129556594|NCT00410410|466332781|FG005|Maintenance Period (MP)|Adverse Event|0|||
129556595|NCT00410410|466332782|FG006|Maintenance Period (MP)|Adverse Event|1|||
129556596|NCT00410410|466332783|FG007|Maintenance Period (MP)|Adverse Event|3|||
129556597|NCT00410410|466332784|FG008|Maintenance Period (MP)|Adverse Event|0|||
129556598|NCT00410410|466332776|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
129556599|NCT00410410|466332777|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
129556600|NCT00410410|466332778|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
129556601|NCT00410410|466332779|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
129556602|NCT00410410|466332780|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
129556603|NCT00410410|466332781|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
129556604|NCT00410410|466332782|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
129556605|NCT00410410|466332783|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
129556606|NCT00410410|466332784|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
129556607|NCT00410410|466332776|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
129556608|NCT00410410|466332777|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
129556609|NCT00410410|466332778|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
129556610|NCT00410410|466332779|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
129556611|NCT00410410|466332780|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
129556612|NCT00410410|466332781|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
129556613|NCT00410410|466332782|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
129556614|NCT00410410|466332783|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
129556615|NCT00410410|466332784|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
129556616|NCT00410410|466332776|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556617|NCT00410410|466332777|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556618|NCT00410410|466332778|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556619|NCT00410410|466332779|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556620|NCT00410410|466332780|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556621|NCT00410410|466332781|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556622|NCT00410410|466332782|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
129556623|NCT00410410|466332783|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
129556624|NCT00410410|466332784|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
129556625|NCT00410410|466332776|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129556626|NCT00410410|466332777|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129556627|NCT00410410|466332778|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129556628|NCT00410410|466332779|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129777326|NCT02023697|467151299|FG000|Treatment Period|Clinical progression|10|||
129777327|NCT02023697|467151300|FG001|Treatment Period|Clinical progression|8|||
129777328|NCT02023697|467151301|FG002|Treatment Period|Clinical progression|28|||
129556629|NCT00410410|466332780|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129777329|NCT02023697|467151299|FG000|Treatment Period|Withdrawal by Subject|4|||
129556630|NCT00410410|466332781|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129556631|NCT00410410|466332782|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
129556632|NCT00410410|466332783|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
129556633|NCT00410410|466332784|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
129556634|NCT00410410|466332776|FG000|Open-Label Period (OL)|Death|0|||
129556635|NCT00410410|466332777|FG001|Open-Label Period (OL)|Death|0|||
129777330|NCT02023697|467151300|FG001|Treatment Period|Withdrawal by Subject|5|||
129556636|NCT00410410|466332778|FG002|Open-Label Period (OL)|Death|0|||
129556637|NCT00410410|466332779|FG003|Open-Label Period (OL)|Death|0|||
129556638|NCT00410410|466332780|FG004|Open-Label Period (OL)|Death|0|||
129556639|NCT00410410|466332781|FG005|Open-Label Period (OL)|Death|0|||
129556640|NCT00410410|466332782|FG006|Open-Label Period (OL)|Death|0|||
129556641|NCT00410410|466332783|FG007|Open-Label Period (OL)|Death|0|||
129556642|NCT00410410|466332784|FG008|Open-Label Period (OL)|Death|1|||
129556643|NCT00410410|466332776|FG000|Open-Label Period (OL)|Adverse Event|0|||
129556644|NCT00410410|466332777|FG001|Open-Label Period (OL)|Adverse Event|0|||
129556645|NCT00410410|466332778|FG002|Open-Label Period (OL)|Adverse Event|0|||
129556646|NCT00410410|466332779|FG003|Open-Label Period (OL)|Adverse Event|0|||
129556647|NCT00410410|466332780|FG004|Open-Label Period (OL)|Adverse Event|0|||
129556648|NCT00410410|466332781|FG005|Open-Label Period (OL)|Adverse Event|0|||
129556649|NCT00410410|466332782|FG006|Open-Label Period (OL)|Adverse Event|0|||
129556650|NCT00410410|466332783|FG007|Open-Label Period (OL)|Adverse Event|0|||
129556651|NCT00410410|466332784|FG008|Open-Label Period (OL)|Adverse Event|10|||
129556652|NCT00410410|466332776|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
129556653|NCT00410410|466332777|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
129556654|NCT00410410|466332778|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
129556655|NCT00410410|466332779|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
129556656|NCT00410410|466332780|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
129556657|NCT00410410|466332781|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
129556658|NCT00410410|466332782|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
129556659|NCT00410410|466332783|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
129556660|NCT00410410|466332784|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
129556661|NCT00410410|466332776|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
129556662|NCT00410410|466332777|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
129556663|NCT00410410|466332778|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
129556664|NCT00410410|466332779|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
129556665|NCT00410410|466332780|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
129556666|NCT00410410|466332781|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
129556667|NCT00410410|466332782|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
129556668|NCT00410410|466332783|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
129556669|NCT00410410|466332784|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
129556670|NCT00410410|466332776|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556671|NCT00410410|466332777|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556672|NCT00410410|466332778|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556673|NCT00410410|466332779|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556674|NCT00410410|466332780|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556675|NCT00410410|466332781|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556676|NCT00410410|466332782|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556677|NCT00410410|466332783|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
129556678|NCT00410410|466332784|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
129556679|NCT00410410|466332776|FG000|Open-Label Period (OL)|Pregnancy|0|||
129556680|NCT00410410|466332777|FG001|Open-Label Period (OL)|Pregnancy|0|||
129556681|NCT00410410|466332778|FG002|Open-Label Period (OL)|Pregnancy|0|||
129556682|NCT00410410|466332779|FG003|Open-Label Period (OL)|Pregnancy|0|||
129556683|NCT00410410|466332780|FG004|Open-Label Period (OL)|Pregnancy|0|||
129556684|NCT00410410|466332781|FG005|Open-Label Period (OL)|Pregnancy|0|||
129556685|NCT00410410|466332782|FG006|Open-Label Period (OL)|Pregnancy|0|||
129556686|NCT00410410|466332783|FG007|Open-Label Period (OL)|Pregnancy|0|||
129556687|NCT00410410|466332784|FG008|Open-Label Period (OL)|Pregnancy|1|||
129556688|NCT00410410|466332776|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556689|NCT00410410|466332777|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556690|NCT00410410|466332778|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556691|NCT00410410|466332779|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556692|NCT00410410|466332780|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556693|NCT00410410|466332781|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556694|NCT00410410|466332782|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556695|NCT00410410|466332783|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
129556696|NCT00410410|466332784|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
129556697|NCT00410410|466332776|FG000|Open-Label Period (OL)|Other|0|||
129556698|NCT00410410|466332777|FG001|Open-Label Period (OL)|Other|0|||
129556699|NCT00410410|466332778|FG002|Open-Label Period (OL)|Other|0|||
129556700|NCT00410410|466332779|FG003|Open-Label Period (OL)|Other|0|||
129556701|NCT00410410|466332780|FG004|Open-Label Period (OL)|Other|0|||
129556702|NCT00410410|466332781|FG005|Open-Label Period (OL)|Other|0|||
129556703|NCT00410410|466332782|FG006|Open-Label Period (OL)|Other|0|||
129556704|NCT00410410|466332783|FG007|Open-Label Period (OL)|Other|0|||
129556705|NCT00410410|466332784|FG008|Open-Label Period (OL)|Other|7|||
129556706|NCT01023269|466332785|FG000|Overall Study|early termination of the study|2|||
129556707|NCT01023269|466332786|FG001|Overall Study|early termination of the study|0|||
129556708|NCT00947011|466332789|FG000|Overall Study|Study was terminated,PI left institution|12|||
129556709|NCT00814658|466332790|FG000|Overall Study|Lost to Follow-up|0|||
129556710|NCT00814658|466332791|FG001|Overall Study|Lost to Follow-up|1|||
129556711|NCT00814658|466332790|FG000|Overall Study|Physician Decision|1|||
129556712|NCT00814658|466332791|FG001|Overall Study|Physician Decision|0|||
129556713|NCT00814658|466332790|FG000|Overall Study|Adverse Event|3|||
129556714|NCT00814658|466332791|FG001|Overall Study|Adverse Event|3|||
129556715|NCT05266456|466332792|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
129556716|NCT05266456|466332793|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
129556717|NCT05266456|466332794|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
129556718|NCT05266456|466332795|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
129556719|NCT05266456|466332792|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
129556720|NCT05266456|466332793|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
129556721|NCT05266456|466332794|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
129556722|NCT05266456|466332795|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
129556723|NCT05266456|466332792|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
129556724|NCT05266456|466332793|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
129556725|NCT05266456|466332794|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
129556726|NCT05266456|466332795|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
129556727|NCT05266456|466332792|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
129556728|NCT05266456|466332793|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
129556729|NCT05266456|466332794|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
129556730|NCT05266456|466332795|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
129556731|NCT05266456|466332792|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
129556732|NCT05266456|466332793|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
129556733|NCT05266456|466332794|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
129556734|NCT05266456|466332795|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
129556735|NCT01141283|466332796|FG000|Overall Study|Adverse Event|56|||
129556736|NCT01141283|466332796|FG000|Overall Study|Lost to Follow-up|4|||
129556737|NCT01141283|466332796|FG000|Overall Study|Withdrawal by Subject|14|||
129556738|NCT01141283|466332796|FG000|Overall Study|Administrative|4|||
129556739|NCT01141283|466332796|FG000|Overall Study|Lack of Efficacy|10|||
129556740|NCT02868281|466332797|FG000|Overall Study|Adverse Event|2|||
129556741|NCT02868281|466332798|FG001|Overall Study|Adverse Event|2|||
129556742|NCT02868281|466332797|FG000|Overall Study|Protocol Violation|13|||
129556743|NCT02868281|466332798|FG001|Overall Study|Protocol Violation|10|||
129556744|NCT02868281|466332797|FG000|Overall Study|Lost to Follow-up|3|||
129556745|NCT02868281|466332798|FG001|Overall Study|Lost to Follow-up|6|||
129556746|NCT02868281|466332797|FG000|Overall Study|Withdrawal by Subject|11|||
129556747|NCT02868281|466332798|FG001|Overall Study|Withdrawal by Subject|15|||
129556748|NCT02868281|466332797|FG000|Overall Study|Physician Decision|2|||
129556749|NCT02868281|466332798|FG001|Overall Study|Physician Decision|0|||
129556750|NCT02868281|466332797|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
129556751|NCT02868281|466332798|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
129556752|NCT02868281|466332797|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
129556753|NCT02868281|466332798|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
129556754|NCT02868281|466332797|FG000|Overall Study|Long journey/moving away|1|||
129556755|NCT02868281|466332798|FG001|Overall Study|Long journey/moving away|1|||
129556756|NCT03124381|466332799|FG000|Overall Study|Lost to Follow-up|1|||
129556757|NCT03124381|466332800|FG001|Overall Study|Lost to Follow-up|1|||
129556758|NCT03124381|466332799|FG000|Overall Study|Withdrawal by Subject|6|||
129556759|NCT03124381|466332800|FG001|Overall Study|Withdrawal by Subject|3|||
129556760|NCT03124381|466332799|FG000|Overall Study|Protocol Violation|0|||
129556761|NCT03124381|466332800|FG001|Overall Study|Protocol Violation|1|||
129556762|NCT03124381|466332799|FG000|Overall Study|Adverse Event|1|||
129556763|NCT03124381|466332800|FG001|Overall Study|Adverse Event|1|||
129777331|NCT02023697|467151301|FG002|Treatment Period|Withdrawal by Subject|13|||
129777332|NCT02023697|467151299|FG000|Treatment Period|Safety outcome reached|0|||
129777333|NCT02023697|467151300|FG001|Treatment Period|Safety outcome reached|1|||
129777334|NCT02023697|467151301|FG002|Treatment Period|Safety outcome reached|0|||
129777335|NCT02023697|467151299|FG000|Treatment Period|Physician Decision|0|||
129777336|NCT02023697|467151300|FG001|Treatment Period|Physician Decision|0|||
129777337|NCT02023697|467151301|FG002|Treatment Period|Physician Decision|1|||
129777338|NCT02023697|467151299|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
129777339|NCT02023697|467151300|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
129777340|NCT02023697|467151301|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
129777341|NCT02023697|467151299|FG000|Active Follow-up Period|Lost to Follow-up|1|||
129777342|NCT02023697|467151300|FG001|Active Follow-up Period|Lost to Follow-up|1|||
129556764|NCT03124381|466332799|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
129556765|NCT03124381|466332800|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
129556766|NCT02533999|466332806|FG000|Overall Study|Lost to Follow-up|3|||
129556767|NCT02533999|466332807|FG001|Overall Study|Lost to Follow-up|5|||
129777343|NCT02023697|467151301|FG002|Active Follow-up Period|Lost to Follow-up|1|||
129556768|NCT02533999|466332806|FG000|Overall Study|Protocol Violation|3|||
129556769|NCT02533999|466332807|FG001|Overall Study|Protocol Violation|0|||
129556770|NCT02533999|466332806|FG000|Overall Study|Adverse Event|0|||
129556771|NCT02533999|466332807|FG001|Overall Study|Adverse Event|1|||
129556772|NCT02533999|466332806|FG000|Overall Study|Randomized but intervention not received|0|||
129556773|NCT02533999|466332807|FG001|Overall Study|Randomized but intervention not received|1|||
129556774|NCT01875445|466332808|FG000|Overall Study|Lost to Follow-up|5|||
129556775|NCT01875445|466332809|FG001|Overall Study|Lost to Follow-up|0|||
129556776|NCT01875445|466332808|FG000|Overall Study|Withdrawal by Subject|2|||
129556777|NCT01875445|466332809|FG001|Overall Study|Withdrawal by Subject|0|||
129556778|NCT01328054|466332810|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
129556779|NCT01328054|466332811|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
129556780|NCT01328054|466332810|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
129556781|NCT01328054|466332811|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
129556782|NCT01328054|466332810|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
129556783|NCT01328054|466332811|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
129556784|NCT05478603|466332812|FG000|Overall Study|Withdrawal by Subject|0|||
129556785|NCT05478603|466332813|FG001|Overall Study|Withdrawal by Subject|1|||
129556786|NCT05478603|466332814|FG002|Overall Study|Withdrawal by Subject|0|||
129556787|NCT05478603|466332815|FG003|Overall Study|Withdrawal by Subject|0|||
129556788|NCT00291330|466332818|FG000|Overall Study|Adverse Event|47|||
129556789|NCT00291330|466332819|FG001|Overall Study|Adverse Event|40|||
129556790|NCT00291330|466332818|FG000|Overall Study|Protocol Violation|13|||
129556791|NCT00291330|466332819|FG001|Overall Study|Protocol Violation|20|||
129556792|NCT00291330|466332818|FG000|Overall Study|Lost to Follow-up|16|||
129556793|NCT00291330|466332819|FG001|Overall Study|Lost to Follow-up|11|||
129556794|NCT00291330|466332818|FG000|Overall Study|Withdrawal by Subject|22|||
129556795|NCT00291330|466332819|FG001|Overall Study|Withdrawal by Subject|25|||
129556796|NCT00291330|466332818|FG000|Overall Study|Other|3|||
129556797|NCT00291330|466332819|FG001|Overall Study|Other|1|||
129556798|NCT02378506|466332824|FG000|Overall Study|Lack of Efficacy|3|||
129556799|NCT02378506|466332824|FG000|Overall Study|Withdrawal by Subject|4|||
129556800|NCT02378506|466332824|FG000|Overall Study|Protocol Violation|2|||
129556801|NCT02378506|466332824|FG000|Overall Study|Death|1|||
129556802|NCT02378506|466332824|FG000|Overall Study|Adverse Event|14|||
129556803|NCT02378506|466332824|FG000|Overall Study|Randomized But Not Treated|1|||
129556804|NCT01606137|466332825|FG000|Overall Study|Adverse Event|85|||
129556805|NCT01606137|466332825|FG000|Overall Study|Withdrawal by Subject|74|||
129556806|NCT01606137|466332825|FG000|Overall Study|Lack of Efficacy|56|||
129556807|NCT01606137|466332825|FG000|Overall Study|Lost to Follow-up|15|||
129556808|NCT01606137|466332825|FG000|Overall Study|Protocol Violation|1|||
129556809|NCT01606137|466332825|FG000|Overall Study|Patient non-compliance|9|||
129556810|NCT01606137|466332825|FG000|Overall Study|Death|1|||
129556811|NCT01606137|466332825|FG000|Overall Study|Decreased/no pain|4|||
129556812|NCT01606137|466332825|FG000|Overall Study|Issues with driving|4|||
129556813|NCT01606137|466332825|FG000|Overall Study|multiple sclerosis less stable|1|||
129556814|NCT01606137|466332825|FG000|Overall Study|Increased bilirubin|1|||
129556815|NCT01606137|466332825|FG000|Overall Study|Spray causes nausea|1|||
129556816|NCT01606137|466332825|FG000|Overall Study|Not enough improvement|4|||
129556817|NCT01606137|466332825|FG000|Overall Study|Wanted to try another treatment|1|||
129556818|NCT01606137|466332825|FG000|Overall Study|Patient leaving country|1|||
129556819|NCT01606137|466332825|FG000|Overall Study|Personal reasons|1|||
129556820|NCT01606137|466332825|FG000|Overall Study|Unable to tolerate study med. taste|1|||
129556821|NCT01606137|466332825|FG000|Overall Study|Patient moving|1|||
129556822|NCT01606137|466332825|FG000|Overall Study|Unable to collect consistent data|1|||
129556823|NCT00720798|466334997|FG000|Overall Study|Adverse Event|304|||
129556824|NCT00720798|466334997|FG000|Overall Study|Death|39|||
129556825|NCT00720798|466334997|FG000|Overall Study|Insufficient Therapeutic Response|129|||
129556826|NCT00720798|466334997|FG000|Overall Study|Protocol Violation|4|||
129556827|NCT00720798|466334997|FG000|Overall Study|Refused Treatment|151|||
129556828|NCT00720798|466334997|FG000|Overall Study|Failure to Return|46|||
129556829|NCT00720798|466334997|FG000|Overall Study|Reason not Specified|83|||
129556830|NCT00433381|466334998|FG000|Overall Study|Ineligible / no protocol treatment|3|||
129556831|NCT00433381|466334999|FG001|Overall Study|Ineligible / no protocol treatment|3|||
129556832|NCT01059071|466335001|FG000|Overall Study|Lack of Efficacy|1|||
129556833|NCT01059071|466335002|FG001|Overall Study|Lack of Efficacy|4|||
129556834|NCT01059071|466335003|FG002|Overall Study|Lack of Efficacy|2|||
129556835|NCT01059071|466335004|FG003|Overall Study|Lack of Efficacy|3|||
129556836|NCT01059071|466335001|FG000|Overall Study|Withdrawal by Subject|1|||
129556837|NCT01059071|466335002|FG001|Overall Study|Withdrawal by Subject|0|||
129556838|NCT01059071|466335003|FG002|Overall Study|Withdrawal by Subject|0|||
129556839|NCT01059071|466335004|FG003|Overall Study|Withdrawal by Subject|2|||
129556840|NCT01059071|466335001|FG000|Overall Study|Physician Decision|0|||
129556841|NCT01059071|466335002|FG001|Overall Study|Physician Decision|0|||
129556842|NCT01059071|466335003|FG002|Overall Study|Physician Decision|0|||
129556843|NCT01059071|466335004|FG003|Overall Study|Physician Decision|1|||
129556844|NCT00936884|466335007|FG000|Double-blind|Withdrawal by Subject|6|||
129556845|NCT00936884|466335008|FG001|Double-blind|Withdrawal by Subject|4|||
129556846|NCT00936884|466335009|FG002|Double-blind|Withdrawal by Subject|0|||
129556847|NCT00936884|466335007|FG000|Double-blind|Death|2|||
129556848|NCT00936884|466335008|FG001|Double-blind|Death|1|||
129556849|NCT00936884|466335009|FG002|Double-blind|Death|0|||
129556850|NCT00936884|466335007|FG000|Double-blind|Lack of Efficacy|1|||
129556851|NCT00936884|466335008|FG001|Double-blind|Lack of Efficacy|1|||
129556852|NCT00936884|466335009|FG002|Double-blind|Lack of Efficacy|0|||
129556853|NCT00936884|466335007|FG000|Double-blind|Adverse Event|1|||
129556854|NCT00936884|466335008|FG001|Double-blind|Adverse Event|0|||
129556855|NCT00936884|466335009|FG002|Double-blind|Adverse Event|0|||
129556856|NCT00936884|466335007|FG000|Double-blind|Physician Decision|1|||
129556857|NCT00936884|466335008|FG001|Double-blind|Physician Decision|0|||
129556858|NCT00936884|466335009|FG002|Double-blind|Physician Decision|0|||
129556859|NCT00936884|466335007|FG000|Double-blind|No post baseline diary entry|1|||
129556860|NCT00936884|466335008|FG001|Double-blind|No post baseline diary entry|0|||
129556861|NCT00936884|466335009|FG002|Double-blind|No post baseline diary entry|0|||
129556862|NCT00936884|466335007|FG000|Double-blind|Did not receive study drug|0|||
129556863|NCT00936884|466335008|FG001|Double-blind|Did not receive study drug|1|||
129556864|NCT00936884|466335009|FG002|Double-blind|Did not receive study drug|0|||
129556865|NCT01859390|466335010|FG000|Overall Study|Insufficient Sputum Collected|1|||
129556866|NCT01859390|466335011|FG001|Overall Study|Insufficient Sputum Collected|3|||
129556867|NCT01859390|466335010|FG000|Overall Study|Sample Missing Collection Date|0|||
129556868|NCT01859390|466335011|FG001|Overall Study|Sample Missing Collection Date|1|||
129556869|NCT01859390|466335010|FG000|Overall Study|Tube Cracked|0|||
129556870|NCT01859390|466335011|FG001|Overall Study|Tube Cracked|2|||
129556871|NCT01859390|466335010|FG000|Overall Study|Shipment Error|0|||
129556872|NCT01859390|466335011|FG001|Overall Study|Shipment Error|1|||
129556873|NCT02038634|466335013|FG000|Overall Study|Lost to Follow-up|0|||
129556874|NCT02038634|466335014|FG001|Overall Study|Lost to Follow-up|1|||
129556875|NCT01664052|466335015|FG000|Phase 1|No device placement|6|||
129556876|NCT01664052|466335016|FG001|Phase 1|No device placement|0|||
129556877|NCT01664052|466335015|FG000|Phase 1|No HSG 1 hr post placement|1|||
129556878|NCT01664052|466335016|FG001|Phase 1|No HSG 1 hr post placement|0|||
129556879|NCT01664052|466335015|FG000|Phase 2|No device placement|0|||
129556880|NCT01664052|466335016|FG001|Phase 2|No device placement|4|||
129556881|NCT01084005|466335017|FG000|Overall Study|Adverse Event|1|||
129556882|NCT01084005|466335018|FG001|Overall Study|Adverse Event|8|||
129556883|NCT01084005|466335017|FG000|Overall Study|Protocol Violation|3|||
129556884|NCT01084005|466335018|FG001|Overall Study|Protocol Violation|7|||
129556885|NCT01084005|466335017|FG000|Overall Study|Withdrawal by Subject|1|||
129556886|NCT01084005|466335018|FG001|Overall Study|Withdrawal by Subject|1|||
129556887|NCT00549198|466335019|FG000|Overall Study|Adverse Event|28|||
129556888|NCT00549198|466335020|FG001|Overall Study|Adverse Event|26|||
129556889|NCT00549198|466335019|FG000|Overall Study|Insufficient Viral Load Response|4|||
129556890|NCT00549198|466335020|FG001|Overall Study|Insufficient Viral Load Response|2|||
129556891|NCT00549198|466335019|FG000|Overall Study|Protocol-defined Virological Failure|7|||
129556892|NCT00549198|466335020|FG001|Overall Study|Protocol-defined Virological Failure|0|||
129556893|NCT00549198|466335019|FG000|Overall Study|Non-compliance|2|||
129556894|NCT00549198|466335020|FG001|Overall Study|Non-compliance|4|||
129556895|NCT00549198|466335019|FG000|Overall Study|Lost to Follow-up|7|||
129556896|NCT00549198|466335020|FG001|Overall Study|Lost to Follow-up|8|||
129556897|NCT00549198|466335019|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
129556898|NCT00549198|466335020|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129556899|NCT00549198|466335019|FG000|Overall Study|Protocol Violation|7|||
129556900|NCT00549198|466335020|FG001|Overall Study|Protocol Violation|2|||
129556901|NCT00549198|466335019|FG000|Overall Study|Investigator Decision|4|||
129556902|NCT00549198|466335020|FG001|Overall Study|Investigator Decision|3|||
129556903|NCT00549198|466335019|FG000|Overall Study|Withdrawal by Subject|7|||
129556904|NCT00549198|466335020|FG001|Overall Study|Withdrawal by Subject|7|||
129556905|NCT00549198|466335019|FG000|Overall Study|Disease Progression|1|||
129556906|NCT00549198|466335020|FG001|Overall Study|Disease Progression|0|||
129556907|NCT00549198|466335019|FG000|Overall Study|Participant Moved|2|||
129556908|NCT00549198|466335020|FG001|Overall Study|Participant Moved|0|||
129556909|NCT00549198|466335019|FG000|Overall Study|Participant not able to perform Week 96|1|||
129556910|NCT00549198|466335020|FG001|Overall Study|Participant not able to perform Week 96|0|||
129556911|NCT00549198|466335019|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
129556912|NCT00549198|466335020|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
129556913|NCT00549198|466335019|FG000|Overall Study|Prohibited Medication|1|||
129556914|NCT00549198|466335020|FG001|Overall Study|Prohibited Medication|2|||
129556915|NCT00549198|466335019|FG000|Overall Study|Participant planning pregnancy|1|||
129556916|NCT00549198|466335020|FG001|Overall Study|Participant planning pregnancy|0|||
129556917|NCT00549198|466335019|FG000|Overall Study|Participant overweight, no scan possible|1|||
129556918|NCT00549198|466335020|FG001|Overall Study|Participant overweight, no scan possible|0|||
129556919|NCT00549198|466335019|FG000|Overall Study|No scan facilities|0|||
129556920|NCT00549198|466335020|FG001|Overall Study|No scan facilities|2|||
129556921|NCT00549198|466335019|FG000|Overall Study|Pregnancy|0|||
129556922|NCT00549198|466335020|FG001|Overall Study|Pregnancy|3|||
129556923|NCT00549198|466335019|FG000|Overall Study|Not Exposed to Study Drug|3|||
129556924|NCT00549198|466335020|FG001|Overall Study|Not Exposed to Study Drug|4|||
129556925|NCT02480010|466335021|FG000|Overall Study|Adverse Event|3|||
129556926|NCT02480010|466335022|FG001|Overall Study|Adverse Event|1|||
129556927|NCT02480010|466335021|FG000|Overall Study|Death|1|||
129556928|NCT02480010|466335022|FG001|Overall Study|Death|0|||
129556929|NCT02480010|466335021|FG000|Overall Study|Insufficient therapeutic response|31|||
129556930|NCT02480010|466335022|FG001|Overall Study|Insufficient therapeutic response|29|||
129556931|NCT02480010|466335021|FG000|Overall Study|Refused Treatment|0|||
129556932|NCT02480010|466335022|FG001|Overall Study|Refused Treatment|3|||
129556933|NCT01034137|466335024|FG000|Overall Study|Adverse Event|9|||
129556934|NCT01034137|466335025|FG001|Overall Study|Adverse Event|10|||
129556935|NCT01034137|466335026|FG002|Overall Study|Adverse Event|8|||
129556936|NCT01034137|466335024|FG000|Overall Study|Withdrawal by Subject|4|||
129556937|NCT01034137|466335025|FG001|Overall Study|Withdrawal by Subject|3|||
129556938|NCT01034137|466335026|FG002|Overall Study|Withdrawal by Subject|3|||
129556939|NCT01034137|466335024|FG000|Overall Study|Lack of Efficacy|9|||
129556940|NCT01034137|466335025|FG001|Overall Study|Lack of Efficacy|4|||
129556941|NCT01034137|466335026|FG002|Overall Study|Lack of Efficacy|13|||
129556942|NCT01034137|466335024|FG000|Overall Study|Protocol Violation|2|||
129556943|NCT01034137|466335025|FG001|Overall Study|Protocol Violation|2|||
129556944|NCT01034137|466335026|FG002|Overall Study|Protocol Violation|1|||
129556945|NCT01034137|466335024|FG000|Overall Study|Refused treatment or did not cooperate|2|||
129556946|NCT01034137|466335025|FG001|Overall Study|Refused treatment or did not cooperate|0|||
129556947|NCT01034137|466335026|FG002|Overall Study|Refused treatment or did not cooperate|1|||
129556948|NCT01034137|466335024|FG000|Overall Study|Administrative or other|2|||
129556949|NCT01034137|466335025|FG001|Overall Study|Administrative or other|3|||
129556950|NCT01034137|466335026|FG002|Overall Study|Administrative or other|4|||
129556951|NCT01764854|466335030|FG000|Overall Study|Adverse Event|0|||
129556952|NCT01764854|466335031|FG001|Overall Study|Adverse Event|0|||
129556953|NCT01764854|466335032|FG002|Overall Study|Adverse Event|2|||
129556954|NCT01764854|466335033|FG003|Overall Study|Adverse Event|0|||
129556955|NCT01764854|466335030|FG000|Overall Study|Withdrawal by Subject|0|||
129556956|NCT01764854|466335031|FG001|Overall Study|Withdrawal by Subject|0|||
129556957|NCT01764854|466335032|FG002|Overall Study|Withdrawal by Subject|1|||
129556958|NCT01764854|466335033|FG003|Overall Study|Withdrawal by Subject|0|||
129556959|NCT01764854|466335030|FG000|Overall Study|relocation|0|||
129556960|NCT01764854|466335031|FG001|Overall Study|relocation|0|||
129556961|NCT01764854|466335032|FG002|Overall Study|relocation|2|||
129556962|NCT01764854|466335033|FG003|Overall Study|relocation|0|||
129556963|NCT01764854|466335030|FG000|Overall Study|Protocol Violation|0|||
129556964|NCT01764854|466335031|FG001|Overall Study|Protocol Violation|0|||
129556965|NCT01764854|466335032|FG002|Overall Study|Protocol Violation|1|||
129556966|NCT01764854|466335033|FG003|Overall Study|Protocol Violation|2|||
129556967|NCT03377556|466335042|FG000|Overall Study|Adverse Event|5|||
129556968|NCT03377556|466335042|FG000|Overall Study|Refusal unrelated to adverse events|1|||
129556969|NCT03377556|466335042|FG000|Overall Study|Progression/relapse|38|||
129556970|NCT03377556|466335042|FG000|Overall Study|Death|3|||
129777344|NCT02023697|467151299|FG000|Active Follow-up Period|Deterioration of general condition|1|||
129556971|NCT00472446|466335043|FG000|Overall Study|Protocol Violation|0|||
129556972|NCT00472446|466335044|FG001|Overall Study|Protocol Violation|0|||
129556973|NCT00472446|466335045|FG002|Overall Study|Protocol Violation|0|||
129556974|NCT00472446|466335046|FG003|Overall Study|Protocol Violation|1|||
129556975|NCT00472446|466335043|FG000|Overall Study|Reintervention|0|||
129556976|NCT00472446|466335044|FG001|Overall Study|Reintervention|0|||
129556977|NCT00472446|466335045|FG002|Overall Study|Reintervention|1|||
129556978|NCT00472446|466335046|FG003|Overall Study|Reintervention|1|||
129556979|NCT00472446|466335043|FG000|Overall Study|Questionnaires not returned|5|||
129556980|NCT00472446|466335044|FG001|Overall Study|Questionnaires not returned|6|||
129556981|NCT00472446|466335045|FG002|Overall Study|Questionnaires not returned|6|||
129556982|NCT00472446|466335046|FG003|Overall Study|Questionnaires not returned|4|||
129556983|NCT01165684|466335049|FG000|Overall Study|Adverse Event|1|||
129556984|NCT01165684|466335050|FG001|Overall Study|Adverse Event|1|||
129556985|NCT01165684|466335049|FG000|Overall Study|Lack of Efficacy|2|||
129556986|NCT01165684|466335050|FG001|Overall Study|Lack of Efficacy|1|||
129556987|NCT01165684|466335049|FG000|Overall Study|Protocol Violation|7|||
129556988|NCT01165684|466335050|FG001|Overall Study|Protocol Violation|15|||
129556989|NCT01165684|466335049|FG000|Overall Study|Withdrawal Criteria|2|||
129556990|NCT01165684|466335050|FG001|Overall Study|Withdrawal Criteria|13|||
129556991|NCT01165684|466335049|FG000|Overall Study|Unclassified|16|||
129556992|NCT01165684|466335050|FG001|Overall Study|Unclassified|22|||
129556993|NCT00671879|466335053|FG000|Overall Study|Withdrawal by Subject|0|||
129556994|NCT00671879|466335054|FG001|Overall Study|Withdrawal by Subject|4|||
129556995|NCT00671879|466335055|FG002|Overall Study|Withdrawal by Subject|6|||
129556996|NCT04633837|466335056|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
129556997|NCT04633837|466335057|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
129556998|NCT00901628|466335058|FG000|Overall Study|disconnection of catheter|4|||
129556999|NCT00901628|466335059|FG001|Overall Study|disconnection of catheter|8|||
129557000|NCT00901628|466335058|FG000|Overall Study|disconnection of drain|0|||
129557001|NCT00901628|466335059|FG001|Overall Study|disconnection of drain|1|||
129557002|NCT00901628|466335058|FG000|Overall Study|peroneal nerve palsy|0|||
129557003|NCT00901628|466335059|FG001|Overall Study|peroneal nerve palsy|1|||
129557004|NCT00608205|466335062|FG000|Overall Study|Adverse Event|3|||
129557005|NCT00608205|466335063|FG001|Overall Study|Adverse Event|2|||
129557006|NCT00608205|466335062|FG000|Overall Study|Patient non-compliant|0|||
129557007|NCT00608205|466335063|FG001|Overall Study|Patient non-compliant|1|||
129557008|NCT01797120|466335064|FG000|Overall Study|Disesae progression|37|||
129557009|NCT01797120|466335065|FG001|Overall Study|Disesae progression|49|||
129557010|NCT01797120|466335064|FG000|Overall Study|Adverse Event|13|||
129557011|NCT01797120|466335065|FG001|Overall Study|Adverse Event|5|||
129557012|NCT01797120|466335064|FG000|Overall Study|Withdrawal by Subject|6|||
129557013|NCT01797120|466335065|FG001|Overall Study|Withdrawal by Subject|6|||
129557014|NCT01797120|466335064|FG000|Overall Study|Symptomatic progression|2|||
129557015|NCT01797120|466335065|FG001|Overall Study|Symptomatic progression|1|||
129557016|NCT01797120|466335064|FG000|Overall Study|Non-compliance|1|||
129557017|NCT01797120|466335065|FG001|Overall Study|Non-compliance|0|||
129557018|NCT01797120|466335064|FG000|Overall Study|Physician Decision|3|||
129557019|NCT01797120|466335065|FG001|Overall Study|Physician Decision|0|||
129557020|NCT01797120|466335064|FG000|Overall Study|still on treatment|2|||
129557021|NCT01797120|466335065|FG001|Overall Study|still on treatment|4|||
129557022|NCT01797120|466335064|FG000|Overall Study|never start protocol therapy|2|||
129557023|NCT01797120|466335065|FG001|Overall Study|never start protocol therapy|0|||
129557024|NCT01909466|466335071|FG000|Overall Study|Lost to Follow-up|5|||
129557025|NCT01909466|466335072|FG001|Overall Study|Lost to Follow-up|7|||
129557026|NCT01909466|466335071|FG000|Overall Study|Adverse Event|3|||
129557027|NCT01909466|466335072|FG001|Overall Study|Adverse Event|4|||
129557028|NCT01909466|466335071|FG000|Overall Study|Met Withdrawal Criteria|0|||
129557029|NCT01909466|466335072|FG001|Overall Study|Met Withdrawal Criteria|3|||
129557030|NCT01909466|466335071|FG000|Overall Study|Physician Decision|2|||
129557031|NCT01909466|466335072|FG001|Overall Study|Physician Decision|0|||
129557032|NCT01909466|466335071|FG000|Overall Study|Withdrawal by Subject|11|||
129557033|NCT01909466|466335072|FG001|Overall Study|Withdrawal by Subject|9|||
129557034|NCT01909466|466335071|FG000|Overall Study|Lack of Efficacy|1|||
129557035|NCT01909466|466335072|FG001|Overall Study|Lack of Efficacy|0|||
129557036|NCT01339910|466335073|FG000|Overall Study|Withdrawal by Subject|1|||
129557037|NCT01339910|466335074|FG001|Overall Study|Withdrawal by Subject|0|||
129557038|NCT01339910|466335073|FG000|Overall Study|Physician Decision|1|||
129557039|NCT01339910|466335074|FG001|Overall Study|Physician Decision|0|||
129687280|NCT02573467|466812127|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
129557040|NCT01339910|466335073|FG000|Overall Study|Disease relapse|1|||
129557041|NCT01339910|466335074|FG001|Overall Study|Disease relapse|4|||
129557042|NCT01567306|466335078|FG000|Overall Study|Protocol Violation|2|||
129557043|NCT01567306|466335079|FG001|Overall Study|Protocol Violation|2|||
129557044|NCT01567306|466335080|FG002|Overall Study|Protocol Violation|0|||
129557045|NCT01567306|466335081|FG003|Overall Study|Protocol Violation|3|||
129557046|NCT01567306|466335082|FG004|Overall Study|Protocol Violation|1|||
129557047|NCT01567306|466335083|FG005|Overall Study|Protocol Violation|1|||
129557048|NCT01567306|466335078|FG000|Overall Study|Change site living|1|||
129557049|NCT01567306|466335079|FG001|Overall Study|Change site living|0|||
129557050|NCT01567306|466335080|FG002|Overall Study|Change site living|0|||
129557051|NCT01567306|466335081|FG003|Overall Study|Change site living|0|||
129557052|NCT01567306|466335082|FG004|Overall Study|Change site living|0|||
129557053|NCT01567306|466335083|FG005|Overall Study|Change site living|0|||
129557054|NCT01567306|466335078|FG000|Overall Study|Adverse Event|0|||
129557055|NCT01567306|466335079|FG001|Overall Study|Adverse Event|0|||
129557056|NCT01567306|466335080|FG002|Overall Study|Adverse Event|0|||
129557057|NCT01567306|466335081|FG003|Overall Study|Adverse Event|2|||
129557058|NCT01567306|466335082|FG004|Overall Study|Adverse Event|4|||
129557059|NCT01567306|466335083|FG005|Overall Study|Adverse Event|1|||
129557060|NCT01567306|466335078|FG000|Overall Study|Lost to Follow-up|0|||
129557061|NCT01567306|466335079|FG001|Overall Study|Lost to Follow-up|0|||
129557062|NCT01567306|466335080|FG002|Overall Study|Lost to Follow-up|0|||
129557063|NCT01567306|466335081|FG003|Overall Study|Lost to Follow-up|0|||
129557064|NCT01567306|466335082|FG004|Overall Study|Lost to Follow-up|2|||
129557065|NCT01567306|466335083|FG005|Overall Study|Lost to Follow-up|0|||
129557066|NCT01567306|466335078|FG000|Overall Study|Withdrawal by Subject|0|||
129557067|NCT01567306|466335079|FG001|Overall Study|Withdrawal by Subject|0|||
129557068|NCT01567306|466335080|FG002|Overall Study|Withdrawal by Subject|0|||
129557069|NCT01567306|466335081|FG003|Overall Study|Withdrawal by Subject|0|||
129557070|NCT01567306|466335082|FG004|Overall Study|Withdrawal by Subject|0|||
129557071|NCT01567306|466335083|FG005|Overall Study|Withdrawal by Subject|1|||
129557072|NCT00738673|466335086|FG000|Overall Study|Adverse Event|1|||
129557073|NCT00738673|466335087|FG001|Overall Study|Adverse Event|0|||
129557074|NCT00738673|466335086|FG000|Overall Study|Lack of Efficacy|19|||
129557075|NCT00738673|466335087|FG001|Overall Study|Lack of Efficacy|8|||
129557076|NCT00738673|466335086|FG000|Overall Study|Protocol Violation|1|||
129557077|NCT00738673|466335087|FG001|Overall Study|Protocol Violation|2|||
129557078|NCT00738673|466335086|FG000|Overall Study|Withdrawal by Subject|3|||
129557079|NCT00738673|466335087|FG001|Overall Study|Withdrawal by Subject|1|||
129557080|NCT02736227|466335090|FG000|Overall Study|Withdrawal by Subject|0|||
129557081|NCT02736227|466335091|FG001|Overall Study|Withdrawal by Subject|0|||
129557082|NCT02736227|466335092|FG002|Overall Study|Withdrawal by Subject|1|||
129557083|NCT02736227|466335090|FG000|Overall Study|Physician Decision|0|||
129557084|NCT02736227|466335091|FG001|Overall Study|Physician Decision|0|||
129557085|NCT02736227|466335092|FG002|Overall Study|Physician Decision|5|||
129557086|NCT02736227|466335090|FG000|Overall Study|Non Compliant|0|||
129557087|NCT02736227|466335091|FG001|Overall Study|Non Compliant|0|||
129557088|NCT02736227|466335092|FG002|Overall Study|Non Compliant|2|||
129557089|NCT04120194|466335093|FG000|Overall Study|Lost to Follow-up|11|||
129557090|NCT04120194|466335094|FG001|Overall Study|Lost to Follow-up|8|||
129557091|NCT04120194|466335093|FG000|Overall Study|Adverse Event|4|||
129557092|NCT04120194|466335094|FG001|Overall Study|Adverse Event|5|||
129557093|NCT04120194|466335093|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
129557094|NCT04120194|466335094|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
129557095|NCT04120194|466335093|FG000|Overall Study|Miscellaneous|4|||
129557096|NCT04120194|466335094|FG001|Overall Study|Miscellaneous|5|||
129557097|NCT00827359|466335098|FG000|Overall Study|Progressive Diseas|19|||
129557098|NCT00827359|466335098|FG000|Overall Study|Unacceptable Toxicity|5|||
129557099|NCT00827359|466335098|FG000|Overall Study|Ineligible|1|||
129557100|NCT01159769|466335099|FG000|Overall Study|Adverse Event|1|||
129557101|NCT02555618|466335100|FG000|Overall Study|Sponsor's Circumstances|1|||
129557102|NCT02555618|466335101|FG001|Overall Study|Sponsor's Circumstances|0|||
129557103|NCT02063698|466335102|FG000|Overall Study|did not complete booklet for days 2-8|1|||
129557104|NCT02063698|466335103|FG001|Overall Study|did not complete booklet for days 2-8|2|||
129557105|NCT03652961|466335108|FG000|Overall Study|Lost to Follow-up|3|||
129557106|NCT03652961|466335108|FG000|Overall Study|Screen Failure|1|||
129557107|NCT01783496|466335109|FG000|Overall Study|Lost to Follow-up|0|||
129557108|NCT01783496|466335110|FG001|Overall Study|Lost to Follow-up|0|||
129557109|NCT01783496|466335111|FG002|Overall Study|Lost to Follow-up|0|||
129557110|NCT01783496|466335112|FG003|Overall Study|Lost to Follow-up|2|||
129557111|NCT01783496|466335113|FG004|Overall Study|Lost to Follow-up|0|||
129557112|NCT01783496|466335114|FG005|Overall Study|Lost to Follow-up|1|||
129557113|NCT01783496|466335109|FG000|Overall Study|Withdrawal by Subject|1|||
129557114|NCT01783496|466335110|FG001|Overall Study|Withdrawal by Subject|0|||
129557115|NCT01783496|466335111|FG002|Overall Study|Withdrawal by Subject|0|||
129557116|NCT01783496|466335112|FG003|Overall Study|Withdrawal by Subject|0|||
129557117|NCT01783496|466335113|FG004|Overall Study|Withdrawal by Subject|0|||
129557118|NCT01783496|466335114|FG005|Overall Study|Withdrawal by Subject|0|||
129557119|NCT01953783|466335115|FG000|Overall Study|Progressive disease|2|||
129557120|NCT00686920|466335116|FG000|Overall Study|Death|45|||
129557121|NCT00686920|466335117|FG001|Overall Study|Death|14|||
129557122|NCT00686920|466335116|FG000|Overall Study|Liver Transplant|23|||
129557123|NCT00686920|466335117|FG001|Overall Study|Liver Transplant|8|||
129557124|NCT00686920|466335116|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
129557125|NCT00686920|466335117|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
129557126|NCT00686920|466335116|FG000|Overall Study|Withdrawal by Subject|23|||
129557127|NCT00686920|466335117|FG001|Overall Study|Withdrawal by Subject|5|||
129557128|NCT00686920|466335116|FG000|Overall Study|Protocol Violation|2|||
129557129|NCT00686920|466335117|FG001|Overall Study|Protocol Violation|1|||
129557130|NCT00686920|466335116|FG000|Overall Study|Adverse Event|10|||
129557131|NCT00686920|466335117|FG001|Overall Study|Adverse Event|2|||
129557132|NCT00686920|466335116|FG000|Overall Study|Personal Reason|0|||
129557133|NCT00686920|466335117|FG001|Overall Study|Personal Reason|1|||
129557134|NCT00686920|466335116|FG000|Overall Study|Lost to Follow-up|15|||
129557135|NCT00686920|466335117|FG001|Overall Study|Lost to Follow-up|3|||
129557136|NCT00686920|466335116|FG000|Overall Study|Moved to Another State|1|||
129557137|NCT00686920|466335117|FG001|Overall Study|Moved to Another State|0|||
129557138|NCT00686920|466335116|FG000|Overall Study|Transferred to Nursing Home|1|||
129557139|NCT00686920|466335117|FG001|Overall Study|Transferred to Nursing Home|0|||
129557140|NCT00686920|466335116|FG000|Overall Study|Noncompliance|9|||
129557141|NCT00686920|466335117|FG001|Overall Study|Noncompliance|0|||
129557142|NCT00686920|466335116|FG000|Overall Study|Principal Investigator Decision|2|||
129557143|NCT00686920|466335117|FG001|Overall Study|Principal Investigator Decision|0|||
129557144|NCT00591253|466335120|FG000|Overall Study|Adverse Event|3|||
129557145|NCT00591253|466335121|FG001|Overall Study|Adverse Event|3|||
129557146|NCT00591253|466335122|FG002|Overall Study|Adverse Event|1|||
129557147|NCT00591253|466335120|FG000|Overall Study|Protocol Violation|2|||
129557148|NCT00591253|466335121|FG001|Overall Study|Protocol Violation|2|||
129557149|NCT00591253|466335122|FG002|Overall Study|Protocol Violation|2|||
129557150|NCT00591253|466335120|FG000|Overall Study|Lost to Follow-up|2|||
129557151|NCT00591253|466335121|FG001|Overall Study|Lost to Follow-up|4|||
129557152|NCT00591253|466335122|FG002|Overall Study|Lost to Follow-up|0|||
129557153|NCT00591253|466335120|FG000|Overall Study|Withdrawal by Subject|1|||
129557154|NCT00591253|466335121|FG001|Overall Study|Withdrawal by Subject|7|||
129557155|NCT00591253|466335122|FG002|Overall Study|Withdrawal by Subject|6|||
129557156|NCT00591253|466335120|FG000|Overall Study|Lack of Efficacy|1|||
129557157|NCT00591253|466335121|FG001|Overall Study|Lack of Efficacy|0|||
129557158|NCT00591253|466335122|FG002|Overall Study|Lack of Efficacy|3|||
129557159|NCT00591253|466335120|FG000|Overall Study|Other|5|||
129557160|NCT00591253|466335121|FG001|Overall Study|Other|5|||
129557161|NCT00591253|466335122|FG002|Overall Study|Other|3|||
129557162|NCT03811249|466335123|FG000|Overall Study|Withdrawal by Subject|44|||
129557163|NCT03811249|466335123|FG000|Overall Study|Missed Visit|24|||
129557164|NCT01783730|466335124|FG000|Overall Study|Failed to meet inclusion criteria|6|||
129557165|NCT01841359|466335125|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
129557166|NCT01841359|466335125|FG000|Overall Study|Concommitant medical issues|2|||
129557167|NCT01841359|466335125|FG000|Overall Study|Adverse Event|3|||
129557168|NCT01841359|466335125|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
129557169|NCT02151461|466335126|FG000|Overall Study|Adverse Event|5|||
129557170|NCT02151461|466335127|FG001|Overall Study|Adverse Event|1|||
129557171|NCT02151461|466335128|FG002|Overall Study|Adverse Event|0|||
129557172|NCT02151461|466335129|FG003|Overall Study|Adverse Event|2|||
129557173|NCT02151461|466335126|FG000|Overall Study|Lost to Follow-up|0|||
129777345|NCT02023697|467151300|FG001|Active Follow-up Period|Deterioration of general condition|1|||
129777346|NCT02023697|467151301|FG002|Active Follow-up Period|Deterioration of general condition|1|||
129557174|NCT02151461|466335127|FG001|Overall Study|Lost to Follow-up|0|||
129557175|NCT02151461|466335128|FG002|Overall Study|Lost to Follow-up|1|||
129557176|NCT02151461|466335129|FG003|Overall Study|Lost to Follow-up|1|||
129557177|NCT02151461|466335126|FG000|Overall Study|Withdrawal by Subject|1|||
129557178|NCT02151461|466335127|FG001|Overall Study|Withdrawal by Subject|0|||
129777347|NCT02023697|467151299|FG000|Active Follow-up Period|Other unspecified|2|||
129777348|NCT02023697|467151300|FG001|Active Follow-up Period|Other unspecified|0|||
129557179|NCT02151461|466335128|FG002|Overall Study|Withdrawal by Subject|1|||
129557180|NCT02151461|466335129|FG003|Overall Study|Withdrawal by Subject|1|||
129557181|NCT02151461|466335126|FG000|Overall Study|Treatment discontinuation|0|||
129557182|NCT02151461|466335127|FG001|Overall Study|Treatment discontinuation|0|||
129557183|NCT02151461|466335128|FG002|Overall Study|Treatment discontinuation|1|||
129557184|NCT02151461|466335129|FG003|Overall Study|Treatment discontinuation|0|||
129557185|NCT02168270|466335130|FG000|Overall Study|Lack of Efficacy|4|||
129557186|NCT01102777|466335131|FG000|Overall Study|Death|2|||
129557187|NCT01102777|466335132|FG001|Overall Study|Death|6|||
129557188|NCT01102777|466335131|FG000|Overall Study|Lost to Follow-up|7|||
129557189|NCT01102777|466335132|FG001|Overall Study|Lost to Follow-up|10|||
129557190|NCT00706706|466335133|FG000|Overall Study|Death|53|||
129557191|NCT00706706|466335133|FG000|Overall Study|Lost to Follow-up|7|||
129557192|NCT00706706|466335133|FG000|Overall Study|Study endpoint had reached|45|||
129557193|NCT05017493|466335134|FG000|Overall Study|Withdrawal by Subject|26|||
129557194|NCT05017493|466335135|FG001|Overall Study|Withdrawal by Subject|0|||
129557195|NCT05017493|466335134|FG000|Overall Study|Physician Decision|15|||
129557196|NCT05017493|466335135|FG001|Overall Study|Physician Decision|0|||
129557197|NCT05017493|466335134|FG000|Overall Study|Protocol Violation|81|||
129557198|NCT05017493|466335135|FG001|Overall Study|Protocol Violation|0|||
129557199|NCT01154153|466335142|FG000|Overall Study|Poor compliance to protocol|2|||
129557200|NCT01154153|466335143|FG001|Overall Study|Poor compliance to protocol|0|||
129557201|NCT01154153|466335142|FG000|Overall Study|Unable to use labs|2|||
129557202|NCT01154153|466335143|FG001|Overall Study|Unable to use labs|3|||
129557203|NCT01154153|466335142|FG000|Overall Study|Withdrew consent|1|||
129557204|NCT01154153|466335143|FG001|Overall Study|Withdrew consent|0|||
129557205|NCT00771901|466335144|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
129557206|NCT00771901|466335145|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
129557207|NCT00771901|466335146|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
129557208|NCT01965652|466335147|FG000|Overall Study|Adverse Event|40|||
129557209|NCT01965652|466335148|FG001|Overall Study|Adverse Event|37|||
129557210|NCT01965652|466335147|FG000|Overall Study|Withdrawal by Subject|62|||
129557211|NCT01965652|466335148|FG001|Overall Study|Withdrawal by Subject|69|||
129557212|NCT01965652|466335147|FG000|Overall Study|Lost to Follow-up|53|||
129557213|NCT01965652|466335148|FG001|Overall Study|Lost to Follow-up|40|||
129557214|NCT01965652|466335147|FG000|Overall Study|Protocol Violation|34|||
129557215|NCT01965652|466335148|FG001|Overall Study|Protocol Violation|38|||
129557216|NCT01965652|466335147|FG000|Overall Study|Death|3|||
129557217|NCT01965652|466335148|FG001|Overall Study|Death|4|||
129557218|NCT01965652|466335147|FG000|Overall Study|Other - Miscellaneous|18|||
129557219|NCT01965652|466335148|FG001|Overall Study|Other - Miscellaneous|21|||
129557220|NCT01965652|466335147|FG000|Overall Study|Pregnancy|0|||
129557221|NCT01965652|466335148|FG001|Overall Study|Pregnancy|1|||
129557222|NCT01121900|466335151|FG000|First Intervention Period|Adverse Event|1|||
129557223|NCT01121900|466335152|FG001|First Intervention Period|Adverse Event|1|||
129557224|NCT01121900|466335151|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129557225|NCT01121900|466335152|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129557226|NCT03469271|466335153|FG000|Overall Study|Withdrawal by Subject|2|||
129557227|NCT03469271|466335154|FG001|Overall Study|Withdrawal by Subject|0|||
129557228|NCT03469271|466335155|FG002|Overall Study|Withdrawal by Subject|0|||
129557229|NCT03469271|466335156|FG003|Overall Study|Withdrawal by Subject|1|||
129557230|NCT03493698|466335157|FG000|Treatment Period C|Adverse Event|1|||
129557231|NCT03493698|466335157|FG000|Treatment Period C|Withdrawal by Subject|1|||
129557232|NCT00408876|466335158|FG000|Overall Study|Adverse Event|9|||
129557233|NCT00408876|466335159|FG001|Overall Study|Adverse Event|17|||
129557234|NCT00408876|466335160|FG002|Overall Study|Adverse Event|27|||
129557235|NCT00408876|466335161|FG003|Overall Study|Adverse Event|10|||
129557236|NCT00408876|466335158|FG000|Overall Study|Withdrawal by Subject|3|||
129557237|NCT00408876|466335159|FG001|Overall Study|Withdrawal by Subject|6|||
129557238|NCT00408876|466335160|FG002|Overall Study|Withdrawal by Subject|6|||
129557239|NCT00408876|466335161|FG003|Overall Study|Withdrawal by Subject|14|||
129557240|NCT00408876|466335158|FG000|Overall Study|Lack of Efficacy|2|||
129557241|NCT00408876|466335159|FG001|Overall Study|Lack of Efficacy|4|||
129557242|NCT00408876|466335160|FG002|Overall Study|Lack of Efficacy|5|||
129557243|NCT00408876|466335161|FG003|Overall Study|Lack of Efficacy|6|||
129557244|NCT00408876|466335158|FG000|Overall Study|Lost to Follow-up|1|||
129557245|NCT00408876|466335159|FG001|Overall Study|Lost to Follow-up|6|||
129557246|NCT00408876|466335160|FG002|Overall Study|Lost to Follow-up|5|||
129557247|NCT00408876|466335161|FG003|Overall Study|Lost to Follow-up|2|||
129557248|NCT00408876|466335158|FG000|Overall Study|Protocol Violation|0|||
129557249|NCT00408876|466335159|FG001|Overall Study|Protocol Violation|3|||
129557250|NCT00408876|466335160|FG002|Overall Study|Protocol Violation|4|||
129557251|NCT00408876|466335161|FG003|Overall Study|Protocol Violation|3|||
129557252|NCT00408876|466335158|FG000|Overall Study|Physician Decision|1|||
129557253|NCT00408876|466335159|FG001|Overall Study|Physician Decision|0|||
129557254|NCT00408876|466335160|FG002|Overall Study|Physician Decision|3|||
129557255|NCT00408876|466335161|FG003|Overall Study|Physician Decision|0|||
129557256|NCT02006147|466335162|FG000|Overall Study|Protocol Violation|1|||
129557257|NCT02006147|466335163|FG001|Overall Study|Protocol Violation|1|||
129557258|NCT02006147|466335164|FG002|Overall Study|Protocol Violation|0|||
129557259|NCT02006147|466335165|FG003|Overall Study|Protocol Violation|0|||
129557260|NCT02006147|466335162|FG000|Overall Study|Withdrawal by Subject|0|||
129557261|NCT02006147|466335163|FG001|Overall Study|Withdrawal by Subject|1|||
129557262|NCT02006147|466335164|FG002|Overall Study|Withdrawal by Subject|0|||
129557263|NCT02006147|466335165|FG003|Overall Study|Withdrawal by Subject|0|||
129557264|NCT02006147|466335162|FG000|Overall Study|Withdrawal by Sponsor|1|||
129557265|NCT02006147|466335163|FG001|Overall Study|Withdrawal by Sponsor|0|||
129557266|NCT02006147|466335164|FG002|Overall Study|Withdrawal by Sponsor|0|||
129557267|NCT02006147|466335165|FG003|Overall Study|Withdrawal by Sponsor|0|||
129777349|NCT02023697|467151301|FG002|Active Follow-up Period|Other unspecified|1|||
129777350|NCT02023697|467151299|FG000|Active Follow-up Period|Clinical progression|0|||
129777351|NCT02023697|467151300|FG001|Active Follow-up Period|Clinical progression|2|||
129777352|NCT02023697|467151301|FG002|Active Follow-up Period|Clinical progression|1|||
129777353|NCT02023697|467151299|FG000|Active Follow-up Period|Radiological progression|0|||
129777354|NCT02023697|467151300|FG001|Active Follow-up Period|Radiological progression|0|||
129777355|NCT02023697|467151301|FG002|Active Follow-up Period|Radiological progression|1|||
129777356|NCT02023697|467151299|FG000|Active Follow-up Period|Death|83|||
129777357|NCT02023697|467151300|FG001|Active Follow-up Period|Death|82|||
129777358|NCT02023697|467151301|FG002|Active Follow-up Period|Death|87|||
129777359|NCT02023697|467151299|FG000|Long-term Follow-up Period|Death|9|||
129777360|NCT02023697|467151300|FG001|Long-term Follow-up Period|Death|6|||
129777361|NCT02023697|467151301|FG002|Long-term Follow-up Period|Death|4|||
129777362|NCT02023697|467151299|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
129777363|NCT02023697|467151300|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
129777364|NCT02023697|467151301|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
129777365|NCT02023697|467151299|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
129777366|NCT02023697|467151300|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
129777367|NCT02023697|467151301|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
129777368|NCT02023697|467151299|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
129777369|NCT02023697|467151300|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
129777370|NCT02023697|467151301|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
129777371|NCT02023697|467151299|FG000|Long-term Follow-up Period|Technical problems|0|||
129777372|NCT02023697|467151300|FG001|Long-term Follow-up Period|Technical problems|0|||
129777373|NCT02023697|467151301|FG002|Long-term Follow-up Period|Technical problems|1|||
129777374|NCT02023697|467151299|FG000|Long-term Follow-up Period|Other unspecified|6|||
129777375|NCT02023697|467151300|FG001|Long-term Follow-up Period|Other unspecified|3|||
129777376|NCT02023697|467151301|FG002|Long-term Follow-up Period|Other unspecified|5|||
129777377|NCT00845897|467151302|FG000|Overall Study|Lost to Follow-up|1|||
129777378|NCT00845897|467151303|FG001|Overall Study|Lost to Follow-up|1|||
129777379|NCT00845897|467151304|FG002|Overall Study|Lost to Follow-up|0|||
129777380|NCT00845897|467151302|FG000|Overall Study|Withdrawal by Subject|0|||
129777381|NCT00845897|467151303|FG001|Overall Study|Withdrawal by Subject|3|||
129777382|NCT00845897|467151304|FG002|Overall Study|Withdrawal by Subject|2|||
129777383|NCT00845897|467151302|FG000|Overall Study|Ulcer did not heal|1|||
129777384|NCT00845897|467151303|FG001|Overall Study|Ulcer did not heal|0|||
129777385|NCT00845897|467151304|FG002|Overall Study|Ulcer did not heal|1|||
129777386|NCT00845897|467151302|FG000|Overall Study|Too ill to participate|0|||
129557268|NCT03361956|466335166|FG000|Overall Study|Adverse Event|1|||
129557269|NCT03361956|466335167|FG001|Overall Study|Adverse Event|0|||
129777387|NCT00845897|467151303|FG001|Overall Study|Too ill to participate|1|||
129777388|NCT00845897|467151304|FG002|Overall Study|Too ill to participate|0|||
129777389|NCT02722499|467151305|FG000|Overall Study|Lost to Follow-up|2|||
129777390|NCT02722499|467151306|FG001|Overall Study|Lost to Follow-up|0|||
129557270|NCT03361956|466335168|FG002|Overall Study|Adverse Event|1|||
129557271|NCT03361956|466335169|FG003|Overall Study|Adverse Event|1|||
129557272|NCT03361956|466335170|FG004|Overall Study|Adverse Event|0|||
129557273|NCT03361956|466335166|FG000|Overall Study|Other|0|||
129557274|NCT03361956|466335167|FG001|Overall Study|Other|0|||
129557275|NCT03361956|466335168|FG002|Overall Study|Other|0|||
129557276|NCT03361956|466335169|FG003|Overall Study|Other|1|||
129557277|NCT03361956|466335170|FG004|Overall Study|Other|0|||
129557278|NCT03361956|466335166|FG000|Overall Study|Withdrawal by Subject|2|||
129557279|NCT03361956|466335167|FG001|Overall Study|Withdrawal by Subject|2|||
129557280|NCT03361956|466335168|FG002|Overall Study|Withdrawal by Subject|2|||
129557281|NCT03361956|466335169|FG003|Overall Study|Withdrawal by Subject|0|||
129557282|NCT03361956|466335170|FG004|Overall Study|Withdrawal by Subject|3|||
129557283|NCT03361956|466335166|FG000|Overall Study|Disease Relapse|0|||
129557284|NCT03361956|466335167|FG001|Overall Study|Disease Relapse|0|||
129557285|NCT03361956|466335168|FG002|Overall Study|Disease Relapse|1|||
129557286|NCT03361956|466335169|FG003|Overall Study|Disease Relapse|0|||
129557287|NCT03361956|466335170|FG004|Overall Study|Disease Relapse|0|||
129557288|NCT03361956|466335166|FG000|Overall Study|Physician Decision|0|||
129557289|NCT03361956|466335167|FG001|Overall Study|Physician Decision|2|||
129557290|NCT03361956|466335168|FG002|Overall Study|Physician Decision|0|||
129557291|NCT03361956|466335169|FG003|Overall Study|Physician Decision|1|||
129557292|NCT03361956|466335170|FG004|Overall Study|Physician Decision|0|||
129557293|NCT03361956|466335166|FG000|Overall Study|Lost to Follow-up|0|||
129557294|NCT03361956|466335167|FG001|Overall Study|Lost to Follow-up|0|||
129557295|NCT03361956|466335168|FG002|Overall Study|Lost to Follow-up|1|||
129557296|NCT03361956|466335169|FG003|Overall Study|Lost to Follow-up|1|||
129557297|NCT03361956|466335170|FG004|Overall Study|Lost to Follow-up|2|||
129557298|NCT03760510|466335175|FG000|Overall Study|Not ventilated for 24 hours|105|||
129557299|NCT03760510|466335176|FG001|Overall Study|Not ventilated for 24 hours|97|||
129557300|NCT00566709|466335178|FG000|Overall Study|Protocol Violation|5|||
129557301|NCT00566709|466335179|FG001|Overall Study|Protocol Violation|0|||
129557302|NCT03443869|466335180|FG000|Overall Study|Death|3|||
129557303|NCT03443869|466335181|FG001|Overall Study|Death|3|||
129557304|NCT03443869|466335180|FG000|Overall Study|Withdrawal by Subject|34|||
129557305|NCT03443869|466335181|FG001|Overall Study|Withdrawal by Subject|22|||
129557306|NCT03443869|466335180|FG000|Overall Study|Lost to Follow-up|1|||
129557307|NCT03443869|466335181|FG001|Overall Study|Lost to Follow-up|2|||
129557308|NCT03443869|466335180|FG000|Overall Study|Physician Decision|3|||
129557309|NCT03443869|466335181|FG001|Overall Study|Physician Decision|3|||
129557310|NCT03443869|466335180|FG000|Overall Study|Other|4|||
129557311|NCT03443869|466335181|FG001|Overall Study|Other|4|||
129557312|NCT00299728|466335182|FG000|Overall Study|Lost to Follow-up|0|||
129557313|NCT00299728|466335183|FG001|Overall Study|Lost to Follow-up|1|||
129557314|NCT00299728|466335182|FG000|Overall Study|Withdrawal by Subject|0|||
129557315|NCT00299728|466335183|FG001|Overall Study|Withdrawal by Subject|1|||
129557316|NCT00299728|466335182|FG000|Overall Study|Progressive disease|0|||
129557317|NCT00299728|466335183|FG001|Overall Study|Progressive disease|1|||
129557318|NCT00598559|466336608|FG000|Overall Study|Adverse Event|11|||
129557319|NCT00598559|466336609|FG001|Overall Study|Adverse Event|7|||
129557320|NCT00598559|466336610|FG002|Overall Study|Adverse Event|0|||
129557321|NCT00598559|466336608|FG000|Overall Study|Withdrawal by Subject|2|||
129557322|NCT00598559|466336609|FG001|Overall Study|Withdrawal by Subject|2|||
129557323|NCT00598559|466336610|FG002|Overall Study|Withdrawal by Subject|0|||
129557324|NCT00598559|466336608|FG000|Overall Study|Protocol Non-compliance|1|||
129557325|NCT00598559|466336609|FG001|Overall Study|Protocol Non-compliance|0|||
129557326|NCT00598559|466336610|FG002|Overall Study|Protocol Non-compliance|0|||
129557327|NCT00598559|466336608|FG000|Overall Study|Early discharge from hospital|9|||
129557328|NCT00598559|466336609|FG001|Overall Study|Early discharge from hospital|12|||
129557329|NCT00598559|466336610|FG002|Overall Study|Early discharge from hospital|3|||
129557330|NCT00598559|466336608|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
129557331|NCT00598559|466336609|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
129557332|NCT00598559|466336610|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
129557333|NCT00827827|466336616|FG000|Overall Study|Lost to Follow-up|3|||
129557334|NCT00827827|466336617|FG001|Overall Study|Lost to Follow-up|0|||
129557335|NCT00827827|466336616|FG000|Overall Study|Fall at home- hospitalization|1|||
129557336|NCT00827827|466336617|FG001|Overall Study|Fall at home- hospitalization|0|||
129557337|NCT00827827|466336616|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
129557338|NCT00827827|466336617|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
129557339|NCT00827827|466336616|FG000|Overall Study|Gout|1|||
129557340|NCT00827827|466336617|FG001|Overall Study|Gout|0|||
129557341|NCT00827827|466336616|FG000|Overall Study|Transportation issues|1|||
129557342|NCT00827827|466336617|FG001|Overall Study|Transportation issues|0|||
129557343|NCT00827827|466336616|FG000|Overall Study|Burned with water at home|1|||
129557344|NCT00827827|466336617|FG001|Overall Study|Burned with water at home|0|||
129557345|NCT01418352|466336621|FG000|Overall Study|Lost to Follow-up|2|||
129557346|NCT01418352|466336622|FG001|Overall Study|Lost to Follow-up|0|||
129557347|NCT01418352|466336623|FG002|Overall Study|Lost to Follow-up|0|||
129557348|NCT01418352|466336624|FG003|Overall Study|Lost to Follow-up|0|||
129557349|NCT01418352|466336621|FG000|Overall Study|Adverse Event|0|||
129557350|NCT01418352|466336622|FG001|Overall Study|Adverse Event|1|||
129557351|NCT01418352|466336623|FG002|Overall Study|Adverse Event|0|||
129557352|NCT01418352|466336624|FG003|Overall Study|Adverse Event|0|||
129557353|NCT01418352|466336621|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
129884510|NCT02293837|467536434|FG002|Overall Study|COVID-19 Related|0|||
129557354|NCT01418352|466336622|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
129557355|NCT01418352|466336623|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
129557356|NCT01418352|466336624|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
129557357|NCT01418352|466336621|FG000|Overall Study|Subject Withdrew Consent|0|||
129777391|NCT02722499|467151307|FG002|Overall Study|Lost to Follow-up|1|||
129557358|NCT01418352|466336622|FG001|Overall Study|Subject Withdrew Consent|1|||
129557359|NCT01418352|466336623|FG002|Overall Study|Subject Withdrew Consent|2|||
129557360|NCT01418352|466336624|FG003|Overall Study|Subject Withdrew Consent|1|||
129557361|NCT01418352|466336621|FG000|Overall Study|Protocol Deviation|0|||
129557362|NCT01418352|466336622|FG001|Overall Study|Protocol Deviation|0|||
129557363|NCT01418352|466336623|FG002|Overall Study|Protocol Deviation|1|||
129557364|NCT01418352|466336624|FG003|Overall Study|Protocol Deviation|0|||
129557365|NCT01418352|466336621|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
129557366|NCT01418352|466336622|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
129557367|NCT01418352|466336623|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
129557368|NCT01418352|466336624|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
129557369|NCT00619619|466336625|FG000|Overall Study|Physician Decision|0|||
129557370|NCT00619619|466336626|FG001|Overall Study|Physician Decision|0|||
129557371|NCT00619619|466336627|FG002|Overall Study|Physician Decision|1|||
129557372|NCT00619619|466336628|FG003|Overall Study|Physician Decision|0|||
129557373|NCT00619619|466336629|FG004|Overall Study|Physician Decision|0|||
129557374|NCT00619619|466336630|FG005|Overall Study|Physician Decision|0|||
129557375|NCT00619619|466336631|FG006|Overall Study|Physician Decision|0|||
129557376|NCT00619619|466336632|FG007|Overall Study|Physician Decision|0|||
129557377|NCT00619619|466336625|FG000|Overall Study|Protocol Violation|0|||
129557378|NCT00619619|466336626|FG001|Overall Study|Protocol Violation|0|||
129557379|NCT00619619|466336627|FG002|Overall Study|Protocol Violation|0|||
129557380|NCT00619619|466336628|FG003|Overall Study|Protocol Violation|1|||
129557381|NCT00619619|466336629|FG004|Overall Study|Protocol Violation|0|||
129557382|NCT00619619|466336630|FG005|Overall Study|Protocol Violation|0|||
129557383|NCT00619619|466336631|FG006|Overall Study|Protocol Violation|1|||
129557384|NCT00619619|466336632|FG007|Overall Study|Protocol Violation|1|||
129557385|NCT00619619|466336625|FG000|Overall Study|Adverse Event|0|||
129557386|NCT00619619|466336626|FG001|Overall Study|Adverse Event|0|||
129557387|NCT00619619|466336627|FG002|Overall Study|Adverse Event|0|||
129557388|NCT00619619|466336628|FG003|Overall Study|Adverse Event|0|||
129557389|NCT00619619|466336629|FG004|Overall Study|Adverse Event|2|||
129557390|NCT00619619|466336630|FG005|Overall Study|Adverse Event|0|||
129557391|NCT00619619|466336631|FG006|Overall Study|Adverse Event|0|||
129557392|NCT00619619|466336632|FG007|Overall Study|Adverse Event|2|||
129557393|NCT01092702|466336633|FG000|Overall Study|Withdrawal by Subject|7|||
129557394|NCT01092702|466336633|FG000|Overall Study|Lost to Follow-up|2|||
129557395|NCT03263819|466336634|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
129557396|NCT03263819|466336635|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
129557397|NCT01271933|466336643|FG000|Single-Blind Phase|Lack of Efficacy|37|||
129557398|NCT01271933|466336644|FG001|Single-Blind Phase|Lack of Efficacy|0|||
129557399|NCT01271933|466336645|FG002|Single-Blind Phase|Lack of Efficacy|0|||
129557400|NCT01271933|466336643|FG000|Single-Blind Phase|Lost to Follow-up|10|||
129557401|NCT01271933|466336644|FG001|Single-Blind Phase|Lost to Follow-up|0|||
129557402|NCT01271933|466336645|FG002|Single-Blind Phase|Lost to Follow-up|0|||
129557403|NCT01271933|466336643|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
129557404|NCT01271933|466336644|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
129557405|NCT01271933|466336645|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
129557406|NCT01271933|466336643|FG000|Single-Blind Phase|Protocol Violation|3|||
129557407|NCT01271933|466336644|FG001|Single-Blind Phase|Protocol Violation|0|||
129557408|NCT01271933|466336645|FG002|Single-Blind Phase|Protocol Violation|0|||
129557409|NCT01271933|466336643|FG000|Single-Blind Phase|Adverse Event|52|||
129557410|NCT01271933|466336644|FG001|Single-Blind Phase|Adverse Event|0|||
129557411|NCT01271933|466336645|FG002|Single-Blind Phase|Adverse Event|0|||
129557412|NCT01271933|466336643|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
129557413|NCT01271933|466336644|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
129557414|NCT01271933|466336645|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
129557415|NCT01271933|466336643|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
129557416|NCT01271933|466336644|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
129557417|NCT01271933|466336645|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
129557418|NCT01271933|466336643|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
129557419|NCT01271933|466336644|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
129557420|NCT01271933|466336645|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
129557421|NCT01271933|466336643|FG000|Double-Blind Phase|Randomized but not treated|0|||
129557422|NCT01271933|466336644|FG001|Double-Blind Phase|Randomized but not treated|0|||
129557423|NCT01271933|466336645|FG002|Double-Blind Phase|Randomized but not treated|1|||
129557424|NCT01271933|466336643|FG000|Double-Blind Phase|Lack of Efficacy|0|||
129557425|NCT01271933|466336644|FG001|Double-Blind Phase|Lack of Efficacy|6|||
129557426|NCT01271933|466336645|FG002|Double-Blind Phase|Lack of Efficacy|9|||
129557427|NCT01271933|466336643|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129557428|NCT01271933|466336644|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129557429|NCT01271933|466336645|FG002|Double-Blind Phase|Lost to Follow-up|1|||
129557430|NCT01271933|466336643|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129557431|NCT01271933|466336644|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
129557432|NCT01271933|466336645|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
129557433|NCT01271933|466336643|FG000|Double-Blind Phase|Adverse Event|0|||
129557434|NCT01271933|466336644|FG001|Double-Blind Phase|Adverse Event|3|||
129557435|NCT01271933|466336645|FG002|Double-Blind Phase|Adverse Event|0|||
129557436|NCT01271933|466336643|FG000|Double-Blind Phase|Participant request-personal reason|0|||
129557437|NCT01271933|466336644|FG001|Double-Blind Phase|Participant request-personal reason|1|||
129557438|NCT01271933|466336645|FG002|Double-Blind Phase|Participant request-personal reason|0|||
129557439|NCT01138150|466336646|FG000|Overall Study|blood unable to be processed|0|||
129557440|NCT01138150|466336647|FG001|Overall Study|blood unable to be processed|1|||
129557441|NCT01138150|466336646|FG000|Overall Study|Physician Decision|1|||
129557442|NCT01138150|466336647|FG001|Overall Study|Physician Decision|0|||
129557443|NCT01620983|466336648|FG000|Overall Study|Lost to Follow-up|8|||
129557444|NCT01620983|466336649|FG001|Overall Study|Lost to Follow-up|4|||
129557445|NCT01620983|466336650|FG002|Overall Study|Lost to Follow-up|9|||
129557446|NCT01620983|466336648|FG000|Overall Study|Withdrawal by Subject|6|||
129557447|NCT01620983|466336649|FG001|Overall Study|Withdrawal by Subject|8|||
129557448|NCT01620983|466336650|FG002|Overall Study|Withdrawal by Subject|1|||
129557449|NCT01620983|466336648|FG000|Overall Study|Death|2|||
129557450|NCT01620983|466336649|FG001|Overall Study|Death|0|||
129557451|NCT01620983|466336650|FG002|Overall Study|Death|0|||
129557452|NCT01620983|466336648|FG000|Overall Study|Physician Decision|3|||
129557453|NCT01620983|466336649|FG001|Overall Study|Physician Decision|10|||
129557454|NCT01620983|466336650|FG002|Overall Study|Physician Decision|5|||
129557455|NCT05085964|466336652|FG000|Overall Study|Premature termination of study|21|||
129557456|NCT05085964|466336653|FG001|Overall Study|Premature termination of study|0|||
129557457|NCT00545233|466336654|FG000|Overall Study|Adverse Event|10|||
129557458|NCT00545233|466336655|FG001|Overall Study|Adverse Event|5|||
129557459|NCT00545233|466336654|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
129557460|NCT00545233|466336655|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129557461|NCT00545233|466336654|FG000|Overall Study|Protocol Violation|2|||
129557462|NCT00545233|466336655|FG001|Overall Study|Protocol Violation|0|||
129557463|NCT00545233|466336654|FG000|Overall Study|Refused Treatment|9|||
129557464|NCT00545233|466336655|FG001|Overall Study|Refused Treatment|7|||
129557465|NCT00545233|466336654|FG000|Overall Study|Failure to Return|4|||
129557466|NCT00545233|466336655|FG001|Overall Study|Failure to Return|6|||
129557467|NCT00545233|466336654|FG000|Overall Study|Insufficient response|14|||
129557468|NCT00545233|466336655|FG001|Overall Study|Insufficient response|15|||
129557469|NCT00545233|466336654|FG000|Overall Study|Physician Decision|2|||
129557470|NCT00545233|466336655|FG001|Overall Study|Physician Decision|1|||
129557471|NCT01208402|466336656|FG000|Overall Study|Withdrawal by Subject|1|||
129557472|NCT01208402|466336657|FG001|Overall Study|Withdrawal by Subject|0|||
129557473|NCT03156270|466336660|FG000|Overall Study|Failed pre-treatment screening|1|||
129557474|NCT03156270|466336660|FG000|Overall Study|Lost to Follow-up|1|||
129557475|NCT01504867|466336664|FG000|Overall Study|Inclusion criteria not met|2|||
129557476|NCT01504867|466336665|FG001|Overall Study|Inclusion criteria not met|2|||
129557477|NCT01504867|466336664|FG000|Overall Study|Consent revoked|5|||
129557478|NCT01504867|466336665|FG001|Overall Study|Consent revoked|1|||
129557479|NCT00871169|466336666|FG000|Overall Study|Protocol Violation|1|||
129557480|NCT00871169|466336666|FG000|Overall Study|Patient did not receive study treatment|2|||
129557481|NCT02110706|466336670|FG000|Overall Study|Adverse Event|2|||
129557482|NCT02110706|466336671|FG001|Overall Study|Adverse Event|3|||
129557483|NCT02110706|466336670|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
129557484|NCT02110706|466336671|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
129557485|NCT03210259|466336672|FG000|12-Week Run-in Period|Adverse Event|1|||
129557486|NCT03210259|466336673|FG001|12-Week Run-in Period|Adverse Event|0|||
129557487|NCT03210259|466336674|FG002|12-Week Run-in Period|Adverse Event|0|||
129557488|NCT03210259|466336672|FG000|12-Week Run-in Period|Death|1|||
129557489|NCT03210259|466336673|FG001|12-Week Run-in Period|Death|0|||
129557490|NCT03210259|466336674|FG002|12-Week Run-in Period|Death|0|||
129557491|NCT03210259|466336672|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
129557492|NCT03210259|466336673|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
129557493|NCT03210259|466336674|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
129557494|NCT03210259|466336672|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
129557495|NCT03210259|466336673|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
129557496|NCT03210259|466336674|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
129557497|NCT03210259|466336672|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
129557498|NCT03210259|466336673|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
129557499|NCT03210259|466336674|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
129557500|NCT03210259|466336672|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
129557501|NCT03210259|466336673|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
129557502|NCT03210259|466336674|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
129557503|NCT03210259|466336672|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
129557504|NCT03210259|466336673|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
129557505|NCT03210259|466336674|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
129557506|NCT03210259|466336672|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
129557507|NCT03210259|466336673|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
129777392|NCT03566485|467151317|FG000|Overall Study|Disease progression|5|||
129777393|NCT03566485|467151318|FG001|Overall Study|Disease progression|4|||
129777394|NCT03566485|467151317|FG000|Overall Study|Clinical progression|0|||
129777395|NCT03566485|467151318|FG001|Overall Study|Clinical progression|1|||
129777396|NCT03566485|467151317|FG000|Overall Study|Toxicity|0|||
129777397|NCT03566485|467151318|FG001|Overall Study|Toxicity|2|||
129777398|NCT04999852|467151319|FG000|Overall Study|Withdrawal by Subject|11|||
129777399|NCT04999852|467151320|FG001|Overall Study|Withdrawal by Subject|1|||
129777400|NCT04999852|467151319|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
129777401|NCT04999852|467151320|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
129557508|NCT03210259|466336674|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
129557509|NCT03210259|466336672|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
129557510|NCT03210259|466336673|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
129557511|NCT03210259|466336674|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
129557512|NCT03210259|466336672|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
129557513|NCT03210259|466336673|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
129557514|NCT03210259|466336674|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
129557515|NCT03210259|466336672|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
129557516|NCT03210259|466336673|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
129557517|NCT03210259|466336674|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
129557518|NCT02087059|466336675|FG000|Overall Study|Disease Progression|1|||
129557519|NCT02087059|466336675|FG000|Overall Study|Adverse Event|5|||
129557520|NCT02087059|466336675|FG000|Overall Study|Lost to Follow-up|1|||
129557521|NCT00252187|466336676|FG000|Overall Study|Adverse Event|3|||
129557522|NCT00252187|466336677|FG001|Overall Study|Adverse Event|1|||
129557523|NCT00252187|466336676|FG000|Overall Study|Withdrawal by Subject|1|||
129557524|NCT00252187|466336677|FG001|Overall Study|Withdrawal by Subject|0|||
129557525|NCT02175966|466336680|FG000|Follow-up Period|Lack of Efficacy|10|||
129557526|NCT02175966|466336681|FG001|Follow-up Period|Lack of Efficacy|6|||
129557527|NCT00210626|466336686|FG000|Overall Study|Adverse Event|1|||
129557528|NCT00210626|466336687|FG001|Overall Study|Adverse Event|2|||
129557529|NCT00210626|466336686|FG000|Overall Study|Protocol Violation|1|||
129557530|NCT00210626|466336687|FG001|Overall Study|Protocol Violation|5|||
129557531|NCT00210626|466336686|FG000|Overall Study|Lost to Follow-up|11|||
129557532|NCT00210626|466336687|FG001|Overall Study|Lost to Follow-up|11|||
129557533|NCT00210626|466336686|FG000|Overall Study|Death|1|||
129557534|NCT00210626|466336687|FG001|Overall Study|Death|0|||
129557535|NCT00210626|466336686|FG000|Overall Study|Withdrawal by Subject|29|||
129557536|NCT00210626|466336687|FG001|Overall Study|Withdrawal by Subject|20|||
129557537|NCT00210626|466336686|FG000|Overall Study|Physician Decision|0|||
129557538|NCT00210626|466336687|FG001|Overall Study|Physician Decision|2|||
129557539|NCT00210626|466336686|FG000|Overall Study|Sponser Request|1|||
129557540|NCT00210626|466336687|FG001|Overall Study|Sponser Request|0|||
129557541|NCT00210626|466336686|FG000|Overall Study|Other|4|||
129557542|NCT00210626|466336687|FG001|Overall Study|Other|5|||
129557543|NCT02473510|466336688|FG000|Overall Study|Lost to Follow-up|1|||
129557544|NCT02473510|466336689|FG001|Overall Study|Lost to Follow-up|2|||
129557545|NCT01306253|466336690|FG000|Overall Study|Lost to Follow-up|1|||
129557546|NCT01306253|466336691|FG001|Overall Study|Lost to Follow-up|1|||
129557547|NCT01261325|466336692|FG000|Overall Study|Lack of Efficacy|1|||
129557548|NCT01261325|466336693|FG001|Overall Study|Lack of Efficacy|1|||
129557549|NCT01261325|466336694|FG002|Overall Study|Lack of Efficacy|0|||
129557550|NCT01261325|466336692|FG000|Overall Study|Withdrawal by Subject|2|||
129557551|NCT01261325|466336693|FG001|Overall Study|Withdrawal by Subject|2|||
129557552|NCT01261325|466336694|FG002|Overall Study|Withdrawal by Subject|4|||
129557553|NCT01261325|466336692|FG000|Overall Study|SAE, non-fatal|1|||
129557554|NCT01261325|466336693|FG001|Overall Study|SAE, non-fatal|5|||
129557555|NCT01261325|466336694|FG002|Overall Study|SAE, non-fatal|1|||
129557556|NCT01261325|466336692|FG000|Overall Study|AE, non-serious non-fatal|9|||
129557557|NCT01261325|466336693|FG001|Overall Study|AE, non-serious non-fatal|15|||
129557558|NCT01261325|466336694|FG002|Overall Study|AE, non-serious non-fatal|13|||
129557559|NCT01261325|466336692|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129777402|NCT04638660|467151321|FG000|Overall Study|Withdrawal by Subject|2|||
129777403|NCT04638660|467151322|FG001|Overall Study|Withdrawal by Subject|0|||
129884511|NCT02293837|467536435|FG003|Overall Study|COVID-19 Related|0|||
129884512|NCT02293837|467536432|FG000|Overall Study|Participant ill and could not be infused|0|||
129557560|NCT01261325|466336693|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129557561|NCT01261325|466336694|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129557562|NCT01261325|466336692|FG000|Overall Study|Non Compliance|2|||
129557563|NCT01261325|466336693|FG001|Overall Study|Non Compliance|0|||
129557564|NCT01261325|466336694|FG002|Overall Study|Non Compliance|0|||
129557565|NCT01261325|466336692|FG000|Overall Study|Patient Randomized by Mistake|0|||
129557566|NCT01261325|466336693|FG001|Overall Study|Patient Randomized by Mistake|1|||
129557567|NCT01261325|466336694|FG002|Overall Study|Patient Randomized by Mistake|0|||
129557568|NCT01261325|466336692|FG000|Overall Study|Erroneously Randomized|1|||
129557569|NCT01261325|466336693|FG001|Overall Study|Erroneously Randomized|0|||
129557570|NCT01261325|466336694|FG002|Overall Study|Erroneously Randomized|0|||
129557571|NCT01261325|466336692|FG000|Overall Study|Screen Failure|1|||
129557572|NCT01261325|466336693|FG001|Overall Study|Screen Failure|0|||
129557573|NCT01261325|466336694|FG002|Overall Study|Screen Failure|0|||
129557574|NCT01261325|466336692|FG000|Overall Study|Randomized in Error|0|||
129557575|NCT01261325|466336693|FG001|Overall Study|Randomized in Error|0|||
129557576|NCT01261325|466336694|FG002|Overall Study|Randomized in Error|1|||
129557577|NCT01261325|466336692|FG000|Overall Study|Protocol Violation|0|||
129557578|NCT01261325|466336693|FG001|Overall Study|Protocol Violation|3|||
129557579|NCT01261325|466336694|FG002|Overall Study|Protocol Violation|1|||
129557580|NCT01261325|466336692|FG000|Overall Study|Lost to Follow-up|0|||
129557581|NCT01261325|466336693|FG001|Overall Study|Lost to Follow-up|1|||
129557582|NCT01261325|466336694|FG002|Overall Study|Lost to Follow-up|3|||
129557583|NCT01261325|466336692|FG000|Overall Study|AE, serious fatal|0|||
129557584|NCT01261325|466336693|FG001|Overall Study|AE, serious fatal|0|||
129557585|NCT01261325|466336694|FG002|Overall Study|AE, serious fatal|2|||
129557586|NCT01086215|466336697|FG000|Overall Study|Death|14|||
129557587|NCT01086215|466336698|FG001|Overall Study|Death|8|||
129557588|NCT01086215|466336699|FG002|Overall Study|Death|8|||
129557589|NCT01086215|466336700|FG003|Overall Study|Death|1|||
129557590|NCT01086215|466336697|FG000|Overall Study|Lost to Follow-up|22|||
129557591|NCT01086215|466336698|FG001|Overall Study|Lost to Follow-up|39|||
129557592|NCT01086215|466336699|FG002|Overall Study|Lost to Follow-up|18|||
129557593|NCT01086215|466336700|FG003|Overall Study|Lost to Follow-up|2|||
129557594|NCT01829295|466336701|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
129557595|NCT01829295|466336702|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
129557596|NCT01829295|466336703|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
129557597|NCT01829295|466336704|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
129557598|NCT01829295|466336701|FG000|6-12 Months|Adverse Event|0|||
129557599|NCT01829295|466336702|FG001|6-12 Months|Adverse Event|0|||
129557600|NCT01829295|466336703|FG002|6-12 Months|Adverse Event|3|||
129557601|NCT01829295|466336704|FG003|6-12 Months|Adverse Event|2|||
129557602|NCT01829295|466336701|FG000|6-12 Months|Lost to Follow-up|2|||
129557603|NCT01829295|466336702|FG001|6-12 Months|Lost to Follow-up|0|||
129777404|NCT04638660|467151321|FG000|Overall Study|Lost to Follow-up|1|||
129557604|NCT01829295|466336703|FG002|6-12 Months|Lost to Follow-up|0|||
129557605|NCT01829295|466336704|FG003|6-12 Months|Lost to Follow-up|0|||
129557606|NCT01829295|466336701|FG000|6-12 Months|Withdrawal by Subject|2|||
129557607|NCT01829295|466336702|FG001|6-12 Months|Withdrawal by Subject|2|||
129557608|NCT01829295|466336703|FG002|6-12 Months|Withdrawal by Subject|0|||
129557609|NCT01829295|466336704|FG003|6-12 Months|Withdrawal by Subject|0|||
129557610|NCT02826603|466336705|FG000|Overall Study|Adverse Event|17|||
129557611|NCT02826603|466336706|FG001|Overall Study|Adverse Event|9|||
129557612|NCT02826603|466336705|FG000|Overall Study|Lack of Efficacy|4|||
129557613|NCT02826603|466336706|FG001|Overall Study|Lack of Efficacy|9|||
129557614|NCT02826603|466336705|FG000|Overall Study|Lost to Follow-up|13|||
129557615|NCT02826603|466336706|FG001|Overall Study|Lost to Follow-up|12|||
129557616|NCT02826603|466336705|FG000|Overall Study|Noncompliance with treatment|0|||
129777405|NCT04638660|467151322|FG001|Overall Study|Lost to Follow-up|0|||
129777406|NCT03610269|467151324|FG000|Overall Study|Physician Decision|10|||
129777407|NCT03610269|467151324|FG000|Overall Study|Protocol Violation|1|||
129777408|NCT03610269|467151324|FG000|Overall Study|Unable to draw blood|1|||
129777409|NCT03610269|467151324|FG000|Overall Study|Screen fail|4|||
129557617|NCT02826603|466336706|FG001|Overall Study|Noncompliance with treatment|2|||
129557618|NCT02826603|466336705|FG000|Overall Study|Physician Decision|1|||
129557619|NCT02826603|466336706|FG001|Overall Study|Physician Decision|7|||
129557620|NCT02826603|466336705|FG000|Overall Study|Pregnancy|1|||
129557621|NCT02826603|466336706|FG001|Overall Study|Pregnancy|2|||
129557622|NCT02826603|466336705|FG000|Overall Study|Protocol Violation|3|||
129557623|NCT02826603|466336706|FG001|Overall Study|Protocol Violation|3|||
129557624|NCT02826603|466336705|FG000|Overall Study|Withdrawal by Subject|20|||
129557625|NCT02826603|466336706|FG001|Overall Study|Withdrawal by Subject|19|||
129557626|NCT02826603|466336705|FG000|Overall Study|Death|2|||
129557627|NCT02826603|466336706|FG001|Overall Study|Death|0|||
129557628|NCT02826603|466336705|FG000|Overall Study|New therapy for study indication|0|||
129557629|NCT02826603|466336706|FG001|Overall Study|New therapy for study indication|1|||
129557630|NCT01337050|466336710|FG000|Overall Study|Death|0|||
129557631|NCT01337050|466336711|FG001|Overall Study|Death|0|||
129777410|NCT00478023|467151325|FG000|Overall Study|Adverse Event|11|||
129557632|NCT01337050|466336712|FG002|Overall Study|Death|4|||
129557633|NCT01337050|466336710|FG000|Overall Study|Other|4|||
129777411|NCT00478023|467151326|FG001|Overall Study|Adverse Event|7|||
129557634|NCT01337050|466336711|FG001|Overall Study|Other|6|||
129557635|NCT01337050|466336712|FG002|Overall Study|Other|8|||
129557636|NCT01337050|466336710|FG000|Overall Study|Participants refused further follow-up|0|||
129557637|NCT01337050|466336711|FG001|Overall Study|Participants refused further follow-up|7|||
129557638|NCT01337050|466336712|FG002|Overall Study|Participants refused further follow-up|7|||
129557639|NCT00003102|466336713|FG000|Overall Study|Physician Decision|1|||
129557640|NCT00003102|466336714|FG001|Overall Study|Physician Decision|1|||
129557641|NCT00003102|466336715|FG002|Overall Study|Physician Decision|0|||
129777412|NCT00478023|467151327|FG002|Overall Study|Adverse Event|8|||
129777413|NCT00478023|467151328|FG003|Overall Study|Adverse Event|14|||
129777414|NCT00478023|467151329|FG004|Overall Study|Adverse Event|6|||
129777415|NCT00478023|467151325|FG000|Overall Study|Death|1|||
129777416|NCT00478023|467151326|FG001|Overall Study|Death|0|||
129777417|NCT00478023|467151327|FG002|Overall Study|Death|0|||
129777418|NCT00478023|467151328|FG003|Overall Study|Death|0|||
129777419|NCT00478023|467151329|FG004|Overall Study|Death|0|||
129777420|NCT00478023|467151325|FG000|Overall Study|Lack of Efficacy|11|||
129777421|NCT00478023|467151326|FG001|Overall Study|Lack of Efficacy|10|||
129777422|NCT00478023|467151327|FG002|Overall Study|Lack of Efficacy|4|||
129777423|NCT00478023|467151328|FG003|Overall Study|Lack of Efficacy|5|||
129777424|NCT00478023|467151329|FG004|Overall Study|Lack of Efficacy|41|||
129777425|NCT00478023|467151325|FG000|Overall Study|Lost to Follow-up|3|||
129777426|NCT00478023|467151326|FG001|Overall Study|Lost to Follow-up|1|||
129777427|NCT00478023|467151327|FG002|Overall Study|Lost to Follow-up|1|||
129777428|NCT00478023|467151328|FG003|Overall Study|Lost to Follow-up|1|||
129777429|NCT00478023|467151329|FG004|Overall Study|Lost to Follow-up|0|||
129777430|NCT00478023|467151325|FG000|Overall Study|Withdrawal by Subject|2|||
129777431|NCT00478023|467151326|FG001|Overall Study|Withdrawal by Subject|3|||
129777432|NCT00478023|467151327|FG002|Overall Study|Withdrawal by Subject|2|||
129777433|NCT00478023|467151328|FG003|Overall Study|Withdrawal by Subject|4|||
129777434|NCT00478023|467151329|FG004|Overall Study|Withdrawal by Subject|5|||
129777435|NCT00478023|467151325|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
129777436|NCT00478023|467151326|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
129777437|NCT00478023|467151327|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
129777438|NCT00478023|467151328|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
129777439|NCT00478023|467151329|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
129777440|NCT00611026|467151331|FG000|Randomized to Double-blind Treatment|Not treated|2|||
129777441|NCT00611026|467151332|FG001|Randomized to Double-blind Treatment|Not treated|1|||
129777442|NCT00611026|467151333|FG002|Randomized to Double-blind Treatment|Not treated|3|||
129777443|NCT00611026|467151331|FG000|Double-blind Treatment Period|Death|1|||
129777444|NCT00611026|467151332|FG001|Double-blind Treatment Period|Death|0|||
129777445|NCT00611026|467151333|FG002|Double-blind Treatment Period|Death|0|||
129777446|NCT00611026|467151331|FG000|Double-blind Treatment Period|Adverse Event|9|||
129777447|NCT00611026|467151332|FG001|Double-blind Treatment Period|Adverse Event|28|||
129777448|NCT00611026|467151333|FG002|Double-blind Treatment Period|Adverse Event|46|||
129777449|NCT00611026|467151331|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
129777450|NCT00611026|467151332|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
129777451|NCT00611026|467151333|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
129777452|NCT00611026|467151331|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
129777453|NCT00611026|467151332|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
129777454|NCT00611026|467151333|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
129777455|NCT00611026|467151331|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
129777456|NCT00611026|467151332|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
129777457|NCT00611026|467151333|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
129777458|NCT00611026|467151331|FG000|Double-blind Treatment Period|Other|13|||
129777459|NCT00611026|467151332|FG001|Double-blind Treatment Period|Other|20|||
129777460|NCT00611026|467151333|FG002|Double-blind Treatment Period|Other|18|||
129777461|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
129777462|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
129777463|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
129777464|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
129777465|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
129777466|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
129557642|NCT00003102|466336713|FG000|Overall Study|Progressive Disease|0|||
129777467|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
129777468|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129777469|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129777470|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129557643|NCT00003102|466336714|FG001|Overall Study|Progressive Disease|1|||
129557644|NCT00003102|466336715|FG002|Overall Study|Progressive Disease|0|||
129777471|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
129777472|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129777473|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129557645|NCT00003102|466336713|FG000|Overall Study|Adverse Event|0|||
129557646|NCT00003102|466336714|FG001|Overall Study|Adverse Event|1|||
129557647|NCT00003102|466336715|FG002|Overall Study|Adverse Event|1|||
129557648|NCT00003102|466336713|FG000|Overall Study|Death|0|||
129557649|NCT00003102|466336714|FG001|Overall Study|Death|0|||
129557650|NCT00003102|466336715|FG002|Overall Study|Death|1|||
129557651|NCT00583596|466336716|FG000|Overall Study|Lost to Follow-up|110|||
129557652|NCT00583596|466336716|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
129557653|NCT00583596|466336716|FG000|Overall Study|Death|2|||
129557654|NCT00583596|466336716|FG000|Overall Study|Withdrawal by Subject|6|||
129557655|NCT00583596|466336716|FG000|Overall Study|Lost to Follow-up|94|||
129557656|NCT00583596|466336716|FG000|Overall Study|Data not complete|1|||
129557657|NCT00583596|466336716|FG000|Overall Study|Not consented|15|||
129557658|NCT00583596|466336716|FG000|Overall Study|Outside f-up window|26|||
129557659|NCT00656019|466336717|FG000|Overall Study|Not Eligible|10|||
129557660|NCT00656019|466336718|FG001|Overall Study|Not Eligible|0|||
129557661|NCT00656019|466336719|FG002|Overall Study|Not Eligible|0|||
129557662|NCT00656019|466336720|FG003|Overall Study|Not Eligible|0|||
129557663|NCT00656019|466336717|FG000|Overall Study|Withdrawal by Subject|2|||
129557664|NCT00656019|466336718|FG001|Overall Study|Withdrawal by Subject|0|||
129557665|NCT00656019|466336719|FG002|Overall Study|Withdrawal by Subject|0|||
129557666|NCT00656019|466336720|FG003|Overall Study|Withdrawal by Subject|0|||
129557667|NCT00656019|466336717|FG000|Overall Study|Lost to Follow-up|2|||
129557668|NCT00656019|466336718|FG001|Overall Study|Lost to Follow-up|1|||
129557669|NCT00656019|466336719|FG002|Overall Study|Lost to Follow-up|0|||
129557670|NCT00656019|466336720|FG003|Overall Study|Lost to Follow-up|0|||
129557671|NCT00096486|466336721|FG000|Overall Study|Withdrawal by Subject|0|||
129557672|NCT00096486|466336722|FG001|Overall Study|Withdrawal by Subject|0|||
129557673|NCT00096486|466336723|FG002|Overall Study|Withdrawal by Subject|1|||
129557674|NCT00096486|466336724|FG003|Overall Study|Withdrawal by Subject|1|||
129557675|NCT00096486|466336721|FG000|Overall Study|Not Treated|0|||
129557676|NCT00096486|466336722|FG001|Overall Study|Not Treated|0|||
129557677|NCT00096486|466336723|FG002|Overall Study|Not Treated|1|||
129557678|NCT00096486|466336724|FG003|Overall Study|Not Treated|1|||
129557679|NCT03558997|466336725|FG000|Overall Study|Adverse Event|0|||
129557680|NCT03558997|466336726|FG001|Overall Study|Adverse Event|2|||
129557681|NCT03558997|466336727|FG002|Overall Study|Adverse Event|5|||
129557682|NCT03558997|466336728|FG003|Overall Study|Adverse Event|1|||
129557683|NCT03558997|466336725|FG000|Overall Study|Physician Decision|0|||
129557684|NCT03558997|466336726|FG001|Overall Study|Physician Decision|0|||
129557685|NCT03558997|466336727|FG002|Overall Study|Physician Decision|1|||
129557686|NCT03558997|466336728|FG003|Overall Study|Physician Decision|0|||
129557687|NCT03558997|466336725|FG000|Overall Study|Withdrawal by Subject|1|||
129557688|NCT03558997|466336726|FG001|Overall Study|Withdrawal by Subject|0|||
129557689|NCT03558997|466336727|FG002|Overall Study|Withdrawal by Subject|1|||
129557690|NCT03558997|466336728|FG003|Overall Study|Withdrawal by Subject|1|||
129557691|NCT03558997|466336725|FG000|Overall Study|Lost to Follow-up|0|||
129557692|NCT03558997|466336726|FG001|Overall Study|Lost to Follow-up|0|||
129557693|NCT03558997|466336727|FG002|Overall Study|Lost to Follow-up|1|||
129557694|NCT03558997|466336728|FG003|Overall Study|Lost to Follow-up|0|||
129557695|NCT02230085|466336731|FG000|Overall Study|Physician Decision|1|||
129557696|NCT02230085|466336731|FG000|Overall Study|Withdrawal by Subject|3|||
129557697|NCT01360632|466336737|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
129557698|NCT01360632|466336738|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
129557699|NCT01360632|466336739|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
129557700|NCT01360632|466336740|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
129557701|NCT01360632|466336741|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
129557702|NCT01360632|466336737|FG000|Phase A (8 Weeks)|Adverse Event|60|||
129557703|NCT01360632|466336738|FG001|Phase A (8 Weeks)|Adverse Event|0|||
129557704|NCT01360632|466336739|FG002|Phase A (8 Weeks)|Adverse Event|0|||
129557705|NCT01360632|466336740|FG003|Phase A (8 Weeks)|Adverse Event|0|||
129557706|NCT01360632|466336741|FG004|Phase A (8 Weeks)|Adverse Event|0|||
129557707|NCT01360632|466336737|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
129557708|NCT01360632|466336738|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129557709|NCT01360632|466336739|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129557710|NCT01360632|466336740|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129557711|NCT01360632|466336741|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
129557712|NCT01360632|466336737|FG000|Phase A (8 Weeks)|Physician Decision|10|||
129557713|NCT01360632|466336738|FG001|Phase A (8 Weeks)|Physician Decision|0|||
129557714|NCT01360632|466336739|FG002|Phase A (8 Weeks)|Physician Decision|0|||
129557715|NCT01360632|466336740|FG003|Phase A (8 Weeks)|Physician Decision|0|||
129557716|NCT01360632|466336741|FG004|Phase A (8 Weeks)|Physician Decision|0|||
129557717|NCT01360632|466336737|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
129557718|NCT01360632|466336738|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
129557719|NCT01360632|466336739|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
129557720|NCT01360632|466336740|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
129557721|NCT01360632|466336741|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
129557722|NCT01360632|466336737|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
129557723|NCT01360632|466336738|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
129557724|NCT01360632|466336739|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
129557725|NCT01360632|466336740|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
129557726|NCT01360632|466336741|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
129557727|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
129557728|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
129557729|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
129557730|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
129557731|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
129557732|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Adverse Event|0|||
129557733|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Adverse Event|3|||
129557734|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Adverse Event|9|||
129557735|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Adverse Event|3|||
129557736|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Adverse Event|0|||
129557737|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129557738|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129557739|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
129557740|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
129557741|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129557742|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Physician Decision|0|||
129557743|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Physician Decision|0|||
129557744|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Physician Decision|0|||
129557745|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Physician Decision|1|||
129557746|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Physician Decision|0|||
129557747|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
129557748|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
129557749|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
129557750|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
129557751|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
129557752|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
129557753|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
129557754|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
129557755|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
129557756|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
129557757|NCT01360632|466336737|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
129557758|NCT01360632|466336738|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
129557759|NCT01360632|466336739|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
129557760|NCT01360632|466336740|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
129557761|NCT01360632|466336741|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
129557762|NCT01360632|466336737|FG000|Phase A+|Lost to Follow-up|0|||
129557763|NCT01360632|466336738|FG001|Phase A+|Lost to Follow-up|0|||
129557764|NCT01360632|466336739|FG002|Phase A+|Lost to Follow-up|0|||
129557765|NCT01360632|466336740|FG003|Phase A+|Lost to Follow-up|0|||
129557766|NCT01360632|466336741|FG004|Phase A+|Lost to Follow-up|2|||
129557767|NCT01360632|466336737|FG000|Phase A+|Adverse Event|0|||
129557768|NCT01360632|466336738|FG001|Phase A+|Adverse Event|0|||
129557769|NCT01360632|466336739|FG002|Phase A+|Adverse Event|0|||
129557770|NCT01360632|466336740|FG003|Phase A+|Adverse Event|0|||
129557771|NCT01360632|466336741|FG004|Phase A+|Adverse Event|2|||
129557772|NCT01360632|466336737|FG000|Phase A+|Met Withdrawal Criteria|0|||
129557773|NCT01360632|466336738|FG001|Phase A+|Met Withdrawal Criteria|0|||
129557774|NCT01360632|466336739|FG002|Phase A+|Met Withdrawal Criteria|0|||
129777474|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129777475|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
129557775|NCT01360632|466336740|FG003|Phase A+|Met Withdrawal Criteria|0|||
129557776|NCT01360632|466336741|FG004|Phase A+|Met Withdrawal Criteria|7|||
129557777|NCT01360632|466336737|FG000|Phase A+|Physician Decision|0|||
129557778|NCT01360632|466336738|FG001|Phase A+|Physician Decision|0|||
129557779|NCT01360632|466336739|FG002|Phase A+|Physician Decision|0|||
129557780|NCT01360632|466336740|FG003|Phase A+|Physician Decision|0|||
129557781|NCT01360632|466336741|FG004|Phase A+|Physician Decision|3|||
129557782|NCT01360632|466336737|FG000|Phase A+|Withdrawal by Subject|0|||
129557783|NCT01360632|466336738|FG001|Phase A+|Withdrawal by Subject|0|||
129557784|NCT01360632|466336739|FG002|Phase A+|Withdrawal by Subject|0|||
129557785|NCT01360632|466336740|FG003|Phase A+|Withdrawal by Subject|0|||
129557786|NCT01360632|466336741|FG004|Phase A+|Withdrawal by Subject|8|||
129557787|NCT01360632|466336737|FG000|Phase A+|Protocol Deviation|0|||
129557788|NCT01360632|466336738|FG001|Phase A+|Protocol Deviation|0|||
129557789|NCT01360632|466336739|FG002|Phase A+|Protocol Deviation|0|||
129557790|NCT01360632|466336740|FG003|Phase A+|Protocol Deviation|0|||
129557791|NCT01360632|466336741|FG004|Phase A+|Protocol Deviation|3|||
129557792|NCT02173301|466336742|FG000|Overall Study|Adverse Event|7|||
129557793|NCT02173301|466336743|FG001|Overall Study|Adverse Event|8|||
129557794|NCT02173301|466336744|FG002|Overall Study|Adverse Event|13|||
129557795|NCT02173301|466336745|FG003|Overall Study|Adverse Event|5|||
129557796|NCT02173301|466336742|FG000|Overall Study|Withdrawal by Subject|8|||
129557797|NCT02173301|466336743|FG001|Overall Study|Withdrawal by Subject|10|||
129557798|NCT02173301|466336744|FG002|Overall Study|Withdrawal by Subject|4|||
129557799|NCT02173301|466336745|FG003|Overall Study|Withdrawal by Subject|8|||
129557800|NCT02173301|466336742|FG000|Overall Study|Lost to Follow-up|4|||
129557801|NCT02173301|466336743|FG001|Overall Study|Lost to Follow-up|4|||
129557802|NCT02173301|466336744|FG002|Overall Study|Lost to Follow-up|2|||
129557803|NCT02173301|466336745|FG003|Overall Study|Lost to Follow-up|2|||
129557804|NCT02173301|466336742|FG000|Overall Study|Protocol Violation|0|||
129557805|NCT02173301|466336743|FG001|Overall Study|Protocol Violation|1|||
129557806|NCT02173301|466336744|FG002|Overall Study|Protocol Violation|0|||
129557807|NCT02173301|466336745|FG003|Overall Study|Protocol Violation|0|||
129557808|NCT02173301|466336742|FG000|Overall Study|Physician Decision|0|||
129557809|NCT02173301|466336743|FG001|Overall Study|Physician Decision|0|||
129557810|NCT02173301|466336744|FG002|Overall Study|Physician Decision|1|||
129557811|NCT02173301|466336745|FG003|Overall Study|Physician Decision|0|||
129557812|NCT02173301|466336742|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
129557813|NCT02173301|466336743|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
129557814|NCT02173301|466336744|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
129557815|NCT02173301|466336745|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
129557816|NCT03016078|466336747|FG000|Overall Study|Protocol Violation|1|||
129557817|NCT03016078|466336747|FG000|Overall Study|Protocol Violation|1|||
129557818|NCT01715415|466336753|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
129557819|NCT01715415|466336754|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
129557820|NCT01715415|466336753|FG000|Double-blind Treatment|Adverse Event|3|||
129557821|NCT01715415|466336754|FG001|Double-blind Treatment|Adverse Event|0|||
129557822|NCT01715415|466336753|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
129557823|NCT01715415|466336754|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
129557824|NCT01715415|466336753|FG000|Double-blind Treatment|Other|1|||
129557825|NCT01715415|466336754|FG001|Double-blind Treatment|Other|0|||
129557826|NCT01715415|466336753|FG000|Open-label Treatment|Adverse Event|0|||
129557827|NCT01715415|466336754|FG001|Open-label Treatment|Adverse Event|1|||
129557828|NCT01715415|466336753|FG000|Open-label Treatment|Subject Noncompliant|0|||
129557829|NCT01715415|466336754|FG001|Open-label Treatment|Subject Noncompliant|1|||
129557830|NCT05028751|466336755|FG000|Overall Study|Study Terminated by Sponsor|3|||
129557831|NCT05028751|466336756|FG001|Overall Study|Study Terminated by Sponsor|0|||
129557832|NCT05028751|466336757|FG002|Overall Study|Study Terminated by Sponsor|0|||
129557833|NCT05028751|466336758|FG003|Overall Study|Study Terminated by Sponsor|0|||
129557834|NCT05028751|466336755|FG000|Overall Study|Death|9|||
129557835|NCT05028751|466336756|FG001|Overall Study|Death|3|||
129557836|NCT05028751|466336757|FG002|Overall Study|Death|2|||
129557837|NCT05028751|466336758|FG003|Overall Study|Death|4|||
129557838|NCT05028751|466336755|FG000|Overall Study|Withdrawal by Subject|0|||
129557839|NCT05028751|466336756|FG001|Overall Study|Withdrawal by Subject|0|||
129557840|NCT05028751|466336757|FG002|Overall Study|Withdrawal by Subject|1|||
129557841|NCT05028751|466336758|FG003|Overall Study|Withdrawal by Subject|0|||
129557842|NCT05028751|466336755|FG000|Overall Study|Miscellaneous|2|||
129557843|NCT05028751|466336756|FG001|Overall Study|Miscellaneous|0|||
129557844|NCT05028751|466336757|FG002|Overall Study|Miscellaneous|0|||
129557845|NCT05028751|466336758|FG003|Overall Study|Miscellaneous|0|||
129557846|NCT00395083|466336761|FG000|Overall Study|Withdrawal by Subject|6|||
129557847|NCT00395083|466336762|FG001|Overall Study|Withdrawal by Subject|5|||
129557848|NCT00395083|466336761|FG000|Overall Study|Developed another disease|4|||
129557849|NCT00395083|466336762|FG001|Overall Study|Developed another disease|3|||
129557850|NCT00972153|466336763|FG000|Overall Study|Equipment malfunction during case|0|||
129557851|NCT00972153|466336764|FG001|Overall Study|Equipment malfunction during case|1|||
129557852|NCT00972153|466336765|FG002|Overall Study|Equipment malfunction during case|0|||
129557853|NCT04136626|466336766|FG000|Treatment Phase|Withdrawal by Subject|1|||
129557854|NCT04136626|466336767|FG001|Treatment Phase|Withdrawal by Subject|9|||
129557855|NCT04136626|466336766|FG000|Treatment Phase|Adverse Event|1|||
129557856|NCT04136626|466336767|FG001|Treatment Phase|Adverse Event|0|||
129557857|NCT04136626|466336766|FG000|Treatment Phase|Lost to Follow-up|1|||
129557858|NCT04136626|466336767|FG001|Treatment Phase|Lost to Follow-up|5|||
129557859|NCT04136626|466336766|FG000|12-month Follow-up|Lost to Follow-up|8|||
129557860|NCT04136626|466336767|FG001|12-month Follow-up|Lost to Follow-up|7|||
129557861|NCT03572933|466339120|FG000|Overall Study|Adverse Event|4|||
129557862|NCT03572933|466339121|FG001|Overall Study|Adverse Event|1|||
129557863|NCT03572933|466339120|FG000|Overall Study|Withdrawal by Subject|0|||
129557864|NCT03572933|466339121|FG001|Overall Study|Withdrawal by Subject|1|||
129557865|NCT01907737|466339122|FG000|Overall Study|Withdrawal by Subject|1|||
129557866|NCT01772368|466339124|FG000|Overall Study|Adverse Event|1|||
129557867|NCT01772368|466339124|FG000|Overall Study|Withdrawal by Subject|3|||
129557868|NCT01772368|466339124|FG000|Overall Study|Protocol Violation|2|||
129557869|NCT01772368|466339124|FG000|Overall Study|Other|1|||
129557870|NCT01452529|466339125|FG000|Run-in Period|Adverse Event|96|||
129557871|NCT01452529|466339126|FG001|Run-in Period|Adverse Event|0|||
129557872|NCT01452529|466339127|FG002|Run-in Period|Adverse Event|0|||
129777476|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
129777477|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
129557873|NCT01452529|466339125|FG000|Run-in Period|Withdrawal by Subject|49|||
129557874|NCT01452529|466339126|FG001|Run-in Period|Withdrawal by Subject|0|||
129557875|NCT01452529|466339127|FG002|Run-in Period|Withdrawal by Subject|0|||
129557876|NCT01452529|466339125|FG000|Run-in Period|Lost to Follow-up|19|||
129557877|NCT01452529|466339126|FG001|Run-in Period|Lost to Follow-up|0|||
129557878|NCT01452529|466339127|FG002|Run-in Period|Lost to Follow-up|0|||
129557879|NCT01452529|466339125|FG000|Run-in Period|Lack of Efficacy|46|||
129557880|NCT01452529|466339126|FG001|Run-in Period|Lack of Efficacy|0|||
129557881|NCT01452529|466339127|FG002|Run-in Period|Lack of Efficacy|0|||
129557882|NCT01452529|466339125|FG000|Run-in Period|Confirmed or suspected diversion|23|||
129557883|NCT01452529|466339126|FG001|Run-in Period|Confirmed or suspected diversion|0|||
129557884|NCT01452529|466339127|FG002|Run-in Period|Confirmed or suspected diversion|0|||
129557885|NCT01452529|466339125|FG000|Run-in Period|Administrative|21|||
129557886|NCT01452529|466339126|FG001|Run-in Period|Administrative|0|||
129557887|NCT01452529|466339127|FG002|Run-in Period|Administrative|0|||
129557888|NCT01452529|466339125|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
129557889|NCT01452529|466339126|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
129557890|NCT01452529|466339127|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
129557891|NCT01452529|466339125|FG000|Double-blind (DB) Period|Adverse Event|0|||
129557892|NCT01452529|466339126|FG001|Double-blind (DB) Period|Adverse Event|18|||
129557893|NCT01452529|466339127|FG002|Double-blind (DB) Period|Adverse Event|11|||
129557894|NCT01452529|466339125|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
129557895|NCT01452529|466339126|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
129557896|NCT01452529|466339127|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
129557897|NCT01452529|466339125|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
129557898|NCT01452529|466339126|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
129557899|NCT01452529|466339127|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
129557900|NCT01452529|466339125|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
129557901|NCT01452529|466339126|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
129557902|NCT01452529|466339127|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
129557903|NCT01452529|466339125|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
129557904|NCT01452529|466339126|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
129557905|NCT01452529|466339127|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
129557906|NCT01452529|466339125|FG000|Double-blind (DB) Period|Administrative|0|||
129557907|NCT01452529|466339126|FG001|Double-blind (DB) Period|Administrative|11|||
129557908|NCT01452529|466339127|FG002|Double-blind (DB) Period|Administrative|7|||
129557909|NCT03347695|466339134|FG000|Overall Study|Death|0|||
129557910|NCT03347695|466339135|FG001|Overall Study|Death|4|||
129557911|NCT03347695|466339134|FG000|Overall Study|Lost to Follow-up|0|||
129557912|NCT03347695|466339135|FG001|Overall Study|Lost to Follow-up|1|||
129557913|NCT02884206|466339156|FG000|Valsartan Run-in Period|Death|1|||
129557914|NCT02884206|466339157|FG001|Valsartan Run-in Period|Death|0|||
129557915|NCT02884206|466339158|FG002|Valsartan Run-in Period|Death|0|||
129557916|NCT02884206|466339156|FG000|Valsartan Run-in Period|Adverse Event|31|||
129557917|NCT02884206|466339157|FG001|Valsartan Run-in Period|Adverse Event|0|||
129557918|NCT02884206|466339158|FG002|Valsartan Run-in Period|Adverse Event|0|||
129557919|NCT02884206|466339156|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
129557920|NCT02884206|466339157|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
129557921|NCT02884206|466339158|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
129557922|NCT02884206|466339156|FG000|Valsartan Run-in Period|Protocol deviation|4|||
129557923|NCT02884206|466339157|FG001|Valsartan Run-in Period|Protocol deviation|0|||
129557924|NCT02884206|466339158|FG002|Valsartan Run-in Period|Protocol deviation|0|||
129557925|NCT02884206|466339156|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
129557926|NCT02884206|466339157|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
129557927|NCT02884206|466339158|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
129557928|NCT02884206|466339156|FG000|Valsartan Run-in Period|Physician Decision|1|||
129557929|NCT02884206|466339157|FG001|Valsartan Run-in Period|Physician Decision|0|||
129557930|NCT02884206|466339158|FG002|Valsartan Run-in Period|Physician Decision|0|||
129557931|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Adverse Event|38|||
129557932|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Adverse Event|0|||
129557933|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Adverse Event|0|||
129557934|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Death|2|||
129557935|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Death|0|||
129557936|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Death|0|||
129557937|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
129557938|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
129557939|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
129557940|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
129557941|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
129557942|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
129557943|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
129557944|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
129557945|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
129557946|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Physician Decision|1|||
129557947|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Physician Decision|0|||
129557948|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Physician Decision|0|||
129557949|NCT02884206|466339156|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
129557950|NCT02884206|466339157|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
129557951|NCT02884206|466339158|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
129557952|NCT02884206|466339156|FG000|Double-Blind Period|Death|0|||
129557953|NCT02884206|466339157|FG001|Double-Blind Period|Death|28|||
129557954|NCT02884206|466339158|FG002|Double-Blind Period|Death|39|||
129557955|NCT02884206|466339156|FG000|Double-Blind Period|Patient/guardian decision|0|||
129557956|NCT02884206|466339157|FG001|Double-Blind Period|Patient/guardian decision|10|||
129557957|NCT02884206|466339158|FG002|Double-Blind Period|Patient/guardian decision|13|||
129557958|NCT02884206|466339156|FG000|Double-Blind Period|Lost to Follow-up|0|||
129557959|NCT02884206|466339157|FG001|Double-Blind Period|Lost to Follow-up|4|||
129557960|NCT02884206|466339158|FG002|Double-Blind Period|Lost to Follow-up|4|||
129557961|NCT02884206|466339156|FG000|Double-Blind Period|Physician Decision|0|||
129557962|NCT02884206|466339157|FG001|Double-Blind Period|Physician Decision|2|||
129557963|NCT02884206|466339158|FG002|Double-Blind Period|Physician Decision|0|||
129557964|NCT02884206|466339156|FG000|Double-Blind Period|Adverse Event|0|||
129557965|NCT02884206|466339157|FG001|Double-Blind Period|Adverse Event|0|||
129557966|NCT02884206|466339158|FG002|Double-Blind Period|Adverse Event|3|||
129557967|NCT02884206|466339156|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
129557968|NCT02884206|466339157|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
129557969|NCT02884206|466339158|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
129557970|NCT00112489|466339161|FG000|Overall Study|Refused further treatment|8|||
129557971|NCT00112489|466339161|FG000|Overall Study|Adverse Event|12|||
129557972|NCT00112489|466339161|FG000|Overall Study|Death|2|||
129557973|NCT00112489|466339161|FG000|Overall Study|Other, Not Specified|9|||
129557974|NCT00112489|466339161|FG000|Overall Study|Patient never treated|2|||
129557975|NCT00112489|466339161|FG000|Overall Study|Ineligible|7|||
129557976|NCT01003886|466339162|FG000|Overall Study|Lack of Efficacy|5|||
129557977|NCT01003886|466339162|FG000|Overall Study|Lost to Follow-up|169|||
129557978|NCT01003886|466339162|FG000|Overall Study|Withdrawal by Subject|39|||
129557979|NCT01003886|466339162|FG000|Overall Study|Other|14|||
129557980|NCT01003886|466339162|FG000|Overall Study|Adverse Event|3|||
129557981|NCT05751629|466339163|FG000|Overall Study|Withdrawal by Subject|6|||
129557982|NCT05751629|466339163|FG000|Overall Study|Death|25|||
129557983|NCT05751629|466339163|FG000|Overall Study|Study Site Closed|9|||
129557984|NCT05751629|466339163|FG000|Overall Study|Physician Decision|1|||
129557985|NCT00295854|466339166|FG000|Overall Study|Adverse Event|7|||
129557986|NCT00295854|466339167|FG001|Overall Study|Adverse Event|7|||
129557987|NCT00295854|466339168|FG002|Overall Study|Adverse Event|6|||
129557988|NCT00295854|466339166|FG000|Overall Study|Protocol Violation|1|||
129557989|NCT00295854|466339167|FG001|Overall Study|Protocol Violation|1|||
129557990|NCT00295854|466339168|FG002|Overall Study|Protocol Violation|1|||
129557991|NCT00295854|466339166|FG000|Overall Study|Lost to Follow-up|2|||
129557992|NCT00295854|466339167|FG001|Overall Study|Lost to Follow-up|0|||
129557993|NCT00295854|466339168|FG002|Overall Study|Lost to Follow-up|1|||
129557994|NCT00295854|466339166|FG000|Overall Study|Withdrawal by Subject|3|||
129557995|NCT00295854|466339167|FG001|Overall Study|Withdrawal by Subject|7|||
129557996|NCT00295854|466339168|FG002|Overall Study|Withdrawal by Subject|4|||
129557997|NCT00295854|466339166|FG000|Overall Study|did not continue to meet criteria|1|||
129557998|NCT00295854|466339167|FG001|Overall Study|did not continue to meet criteria|1|||
129557999|NCT00295854|466339168|FG002|Overall Study|did not continue to meet criteria|2|||
129558000|NCT00295854|466339166|FG000|Overall Study|required a prohibited medication|1|||
129558001|NCT00295854|466339167|FG001|Overall Study|required a prohibited medication|0|||
129558002|NCT00295854|466339168|FG002|Overall Study|required a prohibited medication|0|||
129558003|NCT00295854|466339166|FG000|Overall Study|Other|3|||
129558004|NCT00295854|466339167|FG001|Overall Study|Other|5|||
129558005|NCT00295854|466339168|FG002|Overall Study|Other|1|||
129558006|NCT00772577|466339169|FG000|Overall Study|Adverse Event|6|||
129558007|NCT00772577|466339170|FG001|Overall Study|Adverse Event|3|||
129558008|NCT00772577|466339169|FG000|Overall Study|Abnormal laboratory values|0|||
129558009|NCT00772577|466339170|FG001|Overall Study|Abnormal laboratory values|1|||
129558010|NCT00772577|466339169|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129558011|NCT00772577|466339170|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129558012|NCT00772577|466339169|FG000|Overall Study|Patient withdrew consent|8|||
129558013|NCT00772577|466339170|FG001|Overall Study|Patient withdrew consent|5|||
129558014|NCT00772577|466339169|FG000|Overall Study|Lost to Follow-up|4|||
129558015|NCT00772577|466339170|FG001|Overall Study|Lost to Follow-up|3|||
129558016|NCT00772577|466339169|FG000|Overall Study|Administrative problems|2|||
129558017|NCT00772577|466339170|FG001|Overall Study|Administrative problems|1|||
129558018|NCT00772577|466339169|FG000|Overall Study|Protocol Deviation|3|||
129558019|NCT00772577|466339170|FG001|Overall Study|Protocol Deviation|2|||
129558020|NCT00672620|466339171|FG000|Overall Study|Adverse Event|7|||
129558021|NCT00672620|466339172|FG001|Overall Study|Adverse Event|7|||
129558022|NCT00672620|466339173|FG002|Overall Study|Adverse Event|12|||
129558023|NCT00672620|466339174|FG003|Overall Study|Adverse Event|17|||
129558024|NCT00672620|466339171|FG000|Overall Study|Lack of Efficacy|1|||
129558025|NCT00672620|466339172|FG001|Overall Study|Lack of Efficacy|2|||
129558026|NCT00672620|466339173|FG002|Overall Study|Lack of Efficacy|2|||
129558027|NCT00672620|466339174|FG003|Overall Study|Lack of Efficacy|0|||
129558028|NCT00672620|466339171|FG000|Overall Study|Noncompliance with Study Drug|3|||
129558029|NCT00672620|466339172|FG001|Overall Study|Noncompliance with Study Drug|4|||
129558030|NCT00672620|466339173|FG002|Overall Study|Noncompliance with Study Drug|0|||
129558031|NCT00672620|466339174|FG003|Overall Study|Noncompliance with Study Drug|2|||
129558032|NCT00672620|466339171|FG000|Overall Study|Protocol Deviations|5|||
129558033|NCT00672620|466339172|FG001|Overall Study|Protocol Deviations|7|||
129558034|NCT00672620|466339173|FG002|Overall Study|Protocol Deviations|2|||
129558035|NCT00672620|466339174|FG003|Overall Study|Protocol Deviations|5|||
129558036|NCT00672620|466339171|FG000|Overall Study|Withdrawal of Consent|6|||
129558037|NCT00672620|466339172|FG001|Overall Study|Withdrawal of Consent|12|||
129558038|NCT00672620|466339173|FG002|Overall Study|Withdrawal of Consent|5|||
129558039|NCT00672620|466339174|FG003|Overall Study|Withdrawal of Consent|6|||
129558040|NCT00672620|466339171|FG000|Overall Study|Lost to Follow-up|8|||
129558041|NCT00672620|466339172|FG001|Overall Study|Lost to Follow-up|19|||
129558042|NCT00672620|466339173|FG002|Overall Study|Lost to Follow-up|8|||
129558043|NCT00672620|466339174|FG003|Overall Study|Lost to Follow-up|11|||
129558044|NCT00672620|466339171|FG000|Overall Study|Reason not Specified|3|||
129558045|NCT00672620|466339172|FG001|Overall Study|Reason not Specified|3|||
129558046|NCT00672620|466339173|FG002|Overall Study|Reason not Specified|2|||
129558047|NCT00672620|466339174|FG003|Overall Study|Reason not Specified|1|||
129558048|NCT03211156|466339175|FG000|Overall Study|Withdrawal by Subject|0|||
129558049|NCT03211156|466339176|FG001|Overall Study|Withdrawal by Subject|2|||
129558050|NCT03211156|466339175|FG000|Overall Study|Lost to Follow-up|1|||
129558051|NCT03211156|466339176|FG001|Overall Study|Lost to Follow-up|1|||
129558052|NCT03211156|466339175|FG000|Overall Study|Adverse Event|1|||
129558053|NCT03211156|466339176|FG001|Overall Study|Adverse Event|0|||
129558054|NCT00829413|466339177|FG000|Overall Study|No study drug admimnistered|13|||
129558055|NCT00829413|466339177|FG000|Overall Study|Training Patients|67|||
129558056|NCT00829413|466339177|FG000|Overall Study|No truth standard procedure available|9|||
129558057|NCT00829413|466339177|FG000|Overall Study|Technically inadequate truth standard|2|||
129558058|NCT00829413|466339177|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
129558059|NCT03487796|466339179|FG000|Overall Study|Lost to Follow-up|18|||
129558060|NCT03487796|466339180|FG001|Overall Study|Lost to Follow-up|6|||
129558061|NCT04272775|466339181|FG000|Overall Study|Study Terminated by Sponsor|1|||
129558062|NCT04272775|466339182|FG001|Overall Study|Study Terminated by Sponsor|0|||
129558063|NCT04272775|466339181|FG000|Overall Study|Protocol Violation|0|||
129558064|NCT04272775|466339182|FG001|Overall Study|Protocol Violation|1|||
129558065|NCT04272775|466339181|FG000|Overall Study|Symptomatic Deterioration|1|||
129558066|NCT04272775|466339182|FG001|Overall Study|Symptomatic Deterioration|1|||
129558067|NCT04272775|466339181|FG000|Overall Study|Withdrawal by Subject|1|||
129558068|NCT04272775|466339182|FG001|Overall Study|Withdrawal by Subject|2|||
129558069|NCT04272775|466339181|FG000|Overall Study|Adverse Event|1|||
129777478|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
129777479|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129777480|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129777481|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129777482|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
129777483|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129777484|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
129558070|NCT04272775|466339182|FG001|Overall Study|Adverse Event|2|||
129558071|NCT04272775|466339181|FG000|Overall Study|Progressive Disease|3|||
129558072|NCT04272775|466339182|FG001|Overall Study|Progressive Disease|1|||
129558073|NCT00124020|466339183|FG000|Overall Study|Death|67|||
129558074|NCT00124020|466339184|FG001|Overall Study|Death|71|||
129558075|NCT00124020|466339183|FG000|Overall Study|Withdrawal by Subject|13|||
129558076|NCT00124020|466339184|FG001|Overall Study|Withdrawal by Subject|11|||
129558077|NCT00124020|466339183|FG000|Overall Study|Lost to Follow-up|5|||
129558078|NCT00124020|466339184|FG001|Overall Study|Lost to Follow-up|8|||
129558079|NCT00124020|466339183|FG000|Overall Study|Other|1|||
129558080|NCT00124020|466339184|FG001|Overall Study|Other|1|||
129558081|NCT00124020|466339183|FG000|Overall Study|Transfer to another hospital|2|||
129558082|NCT00124020|466339184|FG001|Overall Study|Transfer to another hospital|0|||
129558083|NCT02043366|466339185|FG000|Overall Study|Lost to Follow-up|2|||
129558084|NCT02043366|466339186|FG001|Overall Study|Lost to Follow-up|2|||
129558085|NCT02043366|466339187|FG002|Overall Study|Lost to Follow-up|2|||
129558086|NCT02043366|466339188|FG003|Overall Study|Lost to Follow-up|2|||
129558087|NCT02043366|466339189|FG004|Overall Study|Lost to Follow-up|2|||
129558088|NCT02043366|466339190|FG005|Overall Study|Lost to Follow-up|2|||
129558089|NCT00891774|466339193|FG000|Overall Study|Lost to Follow-up|5|||
129558090|NCT00891774|466339193|FG000|Overall Study|Illness (Self/Mother)|3|||
129558091|NCT00891774|466339193|FG000|Overall Study|Withdrawal by Subject|2|||
129558092|NCT00891774|466339193|FG000|Overall Study|Protocol Violation|4|||
129558093|NCT03175120|466339195|FG000|Overall Study|Adverse Event|2|||
129558094|NCT03175120|466339196|FG001|Overall Study|Adverse Event|2|||
129558095|NCT03175120|466339195|FG000|Overall Study|Protocol Violation|5|||
129558096|NCT03175120|466339196|FG001|Overall Study|Protocol Violation|2|||
129558097|NCT03175120|466339195|FG000|Overall Study|Lost to Follow-up|1|||
129558098|NCT03175120|466339196|FG001|Overall Study|Lost to Follow-up|0|||
129558099|NCT03175120|466339195|FG000|Overall Study|Withdrawal by Subject|2|||
129558100|NCT03175120|466339196|FG001|Overall Study|Withdrawal by Subject|5|||
129558101|NCT03175120|466339195|FG000|Overall Study|Other|2|||
129558102|NCT03175120|466339196|FG001|Overall Study|Other|3|||
129558103|NCT01977092|466339197|FG000|Overall Study|Death|3|||
129558104|NCT01977092|466339198|FG001|Overall Study|Death|4|||
129558105|NCT01977092|466339197|FG000|Overall Study|Lost to Follow-up|23|||
129558106|NCT01977092|466339198|FG001|Overall Study|Lost to Follow-up|14|||
129558107|NCT01977092|466339197|FG000|Overall Study|Withdrawal by Subject|2|||
129558108|NCT01977092|466339198|FG001|Overall Study|Withdrawal by Subject|1|||
129558109|NCT01977092|466339197|FG000|Overall Study|In prison|3|||
129558110|NCT01977092|466339198|FG001|Overall Study|In prison|11|||
129558111|NCT00678392|466339199|FG000|Overall Study|Adverse Event|0|||
129558112|NCT00678392|466339200|FG001|Overall Study|Adverse Event|6|||
129558113|NCT00678392|466339199|FG000|Overall Study|Death|280|||
129558114|NCT00678392|466339200|FG001|Overall Study|Death|269|||
129558115|NCT00678392|466339199|FG000|Overall Study|Lost to Follow-up|15|||
129558116|NCT00678392|466339200|FG001|Overall Study|Lost to Follow-up|13|||
129558117|NCT00678392|466339199|FG000|Overall Study|Objective Progression or Relapse|3|||
129558118|NCT00678392|466339200|FG001|Overall Study|Objective Progression or Relapse|8|||
129558119|NCT00678392|466339199|FG000|Overall Study|Sponsor's Decision|1|||
129558120|NCT00678392|466339200|FG001|Overall Study|Sponsor's Decision|2|||
129558121|NCT00678392|466339199|FG000|Overall Study|Withdrawal by Subject|4|||
129558122|NCT00678392|466339200|FG001|Overall Study|Withdrawal by Subject|4|||
129558123|NCT00678392|466339199|FG000|Overall Study|Randomized But Not Treated|2|||
129558124|NCT00678392|466339200|FG001|Overall Study|Randomized But Not Treated|7|||
129558125|NCT00678392|466339199|FG000|Overall Study|Other|56|||
129777485|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129777486|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129777487|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129777488|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
129777489|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
129777490|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
129777491|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
129777492|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
129558126|NCT00678392|466339200|FG001|Overall Study|Other|53|||
129558127|NCT03038113|466339201|FG000|Overall Study|Withdrawal by Subject|0|||
129558128|NCT03038113|466339202|FG001|Overall Study|Withdrawal by Subject|0|||
129558129|NCT03038113|466339203|FG002|Overall Study|Withdrawal by Subject|1|||
129558130|NCT03038113|466339204|FG003|Overall Study|Withdrawal by Subject|0|||
129558131|NCT03038113|466339205|FG004|Overall Study|Withdrawal by Subject|0|||
129558132|NCT03038113|466339206|FG005|Overall Study|Withdrawal by Subject|0|||
129558133|NCT03038113|466339207|FG006|Overall Study|Withdrawal by Subject|0|||
129558134|NCT03038113|466339208|FG007|Overall Study|Withdrawal by Subject|0|||
129558135|NCT03038113|466339209|FG008|Overall Study|Withdrawal by Subject|0|||
129558136|NCT03038113|466339210|FG009|Overall Study|Withdrawal by Subject|0|||
129558137|NCT03038113|466339211|FG010|Overall Study|Withdrawal by Subject|0|||
129558138|NCT03038113|466339212|FG011|Overall Study|Withdrawal by Subject|0|||
129558139|NCT03038113|466339213|FG012|Overall Study|Withdrawal by Subject|0|||
129558140|NCT03038113|466339214|FG013|Overall Study|Withdrawal by Subject|1|||
129558141|NCT03038113|466339201|FG000|Overall Study|Lost to Follow-up|0|||
129558142|NCT03038113|466339202|FG001|Overall Study|Lost to Follow-up|0|||
129558143|NCT03038113|466339203|FG002|Overall Study|Lost to Follow-up|0|||
129558144|NCT03038113|466339204|FG003|Overall Study|Lost to Follow-up|0|||
129558145|NCT03038113|466339205|FG004|Overall Study|Lost to Follow-up|0|||
129558146|NCT03038113|466339206|FG005|Overall Study|Lost to Follow-up|0|||
129558147|NCT03038113|466339207|FG006|Overall Study|Lost to Follow-up|1|||
129558148|NCT03038113|466339208|FG007|Overall Study|Lost to Follow-up|0|||
129558149|NCT03038113|466339209|FG008|Overall Study|Lost to Follow-up|0|||
129558150|NCT03038113|466339210|FG009|Overall Study|Lost to Follow-up|0|||
129558151|NCT03038113|466339211|FG010|Overall Study|Lost to Follow-up|0|||
129558152|NCT03038113|466339212|FG011|Overall Study|Lost to Follow-up|0|||
129558153|NCT03038113|466339213|FG012|Overall Study|Lost to Follow-up|0|||
129558154|NCT03038113|466339214|FG013|Overall Study|Lost to Follow-up|0|||
129558155|NCT03341507|466339215|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
129558156|NCT02927847|466339217|FG000|Overall Study|Lost to Follow-up|1|||
129558157|NCT02927847|466339218|FG001|Overall Study|Lost to Follow-up|0|||
129558158|NCT02927847|466339217|FG000|Overall Study|Withdrawal by Subject|4|||
129558159|NCT02927847|466339218|FG001|Overall Study|Withdrawal by Subject|2|||
129558160|NCT02927847|466339217|FG000|Overall Study|PI withdrawn due to missed visits|1|||
129558161|NCT02927847|466339218|FG001|Overall Study|PI withdrawn due to missed visits|1|||
129558162|NCT00723554|466339219|FG000|Overall Study|Adverse Event|12|||
129558163|NCT00723554|466339219|FG000|Overall Study|Investigator's judgement|5|||
129558164|NCT00723554|466339219|FG000|Overall Study|Inhaled medication other than iloprost|4|||
129558165|NCT00723554|466339219|FG000|Overall Study|Withdrawal of consent|3|||
129558166|NCT00723554|466339219|FG000|Overall Study|Other|3|||
129777493|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
129777494|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
129777495|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
129777496|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
129777497|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777498|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777499|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777500|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777501|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777502|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777503|NCT05019521|467151334|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129777504|NCT05019521|467151335|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129777505|NCT05019521|467151336|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129777506|NCT05019521|467151337|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
129777507|NCT05019521|467151338|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129777508|NCT05019521|467151339|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129777509|NCT05019521|467151340|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129777510|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
129777511|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
129777512|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
129777513|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
129777514|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
129777515|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
129777516|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
129777517|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129777518|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
129777519|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129777520|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129777521|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129777522|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
129777523|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
129777524|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
129800232|NCT02891161|467236267|FG001|Follow up|Refused to Follow up|2|||
129800233|NCT02891161|467236266|FG000|Follow up|Symptomatic deterioration|0|||
129558167|NCT00723554|466339219|FG000|Overall Study|Lost to Follow-up|1|||
129558168|NCT00723554|466339219|FG000|Overall Study|Non-compliance|1|||
129558169|NCT01405820|466339220|FG000|Randomized Treatment Period|Adverse Event|3|||
129558170|NCT01405820|466339221|FG001|Randomized Treatment Period|Adverse Event|3|||
129558171|NCT01405820|466339222|FG002|Randomized Treatment Period|Adverse Event|3|||
129558172|NCT01405820|466339223|FG003|Randomized Treatment Period|Adverse Event|0|||
129558173|NCT01405820|466339224|FG004|Randomized Treatment Period|Adverse Event|2|||
129558174|NCT01405820|466339225|FG005|Randomized Treatment Period|Adverse Event|1|||
129558175|NCT01405820|466339220|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
129558176|NCT01405820|466339221|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
129558177|NCT01405820|466339222|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
129558178|NCT01405820|466339223|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
129558179|NCT01405820|466339224|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
129558180|NCT01405820|466339225|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
129558181|NCT01405820|466339220|FG000|Randomized Treatment Period|Other|2|||
129558182|NCT01405820|466339221|FG001|Randomized Treatment Period|Other|2|||
129558183|NCT01405820|466339222|FG002|Randomized Treatment Period|Other|1|||
129558184|NCT01405820|466339223|FG003|Randomized Treatment Period|Other|1|||
129558185|NCT01405820|466339224|FG004|Randomized Treatment Period|Other|0|||
129558186|NCT01405820|466339225|FG005|Randomized Treatment Period|Other|0|||
129558187|NCT01405820|466339220|FG000|Randomized Treatment Period|Physician Decision|0|||
129558188|NCT01405820|466339221|FG001|Randomized Treatment Period|Physician Decision|2|||
129558189|NCT01405820|466339222|FG002|Randomized Treatment Period|Physician Decision|1|||
129558190|NCT01405820|466339223|FG003|Randomized Treatment Period|Physician Decision|0|||
129558191|NCT01405820|466339224|FG004|Randomized Treatment Period|Physician Decision|0|||
129558192|NCT01405820|466339225|FG005|Randomized Treatment Period|Physician Decision|0|||
129558193|NCT01405820|466339220|FG000|Randomized Treatment Period|Rescue|0|||
129558194|NCT01405820|466339221|FG001|Randomized Treatment Period|Rescue|1|||
129558195|NCT01405820|466339222|FG002|Randomized Treatment Period|Rescue|13|||
129558196|NCT01405820|466339223|FG003|Randomized Treatment Period|Rescue|10|||
129558197|NCT01405820|466339224|FG004|Randomized Treatment Period|Rescue|8|||
129558198|NCT01405820|466339225|FG005|Randomized Treatment Period|Rescue|8|||
129558199|NCT01405820|466339220|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
129558200|NCT01405820|466339221|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
129558201|NCT01405820|466339222|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
129558202|NCT01405820|466339223|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
129558203|NCT01405820|466339224|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
129558204|NCT01405820|466339225|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
129558205|NCT01405820|466339220|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
129558206|NCT01405820|466339221|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
129558207|NCT01405820|466339222|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
129558208|NCT01405820|466339223|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
129558209|NCT01405820|466339224|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
129558210|NCT01405820|466339225|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
129558211|NCT01405820|466339220|FG000|Randomized Treatment Period|Death|0|||
129558212|NCT01405820|466339221|FG001|Randomized Treatment Period|Death|0|||
129558213|NCT01405820|466339222|FG002|Randomized Treatment Period|Death|0|||
129558214|NCT01405820|466339223|FG003|Randomized Treatment Period|Death|1|||
129558215|NCT01405820|466339224|FG004|Randomized Treatment Period|Death|0|||
129558216|NCT01405820|466339225|FG005|Randomized Treatment Period|Death|0|||
129558217|NCT01405820|466339220|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129558218|NCT01405820|466339221|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129558219|NCT01405820|466339222|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129558220|NCT01405820|466339223|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
129558221|NCT01405820|466339224|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129558222|NCT01405820|466339225|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
129558223|NCT01405820|466339220|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
129558224|NCT01405820|466339221|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
129558225|NCT01405820|466339222|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
129558226|NCT01405820|466339223|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
129558227|NCT01405820|466339224|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
129558228|NCT01405820|466339225|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
129558229|NCT01405820|466339220|FG000|Open-Label Treatment Period|Other|1|||
129558230|NCT01405820|466339221|FG001|Open-Label Treatment Period|Other|1|||
129558231|NCT01405820|466339222|FG002|Open-Label Treatment Period|Other|1|||
129558232|NCT01405820|466339223|FG003|Open-Label Treatment Period|Other|1|||
129558233|NCT01405820|466339224|FG004|Open-Label Treatment Period|Other|1|||
129558234|NCT01405820|466339225|FG005|Open-Label Treatment Period|Other|1|||
129558235|NCT01405820|466339220|FG000|Open-Label Treatment Period|Physician Decision|0|||
129558236|NCT01405820|466339221|FG001|Open-Label Treatment Period|Physician Decision|0|||
129558237|NCT01405820|466339222|FG002|Open-Label Treatment Period|Physician Decision|1|||
129558238|NCT01405820|466339223|FG003|Open-Label Treatment Period|Physician Decision|2|||
129558239|NCT01405820|466339224|FG004|Open-Label Treatment Period|Physician Decision|1|||
129558240|NCT01405820|466339225|FG005|Open-Label Treatment Period|Physician Decision|0|||
129558241|NCT01405820|466339220|FG000|Open-Label Treatment Period|Adverse Event|0|||
129558242|NCT01405820|466339221|FG001|Open-Label Treatment Period|Adverse Event|0|||
129558243|NCT01405820|466339222|FG002|Open-Label Treatment Period|Adverse Event|0|||
129558244|NCT01405820|466339223|FG003|Open-Label Treatment Period|Adverse Event|1|||
129558245|NCT01405820|466339224|FG004|Open-Label Treatment Period|Adverse Event|0|||
129558246|NCT01405820|466339225|FG005|Open-Label Treatment Period|Adverse Event|0|||
129558247|NCT01335464|466339238|FG000|Overall Study|Adverse Event|15|||
129558248|NCT01335464|466339239|FG001|Overall Study|Adverse Event|25|||
129558249|NCT01335464|466339238|FG000|Overall Study|Non compliant with protocol|2|||
129558250|NCT01335464|466339239|FG001|Overall Study|Non compliant with protocol|0|||
129558251|NCT01335464|466339238|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
129558252|NCT01335464|466339239|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
129558253|NCT01335464|466339238|FG000|Overall Study|Not treated|2|||
129558254|NCT01335464|466339239|FG001|Overall Study|Not treated|0|||
129558255|NCT01335464|466339238|FG000|Overall Study|Reason other than those stated above|1|||
129558256|NCT01335464|466339239|FG001|Overall Study|Reason other than those stated above|1|||
129558257|NCT00446654|466339240|FG000|Overall Study|Withdrawal by Subject|1|||
129558258|NCT00446654|466339241|FG001|Overall Study|Withdrawal by Subject|0|||
129558259|NCT00446654|466339240|FG000|Overall Study|Adverse Event|1|||
129558260|NCT00446654|466339241|FG001|Overall Study|Adverse Event|0|||
129558261|NCT02280356|466339245|FG000|Overall Study|Not Treated|2|||
129558262|NCT02280356|466339245|FG000|Overall Study|Withdrawal by Subject|1|||
129558263|NCT02280356|466339245|FG000|Overall Study|Not evaluable|2|||
129558264|NCT00871728|466339253|FG000|Overall Study|Adverse Event|1|||
129558265|NCT00871728|466339253|FG000|Overall Study|Protocol Violation|7|||
129558266|NCT00871728|466339253|FG000|Overall Study|Lost to Follow-up|2|||
129558267|NCT00871728|466339253|FG000|Overall Study|Failed to Visit Hospital|4|||
129558268|NCT00871728|466339253|FG000|Overall Study|Participant Non-compliance|1|||
129558269|NCT00871728|466339253|FG000|Overall Study|Withdrawal of Informed Consent|5|||
129558270|NCT04147715|466339254|FG000|Overall Study|Adverse Event|0|||
129558271|NCT04147715|466339255|FG001|Overall Study|Adverse Event|0|||
129558272|NCT04147715|466339256|FG002|Overall Study|Adverse Event|0|||
129558273|NCT04147715|466339257|FG003|Overall Study|Adverse Event|0|||
129558274|NCT04147715|466339258|FG004|Overall Study|Adverse Event|0|||
129558275|NCT04147715|466339259|FG005|Overall Study|Adverse Event|0|||
129558276|NCT04147715|466339260|FG006|Overall Study|Adverse Event|0|||
129558277|NCT04147715|466339261|FG007|Overall Study|Adverse Event|2|||
129558278|NCT04147715|466339262|FG008|Overall Study|Adverse Event|1|||
129558279|NCT04147715|466339263|FG009|Overall Study|Adverse Event|0|||
129558280|NCT04147715|466339264|FG010|Overall Study|Adverse Event|0|||
129558281|NCT04147715|466339265|FG011|Overall Study|Adverse Event|0|||
129558282|NCT03404206|466339266|FG000|Overall Study|Withdrawal by Subject|1|||
129558283|NCT03404206|466339267|FG001|Overall Study|Withdrawal by Subject|1|||
129558284|NCT03404206|466339268|FG002|Overall Study|Withdrawal by Subject|0|||
129558285|NCT03404206|466339266|FG000|Overall Study|Lost to Follow-up|3|||
129558286|NCT03404206|466339267|FG001|Overall Study|Lost to Follow-up|1|||
129558287|NCT03404206|466339268|FG002|Overall Study|Lost to Follow-up|0|||
129558288|NCT01626859|466339277|FG000|Overall Study|Adverse Event|1|||
129558289|NCT01626859|466339278|FG001|Overall Study|Adverse Event|3|||
129558290|NCT01626859|466339279|FG002|Overall Study|Adverse Event|2|||
129558291|NCT01626859|466339277|FG000|Overall Study|Physician Decision|0|||
129558292|NCT01626859|466339278|FG001|Overall Study|Physician Decision|1|||
129558293|NCT01626859|466339279|FG002|Overall Study|Physician Decision|0|||
129558294|NCT01626859|466339277|FG000|Overall Study|Withdrawal by Subject|1|||
129558295|NCT01626859|466339278|FG001|Overall Study|Withdrawal by Subject|4|||
129558296|NCT01626859|466339279|FG002|Overall Study|Withdrawal by Subject|2|||
129558297|NCT02629965|466339280|FG000|Period 1|Adverse Event|1|||
129558298|NCT02629965|466339281|FG001|Period 1|Adverse Event|0|||
129558299|NCT02629965|466339280|FG000|Period 1|Unexpected worsening of disease|2|||
129558300|NCT02629965|466339281|FG001|Period 1|Unexpected worsening of disease|0|||
129558301|NCT02629965|466339280|FG000|Period 1|Other than listed above|1|||
129558302|NCT02629965|466339281|FG001|Period 1|Other than listed above|2|||
129558303|NCT02629965|466339280|FG000|Period 2|Adverse Event|1|||
129558304|NCT02629965|466339281|FG001|Period 2|Adverse Event|0|||
129558305|NCT02330081|466339282|FG000|Overall Study|Adverse Event|1|||
129558306|NCT02330081|466339282|FG000|Overall Study|Donation did not meet criteria|1|||
129558307|NCT02330081|466339282|FG000|Overall Study|Protocol Violation|6|||
129558308|NCT00905489|466339285|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
129558309|NCT00905489|466339285|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
129558310|NCT00905489|466339285|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
129558311|NCT02668302|466339289|FG000|Overall Study|Withdrawal by Subject|1|||
129558312|NCT02668302|466339290|FG001|Overall Study|Withdrawal by Subject|0|||
129558313|NCT00895583|466339295|FG000|Overall Study|Adverse Event|28|||
129558314|NCT00895583|466339296|FG001|Overall Study|Adverse Event|4|||
129558315|NCT00895583|466339295|FG000|Overall Study|Death|2|||
129558316|NCT00895583|466339296|FG001|Overall Study|Death|1|||
129558317|NCT00895583|466339295|FG000|Overall Study|Physician Decision|3|||
129558318|NCT00895583|466339296|FG001|Overall Study|Physician Decision|1|||
129558319|NCT00895583|466339295|FG000|Overall Study|Lost to Follow-up|1|||
129558320|NCT00895583|466339296|FG001|Overall Study|Lost to Follow-up|3|||
129558321|NCT00895583|466339295|FG000|Overall Study|Protocol Violation|1|||
129558322|NCT00895583|466339296|FG001|Overall Study|Protocol Violation|0|||
129558323|NCT00895583|466339295|FG000|Overall Study|Withdrawal by Subject|4|||
129558324|NCT00895583|466339296|FG001|Overall Study|Withdrawal by Subject|2|||
129558325|NCT00895583|466339295|FG000|Overall Study|Lack of Efficacy|5|||
129558326|NCT00895583|466339296|FG001|Overall Study|Lack of Efficacy|0|||
129558327|NCT00895583|466339295|FG000|Overall Study|Other|0|||
129558328|NCT00895583|466339296|FG001|Overall Study|Other|1|||
129558329|NCT00616928|466339297|FG000|Overall Study|Adverse Event|6|||
129558330|NCT00616928|466339298|FG001|Overall Study|Adverse Event|3|||
129558331|NCT00616928|466339299|FG002|Overall Study|Adverse Event|2|||
129558332|NCT00616928|466339300|FG003|Overall Study|Adverse Event|2|||
129558333|NCT00616928|466339297|FG000|Overall Study|Other|51|||
129558334|NCT00616928|466339298|FG001|Overall Study|Other|8|||
129558335|NCT00616928|466339299|FG002|Overall Study|Other|15|||
129558336|NCT00616928|466339300|FG003|Overall Study|Other|5|||
129558337|NCT00616928|466339297|FG000|Overall Study|Lost to Follow-up|5|||
129558338|NCT00616928|466339298|FG001|Overall Study|Lost to Follow-up|7|||
129558339|NCT00616928|466339299|FG002|Overall Study|Lost to Follow-up|0|||
129558340|NCT00616928|466339300|FG003|Overall Study|Lost to Follow-up|0|||
129558341|NCT04535583|466339301|FG000|Overall Study|Lost to Follow-up|1|||
129558342|NCT04535583|466339301|FG000|Overall Study|Physician Decision|1|||
129558343|NCT04535583|466339301|FG000|Overall Study|Withdrawal by Subject|1|||
129558344|NCT01078090|466339302|FG000|Overall Study|Lost to Follow-up|2363|||
129558345|NCT01078090|466339302|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
129558346|NCT01078090|466339302|FG000|Overall Study|Lack of Efficacy|1193|||
129558347|NCT01078090|466339302|FG000|Overall Study|ADR and lack of efficacy|61|||
129558348|NCT01078090|466339302|FG000|Overall Study|Other|523|||
129558349|NCT04049552|466339304|FG000|Overall Study|Lost to Follow-up|1|||
129558350|NCT02123459|466339307|FG000|Washout Period (1 Day)|Adverse Event|1|||
129558351|NCT02123459|466339308|FG001|Washout Period (1 Day)|Adverse Event|0|||
129558352|NCT02196506|466339313|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
129558353|NCT02196506|466339314|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
129558354|NCT02196506|466339315|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
129558355|NCT02196506|466339316|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
129558356|NCT02196506|466339313|FG000|Phase A|Withdrawal by Subject|34|||
129558357|NCT02196506|466339314|FG001|Phase A|Withdrawal by Subject|0|||
129558358|NCT02196506|466339315|FG002|Phase A|Withdrawal by Subject|0|||
129558359|NCT02196506|466339316|FG003|Phase A|Withdrawal by Subject|0|||
129558360|NCT02196506|466339313|FG000|Phase A|Adverse Event|22|||
129558361|NCT02196506|466339314|FG001|Phase A|Adverse Event|0|||
129558362|NCT02196506|466339315|FG002|Phase A|Adverse Event|0|||
129558363|NCT02196506|466339316|FG003|Phase A|Adverse Event|0|||
129558364|NCT02196506|466339313|FG000|Phase A|Lost to Follow-up|9|||
129558365|NCT02196506|466339314|FG001|Phase A|Lost to Follow-up|0|||
129558366|NCT02196506|466339315|FG002|Phase A|Lost to Follow-up|0|||
129558367|NCT02196506|466339316|FG003|Phase A|Lost to Follow-up|0|||
129558368|NCT02196506|466339313|FG000|Phase A|Protocol deviation|12|||
129558369|NCT02196506|466339314|FG001|Phase A|Protocol deviation|0|||
129558370|NCT02196506|466339315|FG002|Phase A|Protocol deviation|0|||
129558371|NCT02196506|466339316|FG003|Phase A|Protocol deviation|0|||
129558372|NCT02196506|466339313|FG000|Phase A|Participant withdrawn by investigator|10|||
129558373|NCT02196506|466339314|FG001|Phase A|Participant withdrawn by investigator|0|||
129558374|NCT02196506|466339315|FG002|Phase A|Participant withdrawn by investigator|0|||
129558375|NCT02196506|466339316|FG003|Phase A|Participant withdrawn by investigator|0|||
129558376|NCT02196506|466339313|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
129558377|NCT02196506|466339314|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
129558378|NCT02196506|466339315|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
129558379|NCT02196506|466339316|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
129558380|NCT02196506|466339313|FG000|Phase B|Lack of Efficacy|0|||
129558381|NCT02196506|466339314|FG001|Phase B|Lack of Efficacy|1|||
129558382|NCT02196506|466339315|FG002|Phase B|Lack of Efficacy|2|||
129558383|NCT02196506|466339316|FG003|Phase B|Lack of Efficacy|0|||
129558384|NCT02196506|466339313|FG000|Phase B|Withdrawal by Participant|0|||
129558385|NCT02196506|466339314|FG001|Phase B|Withdrawal by Participant|8|||
129558386|NCT02196506|466339315|FG002|Phase B|Withdrawal by Participant|1|||
129558387|NCT02196506|466339316|FG003|Phase B|Withdrawal by Participant|0|||
129558388|NCT02196506|466339313|FG000|Phase B|Adverse Event|0|||
129558389|NCT02196506|466339314|FG001|Phase B|Adverse Event|4|||
129558390|NCT02196506|466339315|FG002|Phase B|Adverse Event|1|||
129558391|NCT02196506|466339316|FG003|Phase B|Adverse Event|0|||
129558392|NCT02196506|466339313|FG000|Phase B|Lost to Follow-up|0|||
129558393|NCT02196506|466339314|FG001|Phase B|Lost to Follow-up|2|||
129558394|NCT02196506|466339315|FG002|Phase B|Lost to Follow-up|1|||
129558395|NCT02196506|466339316|FG003|Phase B|Lost to Follow-up|0|||
129558396|NCT02196506|466339313|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
129558397|NCT02196506|466339314|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
129558398|NCT02196506|466339315|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
129558399|NCT02196506|466339316|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
129558400|NCT02196506|466339313|FG000|Phase A+|Withdrawal by Participant|0|||
129558401|NCT02196506|466339314|FG001|Phase A+|Withdrawal by Participant|0|||
129558402|NCT02196506|466339315|FG002|Phase A+|Withdrawal by Participant|0|||
129558403|NCT02196506|466339316|FG003|Phase A+|Withdrawal by Participant|5|||
129558404|NCT02196506|466339313|FG000|Phase A+|Adverse Event|0|||
129777525|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129777526|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129777527|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
129777528|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
129777529|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
129777530|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
129777531|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129777532|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
129777533|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
129777534|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129777535|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129777536|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129777537|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
129777538|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
129777539|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
129777540|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
129777541|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
129777542|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
129777543|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
129777544|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
129777545|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777546|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777547|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777548|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777549|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777550|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
129777551|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
129777552|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129777553|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
129777554|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
129558405|NCT02196506|466339314|FG001|Phase A+|Adverse Event|0|||
129558406|NCT02196506|466339315|FG002|Phase A+|Adverse Event|0|||
129558407|NCT02196506|466339316|FG003|Phase A+|Adverse Event|1|||
129558408|NCT02196506|466339313|FG000|Phase A+|Lost to Follow-up|0|||
129558409|NCT02196506|466339314|FG001|Phase A+|Lost to Follow-up|0|||
129558410|NCT02196506|466339315|FG002|Phase A+|Lost to Follow-up|0|||
129558411|NCT02196506|466339316|FG003|Phase A+|Lost to Follow-up|6|||
129777555|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129777556|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129558412|NCT02196506|466339313|FG000|Phase A+|Participant withdrawn by investigator|0|||
129558413|NCT02196506|466339314|FG001|Phase A+|Participant withdrawn by investigator|0|||
129777557|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
129777558|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
129777559|NCT05019521|467151334|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
129777560|NCT05019521|467151335|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
129777561|NCT05019521|467151336|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
129777562|NCT05019521|467151337|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
129777563|NCT05019521|467151338|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
129777564|NCT05019521|467151339|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
129777565|NCT05019521|467151340|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
129777566|NCT01147874|467151342|FG000|Overall Study|Adverse Event|5|||
129777567|NCT01147874|467151342|FG000|Overall Study|Investigator's Request|1|||
129777568|NCT01147874|467151342|FG000|Overall Study|Lost to Follow-up|25|||
129777569|NCT01147874|467151342|FG000|Overall Study|Other|5|||
129777570|NCT01147874|467151342|FG000|Overall Study|Protocol Violation|5|||
129777571|NCT01147874|467151342|FG000|Overall Study|Sponsor's Decision|2|||
129777572|NCT01147874|467151342|FG000|Overall Study|Withdrawal by Subject|24|||
129777573|NCT02533453|467151350|FG000|Overall Study|Adverse Event|6|||
129777574|NCT02533453|467151350|FG000|Overall Study|Protocol Violation|1|||
129777575|NCT02533453|467151350|FG000|Overall Study|Withdrawal by Subject|2|||
129777576|NCT00885534|467151351|FG000|Overall Study|Patient deemed ineligible|1|||
129777577|NCT04292899|467151353|FG000|Overall Study|Death|21|||
129777578|NCT04292899|467151354|FG001|Overall Study|Death|28|||
129777579|NCT04292899|467151355|FG002|Overall Study|Death|188|||
129777580|NCT04292899|467151356|FG003|Overall Study|Death|371|||
129777581|NCT04292899|467151353|FG000|Overall Study|Lost to Follow-up|8|||
129777582|NCT04292899|467151354|FG001|Overall Study|Lost to Follow-up|4|||
129777583|NCT04292899|467151355|FG002|Overall Study|Lost to Follow-up|22|||
129777584|NCT04292899|467151356|FG003|Overall Study|Lost to Follow-up|235|||
129777585|NCT04292899|467151353|FG000|Overall Study|Withdrew consent|1|||
129777586|NCT04292899|467151354|FG001|Overall Study|Withdrew consent|0|||
129777587|NCT04292899|467151355|FG002|Overall Study|Withdrew consent|11|||
129777588|NCT04292899|467151356|FG003|Overall Study|Withdrew consent|32|||
129777589|NCT04292899|467151353|FG000|Overall Study|Adverse Event|2|||
129777590|NCT04292899|467151354|FG001|Overall Study|Adverse Event|1|||
129777591|NCT04292899|467151355|FG002|Overall Study|Adverse Event|2|||
129777592|NCT04292899|467151356|FG003|Overall Study|Adverse Event|2|||
129777593|NCT04292899|467151353|FG000|Overall Study|Investigator's Discretion|0|||
129777594|NCT04292899|467151354|FG001|Overall Study|Investigator's Discretion|0|||
129777595|NCT04292899|467151355|FG002|Overall Study|Investigator's Discretion|0|||
129777596|NCT04292899|467151356|FG003|Overall Study|Investigator's Discretion|3|||
129777597|NCT04292899|467151353|FG000|Overall Study|Non-compliance With Study Drug|0|||
129777598|NCT04292899|467151354|FG001|Overall Study|Non-compliance With Study Drug|0|||
129777599|NCT04292899|467151355|FG002|Overall Study|Non-compliance With Study Drug|0|||
129777600|NCT04292899|467151356|FG003|Overall Study|Non-compliance With Study Drug|1|||
129777601|NCT04292899|467151353|FG000|Overall Study|Protocol Violation|0|||
129777602|NCT04292899|467151354|FG001|Overall Study|Protocol Violation|0|||
129777603|NCT04292899|467151355|FG002|Overall Study|Protocol Violation|0|||
129777604|NCT04292899|467151356|FG003|Overall Study|Protocol Violation|1|||
129777605|NCT01209325|467151360|FG000|Overall Study|Lost to Follow-up|24|||
129777606|NCT01209325|467151360|FG000|Overall Study|Adverse Event|1|||
129777607|NCT01209325|467151360|FG000|Overall Study|Relocated|3|||
129777608|NCT01209325|467151360|FG000|Overall Study|Refusal after starting therapy|8|||
129777609|NCT01209325|467151360|FG000|Overall Study|Protocol Violation|4|||
129777610|NCT01209325|467151360|FG000|Overall Study|Refusal prior to therapy|1|||
129777611|NCT01209325|467151360|FG000|Overall Study|Incarceration|2|||
129777612|NCT00396253|467151361|FG000|Overall Study|Protocol Violation|1|||
129777613|NCT00396253|467151361|FG000|Overall Study|Withdrawal by Subject|7|||
129777614|NCT00396253|467151361|FG000|Overall Study|Death|3|||
129777615|NCT00396253|467151361|FG000|Overall Study|Physician Decision|1|||
129777616|NCT00396253|467151361|FG000|Overall Study|Change in eligibility status|1|||
129777617|NCT05340478|467151365|FG000|Overall Study|Scheduling Issues|10|||
129777618|NCT05340478|467151366|FG001|Overall Study|Scheduling Issues|4|||
129777619|NCT05340478|467151365|FG000|Overall Study|Neither member of dyad started treatment|2|||
129777620|NCT05340478|467151366|FG001|Overall Study|Neither member of dyad started treatment|2|||
129777621|NCT05340478|467151365|FG000|Overall Study|Withdrawn from study|2|||
129777622|NCT05340478|467151366|FG001|Overall Study|Withdrawn from study|2|||
129777623|NCT05340478|467151365|FG000|Overall Study|Lost to Follow-up|1|||
129777624|NCT05340478|467151366|FG001|Overall Study|Lost to Follow-up|4|||
129777625|NCT02116205|467151370|FG000|Overall Study|Withdrawal by Subject|2|||
129777626|NCT02116205|467151371|FG001|Overall Study|Withdrawal by Subject|4|||
129777627|NCT02116205|467151372|FG002|Overall Study|Withdrawal by Subject|1|||
129777628|NCT02116205|467151373|FG003|Overall Study|Withdrawal by Subject|3|||
129777629|NCT02116205|467151370|FG000|Overall Study|Lost to Follow-up|0|||
129777630|NCT02116205|467151371|FG001|Overall Study|Lost to Follow-up|2|||
129777631|NCT02116205|467151372|FG002|Overall Study|Lost to Follow-up|1|||
129558414|NCT02196506|466339315|FG002|Phase A+|Participant withdrawn by investigator|0|||
129558415|NCT02196506|466339316|FG003|Phase A+|Participant withdrawn by investigator|1|||
129558416|NCT00254397|466339317|FG000|Overall Study|Disease Progression|4|||
129558417|NCT00254397|466339318|FG001|Overall Study|Disease Progression|1|||
129558418|NCT00254397|466339319|FG002|Overall Study|Disease Progression|16|||
129558419|NCT00254397|466339320|FG003|Overall Study|Disease Progression|23|||
129558420|NCT00254397|466339317|FG000|Overall Study|Non-Compliant|0|||
129558421|NCT00254397|466339318|FG001|Overall Study|Non-Compliant|0|||
129558422|NCT00254397|466339319|FG002|Overall Study|Non-Compliant|0|||
129558423|NCT00254397|466339320|FG003|Overall Study|Non-Compliant|1|||
129558424|NCT00254397|466339317|FG000|Overall Study|Adverse Event|2|||
129558425|NCT00254397|466339318|FG001|Overall Study|Adverse Event|0|||
129558426|NCT00254397|466339319|FG002|Overall Study|Adverse Event|3|||
129558427|NCT00254397|466339320|FG003|Overall Study|Adverse Event|1|||
129558428|NCT01015612|466339327|FG000|Overall Study|Death|113|||
129558429|NCT01015612|466339327|FG000|Overall Study|Withdrawal by Subject|40|||
129558430|NCT00066807|466339328|FG000|Overall Study|Study was terminated early|14|||
129558431|NCT00066807|466339329|FG001|Overall Study|Study was terminated early|15|||
129558432|NCT03586830|466339331|FG000|Overall Study|Site terminated by Sponsor|1|||
129558433|NCT03586830|466339332|FG001|Overall Study|Site terminated by Sponsor|4|||
129558434|NCT03586830|466339333|FG002|Overall Study|Site terminated by Sponsor|3|||
129558435|NCT03586830|466339334|FG003|Overall Study|Site terminated by Sponsor|3|||
129558436|NCT03586830|466339331|FG000|Overall Study|Lost to Follow-up|0|||
129558437|NCT03586830|466339332|FG001|Overall Study|Lost to Follow-up|2|||
129558438|NCT03586830|466339333|FG002|Overall Study|Lost to Follow-up|2|||
129558439|NCT03586830|466339334|FG003|Overall Study|Lost to Follow-up|1|||
129558440|NCT03586830|466339331|FG000|Overall Study|Withdrawal by Subject|1|||
129558441|NCT03586830|466339332|FG001|Overall Study|Withdrawal by Subject|0|||
129558442|NCT03586830|466339333|FG002|Overall Study|Withdrawal by Subject|3|||
129558443|NCT03586830|466339334|FG003|Overall Study|Withdrawal by Subject|1|||
129558444|NCT04578548|466339335|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129558445|NCT04578548|466339336|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129558446|NCT04578548|466339335|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
129558447|NCT04578548|466339336|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
129558448|NCT04578548|466339335|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
129558449|NCT04578548|466339336|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
129558450|NCT04578548|466339335|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
129558451|NCT04578548|466339336|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
129558452|NCT04578548|466339335|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
129558453|NCT04578548|466339336|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
129558454|NCT04578548|466339335|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
129558455|NCT04578548|466339336|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
129558456|NCT00628745|466339337|FG000|Overall Study|Withdrawal by Subject|63|||
129558457|NCT00628745|466339338|FG001|Overall Study|Withdrawal by Subject|3|||
129558458|NCT00628745|466339339|FG002|Overall Study|Withdrawal by Subject|9|||
129558459|NCT00628745|466339340|FG003|Overall Study|Withdrawal by Subject|2|||
129558460|NCT00628745|466339341|FG004|Overall Study|Withdrawal by Subject|69|||
129558461|NCT00628745|466339337|FG000|Overall Study|Does not meet inclusion criteria|0|||
129558462|NCT00628745|466339338|FG001|Overall Study|Does not meet inclusion criteria|12|||
129558463|NCT00628745|466339339|FG002|Overall Study|Does not meet inclusion criteria|0|||
129558464|NCT00628745|466339340|FG003|Overall Study|Does not meet inclusion criteria|0|||
129558465|NCT00628745|466339341|FG004|Overall Study|Does not meet inclusion criteria|18|||
129558466|NCT00628745|466339337|FG000|Overall Study|Participation in an interventional clinical trial|81|||
129558467|NCT00628745|466339338|FG001|Overall Study|Participation in an interventional clinical trial|4|||
129558468|NCT00628745|466339339|FG002|Overall Study|Participation in an interventional clinical trial|7|||
129558469|NCT00628745|466339340|FG003|Overall Study|Participation in an interventional clinical trial|0|||
129558470|NCT00628745|466339341|FG004|Overall Study|Participation in an interventional clinical trial|63|||
129558471|NCT00628745|466339337|FG000|Overall Study|Physician Decision|8|||
129558472|NCT00628745|466339338|FG001|Overall Study|Physician Decision|4|||
129687281|NCT02573467|466812128|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
129687282|NCT02573467|466812129|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
129558473|NCT00628745|466339339|FG002|Overall Study|Physician Decision|3|||
129558474|NCT00628745|466339340|FG003|Overall Study|Physician Decision|0|||
129558475|NCT00628745|466339341|FG004|Overall Study|Physician Decision|30|||
129558476|NCT00628745|466339337|FG000|Overall Study|Lost to Follow-up|109|||
129558477|NCT00628745|466339338|FG001|Overall Study|Lost to Follow-up|7|||
129558478|NCT00628745|466339339|FG002|Overall Study|Lost to Follow-up|7|||
129558479|NCT00628745|466339340|FG003|Overall Study|Lost to Follow-up|0|||
129558480|NCT00628745|466339341|FG004|Overall Study|Lost to Follow-up|498|||
129558481|NCT00628745|466339337|FG000|Overall Study|Death|197|||
129558482|NCT00628745|466339338|FG001|Overall Study|Death|81|||
129558483|NCT00628745|466339339|FG002|Overall Study|Death|12|||
129558484|NCT00628745|466339340|FG003|Overall Study|Death|4|||
129558485|NCT00628745|466339341|FG004|Overall Study|Death|939|||
129558486|NCT00628745|466339337|FG000|Overall Study|Participant transferred to another THAOS site|6|||
129558487|NCT00628745|466339338|FG001|Overall Study|Participant transferred to another THAOS site|0|||
129558488|NCT00628745|466339339|FG002|Overall Study|Participant transferred to another THAOS site|0|||
129558489|NCT00628745|466339340|FG003|Overall Study|Participant transferred to another THAOS site|0|||
129558490|NCT00628745|466339341|FG004|Overall Study|Participant transferred to another THAOS site|7|||
129558491|NCT00628745|466339337|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
129558492|NCT00628745|466339338|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
129558493|NCT00628745|466339339|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
129558494|NCT00628745|466339340|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
129558495|NCT00628745|466339341|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
129558496|NCT00628745|466339337|FG000|Overall Study|Site closure|152|||
129558497|NCT00628745|466339338|FG001|Overall Study|Site closure|146|||
129558498|NCT00628745|466339339|FG002|Overall Study|Site closure|6|||
129558499|NCT00628745|466339340|FG003|Overall Study|Site closure|8|||
129558500|NCT00628745|466339341|FG004|Overall Study|Site closure|691|||
129558501|NCT00628745|466339337|FG000|Overall Study|Duplicate participant|0|||
129558502|NCT00628745|466339338|FG001|Overall Study|Duplicate participant|0|||
129558503|NCT00628745|466339339|FG002|Overall Study|Duplicate participant|0|||
129558504|NCT00628745|466339340|FG003|Overall Study|Duplicate participant|0|||
129558505|NCT00628745|466339341|FG004|Overall Study|Duplicate participant|1|||
129558506|NCT00628745|466339337|FG000|Overall Study|Missing|4|||
129558507|NCT00628745|466339338|FG001|Overall Study|Missing|3|||
129558508|NCT00628745|466339339|FG002|Overall Study|Missing|0|||
129558509|NCT00628745|466339340|FG003|Overall Study|Missing|0|||
129558510|NCT00628745|466339341|FG004|Overall Study|Missing|10|||
129558511|NCT00628745|466339337|FG000|Overall Study|Othe reasons|987|||
129558512|NCT00628745|466339338|FG001|Overall Study|Othe reasons|373|||
129558513|NCT00628745|466339339|FG002|Overall Study|Othe reasons|105|||
129558514|NCT00628745|466339340|FG003|Overall Study|Othe reasons|1|||
129558515|NCT00628745|466339341|FG004|Overall Study|Othe reasons|1772|||
129558516|NCT03322462|466340932|FG000|Overall Study|Technical difficulties|2|||
129558517|NCT03322462|466340932|FG000|Overall Study|Other|1|||
129558518|NCT02004847|466340936|FG000|Overall Study|Protocol Violation|1|||
129558519|NCT02004847|466340937|FG001|Overall Study|Protocol Violation|1|||
129558520|NCT02034799|466340938|FG000|Overall Study|Withdrawal by Subject|0|||
129558521|NCT02034799|466340939|FG001|Overall Study|Withdrawal by Subject|2|||
129558522|NCT02034799|466340938|FG000|Overall Study|Lost to Follow-up|0|||
129558523|NCT02034799|466340939|FG001|Overall Study|Lost to Follow-up|1|||
129558524|NCT02034799|466340938|FG000|Overall Study|Death|2|||
129558525|NCT02034799|466340939|FG001|Overall Study|Death|1|||
129558526|NCT00759148|466340948|FG000|Overall Study|Adverse Event|1|||
129558527|NCT00759148|466340949|FG001|Overall Study|Adverse Event|6|||
129558528|NCT00759148|466340948|FG000|Overall Study|Withdrawal by Subject|3|||
129558529|NCT00759148|466340949|FG001|Overall Study|Withdrawal by Subject|7|||
129558530|NCT00759148|466340948|FG000|Overall Study|Lost to Follow-up|3|||
129558531|NCT00759148|466340949|FG001|Overall Study|Lost to Follow-up|9|||
129558532|NCT00759148|466340948|FG000|Overall Study|Treatment Failure|6|||
129558533|NCT00759148|466340949|FG001|Overall Study|Treatment Failure|10|||
129777632|NCT02116205|467151373|FG003|Overall Study|Lost to Follow-up|2|||
129777633|NCT02116205|467151370|FG000|Overall Study|Physician Decision|0|||
129777634|NCT02116205|467151371|FG001|Overall Study|Physician Decision|1|||
129777635|NCT02116205|467151372|FG002|Overall Study|Physician Decision|1|||
129777636|NCT02116205|467151373|FG003|Overall Study|Physician Decision|1|||
129558534|NCT00759148|466340948|FG000|Overall Study|Reason not given|1|||
129558535|NCT00759148|466340949|FG001|Overall Study|Reason not given|0|||
129558536|NCT03381248|466340950|FG000|0-6 Months|Withdrawal by Subject|4|||
129558537|NCT03381248|466340951|FG001|0-6 Months|Withdrawal by Subject|1|||
129558538|NCT03381248|466340950|FG000|0-6 Months|Lost to Follow-up|3|||
129558539|NCT03381248|466340951|FG001|0-6 Months|Lost to Follow-up|2|||
129558540|NCT03381248|466340950|FG000|0-6 Months|Lack of Efficacy|1|||
129777637|NCT02116205|467151370|FG000|Overall Study|Exclusion criteria|0|||
129558541|NCT03381248|466340951|FG001|0-6 Months|Lack of Efficacy|0|||
129558542|NCT03381248|466340950|FG000|0-6 Months|Adverse Event|1|||
129558543|NCT03381248|466340951|FG001|0-6 Months|Adverse Event|0|||
129777638|NCT02116205|467151371|FG001|Overall Study|Exclusion criteria|0|||
129558544|NCT03381248|466340950|FG000|0-6 Months|Protocol Violation|2|||
129558545|NCT03381248|466340951|FG001|0-6 Months|Protocol Violation|1|||
129558546|NCT03381248|466340950|FG000|0-6 Months|Physician Decision|1|||
129558547|NCT03381248|466340951|FG001|0-6 Months|Physician Decision|0|||
129558548|NCT03381248|466340950|FG000|0-6 Months|Planning another procedure|1|||
129558549|NCT03381248|466340951|FG001|0-6 Months|Planning another procedure|2|||
129558550|NCT03381248|466340950|FG000|6-12 Months|Withdrawal by Subject|1|||
129558551|NCT03381248|466340951|FG001|6-12 Months|Withdrawal by Subject|3|||
129558552|NCT03381248|466340950|FG000|6-12 Months|Lost to Follow-up|0|||
129558553|NCT03381248|466340951|FG001|6-12 Months|Lost to Follow-up|2|||
129558554|NCT03381248|466340950|FG000|6-12 Months|Protocol Violation|3|||
129558555|NCT03381248|466340951|FG001|6-12 Months|Protocol Violation|2|||
129558556|NCT03381248|466340950|FG000|6-12 Months|Planning another procedure|6|||
129558557|NCT03381248|466340951|FG001|6-12 Months|Planning another procedure|2|||
129558558|NCT03381248|466340950|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
129558559|NCT03381248|466340951|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
129558560|NCT03381248|466340950|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
129558561|NCT03381248|466340951|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
129558562|NCT03381248|466340950|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
129558563|NCT03381248|466340951|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
129558564|NCT01133821|466340952|FG000|Overall Study|Lost to Follow-up|8|||
129558565|NCT01133821|466340953|FG001|Overall Study|Lost to Follow-up|11|||
129558566|NCT01133821|466340952|FG000|Overall Study|Withdrawal by Subject|8|||
129558567|NCT01133821|466340953|FG001|Overall Study|Withdrawal by Subject|3|||
129558568|NCT01133821|466340952|FG000|Overall Study|preferred other treatment|1|||
129558569|NCT01133821|466340953|FG001|Overall Study|preferred other treatment|1|||
129558570|NCT01133821|466340952|FG000|Overall Study|Protocol Violation|0|||
129558571|NCT01133821|466340953|FG001|Overall Study|Protocol Violation|1|||
129558572|NCT01133821|466340952|FG000|Overall Study|Refused participation|1|||
129558573|NCT01133821|466340953|FG001|Overall Study|Refused participation|3|||
129558574|NCT00434161|466340956|FG000|Overall Study|Adverse Event|5|||
129558575|NCT00434161|466340957|FG001|Overall Study|Adverse Event|1|||
129558576|NCT00434161|466340958|FG002|Overall Study|Adverse Event|4|||
129558577|NCT00434161|466340956|FG000|Overall Study|Lost to Follow-up|0|||
129558578|NCT00434161|466340957|FG001|Overall Study|Lost to Follow-up|1|||
129558579|NCT00434161|466340958|FG002|Overall Study|Lost to Follow-up|0|||
129558580|NCT00434161|466340956|FG000|Overall Study|Death|1|||
129558581|NCT00434161|466340957|FG001|Overall Study|Death|0|||
129558582|NCT00434161|466340958|FG002|Overall Study|Death|1|||
129558583|NCT00434161|466340956|FG000|Overall Study|Non-Compliance|1|||
129558584|NCT00434161|466340957|FG001|Overall Study|Non-Compliance|1|||
129558585|NCT00434161|466340958|FG002|Overall Study|Non-Compliance|0|||
129558586|NCT00434161|466340956|FG000|Overall Study|Withdrawal by Subject|2|||
129558587|NCT00434161|466340957|FG001|Overall Study|Withdrawal by Subject|0|||
129558588|NCT00434161|466340958|FG002|Overall Study|Withdrawal by Subject|3|||
129558589|NCT00434161|466340956|FG000|Overall Study|Logistical error study assessments|1|||
129558590|NCT00434161|466340957|FG001|Overall Study|Logistical error study assessments|0|||
129558591|NCT00434161|466340958|FG002|Overall Study|Logistical error study assessments|3|||
129558592|NCT03342898|466340959|FG000|Overall Study|Adverse Event|3|||
129558593|NCT03342898|466340960|FG001|Overall Study|Adverse Event|1|||
129558594|NCT03342898|466340961|FG002|Overall Study|Adverse Event|0|||
129558595|NCT03342898|466340959|FG000|Overall Study|Lost to Follow-up|44|||
129558596|NCT03342898|466340960|FG001|Overall Study|Lost to Follow-up|40|||
129558597|NCT03342898|466340961|FG002|Overall Study|Lost to Follow-up|42|||
129558598|NCT03342898|466340959|FG000|Overall Study|Withdrawal of Consent|5|||
129558599|NCT03342898|466340960|FG001|Overall Study|Withdrawal of Consent|9|||
129558600|NCT03342898|466340961|FG002|Overall Study|Withdrawal of Consent|11|||
129558601|NCT03342898|466340959|FG000|Overall Study|Death|0|||
129558602|NCT03342898|466340960|FG001|Overall Study|Death|1|||
129687283|NCT02573467|466812130|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
129687284|NCT02573467|466812127|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
129777639|NCT02116205|467151372|FG002|Overall Study|Exclusion criteria|1|||
129558603|NCT03342898|466340961|FG002|Overall Study|Death|1|||
129558604|NCT03342898|466340959|FG000|Overall Study|Reason not Specified|2|||
129558605|NCT03342898|466340960|FG001|Overall Study|Reason not Specified|2|||
129558606|NCT03342898|466340961|FG002|Overall Study|Reason not Specified|0|||
129558607|NCT01387282|466340962|FG000|Overall Study|Death|47|||
129558608|NCT01387282|466340963|FG001|Overall Study|Death|16|||
129558609|NCT01387282|466340962|FG000|Overall Study|Other|5|||
129558610|NCT01387282|466340963|FG001|Overall Study|Other|1|||
129558611|NCT01387282|466340962|FG000|Overall Study|Unrelated AE|6|||
129558612|NCT01387282|466340963|FG001|Overall Study|Unrelated AE|4|||
129558613|NCT01387282|466340962|FG000|Overall Study|Withdrawal by patient|33|||
129558614|NCT01387282|466340963|FG001|Overall Study|Withdrawal by patient|23|||
129558615|NCT01387282|466340962|FG000|Overall Study|Study drug-related AE|2|||
129558616|NCT01387282|466340963|FG001|Overall Study|Study drug-related AE|2|||
129558617|NCT01387282|466340962|FG000|Overall Study|Lost to Follow-up|4|||
129558618|NCT01387282|466340963|FG001|Overall Study|Lost to Follow-up|1|||
129558619|NCT01405950|466340972|FG000|Overall Study|Withdrawal by Subject|1|||
129558620|NCT01405950|466340973|FG001|Overall Study|Withdrawal by Subject|0|||
129558621|NCT01405950|466340974|FG002|Overall Study|Withdrawal by Subject|0|||
129558622|NCT01405950|466340975|FG003|Overall Study|Withdrawal by Subject|0|||
129558623|NCT02410252|466340976|FG000|Overall Study|Withdrawal by Subject|4|||
129558624|NCT02410252|466340976|FG000|Overall Study|Physician Decision|2|||
129558625|NCT00387712|466340979|FG000|Overall Study|Physician Decision|6|||
129558626|NCT00387712|466340980|FG001|Overall Study|Physician Decision|4|||
129558627|NCT00387712|466340979|FG000|Overall Study|Lost to Follow-up|17|||
129558628|NCT00387712|466340980|FG001|Overall Study|Lost to Follow-up|20|||
129558629|NCT00387712|466340979|FG000|Overall Study|Withdrawal by Subject|6|||
129558630|NCT00387712|466340980|FG001|Overall Study|Withdrawal by Subject|12|||
129558631|NCT03551730|466340989|FG000|Overall Study|Adverse Event|1|||
129558632|NCT03551730|466340990|FG001|Overall Study|Adverse Event|0|||
129558633|NCT03551730|466340991|FG002|Overall Study|Adverse Event|0|||
129558634|NCT03551730|466340992|FG003|Overall Study|Adverse Event|0|||
129558635|NCT02668783|466340993|FG000|Overall Study|Pregnancy|0|||
129558636|NCT02668783|466340994|FG001|Overall Study|Pregnancy|1|||
129558637|NCT02668783|466340993|FG000|Overall Study|Protocol Violation|2|||
129558638|NCT02668783|466340994|FG001|Overall Study|Protocol Violation|1|||
129558639|NCT02668783|466340993|FG000|Overall Study|Study terminated by sponsor|9|||
129558640|NCT02668783|466340994|FG001|Overall Study|Study terminated by sponsor|10|||
129558641|NCT02668783|466340993|FG000|Overall Study|Subject moved|1|||
129558642|NCT02668783|466340994|FG001|Overall Study|Subject moved|0|||
129558643|NCT02668783|466340993|FG000|Overall Study|Withdrawal by Subject|1|||
129558644|NCT02668783|466340994|FG001|Overall Study|Withdrawal by Subject|0|||
129558645|NCT04467697|466340995|FG000|Overall Study|Adverse Event|2|||
129558646|NCT04467697|466340995|FG000|Overall Study|Lost to Follow-up|6|||
129558647|NCT04467697|466340995|FG000|Overall Study|Withdrawal by Subject|9|||
129558648|NCT04467697|466340995|FG000|Overall Study|Protocol Violation|3|||
129558649|NCT00909727|466340998|FG000|Overall Study|Adverse Event|1|||
129558650|NCT00909727|466340999|FG001|Overall Study|Adverse Event|0|||
129558651|NCT00909727|466340998|FG000|Overall Study|Wrong Genotype|1|||
129558652|NCT00909727|466340999|FG001|Overall Study|Wrong Genotype|0|||
129558653|NCT00909727|466340998|FG000|Overall Study|Withdrawal of Consent|1|||
129558654|NCT00909727|466340999|FG001|Overall Study|Withdrawal of Consent|0|||
129884513|NCT02293837|467536433|FG001|Overall Study|Participant ill and could not be infused|0|||
129558655|NCT00909727|466340998|FG000|Overall Study|Prohibited Medication|1|||
129558656|NCT00909727|466340999|FG001|Overall Study|Prohibited Medication|0|||
129558657|NCT02231710|466341000|FG000|Overall Study|Physician Decision|1|||
129558658|NCT04081337|466341001|FG000|Overall Study|Adverse Event|0|||
129558659|NCT04081337|466341002|FG001|Overall Study|Adverse Event|1|||
129558660|NCT04081337|466341001|FG000|Overall Study|Withdrawal by Subject|2|||
129558661|NCT04081337|466341002|FG001|Overall Study|Withdrawal by Subject|0|||
129558662|NCT04081337|466341001|FG000|Overall Study|Physician Decision|1|||
129884514|NCT02293837|467536434|FG002|Overall Study|Participant ill and could not be infused|1|||
129558663|NCT04081337|466341002|FG001|Overall Study|Physician Decision|2|||
129558664|NCT04081337|466341001|FG000|Overall Study|Lost to Follow-up|1|||
129558665|NCT04081337|466341002|FG001|Overall Study|Lost to Follow-up|0|||
129558666|NCT00673361|466341007|FG000|Overall Study|Screen Failure|2|||
129558667|NCT01799590|466341010|FG000|Overall Study|Adverse Event|13|||
129558668|NCT01799590|466341011|FG001|Overall Study|Adverse Event|7|||
129558669|NCT01799590|466341012|FG002|Overall Study|Adverse Event|5|||
129558670|NCT01799590|466341010|FG000|Overall Study|Pregnancy|2|||
129558671|NCT01799590|466341011|FG001|Overall Study|Pregnancy|0|||
129558672|NCT01799590|466341012|FG002|Overall Study|Pregnancy|0|||
129558673|NCT01799590|466341010|FG000|Overall Study|Lack of Efficacy|3|||
129558674|NCT01799590|466341011|FG001|Overall Study|Lack of Efficacy|1|||
129558675|NCT01799590|466341012|FG002|Overall Study|Lack of Efficacy|3|||
129558676|NCT01799590|466341010|FG000|Overall Study|Participants convenience|4|||
129558677|NCT01799590|466341011|FG001|Overall Study|Participants convenience|4|||
129558678|NCT01799590|466341012|FG002|Overall Study|Participants convenience|2|||
129558679|NCT01799590|466341010|FG000|Overall Study|Aggravation of complications|0|||
129558680|NCT01799590|466341011|FG001|Overall Study|Aggravation of complications|1|||
129558681|NCT01799590|466341012|FG002|Overall Study|Aggravation of complications|1|||
129558682|NCT01799590|466341010|FG000|Overall Study|Using drugs with restricted days of use|0|||
129558683|NCT01799590|466341011|FG001|Overall Study|Using drugs with restricted days of use|3|||
129558684|NCT01799590|466341012|FG002|Overall Study|Using drugs with restricted days of use|2|||
129558685|NCT01799590|466341010|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
129558686|NCT01799590|466341011|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
129558687|NCT01799590|466341012|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
129558688|NCT01799590|466341010|FG000|Overall Study|Other|3|||
129558689|NCT01799590|466341011|FG001|Overall Study|Other|0|||
129558690|NCT01799590|466341012|FG002|Overall Study|Other|1|||
129558691|NCT01489956|466341013|FG000|Overall Study|Lost to Follow-up|1|||
129558692|NCT01489956|466341014|FG001|Overall Study|Lost to Follow-up|0|||
129558693|NCT01489956|466341015|FG002|Overall Study|Lost to Follow-up|0|||
129558694|NCT01489956|466341013|FG000|Overall Study|Withdrawal by Subject|0|||
129558695|NCT01489956|466341014|FG001|Overall Study|Withdrawal by Subject|0|||
129558696|NCT01489956|466341015|FG002|Overall Study|Withdrawal by Subject|1|||
129558697|NCT03255031|466341018|FG000|Overall Study|Adverse Event|5|||
129558698|NCT03255031|466341019|FG001|Overall Study|Adverse Event|3|||
129558699|NCT03255031|466341018|FG000|Overall Study|Physician Decision|2|||
129558700|NCT03255031|466341019|FG001|Overall Study|Physician Decision|1|||
129558701|NCT03255031|466341018|FG000|Overall Study|Withdrawal by Subject|9|||
129558702|NCT03255031|466341019|FG001|Overall Study|Withdrawal by Subject|3|||
129558703|NCT01689974|466341021|FG000|Overall Study|Termination of Study|5|||
129558704|NCT01689974|466341022|FG001|Overall Study|Termination of Study|5|||
129558705|NCT00415532|466341026|FG000|Treatment Period|Adverse Event|2|||
129558706|NCT00415532|466341027|FG001|Treatment Period|Adverse Event|3|||
129558707|NCT00415532|466341026|FG000|Treatment Period|Death|2|||
129558708|NCT00415532|466341027|FG001|Treatment Period|Death|1|||
129558709|NCT00415532|466341026|FG000|Treatment Period|Lost to Follow-up|1|||
129558710|NCT00415532|466341027|FG001|Treatment Period|Lost to Follow-up|1|||
129558711|NCT00415532|466341026|FG000|Treatment Period|Protocol Violation|1|||
129558712|NCT00415532|466341027|FG001|Treatment Period|Protocol Violation|0|||
129558713|NCT00415532|466341026|FG000|Treatment Period|Withdrawal by Subject|6|||
129558714|NCT00415532|466341027|FG001|Treatment Period|Withdrawal by Subject|6|||
129558715|NCT00415532|466341026|FG000|Treatment Period|Other|2|||
129558716|NCT00415532|466341027|FG001|Treatment Period|Other|2|||
129558717|NCT00415532|466341026|FG000|Treatment Period|Ineligibility determined|1|||
129558718|NCT00415532|466341027|FG001|Treatment Period|Ineligibility determined|1|||
129558719|NCT00415532|466341026|FG000|Treatment Period|Noncompliance|1|||
129558720|NCT00415532|466341027|FG001|Treatment Period|Noncompliance|1|||
129558721|NCT00415532|466341026|FG000|Treatment Period|Requirement for alternative therapy|1|||
129558722|NCT00415532|466341027|FG001|Treatment Period|Requirement for alternative therapy|0|||
129558723|NCT00415532|466341026|FG000|Safety Follow Up Period|Adverse Event|1|||
129558724|NCT00415532|466341027|FG001|Safety Follow Up Period|Adverse Event|3|||
129558725|NCT00415532|466341026|FG000|Safety Follow Up Period|Death|3|||
129558726|NCT00415532|466341027|FG001|Safety Follow Up Period|Death|0|||
129558727|NCT00415532|466341026|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
129558728|NCT00415532|466341027|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
129558729|NCT00415532|466341026|FG000|Safety Follow Up Period|Other|1|||
129558730|NCT00415532|466341027|FG001|Safety Follow Up Period|Other|4|||
129558731|NCT00415532|466341026|FG000|Safety Follow Up Period|Ineligibility determined|1|||
129558732|NCT00415532|466341027|FG001|Safety Follow Up Period|Ineligibility determined|1|||
129558733|NCT00415532|466341026|FG000|Safety Follow Up Period|Noncompliance|1|||
129558734|NCT00415532|466341027|FG001|Safety Follow Up Period|Noncompliance|0|||
129558735|NCT00415532|466341026|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
129558736|NCT00415532|466341027|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
129558737|NCT01698320|466341028|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
129558738|NCT01698320|466341029|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
129558739|NCT01698320|466341030|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
129558740|NCT01698320|466341028|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
129558741|NCT01698320|466341029|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
129558742|NCT01698320|466341030|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
129558743|NCT01698320|466341028|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
129558744|NCT01698320|466341029|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
129558745|NCT01698320|466341030|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
129558746|NCT01698320|466341028|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
129558747|NCT01698320|466341029|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
129558748|NCT01698320|466341030|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
129558749|NCT01698320|466341028|FG000|12-Week Double-Blind Period|Adverse Event|0|||
129558750|NCT01698320|466341029|FG001|12-Week Double-Blind Period|Adverse Event|1|||
129558751|NCT01698320|466341030|FG002|12-Week Double-Blind Period|Adverse Event|1|||
129558752|NCT01698320|466341028|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
129558753|NCT01698320|466341029|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
129558754|NCT01698320|466341030|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
129558755|NCT01698320|466341028|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
129558756|NCT01698320|466341029|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
129558757|NCT01698320|466341030|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
129558758|NCT01698320|466341028|FG000|12-Week Double-Blind Period|Pregnancy|0|||
129558759|NCT01698320|466341029|FG001|12-Week Double-Blind Period|Pregnancy|1|||
129558760|NCT01698320|466341030|FG002|12-Week Double-Blind Period|Pregnancy|1|||
129558761|NCT01698320|466341028|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
129558762|NCT01698320|466341029|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
129558763|NCT01698320|466341030|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
129558764|NCT01698320|466341028|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
129558765|NCT01698320|466341029|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
129558766|NCT01698320|466341030|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
129558767|NCT01698320|466341028|FG000|40-Week Open-Label Period|Adverse Event|0|||
129558768|NCT01698320|466341029|FG001|40-Week Open-Label Period|Adverse Event|3|||
129558769|NCT01698320|466341030|FG002|40-Week Open-Label Period|Adverse Event|2|||
129558770|NCT01698320|466341028|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
129558771|NCT01698320|466341029|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
129558772|NCT01698320|466341030|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
129558773|NCT01698320|466341028|FG000|40-Week Open-Label Period|Pregnancy|0|||
129558774|NCT01698320|466341029|FG001|40-Week Open-Label Period|Pregnancy|2|||
129558775|NCT01698320|466341030|FG002|40-Week Open-Label Period|Pregnancy|1|||
129777640|NCT02116205|467151373|FG003|Overall Study|Exclusion criteria|0|||
129558776|NCT01698320|466341028|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
129777641|NCT02541604|467151374|FG000|Overall Study|Death|6|||
129777642|NCT02541604|467151375|FG001|Overall Study|Death|5|||
129558777|NCT01698320|466341029|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
129777643|NCT02541604|467151376|FG002|Overall Study|Death|7|||
129558778|NCT01698320|466341030|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
129777644|NCT02541604|467151377|FG003|Overall Study|Death|2|||
129777645|NCT02541604|467151378|FG004|Overall Study|Death|9|||
129777646|NCT02541604|467151379|FG005|Overall Study|Death|8|||
129558779|NCT01698320|466341028|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
129558780|NCT01698320|466341029|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
129558781|NCT01698320|466341030|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
129558782|NCT01952574|466341031|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
129558783|NCT01952574|466341032|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
129558784|NCT01952574|466341033|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
129558785|NCT01952574|466341034|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
129558786|NCT01952574|466341035|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129558787|NCT01952574|466341036|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129558788|NCT01952574|466341037|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129558789|NCT01952574|466341031|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
129558790|NCT01952574|466341032|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
129558791|NCT01952574|466341033|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
129558792|NCT01952574|466341034|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
129558793|NCT01952574|466341035|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
129558794|NCT01952574|466341036|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
129558795|NCT01952574|466341037|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
129558796|NCT01952574|466341031|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
129558797|NCT01952574|466341032|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
129558798|NCT01952574|466341033|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
129558799|NCT01952574|466341034|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
129558800|NCT01952574|466341035|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
129558801|NCT01952574|466341036|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
129558802|NCT01952574|466341037|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
129558803|NCT01952574|466341031|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
129558804|NCT01952574|466341032|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
129558805|NCT01952574|466341033|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
129558806|NCT01952574|466341034|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
129558807|NCT01952574|466341035|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
129558808|NCT01952574|466341036|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
129558809|NCT01952574|466341037|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
129558810|NCT01952574|466341031|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
129558811|NCT01952574|466341032|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
129558812|NCT01952574|466341033|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
129558813|NCT01952574|466341034|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
129558814|NCT01952574|466341035|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
129558815|NCT01952574|466341036|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
129558816|NCT01952574|466341037|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
129558817|NCT01952574|466341031|FG000|Open-label Treatment Phase|Missing|0|||
129558818|NCT01952574|466341032|FG001|Open-label Treatment Phase|Missing|0|||
129558819|NCT01952574|466341033|FG002|Open-label Treatment Phase|Missing|0|||
129558820|NCT01952574|466341034|FG003|Open-label Treatment Phase|Missing|0|||
129777647|NCT02541604|467151380|FG006|Overall Study|Death|9|||
129558821|NCT01952574|466341035|FG004|Open-label Treatment Phase|Missing|4|||
129558822|NCT01952574|466341036|FG005|Open-label Treatment Phase|Missing|0|||
129558823|NCT01952574|466341037|FG006|Open-label Treatment Phase|Missing|0|||
129558824|NCT01952574|466341031|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
129558825|NCT01952574|466341032|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
129558826|NCT01952574|466341033|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
129558827|NCT01952574|466341034|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
129558828|NCT01952574|466341035|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
129558829|NCT01952574|466341036|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
129558830|NCT01952574|466341037|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
129558831|NCT01952574|466341031|FG000|Open-label Treatment Phase|Death|0|||
129558832|NCT01952574|466341032|FG001|Open-label Treatment Phase|Death|0|||
129558833|NCT01952574|466341033|FG002|Open-label Treatment Phase|Death|0|||
129558834|NCT01952574|466341034|FG003|Open-label Treatment Phase|Death|0|||
129558835|NCT01952574|466341035|FG004|Open-label Treatment Phase|Death|1|||
129558836|NCT01952574|466341036|FG005|Open-label Treatment Phase|Death|0|||
129558837|NCT01952574|466341037|FG006|Open-label Treatment Phase|Death|0|||
129558838|NCT01952574|466341031|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129558839|NCT01952574|466341032|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129558840|NCT01952574|466341033|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129558841|NCT01952574|466341034|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129558842|NCT01952574|466341035|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129558843|NCT01952574|466341036|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
129558844|NCT01952574|466341037|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
129558845|NCT01952574|466341031|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
129558846|NCT01952574|466341032|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
129558847|NCT01952574|466341033|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
129558848|NCT01952574|466341034|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
129558849|NCT01952574|466341035|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
129558850|NCT01952574|466341036|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
129558851|NCT01952574|466341037|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
129558852|NCT00770991|466341047|FG000|Overall Study|Physician Decision|2|||
129558853|NCT00770991|466341048|FG001|Overall Study|Physician Decision|0|||
129558854|NCT00770991|466341047|FG000|Overall Study|Withdrawal by Subject|1|||
129558855|NCT00770991|466341048|FG001|Overall Study|Withdrawal by Subject|0|||
129558856|NCT00770991|466341047|FG000|Overall Study|Adverse Event|1|||
129558857|NCT00770991|466341048|FG001|Overall Study|Adverse Event|5|||
129558858|NCT00770991|466341047|FG000|Overall Study|Pregnancy|1|||
129558859|NCT00770991|466341048|FG001|Overall Study|Pregnancy|0|||
129558860|NCT02040766|466341050|FG000|Overall Study|Adverse Event|1|||
129558861|NCT02040766|466341051|FG001|Overall Study|Adverse Event|1|||
129558862|NCT02040766|466341052|FG002|Overall Study|Adverse Event|1|||
129558863|NCT02040766|466341053|FG003|Overall Study|Adverse Event|0|||
129558864|NCT02040766|466341054|FG004|Overall Study|Adverse Event|2|||
129558865|NCT02040766|466341050|FG000|Overall Study|Withdrawal by Subject|4|||
129558866|NCT02040766|466341051|FG001|Overall Study|Withdrawal by Subject|3|||
129558867|NCT02040766|466341052|FG002|Overall Study|Withdrawal by Subject|2|||
129558868|NCT02040766|466341053|FG003|Overall Study|Withdrawal by Subject|3|||
129558869|NCT02040766|466341054|FG004|Overall Study|Withdrawal by Subject|2|||
129558870|NCT02040766|466341050|FG000|Overall Study|Non-compliance|0|||
129558871|NCT02040766|466341051|FG001|Overall Study|Non-compliance|1|||
129558872|NCT02040766|466341052|FG002|Overall Study|Non-compliance|0|||
129558873|NCT02040766|466341053|FG003|Overall Study|Non-compliance|0|||
129558874|NCT02040766|466341054|FG004|Overall Study|Non-compliance|0|||
129558875|NCT02040766|466341050|FG000|Overall Study|Protocol Violation|2|||
129558876|NCT02040766|466341051|FG001|Overall Study|Protocol Violation|1|||
129558877|NCT02040766|466341052|FG002|Overall Study|Protocol Violation|2|||
129558878|NCT02040766|466341053|FG003|Overall Study|Protocol Violation|3|||
129558879|NCT02040766|466341054|FG004|Overall Study|Protocol Violation|0|||
129558880|NCT02040766|466341050|FG000|Overall Study|Lost to Follow-up|4|||
129558881|NCT02040766|466341051|FG001|Overall Study|Lost to Follow-up|1|||
129558882|NCT02040766|466341052|FG002|Overall Study|Lost to Follow-up|3|||
129558883|NCT02040766|466341053|FG003|Overall Study|Lost to Follow-up|1|||
129558884|NCT02040766|466341054|FG004|Overall Study|Lost to Follow-up|4|||
129558885|NCT02040766|466341050|FG000|Overall Study|Not reported|1|||
129558886|NCT02040766|466341051|FG001|Overall Study|Not reported|0|||
129558887|NCT02040766|466341052|FG002|Overall Study|Not reported|0|||
129558888|NCT02040766|466341053|FG003|Overall Study|Not reported|0|||
129558889|NCT02040766|466341054|FG004|Overall Study|Not reported|0|||
129558890|NCT02040766|466341050|FG000|Overall Study|Lack of Efficacy|6|||
129558891|NCT02040766|466341051|FG001|Overall Study|Lack of Efficacy|3|||
129558892|NCT02040766|466341052|FG002|Overall Study|Lack of Efficacy|4|||
129558893|NCT02040766|466341053|FG003|Overall Study|Lack of Efficacy|6|||
129558894|NCT02040766|466341054|FG004|Overall Study|Lack of Efficacy|5|||
129558895|NCT02974114|466341055|FG000|Overall Study|Other (Not specified)|0|||
129558896|NCT02974114|466341056|FG001|Overall Study|Other (Not specified)|1|||
129558897|NCT02974114|466341057|FG002|Overall Study|Other (Not specified)|2|||
129558898|NCT01580020|466341058|FG000|Overall Study|Lack of Efficacy|0|||
129558899|NCT01580020|466341059|FG001|Overall Study|Lack of Efficacy|5|||
129558900|NCT01580020|466341060|FG002|Overall Study|Lack of Efficacy|0|||
129558901|NCT01580020|466341061|FG003|Overall Study|Lack of Efficacy|1|||
129558902|NCT01580020|466341058|FG000|Overall Study|Withdrawal by Subject|0|||
129558903|NCT01580020|466341059|FG001|Overall Study|Withdrawal by Subject|1|||
129558904|NCT01580020|466341060|FG002|Overall Study|Withdrawal by Subject|1|||
129558905|NCT01580020|466341061|FG003|Overall Study|Withdrawal by Subject|0|||
129558906|NCT01580020|466341058|FG000|Overall Study|Adverse Event|1|||
129558907|NCT01580020|466341059|FG001|Overall Study|Adverse Event|1|||
129558908|NCT01580020|466341060|FG002|Overall Study|Adverse Event|1|||
129558909|NCT01580020|466341061|FG003|Overall Study|Adverse Event|1|||
129558910|NCT01580020|466341058|FG000|Overall Study|Administrative Problems|0|||
129558911|NCT01580020|466341059|FG001|Overall Study|Administrative Problems|0|||
129558912|NCT01580020|466341060|FG002|Overall Study|Administrative Problems|1|||
129558913|NCT01580020|466341061|FG003|Overall Study|Administrative Problems|0|||
129558914|NCT01580020|466341058|FG000|Overall Study|Lost to Follow-up|0|||
129558915|NCT01580020|466341059|FG001|Overall Study|Lost to Follow-up|0|||
129558916|NCT01580020|466341060|FG002|Overall Study|Lost to Follow-up|1|||
129558917|NCT01580020|466341061|FG003|Overall Study|Lost to Follow-up|0|||
129558918|NCT01724359|466341062|FG000|Overall Study|Adverse Event|10|||
129558919|NCT01724359|466341062|FG000|Overall Study|Death|1|||
129558920|NCT01724359|466341062|FG000|Overall Study|Other|20|||
129558921|NCT00593333|466341064|FG000|Overall Study|Lost to Follow-up|10|||
129558922|NCT00593333|466341065|FG001|Overall Study|Lost to Follow-up|11|||
129558923|NCT01752920|466341066|FG000|Overall Study|Adverse Event|1|||
129558924|NCT01752920|466341067|FG001|Overall Study|Adverse Event|0|||
129558925|NCT01752920|466341068|FG002|Overall Study|Adverse Event|5|||
129558926|NCT01752920|466341069|FG003|Overall Study|Adverse Event|10|||
129558927|NCT01752920|466341066|FG000|Overall Study|Clinical Disease Progression|6|||
129558928|NCT01752920|466341067|FG001|Overall Study|Clinical Disease Progression|4|||
129558929|NCT01752920|466341068|FG002|Overall Study|Clinical Disease Progression|1|||
129777648|NCT02541604|467151381|FG007|Overall Study|Death|9|||
129777649|NCT02541604|467151382|FG008|Overall Study|Death|3|||
129777650|NCT02541604|467151383|FG009|Overall Study|Death|4|||
129777651|NCT02541604|467151384|FG010|Overall Study|Death|2|||
129777652|NCT02541604|467151385|FG011|Overall Study|Death|3|||
129777653|NCT02541604|467151374|FG000|Overall Study|Lost to Follow-up|2|||
129777654|NCT02541604|467151375|FG001|Overall Study|Lost to Follow-up|0|||
129777655|NCT02541604|467151376|FG002|Overall Study|Lost to Follow-up|1|||
129777656|NCT02541604|467151377|FG003|Overall Study|Lost to Follow-up|0|||
129777657|NCT02541604|467151378|FG004|Overall Study|Lost to Follow-up|0|||
129777658|NCT02541604|467151379|FG005|Overall Study|Lost to Follow-up|1|||
129777659|NCT02541604|467151380|FG006|Overall Study|Lost to Follow-up|1|||
129777660|NCT02541604|467151381|FG007|Overall Study|Lost to Follow-up|0|||
129777661|NCT02541604|467151382|FG008|Overall Study|Lost to Follow-up|0|||
129777662|NCT02541604|467151383|FG009|Overall Study|Lost to Follow-up|0|||
129777663|NCT02541604|467151384|FG010|Overall Study|Lost to Follow-up|0|||
129777664|NCT02541604|467151385|FG011|Overall Study|Lost to Follow-up|0|||
129777665|NCT02541604|467151374|FG000|Overall Study|Withdrawal by Subject|2|||
129777666|NCT02541604|467151375|FG001|Overall Study|Withdrawal by Subject|0|||
129777667|NCT02541604|467151376|FG002|Overall Study|Withdrawal by Subject|1|||
129777668|NCT02541604|467151377|FG003|Overall Study|Withdrawal by Subject|0|||
129777669|NCT02541604|467151378|FG004|Overall Study|Withdrawal by Subject|1|||
129777670|NCT02541604|467151379|FG005|Overall Study|Withdrawal by Subject|1|||
129777671|NCT02541604|467151380|FG006|Overall Study|Withdrawal by Subject|0|||
129777672|NCT02541604|467151381|FG007|Overall Study|Withdrawal by Subject|0|||
129558930|NCT01752920|466341069|FG003|Overall Study|Clinical Disease Progression|13|||
129558931|NCT01752920|466341066|FG000|Overall Study|Physician Decision|1|||
129558932|NCT01752920|466341067|FG001|Overall Study|Physician Decision|0|||
129558933|NCT01752920|466341068|FG002|Overall Study|Physician Decision|0|||
129558934|NCT01752920|466341069|FG003|Overall Study|Physician Decision|3|||
129558935|NCT01752920|466341066|FG000|Overall Study|Radiographic Disease Progression|20|||
129558936|NCT01752920|466341067|FG001|Overall Study|Radiographic Disease Progression|7|||
129777673|NCT02541604|467151382|FG008|Overall Study|Withdrawal by Subject|1|||
129777674|NCT02541604|467151383|FG009|Overall Study|Withdrawal by Subject|0|||
129777675|NCT02541604|467151384|FG010|Overall Study|Withdrawal by Subject|0|||
129777676|NCT02541604|467151385|FG011|Overall Study|Withdrawal by Subject|0|||
129558937|NCT01752920|466341068|FG002|Overall Study|Radiographic Disease Progression|12|||
129558938|NCT01752920|466341069|FG003|Overall Study|Radiographic Disease Progression|29|||
129777677|NCT02541604|467151374|FG000|Overall Study|Study Terminated by Sponsor|1|||
129777678|NCT02541604|467151375|FG001|Overall Study|Study Terminated by Sponsor|4|||
129558939|NCT01752920|466341066|FG000|Overall Study|Study Terminated by Sponsor|0|||
129558940|NCT01752920|466341067|FG001|Overall Study|Study Terminated by Sponsor|0|||
129558941|NCT01752920|466341068|FG002|Overall Study|Study Terminated by Sponsor|0|||
129558942|NCT01752920|466341069|FG003|Overall Study|Study Terminated by Sponsor|1|||
129558943|NCT01752920|466341066|FG000|Overall Study|Withdrawal by Subject|0|||
129558944|NCT01752920|466341067|FG001|Overall Study|Withdrawal by Subject|1|||
129558945|NCT01752920|466341068|FG002|Overall Study|Withdrawal by Subject|0|||
129558946|NCT01752920|466341069|FG003|Overall Study|Withdrawal by Subject|1|||
129558947|NCT01752920|466341066|FG000|Overall Study|Lack of clinical benefit|1|||
129558948|NCT01752920|466341067|FG001|Overall Study|Lack of clinical benefit|1|||
129558949|NCT01752920|466341068|FG002|Overall Study|Lack of clinical benefit|1|||
129558950|NCT01752920|466341069|FG003|Overall Study|Lack of clinical benefit|1|||
129558951|NCT01186978|466341070|FG000|Overall Study|Withdrawal by Subject|1|||
129558952|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
129558953|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
129558954|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
129558955|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
129558956|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
129558957|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
129558958|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
129558959|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
129558960|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
129558961|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
129558962|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
129558963|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
129558964|NCT01227668|466341071|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
129558965|NCT01227668|466341072|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
129558966|NCT01227668|466341071|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
129558967|NCT01227668|466341072|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
129558968|NCT01227668|466341071|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
129558969|NCT01227668|466341072|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
129558970|NCT01227668|466341071|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
129558971|NCT01227668|466341072|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
129558972|NCT01227668|466341071|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
129558973|NCT01227668|466341072|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
129558974|NCT01227668|466341071|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
129558975|NCT01227668|466341072|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
129558976|NCT01709383|466341078|FG000|Overall Study|Lost to Follow-up|1|||
129558977|NCT01709383|466341079|FG001|Overall Study|Lost to Follow-up|0|||
129558978|NCT03264066|466341080|FG000|Overall Study|Adverse Event|1|||
129558979|NCT03264066|466341081|FG001|Overall Study|Adverse Event|1|||
129558980|NCT03264066|466341082|FG002|Overall Study|Adverse Event|0|||
129558981|NCT03264066|466341083|FG003|Overall Study|Adverse Event|0|||
129558982|NCT03264066|466341084|FG004|Overall Study|Adverse Event|0|||
129558983|NCT03264066|466341085|FG005|Overall Study|Adverse Event|0|||
129558984|NCT03264066|466341080|FG000|Overall Study|Death|12|||
129558985|NCT03264066|466341081|FG001|Overall Study|Death|12|||
129558986|NCT03264066|466341082|FG002|Overall Study|Death|8|||
129558987|NCT03264066|466341083|FG003|Overall Study|Death|10|||
129558988|NCT03264066|466341084|FG004|Overall Study|Death|6|||
129558989|NCT03264066|466341085|FG005|Overall Study|Death|1|||
129558990|NCT03264066|466341080|FG000|Overall Study|Lost to Follow-up|1|||
129558991|NCT03264066|466341081|FG001|Overall Study|Lost to Follow-up|0|||
129558992|NCT03264066|466341082|FG002|Overall Study|Lost to Follow-up|0|||
129558993|NCT03264066|466341083|FG003|Overall Study|Lost to Follow-up|0|||
129558994|NCT03264066|466341084|FG004|Overall Study|Lost to Follow-up|0|||
129558995|NCT03264066|466341085|FG005|Overall Study|Lost to Follow-up|0|||
129558996|NCT03264066|466341080|FG000|Overall Study|Progressive Disease|0|||
129558997|NCT03264066|466341081|FG001|Overall Study|Progressive Disease|2|||
129558998|NCT03264066|466341082|FG002|Overall Study|Progressive Disease|1|||
129558999|NCT03264066|466341083|FG003|Overall Study|Progressive Disease|0|||
129559000|NCT03264066|466341084|FG004|Overall Study|Progressive Disease|0|||
129559001|NCT03264066|466341085|FG005|Overall Study|Progressive Disease|0|||
129559002|NCT03264066|466341080|FG000|Overall Study|Study Terminated by Sponsor|5|||
129559003|NCT03264066|466341081|FG001|Overall Study|Study Terminated by Sponsor|5|||
129559004|NCT03264066|466341082|FG002|Overall Study|Study Terminated by Sponsor|8|||
129559005|NCT03264066|466341083|FG003|Overall Study|Study Terminated by Sponsor|5|||
129559006|NCT03264066|466341084|FG004|Overall Study|Study Terminated by Sponsor|1|||
129559007|NCT03264066|466341085|FG005|Overall Study|Study Terminated by Sponsor|2|||
129777679|NCT02541604|467151376|FG002|Overall Study|Study Terminated by Sponsor|2|||
129777680|NCT02541604|467151377|FG003|Overall Study|Study Terminated by Sponsor|1|||
129777681|NCT02541604|467151378|FG004|Overall Study|Study Terminated by Sponsor|0|||
129559008|NCT03264066|466341080|FG000|Overall Study|Withdrawal by Subject|1|||
129559009|NCT03264066|466341081|FG001|Overall Study|Withdrawal by Subject|0|||
129559010|NCT03264066|466341082|FG002|Overall Study|Withdrawal by Subject|0|||
129559011|NCT03264066|466341083|FG003|Overall Study|Withdrawal by Subject|5|||
129559012|NCT03264066|466341084|FG004|Overall Study|Withdrawal by Subject|0|||
129559013|NCT03264066|466341085|FG005|Overall Study|Withdrawal by Subject|0|||
129559014|NCT01193517|466341091|FG000|Overall Study|Early Progression|1|||
129559015|NCT01193517|466341092|FG001|Overall Study|Early Progression|0|||
129559016|NCT01193517|466341093|FG002|Overall Study|Early Progression|0|||
129559017|NCT02115256|466341094|FG000|Overall Study|Withdrawal by Subject|0|||
129559018|NCT02115256|466341095|FG001|Overall Study|Withdrawal by Subject|1|||
129559019|NCT03775681|466341098|FG000|Overall Study|Physician Decision|3|||
129559020|NCT01512979|466341103|FG000|Overall Study|Adverse Event|2|||
129559021|NCT01512979|466341104|FG001|Overall Study|Adverse Event|2|||
129559022|NCT01512979|466341103|FG000|Overall Study|Protocol Violation|1|||
129559023|NCT01512979|466341104|FG001|Overall Study|Protocol Violation|4|||
129559024|NCT01512979|466341103|FG000|Overall Study|Lost to Follow-up|2|||
129559025|NCT01512979|466341104|FG001|Overall Study|Lost to Follow-up|5|||
129559026|NCT01512979|466341103|FG000|Overall Study|Withdrawal by Subject|1|||
129559027|NCT01512979|466341104|FG001|Overall Study|Withdrawal by Subject|2|||
129559028|NCT01512979|466341103|FG000|Overall Study|Reason other than stated above|13|||
129559029|NCT01512979|466341104|FG001|Overall Study|Reason other than stated above|9|||
129559030|NCT00526890|466341108|FG000|Overall Study|Adverse Event|2|||
129559031|NCT03529955|466341109|FG000|Overall Study|Adverse Event|1|||
129559032|NCT03529955|466341109|FG000|Overall Study|Lack of Efficacy|1|||
129559033|NCT00580983|466341110|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
129559034|NCT02468557|466342349|FG000|Overall Study|Adverse Event|1|||
129559035|NCT02468557|466342349|FG000|Overall Study|Death|1|||
129559036|NCT02468557|466342349|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
129559037|NCT02468557|466342349|FG000|Overall Study|All Enrolled but Never Dosed|4|||
129559038|NCT00982410|466342350|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
129559039|NCT00982410|466342351|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
129559040|NCT00982410|466342350|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
129559041|NCT00982410|466342351|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
129559042|NCT00982410|466342350|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
129559043|NCT00982410|466342351|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
129559044|NCT00982410|466342350|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
129559045|NCT00982410|466342351|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
129559046|NCT00982410|466342350|FG000|6-month Follow-up Assessment|participant no transportation|1|||
129559047|NCT00982410|466342351|FG001|6-month Follow-up Assessment|participant no transportation|0|||
129559048|NCT00982410|466342350|FG000|6-month Follow-up Assessment|incarceration|0|||
129559049|NCT00982410|466342351|FG001|6-month Follow-up Assessment|incarceration|2|||
129559050|NCT00982410|466342350|FG000|6-month Follow-up Assessment|patent surgery|0|||
129559051|NCT00982410|466342351|FG001|6-month Follow-up Assessment|patent surgery|1|||
129559052|NCT00982410|466342350|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
129559053|NCT00982410|466342351|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
129559054|NCT00982410|466342350|FG000|12-month Follow-up Assessment|Death|0|||
129559055|NCT00982410|466342351|FG001|12-month Follow-up Assessment|Death|2|||
129559056|NCT00982410|466342350|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
129559057|NCT00982410|466342351|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
129559058|NCT00982410|466342350|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
129559059|NCT00982410|466342351|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
129559060|NCT00982410|466342350|FG000|12-month Follow-up Assessment|incarceration|2|||
129559061|NCT00982410|466342351|FG001|12-month Follow-up Assessment|incarceration|1|||
129559062|NCT00982410|466342350|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
129559063|NCT00982410|466342351|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
129559064|NCT01267266|466342352|FG000|Enrollment Phase|Withdrawal by Subject|2|||
129559065|NCT01267266|466342353|FG001|Enrollment Phase|Withdrawal by Subject|0|||
129559066|NCT01267266|466342352|FG000|Lead-in Phase|Lack of Efficacy|20|||
129559067|NCT01267266|466342353|FG001|Lead-in Phase|Lack of Efficacy|0|||
129559068|NCT01267266|466342352|FG000|Lead-in Phase|Adverse Event|2|||
129559069|NCT01267266|466342353|FG001|Lead-in Phase|Adverse Event|0|||
129559070|NCT01267266|466342352|FG000|Lead-in Phase|Withdrawal by Subject|1|||
129559071|NCT01267266|466342353|FG001|Lead-in Phase|Withdrawal by Subject|0|||
129559072|NCT01466686|466342357|FG000|Overall Study|Withdrawal by Subject|1|||
129559073|NCT02049359|466342359|FG000|Overall Study|Lost to Follow-up|26|||
129559074|NCT02049359|466342360|FG001|Overall Study|Lost to Follow-up|19|||
129559075|NCT01907087|466342361|FG000|Overall Study|Withdrawal by Subject|1|||
129559076|NCT03273387|466342362|FG000|Overall Study|Death|2|||
129559077|NCT03273387|466342363|FG001|Overall Study|Death|2|||
129559078|NCT03273387|466342362|FG000|Overall Study|Withdrawal by Subject|1|||
129559079|NCT03273387|466342363|FG001|Overall Study|Withdrawal by Subject|1|||
129559080|NCT05216978|466342364|FG000|Overall Study|Withdrawal by Subject|3|||
129559081|NCT05216978|466342364|FG000|Overall Study|Lost to Follow-up|5|||
129559082|NCT00658320|466342368|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
129559083|NCT00658320|466342369|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
129559084|NCT00658320|466342368|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
129559085|NCT00658320|466342369|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
129559086|NCT00658320|466342368|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
129559087|NCT00658320|466342369|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
129559088|NCT00658320|466342368|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
129559089|NCT00658320|466342369|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
129559090|NCT03907280|466342375|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
129559091|NCT03907280|466342376|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
129559092|NCT03907280|466342377|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
129559093|NCT01464827|466342380|FG000|Overall Study|Adverse Event|0|||
129559094|NCT01464827|466342381|FG001|Overall Study|Adverse Event|0|||
129559095|NCT01464827|466342382|FG002|Overall Study|Adverse Event|0|||
129559096|NCT01464827|466342383|FG003|Overall Study|Adverse Event|0|||
129559097|NCT01464827|466342384|FG004|Overall Study|Adverse Event|0|||
129559098|NCT01464827|466342385|FG005|Overall Study|Adverse Event|0|||
129559099|NCT01464827|466342386|FG006|Overall Study|Adverse Event|0|||
129559100|NCT01464827|466342387|FG007|Overall Study|Adverse Event|0|||
129559101|NCT01464827|466342388|FG008|Overall Study|Adverse Event|0|||
129559102|NCT01464827|466342389|FG009|Overall Study|Adverse Event|0|||
129559103|NCT01464827|466342390|FG010|Overall Study|Adverse Event|0|||
129559104|NCT01464827|466342391|FG011|Overall Study|Adverse Event|0|||
129559105|NCT01464827|466342392|FG012|Overall Study|Adverse Event|1|||
129559106|NCT01464827|466342393|FG013|Overall Study|Adverse Event|0|||
129559107|NCT01464827|466342380|FG000|Overall Study|Withdrawal by Subject|1|||
129559108|NCT01464827|466342381|FG001|Overall Study|Withdrawal by Subject|0|||
129559109|NCT01464827|466342382|FG002|Overall Study|Withdrawal by Subject|0|||
129559110|NCT01464827|466342383|FG003|Overall Study|Withdrawal by Subject|0|||
129559111|NCT01464827|466342384|FG004|Overall Study|Withdrawal by Subject|1|||
129559112|NCT01464827|466342385|FG005|Overall Study|Withdrawal by Subject|0|||
129559113|NCT01464827|466342386|FG006|Overall Study|Withdrawal by Subject|0|||
129559114|NCT01464827|466342387|FG007|Overall Study|Withdrawal by Subject|1|||
129559115|NCT01464827|466342388|FG008|Overall Study|Withdrawal by Subject|0|||
129559116|NCT01464827|466342389|FG009|Overall Study|Withdrawal by Subject|0|||
129559117|NCT01464827|466342390|FG010|Overall Study|Withdrawal by Subject|0|||
129559118|NCT01464827|466342391|FG011|Overall Study|Withdrawal by Subject|0|||
129559119|NCT01464827|466342392|FG012|Overall Study|Withdrawal by Subject|0|||
129559120|NCT01464827|466342393|FG013|Overall Study|Withdrawal by Subject|0|||
129559121|NCT01464827|466342380|FG000|Overall Study|Lost to Follow-up|0|||
129559122|NCT01464827|466342381|FG001|Overall Study|Lost to Follow-up|2|||
129559123|NCT01464827|466342382|FG002|Overall Study|Lost to Follow-up|0|||
129559124|NCT01464827|466342383|FG003|Overall Study|Lost to Follow-up|2|||
129559125|NCT01464827|466342384|FG004|Overall Study|Lost to Follow-up|3|||
129559126|NCT01464827|466342385|FG005|Overall Study|Lost to Follow-up|1|||
129559127|NCT01464827|466342386|FG006|Overall Study|Lost to Follow-up|2|||
129559128|NCT01464827|466342387|FG007|Overall Study|Lost to Follow-up|2|||
129559129|NCT01464827|466342388|FG008|Overall Study|Lost to Follow-up|0|||
129559130|NCT01464827|466342389|FG009|Overall Study|Lost to Follow-up|0|||
129559131|NCT01464827|466342390|FG010|Overall Study|Lost to Follow-up|0|||
129559132|NCT01464827|466342391|FG011|Overall Study|Lost to Follow-up|1|||
129559133|NCT01464827|466342392|FG012|Overall Study|Lost to Follow-up|0|||
129559134|NCT01464827|466342393|FG013|Overall Study|Lost to Follow-up|1|||
129559135|NCT01464827|466342380|FG000|Overall Study|Other|2|||
129559136|NCT01464827|466342381|FG001|Overall Study|Other|3|||
129559137|NCT01464827|466342382|FG002|Overall Study|Other|0|||
129559138|NCT01464827|466342383|FG003|Overall Study|Other|2|||
129559139|NCT01464827|466342384|FG004|Overall Study|Other|3|||
129559140|NCT01464827|466342385|FG005|Overall Study|Other|0|||
129559141|NCT01464827|466342386|FG006|Overall Study|Other|1|||
129559142|NCT01464827|466342387|FG007|Overall Study|Other|0|||
129559143|NCT01464827|466342388|FG008|Overall Study|Other|3|||
129559144|NCT01464827|466342389|FG009|Overall Study|Other|1|||
129559145|NCT01464827|466342390|FG010|Overall Study|Other|2|||
129777682|NCT02541604|467151379|FG005|Overall Study|Study Terminated by Sponsor|0|||
129777683|NCT02541604|467151380|FG006|Overall Study|Study Terminated by Sponsor|0|||
129559146|NCT01464827|466342391|FG011|Overall Study|Other|0|||
129559147|NCT01464827|466342392|FG012|Overall Study|Other|1|||
129559148|NCT01464827|466342393|FG013|Overall Study|Other|0|||
129559149|NCT01464827|466342380|FG000|Overall Study|Not Treated|0|||
129559150|NCT01464827|466342381|FG001|Overall Study|Not Treated|2|||
129559151|NCT01464827|466342382|FG002|Overall Study|Not Treated|0|||
129559152|NCT01464827|466342383|FG003|Overall Study|Not Treated|0|||
129559153|NCT01464827|466342384|FG004|Overall Study|Not Treated|1|||
129559154|NCT01464827|466342385|FG005|Overall Study|Not Treated|0|||
129559155|NCT01464827|466342386|FG006|Overall Study|Not Treated|1|||
129559156|NCT01464827|466342387|FG007|Overall Study|Not Treated|0|||
129559157|NCT01464827|466342388|FG008|Overall Study|Not Treated|0|||
129559158|NCT01464827|466342389|FG009|Overall Study|Not Treated|2|||
129559159|NCT01464827|466342390|FG010|Overall Study|Not Treated|0|||
129559160|NCT01464827|466342391|FG011|Overall Study|Not Treated|1|||
129559161|NCT01464827|466342392|FG012|Overall Study|Not Treated|0|||
129559162|NCT01464827|466342393|FG013|Overall Study|Not Treated|2|||
129559163|NCT05487456|466342394|FG000|Overall Study|Withdrawal by Subject|0|||
129559164|NCT05487456|466342395|FG001|Overall Study|Withdrawal by Subject|0|||
129559165|NCT05487456|466342396|FG002|Overall Study|Withdrawal by Subject|1|||
129559166|NCT05487456|466342397|FG003|Overall Study|Withdrawal by Subject|0|||
129559167|NCT03882047|466342400|FG000|Overall Study|Adverse Event|0|||
129559168|NCT03882047|466342401|FG001|Overall Study|Adverse Event|2|||
129559169|NCT03882047|466342402|FG002|Overall Study|Adverse Event|2|||
129559170|NCT03882047|466342400|FG000|Overall Study|Treatment Failure|3|||
129559171|NCT03882047|466342401|FG001|Overall Study|Treatment Failure|3|||
129559172|NCT03882047|466342402|FG002|Overall Study|Treatment Failure|12|||
129559173|NCT03882047|466342400|FG000|Overall Study|Lost to Follow-up|0|||
129559174|NCT03882047|466342401|FG001|Overall Study|Lost to Follow-up|1|||
129559175|NCT03882047|466342402|FG002|Overall Study|Lost to Follow-up|0|||
129559176|NCT03882047|466342400|FG000|Overall Study|Did Not Wish to Continue|1|||
129559177|NCT03882047|466342401|FG001|Overall Study|Did Not Wish to Continue|4|||
129559178|NCT03882047|466342402|FG002|Overall Study|Did Not Wish to Continue|1|||
129559179|NCT03882047|466342400|FG000|Overall Study|Noncompliance With Protocol|2|||
129559180|NCT03882047|466342401|FG001|Overall Study|Noncompliance With Protocol|0|||
129559181|NCT03882047|466342402|FG002|Overall Study|Noncompliance With Protocol|0|||
129559182|NCT03882047|466342400|FG000|Overall Study|Did Not Meet Eligibility|0|||
129559183|NCT03882047|466342401|FG001|Overall Study|Did Not Meet Eligibility|0|||
129559184|NCT03882047|466342402|FG002|Overall Study|Did Not Meet Eligibility|1|||
129559185|NCT00441584|466342403|FG000|Overall Study|Lack of Efficacy|79|||
129559186|NCT00441584|466342403|FG000|Overall Study|Withdrawal by Subject|8|||
129559187|NCT00441584|466342403|FG000|Overall Study|Adverse Event|6|||
129559188|NCT00441584|466342403|FG000|Overall Study|Protocol Violation|5|||
129559189|NCT00441584|466342403|FG000|Overall Study|Lost to Follow-up|4|||
129559190|NCT00441584|466342403|FG000|Overall Study|Failure to meet eligibility criteria|3|||
129559191|NCT02022007|466342406|FG000|Overall Study|Withdrawal by Subject|1|||
129559192|NCT02022007|466342407|FG001|Overall Study|Withdrawal by Subject|1|||
129559193|NCT02022007|466342408|FG002|Overall Study|Withdrawal by Subject|1|||
129559194|NCT02022007|466342406|FG000|Overall Study|Noncompliant|0|||
129559195|NCT02022007|466342407|FG001|Overall Study|Noncompliant|0|||
129559196|NCT02022007|466342408|FG002|Overall Study|Noncompliant|1|||
129559197|NCT01107535|466342409|FG000|Overall Study|Death|5|||
129559198|NCT01214603|466342410|FG000|Overall Study|Adverse Event|0|||
129559199|NCT01214603|466342411|FG001|Overall Study|Adverse Event|0|||
129559200|NCT01214603|466342412|FG002|Overall Study|Adverse Event|1|||
129559201|NCT01214603|466342410|FG000|Overall Study|Death|1|||
129559202|NCT01214603|466342411|FG001|Overall Study|Death|0|||
129559203|NCT01214603|466342412|FG002|Overall Study|Death|0|||
129559204|NCT01214603|466342410|FG000|Overall Study|Progressive Disease|4|||
129777684|NCT02541604|467151381|FG007|Overall Study|Study Terminated by Sponsor|0|||
129559205|NCT01214603|466342411|FG001|Overall Study|Progressive Disease|1|||
129559206|NCT01214603|466342412|FG002|Overall Study|Progressive Disease|3|||
129559207|NCT01388647|466342413|FG000|Overall Study|Adverse Event|1|||
129559208|NCT01388647|466342414|FG001|Overall Study|Adverse Event|2|||
129559209|NCT03567057|466342415|FG000|Overall Study|Adverse Event|56|||
129559210|NCT03567057|466342416|FG001|Overall Study|Adverse Event|53|||
129559211|NCT03567057|466342417|FG002|Overall Study|Adverse Event|28|||
129559212|NCT03567057|466342415|FG000|Overall Study|Withdrawal by Subject|22|||
129559213|NCT03567057|466342416|FG001|Overall Study|Withdrawal by Subject|24|||
129559214|NCT03567057|466342417|FG002|Overall Study|Withdrawal by Subject|13|||
129559215|NCT03567057|466342415|FG000|Overall Study|Lost to Follow-up|3|||
129559216|NCT03567057|466342416|FG001|Overall Study|Lost to Follow-up|5|||
129777685|NCT02541604|467151382|FG008|Overall Study|Study Terminated by Sponsor|0|||
129559217|NCT03567057|466342417|FG002|Overall Study|Lost to Follow-up|2|||
129559218|NCT03567057|466342415|FG000|Overall Study|COVID-19 pandemic|4|||
129559219|NCT03567057|466342416|FG001|Overall Study|COVID-19 pandemic|3|||
129559220|NCT03567057|466342417|FG002|Overall Study|COVID-19 pandemic|0|||
129777686|NCT02541604|467151383|FG009|Overall Study|Study Terminated by Sponsor|0|||
129777687|NCT02541604|467151384|FG010|Overall Study|Study Terminated by Sponsor|0|||
129777688|NCT02541604|467151385|FG011|Overall Study|Study Terminated by Sponsor|0|||
129777689|NCT02541604|467151374|FG000|Overall Study|Medical condition may jeopardize safety|0|||
129777690|NCT02541604|467151375|FG001|Overall Study|Medical condition may jeopardize safety|0|||
129777691|NCT02541604|467151376|FG002|Overall Study|Medical condition may jeopardize safety|0|||
129777692|NCT02541604|467151377|FG003|Overall Study|Medical condition may jeopardize safety|0|||
129777693|NCT02541604|467151378|FG004|Overall Study|Medical condition may jeopardize safety|0|||
129777694|NCT02541604|467151379|FG005|Overall Study|Medical condition may jeopardize safety|0|||
129777695|NCT02541604|467151380|FG006|Overall Study|Medical condition may jeopardize safety|0|||
129777696|NCT02541604|467151381|FG007|Overall Study|Medical condition may jeopardize safety|1|||
129777697|NCT02541604|467151382|FG008|Overall Study|Medical condition may jeopardize safety|0|||
129777698|NCT02541604|467151383|FG009|Overall Study|Medical condition may jeopardize safety|0|||
129777699|NCT02541604|467151384|FG010|Overall Study|Medical condition may jeopardize safety|0|||
129777700|NCT02541604|467151385|FG011|Overall Study|Medical condition may jeopardize safety|0|||
129777701|NCT02752165|467151392|FG000|Overall Study|Withdrawal by Subject|6|||
129777702|NCT02752165|467151393|FG001|Overall Study|Withdrawal by Subject|6|||
129777703|NCT02752165|467151392|FG000|Overall Study|Protocol Violation|6|||
129777704|NCT02752165|467151393|FG001|Overall Study|Protocol Violation|5|||
129777705|NCT02752165|467151392|FG000|Overall Study|Lost to Follow-up|33|||
129777706|NCT02752165|467151393|FG001|Overall Study|Lost to Follow-up|38|||
129777707|NCT01704599|467151395|FG000|Overall Study|Adverse Event|1|||
129777708|NCT02840461|467151396|FG000|Overall Study|Adverse Event|1|||
129777709|NCT02840461|467151397|FG001|Overall Study|Adverse Event|5|||
129777710|NCT02840461|467151398|FG002|Overall Study|Adverse Event|3|||
129777711|NCT02840461|467151396|FG000|Overall Study|Lost to Follow-up|10|||
129777712|NCT02840461|467151397|FG001|Overall Study|Lost to Follow-up|7|||
129777713|NCT02840461|467151398|FG002|Overall Study|Lost to Follow-up|6|||
129777714|NCT02840461|467151396|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
129777715|NCT02840461|467151397|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
129777716|NCT02840461|467151398|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
129777717|NCT02840461|467151396|FG000|Overall Study|Protocol Violation|2|||
129777718|NCT02840461|467151397|FG001|Overall Study|Protocol Violation|3|||
129777719|NCT02840461|467151398|FG002|Overall Study|Protocol Violation|1|||
129777720|NCT02840461|467151396|FG000|Overall Study|Withdrawal by Subject|10|||
129777721|NCT02840461|467151397|FG001|Overall Study|Withdrawal by Subject|6|||
129777722|NCT02840461|467151398|FG002|Overall Study|Withdrawal by Subject|2|||
129777723|NCT02840461|467151396|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
129777724|NCT02840461|467151397|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
129777725|NCT02840461|467151398|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
129777726|NCT01737502|467151401|FG000|Phase I|Disease progression|2|||
129777727|NCT01737502|467151402|FG001|Phase I|Disease progression|3|||
129777728|NCT01737502|467151401|FG000|Phase I|Complicating disease|1|||
129777729|NCT01737502|467151402|FG001|Phase I|Complicating disease|0|||
129777730|NCT01737502|467151401|FG000|Phase II|Adverse Event|0|||
129777731|NCT01737502|467151402|FG001|Phase II|Adverse Event|3|||
129777732|NCT01737502|467151401|FG000|Phase II|Disease progression|0|||
129777733|NCT01737502|467151402|FG001|Phase II|Disease progression|18|||
129777734|NCT01737502|467151401|FG000|Phase II|Death|0|||
129777735|NCT01737502|467151402|FG001|Phase II|Death|1|||
129777736|NCT01737502|467151401|FG000|Phase II|Transition to hospice care|0|||
129777737|NCT01737502|467151402|FG001|Phase II|Transition to hospice care|1|||
129777738|NCT04672655|467151406|FG000|Overall Study|Lost to Follow-up|12|||
129777739|NCT04672655|467151407|FG001|Overall Study|Lost to Follow-up|17|||
129777740|NCT04672655|467151406|FG000|Overall Study|Withdrawal by Subject|1|||
129777741|NCT04672655|467151407|FG001|Overall Study|Withdrawal by Subject|0|||
129777742|NCT04672655|467151406|FG000|Overall Study|Withdrawal by Study|1|||
129777743|NCT04672655|467151407|FG001|Overall Study|Withdrawal by Study|0|||
129777744|NCT00494676|467151408|FG000|Allocation|Withdrawal by Subject|2|||
129777745|NCT00494676|467151409|FG001|Allocation|Withdrawal by Subject|4|||
129777746|NCT00494676|467151408|FG000|First Intervention|Withdrawal by Subject|1|||
129777747|NCT00494676|467151409|FG001|First Intervention|Withdrawal by Subject|3|||
129777748|NCT00494676|467151408|FG000|Second Intervention|Withdrawal by Subject|1|||
129777749|NCT00494676|467151409|FG001|Second Intervention|Withdrawal by Subject|1|||
129777750|NCT05767749|467151413|FG000|Overall Study|Withdrawal by Subject|0|||
129777751|NCT05767749|467151414|FG001|Overall Study|Withdrawal by Subject|0|||
129777752|NCT05767749|467151415|FG002|Overall Study|Withdrawal by Subject|2|||
129777753|NCT05767749|467151416|FG003|Overall Study|Withdrawal by Subject|2|||
129777754|NCT05767749|467151417|FG004|Overall Study|Withdrawal by Subject|2|||
129777755|NCT05767749|467151418|FG005|Overall Study|Withdrawal by Subject|2|||
129777756|NCT02067676|467152414|FG000|Overall Study|Withdrawal by Subject|1|||
129777757|NCT02067676|467152415|FG001|Overall Study|Withdrawal by Subject|0|||
129777758|NCT02067676|467152416|FG002|Overall Study|Withdrawal by Subject|0|||
129777759|NCT02067676|467152417|FG003|Overall Study|Withdrawal by Subject|0|||
129559221|NCT03567057|466342415|FG000|Overall Study|Non-compliance with study drug|4|||
129559222|NCT03567057|466342416|FG001|Overall Study|Non-compliance with study drug|2|||
129559223|NCT03567057|466342417|FG002|Overall Study|Non-compliance with study drug|0|||
129559224|NCT03567057|466342415|FG000|Overall Study|Lack of Efficacy|3|||
129559225|NCT03567057|466342416|FG001|Overall Study|Lack of Efficacy|0|||
129559226|NCT03567057|466342417|FG002|Overall Study|Lack of Efficacy|1|||
129559227|NCT03567057|466342415|FG000|Overall Study|Death|1|||
129559228|NCT03567057|466342416|FG001|Overall Study|Death|0|||
129559229|NCT03567057|466342417|FG002|Overall Study|Death|0|||
129559230|NCT03567057|466342415|FG000|Overall Study|Physician Decision|1|||
129559231|NCT03567057|466342416|FG001|Overall Study|Physician Decision|0|||
129559232|NCT03567057|466342417|FG002|Overall Study|Physician Decision|0|||
129559233|NCT03567057|466342415|FG000|Overall Study|Unstable medical condition|1|||
129559234|NCT03567057|466342416|FG001|Overall Study|Unstable medical condition|0|||
129559235|NCT03567057|466342417|FG002|Overall Study|Unstable medical condition|0|||
129559236|NCT03567057|466342415|FG000|Overall Study|Medical history event|0|||
129559237|NCT03567057|466342416|FG001|Overall Study|Medical history event|0|||
129559238|NCT03567057|466342417|FG002|Overall Study|Medical history event|1|||
129559239|NCT03567057|466342415|FG000|Overall Study|Other|0|||
129559240|NCT03567057|466342416|FG001|Overall Study|Other|0|||
129559241|NCT03567057|466342417|FG002|Overall Study|Other|1|||
129559242|NCT00490061|466342418|FG000|Overall Study|Physician Decision|1|||
129559243|NCT00886483|466342423|FG000|Overall Study|Lost to Follow-up|0|||
129559244|NCT00886483|466342424|FG001|Overall Study|Lost to Follow-up|1|||
129559245|NCT00886483|466342423|FG000|Overall Study|Pursue medications|1|||
129559246|NCT00886483|466342424|FG001|Overall Study|Pursue medications|2|||
129559247|NCT00886483|466342423|FG000|Overall Study|Distance to center, poor grades|1|||
129559248|NCT00886483|466342424|FG001|Overall Study|Distance to center, poor grades|0|||
129559249|NCT00192296|466342427|FG000|Overall Study|Withdrawal by Subject|0|||
129559250|NCT00192296|466342428|FG001|Overall Study|Withdrawal by Subject|1|||
129559251|NCT00192296|466342429|FG002|Overall Study|Withdrawal by Subject|0|||
129559252|NCT00192296|466342430|FG003|Overall Study|Withdrawal by Subject|0|||
129559253|NCT03465891|466342431|FG000|Overall Study|Withdrawal by Subject|0|||
129559254|NCT03465891|466342432|FG001|Overall Study|Withdrawal by Subject|1|||
129559255|NCT03465891|466342431|FG000|Overall Study|Disease progression|1|||
129559256|NCT03465891|466342432|FG001|Overall Study|Disease progression|0|||
129559257|NCT01001169|466342433|FG000|Overall Study|Withdrawal by Subject|2|||
129559258|NCT01001169|466342434|FG001|Overall Study|Withdrawal by Subject|1|||
129559259|NCT02536378|466342439|FG000|Overall Study|Physician Decision|0|||
129559260|NCT02536378|466342440|FG001|Overall Study|Physician Decision|2|||
129559261|NCT02536378|466342439|FG000|Overall Study|Withdrawal by Subject|0|||
129559262|NCT02536378|466342440|FG001|Overall Study|Withdrawal by Subject|1|||
129559263|NCT02536378|466342439|FG000|Overall Study|Death|1|||
129559264|NCT02536378|466342440|FG001|Overall Study|Death|2|||
129559265|NCT02536378|466342439|FG000|Overall Study|Patient refused further follow up|6|||
129559266|NCT02536378|466342440|FG001|Overall Study|Patient refused further follow up|2|||
129559267|NCT00798889|466342441|FG000|Overall Study|Adverse Event|53|||
129559268|NCT00798889|466342441|FG000|Overall Study|Protocol Violation|2|||
129559269|NCT00798889|466342441|FG000|Overall Study|Withdrawal by Subject|31|||
129559270|NCT00798889|466342441|FG000|Overall Study|Lost to Follow-up|1|||
129559271|NCT00798889|466342441|FG000|Overall Study|Lack of Efficacy|213|||
129559272|NCT00798889|466342441|FG000|Overall Study|Decision of Sponsor|11|||
129559273|NCT00798889|466342441|FG000|Overall Study|Enrolled, Not treated|3|||
129559274|NCT00358826|466342442|FG000|Core Study|Adverse Event|1|||
129559275|NCT00358826|466342443|FG001|Core Study|Adverse Event|3|||
129559276|NCT00358826|466342444|FG002|Core Study|Adverse Event|1|||
129559277|NCT00358826|466342445|FG003|Core Study|Adverse Event|1|||
129559278|NCT00358826|466342446|FG004|Core Study|Adverse Event|0|||
129559279|NCT00358826|466342447|FG005|Core Study|Adverse Event|0|||
129777760|NCT02067676|467152418|FG004|Overall Study|Withdrawal by Subject|0|||
129777761|NCT02067676|467152419|FG005|Overall Study|Withdrawal by Subject|0|||
129777762|NCT00996333|467152420|FG000|Overall Study|Screen failure|1|||
129559280|NCT00358826|466342448|FG006|Core Study|Adverse Event|0|||
129559281|NCT00358826|466342449|FG007|Core Study|Adverse Event|0|||
129777763|NCT00996333|467152420|FG000|Overall Study|Withdrawal by Subject|1|||
129559282|NCT00358826|466342442|FG000|Core Study|Withdrawal by Subject|2|||
129559283|NCT00358826|466342443|FG001|Core Study|Withdrawal by Subject|2|||
129559284|NCT00358826|466342444|FG002|Core Study|Withdrawal by Subject|0|||
129559285|NCT00358826|466342445|FG003|Core Study|Withdrawal by Subject|0|||
129559286|NCT00358826|466342446|FG004|Core Study|Withdrawal by Subject|0|||
129559287|NCT00358826|466342447|FG005|Core Study|Withdrawal by Subject|0|||
129777764|NCT00996333|467152420|FG000|Overall Study|Death|4|||
129559288|NCT00358826|466342448|FG006|Core Study|Withdrawal by Subject|0|||
129559289|NCT00358826|466342449|FG007|Core Study|Withdrawal by Subject|0|||
129559290|NCT00358826|466342442|FG000|Core Study|Lost to Follow-up|0|||
129559291|NCT00358826|466342443|FG001|Core Study|Lost to Follow-up|0|||
129559292|NCT00358826|466342444|FG002|Core Study|Lost to Follow-up|0|||
129559293|NCT00358826|466342445|FG003|Core Study|Lost to Follow-up|1|||
129559294|NCT00358826|466342446|FG004|Core Study|Lost to Follow-up|0|||
129559295|NCT00358826|466342447|FG005|Core Study|Lost to Follow-up|0|||
129559296|NCT00358826|466342448|FG006|Core Study|Lost to Follow-up|0|||
129559297|NCT00358826|466342449|FG007|Core Study|Lost to Follow-up|0|||
129559298|NCT00358826|466342442|FG000|Core Study|Physician Decision|0|||
129559299|NCT00358826|466342443|FG001|Core Study|Physician Decision|0|||
129559300|NCT00358826|466342444|FG002|Core Study|Physician Decision|1|||
129559301|NCT00358826|466342445|FG003|Core Study|Physician Decision|0|||
129559302|NCT00358826|466342446|FG004|Core Study|Physician Decision|0|||
129559303|NCT00358826|466342447|FG005|Core Study|Physician Decision|0|||
129559304|NCT00358826|466342448|FG006|Core Study|Physician Decision|0|||
129559305|NCT00358826|466342449|FG007|Core Study|Physician Decision|0|||
129559306|NCT00358826|466342442|FG000|MDCT Substudy|Adverse Event|0|||
129559307|NCT00358826|466342443|FG001|MDCT Substudy|Adverse Event|0|||
129559308|NCT00358826|466342444|FG002|MDCT Substudy|Adverse Event|0|||
129559309|NCT00358826|466342445|FG003|MDCT Substudy|Adverse Event|0|||
129559310|NCT00358826|466342446|FG004|MDCT Substudy|Adverse Event|1|||
129559311|NCT00358826|466342447|FG005|MDCT Substudy|Adverse Event|0|||
129559312|NCT00358826|466342448|FG006|MDCT Substudy|Adverse Event|0|||
129559313|NCT00358826|466342449|FG007|MDCT Substudy|Adverse Event|0|||
129559314|NCT00358826|466342442|FG000|MDCT Substudy|Lost to Follow-up|0|||
129559315|NCT00358826|466342443|FG001|MDCT Substudy|Lost to Follow-up|0|||
129559316|NCT00358826|466342444|FG002|MDCT Substudy|Lost to Follow-up|0|||
129559317|NCT00358826|466342445|FG003|MDCT Substudy|Lost to Follow-up|0|||
129559318|NCT00358826|466342446|FG004|MDCT Substudy|Lost to Follow-up|0|||
129559319|NCT00358826|466342447|FG005|MDCT Substudy|Lost to Follow-up|1|||
129559320|NCT00358826|466342448|FG006|MDCT Substudy|Lost to Follow-up|0|||
129559321|NCT00358826|466342449|FG007|MDCT Substudy|Lost to Follow-up|0|||
129559322|NCT00358826|466342442|FG000|MDCT Substudy|Withdrawal by Subject|0|||
129559323|NCT00358826|466342443|FG001|MDCT Substudy|Withdrawal by Subject|0|||
129559324|NCT00358826|466342444|FG002|MDCT Substudy|Withdrawal by Subject|0|||
129559325|NCT00358826|466342445|FG003|MDCT Substudy|Withdrawal by Subject|0|||
129559326|NCT00358826|466342446|FG004|MDCT Substudy|Withdrawal by Subject|0|||
129559327|NCT00358826|466342447|FG005|MDCT Substudy|Withdrawal by Subject|1|||
129559328|NCT00358826|466342448|FG006|MDCT Substudy|Withdrawal by Subject|0|||
129559329|NCT00358826|466342449|FG007|MDCT Substudy|Withdrawal by Subject|0|||
129559330|NCT00903383|466342453|FG000|Overall Study|Adverse Event|1|||
129559331|NCT00903383|466342454|FG001|Overall Study|Adverse Event|2|||
129559332|NCT00903383|466342455|FG002|Overall Study|Adverse Event|3|||
129559333|NCT00903383|466342456|FG003|Overall Study|Adverse Event|1|||
129559334|NCT00903383|466342453|FG000|Overall Study|Physician Decision|1|||
129559335|NCT00903383|466342454|FG001|Overall Study|Physician Decision|2|||
129559336|NCT00903383|466342455|FG002|Overall Study|Physician Decision|0|||
129559337|NCT00903383|466342456|FG003|Overall Study|Physician Decision|0|||
129559338|NCT00903383|466342453|FG000|Overall Study|Lost to Follow-up|0|||
129559339|NCT00903383|466342454|FG001|Overall Study|Lost to Follow-up|0|||
129559340|NCT00903383|466342455|FG002|Overall Study|Lost to Follow-up|0|||
129559341|NCT00903383|466342456|FG003|Overall Study|Lost to Follow-up|1|||
129559342|NCT00903383|466342453|FG000|Overall Study|Decision of Sponsor|1|||
129559343|NCT00903383|466342454|FG001|Overall Study|Decision of Sponsor|0|||
129559344|NCT00903383|466342455|FG002|Overall Study|Decision of Sponsor|0|||
129559345|NCT00903383|466342456|FG003|Overall Study|Decision of Sponsor|0|||
129559346|NCT00903383|466342453|FG000|Overall Study|Withdrawal by Subject|4|||
129559347|NCT00903383|466342454|FG001|Overall Study|Withdrawal by Subject|1|||
129559348|NCT00903383|466342455|FG002|Overall Study|Withdrawal by Subject|0|||
129559349|NCT00903383|466342456|FG003|Overall Study|Withdrawal by Subject|2|||
129559350|NCT00903383|466342453|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
129559351|NCT00903383|466342454|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
129559352|NCT00903383|466342455|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
129559353|NCT00903383|466342456|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
129559354|NCT00903383|466342453|FG000|Overall Study|Patient Decision|0|||
129559355|NCT00903383|466342454|FG001|Overall Study|Patient Decision|0|||
129559356|NCT00903383|466342455|FG002|Overall Study|Patient Decision|0|||
129559357|NCT00903383|466342456|FG003|Overall Study|Patient Decision|1|||
129559358|NCT01821625|466342459|FG000|Overall Study|Withdrawal by Subject|2|||
129559359|NCT01821625|466342459|FG000|Overall Study|Lack of Efficacy|2|||
129559360|NCT01821625|466342459|FG000|Overall Study|Adverse Event|1|||
129559361|NCT01821625|466342459|FG000|Overall Study|Medical contraindication|1|||
129559362|NCT01716754|466342464|FG000|Overall Study|Death|0|||
129559363|NCT01716754|466342465|FG001|Overall Study|Death|0|||
129559364|NCT01716754|466342466|FG002|Overall Study|Death|0|||
129559365|NCT01716754|466342467|FG003|Overall Study|Death|1|||
129559366|NCT01716754|466342464|FG000|Overall Study|Protocol deviation|0|||
129559367|NCT01716754|466342465|FG001|Overall Study|Protocol deviation|2|||
129559368|NCT01716754|466342466|FG002|Overall Study|Protocol deviation|7|||
129559369|NCT01716754|466342467|FG003|Overall Study|Protocol deviation|2|||
129559370|NCT01716754|466342464|FG000|Overall Study|Non-compliance with study treatment|0|||
129559371|NCT01716754|466342465|FG001|Overall Study|Non-compliance with study treatment|0|||
129559372|NCT01716754|466342466|FG002|Overall Study|Non-compliance with study treatment|1|||
129777765|NCT00996333|467152420|FG000|Overall Study|Adverse Event|1|||
129777766|NCT00996333|467152420|FG000|Overall Study|Physician Decision|1|||
129777767|NCT00996333|467152420|FG000|Overall Study|Other|5|||
129777768|NCT04939415|467152428|FG000|Overall Study|Withdrawal by Subject|1|||
129777769|NCT04939415|467152429|FG001|Overall Study|Withdrawal by Subject|3|||
129777770|NCT04939415|467152428|FG000|Overall Study|Lost to Follow-up|0|||
129777771|NCT04939415|467152429|FG001|Overall Study|Lost to Follow-up|2|||
129777772|NCT00369265|467152430|FG000|Overall Study|Study terminated|4|||
129777773|NCT00369265|467152431|FG001|Overall Study|Study terminated|7|||
129777774|NCT00068419|467152434|FG000|Overall Study|Adverse Event|3|||
129777775|NCT00068419|467152434|FG000|Overall Study|Lack of Efficacy|24|||
129777776|NCT00068419|467152434|FG000|Overall Study|Lost to Follow-up|1|||
129777777|NCT00068419|467152434|FG000|Overall Study|Physician Decision|7|||
129777778|NCT00068419|467152434|FG000|Overall Study|Withdrawal by Subject|14|||
129777779|NCT00068419|467152434|FG000|Overall Study|Ineligible|11|||
129777780|NCT02506244|467152437|FG000|Overall Study|Did not undergo active monitoring|458|||
129777781|NCT02506244|467152438|FG001|Overall Study|Did not undergo active monitoring|459|||
129777782|NCT02506244|467152439|FG002|Overall Study|Did not undergo active monitoring|0|||
129777783|NCT01160822|467152440|FG000|Overall Study|Adverse Event|0|||
129777784|NCT01160822|467152441|FG001|Overall Study|Adverse Event|0|||
129777785|NCT01160822|467152442|FG002|Overall Study|Adverse Event|0|||
129777786|NCT01160822|467152443|FG003|Overall Study|Adverse Event|0|||
129777787|NCT01160822|467152444|FG004|Overall Study|Adverse Event|1|||
129777788|NCT01160822|467152445|FG005|Overall Study|Adverse Event|2|||
129777789|NCT01160822|467152446|FG006|Overall Study|Adverse Event|5|||
129777790|NCT01160822|467152440|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129777791|NCT01160822|467152441|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129777792|NCT01160822|467152442|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129777793|NCT01160822|467152443|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129777794|NCT01160822|467152444|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
129777795|NCT01160822|467152445|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
129777796|NCT01160822|467152446|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
129777797|NCT01160822|467152440|FG000|Overall Study|Withdrawal by Subject|0|||
129777798|NCT01160822|467152441|FG001|Overall Study|Withdrawal by Subject|0|||
129777799|NCT01160822|467152442|FG002|Overall Study|Withdrawal by Subject|0|||
129777800|NCT01160822|467152443|FG003|Overall Study|Withdrawal by Subject|0|||
129777801|NCT01160822|467152444|FG004|Overall Study|Withdrawal by Subject|0|||
129777802|NCT01160822|467152445|FG005|Overall Study|Withdrawal by Subject|0|||
129777803|NCT01160822|467152446|FG006|Overall Study|Withdrawal by Subject|1|||
129777804|NCT01160822|467152440|FG000|Overall Study|Lost to Follow-up|0|||
129777805|NCT01160822|467152441|FG001|Overall Study|Lost to Follow-up|0|||
129777806|NCT01160822|467152442|FG002|Overall Study|Lost to Follow-up|0|||
129777807|NCT01160822|467152443|FG003|Overall Study|Lost to Follow-up|0|||
129777808|NCT01160822|467152444|FG004|Overall Study|Lost to Follow-up|1|||
129777809|NCT01160822|467152445|FG005|Overall Study|Lost to Follow-up|0|||
129777810|NCT01160822|467152446|FG006|Overall Study|Lost to Follow-up|0|||
129777811|NCT01160822|467152440|FG000|Overall Study|Administrative problems|0|||
129777812|NCT01160822|467152441|FG001|Overall Study|Administrative problems|0|||
129777813|NCT01160822|467152442|FG002|Overall Study|Administrative problems|0|||
129777814|NCT01160822|467152443|FG003|Overall Study|Administrative problems|0|||
129777815|NCT01160822|467152444|FG004|Overall Study|Administrative problems|1|||
129777816|NCT01160822|467152445|FG005|Overall Study|Administrative problems|0|||
129777817|NCT01160822|467152446|FG006|Overall Study|Administrative problems|0|||
129777818|NCT01160822|467152440|FG000|Overall Study|Protocol deviation|0|||
129777819|NCT01160822|467152441|FG001|Overall Study|Protocol deviation|0|||
129777820|NCT01160822|467152442|FG002|Overall Study|Protocol deviation|0|||
129777821|NCT01160822|467152443|FG003|Overall Study|Protocol deviation|0|||
129777822|NCT01160822|467152444|FG004|Overall Study|Protocol deviation|2|||
129777823|NCT01160822|467152445|FG005|Overall Study|Protocol deviation|0|||
129777824|NCT01160822|467152446|FG006|Overall Study|Protocol deviation|0|||
129777825|NCT00092443|467152447|FG000|Overall Study|Adverse Event|9|||
129777826|NCT00092443|467152448|FG001|Overall Study|Adverse Event|13|||
129777827|NCT00092443|467152447|FG000|Overall Study|Lost to Follow-up|7|||
129777828|NCT00092443|467152448|FG001|Overall Study|Lost to Follow-up|3|||
129777829|NCT00092443|467152447|FG000|Overall Study|Protocol Violation|11|||
129884515|NCT02293837|467536435|FG003|Overall Study|Participant ill and could not be infused|0|||
129559373|NCT01716754|466342467|FG003|Overall Study|Non-compliance with study treatment|0|||
129559374|NCT01716754|466342464|FG000|Overall Study|Physician Decision|1|||
129559375|NCT01716754|466342465|FG001|Overall Study|Physician Decision|0|||
129559376|NCT01716754|466342466|FG002|Overall Study|Physician Decision|0|||
129559377|NCT01716754|466342467|FG003|Overall Study|Physician Decision|0|||
129559378|NCT01716754|466342464|FG000|Overall Study|Lost to Follow-up|1|||
129559379|NCT01716754|466342465|FG001|Overall Study|Lost to Follow-up|0|||
129559380|NCT01716754|466342466|FG002|Overall Study|Lost to Follow-up|0|||
129559381|NCT01716754|466342467|FG003|Overall Study|Lost to Follow-up|1|||
129559382|NCT01716754|466342464|FG000|Overall Study|Adverse Event|4|||
129559383|NCT01716754|466342465|FG001|Overall Study|Adverse Event|2|||
129559384|NCT01716754|466342466|FG002|Overall Study|Adverse Event|2|||
129559385|NCT01716754|466342467|FG003|Overall Study|Adverse Event|1|||
129559386|NCT01716754|466342464|FG000|Overall Study|Withdrawal by Subject|5|||
129559387|NCT01716754|466342465|FG001|Overall Study|Withdrawal by Subject|0|||
129559388|NCT01716754|466342466|FG002|Overall Study|Withdrawal by Subject|4|||
129559389|NCT01716754|466342467|FG003|Overall Study|Withdrawal by Subject|3|||
129559390|NCT00481247|466342468|FG000|Overall Study|Death|0|||
129559391|NCT00481247|466342469|FG001|Overall Study|Death|1|||
129559392|NCT00481247|466342468|FG000|Overall Study|Disease progression|18|||
129559393|NCT00481247|466342469|FG001|Overall Study|Disease progression|22|||
129559394|NCT00481247|466342468|FG000|Overall Study|Intolerance|42|||
129559395|NCT00481247|466342469|FG001|Overall Study|Intolerance|17|||
129559396|NCT00481247|466342468|FG000|Overall Study|Treatment failure|10|||
129559397|NCT00481247|466342469|FG001|Overall Study|Treatment failure|14|||
129559398|NCT00481247|466342468|FG000|Overall Study|AE unrelated to study drug|13|||
129559399|NCT00481247|466342469|FG001|Overall Study|AE unrelated to study drug|4|||
129777830|NCT00092443|467152448|FG001|Overall Study|Protocol Violation|9|||
129559400|NCT00481247|466342468|FG000|Overall Study|Withdrawal by Subject|8|||
129559401|NCT00481247|466342469|FG001|Overall Study|Withdrawal by Subject|13|||
129559402|NCT00481247|466342468|FG000|Overall Study|Pregnancy|2|||
129559403|NCT00481247|466342469|FG001|Overall Study|Pregnancy|1|||
129777831|NCT00092443|467152447|FG000|Overall Study|Withdrawal by Subject|9|||
129559404|NCT00481247|466342468|FG000|Overall Study|Lost to Follow-up|1|||
129559405|NCT00481247|466342469|FG001|Overall Study|Lost to Follow-up|2|||
129559406|NCT00481247|466342468|FG000|Overall Study|Poor compliance/noncompliance|1|||
129559407|NCT00481247|466342469|FG001|Overall Study|Poor compliance/noncompliance|7|||
129559408|NCT00481247|466342468|FG000|Overall Study|Administrative reason by sponsor|157|||
129777832|NCT00092443|467152448|FG001|Overall Study|Withdrawal by Subject|11|||
129777833|NCT00092443|467152447|FG000|Overall Study|Moved|5|||
129777834|NCT00092443|467152448|FG001|Overall Study|Moved|5|||
129777835|NCT00092443|467152447|FG000|Overall Study|Other|17|||
129777836|NCT00092443|467152448|FG001|Overall Study|Other|13|||
129777837|NCT00314795|467152452|FG000|Overall Study|Adverse Event|8|||
129777838|NCT00314795|467152452|FG000|Overall Study|Death|4|||
129777839|NCT00314795|467152452|FG000|Overall Study|Reason not Specified|3|||
129777840|NCT00314795|467152452|FG000|Overall Study|Renal Transplant|3|||
129777841|NCT00314795|467152452|FG000|Overall Study|Participants Withdrew Consent|2|||
129777842|NCT04717336|467152454|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
129777843|NCT04717336|467152455|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
129777844|NCT04717336|467152454|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
129777845|NCT04717336|467152455|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
129777846|NCT01500720|467152462|FG000|Overall Study|Randomized But Not Treated|1|||
129777847|NCT01500720|467152463|FG001|Overall Study|Randomized But Not Treated|1|||
129777848|NCT01500720|467152462|FG000|Overall Study|Other|4|||
129777849|NCT01500720|467152463|FG001|Overall Study|Other|8|||
129777850|NCT02527421|467152464|FG000|Overall Study|Withdrawal by Subject|1|||
129777851|NCT02527421|467152465|FG001|Overall Study|Withdrawal by Subject|0|||
129777852|NCT00806819|467152466|FG000|Overall Study|progressive disease (modified RECIST )|217|||
129777853|NCT00806819|467152467|FG001|Overall Study|progressive disease (modified RECIST )|216|||
129777854|NCT00806819|467152466|FG000|Overall Study|Worsening or AE of underlying disease|18|||
129777855|NCT00806819|467152467|FG001|Overall Study|Worsening or AE of underlying disease|25|||
129777856|NCT00806819|467152466|FG000|Overall Study|Other AE|38|||
129777857|NCT00806819|467152467|FG001|Overall Study|Other AE|40|||
129777858|NCT00806819|467152466|FG000|Overall Study|Protocol Violation|9|||
129777859|NCT00806819|467152467|FG001|Overall Study|Protocol Violation|4|||
129777860|NCT00806819|467152466|FG000|Overall Study|Lost to Follow-up|1|||
129777861|NCT00806819|467152467|FG001|Overall Study|Lost to Follow-up|0|||
129777862|NCT00806819|467152466|FG000|Overall Study|Withdrawal by Subject|32|||
129777863|NCT00806819|467152467|FG001|Overall Study|Withdrawal by Subject|29|||
129777864|NCT00806819|467152466|FG000|Overall Study|Not treated|6|||
129777865|NCT00806819|467152467|FG001|Overall Study|Not treated|3|||
129777866|NCT00806819|467152466|FG000|Overall Study|Reasons other than stated above|25|||
129777867|NCT00806819|467152467|FG001|Overall Study|Reasons other than stated above|41|||
129777868|NCT01615029|467152473|FG000|Overall Study|Adverse Event|0|||
129777869|NCT01615029|467152474|FG001|Overall Study|Adverse Event|0|||
129777870|NCT01615029|467152475|FG002|Overall Study|Adverse Event|0|||
129777871|NCT01615029|467152476|FG003|Overall Study|Adverse Event|0|||
129777872|NCT01615029|467152477|FG004|Overall Study|Adverse Event|1|||
129777873|NCT01615029|467152473|FG000|Overall Study|Death|0|||
129777874|NCT01615029|467152474|FG001|Overall Study|Death|0|||
129777875|NCT01615029|467152475|FG002|Overall Study|Death|0|||
129777876|NCT01615029|467152476|FG003|Overall Study|Death|0|||
129777877|NCT01615029|467152477|FG004|Overall Study|Death|1|||
129777878|NCT01615029|467152473|FG000|Overall Study|Lost to Follow-up|0|||
129777879|NCT01615029|467152474|FG001|Overall Study|Lost to Follow-up|0|||
129777880|NCT01615029|467152475|FG002|Overall Study|Lost to Follow-up|0|||
129777881|NCT01615029|467152476|FG003|Overall Study|Lost to Follow-up|0|||
129777882|NCT01615029|467152477|FG004|Overall Study|Lost to Follow-up|1|||
129777883|NCT01615029|467152473|FG000|Overall Study|Progressive disease|2|||
129777884|NCT01615029|467152474|FG001|Overall Study|Progressive disease|1|||
129777885|NCT01615029|467152475|FG002|Overall Study|Progressive disease|1|||
129777886|NCT01615029|467152476|FG003|Overall Study|Progressive disease|1|||
129777887|NCT01615029|467152477|FG004|Overall Study|Progressive disease|5|||
129777888|NCT01615029|467152473|FG000|Overall Study|Physician Decision|0|||
129777889|NCT01615029|467152474|FG001|Overall Study|Physician Decision|0|||
129777890|NCT01615029|467152475|FG002|Overall Study|Physician Decision|0|||
129777891|NCT01615029|467152476|FG003|Overall Study|Physician Decision|0|||
129777892|NCT01615029|467152477|FG004|Overall Study|Physician Decision|1|||
129777893|NCT01615029|467152473|FG000|Overall Study|Ongoing|1|||
129777894|NCT01615029|467152474|FG001|Overall Study|Ongoing|2|||
129777895|NCT01615029|467152475|FG002|Overall Study|Ongoing|3|||
129777896|NCT01615029|467152476|FG003|Overall Study|Ongoing|2|||
129777897|NCT01615029|467152477|FG004|Overall Study|Ongoing|23|||
129777898|NCT00802945|467152483|FG000|Overall Study|Death|27|||
129777899|NCT00802945|467152484|FG001|Overall Study|Death|23|||
129777900|NCT00802945|467152483|FG000|Overall Study|Terminated by sponsor|8|||
129777901|NCT00802945|467152484|FG001|Overall Study|Terminated by sponsor|12|||
129777902|NCT03843541|467152485|FG000|Overall Study|Adverse Event|4|||
129777903|NCT03843541|467152486|FG001|Overall Study|Adverse Event|2|||
129777904|NCT03843541|467152487|FG002|Overall Study|Adverse Event|3|||
129777905|NCT03843541|467152485|FG000|Overall Study|Death|1|||
129777906|NCT03843541|467152486|FG001|Overall Study|Death|0|||
129777907|NCT03843541|467152487|FG002|Overall Study|Death|0|||
129777908|NCT03843541|467152485|FG000|Overall Study|Lack of adherence to study medication|0|||
129777909|NCT03843541|467152486|FG001|Overall Study|Lack of adherence to study medication|0|||
129777910|NCT03843541|467152487|FG002|Overall Study|Lack of adherence to study medication|1|||
129777911|NCT03843541|467152485|FG000|Overall Study|Physician Decision|1|||
129777912|NCT03843541|467152486|FG001|Overall Study|Physician Decision|2|||
129777913|NCT03843541|467152487|FG002|Overall Study|Physician Decision|2|||
129777914|NCT03843541|467152485|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
129777915|NCT03843541|467152486|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
129777916|NCT03843541|467152487|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
129777917|NCT03843541|467152485|FG000|Overall Study|Withdrawal by Subject|6|||
129777918|NCT03843541|467152486|FG001|Overall Study|Withdrawal by Subject|9|||
129777919|NCT03843541|467152487|FG002|Overall Study|Withdrawal by Subject|7|||
129777920|NCT03843541|467152485|FG000|Overall Study|Administration of rescue mucolytic|0|||
129777921|NCT03843541|467152486|FG001|Overall Study|Administration of rescue mucolytic|0|||
129777922|NCT03843541|467152487|FG002|Overall Study|Administration of rescue mucolytic|1|||
129777923|NCT03843541|467152485|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
129777924|NCT03843541|467152486|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
129777925|NCT03843541|467152487|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
129777926|NCT05307692|467152491|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
129777927|NCT05307692|467152492|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
129777928|NCT05307692|467152493|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
129777929|NCT05307692|467152494|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
129777930|NCT05307692|467152491|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
129777931|NCT05307692|467152492|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
129777932|NCT05307692|467152493|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
129559409|NCT00481247|466342469|FG001|Overall Study|Administrative reason by sponsor|162|||
129777933|NCT05307692|467152494|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
129777934|NCT05307692|467152491|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
129777935|NCT05307692|467152492|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
129777936|NCT05307692|467152493|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
129777937|NCT05307692|467152494|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
129777938|NCT05307692|467152491|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
129777939|NCT05307692|467152492|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
129777940|NCT05307692|467152493|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
129777941|NCT05307692|467152494|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
129777942|NCT05307692|467152491|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
129559410|NCT00481247|466342468|FG000|Overall Study|Varied|6|||
129559411|NCT00481247|466342469|FG001|Overall Study|Varied|15|||
129559412|NCT00481247|466342468|FG000|Overall Study|Did not receive treatment|1|||
129559413|NCT00481247|466342469|FG001|Overall Study|Did not receive treatment|2|||
129559414|NCT02535000|466342471|FG000|Overall Study|Cancellation of surgery.|1|||
129559415|NCT02535000|466342472|FG001|Overall Study|Cancellation of surgery.|2|||
129559416|NCT04317781|466342473|FG000|Overall Study|Adverse Event|1|||
129559417|NCT04317781|466342473|FG000|Overall Study|Disease relapse|1|||
129559418|NCT04317781|466342473|FG000|Overall Study|Withdrawal by Subject|1|||
129559419|NCT01620489|466342474|FG000|Overall Study|Adverse Event|17|||
129559420|NCT01620489|466342475|FG001|Overall Study|Adverse Event|4|||
129777943|NCT05307692|467152492|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
129777944|NCT05307692|467152493|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
129777945|NCT05307692|467152494|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
129777946|NCT05307692|467152491|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
129559421|NCT01620489|466342474|FG000|Overall Study|Protocol Violation|0|||
129559422|NCT01620489|466342475|FG001|Overall Study|Protocol Violation|3|||
129559423|NCT01620489|466342474|FG000|Overall Study|Withdrawal Criteria|17|||
129777947|NCT05307692|467152492|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
129800234|NCT02891161|467236267|FG001|Follow up|Symptomatic deterioration|1|||
129687285|NCT02573467|466812128|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
129687286|NCT02573467|466812129|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
129687287|NCT02573467|466812130|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
129559424|NCT01620489|466342475|FG001|Overall Study|Withdrawal Criteria|25|||
129559425|NCT01620489|466342474|FG000|Overall Study|Unclassified|1|||
129559426|NCT01620489|466342475|FG001|Overall Study|Unclassified|2|||
129559427|NCT01738581|466342476|FG000|Overall Study|Lost to Follow-up|1|||
129559428|NCT01738581|466342477|FG001|Overall Study|Lost to Follow-up|0|||
129559429|NCT00696709|466342478|FG000|Overall Study|Withdrawal by Subject|1|||
129559430|NCT00696709|466342479|FG001|Overall Study|Withdrawal by Subject|2|||
129559431|NCT00696709|466342480|FG002|Overall Study|Withdrawal by Subject|1|||
129559432|NCT00696709|466342481|FG003|Overall Study|Withdrawal by Subject|4|||
129559433|NCT00696709|466342482|FG004|Overall Study|Withdrawal by Subject|3|||
129559434|NCT00696709|466342478|FG000|Overall Study|Protocol Violation|1|||
129559435|NCT00696709|466342479|FG001|Overall Study|Protocol Violation|0|||
129559436|NCT00696709|466342480|FG002|Overall Study|Protocol Violation|0|||
129559437|NCT00696709|466342481|FG003|Overall Study|Protocol Violation|0|||
129559438|NCT00696709|466342482|FG004|Overall Study|Protocol Violation|0|||
129559439|NCT00696709|466342478|FG000|Overall Study|Lost to Follow-up|1|||
129559440|NCT00696709|466342479|FG001|Overall Study|Lost to Follow-up|1|||
129559441|NCT00696709|466342480|FG002|Overall Study|Lost to Follow-up|0|||
129559442|NCT00696709|466342481|FG003|Overall Study|Lost to Follow-up|0|||
129559443|NCT00696709|466342482|FG004|Overall Study|Lost to Follow-up|0|||
129559444|NCT00696709|466342478|FG000|Overall Study|Adverse Event|0|||
129559445|NCT00696709|466342479|FG001|Overall Study|Adverse Event|0|||
129559446|NCT00696709|466342480|FG002|Overall Study|Adverse Event|0|||
129559447|NCT00696709|466342481|FG003|Overall Study|Adverse Event|1|||
129559448|NCT00696709|466342482|FG004|Overall Study|Adverse Event|0|||
129559449|NCT00321711|466342483|FG000|Part A|Adverse Event|3|||
129559450|NCT00321711|466342484|FG001|Part A|Adverse Event|3|||
129559451|NCT00321711|466342485|FG002|Part A|Adverse Event|2|||
129559452|NCT00321711|466342486|FG003|Part A|Adverse Event|0|||
129559453|NCT00321711|466342487|FG004|Part A|Adverse Event|0|||
129559454|NCT00321711|466342483|FG000|Part A|Withdrawal by Subject|1|||
129559455|NCT00321711|466342484|FG001|Part A|Withdrawal by Subject|1|||
129559456|NCT00321711|466342485|FG002|Part A|Withdrawal by Subject|1|||
129559457|NCT00321711|466342486|FG003|Part A|Withdrawal by Subject|0|||
129559458|NCT00321711|466342487|FG004|Part A|Withdrawal by Subject|0|||
129559459|NCT00321711|466342483|FG000|Part A|Disease progression|0|||
129559460|NCT00321711|466342484|FG001|Part A|Disease progression|1|||
129559461|NCT00321711|466342485|FG002|Part A|Disease progression|0|||
129559462|NCT00321711|466342486|FG003|Part A|Disease progression|0|||
129559463|NCT00321711|466342487|FG004|Part A|Disease progression|0|||
129559464|NCT00321711|466342483|FG000|Part A|Requirement for alternative therapy|0|||
129559465|NCT00321711|466342484|FG001|Part A|Requirement for alternative therapy|2|||
129559466|NCT00321711|466342485|FG002|Part A|Requirement for alternative therapy|1|||
129559467|NCT00321711|466342486|FG003|Part A|Requirement for alternative therapy|0|||
129559468|NCT00321711|466342487|FG004|Part A|Requirement for alternative therapy|0|||
129559469|NCT00321711|466342483|FG000|Part A|Physician Decision|0|||
129559470|NCT00321711|466342484|FG001|Part A|Physician Decision|1|||
129559471|NCT00321711|466342485|FG002|Part A|Physician Decision|3|||
129559472|NCT00321711|466342486|FG003|Part A|Physician Decision|0|||
129559473|NCT00321711|466342487|FG004|Part A|Physician Decision|0|||
129559474|NCT00321711|466342483|FG000|Part A|Other|1|||
129559475|NCT00321711|466342484|FG001|Part A|Other|2|||
129559476|NCT00321711|466342485|FG002|Part A|Other|3|||
129559477|NCT00321711|466342486|FG003|Part A|Other|0|||
129559478|NCT00321711|466342487|FG004|Part A|Other|0|||
129559479|NCT00321711|466342483|FG000|Part A|Protocol deviation|0|||
129559480|NCT00321711|466342484|FG001|Part A|Protocol deviation|0|||
129559481|NCT00321711|466342485|FG002|Part A|Protocol deviation|1|||
129559482|NCT00321711|466342486|FG003|Part A|Protocol deviation|0|||
129559483|NCT00321711|466342487|FG004|Part A|Protocol deviation|0|||
129559484|NCT00321711|466342483|FG000|Part B|Noncompliance|0|||
129559485|NCT00321711|466342484|FG001|Part B|Noncompliance|0|||
129559486|NCT00321711|466342485|FG002|Part B|Noncompliance|0|||
129559487|NCT00321711|466342486|FG003|Part B|Noncompliance|0|||
129559488|NCT00321711|466342487|FG004|Part B|Noncompliance|1|||
129687288|NCT02573467|466812127|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
129687289|NCT02573467|466812128|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
129800235|NCT02891161|467236266|FG000|Follow up|Study terminated|0|||
129559489|NCT00321711|466342483|FG000|Part B|Adverse Event|0|||
129559490|NCT00321711|466342484|FG001|Part B|Adverse Event|0|||
129559491|NCT00321711|466342485|FG002|Part B|Adverse Event|0|||
129559492|NCT00321711|466342486|FG003|Part B|Adverse Event|2|||
129559493|NCT00321711|466342487|FG004|Part B|Adverse Event|1|||
129559494|NCT00321711|466342483|FG000|Part B|Disease progression|0|||
129559495|NCT00321711|466342484|FG001|Part B|Disease progression|0|||
129559496|NCT00321711|466342485|FG002|Part B|Disease progression|0|||
129559497|NCT00321711|466342486|FG003|Part B|Disease progression|1|||
129559498|NCT00321711|466342487|FG004|Part B|Disease progression|0|||
129559499|NCT00321711|466342483|FG000|Part B|Physician Decision|0|||
129559500|NCT00321711|466342484|FG001|Part B|Physician Decision|0|||
129559501|NCT00321711|466342485|FG002|Part B|Physician Decision|0|||
129559502|NCT00321711|466342486|FG003|Part B|Physician Decision|1|||
129559503|NCT00321711|466342487|FG004|Part B|Physician Decision|2|||
129559504|NCT00321711|466342483|FG000|Part B|Death|0|||
129559505|NCT00321711|466342484|FG001|Part B|Death|0|||
129559506|NCT00321711|466342485|FG002|Part B|Death|0|||
129559507|NCT00321711|466342486|FG003|Part B|Death|2|||
129559508|NCT00321711|466342487|FG004|Part B|Death|1|||
129559509|NCT01484028|466342492|FG000|Period 1|Lost to Follow-up|0|||
129559510|NCT01484028|466342493|FG001|Period 1|Lost to Follow-up|1|||
129559511|NCT01484028|466342494|FG002|Period 1|Lost to Follow-up|0|||
129559512|NCT01484028|466342495|FG003|Period 1|Lost to Follow-up|0|||
129559513|NCT01484028|466342492|FG000|Period 1|Non-Compliance to Protocol|0|||
129559514|NCT01484028|466342493|FG001|Period 1|Non-Compliance to Protocol|1|||
129559515|NCT01484028|466342494|FG002|Period 1|Non-Compliance to Protocol|0|||
129559516|NCT01484028|466342495|FG003|Period 1|Non-Compliance to Protocol|1|||
129559517|NCT01484028|466342492|FG000|Period 1|Lens Discomfort|0|||
129559518|NCT01484028|466342493|FG001|Period 1|Lens Discomfort|1|||
129559519|NCT01484028|466342494|FG002|Period 1|Lens Discomfort|0|||
129559520|NCT01484028|466342495|FG003|Period 1|Lens Discomfort|0|||
129559521|NCT01855126|466342500|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
129559522|NCT01855126|466342501|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
129559523|NCT01855126|466342500|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129559524|NCT01855126|466342501|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129559525|NCT01748890|466342512|FG000|Overall Study|Insufficient recruitment for analysis|4|||
129559526|NCT03740100|466342513|FG000|Overall Study|Adverse Event|1|||
129559527|NCT03740100|466342513|FG000|Overall Study|Death|1|||
129559528|NCT03387059|466342515|FG000|Overall Study|Study termination|5|||
129559529|NCT03387059|466342516|FG001|Overall Study|Study termination|4|||
129559530|NCT01859702|466342517|FG000|Overall Study|Protocol deviation|3|||
129559531|NCT01859702|466342517|FG000|Overall Study|Adverse Event|2|||
129559532|NCT04014959|466344215|FG000|Baseline MRI and Assessments|Physician Decision|2|||
129559533|NCT04014959|466344215|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
129559534|NCT04014959|466344215|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
129559535|NCT03997448|466344220|FG000|Study Treatment|Disease Progression|1|||
129559536|NCT03997448|466344220|FG000|Study Treatment|Symptomatic Deterioration|1|||
129559537|NCT03997448|466344220|FG000|Follow up|Death|2|||
129559538|NCT03997448|466344220|FG000|Follow up|study terminated|1|||
129559539|NCT02482805|466344221|FG000|Overall Study|Lost to Follow-up|4|||
129559540|NCT02482805|466344222|FG001|Overall Study|Lost to Follow-up|4|||
129559541|NCT02482805|466344223|FG002|Overall Study|Lost to Follow-up|0|||
129559542|NCT00633152|466344235|FG000|Overall Study|Adverse Event|1|||
129559543|NCT00633152|466344236|FG001|Overall Study|Adverse Event|0|||
129559544|NCT00633152|466344235|FG000|Overall Study|Randomized, did not receive study drug|5|||
129559545|NCT00633152|466344236|FG001|Overall Study|Randomized, did not receive study drug|2|||
129559546|NCT00633152|466344235|FG000|Overall Study|Withdrawal by Subject|1|||
129559547|NCT00633152|466344236|FG001|Overall Study|Withdrawal by Subject|1|||
129559548|NCT00633152|466344235|FG000|Overall Study|Lost to Follow-up|4|||
129559549|NCT00633152|466344236|FG001|Overall Study|Lost to Follow-up|1|||
129559550|NCT00633152|466344235|FG000|Overall Study|Miscellaneous Other|3|||
129559551|NCT00633152|466344236|FG001|Overall Study|Miscellaneous Other|2|||
129559552|NCT02180061|466344237|FG000|Overall Study|Adverse Event|4|||
129559553|NCT02180061|466344238|FG001|Overall Study|Adverse Event|2|||
129559554|NCT02180061|466344237|FG000|Overall Study|Clinical Progression|5|||
129559555|NCT02180061|466344238|FG001|Overall Study|Clinical Progression|1|||
129559556|NCT02180061|466344237|FG000|Overall Study|Progressive Disease|15|||
129559557|NCT02180061|466344238|FG001|Overall Study|Progressive Disease|5|||
129559558|NCT02180061|466344237|FG000|Overall Study|Physician Decision|1|||
129559559|NCT02180061|466344238|FG001|Overall Study|Physician Decision|0|||
129559560|NCT01007916|466344255|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
129559561|NCT01007916|466344256|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
129559562|NCT01007916|466344255|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
129559563|NCT01007916|466344256|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
129559564|NCT02040428|466344260|FG000|Overall Study|Death|4|||
129559565|NCT02040428|466344261|FG001|Overall Study|Death|3|||
129777948|NCT05307692|467152493|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
129777949|NCT05307692|467152494|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
129559566|NCT02040428|466344260|FG000|Overall Study|Withdrawal by Subject|1|||
129559567|NCT02040428|466344261|FG001|Overall Study|Withdrawal by Subject|1|||
129559568|NCT01165996|466344275|FG000|Overall Study|Death|1|||
129559569|NCT01165996|466344275|FG000|Overall Study|Physician Decision|1|||
129559570|NCT01927757|466344276|FG000|Overall Study|Withdrawal by Subject|14|||
129559571|NCT01927757|466344276|FG000|Overall Study|Lost to Follow-up|2|||
129559572|NCT01927757|466344276|FG000|Overall Study|Decision by Sponsor|2|||
129559573|NCT01927757|466344276|FG000|Overall Study|Other|1|||
129559574|NCT01927757|466344276|FG000|Overall Study|Ethical Reasons|4|||
129559575|NCT00268346|466344277|FG000|Overall Study|Adverse Event|0|||
129559576|NCT00268346|466344278|FG001|Overall Study|Adverse Event|1|||
129559577|NCT00268346|466344277|FG000|Overall Study|Death|0|||
129559578|NCT00268346|466344278|FG001|Overall Study|Death|1|||
129559579|NCT00268346|466344277|FG000|Overall Study|Withdrawal by Subject|0|||
129559580|NCT00268346|466344278|FG001|Overall Study|Withdrawal by Subject|1|||
129559581|NCT00294723|466344279|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
129559582|NCT00294723|466344280|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
129559583|NCT00294723|466344281|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
129559584|NCT00294723|466344279|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
129559585|NCT00294723|466344280|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
129559586|NCT00294723|466344281|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
129559587|NCT00294723|466344279|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
129559588|NCT00294723|466344280|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
129559589|NCT00294723|466344281|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
129559590|NCT00294723|466344279|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
129559591|NCT00294723|466344280|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
129559592|NCT00294723|466344281|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
129559593|NCT00294723|466344279|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
129559594|NCT00294723|466344280|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
129559595|NCT00294723|466344281|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
129559596|NCT00294723|466344279|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
129559597|NCT00294723|466344280|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
129559598|NCT00294723|466344281|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
129559599|NCT00294723|466344279|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
129559600|NCT00294723|466344280|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
129559601|NCT00294723|466344281|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
129559602|NCT00294723|466344279|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
129559603|NCT00294723|466344280|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
129559604|NCT00294723|466344281|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
129559605|NCT00294723|466344279|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
129559606|NCT00294723|466344280|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
129559607|NCT00294723|466344281|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
129559608|NCT00294723|466344279|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
129559609|NCT00294723|466344280|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
129559610|NCT00294723|466344281|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
129559611|NCT00294723|466344279|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
129559612|NCT00294723|466344280|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
129559613|NCT00294723|466344281|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
129559614|NCT00294723|466344279|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
129559615|NCT00294723|466344280|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
129559616|NCT00294723|466344281|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
129559617|NCT01958281|466344282|FG000|Overall Study|Lack of Efficacy|5|||
129559618|NCT01958281|466344283|FG001|Overall Study|Lack of Efficacy|2|||
129559619|NCT01958281|466344284|FG002|Overall Study|Lack of Efficacy|0|||
129559620|NCT01958281|466344282|FG000|Overall Study|Adverse Event|0|||
129559621|NCT01958281|466344283|FG001|Overall Study|Adverse Event|2|||
129559622|NCT01958281|466344284|FG002|Overall Study|Adverse Event|0|||
129559623|NCT01958281|466344282|FG000|Overall Study|Withdrew Consent|1|||
129559624|NCT01958281|466344283|FG001|Overall Study|Withdrew Consent|0|||
129559625|NCT01958281|466344284|FG002|Overall Study|Withdrew Consent|0|||
129687290|NCT02573467|466812129|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
129687291|NCT02573467|466812130|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
129687292|NCT02573467|466812127|FG000|Post-treatment Follow up Epoch|Death|1|||
129687293|NCT02573467|466812128|FG001|Post-treatment Follow up Epoch|Death|1|||
129687294|NCT02573467|466812129|FG002|Post-treatment Follow up Epoch|Death|0|||
129687295|NCT02573467|466812130|FG003|Post-treatment Follow up Epoch|Death|1|||
129687296|NCT02573467|466812127|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
129687297|NCT02573467|466812128|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
129687298|NCT02573467|466812129|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
129687299|NCT02573467|466812130|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
129687300|NCT02573467|466812127|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
129687301|NCT02573467|466812128|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
129687302|NCT02573467|466812129|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
129687303|NCT02573467|466812130|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
129687304|NCT00923702|466812131|FG000|Overall Study|Ongoing enrollment|0|||
129559626|NCT02784106|466344285|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
129559627|NCT02784106|466344286|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
129559628|NCT02784106|466344287|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129559629|NCT02784106|466344288|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129559630|NCT02784106|466344285|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129559631|NCT02784106|466344286|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129559632|NCT02784106|466344287|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129559633|NCT02784106|466344288|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129559634|NCT02784106|466344285|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
129559635|NCT02784106|466344286|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
129559636|NCT02784106|466344287|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
129559637|NCT02784106|466344288|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
129559638|NCT02784106|466344285|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
129559639|NCT02784106|466344286|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129559640|NCT02784106|466344287|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129559641|NCT02784106|466344288|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129559642|NCT02784106|466344285|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
129559643|NCT02784106|466344286|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
129559644|NCT02784106|466344287|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
129559645|NCT02784106|466344288|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
129559646|NCT02784106|466344285|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
129559647|NCT02784106|466344286|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
129559648|NCT02784106|466344287|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
129559649|NCT02784106|466344288|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
129559650|NCT03222141|466344291|FG000|Overall Study|Death|15|||
129559651|NCT03222141|466344291|FG000|Overall Study|Lost to Follow-up|3|||
129559652|NCT01333033|466344297|FG000|Overall Study|Ineligible|0|||
129559653|NCT01333033|466344298|FG001|Overall Study|Ineligible|0|||
129559654|NCT01333033|466344299|FG002|Overall Study|Ineligible|0|||
129559655|NCT01333033|466344300|FG003|Overall Study|Ineligible|0|||
129559656|NCT01333033|466344301|FG004|Overall Study|Ineligible|6|||
129559657|NCT01333033|466344302|FG005|Overall Study|Ineligible|8|||
129559658|NCT01333033|466344297|FG000|Overall Study|Withdrawal by Subject|0|||
129559659|NCT01333033|466344298|FG001|Overall Study|Withdrawal by Subject|0|||
129559660|NCT01333033|466344299|FG002|Overall Study|Withdrawal by Subject|0|||
129559661|NCT01333033|466344300|FG003|Overall Study|Withdrawal by Subject|0|||
129559662|NCT01333033|466344301|FG004|Overall Study|Withdrawal by Subject|4|||
129559663|NCT01333033|466344302|FG005|Overall Study|Withdrawal by Subject|2|||
129559664|NCT01333033|466344297|FG000|Overall Study|PET inevaluable|0|||
129559665|NCT01333033|466344298|FG001|Overall Study|PET inevaluable|0|||
129559666|NCT01333033|466344299|FG002|Overall Study|PET inevaluable|0|||
129559667|NCT01333033|466344300|FG003|Overall Study|PET inevaluable|0|||
129559668|NCT01333033|466344301|FG004|Overall Study|PET inevaluable|2|||
129559669|NCT01333033|466344302|FG005|Overall Study|PET inevaluable|4|||
129559670|NCT01333033|466344297|FG000|Overall Study|Adverse Event|0|||
129559671|NCT01333033|466344298|FG001|Overall Study|Adverse Event|0|||
129559672|NCT01333033|466344299|FG002|Overall Study|Adverse Event|0|||
129559673|NCT01333033|466344300|FG003|Overall Study|Adverse Event|0|||
129559674|NCT01333033|466344301|FG004|Overall Study|Adverse Event|2|||
129559675|NCT01333033|466344302|FG005|Overall Study|Adverse Event|1|||
129559676|NCT01333033|466344297|FG000|Overall Study|Progression|0|||
129559677|NCT01333033|466344298|FG001|Overall Study|Progression|0|||
129559678|NCT01333033|466344299|FG002|Overall Study|Progression|0|||
129559679|NCT01333033|466344300|FG003|Overall Study|Progression|0|||
129559680|NCT01333033|466344301|FG004|Overall Study|Progression|0|||
129559681|NCT01333033|466344302|FG005|Overall Study|Progression|1|||
129559682|NCT01333033|466344297|FG000|Overall Study|MD Decision|0|||
129559683|NCT01333033|466344298|FG001|Overall Study|MD Decision|0|||
129559684|NCT01333033|466344299|FG002|Overall Study|MD Decision|0|||
129687305|NCT00923702|466812132|FG001|Overall Study|Ongoing enrollment|0|||
129687306|NCT00923702|466812133|FG002|Overall Study|Ongoing enrollment|0|||
129687307|NCT00923702|466812134|FG003|Overall Study|Ongoing enrollment|0|||
129559685|NCT01333033|466344300|FG003|Overall Study|MD Decision|0|||
129559686|NCT01333033|466344301|FG004|Overall Study|MD Decision|0|||
129559687|NCT01333033|466344302|FG005|Overall Study|MD Decision|2|||
129559688|NCT03687125|466344303|FG000|Overall Study|Progressive Disease|2|||
129559689|NCT03687125|466344304|FG001|Overall Study|Progressive Disease|1|||
129559690|NCT03687125|466344303|FG000|Overall Study|Protocol Violation|1|||
129559691|NCT03687125|466344304|FG001|Overall Study|Protocol Violation|0|||
129559692|NCT01992107|466344307|FG000|Overall Study|Administrative reasons|2|||
129559693|NCT01992107|466344308|FG001|Overall Study|Administrative reasons|0|||
129559694|NCT01992107|466344309|FG002|Overall Study|Administrative reasons|0|||
129559695|NCT01992107|466344307|FG000|Overall Study|Adverse Event|0|||
129559696|NCT01992107|466344308|FG001|Overall Study|Adverse Event|1|||
129559697|NCT01992107|466344309|FG002|Overall Study|Adverse Event|0|||
129559698|NCT01992107|466344307|FG000|Overall Study|Lost to Follow-up|46|||
129559699|NCT01992107|466344308|FG001|Overall Study|Lost to Follow-up|22|||
129559700|NCT01992107|466344309|FG002|Overall Study|Lost to Follow-up|26|||
129559701|NCT01992107|466344307|FG000|Overall Study|noncompliance and were unavailable|7|||
129559702|NCT01992107|466344308|FG001|Overall Study|noncompliance and were unavailable|3|||
129559703|NCT01992107|466344309|FG002|Overall Study|noncompliance and were unavailable|2|||
129559704|NCT01992107|466344307|FG000|Overall Study|Withdrawal by Subject|13|||
129559705|NCT01992107|466344308|FG001|Overall Study|Withdrawal by Subject|7|||
129559706|NCT01992107|466344309|FG002|Overall Study|Withdrawal by Subject|8|||
129559707|NCT02087046|466344310|FG000|Overall Study|Adverse Event|4|||
129559708|NCT02087046|466344310|FG000|Overall Study|Death|1|||
129559709|NCT02087046|466344310|FG000|Overall Study|Lost to Follow-up|3|||
129559710|NCT02087046|466344310|FG000|Overall Study|Withdrawal by Subject|2|||
129559711|NCT02087046|466344310|FG000|Overall Study|Physician Decision|1|||
129559712|NCT02444533|466344311|FG000|Overall Study|Not able to complete forms|0|||
129559713|NCT02444533|466344312|FG001|Overall Study|Not able to complete forms|2|||
129559714|NCT02444533|466344311|FG000|Overall Study|Only gave post-procedure complications|2|||
129559715|NCT02444533|466344312|FG001|Overall Study|Only gave post-procedure complications|2|||
129559716|NCT01155583|466344313|FG000|Phase I|Screen failure - did not start treatment|0|||
129559717|NCT01155583|466344314|FG001|Phase I|Screen failure - did not start treatment|0|||
129559718|NCT01155583|466344315|FG002|Phase I|Screen failure - did not start treatment|0|||
129559719|NCT01155583|466344316|FG003|Phase I|Screen failure - did not start treatment|0|||
129559720|NCT01155583|466344317|FG004|Phase I|Screen failure - did not start treatment|1|||
129559721|NCT01155583|466344318|FG005|Phase I|Screen failure - did not start treatment|0|||
129559722|NCT01155583|466344319|FG006|Phase I|Screen failure - did not start treatment|0|||
129559723|NCT01155583|466344320|FG007|Phase I|Screen failure - did not start treatment|2|||
129559724|NCT01155583|466344321|FG008|Phase I|Screen failure - did not start treatment|0|||
129559725|NCT01155583|466344313|FG000|Phase I|Withdrawal by Subject|0|||
129559726|NCT01155583|466344314|FG001|Phase I|Withdrawal by Subject|0|||
129559727|NCT01155583|466344315|FG002|Phase I|Withdrawal by Subject|0|||
129559728|NCT01155583|466344316|FG003|Phase I|Withdrawal by Subject|0|||
129559729|NCT01155583|466344317|FG004|Phase I|Withdrawal by Subject|0|||
129559730|NCT01155583|466344318|FG005|Phase I|Withdrawal by Subject|0|||
129559731|NCT01155583|466344319|FG006|Phase I|Withdrawal by Subject|0|||
129559732|NCT01155583|466344320|FG007|Phase I|Withdrawal by Subject|1|||
129559733|NCT01155583|466344321|FG008|Phase I|Withdrawal by Subject|0|||
129559734|NCT00952484|466344322|FG000|Overall Study|Withdrawal by Subject|0|||
129559735|NCT00952484|466344323|FG001|Overall Study|Withdrawal by Subject|1|||
129559736|NCT00952484|466344324|FG002|Overall Study|Withdrawal by Subject|0|||
129559737|NCT00617461|466344331|FG000|First Treatment Intervention Period|Adverse Event|2|||
129559738|NCT00617461|466344332|FG001|First Treatment Intervention Period|Adverse Event|0|||
129559739|NCT00617461|466344331|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
129559740|NCT00617461|466344332|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
129559741|NCT00617461|466344331|FG000|First Treatment Intervention Period|Protocol Violation|2|||
129559742|NCT00617461|466344332|FG001|First Treatment Intervention Period|Protocol Violation|1|||
129559743|NCT00617461|466344331|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
129559744|NCT00617461|466344332|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
129559745|NCT00617461|466344331|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
129559746|NCT00617461|466344332|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
129559747|NCT00617461|466344331|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
129559748|NCT00617461|466344332|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
129559749|NCT00617461|466344331|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
129559750|NCT00617461|466344332|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
129559751|NCT00617461|466344331|FG000|Second Treatment Intervention Period|Adverse Event|0|||
129559752|NCT00617461|466344332|FG001|Second Treatment Intervention Period|Adverse Event|1|||
129559753|NCT00617461|466344331|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
129559754|NCT00617461|466344332|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
129559755|NCT00617461|466344331|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
129559756|NCT00617461|466344332|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
129559757|NCT00617461|466344331|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
129559758|NCT00617461|466344332|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
129559759|NCT00320593|466344335|FG000|Overall Study|Lost to Follow-up|3|||
129559760|NCT00320593|466344336|FG001|Overall Study|Lost to Follow-up|0|||
129559761|NCT00320593|466344335|FG000|Overall Study|Moved to another state|1|||
129559762|NCT00320593|466344336|FG001|Overall Study|Moved to another state|0|||
129559763|NCT00320593|466344335|FG000|Overall Study|Withdrawal by Subject|2|||
129559764|NCT00320593|466344336|FG001|Overall Study|Withdrawal by Subject|1|||
129559765|NCT00320593|466344335|FG000|Overall Study|Withdrawal by clinical center|1|||
129559766|NCT00320593|466344336|FG001|Overall Study|Withdrawal by clinical center|0|||
129559767|NCT00457665|466344337|FG000|12 Months|Drug allergy|1|||
129559768|NCT00457665|466344338|FG001|12 Months|Drug allergy|1|||
129559769|NCT00457665|466344337|FG000|12 Months|High HIV viral load|5|||
129559770|NCT00457665|466344338|FG001|12 Months|High HIV viral load|1|||
129559771|NCT00457665|466344337|FG000|12 Months|Lipodystrophy|2|||
129559772|NCT00457665|466344338|FG001|12 Months|Lipodystrophy|0|||
129559773|NCT00457665|466344337|FG000|12 Months|Withdrawal by Subject|0|||
129559774|NCT00457665|466344338|FG001|12 Months|Withdrawal by Subject|2|||
129559775|NCT00457665|466344337|FG000|12 Months|Abnormal Liver function tests|0|||
129559776|NCT00457665|466344338|FG001|12 Months|Abnormal Liver function tests|5|||
129559777|NCT00457665|466344337|FG000|24 Months|Withdrawal by Subject|3|||
129559778|NCT00457665|466344338|FG001|24 Months|Withdrawal by Subject|2|||
129559779|NCT00457665|466344337|FG000|24 Months|Lipodystrophy|1|||
129559780|NCT00457665|466344338|FG001|24 Months|Lipodystrophy|1|||
129559781|NCT00457665|466344337|FG000|24 Months|Abnormal liver function tests|1|||
129559782|NCT00457665|466344338|FG001|24 Months|Abnormal liver function tests|5|||
129559783|NCT02649231|466344340|FG000|Overall Study|Adverse Event|0|||
129559784|NCT02649231|466344341|FG001|Overall Study|Adverse Event|0|||
129559785|NCT02649231|466344342|FG002|Overall Study|Adverse Event|0|||
129559786|NCT02649231|466344343|FG003|Overall Study|Adverse Event|1|||
129559787|NCT02649231|466344340|FG000|Overall Study|Lost to Follow-up|2|||
129559788|NCT02649231|466344341|FG001|Overall Study|Lost to Follow-up|1|||
129559789|NCT02649231|466344342|FG002|Overall Study|Lost to Follow-up|1|||
129559790|NCT02649231|466344343|FG003|Overall Study|Lost to Follow-up|0|||
129559791|NCT02649231|466344340|FG000|Overall Study|Withdrawal by Subject|0|||
129559792|NCT02649231|466344341|FG001|Overall Study|Withdrawal by Subject|1|||
129559793|NCT02649231|466344342|FG002|Overall Study|Withdrawal by Subject|0|||
129559794|NCT02649231|466344343|FG003|Overall Study|Withdrawal by Subject|1|||
129559795|NCT02649231|466344340|FG000|Overall Study|Protocol Violation|2|||
129559796|NCT02649231|466344341|FG001|Overall Study|Protocol Violation|1|||
129559797|NCT02649231|466344342|FG002|Overall Study|Protocol Violation|1|||
129559798|NCT02649231|466344343|FG003|Overall Study|Protocol Violation|0|||
129559799|NCT01851590|466344348|FG000|Overall Study|Withdrawal by Subject|0|||
129559800|NCT01851590|466344349|FG001|Overall Study|Withdrawal by Subject|0|||
129559801|NCT01851590|466344350|FG002|Overall Study|Withdrawal by Subject|1|||
129559802|NCT01851590|466344348|FG000|Overall Study|Adverse Event|0|||
129559803|NCT01851590|466344349|FG001|Overall Study|Adverse Event|0|||
129559804|NCT01851590|466344350|FG002|Overall Study|Adverse Event|2|||
129559805|NCT01851590|466344348|FG000|Overall Study|Lack of Efficacy|0|||
129559806|NCT01851590|466344349|FG001|Overall Study|Lack of Efficacy|1|||
129559807|NCT01851590|466344350|FG002|Overall Study|Lack of Efficacy|0|||
129559808|NCT00310856|466344353|FG000|Overall Study|Withdrawal by Subject|2|||
129559809|NCT00310856|466344354|FG001|Overall Study|Withdrawal by Subject|2|||
129559810|NCT00310856|466344355|FG002|Overall Study|Withdrawal by Subject|2|||
129559811|NCT00310856|466344353|FG000|Overall Study|Lost to Follow-up|1|||
129559812|NCT00310856|466344354|FG001|Overall Study|Lost to Follow-up|2|||
129559813|NCT00310856|466344355|FG002|Overall Study|Lost to Follow-up|6|||
129559814|NCT00310856|466344353|FG000|Overall Study|Inappropriate enrollment|1|||
129559815|NCT00310856|466344354|FG001|Overall Study|Inappropriate enrollment|1|||
129559816|NCT00310856|466344355|FG002|Overall Study|Inappropriate enrollment|0|||
129559817|NCT00310856|466344353|FG000|Overall Study|Unable to classify|1|||
129559818|NCT00310856|466344354|FG001|Overall Study|Unable to classify|0|||
129559819|NCT00310856|466344355|FG002|Overall Study|Unable to classify|0|||
129559820|NCT02611752|466344356|FG000|Overall Study|Adverse Event|0|||
129559821|NCT02611752|466344357|FG001|Overall Study|Adverse Event|1|||
129559822|NCT00947856|466344363|FG000|Treatment Period|Progressive Disease|33|||
129559823|NCT00947856|466344364|FG001|Treatment Period|Progressive Disease|12|||
129559824|NCT00947856|466344363|FG000|Treatment Period|Adverse Event|15|||
129559825|NCT00947856|466344364|FG001|Treatment Period|Adverse Event|9|||
129559826|NCT00947856|466344363|FG000|Treatment Period|Physician Decision|14|||
129559827|NCT00947856|466344364|FG001|Treatment Period|Physician Decision|6|||
129559828|NCT00947856|466344363|FG000|Treatment Period|Study Stopped by Sponsor|4|||
129559829|NCT00947856|466344364|FG001|Treatment Period|Study Stopped by Sponsor|4|||
129559830|NCT00947856|466344363|FG000|Treatment Period|Withdrawal by Subject|12|||
129559831|NCT00947856|466344364|FG001|Treatment Period|Withdrawal by Subject|1|||
129559832|NCT00947856|466344363|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
129559833|NCT00947856|466344364|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
129559834|NCT00947856|466344363|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
129559835|NCT00947856|466344364|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
129559836|NCT00947856|466344363|FG000|Follow-up Period|Lost to Follow-up|7|||
129559837|NCT00947856|466344364|FG001|Follow-up Period|Lost to Follow-up|0|||
129559838|NCT00947856|466344363|FG000|Follow-up Period|Patient unavailable for site visits|1|||
129559839|NCT00947856|466344364|FG001|Follow-up Period|Patient unavailable for site visits|0|||
129559840|NCT00947856|466344363|FG000|Follow-up Period|Withdrawal by Subject|1|||
129559841|NCT00947856|466344364|FG001|Follow-up Period|Withdrawal by Subject|0|||
129559842|NCT00543439|466344365|FG000|Period 1|Adverse Event|0|||
129559843|NCT00543439|466344366|FG001|Period 1|Adverse Event|2|||
129559844|NCT00543439|466344367|FG002|Period 1|Adverse Event|1|||
129559845|NCT00543439|466344365|FG000|Period 1|Withdrawal by Subject|1|||
129559846|NCT00543439|466344366|FG001|Period 1|Withdrawal by Subject|1|||
129559847|NCT00543439|466344367|FG002|Period 1|Withdrawal by Subject|0|||
129777950|NCT05307692|467152491|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
129777951|NCT05307692|467152492|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
129777952|NCT05307692|467152493|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
129777953|NCT05307692|467152494|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
129777954|NCT05307692|467152491|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
129777955|NCT05307692|467152492|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
129777956|NCT05307692|467152493|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
129777957|NCT05307692|467152494|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
129777958|NCT02003924|467152497|FG000|Double-blind Phase|Lost to Follow-up|2|||
129777959|NCT02003924|467152498|FG001|Double-blind Phase|Lost to Follow-up|1|||
129777960|NCT02003924|467152499|FG002|Double-blind Phase|Lost to Follow-up|0|||
129777961|NCT02003924|467152497|FG000|Double-blind Phase|Protocol Violation|1|||
129777962|NCT02003924|467152498|FG001|Double-blind Phase|Protocol Violation|2|||
129777963|NCT02003924|467152499|FG002|Double-blind Phase|Protocol Violation|0|||
129777964|NCT02003924|467152497|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
129777965|NCT02003924|467152498|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
129777966|NCT02003924|467152499|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
129777967|NCT02003924|467152497|FG000|Double-blind Phase|Disease Progression|229|||
129777968|NCT02003924|467152498|FG001|Double-blind Phase|Disease Progression|247|||
129777969|NCT02003924|467152499|FG002|Double-blind Phase|Disease Progression|0|||
129777970|NCT02003924|467152497|FG000|Double-blind Phase|Adverse Event|120|||
129559848|NCT00543439|466344365|FG000|Period 1|Physician Decision|0|||
129559849|NCT00543439|466344366|FG001|Period 1|Physician Decision|0|||
129559850|NCT00543439|466344367|FG002|Period 1|Physician Decision|1|||
129559851|NCT00543439|466344365|FG000|Period 2|Protocol Violation|1|||
129559852|NCT00543439|466344366|FG001|Period 2|Protocol Violation|0|||
129559853|NCT00543439|466344367|FG002|Period 2|Protocol Violation|1|||
129559854|NCT00543439|466344365|FG000|Period 2|Adverse Event|0|||
129559855|NCT00543439|466344366|FG001|Period 2|Adverse Event|1|||
129559856|NCT00543439|466344367|FG002|Period 2|Adverse Event|1|||
129559857|NCT01211769|466344368|FG000|Overall Study|Lost to Follow-up|7|||
129559858|NCT01211769|466344369|FG001|Overall Study|Lost to Follow-up|9|||
129559859|NCT01211769|466344370|FG002|Overall Study|Lost to Follow-up|5|||
129559860|NCT01211769|466344371|FG003|Overall Study|Lost to Follow-up|9|||
129559861|NCT01211769|466344368|FG000|Overall Study|Physician Decision|2|||
129559862|NCT01211769|466344369|FG001|Overall Study|Physician Decision|0|||
129559863|NCT01211769|466344370|FG002|Overall Study|Physician Decision|2|||
129559864|NCT01211769|466344371|FG003|Overall Study|Physician Decision|1|||
129559865|NCT01211769|466344368|FG000|Overall Study|Adverse Event|0|||
129559866|NCT01211769|466344369|FG001|Overall Study|Adverse Event|1|||
129559867|NCT01211769|466344370|FG002|Overall Study|Adverse Event|1|||
129559868|NCT01211769|466344371|FG003|Overall Study|Adverse Event|1|||
129559869|NCT01214330|466344372|FG000|Overall Study|Withdrawal by Subject|2|||
129559870|NCT01214330|466344372|FG000|Overall Study|Withdrawal by Subject|2|||
129559871|NCT01348542|466344374|FG000|Overall Study|Withdrawal by Subject|3|||
129559872|NCT01348542|466344375|FG001|Overall Study|Withdrawal by Subject|0|||
129559873|NCT03402893|466344376|FG000|Overall Study|Withdrawal by Subject|1|||
129559874|NCT00686036|466344377|FG000|Overall Study|Adverse Event|3|||
129559875|NCT00686036|466344378|FG001|Overall Study|Adverse Event|0|||
129559876|NCT00686036|466344377|FG000|Overall Study|Withdrawal by Subject|3|||
129559877|NCT00686036|466344378|FG001|Overall Study|Withdrawal by Subject|1|||
129559878|NCT00686036|466344377|FG000|Overall Study|Study terminated by AstraZeneca|2|||
129559879|NCT00686036|466344378|FG001|Overall Study|Study terminated by AstraZeneca|1|||
129559880|NCT00686036|466344377|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
129559881|NCT00686036|466344378|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
129559882|NCT00686036|466344377|FG000|Overall Study|Other reasons not identified|0|||
129559883|NCT00686036|466344378|FG001|Overall Study|Other reasons not identified|4|||
129687308|NCT00923702|466812135|FG004|Overall Study|Ongoing enrollment|354|||
129687309|NCT00367458|466812136|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
129687310|NCT00367458|466812137|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
129687311|NCT04339972|466812143|FG000|Overall Study|Scheduling Issues|3|||
129687312|NCT04339972|466812144|FG001|Overall Study|Scheduling Issues|3|||
129687313|NCT04339972|466812143|FG000|Overall Study|dropout|1|||
129687314|NCT04339972|466812144|FG001|Overall Study|dropout|1|||
129687315|NCT04339972|466812143|FG000|Overall Study|Technical issues|1|||
129687316|NCT04339972|466812144|FG001|Overall Study|Technical issues|0|||
129687317|NCT04339972|466812143|FG000|Overall Study|Claustraphobia|0|||
129687318|NCT04339972|466812144|FG001|Overall Study|Claustraphobia|1|||
129687319|NCT02691663|466812145|FG000|Overall Study|Screen failure after baseline|2|||
129687320|NCT02691663|466812146|FG001|Overall Study|Screen failure after baseline|2|||
129687321|NCT02691663|466812145|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
129687322|NCT02691663|466812146|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
129687323|NCT02691663|466812145|FG000|Overall Study|Withdrawn after Follow up 2|1|||
129687324|NCT02691663|466812146|FG001|Overall Study|Withdrawn after Follow up 2|1|||
129687325|NCT02691663|466812145|FG000|Overall Study|Lost to Follow-up|3|||
129687326|NCT02691663|466812146|FG001|Overall Study|Lost to Follow-up|2|||
129687327|NCT02942407|466812150|FG000|Overall Study|Lost to Follow-up|3|||
129687328|NCT02942407|466812151|FG001|Overall Study|Lost to Follow-up|2|||
129687329|NCT02942407|466812150|FG000|Overall Study|Withdrawal by Subject|7|||
129687330|NCT02942407|466812151|FG001|Overall Study|Withdrawal by Subject|9|||
129687331|NCT02942407|466812150|FG000|Overall Study|Death|16|||
129687332|NCT02942407|466812151|FG001|Overall Study|Death|13|||
129687333|NCT01716156|466812153|FG000|Overall Study|Protocol Violation|1|||
129687334|NCT01716156|466812154|FG001|Overall Study|Protocol Violation|0|||
129687335|NCT01716156|466812155|FG002|Overall Study|Protocol Violation|0|||
129687336|NCT01716156|466812153|FG000|Overall Study|Withdrawal by Subject|0|||
129687337|NCT01716156|466812154|FG001|Overall Study|Withdrawal by Subject|1|||
129687338|NCT01716156|466812155|FG002|Overall Study|Withdrawal by Subject|2|||
129687339|NCT01716156|466812153|FG000|Overall Study|Lost to Follow-up|1|||
129687340|NCT01716156|466812154|FG001|Overall Study|Lost to Follow-up|0|||
129687341|NCT01716156|466812155|FG002|Overall Study|Lost to Follow-up|0|||
129687342|NCT03925220|466812156|FG000|Overall Study|Withdrawal by Subject|4|||
129687343|NCT03925220|466812157|FG001|Overall Study|Withdrawal by Subject|4|||
129687344|NCT03925220|466812158|FG002|Overall Study|Withdrawal by Subject|4|||
129687345|NCT03925220|466812159|FG003|Overall Study|Withdrawal by Subject|4|||
129559884|NCT00926289|466344379|FG000|Overall Study|Adverse Event|9|||
129559885|NCT00926289|466344380|FG001|Overall Study|Adverse Event|11|||
129559886|NCT00926289|466344379|FG000|Overall Study|Protocol Violation|8|||
129559887|NCT00926289|466344380|FG001|Overall Study|Protocol Violation|12|||
129687346|NCT03925220|466812156|FG000|Overall Study|Lost to Follow-up|40|||
129687347|NCT03925220|466812157|FG001|Overall Study|Lost to Follow-up|46|||
129687348|NCT03925220|466812158|FG002|Overall Study|Lost to Follow-up|37|||
129687349|NCT03925220|466812159|FG003|Overall Study|Lost to Follow-up|38|||
129687350|NCT05221866|466812160|FG000|Overall Study|Withdrawal by Subject|5|||
129559888|NCT00926289|466344379|FG000|Overall Study|Lost to Follow-up|3|||
129559889|NCT00926289|466344380|FG001|Overall Study|Lost to Follow-up|6|||
129559890|NCT00926289|466344379|FG000|Overall Study|Withdrawal by Subject|4|||
129559891|NCT00926289|466344380|FG001|Overall Study|Withdrawal by Subject|4|||
129559892|NCT00926289|466344379|FG000|Overall Study|Other|1|||
129559893|NCT00926289|466344380|FG001|Overall Study|Other|3|||
129559894|NCT00146770|466344382|FG000|Overall Study|Adverse Event|2|||
129559895|NCT00146770|466344383|FG001|Overall Study|Adverse Event|0|||
129559896|NCT00146770|466344382|FG000|Overall Study|Pregnancy|1|||
129559897|NCT00146770|466344383|FG001|Overall Study|Pregnancy|0|||
129559898|NCT00146770|466344382|FG000|Overall Study|Withdrawal by Subject|2|||
129559899|NCT00146770|466344383|FG001|Overall Study|Withdrawal by Subject|0|||
129559900|NCT02995837|466344389|FG000|Overall Study|Lost to Follow-up|9|||
129559901|NCT02995837|466344390|FG001|Overall Study|Lost to Follow-up|8|||
129559902|NCT01077713|466344391|FG000|Overall Study|Withdrawal by Subject|1|||
129559903|NCT01077713|466344392|FG001|Overall Study|Withdrawal by Subject|2|||
129559904|NCT01077713|466344391|FG000|Overall Study|Progressive Disease (PD)|0|||
129559905|NCT01077713|466344392|FG001|Overall Study|Progressive Disease (PD)|1|||
129559906|NCT01077713|466344391|FG000|Overall Study|Death|28|||
129559907|NCT01077713|466344392|FG001|Overall Study|Death|29|||
129559908|NCT01077713|466344391|FG000|Overall Study|Lost to Follow-up|1|||
129559909|NCT01077713|466344392|FG001|Overall Study|Lost to Follow-up|1|||
129559910|NCT01077713|466344391|FG000|Overall Study|Adverse Event|2|||
129559911|NCT01077713|466344392|FG001|Overall Study|Adverse Event|1|||
129559912|NCT01077713|466344391|FG000|Overall Study|Other|4|||
129559913|NCT01077713|466344392|FG001|Overall Study|Other|2|||
129559914|NCT00289458|466344393|FG000|Overall Study|Death|1|||
129559915|NCT00289458|466344394|FG001|Overall Study|Death|0|||
129559916|NCT00289458|466344395|FG002|Overall Study|Death|0|||
129559917|NCT00289458|466344393|FG000|Overall Study|Physician Decision|3|||
129559918|NCT00289458|466344394|FG001|Overall Study|Physician Decision|4|||
129559919|NCT00289458|466344395|FG002|Overall Study|Physician Decision|2|||
129559920|NCT00289458|466344393|FG000|Overall Study|Withdrawal by Subject|2|||
129559921|NCT00289458|466344394|FG001|Overall Study|Withdrawal by Subject|2|||
129559922|NCT00289458|466344395|FG002|Overall Study|Withdrawal by Subject|4|||
129559923|NCT00874757|466344396|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
129559924|NCT02806232|466346379|FG000|Overall Study|Lost to Follow-up|1|||
129559925|NCT02806232|466346380|FG001|Overall Study|Lost to Follow-up|2|||
129559926|NCT02806232|466346381|FG002|Overall Study|Lost to Follow-up|1|||
129559927|NCT02806232|466346382|FG003|Overall Study|Lost to Follow-up|0|||
129559928|NCT02806232|466346383|FG004|Overall Study|Lost to Follow-up|0|||
129559929|NCT02806232|466346384|FG005|Overall Study|Lost to Follow-up|1|||
129559930|NCT02806232|466346385|FG006|Overall Study|Lost to Follow-up|0|||
129559931|NCT02806232|466346386|FG007|Overall Study|Lost to Follow-up|0|||
129559932|NCT02806232|466346387|FG008|Overall Study|Lost to Follow-up|0|||
129559933|NCT02806232|466346379|FG000|Overall Study|Withdrawal by Subject|0|||
129559934|NCT02806232|466346380|FG001|Overall Study|Withdrawal by Subject|2|||
129559935|NCT02806232|466346381|FG002|Overall Study|Withdrawal by Subject|0|||
129559936|NCT02806232|466346382|FG003|Overall Study|Withdrawal by Subject|0|||
129559937|NCT02806232|466346383|FG004|Overall Study|Withdrawal by Subject|2|||
129559938|NCT02806232|466346384|FG005|Overall Study|Withdrawal by Subject|1|||
129559939|NCT02806232|466346385|FG006|Overall Study|Withdrawal by Subject|0|||
129559940|NCT02806232|466346386|FG007|Overall Study|Withdrawal by Subject|0|||
129559941|NCT02806232|466346387|FG008|Overall Study|Withdrawal by Subject|0|||
129559942|NCT01806597|466346392|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
129559943|NCT01806597|466346393|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
129559944|NCT01806597|466346394|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
129559945|NCT01806597|466346395|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
129559946|NCT01806597|466346396|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
129559947|NCT01806597|466346397|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
129559948|NCT01806597|466346392|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
129559949|NCT01806597|466346393|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129559950|NCT01806597|466346394|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129559951|NCT01806597|466346395|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129559952|NCT01806597|466346396|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
129559953|NCT01806597|466346397|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
129559954|NCT01806597|466346392|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129559955|NCT01806597|466346393|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
129559956|NCT01806597|466346394|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129559957|NCT01806597|466346395|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129559958|NCT01806597|466346396|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129559959|NCT01806597|466346397|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
129559960|NCT01806597|466346392|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
129884516|NCT04779242|467536436|FG000|Overall Study|Adverse Event|1|||
129559961|NCT01806597|466346393|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
129559962|NCT01806597|466346394|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
129559963|NCT01806597|466346395|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
129559964|NCT01806597|466346396|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
129559965|NCT01806597|466346397|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
129559966|NCT01806597|466346392|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129559967|NCT01806597|466346393|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
129559968|NCT01806597|466346394|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129559969|NCT01806597|466346395|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129559970|NCT01806597|466346396|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129559971|NCT01806597|466346397|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
129559972|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
129559973|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
129559974|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
129559975|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
129559976|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
129559977|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
129559978|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
129559979|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
129559980|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
129559981|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
129559982|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
129559983|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
129559984|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
129559985|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129559986|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129559987|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129559988|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129559989|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
129559990|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
129559991|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
129559992|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129559993|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129559994|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129559995|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
129559996|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
129559997|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129559998|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129559999|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129560000|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129560001|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
129560002|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129560003|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
129560004|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129560005|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
129560006|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129560007|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
129560008|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
129560009|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
129560010|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
129560011|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
129560012|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
129560013|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
129560014|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
129560015|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
129560016|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
129687351|NCT05221866|466812161|FG001|Overall Study|Withdrawal by Subject|7|||
129687352|NCT05221866|466812162|FG002|Overall Study|Withdrawal by Subject|6|||
129687353|NCT05221866|466812163|FG003|Overall Study|Withdrawal by Subject|4|||
129687354|NCT05221866|466812160|FG000|Overall Study|Physician Decision|3|||
129687355|NCT05221866|466812161|FG001|Overall Study|Physician Decision|2|||
129687356|NCT05221866|466812162|FG002|Overall Study|Physician Decision|1|||
129560017|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
129560018|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
129560019|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
129560020|NCT01806597|466346392|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
129560021|NCT01806597|466346393|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129560022|NCT01806597|466346394|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129560023|NCT01806597|466346395|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129560024|NCT01806597|466346396|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129560025|NCT01806597|466346397|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
129560026|NCT01806597|466346392|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129560027|NCT01806597|466346393|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129560028|NCT01806597|466346394|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129560029|NCT01806597|466346395|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129560030|NCT01806597|466346396|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
129560031|NCT01806597|466346397|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
129560032|NCT01806597|466346392|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129560033|NCT01806597|466346393|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129560034|NCT01806597|466346394|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129560035|NCT01806597|466346395|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129560036|NCT01806597|466346396|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
129560037|NCT01806597|466346397|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
129560038|NCT01806597|466346392|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129560039|NCT01806597|466346393|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129560040|NCT01806597|466346394|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129560041|NCT01806597|466346395|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129560042|NCT01806597|466346396|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
129560043|NCT01806597|466346397|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
129560044|NCT01806597|466346392|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129560045|NCT01806597|466346393|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129560046|NCT01806597|466346394|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129560047|NCT01806597|466346395|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129560048|NCT01806597|466346396|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
129560049|NCT01806597|466346397|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
129560050|NCT01806597|466346392|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129560051|NCT01806597|466346393|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129560052|NCT01806597|466346394|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129560053|NCT01806597|466346395|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129560054|NCT01806597|466346396|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
129560055|NCT01806597|466346397|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
129687357|NCT05221866|466812163|FG003|Overall Study|Physician Decision|4|||
129687358|NCT05221866|466812160|FG000|Overall Study|Lost to Follow-up|12|||
129687359|NCT05221866|466812161|FG001|Overall Study|Lost to Follow-up|17|||
129687360|NCT05221866|466812162|FG002|Overall Study|Lost to Follow-up|14|||
129687361|NCT05221866|466812163|FG003|Overall Study|Lost to Follow-up|14|||
129687362|NCT05221866|466812160|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
129687363|NCT05221866|466812161|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
129687364|NCT05221866|466812162|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
129687365|NCT05221866|466812163|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
129687366|NCT05561140|466812164|FG000|Randomized Treatment Period|Adverse Event|1|||
129687367|NCT05561140|466812165|FG001|Randomized Treatment Period|Adverse Event|0|||
129687368|NCT05561140|466812164|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129687369|NCT05561140|466812165|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
129687370|NCT05561140|466812164|FG000|Open Label Treatment Period|Adverse Event|6|||
129687371|NCT05561140|466812165|FG001|Open Label Treatment Period|Adverse Event|4|||
129687372|NCT05561140|466812164|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
129687373|NCT05561140|466812165|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
129687374|NCT05561140|466812164|FG000|Open Label Treatment Period|Physician Decision|0|||
129687375|NCT05561140|466812165|FG001|Open Label Treatment Period|Physician Decision|1|||
129687376|NCT05561140|466812164|FG000|Open Label Treatment Period|Pregnancy|1|||
129687377|NCT05561140|466812165|FG001|Open Label Treatment Period|Pregnancy|0|||
129687378|NCT05561140|466812164|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
129560056|NCT01144663|466346398|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
129560057|NCT01144663|466346399|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
129560058|NCT01144663|466346400|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
129777971|NCT02003924|467152498|FG001|Double-blind Phase|Adverse Event|31|||
129777972|NCT02003924|467152499|FG002|Double-blind Phase|Adverse Event|0|||
129687379|NCT05561140|466812165|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
129687380|NCT05561140|466812164|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
129687381|NCT05561140|466812165|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
129687382|NCT05561140|466812164|FG000|Open Label Treatment Period|Other|1|||
129687383|NCT05561140|466812165|FG001|Open Label Treatment Period|Other|0|||
129687384|NCT01944774|466812166|FG000|Overall Study|Withdrawal by Subject|2|||
129687385|NCT01944774|466812167|FG001|Overall Study|Withdrawal by Subject|3|||
129687386|NCT01944774|466812168|FG002|Overall Study|Withdrawal by Subject|3|||
129560059|NCT01144663|466346401|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
129560060|NCT01144663|466346398|FG000|Primary Vaccination Phase|Adverse Event|1|||
129560061|NCT01144663|466346399|FG001|Primary Vaccination Phase|Adverse Event|0|||
129560062|NCT01144663|466346400|FG002|Primary Vaccination Phase|Adverse Event|0|||
129560063|NCT01144663|466346401|FG003|Primary Vaccination Phase|Adverse Event|1|||
129560064|NCT01144663|466346398|FG000|Primary Vaccination Phase|Protocol Violation|2|||
129560065|NCT01144663|466346399|FG001|Primary Vaccination Phase|Protocol Violation|0|||
129560066|NCT01144663|466346400|FG002|Primary Vaccination Phase|Protocol Violation|1|||
129560067|NCT01144663|466346401|FG003|Primary Vaccination Phase|Protocol Violation|0|||
129560068|NCT01144663|466346398|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
129560069|NCT01144663|466346399|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
129560070|NCT01144663|466346400|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
129560071|NCT01144663|466346401|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
129560072|NCT01144663|466346398|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
129560073|NCT01144663|466346399|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
129560074|NCT01144663|466346400|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
129560075|NCT01144663|466346401|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
129560076|NCT01144663|466346398|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
129560077|NCT01144663|466346399|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
129560078|NCT01144663|466346400|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
129560079|NCT01144663|466346401|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
129560080|NCT01144663|466346398|FG000|Primary Vaccination Phase|Other|0|||
129560081|NCT01144663|466346399|FG001|Primary Vaccination Phase|Other|1|||
129560082|NCT01144663|466346400|FG002|Primary Vaccination Phase|Other|0|||
129560083|NCT01144663|466346401|FG003|Primary Vaccination Phase|Other|2|||
129884517|NCT04779242|467536437|FG001|Overall Study|Adverse Event|1|||
129884518|NCT04779242|467536436|FG000|Overall Study|Lost to Follow-up|2|||
129560084|NCT01144663|466346398|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
129560085|NCT01144663|466346399|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129560086|NCT01144663|466346400|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
129560087|NCT01144663|466346401|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
129560088|NCT01144663|466346398|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
129560089|NCT01144663|466346399|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
129560090|NCT01144663|466346400|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
129560091|NCT01144663|466346401|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
129560092|NCT01144663|466346398|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
129560093|NCT01144663|466346399|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
129560094|NCT01144663|466346400|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
129560095|NCT01144663|466346401|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
129560096|NCT01144663|466346398|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
129560097|NCT01144663|466346399|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
129560098|NCT01144663|466346400|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
129560099|NCT01144663|466346401|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
129560100|NCT01144663|466346398|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
129560101|NCT01144663|466346399|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
129560102|NCT01144663|466346400|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
129560103|NCT01144663|466346401|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
129560104|NCT01144663|466346398|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
129560105|NCT01144663|466346399|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
129560106|NCT01144663|466346400|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
129560107|NCT01144663|466346401|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
129560108|NCT01073020|466346404|FG000|Overall Study|Withdrawal by Subject|6|||
129560109|NCT01073020|466346405|FG001|Overall Study|Withdrawal by Subject|4|||
129560110|NCT01073020|466346406|FG002|Overall Study|Withdrawal by Subject|1|||
129560111|NCT01073020|466346407|FG003|Overall Study|Withdrawal by Subject|2|||
129560112|NCT01073020|466346404|FG000|Overall Study|Physician Decision|1|||
129560113|NCT01073020|466346405|FG001|Overall Study|Physician Decision|0|||
129560114|NCT01073020|466346406|FG002|Overall Study|Physician Decision|2|||
129560115|NCT01073020|466346407|FG003|Overall Study|Physician Decision|0|||
129560116|NCT01073020|466346404|FG000|Overall Study|Death|0|||
129560117|NCT01073020|466346405|FG001|Overall Study|Death|1|||
129560118|NCT01073020|466346406|FG002|Overall Study|Death|0|||
129560119|NCT01073020|466346407|FG003|Overall Study|Death|0|||
129560120|NCT01335477|466346408|FG000|Overall Study|Adverse Event|30|||
129560121|NCT01335477|466346409|FG001|Overall Study|Adverse Event|42|||
129560122|NCT01335477|466346408|FG000|Overall Study|Non compliant with protocol|0|||
129560123|NCT01335477|466346409|FG001|Overall Study|Non compliant with protocol|2|||
129560124|NCT01335477|466346408|FG000|Overall Study|Lost to Follow-up|1|||
129560125|NCT01335477|466346409|FG001|Overall Study|Lost to Follow-up|2|||
129687387|NCT01944774|466812166|FG000|Overall Study|Adverse Event|3|||
129687388|NCT01944774|466812167|FG001|Overall Study|Adverse Event|2|||
129687389|NCT01944774|466812168|FG002|Overall Study|Adverse Event|3|||
129687390|NCT01944774|466812166|FG000|Overall Study|Lack of Efficacy|1|||
129687391|NCT01944774|466812167|FG001|Overall Study|Lack of Efficacy|2|||
129687392|NCT01944774|466812168|FG002|Overall Study|Lack of Efficacy|2|||
129687393|NCT01944774|466812166|FG000|Overall Study|Lost to Follow-up|0|||
129687394|NCT01944774|466812167|FG001|Overall Study|Lost to Follow-up|1|||
129687395|NCT01944774|466812168|FG002|Overall Study|Lost to Follow-up|0|||
129687396|NCT03325439|466812174|FG000|Overall Study|Ineligibility|3|||
129687397|NCT00774748|466812175|FG000|Overall Study|Lost to Follow-up|3|||
129687398|NCT00866320|466812176|FG000|Overall Study|Withdrawal by Subject|4|||
129687399|NCT00866320|466812176|FG000|Overall Study|Death|2|||
129560126|NCT01335477|466346408|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
129560127|NCT01335477|466346409|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
129560128|NCT01335477|466346408|FG000|Overall Study|Not treated|1|||
129560129|NCT01335477|466346409|FG001|Overall Study|Not treated|2|||
129560130|NCT01335477|466346408|FG000|Overall Study|Reason other than those stated above|2|||
129560131|NCT01335477|466346409|FG001|Overall Study|Reason other than those stated above|2|||
129560132|NCT02497391|466346413|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
129560133|NCT02497391|466346414|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
129560134|NCT02497391|466346415|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
129560135|NCT02497391|466346416|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
129560136|NCT02497391|466346417|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
129560137|NCT02497391|466346418|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
129560138|NCT02497391|466346413|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
129560139|NCT02497391|466346414|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
129560140|NCT02497391|466346415|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
129560141|NCT02497391|466346416|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
129560142|NCT02497391|466346417|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
129560143|NCT02497391|466346418|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
129560144|NCT02497391|466346413|FG000|Period 3 (14 Days)|Adverse Event|0|||
129560145|NCT02497391|466346414|FG001|Period 3 (14 Days)|Adverse Event|1|||
129560146|NCT02497391|466346415|FG002|Period 3 (14 Days)|Adverse Event|0|||
129560147|NCT02497391|466346416|FG003|Period 3 (14 Days)|Adverse Event|0|||
129560148|NCT02497391|466346417|FG004|Period 3 (14 Days)|Adverse Event|0|||
129560149|NCT02497391|466346418|FG005|Period 3 (14 Days)|Adverse Event|0|||
129560150|NCT02497391|466346413|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
129560151|NCT02497391|466346414|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
129560152|NCT02497391|466346415|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
129560153|NCT02497391|466346416|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
129560154|NCT02497391|466346417|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
129560155|NCT02497391|466346418|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
129560156|NCT02497391|466346413|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
129560157|NCT02497391|466346414|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
129560158|NCT02497391|466346415|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
129560159|NCT02497391|466346416|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
129560160|NCT02497391|466346417|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
129560161|NCT02497391|466346418|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
129560162|NCT03031899|466346421|FG000|Overall Study|Protocol Violation|1|||
129560163|NCT03031899|466346421|FG000|Overall Study|lesion disappeared after stopping habit|1|||
129560164|NCT03740698|466346423|FG000|Overall Study|Physician Decision|0|||
129560165|NCT03740698|466346424|FG001|Overall Study|Physician Decision|1|||
129560166|NCT03740698|466346425|FG002|Overall Study|Physician Decision|1|||
129560167|NCT01469364|466346426|FG000|Overall Study|Adverse Event|1|||
129560168|NCT01469364|466346426|FG000|Overall Study|Withdrawal by Subject|1|||
129560169|NCT03433001|466346429|FG000|Overall Study|Lack of Efficacy|109|||
129560170|NCT03433001|466346429|FG000|Overall Study|Adverse Event|69|||
129560171|NCT03433001|466346429|FG000|Overall Study|Withdrawal by Subject|10|||
129560172|NCT03433001|466346429|FG000|Overall Study|Death|12|||
129560173|NCT03433001|466346429|FG000|Overall Study|Lost to Follow-up|4|||
129560174|NCT03433001|466346429|FG000|Overall Study|Other|25|||
129560175|NCT01399723|466346446|FG000|Overall Study|Lost to Follow-up|0|||
129560176|NCT01399723|466346447|FG001|Overall Study|Lost to Follow-up|1|||
129560177|NCT00752791|466346451|FG000|Overall Study|Adverse Event|7|||
129687400|NCT03349515|466812177|FG000|Overall Study|Lack of Efficacy|2|||
129687401|NCT03349515|466812178|FG001|Overall Study|Lack of Efficacy|0|||
129687402|NCT03349515|466812177|FG000|Overall Study|Physician Decision|3|||
129687403|NCT03349515|466812178|FG001|Overall Study|Physician Decision|1|||
129687404|NCT02503865|466812179|FG000|Overall Study|Moved out of area|1|||
129687405|NCT02503865|466812180|FG001|Overall Study|Moved out of area|8|||
129687406|NCT02503865|466812181|FG002|Overall Study|Moved out of area|0|||
129687407|NCT02503865|466812179|FG000|Overall Study|Refused treatment|4|||
129687408|NCT02503865|466812180|FG001|Overall Study|Refused treatment|39|||
129687409|NCT02503865|466812181|FG002|Overall Study|Refused treatment|2|||
129687410|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
129687411|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
129687412|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
129687413|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Death|1|||
129687414|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Death|0|||
129560178|NCT00752791|466346451|FG000|Overall Study|Withdrawal by Subject|1|||
129687415|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Death|0|||
129687416|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
129687417|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
129560179|NCT00752791|466346451|FG000|Overall Study|Physician Decision|1|||
129560180|NCT00752791|466346451|FG000|Overall Study|Death|1|||
129560181|NCT00752791|466346451|FG000|Overall Study|Renal transplant|3|||
129560182|NCT00752791|466346451|FG000|Overall Study|Switched to hemodialysis|2|||
129560183|NCT00752791|466346451|FG000|Overall Study|Protocol deviation|1|||
129800236|NCT02891161|467236267|FG001|Follow up|Study terminated|6|||
129560184|NCT01787825|466346453|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
129560185|NCT01787825|466346454|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
129560186|NCT01787825|466346453|FG000|Overall Study|Data Not Analyzable|5|||
129560187|NCT01787825|466346454|FG001|Overall Study|Data Not Analyzable|1|||
129560188|NCT00989261|466346459|FG000|Overall Study|Still in follow up|12|||
129560189|NCT00989261|466346460|FG001|Overall Study|Still in follow up|21|||
129560190|NCT00989261|466346459|FG000|Overall Study|Withdrawal by Subject|0|||
129560191|NCT00989261|466346460|FG001|Overall Study|Withdrawal by Subject|1|||
129560192|NCT00989261|466346459|FG000|Overall Study|Lost to Follow-up|3|||
129560193|NCT00989261|466346460|FG001|Overall Study|Lost to Follow-up|0|||
129560194|NCT01507896|466346463|FG000|Overall Study|Withdrawal by Subject|1|||
129560195|NCT01507896|466346463|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
129560196|NCT00585351|466346465|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
129560197|NCT00585351|466346466|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
129560198|NCT00585351|466346467|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
129560199|NCT00585351|466346468|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
129560200|NCT00585351|466346469|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
129560201|NCT00585351|466346470|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
129560202|NCT00585351|466346471|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
129560203|NCT00585351|466346472|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
129560204|NCT00585351|466346465|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
129560205|NCT00585351|466346466|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
129560206|NCT00585351|466346467|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
129560207|NCT00585351|466346468|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
129560208|NCT00585351|466346469|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
129560209|NCT00585351|466346470|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
129560210|NCT00585351|466346471|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
129560211|NCT00585351|466346472|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
129560212|NCT00585351|466346465|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
129560213|NCT00585351|466346466|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
129560214|NCT00585351|466346467|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
129560215|NCT00585351|466346468|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
129560216|NCT00585351|466346469|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
129560217|NCT00585351|466346470|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
129560218|NCT00585351|466346471|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
129560219|NCT00585351|466346472|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
129560220|NCT00585351|466346465|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
129560221|NCT00585351|466346466|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
129560222|NCT00585351|466346467|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129560223|NCT00585351|466346468|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129560224|NCT00585351|466346469|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129560225|NCT00585351|466346470|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129560226|NCT00585351|466346471|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129560227|NCT00585351|466346472|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
129560228|NCT00585351|466346465|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129560229|NCT00585351|466346466|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129560230|NCT00585351|466346467|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129560231|NCT00585351|466346468|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129560232|NCT00585351|466346469|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129560233|NCT00585351|466346470|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
129687418|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
129687419|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
129687420|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
129687421|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
129687422|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
129687423|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
129687424|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
129687425|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
129687426|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
129687427|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
129687428|NCT05073315|466812182|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
129687429|NCT05073315|466812183|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
129687430|NCT05073315|466812184|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
129687431|NCT05073315|466812182|FG000|Period 2|Adverse Event|0|||
129687432|NCT05073315|466812183|FG001|Period 2|Adverse Event|3|||
129687433|NCT05073315|466812184|FG002|Period 2|Adverse Event|6|||
129687434|NCT05073315|466812182|FG000|Period 2|Lost to Follow-up|0|||
129687435|NCT05073315|466812183|FG001|Period 2|Lost to Follow-up|5|||
129560234|NCT00585351|466346471|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
129560235|NCT00585351|466346472|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
129560236|NCT00585351|466346465|FG000|Enrollment Period (Intervention)|Death|0|||
129560237|NCT00585351|466346466|FG001|Enrollment Period (Intervention)|Death|0|||
129560238|NCT00585351|466346467|FG002|Enrollment Period (Intervention)|Death|0|||
129560239|NCT00585351|466346468|FG003|Enrollment Period (Intervention)|Death|0|||
129560240|NCT00585351|466346469|FG004|Enrollment Period (Intervention)|Death|1|||
129560241|NCT00585351|466346470|FG005|Enrollment Period (Intervention)|Death|0|||
129560242|NCT00585351|466346471|FG006|Enrollment Period (Intervention)|Death|1|||
129560243|NCT00585351|466346472|FG007|Enrollment Period (Intervention)|Death|0|||
129560244|NCT00585351|466346465|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129560245|NCT00585351|466346466|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129560246|NCT00585351|466346467|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129560247|NCT00585351|466346468|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129560248|NCT00585351|466346469|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
129560249|NCT00585351|466346470|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
129560250|NCT00585351|466346471|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129560251|NCT00585351|466346472|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
129560252|NCT01842958|466346474|FG000|Overall Study|Lost to Follow-up|1|||
129560253|NCT01842958|466346475|FG001|Overall Study|Lost to Follow-up|1|||
129560254|NCT01829477|466346476|FG000|Overall Study|Study Terminated by Sponsor|15|||
129560255|NCT01829477|466346477|FG001|Overall Study|Study Terminated by Sponsor|15|||
129560256|NCT01829477|466346476|FG000|Overall Study|Withdrawal by Subject|1|||
129560257|NCT01829477|466346477|FG001|Overall Study|Withdrawal by Subject|0|||
129560258|NCT00818623|466346482|FG000|Overall Study|Adverse Event|1|||
129560259|NCT00818623|466346483|FG001|Overall Study|Adverse Event|0|||
129560260|NCT00818623|466346484|FG002|Overall Study|Adverse Event|1|||
129560261|NCT00818623|466346485|FG003|Overall Study|Adverse Event|0|||
129560262|NCT00818623|466346486|FG004|Overall Study|Adverse Event|0|||
129560263|NCT00818623|466346487|FG005|Overall Study|Adverse Event|1|||
129560264|NCT00818623|466346488|FG006|Overall Study|Adverse Event|0|||
129560265|NCT00818623|466346489|FG007|Overall Study|Adverse Event|0|||
129560266|NCT00818623|466346482|FG000|Overall Study|Bad prostate specific antigen response|0|||
129560267|NCT00818623|466346483|FG001|Overall Study|Bad prostate specific antigen response|3|||
129560268|NCT00818623|466346484|FG002|Overall Study|Bad prostate specific antigen response|2|||
129560269|NCT00818623|466346485|FG003|Overall Study|Bad prostate specific antigen response|5|||
129560270|NCT00818623|466346486|FG004|Overall Study|Bad prostate specific antigen response|0|||
129560271|NCT00818623|466346487|FG005|Overall Study|Bad prostate specific antigen response|1|||
129560272|NCT00818623|466346488|FG006|Overall Study|Bad prostate specific antigen response|0|||
129560273|NCT00818623|466346489|FG007|Overall Study|Bad prostate specific antigen response|0|||
129560274|NCT00818623|466346482|FG000|Overall Study|Withdrawal by Subject|0|||
129560275|NCT00818623|466346483|FG001|Overall Study|Withdrawal by Subject|1|||
129560276|NCT00818623|466346484|FG002|Overall Study|Withdrawal by Subject|1|||
129560277|NCT00818623|466346485|FG003|Overall Study|Withdrawal by Subject|0|||
129560278|NCT00818623|466346486|FG004|Overall Study|Withdrawal by Subject|0|||
129560279|NCT00818623|466346487|FG005|Overall Study|Withdrawal by Subject|1|||
129560280|NCT00818623|466346488|FG006|Overall Study|Withdrawal by Subject|1|||
129560281|NCT00818623|466346489|FG007|Overall Study|Withdrawal by Subject|1|||
129560282|NCT00818623|466346482|FG000|Overall Study|Protocol Violation|1|||
129560283|NCT00818623|466346483|FG001|Overall Study|Protocol Violation|0|||
129560284|NCT00818623|466346484|FG002|Overall Study|Protocol Violation|0|||
129560285|NCT00818623|466346485|FG003|Overall Study|Protocol Violation|0|||
129560286|NCT00818623|466346486|FG004|Overall Study|Protocol Violation|1|||
129560287|NCT00818623|466346487|FG005|Overall Study|Protocol Violation|0|||
129560288|NCT00818623|466346488|FG006|Overall Study|Protocol Violation|1|||
129560289|NCT00818623|466346489|FG007|Overall Study|Protocol Violation|0|||
129560290|NCT00818623|466346482|FG000|Overall Study|Need of additional treatment|0|||
129560291|NCT00818623|466346483|FG001|Overall Study|Need of additional treatment|0|||
129560292|NCT00818623|466346484|FG002|Overall Study|Need of additional treatment|0|||
129560293|NCT00818623|466346485|FG003|Overall Study|Need of additional treatment|0|||
129560294|NCT00818623|466346486|FG004|Overall Study|Need of additional treatment|1|||
129560295|NCT00818623|466346487|FG005|Overall Study|Need of additional treatment|0|||
129560296|NCT00818623|466346488|FG006|Overall Study|Need of additional treatment|0|||
129560297|NCT00818623|466346489|FG007|Overall Study|Need of additional treatment|0|||
129560298|NCT00818623|466346482|FG000|Overall Study|Lack of trial drug at site|0|||
129560299|NCT00818623|466346483|FG001|Overall Study|Lack of trial drug at site|0|||
129560300|NCT00818623|466346484|FG002|Overall Study|Lack of trial drug at site|0|||
129560301|NCT00818623|466346485|FG003|Overall Study|Lack of trial drug at site|0|||
129560302|NCT00818623|466346486|FG004|Overall Study|Lack of trial drug at site|2|||
129560303|NCT00818623|466346487|FG005|Overall Study|Lack of trial drug at site|0|||
129560304|NCT00818623|466346488|FG006|Overall Study|Lack of trial drug at site|1|||
129560305|NCT00818623|466346489|FG007|Overall Study|Lack of trial drug at site|0|||
129560306|NCT00818623|466346482|FG000|Overall Study|Disease progression|0|||
129560307|NCT00818623|466346483|FG001|Overall Study|Disease progression|0|||
129560308|NCT00818623|466346484|FG002|Overall Study|Disease progression|0|||
129560309|NCT00818623|466346485|FG003|Overall Study|Disease progression|0|||
129560310|NCT00818623|466346486|FG004|Overall Study|Disease progression|0|||
129560311|NCT00818623|466346487|FG005|Overall Study|Disease progression|0|||
129560312|NCT00818623|466346488|FG006|Overall Study|Disease progression|1|||
129560313|NCT00818623|466346489|FG007|Overall Study|Disease progression|0|||
129560314|NCT00602030|466346490|FG000|Lead-in Phase|Disease Progression|2|||
129560315|NCT00602030|466346491|FG001|Lead-in Phase|Disease Progression|3|||
129560316|NCT00602030|466346492|FG002|Lead-in Phase|Disease Progression|0|||
129560317|NCT00602030|466346493|FG003|Lead-in Phase|Disease Progression|0|||
129560318|NCT00602030|466346494|FG004|Lead-in Phase|Disease Progression|0|||
129560319|NCT00602030|466346490|FG000|Lead-in Phase|Adverse Event|0|||
129560320|NCT00602030|466346491|FG001|Lead-in Phase|Adverse Event|2|||
129560321|NCT00602030|466346492|FG002|Lead-in Phase|Adverse Event|0|||
129560322|NCT00602030|466346493|FG003|Lead-in Phase|Adverse Event|0|||
129560323|NCT00602030|466346494|FG004|Lead-in Phase|Adverse Event|0|||
129560324|NCT00602030|466346490|FG000|Double-blind Phase|Disease progression|0|||
129560325|NCT00602030|466346491|FG001|Double-blind Phase|Disease progression|0|||
129560326|NCT00602030|466346492|FG002|Double-blind Phase|Disease progression|33|||
129560327|NCT00602030|466346493|FG003|Double-blind Phase|Disease progression|30|||
129560328|NCT00602030|466346494|FG004|Double-blind Phase|Disease progression|0|||
129560329|NCT00602030|466346490|FG000|Double-blind Phase|Adverse Event|0|||
129560330|NCT00602030|466346491|FG001|Double-blind Phase|Adverse Event|0|||
129560331|NCT00602030|466346492|FG002|Double-blind Phase|Adverse Event|9|||
129560332|NCT00602030|466346493|FG003|Double-blind Phase|Adverse Event|18|||
129560333|NCT00602030|466346494|FG004|Double-blind Phase|Adverse Event|0|||
129560334|NCT00602030|466346490|FG000|Double-blind Phase|Consent withdrawal|0|||
129560335|NCT00602030|466346491|FG001|Double-blind Phase|Consent withdrawal|0|||
129560336|NCT00602030|466346492|FG002|Double-blind Phase|Consent withdrawal|4|||
129560337|NCT00602030|466346493|FG003|Double-blind Phase|Consent withdrawal|3|||
129560338|NCT00602030|466346494|FG004|Double-blind Phase|Consent withdrawal|0|||
129560339|NCT00602030|466346490|FG000|Double-blind Phase|Death|0|||
129560340|NCT00602030|466346491|FG001|Double-blind Phase|Death|0|||
129560341|NCT00602030|466346492|FG002|Double-blind Phase|Death|3|||
129560342|NCT00602030|466346493|FG003|Double-blind Phase|Death|3|||
129560343|NCT00602030|466346494|FG004|Double-blind Phase|Death|0|||
129560344|NCT00602030|466346490|FG000|Double-blind Phase|Administrative decision|0|||
129560345|NCT00602030|466346491|FG001|Double-blind Phase|Administrative decision|0|||
129560346|NCT00602030|466346492|FG002|Double-blind Phase|Administrative decision|0|||
129560347|NCT00602030|466346493|FG003|Double-blind Phase|Administrative decision|2|||
129560348|NCT00602030|466346494|FG004|Double-blind Phase|Administrative decision|0|||
129560349|NCT00602030|466346490|FG000|Double-blind Phase|Ineligibility|0|||
129560350|NCT00602030|466346491|FG001|Double-blind Phase|Ineligibility|0|||
129560351|NCT00602030|466346492|FG002|Double-blind Phase|Ineligibility|0|||
129560352|NCT00602030|466346493|FG003|Double-blind Phase|Ineligibility|1|||
129560353|NCT00602030|466346494|FG004|Double-blind Phase|Ineligibility|0|||
129560354|NCT00602030|466346490|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
129560355|NCT00602030|466346491|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
129560356|NCT00602030|466346492|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
129687436|NCT05073315|466812184|FG002|Period 2|Lost to Follow-up|5|||
129687437|NCT05073315|466812182|FG000|Period 2|Withdrawal by Subject|0|||
129687438|NCT05073315|466812183|FG001|Period 2|Withdrawal by Subject|4|||
129687439|NCT05073315|466812184|FG002|Period 2|Withdrawal by Subject|9|||
129687440|NCT05073315|466812182|FG000|Period 2|Protocol Violation|0|||
129687441|NCT05073315|466812183|FG001|Period 2|Protocol Violation|0|||
129687442|NCT05073315|466812184|FG002|Period 2|Protocol Violation|1|||
129687443|NCT01529268|466812185|FG000|Overall Study|Lost to Follow-up|9|||
129687444|NCT01529268|466812186|FG001|Overall Study|Lost to Follow-up|3|||
129687445|NCT01529268|466812185|FG000|Overall Study|Moved|3|||
129687446|NCT01529268|466812186|FG001|Overall Study|Moved|0|||
129687447|NCT04069520|466812192|FG000|Overall Study|Lost to Follow-up|0|||
129687448|NCT04069520|466812193|FG001|Overall Study|Lost to Follow-up|2|||
129687449|NCT04069520|466812192|FG000|Overall Study|Withdrawal by Subject|0|||
129687450|NCT04069520|466812193|FG001|Overall Study|Withdrawal by Subject|1|||
129687451|NCT04069520|466812192|FG000|Overall Study|Prior Injury|1|||
129687452|NCT04069520|466812193|FG001|Overall Study|Prior Injury|0|||
129560357|NCT00602030|466346493|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
129560358|NCT00602030|466346494|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
129560359|NCT00602030|466346490|FG000|Double-blind Phase|Reason not specified|0|||
129560360|NCT00602030|466346491|FG001|Double-blind Phase|Reason not specified|0|||
129560361|NCT00602030|466346492|FG002|Double-blind Phase|Reason not specified|4|||
129560362|NCT00602030|466346493|FG003|Double-blind Phase|Reason not specified|2|||
129560363|NCT00602030|466346494|FG004|Double-blind Phase|Reason not specified|0|||
129560364|NCT00602030|466346490|FG000|Crossover Phase|Disease Progression|0|||
129560365|NCT00602030|466346491|FG001|Crossover Phase|Disease Progression|0|||
129560366|NCT00602030|466346492|FG002|Crossover Phase|Disease Progression|0|||
129687453|NCT04069520|466812192|FG000|Overall Study|Orthodontia|1|||
129560367|NCT00602030|466346493|FG003|Crossover Phase|Disease Progression|0|||
129560368|NCT00602030|466346494|FG004|Crossover Phase|Disease Progression|11|||
129560369|NCT00602030|466346490|FG000|Crossover Phase|Adverse Event|0|||
129560370|NCT00602030|466346491|FG001|Crossover Phase|Adverse Event|0|||
129560371|NCT00602030|466346492|FG002|Crossover Phase|Adverse Event|0|||
129560372|NCT00602030|466346493|FG003|Crossover Phase|Adverse Event|0|||
129560373|NCT00602030|466346494|FG004|Crossover Phase|Adverse Event|3|||
129560374|NCT00602030|466346490|FG000|Crossover Phase|Consent withdrawal|0|||
129560375|NCT00602030|466346491|FG001|Crossover Phase|Consent withdrawal|0|||
129560376|NCT00602030|466346492|FG002|Crossover Phase|Consent withdrawal|0|||
129560377|NCT00602030|466346493|FG003|Crossover Phase|Consent withdrawal|0|||
129560378|NCT00602030|466346494|FG004|Crossover Phase|Consent withdrawal|2|||
129560379|NCT00638157|466346517|FG000|Overall Study|Adverse Event|0|||
129560380|NCT00638157|466346518|FG001|Overall Study|Adverse Event|1|||
129560381|NCT00638157|466346517|FG000|Overall Study|Clinical (symptomatic) failure|1|||
129560382|NCT00638157|466346518|FG001|Overall Study|Clinical (symptomatic) failure|1|||
129560383|NCT00638157|466346517|FG000|Overall Study|Microbiological failure|1|||
129560384|NCT00638157|466346518|FG001|Overall Study|Microbiological failure|0|||
129560385|NCT00638157|466346517|FG000|Overall Study|Lost to Follow-up|1|||
129560386|NCT00638157|466346518|FG001|Overall Study|Lost to Follow-up|0|||
129560387|NCT00638157|466346517|FG000|Overall Study|Physician Decision|1|||
129560388|NCT00638157|466346518|FG001|Overall Study|Physician Decision|0|||
129560389|NCT00638157|466346517|FG000|Overall Study|Other|1|||
129560390|NCT00638157|466346518|FG001|Overall Study|Other|2|||
129560391|NCT00638157|466346517|FG000|Overall Study|Randomized, not treated|2|||
129560392|NCT00638157|466346518|FG001|Overall Study|Randomized, not treated|0|||
129560393|NCT00876733|466346519|FG000|Overall Study|Adverse Event|34|||
129560394|NCT00876733|466346520|FG001|Overall Study|Adverse Event|20|||
129560395|NCT00876733|466346521|FG002|Overall Study|Adverse Event|10|||
129560396|NCT00876733|466346522|FG003|Overall Study|Adverse Event|3|||
129560397|NCT00876733|466346519|FG000|Overall Study|Lack of Efficacy|17|||
129560398|NCT00876733|466346520|FG001|Overall Study|Lack of Efficacy|9|||
129560399|NCT00876733|466346521|FG002|Overall Study|Lack of Efficacy|10|||
129560400|NCT00876733|466346522|FG003|Overall Study|Lack of Efficacy|1|||
129560401|NCT00876733|466346519|FG000|Overall Study|Lost to Follow-up|26|||
129560402|NCT00876733|466346520|FG001|Overall Study|Lost to Follow-up|10|||
129560403|NCT00876733|466346521|FG002|Overall Study|Lost to Follow-up|3|||
129560404|NCT00876733|466346522|FG003|Overall Study|Lost to Follow-up|2|||
129560405|NCT00876733|466346519|FG000|Overall Study|Data not available|14|||
129560406|NCT00876733|466346520|FG001|Overall Study|Data not available|3|||
129560407|NCT00876733|466346521|FG002|Overall Study|Data not available|7|||
129560408|NCT00876733|466346522|FG003|Overall Study|Data not available|1|||
129560409|NCT02843074|466346523|FG000|Overall Study|Withdrawal by Subject|5|||
129560410|NCT02843074|466346523|FG000|Overall Study|Progressive disease|1|||
129560411|NCT02843074|466346523|FG000|Overall Study|Physician Decision|1|||
129560412|NCT02843074|466346523|FG000|Overall Study|Lost to Follow-up|1|||
129560413|NCT02843074|466346523|FG000|Overall Study|Death|9|||
129560414|NCT01199601|466346527|FG000|Overall Study|Lost to Follow-up|47|||
129560415|NCT01199601|466346528|FG001|Overall Study|Lost to Follow-up|66|||
129560416|NCT01199601|466346527|FG000|Overall Study|Withdrawal by Subject|15|||
129560417|NCT01199601|466346528|FG001|Overall Study|Withdrawal by Subject|3|||
129560418|NCT01199601|466346527|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
129560419|NCT01199601|466346528|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
129687454|NCT04069520|466812193|FG001|Overall Study|Orthodontia|0|||
129687455|NCT04069520|466812192|FG000|Overall Study|Cut from team|0|||
129687456|NCT04069520|466812193|FG001|Overall Study|Cut from team|2|||
129687457|NCT01068912|466812194|FG000|Overall Study|Adverse Event|2|||
129687458|NCT01068912|466812195|FG001|Overall Study|Adverse Event|3|||
129687459|NCT01068912|466812196|FG002|Overall Study|Adverse Event|2|||
129687460|NCT01068912|466812194|FG000|Overall Study|Withdrawal by Subject|5|||
129687461|NCT01068912|466812195|FG001|Overall Study|Withdrawal by Subject|6|||
129687462|NCT01068912|466812196|FG002|Overall Study|Withdrawal by Subject|6|||
129687463|NCT01068912|466812194|FG000|Overall Study|Lost to Follow-up|3|||
129560420|NCT02669264|466346529|FG000|Overall Study|Death|5|||
129560421|NCT02669264|466346530|FG001|Overall Study|Death|5|||
129560422|NCT02669264|466346531|FG002|Overall Study|Death|3|||
129687464|NCT01068912|466812195|FG001|Overall Study|Lost to Follow-up|7|||
129687465|NCT01068912|466812196|FG002|Overall Study|Lost to Follow-up|3|||
129560423|NCT02669264|466346532|FG003|Overall Study|Death|3|||
129560424|NCT02669264|466346533|FG004|Overall Study|Death|3|||
129560425|NCT02669264|466346534|FG005|Overall Study|Death|6|||
129560426|NCT02669264|466346535|FG006|Overall Study|Death|3|||
129560427|NCT02669264|466346529|FG000|Overall Study|Withdrawal by Subject|0|||
129560428|NCT02669264|466346530|FG001|Overall Study|Withdrawal by Subject|1|||
129560429|NCT02669264|466346531|FG002|Overall Study|Withdrawal by Subject|0|||
129560430|NCT02669264|466346532|FG003|Overall Study|Withdrawal by Subject|0|||
129560431|NCT02669264|466346533|FG004|Overall Study|Withdrawal by Subject|1|||
129560432|NCT02669264|466346534|FG005|Overall Study|Withdrawal by Subject|0|||
129560433|NCT02669264|466346535|FG006|Overall Study|Withdrawal by Subject|0|||
129560434|NCT02669264|466346529|FG000|Overall Study|Lost to Follow-up|0|||
129560435|NCT02669264|466346530|FG001|Overall Study|Lost to Follow-up|0|||
129560436|NCT02669264|466346531|FG002|Overall Study|Lost to Follow-up|0|||
129560437|NCT02669264|466346532|FG003|Overall Study|Lost to Follow-up|0|||
129560438|NCT02669264|466346533|FG004|Overall Study|Lost to Follow-up|1|||
129560439|NCT02669264|466346534|FG005|Overall Study|Lost to Follow-up|0|||
129560440|NCT02669264|466346535|FG006|Overall Study|Lost to Follow-up|0|||
129560441|NCT02669264|466346529|FG000|Overall Study|Miscellaneous|0|||
129560442|NCT02669264|466346530|FG001|Overall Study|Miscellaneous|0|||
129560443|NCT02669264|466346531|FG002|Overall Study|Miscellaneous|0|||
129560444|NCT02669264|466346532|FG003|Overall Study|Miscellaneous|0|||
129560445|NCT02669264|466346533|FG004|Overall Study|Miscellaneous|0|||
129560446|NCT02669264|466346534|FG005|Overall Study|Miscellaneous|0|||
129560447|NCT02669264|466346535|FG006|Overall Study|Miscellaneous|2|||
129560448|NCT01688037|466346536|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
129560449|NCT01688037|466346537|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
129560450|NCT01688037|466346538|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
129560451|NCT01688037|466346536|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
129560452|NCT01688037|466346537|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
129560453|NCT01688037|466346538|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
129560454|NCT01688037|466346536|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
129560455|NCT01688037|466346537|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
129560456|NCT01688037|466346538|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
129560457|NCT01688037|466346536|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
129560458|NCT01688037|466346537|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
129560459|NCT01688037|466346538|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
129560460|NCT01688037|466346536|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
129560461|NCT01688037|466346537|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
129560462|NCT01688037|466346538|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
129560463|NCT01688037|466346536|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
129560464|NCT01688037|466346537|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
129560465|NCT01688037|466346538|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
129560466|NCT01688037|466346536|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
129560467|NCT01688037|466346537|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
129560468|NCT01688037|466346538|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
129560469|NCT01688037|466346536|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
129560470|NCT01688037|466346537|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
129560471|NCT01688037|466346538|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
129560472|NCT01688037|466346536|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
129560473|NCT01688037|466346537|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
129560474|NCT01688037|466346538|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
129777973|NCT02003924|467152497|FG000|Double-blind Phase|Randomized But not Treated|3|||
129777974|NCT02003924|467152498|FG001|Double-blind Phase|Randomized But not Treated|3|||
129777975|NCT02003924|467152499|FG002|Double-blind Phase|Randomized But not Treated|0|||
129777976|NCT02003924|467152497|FG000|Double-blind Phase|Other|29|||
129777977|NCT02003924|467152498|FG001|Double-blind Phase|Other|50|||
129777978|NCT02003924|467152499|FG002|Double-blind Phase|Other|0|||
129777979|NCT02003924|467152497|FG000|Open-label Phase|Lost to Follow-up|0|||
129777980|NCT02003924|467152498|FG001|Open-label Phase|Lost to Follow-up|0|||
129777981|NCT02003924|467152499|FG002|Open-label Phase|Lost to Follow-up|1|||
129777982|NCT02003924|467152497|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
129777983|NCT02003924|467152498|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
129777984|NCT02003924|467152499|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
129777985|NCT02003924|467152497|FG000|Open-label Phase|Disease Progression|59|||
129777986|NCT02003924|467152498|FG001|Open-label Phase|Disease Progression|0|||
129777987|NCT02003924|467152499|FG002|Open-label Phase|Disease Progression|5|||
129777988|NCT02003924|467152497|FG000|Open-label Phase|Adverse Event|25|||
129777989|NCT02003924|467152498|FG001|Open-label Phase|Adverse Event|0|||
129777990|NCT02003924|467152499|FG002|Open-label Phase|Adverse Event|10|||
129777991|NCT02003924|467152497|FG000|Open-label Phase|Other|7|||
129777992|NCT02003924|467152498|FG001|Open-label Phase|Other|0|||
129777993|NCT02003924|467152499|FG002|Open-label Phase|Other|0|||
129777994|NCT02003924|467152497|FG000|Long-term Follow-up Phase|Death|288|||
129884519|NCT04779242|467536437|FG001|Overall Study|Lost to Follow-up|4|||
129560475|NCT01688037|466346536|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
129560476|NCT01688037|466346537|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
129560477|NCT01688037|466346538|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
129560478|NCT02100956|466346539|FG000|At Least One Week Between Injections|Adverse Event|0|||
129560479|NCT02100956|466346540|FG001|At Least One Week Between Injections|Adverse Event|1|||
129560480|NCT03035227|466346541|FG000|Overall Study|study stopped due to PI leaving institut|1|||
129560481|NCT03035227|466346542|FG001|Overall Study|study stopped due to PI leaving institut|1|||
129560482|NCT00859469|466346544|FG000|Overall Study|Adverse Event|2|||
129777995|NCT02003924|467152498|FG001|Long-term Follow-up Phase|Death|174|||
129560483|NCT00859469|466346544|FG000|Overall Study|Lack of Efficacy|9|||
129560484|NCT00859469|466346544|FG000|Overall Study|Withdrawal by Subject|1|||
129560485|NCT00859469|466346544|FG000|Overall Study|Death|16|||
129560486|NCT02220907|466346545|FG000|Overall Study|Adverse Event|7|||
129560487|NCT02220907|466346545|FG000|Overall Study|Physician Decision|1|||
129560488|NCT02220907|466346545|FG000|Overall Study|Withdrawal by Subject|2|||
129560489|NCT02220907|466346545|FG000|Overall Study|Conflict with the stopping criteria|1|||
129560490|NCT03111147|466346546|FG000|Overall Study|Lost to Follow-up|2|||
129560491|NCT03111147|466346547|FG001|Overall Study|Lost to Follow-up|5|||
129560492|NCT03111147|466346546|FG000|Overall Study|Withdrawal by Subject|4|||
129560493|NCT03111147|466346547|FG001|Overall Study|Withdrawal by Subject|3|||
129560494|NCT03111147|466346546|FG000|Overall Study|Protocol Violation|2|||
129560495|NCT03111147|466346547|FG001|Overall Study|Protocol Violation|1|||
129560496|NCT03111147|466346546|FG000|Overall Study|Death|1|||
129560497|NCT03111147|466346547|FG001|Overall Study|Death|1|||
129560498|NCT00095199|466346550|FG000|Overall Study|Adverse Event|40|||
129560499|NCT00095199|466346551|FG001|Overall Study|Adverse Event|22|||
129560500|NCT00095199|466346552|FG002|Overall Study|Adverse Event|26|||
129560501|NCT00095199|466346553|FG003|Overall Study|Adverse Event|11|||
129560502|NCT00095199|466346550|FG000|Overall Study|Progressive disease|213|||
129560503|NCT00095199|466346551|FG001|Overall Study|Progressive disease|179|||
129560504|NCT00095199|466346552|FG002|Overall Study|Progressive disease|105|||
129560505|NCT00095199|466346553|FG003|Overall Study|Progressive disease|98|||
129560506|NCT00095199|466346550|FG000|Overall Study|Death|10|||
129560507|NCT00095199|466346551|FG001|Overall Study|Death|6|||
129560508|NCT00095199|466346552|FG002|Overall Study|Death|11|||
129560509|NCT00095199|466346553|FG003|Overall Study|Death|9|||
129560510|NCT00095199|466346550|FG000|Overall Study|Withdrawal by Subject|21|||
129560511|NCT00095199|466346551|FG001|Overall Study|Withdrawal by Subject|16|||
129560512|NCT00095199|466346552|FG002|Overall Study|Withdrawal by Subject|13|||
129560513|NCT00095199|466346553|FG003|Overall Study|Withdrawal by Subject|22|||
129560514|NCT00095199|466346550|FG000|Overall Study|Protocol Violation|4|||
129560515|NCT00095199|466346551|FG001|Overall Study|Protocol Violation|4|||
129560516|NCT00095199|466346552|FG002|Overall Study|Protocol Violation|2|||
129560517|NCT00095199|466346553|FG003|Overall Study|Protocol Violation|0|||
129560518|NCT00095199|466346550|FG000|Overall Study|Liver function test results elevated|0|||
129560519|NCT00095199|466346551|FG001|Overall Study|Liver function test results elevated|0|||
129560520|NCT00095199|466346552|FG002|Overall Study|Liver function test results elevated|1|||
129560521|NCT00095199|466346553|FG003|Overall Study|Liver function test results elevated|1|||
129560522|NCT00095199|466346550|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
129560523|NCT00095199|466346551|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
129560524|NCT00095199|466346552|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
129560525|NCT00095199|466346553|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
129560526|NCT00095199|466346550|FG000|Overall Study|Physician Decision|5|||
129560527|NCT00095199|466346551|FG001|Overall Study|Physician Decision|6|||
129560528|NCT00095199|466346552|FG002|Overall Study|Physician Decision|1|||
129560529|NCT00095199|466346553|FG003|Overall Study|Physician Decision|1|||
129560530|NCT00095199|466346550|FG000|Overall Study|Not eligible|1|||
129560531|NCT00095199|466346551|FG001|Overall Study|Not eligible|7|||
129560532|NCT00095199|466346552|FG002|Overall Study|Not eligible|0|||
129560533|NCT00095199|466346553|FG003|Overall Study|Not eligible|1|||
129560534|NCT00095199|466346550|FG000|Overall Study|Started Palliative Radiotherapy|1|||
129560535|NCT00095199|466346551|FG001|Overall Study|Started Palliative Radiotherapy|0|||
129560536|NCT00095199|466346552|FG002|Overall Study|Started Palliative Radiotherapy|0|||
129560537|NCT00095199|466346553|FG003|Overall Study|Started Palliative Radiotherapy|0|||
129560538|NCT00095199|466346550|FG000|Overall Study|Started radiotherapy regimen|0|||
129560539|NCT00095199|466346551|FG001|Overall Study|Started radiotherapy regimen|1|||
129560540|NCT00095199|466346552|FG002|Overall Study|Started radiotherapy regimen|0|||
129560541|NCT00095199|466346553|FG003|Overall Study|Started radiotherapy regimen|0|||
129687466|NCT01068912|466812194|FG000|Overall Study|Protocol Violation|0|||
129687467|NCT01068912|466812195|FG001|Overall Study|Protocol Violation|2|||
129687468|NCT01068912|466812196|FG002|Overall Study|Protocol Violation|0|||
129687469|NCT01068912|466812194|FG000|Overall Study|aggravation influenza|1|||
129560542|NCT00095199|466346550|FG000|Overall Study|Primary tumor removed in other surgery|0|||
129560543|NCT00095199|466346551|FG001|Overall Study|Primary tumor removed in other surgery|1|||
129560544|NCT00095199|466346552|FG002|Overall Study|Primary tumor removed in other surgery|0|||
129560545|NCT00095199|466346553|FG003|Overall Study|Primary tumor removed in other surgery|0|||
129560546|NCT00095199|466346550|FG000|Overall Study|Data inadvertently lost by site|1|||
129560547|NCT00095199|466346551|FG001|Overall Study|Data inadvertently lost by site|0|||
129560548|NCT00095199|466346552|FG002|Overall Study|Data inadvertently lost by site|0|||
129560549|NCT00095199|466346553|FG003|Overall Study|Data inadvertently lost by site|0|||
129560550|NCT01896297|466346556|FG000|Overall Study|Died in post treatment phase|1|||
129560551|NCT01070394|466346557|FG000|Overall Study|Adverse Event|6|||
129560552|NCT01070394|466346557|FG000|Overall Study|Withdrawal by Subject|1|||
129560553|NCT01098240|466346558|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
129687470|NCT01068912|466812195|FG001|Overall Study|aggravation influenza|1|||
129560554|NCT01098240|466346559|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
129560555|NCT01098240|466346560|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
129560556|NCT01098240|466346558|FG000|Open-Label Phase|Protocol Violation|4|||
129560557|NCT01098240|466346559|FG001|Open-Label Phase|Protocol Violation|0|||
129560558|NCT01098240|466346560|FG002|Open-Label Phase|Protocol Violation|0|||
129560559|NCT01098240|466346558|FG000|Open-Label Phase|Lost to Follow-up|13|||
129560560|NCT01098240|466346559|FG001|Open-Label Phase|Lost to Follow-up|0|||
129560561|NCT01098240|466346560|FG002|Open-Label Phase|Lost to Follow-up|0|||
129560562|NCT01098240|466346558|FG000|Open-Label Phase|Other|19|||
129560563|NCT01098240|466346559|FG001|Open-Label Phase|Other|0|||
129560564|NCT01098240|466346560|FG002|Open-Label Phase|Other|0|||
129560565|NCT01098240|466346558|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
129560566|NCT01098240|466346559|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129560567|NCT01098240|466346560|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129560568|NCT01098240|466346558|FG000|Open-Label Phase|Pregnancy|1|||
129560569|NCT01098240|466346559|FG001|Open-Label Phase|Pregnancy|0|||
129560570|NCT01098240|466346560|FG002|Open-Label Phase|Pregnancy|0|||
129560571|NCT01098240|466346558|FG000|Open-Label Phase|Withdrawal by Subject|9|||
129560572|NCT01098240|466346559|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129560573|NCT01098240|466346560|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129560574|NCT01098240|466346558|FG000|Open-Label Phase|Adverse Event|12|||
129560575|NCT01098240|466346559|FG001|Open-Label Phase|Adverse Event|0|||
129560576|NCT01098240|466346560|FG002|Open-Label Phase|Adverse Event|0|||
129560577|NCT01098240|466346558|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
129560578|NCT01098240|466346559|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
129560579|NCT01098240|466346560|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
129560580|NCT01098240|466346558|FG000|Double-Blind Phase|Protocol Violation|0|||
129560581|NCT01098240|466346559|FG001|Double-Blind Phase|Protocol Violation|2|||
129560582|NCT01098240|466346560|FG002|Double-Blind Phase|Protocol Violation|4|||
129560583|NCT01098240|466346558|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129560584|NCT01098240|466346559|FG001|Double-Blind Phase|Lost to Follow-up|2|||
129560585|NCT01098240|466346560|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129560586|NCT01098240|466346558|FG000|Double-Blind Phase|Other|0|||
129560587|NCT01098240|466346559|FG001|Double-Blind Phase|Other|2|||
129560588|NCT01098240|466346560|FG002|Double-Blind Phase|Other|2|||
129560589|NCT01098240|466346558|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
129560590|NCT01098240|466346559|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
129560591|NCT01098240|466346560|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
129560592|NCT01098240|466346558|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
129560593|NCT01098240|466346559|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
129560594|NCT01098240|466346560|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
129560595|NCT01098240|466346558|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129560596|NCT01098240|466346559|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
129560597|NCT01098240|466346560|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
129560598|NCT01098240|466346558|FG000|Double-Blind Phase|Adverse Event|0|||
129560599|NCT01098240|466346559|FG001|Double-Blind Phase|Adverse Event|3|||
129560600|NCT01098240|466346560|FG002|Double-Blind Phase|Adverse Event|3|||
129560601|NCT03280537|466346561|FG000|Overall Study|Withdrawal by Subject|2|||
129560602|NCT03280537|466346562|FG001|Overall Study|Withdrawal by Subject|4|||
129560603|NCT01588106|466346563|FG000|Overall Study|Withdrawal by Subject|5|||
129560604|NCT01588106|466346564|FG001|Overall Study|Withdrawal by Subject|4|||
129560605|NCT03083132|466346565|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
129560606|NCT03083132|466346566|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
129560607|NCT03083132|466346565|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
129560608|NCT03083132|466346566|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
129560609|NCT03083132|466346565|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
129560610|NCT03083132|466346566|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
129777996|NCT02003924|467152499|FG002|Long-term Follow-up Phase|Death|4|||
129560611|NCT03118739|466346567|FG000|Overall Study|Physician Decision|0|||
129560612|NCT03118739|466346568|FG001|Overall Study|Physician Decision|1|||
129560613|NCT03118739|466346567|FG000|Overall Study|Withdrawal by Subject|5|||
129560614|NCT03118739|466346568|FG001|Overall Study|Withdrawal by Subject|3|||
129560615|NCT03118739|466346567|FG000|Overall Study|Lost to Follow-up|2|||
129560616|NCT03118739|466346568|FG001|Overall Study|Lost to Follow-up|0|||
129560617|NCT00669955|466346569|FG000|Overall Study|Adverse Event|3|||
129560618|NCT00669955|466346570|FG001|Overall Study|Adverse Event|5|||
129560619|NCT00669955|466346569|FG000|Overall Study|Death|0|||
129560620|NCT00669955|466346570|FG001|Overall Study|Death|1|||
129560621|NCT00669955|466346569|FG000|Overall Study|Withdrawal by Subject|2|||
129560622|NCT00669955|466346570|FG001|Overall Study|Withdrawal by Subject|3|||
129560623|NCT00669955|466346569|FG000|Overall Study|Lost to Follow-up|5|||
129560624|NCT00669955|466346570|FG001|Overall Study|Lost to Follow-up|7|||
129560625|NCT00669955|466346569|FG000|Overall Study|Protocol Violation|2|||
129560626|NCT00669955|466346570|FG001|Overall Study|Protocol Violation|7|||
129560627|NCT00669955|466346569|FG000|Overall Study|Investigator Sponsor Judgement|0|||
129560628|NCT00669955|466346570|FG001|Overall Study|Investigator Sponsor Judgement|1|||
129560629|NCT00669955|466346569|FG000|Overall Study|not compliant with study drug/visit|2|||
129560630|NCT00669955|466346570|FG001|Overall Study|not compliant with study drug/visit|3|||
129560631|NCT04274192|466346574|FG000|Overall Study|Protocol Violation|1|||
129560632|NCT04274192|466346575|FG001|Overall Study|Protocol Violation|0|||
129560633|NCT03507439|466346576|FG000|Overall Study|Other|2|||
129560634|NCT03507439|466346577|FG001|Overall Study|Other|1|||
129560635|NCT03507439|466346576|FG000|Overall Study|Withdrawal by Subject|1|||
129560636|NCT03507439|466346577|FG001|Overall Study|Withdrawal by Subject|0|||
129560637|NCT03507439|466346576|FG000|Overall Study|Death|1|||
129560638|NCT03507439|466346577|FG001|Overall Study|Death|1|||
129560639|NCT01621490|466348137|FG000|Overall Study|Subject no longer meets study criteria|0|||
129560640|NCT01621490|466348138|FG001|Overall Study|Subject no longer meets study criteria|0|||
129560641|NCT01621490|466348139|FG002|Overall Study|Subject no longer meets study criteria|0|||
129560642|NCT01621490|466348140|FG003|Overall Study|Subject no longer meets study criteria|0|||
129560643|NCT01621490|466348141|FG004|Overall Study|Subject no longer meets study criteria|1|||
129560644|NCT01621490|466348142|FG005|Overall Study|Subject no longer meets study criteria|0|||
129560645|NCT01621490|466348143|FG006|Overall Study|Subject no longer meets study criteria|0|||
129560646|NCT01621490|466348144|FG007|Overall Study|Subject no longer meets study criteria|0|||
129560647|NCT01621490|466348145|FG008|Overall Study|Subject no longer meets study criteria|0|||
129560648|NCT01621490|466348146|FG009|Overall Study|Subject no longer meets study criteria|0|||
129560649|NCT01621490|466348147|FG010|Overall Study|Subject no longer meets study criteria|0|||
129560650|NCT01621490|466348137|FG000|Overall Study|Maximum clinical benefit|3|||
129560651|NCT01621490|466348138|FG001|Overall Study|Maximum clinical benefit|2|||
129560652|NCT01621490|466348139|FG002|Overall Study|Maximum clinical benefit|0|||
129560653|NCT01621490|466348140|FG003|Overall Study|Maximum clinical benefit|0|||
129560654|NCT01621490|466348141|FG004|Overall Study|Maximum clinical benefit|0|||
129560655|NCT01621490|466348142|FG005|Overall Study|Maximum clinical benefit|0|||
129560656|NCT01621490|466348143|FG006|Overall Study|Maximum clinical benefit|1|||
129560657|NCT01621490|466348144|FG007|Overall Study|Maximum clinical benefit|2|||
129560658|NCT01621490|466348145|FG008|Overall Study|Maximum clinical benefit|2|||
129560659|NCT01621490|466348146|FG009|Overall Study|Maximum clinical benefit|0|||
129560660|NCT01621490|466348147|FG010|Overall Study|Maximum clinical benefit|0|||
129560661|NCT01621490|466348137|FG000|Overall Study|Withdrawal by Subject|1|||
129560662|NCT01621490|466348138|FG001|Overall Study|Withdrawal by Subject|0|||
129560663|NCT01621490|466348139|FG002|Overall Study|Withdrawal by Subject|0|||
129560664|NCT01621490|466348140|FG003|Overall Study|Withdrawal by Subject|0|||
129560665|NCT01621490|466348141|FG004|Overall Study|Withdrawal by Subject|0|||
129560666|NCT01621490|466348142|FG005|Overall Study|Withdrawal by Subject|1|||
129560667|NCT01621490|466348143|FG006|Overall Study|Withdrawal by Subject|0|||
129560668|NCT01621490|466348144|FG007|Overall Study|Withdrawal by Subject|0|||
129560669|NCT01621490|466348145|FG008|Overall Study|Withdrawal by Subject|0|||
129560670|NCT01621490|466348146|FG009|Overall Study|Withdrawal by Subject|0|||
129560671|NCT01621490|466348147|FG010|Overall Study|Withdrawal by Subject|0|||
129560672|NCT01621490|466348137|FG000|Overall Study|Subject request to discontinue study|1|||
129560673|NCT01621490|466348138|FG001|Overall Study|Subject request to discontinue study|3|||
129560674|NCT01621490|466348139|FG002|Overall Study|Subject request to discontinue study|1|||
129560675|NCT01621490|466348140|FG003|Overall Study|Subject request to discontinue study|1|||
129560676|NCT01621490|466348141|FG004|Overall Study|Subject request to discontinue study|0|||
129560677|NCT01621490|466348142|FG005|Overall Study|Subject request to discontinue study|2|||
129560678|NCT01621490|466348143|FG006|Overall Study|Subject request to discontinue study|1|||
129560679|NCT01621490|466348144|FG007|Overall Study|Subject request to discontinue study|0|||
129560680|NCT01621490|466348145|FG008|Overall Study|Subject request to discontinue study|1|||
129687471|NCT01068912|466812196|FG002|Overall Study|aggravation influenza|1|||
129687472|NCT01068912|466812194|FG000|Overall Study|other underlying illness|0|||
129687473|NCT01068912|466812195|FG001|Overall Study|other underlying illness|3|||
129687474|NCT01068912|466812196|FG002|Overall Study|other underlying illness|3|||
129687475|NCT01947933|466812197|FG000|Overall Study|Withdrawal by Subject|0|||
129687476|NCT01947933|466812198|FG001|Overall Study|Withdrawal by Subject|0|||
129560681|NCT01621490|466348146|FG009|Overall Study|Subject request to discontinue study|0|||
129687477|NCT01947933|466812199|FG002|Overall Study|Withdrawal by Subject|1|||
129560682|NCT01621490|466348147|FG010|Overall Study|Subject request to discontinue study|0|||
129560683|NCT01621490|466348137|FG000|Overall Study|Adverse event unrelated to study drug|1|||
129560684|NCT01621490|466348138|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129560685|NCT01621490|466348139|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129560686|NCT01621490|466348140|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129560687|NCT01621490|466348141|FG004|Overall Study|Adverse event unrelated to study drug|0|||
129687478|NCT01947933|466812200|FG003|Overall Study|Withdrawal by Subject|0|||
129560688|NCT01621490|466348142|FG005|Overall Study|Adverse event unrelated to study drug|0|||
129560689|NCT01621490|466348143|FG006|Overall Study|Adverse event unrelated to study drug|0|||
129560690|NCT01621490|466348144|FG007|Overall Study|Adverse event unrelated to study drug|2|||
129560691|NCT01621490|466348145|FG008|Overall Study|Adverse event unrelated to study drug|0|||
129560692|NCT01621490|466348146|FG009|Overall Study|Adverse event unrelated to study drug|0|||
129560693|NCT01621490|466348147|FG010|Overall Study|Adverse event unrelated to study drug|0|||
129560694|NCT01621490|466348137|FG000|Overall Study|Disease progression|27|||
129560695|NCT01621490|466348138|FG001|Overall Study|Disease progression|28|||
129560696|NCT01621490|466348139|FG002|Overall Study|Disease progression|1|||
129560697|NCT01621490|466348140|FG003|Overall Study|Disease progression|5|||
129560698|NCT01621490|466348141|FG004|Overall Study|Disease progression|3|||
129560699|NCT01621490|466348142|FG005|Overall Study|Disease progression|8|||
129560700|NCT01621490|466348143|FG006|Overall Study|Disease progression|7|||
129560701|NCT01621490|466348144|FG007|Overall Study|Disease progression|1|||
129560702|NCT01621490|466348145|FG008|Overall Study|Disease progression|4|||
129560703|NCT01621490|466348146|FG009|Overall Study|Disease progression|1|||
129560704|NCT01621490|466348147|FG010|Overall Study|Disease progression|1|||
129560705|NCT01621490|466348137|FG000|Overall Study|Study drug toxicity|1|||
129560706|NCT01621490|466348138|FG001|Overall Study|Study drug toxicity|4|||
129560707|NCT01621490|466348139|FG002|Overall Study|Study drug toxicity|5|||
129560708|NCT01621490|466348140|FG003|Overall Study|Study drug toxicity|3|||
129560709|NCT01621490|466348141|FG004|Overall Study|Study drug toxicity|1|||
129560710|NCT01621490|466348142|FG005|Overall Study|Study drug toxicity|10|||
129560711|NCT01621490|466348143|FG006|Overall Study|Study drug toxicity|1|||
129560712|NCT01621490|466348144|FG007|Overall Study|Study drug toxicity|4|||
129560713|NCT01621490|466348145|FG008|Overall Study|Study drug toxicity|1|||
129560714|NCT01621490|466348146|FG009|Overall Study|Study drug toxicity|0|||
129560715|NCT01621490|466348147|FG010|Overall Study|Study drug toxicity|0|||
129560716|NCT01621490|466348137|FG000|Overall Study|Death|0|||
129560717|NCT01621490|466348138|FG001|Overall Study|Death|0|||
129560718|NCT01621490|466348139|FG002|Overall Study|Death|0|||
129560719|NCT01621490|466348140|FG003|Overall Study|Death|0|||
129560720|NCT01621490|466348141|FG004|Overall Study|Death|0|||
129560721|NCT01621490|466348142|FG005|Overall Study|Death|0|||
129560722|NCT01621490|466348143|FG006|Overall Study|Death|0|||
129560723|NCT01621490|466348144|FG007|Overall Study|Death|0|||
129560724|NCT01621490|466348145|FG008|Overall Study|Death|1|||
129560725|NCT01621490|466348146|FG009|Overall Study|Death|0|||
129560726|NCT01621490|466348147|FG010|Overall Study|Death|0|||
129560727|NCT01621490|466348137|FG000|Overall Study|Other reasons|7|||
129560728|NCT01621490|466348138|FG001|Overall Study|Other reasons|6|||
129560729|NCT01621490|466348139|FG002|Overall Study|Other reasons|4|||
129560730|NCT01621490|466348140|FG003|Overall Study|Other reasons|1|||
129560731|NCT01621490|466348141|FG004|Overall Study|Other reasons|1|||
129560732|NCT01621490|466348142|FG005|Overall Study|Other reasons|3|||
129560733|NCT01621490|466348143|FG006|Overall Study|Other reasons|1|||
129560734|NCT01621490|466348144|FG007|Overall Study|Other reasons|1|||
129560735|NCT01621490|466348145|FG008|Overall Study|Other reasons|1|||
129560736|NCT01621490|466348146|FG009|Overall Study|Other reasons|0|||
129560737|NCT01621490|466348147|FG010|Overall Study|Other reasons|0|||
129560738|NCT00506753|466348148|FG000|Overall Study|Lost to Follow-up|21|||
129560739|NCT00506753|466348149|FG001|Overall Study|Lost to Follow-up|15|||
129560740|NCT00125359|466348150|FG000|Overall Study|Death|4|||
129560741|NCT00125359|466348150|FG000|Overall Study|Adverse Event|5|||
129560742|NCT00125359|466348150|FG000|Overall Study|Physician Decision|14|||
129560743|NCT02451670|466348151|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
129560744|NCT02451670|466348152|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
129560745|NCT00461500|466348153|FG000|Overall Study|Adverse Event|1|||
129560746|NCT00461500|466348154|FG001|Overall Study|Adverse Event|0|||
129560747|NCT00461500|466348153|FG000|Overall Study|Lack of Efficacy|0|||
129560748|NCT00461500|466348154|FG001|Overall Study|Lack of Efficacy|1|||
129560749|NCT00461500|466348153|FG000|Overall Study|Expired Drug Treatment|1|||
129687479|NCT01947933|466812201|FG004|Overall Study|Withdrawal by Subject|0|||
129560750|NCT00461500|466348154|FG001|Overall Study|Expired Drug Treatment|1|||
129560751|NCT00461500|466348153|FG000|Overall Study|Study Stopped|1|||
129560752|NCT00461500|466348154|FG001|Overall Study|Study Stopped|2|||
129560753|NCT00461500|466348153|FG000|Overall Study|Drug Treatment Misuse|1|||
129560754|NCT00461500|466348154|FG001|Overall Study|Drug Treatment Misuse|0|||
129560755|NCT00461500|466348153|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
129560756|NCT00461500|466348154|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
129560757|NCT00461500|466348153|FG000|Overall Study|Lost to Follow-up|2|||
129560758|NCT00461500|466348154|FG001|Overall Study|Lost to Follow-up|2|||
129560759|NCT01513551|466348155|FG000|Overall Study|Death|0|||
129560760|NCT01513551|466348156|FG001|Overall Study|Death|1|||
129560761|NCT01513551|466348157|FG002|Overall Study|Death|0|||
129560762|NCT01513551|466348155|FG000|Overall Study|Lost to Follow-up|3|||
129560763|NCT01513551|466348156|FG001|Overall Study|Lost to Follow-up|5|||
129560764|NCT01513551|466348157|FG002|Overall Study|Lost to Follow-up|2|||
129560765|NCT01513551|466348155|FG000|Overall Study|Withdrawal by Subject|1|||
129560766|NCT01513551|466348156|FG001|Overall Study|Withdrawal by Subject|0|||
129560767|NCT01513551|466348157|FG002|Overall Study|Withdrawal by Subject|2|||
129560768|NCT01513551|466348155|FG000|Overall Study|Randomized but not vaccinated|0|||
129560769|NCT01513551|466348156|FG001|Overall Study|Randomized but not vaccinated|0|||
129560770|NCT01513551|466348157|FG002|Overall Study|Randomized but not vaccinated|1|||
129560771|NCT02247479|466348159|FG000|Overall Study|Adverse Event|8|||
129560772|NCT02247479|466348160|FG001|Overall Study|Adverse Event|9|||
129560773|NCT02247479|466348161|FG002|Overall Study|Adverse Event|8|||
129560774|NCT02247479|466348159|FG000|Overall Study|Death|5|||
129560775|NCT02247479|466348160|FG001|Overall Study|Death|4|||
129560776|NCT02247479|466348161|FG002|Overall Study|Death|6|||
129560777|NCT02247479|466348159|FG000|Overall Study|Lost to Follow-up|3|||
129560778|NCT02247479|466348160|FG001|Overall Study|Lost to Follow-up|3|||
129560779|NCT02247479|466348161|FG002|Overall Study|Lost to Follow-up|1|||
129560780|NCT02247479|466348159|FG000|Overall Study|Non-compliance|0|||
129560781|NCT02247479|466348160|FG001|Overall Study|Non-compliance|0|||
129560782|NCT02247479|466348161|FG002|Overall Study|Non-compliance|1|||
129560783|NCT02247479|466348159|FG000|Overall Study|Withdrawal by Subject|25|||
129560784|NCT02247479|466348160|FG001|Overall Study|Withdrawal by Subject|29|||
129560785|NCT02247479|466348161|FG002|Overall Study|Withdrawal by Subject|24|||
129560786|NCT02247479|466348159|FG000|Overall Study|Study Terminated by Sponsor|98|||
129560787|NCT02247479|466348160|FG001|Overall Study|Study Terminated by Sponsor|88|||
129560788|NCT02247479|466348161|FG002|Overall Study|Study Terminated by Sponsor|94|||
129560789|NCT02247479|466348159|FG000|Overall Study|Physician Decision|1|||
129560790|NCT02247479|466348160|FG001|Overall Study|Physician Decision|0|||
129560791|NCT02247479|466348161|FG002|Overall Study|Physician Decision|2|||
129560792|NCT02247479|466348159|FG000|Overall Study|Unspecified Reason|2|||
129560793|NCT02247479|466348160|FG001|Overall Study|Unspecified Reason|5|||
129560794|NCT02247479|466348161|FG002|Overall Study|Unspecified Reason|2|||
129560795|NCT00094302|466348163|FG000|Overall Study|Lost to Follow-up|43|||
129560796|NCT00094302|466348164|FG001|Overall Study|Lost to Follow-up|41|||
129560797|NCT00094302|466348163|FG000|Overall Study|Physician Decision|5|||
129560798|NCT00094302|466348164|FG001|Overall Study|Physician Decision|8|||
129560799|NCT00094302|466348163|FG000|Overall Study|Withdrawal by Subject|103|||
129560800|NCT00094302|466348164|FG001|Overall Study|Withdrawal by Subject|111|||
129560801|NCT00094302|466348163|FG000|Overall Study|Death|266|||
129560802|NCT00094302|466348164|FG001|Overall Study|Death|246|||
129560803|NCT01162499|466348170|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
129560804|NCT01162499|466348171|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
129560805|NCT01590433|466348172|FG000|Overall Study|Lost to Follow-up|20|||
129560806|NCT01590433|466348173|FG001|Overall Study|Lost to Follow-up|8|||
129560807|NCT01590433|466348172|FG000|Overall Study|Withdrawal by Subject|21|||
129560808|NCT01590433|466348173|FG001|Overall Study|Withdrawal by Subject|11|||
129560809|NCT01590433|466348172|FG000|Overall Study|Adverse Event|11|||
129560810|NCT01590433|466348173|FG001|Overall Study|Adverse Event|3|||
129560811|NCT00555009|466348174|FG000|Overall Study|Withdrawal by Subject|0|||
129560812|NCT00555009|466348175|FG001|Overall Study|Withdrawal by Subject|1|||
129560813|NCT00555009|466348174|FG000|Overall Study|Terminated by Sponsor|2|||
129560814|NCT00555009|466348175|FG001|Overall Study|Terminated by Sponsor|5|||
129560815|NCT02058628|466348176|FG000|Overall Study|Adverse Event|1|||
129687480|NCT01947933|466812202|FG005|Overall Study|Withdrawal by Subject|0|||
129687481|NCT01947933|466812203|FG006|Overall Study|Withdrawal by Subject|0|||
129687482|NCT01947933|466812204|FG007|Overall Study|Withdrawal by Subject|0|||
129687483|NCT01947933|466812205|FG008|Overall Study|Withdrawal by Subject|0|||
129687484|NCT01947933|466812197|FG000|Overall Study|Lost to Follow-up|0|||
129687485|NCT01947933|466812198|FG001|Overall Study|Lost to Follow-up|0|||
129687486|NCT01947933|466812199|FG002|Overall Study|Lost to Follow-up|0|||
129687487|NCT01947933|466812200|FG003|Overall Study|Lost to Follow-up|0|||
129687488|NCT01947933|466812201|FG004|Overall Study|Lost to Follow-up|0|||
129687489|NCT01947933|466812202|FG005|Overall Study|Lost to Follow-up|0|||
129687490|NCT01947933|466812203|FG006|Overall Study|Lost to Follow-up|0|||
129560816|NCT02058628|466348177|FG001|Overall Study|Adverse Event|0|||
129560817|NCT02058628|466348176|FG000|Overall Study|Withdrawal by Subject|2|||
129560818|NCT02058628|466348177|FG001|Overall Study|Withdrawal by Subject|2|||
129560819|NCT02058628|466348176|FG000|Overall Study|Lost to Follow-up|2|||
129560820|NCT02058628|466348177|FG001|Overall Study|Lost to Follow-up|4|||
129560821|NCT02058628|466348176|FG000|Overall Study|Not in time schedule|0|||
129560822|NCT02058628|466348177|FG001|Overall Study|Not in time schedule|1|||
129560823|NCT02058628|466348176|FG000|Overall Study|The visit date was not in timeline|0|||
129560824|NCT02058628|466348177|FG001|Overall Study|The visit date was not in timeline|1|||
129560825|NCT02058628|466348176|FG000|Overall Study|A lot of time for study for participant|1|||
129560826|NCT02058628|466348177|FG001|Overall Study|A lot of time for study for participant|0|||
129560827|NCT02058628|466348176|FG000|Overall Study|Non compliance|1|||
129687491|NCT01947933|466812204|FG007|Overall Study|Lost to Follow-up|0|||
129687492|NCT01947933|466812205|FG008|Overall Study|Lost to Follow-up|1|||
129687493|NCT00294398|466812206|FG000|Overall Study|Lost to Follow-up|21|||
129560828|NCT02058628|466348177|FG001|Overall Study|Non compliance|0|||
129560829|NCT03355742|466348178|FG000|Overall Study|Lost to Follow-up|4|||
129560830|NCT03355742|466348178|FG000|Overall Study|Withdrawal by Subject|29|||
129560831|NCT03355742|466348178|FG000|Overall Study|Physician Decision|6|||
129560832|NCT03355742|466348178|FG000|Overall Study|Death|55|||
129560833|NCT03355742|466348178|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
129560834|NCT04527471|466348181|FG000|Overall Study|Adverse Event|1|||
129560835|NCT04527471|466348182|FG001|Overall Study|Adverse Event|0|||
129560836|NCT04527471|466348181|FG000|Overall Study|Lost to Follow-up|1|||
129560837|NCT04527471|466348182|FG001|Overall Study|Lost to Follow-up|0|||
129560838|NCT00096265|466348190|FG000|Overall Study|Ineligible|1|||
129560839|NCT00096265|466348191|FG001|Overall Study|Ineligible|0|||
129560840|NCT00096265|466348192|FG002|Overall Study|Ineligible|0|||
129560841|NCT01506323|466348193|FG000|Overall Study|Lost to Follow-up|5|||
129560842|NCT01506323|466348194|FG001|Overall Study|Lost to Follow-up|4|||
129560843|NCT01506323|466348193|FG000|Overall Study|Withdrawal by Subject|4|||
129560844|NCT01506323|466348194|FG001|Overall Study|Withdrawal by Subject|4|||
129560845|NCT01506323|466348193|FG000|Overall Study|Lack of Efficacy|1|||
129560846|NCT01506323|466348194|FG001|Overall Study|Lack of Efficacy|3|||
129560847|NCT01506323|466348193|FG000|Overall Study|Moved out of area|5|||
129560848|NCT01506323|466348194|FG001|Overall Study|Moved out of area|2|||
129560849|NCT01506323|466348193|FG000|Overall Study|Schedule or Transportation conflict|8|||
129560850|NCT01506323|466348194|FG001|Overall Study|Schedule or Transportation conflict|0|||
129560851|NCT01506323|466348193|FG000|Overall Study|Started another treatment|1|||
129560852|NCT01506323|466348194|FG001|Overall Study|Started another treatment|0|||
129560853|NCT02891200|466348195|FG000|Overall Study|Lost to Follow-up|31|||
129560854|NCT02891200|466348196|FG001|Overall Study|Lost to Follow-up|36|||
129560855|NCT02891200|466348195|FG000|Overall Study|Death|10|||
129560856|NCT02891200|466348196|FG001|Overall Study|Death|9|||
129560857|NCT02891200|466348195|FG000|Overall Study|Withdrawal by Subject|1|||
129560858|NCT02891200|466348196|FG001|Overall Study|Withdrawal by Subject|4|||
129560859|NCT00444795|466348198|FG000|Overall Study|Not Treated|1|||
129560860|NCT00444795|466348198|FG000|Overall Study|Treated Prior to the Contract Date|2|||
129560861|NCT00988169|466348199|FG000|Overall Study|Withdrawal by Subject|1|||
129560862|NCT03083483|466348207|FG000|Overall Study|Adverse Event|1|||
129560863|NCT03083483|466348208|FG001|Overall Study|Adverse Event|1|||
129560864|NCT03083483|466348209|FG002|Overall Study|Adverse Event|1|||
129560865|NCT03083483|466348207|FG000|Overall Study|Lost to Follow-up|2|||
129560866|NCT03083483|466348208|FG001|Overall Study|Lost to Follow-up|1|||
129560867|NCT03083483|466348209|FG002|Overall Study|Lost to Follow-up|1|||
129560868|NCT03083483|466348207|FG000|Overall Study|technological issues|1|||
129560869|NCT03083483|466348208|FG001|Overall Study|technological issues|0|||
129560870|NCT03083483|466348209|FG002|Overall Study|technological issues|1|||
129560871|NCT02710071|466348213|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
129560872|NCT02710071|466348214|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
129560873|NCT02710071|466348213|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
129560874|NCT02710071|466348214|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
129560875|NCT00449072|466348218|FG000|Overall Study|Adverse Event|3|||
129560876|NCT00449072|466348219|FG001|Overall Study|Adverse Event|1|||
129560877|NCT00449072|466348218|FG000|Overall Study|Protocol Violation|14|||
129560878|NCT00449072|466348219|FG001|Overall Study|Protocol Violation|12|||
129560879|NCT00449072|466348218|FG000|Overall Study|Lost to Follow-up|5|||
129560880|NCT00449072|466348219|FG001|Overall Study|Lost to Follow-up|7|||
129560881|NCT00449072|466348218|FG000|Overall Study|Withdrawal by Subject|11|||
129560882|NCT00449072|466348219|FG001|Overall Study|Withdrawal by Subject|8|||
129560883|NCT00449072|466348218|FG000|Overall Study|Lack of Efficacy|1|||
129560884|NCT00449072|466348219|FG001|Overall Study|Lack of Efficacy|1|||
129560885|NCT00449072|466348218|FG000|Overall Study|Physician Decision|1|||
129560886|NCT00449072|466348219|FG001|Overall Study|Physician Decision|0|||
129560887|NCT00449072|466348218|FG000|Overall Study|Not treated|0|||
129560888|NCT00449072|466348219|FG001|Overall Study|Not treated|1|||
129560889|NCT00449072|466348218|FG000|Overall Study|Excluded medication|0|||
129560890|NCT00449072|466348219|FG001|Overall Study|Excluded medication|2|||
129560891|NCT00449072|466348218|FG000|Overall Study|Non-compliance|2|||
129560892|NCT00449072|466348219|FG001|Overall Study|Non-compliance|5|||
129560893|NCT00449072|466348218|FG000|Overall Study|Sponsor decision|1|||
129560894|NCT00449072|466348219|FG001|Overall Study|Sponsor decision|3|||
129560895|NCT00449072|466348218|FG000|Overall Study|Relocation|3|||
129560896|NCT00449072|466348219|FG001|Overall Study|Relocation|2|||
129560897|NCT00718159|466348220|FG000|Overall Study|Progressive Disease|3|||
129560898|NCT00718159|466348221|FG001|Overall Study|Progressive Disease|3|||
129560899|NCT00718159|466348222|FG002|Overall Study|Progressive Disease|2|||
129560900|NCT00718159|466348223|FG003|Overall Study|Progressive Disease|0|||
129560901|NCT00718159|466348224|FG004|Overall Study|Progressive Disease|6|||
129560902|NCT00718159|466348225|FG005|Overall Study|Progressive Disease|0|||
129560903|NCT00718159|466348226|FG006|Overall Study|Progressive Disease|0|||
129560904|NCT00718159|466348220|FG000|Overall Study|Death due to Adverse Event|0|||
129560905|NCT00718159|466348221|FG001|Overall Study|Death due to Adverse Event|0|||
129560906|NCT00718159|466348222|FG002|Overall Study|Death due to Adverse Event|0|||
129560907|NCT00718159|466348223|FG003|Overall Study|Death due to Adverse Event|2|||
129560908|NCT00718159|466348224|FG004|Overall Study|Death due to Adverse Event|2|||
129560909|NCT00718159|466348225|FG005|Overall Study|Death due to Adverse Event|0|||
129560910|NCT00718159|466348226|FG006|Overall Study|Death due to Adverse Event|0|||
129560911|NCT00718159|466348220|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
129560912|NCT00718159|466348221|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
129560913|NCT00718159|466348222|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
129560914|NCT00718159|466348223|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
129560915|NCT00718159|466348224|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
129560916|NCT00718159|466348225|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
129560917|NCT00718159|466348226|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
129687494|NCT00294398|466812207|FG001|Overall Study|Lost to Follow-up|26|||
129687495|NCT02965833|466812208|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
129687496|NCT02965833|466812209|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
129687497|NCT02965833|466812208|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129687498|NCT02965833|466812209|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129687499|NCT02965833|466812208|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
129687500|NCT02965833|466812209|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
129687501|NCT02965833|466812208|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
129687502|NCT02965833|466812209|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
129687503|NCT02965833|466812208|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
129687504|NCT02965833|466812209|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
129560918|NCT00718159|466348220|FG000|Overall Study|Investigator Decision|0|||
129560919|NCT00718159|466348221|FG001|Overall Study|Investigator Decision|0|||
129560920|NCT00718159|466348222|FG002|Overall Study|Investigator Decision|0|||
129560921|NCT00718159|466348223|FG003|Overall Study|Investigator Decision|0|||
129560922|NCT00718159|466348224|FG004|Overall Study|Investigator Decision|0|||
129560923|NCT00718159|466348225|FG005|Overall Study|Investigator Decision|1|||
129687505|NCT00118287|466812213|FG000|Overall Study|Intracranial haemorrhage|1|||
129560924|NCT00718159|466348226|FG006|Overall Study|Investigator Decision|1|||
129560925|NCT01798485|466348235|FG000|Overall Study|Adverse Event|32|||
129560926|NCT01798485|466348236|FG001|Overall Study|Adverse Event|40|||
129560927|NCT01798485|466348235|FG000|Overall Study|Withdrawal by Subject|27|||
129560928|NCT01798485|466348236|FG001|Overall Study|Withdrawal by Subject|31|||
129560929|NCT01798485|466348235|FG000|Overall Study|Lost to Follow-up|0|||
129560930|NCT01798485|466348236|FG001|Overall Study|Lost to Follow-up|3|||
129560931|NCT01798485|466348235|FG000|Overall Study|Physician Decision|14|||
129560932|NCT01798485|466348236|FG001|Overall Study|Physician Decision|10|||
129560933|NCT01798485|466348235|FG000|Overall Study|Objective Disease Progression|152|||
129560934|NCT01798485|466348236|FG001|Overall Study|Objective Disease Progression|106|||
129560935|NCT01798485|466348235|FG000|Overall Study|Death|25|||
129560936|NCT01798485|466348236|FG001|Overall Study|Death|22|||
129560937|NCT01798485|466348235|FG000|Overall Study|Sponsor Decision|61|||
129560938|NCT01798485|466348236|FG001|Overall Study|Sponsor Decision|54|||
129560939|NCT01798485|466348235|FG000|Overall Study|Clinical Progression|35|||
129560940|NCT01798485|466348236|FG001|Overall Study|Clinical Progression|24|||
129560941|NCT00681863|466348237|FG000|Overall Study|Adverse Event|1|||
129560942|NCT00681863|466348237|FG000|Overall Study|Lost to Follow-up|2|||
129560943|NCT00681863|466348237|FG000|Overall Study|Lack of Efficacy|2|||
129560944|NCT00681863|466348237|FG000|Overall Study|Other|18|||
129560945|NCT01076166|466348238|FG000|Overall Study|Adverse Event|3|||
129560946|NCT01076166|466348238|FG000|Overall Study|Symptoms improved/resolved|6|||
129560947|NCT05476679|466348243|FG000|Overall Study|Withdrawal by Subject|0|||
129560948|NCT05476679|466348244|FG001|Overall Study|Withdrawal by Subject|0|||
129560949|NCT05476679|466348245|FG002|Overall Study|Withdrawal by Subject|0|||
129560950|NCT05476679|466348246|FG003|Overall Study|Withdrawal by Subject|1|||
129560951|NCT05476679|466348247|FG004|Overall Study|Withdrawal by Subject|0|||
129560952|NCT05476679|466348243|FG000|Overall Study|Lost to Follow-up|0|||
129560953|NCT05476679|466348244|FG001|Overall Study|Lost to Follow-up|0|||
129560954|NCT05476679|466348245|FG002|Overall Study|Lost to Follow-up|0|||
129560955|NCT05476679|466348246|FG003|Overall Study|Lost to Follow-up|1|||
129560956|NCT05476679|466348247|FG004|Overall Study|Lost to Follow-up|0|||
129560957|NCT01498484|466348250|FG000|Overall Study|Death|6|||
129560958|NCT01498484|466348251|FG001|Overall Study|Death|3|||
129560959|NCT01498484|466348252|FG002|Overall Study|Death|1|||
129560960|NCT01498484|466348253|FG003|Overall Study|Death|1|||
129560961|NCT01498484|466348254|FG004|Overall Study|Death|0|||
129560962|NCT01498484|466348255|FG005|Overall Study|Death|0|||
129560963|NCT01498484|466348256|FG006|Overall Study|Death|10|||
129560964|NCT01498484|466348257|FG007|Overall Study|Death|1|||
129560965|NCT01498484|466348258|FG008|Overall Study|Death|0|||
129560966|NCT01498484|466348250|FG000|Overall Study|Physician Decision|3|||
129560967|NCT01498484|466348251|FG001|Overall Study|Physician Decision|2|||
129560968|NCT01498484|466348252|FG002|Overall Study|Physician Decision|1|||
129560969|NCT01498484|466348253|FG003|Overall Study|Physician Decision|1|||
129560970|NCT01498484|466348254|FG004|Overall Study|Physician Decision|0|||
129560971|NCT01498484|466348255|FG005|Overall Study|Physician Decision|0|||
129560972|NCT01498484|466348256|FG006|Overall Study|Physician Decision|8|||
129560973|NCT01498484|466348257|FG007|Overall Study|Physician Decision|13|||
129560974|NCT01498484|466348258|FG008|Overall Study|Physician Decision|1|||
129560975|NCT01498484|466348250|FG000|Overall Study|Adverse Event|0|||
129560976|NCT01498484|466348251|FG001|Overall Study|Adverse Event|0|||
129560977|NCT01498484|466348252|FG002|Overall Study|Adverse Event|0|||
129560978|NCT01498484|466348253|FG003|Overall Study|Adverse Event|0|||
129560979|NCT01498484|466348254|FG004|Overall Study|Adverse Event|0|||
129560980|NCT01498484|466348255|FG005|Overall Study|Adverse Event|1|||
129560981|NCT01498484|466348256|FG006|Overall Study|Adverse Event|0|||
129560982|NCT01498484|466348257|FG007|Overall Study|Adverse Event|0|||
129560983|NCT01498484|466348258|FG008|Overall Study|Adverse Event|0|||
129560984|NCT01498484|466348250|FG000|Overall Study|Withdrawal by Subject|0|||
129560985|NCT01498484|466348251|FG001|Overall Study|Withdrawal by Subject|0|||
129560986|NCT01498484|466348252|FG002|Overall Study|Withdrawal by Subject|0|||
129687506|NCT00118287|466812213|FG000|Overall Study|Muscle pain|1|||
129687507|NCT03407482|466812214|FG000|Overall Study|Adverse Event|12|||
129687508|NCT03407482|466812214|FG000|Overall Study|Disease Relapse|1|||
129687509|NCT03407482|466812214|FG000|Overall Study|Lost to Follow-up|1|||
129687510|NCT03407482|466812214|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129687511|NCT03407482|466812214|FG000|Overall Study|Pregnancy|2|||
129687512|NCT03407482|466812214|FG000|Overall Study|Protocol Violation|1|||
129687513|NCT03407482|466812214|FG000|Overall Study|Study Terminated By Sponsor|106|||
129687514|NCT03407482|466812214|FG000|Overall Study|Withdrawal by Subject|6|||
129687515|NCT03407482|466812214|FG000|Overall Study|Data Entry Error|1|||
129560987|NCT01498484|466348253|FG003|Overall Study|Withdrawal by Subject|1|||
129687516|NCT05089357|466812217|FG000|Overall Study|Withdrawal by Subject|23|||
129777997|NCT02003924|467152497|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
129560988|NCT01498484|466348254|FG004|Overall Study|Withdrawal by Subject|0|||
129560989|NCT01498484|466348255|FG005|Overall Study|Withdrawal by Subject|0|||
129560990|NCT01498484|466348256|FG006|Overall Study|Withdrawal by Subject|1|||
129560991|NCT01498484|466348257|FG007|Overall Study|Withdrawal by Subject|0|||
129560992|NCT01498484|466348258|FG008|Overall Study|Withdrawal by Subject|0|||
129560993|NCT01498484|466348250|FG000|Overall Study|Other|5|||
129687517|NCT05089357|466812217|FG000|Overall Study|Lost to Follow-up|6|||
129687518|NCT05089357|466812217|FG000|Overall Study|Medical reason|1|||
129777998|NCT02003924|467152498|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
129777999|NCT02003924|467152499|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
129778000|NCT02003924|467152497|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
129778001|NCT02003924|467152498|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
129778002|NCT02003924|467152499|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
129778003|NCT02003924|467152497|FG000|Long-term Follow-up Phase|Other|5|||
129778004|NCT02003924|467152498|FG001|Long-term Follow-up Phase|Other|2|||
129560994|NCT01498484|466348251|FG001|Overall Study|Other|2|||
129560995|NCT01498484|466348252|FG002|Overall Study|Other|0|||
129560996|NCT01498484|466348253|FG003|Overall Study|Other|0|||
129560997|NCT01498484|466348254|FG004|Overall Study|Other|1|||
129560998|NCT01498484|466348255|FG005|Overall Study|Other|0|||
129560999|NCT01498484|466348256|FG006|Overall Study|Other|3|||
129561000|NCT01498484|466348257|FG007|Overall Study|Other|0|||
129561001|NCT01498484|466348258|FG008|Overall Study|Other|1|||
129561002|NCT00319956|466348259|FG000|Overall Study|Death|20|||
129561003|NCT00319956|466348260|FG001|Overall Study|Death|24|||
129561004|NCT00753714|466348262|FG000|Overall Study|Lack of Efficacy|21|||
129561005|NCT00753714|466348263|FG001|Overall Study|Lack of Efficacy|34|||
129561006|NCT00753714|466348262|FG000|Overall Study|Adverse Event|26|||
129561007|NCT00753714|466348263|FG001|Overall Study|Adverse Event|18|||
129561008|NCT00753714|466348262|FG000|Overall Study|Protocol Violation|1|||
129561009|NCT00753714|466348263|FG001|Overall Study|Protocol Violation|0|||
129561010|NCT00753714|466348262|FG000|Overall Study|Lost to Follow-up|0|||
129561011|NCT00753714|466348263|FG001|Overall Study|Lost to Follow-up|1|||
129561012|NCT00753714|466348262|FG000|Overall Study|Withdrawal by Subject|2|||
129561013|NCT00753714|466348263|FG001|Overall Study|Withdrawal by Subject|1|||
129561014|NCT00753714|466348262|FG000|Overall Study|Death|3|||
129561015|NCT00753714|466348263|FG001|Overall Study|Death|3|||
129561016|NCT00753714|466348262|FG000|Overall Study|Other|7|||
129561017|NCT00753714|466348263|FG001|Overall Study|Other|5|||
129561018|NCT02607800|466348264|FG000|Overall Study|Lost to Follow-up|7|||
129561019|NCT02607800|466348265|FG001|Overall Study|Lost to Follow-up|10|||
129561020|NCT02607800|466348264|FG000|Overall Study|Withdrew Consent|2|||
129561021|NCT02607800|466348265|FG001|Overall Study|Withdrew Consent|0|||
129561022|NCT02607800|466348264|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
129561023|NCT02607800|466348265|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
129561024|NCT02486796|466348266|FG000|Overall Study|Withdrawal by Subject|1|||
129561025|NCT02486796|466348267|FG001|Overall Study|Withdrawal by Subject|1|||
129561026|NCT02486796|466348266|FG000|Overall Study|Physician Decision|1|||
129561027|NCT02486796|466348267|FG001|Overall Study|Physician Decision|0|||
129561028|NCT01185288|466348268|FG000|Overall Study|Adverse Event|7|||
129561029|NCT01185288|466348269|FG001|Overall Study|Adverse Event|6|||
129561030|NCT01185288|466348268|FG000|Overall Study|Withdrawal by Subject|6|||
129561031|NCT01185288|466348269|FG001|Overall Study|Withdrawal by Subject|4|||
129561032|NCT01185288|466348268|FG000|Overall Study|Lost to Follow-up|2|||
129561033|NCT01185288|466348269|FG001|Overall Study|Lost to Follow-up|5|||
129561034|NCT01185288|466348268|FG000|Overall Study|Lack of Efficacy|2|||
129561035|NCT01185288|466348269|FG001|Overall Study|Lack of Efficacy|0|||
129561036|NCT01185288|466348268|FG000|Overall Study|Investigator discretion|1|||
129561037|NCT01185288|466348269|FG001|Overall Study|Investigator discretion|0|||
129687519|NCT05089357|466812217|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
129687520|NCT05089357|466812217|FG000|Overall Study|Pregnancy|2|||
129687521|NCT05537571|466812218|FG000|Overall Study|Withdrawal by Subject|1|||
129687522|NCT05537571|466812219|FG001|Overall Study|Withdrawal by Subject|1|||
129687523|NCT05537571|466812220|FG002|Overall Study|Withdrawal by Subject|0|||
129687524|NCT05537571|466812221|FG003|Overall Study|Withdrawal by Subject|0|||
129687525|NCT05537571|466812222|FG004|Overall Study|Withdrawal by Subject|0|||
129687526|NCT05537571|466812218|FG000|Overall Study|Adverse Event|2|||
129687527|NCT05537571|466812219|FG001|Overall Study|Adverse Event|0|||
129687528|NCT05537571|466812220|FG002|Overall Study|Adverse Event|0|||
129687529|NCT05537571|466812221|FG003|Overall Study|Adverse Event|0|||
129778005|NCT02003924|467152499|FG002|Long-term Follow-up Phase|Other|1|||
129778006|NCT00560352|467152504|FG000|Overall Study|Adverse event unrelated to study drug|2|||
129561038|NCT01185288|466348268|FG000|Overall Study|Did not meet inclusion criteria|1|||
129561039|NCT01185288|466348269|FG001|Overall Study|Did not meet inclusion criteria|0|||
129687530|NCT05537571|466812222|FG004|Overall Study|Adverse Event|0|||
129561040|NCT01185288|466348268|FG000|Overall Study|Noncompliance|0|||
129561041|NCT01185288|466348269|FG001|Overall Study|Noncompliance|1|||
129561042|NCT00278512|466348270|FG000|Overall Study|Death|1|||
129561043|NCT00278512|466348271|FG001|Overall Study|Death|0|||
129561044|NCT01202747|466348272|FG000|Overall Study|Withdrawal by Subject|1|||
129561045|NCT01620177|466348273|FG000|Overall Study|Failure at Screening Visit|43|||
129561046|NCT01620177|466348273|FG000|Overall Study|Withdrawal by Subject|26|||
129561047|NCT01620177|466348273|FG000|Overall Study|Lost to Follow-up|7|||
129561048|NCT01620177|466348273|FG000|Overall Study|Physician Decision|2|||
129687531|NCT05537571|466812218|FG000|Overall Study|Hepatitis A screening result|2|||
129778007|NCT00560352|467152505|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129561049|NCT01620177|466348273|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
129561050|NCT01626885|466348279|FG000|Overall Study|Adverse Event|8|||
129561051|NCT01626885|466348279|FG000|Overall Study|Withdrawal by Subject|4|||
129561052|NCT01533428|466348282|FG000|Overall Study|Adverse Event|0|||
129561053|NCT01533428|466348283|FG001|Overall Study|Adverse Event|1|||
129561054|NCT01533428|466348282|FG000|Overall Study|Lost to Follow-up|2|||
129561055|NCT01533428|466348283|FG001|Overall Study|Lost to Follow-up|1|||
129561056|NCT01533428|466348282|FG000|Overall Study|Withdrawal by Subject|7|||
129561057|NCT01533428|466348283|FG001|Overall Study|Withdrawal by Subject|6|||
129561058|NCT01364870|466348284|FG000|Overall Study|Withdrawal by Subject|13|||
129561059|NCT01364870|466348285|FG001|Overall Study|Withdrawal by Subject|24|||
129561060|NCT01364870|466348286|FG002|Overall Study|Withdrawal by Subject|10|||
129561061|NCT01364870|466348284|FG000|Overall Study|Adverse Event|8|||
129561062|NCT01364870|466348285|FG001|Overall Study|Adverse Event|6|||
129561063|NCT01364870|466348286|FG002|Overall Study|Adverse Event|4|||
129561064|NCT01364870|466348284|FG000|Overall Study|Protocol Violation|1|||
129561065|NCT01364870|466348285|FG001|Overall Study|Protocol Violation|0|||
129561066|NCT01364870|466348286|FG002|Overall Study|Protocol Violation|0|||
129561067|NCT02666430|466348287|FG000|Period 1|Lost to Follow-up|1|||
129561068|NCT02666430|466348288|FG001|Period 1|Lost to Follow-up|0|||
129561069|NCT02666430|466348287|FG000|Period 1|Adverse Event|0|||
129561070|NCT02666430|466348288|FG001|Period 1|Adverse Event|1|||
129561071|NCT02666430|466348287|FG000|Period 2|Withdrawal by Subject|1|||
129561072|NCT02666430|466348288|FG001|Period 2|Withdrawal by Subject|4|||
129561073|NCT02666430|466348287|FG000|Period 3|Lost to Follow-up|1|||
129561074|NCT02666430|466348288|FG001|Period 3|Lost to Follow-up|0|||
129561075|NCT03828461|466348289|FG000|Overall Study|Lost to Follow-up|1|||
129561076|NCT03828461|466348289|FG000|Overall Study|Withdrawal by Subject|3|||
129561077|NCT00576199|466348290|FG000|Overall Study|Adverse Event|12|||
129561078|NCT00576199|466348290|FG000|Overall Study|Insufficient Therapeutic Response|14|||
129561079|NCT00576199|466348290|FG000|Overall Study|Refused Treatment|2|||
129561080|NCT00576199|466348290|FG000|Overall Study|Reason Unspecified|2|||
129561081|NCT04317053|466348292|FG000|Overall Study|Withdrawn (screen failure)|4|||
129561082|NCT04317053|466348293|FG001|Overall Study|Withdrawn (screen failure)|2|||
129561083|NCT02637557|466350052|FG000|Overall Study|Adverse Event|3|||
129561084|NCT02637557|466350053|FG001|Overall Study|Adverse Event|1|||
129561085|NCT02637557|466350054|FG002|Overall Study|Adverse Event|3|||
129561086|NCT02637557|466350055|FG003|Overall Study|Adverse Event|3|||
129561087|NCT02637557|466350052|FG000|Overall Study|Lost to Follow-up|1|||
129561088|NCT02637557|466350053|FG001|Overall Study|Lost to Follow-up|1|||
129561089|NCT02637557|466350054|FG002|Overall Study|Lost to Follow-up|0|||
129561090|NCT02637557|466350055|FG003|Overall Study|Lost to Follow-up|1|||
129561091|NCT02637557|466350052|FG000|Overall Study|Physician Decision|1|||
129561092|NCT02637557|466350053|FG001|Overall Study|Physician Decision|0|||
129561093|NCT02637557|466350054|FG002|Overall Study|Physician Decision|0|||
129561094|NCT02637557|466350055|FG003|Overall Study|Physician Decision|0|||
129561095|NCT02637557|466350052|FG000|Overall Study|Protocol Violation|2|||
129561096|NCT02637557|466350053|FG001|Overall Study|Protocol Violation|0|||
129561097|NCT02637557|466350054|FG002|Overall Study|Protocol Violation|2|||
129561098|NCT02637557|466350055|FG003|Overall Study|Protocol Violation|1|||
129561099|NCT02637557|466350052|FG000|Overall Study|Withdrawal by Subject|1|||
129561100|NCT02637557|466350053|FG001|Overall Study|Withdrawal by Subject|3|||
129561101|NCT02637557|466350054|FG002|Overall Study|Withdrawal by Subject|4|||
129561102|NCT02637557|466350055|FG003|Overall Study|Withdrawal by Subject|2|||
129561103|NCT00613574|466350056|FG000|Overall Study|Adverse Event|3|||
129561104|NCT00613574|466350056|FG000|Overall Study|Lost to Follow-up|2|||
129561105|NCT00613574|466350056|FG000|Overall Study|Other|1|||
129561106|NCT04604184|466350063|FG000|Overall Study|Adverse Event|5|||
129561107|NCT04604184|466350064|FG001|Overall Study|Adverse Event|5|||
129561108|NCT04604184|466350063|FG000|Overall Study|Death|2|||
129561109|NCT04604184|466350064|FG001|Overall Study|Death|1|||
129561110|NCT04604184|466350063|FG000|Overall Study|Withdrawal by Subject|1|||
129561111|NCT04604184|466350064|FG001|Overall Study|Withdrawal by Subject|3|||
129561112|NCT04604184|466350063|FG000|Overall Study|Not treated|2|||
129561113|NCT04604184|466350064|FG001|Overall Study|Not treated|2|||
129561114|NCT04604184|466350063|FG000|Overall Study|Due to sponsor decision|9|||
129561115|NCT04604184|466350064|FG001|Overall Study|Due to sponsor decision|7|||
129561116|NCT04604184|466350063|FG000|Overall Study|Physician Decision|0|||
129561117|NCT04604184|466350064|FG001|Overall Study|Physician Decision|1|||
129561118|NCT04604184|466350063|FG000|Overall Study|Transfer to healthcare|1|||
129561119|NCT04604184|466350064|FG001|Overall Study|Transfer to healthcare|0|||
129561120|NCT01751412|466350065|FG000|Overall Study|Disease Progression Before Treatment|1|||
129561121|NCT03734237|466350068|FG000|Overall Study|Lost to Follow-up|1|||
129561122|NCT03734237|466350069|FG001|Overall Study|Lost to Follow-up|3|||
129561123|NCT03734237|466350070|FG002|Overall Study|Lost to Follow-up|0|||
129561124|NCT03734237|466350068|FG000|Overall Study|Withdrawal by Subject|7|||
129561125|NCT03734237|466350069|FG001|Overall Study|Withdrawal by Subject|9|||
129561126|NCT03734237|466350070|FG002|Overall Study|Withdrawal by Subject|10|||
129561127|NCT02711956|466350071|FG000|Overall Study|Adverse Event|0|||
129561128|NCT02711956|466350072|FG001|Overall Study|Adverse Event|0|||
129561129|NCT02711956|466350073|FG002|Overall Study|Adverse Event|0|||
129561130|NCT02711956|466350074|FG003|Overall Study|Adverse Event|1|||
129561131|NCT02711956|466350075|FG004|Overall Study|Adverse Event|2|||
129561132|NCT02711956|466350076|FG005|Overall Study|Adverse Event|0|||
129561133|NCT02711956|466350077|FG006|Overall Study|Adverse Event|0|||
129561134|NCT02711956|466350078|FG007|Overall Study|Adverse Event|1|||
129561135|NCT02711956|466350079|FG008|Overall Study|Adverse Event|1|||
129561136|NCT02711956|466350080|FG009|Overall Study|Adverse Event|1|||
129561137|NCT02711956|466350081|FG010|Overall Study|Adverse Event|1|||
129561138|NCT02711956|466350082|FG011|Overall Study|Adverse Event|0|||
129561139|NCT02711956|466350083|FG012|Overall Study|Adverse Event|0|||
129561140|NCT02711956|466350084|FG013|Overall Study|Adverse Event|0|||
129561141|NCT02711956|466350085|FG014|Overall Study|Adverse Event|2|||
129561142|NCT02711956|466350071|FG000|Overall Study|Physician Decision|0|||
129561143|NCT02711956|466350072|FG001|Overall Study|Physician Decision|0|||
129561144|NCT02711956|466350073|FG002|Overall Study|Physician Decision|0|||
129561145|NCT02711956|466350074|FG003|Overall Study|Physician Decision|2|||
129561146|NCT02711956|466350075|FG004|Overall Study|Physician Decision|0|||
129561147|NCT02711956|466350076|FG005|Overall Study|Physician Decision|0|||
129561148|NCT02711956|466350077|FG006|Overall Study|Physician Decision|0|||
129561149|NCT02711956|466350078|FG007|Overall Study|Physician Decision|0|||
129561150|NCT02711956|466350079|FG008|Overall Study|Physician Decision|0|||
129561151|NCT02711956|466350080|FG009|Overall Study|Physician Decision|0|||
129561152|NCT02711956|466350081|FG010|Overall Study|Physician Decision|0|||
129561153|NCT02711956|466350082|FG011|Overall Study|Physician Decision|0|||
129561154|NCT02711956|466350083|FG012|Overall Study|Physician Decision|0|||
129561155|NCT02711956|466350084|FG013|Overall Study|Physician Decision|0|||
129561156|NCT02711956|466350085|FG014|Overall Study|Physician Decision|0|||
129561157|NCT02711956|466350071|FG000|Overall Study|Withdrawal by Subject|0|||
129561158|NCT02711956|466350072|FG001|Overall Study|Withdrawal by Subject|0|||
129561159|NCT02711956|466350073|FG002|Overall Study|Withdrawal by Subject|0|||
129561160|NCT02711956|466350074|FG003|Overall Study|Withdrawal by Subject|0|||
129561161|NCT02711956|466350075|FG004|Overall Study|Withdrawal by Subject|0|||
129561162|NCT02711956|466350076|FG005|Overall Study|Withdrawal by Subject|0|||
129561163|NCT02711956|466350077|FG006|Overall Study|Withdrawal by Subject|1|||
129561164|NCT02711956|466350078|FG007|Overall Study|Withdrawal by Subject|0|||
129561165|NCT02711956|466350079|FG008|Overall Study|Withdrawal by Subject|0|||
129561166|NCT02711956|466350080|FG009|Overall Study|Withdrawal by Subject|0|||
129561167|NCT02711956|466350081|FG010|Overall Study|Withdrawal by Subject|0|||
129561168|NCT02711956|466350082|FG011|Overall Study|Withdrawal by Subject|1|||
129561169|NCT02711956|466350083|FG012|Overall Study|Withdrawal by Subject|6|||
129561170|NCT02711956|466350084|FG013|Overall Study|Withdrawal by Subject|0|||
129561171|NCT02711956|466350085|FG014|Overall Study|Withdrawal by Subject|1|||
129561172|NCT02711956|466350071|FG000|Overall Study|Clinical progression|1|||
129561173|NCT02711956|466350072|FG001|Overall Study|Clinical progression|0|||
129561174|NCT02711956|466350073|FG002|Overall Study|Clinical progression|0|||
129687532|NCT05537571|466812219|FG001|Overall Study|Hepatitis A screening result|0|||
129687533|NCT05537571|466812220|FG002|Overall Study|Hepatitis A screening result|0|||
129687534|NCT05537571|466812221|FG003|Overall Study|Hepatitis A screening result|0|||
129687535|NCT05537571|466812222|FG004|Overall Study|Hepatitis A screening result|0|||
129687536|NCT05537571|466812218|FG000|Overall Study|Lost to Follow-up|0|||
129687537|NCT05537571|466812219|FG001|Overall Study|Lost to Follow-up|0|||
129687538|NCT05537571|466812220|FG002|Overall Study|Lost to Follow-up|1|||
129687539|NCT05537571|466812221|FG003|Overall Study|Lost to Follow-up|0|||
129687540|NCT05537571|466812222|FG004|Overall Study|Lost to Follow-up|1|||
129687541|NCT05752487|466812227|FG000|Overall Study|Enrolled, not treated|9|||
129687542|NCT05752487|466812227|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
129687543|NCT05752487|466812227|FG000|Overall Study|Withdrawal by Subject|2|||
129561175|NCT02711956|466350074|FG003|Overall Study|Clinical progression|0|||
129561176|NCT02711956|466350075|FG004|Overall Study|Clinical progression|0|||
129561177|NCT02711956|466350076|FG005|Overall Study|Clinical progression|0|||
129561178|NCT02711956|466350077|FG006|Overall Study|Clinical progression|1|||
129561179|NCT02711956|466350078|FG007|Overall Study|Clinical progression|0|||
129561180|NCT02711956|466350079|FG008|Overall Study|Clinical progression|1|||
129561181|NCT02711956|466350080|FG009|Overall Study|Clinical progression|0|||
129561182|NCT02711956|466350081|FG010|Overall Study|Clinical progression|0|||
129561183|NCT02711956|466350082|FG011|Overall Study|Clinical progression|2|||
129561184|NCT02711956|466350083|FG012|Overall Study|Clinical progression|4|||
129561185|NCT02711956|466350084|FG013|Overall Study|Clinical progression|1|||
129561186|NCT02711956|466350085|FG014|Overall Study|Clinical progression|1|||
129561187|NCT02711956|466350071|FG000|Overall Study|Radiographic progression|1|||
129561188|NCT02711956|466350072|FG001|Overall Study|Radiographic progression|1|||
129561189|NCT02711956|466350073|FG002|Overall Study|Radiographic progression|2|||
129561190|NCT02711956|466350074|FG003|Overall Study|Radiographic progression|0|||
129687544|NCT03091439|466812228|FG000|Overall Study|Study Terminated by the Sponsor|1|||
129687545|NCT03091439|466812229|FG001|Overall Study|Study Terminated by the Sponsor|0|||
129561191|NCT02711956|466350075|FG004|Overall Study|Radiographic progression|1|||
129561192|NCT02711956|466350076|FG005|Overall Study|Radiographic progression|0|||
129561193|NCT02711956|466350077|FG006|Overall Study|Radiographic progression|0|||
129561194|NCT02711956|466350078|FG007|Overall Study|Radiographic progression|0|||
129561195|NCT02711956|466350079|FG008|Overall Study|Radiographic progression|2|||
129561196|NCT02711956|466350080|FG009|Overall Study|Radiographic progression|1|||
129561197|NCT02711956|466350081|FG010|Overall Study|Radiographic progression|0|||
129561198|NCT02711956|466350082|FG011|Overall Study|Radiographic progression|5|||
129561199|NCT02711956|466350083|FG012|Overall Study|Radiographic progression|3|||
129561200|NCT02711956|466350084|FG013|Overall Study|Radiographic progression|0|||
129561201|NCT02711956|466350085|FG014|Overall Study|Radiographic progression|1|||
129561202|NCT02711956|466350071|FG000|Overall Study|PSA progression with clinical progression|0|||
129561203|NCT02711956|466350072|FG001|Overall Study|PSA progression with clinical progression|0|||
129561204|NCT02711956|466350073|FG002|Overall Study|PSA progression with clinical progression|0|||
129561205|NCT02711956|466350074|FG003|Overall Study|PSA progression with clinical progression|0|||
129561206|NCT02711956|466350075|FG004|Overall Study|PSA progression with clinical progression|1|||
129561207|NCT02711956|466350076|FG005|Overall Study|PSA progression with clinical progression|0|||
129561208|NCT02711956|466350077|FG006|Overall Study|PSA progression with clinical progression|0|||
129561209|NCT02711956|466350078|FG007|Overall Study|PSA progression with clinical progression|0|||
129561210|NCT02711956|466350079|FG008|Overall Study|PSA progression with clinical progression|0|||
129561211|NCT02711956|466350080|FG009|Overall Study|PSA progression with clinical progression|0|||
129561212|NCT02711956|466350081|FG010|Overall Study|PSA progression with clinical progression|0|||
129561213|NCT02711956|466350082|FG011|Overall Study|PSA progression with clinical progression|0|||
129561214|NCT02711956|466350083|FG012|Overall Study|PSA progression with clinical progression|1|||
129687546|NCT01860989|466812230|FG000|Overall Study|Unsatisfactory therapeutic|5|||
129687547|NCT01685437|466812233|FG000|Overall Study|Withdrawal by Subject|22|||
129687548|NCT01685437|466812233|FG000|Overall Study|Lost to Follow-up|3|||
129687549|NCT01685437|466812233|FG000|Overall Study|Adverse Event|1|||
129687550|NCT01685437|466812233|FG000|Overall Study|Protocol Violation|4|||
129687551|NCT01685437|466812233|FG000|Overall Study|Unable to make visits due to work|1|||
129687552|NCT01214720|466812236|FG000|Overall Study|Alive and still on treatment|34|||
129687553|NCT01214720|466812237|FG001|Overall Study|Alive and still on treatment|18|||
129687554|NCT01214720|466812236|FG000|Overall Study|Alive and in follow-up|45|||
129687555|NCT01214720|466812237|FG001|Overall Study|Alive and in follow-up|48|||
129687556|NCT01214720|466812236|FG000|Overall Study|Lost to Follow-up|6|||
129687557|NCT01214720|466812237|FG001|Overall Study|Lost to Follow-up|2|||
129687558|NCT02347787|466812238|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
129687559|NCT02347787|466812239|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
129687560|NCT02347787|466812238|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
129687561|NCT02347787|466812239|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
129687562|NCT02347787|466812238|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
129687563|NCT02347787|466812239|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
129687564|NCT02347787|466812238|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
129687565|NCT02347787|466812239|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
129687566|NCT01039675|466812248|FG000|Overall Study|Adverse Event|0|||
129687567|NCT01039675|466812249|FG001|Overall Study|Adverse Event|2|||
129687568|NCT01039675|466812248|FG000|Overall Study|Lack of Efficacy|0|||
129687569|NCT01039675|466812249|FG001|Overall Study|Lack of Efficacy|2|||
129687570|NCT01039675|466812248|FG000|Overall Study|Withdrawal by Subject|0|||
129687571|NCT01039675|466812249|FG001|Overall Study|Withdrawal by Subject|1|||
129687572|NCT01039675|466812248|FG000|Overall Study|Lost to Follow-up|0|||
129687573|NCT01039675|466812249|FG001|Overall Study|Lost to Follow-up|1|||
129687574|NCT01039675|466812248|FG000|Overall Study|Physician Decision|0|||
129687575|NCT01039675|466812249|FG001|Overall Study|Physician Decision|1|||
129687576|NCT00992836|466814204|FG000|Overall Study|Lost to Follow-up|1|||
129687577|NCT00992836|466814204|FG000|Overall Study|Withdrawal by Subject|2|||
129687578|NCT00992836|466814204|FG000|Overall Study|Protocol Violation|2|||
129687579|NCT01617967|466814208|FG000|Overall Study|Protocol Violation|0|||
129687580|NCT01617967|466814209|FG001|Overall Study|Protocol Violation|0|||
129687581|NCT01617967|466814210|FG002|Overall Study|Protocol Violation|0|||
129687582|NCT01617967|466814211|FG003|Overall Study|Protocol Violation|1|||
129687583|NCT01617967|466814212|FG004|Overall Study|Protocol Violation|0|||
129687584|NCT01617967|466814213|FG005|Overall Study|Protocol Violation|0|||
129687585|NCT01617967|466814208|FG000|Overall Study|Withdrawal by Subject|0|||
129687586|NCT01617967|466814209|FG001|Overall Study|Withdrawal by Subject|0|||
129561215|NCT02711956|466350084|FG013|Overall Study|PSA progression with clinical progression|1|||
129561216|NCT02711956|466350085|FG014|Overall Study|PSA progression with clinical progression|0|||
129561217|NCT02711956|466350071|FG000|Overall Study|PSA progression with radiographic progression|0|||
129687587|NCT01617967|466814210|FG002|Overall Study|Withdrawal by Subject|0|||
129687588|NCT01617967|466814211|FG003|Overall Study|Withdrawal by Subject|0|||
129687589|NCT01617967|466814212|FG004|Overall Study|Withdrawal by Subject|0|||
129687590|NCT01617967|466814213|FG005|Overall Study|Withdrawal by Subject|1|||
129687591|NCT01617967|466814208|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
129687592|NCT01617967|466814209|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
129561218|NCT02711956|466350072|FG001|Overall Study|PSA progression with radiographic progression|1|||
129561219|NCT02711956|466350073|FG002|Overall Study|PSA progression with radiographic progression|0|||
129561220|NCT02711956|466350074|FG003|Overall Study|PSA progression with radiographic progression|0|||
129561221|NCT02711956|466350075|FG004|Overall Study|PSA progression with radiographic progression|0|||
129561222|NCT02711956|466350076|FG005|Overall Study|PSA progression with radiographic progression|2|||
129561223|NCT02711956|466350077|FG006|Overall Study|PSA progression with radiographic progression|2|||
129561224|NCT02711956|466350078|FG007|Overall Study|PSA progression with radiographic progression|1|||
129561225|NCT02711956|466350079|FG008|Overall Study|PSA progression with radiographic progression|0|||
129561226|NCT02711956|466350080|FG009|Overall Study|PSA progression with radiographic progression|1|||
129561227|NCT02711956|466350081|FG010|Overall Study|PSA progression with radiographic progression|0|||
129561228|NCT02711956|466350082|FG011|Overall Study|PSA progression with radiographic progression|1|||
129561229|NCT02711956|466350083|FG012|Overall Study|PSA progression with radiographic progression|2|||
129561230|NCT02711956|466350084|FG013|Overall Study|PSA progression with radiographic progression|3|||
129561231|NCT02711956|466350085|FG014|Overall Study|PSA progression with radiographic progression|3|||
129561232|NCT01844583|466350086|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
129561233|NCT01844583|466350087|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
129561234|NCT01625377|466350088|FG000|Overall Study|Death|1|||
129561235|NCT01625377|466350089|FG001|Overall Study|Death|1|||
129561236|NCT01625377|466350088|FG000|Overall Study|Administrative Problem|1|||
129561237|NCT01625377|466350089|FG001|Overall Study|Administrative Problem|1|||
129561238|NCT01625377|466350088|FG000|Overall Study|Protocol Violation|0|||
129561239|NCT01625377|466350089|FG001|Overall Study|Protocol Violation|3|||
129561240|NCT01625377|466350088|FG000|Overall Study|Adverse Event|3|||
129561241|NCT01625377|466350089|FG001|Overall Study|Adverse Event|16|||
129561242|NCT01625377|466350088|FG000|Overall Study|Graft loss|1|||
129561243|NCT01625377|466350089|FG001|Overall Study|Graft loss|0|||
129561244|NCT01625377|466350088|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129561245|NCT01625377|466350089|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129561246|NCT01625377|466350088|FG000|Overall Study|Abnormal laboratory values|1|||
129561247|NCT01625377|466350089|FG001|Overall Study|Abnormal laboratory values|0|||
129561248|NCT03294538|466350094|FG000|Overall Study|Adverse Event|0|||
129561249|NCT03294538|466350095|FG001|Overall Study|Adverse Event|1|||
129561250|NCT03294538|466350096|FG002|Overall Study|Adverse Event|1|||
129561251|NCT03294538|466350094|FG000|Overall Study|Lost to Follow-up|1|||
129561252|NCT03294538|466350095|FG001|Overall Study|Lost to Follow-up|0|||
129561253|NCT03294538|466350096|FG002|Overall Study|Lost to Follow-up|0|||
129561254|NCT03294538|466350094|FG000|Overall Study|Outside of Visit Window|4|||
129561255|NCT03294538|466350095|FG001|Overall Study|Outside of Visit Window|4|||
129561256|NCT03294538|466350096|FG002|Overall Study|Outside of Visit Window|1|||
129561257|NCT01769378|466350102|FG000|Overall Study|Adverse Event|10|||
129561258|NCT01769378|466350103|FG001|Overall Study|Adverse Event|0|||
129561259|NCT01769378|466350102|FG000|Overall Study|Entry criteria not met|1|||
129561260|NCT01769378|466350103|FG001|Overall Study|Entry criteria not met|0|||
129561261|NCT01769378|466350102|FG000|Overall Study|Protocol Violation|1|||
129561262|NCT01769378|466350103|FG001|Overall Study|Protocol Violation|1|||
129561263|NCT01769378|466350102|FG000|Overall Study|Withdrawal by Subject|10|||
129561264|NCT01769378|466350103|FG001|Overall Study|Withdrawal by Subject|3|||
129561265|NCT01769378|466350102|FG000|Overall Study|Sponsor Decision|1|||
129561266|NCT01769378|466350103|FG001|Overall Study|Sponsor Decision|0|||
129561267|NCT01769378|466350102|FG000|Overall Study|Lost to Follow-up|2|||
129561268|NCT01769378|466350103|FG001|Overall Study|Lost to Follow-up|0|||
129561269|NCT01238848|466350106|FG000|Overall Study|Physician Decision|13|||
129561270|NCT01238848|466350107|FG001|Overall Study|Physician Decision|5|||
129561271|NCT00576901|466350108|FG000|Overall Study|Withdrawal by Subject|1|||
129561272|NCT00576901|466350108|FG000|Overall Study|Disease course|1|||
129561273|NCT00576901|466350108|FG000|Overall Study|Protocol Violation|1|||
129561274|NCT01755858|466350111|FG000|Overall Study|Adverse Event|1|||
129561275|NCT01755858|466350112|FG001|Overall Study|Adverse Event|1|||
129561276|NCT00782509|466350113|FG000|Overall Study|Adverse Event|20|||
129561277|NCT00782509|466350114|FG001|Overall Study|Adverse Event|10|||
129561278|NCT00782509|466350115|FG002|Overall Study|Adverse Event|20|||
129561279|NCT00782509|466350113|FG000|Overall Study|Lost to Follow-up|1|||
129561280|NCT00782509|466350114|FG001|Overall Study|Lost to Follow-up|2|||
129561281|NCT00782509|466350115|FG002|Overall Study|Lost to Follow-up|3|||
129561282|NCT00782509|466350113|FG000|Overall Study|Withdrawal by Subject|3|||
129687593|NCT01617967|466814210|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
129687594|NCT01617967|466814211|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
129561283|NCT00782509|466350114|FG001|Overall Study|Withdrawal by Subject|5|||
129561284|NCT00782509|466350115|FG002|Overall Study|Withdrawal by Subject|8|||
129561285|NCT00782509|466350113|FG000|Overall Study|Non compliance with protocol|2|||
129561286|NCT00782509|466350114|FG001|Overall Study|Non compliance with protocol|0|||
129687595|NCT01617967|466814212|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
129561287|NCT00782509|466350115|FG002|Overall Study|Non compliance with protocol|0|||
129561288|NCT00782509|466350113|FG000|Overall Study|Other reasons not stated above|5|||
129561289|NCT00782509|466350114|FG001|Overall Study|Other reasons not stated above|2|||
129561290|NCT00782509|466350115|FG002|Overall Study|Other reasons not stated above|3|||
129561291|NCT00782509|466350113|FG000|Overall Study|Lack of Efficacy|10|||
129561292|NCT00782509|466350114|FG001|Overall Study|Lack of Efficacy|5|||
129561293|NCT00782509|466350115|FG002|Overall Study|Lack of Efficacy|2|||
129561294|NCT02398188|466350116|FG000|Overall Study|Adverse Event|2|||
129561295|NCT02398188|466350117|FG001|Overall Study|Adverse Event|3|||
129561296|NCT02398188|466350116|FG000|Overall Study|Lost to Follow-up|5|||
129561297|NCT02398188|466350117|FG001|Overall Study|Lost to Follow-up|0|||
129561298|NCT02398188|466350116|FG000|Overall Study|Non-compliance|4|||
129561299|NCT02398188|466350117|FG001|Overall Study|Non-compliance|4|||
129561300|NCT02398188|466350116|FG000|Overall Study|Protocol Violation|6|||
129561301|NCT02398188|466350117|FG001|Overall Study|Protocol Violation|10|||
129561302|NCT02398188|466350116|FG000|Overall Study|Sponsor Decision|2|||
129561303|NCT02398188|466350117|FG001|Overall Study|Sponsor Decision|1|||
129561304|NCT02398188|466350116|FG000|Overall Study|Pregnancy|1|||
129561305|NCT02398188|466350117|FG001|Overall Study|Pregnancy|0|||
129561306|NCT02398188|466350116|FG000|Overall Study|Withdrawal by Subject|7|||
129561307|NCT02398188|466350117|FG001|Overall Study|Withdrawal by Subject|16|||
129561308|NCT01259869|466350118|FG000|Overall Study|Duplicated registration|1|||
129561309|NCT00175019|466350119|FG000|Overall Study|Adverse Event|54|||
129561310|NCT00175019|466350120|FG001|Overall Study|Adverse Event|22|||
129561311|NCT00175019|466350121|FG002|Overall Study|Adverse Event|2|||
129561312|NCT00175019|466350119|FG000|Overall Study|Protocol Violation|6|||
129561313|NCT00175019|466350120|FG001|Overall Study|Protocol Violation|3|||
129561314|NCT00175019|466350121|FG002|Overall Study|Protocol Violation|3|||
129561315|NCT00175019|466350119|FG000|Overall Study|Lost to Follow-up|42|||
129561316|NCT00175019|466350120|FG001|Overall Study|Lost to Follow-up|39|||
129561317|NCT00175019|466350121|FG002|Overall Study|Lost to Follow-up|9|||
129561318|NCT00175019|466350119|FG000|Overall Study|Did not continue under Amendment 4|1|||
129561319|NCT00175019|466350120|FG001|Overall Study|Did not continue under Amendment 4|1|||
129561320|NCT00175019|466350121|FG002|Overall Study|Did not continue under Amendment 4|2|||
129561321|NCT00175019|466350119|FG000|Overall Study|Personal Reason(s)|39|||
129561322|NCT00175019|466350120|FG001|Overall Study|Personal Reason(s)|31|||
129561323|NCT00175019|466350121|FG002|Overall Study|Personal Reason(s)|8|||
129561324|NCT00175019|466350119|FG000|Overall Study|Therapeutic Failure|10|||
129561325|NCT00175019|466350120|FG001|Overall Study|Therapeutic Failure|38|||
129561326|NCT00175019|466350121|FG002|Overall Study|Therapeutic Failure|22|||
129561327|NCT00175019|466350119|FG000|Overall Study|Gout Flare|2|||
129561328|NCT00175019|466350120|FG001|Overall Study|Gout Flare|3|||
129561329|NCT00175019|466350121|FG002|Overall Study|Gout Flare|0|||
129561330|NCT00175019|466350119|FG000|Overall Study|Reason Not Specified|40|||
129561331|NCT00175019|466350120|FG001|Overall Study|Reason Not Specified|34|||
129561332|NCT00175019|466350121|FG002|Overall Study|Reason Not Specified|11|||
129561333|NCT03209570|466350122|FG000|Overall Study|Death|1|||
129561334|NCT03209570|466350123|FG001|Overall Study|Death|0|||
129561335|NCT03209570|466350122|FG000|Overall Study|Incomplete Data|8|||
129561336|NCT03209570|466350123|FG001|Overall Study|Incomplete Data|10|||
129561337|NCT03209570|466350122|FG000|Overall Study|Protocol Violation|1|||
129561338|NCT03209570|466350123|FG001|Overall Study|Protocol Violation|0|||
129561339|NCT03209570|466350122|FG000|Overall Study|Withdrawal by Subject|0|||
129561340|NCT03209570|466350123|FG001|Overall Study|Withdrawal by Subject|3|||
129561341|NCT00220701|466350134|FG000|Overall Study|Lost to Follow-up|5|||
129561342|NCT00220701|466350135|FG001|Overall Study|Lost to Follow-up|4|||
129561343|NCT00755326|466350137|FG000|Overall Study|Lost to Follow-up|2|||
129561344|NCT00755326|466350138|FG001|Overall Study|Lost to Follow-up|3|||
129561345|NCT01338636|466350144|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
129561346|NCT02385526|466350145|FG000|Overall Study|Withdrawal by Subject|0|||
129687596|NCT01617967|466814213|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
129687597|NCT05276804|466814220|FG000|Overall Study|screen failure|23|||
129561347|NCT02385526|466350146|FG001|Overall Study|Withdrawal by Subject|2|||
129561348|NCT02385526|466350147|FG002|Overall Study|Withdrawal by Subject|0|||
129561349|NCT02385526|466350145|FG000|Overall Study|Lost to Follow-up|0|||
129561350|NCT02385526|466350146|FG001|Overall Study|Lost to Follow-up|1|||
129687598|NCT05276804|466814221|FG001|Overall Study|screen failure|0|||
129687599|NCT02827708|466814222|FG000|Overall Study|Lost to Follow-up|3|||
129561351|NCT02385526|466350147|FG002|Overall Study|Lost to Follow-up|0|||
129561352|NCT02385526|466350145|FG000|Overall Study|Physician Decision|1|||
129561353|NCT02385526|466350146|FG001|Overall Study|Physician Decision|0|||
129561354|NCT02385526|466350147|FG002|Overall Study|Physician Decision|0|||
129561355|NCT02385526|466350145|FG000|Overall Study|Protocol Violation|1|||
129561356|NCT02385526|466350146|FG001|Overall Study|Protocol Violation|0|||
129687600|NCT02827708|466814223|FG001|Overall Study|Lost to Follow-up|1|||
129561357|NCT02385526|466350147|FG002|Overall Study|Protocol Violation|0|||
129561358|NCT03532009|466350148|FG000|Overall Study|Other|1|||
129687601|NCT02827708|466814222|FG000|Overall Study|Withdrawal by Subject|1|||
129561359|NCT03532009|466350149|FG001|Overall Study|Other|1|||
129561360|NCT03532009|466350148|FG000|Overall Study|Death|1|||
129561361|NCT03532009|466350149|FG001|Overall Study|Death|1|||
129561362|NCT03532009|466350148|FG000|Overall Study|Withdrawal by Patient|0|||
129561363|NCT03532009|466350149|FG001|Overall Study|Withdrawal by Patient|2|||
129561364|NCT02035137|466350150|FG000|Overall Study|Physician Decision|0|||
129561365|NCT02035137|466350151|FG001|Overall Study|Physician Decision|0|||
129561366|NCT02035137|466350152|FG002|Overall Study|Physician Decision|1|||
129561367|NCT02035137|466350150|FG000|Overall Study|Withdrawal by Subject|0|||
129561368|NCT02035137|466350151|FG001|Overall Study|Withdrawal by Subject|1|||
129561369|NCT02035137|466350152|FG002|Overall Study|Withdrawal by Subject|2|||
129561370|NCT02035137|466350150|FG000|Overall Study|Ineligible|0|||
129561371|NCT02035137|466350151|FG001|Overall Study|Ineligible|1|||
129561372|NCT02035137|466350152|FG002|Overall Study|Ineligible|2|||
129561373|NCT02035137|466350150|FG000|Overall Study|Disease progression prior to treatment start|2|||
129561374|NCT02035137|466350151|FG001|Overall Study|Disease progression prior to treatment start|0|||
129561375|NCT02035137|466350152|FG002|Overall Study|Disease progression prior to treatment start|0|||
129561376|NCT01006707|466350159|FG000|Study Session 1|Lost to Follow-up|2|||
129561377|NCT01006707|466350160|FG001|Study Session 1|Lost to Follow-up|0|||
129561378|NCT01006707|466350161|FG002|Study Session 1|Lost to Follow-up|0|||
129561379|NCT01006707|466350159|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
129561380|NCT01006707|466350160|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
129561381|NCT01006707|466350161|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
129561382|NCT05034731|466350162|FG000|Overall Study|Screen fail|1|||
129561383|NCT05034731|466350163|FG001|Overall Study|Screen fail|1|||
129561384|NCT00283686|466350165|FG000|Overall Study|Death|1|||
129561385|NCT00283686|466350166|FG001|Overall Study|Death|1|||
129561386|NCT00283686|466350167|FG002|Overall Study|Death|1|||
129561387|NCT00283686|466350168|FG003|Overall Study|Death|0|||
129561388|NCT00283686|466350165|FG000|Overall Study|Lost to Follow-up|21|||
129561389|NCT00283686|466350166|FG001|Overall Study|Lost to Follow-up|31|||
129561390|NCT00283686|466350167|FG002|Overall Study|Lost to Follow-up|26|||
129561391|NCT00283686|466350168|FG003|Overall Study|Lost to Follow-up|20|||
129561392|NCT00283686|466350165|FG000|Overall Study|Less than full participation|7|||
129561393|NCT00283686|466350166|FG001|Overall Study|Less than full participation|9|||
129561394|NCT00283686|466350167|FG002|Overall Study|Less than full participation|6|||
129561395|NCT00283686|466350168|FG003|Overall Study|Less than full participation|12|||
129561396|NCT02970669|466350169|FG000|Double-blind Period|Adverse Event|4|||
129561397|NCT02970669|466350170|FG001|Double-blind Period|Adverse Event|0|||
129561398|NCT02970669|466350169|FG000|Double-blind Period|Death|1|||
129561399|NCT02970669|466350170|FG001|Double-blind Period|Death|0|||
129561400|NCT02970669|466350169|FG000|Double-blind Period|Study terminated by sponsor|1|||
129561401|NCT02970669|466350170|FG001|Double-blind Period|Study terminated by sponsor|2|||
129561402|NCT02970669|466350169|FG000|Double-blind Period|Physician Decision|0|||
129561403|NCT02970669|466350170|FG001|Double-blind Period|Physician Decision|2|||
129561404|NCT02970669|466350169|FG000|Double-blind Period|Withdrawal by Subject|2|||
129561405|NCT02970669|466350170|FG001|Double-blind Period|Withdrawal by Subject|2|||
129561406|NCT02970669|466350169|FG000|Open-label Period|Withdrawal by Subject|2|||
129561407|NCT02970669|466350170|FG001|Open-label Period|Withdrawal by Subject|2|||
129561408|NCT02970669|466350169|FG000|Open-label Period|Adverse Event|1|||
129561409|NCT02970669|466350170|FG001|Open-label Period|Adverse Event|0|||
129561410|NCT02970669|466350169|FG000|Open-label Period|Physician Decision|1|||
129561411|NCT02970669|466350170|FG001|Open-label Period|Physician Decision|0|||
129561412|NCT03521999|466350171|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
129561413|NCT03521999|466350172|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
129561414|NCT03521999|466350171|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
129561415|NCT03521999|466350172|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
129561416|NCT03521999|466350171|FG000|Completed 3 Month Follow up|Death|0|||
129687602|NCT02827708|466814223|FG001|Overall Study|Withdrawal by Subject|2|||
129687603|NCT02827708|466814222|FG000|Overall Study|Death|1|||
129687604|NCT02827708|466814223|FG001|Overall Study|Death|2|||
129687605|NCT01137812|466814224|FG000|Overall Study|Adverse Event|21|||
129687606|NCT01137812|466814225|FG001|Overall Study|Adverse Event|14|||
129561417|NCT03521999|466350172|FG001|Completed 3 Month Follow up|Death|1|||
129561418|NCT03521999|466350171|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
129561419|NCT03521999|466350172|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
129561420|NCT00467584|466350177|FG000|Overall Study|Withdrawal by Subject|4|||
129561421|NCT00467584|466350178|FG001|Overall Study|Withdrawal by Subject|5|||
129561422|NCT00467584|466350179|FG002|Overall Study|Withdrawal by Subject|1|||
129561423|NCT02292238|466350183|FG000|Overall Study|Protocol Violation|1|||
129561424|NCT02292238|466350184|FG001|Overall Study|Protocol Violation|2|||
129561425|NCT02292238|466350183|FG000|Overall Study|Withdrawal by Subject|2|||
129561426|NCT02292238|466350184|FG001|Overall Study|Withdrawal by Subject|1|||
129561427|NCT02292238|466350183|FG000|Overall Study|Lost to Follow-up|1|||
129561428|NCT02292238|466350184|FG001|Overall Study|Lost to Follow-up|0|||
129687607|NCT01137812|466814224|FG000|Overall Study|Lost to Follow-up|6|||
129778008|NCT00560352|467152506|FG002|Overall Study|Adverse event unrelated to study drug|1|||
129778009|NCT00560352|467152504|FG000|Overall Study|Study drug toxicity|3|||
129778010|NCT00560352|467152505|FG001|Overall Study|Study drug toxicity|0|||
129778011|NCT00560352|467152506|FG002|Overall Study|Study drug toxicity|1|||
129778012|NCT00560352|467152504|FG000|Overall Study|Disease progression|0|||
129778013|NCT00560352|467152505|FG001|Overall Study|Disease progression|1|||
129778014|NCT00560352|467152506|FG002|Overall Study|Disease progression|1|||
129778015|NCT00560352|467152504|FG000|Overall Study|Withdrawal by Subject|1|||
129778016|NCT00560352|467152505|FG001|Overall Study|Withdrawal by Subject|1|||
129778017|NCT00560352|467152506|FG002|Overall Study|Withdrawal by Subject|1|||
129778018|NCT00560352|467152504|FG000|Overall Study|Maximum clinical benefit|1|||
129778019|NCT00560352|467152505|FG001|Overall Study|Maximum clinical benefit|0|||
129778020|NCT00560352|467152506|FG002|Overall Study|Maximum clinical benefit|0|||
129778021|NCT03083873|467154401|FG000|Overall Study|Death|6|||
129778022|NCT03083873|467154402|FG001|Overall Study|Death|15|||
129778023|NCT03083873|467154403|FG002|Overall Study|Death|13|||
129778024|NCT03083873|467154404|FG003|Overall Study|Death|9|||
129778025|NCT03083873|467154405|FG004|Overall Study|Death|0|||
129778026|NCT03083873|467154401|FG000|Overall Study|Sponsor Terminated Study|0|||
129778027|NCT03083873|467154402|FG001|Overall Study|Sponsor Terminated Study|1|||
129778028|NCT03083873|467154403|FG002|Overall Study|Sponsor Terminated Study|2|||
129561429|NCT02292238|466350183|FG000|Overall Study|Physician Decision|0|||
129561430|NCT02292238|466350184|FG001|Overall Study|Physician Decision|1|||
129561431|NCT01789320|466350185|FG000|Overall Study|Re-enrolled into study|1|||
129561432|NCT01789320|466350185|FG000|Overall Study|Lost to Follow-up|1|||
129561433|NCT02789111|466350190|FG000|Overall Study|Withdrawal by Subject|1|||
129561434|NCT02789111|466350191|FG001|Overall Study|Withdrawal by Subject|4|||
129561435|NCT00673790|466350194|FG000|Overall Study|Adverse Event|23|||
129561436|NCT00673790|466350195|FG001|Overall Study|Adverse Event|14|||
129561437|NCT00673790|466350196|FG002|Overall Study|Adverse Event|2|||
129561438|NCT00673790|466350194|FG000|Overall Study|Lack of Efficacy|2|||
129561439|NCT00673790|466350195|FG001|Overall Study|Lack of Efficacy|2|||
129561440|NCT00673790|466350196|FG002|Overall Study|Lack of Efficacy|2|||
129561441|NCT00673790|466350194|FG000|Overall Study|Protocol Violation|6|||
129561442|NCT00673790|466350195|FG001|Overall Study|Protocol Violation|9|||
129561443|NCT00673790|466350196|FG002|Overall Study|Protocol Violation|1|||
129561444|NCT00673790|466350194|FG000|Overall Study|Withdrawal by Subject|7|||
129561445|NCT00673790|466350195|FG001|Overall Study|Withdrawal by Subject|4|||
129561446|NCT00673790|466350196|FG002|Overall Study|Withdrawal by Subject|1|||
129561447|NCT00673790|466350194|FG000|Overall Study|Lost to Follow-up|6|||
129561448|NCT00673790|466350195|FG001|Overall Study|Lost to Follow-up|6|||
129561449|NCT00673790|466350196|FG002|Overall Study|Lost to Follow-up|5|||
129561450|NCT00673790|466350194|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
129561451|NCT00673790|466350195|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
129561452|NCT00673790|466350196|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
129561453|NCT00673790|466350194|FG000|Overall Study|Poor compliance|1|||
129561454|NCT00673790|466350195|FG001|Overall Study|Poor compliance|0|||
129561455|NCT00673790|466350196|FG002|Overall Study|Poor compliance|0|||
129561456|NCT00673790|466350194|FG000|Overall Study|Participated in two Nebivolol studies|0|||
129561457|NCT00673790|466350195|FG001|Overall Study|Participated in two Nebivolol studies|0|||
129561458|NCT00673790|466350196|FG002|Overall Study|Participated in two Nebivolol studies|1|||
129561459|NCT00673790|466350194|FG000|Overall Study|Unconfirmed pregnancy|0|||
129561460|NCT00673790|466350195|FG001|Overall Study|Unconfirmed pregnancy|1|||
129561461|NCT00673790|466350196|FG002|Overall Study|Unconfirmed pregnancy|0|||
129561462|NCT00673790|466350194|FG000|Overall Study|Randomization criteria not met|0|||
129561463|NCT00673790|466350195|FG001|Overall Study|Randomization criteria not met|1|||
129561464|NCT00673790|466350196|FG002|Overall Study|Randomization criteria not met|0|||
129561465|NCT00601484|466350200|FG000|Overall Study|Adverse Event|0|||
129561466|NCT00601484|466350201|FG001|Overall Study|Adverse Event|1|||
129561467|NCT00601484|466350200|FG000|Overall Study|Lost to Follow-up|4|||
129561468|NCT00601484|466350201|FG001|Overall Study|Lost to Follow-up|3|||
129561469|NCT00601484|466350200|FG000|Overall Study|Lack of Efficacy|0|||
129561470|NCT00601484|466350201|FG001|Overall Study|Lack of Efficacy|2|||
129561471|NCT00601484|466350200|FG000|Overall Study|Withdrawal by Subject|1|||
129687608|NCT01137812|466814225|FG001|Overall Study|Lost to Follow-up|8|||
129687609|NCT01137812|466814224|FG000|Overall Study|Physician Decision|25|||
129687610|NCT01137812|466814225|FG001|Overall Study|Physician Decision|17|||
129687611|NCT01137812|466814224|FG000|Overall Study|Protocol Violation|5|||
129687612|NCT01137812|466814225|FG001|Overall Study|Protocol Violation|4|||
129687613|NCT01137812|466814224|FG000|Overall Study|Withdrawal by Subject|5|||
129687614|NCT01137812|466814225|FG001|Overall Study|Withdrawal by Subject|13|||
129687615|NCT01137812|466814224|FG000|Overall Study|Death|2|||
129687616|NCT01137812|466814225|FG001|Overall Study|Death|0|||
129687617|NCT01137812|466814224|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
129687618|NCT01137812|466814225|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
129687619|NCT01137812|466814224|FG000|Overall Study|Other|19|||
129687620|NCT01137812|466814225|FG001|Overall Study|Other|27|||
129687621|NCT04621760|466814226|FG000|Overall Study|Lost to Follow-up|2|||
129687622|NCT04621760|466814227|FG001|Overall Study|Lost to Follow-up|4|||
129687623|NCT04621760|466814226|FG000|Overall Study|Withdrawal by Subject|1|||
129687624|NCT04621760|466814227|FG001|Overall Study|Withdrawal by Subject|0|||
129687625|NCT04602000|466814230|FG000|Overall Study|Withdrawal by Subject|3|||
129687626|NCT04602000|466814231|FG001|Overall Study|Withdrawal by Subject|6|||
129561472|NCT00601484|466350201|FG001|Overall Study|Withdrawal by Subject|1|||
129561473|NCT00601484|466350200|FG000|Overall Study|Randomized, but not treated|0|||
129561474|NCT00601484|466350201|FG001|Overall Study|Randomized, but not treated|1|||
129561475|NCT01200394|466350202|FG000|Overall Study|Adverse Event|0|||
129561476|NCT01200394|466350203|FG001|Overall Study|Adverse Event|14|||
129687627|NCT04602000|466814232|FG002|Overall Study|Withdrawal by Subject|3|||
129687628|NCT04602000|466814233|FG003|Overall Study|Withdrawal by Subject|27|||
129884520|NCT04779242|467536436|FG000|Overall Study|Withdrawal by Subject|7|||
129561477|NCT01200394|466350202|FG000|Overall Study|Death|1|||
129561478|NCT01200394|466350203|FG001|Overall Study|Death|0|||
129687629|NCT04602000|466814234|FG004|Overall Study|Withdrawal by Subject|39|||
129687630|NCT04602000|466814230|FG000|Overall Study|Physician Decision|1|||
129687631|NCT04602000|466814231|FG001|Overall Study|Physician Decision|0|||
129687632|NCT04602000|466814232|FG002|Overall Study|Physician Decision|0|||
129561479|NCT01200394|466350202|FG000|Overall Study|Lost to Follow-up|0|||
129561480|NCT01200394|466350203|FG001|Overall Study|Lost to Follow-up|1|||
129561481|NCT01200394|466350202|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129561482|NCT01200394|466350203|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
129561483|NCT01200394|466350202|FG000|Overall Study|Protocol Violation|0|||
129561484|NCT01200394|466350203|FG001|Overall Study|Protocol Violation|3|||
129561485|NCT01200394|466350202|FG000|Overall Study|Withdrawal by Subject|0|||
129561486|NCT01200394|466350203|FG001|Overall Study|Withdrawal by Subject|5|||
129561487|NCT01200394|466350202|FG000|Overall Study|Other|0|||
129561488|NCT01200394|466350203|FG001|Overall Study|Other|1|||
129561489|NCT01463683|466350207|FG000|Overall Study|Adverse Event|2|||
129561490|NCT01463683|466350208|FG001|Overall Study|Adverse Event|0|||
129561491|NCT01463683|466350209|FG002|Overall Study|Adverse Event|0|||
129561492|NCT01463683|466350207|FG000|Overall Study|Lost to Follow-up|10|||
129561493|NCT01463683|466350208|FG001|Overall Study|Lost to Follow-up|9|||
129561494|NCT01463683|466350209|FG002|Overall Study|Lost to Follow-up|7|||
129561495|NCT01463683|466350207|FG000|Overall Study|Physician Decision|0|||
129561496|NCT01463683|466350208|FG001|Overall Study|Physician Decision|3|||
129561497|NCT01463683|466350209|FG002|Overall Study|Physician Decision|1|||
129561498|NCT01463683|466350207|FG000|Overall Study|Pregnancy|2|||
129561499|NCT01463683|466350208|FG001|Overall Study|Pregnancy|2|||
129561500|NCT01463683|466350209|FG002|Overall Study|Pregnancy|1|||
129561501|NCT01463683|466350207|FG000|Overall Study|Withdrawal by Subject|5|||
129561502|NCT01463683|466350208|FG001|Overall Study|Withdrawal by Subject|17|||
129561503|NCT01463683|466350209|FG002|Overall Study|Withdrawal by Subject|2|||
129561504|NCT04345471|466350214|FG000|Overall Study|Adverse Event|8|||
129561505|NCT04345471|466350215|FG001|Overall Study|Adverse Event|5|||
129561506|NCT04345471|466350216|FG002|Overall Study|Adverse Event|6|||
129561507|NCT04345471|466350214|FG000|Overall Study|Lack of Efficacy|1|||
129561508|NCT04345471|466350215|FG001|Overall Study|Lack of Efficacy|1|||
129561509|NCT04345471|466350216|FG002|Overall Study|Lack of Efficacy|0|||
129561510|NCT04345471|466350214|FG000|Overall Study|Protocol Violation|0|||
129561511|NCT04345471|466350215|FG001|Overall Study|Protocol Violation|1|||
129561512|NCT04345471|466350216|FG002|Overall Study|Protocol Violation|2|||
129561513|NCT04345471|466350214|FG000|Overall Study|Withdrawal by Subject|10|||
129561514|NCT04345471|466350215|FG001|Overall Study|Withdrawal by Subject|5|||
129561515|NCT04345471|466350216|FG002|Overall Study|Withdrawal by Subject|10|||
129561516|NCT03896490|466350251|FG000|Overall Study|Withdrawal by Subject|1|||
129561517|NCT03896490|466350252|FG001|Overall Study|Withdrawal by Subject|1|||
129561518|NCT00003782|466350253|FG000|Overall Study|No follow up data|30|||
129561519|NCT00003782|466350254|FG001|Overall Study|No follow up data|31|||
129561520|NCT00003782|466350255|FG002|Overall Study|No follow up data|26|||
129561521|NCT01890707|466350256|FG000|Overall Study|Lost to Follow-up|1|||
129561522|NCT01890707|466350257|FG001|Overall Study|Lost to Follow-up|1|||
129561523|NCT01326026|466350259|FG000|Overall Study|Adverse Event|4|||
129561524|NCT01326026|466350260|FG001|Overall Study|Adverse Event|3|||
129561525|NCT01326026|466350259|FG000|Overall Study|Withdrawal Criteria|5|||
129561526|NCT01326026|466350260|FG001|Overall Study|Withdrawal Criteria|7|||
129561527|NCT01326026|466350259|FG000|Overall Study|Other|3|||
129561528|NCT01326026|466350260|FG001|Overall Study|Other|3|||
129561529|NCT05188521|466351759|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
129561530|NCT05188521|466351760|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
129561531|NCT01341639|466351761|FG000|Infant Series|Protocol Violation|1|||
129561532|NCT01341639|466351762|FG001|Infant Series|Protocol Violation|0|||
129561533|NCT01341639|466351761|FG000|Infant Series|Not Vaccinated|0|||
129561534|NCT01341639|466351762|FG001|Infant Series|Not Vaccinated|1|||
129561535|NCT01341639|466351761|FG000|Infant Series|Adverse Event|0|||
129561536|NCT01341639|466351762|FG001|Infant Series|Adverse Event|5|||
129561537|NCT01341639|466351761|FG000|Infant Series|Withdrawal by Subject|11|||
129561538|NCT01341639|466351762|FG001|Infant Series|Withdrawal by Subject|8|||
129561539|NCT01341639|466351761|FG000|Infant Series|Lost to Follow-up|0|||
129561540|NCT01341639|466351762|FG001|Infant Series|Lost to Follow-up|2|||
129561541|NCT01341639|466351761|FG000|Infant Series|Site 0048 Participants|17|||
129561542|NCT01341639|466351762|FG001|Infant Series|Site 0048 Participants|16|||
129561543|NCT01341639|466351761|FG000|Interim Period|Withdrawal by Subject|6|||
129561544|NCT01341639|466351762|FG001|Interim Period|Withdrawal by Subject|7|||
129561545|NCT01341639|466351761|FG000|Interim Period|Lost to Follow-up|2|||
129561546|NCT01341639|466351762|FG001|Interim Period|Lost to Follow-up|0|||
129561547|NCT01341639|466351761|FG000|Interim Period|Physician Decision|0|||
129561548|NCT01341639|466351762|FG001|Interim Period|Physician Decision|1|||
129561549|NCT01341639|466351761|FG000|Interim Period|Protocol Violation|0|||
129561550|NCT01341639|466351762|FG001|Interim Period|Protocol Violation|1|||
129561551|NCT01341639|466351761|FG000|Post-Treatment|Withdrawal by Subject|0|||
129561552|NCT01341639|466351762|FG001|Post-Treatment|Withdrawal by Subject|1|||
129561553|NCT01341639|466351761|FG000|Post-Treatment|Adverse Event|0|||
129687633|NCT04602000|466814233|FG003|Overall Study|Physician Decision|2|||
129561554|NCT01341639|466351762|FG001|Post-Treatment|Adverse Event|2|||
129561555|NCT04582266|466351763|FG000|Overall Study|Lost to Follow-up|7|||
129561556|NCT04582266|466351764|FG001|Overall Study|Lost to Follow-up|5|||
129561557|NCT04582266|466351763|FG000|Overall Study|Withdrawal by Subject|1|||
129561558|NCT04582266|466351764|FG001|Overall Study|Withdrawal by Subject|0|||
129561559|NCT04582266|466351763|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
129561560|NCT04582266|466351764|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
129561561|NCT01241461|466351765|FG000|Overall Study|Progressive Disease|3|||
129561562|NCT01241461|466351766|FG001|Overall Study|Progressive Disease|6|||
129561563|NCT01132118|466351767|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
129561564|NCT01132118|466351768|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
129561565|NCT01132118|466351767|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129561566|NCT01132118|466351768|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
129561567|NCT01132118|466351767|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
129561568|NCT01132118|466351768|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
129561569|NCT03705351|466351771|FG000|Overall Study|Study termination|3|||
129561570|NCT03705351|466351771|FG000|Overall Study|Death|1|||
129561571|NCT03705351|466351771|FG000|Overall Study|Lack of Efficacy|2|||
129561572|NCT03705351|466351771|FG000|Overall Study|Withdrawal by Subject|1|||
129561573|NCT01299038|466351779|FG000|Overall Study|Withdrawal by Subject|1|||
129561574|NCT01299038|466351780|FG001|Overall Study|Withdrawal by Subject|0|||
129561575|NCT00322556|466351781|FG000|Overall Study|Adverse Event|1|||
129561576|NCT00322556|466351781|FG000|Overall Study|Withdrawal by Subject|1|||
129561577|NCT00322556|466351781|FG000|Overall Study|Lost to Follow-up|3|||
129561578|NCT00322556|466351781|FG000|Overall Study|Other Reason|7|||
129561579|NCT00832078|466351782|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
129561580|NCT00832078|466351783|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
129561581|NCT00832078|466351782|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
129561582|NCT00832078|466351783|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
129561583|NCT01767597|466351784|FG000|Overall Study|Incomplete intervention|3|||
129561584|NCT01767597|466351785|FG001|Overall Study|Incomplete intervention|1|||
129561585|NCT01767597|466351784|FG000|Overall Study|Withdrawal by Subject|1|||
129561586|NCT01767597|466351785|FG001|Overall Study|Withdrawal by Subject|0|||
129561587|NCT02961920|466351786|FG000|Overall Study|did not achive stydy protocol schedule|1|||
129561588|NCT02961920|466351787|FG001|Overall Study|did not achive stydy protocol schedule|1|||
129561589|NCT02232074|466351788|FG000|Overall Study|Withdrawal by Subject|5|||
129561590|NCT02232074|466351789|FG001|Overall Study|Withdrawal by Subject|3|||
129561591|NCT02232074|466351788|FG000|Overall Study|No legal concerns at baseline|36|||
129561592|NCT02232074|466351789|FG001|Overall Study|No legal concerns at baseline|41|||
129561593|NCT02232074|466351788|FG000|Overall Study|deemed ineligible|0|||
129561594|NCT02232074|466351789|FG001|Overall Study|deemed ineligible|1|||
129561595|NCT04480463|466351792|FG000|Overall Study|Death|0|||
129561596|NCT04480463|466351793|FG001|Overall Study|Death|1|||
129561597|NCT04480463|466351792|FG000|Overall Study|Adverse Event|6|||
129561598|NCT04480463|466351793|FG001|Overall Study|Adverse Event|8|||
129561599|NCT04480463|466351792|FG000|Overall Study|Lost to Follow-up|3|||
129561600|NCT04480463|466351793|FG001|Overall Study|Lost to Follow-up|2|||
129561601|NCT04480463|466351792|FG000|Overall Study|Physician Decision|2|||
129561602|NCT04480463|466351793|FG001|Overall Study|Physician Decision|5|||
129561603|NCT04480463|466351792|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
129561604|NCT04480463|466351793|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
129561605|NCT04480463|466351792|FG000|Overall Study|Protocol Violation|2|||
129561606|NCT04480463|466351793|FG001|Overall Study|Protocol Violation|1|||
129561607|NCT04480463|466351792|FG000|Overall Study|Withdrawal by Subject|6|||
129561608|NCT04480463|466351793|FG001|Overall Study|Withdrawal by Subject|7|||
129561609|NCT04480463|466351792|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
129561610|NCT04480463|466351793|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
129561611|NCT04480463|466351792|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
129561612|NCT04480463|466351793|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
129561613|NCT04480463|466351792|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
129561614|NCT04480463|466351793|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
129561615|NCT04480463|466351792|FG000|Overall Study|Other|6|||
129561616|NCT04480463|466351793|FG001|Overall Study|Other|4|||
129561617|NCT00704418|466351795|FG000|Overall Study|Withdrawal by Subject|2|||
129561618|NCT00704418|466351796|FG001|Overall Study|Withdrawal by Subject|0|||
129561619|NCT00704418|466351795|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
129561620|NCT00704418|466351796|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
129561621|NCT02322879|466351797|FG000|First Intervention|Physician Decision|1|||
129561622|NCT02322879|466351798|FG001|First Intervention|Physician Decision|0|||
129561623|NCT01579474|466351799|FG000|Overall Study|Adverse Event|1|||
129561624|NCT01579474|466351800|FG001|Overall Study|Adverse Event|13|||
129561625|NCT01579474|466351801|FG002|Overall Study|Adverse Event|2|||
129561626|NCT01579474|466351802|FG003|Overall Study|Adverse Event|0|||
129561627|NCT01579474|466351803|FG004|Overall Study|Adverse Event|0|||
129561628|NCT01579474|466351804|FG005|Overall Study|Adverse Event|1|||
129561629|NCT01579474|466351799|FG000|Overall Study|Lack of Efficacy|1|||
129561630|NCT01579474|466351800|FG001|Overall Study|Lack of Efficacy|0|||
129561631|NCT01579474|466351801|FG002|Overall Study|Lack of Efficacy|0|||
129561632|NCT01579474|466351802|FG003|Overall Study|Lack of Efficacy|0|||
129561633|NCT01579474|466351803|FG004|Overall Study|Lack of Efficacy|1|||
129561634|NCT01579474|466351804|FG005|Overall Study|Lack of Efficacy|0|||
129561635|NCT01579474|466351799|FG000|Overall Study|Withdrawal by Subject|1|||
129561636|NCT01579474|466351800|FG001|Overall Study|Withdrawal by Subject|0|||
129561637|NCT01579474|466351801|FG002|Overall Study|Withdrawal by Subject|0|||
129561638|NCT01579474|466351802|FG003|Overall Study|Withdrawal by Subject|0|||
129561639|NCT01579474|466351803|FG004|Overall Study|Withdrawal by Subject|0|||
129561640|NCT01579474|466351804|FG005|Overall Study|Withdrawal by Subject|0|||
129561641|NCT02637076|466351805|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
129561642|NCT02637076|466351806|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
129561643|NCT02637076|466351805|FG000|Overall Study|Withdrawal by Subject|0|||
129561644|NCT02637076|466351806|FG001|Overall Study|Withdrawal by Subject|4|||
129561645|NCT00130520|466351807|FG000|Overall Study|Adverse Event|11|||
129561646|NCT00130520|466351807|FG000|Overall Study|Death|1|||
129561647|NCT00130520|466351807|FG000|Overall Study|Physician Decision|1|||
129561648|NCT00130520|466351807|FG000|Overall Study|Withdrawal by Subject|1|||
129561649|NCT00130520|466351807|FG000|Overall Study|Disease Progression|23|||
129561650|NCT00130520|466351807|FG000|Overall Study|Protocol non-compliance|1|||
129561651|NCT00130520|466351807|FG000|Overall Study|Did not meet re-treatment criteria|1|||
129561652|NCT01673009|466351808|FG000|Overall Study|Physician Decision|5|||
129561653|NCT01673009|466351808|FG000|Overall Study|Withdrawal by Subject|8|||
129561654|NCT04041570|466351811|FG000|Overall Study|Moved from Area|0|||
129561655|NCT04041570|466351812|FG001|Overall Study|Moved from Area|2|||
129561656|NCT00384033|466351823|FG000|Overall Study|Adverse Event|10|||
129561657|NCT00384033|466351824|FG001|Overall Study|Adverse Event|8|||
129561658|NCT00384033|466351825|FG002|Overall Study|Adverse Event|11|||
129561659|NCT00384033|466351826|FG003|Overall Study|Adverse Event|20|||
129561660|NCT00384033|466351823|FG000|Overall Study|Failed to return|1|||
129561661|NCT00384033|466351824|FG001|Overall Study|Failed to return|3|||
129561662|NCT00384033|466351825|FG002|Overall Study|Failed to return|2|||
129561663|NCT00384033|466351826|FG003|Overall Study|Failed to return|2|||
129561664|NCT00384033|466351823|FG000|Overall Study|Physician Decision|1|||
129561665|NCT00384033|466351824|FG001|Overall Study|Physician Decision|0|||
129561666|NCT00384033|466351825|FG002|Overall Study|Physician Decision|0|||
129561667|NCT00384033|466351826|FG003|Overall Study|Physician Decision|0|||
129778029|NCT03083873|467154404|FG003|Overall Study|Sponsor Terminated Study|3|||
129778030|NCT03083873|467154405|FG004|Overall Study|Sponsor Terminated Study|0|||
129778031|NCT03083873|467154401|FG000|Overall Study|Lost to Follow-up|0|||
129778032|NCT03083873|467154402|FG001|Overall Study|Lost to Follow-up|1|||
129778033|NCT03083873|467154403|FG002|Overall Study|Lost to Follow-up|1|||
129778034|NCT03083873|467154404|FG003|Overall Study|Lost to Follow-up|0|||
129778035|NCT03083873|467154405|FG004|Overall Study|Lost to Follow-up|0|||
129778036|NCT03083873|467154401|FG000|Overall Study|Withdrawal by Subject|2|||
129561668|NCT00384033|466351823|FG000|Overall Study|Lost to Follow-up|6|||
129561669|NCT00384033|466351824|FG001|Overall Study|Lost to Follow-up|12|||
129561670|NCT00384033|466351825|FG002|Overall Study|Lost to Follow-up|7|||
129561671|NCT00384033|466351826|FG003|Overall Study|Lost to Follow-up|7|||
129561672|NCT00384033|466351823|FG000|Overall Study|Other|2|||
129561673|NCT00384033|466351824|FG001|Overall Study|Other|0|||
129778037|NCT03083873|467154402|FG001|Overall Study|Withdrawal by Subject|0|||
129561674|NCT00384033|466351825|FG002|Overall Study|Other|0|||
129561675|NCT00384033|466351826|FG003|Overall Study|Other|0|||
129778038|NCT03083873|467154403|FG002|Overall Study|Withdrawal by Subject|0|||
129778039|NCT03083873|467154404|FG003|Overall Study|Withdrawal by Subject|0|||
129561676|NCT00384033|466351823|FG000|Overall Study|Protocol Violation|5|||
129561677|NCT00384033|466351824|FG001|Overall Study|Protocol Violation|0|||
129561678|NCT00384033|466351825|FG002|Overall Study|Protocol Violation|5|||
129561679|NCT00384033|466351826|FG003|Overall Study|Protocol Violation|6|||
129561680|NCT00384033|466351823|FG000|Overall Study|Withdrawal by Subject|6|||
129561681|NCT00384033|466351824|FG001|Overall Study|Withdrawal by Subject|2|||
129561682|NCT00384033|466351825|FG002|Overall Study|Withdrawal by Subject|5|||
129561683|NCT00384033|466351826|FG003|Overall Study|Withdrawal by Subject|2|||
129561684|NCT00384033|466351823|FG000|Overall Study|Lack of Efficacy|7|||
129561685|NCT00384033|466351824|FG001|Overall Study|Lack of Efficacy|3|||
129561686|NCT00384033|466351825|FG002|Overall Study|Lack of Efficacy|3|||
129561687|NCT00384033|466351826|FG003|Overall Study|Lack of Efficacy|1|||
129561688|NCT00384033|466351823|FG000|Overall Study|Randomized but not treated|3|||
129561689|NCT00384033|466351824|FG001|Overall Study|Randomized but not treated|7|||
129561690|NCT00384033|466351825|FG002|Overall Study|Randomized but not treated|10|||
129561691|NCT00384033|466351826|FG003|Overall Study|Randomized but not treated|2|||
129561692|NCT00290745|466351827|FG000|Overall Study|Withdrawal by Subject|4|||
129561693|NCT00290745|466351827|FG000|Overall Study|Physician Decision|2|||
129561694|NCT00290745|466351827|FG000|Overall Study|Surgery after 3 months for progression|3|||
129561695|NCT00290745|466351827|FG000|Overall Study|Baseline MRI not available|3|||
129561696|NCT02750306|466351828|FG000|Overall Study|Withdrawal by Subject|5|||
129561697|NCT02750306|466351829|FG001|Overall Study|Withdrawal by Subject|2|||
129561698|NCT02750306|466351828|FG000|Overall Study|Protocol Violation|1|||
129561699|NCT02750306|466351829|FG001|Overall Study|Protocol Violation|0|||
129561700|NCT02737306|466351830|FG000|Overall Study|Adverse Event|3|||
129561701|NCT02737306|466351831|FG001|Overall Study|Adverse Event|0|||
129561702|NCT02737306|466351830|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
129561703|NCT02737306|466351831|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
129561704|NCT03361423|466351832|FG000|Overall Study|Withdrawal by Subject|4|||
129561705|NCT03361423|466351833|FG001|Overall Study|Withdrawal by Subject|3|||
129561706|NCT03361423|466351832|FG000|Overall Study|Did not treat|19|||
129561707|NCT03361423|466351833|FG001|Overall Study|Did not treat|18|||
129561708|NCT03361423|466351832|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
129561709|NCT03361423|466351833|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
129561710|NCT03361423|466351832|FG000|Overall Study|Missing data|4|||
129561711|NCT03361423|466351833|FG001|Overall Study|Missing data|1|||
129561712|NCT01336894|466351834|FG000|Follow-up|Study terminated prematurely|2|||
129561713|NCT01336894|466351835|FG001|Follow-up|Study terminated prematurely|7|||
129561714|NCT00622908|466351836|FG000|Overall Study|Protocol Violation|1|||
129561715|NCT00622908|466351837|FG001|Overall Study|Protocol Violation|0|||
129561716|NCT00622908|466351836|FG000|Overall Study|Adverse Event|0|||
129561717|NCT00622908|466351837|FG001|Overall Study|Adverse Event|1|||
129561718|NCT00622908|466351836|FG000|Overall Study|Lack of Efficacy|1|||
129561719|NCT00622908|466351837|FG001|Overall Study|Lack of Efficacy|7|||
129561720|NCT00622908|466351836|FG000|Overall Study|Lost to Follow-up|1|||
129561721|NCT00622908|466351837|FG001|Overall Study|Lost to Follow-up|0|||
129561722|NCT00622908|466351836|FG000|Overall Study|Refusal|0|||
129561723|NCT00622908|466351837|FG001|Overall Study|Refusal|1|||
129561724|NCT00622908|466351836|FG000|Overall Study|Termination by study sponser|0|||
129561725|NCT00622908|466351837|FG001|Overall Study|Termination by study sponser|1|||
129561726|NCT03937466|466351838|FG000|Overall Study|not eligbile after the 2-week diary|9|||
129561727|NCT03937466|466351838|FG000|Overall Study|never returned their diary|6|||
129561728|NCT03937466|466351838|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
129561729|NCT03937466|466351838|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
129561730|NCT00113490|466351839|FG000|Overall Study|Withdrawal by Subject|1|||
129687634|NCT04602000|466814234|FG004|Overall Study|Physician Decision|2|||
129687635|NCT04602000|466814230|FG000|Overall Study|Death|0|||
129687636|NCT04602000|466814231|FG001|Overall Study|Death|1|||
129687637|NCT04602000|466814232|FG002|Overall Study|Death|0|||
129687638|NCT04602000|466814233|FG003|Overall Study|Death|1|||
129687639|NCT04602000|466814234|FG004|Overall Study|Death|2|||
129561731|NCT00113490|466351840|FG001|Overall Study|Withdrawal by Subject|3|||
129687640|NCT04602000|466814230|FG000|Overall Study|Lost to Follow-up|0|||
129561732|NCT00113490|466351839|FG000|Overall Study|Lost to Follow-up|1|||
129561733|NCT00113490|466351840|FG001|Overall Study|Lost to Follow-up|0|||
129561734|NCT02162758|466351841|FG000|Overall Study|Study termination|0|||
129561735|NCT02162758|466351842|FG001|Overall Study|Study termination|1|||
129561736|NCT04471935|466351843|FG000|Overall Study|Withdrawal by Subject|1|||
129561737|NCT04471935|466351843|FG000|Overall Study|Deemed ineligible to participate|1|||
129561738|NCT03213210|466351846|FG000|Overall Study|Lost to Follow-up|2|||
129561739|NCT03213210|466351846|FG000|Overall Study|Study termination|3|||
129561740|NCT01325207|466351854|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129687641|NCT04602000|466814231|FG001|Overall Study|Lost to Follow-up|0|||
129687642|NCT04602000|466814232|FG002|Overall Study|Lost to Follow-up|0|||
129687643|NCT04602000|466814233|FG003|Overall Study|Lost to Follow-up|3|||
129687644|NCT04602000|466814234|FG004|Overall Study|Lost to Follow-up|4|||
129687645|NCT04602000|466814230|FG000|Overall Study|Other|4|||
129687646|NCT04602000|466814231|FG001|Overall Study|Other|1|||
129561741|NCT01325207|466351855|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129561742|NCT01325207|466351856|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129687647|NCT04602000|466814232|FG002|Overall Study|Other|2|||
129687648|NCT04602000|466814233|FG003|Overall Study|Other|5|||
129687649|NCT04602000|466814234|FG004|Overall Study|Other|4|||
129687650|NCT04602000|466814230|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129561743|NCT01325207|466351857|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129561744|NCT01325207|466351858|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
129561745|NCT01325207|466351859|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
129561746|NCT01325207|466351854|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
129561747|NCT01325207|466351855|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
129561748|NCT01325207|466351856|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
129561749|NCT01325207|466351857|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
129561750|NCT01325207|466351858|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
129561751|NCT01325207|466351859|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
129561752|NCT01325207|466351854|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129561753|NCT01325207|466351855|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129561754|NCT01325207|466351856|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129561755|NCT01325207|466351857|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
129561756|NCT01325207|466351858|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
129561757|NCT01325207|466351859|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
129561758|NCT01325207|466351854|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129561759|NCT01325207|466351855|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
129687651|NCT04602000|466814231|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129687652|NCT04602000|466814232|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
129687653|NCT04602000|466814233|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129687654|NCT04602000|466814234|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
129687655|NCT00471354|466814235|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
129687656|NCT00471354|466814235|FG000|Overall Study|Adverse Event|13|||
129687657|NCT00471354|466814235|FG000|Overall Study|Protocol Violation|12|||
129687658|NCT00471354|466814235|FG000|Overall Study|Withdrawal by Subject|1|||
129687659|NCT00471354|466814235|FG000|Overall Study|Physician Decision|4|||
129687660|NCT00471354|466814235|FG000|Overall Study|Sponsor Decision|1|||
129687661|NCT00471354|466814235|FG000|Overall Study|Lost to Follow-up|3|||
129687662|NCT00471354|466814235|FG000|Overall Study|Lack of Efficacy|5|||
129687663|NCT00471354|466814235|FG000|Overall Study|Patient/Caregiver Decision|12|||
129687664|NCT02153827|466814239|FG000|Overall Study|Lost to Follow-up|3|||
129687665|NCT02153827|466814240|FG001|Overall Study|Lost to Follow-up|9|||
129687666|NCT01158404|466814241|FG000|Overall Study|Withdrawal by Subject|0|||
129687667|NCT01158404|466814242|FG001|Overall Study|Withdrawal by Subject|1|||
129687668|NCT01158404|466814243|FG002|Overall Study|Withdrawal by Subject|0|||
129561760|NCT01325207|466351856|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129687669|NCT01158404|466814244|FG003|Overall Study|Withdrawal by Subject|0|||
129687670|NCT01158404|466814245|FG004|Overall Study|Withdrawal by Subject|3|||
129687671|NCT01158404|466814246|FG005|Overall Study|Withdrawal by Subject|1|||
129687672|NCT01158404|466814247|FG006|Overall Study|Withdrawal by Subject|0|||
129687673|NCT01158404|466814248|FG007|Overall Study|Withdrawal by Subject|1|||
129561761|NCT01325207|466351857|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129561762|NCT01325207|466351858|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129561763|NCT01325207|466351859|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
129561764|NCT01325207|466351854|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129561765|NCT01325207|466351855|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129561766|NCT01325207|466351856|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129561767|NCT01325207|466351857|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129561768|NCT01325207|466351858|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
129561769|NCT01325207|466351859|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
129561770|NCT01325207|466351854|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129561771|NCT01325207|466351855|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129561772|NCT01325207|466351856|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129561773|NCT01325207|466351857|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129561774|NCT01325207|466351858|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
129561775|NCT01325207|466351859|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
129561776|NCT01325207|466351854|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129561777|NCT01325207|466351855|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129561778|NCT01325207|466351856|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129561779|NCT01325207|466351857|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129561780|NCT01325207|466351858|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
129561781|NCT01325207|466351859|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
129561782|NCT00708422|466351860|FG000|Overall Study|Adverse Event|3|||
129561783|NCT00708422|466351861|FG001|Overall Study|Adverse Event|1|||
129561784|NCT00708422|466351860|FG000|Overall Study|Withdrawal by Subject|1|||
129561785|NCT00708422|466351861|FG001|Overall Study|Withdrawal by Subject|0|||
129687674|NCT01158404|466814241|FG000|Overall Study|Physician Decision|0|||
129687675|NCT01158404|466814242|FG001|Overall Study|Physician Decision|0|||
129687676|NCT01158404|466814243|FG002|Overall Study|Physician Decision|0|||
129687677|NCT01158404|466814244|FG003|Overall Study|Physician Decision|0|||
129687678|NCT01158404|466814245|FG004|Overall Study|Physician Decision|0|||
129687679|NCT01158404|466814246|FG005|Overall Study|Physician Decision|0|||
129687680|NCT01158404|466814247|FG006|Overall Study|Physician Decision|0|||
129687681|NCT01158404|466814248|FG007|Overall Study|Physician Decision|1|||
129687682|NCT01158404|466814241|FG000|Overall Study|Progressive Disease|0|||
129687683|NCT01158404|466814242|FG001|Overall Study|Progressive Disease|0|||
129687684|NCT01158404|466814243|FG002|Overall Study|Progressive Disease|0|||
129687685|NCT01158404|466814244|FG003|Overall Study|Progressive Disease|0|||
129687686|NCT01158404|466814245|FG004|Overall Study|Progressive Disease|0|||
129687687|NCT01158404|466814246|FG005|Overall Study|Progressive Disease|0|||
129687688|NCT01158404|466814247|FG006|Overall Study|Progressive Disease|1|||
129687689|NCT01158404|466814248|FG007|Overall Study|Progressive Disease|0|||
129687690|NCT02143778|466814250|FG000|Overall Study|Withdrawal by Subject|2|||
129687691|NCT02143778|466814250|FG000|Overall Study|Device malfunction|1|||
129687692|NCT00625378|466814252|FG000|Overall Study|Adverse Event|22|||
129687693|NCT00625378|466814253|FG001|Overall Study|Adverse Event|0|||
129687694|NCT00625378|466814252|FG000|Overall Study|Withdrawal by Subject|16|||
129687695|NCT00625378|466814253|FG001|Overall Study|Withdrawal by Subject|0|||
129687696|NCT00625378|466814252|FG000|Overall Study|Death|38|||
129687697|NCT00625378|466814253|FG001|Overall Study|Death|0|||
129687698|NCT00625378|466814252|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
129687699|NCT00625378|466814253|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
129687700|NCT00625378|466814252|FG000|Overall Study|Lost to Follow-up|17|||
129687701|NCT00625378|466814253|FG001|Overall Study|Lost to Follow-up|0|||
129687702|NCT00625378|466814252|FG000|Overall Study|Non-compliant with study medication|3|||
129687703|NCT00625378|466814253|FG001|Overall Study|Non-compliant with study medication|0|||
129687704|NCT00625378|466814252|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
129687705|NCT00625378|466814253|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
129687706|NCT00625378|466814252|FG000|Overall Study|Medical decision|1|||
129687707|NCT00625378|466814253|FG001|Overall Study|Medical decision|0|||
129687708|NCT00625378|466814252|FG000|Overall Study|Multiple toxicities|1|||
129687709|NCT00625378|466814253|FG001|Overall Study|Multiple toxicities|0|||
129687710|NCT00625378|466814252|FG000|Overall Study|New cancer|1|||
129687711|NCT00625378|466814253|FG001|Overall Study|New cancer|0|||
129687712|NCT00625378|466814252|FG000|Overall Study|PTA program|2|||
129687713|NCT00625378|466814253|FG001|Overall Study|PTA program|0|||
129687714|NCT00625378|466814252|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
129687715|NCT00625378|466814253|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
129687716|NCT00625378|466814252|FG000|Overall Study|Sponsor decision|1|||
129687717|NCT00625378|466814253|FG001|Overall Study|Sponsor decision|0|||
129687718|NCT00625378|466814252|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
129687719|NCT00625378|466814253|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
129778040|NCT03083873|467154405|FG004|Overall Study|Withdrawal by Subject|0|||
129778041|NCT03083873|467154401|FG000|Overall Study|Did Not Receive TIL|2|||
129561786|NCT01254409|466351862|FG000|Overall Study|Adverse Event|0|||
129561787|NCT01254409|466351863|FG001|Overall Study|Adverse Event|1|||
129561788|NCT01254409|466351864|FG002|Overall Study|Adverse Event|0|||
129561789|NCT01254409|466351865|FG003|Overall Study|Adverse Event|0|||
129561790|NCT01564758|466351873|FG000|Overall Study|Death|8|||
129561791|NCT01564758|466351873|FG000|Overall Study|Adverse Event|3|||
129561792|NCT01564758|466351873|FG000|Overall Study|Other|3|||
129561793|NCT00249821|466351874|FG000|Overall Study|Technical problem|0|||
129561794|NCT00249821|466351875|FG001|Overall Study|Technical problem|1|||
129561795|NCT02482571|466351876|FG000|Overall Study|Adverse Event|1|||
129778042|NCT03083873|467154402|FG001|Overall Study|Did Not Receive TIL|5|||
129778043|NCT03083873|467154403|FG002|Overall Study|Did Not Receive TIL|3|||
129778044|NCT03083873|467154404|FG003|Overall Study|Did Not Receive TIL|1|||
129778045|NCT03083873|467154405|FG004|Overall Study|Did Not Receive TIL|0|||
129778046|NCT01677377|467154406|FG000|Overall Study|Protocol Violation|1|||
129778047|NCT01677377|467154407|FG001|Overall Study|Protocol Violation|0|||
129778048|NCT01677377|467154408|FG002|Overall Study|Protocol Violation|0|||
129778049|NCT01677377|467154406|FG000|Overall Study|Lost to Follow-up|0|||
129778050|NCT01677377|467154407|FG001|Overall Study|Lost to Follow-up|1|||
129778051|NCT01677377|467154408|FG002|Overall Study|Lost to Follow-up|1|||
129778052|NCT01677377|467154406|FG000|Overall Study|Withdrawal by Subject|0|||
129778053|NCT01677377|467154407|FG001|Overall Study|Withdrawal by Subject|0|||
129778054|NCT01677377|467154408|FG002|Overall Study|Withdrawal by Subject|3|||
129561796|NCT02482571|466351876|FG000|Overall Study|Scanner or Respiract failure|3|||
129561797|NCT02482571|466351876|FG000|Overall Study|Withdrawal by Subject|4|||
129561798|NCT01446913|466351877|FG000|Overall Study|Significant illness|1|||
129561799|NCT01446913|466351878|FG001|Overall Study|Significant illness|1|||
129778055|NCT01677377|467154406|FG000|Overall Study|Lack of Efficacy|0|||
129561800|NCT01446913|466351879|FG002|Overall Study|Significant illness|1|||
129561801|NCT01446913|466351877|FG000|Overall Study|Withdrawal by Subject|5|||
129561802|NCT01446913|466351878|FG001|Overall Study|Withdrawal by Subject|3|||
129561803|NCT01446913|466351879|FG002|Overall Study|Withdrawal by Subject|5|||
129561804|NCT01446913|466351877|FG000|Overall Study|Physician Decision|0|||
129561805|NCT01446913|466351878|FG001|Overall Study|Physician Decision|0|||
129561806|NCT01446913|466351879|FG002|Overall Study|Physician Decision|2|||
129561807|NCT01446913|466351877|FG000|Overall Study|Lost to Follow-up|3|||
129561808|NCT01446913|466351878|FG001|Overall Study|Lost to Follow-up|5|||
129561809|NCT01446913|466351879|FG002|Overall Study|Lost to Follow-up|3|||
129561810|NCT00814320|466351884|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
129561811|NCT00814320|466351885|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
129561812|NCT00814320|466351884|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
129561813|NCT00814320|466351885|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
129561814|NCT00814320|466351884|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
129561815|NCT00814320|466351885|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
129561816|NCT00814320|466351884|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
129561817|NCT00814320|466351885|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
129561818|NCT00814320|466351884|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
129778056|NCT01677377|467154407|FG001|Overall Study|Lack of Efficacy|0|||
129778057|NCT01677377|467154408|FG002|Overall Study|Lack of Efficacy|1|||
129778058|NCT01677377|467154406|FG000|Overall Study|Pregnancy|0|||
129778059|NCT01677377|467154407|FG001|Overall Study|Pregnancy|0|||
129778060|NCT01677377|467154408|FG002|Overall Study|Pregnancy|1|||
129778061|NCT02656693|467154422|FG000|Overall Study|Pregnancy|1|||
129778062|NCT02656693|467154423|FG001|Overall Study|Pregnancy|1|||
129778063|NCT02656693|467154424|FG002|Overall Study|Pregnancy|1|||
129778064|NCT02656693|467154422|FG000|Overall Study|Bariatric surgery|0|||
129778065|NCT02656693|467154423|FG001|Overall Study|Bariatric surgery|1|||
129778066|NCT02656693|467154424|FG002|Overall Study|Bariatric surgery|2|||
129778067|NCT02269267|467154426|FG000|Overall Study|Death|5|||
129778068|NCT00796419|467154428|FG000|Overall Study|Death|0|||
129778069|NCT00796419|467154429|FG001|Overall Study|Death|1|||
129778070|NCT01193257|467154433|FG000|Overall Study|Death|202|||
129778071|NCT01193257|467154434|FG001|Overall Study|Death|391|||
129778072|NCT01193257|467154433|FG000|Overall Study|Study termination by sponsor|0|||
129778073|NCT01193257|467154434|FG001|Overall Study|Study termination by sponsor|3|||
129778074|NCT01193257|467154433|FG000|Overall Study|Withdrawal by Subject|26|||
129778075|NCT01193257|467154434|FG001|Overall Study|Withdrawal by Subject|86|||
129778076|NCT01193257|467154433|FG000|Overall Study|Lost to Follow-up|2|||
129778077|NCT01193257|467154434|FG001|Overall Study|Lost to Follow-up|3|||
129778078|NCT01193257|467154433|FG000|Overall Study|Unblinded due to futility|135|||
129778079|NCT01193257|467154434|FG001|Overall Study|Unblinded due to futility|251|||
129778080|NCT01027273|467154437|FG000|Overall Study|Lost to Follow-up|57|||
129778081|NCT01027273|467154438|FG001|Overall Study|Lost to Follow-up|31|||
129778082|NCT01027273|467154437|FG000|Overall Study|Death|2|||
129778083|NCT01027273|467154438|FG001|Overall Study|Death|2|||
129778084|NCT00337675|467154440|FG000|Overall Study|Adverse Event|10|||
129778085|NCT00337675|467154441|FG001|Overall Study|Adverse Event|9|||
129778086|NCT00337675|467154442|FG002|Overall Study|Adverse Event|19|||
129778087|NCT00337675|467154440|FG000|Overall Study|Lack of Efficacy|10|||
129778088|NCT00337675|467154441|FG001|Overall Study|Lack of Efficacy|7|||
129778089|NCT00337675|467154442|FG002|Overall Study|Lack of Efficacy|9|||
129778090|NCT00337675|467154440|FG000|Overall Study|Lost to Follow-up|22|||
129561819|NCT00814320|466351885|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
129561820|NCT00814320|466351884|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
129561821|NCT00814320|466351885|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
129561822|NCT00814320|466351884|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
129561823|NCT00814320|466351885|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
129561824|NCT00814320|466351884|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
129561825|NCT00814320|466351885|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
129778091|NCT00337675|467154441|FG001|Overall Study|Lost to Follow-up|19|||
129778092|NCT00337675|467154442|FG002|Overall Study|Lost to Follow-up|17|||
129778093|NCT00337675|467154440|FG000|Overall Study|Physician Decision|9|||
129778094|NCT00337675|467154441|FG001|Overall Study|Physician Decision|17|||
129778095|NCT00337675|467154442|FG002|Overall Study|Physician Decision|14|||
129778096|NCT00337675|467154440|FG000|Overall Study|Protocol Violation|21|||
129778097|NCT00337675|467154441|FG001|Overall Study|Protocol Violation|24|||
129778098|NCT00337675|467154442|FG002|Overall Study|Protocol Violation|19|||
129561826|NCT00814320|466351884|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
129561827|NCT00814320|466351885|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
129561828|NCT00814320|466351884|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
129561829|NCT00814320|466351885|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
129561830|NCT00491504|466351886|FG000|Overall Study|Adverse Event|0|||
129561831|NCT00491504|466351887|FG001|Overall Study|Adverse Event|1|||
129561832|NCT00491504|466351888|FG002|Overall Study|Adverse Event|0|||
129561833|NCT00491504|466351889|FG003|Overall Study|Adverse Event|0|||
129561834|NCT00491504|466351886|FG000|Overall Study|Withdrawal by Subject|0|||
129561835|NCT00491504|466351887|FG001|Overall Study|Withdrawal by Subject|0|||
129561836|NCT00491504|466351888|FG002|Overall Study|Withdrawal by Subject|1|||
129778099|NCT00337675|467154440|FG000|Overall Study|Withdrawal by Subject|25|||
129778100|NCT00337675|467154441|FG001|Overall Study|Withdrawal by Subject|25|||
129778101|NCT00337675|467154442|FG002|Overall Study|Withdrawal by Subject|19|||
129778102|NCT00337675|467154440|FG000|Overall Study|Progressive Disease|0|||
129778103|NCT00337675|467154441|FG001|Overall Study|Progressive Disease|2|||
129778104|NCT00337675|467154442|FG002|Overall Study|Progressive Disease|0|||
129778105|NCT00337675|467154440|FG000|Overall Study|Trial Terminated|0|||
129778106|NCT00337675|467154441|FG001|Overall Study|Trial Terminated|0|||
129778107|NCT00337675|467154442|FG002|Overall Study|Trial Terminated|2|||
129778108|NCT06170242|467154443|FG000|Overall Study|Lost to Follow-up|0|||
129778109|NCT06170242|467154444|FG001|Overall Study|Lost to Follow-up|0|||
129778110|NCT06170242|467154445|FG002|Overall Study|Lost to Follow-up|1|||
129778111|NCT06170242|467154446|FG003|Overall Study|Lost to Follow-up|1|||
129778112|NCT02586207|467154454|FG000|Overall Study|Physician Decision|1|||
129778113|NCT02586207|467154454|FG000|Overall Study|Withdrawal by Subject|1|||
129778114|NCT00441064|467154455|FG000|Overall Study|Adverse Event|1|||
129778115|NCT00441064|467154456|FG001|Overall Study|Adverse Event|0|||
129778116|NCT00441064|467154455|FG000|Overall Study|Abnormal laboratory values|0|||
129778117|NCT00441064|467154456|FG001|Overall Study|Abnormal laboratory values|2|||
129778118|NCT00441064|467154455|FG000|Overall Study|Abnormal test procedure results|0|||
129778119|NCT00441064|467154456|FG001|Overall Study|Abnormal test procedure results|1|||
129778120|NCT00441064|467154455|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129778121|NCT00441064|467154456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129778122|NCT00441064|467154455|FG000|Overall Study|Protocol Deviation|3|||
129778123|NCT00441064|467154456|FG001|Overall Study|Protocol Deviation|2|||
129778124|NCT00441064|467154455|FG000|Overall Study|Patient withdrew consent|5|||
129778125|NCT00441064|467154456|FG001|Overall Study|Patient withdrew consent|2|||
129778126|NCT03962504|467154457|FG000|Overall Study|Other|11|||
129778127|NCT03962504|467154458|FG001|Overall Study|Other|32|||
129778128|NCT03776812|467154459|FG000|Overall Study|Death|53|||
129778129|NCT03776812|467154460|FG001|Overall Study|Death|49|||
129778130|NCT03776812|467154461|FG002|Overall Study|Death|56|||
129778131|NCT03776812|467154459|FG000|Overall Study|Withdrawal by Subject|1|||
129778132|NCT03776812|467154460|FG001|Overall Study|Withdrawal by Subject|7|||
129778133|NCT03776812|467154461|FG002|Overall Study|Withdrawal by Subject|2|||
129778134|NCT03776812|467154459|FG000|Overall Study|Lost to Follow-up|1|||
129778135|NCT03776812|467154460|FG001|Overall Study|Lost to Follow-up|1|||
129778136|NCT03776812|467154461|FG002|Overall Study|Lost to Follow-up|0|||
129778137|NCT03776812|467154459|FG000|Overall Study|Did not enter long-term follow-up|3|||
129778138|NCT03776812|467154460|FG001|Overall Study|Did not enter long-term follow-up|3|||
129778139|NCT03776812|467154461|FG002|Overall Study|Did not enter long-term follow-up|2|||
129778140|NCT00048074|467154464|FG000|Overall Study|Adverse Event|46|||
129778141|NCT00048074|467154465|FG001|Overall Study|Adverse Event|41|||
129561837|NCT00491504|466351889|FG003|Overall Study|Withdrawal by Subject|2|||
129561838|NCT00491504|466351886|FG000|Overall Study|Protocol Violation|0|||
129561839|NCT00491504|466351887|FG001|Overall Study|Protocol Violation|0|||
129561840|NCT00491504|466351888|FG002|Overall Study|Protocol Violation|3|||
129778142|NCT00048074|467154466|FG002|Overall Study|Adverse Event|53|||
129778143|NCT00048074|467154464|FG000|Overall Study|Death|3|||
129778144|NCT00048074|467154465|FG001|Overall Study|Death|3|||
129778145|NCT00048074|467154466|FG002|Overall Study|Death|2|||
129778146|NCT00048074|467154464|FG000|Overall Study|Lost to Follow-up|2|||
129778147|NCT00048074|467154465|FG001|Overall Study|Lost to Follow-up|6|||
129778148|NCT00048074|467154466|FG002|Overall Study|Lost to Follow-up|6|||
129561841|NCT00491504|466351889|FG003|Overall Study|Protocol Violation|2|||
129561842|NCT02041702|466351890|FG000|Overall Study|Lost to Follow-up|1|||
129561843|NCT02041702|466351891|FG001|Overall Study|Lost to Follow-up|6|||
129561844|NCT02041702|466351890|FG000|Overall Study|Death|4|||
129561845|NCT02041702|466351891|FG001|Overall Study|Death|0|||
129561846|NCT02041702|466351890|FG000|Overall Study|Withdrawal by Subject|4|||
129561847|NCT02041702|466351891|FG001|Overall Study|Withdrawal by Subject|3|||
129561848|NCT02041702|466351890|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
129561849|NCT02041702|466351891|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
129561850|NCT02041702|466351890|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
129561851|NCT02041702|466351891|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
129561852|NCT00717756|466351893|FG000|Overall Study|Withdrawal by Subject|1|||
129561853|NCT00745251|466351894|FG000|Overall Study|Adverse Event|1|||
129561854|NCT00745251|466351895|FG001|Overall Study|Adverse Event|2|||
129561855|NCT00745251|466351894|FG000|Overall Study|Withdrawal by Subject|1|||
129687720|NCT00625378|466814252|FG000|Overall Study|Switch to commercial drug|6|||
129687721|NCT00625378|466814253|FG001|Overall Study|Switch to commercial drug|1|||
129687722|NCT00625378|466814252|FG000|Overall Study|Missing|2|||
129561856|NCT00745251|466351895|FG001|Overall Study|Withdrawal by Subject|1|||
129561857|NCT02928848|466351896|FG000|Arm 2|Withdrawal by Subject|1|||
129561858|NCT02928848|466351897|FG001|Arm 2|Withdrawal by Subject|0|||
129687723|NCT00625378|466814253|FG001|Overall Study|Missing|0|||
129561859|NCT00969332|466351898|FG000|Overall Study|Physician Decision|8|||
129561860|NCT00969332|466351898|FG000|Overall Study|Withdrawal by Subject|3|||
129561861|NCT02729896|466351900|FG000|Overall Study|Death|0|||
129561862|NCT02729896|466351901|FG001|Overall Study|Death|2|||
129561863|NCT02729896|466351902|FG002|Overall Study|Death|13|||
129561864|NCT02729896|466351900|FG000|Overall Study|Lost to Follow-up|0|||
129561865|NCT02729896|466351901|FG001|Overall Study|Lost to Follow-up|2|||
129561866|NCT02729896|466351902|FG002|Overall Study|Lost to Follow-up|3|||
129561867|NCT02729896|466351900|FG000|Overall Study|Other|0|||
129561868|NCT02729896|466351901|FG001|Overall Study|Other|2|||
129561869|NCT02729896|466351902|FG002|Overall Study|Other|0|||
129561870|NCT02729896|466351900|FG000|Overall Study|Physician Decision|1|||
129561871|NCT02729896|466351901|FG001|Overall Study|Physician Decision|2|||
129561872|NCT02729896|466351902|FG002|Overall Study|Physician Decision|3|||
129561873|NCT02729896|466351900|FG000|Overall Study|Progressive Disease|0|||
129561874|NCT02729896|466351901|FG001|Overall Study|Progressive Disease|1|||
129561875|NCT02729896|466351902|FG002|Overall Study|Progressive Disease|0|||
129561876|NCT02729896|466351900|FG000|Overall Study|Withdrawal by Subject|1|||
129561877|NCT02729896|466351901|FG001|Overall Study|Withdrawal by Subject|0|||
129561878|NCT02729896|466351902|FG002|Overall Study|Withdrawal by Subject|3|||
129561879|NCT00582309|466351903|FG000|Overall Study|Protocol Violation|0|||
129561880|NCT00582309|466351904|FG001|Overall Study|Protocol Violation|0|||
129561881|NCT00582309|466351905|FG002|Overall Study|Protocol Violation|2|||
129561882|NCT01618305|466351906|FG000|Overall Study|Death|0|||
129561883|NCT01618305|466351907|FG001|Overall Study|Death|1|||
129778149|NCT00048074|467154464|FG000|Overall Study|Withdrawal by Subject|28|||
129778150|NCT00048074|467154465|FG001|Overall Study|Withdrawal by Subject|30|||
129778151|NCT00048074|467154466|FG002|Overall Study|Withdrawal by Subject|35|||
129561884|NCT01618305|466351906|FG000|Overall Study|Lost to Follow-up|11|||
129561885|NCT01618305|466351907|FG001|Overall Study|Lost to Follow-up|7|||
129561886|NCT01618305|466351906|FG000|Overall Study|Protocol Violation|1|||
129561887|NCT01618305|466351907|FG001|Overall Study|Protocol Violation|0|||
129778152|NCT00048074|467154464|FG000|Overall Study|Protocol Violation|1|||
129778153|NCT00048074|467154465|FG001|Overall Study|Protocol Violation|3|||
129561888|NCT01618305|466351906|FG000|Overall Study|Withdrawal by Subject|3|||
129561889|NCT01618305|466351907|FG001|Overall Study|Withdrawal by Subject|2|||
129561890|NCT02708277|466351908|FG000|Overall Study|Lost to Follow-up|7|||
129561891|NCT02708277|466351909|FG001|Overall Study|Lost to Follow-up|4|||
129561892|NCT01058421|466351910|FG000|1 Month Outcomes|Death|10|||
129561893|NCT01058421|466351911|FG001|1 Month Outcomes|Death|6|||
129561894|NCT01058421|466351910|FG000|1 Month Outcomes|Lost to Follow-up|8|||
129687724|NCT00625378|466814252|FG000|Overall Study|End of treatment not available|2|||
129687725|NCT00625378|466814253|FG001|Overall Study|End of treatment not available|0|||
129561895|NCT01058421|466351911|FG001|1 Month Outcomes|Lost to Follow-up|7|||
129687726|NCT00625378|466814252|FG000|Overall Study|Never treated|2|||
129687727|NCT00625378|466814253|FG001|Overall Study|Never treated|0|||
129561896|NCT01058421|466351910|FG000|1 Month Outcomes|Remained in Hospital|5|||
129561897|NCT01058421|466351911|FG001|1 Month Outcomes|Remained in Hospital|12|||
129561898|NCT01058421|466351910|FG000|1 Month Outcomes|Remained in Other Facility|16|||
129687728|NCT02639559|466814255|FG000|Overall Study|Mobilization failure|0|||
129687729|NCT02639559|466814256|FG001|Overall Study|Mobilization failure|3|||
129687730|NCT02639559|466814255|FG000|Overall Study|Issues with vascular acess|1|||
129687731|NCT02639559|466814256|FG001|Overall Study|Issues with vascular acess|0|||
129561899|NCT01058421|466351911|FG001|1 Month Outcomes|Remained in Other Facility|17|||
129561900|NCT01058421|466351910|FG000|3 Month Outcomes|Death|3|||
129687732|NCT03880565|466814257|FG000|Overall Study|Withdrawal by Subject|1|||
129687733|NCT03880565|466814258|FG001|Overall Study|Withdrawal by Subject|0|||
129687734|NCT02969018|466814263|FG000|Overall Study|Adverse Event|2|||
129687735|NCT02969018|466814264|FG001|Overall Study|Adverse Event|4|||
129687736|NCT02969018|466814265|FG002|Overall Study|Adverse Event|1|||
129687737|NCT02969018|466814266|FG003|Overall Study|Adverse Event|2|||
129884521|NCT04779242|467536437|FG001|Overall Study|Withdrawal by Subject|9|||
129687738|NCT02969018|466814267|FG004|Overall Study|Adverse Event|0|||
129687739|NCT02969018|466814268|FG005|Overall Study|Adverse Event|1|||
129687740|NCT02969018|466814269|FG006|Overall Study|Adverse Event|2|||
129687741|NCT02969018|466814270|FG007|Overall Study|Adverse Event|0|||
129687742|NCT02969018|466814263|FG000|Overall Study|Lack of Efficacy|0|||
129687743|NCT02969018|466814264|FG001|Overall Study|Lack of Efficacy|1|||
129687744|NCT02969018|466814265|FG002|Overall Study|Lack of Efficacy|0|||
129687745|NCT02969018|466814266|FG003|Overall Study|Lack of Efficacy|0|||
129687746|NCT02969018|466814267|FG004|Overall Study|Lack of Efficacy|1|||
129687747|NCT02969018|466814268|FG005|Overall Study|Lack of Efficacy|1|||
129687748|NCT02969018|466814269|FG006|Overall Study|Lack of Efficacy|1|||
129561901|NCT01058421|466351911|FG001|3 Month Outcomes|Death|5|||
129561902|NCT01058421|466351910|FG000|3 Month Outcomes|Lost to Follow-up|12|||
129561903|NCT01058421|466351911|FG001|3 Month Outcomes|Lost to Follow-up|11|||
129561904|NCT01058421|466351910|FG000|3 Month Outcomes|Remained in Hospital|0|||
129561905|NCT01058421|466351911|FG001|3 Month Outcomes|Remained in Hospital|2|||
129561906|NCT01058421|466351910|FG000|3 Month Outcomes|Remained in Other Facility|5|||
129561907|NCT01058421|466351911|FG001|3 Month Outcomes|Remained in Other Facility|8|||
129561908|NCT01058421|466351910|FG000|6 Month Outcomes|Death|2|||
129561909|NCT01058421|466351911|FG001|6 Month Outcomes|Death|2|||
129561910|NCT01058421|466351910|FG000|6 Month Outcomes|Lost to Follow-up|16|||
129561911|NCT01058421|466351911|FG001|6 Month Outcomes|Lost to Follow-up|21|||
129561912|NCT01058421|466351910|FG000|6 Month Outcomes|Remained in Other Facility|1|||
129561913|NCT01058421|466351911|FG001|6 Month Outcomes|Remained in Other Facility|3|||
129561914|NCT01960816|466351912|FG000|Overall Study|Lost to Follow-up|1|||
129561915|NCT01118728|466351913|FG000|Overall Study|Adverse Event|17|||
129561916|NCT01118728|466351913|FG000|Overall Study|Lack of Efficacy|27|||
129561917|NCT01118728|466351913|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
129687749|NCT02969018|466814270|FG007|Overall Study|Lack of Efficacy|1|||
129687750|NCT02969018|466814263|FG000|Overall Study|Lost to Follow-up|1|||
129687751|NCT02969018|466814264|FG001|Overall Study|Lost to Follow-up|2|||
129561918|NCT01118728|466351913|FG000|Overall Study|Withdrawal by Subject|3|||
129561919|NCT01118728|466351913|FG000|Overall Study|Lost to Follow-up|4|||
129561920|NCT00385541|466351914|FG000|Overall Study|severe pain, clinician requested unblind|0|||
129561921|NCT00385541|466351915|FG001|Overall Study|severe pain, clinician requested unblind|1|||
129561922|NCT00929708|466351916|FG000|Overall Study|Protocol Violation|2|||
129561923|NCT00929708|466351917|FG001|Overall Study|Protocol Violation|1|||
129561924|NCT00929708|466351918|FG002|Overall Study|Protocol Violation|1|||
129561925|NCT00929708|466351919|FG003|Overall Study|Protocol Violation|1|||
129561926|NCT00929708|466351920|FG004|Overall Study|Protocol Violation|1|||
129561927|NCT00929708|466351916|FG000|Overall Study|Withdrawal by Subject|2|||
129561928|NCT00929708|466351917|FG001|Overall Study|Withdrawal by Subject|0|||
129561929|NCT00929708|466351918|FG002|Overall Study|Withdrawal by Subject|0|||
129561930|NCT00929708|466351919|FG003|Overall Study|Withdrawal by Subject|2|||
129561931|NCT00929708|466351920|FG004|Overall Study|Withdrawal by Subject|1|||
129561932|NCT00929708|466351916|FG000|Overall Study|Adverse Event|0|||
129561933|NCT00929708|466351917|FG001|Overall Study|Adverse Event|0|||
129561934|NCT00929708|466351918|FG002|Overall Study|Adverse Event|0|||
129561935|NCT00929708|466351919|FG003|Overall Study|Adverse Event|0|||
129561936|NCT00929708|466351920|FG004|Overall Study|Adverse Event|3|||
129561937|NCT00929708|466351916|FG000|Overall Study|Physician Decision|0|||
129561938|NCT00929708|466351917|FG001|Overall Study|Physician Decision|2|||
129561939|NCT00929708|466351918|FG002|Overall Study|Physician Decision|2|||
129561940|NCT00929708|466351919|FG003|Overall Study|Physician Decision|2|||
129561941|NCT00929708|466351920|FG004|Overall Study|Physician Decision|1|||
129561942|NCT00929708|466351916|FG000|Overall Study|Lost to Follow-up|0|||
129561943|NCT00929708|466351917|FG001|Overall Study|Lost to Follow-up|0|||
129561944|NCT00929708|466351918|FG002|Overall Study|Lost to Follow-up|0|||
129561945|NCT00929708|466351919|FG003|Overall Study|Lost to Follow-up|1|||
129561946|NCT00929708|466351920|FG004|Overall Study|Lost to Follow-up|0|||
129561947|NCT01893138|466351921|FG000|Double-Blind Period|Withdrawal by Subject|1|||
129561948|NCT01893138|466351922|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129561949|NCT01893138|466351921|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
129561950|NCT01893138|466351922|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
129561951|NCT01893138|466351921|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
129561952|NCT01893138|466351922|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
129561953|NCT01893138|466351921|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
129561954|NCT01893138|466351922|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
129561955|NCT01893138|466351921|FG000|Open Label - Unblinded Period|Adverse Event|1|||
129561956|NCT01893138|466351922|FG001|Open Label - Unblinded Period|Adverse Event|0|||
129561957|NCT01628120|466353729|FG000|Overall Study|Withdrawal by Subject|7|||
129561958|NCT01628120|466353729|FG000|Overall Study|Adverse Event|12|||
129561959|NCT01628120|466353729|FG000|Overall Study|Lost to Follow-up|1|||
129687752|NCT02969018|466814265|FG002|Overall Study|Lost to Follow-up|2|||
129561960|NCT01628120|466353729|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
129561961|NCT01628120|466353729|FG000|Overall Study|Non-compliant with Study Procedures|1|||
129561962|NCT01628120|466353729|FG000|Overall Study|Not Treated|3|||
129561963|NCT01628120|466353729|FG000|Overall Study|Sponsor Decision|5|||
129561964|NCT01628120|466353729|FG000|Overall Study|Switched Dialysis Method|2|||
129561965|NCT01628120|466353729|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
129561966|NCT01628120|466353729|FG000|Overall Study|Moved or Relocated|5|||
129561967|NCT01628120|466353729|FG000|Overall Study|Kidney Transplant|2|||
129561968|NCT01628120|466353729|FG000|Overall Study|Use of Standard of Care|1|||
129561969|NCT02295774|466353732|FG000|Overall Study|Physician Decision|1|||
129561970|NCT02295774|466353732|FG000|Overall Study|Withdrawal by Subject|2|||
129561971|NCT00586521|466353733|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
129561972|NCT02207621|466353738|FG000|Overall Study|Adverse Event|71|||
129561973|NCT02207621|466353739|FG001|Overall Study|Adverse Event|15|||
129561974|NCT02207621|466353740|FG002|Overall Study|Adverse Event|132|||
129561975|NCT02207621|466353738|FG000|Overall Study|Withdrawal by Subject|9|||
129561976|NCT02207621|466353739|FG001|Overall Study|Withdrawal by Subject|9|||
129561977|NCT02207621|466353740|FG002|Overall Study|Withdrawal by Subject|13|||
129561978|NCT02207621|466353738|FG000|Overall Study|Non-Compliant|3|||
129561979|NCT02207621|466353739|FG001|Overall Study|Non-Compliant|3|||
129561980|NCT02207621|466353740|FG002|Overall Study|Non-Compliant|1|||
129561981|NCT02207621|466353738|FG000|Overall Study|Lost to Follow-up|1|||
129561982|NCT02207621|466353739|FG001|Overall Study|Lost to Follow-up|0|||
129561983|NCT02207621|466353740|FG002|Overall Study|Lost to Follow-up|3|||
129561984|NCT02207621|466353738|FG000|Overall Study|Lack of Efficacy|10|||
129561985|NCT02207621|466353739|FG001|Overall Study|Lack of Efficacy|2|||
129561986|NCT02207621|466353740|FG002|Overall Study|Lack of Efficacy|4|||
129561987|NCT02207621|466353738|FG000|Overall Study|Disallowed Concurrent Medication|2|||
129687753|NCT02969018|466814266|FG003|Overall Study|Lost to Follow-up|0|||
129687754|NCT02969018|466814267|FG004|Overall Study|Lost to Follow-up|1|||
129561988|NCT02207621|466353739|FG001|Overall Study|Disallowed Concurrent Medication|5|||
129561989|NCT02207621|466353740|FG002|Overall Study|Disallowed Concurrent Medication|2|||
129561990|NCT02207621|466353738|FG000|Overall Study|Physician Decision|1|||
129561991|NCT02207621|466353739|FG001|Overall Study|Physician Decision|2|||
129561992|NCT02207621|466353740|FG002|Overall Study|Physician Decision|2|||
129561993|NCT02207621|466353738|FG000|Overall Study|Protocol Violation|4|||
129561994|NCT02207621|466353739|FG001|Overall Study|Protocol Violation|10|||
129561995|NCT02207621|466353740|FG002|Overall Study|Protocol Violation|6|||
129561996|NCT02207621|466353738|FG000|Overall Study|Death|2|||
129561997|NCT02207621|466353739|FG001|Overall Study|Death|0|||
129561998|NCT02207621|466353740|FG002|Overall Study|Death|0|||
129561999|NCT02207621|466353738|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
129562000|NCT02207621|466353739|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
129562001|NCT02207621|466353740|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
129562002|NCT02623959|466353741|FG000|Overall Study|Progression|0|||
129562003|NCT02623959|466353742|FG001|Overall Study|Progression|1|||
129562004|NCT00992407|466353745|FG000|Overall Study|Protocol Violation|2|||
129562005|NCT00992407|466353746|FG001|Overall Study|Protocol Violation|1|||
129562006|NCT00992407|466353745|FG000|Overall Study|Lost to Follow-up|3|||
129562007|NCT00992407|466353746|FG001|Overall Study|Lost to Follow-up|3|||
129562008|NCT00992407|466353745|FG000|Overall Study|Adverse Event|3|||
129562009|NCT00992407|466353746|FG001|Overall Study|Adverse Event|2|||
129562010|NCT00992407|466353745|FG000|Overall Study|protocol Violation & Adverse events|2|||
129562011|NCT00992407|466353746|FG001|Overall Study|protocol Violation & Adverse events|4|||
129562012|NCT00992407|466353745|FG000|Overall Study|Other|2|||
129562013|NCT00992407|466353746|FG001|Overall Study|Other|0|||
129562014|NCT00992407|466353745|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
129562015|NCT00992407|466353746|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
129562016|NCT00992407|466353745|FG000|Overall Study|Study medication not administered|17|||
129562017|NCT00992407|466353746|FG001|Overall Study|Study medication not administered|13|||
129562018|NCT01000337|466353751|FG000|Overall Study|Lost to Follow-up|4|||
129562019|NCT01000337|466353752|FG001|Overall Study|Lost to Follow-up|3|||
129562020|NCT02173704|466353753|FG000|Overall Study|Adverse Event|1|||
129562021|NCT02173704|466353754|FG001|Overall Study|Adverse Event|0|||
129562022|NCT02173704|466353753|FG000|Overall Study|Lost to Follow-up|1|||
129562023|NCT02173704|466353754|FG001|Overall Study|Lost to Follow-up|0|||
129562024|NCT02173704|466353753|FG000|Overall Study|Other|1|||
129562025|NCT02173704|466353754|FG001|Overall Study|Other|0|||
129562026|NCT02173704|466353753|FG000|Overall Study|Protocol Violation|1|||
129562027|NCT02173704|466353754|FG001|Overall Study|Protocol Violation|0|||
129562028|NCT02173704|466353753|FG000|Overall Study|Withdrawal by Subject|9|||
129562029|NCT02173704|466353754|FG001|Overall Study|Withdrawal by Subject|4|||
129562030|NCT00419926|466353755|FG000|Overall Study|Withdrawal by Subject|7|||
129562031|NCT00419926|466353756|FG001|Overall Study|Withdrawal by Subject|3|||
129562032|NCT00419926|466353755|FG000|Overall Study|Administrative Problem|4|||
129562033|NCT00419926|466353756|FG001|Overall Study|Administrative Problem|4|||
129778154|NCT00048074|467154466|FG002|Overall Study|Protocol Violation|0|||
129778155|NCT00048074|467154464|FG000|Overall Study|Study participation was terminated|0|||
129778156|NCT00048074|467154465|FG001|Overall Study|Study participation was terminated|1|||
129778157|NCT00048074|467154466|FG002|Overall Study|Study participation was terminated|0|||
129778158|NCT00048074|467154464|FG000|Overall Study|Husband ill|0|||
129778159|NCT00048074|467154465|FG001|Overall Study|Husband ill|1|||
129778160|NCT00048074|467154466|FG002|Overall Study|Husband ill|0|||
129778161|NCT00048074|467154464|FG000|Overall Study|Poor compliance|0|||
129778162|NCT00048074|467154465|FG001|Overall Study|Poor compliance|1|||
129778163|NCT00048074|467154466|FG002|Overall Study|Poor compliance|0|||
129778164|NCT00048074|467154464|FG000|Overall Study|Out of station|0|||
129778165|NCT00048074|467154465|FG001|Overall Study|Out of station|1|||
129778166|NCT00048074|467154466|FG002|Overall Study|Out of station|1|||
129778167|NCT00048074|467154464|FG000|Overall Study|Social reasons|1|||
129778168|NCT00048074|467154465|FG001|Overall Study|Social reasons|0|||
129778169|NCT00048074|467154466|FG002|Overall Study|Social reasons|0|||
129562034|NCT00419926|466353755|FG000|Overall Study|Lost to Follow-up|1|||
129562035|NCT00419926|466353756|FG001|Overall Study|Lost to Follow-up|2|||
129778170|NCT02873377|467154467|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
129778171|NCT02873377|467154468|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
129778172|NCT02873377|467154467|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
129778173|NCT02873377|467154468|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
129778174|NCT01032889|467154478|FG000|Overall Study|Adverse Event|2|||
129562036|NCT00419926|466353755|FG000|Overall Study|Death|2|||
129562037|NCT00419926|466353756|FG001|Overall Study|Death|1|||
129562038|NCT02374918|466353761|FG000|Overall Study|Protocol Violation|2|||
129778175|NCT01032889|467154479|FG001|Overall Study|Adverse Event|2|||
129778176|NCT01032889|467154480|FG002|Overall Study|Adverse Event|0|||
129778177|NCT01032889|467154478|FG000|Overall Study|Withdrawal of Consent|1|||
129778178|NCT01032889|467154479|FG001|Overall Study|Withdrawal of Consent|2|||
129778179|NCT01032889|467154480|FG002|Overall Study|Withdrawal of Consent|1|||
129687755|NCT02969018|466814268|FG005|Overall Study|Lost to Follow-up|1|||
129562039|NCT02374918|466353762|FG001|Overall Study|Protocol Violation|0|||
129687756|NCT02969018|466814269|FG006|Overall Study|Lost to Follow-up|0|||
129687757|NCT02969018|466814270|FG007|Overall Study|Lost to Follow-up|1|||
129687758|NCT02969018|466814263|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129562040|NCT02374918|466353763|FG002|Overall Study|Protocol Violation|2|||
129687759|NCT02969018|466814264|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129687760|NCT02969018|466814265|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129562041|NCT02374918|466353764|FG003|Overall Study|Protocol Violation|1|||
129687761|NCT02969018|466814266|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129687762|NCT02969018|466814267|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129687763|NCT02969018|466814268|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129687764|NCT02969018|466814269|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
129687765|NCT02969018|466814270|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129687766|NCT02969018|466814263|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129687767|NCT02969018|466814264|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129687768|NCT02969018|466814265|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129687769|NCT02969018|466814266|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129687770|NCT02969018|466814267|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129778180|NCT01032889|467154478|FG000|Overall Study|Patient Request|0|||
129562042|NCT02374918|466353761|FG000|Overall Study|Withdrawal by Subject|1|||
129562043|NCT02374918|466353762|FG001|Overall Study|Withdrawal by Subject|1|||
129562044|NCT02374918|466353763|FG002|Overall Study|Withdrawal by Subject|1|||
129562045|NCT02374918|466353764|FG003|Overall Study|Withdrawal by Subject|0|||
129562046|NCT02374918|466353761|FG000|Overall Study|Lack of Efficacy|0|||
129562047|NCT02374918|466353762|FG001|Overall Study|Lack of Efficacy|0|||
129687771|NCT02969018|466814268|FG005|Overall Study|Non-Compliance With Study Drug|0|||
129687772|NCT02969018|466814269|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129562048|NCT02374918|466353763|FG002|Overall Study|Lack of Efficacy|1|||
129687773|NCT02969018|466814270|FG007|Overall Study|Non-Compliance With Study Drug|0|||
129687774|NCT02969018|466814263|FG000|Overall Study|Other|0|||
129687775|NCT02969018|466814264|FG001|Overall Study|Other|0|||
129687776|NCT02969018|466814265|FG002|Overall Study|Other|0|||
129687777|NCT02969018|466814266|FG003|Overall Study|Other|1|||
129687778|NCT02969018|466814267|FG004|Overall Study|Other|0|||
129687779|NCT02969018|466814268|FG005|Overall Study|Other|0|||
129687780|NCT02969018|466814269|FG006|Overall Study|Other|0|||
129687781|NCT02969018|466814270|FG007|Overall Study|Other|2|||
129687782|NCT02969018|466814263|FG000|Overall Study|Pregnancy|0|||
129687783|NCT02969018|466814264|FG001|Overall Study|Pregnancy|0|||
129687784|NCT02969018|466814265|FG002|Overall Study|Pregnancy|0|||
129687785|NCT02969018|466814266|FG003|Overall Study|Pregnancy|0|||
129562049|NCT02374918|466353764|FG003|Overall Study|Lack of Efficacy|1|||
129562050|NCT01180244|466353765|FG000|Overall Study|Lack of Efficacy|0|||
129562051|NCT01180244|466353766|FG001|Overall Study|Lack of Efficacy|7|||
129562052|NCT01180244|466353765|FG000|Overall Study|Physician Decision|3|||
129562053|NCT01180244|466353766|FG001|Overall Study|Physician Decision|0|||
129562054|NCT01180244|466353765|FG000|Overall Study|Adverse Event|1|||
129562055|NCT01180244|466353766|FG001|Overall Study|Adverse Event|0|||
129562056|NCT01180244|466353765|FG000|Overall Study|Withdrawal by Subject|0|||
129562057|NCT01180244|466353766|FG001|Overall Study|Withdrawal by Subject|1|||
129562058|NCT01180244|466353765|FG000|Overall Study|Protocol Violation|1|||
129562059|NCT01180244|466353766|FG001|Overall Study|Protocol Violation|0|||
129562060|NCT01180244|466353765|FG000|Overall Study|Lost to Follow-up|1|||
129562061|NCT01180244|466353766|FG001|Overall Study|Lost to Follow-up|0|||
129562062|NCT00729859|466353767|FG000|Overall Study|Adverse Event|0|||
129562063|NCT00729859|466353768|FG001|Overall Study|Adverse Event|1|||
129562064|NCT00729859|466353769|FG002|Overall Study|Adverse Event|0|||
129562065|NCT00729859|466353767|FG000|Overall Study|Withdrawal by Subject|0|||
129562066|NCT00729859|466353768|FG001|Overall Study|Withdrawal by Subject|1|||
129562067|NCT00729859|466353769|FG002|Overall Study|Withdrawal by Subject|0|||
129562068|NCT02623829|466353772|FG000|Overall Study|Lost to Follow-up|1|||
129562069|NCT02623829|466353773|FG001|Overall Study|Lost to Follow-up|1|||
129562070|NCT03349333|466353774|FG000|Overall Study|Progression of Disease|36|||
129562071|NCT03349333|466353774|FG000|Overall Study|Adverse Event|11|||
129562072|NCT03349333|466353774|FG000|Overall Study|Other|6|||
129562073|NCT03349333|466353774|FG000|Overall Study|Withdrawal by Subject|5|||
129562074|NCT03349333|466353774|FG000|Overall Study|Conditions interfere with participation|2|||
129562075|NCT03349333|466353774|FG000|Overall Study|Physician Decision|2|||
129562076|NCT03349333|466353774|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
129562077|NCT03349333|466353774|FG000|Overall Study|Patients in treatment less than 24 month|8|||
129562078|NCT00783796|466353775|FG000|Overall Study|Did not receive any stent|4|||
129562079|NCT00783796|466353775|FG000|Overall Study|Received non-XIENCE V stent|1|||
129562080|NCT00783796|466353775|FG000|Overall Study|Received commercial XIENCE V stent|1|||
129562081|NCT03267264|466353777|FG000|Overall Study|Withdrawal by Subject|1|||
129562082|NCT03267264|466353778|FG001|Overall Study|Withdrawal by Subject|0|||
129562083|NCT03267264|466353779|FG002|Overall Study|Withdrawal by Subject|2|||
129562084|NCT03267264|466353780|FG003|Overall Study|Withdrawal by Subject|4|||
129562085|NCT01766921|466353781|FG000|Overall Study|Administrative Reason|5|||
129562086|NCT01766921|466353782|FG001|Overall Study|Administrative Reason|5|||
129562087|NCT01766921|466353781|FG000|Overall Study|Death|1|||
129562088|NCT01766921|466353782|FG001|Overall Study|Death|1|||
129562089|NCT01766921|466353781|FG000|Overall Study|Lost to Follow-up|1|||
129562090|NCT01766921|466353782|FG001|Overall Study|Lost to Follow-up|3|||
129562091|NCT01766921|466353781|FG000|Overall Study|Unclassified|2|||
129562092|NCT01766921|466353782|FG001|Overall Study|Unclassified|2|||
129562093|NCT01766921|466353781|FG000|Overall Study|Protocol Violation|1|||
129562094|NCT01766921|466353782|FG001|Overall Study|Protocol Violation|1|||
129562095|NCT01766921|466353781|FG000|Overall Study|Withdrawal by Subject|14|||
129562096|NCT01766921|466353782|FG001|Overall Study|Withdrawal by Subject|5|||
129562097|NCT03019965|466353785|FG000|Overall Study|Withdrawal by Subject|1|||
129562098|NCT03019965|466353786|FG001|Overall Study|Withdrawal by Subject|0|||
129562099|NCT03019965|466353785|FG000|Overall Study|Protocol Violation|1|||
129562100|NCT03019965|466353786|FG001|Overall Study|Protocol Violation|3|||
129562101|NCT03019965|466353785|FG000|Overall Study|viral or fungal infection|3|||
129562102|NCT03019965|466353786|FG001|Overall Study|viral or fungal infection|4|||
129562103|NCT03019965|466353785|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
129562104|NCT03019965|466353786|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
129562105|NCT03019965|466353785|FG000|Overall Study|Physician Decision|1|||
129562106|NCT03019965|466353786|FG001|Overall Study|Physician Decision|1|||
129562107|NCT01659567|466353787|FG000|Overall Study|Lack of Efficacy|22|||
129562108|NCT01659567|466353787|FG000|Overall Study|Switched to Pegferon|6|||
129562109|NCT01659567|466353787|FG000|Overall Study|Adverse Event|12|||
129562110|NCT01659567|466353787|FG000|Overall Study|Good result at early stage of treatment|5|||
129562111|NCT01659567|466353787|FG000|Overall Study|Withdrawal by Subject|64|||
129562112|NCT01659567|466353787|FG000|Overall Study|Progression of the main disease|1|||
129562113|NCT01659567|466353787|FG000|Overall Study|Other|13|||
129562114|NCT01915732|466353788|FG000|Overall Study|Withdrawal by Subject|18|||
129562115|NCT01915732|466353789|FG001|Overall Study|Withdrawal by Subject|18|||
129562116|NCT01915732|466353788|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
129562117|NCT01915732|466353789|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129562118|NCT01915732|466353788|FG000|Overall Study|Adverse Event|12|||
129562119|NCT01915732|466353789|FG001|Overall Study|Adverse Event|4|||
129562120|NCT01915732|466353788|FG000|Overall Study|Protocol Violation|5|||
129562121|NCT01915732|466353789|FG001|Overall Study|Protocol Violation|5|||
129562122|NCT01915732|466353788|FG000|Overall Study|Lack of Efficacy|6|||
129562123|NCT01915732|466353789|FG001|Overall Study|Lack of Efficacy|11|||
129562124|NCT01915732|466353788|FG000|Overall Study|Lost to Follow-up|22|||
129562125|NCT01915732|466353789|FG001|Overall Study|Lost to Follow-up|26|||
129562126|NCT01915732|466353788|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
129562127|NCT01915732|466353789|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
129778181|NCT01032889|467154479|FG001|Overall Study|Patient Request|1|||
129778182|NCT01032889|467154480|FG002|Overall Study|Patient Request|0|||
129778183|NCT01032889|467154478|FG000|Overall Study|Lost to Follow-up|1|||
129778184|NCT01032889|467154479|FG001|Overall Study|Lost to Follow-up|1|||
129778185|NCT01032889|467154480|FG002|Overall Study|Lost to Follow-up|0|||
129778186|NCT01032889|467154478|FG000|Overall Study|Lack of Submental Fat|2|||
129778187|NCT01032889|467154479|FG001|Overall Study|Lack of Submental Fat|8|||
129778188|NCT01032889|467154480|FG002|Overall Study|Lack of Submental Fat|1|||
129778189|NCT01032889|467154478|FG000|Overall Study|Miscellaneous Reasons|2|||
129778190|NCT01032889|467154479|FG001|Overall Study|Miscellaneous Reasons|1|||
129778191|NCT01032889|467154480|FG002|Overall Study|Miscellaneous Reasons|1|||
129778192|NCT02039843|467154481|FG000|Randomization and Observation Period|Adverse Event|2|||
129778193|NCT02039843|467154482|FG001|Randomization and Observation Period|Adverse Event|0|||
129778194|NCT02039843|467154481|FG000|Randomization and Observation Period|Death|1|||
129778195|NCT02039843|467154482|FG001|Randomization and Observation Period|Death|0|||
129778196|NCT02039843|467154481|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
129778197|NCT02039843|467154482|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
129778198|NCT02039843|467154481|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
129562128|NCT01915732|466353788|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
129562129|NCT01915732|466353789|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
129562130|NCT01915732|466353788|FG000|Overall Study|Drug Release Error|1|||
129562131|NCT01915732|466353789|FG001|Overall Study|Drug Release Error|0|||
129562132|NCT01915732|466353788|FG000|Overall Study|Recovered|1|||
129778199|NCT02039843|467154482|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
129562133|NCT01915732|466353789|FG001|Overall Study|Recovered|0|||
129562134|NCT01915732|466353788|FG000|Overall Study|Pregnancy|1|||
129562135|NCT01915732|466353789|FG001|Overall Study|Pregnancy|0|||
129562136|NCT01915732|466353788|FG000|Overall Study|Poor Perceived Efficacy|1|||
129562137|NCT01915732|466353789|FG001|Overall Study|Poor Perceived Efficacy|0|||
129562138|NCT01915732|466353788|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
129562139|NCT01915732|466353789|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
129562140|NCT01915732|466353788|FG000|Overall Study|Got Well|0|||
129562141|NCT01915732|466353789|FG001|Overall Study|Got Well|1|||
129562142|NCT01915732|466353788|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
129562143|NCT01915732|466353789|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
129562144|NCT01915732|466353788|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
129562145|NCT01915732|466353789|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
129562146|NCT01915732|466353788|FG000|Overall Study|Job Transfer|0|||
129562147|NCT01915732|466353789|FG001|Overall Study|Job Transfer|1|||
129562148|NCT01915732|466353788|FG000|Overall Study|Improper Facial Procedure|0|||
129562149|NCT01915732|466353789|FG001|Overall Study|Improper Facial Procedure|1|||
129562150|NCT01915732|466353788|FG000|Overall Study|Poor Conscious Effect|0|||
129562151|NCT01915732|466353789|FG001|Overall Study|Poor Conscious Effect|1|||
129562152|NCT00299156|466353792|FG000|Period 2 (Randomized)|Screen Failure|0|||
129562153|NCT00299156|466353793|FG001|Period 2 (Randomized)|Screen Failure|1|||
129562154|NCT00299156|466353794|FG002|Period 2 (Randomized)|Screen Failure|0|||
129562155|NCT01166568|466353806|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
129562156|NCT01166568|466353807|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
129562157|NCT01166568|466353808|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
129562158|NCT01166568|466353806|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
129562159|NCT01166568|466353807|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
129562160|NCT01166568|466353808|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
129562161|NCT01166568|466353806|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
129562162|NCT01166568|466353807|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
129562163|NCT01166568|466353808|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
129562164|NCT01654380|466353809|FG000|Part B, Period 1|Physician Decision|0|||
129562165|NCT01654380|466353810|FG001|Part B, Period 1|Physician Decision|0|||
129562166|NCT01654380|466353811|FG002|Part B, Period 1|Physician Decision|1|||
129562167|NCT01654380|466353812|FG003|Part B, Period 1|Physician Decision|0|||
129687786|NCT02969018|466814267|FG004|Overall Study|Pregnancy|0|||
129687787|NCT02969018|466814268|FG005|Overall Study|Pregnancy|1|||
129687788|NCT02969018|466814269|FG006|Overall Study|Pregnancy|0|||
129687789|NCT02969018|466814270|FG007|Overall Study|Pregnancy|0|||
129687790|NCT02969018|466814263|FG000|Overall Study|Protocol Violation|0|||
129687791|NCT02969018|466814264|FG001|Overall Study|Protocol Violation|0|||
129562168|NCT00684671|466353813|FG000|Overall Study|Adverse Event|1|||
129562169|NCT00684671|466353814|FG001|Overall Study|Adverse Event|0|||
129562170|NCT00684671|466353815|FG002|Overall Study|Adverse Event|0|||
129687792|NCT02969018|466814265|FG002|Overall Study|Protocol Violation|1|||
129687793|NCT02969018|466814266|FG003|Overall Study|Protocol Violation|1|||
129562171|NCT00684671|466353813|FG000|Overall Study|Lost to Follow-up|1|||
129562172|NCT00684671|466353814|FG001|Overall Study|Lost to Follow-up|0|||
129562173|NCT00684671|466353815|FG002|Overall Study|Lost to Follow-up|0|||
129562174|NCT00684671|466353813|FG000|Overall Study|Alcoholic dependance|1|||
129562175|NCT00684671|466353814|FG001|Overall Study|Alcoholic dependance|0|||
129562176|NCT00684671|466353815|FG002|Overall Study|Alcoholic dependance|0|||
129562177|NCT03335371|466353816|FG000|Overall Study|Lost to Follow-up|0|||
129562178|NCT03335371|466353817|FG001|Overall Study|Lost to Follow-up|0|||
129562179|NCT03335371|466353818|FG002|Overall Study|Lost to Follow-up|0|||
129562180|NCT03335371|466353819|FG003|Overall Study|Lost to Follow-up|0|||
129562181|NCT03335371|466353820|FG004|Overall Study|Lost to Follow-up|1|||
129562182|NCT03335371|466353816|FG000|Overall Study|Withdrawal by Subject|0|||
129562183|NCT03335371|466353817|FG001|Overall Study|Withdrawal by Subject|0|||
129562184|NCT03335371|466353818|FG002|Overall Study|Withdrawal by Subject|0|||
129562185|NCT03335371|466353819|FG003|Overall Study|Withdrawal by Subject|0|||
129562186|NCT03335371|466353820|FG004|Overall Study|Withdrawal by Subject|1|||
129562187|NCT03335371|466353816|FG000|Overall Study|Randomization Error|0|||
129562188|NCT03335371|466353817|FG001|Overall Study|Randomization Error|0|||
129562189|NCT03335371|466353818|FG002|Overall Study|Randomization Error|1|||
129562190|NCT03335371|466353819|FG003|Overall Study|Randomization Error|0|||
129562191|NCT03335371|466353820|FG004|Overall Study|Randomization Error|0|||
129562192|NCT01725451|466353822|FG000|Period 1|Withdrawal by Subject|1|||
129562193|NCT01725451|466353823|FG001|Period 1|Withdrawal by Subject|0|||
129562194|NCT01725451|466353824|FG002|Period 1|Withdrawal by Subject|0|||
129562195|NCT01725451|466353825|FG003|Period 1|Withdrawal by Subject|0|||
129562196|NCT01725451|466353822|FG000|Washout From Period 3|Protocol Violation|0|||
129562197|NCT01725451|466353823|FG001|Washout From Period 3|Protocol Violation|0|||
129562198|NCT01725451|466353824|FG002|Washout From Period 3|Protocol Violation|1|||
129562199|NCT01725451|466353825|FG003|Washout From Period 3|Protocol Violation|0|||
129562200|NCT01725451|466353822|FG000|Washout From Period 3|Adverse Event|0|||
129562201|NCT01725451|466353823|FG001|Washout From Period 3|Adverse Event|1|||
129562202|NCT01725451|466353824|FG002|Washout From Period 3|Adverse Event|0|||
129562203|NCT01725451|466353825|FG003|Washout From Period 3|Adverse Event|0|||
129562204|NCT01725451|466353822|FG000|Period 4|Adverse Event|0|||
129562205|NCT01725451|466353823|FG001|Period 4|Adverse Event|0|||
129562206|NCT01725451|466353824|FG002|Period 4|Adverse Event|1|||
129562207|NCT01725451|466353825|FG003|Period 4|Adverse Event|0|||
129562208|NCT02015793|466353828|FG000|Overall Study|Adverse Event|3|||
129562209|NCT02015793|466353829|FG001|Overall Study|Adverse Event|3|||
129562210|NCT02015793|466353828|FG000|Overall Study|Withdrawal by Subject|1|||
129562211|NCT02015793|466353829|FG001|Overall Study|Withdrawal by Subject|1|||
129562212|NCT00437281|466353830|FG000|Overall Study|Adverse Event|0|||
129562213|NCT00437281|466353831|FG001|Overall Study|Adverse Event|0|||
129562214|NCT00437281|466353832|FG002|Overall Study|Adverse Event|0|||
129562215|NCT00437281|466353833|FG003|Overall Study|Adverse Event|1|||
129562216|NCT00437281|466353834|FG004|Overall Study|Adverse Event|0|||
129562217|NCT00437281|466353835|FG005|Overall Study|Adverse Event|1|||
129562218|NCT00437281|466353836|FG006|Overall Study|Adverse Event|0|||
129562219|NCT00437281|466353837|FG007|Overall Study|Adverse Event|0|||
129562220|NCT00437281|466353838|FG008|Overall Study|Adverse Event|0|||
129562221|NCT00437281|466353839|FG009|Overall Study|Adverse Event|1|||
129562222|NCT00437281|466353840|FG010|Overall Study|Adverse Event|0|||
129562223|NCT00437281|466353841|FG011|Overall Study|Adverse Event|0|||
129562224|NCT00437281|466353842|FG012|Overall Study|Adverse Event|0|||
129562225|NCT00437281|466353843|FG013|Overall Study|Adverse Event|1|||
129562226|NCT00437281|466353844|FG014|Overall Study|Adverse Event|1|||
129562227|NCT00437281|466353845|FG015|Overall Study|Adverse Event|0|||
129562228|NCT00437281|466353846|FG016|Overall Study|Adverse Event|0|||
129562229|NCT00437281|466353847|FG017|Overall Study|Adverse Event|0|||
129562230|NCT00437281|466353848|FG018|Overall Study|Adverse Event|1|||
129562231|NCT00437281|466353849|FG019|Overall Study|Adverse Event|0|||
129562232|NCT00437281|466353830|FG000|Overall Study|Lost to Follow-up|0|||
129562233|NCT00437281|466353831|FG001|Overall Study|Lost to Follow-up|0|||
129562234|NCT00437281|466353832|FG002|Overall Study|Lost to Follow-up|0|||
129562235|NCT00437281|466353833|FG003|Overall Study|Lost to Follow-up|0|||
129562236|NCT00437281|466353834|FG004|Overall Study|Lost to Follow-up|0|||
129562237|NCT00437281|466353835|FG005|Overall Study|Lost to Follow-up|0|||
129562238|NCT00437281|466353836|FG006|Overall Study|Lost to Follow-up|0|||
129562239|NCT00437281|466353837|FG007|Overall Study|Lost to Follow-up|0|||
129562240|NCT00437281|466353838|FG008|Overall Study|Lost to Follow-up|0|||
129562241|NCT00437281|466353839|FG009|Overall Study|Lost to Follow-up|0|||
129562242|NCT00437281|466353840|FG010|Overall Study|Lost to Follow-up|0|||
129562243|NCT00437281|466353841|FG011|Overall Study|Lost to Follow-up|0|||
129562244|NCT00437281|466353842|FG012|Overall Study|Lost to Follow-up|0|||
129562245|NCT00437281|466353843|FG013|Overall Study|Lost to Follow-up|0|||
129562246|NCT00437281|466353844|FG014|Overall Study|Lost to Follow-up|0|||
129562247|NCT00437281|466353845|FG015|Overall Study|Lost to Follow-up|0|||
129562248|NCT00437281|466353846|FG016|Overall Study|Lost to Follow-up|0|||
129562249|NCT00437281|466353847|FG017|Overall Study|Lost to Follow-up|0|||
129562250|NCT00437281|466353848|FG018|Overall Study|Lost to Follow-up|0|||
129562251|NCT00437281|466353849|FG019|Overall Study|Lost to Follow-up|1|||
129562252|NCT00947427|466353850|FG000|Overall Study|Withdrawal by Subject|1|||
129562253|NCT00947427|466353851|FG001|Overall Study|Withdrawal by Subject|3|||
129562254|NCT00947427|466353850|FG000|Overall Study|Protocol Violation|0|||
129562255|NCT00947427|466353851|FG001|Overall Study|Protocol Violation|1|||
129562256|NCT00601354|466353852|FG000|Overall Study|Lost to Follow-up|4|||
129562257|NCT00601354|466353853|FG001|Overall Study|Lost to Follow-up|5|||
129562258|NCT01862328|466353856|FG000|Overall Study|Progressive Disease|3|||
129562259|NCT01862328|466353857|FG001|Overall Study|Progressive Disease|11|||
129562260|NCT01862328|466353858|FG002|Overall Study|Progressive Disease|5|||
129562261|NCT01862328|466353859|FG003|Overall Study|Progressive Disease|6|||
129562262|NCT01862328|466353860|FG004|Overall Study|Progressive Disease|7|||
129562263|NCT01862328|466353861|FG005|Overall Study|Progressive Disease|4|||
129562264|NCT01862328|466353862|FG006|Overall Study|Progressive Disease|3|||
129562265|NCT01862328|466353856|FG000|Overall Study|Adverse Event|0|||
129562266|NCT01862328|466353857|FG001|Overall Study|Adverse Event|4|||
129562267|NCT01862328|466353858|FG002|Overall Study|Adverse Event|0|||
129562268|NCT01862328|466353859|FG003|Overall Study|Adverse Event|1|||
129562269|NCT01862328|466353860|FG004|Overall Study|Adverse Event|0|||
129562270|NCT01862328|466353861|FG005|Overall Study|Adverse Event|2|||
129562271|NCT01862328|466353862|FG006|Overall Study|Adverse Event|4|||
129562272|NCT01862328|466353856|FG000|Overall Study|Other|0|||
129562273|NCT01862328|466353857|FG001|Overall Study|Other|2|||
129562274|NCT01862328|466353858|FG002|Overall Study|Other|1|||
129562275|NCT01862328|466353859|FG003|Overall Study|Other|0|||
129562276|NCT01862328|466353860|FG004|Overall Study|Other|4|||
129562277|NCT01862328|466353861|FG005|Overall Study|Other|0|||
129562278|NCT01862328|466353862|FG006|Overall Study|Other|1|||
129562279|NCT01862328|466353856|FG000|Overall Study|Withdrawal by Subject|1|||
129562280|NCT01862328|466353857|FG001|Overall Study|Withdrawal by Subject|1|||
129562281|NCT01862328|466353858|FG002|Overall Study|Withdrawal by Subject|0|||
129562282|NCT01862328|466353859|FG003|Overall Study|Withdrawal by Subject|0|||
129562283|NCT01862328|466353860|FG004|Overall Study|Withdrawal by Subject|1|||
129562284|NCT01862328|466353861|FG005|Overall Study|Withdrawal by Subject|1|||
129562285|NCT01862328|466353862|FG006|Overall Study|Withdrawal by Subject|1|||
129562286|NCT01862328|466353856|FG000|Overall Study|Symptomatic Deterioration|0|||
129562287|NCT01862328|466353857|FG001|Overall Study|Symptomatic Deterioration|0|||
129562288|NCT01862328|466353858|FG002|Overall Study|Symptomatic Deterioration|0|||
129562289|NCT01862328|466353859|FG003|Overall Study|Symptomatic Deterioration|0|||
129562290|NCT01862328|466353860|FG004|Overall Study|Symptomatic Deterioration|0|||
129562291|NCT01862328|466353861|FG005|Overall Study|Symptomatic Deterioration|0|||
129562292|NCT01862328|466353862|FG006|Overall Study|Symptomatic Deterioration|1|||
129562293|NCT00936975|466353863|FG000|Overall Study|Withdrawal by Subject|1|||
129562294|NCT00936975|466353863|FG000|Overall Study|Disease progression|3|||
129562295|NCT00936975|466353863|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
129562296|NCT04104646|466353865|FG000|Overall Study|Withdrawal by Subject|1|||
129562297|NCT04104646|466353866|FG001|Overall Study|Withdrawal by Subject|1|||
129562298|NCT04104646|466353865|FG000|Overall Study|Lost to Follow-up|1|||
129562299|NCT04104646|466353866|FG001|Overall Study|Lost to Follow-up|0|||
129562300|NCT04104646|466353865|FG000|Overall Study|Physician Decision|2|||
129562301|NCT04104646|466353866|FG001|Overall Study|Physician Decision|0|||
129562302|NCT01656889|466353867|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
129562303|NCT01656889|466353868|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
129562304|NCT01656889|466353867|FG000|Treatment Period, 12 Weeks|Death|0|||
129562305|NCT01656889|466353868|FG001|Treatment Period, 12 Weeks|Death|1|||
129562306|NCT01656889|466353867|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
129562307|NCT01656889|466353868|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
129562308|NCT01656889|466353867|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
129562309|NCT01656889|466353868|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
129562310|NCT01656889|466353867|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
129562311|NCT01656889|466353868|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
129562312|NCT01656889|466353867|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
129562313|NCT01656889|466353868|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
129687794|NCT02969018|466814267|FG004|Overall Study|Protocol Violation|0|||
129687795|NCT02969018|466814268|FG005|Overall Study|Protocol Violation|0|||
129687796|NCT02969018|466814269|FG006|Overall Study|Protocol Violation|0|||
129687797|NCT02969018|466814270|FG007|Overall Study|Protocol Violation|0|||
129562314|NCT01656889|466353867|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
129562315|NCT01656889|466353868|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
129562316|NCT01656889|466353867|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
129562317|NCT01656889|466353868|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
129562318|NCT01656889|466353867|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
129562319|NCT01656889|466353868|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
129562320|NCT01656889|466353867|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
129562321|NCT01656889|466353868|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
129562322|NCT02521948|466353869|FG000|Overall Study|Adverse Event|2|||
129562323|NCT02521948|466353869|FG000|Overall Study|Death|4|||
129562324|NCT02521948|466353869|FG000|Overall Study|Lost to Follow-up|1|||
129562325|NCT02521948|466353869|FG000|Overall Study|Did not attend one or both follow-ups|6|||
129562326|NCT02427607|466353870|FG000|Overall Study|Withdrawal by Subject|1|||
129562327|NCT00423800|466353871|FG000|Overall Study|Protocol Violation|0|||
129562328|NCT00423800|466353872|FG001|Overall Study|Protocol Violation|1|||
129562329|NCT04000009|466353873|FG000|Overall Study|Adverse Event|13|||
129562330|NCT04000009|466353873|FG000|Overall Study|Lack of Efficacy|7|||
129562331|NCT04000009|466353873|FG000|Overall Study|Lost to Follow-up|8|||
129562332|NCT04000009|466353873|FG000|Overall Study|Noncompliance with study drug|4|||
129562333|NCT04000009|466353873|FG000|Overall Study|Physician Decision|1|||
129562334|NCT04000009|466353873|FG000|Overall Study|Use of prohibited medication|3|||
129562335|NCT04000009|466353873|FG000|Overall Study|Pregnancy|1|||
129562336|NCT04000009|466353873|FG000|Overall Study|Withdrawal by Subject|22|||
129562337|NCT04000009|466353873|FG000|Overall Study|Study terminated by sponsor|98|||
129562338|NCT04000009|466353873|FG000|Overall Study|Not further specified|8|||
129562339|NCT00679783|466353875|FG000|Overall Study|Adverse Event|0|||
129562340|NCT00679783|466353876|FG001|Overall Study|Adverse Event|0|||
129562341|NCT00679783|466353877|FG002|Overall Study|Adverse Event|0|||
129562342|NCT00679783|466353878|FG003|Overall Study|Adverse Event|3|||
129562343|NCT00679783|466353879|FG004|Overall Study|Adverse Event|0|||
129562344|NCT00679783|466353880|FG005|Overall Study|Adverse Event|0|||
129562345|NCT00679783|466353881|FG006|Overall Study|Adverse Event|1|||
129562346|NCT00679783|466353875|FG000|Overall Study|Lack of Efficacy|0|||
129562347|NCT00679783|466353876|FG001|Overall Study|Lack of Efficacy|1|||
129562348|NCT00679783|466353877|FG002|Overall Study|Lack of Efficacy|0|||
129562349|NCT00679783|466353878|FG003|Overall Study|Lack of Efficacy|2|||
129562350|NCT00679783|466353879|FG004|Overall Study|Lack of Efficacy|0|||
129562351|NCT00679783|466353880|FG005|Overall Study|Lack of Efficacy|0|||
129562352|NCT00679783|466353881|FG006|Overall Study|Lack of Efficacy|0|||
129562353|NCT00679783|466353875|FG000|Overall Study|Withdrawal by Subject|0|||
129562354|NCT00679783|466353876|FG001|Overall Study|Withdrawal by Subject|0|||
129562355|NCT00679783|466353877|FG002|Overall Study|Withdrawal by Subject|1|||
129562356|NCT00679783|466353878|FG003|Overall Study|Withdrawal by Subject|1|||
129562357|NCT00679783|466353879|FG004|Overall Study|Withdrawal by Subject|0|||
129562358|NCT00679783|466353880|FG005|Overall Study|Withdrawal by Subject|0|||
129562359|NCT00679783|466353881|FG006|Overall Study|Withdrawal by Subject|0|||
129562360|NCT00679783|466353875|FG000|Overall Study|Not Captured|0|||
129562361|NCT00679783|466353876|FG001|Overall Study|Not Captured|0|||
129562362|NCT00679783|466353877|FG002|Overall Study|Not Captured|0|||
129562363|NCT00679783|466353878|FG003|Overall Study|Not Captured|5|||
129562364|NCT00679783|466353879|FG004|Overall Study|Not Captured|0|||
129562365|NCT00679783|466353880|FG005|Overall Study|Not Captured|0|||
129778200|NCT02039843|467154481|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
129778201|NCT02039843|467154482|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
129778202|NCT02039843|467154481|FG000|Pairing With a Study Dog|Death|1|||
129778203|NCT02039843|467154482|FG001|Pairing With a Study Dog|Death|0|||
129562366|NCT00679783|466353881|FG006|Overall Study|Not Captured|0|||
129778204|NCT02039843|467154481|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
129778205|NCT02039843|467154482|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
129778206|NCT02039843|467154481|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
129778207|NCT02039843|467154482|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
129778208|NCT02039843|467154481|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
129778209|NCT02039843|467154482|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
129778210|NCT02624986|467154486|FG000|Overall Study|Death|0|||
129778211|NCT02624986|467154487|FG001|Overall Study|Death|1|||
129778212|NCT02624986|467154488|FG002|Overall Study|Death|2|||
129778213|NCT02624986|467154489|FG003|Overall Study|Death|2|||
129562367|NCT00679783|466353875|FG000|Overall Study|Ongoing at data cut-off|2|||
129778214|NCT02624986|467154490|FG004|Overall Study|Death|2|||
129778215|NCT02624986|467154491|FG005|Overall Study|Death|0|||
129778216|NCT02624986|467154492|FG006|Overall Study|Death|0|||
129562368|NCT00679783|466353876|FG001|Overall Study|Ongoing at data cut-off|2|||
129562369|NCT00679783|466353877|FG002|Overall Study|Ongoing at data cut-off|0|||
129562370|NCT00679783|466353878|FG003|Overall Study|Ongoing at data cut-off|9|||
129562371|NCT00679783|466353879|FG004|Overall Study|Ongoing at data cut-off|1|||
129562372|NCT00679783|466353880|FG005|Overall Study|Ongoing at data cut-off|0|||
129562373|NCT00679783|466353881|FG006|Overall Study|Ongoing at data cut-off|0|||
129778217|NCT02624986|467154493|FG007|Overall Study|Death|1|||
129562374|NCT01754259|466353882|FG000|Overall Study|Withdrawal by Subject|2|||
129562375|NCT01754259|466353883|FG001|Overall Study|Withdrawal by Subject|4|||
129562376|NCT01754259|466353882|FG000|Overall Study|Adverse Event|3|||
129562377|NCT01754259|466353883|FG001|Overall Study|Adverse Event|1|||
129562378|NCT01754259|466353882|FG000|Overall Study|Lost to Follow-up|0|||
129562379|NCT01754259|466353883|FG001|Overall Study|Lost to Follow-up|1|||
129562380|NCT00619385|466353884|FG000|Overall Study|Adverse Event|0|||
129562381|NCT00619385|466353885|FG001|Overall Study|Adverse Event|0|||
129562382|NCT00619385|466353886|FG002|Overall Study|Adverse Event|3|||
129562383|NCT00619385|466353884|FG000|Overall Study|Other|1|||
129562384|NCT00619385|466353885|FG001|Overall Study|Other|2|||
129562385|NCT00619385|466353886|FG002|Overall Study|Other|1|||
129562386|NCT00306384|466353889|FG000|Overall Study|Adverse Event|103|||
129562387|NCT00306384|466353890|FG001|Overall Study|Adverse Event|87|||
129562388|NCT00306384|466353891|FG002|Overall Study|Adverse Event|40|||
129562389|NCT00306384|466353889|FG000|Overall Study|Major protocol deviation|43|||
129562390|NCT00306384|466353890|FG001|Overall Study|Major protocol deviation|51|||
129562391|NCT00306384|466353891|FG002|Overall Study|Major protocol deviation|18|||
129562392|NCT00306384|466353889|FG000|Overall Study|Lost to Follow-up|57|||
129562393|NCT00306384|466353890|FG001|Overall Study|Lost to Follow-up|41|||
129562394|NCT00306384|466353891|FG002|Overall Study|Lost to Follow-up|35|||
129562395|NCT00306384|466353889|FG000|Overall Study|Voluntary withdrawal|199|||
129562396|NCT00306384|466353890|FG001|Overall Study|Voluntary withdrawal|187|||
129562397|NCT00306384|466353891|FG002|Overall Study|Voluntary withdrawal|91|||
129562398|NCT00306384|466353889|FG000|Overall Study|Study termination|1|||
129562399|NCT00306384|466353890|FG001|Overall Study|Study termination|0|||
129562400|NCT00306384|466353891|FG002|Overall Study|Study termination|1|||
129562401|NCT00306384|466353889|FG000|Overall Study|Pregnancy|3|||
129562402|NCT00306384|466353890|FG001|Overall Study|Pregnancy|1|||
129562403|NCT00306384|466353891|FG002|Overall Study|Pregnancy|1|||
129562404|NCT00306384|466353889|FG000|Overall Study|Lack of Efficacy|26|||
129562405|NCT00306384|466353890|FG001|Overall Study|Lack of Efficacy|40|||
129562406|NCT00306384|466353891|FG002|Overall Study|Lack of Efficacy|38|||
129562407|NCT00306384|466353889|FG000|Overall Study|Investigator discretion|28|||
129562408|NCT00306384|466353890|FG001|Overall Study|Investigator discretion|31|||
129562409|NCT00306384|466353891|FG002|Overall Study|Investigator discretion|21|||
129562410|NCT00306384|466353889|FG000|Overall Study|Other|80|||
129562411|NCT00306384|466353890|FG001|Overall Study|Other|70|||
129562412|NCT00306384|466353891|FG002|Overall Study|Other|32|||
129562413|NCT00306384|466353889|FG000|Overall Study|Site closure|2|||
129562414|NCT00306384|466353890|FG001|Overall Study|Site closure|0|||
129562415|NCT00306384|466353891|FG002|Overall Study|Site closure|0|||
129562416|NCT03850509|466353892|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
129562417|NCT03850509|466353893|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
129562418|NCT01565083|466353896|FG000|Overall Study|Withdrawal by Subject|6|||
129562419|NCT01565083|466353897|FG001|Overall Study|Withdrawal by Subject|4|||
129562420|NCT01565083|466353896|FG000|Overall Study|Lost to Follow-up|2|||
129562421|NCT01565083|466353897|FG001|Overall Study|Lost to Follow-up|7|||
129562422|NCT01565083|466353896|FG000|Overall Study|Death|22|||
129562423|NCT01565083|466353897|FG001|Overall Study|Death|23|||
129562424|NCT01565083|466353896|FG000|Overall Study|Other|3|||
129562425|NCT01565083|466353897|FG001|Overall Study|Other|5|||
129562426|NCT01379781|466355451|FG000|Overall Study|Lost to Follow-up|11|||
129562427|NCT01379781|466355452|FG001|Overall Study|Lost to Follow-up|8|||
129562428|NCT03329027|466355455|FG000|Overall Study|Lost to Follow-up|1|||
129562429|NCT03329027|466355456|FG001|Overall Study|Lost to Follow-up|0|||
129562430|NCT03329027|466355457|FG002|Overall Study|Lost to Follow-up|1|||
129562431|NCT03329027|466355455|FG000|Overall Study|Protocol Violation|9|||
129562432|NCT03329027|466355456|FG001|Overall Study|Protocol Violation|5|||
129778218|NCT02624986|467154486|FG000|Overall Study|Study Terminated by Sponsor|1|||
129778219|NCT02624986|467154487|FG001|Overall Study|Study Terminated by Sponsor|1|||
129778220|NCT02624986|467154488|FG002|Overall Study|Study Terminated by Sponsor|0|||
129778221|NCT02624986|467154489|FG003|Overall Study|Study Terminated by Sponsor|1|||
129778222|NCT02624986|467154490|FG004|Overall Study|Study Terminated by Sponsor|2|||
129778223|NCT02624986|467154491|FG005|Overall Study|Study Terminated by Sponsor|2|||
129562433|NCT03329027|466355457|FG002|Overall Study|Protocol Violation|7|||
129778224|NCT02624986|467154492|FG006|Overall Study|Study Terminated by Sponsor|4|||
129778225|NCT02624986|467154493|FG007|Overall Study|Study Terminated by Sponsor|3|||
129562434|NCT02742090|466355469|FG000|Overall Study|Adverse Event|10|||
129562435|NCT02742090|466355469|FG000|Overall Study|Death|3|||
129562436|NCT02742090|466355469|FG000|Overall Study|Disease Progression|25|||
129562437|NCT02742090|466355469|FG000|Overall Study|Investigator's Decision|1|||
129562438|NCT02742090|466355469|FG000|Overall Study|Lost to Follow-up|1|||
129562439|NCT02742090|466355469|FG000|Overall Study|Non-compliance with Study|1|||
129562440|NCT02742090|466355469|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
129562441|NCT02742090|466355469|FG000|Overall Study|Withdrawal by Subject|4|||
129562442|NCT02742090|466355469|FG000|Overall Study|Reason Not Specified|1|||
129562443|NCT00836927|466355472|FG000|Overall Study|Progressive disease|2|||
129562444|NCT00836927|466355473|FG001|Overall Study|Progressive disease|0|||
129562445|NCT00836927|466355474|FG002|Overall Study|Progressive disease|0|||
129562446|NCT00836927|466355475|FG003|Overall Study|Progressive disease|1|||
129778226|NCT02624986|467154486|FG000|Overall Study|Progressive Disease|0|||
129778227|NCT02624986|467154487|FG001|Overall Study|Progressive Disease|1|||
129778228|NCT02624986|467154488|FG002|Overall Study|Progressive Disease|0|||
129778229|NCT02624986|467154489|FG003|Overall Study|Progressive Disease|0|||
129778230|NCT02624986|467154490|FG004|Overall Study|Progressive Disease|0|||
129778231|NCT02624986|467154491|FG005|Overall Study|Progressive Disease|0|||
129778232|NCT02624986|467154492|FG006|Overall Study|Progressive Disease|0|||
129778233|NCT02624986|467154493|FG007|Overall Study|Progressive Disease|0|||
129778234|NCT02624986|467154486|FG000|Overall Study|Protocol Violation|1|||
129778235|NCT02624986|467154487|FG001|Overall Study|Protocol Violation|0|||
129778236|NCT02624986|467154488|FG002|Overall Study|Protocol Violation|0|||
129778237|NCT02624986|467154489|FG003|Overall Study|Protocol Violation|0|||
129778238|NCT02624986|467154490|FG004|Overall Study|Protocol Violation|0|||
129778239|NCT02624986|467154491|FG005|Overall Study|Protocol Violation|0|||
129778240|NCT02624986|467154492|FG006|Overall Study|Protocol Violation|0|||
129778241|NCT02624986|467154493|FG007|Overall Study|Protocol Violation|0|||
129562447|NCT00836927|466355476|FG004|Overall Study|Progressive disease|1|||
129778242|NCT02624986|467154486|FG000|Overall Study|Withdrawal by Subject|0|||
129778243|NCT02624986|467154487|FG001|Overall Study|Withdrawal by Subject|0|||
129778244|NCT02624986|467154488|FG002|Overall Study|Withdrawal by Subject|0|||
129778245|NCT02624986|467154489|FG003|Overall Study|Withdrawal by Subject|0|||
129778246|NCT02624986|467154490|FG004|Overall Study|Withdrawal by Subject|0|||
129778247|NCT02624986|467154491|FG005|Overall Study|Withdrawal by Subject|0|||
129778248|NCT02624986|467154492|FG006|Overall Study|Withdrawal by Subject|0|||
129778249|NCT02624986|467154493|FG007|Overall Study|Withdrawal by Subject|1|||
129778250|NCT00740857|467154495|FG000|Overall Study|Withdrawal by Subject|1|||
129778251|NCT00740857|467154496|FG001|Overall Study|Withdrawal by Subject|0|||
129778252|NCT00740857|467154497|FG002|Overall Study|Withdrawal by Subject|0|||
129778253|NCT03532451|467154501|FG000|Overall Study|Withdrawal by Subject|0|||
129778254|NCT03532451|467154502|FG001|Overall Study|Withdrawal by Subject|1|||
129778255|NCT03532451|467154501|FG000|Overall Study|Did not undergo surgery|1|||
129778256|NCT03532451|467154502|FG001|Overall Study|Did not undergo surgery|1|||
129778257|NCT00912197|467154505|FG000|Overall Study|Withdrawal by Subject|3|||
129778258|NCT00912197|467154506|FG001|Overall Study|Withdrawal by Subject|3|||
129778259|NCT01326104|467154510|FG000|Overall Study|progressed prior to vaccine|0|||
129778260|NCT01326104|467154511|FG001|Overall Study|progressed prior to vaccine|2|||
129778261|NCT01326104|467154510|FG000|Overall Study|unable to make vaccine|0|||
129778262|NCT01326104|467154511|FG001|Overall Study|unable to make vaccine|2|||
129778263|NCT01287741|467154512|FG000|Overall Study|Withdrawal by Subject|35|||
129778264|NCT01287741|467154513|FG001|Overall Study|Withdrawal by Subject|38|||
129562448|NCT00836927|466355472|FG000|Overall Study|Withdrawal by Subject|1|||
129562449|NCT00836927|466355473|FG001|Overall Study|Withdrawal by Subject|0|||
129562450|NCT00836927|466355474|FG002|Overall Study|Withdrawal by Subject|0|||
129562451|NCT00836927|466355475|FG003|Overall Study|Withdrawal by Subject|0|||
129562452|NCT00836927|466355476|FG004|Overall Study|Withdrawal by Subject|0|||
129562453|NCT02192905|466355482|FG000|Overall Study|Lost to Follow-up|1|||
129562454|NCT04820842|466355484|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129562455|NCT04820842|466355485|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
129562456|NCT04820842|466355486|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
129562457|NCT04820842|466355487|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129562458|NCT04820842|466355488|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129562459|NCT04820842|466355489|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129562460|NCT04820842|466355490|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
129562461|NCT04820842|466355484|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
129562462|NCT04820842|466355485|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
129562463|NCT04820842|466355486|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
129562464|NCT04820842|466355487|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562465|NCT04820842|466355488|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562466|NCT04820842|466355489|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562467|NCT04820842|466355490|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562468|NCT04820842|466355484|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129778265|NCT01287741|467154512|FG000|Overall Study|Protocol Violation|2|||
129778266|NCT01287741|467154513|FG001|Overall Study|Protocol Violation|0|||
129778267|NCT01287741|467154512|FG000|Overall Study|Physician Decision|15|||
129778268|NCT01287741|467154513|FG001|Overall Study|Physician Decision|23|||
129778269|NCT01287741|467154512|FG000|Overall Study|Non-compliance|8|||
129778270|NCT01287741|467154513|FG001|Overall Study|Non-compliance|6|||
129778271|NCT01287741|467154512|FG000|Overall Study|Lost to Follow-up|10|||
129562469|NCT04820842|466355485|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
129562470|NCT04820842|466355486|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129562471|NCT04820842|466355487|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129562472|NCT04820842|466355488|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129562473|NCT04820842|466355489|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129562474|NCT04820842|466355490|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129562475|NCT04820842|466355484|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562476|NCT04820842|466355485|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562477|NCT04820842|466355486|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562478|NCT04820842|466355487|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
129562479|NCT04820842|466355488|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562480|NCT04820842|466355489|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
129562481|NCT04820842|466355490|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
129562482|NCT02688400|466355495|FG000|Overall Study|Protocol Violation|2|||
129562483|NCT02688400|466355496|FG001|Overall Study|Protocol Violation|5|||
129562484|NCT02688400|466355495|FG000|Overall Study|Lack of Efficacy|7|||
129562485|NCT02688400|466355496|FG001|Overall Study|Lack of Efficacy|7|||
129562486|NCT02688400|466355495|FG000|Overall Study|Adverse Event|21|||
129562487|NCT02688400|466355496|FG001|Overall Study|Adverse Event|12|||
129562488|NCT02688400|466355495|FG000|Overall Study|Withdrawal by Subject|15|||
129562489|NCT02688400|466355496|FG001|Overall Study|Withdrawal by Subject|13|||
129562490|NCT02688400|466355495|FG000|Overall Study|No study medication intake|1|||
129562491|NCT02688400|466355496|FG001|Overall Study|No study medication intake|4|||
129562492|NCT02688400|466355495|FG000|Overall Study|Lost to Follow-up|0|||
129562493|NCT02688400|466355496|FG001|Overall Study|Lost to Follow-up|3|||
129562494|NCT01075763|466355498|FG000|Overall Study|Lost to Follow-up|2|||
129562495|NCT01075763|466355499|FG001|Overall Study|Lost to Follow-up|1|||
129562496|NCT01075763|466355498|FG000|Overall Study|Lack of Efficacy|0|||
129562497|NCT01075763|466355499|FG001|Overall Study|Lack of Efficacy|1|||
129562498|NCT01075763|466355498|FG000|Overall Study|Withdrawal by Subject|2|||
129562499|NCT01075763|466355499|FG001|Overall Study|Withdrawal by Subject|2|||
129562500|NCT03731182|466355504|FG000|Overall Study|Lost to Follow-up|2|||
129562501|NCT03731182|466355505|FG001|Overall Study|Lost to Follow-up|0|||
129562502|NCT03731182|466355504|FG000|Overall Study|Physician Decision|1|||
129562503|NCT03731182|466355505|FG001|Overall Study|Physician Decision|0|||
129562504|NCT03731182|466355504|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
129687798|NCT02969018|466814263|FG000|Overall Study|Withdrawal by Subject|0|||
129687799|NCT02969018|466814264|FG001|Overall Study|Withdrawal by Subject|1|||
129687800|NCT02969018|466814265|FG002|Overall Study|Withdrawal by Subject|2|||
129562505|NCT03731182|466355505|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129562506|NCT02006706|466355506|FG000|Overall Study|Lost to Follow-up|1|||
129562507|NCT00582036|466355507|FG000|Overall Study|Withdrawal by Subject|0|||
129562508|NCT00582036|466355508|FG001|Overall Study|Withdrawal by Subject|1|||
129687801|NCT02969018|466814266|FG003|Overall Study|Withdrawal by Subject|1|||
129687802|NCT02969018|466814267|FG004|Overall Study|Withdrawal by Subject|0|||
129687803|NCT02969018|466814268|FG005|Overall Study|Withdrawal by Subject|4|||
129687804|NCT02969018|466814269|FG006|Overall Study|Withdrawal by Subject|4|||
129687805|NCT02969018|466814270|FG007|Overall Study|Withdrawal by Subject|3|||
129687806|NCT04790201|466814274|FG000|Overall Study|Lost to Follow-up|0|||
129687807|NCT04790201|466814275|FG001|Overall Study|Lost to Follow-up|0|||
129687808|NCT04790201|466814276|FG002|Overall Study|Lost to Follow-up|2|||
129687809|NCT04790201|466814274|FG000|Overall Study|Death|0|||
129687810|NCT04790201|466814275|FG001|Overall Study|Death|1|||
129687811|NCT04790201|466814276|FG002|Overall Study|Death|0|||
129687812|NCT04790201|466814274|FG000|Overall Study|Protocol Violation|1|||
129687813|NCT04790201|466814275|FG001|Overall Study|Protocol Violation|0|||
129687814|NCT04790201|466814276|FG002|Overall Study|Protocol Violation|1|||
129687815|NCT05762679|466814279|FG000|Overall Study|Withdrawal by Subject|1|||
129687816|NCT05762679|466814279|FG000|Overall Study|No analyzable imaging data|1|||
129687817|NCT03670628|466814280|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
129687818|NCT03670628|466814281|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
129687819|NCT03670628|466814280|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
129687820|NCT03670628|466814281|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
129778272|NCT01287741|467154513|FG001|Overall Study|Lost to Follow-up|8|||
129778273|NCT01287741|467154512|FG000|Overall Study|Death|32|||
129778274|NCT01287741|467154513|FG001|Overall Study|Death|44|||
129687821|NCT06377488|466814282|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
129687822|NCT06377488|466814282|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
129687823|NCT06377488|466814282|FG000|Overall Study|Protocol Violation|1|||
129687824|NCT06377488|466814282|FG000|Overall Study|Lost to Follow-up|1|||
129687825|NCT06377488|466814282|FG000|Overall Study|Incorrect Lens Dispensed|2|||
129687826|NCT01179516|466814283|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
129778275|NCT01287741|467154512|FG000|Overall Study|Adverse Event|4|||
129562509|NCT04161144|466355509|FG000|Overall Study|Withdrawal by Subject|0|||
129562510|NCT04161144|466355510|FG001|Overall Study|Withdrawal by Subject|1|||
129562511|NCT04161144|466355509|FG000|Overall Study|Protocol Violation|1|||
129562512|NCT04161144|466355510|FG001|Overall Study|Protocol Violation|0|||
129562513|NCT00958256|466355513|FG000|Overall Study|Adverse Event|3|||
129562514|NCT03036579|466355516|FG000|2 Years|Lost to Follow-up|1|||
129562515|NCT03036579|466355517|FG001|2 Years|Lost to Follow-up|0|||
129562516|NCT03036579|466355516|FG000|3 Years|Lost to Follow-up|0|||
129562517|NCT03036579|466355517|FG001|3 Years|Lost to Follow-up|1|||
129562518|NCT02848599|466355518|FG000|Overall Study|Protocol Violation|7|||
129562519|NCT02848599|466355519|FG001|Overall Study|Protocol Violation|9|||
129562520|NCT01090765|466355520|FG000|Overall Study|Patient withdrew consent|0|||
129562521|NCT01090765|466355521|FG001|Overall Study|Patient withdrew consent|0|||
129562522|NCT01090765|466355522|FG002|Overall Study|Patient withdrew consent|0|||
129562523|NCT01090765|466355523|FG003|Overall Study|Patient withdrew consent|0|||
129562524|NCT01090765|466355524|FG004|Overall Study|Patient withdrew consent|1|||
129562525|NCT01090765|466355525|FG005|Overall Study|Patient withdrew consent|1|||
129562526|NCT01090765|466355520|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
129562527|NCT01090765|466355521|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
129562528|NCT01090765|466355522|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
129562529|NCT01090765|466355523|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
129562530|NCT01090765|466355524|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
129562531|NCT01090765|466355525|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
129562532|NCT01090765|466355520|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
129562533|NCT01090765|466355521|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
129562534|NCT01090765|466355522|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
129562535|NCT01090765|466355523|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
129562536|NCT01090765|466355524|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
129562537|NCT01090765|466355525|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
129562538|NCT00421174|466355529|FG000|Overall Study|Withdrawal by Subject|0|||
129562539|NCT00421174|466355530|FG001|Overall Study|Withdrawal by Subject|1|||
129562540|NCT00421174|466355529|FG000|Overall Study|Ineligible due to infection|2|||
129562541|NCT00421174|466355530|FG001|Overall Study|Ineligible due to infection|0|||
129562542|NCT02396381|466355531|FG000|Overall Study|Adverse Event|3|||
129562543|NCT02396381|466355532|FG001|Overall Study|Adverse Event|2|||
129562544|NCT02396381|466355531|FG000|Overall Study|Withdrawal by Subject|33|||
129562545|NCT02396381|466355532|FG001|Overall Study|Withdrawal by Subject|24|||
129562546|NCT02396381|466355531|FG000|Overall Study|Lost to Follow-up|49|||
129562547|NCT02396381|466355532|FG001|Overall Study|Lost to Follow-up|31|||
129562548|NCT02396381|466355531|FG000|Overall Study|Protocol Violation|1|||
129562549|NCT02396381|466355532|FG001|Overall Study|Protocol Violation|0|||
129562550|NCT02396381|466355531|FG000|Overall Study|Site terminated by sponsor|7|||
129562551|NCT02396381|466355532|FG001|Overall Study|Site terminated by sponsor|8|||
129562552|NCT02396381|466355531|FG000|Overall Study|Physician Decision|5|||
129562553|NCT02396381|466355532|FG001|Overall Study|Physician Decision|5|||
129562554|NCT02396381|466355531|FG000|Overall Study|Pregnancy|2|||
129562555|NCT02396381|466355532|FG001|Overall Study|Pregnancy|0|||
129562556|NCT02396381|466355531|FG000|Overall Study|Non-compliance with study procedures|1|||
129562557|NCT02396381|466355532|FG001|Overall Study|Non-compliance with study procedures|0|||
129562558|NCT02396381|466355531|FG000|Overall Study|Moved out of town/state|1|||
129562559|NCT02396381|466355532|FG001|Overall Study|Moved out of town/state|3|||
129562560|NCT02396381|466355531|FG000|Overall Study|Could not complete visit|1|||
129562561|NCT02396381|466355532|FG001|Overall Study|Could not complete visit|0|||
129562562|NCT02396381|466355531|FG000|Overall Study|Possible conflict of interest|1|||
129562563|NCT02396381|466355532|FG001|Overall Study|Possible conflict of interest|0|||
129562564|NCT02396381|466355531|FG000|Overall Study|Randomization/Screening Error|3|||
129562565|NCT02396381|466355532|FG001|Overall Study|Randomization/Screening Error|1|||
129562566|NCT00356200|466355533|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
129562567|NCT00356200|466355534|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
129562568|NCT00356200|466355533|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
129562569|NCT00356200|466355534|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
129562570|NCT00812253|466355535|FG000|Overall Study|Withdrawal by Subject|3|||
129562571|NCT00812253|466355536|FG001|Overall Study|Withdrawal by Subject|2|||
129562572|NCT00812253|466355535|FG000|Overall Study|Protocol Violation|1|||
129687827|NCT01179516|466814284|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
129687828|NCT01179516|466814285|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
129562573|NCT00812253|466355536|FG001|Overall Study|Protocol Violation|1|||
129562574|NCT00812253|466355535|FG000|Overall Study|Lost to Follow-up|2|||
129687829|NCT01179516|466814283|FG000|Overall Study|Lack of Efficacy|4|||
129687830|NCT01179516|466814284|FG001|Overall Study|Lack of Efficacy|2|||
129562575|NCT00812253|466355536|FG001|Overall Study|Lost to Follow-up|0|||
129562576|NCT02918162|466355537|FG000|Overall Study|Withdrawal by Subject|1|||
129562577|NCT02918162|466355537|FG000|Overall Study|Omental Disease|1|||
129562578|NCT00395226|466355538|FG000|Overall Study|Adverse Event|4|||
129562579|NCT00395226|466355539|FG001|Overall Study|Adverse Event|3|||
129562580|NCT00395226|466355538|FG000|Overall Study|Withdrawal by Subject|0|||
129562581|NCT00395226|466355539|FG001|Overall Study|Withdrawal by Subject|1|||
129562582|NCT00395226|466355538|FG000|Overall Study|Lost to Follow-up|0|||
129778276|NCT01287741|467154513|FG001|Overall Study|Adverse Event|6|||
129562583|NCT00395226|466355539|FG001|Overall Study|Lost to Follow-up|1|||
129562584|NCT01612000|466355540|FG000|Overall Study|Lost to Follow-up|6|||
129778277|NCT01287741|467154512|FG000|Overall Study|Study terminated by Sponsor|307|||
129778278|NCT01287741|467154513|FG001|Overall Study|Study terminated by Sponsor|315|||
129562585|NCT01612000|466355541|FG001|Overall Study|Lost to Follow-up|4|||
129562586|NCT01612000|466355542|FG002|Overall Study|Lost to Follow-up|4|||
129562587|NCT01612000|466355543|FG003|Overall Study|Lost to Follow-up|8|||
129562588|NCT01612000|466355540|FG000|Overall Study|Physician Decision|0|||
129562589|NCT01612000|466355541|FG001|Overall Study|Physician Decision|0|||
129562590|NCT01612000|466355542|FG002|Overall Study|Physician Decision|1|||
129562591|NCT01612000|466355543|FG003|Overall Study|Physician Decision|0|||
129562592|NCT01612000|466355540|FG000|Overall Study|Withdrawal by Subject|3|||
129562593|NCT01612000|466355541|FG001|Overall Study|Withdrawal by Subject|1|||
129562594|NCT01612000|466355542|FG002|Overall Study|Withdrawal by Subject|2|||
129562595|NCT01612000|466355543|FG003|Overall Study|Withdrawal by Subject|2|||
129562596|NCT04652453|466355547|FG000|Overall Study|Death|8|||
129562597|NCT04652453|466355548|FG001|Overall Study|Death|2|||
129562598|NCT04652453|466355549|FG002|Overall Study|Death|0|||
129562599|NCT04652453|466355547|FG000|Overall Study|Hospice|5|||
129562600|NCT04652453|466355548|FG001|Overall Study|Hospice|5|||
129562601|NCT04652453|466355549|FG002|Overall Study|Hospice|0|||
129562602|NCT04652453|466355547|FG000|Overall Study|Withdrawal by Subject|2|||
129562603|NCT04652453|466355548|FG001|Overall Study|Withdrawal by Subject|0|||
129562604|NCT04652453|466355549|FG002|Overall Study|Withdrawal by Subject|0|||
129562605|NCT02978326|466355550|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
129562606|NCT02978326|466355551|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
129562607|NCT02978326|466355552|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
129562608|NCT02978326|466355550|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
129562609|NCT02978326|466355551|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
129562610|NCT02978326|466355552|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
129562611|NCT02978326|466355550|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
129562612|NCT02978326|466355551|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
129562613|NCT02978326|466355552|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
129562614|NCT02978326|466355550|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
129562615|NCT02978326|466355551|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
129562616|NCT02978326|466355552|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
129562617|NCT01411995|466355555|FG000|Overall Study|Failed IUD insertion|0|||
129562618|NCT01411995|466355556|FG001|Overall Study|Failed IUD insertion|1|||
129562619|NCT01937364|466355557|FG000|Overall Study|Adverse Event|2|||
129562620|NCT01937364|466355558|FG001|Overall Study|Adverse Event|1|||
129562621|NCT02974153|466355559|FG000|Overall Study|Adverse Event|6|||
129562622|NCT02974153|466355560|FG001|Overall Study|Adverse Event|0|||
129562623|NCT02974153|466355561|FG002|Overall Study|Adverse Event|1|||
129562624|NCT02974153|466355559|FG000|Overall Study|Lack of Efficacy|6|||
129562625|NCT02974153|466355560|FG001|Overall Study|Lack of Efficacy|5|||
129562626|NCT02974153|466355561|FG002|Overall Study|Lack of Efficacy|10|||
129562627|NCT02974153|466355559|FG000|Overall Study|Lost to Follow-up|9|||
129562628|NCT02974153|466355560|FG001|Overall Study|Lost to Follow-up|10|||
129562629|NCT02974153|466355561|FG002|Overall Study|Lost to Follow-up|17|||
129562630|NCT02974153|466355559|FG000|Overall Study|Physician Decision|0|||
129562631|NCT02974153|466355560|FG001|Overall Study|Physician Decision|2|||
129562632|NCT02974153|466355561|FG002|Overall Study|Physician Decision|1|||
129562633|NCT02974153|466355559|FG000|Overall Study|Withdrawal by Subject|9|||
129562634|NCT02974153|466355560|FG001|Overall Study|Withdrawal by Subject|16|||
129562635|NCT02974153|466355561|FG002|Overall Study|Withdrawal by Subject|11|||
129562636|NCT02974153|466355559|FG000|Overall Study|Study Burden|8|||
129562637|NCT02974153|466355560|FG001|Overall Study|Study Burden|7|||
129562638|NCT02974153|466355561|FG002|Overall Study|Study Burden|3|||
129562639|NCT02974153|466355559|FG000|Overall Study|Other|14|||
129562640|NCT02974153|466355560|FG001|Overall Study|Other|8|||
129562641|NCT02974153|466355561|FG002|Overall Study|Other|7|||
129562642|NCT02277769|466355562|FG000|Overall Study|Protocol Violation|3|||
129562643|NCT02277769|466355563|FG001|Overall Study|Protocol Violation|3|||
129562644|NCT02277769|466355564|FG002|Overall Study|Protocol Violation|5|||
129562645|NCT02277769|466355562|FG000|Overall Study|Lack of Efficacy|17|||
129562646|NCT02277769|466355563|FG001|Overall Study|Lack of Efficacy|0|||
129562647|NCT02277769|466355564|FG002|Overall Study|Lack of Efficacy|4|||
129562648|NCT02277769|466355562|FG000|Overall Study|Adverse Event|14|||
129562649|NCT02277769|466355563|FG001|Overall Study|Adverse Event|2|||
129562650|NCT02277769|466355564|FG002|Overall Study|Adverse Event|4|||
129562651|NCT02277769|466355562|FG000|Overall Study|Other than specified above|12|||
129562652|NCT02277769|466355563|FG001|Overall Study|Other than specified above|8|||
129562653|NCT02277769|466355564|FG002|Overall Study|Other than specified above|5|||
129562654|NCT00203307|466355565|FG000|First Intervention|Adverse Event|2|||
129562655|NCT00203307|466355566|FG001|First Intervention|Adverse Event|0|||
129562656|NCT03730103|466355567|FG000|Overall Study|Did not meet inclusion criteria|0|||
129562657|NCT03730103|466355568|FG001|Overall Study|Did not meet inclusion criteria|5|||
129562658|NCT01488578|466355569|FG000|Overall Study|Protocol Violation|1836|||
129562659|NCT02308111|466355570|FG000|Overall Study|Adverse Event|31|||
129562660|NCT02308111|466355571|FG001|Overall Study|Adverse Event|19|||
129562661|NCT02308111|466355570|FG000|Overall Study|Death|9|||
129562662|NCT02308111|466355571|FG001|Overall Study|Death|6|||
129562663|NCT02308111|466355570|FG000|Overall Study|Lost to Follow-up|2|||
129562664|NCT02308111|466355571|FG001|Overall Study|Lost to Follow-up|7|||
129562665|NCT02308111|466355570|FG000|Overall Study|Physician Decision|6|||
129562666|NCT02308111|466355571|FG001|Overall Study|Physician Decision|17|||
129562667|NCT02308111|466355570|FG000|Overall Study|Protocol Violation|0|||
129562668|NCT02308111|466355571|FG001|Overall Study|Protocol Violation|1|||
129562669|NCT02308111|466355570|FG000|Overall Study|Withdrawal by Subject|28|||
129562670|NCT02308111|466355571|FG001|Overall Study|Withdrawal by Subject|38|||
129562671|NCT02308111|466355570|FG000|Overall Study|Study Terminated by Sponsor|72|||
129562672|NCT02308111|466355571|FG001|Overall Study|Study Terminated by Sponsor|61|||
129562673|NCT02308111|466355570|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
129562674|NCT02308111|466355571|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
129562675|NCT02308111|466355570|FG000|Overall Study|Site Closure|3|||
129562676|NCT02308111|466355571|FG001|Overall Study|Site Closure|3|||
129562677|NCT02308111|466355570|FG000|Overall Study|Non-compliance with Study Drug|3|||
129562678|NCT02308111|466355571|FG001|Overall Study|Non-compliance with Study Drug|1|||
129562679|NCT02308111|466355570|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
129562680|NCT02308111|466355571|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
129562681|NCT02308111|466355570|FG000|Overall Study|Liver Transplant|3|||
129562682|NCT02308111|466355571|FG001|Overall Study|Liver Transplant|3|||
129562683|NCT02308111|466355570|FG000|Overall Study|Liver Transplant Waitlist|2|||
129562684|NCT02308111|466355571|FG001|Overall Study|Liver Transplant Waitlist|2|||
129562685|NCT02308111|466355570|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
129562686|NCT02308111|466355571|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
129562687|NCT03271528|466355574|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
129562688|NCT03271528|466355575|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
129562689|NCT03271528|466355574|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
129562690|NCT03271528|466355575|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
129562691|NCT03271528|466355574|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
129562692|NCT03271528|466355575|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
129562693|NCT03271528|466355574|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
129562694|NCT03271528|466355575|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
129562695|NCT03271528|466355574|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
129562696|NCT03271528|466355575|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
129562697|NCT03271528|466355574|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
129562698|NCT03271528|466355575|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
129562699|NCT03271528|466355574|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
129687831|NCT01179516|466814285|FG002|Overall Study|Lack of Efficacy|0|||
129687832|NCT01179516|466814283|FG000|Overall Study|Noncompliance with Study Drug|2|||
129687833|NCT01179516|466814284|FG001|Overall Study|Noncompliance with Study Drug|0|||
129687834|NCT01179516|466814285|FG002|Overall Study|Noncompliance with Study Drug|1|||
129562700|NCT03271528|466355575|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
129562701|NCT01873859|466355578|FG000|Overall Study|Withdrawal by Subject|0|||
129562702|NCT01873859|466355579|FG001|Overall Study|Withdrawal by Subject|4|||
129687835|NCT01179516|466814283|FG000|Overall Study|Protocol Deviations|4|||
129687836|NCT01179516|466814284|FG001|Overall Study|Protocol Deviations|3|||
129687837|NCT01179516|466814285|FG002|Overall Study|Protocol Deviations|3|||
129687838|NCT01179516|466814283|FG000|Overall Study|Withdrawal of Consent|2|||
129778279|NCT01287741|467154512|FG000|Overall Study|Progressive disease|190|||
129778280|NCT01287741|467154513|FG001|Overall Study|Progressive disease|166|||
129562703|NCT03977584|466355580|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
129687839|NCT01179516|466814284|FG001|Overall Study|Withdrawal of Consent|6|||
129687840|NCT01179516|466814285|FG002|Overall Study|Withdrawal of Consent|10|||
129687841|NCT01179516|466814283|FG000|Overall Study|Lost to Follow-up|7|||
129687842|NCT01179516|466814284|FG001|Overall Study|Lost to Follow-up|7|||
129562704|NCT03977584|466355581|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
129562705|NCT03977584|466355582|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
129562706|NCT03504852|466355586|FG000|Overall Study|Withdrawal of informed consent|2|||
129562707|NCT03504852|466355587|FG001|Overall Study|Withdrawal of informed consent|1|||
129562708|NCT03504852|466355588|FG002|Overall Study|Withdrawal of informed consent|0|||
129562709|NCT03504852|466355586|FG000|Overall Study|Withdrawal by Subject|5|||
129562710|NCT03504852|466355587|FG001|Overall Study|Withdrawal by Subject|5|||
129562711|NCT03504852|466355588|FG002|Overall Study|Withdrawal by Subject|1|||
129562712|NCT03504852|466355586|FG000|Overall Study|Lost to Follow-up|4|||
129562713|NCT03504852|466355587|FG001|Overall Study|Lost to Follow-up|1|||
129562714|NCT03504852|466355588|FG002|Overall Study|Lost to Follow-up|0|||
129562715|NCT03504852|466355586|FG000|Overall Study|New therapy for study indication|1|||
129562716|NCT03504852|466355587|FG001|Overall Study|New therapy for study indication|0|||
129562717|NCT03504852|466355588|FG002|Overall Study|New therapy for study indication|0|||
129562718|NCT03504852|466355586|FG000|Overall Study|Lack of Efficacy|1|||
129562719|NCT03504852|466355587|FG001|Overall Study|Lack of Efficacy|2|||
129562720|NCT03504852|466355588|FG002|Overall Study|Lack of Efficacy|0|||
129562721|NCT03504852|466355586|FG000|Overall Study|Death|0|||
129562722|NCT03504852|466355587|FG001|Overall Study|Death|1|||
129562723|NCT03504852|466355588|FG002|Overall Study|Death|0|||
129562724|NCT03504852|466355586|FG000|Overall Study|Adverse Event|4|||
129562725|NCT03504852|466355587|FG001|Overall Study|Adverse Event|8|||
129562726|NCT03504852|466355588|FG002|Overall Study|Adverse Event|2|||
129562727|NCT01066052|466355589|FG000|Overall Study|Enrolled But Not Treated|3|||
129562728|NCT01066052|466355590|FG001|Overall Study|Enrolled But Not Treated|0|||
129562729|NCT01835145|466355591|FG000|Overall Study|Ineligible prior to treatment|1|||
129562730|NCT01835145|466355592|FG001|Overall Study|Ineligible prior to treatment|0|||
129562731|NCT01309919|466355613|FG000|Overall Study|Did not receive a postpartum IUD|17|||
129562732|NCT01309919|466355614|FG001|Overall Study|Did not receive a postpartum IUD|48|||
129562733|NCT00319449|466355615|FG000|Overall Study|Subject did not wish to continue|1|||
129562734|NCT00319449|466355616|FG001|Overall Study|Subject did not wish to continue|0|||
129562735|NCT00319449|466355615|FG000|Overall Study|Noncompliance with the protocol|1|||
129562736|NCT00319449|466355616|FG001|Overall Study|Noncompliance with the protocol|0|||
129562737|NCT02102490|466355617|FG000|Overall Study|Death|6|||
129562738|NCT02102490|466355617|FG000|Overall Study|Lost to Follow-up|1|||
129562739|NCT01346410|466355618|FG000|Overall Study|Death|1|||
129562740|NCT00458302|466357501|FG000|Overall Study|Adverse Event|4|||
129687843|NCT01179516|466814285|FG002|Overall Study|Lost to Follow-up|3|||
129687844|NCT01179516|466814283|FG000|Overall Study|Other|2|||
129687845|NCT01179516|466814284|FG001|Overall Study|Other|0|||
129687846|NCT01179516|466814285|FG002|Overall Study|Other|2|||
129687847|NCT02112552|466814288|FG000|Overall Study|Withdrawal by Subject|1|||
129687848|NCT02112552|466814288|FG000|Overall Study|Adverse Event|1|||
129687849|NCT02965456|466814289|FG000|Overall Study|Lost to Follow-up|40|||
129687850|NCT02965456|466814290|FG001|Overall Study|Lost to Follow-up|18|||
129687851|NCT02965456|466814289|FG000|Overall Study|Subject Request|22|||
129687852|NCT02965456|466814290|FG001|Overall Study|Subject Request|13|||
129687853|NCT02965456|466814289|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
129687854|NCT02965456|466814290|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
129687855|NCT02965456|466814289|FG000|Overall Study|Adverse Event|3|||
129687856|NCT02965456|466814290|FG001|Overall Study|Adverse Event|0|||
129687857|NCT02965456|466814289|FG000|Overall Study|Noncompliance with Study Drug|1|||
129687858|NCT02965456|466814290|FG001|Overall Study|Noncompliance with Study Drug|1|||
129687859|NCT02965456|466814289|FG000|Overall Study|Worsening Condition|0|||
129687860|NCT02965456|466814290|FG001|Overall Study|Worsening Condition|2|||
129687861|NCT02965456|466814289|FG000|Overall Study|Lack of Efficacy|1|||
129687862|NCT02965456|466814290|FG001|Overall Study|Lack of Efficacy|0|||
129687863|NCT02965456|466814289|FG000|Overall Study|Physician Decision|0|||
129687864|NCT02965456|466814290|FG001|Overall Study|Physician Decision|1|||
129687865|NCT02965456|466814289|FG000|Overall Study|Pregnancy|1|||
129687866|NCT02965456|466814290|FG001|Overall Study|Pregnancy|0|||
129687867|NCT02965456|466814289|FG000|Overall Study|Protocol Violation|0|||
129687868|NCT02965456|466814290|FG001|Overall Study|Protocol Violation|1|||
129687869|NCT02965456|466814289|FG000|Overall Study|Participant ran out of study drug|0|||
129687870|NCT02965456|466814290|FG001|Overall Study|Participant ran out of study drug|1|||
129687871|NCT00303953|466814291|FG000|Overall Study|Ineligible|1|||
129687872|NCT00303953|466814291|FG000|Overall Study|Death|1|||
129687873|NCT00303953|466814291|FG000|Overall Study|Adverse Event|4|||
129687874|NCT00303953|466814291|FG000|Overall Study|Lack of Efficacy|12|||
129687875|NCT00303953|466814291|FG000|Overall Study|Physician Decision|1|||
129687876|NCT04465955|466814292|FG000|Overall Study|Withdrew consent|6|||
129687877|NCT04465955|466814293|FG001|Overall Study|Withdrew consent|10|||
129687878|NCT04465955|466814294|FG002|Overall Study|Withdrew consent|7|||
129687879|NCT04465955|466814292|FG000|Overall Study|Adverse Event|6|||
129687880|NCT04465955|466814293|FG001|Overall Study|Adverse Event|5|||
129562741|NCT00458302|466357502|FG001|Overall Study|Adverse Event|14|||
129562742|NCT00458302|466357501|FG000|Overall Study|Pregnancy|2|||
129562743|NCT00458302|466357502|FG001|Overall Study|Pregnancy|1|||
129562744|NCT00458302|466357501|FG000|Overall Study|Protocol Violation|0|||
129562745|NCT00458302|466357502|FG001|Overall Study|Protocol Violation|2|||
129562746|NCT00458302|466357501|FG000|Overall Study|Withdrawal by Subject|6|||
129562747|NCT00458302|466357502|FG001|Overall Study|Withdrawal by Subject|4|||
129562748|NCT00458302|466357501|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
129562749|NCT00458302|466357502|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
129562750|NCT00458302|466357501|FG000|Overall Study|Study Termination By Sponsor|1|||
129562751|NCT00458302|466357502|FG001|Overall Study|Study Termination By Sponsor|0|||
129562752|NCT00458302|466357501|FG000|Overall Study|Lost to Follow-up|2|||
129562753|NCT00458302|466357502|FG001|Overall Study|Lost to Follow-up|0|||
129562754|NCT00458302|466357501|FG000|Overall Study|Other|4|||
129562755|NCT00458302|466357502|FG001|Overall Study|Other|2|||
129562756|NCT02178709|466357504|FG000|Overall Study|Adverse Event|5|||
129562757|NCT02178709|466357504|FG000|Overall Study|Death|2|||
129562758|NCT02178709|466357504|FG000|Overall Study|Withdrawal by Subject|2|||
129562759|NCT02178709|466357504|FG000|Overall Study|Physician Decision|2|||
129562760|NCT02178709|466357504|FG000|Overall Study|Disease Progression|5|||
129562761|NCT02224456|466357505|FG000|Overall Study|Lack of Efficacy|1|||
129562762|NCT02224456|466357505|FG000|Overall Study|Lost to Follow-up|15|||
129562763|NCT02224456|466357505|FG000|Overall Study|Withdrawal by Subject|9|||
129562764|NCT02224456|466357505|FG000|Overall Study|Physician Decision|3|||
129562765|NCT02224456|466357505|FG000|Overall Study|Death|2|||
129562766|NCT02224456|466357505|FG000|Overall Study|Pregnancy|4|||
129562767|NCT02224456|466357505|FG000|Overall Study|Protocol Violation|1|||
129562768|NCT02224456|466357505|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
129562769|NCT02946385|466357506|FG000|Overall Study|Lost to Follow-up|0|||
129562770|NCT02946385|466357507|FG001|Overall Study|Lost to Follow-up|0|||
129562771|NCT02946385|466357508|FG002|Overall Study|Lost to Follow-up|3|||
129562772|NCT02946385|466357509|FG003|Overall Study|Lost to Follow-up|0|||
129562773|NCT02946385|466357510|FG004|Overall Study|Lost to Follow-up|2|||
129562774|NCT02946385|466357511|FG005|Overall Study|Lost to Follow-up|1|||
129562775|NCT01644890|466357512|FG000|Overall Study|Adverse Event|7|||
129562776|NCT01644890|466357513|FG001|Overall Study|Adverse Event|20|||
129562777|NCT01644890|466357512|FG000|Overall Study|Death|1|||
129562778|NCT01644890|466357513|FG001|Overall Study|Death|3|||
129562779|NCT01644890|466357512|FG000|Overall Study|Physician Decision|3|||
129562780|NCT01644890|466357513|FG001|Overall Study|Physician Decision|9|||
129562781|NCT01644890|466357512|FG000|Overall Study|Protocol Violation|6|||
129562782|NCT01644890|466357513|FG001|Overall Study|Protocol Violation|7|||
129562783|NCT01644890|466357512|FG000|Overall Study|Withdrawal by Subject|19|||
129562784|NCT01644890|466357513|FG001|Overall Study|Withdrawal by Subject|27|||
129562785|NCT01644890|466357512|FG000|Overall Study|Progression Disease|160|||
129562786|NCT01644890|466357513|FG001|Overall Study|Progression Disease|131|||
129562787|NCT01644890|466357512|FG000|Overall Study|Clinical Progression|6|||
129562788|NCT01644890|466357513|FG001|Overall Study|Clinical Progression|6|||
129562789|NCT01644890|466357512|FG000|Overall Study|> 28 days since last dose of study drug|6|||
129562790|NCT01644890|466357513|FG001|Overall Study|> 28 days since last dose of study drug|3|||
129562791|NCT01644890|466357512|FG000|Overall Study|Other|8|||
129562792|NCT01644890|466357513|FG001|Overall Study|Other|9|||
129562793|NCT01060670|466357514|FG000|Run In|screen failure|0|||
129562794|NCT01060670|466357515|FG001|Run In|screen failure|238|||
129562795|NCT04849988|466357518|FG000|Overall Study|Lack of Efficacy|3|||
129562796|NCT04849988|466357519|FG001|Overall Study|Lack of Efficacy|4|||
129562797|NCT04849988|466357520|FG002|Overall Study|Lack of Efficacy|1|||
129562798|NCT04849988|466357521|FG003|Overall Study|Lack of Efficacy|4|||
129562799|NCT04849988|466357518|FG000|Overall Study|Other reasons|1|||
129562800|NCT04849988|466357519|FG001|Overall Study|Other reasons|2|||
129687881|NCT04465955|466814294|FG002|Overall Study|Adverse Event|1|||
129687882|NCT04465955|466814292|FG000|Overall Study|Lost to Follow-up|2|||
129687883|NCT04465955|466814293|FG001|Overall Study|Lost to Follow-up|0|||
129687884|NCT04465955|466814294|FG002|Overall Study|Lost to Follow-up|3|||
129687885|NCT04465955|466814292|FG000|Overall Study|Other|1|||
129687886|NCT04465955|466814293|FG001|Overall Study|Other|1|||
129562801|NCT04849988|466357520|FG002|Overall Study|Other reasons|2|||
129562802|NCT04849988|466357521|FG003|Overall Study|Other reasons|1|||
129562803|NCT02761980|466357526|FG000|Overall Study|Adverse Event|4|||
129562804|NCT02761980|466357527|FG001|Overall Study|Adverse Event|6|||
129562805|NCT02761980|466357528|FG002|Overall Study|Adverse Event|5|||
129562806|NCT02761980|466357529|FG003|Overall Study|Adverse Event|6|||
129562807|NCT02761980|466357526|FG000|Overall Study|Withdrawal by Subject|0|||
129687887|NCT04465955|466814294|FG002|Overall Study|Other|3|||
129687888|NCT00387127|466814297|FG000|Overall Study|Lost to Follow-up|0|||
129562808|NCT02761980|466357527|FG001|Overall Study|Withdrawal by Subject|1|||
129562809|NCT02761980|466357528|FG002|Overall Study|Withdrawal by Subject|0|||
129562810|NCT02761980|466357529|FG003|Overall Study|Withdrawal by Subject|0|||
129562811|NCT02761980|466357526|FG000|Overall Study|Other|0|||
129562812|NCT02761980|466357527|FG001|Overall Study|Other|0|||
129562813|NCT02761980|466357528|FG002|Overall Study|Other|1|||
129562814|NCT02761980|466357529|FG003|Overall Study|Other|0|||
129562815|NCT01052116|466357530|FG000|Overall Study|Lost to Follow-up|11|||
129562816|NCT01052116|466357531|FG001|Overall Study|Lost to Follow-up|17|||
129562817|NCT01052116|466357530|FG000|Overall Study|Withdrawal by Subject|3|||
129562818|NCT01052116|466357531|FG001|Overall Study|Withdrawal by Subject|6|||
129562819|NCT01052116|466357530|FG000|Overall Study|Spirometry not performed|0|||
129562820|NCT01052116|466357531|FG001|Overall Study|Spirometry not performed|4|||
129562821|NCT02146430|466357532|FG000|Overall Study|Protocol Violation|5|||
129562822|NCT02146430|466357533|FG001|Overall Study|Protocol Violation|4|||
129562823|NCT02146430|466357534|FG002|Overall Study|Protocol Violation|8|||
129562824|NCT02146430|466357535|FG003|Overall Study|Protocol Violation|6|||
129562825|NCT02146430|466357532|FG000|Overall Study|Lack of Efficacy|13|||
129562826|NCT02146430|466357533|FG001|Overall Study|Lack of Efficacy|11|||
129562827|NCT02146430|466357534|FG002|Overall Study|Lack of Efficacy|8|||
129562828|NCT02146430|466357535|FG003|Overall Study|Lack of Efficacy|5|||
129562829|NCT02146430|466357532|FG000|Overall Study|Adverse Event|20|||
129562830|NCT02146430|466357533|FG001|Overall Study|Adverse Event|40|||
129562831|NCT02146430|466357534|FG002|Overall Study|Adverse Event|32|||
129562832|NCT02146430|466357535|FG003|Overall Study|Adverse Event|49|||
129562833|NCT02146430|466357532|FG000|Overall Study|Reason missing or not reported|2|||
129562834|NCT02146430|466357533|FG001|Overall Study|Reason missing or not reported|3|||
129562835|NCT02146430|466357534|FG002|Overall Study|Reason missing or not reported|4|||
129562836|NCT02146430|466357535|FG003|Overall Study|Reason missing or not reported|5|||
129562837|NCT02146430|466357532|FG000|Overall Study|Withdrawal by Subject|27|||
129562838|NCT02146430|466357533|FG001|Overall Study|Withdrawal by Subject|29|||
129562839|NCT02146430|466357534|FG002|Overall Study|Withdrawal by Subject|30|||
129562840|NCT02146430|466357535|FG003|Overall Study|Withdrawal by Subject|34|||
129562841|NCT01893905|466357536|FG000|Overall Study|Withdrawal by Subject|1|||
129562842|NCT01893905|466357537|FG001|Overall Study|Withdrawal by Subject|0|||
129562843|NCT01893905|466357536|FG000|Overall Study|Adverse Event|9|||
129562844|NCT01893905|466357537|FG001|Overall Study|Adverse Event|3|||
129562845|NCT01893905|466357536|FG000|Overall Study|Lack of Efficacy|5|||
129562846|NCT01893905|466357537|FG001|Overall Study|Lack of Efficacy|7|||
129562847|NCT01893905|466357536|FG000|Overall Study|Lost to Follow-up|1|||
129562848|NCT01893905|466357537|FG001|Overall Study|Lost to Follow-up|0|||
129562849|NCT01893905|466357536|FG000|Overall Study|Protocol Violation|6|||
129562850|NCT01893905|466357537|FG001|Overall Study|Protocol Violation|1|||
129562851|NCT01893905|466357536|FG000|Overall Study|Lack of adherence to treatment|2|||
129562852|NCT01893905|466357537|FG001|Overall Study|Lack of adherence to treatment|0|||
129562853|NCT01893905|466357536|FG000|Overall Study|Other reason|1|||
129562854|NCT01893905|466357537|FG001|Overall Study|Other reason|3|||
129562855|NCT01768858|466357538|FG000|Overall Study|Lost to Follow-up|9|||
129562856|NCT01768858|466357538|FG000|Overall Study|Lack of Efficacy|8|||
129562857|NCT01768858|466357538|FG000|Overall Study|Serious Adverse Event|1|||
129562858|NCT01768858|466357538|FG000|Overall Study|Participant moved to Germany|1|||
129562859|NCT01768858|466357538|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
129562860|NCT01768858|466357538|FG000|Overall Study|Exanthema|1|||
129562861|NCT01768858|466357538|FG000|Overall Study|Withdrawal by Subject|1|||
129562862|NCT00614055|466357542|FG000|Overall Study|Adverse Event|1|||
129562863|NCT00614055|466357543|FG001|Overall Study|Adverse Event|0|||
129562864|NCT00614055|466357544|FG002|Overall Study|Adverse Event|0|||
129562865|NCT00614055|466357542|FG000|Overall Study|Protocol Violation|2|||
129562866|NCT00614055|466357543|FG001|Overall Study|Protocol Violation|2|||
129687889|NCT00387127|466814298|FG001|Overall Study|Lost to Follow-up|4|||
129562867|NCT00614055|466357544|FG002|Overall Study|Protocol Violation|1|||
129562868|NCT00614055|466357542|FG000|Overall Study|Lack of Efficacy|0|||
129562869|NCT00614055|466357543|FG001|Overall Study|Lack of Efficacy|0|||
129562870|NCT00614055|466357544|FG002|Overall Study|Lack of Efficacy|2|||
129562871|NCT00614055|466357542|FG000|Overall Study|Unclassified|1|||
129562872|NCT00614055|466357543|FG001|Overall Study|Unclassified|4|||
129562873|NCT00614055|466357544|FG002|Overall Study|Unclassified|2|||
129562874|NCT01691859|466357546|FG000|Overall Study|Adverse Event|19|||
129562875|NCT01691859|466357546|FG000|Overall Study|Lack of Efficacy|11|||
129562876|NCT01691859|466357546|FG000|Overall Study|Protocol Violation|4|||
129562877|NCT01691859|466357546|FG000|Overall Study|Product commercially available|221|||
129562878|NCT01691859|466357546|FG000|Overall Study|Study closed/terminated|50|||
129562879|NCT01691859|466357546|FG000|Overall Study|Lost to Follow-up|5|||
129562880|NCT01691859|466357546|FG000|Overall Study|Physician Decision|6|||
129562881|NCT01691859|466357546|FG000|Overall Study|Withdrawal by Subject|31|||
129562882|NCT01296932|466357547|FG000|Overall Study|Dose limiting toxicity|0|||
129687890|NCT00387127|466814297|FG000|Overall Study|Death|16|||
129562883|NCT01296932|466357548|FG001|Overall Study|Dose limiting toxicity|0|||
129562884|NCT01296932|466357549|FG002|Overall Study|Dose limiting toxicity|0|||
129562885|NCT01296932|466357550|FG003|Overall Study|Dose limiting toxicity|0|||
129562886|NCT01296932|466357551|FG004|Overall Study|Dose limiting toxicity|0|||
129562887|NCT01296932|466357552|FG005|Overall Study|Dose limiting toxicity|0|||
129562888|NCT01296932|466357553|FG006|Overall Study|Dose limiting toxicity|1|||
129562889|NCT01296932|466357554|FG007|Overall Study|Dose limiting toxicity|0|||
129562890|NCT01296932|466357555|FG008|Overall Study|Dose limiting toxicity|1|||
129562891|NCT01296932|466357547|FG000|Overall Study|Progressive disease|2|||
129562892|NCT01296932|466357548|FG001|Overall Study|Progressive disease|0|||
129562893|NCT01296932|466357549|FG002|Overall Study|Progressive disease|1|||
129562894|NCT01296932|466357550|FG003|Overall Study|Progressive disease|1|||
129562895|NCT01296932|466357551|FG004|Overall Study|Progressive disease|2|||
129562896|NCT01296932|466357552|FG005|Overall Study|Progressive disease|3|||
129562897|NCT01296932|466357553|FG006|Overall Study|Progressive disease|1|||
129562898|NCT01296932|466357554|FG007|Overall Study|Progressive disease|0|||
129562899|NCT01296932|466357555|FG008|Overall Study|Progressive disease|0|||
129562900|NCT01296932|466357547|FG000|Overall Study|Withdrawal by Subject|0|||
129562901|NCT01296932|466357548|FG001|Overall Study|Withdrawal by Subject|0|||
129562902|NCT01296932|466357549|FG002|Overall Study|Withdrawal by Subject|1|||
129562903|NCT01296932|466357550|FG003|Overall Study|Withdrawal by Subject|1|||
129562904|NCT01296932|466357551|FG004|Overall Study|Withdrawal by Subject|0|||
129562905|NCT01296932|466357552|FG005|Overall Study|Withdrawal by Subject|0|||
129562906|NCT01296932|466357553|FG006|Overall Study|Withdrawal by Subject|3|||
129562907|NCT01296932|466357554|FG007|Overall Study|Withdrawal by Subject|0|||
129562908|NCT01296932|466357555|FG008|Overall Study|Withdrawal by Subject|0|||
129562909|NCT01296932|466357547|FG000|Overall Study|Adverse Event|1|||
129562910|NCT01296932|466357548|FG001|Overall Study|Adverse Event|1|||
129562911|NCT01296932|466357549|FG002|Overall Study|Adverse Event|1|||
129562912|NCT01296932|466357550|FG003|Overall Study|Adverse Event|2|||
129562913|NCT01296932|466357551|FG004|Overall Study|Adverse Event|1|||
129562914|NCT01296932|466357552|FG005|Overall Study|Adverse Event|0|||
129562915|NCT01296932|466357553|FG006|Overall Study|Adverse Event|0|||
129562916|NCT01296932|466357554|FG007|Overall Study|Adverse Event|0|||
129562917|NCT01296932|466357555|FG008|Overall Study|Adverse Event|1|||
129562918|NCT01296932|466357547|FG000|Overall Study|Investigator decision|0|||
129562919|NCT01296932|466357548|FG001|Overall Study|Investigator decision|1|||
129562920|NCT01296932|466357549|FG002|Overall Study|Investigator decision|0|||
129562921|NCT01296932|466357550|FG003|Overall Study|Investigator decision|1|||
129562922|NCT01296932|466357551|FG004|Overall Study|Investigator decision|0|||
129562923|NCT01296932|466357552|FG005|Overall Study|Investigator decision|0|||
129562924|NCT01296932|466357553|FG006|Overall Study|Investigator decision|1|||
129562925|NCT01296932|466357554|FG007|Overall Study|Investigator decision|0|||
129562926|NCT01296932|466357555|FG008|Overall Study|Investigator decision|1|||
129562927|NCT01296932|466357547|FG000|Overall Study|No clinical benefit anymore|0|||
129562928|NCT01296932|466357548|FG001|Overall Study|No clinical benefit anymore|1|||
129562929|NCT01296932|466357549|FG002|Overall Study|No clinical benefit anymore|0|||
129562930|NCT01296932|466357550|FG003|Overall Study|No clinical benefit anymore|0|||
129562931|NCT01296932|466357551|FG004|Overall Study|No clinical benefit anymore|0|||
129562932|NCT01296932|466357552|FG005|Overall Study|No clinical benefit anymore|0|||
129562933|NCT01296932|466357553|FG006|Overall Study|No clinical benefit anymore|0|||
129562934|NCT01296932|466357554|FG007|Overall Study|No clinical benefit anymore|0|||
129562935|NCT01296932|466357555|FG008|Overall Study|No clinical benefit anymore|0|||
129562936|NCT01296932|466357547|FG000|Overall Study|Physician Decision|0|||
129562937|NCT01296932|466357548|FG001|Overall Study|Physician Decision|0|||
129562938|NCT01296932|466357549|FG002|Overall Study|Physician Decision|1|||
129562939|NCT01296932|466357550|FG003|Overall Study|Physician Decision|0|||
129562940|NCT01296932|466357551|FG004|Overall Study|Physician Decision|0|||
129562941|NCT01296932|466357552|FG005|Overall Study|Physician Decision|0|||
129562942|NCT01296932|466357553|FG006|Overall Study|Physician Decision|0|||
129562943|NCT01296932|466357554|FG007|Overall Study|Physician Decision|0|||
129562944|NCT01296932|466357555|FG008|Overall Study|Physician Decision|0|||
129562945|NCT01296932|466357547|FG000|Overall Study|IV problems, administration not possible|0|||
129562946|NCT01296932|466357548|FG001|Overall Study|IV problems, administration not possible|0|||
129562947|NCT01296932|466357549|FG002|Overall Study|IV problems, administration not possible|1|||
129562948|NCT01296932|466357550|FG003|Overall Study|IV problems, administration not possible|0|||
129562949|NCT01296932|466357551|FG004|Overall Study|IV problems, administration not possible|0|||
129687891|NCT00387127|466814298|FG001|Overall Study|Death|16|||
129687892|NCT00387127|466814297|FG000|Overall Study|Physician Decision|0|||
129687893|NCT00387127|466814298|FG001|Overall Study|Physician Decision|1|||
129562950|NCT01296932|466357552|FG005|Overall Study|IV problems, administration not possible|0|||
129562951|NCT01296932|466357553|FG006|Overall Study|IV problems, administration not possible|0|||
129562952|NCT01296932|466357554|FG007|Overall Study|IV problems, administration not possible|0|||
129562953|NCT01296932|466357555|FG008|Overall Study|IV problems, administration not possible|0|||
129562954|NCT01296932|466357547|FG000|Overall Study|per protocol|0|||
129687894|NCT00387127|466814297|FG000|Overall Study|Withdrawal by Subject|3|||
129562955|NCT01296932|466357548|FG001|Overall Study|per protocol|0|||
129562956|NCT01296932|466357549|FG002|Overall Study|per protocol|1|||
129562957|NCT01296932|466357550|FG003|Overall Study|per protocol|1|||
129562958|NCT01296932|466357551|FG004|Overall Study|per protocol|0|||
129562959|NCT01296932|466357552|FG005|Overall Study|per protocol|0|||
129562960|NCT01296932|466357553|FG006|Overall Study|per protocol|0|||
129562961|NCT01296932|466357554|FG007|Overall Study|per protocol|0|||
129562962|NCT01296932|466357555|FG008|Overall Study|per protocol|0|||
129687895|NCT00387127|466814298|FG001|Overall Study|Withdrawal by Subject|2|||
129562963|NCT01296932|466357547|FG000|Overall Study|Low benefit and too many side effects|0|||
129562964|NCT01296932|466357548|FG001|Overall Study|Low benefit and too many side effects|0|||
129562965|NCT01296932|466357549|FG002|Overall Study|Low benefit and too many side effects|0|||
129562966|NCT01296932|466357550|FG003|Overall Study|Low benefit and too many side effects|0|||
129562967|NCT01296932|466357551|FG004|Overall Study|Low benefit and too many side effects|0|||
129562968|NCT01296932|466357552|FG005|Overall Study|Low benefit and too many side effects|0|||
129562969|NCT01296932|466357553|FG006|Overall Study|Low benefit and too many side effects|0|||
129562970|NCT01296932|466357554|FG007|Overall Study|Low benefit and too many side effects|1|||
129562971|NCT01296932|466357555|FG008|Overall Study|Low benefit and too many side effects|0|||
129562972|NCT01296932|466357547|FG000|Overall Study|No adequate treatment response|0|||
129562973|NCT01296932|466357548|FG001|Overall Study|No adequate treatment response|0|||
129562974|NCT01296932|466357549|FG002|Overall Study|No adequate treatment response|0|||
129562975|NCT01296932|466357550|FG003|Overall Study|No adequate treatment response|0|||
129562976|NCT01296932|466357551|FG004|Overall Study|No adequate treatment response|0|||
129562977|NCT01296932|466357552|FG005|Overall Study|No adequate treatment response|0|||
129562978|NCT01296932|466357553|FG006|Overall Study|No adequate treatment response|0|||
129562979|NCT01296932|466357554|FG007|Overall Study|No adequate treatment response|1|||
129562980|NCT01296932|466357555|FG008|Overall Study|No adequate treatment response|0|||
129562981|NCT01296932|466357547|FG000|Overall Study|Dosage already reduced, AE still present|0|||
129562982|NCT01296932|466357548|FG001|Overall Study|Dosage already reduced, AE still present|0|||
129562983|NCT01296932|466357549|FG002|Overall Study|Dosage already reduced, AE still present|0|||
129562984|NCT01296932|466357550|FG003|Overall Study|Dosage already reduced, AE still present|0|||
129562985|NCT01296932|466357551|FG004|Overall Study|Dosage already reduced, AE still present|0|||
129562986|NCT01296932|466357552|FG005|Overall Study|Dosage already reduced, AE still present|0|||
129562987|NCT01296932|466357553|FG006|Overall Study|Dosage already reduced, AE still present|0|||
129562988|NCT01296932|466357554|FG007|Overall Study|Dosage already reduced, AE still present|0|||
129562989|NCT01296932|466357555|FG008|Overall Study|Dosage already reduced, AE still present|1|||
129562990|NCT02352337|466357556|FG000|Overall Study|Patients never treated|4|||
129562991|NCT02352337|466357557|FG001|Overall Study|Patients never treated|1|||
129562992|NCT02352337|466357558|FG002|Overall Study|Patients never treated|2|||
129562993|NCT01829464|466357559|FG000|Overall Study|Adverse Event|1|||
129562994|NCT01829464|466357560|FG001|Overall Study|Adverse Event|0|||
129562995|NCT01829464|466357561|FG002|Overall Study|Adverse Event|0|||
129562996|NCT01829464|466357559|FG000|Overall Study|Lost to Follow-up|0|||
129562997|NCT01829464|466357560|FG001|Overall Study|Lost to Follow-up|0|||
129562998|NCT01829464|466357561|FG002|Overall Study|Lost to Follow-up|1|||
129562999|NCT01829464|466357559|FG000|Overall Study|Withdrawal by Subject|2|||
129563000|NCT01829464|466357560|FG001|Overall Study|Withdrawal by Subject|0|||
129563001|NCT01829464|466357561|FG002|Overall Study|Withdrawal by Subject|0|||
129563002|NCT01829464|466357559|FG000|Overall Study|Study terminated by sponsor|25|||
129563003|NCT01829464|466357560|FG001|Overall Study|Study terminated by sponsor|28|||
129563004|NCT01829464|466357561|FG002|Overall Study|Study terminated by sponsor|25|||
129563005|NCT01829464|466357559|FG000|Overall Study|Lack of Efficacy|0|||
129563006|NCT01829464|466357560|FG001|Overall Study|Lack of Efficacy|1|||
129563007|NCT01829464|466357561|FG002|Overall Study|Lack of Efficacy|0|||
129563008|NCT02336737|466357568|FG000|Overall Study|Withdrawal by Subject|5|||
129563009|NCT02336737|466357568|FG000|Overall Study|Physician Decision|8|||
129563010|NCT00635778|466357569|FG000|Overall Study|Adverse Event|1|||
129563011|NCT00635778|466357570|FG001|Overall Study|Adverse Event|0|||
129563012|NCT00635778|466357571|FG002|Overall Study|Adverse Event|0|||
129563013|NCT00635778|466357572|FG003|Overall Study|Adverse Event|3|||
129563014|NCT00635778|466357573|FG004|Overall Study|Adverse Event|3|||
129563015|NCT00635778|466357574|FG005|Overall Study|Adverse Event|6|||
129563016|NCT00635778|466357575|FG006|Overall Study|Adverse Event|1|||
129563017|NCT00635778|466357569|FG000|Overall Study|Withdrawal by Subject|0|||
129563018|NCT00635778|466357570|FG001|Overall Study|Withdrawal by Subject|0|||
129563019|NCT00635778|466357571|FG002|Overall Study|Withdrawal by Subject|0|||
129563020|NCT00635778|466357572|FG003|Overall Study|Withdrawal by Subject|1|||
129563021|NCT00635778|466357573|FG004|Overall Study|Withdrawal by Subject|0|||
129563022|NCT00635778|466357574|FG005|Overall Study|Withdrawal by Subject|1|||
129563023|NCT00635778|466357575|FG006|Overall Study|Withdrawal by Subject|1|||
129563024|NCT00635778|466357569|FG000|Overall Study|Progressive disease|0|||
129563025|NCT00635778|466357570|FG001|Overall Study|Progressive disease|3|||
129563026|NCT00635778|466357571|FG002|Overall Study|Progressive disease|3|||
129563027|NCT00635778|466357572|FG003|Overall Study|Progressive disease|4|||
129563028|NCT00635778|466357573|FG004|Overall Study|Progressive disease|5|||
129563029|NCT00635778|466357574|FG005|Overall Study|Progressive disease|14|||
129563030|NCT00635778|466357575|FG006|Overall Study|Progressive disease|4|||
129563031|NCT01884025|466357576|FG000|Overall Study|Lost to Follow-up|3|||
129563032|NCT01884025|466357577|FG001|Overall Study|Lost to Follow-up|4|||
129563033|NCT02324465|466357578|FG000|Overall Study|device failure|0|||
129687896|NCT00387127|466814297|FG000|Overall Study|Required by Protocol Amendment #4|12|||
129563034|NCT02324465|466357579|FG001|Overall Study|device failure|1|||
129563035|NCT02655237|466357582|FG000|Overall Study|Adverse Event|10|||
129563036|NCT02655237|466357583|FG001|Overall Study|Adverse Event|7|||
129563037|NCT02655237|466357582|FG000|Overall Study|Protocol Deviation|2|||
129563038|NCT02655237|466357583|FG001|Overall Study|Protocol Deviation|0|||
129563039|NCT02655237|466357582|FG000|Overall Study|Withdrawal by Participant|1|||
129563040|NCT02655237|466357583|FG001|Overall Study|Withdrawal by Participant|2|||
129563041|NCT02655237|466357582|FG000|Overall Study|Lack of Efficacy|0|||
129563042|NCT02655237|466357583|FG001|Overall Study|Lack of Efficacy|1|||
129563043|NCT02655237|466357582|FG000|Overall Study|Recovery Leading to Surgery|2|||
129563044|NCT02655237|466357583|FG001|Overall Study|Recovery Leading to Surgery|1|||
129563045|NCT02655237|466357582|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
129563046|NCT02655237|466357583|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
129563047|NCT02655237|466357582|FG000|Overall Study|Randomized but Not Treated|1|||
129563048|NCT02655237|466357583|FG001|Overall Study|Randomized but Not Treated|0|||
129563049|NCT02132247|466357584|FG000|Overall Study|Protocol Violation|1|||
129563050|NCT02132247|466357585|FG001|Overall Study|Protocol Violation|0|||
129563051|NCT03679741|466357588|FG000|Period 1|No longer meet eligibility criteria|1|||
129563052|NCT03679741|466357589|FG001|Period 1|No longer meet eligibility criteria|0|||
129563053|NCT03679741|466357588|FG000|Period 1|Lost to Follow-up|0|||
129563054|NCT03679741|466357589|FG001|Period 1|Lost to Follow-up|1|||
129563055|NCT03679741|466357588|FG000|Period 1|Adverse Event|1|||
129563056|NCT03679741|466357589|FG001|Period 1|Adverse Event|1|||
129563057|NCT03679741|466357588|FG000|Period 1|Withdrawal by Subject|0|||
129563058|NCT03679741|466357589|FG001|Period 1|Withdrawal by Subject|1|||
129563059|NCT03679741|466357588|FG000|Period 2|Adverse Event|2|||
129563060|NCT03679741|466357589|FG001|Period 2|Adverse Event|1|||
129563061|NCT03679741|466357588|FG000|Period 2|Withdrawal by Subject|1|||
129563062|NCT03679741|466357589|FG001|Period 2|Withdrawal by Subject|1|||
129563063|NCT01860976|466357591|FG000|Blinded Treatment|Adverse Event|1|||
129563064|NCT01860976|466357592|FG001|Blinded Treatment|Adverse Event|3|||
129563065|NCT01860976|466357591|FG000|Blinded Treatment|Lack of Efficacy|5|||
129563066|NCT01860976|466357592|FG001|Blinded Treatment|Lack of Efficacy|12|||
129563067|NCT01860976|466357591|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
129563068|NCT01860976|466357592|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
129563069|NCT01860976|466357591|FG000|Blinded Treatment|Withdrawal by Subject|3|||
129563070|NCT01860976|466357592|FG001|Blinded Treatment|Withdrawal by Subject|5|||
129563071|NCT01860976|466357591|FG000|Blinded Treatment|Subject no longer met criteria|1|||
129563072|NCT01860976|466357592|FG001|Blinded Treatment|Subject no longer met criteria|0|||
129563073|NCT01860976|466357591|FG000|Blinded Treatment|Entered Open-Label in error|0|||
129563074|NCT01860976|466357592|FG001|Blinded Treatment|Entered Open-Label in error|1|||
129563075|NCT01860976|466357591|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
129563076|NCT01860976|466357592|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
129563077|NCT01860976|466357591|FG000|Open-Label|Adverse Event|2|||
129563078|NCT01860976|466357592|FG001|Open-Label|Adverse Event|4|||
129563079|NCT01860976|466357591|FG000|Open-Label|Lack of Efficacy|16|||
129563080|NCT01860976|466357592|FG001|Open-Label|Lack of Efficacy|8|||
129563081|NCT01860976|466357591|FG000|Open-Label|Lost to Follow-up|1|||
129563082|NCT01860976|466357592|FG001|Open-Label|Lost to Follow-up|2|||
129563083|NCT01860976|466357591|FG000|Open-Label|Subject request discontinue treatment|4|||
129563084|NCT01860976|466357592|FG001|Open-Label|Subject request discontinue treatment|3|||
129563085|NCT01860976|466357591|FG000|Open-Label|Withdrawal by Subject|4|||
129563086|NCT01860976|466357592|FG001|Open-Label|Withdrawal by Subject|1|||
129563087|NCT01860976|466357591|FG000|Open-Label|Other Reasons|1|||
129563088|NCT01860976|466357592|FG001|Open-Label|Other Reasons|1|||
129563089|NCT01860976|466357591|FG000|Long Term Extension|Adverse Event|4|||
129563090|NCT01860976|466357592|FG001|Long Term Extension|Adverse Event|0|||
129563091|NCT01860976|466357591|FG000|Long Term Extension|Lack of Efficacy|2|||
129563092|NCT01860976|466357592|FG001|Long Term Extension|Lack of Efficacy|0|||
129563093|NCT01860976|466357591|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
129563094|NCT01860976|466357592|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
129563095|NCT01860976|466357591|FG000|Long Term Extension|Lost to Follow-up|2|||
129563096|NCT01860976|466357592|FG001|Long Term Extension|Lost to Follow-up|0|||
129778281|NCT01287741|467154512|FG000|Overall Study|Reason not specified|23|||
129563097|NCT01860976|466357591|FG000|Long Term Extension|subject withdrew consent|7|||
129563098|NCT01860976|466357592|FG001|Long Term Extension|subject withdrew consent|0|||
129563099|NCT02227862|466357593|FG000|Overall Study|Protocol Violation|7|||
129563100|NCT02227862|466357594|FG001|Overall Study|Protocol Violation|9|||
129563101|NCT02227862|466357593|FG000|Overall Study|Other|0|||
129563102|NCT02227862|466357594|FG001|Overall Study|Other|2|||
129563103|NCT02227862|466357593|FG000|Overall Study|Adverse Event|4|||
129563104|NCT02227862|466357594|FG001|Overall Study|Adverse Event|3|||
129563105|NCT02227862|466357593|FG000|Overall Study|Withdrawal by Subject|7|||
129563106|NCT02227862|466357594|FG001|Overall Study|Withdrawal by Subject|6|||
129778282|NCT01287741|467154513|FG001|Overall Study|Reason not specified|9|||
129563107|NCT02227862|466357593|FG000|Overall Study|Lost to Follow-up|1|||
129563108|NCT02227862|466357594|FG001|Overall Study|Lost to Follow-up|2|||
129563109|NCT02354586|466357600|FG000|Overall Study|Death|230|||
129563110|NCT02354586|466357600|FG000|Overall Study|Withdrawal by Subject|59|||
129563111|NCT02354586|466357600|FG000|Overall Study|Lost to Follow-up|11|||
129563112|NCT02354586|466357600|FG000|Overall Study|Sponsor decision|51|||
129563113|NCT02354586|466357600|FG000|Overall Study|Site closure|2|||
129563114|NCT02354586|466357600|FG000|Overall Study|Intercurrent illness|1|||
129563115|NCT02354586|466357600|FG000|Overall Study|Protocol Violation|3|||
129563116|NCT02354586|466357600|FG000|Overall Study|Physician Decision|13|||
129563117|NCT02354586|466357600|FG000|Overall Study|Lack of Efficacy|86|||
129563118|NCT02354586|466357600|FG000|Overall Study|Adverse Event|7|||
129563119|NCT00634907|466357602|FG000|Overall Study|Withdrawal by Subject|3|||
129563120|NCT00634907|466357603|FG001|Overall Study|Withdrawal by Subject|0|||
129563121|NCT00634907|466357602|FG000|Overall Study|Physician Decision|3|||
129563122|NCT00634907|466357603|FG001|Overall Study|Physician Decision|9|||
129563123|NCT00634907|466357602|FG000|Overall Study|Withdrawal by Subject|11|||
129563124|NCT00634907|466357603|FG001|Overall Study|Withdrawal by Subject|8|||
129563125|NCT02419313|466357610|FG000|First Intervention|Lost to Follow-up|2|||
129563126|NCT02419313|466357611|FG001|First Intervention|Lost to Follow-up|0|||
129563127|NCT02419313|466357610|FG000|Second Intervention|Lost to Follow-up|1|||
129563128|NCT02419313|466357611|FG001|Second Intervention|Lost to Follow-up|0|||
129563129|NCT02204371|466357612|FG000|Overall Study|Adverse Event|1|||
129563130|NCT00620763|466357615|FG000|Period: First Intervention|Withdrawal by Subject|0|||
129563131|NCT00620763|466357616|FG001|Period: First Intervention|Withdrawal by Subject|2|||
129563132|NCT00620763|466357615|FG000|Period: First Intervention|Protocol Violation|0|||
129563133|NCT00620763|466357616|FG001|Period: First Intervention|Protocol Violation|3|||
129563134|NCT00620763|466357615|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
129563135|NCT00620763|466357616|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
129563136|NCT00368966|466357620|FG000|Infant Series|Withdrawal by Subject|11|||
129563137|NCT00368966|466357621|FG001|Infant Series|Withdrawal by Subject|6|||
129563138|NCT00368966|466357620|FG000|Infant Series|Protocol Violation|2|||
129563139|NCT00368966|466357621|FG001|Infant Series|Protocol Violation|1|||
129563140|NCT00368966|466357620|FG000|Infant Series|Lost to Follow-up|2|||
129563141|NCT00368966|466357621|FG001|Infant Series|Lost to Follow-up|0|||
129563142|NCT00368966|466357620|FG000|Infant Series|Randomization error|0|||
129563143|NCT00368966|466357621|FG001|Infant Series|Randomization error|1|||
129563144|NCT00368966|466357620|FG000|Infant Series|Failed to meet eligibility criteria|0|||
129563145|NCT00368966|466357621|FG001|Infant Series|Failed to meet eligibility criteria|1|||
129563146|NCT00368966|466357620|FG000|Infant Series|Adverse Event|0|||
129563147|NCT00368966|466357621|FG001|Infant Series|Adverse Event|1|||
129563148|NCT00368966|466357620|FG000|Infant Series|Failed to return|1|||
129563149|NCT00368966|466357621|FG001|Infant Series|Failed to return|0|||
129563150|NCT00368966|466357620|FG000|After Infant|Failed to return|3|||
129563151|NCT00368966|466357621|FG001|After Infant|Failed to return|1|||
129563152|NCT00368966|466357620|FG000|After Infant|Adverse Event|1|||
129563153|NCT00368966|466357621|FG001|After Infant|Adverse Event|2|||
129563154|NCT00368966|466357620|FG000|After Infant|Withdrawal by Subject|1|||
129563155|NCT00368966|466357621|FG001|After Infant|Withdrawal by Subject|1|||
129563156|NCT00368966|466357620|FG000|After Infant|Death|1|||
129563157|NCT00368966|466357621|FG001|After Infant|Death|0|||
129563158|NCT00368966|466357620|FG000|After Infant|Lost to Follow-up|0|||
129563159|NCT00368966|466357621|FG001|After Infant|Lost to Follow-up|1|||
129563160|NCT00368966|466357620|FG000|Toddler Dose|Withdrawal by Subject|1|||
129563161|NCT00368966|466357621|FG001|Toddler Dose|Withdrawal by Subject|1|||
129563162|NCT00368966|466357620|FG000|Toddler Dose|Lost to Follow-up|0|||
129563163|NCT00368966|466357621|FG001|Toddler Dose|Lost to Follow-up|2|||
129563164|NCT02866175|466357622|FG000|Overall Study|Adverse Event|56|||
129563165|NCT02866175|466357623|FG001|Overall Study|Adverse Event|54|||
129563166|NCT02866175|466357622|FG000|Overall Study|Withdrawal by Subject|31|||
129563167|NCT02866175|466357623|FG001|Overall Study|Withdrawal by Subject|52|||
129563168|NCT02866175|466357622|FG000|Overall Study|Death|30|||
129563169|NCT02866175|466357623|FG001|Overall Study|Death|23|||
129563170|NCT02866175|466357622|FG000|Overall Study|Other|7|||
129563171|NCT02866175|466357623|FG001|Overall Study|Other|14|||
129563172|NCT02866175|466357622|FG000|Overall Study|Progressive disease|1|||
129563173|NCT02866175|466357623|FG001|Overall Study|Progressive disease|1|||
129563174|NCT02866175|466357622|FG000|Overall Study|Lost to Follow-up|2|||
129563175|NCT02866175|466357623|FG001|Overall Study|Lost to Follow-up|0|||
129563176|NCT02866175|466357622|FG000|Overall Study|Lack of Efficacy|0|||
129778283|NCT04421027|467154514|FG000|Treatment Period|Adverse Event|5|||
129563177|NCT02866175|466357623|FG001|Overall Study|Lack of Efficacy|1|||
129563178|NCT02866175|466357622|FG000|Overall Study|Physician Decision|3|||
129563179|NCT02866175|466357623|FG001|Overall Study|Physician Decision|15|||
129563180|NCT02866175|466357622|FG000|Overall Study|Did not receive treatment|5|||
129778284|NCT04421027|467154515|FG001|Treatment Period|Adverse Event|3|||
129563181|NCT02866175|466357623|FG001|Overall Study|Did not receive treatment|15|||
129778285|NCT04421027|467154516|FG002|Treatment Period|Adverse Event|0|||
129563182|NCT01694485|466357624|FG000|Overall Study|Withdrawal by Subject|20|||
129563183|NCT01694485|466357625|FG001|Overall Study|Withdrawal by Subject|6|||
129563184|NCT01694485|466357626|FG002|Overall Study|Withdrawal by Subject|7|||
129563185|NCT01694485|466357627|FG003|Overall Study|Withdrawal by Subject|25|||
129563186|NCT01694485|466357628|FG004|Overall Study|Withdrawal by Subject|18|||
129563187|NCT01694485|466357624|FG000|Overall Study|Sponsor Decision|3|||
129563188|NCT01694485|466357625|FG001|Overall Study|Sponsor Decision|0|||
129563189|NCT01694485|466357626|FG002|Overall Study|Sponsor Decision|0|||
129563190|NCT01694485|466357627|FG003|Overall Study|Sponsor Decision|2|||
129563191|NCT01694485|466357628|FG004|Overall Study|Sponsor Decision|0|||
129563192|NCT01694485|466357624|FG000|Overall Study|Lost to Follow-up|9|||
129563193|NCT01694485|466357625|FG001|Overall Study|Lost to Follow-up|1|||
129563194|NCT01694485|466357626|FG002|Overall Study|Lost to Follow-up|6|||
129563195|NCT01694485|466357627|FG003|Overall Study|Lost to Follow-up|10|||
129563196|NCT01694485|466357628|FG004|Overall Study|Lost to Follow-up|7|||
129563197|NCT01694485|466357624|FG000|Overall Study|Death|1|||
129563198|NCT01694485|466357625|FG001|Overall Study|Death|0|||
129563199|NCT01694485|466357626|FG002|Overall Study|Death|0|||
129563200|NCT01694485|466357627|FG003|Overall Study|Death|1|||
129563201|NCT01694485|466357628|FG004|Overall Study|Death|0|||
129563202|NCT01595009|466357629|FG000|Core|Patients completed per protocol|85|||
129563203|NCT01595009|466357630|FG001|Core|Patients completed per protocol|44|||
129563204|NCT01595009|466357631|FG002|Core|Patients completed per protocol|0|||
129563205|NCT01595009|466357632|FG003|Core|Patients completed per protocol|0|||
129563206|NCT01595009|466357629|FG000|Core|Adverse Event|19|||
129563207|NCT01595009|466357630|FG001|Core|Adverse Event|23|||
129563208|NCT01595009|466357631|FG002|Core|Adverse Event|0|||
129687897|NCT00387127|466814298|FG001|Overall Study|Required by Protocol Amendment #4|10|||
129563209|NCT01595009|466357632|FG003|Core|Adverse Event|0|||
129563210|NCT01595009|466357629|FG000|Core|Disease progression|14|||
129563211|NCT01595009|466357630|FG001|Core|Disease progression|26|||
129563212|NCT01595009|466357631|FG002|Core|Disease progression|0|||
129563213|NCT01595009|466357632|FG003|Core|Disease progression|0|||
129563214|NCT01595009|466357629|FG000|Core|Withdrawal by Subject|4|||
129563215|NCT01595009|466357630|FG001|Core|Withdrawal by Subject|17|||
129687898|NCT00387127|466814297|FG000|Overall Study|Serious Adverse Event|1|||
129563216|NCT01595009|466357631|FG002|Core|Withdrawal by Subject|0|||
129563217|NCT01595009|466357632|FG003|Core|Withdrawal by Subject|0|||
129563218|NCT01595009|466357629|FG000|Core|Death|3|||
129563219|NCT01595009|466357630|FG001|Core|Death|6|||
129563220|NCT01595009|466357631|FG002|Core|Death|0|||
129563221|NCT01595009|466357632|FG003|Core|Death|0|||
129563222|NCT01595009|466357629|FG000|Core|Lost to Follow-up|1|||
129563223|NCT01595009|466357630|FG001|Core|Lost to Follow-up|2|||
129563224|NCT01595009|466357631|FG002|Core|Lost to Follow-up|0|||
129563225|NCT01595009|466357632|FG003|Core|Lost to Follow-up|0|||
129563226|NCT01595009|466357629|FG000|Core|Protocol deviation|0|||
129563227|NCT01595009|466357630|FG001|Core|Protocol deviation|1|||
129563228|NCT01595009|466357631|FG002|Core|Protocol deviation|0|||
129563229|NCT01595009|466357632|FG003|Core|Protocol deviation|0|||
129563230|NCT01595009|466357629|FG000|Core|Administrative problems|0|||
129563231|NCT01595009|466357630|FG001|Core|Administrative problems|1|||
129563232|NCT01595009|466357631|FG002|Core|Administrative problems|0|||
129563233|NCT01595009|466357632|FG003|Core|Administrative problems|0|||
129563234|NCT01595009|466357629|FG000|Extension|Administrative problems|0|||
129563235|NCT01595009|466357630|FG001|Extension|Administrative problems|0|||
129563236|NCT01595009|466357631|FG002|Extension|Administrative problems|0|||
129563237|NCT01595009|466357632|FG003|Extension|Administrative problems|1|||
129563238|NCT01595009|466357629|FG000|Extension|Patients completed per protocol|0|||
129563239|NCT01595009|466357630|FG001|Extension|Patients completed per protocol|0|||
129563240|NCT01595009|466357631|FG002|Extension|Patients completed per protocol|0|||
129563241|NCT01595009|466357632|FG003|Extension|Patients completed per protocol|2|||
129563242|NCT01595009|466357629|FG000|Extension|Disease progression|0|||
129563243|NCT01595009|466357630|FG001|Extension|Disease progression|0|||
129563244|NCT01595009|466357631|FG002|Extension|Disease progression|4|||
129563245|NCT01595009|466357632|FG003|Extension|Disease progression|7|||
129563246|NCT01595009|466357629|FG000|Extension|Adverse Event|0|||
129563247|NCT01595009|466357630|FG001|Extension|Adverse Event|0|||
129563248|NCT01595009|466357631|FG002|Extension|Adverse Event|0|||
129687899|NCT00387127|466814298|FG001|Overall Study|Serious Adverse Event|1|||
129687900|NCT00387127|466814297|FG000|Overall Study|Sponsor Unblinded|1|||
129687901|NCT00387127|466814298|FG001|Overall Study|Sponsor Unblinded|0|||
129687902|NCT00812097|466814299|FG000|Overall Study|Death|3|||
129687903|NCT00812097|466814300|FG001|Overall Study|Death|10|||
129687904|NCT00812097|466814301|FG002|Overall Study|Death|3|||
129687905|NCT00812097|466814302|FG003|Overall Study|Death|3|||
129687906|NCT00812097|466814299|FG000|Overall Study|Withdrawal by Subject|14|||
129687907|NCT00812097|466814300|FG001|Overall Study|Withdrawal by Subject|12|||
129687908|NCT00812097|466814301|FG002|Overall Study|Withdrawal by Subject|8|||
129687909|NCT00812097|466814302|FG003|Overall Study|Withdrawal by Subject|2|||
129687910|NCT00812097|466814299|FG000|Overall Study|Lost to Follow-up|90|||
129563249|NCT01595009|466357632|FG003|Extension|Adverse Event|1|||
129563250|NCT02907203|466357633|FG000|Overall Study|Death|1|||
129563251|NCT02907203|466357633|FG000|Overall Study|Lost to Follow-up|3|||
129687911|NCT00812097|466814300|FG001|Overall Study|Lost to Follow-up|14|||
129687912|NCT00812097|466814301|FG002|Overall Study|Lost to Follow-up|17|||
129687913|NCT00812097|466814302|FG003|Overall Study|Lost to Follow-up|5|||
129687914|NCT00812097|466814299|FG000|Overall Study|Explantation of study device(s)|27|||
129687915|NCT00812097|466814300|FG001|Overall Study|Explantation of study device(s)|29|||
129563252|NCT02907203|466357633|FG000|Overall Study|Withdrawal by Subject|3|||
129563253|NCT02907203|466357633|FG000|Overall Study|Surgical bypass|1|||
129563254|NCT04956666|466357635|FG000|Overall Study|Adverse Event|18|||
129563255|NCT04956666|466357635|FG000|Overall Study|Physician Decision|5|||
129687916|NCT00812097|466814301|FG002|Overall Study|Explantation of study device(s)|14|||
129563256|NCT00662025|466357639|FG000|Overall Study|Objective progression or relapse|51|||
129563257|NCT00662025|466357639|FG000|Overall Study|Adverse Event|7|||
129563258|NCT00662025|466357639|FG000|Overall Study|Withdrawal by Subject|1|||
129563259|NCT00662025|466357639|FG000|Overall Study|Results of other clinical study|2|||
129563260|NCT00662025|466357639|FG000|Overall Study|Target lesion cannot be evaluated|1|||
129563261|NCT00662025|466357639|FG000|Overall Study|Domestic circumstances|1|||
129563262|NCT00760383|466357640|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
129563263|NCT00760383|466357641|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
129563264|NCT00626925|466357642|FG000|Overall Study|Lost to Follow-up|1|||
129563265|NCT00626925|466357643|FG001|Overall Study|Lost to Follow-up|2|||
129563266|NCT00626925|466357642|FG000|Overall Study|relapse|1|||
129563267|NCT00626925|466357643|FG001|Overall Study|relapse|0|||
129563268|NCT00626925|466357642|FG000|Overall Study|Adverse effect|6|||
129563269|NCT00626925|466357643|FG001|Overall Study|Adverse effect|2|||
129563270|NCT00626925|466357642|FG000|Overall Study|Lack of Efficacy|1|||
129563271|NCT00626925|466357643|FG001|Overall Study|Lack of Efficacy|4|||
129563272|NCT00626925|466357642|FG000|Overall Study|Time constraints|3|||
129563273|NCT00626925|466357643|FG001|Overall Study|Time constraints|1|||
129563274|NCT01215942|466357648|FG000|Treatment Period|Adverse Event|15|||
129563275|NCT01215942|466357649|FG001|Treatment Period|Adverse Event|26|||
129563276|NCT01215942|466357648|FG000|Treatment Period|Death|2|||
129563277|NCT01215942|466357649|FG001|Treatment Period|Death|4|||
129563278|NCT01215942|466357648|FG000|Treatment Period|Lack of Efficacy|23|||
129563279|NCT01215942|466357649|FG001|Treatment Period|Lack of Efficacy|62|||
129563280|NCT01215942|466357648|FG000|Treatment Period|Lost to Follow-up|3|||
129563281|NCT01215942|466357649|FG001|Treatment Period|Lost to Follow-up|4|||
129563282|NCT01215942|466357648|FG000|Treatment Period|Withdrawal by Subject|17|||
129563283|NCT01215942|466357649|FG001|Treatment Period|Withdrawal by Subject|40|||
129563284|NCT01215942|466357648|FG000|Treatment Period|Physician Decision|5|||
129563285|NCT01215942|466357649|FG001|Treatment Period|Physician Decision|5|||
129563286|NCT01215942|466357648|FG000|Treatment Period|Protocol Violation|0|||
129563287|NCT01215942|466357649|FG001|Treatment Period|Protocol Violation|1|||
129563288|NCT01215942|466357648|FG000|Treatment Period|Sponsor Decision|349|||
129563289|NCT01215942|466357649|FG001|Treatment Period|Sponsor Decision|530|||
129563290|NCT01215942|466357648|FG000|Post-Treatment Follow-Up Period|Death|0|||
129563291|NCT01215942|466357649|FG001|Post-Treatment Follow-Up Period|Death|1|||
129563292|NCT01215942|466357648|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
129563293|NCT01215942|466357649|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
129563294|NCT01215942|466357648|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
129563295|NCT01215942|466357649|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
129563296|NCT01215942|466357648|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
129563297|NCT01215942|466357649|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
129563298|NCT01215942|466357648|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
129687917|NCT00812097|466814302|FG003|Overall Study|Explantation of study device(s)|20|||
129687918|NCT00812097|466814299|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
129687919|NCT00812097|466814300|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
129687920|NCT00812097|466814301|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
129687921|NCT00812097|466814302|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
129687922|NCT01786109|466814303|FG000|Overall Study|fail manometry barostat tube placement|1|||
129687923|NCT01786109|466814304|FG001|Overall Study|fail manometry barostat tube placement|0|||
129687924|NCT01786109|466814305|FG002|Overall Study|fail manometry barostat tube placement|0|||
129563299|NCT01215942|466357649|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
129563300|NCT03305055|466357650|FG000|Overall Study|Withdrawal by Subject|0|||
129563301|NCT03305055|466357651|FG001|Overall Study|Withdrawal by Subject|1|||
129563302|NCT03305055|466357650|FG000|Overall Study|Adverse Event|1|||
129563303|NCT03305055|466357651|FG001|Overall Study|Adverse Event|1|||
129563304|NCT01047345|466357656|FG000|Base Study|Adverse Event|3|||
129563305|NCT01047345|466357657|FG001|Base Study|Adverse Event|0|||
129563306|NCT01047345|466357658|FG002|Base Study|Adverse Event|0|||
129563307|NCT01047345|466357656|FG000|Base Study|Lost to Follow-up|4|||
129563308|NCT01047345|466357657|FG001|Base Study|Lost to Follow-up|1|||
129563309|NCT01047345|466357658|FG002|Base Study|Lost to Follow-up|0|||
129563310|NCT01047345|466357656|FG000|Base Study|Protocol Violation|3|||
129563311|NCT01047345|466357657|FG001|Base Study|Protocol Violation|1|||
129563312|NCT01047345|466357658|FG002|Base Study|Protocol Violation|0|||
129563313|NCT01047345|466357656|FG000|Base Study|Withdrawal by Subject|12|||
129563314|NCT01047345|466357657|FG001|Base Study|Withdrawal by Subject|4|||
129563315|NCT01047345|466357658|FG002|Base Study|Withdrawal by Subject|0|||
129563316|NCT01047345|466357656|FG000|Extension|Withdrawal by Subject|0|||
129563317|NCT01047345|466357657|FG001|Extension|Withdrawal by Subject|0|||
129563318|NCT01047345|466357658|FG002|Extension|Withdrawal by Subject|1|||
129563319|NCT01047345|466357656|FG000|Extension|Lost to Follow-up|0|||
129563320|NCT01047345|466357657|FG001|Extension|Lost to Follow-up|0|||
129563321|NCT01047345|466357658|FG002|Extension|Lost to Follow-up|5|||
129563322|NCT01816477|466357659|FG000|Overall Study|Withdrawal by Subject|13|||
129563323|NCT01816477|466357660|FG001|Overall Study|Withdrawal by Subject|1|||
129563324|NCT01816477|466357659|FG000|Overall Study|Unable to tolerate catheter placement|3|||
129563325|NCT01816477|466357660|FG001|Overall Study|Unable to tolerate catheter placement|0|||
129563326|NCT00819247|466357663|FG000|Overall Study|Adverse Event|0|||
129563327|NCT00819247|466357664|FG001|Overall Study|Adverse Event|5|||
129563328|NCT00819247|466357665|FG002|Overall Study|Adverse Event|3|||
129563329|NCT00819247|466357663|FG000|Overall Study|Insufficient testosterone response|5|||
129563330|NCT00819247|466357664|FG001|Overall Study|Insufficient testosterone response|8|||
129563331|NCT00819247|466357665|FG002|Overall Study|Insufficient testosterone response|10|||
129563332|NCT00819247|466357663|FG000|Overall Study|Withdrawal by Subject|1|||
129563333|NCT00819247|466357664|FG001|Overall Study|Withdrawal by Subject|0|||
129563334|NCT00819247|466357665|FG002|Overall Study|Withdrawal by Subject|0|||
129563335|NCT00819247|466357663|FG000|Overall Study|Protocol Violation|1|||
129563336|NCT00819247|466357664|FG001|Overall Study|Protocol Violation|0|||
129563337|NCT00819247|466357665|FG002|Overall Study|Protocol Violation|1|||
129563338|NCT00819247|466357663|FG000|Overall Study|Mistakenly withdrawn|0|||
129563339|NCT00819247|466357664|FG001|Overall Study|Mistakenly withdrawn|1|||
129563340|NCT00819247|466357665|FG002|Overall Study|Mistakenly withdrawn|0|||
129563341|NCT00819247|466357663|FG000|Overall Study|Bad prostate-specific antigen response|3|||
129563342|NCT00819247|466357664|FG001|Overall Study|Bad prostate-specific antigen response|2|||
129563343|NCT00819247|466357665|FG002|Overall Study|Bad prostate-specific antigen response|0|||
129563344|NCT00819247|466357663|FG000|Overall Study|Other|1|||
129563345|NCT00819247|466357664|FG001|Overall Study|Other|0|||
129563346|NCT00819247|466357665|FG002|Overall Study|Other|0|||
129563347|NCT00282256|466357666|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
129563348|NCT00282256|466357666|FG000|Extension Treatment Period|Adverse Event|2|||
129563349|NCT02540356|466357667|FG000|Overall Study|Terminated due to disease progression|1|||
129563350|NCT02540356|466357668|FG001|Overall Study|Terminated due to disease progression|0|||
129563351|NCT01513148|466357669|FG000|Overall Study|Protocol Violation|2|||
129563352|NCT01513148|466357670|FG001|Overall Study|Protocol Violation|2|||
129563353|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
129563354|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
129563355|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
129563356|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
129563357|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
129563358|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
129563359|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
129563360|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
129563361|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
129687925|NCT01786109|466814303|FG000|Overall Study|unrelated illness|0|||
129687926|NCT01786109|466814304|FG001|Overall Study|unrelated illness|0|||
129687927|NCT01786109|466814305|FG002|Overall Study|unrelated illness|1|||
129687928|NCT01786109|466814303|FG000|Overall Study|adverse effects colon preparation|0|||
129687929|NCT01786109|466814304|FG001|Overall Study|adverse effects colon preparation|0|||
129563362|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
129563363|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
129687930|NCT01786109|466814305|FG002|Overall Study|adverse effects colon preparation|1|||
129687931|NCT00317369|466814306|FG000|Overall Study|Adverse Event|2|||
129884522|NCT04779242|467536436|FG000|Overall Study|Death|6|||
129563364|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
129563365|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
129563366|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
129563367|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
129563368|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
129884523|NCT04779242|467536437|FG001|Overall Study|Death|6|||
129563369|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
129563370|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
129563371|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
129563372|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
129563373|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
129563374|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
129563375|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
129563376|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
129563377|NCT00455533|466357680|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
129563378|NCT00455533|466357681|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
129563379|NCT00455533|466357682|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
129563380|NCT00455533|466357680|FG000|Period Two: Randomized Period|Death|0|||
129563381|NCT00455533|466357681|FG001|Period Two: Randomized Period|Death|0|||
129563382|NCT00455533|466357682|FG002|Period Two: Randomized Period|Death|3|||
129563383|NCT00455533|466357680|FG000|Period Two: Randomized Period|Disease Progression|0|||
129563384|NCT00455533|466357681|FG001|Period Two: Randomized Period|Disease Progression|1|||
129563385|NCT00455533|466357682|FG002|Period Two: Randomized Period|Disease Progression|1|||
129563386|NCT00455533|466357680|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
129563387|NCT00455533|466357681|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
129563388|NCT00455533|466357682|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
129563389|NCT00455533|466357680|FG000|Period Two: Randomized Period|Other - need reasons|0|||
129563390|NCT00455533|466357681|FG001|Period Two: Randomized Period|Other - need reasons|1|||
129563391|NCT00455533|466357682|FG002|Period Two: Randomized Period|Other - need reasons|0|||
129563392|NCT00455533|466357680|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
129563393|NCT00455533|466357681|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
129563394|NCT00455533|466357682|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
129563395|NCT00455533|466357680|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
129563396|NCT00455533|466357681|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
129563397|NCT00455533|466357682|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
129563398|NCT00979628|466357687|FG000|Overall Study|received regimen < 24 hours|7|||
129563399|NCT00979628|466357688|FG001|Overall Study|received regimen < 24 hours|6|||
129563400|NCT00979628|466357689|FG002|Overall Study|received regimen < 24 hours|5|||
129563401|NCT00979628|466357687|FG000|Overall Study|received steroids|1|||
129563402|NCT00979628|466357688|FG001|Overall Study|received steroids|1|||
129563403|NCT00979628|466357689|FG002|Overall Study|received steroids|0|||
129563404|NCT00979628|466357687|FG000|Overall Study|transferred to ICU|1|||
129563405|NCT00979628|466357688|FG001|Overall Study|transferred to ICU|2|||
129563406|NCT00979628|466357689|FG002|Overall Study|transferred to ICU|1|||
129563407|NCT01736553|466357694|FG000|Overall Study|Death|12|||
129563408|NCT01736553|466357695|FG001|Overall Study|Death|0|||
129563409|NCT01736553|466357694|FG000|Overall Study|Withdrawal by Subject|5|||
129563410|NCT01736553|466357695|FG001|Overall Study|Withdrawal by Subject|2|||
129563411|NCT01736553|466357694|FG000|Overall Study|Lost to Follow-up|2|||
129563412|NCT01736553|466357695|FG001|Overall Study|Lost to Follow-up|2|||
129563413|NCT02154529|466357696|FG000|Overall Study|Death|1|||
129563414|NCT02154529|466357697|FG001|Overall Study|Death|1|||
129563415|NCT02154529|466357698|FG002|Overall Study|Death|5|||
129563416|NCT02154529|466357699|FG003|Overall Study|Death|1|||
129563417|NCT02154529|466357696|FG000|Overall Study|Termination of study by sponsor|2|||
129563418|NCT02154529|466357697|FG001|Overall Study|Termination of study by sponsor|2|||
129563419|NCT02154529|466357698|FG002|Overall Study|Termination of study by sponsor|3|||
129563420|NCT02154529|466357699|FG003|Overall Study|Termination of study by sponsor|1|||
129563421|NCT02154529|466357696|FG000|Overall Study|Lost to Follow-up|1|||
129563422|NCT02154529|466357697|FG001|Overall Study|Lost to Follow-up|0|||
129563423|NCT02154529|466357698|FG002|Overall Study|Lost to Follow-up|0|||
129563424|NCT02154529|466357699|FG003|Overall Study|Lost to Follow-up|0|||
129563425|NCT00313703|466359625|FG000|Overall Study|Lost to Follow-up|11|||
129563426|NCT00313703|466359626|FG001|Overall Study|Lost to Follow-up|2|||
129563427|NCT00313703|466359627|FG002|Overall Study|Lost to Follow-up|5|||
129563428|NCT00313703|466359628|FG003|Overall Study|Lost to Follow-up|12|||
129563429|NCT00101582|466359631|FG000|Overall Study|Ineligibility determined|0|||
129563430|NCT00101582|466359632|FG001|Overall Study|Ineligibility determined|1|||
129563431|NCT00101582|466359631|FG000|Overall Study|Adverse Event|1|||
129563432|NCT00101582|466359632|FG001|Overall Study|Adverse Event|4|||
129563433|NCT00101582|466359631|FG000|Overall Study|Withdrawal by Subject|6|||
129563434|NCT00101582|466359632|FG001|Overall Study|Withdrawal by Subject|4|||
129563435|NCT00101582|466359631|FG000|Overall Study|Physician Decision|1|||
129563436|NCT00101582|466359632|FG001|Overall Study|Physician Decision|0|||
129563437|NCT00101582|466359631|FG000|Overall Study|Death|3|||
129563438|NCT00101582|466359632|FG001|Overall Study|Death|5|||
129563439|NCT00101582|466359631|FG000|Overall Study|Other|0|||
129563440|NCT00101582|466359632|FG001|Overall Study|Other|1|||
129563441|NCT00056160|466359633|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
129563442|NCT00056160|466359634|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
129563443|NCT00056160|466359633|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
129563444|NCT00056160|466359634|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
129563445|NCT00056160|466359633|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
129563446|NCT00056160|466359634|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
129563447|NCT00056160|466359633|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
129563448|NCT00056160|466359634|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
129563449|NCT00056160|466359633|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
129563450|NCT00056160|466359634|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
129563451|NCT00056160|466359633|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
129563452|NCT00056160|466359634|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
129563453|NCT00056160|466359633|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
129563454|NCT00056160|466359634|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
129563455|NCT00056160|466359633|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
129563456|NCT00056160|466359634|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
129563457|NCT00056160|466359633|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
129563458|NCT00056160|466359634|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
129563459|NCT00056160|466359633|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
129563460|NCT00056160|466359634|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
129563461|NCT00056160|466359633|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
129563462|NCT00056160|466359634|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
129563463|NCT00056160|466359633|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
129563464|NCT00056160|466359634|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
129563465|NCT00056160|466359633|FG000|Final Follow-up|Transferred into expanded access study.|3|||
129563466|NCT00056160|466359634|FG001|Final Follow-up|Transferred into expanded access study.|0|||
129563467|NCT00056160|466359633|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
129563468|NCT00056160|466359634|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
129563469|NCT00056160|466359633|FG000|Final Follow-up|Adverse Event|1|||
129563470|NCT00056160|466359634|FG001|Final Follow-up|Adverse Event|0|||
129563471|NCT03312530|466359636|FG000|Overall Study|Death|5|||
129563472|NCT03312530|466359637|FG001|Overall Study|Death|5|||
129563473|NCT03312530|466359638|FG002|Overall Study|Death|4|||
129563474|NCT03312530|466359639|FG003|Overall Study|Death|10|||
129563475|NCT03312530|466359640|FG004|Overall Study|Death|8|||
129563476|NCT03312530|466359636|FG000|Overall Study|Lost to Follow-up|0|||
129563477|NCT03312530|466359637|FG001|Overall Study|Lost to Follow-up|0|||
129563478|NCT03312530|466359638|FG002|Overall Study|Lost to Follow-up|0|||
129563479|NCT03312530|466359639|FG003|Overall Study|Lost to Follow-up|1|||
129563480|NCT03312530|466359640|FG004|Overall Study|Lost to Follow-up|0|||
129563481|NCT03312530|466359636|FG000|Overall Study|Participant in another sponsor study.|0|||
129563482|NCT03312530|466359637|FG001|Overall Study|Participant in another sponsor study.|0|||
129563483|NCT03312530|466359638|FG002|Overall Study|Participant in another sponsor study.|0|||
129563484|NCT03312530|466359639|FG003|Overall Study|Participant in another sponsor study.|1|||
129563485|NCT03312530|466359640|FG004|Overall Study|Participant in another sponsor study.|0|||
129563486|NCT03312530|466359636|FG000|Overall Study|Study terminated by sponsor|1|||
129563487|NCT03312530|466359637|FG001|Overall Study|Study terminated by sponsor|0|||
129563488|NCT03312530|466359638|FG002|Overall Study|Study terminated by sponsor|2|||
129563489|NCT03312530|466359639|FG003|Overall Study|Study terminated by sponsor|3|||
129563490|NCT03312530|466359640|FG004|Overall Study|Study terminated by sponsor|7|||
129563491|NCT03312530|466359636|FG000|Overall Study|Withdrawal by Subject|0|||
129563492|NCT03312530|466359637|FG001|Overall Study|Withdrawal by Subject|1|||
129563493|NCT03312530|466359638|FG002|Overall Study|Withdrawal by Subject|0|||
129563494|NCT03312530|466359639|FG003|Overall Study|Withdrawal by Subject|0|||
129563495|NCT03312530|466359640|FG004|Overall Study|Withdrawal by Subject|0|||
129563496|NCT03312530|466359636|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129563497|NCT03312530|466359637|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129563498|NCT03312530|466359638|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129563499|NCT03312530|466359639|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
129687932|NCT00317369|466814307|FG001|Overall Study|Adverse Event|1|||
129687933|NCT00317369|466814308|FG002|Overall Study|Adverse Event|0|||
129687934|NCT00317369|466814306|FG000|Overall Study|Lack of Efficacy|0|||
129687935|NCT00317369|466814307|FG001|Overall Study|Lack of Efficacy|1|||
129687936|NCT00317369|466814308|FG002|Overall Study|Lack of Efficacy|1|||
129687937|NCT00317369|466814306|FG000|Overall Study|Withdrawal by Subject|0|||
129687938|NCT00317369|466814307|FG001|Overall Study|Withdrawal by Subject|0|||
129687939|NCT00317369|466814308|FG002|Overall Study|Withdrawal by Subject|1|||
129687940|NCT00825175|466814311|FG000|Overall Study|Withdrawal by Subject|0|||
129687941|NCT00825175|466814312|FG001|Overall Study|Withdrawal by Subject|5|||
129563500|NCT03312530|466359640|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
129563501|NCT03093324|466359641|FG000|Overall Study|Adverse Event|4|||
129563502|NCT03093324|466359642|FG001|Overall Study|Adverse Event|15|||
129563503|NCT03093324|466359641|FG000|Overall Study|Lost to Follow-up|1|||
129563504|NCT03093324|466359642|FG001|Overall Study|Lost to Follow-up|0|||
129563505|NCT03093324|466359641|FG000|Overall Study|Protocol Deviation|2|||
129563506|NCT03093324|466359642|FG001|Overall Study|Protocol Deviation|2|||
129563507|NCT03093324|466359641|FG000|Overall Study|Withdrawal by Subject|2|||
129563508|NCT03093324|466359642|FG001|Overall Study|Withdrawal by Subject|2|||
129563509|NCT04583579|466359643|FG000|Overall Study|Lost to Follow-up|4|||
129563510|NCT00278200|466359644|FG000|Overall Study|Death|1|||
129563511|NCT00278200|466359645|FG001|Overall Study|Death|3|||
129563512|NCT00278200|466359644|FG000|Overall Study|Physician Decision|0|||
129563513|NCT00278200|466359645|FG001|Overall Study|Physician Decision|1|||
129563514|NCT03519256|466359653|FG000|Overall Study|Disease recurrence|4|||
129563515|NCT03519256|466359654|FG001|Overall Study|Disease recurrence|4|||
129563516|NCT03519256|466359655|FG002|Overall Study|Disease recurrence|5|||
129563517|NCT03519256|466359656|FG003|Overall Study|Disease recurrence|2|||
129563518|NCT03519256|466359653|FG000|Overall Study|Study drug toxicity|0|||
129563519|NCT03519256|466359654|FG001|Overall Study|Study drug toxicity|2|||
129563520|NCT03519256|466359655|FG002|Overall Study|Study drug toxicity|5|||
129563521|NCT03519256|466359656|FG003|Overall Study|Study drug toxicity|2|||
129563522|NCT03519256|466359653|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129563523|NCT03519256|466359654|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129563524|NCT03519256|466359655|FG002|Overall Study|Adverse event unrelated to study drug|1|||
129563525|NCT03519256|466359656|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129563526|NCT03519256|466359653|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129778286|NCT04421027|467154517|FG003|Treatment Period|Adverse Event|0|||
129778287|NCT04421027|467154514|FG000|Treatment Period|Death|98|||
129778288|NCT04421027|467154515|FG001|Treatment Period|Death|61|||
129687942|NCT02762604|466814313|FG000|Overall Study|Lost to Follow-up|2|||
129687943|NCT02762604|466814314|FG001|Overall Study|Lost to Follow-up|7|||
129687944|NCT02762604|466814313|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
129687945|NCT02762604|466814314|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
129687946|NCT02691572|466814320|FG000|Overall Study|Withdrawal by Subject|1|||
129687947|NCT02691572|466814321|FG001|Overall Study|Withdrawal by Subject|0|||
129687948|NCT02691572|466814320|FG000|Overall Study|Protocol Violation|0|||
129687949|NCT02691572|466814321|FG001|Overall Study|Protocol Violation|1|||
129687950|NCT00699751|466814322|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
129687951|NCT00699751|466814323|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
129687952|NCT00699751|466814322|FG000|Period 1: Without/Before Drug Switch|Death|28|||
129687953|NCT00699751|466814323|FG001|Period 1: Without/Before Drug Switch|Death|29|||
129687954|NCT00699751|466814322|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
129687955|NCT00699751|466814323|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
129687956|NCT00699751|466814322|FG000|Period 1: Without/Before Drug Switch|Other|30|||
129687957|NCT00699751|466814323|FG001|Period 1: Without/Before Drug Switch|Other|20|||
129687958|NCT00699751|466814322|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
129687959|NCT00699751|466814323|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
129687960|NCT00699751|466814322|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
129687961|NCT00699751|466814323|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
129687962|NCT00699751|466814322|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
129687963|NCT00699751|466814323|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
129687964|NCT00699751|466814322|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
129687965|NCT00699751|466814323|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
129687966|NCT03370302|466814326|FG000|Dose Escalation Phase|Other|0|||
129687967|NCT03370302|466814327|FG001|Dose Escalation Phase|Other|1|||
129687968|NCT03370302|466814328|FG002|Dose Escalation Phase|Other|1|||
129687969|NCT03370302|466814329|FG003|Dose Escalation Phase|Other|0|||
129687970|NCT03370302|466814330|FG004|Dose Escalation Phase|Other|0|||
129687971|NCT03370302|466814331|FG005|Dose Escalation Phase|Other|0|||
129778289|NCT04421027|467154516|FG002|Treatment Period|Death|0|||
129687972|NCT03370302|466814326|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129563527|NCT03519256|466359654|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129563528|NCT03519256|466359655|FG002|Overall Study|Participant request to discontinue study treatment|0|||
129563529|NCT03519256|466359656|FG003|Overall Study|Participant request to discontinue study treatment|2|||
129687973|NCT03370302|466814327|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
129687974|NCT03370302|466814328|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
129687975|NCT03370302|466814329|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129687976|NCT03370302|466814330|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
129778290|NCT04421027|467154517|FG003|Treatment Period|Death|0|||
129778291|NCT04421027|467154514|FG000|Treatment Period|Lost to Follow-up|22|||
129563530|NCT03519256|466359653|FG000|Overall Study|Other reasons|0|||
129563531|NCT03519256|466359654|FG001|Overall Study|Other reasons|0|||
129563532|NCT03519256|466359655|FG002|Overall Study|Other reasons|2|||
129563533|NCT03519256|466359656|FG003|Overall Study|Other reasons|0|||
129563534|NCT03519256|466359653|FG000|Overall Study|Disease progression|6|||
129563535|NCT03519256|466359654|FG001|Overall Study|Disease progression|3|||
129563536|NCT03519256|466359655|FG002|Overall Study|Disease progression|2|||
129563537|NCT03519256|466359656|FG003|Overall Study|Disease progression|1|||
129563538|NCT03519256|466359653|FG000|Overall Study|Lost to Follow-up|0|||
129563539|NCT03519256|466359654|FG001|Overall Study|Lost to Follow-up|1|||
129563540|NCT03519256|466359655|FG002|Overall Study|Lost to Follow-up|0|||
129563541|NCT03519256|466359656|FG003|Overall Study|Lost to Follow-up|0|||
129563542|NCT05431153|466359657|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129563543|NCT05431153|466359658|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129563544|NCT05431153|466359659|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129563545|NCT05431153|466359660|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129563546|NCT05431153|466359661|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
129563547|NCT05431153|466359662|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129563548|NCT04828161|466359663|FG000|Overall Study|Withdrawal by Subject|0|||
129563549|NCT04828161|466359664|FG001|Overall Study|Withdrawal by Subject|3|||
129563550|NCT04828161|466359665|FG002|Overall Study|Withdrawal by Subject|3|||
129563551|NCT04828161|466359666|FG003|Overall Study|Withdrawal by Subject|4|||
129563552|NCT04828161|466359663|FG000|Overall Study|Lost to Follow-up|1|||
129563553|NCT04828161|466359664|FG001|Overall Study|Lost to Follow-up|4|||
129563554|NCT04828161|466359665|FG002|Overall Study|Lost to Follow-up|2|||
129563555|NCT04828161|466359666|FG003|Overall Study|Lost to Follow-up|2|||
129563556|NCT04828161|466359663|FG000|Overall Study|Other|2|||
129563557|NCT04828161|466359664|FG001|Overall Study|Other|0|||
129563558|NCT04828161|466359665|FG002|Overall Study|Other|2|||
129563559|NCT04828161|466359666|FG003|Overall Study|Other|0|||
129563560|NCT04828161|466359663|FG000|Overall Study|Death|0|||
129563561|NCT04828161|466359664|FG001|Overall Study|Death|0|||
129563562|NCT04828161|466359665|FG002|Overall Study|Death|0|||
129563563|NCT04828161|466359666|FG003|Overall Study|Death|2|||
129563564|NCT02458638|466359669|FG000|Overall Study|Death|309|||
129563565|NCT02458638|466359669|FG000|Overall Study|End of Cohort/End of Study|67|||
129563566|NCT02458638|466359669|FG000|Overall Study|Lost to Follow-up|31|||
129563567|NCT02458638|466359669|FG000|Overall Study|Other Reasons|4|||
129563568|NCT02458638|466359669|FG000|Overall Study|Physician Decision|1|||
129563569|NCT02458638|466359669|FG000|Overall Study|Withdrawal by Subject|47|||
129563570|NCT00135707|466359678|FG000|Overall Study|Lost to Follow-up|94|||
129563571|NCT00135707|466359679|FG001|Overall Study|Lost to Follow-up|89|||
129563572|NCT00135707|466359678|FG000|Overall Study|Withdrawal by Subject|0|||
129563573|NCT00135707|466359679|FG001|Overall Study|Withdrawal by Subject|1|||
129778292|NCT04421027|467154515|FG001|Treatment Period|Lost to Follow-up|20|||
129778293|NCT04421027|467154516|FG002|Treatment Period|Lost to Follow-up|0|||
129563574|NCT00135707|466359678|FG000|Overall Study|Institutional review board request|1|||
129563575|NCT00135707|466359679|FG001|Overall Study|Institutional review board request|0|||
129563576|NCT03093454|466359680|FG000|Overall Study|Withdrawal by Subject|1|||
129563577|NCT03093454|466359681|FG001|Overall Study|Withdrawal by Subject|1|||
129563578|NCT03093454|466359680|FG000|Overall Study|Scheduling conflict|3|||
129563579|NCT03093454|466359681|FG001|Overall Study|Scheduling conflict|1|||
129563580|NCT03093454|466359680|FG000|Overall Study|Physician Decision|2|||
129563581|NCT03093454|466359681|FG001|Overall Study|Physician Decision|1|||
129563582|NCT04540497|466359685|FG000|Overall Study|Adverse Event|0|||
129563583|NCT04540497|466359686|FG001|Overall Study|Adverse Event|2|||
129563584|NCT04540497|466359685|FG000|Overall Study|Lost to Follow-up|1|||
129563585|NCT04540497|466359686|FG001|Overall Study|Lost to Follow-up|0|||
129563586|NCT04540497|466359685|FG000|Overall Study|Withdrawal by Subject|1|||
129563587|NCT04540497|466359686|FG001|Overall Study|Withdrawal by Subject|1|||
129563588|NCT04540497|466359685|FG000|Overall Study|Miscellaneous|2|||
129563589|NCT04540497|466359686|FG001|Overall Study|Miscellaneous|1|||
129563590|NCT02524379|466359691|FG000|Overall Study|Death|1|||
129563591|NCT01290263|466359694|FG000|Overall Study|Adverse Event|0|||
129563592|NCT01290263|466359695|FG001|Overall Study|Adverse Event|0|||
129563593|NCT01290263|466359696|FG002|Overall Study|Adverse Event|0|||
129563594|NCT01290263|466359697|FG003|Overall Study|Adverse Event|1|||
129563595|NCT01290263|466359698|FG004|Overall Study|Adverse Event|1|||
129563596|NCT01290263|466359694|FG000|Overall Study|Lack of Efficacy|8|||
129563597|NCT01290263|466359695|FG001|Overall Study|Lack of Efficacy|2|||
129563598|NCT01290263|466359696|FG002|Overall Study|Lack of Efficacy|7|||
129563599|NCT01290263|466359697|FG003|Overall Study|Lack of Efficacy|24|||
129778294|NCT04421027|467154517|FG003|Treatment Period|Lost to Follow-up|0|||
129563600|NCT01290263|466359698|FG004|Overall Study|Lack of Efficacy|33|||
129563601|NCT01290263|466359694|FG000|Overall Study|Withdrawal by Subject|3|||
129563602|NCT01290263|466359695|FG001|Overall Study|Withdrawal by Subject|1|||
129563603|NCT01290263|466359696|FG002|Overall Study|Withdrawal by Subject|0|||
129563604|NCT01290263|466359697|FG003|Overall Study|Withdrawal by Subject|1|||
129563605|NCT01290263|466359698|FG004|Overall Study|Withdrawal by Subject|2|||
129563606|NCT01290263|466359694|FG000|Overall Study|Participant Non-Compliance|0|||
129563607|NCT01290263|466359695|FG001|Overall Study|Participant Non-Compliance|0|||
129563608|NCT01290263|466359696|FG002|Overall Study|Participant Non-Compliance|0|||
129563609|NCT01290263|466359697|FG003|Overall Study|Participant Non-Compliance|1|||
129563610|NCT01290263|466359698|FG004|Overall Study|Participant Non-Compliance|1|||
129563611|NCT03738332|466359699|FG000|Overall Study|Withdrawal by Subject|1|||
129563612|NCT04700449|466359700|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
129563613|NCT04700449|466359701|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
129563614|NCT04700449|466359702|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
129563615|NCT04700449|466359703|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
129563616|NCT04700449|466359700|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
129563617|NCT04700449|466359701|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
129563618|NCT04700449|466359702|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
129563619|NCT04700449|466359703|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
129563620|NCT04700449|466359700|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
129563621|NCT04700449|466359701|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
129563622|NCT04700449|466359702|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
129563623|NCT04700449|466359703|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
129563624|NCT04700449|466359700|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
129563625|NCT04700449|466359701|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129563626|NCT04700449|466359702|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129563627|NCT04700449|466359703|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
129563628|NCT04700449|466359700|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
129563629|NCT04700449|466359701|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
129563630|NCT04700449|466359702|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
129563631|NCT04700449|466359703|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
129563632|NCT04700449|466359700|FG000|Stage 1: Double-Blind Period|Other|0|||
129563633|NCT04700449|466359701|FG001|Stage 1: Double-Blind Period|Other|0|||
129563634|NCT04700449|466359702|FG002|Stage 1: Double-Blind Period|Other|1|||
129563635|NCT04700449|466359703|FG003|Stage 1: Double-Blind Period|Other|0|||
129563636|NCT04700449|466359700|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
129563637|NCT04700449|466359701|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
129563638|NCT04700449|466359702|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
129563639|NCT04700449|466359703|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
129563640|NCT04700449|466359700|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
129563641|NCT04700449|466359701|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
129563642|NCT04700449|466359702|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
129563643|NCT04700449|466359703|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
129563644|NCT04700449|466359700|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
129563645|NCT04700449|466359701|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
129563646|NCT04700449|466359702|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
129563647|NCT04700449|466359703|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
129563648|NCT04700449|466359700|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
129563649|NCT04700449|466359701|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
129778295|NCT04421027|467154514|FG000|Treatment Period|Other-Unknown|15|||
129778296|NCT04421027|467154515|FG001|Treatment Period|Other-Unknown|9|||
129563650|NCT04700449|466359702|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
129563651|NCT04700449|466359703|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
129563652|NCT04700449|466359700|FG000|Stage 2 Sub-study 1|Other|1|||
129563653|NCT04700449|466359701|FG001|Stage 2 Sub-study 1|Other|2|||
129563654|NCT04700449|466359702|FG002|Stage 2 Sub-study 1|Other|0|||
129563655|NCT04700449|466359703|FG003|Stage 2 Sub-study 1|Other|0|||
129563656|NCT04700449|466359700|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
129563657|NCT04700449|466359701|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
129563658|NCT04700449|466359702|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
129778297|NCT04421027|467154516|FG002|Treatment Period|Other-Unknown|0|||
129563659|NCT04700449|466359703|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
129563660|NCT04700449|466359700|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
129563661|NCT04700449|466359701|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
129563662|NCT04700449|466359702|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
129563663|NCT04700449|466359703|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
129563664|NCT04700449|466359700|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
129563665|NCT04700449|466359701|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
129563666|NCT04700449|466359702|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
129563667|NCT04700449|466359703|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
129563668|NCT04700449|466359700|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129563669|NCT04700449|466359701|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129563670|NCT04700449|466359702|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
129563671|NCT04700449|466359703|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
129563672|NCT04700449|466359700|FG000|Stage 2 Sub-study 2|Other|0|||
129563673|NCT04700449|466359701|FG001|Stage 2 Sub-study 2|Other|0|||
129563674|NCT04700449|466359702|FG002|Stage 2 Sub-study 2|Other|0|||
129563675|NCT04700449|466359703|FG003|Stage 2 Sub-study 2|Other|5|||
129563676|NCT01521559|466359704|FG000|Overall Study|Adverse Event|0|||
129563677|NCT01521559|466359705|FG001|Overall Study|Adverse Event|4|||
129563678|NCT01521559|466359704|FG000|Overall Study|Death|1|||
129563679|NCT01521559|466359705|FG001|Overall Study|Death|0|||
129563680|NCT01521559|466359704|FG000|Overall Study|Withdrawal by Subject|9|||
129563681|NCT01521559|466359705|FG001|Overall Study|Withdrawal by Subject|11|||
129563682|NCT01521559|466359704|FG000|Overall Study|Lost to Follow-up|3|||
129563683|NCT01521559|466359705|FG001|Overall Study|Lost to Follow-up|1|||
129563684|NCT01521559|466359704|FG000|Overall Study|Protocol Violation|1|||
129563685|NCT01521559|466359705|FG001|Overall Study|Protocol Violation|0|||
129687977|NCT03370302|466814331|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
129687978|NCT03370302|466814326|FG000|Dose Escalation Phase|Adverse Event|1|||
129687979|NCT03370302|466814327|FG001|Dose Escalation Phase|Adverse Event|0|||
129687980|NCT03370302|466814328|FG002|Dose Escalation Phase|Adverse Event|2|||
129687981|NCT03370302|466814329|FG003|Dose Escalation Phase|Adverse Event|0|||
129563686|NCT01521559|466359704|FG000|Overall Study|Other|1|||
129563687|NCT01521559|466359705|FG001|Overall Study|Other|2|||
129563688|NCT02228382|466359706|FG000|Overall Study|Death|5|||
129687982|NCT03370302|466814330|FG004|Dose Escalation Phase|Adverse Event|0|||
129687983|NCT03370302|466814331|FG005|Dose Escalation Phase|Adverse Event|0|||
129563689|NCT02228382|466359707|FG001|Overall Study|Death|7|||
129563690|NCT02228382|466359708|FG002|Overall Study|Death|5|||
129563691|NCT02228382|466359709|FG003|Overall Study|Death|0|||
129563692|NCT02228382|466359710|FG004|Overall Study|Death|2|||
129563693|NCT02228382|466359706|FG000|Overall Study|Participant refused further follow-up|0|||
129687984|NCT03370302|466814326|FG000|Dose Escalation Phase|Progressive Disease|2|||
129778298|NCT04421027|467154517|FG003|Treatment Period|Other-Unknown|0|||
129563694|NCT02228382|466359707|FG001|Overall Study|Participant refused further follow-up|0|||
129563695|NCT02228382|466359708|FG002|Overall Study|Participant refused further follow-up|1|||
129563696|NCT02228382|466359709|FG003|Overall Study|Participant refused further follow-up|0|||
129563697|NCT02228382|466359710|FG004|Overall Study|Participant refused further follow-up|0|||
129563698|NCT02228382|466359706|FG000|Overall Study|Study terminated by sponsor|3|||
129563699|NCT02228382|466359707|FG001|Overall Study|Study terminated by sponsor|5|||
129563700|NCT02228382|466359708|FG002|Overall Study|Study terminated by sponsor|7|||
129563701|NCT02228382|466359709|FG003|Overall Study|Study terminated by sponsor|0|||
129563702|NCT02228382|466359710|FG004|Overall Study|Study terminated by sponsor|0|||
129563703|NCT02228382|466359706|FG000|Overall Study|Lost to Follow-up|0|||
129563704|NCT02228382|466359707|FG001|Overall Study|Lost to Follow-up|0|||
129563705|NCT02228382|466359708|FG002|Overall Study|Lost to Follow-up|3|||
129563706|NCT02228382|466359709|FG003|Overall Study|Lost to Follow-up|1|||
129563707|NCT02228382|466359710|FG004|Overall Study|Lost to Follow-up|0|||
129563708|NCT02228382|466359706|FG000|Overall Study|Withdrawal by Subject|0|||
129563709|NCT02228382|466359707|FG001|Overall Study|Withdrawal by Subject|3|||
129563710|NCT02228382|466359708|FG002|Overall Study|Withdrawal by Subject|2|||
129563711|NCT02228382|466359709|FG003|Overall Study|Withdrawal by Subject|1|||
129563712|NCT02228382|466359710|FG004|Overall Study|Withdrawal by Subject|0|||
129563713|NCT02228382|466359706|FG000|Overall Study|Other|2|||
129687985|NCT03370302|466814327|FG001|Dose Escalation Phase|Progressive Disease|4|||
129687986|NCT03370302|466814328|FG002|Dose Escalation Phase|Progressive Disease|2|||
129687987|NCT03370302|466814329|FG003|Dose Escalation Phase|Progressive Disease|0|||
129687988|NCT03370302|466814330|FG004|Dose Escalation Phase|Progressive Disease|3|||
129687989|NCT03370302|466814331|FG005|Dose Escalation Phase|Progressive Disease|1|||
129687990|NCT03370302|466814326|FG000|Dose Expansion Phase|Progressive Disease|0|||
129687991|NCT03370302|466814327|FG001|Dose Expansion Phase|Progressive Disease|0|||
129687992|NCT03370302|466814328|FG002|Dose Expansion Phase|Progressive Disease|0|||
129687993|NCT03370302|466814329|FG003|Dose Expansion Phase|Progressive Disease|6|||
129687994|NCT03370302|466814330|FG004|Dose Expansion Phase|Progressive Disease|0|||
129687995|NCT03370302|466814331|FG005|Dose Expansion Phase|Progressive Disease|0|||
129687996|NCT01428128|466814332|FG000|Overall Study|Withdrawal by Subject|4|||
129687997|NCT01428128|466814332|FG000|Overall Study|Screen failure by p53|10|||
129687998|NCT01428128|466814332|FG000|Overall Study|Received Neulasta in one cycle|2|||
129687999|NCT01428128|466814332|FG000|Overall Study|Adverse Event|1|||
129688000|NCT00985790|466814335|FG000|Overall Study|Withdrawal by Subject|1|||
129688001|NCT00985790|466814336|FG001|Overall Study|Withdrawal by Subject|1|||
129688002|NCT00985790|466814335|FG000|Overall Study|Lost to Follow-up|6|||
129688003|NCT00985790|466814336|FG001|Overall Study|Lost to Follow-up|7|||
129688004|NCT04124965|466814340|FG000|Overall Study|Adverse event, non-fatal|3|||
129688005|NCT04124965|466814341|FG001|Overall Study|Adverse event, non-fatal|1|||
129688006|NCT04124965|466814340|FG000|Overall Study|Withdrawal by Subject|1|||
129688007|NCT04124965|466814341|FG001|Overall Study|Withdrawal by Subject|1|||
129688008|NCT04124965|466814340|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
129688009|NCT04124965|466814341|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
129688010|NCT04124965|466814340|FG000|Overall Study|Pregnancy|1|||
129688011|NCT04124965|466814341|FG001|Overall Study|Pregnancy|0|||
129688012|NCT04124965|466814340|FG000|Overall Study|Sponsor and participant decision|0|||
129688013|NCT04124965|466814341|FG001|Overall Study|Sponsor and participant decision|1|||
129688014|NCT04124965|466814340|FG000|Overall Study|Personal surgery|0|||
129688015|NCT04124965|466814341|FG001|Overall Study|Personal surgery|1|||
129688016|NCT04124965|466814340|FG000|Overall Study|Physician Decision|0|||
129688017|NCT04124965|466814341|FG001|Overall Study|Physician Decision|1|||
129688018|NCT02184156|466814342|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
129688019|NCT02184156|466814343|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
129688020|NCT02184156|466814342|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
129688021|NCT02184156|466814343|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
129688022|NCT00002874|466814344|FG000|Overall Study|Withdrawal by Subject|1|||
129688023|NCT00002874|466814345|FG001|Overall Study|Withdrawal by Subject|1|||
129688024|NCT00002874|466814344|FG000|Overall Study|Protocol Violation|44|||
129688025|NCT00002874|466814345|FG001|Overall Study|Protocol Violation|34|||
129688026|NCT01397747|466814348|FG000|Overall Study|Multitarget DNA test excluded|689|||
129688027|NCT01397747|466814348|FG000|Overall Study|Colonoscopy excluded|304|||
129563714|NCT02228382|466359707|FG001|Overall Study|Other|3|||
129563715|NCT02228382|466359708|FG002|Overall Study|Other|3|||
129563716|NCT02228382|466359709|FG003|Overall Study|Other|0|||
129688028|NCT01397747|466814348|FG000|Overall Study|FIT excluded|34|||
129688029|NCT03828383|466814349|FG000|Overall Study|Lost to Follow-up|3|||
129688030|NCT03828383|466814350|FG001|Overall Study|Lost to Follow-up|2|||
129688031|NCT03828383|466814349|FG000|Overall Study|Withdrawal by Subject|4|||
129688032|NCT03828383|466814350|FG001|Overall Study|Withdrawal by Subject|5|||
129688033|NCT00308685|466814352|FG000|Overall Study|Lost to Follow-up|1|||
129688034|NCT00308685|466814353|FG001|Overall Study|Lost to Follow-up|0|||
129563717|NCT02228382|466359710|FG004|Overall Study|Other|0|||
129563718|NCT00275002|466359712|FG000|Overall Study|Death|1|||
129563719|NCT00275002|466359713|FG001|Overall Study|Death|0|||
129563720|NCT00275002|466359712|FG000|Overall Study|Disease progression|21|||
129563721|NCT00275002|466359713|FG001|Overall Study|Disease progression|15|||
129563722|NCT00275002|466359712|FG000|Overall Study|Adverse Event|0|||
129563723|NCT00275002|466359713|FG001|Overall Study|Adverse Event|1|||
129563724|NCT00576381|466359723|FG000|Overall Study|Reoperation|3|||
129563725|NCT00576381|466359723|FG000|Overall Study|Adverse Event|4|||
129563726|NCT01031537|466359724|FG000|Overall Study|medical reasons not related to study|3|||
129563727|NCT01031537|466359724|FG000|Overall Study|Lack of Efficacy|1|||
129563728|NCT01031537|466359724|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
129563729|NCT01031537|466359724|FG000|Overall Study|moved, met exclusion criteria|10|||
129563730|NCT01031537|466359724|FG000|Overall Study|Withdrawal by Subject|5|||
129563731|NCT01031537|466359724|FG000|Overall Study|PI removal, no longer met eligibility|12|||
129688035|NCT00308685|466814352|FG000|Overall Study|Need to administer prohibited medication|1|||
129688036|NCT00308685|466814353|FG001|Overall Study|Need to administer prohibited medication|2|||
129688037|NCT00308685|466814352|FG000|Overall Study|Other than specified|1|||
129688038|NCT00308685|466814353|FG001|Overall Study|Other than specified|3|||
129688039|NCT03158311|466814356|FG000|Overall Study|Subject/Guardian Decision|10|||
129688040|NCT03158311|466814357|FG001|Overall Study|Subject/Guardian Decision|6|||
129688041|NCT03158311|466814358|FG002|Overall Study|Subject/Guardian Decision|11|||
129688042|NCT03158311|466814356|FG000|Overall Study|Adverse Event|5|||
129688043|NCT03158311|466814357|FG001|Overall Study|Adverse Event|3|||
129688044|NCT03158311|466814358|FG002|Overall Study|Adverse Event|3|||
129688045|NCT03158311|466814356|FG000|Overall Study|Techinical Problems|3|||
129688046|NCT03158311|466814357|FG001|Overall Study|Techinical Problems|1|||
129688047|NCT03158311|466814358|FG002|Overall Study|Techinical Problems|5|||
129688048|NCT03158311|466814356|FG000|Overall Study|Physician Decision|2|||
129688049|NCT03158311|466814357|FG001|Overall Study|Physician Decision|3|||
129688050|NCT03158311|466814358|FG002|Overall Study|Physician Decision|7|||
129563732|NCT00520741|466359725|FG000|Overall Study|Adverse Event|16|||
129563733|NCT00520741|466359726|FG001|Overall Study|Adverse Event|56|||
129563734|NCT00520741|466359725|FG000|Overall Study|Lack of Efficacy|11|||
129563735|NCT00520741|466359726|FG001|Overall Study|Lack of Efficacy|30|||
129563736|NCT00520741|466359725|FG000|Overall Study|Withdrawal by Subject|0|||
129563737|NCT00520741|466359726|FG001|Overall Study|Withdrawal by Subject|11|||
129563738|NCT00520741|466359725|FG000|Overall Study|Protocol Violation|2|||
129563739|NCT00520741|466359726|FG001|Overall Study|Protocol Violation|15|||
129563740|NCT00520741|466359725|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
129563741|NCT00520741|466359726|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
129563742|NCT00520741|466359725|FG000|Overall Study|Lost to Follow-up|4|||
129563743|NCT00520741|466359726|FG001|Overall Study|Lost to Follow-up|4|||
129563744|NCT00520741|466359725|FG000|Overall Study|Other reasons for premature termination|0|||
129563745|NCT00520741|466359726|FG001|Overall Study|Other reasons for premature termination|6|||
129563746|NCT02750761|466359727|FG000|Overall Study|Lost to Follow-up|0|||
129563747|NCT02750761|466359728|FG001|Overall Study|Lost to Follow-up|0|||
129688051|NCT03158311|466814356|FG000|Overall Study|Lost to Follow-up|1|||
129688052|NCT03158311|466814357|FG001|Overall Study|Lost to Follow-up|1|||
129688053|NCT03158311|466814358|FG002|Overall Study|Lost to Follow-up|1|||
129688054|NCT03158311|466814356|FG000|Overall Study|Sponsor decision|1|||
129688055|NCT03158311|466814357|FG001|Overall Study|Sponsor decision|0|||
129688056|NCT03158311|466814358|FG002|Overall Study|Sponsor decision|0|||
129688057|NCT03158311|466814356|FG000|Overall Study|Pregnancy|0|||
129688058|NCT03158311|466814357|FG001|Overall Study|Pregnancy|2|||
129688059|NCT03158311|466814358|FG002|Overall Study|Pregnancy|0|||
129688060|NCT03158311|466814356|FG000|Overall Study|Randomized in error|0|||
129688061|NCT03158311|466814357|FG001|Overall Study|Randomized in error|0|||
129688062|NCT03158311|466814358|FG002|Overall Study|Randomized in error|1|||
129688063|NCT01018953|466814359|FG000|Overall Study|Adverse Event|2|||
129688064|NCT01018953|466814359|FG000|Overall Study|Withdrawal by Subject|1|||
129688065|NCT01018953|466814359|FG000|Overall Study|Study termination by sponsor|5|||
129688066|NCT02665455|466814360|FG000|Overall Study|Withdrawal by Subject|6|||
129688067|NCT02665455|466814360|FG000|Overall Study|Lost to Follow-up|1|||
129688068|NCT02665455|466814360|FG000|Overall Study|Adverse Event|1|||
129688069|NCT02665455|466814360|FG000|Overall Study|Protocol Violation|1|||
129688070|NCT01928771|466814362|FG000|Overall Study|Adverse Event|6|||
129688071|NCT01928771|466814363|FG001|Overall Study|Adverse Event|5|||
129688072|NCT01928771|466814364|FG002|Overall Study|Adverse Event|1|||
129688073|NCT01928771|466814362|FG000|Overall Study|Death|2|||
129688074|NCT01928771|466814363|FG001|Overall Study|Death|2|||
129688075|NCT01928771|466814364|FG002|Overall Study|Death|2|||
129688076|NCT01928771|466814362|FG000|Overall Study|Lost to Follow-up|5|||
129688077|NCT01928771|466814363|FG001|Overall Study|Lost to Follow-up|6|||
129688078|NCT01928771|466814364|FG002|Overall Study|Lost to Follow-up|3|||
129688079|NCT01928771|466814362|FG000|Overall Study|Withdrawal by Subject|20|||
129688080|NCT01928771|466814363|FG001|Overall Study|Withdrawal by Subject|15|||
129688081|NCT01928771|466814364|FG002|Overall Study|Withdrawal by Subject|17|||
129688082|NCT01928771|466814362|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
129688083|NCT01928771|466814363|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129688084|NCT01928771|466814364|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
129688085|NCT01928771|466814362|FG000|Overall Study|Other Reasons|9|||
129563748|NCT02750761|466359729|FG002|Overall Study|Lost to Follow-up|1|||
129563749|NCT02750761|466359730|FG003|Overall Study|Lost to Follow-up|0|||
129688086|NCT01928771|466814363|FG001|Overall Study|Other Reasons|9|||
129688087|NCT01928771|466814364|FG002|Overall Study|Other Reasons|14|||
129688088|NCT01928771|466814362|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
129688089|NCT01928771|466814363|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
129688090|NCT01928771|466814364|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
129688091|NCT03921541|466816122|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
129563750|NCT02750761|466359731|FG004|Overall Study|Lost to Follow-up|0|||
129688092|NCT03921541|466816123|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
129688093|NCT02642679|466816124|FG000|Overall Study|Withdrawal by Subject|1|||
129563751|NCT02750761|466359732|FG005|Overall Study|Lost to Follow-up|0|||
129563752|NCT03522948|466359746|FG000|Overall Study|Lost to Follow-up|1|||
129563753|NCT01802879|466359747|FG000|Overall Study|Administrative problems|2|||
129563754|NCT01802879|466359747|FG000|Overall Study|Disease progression|6|||
129563755|NCT00698685|466359748|FG000|Overall Study|Sister withdrew as donor|1|||
129563756|NCT00698685|466359748|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
129563757|NCT02799602|466359749|FG000|Overall Study|Protocol Violation|1|||
129563758|NCT02799602|466359750|FG001|Overall Study|Protocol Violation|0|||
129563759|NCT02799602|466359749|FG000|Overall Study|Physician Decision|5|||
129563760|NCT02799602|466359750|FG001|Overall Study|Physician Decision|6|||
129563761|NCT02799602|466359749|FG000|Overall Study|Lost to Follow-up|4|||
129688094|NCT02642679|466816124|FG000|Overall Study|Physician Decision|1|||
129563762|NCT02799602|466359750|FG001|Overall Study|Lost to Follow-up|2|||
129563763|NCT02799602|466359749|FG000|Overall Study|Additional primary malignancy|11|||
129563764|NCT02799602|466359750|FG001|Overall Study|Additional primary malignancy|6|||
129563765|NCT02799602|466359749|FG000|Overall Study|Non-compliance with study drug|14|||
129563766|NCT02799602|466359750|FG001|Overall Study|Non-compliance with study drug|12|||
129563767|NCT02799602|466359749|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
129563768|NCT02799602|466359750|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
129563769|NCT02799602|466359749|FG000|Overall Study|Withdrawal by Subject|26|||
129563770|NCT02799602|466359750|FG001|Overall Study|Withdrawal by Subject|40|||
129563771|NCT02799602|466359749|FG000|Overall Study|Progressive disease - clinical progression|131|||
129563772|NCT02799602|466359750|FG001|Overall Study|Progressive disease - clinical progression|276|||
129563773|NCT02799602|466359749|FG000|Overall Study|Progressive disease - radiological progression|90|||
129563774|NCT02799602|466359750|FG001|Overall Study|Progressive disease - radiological progression|133|||
129563775|NCT02799602|466359749|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
129688095|NCT02642679|466816124|FG000|Overall Study|Physician Decision|1|||
129688096|NCT01653262|466816125|FG000|Overall Study|Lack of Efficacy|1|||
129688097|NCT01653262|466816125|FG000|Overall Study|SAE, non-fatal|1|||
129688098|NCT01653262|466816125|FG000|Overall Study|AE, non-serious non-fatal|1|||
129688099|NCT01112267|466816127|FG000|Overall Study|Adverse Event|24|||
129688100|NCT01112267|466816128|FG001|Overall Study|Adverse Event|6|||
129688101|NCT01112267|466816127|FG000|Overall Study|Withdrawal by Subject|3|||
129688102|NCT01112267|466816128|FG001|Overall Study|Withdrawal by Subject|5|||
129688103|NCT01112267|466816127|FG000|Overall Study|Protocol Violation|5|||
129688104|NCT01112267|466816128|FG001|Overall Study|Protocol Violation|3|||
129688105|NCT01112267|466816127|FG000|Overall Study|Participants not compliant|1|||
129688106|NCT01112267|466816128|FG001|Overall Study|Participants not compliant|2|||
129688107|NCT01112267|466816127|FG000|Overall Study|Participants not receive any study drug|1|||
129688108|NCT01112267|466816128|FG001|Overall Study|Participants not receive any study drug|2|||
129688109|NCT00420407|466816130|FG000|Overall Study|Lost to Follow-up|0|||
129688110|NCT00420407|466816131|FG001|Overall Study|Lost to Follow-up|3|||
129688111|NCT00420407|466816130|FG000|Overall Study|Physician Decision|2|||
129688112|NCT00420407|466816131|FG001|Overall Study|Physician Decision|1|||
129688113|NCT00420407|466816130|FG000|Overall Study|subject identified as detainee|1|||
129688114|NCT00420407|466816131|FG001|Overall Study|subject identified as detainee|0|||
129688115|NCT00420407|466816130|FG000|Overall Study|subject identified as Jehovah's witness|1|||
129688116|NCT00420407|466816131|FG001|Overall Study|subject identified as Jehovah's witness|0|||
129688117|NCT00420407|466816130|FG000|Overall Study|Withdrawal by Subject|0|||
129688118|NCT00420407|466816131|FG001|Overall Study|Withdrawal by Subject|2|||
129688119|NCT05638737|466816134|FG000|Overall Study|Withdrawal by Subject|4|||
129688120|NCT05638737|466816135|FG001|Overall Study|Withdrawal by Subject|7|||
129688121|NCT04633447|466816138|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
129688122|NCT04633447|466816139|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
129688123|NCT04633447|466816138|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
129688124|NCT04633447|466816139|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
129688125|NCT04633447|466816138|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
129688126|NCT04633447|466816139|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
129688127|NCT04633447|466816138|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
129688128|NCT04633447|466816139|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
129688129|NCT04633447|466816138|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
129688130|NCT04633447|466816139|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
129688131|NCT04633447|466816138|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
129688132|NCT04633447|466816139|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
129688133|NCT03641924|466816140|FG000|Overall Study|Withdrawal by Subject|26|||
129688134|NCT03641924|466816140|FG000|Overall Study|Lost to Follow-up|16|||
129688135|NCT03641924|466816140|FG000|Overall Study|Protocol Violation|10|||
129688136|NCT04333498|466816141|FG000|Overall Study|Lost to Follow-up|1|||
129688137|NCT04333498|466816142|FG001|Overall Study|Lost to Follow-up|0|||
129688138|NCT04333498|466816141|FG000|Overall Study|Lost to Follow-up|0|||
129688139|NCT04333498|466816142|FG001|Overall Study|Lost to Follow-up|1|||
129688140|NCT01565694|466816143|FG000|Dose-Titration Period|Adverse Event|4|||
129688141|NCT01565694|466816143|FG000|Dose-Titration Period|Protocol Violation|10|||
129688142|NCT01565694|466816143|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
129688143|NCT00134719|466816149|FG000|Primary Vaccination Phase|Adverse Event|4|||
129688144|NCT00134719|466816150|FG001|Primary Vaccination Phase|Adverse Event|0|||
129884524|NCT04779242|467536436|FG000|Overall Study|COVID-19 related reasons|2|||
129688145|NCT00134719|466816151|FG002|Primary Vaccination Phase|Adverse Event|0|||
129688146|NCT00134719|466816149|FG000|Primary Vaccination Phase|Protocol Violation|1|||
129688147|NCT00134719|466816150|FG001|Primary Vaccination Phase|Protocol Violation|0|||
129688148|NCT00134719|466816151|FG002|Primary Vaccination Phase|Protocol Violation|0|||
129563776|NCT02799602|466359750|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
129563777|NCT02799602|466359749|FG000|Overall Study|Death|9|||
129563778|NCT02799602|466359750|FG001|Overall Study|Death|5|||
129563779|NCT02799602|466359749|FG000|Overall Study|Other|287|||
129563780|NCT02799602|466359750|FG001|Overall Study|Other|118|||
129563781|NCT02799602|466359749|FG000|Overall Study|Study drug never administered|0|||
129563782|NCT02799602|466359750|FG001|Overall Study|Study drug never administered|3|||
129563783|NCT02626949|466359751|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
129563784|NCT02626949|466359752|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
129563785|NCT02626949|466359751|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
129563786|NCT02626949|466359752|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
129563787|NCT02626949|466359751|FG000|Enrolled|Lost to Follow-up|7|||
129688149|NCT00134719|466816149|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
129688150|NCT00134719|466816150|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
129688151|NCT00134719|466816151|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
129688152|NCT00134719|466816149|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
129688153|NCT00134719|466816150|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
129688154|NCT00134719|466816151|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
129688155|NCT00134719|466816149|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
129688156|NCT00134719|466816150|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
129688157|NCT00134719|466816151|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
129688158|NCT00134719|466816149|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
129688159|NCT00134719|466816150|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
129688160|NCT00134719|466816151|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
129688161|NCT00541229|466816152|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
129688162|NCT00541229|466816153|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
129688163|NCT00541229|466816154|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
129688164|NCT00541229|466816155|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
129688165|NCT00541229|466816156|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
129688166|NCT00541229|466816157|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
129688167|NCT00541229|466816152|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129688168|NCT00541229|466816153|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129688169|NCT00541229|466816154|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129688170|NCT00541229|466816155|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129688171|NCT00541229|466816156|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
129688172|NCT00541229|466816157|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
129688173|NCT00541229|466816152|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129688174|NCT00541229|466816153|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129688175|NCT00541229|466816154|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129688176|NCT00541229|466816155|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129688177|NCT00541229|466816156|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
129778299|NCT04421027|467154514|FG000|Treatment Period|Physician Decision|1|||
129778300|NCT04421027|467154515|FG001|Treatment Period|Physician Decision|1|||
129778301|NCT04421027|467154516|FG002|Treatment Period|Physician Decision|0|||
129778302|NCT04421027|467154517|FG003|Treatment Period|Physician Decision|0|||
129778303|NCT04421027|467154514|FG000|Treatment Period|Withdrawal by Subject|7|||
129778304|NCT04421027|467154515|FG001|Treatment Period|Withdrawal by Subject|12|||
129778305|NCT04421027|467154516|FG002|Treatment Period|Withdrawal by Subject|0|||
129778306|NCT04421027|467154517|FG003|Treatment Period|Withdrawal by Subject|0|||
129778307|NCT04421027|467154514|FG000|Treatment Period|Randomized Not Dosed|9|||
129778308|NCT04421027|467154515|FG001|Treatment Period|Randomized Not Dosed|14|||
129778309|NCT04421027|467154516|FG002|Treatment Period|Randomized Not Dosed|0|||
129778310|NCT04421027|467154517|FG003|Treatment Period|Randomized Not Dosed|0|||
129778311|NCT04421027|467154514|FG000|Follow-Up Period|Adverse Event|0|||
129778312|NCT04421027|467154515|FG001|Follow-Up Period|Adverse Event|0|||
129778313|NCT04421027|467154516|FG002|Follow-Up Period|Adverse Event|0|||
129778314|NCT04421027|467154517|FG003|Follow-Up Period|Adverse Event|3|||
129778315|NCT04421027|467154514|FG000|Follow-Up Period|Death|0|||
129778316|NCT04421027|467154515|FG001|Follow-Up Period|Death|0|||
129778317|NCT04421027|467154516|FG002|Follow-Up Period|Death|16|||
129778318|NCT04421027|467154517|FG003|Follow-Up Period|Death|17|||
129778319|NCT04421027|467154514|FG000|Follow-Up Period|Lost to Follow-up|0|||
129778320|NCT04421027|467154515|FG001|Follow-Up Period|Lost to Follow-up|0|||
129778321|NCT04421027|467154516|FG002|Follow-Up Period|Lost to Follow-up|7|||
129778322|NCT04421027|467154517|FG003|Follow-Up Period|Lost to Follow-up|7|||
129778323|NCT04421027|467154514|FG000|Follow-Up Period|Protocol Deviation|0|||
129778324|NCT04421027|467154515|FG001|Follow-Up Period|Protocol Deviation|0|||
129778325|NCT04421027|467154516|FG002|Follow-Up Period|Protocol Deviation|1|||
129778326|NCT04421027|467154517|FG003|Follow-Up Period|Protocol Deviation|0|||
129778327|NCT04421027|467154514|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
129778328|NCT04421027|467154515|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
129778329|NCT04421027|467154516|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
129778330|NCT04421027|467154517|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
129778331|NCT04421027|467154514|FG000|Follow-Up Period|Left message, participant did not call back|0|||
129778332|NCT04421027|467154515|FG001|Follow-Up Period|Left message, participant did not call back|0|||
129778333|NCT04421027|467154516|FG002|Follow-Up Period|Left message, participant did not call back|0|||
129778334|NCT04421027|467154517|FG003|Follow-Up Period|Left message, participant did not call back|1|||
129778335|NCT04421027|467154514|FG000|Follow-Up Period|Participant died|0|||
129778336|NCT04421027|467154515|FG001|Follow-Up Period|Participant died|0|||
129778337|NCT04421027|467154516|FG002|Follow-Up Period|Participant died|0|||
129778338|NCT04421027|467154517|FG003|Follow-Up Period|Participant died|1|||
129778339|NCT04421027|467154514|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
129778340|NCT04421027|467154515|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
129778341|NCT04421027|467154516|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
129778342|NCT04421027|467154517|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
129778343|NCT02930018|467154527|FG000|Overall Study|Lost to Follow-up|1|||
129778344|NCT02930018|467154528|FG001|Overall Study|Lost to Follow-up|1|||
129688178|NCT00541229|466816157|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
129688179|NCT00541229|466816152|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
129688180|NCT00541229|466816153|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
129688181|NCT00541229|466816154|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
129688182|NCT00541229|466816155|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
129688183|NCT00541229|466816156|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
129688184|NCT00541229|466816157|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
129688185|NCT00541229|466816152|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
129688186|NCT00541229|466816153|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
129688187|NCT00541229|466816154|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
129688188|NCT00541229|466816155|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
129688189|NCT00541229|466816156|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
129688190|NCT00541229|466816157|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
129688191|NCT00541229|466816152|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
129688192|NCT00541229|466816153|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
129688193|NCT00541229|466816154|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
129688194|NCT00541229|466816155|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
129688195|NCT00541229|466816156|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
129688196|NCT00541229|466816157|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
129778345|NCT02930018|467154527|FG000|Overall Study|Withdrawal by Subject|5|||
129778346|NCT02930018|467154528|FG001|Overall Study|Withdrawal by Subject|2|||
129778347|NCT04434937|467154532|FG000|Overall Study|Death|4|||
129778348|NCT04434937|467154532|FG000|Overall Study|Withdrawal by Subject|1|||
129778349|NCT04434937|467154532|FG000|Overall Study|Transitioned to Rollover Study|19|||
129778350|NCT04434937|467154532|FG000|Overall Study|Progressive Disease|18|||
129778351|NCT00114517|467154533|FG000|Overall Study|Adverse Event|6|||
129778352|NCT00114517|467154534|FG001|Overall Study|Adverse Event|1|||
129778353|NCT00114517|467154535|FG002|Overall Study|Adverse Event|6|||
129778354|NCT00114517|467154536|FG003|Overall Study|Adverse Event|3|||
129778355|NCT00114517|467154533|FG000|Overall Study|Lost to Follow-up|2|||
129563788|NCT02626949|466359752|FG001|Enrolled|Lost to Follow-up|6|||
129563789|NCT02626949|466359751|FG000|Enrolled|Withdrawal by Subject|3|||
129563790|NCT02626949|466359752|FG001|Enrolled|Withdrawal by Subject|2|||
129563791|NCT00329602|466359756|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
129778356|NCT00114517|467154534|FG001|Overall Study|Lost to Follow-up|2|||
129778357|NCT00114517|467154535|FG002|Overall Study|Lost to Follow-up|2|||
129778358|NCT00114517|467154536|FG003|Overall Study|Lost to Follow-up|1|||
129778359|NCT00114517|467154533|FG000|Overall Study|Too busy|3|||
129778360|NCT00114517|467154534|FG001|Overall Study|Too busy|1|||
129778361|NCT00114517|467154535|FG002|Overall Study|Too busy|1|||
129778362|NCT00114517|467154536|FG003|Overall Study|Too busy|2|||
129778363|NCT00114517|467154533|FG000|Overall Study|Moved from area|0|||
129778364|NCT00114517|467154534|FG001|Overall Study|Moved from area|3|||
129778365|NCT00114517|467154535|FG002|Overall Study|Moved from area|2|||
129778366|NCT00114517|467154536|FG003|Overall Study|Moved from area|1|||
129778367|NCT00114517|467154533|FG000|Overall Study|Did not want estradiol|1|||
129778368|NCT00114517|467154534|FG001|Overall Study|Did not want estradiol|1|||
129778369|NCT00114517|467154535|FG002|Overall Study|Did not want estradiol|0|||
129778370|NCT00114517|467154536|FG003|Overall Study|Did not want estradiol|0|||
129778371|NCT00114517|467154533|FG000|Overall Study|Armed-services duty|0|||
129778372|NCT00114517|467154534|FG001|Overall Study|Armed-services duty|1|||
129778373|NCT00114517|467154535|FG002|Overall Study|Armed-services duty|0|||
129778374|NCT00114517|467154536|FG003|Overall Study|Armed-services duty|1|||
129778375|NCT00114517|467154533|FG000|Overall Study|Competing family issue|0|||
129778376|NCT00114517|467154534|FG001|Overall Study|Competing family issue|1|||
129778377|NCT00114517|467154535|FG002|Overall Study|Competing family issue|0|||
129778378|NCT00114517|467154536|FG003|Overall Study|Competing family issue|1|||
129778379|NCT00114517|467154533|FG000|Overall Study|Physician Decision|0|||
129778380|NCT00114517|467154534|FG001|Overall Study|Physician Decision|1|||
129778381|NCT00114517|467154535|FG002|Overall Study|Physician Decision|0|||
129778382|NCT00114517|467154536|FG003|Overall Study|Physician Decision|0|||
129778383|NCT00114517|467154533|FG000|Overall Study|Lost interest|0|||
129778384|NCT00114517|467154534|FG001|Overall Study|Lost interest|0|||
129778385|NCT00114517|467154535|FG002|Overall Study|Lost interest|1|||
129778386|NCT00114517|467154536|FG003|Overall Study|Lost interest|0|||
129778387|NCT00114517|467154533|FG000|Overall Study|Weight increase|0|||
129778388|NCT00114517|467154534|FG001|Overall Study|Weight increase|0|||
129778389|NCT00114517|467154535|FG002|Overall Study|Weight increase|1|||
129778390|NCT00114517|467154536|FG003|Overall Study|Weight increase|0|||
129778391|NCT00114517|467154533|FG000|Overall Study|Concern about blood clots|0|||
129778392|NCT00114517|467154534|FG001|Overall Study|Concern about blood clots|0|||
129778393|NCT00114517|467154535|FG002|Overall Study|Concern about blood clots|1|||
129778394|NCT00114517|467154536|FG003|Overall Study|Concern about blood clots|0|||
129778395|NCT00114517|467154533|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129778396|NCT00114517|467154534|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129778397|NCT00114517|467154535|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
129778398|NCT00114517|467154536|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
129778399|NCT04695977|467154537|FG000|Overall Study|Sponsor Decision|9|||
129778400|NCT04695977|467154538|FG001|Overall Study|Sponsor Decision|4|||
129778401|NCT04695977|467154537|FG000|Overall Study|Death|2|||
129778402|NCT04695977|467154538|FG001|Overall Study|Death|5|||
129778403|NCT03474965|467154539|FG000|Overall Study|Pregnancy|1|||
129778404|NCT03474965|467154540|FG001|Overall Study|Pregnancy|0|||
129778405|NCT03474965|467154541|FG002|Overall Study|Pregnancy|0|||
129778406|NCT03474965|467154542|FG003|Overall Study|Pregnancy|0|||
129778407|NCT03474965|467154539|FG000|Overall Study|Lost to Follow-up|0|||
129778408|NCT03474965|467154540|FG001|Overall Study|Lost to Follow-up|0|||
129778409|NCT03474965|467154541|FG002|Overall Study|Lost to Follow-up|1|||
129778410|NCT03474965|467154542|FG003|Overall Study|Lost to Follow-up|0|||
129778411|NCT03474965|467154539|FG000|Overall Study|Death|1|||
129778412|NCT03474965|467154540|FG001|Overall Study|Death|0|||
129778413|NCT03474965|467154541|FG002|Overall Study|Death|0|||
129563792|NCT00329602|466359757|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
129778414|NCT03474965|467154542|FG003|Overall Study|Death|0|||
129778415|NCT03474965|467154539|FG000|Overall Study|Adverse Event|1|||
129778416|NCT03474965|467154540|FG001|Overall Study|Adverse Event|0|||
129778417|NCT03474965|467154541|FG002|Overall Study|Adverse Event|0|||
129778418|NCT03474965|467154542|FG003|Overall Study|Adverse Event|1|||
129778419|NCT03474965|467154539|FG000|Overall Study|Physician Decision|3|||
129778420|NCT03474965|467154540|FG001|Overall Study|Physician Decision|1|||
129778421|NCT03474965|467154541|FG002|Overall Study|Physician Decision|2|||
129778422|NCT03474965|467154542|FG003|Overall Study|Physician Decision|0|||
129778423|NCT03474965|467154539|FG000|Overall Study|Participant Decision|7|||
129778424|NCT03474965|467154540|FG001|Overall Study|Participant Decision|0|||
129778425|NCT03474965|467154541|FG002|Overall Study|Participant Decision|1|||
129778426|NCT03474965|467154542|FG003|Overall Study|Participant Decision|0|||
129778427|NCT03474965|467154539|FG000|Overall Study|Guardian Decision|4|||
129778428|NCT03474965|467154540|FG001|Overall Study|Guardian Decision|2|||
129563793|NCT00329602|466359758|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
129688197|NCT00541229|466816152|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
129688198|NCT00541229|466816153|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
129688199|NCT00541229|466816154|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
129688200|NCT00541229|466816155|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
129688201|NCT00541229|466816156|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
129688202|NCT00541229|466816157|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
129688203|NCT00541229|466816152|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
129688204|NCT00541229|466816153|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
129688205|NCT00541229|466816154|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
129563794|NCT00329602|466359756|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
129563795|NCT00329602|466359757|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
129563796|NCT00329602|466359758|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
129563797|NCT00329602|466359756|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
129563798|NCT00329602|466359757|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
129563799|NCT00329602|466359758|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
129563800|NCT00329602|466359756|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
129563801|NCT00329602|466359757|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
129563802|NCT00329602|466359758|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
129563803|NCT00329602|466359756|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
129563804|NCT00329602|466359757|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
129688206|NCT00541229|466816155|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
129688207|NCT00541229|466816156|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
129688208|NCT00541229|466816157|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
129688209|NCT00541229|466816152|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
129688210|NCT00541229|466816153|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
129688211|NCT00541229|466816154|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
129688212|NCT00541229|466816155|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
129688213|NCT00541229|466816156|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
129688214|NCT00541229|466816157|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
129688215|NCT00541229|466816152|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
129688216|NCT00541229|466816153|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
129688217|NCT00541229|466816154|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
129688218|NCT00541229|466816155|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
129688219|NCT00541229|466816156|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
129688220|NCT00541229|466816157|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
129688221|NCT00541229|466816152|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
129688222|NCT00541229|466816153|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
129688223|NCT00541229|466816154|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
129688224|NCT00541229|466816155|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
129688225|NCT00541229|466816156|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
129688226|NCT00541229|466816157|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
129688227|NCT00541229|466816152|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129688228|NCT00541229|466816153|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129688229|NCT00541229|466816154|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129688230|NCT00541229|466816155|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129688231|NCT00541229|466816156|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
129688232|NCT00541229|466816157|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
129688233|NCT00541229|466816152|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
129688234|NCT00541229|466816153|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
129688235|NCT00541229|466816154|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
129688236|NCT00541229|466816155|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
129688237|NCT00541229|466816156|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
129688238|NCT00541229|466816157|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
129688239|NCT00541229|466816152|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
129688240|NCT00541229|466816153|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
129688241|NCT00541229|466816154|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
129688242|NCT00541229|466816155|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
129778429|NCT03474965|467154541|FG002|Overall Study|Guardian Decision|7|||
129563805|NCT00329602|466359758|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
129563806|NCT00329602|466359756|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
129563807|NCT00329602|466359757|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
129563808|NCT00329602|466359758|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
129563809|NCT02576990|466359759|FG000|Overall Study|Death|29|||
129563810|NCT02576990|466359760|FG001|Overall Study|Death|18|||
129563811|NCT02576990|466359759|FG000|Overall Study|Physician Decision|1|||
129563812|NCT02576990|466359760|FG001|Overall Study|Physician Decision|0|||
129563813|NCT02576990|466359759|FG000|Overall Study|Screen failure|2|||
129688243|NCT00541229|466816156|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
129688244|NCT00541229|466816157|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
129688245|NCT00541229|466816152|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129688246|NCT00541229|466816153|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129688247|NCT00541229|466816154|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129688248|NCT00541229|466816155|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129688249|NCT00541229|466816156|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
129688250|NCT00541229|466816157|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
129688251|NCT00541229|466816152|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129688252|NCT00541229|466816153|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129688253|NCT00541229|466816154|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
129688254|NCT00541229|466816155|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129688255|NCT00541229|466816156|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129688256|NCT00541229|466816157|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
129688257|NCT03439839|466816158|FG000|Overall Study|Death|3|||
129688258|NCT03439839|466816159|FG001|Overall Study|Death|0|||
129688259|NCT01807520|466816162|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129688260|NCT01807520|466816163|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
129688261|NCT01807520|466816164|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
129688262|NCT01807520|466816165|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129688263|NCT01807520|466816166|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129688264|NCT01807520|466816167|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129688265|NCT01807520|466816168|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
129688266|NCT01807520|466816162|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
129688267|NCT01807520|466816163|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129688268|NCT01807520|466816164|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
129688269|NCT01807520|466816165|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129688270|NCT01807520|466816166|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129688271|NCT01807520|466816167|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129688272|NCT01807520|466816168|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
129688273|NCT01807520|466816162|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129688274|NCT01807520|466816163|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129688275|NCT01807520|466816164|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
129688276|NCT01807520|466816165|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129688277|NCT01807520|466816166|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129688278|NCT01807520|466816167|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129688279|NCT01807520|466816168|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
129688280|NCT01807520|466816162|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
129688281|NCT01807520|466816163|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129688282|NCT01807520|466816164|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129688283|NCT01807520|466816165|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129688284|NCT01807520|466816166|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129563814|NCT02576990|466359760|FG001|Overall Study|Screen failure|0|||
129563815|NCT02576990|466359759|FG000|Overall Study|Sponsor's decision|24|||
129563816|NCT02576990|466359760|FG001|Overall Study|Sponsor's decision|4|||
129563817|NCT02576990|466359759|FG000|Overall Study|Withdrawal by Subject|0|||
129563818|NCT02576990|466359760|FG001|Overall Study|Withdrawal by Subject|2|||
129563819|NCT02415959|466359761|FG000|Overall Study|Adverse Event|0|||
129563820|NCT02415959|466359762|FG001|Overall Study|Adverse Event|1|||
129563821|NCT02415959|466359763|FG002|Overall Study|Adverse Event|0|||
129563822|NCT02415959|466359764|FG003|Overall Study|Adverse Event|0|||
129563823|NCT02415959|466359765|FG004|Overall Study|Adverse Event|0|||
129563824|NCT02415959|466359761|FG000|Overall Study|Protocol Violation|0|||
129563825|NCT02415959|466359762|FG001|Overall Study|Protocol Violation|0|||
129563826|NCT02415959|466359763|FG002|Overall Study|Protocol Violation|0|||
129563827|NCT02415959|466359764|FG003|Overall Study|Protocol Violation|1|||
129563828|NCT02415959|466359765|FG004|Overall Study|Protocol Violation|0|||
129563829|NCT00911859|466359766|FG000|Treatment Period|Adverse Event|3|||
129563830|NCT00911859|466359767|FG001|Treatment Period|Adverse Event|3|||
129563831|NCT00911859|466359768|FG002|Treatment Period|Adverse Event|7|||
129563832|NCT00911859|466359766|FG000|Treatment Period|Death|1|||
129563833|NCT00911859|466359767|FG001|Treatment Period|Death|3|||
129563834|NCT00911859|466359768|FG002|Treatment Period|Death|5|||
129563835|NCT00911859|466359766|FG000|Treatment Period|Lack of Efficacy|1|||
129563836|NCT00911859|466359767|FG001|Treatment Period|Lack of Efficacy|7|||
129563837|NCT00911859|466359768|FG002|Treatment Period|Lack of Efficacy|5|||
129563838|NCT00911859|466359766|FG000|Treatment Period|Physician Decision|3|||
129563839|NCT00911859|466359767|FG001|Treatment Period|Physician Decision|3|||
129563840|NCT00911859|466359768|FG002|Treatment Period|Physician Decision|3|||
129563841|NCT00911859|466359766|FG000|Treatment Period|Withdrawal by Subject|0|||
129563842|NCT00911859|466359767|FG001|Treatment Period|Withdrawal by Subject|4|||
129563843|NCT00911859|466359768|FG002|Treatment Period|Withdrawal by Subject|5|||
129563844|NCT00911859|466359766|FG000|Treatment Period|Did not receive study treatment|0|||
129563845|NCT00911859|466359767|FG001|Treatment Period|Did not receive study treatment|1|||
129563846|NCT00911859|466359768|FG002|Treatment Period|Did not receive study treatment|0|||
129688285|NCT01807520|466816167|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129688286|NCT01807520|466816168|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
129688287|NCT01807520|466816162|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129563847|NCT00911859|466359766|FG000|Maintainance Period|Lack of Efficacy|0|||
129563848|NCT00911859|466359767|FG001|Maintainance Period|Lack of Efficacy|0|||
129688288|NCT01807520|466816163|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129688289|NCT01807520|466816164|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
129688290|NCT01807520|466816165|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129688291|NCT01807520|466816166|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129688292|NCT01807520|466816167|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129688293|NCT01807520|466816168|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
129688294|NCT01807520|466816162|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
129688295|NCT01807520|466816163|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129688296|NCT01807520|466816164|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129688297|NCT01807520|466816165|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129688298|NCT01807520|466816166|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129688299|NCT01807520|466816167|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129688300|NCT01807520|466816168|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
129688301|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
129688302|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
129688303|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129563849|NCT00911859|466359768|FG002|Maintainance Period|Lack of Efficacy|9|||
129563850|NCT00911859|466359766|FG000|Maintainance Period|Physician Decision|0|||
129563851|NCT00911859|466359767|FG001|Maintainance Period|Physician Decision|0|||
129563852|NCT00911859|466359768|FG002|Maintainance Period|Physician Decision|9|||
129563853|NCT00911859|466359766|FG000|Maintainance Period|Withdrawal by Subject|0|||
129563854|NCT00911859|466359767|FG001|Maintainance Period|Withdrawal by Subject|0|||
129563855|NCT00911859|466359768|FG002|Maintainance Period|Withdrawal by Subject|3|||
129563856|NCT00911859|466359766|FG000|Follow-up Period|Death|5|||
129563857|NCT00911859|466359767|FG001|Follow-up Period|Death|8|||
129563858|NCT00911859|466359768|FG002|Follow-up Period|Death|10|||
129778430|NCT03474965|467154542|FG003|Overall Study|Guardian Decision|2|||
129563859|NCT00911859|466359766|FG000|Follow-up Period|Lost to Follow-up|1|||
129563860|NCT00911859|466359767|FG001|Follow-up Period|Lost to Follow-up|1|||
129563861|NCT00911859|466359768|FG002|Follow-up Period|Lost to Follow-up|0|||
129563862|NCT00911859|466359766|FG000|Follow-up Period|Withdrawal by Subject|0|||
129563863|NCT00911859|466359767|FG001|Follow-up Period|Withdrawal by Subject|4|||
129778431|NCT02255435|467155618|FG000|Overall Study|Patient's Limited Time Availability|0|||
129778432|NCT02255435|467155619|FG001|Overall Study|Patient's Limited Time Availability|0|||
129778433|NCT02255435|467155620|FG002|Overall Study|Patient's Limited Time Availability|0|||
129778434|NCT02255435|467155621|FG003|Overall Study|Patient's Limited Time Availability|0|||
129778435|NCT02255435|467155622|FG004|Overall Study|Patient's Limited Time Availability|0|||
129778436|NCT02255435|467155623|FG005|Overall Study|Patient's Limited Time Availability|0|||
129778437|NCT02255435|467155624|FG006|Overall Study|Patient's Limited Time Availability|0|||
129778438|NCT02255435|467155625|FG007|Overall Study|Patient's Limited Time Availability|1|||
129778439|NCT02255435|467155626|FG008|Overall Study|Patient's Limited Time Availability|0|||
129778440|NCT02255435|467155627|FG009|Overall Study|Patient's Limited Time Availability|0|||
129778441|NCT02255435|467155618|FG000|Overall Study|Withdrawal by Subject|0|||
129778442|NCT02255435|467155619|FG001|Overall Study|Withdrawal by Subject|0|||
129778443|NCT02255435|467155620|FG002|Overall Study|Withdrawal by Subject|0|||
129778444|NCT02255435|467155621|FG003|Overall Study|Withdrawal by Subject|0|||
129778445|NCT02255435|467155622|FG004|Overall Study|Withdrawal by Subject|0|||
129778446|NCT02255435|467155623|FG005|Overall Study|Withdrawal by Subject|0|||
129778447|NCT02255435|467155624|FG006|Overall Study|Withdrawal by Subject|0|||
129778448|NCT02255435|467155625|FG007|Overall Study|Withdrawal by Subject|0|||
129778449|NCT02255435|467155626|FG008|Overall Study|Withdrawal by Subject|1|||
129778450|NCT02255435|467155627|FG009|Overall Study|Withdrawal by Subject|4|||
129778451|NCT02255435|467155618|FG000|Overall Study|Administrative reasons|0|||
129778452|NCT02255435|467155619|FG001|Overall Study|Administrative reasons|0|||
129778453|NCT02255435|467155620|FG002|Overall Study|Administrative reasons|0|||
129778454|NCT02255435|467155621|FG003|Overall Study|Administrative reasons|0|||
129778455|NCT02255435|467155622|FG004|Overall Study|Administrative reasons|0|||
129778456|NCT02255435|467155623|FG005|Overall Study|Administrative reasons|0|||
129778457|NCT02255435|467155624|FG006|Overall Study|Administrative reasons|0|||
129778458|NCT02255435|467155625|FG007|Overall Study|Administrative reasons|0|||
129778459|NCT02255435|467155626|FG008|Overall Study|Administrative reasons|0|||
129778460|NCT02255435|467155627|FG009|Overall Study|Administrative reasons|2|||
129778461|NCT03656562|467155628|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
129563864|NCT00911859|466359768|FG002|Follow-up Period|Withdrawal by Subject|4|||
129563865|NCT00911859|466359766|FG000|Follow-up Period|Study terminated by sponsor|5|||
129778462|NCT03656562|467155629|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
129778463|NCT03656562|467155630|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
129778464|NCT03656562|467155631|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
129778465|NCT03656562|467155628|FG000|Overall Study|Physician Decision|1|||
129778466|NCT03656562|467155629|FG001|Overall Study|Physician Decision|2|||
129778467|NCT03656562|467155630|FG002|Overall Study|Physician Decision|0|||
129778468|NCT03656562|467155631|FG003|Overall Study|Physician Decision|0|||
129778469|NCT03656562|467155628|FG000|Overall Study|Subject Decision|3|||
129778470|NCT03656562|467155629|FG001|Overall Study|Subject Decision|5|||
129778471|NCT03656562|467155630|FG002|Overall Study|Subject Decision|0|||
129778472|NCT03656562|467155631|FG003|Overall Study|Subject Decision|2|||
129778473|NCT04269265|467155632|FG000|Overall Study|Physician Decision|1|||
129778474|NCT04269265|467155632|FG000|Overall Study|Withdrawal by Subject|1|||
129778475|NCT04269265|467155632|FG000|Overall Study|Overenrolled (sample size reached)|4|||
129778476|NCT04838626|467155633|FG000|Overall Study|Adverse Event|2|||
129778477|NCT04838626|467155633|FG000|Overall Study|Physician Decision|6|||
129778478|NCT04838626|467155633|FG000|Overall Study|Protocol Violation|3|||
129778479|NCT04838626|467155633|FG000|Overall Study|Withdrawal by Subject|9|||
129778480|NCT04838626|467155633|FG000|Overall Study|Technical Problems|2|||
129778481|NCT02867384|467155634|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
129778482|NCT02867384|467155635|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
129778483|NCT02867384|467155636|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
129778484|NCT02867384|467155634|FG000|Overall Study|Progression/ Relapse|15|||
129778485|NCT02867384|467155635|FG001|Overall Study|Progression/ Relapse|19|||
129778486|NCT02867384|467155636|FG002|Overall Study|Progression/ Relapse|0|||
129778487|NCT02867384|467155634|FG000|Overall Study|Adverse Event|13|||
129778488|NCT02867384|467155635|FG001|Overall Study|Adverse Event|1|||
129778489|NCT02867384|467155636|FG002|Overall Study|Adverse Event|0|||
129778490|NCT02867384|467155634|FG000|Overall Study|Withdrawal by Subject|6|||
129778491|NCT02867384|467155635|FG001|Overall Study|Withdrawal by Subject|5|||
129778492|NCT02867384|467155636|FG002|Overall Study|Withdrawal by Subject|0|||
129778493|NCT02867384|467155634|FG000|Overall Study|Physician Decision|1|||
129778494|NCT02867384|467155635|FG001|Overall Study|Physician Decision|2|||
129778495|NCT02867384|467155636|FG002|Overall Study|Physician Decision|0|||
129778496|NCT02867384|467155634|FG000|Overall Study|Patient compliance|1|||
129778497|NCT02867384|467155635|FG001|Overall Study|Patient compliance|0|||
129778498|NCT02867384|467155636|FG002|Overall Study|Patient compliance|0|||
129778499|NCT02867384|467155634|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
129778500|NCT02867384|467155635|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
129778501|NCT02867384|467155636|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
129778502|NCT02867384|467155634|FG000|Overall Study|Never start treatment|3|||
129778503|NCT02867384|467155635|FG001|Overall Study|Never start treatment|0|||
129778504|NCT02867384|467155636|FG002|Overall Study|Never start treatment|0|||
129778505|NCT03901469|467155640|FG000|Overall Study|Radiographic Progression|4|||
129778506|NCT03901469|467155641|FG001|Overall Study|Radiographic Progression|6|||
129778507|NCT03901469|467155642|FG002|Overall Study|Radiographic Progression|3|||
129778508|NCT03901469|467155643|FG003|Overall Study|Radiographic Progression|30|||
129778509|NCT03901469|467155644|FG004|Overall Study|Radiographic Progression|7|||
129778510|NCT03901469|467155645|FG005|Overall Study|Radiographic Progression|2|||
129778511|NCT03901469|467155646|FG006|Overall Study|Radiographic Progression|11|||
129778512|NCT03901469|467155640|FG000|Overall Study|Clinical Progression|0|||
129563866|NCT00911859|466359767|FG001|Follow-up Period|Study terminated by sponsor|33|||
129563867|NCT00911859|466359768|FG002|Follow-up Period|Study terminated by sponsor|27|||
129563868|NCT01048333|466359769|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129563869|NCT01048333|466359770|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
129563870|NCT01048333|466359771|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129778513|NCT03901469|467155641|FG001|Overall Study|Clinical Progression|2|||
129778514|NCT03901469|467155642|FG002|Overall Study|Clinical Progression|0|||
129778515|NCT03901469|467155643|FG003|Overall Study|Clinical Progression|7|||
129778516|NCT03901469|467155644|FG004|Overall Study|Clinical Progression|6|||
129778517|NCT03901469|467155645|FG005|Overall Study|Clinical Progression|0|||
129778518|NCT03901469|467155646|FG006|Overall Study|Clinical Progression|2|||
129563871|NCT01048333|466359772|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129778519|NCT03901469|467155640|FG000|Overall Study|Adverse Event|1|||
129778520|NCT03901469|467155641|FG001|Overall Study|Adverse Event|0|||
129778521|NCT03901469|467155642|FG002|Overall Study|Adverse Event|0|||
129778522|NCT03901469|467155643|FG003|Overall Study|Adverse Event|0|||
129778523|NCT03901469|467155644|FG004|Overall Study|Adverse Event|0|||
129778524|NCT03901469|467155645|FG005|Overall Study|Adverse Event|0|||
129778525|NCT03901469|467155646|FG006|Overall Study|Adverse Event|9|||
129778526|NCT03901469|467155640|FG000|Overall Study|Physician Decision|0|||
129778527|NCT03901469|467155641|FG001|Overall Study|Physician Decision|0|||
129778528|NCT03901469|467155642|FG002|Overall Study|Physician Decision|0|||
129778529|NCT03901469|467155643|FG003|Overall Study|Physician Decision|1|||
129778530|NCT03901469|467155644|FG004|Overall Study|Physician Decision|0|||
129778531|NCT03901469|467155645|FG005|Overall Study|Physician Decision|0|||
129563872|NCT01048333|466359773|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129563873|NCT01048333|466359774|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
129563874|NCT00634179|466359782|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
129688304|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129688305|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
129688306|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129688307|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
129688308|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129688309|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129688310|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129688311|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
129688312|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129688313|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129688314|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
129688315|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
129688316|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129688317|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129688318|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129563875|NCT00767325|466359785|FG000|Overall Study|Lack of Efficacy|2|||
129688319|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129688320|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129688321|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
129778532|NCT03901469|467155646|FG006|Overall Study|Physician Decision|0|||
129778533|NCT03901469|467155640|FG000|Overall Study|Withdrawal by Subject|0|||
129778534|NCT03901469|467155641|FG001|Overall Study|Withdrawal by Subject|0|||
129778535|NCT03901469|467155642|FG002|Overall Study|Withdrawal by Subject|0|||
129778536|NCT03901469|467155643|FG003|Overall Study|Withdrawal by Subject|0|||
129778537|NCT03901469|467155644|FG004|Overall Study|Withdrawal by Subject|2|||
129778538|NCT03901469|467155645|FG005|Overall Study|Withdrawal by Subject|0|||
129778539|NCT03901469|467155646|FG006|Overall Study|Withdrawal by Subject|8|||
129778540|NCT03901469|467155640|FG000|Overall Study|Death|0|||
129778541|NCT03901469|467155641|FG001|Overall Study|Death|0|||
129778542|NCT03901469|467155642|FG002|Overall Study|Death|0|||
129778543|NCT03901469|467155643|FG003|Overall Study|Death|3|||
129778544|NCT03901469|467155644|FG004|Overall Study|Death|5|||
129778545|NCT03901469|467155645|FG005|Overall Study|Death|0|||
129778546|NCT03901469|467155646|FG006|Overall Study|Death|1|||
129778547|NCT03901469|467155640|FG000|Overall Study|Termination of study by sponsor|0|||
129778548|NCT03901469|467155641|FG001|Overall Study|Termination of study by sponsor|0|||
129778549|NCT03901469|467155642|FG002|Overall Study|Termination of study by sponsor|0|||
129778550|NCT03901469|467155643|FG003|Overall Study|Termination of study by sponsor|0|||
129778551|NCT03901469|467155644|FG004|Overall Study|Termination of study by sponsor|1|||
129778552|NCT03901469|467155645|FG005|Overall Study|Termination of study by sponsor|1|||
129778553|NCT03901469|467155646|FG006|Overall Study|Termination of study by sponsor|0|||
129778554|NCT03901469|467155640|FG000|Overall Study|Not Reported|1|||
129778555|NCT03901469|467155641|FG001|Overall Study|Not Reported|0|||
129778556|NCT03901469|467155642|FG002|Overall Study|Not Reported|0|||
129778557|NCT03901469|467155643|FG003|Overall Study|Not Reported|1|||
129778558|NCT03901469|467155644|FG004|Overall Study|Not Reported|0|||
129778559|NCT03901469|467155645|FG005|Overall Study|Not Reported|0|||
129778560|NCT03901469|467155646|FG006|Overall Study|Not Reported|1|||
129778561|NCT03738228|467155650|FG000|Overall Study|Never received study treatment|2|||
129778562|NCT03738228|467155651|FG001|Overall Study|Never received study treatment|2|||
129778563|NCT04896073|467155652|FG000|Overall Study|Screen failure|0|||
129778564|NCT04896073|467155653|FG001|Overall Study|Screen failure|2|||
129778565|NCT04896073|467155652|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
129778566|NCT04896073|467155653|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
129688322|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129688323|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
129688324|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129688325|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129688326|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129688327|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129688328|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
129688329|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
129688330|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129688331|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129688332|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
129688333|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129688334|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129688335|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
129688336|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
129688337|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
129688338|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129688339|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129688340|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
129688341|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129688342|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
129778567|NCT01385176|467155654|FG000|Randomization Phase|Death|1|||
129778568|NCT01385176|467155655|FG001|Randomization Phase|Death|2|||
129778569|NCT01385176|467155654|FG000|6-18 Month All VNS Active|Death|1|||
129778570|NCT01385176|467155655|FG001|6-18 Month All VNS Active|Death|2|||
129778571|NCT01385176|467155654|FG000|6-18 Month All VNS Active|Physician Decision|0|||
129778572|NCT01385176|467155655|FG001|6-18 Month All VNS Active|Physician Decision|1|||
129778573|NCT01385176|467155654|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
129563876|NCT00767325|466359785|FG000|Overall Study|Adverse Event|7|||
129563877|NCT00767325|466359785|FG000|Overall Study|Lost to Follow-up|3|||
129563878|NCT00767325|466359785|FG000|Overall Study|No longer met study criteria|2|||
129563879|NCT00767325|466359785|FG000|Overall Study|Missed visit due to family reasons|1|||
129563880|NCT03538756|466359786|FG000|Long-Term Follow-up|Adverse Event|0|||
129563881|NCT03538756|466359787|FG001|Long-Term Follow-up|Adverse Event|0|||
129563882|NCT03538756|466359788|FG002|Long-Term Follow-up|Adverse Event|6|||
129563883|NCT03538756|466359786|FG000|Long-Term Follow-up|Death|0|||
129563884|NCT03538756|466359787|FG001|Long-Term Follow-up|Death|0|||
129563885|NCT03538756|466359788|FG002|Long-Term Follow-up|Death|1|||
129563886|NCT03538756|466359786|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
129563887|NCT03538756|466359787|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
129563888|NCT03538756|466359788|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
129563889|NCT03538756|466359786|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
129563890|NCT03538756|466359787|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
129563891|NCT03538756|466359788|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
129688343|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
129688344|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
129688345|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129688346|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
129688347|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129688348|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129688349|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
129688350|NCT01807520|466816162|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
129688351|NCT01807520|466816163|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
129688352|NCT01807520|466816164|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
129688353|NCT01807520|466816165|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
129688354|NCT01807520|466816166|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
129688355|NCT01807520|466816167|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
129688356|NCT01807520|466816168|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
129688357|NCT01807520|466816162|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129688358|NCT01807520|466816163|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129688359|NCT01807520|466816164|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129688360|NCT01807520|466816165|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129688361|NCT01807520|466816166|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129688362|NCT01807520|466816167|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
129688363|NCT01807520|466816168|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
129688364|NCT01807520|466816162|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129688365|NCT01807520|466816163|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129688366|NCT01807520|466816164|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129688367|NCT01807520|466816165|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129688368|NCT01807520|466816166|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129688369|NCT01807520|466816167|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
129688370|NCT01807520|466816168|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
129563892|NCT03538756|466359786|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
129563893|NCT03538756|466359787|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
129563894|NCT03538756|466359788|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
129563895|NCT00752856|466359789|FG000|Overall Study|randomized but did not do viral kinetics|0|||
129563896|NCT00752856|466359790|FG001|Overall Study|randomized but did not do viral kinetics|1|||
129563897|NCT03131999|466359791|FG000|Overall Study|Withdrawal by Subject|0|||
129688371|NCT01807520|466816162|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129688372|NCT01807520|466816163|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129688373|NCT01807520|466816164|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129688374|NCT01807520|466816165|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129778574|NCT01385176|467155655|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
129778575|NCT01385176|467155654|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
129778576|NCT01385176|467155655|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
129778577|NCT02306161|467155656|FG000|Overall Study|Death|1|||
129778578|NCT02306161|467155657|FG001|Overall Study|Death|3|||
129778579|NCT02306161|467155656|FG000|Overall Study|Lack of Efficacy|20|||
129778580|NCT02306161|467155657|FG001|Overall Study|Lack of Efficacy|43|||
129778581|NCT02306161|467155656|FG000|Overall Study|Physician Decision|30|||
129778582|NCT02306161|467155657|FG001|Overall Study|Physician Decision|18|||
129778583|NCT02306161|467155656|FG000|Overall Study|Withdrawal by Subject|4|||
129778584|NCT02306161|467155657|FG001|Overall Study|Withdrawal by Subject|0|||
129778585|NCT02306161|467155656|FG000|Overall Study|Ineligible|9|||
129778586|NCT02306161|467155657|FG001|Overall Study|Ineligible|5|||
129778587|NCT04995419|467155658|FG000|Overall Study|Withdrawal by Subject|3|||
129778588|NCT04995419|467155658|FG000|Overall Study|Progressive Disease|19|||
129778589|NCT04995419|467155658|FG000|Overall Study|Adverse Event|2|||
129778590|NCT04995419|467155658|FG000|Overall Study|Ongoing|16|||
129778591|NCT03306173|467155659|FG000|Overall Study|Lost to Follow-up|16|||
129778592|NCT03306173|467155660|FG001|Overall Study|Lost to Follow-up|23|||
129778593|NCT03306173|467155659|FG000|Overall Study|Withdrawal by Subject|4|||
129778594|NCT03306173|467155660|FG001|Overall Study|Withdrawal by Subject|3|||
129778595|NCT03306173|467155659|FG000|Overall Study|Discontinued|4|||
129778596|NCT03306173|467155660|FG001|Overall Study|Discontinued|4|||
129778597|NCT04758637|467155661|FG000|Overall Study|Lost to Follow-up|0|||
129778598|NCT04758637|467155662|FG001|Overall Study|Lost to Follow-up|1|||
129778599|NCT04758637|467155663|FG002|Overall Study|Lost to Follow-up|0|||
129778600|NCT04758637|467155664|FG003|Overall Study|Lost to Follow-up|0|||
129778601|NCT05064358|467155670|FG000|Overall Study|Death|23|||
129778602|NCT05064358|467155671|FG001|Overall Study|Death|23|||
129778603|NCT05064358|467155672|FG002|Overall Study|Death|25|||
129778604|NCT05064358|467155673|FG003|Overall Study|Death|21|||
129778605|NCT05064358|467155674|FG004|Overall Study|Death|5|||
129778606|NCT05064358|467155670|FG000|Overall Study|Lost to Follow-up|1|||
129778607|NCT05064358|467155671|FG001|Overall Study|Lost to Follow-up|2|||
129778608|NCT05064358|467155672|FG002|Overall Study|Lost to Follow-up|0|||
129778609|NCT05064358|467155673|FG003|Overall Study|Lost to Follow-up|2|||
129688375|NCT01807520|466816166|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
129688376|NCT01807520|466816167|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
129688377|NCT01807520|466816168|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
129688378|NCT01797185|466816172|FG000|Overall Study|Adverse Event|5|||
129688379|NCT01797185|466816173|FG001|Overall Study|Adverse Event|15|||
129688380|NCT01797185|466816174|FG002|Overall Study|Adverse Event|6|||
129688381|NCT01797185|466816172|FG000|Overall Study|Withdrawal by Subject|6|||
129688382|NCT01797185|466816173|FG001|Overall Study|Withdrawal by Subject|9|||
129688383|NCT01797185|466816174|FG002|Overall Study|Withdrawal by Subject|5|||
129688384|NCT01797185|466816172|FG000|Overall Study|Site terminated|8|||
129688385|NCT01797185|466816173|FG001|Overall Study|Site terminated|4|||
129778610|NCT05064358|467155674|FG004|Overall Study|Lost to Follow-up|0|||
129778611|NCT05064358|467155670|FG000|Overall Study|Physician Decision|1|||
129778612|NCT05064358|467155671|FG001|Overall Study|Physician Decision|1|||
129778613|NCT05064358|467155672|FG002|Overall Study|Physician Decision|2|||
129778614|NCT05064358|467155673|FG003|Overall Study|Physician Decision|0|||
129778615|NCT05064358|467155674|FG004|Overall Study|Physician Decision|0|||
129778616|NCT05064358|467155670|FG000|Overall Study|Withdrawal by Subject|4|||
129778617|NCT05064358|467155671|FG001|Overall Study|Withdrawal by Subject|5|||
129778618|NCT05064358|467155672|FG002|Overall Study|Withdrawal by Subject|3|||
129563898|NCT03131999|466359792|FG001|Overall Study|Withdrawal by Subject|1|||
129563899|NCT00996736|466359798|FG000|Overall Study|Death|1|||
129563900|NCT00996736|466359799|FG001|Overall Study|Death|1|||
129563901|NCT00996736|466359798|FG000|Overall Study|Lost to Follow-up|15|||
129563902|NCT00996736|466359799|FG001|Overall Study|Lost to Follow-up|14|||
129563903|NCT00996736|466359798|FG000|Overall Study|Visit not within 3-month window|5|||
129563904|NCT00996736|466359799|FG001|Overall Study|Visit not within 3-month window|3|||
129563905|NCT02688608|466359800|FG000|Overall Study|Lost to Follow-up|1|||
129563906|NCT02456909|466359801|FG000|Overall Study|Did not receive allocated intervention|24|||
129563907|NCT02456909|466359802|FG001|Overall Study|Did not receive allocated intervention|26|||
129688386|NCT01797185|466816174|FG002|Overall Study|Site terminated|0|||
129688387|NCT01797185|466816172|FG000|Overall Study|Lost to Follow-up|2|||
129688388|NCT01797185|466816173|FG001|Overall Study|Lost to Follow-up|6|||
129688389|NCT01797185|466816174|FG002|Overall Study|Lost to Follow-up|1|||
129688390|NCT01797185|466816172|FG000|Overall Study|Withdrawn per sponsor|5|||
129688391|NCT01797185|466816173|FG001|Overall Study|Withdrawn per sponsor|0|||
129688392|NCT01797185|466816174|FG002|Overall Study|Withdrawn per sponsor|0|||
129688393|NCT01797185|466816172|FG000|Overall Study|Physician Decision|1|||
129688394|NCT01797185|466816173|FG001|Overall Study|Physician Decision|3|||
129688395|NCT01797185|466816174|FG002|Overall Study|Physician Decision|0|||
129688396|NCT01797185|466816172|FG000|Overall Study|Protocol Violation|1|||
129688397|NCT01797185|466816173|FG001|Overall Study|Protocol Violation|1|||
129688398|NCT01797185|466816174|FG002|Overall Study|Protocol Violation|0|||
129688399|NCT00723944|466816175|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
129688400|NCT00723944|466816176|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
129688401|NCT00723944|466816175|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
129688402|NCT00723944|466816176|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
129688403|NCT00723944|466816175|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
129688404|NCT00723944|466816176|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
129688405|NCT05177094|466816177|FG000|Overall Study|Adverse Event|5|||
129688406|NCT05177094|466816178|FG001|Overall Study|Adverse Event|5|||
129688407|NCT05177094|466816177|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
129688408|NCT05177094|466816178|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
129688409|NCT05177094|466816177|FG000|Overall Study|Protocol Deviation|3|||
129688410|NCT05177094|466816178|FG001|Overall Study|Protocol Deviation|0|||
129688411|NCT05177094|466816177|FG000|Overall Study|Withdrawal by Subject|6|||
129688412|NCT05177094|466816178|FG001|Overall Study|Withdrawal by Subject|3|||
129688413|NCT05177094|466816177|FG000|Overall Study|Participant could not tolerate long study visits|1|||
129688414|NCT05177094|466816178|FG001|Overall Study|Participant could not tolerate long study visits|0|||
129563908|NCT02456909|466359801|FG000|Overall Study|Did not complete the primary outcome|0|||
129563909|NCT02456909|466359802|FG001|Overall Study|Did not complete the primary outcome|1|||
129688415|NCT02400736|466816179|FG000|Overall Study|Lost to Follow-up|6|||
129778619|NCT05064358|467155673|FG003|Overall Study|Withdrawal by Subject|6|||
129778620|NCT05064358|467155674|FG004|Overall Study|Withdrawal by Subject|3|||
129688416|NCT02400736|466816180|FG001|Overall Study|Lost to Follow-up|6|||
129688417|NCT02400736|466816179|FG000|Overall Study|Withdrawal by Subject|2|||
129688418|NCT02400736|466816180|FG001|Overall Study|Withdrawal by Subject|1|||
129688419|NCT02400736|466816179|FG000|Overall Study|Moved from the area|3|||
129688420|NCT02400736|466816180|FG001|Overall Study|Moved from the area|1|||
129688421|NCT03520569|466816181|FG000|Overall Study|Withdrawal by Subject|1|||
129688422|NCT03418675|466816182|FG000|Overall Study|Lost to Follow-up|13|||
129688423|NCT03418675|466816183|FG001|Overall Study|Lost to Follow-up|10|||
129688424|NCT03418675|466816182|FG000|Overall Study|Adverse Event|2|||
129688425|NCT03418675|466816183|FG001|Overall Study|Adverse Event|0|||
129778621|NCT05064358|467155670|FG000|Overall Study|Ongoing at the time of analysis|1|||
129778622|NCT05064358|467155671|FG001|Overall Study|Ongoing at the time of analysis|2|||
129778623|NCT05064358|467155672|FG002|Overall Study|Ongoing at the time of analysis|2|||
129778624|NCT05064358|467155673|FG003|Overall Study|Ongoing at the time of analysis|2|||
129778625|NCT05064358|467155674|FG004|Overall Study|Ongoing at the time of analysis|2|||
129778626|NCT04976192|467155675|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778627|NCT04976192|467155676|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
129778628|NCT04976192|467155677|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778629|NCT04976192|467155678|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778630|NCT04976192|467155679|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778631|NCT04976192|467155680|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778632|NCT04976192|467155681|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778633|NCT04976192|467155682|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778634|NCT04976192|467155683|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778635|NCT04976192|467155684|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
129778636|NCT04976192|467155675|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
129778637|NCT04976192|467155676|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
129778638|NCT04976192|467155677|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
129778639|NCT04976192|467155678|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129778640|NCT04976192|467155679|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129688426|NCT01178411|466816184|FG000|Overall Study|Adverse Event|5|||
129688427|NCT01178411|466816184|FG000|Overall Study|Withdrawal by Subject|4|||
129688428|NCT01178411|466816184|FG000|Overall Study|Protocol Violation|1|||
129688429|NCT01178411|466816184|FG000|Overall Study|Progressive disease per RECIST|32|||
129688430|NCT01178411|466816184|FG000|Overall Study|Progressive disease per clinician|9|||
129688431|NCT01178411|466816184|FG000|Overall Study|Physician Decision|6|||
129778641|NCT04976192|467155680|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778642|NCT04976192|467155681|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778643|NCT04976192|467155682|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778644|NCT04976192|467155683|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778645|NCT04976192|467155684|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778646|NCT04976192|467155675|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
129778647|NCT04976192|467155676|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778648|NCT04976192|467155677|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
129778649|NCT04976192|467155678|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129688432|NCT01178411|466816184|FG000|Overall Study|Death|1|||
129688433|NCT01178411|466816184|FG000|Overall Study|No reason provided|1|||
129688434|NCT01178411|466816184|FG000|Overall Study|Drug manufacturing ended|1|||
129688435|NCT01875237|466816185|FG000|Overall Study|GVDH before DLI|1|||
129688436|NCT01875237|466816186|FG001|Overall Study|GVDH before DLI|0|||
129688437|NCT01875237|466816185|FG000|Overall Study|DLI cells could not be produced|1|||
129778650|NCT04976192|467155679|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778651|NCT04976192|467155680|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778652|NCT04976192|467155681|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778653|NCT04976192|467155682|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778654|NCT04976192|467155683|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778655|NCT04976192|467155684|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
129778656|NCT04976192|467155675|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778657|NCT04976192|467155676|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778658|NCT04976192|467155677|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778659|NCT04976192|467155678|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129778660|NCT04976192|467155679|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
129778661|NCT04976192|467155680|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
129778662|NCT04976192|467155681|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129778663|NCT04976192|467155682|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129778664|NCT04976192|467155683|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
129778665|NCT04976192|467155684|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
129778666|NCT04976192|467155675|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778667|NCT04976192|467155676|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778668|NCT04976192|467155677|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778669|NCT04976192|467155678|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778670|NCT04976192|467155679|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
129778671|NCT04976192|467155680|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778672|NCT04976192|467155681|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778673|NCT04976192|467155682|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778674|NCT04976192|467155683|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778675|NCT04976192|467155684|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
129778676|NCT04976192|467155675|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778677|NCT04976192|467155676|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778678|NCT04976192|467155677|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778679|NCT04976192|467155678|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778680|NCT04976192|467155679|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778681|NCT04976192|467155680|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129778682|NCT04976192|467155681|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778683|NCT04976192|467155682|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778684|NCT04976192|467155683|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778685|NCT04976192|467155684|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129778686|NCT02621151|467155685|FG000|Overall Study|Not eligible for trial|6|||
129778687|NCT04073225|467155686|FG000|Overall Study|Lost to Follow-up|4|||
129778688|NCT04073225|467155687|FG001|Overall Study|Lost to Follow-up|3|||
129778689|NCT02253316|467155697|FG000|Consolidation|Progression|4|||
129778690|NCT02253316|467155698|FG001|Consolidation|Progression|0|||
129778691|NCT02253316|467155699|FG002|Consolidation|Progression|0|||
129778692|NCT02253316|467155697|FG000|Consolidation|Non-Compliance|1|||
129778693|NCT02253316|467155698|FG001|Consolidation|Non-Compliance|0|||
129778694|NCT02253316|467155699|FG002|Consolidation|Non-Compliance|0|||
129778695|NCT02253316|467155697|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
129778696|NCT02253316|467155698|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
129778697|NCT02253316|467155699|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
129778698|NCT02253316|467155697|FG000|Consolidation|Secondary Malignancy|2|||
129778699|NCT02253316|467155698|FG001|Consolidation|Secondary Malignancy|0|||
129778700|NCT02253316|467155699|FG002|Consolidation|Secondary Malignancy|0|||
129778701|NCT02253316|467155697|FG000|Consolidation|Adverse Event|7|||
129778702|NCT02253316|467155698|FG001|Consolidation|Adverse Event|0|||
129778703|NCT02253316|467155699|FG002|Consolidation|Adverse Event|0|||
129778704|NCT02253316|467155697|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
129778705|NCT02253316|467155698|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
129778706|NCT02253316|467155699|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
129778707|NCT02253316|467155697|FG000|Maintenance|Physician Decision|0|||
129778708|NCT02253316|467155698|FG001|Maintenance|Physician Decision|7|||
129778709|NCT02253316|467155699|FG002|Maintenance|Physician Decision|16|||
129778710|NCT02253316|467155697|FG000|Maintenance|Non-Compliance|0|||
129778711|NCT02253316|467155698|FG001|Maintenance|Non-Compliance|1|||
129778712|NCT02253316|467155699|FG002|Maintenance|Non-Compliance|1|||
129778713|NCT02253316|467155697|FG000|Maintenance|Secondary Malignancy|0|||
129778714|NCT02253316|467155698|FG001|Maintenance|Secondary Malignancy|2|||
129778715|NCT02253316|467155699|FG002|Maintenance|Secondary Malignancy|6|||
129778716|NCT02253316|467155697|FG000|Maintenance|Adverse Event|0|||
129778717|NCT02253316|467155698|FG001|Maintenance|Adverse Event|8|||
129563910|NCT01497938|466359805|FG000|Overall Study|Adverse Event|0|||
129563911|NCT01497938|466359806|FG001|Overall Study|Adverse Event|1|||
129563912|NCT01497938|466359805|FG000|Overall Study|Physician Decision|0|||
129688438|NCT01875237|466816186|FG001|Overall Study|DLI cells could not be produced|0|||
129688439|NCT03558672|466816187|FG000|Overall Study|Study Early Termination|10|||
129688440|NCT00421733|466816189|FG000|Overall Study|Adverse Event|4|||
129688441|NCT00421733|466816190|FG001|Overall Study|Adverse Event|9|||
129688442|NCT00421733|466816191|FG002|Overall Study|Adverse Event|2|||
129688443|NCT00421733|466816189|FG000|Overall Study|Lost to Follow-up|1|||
129688444|NCT00421733|466816190|FG001|Overall Study|Lost to Follow-up|2|||
129688445|NCT00421733|466816191|FG002|Overall Study|Lost to Follow-up|4|||
129688446|NCT00421733|466816189|FG000|Overall Study|Withdrawal by Subject|1|||
129688447|NCT00421733|466816190|FG001|Overall Study|Withdrawal by Subject|2|||
129688448|NCT00421733|466816191|FG002|Overall Study|Withdrawal by Subject|7|||
129688449|NCT00421733|466816189|FG000|Overall Study|Death|0|||
129688450|NCT00421733|466816190|FG001|Overall Study|Death|3|||
129688451|NCT00421733|466816191|FG002|Overall Study|Death|0|||
129688452|NCT00421733|466816189|FG000|Overall Study|Required dialysis|1|||
129688453|NCT00421733|466816190|FG001|Overall Study|Required dialysis|0|||
129688454|NCT00421733|466816191|FG002|Overall Study|Required dialysis|0|||
129688455|NCT00421733|466816189|FG000|Overall Study|Administrative|2|||
129688456|NCT00421733|466816190|FG001|Overall Study|Administrative|0|||
129688457|NCT00421733|466816191|FG002|Overall Study|Administrative|0|||
129688458|NCT00421733|466816189|FG000|Overall Study|Did not satisfy entry criteria|1|||
129688459|NCT00421733|466816190|FG001|Overall Study|Did not satisfy entry criteria|3|||
129688460|NCT00421733|466816191|FG002|Overall Study|Did not satisfy entry criteria|2|||
129688461|NCT00421733|466816189|FG000|Overall Study|Sponsor request|1|||
129688462|NCT00421733|466816190|FG001|Overall Study|Sponsor request|0|||
129688463|NCT00421733|466816191|FG002|Overall Study|Sponsor request|3|||
129688464|NCT00421733|466816189|FG000|Overall Study|Protocol deviation|4|||
129688465|NCT00421733|466816190|FG001|Overall Study|Protocol deviation|7|||
129688466|NCT00421733|466816191|FG002|Overall Study|Protocol deviation|2|||
129688467|NCT02265744|466816196|FG000|Overall Study|Poor/Non-compliance|1|||
129688468|NCT02265744|466816197|FG001|Overall Study|Poor/Non-compliance|1|||
129688469|NCT02265744|466816198|FG002|Overall Study|Poor/Non-compliance|0|||
129688470|NCT02265744|466816199|FG003|Overall Study|Poor/Non-compliance|0|||
129688471|NCT02265744|466816200|FG004|Overall Study|Poor/Non-compliance|2|||
129688472|NCT02265744|466816196|FG000|Overall Study|Lost to Follow-up|0|||
129688473|NCT02265744|466816197|FG001|Overall Study|Lost to Follow-up|0|||
129688474|NCT02265744|466816198|FG002|Overall Study|Lost to Follow-up|0|||
129688475|NCT02265744|466816199|FG003|Overall Study|Lost to Follow-up|1|||
129688476|NCT02265744|466816200|FG004|Overall Study|Lost to Follow-up|0|||
129688477|NCT02265744|466816196|FG000|Overall Study|Death|0|||
129688478|NCT02265744|466816197|FG001|Overall Study|Death|0|||
129688479|NCT02265744|466816198|FG002|Overall Study|Death|0|||
129688480|NCT02265744|466816199|FG003|Overall Study|Death|2|||
129688481|NCT02265744|466816200|FG004|Overall Study|Death|0|||
129688482|NCT02265744|466816196|FG000|Overall Study|Withdrawal by Subject|2|||
129688483|NCT02265744|466816197|FG001|Overall Study|Withdrawal by Subject|0|||
129688484|NCT02265744|466816198|FG002|Overall Study|Withdrawal by Subject|0|||
129688485|NCT02265744|466816199|FG003|Overall Study|Withdrawal by Subject|2|||
129688486|NCT02265744|466816200|FG004|Overall Study|Withdrawal by Subject|0|||
129688487|NCT02265744|466816196|FG000|Overall Study|Participant request to discontinue|2|||
129688488|NCT02265744|466816197|FG001|Overall Study|Participant request to discontinue|2|||
129688489|NCT02265744|466816198|FG002|Overall Study|Participant request to discontinue|2|||
129688490|NCT02265744|466816199|FG003|Overall Study|Participant request to discontinue|0|||
129688491|NCT02265744|466816200|FG004|Overall Study|Participant request to discontinue|0|||
129688492|NCT02265744|466816196|FG000|Overall Study|Adverse Event|8|||
129688493|NCT02265744|466816197|FG001|Overall Study|Adverse Event|4|||
129563913|NCT01497938|466359806|FG001|Overall Study|Physician Decision|1|||
129688494|NCT02265744|466816198|FG002|Overall Study|Adverse Event|9|||
129688495|NCT02265744|466816199|FG003|Overall Study|Adverse Event|8|||
129688496|NCT02265744|466816200|FG004|Overall Study|Adverse Event|2|||
129688497|NCT02265744|466816196|FG000|Overall Study|Lack of Efficacy|2|||
129688498|NCT02265744|466816197|FG001|Overall Study|Lack of Efficacy|4|||
129688499|NCT02265744|466816198|FG002|Overall Study|Lack of Efficacy|3|||
129688500|NCT02265744|466816199|FG003|Overall Study|Lack of Efficacy|4|||
129688501|NCT02265744|466816200|FG004|Overall Study|Lack of Efficacy|5|||
129688502|NCT02265744|466816196|FG000|Overall Study|Reason not provided by Investigator|1|||
129688503|NCT02265744|466816197|FG001|Overall Study|Reason not provided by Investigator|0|||
129688504|NCT02265744|466816198|FG002|Overall Study|Reason not provided by Investigator|0|||
129563914|NCT01497938|466359805|FG000|Overall Study|Withdrawal by Subject|4|||
129778718|NCT02253316|467155699|FG002|Maintenance|Adverse Event|12|||
129778719|NCT02253316|467155697|FG000|Maintenance|Still receiving active treatment|0|||
129778720|NCT02253316|467155698|FG001|Maintenance|Still receiving active treatment|4|||
129778721|NCT02253316|467155699|FG002|Maintenance|Still receiving active treatment|0|||
129778722|NCT00124306|467155703|FG000|Overall Study|Adverse Event|7|||
129778723|NCT00124306|467155704|FG001|Overall Study|Adverse Event|2|||
129778724|NCT00124306|467155703|FG000|Overall Study|Lost to Follow-up|10|||
129778725|NCT00124306|467155704|FG001|Overall Study|Lost to Follow-up|6|||
129778726|NCT00124306|467155703|FG000|Overall Study|Lack of Efficacy|3|||
129778727|NCT00124306|467155704|FG001|Overall Study|Lack of Efficacy|6|||
129778728|NCT00124306|467155703|FG000|Overall Study|Personal constraints|0|||
129778729|NCT00124306|467155704|FG001|Overall Study|Personal constraints|2|||
129778730|NCT00124306|467155703|FG000|Overall Study|Use of unacceptable medication|1|||
129778731|NCT00124306|467155704|FG001|Overall Study|Use of unacceptable medication|0|||
129563915|NCT01497938|466359806|FG001|Overall Study|Withdrawal by Subject|0|||
129563916|NCT01497938|466359805|FG000|Overall Study|Device Violation|1|||
129563917|NCT01497938|466359806|FG001|Overall Study|Device Violation|0|||
129778732|NCT00124306|467155703|FG000|Overall Study|Abnormal lab result|0|||
129778733|NCT00124306|467155704|FG001|Overall Study|Abnormal lab result|1|||
129778734|NCT00124306|467155703|FG000|Overall Study|Other|2|||
129778735|NCT00124306|467155704|FG001|Overall Study|Other|0|||
129778736|NCT02112916|467155705|FG000|Overall Study|Adverse Event|6|||
129778737|NCT02112916|467155706|FG001|Overall Study|Adverse Event|9|||
129778738|NCT02112916|467155707|FG002|Overall Study|Adverse Event|3|||
129778739|NCT02112916|467155708|FG003|Overall Study|Adverse Event|2|||
129778740|NCT02112916|467155705|FG000|Overall Study|Death|9|||
129778741|NCT02112916|467155706|FG001|Overall Study|Death|9|||
129778742|NCT02112916|467155707|FG002|Overall Study|Death|3|||
129778743|NCT02112916|467155708|FG003|Overall Study|Death|4|||
129778744|NCT02112916|467155705|FG000|Overall Study|Lost to Follow-up|1|||
129778745|NCT02112916|467155706|FG001|Overall Study|Lost to Follow-up|0|||
129778746|NCT02112916|467155707|FG002|Overall Study|Lost to Follow-up|0|||
129778747|NCT02112916|467155708|FG003|Overall Study|Lost to Follow-up|0|||
129778748|NCT02112916|467155705|FG000|Overall Study|Physician Decision|94|||
129778749|NCT02112916|467155706|FG001|Overall Study|Physician Decision|72|||
129778750|NCT02112916|467155707|FG002|Overall Study|Physician Decision|24|||
129778751|NCT02112916|467155708|FG003|Overall Study|Physician Decision|15|||
129778752|NCT02112916|467155705|FG000|Overall Study|Withdrawal by Subject|5|||
129778753|NCT02112916|467155706|FG001|Overall Study|Withdrawal by Subject|3|||
129778754|NCT02112916|467155707|FG002|Overall Study|Withdrawal by Subject|1|||
129778755|NCT02112916|467155708|FG003|Overall Study|Withdrawal by Subject|1|||
129778756|NCT02112916|467155705|FG000|Overall Study|Ineligible|4|||
129778757|NCT02112916|467155706|FG001|Overall Study|Ineligible|8|||
129778758|NCT02112916|467155707|FG002|Overall Study|Ineligible|3|||
129778759|NCT02112916|467155708|FG003|Overall Study|Ineligible|8|||
129778760|NCT02112916|467155705|FG000|Overall Study|Inevaluable|6|||
129778761|NCT02112916|467155706|FG001|Overall Study|Inevaluable|4|||
129778762|NCT02112916|467155707|FG002|Overall Study|Inevaluable|5|||
129778763|NCT02112916|467155708|FG003|Overall Study|Inevaluable|5|||
129778764|NCT02112916|467155705|FG000|Overall Study|Refusal of further protocol therapy|19|||
129778765|NCT02112916|467155706|FG001|Overall Study|Refusal of further protocol therapy|16|||
129778766|NCT02112916|467155707|FG002|Overall Study|Refusal of further protocol therapy|1|||
129778767|NCT02112916|467155708|FG003|Overall Study|Refusal of further protocol therapy|7|||
129778768|NCT02112916|467155705|FG000|Overall Study|Development of SMN|1|||
129778769|NCT02112916|467155706|FG001|Overall Study|Development of SMN|0|||
129778770|NCT02112916|467155707|FG002|Overall Study|Development of SMN|0|||
129778771|NCT02112916|467155708|FG003|Overall Study|Development of SMN|1|||
129778772|NCT02112916|467155705|FG000|Overall Study|Relapse/Progression|10|||
129778773|NCT02112916|467155706|FG001|Overall Study|Relapse/Progression|18|||
129778774|NCT02112916|467155707|FG002|Overall Study|Relapse/Progression|15|||
129778775|NCT02112916|467155708|FG003|Overall Study|Relapse/Progression|2|||
129778776|NCT02112916|467155705|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
129778777|NCT02112916|467155706|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
129778778|NCT02112916|467155707|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
129778779|NCT02112916|467155708|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
129778780|NCT02112916|467155705|FG000|Overall Study|Still on Therapy|44|||
129778781|NCT02112916|467155706|FG001|Overall Study|Still on Therapy|47|||
129778782|NCT02112916|467155707|FG002|Overall Study|Still on Therapy|3|||
129778783|NCT02112916|467155708|FG003|Overall Study|Still on Therapy|2|||
129778784|NCT02112916|467155705|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
129778785|NCT02112916|467155706|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
129778786|NCT02112916|467155707|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
129778787|NCT02112916|467155708|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
129778788|NCT02112916|467155705|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
129778789|NCT02112916|467155706|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
129778790|NCT02112916|467155707|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
129778791|NCT02112916|467155708|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
129778792|NCT04238819|467155709|FG000|Overall Study|Ongoing Treatment|0|||
129778793|NCT04238819|467155710|FG001|Overall Study|Ongoing Treatment|0|||
129778794|NCT04238819|467155711|FG002|Overall Study|Ongoing Treatment|0|||
129778795|NCT04238819|467155712|FG003|Overall Study|Ongoing Treatment|0|||
129778796|NCT04238819|467155713|FG004|Overall Study|Ongoing Treatment|1|||
129778797|NCT04238819|467155714|FG005|Overall Study|Ongoing Treatment|4|||
129778798|NCT04238819|467155715|FG006|Overall Study|Ongoing Treatment|0|||
129778799|NCT04238819|467155709|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
129778800|NCT04238819|467155710|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
129778801|NCT04238819|467155711|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
129778802|NCT04238819|467155712|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
129778803|NCT04238819|467155713|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
129778804|NCT04238819|467155714|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
129778805|NCT04238819|467155715|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
129778806|NCT03892967|467155716|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
129778807|NCT03892967|467155717|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
129778808|NCT03892967|467155718|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
129778809|NCT03892967|467155719|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
129778810|NCT03892967|467155720|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
129778811|NCT03892967|467155716|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
129778812|NCT03892967|467155717|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
129778813|NCT03892967|467155718|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
129778814|NCT03892967|467155719|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
129778815|NCT03892967|467155720|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
129778816|NCT03892967|467155716|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
129778817|NCT03892967|467155717|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
129778818|NCT03892967|467155718|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
129778819|NCT03892967|467155719|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
129778820|NCT03892967|467155720|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
129778821|NCT03892967|467155716|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
129778822|NCT03892967|467155717|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
129778823|NCT03892967|467155718|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
129778824|NCT03892967|467155719|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
129778825|NCT03892967|467155720|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
129778826|NCT03892967|467155716|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
129778827|NCT03892967|467155717|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
129778828|NCT03892967|467155718|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
129778829|NCT03892967|467155719|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
129778830|NCT03892967|467155720|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
129778831|NCT03892967|467155716|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
129778832|NCT03892967|467155717|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
129778833|NCT03892967|467155718|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
129778834|NCT03892967|467155719|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
129778835|NCT03892967|467155720|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
129778836|NCT03568461|467155721|FG000|Overall Study|Death|7|||
129778837|NCT03568461|467155721|FG000|Overall Study|Physician Decision|5|||
129778838|NCT03568461|467155721|FG000|Overall Study|Subject decision|5|||
129778839|NCT03568461|467155721|FG000|Overall Study|Lost to Follow-up|1|||
129778840|NCT05109234|467155722|FG000|Overall Study|Adverse Event|2|||
129778841|NCT05109234|467155723|FG001|Overall Study|Adverse Event|2|||
129778842|NCT05109234|467155722|FG000|Overall Study|Lack of Efficacy|5|||
129778843|NCT05109234|467155723|FG001|Overall Study|Lack of Efficacy|0|||
129778844|NCT05109234|467155722|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
129778845|NCT05109234|467155723|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
129778846|NCT05109234|467155722|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
129778847|NCT05109234|467155723|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
129778848|NCT05109234|467155722|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
129778849|NCT05109234|467155723|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
129778850|NCT05109234|467155722|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
129778851|NCT05109234|467155723|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
129778852|NCT02355184|467155724|FG000|Overall Study|Lost to Follow-up|2|||
129778853|NCT02355184|467155724|FG000|Overall Study|Study Terminated|10|||
129778854|NCT00539864|467156352|FG000|Overall Study|Lost to Follow-up|0|||
129778855|NCT00539864|467156353|FG001|Overall Study|Lost to Follow-up|1|||
129778856|NCT00539864|467156352|FG000|Overall Study|Withdrawal by Subject|1|||
129778857|NCT00539864|467156353|FG001|Overall Study|Withdrawal by Subject|1|||
129778858|NCT00943072|467156356|FG000|Overall Study|Adverse Event|0|||
129778859|NCT00943072|467156357|FG001|Overall Study|Adverse Event|3|||
129778860|NCT00943072|467156356|FG000|Overall Study|Death|0|||
129778861|NCT00943072|467156357|FG001|Overall Study|Death|2|||
129778862|NCT00943072|467156356|FG000|Overall Study|Withdrawal by Subject|3|||
129688505|NCT02265744|466816199|FG003|Overall Study|Reason not provided by Investigator|2|||
129688506|NCT02265744|466816200|FG004|Overall Study|Reason not provided by Investigator|0|||
129688507|NCT02265744|466816196|FG000|Overall Study|Administrative reason by sponsor|3|||
129688508|NCT02265744|466816197|FG001|Overall Study|Administrative reason by sponsor|2|||
129688509|NCT02265744|466816198|FG002|Overall Study|Administrative reason by sponsor|2|||
129688510|NCT02265744|466816199|FG003|Overall Study|Administrative reason by sponsor|3|||
129688511|NCT02265744|466816200|FG004|Overall Study|Administrative reason by sponsor|3|||
129688512|NCT02265744|466816196|FG000|Overall Study|Subject no longer meets study criteria|0|||
129688513|NCT02265744|466816197|FG001|Overall Study|Subject no longer meets study criteria|0|||
129778863|NCT00943072|467156357|FG001|Overall Study|Withdrawal by Subject|1|||
129778864|NCT00943072|467156356|FG000|Overall Study|Protocol Violation|0|||
129778865|NCT00943072|467156357|FG001|Overall Study|Protocol Violation|1|||
129688514|NCT02265744|466816198|FG002|Overall Study|Subject no longer meets study criteria|0|||
129688515|NCT02265744|466816199|FG003|Overall Study|Subject no longer meets study criteria|0|||
129688516|NCT02265744|466816200|FG004|Overall Study|Subject no longer meets study criteria|1|||
129688517|NCT02265744|466816196|FG000|Overall Study|Pregnancy|1|||
129688518|NCT02265744|466816197|FG001|Overall Study|Pregnancy|2|||
129688519|NCT02265744|466816198|FG002|Overall Study|Pregnancy|1|||
129688520|NCT02265744|466816199|FG003|Overall Study|Pregnancy|1|||
129688521|NCT02265744|466816200|FG004|Overall Study|Pregnancy|0|||
129688522|NCT05161936|466816203|FG000|Overall Study|Study terminated by Sponsor|1|||
129688523|NCT05161936|466816204|FG001|Overall Study|Study terminated by Sponsor|0|||
129688524|NCT05161936|466816205|FG002|Overall Study|Study terminated by Sponsor|0|||
129688525|NCT05161936|466816203|FG000|Overall Study|Withdrawal by Subject|0|||
129688526|NCT05161936|466816204|FG001|Overall Study|Withdrawal by Subject|0|||
129688527|NCT05161936|466816205|FG002|Overall Study|Withdrawal by Subject|1|||
129688528|NCT02384460|466816210|FG000|Overall Study|Protocol Violation|0|||
129688529|NCT02384460|466816211|FG001|Overall Study|Protocol Violation|1|||
129688530|NCT02384460|466816210|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
129688531|NCT02384460|466816211|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
129688532|NCT02384460|466816210|FG000|Overall Study|Adverse Event|5|||
129688533|NCT02384460|466816211|FG001|Overall Study|Adverse Event|2|||
129688534|NCT02384460|466816210|FG000|Overall Study|Withdrawal by Subject|0|||
129688535|NCT02384460|466816211|FG001|Overall Study|Withdrawal by Subject|3|||
129688536|NCT02384460|466816210|FG000|Overall Study|Elective medical treatment|1|||
129688537|NCT02384460|466816211|FG001|Overall Study|Elective medical treatment|0|||
129688538|NCT02384460|466816210|FG000|Overall Study|Non-compliance|1|||
129688539|NCT02384460|466816211|FG001|Overall Study|Non-compliance|0|||
129688540|NCT01060111|466816212|FG000|Overall Study|Adverse Event|9|||
129688541|NCT01060111|466816213|FG001|Overall Study|Adverse Event|5|||
129688542|NCT01060111|466816214|FG002|Overall Study|Adverse Event|18|||
129688543|NCT01060111|466816212|FG000|Overall Study|Lack of Efficacy|2|||
129688544|NCT01060111|466816213|FG001|Overall Study|Lack of Efficacy|1|||
129688545|NCT01060111|466816214|FG002|Overall Study|Lack of Efficacy|0|||
129688546|NCT01060111|466816212|FG000|Overall Study|Inappropriate participant|5|||
129688547|NCT01060111|466816213|FG001|Overall Study|Inappropriate participant|4|||
129688548|NCT01060111|466816214|FG002|Overall Study|Inappropriate participant|5|||
129688549|NCT01060111|466816212|FG000|Overall Study|Participants' evasion for hospital visit|0|||
129688550|NCT01060111|466816213|FG001|Overall Study|Participants' evasion for hospital visit|3|||
129688551|NCT01060111|466816214|FG002|Overall Study|Participants' evasion for hospital visit|2|||
129688552|NCT01060111|466816212|FG000|Overall Study|Participants' non-cooperation|8|||
129688553|NCT01060111|466816213|FG001|Overall Study|Participants' non-cooperation|6|||
129688554|NCT01060111|466816214|FG002|Overall Study|Participants' non-cooperation|6|||
129688555|NCT01060111|466816212|FG000|Overall Study|Adverse event and insufficient effect|0|||
129688556|NCT01060111|466816213|FG001|Overall Study|Adverse event and insufficient effect|1|||
129688557|NCT01060111|466816214|FG002|Overall Study|Adverse event and insufficient effect|0|||
129688558|NCT01060111|466816212|FG000|Overall Study|Participants' non-cooperation|1|||
129688559|NCT01060111|466816213|FG001|Overall Study|Participants' non-cooperation|0|||
129688560|NCT01060111|466816214|FG002|Overall Study|Participants' non-cooperation|0|||
129688561|NCT01060111|466816212|FG000|Overall Study|Other|2|||
129688562|NCT01060111|466816213|FG001|Overall Study|Other|3|||
129688563|NCT01060111|466816214|FG002|Overall Study|Other|4|||
129688564|NCT04999020|466816217|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
129688565|NCT04999020|466816218|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
129688566|NCT04999020|466816219|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
129688567|NCT04999020|466816220|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
129688568|NCT04999020|466816217|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
129688569|NCT04999020|466816218|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
129688570|NCT04999020|466816219|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
129688571|NCT04999020|466816220|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
129688572|NCT04999020|466816217|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
129688573|NCT04999020|466816218|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
129688574|NCT04999020|466816219|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
129688575|NCT04999020|466816220|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
129688576|NCT04999020|466816217|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129688577|NCT04999020|466816218|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129688578|NCT04999020|466816219|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
129778866|NCT00943072|467156356|FG000|Overall Study|Lost to Follow-up|1|||
129563918|NCT00365352|466359807|FG000|Overall Study|Adverse Event|6|||
129563919|NCT00365352|466359808|FG001|Overall Study|Adverse Event|7|||
129563920|NCT00365352|466359809|FG002|Overall Study|Adverse Event|8|||
129563921|NCT00365352|466359807|FG000|Overall Study|Participant Withdrew Consent|8|||
129563922|NCT00365352|466359808|FG001|Overall Study|Participant Withdrew Consent|3|||
129563923|NCT00365352|466359809|FG002|Overall Study|Participant Withdrew Consent|4|||
129563924|NCT00365352|466359807|FG000|Overall Study|Lack of Efficacy|3|||
129563925|NCT00365352|466359808|FG001|Overall Study|Lack of Efficacy|0|||
129778867|NCT00943072|467156357|FG001|Overall Study|Lost to Follow-up|2|||
129778868|NCT00943072|467156356|FG000|Overall Study|Lack of Efficacy|0|||
129778869|NCT00943072|467156357|FG001|Overall Study|Lack of Efficacy|4|||
129778870|NCT00943072|467156356|FG000|Overall Study|Other|1|||
129778871|NCT00943072|467156357|FG001|Overall Study|Other|1|||
129778872|NCT03887702|467156360|FG000|Overall Study|Study terminated|0|||
129778873|NCT03887702|467156361|FG001|Overall Study|Study terminated|0|||
129778874|NCT03887702|467156362|FG002|Overall Study|Study terminated|2|||
129778875|NCT03887702|467156363|FG003|Overall Study|Study terminated|2|||
129778876|NCT01088048|467156369|FG000|Overall Study|Adverse Event|7|||
129778877|NCT01088048|467156370|FG001|Overall Study|Adverse Event|9|||
129778878|NCT01088048|467156371|FG002|Overall Study|Adverse Event|7|||
129778879|NCT01088048|467156372|FG003|Overall Study|Adverse Event|5|||
129778880|NCT01088048|467156373|FG004|Overall Study|Adverse Event|6|||
129778881|NCT01088048|467156374|FG005|Overall Study|Adverse Event|3|||
129778882|NCT01088048|467156375|FG006|Overall Study|Adverse Event|3|||
129778883|NCT01088048|467156376|FG007|Overall Study|Adverse Event|0|||
129778884|NCT01088048|467156377|FG008|Overall Study|Adverse Event|2|||
129778885|NCT01088048|467156378|FG009|Overall Study|Adverse Event|2|||
129778886|NCT01088048|467156369|FG000|Overall Study|Withdrew Consent|1|||
129778887|NCT01088048|467156370|FG001|Overall Study|Withdrew Consent|1|||
129778888|NCT01088048|467156371|FG002|Overall Study|Withdrew Consent|1|||
129778889|NCT01088048|467156372|FG003|Overall Study|Withdrew Consent|1|||
129778890|NCT01088048|467156373|FG004|Overall Study|Withdrew Consent|2|||
129778891|NCT01088048|467156374|FG005|Overall Study|Withdrew Consent|1|||
129778892|NCT01088048|467156375|FG006|Overall Study|Withdrew Consent|0|||
129778893|NCT01088048|467156376|FG007|Overall Study|Withdrew Consent|2|||
129778894|NCT01088048|467156377|FG008|Overall Study|Withdrew Consent|2|||
129778895|NCT01088048|467156378|FG009|Overall Study|Withdrew Consent|1|||
129778896|NCT01088048|467156369|FG000|Overall Study|Concomitant Medication Prohibited|1|||
129778897|NCT01088048|467156370|FG001|Overall Study|Concomitant Medication Prohibited|0|||
129778898|NCT01088048|467156371|FG002|Overall Study|Concomitant Medication Prohibited|0|||
129778899|NCT01088048|467156372|FG003|Overall Study|Concomitant Medication Prohibited|0|||
129778900|NCT01088048|467156373|FG004|Overall Study|Concomitant Medication Prohibited|0|||
129778901|NCT01088048|467156374|FG005|Overall Study|Concomitant Medication Prohibited|0|||
129778902|NCT01088048|467156375|FG006|Overall Study|Concomitant Medication Prohibited|0|||
129778903|NCT01088048|467156376|FG007|Overall Study|Concomitant Medication Prohibited|0|||
129778904|NCT01088048|467156377|FG008|Overall Study|Concomitant Medication Prohibited|0|||
129778905|NCT01088048|467156378|FG009|Overall Study|Concomitant Medication Prohibited|0|||
129778906|NCT01088048|467156369|FG000|Overall Study|Investigator Request|2|||
129778907|NCT01088048|467156370|FG001|Overall Study|Investigator Request|2|||
129778908|NCT01088048|467156371|FG002|Overall Study|Investigator Request|0|||
129778909|NCT01088048|467156372|FG003|Overall Study|Investigator Request|0|||
129778910|NCT01088048|467156373|FG004|Overall Study|Investigator Request|3|||
129778911|NCT01088048|467156374|FG005|Overall Study|Investigator Request|1|||
129778912|NCT01088048|467156375|FG006|Overall Study|Investigator Request|1|||
129778913|NCT01088048|467156376|FG007|Overall Study|Investigator Request|0|||
129563926|NCT00365352|466359809|FG002|Overall Study|Lack of Efficacy|0|||
129563927|NCT00365352|466359807|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
129563928|NCT00365352|466359808|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
129563929|NCT00365352|466359809|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
129778914|NCT01088048|467156377|FG008|Overall Study|Investigator Request|0|||
129778915|NCT01088048|467156378|FG009|Overall Study|Investigator Request|0|||
129778916|NCT01088048|467156369|FG000|Overall Study|Patient Non-compliance|0|||
129778917|NCT01088048|467156370|FG001|Overall Study|Patient Non-compliance|1|||
129778918|NCT01088048|467156371|FG002|Overall Study|Patient Non-compliance|0|||
129563930|NCT00365352|466359807|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
129778919|NCT01088048|467156372|FG003|Overall Study|Patient Non-compliance|0|||
129778920|NCT01088048|467156373|FG004|Overall Study|Patient Non-compliance|0|||
129778921|NCT01088048|467156374|FG005|Overall Study|Patient Non-compliance|0|||
129778922|NCT01088048|467156375|FG006|Overall Study|Patient Non-compliance|0|||
129778923|NCT01088048|467156376|FG007|Overall Study|Patient Non-compliance|0|||
129778924|NCT01088048|467156377|FG008|Overall Study|Patient Non-compliance|0|||
129778925|NCT01088048|467156378|FG009|Overall Study|Patient Non-compliance|0|||
129688579|NCT04999020|466816220|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
129688580|NCT04999020|466816217|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
129688581|NCT04999020|466816218|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
129688582|NCT04999020|466816219|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
129688583|NCT04999020|466816220|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
129688584|NCT04999020|466816217|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
129688585|NCT04999020|466816218|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
129688586|NCT04999020|466816219|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
129688587|NCT04999020|466816220|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
129688588|NCT04999020|466816217|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
129688589|NCT04999020|466816218|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
129688590|NCT04999020|466816219|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
129688591|NCT04999020|466816220|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
129688592|NCT04999020|466816217|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
129688593|NCT04999020|466816218|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
129688594|NCT04999020|466816219|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
129688595|NCT04999020|466816220|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
129688596|NCT02448043|466816221|FG000|Overall Study|Withdrawal by Subject|2|||
129688597|NCT02448043|466816222|FG001|Overall Study|Withdrawal by Subject|2|||
129688598|NCT02448043|466816221|FG000|Overall Study|Protocol Violation|1|||
129688599|NCT02448043|466816222|FG001|Overall Study|Protocol Violation|2|||
129688600|NCT00997126|466816223|FG000|Overall Study|Physician Decision|7|||
129688601|NCT00997126|466816224|FG001|Overall Study|Physician Decision|11|||
129688602|NCT02583477|466816229|FG000|Overall Study|Adverse Event|0|||
129688603|NCT02583477|466816230|FG001|Overall Study|Adverse Event|2|||
129688604|NCT02583477|466816229|FG000|Overall Study|Death|1|||
129688605|NCT02583477|466816230|FG001|Overall Study|Death|16|||
129688606|NCT02583477|466816229|FG000|Overall Study|Study terminated|2|||
129688607|NCT02583477|466816230|FG001|Overall Study|Study terminated|2|||
129688608|NCT01327703|466816233|FG000|Second Treatment Period|Adverse Event|1|||
129688609|NCT01327703|466816234|FG001|Second Treatment Period|Adverse Event|1|||
129688610|NCT01327703|466816233|FG000|Second Treatment Period|Protocol Violation|0|||
129688611|NCT01327703|466816234|FG001|Second Treatment Period|Protocol Violation|1|||
129688612|NCT01131585|466816235|FG000|Overall Study|Adverse Event|0|||
129688613|NCT01131585|466816236|FG001|Overall Study|Adverse Event|2|||
129688614|NCT01131585|466816235|FG000|Overall Study|Abnormal laboratory value|1|||
129688615|NCT01131585|466816236|FG001|Overall Study|Abnormal laboratory value|0|||
129688616|NCT01131585|466816235|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129688617|NCT01131585|466816236|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129688618|NCT01131585|466816235|FG000|Overall Study|Protocol Violation|2|||
129688619|NCT01131585|466816236|FG001|Overall Study|Protocol Violation|1|||
129688620|NCT01131585|466816235|FG000|Overall Study|Withdrawal by Subject|3|||
129688621|NCT01131585|466816236|FG001|Overall Study|Withdrawal by Subject|3|||
129688622|NCT01131585|466816235|FG000|Overall Study|Lost to Follow-up|0|||
129688623|NCT01131585|466816236|FG001|Overall Study|Lost to Follow-up|1|||
129688624|NCT01131585|466816235|FG000|Overall Study|Administrative problems|1|||
129884525|NCT04779242|467536437|FG001|Overall Study|COVID-19 related reasons|1|||
129884526|NCT04779242|467536436|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
129884527|NCT04779242|467536437|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
129884528|NCT04779242|467536436|FG000|Overall Study|Martial Law in Ukraine|2|||
129884529|NCT04779242|467536437|FG001|Overall Study|Martial Law in Ukraine|3|||
129884530|NCT01680458|467536441|FG000|Overall Study|Protocol Violation|3|||
129884531|NCT03012061|467536450|FG000|Overall Study|Withdrawal by Subject|1|||
129884532|NCT03012061|467536451|FG001|Overall Study|Withdrawal by Subject|5|||
129884533|NCT03012061|467536452|FG002|Overall Study|Withdrawal by Subject|4|||
129884534|NCT03012061|467536450|FG000|Overall Study|Investigator Site Closed|1|||
129884535|NCT03012061|467536451|FG001|Overall Study|Investigator Site Closed|2|||
129884536|NCT03012061|467536452|FG002|Overall Study|Investigator Site Closed|0|||
129884537|NCT03012061|467536450|FG000|Overall Study|Lost to Follow-up|2|||
129884538|NCT03012061|467536451|FG001|Overall Study|Lost to Follow-up|1|||
129884539|NCT03012061|467536452|FG002|Overall Study|Lost to Follow-up|0|||
129884540|NCT03012061|467536450|FG000|Overall Study|Study closed/ Terminated|0|||
129884541|NCT03012061|467536451|FG001|Overall Study|Study closed/ Terminated|0|||
129884542|NCT03012061|467536452|FG002|Overall Study|Study closed/ Terminated|1|||
129884543|NCT03012061|467536450|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
129884544|NCT03012061|467536451|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
129884545|NCT03012061|467536452|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
129884546|NCT03012061|467536450|FG000|Overall Study|Protocol Violation|0|||
129884547|NCT03012061|467536451|FG001|Overall Study|Protocol Violation|0|||
129884548|NCT03012061|467536452|FG002|Overall Study|Protocol Violation|2|||
129884549|NCT03012061|467536450|FG000|Overall Study|Lack of Efficacy|0|||
129563931|NCT00365352|466359808|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
129778926|NCT01088048|467156369|FG000|Overall Study|Disease Progression|7|||
129778927|NCT01088048|467156370|FG001|Overall Study|Disease Progression|4|||
129778928|NCT01088048|467156371|FG002|Overall Study|Disease Progression|3|||
129778929|NCT01088048|467156372|FG003|Overall Study|Disease Progression|5|||
129778930|NCT01088048|467156373|FG004|Overall Study|Disease Progression|3|||
129778931|NCT01088048|467156374|FG005|Overall Study|Disease Progression|3|||
129778932|NCT01088048|467156375|FG006|Overall Study|Disease Progression|2|||
129778933|NCT01088048|467156376|FG007|Overall Study|Disease Progression|1|||
129778934|NCT01088048|467156377|FG008|Overall Study|Disease Progression|0|||
129778935|NCT01088048|467156378|FG009|Overall Study|Disease Progression|0|||
129778936|NCT01088048|467156369|FG000|Overall Study|Death|1|||
129778937|NCT01088048|467156370|FG001|Overall Study|Death|5|||
129778938|NCT01088048|467156371|FG002|Overall Study|Death|3|||
129778939|NCT01088048|467156372|FG003|Overall Study|Death|3|||
129778940|NCT01088048|467156373|FG004|Overall Study|Death|1|||
129778941|NCT01088048|467156374|FG005|Overall Study|Death|3|||
129778942|NCT01088048|467156375|FG006|Overall Study|Death|0|||
129778943|NCT01088048|467156376|FG007|Overall Study|Death|0|||
129778944|NCT01088048|467156377|FG008|Overall Study|Death|3|||
129778945|NCT01088048|467156378|FG009|Overall Study|Death|1|||
129778946|NCT01088048|467156369|FG000|Overall Study|Other|3|||
129563932|NCT00365352|466359809|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
129778947|NCT01088048|467156370|FG001|Overall Study|Other|5|||
129778948|NCT01088048|467156371|FG002|Overall Study|Other|0|||
129778949|NCT01088048|467156372|FG003|Overall Study|Other|0|||
129778950|NCT01088048|467156373|FG004|Overall Study|Other|2|||
129778951|NCT01088048|467156374|FG005|Overall Study|Other|0|||
129778952|NCT01088048|467156375|FG006|Overall Study|Other|0|||
129778953|NCT01088048|467156376|FG007|Overall Study|Other|2|||
129563933|NCT00365352|466359807|FG000|Overall Study|Lost to Follow-up|1|||
129563934|NCT00365352|466359808|FG001|Overall Study|Lost to Follow-up|1|||
129563935|NCT00365352|466359809|FG002|Overall Study|Lost to Follow-up|0|||
129563936|NCT00365352|466359807|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
129563937|NCT00365352|466359808|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
129563938|NCT00365352|466359809|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
129563939|NCT00409578|466359814|FG000|Overall Study|Adverse Event|27|||
129563940|NCT00409578|466359815|FG001|Overall Study|Adverse Event|37|||
129563941|NCT00409578|466359816|FG002|Overall Study|Adverse Event|25|||
129563942|NCT00409578|466359817|FG003|Overall Study|Adverse Event|33|||
129563943|NCT00409578|466359814|FG000|Overall Study|Abnormal laboratory value(s)|2|||
129563944|NCT00409578|466359815|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129563945|NCT00409578|466359816|FG002|Overall Study|Abnormal laboratory value(s)|2|||
129563946|NCT00409578|466359817|FG003|Overall Study|Abnormal laboratory value(s)|4|||
129563947|NCT00409578|466359814|FG000|Overall Study|Lack of Efficacy|0|||
129563948|NCT00409578|466359815|FG001|Overall Study|Lack of Efficacy|0|||
129563949|NCT00409578|466359816|FG002|Overall Study|Lack of Efficacy|0|||
129563950|NCT00409578|466359817|FG003|Overall Study|Lack of Efficacy|2|||
129563951|NCT00409578|466359814|FG000|Overall Study|Subject no longer requires study drug|0|||
129563952|NCT00409578|466359815|FG001|Overall Study|Subject no longer requires study drug|0|||
129563953|NCT00409578|466359816|FG002|Overall Study|Subject no longer requires study drug|0|||
129563954|NCT00409578|466359817|FG003|Overall Study|Subject no longer requires study drug|1|||
129563955|NCT00409578|466359814|FG000|Overall Study|Withdrawal by Subject|8|||
129563956|NCT00409578|466359815|FG001|Overall Study|Withdrawal by Subject|15|||
129563957|NCT00409578|466359816|FG002|Overall Study|Withdrawal by Subject|16|||
129563958|NCT00409578|466359817|FG003|Overall Study|Withdrawal by Subject|17|||
129563959|NCT00409578|466359814|FG000|Overall Study|Lost to Follow-up|2|||
129563960|NCT00409578|466359815|FG001|Overall Study|Lost to Follow-up|0|||
129563961|NCT00409578|466359816|FG002|Overall Study|Lost to Follow-up|2|||
129563962|NCT00409578|466359817|FG003|Overall Study|Lost to Follow-up|2|||
129563963|NCT00409578|466359814|FG000|Overall Study|Administrative problems|8|||
129563964|NCT00409578|466359815|FG001|Overall Study|Administrative problems|9|||
129563965|NCT00409578|466359816|FG002|Overall Study|Administrative problems|2|||
129563966|NCT00409578|466359817|FG003|Overall Study|Administrative problems|4|||
129563967|NCT00409578|466359814|FG000|Overall Study|Death|2|||
129563968|NCT00409578|466359815|FG001|Overall Study|Death|4|||
129563969|NCT00409578|466359816|FG002|Overall Study|Death|4|||
129778954|NCT01088048|467156377|FG008|Overall Study|Other|0|||
129563970|NCT00409578|466359817|FG003|Overall Study|Death|2|||
129563971|NCT00409578|466359814|FG000|Overall Study|Protocol Violation|3|||
129563972|NCT00409578|466359815|FG001|Overall Study|Protocol Violation|2|||
129563973|NCT00409578|466359816|FG002|Overall Study|Protocol Violation|3|||
129563974|NCT00409578|466359817|FG003|Overall Study|Protocol Violation|1|||
129778955|NCT01088048|467156378|FG009|Overall Study|Other|0|||
129778956|NCT02563067|467156380|FG000|Overall Study|Subject/guardian decision|14|||
129778957|NCT02563067|467156381|FG001|Overall Study|Subject/guardian decision|20|||
129778958|NCT02563067|467156382|FG002|Overall Study|Subject/guardian decision|16|||
129778959|NCT02563067|467156380|FG000|Overall Study|Physician Decision|0|||
129778960|NCT02563067|467156381|FG001|Overall Study|Physician Decision|1|||
129563975|NCT00409578|466359814|FG000|Overall Study|Missing|0|||
129563976|NCT00409578|466359815|FG001|Overall Study|Missing|1|||
129563977|NCT00409578|466359816|FG002|Overall Study|Missing|0|||
129563978|NCT00409578|466359817|FG003|Overall Study|Missing|1|||
129563979|NCT02109133|466359818|FG000|Overall Study|Lost to Follow-up|1|||
129563980|NCT02109133|466359819|FG001|Overall Study|Lost to Follow-up|0|||
129563981|NCT05200858|466359822|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
129563982|NCT05200858|466359823|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
129563983|NCT05200858|466359824|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
129563984|NCT05200858|466359825|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
129563985|NCT00623103|466362027|FG000|Overall Study|Adverse Event|70|||
129563986|NCT00623103|466362028|FG001|Overall Study|Adverse Event|60|||
129563987|NCT00623103|466362027|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129563988|NCT00623103|466362028|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
129563989|NCT00623103|466362027|FG000|Overall Study|Withdrawal by Subject|18|||
129563990|NCT00623103|466362028|FG001|Overall Study|Withdrawal by Subject|24|||
129563991|NCT00623103|466362027|FG000|Overall Study|Lost to Follow-up|4|||
129563992|NCT00623103|466362028|FG001|Overall Study|Lost to Follow-up|1|||
129563993|NCT00623103|466362027|FG000|Overall Study|Administrative problems|2|||
129563994|NCT00623103|466362028|FG001|Overall Study|Administrative problems|4|||
129563995|NCT00623103|466362027|FG000|Overall Study|Death|11|||
129563996|NCT00623103|466362028|FG001|Overall Study|Death|11|||
129563997|NCT00623103|466362027|FG000|Overall Study|Protocol deviation|2|||
129563998|NCT00623103|466362028|FG001|Overall Study|Protocol deviation|1|||
129563999|NCT01506947|466362034|FG000|Overall Study|Lost to Follow-up|7|||
129564000|NCT01506947|466362034|FG000|Overall Study|Adverse Event|5|||
129564001|NCT01506947|466362034|FG000|Overall Study|Death|1|||
129564002|NCT01506947|466362034|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
129564003|NCT01700621|466362035|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
129778961|NCT02563067|467156382|FG002|Overall Study|Physician Decision|3|||
129778962|NCT02563067|467156380|FG000|Overall Study|Lost to Follow-up|1|||
129778963|NCT02563067|467156381|FG001|Overall Study|Lost to Follow-up|2|||
129778964|NCT02563067|467156382|FG002|Overall Study|Lost to Follow-up|0|||
129778965|NCT02563067|467156380|FG000|Overall Study|Technical problems|0|||
129778966|NCT02563067|467156381|FG001|Overall Study|Technical problems|1|||
129778967|NCT02563067|467156382|FG002|Overall Study|Technical problems|0|||
129778968|NCT02563067|467156380|FG000|Overall Study|Lack of Efficacy|1|||
129778969|NCT02563067|467156381|FG001|Overall Study|Lack of Efficacy|0|||
129778970|NCT02563067|467156382|FG002|Overall Study|Lack of Efficacy|0|||
129778971|NCT02563067|467156380|FG000|Overall Study|Death|0|||
129778972|NCT02563067|467156381|FG001|Overall Study|Death|1|||
129778973|NCT02563067|467156382|FG002|Overall Study|Death|1|||
129778974|NCT02563067|467156380|FG000|Overall Study|Adverse Event|2|||
129778975|NCT02563067|467156381|FG001|Overall Study|Adverse Event|1|||
129778976|NCT02563067|467156382|FG002|Overall Study|Adverse Event|0|||
129778977|NCT02563067|467156380|FG000|Overall Study|Death post Treatment/safety period|1|||
129778978|NCT02563067|467156381|FG001|Overall Study|Death post Treatment/safety period|0|||
129778979|NCT02563067|467156382|FG002|Overall Study|Death post Treatment/safety period|0|||
129778980|NCT03544333|467156392|FG000|Overall Study|Withdrawal by Subject|1|||
129778981|NCT03544333|467156393|FG001|Overall Study|Withdrawal by Subject|0|||
129778982|NCT01039519|467156397|FG000|Treatment|Progressive disease|20|||
129778983|NCT01039519|467156397|FG000|Treatment|Treatment failure|2|||
129778984|NCT01039519|467156397|FG000|Treatment|Adverse Event|3|||
129778985|NCT01039519|467156397|FG000|Treatment|Physician Decision|2|||
129778986|NCT01039519|467156397|FG000|Survival Follow-up|Death|23|||
129778987|NCT01039519|467156397|FG000|Survival Follow-up|Sponsor decision|4|||
129778988|NCT01330108|467156400|FG000|Overall Study|Withdrawal by Subject|4|||
129778989|NCT00485134|467156401|FG000|Overall Study|Lost to Follow-up|1|||
129778990|NCT00485134|467156402|FG001|Overall Study|Lost to Follow-up|0|||
129778991|NCT00485134|467156403|FG002|Overall Study|Lost to Follow-up|0|||
129778992|NCT00485134|467156404|FG003|Overall Study|Lost to Follow-up|0|||
129778993|NCT00485134|467156405|FG004|Overall Study|Lost to Follow-up|0|||
129778994|NCT00485134|467156406|FG005|Overall Study|Lost to Follow-up|0|||
129778995|NCT00485134|467156407|FG006|Overall Study|Lost to Follow-up|0|||
129778996|NCT00485134|467156408|FG007|Overall Study|Lost to Follow-up|0|||
129778997|NCT00485134|467156401|FG000|Overall Study|Withdrawal by Subject|0|||
129778998|NCT00485134|467156402|FG001|Overall Study|Withdrawal by Subject|1|||
129778999|NCT00485134|467156403|FG002|Overall Study|Withdrawal by Subject|0|||
129564004|NCT01700621|466362036|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
129564005|NCT01700621|466362035|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
129564006|NCT01700621|466362036|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
129564007|NCT01700621|466362035|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
129564008|NCT01700621|466362036|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
129564009|NCT02166697|466362037|FG000|Overall Study|Protocol Violation|347|||
129564010|NCT02720510|466362041|FG000|Overall Study|Study Terminated by the sponsor|2|||
129564011|NCT02720510|466362042|FG001|Overall Study|Study Terminated by the sponsor|0|||
129564012|NCT02720510|466362041|FG000|Overall Study|Adverse Event|0|||
129564013|NCT02720510|466362042|FG001|Overall Study|Adverse Event|1|||
129564014|NCT02720510|466362041|FG000|Overall Study|Physician Decision|1|||
129564015|NCT02720510|466362042|FG001|Overall Study|Physician Decision|2|||
129564016|NCT01618266|466362048|FG000|Overall Study|Lost to Follow-up|9|||
129564017|NCT01618266|466362048|FG000|Overall Study|Treatment satisfaction|10|||
129564018|NCT01618266|466362048|FG000|Overall Study|Other reasons|11|||
129564019|NCT01618266|466362048|FG000|Overall Study|Lack of Efficacy|23|||
129564020|NCT01618266|466362048|FG000|Overall Study|Protocol Violation|43|||
129564021|NCT02985151|466362049|FG000|Original Randomization|Withdrawal by Subject|0|||
129564022|NCT02985151|466362050|FG001|Original Randomization|Withdrawal by Subject|1|||
129564023|NCT01966042|466362053|FG000|Overall Study|Death|2|||
129564024|NCT00625807|466362054|FG000|Overall Study|schedule conflict|2|||
129564025|NCT00625807|466362055|FG001|Overall Study|schedule conflict|8|||
129564026|NCT02224391|466362056|FG000|Overall Study|Lost to Follow-up|26|||
129564027|NCT02224391|466362057|FG001|Overall Study|Lost to Follow-up|19|||
129564028|NCT02224391|466362056|FG000|Overall Study|Withdrawal by Subject|6|||
129564029|NCT02224391|466362057|FG001|Overall Study|Withdrawal by Subject|5|||
129564030|NCT00084084|466362059|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
129779000|NCT00485134|467156404|FG003|Overall Study|Withdrawal by Subject|0|||
129564031|NCT00084084|466362059|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
129564032|NCT00108732|466362060|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
129779001|NCT00485134|467156405|FG004|Overall Study|Withdrawal by Subject|0|||
129779002|NCT00485134|467156406|FG005|Overall Study|Withdrawal by Subject|0|||
129779003|NCT00485134|467156407|FG006|Overall Study|Withdrawal by Subject|0|||
129779004|NCT00485134|467156408|FG007|Overall Study|Withdrawal by Subject|0|||
129779005|NCT00485134|467156401|FG000|Overall Study|Change in health status|0|||
129779006|NCT00485134|467156402|FG001|Overall Study|Change in health status|1|||
129779007|NCT00485134|467156403|FG002|Overall Study|Change in health status|2|||
129779008|NCT00485134|467156404|FG003|Overall Study|Change in health status|1|||
129779009|NCT00485134|467156405|FG004|Overall Study|Change in health status|0|||
129779010|NCT00485134|467156406|FG005|Overall Study|Change in health status|1|||
129779011|NCT00485134|467156407|FG006|Overall Study|Change in health status|0|||
129779012|NCT00485134|467156408|FG007|Overall Study|Change in health status|0|||
129779013|NCT00485134|467156401|FG000|Overall Study|Withdrew for adverse event|0|||
129779014|NCT00485134|467156402|FG001|Overall Study|Withdrew for adverse event|0|||
129779015|NCT00485134|467156403|FG002|Overall Study|Withdrew for adverse event|1|||
129779016|NCT00485134|467156404|FG003|Overall Study|Withdrew for adverse event|0|||
129779017|NCT00485134|467156405|FG004|Overall Study|Withdrew for adverse event|0|||
129779018|NCT00485134|467156406|FG005|Overall Study|Withdrew for adverse event|0|||
129779019|NCT00485134|467156407|FG006|Overall Study|Withdrew for adverse event|0|||
129779020|NCT00485134|467156408|FG007|Overall Study|Withdrew for adverse event|0|||
129779021|NCT00485134|467156401|FG000|Overall Study|Positive drug test|0|||
129779022|NCT00485134|467156402|FG001|Overall Study|Positive drug test|0|||
129779023|NCT00485134|467156403|FG002|Overall Study|Positive drug test|0|||
129779024|NCT00485134|467156404|FG003|Overall Study|Positive drug test|0|||
129779025|NCT00485134|467156405|FG004|Overall Study|Positive drug test|2|||
129779026|NCT00485134|467156406|FG005|Overall Study|Positive drug test|1|||
129779027|NCT00485134|467156407|FG006|Overall Study|Positive drug test|0|||
129779028|NCT00485134|467156408|FG007|Overall Study|Positive drug test|0|||
129779029|NCT00485134|467156401|FG000|Overall Study|Non-compliance|0|||
129779030|NCT00485134|467156402|FG001|Overall Study|Non-compliance|0|||
129779031|NCT00485134|467156403|FG002|Overall Study|Non-compliance|0|||
129779032|NCT00485134|467156404|FG003|Overall Study|Non-compliance|0|||
129779033|NCT00485134|467156405|FG004|Overall Study|Non-compliance|1|||
129779034|NCT00485134|467156406|FG005|Overall Study|Non-compliance|2|||
129779035|NCT00485134|467156407|FG006|Overall Study|Non-compliance|2|||
129779036|NCT00485134|467156408|FG007|Overall Study|Non-compliance|0|||
129779037|NCT00485134|467156401|FG000|Overall Study|Unable to comply with study schedule|0|||
129779038|NCT00485134|467156402|FG001|Overall Study|Unable to comply with study schedule|0|||
129779039|NCT00485134|467156403|FG002|Overall Study|Unable to comply with study schedule|0|||
129779040|NCT00485134|467156404|FG003|Overall Study|Unable to comply with study schedule|0|||
129779041|NCT00485134|467156405|FG004|Overall Study|Unable to comply with study schedule|0|||
129779042|NCT00485134|467156406|FG005|Overall Study|Unable to comply with study schedule|0|||
129779043|NCT00485134|467156407|FG006|Overall Study|Unable to comply with study schedule|0|||
129779044|NCT00485134|467156408|FG007|Overall Study|Unable to comply with study schedule|1|||
129779045|NCT00485134|467156401|FG000|Overall Study|Pregnancy|0|||
129779046|NCT00485134|467156402|FG001|Overall Study|Pregnancy|0|||
129779047|NCT00485134|467156403|FG002|Overall Study|Pregnancy|0|||
129779048|NCT00485134|467156404|FG003|Overall Study|Pregnancy|0|||
129779049|NCT00485134|467156405|FG004|Overall Study|Pregnancy|0|||
129779050|NCT00485134|467156406|FG005|Overall Study|Pregnancy|0|||
129779051|NCT00485134|467156407|FG006|Overall Study|Pregnancy|1|||
129779052|NCT00485134|467156408|FG007|Overall Study|Pregnancy|0|||
129779053|NCT04294680|467156409|FG000|Overall Study|Withdrawal by Subject|2|||
129779054|NCT04294680|467156410|FG001|Overall Study|Withdrawal by Subject|1|||
129779055|NCT04294680|467156409|FG000|Overall Study|Follow-up visits completed outside of window|1|||
129779056|NCT04294680|467156410|FG001|Overall Study|Follow-up visits completed outside of window|0|||
129779057|NCT04027608|467156411|FG000|Overall Study|Withdrawal by Subject|13|||
129779058|NCT04027608|467156412|FG001|Overall Study|Withdrawal by Subject|2|||
129779059|NCT04027608|467156411|FG000|Overall Study|Protocol Violation|2|||
129779060|NCT04027608|467156412|FG001|Overall Study|Protocol Violation|1|||
129779061|NCT04027608|467156411|FG000|Overall Study|Physician Decision|1|||
129779062|NCT04027608|467156412|FG001|Overall Study|Physician Decision|0|||
129779063|NCT04027608|467156411|FG000|Overall Study|Lost to Follow-up|20|||
129779064|NCT04027608|467156412|FG001|Overall Study|Lost to Follow-up|4|||
129779065|NCT05564052|467156415|FG000|Overall Study|Withdrawal by Subject|0|||
129779066|NCT05564052|467156416|FG001|Overall Study|Withdrawal by Subject|0|||
129779067|NCT05564052|467156417|FG002|Overall Study|Withdrawal by Subject|0|||
129779068|NCT05564052|467156418|FG003|Overall Study|Withdrawal by Subject|1|||
129779069|NCT03978624|467156419|FG000|Overall Study|Protocol Violation|1|||
129779070|NCT03978624|467156420|FG001|Overall Study|Protocol Violation|0|||
129779071|NCT00924027|467156423|FG000|Overall Study|Lost to Further Follow-Up|4|||
129779072|NCT00924027|467156424|FG001|Overall Study|Lost to Further Follow-Up|0|||
129779073|NCT00924027|467156425|FG002|Overall Study|Lost to Further Follow-Up|0|||
129779074|NCT00924027|467156426|FG003|Overall Study|Lost to Further Follow-Up|0|||
129779075|NCT00924027|467156423|FG000|Overall Study|Physician Decision|1|||
129779076|NCT00924027|467156424|FG001|Overall Study|Physician Decision|0|||
129779077|NCT00924027|467156425|FG002|Overall Study|Physician Decision|0|||
129688625|NCT01131585|466816236|FG001|Overall Study|Administrative problems|1|||
129779078|NCT00924027|467156426|FG003|Overall Study|Physician Decision|1|||
129779079|NCT00924027|467156423|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
129779080|NCT00924027|467156424|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
129779081|NCT00924027|467156425|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
129779082|NCT00924027|467156426|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
129779083|NCT00924027|467156423|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
129779084|NCT00924027|467156424|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
129779085|NCT00924027|467156425|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
129779086|NCT00924027|467156426|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
129779087|NCT00924027|467156423|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
129779088|NCT00924027|467156424|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
129779089|NCT00924027|467156425|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
129779090|NCT00924027|467156426|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
129779091|NCT04193189|467156427|FG000|Overall Study|Lost to Follow-up|9|||
129779092|NCT04193189|467156428|FG001|Overall Study|Lost to Follow-up|7|||
129779093|NCT04193189|467156429|FG002|Overall Study|Lost to Follow-up|9|||
129779094|NCT04193189|467156430|FG003|Overall Study|Lost to Follow-up|0|||
129779095|NCT04193189|467156427|FG000|Overall Study|Withdrawal by Subject|1|||
129779096|NCT04193189|467156428|FG001|Overall Study|Withdrawal by Subject|2|||
129779097|NCT04193189|467156429|FG002|Overall Study|Withdrawal by Subject|2|||
129779098|NCT04193189|467156430|FG003|Overall Study|Withdrawal by Subject|0|||
129779099|NCT04193189|467156427|FG000|Overall Study|Death|1|||
129779100|NCT04193189|467156428|FG001|Overall Study|Death|1|||
129779101|NCT04193189|467156429|FG002|Overall Study|Death|0|||
129688626|NCT01131585|466816235|FG000|Overall Study|Study termination|78|||
129688627|NCT01131585|466816236|FG001|Overall Study|Study termination|32|||
129688628|NCT00927082|466816237|FG000|Overall Study|Lost to Follow-up|9|||
129688629|NCT00927082|466816238|FG001|Overall Study|Lost to Follow-up|8|||
129688630|NCT00927082|466816239|FG002|Overall Study|Lost to Follow-up|12|||
129688631|NCT00927082|466816240|FG003|Overall Study|Lost to Follow-up|16|||
129688632|NCT00927082|466816237|FG000|Overall Study|Withdrawal by Subject|3|||
129688633|NCT00927082|466816238|FG001|Overall Study|Withdrawal by Subject|2|||
129688634|NCT00927082|466816239|FG002|Overall Study|Withdrawal by Subject|7|||
129688635|NCT00927082|466816240|FG003|Overall Study|Withdrawal by Subject|2|||
129688636|NCT00927082|466816237|FG000|Overall Study|Death|0|||
129688637|NCT00927082|466816238|FG001|Overall Study|Death|0|||
129688638|NCT00927082|466816239|FG002|Overall Study|Death|1|||
129688639|NCT00927082|466816240|FG003|Overall Study|Death|0|||
129688640|NCT00927082|466816237|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
129688641|NCT00927082|466816238|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
129688642|NCT00927082|466816239|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
129688643|NCT00927082|466816240|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
129688644|NCT01860404|466816242|FG000|Overall Study|Lost to Follow-up|3|||
129688645|NCT01860404|466816243|FG001|Overall Study|Lost to Follow-up|4|||
129688646|NCT01860404|466816244|FG002|Overall Study|Lost to Follow-up|1|||
129688647|NCT01860404|466816245|FG003|Overall Study|Lost to Follow-up|6|||
129688648|NCT01860404|466816246|FG004|Overall Study|Lost to Follow-up|4|||
129688649|NCT01860404|466816242|FG000|Overall Study|Withdrawal by Subject|0|||
129688650|NCT01860404|466816243|FG001|Overall Study|Withdrawal by Subject|0|||
129688651|NCT01860404|466816244|FG002|Overall Study|Withdrawal by Subject|4|||
129688652|NCT01860404|466816245|FG003|Overall Study|Withdrawal by Subject|0|||
129688653|NCT01860404|466816246|FG004|Overall Study|Withdrawal by Subject|0|||
129688654|NCT00849472|466816247|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
129688655|NCT00849472|466816247|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
129688656|NCT00849472|466816247|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
129688657|NCT00849472|466816247|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
129688658|NCT00849472|466816247|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
129688659|NCT00849472|466816247|FG000|Weekly Paclitaxel|Disease Progression|1|||
129688660|NCT00849472|466816247|FG000|Weekly Paclitaxel|Adverse Event|11|||
129779102|NCT04193189|467156430|FG003|Overall Study|Death|0|||
129779103|NCT04193189|467156427|FG000|Overall Study|Protocol Violation|0|||
129688661|NCT00849472|466816247|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
129688662|NCT00849472|466816247|FG000|Weekly Paclitaxel|Physician Decision|3|||
129779104|NCT04193189|467156428|FG001|Overall Study|Protocol Violation|0|||
129779105|NCT04193189|467156429|FG002|Overall Study|Protocol Violation|0|||
129779106|NCT04193189|467156430|FG003|Overall Study|Protocol Violation|1|||
129779107|NCT02840799|467158047|FG000|Phase 1|Physician Decision|1|||
129779108|NCT02840799|467158048|FG001|Phase 1|Physician Decision|3|||
129779109|NCT02840799|467158047|FG000|Phase 1|Withdrawal by Subject|4|||
129688663|NCT00849472|466816247|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
129688664|NCT00849472|466816247|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
129688665|NCT00849472|466816247|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
129688666|NCT00849472|466816247|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
129688667|NCT00849472|466816247|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
129688668|NCT00849472|466816247|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
129688669|NCT00849472|466816247|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
129688670|NCT00849472|466816247|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
129688671|NCT05259033|466816252|FG000|Overall Study|Withdrawal by Subject|10|||
129688672|NCT05259033|466816253|FG001|Overall Study|Withdrawal by Subject|5|||
129688673|NCT05259033|466816252|FG000|Overall Study|Lost to Follow-up|1|||
129688674|NCT05259033|466816253|FG001|Overall Study|Lost to Follow-up|0|||
129688675|NCT05259033|466816252|FG000|Overall Study|Death|2|||
129688676|NCT05259033|466816253|FG001|Overall Study|Death|0|||
129688677|NCT04180696|466816254|FG000|Overall Study|Death|5|||
129688678|NCT04180696|466816255|FG001|Overall Study|Death|6|||
129688679|NCT04180696|466816254|FG000|Overall Study|Lost to Follow-up|1|||
129688680|NCT04180696|466816255|FG001|Overall Study|Lost to Follow-up|0|||
129688681|NCT04180696|466816254|FG000|Overall Study|Withdrawal by Subject|0|||
129688682|NCT04180696|466816255|FG001|Overall Study|Withdrawal by Subject|1|||
129688683|NCT04210375|466816256|FG000|Overall Study|Death|0|||
129688684|NCT04210375|466816257|FG001|Overall Study|Death|1|||
129688685|NCT04210375|466816258|FG002|Overall Study|Death|0|||
129688686|NCT04210375|466816259|FG003|Overall Study|Death|0|||
129688687|NCT00424008|466816260|FG000|Overall Study|Adverse Event|8|||
129688688|NCT00424008|466816261|FG001|Overall Study|Adverse Event|6|||
129688689|NCT00424008|466816260|FG000|Overall Study|Lack of Efficacy|40|||
129688690|NCT00424008|466816261|FG001|Overall Study|Lack of Efficacy|34|||
129688691|NCT00424008|466816260|FG000|Overall Study|Lost to Follow-up|1|||
129688692|NCT00424008|466816261|FG001|Overall Study|Lost to Follow-up|2|||
129688693|NCT00424008|466816260|FG000|Overall Study|Withdrawal by Subject|5|||
129688694|NCT00424008|466816261|FG001|Overall Study|Withdrawal by Subject|8|||
129688695|NCT00424008|466816260|FG000|Overall Study|Noncompliance with protocol|13|||
129688696|NCT00424008|466816261|FG001|Overall Study|Noncompliance with protocol|7|||
129688697|NCT00424008|466816260|FG000|Overall Study|Did not meet protocol eligibility|16|||
129688698|NCT00424008|466816261|FG001|Overall Study|Did not meet protocol eligibility|21|||
129688699|NCT00424008|466816260|FG000|Overall Study|Administrative|266|||
129688700|NCT00424008|466816261|FG001|Overall Study|Administrative|257|||
129688701|NCT02593864|466816264|FG000|Overall Study|Withdrawal by Subject|3|||
129688702|NCT02593864|466816264|FG000|Overall Study|Lost to Follow-up|3|||
129688703|NCT01405911|466816265|FG000|Overall Study|Pre-treatment lab AE|0|||
129688704|NCT01405911|466816266|FG001|Overall Study|Pre-treatment lab AE|1|||
129688705|NCT01405911|466816267|FG002|Overall Study|Pre-treatment lab AE|0|||
129688706|NCT01405911|466816265|FG000|Overall Study|Lost to Follow-up|0|||
129688707|NCT01405911|466816266|FG001|Overall Study|Lost to Follow-up|1|||
129688708|NCT01405911|466816267|FG002|Overall Study|Lost to Follow-up|0|||
129688709|NCT01405911|466816265|FG000|Overall Study|Protocol Violation|1|||
129688710|NCT01405911|466816266|FG001|Overall Study|Protocol Violation|0|||
129688711|NCT01405911|466816267|FG002|Overall Study|Protocol Violation|0|||
129688712|NCT01405911|466816265|FG000|Overall Study|Withdrawal by Subject|3|||
129688713|NCT01405911|466816266|FG001|Overall Study|Withdrawal by Subject|1|||
129688714|NCT01405911|466816267|FG002|Overall Study|Withdrawal by Subject|1|||
129688715|NCT03932331|466816272|FG000|Overall Study|Death|0|||
129688716|NCT03932331|466816273|FG001|Overall Study|Death|7|||
129688717|NCT03932331|466816274|FG002|Overall Study|Death|2|||
129688718|NCT03932331|466816272|FG000|Overall Study|Withdrawal by Subject|0|||
129688719|NCT03932331|466816273|FG001|Overall Study|Withdrawal by Subject|3|||
129688720|NCT03932331|466816274|FG002|Overall Study|Withdrawal by Subject|0|||
129688721|NCT03932331|466816272|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
129688722|NCT03932331|466816273|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
129688723|NCT03932331|466816274|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
129688724|NCT03932331|466816272|FG000|Overall Study|Progressive disease|3|||
129688725|NCT03932331|466816273|FG001|Overall Study|Progressive disease|0|||
129688726|NCT03932331|466816274|FG002|Overall Study|Progressive disease|0|||
129688727|NCT03932331|466816272|FG000|Overall Study|Lung infection|1|||
129688728|NCT03932331|466816273|FG001|Overall Study|Lung infection|0|||
129688729|NCT03932331|466816274|FG002|Overall Study|Lung infection|0|||
129564033|NCT00108732|466362060|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
129564034|NCT00108732|466362060|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
129688730|NCT03932331|466816272|FG000|Overall Study|Other|0|||
129688731|NCT03932331|466816273|FG001|Overall Study|Other|0|||
129688732|NCT03932331|466816274|FG002|Overall Study|Other|58|||
129688733|NCT01937117|466816275|FG000|Overall Study|Disease Progression|7|||
129688734|NCT01937117|466816275|FG000|Overall Study|Physician Decision|4|||
129688735|NCT01937117|466816275|FG000|Overall Study|Adverse Event|2|||
129688736|NCT01407367|466816280|FG000|Overall Study|Death|24|||
129688737|NCT01407367|466816281|FG001|Overall Study|Death|32|||
129688738|NCT01407367|466816280|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
129688739|NCT01407367|466816281|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
129688740|NCT01407367|466816280|FG000|Overall Study|Withdrawal by Subject|4|||
129688741|NCT01407367|466816281|FG001|Overall Study|Withdrawal by Subject|15|||
129688742|NCT01407367|466816280|FG000|Overall Study|Lost to Follow-up|0|||
129688743|NCT01407367|466816281|FG001|Overall Study|Lost to Follow-up|2|||
129688744|NCT01452347|466816282|FG000|Overall Study|Adverse Event|2|||
129688745|NCT01452347|466816283|FG001|Overall Study|Adverse Event|1|||
129688746|NCT01452347|466816282|FG000|Overall Study|Non compliance protocol|2|||
129688747|NCT01452347|466816283|FG001|Overall Study|Non compliance protocol|0|||
129688748|NCT01452347|466816282|FG000|Overall Study|Lost to Follow-up|2|||
129688749|NCT01452347|466816283|FG001|Overall Study|Lost to Follow-up|0|||
129688750|NCT01452347|466816282|FG000|Overall Study|Withdrawal by Subject|3|||
129688751|NCT01452347|466816283|FG001|Overall Study|Withdrawal by Subject|3|||
129688752|NCT01452347|466816282|FG000|Overall Study|Not treated|6|||
129688753|NCT01452347|466816283|FG001|Overall Study|Not treated|3|||
129688754|NCT01452347|466816282|FG000|Overall Study|Other reason not defined above|2|||
129688755|NCT01452347|466816283|FG001|Overall Study|Other reason not defined above|0|||
129688756|NCT05417113|466817862|FG000|Overall Study|Lost to Follow-up|2|||
129688757|NCT05417113|466817863|FG001|Overall Study|Lost to Follow-up|2|||
129688758|NCT01022580|466817864|FG000|Overall Study|Death|18|||
129688759|NCT01022580|466817865|FG001|Overall Study|Death|22|||
129688760|NCT01500096|466817868|FG000|Overall Study|Lost to Follow-up|1|||
129688761|NCT01500096|466817869|FG001|Overall Study|Lost to Follow-up|0|||
129688762|NCT01500096|466817870|FG002|Overall Study|Lost to Follow-up|0|||
129688763|NCT01500096|466817871|FG003|Overall Study|Lost to Follow-up|2|||
129688764|NCT01734928|466817872|FG000|Randomization|Physician Decision|0|||
129688765|NCT01734928|466817873|FG001|Randomization|Physician Decision|1|||
129688766|NCT01734928|466817872|FG000|Randomization|clinical progression|0|||
129688767|NCT01734928|466817873|FG001|Randomization|clinical progression|1|||
129688768|NCT01734928|466817872|FG000|Randomization|progressive disease|0|||
129688769|NCT01734928|466817873|FG001|Randomization|progressive disease|2|||
129688770|NCT01734928|466817872|FG000|Randomization|Withdrew informed consent|0|||
129688771|NCT01734928|466817873|FG001|Randomization|Withdrew informed consent|4|||
129688772|NCT01734928|466817872|FG000|Randomization|Death|1|||
129688773|NCT01734928|466817873|FG001|Randomization|Death|0|||
129688774|NCT01734928|466817872|FG000|Randomization|Randomization error|1|||
129688775|NCT01734928|466817873|FG001|Randomization|Randomization error|0|||
129688776|NCT01734928|466817872|FG000|Randomization|Lost to Follow-up|1|||
129688777|NCT01734928|466817873|FG001|Randomization|Lost to Follow-up|0|||
129688778|NCT01734928|466817872|FG000|Treatment Period|Lost to Follow-up|0|||
129688779|NCT01734928|466817873|FG001|Treatment Period|Lost to Follow-up|2|||
129688780|NCT01734928|466817872|FG000|Treatment Period|Progressive Disease|167|||
129688781|NCT01734928|466817873|FG001|Treatment Period|Progressive Disease|165|||
129688782|NCT01734928|466817872|FG000|Treatment Period|Adverse Event|39|||
129688783|NCT01734928|466817873|FG001|Treatment Period|Adverse Event|52|||
129688784|NCT01734928|466817872|FG000|Treatment Period|Withdrawal of Consent|25|||
129688785|NCT01734928|466817873|FG001|Treatment Period|Withdrawal of Consent|22|||
129688786|NCT01734928|466817872|FG000|Treatment Period|Death|20|||
129688787|NCT01734928|466817873|FG001|Treatment Period|Death|9|||
129688788|NCT01734928|466817872|FG000|Treatment Period|Other Reasons|27|||
129688789|NCT01734928|466817873|FG001|Treatment Period|Other Reasons|19|||
129688790|NCT01734928|466817872|FG000|Treatment Period|Pregnancy|0|||
129688791|NCT01734928|466817873|FG001|Treatment Period|Pregnancy|1|||
129688792|NCT01778985|466817874|FG000|Overall Study|Lost to Follow-up|1|||
129688793|NCT01778985|466817875|FG001|Overall Study|Lost to Follow-up|0|||
129688794|NCT01778985|466817874|FG000|Overall Study|Physician Decision|2|||
129688795|NCT01778985|466817875|FG001|Overall Study|Physician Decision|2|||
129688796|NCT01778985|466817874|FG000|Overall Study|Protocol Violation|4|||
129688797|NCT01778985|466817875|FG001|Overall Study|Protocol Violation|1|||
129688798|NCT00088881|466817876|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
129688799|NCT00088881|466817876|FG000|Step 1 - R-CHOP|Adverse Event|1|||
129688800|NCT00088881|466817876|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
129688801|NCT00088881|466817876|FG000|Step 1 - R-CHOP|Physician Decision|1|||
129688802|NCT00088881|466817876|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
129688803|NCT00088881|466817876|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
129688804|NCT00088881|466817876|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
129688805|NCT01631188|466817882|FG000|Overall Study|Physician Decision|75|||
129688806|NCT03600350|466817883|FG000|Overall Study|Death|1|||
129564035|NCT00108732|466362060|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
129564036|NCT00108732|466362060|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
129564037|NCT00108732|466362060|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
129564038|NCT00108732|466362060|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
129564039|NCT02187042|466362061|FG000|Overall Study|Death|1|||
129564040|NCT02187042|466362062|FG001|Overall Study|Death|1|||
129688807|NCT03600350|466817883|FG000|Overall Study|On Follow Up|18|||
129688808|NCT00835978|466817884|FG000|Overall Study|Death|33|||
129688809|NCT00835978|466817885|FG001|Overall Study|Death|40|||
129688810|NCT00835978|466817886|FG002|Overall Study|Death|49|||
129688811|NCT00835978|466817887|FG003|Overall Study|Death|4|||
129688812|NCT00835978|466817884|FG000|Overall Study|Lost to Follow-up|3|||
129688813|NCT00835978|466817885|FG001|Overall Study|Lost to Follow-up|4|||
129688814|NCT00835978|466817886|FG002|Overall Study|Lost to Follow-up|2|||
129688815|NCT00835978|466817887|FG003|Overall Study|Lost to Follow-up|1|||
129688816|NCT00835978|466817884|FG000|Overall Study|Other|5|||
129688817|NCT00835978|466817885|FG001|Overall Study|Other|1|||
129688818|NCT00835978|466817886|FG002|Overall Study|Other|8|||
129688819|NCT00835978|466817887|FG003|Overall Study|Other|0|||
129688820|NCT00835978|466817884|FG000|Overall Study|Objective progression or relapse|2|||
129688821|NCT00835978|466817885|FG001|Overall Study|Objective progression or relapse|0|||
129688822|NCT00835978|466817886|FG002|Overall Study|Objective progression or relapse|1|||
129688823|NCT00835978|466817887|FG003|Overall Study|Objective progression or relapse|0|||
129688824|NCT00835978|466817884|FG000|Overall Study|Adverse Event|1|||
129688825|NCT00835978|466817885|FG001|Overall Study|Adverse Event|0|||
129688826|NCT00835978|466817886|FG002|Overall Study|Adverse Event|1|||
129688827|NCT00835978|466817887|FG003|Overall Study|Adverse Event|0|||
129688828|NCT00835978|466817884|FG000|Overall Study|Withdrawal by Subject|0|||
129688829|NCT00835978|466817885|FG001|Overall Study|Withdrawal by Subject|3|||
129688830|NCT00835978|466817886|FG002|Overall Study|Withdrawal by Subject|0|||
129688831|NCT00835978|466817887|FG003|Overall Study|Withdrawal by Subject|5|||
129688832|NCT00835978|466817884|FG000|Overall Study|Study terminated by sponsor|12|||
129688833|NCT00835978|466817885|FG001|Overall Study|Study terminated by sponsor|8|||
129688834|NCT00835978|466817886|FG002|Overall Study|Study terminated by sponsor|30|||
129688835|NCT00835978|466817887|FG003|Overall Study|Study terminated by sponsor|0|||
129688836|NCT03684057|466817888|FG000|Overall Study|Withdrawal by Subject|4|||
129688837|NCT03684057|466817889|FG001|Overall Study|Withdrawal by Subject|5|||
129688838|NCT01105130|466817890|FG000|Overall Study|Withdrawal by Subject|4|||
129688839|NCT01105130|466817891|FG001|Overall Study|Withdrawal by Subject|6|||
129688840|NCT01105130|466817892|FG002|Overall Study|Withdrawal by Subject|2|||
129688841|NCT01105130|466817890|FG000|Overall Study|Never Started|2|||
129688842|NCT01105130|466817891|FG001|Overall Study|Never Started|2|||
129688843|NCT01105130|466817892|FG002|Overall Study|Never Started|4|||
129688844|NCT01105130|466817890|FG000|Overall Study|Toxicity|1|||
129688845|NCT01105130|466817891|FG001|Overall Study|Toxicity|3|||
129688846|NCT01105130|466817892|FG002|Overall Study|Toxicity|2|||
129688847|NCT01105130|466817890|FG000|Overall Study|Multiple Reasons|3|||
129688848|NCT01105130|466817891|FG001|Overall Study|Multiple Reasons|0|||
129688849|NCT01105130|466817892|FG002|Overall Study|Multiple Reasons|2|||
129688850|NCT02927145|466817894|FG000|Initial Recruitment|Withdrawal by Subject|0|||
129688851|NCT02927145|466817895|FG001|Initial Recruitment|Withdrawal by Subject|1|||
129688852|NCT02927145|466817896|FG002|Initial Recruitment|Withdrawal by Subject|1|||
129688853|NCT02927145|466817897|FG003|Initial Recruitment|Withdrawal by Subject|4|||
129688854|NCT02927145|466817898|FG004|Initial Recruitment|Withdrawal by Subject|1|||
129688855|NCT02927145|466817899|FG005|Initial Recruitment|Withdrawal by Subject|1|||
129688856|NCT02927145|466817900|FG006|Initial Recruitment|Withdrawal by Subject|0|||
129688857|NCT02927145|466817901|FG007|Initial Recruitment|Withdrawal by Subject|0|||
129688858|NCT02927145|466817902|FG008|Initial Recruitment|Withdrawal by Subject|2|||
129688859|NCT02927145|466817894|FG000|Initial Recruitment|Adverse Event|0|||
129564041|NCT02187042|466362061|FG000|Overall Study|Toxicity|6|||
129688860|NCT02927145|466817895|FG001|Initial Recruitment|Adverse Event|0|||
129688861|NCT02927145|466817896|FG002|Initial Recruitment|Adverse Event|0|||
129688862|NCT02927145|466817897|FG003|Initial Recruitment|Adverse Event|0|||
129688863|NCT02927145|466817898|FG004|Initial Recruitment|Adverse Event|2|||
129564042|NCT02187042|466362062|FG001|Overall Study|Toxicity|5|||
129688864|NCT02927145|466817899|FG005|Initial Recruitment|Adverse Event|0|||
129688865|NCT02927145|466817900|FG006|Initial Recruitment|Adverse Event|0|||
129688866|NCT02927145|466817901|FG007|Initial Recruitment|Adverse Event|0|||
129688867|NCT02927145|466817902|FG008|Initial Recruitment|Adverse Event|0|||
129688868|NCT02927145|466817894|FG000|Invitation for Additional Challenge|Pregnancy|0|||
129688869|NCT02927145|466817895|FG001|Invitation for Additional Challenge|Pregnancy|0|||
129688870|NCT02927145|466817896|FG002|Invitation for Additional Challenge|Pregnancy|0|||
129688871|NCT02927145|466817897|FG003|Invitation for Additional Challenge|Pregnancy|0|||
129688872|NCT02927145|466817898|FG004|Invitation for Additional Challenge|Pregnancy|0|||
129688873|NCT02927145|466817899|FG005|Invitation for Additional Challenge|Pregnancy|0|||
129688874|NCT02927145|466817900|FG006|Invitation for Additional Challenge|Pregnancy|1|||
129688875|NCT02927145|466817901|FG007|Invitation for Additional Challenge|Pregnancy|0|||
129688876|NCT02927145|466817902|FG008|Invitation for Additional Challenge|Pregnancy|0|||
129688877|NCT01363440|466817903|FG000|Overall Study|Adverse Event|5|||
129688878|NCT01363440|466817904|FG001|Overall Study|Adverse Event|4|||
129688879|NCT01363440|466817905|FG002|Overall Study|Adverse Event|4|||
129688880|NCT01363440|466817903|FG000|Overall Study|Death|3|||
129688881|NCT01363440|466817904|FG001|Overall Study|Death|7|||
129688882|NCT01363440|466817905|FG002|Overall Study|Death|5|||
129688883|NCT01363440|466817903|FG000|Overall Study|Withdrawal by Subject|9|||
129688884|NCT01363440|466817904|FG001|Overall Study|Withdrawal by Subject|11|||
129688885|NCT01363440|466817905|FG002|Overall Study|Withdrawal by Subject|11|||
129688886|NCT01363440|466817903|FG000|Overall Study|Lost to Follow-up|2|||
129688887|NCT01363440|466817904|FG001|Overall Study|Lost to Follow-up|4|||
129688888|NCT01363440|466817905|FG002|Overall Study|Lost to Follow-up|5|||
129688889|NCT01363440|466817903|FG000|Overall Study|Other|4|||
129688890|NCT01363440|466817904|FG001|Overall Study|Other|5|||
129688891|NCT01363440|466817905|FG002|Overall Study|Other|2|||
129688892|NCT02323334|466817908|FG000|Period 3|Lost to Follow-up|0|||
129688893|NCT02323334|466817909|FG001|Period 3|Lost to Follow-up|0|||
129688894|NCT02323334|466817910|FG002|Period 3|Lost to Follow-up|1|||
129688895|NCT02323334|466817911|FG003|Period 3|Lost to Follow-up|0|||
129688896|NCT02323334|466817912|FG004|Period 3|Lost to Follow-up|0|||
129688897|NCT02323334|466817913|FG005|Period 3|Lost to Follow-up|0|||
129688898|NCT02323334|466817914|FG006|Period 3|Lost to Follow-up|0|||
129688899|NCT02323334|466817915|FG007|Period 3|Lost to Follow-up|0|||
129688900|NCT02323334|466817916|FG008|Period 3|Lost to Follow-up|0|||
129688901|NCT02323334|466817917|FG009|Period 3|Lost to Follow-up|0|||
129688902|NCT02323334|466817918|FG010|Period 3|Lost to Follow-up|0|||
129688903|NCT02323334|466817919|FG011|Period 3|Lost to Follow-up|0|||
129688904|NCT02323334|466817920|FG012|Period 3|Lost to Follow-up|0|||
129688905|NCT02323334|466817921|FG013|Period 3|Lost to Follow-up|0|||
129688906|NCT02323334|466817922|FG014|Period 3|Lost to Follow-up|0|||
129688907|NCT02323334|466817923|FG015|Period 3|Lost to Follow-up|0|||
129688908|NCT02323334|466817924|FG016|Period 3|Lost to Follow-up|0|||
129688909|NCT02323334|466817908|FG000|Period 3|Withdrawal by Subject|1|||
129688910|NCT02323334|466817909|FG001|Period 3|Withdrawal by Subject|0|||
129688911|NCT02323334|466817910|FG002|Period 3|Withdrawal by Subject|0|||
129688912|NCT02323334|466817911|FG003|Period 3|Withdrawal by Subject|0|||
129688913|NCT02323334|466817912|FG004|Period 3|Withdrawal by Subject|0|||
129688914|NCT02323334|466817913|FG005|Period 3|Withdrawal by Subject|0|||
129688915|NCT02323334|466817914|FG006|Period 3|Withdrawal by Subject|0|||
129688916|NCT02323334|466817915|FG007|Period 3|Withdrawal by Subject|0|||
129688917|NCT02323334|466817916|FG008|Period 3|Withdrawal by Subject|0|||
129688918|NCT02323334|466817917|FG009|Period 3|Withdrawal by Subject|0|||
129688919|NCT02323334|466817918|FG010|Period 3|Withdrawal by Subject|0|||
129688920|NCT02323334|466817919|FG011|Period 3|Withdrawal by Subject|0|||
129688921|NCT02323334|466817920|FG012|Period 3|Withdrawal by Subject|0|||
129688922|NCT02323334|466817921|FG013|Period 3|Withdrawal by Subject|0|||
129688923|NCT02323334|466817922|FG014|Period 3|Withdrawal by Subject|0|||
129688924|NCT02323334|466817923|FG015|Period 3|Withdrawal by Subject|0|||
129688925|NCT02323334|466817924|FG016|Period 3|Withdrawal by Subject|0|||
129688926|NCT02506036|466817925|FG000|First Intervention (4-6 Weeks)|Death|1|||
129688927|NCT02506036|466817926|FG001|First Intervention (4-6 Weeks)|Death|0|||
129688928|NCT02506036|466817925|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
129688929|NCT02506036|466817926|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
129688930|NCT02506036|466817925|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
129688931|NCT02506036|466817926|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
129688932|NCT00552058|466817927|FG000|Overall Study|Adverse Event|8|||
129564043|NCT02187042|466362061|FG000|Overall Study|Participant choice|1|||
129564044|NCT02187042|466362062|FG001|Overall Study|Participant choice|0|||
129688933|NCT00552058|466817928|FG001|Overall Study|Adverse Event|7|||
129688934|NCT00552058|466817927|FG000|Overall Study|Lack of Efficacy|1|||
129688935|NCT00552058|466817928|FG001|Overall Study|Lack of Efficacy|5|||
129688936|NCT00552058|466817927|FG000|Overall Study|Lost to Follow-up|1|||
129688937|NCT00552058|466817928|FG001|Overall Study|Lost to Follow-up|0|||
129688938|NCT00552058|466817927|FG000|Overall Study|Withdrawal by Subject|4|||
129688939|NCT00552058|466817928|FG001|Overall Study|Withdrawal by Subject|4|||
129688940|NCT00552058|466817927|FG000|Overall Study|Other: Protocol Violation|0|||
129688941|NCT00552058|466817928|FG001|Overall Study|Other: Protocol Violation|1|||
129688942|NCT00552058|466817927|FG000|Overall Study|Other: Non Compliance|1|||
129688943|NCT00552058|466817928|FG001|Overall Study|Other: Non Compliance|2|||
129688944|NCT00552058|466817927|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
129688945|NCT00552058|466817928|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
129688946|NCT00552058|466817927|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
129688947|NCT00552058|466817928|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
129688948|NCT00552058|466817927|FG000|Overall Study|Other: Positive Stool Result|0|||
129688949|NCT00552058|466817928|FG001|Overall Study|Other: Positive Stool Result|1|||
129688950|NCT00552058|466817927|FG000|Overall Study|Other: Randomized in error|0|||
129688951|NCT00552058|466817928|FG001|Overall Study|Other: Randomized in error|1|||
129688952|NCT00552058|466817927|FG000|Overall Study|Other: Sponsors Decision|0|||
129688953|NCT00552058|466817928|FG001|Overall Study|Other: Sponsors Decision|1|||
129688954|NCT00552058|466817927|FG000|Overall Study|Other: Early Roll Over|1|||
129688955|NCT00552058|466817928|FG001|Overall Study|Other: Early Roll Over|0|||
129688956|NCT03422718|466817931|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
129688957|NCT03422718|466817932|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
129688958|NCT03422718|466817933|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
129688959|NCT03422718|466817934|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
129688960|NCT03422718|466817935|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
129688961|NCT03422718|466817936|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
129688962|NCT03422718|466817937|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
129688963|NCT03422718|466817938|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
129688964|NCT03422718|466817931|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
129688965|NCT03422718|466817932|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
129688966|NCT03422718|466817933|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
129688967|NCT03422718|466817934|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
129688968|NCT03422718|466817935|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
129688969|NCT03422718|466817936|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
129688970|NCT03422718|466817937|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
129688971|NCT03422718|466817938|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
129688972|NCT03422718|466817931|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
129688973|NCT03422718|466817932|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
129688974|NCT03422718|466817933|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
129688975|NCT03422718|466817934|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
129688976|NCT03422718|466817935|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
129688977|NCT03422718|466817936|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
129688978|NCT03422718|466817937|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
129688979|NCT03422718|466817938|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
129688980|NCT03422718|466817931|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129688981|NCT03422718|466817932|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
129688982|NCT03422718|466817933|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129688983|NCT03422718|466817934|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129688984|NCT03422718|466817935|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
129688985|NCT03422718|466817936|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
129688986|NCT03422718|466817937|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129688987|NCT03422718|466817938|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
129688988|NCT03422718|466817931|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
129688989|NCT03422718|466817932|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
129688990|NCT03422718|466817933|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
129688991|NCT03422718|466817934|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
129688992|NCT03422718|466817935|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
129688993|NCT03422718|466817936|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
129688994|NCT03422718|466817937|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
129688995|NCT03422718|466817938|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
129688996|NCT03422718|466817931|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
129779110|NCT02840799|467158048|FG001|Phase 1|Withdrawal by Subject|0|||
129564045|NCT02187042|466362061|FG000|Overall Study|Doctor choice|1|||
129779111|NCT02840799|467158047|FG000|Phase 2 (Crossover)|Adverse Event|0|||
129779112|NCT02840799|467158048|FG001|Phase 2 (Crossover)|Adverse Event|1|||
129779113|NCT02840799|467158047|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
129779114|NCT02840799|467158048|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
129779115|NCT02565784|467158049|FG000|First Treatment|Adverse Event|1|||
129779116|NCT02565784|467158049|FG000|First Treatment|Withdrawal by Subject|1|||
129779117|NCT02565784|467158049|FG000|Second Treatment|Withdrawal by Subject|2|||
129779118|NCT00552188|467158055|FG000|Overall Study|Adverse Event|0|||
129779119|NCT00552188|467158056|FG001|Overall Study|Adverse Event|2|||
129779120|NCT00552188|467158055|FG000|Overall Study|Lost to Follow-up|2|||
129779121|NCT00552188|467158056|FG001|Overall Study|Lost to Follow-up|1|||
129779122|NCT00552188|467158055|FG000|Overall Study|Withdrawal of consent|0|||
129779123|NCT00552188|467158056|FG001|Overall Study|Withdrawal of consent|1|||
129779124|NCT00552188|467158055|FG000|Overall Study|Subject returned to home country|0|||
129779125|NCT00552188|467158056|FG001|Overall Study|Subject returned to home country|1|||
129779126|NCT00476008|467158066|FG000|Overall Study|Adverse Event|4|||
129779127|NCT00476008|467158067|FG001|Overall Study|Adverse Event|4|||
129779128|NCT00476008|467158066|FG000|Overall Study|Placebo concerns|2|||
129779129|NCT00476008|467158067|FG001|Overall Study|Placebo concerns|2|||
129779130|NCT00476008|467158066|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
129779131|NCT00476008|467158067|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
129779132|NCT00476008|467158066|FG000|Overall Study|Withdrawal by Subject|0|||
129779133|NCT00476008|467158067|FG001|Overall Study|Withdrawal by Subject|1|||
129779134|NCT00476008|467158066|FG000|Overall Study|Death|1|||
129779135|NCT00476008|467158067|FG001|Overall Study|Death|0|||
129779136|NCT01168219|467158071|FG000|Overall Study|off study before starting treatment|2|||
129779137|NCT01168219|467158071|FG000|Overall Study|withdrew before transplant|1|||
129779138|NCT01168219|467158071|FG000|Overall Study|ineligible due to CML|2|||
129779139|NCT00792571|467158072|FG000|Overall Study|Death|1|||
129779140|NCT00792571|467158072|FG000|Overall Study|Adverse Event|4|||
129779141|NCT00792571|467158072|FG000|Overall Study|Withdrawal by Subject|1|||
129779142|NCT00792571|467158072|FG000|Overall Study|Other|4|||
129779143|NCT02600819|467158073|FG000|GEN Phase|Adverse Event|2|||
129779144|NCT02600819|467158074|FG001|GEN Phase|Adverse Event|0|||
129779145|NCT02600819|467158073|FG000|GEN Phase|Death|2|||
129779146|NCT02600819|467158074|FG001|GEN Phase|Death|0|||
129779147|NCT02600819|467158073|FG000|GEN Phase|Investigator's Discretion|4|||
129779148|NCT02600819|467158074|FG001|GEN Phase|Investigator's Discretion|0|||
129779149|NCT02600819|467158073|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
129779150|NCT02600819|467158074|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
129779151|NCT02600819|467158073|FG000|GEN Phase|Withdrew Consent|5|||
129779152|NCT02600819|467158074|FG001|GEN Phase|Withdrew Consent|0|||
129779153|NCT02600819|467158073|FG000|GEN Phase|Lost to Follow-up|2|||
129779154|NCT02600819|467158074|FG001|GEN Phase|Lost to Follow-up|0|||
129779155|NCT01621802|467158076|FG000|Overall Study|Protocol Violation|0|||
129779156|NCT01621802|467158077|FG001|Overall Study|Protocol Violation|0|||
129779157|NCT01621802|467158078|FG002|Overall Study|Protocol Violation|0|||
129779158|NCT01621802|467158079|FG003|Overall Study|Protocol Violation|0|||
129779159|NCT01621802|467158080|FG004|Overall Study|Protocol Violation|0|||
129779160|NCT01621802|467158081|FG005|Overall Study|Protocol Violation|1|||
129779161|NCT01621802|467158076|FG000|Overall Study|Withdrawal by Subject|8|||
129779162|NCT01621802|467158077|FG001|Overall Study|Withdrawal by Subject|4|||
129779163|NCT01621802|467158078|FG002|Overall Study|Withdrawal by Subject|4|||
129779164|NCT01621802|467158079|FG003|Overall Study|Withdrawal by Subject|2|||
129779165|NCT01621802|467158080|FG004|Overall Study|Withdrawal by Subject|2|||
129779166|NCT01621802|467158081|FG005|Overall Study|Withdrawal by Subject|0|||
129779167|NCT01621802|467158076|FG000|Overall Study|Migrated/moved from study area|0|||
129779168|NCT01621802|467158077|FG001|Overall Study|Migrated/moved from study area|0|||
129779169|NCT01621802|467158078|FG002|Overall Study|Migrated/moved from study area|2|||
129779170|NCT01621802|467158079|FG003|Overall Study|Migrated/moved from study area|0|||
129779171|NCT01621802|467158080|FG004|Overall Study|Migrated/moved from study area|1|||
129779172|NCT01621802|467158081|FG005|Overall Study|Migrated/moved from study area|0|||
129779173|NCT01621802|467158076|FG000|Overall Study|Others|3|||
129779174|NCT01621802|467158077|FG001|Overall Study|Others|3|||
129779175|NCT01621802|467158078|FG002|Overall Study|Others|3|||
129779176|NCT01621802|467158079|FG003|Overall Study|Others|2|||
129779177|NCT01621802|467158080|FG004|Overall Study|Others|1|||
129779178|NCT01621802|467158081|FG005|Overall Study|Others|0|||
129779179|NCT01621802|467158076|FG000|Overall Study|Lost to Follow-up|36|||
129779180|NCT01621802|467158077|FG001|Overall Study|Lost to Follow-up|16|||
129779181|NCT01621802|467158078|FG002|Overall Study|Lost to Follow-up|24|||
129779182|NCT01621802|467158079|FG003|Overall Study|Lost to Follow-up|7|||
129779183|NCT01621802|467158080|FG004|Overall Study|Lost to Follow-up|31|||
129779184|NCT01621802|467158081|FG005|Overall Study|Lost to Follow-up|11|||
129779185|NCT03790696|467158082|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
129779186|NCT03790696|467158083|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
129779187|NCT01149148|467158084|FG000|Overall Study|Lost to Follow-up|1|||
129779188|NCT01149148|467158085|FG001|Overall Study|Lost to Follow-up|2|||
129779189|NCT01149148|467158084|FG000|Overall Study|Death|1|||
129779190|NCT01149148|467158085|FG001|Overall Study|Death|0|||
129779191|NCT03436082|467158086|FG000|Overall Study|Did not undergo procedure|1|||
129779192|NCT03436082|467158087|FG001|Overall Study|Did not undergo procedure|0|||
129779193|NCT00950859|467158090|FG000|Overall Study|Adverse Event|3|||
129779194|NCT00950859|467158091|FG001|Overall Study|Adverse Event|3|||
129779195|NCT00950859|467158090|FG000|Overall Study|Insufficient Viral Load Response|12|||
129779196|NCT00950859|467158091|FG001|Overall Study|Insufficient Viral Load Response|3|||
129779197|NCT00950859|467158090|FG000|Overall Study|Protocol Violation|1|||
129779198|NCT00950859|467158091|FG001|Overall Study|Protocol Violation|1|||
129779199|NCT00950859|467158090|FG000|Overall Study|Lost to Follow-up|0|||
129779200|NCT00950859|467158091|FG001|Overall Study|Lost to Follow-up|3|||
129779201|NCT04896086|467158092|FG000|Overall Study|Lost to Follow-up|0|||
129779202|NCT04896086|467158093|FG001|Overall Study|Lost to Follow-up|2|||
129779203|NCT04896086|467158094|FG002|Overall Study|Lost to Follow-up|1|||
129779204|NCT04896086|467158095|FG003|Overall Study|Lost to Follow-up|0|||
129779205|NCT04896086|467158096|FG004|Overall Study|Lost to Follow-up|0|||
129779206|NCT04896086|467158092|FG000|Overall Study|Physician Decision|0|||
129779207|NCT04896086|467158093|FG001|Overall Study|Physician Decision|1|||
129779208|NCT04896086|467158094|FG002|Overall Study|Physician Decision|0|||
129779209|NCT04896086|467158095|FG003|Overall Study|Physician Decision|0|||
129779210|NCT04896086|467158096|FG004|Overall Study|Physician Decision|0|||
129779211|NCT04896086|467158092|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
129779212|NCT04896086|467158093|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
129779213|NCT04896086|467158094|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
129779214|NCT04896086|467158095|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
129779215|NCT04896086|467158096|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
129779216|NCT04896086|467158092|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
129779217|NCT04896086|467158093|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
129779218|NCT04896086|467158094|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
129779219|NCT04896086|467158095|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
129779220|NCT04896086|467158096|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
129779221|NCT02249832|467158099|FG000|Overall Study|Withdrawal by Subject|3|||
129779222|NCT02249832|467158099|FG000|Overall Study|Lost to Follow-up|10|||
129779223|NCT00243269|467158108|FG000|Overall Study|Protocol Violation|2|||
129779224|NCT00243269|467158109|FG001|Overall Study|Protocol Violation|1|||
129779225|NCT00243269|467158110|FG002|Overall Study|Protocol Violation|0|||
129779226|NCT00243269|467158111|FG003|Overall Study|Protocol Violation|1|||
129779227|NCT00243269|467158108|FG000|Overall Study|Lost to Follow-up|1|||
129779228|NCT00243269|467158109|FG001|Overall Study|Lost to Follow-up|0|||
129779229|NCT00243269|467158110|FG002|Overall Study|Lost to Follow-up|1|||
129779230|NCT00243269|467158111|FG003|Overall Study|Lost to Follow-up|3|||
129779231|NCT00970684|467158113|FG000|Overall Study|Lack of Efficacy|5|||
129779232|NCT00970684|467158113|FG000|Overall Study|Adverse Event|4|||
129779233|NCT00970684|467158113|FG000|Overall Study|Withdrawal by Subject|1|||
129779234|NCT00481091|467158114|FG000|Overall Study|Withdrawal by Subject|0|||
129779235|NCT00481091|467158115|FG001|Overall Study|Withdrawal by Subject|1|||
129779236|NCT00481091|467158116|FG002|Overall Study|Withdrawal by Subject|1|||
129779237|NCT00481091|467158117|FG003|Overall Study|Withdrawal by Subject|0|||
129779238|NCT00481091|467158118|FG004|Overall Study|Withdrawal by Subject|0|||
129779239|NCT00481091|467158119|FG005|Overall Study|Withdrawal by Subject|0|||
129779240|NCT00481091|467158120|FG006|Overall Study|Withdrawal by Subject|0|||
129779241|NCT00481091|467158121|FG007|Overall Study|Withdrawal by Subject|0|||
129779242|NCT00481091|467158122|FG008|Overall Study|Withdrawal by Subject|1|||
129779243|NCT00481091|467158123|FG009|Overall Study|Withdrawal by Subject|6|||
129779244|NCT00481091|467158114|FG000|Overall Study|Other, Not Specified|0|||
129779245|NCT00481091|467158115|FG001|Overall Study|Other, Not Specified|1|||
129779246|NCT00481091|467158116|FG002|Overall Study|Other, Not Specified|1|||
129564046|NCT02187042|466362062|FG001|Overall Study|Doctor choice|0|||
129564047|NCT02187042|466362061|FG000|Overall Study|Progressive disease|4|||
129564048|NCT02187042|466362062|FG001|Overall Study|Progressive disease|8|||
129564049|NCT02116803|466362064|FG000|Overall Study|Adverse Event|2|||
129564050|NCT02116803|466362065|FG001|Overall Study|Adverse Event|1|||
129779247|NCT00481091|467158117|FG003|Overall Study|Other, Not Specified|0|||
129779248|NCT00481091|467158118|FG004|Overall Study|Other, Not Specified|0|||
129779249|NCT00481091|467158119|FG005|Overall Study|Other, Not Specified|1|||
129779250|NCT00481091|467158120|FG006|Overall Study|Other, Not Specified|0|||
129779251|NCT00481091|467158121|FG007|Overall Study|Other, Not Specified|0|||
129779252|NCT00481091|467158122|FG008|Overall Study|Other, Not Specified|0|||
129779253|NCT00481091|467158123|FG009|Overall Study|Other, Not Specified|4|||
129779254|NCT00481091|467158114|FG000|Overall Study|Adverse Event|1|||
129564051|NCT02116803|466362064|FG000|Overall Study|Physician Decision|1|||
129779255|NCT00481091|467158115|FG001|Overall Study|Adverse Event|2|||
129779256|NCT00481091|467158116|FG002|Overall Study|Adverse Event|0|||
129779257|NCT00481091|467158117|FG003|Overall Study|Adverse Event|1|||
129779258|NCT00481091|467158118|FG004|Overall Study|Adverse Event|1|||
129779259|NCT00481091|467158119|FG005|Overall Study|Adverse Event|1|||
129779260|NCT00481091|467158120|FG006|Overall Study|Adverse Event|2|||
129779261|NCT00481091|467158121|FG007|Overall Study|Adverse Event|1|||
129779262|NCT00481091|467158122|FG008|Overall Study|Adverse Event|1|||
129779263|NCT00481091|467158123|FG009|Overall Study|Adverse Event|6|||
129779264|NCT00481091|467158114|FG000|Overall Study|Progressive disease clinical|0|||
129779265|NCT00481091|467158115|FG001|Overall Study|Progressive disease clinical|0|||
129779266|NCT00481091|467158116|FG002|Overall Study|Progressive disease clinical|0|||
129779267|NCT00481091|467158117|FG003|Overall Study|Progressive disease clinical|0|||
129779268|NCT00481091|467158118|FG004|Overall Study|Progressive disease clinical|0|||
129779269|NCT00481091|467158119|FG005|Overall Study|Progressive disease clinical|0|||
129779270|NCT00481091|467158120|FG006|Overall Study|Progressive disease clinical|0|||
129779271|NCT00481091|467158121|FG007|Overall Study|Progressive disease clinical|0|||
129779272|NCT00481091|467158122|FG008|Overall Study|Progressive disease clinical|1|||
129779273|NCT00481091|467158123|FG009|Overall Study|Progressive disease clinical|7|||
129779274|NCT00481091|467158114|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
129779275|NCT00481091|467158115|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
129779276|NCT00481091|467158116|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779277|NCT00481091|467158117|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779278|NCT00481091|467158118|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779279|NCT00481091|467158119|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
129779280|NCT00481091|467158120|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779281|NCT00481091|467158121|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779282|NCT00481091|467158122|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779283|NCT00481091|467158123|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
129779284|NCT00481091|467158114|FG000|Overall Study|Progressive disease other|1|||
129779285|NCT00481091|467158115|FG001|Overall Study|Progressive disease other|1|||
129779286|NCT00481091|467158116|FG002|Overall Study|Progressive disease other|0|||
129779287|NCT00481091|467158117|FG003|Overall Study|Progressive disease other|1|||
129779288|NCT00481091|467158118|FG004|Overall Study|Progressive disease other|1|||
129779289|NCT00481091|467158119|FG005|Overall Study|Progressive disease other|1|||
129779290|NCT00481091|467158120|FG006|Overall Study|Progressive disease other|0|||
129779291|NCT00481091|467158121|FG007|Overall Study|Progressive disease other|2|||
129779292|NCT00481091|467158122|FG008|Overall Study|Progressive disease other|0|||
129779293|NCT00481091|467158123|FG009|Overall Study|Progressive disease other|0|||
129779294|NCT00481091|467158114|FG000|Overall Study|No reason given|0|||
129779295|NCT00481091|467158115|FG001|Overall Study|No reason given|0|||
129779296|NCT00481091|467158116|FG002|Overall Study|No reason given|1|||
129779297|NCT00481091|467158117|FG003|Overall Study|No reason given|1|||
129779298|NCT00481091|467158118|FG004|Overall Study|No reason given|1|||
129779299|NCT00481091|467158119|FG005|Overall Study|No reason given|0|||
129779300|NCT00481091|467158120|FG006|Overall Study|No reason given|1|||
129779301|NCT00481091|467158121|FG007|Overall Study|No reason given|1|||
129779302|NCT00481091|467158122|FG008|Overall Study|No reason given|1|||
129779303|NCT00481091|467158123|FG009|Overall Study|No reason given|4|||
129779304|NCT01296672|467158124|FG000|Overall Study|Lost to Follow-up|73|||
129779305|NCT01296672|467158125|FG001|Overall Study|Lost to Follow-up|18|||
129779306|NCT04661579|467158126|FG000|Overall Study|Lost to Follow-up|19|||
129779307|NCT04661579|467158127|FG001|Overall Study|Lost to Follow-up|10|||
129779308|NCT04661579|467158128|FG002|Overall Study|Lost to Follow-up|2|||
129779309|NCT04661579|467158129|FG003|Overall Study|Lost to Follow-up|7|||
129779310|NCT04661579|467158130|FG004|Overall Study|Lost to Follow-up|11|||
129779311|NCT04661579|467158126|FG000|Overall Study|Physician Decision|2|||
129779312|NCT04661579|467158127|FG001|Overall Study|Physician Decision|0|||
129779313|NCT04661579|467158128|FG002|Overall Study|Physician Decision|0|||
129779314|NCT04661579|467158129|FG003|Overall Study|Physician Decision|1|||
129779315|NCT04661579|467158130|FG004|Overall Study|Physician Decision|0|||
129779316|NCT04661579|467158126|FG000|Overall Study|Withdrawal by Subject|1|||
129779317|NCT04661579|467158127|FG001|Overall Study|Withdrawal by Subject|4|||
129779318|NCT04661579|467158128|FG002|Overall Study|Withdrawal by Subject|0|||
129779319|NCT04661579|467158129|FG003|Overall Study|Withdrawal by Subject|2|||
129779320|NCT04661579|467158130|FG004|Overall Study|Withdrawal by Subject|0|||
129779321|NCT04661579|467158126|FG000|Overall Study|Death|1|||
129564052|NCT02116803|466362065|FG001|Overall Study|Physician Decision|0|||
129779322|NCT04661579|467158127|FG001|Overall Study|Death|0|||
129779323|NCT04661579|467158128|FG002|Overall Study|Death|0|||
129779324|NCT04661579|467158129|FG003|Overall Study|Death|0|||
129779325|NCT04661579|467158130|FG004|Overall Study|Death|0|||
129779326|NCT04661579|467158126|FG000|Overall Study|Other|1|||
129779327|NCT04661579|467158127|FG001|Overall Study|Other|2|||
129688997|NCT03422718|466817932|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
129688998|NCT03422718|466817933|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
129688999|NCT03422718|466817934|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
129689000|NCT03422718|466817935|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
129689001|NCT03422718|466817936|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
129689002|NCT03422718|466817937|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
129689003|NCT03422718|466817938|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
129689004|NCT01129284|466817939|FG000|Overall Study|Adverse Event|2|||
129689005|NCT01129284|466817940|FG001|Overall Study|Adverse Event|0|||
129689006|NCT01129284|466817941|FG002|Overall Study|Adverse Event|1|||
129689007|NCT00845182|466817949|FG000|Overall Study|Lost to Follow-up|3|||
129689008|NCT00845182|466817950|FG001|Overall Study|Lost to Follow-up|3|||
129689009|NCT00845182|466817951|FG002|Overall Study|Lost to Follow-up|4|||
129689010|NCT00845182|466817949|FG000|Overall Study|Adverse Event|0|||
129689011|NCT00845182|466817950|FG001|Overall Study|Adverse Event|1|||
129689012|NCT00845182|466817951|FG002|Overall Study|Adverse Event|1|||
129689013|NCT00845182|466817949|FG000|Overall Study|Physician Decision|0|||
129689014|NCT00845182|466817950|FG001|Overall Study|Physician Decision|0|||
129689015|NCT00845182|466817951|FG002|Overall Study|Physician Decision|1|||
129689016|NCT01625182|466817952|FG000|Overall Study|Administrative problems|1|||
129689017|NCT01625182|466817953|FG001|Overall Study|Administrative problems|0|||
129689018|NCT01625182|466817952|FG000|Overall Study|Protocol deviation|0|||
129689019|NCT01625182|466817953|FG001|Overall Study|Protocol deviation|2|||
129689020|NCT01625182|466817952|FG000|Overall Study|Adverse Event|2|||
129689021|NCT01625182|466817953|FG001|Overall Study|Adverse Event|0|||
129689022|NCT01625182|466817952|FG000|Overall Study|Withdrawal by Subject|5|||
129689023|NCT01625182|466817953|FG001|Overall Study|Withdrawal by Subject|1|||
129689024|NCT01625182|466817952|FG000|Overall Study|Lack of Efficacy|12|||
129689025|NCT01625182|466817953|FG001|Overall Study|Lack of Efficacy|8|||
129689026|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
129689027|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
129689028|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
129689029|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
129689030|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
129689031|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
129689032|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
129689033|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
129689034|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
129689035|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
129689036|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
129689037|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
129689038|NCT00447278|466817956|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
129689039|NCT00447278|466817957|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
129689040|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
129689041|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
129689042|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
129689043|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
129689044|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
129689045|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
129689046|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
129689047|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
129689048|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
129689049|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
129689050|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
129689051|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
129689052|NCT00447278|466817956|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
129689053|NCT00447278|466817957|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
129689054|NCT01348698|466817958|FG000|Overall Study|Does not meet lesion size criteria|1|||
129689055|NCT01348698|466817958|FG000|Overall Study|Death|3|||
129689056|NCT01348698|466817958|FG000|Overall Study|PI decision to close study|68|||
129689057|NCT02595749|466817959|FG000|Overall Study|Withdrawal by Subject|12|||
129689058|NCT02595749|466817960|FG001|Overall Study|Withdrawal by Subject|7|||
129689059|NCT00263562|466817961|FG000|Overall Study|Protocol Violation|3|||
129689060|NCT00263562|466817962|FG001|Overall Study|Protocol Violation|0|||
129689061|NCT05427916|466817968|FG000|Overall Study|Adverse Event|3|||
129689062|NCT05427916|466817969|FG001|Overall Study|Adverse Event|0|||
129689063|NCT05427916|466817968|FG000|Overall Study|Lack of Efficacy|6|||
129689064|NCT05427916|466817969|FG001|Overall Study|Lack of Efficacy|0|||
129689065|NCT05427916|466817968|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
129689066|NCT05427916|466817969|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
129689067|NCT05558410|466817970|FG000|Overall Study|Adverse Event|1|||
129689068|NCT05558410|466817971|FG001|Overall Study|Adverse Event|2|||
129779328|NCT04661579|467158128|FG002|Overall Study|Other|1|||
129779329|NCT04661579|467158129|FG003|Overall Study|Other|1|||
129779330|NCT04661579|467158130|FG004|Overall Study|Other|1|||
129779331|NCT04661579|467158126|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
129779332|NCT04661579|467158127|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
129779333|NCT04661579|467158128|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
129779334|NCT04661579|467158129|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
129779335|NCT04661579|467158130|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
129779336|NCT00796978|467158132|FG000|Overall Study|Cardiac adverse event|5|||
129779337|NCT00796978|467158132|FG000|Overall Study|Adverse Event|4|||
129779338|NCT00796978|467158132|FG000|Overall Study|Withdrawal by Subject|3|||
129779339|NCT00859456|467158133|FG000|Overall Study|Adverse Event|3|||
129779340|NCT00859456|467158133|FG000|Overall Study|Progressive disease|2|||
129779341|NCT00859456|467158133|FG000|Overall Study|Non-compliance|3|||
129779342|NCT00578292|467158134|FG000|Overall Study|Death|1|||
129779343|NCT00578292|467158134|FG000|Overall Study|Graft failure|2|||
129779344|NCT04849559|467158135|FG000|Overall Study|Withdrawal by Subject|2|||
129779345|NCT04849559|467158136|FG001|Overall Study|Withdrawal by Subject|1|||
129779346|NCT02910986|467158137|FG000|Overall Study|non-Latina|14|||
129779347|NCT02910986|467158138|FG001|Overall Study|non-Latina|13|||
129779348|NCT02910986|467158139|FG002|Overall Study|non-Latina|12|||
129779349|NCT02910986|467158137|FG000|Overall Study|Failure to return T! survey|72|||
129779350|NCT02910986|467158138|FG001|Overall Study|Failure to return T! survey|84|||
129779351|NCT02910986|467158139|FG002|Overall Study|Failure to return T! survey|72|||
129779352|NCT02910986|467158137|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
129779353|NCT02910986|467158138|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
129779354|NCT02910986|467158139|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
129779355|NCT02910986|467158137|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
129779356|NCT02910986|467158138|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
129779357|NCT02910986|467158139|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
129779358|NCT03527732|467158142|FG000|Overall Study|Lost to Follow-up|21|||
129779359|NCT03527732|467158143|FG001|Overall Study|Lost to Follow-up|23|||
129779360|NCT03527732|467158144|FG002|Overall Study|Lost to Follow-up|80|||
129779361|NCT03527732|467158145|FG003|Overall Study|Lost to Follow-up|62|||
129779362|NCT03527732|467158146|FG004|Overall Study|Lost to Follow-up|12|||
129779363|NCT03527732|467158147|FG005|Overall Study|Lost to Follow-up|20|||
129779364|NCT02280408|467158148|FG000|Overall Study|Lost to Follow-up|0|||
129779365|NCT02280408|467158149|FG001|Overall Study|Lost to Follow-up|2|||
129779366|NCT02280408|467158150|FG002|Overall Study|Lost to Follow-up|0|||
129779367|NCT02280408|467158151|FG003|Overall Study|Lost to Follow-up|0|||
129779368|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
129779369|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
129779370|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
129779371|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
129779372|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
129779373|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
129779374|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
129779375|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
129779376|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
129779377|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
129779378|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
129779379|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
129779380|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
129779381|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
129779382|NCT04173494|467158152|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
129779383|NCT04173494|467158153|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
129779384|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
129779385|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
129779386|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
129779387|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
129779388|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
129779389|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
129779390|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
129779391|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
129779392|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
129779393|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
129779394|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
129779395|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
129779396|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
129779397|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
129800237|NCT04755283|467236268|FG000|Overall Study|Withdrawal by Subject|14|||
129779398|NCT04173494|467158152|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
129779399|NCT04173494|467158153|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
129779400|NCT02474069|467158154|FG000|Selection Phase (SP)|Adverse Event|8|||
129779401|NCT02474069|467158155|FG001|Selection Phase (SP)|Adverse Event|0|||
129779402|NCT02474069|467158156|FG002|Selection Phase (SP)|Adverse Event|0|||
129779403|NCT02474069|467158154|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
129779404|NCT02474069|467158155|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
129779405|NCT02474069|467158156|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
129779406|NCT02474069|467158154|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
129779407|NCT02474069|467158155|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
129779408|NCT02474069|467158156|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
129779409|NCT02474069|467158154|FG000|Selection Phase (SP)|Physician Decision|1|||
129779410|NCT02474069|467158155|FG001|Selection Phase (SP)|Physician Decision|0|||
129779411|NCT02474069|467158156|FG002|Selection Phase (SP)|Physician Decision|0|||
129779412|NCT02474069|467158154|FG000|Selection Phase (SP)|Protocol Violation|1|||
129779413|NCT02474069|467158155|FG001|Selection Phase (SP)|Protocol Violation|0|||
129779414|NCT02474069|467158156|FG002|Selection Phase (SP)|Protocol Violation|0|||
129779415|NCT02474069|467158154|FG000|Selection Phase (SP)|No longer requires treatment|1|||
129779416|NCT02474069|467158155|FG001|Selection Phase (SP)|No longer requires treatment|0|||
129779417|NCT02474069|467158156|FG002|Selection Phase (SP)|No longer requires treatment|0|||
129779418|NCT02474069|467158154|FG000|Selection Phase (SP)|Technical Problem|1|||
129779419|NCT02474069|467158155|FG001|Selection Phase (SP)|Technical Problem|0|||
129779420|NCT02474069|467158156|FG002|Selection Phase (SP)|Technical Problem|0|||
129779421|NCT02474069|467158154|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
129779422|NCT02474069|467158155|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
129779423|NCT02474069|467158156|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
129779424|NCT02474069|467158154|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
129779425|NCT02474069|467158155|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
129779426|NCT02474069|467158156|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
129779427|NCT02474069|467158154|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
129779428|NCT02474069|467158155|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
129779429|NCT02474069|467158156|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
129779430|NCT02474069|467158154|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
129779431|NCT02474069|467158155|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
129779432|NCT02474069|467158156|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
129779433|NCT02474069|467158154|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
129779434|NCT02474069|467158155|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
129779435|NCT02474069|467158156|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
129779436|NCT02474069|467158154|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
129779437|NCT02474069|467158155|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
129779438|NCT02474069|467158156|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
129779439|NCT01623050|467158159|FG000|Overall Study|Lost to Follow-up|9|||
129779440|NCT01191762|467158160|FG000|Overall Study|Adverse Event|1|||
129779441|NCT01191762|467158161|FG001|Overall Study|Adverse Event|0|||
129779442|NCT00459186|467158162|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
129779443|NCT00459186|467158162|FG000|PET Imaging and Assessment|Adverse Event|3|||
129779444|NCT03710083|467158163|FG000|Overall Study|Withdrawal by Subject|2|||
129779445|NCT03710083|467158163|FG000|Overall Study|Unsuccessful Procedure|1|||
129779446|NCT00838513|467158164|FG000|Screening Period|Screen Failure|3|||
129779447|NCT00838513|467158164|FG000|Extension Treatment Period|Death|1|||
129779448|NCT00838513|467158164|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
129779449|NCT00889720|467158169|FG000|Overall Study|Withdrawal by Subject|4|||
129779450|NCT00889720|467158169|FG000|Overall Study|Other|4|||
129779451|NCT00775593|467158170|FG000|Overall Study|Unmet eligibility criteria|6|||
129779452|NCT00775593|467158170|FG000|Overall Study|Death|1|||
129779453|NCT03904693|467158171|FG000|Overall Study|Death|0|||
129779454|NCT03904693|467158172|FG001|Overall Study|Death|0|||
129779455|NCT03904693|467158173|FG002|Overall Study|Death|3|||
129779456|NCT03904693|467158171|FG000|Overall Study|Physician Decision|0|||
129779457|NCT03904693|467158172|FG001|Overall Study|Physician Decision|0|||
129779458|NCT03904693|467158173|FG002|Overall Study|Physician Decision|2|||
129779459|NCT03904693|467158171|FG000|Overall Study|Withdrawal by Subject|0|||
129779460|NCT03904693|467158172|FG001|Overall Study|Withdrawal by Subject|1|||
129779461|NCT03904693|467158173|FG002|Overall Study|Withdrawal by Subject|4|||
129779462|NCT02100696|467158174|FG000|Induction Phase|Adverse Event|0|||
129689069|NCT05558410|466817972|FG002|Overall Study|Adverse Event|0|||
129689070|NCT05558410|466817970|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
129689071|NCT05558410|466817971|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129689072|NCT05558410|466817972|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
129689073|NCT05558410|466817970|FG000|Overall Study|Lost to Follow-up|10|||
129689074|NCT05558410|466817971|FG001|Overall Study|Lost to Follow-up|17|||
129689075|NCT05558410|466817972|FG002|Overall Study|Lost to Follow-up|19|||
129689076|NCT05558410|466817970|FG000|Overall Study|Death|1|||
129689077|NCT05558410|466817971|FG001|Overall Study|Death|0|||
129689078|NCT05558410|466817972|FG002|Overall Study|Death|0|||
129689079|NCT05558410|466817970|FG000|Overall Study|Other non-compliance|0|||
129689080|NCT05558410|466817971|FG001|Overall Study|Other non-compliance|1|||
129689081|NCT05558410|466817972|FG002|Overall Study|Other non-compliance|2|||
129689082|NCT05558410|466817970|FG000|Overall Study|Sponsor Decision|1|||
129689083|NCT05558410|466817971|FG001|Overall Study|Sponsor Decision|0|||
129689084|NCT05558410|466817972|FG002|Overall Study|Sponsor Decision|0|||
129689085|NCT05558410|466817970|FG000|Overall Study|Other|1|||
129689086|NCT05558410|466817971|FG001|Overall Study|Other|0|||
129689087|NCT05558410|466817972|FG002|Overall Study|Other|1|||
129689088|NCT00933166|466817977|FG000|Overall Study|Lost to Follow-up|4|||
129689089|NCT00933166|466817977|FG000|Overall Study|Lack of Efficacy|9|||
129689090|NCT00933166|466817977|FG000|Overall Study|Unavailable|4|||
129689091|NCT00933166|466817977|FG000|Overall Study|Withdrawal by Subject|1|||
129689092|NCT03501277|466817981|FG000|Intervention Period 1 (4 Days)|Other|0|||
129689093|NCT03501277|466817982|FG001|Intervention Period 1 (4 Days)|Other|0|||
129689094|NCT03501277|466817983|FG002|Intervention Period 1 (4 Days)|Other|1|||
129689095|NCT03501277|466817984|FG003|Intervention Period 1 (4 Days)|Other|0|||
129689096|NCT03501277|466817981|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
129689097|NCT03501277|466817982|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
129689098|NCT03501277|466817983|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
129689099|NCT03501277|466817984|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
129689100|NCT03501277|466817981|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
129689101|NCT03501277|466817982|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
129689102|NCT03501277|466817983|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
129689103|NCT03501277|466817984|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
129689104|NCT03501277|466817981|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
129689105|NCT03501277|466817982|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
129689106|NCT03501277|466817983|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
129689107|NCT03501277|466817984|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
129689108|NCT06038643|466817988|FG000|Overall Study|Withdrawal by Subject|9|||
129689109|NCT06038643|466817989|FG001|Overall Study|Withdrawal by Subject|4|||
129779463|NCT02100696|467158175|FG001|Induction Phase|Adverse Event|0|||
129779464|NCT02100696|467158176|FG002|Induction Phase|Adverse Event|1|||
129779465|NCT02100696|467158177|FG003|Induction Phase|Adverse Event|0|||
129779466|NCT02100696|467158178|FG004|Induction Phase|Adverse Event|0|||
129779467|NCT02100696|467158179|FG005|Induction Phase|Adverse Event|0|||
129779468|NCT02100696|467158174|FG000|Induction Phase|Lost to Follow-up|1|||
129779469|NCT02100696|467158175|FG001|Induction Phase|Lost to Follow-up|0|||
129779470|NCT02100696|467158176|FG002|Induction Phase|Lost to Follow-up|1|||
129779471|NCT02100696|467158177|FG003|Induction Phase|Lost to Follow-up|0|||
129779472|NCT02100696|467158178|FG004|Induction Phase|Lost to Follow-up|0|||
129779473|NCT02100696|467158179|FG005|Induction Phase|Lost to Follow-up|0|||
129779474|NCT02100696|467158174|FG000|Induction Phase|Protocol Violation|0|||
129779475|NCT02100696|467158175|FG001|Induction Phase|Protocol Violation|1|||
129779476|NCT02100696|467158176|FG002|Induction Phase|Protocol Violation|1|||
129779477|NCT02100696|467158177|FG003|Induction Phase|Protocol Violation|0|||
129779478|NCT02100696|467158178|FG004|Induction Phase|Protocol Violation|0|||
129779479|NCT02100696|467158179|FG005|Induction Phase|Protocol Violation|0|||
129689110|NCT06038643|466817988|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
129689111|NCT06038643|466817989|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
129779480|NCT02100696|467158174|FG000|Induction Phase|Withdrawal by Subject|8|||
129689112|NCT04739709|466817996|FG000|Overall Study|Physician Decision|1|||
129689113|NCT04739709|466817997|FG001|Overall Study|Physician Decision|0|||
129779481|NCT02100696|467158175|FG001|Induction Phase|Withdrawal by Subject|2|||
129779482|NCT02100696|467158176|FG002|Induction Phase|Withdrawal by Subject|13|||
129779483|NCT02100696|467158177|FG003|Induction Phase|Withdrawal by Subject|0|||
129689114|NCT02530242|466818006|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
129689115|NCT02530242|466818007|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
129689116|NCT00283959|466818008|FG000|Extension Period|Low Compliance|1|||
129689117|NCT05591755|466818009|FG000|Overall Study|Screen Failure|1|||
129689118|NCT05591755|466818010|FG001|Overall Study|Screen Failure|0|||
129689119|NCT05591755|466818011|FG002|Overall Study|Screen Failure|0|||
129689120|NCT05591755|466818012|FG003|Overall Study|Screen Failure|0|||
129689121|NCT05591755|466818009|FG000|Overall Study|Protocol Violation|0|||
129689122|NCT05591755|466818010|FG001|Overall Study|Protocol Violation|0|||
129564053|NCT02116803|466362064|FG000|Overall Study|Progressive disease|4|||
129564054|NCT02116803|466362065|FG001|Overall Study|Progressive disease|0|||
129564055|NCT02116803|466362064|FG000|Overall Study|Study terminated by sponsor|2|||
129564056|NCT02116803|466362065|FG001|Overall Study|Study terminated by sponsor|1|||
129564057|NCT02116803|466362064|FG000|Overall Study|Death|1|||
129564058|NCT02116803|466362065|FG001|Overall Study|Death|0|||
129564059|NCT01974895|466362068|FG000|Overall Study|Protocol Violation|1|||
129564060|NCT01974895|466362069|FG001|Overall Study|Protocol Violation|0|||
129564061|NCT01974895|466362068|FG000|Overall Study|Lost to Follow-up|4|||
129564062|NCT01974895|466362069|FG001|Overall Study|Lost to Follow-up|6|||
129564063|NCT01974895|466362068|FG000|Overall Study|Withdrawal by Subject|0|||
129689123|NCT05591755|466818011|FG002|Overall Study|Protocol Violation|2|||
129689124|NCT05591755|466818012|FG003|Overall Study|Protocol Violation|0|||
129689125|NCT05591755|466818009|FG000|Overall Study|Withdrawal by Subject|0|||
129689126|NCT05591755|466818010|FG001|Overall Study|Withdrawal by Subject|1|||
129689127|NCT05591755|466818011|FG002|Overall Study|Withdrawal by Subject|0|||
129564064|NCT01974895|466362069|FG001|Overall Study|Withdrawal by Subject|1|||
129564065|NCT01974895|466362068|FG000|Overall Study|Other (Missed Visit)|1|||
129564066|NCT01974895|466362069|FG001|Overall Study|Other (Missed Visit)|0|||
129689128|NCT05591755|466818012|FG003|Overall Study|Withdrawal by Subject|0|||
129689129|NCT00433290|466818013|FG000|Overall Study|Adverse Event|24|||
129689130|NCT00433290|466818014|FG001|Overall Study|Adverse Event|7|||
129564067|NCT01974895|466362068|FG000|Overall Study|Other (Reason unknown)|9|||
129689131|NCT00433290|466818013|FG000|Overall Study|Lack of Efficacy|1|||
129689132|NCT00433290|466818014|FG001|Overall Study|Lack of Efficacy|5|||
129689133|NCT00433290|466818013|FG000|Overall Study|Withdrawal by Subject|4|||
129689134|NCT00433290|466818014|FG001|Overall Study|Withdrawal by Subject|2|||
129689135|NCT00433290|466818013|FG000|Overall Study|Protocol Violation|3|||
129689136|NCT00433290|466818014|FG001|Overall Study|Protocol Violation|2|||
129689137|NCT00433290|466818013|FG000|Overall Study|Physician Decision|2|||
129689138|NCT00433290|466818014|FG001|Overall Study|Physician Decision|0|||
129689139|NCT00433290|466818013|FG000|Overall Study|Entry Criteria Not Met|0|||
129689140|NCT00433290|466818014|FG001|Overall Study|Entry Criteria Not Met|1|||
129689141|NCT00433290|466818013|FG000|Overall Study|Lost to Follow-up|1|||
129689142|NCT00433290|466818014|FG001|Overall Study|Lost to Follow-up|0|||
129689143|NCT01483651|466818015|FG000|Overall Study|Withdrawal by Subject|0|||
129689144|NCT01483651|466818016|FG001|Overall Study|Withdrawal by Subject|1|||
129689145|NCT01483651|466818017|FG002|Overall Study|Withdrawal by Subject|1|||
129689146|NCT01483651|466818018|FG003|Overall Study|Withdrawal by Subject|0|||
129689147|NCT01483651|466818019|FG004|Overall Study|Withdrawal by Subject|0|||
129689148|NCT01483651|466818020|FG005|Overall Study|Withdrawal by Subject|1|||
129689149|NCT00504309|466818030|FG000|Overall Study|Death|0|||
129689150|NCT00504309|466818031|FG001|Overall Study|Death|0|||
129689151|NCT00504309|466818032|FG002|Overall Study|Death|0|||
129689152|NCT00504309|466818033|FG003|Overall Study|Death|0|||
129689153|NCT00504309|466818034|FG004|Overall Study|Death|1|||
129689154|NCT00504309|466818035|FG005|Overall Study|Death|0|||
129689155|NCT00504309|466818030|FG000|Overall Study|Withdrawal by Subject|0|||
129689156|NCT00504309|466818031|FG001|Overall Study|Withdrawal by Subject|0|||
129689157|NCT00504309|466818032|FG002|Overall Study|Withdrawal by Subject|1|||
129689158|NCT00504309|466818033|FG003|Overall Study|Withdrawal by Subject|0|||
129689159|NCT00504309|466818034|FG004|Overall Study|Withdrawal by Subject|0|||
129689160|NCT00504309|466818035|FG005|Overall Study|Withdrawal by Subject|0|||
129689161|NCT03345095|466818036|FG000|Overall Study|Lack of Efficacy|184|||
129689162|NCT03345095|466818037|FG001|Overall Study|Lack of Efficacy|156|||
129689163|NCT03345095|466818036|FG000|Overall Study|Adverse Event|36|||
129689164|NCT03345095|466818037|FG001|Overall Study|Adverse Event|118|||
129689165|NCT03345095|466818036|FG000|Overall Study|Withdrawal by Subject|22|||
129689166|NCT03345095|466818037|FG001|Overall Study|Withdrawal by Subject|59|||
129689167|NCT03345095|466818036|FG000|Overall Study|Physician Decision|3|||
129689168|NCT03345095|466818037|FG001|Overall Study|Physician Decision|18|||
129689169|NCT03345095|466818036|FG000|Overall Study|Death|2|||
129689170|NCT03345095|466818037|FG001|Overall Study|Death|4|||
129689171|NCT03345095|466818036|FG000|Overall Study|Other reasons|2|||
129689172|NCT03345095|466818037|FG001|Overall Study|Other reasons|11|||
129689173|NCT03345095|466818036|FG000|Overall Study|Protocol Violation|0|||
129564068|NCT01974895|466362069|FG001|Overall Study|Other (Reason unknown)|8|||
129689174|NCT03345095|466818037|FG001|Overall Study|Protocol Violation|1|||
129689175|NCT01121575|466818038|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
129564069|NCT01984242|466362070|FG000|Overall Study|Death|52|||
129564070|NCT01984242|466362071|FG001|Overall Study|Death|50|||
129689176|NCT01121575|466818039|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
129564071|NCT01984242|466362072|FG002|Overall Study|Death|52|||
129564072|NCT01984242|466362070|FG000|Overall Study|Withdrawal by Subject|5|||
129564073|NCT01984242|466362071|FG001|Overall Study|Withdrawal by Subject|3|||
129564074|NCT01984242|466362072|FG002|Overall Study|Withdrawal by Subject|10|||
129564075|NCT01984242|466362070|FG000|Overall Study|Physician Decision|0|||
129564076|NCT01984242|466362071|FG001|Overall Study|Physician Decision|0|||
129564077|NCT01984242|466362072|FG002|Overall Study|Physician Decision|1|||
129564078|NCT01984242|466362070|FG000|Overall Study|Lost to Follow-up|4|||
129564079|NCT01984242|466362071|FG001|Overall Study|Lost to Follow-up|0|||
129564080|NCT01984242|466362072|FG002|Overall Study|Lost to Follow-up|3|||
129564081|NCT01984242|466362070|FG000|Overall Study|Sponsor Decision|1|||
129564082|NCT01984242|466362071|FG001|Overall Study|Sponsor Decision|0|||
129564083|NCT01984242|466362072|FG002|Overall Study|Sponsor Decision|0|||
129564084|NCT01984242|466362070|FG000|Overall Study|Non-Compliance|1|||
129564085|NCT01984242|466362071|FG001|Overall Study|Non-Compliance|0|||
129564086|NCT01984242|466362072|FG002|Overall Study|Non-Compliance|0|||
129564087|NCT01984242|466362070|FG000|Overall Study|Study terminated by Sponsor|38|||
129564088|NCT01984242|466362071|FG001|Overall Study|Study terminated by Sponsor|50|||
129564089|NCT01984242|466362072|FG002|Overall Study|Study terminated by Sponsor|34|||
129564090|NCT01984242|466362070|FG000|Overall Study|Disease Progression|0|||
129564091|NCT01984242|466362071|FG001|Overall Study|Disease Progression|0|||
129564092|NCT01984242|466362072|FG002|Overall Study|Disease Progression|1|||
129564093|NCT04543136|466362075|FG000|Overall Study|Withdrawal by Subject|0|||
129779484|NCT02100696|467158178|FG004|Induction Phase|Withdrawal by Subject|0|||
129779485|NCT02100696|467158179|FG005|Induction Phase|Withdrawal by Subject|0|||
129779486|NCT02100696|467158174|FG000|Induction Phase|Physician Decision|1|||
129779487|NCT02100696|467158175|FG001|Induction Phase|Physician Decision|0|||
129779488|NCT02100696|467158176|FG002|Induction Phase|Physician Decision|2|||
129779489|NCT02100696|467158177|FG003|Induction Phase|Physician Decision|0|||
129779490|NCT02100696|467158178|FG004|Induction Phase|Physician Decision|0|||
129779491|NCT02100696|467158179|FG005|Induction Phase|Physician Decision|0|||
129779492|NCT02100696|467158174|FG000|Induction Phase|Multiple Reasons|5|||
129779493|NCT02100696|467158175|FG001|Induction Phase|Multiple Reasons|2|||
129779494|NCT02100696|467158176|FG002|Induction Phase|Multiple Reasons|8|||
129779495|NCT02100696|467158177|FG003|Induction Phase|Multiple Reasons|0|||
129779496|NCT02100696|467158178|FG004|Induction Phase|Multiple Reasons|0|||
129779497|NCT02100696|467158179|FG005|Induction Phase|Multiple Reasons|0|||
129779498|NCT02100696|467158174|FG000|Maintenance Phase|Adverse Event|0|||
129779499|NCT02100696|467158175|FG001|Maintenance Phase|Adverse Event|0|||
129779500|NCT02100696|467158176|FG002|Maintenance Phase|Adverse Event|0|||
129779501|NCT02100696|467158177|FG003|Maintenance Phase|Adverse Event|0|||
129779502|NCT02100696|467158178|FG004|Maintenance Phase|Adverse Event|0|||
129779503|NCT02100696|467158179|FG005|Maintenance Phase|Adverse Event|2|||
129779504|NCT02100696|467158174|FG000|Maintenance Phase|Lost to Follow-up|0|||
129779505|NCT02100696|467158175|FG001|Maintenance Phase|Lost to Follow-up|0|||
129779506|NCT02100696|467158176|FG002|Maintenance Phase|Lost to Follow-up|0|||
129779507|NCT02100696|467158177|FG003|Maintenance Phase|Lost to Follow-up|0|||
129779508|NCT02100696|467158178|FG004|Maintenance Phase|Lost to Follow-up|1|||
129779509|NCT02100696|467158179|FG005|Maintenance Phase|Lost to Follow-up|0|||
129779510|NCT02100696|467158174|FG000|Maintenance Phase|Protocol Violation|0|||
129779511|NCT02100696|467158175|FG001|Maintenance Phase|Protocol Violation|0|||
129779512|NCT02100696|467158176|FG002|Maintenance Phase|Protocol Violation|0|||
129779513|NCT02100696|467158177|FG003|Maintenance Phase|Protocol Violation|0|||
129779514|NCT02100696|467158178|FG004|Maintenance Phase|Protocol Violation|1|||
129779515|NCT02100696|467158179|FG005|Maintenance Phase|Protocol Violation|0|||
129779516|NCT02100696|467158174|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129779517|NCT02100696|467158175|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129779518|NCT02100696|467158176|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129779519|NCT02100696|467158177|FG003|Maintenance Phase|Withdrawal by Subject|1|||
129779520|NCT02100696|467158178|FG004|Maintenance Phase|Withdrawal by Subject|4|||
129779521|NCT02100696|467158179|FG005|Maintenance Phase|Withdrawal by Subject|2|||
129779522|NCT02100696|467158174|FG000|Maintenance Phase|Physician Decision|0|||
129779523|NCT02100696|467158175|FG001|Maintenance Phase|Physician Decision|0|||
129779524|NCT02100696|467158176|FG002|Maintenance Phase|Physician Decision|0|||
129779525|NCT02100696|467158177|FG003|Maintenance Phase|Physician Decision|0|||
129564094|NCT04543136|466362076|FG001|Overall Study|Withdrawal by Subject|1|||
129564095|NCT04543136|466362077|FG002|Overall Study|Withdrawal by Subject|0|||
129564096|NCT04543136|466362078|FG003|Overall Study|Withdrawal by Subject|1|||
129779526|NCT02100696|467158178|FG004|Maintenance Phase|Physician Decision|1|||
129779527|NCT02100696|467158179|FG005|Maintenance Phase|Physician Decision|0|||
129779528|NCT02100696|467158174|FG000|Maintenance Phase|Multiple Reasons|0|||
129779529|NCT02100696|467158175|FG001|Maintenance Phase|Multiple Reasons|0|||
129564097|NCT04543136|466362079|FG004|Overall Study|Withdrawal by Subject|0|||
129564098|NCT04543136|466362080|FG005|Overall Study|Withdrawal by Subject|0|||
129779530|NCT02100696|467158176|FG002|Maintenance Phase|Multiple Reasons|0|||
129564099|NCT01626079|466362083|FG000|Overall Study|Death|167|||
129564100|NCT01626079|466362084|FG001|Overall Study|Death|192|||
129564101|NCT01626079|466362085|FG002|Overall Study|Death|39|||
129564102|NCT01626079|466362083|FG000|Overall Study|Withdrawal by Subject|23|||
129564103|NCT01626079|466362084|FG001|Overall Study|Withdrawal by Subject|37|||
129564104|NCT01626079|466362085|FG002|Overall Study|Withdrawal by Subject|5|||
129564105|NCT01626079|466362083|FG000|Overall Study|Lost to Follow-up|7|||
129564106|NCT01626079|466362084|FG001|Overall Study|Lost to Follow-up|4|||
129564107|NCT01626079|466362085|FG002|Overall Study|Lost to Follow-up|2|||
129564108|NCT01626079|466362083|FG000|Overall Study|Missed Visits|1|||
129564109|NCT01626079|466362084|FG001|Overall Study|Missed Visits|4|||
129564110|NCT01626079|466362085|FG002|Overall Study|Missed Visits|6|||
129564111|NCT01457053|466362087|FG000|Overall Study|Unable to undergo selected treatment|1|||
129564112|NCT01457053|466362088|FG001|Overall Study|Unable to undergo selected treatment|1|||
129564113|NCT03982433|466362089|FG000|Overall Study|Lost to Follow-up|1|||
129564114|NCT00865709|466362090|FG000|Treatment|Adverse Event|9|||
129564115|NCT00865709|466362091|FG001|Treatment|Adverse Event|6|||
129564116|NCT00865709|466362090|FG000|Treatment|Withdrawal by Subject|10|||
129564117|NCT00865709|466362091|FG001|Treatment|Withdrawal by Subject|7|||
129564118|NCT00865709|466362090|FG000|Treatment|Physician Decision|3|||
129564119|NCT00865709|466362091|FG001|Treatment|Physician Decision|2|||
129564120|NCT00865709|466362090|FG000|Treatment|Surgery|8|||
129564121|NCT00865709|466362091|FG001|Treatment|Surgery|3|||
129564122|NCT00429923|466362092|FG000|Overall Study|Adverse Event|0|||
129564123|NCT00429923|466362093|FG001|Overall Study|Adverse Event|2|||
129564124|NCT00429923|466362094|FG002|Overall Study|Adverse Event|3|||
129689177|NCT01121575|466818040|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
129564125|NCT00429923|466362092|FG000|Overall Study|Lack of Efficacy|4|||
129564126|NCT00429923|466362093|FG001|Overall Study|Lack of Efficacy|1|||
129564127|NCT00429923|466362094|FG002|Overall Study|Lack of Efficacy|33|||
129564128|NCT00429923|466362092|FG000|Overall Study|Lost to Follow-up|0|||
129564129|NCT00429923|466362093|FG001|Overall Study|Lost to Follow-up|0|||
129564130|NCT00429923|466362094|FG002|Overall Study|Lost to Follow-up|2|||
129564131|NCT00429923|466362092|FG000|Overall Study|Withdrew Consent|1|||
129564132|NCT00429923|466362093|FG001|Overall Study|Withdrew Consent|0|||
129564133|NCT00429923|466362094|FG002|Overall Study|Withdrew Consent|1|||
129564134|NCT00429923|466362092|FG000|Overall Study|Early Termination|0|||
129564135|NCT00429923|466362093|FG001|Overall Study|Early Termination|1|||
129564136|NCT00429923|466362094|FG002|Overall Study|Early Termination|0|||
129564137|NCT03922477|466362101|FG000|Overall Study|Death|9|||
129564138|NCT03922477|466362101|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
129564139|NCT03922477|466362101|FG000|Overall Study|Physician Decision|1|||
129564140|NCT03922477|466362101|FG000|Overall Study|Withdrawal by Subject|2|||
129564141|NCT03387098|466362107|FG000|Overall Study|progressive disease|1|||
129564142|NCT03387098|466362107|FG000|Overall Study|Withdrawal by Subject|2|||
129564143|NCT03387098|466362107|FG000|Overall Study|study terminated by sponsor|1|||
129564144|NCT00662129|466362108|FG000|Overall Study|Protocol Violation|1|||
129564145|NCT00662129|466362108|FG000|Overall Study|Cancel prior to beginning treatment|1|||
129564146|NCT00662129|466362108|FG000|Overall Study|Ineligible|1|||
129564147|NCT02153736|466362109|FG000|Overall Study|Lost to Follow-up|1|||
129564148|NCT02153736|466362110|FG001|Overall Study|Lost to Follow-up|0|||
129564149|NCT02153736|466362109|FG000|Overall Study|Medical status change made ineligible|1|||
129564150|NCT02153736|466362110|FG001|Overall Study|Medical status change made ineligible|0|||
129564151|NCT02153736|466362109|FG000|Overall Study|Death|0|||
129564152|NCT02153736|466362110|FG001|Overall Study|Death|1|||
129564153|NCT02153736|466362109|FG000|Overall Study|Withdrawal by Subject|0|||
129564154|NCT02153736|466362110|FG001|Overall Study|Withdrawal by Subject|1|||
129564155|NCT00720122|466362121|FG000|Overall Study|Lost to Follow-up|1|||
129564156|NCT00720122|466362121|FG000|Overall Study|Physician Decision|1|||
129564157|NCT00720122|466362121|FG000|Overall Study|Withdrawal by Subject|7|||
129564158|NCT03072459|466362122|FG000|Overall Study|Device revised/removed|1|||
129564159|NCT03072459|466362122|FG000|Overall Study|Subject not able to return|1|||
129564160|NCT02275364|466362123|FG000|Period 1|Withdrawal by Subject|1|||
129564161|NCT02275364|466362124|FG001|Period 1|Withdrawal by Subject|0|||
129564162|NCT02275364|466362123|FG000|Period 1|Other reason|1|||
129564163|NCT02275364|466362124|FG001|Period 1|Other reason|0|||
129564164|NCT02579096|466362125|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
129564165|NCT02579096|466362126|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
129564166|NCT02579096|466362125|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
129564167|NCT02579096|466362126|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
129564168|NCT02579096|466362125|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
129564169|NCT02579096|466362126|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
129564170|NCT02579096|466362125|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
129564171|NCT02579096|466362126|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
129564172|NCT02579096|466362125|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
129564173|NCT02579096|466362126|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
129564174|NCT02579096|466362125|FG000|Phase 2, Weeks 25 - 48|Death|2|||
129564175|NCT02579096|466362126|FG001|Phase 2, Weeks 25 - 48|Death|4|||
129564176|NCT02579096|466362125|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
129564177|NCT02579096|466362126|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
129564178|NCT02579096|466362125|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
129564179|NCT02579096|466362126|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
129564180|NCT02579096|466362125|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
129564181|NCT02579096|466362126|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
129564182|NCT02579096|466362125|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
129564183|NCT02579096|466362126|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
129564184|NCT02579096|466362125|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
129564185|NCT02579096|466362126|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
129564186|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Death|3|||
129564187|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Death|2|||
129564188|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
129564189|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
129564190|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
129779531|NCT02100696|467158177|FG003|Maintenance Phase|Multiple Reasons|0|||
129779532|NCT02100696|467158178|FG004|Maintenance Phase|Multiple Reasons|2|||
129779533|NCT02100696|467158179|FG005|Maintenance Phase|Multiple Reasons|1|||
129779534|NCT03865381|467158182|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
129779535|NCT03865381|467158182|FG000|Overall Study|Withdrawal by Subject|2|||
129779536|NCT05626322|467158183|FG000|Overall Study|Death|2|||
129779537|NCT05626322|467158184|FG001|Overall Study|Death|0|||
129779538|NCT05626322|467158185|FG002|Overall Study|Death|0|||
129779539|NCT05626322|467158183|FG000|Overall Study|Physician Decision|1|||
129779540|NCT05626322|467158184|FG001|Overall Study|Physician Decision|0|||
129779541|NCT05626322|467158185|FG002|Overall Study|Physician Decision|0|||
129779542|NCT05626322|467158183|FG000|Overall Study|Progressive Disease|0|||
129779543|NCT05626322|467158184|FG001|Overall Study|Progressive Disease|1|||
129779544|NCT05626322|467158185|FG002|Overall Study|Progressive Disease|1|||
129779545|NCT05626322|467158183|FG000|Overall Study|Study terminated by sponsor|0|||
129779546|NCT05626322|467158184|FG001|Overall Study|Study terminated by sponsor|1|||
129779547|NCT05626322|467158185|FG002|Overall Study|Study terminated by sponsor|0|||
129779548|NCT01668589|467158190|FG000|Overall Study|Lost to Follow-up|29|||
129564191|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
129564192|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
129564193|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
129564194|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
129564195|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
129564196|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
129564197|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
129564198|NCT02579096|466362125|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
129564199|NCT02579096|466362126|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
129564200|NCT02097121|466362131|FG000|Overall Study|Other, not specified|4|||
129564201|NCT02097121|466362132|FG001|Overall Study|Other, not specified|2|||
129564202|NCT02097121|466362133|FG002|Overall Study|Other, not specified|3|||
129564203|NCT02097121|466362131|FG000|Overall Study|Lack of Efficacy|2|||
129564204|NCT02097121|466362132|FG001|Overall Study|Lack of Efficacy|1|||
129564205|NCT02097121|466362133|FG002|Overall Study|Lack of Efficacy|3|||
129564206|NCT02097121|466362131|FG000|Overall Study|Withdrawal by Subject|0|||
129564207|NCT02097121|466362132|FG001|Overall Study|Withdrawal by Subject|1|||
129564208|NCT02097121|466362133|FG002|Overall Study|Withdrawal by Subject|2|||
129564209|NCT02097121|466362131|FG000|Overall Study|Adverse Event|0|||
129564210|NCT02097121|466362132|FG001|Overall Study|Adverse Event|1|||
129564211|NCT02097121|466362133|FG002|Overall Study|Adverse Event|0|||
129564212|NCT02097121|466362131|FG000|Overall Study|Lost to Follow-up|1|||
129564213|NCT02097121|466362132|FG001|Overall Study|Lost to Follow-up|1|||
129689178|NCT01121575|466818041|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
129689179|NCT01121575|466818042|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
129564214|NCT02097121|466362133|FG002|Overall Study|Lost to Follow-up|2|||
129564215|NCT03066999|466362134|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
129564216|NCT03066999|466362135|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
129564217|NCT00661999|466362136|FG000|Overall Study|Adverse Event|11|||
129689180|NCT01121575|466818043|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
129689181|NCT01121575|466818038|FG000|Overall Study|Unspecified Reasons|8|||
129689182|NCT01121575|466818039|FG001|Overall Study|Unspecified Reasons|6|||
129564218|NCT00661999|466362137|FG001|Overall Study|Adverse Event|5|||
129689183|NCT01121575|466818040|FG002|Overall Study|Unspecified Reasons|7|||
129564219|NCT00661999|466362138|FG002|Overall Study|Adverse Event|8|||
129564220|NCT00661999|466362136|FG000|Overall Study|Death|8|||
129564221|NCT00661999|466362137|FG001|Overall Study|Death|6|||
129564222|NCT00661999|466362138|FG002|Overall Study|Death|3|||
129564223|NCT00661999|466362136|FG000|Overall Study|Other Reasons|5|||
129564224|NCT00661999|466362137|FG001|Overall Study|Other Reasons|12|||
129564225|NCT00661999|466362138|FG002|Overall Study|Other Reasons|23|||
129564226|NCT00661999|466362136|FG000|Overall Study|Withdrawal by Subject|30|||
129564227|NCT00661999|466362137|FG001|Overall Study|Withdrawal by Subject|23|||
129564228|NCT00661999|466362138|FG002|Overall Study|Withdrawal by Subject|14|||
129564229|NCT00661999|466362136|FG000|Overall Study|Alternative Treatment|1|||
129564230|NCT00661999|466362137|FG001|Overall Study|Alternative Treatment|0|||
129564231|NCT00661999|466362138|FG002|Overall Study|Alternative Treatment|0|||
129564232|NCT00661999|466362136|FG000|Overall Study|Other Medical Problems|4|||
129564233|NCT00661999|466362137|FG001|Overall Study|Other Medical Problems|4|||
129564234|NCT00661999|466362138|FG002|Overall Study|Other Medical Problems|9|||
129564235|NCT00510510|466362139|FG000|Overall Study|Adverse Event|4|||
129564236|NCT00510510|466362140|FG001|Overall Study|Adverse Event|3|||
129564237|NCT00510510|466362141|FG002|Overall Study|Adverse Event|6|||
129564238|NCT00510510|466362139|FG000|Overall Study|Lack of Efficacy|0|||
129564239|NCT00510510|466362140|FG001|Overall Study|Lack of Efficacy|1|||
129564240|NCT00510510|466362141|FG002|Overall Study|Lack of Efficacy|1|||
129564241|NCT00510510|466362139|FG000|Overall Study|Subjects no longer requires study drug|0|||
129564242|NCT00510510|466362140|FG001|Overall Study|Subjects no longer requires study drug|0|||
129564243|NCT00510510|466362141|FG002|Overall Study|Subjects no longer requires study drug|2|||
129564244|NCT00510510|466362139|FG000|Overall Study|Withdrawal by Subject|1|||
129564245|NCT00510510|466362140|FG001|Overall Study|Withdrawal by Subject|2|||
129564246|NCT00510510|466362141|FG002|Overall Study|Withdrawal by Subject|3|||
129564247|NCT00510510|466362139|FG000|Overall Study|Lost to Follow-up|0|||
129564248|NCT00510510|466362140|FG001|Overall Study|Lost to Follow-up|0|||
129564249|NCT00510510|466362141|FG002|Overall Study|Lost to Follow-up|1|||
129564250|NCT00510510|466362139|FG000|Overall Study|Protocol Violation|0|||
129564251|NCT00510510|466362140|FG001|Overall Study|Protocol Violation|3|||
129564252|NCT00510510|466362141|FG002|Overall Study|Protocol Violation|4|||
129564253|NCT03595657|466362142|FG000|Overall Study|Adverse Event|14|||
129564254|NCT03595657|466362142|FG000|Overall Study|Death|1|||
129564255|NCT03595657|466362142|FG000|Overall Study|Lack of Efficacy|40|||
129564256|NCT03595657|466362142|FG000|Overall Study|Withdrawal by Subject|10|||
129564257|NCT03595657|466362142|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
129564258|NCT03595657|466362142|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
129564259|NCT01361126|466362143|FG000|Overall Study|Sponsor decision|0|||
129564260|NCT01361126|466362144|FG001|Overall Study|Sponsor decision|2|||
129564261|NCT00663871|466362146|FG000|Overall Study|Lost to Follow-up|5|||
129564262|NCT00663871|466362147|FG001|Overall Study|Lost to Follow-up|5|||
129564263|NCT00663871|466362146|FG000|Overall Study|Withdrawal by Subject|5|||
129564264|NCT00663871|466362147|FG001|Overall Study|Withdrawal by Subject|2|||
129564265|NCT04094870|466362148|FG000|Overall Study|Lost to Follow-up|1|||
129564266|NCT04094870|466362149|FG001|Overall Study|Lost to Follow-up|1|||
129564267|NCT03384745|466362150|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129779549|NCT01668589|467158191|FG001|Overall Study|Lost to Follow-up|37|||
129779550|NCT01668589|467158192|FG002|Overall Study|Lost to Follow-up|15|||
129779551|NCT01668589|467158193|FG003|Overall Study|Lost to Follow-up|5|||
129779552|NCT01668589|467158190|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
129779553|NCT01668589|467158191|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
129779554|NCT01668589|467158192|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
129779555|NCT01668589|467158193|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
129779556|NCT01668589|467158190|FG000|Overall Study|Death|12|||
129779557|NCT01668589|467158191|FG001|Overall Study|Death|3|||
129564268|NCT03384745|466362151|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129564269|NCT03384745|466362152|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
129564270|NCT03384745|466362153|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
129564271|NCT03384745|466362154|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129564272|NCT03384745|466362155|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
129564273|NCT03384745|466362150|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129564274|NCT03384745|466362151|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129779558|NCT01668589|467158192|FG002|Overall Study|Death|2|||
129779559|NCT01668589|467158193|FG003|Overall Study|Death|11|||
129779560|NCT01668589|467158190|FG000|Overall Study|Other|44|||
129779561|NCT01668589|467158191|FG001|Overall Study|Other|10|||
129564275|NCT03384745|466362152|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129564276|NCT03384745|466362153|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
129564277|NCT03384745|466362154|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
129564278|NCT03384745|466362155|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
129564279|NCT03384745|466362150|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
129564280|NCT03384745|466362151|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
129564281|NCT03384745|466362152|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
129564282|NCT03384745|466362153|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
129564283|NCT03384745|466362154|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
129564284|NCT03384745|466362155|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
129564285|NCT03384745|466362150|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129564286|NCT03384745|466362151|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129564287|NCT03384745|466362152|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
129564288|NCT03384745|466362153|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129564289|NCT03384745|466362154|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129564290|NCT03384745|466362155|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
129564291|NCT03384745|466362150|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129564292|NCT03384745|466362151|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129564293|NCT03384745|466362152|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129564294|NCT03384745|466362153|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
129564295|NCT03384745|466362154|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
129564296|NCT03384745|466362155|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
129564297|NCT03384745|466362150|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129564298|NCT03384745|466362151|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129564299|NCT03384745|466362152|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129564300|NCT03384745|466362153|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129564301|NCT03384745|466362154|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
129564302|NCT03384745|466362155|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
129564303|NCT03384745|466362150|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129564304|NCT03384745|466362151|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129564305|NCT03384745|466362152|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
129564306|NCT03384745|466362153|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
129564307|NCT03384745|466362154|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129564308|NCT03384745|466362155|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
129564309|NCT03384745|466362150|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
129564310|NCT03384745|466362151|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
129564311|NCT03384745|466362152|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
129564312|NCT03384745|466362153|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
129564313|NCT03384745|466362154|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
129564314|NCT03384745|466362155|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
129564315|NCT03384745|466362150|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
129564316|NCT03384745|466362151|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
129564317|NCT03384745|466362152|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
129564318|NCT03384745|466362153|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
129564319|NCT03384745|466362154|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
129564320|NCT03384745|466362155|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
129564321|NCT03384745|466362150|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129564322|NCT03384745|466362151|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129564323|NCT03384745|466362152|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129564324|NCT03384745|466362153|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
129564325|NCT03384745|466362154|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129564326|NCT03384745|466362155|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
129564327|NCT03384745|466362150|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
129564328|NCT03384745|466362151|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
129564329|NCT03384745|466362152|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
129564330|NCT03384745|466362153|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
129689184|NCT01121575|466818041|FG003|Overall Study|Unspecified Reasons|5|||
129689185|NCT01121575|466818042|FG004|Overall Study|Unspecified Reasons|13|||
129689186|NCT01121575|466818043|FG005|Overall Study|Unspecified Reasons|10|||
129689187|NCT01121575|466818038|FG000|Overall Study|Death|6|||
129689188|NCT01121575|466818039|FG001|Overall Study|Death|0|||
129689189|NCT01121575|466818040|FG002|Overall Study|Death|0|||
129689190|NCT01121575|466818041|FG003|Overall Study|Death|1|||
129564331|NCT03384745|466362154|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
129564332|NCT03384745|466362155|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
129564333|NCT02984683|466362160|FG000|Overall Study|Adverse Event|3|||
129689191|NCT01121575|466818042|FG004|Overall Study|Death|7|||
129689192|NCT01121575|466818043|FG005|Overall Study|Death|1|||
129689193|NCT00724503|466818045|FG000|Overall Study|Lost to Follow-up|4|||
129564334|NCT02984683|466362161|FG001|Overall Study|Adverse Event|3|||
129564335|NCT02984683|466362160|FG000|Overall Study|Withdrawal by Subject|1|||
129564336|NCT02984683|466362161|FG001|Overall Study|Withdrawal by Subject|0|||
129564337|NCT02984683|466362160|FG000|Overall Study|Disease progression|7|||
129564338|NCT02984683|466362161|FG001|Overall Study|Disease progression|9|||
129564339|NCT02742181|466362162|FG000|Overall Study|Physician Decision|1|||
129564340|NCT02742181|466362163|FG001|Overall Study|Physician Decision|0|||
129564341|NCT02739984|466362164|FG000|Overall Study|Sponsor Decision|1|||
129564342|NCT02739984|466362165|FG001|Overall Study|Sponsor Decision|0|||
129564343|NCT02739984|466362164|FG000|Overall Study|Withdrawal by Subject|1|||
129564344|NCT02739984|466362165|FG001|Overall Study|Withdrawal by Subject|1|||
129564345|NCT02739984|466362164|FG000|Overall Study|Death|0|||
129564346|NCT02739984|466362165|FG001|Overall Study|Death|1|||
129564347|NCT02739984|466362164|FG000|Overall Study|Lost to Follow-up|3|||
129564348|NCT02739984|466362165|FG001|Overall Study|Lost to Follow-up|0|||
129564349|NCT02260492|466362166|FG000|Overall Study|Adverse Event|6|||
129564350|NCT02260492|466362167|FG001|Overall Study|Adverse Event|1|||
129564351|NCT02260492|466362168|FG002|Overall Study|Adverse Event|2|||
129564352|NCT02260492|466362166|FG000|Overall Study|Death|0|||
129564353|NCT02260492|466362167|FG001|Overall Study|Death|1|||
129564354|NCT02260492|466362168|FG002|Overall Study|Death|0|||
129564355|NCT02260492|466362166|FG000|Overall Study|Lost to Follow-up|12|||
129564356|NCT02260492|466362167|FG001|Overall Study|Lost to Follow-up|9|||
129564357|NCT02260492|466362168|FG002|Overall Study|Lost to Follow-up|0|||
129564358|NCT02260492|466362166|FG000|Overall Study|Physician Decision|2|||
129564359|NCT02260492|466362167|FG001|Overall Study|Physician Decision|0|||
129564360|NCT02260492|466362168|FG002|Overall Study|Physician Decision|1|||
129564361|NCT02260492|466362166|FG000|Overall Study|Withdrawal by Subject|3|||
129564362|NCT02260492|466362167|FG001|Overall Study|Withdrawal by Subject|2|||
129564363|NCT02260492|466362168|FG002|Overall Study|Withdrawal by Subject|2|||
129564364|NCT01691508|466364047|FG000|Overall Study|Adverse Event|3|||
129564365|NCT01691508|466364048|FG001|Overall Study|Adverse Event|3|||
129779562|NCT01668589|467158192|FG002|Overall Study|Other|7|||
129779563|NCT01668589|467158193|FG003|Overall Study|Other|15|||
129779564|NCT01519167|467158194|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
129779565|NCT01519167|467158195|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
129779566|NCT01519167|467158194|FG000|Overall Study|Adverse Event|0|||
129779567|NCT01519167|467158195|FG001|Overall Study|Adverse Event|1|||
129779568|NCT01519167|467158194|FG000|Overall Study|Lack of Efficacy|0|||
129779569|NCT01519167|467158195|FG001|Overall Study|Lack of Efficacy|1|||
129779570|NCT01519167|467158194|FG000|Overall Study|Medical condition changes&deep sedation|0|||
129779571|NCT01519167|467158195|FG001|Overall Study|Medical condition changes&deep sedation|2|||
129779572|NCT01519167|467158194|FG000|Overall Study|Physician Decision|0|||
129779573|NCT01519167|467158195|FG001|Overall Study|Physician Decision|1|||
129779574|NCT04200352|467158203|FG000|Overall Study|Death|1|||
129779575|NCT04200352|467158203|FG000|Overall Study|Adverse Event|6|||
129779576|NCT04200352|467158203|FG000|Overall Study|Withdrawal by parent/guardian|6|||
129779577|NCT04200352|467158203|FG000|Overall Study|Lack of Efficacy|1|||
129779578|NCT04200352|467158203|FG000|Overall Study|Other than specified|6|||
129779579|NCT00993148|467158204|FG000|Overall Study|Lost to Follow-up|2|||
129779580|NCT00993148|467158204|FG000|Overall Study|never initiated treatment|1|||
129779581|NCT00233064|467158205|FG000|Overall Study|Lost to Follow-up|7|||
129779582|NCT00233064|467158206|FG001|Overall Study|Lost to Follow-up|7|||
129779583|NCT00233064|467158205|FG000|Overall Study|Withdrawal by Subject|5|||
129779584|NCT00233064|467158206|FG001|Overall Study|Withdrawal by Subject|3|||
129779585|NCT00233064|467158205|FG000|Overall Study|Death|0|||
129564366|NCT01691508|466364047|FG000|Overall Study|Withdrawal by Subject|1|||
129564367|NCT01691508|466364048|FG001|Overall Study|Withdrawal by Subject|0|||
129564368|NCT02309099|466364054|FG000|Overall Study|Adverse Event|2|||
129564369|NCT02309099|466364055|FG001|Overall Study|Adverse Event|0|||
129564370|NCT06165744|466364056|FG000|Overall Study|Non device-related adverse event|1|||
129564371|NCT02518113|466364057|FG000|Overall Study|Adverse Event|1|||
129564372|NCT02518113|466364058|FG001|Overall Study|Adverse Event|0|||
129564373|NCT02518113|466364059|FG002|Overall Study|Adverse Event|1|||
129564374|NCT02518113|466364060|FG003|Overall Study|Adverse Event|0|||
129564375|NCT02518113|466364057|FG000|Overall Study|Death|1|||
129564376|NCT02518113|466364058|FG001|Overall Study|Death|2|||
129564377|NCT02518113|466364059|FG002|Overall Study|Death|0|||
129564378|NCT02518113|466364060|FG003|Overall Study|Death|0|||
129564379|NCT02518113|466364057|FG000|Overall Study|Physician Decision|0|||
129564380|NCT02518113|466364058|FG001|Overall Study|Physician Decision|1|||
129564381|NCT02518113|466364059|FG002|Overall Study|Physician Decision|0|||
129564382|NCT02518113|466364060|FG003|Overall Study|Physician Decision|0|||
129564383|NCT02518113|466364057|FG000|Overall Study|Progressive Disease|1|||
129779586|NCT00233064|467158206|FG001|Overall Study|Death|1|||
129779587|NCT00233064|467158205|FG000|Overall Study|Relocation|0|||
129564384|NCT02518113|466364058|FG001|Overall Study|Progressive Disease|2|||
129564385|NCT02518113|466364059|FG002|Overall Study|Progressive Disease|3|||
129564386|NCT02518113|466364060|FG003|Overall Study|Progressive Disease|0|||
129564387|NCT00527423|466364081|FG000|Overall Study|Protocol Violation|1|||
129564388|NCT00527423|466364081|FG000|Overall Study|Adverse Event|5|||
129564389|NCT00527423|466364081|FG000|Overall Study|Physician Decision|4|||
129564390|NCT00527423|466364081|FG000|Overall Study|Withdrawal by Subject|10|||
129564391|NCT00527423|466364081|FG000|Overall Study|Lost to Follow-up|4|||
129564392|NCT00527423|466364081|FG000|Overall Study|OTHER|4|||
129564393|NCT00527423|466364081|FG000|Overall Study|Death|9|||
129564394|NCT03702621|466364082|FG000|Overall Study|Physician Decision|6|||
129564395|NCT03702621|466364083|FG001|Overall Study|Physician Decision|6|||
129564396|NCT03194464|466364085|FG000|Overall Study|data not usable|2|||
129564397|NCT03103100|466364086|FG000|Overall Study|Adverse Event|1|||
129564398|NCT03103100|466364087|FG001|Overall Study|Adverse Event|0|||
129564399|NCT03103100|466364088|FG002|Overall Study|Adverse Event|0|||
129564400|NCT03103100|466364086|FG000|Overall Study|Physician Decision|1|||
129564401|NCT03103100|466364087|FG001|Overall Study|Physician Decision|0|||
129564402|NCT03103100|466364088|FG002|Overall Study|Physician Decision|2|||
129564403|NCT00436007|466364091|FG000|Overall Study|Withdrawal by Subject|5|||
129564404|NCT00436007|466364092|FG001|Overall Study|Withdrawal by Subject|3|||
129564405|NCT00436007|466364093|FG002|Overall Study|Withdrawal by Subject|4|||
129564406|NCT00436007|466364091|FG000|Overall Study|Lost to Follow-up|14|||
129564407|NCT00436007|466364092|FG001|Overall Study|Lost to Follow-up|10|||
129564408|NCT00436007|466364093|FG002|Overall Study|Lost to Follow-up|13|||
129564409|NCT00436007|466364091|FG000|Overall Study|Physician Decision|0|||
129564410|NCT00436007|466364092|FG001|Overall Study|Physician Decision|0|||
129564411|NCT00436007|466364093|FG002|Overall Study|Physician Decision|2|||
129564412|NCT00436007|466364091|FG000|Overall Study|Death|0|||
129564413|NCT00436007|466364092|FG001|Overall Study|Death|1|||
129564414|NCT00436007|466364093|FG002|Overall Study|Death|3|||
129564415|NCT00436007|466364091|FG000|Overall Study|Other|0|||
129564416|NCT00436007|466364092|FG001|Overall Study|Other|0|||
129564417|NCT00436007|466364093|FG002|Overall Study|Other|1|||
129564418|NCT01957488|466364094|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
129564419|NCT01957488|466364095|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
129564420|NCT01957488|466364096|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
129564421|NCT01957488|466364097|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
129564422|NCT01957488|466364098|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
129564423|NCT01957488|466364099|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
129689194|NCT00724503|466818046|FG001|Overall Study|Lost to Follow-up|8|||
129689195|NCT00724503|466818045|FG000|Overall Study|Withdrawal by Subject|11|||
129689196|NCT00724503|466818046|FG001|Overall Study|Withdrawal by Subject|23|||
129689197|NCT00724503|466818045|FG000|Overall Study|Death|190|||
129689198|NCT00724503|466818046|FG001|Overall Study|Death|182|||
129689199|NCT00724503|466818045|FG000|Overall Study|Adverse Event|1|||
129689200|NCT00724503|466818046|FG001|Overall Study|Adverse Event|0|||
129689201|NCT00724503|466818045|FG000|Overall Study|Not otherwise specified|4|||
129689202|NCT00724503|466818046|FG001|Overall Study|Not otherwise specified|7|||
129689203|NCT01186419|466818049|FG000|Overall Study|Withdrawal by Subject|5|||
129689204|NCT01186419|466818050|FG001|Overall Study|Withdrawal by Subject|3|||
129689205|NCT01186419|466818049|FG000|Overall Study|Adverse Event|1|||
129689206|NCT01186419|466818050|FG001|Overall Study|Adverse Event|2|||
129689207|NCT01186419|466818049|FG000|Overall Study|Physician Decision|0|||
129689208|NCT01186419|466818050|FG001|Overall Study|Physician Decision|3|||
129689209|NCT01186419|466818049|FG000|Overall Study|Other|1|||
129689210|NCT01186419|466818050|FG001|Overall Study|Other|1|||
129689211|NCT01560416|466818054|FG000|Randomized Phase|Crossover Participants|7|||
129689212|NCT01560416|466818055|FG001|Randomized Phase|Crossover Participants|0|||
129689213|NCT00504231|466819762|FG000|Overall Study|Discrepant chart documentation re route|0|||
129564424|NCT01957488|466364094|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
129564425|NCT01957488|466364095|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
129564426|NCT01957488|466364096|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
129564427|NCT01957488|466364097|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
129564428|NCT01957488|466364098|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
129564429|NCT01957488|466364099|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
129564430|NCT01957488|466364094|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
129564431|NCT01957488|466364095|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
129564432|NCT01957488|466364096|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
129689214|NCT00504231|466819763|FG001|Overall Study|Discrepant chart documentation re route|0|||
129689215|NCT00504231|466819764|FG002|Overall Study|Discrepant chart documentation re route|1|||
129689216|NCT00504231|466819765|FG003|Overall Study|Discrepant chart documentation re route|0|||
129689217|NCT00456612|466819767|FG000|Overall Study|Withdrawal by Subject|3|||
129689218|NCT00266812|466819768|FG000|Overall Study|Disease Progression|9|||
129689219|NCT00266812|466819769|FG001|Overall Study|Disease Progression|3|||
129689220|NCT00266812|466819768|FG000|Overall Study|Death|5|||
129689221|NCT00266812|466819769|FG001|Overall Study|Death|4|||
129689222|NCT00266812|466819768|FG000|Overall Study|Adverse Event|3|||
129689223|NCT00266812|466819769|FG001|Overall Study|Adverse Event|1|||
129564433|NCT01957488|466364097|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
129564434|NCT01957488|466364098|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
129564435|NCT01957488|466364099|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
129564436|NCT01957488|466364094|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129564437|NCT01957488|466364095|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129564438|NCT01957488|466364096|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129564439|NCT01957488|466364097|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
129564440|NCT01957488|466364098|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
129564441|NCT01957488|466364099|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
129564442|NCT01957488|466364094|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129564443|NCT01957488|466364095|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129564444|NCT01957488|466364096|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129564445|NCT01957488|466364097|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129564446|NCT01957488|466364098|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
129564447|NCT01957488|466364099|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
129564448|NCT01957488|466364094|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
129564449|NCT01957488|466364095|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
129564450|NCT01957488|466364096|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
129564451|NCT01957488|466364097|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
129564452|NCT01957488|466364098|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
129564453|NCT01957488|466364099|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
129564454|NCT01957488|466364094|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
129564455|NCT01957488|466364095|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129564456|NCT01957488|466364096|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
129564457|NCT01957488|466364097|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
129564458|NCT01957488|466364098|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129564459|NCT01957488|466364099|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
129564460|NCT01957488|466364094|FG000|Test Period 2 (2 Weeks)|Other|1|||
129564461|NCT01957488|466364095|FG001|Test Period 2 (2 Weeks)|Other|0|||
129564462|NCT01957488|466364096|FG002|Test Period 2 (2 Weeks)|Other|0|||
129564463|NCT01957488|466364097|FG003|Test Period 2 (2 Weeks)|Other|0|||
129564464|NCT01957488|466364098|FG004|Test Period 2 (2 Weeks)|Other|0|||
129564465|NCT01957488|466364099|FG005|Test Period 2 (2 Weeks)|Other|0|||
129564466|NCT01957488|466364094|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129564467|NCT01957488|466364095|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
129564468|NCT01957488|466364096|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129564469|NCT01957488|466364097|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129564470|NCT01957488|466364098|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129564471|NCT01957488|466364099|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
129564472|NCT01957488|466364094|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
129564473|NCT01957488|466364095|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
129564474|NCT01957488|466364096|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
129564475|NCT01957488|466364097|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
129564476|NCT01957488|466364098|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
129564477|NCT01957488|466364099|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
129564478|NCT01957488|466364094|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129689224|NCT00266812|466819768|FG000|Overall Study|Protocol Violation|0|||
129689225|NCT00266812|466819769|FG001|Overall Study|Protocol Violation|1|||
129689226|NCT00266812|466819768|FG000|Overall Study|Withdrawal by Subject|0|||
129689227|NCT00266812|466819769|FG001|Overall Study|Withdrawal by Subject|2|||
129689228|NCT00266812|466819768|FG000|Overall Study|Discontinued before starting study drug|4|||
129689229|NCT00266812|466819769|FG001|Overall Study|Discontinued before starting study drug|0|||
129689230|NCT03695094|466819770|FG000|Overall Study|Adverse Event|1|||
129689231|NCT03695094|466819771|FG001|Overall Study|Adverse Event|1|||
129689232|NCT03695094|466819770|FG000|Overall Study|Withdrawal by Subject|1|||
129689233|NCT03695094|466819771|FG001|Overall Study|Withdrawal by Subject|0|||
129689234|NCT00530075|466819774|FG000|Overall Study|Adverse Event|1|||
129689235|NCT00530075|466819774|FG000|Overall Study|Death|1|||
129689236|NCT00530075|466819774|FG000|Overall Study|Lack of Efficacy|3|||
129689237|NCT00530075|466819774|FG000|Overall Study|Protocol Violation|1|||
129689238|NCT00530075|466819774|FG000|Overall Study|Withdrawal by Subject|1|||
129564479|NCT01957488|466364095|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129564480|NCT01957488|466364096|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129564481|NCT01957488|466364097|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129564482|NCT01957488|466364098|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
129564483|NCT01957488|466364099|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
129689239|NCT02316613|466819775|FG000|Overall Study|Death|63|||
129689240|NCT02316613|466819775|FG000|Overall Study|Lost to Follow-up|9|||
129689241|NCT02316613|466819775|FG000|Overall Study|Lymphoma transformation|2|||
129689242|NCT02316613|466819775|FG000|Overall Study|Participant moved/changed medical team|11|||
129689243|NCT02316613|466819775|FG000|Overall Study|No data and duplicate cases|5|||
129689244|NCT02316613|466819775|FG000|Overall Study|Did not met selection criteria|14|||
129689245|NCT00758043|466819779|FG000|Overall Study|Adverse Event|1|||
129564484|NCT01957488|466364094|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
129564485|NCT01957488|466364095|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129564486|NCT01957488|466364096|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129564487|NCT01957488|466364097|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129564488|NCT01957488|466364098|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129564489|NCT01957488|466364099|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
129564490|NCT01957488|466364094|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129564491|NCT01957488|466364095|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
129564492|NCT01957488|466364096|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129564493|NCT01957488|466364097|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129564494|NCT01957488|466364098|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129564495|NCT01957488|466364099|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
129564496|NCT01439165|466364101|FG000|Overall Study|Protocol Violation|3|||
129564497|NCT01439165|466364102|FG001|Overall Study|Protocol Violation|0|||
129564498|NCT01439165|466364101|FG000|Overall Study|Lost to Follow-up|11|||
129564499|NCT01439165|466364102|FG001|Overall Study|Lost to Follow-up|1|||
129564500|NCT01439165|466364101|FG000|Overall Study|Withdrawal by Subject|7|||
129564501|NCT01439165|466364102|FG001|Overall Study|Withdrawal by Subject|1|||
129564502|NCT00810368|466364103|FG000|Overall Study|Lost to Follow-up|4|||
129564503|NCT00810368|466364104|FG001|Overall Study|Lost to Follow-up|2|||
129564504|NCT00810368|466364103|FG000|Overall Study|Lack of Efficacy|2|||
129564505|NCT00810368|466364104|FG001|Overall Study|Lack of Efficacy|0|||
129564506|NCT02433678|466364105|FG000|Overall Study|Lost to Follow-up|1|||
129564507|NCT02433678|466364106|FG001|Overall Study|Lost to Follow-up|2|||
129564508|NCT03365375|466364109|FG000|Overall Study|Withdrawal by Subject|0|||
129564509|NCT03365375|466364110|FG001|Overall Study|Withdrawal by Subject|1|||
129564510|NCT03365375|466364109|FG000|Overall Study|Lost to Follow-up|0|||
129564511|NCT03365375|466364110|FG001|Overall Study|Lost to Follow-up|4|||
129564512|NCT00266409|466364114|FG000|Overall Study|Lack of Efficacy|2|||
129564513|NCT00266409|466364115|FG001|Overall Study|Lack of Efficacy|6|||
129564514|NCT00266409|466364116|FG002|Overall Study|Lack of Efficacy|1|||
129564515|NCT00266409|466364117|FG003|Overall Study|Lack of Efficacy|2|||
129564516|NCT00266409|466364114|FG000|Overall Study|Adverse Event|7|||
129564517|NCT00266409|466364115|FG001|Overall Study|Adverse Event|2|||
129564518|NCT00266409|466364116|FG002|Overall Study|Adverse Event|1|||
129564519|NCT00266409|466364117|FG003|Overall Study|Adverse Event|1|||
129564520|NCT00266409|466364114|FG000|Overall Study|Lost to Follow-up|18|||
129564521|NCT00266409|466364115|FG001|Overall Study|Lost to Follow-up|21|||
129564522|NCT00266409|466364116|FG002|Overall Study|Lost to Follow-up|6|||
129564523|NCT00266409|466364117|FG003|Overall Study|Lost to Follow-up|8|||
129564524|NCT00266409|466364114|FG000|Overall Study|Withdrawal by Subject|6|||
129564525|NCT00266409|466364115|FG001|Overall Study|Withdrawal by Subject|10|||
129564526|NCT00266409|466364116|FG002|Overall Study|Withdrawal by Subject|3|||
129564527|NCT00266409|466364117|FG003|Overall Study|Withdrawal by Subject|9|||
129564528|NCT00266409|466364114|FG000|Overall Study|Protocol Violation|5|||
129564529|NCT00266409|466364115|FG001|Overall Study|Protocol Violation|3|||
129564530|NCT00266409|466364116|FG002|Overall Study|Protocol Violation|4|||
129564531|NCT00266409|466364117|FG003|Overall Study|Protocol Violation|2|||
129564532|NCT00266409|466364114|FG000|Overall Study|Other|7|||
129564533|NCT00266409|466364115|FG001|Overall Study|Other|4|||
129564534|NCT00266409|466364116|FG002|Overall Study|Other|2|||
129564535|NCT00266409|466364117|FG003|Overall Study|Other|0|||
129564536|NCT00635154|466364121|FG000|Overall Study|Alternative Treatment|8|||
129564537|NCT00635154|466364121|FG000|Overall Study|Other|4|||
129564538|NCT00635154|466364121|FG000|Overall Study|Still on treatment|21|||
129564539|NCT01399736|466364122|FG000|Overall Study|Withdrawal by Subject|4|||
129564540|NCT01399736|466364123|FG001|Overall Study|Withdrawal by Subject|2|||
129564541|NCT01399736|466364122|FG000|Overall Study|Lost to Follow-up|0|||
129564542|NCT01399736|466364123|FG001|Overall Study|Lost to Follow-up|2|||
129564543|NCT03500484|466364124|FG000|Overall Study|Adverse Event|2|||
129564544|NCT03500484|466364125|FG001|Overall Study|Adverse Event|0|||
129564545|NCT03500484|466364124|FG000|Overall Study|Physician Decision|1|||
129689246|NCT00758043|466819780|FG001|Overall Study|Adverse Event|20|||
129564546|NCT03500484|466364125|FG001|Overall Study|Physician Decision|0|||
129564547|NCT03500484|466364124|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
129564548|NCT03500484|466364125|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
129564549|NCT00536575|466364126|FG000|Overall Study|Withdrawal by Subject|1|||
129564550|NCT00536575|466364126|FG000|Overall Study|Death|1|||
129564551|NCT00927810|466364130|FG000|Overall Study|Withdrawal by Subject|0|||
129564552|NCT00927810|466364131|FG001|Overall Study|Withdrawal by Subject|3|||
129564553|NCT00927810|466364132|FG002|Overall Study|Withdrawal by Subject|0|||
129564554|NCT00927810|466364133|FG003|Overall Study|Withdrawal by Subject|1|||
129564555|NCT00927810|466364130|FG000|Overall Study|Lost to Follow-up|0|||
129564556|NCT00927810|466364131|FG001|Overall Study|Lost to Follow-up|2|||
129564557|NCT00927810|466364132|FG002|Overall Study|Lost to Follow-up|1|||
129689247|NCT00758043|466819781|FG002|Overall Study|Adverse Event|12|||
129689248|NCT00758043|466819782|FG003|Overall Study|Adverse Event|62|||
129689249|NCT00758043|466819779|FG000|Overall Study|Lack of Efficacy|0|||
129689250|NCT00758043|466819780|FG001|Overall Study|Lack of Efficacy|6|||
129689251|NCT00758043|466819781|FG002|Overall Study|Lack of Efficacy|18|||
129689252|NCT00758043|466819782|FG003|Overall Study|Lack of Efficacy|12|||
129689253|NCT00758043|466819779|FG000|Overall Study|Refused Further Treatment|0|||
129689254|NCT00758043|466819780|FG001|Overall Study|Refused Further Treatment|11|||
129689255|NCT00758043|466819781|FG002|Overall Study|Refused Further Treatment|5|||
129689256|NCT00758043|466819782|FG003|Overall Study|Refused Further Treatment|8|||
129689257|NCT00758043|466819779|FG000|Overall Study|Lost to Follow-up|0|||
129689258|NCT00758043|466819780|FG001|Overall Study|Lost to Follow-up|2|||
129689259|NCT00758043|466819781|FG002|Overall Study|Lost to Follow-up|2|||
129689260|NCT00758043|466819782|FG003|Overall Study|Lost to Follow-up|5|||
129689261|NCT00758043|466819779|FG000|Overall Study|Withdrawal by Subject|0|||
129689262|NCT00758043|466819780|FG001|Overall Study|Withdrawal by Subject|1|||
129689263|NCT00758043|466819781|FG002|Overall Study|Withdrawal by Subject|1|||
129689264|NCT00758043|466819782|FG003|Overall Study|Withdrawal by Subject|4|||
129689265|NCT00758043|466819779|FG000|Overall Study|Required Prohibited Medication|0|||
129689266|NCT00758043|466819780|FG001|Overall Study|Required Prohibited Medication|0|||
129689267|NCT00758043|466819781|FG002|Overall Study|Required Prohibited Medication|1|||
129689268|NCT00758043|466819782|FG003|Overall Study|Required Prohibited Medication|3|||
129564558|NCT00927810|466364133|FG003|Overall Study|Lost to Follow-up|1|||
129564559|NCT00927810|466364130|FG000|Overall Study|Death|0|||
129564560|NCT00927810|466364131|FG001|Overall Study|Death|2|||
129564561|NCT00927810|466364132|FG002|Overall Study|Death|0|||
129564562|NCT00927810|466364133|FG003|Overall Study|Death|0|||
129564563|NCT00927810|466364130|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129564564|NCT00927810|466364131|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129564565|NCT00927810|466364132|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129564566|NCT00927810|466364133|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129564567|NCT00814463|466364137|FG000|Overall Study|Lost to Follow-up|1|||
129564568|NCT02430870|466364139|FG000|Part 2|Voluntary Withdrawal|0|||
129564569|NCT02430870|466364140|FG001|Part 2|Voluntary Withdrawal|0|||
129564570|NCT02430870|466364141|FG002|Part 2|Voluntary Withdrawal|0|||
129564571|NCT02430870|466364142|FG003|Part 2|Voluntary Withdrawal|0|||
129564572|NCT02430870|466364143|FG004|Part 2|Voluntary Withdrawal|0|||
129564573|NCT02430870|466364144|FG005|Part 2|Voluntary Withdrawal|0|||
129564574|NCT02430870|466364145|FG006|Part 2|Voluntary Withdrawal|1|||
129564575|NCT02430870|466364146|FG007|Part 2|Voluntary Withdrawal|0|||
129564576|NCT02430870|466364139|FG000|Part 2|Other Reason Not Specified|0|||
129564577|NCT02430870|466364140|FG001|Part 2|Other Reason Not Specified|0|||
129564578|NCT02430870|466364141|FG002|Part 2|Other Reason Not Specified|0|||
129564579|NCT02430870|466364142|FG003|Part 2|Other Reason Not Specified|0|||
129564580|NCT02430870|466364143|FG004|Part 2|Other Reason Not Specified|0|||
129564581|NCT02430870|466364144|FG005|Part 2|Other Reason Not Specified|0|||
129564582|NCT02430870|466364145|FG006|Part 2|Other Reason Not Specified|0|||
129564583|NCT02430870|466364146|FG007|Part 2|Other Reason Not Specified|1|||
129564584|NCT01265784|466364147|FG000|Overall Study|Lost to Follow-up|5|||
129564585|NCT01265784|466364148|FG001|Overall Study|Lost to Follow-up|3|||
129564586|NCT01265784|466364149|FG002|Overall Study|Lost to Follow-up|2|||
129564587|NCT01265784|466364147|FG000|Overall Study|Withdrawal by Subject|0|||
129564588|NCT01265784|466364148|FG001|Overall Study|Withdrawal by Subject|5|||
129564589|NCT01265784|466364149|FG002|Overall Study|Withdrawal by Subject|0|||
129564590|NCT01265784|466364147|FG000|Overall Study|Physician Decision|1|||
129564591|NCT01265784|466364148|FG001|Overall Study|Physician Decision|0|||
129564592|NCT01265784|466364149|FG002|Overall Study|Physician Decision|1|||
129564593|NCT01265784|466364147|FG000|Overall Study|Adverse Event|1|||
129564594|NCT01265784|466364148|FG001|Overall Study|Adverse Event|0|||
129564595|NCT01265784|466364149|FG002|Overall Study|Adverse Event|0|||
129564596|NCT01265784|466364147|FG000|Overall Study|Death|3|||
129564597|NCT01265784|466364148|FG001|Overall Study|Death|0|||
129564598|NCT01265784|466364149|FG002|Overall Study|Death|0|||
129564599|NCT01265784|466364147|FG000|Overall Study|Protocol Violation|2|||
129564600|NCT01265784|466364148|FG001|Overall Study|Protocol Violation|0|||
129564601|NCT01265784|466364149|FG002|Overall Study|Protocol Violation|0|||
129564602|NCT01265784|466364147|FG000|Overall Study|Incorrectly Randomized|0|||
129564603|NCT01265784|466364148|FG001|Overall Study|Incorrectly Randomized|0|||
129564604|NCT01265784|466364149|FG002|Overall Study|Incorrectly Randomized|1|||
129564605|NCT00984295|466364152|FG000|Overall Study|Lost to Follow-up|31|||
129564606|NCT00984295|466364153|FG001|Overall Study|Lost to Follow-up|12|||
129564607|NCT00984295|466364154|FG002|Overall Study|Lost to Follow-up|13|||
129564608|NCT00984295|466364152|FG000|Overall Study|Protocol Violation|2|||
129564609|NCT00984295|466364153|FG001|Overall Study|Protocol Violation|1|||
129564610|NCT00984295|466364154|FG002|Overall Study|Protocol Violation|4|||
129564611|NCT00984295|466364152|FG000|Overall Study|Withdrawal by Subject|18|||
129564612|NCT00984295|466364153|FG001|Overall Study|Withdrawal by Subject|9|||
129564613|NCT00984295|466364154|FG002|Overall Study|Withdrawal by Subject|12|||
129564614|NCT00984295|466364152|FG000|Overall Study|CAE - discontinued test vaccine|0|||
129564615|NCT00984295|466364153|FG001|Overall Study|CAE - discontinued test vaccine|1|||
129564616|NCT00984295|466364154|FG002|Overall Study|CAE - discontinued test vaccine|3|||
129564617|NCT00984295|466364152|FG000|Overall Study|Missed one or more blood samplings|3|||
129564618|NCT00984295|466364153|FG001|Overall Study|Missed one or more blood samplings|7|||
129564619|NCT00984295|466364154|FG002|Overall Study|Missed one or more blood samplings|2|||
129564620|NCT00984295|466364152|FG000|Overall Study|Incomplete safety follow-up|11|||
129564621|NCT00984295|466364153|FG001|Overall Study|Incomplete safety follow-up|2|||
129564622|NCT00984295|466364154|FG002|Overall Study|Incomplete safety follow-up|3|||
129564623|NCT04799158|466364155|FG000|Run-In Period|Adverse Event|6|||
129564624|NCT04799158|466364156|FG001|Run-In Period|Adverse Event|0|||
129564625|NCT04799158|466364157|FG002|Run-In Period|Adverse Event|0|||
129564626|NCT04799158|466364158|FG003|Run-In Period|Adverse Event|0|||
129564627|NCT04799158|466364159|FG004|Run-In Period|Adverse Event|0|||
129564628|NCT04799158|466364155|FG000|Run-In Period|Lost to Follow-up|4|||
129564629|NCT04799158|466364156|FG001|Run-In Period|Lost to Follow-up|0|||
129564630|NCT04799158|466364157|FG002|Run-In Period|Lost to Follow-up|0|||
129564631|NCT04799158|466364158|FG003|Run-In Period|Lost to Follow-up|0|||
129564632|NCT04799158|466364159|FG004|Run-In Period|Lost to Follow-up|0|||
129564633|NCT04799158|466364155|FG000|Run-In Period|Significant Protocol Deviation|1|||
129564634|NCT04799158|466364156|FG001|Run-In Period|Significant Protocol Deviation|0|||
129564635|NCT04799158|466364157|FG002|Run-In Period|Significant Protocol Deviation|0|||
129564636|NCT04799158|466364158|FG003|Run-In Period|Significant Protocol Deviation|0|||
129689269|NCT00758043|466819779|FG000|Overall Study|Non-Compliant With study Drug|0|||
129689270|NCT00758043|466819780|FG001|Overall Study|Non-Compliant With study Drug|0|||
129689271|NCT00758043|466819781|FG002|Overall Study|Non-Compliant With study Drug|0|||
129689272|NCT00758043|466819782|FG003|Overall Study|Non-Compliant With study Drug|1|||
129689273|NCT00758043|466819779|FG000|Overall Study|Other Reasons|0|||
129689274|NCT00758043|466819780|FG001|Overall Study|Other Reasons|1|||
129689275|NCT00758043|466819781|FG002|Overall Study|Other Reasons|0|||
129689276|NCT00758043|466819782|FG003|Overall Study|Other Reasons|5|||
129689277|NCT02400580|466819785|FG000|Overall Study|Withdrawal by Subject|1|||
129689278|NCT02400580|466819786|FG001|Overall Study|Withdrawal by Subject|1|||
129689279|NCT02400580|466819785|FG000|Overall Study|Adverse Event|1|||
129689280|NCT02400580|466819786|FG001|Overall Study|Adverse Event|0|||
129689281|NCT00965094|466819789|FG000|Overall Study|Adverse Event|5|||
129689282|NCT00965094|466819790|FG001|Overall Study|Adverse Event|0|||
129689283|NCT00965094|466819789|FG000|Overall Study|Lost to Follow-up|0|||
129689284|NCT00965094|466819790|FG001|Overall Study|Lost to Follow-up|1|||
129689285|NCT01336972|466819794|FG000|Overall Study|Adverse Event|1|||
129689286|NCT01336972|466819795|FG001|Overall Study|Adverse Event|1|||
129689287|NCT01336972|466819796|FG002|Overall Study|Adverse Event|0|||
129689288|NCT02441114|466819798|FG000|Washout2|Withdrawal by Subject|4|||
129689289|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
129689290|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
129689291|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
129689292|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
129689293|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
129689294|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
129689295|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
129689296|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
129564637|NCT04799158|466364159|FG004|Run-In Period|Significant Protocol Deviation|0|||
129564638|NCT04799158|466364155|FG000|Run-In Period|Withdrawal by Subject|11|||
129564639|NCT04799158|466364156|FG001|Run-In Period|Withdrawal by Subject|0|||
129564640|NCT04799158|466364157|FG002|Run-In Period|Withdrawal by Subject|0|||
129564641|NCT04799158|466364158|FG003|Run-In Period|Withdrawal by Subject|0|||
129564642|NCT04799158|466364159|FG004|Run-In Period|Withdrawal by Subject|0|||
129564643|NCT04799158|466364155|FG000|Run-In Period|Miscellaneous|3|||
129564644|NCT04799158|466364156|FG001|Run-In Period|Miscellaneous|0|||
129564645|NCT04799158|466364157|FG002|Run-In Period|Miscellaneous|0|||
129564646|NCT04799158|466364158|FG003|Run-In Period|Miscellaneous|0|||
129564647|NCT04799158|466364159|FG004|Run-In Period|Miscellaneous|0|||
129564648|NCT04799158|466364155|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
129564649|NCT04799158|466364156|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129564650|NCT04799158|466364157|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129564651|NCT04799158|466364158|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129564652|NCT04799158|466364159|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
129564653|NCT04799158|466364155|FG000|On-Demand Treatment Period|Adverse Event|0|||
129564654|NCT04799158|466364156|FG001|On-Demand Treatment Period|Adverse Event|1|||
129564655|NCT04799158|466364157|FG002|On-Demand Treatment Period|Adverse Event|0|||
129564656|NCT04799158|466364158|FG003|On-Demand Treatment Period|Adverse Event|0|||
129564657|NCT04799158|466364159|FG004|On-Demand Treatment Period|Adverse Event|1|||
129564658|NCT04799158|466364155|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
129564659|NCT04799158|466364156|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
129564660|NCT04799158|466364157|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
129564661|NCT04799158|466364158|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
129564662|NCT04799158|466364159|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
129689297|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
129689298|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
129689299|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
129689300|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
129707764|NCT01280968|466892118|FG001|Overall Study|Scheduling Conflicts|1|||
129564663|NCT04799158|466364155|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129564664|NCT04799158|466364156|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129564665|NCT04799158|466364157|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129564666|NCT04799158|466364158|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
129564667|NCT04799158|466364159|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
129564668|NCT04799158|466364155|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
129564669|NCT04799158|466364156|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
129564670|NCT04799158|466364157|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
129564671|NCT04799158|466364158|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
129564672|NCT04799158|466364159|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
129564673|NCT04799158|466364155|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
129564674|NCT04799158|466364156|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
129564675|NCT04799158|466364157|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
129564676|NCT04799158|466364158|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
129564677|NCT04799158|466364159|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
129564678|NCT04799158|466364155|FG000|On-Demand Treatment Period|Miscellaneous|0|||
129564679|NCT04799158|466364156|FG001|On-Demand Treatment Period|Miscellaneous|0|||
129564680|NCT04799158|466364157|FG002|On-Demand Treatment Period|Miscellaneous|0|||
129564681|NCT04799158|466364158|FG003|On-Demand Treatment Period|Miscellaneous|0|||
129564682|NCT04799158|466364159|FG004|On-Demand Treatment Period|Miscellaneous|1|||
129564683|NCT00788957|466364162|FG000|Part 1|Death|8|||
129564684|NCT00788957|466364163|FG001|Part 1|Death|0|||
129564685|NCT00788957|466364164|FG002|Part 1|Death|0|||
129564686|NCT00788957|466364165|FG003|Part 1|Death|0|||
129564687|NCT00788957|466364166|FG004|Part 1|Death|0|||
129564688|NCT00788957|466364167|FG005|Part 1|Death|0|||
129564689|NCT00788957|466364162|FG000|Part 1|Lost to Follow-up|1|||
129564690|NCT00788957|466364163|FG001|Part 1|Lost to Follow-up|0|||
129564691|NCT00788957|466364164|FG002|Part 1|Lost to Follow-up|0|||
129564692|NCT00788957|466364165|FG003|Part 1|Lost to Follow-up|0|||
129564693|NCT00788957|466364166|FG004|Part 1|Lost to Follow-up|0|||
129564694|NCT00788957|466364167|FG005|Part 1|Lost to Follow-up|0|||
129564695|NCT00788957|466364162|FG000|Part 2|Withdrawal by Subject|0|||
129564696|NCT00788957|466364163|FG001|Part 2|Withdrawal by Subject|9|||
129564697|NCT00788957|466364164|FG002|Part 2|Withdrawal by Subject|5|||
129564698|NCT00788957|466364165|FG003|Part 2|Withdrawal by Subject|3|||
129564699|NCT00788957|466364166|FG004|Part 2|Withdrawal by Subject|0|||
129564700|NCT00788957|466364167|FG005|Part 2|Withdrawal by Subject|0|||
129564701|NCT00788957|466364162|FG000|Part 2|Death|0|||
129564702|NCT00788957|466364163|FG001|Part 2|Death|32|||
129564703|NCT00788957|466364164|FG002|Part 2|Death|35|||
129564704|NCT00788957|466364165|FG003|Part 2|Death|37|||
129564705|NCT00788957|466364166|FG004|Part 2|Death|0|||
129564706|NCT00788957|466364167|FG005|Part 2|Death|0|||
129564707|NCT00788957|466364162|FG000|Part 2|Lost to Follow-up|0|||
129564708|NCT00788957|466364163|FG001|Part 2|Lost to Follow-up|0|||
129564709|NCT00788957|466364164|FG002|Part 2|Lost to Follow-up|3|||
129564710|NCT00788957|466364165|FG003|Part 2|Lost to Follow-up|0|||
129564711|NCT00788957|466364166|FG004|Part 2|Lost to Follow-up|0|||
129564712|NCT00788957|466364167|FG005|Part 2|Lost to Follow-up|0|||
129564713|NCT00788957|466364162|FG000|Part 2|On-study at time of data cut-off|0|||
129564714|NCT00788957|466364163|FG001|Part 2|On-study at time of data cut-off|1|||
129564715|NCT00788957|466364164|FG002|Part 2|On-study at time of data cut-off|1|||
129564716|NCT00788957|466364165|FG003|Part 2|On-study at time of data cut-off|1|||
129564717|NCT00788957|466364166|FG004|Part 2|On-study at time of data cut-off|0|||
129564718|NCT00788957|466364167|FG005|Part 2|On-study at time of data cut-off|0|||
129564719|NCT00788957|466364162|FG000|Part 3|Withdrawal by Subject|0|||
129564720|NCT00788957|466364163|FG001|Part 3|Withdrawal by Subject|0|||
129564721|NCT00788957|466364164|FG002|Part 3|Withdrawal by Subject|0|||
129564722|NCT00788957|466364165|FG003|Part 3|Withdrawal by Subject|0|||
129564723|NCT00788957|466364166|FG004|Part 3|Withdrawal by Subject|0|||
129564724|NCT00788957|466364167|FG005|Part 3|Withdrawal by Subject|2|||
129564725|NCT00788957|466364162|FG000|Part 3|Death|0|||
129564726|NCT00788957|466364163|FG001|Part 3|Death|0|||
129564727|NCT00788957|466364164|FG002|Part 3|Death|0|||
129564728|NCT00788957|466364165|FG003|Part 3|Death|0|||
129564729|NCT00788957|466364166|FG004|Part 3|Death|8|||
129564730|NCT00788957|466364167|FG005|Part 3|Death|8|||
129564731|NCT00788957|466364162|FG000|Part 3|On-study at time of data cut-off|0|||
129564732|NCT00788957|466364163|FG001|Part 3|On-study at time of data cut-off|0|||
129564733|NCT00788957|466364164|FG002|Part 3|On-study at time of data cut-off|0|||
129564734|NCT00788957|466364165|FG003|Part 3|On-study at time of data cut-off|0|||
129564735|NCT00788957|466364166|FG004|Part 3|On-study at time of data cut-off|1|||
129564736|NCT00788957|466364167|FG005|Part 3|On-study at time of data cut-off|0|||
129564737|NCT03276975|466364168|FG000|Overall Study|Withdrawal by Subject|1|||
129564738|NCT03276975|466364169|FG001|Overall Study|Withdrawal by Subject|0|||
129564739|NCT00918567|466364172|FG000|Overall Study|Lack of Efficacy|3|||
129564740|NCT00918567|466364173|FG001|Overall Study|Lack of Efficacy|1|||
129564741|NCT00918567|466364172|FG000|Overall Study|Withdrawal by Subject|1|||
129564742|NCT00918567|466364173|FG001|Overall Study|Withdrawal by Subject|1|||
129564743|NCT00918567|466364172|FG000|Overall Study|Adverse Event|1|||
129564744|NCT00918567|466364173|FG001|Overall Study|Adverse Event|0|||
129564745|NCT02568384|466364178|FG000|Overall Study|Mobile devices incompatible with App|2|||
129564746|NCT01485536|466364179|FG000|Overall Study|Withdrawal by Subject|3|||
129564747|NCT01485536|466364179|FG000|Overall Study|Adverse Event|1|||
129564748|NCT00796510|466364180|FG000|Overall Study|Death|1|||
129564749|NCT00796510|466364181|FG001|Overall Study|Death|0|||
129564750|NCT00796510|466364180|FG000|Overall Study|Study Terminated|2|||
129564751|NCT00796510|466364181|FG001|Overall Study|Study Terminated|0|||
129564752|NCT03008460|466364182|FG000|Overall Study|Protocol deviation|0|||
129564753|NCT03008460|466364183|FG001|Overall Study|Protocol deviation|2|||
129564754|NCT03008460|466364182|FG000|Overall Study|Study drug not dispensed|0|||
129564755|NCT03008460|466364183|FG001|Overall Study|Study drug not dispensed|1|||
129564756|NCT03008460|466364182|FG000|Overall Study|Adverse Event|0|||
129564757|NCT03008460|466364183|FG001|Overall Study|Adverse Event|1|||
129564758|NCT03008460|466364182|FG000|Overall Study|Withdrawal by Subject|5|||
129564759|NCT03008460|466364183|FG001|Overall Study|Withdrawal by Subject|6|||
129564760|NCT03008460|466364182|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
129564761|NCT03008460|466364183|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
129564762|NCT03008460|466364182|FG000|Overall Study|End of study visit outside permitted time window|0|||
129564763|NCT03008460|466364183|FG001|Overall Study|End of study visit outside permitted time window|1|||
129564764|NCT03008460|466364182|FG000|Overall Study|Lost to Follow-up|1|||
129564765|NCT03008460|466364183|FG001|Overall Study|Lost to Follow-up|3|||
129779588|NCT00233064|467158206|FG001|Overall Study|Relocation|1|||
129779589|NCT00233064|467158205|FG000|Overall Study|Protocol Violation|1|||
129779590|NCT00233064|467158206|FG001|Overall Study|Protocol Violation|0|||
129779591|NCT00233064|467158205|FG000|Overall Study|Moved to Dom. Republic|1|||
129779592|NCT00233064|467158206|FG001|Overall Study|Moved to Dom. Republic|0|||
129779593|NCT01120964|467158213|FG000|Overall Study|Did not receive full treatment|1|||
129779594|NCT01120964|467158214|FG001|Overall Study|Did not receive full treatment|0|||
129779595|NCT04237116|467158218|FG000|Overall Study|Adverse Event|0|||
129779596|NCT04237116|467158219|FG001|Overall Study|Adverse Event|1|||
129779597|NCT04237116|467158218|FG000|Overall Study|Study terminated by Sponsor|4|||
129779598|NCT04237116|467158219|FG001|Overall Study|Study terminated by Sponsor|1|||
129779599|NCT00829504|467158220|FG000|First Intervention|Adverse Event|1|||
129779600|NCT00829504|467158221|FG001|First Intervention|Adverse Event|0|||
129779601|NCT00829504|467158220|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129779602|NCT00829504|467158221|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129779603|NCT00829504|467158220|FG000|Second Intervention|Physician Decision|1|||
129779604|NCT00829504|467158221|FG001|Second Intervention|Physician Decision|0|||
129779605|NCT03212144|467158222|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
129779606|NCT03212144|467158223|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
129779607|NCT03212144|467158222|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
129779608|NCT03212144|467158223|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
129779609|NCT00599339|467158224|FG000|Overall Study|Adverse Event|79|||
129779610|NCT00599339|467158224|FG000|Overall Study|Withdrawal by Subject|137|||
129779611|NCT00599339|467158224|FG000|Overall Study|Other Reason|179|||
129779612|NCT00599339|467158224|FG000|Overall Study|Lost to Follow-up|221|||
129779613|NCT00599339|467158224|FG000|Overall Study|No valid data consent|36|||
129779614|NCT00599339|467158224|FG000|Overall Study|Study Termination Status Unknown|12|||
129779615|NCT02102204|467159897|FG000|Overall Study|Withdrawal by Subject|137|||
129779616|NCT02102204|467159897|FG000|Overall Study|Death|92|||
129779617|NCT02102204|467159897|FG000|Overall Study|Lost to Follow-up|65|||
129779618|NCT02102204|467159897|FG000|Overall Study|Sponsor Decision|5|||
129779619|NCT02102204|467159897|FG000|Overall Study|Ongoing|5|||
129779620|NCT02260180|467159898|FG000|Overall Study|Adverse Event|2|||
129779621|NCT02260180|467159899|FG001|Overall Study|Adverse Event|0|||
129779622|NCT02260180|467159900|FG002|Overall Study|Adverse Event|1|||
129779623|NCT03860818|467159903|FG000|Overall Study|Death|144|||
129779624|NCT03860818|467159904|FG001|Overall Study|Death|195|||
129779625|NCT03860818|467159903|FG000|Overall Study|Graft Loss|32|||
129779626|NCT03860818|467159904|FG001|Overall Study|Graft Loss|45|||
129779627|NCT03126344|467159905|FG000|Overall Study|Lost to Follow-up|0|||
129779628|NCT03126344|467159906|FG001|Overall Study|Lost to Follow-up|0|||
129779629|NCT03126344|467159907|FG002|Overall Study|Lost to Follow-up|5|||
129779630|NCT03052400|467159908|FG000|Overall Study|Lost to Follow-up|1|||
129779631|NCT03052400|467159909|FG001|Overall Study|Lost to Follow-up|0|||
129779632|NCT03052400|467159908|FG000|Overall Study|Withdrawal by Subject|0|||
129564766|NCT04947579|466364186|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129779633|NCT03052400|467159909|FG001|Overall Study|Withdrawal by Subject|1|||
129779634|NCT00555061|467159910|FG000|Overall Study|Adverse Event|3|||
129779635|NCT00555061|467159910|FG000|Overall Study|Protocol Violation|1|||
129779636|NCT00555061|467159910|FG000|Overall Study|Lost to Follow-up|2|||
129564767|NCT04947579|466364187|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129564768|NCT04947579|466364188|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129779637|NCT00555061|467159910|FG000|Overall Study|Withdrawal by Subject|2|||
129779638|NCT00555061|467159910|FG000|Overall Study|Participant enrolled, but never treated|1|||
129779639|NCT01396447|467159911|FG000|Overall Study|Did Not Receive Treatment|3|||
129564769|NCT04947579|466364189|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
129564770|NCT04947579|466364190|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129564771|NCT04947579|466364191|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
129564772|NCT04947579|466364186|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129564773|NCT04947579|466364187|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129564774|NCT04947579|466364188|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
129564775|NCT04947579|466364189|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129564776|NCT04947579|466364190|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129564777|NCT04947579|466364191|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
129564778|NCT04947579|466364186|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
129564779|NCT04947579|466364187|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
129564780|NCT04947579|466364188|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
129564781|NCT04947579|466364189|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
129564782|NCT04947579|466364190|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
129564783|NCT04947579|466364191|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
129564784|NCT04947579|466364186|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
129564785|NCT04947579|466364187|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
129564786|NCT04947579|466364188|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
129564787|NCT04947579|466364189|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
129564788|NCT04947579|466364190|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
129564789|NCT04947579|466364191|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
129564790|NCT04947579|466364186|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
129564791|NCT04947579|466364187|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129564792|NCT04947579|466364188|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129564793|NCT04947579|466364189|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129564794|NCT04947579|466364190|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129564795|NCT04947579|466364191|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
129564796|NCT04947579|466364186|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129564797|NCT04947579|466364187|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129564798|NCT04947579|466364188|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
129564799|NCT04947579|466364189|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129564800|NCT04947579|466364190|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129564801|NCT04947579|466364191|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
129564802|NCT04947579|466364186|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129564803|NCT04947579|466364187|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
129564804|NCT04947579|466364188|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129564805|NCT04947579|466364189|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129564806|NCT04947579|466364190|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
129564807|NCT04947579|466364191|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
129564808|NCT04947579|466364186|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129564809|NCT04947579|466364187|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129564810|NCT04947579|466364188|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
129564811|NCT04947579|466364189|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129564812|NCT04947579|466364190|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129564813|NCT04947579|466364191|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
129564814|NCT04947579|466364186|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
129564815|NCT04947579|466364187|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
129564816|NCT04947579|466364188|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
129564817|NCT04947579|466364189|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
129564818|NCT04947579|466364190|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
129564819|NCT04947579|466364191|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
129564820|NCT04947579|466364186|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
129564821|NCT04947579|466364187|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
129564822|NCT04947579|466364188|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
129564823|NCT04947579|466364189|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
129564824|NCT04947579|466364190|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
129564825|NCT04947579|466364191|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
129564826|NCT04947579|466364186|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
129564827|NCT04947579|466364187|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
129564828|NCT04947579|466364188|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
129564829|NCT04947579|466364189|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
129564830|NCT04947579|466364190|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
129564831|NCT04947579|466364191|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
129564832|NCT01575054|466364192|FG000|Overall Study|Other Reasons|5|||
129564833|NCT01575054|466364193|FG001|Overall Study|Other Reasons|3|||
129564834|NCT01575054|466364192|FG000|Overall Study|Protocol Violation|2|||
129564835|NCT01575054|466364193|FG001|Overall Study|Protocol Violation|1|||
129564836|NCT01575054|466364192|FG000|Overall Study|Personal Reasons|10|||
129564837|NCT01575054|466364193|FG001|Overall Study|Personal Reasons|11|||
129564838|NCT01575054|466364192|FG000|Overall Study|Lost to Follow-up|3|||
129564839|NCT01575054|466364193|FG001|Overall Study|Lost to Follow-up|3|||
129564840|NCT01575054|466364192|FG000|Overall Study|Adverse Event|9|||
129564841|NCT01575054|466364193|FG001|Overall Study|Adverse Event|8|||
129564842|NCT00462982|466364198|FG000|Overall Study|Adverse Event|1|||
129564843|NCT00462982|466364198|FG000|Overall Study|Patient Not Treated|2|||
129564844|NCT01611090|466364199|FG000|Randomized Period|Lost to Follow-up|8|||
129564845|NCT01611090|466364200|FG001|Randomized Period|Lost to Follow-up|3|||
129564846|NCT01611090|466364201|FG002|Randomized Period|Lost to Follow-up|0|||
129564847|NCT01611090|466364199|FG000|Randomized Period|Withdrawal by Subject|22|||
129564848|NCT01611090|466364200|FG001|Randomized Period|Withdrawal by Subject|26|||
129564849|NCT01611090|466364201|FG002|Randomized Period|Withdrawal by Subject|0|||
129564850|NCT01611090|466364199|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
129564851|NCT01611090|466364200|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
129564852|NCT01611090|466364201|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
129564853|NCT01611090|466364199|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
129564854|NCT01611090|466364200|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
129564855|NCT01611090|466364201|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
129564856|NCT01922349|466364202|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
129564857|NCT01922349|466364203|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
129564858|NCT01922349|466364204|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
129564859|NCT01922349|466364205|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
129564860|NCT02448771|466364206|FG000|Overall Study|Disease Progression|30|||
129564861|NCT02448771|466364206|FG000|Overall Study|Unacceptable Toxicity|1|||
129564862|NCT02448771|466364206|FG000|Overall Study|Physician Decision|3|||
129564863|NCT02448771|466364206|FG000|Overall Study|Started new therapy|2|||
129564864|NCT02683187|466364208|FG000|Overall Study|Failed IV access|3|||
129564865|NCT02683187|466364208|FG000|Overall Study|Withdrawal by Subject|5|||
129564866|NCT00770315|466364209|FG000|Overall Study|Adverse Event|11|||
129564867|NCT00770315|466364210|FG001|Overall Study|Adverse Event|17|||
129564868|NCT00770315|466364211|FG002|Overall Study|Adverse Event|16|||
129564869|NCT00770315|466364212|FG003|Overall Study|Adverse Event|6|||
129564870|NCT00770315|466364209|FG000|Overall Study|Lost to Follow-up|9|||
129564871|NCT00770315|466364210|FG001|Overall Study|Lost to Follow-up|5|||
129564872|NCT00770315|466364211|FG002|Overall Study|Lost to Follow-up|10|||
129564873|NCT00770315|466364212|FG003|Overall Study|Lost to Follow-up|3|||
129564874|NCT00770315|466364209|FG000|Overall Study|Withdrawal by Subject|13|||
129564875|NCT00770315|466364210|FG001|Overall Study|Withdrawal by Subject|17|||
129564876|NCT00770315|466364211|FG002|Overall Study|Withdrawal by Subject|24|||
129564877|NCT00770315|466364212|FG003|Overall Study|Withdrawal by Subject|20|||
129564878|NCT00770315|466364209|FG000|Overall Study|Noncompliance with Protocol|7|||
129564879|NCT00770315|466364210|FG001|Overall Study|Noncompliance with Protocol|4|||
129564880|NCT00770315|466364211|FG002|Overall Study|Noncompliance with Protocol|7|||
129564881|NCT00770315|466364212|FG003|Overall Study|Noncompliance with Protocol|9|||
129564882|NCT02585258|466364213|FG000|Overall Study|Adverse Event|28|||
129564883|NCT02585258|466364214|FG001|Overall Study|Adverse Event|29|||
129564884|NCT02585258|466364213|FG000|Overall Study|Death|3|||
129564885|NCT02585258|466364214|FG001|Overall Study|Death|2|||
129564886|NCT02585258|466364213|FG000|Overall Study|Lack of Efficacy|7|||
129564887|NCT02585258|466364214|FG001|Overall Study|Lack of Efficacy|9|||
129564888|NCT02585258|466364213|FG000|Overall Study|includes covid-related access problems|42|||
129564889|NCT02585258|466364214|FG001|Overall Study|includes covid-related access problems|46|||
129564890|NCT02585258|466364213|FG000|Overall Study|Lost to Follow-up|5|||
129564891|NCT02585258|466364214|FG001|Overall Study|Lost to Follow-up|2|||
129564892|NCT01919190|466366197|FG000|Overall Study|Intra-op findings, etc.|3|||
129564893|NCT01919190|466366198|FG001|Overall Study|Intra-op findings, etc.|0|||
129564894|NCT02322047|466366199|FG000|Overall Study|Physician Decision|1|||
129564895|NCT02322047|466366200|FG001|Overall Study|Physician Decision|0|||
129564896|NCT02322047|466366201|FG002|Overall Study|Physician Decision|0|||
129564897|NCT02322047|466366202|FG003|Overall Study|Physician Decision|0|||
129564898|NCT02322047|466366199|FG000|Overall Study|Withdrawal by Subject|1|||
129564899|NCT02322047|466366200|FG001|Overall Study|Withdrawal by Subject|0|||
129564900|NCT02322047|466366201|FG002|Overall Study|Withdrawal by Subject|0|||
129564901|NCT02322047|466366202|FG003|Overall Study|Withdrawal by Subject|1|||
129564902|NCT02322047|466366199|FG000|Overall Study|Adverse Event|0|||
129564903|NCT02322047|466366200|FG001|Overall Study|Adverse Event|1|||
129564904|NCT02322047|466366201|FG002|Overall Study|Adverse Event|0|||
129564905|NCT02322047|466366202|FG003|Overall Study|Adverse Event|0|||
129564906|NCT02322047|466366199|FG000|Overall Study|Lost to Follow-up|0|||
129564907|NCT02322047|466366200|FG001|Overall Study|Lost to Follow-up|0|||
129564908|NCT02322047|466366201|FG002|Overall Study|Lost to Follow-up|1|||
129564909|NCT02322047|466366202|FG003|Overall Study|Lost to Follow-up|1|||
129564910|NCT02207231|466366203|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
129564911|NCT02207231|466366204|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
129564912|NCT02207231|466366205|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
129564913|NCT02207231|466366206|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
129564914|NCT02207231|466366203|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
129564915|NCT02207231|466366204|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
129564916|NCT02207231|466366205|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
129564917|NCT02207231|466366206|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
129564918|NCT02207231|466366203|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
129564919|NCT02207231|466366204|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
129564920|NCT02207231|466366205|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
129564921|NCT02207231|466366206|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
129564922|NCT02207231|466366203|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
129564923|NCT02207231|466366204|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
129564924|NCT02207231|466366205|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
129564925|NCT02207231|466366206|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
129564926|NCT02207231|466366203|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
129564927|NCT02207231|466366204|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
129564928|NCT02207231|466366205|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
129564929|NCT02207231|466366206|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
129564930|NCT02207231|466366203|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
129564931|NCT02207231|466366204|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
129564932|NCT02207231|466366205|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
129564933|NCT02207231|466366206|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
129564934|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
129564935|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
129564936|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
129564937|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
129564938|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
129564939|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
129564940|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
129564941|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
129564942|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
129564943|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
129564944|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
129564945|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
129564946|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
129564947|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
129564948|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
129564949|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
129564950|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
129689301|NCT03446573|466819799|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
129689302|NCT03446573|466819800|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
129689303|NCT03446573|466819799|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
129689304|NCT03446573|466819800|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
129689305|NCT03446573|466819799|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
129689306|NCT03446573|466819800|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
129689307|NCT03446573|466819799|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
129689308|NCT03446573|466819800|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
129689309|NCT03446573|466819799|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
129689310|NCT03446573|466819800|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
129689311|NCT03446573|466819799|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
129689312|NCT03446573|466819800|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
129689313|NCT03446573|466819799|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
129689314|NCT03446573|466819800|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
129689315|NCT01371565|466819803|FG000|Overall Study|Withdrawal by Subject|1|||
129689316|NCT01371565|466819803|FG000|Overall Study|Death|1|||
129779640|NCT01396447|467159912|FG001|Overall Study|Did Not Receive Treatment|2|||
129779641|NCT01396447|467159913|FG002|Overall Study|Did Not Receive Treatment|1|||
129564951|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
129564952|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
129564953|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
129564954|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
129564955|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
129564956|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
129564957|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
129564958|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
129564959|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
129564960|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
129779642|NCT01396447|467159914|FG003|Overall Study|Did Not Receive Treatment|0|||
129779643|NCT01396447|467159911|FG000|Overall Study|Adverse Event|15|||
129779644|NCT01396447|467159912|FG001|Overall Study|Adverse Event|12|||
129779645|NCT01396447|467159913|FG002|Overall Study|Adverse Event|12|||
129779646|NCT01396447|467159914|FG003|Overall Study|Adverse Event|17|||
129779647|NCT01396447|467159911|FG000|Overall Study|Insufficient Therapeutic Response|5|||
129779648|NCT01396447|467159912|FG001|Overall Study|Insufficient Therapeutic Response|5|||
129779649|NCT01396447|467159913|FG002|Overall Study|Insufficient Therapeutic Response|2|||
129779650|NCT01396447|467159914|FG003|Overall Study|Insufficient Therapeutic Response|4|||
129779651|NCT01396447|467159911|FG000|Overall Study|Protocol Violation|5|||
129779652|NCT01396447|467159912|FG001|Overall Study|Protocol Violation|2|||
129779653|NCT01396447|467159913|FG002|Overall Study|Protocol Violation|3|||
129779654|NCT01396447|467159914|FG003|Overall Study|Protocol Violation|7|||
129779655|NCT01396447|467159911|FG000|Overall Study|Withdrawal of Consent|11|||
129779656|NCT01396447|467159912|FG001|Overall Study|Withdrawal of Consent|9|||
129779657|NCT01396447|467159913|FG002|Overall Study|Withdrawal of Consent|4|||
129779658|NCT01396447|467159914|FG003|Overall Study|Withdrawal of Consent|15|||
129779659|NCT01396447|467159911|FG000|Overall Study|Lost to Follow-up|4|||
129779660|NCT01396447|467159912|FG001|Overall Study|Lost to Follow-up|8|||
129779661|NCT01396447|467159913|FG002|Overall Study|Lost to Follow-up|7|||
129779662|NCT01396447|467159914|FG003|Overall Study|Lost to Follow-up|9|||
129779663|NCT01396447|467159911|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129779664|NCT01396447|467159912|FG001|Overall Study|Other Miscellaneous Reasons|2|||
129779665|NCT01396447|467159913|FG002|Overall Study|Other Miscellaneous Reasons|1|||
129779666|NCT01396447|467159914|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129779667|NCT04881942|467159915|FG000|Overall Study|Adverse Event|0|||
129779668|NCT04881942|467159916|FG001|Overall Study|Adverse Event|0|||
129779669|NCT04881942|467159917|FG002|Overall Study|Adverse Event|0|||
129779670|NCT04881942|467159918|FG003|Overall Study|Adverse Event|0|||
129779671|NCT04881942|467159919|FG004|Overall Study|Adverse Event|1|||
129779672|NCT04881942|467159915|FG000|Overall Study|Alternates|0|||
129779673|NCT04881942|467159916|FG001|Overall Study|Alternates|0|||
129779674|NCT04881942|467159917|FG002|Overall Study|Alternates|0|||
129779675|NCT04881942|467159918|FG003|Overall Study|Alternates|0|||
129779676|NCT04881942|467159919|FG004|Overall Study|Alternates|2|||
129779677|NCT01349959|467159920|FG000|Overall Study|Adverse Event|7|||
129779678|NCT02675634|467159921|FG000|Test Period 1|Adverse Event|0|||
129779679|NCT02675634|467159922|FG001|Test Period 1|Adverse Event|1|||
129779680|NCT02675634|467159923|FG002|Test Period 1|Adverse Event|0|||
129779681|NCT02675634|467159924|FG003|Test Period 1|Adverse Event|1|||
129779682|NCT02675634|467159925|FG004|Test Period 1|Adverse Event|0|||
129564961|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
129564962|NCT02207231|466366203|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
129689317|NCT01371565|466819803|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
129689318|NCT04270760|466819804|FG000|Overall Study|Withdrawal by Subject|0|||
129689319|NCT04270760|466819805|FG001|Overall Study|Withdrawal by Subject|1|||
129689320|NCT04270760|466819806|FG002|Overall Study|Withdrawal by Subject|3|||
129689321|NCT04270760|466819807|FG003|Overall Study|Withdrawal by Subject|0|||
129689322|NCT04270760|466819808|FG004|Overall Study|Withdrawal by Subject|0|||
129689323|NCT04270760|466819804|FG000|Overall Study|Lost to Follow-up|1|||
129689324|NCT04270760|466819805|FG001|Overall Study|Lost to Follow-up|2|||
129689325|NCT04270760|466819806|FG002|Overall Study|Lost to Follow-up|1|||
129689326|NCT04270760|466819807|FG003|Overall Study|Lost to Follow-up|0|||
129779683|NCT02675634|467159926|FG005|Test Period 1|Adverse Event|0|||
129779684|NCT02675634|467159921|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
129779685|NCT02675634|467159922|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
129689327|NCT04270760|466819808|FG004|Overall Study|Lost to Follow-up|0|||
129689328|NCT04270760|466819804|FG000|Overall Study|Death|0|||
129779686|NCT02675634|467159923|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
129779687|NCT02675634|467159924|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
129779688|NCT02675634|467159925|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
129779689|NCT02675634|467159926|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
129779690|NCT02675634|467159921|FG000|Test Period 2|Lack of Efficacy|1|||
129779691|NCT02675634|467159922|FG001|Test Period 2|Lack of Efficacy|0|||
129779692|NCT02675634|467159923|FG002|Test Period 2|Lack of Efficacy|0|||
129564963|NCT02207231|466366204|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
129564964|NCT02207231|466366205|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
129564965|NCT02207231|466366206|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
129564966|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
129564967|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
129564968|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
129564969|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
129564970|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
129564971|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
129564972|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
129564973|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
129564974|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
129564975|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
129564976|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
129564977|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
129564978|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
129564979|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
129564980|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
129564981|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
129564982|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
129564983|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
129564984|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
129564985|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
129564986|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
129564987|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
129564988|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
129564989|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
129564990|NCT02207231|466366203|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
129564991|NCT02207231|466366204|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
129564992|NCT02207231|466366205|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
129564993|NCT02207231|466366206|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
129564994|NCT02016300|466366214|FG000|Overall Study|Lost to Follow-up|0|||
129564995|NCT02016300|466366215|FG001|Overall Study|Lost to Follow-up|3|||
129564996|NCT05456529|466366216|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
129564997|NCT05456529|466366216|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
129564998|NCT05456529|466366216|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
129564999|NCT05456529|466366216|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
129565000|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
129565001|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
129565002|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Physician Decision|2|||
129565003|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
129565004|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
129565005|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
129565006|NCT05456529|466366216|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
129565007|NCT00797108|466366217|FG000|Overall Study|Adverse Event|1|||
129565008|NCT00797108|466366218|FG001|Overall Study|Adverse Event|0|||
129565009|NCT00797108|466366219|FG002|Overall Study|Adverse Event|3|||
129565010|NCT00797108|466366217|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
129565011|NCT00797108|466366218|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
129565012|NCT00797108|466366219|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
129565013|NCT00797108|466366217|FG000|Overall Study|Global Deterioration of Health Status|0|||
129565014|NCT00797108|466366218|FG001|Overall Study|Global Deterioration of Health Status|1|||
129565015|NCT00797108|466366219|FG002|Overall Study|Global Deterioration of Health Status|0|||
129565016|NCT00797108|466366217|FG000|Overall Study|Lack of Efficacy|1|||
129565017|NCT00797108|466366218|FG001|Overall Study|Lack of Efficacy|0|||
129565018|NCT00797108|466366219|FG002|Overall Study|Lack of Efficacy|1|||
129565019|NCT00797108|466366217|FG000|Overall Study|Other|0|||
129565020|NCT00797108|466366218|FG001|Overall Study|Other|0|||
129565021|NCT00797108|466366219|FG002|Overall Study|Other|2|||
129565022|NCT00797108|466366217|FG000|Overall Study|Randomized but not Treated|2|||
129565023|NCT00797108|466366218|FG001|Overall Study|Randomized but not Treated|0|||
129565024|NCT00797108|466366219|FG002|Overall Study|Randomized but not Treated|0|||
129565025|NCT02270736|466366220|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129565026|NCT02270736|466366221|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
129565027|NCT02270736|466366222|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129565028|NCT02270736|466366223|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129565029|NCT02270736|466366224|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
129689329|NCT04270760|466819805|FG001|Overall Study|Death|0|||
129565030|NCT02270736|466366220|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
129565031|NCT02270736|466366221|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
129565032|NCT02270736|466366222|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
129565033|NCT02270736|466366223|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
129565034|NCT02270736|466366224|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
129565035|NCT02270736|466366220|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129565036|NCT02270736|466366221|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
129565037|NCT02270736|466366222|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129565038|NCT02270736|466366223|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129565039|NCT02270736|466366224|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
129565040|NCT02270736|466366220|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129565041|NCT02270736|466366221|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129565042|NCT02270736|466366222|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
129565043|NCT02270736|466366223|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129565044|NCT02270736|466366224|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
129565045|NCT02270736|466366220|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129565046|NCT02270736|466366221|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129565047|NCT02270736|466366222|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129565048|NCT02270736|466366223|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
129565049|NCT02270736|466366224|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
129565050|NCT02270736|466366220|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129565051|NCT02270736|466366221|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129565052|NCT02270736|466366222|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129565053|NCT02270736|466366223|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
129565054|NCT02270736|466366224|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
129565055|NCT02270736|466366220|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129565056|NCT02270736|466366221|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129565057|NCT02270736|466366222|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129565058|NCT02270736|466366223|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
129565059|NCT02270736|466366224|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
129565060|NCT02270736|466366220|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129565061|NCT02270736|466366221|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129565062|NCT02270736|466366222|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129565063|NCT02270736|466366223|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
129565064|NCT02270736|466366224|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
129565065|NCT02270736|466366220|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129565066|NCT02270736|466366221|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129565067|NCT02270736|466366222|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129565068|NCT02270736|466366223|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
129565069|NCT02270736|466366224|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
129565070|NCT01631864|466366225|FG000|Overall Study|Withdrawal by Subject|0|||
129565071|NCT01631864|466366226|FG001|Overall Study|Withdrawal by Subject|1|||
129689330|NCT04270760|466819806|FG002|Overall Study|Death|0|||
129689331|NCT04270760|466819807|FG003|Overall Study|Death|0|||
129689332|NCT04270760|466819808|FG004|Overall Study|Death|1|||
129689333|NCT02070991|466819809|FG000|Overall Study|Death|2|||
129689334|NCT02070991|466819810|FG001|Overall Study|Death|0|||
129689335|NCT02070991|466819809|FG000|Overall Study|Withdrawal by Subject|1|||
129689336|NCT02070991|466819810|FG001|Overall Study|Withdrawal by Subject|0|||
129689337|NCT00827242|466819811|FG000|Overall Study|Withdrawal by Subject|2|||
129689338|NCT00827242|466819812|FG001|Overall Study|Withdrawal by Subject|4|||
129689339|NCT00827242|466819811|FG000|Overall Study|Protocol Violation|1|||
129689340|NCT00827242|466819812|FG001|Overall Study|Protocol Violation|3|||
129689341|NCT00827242|466819811|FG000|Overall Study|Lost to Follow-up|0|||
129689342|NCT00827242|466819812|FG001|Overall Study|Lost to Follow-up|3|||
129689343|NCT00827242|466819811|FG000|Overall Study|Adverse Event Excluding Death|2|||
129689344|NCT00827242|466819812|FG001|Overall Study|Adverse Event Excluding Death|1|||
129689345|NCT00827242|466819811|FG000|Overall Study|Entry Criteria Not Met|4|||
129689346|NCT00827242|466819812|FG001|Overall Study|Entry Criteria Not Met|1|||
129689347|NCT00827242|466819811|FG000|Overall Study|Physician Decision|2|||
129689348|NCT00827242|466819812|FG001|Overall Study|Physician Decision|0|||
129689349|NCT00827242|466819811|FG000|Overall Study|Death|1|||
129689350|NCT00827242|466819812|FG001|Overall Study|Death|0|||
129565072|NCT01631864|466366225|FG000|Overall Study|Adverse Event|2|||
129689351|NCT00827242|466819811|FG000|Overall Study|Lack of Efficacy|1|||
129689352|NCT00827242|466819812|FG001|Overall Study|Lack of Efficacy|0|||
129689353|NCT02609633|466819817|FG000|Overall Study|Consent Withdrawn|0|||
129689354|NCT02609633|466819818|FG001|Overall Study|Consent Withdrawn|1|||
129689355|NCT02609633|466819817|FG000|Overall Study|Protocol Deviation|1|||
129689356|NCT02609633|466819818|FG001|Overall Study|Protocol Deviation|0|||
129565073|NCT01631864|466366226|FG001|Overall Study|Adverse Event|3|||
129565074|NCT02153398|466366229|FG000|Overall Study|Withdrawal by Subject|1|||
129565075|NCT02153398|466366230|FG001|Overall Study|Withdrawal by Subject|0|||
129565076|NCT02153398|466366231|FG002|Overall Study|Withdrawal by Subject|0|||
129565077|NCT02153398|466366232|FG003|Overall Study|Withdrawal by Subject|0|||
129565078|NCT02153398|466366233|FG004|Overall Study|Withdrawal by Subject|0|||
129565079|NCT02153398|466366229|FG000|Overall Study|Adverse Event|0|||
129565080|NCT02153398|466366230|FG001|Overall Study|Adverse Event|0|||
129565081|NCT02153398|466366231|FG002|Overall Study|Adverse Event|1|||
129565082|NCT02153398|466366232|FG003|Overall Study|Adverse Event|1|||
129565083|NCT02153398|466366233|FG004|Overall Study|Adverse Event|0|||
129565084|NCT02402166|466366234|FG000|Overall Study|Adverse Event|2|||
129565085|NCT02402166|466366234|FG000|Overall Study|Withdrawal by Subject|2|||
129565086|NCT02402166|466366234|FG000|Overall Study|Lost to Follow-up|1|||
129565087|NCT03331042|466366235|FG000|Overall Study|Protocol Violation|1|||
129565088|NCT03331042|466366236|FG001|Overall Study|Protocol Violation|0|||
129565089|NCT03331042|466366237|FG002|Overall Study|Protocol Violation|0|||
129565090|NCT03331042|466366238|FG003|Overall Study|Protocol Violation|0|||
129565091|NCT03331042|466366235|FG000|Overall Study|Physician Decision|0|||
129565092|NCT03331042|466366236|FG001|Overall Study|Physician Decision|0|||
129565093|NCT03331042|466366237|FG002|Overall Study|Physician Decision|1|||
129565094|NCT03331042|466366238|FG003|Overall Study|Physician Decision|0|||
129565095|NCT03331042|466366235|FG000|Overall Study|Lost to Follow-up|0|||
129565096|NCT03331042|466366236|FG001|Overall Study|Lost to Follow-up|0|||
129565097|NCT03331042|466366237|FG002|Overall Study|Lost to Follow-up|0|||
129565098|NCT03331042|466366238|FG003|Overall Study|Lost to Follow-up|1|||
129565099|NCT00001849|466366242|FG000|Overall Study|Death|4|||
129565100|NCT00001849|466366242|FG000|Overall Study|Lost to Follow-up|2|||
129565101|NCT00001849|466366242|FG000|Overall Study|Withdrawal by Subject|2|||
129565102|NCT00001849|466366242|FG000|Overall Study|tumor remained occult|6|||
129565103|NCT02428699|466366244|FG000|Washout Period 1|Screen Failure|1|||
129565104|NCT02428699|466366245|FG001|Washout Period 1|Screen Failure|2|||
129565105|NCT01781286|466366248|FG000|Overall Study|Lost to Follow-up|0|||
129565106|NCT01781286|466366249|FG001|Overall Study|Lost to Follow-up|0|||
129565107|NCT01781286|466366250|FG002|Overall Study|Lost to Follow-up|0|||
129565108|NCT01781286|466366251|FG003|Overall Study|Lost to Follow-up|0|||
129565109|NCT01781286|466366252|FG004|Overall Study|Lost to Follow-up|0|||
129565110|NCT01781286|466366253|FG005|Overall Study|Lost to Follow-up|1|||
129565111|NCT01781286|466366248|FG000|Overall Study|Time Constraints|2|||
129565112|NCT01781286|466366249|FG001|Overall Study|Time Constraints|0|||
129565113|NCT01781286|466366250|FG002|Overall Study|Time Constraints|2|||
129565114|NCT01781286|466366251|FG003|Overall Study|Time Constraints|0|||
129565115|NCT01781286|466366252|FG004|Overall Study|Time Constraints|0|||
129565116|NCT01781286|466366253|FG005|Overall Study|Time Constraints|0|||
129565117|NCT01781286|466366248|FG000|Overall Study|Noncompliance|0|||
129565118|NCT01781286|466366249|FG001|Overall Study|Noncompliance|0|||
129565119|NCT01781286|466366250|FG002|Overall Study|Noncompliance|0|||
129565120|NCT01781286|466366251|FG003|Overall Study|Noncompliance|1|||
129565121|NCT01781286|466366252|FG004|Overall Study|Noncompliance|0|||
129565122|NCT01781286|466366253|FG005|Overall Study|Noncompliance|0|||
129565123|NCT03594123|466366254|FG000|Overall Study|Lost to Follow-up|0|||
129565124|NCT03594123|466366255|FG001|Overall Study|Lost to Follow-up|1|||
129565125|NCT03594123|466366254|FG000|Overall Study|Adverse Event|8|||
129565126|NCT03594123|466366255|FG001|Overall Study|Adverse Event|5|||
129565127|NCT03594123|466366254|FG000|Overall Study|Site Terminated by Sponsor|4|||
129565128|NCT03594123|466366255|FG001|Overall Study|Site Terminated by Sponsor|1|||
129565129|NCT03594123|466366254|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
129565130|NCT03594123|466366255|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
129689357|NCT02609633|466819817|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
129689358|NCT02609633|466819818|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
129689359|NCT02609633|466819817|FG000|Overall Study|Reason not Specified|2|||
129689360|NCT02609633|466819818|FG001|Overall Study|Reason not Specified|1|||
129689361|NCT05987540|466819819|FG000|Overall Study|Withdrawal by Subject|2|||
129689362|NCT05987540|466819819|FG000|Overall Study|Death|1|||
129565131|NCT03594123|466366254|FG000|Overall Study|Lack of Efficacy|1|||
129689363|NCT05987540|466819819|FG000|Overall Study|Study Termination|1|||
129565132|NCT03594123|466366255|FG001|Overall Study|Lack of Efficacy|0|||
129565133|NCT03594123|466366254|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
129565134|NCT03594123|466366255|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
129565135|NCT02483975|466366256|FG000|Overall Study|Adverse Event|0|||
129565136|NCT02483975|466366257|FG001|Overall Study|Adverse Event|1|||
129565137|NCT02483975|466366256|FG000|Overall Study|Lost to Follow-up|0|||
129565138|NCT02483975|466366257|FG001|Overall Study|Lost to Follow-up|1|||
129565139|NCT02483975|466366256|FG000|Overall Study|Physician Decision|2|||
129565140|NCT02483975|466366257|FG001|Overall Study|Physician Decision|0|||
129565141|NCT01505530|466366260|FG000|Overall Study|Progressive Disease|19|||
129565142|NCT01505530|466366261|FG001|Overall Study|Progressive Disease|17|||
129689364|NCT05987540|466819819|FG000|Overall Study|Adverse Event|2|||
129689365|NCT00471107|466819820|FG000|Overall Study|Technical problems/data loss|3|||
129565143|NCT01505530|466366262|FG002|Overall Study|Progressive Disease|18|||
129565144|NCT01505530|466366260|FG000|Overall Study|Adverse Event|1|||
129565145|NCT01505530|466366261|FG001|Overall Study|Adverse Event|1|||
129565146|NCT01505530|466366262|FG002|Overall Study|Adverse Event|0|||
129565147|NCT01505530|466366260|FG000|Overall Study|Withdrawal by Subject|7|||
129565148|NCT01505530|466366261|FG001|Overall Study|Withdrawal by Subject|8|||
129565149|NCT01505530|466366262|FG002|Overall Study|Withdrawal by Subject|6|||
129565150|NCT01505530|466366260|FG000|Overall Study|Physician Decision|6|||
129565151|NCT01505530|466366261|FG001|Overall Study|Physician Decision|2|||
129565152|NCT01505530|466366262|FG002|Overall Study|Physician Decision|5|||
129565153|NCT01505530|466366260|FG000|Overall Study|Sponsor Decision|1|||
129565154|NCT01505530|466366261|FG001|Overall Study|Sponsor Decision|8|||
129565155|NCT01505530|466366262|FG002|Overall Study|Sponsor Decision|7|||
129565156|NCT01505530|466366260|FG000|Overall Study|Death|7|||
129565157|NCT01505530|466366261|FG001|Overall Study|Death|6|||
129565158|NCT01505530|466366262|FG002|Overall Study|Death|5|||
129565159|NCT01505530|466366260|FG000|Overall Study|entry criteria not met|0|||
129565160|NCT01505530|466366261|FG001|Overall Study|entry criteria not met|1|||
129565161|NCT01505530|466366262|FG002|Overall Study|entry criteria not met|0|||
129565162|NCT02492958|466366263|FG000|Overall Study|Withdrawal by Subject|0|||
129565163|NCT02492958|466366264|FG001|Overall Study|Withdrawal by Subject|0|||
129565164|NCT02492958|466366265|FG002|Overall Study|Withdrawal by Subject|1|||
129565165|NCT02492958|466366266|FG003|Overall Study|Withdrawal by Subject|0|||
129565166|NCT02492958|466366263|FG000|Overall Study|Adverse Event|1|||
129565167|NCT02492958|466366264|FG001|Overall Study|Adverse Event|0|||
129565168|NCT02492958|466366265|FG002|Overall Study|Adverse Event|1|||
129565169|NCT02492958|466366266|FG003|Overall Study|Adverse Event|0|||
129565170|NCT02795104|466366267|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
129565171|NCT02795104|466366268|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
129565172|NCT02795104|466366269|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
129565173|NCT02795104|466366267|FG000|Overall Study|Withdrawal by Subject|0|||
129565174|NCT02795104|466366268|FG001|Overall Study|Withdrawal by Subject|2|||
129565175|NCT02795104|466366269|FG002|Overall Study|Withdrawal by Subject|0|||
129565176|NCT02795104|466366267|FG000|Overall Study|Lost to Follow-up|0|||
129565177|NCT02795104|466366268|FG001|Overall Study|Lost to Follow-up|0|||
129565178|NCT02795104|466366269|FG002|Overall Study|Lost to Follow-up|1|||
129565179|NCT00948675|466366270|FG000|Overall Study|Lost to Follow-up|1|||
129565180|NCT00948675|466366271|FG001|Overall Study|Lost to Follow-up|0|||
129565181|NCT02660242|466366276|FG000|Glucose Tabs|Lost to Follow-up|1|||
129565182|NCT02660242|466366276|FG000|Glucagon Injection|Lost to Follow-up|1|||
129565183|NCT00770510|466366278|FG000|Overall Study|Lost to Follow-up|2|||
129565184|NCT00770510|466366278|FG000|Overall Study|Pregnancy|1|||
129565185|NCT00770510|466366278|FG000|Overall Study|Withdrawal by Subject|2|||
129565186|NCT02192099|466366284|FG000|Overall Study|Adverse Event|1|||
129565187|NCT02192099|466366284|FG000|Overall Study|Lost to Follow-up|2|||
129565188|NCT02192099|466366284|FG000|Overall Study|Physician Decision|1|||
129565189|NCT02192099|466366284|FG000|Overall Study|Pregnancy|1|||
129565190|NCT02192099|466366284|FG000|Overall Study|Protocol Violation|8|||
129565191|NCT02192099|466366284|FG000|Overall Study|Study Terminated by Sponsor|32|||
129565192|NCT02192099|466366284|FG000|Overall Study|Withdrawal by Subject|11|||
129565193|NCT02192099|466366284|FG000|Overall Study|Miscellaneous Reasons|5|||
129565194|NCT01089647|466366290|FG000|Overall Study|Lost to Follow-up|2|||
129565195|NCT01089647|466366291|FG001|Overall Study|Lost to Follow-up|2|||
129565196|NCT01089647|466366290|FG000|Overall Study|Withdrawal by Subject|2|||
129565197|NCT01089647|466366291|FG001|Overall Study|Withdrawal by Subject|1|||
129565198|NCT01089647|466366290|FG000|Overall Study|Adverse Event|0|||
129565199|NCT01089647|466366291|FG001|Overall Study|Adverse Event|1|||
129565200|NCT00995553|466366292|FG000|Overall Study|Withdrawal by Subject|2|||
129689366|NCT00471107|466819821|FG001|Overall Study|Technical problems/data loss|1|||
129689367|NCT00471107|466819822|FG002|Overall Study|Technical problems/data loss|3|||
129689368|NCT01769443|466819823|FG000|Overall Study|Study closure|1|||
129565201|NCT00995553|466366293|FG001|Overall Study|Withdrawal by Subject|6|||
129565202|NCT00198029|466366296|FG000|Overall Study|Withdrawal by Subject|4|||
129565203|NCT02001558|466366297|FG000|Overall Study|Lost to Follow-up|8|||
129565204|NCT02001558|466366298|FG001|Overall Study|Lost to Follow-up|14|||
129565205|NCT04128007|466366299|FG000|Overall Study|Withdrawal by Subject|9|||
129565206|NCT04128007|466366300|FG001|Overall Study|Withdrawal by Subject|6|||
129565207|NCT04128007|466366299|FG000|Overall Study|Protocol Violation|1|||
129565208|NCT04128007|466366300|FG001|Overall Study|Protocol Violation|0|||
129565209|NCT04128007|466366299|FG000|Overall Study|Lost to Follow-up|8|||
129565210|NCT04128007|466366300|FG001|Overall Study|Lost to Follow-up|7|||
129565211|NCT04128007|466366299|FG000|Overall Study|Adverse Event|5|||
129565212|NCT04128007|466366300|FG001|Overall Study|Adverse Event|2|||
129689369|NCT01769443|466819824|FG001|Overall Study|Study closure|0|||
129565213|NCT04128007|466366299|FG000|Overall Study|Not reported|0|||
129565214|NCT04128007|466366300|FG001|Overall Study|Not reported|2|||
129565215|NCT04117607|466366301|FG000|Overall Study|Early Termination|0|||
129565216|NCT04117607|466366302|FG001|Overall Study|Early Termination|1|||
129565217|NCT04117607|466366303|FG002|Overall Study|Early Termination|0|||
129565218|NCT04117607|466366304|FG003|Overall Study|Early Termination|0|||
129565219|NCT04117607|466366305|FG004|Overall Study|Early Termination|0|||
129565220|NCT04117607|466366306|FG005|Overall Study|Early Termination|0|||
129565221|NCT04117607|466366307|FG006|Overall Study|Early Termination|1|||
129565222|NCT04117607|466366308|FG007|Overall Study|Early Termination|0|||
129565223|NCT04117607|466366309|FG008|Overall Study|Early Termination|0|||
129565224|NCT04117607|466366310|FG009|Overall Study|Early Termination|0|||
129565225|NCT04117607|466366311|FG010|Overall Study|Early Termination|0|||
129565226|NCT04117607|466366312|FG011|Overall Study|Early Termination|0|||
129565227|NCT04117607|466366313|FG012|Overall Study|Early Termination|0|||
129565228|NCT04117607|466366314|FG013|Overall Study|Early Termination|0|||
129565229|NCT00368277|466366318|FG000|Overall Study|Adverse Event|33|||
129565230|NCT00368277|466366319|FG001|Overall Study|Adverse Event|49|||
129565231|NCT00368277|466366318|FG000|Overall Study|Death|2|||
129565232|NCT00368277|466366319|FG001|Overall Study|Death|1|||
129565233|NCT00368277|466366318|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
129565234|NCT00368277|466366319|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
129565235|NCT00368277|466366318|FG000|Overall Study|Protocol deviation|7|||
129565236|NCT00368277|466366319|FG001|Overall Study|Protocol deviation|0|||
129565237|NCT00368277|466366318|FG000|Overall Study|Patient withdrew consent|32|||
129565238|NCT00368277|466366319|FG001|Overall Study|Patient withdrew consent|28|||
129565239|NCT00368277|466366318|FG000|Overall Study|Lost to Follow-up|8|||
129565240|NCT00368277|466366319|FG001|Overall Study|Lost to Follow-up|6|||
129565241|NCT03283709|466366331|FG000|Overall Study|trial terminated|0|||
129565242|NCT03283709|466366332|FG001|Overall Study|trial terminated|1|||
129565243|NCT01734772|466366333|FG000|Overall Study|Adverse Event|1|||
129565244|NCT01734772|466366334|FG001|Overall Study|Adverse Event|2|||
129565245|NCT01734772|466366333|FG000|Overall Study|Withdrawal by Subject|0|||
129565246|NCT01734772|466366334|FG001|Overall Study|Withdrawal by Subject|1|||
129565247|NCT01867242|466366335|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
129565248|NCT01867242|466366336|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
129565249|NCT01867242|466366337|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
129565250|NCT01790568|466366343|FG000|Overall Study|Progression prior to transplant|0|||
129565251|NCT01790568|466366344|FG001|Overall Study|Progression prior to transplant|1|||
129565252|NCT00264810|466366345|FG000|Baseline|Withdrawal by Subject|10|||
129565253|NCT00264810|466366346|FG001|Baseline|Withdrawal by Subject|10|||
129565254|NCT00264810|466366345|FG000|Baseline|Physician Decision|7|||
129565255|NCT00264810|466366346|FG001|Baseline|Physician Decision|8|||
129565256|NCT00264810|466366345|FG000|Baseline|Subject Compliance Failure|3|||
129565257|NCT00264810|466366346|FG001|Baseline|Subject Compliance Failure|3|||
129565258|NCT00264810|466366345|FG000|Baseline|Insufficient Seizure Frequency|2|||
129565259|NCT00264810|466366346|FG001|Baseline|Insufficient Seizure Frequency|2|||
129565260|NCT00264810|466366345|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
129565261|NCT00264810|466366346|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
129565262|NCT00264810|466366345|FG000|Baseline|Other|0|||
129565263|NCT00264810|466366346|FG001|Baseline|Other|1|||
129689370|NCT04996264|466819825|FG000|Overall Study|Lost to Follow-up|0|||
129689371|NCT04996264|466819826|FG001|Overall Study|Lost to Follow-up|1|||
129689372|NCT04996264|466819825|FG000|Overall Study|Withdrawal by Subject|4|||
129689373|NCT04996264|466819826|FG001|Overall Study|Withdrawal by Subject|3|||
129689374|NCT04996264|466819825|FG000|Overall Study|1 left AMA|0|||
129689375|NCT04996264|466819826|FG001|Overall Study|1 left AMA|1|||
129689376|NCT04996264|466819825|FG000|Overall Study|Subject changed hospitals|0|||
129689377|NCT04996264|466819826|FG001|Overall Study|Subject changed hospitals|1|||
129689378|NCT04996264|466819825|FG000|Overall Study|unable to complete due to work|0|||
129689379|NCT04996264|466819826|FG001|Overall Study|unable to complete due to work|1|||
129689380|NCT04433975|466819827|FG000|1-month Follow Up|Withdrawal by Subject|1|||
129689381|NCT04433975|466819828|FG001|1-month Follow Up|Withdrawal by Subject|1|||
129565264|NCT00264810|466366345|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
129565265|NCT00264810|466366346|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
129565266|NCT00264810|466366345|FG000|Stimulation Optimization Period|Death|0|||
129565267|NCT00264810|466366346|FG001|Stimulation Optimization Period|Death|1|||
129565268|NCT00264810|466366345|FG000|Blinded Evaluation Period|Explant due to infection|1|||
129565269|NCT00264810|466366346|FG001|Blinded Evaluation Period|Explant due to infection|1|||
129565270|NCT00264810|466366345|FG000|Open Label Evaluation Period|Explant due to infection|1|||
129565271|NCT00264810|466366346|FG001|Open Label Evaluation Period|Explant due to infection|1|||
129565272|NCT00264810|466366345|FG000|Open Label Evaluation Period|Death|3|||
129565273|NCT00264810|466366346|FG001|Open Label Evaluation Period|Death|2|||
129565274|NCT00264810|466366345|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
129689382|NCT04433975|466819827|FG000|1-month Follow Up|Lost to Follow-up|21|||
129689383|NCT04433975|466819828|FG001|1-month Follow Up|Lost to Follow-up|25|||
129689384|NCT04433975|466819827|FG000|3-month Follow Up|Lost to Follow-up|20|||
129565275|NCT00264810|466366346|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
129565276|NCT02994056|466366347|FG000|Overall Study|Death|8|||
129565277|NCT02994056|466366347|FG000|Overall Study|Withdrew Consent|1|||
129565278|NCT02199509|466366350|FG000|Overall Study|Suicidal Ideation|0|||
129565279|NCT02199509|466366351|FG001|Overall Study|Suicidal Ideation|1|||
129565280|NCT02199509|466366350|FG000|Overall Study|Misunderstood titration schedule|1|||
129565281|NCT02199509|466366351|FG001|Overall Study|Misunderstood titration schedule|0|||
129565282|NCT02093689|466366352|FG000|Overall Study|Physician Decision|4|||
129565283|NCT02093689|466366353|FG001|Overall Study|Physician Decision|0|||
129565284|NCT02093689|466366354|FG002|Overall Study|Physician Decision|0|||
129565285|NCT03481309|466366358|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
129565286|NCT03481309|466366359|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129565287|NCT03481309|466366360|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129565288|NCT03481309|466366361|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129565289|NCT03481309|466366362|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129565290|NCT03481309|466366363|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
129565291|NCT03309956|466366364|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
129565292|NCT03495869|466366365|FG000|Overall Study|Lost to Follow-up|4|||
129565293|NCT03495869|466366366|FG001|Overall Study|Lost to Follow-up|17|||
129565294|NCT03495869|466366367|FG002|Overall Study|Lost to Follow-up|8|||
129565295|NCT03495869|466366368|FG003|Overall Study|Lost to Follow-up|14|||
129565296|NCT03495869|466366365|FG000|Overall Study|Withdrawal by Subject|0|||
129565297|NCT03495869|466366366|FG001|Overall Study|Withdrawal by Subject|3|||
129565298|NCT03495869|466366367|FG002|Overall Study|Withdrawal by Subject|0|||
129565299|NCT03495869|466366368|FG003|Overall Study|Withdrawal by Subject|3|||
129565300|NCT03495869|466366365|FG000|Overall Study|Dropped from study|0|||
129565301|NCT03495869|466366366|FG001|Overall Study|Dropped from study|7|||
129565302|NCT03495869|466366367|FG002|Overall Study|Dropped from study|2|||
129565303|NCT03495869|466366368|FG003|Overall Study|Dropped from study|4|||
129565304|NCT02768298|466366369|FG000|Overall Study|Adverse Event|1|||
129565305|NCT02768298|466366370|FG001|Overall Study|Adverse Event|4|||
129565306|NCT02768298|466366369|FG000|Overall Study|Death|2|||
129565307|NCT02768298|466366370|FG001|Overall Study|Death|1|||
129565308|NCT02768298|466366369|FG000|Overall Study|Non-compliance with study treatment|0|||
129565309|NCT02768298|466366370|FG001|Overall Study|Non-compliance with study treatment|1|||
129565310|NCT02768298|466366369|FG000|Overall Study|Subject/guardian decision|1|||
129565311|NCT02768298|466366370|FG001|Overall Study|Subject/guardian decision|0|||
129565312|NCT02768298|466366369|FG000|Overall Study|Withdrawal of informed consent|0|||
129565313|NCT02768298|466366370|FG001|Overall Study|Withdrawal of informed consent|1|||
129565314|NCT04634409|466366371|FG000|Overall Study|Death|0|||
129565315|NCT04634409|466366372|FG001|Overall Study|Death|0|||
129565316|NCT04634409|466366373|FG002|Overall Study|Death|0|||
129565317|NCT04634409|466366374|FG003|Overall Study|Death|0|||
129565318|NCT04634409|466366375|FG004|Overall Study|Death|0|||
129565319|NCT04634409|466366376|FG005|Overall Study|Death|0|||
129689385|NCT04433975|466819828|FG001|3-month Follow Up|Lost to Follow-up|24|||
129689386|NCT04433975|466819827|FG000|3-month Follow Up|Death|1|||
129689387|NCT04433975|466819828|FG001|3-month Follow Up|Death|0|||
129689388|NCT04433975|466819827|FG000|3-month Follow Up|Withdrawal by Subject|2|||
129689389|NCT04433975|466819828|FG001|3-month Follow Up|Withdrawal by Subject|0|||
129689390|NCT04433975|466819827|FG000|6-month Follow Up|Lost to Follow-up|23|||
129689391|NCT04433975|466819828|FG001|6-month Follow Up|Lost to Follow-up|28|||
129689392|NCT04433975|466819827|FG000|6-month Follow Up|Withdrawal by Subject|1|||
129689393|NCT04433975|466819828|FG001|6-month Follow Up|Withdrawal by Subject|1|||
129689394|NCT04433975|466819827|FG000|9-month Follow Up|Lost to Follow-up|27|||
129689395|NCT04433975|466819828|FG001|9-month Follow Up|Lost to Follow-up|36|||
129689396|NCT04433975|466819827|FG000|9-month Follow Up|Death|0|||
129689397|NCT04433975|466819828|FG001|9-month Follow Up|Death|1|||
129689398|NCT04433975|466819827|FG000|12-month Follow Up|Lost to Follow-up|27|||
129689399|NCT04433975|466819828|FG001|12-month Follow Up|Lost to Follow-up|31|||
129689400|NCT04606771|466819829|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
129689401|NCT04606771|466819830|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
129689402|NCT04606771|466819829|FG000|Overall Study|Death|5|||
129689403|NCT04606771|466819830|FG001|Overall Study|Death|6|||
129565320|NCT04634409|466366377|FG006|Overall Study|Death|0|||
129565321|NCT04634409|466366378|FG007|Overall Study|Death|0|||
129565322|NCT04634409|466366379|FG008|Overall Study|Death|0|||
129565323|NCT04634409|466366380|FG009|Overall Study|Death|0|||
129565324|NCT04634409|466366381|FG010|Overall Study|Death|1|||
129565325|NCT04634409|466366382|FG011|Overall Study|Death|0|||
129565326|NCT04634409|466366383|FG012|Overall Study|Death|1|||
129565327|NCT04634409|466366384|FG013|Overall Study|Death|0|||
129565328|NCT04634409|466366385|FG014|Overall Study|Death|0|||
129689404|NCT04606771|466819829|FG000|Overall Study|Wrong randomisation|0|||
129689405|NCT04606771|466819830|FG001|Overall Study|Wrong randomisation|1|||
129689406|NCT04392635|466819831|FG000|Overall Study|Lost to Follow-up|0|||
129689407|NCT04392635|466819832|FG001|Overall Study|Lost to Follow-up|1|||
129689408|NCT02030418|466819833|FG000|Overall Study|Death|78|||
129779693|NCT02675634|467159924|FG003|Test Period 2|Lack of Efficacy|0|||
129779694|NCT02675634|467159925|FG004|Test Period 2|Lack of Efficacy|0|||
129565329|NCT04634409|466366386|FG015|Overall Study|Death|0|||
129565330|NCT04634409|466366387|FG016|Overall Study|Death|0|||
129565331|NCT04634409|466366388|FG017|Overall Study|Death|0|||
129565332|NCT04634409|466366389|FG018|Overall Study|Death|0|||
129565333|NCT04634409|466366390|FG019|Overall Study|Death|0|||
129565334|NCT04634409|466366391|FG020|Overall Study|Death|0|||
129565335|NCT04634409|466366392|FG021|Overall Study|Death|0|||
129565336|NCT04634409|466366393|FG022|Overall Study|Death|0|||
129565337|NCT04634409|466366394|FG023|Overall Study|Death|0|||
129565338|NCT04634409|466366395|FG024|Overall Study|Death|0|||
129565339|NCT04634409|466366396|FG025|Overall Study|Death|0|||
129565340|NCT04634409|466366397|FG026|Overall Study|Death|0|||
129565341|NCT04634409|466366371|FG000|Overall Study|Adverse Event|0|||
129565342|NCT04634409|466366372|FG001|Overall Study|Adverse Event|0|||
129565343|NCT04634409|466366373|FG002|Overall Study|Adverse Event|1|||
129565344|NCT04634409|466366374|FG003|Overall Study|Adverse Event|0|||
129565345|NCT04634409|466366375|FG004|Overall Study|Adverse Event|0|||
129565346|NCT04634409|466366376|FG005|Overall Study|Adverse Event|1|||
129565347|NCT04634409|466366377|FG006|Overall Study|Adverse Event|0|||
129565348|NCT04634409|466366378|FG007|Overall Study|Adverse Event|0|||
129565349|NCT04634409|466366379|FG008|Overall Study|Adverse Event|0|||
129565350|NCT04634409|466366380|FG009|Overall Study|Adverse Event|0|||
129565351|NCT04634409|466366381|FG010|Overall Study|Adverse Event|0|||
129565352|NCT04634409|466366382|FG011|Overall Study|Adverse Event|0|||
129565353|NCT04634409|466366383|FG012|Overall Study|Adverse Event|0|||
129689409|NCT02030418|466819833|FG000|Overall Study|Missed 12-Month Visit|9|||
129689410|NCT02030418|466819833|FG000|Overall Study|Withdrawn|57|||
129689411|NCT00250718|466819835|FG000|Overall Study|Death|1|||
129689412|NCT00250718|466819835|FG000|Overall Study|Adverse Event|1|||
129689413|NCT00250718|466819835|FG000|Overall Study|Withdrawal by Subject|1|||
129689414|NCT06100250|466819836|FG000|Overall Study|Lost to Follow-up|5|||
129689415|NCT02021318|466819837|FG000|Overall Study|Adverse Event|2|||
129689416|NCT02021318|466819838|FG001|Overall Study|Adverse Event|1|||
129689417|NCT02021318|466819837|FG000|Overall Study|Death|33|||
129689418|NCT02021318|466819838|FG001|Overall Study|Death|34|||
129689419|NCT02021318|466819837|FG000|Overall Study|Lost to Follow-up|3|||
129689420|NCT02021318|466819838|FG001|Overall Study|Lost to Follow-up|3|||
129689421|NCT02021318|466819837|FG000|Overall Study|Progressive Disease|0|||
129689422|NCT02021318|466819838|FG001|Overall Study|Progressive Disease|1|||
129689423|NCT02021318|466819837|FG000|Overall Study|Withdrawal by Subject|30|||
129689424|NCT02021318|466819838|FG001|Overall Study|Withdrawal by Subject|18|||
129689425|NCT02021318|466819837|FG000|Overall Study|Physician Decision|3|||
129689426|NCT02021318|466819838|FG001|Overall Study|Physician Decision|3|||
129689427|NCT02021318|466819837|FG000|Overall Study|Miscellaneous|2|||
129689428|NCT02021318|466819838|FG001|Overall Study|Miscellaneous|3|||
129689429|NCT00421993|466819842|FG000|Overall Study|Withdrawal by Subject|22|||
129689430|NCT00421993|466819843|FG001|Overall Study|Withdrawal by Subject|23|||
129689431|NCT00421993|466819844|FG002|Overall Study|Withdrawal by Subject|23|||
129689432|NCT00421993|466819845|FG003|Overall Study|Withdrawal by Subject|24|||
129689433|NCT00421993|466819842|FG000|Overall Study|Lost to Follow-up|18|||
129689434|NCT00421993|466819843|FG001|Overall Study|Lost to Follow-up|19|||
129689435|NCT00421993|466819844|FG002|Overall Study|Lost to Follow-up|22|||
129689436|NCT00421993|466819845|FG003|Overall Study|Lost to Follow-up|20|||
129689437|NCT00421993|466819842|FG000|Overall Study|Adverse Event|11|||
129689438|NCT00421993|466819843|FG001|Overall Study|Adverse Event|1|||
129689439|NCT00421993|466819844|FG002|Overall Study|Adverse Event|6|||
129689440|NCT00421993|466819845|FG003|Overall Study|Adverse Event|4|||
129689441|NCT00421993|466819842|FG000|Overall Study|Protocol Violation|2|||
129689442|NCT00421993|466819843|FG001|Overall Study|Protocol Violation|2|||
129689443|NCT00421993|466819844|FG002|Overall Study|Protocol Violation|0|||
129689444|NCT00421993|466819845|FG003|Overall Study|Protocol Violation|1|||
129689445|NCT00421993|466819842|FG000|Overall Study|Lack of Efficacy|0|||
129689446|NCT00421993|466819843|FG001|Overall Study|Lack of Efficacy|3|||
129689447|NCT00421993|466819844|FG002|Overall Study|Lack of Efficacy|0|||
129689448|NCT00421993|466819845|FG003|Overall Study|Lack of Efficacy|5|||
129689449|NCT00421993|466819842|FG000|Overall Study|Pregnancy|0|||
129689450|NCT00421993|466819843|FG001|Overall Study|Pregnancy|1|||
129689451|NCT00421993|466819844|FG002|Overall Study|Pregnancy|1|||
129565354|NCT04634409|466366384|FG013|Overall Study|Adverse Event|0|||
129565355|NCT04634409|466366385|FG014|Overall Study|Adverse Event|0|||
129565356|NCT04634409|466366386|FG015|Overall Study|Adverse Event|0|||
129565357|NCT04634409|466366387|FG016|Overall Study|Adverse Event|0|||
129565358|NCT04634409|466366388|FG017|Overall Study|Adverse Event|0|||
129565359|NCT04634409|466366389|FG018|Overall Study|Adverse Event|0|||
129565360|NCT04634409|466366390|FG019|Overall Study|Adverse Event|0|||
129565361|NCT04634409|466366391|FG020|Overall Study|Adverse Event|0|||
129689452|NCT00421993|466819845|FG003|Overall Study|Pregnancy|2|||
129689453|NCT00421993|466819842|FG000|Overall Study|Subject transportation issues|0|||
129689454|NCT00421993|466819843|FG001|Overall Study|Subject transportation issues|0|||
129565362|NCT04634409|466366392|FG021|Overall Study|Adverse Event|0|||
129565363|NCT04634409|466366393|FG022|Overall Study|Adverse Event|0|||
129565364|NCT04634409|466366394|FG023|Overall Study|Adverse Event|0|||
129565365|NCT04634409|466366395|FG024|Overall Study|Adverse Event|0|||
129565366|NCT04634409|466366396|FG025|Overall Study|Adverse Event|0|||
129565367|NCT04634409|466366397|FG026|Overall Study|Adverse Event|0|||
129565368|NCT04634409|466366371|FG000|Overall Study|Lost to Follow-up|3|||
129565369|NCT04634409|466366372|FG001|Overall Study|Lost to Follow-up|1|||
129565370|NCT04634409|466366373|FG002|Overall Study|Lost to Follow-up|1|||
129565371|NCT04634409|466366374|FG003|Overall Study|Lost to Follow-up|3|||
129565372|NCT04634409|466366375|FG004|Overall Study|Lost to Follow-up|1|||
129565373|NCT04634409|466366376|FG005|Overall Study|Lost to Follow-up|1|||
129565374|NCT04634409|466366377|FG006|Overall Study|Lost to Follow-up|1|||
129565375|NCT04634409|466366378|FG007|Overall Study|Lost to Follow-up|3|||
129565376|NCT04634409|466366379|FG008|Overall Study|Lost to Follow-up|3|||
129565377|NCT04634409|466366380|FG009|Overall Study|Lost to Follow-up|11|||
129565378|NCT04634409|466366381|FG010|Overall Study|Lost to Follow-up|8|||
129565379|NCT04634409|466366382|FG011|Overall Study|Lost to Follow-up|15|||
129565380|NCT04634409|466366383|FG012|Overall Study|Lost to Follow-up|3|||
129565381|NCT04634409|466366384|FG013|Overall Study|Lost to Follow-up|2|||
129565382|NCT04634409|466366385|FG014|Overall Study|Lost to Follow-up|7|||
129565383|NCT04634409|466366386|FG015|Overall Study|Lost to Follow-up|0|||
129565384|NCT04634409|466366387|FG016|Overall Study|Lost to Follow-up|0|||
129565385|NCT04634409|466366388|FG017|Overall Study|Lost to Follow-up|0|||
129565386|NCT04634409|466366389|FG018|Overall Study|Lost to Follow-up|0|||
129565387|NCT04634409|466366390|FG019|Overall Study|Lost to Follow-up|0|||
129565388|NCT04634409|466366391|FG020|Overall Study|Lost to Follow-up|0|||
129565389|NCT04634409|466366392|FG021|Overall Study|Lost to Follow-up|0|||
129565390|NCT04634409|466366393|FG022|Overall Study|Lost to Follow-up|0|||
129565391|NCT04634409|466366394|FG023|Overall Study|Lost to Follow-up|0|||
129565392|NCT04634409|466366395|FG024|Overall Study|Lost to Follow-up|0|||
129565393|NCT04634409|466366396|FG025|Overall Study|Lost to Follow-up|0|||
129565394|NCT04634409|466366397|FG026|Overall Study|Lost to Follow-up|0|||
129565395|NCT04634409|466366371|FG000|Overall Study|Withdrawal by Subject|3|||
129565396|NCT04634409|466366372|FG001|Overall Study|Withdrawal by Subject|1|||
129565397|NCT04634409|466366373|FG002|Overall Study|Withdrawal by Subject|6|||
129565398|NCT04634409|466366374|FG003|Overall Study|Withdrawal by Subject|4|||
129565399|NCT04634409|466366375|FG004|Overall Study|Withdrawal by Subject|2|||
129565400|NCT04634409|466366376|FG005|Overall Study|Withdrawal by Subject|0|||
129565401|NCT04634409|466366377|FG006|Overall Study|Withdrawal by Subject|0|||
129565402|NCT04634409|466366378|FG007|Overall Study|Withdrawal by Subject|2|||
129565403|NCT04634409|466366379|FG008|Overall Study|Withdrawal by Subject|3|||
129565404|NCT04634409|466366380|FG009|Overall Study|Withdrawal by Subject|2|||
129565405|NCT04634409|466366381|FG010|Overall Study|Withdrawal by Subject|3|||
129565406|NCT04634409|466366382|FG011|Overall Study|Withdrawal by Subject|2|||
129565407|NCT04634409|466366383|FG012|Overall Study|Withdrawal by Subject|2|||
129565408|NCT04634409|466366384|FG013|Overall Study|Withdrawal by Subject|1|||
129565409|NCT04634409|466366385|FG014|Overall Study|Withdrawal by Subject|5|||
129565410|NCT04634409|466366386|FG015|Overall Study|Withdrawal by Subject|0|||
129565411|NCT04634409|466366387|FG016|Overall Study|Withdrawal by Subject|0|||
129565412|NCT04634409|466366388|FG017|Overall Study|Withdrawal by Subject|1|||
129565413|NCT04634409|466366389|FG018|Overall Study|Withdrawal by Subject|0|||
129565414|NCT04634409|466366390|FG019|Overall Study|Withdrawal by Subject|0|||
129565415|NCT04634409|466366391|FG020|Overall Study|Withdrawal by Subject|0|||
129565416|NCT04634409|466366392|FG021|Overall Study|Withdrawal by Subject|0|||
129565417|NCT04634409|466366393|FG022|Overall Study|Withdrawal by Subject|0|||
129565418|NCT04634409|466366394|FG023|Overall Study|Withdrawal by Subject|1|||
129565419|NCT04634409|466366395|FG024|Overall Study|Withdrawal by Subject|0|||
129565420|NCT04634409|466366396|FG025|Overall Study|Withdrawal by Subject|0|||
129565421|NCT04634409|466366397|FG026|Overall Study|Withdrawal by Subject|0|||
129565422|NCT04634409|466366371|FG000|Overall Study|Other - As reported by Investigator|1|||
129565423|NCT04634409|466366372|FG001|Overall Study|Other - As reported by Investigator|0|||
129565424|NCT04634409|466366373|FG002|Overall Study|Other - As reported by Investigator|0|||
129565425|NCT04634409|466366374|FG003|Overall Study|Other - As reported by Investigator|0|||
129565426|NCT04634409|466366375|FG004|Overall Study|Other - As reported by Investigator|0|||
129565427|NCT04634409|466366376|FG005|Overall Study|Other - As reported by Investigator|0|||
129565428|NCT04634409|466366377|FG006|Overall Study|Other - As reported by Investigator|0|||
129565429|NCT04634409|466366378|FG007|Overall Study|Other - As reported by Investigator|6|||
129565430|NCT04634409|466366379|FG008|Overall Study|Other - As reported by Investigator|4|||
129565431|NCT04634409|466366380|FG009|Overall Study|Other - As reported by Investigator|0|||
129565432|NCT04634409|466366381|FG010|Overall Study|Other - As reported by Investigator|1|||
129565433|NCT04634409|466366382|FG011|Overall Study|Other - As reported by Investigator|2|||
129565434|NCT04634409|466366383|FG012|Overall Study|Other - As reported by Investigator|2|||
129565435|NCT04634409|466366384|FG013|Overall Study|Other - As reported by Investigator|1|||
129565436|NCT04634409|466366385|FG014|Overall Study|Other - As reported by Investigator|0|||
129565437|NCT04634409|466366386|FG015|Overall Study|Other - As reported by Investigator|0|||
129565438|NCT04634409|466366387|FG016|Overall Study|Other - As reported by Investigator|0|||
129565439|NCT04634409|466366388|FG017|Overall Study|Other - As reported by Investigator|0|||
129565440|NCT04634409|466366389|FG018|Overall Study|Other - As reported by Investigator|0|||
129565441|NCT04634409|466366390|FG019|Overall Study|Other - As reported by Investigator|0|||
129565442|NCT04634409|466366391|FG020|Overall Study|Other - As reported by Investigator|0|||
129565443|NCT04634409|466366392|FG021|Overall Study|Other - As reported by Investigator|0|||
129565444|NCT04634409|466366393|FG022|Overall Study|Other - As reported by Investigator|0|||
129565445|NCT04634409|466366394|FG023|Overall Study|Other - As reported by Investigator|0|||
129565446|NCT04634409|466366395|FG024|Overall Study|Other - As reported by Investigator|0|||
129565447|NCT04634409|466366396|FG025|Overall Study|Other - As reported by Investigator|0|||
129565448|NCT04634409|466366397|FG026|Overall Study|Other - As reported by Investigator|0|||
129565449|NCT02346201|466366399|FG000|Overall Study|Adverse Event|3|||
129565450|NCT02346201|466366400|FG001|Overall Study|Adverse Event|2|||
129565451|NCT02346201|466366399|FG000|Overall Study|Lost to Follow-up|1|||
129565452|NCT02346201|466366400|FG001|Overall Study|Lost to Follow-up|0|||
129565453|NCT02346201|466366399|FG000|Overall Study|Withdrawal by Subject|6|||
129565454|NCT02346201|466366400|FG001|Overall Study|Withdrawal by Subject|3|||
129565455|NCT02346201|466366399|FG000|Overall Study|Unavailable for future follow-up|0|||
129565456|NCT02346201|466366400|FG001|Overall Study|Unavailable for future follow-up|1|||
129565457|NCT02346201|466366399|FG000|Overall Study|Physician Decision|0|||
129565458|NCT02346201|466366400|FG001|Overall Study|Physician Decision|1|||
129565459|NCT02346201|466366399|FG000|Overall Study|Missed final visit|0|||
129565460|NCT02346201|466366400|FG001|Overall Study|Missed final visit|2|||
129565461|NCT03708211|466366401|FG000|Overall Study|Progressive Disease|10|||
129565462|NCT03708211|466366402|FG001|Overall Study|Progressive Disease|7|||
129565463|NCT03708211|466366401|FG000|Overall Study|Withdrawal by Subject|0|||
129565464|NCT03708211|466366402|FG001|Overall Study|Withdrawal by Subject|1|||
129565465|NCT03708211|466366401|FG000|Overall Study|Other|2|||
129565466|NCT03708211|466366402|FG001|Overall Study|Other|0|||
129565467|NCT01508936|466366403|FG000|Overall Study|Adverse Event|11|||
129565468|NCT01508936|466366404|FG001|Overall Study|Adverse Event|32|||
129565469|NCT01508936|466366403|FG000|Overall Study|Lack of Efficacy|0|||
129565470|NCT01508936|466366404|FG001|Overall Study|Lack of Efficacy|1|||
129565471|NCT01508936|466366403|FG000|Overall Study|Withdrawal by Subject|4|||
129565472|NCT01508936|466366404|FG001|Overall Study|Withdrawal by Subject|18|||
129565473|NCT01508936|466366403|FG000|Overall Study|Protocol Violation|2|||
129565474|NCT01508936|466366404|FG001|Overall Study|Protocol Violation|3|||
129565475|NCT01508936|466366403|FG000|Overall Study|Lost to Follow-up|2|||
129565476|NCT01508936|466366404|FG001|Overall Study|Lost to Follow-up|9|||
129565477|NCT01508936|466366403|FG000|Overall Study|Other|0|||
129565478|NCT01508936|466366404|FG001|Overall Study|Other|5|||
129565479|NCT01508936|466366403|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
129565480|NCT01508936|466366404|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
129565481|NCT00679367|466366405|FG000|Overall Study|Adverse Event|7|||
129565482|NCT00679367|466366405|FG000|Overall Study|inability to swallow oral drugs|1|||
129565483|NCT00679367|466366405|FG000|Overall Study|Lack of Efficacy|3|||
129565484|NCT00679367|466366405|FG000|Overall Study|Withdrawal by Subject|1|||
129565485|NCT04603937|466366408|FG000|Overall Study|Adverse Event|9|||
129565486|NCT04603937|466366409|FG001|Overall Study|Adverse Event|10|||
129565487|NCT04603937|466366408|FG000|Overall Study|Withdrawal by Subject|7|||
129565488|NCT04603937|466366409|FG001|Overall Study|Withdrawal by Subject|6|||
129565489|NCT04603937|466366408|FG000|Overall Study|Lost to Follow-up|5|||
129565490|NCT04603937|466366409|FG001|Overall Study|Lost to Follow-up|6|||
129565491|NCT04603937|466366408|FG000|Overall Study|Physician Decision|0|||
129565492|NCT04603937|466366409|FG001|Overall Study|Physician Decision|1|||
129565493|NCT04603937|466366408|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
129565494|NCT04603937|466366409|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
129565495|NCT02518685|466366410|FG000|Overall Study|Adverse Event|29|||
129565496|NCT02518685|466366411|FG001|Overall Study|Adverse Event|1|||
129565497|NCT02518685|466366410|FG000|Overall Study|Withdrawal by Subject|10|||
129565498|NCT02518685|466366411|FG001|Overall Study|Withdrawal by Subject|3|||
129565499|NCT02518685|466366410|FG000|Overall Study|relocation, study fatigue|7|||
129565500|NCT02518685|466366411|FG001|Overall Study|relocation, study fatigue|2|||
129565501|NCT02518685|466366410|FG000|Overall Study|Pregnancy|1|||
129565502|NCT02518685|466366411|FG001|Overall Study|Pregnancy|0|||
129565503|NCT02518685|466366410|FG000|Overall Study|Physician Decision|1|||
129565504|NCT02518685|466366411|FG001|Overall Study|Physician Decision|0|||
129565505|NCT02518685|466366410|FG000|Overall Study|Lost to Follow-up|1|||
129779695|NCT02675634|467159926|FG005|Test Period 2|Lack of Efficacy|0|||
129565506|NCT02518685|466366411|FG001|Overall Study|Lost to Follow-up|4|||
129565507|NCT00922779|466366412|FG000|Overall Study|Adverse Event|67|||
129779696|NCT02675634|467159921|FG000|Test Period 2|Adverse Event|0|||
129779697|NCT02675634|467159922|FG001|Test Period 2|Adverse Event|0|||
129565508|NCT00922779|466366412|FG000|Overall Study|Pregnancy|7|||
129779698|NCT02675634|467159923|FG002|Test Period 2|Adverse Event|0|||
129565509|NCT00922779|466366412|FG000|Overall Study|Withdrawal by Subject|308|||
129565510|NCT00922779|466366412|FG000|Overall Study|Lost to Follow-up|44|||
129565511|NCT00922779|466366412|FG000|Overall Study|Other|27|||
129565512|NCT00922779|466366412|FG000|Overall Study|Missing|1874|||
129565513|NCT01298570|466368100|FG000|Overall Study|Disease progression, relapse during acti|64|||
129565514|NCT01298570|466368101|FG001|Overall Study|Disease progression, relapse during acti|40|||
129565515|NCT01298570|466368100|FG000|Overall Study|Adverse Event|20|||
129565516|NCT01298570|466368101|FG001|Overall Study|Adverse Event|2|||
129565517|NCT01298570|466368100|FG000|Overall Study|Withdrawal by Subject|21|||
129565518|NCT01298570|466368101|FG001|Overall Study|Withdrawal by Subject|6|||
129565519|NCT01298570|466368100|FG000|Overall Study|Treatment delay > 4 weeks|4|||
129565520|NCT01298570|466368101|FG001|Overall Study|Treatment delay > 4 weeks|5|||
129565521|NCT01298570|466368100|FG000|Overall Study|Physician Decision|4|||
129565522|NCT01298570|466368101|FG001|Overall Study|Physician Decision|2|||
129565523|NCT01298570|466368100|FG000|Overall Study|Other complicating disease|2|||
129565524|NCT01298570|466368101|FG001|Overall Study|Other complicating disease|1|||
129565525|NCT01298570|466368100|FG000|Overall Study|Surgery|2|||
129565526|NCT01298570|466368101|FG001|Overall Study|Surgery|1|||
129565527|NCT01298570|466368100|FG000|Overall Study|Symptomatic progression/deterioration|3|||
129565528|NCT01298570|466368101|FG001|Overall Study|Symptomatic progression/deterioration|2|||
129689455|NCT00421993|466819844|FG002|Overall Study|Subject transportation issues|0|||
129689456|NCT00421993|466819845|FG003|Overall Study|Subject transportation issues|1|||
129689457|NCT01980888|466819846|FG000|Overall Study|Study Terminated by Sponsor|116|||
129689458|NCT01980888|466819847|FG001|Overall Study|Study Terminated by Sponsor|122|||
129689459|NCT01980888|466819846|FG000|Overall Study|Withdrew Consent|17|||
129689460|NCT01980888|466819847|FG001|Overall Study|Withdrew Consent|6|||
129565529|NCT01298570|466368100|FG000|Overall Study|Death|0|||
129565530|NCT01298570|466368101|FG001|Overall Study|Death|1|||
129565531|NCT01298570|466368100|FG000|Overall Study|Ineligibility|0|||
129565532|NCT01298570|466368101|FG001|Overall Study|Ineligibility|1|||
129565533|NCT01210001|466368102|FG000|Overall Study|Not treated|1|||
129565534|NCT01210001|466368103|FG001|Overall Study|Not treated|0|||
129565535|NCT01210001|466368104|FG002|Overall Study|Not treated|0|||
129565536|NCT01210001|466368102|FG000|Overall Study|Adverse Event|4|||
129565537|NCT01210001|466368103|FG001|Overall Study|Adverse Event|2|||
129565538|NCT01210001|466368104|FG002|Overall Study|Adverse Event|5|||
129689461|NCT01980888|466819846|FG000|Overall Study|Investigator's Discretion|8|||
129689462|NCT01980888|466819847|FG001|Overall Study|Investigator's Discretion|3|||
129689463|NCT01980888|466819846|FG000|Overall Study|Non-Compliance with Study Drug|3|||
129689464|NCT01980888|466819847|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129689465|NCT05762744|466819853|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
129689466|NCT05762744|466819854|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
129689467|NCT05762744|466819853|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
129689468|NCT05762744|466819854|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
129689469|NCT01671059|466819855|FG000|Overall Study|Adverse Event|4|||
129689470|NCT01671059|466819855|FG000|Overall Study|Lack of Efficacy|1|||
129689471|NCT01030900|466819862|FG000|Overall Study|Not treated due to congestive heart failure|1|||
129689472|NCT01030900|466819862|FG000|Overall Study|Not treated due to rapid disease|1|||
129689473|NCT01179399|466819863|FG000|Overall Study|Adverse Event|1|||
129689474|NCT01179399|466819863|FG000|Overall Study|Lack of Efficacy|30|||
129689475|NCT01179399|466819863|FG000|Overall Study|Withdrawal by Subject|1|||
129689476|NCT00441896|466819864|FG000|Overall Study|Withdrawal by Subject|0|||
129689477|NCT00441896|466819865|FG001|Overall Study|Withdrawal by Subject|0|||
129689478|NCT00441896|466819866|FG002|Overall Study|Withdrawal by Subject|0|||
129689479|NCT00441896|466819867|FG003|Overall Study|Withdrawal by Subject|1|||
129689480|NCT00441896|466819868|FG004|Overall Study|Withdrawal by Subject|0|||
129689481|NCT00441896|466819869|FG005|Overall Study|Withdrawal by Subject|0|||
129689482|NCT00441896|466819870|FG006|Overall Study|Withdrawal by Subject|0|||
129689483|NCT00441896|466819871|FG007|Overall Study|Withdrawal by Subject|0|||
129689484|NCT00441896|466819872|FG008|Overall Study|Withdrawal by Subject|0|||
129689485|NCT00441896|466819873|FG009|Overall Study|Withdrawal by Subject|0|||
129689486|NCT00441896|466819864|FG000|Overall Study|Other|0|||
129689487|NCT00441896|466819865|FG001|Overall Study|Other|0|||
129689488|NCT00441896|466819866|FG002|Overall Study|Other|0|||
129689489|NCT00441896|466819867|FG003|Overall Study|Other|0|||
129689490|NCT00441896|466819868|FG004|Overall Study|Other|1|||
129565539|NCT01210001|466368102|FG000|Overall Study|Non compliant with protocol|2|||
129565540|NCT01210001|466368103|FG001|Overall Study|Non compliant with protocol|2|||
129565541|NCT01210001|466368104|FG002|Overall Study|Non compliant with protocol|3|||
129565542|NCT01210001|466368102|FG000|Overall Study|Lost to Follow-up|4|||
129565543|NCT01210001|466368103|FG001|Overall Study|Lost to Follow-up|3|||
129565544|NCT01210001|466368104|FG002|Overall Study|Lost to Follow-up|2|||
129689491|NCT00441896|466819869|FG005|Overall Study|Other|0|||
129689492|NCT00441896|466819870|FG006|Overall Study|Other|0|||
129689493|NCT00441896|466819871|FG007|Overall Study|Other|0|||
129689494|NCT00441896|466819872|FG008|Overall Study|Other|0|||
129565545|NCT01210001|466368102|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
129565546|NCT01210001|466368103|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
129565547|NCT01210001|466368104|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
129565548|NCT01210001|466368102|FG000|Overall Study|Other reason not defined above|2|||
129565549|NCT01210001|466368103|FG001|Overall Study|Other reason not defined above|2|||
129565550|NCT01210001|466368104|FG002|Overall Study|Other reason not defined above|1|||
129565551|NCT01739790|466368105|FG000|Overall Study|Early Trial Termination|2|||
129565552|NCT01739790|466368106|FG001|Overall Study|Early Trial Termination|4|||
129565553|NCT01451762|466368110|FG000|Overall Study|Lost to Follow-up|3|||
129565554|NCT01451762|466368111|FG001|Overall Study|Lost to Follow-up|6|||
129565555|NCT01451762|466368112|FG002|Overall Study|Lost to Follow-up|6|||
129565556|NCT00502775|466368118|FG000|Overall Study|Adverse Event|1|||
129565557|NCT00502775|466368119|FG001|Overall Study|Adverse Event|2|||
129565558|NCT00502775|466368120|FG002|Overall Study|Adverse Event|1|||
129565559|NCT00502775|466368118|FG000|Overall Study|Protocol Violation|1|||
129565560|NCT00502775|466368119|FG001|Overall Study|Protocol Violation|5|||
129565561|NCT00502775|466368120|FG002|Overall Study|Protocol Violation|2|||
129565562|NCT00502775|466368118|FG000|Overall Study|Withdrawal by Subject|1|||
129565563|NCT00502775|466368119|FG001|Overall Study|Withdrawal by Subject|1|||
129565564|NCT00502775|466368120|FG002|Overall Study|Withdrawal by Subject|2|||
129565565|NCT00502775|466368118|FG000|Overall Study|Sponsor Terminated Study|1|||
129565566|NCT00502775|466368119|FG001|Overall Study|Sponsor Terminated Study|0|||
129565567|NCT00502775|466368120|FG002|Overall Study|Sponsor Terminated Study|1|||
129565568|NCT00502775|466368118|FG000|Overall Study|Non-compliance with eDiary|4|||
129565569|NCT00502775|466368119|FG001|Overall Study|Non-compliance with eDiary|1|||
129565570|NCT00502775|466368120|FG002|Overall Study|Non-compliance with eDiary|1|||
129565571|NCT00502775|466368118|FG000|Overall Study|Subject unable to swallow capsule|1|||
129565572|NCT00502775|466368119|FG001|Overall Study|Subject unable to swallow capsule|0|||
129565573|NCT00502775|466368120|FG002|Overall Study|Subject unable to swallow capsule|1|||
129565574|NCT00502775|466368118|FG000|Overall Study|Logpad compliance <80%|1|||
129565575|NCT00502775|466368119|FG001|Overall Study|Logpad compliance <80%|0|||
129565576|NCT00502775|466368120|FG002|Overall Study|Logpad compliance <80%|0|||
129565577|NCT00502775|466368118|FG000|Overall Study|Randomized in error|0|||
129565578|NCT00502775|466368119|FG001|Overall Study|Randomized in error|1|||
129565579|NCT00502775|466368120|FG002|Overall Study|Randomized in error|1|||
129565580|NCT00502775|466368118|FG000|Overall Study|Non-compliance|0|||
129565581|NCT00502775|466368119|FG001|Overall Study|Non-compliance|2|||
129565582|NCT00502775|466368120|FG002|Overall Study|Non-compliance|2|||
129565583|NCT00502775|466368118|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
129565584|NCT00502775|466368119|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
129565585|NCT00502775|466368120|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
129565586|NCT00502775|466368118|FG000|Overall Study|Declining pollen counts|0|||
129565587|NCT00502775|466368119|FG001|Overall Study|Declining pollen counts|1|||
129565588|NCT00502775|466368120|FG002|Overall Study|Declining pollen counts|1|||
129565589|NCT00502775|466368118|FG000|Overall Study|Subject in jail|0|||
129565590|NCT00502775|466368119|FG001|Overall Study|Subject in jail|1|||
129565591|NCT00502775|466368120|FG002|Overall Study|Subject in jail|0|||
129565592|NCT00502775|466368118|FG000|Overall Study|Subject took disallowed drug|0|||
129565593|NCT00502775|466368119|FG001|Overall Study|Subject took disallowed drug|0|||
129565594|NCT00502775|466368120|FG002|Overall Study|Subject took disallowed drug|1|||
129565595|NCT00287118|466368122|FG000|Overall Study|Adverse Event|30|||
129565596|NCT00287118|466368122|FG000|Overall Study|Death|1|||
129565597|NCT00287118|466368122|FG000|Overall Study|Lack of Efficacy|11|||
129565598|NCT00287118|466368122|FG000|Overall Study|Lost to Follow-up|1|||
129565599|NCT00287118|466368122|FG000|Overall Study|Protocol Violation|2|||
129689495|NCT00441896|466819873|FG009|Overall Study|Other|0|||
129565600|NCT00287118|466368122|FG000|Overall Study|Other|7|||
129565601|NCT00262600|466368123|FG000|Overall Study|Lost to Follow-up|17|||
129565602|NCT00262600|466368124|FG001|Overall Study|Lost to Follow-up|31|||
129565603|NCT00262600|466368125|FG002|Overall Study|Lost to Follow-up|41|||
129565604|NCT00262600|466368123|FG000|Overall Study|Withdrawal by Subject|128|||
129565605|NCT00262600|466368124|FG001|Overall Study|Withdrawal by Subject|145|||
129565606|NCT00262600|466368125|FG002|Overall Study|Withdrawal by Subject|139|||
129565607|NCT00262600|466368123|FG000|Overall Study|Not Treated|32|||
129565608|NCT00262600|466368124|FG001|Overall Study|Not Treated|17|||
129565609|NCT00262600|466368125|FG002|Overall Study|Not Treated|24|||
129565610|NCT00262600|466368123|FG000|Overall Study|Other|58|||
129565611|NCT00262600|466368124|FG001|Overall Study|Other|59|||
129565612|NCT00262600|466368125|FG002|Overall Study|Other|62|||
129565613|NCT04471207|466368126|FG000|Overall Study|Lost to Follow-up|4|||
129565614|NCT04471207|466368127|FG001|Overall Study|Lost to Follow-up|1|||
129565615|NCT04471207|466368126|FG000|Overall Study|Medication Contraindication|0|||
129565616|NCT04471207|466368127|FG001|Overall Study|Medication Contraindication|1|||
129565617|NCT04471207|466368126|FG000|Overall Study|Loss of Interest|2|||
129565618|NCT04471207|466368127|FG001|Overall Study|Loss of Interest|1|||
129565619|NCT04471207|466368126|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
129565620|NCT04471207|466368127|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
129689496|NCT01301092|466819874|FG000|Overall Study|Lost to Follow-up|0|||
129565621|NCT04471207|466368126|FG000|Overall Study|Scheduling Conflicts|3|||
129565622|NCT04471207|466368127|FG001|Overall Study|Scheduling Conflicts|1|||
129565623|NCT04471207|466368126|FG000|Overall Study|Physician Decision|1|||
129565624|NCT04471207|466368127|FG001|Overall Study|Physician Decision|0|||
129565625|NCT04471207|466368126|FG000|Overall Study|Unwilling to Use System|0|||
129565626|NCT04471207|466368127|FG001|Overall Study|Unwilling to Use System|1|||
129565627|NCT00561730|466368128|FG000|Overall Study|Adverse Event|2|||
129565628|NCT00561730|466368128|FG000|Overall Study|Handling of the drug|1|||
129565629|NCT00561730|466368128|FG000|Overall Study|Lost to Follow-up|5|||
129565630|NCT00561730|466368128|FG000|Overall Study|Not specified reasons|1|||
129565631|NCT00376220|466368129|FG000|Overall Study|Lost to Follow-up|7|||
129565632|NCT00376220|466368130|FG001|Overall Study|Lost to Follow-up|10|||
129565633|NCT00376220|466368129|FG000|Overall Study|Withdrawal by Subject|3|||
129565634|NCT00376220|466368130|FG001|Overall Study|Withdrawal by Subject|2|||
129565635|NCT00531206|466368135|FG000|Overall Study|Adverse Event related|5|||
129565636|NCT00531206|466368135|FG000|Overall Study|Lack of Efficacy|2|||
129565637|NCT00531206|466368135|FG000|Overall Study|Lost to Follow-up|5|||
129565638|NCT00531206|466368135|FG000|Overall Study|including non-related adverse events|8|||
129565639|NCT02906709|466368142|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
129565640|NCT02906709|466368143|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
129565641|NCT02906709|466368142|FG000|Phase A (Week 0 to Week 16)|Death|0|||
129565642|NCT02906709|466368143|FG001|Phase A (Week 0 to Week 16)|Death|1|||
129565643|NCT02906709|466368142|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
129565644|NCT02906709|466368143|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
129565645|NCT02906709|466368142|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
129565646|NCT02906709|466368143|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
129565647|NCT00721409|466368144|FG000|Overall Study|Global deterioration of health status|2|||
129565648|NCT00721409|466368145|FG001|Overall Study|Global deterioration of health status|6|||
129565649|NCT00721409|466368146|FG002|Overall Study|Global deterioration of health status|3|||
129565650|NCT00721409|466368144|FG000|Overall Study|Death|0|||
129565651|NCT00721409|466368145|FG001|Overall Study|Death|1|||
129565652|NCT00721409|466368146|FG002|Overall Study|Death|0|||
129565653|NCT00721409|466368144|FG000|Overall Study|Randomized not Treated|0|||
129565654|NCT00721409|466368145|FG001|Overall Study|Randomized not Treated|1|||
129565655|NCT00721409|466368146|FG002|Overall Study|Randomized not Treated|4|||
129565656|NCT00721409|466368144|FG000|Overall Study|Reason not specified|1|||
129565657|NCT00721409|466368145|FG001|Overall Study|Reason not specified|0|||
129565658|NCT00721409|466368146|FG002|Overall Study|Reason not specified|2|||
129565659|NCT00721409|466368144|FG000|Overall Study|Adverse Event|0|||
129565660|NCT00721409|466368145|FG001|Overall Study|Adverse Event|13|||
129565661|NCT00721409|466368146|FG002|Overall Study|Adverse Event|2|||
129565662|NCT00721409|466368144|FG000|Overall Study|Lost to Follow-up|0|||
129565663|NCT00721409|466368145|FG001|Overall Study|Lost to Follow-up|0|||
129565664|NCT00721409|466368146|FG002|Overall Study|Lost to Follow-up|1|||
129565665|NCT00721409|466368144|FG000|Overall Study|Withdrawal by Subject|1|||
129565666|NCT00721409|466368145|FG001|Overall Study|Withdrawal by Subject|6|||
129565667|NCT00721409|466368146|FG002|Overall Study|Withdrawal by Subject|5|||
129565668|NCT00721409|466368144|FG000|Overall Study|Objective progression or relapse|8|||
129565669|NCT00721409|466368145|FG001|Overall Study|Objective progression or relapse|55|||
129565670|NCT00721409|466368146|FG002|Overall Study|Objective progression or relapse|62|||
129565671|NCT00322491|466368150|FG000|Overall Study|Adverse Event|1|||
129565672|NCT00322491|466368151|FG001|Overall Study|Adverse Event|0|||
129565673|NCT00322491|466368150|FG000|Overall Study|Death|1|||
129565674|NCT00322491|466368151|FG001|Overall Study|Death|2|||
129565675|NCT00688064|466368153|FG000|Overall Study|Protocol Violation|0|||
129565676|NCT00688064|466368154|FG001|Overall Study|Protocol Violation|1|||
129565677|NCT00688064|466368153|FG000|Overall Study|Adverse Event|2|||
129565678|NCT00688064|466368154|FG001|Overall Study|Adverse Event|4|||
129565679|NCT00688064|466368153|FG000|Overall Study|Withdrawal by Subject|7|||
129565680|NCT00688064|466368154|FG001|Overall Study|Withdrawal by Subject|7|||
129565681|NCT00688064|466368153|FG000|Overall Study|Lost to Follow-up|10|||
129565682|NCT00688064|466368154|FG001|Overall Study|Lost to Follow-up|10|||
129565683|NCT00688064|466368153|FG000|Overall Study|Lack of Efficacy|0|||
129565684|NCT00688064|466368154|FG001|Overall Study|Lack of Efficacy|1|||
129565685|NCT00688064|466368153|FG000|Overall Study|Pregnancy|1|||
129565686|NCT00688064|466368154|FG001|Overall Study|Pregnancy|0|||
129565687|NCT00688064|466368153|FG000|Overall Study|Any other reasons|1|||
129565688|NCT00688064|466368154|FG001|Overall Study|Any other reasons|3|||
129565689|NCT00720096|466368155|FG000|Overall Study|Withdrawal by Subject|0|||
129565690|NCT00720096|466368156|FG001|Overall Study|Withdrawal by Subject|2|||
129565691|NCT00442936|466368157|FG000|Overall Study|Protocol Violation|1|||
129565692|NCT00442936|466368158|FG001|Overall Study|Protocol Violation|0|||
129565693|NCT00442936|466368159|FG002|Overall Study|Protocol Violation|1|||
129565694|NCT00442936|466368160|FG003|Overall Study|Protocol Violation|1|||
129565695|NCT00524459|466368161|FG000|Overall Study|Withdrawal by Subject|1|||
129565696|NCT00524459|466368161|FG000|Overall Study|Other|1|||
129565697|NCT01574248|466368162|FG000|Overall Study|Withdrawal by Subject|2|||
129565698|NCT01574248|466368163|FG001|Overall Study|Withdrawal by Subject|0|||
129565699|NCT01574248|466368162|FG000|Overall Study|Missing primary endpoint data|1|||
129565700|NCT01574248|466368163|FG001|Overall Study|Missing primary endpoint data|0|||
129565701|NCT01424722|466368164|FG000|Overall Study|Sponsor terminated investigation|2258|||
129565702|NCT00995410|466368165|FG000|Overall Study|Adverse Event|51|||
129565703|NCT00995410|466368165|FG000|Overall Study|Withdrawal by Subject|7|||
129565704|NCT00995410|466368165|FG000|Overall Study|Lost to Follow-up|2|||
129565705|NCT00995410|466368165|FG000|Overall Study|Misc|28|||
129565706|NCT00818883|466368166|FG000|Overall Study|Adverse Event|28|||
129565707|NCT00818883|466368167|FG001|Overall Study|Adverse Event|19|||
129565708|NCT00818883|466368166|FG000|Overall Study|Protocol Violation|2|||
129565709|NCT00818883|466368167|FG001|Overall Study|Protocol Violation|2|||
129565710|NCT00818883|466368166|FG000|Overall Study|Lost to Follow-up|3|||
129565711|NCT00818883|466368167|FG001|Overall Study|Lost to Follow-up|2|||
129565712|NCT00818883|466368166|FG000|Overall Study|Withdrawal by Subject|16|||
129565713|NCT00818883|466368167|FG001|Overall Study|Withdrawal by Subject|14|||
129565714|NCT00818883|466368166|FG000|Overall Study|Lack of Efficacy|0|||
129565715|NCT00818883|466368167|FG001|Overall Study|Lack of Efficacy|2|||
129565716|NCT00818883|466368166|FG000|Overall Study|Other|2|||
129565717|NCT00818883|466368167|FG001|Overall Study|Other|7|||
129565718|NCT03992196|466368168|FG000|Enrollment|lost to follow-up prior dosing|1|||
129565719|NCT03992196|466368169|FG001|Enrollment|lost to follow-up prior dosing|0|||
129565720|NCT03992196|466368170|FG002|Enrollment|lost to follow-up prior dosing|0|||
129565721|NCT03992196|466368168|FG000|Treatment|Protocol Violation|0|||
129565722|NCT03992196|466368169|FG001|Treatment|Protocol Violation|0|||
129565723|NCT03992196|466368170|FG002|Treatment|Protocol Violation|1|||
129565724|NCT03992196|466368168|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
129565725|NCT03992196|466368169|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
129565726|NCT03992196|466368170|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
129565727|NCT03992196|466368168|FG000|Treatment|Withdrawal due to non-compliance|0|||
129565728|NCT03992196|466368169|FG001|Treatment|Withdrawal due to non-compliance|0|||
129779699|NCT02675634|467159924|FG003|Test Period 2|Adverse Event|0|||
129779700|NCT02675634|467159925|FG004|Test Period 2|Adverse Event|0|||
129779701|NCT02675634|467159926|FG005|Test Period 2|Adverse Event|1|||
129779702|NCT01652534|467159927|FG000|Overall Study|Lack of Efficacy|1|||
129779703|NCT01652534|467159928|FG001|Overall Study|Lack of Efficacy|0|||
129779704|NCT02105961|467159929|FG000|Overall Study|Adverse Event|18|||
129779705|NCT02105961|467159930|FG001|Overall Study|Adverse Event|7|||
129779706|NCT02105961|467159931|FG002|Overall Study|Adverse Event|13|||
129779707|NCT02105961|467159929|FG000|Overall Study|Lack of Efficacy|3|||
129779708|NCT02105961|467159930|FG001|Overall Study|Lack of Efficacy|0|||
129779709|NCT02105961|467159931|FG002|Overall Study|Lack of Efficacy|3|||
129779710|NCT02105961|467159929|FG000|Overall Study|Lost to Follow-up|2|||
129779711|NCT02105961|467159930|FG001|Overall Study|Lost to Follow-up|0|||
129779712|NCT02105961|467159931|FG002|Overall Study|Lost to Follow-up|1|||
129779713|NCT02105961|467159929|FG000|Overall Study|Physician Decision|3|||
129779714|NCT02105961|467159930|FG001|Overall Study|Physician Decision|3|||
129779715|NCT02105961|467159931|FG002|Overall Study|Physician Decision|2|||
129779716|NCT02105961|467159929|FG000|Overall Study|Withdrawal by Subject|15|||
129779717|NCT02105961|467159930|FG001|Overall Study|Withdrawal by Subject|7|||
129779718|NCT02105961|467159931|FG002|Overall Study|Withdrawal by Subject|11|||
129779719|NCT03860259|467159932|FG000|Overall Study|Lost to Follow-up|5|||
129779720|NCT03860259|467159933|FG001|Overall Study|Lost to Follow-up|5|||
129779721|NCT03860259|467159932|FG000|Overall Study|Protocol Violation|1|||
129779722|NCT03860259|467159933|FG001|Overall Study|Protocol Violation|0|||
129779723|NCT00811018|467159934|FG000|Overall Study|Additional Chronic Treatment|31|||
129779724|NCT00811018|467159934|FG000|Overall Study|Adverse Event|79|||
129779725|NCT00811018|467159934|FG000|Overall Study|Death|147|||
129779726|NCT00811018|467159934|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
129779727|NCT00811018|467159934|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
129779728|NCT00811018|467159934|FG000|Overall Study|Investigator Decision|57|||
129779729|NCT00811018|467159934|FG000|Overall Study|Lost to Follow-up|19|||
129779730|NCT00811018|467159934|FG000|Overall Study|Pregnancy|6|||
129779731|NCT00811018|467159934|FG000|Overall Study|Sponsor Decision|450|||
129779732|NCT00811018|467159934|FG000|Overall Study|Withdrawal by Subject|70|||
129565729|NCT03992196|466368170|FG002|Treatment|Withdrawal due to non-compliance|1|||
129565730|NCT03992196|466368168|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
129565731|NCT03992196|466368169|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
129779733|NCT00811018|467159934|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
129779734|NCT00811018|467159934|FG000|Overall Study|Other|26|||
129779735|NCT00934362|467159938|FG000|Overall Study|Adverse Event|1|||
129565732|NCT03992196|466368170|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
129565733|NCT03992196|466368168|FG000|Treatment|Withdrawal by parent/guardian|0|||
129565734|NCT03992196|466368169|FG001|Treatment|Withdrawal by parent/guardian|0|||
129779736|NCT00934362|467159939|FG001|Overall Study|Adverse Event|0|||
129779737|NCT01092117|467159940|FG000|Index Procedure to 1 Month|Death|1|||
129779738|NCT01092117|467159940|FG000|1 Month|Death|1|||
129565735|NCT03992196|466368170|FG002|Treatment|Withdrawal by parent/guardian|2|||
129565736|NCT00048048|466368171|FG000|Core Treatment|Withdrawal by Subject|0|||
129565737|NCT00048048|466368172|FG001|Core Treatment|Withdrawal by Subject|0|||
129565738|NCT00048048|466368173|FG002|Core Treatment|Withdrawal by Subject|1|||
129565739|NCT00048048|466368174|FG003|Core Treatment|Withdrawal by Subject|0|||
129565740|NCT00048048|466368175|FG004|Core Treatment|Withdrawal by Subject|0|||
129565741|NCT00048048|466368176|FG005|Core Treatment|Withdrawal by Subject|0|||
129565742|NCT00048048|466368177|FG006|Core Treatment|Withdrawal by Subject|0|||
129565743|NCT00048048|466368178|FG007|Core Treatment|Withdrawal by Subject|0|||
129565744|NCT00048048|466368179|FG008|Core Treatment|Withdrawal by Subject|0|||
129565745|NCT00048048|466368180|FG009|Core Treatment|Withdrawal by Subject|0|||
129565746|NCT00048048|466368181|FG010|Core Treatment|Withdrawal by Subject|0|||
129565747|NCT00048048|466368182|FG011|Core Treatment|Withdrawal by Subject|0|||
129565748|NCT00048048|466368171|FG000|Core Treatment|Adverse Event|0|||
129565749|NCT00048048|466368172|FG001|Core Treatment|Adverse Event|0|||
129565750|NCT00048048|466368173|FG002|Core Treatment|Adverse Event|0|||
129565751|NCT00048048|466368174|FG003|Core Treatment|Adverse Event|0|||
129565752|NCT00048048|466368175|FG004|Core Treatment|Adverse Event|0|||
129565753|NCT00048048|466368176|FG005|Core Treatment|Adverse Event|0|||
129565754|NCT00048048|466368177|FG006|Core Treatment|Adverse Event|0|||
129565755|NCT00048048|466368178|FG007|Core Treatment|Adverse Event|1|||
129565756|NCT00048048|466368179|FG008|Core Treatment|Adverse Event|0|||
129565757|NCT00048048|466368180|FG009|Core Treatment|Adverse Event|0|||
129565758|NCT00048048|466368181|FG010|Core Treatment|Adverse Event|0|||
129565759|NCT00048048|466368182|FG011|Core Treatment|Adverse Event|0|||
129565760|NCT00048048|466368171|FG000|Extension Year 1|Early withdrawals|0|||
129565761|NCT00048048|466368172|FG001|Extension Year 1|Early withdrawals|0|||
129565762|NCT00048048|466368173|FG002|Extension Year 1|Early withdrawals|0|||
129565763|NCT00048048|466368174|FG003|Extension Year 1|Early withdrawals|0|||
129565764|NCT00048048|466368175|FG004|Extension Year 1|Early withdrawals|0|||
129565765|NCT00048048|466368176|FG005|Extension Year 1|Early withdrawals|0|||
129565766|NCT00048048|466368177|FG006|Extension Year 1|Early withdrawals|0|||
129565767|NCT00048048|466368178|FG007|Extension Year 1|Early withdrawals|0|||
129565768|NCT00048048|466368179|FG008|Extension Year 1|Early withdrawals|0|||
129565769|NCT00048048|466368180|FG009|Extension Year 1|Early withdrawals|2|||
129565770|NCT00048048|466368181|FG010|Extension Year 1|Early withdrawals|2|||
129565771|NCT00048048|466368182|FG011|Extension Year 1|Early withdrawals|4|||
129565772|NCT00048048|466368171|FG000|Extension Year 2|Early withdrawals|0|||
129565773|NCT00048048|466368172|FG001|Extension Year 2|Early withdrawals|0|||
129565774|NCT00048048|466368173|FG002|Extension Year 2|Early withdrawals|0|||
129565775|NCT00048048|466368174|FG003|Extension Year 2|Early withdrawals|0|||
129565776|NCT00048048|466368175|FG004|Extension Year 2|Early withdrawals|0|||
129565777|NCT00048048|466368176|FG005|Extension Year 2|Early withdrawals|0|||
129565778|NCT00048048|466368177|FG006|Extension Year 2|Early withdrawals|0|||
129565779|NCT00048048|466368178|FG007|Extension Year 2|Early withdrawals|0|||
129565780|NCT00048048|466368179|FG008|Extension Year 2|Early withdrawals|0|||
129565781|NCT00048048|466368180|FG009|Extension Year 2|Early withdrawals|0|||
129565782|NCT00048048|466368181|FG010|Extension Year 2|Early withdrawals|4|||
129565783|NCT00048048|466368182|FG011|Extension Year 2|Early withdrawals|2|||
129565784|NCT02684578|466368183|FG000|Overall Study|Withdrawal by Subject|10|||
129565785|NCT02684578|466368184|FG001|Overall Study|Withdrawal by Subject|7|||
129565786|NCT02684578|466368183|FG000|Overall Study|Lost to Follow-up|0|||
129565787|NCT02684578|466368184|FG001|Overall Study|Lost to Follow-up|3|||
129565788|NCT02684578|466368183|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
129565789|NCT02684578|466368184|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
129565790|NCT02684578|466368183|FG000|Overall Study|Missing follow-up data|0|||
129565791|NCT02684578|466368184|FG001|Overall Study|Missing follow-up data|1|||
129565792|NCT00973700|466368185|FG000|Overall Study|Withdrawal by Subject|2|||
129565793|NCT00973700|466368186|FG001|Overall Study|Withdrawal by Subject|2|||
129565794|NCT00973700|466368187|FG002|Overall Study|Withdrawal by Subject|8|||
129565795|NCT00973700|466368188|FG003|Overall Study|Withdrawal by Subject|4|||
129689497|NCT01301092|466819875|FG001|Overall Study|Lost to Follow-up|0|||
129689498|NCT01301092|466819876|FG002|Overall Study|Lost to Follow-up|1|||
129689499|NCT03334175|466819877|FG000|Overall Study|Lost to Follow-up|0|||
129689500|NCT03334175|466819878|FG001|Overall Study|Lost to Follow-up|1|||
129689501|NCT01350973|466819879|FG000|Overall Study|Adverse Event|4|||
129565796|NCT00973700|466368189|FG004|Overall Study|Withdrawal by Subject|4|||
129565797|NCT00973700|466368185|FG000|Overall Study|Lost to Follow-up|5|||
129565798|NCT00973700|466368186|FG001|Overall Study|Lost to Follow-up|0|||
129565799|NCT00973700|466368187|FG002|Overall Study|Lost to Follow-up|1|||
129565800|NCT00973700|466368188|FG003|Overall Study|Lost to Follow-up|8|||
129565801|NCT00973700|466368189|FG004|Overall Study|Lost to Follow-up|5|||
129689502|NCT01350973|466819880|FG001|Overall Study|Adverse Event|7|||
129689503|NCT01350973|466819881|FG002|Overall Study|Adverse Event|7|||
129689504|NCT01350973|466819879|FG000|Overall Study|Voluntary Withdrawal|2|||
129565802|NCT00973700|466368185|FG000|Overall Study|Inappropriate enrolment|0|||
129689505|NCT01350973|466819880|FG001|Overall Study|Voluntary Withdrawal|1|||
129689506|NCT01350973|466819881|FG002|Overall Study|Voluntary Withdrawal|1|||
129689507|NCT03738215|466819885|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
129689508|NCT03738215|466819886|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
129689509|NCT03738215|466819887|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
129689510|NCT03738215|466819885|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
129689511|NCT03738215|466819886|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
129689512|NCT03738215|466819887|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129689513|NCT03738215|466819885|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
129689514|NCT03738215|466819886|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
129689515|NCT03738215|466819887|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
129689516|NCT03738215|466819885|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
129689517|NCT03738215|466819886|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
129689518|NCT03738215|466819887|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
129689519|NCT03738215|466819885|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
129689520|NCT03738215|466819886|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
129689521|NCT03738215|466819887|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
129689522|NCT03738215|466819885|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
129689523|NCT03738215|466819886|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
129689524|NCT03738215|466819887|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
129689525|NCT03738215|466819885|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
129689526|NCT03738215|466819886|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
129689527|NCT03738215|466819887|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
129689528|NCT03738215|466819885|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
129689529|NCT03738215|466819886|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
129689530|NCT03738215|466819887|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
129689531|NCT03738215|466819885|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
129689532|NCT03738215|466819886|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
129689533|NCT03738215|466819887|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
129689534|NCT03738215|466819885|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
129689535|NCT03738215|466819886|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
129689536|NCT03738215|466819887|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
129689537|NCT00853047|466819888|FG000|Core Phase|Participant Request|0|||
129689538|NCT00853047|466819889|FG001|Core Phase|Participant Request|0|||
129689539|NCT00853047|466819890|FG002|Core Phase|Participant Request|0|||
129689540|NCT00853047|466819891|FG003|Core Phase|Participant Request|1|||
129689541|NCT00853047|466819892|FG004|Core Phase|Participant Request|0|||
129689542|NCT00853047|466819893|FG005|Core Phase|Participant Request|0|||
129689543|NCT00853047|466819888|FG000|Open-Label Extension Phase|Participant Request|0|||
129689544|NCT00853047|466819889|FG001|Open-Label Extension Phase|Participant Request|0|||
129689545|NCT00853047|466819890|FG002|Open-Label Extension Phase|Participant Request|0|||
129689546|NCT00853047|466819891|FG003|Open-Label Extension Phase|Participant Request|0|||
129689547|NCT00853047|466819892|FG004|Open-Label Extension Phase|Participant Request|0|||
129689548|NCT00853047|466819893|FG005|Open-Label Extension Phase|Participant Request|7|||
129689549|NCT00853047|466819888|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129689550|NCT00853047|466819889|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129689551|NCT00853047|466819890|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129689552|NCT00853047|466819891|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
129689553|NCT00853047|466819892|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
129689554|NCT00853047|466819893|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
129689555|NCT00853047|466819888|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129689556|NCT00853047|466819889|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129689557|NCT00853047|466819890|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129689558|NCT00853047|466819891|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129689559|NCT00853047|466819892|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
129565803|NCT00973700|466368186|FG001|Overall Study|Inappropriate enrolment|0|||
129565804|NCT00973700|466368187|FG002|Overall Study|Inappropriate enrolment|0|||
129565805|NCT00973700|466368188|FG003|Overall Study|Inappropriate enrolment|4|||
129565806|NCT00973700|466368189|FG004|Overall Study|Inappropriate enrolment|0|||
129565807|NCT00973700|466368185|FG000|Overall Study|Unable to Classify|0|||
129565808|NCT00973700|466368186|FG001|Overall Study|Unable to Classify|0|||
129565809|NCT00973700|466368187|FG002|Overall Study|Unable to Classify|1|||
129565810|NCT00973700|466368188|FG003|Overall Study|Unable to Classify|2|||
129565811|NCT00973700|466368189|FG004|Overall Study|Unable to Classify|1|||
129565812|NCT05518487|466368190|FG000|Overall Study|Withdrawal by Subject|3|||
129565813|NCT02752776|466368192|FG000|Overall Study|Adverse Event|15|||
129565814|NCT02752776|466368193|FG001|Overall Study|Adverse Event|23|||
129565815|NCT02752776|466368194|FG002|Overall Study|Adverse Event|11|||
129565816|NCT02752776|466368192|FG000|Overall Study|Lack of Efficacy|2|||
129565817|NCT02752776|466368193|FG001|Overall Study|Lack of Efficacy|6|||
129565818|NCT02752776|466368194|FG002|Overall Study|Lack of Efficacy|14|||
129565819|NCT02752776|466368192|FG000|Overall Study|Lost to Follow-up|11|||
129565820|NCT02752776|466368193|FG001|Overall Study|Lost to Follow-up|12|||
129565821|NCT02752776|466368194|FG002|Overall Study|Lost to Follow-up|4|||
129565822|NCT02752776|466368192|FG000|Overall Study|Non-compliance with study treatment|0|||
129565823|NCT02752776|466368193|FG001|Overall Study|Non-compliance with study treatment|0|||
129565824|NCT02752776|466368194|FG002|Overall Study|Non-compliance with study treatment|1|||
129565825|NCT02752776|466368192|FG000|Overall Study|Physician Decision|2|||
129565826|NCT02752776|466368193|FG001|Overall Study|Physician Decision|6|||
129565827|NCT02752776|466368194|FG002|Overall Study|Physician Decision|2|||
129565828|NCT02752776|466368192|FG000|Overall Study|Pregnancy|1|||
129565829|NCT02752776|466368193|FG001|Overall Study|Pregnancy|6|||
129565830|NCT02752776|466368194|FG002|Overall Study|Pregnancy|3|||
129565831|NCT02752776|466368192|FG000|Overall Study|Protocol Violation|10|||
129565832|NCT02752776|466368193|FG001|Overall Study|Protocol Violation|13|||
129565833|NCT02752776|466368194|FG002|Overall Study|Protocol Violation|6|||
129565834|NCT02752776|466368192|FG000|Overall Study|Subject/guardian decision|8|||
129565835|NCT02752776|466368193|FG001|Overall Study|Subject/guardian decision|6|||
129565836|NCT02752776|466368194|FG002|Overall Study|Subject/guardian decision|4|||
129565837|NCT02752776|466368192|FG000|Overall Study|Death|0|||
129565838|NCT02752776|466368193|FG001|Overall Study|Death|0|||
129565839|NCT02752776|466368194|FG002|Overall Study|Death|1|||
129565840|NCT02752776|466368192|FG000|Overall Study|Withdrawal by Subject|3|||
129565841|NCT02752776|466368193|FG001|Overall Study|Withdrawal by Subject|4|||
129565842|NCT02752776|466368194|FG002|Overall Study|Withdrawal by Subject|2|||
129565843|NCT01193608|466368195|FG000|Overall Study|Other|0|||
129565844|NCT01193608|466368196|FG001|Overall Study|Other|1|||
129565845|NCT01193608|466368197|FG002|Overall Study|Other|0|||
129565846|NCT01193608|466368198|FG003|Overall Study|Other|0|||
129689560|NCT00853047|466819893|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
129689561|NCT00853047|466819888|FG000|Open-Label Extension Phase|Investigator Decision|0|||
129689562|NCT00853047|466819889|FG001|Open-Label Extension Phase|Investigator Decision|0|||
129689563|NCT00853047|466819890|FG002|Open-Label Extension Phase|Investigator Decision|0|||
129689564|NCT00853047|466819891|FG003|Open-Label Extension Phase|Investigator Decision|0|||
129689565|NCT00853047|466819892|FG004|Open-Label Extension Phase|Investigator Decision|0|||
129689566|NCT00853047|466819893|FG005|Open-Label Extension Phase|Investigator Decision|1|||
129689567|NCT00853047|466819888|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
129689568|NCT00853047|466819889|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
129689569|NCT00853047|466819890|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
129689570|NCT00853047|466819891|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
129689571|NCT00853047|466819892|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
129689572|NCT00853047|466819893|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
129689573|NCT02638493|466819894|FG000|Overall Study|Inability to provide semen samples|2|||
129689574|NCT02638493|466819895|FG001|Overall Study|Inability to provide semen samples|0|||
129689575|NCT02638493|466819896|FG002|Overall Study|Inability to provide semen samples|0|||
129689576|NCT01033071|466819897|FG000|Overall Study|Adverse Event|28|||
129689577|NCT01033071|466819898|FG001|Overall Study|Adverse Event|51|||
129689578|NCT01033071|466819899|FG002|Overall Study|Adverse Event|26|||
129689579|NCT01033071|466819897|FG000|Overall Study|Protocol Violation|0|||
129689580|NCT01033071|466819898|FG001|Overall Study|Protocol Violation|2|||
129689581|NCT01033071|466819899|FG002|Overall Study|Protocol Violation|1|||
129565847|NCT01193608|466368199|FG004|Overall Study|Other|0|||
129565848|NCT01193608|466368200|FG005|Overall Study|Other|0|||
129565849|NCT01193608|466368195|FG000|Overall Study|Withdrawal by Subject|0|||
129565850|NCT01193608|466368196|FG001|Overall Study|Withdrawal by Subject|1|||
129565851|NCT01193608|466368197|FG002|Overall Study|Withdrawal by Subject|2|||
129565852|NCT01193608|466368198|FG003|Overall Study|Withdrawal by Subject|3|||
129565853|NCT01193608|466368199|FG004|Overall Study|Withdrawal by Subject|3|||
129565854|NCT01193608|466368200|FG005|Overall Study|Withdrawal by Subject|0|||
129689582|NCT01033071|466819897|FG000|Overall Study|Lost to Follow-up|4|||
129689583|NCT01033071|466819898|FG001|Overall Study|Lost to Follow-up|5|||
129689584|NCT01033071|466819899|FG002|Overall Study|Lost to Follow-up|5|||
129689585|NCT01033071|466819897|FG000|Overall Study|Withdrawal by Subject|17|||
129779739|NCT01092117|467159940|FG000|1 Month|Withdrawal by Subject|1|||
129565855|NCT01193608|466368195|FG000|Overall Study|Lost to Follow-up|0|||
129565856|NCT01193608|466368196|FG001|Overall Study|Lost to Follow-up|0|||
129565857|NCT01193608|466368197|FG002|Overall Study|Lost to Follow-up|0|||
129565858|NCT01193608|466368198|FG003|Overall Study|Lost to Follow-up|0|||
129565859|NCT01193608|466368199|FG004|Overall Study|Lost to Follow-up|1|||
129565860|NCT01193608|466368200|FG005|Overall Study|Lost to Follow-up|2|||
129565861|NCT01193608|466368195|FG000|Overall Study|Adverse Event|0|||
129565862|NCT01193608|466368196|FG001|Overall Study|Adverse Event|0|||
129565863|NCT01193608|466368197|FG002|Overall Study|Adverse Event|0|||
129565864|NCT01193608|466368198|FG003|Overall Study|Adverse Event|0|||
129565865|NCT01193608|466368199|FG004|Overall Study|Adverse Event|1|||
129565866|NCT01193608|466368200|FG005|Overall Study|Adverse Event|0|||
129565867|NCT00712010|466368201|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
129565868|NCT01946165|466368202|FG000|Overall Study|Physician Decision|2|||
129565869|NCT01946165|466368203|FG001|Overall Study|Physician Decision|0|||
129565870|NCT01946165|466368202|FG000|Overall Study|Withdrawal by Subject|0|||
129565871|NCT01946165|466368203|FG001|Overall Study|Withdrawal by Subject|2|||
129565872|NCT01901055|466368204|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
129565873|NCT01901055|466368205|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
129565874|NCT01901055|466368204|FG000|Randomization But Not Titrated|Physician Decision|0|||
129565875|NCT01901055|466368205|FG001|Randomization But Not Titrated|Physician Decision|1|||
129565876|NCT01901055|466368204|FG000|Started Protocol to Week 6|Physician Decision|2|||
129565877|NCT01901055|466368205|FG001|Started Protocol to Week 6|Physician Decision|1|||
129565878|NCT01901055|466368204|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
129565879|NCT01901055|466368205|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
129565880|NCT01901055|466368204|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
129565881|NCT01901055|466368205|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
129565882|NCT01901055|466368204|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
129565883|NCT01901055|466368205|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
129565884|NCT01901055|466368204|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
129565885|NCT01901055|466368205|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
129565886|NCT01901055|466368204|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
129565887|NCT01901055|466368205|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
129565888|NCT01901055|466368204|FG000|Week 24|Withdrawal by Subject|13|||
129565889|NCT01901055|466368205|FG001|Week 24|Withdrawal by Subject|19|||
129565890|NCT01901055|466368204|FG000|Week 24|Physician Decision|1|||
129565891|NCT01901055|466368205|FG001|Week 24|Physician Decision|0|||
129565892|NCT01901055|466368204|FG000|Week 36|Withdrawal by Subject|0|||
129565893|NCT01901055|466368205|FG001|Week 36|Withdrawal by Subject|5|||
129565894|NCT00525590|466368214|FG000|Overall Study|Adverse Event|3|||
129565895|NCT00525590|466368214|FG000|Overall Study|Physician Decision|3|||
129565896|NCT00525590|466368214|FG000|Overall Study|Withdrawal by Subject|16|||
129565897|NCT00525590|466368214|FG000|Overall Study|Lost to Follow-up|1|||
129565898|NCT00525590|466368214|FG000|Overall Study|Death|9|||
129565899|NCT00525590|466368214|FG000|Overall Study|Other|13|||
129565900|NCT00449150|466368219|FG000|Overall Study|Adverse Event|11|||
129565901|NCT00449150|466368220|FG001|Overall Study|Adverse Event|18|||
129565902|NCT00449150|466368221|FG002|Overall Study|Adverse Event|9|||
129565903|NCT00449150|466368219|FG000|Overall Study|Lack of Efficacy|1|||
129565904|NCT00449150|466368220|FG001|Overall Study|Lack of Efficacy|2|||
129565905|NCT00449150|466368221|FG002|Overall Study|Lack of Efficacy|2|||
129565906|NCT00449150|466368219|FG000|Overall Study|Other|16|||
129565907|NCT00449150|466368220|FG001|Overall Study|Other|13|||
129565908|NCT00449150|466368221|FG002|Overall Study|Other|14|||
129565909|NCT00449150|466368219|FG000|Overall Study|Withdrawal by Subject|17|||
129779740|NCT01092117|467159940|FG000|1 Month|Lost to Follow-up|1|||
129779741|NCT01092117|467159940|FG000|6 Months|Death|2|||
129779742|NCT01092117|467159940|FG000|6 Months|Withdrawal by Subject|3|||
129779743|NCT01092117|467159940|FG000|12 Month|Death|11|||
129779744|NCT01092117|467159940|FG000|12 Month|Withdrawal by Subject|2|||
129565910|NCT00449150|466368220|FG001|Overall Study|Withdrawal by Subject|18|||
129565911|NCT00449150|466368221|FG002|Overall Study|Withdrawal by Subject|21|||
129565912|NCT00449150|466368219|FG000|Overall Study|Protocol Violation|1|||
129565913|NCT00449150|466368220|FG001|Overall Study|Protocol Violation|2|||
129565914|NCT00449150|466368221|FG002|Overall Study|Protocol Violation|1|||
129565915|NCT02674334|466368222|FG000|Overall Study|Lost to Follow-up|5|||
129565916|NCT02674334|466368223|FG001|Overall Study|Lost to Follow-up|3|||
129565917|NCT02674334|466368222|FG000|Overall Study|participant difficulty breathing|1|||
129565918|NCT02674334|466368223|FG001|Overall Study|participant difficulty breathing|0|||
129565919|NCT02674334|466368222|FG000|Overall Study|NIRS not recording|1|||
129565920|NCT02674334|466368223|FG001|Overall Study|NIRS not recording|0|||
129565921|NCT01345019|466368230|FG000|Blinded Treatment Phase|Death|147|||
129565922|NCT01345019|466368231|FG001|Blinded Treatment Phase|Death|137|||
129565923|NCT01345019|466368230|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
129779745|NCT01092117|467159940|FG000|12 Month|Lost to Follow-up|1|||
129565924|NCT01345019|466368231|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
129565925|NCT01345019|466368230|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
129565926|NCT01345019|466368231|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
129565927|NCT01345019|466368230|FG000|Blinded Treatment Phase|Disease Progression|12|||
129565928|NCT01345019|466368231|FG001|Blinded Treatment Phase|Disease Progression|10|||
129565929|NCT01345019|466368230|FG000|Blinded Treatment Phase|Adverse Event|6|||
129565930|NCT01345019|466368231|FG001|Blinded Treatment Phase|Adverse Event|13|||
129565931|NCT01345019|466368230|FG000|Blinded Treatment Phase|Administrative Decision|10|||
129565932|NCT01345019|466368231|FG001|Blinded Treatment Phase|Administrative Decision|8|||
129565933|NCT01345019|466368230|FG000|Blinded Treatment Phase|Noncompliance|5|||
129565934|NCT01345019|466368231|FG001|Blinded Treatment Phase|Noncompliance|3|||
129565935|NCT01345019|466368230|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
129565936|NCT01345019|466368231|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
129565937|NCT01345019|466368230|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
129565938|NCT01345019|466368231|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
129565939|NCT01345019|466368230|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
129565940|NCT01345019|466368231|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
129565941|NCT01345019|466368230|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
129565942|NCT01345019|466368231|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
129565943|NCT01345019|466368230|FG000|Open Label Treatment Phase|Death|49|||
129565944|NCT01345019|466368231|FG001|Open Label Treatment Phase|Death|48|||
129565945|NCT01345019|466368230|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
129565946|NCT01345019|466368231|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
129565947|NCT01345019|466368230|FG000|Open Label Treatment Phase|Adverse Event|30|||
129565948|NCT01345019|466368231|FG001|Open Label Treatment Phase|Adverse Event|51|||
129565949|NCT01345019|466368230|FG000|Open Label Treatment Phase|Administrative Decision|30|||
129565950|NCT01345019|466368231|FG001|Open Label Treatment Phase|Administrative Decision|15|||
129565951|NCT01345019|466368230|FG000|Open Label Treatment Phase|Disease Progression|17|||
129565952|NCT01345019|466368231|FG001|Open Label Treatment Phase|Disease Progression|18|||
129565953|NCT01345019|466368230|FG000|Open Label Treatment Phase|Noncompliance|5|||
129565954|NCT01345019|466368231|FG001|Open Label Treatment Phase|Noncompliance|4|||
129565955|NCT01345019|466368230|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
129565956|NCT01345019|466368231|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
129565957|NCT01345019|466368230|FG000|Open Label Treatment Phase|Pregnancy|1|||
129565958|NCT01345019|466368231|FG001|Open Label Treatment Phase|Pregnancy|0|||
129565959|NCT01345019|466368230|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
129565960|NCT01345019|466368231|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
129565961|NCT01345019|466368230|FG000|Open Label Treatment Phase|Protocol Violation|0|||
129565962|NCT01345019|466368231|FG001|Open Label Treatment Phase|Protocol Violation|1|||
129565963|NCT03830164|466368232|FG000|Overall Study|Adverse Event|0|||
129565964|NCT03830164|466368233|FG001|Overall Study|Adverse Event|2|||
129565965|NCT03830164|466368234|FG002|Overall Study|Adverse Event|0|||
129565966|NCT03830164|466368232|FG000|Overall Study|Lack of Efficacy|1|||
129565967|NCT03830164|466368233|FG001|Overall Study|Lack of Efficacy|5|||
129565968|NCT03830164|466368234|FG002|Overall Study|Lack of Efficacy|0|||
129565969|NCT03830164|466368232|FG000|Overall Study|Lost to Follow-up|0|||
129565970|NCT03830164|466368233|FG001|Overall Study|Lost to Follow-up|1|||
129565971|NCT03830164|466368234|FG002|Overall Study|Lost to Follow-up|0|||
129565972|NCT03830164|466368232|FG000|Overall Study|Withdrawal by Subject|1|||
129565973|NCT03830164|466368233|FG001|Overall Study|Withdrawal by Subject|0|||
129565974|NCT03830164|466368234|FG002|Overall Study|Withdrawal by Subject|0|||
129565975|NCT02796664|466368235|FG000|Overall Study|Withdrawal by Subject|0|||
129779746|NCT01092117|467159940|FG000|Year 2|Death|5|||
129779747|NCT01092117|467159940|FG000|Year 2|Withdrawal by Subject|4|||
129779748|NCT01092117|467159940|FG000|Year 2|Lost to Follow-up|1|||
129779749|NCT01092117|467159940|FG000|Year 3|Death|7|||
129779750|NCT01092117|467159940|FG000|Year 3|Withdrawal by Subject|9|||
129565976|NCT02796664|466368236|FG001|Overall Study|Withdrawal by Subject|3|||
129565977|NCT02796664|466368235|FG000|Overall Study|Noncompliance|1|||
129565978|NCT02796664|466368236|FG001|Overall Study|Noncompliance|1|||
129565979|NCT02796664|466368235|FG000|Overall Study|Death|0|||
129565980|NCT02796664|466368236|FG001|Overall Study|Death|1|||
129565981|NCT02246478|466368237|FG000|Multiple-dose Phase|Protocol Violation|1|||
129565982|NCT02246478|466368238|FG001|Multiple-dose Phase|Protocol Violation|0|||
129565983|NCT02246478|466368239|FG002|Multiple-dose Phase|Protocol Violation|0|||
129565984|NCT02246478|466368240|FG003|Multiple-dose Phase|Protocol Violation|1|||
129565985|NCT01531205|466368242|FG000|Overall Study|Did not proceed to surgery|1|||
129565986|NCT00950807|466368245|FG000|Treatment Period 1|Lack of Efficacy|1|||
129565987|NCT00950807|466368246|FG001|Treatment Period 1|Lack of Efficacy|0|||
129565988|NCT00950807|466368247|FG002|Treatment Period 1|Lack of Efficacy|0|||
129565989|NCT00950807|466368248|FG003|Treatment Period 1|Lack of Efficacy|0|||
129565990|NCT00950807|466368249|FG004|Treatment Period 1|Lack of Efficacy|0|||
129565991|NCT00950807|466368250|FG005|Treatment Period 1|Lack of Efficacy|1|||
129565992|NCT00950807|466368251|FG006|Treatment Period 1|Lack of Efficacy|0|||
129779751|NCT01092117|467159940|FG000|Year 3|Lost to Follow-up|3|||
129689586|NCT01033071|466819898|FG001|Overall Study|Withdrawal by Subject|14|||
129689587|NCT01033071|466819899|FG002|Overall Study|Withdrawal by Subject|11|||
129689588|NCT01033071|466819897|FG000|Overall Study|Lack of Efficacy|0|||
129689589|NCT01033071|466819898|FG001|Overall Study|Lack of Efficacy|1|||
129689590|NCT01033071|466819899|FG002|Overall Study|Lack of Efficacy|1|||
129565993|NCT00950807|466368252|FG007|Treatment Period 1|Lack of Efficacy|0|||
129565994|NCT00950807|466368253|FG008|Treatment Period 1|Lack of Efficacy|0|||
129565995|NCT00950807|466368254|FG009|Treatment Period 1|Lack of Efficacy|0|||
129565996|NCT00950807|466368245|FG000|Treatment Period 1|Protocol Violation|1|||
129565997|NCT00950807|466368246|FG001|Treatment Period 1|Protocol Violation|0|||
129565998|NCT00950807|466368247|FG002|Treatment Period 1|Protocol Violation|0|||
129565999|NCT00950807|466368248|FG003|Treatment Period 1|Protocol Violation|0|||
129689591|NCT01033071|466819897|FG000|Overall Study|Other|6|||
129689592|NCT01033071|466819898|FG001|Overall Study|Other|4|||
129566000|NCT00950807|466368249|FG004|Treatment Period 1|Protocol Violation|0|||
129566001|NCT00950807|466368250|FG005|Treatment Period 1|Protocol Violation|0|||
129566002|NCT00950807|466368251|FG006|Treatment Period 1|Protocol Violation|0|||
129566003|NCT00950807|466368252|FG007|Treatment Period 1|Protocol Violation|0|||
129566004|NCT00950807|466368253|FG008|Treatment Period 1|Protocol Violation|0|||
129566005|NCT00950807|466368254|FG009|Treatment Period 1|Protocol Violation|0|||
129566006|NCT00950807|466368245|FG000|Treatment Period 1|Lost to Follow-up|0|||
129566007|NCT00950807|466368246|FG001|Treatment Period 1|Lost to Follow-up|0|||
129566008|NCT00950807|466368247|FG002|Treatment Period 1|Lost to Follow-up|1|||
129566009|NCT00950807|466368248|FG003|Treatment Period 1|Lost to Follow-up|0|||
129566010|NCT00950807|466368249|FG004|Treatment Period 1|Lost to Follow-up|0|||
129566011|NCT00950807|466368250|FG005|Treatment Period 1|Lost to Follow-up|0|||
129566012|NCT00950807|466368251|FG006|Treatment Period 1|Lost to Follow-up|0|||
129566013|NCT00950807|466368252|FG007|Treatment Period 1|Lost to Follow-up|0|||
129689593|NCT01033071|466819899|FG002|Overall Study|Other|3|||
129566014|NCT00950807|466368253|FG008|Treatment Period 1|Lost to Follow-up|0|||
129566015|NCT00950807|466368254|FG009|Treatment Period 1|Lost to Follow-up|0|||
129566016|NCT00950807|466368245|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129566017|NCT00950807|466368246|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129566018|NCT00950807|466368247|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129566019|NCT00950807|466368248|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129689594|NCT01695772|466819903|FG000|Overall Study|Withdrawal by Subject|18|||
129689595|NCT01695772|466819903|FG000|Overall Study|Progressive Disease|8|||
129689596|NCT01695772|466819903|FG000|Overall Study|Investigator Decision|5|||
129689597|NCT01695772|466819903|FG000|Overall Study|Lost to Follow-up|4|||
129689598|NCT01695772|466819903|FG000|Overall Study|Protocol Violation|2|||
129689599|NCT01695772|466819903|FG000|Overall Study|Unspecified Reason|1|||
129689600|NCT00004859|466819907|FG000|Overall Study|Lack of Efficacy|43|||
129689601|NCT00004859|466819908|FG001|Overall Study|Lack of Efficacy|113|||
129689602|NCT00004859|466819907|FG000|Overall Study|Adverse Event|31|||
129689603|NCT00004859|466819908|FG001|Overall Study|Adverse Event|93|||
129689604|NCT00004859|466819907|FG000|Overall Study|Death|5|||
129689605|NCT00004859|466819908|FG001|Overall Study|Death|5|||
129689606|NCT00004859|466819907|FG000|Overall Study|Withdrawal by Subject|7|||
129689607|NCT00004859|466819908|FG001|Overall Study|Withdrawal by Subject|33|||
129689608|NCT00004859|466819907|FG000|Overall Study|Protocol Violation|2|||
129689609|NCT00004859|466819908|FG001|Overall Study|Protocol Violation|2|||
129689610|NCT00004859|466819907|FG000|Overall Study|other disease|0|||
129689611|NCT00004859|466819908|FG001|Overall Study|other disease|3|||
129689612|NCT00004859|466819907|FG000|Overall Study|error|3|||
129689613|NCT00004859|466819908|FG001|Overall Study|error|1|||
129689614|NCT00004859|466819907|FG000|Overall Study|missing data|14|||
129689615|NCT00004859|466819908|FG001|Overall Study|missing data|11|||
129689616|NCT00004859|466819907|FG000|Overall Study|Other|13|||
129689617|NCT00004859|466819908|FG001|Overall Study|Other|21|||
129689618|NCT04073407|466819909|FG000|Part 1|Withdrawal by Subject|1|||
129689619|NCT04073407|466819910|FG001|Part 1|Withdrawal by Subject|0|||
129689620|NCT04073407|466819909|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
129689621|NCT04073407|466819910|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
129689622|NCT04073407|466819909|FG000|Part 2|Withdrawal by Subject|0|||
129689623|NCT04073407|466819910|FG001|Part 2|Withdrawal by Subject|1|||
129689624|NCT04941898|466822310|FG000|Overall Study|Protocol Violation|1|||
129689625|NCT02724644|466822311|FG000|Overall Study|Adverse Event|7|||
129689626|NCT02724644|466822312|FG001|Overall Study|Adverse Event|1|||
129689627|NCT02724644|466822311|FG000|Overall Study|Lost to Follow-up|6|||
129689628|NCT02724644|466822312|FG001|Overall Study|Lost to Follow-up|2|||
129689629|NCT02724644|466822311|FG000|Overall Study|Withdrawal by Subject|7|||
129689630|NCT02724644|466822312|FG001|Overall Study|Withdrawal by Subject|1|||
129689631|NCT02724644|466822311|FG000|Overall Study|Administrative|1|||
129689632|NCT02724644|466822312|FG001|Overall Study|Administrative|0|||
129689633|NCT03022630|466822313|FG000|Overall Study|Death|9|||
129689634|NCT03022630|466822314|FG001|Overall Study|Death|7|||
129689635|NCT03022630|466822313|FG000|Overall Study|Withdrawal by Subject|0|||
129689636|NCT03022630|466822314|FG001|Overall Study|Withdrawal by Subject|5|||
129566020|NCT00950807|466368249|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129566021|NCT00950807|466368250|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129566022|NCT00950807|466368251|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129566023|NCT00950807|466368252|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129566024|NCT00950807|466368253|FG008|Treatment Period 1|Withdrawal by Subject|1|||
129566025|NCT00950807|466368254|FG009|Treatment Period 1|Withdrawal by Subject|0|||
129566026|NCT00950807|466368245|FG000|Treatment Period 1|Adverse Event|0|||
129566027|NCT00950807|466368246|FG001|Treatment Period 1|Adverse Event|0|||
129566028|NCT00950807|466368247|FG002|Treatment Period 1|Adverse Event|0|||
129566029|NCT00950807|466368248|FG003|Treatment Period 1|Adverse Event|0|||
129566030|NCT00950807|466368249|FG004|Treatment Period 1|Adverse Event|0|||
129566031|NCT00950807|466368250|FG005|Treatment Period 1|Adverse Event|1|||
129566032|NCT00950807|466368251|FG006|Treatment Period 1|Adverse Event|0|||
129566033|NCT00950807|466368252|FG007|Treatment Period 1|Adverse Event|0|||
129566034|NCT00950807|466368253|FG008|Treatment Period 1|Adverse Event|0|||
129566035|NCT00950807|466368254|FG009|Treatment Period 1|Adverse Event|0|||
129566036|NCT00950807|466368245|FG000|Washout Period 1|Lack of Efficacy|0|||
129566037|NCT00950807|466368246|FG001|Washout Period 1|Lack of Efficacy|0|||
129566038|NCT00950807|466368247|FG002|Washout Period 1|Lack of Efficacy|0|||
129566039|NCT00950807|466368248|FG003|Washout Period 1|Lack of Efficacy|0|||
129566040|NCT00950807|466368249|FG004|Washout Period 1|Lack of Efficacy|0|||
129566041|NCT00950807|466368250|FG005|Washout Period 1|Lack of Efficacy|0|||
129566042|NCT00950807|466368251|FG006|Washout Period 1|Lack of Efficacy|1|||
129566043|NCT00950807|466368252|FG007|Washout Period 1|Lack of Efficacy|0|||
129566044|NCT00950807|466368253|FG008|Washout Period 1|Lack of Efficacy|0|||
129566045|NCT00950807|466368254|FG009|Washout Period 1|Lack of Efficacy|0|||
129566046|NCT00950807|466368245|FG000|Washout Period 1|Withdrawal by Subject|0|||
129566047|NCT00950807|466368246|FG001|Washout Period 1|Withdrawal by Subject|0|||
129566048|NCT00950807|466368247|FG002|Washout Period 1|Withdrawal by Subject|0|||
129566049|NCT00950807|466368248|FG003|Washout Period 1|Withdrawal by Subject|0|||
129566050|NCT00950807|466368249|FG004|Washout Period 1|Withdrawal by Subject|0|||
129566051|NCT00950807|466368250|FG005|Washout Period 1|Withdrawal by Subject|0|||
129566052|NCT00950807|466368251|FG006|Washout Period 1|Withdrawal by Subject|0|||
129566053|NCT00950807|466368252|FG007|Washout Period 1|Withdrawal by Subject|0|||
129566054|NCT00950807|466368253|FG008|Washout Period 1|Withdrawal by Subject|1|||
129566055|NCT00950807|466368254|FG009|Washout Period 1|Withdrawal by Subject|0|||
129566056|NCT00950807|466368245|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
129566057|NCT00950807|466368246|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566058|NCT00950807|466368247|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566059|NCT00950807|466368248|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566060|NCT00950807|466368249|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566061|NCT00950807|466368250|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566062|NCT00950807|466368251|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
129566063|NCT00950807|466368252|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
129566064|NCT00950807|466368253|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566065|NCT00950807|466368254|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
129566066|NCT00950807|466368245|FG000|Washout Period 1|Adverse Event|2|||
129566067|NCT00950807|466368246|FG001|Washout Period 1|Adverse Event|0|||
129566068|NCT00950807|466368247|FG002|Washout Period 1|Adverse Event|0|||
129566069|NCT00950807|466368248|FG003|Washout Period 1|Adverse Event|1|||
129566070|NCT00950807|466368249|FG004|Washout Period 1|Adverse Event|1|||
129566071|NCT00950807|466368250|FG005|Washout Period 1|Adverse Event|0|||
129566072|NCT00950807|466368251|FG006|Washout Period 1|Adverse Event|0|||
129566073|NCT00950807|466368252|FG007|Washout Period 1|Adverse Event|0|||
129689637|NCT00884949|466822315|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
129689638|NCT00884949|466822315|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
129689639|NCT01567085|466822318|FG000|Overall Study|Death|6|||
129689640|NCT01567085|466822318|FG000|Overall Study|Adverse Event|6|||
129689641|NCT01567085|466822318|FG000|Overall Study|Lost to Follow-up|3|||
129689642|NCT01567085|466822318|FG000|Overall Study|Graft loss|2|||
129689643|NCT01567085|466822318|FG000|Overall Study|Renal transplantectomy|1|||
129566074|NCT00950807|466368253|FG008|Washout Period 1|Adverse Event|0|||
129566075|NCT00950807|466368254|FG009|Washout Period 1|Adverse Event|0|||
129566076|NCT00950807|466368245|FG000|Treatment Period 2|Lack of Efficacy|1|||
129566077|NCT00950807|466368246|FG001|Treatment Period 2|Lack of Efficacy|0|||
129566078|NCT00950807|466368247|FG002|Treatment Period 2|Lack of Efficacy|0|||
129566079|NCT00950807|466368248|FG003|Treatment Period 2|Lack of Efficacy|0|||
129566080|NCT00950807|466368249|FG004|Treatment Period 2|Lack of Efficacy|0|||
129689644|NCT01567085|466822318|FG000|Overall Study|Returned to chronic dialysis|1|||
129566081|NCT00950807|466368250|FG005|Treatment Period 2|Lack of Efficacy|0|||
129566082|NCT00950807|466368251|FG006|Treatment Period 2|Lack of Efficacy|0|||
129566083|NCT00950807|466368252|FG007|Treatment Period 2|Lack of Efficacy|0|||
129566084|NCT00950807|466368253|FG008|Treatment Period 2|Lack of Efficacy|0|||
129566085|NCT00950807|466368254|FG009|Treatment Period 2|Lack of Efficacy|0|||
129566086|NCT00950807|466368245|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129566087|NCT00950807|466368246|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129566088|NCT00950807|466368247|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129566089|NCT00950807|466368248|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129566090|NCT00950807|466368249|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129566091|NCT00950807|466368250|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129566092|NCT00950807|466368251|FG006|Treatment Period 2|Withdrawal by Subject|1|||
129566093|NCT00950807|466368252|FG007|Treatment Period 2|Withdrawal by Subject|2|||
129566094|NCT00950807|466368253|FG008|Treatment Period 2|Withdrawal by Subject|0|||
129566095|NCT00950807|466368254|FG009|Treatment Period 2|Withdrawal by Subject|0|||
129566096|NCT00950807|466368245|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
129566097|NCT00950807|466368246|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566098|NCT00950807|466368247|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566099|NCT00950807|466368248|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566100|NCT00950807|466368249|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566101|NCT00950807|466368250|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566102|NCT00950807|466368251|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566103|NCT00950807|466368252|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566104|NCT00950807|466368253|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566105|NCT00950807|466368254|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129566106|NCT00950807|466368245|FG000|Treatment Period 2|Adverse Event|0|||
129566107|NCT00950807|466368246|FG001|Treatment Period 2|Adverse Event|1|||
129566108|NCT00950807|466368247|FG002|Treatment Period 2|Adverse Event|0|||
129566109|NCT00950807|466368248|FG003|Treatment Period 2|Adverse Event|1|||
129566110|NCT00950807|466368249|FG004|Treatment Period 2|Adverse Event|0|||
129566111|NCT00950807|466368250|FG005|Treatment Period 2|Adverse Event|1|||
129566112|NCT00950807|466368251|FG006|Treatment Period 2|Adverse Event|0|||
129566113|NCT00950807|466368252|FG007|Treatment Period 2|Adverse Event|1|||
129566114|NCT00950807|466368253|FG008|Treatment Period 2|Adverse Event|0|||
129566115|NCT00950807|466368254|FG009|Treatment Period 2|Adverse Event|0|||
129779752|NCT01092117|467159940|FG000|Year 4|Death|8|||
129779753|NCT01092117|467159940|FG000|Year 4|Withdrawal by Subject|4|||
129779754|NCT01092117|467159940|FG000|Year 4|Lost to Follow-up|4|||
129779755|NCT04380519|467159941|FG000|Overall Study|Withdrawal by Subject|4|||
129779756|NCT04380519|467159942|FG001|Overall Study|Withdrawal by Subject|0|||
129779757|NCT04380519|467159943|FG002|Overall Study|Withdrawal by Subject|1|||
129779758|NCT04380519|467159941|FG000|Overall Study|Death|14|||
129779759|NCT04380519|467159942|FG001|Overall Study|Death|9|||
129779760|NCT04380519|467159943|FG002|Overall Study|Death|6|||
129779761|NCT04380519|467159941|FG000|Overall Study|Adverse Event|0|||
129779762|NCT04380519|467159942|FG001|Overall Study|Adverse Event|1|||
129779763|NCT04380519|467159943|FG002|Overall Study|Adverse Event|0|||
129779764|NCT04380519|467159941|FG000|Overall Study|relatives' decision|0|||
129779765|NCT04380519|467159942|FG001|Overall Study|relatives' decision|1|||
129779766|NCT04380519|467159943|FG002|Overall Study|relatives' decision|0|||
129779767|NCT02147561|467159946|FG000|Overall Study|Lost to Follow-up|3|||
129779768|NCT02147561|467159946|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
129779769|NCT00393861|467159949|FG000|Overall Study|Adverse Event|2|||
129779770|NCT00393861|467159949|FG000|Overall Study|Disease Progression|24|||
129779771|NCT05300763|467159950|FG000|Overall Study|Adverse Event|0|||
129779772|NCT05300763|467159951|FG001|Overall Study|Adverse Event|1|||
129779773|NCT05300763|467159950|FG000|Overall Study|Major Protocol Deviation|1|||
129884550|NCT03012061|467536451|FG001|Overall Study|Lack of Efficacy|1|||
129566116|NCT00950807|466368245|FG000|Washout Period 2|Lack of Efficacy|1|||
129566117|NCT00950807|466368246|FG001|Washout Period 2|Lack of Efficacy|0|||
129566118|NCT00950807|466368247|FG002|Washout Period 2|Lack of Efficacy|0|||
129566119|NCT00950807|466368248|FG003|Washout Period 2|Lack of Efficacy|0|||
129566120|NCT00950807|466368249|FG004|Washout Period 2|Lack of Efficacy|0|||
129566121|NCT00950807|466368250|FG005|Washout Period 2|Lack of Efficacy|0|||
129779774|NCT05300763|467159951|FG001|Overall Study|Major Protocol Deviation|0|||
129779775|NCT05300763|467159950|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
129884551|NCT03012061|467536452|FG002|Overall Study|Lack of Efficacy|0|||
129566122|NCT00950807|466368251|FG006|Washout Period 2|Lack of Efficacy|0|||
129566123|NCT00950807|466368252|FG007|Washout Period 2|Lack of Efficacy|0|||
129566124|NCT00950807|466368253|FG008|Washout Period 2|Lack of Efficacy|0|||
129566125|NCT00950807|466368254|FG009|Washout Period 2|Lack of Efficacy|0|||
129566126|NCT00950807|466368245|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129566127|NCT00950807|466368246|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129566128|NCT00950807|466368247|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129566129|NCT00950807|466368248|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129566130|NCT00950807|466368249|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129566131|NCT00950807|466368250|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129566132|NCT00950807|466368251|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129566133|NCT00950807|466368252|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
129566134|NCT00950807|466368253|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129566135|NCT00950807|466368254|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
129566136|NCT00950807|466368245|FG000|Washout Period 2|Adverse Event|3|||
129566137|NCT00950807|466368246|FG001|Washout Period 2|Adverse Event|0|||
129566138|NCT00950807|466368247|FG002|Washout Period 2|Adverse Event|0|||
129566139|NCT00950807|466368248|FG003|Washout Period 2|Adverse Event|1|||
129566140|NCT00950807|466368249|FG004|Washout Period 2|Adverse Event|0|||
129566141|NCT00950807|466368250|FG005|Washout Period 2|Adverse Event|0|||
129566142|NCT00950807|466368251|FG006|Washout Period 2|Adverse Event|0|||
129566143|NCT00950807|466368252|FG007|Washout Period 2|Adverse Event|0|||
129566144|NCT00950807|466368253|FG008|Washout Period 2|Adverse Event|0|||
129566145|NCT00950807|466368254|FG009|Washout Period 2|Adverse Event|0|||
129566146|NCT00950807|466368245|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129566147|NCT00950807|466368246|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129566148|NCT00950807|466368247|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129566149|NCT00950807|466368248|FG003|Treatment Period 3|Withdrawal by Subject|0|||
129566150|NCT00950807|466368249|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129566151|NCT00950807|466368250|FG005|Treatment Period 3|Withdrawal by Subject|0|||
129566152|NCT00950807|466368251|FG006|Treatment Period 3|Withdrawal by Subject|0|||
129566153|NCT00950807|466368252|FG007|Treatment Period 3|Withdrawal by Subject|0|||
129566154|NCT00950807|466368253|FG008|Treatment Period 3|Withdrawal by Subject|0|||
129566155|NCT00950807|466368254|FG009|Treatment Period 3|Withdrawal by Subject|1|||
129566156|NCT00950807|466368245|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
129566157|NCT00950807|466368246|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566158|NCT00950807|466368247|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566159|NCT00950807|466368248|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566160|NCT00950807|466368249|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566161|NCT00950807|466368250|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566162|NCT00950807|466368251|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566163|NCT00950807|466368252|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
129566164|NCT00950807|466368253|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566165|NCT00950807|466368254|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129566166|NCT00950807|466368245|FG000|Treatment Period 3|Adverse Event|0|||
129566167|NCT00950807|466368246|FG001|Treatment Period 3|Adverse Event|0|||
129566168|NCT00950807|466368247|FG002|Treatment Period 3|Adverse Event|0|||
129566169|NCT00950807|466368248|FG003|Treatment Period 3|Adverse Event|0|||
129566170|NCT00950807|466368249|FG004|Treatment Period 3|Adverse Event|0|||
129566171|NCT00950807|466368250|FG005|Treatment Period 3|Adverse Event|0|||
129566172|NCT00950807|466368251|FG006|Treatment Period 3|Adverse Event|1|||
129689645|NCT01567085|466822318|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
129689646|NCT03928704|466822322|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129689647|NCT03928704|466822323|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
129689648|NCT03928704|466822324|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129689649|NCT03928704|466822325|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129689650|NCT03928704|466822326|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129689651|NCT03928704|466822327|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
129689652|NCT03928704|466822322|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
129689653|NCT03928704|466822323|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129689654|NCT03928704|466822324|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129707765|NCT01280968|466892117|FG000|Overall Study|Pre-existing Neurological Condition|1|||
129707766|NCT01280968|466892118|FG001|Overall Study|Pre-existing Neurological Condition|0|||
129707767|NCT01280968|466892117|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
129566173|NCT00950807|466368252|FG007|Treatment Period 3|Adverse Event|0|||
129566174|NCT00950807|466368253|FG008|Treatment Period 3|Adverse Event|0|||
129566175|NCT00950807|466368254|FG009|Treatment Period 3|Adverse Event|0|||
129566176|NCT00337077|466368255|FG000|Overall Study|Progressive disease|25|||
129566177|NCT00337077|466368256|FG001|Overall Study|Progressive disease|37|||
129566178|NCT00337077|466368257|FG002|Overall Study|Progressive disease|19|||
129566179|NCT00337077|466368255|FG000|Overall Study|Adverse Event|7|||
129566180|NCT00337077|466368256|FG001|Overall Study|Adverse Event|7|||
129566181|NCT00337077|466368257|FG002|Overall Study|Adverse Event|1|||
129566182|NCT00337077|466368255|FG000|Overall Study|Death|0|||
129566183|NCT00337077|466368256|FG001|Overall Study|Death|1|||
129566184|NCT00337077|466368257|FG002|Overall Study|Death|0|||
129566185|NCT00337077|466368255|FG000|Overall Study|Withdrawal by Subject|7|||
129566186|NCT00337077|466368256|FG001|Overall Study|Withdrawal by Subject|2|||
129566187|NCT00337077|466368257|FG002|Overall Study|Withdrawal by Subject|2|||
129566188|NCT00337077|466368255|FG000|Overall Study|Alternative therapy|1|||
129566189|NCT00337077|466368256|FG001|Overall Study|Alternative therapy|0|||
129566190|NCT00337077|466368257|FG002|Overall Study|Alternative therapy|0|||
129566191|NCT00337077|466368255|FG000|Overall Study|Physician Decision|1|||
129566192|NCT00337077|466368256|FG001|Overall Study|Physician Decision|4|||
129566193|NCT00337077|466368257|FG002|Overall Study|Physician Decision|2|||
129566194|NCT00337077|466368255|FG000|Overall Study|Never started treatment|1|||
129566195|NCT00337077|466368256|FG001|Overall Study|Never started treatment|1|||
129566196|NCT00337077|466368257|FG002|Overall Study|Never started treatment|0|||
129566197|NCT00337077|466368255|FG000|Overall Study|Ineligible|1|||
129566198|NCT00337077|466368256|FG001|Overall Study|Ineligible|1|||
129566199|NCT00337077|466368257|FG002|Overall Study|Ineligible|1|||
129566200|NCT02780687|466368268|FG000|Overall Study|Adverse Event|1|||
129566201|NCT02780687|466368269|FG001|Overall Study|Adverse Event|1|||
129566202|NCT02780687|466368268|FG000|Overall Study|Withdrawal by Subject|2|||
129566203|NCT02780687|466368269|FG001|Overall Study|Withdrawal by Subject|1|||
129566204|NCT02780687|466368268|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
129566205|NCT02780687|466368269|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
129566206|NCT02780687|466368268|FG000|Overall Study|progressive disease|29|||
129566207|NCT02780687|466368269|FG001|Overall Study|progressive disease|6|||
129566208|NCT00920140|466369951|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
129566209|NCT00920140|466369952|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
129566210|NCT00920140|466369953|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
129566211|NCT00920140|466369954|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
129566212|NCT00920140|466369955|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
129566213|NCT00920140|466369951|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
129566214|NCT00920140|466369952|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
129566215|NCT00920140|466369953|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
129566216|NCT00920140|466369954|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
129566217|NCT00920140|466369955|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
129566218|NCT00920140|466369951|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129566219|NCT00920140|466369952|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
129566220|NCT00920140|466369953|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129566221|NCT00920140|466369954|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129566222|NCT00920140|466369955|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129566223|NCT00920140|466369951|FG000|Phase 2|Adverse Event|0|||
129566224|NCT00920140|466369952|FG001|Phase 2|Adverse Event|0|||
129566225|NCT00920140|466369953|FG002|Phase 2|Adverse Event|14|||
129566226|NCT00920140|466369954|FG003|Phase 2|Adverse Event|2|||
129566227|NCT00920140|466369955|FG004|Phase 2|Adverse Event|3|||
129566228|NCT00920140|466369951|FG000|Phase 2|Lack of Efficacy|0|||
129566229|NCT00920140|466369952|FG001|Phase 2|Lack of Efficacy|0|||
129566230|NCT00920140|466369953|FG002|Phase 2|Lack of Efficacy|29|||
129566231|NCT00920140|466369954|FG003|Phase 2|Lack of Efficacy|14|||
129566232|NCT00920140|466369955|FG004|Phase 2|Lack of Efficacy|5|||
129566233|NCT00920140|466369951|FG000|Phase 2|Lost to Follow-up|0|||
129566234|NCT00920140|466369952|FG001|Phase 2|Lost to Follow-up|0|||
129566235|NCT00920140|466369953|FG002|Phase 2|Lost to Follow-up|0|||
129566236|NCT00920140|466369954|FG003|Phase 2|Lost to Follow-up|1|||
129566237|NCT00920140|466369955|FG004|Phase 2|Lost to Follow-up|0|||
129779776|NCT05300763|467159951|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129779777|NCT01727024|467159952|FG000|Period 1|Lost to Follow-up|1|||
129779778|NCT01727024|467159953|FG001|Period 1|Lost to Follow-up|1|||
129779779|NCT01727024|467159952|FG000|Period 1|Withdrawal by Subject|2|||
129779780|NCT01727024|467159953|FG001|Period 1|Withdrawal by Subject|3|||
129779781|NCT01485172|467159954|FG000|Overall Study|Adverse Event|2|||
129779782|NCT01485172|467159955|FG001|Overall Study|Adverse Event|1|||
129779783|NCT01485172|467159956|FG002|Overall Study|Adverse Event|2|||
129566238|NCT00920140|466369951|FG000|Phase 2|Physician Decision|0|||
129566239|NCT00920140|466369952|FG001|Phase 2|Physician Decision|0|||
129566240|NCT00920140|466369953|FG002|Phase 2|Physician Decision|3|||
129566241|NCT00920140|466369954|FG003|Phase 2|Physician Decision|3|||
129566242|NCT00920140|466369955|FG004|Phase 2|Physician Decision|2|||
129566243|NCT00920140|466369951|FG000|Phase 2|Withdrawal by Subject|0|||
129566244|NCT00920140|466369952|FG001|Phase 2|Withdrawal by Subject|0|||
129566245|NCT00920140|466369953|FG002|Phase 2|Withdrawal by Subject|4|||
129779784|NCT01485172|467159957|FG003|Overall Study|Adverse Event|2|||
129779785|NCT01485172|467159958|FG004|Overall Study|Adverse Event|1|||
129566246|NCT00920140|466369954|FG003|Phase 2|Withdrawal by Subject|2|||
129566247|NCT00920140|466369955|FG004|Phase 2|Withdrawal by Subject|1|||
129566248|NCT01124149|466369956|FG000|Acute Phase|Withdrawal by Subject|22|||
129566249|NCT01124149|466369956|FG000|Acute Phase|Adverse Event|21|||
129779786|NCT01485172|467159959|FG005|Overall Study|Adverse Event|2|||
129566250|NCT01124149|466369956|FG000|Acute Phase|Lack of Efficacy|17|||
129566251|NCT01124149|466369956|FG000|Acute Phase|Protocol Violation|14|||
129566252|NCT01124149|466369956|FG000|Acute Phase|Lost to Follow-up|2|||
129566253|NCT01124149|466369956|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
129566254|NCT01124149|466369956|FG000|Acute Phase|Sponsor request|1|||
129566255|NCT01124149|466369956|FG000|Acute Phase|UC symptoms not ameliorated|1|||
129566256|NCT01124149|466369956|FG000|Acute Phase|Non-compliance|1|||
129566257|NCT01124149|466369956|FG000|Acute Phase|Low hemoglobin|1|||
129566258|NCT01124149|466369956|FG000|Acute Phase|Travelling to another country|1|||
129566259|NCT01124149|466369956|FG000|Acute Phase|Sponsor decision|1|||
129566260|NCT01124149|466369956|FG000|Maintenance Phase|Lack of Efficacy|40|||
129566261|NCT01124149|466369956|FG000|Maintenance Phase|Adverse Event|24|||
129566262|NCT01124149|466369956|FG000|Maintenance Phase|Lost to Follow-up|15|||
129566263|NCT01124149|466369956|FG000|Maintenance Phase|Withdrawal by Subject|10|||
129566264|NCT01124149|466369956|FG000|Maintenance Phase|Protocol Violation|5|||
129566265|NCT01124149|466369956|FG000|Maintenance Phase|Coordinator error|1|||
129566266|NCT01124149|466369956|FG000|Maintenance Phase|Non-compliance|1|||
129566267|NCT00977106|466369957|FG000|Overall Study|Adverse Event|5|||
129566268|NCT00977106|466369958|FG001|Overall Study|Adverse Event|6|||
129566269|NCT00977106|466369957|FG000|Overall Study|Withdrawal by Subject|2|||
129566270|NCT00977106|466369958|FG001|Overall Study|Withdrawal by Subject|2|||
129566271|NCT00977106|466369957|FG000|Overall Study|Lack of Efficacy|2|||
129566272|NCT00977106|466369958|FG001|Overall Study|Lack of Efficacy|2|||
129566273|NCT00977106|466369957|FG000|Overall Study|Protocol Violation|0|||
129566274|NCT00977106|466369958|FG001|Overall Study|Protocol Violation|1|||
129566275|NCT00977106|466369957|FG000|Overall Study|Other|1|||
129566276|NCT00977106|466369958|FG001|Overall Study|Other|0|||
129566277|NCT01644500|466369959|FG000|Overall Study|Adverse Event|6|||
129566278|NCT01644500|466369960|FG001|Overall Study|Adverse Event|1|||
129566279|NCT01644500|466369961|FG002|Overall Study|Adverse Event|2|||
129566280|NCT01644500|466369959|FG000|Overall Study|Death|0|||
129566281|NCT01644500|466369960|FG001|Overall Study|Death|1|||
129566282|NCT01644500|466369961|FG002|Overall Study|Death|0|||
129566283|NCT01644500|466369959|FG000|Overall Study|Lost to Follow-up|3|||
129566284|NCT01644500|466369960|FG001|Overall Study|Lost to Follow-up|8|||
129566285|NCT01644500|466369961|FG002|Overall Study|Lost to Follow-up|0|||
129566286|NCT01644500|466369959|FG000|Overall Study|Protocol Violation|1|||
129566287|NCT01644500|466369960|FG001|Overall Study|Protocol Violation|1|||
129566288|NCT01644500|466369961|FG002|Overall Study|Protocol Violation|0|||
129566289|NCT01644500|466369959|FG000|Overall Study|Withdrawal by Subject|11|||
129566290|NCT01644500|466369960|FG001|Overall Study|Withdrawal by Subject|12|||
129566291|NCT01644500|466369961|FG002|Overall Study|Withdrawal by Subject|12|||
129566292|NCT01644500|466369959|FG000|Overall Study|Physician Decision|1|||
129566293|NCT01644500|466369960|FG001|Overall Study|Physician Decision|1|||
129566294|NCT01644500|466369961|FG002|Overall Study|Physician Decision|1|||
129566295|NCT01400425|466369969|FG000|Overall Study|Withdrawal by Subject|10|||
129566296|NCT02388763|466369972|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
129566297|NCT02388763|466369973|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
129566298|NCT02388763|466369972|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
129566299|NCT02388763|466369973|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
129566300|NCT01458405|466369984|FG000|Phase 1 (up to 12 Months)|Other|0|||
129566301|NCT01458405|466369985|FG001|Phase 1 (up to 12 Months)|Other|1|||
129689655|NCT03928704|466822325|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129689656|NCT03928704|466822326|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129689657|NCT03928704|466822327|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
129689658|NCT03928704|466822322|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
129689659|NCT03928704|466822323|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129689660|NCT03928704|466822324|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129689661|NCT03928704|466822325|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129689662|NCT03928704|466822326|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129689663|NCT03928704|466822327|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
129566302|NCT01458405|466369986|FG002|Phase 1 (up to 12 Months)|Other|0|||
129566303|NCT01458405|466369987|FG003|Phase 1 (up to 12 Months)|Other|0|||
129566304|NCT01458405|466369984|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
129566305|NCT01458405|466369985|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
129566306|NCT01458405|466369986|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
129566307|NCT01458405|466369987|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
129566308|NCT01458405|466369984|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
129566309|NCT01458405|466369985|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
129566310|NCT01458405|466369986|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
129566311|NCT01458405|466369987|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
129566312|NCT01458405|466369984|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
129566313|NCT01458405|466369985|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
129566314|NCT01458405|466369986|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
129566315|NCT01458405|466369987|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
129566316|NCT02194998|466369988|FG000|On-HCV Treatment|Did not pick up study medication|0|||
129566317|NCT02194998|466369989|FG001|On-HCV Treatment|Did not pick up study medication|1|||
129566318|NCT02194998|466369990|FG002|On-HCV Treatment|Did not pick up study medication|0|||
129566319|NCT02194998|466369991|FG003|On-HCV Treatment|Did not pick up study medication|0|||
129566320|NCT02194998|466369988|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
129566321|NCT02194998|466369989|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
129566322|NCT02194998|466369990|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
129566323|NCT02194998|466369991|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
129566324|NCT02497781|466369992|FG000|Overall Study|Withdrawal by Subject|2|||
129566325|NCT02497781|466369993|FG001|Overall Study|Withdrawal by Subject|0|||
129566326|NCT02497781|466369992|FG000|Overall Study|Lack of Efficacy|0|||
129566327|NCT02497781|466369993|FG001|Overall Study|Lack of Efficacy|1|||
129566328|NCT02497781|466369992|FG000|Overall Study|Randomised but not treated|1|||
129566329|NCT02497781|466369993|FG001|Overall Study|Randomised but not treated|1|||
129566330|NCT02497781|466369992|FG000|Overall Study|Lost to Follow-up|1|||
129566331|NCT02497781|466369993|FG001|Overall Study|Lost to Follow-up|1|||
129566332|NCT02236130|466369994|FG000|Overall Study|Lost to Follow-up|7|||
129566333|NCT02236130|466369995|FG001|Overall Study|Lost to Follow-up|12|||
129566334|NCT00454636|466369996|FG000|Overall Study|Adverse Event|10|||
129566335|NCT00454636|466369997|FG001|Overall Study|Adverse Event|6|||
129566336|NCT00454636|466369998|FG002|Overall Study|Adverse Event|9|||
129566337|NCT00454636|466369999|FG003|Overall Study|Adverse Event|15|||
129566338|NCT00454636|466369996|FG000|Overall Study|Disease Progression|11|||
129566339|NCT00454636|466369997|FG001|Overall Study|Disease Progression|12|||
129566340|NCT00454636|466369998|FG002|Overall Study|Disease Progression|4|||
129566341|NCT00454636|466369999|FG003|Overall Study|Disease Progression|11|||
129566342|NCT00454636|466369996|FG000|Overall Study|Protocol Violation|3|||
129566343|NCT00454636|466369997|FG001|Overall Study|Protocol Violation|2|||
129566344|NCT00454636|466369998|FG002|Overall Study|Protocol Violation|3|||
129566345|NCT00454636|466369999|FG003|Overall Study|Protocol Violation|3|||
129566346|NCT00454636|466369996|FG000|Overall Study|Death|6|||
129566347|NCT00454636|466369997|FG001|Overall Study|Death|1|||
129566348|NCT00454636|466369998|FG002|Overall Study|Death|1|||
129566349|NCT00454636|466369999|FG003|Overall Study|Death|1|||
129566350|NCT00454636|466369996|FG000|Overall Study|Patient refusal|1|||
129566351|NCT00454636|466369997|FG001|Overall Study|Patient refusal|1|||
129566352|NCT00454636|466369998|FG002|Overall Study|Patient refusal|3|||
129566353|NCT00454636|466369999|FG003|Overall Study|Patient refusal|2|||
129566354|NCT00454636|466369996|FG000|Overall Study|Lost to Follow-up|0|||
129566355|NCT00454636|466369997|FG001|Overall Study|Lost to Follow-up|1|||
129566356|NCT00454636|466369998|FG002|Overall Study|Lost to Follow-up|0|||
129566357|NCT00454636|466369999|FG003|Overall Study|Lost to Follow-up|0|||
129566358|NCT01400113|466370000|FG000|Overall Study|Withdrawal by Subject|1|||
129566359|NCT01400113|466370001|FG001|Overall Study|Withdrawal by Subject|1|||
129566360|NCT01179919|466370002|FG000|Overall Study|Protocol Violation|1|||
129566361|NCT01179919|466370002|FG000|Overall Study|Adverse Event|1|||
129566362|NCT00806156|466370003|FG000|Overall Study|Death|35|||
129566363|NCT00806156|466370004|FG001|Overall Study|Death|95|||
129566364|NCT00806156|466370003|FG000|Overall Study|Did not meet eligibility criteria|1|||
129566365|NCT00806156|466370004|FG001|Overall Study|Did not meet eligibility criteria|0|||
129566366|NCT00806156|466370003|FG000|Overall Study|Study terminated by Sponsor|2|||
129566367|NCT00806156|466370004|FG001|Overall Study|Study terminated by Sponsor|40|||
129566368|NCT00806156|466370003|FG000|Overall Study|Consent withdrawn by subject|1|||
129566369|NCT00806156|466370004|FG001|Overall Study|Consent withdrawn by subject|3|||
129566370|NCT00806156|466370003|FG000|Overall Study|Lost to Follow-up|0|||
129566371|NCT00806156|466370004|FG001|Overall Study|Lost to Follow-up|1|||
129566372|NCT01025037|466370009|FG000|Overall Study|Adverse Event|3|||
129566373|NCT01025037|466370009|FG000|Overall Study|Lost to Follow-up|7|||
129566374|NCT01025037|466370009|FG000|Overall Study|Withdrawal by Subject|1|||
129566375|NCT00337571|466370010|FG000|Overall Study|Lack of Efficacy|3|||
129566376|NCT00337571|466370011|FG001|Overall Study|Lack of Efficacy|0|||
129566377|NCT00337571|466370012|FG002|Overall Study|Lack of Efficacy|0|||
129566378|NCT00337571|466370013|FG003|Overall Study|Lack of Efficacy|0|||
129566379|NCT00337571|466370010|FG000|Overall Study|Adverse Event|4|||
129566380|NCT00337571|466370011|FG001|Overall Study|Adverse Event|5|||
129566381|NCT00337571|466370012|FG002|Overall Study|Adverse Event|8|||
129566382|NCT00337571|466370013|FG003|Overall Study|Adverse Event|4|||
129566383|NCT00337571|466370010|FG000|Overall Study|Withdrawal by Subject|2|||
129566384|NCT00337571|466370011|FG001|Overall Study|Withdrawal by Subject|2|||
129566385|NCT00337571|466370012|FG002|Overall Study|Withdrawal by Subject|1|||
129566386|NCT00337571|466370013|FG003|Overall Study|Withdrawal by Subject|0|||
129566387|NCT00337571|466370010|FG000|Overall Study|Lost to Follow-up|3|||
129566388|NCT00337571|466370011|FG001|Overall Study|Lost to Follow-up|1|||
129566389|NCT00337571|466370012|FG002|Overall Study|Lost to Follow-up|0|||
129566390|NCT00337571|466370013|FG003|Overall Study|Lost to Follow-up|1|||
129566391|NCT00337571|466370010|FG000|Overall Study|Poor/noncompliance|1|||
129566392|NCT00337571|466370011|FG001|Overall Study|Poor/noncompliance|1|||
129566393|NCT00337571|466370012|FG002|Overall Study|Poor/noncompliance|1|||
129566394|NCT00337571|466370013|FG003|Overall Study|Poor/noncompliance|1|||
129566395|NCT00337571|466370010|FG000|Overall Study|No longer met study criteria|1|||
129566396|NCT00337571|466370011|FG001|Overall Study|No longer met study criteria|0|||
129566397|NCT00337571|466370012|FG002|Overall Study|No longer met study criteria|0|||
129566398|NCT00337571|466370013|FG003|Overall Study|No longer met study criteria|0|||
129566399|NCT00337571|466370010|FG000|Overall Study|High Potassium level|0|||
129566400|NCT00337571|466370011|FG001|Overall Study|High Potassium level|0|||
129566401|NCT00337571|466370012|FG002|Overall Study|High Potassium level|0|||
129566402|NCT00337571|466370013|FG003|Overall Study|High Potassium level|1|||
129566403|NCT01890915|466370015|FG000|Overall Study|Adverse Event|1|||
129566404|NCT01890915|466370016|FG001|Overall Study|Adverse Event|0|||
129566405|NCT01890915|466370015|FG000|Overall Study|Protocol Violation|2|||
129566406|NCT01890915|466370016|FG001|Overall Study|Protocol Violation|0|||
129566407|NCT01890915|466370015|FG000|Overall Study|Equipment Malfunction|0|||
129566408|NCT01890915|466370016|FG001|Overall Study|Equipment Malfunction|1|||
129566409|NCT02114697|466370017|FG000|Overall Study|Study terminated|5|||
129566410|NCT02114697|466370018|FG001|Overall Study|Study terminated|4|||
129566411|NCT00424489|466370019|FG000|Overall Study|Death|3|||
129566412|NCT03552757|466370022|FG000|Overall Study|Withdrawal by Subject|10|||
129566413|NCT03552757|466370023|FG001|Overall Study|Withdrawal by Subject|5|||
129566414|NCT03552757|466370024|FG002|Overall Study|Withdrawal by Subject|12|||
129566415|NCT03552757|466370022|FG000|Overall Study|Lost to Follow-up|2|||
129566416|NCT03552757|466370023|FG001|Overall Study|Lost to Follow-up|7|||
129566417|NCT03552757|466370024|FG002|Overall Study|Lost to Follow-up|7|||
129566418|NCT03552757|466370022|FG000|Overall Study|Death|1|||
129566419|NCT03552757|466370023|FG001|Overall Study|Death|1|||
129566420|NCT03552757|466370024|FG002|Overall Study|Death|1|||
129566421|NCT00386009|466370028|FG000|Overall Study|Adverse Event|0|||
129566422|NCT00386009|466370029|FG001|Overall Study|Adverse Event|2|||
129566423|NCT00386009|466370028|FG000|Overall Study|Death|1|||
129566424|NCT00386009|466370029|FG001|Overall Study|Death|0|||
129566425|NCT00386009|466370028|FG000|Overall Study|Entry Criteria Not Met|0|||
129566426|NCT00386009|466370029|FG001|Overall Study|Entry Criteria Not Met|2|||
129566427|NCT00386009|466370028|FG000|Overall Study|Lost to Follow-up|1|||
129566428|NCT00386009|466370029|FG001|Overall Study|Lost to Follow-up|1|||
129566429|NCT00386009|466370028|FG000|Overall Study|Protocol Violation|1|||
129566430|NCT00386009|466370029|FG001|Overall Study|Protocol Violation|0|||
129566431|NCT00386009|466370028|FG000|Overall Study|Sponsor Decision|1|||
129566432|NCT00386009|466370029|FG001|Overall Study|Sponsor Decision|1|||
129566433|NCT00386009|466370028|FG000|Overall Study|Withdrawal by Subject|5|||
129566434|NCT00386009|466370029|FG001|Overall Study|Withdrawal by Subject|4|||
129566435|NCT00497796|466370030|FG000|Overall Study|Adverse event (not related)|9|||
129566436|NCT00497796|466370031|FG001|Overall Study|Adverse event (not related)|9|||
129566437|NCT00497796|466370030|FG000|Overall Study|Adverse event (related)|5|||
129566438|NCT00497796|466370031|FG001|Overall Study|Adverse event (related)|4|||
129566439|NCT00497796|466370030|FG000|Overall Study|CMV infection or disease treatment|30|||
129566440|NCT00497796|466370031|FG001|Overall Study|CMV infection or disease treatment|4|||
129566441|NCT00497796|466370030|FG000|Overall Study|Consent withdrawn|10|||
129566442|NCT00497796|466370031|FG001|Overall Study|Consent withdrawn|3|||
129566443|NCT00497796|466370030|FG000|Overall Study|Investigator/sponsor discretion|31|||
129566444|NCT00497796|466370031|FG001|Overall Study|Investigator/sponsor discretion|34|||
129566445|NCT00497796|466370030|FG000|Overall Study|Lost to Follow-up|0|||
129566446|NCT00497796|466370031|FG001|Overall Study|Lost to Follow-up|1|||
129566447|NCT00497796|466370030|FG000|Overall Study|Not applicable (randomized not treated)|0|||
129566448|NCT00497796|466370031|FG001|Overall Study|Not applicable (randomized not treated)|4|||
129566449|NCT01492400|466370034|FG000|Overall Study|Miscellaneous Reasons|2|||
129779787|NCT01485172|467159954|FG000|Overall Study|Lack of Efficacy|2|||
129779788|NCT01485172|467159955|FG001|Overall Study|Lack of Efficacy|0|||
129779789|NCT01485172|467159956|FG002|Overall Study|Lack of Efficacy|0|||
129779790|NCT01485172|467159957|FG003|Overall Study|Lack of Efficacy|0|||
129566450|NCT01492400|466370035|FG001|Overall Study|Miscellaneous Reasons|3|||
129566451|NCT01492400|466370034|FG000|Overall Study|Personal Reasons|0|||
129566452|NCT01492400|466370035|FG001|Overall Study|Personal Reasons|5|||
129779791|NCT01485172|467159958|FG004|Overall Study|Lack of Efficacy|0|||
129566453|NCT01492400|466370034|FG000|Overall Study|Lost to Follow-up|3|||
129566454|NCT01492400|466370035|FG001|Overall Study|Lost to Follow-up|1|||
129566455|NCT01492400|466370034|FG000|Overall Study|Pregnancy|0|||
129566456|NCT01492400|466370035|FG001|Overall Study|Pregnancy|1|||
129566457|NCT01492400|466370034|FG000|Overall Study|Lack of Efficacy|1|||
129566458|NCT01492400|466370035|FG001|Overall Study|Lack of Efficacy|1|||
129566459|NCT01492400|466370034|FG000|Overall Study|Adverse Event|10|||
129779792|NCT01485172|467159959|FG005|Overall Study|Lack of Efficacy|0|||
129566460|NCT01492400|466370035|FG001|Overall Study|Adverse Event|5|||
129566461|NCT00604500|466370036|FG000|Overall Study|Adverse Event|2|||
129566462|NCT00604500|466370036|FG000|Overall Study|Protocol Violation|2|||
129566463|NCT00604500|466370036|FG000|Overall Study|Treatment Failure|1|||
129566464|NCT00604500|466370036|FG000|Overall Study|Withdrawal by Subject|4|||
129566465|NCT00604500|466370036|FG000|Overall Study|Administrative|1|||
129566466|NCT00604500|466370036|FG000|Overall Study|Did not meet protocol eligibility|1|||
129566467|NCT00320112|466370037|FG000|Overall Study|Lost to Follow-up|3|||
129566468|NCT00320112|466370038|FG001|Overall Study|Lost to Follow-up|4|||
129566469|NCT00320112|466370037|FG000|Overall Study|Withdrawal by Subject|3|||
129566470|NCT00320112|466370038|FG001|Overall Study|Withdrawal by Subject|0|||
129566471|NCT00320112|466370037|FG000|Overall Study|Death|2|||
129566472|NCT00320112|466370038|FG001|Overall Study|Death|1|||
129566473|NCT02899338|466370039|FG000|Overall Study|Adverse Event|1|||
129566474|NCT02899338|466370040|FG001|Overall Study|Adverse Event|2|||
129566475|NCT02899338|466370039|FG000|Overall Study|Withdrawal by Subject|2|||
129566476|NCT02899338|466370040|FG001|Overall Study|Withdrawal by Subject|0|||
129566477|NCT02353169|466370043|FG000|Overall Study|QTc > 450 msec|1|||
129566478|NCT02353169|466370044|FG001|Overall Study|QTc > 450 msec|1|||
129566479|NCT02353169|466370045|FG002|Overall Study|QTc > 450 msec|1|||
129566480|NCT02353169|466370046|FG003|Overall Study|QTc > 450 msec|1|||
129566481|NCT02353169|466370043|FG000|Overall Study|OR team declined|2|||
129566482|NCT02353169|466370044|FG001|Overall Study|OR team declined|0|||
129566483|NCT02353169|466370045|FG002|Overall Study|OR team declined|0|||
129566484|NCT02353169|466370046|FG003|Overall Study|OR team declined|0|||
129566485|NCT02353169|466370043|FG000|Overall Study|Inhalational induction|0|||
129566486|NCT02353169|466370044|FG001|Overall Study|Inhalational induction|2|||
129566487|NCT02353169|466370045|FG002|Overall Study|Inhalational induction|0|||
129566488|NCT02353169|466370046|FG003|Overall Study|Inhalational induction|0|||
129566489|NCT02353169|466370043|FG000|Overall Study|ECG data error|0|||
129566490|NCT02353169|466370044|FG001|Overall Study|ECG data error|3|||
129566491|NCT02353169|466370045|FG002|Overall Study|ECG data error|2|||
129566492|NCT02353169|466370046|FG003|Overall Study|ECG data error|2|||
129566493|NCT02353169|466370043|FG000|Overall Study|Pre-op medication|0|||
129566494|NCT02353169|466370044|FG001|Overall Study|Pre-op medication|0|||
129566495|NCT02353169|466370045|FG002|Overall Study|Pre-op medication|1|||
129566496|NCT02353169|466370046|FG003|Overall Study|Pre-op medication|0|||
129566497|NCT04646109|466370051|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
129566498|NCT04646109|466370052|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
129566499|NCT00117949|466370053|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
129566500|NCT00117949|466370054|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
129566501|NCT00117949|466370055|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
129566502|NCT00117949|466370056|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
129566503|NCT00117949|466370053|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
129566504|NCT00117949|466370054|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
129566505|NCT00117949|466370055|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
129566506|NCT00117949|466370056|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
129566507|NCT00117949|466370053|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
129566508|NCT00117949|466370054|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
129566509|NCT00117949|466370055|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
129566510|NCT00117949|466370056|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
129566511|NCT00117949|466370053|FG000|Overall Study|PSA increase >=10ng/mL|0|||
129566512|NCT00117949|466370054|FG001|Overall Study|PSA increase >=10ng/mL|1|||
129566513|NCT00117949|466370055|FG002|Overall Study|PSA increase >=10ng/mL|1|||
129566514|NCT00117949|466370056|FG003|Overall Study|PSA increase >=10ng/mL|0|||
129566515|NCT00117949|466370053|FG000|Overall Study|PSA reduction <=50%|0|||
129566516|NCT00117949|466370054|FG001|Overall Study|PSA reduction <=50%|2|||
129566517|NCT00117949|466370055|FG002|Overall Study|PSA reduction <=50%|2|||
129566518|NCT00117949|466370056|FG003|Overall Study|PSA reduction <=50%|4|||
129566519|NCT00117949|466370053|FG000|Overall Study|Hepatic abnormalities|0|||
129566520|NCT00117949|466370054|FG001|Overall Study|Hepatic abnormalities|1|||
129566521|NCT00117949|466370055|FG002|Overall Study|Hepatic abnormalities|0|||
129566522|NCT00117949|466370056|FG003|Overall Study|Hepatic abnormalities|1|||
129566523|NCT03184441|466370064|FG000|Overall Study|Withdrawal by Subject|1|||
129566524|NCT01868009|466370065|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
129566525|NCT01868009|466370066|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
129566526|NCT01868009|466370065|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
129566527|NCT01868009|466370066|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
129566528|NCT01868009|466370065|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
129566529|NCT01868009|466370066|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
129566530|NCT04803357|466370069|FG000|Overall Study|Withdrawal by Subject|31|||
129566531|NCT04803357|466370070|FG001|Overall Study|Withdrawal by Subject|5|||
129566532|NCT00182091|466370071|FG000|Overall Study|Withdrawal by Subject|1|||
129566533|NCT00182091|466370072|FG001|Overall Study|Withdrawal by Subject|0|||
129566534|NCT00182091|466370073|FG002|Overall Study|Withdrawal by Subject|0|||
129566535|NCT00182091|466370074|FG003|Overall Study|Withdrawal by Subject|0|||
129566536|NCT01046253|466370075|FG000|Second Intervention|Adverse Event|0|||
129566537|NCT01046253|466370076|FG001|Second Intervention|Adverse Event|1|||
129566538|NCT01046253|466370075|FG000|Second Intervention|Protocol Violation|0|||
129566539|NCT01046253|466370076|FG001|Second Intervention|Protocol Violation|1|||
129566540|NCT02339909|466370079|FG000|Overall Study|Became ineligible after randomisation|89|||
129566541|NCT02339909|466370080|FG001|Overall Study|Became ineligible after randomisation|63|||
129566542|NCT02339909|466370081|FG002|Overall Study|Became ineligible after randomisation|71|||
129566543|NCT00860028|466370089|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
129566544|NCT00860028|466370090|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
129566545|NCT00993616|466370092|FG000|Overall Study|No tumor at entry|1|||
129566546|NCT00993616|466370092|FG000|Overall Study|Never treated|1|||
129566547|NCT03815942|466371572|FG000|Overall Study|Withdrawal by Subject|0|||
129566548|NCT03815942|466371573|FG001|Overall Study|Withdrawal by Subject|17|||
129566549|NCT02785913|466371574|FG000|Overall Study|Adverse Event|5|||
129566550|NCT02785913|466371574|FG000|Overall Study|Death|2|||
129566551|NCT02785913|466371574|FG000|Overall Study|Progression|18|||
129566552|NCT02785913|466371574|FG000|Overall Study|Not protocol specified|1|||
129566553|NCT03717064|466371575|FG000|Period 2|Adverse Event|1|||
129566554|NCT02841709|466371576|FG000|5th Intervention|Adverse Event|2|||
129566555|NCT02841709|466371577|FG001|5th Intervention|Adverse Event|0|||
129566556|NCT02841709|466371578|FG002|5th Intervention|Adverse Event|0|||
129566557|NCT02841709|466371579|FG003|5th Intervention|Adverse Event|0|||
129566558|NCT02841709|466371580|FG004|5th Intervention|Adverse Event|2|||
129566559|NCT01929109|466371581|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
129566560|NCT01929109|466371582|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
129566561|NCT01929109|466371583|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
129566562|NCT01929109|466371584|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
129566563|NCT01929109|466371585|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
129566564|NCT00076102|466371586|FG000|Overall Study|Clinical progression|1|||
129566565|NCT00076102|466371586|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
129566566|NCT00076102|466371586|FG000|Overall Study|plexiform neurofibroma surgery|1|||
129566567|NCT00076102|466371586|FG000|Overall Study|refusal of further therapy|2|||
129566568|NCT01402908|466371588|FG000|Overall Study|Withdrawal by Subject|30|||
129566569|NCT01402908|466371589|FG001|Overall Study|Withdrawal by Subject|17|||
129566570|NCT01402908|466371588|FG000|Overall Study|Lost to Follow-up|3|||
129566571|NCT01402908|466371589|FG001|Overall Study|Lost to Follow-up|1|||
129566572|NCT01402908|466371588|FG000|Overall Study|Physician Decision|1|||
129566573|NCT01402908|466371589|FG001|Overall Study|Physician Decision|0|||
129566574|NCT02581345|466371591|FG000|Part 1: up to Week 16|Adverse Event|3|||
129566575|NCT02581345|466371592|FG001|Part 1: up to Week 16|Adverse Event|8|||
129566576|NCT02581345|466371593|FG002|Part 1: up to Week 16|Adverse Event|0|||
129566577|NCT02581345|466371594|FG003|Part 1: up to Week 16|Adverse Event|0|||
129566578|NCT02581345|466371591|FG000|Part 1: up to Week 16|Physician Decision|2|||
129566579|NCT02581345|466371592|FG001|Part 1: up to Week 16|Physician Decision|4|||
129566580|NCT02581345|466371593|FG002|Part 1: up to Week 16|Physician Decision|0|||
129566581|NCT02581345|466371594|FG003|Part 1: up to Week 16|Physician Decision|0|||
129566582|NCT02581345|466371591|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
129566583|NCT02581345|466371592|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
129566584|NCT02581345|466371593|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
129566585|NCT02581345|466371594|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
129566586|NCT02581345|466371591|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
129566587|NCT02581345|466371592|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
129566588|NCT02581345|466371593|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
129566589|NCT02581345|466371594|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
129566590|NCT02581345|466371591|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
129566591|NCT02581345|466371592|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
129566592|NCT02581345|466371593|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
129566593|NCT02581345|466371594|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
129566594|NCT02581345|466371591|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
129566595|NCT02581345|466371592|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
129566596|NCT02581345|466371593|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
129566597|NCT02581345|466371594|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
129566598|NCT02581345|466371591|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
129566599|NCT02581345|466371592|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
129689664|NCT03928704|466822322|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
129689665|NCT03928704|466822323|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
129689666|NCT03928704|466822324|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129689667|NCT03928704|466822325|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129566600|NCT02581345|466371593|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
129566601|NCT02581345|466371594|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
129566602|NCT02581345|466371591|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
129689668|NCT03928704|466822326|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129566603|NCT02581345|466371592|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
129779793|NCT01485172|467159954|FG000|Overall Study|Protocol Violation|0|||
129566604|NCT02581345|466371593|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
129566605|NCT02581345|466371594|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
129566606|NCT02581345|466371591|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
129566607|NCT02581345|466371592|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
129566608|NCT02581345|466371593|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
129566609|NCT02581345|466371594|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
129566610|NCT02581345|466371591|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
129566611|NCT02581345|466371592|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
129566612|NCT02581345|466371593|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
129566613|NCT02581345|466371594|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
129566614|NCT02581345|466371591|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
129566615|NCT02581345|466371592|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
129566616|NCT02581345|466371593|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
129566617|NCT02581345|466371594|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
129566618|NCT02581345|466371591|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
129566619|NCT02581345|466371592|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
129566620|NCT02581345|466371593|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
129566621|NCT02581345|466371594|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
129566622|NCT01244126|466371597|FG000|Overall Study|Protocol Violation|3|||
129566623|NCT01244126|466371598|FG001|Overall Study|Protocol Violation|3|||
129566624|NCT01244126|466371599|FG002|Overall Study|Protocol Violation|9|||
129566625|NCT00863746|466371604|FG000|Treatment|Not treated|4|||
129566626|NCT00863746|466371605|FG001|Treatment|Not treated|2|||
129566627|NCT00863746|466371604|FG000|Treatment|Adverse Event|41|||
129566628|NCT00863746|466371605|FG001|Treatment|Adverse Event|16|||
129566629|NCT00863746|466371604|FG000|Treatment|non-compliant with study medication|4|||
129566630|NCT00863746|466371605|FG001|Treatment|non-compliant with study medication|0|||
129566631|NCT00863746|466371604|FG000|Treatment|Consent withdrawn|15|||
129566632|NCT00863746|466371605|FG001|Treatment|Consent withdrawn|14|||
129566633|NCT00863746|466371604|FG000|Treatment|Lost to Follow-up|1|||
129566634|NCT00863746|466371605|FG001|Treatment|Lost to Follow-up|0|||
129566635|NCT00863746|466371604|FG000|Treatment|Protocol Violation|5|||
129566636|NCT00863746|466371605|FG001|Treatment|Protocol Violation|3|||
129566637|NCT00863746|466371604|FG000|Treatment|Other|1|||
129566638|NCT00863746|466371605|FG001|Treatment|Other|0|||
129566639|NCT00863746|466371604|FG000|Survival Follow up|Death|244|||
129566640|NCT00863746|466371605|FG001|Survival Follow up|Death|271|||
129566641|NCT00863746|466371604|FG000|Survival Follow up|Lost to Follow-up|2|||
129566642|NCT00863746|466371605|FG001|Survival Follow up|Lost to Follow-up|1|||
129566643|NCT00863746|466371604|FG000|Survival Follow up|Consent Withdrawn|7|||
129566644|NCT00863746|466371605|FG001|Survival Follow up|Consent Withdrawn|8|||
129566645|NCT00453362|466371606|FG000|Overall Study|Adverse Event|5|||
129566646|NCT00453362|466371606|FG000|Overall Study|Death|7|||
129566647|NCT00453362|466371606|FG000|Overall Study|Physician Decision|2|||
129566648|NCT00453362|466371606|FG000|Overall Study|Withdrawal by Subject|3|||
129566649|NCT00453362|466371606|FG000|Overall Study|Progression of disease|56|||
129566650|NCT00453362|466371606|FG000|Overall Study|Screening Failure|14|||
129566651|NCT04885296|466371607|FG000|Period 1|Covid-19 Related|1|||
129566652|NCT04885296|466371608|FG001|Period 1|Covid-19 Related|0|||
129566653|NCT04885296|466371607|FG000|Period 1|Adverse Event|0|||
129566654|NCT04885296|466371608|FG001|Period 1|Adverse Event|1|||
129566655|NCT04885296|466371607|FG000|Period 1|Withdrawal by Subject|1|||
129566656|NCT04885296|466371608|FG001|Period 1|Withdrawal by Subject|1|||
129566657|NCT04885296|466371607|FG000|Period 1|Test Article No Longer Available|1|||
129566658|NCT04885296|466371608|FG001|Period 1|Test Article No Longer Available|0|||
129566659|NCT04885296|466371607|FG000|Period 1|Dispensed Study lens in Error|1|||
129566660|NCT04885296|466371608|FG001|Period 1|Dispensed Study lens in Error|0|||
129566661|NCT04885296|466371607|FG000|Period 1|Lost to Follow-up|1|||
129566662|NCT04885296|466371608|FG001|Period 1|Lost to Follow-up|0|||
129689669|NCT03928704|466822327|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
129689670|NCT03928704|466822322|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129566663|NCT04885296|466371607|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
129566664|NCT04885296|466371608|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
129566665|NCT00862979|466371609|FG000|Overall Study|Adverse Event|6|||
129566666|NCT00862979|466371610|FG001|Overall Study|Adverse Event|3|||
129566667|NCT00862979|466371609|FG000|Overall Study|Protocol Violation|0|||
129566668|NCT00862979|466371610|FG001|Overall Study|Protocol Violation|1|||
129566669|NCT00862979|466371609|FG000|Overall Study|Patient withdrew consent|2|||
129566670|NCT00862979|466371610|FG001|Overall Study|Patient withdrew consent|1|||
129566671|NCT00862979|466371609|FG000|Overall Study|Administrative problems|0|||
129566672|NCT00862979|466371610|FG001|Overall Study|Administrative problems|1|||
129566673|NCT00862979|466371609|FG000|Overall Study|Death|0|||
129566674|NCT00862979|466371610|FG001|Overall Study|Death|1|||
129566675|NCT01367275|466371614|FG000|Overall Study|Ineligible|1|||
129566676|NCT01367275|466371614|FG000|Overall Study|Disease Progression|2|||
129566677|NCT05346055|466371615|FG000|Overall Study|Withdrawal by Subject|1|||
129566678|NCT05346055|466371615|FG000|Overall Study|Protocol Violation|1|||
129566679|NCT05346055|466371615|FG000|Overall Study|Therapist decision|1|||
129566680|NCT01545076|466371618|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
129566681|NCT01545076|466371619|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
129566682|NCT01545076|466371620|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
129566683|NCT01545076|466371621|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
129566684|NCT01545076|466371622|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
129566685|NCT01545076|466371618|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
129566686|NCT01545076|466371619|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
129566687|NCT01545076|466371620|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
129566688|NCT01545076|466371621|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
129566689|NCT01545076|466371622|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
129566690|NCT01545076|466371618|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
129566691|NCT01545076|466371619|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
129566692|NCT01545076|466371620|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
129566693|NCT01545076|466371621|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
129566694|NCT01545076|466371622|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
129566695|NCT01545076|466371618|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
129566696|NCT01545076|466371619|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129566697|NCT01545076|466371620|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129566698|NCT01545076|466371621|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129566699|NCT01545076|466371622|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
129566700|NCT01545076|466371618|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
129566701|NCT01545076|466371619|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129566702|NCT01545076|466371620|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129566703|NCT01545076|466371621|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129566704|NCT01545076|466371622|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
129566705|NCT01545076|466371618|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129566706|NCT01545076|466371619|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129566707|NCT01545076|466371620|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129566708|NCT01545076|466371621|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
129779794|NCT01485172|467159955|FG001|Overall Study|Protocol Violation|0|||
129779795|NCT01485172|467159956|FG002|Overall Study|Protocol Violation|4|||
129779796|NCT01485172|467159957|FG003|Overall Study|Protocol Violation|5|||
129779797|NCT01485172|467159958|FG004|Overall Study|Protocol Violation|1|||
129779798|NCT01485172|467159959|FG005|Overall Study|Protocol Violation|0|||
129566709|NCT01545076|466371622|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
129779799|NCT01485172|467159954|FG000|Overall Study|Protocol defined stopping criteria|1|||
129779800|NCT01485172|467159955|FG001|Overall Study|Protocol defined stopping criteria|0|||
129779801|NCT01485172|467159956|FG002|Overall Study|Protocol defined stopping criteria|0|||
129779802|NCT01485172|467159957|FG003|Overall Study|Protocol defined stopping criteria|0|||
129779803|NCT01485172|467159958|FG004|Overall Study|Protocol defined stopping criteria|1|||
129779804|NCT01485172|467159959|FG005|Overall Study|Protocol defined stopping criteria|0|||
129779805|NCT01485172|467159954|FG000|Overall Study|Lost to Follow-up|0|||
129779806|NCT01485172|467159955|FG001|Overall Study|Lost to Follow-up|0|||
129779807|NCT01485172|467159956|FG002|Overall Study|Lost to Follow-up|1|||
129779808|NCT01485172|467159957|FG003|Overall Study|Lost to Follow-up|0|||
129779809|NCT01485172|467159958|FG004|Overall Study|Lost to Follow-up|0|||
129779810|NCT01485172|467159959|FG005|Overall Study|Lost to Follow-up|1|||
129779811|NCT01485172|467159954|FG000|Overall Study|Physician Decision|0|||
129779812|NCT01485172|467159955|FG001|Overall Study|Physician Decision|0|||
129779813|NCT01485172|467159956|FG002|Overall Study|Physician Decision|0|||
129779814|NCT01485172|467159957|FG003|Overall Study|Physician Decision|0|||
129779815|NCT01485172|467159958|FG004|Overall Study|Physician Decision|1|||
129779816|NCT01485172|467159959|FG005|Overall Study|Physician Decision|0|||
129779817|NCT01485172|467159954|FG000|Overall Study|Withdrawal by Subject|2|||
129566710|NCT01545076|466371618|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
129566711|NCT01545076|466371619|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
129779818|NCT01485172|467159955|FG001|Overall Study|Withdrawal by Subject|0|||
129566712|NCT01545076|466371620|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
129566713|NCT01545076|466371621|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
129779819|NCT01485172|467159956|FG002|Overall Study|Withdrawal by Subject|0|||
129779820|NCT01485172|467159957|FG003|Overall Study|Withdrawal by Subject|1|||
129779821|NCT01485172|467159958|FG004|Overall Study|Withdrawal by Subject|1|||
129779822|NCT01485172|467159959|FG005|Overall Study|Withdrawal by Subject|1|||
129779823|NCT02283762|467159960|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
129779824|NCT02283762|467159961|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
129566714|NCT01545076|466371622|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
129566715|NCT01545076|466371618|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
129566716|NCT01545076|466371619|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
129566717|NCT01545076|466371620|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
129566718|NCT01545076|466371621|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
129566719|NCT01545076|466371622|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
129566720|NCT01545076|466371618|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
129566721|NCT01545076|466371619|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
129566722|NCT01545076|466371620|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
129566723|NCT01545076|466371621|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
129566724|NCT01545076|466371622|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
129566725|NCT00264797|466371630|FG000|Overall Study|Withdrawal by Subject|11|||
129566726|NCT00264797|466371631|FG001|Overall Study|Withdrawal by Subject|11|||
129566727|NCT00264797|466371630|FG000|Overall Study|Lost to Follow-up|9|||
129566728|NCT00264797|466371631|FG001|Overall Study|Lost to Follow-up|17|||
129566729|NCT00264797|466371630|FG000|Overall Study|Moved from area|3|||
129566730|NCT00264797|466371631|FG001|Overall Study|Moved from area|1|||
129566731|NCT00264797|466371630|FG000|Overall Study|Practical Problems|2|||
129566732|NCT00264797|466371631|FG001|Overall Study|Practical Problems|3|||
129566733|NCT00264797|466371630|FG000|Overall Study|Incarceration|4|||
129566734|NCT00264797|466371631|FG001|Overall Study|Incarceration|5|||
129566735|NCT00264797|466371630|FG000|Overall Study|Pressure/advice from Outsiders|1|||
129566736|NCT00264797|466371631|FG001|Overall Study|Pressure/advice from Outsiders|1|||
129566737|NCT00264797|466371630|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
129566738|NCT00264797|466371631|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
129566739|NCT00264797|466371630|FG000|Overall Study|Other|3|||
129566740|NCT00264797|466371631|FG001|Overall Study|Other|4|||
129566741|NCT01153984|466371632|FG000|Overall Study|Withdrawal by Subject|1|||
129566742|NCT01153984|466371632|FG000|Overall Study|Adverse Event|1|||
129566743|NCT02460159|466371633|FG000|Overall Study|Adverse Event|4|||
129566744|NCT02460159|466371634|FG001|Overall Study|Adverse Event|1|||
129566745|NCT02460159|466371633|FG000|Overall Study|Withdrawal by Subject|2|||
129566746|NCT02460159|466371634|FG001|Overall Study|Withdrawal by Subject|0|||
129566747|NCT02636907|466371637|FG000|Autoinjector Assessment Period|Adverse Event|2|||
129566748|NCT02636907|466371637|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
129566749|NCT02636907|466371637|FG000|Extension Phase|Adverse Event|2|||
129566750|NCT02636907|466371637|FG000|Extension Phase|Withdrawal by Subject|4|||
129566751|NCT02636907|466371637|FG000|Extension Phase|Physician Decision|1|||
129566752|NCT02636907|466371637|FG000|Extension Phase|Lost to Follow-up|2|||
129566753|NCT02636907|466371637|FG000|Extension Phase|Lack of Efficacy|1|||
129566754|NCT00860405|466371644|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
129566755|NCT00860405|466371645|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
129566756|NCT02465567|466371646|FG000|Overall Study|Adverse Event|118|||
129566757|NCT02465567|466371647|FG001|Overall Study|Adverse Event|113|||
129566758|NCT02465567|466371648|FG002|Overall Study|Adverse Event|147|||
129566759|NCT02465567|466371649|FG003|Overall Study|Adverse Event|138|||
129566760|NCT02465567|466371646|FG000|Overall Study|Lack of Efficacy|103|||
129566761|NCT02465567|466371647|FG001|Overall Study|Lack of Efficacy|102|||
129566762|NCT02465567|466371648|FG002|Overall Study|Lack of Efficacy|171|||
129566763|NCT02465567|466371649|FG003|Overall Study|Lack of Efficacy|135|||
129566764|NCT02465567|466371646|FG000|Overall Study|Withdrawal by Subject|104|||
129566765|NCT02465567|466371647|FG001|Overall Study|Withdrawal by Subject|94|||
129566766|NCT02465567|466371648|FG002|Overall Study|Withdrawal by Subject|123|||
129566767|NCT02465567|466371649|FG003|Overall Study|Withdrawal by Subject|130|||
129566768|NCT02465567|466371646|FG000|Overall Study|Physician Decision|23|||
129566769|NCT02465567|466371647|FG001|Overall Study|Physician Decision|33|||
129566770|NCT02465567|466371648|FG002|Overall Study|Physician Decision|38|||
129566771|NCT02465567|466371649|FG003|Overall Study|Physician Decision|28|||
129689671|NCT03928704|466822323|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129689672|NCT03928704|466822324|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
129689673|NCT03928704|466822325|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129689674|NCT03928704|466822326|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129689675|NCT03928704|466822327|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
129689676|NCT03928704|466822322|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129689677|NCT03928704|466822323|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129689678|NCT03928704|466822324|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
129689679|NCT03928704|466822325|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129689680|NCT03928704|466822326|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129689681|NCT03928704|466822327|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
129689682|NCT03928704|466822322|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
129689683|NCT03928704|466822323|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
129566772|NCT02465567|466371646|FG000|Overall Study|Major Protocol Deviation|24|||
129566773|NCT02465567|466371647|FG001|Overall Study|Major Protocol Deviation|26|||
129566774|NCT02465567|466371648|FG002|Overall Study|Major Protocol Deviation|22|||
129566775|NCT02465567|466371649|FG003|Overall Study|Major Protocol Deviation|25|||
129566776|NCT02465567|466371646|FG000|Overall Study|Lost to Follow-up|25|||
129566777|NCT02465567|466371647|FG001|Overall Study|Lost to Follow-up|21|||
129566778|NCT02465567|466371648|FG002|Overall Study|Lost to Follow-up|19|||
129566779|NCT02465567|466371649|FG003|Overall Study|Lost to Follow-up|15|||
129566780|NCT02465567|466371646|FG000|Overall Study|Protocol Specified Criteria|20|||
129566781|NCT02465567|466371647|FG001|Overall Study|Protocol Specified Criteria|10|||
129566782|NCT02465567|466371648|FG002|Overall Study|Protocol Specified Criteria|9|||
129566783|NCT02465567|466371649|FG003|Overall Study|Protocol Specified Criteria|12|||
129566784|NCT02465567|466371646|FG000|Overall Study|Administrative Reasons|12|||
129566785|NCT02465567|466371647|FG001|Overall Study|Administrative Reasons|9|||
129566786|NCT02465567|466371648|FG002|Overall Study|Administrative Reasons|11|||
129566787|NCT02465567|466371649|FG003|Overall Study|Administrative Reasons|5|||
129566788|NCT02465567|466371646|FG000|Overall Study|Randomized but not treated|1|||
129566789|NCT02465567|466371647|FG001|Overall Study|Randomized but not treated|5|||
129566790|NCT02465567|466371648|FG002|Overall Study|Randomized but not treated|4|||
129566791|NCT02465567|466371649|FG003|Overall Study|Randomized but not treated|5|||
129566792|NCT02465567|466371646|FG000|Overall Study|enrolled in >1 studies|18|||
129566793|NCT02465567|466371647|FG001|Overall Study|enrolled in >1 studies|11|||
129566794|NCT02465567|466371648|FG002|Overall Study|enrolled in >1 studies|19|||
129566795|NCT02465567|466371649|FG003|Overall Study|enrolled in >1 studies|15|||
129566796|NCT02465567|466371646|FG000|Overall Study|missing PI Signature|1|||
129566797|NCT02465567|466371647|FG001|Overall Study|missing PI Signature|0|||
129566798|NCT02465567|466371648|FG002|Overall Study|missing PI Signature|0|||
129566799|NCT02465567|466371649|FG003|Overall Study|missing PI Signature|0|||
129566800|NCT01876706|466371652|FG000|Overall Study|BPH Intervention|9|||
129566801|NCT01876706|466371652|FG000|Overall Study|Lost to Follow-up|7|||
129566802|NCT01876706|466371652|FG000|Overall Study|Withdrawals|6|||
129566803|NCT01876706|466371652|FG000|Overall Study|Death|3|||
129566804|NCT01370408|466371654|FG000|Overall Study|treatment failure|9|||
129566805|NCT01062256|466371655|FG000|Overall Study|Adverse Event|1|||
129566806|NCT01062256|466371656|FG001|Overall Study|Adverse Event|0|||
129566807|NCT01062256|466371657|FG002|Overall Study|Adverse Event|0|||
129566808|NCT01062256|466371655|FG000|Overall Study|Withdrawal by Subject|1|||
129566809|NCT01062256|466371656|FG001|Overall Study|Withdrawal by Subject|1|||
129566810|NCT01062256|466371657|FG002|Overall Study|Withdrawal by Subject|1|||
129566811|NCT01062256|466371655|FG000|Overall Study|Ineligible|1|||
129566812|NCT01062256|466371656|FG001|Overall Study|Ineligible|4|||
129566813|NCT01062256|466371657|FG002|Overall Study|Ineligible|3|||
129566814|NCT01062256|466371655|FG000|Overall Study|Administrative|0|||
129566815|NCT01062256|466371656|FG001|Overall Study|Administrative|2|||
129566816|NCT01062256|466371657|FG002|Overall Study|Administrative|0|||
129566817|NCT03049488|466371658|FG000|Overall Study|Lost to Follow-up|1|||
129566818|NCT03049488|466371659|FG001|Overall Study|Lost to Follow-up|1|||
129566819|NCT03049488|466371660|FG002|Overall Study|Lost to Follow-up|0|||
129566820|NCT03049488|466371661|FG003|Overall Study|Lost to Follow-up|0|||
129566821|NCT03049488|466371662|FG004|Overall Study|Lost to Follow-up|0|||
129566822|NCT03049488|466371663|FG005|Overall Study|Lost to Follow-up|0|||
129566823|NCT03049488|466371658|FG000|Overall Study|Moved from Area|1|||
129566824|NCT03049488|466371659|FG001|Overall Study|Moved from Area|0|||
129566825|NCT03049488|466371660|FG002|Overall Study|Moved from Area|0|||
129566826|NCT03049488|466371661|FG003|Overall Study|Moved from Area|1|||
129566827|NCT03049488|466371662|FG004|Overall Study|Moved from Area|1|||
129566828|NCT03049488|466371663|FG005|Overall Study|Moved from Area|0|||
129566829|NCT03049488|466371658|FG000|Overall Study|Physician Decision|0|||
129566830|NCT03049488|466371659|FG001|Overall Study|Physician Decision|1|||
129566831|NCT03049488|466371660|FG002|Overall Study|Physician Decision|0|||
129566832|NCT03049488|466371661|FG003|Overall Study|Physician Decision|0|||
129566833|NCT03049488|466371662|FG004|Overall Study|Physician Decision|0|||
129566834|NCT03049488|466371663|FG005|Overall Study|Physician Decision|0|||
129566835|NCT03049488|466371658|FG000|Overall Study|Withdrawal by Subject|0|||
129566836|NCT03049488|466371659|FG001|Overall Study|Withdrawal by Subject|0|||
129566837|NCT03049488|466371660|FG002|Overall Study|Withdrawal by Subject|0|||
129566838|NCT03049488|466371661|FG003|Overall Study|Withdrawal by Subject|1|||
129566839|NCT03049488|466371662|FG004|Overall Study|Withdrawal by Subject|1|||
129566840|NCT03049488|466371663|FG005|Overall Study|Withdrawal by Subject|0|||
129566841|NCT00796822|466371665|FG000|Overall Study|Lost to Follow-up|2|||
129566842|NCT00796822|466371666|FG001|Overall Study|Lost to Follow-up|0|||
129566843|NCT00796822|466371665|FG000|Overall Study|Adverse Event|1|||
129566844|NCT00796822|466371666|FG001|Overall Study|Adverse Event|0|||
129566845|NCT00906347|466371667|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
129566846|NCT00906347|466371668|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
129566847|NCT00906347|466371667|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
129566848|NCT00906347|466371668|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
129566849|NCT00906347|466371667|FG000|Received Study Drug|Refused study drug|1|||
129566850|NCT00906347|466371668|FG001|Received Study Drug|Refused study drug|0|||
129566851|NCT00906347|466371667|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
129566852|NCT00906347|466371668|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
129566853|NCT00680121|466371672|FG000|Overall Study|Lost to Follow-up|27|||
129566854|NCT00680121|466371673|FG001|Overall Study|Lost to Follow-up|23|||
129566855|NCT02603952|466371674|FG000|Overall Study|Withdrawal by Subject|1|||
129566856|NCT02603952|466371675|FG001|Overall Study|Withdrawal by Subject|0|||
129566857|NCT02603952|466371676|FG002|Overall Study|Withdrawal by Subject|0|||
129566858|NCT02603952|466371677|FG003|Overall Study|Withdrawal by Subject|0|||
129566859|NCT02603952|466371674|FG000|Overall Study|Received oseltamivir by error|0|||
129566860|NCT02603952|466371675|FG001|Overall Study|Received oseltamivir by error|0|||
129566861|NCT02603952|466371676|FG002|Overall Study|Received oseltamivir by error|0|||
129566862|NCT02603952|466371677|FG003|Overall Study|Received oseltamivir by error|1|||
129566863|NCT00577460|466371680|FG000|Overall Study|Adverse Event|11|||
129566864|NCT00577460|466371681|FG001|Overall Study|Adverse Event|7|||
129566865|NCT00577460|466371682|FG002|Overall Study|Adverse Event|14|||
129566866|NCT00577460|466371680|FG000|Overall Study|Protocol Violation|0|||
129566867|NCT00577460|466371681|FG001|Overall Study|Protocol Violation|1|||
129566868|NCT00577460|466371682|FG002|Overall Study|Protocol Violation|1|||
129566869|NCT00577460|466371680|FG000|Overall Study|Lost to Follow-up|0|||
129566870|NCT00577460|466371681|FG001|Overall Study|Lost to Follow-up|3|||
129566871|NCT00577460|466371682|FG002|Overall Study|Lost to Follow-up|4|||
129566872|NCT00577460|466371680|FG000|Overall Study|Withdrawal by Subject|5|||
129566873|NCT00577460|466371681|FG001|Overall Study|Withdrawal by Subject|5|||
129566874|NCT00577460|466371682|FG002|Overall Study|Withdrawal by Subject|6|||
129566875|NCT00577460|466371680|FG000|Overall Study|Other|0|||
129566876|NCT00577460|466371681|FG001|Overall Study|Other|3|||
129566877|NCT00577460|466371682|FG002|Overall Study|Other|2|||
129566878|NCT01318499|466371683|FG000|Overall Study|Adverse Event|16|||
129566879|NCT01318499|466371684|FG001|Overall Study|Adverse Event|11|||
129566880|NCT01318499|466371685|FG002|Overall Study|Adverse Event|6|||
129566881|NCT01318499|466371683|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
129566882|NCT01318499|466371684|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
129566883|NCT01318499|466371685|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
129566884|NCT01318499|466371683|FG000|Overall Study|Noncompliance|2|||
129566885|NCT01318499|466371684|FG001|Overall Study|Noncompliance|3|||
129566886|NCT01318499|466371685|FG002|Overall Study|Noncompliance|0|||
129566887|NCT01318499|466371683|FG000|Overall Study|Treatment Failure|19|||
129566888|NCT01318499|466371684|FG001|Overall Study|Treatment Failure|19|||
129566889|NCT01318499|466371685|FG002|Overall Study|Treatment Failure|101|||
129566890|NCT01318499|466371683|FG000|Overall Study|Protocol Violation|2|||
129566891|NCT01318499|466371684|FG001|Overall Study|Protocol Violation|4|||
129566892|NCT01318499|466371685|FG002|Overall Study|Protocol Violation|2|||
129566893|NCT01318499|466371683|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
129566894|NCT01318499|466371684|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
129566895|NCT01318499|466371685|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
129566896|NCT01318499|466371683|FG000|Overall Study|Other|7|||
129566897|NCT01318499|466371684|FG001|Overall Study|Other|10|||
129566898|NCT01318499|466371685|FG002|Overall Study|Other|22|||
129566899|NCT01347710|466371689|FG000|Overall Study|Withdrawal by Subject|2|||
129566900|NCT01347710|466371689|FG000|Overall Study|Adverse Event|4|||
129566901|NCT01347710|466371689|FG000|Overall Study|Angio or SPECT not completed|18|||
129566902|NCT01347710|466371689|FG000|Overall Study|issue with vitals prior to dosing|1|||
129689684|NCT03928704|466822324|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
129689685|NCT03928704|466822325|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
129689686|NCT03928704|466822326|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
129689687|NCT03928704|466822327|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
129689688|NCT03928704|466822322|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129689689|NCT03928704|466822323|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129689690|NCT03928704|466822324|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
129689691|NCT03928704|466822325|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129566903|NCT01347710|466371689|FG000|Overall Study|Lost to Follow-up|1|||
129566904|NCT01347710|466371689|FG000|Overall Study|Physician Decision|2|||
129566905|NCT01347710|466371689|FG000|Overall Study|Other|3|||
129566906|NCT04591626|466371690|FG000|Overall Study|Adverse Event|4|||
129566907|NCT04591626|466371691|FG001|Overall Study|Adverse Event|0|||
129566908|NCT04591626|466371690|FG000|Overall Study|Withdrawal by Subject|5|||
129566909|NCT04591626|466371691|FG001|Overall Study|Withdrawal by Subject|3|||
129566910|NCT04591626|466371690|FG000|Overall Study|Physician Decision|0|||
129566911|NCT04591626|466371691|FG001|Overall Study|Physician Decision|1|||
129566912|NCT04591626|466371690|FG000|Overall Study|Death|0|||
129566913|NCT04591626|466371691|FG001|Overall Study|Death|1|||
129566914|NCT04591626|466371690|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129566915|NCT04591626|466371691|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129566916|NCT02672553|466371693|FG000|Overall Study|Death|3|||
129566917|NCT02672553|466371694|FG001|Overall Study|Death|5|||
129566918|NCT02672553|466371693|FG000|Overall Study|Valve Explant|1|||
129566919|NCT02672553|466371694|FG001|Overall Study|Valve Explant|0|||
129566920|NCT02672553|466371693|FG000|Overall Study|Conversion to Commercial Valve|3|||
129566921|NCT02672553|466371694|FG001|Overall Study|Conversion to Commercial Valve|0|||
129566922|NCT02672553|466371693|FG000|Overall Study|Withdrawal by Subject|3|||
129566923|NCT02672553|466371694|FG001|Overall Study|Withdrawal by Subject|3|||
129566924|NCT02672553|466371693|FG000|Overall Study|Intraoperative screen failure|2|||
129566925|NCT02672553|466371694|FG001|Overall Study|Intraoperative screen failure|0|||
129566926|NCT00841100|466371697|FG000|Phase 1 (28 Days)|Adverse Event|1|||
129566927|NCT00841100|466371697|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
129566928|NCT01355081|466371698|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
129566929|NCT01355081|466371699|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
129566930|NCT01355081|466371700|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
129566931|NCT01355081|466371698|FG000|Overall Study|Major Protocol Deviation|0|||
129566932|NCT01355081|466371699|FG001|Overall Study|Major Protocol Deviation|1|||
129566933|NCT01355081|466371700|FG002|Overall Study|Major Protocol Deviation|0|||
129566934|NCT01355081|466371698|FG000|Overall Study|Lost to Follow-up|0|||
129566935|NCT01355081|466371699|FG001|Overall Study|Lost to Follow-up|0|||
129566936|NCT01355081|466371700|FG002|Overall Study|Lost to Follow-up|1|||
129566937|NCT01355081|466371698|FG000|Overall Study|Withdrawal of Consent|2|||
129566938|NCT01355081|466371699|FG001|Overall Study|Withdrawal of Consent|3|||
129566939|NCT01355081|466371700|FG002|Overall Study|Withdrawal of Consent|3|||
129566940|NCT01355081|466371698|FG000|Overall Study|Lack of Efficacy|2|||
129566941|NCT01355081|466371699|FG001|Overall Study|Lack of Efficacy|1|||
129566942|NCT01355081|466371700|FG002|Overall Study|Lack of Efficacy|1|||
129566943|NCT01355081|466371698|FG000|Overall Study|Non Compliance with Study Medication|0|||
129566944|NCT01355081|466371699|FG001|Overall Study|Non Compliance with Study Medication|1|||
129566945|NCT01355081|466371700|FG002|Overall Study|Non Compliance with Study Medication|0|||
129566946|NCT01475474|466371701|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
129566947|NCT01475474|466371701|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
129566948|NCT01658943|466371704|FG000|Overall Study|Adverse Event|6|||
129566949|NCT01658943|466371705|FG001|Overall Study|Adverse Event|13|||
129566950|NCT01658943|466371704|FG000|Overall Study|Withdrawal by Subject|9|||
129566951|NCT01658943|466371705|FG001|Overall Study|Withdrawal by Subject|2|||
129566952|NCT01658943|466371704|FG000|Overall Study|Progression/Relapse|39|||
129566953|NCT01658943|466371705|FG001|Overall Study|Progression/Relapse|40|||
129566954|NCT01658943|466371704|FG000|Overall Study|Death|4|||
129566955|NCT01658943|466371705|FG001|Overall Study|Death|2|||
129566956|NCT01658943|466371704|FG000|Overall Study|not protocol specified|4|||
129566957|NCT01658943|466371705|FG001|Overall Study|not protocol specified|1|||
129566958|NCT01658943|466371704|FG000|Overall Study|Not eligible|7|||
129566959|NCT01658943|466371705|FG001|Overall Study|Not eligible|9|||
129566960|NCT01658943|466371704|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
129689692|NCT03928704|466822326|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129779825|NCT02283762|467159960|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
129566961|NCT01658943|466371705|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
129566962|NCT00475020|466371707|FG000|Overall Study|Physician Decision|3|||
129566963|NCT00475020|466371707|FG000|Overall Study|Insurance Denial|1|||
129566964|NCT00475020|466371707|FG000|Overall Study|Donor not able to donate the last minute|1|||
129689693|NCT03928704|466822327|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
129689694|NCT03928704|466822322|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129689695|NCT03928704|466822323|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129689696|NCT03928704|466822324|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129689697|NCT03928704|466822325|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129689698|NCT03928704|466822326|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
129566965|NCT02514174|466371711|FG000|Overall Study|Patient refused to continue medication|1|||
129566966|NCT02514174|466371711|FG000|Overall Study|Adverse Event|2|||
129566967|NCT02514174|466371711|FG000|Overall Study|Study closed by sponsor|9|||
129566968|NCT02514174|466371711|FG000|Overall Study|Progressive disease|11|||
129566969|NCT02514174|466371711|FG000|Overall Study|Treatment change|1|||
129566970|NCT02514174|466371711|FG000|Overall Study|Treated off study with Afatinib.|1|||
129566971|NCT02130466|466371712|FG000|Overall Study|Death|4|||
129566972|NCT02130466|466371713|FG001|Overall Study|Death|1|||
129566973|NCT02130466|466371714|FG002|Overall Study|Death|1|||
129566974|NCT02130466|466371715|FG003|Overall Study|Death|3|||
129566975|NCT02130466|466371716|FG004|Overall Study|Death|2|||
129566976|NCT02130466|466371717|FG005|Overall Study|Death|30|||
129566977|NCT02130466|466371718|FG006|Overall Study|Death|45|||
129566978|NCT02130466|466371719|FG007|Overall Study|Death|2|||
129566979|NCT02130466|466371720|FG008|Overall Study|Death|3|||
129566980|NCT02130466|466371721|FG009|Overall Study|Death|4|||
129566981|NCT02130466|466371722|FG010|Overall Study|Death|5|||
129566982|NCT02130466|466371723|FG011|Overall Study|Death|3|||
129566983|NCT02130466|466371724|FG012|Overall Study|Death|11|||
129566984|NCT02130466|466371725|FG013|Overall Study|Death|7|||
129566985|NCT02130466|466371712|FG000|Overall Study|Lost to Follow-up|1|||
129566986|NCT02130466|466371713|FG001|Overall Study|Lost to Follow-up|0|||
129566987|NCT02130466|466371714|FG002|Overall Study|Lost to Follow-up|0|||
129566988|NCT02130466|466371715|FG003|Overall Study|Lost to Follow-up|0|||
129566989|NCT02130466|466371716|FG004|Overall Study|Lost to Follow-up|0|||
129566990|NCT02130466|466371717|FG005|Overall Study|Lost to Follow-up|1|||
129566991|NCT02130466|466371718|FG006|Overall Study|Lost to Follow-up|0|||
129566992|NCT02130466|466371719|FG007|Overall Study|Lost to Follow-up|0|||
129566993|NCT02130466|466371720|FG008|Overall Study|Lost to Follow-up|0|||
129566994|NCT02130466|466371721|FG009|Overall Study|Lost to Follow-up|0|||
129566995|NCT02130466|466371722|FG010|Overall Study|Lost to Follow-up|0|||
129566996|NCT02130466|466371723|FG011|Overall Study|Lost to Follow-up|0|||
129566997|NCT02130466|466371724|FG012|Overall Study|Lost to Follow-up|1|||
129566998|NCT02130466|466371725|FG013|Overall Study|Lost to Follow-up|0|||
129566999|NCT02130466|466371712|FG000|Overall Study|Physician Decision|0|||
129567000|NCT02130466|466371713|FG001|Overall Study|Physician Decision|0|||
129567001|NCT02130466|466371714|FG002|Overall Study|Physician Decision|0|||
129567002|NCT02130466|466371715|FG003|Overall Study|Physician Decision|0|||
129567003|NCT02130466|466371716|FG004|Overall Study|Physician Decision|0|||
129567004|NCT02130466|466371717|FG005|Overall Study|Physician Decision|1|||
129567005|NCT02130466|466371718|FG006|Overall Study|Physician Decision|1|||
129567006|NCT02130466|466371719|FG007|Overall Study|Physician Decision|0|||
129567007|NCT02130466|466371720|FG008|Overall Study|Physician Decision|0|||
129567008|NCT02130466|466371721|FG009|Overall Study|Physician Decision|0|||
129567009|NCT02130466|466371722|FG010|Overall Study|Physician Decision|0|||
129567010|NCT02130466|466371723|FG011|Overall Study|Physician Decision|0|||
129567011|NCT02130466|466371724|FG012|Overall Study|Physician Decision|0|||
129567012|NCT02130466|466371725|FG013|Overall Study|Physician Decision|0|||
129567013|NCT02130466|466371712|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129567014|NCT02130466|466371713|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
129567015|NCT02130466|466371714|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129567016|NCT02130466|466371715|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
129567017|NCT02130466|466371716|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129567018|NCT02130466|466371717|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
129567019|NCT02130466|466371718|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
129567020|NCT02130466|466371719|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129567021|NCT02130466|466371720|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129567022|NCT02130466|466371721|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129567023|NCT02130466|466371722|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
129567024|NCT02130466|466371723|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129567025|NCT02130466|466371724|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
129567026|NCT02130466|466371725|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
129567027|NCT02130466|466371712|FG000|Overall Study|Withdrawal by Subject|1|||
129567028|NCT02130466|466371713|FG001|Overall Study|Withdrawal by Subject|0|||
129567029|NCT02130466|466371714|FG002|Overall Study|Withdrawal by Subject|0|||
129567030|NCT02130466|466371715|FG003|Overall Study|Withdrawal by Subject|0|||
129567031|NCT02130466|466371716|FG004|Overall Study|Withdrawal by Subject|0|||
129567032|NCT02130466|466371717|FG005|Overall Study|Withdrawal by Subject|1|||
129567033|NCT02130466|466371718|FG006|Overall Study|Withdrawal by Subject|0|||
129567034|NCT02130466|466371719|FG007|Overall Study|Withdrawal by Subject|0|||
129567035|NCT02130466|466371720|FG008|Overall Study|Withdrawal by Subject|1|||
129567036|NCT02130466|466371721|FG009|Overall Study|Withdrawal by Subject|0|||
129567037|NCT02130466|466371722|FG010|Overall Study|Withdrawal by Subject|0|||
129567038|NCT02130466|466371723|FG011|Overall Study|Withdrawal by Subject|0|||
129567039|NCT02130466|466371724|FG012|Overall Study|Withdrawal by Subject|0|||
129567040|NCT02130466|466371725|FG013|Overall Study|Withdrawal by Subject|0|||
129567041|NCT04529109|466371726|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
129567042|NCT04529109|466371727|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129567043|NCT03100903|466373166|FG000|Overall Study|Withdrawal by Subject|0|||
129567044|NCT03100903|466373167|FG001|Overall Study|Withdrawal by Subject|0|||
129567045|NCT03100903|466373168|FG002|Overall Study|Withdrawal by Subject|1|||
129567046|NCT00433147|466373169|FG000|Overall Study|Adverse Event|0|||
129567047|NCT00433147|466373170|FG001|Overall Study|Adverse Event|1|||
129567048|NCT00433147|466373171|FG002|Overall Study|Adverse Event|0|||
129567049|NCT00433147|466373172|FG003|Overall Study|Adverse Event|0|||
129567050|NCT01027143|466373175|FG000|Overall Study|Lost to Follow-up|9|||
129567051|NCT01027143|466373176|FG001|Overall Study|Lost to Follow-up|4|||
129567052|NCT02564263|466373177|FG000|Overall Study|Adverse Event|31|||
129567053|NCT02564263|466373178|FG001|Overall Study|Adverse Event|29|||
129567054|NCT02564263|466373177|FG000|Overall Study|Death|270|||
129567055|NCT02564263|466373178|FG001|Overall Study|Death|262|||
129567056|NCT02564263|466373177|FG000|Overall Study|Withdrawal by Subject|4|||
129567057|NCT02564263|466373178|FG001|Overall Study|Withdrawal by Subject|19|||
129567058|NCT02564263|466373177|FG000|Overall Study|Sponsor's decision|9|||
129567059|NCT02564263|466373178|FG001|Overall Study|Sponsor's decision|4|||
129567060|NCT03444038|466373179|FG000|Overall Study|Adverse Event|12|||
129567061|NCT03444038|466373179|FG000|Overall Study|Withdrawal by Subject|7|||
129567062|NCT03444038|466373179|FG000|Overall Study|Lost to Follow-up|1|||
129567063|NCT03444038|466373179|FG000|Overall Study|Physician Decision|2|||
129567064|NCT03444038|466373179|FG000|Overall Study|Lack of Efficacy|7|||
129567065|NCT00728949|466373180|FG000|Overall Study|Adverse Event|8|||
129567066|NCT00728949|466373181|FG001|Overall Study|Adverse Event|0|||
129567067|NCT00728949|466373180|FG000|Overall Study|Withdrawal by Subject|2|||
129567068|NCT00728949|466373181|FG001|Overall Study|Withdrawal by Subject|2|||
129567069|NCT00728949|466373180|FG000|Overall Study|Abnormal Lab Results|0|||
129567070|NCT00728949|466373181|FG001|Overall Study|Abnormal Lab Results|2|||
129567071|NCT00728949|466373180|FG000|Overall Study|On treatment at cutoff date|1|||
129567072|NCT00728949|466373181|FG001|Overall Study|On treatment at cutoff date|0|||
129567073|NCT02319148|466373182|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
129567074|NCT02319148|466373183|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
129567075|NCT02319148|466373184|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
129567076|NCT02319148|466373185|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
129567077|NCT02319148|466373182|FG000|Second Intervention Period|No longer willing to participate|0|||
129567078|NCT02319148|466373183|FG001|Second Intervention Period|No longer willing to participate|1|||
129567079|NCT02319148|466373184|FG002|Second Intervention Period|No longer willing to participate|0|||
129567080|NCT02319148|466373185|FG003|Second Intervention Period|No longer willing to participate|0|||
129567081|NCT02319148|466373182|FG000|Second Intervention Period|Other|0|||
129779826|NCT02283762|467159961|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
129779827|NCT02283762|467159960|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
129779828|NCT02283762|467159961|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
129779829|NCT02283762|467159960|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
129779830|NCT02283762|467159961|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
129779831|NCT02283762|467159960|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
129779832|NCT02283762|467159961|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
129779833|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
129779834|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
129567082|NCT02319148|466373183|FG001|Second Intervention Period|Other|0|||
129567083|NCT02319148|466373184|FG002|Second Intervention Period|Other|0|||
129567084|NCT02319148|466373185|FG003|Second Intervention Period|Other|1|||
129779835|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
129779836|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
129779837|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
129779838|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
129567085|NCT01087970|466373187|FG000|Overall Study|Protocol Violation|2|||
129567086|NCT00543309|466373188|FG000|Overall Study|Physician Decision|0|||
129567087|NCT00543309|466373189|FG001|Overall Study|Physician Decision|1|||
129567088|NCT00543309|466373190|FG002|Overall Study|Physician Decision|0|||
129567089|NCT01249664|466373191|FG000|Overall Study|Withdrawal by Subject|5|||
129567090|NCT01249664|466373192|FG001|Overall Study|Withdrawal by Subject|0|||
129779839|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
129779840|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
129779841|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
129779842|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
129779843|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
129567091|NCT01249664|466373191|FG000|Overall Study|Adverse Event|1|||
129567092|NCT01249664|466373192|FG001|Overall Study|Adverse Event|0|||
129567093|NCT00762086|466373193|FG000|Overall Study|Adverse Event|2|||
129567094|NCT00762086|466373194|FG001|Overall Study|Adverse Event|0|||
129567095|NCT00762086|466373193|FG000|Overall Study|Lost to Follow-up|0|||
129567096|NCT00762086|466373194|FG001|Overall Study|Lost to Follow-up|2|||
129567097|NCT00762086|466373193|FG000|Overall Study|Non compliance|1|||
129567098|NCT00762086|466373194|FG001|Overall Study|Non compliance|0|||
129567099|NCT00762086|466373193|FG000|Overall Study|Withdrawal by Subject|2|||
129567100|NCT00762086|466373194|FG001|Overall Study|Withdrawal by Subject|2|||
129567101|NCT00762086|466373193|FG000|Overall Study|Ineligible to participate in the study|1|||
129567102|NCT00762086|466373194|FG001|Overall Study|Ineligible to participate in the study|0|||
129567103|NCT01074554|466373199|FG000|Overall Study|Adverse Event|3|||
129567104|NCT01074554|466373200|FG001|Overall Study|Adverse Event|3|||
129567105|NCT01074554|466373199|FG000|Overall Study|Lost to Follow-up|0|||
129567106|NCT01074554|466373200|FG001|Overall Study|Lost to Follow-up|1|||
129567107|NCT04276883|466373201|FG000|Overall Study|Withdrawal by Subject|2|||
129567108|NCT04276883|466373202|FG001|Overall Study|Withdrawal by Subject|3|||
129567109|NCT04276883|466373203|FG002|Overall Study|Withdrawal by Subject|6|||
129567110|NCT04276883|466373201|FG000|Overall Study|Lost to Follow-up|1|||
129567111|NCT04276883|466373202|FG001|Overall Study|Lost to Follow-up|3|||
129567112|NCT04276883|466373203|FG002|Overall Study|Lost to Follow-up|0|||
129567113|NCT04276883|466373201|FG000|Overall Study|Adverse Event|0|||
129567114|NCT04276883|466373202|FG001|Overall Study|Adverse Event|1|||
129567115|NCT04276883|466373203|FG002|Overall Study|Adverse Event|0|||
129567116|NCT04276883|466373201|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
129567117|NCT04276883|466373202|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
129567118|NCT04276883|466373203|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
129567119|NCT00659607|466373204|FG000|Overall Study|No blood pressure recorded|147|||
129567120|NCT00659607|466373204|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
129567121|NCT00659607|466373204|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
129567122|NCT00659607|466373204|FG000|Overall Study|No recorded efficacy data|15|||
129567123|NCT00659607|466373204|FG000|Overall Study|Inconsistent BP measuring date|2|||
129567124|NCT02073643|466373209|FG000|Overall Study|Lost to Follow-up|24|||
129567125|NCT00891293|466373213|FG000|Overall Study|Adverse Event|2|||
129567126|NCT00891293|466373213|FG000|Overall Study|Protocol Violation|2|||
129567127|NCT00891293|466373213|FG000|Overall Study|Laboratory abnormality|4|||
129567128|NCT00891293|466373213|FG000|Overall Study|Lost to Follow-up|7|||
129567129|NCT00891293|466373213|FG000|Overall Study|Subject withdrew consent|7|||
129567130|NCT00891293|466373213|FG000|Overall Study|Sponsor termination|62|||
129567131|NCT01448057|466373214|FG000|Overall Study|Protocol Violation|3|||
129567132|NCT01448057|466373215|FG001|Overall Study|Protocol Violation|2|||
129567133|NCT01448057|466373214|FG000|Overall Study|Lost to Follow-up|3|||
129567134|NCT01448057|466373215|FG001|Overall Study|Lost to Follow-up|0|||
129567135|NCT01448057|466373214|FG000|Overall Study|Adverse Event|0|||
129567136|NCT01448057|466373215|FG001|Overall Study|Adverse Event|2|||
129567137|NCT01448057|466373214|FG000|Overall Study|Withdrawal by Subject|2|||
129567138|NCT01448057|466373215|FG001|Overall Study|Withdrawal by Subject|0|||
129567139|NCT03883906|466373219|FG000|Overall Study|Withdrawal by Subject|2|||
129567140|NCT03883906|466373219|FG000|Overall Study|Physician Decision|5|||
129567141|NCT00486837|466373220|FG000|Overall Study|Withdrawal by Subject|1|||
129567142|NCT00486837|466373221|FG001|Overall Study|Withdrawal by Subject|0|||
129567143|NCT00486837|466373220|FG000|Overall Study|Adverse Event|1|||
129567144|NCT00486837|466373221|FG001|Overall Study|Adverse Event|1|||
129567145|NCT00486837|466373220|FG000|Overall Study|Protocol Violation|4|||
129567146|NCT00486837|466373221|FG001|Overall Study|Protocol Violation|2|||
129567147|NCT00486837|466373220|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
129567148|NCT00486837|466373221|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
129567149|NCT01199861|466373231|FG000|Overall Study|Administrative problems|1|||
129567150|NCT01199861|466373232|FG001|Overall Study|Administrative problems|0|||
129567151|NCT01199861|466373231|FG000|Overall Study|Adverse Event|1|||
129567152|NCT01199861|466373232|FG001|Overall Study|Adverse Event|0|||
129567153|NCT00669864|466373235|FG000|Overall Study|Lost to Follow-up|2|||
129567154|NCT00669864|466373235|FG000|Overall Study|Protocol Violation|2|||
129567155|NCT00669864|466373235|FG000|Overall Study|Withdrawal by Subject|3|||
129567156|NCT00669864|466373235|FG000|Overall Study|Other|2|||
129567157|NCT02545998|466373246|FG000|Overall Study|Lost to Follow-up|12|||
129567158|NCT02545998|466373247|FG001|Overall Study|Lost to Follow-up|3|||
129567159|NCT02545998|466373246|FG000|Overall Study|Withdrawal by Subject|3|||
129567160|NCT02545998|466373247|FG001|Overall Study|Withdrawal by Subject|2|||
129567161|NCT01226797|466373260|FG000|Overall Study|Adverse Event|1|||
129567162|NCT01226797|466373261|FG001|Overall Study|Adverse Event|0|||
129567163|NCT01226797|466373260|FG000|Overall Study|No longer willing to participate|1|||
129567164|NCT01226797|466373261|FG001|Overall Study|No longer willing to participate|0|||
129567165|NCT01226797|466373260|FG000|Overall Study|Protocol Violation|0|||
129567166|NCT01226797|466373261|FG001|Overall Study|Protocol Violation|1|||
129567167|NCT04977336|466373262|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
129884552|NCT03012061|467536450|FG000|Overall Study|Adverse Event|2|||
129567168|NCT04977336|466373263|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129567169|NCT04977336|466373264|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129567170|NCT04977336|466373265|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
129567171|NCT04977336|466373266|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
129567172|NCT04977336|466373262|FG000|Overall Study|Lost to Follow-up|0|||
129567173|NCT04977336|466373263|FG001|Overall Study|Lost to Follow-up|0|||
129567174|NCT04977336|466373264|FG002|Overall Study|Lost to Follow-up|1|||
129567175|NCT04977336|466373265|FG003|Overall Study|Lost to Follow-up|0|||
129567176|NCT04977336|466373266|FG004|Overall Study|Lost to Follow-up|0|||
129567177|NCT01606306|466373268|FG000|Overall Study|Lack of Efficacy|2|||
129567178|NCT01606306|466373269|FG001|Overall Study|Lack of Efficacy|1|||
129567179|NCT01606306|466373270|FG002|Overall Study|Lack of Efficacy|4|||
129567180|NCT01606306|466373271|FG003|Overall Study|Lack of Efficacy|4|||
129567181|NCT01606306|466373272|FG004|Overall Study|Lack of Efficacy|1|||
129567182|NCT01606306|466373273|FG005|Overall Study|Lack of Efficacy|2|||
129567183|NCT01606306|466373268|FG000|Overall Study|Adverse Event|1|||
129567184|NCT01606306|466373269|FG001|Overall Study|Adverse Event|0|||
129567185|NCT01606306|466373270|FG002|Overall Study|Adverse Event|1|||
129567186|NCT01606306|466373271|FG003|Overall Study|Adverse Event|1|||
129567187|NCT01606306|466373272|FG004|Overall Study|Adverse Event|2|||
129567188|NCT01606306|466373273|FG005|Overall Study|Adverse Event|0|||
129567189|NCT01606306|466373268|FG000|Overall Study|Lost to Follow-up|7|||
129567190|NCT01606306|466373269|FG001|Overall Study|Lost to Follow-up|4|||
129567191|NCT01606306|466373270|FG002|Overall Study|Lost to Follow-up|5|||
129567192|NCT01606306|466373271|FG003|Overall Study|Lost to Follow-up|4|||
129567193|NCT01606306|466373272|FG004|Overall Study|Lost to Follow-up|3|||
129567194|NCT01606306|466373273|FG005|Overall Study|Lost to Follow-up|5|||
129567195|NCT01606306|466373268|FG000|Overall Study|Withdrawal by Subject|4|||
129567196|NCT01606306|466373269|FG001|Overall Study|Withdrawal by Subject|3|||
129567197|NCT01606306|466373270|FG002|Overall Study|Withdrawal by Subject|4|||
129567198|NCT01606306|466373271|FG003|Overall Study|Withdrawal by Subject|4|||
129567199|NCT01606306|466373272|FG004|Overall Study|Withdrawal by Subject|5|||
129567200|NCT01606306|466373273|FG005|Overall Study|Withdrawal by Subject|4|||
129567201|NCT01606306|466373268|FG000|Overall Study|Physician Decision|1|||
129567202|NCT01606306|466373269|FG001|Overall Study|Physician Decision|2|||
129567203|NCT01606306|466373270|FG002|Overall Study|Physician Decision|0|||
129567204|NCT01606306|466373271|FG003|Overall Study|Physician Decision|0|||
129567205|NCT01606306|466373272|FG004|Overall Study|Physician Decision|0|||
129567206|NCT01606306|466373273|FG005|Overall Study|Physician Decision|0|||
129567207|NCT00408902|466373276|FG000|Overall Study|Lack of Efficacy|7|||
129567208|NCT00408902|466373276|FG000|Overall Study|Adverse Event|3|||
129567209|NCT00970281|466373277|FG000|Overall Study|Lack of Efficacy|1|||
129567210|NCT00970281|466373278|FG001|Overall Study|Lack of Efficacy|14|||
129779844|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
129779845|NCT02283762|467159960|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
129779846|NCT02283762|467159961|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
129779847|NCT02920242|467159965|FG000|Overall Study|Withdrawal by Subject|1|||
129779848|NCT02920242|467159966|FG001|Overall Study|Withdrawal by Subject|0|||
129779849|NCT02920242|467159967|FG002|Overall Study|Withdrawal by Subject|1|||
129779850|NCT02920242|467159965|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
129779851|NCT02920242|467159966|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
129779852|NCT02920242|467159967|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
129779853|NCT00202878|467159968|FG000|Overall Study|Death|964|||
129779854|NCT00202878|467159969|FG001|Overall Study|Death|968|||
129779855|NCT00202878|467159968|FG000|Overall Study|Only Vital Status Known|357|||
129779856|NCT00202878|467159969|FG001|Overall Study|Only Vital Status Known|356|||
129779857|NCT00202878|467159968|FG000|Overall Study|Lost to Follow-up|44|||
129779858|NCT00202878|467159969|FG001|Overall Study|Lost to Follow-up|49|||
129779859|NCT00202878|467159968|FG000|Overall Study|Site Closure|39|||
129779860|NCT00202878|467159969|FG001|Overall Study|Site Closure|36|||
129779861|NCT00202878|467159968|FG000|Overall Study|Withdrawal by Subject|795|||
129779862|NCT00202878|467159969|FG001|Overall Study|Withdrawal by Subject|808|||
129567211|NCT00970281|466373277|FG000|Overall Study|Withdrawal by Subject|0|||
129567212|NCT00970281|466373278|FG001|Overall Study|Withdrawal by Subject|1|||
129567213|NCT00970281|466373277|FG000|Overall Study|Physician Decision|1|||
129567214|NCT00970281|466373278|FG001|Overall Study|Physician Decision|1|||
129567215|NCT00878995|466373279|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
129567216|NCT00878995|466373280|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
129567217|NCT03338972|466373281|FG000|Overall Study|Death|1|||
129779863|NCT01587014|467159970|FG000|Overall Study|Death|2|||
129567218|NCT03338972|466373282|FG001|Overall Study|Death|1|||
129567219|NCT03338972|466373283|FG002|Overall Study|Death|0|||
129567220|NCT03338972|466373284|FG003|Overall Study|Death|0|||
129567221|NCT03338972|466373281|FG000|Overall Study|Withdrawal by Subject|1|||
129779864|NCT03801031|467159975|FG000|Overall Study|Lost to Follow-up|1|||
129779865|NCT03801031|467159976|FG001|Overall Study|Lost to Follow-up|0|||
129779866|NCT03801031|467159975|FG000|Overall Study|Unable to comply|1|||
129779867|NCT03801031|467159976|FG001|Overall Study|Unable to comply|0|||
129567222|NCT03338972|466373282|FG001|Overall Study|Withdrawal by Subject|0|||
129567223|NCT03338972|466373283|FG002|Overall Study|Withdrawal by Subject|0|||
129567224|NCT03338972|466373284|FG003|Overall Study|Withdrawal by Subject|0|||
129567225|NCT02480764|466373285|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129567226|NCT02480764|466373286|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
129567227|NCT02480764|466373287|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
129567228|NCT02480764|466373285|FG000|Overall Study|Major Protocol Deviation|1|||
129567229|NCT02480764|466373286|FG001|Overall Study|Major Protocol Deviation|4|||
129567230|NCT02480764|466373287|FG002|Overall Study|Major Protocol Deviation|3|||
129567231|NCT02480764|466373285|FG000|Overall Study|Lost to Follow-up|0|||
129567232|NCT02480764|466373286|FG001|Overall Study|Lost to Follow-up|1|||
129567233|NCT02480764|466373287|FG002|Overall Study|Lost to Follow-up|2|||
129567234|NCT02480764|466373285|FG000|Overall Study|Voluntary Withdrawal|6|||
129567235|NCT02480764|466373286|FG001|Overall Study|Voluntary Withdrawal|5|||
129567236|NCT02480764|466373287|FG002|Overall Study|Voluntary Withdrawal|10|||
129567237|NCT02480764|466373285|FG000|Overall Study|Lack of Efficacy|0|||
129567238|NCT02480764|466373286|FG001|Overall Study|Lack of Efficacy|3|||
129567239|NCT02480764|466373287|FG002|Overall Study|Lack of Efficacy|3|||
129567240|NCT02480764|466373285|FG000|Overall Study|Reason not Specified|0|||
129567241|NCT02480764|466373286|FG001|Overall Study|Reason not Specified|1|||
129567242|NCT02480764|466373287|FG002|Overall Study|Reason not Specified|0|||
129567243|NCT01030965|466373288|FG000|Overall Study|Lack of Efficacy|3|||
129567244|NCT01030965|466373289|FG001|Overall Study|Lack of Efficacy|2|||
129689699|NCT03928704|466822327|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
129689700|NCT03928704|466822322|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
129689701|NCT03928704|466822323|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
129689702|NCT03928704|466822324|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
129689703|NCT03928704|466822325|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
129689704|NCT03928704|466822326|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
129689705|NCT03928704|466822327|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
129689706|NCT04575324|466822330|FG000|Overall Study|Lost to Follow-up|29|||
129689707|NCT04575324|466822331|FG001|Overall Study|Lost to Follow-up|25|||
129567245|NCT01030965|466373290|FG002|Overall Study|Lack of Efficacy|0|||
129567246|NCT01030965|466373291|FG003|Overall Study|Lack of Efficacy|3|||
129567247|NCT01030965|466373288|FG000|Overall Study|Protocol Violation|1|||
129567248|NCT01030965|466373289|FG001|Overall Study|Protocol Violation|1|||
129567249|NCT01030965|466373290|FG002|Overall Study|Protocol Violation|1|||
129567250|NCT01030965|466373291|FG003|Overall Study|Protocol Violation|1|||
129567251|NCT01030965|466373288|FG000|Overall Study|Adverse Event|0|||
129567252|NCT01030965|466373289|FG001|Overall Study|Adverse Event|1|||
129567253|NCT01030965|466373290|FG002|Overall Study|Adverse Event|2|||
129567254|NCT01030965|466373291|FG003|Overall Study|Adverse Event|1|||
129567255|NCT01030965|466373288|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
129567256|NCT01030965|466373289|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
129567257|NCT01030965|466373290|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
129567258|NCT01030965|466373291|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
129567259|NCT01030965|466373288|FG000|Overall Study|Withdrawal by Subject|0|||
129567260|NCT01030965|466373289|FG001|Overall Study|Withdrawal by Subject|1|||
129567261|NCT01030965|466373290|FG002|Overall Study|Withdrawal by Subject|0|||
129567262|NCT01030965|466373291|FG003|Overall Study|Withdrawal by Subject|2|||
129567263|NCT03144687|466373294|FG000|Overall Study|Death|0|||
129567264|NCT03144687|466373295|FG001|Overall Study|Death|2|||
129567265|NCT03144687|466373294|FG000|Overall Study|Lost to Follow-up|0|||
129567266|NCT03144687|466373295|FG001|Overall Study|Lost to Follow-up|1|||
129567267|NCT03144687|466373294|FG000|Overall Study|Physician Decision|0|||
129567268|NCT03144687|466373295|FG001|Overall Study|Physician Decision|1|||
129567269|NCT03144687|466373294|FG000|Overall Study|Withdrawal by Subject|1|||
129689708|NCT04575324|466822330|FG000|Overall Study|Death|1|||
129689709|NCT04575324|466822331|FG001|Overall Study|Death|2|||
129689710|NCT04575324|466822330|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
129689711|NCT04575324|466822331|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
129689712|NCT01002105|466822335|FG000|Overall Study|Lost to Follow-up|10|||
129689713|NCT01002105|466822336|FG001|Overall Study|Lost to Follow-up|16|||
129689714|NCT01002105|466822335|FG000|Overall Study|non compliance|5|||
129689715|NCT01002105|466822336|FG001|Overall Study|non compliance|3|||
129689716|NCT01002105|466822335|FG000|Overall Study|condition worsened|4|||
129689717|NCT01002105|466822336|FG001|Overall Study|condition worsened|2|||
129567270|NCT03144687|466373295|FG001|Overall Study|Withdrawal by Subject|3|||
129689718|NCT00327171|466822340|FG000|Overall Study|Did not receive study medication|3|||
129567271|NCT03144687|466373294|FG000|Overall Study|Not Reported|2|||
129567272|NCT03144687|466373295|FG001|Overall Study|Not Reported|0|||
129567273|NCT01054599|466373296|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
129567274|NCT01054599|466373297|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
129567275|NCT01054599|466373296|FG000|Overall Study|Protocol Violation|1|||
129689719|NCT00327171|466822341|FG001|Overall Study|Did not receive study medication|0|||
129567276|NCT01054599|466373297|FG001|Overall Study|Protocol Violation|0|||
129567277|NCT01054599|466373296|FG000|Overall Study|Spells/seizure-like episodes|1|||
129567278|NCT01054599|466373297|FG001|Overall Study|Spells/seizure-like episodes|1|||
129567279|NCT01054599|466373296|FG000|Overall Study|Timing/scheduling difficulties|1|||
129567280|NCT01054599|466373297|FG001|Overall Study|Timing/scheduling difficulties|1|||
129567281|NCT01054599|466373296|FG000|Overall Study|Visual impairment, WTAR <80|0|||
129567282|NCT01054599|466373297|FG001|Overall Study|Visual impairment, WTAR <80|1|||
129567283|NCT01054599|466373296|FG000|Overall Study|Lost to Follow-up|0|||
129567284|NCT01054599|466373297|FG001|Overall Study|Lost to Follow-up|2|||
129567285|NCT01054599|466373296|FG000|Overall Study|Adverse Event|0|||
129567286|NCT01054599|466373297|FG001|Overall Study|Adverse Event|1|||
129567287|NCT01054599|466373296|FG000|Overall Study|Withdrawal by Subject|0|||
129567288|NCT01054599|466373297|FG001|Overall Study|Withdrawal by Subject|1|||
129567289|NCT00743197|466373298|FG000|Overall Study|Study terminated due to departure of PI.|1|||
129567290|NCT00743197|466373299|FG001|Overall Study|Study terminated due to departure of PI.|2|||
129567291|NCT04025879|466373302|FG000|Randomization|Participant withdrew consent|0|||
129567292|NCT04025879|466373303|FG001|Randomization|Participant withdrew consent|1|||
129567293|NCT04025879|466373302|FG000|Randomization|Participant no longer met study criteria|1|||
129567294|NCT04025879|466373303|FG001|Randomization|Participant no longer met study criteria|1|||
129567295|NCT04025879|466373302|FG000|Treatment|Ongoing treatment|10|||
129567296|NCT04025879|466373303|FG001|Treatment|Ongoing treatment|8|||
129567297|NCT04025879|466373302|FG000|Treatment|Disease progression/recurrence|36|||
129567298|NCT04025879|466373303|FG001|Treatment|Disease progression/recurrence|72|||
129567299|NCT04025879|466373302|FG000|Treatment|Study drug toxicity|36|||
129567300|NCT04025879|466373303|FG001|Treatment|Study drug toxicity|13|||
129567301|NCT04025879|466373302|FG000|Treatment|Death|2|||
129567302|NCT04025879|466373303|FG001|Treatment|Death|0|||
129567303|NCT04025879|466373302|FG000|Treatment|Adverse event unrelated to study drug|21|||
129567304|NCT04025879|466373303|FG001|Treatment|Adverse event unrelated to study drug|14|||
129567305|NCT04025879|466373302|FG000|Treatment|Participant request to discontinue study treatment|16|||
129567306|NCT04025879|466373303|FG001|Treatment|Participant request to discontinue study treatment|8|||
129567307|NCT04025879|466373302|FG000|Treatment|Participant withdrew consent|1|||
129567308|NCT04025879|466373303|FG001|Treatment|Participant withdrew consent|3|||
129567309|NCT04025879|466373302|FG000|Treatment|Participant no longer meets study criteria|3|||
129567310|NCT04025879|466373303|FG001|Treatment|Participant no longer meets study criteria|2|||
129567311|NCT04025879|466373302|FG000|Treatment|Lost to Follow-up|1|||
129567312|NCT04025879|466373303|FG001|Treatment|Lost to Follow-up|0|||
129567313|NCT04025879|466373302|FG000|Treatment|Other reasons|15|||
129567314|NCT04025879|466373303|FG001|Treatment|Other reasons|17|||
129567315|NCT04025879|466373302|FG000|Treatment|Administrative reason by sponsor|0|||
129567316|NCT04025879|466373303|FG001|Treatment|Administrative reason by sponsor|1|||
129567317|NCT04025879|466373302|FG000|Treatment|Not reported|2|||
129567318|NCT04025879|466373303|FG001|Treatment|Not reported|0|||
129567319|NCT02170688|466373304|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
129567320|NCT02170688|466373305|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
129567321|NCT02170688|466373306|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
129567322|NCT02170688|466373307|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
129567323|NCT02170688|466373308|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
129567324|NCT02170688|466373304|FG000|Overall Study|Full dose not received|0|||
129567325|NCT02170688|466373305|FG001|Overall Study|Full dose not received|1|||
129567326|NCT02170688|466373306|FG002|Overall Study|Full dose not received|0|||
129567327|NCT02170688|466373307|FG003|Overall Study|Full dose not received|0|||
129567328|NCT02170688|466373308|FG004|Overall Study|Full dose not received|0|||
129567329|NCT02170688|466373304|FG000|Overall Study|Physician Decision|0|||
129567330|NCT02170688|466373305|FG001|Overall Study|Physician Decision|0|||
129567331|NCT02170688|466373306|FG002|Overall Study|Physician Decision|1|||
129567332|NCT02170688|466373307|FG003|Overall Study|Physician Decision|0|||
129567333|NCT02170688|466373308|FG004|Overall Study|Physician Decision|0|||
129567334|NCT01471522|466373311|FG000|Overall Study|Withdrawal by Subject|28|||
129567335|NCT01471522|466373312|FG001|Overall Study|Withdrawal by Subject|22|||
129567336|NCT01471522|466373311|FG000|Overall Study|Lost to Follow-up|36|||
129567337|NCT01471522|466373312|FG001|Overall Study|Lost to Follow-up|26|||
129567338|NCT02507375|466373314|FG000|Overall Study|Progressive Disease|4|||
129567339|NCT02507375|466373315|FG001|Overall Study|Progressive Disease|5|||
129567340|NCT02507375|466373314|FG000|Overall Study|Death|0|||
129567341|NCT02507375|466373315|FG001|Overall Study|Death|1|||
129567342|NCT02507375|466373314|FG000|Overall Study|Refused treatment|0|||
129567343|NCT02507375|466373315|FG001|Overall Study|Refused treatment|1|||
129567344|NCT02507375|466373314|FG000|Overall Study|Adverse Event|0|||
129567345|NCT02507375|466373315|FG001|Overall Study|Adverse Event|1|||
129567346|NCT00522457|466373316|FG000|Overall Study|Due to disease progression|16|||
129567347|NCT00522457|466373316|FG000|Overall Study|Adverse Event|2|||
129567348|NCT01691248|466373317|FG000|Overall Study|Protocol Violation|43|||
129567349|NCT01691248|466373318|FG001|Overall Study|Protocol Violation|27|||
129567350|NCT01691248|466373317|FG000|Overall Study|Adverse Event|24|||
129567351|NCT01691248|466373318|FG001|Overall Study|Adverse Event|22|||
129567352|NCT01691248|466373317|FG000|Overall Study|Withdrawal by Subject|20|||
129567353|NCT01691248|466373318|FG001|Overall Study|Withdrawal by Subject|18|||
129567354|NCT01691248|466373317|FG000|Overall Study|Confirmed CDAD|14|||
129567355|NCT01691248|466373318|FG001|Overall Study|Confirmed CDAD|31|||
129567356|NCT01691248|466373317|FG000|Overall Study|Lost to Follow-up|2|||
129567357|NCT01691248|466373318|FG001|Overall Study|Lost to Follow-up|5|||
129567358|NCT01691248|466373317|FG000|Overall Study|Reason not provided|4|||
129567359|NCT01691248|466373318|FG001|Overall Study|Reason not provided|4|||
129567360|NCT01691248|466373317|FG000|Overall Study|Not Treated|4|||
129567361|NCT01691248|466373318|FG001|Overall Study|Not Treated|7|||
129567362|NCT02863575|466373319|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
129567363|NCT02863575|466373320|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
129567364|NCT02863575|466373321|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
129567365|NCT02863575|466373319|FG000|Overall Study|Withdrawal by Subject|0|||
129567366|NCT02863575|466373320|FG001|Overall Study|Withdrawal by Subject|1|||
129567367|NCT02863575|466373321|FG002|Overall Study|Withdrawal by Subject|1|||
129567368|NCT02863575|466373319|FG000|Overall Study|Adverse Event|0|||
129567369|NCT02863575|466373320|FG001|Overall Study|Adverse Event|1|||
129567370|NCT02863575|466373321|FG002|Overall Study|Adverse Event|0|||
129567371|NCT00788125|466375135|FG000|Overall Study|Death|6|||
129567372|NCT00444145|466375143|FG000|Overall Study|Withdrawal by Subject|2|||
129567373|NCT00444145|466375143|FG000|Overall Study|Lost to Follow-up|1|||
129567374|NCT00444145|466375143|FG000|Overall Study|non-compliant|11|||
129567375|NCT00444145|466375143|FG000|Overall Study|Screen Failures|5|||
129567376|NCT01374919|466375144|FG000|Overall Study|Withdrawal by Subject|2|||
129567377|NCT00630305|466375145|FG000|Overall Study|Withdrawal by Subject|1|||
129567378|NCT00630305|466375145|FG000|Overall Study|Inability to insert contact lens|1|||
129567379|NCT01494506|466375146|FG000|Overall Study|Lack of Efficacy|77|||
129567380|NCT01494506|466375147|FG001|Overall Study|Lack of Efficacy|83|||
129567381|NCT01494506|466375148|FG002|Overall Study|Lack of Efficacy|57|||
129567382|NCT01494506|466375146|FG000|Overall Study|Adverse Event|17|||
129567383|NCT01494506|466375147|FG001|Overall Study|Adverse Event|10|||
129567384|NCT01494506|466375148|FG002|Overall Study|Adverse Event|11|||
129567385|NCT01494506|466375146|FG000|Overall Study|Death|9|||
129567386|NCT01494506|466375147|FG001|Overall Study|Death|5|||
129567387|NCT01494506|466375148|FG002|Overall Study|Death|2|||
129567388|NCT01494506|466375146|FG000|Overall Study|Physician Decision|7|||
129567389|NCT01494506|466375147|FG001|Overall Study|Physician Decision|5|||
129567390|NCT01494506|466375148|FG002|Overall Study|Physician Decision|4|||
129567391|NCT01494506|466375146|FG000|Overall Study|Withdrawal by Subject|17|||
129567392|NCT01494506|466375147|FG001|Overall Study|Withdrawal by Subject|20|||
129567393|NCT01494506|466375148|FG002|Overall Study|Withdrawal by Subject|14|||
129567394|NCT01494506|466375146|FG000|Overall Study|Clinical Deterioration|21|||
129567395|NCT01494506|466375147|FG001|Overall Study|Clinical Deterioration|17|||
129567396|NCT01494506|466375148|FG002|Overall Study|Clinical Deterioration|13|||
129567397|NCT01494506|466375146|FG000|Overall Study|Sponsor Decision|0|||
129567398|NCT01494506|466375147|FG001|Overall Study|Sponsor Decision|0|||
129567399|NCT01494506|466375148|FG002|Overall Study|Sponsor Decision|1|||
129567400|NCT01494506|466375146|FG000|Overall Study|Other|0|||
129567401|NCT01494506|466375147|FG001|Overall Study|Other|3|||
129567402|NCT01494506|466375148|FG002|Overall Study|Other|1|||
129567403|NCT02777528|466375160|FG000|Overall Study|Still in study|24|||
129567404|NCT02777528|466375161|FG001|Overall Study|Still in study|10|||
129567405|NCT02777528|466375162|FG002|Overall Study|Still in study|1|||
129567406|NCT02777528|466375160|FG000|Overall Study|Study Device Explanted|1|||
129689720|NCT00327171|466822340|FG000|Overall Study|Adverse Event|23|||
129689721|NCT00327171|466822341|FG001|Overall Study|Adverse Event|23|||
129689722|NCT00327171|466822340|FG000|Overall Study|Disease progression/lack of efficacy|68|||
129567407|NCT02777528|466375161|FG001|Overall Study|Study Device Explanted|0|||
129567408|NCT02777528|466375162|FG002|Overall Study|Study Device Explanted|0|||
129567409|NCT02777528|466375160|FG000|Overall Study|Death|14|||
129567410|NCT02777528|466375161|FG001|Overall Study|Death|7|||
129567411|NCT02777528|466375162|FG002|Overall Study|Death|1|||
129567412|NCT02777528|466375160|FG000|Overall Study|Withdrawal by Subject|2|||
129567413|NCT02777528|466375161|FG001|Overall Study|Withdrawal by Subject|2|||
129567414|NCT02777528|466375162|FG002|Overall Study|Withdrawal by Subject|1|||
129567415|NCT02777528|466375160|FG000|Overall Study|Physician Decision|2|||
129567416|NCT02777528|466375161|FG001|Overall Study|Physician Decision|1|||
129567417|NCT02777528|466375162|FG002|Overall Study|Physician Decision|0|||
129567418|NCT02777528|466375160|FG000|Overall Study|Lost to Follow-up|2|||
129567419|NCT02777528|466375161|FG001|Overall Study|Lost to Follow-up|0|||
129567420|NCT02777528|466375162|FG002|Overall Study|Lost to Follow-up|0|||
129567421|NCT02777528|466375160|FG000|Overall Study|Discontinued due to Other|1|||
129567422|NCT02777528|466375161|FG001|Overall Study|Discontinued due to Other|0|||
129567423|NCT02777528|466375162|FG002|Overall Study|Discontinued due to Other|0|||
129567424|NCT01882647|466375165|FG000|Overall Study|Lost to Follow-up|2|||
129567425|NCT01882647|466375166|FG001|Overall Study|Lost to Follow-up|2|||
129567426|NCT01882647|466375165|FG000|Overall Study|Withdrawal by Subject|0|||
129567427|NCT01882647|466375166|FG001|Overall Study|Withdrawal by Subject|4|||
129567428|NCT03292653|466375168|FG000|Overall Study|Adverse Event|0|||
129567429|NCT03292653|466375169|FG001|Overall Study|Adverse Event|0|||
129567430|NCT03292653|466375170|FG002|Overall Study|Adverse Event|1|||
129567431|NCT03292653|466375168|FG000|Overall Study|Did not Receive Treatment|1|||
129567432|NCT03292653|466375169|FG001|Overall Study|Did not Receive Treatment|0|||
129567433|NCT03292653|466375170|FG002|Overall Study|Did not Receive Treatment|0|||
129567434|NCT04720664|466375171|FG000|Overall Study|Adverse Event|2|||
129567435|NCT04720664|466375171|FG000|Overall Study|Lack of Efficacy|9|||
129567436|NCT03311646|466375172|FG000|Overall Study|Physician Decision|1|||
129567437|NCT03311646|466375172|FG000|Overall Study|Withdrawal by Subject|5|||
129567438|NCT03311646|466375172|FG000|Overall Study|Lost to Follow-up|5|||
129567439|NCT03311646|466375172|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
129567440|NCT01492361|466375173|FG000|Overall Study|Withdrawal by Subject|281|||
129567441|NCT01492361|466375174|FG001|Overall Study|Withdrawal by Subject|297|||
129567442|NCT01492361|466375173|FG000|Overall Study|Physician Decision|12|||
129567443|NCT01492361|466375174|FG001|Overall Study|Physician Decision|12|||
129567444|NCT01492361|466375173|FG000|Overall Study|Lost to Follow-up|6|||
129567445|NCT01492361|466375174|FG001|Overall Study|Lost to Follow-up|13|||
129567446|NCT01492361|466375173|FG000|Overall Study|Other than specified above|106|||
129567447|NCT01492361|466375174|FG001|Overall Study|Other than specified above|138|||
129567448|NCT03127137|466375181|FG000|Overall Study|Requested sedation after consent|1|||
129567449|NCT03127137|466375182|FG001|Overall Study|Requested sedation after consent|0|||
129567450|NCT03127137|466375181|FG000|Overall Study|Malfunction in electronic data collection|1|||
129567451|NCT03127137|466375182|FG001|Overall Study|Malfunction in electronic data collection|0|||
129567452|NCT03127137|466375181|FG000|Overall Study|Post procedure testing could not be obtained|0|||
129567453|NCT03127137|466375182|FG001|Overall Study|Post procedure testing could not be obtained|1|||
129567454|NCT03247556|466375185|FG000|Overall Study|Adverse Event|1|||
129567455|NCT03247556|466375186|FG001|Overall Study|Adverse Event|4|||
129567456|NCT03247556|466375187|FG002|Overall Study|Adverse Event|5|||
129567457|NCT03247556|466375185|FG000|Overall Study|Lost to Follow-up|5|||
129567458|NCT03247556|466375186|FG001|Overall Study|Lost to Follow-up|5|||
129567459|NCT03247556|466375187|FG002|Overall Study|Lost to Follow-up|4|||
129567460|NCT03247556|466375185|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
129567461|NCT03247556|466375186|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
129567462|NCT03247556|466375187|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
129567463|NCT03247556|466375185|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
129567464|NCT03247556|466375186|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
129567465|NCT03247556|466375187|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
129567466|NCT03247556|466375185|FG000|Overall Study|Protocol Violation|2|||
129567467|NCT03247556|466375186|FG001|Overall Study|Protocol Violation|0|||
129567468|NCT03247556|466375187|FG002|Overall Study|Protocol Violation|1|||
129567469|NCT03247556|466375185|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
129567470|NCT03247556|466375186|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
129567471|NCT03247556|466375187|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
129567472|NCT01682083|466375188|FG000|Overall Study|Lost to Follow-up|11|||
129567473|NCT01682083|466375189|FG001|Overall Study|Lost to Follow-up|18|||
129567474|NCT01682083|466375188|FG000|Overall Study|Withdrawal by Subject|31|||
129567475|NCT01682083|466375189|FG001|Overall Study|Withdrawal by Subject|40|||
129689723|NCT00327171|466822341|FG001|Overall Study|Disease progression/lack of efficacy|69|||
129689724|NCT00327171|466822340|FG000|Overall Study|Investigator/participant request|1|||
129689725|NCT00327171|466822341|FG001|Overall Study|Investigator/participant request|8|||
129689726|NCT00327171|466822340|FG000|Overall Study|Clinical progression|12|||
129689727|NCT00327171|466822341|FG001|Overall Study|Clinical progression|8|||
129689728|NCT00327171|466822340|FG000|Overall Study|Undisclosed history of ischemia|0|||
129689729|NCT00327171|466822341|FG001|Overall Study|Undisclosed history of ischemia|1|||
129689730|NCT00327171|466822340|FG000|Overall Study|Other|1|||
129689731|NCT00327171|466822341|FG001|Overall Study|Other|0|||
129689732|NCT01166945|466822342|FG000|Randomized|diagnosed with Group A strep|4|||
129689733|NCT01166945|466822343|FG001|Randomized|diagnosed with Group A strep|4|||
129567476|NCT01682083|466375188|FG000|Overall Study|Death|60|||
129689734|NCT01166945|466822342|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
129567477|NCT01682083|466375189|FG001|Overall Study|Death|93|||
129567478|NCT01682083|466375188|FG000|Overall Study|Physician Decision|5|||
129567479|NCT01682083|466375189|FG001|Overall Study|Physician Decision|4|||
129567480|NCT03952143|466375190|FG000|Lead-In Period|Adverse Event|2|||
129567481|NCT03952143|466375191|FG001|Lead-In Period|Adverse Event|0|||
129567482|NCT03952143|466375192|FG002|Lead-In Period|Adverse Event|0|||
129567483|NCT03952143|466375190|FG000|Lead-In Period|Lack of Efficacy|2|||
129567484|NCT03952143|466375191|FG001|Lead-In Period|Lack of Efficacy|0|||
129567485|NCT03952143|466375192|FG002|Lead-In Period|Lack of Efficacy|0|||
129689735|NCT01166945|466822343|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
129567486|NCT03952143|466375190|FG000|Lead-In Period|Physician Decision|5|||
129567487|NCT03952143|466375191|FG001|Lead-In Period|Physician Decision|0|||
129567488|NCT03952143|466375192|FG002|Lead-In Period|Physician Decision|0|||
129567489|NCT03952143|466375190|FG000|Lead-In Period|Protocol Violation|5|||
129567490|NCT03952143|466375191|FG001|Lead-In Period|Protocol Violation|0|||
129567491|NCT03952143|466375192|FG002|Lead-In Period|Protocol Violation|0|||
129567492|NCT03952143|466375190|FG000|Lead-In Period|Withdrawal by Subject|19|||
129567493|NCT03952143|466375191|FG001|Lead-In Period|Withdrawal by Subject|0|||
129567494|NCT03952143|466375192|FG002|Lead-In Period|Withdrawal by Subject|0|||
129567495|NCT03952143|466375190|FG000|Treatment Period|Adverse Event|0|||
129567496|NCT03952143|466375191|FG001|Treatment Period|Adverse Event|0|||
129567497|NCT03952143|466375192|FG002|Treatment Period|Adverse Event|1|||
129567498|NCT03952143|466375190|FG000|Treatment Period|Lost to Follow-up|0|||
129567499|NCT03952143|466375191|FG001|Treatment Period|Lost to Follow-up|2|||
129567500|NCT03952143|466375192|FG002|Treatment Period|Lost to Follow-up|0|||
129567501|NCT03952143|466375190|FG000|Treatment Period|Physician Decision|0|||
129567502|NCT03952143|466375191|FG001|Treatment Period|Physician Decision|0|||
129567503|NCT03952143|466375192|FG002|Treatment Period|Physician Decision|2|||
129567504|NCT03952143|466375190|FG000|Treatment Period|Protocol Violation|0|||
129567505|NCT03952143|466375191|FG001|Treatment Period|Protocol Violation|0|||
129567506|NCT03952143|466375192|FG002|Treatment Period|Protocol Violation|1|||
129567507|NCT03952143|466375190|FG000|Treatment Period|Withdrawal by Subject|0|||
129567508|NCT03952143|466375191|FG001|Treatment Period|Withdrawal by Subject|5|||
129567509|NCT03952143|466375192|FG002|Treatment Period|Withdrawal by Subject|26|||
129567510|NCT03952143|466375190|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
129567511|NCT03952143|466375191|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
129567512|NCT03952143|466375192|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
129567513|NCT03952143|466375190|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
129567514|NCT03952143|466375191|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
129567515|NCT03952143|466375192|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
129567516|NCT01866319|466375193|FG000|Overall Study|Adverse Event|12|||
129567517|NCT01866319|466375194|FG001|Overall Study|Adverse Event|5|||
129567518|NCT01866319|466375195|FG002|Overall Study|Adverse Event|9|||
129567519|NCT01866319|466375193|FG000|Overall Study|Clinical progression|3|||
129567520|NCT01866319|466375194|FG001|Overall Study|Clinical progression|2|||
129567521|NCT01866319|466375195|FG002|Overall Study|Clinical progression|2|||
129567522|NCT01866319|466375193|FG000|Overall Study|Death|153|||
129567523|NCT01866319|466375194|FG001|Overall Study|Death|154|||
129567524|NCT01866319|466375195|FG002|Overall Study|Death|147|||
129567525|NCT01866319|466375193|FG000|Overall Study|Lost to Follow-up|6|||
129567526|NCT01866319|466375194|FG001|Overall Study|Lost to Follow-up|3|||
129567527|NCT01866319|466375195|FG002|Overall Study|Lost to Follow-up|8|||
129567528|NCT01866319|466375193|FG000|Overall Study|Physician Decision|1|||
129567529|NCT01866319|466375194|FG001|Overall Study|Physician Decision|0|||
129567530|NCT01866319|466375195|FG002|Overall Study|Physician Decision|1|||
129567531|NCT01866319|466375193|FG000|Overall Study|Protocol Violation|0|||
129567532|NCT01866319|466375194|FG001|Overall Study|Protocol Violation|0|||
129567533|NCT01866319|466375195|FG002|Overall Study|Protocol Violation|1|||
129567534|NCT01866319|466375193|FG000|Overall Study|Withdrawal by Subject|32|||
129567535|NCT01866319|466375194|FG001|Overall Study|Withdrawal by Subject|14|||
129567536|NCT01866319|466375195|FG002|Overall Study|Withdrawal by Subject|12|||
129567537|NCT03980483|466375200|FG000|Overall Study|Adverse Event|13|||
129567538|NCT03980483|466375201|FG001|Overall Study|Adverse Event|29|||
129567539|NCT03980483|466375202|FG002|Overall Study|Adverse Event|11|||
129567540|NCT03980483|466375203|FG003|Overall Study|Adverse Event|2|||
129567541|NCT03980483|466375204|FG004|Overall Study|Adverse Event|2|||
129567542|NCT03980483|466375205|FG005|Overall Study|Adverse Event|2|||
129567543|NCT03980483|466375200|FG000|Overall Study|Lack of Efficacy|7|||
129567544|NCT03980483|466375201|FG001|Overall Study|Lack of Efficacy|6|||
129567545|NCT03980483|466375202|FG002|Overall Study|Lack of Efficacy|0|||
129567546|NCT03980483|466375203|FG003|Overall Study|Lack of Efficacy|3|||
129567547|NCT03980483|466375204|FG004|Overall Study|Lack of Efficacy|1|||
129567548|NCT03980483|466375205|FG005|Overall Study|Lack of Efficacy|1|||
129567549|NCT03980483|466375200|FG000|Overall Study|Lost to Follow-up|2|||
129567550|NCT03980483|466375201|FG001|Overall Study|Lost to Follow-up|4|||
129567551|NCT03980483|466375202|FG002|Overall Study|Lost to Follow-up|2|||
129567552|NCT03980483|466375203|FG003|Overall Study|Lost to Follow-up|1|||
129567553|NCT03980483|466375204|FG004|Overall Study|Lost to Follow-up|2|||
129567554|NCT03980483|466375205|FG005|Overall Study|Lost to Follow-up|0|||
129567555|NCT03980483|466375200|FG000|Overall Study|Protocol Violation|4|||
129567556|NCT03980483|466375201|FG001|Overall Study|Protocol Violation|2|||
129567557|NCT03980483|466375202|FG002|Overall Study|Protocol Violation|1|||
129567558|NCT03980483|466375203|FG003|Overall Study|Protocol Violation|1|||
129567559|NCT03980483|466375204|FG004|Overall Study|Protocol Violation|0|||
129567560|NCT03980483|466375205|FG005|Overall Study|Protocol Violation|0|||
129567561|NCT03980483|466375200|FG000|Overall Study|Physician Decision|14|||
129567562|NCT03980483|466375201|FG001|Overall Study|Physician Decision|10|||
129567563|NCT03980483|466375202|FG002|Overall Study|Physician Decision|7|||
129567564|NCT03980483|466375203|FG003|Overall Study|Physician Decision|4|||
129567565|NCT03980483|466375204|FG004|Overall Study|Physician Decision|4|||
129567566|NCT03980483|466375205|FG005|Overall Study|Physician Decision|2|||
129567567|NCT03980483|466375200|FG000|Overall Study|Withdrawal by Subject|38|||
129567568|NCT03980483|466375201|FG001|Overall Study|Withdrawal by Subject|21|||
129567569|NCT03980483|466375202|FG002|Overall Study|Withdrawal by Subject|15|||
129567570|NCT03980483|466375203|FG003|Overall Study|Withdrawal by Subject|5|||
129567571|NCT03980483|466375204|FG004|Overall Study|Withdrawal by Subject|3|||
129567572|NCT03980483|466375205|FG005|Overall Study|Withdrawal by Subject|4|||
129567573|NCT03980483|466375200|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
129567574|NCT03980483|466375201|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129567575|NCT03980483|466375202|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129567576|NCT03980483|466375203|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129567577|NCT03980483|466375204|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129567578|NCT03980483|466375205|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129567579|NCT03980483|466375200|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129567580|NCT03980483|466375201|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
129567581|NCT03980483|466375202|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129567582|NCT03980483|466375203|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129567583|NCT03980483|466375204|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129567584|NCT03980483|466375205|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
129567585|NCT03980483|466375200|FG000|Overall Study|Other|0|||
129567586|NCT03980483|466375201|FG001|Overall Study|Other|1|||
129567587|NCT03980483|466375202|FG002|Overall Study|Other|0|||
129567588|NCT03980483|466375203|FG003|Overall Study|Other|0|||
129567589|NCT03980483|466375204|FG004|Overall Study|Other|0|||
129567590|NCT03980483|466375205|FG005|Overall Study|Other|0|||
129567591|NCT00760266|466375208|FG000|Overall Study|Adverse Event|13|||
129567592|NCT00760266|466375209|FG001|Overall Study|Adverse Event|7|||
129567593|NCT00760266|466375208|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129567594|NCT00760266|466375209|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129567595|NCT00760266|466375208|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129567596|NCT00760266|466375209|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129567597|NCT00760266|466375208|FG000|Overall Study|Lack of Efficacy|2|||
129567598|NCT00760266|466375209|FG001|Overall Study|Lack of Efficacy|2|||
129567599|NCT00760266|466375208|FG000|Overall Study|Protocol deviation|2|||
129567600|NCT00760266|466375209|FG001|Overall Study|Protocol deviation|4|||
129567601|NCT00760266|466375208|FG000|Overall Study|Patient withdrew consent|3|||
129567602|NCT00760266|466375209|FG001|Overall Study|Patient withdrew consent|3|||
129567603|NCT00760266|466375208|FG000|Overall Study|Lost to Follow-up|2|||
129567604|NCT00760266|466375209|FG001|Overall Study|Lost to Follow-up|1|||
129567605|NCT00760266|466375208|FG000|Overall Study|Administrative Problems|0|||
129567606|NCT00760266|466375209|FG001|Overall Study|Administrative Problems|1|||
129567607|NCT01225146|466375210|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
129567608|NCT01225146|466375211|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
129567609|NCT01239121|466375212|FG000|Overall Study|Withdrawal by Subject|2|||
129567610|NCT01239121|466375213|FG001|Overall Study|Withdrawal by Subject|4|||
129567611|NCT01239121|466375214|FG002|Overall Study|Withdrawal by Subject|0|||
129567612|NCT00623779|466375218|FG000|Overall Study|Adverse Event|1|||
129567613|NCT00623779|466375219|FG001|Overall Study|Adverse Event|3|||
129567614|NCT00623779|466375220|FG002|Overall Study|Adverse Event|0|||
129567615|NCT00623779|466375218|FG000|Overall Study|Criteria from CSR|2|||
129567616|NCT00623779|466375219|FG001|Overall Study|Criteria from CSR|0|||
129567617|NCT00623779|466375220|FG002|Overall Study|Criteria from CSR|1|||
129567618|NCT00220337|466375223|FG000|Overall Study|Adverse Event|70|||
129567619|NCT00220337|466375223|FG000|Overall Study|Lack of Efficacy|17|||
129567620|NCT00220337|466375223|FG000|Overall Study|Withdrawal by Subject|68|||
129567621|NCT00220337|466375223|FG000|Overall Study|Protocol Violation|2|||
129567622|NCT00220337|466375223|FG000|Overall Study|Lost to Follow-up|5|||
129567623|NCT00220337|466375223|FG000|Overall Study|Other|12|||
129567624|NCT00220337|466375223|FG000|Overall Study|Unsatisfactory compliance|5|||
129567625|NCT00944697|466375224|FG000|Overall Study|Withdrawal by Subject|1|||
129567626|NCT00944697|466375225|FG001|Overall Study|Withdrawal by Subject|1|||
129567627|NCT00944697|466375224|FG000|Overall Study|Adverse Event|0|||
129567628|NCT00944697|466375225|FG001|Overall Study|Adverse Event|3|||
129567629|NCT00944697|466375224|FG000|Overall Study|Administrative|1|||
129567630|NCT00944697|466375225|FG001|Overall Study|Administrative|1|||
129567631|NCT02732210|466375226|FG000|Overall Study|Site Closed|0|||
129567632|NCT02732210|466375227|FG001|Overall Study|Site Closed|11|||
129567633|NCT02732210|466375226|FG000|Overall Study|Study Ended|13|||
129567634|NCT02732210|466375227|FG001|Overall Study|Study Ended|13|||
129567635|NCT02732210|466375226|FG000|Overall Study|Withdrawal by Subject|28|||
129567636|NCT02732210|466375227|FG001|Overall Study|Withdrawal by Subject|87|||
129567637|NCT02732210|466375226|FG000|Overall Study|Lost to Follow-up|5|||
129567638|NCT02732210|466375227|FG001|Overall Study|Lost to Follow-up|57|||
129567639|NCT02732210|466375226|FG000|Overall Study|Death|4|||
129567640|NCT02732210|466375227|FG001|Overall Study|Death|15|||
129567641|NCT02732210|466375226|FG000|Overall Study|Other|35|||
129567642|NCT02732210|466375227|FG001|Overall Study|Other|103|||
129567643|NCT02732210|466375226|FG000|Overall Study|Missing|0|||
129567644|NCT02732210|466375227|FG001|Overall Study|Missing|8|||
129567645|NCT02191891|466375230|FG000|Overall Study|Withdrawal by Subject|0|||
129567646|NCT02191891|466375231|FG001|Overall Study|Withdrawal by Subject|1|||
129567647|NCT02191891|466375232|FG002|Overall Study|Withdrawal by Subject|0|||
129567648|NCT02191891|466375233|FG003|Overall Study|Withdrawal by Subject|0|||
129567649|NCT02191891|466375234|FG004|Overall Study|Withdrawal by Subject|1|||
129567650|NCT02191891|466375230|FG000|Overall Study|Adverse Event|0|||
129567651|NCT02191891|466375231|FG001|Overall Study|Adverse Event|1|||
129567652|NCT02191891|466375232|FG002|Overall Study|Adverse Event|0|||
129567653|NCT02191891|466375233|FG003|Overall Study|Adverse Event|0|||
129567654|NCT02191891|466375234|FG004|Overall Study|Adverse Event|2|||
129567655|NCT02191891|466375230|FG000|Overall Study|Disease Progression|4|||
129567656|NCT02191891|466375231|FG001|Overall Study|Disease Progression|10|||
129567657|NCT02191891|466375232|FG002|Overall Study|Disease Progression|4|||
129567658|NCT02191891|466375233|FG003|Overall Study|Disease Progression|2|||
129567659|NCT02191891|466375234|FG004|Overall Study|Disease Progression|7|||
129567660|NCT02468778|466375236|FG000|Overall Study|Death|2|||
129567661|NCT02468778|466375237|FG001|Overall Study|Death|1|||
129567662|NCT02468778|466375238|FG002|Overall Study|Death|0|||
129567663|NCT02468778|466375236|FG000|Overall Study|Lost to Follow-up|1|||
129567664|NCT02468778|466375237|FG001|Overall Study|Lost to Follow-up|2|||
129567665|NCT02468778|466375238|FG002|Overall Study|Lost to Follow-up|2|||
129567666|NCT02468778|466375236|FG000|Overall Study|Withdrawal by Subject|0|||
129567667|NCT02468778|466375237|FG001|Overall Study|Withdrawal by Subject|1|||
129567668|NCT02468778|466375238|FG002|Overall Study|Withdrawal by Subject|1|||
129567669|NCT00414765|466375239|FG000|Overall Study|Adverse Event|5|||
129567670|NCT00414765|466375240|FG001|Overall Study|Adverse Event|9|||
129567671|NCT00414765|466375239|FG000|Overall Study|Withdrawal by Subject|1|||
129567672|NCT00414765|466375240|FG001|Overall Study|Withdrawal by Subject|1|||
129567673|NCT00414765|466375239|FG000|Overall Study|Disease Progression|0|||
129567674|NCT00414765|466375240|FG001|Overall Study|Disease Progression|1|||
129567675|NCT03130699|466375241|FG000|Overall Study|Lost to Follow-up|34|||
129567676|NCT03130699|466375242|FG001|Overall Study|Lost to Follow-up|37|||
129567677|NCT03130699|466375243|FG002|Overall Study|Lost to Follow-up|26|||
129567678|NCT03130699|466375241|FG000|Overall Study|Withdrawal by Subject|5|||
129567679|NCT03130699|466375242|FG001|Overall Study|Withdrawal by Subject|1|||
129567680|NCT03130699|466375243|FG002|Overall Study|Withdrawal by Subject|0|||
129567681|NCT03130699|466375241|FG000|Overall Study|Withdrawal by PI|1|||
129567682|NCT03130699|466375242|FG001|Overall Study|Withdrawal by PI|2|||
129567683|NCT03130699|466375243|FG002|Overall Study|Withdrawal by PI|5|||
129567684|NCT03130699|466375241|FG000|Overall Study|Death|0|||
129567685|NCT03130699|466375242|FG001|Overall Study|Death|0|||
129567686|NCT03130699|466375243|FG002|Overall Study|Death|1|||
129567687|NCT04534283|466375244|FG000|Overall Study|Physician Decision|2|||
129567688|NCT04534283|466375244|FG000|Overall Study|Withdrawal by Subject|1|||
129567689|NCT04534283|466375244|FG000|Overall Study|Disease Progression|12|||
129567690|NCT04534283|466375244|FG000|Overall Study|Adverse Event|1|||
129567691|NCT00661505|466375245|FG000|Overall Study|Adverse Event|3|||
129567692|NCT00661505|466375245|FG000|Overall Study|Protocol Violation|14|||
129567693|NCT00661505|466375245|FG000|Overall Study|Withdrawal by Subject|8|||
129567694|NCT00661505|466375245|FG000|Overall Study|Lost to Follow-up|3|||
129567695|NCT00661505|466375245|FG000|Overall Study|Other|2|||
129567696|NCT01004172|466375254|FG000|Overall Study|Progressive Disease in CNS Only|16|||
129567697|NCT01004172|466375254|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
129567698|NCT01004172|466375254|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
129567699|NCT01004172|466375254|FG000|Overall Study|Adverse Event|1|||
129567700|NCT01004172|466375254|FG000|Overall Study|Physician Decision|1|||
129567701|NCT01004172|466375254|FG000|Overall Study|Symptomatic Deterioration|2|||
129567702|NCT02003183|466375255|FG000|Overall Study|Lost to Follow-up|0|||
129567703|NCT02003183|466375256|FG001|Overall Study|Lost to Follow-up|2|||
129567704|NCT01759290|466375257|FG000|Overall Study|Subjects withdrawn consent|5|||
129567705|NCT01759290|466375257|FG000|Overall Study|Physician Decision|2|||
129567706|NCT01759290|466375257|FG000|Overall Study|Death|17|||
129567707|NCT01759290|466375257|FG000|Overall Study|Lost to Follow-up|53|||
129567708|NCT01759290|466375257|FG000|Overall Study|Unknown reason|4|||
129567709|NCT03629249|466375258|FG000|Overall Study|Study terminated by sponsor|197|||
129567710|NCT03629249|466375259|FG001|Overall Study|Study terminated by sponsor|197|||
129567711|NCT03629249|466375260|FG002|Overall Study|Study terminated by sponsor|194|||
129567712|NCT03629249|466375258|FG000|Overall Study|Protocol deviation|0|||
129567713|NCT03629249|466375259|FG001|Overall Study|Protocol deviation|2|||
129567714|NCT03629249|466375260|FG002|Overall Study|Protocol deviation|5|||
129567715|NCT03629249|466375258|FG000|Overall Study|Subject decision|1|||
129567716|NCT03629249|466375259|FG001|Overall Study|Subject decision|1|||
129567717|NCT03629249|466375260|FG002|Overall Study|Subject decision|3|||
129567718|NCT03629249|466375258|FG000|Overall Study|Adverse Event|1|||
129567719|NCT03629249|466375259|FG001|Overall Study|Adverse Event|1|||
129567720|NCT03629249|466375260|FG002|Overall Study|Adverse Event|0|||
129567721|NCT03629249|466375258|FG000|Overall Study|Death|1|||
129567722|NCT03629249|466375259|FG001|Overall Study|Death|0|||
129567723|NCT03629249|466375260|FG002|Overall Study|Death|0|||
129567724|NCT03629249|466375258|FG000|Overall Study|Physician Decision|1|||
129567725|NCT03629249|466375259|FG001|Overall Study|Physician Decision|0|||
129567726|NCT03629249|466375260|FG002|Overall Study|Physician Decision|0|||
129567727|NCT00352690|466375261|FG000|Overall Study|Determined to be ineligible|2|||
129567728|NCT00352690|466375262|FG001|Overall Study|Determined to be ineligible|0|||
129567729|NCT02719522|466375267|FG000|Overall Study|Implant Failure|4|||
129567730|NCT02719522|466375267|FG000|Overall Study|Death|2|||
129567731|NCT02719522|466375267|FG000|Overall Study|Lost to Follow-up|5|||
129689736|NCT01166945|466822342|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
129689737|NCT01166945|466822343|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
129689738|NCT01166945|466822342|FG000|Day 30|Lost to Follow-up|4|||
129689739|NCT01166945|466822343|FG001|Day 30|Lost to Follow-up|3|||
129689740|NCT00784927|466822345|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
129567732|NCT02097290|466375268|FG000|Overall Study|Death|6|||
129567733|NCT02097290|466375268|FG000|Overall Study|Total Withdrawals|3|||
129567734|NCT02097290|466375268|FG000|Overall Study|Attempt|8|||
129567735|NCT06096168|466375269|FG000|Overall Study|Death|30|||
129567736|NCT06096168|466375269|FG000|Overall Study|Revision|2|||
129567737|NCT01478620|466375270|FG000|Overall Study|Lost to Follow-up|6|||
129567738|NCT02888171|466375271|FG000|Overall Study|Lost to Follow-up|2|||
129567739|NCT02888171|466375272|FG001|Overall Study|Lost to Follow-up|1|||
129567740|NCT02888171|466375271|FG000|Overall Study|Withdrawal by Subject|3|||
129567741|NCT02888171|466375272|FG001|Overall Study|Withdrawal by Subject|2|||
129567742|NCT02888171|466375271|FG000|Overall Study|Adverse Event|0|||
129567743|NCT02888171|466375272|FG001|Overall Study|Adverse Event|1|||
129689741|NCT00784927|466822345|FG000|Overall Study|Protocol Violation|1|||
129689742|NCT00784927|466822345|FG000|Overall Study|Ineligible|1|||
129689743|NCT00422461|466822352|FG000|Overall Study|Adverse Event|1|||
129567744|NCT01411332|466375275|FG000|Enrollment|Protocol Violation|0|||
129567745|NCT01411332|466375276|FG001|Enrollment|Protocol Violation|1|||
129567746|NCT01411332|466375275|FG000|Enrollment|Withdrawal by Subject|0|||
129567747|NCT01411332|466375276|FG001|Enrollment|Withdrawal by Subject|1|||
129567748|NCT01411332|466375275|FG000|Treatment|Lost to Follow-up|1|||
129567749|NCT01411332|466375276|FG001|Treatment|Lost to Follow-up|0|||
129567750|NCT02848326|466376774|FG000|Treatment Period|Adverse Event|5|||
129567751|NCT02848326|466376775|FG001|Treatment Period|Adverse Event|4|||
129567752|NCT02848326|466376776|FG002|Treatment Period|Adverse Event|11|||
129567753|NCT02848326|466376777|FG003|Treatment Period|Adverse Event|6|||
129567754|NCT02848326|466376778|FG004|Treatment Period|Adverse Event|5|||
129567755|NCT02848326|466376779|FG005|Treatment Period|Adverse Event|7|||
129567756|NCT02848326|466376774|FG000|Treatment Period|Withdrawal of Consent|20|||
129567757|NCT02848326|466376775|FG001|Treatment Period|Withdrawal of Consent|6|||
129567758|NCT02848326|466376776|FG002|Treatment Period|Withdrawal of Consent|9|||
129567759|NCT02848326|466376777|FG003|Treatment Period|Withdrawal of Consent|6|||
129567760|NCT02848326|466376778|FG004|Treatment Period|Withdrawal of Consent|9|||
129567761|NCT02848326|466376779|FG005|Treatment Period|Withdrawal of Consent|6|||
129567762|NCT02848326|466376774|FG000|Treatment Period|Lost to Follow-up|5|||
129567763|NCT02848326|466376775|FG001|Treatment Period|Lost to Follow-up|1|||
129567764|NCT02848326|466376776|FG002|Treatment Period|Lost to Follow-up|11|||
129567765|NCT02848326|466376777|FG003|Treatment Period|Lost to Follow-up|7|||
129567766|NCT02848326|466376778|FG004|Treatment Period|Lost to Follow-up|2|||
129567767|NCT02848326|466376779|FG005|Treatment Period|Lost to Follow-up|3|||
129567768|NCT02848326|466376774|FG000|Treatment Period|Pregnancy|0|||
129689744|NCT00422461|466822353|FG001|Overall Study|Adverse Event|2|||
129689745|NCT00422461|466822354|FG002|Overall Study|Adverse Event|1|||
129567769|NCT02848326|466376775|FG001|Treatment Period|Pregnancy|0|||
129567770|NCT02848326|466376776|FG002|Treatment Period|Pregnancy|1|||
129567771|NCT02848326|466376777|FG003|Treatment Period|Pregnancy|1|||
129567772|NCT02848326|466376778|FG004|Treatment Period|Pregnancy|0|||
129567773|NCT02848326|466376779|FG005|Treatment Period|Pregnancy|1|||
129567774|NCT02848326|466376774|FG000|Treatment Period|Protocol Violation|4|||
129689746|NCT00422461|466822355|FG003|Overall Study|Adverse Event|1|||
129689747|NCT00422461|466822352|FG000|Overall Study|Other|0|||
129689748|NCT00422461|466822353|FG001|Overall Study|Other|0|||
129689749|NCT00422461|466822354|FG002|Overall Study|Other|0|||
129689750|NCT00422461|466822355|FG003|Overall Study|Other|2|||
129689751|NCT00422461|466822352|FG000|Overall Study|Participants no longer willing to participate in study|1|||
129884553|NCT03012061|467536451|FG001|Overall Study|Adverse Event|0|||
129567775|NCT02848326|466376775|FG001|Treatment Period|Protocol Violation|3|||
129567776|NCT02848326|466376776|FG002|Treatment Period|Protocol Violation|4|||
129567777|NCT02848326|466376777|FG003|Treatment Period|Protocol Violation|2|||
129567778|NCT02848326|466376778|FG004|Treatment Period|Protocol Violation|3|||
129567779|NCT02848326|466376779|FG005|Treatment Period|Protocol Violation|3|||
129567780|NCT02848326|466376774|FG000|Treatment Period|Non-compliance with Study Drug|4|||
129567781|NCT02848326|466376775|FG001|Treatment Period|Non-compliance with Study Drug|0|||
129567782|NCT02848326|466376776|FG002|Treatment Period|Non-compliance with Study Drug|0|||
129567783|NCT02848326|466376777|FG003|Treatment Period|Non-compliance with Study Drug|1|||
129567784|NCT02848326|466376778|FG004|Treatment Period|Non-compliance with Study Drug|0|||
129567785|NCT02848326|466376779|FG005|Treatment Period|Non-compliance with Study Drug|0|||
129567786|NCT02848326|466376774|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
129567787|NCT02848326|466376775|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
129567788|NCT02848326|466376776|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
129567789|NCT02848326|466376777|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
129567790|NCT02848326|466376778|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
129567791|NCT02848326|466376779|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
129567792|NCT02848326|466376774|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
129567793|NCT02848326|466376775|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
129567794|NCT02848326|466376776|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
129567795|NCT02848326|466376777|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
129567796|NCT02848326|466376778|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
129567797|NCT02848326|466376779|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
129567798|NCT02637232|466376781|FG000|Overall Study|Lost to Follow-up|42|||
129567799|NCT02637232|466376781|FG000|Overall Study|Adverse Event|11|||
129567800|NCT02637232|466376781|FG000|Overall Study|patient 's decision|2|||
129567801|NCT01781637|466376782|FG000|Overall Study|Adverse Event|1|||
129567802|NCT01781637|466376783|FG001|Overall Study|Adverse Event|0|||
129567803|NCT01781637|466376782|FG000|Overall Study|Lack of Efficacy|2|||
129567804|NCT01781637|466376783|FG001|Overall Study|Lack of Efficacy|6|||
129567805|NCT01781637|466376782|FG000|Overall Study|Withdrawal by Subject|1|||
129567806|NCT01781637|466376783|FG001|Overall Study|Withdrawal by Subject|0|||
129567807|NCT02999178|466376784|FG000|Overall Study|Adverse Event|85|||
129567808|NCT02999178|466376785|FG001|Overall Study|Adverse Event|62|||
129567809|NCT02999178|466376784|FG000|Overall Study|Protocol Violation|1|||
129567810|NCT02999178|466376785|FG001|Overall Study|Protocol Violation|2|||
129567811|NCT02999178|466376784|FG000|Overall Study|Lost to Follow-up|0|||
129567812|NCT02999178|466376785|FG001|Overall Study|Lost to Follow-up|2|||
129567813|NCT02999178|466376784|FG000|Overall Study|Withdrawal by Subject|21|||
129567814|NCT02999178|466376785|FG001|Overall Study|Withdrawal by Subject|21|||
129567815|NCT02999178|466376784|FG000|Overall Study|Other reason not defined above|7|||
129567816|NCT02999178|466376785|FG001|Overall Study|Other reason not defined above|13|||
129567817|NCT00090857|466376787|FG000|Overall Study|Lost to Follow-up|0|||
129567818|NCT00090857|466376788|FG001|Overall Study|Lost to Follow-up|1|||
129567819|NCT00090857|466376787|FG000|Overall Study|Withdrawal by Subject|2|||
129567820|NCT00090857|466376788|FG001|Overall Study|Withdrawal by Subject|0|||
129567821|NCT00090857|466376787|FG000|Overall Study|Adverse Event|2|||
129567822|NCT00090857|466376788|FG001|Overall Study|Adverse Event|2|||
129567823|NCT05097326|466376789|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
129567824|NCT05097326|466376790|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
129567825|NCT02684344|466376792|FG000|Overall Study|Withdrawal by Subject|0|||
129567826|NCT02684344|466376793|FG001|Overall Study|Withdrawal by Subject|1|||
129567827|NCT03480425|466376794|FG000|Overall Study|Force transducer technical failure|1|||
129567828|NCT02424188|466376796|FG000|Overall Study|Death|2|||
129567829|NCT02424188|466376797|FG001|Overall Study|Death|2|||
129567830|NCT02424188|466376796|FG000|Overall Study|Lost to Follow-up|1|||
129567831|NCT02424188|466376797|FG001|Overall Study|Lost to Follow-up|3|||
129567832|NCT02424188|466376796|FG000|Overall Study|Incarceration|1|||
129567833|NCT02424188|466376797|FG001|Overall Study|Incarceration|0|||
129567834|NCT01085045|466376798|FG000|Part A|Withdrawal by Subject|4|||
129567835|NCT01085045|466376798|FG000|Part A|Adverse Event|6|||
129567836|NCT01085045|466376798|FG000|Part A|Protocol Violation|1|||
129567837|NCT01085045|466376798|FG000|Part A|Protocol Specified Criteria|7|||
129567838|NCT01085045|466376798|FG000|Part B|Withdrawal by Subject|2|||
129567839|NCT01085045|466376798|FG000|Part B|Protocol Specified Criteria|6|||
129567840|NCT01085045|466376798|FG000|Part B|Lost to Follow-up|1|||
129567841|NCT01085045|466376798|FG000|Part B|Adverse Event|6|||
129567842|NCT03471078|466376803|FG000|Overall Study|Withdrawal by Subject|9|||
129567843|NCT03471078|466376804|FG001|Overall Study|Withdrawal by Subject|1|||
129567844|NCT03471078|466376803|FG000|Overall Study|Adverse Event|4|||
129567845|NCT03471078|466376804|FG001|Overall Study|Adverse Event|1|||
129567846|NCT03471078|466376803|FG000|Overall Study|Physician Decision|3|||
129567847|NCT03471078|466376804|FG001|Overall Study|Physician Decision|2|||
129567848|NCT03471078|466376803|FG000|Overall Study|Death|2|||
129567849|NCT03471078|466376804|FG001|Overall Study|Death|0|||
129567850|NCT03471078|466376803|FG000|Overall Study|Other|3|||
129567851|NCT03471078|466376804|FG001|Overall Study|Other|2|||
129567852|NCT02473640|466376812|FG000|Treatment Period 1|Adverse Event|1|||
129567853|NCT02395822|466376813|FG000|Overall Study|Withdrawal by Subject|1|||
129567854|NCT02395822|466376813|FG000|Overall Study|Death|1|||
129567855|NCT02127281|466376814|FG000|Overall Study|Lost to Follow-up|1|||
129567856|NCT02127281|466376815|FG001|Overall Study|Lost to Follow-up|0|||
129567857|NCT02937701|466376816|FG000|Day 1 to Week 22|Adverse Event|11|||
129567858|NCT02937701|466376817|FG001|Day 1 to Week 22|Adverse Event|14|||
129567859|NCT02937701|466376818|FG002|Day 1 to Week 22|Adverse Event|0|||
129567860|NCT02937701|466376819|FG003|Day 1 to Week 22|Adverse Event|0|||
129567861|NCT02937701|466376820|FG004|Day 1 to Week 22|Adverse Event|0|||
129567862|NCT02937701|466376816|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
129567863|NCT02937701|466376817|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
129567864|NCT02937701|466376818|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
129567865|NCT02937701|466376819|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
129567866|NCT02937701|466376820|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
129567867|NCT02937701|466376816|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
129567868|NCT02937701|466376817|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
129567869|NCT02937701|466376818|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
129567870|NCT02937701|466376819|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
129567871|NCT02937701|466376820|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
129567872|NCT02937701|466376816|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
129567873|NCT02937701|466376817|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
129567874|NCT02937701|466376818|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
129567875|NCT02937701|466376819|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
129567876|NCT02937701|466376820|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
129567877|NCT02937701|466376816|FG000|Day 1 to Week 22|Death|1|||
129567878|NCT02937701|466376817|FG001|Day 1 to Week 22|Death|1|||
129567879|NCT02937701|466376818|FG002|Day 1 to Week 22|Death|0|||
129567880|NCT02937701|466376819|FG003|Day 1 to Week 22|Death|0|||
129567881|NCT02937701|466376820|FG004|Day 1 to Week 22|Death|0|||
129567882|NCT02937701|466376816|FG000|Day 1 to Week 22|Protocol Violation|1|||
129567883|NCT02937701|466376817|FG001|Day 1 to Week 22|Protocol Violation|1|||
129567884|NCT02937701|466376818|FG002|Day 1 to Week 22|Protocol Violation|0|||
129567885|NCT02937701|466376819|FG003|Day 1 to Week 22|Protocol Violation|0|||
129567886|NCT02937701|466376820|FG004|Day 1 to Week 22|Protocol Violation|0|||
129567887|NCT02937701|466376816|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
129567888|NCT02937701|466376817|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
129567889|NCT02937701|466376818|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
129567890|NCT02937701|466376819|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
129567891|NCT02937701|466376820|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
129567892|NCT02937701|466376816|FG000|Day 1 to Week 22|Physician Decision|2|||
129567893|NCT02937701|466376817|FG001|Day 1 to Week 22|Physician Decision|0|||
129567894|NCT02937701|466376818|FG002|Day 1 to Week 22|Physician Decision|0|||
129567895|NCT02937701|466376819|FG003|Day 1 to Week 22|Physician Decision|0|||
129567896|NCT02937701|466376820|FG004|Day 1 to Week 22|Physician Decision|0|||
129567897|NCT02937701|466376816|FG000|Day 1 to Week 22|Other|1|||
129567898|NCT02937701|466376817|FG001|Day 1 to Week 22|Other|0|||
129567899|NCT02937701|466376818|FG002|Day 1 to Week 22|Other|0|||
129567900|NCT02937701|466376819|FG003|Day 1 to Week 22|Other|0|||
129567901|NCT02937701|466376820|FG004|Day 1 to Week 22|Other|0|||
129567902|NCT02937701|466376816|FG000|Week 22 to Week 50|Adverse Event|0|||
129567903|NCT02937701|466376817|FG001|Week 22 to Week 50|Adverse Event|0|||
129567904|NCT02937701|466376818|FG002|Week 22 to Week 50|Adverse Event|10|||
129567905|NCT02937701|466376819|FG003|Week 22 to Week 50|Adverse Event|3|||
129567906|NCT02937701|466376820|FG004|Week 22 to Week 50|Adverse Event|3|||
129567907|NCT02937701|466376816|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
129567908|NCT02937701|466376817|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
129567909|NCT02937701|466376818|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
129567910|NCT02937701|466376819|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
129567911|NCT02937701|466376820|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
129567912|NCT02937701|466376816|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
129567913|NCT02937701|466376817|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
129567914|NCT02937701|466376818|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
129567915|NCT02937701|466376819|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
129567916|NCT02937701|466376820|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
129689752|NCT00422461|466822353|FG001|Overall Study|Participants no longer willing to participate in study|0|||
129689753|NCT00422461|466822354|FG002|Overall Study|Participants no longer willing to participate in study|0|||
129567917|NCT02937701|466376816|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
129567918|NCT02937701|466376817|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
129567919|NCT02937701|466376818|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
129689754|NCT00422461|466822355|FG003|Overall Study|Participants no longer willing to participate in study|0|||
129689755|NCT00422461|466822352|FG000|Overall Study|Randomized but not treated|1|||
129567920|NCT02937701|466376819|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
129567921|NCT02937701|466376820|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
129567922|NCT02937701|466376816|FG000|Week 22 to Week 50|Physician Decision|0|||
129567923|NCT02937701|466376817|FG001|Week 22 to Week 50|Physician Decision|0|||
129567924|NCT02937701|466376818|FG002|Week 22 to Week 50|Physician Decision|2|||
129567925|NCT02937701|466376819|FG003|Week 22 to Week 50|Physician Decision|0|||
129567926|NCT02937701|466376820|FG004|Week 22 to Week 50|Physician Decision|1|||
129567927|NCT02937701|466376816|FG000|Week 22 to Week 50|Other|0|||
129567928|NCT02937701|466376817|FG001|Week 22 to Week 50|Other|0|||
129567929|NCT02937701|466376818|FG002|Week 22 to Week 50|Other|0|||
129567930|NCT02937701|466376819|FG003|Week 22 to Week 50|Other|0|||
129567931|NCT02937701|466376820|FG004|Week 22 to Week 50|Other|1|||
129567932|NCT01996033|466376826|FG000|Overall Study|Death|1|||
129567933|NCT01996033|466376826|FG000|Overall Study|Physician Decision|1|||
129567934|NCT01996033|466376826|FG000|Overall Study|Withdrawal by Subject|4|||
129567935|NCT01996033|466376826|FG000|Overall Study|Lost to Follow-up|3|||
129567936|NCT03227445|466376831|FG000|Period 1 (28 Days)|Adverse Event|1|||
129567937|NCT03227445|466376832|FG001|Period 1 (28 Days)|Adverse Event|2|||
129567938|NCT03227445|466376833|FG002|Period 1 (28 Days)|Adverse Event|0|||
129567939|NCT03227445|466376834|FG003|Period 1 (28 Days)|Adverse Event|1|||
129567940|NCT03227445|466376831|FG000|Period 1 (28 Days)|Protocol Violation|1|||
129567941|NCT03227445|466376832|FG001|Period 1 (28 Days)|Protocol Violation|0|||
129567942|NCT03227445|466376833|FG002|Period 1 (28 Days)|Protocol Violation|0|||
129567943|NCT03227445|466376834|FG003|Period 1 (28 Days)|Protocol Violation|0|||
129567944|NCT03227445|466376831|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
129567945|NCT03227445|466376832|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
129567946|NCT03227445|466376833|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
129567947|NCT03227445|466376834|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
129567948|NCT03227445|466376831|FG000|Period 2 (28 Days)|Adverse Event|1|||
129567949|NCT03227445|466376832|FG001|Period 2 (28 Days)|Adverse Event|0|||
129567950|NCT03227445|466376833|FG002|Period 2 (28 Days)|Adverse Event|2|||
129567951|NCT03227445|466376834|FG003|Period 2 (28 Days)|Adverse Event|1|||
129567952|NCT03227445|466376831|FG000|Period 2 (28 Days)|Protocol Violation|0|||
129567953|NCT03227445|466376832|FG001|Period 2 (28 Days)|Protocol Violation|0|||
129567954|NCT03227445|466376833|FG002|Period 2 (28 Days)|Protocol Violation|0|||
129567955|NCT03227445|466376834|FG003|Period 2 (28 Days)|Protocol Violation|1|||
129567956|NCT03227445|466376831|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
129567957|NCT03227445|466376832|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
129567958|NCT03227445|466376833|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
129567959|NCT03227445|466376834|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
129567960|NCT00755196|466376836|FG000|Overall Study|Lost to Follow-up|1|||
129567961|NCT00755196|466376836|FG000|Overall Study|Lack of Efficiency|1|||
129567962|NCT00243932|466376837|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
129567963|NCT00243932|466376838|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
129567964|NCT00243932|466376839|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
129567965|NCT02143102|466376842|FG000|Overall Study|Lost to Follow-up|11|||
129567966|NCT02143102|466376843|FG001|Overall Study|Lost to Follow-up|0|||
129567967|NCT01203878|466376844|FG000|Overall Study|Withdrawal by Subject|0|||
129567968|NCT01203878|466376845|FG001|Overall Study|Withdrawal by Subject|0|||
129567969|NCT01203878|466376846|FG002|Overall Study|Withdrawal by Subject|1|||
129567970|NCT01203878|466376844|FG000|Overall Study|Adverse Event|0|||
129567971|NCT01203878|466376845|FG001|Overall Study|Adverse Event|0|||
129567972|NCT01203878|466376846|FG002|Overall Study|Adverse Event|2|||
129567973|NCT01273181|466376847|FG000|Phase I, Dose 1|Study termination|1|||
129567974|NCT01273181|466376848|FG001|Phase I, Dose 1|Study termination|0|||
129567975|NCT01273181|466376849|FG002|Phase I, Dose 1|Study termination|0|||
129567976|NCT01273181|466376850|FG003|Phase I, Dose 1|Study termination|0|||
129567977|NCT01273181|466376847|FG000|Phase I, Dose 2|Death during treatment|0|||
129567978|NCT01273181|466376848|FG001|Phase I, Dose 2|Death during treatment|1|||
129567979|NCT01273181|466376849|FG002|Phase I, Dose 2|Death during treatment|0|||
129567980|NCT01273181|466376850|FG003|Phase I, Dose 2|Death during treatment|0|||
129567981|NCT01273181|466376847|FG000|Phase 2, Dose 1|Study termination|0|||
129567982|NCT01273181|466376848|FG001|Phase 2, Dose 1|Study termination|0|||
129567983|NCT01273181|466376849|FG002|Phase 2, Dose 1|Study termination|1|||
129567984|NCT01273181|466376850|FG003|Phase 2, Dose 1|Study termination|0|||
129567985|NCT01273181|466376847|FG000|Phase 2, Dose 2|Death during treatment|0|||
129567986|NCT01273181|466376848|FG001|Phase 2, Dose 2|Death during treatment|0|||
129567987|NCT01273181|466376849|FG002|Phase 2, Dose 2|Death during treatment|0|||
129567988|NCT01273181|466376850|FG003|Phase 2, Dose 2|Death during treatment|1|||
129567989|NCT03657160|466376851|FG000|Overall Study|Adverse Event|5|||
129567990|NCT03657160|466376852|FG001|Overall Study|Adverse Event|6|||
129567991|NCT03657160|466376851|FG000|Overall Study|Protocol Deviation|3|||
129567992|NCT03657160|466376852|FG001|Overall Study|Protocol Deviation|0|||
129567993|NCT03657160|466376851|FG000|Overall Study|Withdrawal by Subject|18|||
129567994|NCT03657160|466376852|FG001|Overall Study|Withdrawal by Subject|16|||
129567995|NCT03657160|466376851|FG000|Overall Study|Site Termination|1|||
129567996|NCT03657160|466376852|FG001|Overall Study|Site Termination|0|||
129567997|NCT03657160|466376851|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
129567998|NCT03657160|466376852|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
129567999|NCT03657160|466376851|FG000|Overall Study|Death|33|||
129568000|NCT03657160|466376852|FG001|Overall Study|Death|26|||
129568001|NCT03657160|466376851|FG000|Overall Study|Death (COVID-19-Related)|1|||
129884554|NCT03012061|467536452|FG002|Overall Study|Adverse Event|0|||
129568002|NCT03657160|466376852|FG001|Overall Study|Death (COVID-19-Related)|0|||
129568003|NCT03657160|466376851|FG000|Overall Study|Reason Not Specified|5|||
129568004|NCT03657160|466376852|FG001|Overall Study|Reason Not Specified|5|||
129568005|NCT03657160|466376851|FG000|Overall Study|Other (COVID-19-Related)|0|||
129568006|NCT03657160|466376852|FG001|Overall Study|Other (COVID-19-Related)|1|||
129568007|NCT04638153|466376853|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129568008|NCT04638153|466376854|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129568009|NCT04638153|466376855|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129568010|NCT04638153|466376853|FG000|Overall Study|Study terminated by sponsor|4|||
129568011|NCT04638153|466376854|FG001|Overall Study|Study terminated by sponsor|2|||
129689756|NCT00422461|466822353|FG001|Overall Study|Randomized but not treated|1|||
129689757|NCT00422461|466822354|FG002|Overall Study|Randomized but not treated|0|||
129689758|NCT00422461|466822355|FG003|Overall Study|Randomized but not treated|0|||
129689759|NCT01471574|466822356|FG000|Treatment Period|Lack of Efficacy|12|||
129689760|NCT01471574|466822357|FG001|Treatment Period|Lack of Efficacy|4|||
129689761|NCT01471574|466822358|FG002|Treatment Period|Lack of Efficacy|14|||
129689762|NCT01471574|466822359|FG003|Treatment Period|Lack of Efficacy|1|||
129689763|NCT01471574|466822356|FG000|Treatment Period|Adverse Event|7|||
129689764|NCT01471574|466822357|FG001|Treatment Period|Adverse Event|3|||
129689765|NCT01471574|466822358|FG002|Treatment Period|Adverse Event|6|||
129568012|NCT04638153|466376855|FG002|Overall Study|Study terminated by sponsor|14|||
129568013|NCT04006171|466376858|FG000|Overall Study|Withdrawal by Subject|8|||
129568014|NCT04006171|466376859|FG001|Overall Study|Withdrawal by Subject|7|||
129689766|NCT01471574|466822359|FG003|Treatment Period|Adverse Event|1|||
129689767|NCT01471574|466822356|FG000|Treatment Period|Withdrawal by Subject|5|||
129689768|NCT01471574|466822357|FG001|Treatment Period|Withdrawal by Subject|1|||
129689769|NCT01471574|466822358|FG002|Treatment Period|Withdrawal by Subject|1|||
129568015|NCT04006171|466376858|FG000|Overall Study|missing serum samples|2|||
129568016|NCT04006171|466376859|FG001|Overall Study|missing serum samples|2|||
129568017|NCT04006171|466376858|FG000|Overall Study|insufficient sample volume|2|||
129568018|NCT04006171|466376859|FG001|Overall Study|insufficient sample volume|3|||
129568019|NCT00440557|466376861|FG000|Overall Study|Withdrawal by Subject|10|||
129568020|NCT00440557|466376862|FG001|Overall Study|Withdrawal by Subject|5|||
129568021|NCT00440557|466376863|FG002|Overall Study|Withdrawal by Subject|11|||
129568022|NCT00440557|466376861|FG000|Overall Study|Lost to Follow-up|1|||
129568023|NCT00440557|466376862|FG001|Overall Study|Lost to Follow-up|2|||
129568024|NCT00440557|466376863|FG002|Overall Study|Lost to Follow-up|6|||
129568025|NCT00440557|466376861|FG000|Overall Study|Adverse Event|3|||
129568026|NCT00440557|466376862|FG001|Overall Study|Adverse Event|3|||
129568027|NCT00440557|466376863|FG002|Overall Study|Adverse Event|5|||
129568028|NCT00440557|466376861|FG000|Overall Study|Death|2|||
129568029|NCT00440557|466376862|FG001|Overall Study|Death|6|||
129568030|NCT00440557|466376863|FG002|Overall Study|Death|3|||
129568031|NCT00440557|466376861|FG000|Overall Study|Began Dialysis|4|||
129689770|NCT01471574|466822359|FG003|Treatment Period|Withdrawal by Subject|0|||
129689771|NCT01471574|466822356|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
129689772|NCT01471574|466822357|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
129689773|NCT01471574|466822358|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
129689774|NCT01471574|466822359|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
129689775|NCT01471574|466822356|FG000|Treatment Period|Lost to Follow-up|1|||
129689776|NCT01471574|466822357|FG001|Treatment Period|Lost to Follow-up|2|||
129689777|NCT01471574|466822358|FG002|Treatment Period|Lost to Follow-up|2|||
129689778|NCT01471574|466822359|FG003|Treatment Period|Lost to Follow-up|0|||
129689779|NCT01471574|466822356|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
129689780|NCT01471574|466822357|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
129779868|NCT03801031|467159975|FG000|Overall Study|Withdrawal by Subject|0|||
129779869|NCT03801031|467159976|FG001|Overall Study|Withdrawal by Subject|1|||
129779870|NCT02948088|467159977|FG000|Overall Study|Lost to Follow-up|8|||
129779871|NCT02948088|467159977|FG000|Overall Study|Death|1|||
129568032|NCT00440557|466376862|FG001|Overall Study|Began Dialysis|1|||
129689781|NCT01471574|466822358|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
129689782|NCT01471574|466822359|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
129568033|NCT00440557|466376863|FG002|Overall Study|Began Dialysis|4|||
129568034|NCT00440557|466376861|FG000|Overall Study|Principal Investigator decision|0|||
129568035|NCT00440557|466376862|FG001|Overall Study|Principal Investigator decision|3|||
129568036|NCT00440557|466376863|FG002|Overall Study|Principal Investigator decision|1|||
129568037|NCT00440557|466376861|FG000|Overall Study|Patient moved|1|||
129568038|NCT00440557|466376862|FG001|Overall Study|Patient moved|2|||
129568039|NCT00440557|466376863|FG002|Overall Study|Patient moved|1|||
129568040|NCT00440557|466376861|FG000|Overall Study|Principal Investigator's office closed|3|||
129568041|NCT00440557|466376862|FG001|Overall Study|Principal Investigator's office closed|6|||
129568042|NCT00440557|466376863|FG002|Overall Study|Principal Investigator's office closed|4|||
129568043|NCT00440557|466376861|FG000|Overall Study|Patient transferred to nursing home|0|||
129568044|NCT00440557|466376862|FG001|Overall Study|Patient transferred to nursing home|1|||
129568045|NCT00440557|466376863|FG002|Overall Study|Patient transferred to nursing home|0|||
129568046|NCT00440557|466376861|FG000|Overall Study|Patient had surgery|1|||
129568047|NCT00440557|466376862|FG001|Overall Study|Patient had surgery|0|||
129568048|NCT00440557|466376863|FG002|Overall Study|Patient had surgery|0|||
129568049|NCT00874237|466376868|FG000|Overall Study|Physician Decision|0|||
129568050|NCT00874237|466376869|FG001|Overall Study|Physician Decision|1|||
129568051|NCT00874237|466376870|FG002|Overall Study|Physician Decision|0|||
129568052|NCT00874237|466376871|FG003|Overall Study|Physician Decision|0|||
129568053|NCT00874237|466376872|FG004|Overall Study|Physician Decision|0|||
129568054|NCT00874237|466376873|FG005|Overall Study|Physician Decision|0|||
129568055|NCT00874237|466376868|FG000|Overall Study|Withdrawal by Subject|0|||
129568056|NCT00874237|466376869|FG001|Overall Study|Withdrawal by Subject|0|||
129568057|NCT00874237|466376870|FG002|Overall Study|Withdrawal by Subject|1|||
129568058|NCT00874237|466376871|FG003|Overall Study|Withdrawal by Subject|0|||
129568059|NCT00874237|466376872|FG004|Overall Study|Withdrawal by Subject|0|||
129568060|NCT00874237|466376873|FG005|Overall Study|Withdrawal by Subject|0|||
129568061|NCT03912337|466376874|FG000|Overall Study|Withdrawal of Consent From Study|1|||
129568062|NCT03912337|466376875|FG001|Overall Study|Withdrawal of Consent From Study|0|||
129568063|NCT03912337|466376874|FG000|Overall Study|Lost to Follow-up|1|||
129568064|NCT03912337|466376875|FG001|Overall Study|Lost to Follow-up|1|||
129568065|NCT03752528|466376876|FG000|Part A|Lost to Follow-up|1|||
129568066|NCT03752528|466376876|FG000|Part A|Protocol Violation|1|||
129568067|NCT03752528|466376876|FG000|Part B|Protocol Violation|1|||
129568068|NCT03752528|466376876|FG000|Part B|Study terminated by sponsor|3|||
129568069|NCT00537030|466376877|FG000|Overall Study|Physician Decision|2|||
129568070|NCT00537030|466376877|FG000|Overall Study|Withdrawal by Subject|2|||
129568071|NCT00537030|466376877|FG000|Overall Study|≥ Grade 2 allergy|7|||
129568072|NCT00537030|466376877|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
129568073|NCT00537030|466376877|FG000|Overall Study|Ineligible|2|||
129568074|NCT00537030|466376877|FG000|Overall Study|Inevaluable|2|||
129568075|NCT02458469|466376878|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129568076|NCT02458469|466376879|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129568077|NCT02458469|466376880|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
129568078|NCT02458469|466376881|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129568079|NCT02458469|466376882|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129568080|NCT02458469|466376883|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129568081|NCT02458469|466376878|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
129568082|NCT02458469|466376879|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
129568083|NCT02458469|466376880|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
129568084|NCT02458469|466376881|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
129568085|NCT02458469|466376882|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
129568086|NCT02458469|466376883|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
129568087|NCT02458469|466376878|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129568088|NCT02458469|466376879|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129568089|NCT02458469|466376880|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129568090|NCT02458469|466376881|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129568091|NCT02458469|466376882|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
129568092|NCT02458469|466376883|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
129568093|NCT03561883|466376884|FG000|Overall Study|Adverse Event|10|||
129568094|NCT03561883|466376885|FG001|Overall Study|Adverse Event|13|||
129568095|NCT03561883|466376884|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129568096|NCT03561883|466376885|FG001|Overall Study|Non-Compliance With Study Drug|2|||
129568097|NCT03561883|466376884|FG000|Overall Study|Protocol Violation|2|||
129568098|NCT03561883|466376885|FG001|Overall Study|Protocol Violation|3|||
129568099|NCT03561883|466376884|FG000|Overall Study|Withdrawal by Subject|14|||
129689783|NCT01471574|466822356|FG000|Treatment Period|Other|1|||
129689784|NCT01471574|466822357|FG001|Treatment Period|Other|0|||
129689785|NCT01471574|466822358|FG002|Treatment Period|Other|0|||
129689786|NCT01471574|466822359|FG003|Treatment Period|Other|0|||
129689787|NCT01471574|466822356|FG000|Follow-up Period|Withdrawal by Subject|3|||
129689788|NCT01471574|466822357|FG001|Follow-up Period|Withdrawal by Subject|0|||
129689789|NCT01471574|466822358|FG002|Follow-up Period|Withdrawal by Subject|3|||
129568100|NCT03561883|466376885|FG001|Overall Study|Withdrawal by Subject|6|||
129568101|NCT03561883|466376884|FG000|Overall Study|Lost to Follow-up|2|||
129568102|NCT03561883|466376885|FG001|Overall Study|Lost to Follow-up|6|||
129568103|NCT03561883|466376884|FG000|Overall Study|Study Terminated by Sponsor|12|||
129568104|NCT03561883|466376885|FG001|Overall Study|Study Terminated by Sponsor|11|||
129689790|NCT01471574|466822359|FG003|Follow-up Period|Withdrawal by Subject|1|||
129568105|NCT03561883|466376884|FG000|Overall Study|Physician Decision|1|||
129568106|NCT03561883|466376885|FG001|Overall Study|Physician Decision|0|||
129689791|NCT01471574|466822356|FG000|Follow-up Period|Lost to Follow-up|4|||
129568107|NCT03561883|466376884|FG000|Overall Study|Randomized by Mistake|1|||
129568108|NCT03561883|466376885|FG001|Overall Study|Randomized by Mistake|0|||
129568109|NCT03561883|466376884|FG000|Overall Study|Other, Not Specified|3|||
129568110|NCT03561883|466376885|FG001|Overall Study|Other, Not Specified|2|||
129568111|NCT06354270|466376886|FG000|Overall Study|Withdrawal by Subject|1|||
129568112|NCT06354270|466376887|FG001|Overall Study|Withdrawal by Subject|0|||
129568113|NCT01939197|466376888|FG000|Overall Study|Withdrawal by Subject|1|||
129568114|NCT01939197|466376889|FG001|Overall Study|Withdrawal by Subject|0|||
129568115|NCT01939197|466376890|FG002|Overall Study|Withdrawal by Subject|0|||
129568116|NCT01939197|466376891|FG003|Overall Study|Withdrawal by Subject|0|||
129568117|NCT01939197|466376892|FG004|Overall Study|Withdrawal by Subject|1|||
129568118|NCT01939197|466376893|FG005|Overall Study|Withdrawal by Subject|0|||
129568119|NCT01939197|466376894|FG006|Overall Study|Withdrawal by Subject|0|||
129568120|NCT01939197|466376888|FG000|Overall Study|Lost to Follow-up|0|||
129568121|NCT01939197|466376889|FG001|Overall Study|Lost to Follow-up|1|||
129568122|NCT01939197|466376890|FG002|Overall Study|Lost to Follow-up|0|||
129568123|NCT01939197|466376891|FG003|Overall Study|Lost to Follow-up|1|||
129568124|NCT01939197|466376892|FG004|Overall Study|Lost to Follow-up|3|||
129568125|NCT01939197|466376893|FG005|Overall Study|Lost to Follow-up|1|||
129568126|NCT01939197|466376894|FG006|Overall Study|Lost to Follow-up|2|||
129568127|NCT00745095|466376895|FG000|Overall Study|Declined to participate|1|||
129568128|NCT00745095|466376896|FG001|Overall Study|Declined to participate|0|||
129568129|NCT00745095|466376897|FG002|Overall Study|Declined to participate|0|||
129568130|NCT00745095|466376898|FG003|Overall Study|Declined to participate|0|||
129568131|NCT00745095|466376899|FG004|Overall Study|Declined to participate|92|||
129568132|NCT00745095|466376900|FG005|Overall Study|Declined to participate|95|||
129568133|NCT00745095|466376895|FG000|Overall Study|Ineligible due to GFR criteria|0|||
129568134|NCT00745095|466376896|FG001|Overall Study|Ineligible due to GFR criteria|2|||
129568135|NCT00745095|466376897|FG002|Overall Study|Ineligible due to GFR criteria|3|||
129568136|NCT00745095|466376898|FG003|Overall Study|Ineligible due to GFR criteria|3|||
129568137|NCT00745095|466376899|FG004|Overall Study|Ineligible due to GFR criteria|30|||
129568138|NCT00745095|466376900|FG005|Overall Study|Ineligible due to GFR criteria|28|||
129568139|NCT00958243|466376901|FG000|Overall Study|Withdrawal by Subject|0|||
129568140|NCT00958243|466376902|FG001|Overall Study|Withdrawal by Subject|1|||
129568141|NCT00958243|466376903|FG002|Overall Study|Withdrawal by Subject|3|||
129568142|NCT00958243|466376904|FG003|Overall Study|Withdrawal by Subject|1|||
129568143|NCT00958243|466376905|FG004|Overall Study|Withdrawal by Subject|1|||
129568144|NCT00958243|466376906|FG005|Overall Study|Withdrawal by Subject|5|||
129689792|NCT01471574|466822357|FG001|Follow-up Period|Lost to Follow-up|1|||
129689793|NCT01471574|466822358|FG002|Follow-up Period|Lost to Follow-up|3|||
129689794|NCT01471574|466822359|FG003|Follow-up Period|Lost to Follow-up|2|||
129689795|NCT01471574|466822356|FG000|Follow-up Period|Death|0|||
129689796|NCT01471574|466822357|FG001|Follow-up Period|Death|0|||
129689797|NCT01471574|466822358|FG002|Follow-up Period|Death|1|||
129689798|NCT01471574|466822359|FG003|Follow-up Period|Death|0|||
129689799|NCT01471574|466822356|FG000|Follow-up Period|Follow-up no longer required|0|||
129689800|NCT01471574|466822357|FG001|Follow-up Period|Follow-up no longer required|1|||
129689801|NCT01471574|466822358|FG002|Follow-up Period|Follow-up no longer required|0|||
129689802|NCT01471574|466822359|FG003|Follow-up Period|Follow-up no longer required|0|||
129689803|NCT01795937|466822360|FG000|Overall Study|Withdrawal by Subject|1|||
129689804|NCT01795937|466822361|FG001|Overall Study|Withdrawal by Subject|0|||
129689805|NCT01795937|466822362|FG002|Overall Study|Withdrawal by Subject|0|||
129689806|NCT01795937|466822360|FG000|Overall Study|Physician Decision|0|||
129689807|NCT01795937|466822361|FG001|Overall Study|Physician Decision|1|||
129689808|NCT01795937|466822362|FG002|Overall Study|Physician Decision|0|||
129689809|NCT04027946|466822363|FG000|Overall Study|Screen failures|3|||
129689810|NCT01028053|466822368|FG000|Overall Study|Screen Failure|113|||
129689811|NCT01028053|466822368|FG000|Overall Study|Patient Request|11|||
129689812|NCT01028053|466822368|FG000|Overall Study|Protocol Violation|1|||
129689813|NCT01028053|466822368|FG000|Overall Study|Physician Decision|2|||
129689814|NCT01028053|466822368|FG000|Overall Study|Technical Problem|1|||
129689815|NCT01028053|466822368|FG000|Overall Study|Terminated by Sponsor|1|||
129689816|NCT01028053|466822368|FG000|Overall Study|Various reasons|4|||
129689817|NCT00983957|466822370|FG000|Overall Study|Adverse Event|1|||
129689818|NCT00983957|466822370|FG000|Overall Study|Personal Reasons|1|||
129689819|NCT00986232|466822371|FG000|Overall Study|Adverse Event|1|||
129689820|NCT00986232|466822372|FG001|Overall Study|Adverse Event|2|||
129689821|NCT00986232|466822373|FG002|Overall Study|Adverse Event|3|||
129689822|NCT00986232|466822374|FG003|Overall Study|Adverse Event|0|||
129689823|NCT00986232|466822371|FG000|Overall Study|Lost to Follow-up|19|||
129689824|NCT00986232|466822372|FG001|Overall Study|Lost to Follow-up|12|||
129568145|NCT00958243|466376901|FG000|Overall Study|Lost to Follow-up|2|||
129568146|NCT00958243|466376902|FG001|Overall Study|Lost to Follow-up|5|||
129568147|NCT00958243|466376903|FG002|Overall Study|Lost to Follow-up|11|||
129568148|NCT00958243|466376904|FG003|Overall Study|Lost to Follow-up|2|||
129689825|NCT00986232|466822373|FG002|Overall Study|Lost to Follow-up|12|||
129689826|NCT00986232|466822374|FG003|Overall Study|Lost to Follow-up|7|||
129568149|NCT00958243|466376905|FG004|Overall Study|Lost to Follow-up|8|||
129568150|NCT00958243|466376906|FG005|Overall Study|Lost to Follow-up|5|||
129568151|NCT01974141|466376911|FG000|Overall Study|Other Reasons|28|||
129568152|NCT01974141|466376912|FG001|Overall Study|Other Reasons|18|||
129568153|NCT01974141|466376911|FG000|Overall Study|Protocol Violation|2|||
129568154|NCT01974141|466376912|FG001|Overall Study|Protocol Violation|6|||
129779872|NCT02948088|467159977|FG000|Overall Study|Withdrawal by Subject|4|||
129568155|NCT01974141|466376911|FG000|Overall Study|Personal Reasons|21|||
129568156|NCT01974141|466376912|FG001|Overall Study|Personal Reasons|20|||
129779873|NCT02948088|467159977|FG000|Overall Study|Other|2|||
129779874|NCT01942733|467159978|FG000|Overall Study|Lost to Follow-up|1|||
129779875|NCT01942733|467159978|FG000|Overall Study|Non-compliance with IMP|1|||
129779876|NCT01942733|467159978|FG000|Overall Study|Administrative|1|||
129779877|NCT01409811|467159979|FG000|Overall Study|Insurance denial|1|||
129779878|NCT00634101|467159980|FG000|Overall Study|Study Terminated|3|||
129779879|NCT00634101|467159981|FG001|Overall Study|Study Terminated|3|||
129779880|NCT00634101|467159980|FG000|Overall Study|Lost to Follow-up|2|||
129779881|NCT00634101|467159981|FG001|Overall Study|Lost to Follow-up|0|||
129779882|NCT00139477|467159986|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
129779883|NCT00139477|467159987|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
129779884|NCT00139477|467159986|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
129779885|NCT00139477|467159987|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
129779886|NCT00139477|467159986|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
129779887|NCT00139477|467159987|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
129779888|NCT00139477|467159986|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
129779889|NCT00139477|467159987|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
129779890|NCT00139477|467159986|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
129779891|NCT00139477|467159987|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
129779892|NCT00139477|467159986|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
129779893|NCT00139477|467159987|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
129779894|NCT00139477|467159986|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
129779895|NCT00139477|467159987|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
129779896|NCT00573144|467159989|FG000|Overall Study|Withdrawal by Subject|2|||
129779897|NCT00573144|467159990|FG001|Overall Study|Withdrawal by Subject|3|||
129779898|NCT02625909|467159991|FG000|Overall Study|Death|2|||
129779899|NCT02625909|467159992|FG001|Overall Study|Death|0|||
129779900|NCT02625909|467159991|FG000|Overall Study|Lost to Follow-up|3|||
129779901|NCT02625909|467159992|FG001|Overall Study|Lost to Follow-up|5|||
129779902|NCT02625909|467159991|FG000|Overall Study|Lack of Efficacy|9|||
129779903|NCT02625909|467159992|FG001|Overall Study|Lack of Efficacy|2|||
129779904|NCT02625909|467159991|FG000|Overall Study|Reinfection|3|||
129779905|NCT02625909|467159992|FG001|Overall Study|Reinfection|2|||
129779906|NCT00953056|467159993|FG000|Overall Study|Withdrew Consent|0|||
129779907|NCT00953056|467159994|FG001|Overall Study|Withdrew Consent|0|||
129779908|NCT00953056|467159995|FG002|Overall Study|Withdrew Consent|0|||
129779909|NCT00953056|467159996|FG003|Overall Study|Withdrew Consent|0|||
129779910|NCT00953056|467159997|FG004|Overall Study|Withdrew Consent|2|||
129779911|NCT00953056|467159998|FG005|Overall Study|Withdrew Consent|3|||
129779912|NCT00953056|467159993|FG000|Overall Study|Serious Adverse Event|0|||
129779913|NCT00953056|467159994|FG001|Overall Study|Serious Adverse Event|0|||
129779914|NCT00953056|467159995|FG002|Overall Study|Serious Adverse Event|0|||
129779915|NCT00953056|467159996|FG003|Overall Study|Serious Adverse Event|0|||
129779916|NCT00953056|467159997|FG004|Overall Study|Serious Adverse Event|0|||
129779917|NCT00953056|467159998|FG005|Overall Study|Serious Adverse Event|1|||
129779918|NCT02367833|467159999|FG000|Overall Study|Withdrawal by Subject|1|||
129779919|NCT02367833|467160000|FG001|Overall Study|Withdrawal by Subject|1|||
129779920|NCT02367833|467160001|FG002|Overall Study|Withdrawal by Subject|0|||
129568157|NCT01974141|466376911|FG000|Overall Study|Lost to Follow-up|38|||
129568158|NCT01974141|466376912|FG001|Overall Study|Lost to Follow-up|29|||
129568159|NCT01974141|466376911|FG000|Overall Study|Pregnancy|3|||
129779921|NCT01077076|467160002|FG000|First Intervention|Withdrawal by Subject|1|||
129779922|NCT01077076|467160003|FG001|First Intervention|Withdrawal by Subject|0|||
129779923|NCT01077076|467160004|FG002|First Intervention|Withdrawal by Subject|0|||
129779924|NCT01077076|467160005|FG003|First Intervention|Withdrawal by Subject|0|||
129779925|NCT01077076|467160006|FG004|First Intervention|Withdrawal by Subject|0|||
129779926|NCT01077076|467160007|FG005|First Intervention|Withdrawal by Subject|0|||
129779927|NCT01077076|467160002|FG000|Third Intervention|Death in the participant's family|0|||
129779928|NCT01077076|467160003|FG001|Third Intervention|Death in the participant's family|0|||
129779929|NCT01077076|467160004|FG002|Third Intervention|Death in the participant's family|0|||
129779930|NCT01077076|467160005|FG003|Third Intervention|Death in the participant's family|0|||
129779931|NCT01077076|467160006|FG004|Third Intervention|Death in the participant's family|0|||
129568160|NCT01974141|466376912|FG001|Overall Study|Pregnancy|3|||
129568161|NCT01974141|466376911|FG000|Overall Study|Lack of Efficacy|0|||
129568162|NCT01974141|466376912|FG001|Overall Study|Lack of Efficacy|1|||
129568163|NCT01974141|466376911|FG000|Overall Study|Adverse Event|4|||
129568164|NCT01974141|466376912|FG001|Overall Study|Adverse Event|5|||
129568165|NCT00950872|466376916|FG000|Overall Study|Withdrawal by Subject|1|||
129568166|NCT00950872|466376916|FG000|Overall Study|Did not have surgery|2|||
129568167|NCT01139164|466376918|FG000|Overall Study|Withdrawn prior to study start|0|||
129568168|NCT01139164|466376919|FG001|Overall Study|Withdrawn prior to study start|2|||
129568169|NCT01139164|466376920|FG002|Overall Study|Withdrawn prior to study start|0|||
129568170|NCT00406848|466376925|FG000|Overall Study|Withdrawal by Subject|27|||
129568171|NCT00406848|466376926|FG001|Overall Study|Withdrawal by Subject|22|||
129568172|NCT00406848|466376925|FG000|Overall Study|Adverse Event|38|||
129568173|NCT00406848|466376926|FG001|Overall Study|Adverse Event|7|||
129568174|NCT00406848|466376925|FG000|Overall Study|Lack of Efficacy|9|||
129568175|NCT00406848|466376926|FG001|Overall Study|Lack of Efficacy|14|||
129689827|NCT00986232|466822371|FG000|Overall Study|Protocol Violation|2|||
129689828|NCT00986232|466822372|FG001|Overall Study|Protocol Violation|3|||
129689829|NCT00986232|466822373|FG002|Overall Study|Protocol Violation|0|||
129689830|NCT00986232|466822374|FG003|Overall Study|Protocol Violation|1|||
129689831|NCT00986232|466822371|FG000|Overall Study|Withdrawal by Subject|13|||
129689832|NCT00986232|466822372|FG001|Overall Study|Withdrawal by Subject|16|||
129689833|NCT00986232|466822373|FG002|Overall Study|Withdrawal by Subject|12|||
129568176|NCT00406848|466376925|FG000|Overall Study|Protocol Violation|10|||
129568177|NCT00406848|466376926|FG001|Overall Study|Protocol Violation|6|||
129568178|NCT00406848|466376925|FG000|Overall Study|Lost to Follow-up|6|||
129568179|NCT00406848|466376926|FG001|Overall Study|Lost to Follow-up|2|||
129568180|NCT00406848|466376925|FG000|Overall Study|Physician Decision|2|||
129568181|NCT00406848|466376926|FG001|Overall Study|Physician Decision|2|||
129568182|NCT00406848|466376925|FG000|Overall Study|Sponsor Decision|1|||
129568183|NCT00406848|466376926|FG001|Overall Study|Sponsor Decision|1|||
129568184|NCT05277389|466376930|FG000|Overall Study|Lost to Follow-up|1|||
129689834|NCT00986232|466822374|FG003|Overall Study|Withdrawal by Subject|3|||
129689835|NCT00986232|466822371|FG000|Overall Study|Missed one or more bleeds|13|||
129689836|NCT00986232|466822372|FG001|Overall Study|Missed one or more bleeds|10|||
129689837|NCT00986232|466822373|FG002|Overall Study|Missed one or more bleeds|6|||
129689838|NCT00986232|466822374|FG003|Overall Study|Missed one or more bleeds|7|||
129689839|NCT00986232|466822371|FG000|Overall Study|Incomplete safety follow-up|3|||
129689840|NCT00986232|466822372|FG001|Overall Study|Incomplete safety follow-up|7|||
129689841|NCT00986232|466822373|FG002|Overall Study|Incomplete safety follow-up|2|||
129689842|NCT00986232|466822374|FG003|Overall Study|Incomplete safety follow-up|2|||
129689843|NCT00790933|466822375|FG000|Overall Study|Adverse Event|94|||
129689844|NCT00790933|466822376|FG001|Overall Study|Adverse Event|119|||
129689845|NCT00790933|466822377|FG002|Overall Study|Adverse Event|65|||
129689846|NCT00790933|466822378|FG003|Overall Study|Adverse Event|5|||
129689847|NCT00790933|466822379|FG004|Overall Study|Adverse Event|69|||
129689848|NCT00790933|466822375|FG000|Overall Study|Protocol Violation(s)|8|||
129689849|NCT00790933|466822376|FG001|Overall Study|Protocol Violation(s)|18|||
129689850|NCT00790933|466822377|FG002|Overall Study|Protocol Violation(s)|7|||
129689851|NCT00790933|466822378|FG003|Overall Study|Protocol Violation(s)|0|||
129689852|NCT00790933|466822379|FG004|Overall Study|Protocol Violation(s)|12|||
129689853|NCT00790933|466822375|FG000|Overall Study|Lack of Efficacy|192|||
129689854|NCT00790933|466822376|FG001|Overall Study|Lack of Efficacy|176|||
129689855|NCT00790933|466822377|FG002|Overall Study|Lack of Efficacy|130|||
129689856|NCT00790933|466822378|FG003|Overall Study|Lack of Efficacy|1|||
129689857|NCT00790933|466822379|FG004|Overall Study|Lack of Efficacy|121|||
129689858|NCT00790933|466822375|FG000|Overall Study|Study Terminated by Sponsor|0|||
129689859|NCT00790933|466822376|FG001|Overall Study|Study Terminated by Sponsor|0|||
129689860|NCT00790933|466822377|FG002|Overall Study|Study Terminated by Sponsor|1|||
129779932|NCT01077076|467160007|FG005|Third Intervention|Death in the participant's family|1|||
129779933|NCT00035932|467160008|FG000|Overall Study|Adverse Event|10|||
129779934|NCT00035932|467160009|FG001|Overall Study|Adverse Event|9|||
129779935|NCT00035932|467160010|FG002|Overall Study|Adverse Event|9|||
129779936|NCT00035932|467160008|FG000|Overall Study|Death|0|||
129779937|NCT00035932|467160009|FG001|Overall Study|Death|0|||
129779938|NCT00035932|467160010|FG002|Overall Study|Death|1|||
129568185|NCT05277389|466376931|FG001|Overall Study|Lost to Follow-up|4|||
129689861|NCT00790933|466822378|FG003|Overall Study|Study Terminated by Sponsor|0|||
129689862|NCT00790933|466822379|FG004|Overall Study|Study Terminated by Sponsor|0|||
129689863|NCT00790933|466822375|FG000|Overall Study|Withdrawal by Subject|123|||
129689864|NCT00790933|466822376|FG001|Overall Study|Withdrawal by Subject|120|||
129689865|NCT00790933|466822377|FG002|Overall Study|Withdrawal by Subject|52|||
129779939|NCT00035932|467160008|FG000|Overall Study|Disease Progression / Relapse|1|||
129779940|NCT00035932|467160009|FG001|Overall Study|Disease Progression / Relapse|1|||
129568186|NCT03544138|466376934|FG000|Overall Study|Lost to Follow-up|29|||
129568187|NCT01766778|466376935|FG000|Overall Study|Adverse Event|4|||
129568188|NCT01766778|466376936|FG001|Overall Study|Adverse Event|4|||
129568189|NCT01766778|466376935|FG000|Overall Study|Withdrawal by Subject|1|||
129689866|NCT00790933|466822378|FG003|Overall Study|Withdrawal by Subject|6|||
129689867|NCT00790933|466822379|FG004|Overall Study|Withdrawal by Subject|50|||
129689868|NCT00790933|466822375|FG000|Overall Study|Lost to Follow-up|13|||
129689869|NCT00790933|466822376|FG001|Overall Study|Lost to Follow-up|31|||
129568190|NCT01766778|466376936|FG001|Overall Study|Withdrawal by Subject|0|||
129647250|NCT05238025|466663849|FG000|Overall Study|Withdrawal by Subject|203|||
129647251|NCT05238025|466663850|FG001|Overall Study|Withdrawal by Subject|222|||
129647252|NCT05238025|466663849|FG000|Overall Study|Physician Decision|20|||
129647253|NCT05238025|466663850|FG001|Overall Study|Physician Decision|8|||
129647254|NCT05238025|466663849|FG000|Overall Study|Protocol Violation|6|||
129647255|NCT05238025|466663850|FG001|Overall Study|Protocol Violation|2|||
129647256|NCT05238025|466663849|FG000|Overall Study|Death|38|||
129647257|NCT05238025|466663850|FG001|Overall Study|Death|32|||
129647258|NCT05238025|466663849|FG000|Overall Study|Study terminated by Sponsor|6358|||
129647259|NCT05238025|466663850|FG001|Overall Study|Study terminated by Sponsor|6358|||
129647260|NCT05238025|466663849|FG000|Overall Study|Other Reason|669|||
129647261|NCT05238025|466663850|FG001|Overall Study|Other Reason|690|||
129647262|NCT01263782|466663852|FG000|Overall Study|Death|0|||
129647263|NCT01263782|466663853|FG001|Overall Study|Death|0|||
129647264|NCT01263782|466663854|FG002|Overall Study|Death|1|||
129647265|NCT01263782|466663855|FG003|Overall Study|Death|0|||
129647266|NCT01263782|466663852|FG000|Overall Study|Progressive disease|0|||
129647267|NCT01263782|466663853|FG001|Overall Study|Progressive disease|0|||
129647268|NCT01263782|466663854|FG002|Overall Study|Progressive disease|0|||
129647269|NCT01263782|466663855|FG003|Overall Study|Progressive disease|1|||
129647270|NCT01263782|466663852|FG000|Overall Study|Too early|0|||
129647271|NCT01263782|466663853|FG001|Overall Study|Too early|0|||
129647272|NCT01263782|466663854|FG002|Overall Study|Too early|1|||
129647273|NCT01263782|466663855|FG003|Overall Study|Too early|0|||
129647274|NCT01263782|466663852|FG000|Overall Study|Inevaluable|0|||
129647275|NCT01263782|466663853|FG001|Overall Study|Inevaluable|0|||
129647276|NCT01263782|466663854|FG002|Overall Study|Inevaluable|1|||
129647277|NCT01263782|466663855|FG003|Overall Study|Inevaluable|0|||
129647278|NCT04545567|466663856|FG000|Overall Study|tested positive for SARS-co-V2|1|||
129647279|NCT04545567|466663857|FG001|Overall Study|tested positive for SARS-co-V2|1|||
129647280|NCT04545567|466663856|FG000|Overall Study|Withdrawal by Subject|0|||
129647281|NCT04545567|466663857|FG001|Overall Study|Withdrawal by Subject|1|||
129647282|NCT03814720|466663860|FG000|Overall Study|Lost to Follow-up|0|||
129647283|NCT03814720|466663861|FG001|Overall Study|Lost to Follow-up|1|||
129647284|NCT03814720|466663862|FG002|Overall Study|Lost to Follow-up|0|||
129647285|NCT03814720|466663863|FG003|Overall Study|Lost to Follow-up|0|||
129647286|NCT03814720|466663864|FG004|Overall Study|Lost to Follow-up|0|||
129647287|NCT02135107|466663865|FG000|Treatment Period|Withdrawal by Subject|11|||
129647288|NCT02135107|466663866|FG001|Treatment Period|Withdrawal by Subject|0|||
129647289|NCT02135107|466663867|FG002|Treatment Period|Withdrawal by Subject|0|||
129647290|NCT02135107|466663868|FG003|Treatment Period|Withdrawal by Subject|0|||
129647291|NCT02135107|466663865|FG000|Treatment Period|Adverse Event|5|||
129647292|NCT02135107|466663866|FG001|Treatment Period|Adverse Event|2|||
129647293|NCT02135107|466663867|FG002|Treatment Period|Adverse Event|0|||
129647294|NCT02135107|466663868|FG003|Treatment Period|Adverse Event|0|||
129647295|NCT02135107|466663865|FG000|Treatment Period|Pregnancy|1|||
129647296|NCT02135107|466663866|FG001|Treatment Period|Pregnancy|0|||
129647297|NCT02135107|466663867|FG002|Treatment Period|Pregnancy|0|||
129647298|NCT02135107|466663868|FG003|Treatment Period|Pregnancy|0|||
129647299|NCT02135107|466663865|FG000|Treatment Period|Other|115|||
129647300|NCT02135107|466663866|FG001|Treatment Period|Other|24|||
129647301|NCT02135107|466663867|FG002|Treatment Period|Other|0|||
129647302|NCT02135107|466663868|FG003|Treatment Period|Other|0|||
129689870|NCT00790933|466822377|FG002|Overall Study|Lost to Follow-up|10|||
129689871|NCT00790933|466822378|FG003|Overall Study|Lost to Follow-up|1|||
129689872|NCT00790933|466822379|FG004|Overall Study|Lost to Follow-up|15|||
129689873|NCT00790933|466822375|FG000|Overall Study|Reason Not Specified|8|||
129689874|NCT00790933|466822376|FG001|Overall Study|Reason Not Specified|16|||
129689875|NCT00790933|466822377|FG002|Overall Study|Reason Not Specified|4|||
129647303|NCT02135107|466663865|FG000|Maintenance Therapy Period|Adverse Event|0|||
129647304|NCT02135107|466663866|FG001|Maintenance Therapy Period|Adverse Event|0|||
129647305|NCT02135107|466663867|FG002|Maintenance Therapy Period|Adverse Event|3|||
129647306|NCT02135107|466663868|FG003|Maintenance Therapy Period|Adverse Event|7|||
129647307|NCT02135107|466663865|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
129647308|NCT02135107|466663866|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
129647309|NCT02135107|466663867|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
129647310|NCT02135107|466663868|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
129647311|NCT02135107|466663865|FG000|Maintenance Therapy Period|Pregnancy|0|||
129647312|NCT02135107|466663866|FG001|Maintenance Therapy Period|Pregnancy|0|||
129647313|NCT02135107|466663867|FG002|Maintenance Therapy Period|Pregnancy|0|||
129647314|NCT02135107|466663868|FG003|Maintenance Therapy Period|Pregnancy|1|||
129568191|NCT03805438|466378044|FG000|Overall Study|Lack of Efficacy|1|||
129568192|NCT03805438|466378044|FG000|Overall Study|Protocol Violation|1|||
129568193|NCT00366899|466378045|FG000|Infant Series|Withdrawal by Subject|4|||
129568194|NCT00366899|466378046|FG001|Infant Series|Withdrawal by Subject|7|||
129568195|NCT00366899|466378045|FG000|Infant Series|Protocol Violation|2|||
129568196|NCT00366899|466378046|FG001|Infant Series|Protocol Violation|1|||
129568197|NCT00366899|466378045|FG000|Infant Series|Failed to return|1|||
129568198|NCT00366899|466378046|FG001|Infant Series|Failed to return|1|||
129568199|NCT00366899|466378045|FG000|Infant Series|Lost to Follow-up|0|||
129568200|NCT00366899|466378046|FG001|Infant Series|Lost to Follow-up|2|||
129568201|NCT00366899|466378045|FG000|Infant Series|Adverse Event|0|||
129568202|NCT00366899|466378046|FG001|Infant Series|Adverse Event|1|||
129568203|NCT00366899|466378045|FG000|Infant Series|Physician Decision|1|||
129568204|NCT00366899|466378046|FG001|Infant Series|Physician Decision|0|||
129568205|NCT00366899|466378045|FG000|Infant Series|Randomized but not consented|1|||
129568206|NCT00366899|466378046|FG001|Infant Series|Randomized but not consented|0|||
129568207|NCT00366899|466378045|FG000|After Infant Series|Lost to Follow-up|4|||
129568208|NCT00366899|466378046|FG001|After Infant Series|Lost to Follow-up|3|||
129568209|NCT00366899|466378045|FG000|After Infant Series|Withdrawal by Subject|1|||
129568210|NCT00366899|466378046|FG001|After Infant Series|Withdrawal by Subject|4|||
129568211|NCT00366899|466378045|FG000|After Infant Series|Adverse Event|1|||
129568212|NCT00366899|466378046|FG001|After Infant Series|Adverse Event|2|||
129779941|NCT00035932|467160010|FG002|Overall Study|Disease Progression / Relapse|0|||
129779942|NCT00035932|467160008|FG000|Overall Study|Lost to Follow-up|4|||
129779943|NCT00035932|467160009|FG001|Overall Study|Lost to Follow-up|4|||
129779944|NCT00035932|467160010|FG002|Overall Study|Lost to Follow-up|3|||
129779945|NCT00035932|467160008|FG000|Overall Study|Noncompliance|6|||
129779946|NCT00035932|467160009|FG001|Overall Study|Noncompliance|7|||
129779947|NCT00035932|467160010|FG002|Overall Study|Noncompliance|6|||
129779948|NCT00035932|467160008|FG000|Overall Study|Protocol Violation While on Study|0|||
129779949|NCT00035932|467160009|FG001|Overall Study|Protocol Violation While on Study|1|||
129779950|NCT00035932|467160010|FG002|Overall Study|Protocol Violation While on Study|2|||
129779951|NCT00035932|467160008|FG000|Overall Study|Withdrawal by Subject|1|||
129779952|NCT00035932|467160009|FG001|Overall Study|Withdrawal by Subject|5|||
129779953|NCT00035932|467160010|FG002|Overall Study|Withdrawal by Subject|0|||
129779954|NCT00035932|467160008|FG000|Overall Study|Study Termination by Sponsor|1|||
129779955|NCT00035932|467160009|FG001|Overall Study|Study Termination by Sponsor|0|||
129779956|NCT00035932|467160010|FG002|Overall Study|Study Termination by Sponsor|0|||
129779957|NCT00035932|467160008|FG000|Overall Study|Lack of Efficacy|33|||
129779958|NCT00035932|467160009|FG001|Overall Study|Lack of Efficacy|33|||
129779959|NCT00035932|467160010|FG002|Overall Study|Lack of Efficacy|28|||
129779960|NCT01388335|467160011|FG000|Period 1|Progressive Disease|1|||
129779961|NCT01388335|467160011|FG000|Period 2|Progressive Disease|2|||
129779962|NCT01388335|467160011|FG000|Period 2|Sponsor Decision|1|||
129779963|NCT01388335|467160011|FG000|Safety Extension|Progressive Disease|7|||
129779964|NCT00670306|467160014|FG000|Overall Study|Adverse Event|8|||
129779965|NCT00670306|467160014|FG000|Overall Study|Lack of Efficacy|10|||
129779966|NCT00670306|467160014|FG000|Overall Study|Withdrawal by Subject|9|||
129779967|NCT00670306|467160014|FG000|Overall Study|Physician Decision|1|||
129779968|NCT00670306|467160014|FG000|Overall Study|Lost to Follow-up|8|||
129779969|NCT00670306|467160014|FG000|Overall Study|incl/excl criterias did not meet|19|||
129779970|NCT04413617|467160015|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
129779971|NCT04413617|467160016|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
129779972|NCT04413617|467160017|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
129779973|NCT04413617|467160018|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
129779974|NCT04413617|467160019|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
129779975|NCT04413617|467160015|FG000|Overall Study|Protocol Violation|0|||
129779976|NCT04413617|467160016|FG001|Overall Study|Protocol Violation|1|||
129779977|NCT04413617|467160017|FG002|Overall Study|Protocol Violation|0|||
129568213|NCT00366899|466378045|FG000|After Infant Series|Protocol Violation|1|||
129568214|NCT00366899|466378046|FG001|After Infant Series|Protocol Violation|0|||
129779978|NCT04413617|467160018|FG003|Overall Study|Protocol Violation|0|||
129568215|NCT00366899|466378045|FG000|Toddler Dose|Withdrawal by Subject|1|||
129779979|NCT04413617|467160019|FG004|Overall Study|Protocol Violation|1|||
129568216|NCT00366899|466378046|FG001|Toddler Dose|Withdrawal by Subject|1|||
129568217|NCT00366899|466378045|FG000|Toddler Dose|Protocol Violation|1|||
129568218|NCT00366899|466378046|FG001|Toddler Dose|Protocol Violation|0|||
129568219|NCT01619800|466378047|FG000|Overall Study|study terminated|2|||
129568220|NCT01619800|466378048|FG001|Overall Study|study terminated|0|||
129568221|NCT00419770|466378050|FG000|Overall Study|Withdrawal by Subject|5|||
129779980|NCT04413617|467160015|FG000|Overall Study|Lack of Efficacy|2|||
129779981|NCT04413617|467160016|FG001|Overall Study|Lack of Efficacy|0|||
129779982|NCT04413617|467160017|FG002|Overall Study|Lack of Efficacy|2|||
129779983|NCT04413617|467160018|FG003|Overall Study|Lack of Efficacy|1|||
129689876|NCT00790933|466822378|FG003|Overall Study|Reason Not Specified|1|||
129689877|NCT00790933|466822379|FG004|Overall Study|Reason Not Specified|9|||
129689878|NCT00245570|466822382|FG000|Washout Between Periods III and IV|Adverse Event|0|||
129568222|NCT00419770|466378051|FG001|Overall Study|Withdrawal by Subject|1|||
129568223|NCT00414466|466378057|FG000|Overall Study|Adverse Event|0|||
129568224|NCT00414466|466378058|FG001|Overall Study|Adverse Event|0|||
129568225|NCT00414466|466378059|FG002|Overall Study|Adverse Event|1|||
129568226|NCT00414466|466378060|FG003|Overall Study|Adverse Event|1|||
129779984|NCT04413617|467160019|FG004|Overall Study|Lack of Efficacy|0|||
129779985|NCT04413617|467160015|FG000|Overall Study|Withdrawal by Subject|3|||
129779986|NCT04413617|467160016|FG001|Overall Study|Withdrawal by Subject|4|||
129779987|NCT04413617|467160017|FG002|Overall Study|Withdrawal by Subject|2|||
129779988|NCT04413617|467160018|FG003|Overall Study|Withdrawal by Subject|5|||
129779989|NCT04413617|467160019|FG004|Overall Study|Withdrawal by Subject|3|||
129779990|NCT04413617|467160015|FG000|Overall Study|Death|1|||
129779991|NCT04413617|467160016|FG001|Overall Study|Death|0|||
129779992|NCT04413617|467160017|FG002|Overall Study|Death|0|||
129779993|NCT04413617|467160018|FG003|Overall Study|Death|0|||
129779994|NCT04413617|467160019|FG004|Overall Study|Death|0|||
129779995|NCT04413617|467160015|FG000|Overall Study|Adverse Event|1|||
129779996|NCT04413617|467160016|FG001|Overall Study|Adverse Event|0|||
129779997|NCT04413617|467160017|FG002|Overall Study|Adverse Event|0|||
129779998|NCT04413617|467160018|FG003|Overall Study|Adverse Event|1|||
129779999|NCT04413617|467160019|FG004|Overall Study|Adverse Event|1|||
129780000|NCT04413617|467160015|FG000|Overall Study|COVID-19|0|||
129780001|NCT04413617|467160016|FG001|Overall Study|COVID-19|1|||
129780002|NCT04413617|467160017|FG002|Overall Study|COVID-19|0|||
129780003|NCT04413617|467160018|FG003|Overall Study|COVID-19|0|||
129780004|NCT04413617|467160019|FG004|Overall Study|COVID-19|0|||
129780005|NCT01327482|467160020|FG000|Overall Study|Adverse Event|1|||
129780006|NCT00476229|467160021|FG000|Overall Study|Progressive shortness of breath|1|||
129780007|NCT02164461|467160022|FG000|Overall Study|Adverse Event|0|||
129780008|NCT02164461|467160023|FG001|Overall Study|Adverse Event|0|||
129780009|NCT02164461|467160024|FG002|Overall Study|Adverse Event|1|||
129780010|NCT02164461|467160022|FG000|Overall Study|Disease Progression|1|||
129780011|NCT02164461|467160023|FG001|Overall Study|Disease Progression|3|||
129780012|NCT02164461|467160024|FG002|Overall Study|Disease Progression|4|||
129780013|NCT02164461|467160022|FG000|Overall Study|Withdrawal by Subject|0|||
129780014|NCT02164461|467160023|FG001|Overall Study|Withdrawal by Subject|3|||
129780015|NCT02164461|467160024|FG002|Overall Study|Withdrawal by Subject|0|||
129780016|NCT01192191|467160026|FG000|Overall Study|Adverse Event|7|||
129780017|NCT01192191|467160027|FG001|Overall Study|Adverse Event|12|||
129780018|NCT01192191|467160026|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
129780019|NCT01192191|467160027|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
129780020|NCT01192191|467160026|FG000|Overall Study|Lost to Follow-up|0|||
129780021|NCT01192191|467160027|FG001|Overall Study|Lost to Follow-up|1|||
129780022|NCT01192191|467160026|FG000|Overall Study|Withdrawal by Subject|1|||
129780023|NCT01192191|467160027|FG001|Overall Study|Withdrawal by Subject|6|||
129780024|NCT01583296|467160030|FG000|Overall Study|Withdrawal by Subject|11|||
129780025|NCT01583296|467160031|FG001|Overall Study|Withdrawal by Subject|10|||
129780026|NCT01047553|467160032|FG000|Overall Study|Adverse Event|10|||
129780027|NCT01047553|467160033|FG001|Overall Study|Adverse Event|5|||
129780028|NCT01047553|467160032|FG000|Overall Study|Withdrawal by Subject|4|||
129780029|NCT01047553|467160033|FG001|Overall Study|Withdrawal by Subject|2|||
129780030|NCT01047553|467160032|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
129780031|NCT01047553|467160033|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
129780032|NCT01047553|467160032|FG000|Overall Study|Lost to Follow-up|1|||
129780033|NCT01047553|467160033|FG001|Overall Study|Lost to Follow-up|0|||
129780034|NCT01047553|467160032|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
129780035|NCT01047553|467160033|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
129780036|NCT01047553|467160032|FG000|Overall Study|PI's decision|0|||
129780037|NCT01047553|467160033|FG001|Overall Study|PI's decision|1|||
129780038|NCT01063283|467160034|FG000|Cycle 1|Adverse Event|2|||
129780039|NCT01063283|467160035|FG001|Cycle 1|Adverse Event|0|||
129780040|NCT01063283|467160036|FG002|Cycle 1|Adverse Event|0|||
129780041|NCT01063283|467160034|FG000|Cycle 1|Technical failure in data collection|1|||
129780042|NCT01063283|467160035|FG001|Cycle 1|Technical failure in data collection|0|||
129780043|NCT01063283|467160036|FG002|Cycle 1|Technical failure in data collection|0|||
129780044|NCT03179319|467160037|FG000|Overall Study|Lost to Follow-up|6|||
129780045|NCT03179319|467160038|FG001|Overall Study|Lost to Follow-up|0|||
129780046|NCT01120717|467160039|FG000|Overall Study|Withdrawal by Subject|11|||
129780047|NCT01120717|467160040|FG001|Overall Study|Withdrawal by Subject|6|||
129884555|NCT02696902|467536453|FG000|Overall Study|Lost to Follow-up|0|||
129568227|NCT00414466|466378057|FG000|Overall Study|Lack of Efficacy|1|||
129568228|NCT00414466|466378058|FG001|Overall Study|Lack of Efficacy|0|||
129884556|NCT02696902|467536454|FG001|Overall Study|Lost to Follow-up|1|||
129568229|NCT00414466|466378059|FG002|Overall Study|Lack of Efficacy|0|||
129568230|NCT00414466|466378060|FG003|Overall Study|Lack of Efficacy|0|||
129568231|NCT00414466|466378057|FG000|Overall Study|Withdrawn by Sponsor|1|||
129568232|NCT00414466|466378058|FG001|Overall Study|Withdrawn by Sponsor|0|||
129568233|NCT00414466|466378059|FG002|Overall Study|Withdrawn by Sponsor|0|||
129780048|NCT01120717|467160039|FG000|Overall Study|Adverse Event|10|||
129568234|NCT00414466|466378060|FG003|Overall Study|Withdrawn by Sponsor|0|||
129568235|NCT04526210|466378061|FG000|Overall Study|Sponsor decision|7|||
129689879|NCT00245570|466822383|FG001|Washout Between Periods III and IV|Adverse Event|1|||
129689880|NCT00245570|466822384|FG002|Washout Between Periods III and IV|Adverse Event|0|||
129689881|NCT00245570|466822385|FG003|Washout Between Periods III and IV|Adverse Event|0|||
129689882|NCT00245570|466822386|FG004|Washout Between Periods III and IV|Adverse Event|0|||
129689883|NCT00245570|466822387|FG005|Washout Between Periods III and IV|Adverse Event|0|||
129780049|NCT01120717|467160040|FG001|Overall Study|Adverse Event|6|||
129780050|NCT01120717|467160039|FG000|Overall Study|Protocol Deviation|2|||
129780051|NCT01120717|467160040|FG001|Overall Study|Protocol Deviation|5|||
129780052|NCT01120717|467160039|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129780053|NCT01120717|467160040|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129780054|NCT01120717|467160039|FG000|Overall Study|Lost to Follow-up|2|||
129780055|NCT01120717|467160040|FG001|Overall Study|Lost to Follow-up|3|||
129780056|NCT01120717|467160039|FG000|Overall Study|Death|3|||
129780057|NCT01120717|467160040|FG001|Overall Study|Death|1|||
129780058|NCT01120717|467160039|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129780059|NCT01120717|467160040|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129780060|NCT00472030|467160050|FG000|Overall Study|Physician Decision|1|||
129780061|NCT00472030|467160051|FG001|Overall Study|Physician Decision|0|||
129780062|NCT02923921|467162214|FG000|Overall Study|Sponsor Decision|39|||
129780063|NCT02923921|467162215|FG001|Overall Study|Sponsor Decision|38|||
129780064|NCT02923921|467162214|FG000|Overall Study|Lost to Follow-up|1|||
129780065|NCT02923921|467162215|FG001|Overall Study|Lost to Follow-up|0|||
129780066|NCT02923921|467162214|FG000|Overall Study|Withdrawal by Subject|6|||
129780067|NCT02923921|467162215|FG001|Overall Study|Withdrawal by Subject|13|||
129780068|NCT02923921|467162214|FG000|Overall Study|Unknown, Not Collected|7|||
129780069|NCT02923921|467162215|FG001|Overall Study|Unknown, Not Collected|6|||
129780070|NCT00479687|467162216|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
129780071|NCT00479687|467162217|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
129780072|NCT00479687|467162218|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
129568236|NCT04526210|466378062|FG001|Overall Study|Sponsor decision|5|||
129568237|NCT04526210|466378061|FG000|Overall Study|Withdrawal by Subject|3|||
129568238|NCT04526210|466378062|FG001|Overall Study|Withdrawal by Subject|2|||
129568239|NCT00416520|466378064|FG000|Open-label Period|Adverse Event|28|||
129568240|NCT00416520|466378065|FG001|Open-label Period|Adverse Event|10|||
129568241|NCT00416520|466378066|FG002|Open-label Period|Adverse Event|0|||
129568242|NCT00416520|466378067|FG003|Open-label Period|Adverse Event|0|||
129568243|NCT00416520|466378064|FG000|Open-label Period|Death|2|||
129568244|NCT00416520|466378065|FG001|Open-label Period|Death|1|||
129568245|NCT00416520|466378066|FG002|Open-label Period|Death|0|||
129568246|NCT00416520|466378067|FG003|Open-label Period|Death|0|||
129568247|NCT00416520|466378064|FG000|Open-label Period|Lack of Efficacy|8|||
129568248|NCT00416520|466378065|FG001|Open-label Period|Lack of Efficacy|1|||
129568249|NCT00416520|466378066|FG002|Open-label Period|Lack of Efficacy|0|||
129568250|NCT00416520|466378067|FG003|Open-label Period|Lack of Efficacy|0|||
129689884|NCT01829165|466822388|FG000|Overall Study|Did not complete intervention|2|||
129689885|NCT01829165|466822389|FG001|Overall Study|Did not complete intervention|0|||
129689886|NCT04233580|466822410|FG000|Overall Study|Adverse Event|3|||
129689887|NCT04233580|466822411|FG001|Overall Study|Adverse Event|3|||
129689888|NCT04233580|466822410|FG000|Overall Study|Withdrawal by Subject|2|||
129689889|NCT04233580|466822411|FG001|Overall Study|Withdrawal by Subject|1|||
129689890|NCT03954938|466822412|FG000|Overall Study|Withdrawal by Subject|2|||
129689891|NCT03954938|466822412|FG000|Overall Study|Adverse Event|1|||
129689892|NCT02421510|466822413|FG000|Overall Study|Other|4|||
129689893|NCT02421510|466822414|FG001|Overall Study|Other|2|||
129689894|NCT02421510|466822415|FG002|Overall Study|Other|3|||
129689895|NCT02421510|466822413|FG000|Overall Study|Protocol Violation|1|||
129689896|NCT02421510|466822414|FG001|Overall Study|Protocol Violation|2|||
129689897|NCT02421510|466822415|FG002|Overall Study|Protocol Violation|0|||
129689898|NCT02421510|466822413|FG000|Overall Study|Death|1|||
129689899|NCT02421510|466822414|FG001|Overall Study|Death|0|||
129689900|NCT02421510|466822415|FG002|Overall Study|Death|0|||
129689901|NCT02421510|466822413|FG000|Overall Study|Noncompliance with study drug|1|||
129780073|NCT00479687|467162216|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
129780074|NCT00479687|467162217|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
129780075|NCT00479687|467162218|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
129780076|NCT00479687|467162216|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
129780077|NCT00479687|467162217|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
129568251|NCT00416520|466378064|FG000|Open-label Period|Protocol Violation|3|||
129568252|NCT00416520|466378065|FG001|Open-label Period|Protocol Violation|3|||
129568253|NCT00416520|466378066|FG002|Open-label Period|Protocol Violation|0|||
129568254|NCT00416520|466378067|FG003|Open-label Period|Protocol Violation|0|||
129689902|NCT02421510|466822414|FG001|Overall Study|Noncompliance with study drug|0|||
129689903|NCT02421510|466822415|FG002|Overall Study|Noncompliance with study drug|0|||
129689904|NCT02421510|466822413|FG000|Overall Study|Physician Decision|1|||
129689905|NCT02421510|466822414|FG001|Overall Study|Physician Decision|1|||
129780078|NCT00479687|467162218|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
129780079|NCT00479687|467162216|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
129780080|NCT00479687|467162217|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
129780081|NCT00479687|467162218|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
129780082|NCT00479687|467162216|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
129780083|NCT00479687|467162217|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
129780084|NCT00479687|467162218|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
129780085|NCT00479687|467162216|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
129780086|NCT00479687|467162217|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
129780087|NCT00479687|467162218|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
129780088|NCT00479687|467162216|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
129780089|NCT00479687|467162217|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
129780090|NCT00479687|467162218|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
129780091|NCT00479687|467162216|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
129780092|NCT00479687|467162217|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
129780093|NCT00479687|467162218|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
129780094|NCT00479687|467162216|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
129780095|NCT00479687|467162217|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
129780096|NCT00479687|467162218|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
129780097|NCT00295880|467162219|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
129780098|NCT00295880|467162219|FG000|Overall Study|Unit randomization did not occur|1|||
129780099|NCT01474239|467162220|FG000|Overall Study|Disease Progression|37|||
129780100|NCT01474239|467162221|FG001|Overall Study|Disease Progression|25|||
129780101|NCT01474239|467162220|FG000|Overall Study|Adverse Event|12|||
129780102|NCT01474239|467162221|FG001|Overall Study|Adverse Event|3|||
129780103|NCT01474239|467162220|FG000|Overall Study|Withdrawal by Subject|1|||
129780104|NCT01474239|467162221|FG001|Overall Study|Withdrawal by Subject|2|||
129780105|NCT01474239|467162220|FG000|Overall Study|Death|1|||
129780106|NCT01474239|467162221|FG001|Overall Study|Death|1|||
129780107|NCT01474239|467162220|FG000|Overall Study|Clinical Disease Progression|7|||
129780108|NCT01474239|467162221|FG001|Overall Study|Clinical Disease Progression|1|||
129780109|NCT01474239|467162220|FG000|Overall Study|Withdrawal for Economic Reason|1|||
129780110|NCT01474239|467162221|FG001|Overall Study|Withdrawal for Economic Reason|0|||
129780111|NCT01139008|467162222|FG000|Overall Study|Withdrawal by Subject|5|||
129780112|NCT01139008|467162222|FG000|Overall Study|Non-compliant, lost product|1|||
129780113|NCT01715857|467162223|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
129780114|NCT00505778|467162224|FG000|Overall Study|Adverse Event|2|||
129780115|NCT00505778|467162225|FG001|Overall Study|Adverse Event|7|||
129780116|NCT00505778|467162224|FG000|Overall Study|Physician Decision|8|||
129780117|NCT00505778|467162225|FG001|Overall Study|Physician Decision|14|||
129780118|NCT00505778|467162224|FG000|Overall Study|Lost to Follow-up|17|||
129780119|NCT00505778|467162225|FG001|Overall Study|Lost to Follow-up|23|||
129780120|NCT00505778|467162224|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
129780121|NCT00505778|467162225|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
129780122|NCT00505778|467162224|FG000|Overall Study|Protocol Violation|7|||
129780123|NCT00505778|467162225|FG001|Overall Study|Protocol Violation|9|||
129780124|NCT00505778|467162224|FG000|Overall Study|Withdrawal by Subject|29|||
129780125|NCT00505778|467162225|FG001|Overall Study|Withdrawal by Subject|14|||
129780126|NCT00505778|467162224|FG000|Overall Study|Relapse|65|||
129780127|NCT00505778|467162225|FG001|Overall Study|Relapse|65|||
129780128|NCT00505778|467162224|FG000|Overall Study|Took No Study Drug|2|||
129780129|NCT00505778|467162225|FG001|Overall Study|Took No Study Drug|2|||
129780130|NCT05367492|467162227|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
129780131|NCT05367492|467162228|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
129780132|NCT05367492|467162229|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
129780133|NCT05367492|467162227|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
129780134|NCT05367492|467162228|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
129780135|NCT05367492|467162229|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
129780136|NCT05367492|467162227|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
129780137|NCT05367492|467162228|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
129780138|NCT05367492|467162229|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
129568255|NCT00416520|466378064|FG000|Open-label Period|Withdrawal by Subject|16|||
129568256|NCT00416520|466378065|FG001|Open-label Period|Withdrawal by Subject|5|||
129780139|NCT05367492|467162227|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
129568257|NCT00416520|466378066|FG002|Open-label Period|Withdrawal by Subject|0|||
129780140|NCT05367492|467162228|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
129780141|NCT05367492|467162229|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
129780142|NCT00808080|467162231|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
129780143|NCT00423917|467162234|FG000|Overall Study|Cancel|2|||
129780144|NCT00423917|467162234|FG000|Overall Study|Ineligible|1|||
129568258|NCT00416520|466378067|FG003|Open-label Period|Withdrawal by Subject|0|||
129568259|NCT00416520|466378064|FG000|Open-label Period|Other Reasons|3|||
129568260|NCT00416520|466378065|FG001|Open-label Period|Other Reasons|12|||
129568261|NCT00416520|466378066|FG002|Open-label Period|Other Reasons|0|||
129568262|NCT00416520|466378067|FG003|Open-label Period|Other Reasons|0|||
129568263|NCT00416520|466378064|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
129568264|NCT00416520|466378065|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
129568265|NCT00416520|466378066|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
129568266|NCT00416520|466378067|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
129568267|NCT00416520|466378064|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
129568268|NCT00416520|466378065|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
129647315|NCT02135107|466663865|FG000|Maintenance Therapy Period|Other|0|||
129568269|NCT00416520|466378066|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
129568270|NCT00416520|466378067|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
129568271|NCT00416520|466378064|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
129780145|NCT03085797|467162235|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
129780146|NCT03085797|467162236|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
129568272|NCT00416520|466378065|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
129689906|NCT02421510|466822415|FG002|Overall Study|Physician Decision|3|||
129689907|NCT02421510|466822413|FG000|Overall Study|Adverse Event|9|||
129689908|NCT02421510|466822414|FG001|Overall Study|Adverse Event|10|||
129689909|NCT02421510|466822415|FG002|Overall Study|Adverse Event|18|||
129689910|NCT02421510|466822413|FG000|Overall Study|Pregnancy|1|||
129689911|NCT02421510|466822414|FG001|Overall Study|Pregnancy|1|||
129689912|NCT02421510|466822415|FG002|Overall Study|Pregnancy|0|||
129689913|NCT02421510|466822413|FG000|Overall Study|Withdrawal by Subject|14|||
129689914|NCT02421510|466822414|FG001|Overall Study|Withdrawal by Subject|18|||
129689915|NCT02421510|466822415|FG002|Overall Study|Withdrawal by Subject|12|||
129689916|NCT02421510|466822413|FG000|Overall Study|Lost to Follow-up|1|||
129689917|NCT02421510|466822414|FG001|Overall Study|Lost to Follow-up|1|||
129689918|NCT02421510|466822415|FG002|Overall Study|Lost to Follow-up|0|||
129689919|NCT00899847|466822416|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
129689920|NCT00724893|466822419|FG000|Overall Study|Adverse Event|76|||
129689921|NCT00724893|466822420|FG001|Overall Study|Adverse Event|142|||
129689922|NCT00724893|466822419|FG000|Overall Study|Withdrawal by Subject|0|||
129689923|NCT00724893|466822420|FG001|Overall Study|Withdrawal by Subject|1|||
129689924|NCT00724893|466822419|FG000|Overall Study|Lack of virologic response|94|||
129689925|NCT00724893|466822420|FG001|Overall Study|Lack of virologic response|202|||
129689926|NCT00724893|466822419|FG000|Overall Study|Reason not specified|193|||
129689927|NCT00724893|466822420|FG001|Overall Study|Reason not specified|7|||
129689928|NCT00724893|466822419|FG000|Overall Study|Patient choice|0|||
129689929|NCT00724893|466822420|FG001|Overall Study|Patient choice|26|||
129689930|NCT00724893|466822419|FG000|Overall Study|Geographic reasons|0|||
129689931|NCT00724893|466822420|FG001|Overall Study|Geographic reasons|11|||
129689932|NCT00724893|466822419|FG000|Overall Study|Incarceration|0|||
129689933|NCT00724893|466822420|FG001|Overall Study|Incarceration|9|||
129689934|NCT00724893|466822419|FG000|Overall Study|Substance abuse|0|||
129689935|NCT00724893|466822420|FG001|Overall Study|Substance abuse|3|||
129689936|NCT00724893|466822419|FG000|Overall Study|Financial reasons|0|||
129689937|NCT00724893|466822420|FG001|Overall Study|Financial reasons|2|||
129689938|NCT00724893|466822419|FG000|Overall Study|Assigned shorter treatment|0|||
129689939|NCT00724893|466822420|FG001|Overall Study|Assigned shorter treatment|2|||
129689940|NCT00724893|466822419|FG000|Overall Study|Lost to Follow-up|0|||
129689941|NCT00724893|466822420|FG001|Overall Study|Lost to Follow-up|52|||
129689942|NCT00724893|466822419|FG000|Overall Study|Unknown, missing data|1|||
129689943|NCT00724893|466822420|FG001|Overall Study|Unknown, missing data|1|||
129689944|NCT01279200|466822423|FG000|Overall Study|Withdrawal by Subject|1|||
129689945|NCT01279200|466822424|FG001|Overall Study|Withdrawal by Subject|3|||
129689946|NCT01279200|466822423|FG000|Overall Study|Patient withdrawal due to high cost|0|||
129689947|NCT01279200|466822424|FG001|Overall Study|Patient withdrawal due to high cost|1|||
129689948|NCT01279200|466822423|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
129689949|NCT01279200|466822424|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
129689950|NCT01279200|466822423|FG000|Overall Study|ultrasound screening failure|0|||
129689951|NCT01279200|466822424|FG001|Overall Study|ultrasound screening failure|1|||
129689952|NCT01279200|466822423|FG000|Overall Study|Lost to Follow-up|0|||
129689953|NCT01279200|466822424|FG001|Overall Study|Lost to Follow-up|1|||
129689954|NCT01279200|466822423|FG000|Overall Study|Adverse Event|1|||
129689955|NCT01279200|466822424|FG001|Overall Study|Adverse Event|0|||
129689956|NCT01149538|466822429|FG000|Overall Study|Lost to Follow-up|0|||
129689957|NCT01149538|466822430|FG001|Overall Study|Lost to Follow-up|1|||
129689958|NCT01149538|466822429|FG000|Overall Study|Withdrawal by Subject|5|||
129689959|NCT01149538|466822430|FG001|Overall Study|Withdrawal by Subject|3|||
129689960|NCT00888849|466822431|FG000|Overall Study|Death|4|||
129689961|NCT00888849|466822432|FG001|Overall Study|Death|7|||
129689962|NCT00888849|466822431|FG000|Overall Study|Lost to Follow-up|1|||
129689963|NCT00888849|466822432|FG001|Overall Study|Lost to Follow-up|2|||
129689964|NCT00896233|466822437|FG000|Overall Study|Claustrophobia during MRI|1|||
129689965|NCT04280562|466822438|FG000|Study|Adverse Event|2|||
129689966|NCT04280562|466822439|FG001|Study|Adverse Event|0|||
129689967|NCT04280562|466822438|FG000|Study|Lost to Follow-up|3|||
129689968|NCT04280562|466822439|FG001|Study|Lost to Follow-up|3|||
129689969|NCT05507450|466822443|FG000|Overall Study|Death|0|||
129568273|NCT00416520|466378066|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
129689970|NCT05507450|466822444|FG001|Overall Study|Death|0|||
129689971|NCT05507450|466822445|FG002|Overall Study|Death|1|||
129689972|NCT05507450|466822446|FG003|Overall Study|Death|0|||
129689973|NCT05507450|466822443|FG000|Overall Study|Lost to Follow-up|22|||
129689974|NCT05507450|466822444|FG001|Overall Study|Lost to Follow-up|20|||
129689975|NCT05507450|466822445|FG002|Overall Study|Lost to Follow-up|20|||
129689976|NCT05507450|466822446|FG003|Overall Study|Lost to Follow-up|7|||
129780147|NCT03085797|467162235|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
129780148|NCT03085797|467162236|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
129780149|NCT03085797|467162235|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
129780150|NCT03085797|467162236|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
129780151|NCT01837823|467162237|FG000|Overall Study|Lost to Follow-up|6|||
129780152|NCT00436345|467162240|FG000|Overall Study|ICU resident beyond follow-up period|3|||
129780153|NCT00436345|467162241|FG001|Overall Study|ICU resident beyond follow-up period|0|||
129780154|NCT01175083|467162242|FG000|Primary Epoch|Withdrawal by Subject|0|||
129780155|NCT01175083|467162243|FG001|Primary Epoch|Withdrawal by Subject|0|||
129780156|NCT01175083|467162244|FG002|Primary Epoch|Withdrawal by Subject|0|||
129780157|NCT01175083|467162245|FG003|Primary Epoch|Withdrawal by Subject|0|||
129780158|NCT01175083|467162246|FG004|Primary Epoch|Withdrawal by Subject|0|||
129780159|NCT01175083|467162247|FG005|Primary Epoch|Withdrawal by Subject|2|||
129780160|NCT01175083|467162242|FG000|Primary Epoch|Lost to Follow-up|0|||
129780161|NCT01175083|467162243|FG001|Primary Epoch|Lost to Follow-up|0|||
129780162|NCT01175083|467162244|FG002|Primary Epoch|Lost to Follow-up|0|||
129780163|NCT01175083|467162245|FG003|Primary Epoch|Lost to Follow-up|0|||
129780164|NCT01175083|467162246|FG004|Primary Epoch|Lost to Follow-up|0|||
129780165|NCT01175083|467162247|FG005|Primary Epoch|Lost to Follow-up|1|||
129780166|NCT01175083|467162242|FG000|Booster Epoch|Death|0|||
129780167|NCT01175083|467162243|FG001|Booster Epoch|Death|0|||
129780168|NCT01175083|467162244|FG002|Booster Epoch|Death|1|||
129780169|NCT01175083|467162245|FG003|Booster Epoch|Death|0|||
129780170|NCT01175083|467162246|FG004|Booster Epoch|Death|0|||
129780171|NCT01175083|467162247|FG005|Booster Epoch|Death|0|||
129780172|NCT01175083|467162242|FG000|Booster Epoch|Withdrawal by Subject|0|||
129780173|NCT01175083|467162243|FG001|Booster Epoch|Withdrawal by Subject|0|||
129780174|NCT01175083|467162244|FG002|Booster Epoch|Withdrawal by Subject|0|||
129780175|NCT01175083|467162245|FG003|Booster Epoch|Withdrawal by Subject|1|||
129780176|NCT01175083|467162246|FG004|Booster Epoch|Withdrawal by Subject|0|||
129780177|NCT01175083|467162247|FG005|Booster Epoch|Withdrawal by Subject|0|||
129780178|NCT00475306|467162248|FG000|Overall Study|Protocol Violation|1|||
129780179|NCT00475306|467162249|FG001|Overall Study|Protocol Violation|1|||
129780180|NCT00475306|467162250|FG002|Overall Study|Protocol Violation|0|||
129780181|NCT00475306|467162251|FG003|Overall Study|Protocol Violation|1|||
129780182|NCT01716052|467162252|FG000|Overall Study|Withdrawal of funding|1|||
129780183|NCT01716052|467162253|FG001|Overall Study|Withdrawal of funding|1|||
129780184|NCT02405442|467162254|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
129780185|NCT02405442|467162255|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
129780186|NCT02405442|467162256|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
129780187|NCT02405442|467162257|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
129780188|NCT02405442|467162254|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
129780189|NCT02405442|467162255|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
129780190|NCT02405442|467162256|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
129780191|NCT02405442|467162257|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
129780192|NCT02405442|467162254|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
129780193|NCT02405442|467162255|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
129780194|NCT02405442|467162256|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
129780195|NCT02405442|467162257|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
129780196|NCT02405442|467162254|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
129780197|NCT02405442|467162255|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
129780198|NCT02405442|467162256|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
129780199|NCT02405442|467162257|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
129780200|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
129780201|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
129780202|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
129780203|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
129780204|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
129780205|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
129780206|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
129780207|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
129780208|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
129780209|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
129780210|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
129780211|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
129780212|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
129780213|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
129780214|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
129780215|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
129780216|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
129568274|NCT00416520|466378067|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
129568275|NCT01703832|466378068|FG000|Overall Study|Withdrawal by Subject|1|||
129568276|NCT01703832|466378069|FG001|Overall Study|Withdrawal by Subject|0|||
129568277|NCT01991470|466378070|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
129568278|NCT01991470|466378070|FG000|Enlite 1 Period|Adverse Event|1|||
129568279|NCT01991470|466378070|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
129568280|NCT01991470|466378070|FG000|Enlite 3 Period|Lost to Follow-up|1|||
129568281|NCT01991470|466378070|FG000|Enlite 3 Period|Physician Decision|2|||
129568282|NCT01991470|466378070|FG000|Enlite 3 Period|Physician Decision|8|||
129568283|NCT01991470|466378070|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
129568284|NCT00880568|466378071|FG000|Overall Study|Disease progression|3|||
129568285|NCT00880568|466378072|FG001|Overall Study|Disease progression|3|||
129568286|NCT00880568|466378073|FG002|Overall Study|Disease progression|3|||
129568287|NCT00880568|466378074|FG003|Overall Study|Disease progression|1|||
129568288|NCT00880568|466378075|FG004|Overall Study|Disease progression|3|||
129568289|NCT00880568|466378076|FG005|Overall Study|Disease progression|3|||
129568290|NCT00880568|466378077|FG006|Overall Study|Disease progression|5|||
129568291|NCT00880568|466378078|FG007|Overall Study|Disease progression|0|||
129568292|NCT00880568|466378079|FG008|Overall Study|Disease progression|3|||
129568293|NCT00880568|466378071|FG000|Overall Study|Adverse Event|0|||
129568294|NCT00880568|466378072|FG001|Overall Study|Adverse Event|0|||
129568295|NCT00880568|466378073|FG002|Overall Study|Adverse Event|0|||
129568296|NCT00880568|466378074|FG003|Overall Study|Adverse Event|0|||
129568297|NCT00880568|466378075|FG004|Overall Study|Adverse Event|0|||
129568298|NCT00880568|466378076|FG005|Overall Study|Adverse Event|0|||
129568299|NCT00880568|466378077|FG006|Overall Study|Adverse Event|1|||
129568300|NCT00880568|466378078|FG007|Overall Study|Adverse Event|1|||
129568301|NCT00880568|466378079|FG008|Overall Study|Adverse Event|0|||
129568302|NCT00880568|466378071|FG000|Overall Study|Withdrawal by Subject|0|||
129568303|NCT00880568|466378072|FG001|Overall Study|Withdrawal by Subject|0|||
129568304|NCT00880568|466378073|FG002|Overall Study|Withdrawal by Subject|0|||
129780217|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
129568305|NCT00880568|466378074|FG003|Overall Study|Withdrawal by Subject|0|||
129780218|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
129780219|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
129780220|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
129780221|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
129780222|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
129780223|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
129568306|NCT00880568|466378075|FG004|Overall Study|Withdrawal by Subject|0|||
129568307|NCT00880568|466378076|FG005|Overall Study|Withdrawal by Subject|0|||
129568308|NCT00880568|466378077|FG006|Overall Study|Withdrawal by Subject|0|||
129568309|NCT00880568|466378078|FG007|Overall Study|Withdrawal by Subject|1|||
129780224|NCT02405442|467162254|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
129780225|NCT02405442|467162255|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
129780226|NCT02405442|467162256|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
129780227|NCT02405442|467162257|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
129780228|NCT02405442|467162254|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
129568310|NCT00880568|466378079|FG008|Overall Study|Withdrawal by Subject|0|||
129780229|NCT02405442|467162255|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
129568311|NCT00849901|466378080|FG000|Acute Treatment Phase|Adverse Event|9|||
129568312|NCT00849901|466378081|FG001|Acute Treatment Phase|Adverse Event|1|||
129568313|NCT00849901|466378082|FG002|Acute Treatment Phase|Adverse Event|3|||
129568314|NCT00849901|466378080|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
129568315|NCT00849901|466378081|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
129568316|NCT00849901|466378082|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
129568317|NCT00849901|466378080|FG000|Acute Treatment Phase|Protocol Violation|0|||
129568318|NCT00849901|466378081|FG001|Acute Treatment Phase|Protocol Violation|2|||
129568319|NCT00849901|466378082|FG002|Acute Treatment Phase|Protocol Violation|1|||
129568320|NCT00849901|466378080|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
129568321|NCT00849901|466378081|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
129568322|NCT00849901|466378082|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
129568323|NCT00849901|466378080|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
129568324|NCT00849901|466378081|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
129568325|NCT00849901|466378082|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
129568326|NCT00849901|466378080|FG000|Acute Treatment Phase|Physician Decision|1|||
129568327|NCT00849901|466378081|FG001|Acute Treatment Phase|Physician Decision|1|||
129568328|NCT00849901|466378082|FG002|Acute Treatment Phase|Physician Decision|1|||
129568329|NCT00849901|466378080|FG000|Acute Treatment Phase|Sponsor Decision|1|||
129568330|NCT00849901|466378081|FG001|Acute Treatment Phase|Sponsor Decision|0|||
129568331|NCT00849901|466378082|FG002|Acute Treatment Phase|Sponsor Decision|0|||
129568332|NCT00849901|466378080|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
129568333|NCT00849901|466378081|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
129568334|NCT00849901|466378082|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
129568335|NCT00849901|466378080|FG000|Extension Phase|Adverse Event|2|||
129568336|NCT00849901|466378081|FG001|Extension Phase|Adverse Event|8|||
129568337|NCT00849901|466378082|FG002|Extension Phase|Adverse Event|4|||
129568338|NCT00849901|466378080|FG000|Extension Phase|Lost to Follow-up|3|||
129568339|NCT00849901|466378081|FG001|Extension Phase|Lost to Follow-up|0|||
129568340|NCT00849901|466378082|FG002|Extension Phase|Lost to Follow-up|1|||
129780230|NCT02405442|467162256|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
129780231|NCT02405442|467162257|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
129568341|NCT00849901|466378080|FG000|Extension Phase|Protocol Violation|2|||
129568342|NCT00849901|466378081|FG001|Extension Phase|Protocol Violation|2|||
129568343|NCT00849901|466378082|FG002|Extension Phase|Protocol Violation|4|||
129568344|NCT00849901|466378080|FG000|Extension Phase|Withdrawal by Subject|7|||
129568345|NCT00849901|466378081|FG001|Extension Phase|Withdrawal by Subject|6|||
129780232|NCT02405442|467162254|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
129568346|NCT00849901|466378082|FG002|Extension Phase|Withdrawal by Subject|3|||
129568347|NCT00849901|466378080|FG000|Extension Phase|Parent or Caregiver Decision|10|||
129568348|NCT00849901|466378081|FG001|Extension Phase|Parent or Caregiver Decision|4|||
129568349|NCT00849901|466378082|FG002|Extension Phase|Parent or Caregiver Decision|4|||
129568350|NCT00849901|466378080|FG000|Extension Phase|Physician Decision|1|||
129568351|NCT00849901|466378081|FG001|Extension Phase|Physician Decision|2|||
129568352|NCT00849901|466378082|FG002|Extension Phase|Physician Decision|0|||
129568353|NCT00849901|466378080|FG000|Extension Phase|Lack of Efficacy|2|||
129568354|NCT00849901|466378081|FG001|Extension Phase|Lack of Efficacy|4|||
129568355|NCT00849901|466378082|FG002|Extension Phase|Lack of Efficacy|1|||
129568356|NCT00437658|466378083|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
129568357|NCT00437658|466378084|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
129568358|NCT00437658|466378085|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
129568359|NCT00437658|466378083|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
129568360|NCT00437658|466378084|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
129568361|NCT00437658|466378085|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
129568362|NCT00437658|466378083|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
129568363|NCT00437658|466378084|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
129568364|NCT00437658|466378085|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
129568365|NCT00437658|466378083|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
129568366|NCT00437658|466378084|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
129568367|NCT00437658|466378085|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
129568368|NCT00437658|466378083|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
129568369|NCT00437658|466378084|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
129568370|NCT00437658|466378085|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
129568371|NCT00437658|466378083|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
129568372|NCT00437658|466378084|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
129568373|NCT00437658|466378085|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
129568374|NCT00437658|466378083|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
129568375|NCT00437658|466378084|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
129568376|NCT00437658|466378085|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
129568377|NCT00437658|466378083|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
129780233|NCT02405442|467162255|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
129780234|NCT02405442|467162256|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
129780235|NCT02405442|467162257|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
129568378|NCT00437658|466378084|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
129568379|NCT00437658|466378085|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
129568380|NCT00437658|466378083|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
129568381|NCT00437658|466378084|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
129568382|NCT00437658|466378085|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
129568383|NCT00437658|466378083|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
129568384|NCT00437658|466378084|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
129568385|NCT00437658|466378085|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
129568386|NCT00437658|466378083|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
129568387|NCT00437658|466378084|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
129568388|NCT00437658|466378085|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
129568389|NCT00437658|466378083|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
129568390|NCT00437658|466378084|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
129568391|NCT00437658|466378085|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
129568392|NCT04407806|466378086|FG000|Overall Study|Withdrawal by Subject|1|||
129568393|NCT04407806|466378087|FG001|Overall Study|Withdrawal by Subject|2|||
129568394|NCT02731157|466378088|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
129568395|NCT01856309|466378089|FG000|Overall Study|Death|4|||
129568396|NCT01856309|466378090|FG001|Overall Study|Death|6|||
129568397|NCT01856309|466378091|FG002|Overall Study|Death|11|||
129568398|NCT01856309|466378092|FG003|Overall Study|Death|6|||
129568399|NCT01856309|466378089|FG000|Overall Study|Lost to Follow-up|6|||
129568400|NCT01856309|466378090|FG001|Overall Study|Lost to Follow-up|2|||
129568401|NCT01856309|466378091|FG002|Overall Study|Lost to Follow-up|4|||
129568402|NCT01856309|466378092|FG003|Overall Study|Lost to Follow-up|8|||
129568403|NCT01856309|466378089|FG000|Overall Study|Withdrawal by Subject|11|||
129568404|NCT01856309|466378090|FG001|Overall Study|Withdrawal by Subject|13|||
129568405|NCT01856309|466378091|FG002|Overall Study|Withdrawal by Subject|28|||
129568406|NCT01856309|466378092|FG003|Overall Study|Withdrawal by Subject|26|||
129568407|NCT01856309|466378089|FG000|Overall Study|Other|227|||
129568408|NCT01856309|466378090|FG001|Overall Study|Other|225|||
129568409|NCT01856309|466378091|FG002|Overall Study|Other|447|||
129568410|NCT01856309|466378092|FG003|Overall Study|Other|469|||
129568411|NCT01856309|466378089|FG000|Overall Study|Lack of Efficacy|14|||
129568412|NCT01856309|466378090|FG001|Overall Study|Lack of Efficacy|9|||
129568413|NCT01856309|466378091|FG002|Overall Study|Lack of Efficacy|40|||
129568414|NCT01856309|466378092|FG003|Overall Study|Lack of Efficacy|25|||
129568415|NCT01856309|466378089|FG000|Overall Study|Adverse Event|31|||
129568416|NCT01856309|466378090|FG001|Overall Study|Adverse Event|31|||
129568417|NCT01856309|466378091|FG002|Overall Study|Adverse Event|55|||
129568418|NCT01856309|466378092|FG003|Overall Study|Adverse Event|65|||
129568419|NCT01856309|466378089|FG000|Overall Study|Pregnancy|0|||
129568420|NCT01856309|466378090|FG001|Overall Study|Pregnancy|0|||
129568421|NCT01856309|466378091|FG002|Overall Study|Pregnancy|0|||
129568422|NCT01856309|466378092|FG003|Overall Study|Pregnancy|1|||
129568423|NCT01856309|466378089|FG000|Overall Study|Physician Decision|6|||
129568424|NCT01856309|466378090|FG001|Overall Study|Physician Decision|1|||
129568425|NCT01856309|466378091|FG002|Overall Study|Physician Decision|6|||
129568426|NCT01856309|466378092|FG003|Overall Study|Physician Decision|8|||
129568427|NCT01856309|466378089|FG000|Overall Study|Noncompliance With Study Drug|0|||
129568428|NCT01856309|466378090|FG001|Overall Study|Noncompliance With Study Drug|1|||
129568429|NCT01856309|466378091|FG002|Overall Study|Noncompliance With Study Drug|4|||
129568430|NCT01856309|466378092|FG003|Overall Study|Noncompliance With Study Drug|1|||
129568431|NCT01434693|466378093|FG000|Overall Study|Adverse Event|1|||
129568432|NCT01434693|466378094|FG001|Overall Study|Adverse Event|0|||
129568433|NCT01434693|466378095|FG002|Overall Study|Adverse Event|0|||
129568434|NCT01434693|466378096|FG003|Overall Study|Adverse Event|0|||
129568435|NCT01434693|466378093|FG000|Overall Study|Withdrawal by Subject|1|||
129568436|NCT01434693|466378094|FG001|Overall Study|Withdrawal by Subject|0|||
129689977|NCT05507450|466822443|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129689978|NCT05507450|466822444|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
129689979|NCT05507450|466822445|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129568437|NCT01434693|466378095|FG002|Overall Study|Withdrawal by Subject|1|||
129568438|NCT01434693|466378096|FG003|Overall Study|Withdrawal by Subject|1|||
129568439|NCT01434693|466378093|FG000|Overall Study|Lost to Follow-up|1|||
129568440|NCT01434693|466378094|FG001|Overall Study|Lost to Follow-up|0|||
129568441|NCT01434693|466378095|FG002|Overall Study|Lost to Follow-up|0|||
129689980|NCT05507450|466822446|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129568442|NCT01434693|466378096|FG003|Overall Study|Lost to Follow-up|0|||
129689981|NCT05507450|466822443|FG000|Overall Study|Withdrawal by Subject|4|||
129689982|NCT05507450|466822444|FG001|Overall Study|Withdrawal by Subject|11|||
129689983|NCT05507450|466822445|FG002|Overall Study|Withdrawal by Subject|7|||
129568443|NCT01440283|466378097|FG000|Overall Study|Death|3|||
129568444|NCT01440283|466378097|FG000|Overall Study|Withdrawal by Subject|4|||
129568445|NCT01440283|466378097|FG000|Overall Study|Physician Decision|3|||
129689984|NCT05507450|466822446|FG003|Overall Study|Withdrawal by Subject|3|||
129568446|NCT02327130|466378100|FG000|Overall Study|Discharged in less than 5 days|5|||
129568447|NCT02327130|466378100|FG000|Overall Study|Physician Decision|2|||
129568448|NCT02327130|466378100|FG000|Overall Study|Unable to provide breath sample|1|||
129568449|NCT02327130|466378100|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
129568450|NCT02327130|466378100|FG000|Overall Study|Met exclusion criteria|3|||
129568451|NCT01378975|466378104|FG000|Overall Study|Death|77|||
129568452|NCT01378975|466378105|FG001|Overall Study|Death|46|||
129568453|NCT01378975|466378104|FG000|Overall Study|Investigator Request|1|||
129568454|NCT01378975|466378105|FG001|Overall Study|Investigator Request|0|||
129568455|NCT01378975|466378104|FG000|Overall Study|Lost to Follow-up|4|||
129568456|NCT01378975|466378105|FG001|Overall Study|Lost to Follow-up|1|||
129689985|NCT05507450|466822443|FG000|Overall Study|Participant left the country|0|||
129689986|NCT05507450|466822444|FG001|Overall Study|Participant left the country|0|||
129689987|NCT05507450|466822445|FG002|Overall Study|Participant left the country|1|||
129689988|NCT05507450|466822446|FG003|Overall Study|Participant left the country|0|||
129689989|NCT00514917|466822450|FG000|Overall Study|Death|4|||
129689990|NCT00514917|466822451|FG001|Overall Study|Death|10|||
129689991|NCT00514917|466822450|FG000|Overall Study|Protocol Violation|1|||
129689992|NCT00514917|466822451|FG001|Overall Study|Protocol Violation|0|||
129689993|NCT00514917|466822450|FG000|Overall Study|Lost to Follow-up|4|||
129689994|NCT00514917|466822451|FG001|Overall Study|Lost to Follow-up|3|||
129689995|NCT00514917|466822450|FG000|Overall Study|Withdrawal by Subject|18|||
129689996|NCT00514917|466822451|FG001|Overall Study|Withdrawal by Subject|16|||
129689997|NCT00514917|466822450|FG000|Overall Study|Discontinued due to study closure|88|||
129689998|NCT00514917|466822451|FG001|Overall Study|Discontinued due to study closure|81|||
129689999|NCT00514917|466822450|FG000|Overall Study|Undefined|11|||
129690000|NCT00514917|466822451|FG001|Overall Study|Undefined|5|||
129690001|NCT02697422|466822452|FG000|Overall Study|Declined exit survey|9|||
129690002|NCT02697422|466822453|FG001|Overall Study|Declined exit survey|2|||
129690003|NCT02697422|466822452|FG000|Overall Study|Lost to Follow-up|13|||
129690004|NCT02697422|466822453|FG001|Overall Study|Lost to Follow-up|8|||
129690005|NCT02697422|466822452|FG000|Overall Study|Death|2|||
129690006|NCT02697422|466822453|FG001|Overall Study|Death|1|||
129690007|NCT02697422|466822452|FG000|Overall Study|Withdrawal by Subject|0|||
129690008|NCT02697422|466822453|FG001|Overall Study|Withdrawal by Subject|1|||
129690009|NCT02697422|466822452|FG000|Overall Study|Physician Decision|1|||
129690010|NCT02697422|466822453|FG001|Overall Study|Physician Decision|1|||
129690011|NCT02697422|466822452|FG000|Overall Study|Exit survey data lost|1|||
129690012|NCT02697422|466822453|FG001|Overall Study|Exit survey data lost|0|||
129690013|NCT03983109|466822456|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
129690014|NCT03983109|466822457|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
129690015|NCT04149353|466822460|FG000|Overall Study|Study terminated|1|||
129690016|NCT00309244|466822463|FG000|Overall Study|Adverse Event|29|||
129690017|NCT00309244|466822464|FG001|Overall Study|Adverse Event|12|||
129690018|NCT00309244|466822463|FG000|Overall Study|Lost to Follow-up|6|||
129690019|NCT00309244|466822464|FG001|Overall Study|Lost to Follow-up|22|||
129690020|NCT00309244|466822463|FG000|Overall Study|Physician Decision|5|||
129690021|NCT00309244|466822464|FG001|Overall Study|Physician Decision|8|||
129690022|NCT00309244|466822463|FG000|Overall Study|Protocol Violation|6|||
129690023|NCT00309244|466822464|FG001|Overall Study|Protocol Violation|3|||
129690024|NCT00309244|466822463|FG000|Overall Study|Withdrawal by Subject|50|||
129690025|NCT00309244|466822464|FG001|Overall Study|Withdrawal by Subject|32|||
129690026|NCT00309244|466822463|FG000|Overall Study|Various|7|||
129690027|NCT00309244|466822464|FG001|Overall Study|Various|7|||
129690028|NCT00309244|466822463|FG000|Overall Study|Randomized but not dosed|11|||
129690029|NCT00309244|466822464|FG001|Overall Study|Randomized but not dosed|12|||
129690030|NCT00309244|466822463|FG000|Overall Study|Death|4|||
129690031|NCT00309244|466822464|FG001|Overall Study|Death|1|||
129690032|NCT01263028|466822465|FG000|Overall Study|Withdrawal by Subject|1|||
129690033|NCT01263028|466822465|FG000|Overall Study|Adverse Event|1|||
129690034|NCT01263028|466822465|FG000|Overall Study|Study terminated due to low enrollment.|4|||
129690035|NCT03019588|466822466|FG000|Overall Study|Death|44|||
129568457|NCT01378975|466378104|FG000|Overall Study|Withdrew Consent|4|||
129568458|NCT01378975|466378105|FG001|Overall Study|Withdrew Consent|3|||
129568459|NCT02343120|466378109|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
129690036|NCT03019588|466822467|FG001|Overall Study|Death|46|||
129690037|NCT03019588|466822466|FG000|Overall Study|Study terminated by Sponsor|3|||
129690038|NCT03019588|466822467|FG001|Overall Study|Study terminated by Sponsor|1|||
129690039|NCT00887588|466822468|FG000|Core Period|Death|1|||
129568460|NCT02343120|466378110|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
129568461|NCT02343120|466378111|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
129568462|NCT02343120|466378112|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
129568463|NCT02343120|466378113|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
129568464|NCT02343120|466378109|FG000|Part 1: Dose Escalation|Death|1|||
129568465|NCT02343120|466378110|FG001|Part 1: Dose Escalation|Death|2|||
129568466|NCT02343120|466378111|FG002|Part 1: Dose Escalation|Death|2|||
129568467|NCT02343120|466378112|FG003|Part 1: Dose Escalation|Death|2|||
129568468|NCT02343120|466378113|FG004|Part 1: Dose Escalation|Death|1|||
129780236|NCT02405442|467162254|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
129780237|NCT02405442|467162255|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
129568469|NCT02343120|466378109|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
129568470|NCT02343120|466378110|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
129568471|NCT02343120|466378111|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
129568472|NCT02343120|466378112|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
129568473|NCT02343120|466378113|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
129568474|NCT02343120|466378109|FG000|Part 2: Expansion|Sponsor decision|0|||
129568475|NCT02343120|466378110|FG001|Part 2: Expansion|Sponsor decision|0|||
129568476|NCT02343120|466378111|FG002|Part 2: Expansion|Sponsor decision|0|||
129568477|NCT02343120|466378112|FG003|Part 2: Expansion|Sponsor decision|165|||
129568478|NCT02343120|466378113|FG004|Part 2: Expansion|Sponsor decision|67|||
129568479|NCT02343120|466378109|FG000|Part 2: Expansion|Death|0|||
129568480|NCT02343120|466378110|FG001|Part 2: Expansion|Death|0|||
129568481|NCT02343120|466378111|FG002|Part 2: Expansion|Death|0|||
129568482|NCT02343120|466378112|FG003|Part 2: Expansion|Death|74|||
129568483|NCT02343120|466378113|FG004|Part 2: Expansion|Death|17|||
129568484|NCT02343120|466378109|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
129568485|NCT02343120|466378110|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
129568486|NCT02343120|466378111|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
129568487|NCT02343120|466378112|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
129568488|NCT02343120|466378113|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
129568489|NCT02343120|466378109|FG000|Part 2: Expansion|Lost to Follow-up|0|||
129568490|NCT02343120|466378110|FG001|Part 2: Expansion|Lost to Follow-up|0|||
129568491|NCT02343120|466378111|FG002|Part 2: Expansion|Lost to Follow-up|0|||
129568492|NCT02343120|466378112|FG003|Part 2: Expansion|Lost to Follow-up|5|||
129568493|NCT02343120|466378113|FG004|Part 2: Expansion|Lost to Follow-up|2|||
129568494|NCT02343120|466378109|FG000|Part 2: Expansion|Other|0|||
129568495|NCT02343120|466378110|FG001|Part 2: Expansion|Other|0|||
129690040|NCT00887588|466822469|FG001|Core Period|Death|1|||
129690041|NCT00887588|466822468|FG000|Core Period|Lost to Follow-up|3|||
129690042|NCT00887588|466822469|FG001|Core Period|Lost to Follow-up|1|||
129690043|NCT00887588|466822468|FG000|Core Period|Withdrawal by Subject|6|||
129690044|NCT00887588|466822469|FG001|Core Period|Withdrawal by Subject|8|||
129690045|NCT00887588|466822468|FG000|Core Period|Adverse Event|9|||
129690046|NCT00887588|466822469|FG001|Core Period|Adverse Event|11|||
129690047|NCT00887588|466822468|FG000|Extension Period|Adverse Event|4|||
129690048|NCT00887588|466822469|FG001|Extension Period|Adverse Event|4|||
129690049|NCT00887588|466822468|FG000|Extension Period|Death|0|||
129690050|NCT00887588|466822469|FG001|Extension Period|Death|1|||
129690051|NCT00887588|466822468|FG000|Extension Period|Protocol deviation|1|||
129690052|NCT00887588|466822469|FG001|Extension Period|Protocol deviation|0|||
129690053|NCT00887588|466822468|FG000|Extension Period|Lost to Follow-up|1|||
129690054|NCT00887588|466822469|FG001|Extension Period|Lost to Follow-up|0|||
129690055|NCT00366535|466822470|FG000|First Phase: 12 Weeks|Adverse Event|1|||
129690056|NCT00366535|466822471|FG001|First Phase: 12 Weeks|Adverse Event|3|||
129690057|NCT00366535|466822470|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
129690058|NCT00366535|466822471|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
129690059|NCT00366535|466822470|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
129690060|NCT00366535|466822471|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
129690061|NCT00366535|466822470|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
129690062|NCT00366535|466822471|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
129690063|NCT03753542|466822476|FG000|Overall Study|Lost to Follow-up|9|||
129690064|NCT03753542|466822477|FG001|Overall Study|Lost to Follow-up|14|||
129690065|NCT03554473|466824380|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
129690066|NCT03554473|466824381|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
129690067|NCT03554473|466824382|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
129690068|NCT03554473|466824380|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
129690069|NCT03554473|466824381|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
129707768|NCT01280968|466892118|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
129568496|NCT02343120|466378111|FG002|Part 2: Expansion|Other|0|||
129568497|NCT02343120|466378112|FG003|Part 2: Expansion|Other|1|||
129568498|NCT02343120|466378113|FG004|Part 2: Expansion|Other|5|||
129690070|NCT03554473|466824382|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
129690071|NCT03554473|466824380|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
129690072|NCT03554473|466824381|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
129690073|NCT03554473|466824382|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
129690074|NCT04971837|466824386|FG000|Overall Study|Long Term Illness|1|||
129690075|NCT04971837|466824386|FG000|Overall Study|BMI too low|9|||
129690076|NCT04971837|466824386|FG000|Overall Study|geographic location|1|||
129690077|NCT04971837|466824386|FG000|Overall Study|Discontinued scheduling conflict|1|||
129690078|NCT00160615|466824387|FG000|Overall Study|Adverse Event|5|||
129690079|NCT00160615|466824388|FG001|Overall Study|Adverse Event|12|||
129690080|NCT00160615|466824387|FG000|Overall Study|Withdrawal by Subject|0|||
129690081|NCT00160615|466824388|FG001|Overall Study|Withdrawal by Subject|2|||
129690082|NCT00160615|466824387|FG000|Overall Study|Lack of Efficacy|11|||
129690083|NCT00160615|466824388|FG001|Overall Study|Lack of Efficacy|23|||
129690084|NCT00160615|466824387|FG000|Overall Study|Patient decision|1|||
129690085|NCT00160615|466824388|FG001|Overall Study|Patient decision|2|||
129690086|NCT00160615|466824387|FG000|Overall Study|Investigator decision|1|||
129690087|NCT00160615|466824388|FG001|Overall Study|Investigator decision|1|||
129690088|NCT00160615|466824387|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
129690089|NCT00160615|466824388|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
129690090|NCT00160615|466824387|FG000|Overall Study|Switch to surgical treatment|0|||
129690091|NCT00160615|466824388|FG001|Overall Study|Switch to surgical treatment|2|||
129690092|NCT00160615|466824387|FG000|Overall Study|Non-compliance was suspected|0|||
129690093|NCT00160615|466824388|FG001|Overall Study|Non-compliance was suspected|1|||
129568499|NCT02343120|466378109|FG000|Part 2: Expansion|Adverse Event|0|||
129568500|NCT02343120|466378110|FG001|Part 2: Expansion|Adverse Event|0|||
129568501|NCT02343120|466378111|FG002|Part 2: Expansion|Adverse Event|0|||
129568502|NCT02343120|466378112|FG003|Part 2: Expansion|Adverse Event|1|||
129568503|NCT02343120|466378113|FG004|Part 2: Expansion|Adverse Event|1|||
129568504|NCT03991494|466378116|FG000|Overall Study|Progressive Disease|4|||
129568505|NCT02534493|466378119|FG000|Overall Study|Lost to Follow-up|1|||
129568506|NCT02534493|466378119|FG000|Overall Study|Withdrawal by Subject|1|||
129568507|NCT01104662|466378122|FG000|Overall Study|Adverse Event|2|||
129568508|NCT01104662|466378123|FG001|Overall Study|Adverse Event|2|||
129568509|NCT01104662|466378124|FG002|Overall Study|Adverse Event|0|||
129568510|NCT01104662|466378125|FG003|Overall Study|Adverse Event|1|||
129568511|NCT01104662|466378126|FG004|Overall Study|Adverse Event|1|||
129568512|NCT01104662|466378127|FG005|Overall Study|Adverse Event|1|||
129568513|NCT01104662|466378128|FG006|Overall Study|Adverse Event|0|||
129568514|NCT01104662|466378129|FG007|Overall Study|Adverse Event|0|||
129568515|NCT01104662|466378122|FG000|Overall Study|Clinical Failure|1|||
129568516|NCT01104662|466378123|FG001|Overall Study|Clinical Failure|0|||
129568517|NCT01104662|466378124|FG002|Overall Study|Clinical Failure|0|||
129568518|NCT01104662|466378125|FG003|Overall Study|Clinical Failure|0|||
129568519|NCT01104662|466378126|FG004|Overall Study|Clinical Failure|0|||
129568520|NCT01104662|466378127|FG005|Overall Study|Clinical Failure|1|||
129568521|NCT01104662|466378128|FG006|Overall Study|Clinical Failure|0|||
129568522|NCT01104662|466378129|FG007|Overall Study|Clinical Failure|0|||
129568523|NCT01104662|466378122|FG000|Overall Study|Participant left investigator's care|1|||
129568524|NCT01104662|466378123|FG001|Overall Study|Participant left investigator's care|1|||
129568525|NCT01104662|466378124|FG002|Overall Study|Participant left investigator's care|0|||
129568526|NCT01104662|466378125|FG003|Overall Study|Participant left investigator's care|0|||
129568527|NCT01104662|466378126|FG004|Overall Study|Participant left investigator's care|0|||
129568528|NCT01104662|466378127|FG005|Overall Study|Participant left investigator's care|0|||
129568529|NCT01104662|466378128|FG006|Overall Study|Participant left investigator's care|0|||
129568530|NCT01104662|466378129|FG007|Overall Study|Participant left investigator's care|0|||
129568531|NCT01104662|466378122|FG000|Overall Study|Reason not specified|3|||
129568532|NCT01104662|466378123|FG001|Overall Study|Reason not specified|3|||
129568533|NCT01104662|466378124|FG002|Overall Study|Reason not specified|0|||
129568534|NCT01104662|466378125|FG003|Overall Study|Reason not specified|0|||
129568535|NCT01104662|466378126|FG004|Overall Study|Reason not specified|0|||
129568536|NCT01104662|466378127|FG005|Overall Study|Reason not specified|1|||
129568537|NCT01104662|466378128|FG006|Overall Study|Reason not specified|0|||
129568538|NCT01104662|466378129|FG007|Overall Study|Reason not specified|0|||
129568539|NCT01104662|466378122|FG000|Overall Study|Randomized but not treated|3|||
129568540|NCT01104662|466378123|FG001|Overall Study|Randomized but not treated|4|||
129568541|NCT01104662|466378124|FG002|Overall Study|Randomized but not treated|1|||
129568542|NCT01104662|466378125|FG003|Overall Study|Randomized but not treated|0|||
129568543|NCT01104662|466378126|FG004|Overall Study|Randomized but not treated|0|||
129568544|NCT01104662|466378127|FG005|Overall Study|Randomized but not treated|1|||
129568545|NCT01104662|466378128|FG006|Overall Study|Randomized but not treated|0|||
129568546|NCT01104662|466378129|FG007|Overall Study|Randomized but not treated|0|||
129568547|NCT02079532|466378130|FG000|Overall Study|Adverse Event|7|||
129568548|NCT02079532|466378130|FG000|Overall Study|Additional or changed therapy|2|||
129568549|NCT02079532|466378130|FG000|Overall Study|Lack of Efficacy|9|||
129780238|NCT02405442|467162256|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
129780239|NCT02405442|467162257|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
129780240|NCT02078960|467162259|FG000|Treatment Period|Other|0|||
129780241|NCT02078960|467162260|FG001|Treatment Period|Other|0|||
129780242|NCT02078960|467162261|FG002|Treatment Period|Other|1|||
129780243|NCT02078960|467162259|FG000|Treatment Period|Lack of Efficacy|0|||
129780244|NCT02078960|467162260|FG001|Treatment Period|Lack of Efficacy|1|||
129780245|NCT02078960|467162261|FG002|Treatment Period|Lack of Efficacy|0|||
129780246|NCT02078960|467162259|FG000|Treatment Period|Disease progression - accelerated phase|0|||
129884557|NCT02696902|467536455|FG002|Overall Study|Lost to Follow-up|1|||
129568550|NCT02079532|466378130|FG000|Overall Study|Protocol Violation|3|||
129568551|NCT02079532|466378130|FG000|Overall Study|Withdrawal by Subject|1|||
129568552|NCT02079532|466378130|FG000|Overall Study|Administrative problems|1|||
129568553|NCT02079532|466378130|FG000|Overall Study|Inclusion into ReFIRST|3|||
129568554|NCT02079532|466378130|FG000|Overall Study|Other|3|||
129568555|NCT02158936|466378133|FG000|Overall Study|Study closed/ terminated|57|||
129568556|NCT02158936|466378134|FG001|Overall Study|Study closed/ terminated|77|||
129568557|NCT02158936|466378133|FG000|Overall Study|Azacitidine tx discontinued|53|||
129568558|NCT02158936|466378134|FG001|Overall Study|Azacitidine tx discontinued|46|||
129568559|NCT02158936|466378133|FG000|Overall Study|Adverse Event|39|||
129568560|NCT02158936|466378134|FG001|Overall Study|Adverse Event|24|||
129568561|NCT02158936|466378133|FG000|Overall Study|Withdrawal by Subject|15|||
129568562|NCT02158936|466378134|FG001|Overall Study|Withdrawal by Subject|16|||
129568563|NCT02158936|466378133|FG000|Overall Study|Physician Decision|15|||
129568564|NCT02158936|466378134|FG001|Overall Study|Physician Decision|13|||
129568565|NCT02158936|466378133|FG000|Overall Study|Lost to Follow-up|0|||
129568566|NCT02158936|466378134|FG001|Overall Study|Lost to Follow-up|1|||
129568567|NCT01432171|466378135|FG000|Overall Study|Death|1|||
129568568|NCT01432171|466378136|FG001|Overall Study|Death|2|||
129568569|NCT01432171|466378135|FG000|Overall Study|Lost to Follow-up|6|||
129780247|NCT02078960|467162260|FG001|Treatment Period|Disease progression - accelerated phase|1|||
129780248|NCT02078960|467162261|FG002|Treatment Period|Disease progression - accelerated phase|0|||
129780249|NCT02078960|467162259|FG000|Treatment Period|Disease progression - blast phase|1|||
129780250|NCT02078960|467162260|FG001|Treatment Period|Disease progression - blast phase|0|||
129780251|NCT02078960|467162261|FG002|Treatment Period|Disease progression - blast phase|0|||
129780252|NCT02078960|467162259|FG000|Treatment Period|Withdrawal by Subject|0|||
129780253|NCT02078960|467162260|FG001|Treatment Period|Withdrawal by Subject|1|||
129780254|NCT02078960|467162261|FG002|Treatment Period|Withdrawal by Subject|1|||
129780255|NCT02078960|467162259|FG000|Treatment Period|Adverse Event|1|||
129780256|NCT02078960|467162260|FG001|Treatment Period|Adverse Event|0|||
129780257|NCT02078960|467162261|FG002|Treatment Period|Adverse Event|0|||
129780258|NCT02078960|467162259|FG000|Treatment Period|Death|0|||
129780259|NCT02078960|467162260|FG001|Treatment Period|Death|0|||
129780260|NCT02078960|467162261|FG002|Treatment Period|Death|1|||
129780261|NCT02078960|467162259|FG000|Follow-up Period|Death|2|||
129780262|NCT02078960|467162260|FG001|Follow-up Period|Death|0|||
129780263|NCT02078960|467162261|FG002|Follow-up Period|Death|0|||
129780264|NCT02078960|467162259|FG000|Follow-up Period|Lost to Follow-up|0|||
129780265|NCT02078960|467162260|FG001|Follow-up Period|Lost to Follow-up|1|||
129780266|NCT02078960|467162261|FG002|Follow-up Period|Lost to Follow-up|0|||
129780267|NCT03275350|467162262|FG000|Overall Study|Lost to Follow-up|4|||
129780268|NCT03275350|467162263|FG001|Overall Study|Lost to Follow-up|6|||
129780269|NCT03275350|467162262|FG000|Overall Study|Death|2|||
129780270|NCT03275350|467162263|FG001|Overall Study|Death|1|||
129780271|NCT03275350|467162262|FG000|Overall Study|Physician Decision|1|||
129780272|NCT03275350|467162263|FG001|Overall Study|Physician Decision|0|||
129780273|NCT03275350|467162262|FG000|Overall Study|Incarcerated|1|||
129780274|NCT03275350|467162263|FG001|Overall Study|Incarcerated|1|||
129780275|NCT00975689|467162266|FG000|Overall Study|Adverse Event|0|||
129780276|NCT00975689|467162267|FG001|Overall Study|Adverse Event|3|||
129780277|NCT00975689|467162266|FG000|Overall Study|Withdrawal by Subject|1|||
129780278|NCT00975689|467162267|FG001|Overall Study|Withdrawal by Subject|0|||
129780279|NCT00975689|467162266|FG000|Overall Study|Physician Decision|1|||
129780280|NCT00975689|467162267|FG001|Overall Study|Physician Decision|0|||
129780281|NCT02597478|467162272|FG000|Overall Study|Withdrawal by Subject|2|||
129780282|NCT02597478|467162273|FG001|Overall Study|Withdrawal by Subject|0|||
129780283|NCT02597478|467162272|FG000|Overall Study|Change of opioid dose|1|||
129780284|NCT02597478|467162273|FG001|Overall Study|Change of opioid dose|0|||
129780285|NCT02597478|467162272|FG000|Overall Study|Insufficient exertional dyspnea|0|||
129780286|NCT02597478|467162273|FG001|Overall Study|Insufficient exertional dyspnea|1|||
129780287|NCT01652469|467162274|FG000|Overall Study|Withdrawal by Subject|1|||
129780288|NCT01652469|467162275|FG001|Overall Study|Withdrawal by Subject|4|||
129780289|NCT01652469|467162274|FG000|Overall Study|Lost to Follow-up|0|||
129780290|NCT01652469|467162275|FG001|Overall Study|Lost to Follow-up|2|||
129780291|NCT01402102|467162276|FG000|Overall Study|Protocol Violation|1|||
129780292|NCT01402102|467162277|FG001|Overall Study|Protocol Violation|0|||
129780293|NCT01402102|467162276|FG000|Overall Study|Insufficiency of compliance|1|||
129780294|NCT01402102|467162277|FG001|Overall Study|Insufficiency of compliance|1|||
129780295|NCT01402102|467162276|FG000|Overall Study|Withdrawal by Subject|0|||
129780296|NCT01402102|467162277|FG001|Overall Study|Withdrawal by Subject|2|||
129780297|NCT01305577|467162279|FG000|Overall Study|Adverse Event|2|||
129780298|NCT01305577|467162280|FG001|Overall Study|Adverse Event|2|||
129780299|NCT01305577|467162281|FG002|Overall Study|Adverse Event|1|||
129568570|NCT01432171|466378136|FG001|Overall Study|Lost to Follow-up|5|||
129568571|NCT01432171|466378135|FG000|Overall Study|Withdrawal by Subject|3|||
129568572|NCT01432171|466378136|FG001|Overall Study|Withdrawal by Subject|1|||
129780300|NCT01305577|467162279|FG000|Overall Study|Withdrawal by Subject|7|||
129780301|NCT01305577|467162280|FG001|Overall Study|Withdrawal by Subject|5|||
129780302|NCT01305577|467162281|FG002|Overall Study|Withdrawal by Subject|6|||
129780303|NCT01305577|467162279|FG000|Overall Study|Lost to Follow-up|4|||
129780304|NCT01305577|467162280|FG001|Overall Study|Lost to Follow-up|3|||
129780305|NCT01305577|467162281|FG002|Overall Study|Lost to Follow-up|2|||
129780306|NCT01305577|467162279|FG000|Overall Study|Protocol Deviation|0|||
129780307|NCT01305577|467162280|FG001|Overall Study|Protocol Deviation|1|||
129780308|NCT01305577|467162281|FG002|Overall Study|Protocol Deviation|1|||
129780309|NCT00905645|467162282|FG000|Overall Study|Death (not device related)|10|||
129780310|NCT00905645|467162283|FG001|Overall Study|Death (not device related)|4|||
129780311|NCT00905645|467162284|FG002|Overall Study|Death (not device related)|15|||
129780312|NCT00905645|467162285|FG003|Overall Study|Death (not device related)|8|||
129780313|NCT00905645|467162282|FG000|Overall Study|Explantation of study device(s)|78|||
129780314|NCT00905645|467162283|FG001|Overall Study|Explantation of study device(s)|47|||
129780315|NCT00905645|467162284|FG002|Overall Study|Explantation of study device(s)|28|||
129780316|NCT00905645|467162285|FG003|Overall Study|Explantation of study device(s)|21|||
129780317|NCT00905645|467162282|FG000|Overall Study|Subject Request|41|||
129780318|NCT00905645|467162283|FG001|Overall Study|Subject Request|17|||
129780319|NCT00905645|467162284|FG002|Overall Study|Subject Request|13|||
129780320|NCT00905645|467162285|FG003|Overall Study|Subject Request|11|||
129780321|NCT00905645|467162282|FG000|Overall Study|Lost to Follow-up|299|||
129780322|NCT00905645|467162283|FG001|Overall Study|Lost to Follow-up|103|||
129568573|NCT01432171|466378135|FG000|Overall Study|Noncompliance|2|||
129568574|NCT01432171|466378136|FG001|Overall Study|Noncompliance|3|||
129568575|NCT01432171|466378135|FG000|Overall Study|Insurance denial trial coverage|1|||
129568576|NCT01432171|466378136|FG001|Overall Study|Insurance denial trial coverage|0|||
129568577|NCT01432171|466378135|FG000|Overall Study|Patient moved to palliative care|1|||
129568578|NCT01432171|466378136|FG001|Overall Study|Patient moved to palliative care|0|||
129568579|NCT01706926|466378137|FG000|Overall Study|Lost to Follow-up|0|||
129568580|NCT01706926|466378138|FG001|Overall Study|Lost to Follow-up|0|||
129780323|NCT00905645|467162284|FG002|Overall Study|Lost to Follow-up|51|||
129780324|NCT00905645|467162285|FG003|Overall Study|Lost to Follow-up|12|||
129780325|NCT01386970|467162286|FG000|Overall Study|Withdrawal by Subject|0|||
129780326|NCT01386970|467162287|FG001|Overall Study|Withdrawal by Subject|1|||
129780327|NCT01386970|467162286|FG000|Overall Study|Adverse Event|4|||
129780328|NCT01386970|467162287|FG001|Overall Study|Adverse Event|1|||
129780329|NCT04931888|467162288|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
129780330|NCT04931888|467162289|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
129780331|NCT04931888|467162290|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
129780332|NCT04931888|467162291|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
129780333|NCT01976741|467162303|FG000|Overall Study|Withdrawal by Subject|1|||
129780334|NCT01976741|467162304|FG001|Overall Study|Withdrawal by Subject|0|||
129780335|NCT01976741|467162305|FG002|Overall Study|Withdrawal by Subject|1|||
129780336|NCT01976741|467162306|FG003|Overall Study|Withdrawal by Subject|1|||
129780337|NCT01976741|467162307|FG004|Overall Study|Withdrawal by Subject|0|||
129780338|NCT01976741|467162308|FG005|Overall Study|Withdrawal by Subject|0|||
129780339|NCT01976741|467162309|FG006|Overall Study|Withdrawal by Subject|1|||
129780340|NCT01976741|467162310|FG007|Overall Study|Withdrawal by Subject|4|||
129780341|NCT01976741|467162311|FG008|Overall Study|Withdrawal by Subject|0|||
129780342|NCT01976741|467162312|FG009|Overall Study|Withdrawal by Subject|0|||
129780343|NCT01976741|467162303|FG000|Overall Study|Adverse Event|0|||
129780344|NCT01976741|467162304|FG001|Overall Study|Adverse Event|0|||
129780345|NCT01976741|467162305|FG002|Overall Study|Adverse Event|2|||
129780346|NCT01976741|467162306|FG003|Overall Study|Adverse Event|0|||
129780347|NCT01976741|467162307|FG004|Overall Study|Adverse Event|0|||
129780348|NCT01976741|467162308|FG005|Overall Study|Adverse Event|0|||
129780349|NCT01976741|467162309|FG006|Overall Study|Adverse Event|3|||
129780350|NCT01976741|467162310|FG007|Overall Study|Adverse Event|8|||
129780351|NCT01976741|467162311|FG008|Overall Study|Adverse Event|1|||
129780352|NCT01976741|467162312|FG009|Overall Study|Adverse Event|4|||
129780353|NCT02167139|467162313|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
129780354|NCT02167139|467162314|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
129780355|NCT02167139|467162315|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
129780356|NCT02167139|467162316|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
129780357|NCT02167139|467162313|FG000|Randomised, Double-blind|Adverse Event|2|||
129780358|NCT02167139|467162314|FG001|Randomised, Double-blind|Adverse Event|9|||
129780359|NCT02167139|467162315|FG002|Randomised, Double-blind|Adverse Event|0|||
129780360|NCT02167139|467162316|FG003|Randomised, Double-blind|Adverse Event|0|||
129780361|NCT02167139|467162313|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
129780362|NCT02167139|467162314|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
129780363|NCT02167139|467162315|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
129780364|NCT02167139|467162316|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
129780365|NCT02167139|467162313|FG000|Randomised, Double-blind|Other|3|||
129568581|NCT01706926|466378139|FG002|Overall Study|Lost to Follow-up|1|||
129568582|NCT01706926|466378140|FG003|Overall Study|Lost to Follow-up|0|||
129647316|NCT02135107|466663866|FG001|Maintenance Therapy Period|Other|0|||
129780366|NCT02167139|467162314|FG001|Randomised, Double-blind|Other|0|||
129780367|NCT02167139|467162315|FG002|Randomised, Double-blind|Other|0|||
129780368|NCT02167139|467162316|FG003|Randomised, Double-blind|Other|0|||
129780369|NCT02167139|467162313|FG000|Transition-extension|Adverse Event|2|||
129780370|NCT02167139|467162314|FG001|Transition-extension|Adverse Event|0|||
129780371|NCT02167139|467162315|FG002|Transition-extension|Adverse Event|2|||
129780372|NCT02167139|467162316|FG003|Transition-extension|Adverse Event|3|||
129568583|NCT01706926|466378137|FG000|Overall Study|Withdrawal by Subject|2|||
129568584|NCT01706926|466378138|FG001|Overall Study|Withdrawal by Subject|0|||
129780373|NCT02167139|467162313|FG000|Transition-extension|Withdrawal by Subject|2|||
129780374|NCT02167139|467162314|FG001|Transition-extension|Withdrawal by Subject|0|||
129780375|NCT02167139|467162315|FG002|Transition-extension|Withdrawal by Subject|4|||
129780376|NCT02167139|467162316|FG003|Transition-extension|Withdrawal by Subject|1|||
129780377|NCT02167139|467162313|FG000|Transition-extension|Lack of Efficacy|0|||
129780378|NCT02167139|467162314|FG001|Transition-extension|Lack of Efficacy|0|||
129780379|NCT02167139|467162315|FG002|Transition-extension|Lack of Efficacy|1|||
129780380|NCT02167139|467162316|FG003|Transition-extension|Lack of Efficacy|1|||
129780381|NCT02167139|467162313|FG000|Transition-extension|Other|1|||
129780382|NCT02167139|467162314|FG001|Transition-extension|Other|0|||
129780383|NCT02167139|467162315|FG002|Transition-extension|Other|1|||
129780384|NCT02167139|467162316|FG003|Transition-extension|Other|0|||
129780385|NCT02167139|467162313|FG000|Transition-extension|Lost to Follow-up|1|||
129780386|NCT02167139|467162314|FG001|Transition-extension|Lost to Follow-up|0|||
129780387|NCT02167139|467162315|FG002|Transition-extension|Lost to Follow-up|0|||
129780388|NCT02167139|467162316|FG003|Transition-extension|Lost to Follow-up|0|||
129780389|NCT03350672|467162319|FG000|Overall Study|Withdrawal by Subject|7|||
129780390|NCT03350672|467162320|FG001|Overall Study|Withdrawal by Subject|0|||
129780391|NCT03350672|467162321|FG002|Overall Study|Withdrawal by Subject|0|||
129780392|NCT02504216|467162322|FG000|Overall Study|Lost to Follow-up|3|||
129780393|NCT02504216|467162323|FG001|Overall Study|Lost to Follow-up|3|||
129780394|NCT02504216|467162322|FG000|Overall Study|Withdrawal by Subject|8|||
129780395|NCT02504216|467162323|FG001|Overall Study|Withdrawal by Subject|12|||
129780396|NCT00223080|467162324|FG000|Overall Study|Withdrawal by Subject|253|||
129780397|NCT00223080|467162325|FG001|Overall Study|Withdrawal by Subject|232|||
129780398|NCT00223080|467162324|FG000|Overall Study|Required contraindicated med|0|||
129780399|NCT00223080|467162325|FG001|Overall Study|Required contraindicated med|1|||
129780400|NCT00223080|467162324|FG000|Overall Study|Non-compliant|7|||
129780401|NCT00223080|467162325|FG001|Overall Study|Non-compliant|7|||
129780402|NCT00223080|467162324|FG000|Overall Study|Moved from study area|37|||
129780403|NCT00223080|467162325|FG001|Overall Study|Moved from study area|47|||
129780404|NCT00223080|467162324|FG000|Overall Study|Lost to Follow-up|259|||
129780405|NCT00223080|467162325|FG001|Overall Study|Lost to Follow-up|284|||
129780406|NCT00223080|467162324|FG000|Overall Study|Death|85|||
129780407|NCT00223080|467162325|FG001|Overall Study|Death|74|||
129780408|NCT00223080|467162324|FG000|Overall Study|Other|14|||
129780409|NCT00223080|467162325|FG001|Overall Study|Other|11|||
129780410|NCT00223080|467162324|FG000|Overall Study|Reason not provided|141|||
129780411|NCT00223080|467162325|FG001|Overall Study|Reason not provided|140|||
129780412|NCT00223080|467162324|FG000|Overall Study|Adverse Event|0|||
129780413|NCT00223080|467162325|FG001|Overall Study|Adverse Event|1|||
129780414|NCT02598583|467162326|FG000|Extension Period|Withdrawal by Subject|1|||
129780415|NCT02598583|467162327|FG001|Extension Period|Withdrawal by Subject|0|||
129780416|NCT03237286|467162328|FG000|Overall Study|Withdrawal by Subject|1|||
129780417|NCT03237286|467162329|FG001|Overall Study|Withdrawal by Subject|0|||
129780418|NCT03237286|467162330|FG002|Overall Study|Withdrawal by Subject|2|||
129780419|NCT03237286|467162328|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
129780420|NCT03237286|467162329|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
129780421|NCT03237286|467162330|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
129780422|NCT00948441|467162338|FG000|Overall Study|no longer meet inclusion criteria|1|||
129780423|NCT00948441|467162339|FG001|Overall Study|no longer meet inclusion criteria|4|||
129780424|NCT00947882|467162342|FG000|Overall Study|Adverse Event|0|||
129780425|NCT00947882|467162343|FG001|Overall Study|Adverse Event|1|||
129780426|NCT00947882|467162344|FG002|Overall Study|Adverse Event|4|||
129780427|NCT00947882|467162345|FG003|Overall Study|Adverse Event|4|||
129780428|NCT00947882|467162342|FG000|Overall Study|Withdrawal by Subject|2|||
129780429|NCT00947882|467162343|FG001|Overall Study|Withdrawal by Subject|0|||
129780430|NCT00947882|467162344|FG002|Overall Study|Withdrawal by Subject|8|||
129780431|NCT00947882|467162345|FG003|Overall Study|Withdrawal by Subject|2|||
129780432|NCT00947882|467162342|FG000|Overall Study|Protocol Violation|0|||
129780433|NCT00947882|467162343|FG001|Overall Study|Protocol Violation|0|||
129780434|NCT00947882|467162344|FG002|Overall Study|Protocol Violation|1|||
129780435|NCT00947882|467162345|FG003|Overall Study|Protocol Violation|0|||
129780436|NCT00947882|467162342|FG000|Overall Study|Lost to Follow-up|0|||
129780437|NCT00947882|467162343|FG001|Overall Study|Lost to Follow-up|2|||
129780438|NCT00947882|467162344|FG002|Overall Study|Lost to Follow-up|1|||
129780439|NCT00947882|467162345|FG003|Overall Study|Lost to Follow-up|0|||
129780440|NCT00947882|467162342|FG000|Overall Study|Other/Unknown|10|||
129780441|NCT00947882|467162343|FG001|Overall Study|Other/Unknown|13|||
129780442|NCT00947882|467162344|FG002|Overall Study|Other/Unknown|3|||
129780443|NCT00947882|467162345|FG003|Overall Study|Other/Unknown|6|||
129780444|NCT00947882|467162342|FG000|Overall Study|Trial Terminated by Sponsor|62|||
129780445|NCT00947882|467162343|FG001|Overall Study|Trial Terminated by Sponsor|61|||
129780446|NCT00947882|467162344|FG002|Overall Study|Trial Terminated by Sponsor|62|||
129780447|NCT00947882|467162345|FG003|Overall Study|Trial Terminated by Sponsor|70|||
129780448|NCT01262820|467162346|FG000|Overall Study|Adverse Event|5|||
129780449|NCT01262820|467162346|FG000|Overall Study|Lack of Efficacy|9|||
129568585|NCT01706926|466378139|FG002|Overall Study|Withdrawal by Subject|1|||
129568586|NCT01706926|466378140|FG003|Overall Study|Withdrawal by Subject|2|||
129568587|NCT01706926|466378137|FG000|Overall Study|Other|4|||
129568588|NCT01706926|466378138|FG001|Overall Study|Other|4|||
129568589|NCT01706926|466378139|FG002|Overall Study|Other|4|||
129568590|NCT01706926|466378140|FG003|Overall Study|Other|3|||
129568591|NCT05628675|466379881|FG000|Overall Study|Lost to Follow-up|2|||
129568592|NCT05628675|466379881|FG000|Overall Study|Withdrawal by Subject|1|||
129568593|NCT01941095|466379882|FG000|Overall Study|Insufficient therapeutic response|13|||
129568594|NCT01941095|466379882|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
129568595|NCT01941095|466379882|FG000|Overall Study|Adverse Event|11|||
129568596|NCT01941095|466379882|FG000|Overall Study|Physician Decision|3|||
129568597|NCT01941095|466379882|FG000|Overall Study|Withdrawal by Subject|17|||
129568598|NCT01941095|466379882|FG000|Overall Study|Lost to Follow-up|10|||
129568599|NCT02918877|466379888|FG000|Overall Study|Withdrawal by Subject|2|||
129568600|NCT02918877|466379889|FG001|Overall Study|Withdrawal by Subject|2|||
129568601|NCT02918877|466379888|FG000|Overall Study|Surgery cancelled|1|||
129568602|NCT02918877|466379889|FG001|Overall Study|Surgery cancelled|0|||
129690094|NCT00160615|466824387|FG000|Overall Study|Poor compliance|0|||
129690095|NCT00160615|466824388|FG001|Overall Study|Poor compliance|1|||
129690096|NCT03166631|466824389|FG000|Overall Study|Progressive disease|2|||
129690097|NCT03166631|466824390|FG001|Overall Study|Progressive disease|1|||
129690098|NCT03166631|466824391|FG002|Overall Study|Progressive disease|3|||
129690099|NCT03166631|466824392|FG003|Overall Study|Progressive disease|4|||
129690100|NCT03166631|466824393|FG004|Overall Study|Progressive disease|2|||
129690101|NCT03166631|466824394|FG005|Overall Study|Progressive disease|2|||
129690102|NCT03166631|466824395|FG006|Overall Study|Progressive disease|5|||
129690103|NCT03166631|466824396|FG007|Overall Study|Progressive disease|6|||
129690104|NCT03166631|466824397|FG008|Overall Study|Progressive disease|11|||
129690105|NCT03166631|466824398|FG009|Overall Study|Progressive disease|5|||
129690106|NCT03166631|466824399|FG010|Overall Study|Progressive disease|7|||
129690107|NCT03166631|466824389|FG000|Overall Study|Physician Decision|0|||
129690108|NCT03166631|466824390|FG001|Overall Study|Physician Decision|0|||
129690109|NCT03166631|466824391|FG002|Overall Study|Physician Decision|0|||
129690110|NCT03166631|466824392|FG003|Overall Study|Physician Decision|0|||
129690111|NCT03166631|466824393|FG004|Overall Study|Physician Decision|0|||
129690112|NCT03166631|466824394|FG005|Overall Study|Physician Decision|0|||
129690113|NCT03166631|466824395|FG006|Overall Study|Physician Decision|1|||
129690114|NCT03166631|466824396|FG007|Overall Study|Physician Decision|0|||
129690115|NCT03166631|466824397|FG008|Overall Study|Physician Decision|1|||
129690116|NCT03166631|466824398|FG009|Overall Study|Physician Decision|0|||
129690117|NCT03166631|466824399|FG010|Overall Study|Physician Decision|1|||
129690118|NCT03166631|466824389|FG000|Overall Study|Death|0|||
129568603|NCT02918877|466379888|FG000|Overall Study|Physician Decision|1|||
129568604|NCT02918877|466379889|FG001|Overall Study|Physician Decision|0|||
129568605|NCT02918877|466379888|FG000|Overall Study|Received intraoperative steroids|1|||
129647317|NCT02135107|466663867|FG002|Maintenance Therapy Period|Other|7|||
129647318|NCT02135107|466663868|FG003|Maintenance Therapy Period|Other|8|||
129647319|NCT03197324|466663869|FG000|Overall Study|Adverse Event|0|||
129647320|NCT03197324|466663870|FG001|Overall Study|Adverse Event|1|||
129647321|NCT00877071|466663871|FG000|Overall Study|disease progression|2|||
129647322|NCT01984892|466663872|FG000|Overall Study|Progressive disease|7|||
129647323|NCT05723328|466663874|FG000|Overall Study|Investigator's Decision|5|||
129647324|NCT05723328|466663875|FG001|Overall Study|Investigator's Decision|2|||
129647325|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
129647326|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
129647327|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
129647328|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
129647329|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
129647330|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
129647331|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
129647332|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
129647333|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
129647334|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
129647335|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
129647336|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
129647337|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
129647338|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
129647339|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
129647340|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
129568606|NCT02918877|466379889|FG001|Overall Study|Received intraoperative steroids|0|||
129568607|NCT02918877|466379888|FG000|Overall Study|Unable to obtain lab samples|1|||
129568608|NCT02918877|466379889|FG001|Overall Study|Unable to obtain lab samples|0|||
129568609|NCT02918877|466379888|FG000|Overall Study|Unsafe to perform BAL|0|||
129568610|NCT02918877|466379889|FG001|Overall Study|Unsafe to perform BAL|1|||
129568611|NCT01648166|466379890|FG000|Overall Study|inadequate toenail samples|53|||
129568612|NCT01648166|466379891|FG001|Overall Study|inadequate toenail samples|100|||
129568613|NCT00883090|466379892|FG000|Overall Study|Sponsor's decision|1|||
129568614|NCT00883090|466379892|FG000|Overall Study|Withdrawal by Subject|1|||
129568615|NCT02532764|466379893|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568616|NCT02532764|466379894|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568617|NCT02532764|466379895|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568618|NCT02532764|466379896|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568619|NCT02532764|466379897|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568620|NCT02532764|466379898|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568621|NCT02532764|466379899|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
129568622|NCT02532764|466379900|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
129568623|NCT02532764|466379901|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
129568624|NCT02532764|466379902|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
129568625|NCT03527745|466379903|FG000|Overall Study|Lost to Follow-up|3|||
129568626|NCT03527745|466379904|FG001|Overall Study|Lost to Follow-up|6|||
129568627|NCT03527745|466379905|FG002|Overall Study|Lost to Follow-up|7|||
129568628|NCT03527745|466379906|FG003|Overall Study|Lost to Follow-up|9|||
129568629|NCT03527745|466379907|FG004|Overall Study|Lost to Follow-up|0|||
129568630|NCT03527745|466379908|FG005|Overall Study|Lost to Follow-up|2|||
129568631|NCT03527745|466379909|FG006|Overall Study|Lost to Follow-up|3|||
129568632|NCT03527745|466379910|FG007|Overall Study|Lost to Follow-up|2|||
129568633|NCT03527745|466379911|FG008|Overall Study|Lost to Follow-up|3|||
129568634|NCT03527745|466379912|FG009|Overall Study|Lost to Follow-up|2|||
129568635|NCT03527745|466379913|FG010|Overall Study|Lost to Follow-up|1|||
129568636|NCT03527745|466379914|FG011|Overall Study|Lost to Follow-up|1|||
129568637|NCT03527745|466379915|FG012|Overall Study|Lost to Follow-up|0|||
129568638|NCT03527745|466379916|FG013|Overall Study|Lost to Follow-up|0|||
129568639|NCT03527745|466379917|FG014|Overall Study|Lost to Follow-up|0|||
129568640|NCT03527745|466379918|FG015|Overall Study|Lost to Follow-up|0|||
129568641|NCT03527745|466379919|FG016|Overall Study|Lost to Follow-up|1|||
129568642|NCT03527745|466379920|FG017|Overall Study|Lost to Follow-up|0|||
129568643|NCT03527745|466379921|FG018|Overall Study|Lost to Follow-up|0|||
129568644|NCT03527745|466379922|FG019|Overall Study|Lost to Follow-up|1|||
129780450|NCT01262820|467162346|FG000|Overall Study|Drug held for 21+ days|1|||
129780451|NCT00104520|467162347|FG000|Overall Study|Unrelated adverse event|34|||
129568645|NCT03527745|466379923|FG020|Overall Study|Lost to Follow-up|1|||
129568646|NCT03527745|466379924|FG021|Overall Study|Lost to Follow-up|5|||
129568647|NCT03527745|466379925|FG022|Overall Study|Lost to Follow-up|6|||
129568648|NCT03527745|466379926|FG023|Overall Study|Lost to Follow-up|8|||
129568649|NCT03527745|466379927|FG024|Overall Study|Lost to Follow-up|1|||
129568650|NCT03527745|466379928|FG025|Overall Study|Lost to Follow-up|3|||
129568651|NCT01475838|466379931|FG000|Randomized Phase|Randomized but Not Treated|0|||
129568652|NCT01475838|466379932|FG001|Randomized Phase|Randomized but Not Treated|5|||
129568653|NCT01475838|466379931|FG000|Randomized Phase|Adverse Event|6|||
129568654|NCT01475838|466379932|FG001|Randomized Phase|Adverse Event|1|||
129690119|NCT03166631|466824390|FG001|Overall Study|Death|0|||
129690120|NCT03166631|466824391|FG002|Overall Study|Death|0|||
129690121|NCT03166631|466824392|FG003|Overall Study|Death|0|||
129690122|NCT03166631|466824393|FG004|Overall Study|Death|1|||
129690123|NCT03166631|466824394|FG005|Overall Study|Death|0|||
129690124|NCT03166631|466824395|FG006|Overall Study|Death|1|||
129690125|NCT03166631|466824396|FG007|Overall Study|Death|0|||
129690126|NCT03166631|466824397|FG008|Overall Study|Death|0|||
129690127|NCT03166631|466824398|FG009|Overall Study|Death|0|||
129690128|NCT03166631|466824399|FG010|Overall Study|Death|0|||
129690129|NCT03166631|466824389|FG000|Overall Study|Adverse Event|1|||
129690130|NCT03166631|466824390|FG001|Overall Study|Adverse Event|0|||
129690131|NCT03166631|466824391|FG002|Overall Study|Adverse Event|0|||
129780452|NCT00104520|467162348|FG001|Overall Study|Unrelated adverse event|47|||
129780453|NCT00104520|467162347|FG000|Overall Study|Study drug intolerance|0|||
129568655|NCT01475838|466379931|FG000|Randomized Phase|Pregnancy|0|||
129568656|NCT01475838|466379932|FG001|Randomized Phase|Pregnancy|1|||
129568657|NCT01475838|466379931|FG000|Randomized Phase|Investigators Discretion|1|||
129568658|NCT01475838|466379932|FG001|Randomized Phase|Investigators Discretion|2|||
129568659|NCT01475838|466379931|FG000|Randomized Phase|Withdrew Consent|10|||
129568660|NCT01475838|466379932|FG001|Randomized Phase|Withdrew Consent|14|||
129690132|NCT03166631|466824392|FG003|Overall Study|Adverse Event|0|||
129690133|NCT03166631|466824393|FG004|Overall Study|Adverse Event|0|||
129568661|NCT01475838|466379931|FG000|Randomized Phase|Lost to Follow-up|3|||
129568662|NCT01475838|466379932|FG001|Randomized Phase|Lost to Follow-up|4|||
129568663|NCT01475838|466379931|FG000|Randomized Phase|Participant Noncompliance|1|||
129568664|NCT01475838|466379932|FG001|Randomized Phase|Participant Noncompliance|5|||
129568665|NCT01475838|466379931|FG000|Randomized Phase|Protocol Violation|9|||
129568666|NCT01475838|466379932|FG001|Randomized Phase|Protocol Violation|4|||
129568667|NCT01475838|466379931|FG000|Extension Phase|Participant Noncompliance|1|||
129568668|NCT01475838|466379932|FG001|Extension Phase|Participant Noncompliance|0|||
129568669|NCT00048568|466379933|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
129568670|NCT00048568|466379934|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
129568671|NCT00048568|466379935|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
129568672|NCT00048568|466379933|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
129568673|NCT00048568|466379934|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
129568674|NCT00048568|466379935|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
129568675|NCT00048568|466379933|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
129568676|NCT00048568|466379934|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
129568677|NCT00048568|466379935|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
129568678|NCT00048568|466379933|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
129568679|NCT00048568|466379934|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
129568680|NCT00048568|466379935|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
129568681|NCT00048568|466379933|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
129568682|NCT00048568|466379934|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
129568683|NCT00048568|466379935|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
129568684|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|Death|1|||
129568685|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|Death|1|||
129568686|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|Death|0|||
129568687|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
129568688|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
129568689|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
129568690|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
129568691|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
129568692|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
129568693|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
129568694|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
129568695|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
129568696|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
129568697|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
129568698|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
129568699|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
129568700|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
129568701|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
129568702|NCT00048568|466379933|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
129568703|NCT00048568|466379934|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
129568704|NCT00048568|466379935|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
129568705|NCT00048568|466379933|FG000|Open-Label Period|Death|0|||
129568706|NCT00048568|466379934|FG001|Open-Label Period|Death|0|||
129568707|NCT00048568|466379935|FG002|Open-Label Period|Death|13|||
129568708|NCT00048568|466379933|FG000|Open-Label Period|Adverse Event|0|||
129568709|NCT00048568|466379934|FG001|Open-Label Period|Adverse Event|0|||
129568710|NCT00048568|466379935|FG002|Open-Label Period|Adverse Event|49|||
129568711|NCT00048568|466379933|FG000|Open-Label Period|Lack of Efficacy|0|||
129568712|NCT00048568|466379934|FG001|Open-Label Period|Lack of Efficacy|0|||
129568713|NCT00048568|466379935|FG002|Open-Label Period|Lack of Efficacy|32|||
129568714|NCT00048568|466379933|FG000|Open-Label Period|Withdrawal by Subject|0|||
129568715|NCT00048568|466379934|FG001|Open-Label Period|Withdrawal by Subject|0|||
129568716|NCT00048568|466379935|FG002|Open-Label Period|Withdrawal by Subject|26|||
129568717|NCT00048568|466379933|FG000|Open-Label Period|Pregnancy|0|||
129568718|NCT00048568|466379934|FG001|Open-Label Period|Pregnancy|0|||
129568719|NCT00048568|466379935|FG002|Open-Label Period|Pregnancy|5|||
129568720|NCT00048568|466379933|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
129568721|NCT00048568|466379934|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
129568722|NCT00048568|466379935|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
129568723|NCT00048568|466379933|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
129568724|NCT00048568|466379934|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
129568725|NCT00048568|466379935|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
129568726|NCT00048568|466379933|FG000|Open-Label Period|Unknown Reasons|0|||
129568727|NCT00048568|466379934|FG001|Open-Label Period|Unknown Reasons|0|||
129568728|NCT00048568|466379935|FG002|Open-Label Period|Unknown Reasons|25|||
129568729|NCT00048568|466379933|FG000|Open-Label Period|Lost to Follow-up|0|||
129568730|NCT00048568|466379934|FG001|Open-Label Period|Lost to Follow-up|0|||
129568731|NCT00048568|466379935|FG002|Open-Label Period|Lost to Follow-up|7|||
129568732|NCT01717976|466379936|FG000|Overall Study|Protocol Violation|0|||
129780454|NCT00104520|467162348|FG001|Overall Study|Study drug intolerance|1|||
129780455|NCT00104520|467162347|FG000|Overall Study|Related adverse event|13|||
129780456|NCT00104520|467162348|FG001|Overall Study|Related adverse event|15|||
129780457|NCT00104520|467162347|FG000|Overall Study|Lost to Follow-up|1|||
129780458|NCT00104520|467162348|FG001|Overall Study|Lost to Follow-up|0|||
129780459|NCT00104520|467162347|FG000|Overall Study|Noncompliance|0|||
129780460|NCT00104520|467162348|FG001|Overall Study|Noncompliance|2|||
129780461|NCT00104520|467162347|FG000|Overall Study|Personal/administrative|1|||
129780462|NCT00104520|467162348|FG001|Overall Study|Personal/administrative|1|||
129780463|NCT00104520|467162347|FG000|Overall Study|Other|1|||
129780464|NCT00104520|467162348|FG001|Overall Study|Other|5|||
129780465|NCT01026324|467162350|FG000|Follow up/Survival|Withdrawal by Subject|1|||
129568733|NCT01717976|466379937|FG001|Overall Study|Protocol Violation|1|||
129780466|NCT01026324|467162351|FG001|Follow up/Survival|Withdrawal by Subject|0|||
129780467|NCT01026324|467162352|FG002|Follow up/Survival|Withdrawal by Subject|0|||
129780468|NCT05188053|467162353|FG000|Overall Study|Lost to Follow-up|23|||
129780469|NCT05188053|467162354|FG001|Overall Study|Lost to Follow-up|30|||
129780470|NCT05188053|467162353|FG000|Overall Study|Protocol Violation|16|||
129780471|NCT05188053|467162354|FG001|Overall Study|Protocol Violation|16|||
129780472|NCT05188053|467162353|FG000|Overall Study|Physician Decision|3|||
129780473|NCT05188053|467162354|FG001|Overall Study|Physician Decision|0|||
129780474|NCT05188053|467162353|FG000|Overall Study|Withdrawal by Subject|0|||
129780475|NCT05188053|467162354|FG001|Overall Study|Withdrawal by Subject|1|||
129780476|NCT05334212|467162355|FG000|Overall Study|Study terminated prematurely|7|||
129780477|NCT04393454|467162356|FG000|Overall Study|Death|1|||
129780478|NCT04393454|467162356|FG000|Overall Study|Lost to Follow-up|1|||
129780479|NCT03304249|467162358|FG000|Overall Study|Lost to Follow-up|8|||
129780480|NCT03304249|467162359|FG001|Overall Study|Lost to Follow-up|10|||
129780481|NCT03304249|467162358|FG000|Overall Study|Withdrawal by Subject|12|||
129780482|NCT03304249|467162359|FG001|Overall Study|Withdrawal by Subject|2|||
129780483|NCT03304249|467162358|FG000|Overall Study|Moved Out of District|4|||
129780484|NCT03304249|467162359|FG001|Overall Study|Moved Out of District|2|||
129780485|NCT04189224|467162360|FG000|Period 2|Adverse Event|0|||
129780486|NCT04189224|467162361|FG001|Period 2|Adverse Event|1|||
129780487|NCT04198714|467162362|FG000|Overall Study|Physician Decision|0|||
129780488|NCT04198714|467162363|FG001|Overall Study|Physician Decision|1|||
129780489|NCT02970942|467162364|FG000|Overall Study|Death|0|||
129780490|NCT02970942|467162365|FG001|Overall Study|Death|1|||
129780491|NCT02970942|467162366|FG002|Overall Study|Death|0|||
129780492|NCT02970942|467162367|FG003|Overall Study|Death|0|||
129780493|NCT02970942|467162364|FG000|Overall Study|Lost to Follow-up|1|||
129780494|NCT02970942|467162365|FG001|Overall Study|Lost to Follow-up|0|||
129780495|NCT02970942|467162366|FG002|Overall Study|Lost to Follow-up|2|||
129780496|NCT02970942|467162367|FG003|Overall Study|Lost to Follow-up|1|||
129780497|NCT02970942|467162364|FG000|Overall Study|Withdrawal by Subject|3|||
129780498|NCT02970942|467162365|FG001|Overall Study|Withdrawal by Subject|5|||
129780499|NCT02970942|467162366|FG002|Overall Study|Withdrawal by Subject|3|||
129780500|NCT02970942|467162367|FG003|Overall Study|Withdrawal by Subject|2|||
129780501|NCT02529553|467162368|FG000|Overall Study|Progressive Disease|1|||
129780502|NCT02529553|467162369|FG001|Overall Study|Progressive Disease|0|||
129780503|NCT02529553|467162370|FG002|Overall Study|Progressive Disease|1|||
129780504|NCT02529553|467162371|FG003|Overall Study|Progressive Disease|3|||
129780505|NCT02529553|467162372|FG004|Overall Study|Progressive Disease|2|||
129568734|NCT03831048|466379938|FG000|Overall Study|Protocol Violation|9|||
129568735|NCT03831048|466379939|FG001|Overall Study|Protocol Violation|3|||
129568736|NCT03831048|466379938|FG000|Overall Study|Death|4|||
129780506|NCT02529553|467162373|FG005|Overall Study|Progressive Disease|3|||
129780507|NCT02529553|467162374|FG006|Overall Study|Progressive Disease|3|||
129780508|NCT02529553|467162375|FG007|Overall Study|Progressive Disease|5|||
129780509|NCT02529553|467162376|FG008|Overall Study|Progressive Disease|3|||
129780510|NCT02529553|467162368|FG000|Overall Study|Physician Decision|0|||
129780511|NCT02529553|467162369|FG001|Overall Study|Physician Decision|1|||
129780512|NCT02529553|467162370|FG002|Overall Study|Physician Decision|0|||
129780513|NCT02529553|467162371|FG003|Overall Study|Physician Decision|0|||
129780514|NCT02529553|467162372|FG004|Overall Study|Physician Decision|1|||
129780515|NCT02529553|467162373|FG005|Overall Study|Physician Decision|0|||
129780516|NCT02529553|467162374|FG006|Overall Study|Physician Decision|0|||
129780517|NCT02529553|467162375|FG007|Overall Study|Physician Decision|0|||
129780518|NCT02529553|467162376|FG008|Overall Study|Physician Decision|0|||
129780519|NCT02529553|467162368|FG000|Overall Study|Withdrawal by Subject|0|||
129780520|NCT02529553|467162369|FG001|Overall Study|Withdrawal by Subject|0|||
129780521|NCT02529553|467162370|FG002|Overall Study|Withdrawal by Subject|0|||
129780522|NCT02529553|467162371|FG003|Overall Study|Withdrawal by Subject|0|||
129780523|NCT02529553|467162372|FG004|Overall Study|Withdrawal by Subject|0|||
129780524|NCT02529553|467162373|FG005|Overall Study|Withdrawal by Subject|1|||
129780525|NCT02529553|467162374|FG006|Overall Study|Withdrawal by Subject|0|||
129780526|NCT02529553|467162375|FG007|Overall Study|Withdrawal by Subject|1|||
129780527|NCT02529553|467162376|FG008|Overall Study|Withdrawal by Subject|0|||
129780528|NCT00488683|467162377|FG000|Overall Study|Withdrawal by Subject|1|||
129780529|NCT00488683|467162378|FG001|Overall Study|Withdrawal by Subject|2|||
129780530|NCT00488683|467162379|FG002|Overall Study|Withdrawal by Subject|2|||
129780531|NCT00488683|467162377|FG000|Overall Study|Lost to Follow-up|5|||
129780532|NCT00488683|467162378|FG001|Overall Study|Lost to Follow-up|3|||
129780533|NCT00488683|467162379|FG002|Overall Study|Lost to Follow-up|0|||
129780534|NCT00488683|467162377|FG000|Overall Study|Protocol Violation|5|||
129780535|NCT00488683|467162378|FG001|Overall Study|Protocol Violation|1|||
129780536|NCT00488683|467162379|FG002|Overall Study|Protocol Violation|0|||
129780537|NCT00488683|467162377|FG000|Overall Study|Unable to Classify|1|||
129780538|NCT00488683|467162378|FG001|Overall Study|Unable to Classify|0|||
129568737|NCT03831048|466379939|FG001|Overall Study|Death|9|||
129568738|NCT03831048|466379938|FG000|Overall Study|Re-transplant|0|||
129568739|NCT03831048|466379939|FG001|Overall Study|Re-transplant|2|||
129568740|NCT03831048|466379938|FG000|Overall Study|Protocol violation and death|1|||
129568741|NCT03831048|466379939|FG001|Overall Study|Protocol violation and death|1|||
129690134|NCT03166631|466824394|FG005|Overall Study|Adverse Event|1|||
129690135|NCT03166631|466824395|FG006|Overall Study|Adverse Event|1|||
129690136|NCT03166631|466824396|FG007|Overall Study|Adverse Event|0|||
129690137|NCT03166631|466824397|FG008|Overall Study|Adverse Event|1|||
129690138|NCT03166631|466824398|FG009|Overall Study|Adverse Event|2|||
129690139|NCT03166631|466824399|FG010|Overall Study|Adverse Event|1|||
129690140|NCT03166631|466824389|FG000|Overall Study|Withdrawal by Subject|0|||
129690141|NCT03166631|466824390|FG001|Overall Study|Withdrawal by Subject|0|||
129690142|NCT03166631|466824391|FG002|Overall Study|Withdrawal by Subject|0|||
129690143|NCT03166631|466824392|FG003|Overall Study|Withdrawal by Subject|0|||
129690144|NCT03166631|466824393|FG004|Overall Study|Withdrawal by Subject|0|||
129690145|NCT03166631|466824394|FG005|Overall Study|Withdrawal by Subject|0|||
129690146|NCT03166631|466824395|FG006|Overall Study|Withdrawal by Subject|0|||
129690147|NCT03166631|466824396|FG007|Overall Study|Withdrawal by Subject|0|||
129690148|NCT03166631|466824397|FG008|Overall Study|Withdrawal by Subject|1|||
129690149|NCT03166631|466824398|FG009|Overall Study|Withdrawal by Subject|1|||
129690150|NCT03166631|466824399|FG010|Overall Study|Withdrawal by Subject|0|||
129690151|NCT00567580|466824402|FG000|Overall Study|Protocol Violation|28|||
129690152|NCT00567580|466824403|FG001|Overall Study|Protocol Violation|24|||
129690153|NCT00567580|466824404|FG002|Overall Study|Protocol Violation|24|||
129690154|NCT00382070|466824405|FG000|Overall Study|No follow up data mapped to Other|17|||
129690155|NCT00382070|466824406|FG001|Overall Study|No follow up data mapped to Other|19|||
129690156|NCT00382070|466824405|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
129690157|NCT00382070|466824406|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
129690158|NCT00382070|466824405|FG000|Overall Study|No clinical assessment|9|||
129690159|NCT00382070|466824406|FG001|Overall Study|No clinical assessment|11|||
129690160|NCT00284934|466824407|FG000|Overall Study|Adverse Event|1|||
129690161|NCT00284934|466824408|FG001|Overall Study|Adverse Event|2|||
129690162|NCT00284934|466824407|FG000|Overall Study|Other reasons|3|||
129690163|NCT00284934|466824408|FG001|Overall Study|Other reasons|1|||
129690164|NCT03309605|466824413|FG000|Overall Study|Adverse Event|0|||
129690165|NCT03309605|466824414|FG001|Overall Study|Adverse Event|0|||
129690166|NCT03309605|466824415|FG002|Overall Study|Adverse Event|0|||
129690167|NCT03309605|466824416|FG003|Overall Study|Adverse Event|1|||
129690168|NCT03309605|466824417|FG004|Overall Study|Adverse Event|0|||
129690169|NCT03309605|466824418|FG005|Overall Study|Adverse Event|0|||
129690170|NCT03309605|466824419|FG006|Overall Study|Adverse Event|2|||
129690171|NCT03309605|466824420|FG007|Overall Study|Adverse Event|1|||
129780539|NCT00488683|467162379|FG002|Overall Study|Unable to Classify|0|||
129780540|NCT01865552|467163871|FG000|Period 1|Adverse Event|1|||
129780541|NCT01865552|467163872|FG001|Period 1|Adverse Event|0|||
129568742|NCT00560235|466379943|FG000|Phase 1|Discontinued|8|||
129690172|NCT03309605|466824413|FG000|Overall Study|Withdrawal by Subject|0|||
129690173|NCT03309605|466824414|FG001|Overall Study|Withdrawal by Subject|0|||
129690174|NCT03309605|466824415|FG002|Overall Study|Withdrawal by Subject|0|||
129690175|NCT03309605|466824416|FG003|Overall Study|Withdrawal by Subject|0|||
129690176|NCT03309605|466824417|FG004|Overall Study|Withdrawal by Subject|1|||
129690177|NCT03309605|466824418|FG005|Overall Study|Withdrawal by Subject|0|||
129690178|NCT03309605|466824419|FG006|Overall Study|Withdrawal by Subject|1|||
129690179|NCT03309605|466824420|FG007|Overall Study|Withdrawal by Subject|1|||
129690180|NCT03197935|466824421|FG000|Overall Study|Death due to any cause|26|||
129780542|NCT01865552|467163873|FG002|Period 1|Adverse Event|0|||
129780543|NCT01865552|467163874|FG003|Period 1|Adverse Event|1|||
129780544|NCT01865552|467163875|FG004|Period 1|Adverse Event|1|||
129780545|NCT01865552|467163876|FG005|Period 1|Adverse Event|1|||
129568743|NCT00560235|466379944|FG001|Phase 1|Discontinued|0|||
129568744|NCT00560235|466379945|FG002|Phase 1|Discontinued|0|||
129568745|NCT00560235|466379943|FG000|Phase 1B|Discontinued|0|||
129568746|NCT00560235|466379944|FG001|Phase 1B|Discontinued|19|||
129568747|NCT00560235|466379945|FG002|Phase 1B|Discontinued|0|||
129568748|NCT00560235|466379943|FG000|Phase 2|Discontinued|0|||
129568749|NCT00560235|466379944|FG001|Phase 2|Discontinued|0|||
129568750|NCT00560235|466379945|FG002|Phase 2|Discontinued|96|||
129568751|NCT00560235|466379943|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
129568752|NCT00560235|466379944|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
129568753|NCT00560235|466379945|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
129568754|NCT01315249|466379950|FG000|Overall Study|Adverse Event|22|||
129568755|NCT01315249|466379951|FG001|Overall Study|Adverse Event|26|||
129568756|NCT01315249|466379950|FG000|Overall Study|Withdrawal by Subject|11|||
129568757|NCT01315249|466379951|FG001|Overall Study|Withdrawal by Subject|10|||
129568758|NCT01315249|466379950|FG000|Overall Study|Protocol Violation|8|||
129568759|NCT01315249|466379951|FG001|Overall Study|Protocol Violation|5|||
129568760|NCT01315249|466379950|FG000|Overall Study|Abnormal test results|1|||
129568761|NCT01315249|466379951|FG001|Overall Study|Abnormal test results|2|||
129568762|NCT01315249|466379950|FG000|Overall Study|Administrative problems|1|||
129568763|NCT01315249|466379951|FG001|Overall Study|Administrative problems|0|||
129568764|NCT01315249|466379950|FG000|Overall Study|inability to use device|1|||
129568765|NCT01315249|466379951|FG001|Overall Study|inability to use device|0|||
129568766|NCT01315249|466379950|FG000|Overall Study|Lack of Efficacy|0|||
129568767|NCT01315249|466379951|FG001|Overall Study|Lack of Efficacy|1|||
129568768|NCT01315249|466379950|FG000|Overall Study|Lost to Follow-up|0|||
129568769|NCT01315249|466379951|FG001|Overall Study|Lost to Follow-up|2|||
129568770|NCT01315249|466379950|FG000|Overall Study|Death|0|||
129568771|NCT01315249|466379951|FG001|Overall Study|Death|1|||
129568772|NCT00864097|466379972|FG000|Overall Study|Death|0|||
129568773|NCT00864097|466379973|FG001|Overall Study|Death|1|||
129568774|NCT00864097|466379974|FG002|Overall Study|Death|0|||
129568775|NCT00864097|466379975|FG003|Overall Study|Death|0|||
129568776|NCT00864097|466379972|FG000|Overall Study|Adverse Event|6|||
129568777|NCT00864097|466379973|FG001|Overall Study|Adverse Event|8|||
129568778|NCT00864097|466379974|FG002|Overall Study|Adverse Event|11|||
129568779|NCT00864097|466379975|FG003|Overall Study|Adverse Event|9|||
129690181|NCT03197935|466824422|FG001|Overall Study|Death due to any cause|15|||
129780546|NCT01865552|467163871|FG000|Period 1|Pathological lab|0|||
129780547|NCT01865552|467163872|FG001|Period 1|Pathological lab|0|||
129690182|NCT03197935|466824421|FG000|Overall Study|Lost to Follow-up|3|||
129690183|NCT03197935|466824422|FG001|Overall Study|Lost to Follow-up|5|||
129690184|NCT03197935|466824421|FG000|Overall Study|Physician Decision|2|||
129690185|NCT03197935|466824422|FG001|Overall Study|Physician Decision|1|||
129690186|NCT03197935|466824421|FG000|Overall Study|Withdrawal by Subject|16|||
129690187|NCT03197935|466824422|FG001|Overall Study|Withdrawal by Subject|8|||
129690188|NCT02082483|466824423|FG000|Overall Study|Lost to Follow-up|1|||
129690189|NCT02082483|466824424|FG001|Overall Study|Lost to Follow-up|1|||
129690190|NCT02082483|466824423|FG000|Overall Study|Withdrawal by Subject|2|||
129690191|NCT02082483|466824424|FG001|Overall Study|Withdrawal by Subject|1|||
129690192|NCT02082483|466824423|FG000|Overall Study|Physician Decision|1|||
129690193|NCT02082483|466824424|FG001|Overall Study|Physician Decision|1|||
129690194|NCT02082483|466824423|FG000|Overall Study|Death|2|||
129690195|NCT02082483|466824424|FG001|Overall Study|Death|3|||
129690196|NCT00864513|466824426|FG000|Overall Study|Withdrawal by Subject|3|||
129690197|NCT03073109|466824427|FG000|Overall Study|Adverse Event|0|||
129690198|NCT03073109|466824428|FG001|Overall Study|Adverse Event|1|||
129690199|NCT03073109|466824427|FG000|Overall Study|Other|2|||
129690200|NCT03073109|466824428|FG001|Overall Study|Other|0|||
129690201|NCT03073109|466824427|FG000|Overall Study|Lost to Follow-up|8|||
129690202|NCT03073109|466824428|FG001|Overall Study|Lost to Follow-up|1|||
129690203|NCT05938010|466824429|FG000|Overall Study|Lost to Follow-up|2|||
129690204|NCT01562444|466824434|FG000|Overall Study|Did not meet entry criteria|2|||
129690205|NCT01562444|466824435|FG001|Overall Study|Did not meet entry criteria|0|||
129568780|NCT00864097|466379972|FG000|Overall Study|Lack of Efficacy|9|||
129568781|NCT00864097|466379973|FG001|Overall Study|Lack of Efficacy|3|||
129568782|NCT00864097|466379974|FG002|Overall Study|Lack of Efficacy|7|||
129568783|NCT00864097|466379975|FG003|Overall Study|Lack of Efficacy|2|||
129568784|NCT00864097|466379972|FG000|Overall Study|Lost to Follow-up|0|||
129568785|NCT00864097|466379973|FG001|Overall Study|Lost to Follow-up|1|||
129568786|NCT00864097|466379974|FG002|Overall Study|Lost to Follow-up|0|||
129568787|NCT00864097|466379975|FG003|Overall Study|Lost to Follow-up|1|||
129568788|NCT00864097|466379972|FG000|Overall Study|Withdrawal by Subject|15|||
129690206|NCT01562444|466824436|FG002|Overall Study|Did not meet entry criteria|3|||
129690207|NCT01562444|466824434|FG000|Overall Study|Did not comply with blood draw schedule|1|||
129690208|NCT01562444|466824435|FG001|Overall Study|Did not comply with blood draw schedule|0|||
129690209|NCT01562444|466824436|FG002|Overall Study|Did not comply with blood draw schedule|1|||
129780548|NCT01865552|467163873|FG002|Period 1|Pathological lab|0|||
129568789|NCT00864097|466379973|FG001|Overall Study|Withdrawal by Subject|11|||
129568790|NCT00864097|466379974|FG002|Overall Study|Withdrawal by Subject|11|||
129568791|NCT00864097|466379975|FG003|Overall Study|Withdrawal by Subject|12|||
129568792|NCT00864097|466379972|FG000|Overall Study|Protocol Violation|2|||
129568793|NCT00864097|466379973|FG001|Overall Study|Protocol Violation|1|||
129568794|NCT00864097|466379974|FG002|Overall Study|Protocol Violation|0|||
129568795|NCT00864097|466379975|FG003|Overall Study|Protocol Violation|1|||
129568796|NCT00864097|466379972|FG000|Overall Study|Terminated by sponsor|105|||
129568797|NCT00864097|466379973|FG001|Overall Study|Terminated by sponsor|112|||
129568798|NCT00864097|466379974|FG002|Overall Study|Terminated by sponsor|102|||
129568799|NCT00864097|466379975|FG003|Overall Study|Terminated by sponsor|99|||
129568800|NCT00864097|466379972|FG000|Overall Study|Randomized but not treated|2|||
129568801|NCT00864097|466379973|FG001|Overall Study|Randomized but not treated|0|||
129568802|NCT00864097|466379974|FG002|Overall Study|Randomized but not treated|1|||
129690210|NCT01562444|466824434|FG000|Overall Study|Unavailable serological results|0|||
129690211|NCT01562444|466824435|FG001|Overall Study|Unavailable serological results|2|||
129690212|NCT01562444|466824436|FG002|Overall Study|Unavailable serological results|2|||
129568803|NCT00864097|466379975|FG003|Overall Study|Randomized but not treated|0|||
129780549|NCT01865552|467163874|FG003|Period 1|Pathological lab|0|||
129780550|NCT01865552|467163875|FG004|Period 1|Pathological lab|1|||
129568804|NCT00864097|466379972|FG000|Overall Study|Other|0|||
129568805|NCT00864097|466379973|FG001|Overall Study|Other|0|||
129568806|NCT00864097|466379974|FG002|Overall Study|Other|0|||
129568807|NCT00864097|466379975|FG003|Overall Study|Other|1|||
129568808|NCT00262223|466379976|FG000|Treatment Phase|Withdrawal by Subject|3|||
129568809|NCT00262223|466379977|FG001|Treatment Phase|Withdrawal by Subject|6|||
129568810|NCT00262223|466379976|FG000|Treatment Phase|Adverse Event|1|||
129568811|NCT00262223|466379977|FG001|Treatment Phase|Adverse Event|2|||
129568812|NCT00262223|466379976|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
129568813|NCT00262223|466379977|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
129568814|NCT00262223|466379976|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
129568815|NCT00262223|466379977|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
129568816|NCT00262223|466379976|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
129568817|NCT00262223|466379977|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
129568818|NCT01804270|466379980|FG000|Overall Study|Withdrawal by Subject|1|||
129568819|NCT01804270|466379981|FG001|Overall Study|Withdrawal by Subject|1|||
129568820|NCT01328093|466379986|FG000|Double-Blind Phase|Adverse Event|78|||
129568821|NCT01328093|466379987|FG001|Double-Blind Phase|Adverse Event|15|||
129568822|NCT01328093|466379986|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
129568823|NCT01328093|466379987|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
129568824|NCT01328093|466379986|FG000|Double-Blind Phase|Lost to Follow-up|39|||
129568825|NCT01328093|466379987|FG001|Double-Blind Phase|Lost to Follow-up|14|||
129568826|NCT01328093|466379986|FG000|Double-Blind Phase|Protocol Violation|30|||
129568827|NCT01328093|466379987|FG001|Double-Blind Phase|Protocol Violation|10|||
129568828|NCT01328093|466379986|FG000|Double-Blind Phase|Lack of Efficacy|55|||
129568829|NCT01328093|466379987|FG001|Double-Blind Phase|Lack of Efficacy|13|||
129568830|NCT01328093|466379986|FG000|Double-Blind Phase|Sponsor Decision|17|||
129568831|NCT01328093|466379987|FG001|Double-Blind Phase|Sponsor Decision|3|||
129568832|NCT01328093|466379986|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
129568833|NCT01328093|466379987|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
129568834|NCT01328093|466379986|FG000|Double-Blind Phase|Scheduling conflict|8|||
129568835|NCT01328093|466379987|FG001|Double-Blind Phase|Scheduling conflict|3|||
129690213|NCT01562444|466824434|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
129690214|NCT01562444|466824435|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
129690215|NCT01562444|466824436|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
129690216|NCT01562444|466824434|FG000|Overall Study|Protocol forbidden medication|1|||
129690217|NCT01562444|466824435|FG001|Overall Study|Protocol forbidden medication|0|||
129690218|NCT01562444|466824436|FG002|Overall Study|Protocol forbidden medication|0|||
129690219|NCT00574951|466824444|FG000|Overall Study|Ineligible - improper prior treatment|1|||
129690220|NCT01160744|466824449|FG000|Overall Study|Withdrawal by Subject|11|||
129690221|NCT01160744|466824450|FG001|Overall Study|Withdrawal by Subject|5|||
129690222|NCT01160744|466824451|FG002|Overall Study|Withdrawal by Subject|6|||
129690223|NCT01160744|466824452|FG003|Overall Study|Withdrawal by Subject|4|||
129690224|NCT01160744|466824449|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
129690225|NCT01160744|466824450|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
129690226|NCT01160744|466824451|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
129690227|NCT01160744|466824452|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
129690228|NCT02301429|466824453|FG000|Overall Study|not acceptable vascular anatomy|3|||
129690229|NCT02217982|466824454|FG000|Overall Study|Trial discontinued|1|||
129690230|NCT02217982|466824455|FG001|Overall Study|Trial discontinued|0|||
129690231|NCT02217982|466824454|FG000|Overall Study|Adverse Event|0|||
129690232|NCT02217982|466824455|FG001|Overall Study|Adverse Event|1|||
129690233|NCT01755637|466824460|FG000|Period 1|Adverse Event|0|||
129690234|NCT01755637|466824461|FG001|Period 1|Adverse Event|1|||
129690235|NCT01814332|466824462|FG000|Overall Study|Adverse Event|8|||
129690236|NCT01814332|466824463|FG001|Overall Study|Adverse Event|3|||
129690237|NCT01814332|466824462|FG000|Overall Study|Withdrawal by Subject|3|||
129690238|NCT01814332|466824463|FG001|Overall Study|Withdrawal by Subject|8|||
129568836|NCT01328093|466379986|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
129568837|NCT01328093|466379987|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
129690239|NCT01814332|466824462|FG000|Overall Study|Protocol Violation|0|||
129690240|NCT01814332|466824463|FG001|Overall Study|Protocol Violation|4|||
129690241|NCT01814332|466824462|FG000|Overall Study|Lost to Follow-up|5|||
129690242|NCT01814332|466824463|FG001|Overall Study|Lost to Follow-up|1|||
129690243|NCT01096186|466824465|FG000|Overall Study|Adverse Event|16|||
129568838|NCT01328093|466379986|FG000|Double-Blind Phase|Death|1|||
129568839|NCT01328093|466379987|FG001|Double-Blind Phase|Death|0|||
129568840|NCT01328093|466379986|FG000|Open-Label Phase|Sponsor Decision|98|||
129568841|NCT01328093|466379987|FG001|Open-Label Phase|Sponsor Decision|34|||
129568842|NCT01328093|466379986|FG000|Open-Label Phase|Protocol Violation|8|||
129568843|NCT01328093|466379987|FG001|Open-Label Phase|Protocol Violation|3|||
129568844|NCT01328093|466379986|FG000|Open-Label Phase|Lost to Follow-up|10|||
129568845|NCT01328093|466379987|FG001|Open-Label Phase|Lost to Follow-up|1|||
129568846|NCT01328093|466379986|FG000|Open-Label Phase|Adverse Event|10|||
129568847|NCT01328093|466379987|FG001|Open-Label Phase|Adverse Event|4|||
129568848|NCT01328093|466379986|FG000|Open-Label Phase|Lack of Efficacy|5|||
129568849|NCT01328093|466379987|FG001|Open-Label Phase|Lack of Efficacy|6|||
129568850|NCT01328093|466379986|FG000|Open-Label Phase|Withdrawal by Subject|4|||
129568851|NCT01328093|466379987|FG001|Open-Label Phase|Withdrawal by Subject|1|||
129568852|NCT01328093|466379986|FG000|Open-Label Phase|Scheduling conflict|2|||
129568853|NCT01328093|466379987|FG001|Open-Label Phase|Scheduling conflict|1|||
129568854|NCT01328093|466379986|FG000|Open-Label Phase|Subject is moving or has moved|2|||
129568855|NCT01328093|466379987|FG001|Open-Label Phase|Subject is moving or has moved|0|||
129568856|NCT01328093|466379986|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
129568857|NCT01328093|466379987|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
129568858|NCT05150964|466379990|FG000|Overall Study|Lost to Follow-up|2|||
129568859|NCT00832377|466379991|FG000|Overall Study|Protocol Violation|1|||
129568860|NCT03661528|466379992|FG000|Overall Study|Death|1|||
129568861|NCT03661528|466379993|FG001|Overall Study|Death|0|||
129568862|NCT03661528|466379992|FG000|Overall Study|Physician Decision|3|||
129568863|NCT03661528|466379993|FG001|Overall Study|Physician Decision|1|||
129568864|NCT03661528|466379992|FG000|Overall Study|Other than Specified|5|||
129568865|NCT03661528|466379993|FG001|Overall Study|Other than Specified|2|||
129568866|NCT03661528|466379992|FG000|Overall Study|Withdrawal by Subject|5|||
129568867|NCT03661528|466379993|FG001|Overall Study|Withdrawal by Subject|3|||
129568868|NCT03661528|466379992|FG000|Overall Study|Disease Progression|8|||
129568869|NCT03661528|466379993|FG001|Overall Study|Disease Progression|13|||
129568870|NCT03661528|466379992|FG000|Overall Study|Adverse Event|61|||
129568871|NCT03661528|466379993|FG001|Overall Study|Adverse Event|55|||
129568872|NCT00925769|466379995|FG000|Overall Study|Major toxicity|1|||
129568873|NCT00925769|466379996|FG001|Overall Study|Major toxicity|0|||
129568874|NCT00925769|466379997|FG002|Overall Study|Major toxicity|1|||
129568875|NCT00925769|466379998|FG003|Overall Study|Major toxicity|1|||
129568876|NCT00925769|466379999|FG004|Overall Study|Major toxicity|0|||
129568877|NCT00925769|466380000|FG005|Overall Study|Major toxicity|0|||
129568878|NCT00925769|466379995|FG000|Overall Study|Disease progression|4|||
129568879|NCT00925769|466379996|FG001|Overall Study|Disease progression|5|||
129568880|NCT00925769|466379997|FG002|Overall Study|Disease progression|3|||
129568881|NCT00925769|466379998|FG003|Overall Study|Disease progression|4|||
129568882|NCT00925769|466379999|FG004|Overall Study|Disease progression|2|||
129568883|NCT00925769|466380000|FG005|Overall Study|Disease progression|3|||
129568884|NCT00925769|466379995|FG000|Overall Study|Death|0|||
129568885|NCT00925769|466379996|FG001|Overall Study|Death|0|||
129568886|NCT00925769|466379997|FG002|Overall Study|Death|1|||
129568887|NCT00925769|466379998|FG003|Overall Study|Death|0|||
129568888|NCT00925769|466379999|FG004|Overall Study|Death|0|||
129568889|NCT00925769|466380000|FG005|Overall Study|Death|0|||
129568890|NCT00925769|466379995|FG000|Overall Study|Physician Decision|1|||
129568891|NCT00925769|466379996|FG001|Overall Study|Physician Decision|0|||
129568892|NCT00925769|466379997|FG002|Overall Study|Physician Decision|0|||
129568893|NCT00925769|466379998|FG003|Overall Study|Physician Decision|0|||
129568894|NCT00925769|466379999|FG004|Overall Study|Physician Decision|0|||
129568895|NCT00925769|466380000|FG005|Overall Study|Physician Decision|0|||
129568896|NCT00925769|466379995|FG000|Overall Study|Missing documentation|0|||
129568897|NCT00925769|466379996|FG001|Overall Study|Missing documentation|1|||
129568898|NCT00925769|466379997|FG002|Overall Study|Missing documentation|0|||
129568899|NCT00925769|466379998|FG003|Overall Study|Missing documentation|0|||
129568900|NCT00925769|466379999|FG004|Overall Study|Missing documentation|0|||
129568901|NCT00925769|466380000|FG005|Overall Study|Missing documentation|0|||
129568902|NCT00925769|466379995|FG000|Overall Study|End of study visit not done|0|||
129568903|NCT00925769|466379996|FG001|Overall Study|End of study visit not done|0|||
129568904|NCT00925769|466379997|FG002|Overall Study|End of study visit not done|1|||
129568905|NCT00925769|466379998|FG003|Overall Study|End of study visit not done|0|||
129568906|NCT00925769|466379999|FG004|Overall Study|End of study visit not done|0|||
129568907|NCT00925769|466380000|FG005|Overall Study|End of study visit not done|0|||
129568908|NCT00925769|466379995|FG000|Overall Study|Participant is unable to swallow drug|0|||
129568909|NCT00925769|466379996|FG001|Overall Study|Participant is unable to swallow drug|0|||
129568910|NCT00925769|466379997|FG002|Overall Study|Participant is unable to swallow drug|0|||
129568911|NCT00925769|466379998|FG003|Overall Study|Participant is unable to swallow drug|1|||
129568912|NCT00925769|466379999|FG004|Overall Study|Participant is unable to swallow drug|0|||
129568913|NCT00925769|466380000|FG005|Overall Study|Participant is unable to swallow drug|0|||
129568914|NCT00925769|466379995|FG000|Overall Study|Adverse Event|0|||
129568915|NCT00925769|466379996|FG001|Overall Study|Adverse Event|0|||
129780551|NCT01865552|467163876|FG005|Period 1|Pathological lab|0|||
129780552|NCT01865552|467163871|FG000|Period 1|Other|0|||
129780553|NCT01865552|467163872|FG001|Period 1|Other|0|||
129780554|NCT01865552|467163873|FG002|Period 1|Other|0|||
129780555|NCT01865552|467163874|FG003|Period 1|Other|0|||
129780556|NCT01865552|467163875|FG004|Period 1|Other|1|||
129780557|NCT01865552|467163876|FG005|Period 1|Other|0|||
129780558|NCT02175199|467163879|FG000|Overall Study|Withdrawal by Subject|1|||
129780559|NCT02175199|467163880|FG001|Overall Study|Withdrawal by Subject|5|||
129780560|NCT02175199|467163879|FG000|Overall Study|Randomized in Error|1|||
129780561|NCT02175199|467163880|FG001|Overall Study|Randomized in Error|0|||
129780562|NCT02175199|467163879|FG000|Overall Study|Sponsor Decision|1|||
129780563|NCT02175199|467163880|FG001|Overall Study|Sponsor Decision|0|||
129780564|NCT03983317|467163887|FG000|Overall Study|Physician Decision|5|||
129780565|NCT01761162|467163888|FG000|Overall Study|Withdrawal by Subject|3|||
129780566|NCT02741518|467163889|FG000|Overall Study|Withdrawal by Subject|1|||
129780567|NCT02741518|467163890|FG001|Overall Study|Withdrawal by Subject|1|||
129780568|NCT01349049|467163891|FG000|Overall Study|Disease progression|3|||
129780569|NCT01349049|467163892|FG001|Overall Study|Disease progression|5|||
129780570|NCT01349049|467163893|FG002|Overall Study|Disease progression|3|||
129780571|NCT01349049|467163894|FG003|Overall Study|Disease progression|2|||
129780572|NCT01349049|467163895|FG004|Overall Study|Disease progression|2|||
129780573|NCT01349049|467163896|FG005|Overall Study|Disease progression|2|||
129780574|NCT01349049|467163897|FG006|Overall Study|Disease progression|3|||
129780575|NCT01349049|467163898|FG007|Overall Study|Disease progression|2|||
129780576|NCT01349049|467163899|FG008|Overall Study|Disease progression|33|||
129780577|NCT01349049|467163891|FG000|Overall Study|Adverse Event|0|||
129780578|NCT01349049|467163892|FG001|Overall Study|Adverse Event|1|||
129780579|NCT01349049|467163893|FG002|Overall Study|Adverse Event|0|||
129780580|NCT01349049|467163894|FG003|Overall Study|Adverse Event|0|||
129780581|NCT01349049|467163895|FG004|Overall Study|Adverse Event|0|||
129780582|NCT01349049|467163896|FG005|Overall Study|Adverse Event|3|||
129780583|NCT01349049|467163897|FG006|Overall Study|Adverse Event|1|||
129780584|NCT01349049|467163898|FG007|Overall Study|Adverse Event|0|||
129780585|NCT01349049|467163899|FG008|Overall Study|Adverse Event|4|||
129780586|NCT01349049|467163891|FG000|Overall Study|Physician Decision|0|||
129780587|NCT01349049|467163892|FG001|Overall Study|Physician Decision|1|||
129780588|NCT01349049|467163893|FG002|Overall Study|Physician Decision|0|||
129780589|NCT01349049|467163894|FG003|Overall Study|Physician Decision|0|||
129568916|NCT00925769|466379997|FG002|Overall Study|Adverse Event|0|||
129568917|NCT00925769|466379998|FG003|Overall Study|Adverse Event|0|||
129568918|NCT00925769|466379999|FG004|Overall Study|Adverse Event|1|||
129568919|NCT00925769|466380000|FG005|Overall Study|Adverse Event|0|||
129568920|NCT02017964|466380001|FG000|Overall Study|Patient deemed ineligible|1|||
129568921|NCT01449630|466380003|FG000|Period 1|Physician Decision|1|||
129568922|NCT01449630|466380004|FG001|Period 1|Physician Decision|0|||
129568923|NCT01449630|466380005|FG002|Period 1|Physician Decision|0|||
129568924|NCT01449630|466380006|FG003|Period 1|Physician Decision|1|||
129568925|NCT01449630|466380007|FG004|Period 1|Physician Decision|0|||
129568926|NCT01449630|466380008|FG005|Period 1|Physician Decision|0|||
129568927|NCT01449630|466380009|FG006|Period 1|Physician Decision|0|||
129568928|NCT01449630|466380010|FG007|Period 1|Physician Decision|0|||
129568929|NCT01449630|466380011|FG008|Period 1|Physician Decision|0|||
129568930|NCT01449630|466380003|FG000|Period 1|Sponsor Decision|0|||
129568931|NCT01449630|466380004|FG001|Period 1|Sponsor Decision|0|||
129690244|NCT01096186|466824465|FG000|Overall Study|Death|4|||
129690245|NCT01096186|466824465|FG000|Overall Study|Lack of Efficacy|4|||
129690246|NCT01096186|466824465|FG000|Overall Study|Lost to Follow-up|2|||
129568932|NCT01449630|466380005|FG002|Period 1|Sponsor Decision|0|||
129568933|NCT01449630|466380006|FG003|Period 1|Sponsor Decision|0|||
129568934|NCT01449630|466380007|FG004|Period 1|Sponsor Decision|0|||
129568935|NCT01449630|466380008|FG005|Period 1|Sponsor Decision|1|||
129690247|NCT01096186|466824465|FG000|Overall Study|Withdrawal by Subject|22|||
129568936|NCT01449630|466380009|FG006|Period 1|Sponsor Decision|0|||
129568937|NCT01449630|466380010|FG007|Period 1|Sponsor Decision|0|||
129568938|NCT01449630|466380011|FG008|Period 1|Sponsor Decision|0|||
129568939|NCT01449630|466380003|FG000|Period 2|Sponsor Decision|0|||
129568940|NCT01449630|466380004|FG001|Period 2|Sponsor Decision|0|||
129568941|NCT01449630|466380005|FG002|Period 2|Sponsor Decision|0|||
129568942|NCT01449630|466380006|FG003|Period 2|Sponsor Decision|0|||
129568943|NCT01449630|466380007|FG004|Period 2|Sponsor Decision|0|||
129568944|NCT01449630|466380008|FG005|Period 2|Sponsor Decision|0|||
129568945|NCT01449630|466380009|FG006|Period 2|Sponsor Decision|1|||
129568946|NCT01449630|466380010|FG007|Period 2|Sponsor Decision|0|||
129568947|NCT01449630|466380011|FG008|Period 2|Sponsor Decision|0|||
129568948|NCT01735630|466380016|FG000|Overall Study|Adverse Event|8|||
129568949|NCT01735630|466380017|FG001|Overall Study|Adverse Event|7|||
129568950|NCT01735630|466380016|FG000|Overall Study|Lost to Follow-up|1|||
129690248|NCT01096186|466824465|FG000|Overall Study|Physician Decision|1|||
129690249|NCT01096186|466824465|FG000|Overall Study|Noncompliance with study drug|1|||
129690250|NCT00122187|466824470|FG000|Overall Study|Withdrew because of resource limitations|2|||
129690251|NCT00122187|466824471|FG001|Overall Study|Withdrew because of resource limitations|2|||
129690252|NCT02061592|466824472|FG000|Period 1|Withdrawal by Subject|1|||
129690253|NCT02061592|466824473|FG001|Period 1|Withdrawal by Subject|0|||
129690254|NCT02061592|466824472|FG000|Period 1|Protocol Violation|1|||
129690255|NCT02061592|466824473|FG001|Period 1|Protocol Violation|0|||
129690256|NCT02061592|466824472|FG000|Period 2|Lost to Follow-up|0|||
129690257|NCT02061592|466824473|FG001|Period 2|Lost to Follow-up|1|||
129690258|NCT03338023|466824474|FG000|Overall Study|Withdrawal by Subject|3|||
129690259|NCT03338023|466824475|FG001|Overall Study|Withdrawal by Subject|4|||
129690260|NCT03338023|466824474|FG000|Overall Study|Protocol Violation|3|||
129690261|NCT03338023|466824475|FG001|Overall Study|Protocol Violation|3|||
129690262|NCT03338023|466824474|FG000|Overall Study|Lost to Follow-up|2|||
129690263|NCT03338023|466824475|FG001|Overall Study|Lost to Follow-up|1|||
129690264|NCT03338023|466824474|FG000|Overall Study|Physician Decision|1|||
129690265|NCT03338023|466824475|FG001|Overall Study|Physician Decision|2|||
129690266|NCT00685698|466824476|FG000|Overall Study|Withdrawal by Subject|1|||
129690267|NCT00685698|466824476|FG000|Overall Study|Protocol Violation|6|||
129690268|NCT00685698|466824476|FG000|Overall Study|Adverse Event|3|||
129690269|NCT00685698|466824476|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
129690270|NCT00685698|466824476|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
129690271|NCT00685698|466824476|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
129690272|NCT05061706|466824478|FG000|Overall Study|Adverse Event|29|||
129568951|NCT01735630|466380017|FG001|Overall Study|Lost to Follow-up|0|||
129568952|NCT01735630|466380016|FG000|Overall Study|Physician Decision|0|||
129690273|NCT05061706|466824479|FG001|Overall Study|Adverse Event|1|||
129690274|NCT05061706|466824478|FG000|Overall Study|Lack of Efficacy|0|||
129690275|NCT05061706|466824479|FG001|Overall Study|Lack of Efficacy|1|||
129690276|NCT05061706|466824478|FG000|Overall Study|Lost to Follow-up|2|||
129568953|NCT01735630|466380017|FG001|Overall Study|Physician Decision|1|||
129568954|NCT01735630|466380016|FG000|Overall Study|Sponsor Decision|2|||
129568955|NCT01735630|466380017|FG001|Overall Study|Sponsor Decision|1|||
129568956|NCT01735630|466380016|FG000|Overall Study|Withdrawal by Subject|7|||
129568957|NCT01735630|466380017|FG001|Overall Study|Withdrawal by Subject|9|||
129568958|NCT03099538|466380018|FG000|Overall Study|Lack of Efficacy|3|||
129568959|NCT00615069|466380019|FG000|Overall Study|Death|10|||
129568960|NCT00615069|466380019|FG000|Overall Study|Physician Decision|2|||
129568961|NCT00615069|466380019|FG000|Overall Study|Withdrawal by Subject|4|||
129568962|NCT00669942|466380020|FG000|Parts 2 and 3|Adverse Event|0|||
129568963|NCT00669942|466380021|FG001|Parts 2 and 3|Adverse Event|0|||
129568964|NCT00669942|466380022|FG002|Parts 2 and 3|Adverse Event|0|||
129568965|NCT00669942|466380023|FG003|Parts 2 and 3|Adverse Event|0|||
129568966|NCT00669942|466380024|FG004|Parts 2 and 3|Adverse Event|0|||
129568967|NCT00669942|466380025|FG005|Parts 2 and 3|Adverse Event|0|||
129568968|NCT00669942|466380026|FG006|Parts 2 and 3|Adverse Event|0|||
129568969|NCT00669942|466380027|FG007|Parts 2 and 3|Adverse Event|2|||
129568970|NCT00669942|466380028|FG008|Parts 2 and 3|Adverse Event|1|||
129568971|NCT00669942|466380029|FG009|Parts 2 and 3|Adverse Event|0|||
129568972|NCT00669942|466380030|FG010|Parts 2 and 3|Adverse Event|0|||
129568973|NCT00669942|466380031|FG011|Parts 2 and 3|Adverse Event|0|||
129568974|NCT00669942|466380020|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
129568975|NCT00669942|466380021|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
129568976|NCT00669942|466380022|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
129568977|NCT00669942|466380023|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
129568978|NCT00669942|466380024|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
129568979|NCT00669942|466380025|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
129690277|NCT05061706|466824479|FG001|Overall Study|Lost to Follow-up|2|||
129690278|NCT05061706|466824478|FG000|Overall Study|Protocol Violation|3|||
129690279|NCT05061706|466824479|FG001|Overall Study|Protocol Violation|1|||
129690280|NCT05061706|466824478|FG000|Overall Study|Withdrawal by Subject|3|||
129690281|NCT05061706|466824479|FG001|Overall Study|Withdrawal by Subject|9|||
129690282|NCT01873833|466824481|FG000|Overall Study|Withdrawal by Subject|1|||
129690283|NCT02068599|466824487|FG000|Overall Study|Adverse Event|4|||
129690284|NCT02068599|466824488|FG001|Overall Study|Adverse Event|1|||
129690285|NCT02068599|466824489|FG002|Overall Study|Adverse Event|1|||
129690286|NCT02068599|466824487|FG000|Overall Study|Withdrawal by Subject|2|||
129690287|NCT02068599|466824488|FG001|Overall Study|Withdrawal by Subject|7|||
129690288|NCT02068599|466824489|FG002|Overall Study|Withdrawal by Subject|5|||
129690289|NCT02068599|466824487|FG000|Overall Study|Protocol Violation|4|||
129690290|NCT02068599|466824488|FG001|Overall Study|Protocol Violation|2|||
129690291|NCT02068599|466824489|FG002|Overall Study|Protocol Violation|3|||
129690292|NCT02068599|466824487|FG000|Overall Study|Lost to Follow-up|1|||
129690293|NCT02068599|466824488|FG001|Overall Study|Lost to Follow-up|0|||
129690294|NCT02068599|466824489|FG002|Overall Study|Lost to Follow-up|0|||
129690295|NCT02068599|466824487|FG000|Overall Study|Lack of Efficacy|0|||
129690296|NCT02068599|466824488|FG001|Overall Study|Lack of Efficacy|0|||
129690297|NCT02068599|466824489|FG002|Overall Study|Lack of Efficacy|3|||
129690298|NCT02068599|466824487|FG000|Overall Study|Noncompliance|0|||
129690299|NCT02068599|466824488|FG001|Overall Study|Noncompliance|0|||
129690300|NCT02068599|466824489|FG002|Overall Study|Noncompliance|1|||
129690301|NCT01871727|466824490|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
129690302|NCT01871727|466824491|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
129690303|NCT01871727|466824492|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
129690304|NCT01871727|466824493|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
129690305|NCT01871727|466824494|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
129690306|NCT01871727|466824490|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
129690307|NCT01871727|466824491|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
129690308|NCT01871727|466824492|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
129690309|NCT01871727|466824493|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
129690310|NCT01871727|466824494|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
129690311|NCT01871727|466824490|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129690312|NCT01871727|466824491|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129690313|NCT01871727|466824492|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129690314|NCT01871727|466824493|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
129690315|NCT01871727|466824494|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
129690316|NCT01871727|466824490|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129690317|NCT01871727|466824491|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129568980|NCT00669942|466380026|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
129568981|NCT00669942|466380027|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
129568982|NCT00669942|466380028|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
129568983|NCT00669942|466380029|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
129690318|NCT01871727|466824492|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129568984|NCT00669942|466380030|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
129568985|NCT00669942|466380031|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
129568986|NCT00669942|466380020|FG000|Parts 2 and 3|Protocol Violation|0|||
129568987|NCT00669942|466380021|FG001|Parts 2 and 3|Protocol Violation|0|||
129568988|NCT00669942|466380022|FG002|Parts 2 and 3|Protocol Violation|0|||
129568989|NCT00669942|466380023|FG003|Parts 2 and 3|Protocol Violation|0|||
129568990|NCT00669942|466380024|FG004|Parts 2 and 3|Protocol Violation|0|||
129568991|NCT00669942|466380025|FG005|Parts 2 and 3|Protocol Violation|1|||
129568992|NCT00669942|466380026|FG006|Parts 2 and 3|Protocol Violation|0|||
129568993|NCT00669942|466380027|FG007|Parts 2 and 3|Protocol Violation|0|||
129568994|NCT00669942|466380028|FG008|Parts 2 and 3|Protocol Violation|0|||
129568995|NCT00669942|466380029|FG009|Parts 2 and 3|Protocol Violation|0|||
129568996|NCT00669942|466380030|FG010|Parts 2 and 3|Protocol Violation|0|||
129568997|NCT00669942|466380031|FG011|Parts 2 and 3|Protocol Violation|0|||
129568998|NCT01941030|466380046|FG000|Overall Study|Death|3|||
129568999|NCT01941030|466380047|FG001|Overall Study|Death|2|||
129569000|NCT01941030|466380046|FG000|Overall Study|Lost to Follow-up|6|||
129569001|NCT01941030|466380047|FG001|Overall Study|Lost to Follow-up|5|||
129569002|NCT01941030|466380046|FG000|Overall Study|Withdrawal by Subject|4|||
129569003|NCT01941030|466380047|FG001|Overall Study|Withdrawal by Subject|6|||
129569004|NCT00162123|466380050|FG000|Overall Study|Disease progression|27|||
129569005|NCT00162123|466380051|FG001|Overall Study|Disease progression|19|||
129569006|NCT00162123|466380052|FG002|Overall Study|Disease progression|10|||
129569007|NCT00162123|466380053|FG003|Overall Study|Disease progression|4|||
129569008|NCT00162123|466380054|FG004|Overall Study|Disease progression|8|||
129569009|NCT00162123|466380055|FG005|Overall Study|Disease progression|3|||
129569010|NCT00162123|466380056|FG006|Overall Study|Disease progression|1|||
129569011|NCT00162123|466380057|FG007|Overall Study|Disease progression|0|||
129569012|NCT00162123|466380050|FG000|Overall Study|Study drug toxicity|6|||
129569013|NCT00162123|466380051|FG001|Overall Study|Study drug toxicity|1|||
129569014|NCT00162123|466380052|FG002|Overall Study|Study drug toxicity|5|||
129569015|NCT00162123|466380053|FG003|Overall Study|Study drug toxicity|0|||
129569016|NCT00162123|466380054|FG004|Overall Study|Study drug toxicity|4|||
129569017|NCT00162123|466380055|FG005|Overall Study|Study drug toxicity|1|||
129569018|NCT00162123|466380056|FG006|Overall Study|Study drug toxicity|1|||
129569019|NCT00162123|466380057|FG007|Overall Study|Study drug toxicity|0|||
129569020|NCT00162123|466380050|FG000|Overall Study|Death|3|||
129569021|NCT00162123|466380051|FG001|Overall Study|Death|3|||
129569022|NCT00162123|466380052|FG002|Overall Study|Death|1|||
129569023|NCT00162123|466380053|FG003|Overall Study|Death|1|||
129569024|NCT00162123|466380054|FG004|Overall Study|Death|1|||
129569025|NCT00162123|466380055|FG005|Overall Study|Death|1|||
129569026|NCT00162123|466380056|FG006|Overall Study|Death|0|||
129569027|NCT00162123|466380057|FG007|Overall Study|Death|0|||
129569028|NCT00162123|466380050|FG000|Overall Study|Withdrawal by Subject|2|||
129569029|NCT00162123|466380051|FG001|Overall Study|Withdrawal by Subject|0|||
129569030|NCT00162123|466380052|FG002|Overall Study|Withdrawal by Subject|2|||
129569031|NCT00162123|466380053|FG003|Overall Study|Withdrawal by Subject|1|||
129569032|NCT00162123|466380054|FG004|Overall Study|Withdrawal by Subject|1|||
129569033|NCT00162123|466380055|FG005|Overall Study|Withdrawal by Subject|2|||
129569034|NCT00162123|466380056|FG006|Overall Study|Withdrawal by Subject|1|||
129569035|NCT00162123|466380057|FG007|Overall Study|Withdrawal by Subject|0|||
129569036|NCT00162123|466380050|FG000|Overall Study|Deterioration without progression|2|||
129569037|NCT00162123|466380051|FG001|Overall Study|Deterioration without progression|2|||
129569038|NCT00162123|466380052|FG002|Overall Study|Deterioration without progression|3|||
129569039|NCT00162123|466380053|FG003|Overall Study|Deterioration without progression|0|||
129569040|NCT00162123|466380054|FG004|Overall Study|Deterioration without progression|1|||
129569041|NCT00162123|466380055|FG005|Overall Study|Deterioration without progression|0|||
129569042|NCT00162123|466380056|FG006|Overall Study|Deterioration without progression|0|||
129569043|NCT00162123|466380057|FG007|Overall Study|Deterioration without progression|0|||
129569044|NCT00162123|466380050|FG000|Overall Study|Adverse Event|1|||
129569045|NCT00162123|466380051|FG001|Overall Study|Adverse Event|2|||
129569046|NCT00162123|466380052|FG002|Overall Study|Adverse Event|0|||
129569047|NCT00162123|466380053|FG003|Overall Study|Adverse Event|2|||
129569048|NCT00162123|466380054|FG004|Overall Study|Adverse Event|1|||
129569049|NCT00162123|466380055|FG005|Overall Study|Adverse Event|0|||
129569050|NCT00162123|466380056|FG006|Overall Study|Adverse Event|0|||
129569051|NCT00162123|466380057|FG007|Overall Study|Adverse Event|0|||
129569052|NCT00162123|466380050|FG000|Overall Study|Not specified (before treatment)|2|||
129569053|NCT00162123|466380051|FG001|Overall Study|Not specified (before treatment)|0|||
129780590|NCT01349049|467163895|FG004|Overall Study|Physician Decision|0|||
129569054|NCT00162123|466380052|FG002|Overall Study|Not specified (before treatment)|0|||
129569055|NCT00162123|466380053|FG003|Overall Study|Not specified (before treatment)|0|||
129569056|NCT00162123|466380054|FG004|Overall Study|Not specified (before treatment)|12|||
129569057|NCT00162123|466380055|FG005|Overall Study|Not specified (before treatment)|1|||
129569058|NCT00162123|466380056|FG006|Overall Study|Not specified (before treatment)|0|||
129569059|NCT00162123|466380057|FG007|Overall Study|Not specified (before treatment)|0|||
129569060|NCT00162123|466380050|FG000|Overall Study|Not specified (after start of treatment)|0|||
129569061|NCT00162123|466380051|FG001|Overall Study|Not specified (after start of treatment)|0|||
129569062|NCT00162123|466380052|FG002|Overall Study|Not specified (after start of treatment)|0|||
129569063|NCT00162123|466380053|FG003|Overall Study|Not specified (after start of treatment)|0|||
129569064|NCT00162123|466380054|FG004|Overall Study|Not specified (after start of treatment)|3|||
129569065|NCT00162123|466380055|FG005|Overall Study|Not specified (after start of treatment)|0|||
129569066|NCT00162123|466380056|FG006|Overall Study|Not specified (after start of treatment)|0|||
129569067|NCT00162123|466380057|FG007|Overall Study|Not specified (after start of treatment)|0|||
129569068|NCT00162123|466380050|FG000|Overall Study|Physician Decision|1|||
129569069|NCT00162123|466380051|FG001|Overall Study|Physician Decision|2|||
129569070|NCT00162123|466380052|FG002|Overall Study|Physician Decision|0|||
129569071|NCT00162123|466380053|FG003|Overall Study|Physician Decision|0|||
129569072|NCT00162123|466380054|FG004|Overall Study|Physician Decision|0|||
129569073|NCT00162123|466380055|FG005|Overall Study|Physician Decision|1|||
129569074|NCT00162123|466380056|FG006|Overall Study|Physician Decision|1|||
129569075|NCT00162123|466380057|FG007|Overall Study|Physician Decision|0|||
129569076|NCT00162123|466380050|FG000|Overall Study|Tumor assessment only (not treated)|0|||
129569077|NCT00162123|466380051|FG001|Overall Study|Tumor assessment only (not treated)|0|||
129569078|NCT00162123|466380052|FG002|Overall Study|Tumor assessment only (not treated)|0|||
129569079|NCT00162123|466380053|FG003|Overall Study|Tumor assessment only (not treated)|0|||
129569080|NCT00162123|466380054|FG004|Overall Study|Tumor assessment only (not treated)|0|||
129569081|NCT00162123|466380055|FG005|Overall Study|Tumor assessment only (not treated)|0|||
129569082|NCT00162123|466380056|FG006|Overall Study|Tumor assessment only (not treated)|0|||
129569083|NCT00162123|466380057|FG007|Overall Study|Tumor assessment only (not treated)|1|||
129569084|NCT00162123|466380050|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
129569085|NCT00162123|466380051|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
129569086|NCT00162123|466380052|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
129569087|NCT00162123|466380053|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
129569088|NCT00162123|466380054|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
129569089|NCT00162123|466380055|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
129569090|NCT00162123|466380056|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
129569091|NCT00162123|466380057|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
129569092|NCT02016170|466380058|FG000|Overall Study|Adverse Event|1|||
129569093|NCT02016170|466380059|FG001|Overall Study|Adverse Event|1|||
129569094|NCT02016170|466380060|FG002|Overall Study|Adverse Event|0|||
129569095|NCT02016170|466380058|FG000|Overall Study|Protocol Violation|1|||
129569096|NCT02016170|466380059|FG001|Overall Study|Protocol Violation|0|||
129569097|NCT02016170|466380060|FG002|Overall Study|Protocol Violation|0|||
129569098|NCT01479439|466380062|FG000|Overall Study|Adverse Event|1|||
129569099|NCT01479439|466380063|FG001|Overall Study|Adverse Event|0|||
129569100|NCT01479439|466380064|FG002|Overall Study|Adverse Event|0|||
129569101|NCT01479439|466380062|FG000|Overall Study|Lost to Follow-up|0|||
129569102|NCT01479439|466380063|FG001|Overall Study|Lost to Follow-up|1|||
129569103|NCT01479439|466380064|FG002|Overall Study|Lost to Follow-up|0|||
129569104|NCT01479439|466380062|FG000|Overall Study|Protocol Violation|0|||
129569105|NCT01479439|466380063|FG001|Overall Study|Protocol Violation|0|||
129569106|NCT01479439|466380064|FG002|Overall Study|Protocol Violation|2|||
129569107|NCT02365207|466380065|FG000|Overall Study|Withdrawal by Subject|1|||
129690319|NCT01871727|466824493|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
129690320|NCT01871727|466824494|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
129690321|NCT01871727|466824490|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129690322|NCT01871727|466824491|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129690323|NCT01871727|466824492|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129690324|NCT01871727|466824493|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
129690325|NCT01871727|466824494|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
129884558|NCT02696902|467536453|FG000|Overall Study|Withdrawal by Subject|0|||
129569108|NCT02365207|466380065|FG000|Overall Study|Physician Decision|1|||
129569109|NCT01936948|466380066|FG000|Overall Study|no 30-day follow-up data|0|||
129569110|NCT01936948|466380067|FG001|Overall Study|no 30-day follow-up data|3|||
129569111|NCT01936948|466380068|FG002|Overall Study|no 30-day follow-up data|3|||
129569112|NCT01936948|466380069|FG003|Overall Study|no 30-day follow-up data|3|||
129569113|NCT02930005|466380070|FG000|Overall Study|Lost to Follow-up|1|||
129569114|NCT02930005|466380071|FG001|Overall Study|Lost to Follow-up|5|||
129569115|NCT02781727|466380072|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
129569116|NCT02781727|466380073|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
129569117|NCT02781727|466380072|FG000|Treatment Period|Withdrawal by Subject|1|||
129569118|NCT02781727|466380073|FG001|Treatment Period|Withdrawal by Subject|0|||
129569119|NCT02781727|466380072|FG000|Treatment Period|Lost to Follow-up|0|||
129569120|NCT02781727|466380073|FG001|Treatment Period|Lost to Follow-up|1|||
129569121|NCT00822926|466380078|FG000|Second Injection Visit|Lost to Follow-up|1|||
129569122|NCT00822926|466380079|FG001|Second Injection Visit|Lost to Follow-up|0|||
129569123|NCT00822926|466380078|FG000|Second Injection Visit|Withdrawal by Subject|0|||
129569124|NCT00822926|466380079|FG001|Second Injection Visit|Withdrawal by Subject|1|||
129569125|NCT02924038|466381646|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
129569126|NCT02924038|466381647|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
129780591|NCT01349049|467163896|FG005|Overall Study|Physician Decision|0|||
129780592|NCT01349049|467163897|FG006|Overall Study|Physician Decision|0|||
129780593|NCT01349049|467163898|FG007|Overall Study|Physician Decision|0|||
129780594|NCT01349049|467163899|FG008|Overall Study|Physician Decision|2|||
129780595|NCT01349049|467163891|FG000|Overall Study|Protocol Violation|0|||
129780596|NCT01349049|467163892|FG001|Overall Study|Protocol Violation|0|||
129780597|NCT01349049|467163893|FG002|Overall Study|Protocol Violation|0|||
129780598|NCT01349049|467163894|FG003|Overall Study|Protocol Violation|0|||
129780599|NCT01349049|467163895|FG004|Overall Study|Protocol Violation|0|||
129780600|NCT01349049|467163896|FG005|Overall Study|Protocol Violation|0|||
129780601|NCT01349049|467163897|FG006|Overall Study|Protocol Violation|0|||
129780602|NCT01349049|467163898|FG007|Overall Study|Protocol Violation|0|||
129780603|NCT01349049|467163899|FG008|Overall Study|Protocol Violation|1|||
129780604|NCT01349049|467163891|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
129780605|NCT01349049|467163892|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
129780606|NCT01349049|467163893|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
129780607|NCT01349049|467163894|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
129780608|NCT01349049|467163895|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
129780609|NCT01349049|467163896|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
129780610|NCT01349049|467163897|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
129780611|NCT01349049|467163898|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
129780612|NCT01349049|467163899|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
129780613|NCT01349049|467163891|FG000|Overall Study|Other|0|||
129780614|NCT01349049|467163892|FG001|Overall Study|Other|0|||
129780615|NCT01349049|467163893|FG002|Overall Study|Other|0|||
129780616|NCT01349049|467163894|FG003|Overall Study|Other|0|||
129780617|NCT01349049|467163895|FG004|Overall Study|Other|0|||
129780618|NCT01349049|467163896|FG005|Overall Study|Other|1|||
129780619|NCT01349049|467163897|FG006|Overall Study|Other|0|||
129780620|NCT01349049|467163898|FG007|Overall Study|Other|0|||
129780621|NCT01349049|467163899|FG008|Overall Study|Other|4|||
129780622|NCT01349049|467163891|FG000|Overall Study|Death|0|||
129780623|NCT01349049|467163892|FG001|Overall Study|Death|0|||
129780624|NCT01349049|467163893|FG002|Overall Study|Death|0|||
129780625|NCT01349049|467163894|FG003|Overall Study|Death|0|||
129780626|NCT01349049|467163895|FG004|Overall Study|Death|0|||
129780627|NCT01349049|467163896|FG005|Overall Study|Death|0|||
129569127|NCT01108094|466381648|FG000|Overall Study|Adverse Event|2|||
129569128|NCT01108094|466381649|FG001|Overall Study|Adverse Event|0|||
129569129|NCT01108094|466381650|FG002|Overall Study|Adverse Event|0|||
129780628|NCT01349049|467163897|FG006|Overall Study|Death|0|||
129780629|NCT01349049|467163898|FG007|Overall Study|Death|1|||
129780630|NCT01349049|467163899|FG008|Overall Study|Death|5|||
129780631|NCT01349049|467163891|FG000|Overall Study|Non-compliance|0|||
129780632|NCT01349049|467163892|FG001|Overall Study|Non-compliance|0|||
129780633|NCT01349049|467163893|FG002|Overall Study|Non-compliance|0|||
129780634|NCT01349049|467163894|FG003|Overall Study|Non-compliance|1|||
129569130|NCT01108094|466381651|FG003|Overall Study|Adverse Event|0|||
129569131|NCT01108094|466381648|FG000|Overall Study|Withdrawal by Subject|1|||
129569132|NCT01108094|466381649|FG001|Overall Study|Withdrawal by Subject|0|||
129569133|NCT01108094|466381650|FG002|Overall Study|Withdrawal by Subject|0|||
129569134|NCT01108094|466381651|FG003|Overall Study|Withdrawal by Subject|0|||
129569135|NCT01101022|466381659|FG000|Overall Study|Adverse Event|6|||
129569136|NCT01101022|466381660|FG001|Overall Study|Adverse Event|2|||
129569137|NCT01101022|466381659|FG000|Overall Study|Protocol Violation|4|||
129569138|NCT01101022|466381660|FG001|Overall Study|Protocol Violation|3|||
129569139|NCT01101022|466381659|FG000|Overall Study|Withdrawal by Subject|3|||
129569140|NCT01101022|466381660|FG001|Overall Study|Withdrawal by Subject|8|||
129569141|NCT01101022|466381659|FG000|Overall Study|Lost to Follow-up|1|||
129569142|NCT01101022|466381660|FG001|Overall Study|Lost to Follow-up|4|||
129569143|NCT01101022|466381659|FG000|Overall Study|Lack of Efficacy|0|||
129569144|NCT01101022|466381660|FG001|Overall Study|Lack of Efficacy|7|||
129569145|NCT01101022|466381659|FG000|Overall Study|Sponsor decision|1|||
129569146|NCT01101022|466381660|FG001|Overall Study|Sponsor decision|1|||
129569147|NCT01101022|466381659|FG000|Overall Study|Non-compliance|1|||
129569148|NCT01101022|466381660|FG001|Overall Study|Non-compliance|0|||
129569149|NCT01101022|466381659|FG000|Overall Study|Work schedule|1|||
129569150|NCT01101022|466381660|FG001|Overall Study|Work schedule|1|||
129569151|NCT01101022|466381659|FG000|Overall Study|Vacation|0|||
129569152|NCT01101022|466381660|FG001|Overall Study|Vacation|1|||
129569153|NCT01519661|466381661|FG000|Overall Study|Protocol deviation|6|||
129569154|NCT01519661|466381661|FG000|Overall Study|Lost to Follow-up|3|||
129569155|NCT01519661|466381661|FG000|Overall Study|Withdrawal by Subject|17|||
129569156|NCT01519661|466381661|FG000|Overall Study|Lack of Efficacy|6|||
129569157|NCT01519661|466381661|FG000|Overall Study|Adverse Event|29|||
129569158|NCT01139047|466381662|FG000|Overall Study|Withdrawal by Subject|1|||
129569159|NCT05818137|466381663|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
129569160|NCT05818137|466381663|FG000|Extension Treatment Period|Ongoing participants|44|||
129569161|NCT01604850|466381666|FG000|Overall Study|Enrolled but never treated|0|||
129569162|NCT01604850|466381667|FG001|Overall Study|Enrolled but never treated|1|||
129569163|NCT01604850|466381666|FG000|Overall Study|Efficacy Failure|50|||
129569164|NCT01604850|466381667|FG001|Overall Study|Efficacy Failure|29|||
129569165|NCT01604850|466381666|FG000|Overall Study|Lost to Follow-up|1|||
129569166|NCT01604850|466381667|FG001|Overall Study|Lost to Follow-up|0|||
129569167|NCT01604850|466381666|FG000|Overall Study|Subject withdrew consent|1|||
129569168|NCT01604850|466381667|FG001|Overall Study|Subject withdrew consent|0|||
129569169|NCT00727571|466381668|FG000|Overall Study|Ineligibility determined|1|||
129569170|NCT00727571|466381669|FG001|Overall Study|Ineligibility determined|1|||
129569171|NCT00727571|466381670|FG002|Overall Study|Ineligibility determined|1|||
129569172|NCT00727571|466381671|FG003|Overall Study|Ineligibility determined|0|||
129569173|NCT00727571|466381668|FG000|Overall Study|Death|0|||
129569174|NCT00727571|466381669|FG001|Overall Study|Death|19|||
129569175|NCT00727571|466381670|FG002|Overall Study|Death|5|||
129569176|NCT00727571|466381671|FG003|Overall Study|Death|1|||
129569177|NCT00727571|466381668|FG000|Overall Study|Physician Decision|0|||
129569178|NCT00727571|466381669|FG001|Overall Study|Physician Decision|5|||
129569179|NCT00727571|466381670|FG002|Overall Study|Physician Decision|0|||
129569180|NCT00727571|466381671|FG003|Overall Study|Physician Decision|0|||
129569181|NCT00727571|466381668|FG000|Overall Study|Withdrawal by Subject|0|||
129569182|NCT00727571|466381669|FG001|Overall Study|Withdrawal by Subject|10|||
129569183|NCT00727571|466381670|FG002|Overall Study|Withdrawal by Subject|11|||
129569184|NCT00727571|466381671|FG003|Overall Study|Withdrawal by Subject|0|||
129569185|NCT00727571|466381668|FG000|Overall Study|Subject Non Compliance|0|||
129569186|NCT00727571|466381669|FG001|Overall Study|Subject Non Compliance|6|||
129569187|NCT00727571|466381670|FG002|Overall Study|Subject Non Compliance|0|||
129690326|NCT01871727|466824490|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129690327|NCT01871727|466824491|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129690328|NCT01871727|466824492|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129690329|NCT01871727|466824493|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
129569188|NCT00727571|466381671|FG003|Overall Study|Subject Non Compliance|4|||
129569189|NCT00727571|466381668|FG000|Overall Study|Dismissed from nursing home|0|||
129569190|NCT00727571|466381669|FG001|Overall Study|Dismissed from nursing home|9|||
129690330|NCT01871727|466824494|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
129690331|NCT01871727|466824490|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
129690332|NCT01871727|466824491|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
129690333|NCT01871727|466824492|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
129569191|NCT00727571|466381670|FG002|Overall Study|Dismissed from nursing home|5|||
129569192|NCT00727571|466381671|FG003|Overall Study|Dismissed from nursing home|0|||
129569193|NCT00727571|466381668|FG000|Overall Study|Hospitalization|0|||
129569194|NCT00727571|466381669|FG001|Overall Study|Hospitalization|1|||
129569195|NCT00727571|466381670|FG002|Overall Study|Hospitalization|0|||
129569196|NCT00727571|466381671|FG003|Overall Study|Hospitalization|1|||
129569197|NCT00727571|466381668|FG000|Overall Study|AE not leading to hospitalization|0|||
129569198|NCT00727571|466381669|FG001|Overall Study|AE not leading to hospitalization|0|||
129569199|NCT00727571|466381670|FG002|Overall Study|AE not leading to hospitalization|2|||
129569200|NCT00727571|466381671|FG003|Overall Study|AE not leading to hospitalization|0|||
129569201|NCT00727571|466381668|FG000|Overall Study|Other|0|||
129569202|NCT00727571|466381669|FG001|Overall Study|Other|4|||
129569203|NCT00727571|466381670|FG002|Overall Study|Other|6|||
129569204|NCT00727571|466381671|FG003|Overall Study|Other|0|||
129569205|NCT03164772|466381673|FG000|Overall Study|Death|4|||
129569206|NCT03164772|466381674|FG001|Overall Study|Death|2|||
129569207|NCT03164772|466381673|FG000|Overall Study|Adverse Event|1|||
129569208|NCT03164772|466381674|FG001|Overall Study|Adverse Event|4|||
129569209|NCT03164772|466381673|FG000|Overall Study|Progressive Disease|11|||
129569210|NCT03164772|466381674|FG001|Overall Study|Progressive Disease|21|||
129569211|NCT03164772|466381673|FG000|Overall Study|Physician Decision|2|||
129569212|NCT03164772|466381674|FG001|Overall Study|Physician Decision|0|||
129569213|NCT03164772|466381673|FG000|Overall Study|Withdrawal by Subject|0|||
129569214|NCT03164772|466381674|FG001|Overall Study|Withdrawal by Subject|4|||
129569215|NCT04099888|466381677|FG000|Overall Study|Study terminated by sponsor|9|||
129780635|NCT01349049|467163895|FG004|Overall Study|Non-compliance|0|||
129780636|NCT01349049|467163896|FG005|Overall Study|Non-compliance|0|||
129780637|NCT01349049|467163897|FG006|Overall Study|Non-compliance|0|||
129780638|NCT01349049|467163898|FG007|Overall Study|Non-compliance|0|||
129780639|NCT01349049|467163899|FG008|Overall Study|Non-compliance|0|||
129780640|NCT01349049|467163891|FG000|Overall Study|Withdrawal by Subject|0|||
129780641|NCT01349049|467163892|FG001|Overall Study|Withdrawal by Subject|0|||
129780642|NCT01349049|467163893|FG002|Overall Study|Withdrawal by Subject|0|||
129780643|NCT01349049|467163894|FG003|Overall Study|Withdrawal by Subject|0|||
129780644|NCT01349049|467163895|FG004|Overall Study|Withdrawal by Subject|0|||
129780645|NCT01349049|467163896|FG005|Overall Study|Withdrawal by Subject|0|||
129780646|NCT01349049|467163897|FG006|Overall Study|Withdrawal by Subject|0|||
129780647|NCT01349049|467163898|FG007|Overall Study|Withdrawal by Subject|0|||
129780648|NCT01349049|467163899|FG008|Overall Study|Withdrawal by Subject|6|||
129780649|NCT04681352|467163906|FG000|Overall Study|Lost to Follow-up|2|||
129780650|NCT04681352|467163906|FG000|Overall Study|Withdrawal by Subject|22|||
129780651|NCT01643772|467163907|FG000|Overall Study|Protocol Violation|0|||
129780652|NCT01643772|467163908|FG001|Overall Study|Protocol Violation|0|||
129780653|NCT01643772|467163909|FG002|Overall Study|Protocol Violation|0|||
129780654|NCT01643772|467163910|FG003|Overall Study|Protocol Violation|1|||
129780655|NCT01643772|467163907|FG000|Overall Study|Adverse Event|0|||
129780656|NCT01643772|467163908|FG001|Overall Study|Adverse Event|0|||
129780657|NCT01643772|467163909|FG002|Overall Study|Adverse Event|0|||
129780658|NCT01643772|467163910|FG003|Overall Study|Adverse Event|1|||
129780659|NCT02881567|467163919|FG000|Overall Study|Adverse Event|1|||
129780660|NCT02881567|467163919|FG000|Overall Study|Lost to Follow-up|3|||
129780661|NCT02881567|467163919|FG000|Overall Study|Consent withdrawn|1|||
129780662|NCT02881567|467163919|FG000|Overall Study|Investigator decision|1|||
129780663|NCT02881567|467163919|FG000|Overall Study|Study terminated by sponsor|9|||
129780664|NCT02881567|467163919|FG000|Overall Study|Reason not Specified|3|||
129780665|NCT00373113|467163920|FG000|Overall Study|Death|1|||
129780666|NCT00373113|467163921|FG001|Overall Study|Death|7|||
129780667|NCT00373113|467163920|FG000|Overall Study|Adverse Event|38|||
129780668|NCT00373113|467163921|FG001|Overall Study|Adverse Event|24|||
129780669|NCT00373113|467163920|FG000|Overall Study|Study terminated by sponsor|9|||
129780670|NCT00373113|467163921|FG001|Overall Study|Study terminated by sponsor|1|||
129780671|NCT00373113|467163920|FG000|Overall Study|Global deterioration of health status|10|||
129780672|NCT00373113|467163921|FG001|Overall Study|Global deterioration of health status|7|||
129780673|NCT00373113|467163920|FG000|Overall Study|Lost to Follow-up|1|||
129780674|NCT00373113|467163921|FG001|Overall Study|Lost to Follow-up|3|||
129780675|NCT00373113|467163920|FG000|Overall Study|Objective progression or relapse|150|||
129780676|NCT00373113|467163921|FG001|Overall Study|Objective progression or relapse|169|||
129780677|NCT00373113|467163920|FG000|Overall Study|Other|14|||
129569216|NCT04099888|466381678|FG001|Overall Study|Study terminated by sponsor|11|||
129569217|NCT04099888|466381677|FG000|Overall Study|Lost to Follow-up|1|||
129569218|NCT04099888|466381678|FG001|Overall Study|Lost to Follow-up|1|||
129569219|NCT04099888|466381677|FG000|Overall Study|Withdrawal by Subject|5|||
129569220|NCT04099888|466381678|FG001|Overall Study|Withdrawal by Subject|6|||
129569221|NCT04099888|466381677|FG000|Overall Study|Death|5|||
129780678|NCT00373113|467163921|FG001|Overall Study|Other|17|||
129780679|NCT00373113|467163920|FG000|Overall Study|Protocol Violation|5|||
129780680|NCT00373113|467163921|FG001|Overall Study|Protocol Violation|1|||
129780681|NCT00373113|467163920|FG000|Overall Study|Withdrawal by Subject|10|||
129780682|NCT00373113|467163921|FG001|Overall Study|Withdrawal by Subject|15|||
129780683|NCT04248491|467163922|FG000|Overall Study|Lost to Follow-up|1|||
129780684|NCT04248491|467163923|FG001|Overall Study|Lost to Follow-up|0|||
129780685|NCT02364336|467163927|FG000|Overall Study|Adverse Event|0|||
129780686|NCT02364336|467163928|FG001|Overall Study|Adverse Event|1|||
129780687|NCT01731938|467163929|FG000|Preliminary Part I|Withdrawal by Subject|2|||
129569222|NCT04099888|466381678|FG001|Overall Study|Death|2|||
129569223|NCT04099888|466381677|FG000|Overall Study|Other|1|||
129780688|NCT01731938|467163930|FG001|Preliminary Part I|Withdrawal by Subject|2|||
129780689|NCT01731938|467163929|FG000|Preliminary Part I|Physician Decision|1|||
129780690|NCT01731938|467163930|FG001|Preliminary Part I|Physician Decision|0|||
129780691|NCT01731938|467163929|FG000|Preliminary Part I|Lost to Follow-up|0|||
129780692|NCT01731938|467163930|FG001|Preliminary Part I|Lost to Follow-up|3|||
129780693|NCT01731938|467163929|FG000|Preliminary Part I|Missed Week 6 visit|0|||
129780694|NCT01731938|467163930|FG001|Preliminary Part I|Missed Week 6 visit|3|||
129780695|NCT01731938|467163929|FG000|Primary Part II|Withdrawal by Subject|5|||
129780696|NCT01731938|467163930|FG001|Primary Part II|Withdrawal by Subject|4|||
129780697|NCT01731938|467163929|FG000|Primary Part II|Lost to Follow-up|4|||
129780698|NCT01731938|467163930|FG001|Primary Part II|Lost to Follow-up|5|||
129780699|NCT01731938|467163929|FG000|Primary Part II|Death|2|||
129780700|NCT01731938|467163930|FG001|Primary Part II|Death|1|||
129780701|NCT01731938|467163929|FG000|Primary Part II|Missed Week 6 visit|2|||
129569224|NCT04099888|466381678|FG001|Overall Study|Other|0|||
129569225|NCT04538170|466381679|FG000|Overall Study|Withdrawal by Subject|104|||
129569226|NCT04538170|466381680|FG001|Overall Study|Withdrawal by Subject|210|||
129569227|NCT00051025|466381684|FG000|Overall Study|Progressive Disease|1|||
129569228|NCT00051025|466381685|FG001|Overall Study|Progressive Disease|1|||
129569229|NCT00051025|466381684|FG000|Overall Study|Adverse Event|1|||
129569230|NCT00051025|466381685|FG001|Overall Study|Adverse Event|1|||
129569231|NCT00051025|466381684|FG000|Overall Study|Withdrawal by Subject|0|||
129569232|NCT00051025|466381685|FG001|Overall Study|Withdrawal by Subject|1|||
129569233|NCT00051025|466381684|FG000|Overall Study|Death|0|||
129569234|NCT00051025|466381685|FG001|Overall Study|Death|1|||
129569235|NCT00274937|466381686|FG000|Overall Study|Physician Decision|10|||
129569236|NCT00274937|466381686|FG000|Overall Study|Withdrawal by Subject|6|||
129569237|NCT00274937|466381686|FG000|Overall Study|Progressive Disease|4|||
129569238|NCT02189941|466381687|FG000|Overall Study|Non-compliance|0|||
129569239|NCT02189941|466381688|FG001|Overall Study|Non-compliance|0|||
129569240|NCT02189941|466381689|FG002|Overall Study|Non-compliance|1|||
129569241|NCT00445003|466381691|FG000|Overall Study|Death|1|||
129569242|NCT00445003|466381692|FG001|Overall Study|Death|2|||
129569243|NCT00445003|466381693|FG002|Overall Study|Death|1|||
129569244|NCT00445003|466381691|FG000|Overall Study|Missed Visit|3|||
129569245|NCT00445003|466381692|FG001|Overall Study|Missed Visit|5|||
129569246|NCT00445003|466381693|FG002|Overall Study|Missed Visit|1|||
129569247|NCT00445003|466381691|FG000|Overall Study|Dropped|1|||
129569248|NCT00445003|466381692|FG001|Overall Study|Dropped|3|||
129569249|NCT00445003|466381693|FG002|Overall Study|Dropped|2|||
129569250|NCT01471093|466381694|FG000|Overall Study|Adverse Event|1|||
129569251|NCT01471093|466381695|FG001|Overall Study|Adverse Event|0|||
129569252|NCT01471093|466381696|FG002|Overall Study|Adverse Event|0|||
129569253|NCT01471093|466381697|FG003|Overall Study|Adverse Event|0|||
129569254|NCT02475954|466381698|FG000|Overall Study|Withdrawal by Subject|2|||
129569255|NCT02475954|466381699|FG001|Overall Study|Withdrawal by Subject|2|||
129569256|NCT02475954|466381698|FG000|Overall Study|Lost to Follow-up|11|||
129569257|NCT02475954|466381699|FG001|Overall Study|Lost to Follow-up|9|||
129569258|NCT02475954|466381698|FG000|Overall Study|Death|1|||
129569259|NCT02475954|466381699|FG001|Overall Study|Death|1|||
129569260|NCT02932878|466381700|FG000|Overall Study|Due to Lab Results|2|||
129569261|NCT02932878|466381701|FG001|Overall Study|Due to Lab Results|1|||
129569262|NCT01918397|466381702|FG000|Overall Study|Never started treatment|2|||
129569263|NCT01918397|466381703|FG001|Overall Study|Never started treatment|1|||
129569264|NCT01918397|466381704|FG002|Overall Study|Never started treatment|0|||
129569265|NCT01918397|466381705|FG003|Overall Study|Never started treatment|0|||
129569266|NCT01918397|466381702|FG000|Overall Study|Adverse Event|1|||
129569267|NCT01918397|466381703|FG001|Overall Study|Adverse Event|1|||
129569268|NCT01918397|466381704|FG002|Overall Study|Adverse Event|1|||
129569269|NCT01918397|466381705|FG003|Overall Study|Adverse Event|0|||
129569270|NCT01918397|466381702|FG000|Overall Study|Lack of compliance|2|||
129780702|NCT01731938|467163930|FG001|Primary Part II|Missed Week 6 visit|3|||
129780703|NCT00771953|467163931|FG000|Overall Study|Adverse Event|5|||
129569271|NCT01918397|466381703|FG001|Overall Study|Lack of compliance|2|||
129569272|NCT01918397|466381704|FG002|Overall Study|Lack of compliance|3|||
129569273|NCT01918397|466381705|FG003|Overall Study|Lack of compliance|0|||
129569274|NCT01918397|466381702|FG000|Overall Study|Pregnancy|0|||
129569275|NCT01918397|466381703|FG001|Overall Study|Pregnancy|1|||
129569276|NCT01918397|466381704|FG002|Overall Study|Pregnancy|0|||
129569277|NCT01918397|466381705|FG003|Overall Study|Pregnancy|0|||
129569278|NCT01918397|466381702|FG000|Overall Study|Rifampin susceptible|0|||
129569279|NCT01918397|466381703|FG001|Overall Study|Rifampin susceptible|0|||
129569280|NCT01918397|466381704|FG002|Overall Study|Rifampin susceptible|0|||
129569281|NCT01918397|466381705|FG003|Overall Study|Rifampin susceptible|2|||
129780704|NCT00771953|467163932|FG001|Overall Study|Adverse Event|3|||
129569282|NCT01918397|466381702|FG000|Overall Study|Treatment failure|0|||
129569283|NCT01918397|466381703|FG001|Overall Study|Treatment failure|0|||
129569284|NCT01918397|466381704|FG002|Overall Study|Treatment failure|0|||
129569285|NCT01918397|466381705|FG003|Overall Study|Treatment failure|1|||
129569286|NCT01918397|466381702|FG000|Overall Study|Withdrawal by Subject|3|||
129780705|NCT00771953|467163931|FG000|Overall Study|Death|2|||
129780706|NCT00771953|467163932|FG001|Overall Study|Death|2|||
129569287|NCT01918397|466381703|FG001|Overall Study|Withdrawal by Subject|2|||
129569288|NCT01918397|466381704|FG002|Overall Study|Withdrawal by Subject|1|||
129569289|NCT01918397|466381705|FG003|Overall Study|Withdrawal by Subject|1|||
129569290|NCT01918397|466381702|FG000|Overall Study|XDR at baseline|0|||
129569291|NCT01918397|466381703|FG001|Overall Study|XDR at baseline|0|||
129569292|NCT01918397|466381704|FG002|Overall Study|XDR at baseline|1|||
129569293|NCT01918397|466381705|FG003|Overall Study|XDR at baseline|0|||
129569294|NCT01918397|466381702|FG000|Overall Study|Lost to Follow-up|2|||
129569295|NCT01918397|466381703|FG001|Overall Study|Lost to Follow-up|1|||
129569296|NCT01918397|466381704|FG002|Overall Study|Lost to Follow-up|1|||
129569297|NCT01918397|466381705|FG003|Overall Study|Lost to Follow-up|1|||
129569298|NCT01918397|466381702|FG000|Overall Study|Increased QTc|1|||
129780707|NCT00771953|467163931|FG000|Overall Study|Progression before active Tx|1|||
129780708|NCT00771953|467163932|FG001|Overall Study|Progression before active Tx|2|||
129780709|NCT00771953|467163931|FG000|Overall Study|Sponsor decision|1|||
129780710|NCT00771953|467163932|FG001|Overall Study|Sponsor decision|0|||
129780711|NCT00771953|467163931|FG000|Overall Study|Other complicating disease|1|||
129780712|NCT00771953|467163932|FG001|Overall Study|Other complicating disease|0|||
129780713|NCT00771953|467163931|FG000|Overall Study|Withdrawal by Subject|0|||
129780714|NCT00771953|467163932|FG001|Overall Study|Withdrawal by Subject|3|||
129780715|NCT00856518|467163936|FG000|Overall Study|Lost to Follow-up|4|||
129780716|NCT00856518|467163937|FG001|Overall Study|Lost to Follow-up|2|||
129780717|NCT00947193|467163938|FG000|Overall Study|Lost to Follow-up|1|||
129780718|NCT00947193|467163939|FG001|Overall Study|Lost to Follow-up|0|||
129780719|NCT00947193|467163938|FG000|Overall Study|Withdrawal by Subject|1|||
129780720|NCT00947193|467163939|FG001|Overall Study|Withdrawal by Subject|0|||
129780721|NCT00947193|467163938|FG000|Overall Study|Factor VIII >1%|1|||
129780722|NCT00947193|467163939|FG001|Overall Study|Factor VIII >1%|0|||
129780723|NCT00926029|467163941|FG000|Overall Study|Lost to Follow-up|2|||
129780724|NCT00926029|467163942|FG001|Overall Study|Lost to Follow-up|1|||
129780725|NCT00926029|467163943|FG002|Overall Study|Lost to Follow-up|1|||
129780726|NCT05246514|467163944|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
129780727|NCT05246514|467163944|FG000|Overall Study|Withdrawal by Subject|1|||
129780728|NCT05246514|467163944|FG000|Overall Study|Death|13|||
129780729|NCT04154189|467163945|FG000|Overall Study|Withdrawal by Subject|4|||
129780730|NCT04154189|467163946|FG001|Overall Study|Withdrawal by Subject|6|||
129780731|NCT04154189|467163945|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
129780732|NCT04154189|467163946|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
129780733|NCT04154189|467163945|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
129780734|NCT04154189|467163946|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
129780735|NCT04154189|467163945|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
129780736|NCT04154189|467163946|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
129780737|NCT04154189|467163945|FG000|Overall Study|Death|25|||
129780738|NCT04154189|467163946|FG001|Overall Study|Death|25|||
129780739|NCT00486291|467163947|FG000|Overall Study|Adverse Event|3|||
129780740|NCT00486291|467163948|FG001|Overall Study|Adverse Event|4|||
129780741|NCT00486291|467163947|FG000|Overall Study|Lost to Follow-up|3|||
129780742|NCT00486291|467163948|FG001|Overall Study|Lost to Follow-up|7|||
129780743|NCT00486291|467163947|FG000|Overall Study|protocol non-compliance|10|||
129780744|NCT00486291|467163948|FG001|Overall Study|protocol non-compliance|15|||
129780745|NCT00486291|467163947|FG000|Overall Study|requirement for restricted medication|0|||
129780746|NCT00486291|467163948|FG001|Overall Study|requirement for restricted medication|3|||
129780747|NCT00126490|467163949|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
129780748|NCT00975780|467163950|FG000|Follow Up|Death|88|||
129780749|NCT00975780|467163951|FG001|Follow Up|Death|122|||
129780750|NCT00975780|467163950|FG000|Follow Up|Facility Withdrawal|7|||
129780751|NCT00975780|467163951|FG001|Follow Up|Facility Withdrawal|23|||
129780752|NCT00975780|467163950|FG000|Follow Up|Discharged from Facility|7|||
129780753|NCT00975780|467163951|FG001|Follow Up|Discharged from Facility|12|||
129569299|NCT01918397|466381703|FG001|Overall Study|Increased QTc|0|||
129569300|NCT01918397|466381704|FG002|Overall Study|Increased QTc|0|||
129569301|NCT01918397|466381705|FG003|Overall Study|Increased QTc|1|||
129569302|NCT01918397|466381702|FG000|Overall Study|Death|0|||
129569303|NCT01918397|466381703|FG001|Overall Study|Death|0|||
129780754|NCT03051178|467163954|FG000|Overall Study|Withdrawal by Subject|5|||
129780755|NCT01598506|467163955|FG000|Overall Study|Withdrawal by Subject|2|||
129780756|NCT04080167|467163958|FG000|Overall Study|Lost to Follow-up-Patients|7|||
129780757|NCT04080167|467163959|FG001|Overall Study|Lost to Follow-up-Patients|14|||
129780758|NCT04080167|467163960|FG002|Overall Study|Lost to Follow-up-Patients|0|||
129780759|NCT04080167|467163958|FG000|Overall Study|Lost to Follow-up-Providers|2|||
129780760|NCT04080167|467163959|FG001|Overall Study|Lost to Follow-up-Providers|2|||
129780761|NCT04080167|467163960|FG002|Overall Study|Lost to Follow-up-Providers|0|||
129569304|NCT01918397|466381704|FG002|Overall Study|Death|1|||
129569305|NCT01918397|466381705|FG003|Overall Study|Death|0|||
129780762|NCT04080167|467163958|FG000|Overall Study|Withdrawal by Subject|1|||
129780763|NCT04080167|467163959|FG001|Overall Study|Withdrawal by Subject|2|||
129569306|NCT01918397|466381702|FG000|Overall Study|Involved in another investigative trial|0|||
129569307|NCT01918397|466381703|FG001|Overall Study|Involved in another investigative trial|0|||
129569308|NCT01918397|466381704|FG002|Overall Study|Involved in another investigative trial|0|||
129569309|NCT01918397|466381705|FG003|Overall Study|Involved in another investigative trial|1|||
129569310|NCT00620022|466381706|FG000|Treatment Period 1|Adverse Event|4|||
129569311|NCT00620022|466381707|FG001|Treatment Period 1|Adverse Event|6|||
129569312|NCT00620022|466381706|FG000|Treatment Period 1|Subject withdrew consent|1|||
129569313|NCT00620022|466381707|FG001|Treatment Period 1|Subject withdrew consent|0|||
129569314|NCT00620022|466381706|FG000|Treatment Period 2|Adverse Event|2|||
129569315|NCT00620022|466381707|FG001|Treatment Period 2|Adverse Event|2|||
129569316|NCT02152566|466381711|FG000|Overall Study|Lost to Follow-up|1|||
129569317|NCT02152566|466381711|FG000|Overall Study|Withdrawal by Subject|2|||
129569318|NCT02334722|466381712|FG000|Overall Study|Lost to Follow-up|4|||
129569319|NCT02334722|466381713|FG001|Overall Study|Lost to Follow-up|0|||
129569320|NCT02334722|466381712|FG000|Overall Study|6 week questionnaire not completed|2|||
129569321|NCT02334722|466381713|FG001|Overall Study|6 week questionnaire not completed|0|||
129569322|NCT02334722|466381712|FG000|Overall Study|Unable to obtain medication|1|||
129569323|NCT02334722|466381713|FG001|Overall Study|Unable to obtain medication|1|||
129569324|NCT02334722|466381712|FG000|Overall Study|Withdrawal by Subject|0|||
129569325|NCT02334722|466381713|FG001|Overall Study|Withdrawal by Subject|3|||
129569326|NCT02334722|466381712|FG000|Overall Study|Adverse Event|0|||
129569327|NCT02334722|466381713|FG001|Overall Study|Adverse Event|2|||
129569328|NCT02334722|466381712|FG000|Overall Study|Physician Decision|0|||
129569329|NCT02334722|466381713|FG001|Overall Study|Physician Decision|1|||
129569330|NCT00856388|466381714|FG000|Overall Study|Other|1|||
129569331|NCT01617668|466381717|FG000|Overall Study|Adverse Event|7|||
129569332|NCT01617668|466381718|FG001|Overall Study|Adverse Event|0|||
129569333|NCT01617668|466381719|FG002|Overall Study|Adverse Event|12|||
129569334|NCT01617668|466381720|FG003|Overall Study|Adverse Event|5|||
129569335|NCT01617668|466381717|FG000|Overall Study|Physician Decision|1|||
129569336|NCT01617668|466381718|FG001|Overall Study|Physician Decision|2|||
129569337|NCT01617668|466381719|FG002|Overall Study|Physician Decision|3|||
129569338|NCT01617668|466381720|FG003|Overall Study|Physician Decision|0|||
129569339|NCT01617668|466381717|FG000|Overall Study|Progressive Disease|4|||
129569340|NCT01617668|466381718|FG001|Overall Study|Progressive Disease|4|||
129569341|NCT01617668|466381719|FG002|Overall Study|Progressive Disease|6|||
129569342|NCT01617668|466381720|FG003|Overall Study|Progressive Disease|9|||
129569343|NCT01617668|466381717|FG000|Overall Study|Subject/guardian decision|1|||
129569344|NCT01617668|466381718|FG001|Overall Study|Subject/guardian decision|3|||
129569345|NCT01617668|466381719|FG002|Overall Study|Subject/guardian decision|2|||
129569346|NCT01617668|466381720|FG003|Overall Study|Subject/guardian decision|1|||
129569347|NCT00686959|466381721|FG000|Overall Study|Participants censored (no death events)|124|||
129569348|NCT00686959|466381722|FG001|Overall Study|Participants censored (no death events)|117|||
129569349|NCT00150462|466381723|FG000|Overall Study|Disease Progression or Relapse|3|||
129569350|NCT00150462|466381724|FG001|Overall Study|Disease Progression or Relapse|1|||
129569351|NCT00150462|466381725|FG002|Overall Study|Disease Progression or Relapse|2|||
129569352|NCT00150462|466381726|FG003|Overall Study|Disease Progression or Relapse|1|||
129569353|NCT00150462|466381727|FG004|Overall Study|Disease Progression or Relapse|2|||
129569354|NCT00150462|466381728|FG005|Overall Study|Disease Progression or Relapse|2|||
129569355|NCT00150462|466381729|FG006|Overall Study|Disease Progression or Relapse|3|||
129569356|NCT00150462|466381730|FG007|Overall Study|Disease Progression or Relapse|5|||
129569357|NCT00150462|466381731|FG008|Overall Study|Disease Progression or Relapse|5|||
129569358|NCT00150462|466381732|FG009|Overall Study|Disease Progression or Relapse|3|||
129569359|NCT00150462|466381733|FG010|Overall Study|Disease Progression or Relapse|2|||
129569360|NCT00150462|466381723|FG000|Overall Study|Withdrawal by Subject|0|||
129690334|NCT01871727|466824493|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
129690335|NCT01871727|466824494|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
129690336|NCT00356421|466824496|FG000|Overall Study|Lack of Efficacy|3|||
129569361|NCT00150462|466381724|FG001|Overall Study|Withdrawal by Subject|1|||
129569362|NCT00150462|466381725|FG002|Overall Study|Withdrawal by Subject|1|||
129569363|NCT00150462|466381726|FG003|Overall Study|Withdrawal by Subject|0|||
129569364|NCT00150462|466381727|FG004|Overall Study|Withdrawal by Subject|1|||
129690337|NCT00356421|466824497|FG001|Overall Study|Lack of Efficacy|0|||
129690338|NCT00356421|466824496|FG000|Overall Study|Withdrawal by Subject|9|||
129690339|NCT00356421|466824497|FG001|Overall Study|Withdrawal by Subject|2|||
129690340|NCT00356421|466824496|FG000|Overall Study|Related to study drug|15|||
129690341|NCT00356421|466824497|FG001|Overall Study|Related to study drug|12|||
129569365|NCT00150462|466381728|FG005|Overall Study|Withdrawal by Subject|2|||
129569366|NCT00150462|466381729|FG006|Overall Study|Withdrawal by Subject|0|||
129569367|NCT00150462|466381730|FG007|Overall Study|Withdrawal by Subject|1|||
129569368|NCT00150462|466381731|FG008|Overall Study|Withdrawal by Subject|0|||
129569369|NCT00150462|466381732|FG009|Overall Study|Withdrawal by Subject|1|||
129569370|NCT00150462|466381733|FG010|Overall Study|Withdrawal by Subject|0|||
129690342|NCT00356421|466824496|FG000|Overall Study|Not related to study drug|5|||
129690343|NCT00356421|466824497|FG001|Overall Study|Not related to study drug|3|||
129569371|NCT00150462|466381723|FG000|Overall Study|Death|0|||
129569372|NCT00150462|466381724|FG001|Overall Study|Death|1|||
129569373|NCT00150462|466381725|FG002|Overall Study|Death|0|||
129569374|NCT00150462|466381726|FG003|Overall Study|Death|0|||
129569375|NCT00150462|466381727|FG004|Overall Study|Death|0|||
129569376|NCT00150462|466381728|FG005|Overall Study|Death|0|||
129569377|NCT00150462|466381729|FG006|Overall Study|Death|0|||
129569378|NCT00150462|466381730|FG007|Overall Study|Death|0|||
129569379|NCT00150462|466381731|FG008|Overall Study|Death|1|||
129569380|NCT00150462|466381732|FG009|Overall Study|Death|0|||
129569381|NCT00150462|466381733|FG010|Overall Study|Death|0|||
129569382|NCT00150462|466381723|FG000|Overall Study|Adverse Event|0|||
129569383|NCT00150462|466381724|FG001|Overall Study|Adverse Event|0|||
129569384|NCT00150462|466381725|FG002|Overall Study|Adverse Event|0|||
129569385|NCT00150462|466381726|FG003|Overall Study|Adverse Event|1|||
129569386|NCT00150462|466381727|FG004|Overall Study|Adverse Event|0|||
129569387|NCT00150462|466381728|FG005|Overall Study|Adverse Event|0|||
129569388|NCT00150462|466381729|FG006|Overall Study|Adverse Event|0|||
129569389|NCT00150462|466381730|FG007|Overall Study|Adverse Event|2|||
129569390|NCT00150462|466381731|FG008|Overall Study|Adverse Event|0|||
129569391|NCT00150462|466381732|FG009|Overall Study|Adverse Event|1|||
129569392|NCT00150462|466381733|FG010|Overall Study|Adverse Event|0|||
129569393|NCT00150462|466381723|FG000|Overall Study|Physician Decision|0|||
129569394|NCT00150462|466381724|FG001|Overall Study|Physician Decision|0|||
129569395|NCT00150462|466381725|FG002|Overall Study|Physician Decision|1|||
129569396|NCT00150462|466381726|FG003|Overall Study|Physician Decision|1|||
129569397|NCT00150462|466381727|FG004|Overall Study|Physician Decision|0|||
129690344|NCT00501085|466824498|FG000|Overall Study|Lost to Follow-up|195|||
129690345|NCT00501085|466824498|FG000|Overall Study|Withdrawal by Subject|34|||
129690346|NCT00501085|466824498|FG000|Overall Study|Subject Decision|1|||
129690347|NCT00501085|466824498|FG000|Overall Study|Revision Surgery|7|||
129690348|NCT00501085|466824498|FG000|Overall Study|Explantation Surgery|26|||
129690349|NCT00501085|466824498|FG000|Overall Study|Adverse Event|4|||
129690350|NCT00501085|466824498|FG000|Overall Study|Non-Compliance|24|||
129690351|NCT00501085|466824498|FG000|Overall Study|Study closed by sponsor|109|||
129690352|NCT00501085|466824498|FG000|Overall Study|Other loss to follow-up|32|||
129690353|NCT02958527|466824499|FG000|Overall Study|Not collected CRFs|12|||
129690354|NCT02945046|466824500|FG000|Overall Study|Adverse Event|1|||
129690355|NCT02945046|466824501|FG001|Overall Study|Adverse Event|0|||
129690356|NCT02945046|466824502|FG002|Overall Study|Adverse Event|2|||
129690357|NCT02945046|466824500|FG000|Overall Study|Withdrawal by Subject|3|||
129690358|NCT02945046|466824501|FG001|Overall Study|Withdrawal by Subject|3|||
129690359|NCT02945046|466824502|FG002|Overall Study|Withdrawal by Subject|3|||
129690360|NCT02945046|466824500|FG000|Overall Study|Protocol Violation|2|||
129690361|NCT02945046|466824501|FG001|Overall Study|Protocol Violation|3|||
129690362|NCT02945046|466824502|FG002|Overall Study|Protocol Violation|2|||
129690363|NCT02945046|466824500|FG000|Overall Study|Lost to Follow-up|1|||
129690364|NCT02945046|466824501|FG001|Overall Study|Lost to Follow-up|1|||
129690365|NCT02945046|466824502|FG002|Overall Study|Lost to Follow-up|0|||
129690366|NCT02945046|466824500|FG000|Overall Study|Lack of Efficacy|1|||
129690367|NCT02945046|466824501|FG001|Overall Study|Lack of Efficacy|2|||
129690368|NCT02945046|466824502|FG002|Overall Study|Lack of Efficacy|1|||
129690369|NCT02945046|466824500|FG000|Overall Study|Other than specified|5|||
129690370|NCT02945046|466824501|FG001|Overall Study|Other than specified|4|||
129690371|NCT02945046|466824502|FG002|Overall Study|Other than specified|7|||
129690372|NCT03113136|466824503|FG000|Overall Study|Lost to Follow-up|22|||
129690373|NCT03113136|466824504|FG001|Overall Study|Lost to Follow-up|47|||
129690374|NCT03113136|466824505|FG002|Overall Study|Lost to Follow-up|54|||
129690375|NCT03113136|466824503|FG000|Overall Study|Withdrawal by Subject|4|||
129690376|NCT03113136|466824504|FG001|Overall Study|Withdrawal by Subject|13|||
129690377|NCT03113136|466824505|FG002|Overall Study|Withdrawal by Subject|14|||
129690378|NCT03113136|466824503|FG000|Overall Study|Ineligible|0|||
129690379|NCT03113136|466824504|FG001|Overall Study|Ineligible|2|||
129690380|NCT03113136|466824505|FG002|Overall Study|Ineligible|1|||
129690381|NCT03113136|466824503|FG000|Overall Study|Study Team Decision|1|||
129690382|NCT03113136|466824504|FG001|Overall Study|Study Team Decision|4|||
129569398|NCT00150462|466381728|FG005|Overall Study|Physician Decision|0|||
129690383|NCT03113136|466824505|FG002|Overall Study|Study Team Decision|0|||
129690384|NCT01666314|466824509|FG000|Overall Study|Adverse Event|3|||
129690385|NCT01666314|466824510|FG001|Overall Study|Adverse Event|13|||
129690386|NCT01666314|466824511|FG002|Overall Study|Adverse Event|7|||
129690387|NCT01666314|466824512|FG003|Overall Study|Adverse Event|7|||
129690388|NCT01666314|466824509|FG000|Overall Study|Progressive Disease|11|||
129690389|NCT01666314|466824510|FG001|Overall Study|Progressive Disease|9|||
129690390|NCT01666314|466824511|FG002|Overall Study|Progressive Disease|19|||
129690391|NCT01666314|466824512|FG003|Overall Study|Progressive Disease|20|||
129569399|NCT00150462|466381729|FG006|Overall Study|Physician Decision|0|||
129569400|NCT00150462|466381730|FG007|Overall Study|Physician Decision|0|||
129569401|NCT00150462|466381731|FG008|Overall Study|Physician Decision|0|||
129690392|NCT01666314|466824509|FG000|Overall Study|Symptomatic Deterioration|1|||
129569402|NCT00150462|466381732|FG009|Overall Study|Physician Decision|0|||
129569403|NCT00150462|466381733|FG010|Overall Study|Physician Decision|0|||
129569404|NCT00150462|466381723|FG000|Overall Study|Other|0|||
129569405|NCT00150462|466381724|FG001|Overall Study|Other|0|||
129569406|NCT00150462|466381725|FG002|Overall Study|Other|0|||
129569407|NCT00150462|466381726|FG003|Overall Study|Other|0|||
129569408|NCT00150462|466381727|FG004|Overall Study|Other|0|||
129569409|NCT00150462|466381728|FG005|Overall Study|Other|0|||
129569410|NCT00150462|466381729|FG006|Overall Study|Other|0|||
129569411|NCT00150462|466381730|FG007|Overall Study|Other|0|||
129569412|NCT00150462|466381731|FG008|Overall Study|Other|0|||
129569413|NCT00150462|466381732|FG009|Overall Study|Other|1|||
129569414|NCT00150462|466381733|FG010|Overall Study|Other|1|||
129569415|NCT01196052|466381736|FG000|Overall Study|Adverse Event|9|||
129569416|NCT01196052|466381736|FG000|Overall Study|Lost to Follow-up|1|||
129569417|NCT01196052|466381736|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
129569418|NCT01196052|466381736|FG000|Overall Study|Reason not Specified|5|||
129569419|NCT01196052|466381736|FG000|Overall Study|Withdrawal by Subject|6|||
129569420|NCT02178722|466381737|FG000|Overall Study|Withdrawal by Subject|0|||
129569421|NCT02178722|466381738|FG001|Overall Study|Withdrawal by Subject|0|||
129569422|NCT02178722|466381739|FG002|Overall Study|Withdrawal by Subject|0|||
129569423|NCT02178722|466381740|FG003|Overall Study|Withdrawal by Subject|2|||
129569424|NCT02178722|466381741|FG004|Overall Study|Withdrawal by Subject|33|||
129569425|NCT02178722|466381737|FG000|Overall Study|Death|2|||
129569426|NCT02178722|466381738|FG001|Overall Study|Death|13|||
129569427|NCT02178722|466381739|FG002|Overall Study|Death|12|||
129569428|NCT02178722|466381740|FG003|Overall Study|Death|12|||
129569429|NCT02178722|466381741|FG004|Overall Study|Death|205|||
129569430|NCT02178722|466381737|FG000|Overall Study|Lost to Follow-up|0|||
129569431|NCT02178722|466381738|FG001|Overall Study|Lost to Follow-up|0|||
129569432|NCT02178722|466381739|FG002|Overall Study|Lost to Follow-up|0|||
129569433|NCT02178722|466381740|FG003|Overall Study|Lost to Follow-up|2|||
129569434|NCT02178722|466381741|FG004|Overall Study|Lost to Follow-up|11|||
129569435|NCT02178722|466381737|FG000|Overall Study|Study terminated by Sponsor|2|||
129569436|NCT02178722|466381738|FG001|Overall Study|Study terminated by Sponsor|7|||
129569437|NCT02178722|466381739|FG002|Overall Study|Study terminated by Sponsor|6|||
129569438|NCT02178722|466381740|FG003|Overall Study|Study terminated by Sponsor|4|||
129569439|NCT02178722|466381741|FG004|Overall Study|Study terminated by Sponsor|128|||
129569440|NCT02178722|466381737|FG000|Overall Study|Physician Decision|0|||
129569441|NCT02178722|466381738|FG001|Overall Study|Physician Decision|0|||
129569442|NCT02178722|466381739|FG002|Overall Study|Physician Decision|0|||
129569443|NCT02178722|466381740|FG003|Overall Study|Physician Decision|0|||
129569444|NCT02178722|466381741|FG004|Overall Study|Physician Decision|3|||
129569445|NCT02178722|466381737|FG000|Overall Study|Other|0|||
129569446|NCT02178722|466381738|FG001|Overall Study|Other|0|||
129569447|NCT02178722|466381739|FG002|Overall Study|Other|0|||
129569448|NCT02178722|466381740|FG003|Overall Study|Other|0|||
129569449|NCT02178722|466381741|FG004|Overall Study|Other|2|||
129569450|NCT03340727|466381742|FG000|Overall Study|Death|1|||
129569451|NCT03340727|466381743|FG001|Overall Study|Death|0|||
129569452|NCT03340727|466381742|FG000|Overall Study|Lost to Follow-up|31|||
129569453|NCT03340727|466381743|FG001|Overall Study|Lost to Follow-up|35|||
129569454|NCT03340727|466381742|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
129569455|NCT03340727|466381743|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
129569456|NCT03340727|466381742|FG000|Overall Study|Transferred to another facility|10|||
129569457|NCT03340727|466381743|FG001|Overall Study|Transferred to another facility|7|||
129569458|NCT03340727|466381742|FG000|Overall Study|Withdrawal by Subject|28|||
129569459|NCT03340727|466381743|FG001|Overall Study|Withdrawal by Subject|17|||
129690393|NCT01666314|466824510|FG001|Overall Study|Symptomatic Deterioration|0|||
129690394|NCT01666314|466824511|FG002|Overall Study|Symptomatic Deterioration|2|||
129690395|NCT01666314|466824512|FG003|Overall Study|Symptomatic Deterioration|0|||
129690396|NCT01666314|466824509|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
129690397|NCT01666314|466824510|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
129690398|NCT01666314|466824511|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
129569460|NCT01720264|466381744|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
129569461|NCT01720264|466381744|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
129569462|NCT01720264|466381744|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
129569463|NCT00877032|466381745|FG000|Overall Study|Did not meet entrance criteria|0|||
129569464|NCT00877032|466381746|FG001|Overall Study|Did not meet entrance criteria|0|||
129569465|NCT00877032|466381747|FG002|Overall Study|Did not meet entrance criteria|0|||
129690399|NCT01666314|466824512|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
129690400|NCT01666314|466824509|FG000|Overall Study|Withdrawal by Subject|1|||
129569466|NCT00877032|466381748|FG003|Overall Study|Did not meet entrance criteria|1|||
129569467|NCT00877032|466381749|FG004|Overall Study|Did not meet entrance criteria|0|||
129569468|NCT00877032|466381750|FG005|Overall Study|Did not meet entrance criteria|0|||
129569469|NCT00877032|466381751|FG006|Overall Study|Did not meet entrance criteria|2|||
129690401|NCT01666314|466824510|FG001|Overall Study|Withdrawal by Subject|1|||
129569470|NCT00259012|466381762|FG000|Overall Study|Adverse Event|0|||
129569471|NCT00259012|466381763|FG001|Overall Study|Adverse Event|1|||
129569472|NCT00259012|466381762|FG000|Overall Study|Withdrawal by Subject|1|||
129569473|NCT00259012|466381763|FG001|Overall Study|Withdrawal by Subject|0|||
129569474|NCT00259012|466381762|FG000|Overall Study|Physician Decision|0|||
129569475|NCT00259012|466381763|FG001|Overall Study|Physician Decision|1|||
129569476|NCT00259012|466381762|FG000|Overall Study|Lost to Follow-up|0|||
129569477|NCT00259012|466381763|FG001|Overall Study|Lost to Follow-up|1|||
129569478|NCT00259012|466381762|FG000|Overall Study|Protocol Violation|1|||
129569479|NCT00259012|466381763|FG001|Overall Study|Protocol Violation|1|||
129569480|NCT05067647|466381774|FG000|Overall Study|Lost to Follow-up|1|||
129569481|NCT00870870|466381777|FG000|Overall Study|Withdrawal by Subject|0|||
129569482|NCT00870870|466381778|FG001|Overall Study|Withdrawal by Subject|1|||
129569483|NCT00870870|466381779|FG002|Overall Study|Withdrawal by Subject|1|||
129569484|NCT00870870|466381780|FG003|Overall Study|Withdrawal by Subject|3|||
129569485|NCT00870870|466381777|FG000|Overall Study|Adverse Event|0|||
129569486|NCT00870870|466381778|FG001|Overall Study|Adverse Event|0|||
129569487|NCT00870870|466381779|FG002|Overall Study|Adverse Event|2|||
129569488|NCT00870870|466381780|FG003|Overall Study|Adverse Event|2|||
129569489|NCT03125200|466381783|FG000|Overall Study|Study Termination|0|||
129569490|NCT03125200|466381784|FG001|Overall Study|Study Termination|0|||
129569491|NCT03125200|466381785|FG002|Overall Study|Study Termination|0|||
129569492|NCT03125200|466381786|FG003|Overall Study|Study Termination|1|||
129569493|NCT03125200|466381787|FG004|Overall Study|Study Termination|1|||
129569494|NCT03125200|466381788|FG005|Overall Study|Study Termination|2|||
129569495|NCT03125200|466381789|FG006|Overall Study|Study Termination|1|||
129569496|NCT03125200|466381783|FG000|Overall Study|Clinical Progression|0|||
129569497|NCT03125200|466381784|FG001|Overall Study|Clinical Progression|0|||
129569498|NCT03125200|466381785|FG002|Overall Study|Clinical Progression|0|||
129569499|NCT03125200|466381786|FG003|Overall Study|Clinical Progression|1|||
129569500|NCT03125200|466381787|FG004|Overall Study|Clinical Progression|0|||
129569501|NCT03125200|466381788|FG005|Overall Study|Clinical Progression|1|||
129569502|NCT03125200|466381789|FG006|Overall Study|Clinical Progression|0|||
129569503|NCT03125200|466381783|FG000|Overall Study|Progressive Disease|2|||
129569504|NCT03125200|466381784|FG001|Overall Study|Progressive Disease|1|||
129569505|NCT03125200|466381785|FG002|Overall Study|Progressive Disease|2|||
129569506|NCT03125200|466381786|FG003|Overall Study|Progressive Disease|1|||
129569507|NCT03125200|466381787|FG004|Overall Study|Progressive Disease|2|||
129569508|NCT03125200|466381788|FG005|Overall Study|Progressive Disease|0|||
129569509|NCT03125200|466381789|FG006|Overall Study|Progressive Disease|1|||
129569510|NCT03125200|466381783|FG000|Overall Study|Lack of Efficacy|0|||
129690402|NCT01666314|466824511|FG002|Overall Study|Withdrawal by Subject|2|||
129690403|NCT01666314|466824512|FG003|Overall Study|Withdrawal by Subject|3|||
129690404|NCT01666314|466824509|FG000|Overall Study|Reason not Specified|10|||
129690405|NCT01666314|466824510|FG001|Overall Study|Reason not Specified|7|||
129690406|NCT01666314|466824511|FG002|Overall Study|Reason not Specified|5|||
129690407|NCT01666314|466824512|FG003|Overall Study|Reason not Specified|5|||
129690408|NCT02114684|466824515|FG000|Overall Study|Death|6|||
129690409|NCT02114684|466824516|FG001|Overall Study|Death|4|||
129690410|NCT02114684|466824515|FG000|Overall Study|Lost to Follow-up|1|||
129690411|NCT02114684|466824516|FG001|Overall Study|Lost to Follow-up|2|||
129690412|NCT02114684|466824515|FG000|Overall Study|Withdrawal by Subject|1|||
129690413|NCT02114684|466824516|FG001|Overall Study|Withdrawal by Subject|2|||
129690414|NCT02114684|466824515|FG000|Overall Study|Relocation|3|||
129690415|NCT02114684|466824516|FG001|Overall Study|Relocation|1|||
129690416|NCT02114684|466824515|FG000|Overall Study|Rifampicin resistant on culture|0|||
129690417|NCT02114684|466824516|FG001|Overall Study|Rifampicin resistant on culture|1|||
129690418|NCT02114684|466824515|FG000|Overall Study|Patient Incarcerated|1|||
129690419|NCT02114684|466824516|FG001|Overall Study|Patient Incarcerated|0|||
129690420|NCT04625972|466824519|FG000|Overall Study|Death|3|||
129569511|NCT03125200|466381784|FG001|Overall Study|Lack of Efficacy|0|||
129569512|NCT03125200|466381785|FG002|Overall Study|Lack of Efficacy|0|||
129569513|NCT03125200|466381786|FG003|Overall Study|Lack of Efficacy|1|||
129569514|NCT03125200|466381787|FG004|Overall Study|Lack of Efficacy|0|||
129690421|NCT04625972|466824520|FG001|Overall Study|Death|2|||
129569515|NCT03125200|466381788|FG005|Overall Study|Lack of Efficacy|0|||
129569516|NCT03125200|466381789|FG006|Overall Study|Lack of Efficacy|0|||
129569517|NCT03125200|466381783|FG000|Overall Study|Toxicity|0|||
129569518|NCT03125200|466381784|FG001|Overall Study|Toxicity|0|||
129569519|NCT03125200|466381785|FG002|Overall Study|Toxicity|0|||
129569520|NCT03125200|466381786|FG003|Overall Study|Toxicity|1|||
129690422|NCT04625972|466824519|FG000|Overall Study|Lost to Follow-up|82|||
129690423|NCT04625972|466824520|FG001|Overall Study|Lost to Follow-up|38|||
129690424|NCT04625972|466824519|FG000|Overall Study|Physician Decision|2|||
129780764|NCT04080167|467163960|FG002|Overall Study|Withdrawal by Subject|0|||
129780765|NCT04080167|467163958|FG000|Overall Study|Withdrawal by Provider|0|||
129780766|NCT04080167|467163959|FG001|Overall Study|Withdrawal by Provider|0|||
129780767|NCT04080167|467163960|FG002|Overall Study|Withdrawal by Provider|4|||
129780768|NCT04080167|467163958|FG000|Overall Study|Death-Patient|2|||
129780769|NCT04080167|467163959|FG001|Overall Study|Death-Patient|1|||
129780770|NCT04080167|467163960|FG002|Overall Study|Death-Patient|0|||
129780771|NCT04080167|467163958|FG000|Overall Study|Hydroxyurea New Starts|0|||
129780772|NCT04080167|467163959|FG001|Overall Study|Hydroxyurea New Starts|0|||
129780773|NCT04080167|467163960|FG002|Overall Study|Hydroxyurea New Starts|1|||
129780774|NCT04080167|467163958|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
129780775|NCT04080167|467163959|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
129780776|NCT04080167|467163960|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
129780777|NCT02511106|467163961|FG000|Overall Study|Lost to Follow-up|6|||
129780778|NCT02511106|467163962|FG001|Overall Study|Lost to Follow-up|4|||
129780779|NCT02511106|467163961|FG000|Overall Study|Withdrawal by Subject|24|||
129780780|NCT02511106|467163962|FG001|Overall Study|Withdrawal by Subject|21|||
129780781|NCT02511106|467163961|FG000|Overall Study|Death|42|||
129780782|NCT02511106|467163962|FG001|Overall Study|Death|82|||
129780783|NCT02511106|467163961|FG000|Overall Study|Ongoing study at data cut-off|3|||
129780784|NCT02511106|467163962|FG001|Overall Study|Ongoing study at data cut-off|2|||
129780785|NCT02511106|467163961|FG000|Overall Study|Without specified reason|3|||
129780786|NCT02511106|467163962|FG001|Overall Study|Without specified reason|0|||
129780787|NCT02657408|467163964|FG000|Overall Study|Adverse Event|3|||
129780788|NCT02657408|467163965|FG001|Overall Study|Adverse Event|7|||
129780789|NCT00324961|467163967|FG000|Overall Study|Adverse Event|5|||
129780790|NCT00324961|467163967|FG000|Overall Study|Consent Withdrawn|11|||
129690425|NCT04625972|466824520|FG001|Overall Study|Physician Decision|0|||
129690426|NCT04625972|466824519|FG000|Overall Study|Protocol Violation|0|||
129690427|NCT04625972|466824520|FG001|Overall Study|Protocol Violation|1|||
129690428|NCT04625972|466824519|FG000|Overall Study|Withdrawal by Subject|37|||
129690429|NCT04625972|466824520|FG001|Overall Study|Withdrawal by Subject|24|||
129690430|NCT04625972|466824519|FG000|Overall Study|Not specified elsewhere|8|||
129690431|NCT04625972|466824520|FG001|Overall Study|Not specified elsewhere|6|||
129690432|NCT00694122|466824521|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
129690433|NCT00694122|466824522|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
129690434|NCT00694122|466824521|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
129690435|NCT00694122|466824522|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
129690436|NCT00694122|466824521|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
129690437|NCT00694122|466824522|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
129690438|NCT03020888|466824527|FG000|Overall Study|Physician Decision|4|||
129690439|NCT03020888|466824527|FG000|Overall Study|Withdrawal by Subject|6|||
129690440|NCT03020888|466824527|FG000|Overall Study|Insurance coverage|2|||
129690441|NCT03020888|466824527|FG000|Overall Study|Lost to Follow-up|1|||
129690442|NCT01198548|466824534|FG000|Overall Study|Disease Progression|9|||
129690443|NCT01198548|466824534|FG000|Overall Study|Administrative Decision|1|||
129690444|NCT01245062|466824536|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
129690445|NCT01245062|466824537|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
129690446|NCT01245062|466824538|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
129690447|NCT01245062|466824536|FG000|Randomization and Crossover Phase|Physician Decision|2|||
129690448|NCT01245062|466824537|FG001|Randomization and Crossover Phase|Physician Decision|4|||
129690449|NCT01245062|466824538|FG002|Randomization and Crossover Phase|Physician Decision|0|||
129690450|NCT01245062|466824536|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
129690451|NCT01245062|466824537|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
129690452|NCT01245062|466824538|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
129690453|NCT01245062|466824536|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
129690454|NCT01245062|466824537|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
129690455|NCT01245062|466824538|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
129690456|NCT01245062|466824536|FG000|Cross-over Phase|Lost to Follow-up|0|||
129690457|NCT01245062|466824537|FG001|Cross-over Phase|Lost to Follow-up|0|||
129780791|NCT00324961|467163967|FG000|Overall Study|Lost to Follow-up|22|||
129780792|NCT00324961|467163967|FG000|Overall Study|Protocol Violation|3|||
129569521|NCT03125200|466381787|FG004|Overall Study|Toxicity|0|||
129780793|NCT00324961|467163967|FG000|Overall Study|Other|2|||
129780794|NCT00344487|467163968|FG000|Overall Study|immunologic failure|1|||
129690458|NCT01245062|466824538|FG002|Cross-over Phase|Lost to Follow-up|1|||
129690459|NCT01245062|466824536|FG000|Cross-over Phase|Physician Decision|0|||
129780795|NCT01459497|467163972|FG000|Overall Study|Inability to meet trial constraints.|1|||
129569522|NCT03125200|466381788|FG005|Overall Study|Toxicity|0|||
129569523|NCT03125200|466381789|FG006|Overall Study|Toxicity|0|||
129569524|NCT03125200|466381783|FG000|Overall Study|Consent Withdrawn by Subject|0|||
129569525|NCT03125200|466381784|FG001|Overall Study|Consent Withdrawn by Subject|1|||
129569526|NCT03125200|466381785|FG002|Overall Study|Consent Withdrawn by Subject|0|||
129569527|NCT03125200|466381786|FG003|Overall Study|Consent Withdrawn by Subject|0|||
129569528|NCT03125200|466381787|FG004|Overall Study|Consent Withdrawn by Subject|1|||
129569529|NCT03125200|466381788|FG005|Overall Study|Consent Withdrawn by Subject|0|||
129569530|NCT03125200|466381789|FG006|Overall Study|Consent Withdrawn by Subject|1|||
129569531|NCT00119379|466381793|FG000|Overall Study|Adverse Event|4|||
129690460|NCT01245062|466824537|FG001|Cross-over Phase|Physician Decision|0|||
129690461|NCT01245062|466824538|FG002|Cross-over Phase|Physician Decision|1|||
129690462|NCT01245062|466824536|FG000|Cross-over Phase|Withdrew Consent|0|||
129690463|NCT01245062|466824537|FG001|Cross-over Phase|Withdrew Consent|0|||
129690464|NCT01245062|466824538|FG002|Cross-over Phase|Withdrew Consent|4|||
129690465|NCT01245062|466824536|FG000|Cross-over Phase|Study closed/ terminated|0|||
129690466|NCT01245062|466824537|FG001|Cross-over Phase|Study closed/ terminated|0|||
129690467|NCT01245062|466824538|FG002|Cross-over Phase|Study closed/ terminated|11|||
129690468|NCT02015104|466824539|FG000|Overall Study|Withdrew consent after first dose drug|1|||
129690469|NCT02015104|466824540|FG001|Overall Study|Withdrew consent after first dose drug|0|||
129690470|NCT02015104|466824539|FG000|Overall Study|Withdrew consent prior to treatment|0|||
129690471|NCT02015104|466824540|FG001|Overall Study|Withdrew consent prior to treatment|1|||
129690472|NCT05788328|466826332|FG000|Treatment Period 4 (5 Days)|Other|1|||
129690473|NCT05788328|466826332|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
129690474|NCT00145327|466826333|FG000|Overall Study|Withdrawal by Subject|77|||
129690475|NCT00145327|466826334|FG001|Overall Study|Withdrawal by Subject|72|||
129690476|NCT00145327|466826335|FG002|Overall Study|Withdrawal by Subject|164|||
129690477|NCT00145327|466826333|FG000|Overall Study|Death|26|||
129690478|NCT00145327|466826334|FG001|Overall Study|Death|18|||
129690479|NCT00145327|466826335|FG002|Overall Study|Death|30|||
129690480|NCT00145327|466826333|FG000|Overall Study|Adverse Event|14|||
129690481|NCT00145327|466826334|FG001|Overall Study|Adverse Event|11|||
129690482|NCT00145327|466826335|FG002|Overall Study|Adverse Event|22|||
129690483|NCT00145327|466826333|FG000|Overall Study|Lost to Follow-up|9|||
129690484|NCT00145327|466826334|FG001|Overall Study|Lost to Follow-up|14|||
129690485|NCT00145327|466826335|FG002|Overall Study|Lost to Follow-up|14|||
129690486|NCT00145327|466826333|FG000|Overall Study|Administrative problems|12|||
129690487|NCT00145327|466826334|FG001|Overall Study|Administrative problems|9|||
129690488|NCT00145327|466826335|FG002|Overall Study|Administrative problems|13|||
129690489|NCT00145327|466826333|FG000|Overall Study|Protocol Violation|2|||
129690490|NCT00145327|466826334|FG001|Overall Study|Protocol Violation|0|||
129690491|NCT00145327|466826335|FG002|Overall Study|Protocol Violation|2|||
129690492|NCT00145327|466826333|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129690493|NCT00145327|466826334|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129690494|NCT00145327|466826335|FG002|Overall Study|Abnormal laboratory value(s)|2|||
129690495|NCT00145327|466826333|FG000|Overall Study|Missing - not stated|1|||
129690496|NCT00145327|466826334|FG001|Overall Study|Missing - not stated|0|||
129690497|NCT00145327|466826335|FG002|Overall Study|Missing - not stated|1|||
129690498|NCT03315689|466826336|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
129690499|NCT03315689|466826337|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
129690500|NCT03315689|466826336|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
129690501|NCT03315689|466826337|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
129690502|NCT03315689|466826336|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
129690503|NCT03315689|466826337|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
129690504|NCT00762788|466826338|FG000|Overall Study|Lost to Follow-up|26|||
129690505|NCT00762788|466826339|FG001|Overall Study|Lost to Follow-up|37|||
129690506|NCT00762788|466826340|FG002|Overall Study|Lost to Follow-up|21|||
129690507|NCT00762788|466826341|FG003|Overall Study|Lost to Follow-up|26|||
129690508|NCT00762788|466826342|FG004|Overall Study|Lost to Follow-up|13|||
129690509|NCT00762788|466826343|FG005|Overall Study|Lost to Follow-up|21|||
129690510|NCT00669331|466826345|FG000|Randomisation to First Dose|Adverse Event|1|||
129690511|NCT00669331|466826346|FG001|Randomisation to First Dose|Adverse Event|0|||
129690512|NCT00669331|466826345|FG000|Randomisation to First Dose|Protocol Violation|1|||
129690513|NCT00669331|466826346|FG001|Randomisation to First Dose|Protocol Violation|0|||
129690514|NCT00669331|466826345|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
129690515|NCT00669331|466826346|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
129569532|NCT00119379|466381794|FG001|Overall Study|Adverse Event|1|||
129690516|NCT00669331|466826345|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
129690517|NCT00669331|466826346|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
129690518|NCT00669331|466826345|FG000|Randomisation to First Dose|Death|1|||
129690519|NCT00669331|466826346|FG001|Randomisation to First Dose|Death|0|||
129690520|NCT00669331|466826345|FG000|Randomisation to First Dose|Sponsor decision|0|||
129690521|NCT00669331|466826346|FG001|Randomisation to First Dose|Sponsor decision|1|||
129690522|NCT00669331|466826345|FG000|Randomisation to First Dose|Randomised in error|3|||
129690523|NCT00669331|466826346|FG001|Randomisation to First Dose|Randomised in error|10|||
129690524|NCT00669331|466826345|FG000|Blinded Treatment Period|Adverse Event|16|||
129690525|NCT00669331|466826346|FG001|Blinded Treatment Period|Adverse Event|10|||
129690526|NCT00669331|466826345|FG000|Blinded Treatment Period|Protocol Violation|1|||
129690527|NCT00669331|466826346|FG001|Blinded Treatment Period|Protocol Violation|1|||
129690528|NCT00669331|466826345|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
129690529|NCT00669331|466826346|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
129690530|NCT00669331|466826345|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
129690531|NCT00669331|466826346|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
129690532|NCT00669331|466826345|FG000|Blinded Treatment Period|Death|0|||
129690533|NCT00669331|466826346|FG001|Blinded Treatment Period|Death|2|||
129690534|NCT00669331|466826345|FG000|Blinded Treatment Period|Physician Decision|3|||
129690535|NCT00669331|466826346|FG001|Blinded Treatment Period|Physician Decision|3|||
129690536|NCT00669331|466826345|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
129690537|NCT00669331|466826346|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
129690538|NCT01454063|466826347|FG000|Randomized|Adverse Event|1|||
129690539|NCT01454063|466826348|FG001|Randomized|Adverse Event|1|||
129690540|NCT01454063|466826347|FG000|Randomized|Protocol Violation|0|||
129690541|NCT01454063|466826348|FG001|Randomized|Protocol Violation|1|||
129690542|NCT03055195|466826349|FG000|Overall Study|Lack of Efficacy|1|||
129690543|NCT03055195|466826350|FG001|Overall Study|Lack of Efficacy|0|||
129690544|NCT03055195|466826349|FG000|Overall Study|Withdrawal by Subject|6|||
129690545|NCT03055195|466826350|FG001|Overall Study|Withdrawal by Subject|7|||
129690546|NCT03055195|466826349|FG000|Overall Study|Study Terminated by Sponsor|2|||
129690547|NCT03055195|466826350|FG001|Overall Study|Study Terminated by Sponsor|6|||
129690548|NCT03055195|466826349|FG000|Overall Study|Protocol Violation|2|||
129690549|NCT03055195|466826350|FG001|Overall Study|Protocol Violation|1|||
129690550|NCT03055195|466826349|FG000|Overall Study|Physician Decision|1|||
129690551|NCT03055195|466826350|FG001|Overall Study|Physician Decision|0|||
129690552|NCT02568423|466826353|FG000|Overall Study|Lost to Follow-up|0|||
129690553|NCT02568423|466826354|FG001|Overall Study|Lost to Follow-up|2|||
129690554|NCT02568423|466826355|FG002|Overall Study|Lost to Follow-up|0|||
129690555|NCT02568423|466826356|FG003|Overall Study|Lost to Follow-up|0|||
129690556|NCT02568423|466826357|FG004|Overall Study|Lost to Follow-up|0|||
129690557|NCT02568423|466826358|FG005|Overall Study|Lost to Follow-up|0|||
129690558|NCT02568423|466826359|FG006|Overall Study|Lost to Follow-up|0|||
129690559|NCT02568423|466826360|FG007|Overall Study|Lost to Follow-up|0|||
129690560|NCT02568423|466826353|FG000|Overall Study|Physician Decision|0|||
129690561|NCT02568423|466826354|FG001|Overall Study|Physician Decision|0|||
129690562|NCT02568423|466826355|FG002|Overall Study|Physician Decision|0|||
129690563|NCT02568423|466826356|FG003|Overall Study|Physician Decision|0|||
129690564|NCT02568423|466826357|FG004|Overall Study|Physician Decision|0|||
129690565|NCT02568423|466826358|FG005|Overall Study|Physician Decision|1|||
129690566|NCT02568423|466826359|FG006|Overall Study|Physician Decision|0|||
129690567|NCT02568423|466826360|FG007|Overall Study|Physician Decision|0|||
129690568|NCT01027416|466826363|FG000|Overall Study|Withdrawal by Subject|0|||
129690569|NCT01027416|466826364|FG001|Overall Study|Withdrawal by Subject|1|||
129690570|NCT01027416|466826363|FG000|Overall Study|Physician Decision|1|||
129690571|NCT01027416|466826364|FG001|Overall Study|Physician Decision|4|||
129690572|NCT02056288|466826371|FG000|In-Hospital Data|Surgery cancelled|1|||
129690573|NCT02056288|466826372|FG001|In-Hospital Data|Surgery cancelled|0|||
129690574|NCT02056288|466826371|FG000|In-Hospital Data|Protocol Violation|3|||
129690575|NCT02056288|466826372|FG001|In-Hospital Data|Protocol Violation|0|||
129690576|NCT02056288|466826371|FG000|In-Hospital Data|Physician Decision|1|||
129690577|NCT02056288|466826372|FG001|In-Hospital Data|Physician Decision|0|||
129780796|NCT01459497|467163973|FG001|Overall Study|Inability to meet trial constraints.|0|||
129780797|NCT01459497|467163972|FG000|Overall Study|Physician Decision|1|||
129780798|NCT01459497|467163973|FG001|Overall Study|Physician Decision|1|||
129780799|NCT01459497|467163972|FG000|Overall Study|Hospitalization.|0|||
129780800|NCT01459497|467163973|FG001|Overall Study|Hospitalization.|3|||
129780801|NCT01459497|467163972|FG000|Overall Study|Disease progression.|0|||
129780802|NCT01459497|467163973|FG001|Overall Study|Disease progression.|1|||
129780803|NCT03530124|467163974|FG000|Overall Study|Withdrawal by Subject|0|||
129780804|NCT03530124|467163975|FG001|Overall Study|Withdrawal by Subject|1|||
129780805|NCT03530124|467163974|FG000|Overall Study|Protocol Violation|1|||
129780806|NCT03530124|467163975|FG001|Overall Study|Protocol Violation|0|||
129780807|NCT03530124|467163974|FG000|Overall Study|Discharged prior to study completion|1|||
129780808|NCT03530124|467163975|FG001|Overall Study|Discharged prior to study completion|0|||
129780809|NCT05343624|467163976|FG000|Overall Study|Chart review not completed|1|||
129780810|NCT00862082|467163977|FG000|Overall Study|Sponsor decision to terminate the study|5|||
129780811|NCT00862082|467163978|FG001|Overall Study|Sponsor decision to terminate the study|0|||
129780812|NCT00862082|467163977|FG000|Overall Study|Withdrawal by Subject|0|||
129780813|NCT00862082|467163978|FG001|Overall Study|Withdrawal by Subject|1|||
129780814|NCT02447302|467163990|FG000|Overall Study|Physician Decision|1|||
129569533|NCT01937390|466381800|FG000|Overall Study|Death|2|||
129569534|NCT01937390|466381800|FG000|Overall Study|Lost to Follow-up|7|||
129569535|NCT01937390|466381800|FG000|Overall Study|Withdrawal by Subject|5|||
129569536|NCT01937390|466381800|FG000|Overall Study|Fail to return|21|||
129569537|NCT01706536|466381803|FG000|Overall Study|Withdrawal by Subject|1|||
129569538|NCT01706536|466381804|FG001|Overall Study|Withdrawal by Subject|0|||
129569539|NCT01706536|466381805|FG002|Overall Study|Withdrawal by Subject|1|||
129569540|NCT01706536|466381806|FG003|Overall Study|Withdrawal by Subject|0|||
129569541|NCT01706536|466381807|FG004|Overall Study|Withdrawal by Subject|0|||
129569542|NCT01706536|466381803|FG000|Overall Study|Adverse Event|2|||
129569543|NCT01706536|466381804|FG001|Overall Study|Adverse Event|3|||
129569544|NCT01706536|466381805|FG002|Overall Study|Adverse Event|4|||
129569545|NCT01706536|466381806|FG003|Overall Study|Adverse Event|3|||
129569546|NCT01706536|466381807|FG004|Overall Study|Adverse Event|2|||
129569547|NCT01706536|466381803|FG000|Overall Study|Lack of Efficacy|1|||
129569548|NCT01706536|466381804|FG001|Overall Study|Lack of Efficacy|0|||
129569549|NCT01706536|466381805|FG002|Overall Study|Lack of Efficacy|0|||
129569550|NCT01706536|466381806|FG003|Overall Study|Lack of Efficacy|1|||
129569551|NCT01706536|466381807|FG004|Overall Study|Lack of Efficacy|0|||
129569552|NCT01706536|466381803|FG000|Overall Study|non compliance|0|||
129569553|NCT01706536|466381804|FG001|Overall Study|non compliance|1|||
129569554|NCT01706536|466381805|FG002|Overall Study|non compliance|0|||
129690578|NCT02056288|466826371|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
129690579|NCT02056288|466826372|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
129690580|NCT00500110|466826379|FG000|Overall Study|Withdrawal by Subject|3|||
129690581|NCT01502072|466826380|FG000|Overall Study|Withdrawal by Subject|1|||
129690582|NCT01502072|466826381|FG001|Overall Study|Withdrawal by Subject|0|||
129690583|NCT01502072|466826382|FG002|Overall Study|Withdrawal by Subject|0|||
129690584|NCT01502072|466826380|FG000|Overall Study|Death|0|||
129690585|NCT01502072|466826381|FG001|Overall Study|Death|1|||
129690586|NCT01502072|466826382|FG002|Overall Study|Death|0|||
129690587|NCT00617903|466826388|FG000|Overall Study|Withdrawal by Subject|2|||
129690588|NCT00617903|466826389|FG001|Overall Study|Withdrawal by Subject|3|||
129690589|NCT00617903|466826388|FG000|Overall Study|Lost to Follow-up|1|||
129690590|NCT00617903|466826389|FG001|Overall Study|Lost to Follow-up|1|||
129690591|NCT00617903|466826388|FG000|Overall Study|Lack of Efficacy|0|||
129690592|NCT00617903|466826389|FG001|Overall Study|Lack of Efficacy|1|||
129690593|NCT00617903|466826388|FG000|Overall Study|Adverse Event|0|||
129690594|NCT00617903|466826389|FG001|Overall Study|Adverse Event|1|||
129690595|NCT00617903|466826388|FG000|Overall Study|noncompliance|0|||
129690596|NCT00617903|466826389|FG001|Overall Study|noncompliance|1|||
129690597|NCT04676646|466826390|FG000|Open-label Run-in Phase|Adverse Event|3|||
129690598|NCT04676646|466826391|FG001|Open-label Run-in Phase|Adverse Event|0|||
129690599|NCT04676646|466826392|FG002|Open-label Run-in Phase|Adverse Event|0|||
129690600|NCT04676646|466826390|FG000|Open-label Run-in Phase|Death|3|||
129690601|NCT04676646|466826391|FG001|Open-label Run-in Phase|Death|0|||
129690602|NCT04676646|466826392|FG002|Open-label Run-in Phase|Death|0|||
129690603|NCT04676646|466826390|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
129690604|NCT04676646|466826391|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
129780815|NCT02447302|467163991|FG001|Overall Study|Physician Decision|0|||
129780816|NCT02447302|467163992|FG002|Overall Study|Physician Decision|0|||
129780817|NCT02447302|467163990|FG000|Overall Study|Adverse Event|4|||
129690605|NCT04676646|466826392|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
129690606|NCT04676646|466826390|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
129690607|NCT04676646|466826391|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
129690608|NCT04676646|466826392|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
129690609|NCT04676646|466826390|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
129780818|NCT02447302|467163991|FG001|Overall Study|Adverse Event|3|||
129780819|NCT02447302|467163992|FG002|Overall Study|Adverse Event|0|||
129780820|NCT02447302|467163990|FG000|Overall Study|Withdrawal by Subject|0|||
129780821|NCT02447302|467163991|FG001|Overall Study|Withdrawal by Subject|1|||
129780822|NCT02447302|467163992|FG002|Overall Study|Withdrawal by Subject|5|||
129780823|NCT02447302|467163990|FG000|Overall Study|Sponsor Decision|0|||
129780824|NCT02447302|467163991|FG001|Overall Study|Sponsor Decision|0|||
129780825|NCT02447302|467163992|FG002|Overall Study|Sponsor Decision|1|||
129780826|NCT01456897|467163995|FG000|Overall Study|Adverse Event|19|||
129780827|NCT01456897|467163996|FG001|Overall Study|Adverse Event|22|||
129780828|NCT01456897|467163995|FG000|Overall Study|Protocol Violation|3|||
129780829|NCT01456897|467163996|FG001|Overall Study|Protocol Violation|4|||
129780830|NCT01456897|467163995|FG000|Overall Study|Physician Decision|5|||
129780831|NCT01456897|467163996|FG001|Overall Study|Physician Decision|3|||
129780832|NCT01456897|467163995|FG000|Overall Study|Withdrawal by Subject|44|||
129780833|NCT01456897|467163996|FG001|Overall Study|Withdrawal by Subject|17|||
129780834|NCT01456897|467163995|FG000|Overall Study|Lack of Efficacy|4|||
129780835|NCT01456897|467163996|FG001|Overall Study|Lack of Efficacy|11|||
129780836|NCT01396070|467164003|FG000|Overall Study|Withdrawal by Subject|2|||
129780837|NCT01396070|467164003|FG000|Overall Study|Death|2|||
129780838|NCT01396070|467164003|FG000|Overall Study|Adverse Event|8|||
129780839|NCT01396070|467164003|FG000|Overall Study|Physician Decision|3|||
129780840|NCT01396070|467164003|FG000|Overall Study|Lack of Efficacy|4|||
129780841|NCT01561313|467164004|FG000|Overall Study|Withdrawal by Subject|1|||
129780842|NCT01561313|467164005|FG001|Overall Study|Withdrawal by Subject|0|||
129780843|NCT01561313|467164004|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
129780844|NCT01561313|467164005|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
129780845|NCT02152956|467164006|FG000|Overall Study|Adverse Event|0|||
129780846|NCT02152956|467164007|FG001|Overall Study|Adverse Event|0|||
129780847|NCT02152956|467164008|FG002|Overall Study|Adverse Event|0|||
129780848|NCT02152956|467164009|FG003|Overall Study|Adverse Event|0|||
129780849|NCT02152956|467164010|FG004|Overall Study|Adverse Event|0|||
129780850|NCT02152956|467164011|FG005|Overall Study|Adverse Event|0|||
129780851|NCT02152956|467164012|FG006|Overall Study|Adverse Event|0|||
129780852|NCT02152956|467164013|FG007|Overall Study|Adverse Event|0|||
129780853|NCT02152956|467164014|FG008|Overall Study|Adverse Event|0|||
129780854|NCT02152956|467164015|FG009|Overall Study|Adverse Event|0|||
129780855|NCT02152956|467164016|FG010|Overall Study|Adverse Event|0|||
129780856|NCT02152956|467164017|FG011|Overall Study|Adverse Event|4|||
129780857|NCT02152956|467164018|FG012|Overall Study|Adverse Event|0|||
129780858|NCT02152956|467164006|FG000|Overall Study|Death|0|||
129780859|NCT02152956|467164007|FG001|Overall Study|Death|3|||
129780860|NCT02152956|467164008|FG002|Overall Study|Death|3|||
129780861|NCT02152956|467164009|FG003|Overall Study|Death|4|||
129780862|NCT02152956|467164010|FG004|Overall Study|Death|1|||
129780863|NCT02152956|467164011|FG005|Overall Study|Death|2|||
129780864|NCT02152956|467164012|FG006|Overall Study|Death|6|||
129780865|NCT02152956|467164013|FG007|Overall Study|Death|6|||
129569555|NCT01706536|466381806|FG003|Overall Study|non compliance|0|||
129569556|NCT01706536|466381807|FG004|Overall Study|non compliance|0|||
129569557|NCT00683293|466381819|FG000|Overall Study|Withdrawal by Subject|2|||
129569558|NCT00683293|466381820|FG001|Overall Study|Withdrawal by Subject|3|||
129569559|NCT03262012|466381821|FG000|Overall Study|Withdrawal by Subject|15|||
129569560|NCT03262012|466381822|FG001|Overall Study|Withdrawal by Subject|13|||
129569561|NCT03262012|466381823|FG002|Overall Study|Withdrawal by Subject|8|||
129569562|NCT03262012|466381824|FG003|Overall Study|Withdrawal by Subject|7|||
129569563|NCT03262012|466381821|FG000|Overall Study|Adverse Event|10|||
129569564|NCT03262012|466381822|FG001|Overall Study|Adverse Event|12|||
129569565|NCT03262012|466381823|FG002|Overall Study|Adverse Event|4|||
129569566|NCT03262012|466381824|FG003|Overall Study|Adverse Event|6|||
129780866|NCT02152956|467164014|FG008|Overall Study|Death|4|||
129780867|NCT02152956|467164015|FG009|Overall Study|Death|5|||
129780868|NCT02152956|467164016|FG010|Overall Study|Death|3|||
129780869|NCT02152956|467164017|FG011|Overall Study|Death|143|||
129780870|NCT02152956|467164018|FG012|Overall Study|Death|12|||
129780871|NCT02152956|467164006|FG000|Overall Study|Lost to Follow-up|0|||
129780872|NCT02152956|467164007|FG001|Overall Study|Lost to Follow-up|1|||
129569567|NCT03262012|466381821|FG000|Overall Study|Physician Decision|2|||
129780873|NCT02152956|467164008|FG002|Overall Study|Lost to Follow-up|0|||
129780874|NCT02152956|467164009|FG003|Overall Study|Lost to Follow-up|0|||
129780875|NCT02152956|467164010|FG004|Overall Study|Lost to Follow-up|0|||
129780876|NCT02152956|467164011|FG005|Overall Study|Lost to Follow-up|0|||
129780877|NCT02152956|467164012|FG006|Overall Study|Lost to Follow-up|0|||
129780878|NCT02152956|467164013|FG007|Overall Study|Lost to Follow-up|0|||
129780879|NCT02152956|467164014|FG008|Overall Study|Lost to Follow-up|0|||
129569568|NCT03262012|466381822|FG001|Overall Study|Physician Decision|5|||
129569569|NCT03262012|466381823|FG002|Overall Study|Physician Decision|1|||
129569570|NCT03262012|466381824|FG003|Overall Study|Physician Decision|0|||
129690610|NCT04676646|466826391|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
129690611|NCT04676646|466826392|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
129690612|NCT04676646|466826390|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
129690613|NCT04676646|466826391|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
129690614|NCT04676646|466826392|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
129690615|NCT04676646|466826390|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
129690616|NCT04676646|466826391|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
129690617|NCT04676646|466826392|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
129690618|NCT04676646|466826390|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
129690619|NCT04676646|466826391|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
129690620|NCT04676646|466826392|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
129690621|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
129690622|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
129690623|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
129690624|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Death|0|||
129690625|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Death|1|||
129690626|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Death|2|||
129690627|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
129690628|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
129690629|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
129690630|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
129690631|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
129690632|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
129690633|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
129690634|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
129690635|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
129690636|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
129690637|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
129690638|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
129690639|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
129690640|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
129690641|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
129690642|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
129690643|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
129690644|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
129690645|NCT04676646|466826390|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
129690646|NCT04676646|466826391|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
129690647|NCT04676646|466826392|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
129690648|NCT03123588|466826400|FG000|Overall Study|Study Terminated by Sponsor|2|||
129690649|NCT03123588|466826401|FG001|Overall Study|Study Terminated by Sponsor|5|||
129690650|NCT03123588|466826400|FG000|Overall Study|Withdrawal by Subject|1|||
129690651|NCT03123588|466826401|FG001|Overall Study|Withdrawal by Subject|0|||
129690652|NCT03123588|466826400|FG000|Overall Study|Adverse Event|1|||
129690653|NCT03123588|466826401|FG001|Overall Study|Adverse Event|0|||
129690654|NCT03123588|466826400|FG000|Overall Study|Physician Decision|2|||
129690655|NCT03123588|466826401|FG001|Overall Study|Physician Decision|1|||
129690656|NCT01058005|466826402|FG000|Overall Study|Adverse Event|0|||
129690657|NCT01058005|466826403|FG001|Overall Study|Adverse Event|2|||
129690658|NCT01058005|466826404|FG002|Overall Study|Adverse Event|1|||
129690659|NCT01058005|466826402|FG000|Overall Study|Physician Decision|2|||
129690660|NCT01058005|466826403|FG001|Overall Study|Physician Decision|2|||
129690661|NCT01058005|466826404|FG002|Overall Study|Physician Decision|0|||
129690662|NCT01058005|466826402|FG000|Overall Study|Withdrawal by Subject|4|||
129690663|NCT01058005|466826403|FG001|Overall Study|Withdrawal by Subject|5|||
129690664|NCT01058005|466826404|FG002|Overall Study|Withdrawal by Subject|11|||
129690665|NCT01058005|466826402|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
129690666|NCT01058005|466826403|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
129690667|NCT01058005|466826404|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
129690668|NCT01058005|466826402|FG000|Overall Study|Reason Missing|5|||
129690669|NCT01058005|466826403|FG001|Overall Study|Reason Missing|3|||
129569571|NCT03262012|466381821|FG000|Overall Study|Lack of Efficacy|0|||
129569572|NCT03262012|466381822|FG001|Overall Study|Lack of Efficacy|5|||
129569573|NCT03262012|466381823|FG002|Overall Study|Lack of Efficacy|1|||
129569574|NCT03262012|466381824|FG003|Overall Study|Lack of Efficacy|2|||
129569575|NCT03262012|466381821|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
129569576|NCT03262012|466381822|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
129569577|NCT03262012|466381823|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
129569578|NCT03262012|466381824|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
129569579|NCT01469546|466381825|FG000|Received 5 mg Dose|Adverse Event|13|||
129569580|NCT01469546|466381825|FG000|Received 5 mg Dose|Death|2|||
129569581|NCT01469546|466381825|FG000|Received 5 mg Dose|Protocol Violation|2|||
129569582|NCT01469546|466381825|FG000|Received 5 mg Dose|Progressive Disease|3|||
129569583|NCT01469546|466381825|FG000|Received 5 mg Dose|Physician Decision|3|||
129569584|NCT03601637|466383076|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
129569585|NCT03601637|466383077|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
129569586|NCT03601637|466383076|FG000|Overall Study|Adverse Event|1|||
129569587|NCT03601637|466383077|FG001|Overall Study|Adverse Event|1|||
129569588|NCT03601637|466383076|FG000|Overall Study|Other|0|||
129569589|NCT03601637|466383077|FG001|Overall Study|Other|1|||
129569590|NCT01248247|466383078|FG000|Overall Study|Adverse Event|2|||
129569591|NCT01248247|466383079|FG001|Overall Study|Adverse Event|4|||
129569592|NCT01248247|466383080|FG002|Overall Study|Adverse Event|4|||
129569593|NCT01248247|466383081|FG003|Overall Study|Adverse Event|2|||
129569594|NCT01248247|466383078|FG000|Overall Study|Death|0|||
129569595|NCT01248247|466383079|FG001|Overall Study|Death|1|||
129569596|NCT01248247|466383080|FG002|Overall Study|Death|4|||
129569597|NCT01248247|466383081|FG003|Overall Study|Death|7|||
129569598|NCT01248247|466383078|FG000|Overall Study|Lost to Follow-up|0|||
129569599|NCT01248247|466383079|FG001|Overall Study|Lost to Follow-up|1|||
129569600|NCT01248247|466383080|FG002|Overall Study|Lost to Follow-up|1|||
129569601|NCT01248247|466383081|FG003|Overall Study|Lost to Follow-up|0|||
129569602|NCT01248247|466383078|FG000|Overall Study|Alternative treatment|0|||
129569603|NCT01248247|466383079|FG001|Overall Study|Alternative treatment|1|||
129569604|NCT01248247|466383080|FG002|Overall Study|Alternative treatment|0|||
129569605|NCT01248247|466383081|FG003|Overall Study|Alternative treatment|0|||
129569606|NCT01248247|466383078|FG000|Overall Study|Other|2|||
129569607|NCT01248247|466383079|FG001|Overall Study|Other|8|||
129569608|NCT01248247|466383080|FG002|Overall Study|Other|8|||
129569609|NCT01248247|466383081|FG003|Overall Study|Other|5|||
129569610|NCT01248247|466383078|FG000|Overall Study|Progression|18|||
129569611|NCT01248247|466383079|FG001|Overall Study|Progression|27|||
129569612|NCT01248247|466383080|FG002|Overall Study|Progression|56|||
129569613|NCT01248247|466383081|FG003|Overall Study|Progression|44|||
129569614|NCT01248247|466383078|FG000|Overall Study|Refuse further treatment|0|||
129569615|NCT01248247|466383079|FG001|Overall Study|Refuse further treatment|0|||
129569616|NCT01248247|466383080|FG002|Overall Study|Refuse further treatment|1|||
129569617|NCT01248247|466383081|FG003|Overall Study|Refuse further treatment|2|||
129569618|NCT01248247|466383078|FG000|Overall Study|Complicating disease|0|||
129569619|NCT01248247|466383079|FG001|Overall Study|Complicating disease|0|||
129569620|NCT01248247|466383080|FG002|Overall Study|Complicating disease|1|||
129569621|NCT01248247|466383081|FG003|Overall Study|Complicating disease|1|||
129569622|NCT01507051|466383087|FG000|Overall Study|Withdrawal by Subject|1|||
129569623|NCT01507051|466383088|FG001|Overall Study|Withdrawal by Subject|3|||
129569624|NCT01507051|466383089|FG002|Overall Study|Withdrawal by Subject|1|||
129569625|NCT01507051|466383090|FG003|Overall Study|Withdrawal by Subject|6|||
129569626|NCT01507051|466383087|FG000|Overall Study|Physician Decision|0|||
129569627|NCT01507051|466383088|FG001|Overall Study|Physician Decision|0|||
129569628|NCT01507051|466383089|FG002|Overall Study|Physician Decision|0|||
129569629|NCT01507051|466383090|FG003|Overall Study|Physician Decision|1|||
129569630|NCT01507051|466383087|FG000|Overall Study|Adverse Event|1|||
129569631|NCT01507051|466383088|FG001|Overall Study|Adverse Event|0|||
129569632|NCT01507051|466383089|FG002|Overall Study|Adverse Event|0|||
129569633|NCT01507051|466383090|FG003|Overall Study|Adverse Event|0|||
129569634|NCT00420303|466383091|FG000|Overall Study|Serious Adverse Event|1|||
129569635|NCT00420303|466383092|FG001|Overall Study|Serious Adverse Event|0|||
129569636|NCT00420303|466383091|FG000|Overall Study|Lack of Efficacy|0|||
129569637|NCT00420303|466383092|FG001|Overall Study|Lack of Efficacy|3|||
129569638|NCT00420303|466383091|FG000|Overall Study|Physician Decision|0|||
129569639|NCT00420303|466383092|FG001|Overall Study|Physician Decision|1|||
129569640|NCT00745420|466383094|FG000|Overall Study|Ineligible|1|||
129569641|NCT00485472|466383095|FG000|Overall Study|Adverse Event|8|||
129569642|NCT00485472|466383096|FG001|Overall Study|Adverse Event|5|||
129569643|NCT00485472|466383095|FG000|Overall Study|Lack of Efficacy|5|||
129569644|NCT00485472|466383096|FG001|Overall Study|Lack of Efficacy|4|||
129569645|NCT00485472|466383095|FG000|Overall Study|Withdrawal by Subject|1|||
129569646|NCT00485472|466383096|FG001|Overall Study|Withdrawal by Subject|0|||
129569647|NCT00485472|466383095|FG000|Overall Study|Protocol Violation|0|||
129569648|NCT00485472|466383096|FG001|Overall Study|Protocol Violation|1|||
129569649|NCT00485472|466383095|FG000|Overall Study|Other|2|||
129569650|NCT00485472|466383096|FG001|Overall Study|Other|1|||
129569651|NCT00485472|466383095|FG000|Overall Study|Lost to Follow-up|0|||
129569652|NCT00485472|466383096|FG001|Overall Study|Lost to Follow-up|1|||
129569653|NCT04455633|466383100|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
129569654|NCT04455633|466383101|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
129569655|NCT04455633|466383102|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
129569656|NCT04455633|466383100|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
129569657|NCT04455633|466383101|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
129569658|NCT04455633|466383102|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
129569659|NCT04455633|466383100|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
129569660|NCT04455633|466383101|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
129569661|NCT04455633|466383102|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
129569662|NCT04455633|466383100|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
129569663|NCT04455633|466383101|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
129569664|NCT04455633|466383102|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
129569665|NCT04015232|466383104|FG000|Overall Study|Withdrawal by Subject|7|||
129569666|NCT04015232|466383105|FG001|Overall Study|Withdrawal by Subject|4|||
129569667|NCT04015232|466383104|FG000|Overall Study|Protocol Violation|1|||
129569668|NCT04015232|466383105|FG001|Overall Study|Protocol Violation|0|||
129569669|NCT04015232|466383104|FG000|Overall Study|Medical Grounds|3|||
129569670|NCT04015232|466383105|FG001|Overall Study|Medical Grounds|3|||
129569671|NCT01029353|466383106|FG000|Overall Study|Lost to Follow-up|4|||
129569672|NCT01029353|466383107|FG001|Overall Study|Lost to Follow-up|5|||
129569673|NCT01029353|466383108|FG002|Overall Study|Lost to Follow-up|5|||
129569674|NCT01029353|466383109|FG003|Overall Study|Lost to Follow-up|4|||
129569675|NCT01029353|466383106|FG000|Overall Study|Consent Withdrawn|2|||
129569676|NCT01029353|466383107|FG001|Overall Study|Consent Withdrawn|0|||
129569677|NCT01029353|466383108|FG002|Overall Study|Consent Withdrawn|0|||
129569678|NCT01029353|466383109|FG003|Overall Study|Consent Withdrawn|0|||
129569679|NCT01029353|466383106|FG000|Overall Study|Primary Outcome Indeterminate|1|||
129569680|NCT01029353|466383107|FG001|Overall Study|Primary Outcome Indeterminate|3|||
129569681|NCT01029353|466383108|FG002|Overall Study|Primary Outcome Indeterminate|2|||
129569682|NCT01029353|466383109|FG003|Overall Study|Primary Outcome Indeterminate|0|||
129569683|NCT01900730|466383110|FG000|Overall Study|Withdrawal by Subject|1|||
129569684|NCT01900730|466383111|FG001|Overall Study|Withdrawal by Subject|0|||
129569685|NCT01900730|466383110|FG000|Overall Study|Screen Failure|1|||
129569686|NCT01900730|466383111|FG001|Overall Study|Screen Failure|0|||
129569687|NCT03478397|466383112|FG000|Overall Study|Refused to participate|31|||
129569688|NCT03478397|466383113|FG001|Overall Study|Refused to participate|7|||
129690670|NCT01058005|466826404|FG002|Overall Study|Reason Missing|1|||
129569689|NCT02942264|466383114|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569690|NCT02942264|466383115|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
129569691|NCT02942264|466383116|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569692|NCT02942264|466383117|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569693|NCT02942264|466383118|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569694|NCT02942264|466383119|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569695|NCT02942264|466383120|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
129569696|NCT02942264|466383121|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569697|NCT02942264|466383122|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
129569698|NCT02942264|466383114|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569699|NCT02942264|466383115|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569700|NCT02942264|466383116|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569701|NCT02942264|466383117|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569702|NCT02942264|466383118|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569703|NCT02942264|466383119|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569704|NCT02942264|466383120|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569705|NCT02942264|466383121|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
129569706|NCT02942264|466383122|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
129569707|NCT00569374|466383125|FG000|Overall Study|Withdrawal by Subject|4|||
129569708|NCT00912288|466383126|FG000|Overall Study|Death|0|||
129569709|NCT00912288|466383127|FG001|Overall Study|Death|1|||
129569710|NCT00912288|466383126|FG000|Overall Study|Adverse Event|1|||
129569711|NCT00912288|466383127|FG001|Overall Study|Adverse Event|1|||
129569712|NCT00912288|466383126|FG000|Overall Study|Lost to Follow-up|1|||
129569713|NCT00912288|466383127|FG001|Overall Study|Lost to Follow-up|0|||
129569714|NCT00912288|466383126|FG000|Overall Study|Protocol Violation|1|||
129569715|NCT00912288|466383127|FG001|Overall Study|Protocol Violation|0|||
129569716|NCT00912288|466383126|FG000|Overall Study|Withdrawal by Subject|3|||
129569717|NCT00912288|466383127|FG001|Overall Study|Withdrawal by Subject|3|||
129569718|NCT00912288|466383126|FG000|Overall Study|Study terminated by sponsor|34|||
129569719|NCT00912288|466383127|FG001|Overall Study|Study terminated by sponsor|35|||
129569720|NCT00912288|466383126|FG000|Overall Study|Other|1|||
129569721|NCT00912288|466383127|FG001|Overall Study|Other|0|||
129569722|NCT01572948|466383130|FG000|Overall Study|Lost to Follow-up|1|||
129569723|NCT01572948|466383131|FG001|Overall Study|Lost to Follow-up|0|||
129569724|NCT01572948|466383130|FG000|Overall Study|unable to contact|0|||
129569725|NCT01572948|466383131|FG001|Overall Study|unable to contact|1|||
129569726|NCT03553823|466383132|FG000|Overall Study|Physician Decision|0|||
129569727|NCT03553823|466383133|FG001|Overall Study|Physician Decision|1|||
129569728|NCT03603314|466383134|FG000|Overall Study|Lost to Follow-up|0|||
129569729|NCT03603314|466383135|FG001|Overall Study|Lost to Follow-up|3|||
129569730|NCT03603314|466383136|FG002|Overall Study|Lost to Follow-up|0|||
129569731|NCT03603314|466383134|FG000|Overall Study|Protocol Violation|0|||
129569732|NCT03603314|466383135|FG001|Overall Study|Protocol Violation|1|||
129569733|NCT03603314|466383136|FG002|Overall Study|Protocol Violation|0|||
129569734|NCT03603314|466383134|FG000|Overall Study|Adverse Event|2|||
129569735|NCT03603314|466383135|FG001|Overall Study|Adverse Event|0|||
129569736|NCT03603314|466383136|FG002|Overall Study|Adverse Event|0|||
129690671|NCT02287025|466826405|FG000|Overall Study|Not treated|2|||
129690672|NCT02287025|466826406|FG001|Overall Study|Not treated|0|||
129690673|NCT02287025|466826405|FG000|Overall Study|Progression of disease|3|||
129690674|NCT02287025|466826406|FG001|Overall Study|Progression of disease|2|||
129690675|NCT02287025|466826405|FG000|Overall Study|Adverse Event|2|||
129690676|NCT02287025|466826406|FG001|Overall Study|Adverse Event|4|||
129690677|NCT02287025|466826405|FG000|Overall Study|Withdrawal by Subject|2|||
129569737|NCT03603314|466383134|FG000|Overall Study|Physician Decision|1|||
129569738|NCT03603314|466383135|FG001|Overall Study|Physician Decision|1|||
129569739|NCT03603314|466383136|FG002|Overall Study|Physician Decision|0|||
129569740|NCT03603314|466383134|FG000|Overall Study|Withdrawal by Subject|4|||
129569741|NCT03603314|466383135|FG001|Overall Study|Withdrawal by Subject|5|||
129569742|NCT03603314|466383136|FG002|Overall Study|Withdrawal by Subject|3|||
129690678|NCT02287025|466826406|FG001|Overall Study|Withdrawal by Subject|2|||
129569743|NCT03603314|466383134|FG000|Overall Study|Other|0|||
129569744|NCT03603314|466383135|FG001|Overall Study|Other|1|||
129569745|NCT03603314|466383136|FG002|Overall Study|Other|0|||
129569746|NCT03450070|466383137|FG000|Overall Study|Withdrawal by Subject|8|||
129569747|NCT00050778|466383138|FG000|Overall Study|Adverse Event|13|||
129569748|NCT00050778|466383139|FG001|Overall Study|Adverse Event|3|||
129569749|NCT00050778|466383140|FG002|Overall Study|Adverse Event|2|||
129690679|NCT02287025|466826405|FG000|Overall Study|Screening failed|1|||
129884559|NCT02696902|467536454|FG001|Overall Study|Withdrawal by Subject|0|||
129569750|NCT00050778|466383138|FG000|Overall Study|Death|0|||
129569751|NCT00050778|466383139|FG001|Overall Study|Death|1|||
129569752|NCT00050778|466383140|FG002|Overall Study|Death|1|||
129569753|NCT00050778|466383138|FG000|Overall Study|Lack of Efficacy|16|||
129569754|NCT00050778|466383139|FG001|Overall Study|Lack of Efficacy|2|||
129780880|NCT02152956|467164015|FG009|Overall Study|Lost to Follow-up|0|||
129780881|NCT02152956|467164016|FG010|Overall Study|Lost to Follow-up|0|||
129780882|NCT02152956|467164017|FG011|Overall Study|Lost to Follow-up|3|||
129780883|NCT02152956|467164018|FG012|Overall Study|Lost to Follow-up|0|||
129780884|NCT02152956|467164006|FG000|Overall Study|Withdrawal by Subject|1|||
129780885|NCT02152956|467164007|FG001|Overall Study|Withdrawal by Subject|0|||
129780886|NCT02152956|467164008|FG002|Overall Study|Withdrawal by Subject|1|||
129780887|NCT02152956|467164009|FG003|Overall Study|Withdrawal by Subject|0|||
129780888|NCT02152956|467164010|FG004|Overall Study|Withdrawal by Subject|2|||
129780889|NCT02152956|467164011|FG005|Overall Study|Withdrawal by Subject|2|||
129780890|NCT02152956|467164012|FG006|Overall Study|Withdrawal by Subject|0|||
129780891|NCT02152956|467164013|FG007|Overall Study|Withdrawal by Subject|0|||
129780892|NCT02152956|467164014|FG008|Overall Study|Withdrawal by Subject|1|||
129780893|NCT02152956|467164015|FG009|Overall Study|Withdrawal by Subject|0|||
129780894|NCT02152956|467164016|FG010|Overall Study|Withdrawal by Subject|0|||
129780895|NCT02152956|467164017|FG011|Overall Study|Withdrawal by Subject|4|||
129780896|NCT02152956|467164018|FG012|Overall Study|Withdrawal by Subject|0|||
129780897|NCT02152956|467164006|FG000|Overall Study|Physician Decision|0|||
129780898|NCT02152956|467164007|FG001|Overall Study|Physician Decision|0|||
129780899|NCT02152956|467164008|FG002|Overall Study|Physician Decision|0|||
129780900|NCT02152956|467164009|FG003|Overall Study|Physician Decision|0|||
129780901|NCT02152956|467164010|FG004|Overall Study|Physician Decision|0|||
129780902|NCT02152956|467164011|FG005|Overall Study|Physician Decision|0|||
129780903|NCT02152956|467164012|FG006|Overall Study|Physician Decision|0|||
129780904|NCT02152956|467164013|FG007|Overall Study|Physician Decision|0|||
129780905|NCT02152956|467164014|FG008|Overall Study|Physician Decision|0|||
129780906|NCT02152956|467164015|FG009|Overall Study|Physician Decision|0|||
129780907|NCT02152956|467164016|FG010|Overall Study|Physician Decision|0|||
129780908|NCT02152956|467164017|FG011|Overall Study|Physician Decision|1|||
129780909|NCT02152956|467164018|FG012|Overall Study|Physician Decision|0|||
129780910|NCT02152956|467164006|FG000|Overall Study|Study terminated by sponsor|0|||
129780911|NCT02152956|467164007|FG001|Overall Study|Study terminated by sponsor|0|||
129780912|NCT02152956|467164008|FG002|Overall Study|Study terminated by sponsor|0|||
129780913|NCT02152956|467164009|FG003|Overall Study|Study terminated by sponsor|0|||
129780914|NCT02152956|467164010|FG004|Overall Study|Study terminated by sponsor|0|||
129780915|NCT02152956|467164011|FG005|Overall Study|Study terminated by sponsor|0|||
129780916|NCT02152956|467164012|FG006|Overall Study|Study terminated by sponsor|0|||
129780917|NCT02152956|467164013|FG007|Overall Study|Study terminated by sponsor|0|||
129780918|NCT02152956|467164014|FG008|Overall Study|Study terminated by sponsor|0|||
129780919|NCT02152956|467164015|FG009|Overall Study|Study terminated by sponsor|0|||
129780920|NCT02152956|467164016|FG010|Overall Study|Study terminated by sponsor|0|||
129780921|NCT02152956|467164017|FG011|Overall Study|Study terminated by sponsor|29|||
129780922|NCT02152956|467164018|FG012|Overall Study|Study terminated by sponsor|0|||
129780923|NCT02152956|467164006|FG000|Overall Study|progressive disease|0|||
129780924|NCT02152956|467164007|FG001|Overall Study|progressive disease|0|||
129780925|NCT02152956|467164008|FG002|Overall Study|progressive disease|0|||
129780926|NCT02152956|467164009|FG003|Overall Study|progressive disease|0|||
129780927|NCT02152956|467164010|FG004|Overall Study|progressive disease|0|||
129780928|NCT02152956|467164011|FG005|Overall Study|progressive disease|0|||
129780929|NCT02152956|467164012|FG006|Overall Study|progressive disease|0|||
129780930|NCT02152956|467164013|FG007|Overall Study|progressive disease|0|||
129780931|NCT02152956|467164014|FG008|Overall Study|progressive disease|1|||
129780932|NCT02152956|467164015|FG009|Overall Study|progressive disease|0|||
129780933|NCT02152956|467164016|FG010|Overall Study|progressive disease|0|||
129780934|NCT02152956|467164017|FG011|Overall Study|progressive disease|1|||
129780935|NCT02152956|467164018|FG012|Overall Study|progressive disease|0|||
129569755|NCT00050778|466383140|FG002|Overall Study|Lack of Efficacy|2|||
129569756|NCT00050778|466383138|FG000|Overall Study|Lost to Follow-up|0|||
129569757|NCT00050778|466383139|FG001|Overall Study|Lost to Follow-up|2|||
129780936|NCT02445794|467164019|FG000|Overall Study|Adverse Event|0|||
129780937|NCT02445794|467164020|FG001|Overall Study|Adverse Event|0|||
129780938|NCT02445794|467164021|FG002|Overall Study|Adverse Event|2|||
129569758|NCT00050778|466383140|FG002|Overall Study|Lost to Follow-up|4|||
129569759|NCT00050778|466383138|FG000|Overall Study|Physician Decision|3|||
129569760|NCT00050778|466383139|FG001|Overall Study|Physician Decision|0|||
129780939|NCT02445794|467164022|FG003|Overall Study|Adverse Event|0|||
129780940|NCT01064947|467164024|FG000|Overall Study|negative culture|41|||
129780941|NCT04549545|467166003|FG000|Initial Period|Withdrawal by Subject|4|||
129780942|NCT04549545|467166004|FG001|Initial Period|Withdrawal by Subject|0|||
129569761|NCT00050778|466383140|FG002|Overall Study|Physician Decision|2|||
129569762|NCT00050778|466383138|FG000|Overall Study|Protocol Violation|2|||
129569763|NCT00050778|466383139|FG001|Overall Study|Protocol Violation|0|||
129780943|NCT04549545|467166003|FG000|Initial Period|Additional ENT Procedure|3|||
129569764|NCT00050778|466383140|FG002|Overall Study|Protocol Violation|1|||
129569765|NCT00050778|466383138|FG000|Overall Study|Withdrawal by Subject|6|||
129569766|NCT00050778|466383139|FG001|Overall Study|Withdrawal by Subject|8|||
129569767|NCT00050778|466383140|FG002|Overall Study|Withdrawal by Subject|4|||
129569768|NCT00050778|466383138|FG000|Overall Study|Randomized but not treated|4|||
129569769|NCT00050778|466383139|FG001|Overall Study|Randomized but not treated|5|||
129569770|NCT00050778|466383140|FG002|Overall Study|Randomized but not treated|2|||
129569771|NCT00050778|466383138|FG000|Overall Study|Familial and personal reasons|1|||
129569772|NCT00050778|466383139|FG001|Overall Study|Familial and personal reasons|0|||
129569773|NCT00050778|466383140|FG002|Overall Study|Familial and personal reasons|0|||
129569774|NCT01496183|466383148|FG000|Overall Study|Physician Decision|3|||
129569775|NCT01496183|466383149|FG001|Overall Study|Physician Decision|1|||
129569776|NCT01496183|466383148|FG000|Overall Study|Withdrawal by Subject|0|||
129569777|NCT01496183|466383149|FG001|Overall Study|Withdrawal by Subject|1|||
129569778|NCT03002077|466383150|FG000|Overall Study|Non-compliance with Study Drug|4|||
129569779|NCT03002077|466383150|FG000|Overall Study|Non-compliance w/Background ADT|1|||
129569780|NCT03002077|466383150|FG000|Overall Study|Study Terminated by Sponsor|257|||
129569781|NCT03002077|466383150|FG000|Overall Study|Site Terminated by Sponsor|5|||
129569782|NCT03002077|466383150|FG000|Overall Study|Miscellaneous Reasons|10|||
129569783|NCT03002077|466383150|FG000|Overall Study|Adverse Event|23|||
129569784|NCT03002077|466383150|FG000|Overall Study|Lack of Efficacy|20|||
129569785|NCT03002077|466383150|FG000|Overall Study|Withdrawal by Subject|72|||
129569786|NCT03002077|466383150|FG000|Overall Study|Lost to Follow-up|21|||
129569787|NCT03002077|466383150|FG000|Overall Study|Pregnancy|4|||
129569788|NCT03002077|466383150|FG000|Overall Study|Protocol Violation|21|||
129569789|NCT04625114|466383151|FG000|Overall Study|Adverse Event|3|||
129569790|NCT04625114|466383152|FG001|Overall Study|Adverse Event|1|||
129569791|NCT04625114|466383151|FG000|Overall Study|Withdrawal by Subject|2|||
129569792|NCT04625114|466383152|FG001|Overall Study|Withdrawal by Subject|0|||
129569793|NCT00472290|466383153|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
129569794|NCT00472290|466383153|FG000|Overall Study|Protocol Specified Criteria|7|||
129569795|NCT00472290|466383153|FG000|Overall Study|Administrative Decision|37|||
129569796|NCT00472290|466383153|FG000|Overall Study|Death|3|||
129569797|NCT00472290|466383153|FG000|Overall Study|Lost to Follow-up|1|||
129569798|NCT00472290|466383153|FG000|Overall Study|Lack of Efficacy|1|||
129569799|NCT00472290|466383153|FG000|Overall Study|Disease Progression|4|||
129569800|NCT00472290|466383153|FG000|Overall Study|Withdrawal by Subject|5|||
129569801|NCT00472290|466383153|FG000|Overall Study|Adverse Event|6|||
129569802|NCT00472290|466383153|FG000|Overall Study|Requirement for alternative therapy|7|||
129569803|NCT00777829|466383154|FG000|Overall Study|Withdrawal by Subject|0|||
129569804|NCT00777829|466383155|FG001|Overall Study|Withdrawal by Subject|2|||
129569805|NCT00336479|466383160|FG000|Overall Study|Adverse Event|8|||
129569806|NCT00336479|466383161|FG001|Overall Study|Adverse Event|11|||
129569807|NCT00336479|466383162|FG002|Overall Study|Adverse Event|18|||
129690680|NCT02287025|466826406|FG001|Overall Study|Screening failed|1|||
129690681|NCT04053452|466826407|FG000|Overall Study|Withdrawal by Subject|1|||
129690682|NCT04053452|466826408|FG001|Overall Study|Withdrawal by Subject|0|||
129690683|NCT04053452|466826407|FG000|Overall Study|Time restraint due to inpatient needs|1|||
129690684|NCT04053452|466826408|FG001|Overall Study|Time restraint due to inpatient needs|2|||
129690685|NCT01421134|466826409|FG000|Overall Study|Adverse Event|3|||
129690686|NCT01421134|466826410|FG001|Overall Study|Adverse Event|5|||
129690687|NCT01421134|466826409|FG000|Overall Study|Lack of Efficacy|2|||
129690688|NCT01421134|466826410|FG001|Overall Study|Lack of Efficacy|4|||
129690689|NCT01421134|466826409|FG000|Overall Study|Protocol Violation|0|||
129690690|NCT01421134|466826410|FG001|Overall Study|Protocol Violation|3|||
129690691|NCT01421134|466826409|FG000|Overall Study|Withdrawal by Subject|1|||
129690692|NCT01421134|466826410|FG001|Overall Study|Withdrawal by Subject|1|||
129690693|NCT01421134|466826409|FG000|Overall Study|Administrative|0|||
129690694|NCT01421134|466826410|FG001|Overall Study|Administrative|1|||
129690695|NCT01421134|466826409|FG000|Overall Study|Lost to Follow-up|1|||
129690696|NCT01421134|466826410|FG001|Overall Study|Lost to Follow-up|1|||
129690697|NCT02346370|466826413|FG000|Overall Study|Not treated|1|||
129690698|NCT02346370|466826414|FG001|Overall Study|Not treated|0|||
129569808|NCT00336479|466383163|FG003|Overall Study|Adverse Event|4|||
129569809|NCT00336479|466383160|FG000|Overall Study|Noncompliant|1|||
129569810|NCT00336479|466383161|FG001|Overall Study|Noncompliant|7|||
129690699|NCT02346370|466826415|FG002|Overall Study|Not treated|0|||
129690700|NCT02346370|466826413|FG000|Overall Study|Withdrawal of consent|1|||
129569811|NCT00336479|466383162|FG002|Overall Study|Noncompliant|3|||
129569812|NCT00336479|466383163|FG003|Overall Study|Noncompliant|0|||
129569813|NCT00336479|466383160|FG000|Overall Study|Physician Decision|2|||
129569814|NCT00336479|466383161|FG001|Overall Study|Physician Decision|3|||
129569815|NCT00336479|466383162|FG002|Overall Study|Physician Decision|1|||
129690701|NCT02346370|466826414|FG001|Overall Study|Withdrawal of consent|0|||
129690702|NCT02346370|466826415|FG002|Overall Study|Withdrawal of consent|0|||
129690703|NCT02346370|466826413|FG000|Overall Study|Death|1|||
129690704|NCT02346370|466826414|FG001|Overall Study|Death|3|||
129569816|NCT00336479|466383163|FG003|Overall Study|Physician Decision|0|||
129569817|NCT00336479|466383160|FG000|Overall Study|Lost to Follow-up|3|||
129569818|NCT00336479|466383161|FG001|Overall Study|Lost to Follow-up|2|||
129569819|NCT00336479|466383162|FG002|Overall Study|Lost to Follow-up|0|||
129569820|NCT00336479|466383163|FG003|Overall Study|Lost to Follow-up|0|||
129569821|NCT00336479|466383160|FG000|Overall Study|Withdrawal by Subject|3|||
129569822|NCT00336479|466383161|FG001|Overall Study|Withdrawal by Subject|2|||
129569823|NCT00336479|466383162|FG002|Overall Study|Withdrawal by Subject|3|||
129569824|NCT00336479|466383163|FG003|Overall Study|Withdrawal by Subject|0|||
129569825|NCT00336479|466383160|FG000|Overall Study|Other|0|||
129569826|NCT00336479|466383161|FG001|Overall Study|Other|0|||
129569827|NCT00336479|466383162|FG002|Overall Study|Other|1|||
129569828|NCT00336479|466383163|FG003|Overall Study|Other|0|||
129569829|NCT00336479|466383160|FG000|Overall Study|Virologic Stopping Rule|20|||
129569830|NCT00336479|466383161|FG001|Overall Study|Virologic Stopping Rule|0|||
129569831|NCT00336479|466383162|FG002|Overall Study|Virologic Stopping Rule|0|||
129569832|NCT00336479|466383163|FG003|Overall Study|Virologic Stopping Rule|0|||
129569833|NCT01722877|466383164|FG000|Overall Study|Death|1|||
129569834|NCT01722877|466383164|FG000|Overall Study|Lost to Follow-up|1|||
129569835|NCT01395030|466383167|FG000|Overall Study|Did not complete FCH PET/CT|7|||
129569836|NCT02079766|466383168|FG000|Overall Study|Physician Decision|1|||
129569837|NCT02079766|466383169|FG001|Overall Study|Physician Decision|0|||
129569838|NCT02079766|466383168|FG000|Overall Study|Withdrawal by Subject|1|||
129569839|NCT02079766|466383169|FG001|Overall Study|Withdrawal by Subject|0|||
129569840|NCT00857623|466383174|FG000|Overall Study|Adverse Event|5|||
129569841|NCT00857623|466383175|FG001|Overall Study|Adverse Event|2|||
129569842|NCT00857623|466383174|FG000|Overall Study|Study-specific discontinuation criteria|5|||
129569843|NCT00857623|466383175|FG001|Overall Study|Study-specific discontinuation criteria|3|||
129569844|NCT00857623|466383174|FG000|Overall Study|Withdrawal by Subject|2|||
129569845|NCT00857623|466383175|FG001|Overall Study|Withdrawal by Subject|1|||
129569846|NCT00857623|466383174|FG000|Overall Study|Lack of Efficacy|1|||
129569847|NCT00857623|466383175|FG001|Overall Study|Lack of Efficacy|1|||
129569848|NCT00857623|466383174|FG000|Overall Study|Severe non-compliance to protocol|1|||
129569849|NCT00857623|466383175|FG001|Overall Study|Severe non-compliance to protocol|1|||
129569850|NCT00857623|466383174|FG000|Overall Study|Intake of prohibited medication|0|||
129569851|NCT00857623|466383175|FG001|Overall Study|Intake of prohibited medication|1|||
129569852|NCT00857623|466383174|FG000|Overall Study|Positive for HEP C|0|||
129569853|NCT00857623|466383175|FG001|Overall Study|Positive for HEP C|1|||
129569854|NCT00694551|466383176|FG000|Overall Study|Disease Progression|1|||
129569855|NCT00694551|466383177|FG001|Overall Study|Disease Progression|0|||
129569856|NCT00694551|466383178|FG002|Overall Study|Disease Progression|1|||
129569857|NCT02920996|466383183|FG000|Overall Study|Adverse Event|8|||
129690705|NCT02346370|466826415|FG002|Overall Study|Death|1|||
129690706|NCT02346370|466826413|FG000|Overall Study|Sponsor discontinued study|5|||
129690707|NCT02346370|466826414|FG001|Overall Study|Sponsor discontinued study|0|||
129690708|NCT02346370|466826415|FG002|Overall Study|Sponsor discontinued study|2|||
129690709|NCT02346370|466826413|FG000|Overall Study|Radiologic progression|0|||
129690710|NCT02346370|466826414|FG001|Overall Study|Radiologic progression|0|||
129690711|NCT02346370|466826415|FG002|Overall Study|Radiologic progression|1|||
129690712|NCT02346370|466826413|FG000|Overall Study|Physician Decision|0|||
129690713|NCT02346370|466826414|FG001|Overall Study|Physician Decision|1|||
129690714|NCT02346370|466826415|FG002|Overall Study|Physician Decision|0|||
129690715|NCT03528577|466826416|FG000|Sequence 1|Failed Spirometry|1|||
129690716|NCT03528577|466826416|FG000|Sequence 1|Restricted medication|1|||
129690717|NCT03528577|466826416|FG000|Sequence 2|Adverse Event|1|||
129690718|NCT03528577|466826416|FG000|Sequence 2|Withdrawal by Subject|1|||
129690719|NCT03528577|466826416|FG000|Sequence 2|Failed Spirometry|1|||
129569858|NCT02920996|466383184|FG001|Overall Study|Adverse Event|0|||
129569859|NCT02920996|466383183|FG000|Overall Study|Physician Decision|1|||
129569860|NCT02920996|466383184|FG001|Overall Study|Physician Decision|0|||
129569861|NCT02920996|466383183|FG000|Overall Study|Death|1|||
129569862|NCT02920996|466383184|FG001|Overall Study|Death|0|||
129569863|NCT02920996|466383183|FG000|Overall Study|Missing|1|||
129569864|NCT02920996|466383184|FG001|Overall Study|Missing|0|||
129569865|NCT02920996|466383183|FG000|Overall Study|Subject Non-Compliance|1|||
129569866|NCT02920996|466383184|FG001|Overall Study|Subject Non-Compliance|0|||
129569867|NCT01402947|466383187|FG000|First Intervention|Adverse Event|0|||
129569868|NCT01402947|466383188|FG001|First Intervention|Adverse Event|1|||
129569869|NCT00385684|466383189|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
129569870|NCT00385684|466383190|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
129569871|NCT00385684|466383189|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
129569872|NCT00385684|466383190|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
129569873|NCT00385684|466383189|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
129690720|NCT03528577|466826416|FG000|Sequence 3|Failed Spirometry|1|||
129690721|NCT03528577|466826416|FG000|Sequence 4|Failed Spirometry|2|||
129690722|NCT03528577|466826416|FG000|Sequence 4|Adverse Event|1|||
129569874|NCT00385684|466383190|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
129569875|NCT00591630|466383191|FG000|Overall Study|Death|0|||
129569876|NCT00591630|466383192|FG001|Overall Study|Death|0|||
129569877|NCT00591630|466383193|FG002|Overall Study|Death|1|||
129569878|NCT00591630|466383194|FG003|Overall Study|Death|0|||
129569879|NCT00154102|466383195|FG000|Overall Study|investigational study phase ongoing|7|||
129569880|NCT00154102|466383196|FG001|Overall Study|investigational study phase ongoing|2|||
129569881|NCT00463606|466383197|FG000|Overall Study|Adverse Event|21|||
129569882|NCT00463606|466383198|FG001|Overall Study|Adverse Event|18|||
129569883|NCT00463606|466383199|FG002|Overall Study|Adverse Event|11|||
129569884|NCT00463606|466383197|FG000|Overall Study|Withdrawal by Subject|11|||
129569885|NCT00463606|466383198|FG001|Overall Study|Withdrawal by Subject|11|||
129569886|NCT00463606|466383199|FG002|Overall Study|Withdrawal by Subject|5|||
129569887|NCT00463606|466383197|FG000|Overall Study|Lost to Follow-up|2|||
129569888|NCT00463606|466383198|FG001|Overall Study|Lost to Follow-up|2|||
129569889|NCT00463606|466383199|FG002|Overall Study|Lost to Follow-up|3|||
129569890|NCT00463606|466383197|FG000|Overall Study|Subject noncompliance|1|||
129690723|NCT04882215|466826417|FG000|Overall Study|Withdrawal by Subject|5|||
129690724|NCT04882215|466826418|FG001|Overall Study|Withdrawal by Subject|0|||
129690725|NCT04263532|466826419|FG000|Overall Study|Withdrawal by Subject|2|||
129690726|NCT04263532|466826420|FG001|Overall Study|Withdrawal by Subject|0|||
129690727|NCT04098302|466826423|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
129690728|NCT04098302|466826424|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
129690729|NCT04098302|466826425|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
129690730|NCT04098302|466826426|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
129690731|NCT04098302|466826423|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
129690732|NCT04098302|466826424|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
129690733|NCT04098302|466826425|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
129690734|NCT04098302|466826426|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
129569891|NCT00463606|466383198|FG001|Overall Study|Subject noncompliance|1|||
129569892|NCT00463606|466383199|FG002|Overall Study|Subject noncompliance|0|||
129569893|NCT00463606|466383197|FG000|Overall Study|Subject moved out of town|1|||
129569894|NCT00463606|466383198|FG001|Overall Study|Subject moved out of town|0|||
129690735|NCT04098302|466826423|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
129690736|NCT04098302|466826424|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
129569895|NCT00463606|466383199|FG002|Overall Study|Subject moved out of town|0|||
129569896|NCT00463606|466383197|FG000|Overall Study|Physician Decision|0|||
129569897|NCT00463606|466383198|FG001|Overall Study|Physician Decision|1|||
129569898|NCT00463606|466383199|FG002|Overall Study|Physician Decision|0|||
129569899|NCT00463606|466383197|FG000|Overall Study|Sponsor request|0|||
129569900|NCT00463606|466383198|FG001|Overall Study|Sponsor request|1|||
129569901|NCT00463606|466383199|FG002|Overall Study|Sponsor request|0|||
129569902|NCT00463606|466383197|FG000|Overall Study|Exclusion criteria violation|2|||
129569903|NCT00463606|466383198|FG001|Overall Study|Exclusion criteria violation|0|||
129569904|NCT00463606|466383199|FG002|Overall Study|Exclusion criteria violation|0|||
129569905|NCT00463606|466383197|FG000|Overall Study|Coordinator error|1|||
129569906|NCT00463606|466383198|FG001|Overall Study|Coordinator error|0|||
129569907|NCT00463606|466383199|FG002|Overall Study|Coordinator error|0|||
129569908|NCT00463606|466383197|FG000|Overall Study|Patient randomized in error|1|||
129569909|NCT00463606|466383198|FG001|Overall Study|Patient randomized in error|0|||
129569910|NCT00463606|466383199|FG002|Overall Study|Patient randomized in error|0|||
129569911|NCT00463606|466383197|FG000|Overall Study|Participation in another ABT-335 trial|1|||
129569912|NCT00463606|466383198|FG001|Overall Study|Participation in another ABT-335 trial|0|||
129569913|NCT00463606|466383199|FG002|Overall Study|Participation in another ABT-335 trial|0|||
129569914|NCT00463606|466383197|FG000|Overall Study|Protocol Violation|0|||
129569915|NCT00463606|466383198|FG001|Overall Study|Protocol Violation|0|||
129569916|NCT00463606|466383199|FG002|Overall Study|Protocol Violation|1|||
129569917|NCT02682602|466383201|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
129569918|NCT02682602|466383202|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
129569919|NCT02682602|466383201|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
129569920|NCT02682602|466383202|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
129569921|NCT04349917|466384879|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
129569922|NCT04349917|466384880|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
129569923|NCT04349917|466384879|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
129569924|NCT04349917|466384880|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
129569925|NCT00441467|466384881|FG000|Overall Study|Adverse Event|6|||
129569926|NCT00441467|466384881|FG000|Overall Study|Withdrawal by Subject|3|||
129569927|NCT00441467|466384881|FG000|Overall Study|Progressive disease|9|||
129569928|NCT01042522|466384882|FG000|Overall Study|Adverse Event|1|||
129569929|NCT01042522|466384883|FG001|Overall Study|Adverse Event|2|||
129569930|NCT01042522|466384882|FG000|Overall Study|Disease Progression|5|||
129569931|NCT01042522|466384883|FG001|Overall Study|Disease Progression|0|||
129569932|NCT01042522|466384882|FG000|Overall Study|Death|1|||
129569933|NCT01042522|466384883|FG001|Overall Study|Death|0|||
129569934|NCT01042522|466384882|FG000|Overall Study|Patient Refused|0|||
129569935|NCT01042522|466384883|FG001|Overall Study|Patient Refused|3|||
129569936|NCT01042522|466384882|FG000|Overall Study|Withdrawal by Subject|1|||
129569937|NCT01042522|466384883|FG001|Overall Study|Withdrawal by Subject|1|||
129569938|NCT00088829|466384885|FG000|Overall Study|PI left institution and study was close|22|||
129569939|NCT01287013|466384888|FG000|Overall Study|Non-evaluable|3|||
129569940|NCT01287013|466384889|FG001|Overall Study|Non-evaluable|5|||
129569941|NCT01287013|466384890|FG002|Overall Study|Non-evaluable|21|||
129569942|NCT02109042|466384891|FG000|Overall Study|Sponsor Decision|15|||
129569943|NCT03203447|466384892|FG000|Overall Study|Withdrawal by Subject|2|||
129569944|NCT03203447|466384893|FG001|Overall Study|Withdrawal by Subject|1|||
129569945|NCT03203447|466384892|FG000|Overall Study|Lost to Follow-up|1|||
129569946|NCT03203447|466384893|FG001|Overall Study|Lost to Follow-up|10|||
129569947|NCT03203447|466384892|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
129569948|NCT03203447|466384893|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
129569949|NCT00528606|466384894|FG000|Overall Study|Withdrew consent|4|||
129569950|NCT00528606|466384895|FG001|Overall Study|Withdrew consent|3|||
129569951|NCT00528606|466384894|FG000|Overall Study|Lost to Follow-up|4|||
129569952|NCT00528606|466384895|FG001|Overall Study|Lost to Follow-up|1|||
129569953|NCT00528606|466384894|FG000|Overall Study|Adverse Event|3|||
129569954|NCT00528606|466384895|FG001|Overall Study|Adverse Event|0|||
129569955|NCT00528606|466384894|FG000|Overall Study|Other|2|||
129569956|NCT00528606|466384895|FG001|Overall Study|Other|0|||
129690737|NCT04098302|466826425|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
129569957|NCT02188303|466384900|FG000|Overall Study|Adverse Event|0|||
129569958|NCT02188303|466384901|FG001|Overall Study|Adverse Event|0|||
129569959|NCT02188303|466384902|FG002|Overall Study|Adverse Event|0|||
129690738|NCT04098302|466826426|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
129569960|NCT02188303|466384903|FG003|Overall Study|Adverse Event|0|||
129569961|NCT02188303|466384904|FG004|Overall Study|Adverse Event|0|||
129569962|NCT02188303|466384905|FG005|Overall Study|Adverse Event|2|||
129690739|NCT04098302|466826423|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
129569963|NCT02188303|466384906|FG006|Overall Study|Adverse Event|0|||
129569964|NCT02188303|466384907|FG007|Overall Study|Adverse Event|2|||
129569965|NCT02188303|466384900|FG000|Overall Study|Dose Termination Criteria Met|0|||
129569966|NCT02188303|466384901|FG001|Overall Study|Dose Termination Criteria Met|0|||
129569967|NCT02188303|466384902|FG002|Overall Study|Dose Termination Criteria Met|0|||
129569968|NCT02188303|466384903|FG003|Overall Study|Dose Termination Criteria Met|0|||
129569969|NCT02188303|466384904|FG004|Overall Study|Dose Termination Criteria Met|0|||
129569970|NCT02188303|466384905|FG005|Overall Study|Dose Termination Criteria Met|0|||
129569971|NCT02188303|466384906|FG006|Overall Study|Dose Termination Criteria Met|2|||
129569972|NCT02188303|466384907|FG007|Overall Study|Dose Termination Criteria Met|4|||
129569973|NCT04206332|466384908|FG000|Part A|Lost to Follow-up|0|||
129569974|NCT04206332|466384909|FG001|Part A|Lost to Follow-up|1|||
129569975|NCT04206332|466384910|FG002|Part A|Lost to Follow-up|0|||
129569976|NCT04206332|466384911|FG003|Part A|Lost to Follow-up|0|||
129569977|NCT04206332|466384912|FG004|Part A|Lost to Follow-up|0|||
129569978|NCT04206332|466384913|FG005|Part A|Lost to Follow-up|0|||
129569979|NCT04206332|466384914|FG006|Part A|Lost to Follow-up|0|||
129569980|NCT04206332|466384915|FG007|Part A|Lost to Follow-up|0|||
129569981|NCT04206332|466384916|FG008|Part A|Lost to Follow-up|0|||
129569982|NCT04206332|466384917|FG009|Part A|Lost to Follow-up|0|||
129569983|NCT04206332|466384918|FG010|Part A|Lost to Follow-up|0|||
129569984|NCT04206332|466384919|FG011|Part A|Lost to Follow-up|0|||
129569985|NCT04206332|466384920|FG012|Part A|Lost to Follow-up|0|||
129569986|NCT04206332|466384921|FG013|Part A|Lost to Follow-up|0|||
129569987|NCT04206332|466384922|FG014|Part A|Lost to Follow-up|0|||
129569988|NCT04206332|466384923|FG015|Part A|Lost to Follow-up|0|||
129569989|NCT04206332|466384924|FG016|Part A|Lost to Follow-up|0|||
129569990|NCT04206332|466384908|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569991|NCT04206332|466384909|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569992|NCT04206332|466384910|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569993|NCT04206332|466384911|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569994|NCT04206332|466384912|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569995|NCT04206332|466384913|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
129569996|NCT04206332|466384914|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569997|NCT04206332|466384915|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569998|NCT04206332|466384916|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129569999|NCT04206332|466384917|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570000|NCT04206332|466384918|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570001|NCT04206332|466384919|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570002|NCT04206332|466384920|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570003|NCT04206332|466384921|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570004|NCT04206332|466384922|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570005|NCT04206332|466384923|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570006|NCT04206332|466384924|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
129570007|NCT04206332|466384908|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570008|NCT04206332|466384909|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570009|NCT04206332|466384910|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570010|NCT04206332|466384911|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570011|NCT04206332|466384912|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570012|NCT04206332|466384913|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570013|NCT04206332|466384914|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570014|NCT04206332|466384915|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
129570015|NCT04206332|466384916|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570016|NCT04206332|466384917|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570017|NCT04206332|466384918|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
129570018|NCT04206332|466384919|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570019|NCT04206332|466384920|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570020|NCT04206332|466384921|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570021|NCT04206332|466384922|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570022|NCT04206332|466384923|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570023|NCT04206332|466384924|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570024|NCT04206332|466384908|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570025|NCT04206332|466384909|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570026|NCT04206332|466384910|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570027|NCT04206332|466384911|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570028|NCT04206332|466384912|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570029|NCT04206332|466384913|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570030|NCT04206332|466384914|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570031|NCT04206332|466384915|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570032|NCT04206332|466384916|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570033|NCT04206332|466384917|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570034|NCT04206332|466384918|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570035|NCT04206332|466384919|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570036|NCT04206332|466384920|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570037|NCT04206332|466384921|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570038|NCT04206332|466384922|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129780944|NCT04549545|467166004|FG001|Initial Period|Additional ENT Procedure|0|||
129780945|NCT04549545|467166003|FG000|Initial Period|Lost to Follow-up|3|||
129780946|NCT04549545|467166004|FG001|Initial Period|Lost to Follow-up|1|||
129780947|NCT04549545|467166003|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
129780948|NCT04549545|467166004|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
129780949|NCT04549545|467166003|FG000|Crossover Period|Additional ENT Procedure|0|||
129780950|NCT04549545|467166004|FG001|Crossover Period|Additional ENT Procedure|6|||
129780951|NCT04549545|467166003|FG000|Crossover Period|Lost to Follow-up|0|||
129780952|NCT04549545|467166004|FG001|Crossover Period|Lost to Follow-up|1|||
129780953|NCT04549545|467166003|FG000|Crossover Period|Withdrawal by Subject|0|||
129780954|NCT04549545|467166004|FG001|Crossover Period|Withdrawal by Subject|4|||
129780955|NCT01006291|467166005|FG000|Overall Study|Adverse Event|2|||
129570039|NCT04206332|466384923|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
129570040|NCT04206332|466384924|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
129570041|NCT04206332|466384908|FG000|Part C|Withdrawal by Subject|0|||
129570042|NCT04206332|466384909|FG001|Part C|Withdrawal by Subject|0|||
129570043|NCT04206332|466384910|FG002|Part C|Withdrawal by Subject|0|||
129570044|NCT04206332|466384911|FG003|Part C|Withdrawal by Subject|0|||
129570045|NCT04206332|466384912|FG004|Part C|Withdrawal by Subject|0|||
129570046|NCT04206332|466384913|FG005|Part C|Withdrawal by Subject|0|||
129570047|NCT04206332|466384914|FG006|Part C|Withdrawal by Subject|0|||
129570048|NCT04206332|466384915|FG007|Part C|Withdrawal by Subject|0|||
129570049|NCT04206332|466384916|FG008|Part C|Withdrawal by Subject|0|||
129780956|NCT01006291|467166006|FG001|Overall Study|Adverse Event|1|||
129780957|NCT01006291|467166007|FG002|Overall Study|Adverse Event|2|||
129780958|NCT01006291|467166005|FG000|Overall Study|Lack of Efficacy|2|||
129780959|NCT01006291|467166006|FG001|Overall Study|Lack of Efficacy|2|||
129780960|NCT01006291|467166007|FG002|Overall Study|Lack of Efficacy|1|||
129780961|NCT01006291|467166005|FG000|Overall Study|Protocol Violation|3|||
129780962|NCT01006291|467166006|FG001|Overall Study|Protocol Violation|3|||
129780963|NCT01006291|467166007|FG002|Overall Study|Protocol Violation|3|||
129780964|NCT01006291|467166005|FG000|Overall Study|Withdrawal criteria|5|||
129780965|NCT01006291|467166006|FG001|Overall Study|Withdrawal criteria|4|||
129780966|NCT01006291|467166007|FG002|Overall Study|Withdrawal criteria|4|||
129780967|NCT01006291|467166005|FG000|Overall Study|Other|14|||
129570050|NCT04206332|466384917|FG009|Part C|Withdrawal by Subject|0|||
129570051|NCT04206332|466384918|FG010|Part C|Withdrawal by Subject|0|||
129570052|NCT04206332|466384919|FG011|Part C|Withdrawal by Subject|0|||
129570053|NCT04206332|466384920|FG012|Part C|Withdrawal by Subject|0|||
129570054|NCT04206332|466384921|FG013|Part C|Withdrawal by Subject|0|||
129570055|NCT04206332|466384922|FG014|Part C|Withdrawal by Subject|2|||
129570056|NCT04206332|466384923|FG015|Part C|Withdrawal by Subject|0|||
129570057|NCT04206332|466384924|FG016|Part C|Withdrawal by Subject|0|||
129570058|NCT01126736|466384927|FG000|Overall Study|Death|2|||
129570059|NCT01126736|466384928|FG001|Overall Study|Death|2|||
129780968|NCT01006291|467166006|FG001|Overall Study|Other|14|||
129780969|NCT01006291|467166007|FG002|Overall Study|Other|17|||
129570060|NCT01126736|466384929|FG002|Overall Study|Death|1|||
129570061|NCT01126736|466384930|FG003|Overall Study|Death|19|||
129570062|NCT01126736|466384931|FG004|Overall Study|Death|19|||
129570063|NCT01126736|466384927|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
129570064|NCT01126736|466384928|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
129570065|NCT01126736|466384929|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
129780970|NCT03079102|467166008|FG000|Overall Study|Physician Decision|0|||
129780971|NCT03079102|467166009|FG001|Overall Study|Physician Decision|1|||
129780972|NCT02810444|467166010|FG000|Overall Study|Screen Failures|14|||
129780973|NCT02810444|467166010|FG000|Overall Study|Withdrawal by Subject|4|||
129780974|NCT02810444|467166010|FG000|Overall Study|Adverse Event|3|||
129780975|NCT02785770|467166011|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
129780976|NCT02785770|467166012|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
129780977|NCT02785770|467166013|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
129780978|NCT02785770|467166014|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
129780979|NCT02785770|467166011|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
129780980|NCT02785770|467166012|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
129780981|NCT02785770|467166013|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
129780982|NCT02785770|467166014|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
129780983|NCT02785770|467166011|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
129780984|NCT02785770|467166012|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
129780985|NCT02785770|467166013|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
129780986|NCT02785770|467166014|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
129780987|NCT04518995|467166015|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
129780988|NCT04518995|467166016|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
129780989|NCT04518995|467166017|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
129780990|NCT04518995|467166015|FG000|Overall Study|Lack of Efficacy|2|||
129780991|NCT04518995|467166016|FG001|Overall Study|Lack of Efficacy|1|||
129780992|NCT04518995|467166017|FG002|Overall Study|Lack of Efficacy|0|||
129780993|NCT04518995|467166015|FG000|Overall Study|Non-compliance With Study Drug|0|||
129780994|NCT04518995|467166016|FG001|Overall Study|Non-compliance With Study Drug|3|||
129780995|NCT04518995|467166017|FG002|Overall Study|Non-compliance With Study Drug|2|||
129780996|NCT04518995|467166015|FG000|Overall Study|Pregnancy|0|||
129780997|NCT04518995|467166016|FG001|Overall Study|Pregnancy|0|||
129780998|NCT04518995|467166017|FG002|Overall Study|Pregnancy|1|||
129780999|NCT04518995|467166015|FG000|Overall Study|Protocol Violation|2|||
129781000|NCT04518995|467166016|FG001|Overall Study|Protocol Violation|0|||
129781001|NCT04518995|467166017|FG002|Overall Study|Protocol Violation|1|||
129781002|NCT04518995|467166015|FG000|Overall Study|Reason not Specified|4|||
129781003|NCT04518995|467166016|FG001|Overall Study|Reason not Specified|11|||
129570066|NCT01126736|466384930|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
129570067|NCT01126736|466384931|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
129570068|NCT01126736|466384927|FG000|Overall Study|Lost to Follow-up|0|||
129570069|NCT01126736|466384928|FG001|Overall Study|Lost to Follow-up|0|||
129570070|NCT01126736|466384929|FG002|Overall Study|Lost to Follow-up|0|||
129781004|NCT04518995|467166017|FG002|Overall Study|Reason not Specified|2|||
129781005|NCT04518995|467166015|FG000|Overall Study|Lost to Follow-up|1|||
129781006|NCT04518995|467166016|FG001|Overall Study|Lost to Follow-up|10|||
129781007|NCT04518995|467166017|FG002|Overall Study|Lost to Follow-up|6|||
129570071|NCT01126736|466384930|FG003|Overall Study|Lost to Follow-up|1|||
129781008|NCT02891070|467166022|FG000|Overall Study|Adverse Event|1|||
129781009|NCT02891070|467166023|FG001|Overall Study|Adverse Event|0|||
129781010|NCT02891070|467166022|FG000|Overall Study|Physician Decision|0|||
129781011|NCT02891070|467166023|FG001|Overall Study|Physician Decision|1|||
129781012|NCT02891070|467166022|FG000|Overall Study|Lost to Follow-up|4|||
129781013|NCT02891070|467166023|FG001|Overall Study|Lost to Follow-up|4|||
129781014|NCT02891070|467166022|FG000|Overall Study|Other|1|||
129781015|NCT02891070|467166023|FG001|Overall Study|Other|0|||
129781016|NCT02891070|467166022|FG000|Overall Study|Protocol Violation|0|||
129781017|NCT02891070|467166023|FG001|Overall Study|Protocol Violation|1|||
129781018|NCT02891070|467166022|FG000|Overall Study|Withdrawal by Subject|1|||
129781019|NCT02891070|467166023|FG001|Overall Study|Withdrawal by Subject|2|||
129781020|NCT02891070|467166022|FG000|Overall Study|Death|3|||
129781021|NCT02891070|467166023|FG001|Overall Study|Death|0|||
129781022|NCT00545272|467166026|FG000|Overall Study|Protocol deviation|0|||
129570072|NCT01126736|466384931|FG004|Overall Study|Lost to Follow-up|1|||
129570073|NCT01126736|466384927|FG000|Overall Study|Administrative reasons|0|||
129570074|NCT01126736|466384928|FG001|Overall Study|Administrative reasons|0|||
129570075|NCT01126736|466384929|FG002|Overall Study|Administrative reasons|0|||
129570076|NCT01126736|466384930|FG003|Overall Study|Administrative reasons|0|||
129570077|NCT01126736|466384931|FG004|Overall Study|Administrative reasons|1|||
129570078|NCT01126736|466384927|FG000|Overall Study|Progressive disease|0|||
129570079|NCT01126736|466384928|FG001|Overall Study|Progressive disease|0|||
129570080|NCT01126736|466384929|FG002|Overall Study|Progressive disease|0|||
129570081|NCT01126736|466384930|FG003|Overall Study|Progressive disease|2|||
129570082|NCT01126736|466384931|FG004|Overall Study|Progressive disease|1|||
129570083|NCT01126736|466384927|FG000|Overall Study|Withdrawal by Subject|0|||
129570084|NCT01126736|466384928|FG001|Overall Study|Withdrawal by Subject|0|||
129570085|NCT01126736|466384929|FG002|Overall Study|Withdrawal by Subject|0|||
129570086|NCT01126736|466384930|FG003|Overall Study|Withdrawal by Subject|1|||
129570087|NCT01126736|466384931|FG004|Overall Study|Withdrawal by Subject|1|||
129570088|NCT01126736|466384927|FG000|Overall Study|Other|2|||
129570089|NCT01126736|466384928|FG001|Overall Study|Other|4|||
129570090|NCT01126736|466384929|FG002|Overall Study|Other|4|||
129570091|NCT01126736|466384930|FG003|Overall Study|Other|16|||
129570092|NCT01126736|466384931|FG004|Overall Study|Other|15|||
129570093|NCT00064753|466384932|FG000|Overall Study|Death|251|||
129570094|NCT00064753|466384933|FG001|Overall Study|Death|242|||
129570095|NCT00064753|466384932|FG000|Overall Study|Withdrawal by Subject|198|||
129570096|NCT00064753|466384933|FG001|Overall Study|Withdrawal by Subject|171|||
129570097|NCT00064753|466384932|FG000|Overall Study|Lost to Follow-up|225|||
129570098|NCT00064753|466384933|FG001|Overall Study|Lost to Follow-up|235|||
129570099|NCT04869787|466384940|FG000|Screening|Physician Decision|1|||
129570100|NCT04869787|466384940|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
129570101|NCT00813293|466384942|FG000|Overall Study|Intercurrent illness|1|||
129570102|NCT00813293|466384943|FG001|Overall Study|Intercurrent illness|0|||
129570103|NCT00813293|466384942|FG000|Overall Study|Adverse Event|0|||
129570104|NCT00813293|466384943|FG001|Overall Study|Adverse Event|1|||
129570105|NCT02914600|466384944|FG000|Overall Study|Adverse Event|298|||
129570106|NCT02914600|466384945|FG001|Overall Study|Adverse Event|35|||
129570107|NCT02914600|466384946|FG002|Overall Study|Adverse Event|25|||
129570108|NCT02914600|466384944|FG000|Overall Study|Sponsors decision|287|||
129570109|NCT02914600|466384945|FG001|Overall Study|Sponsors decision|41|||
129570110|NCT02914600|466384946|FG002|Overall Study|Sponsors decision|12|||
129570111|NCT02914600|466384944|FG000|Overall Study|Withdrawal by Subject|158|||
129570112|NCT02914600|466384945|FG001|Overall Study|Withdrawal by Subject|20|||
129570113|NCT02914600|466384946|FG002|Overall Study|Withdrawal by Subject|18|||
129781023|NCT00545272|467166027|FG001|Overall Study|Protocol deviation|1|||
129781024|NCT00545272|467166028|FG002|Overall Study|Protocol deviation|0|||
129884560|NCT02696902|467536455|FG002|Overall Study|Withdrawal by Subject|1|||
129570114|NCT02914600|466384944|FG000|Overall Study|Investigators discretion|169|||
129570115|NCT02914600|466384945|FG001|Overall Study|Investigators discretion|14|||
129570116|NCT02914600|466384946|FG002|Overall Study|Investigators discretion|13|||
129570117|NCT02914600|466384944|FG000|Overall Study|Lost to Follow-up|10|||
129570118|NCT02914600|466384945|FG001|Overall Study|Lost to Follow-up|4|||
129570119|NCT02914600|466384946|FG002|Overall Study|Lost to Follow-up|0|||
129570120|NCT02914600|466384944|FG000|Overall Study|Pregnancy|8|||
129570121|NCT02914600|466384945|FG001|Overall Study|Pregnancy|0|||
129570122|NCT02914600|466384946|FG002|Overall Study|Pregnancy|0|||
129570123|NCT02914600|466384944|FG000|Overall Study|Protocol Violation|5|||
129570124|NCT02914600|466384945|FG001|Overall Study|Protocol Violation|3|||
129570125|NCT02914600|466384946|FG002|Overall Study|Protocol Violation|0|||
129781025|NCT00545272|467166029|FG003|Overall Study|Protocol deviation|1|||
129781026|NCT00545272|467166030|FG004|Overall Study|Protocol deviation|0|||
129781027|NCT00545272|467166031|FG005|Overall Study|Protocol deviation|1|||
129781028|NCT00545272|467166026|FG000|Overall Study|Adverse Event|0|||
129781029|NCT00545272|467166027|FG001|Overall Study|Adverse Event|0|||
129781030|NCT00545272|467166028|FG002|Overall Study|Adverse Event|1|||
129884561|NCT02696902|467536453|FG000|Overall Study|Death|19|||
129570126|NCT02914600|466384944|FG000|Overall Study|Non-compliance with study drug|6|||
129570127|NCT02914600|466384945|FG001|Overall Study|Non-compliance with study drug|1|||
129570128|NCT02914600|466384946|FG002|Overall Study|Non-compliance with study drug|0|||
129570129|NCT02914600|466384944|FG000|Overall Study|Death|3|||
129570130|NCT02914600|466384945|FG001|Overall Study|Death|1|||
129570131|NCT02914600|466384946|FG002|Overall Study|Death|1|||
129570132|NCT02914600|466384944|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
129570133|NCT02914600|466384945|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
129570134|NCT02914600|466384946|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
129570135|NCT02914600|466384944|FG000|Overall Study|Enrolled but not treated|1|||
129570136|NCT02914600|466384945|FG001|Overall Study|Enrolled but not treated|0|||
129690740|NCT04098302|466826424|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
129690741|NCT04098302|466826425|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
129690742|NCT04098302|466826426|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
129690743|NCT04098302|466826423|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
129690744|NCT04098302|466826424|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
129690745|NCT04098302|466826425|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
129690746|NCT04098302|466826426|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
129690747|NCT04098302|466826423|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
129690748|NCT04098302|466826424|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
129690749|NCT04098302|466826425|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
129690750|NCT04098302|466826426|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
129690751|NCT04098302|466826423|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
129690752|NCT04098302|466826424|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
129690753|NCT04098302|466826425|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
129690754|NCT04098302|466826426|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
129690755|NCT04098302|466826423|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
129690756|NCT04098302|466826424|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
129690757|NCT04098302|466826425|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
129690758|NCT04098302|466826426|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
129690759|NCT01290731|466826429|FG000|Overall Study|Withdrawal by Subject|1|||
129690760|NCT01399099|466826430|FG000|Overall Study|Lost to Follow-up|14|||
129690761|NCT01399099|466826430|FG000|Overall Study|Physician Decision|1|||
129690762|NCT01399099|466826430|FG000|Overall Study|Protocol Violation|1|||
129690763|NCT01399099|466826430|FG000|Overall Study|Skin Irritation|13|||
129690764|NCT01399099|466826430|FG000|Overall Study|Infection|1|||
129690765|NCT01399099|466826430|FG000|Overall Study|Miscellaneous|4|||
129570137|NCT02914600|466384946|FG002|Overall Study|Enrolled but not treated|0|||
129781031|NCT00545272|467166029|FG003|Overall Study|Adverse Event|0|||
129570138|NCT00454909|466384947|FG000|Overall Study|Withdrawal by Subject|1|||
129570139|NCT00454909|466384948|FG001|Overall Study|Withdrawal by Subject|0|||
129570140|NCT00454909|466384949|FG002|Overall Study|Withdrawal by Subject|0|||
129570141|NCT00454909|466384947|FG000|Overall Study|Migrated/moved from study area|0|||
129570142|NCT00454909|466384948|FG001|Overall Study|Migrated/moved from study area|0|||
129570143|NCT00454909|466384949|FG002|Overall Study|Migrated/moved from study area|1|||
129570144|NCT00454909|466384947|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
129690766|NCT01668537|466826431|FG000|Overall Study|Request to Discontinue Prematurely|1|||
129690767|NCT01668537|466826432|FG001|Overall Study|Request to Discontinue Prematurely|1|||
129690768|NCT01668537|466826431|FG000|Overall Study|Subject unwilling/unable to comply|5|||
129690769|NCT01668537|466826432|FG001|Overall Study|Subject unwilling/unable to comply|0|||
129690770|NCT01668537|466826431|FG000|Overall Study|Reason Precludes Participation|1|||
129690771|NCT01668537|466826432|FG001|Overall Study|Reason Precludes Participation|0|||
129690772|NCT01668537|466826431|FG000|Overall Study|Lost to Follow-up|13|||
129690773|NCT01668537|466826432|FG001|Overall Study|Lost to Follow-up|6|||
129690774|NCT01668537|466826431|FG000|Overall Study|Other|2|||
129690775|NCT01668537|466826432|FG001|Overall Study|Other|3|||
129690776|NCT05064800|466826433|FG000|Period 3|Withdrawal by Subject|0|||
129690777|NCT05064800|466826434|FG001|Period 3|Withdrawal by Subject|0|||
129690778|NCT05064800|466826435|FG002|Period 3|Withdrawal by Subject|0|||
129690779|NCT05064800|466826436|FG003|Period 3|Withdrawal by Subject|0|||
129690780|NCT05064800|466826437|FG004|Period 3|Withdrawal by Subject|1|||
129690781|NCT05064800|466826438|FG005|Period 3|Withdrawal by Subject|0|||
129690782|NCT04477486|466826439|FG000|Overall Study|Death|2|||
129690783|NCT04477486|466826439|FG000|Overall Study|Ongoing at Time of Analysis|11|||
129690784|NCT01078545|466826442|FG000|Overall Study|Lost to Follow-up|13|||
129690785|NCT01078545|466826442|FG000|Overall Study|Physician Decision|6|||
129690786|NCT01078545|466826442|FG000|Overall Study|Withdrawal by Subject|3|||
129690787|NCT01078545|466826442|FG000|Overall Study|Death|3|||
129690788|NCT01078545|466826442|FG000|Overall Study|Participant moved to another physician|1|||
129690789|NCT02497755|466826443|FG000|Overall Study|Protocol Violation|1|||
129690790|NCT02497755|466826444|FG001|Overall Study|Protocol Violation|0|||
129690791|NCT01774370|466826447|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
129690792|NCT01774370|466826447|FG000|Overall Study|Administered prior to the contract date|4|||
129690793|NCT01774370|466826447|FG000|Overall Study|Subjects of contraindications|34|||
129690794|NCT01774370|466826447|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
129570145|NCT00454909|466384948|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
129570146|NCT00454909|466384949|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
129570147|NCT00454909|466384947|FG000|Overall Study|Others|1|||
129570148|NCT00454909|466384948|FG001|Overall Study|Others|0|||
129570149|NCT00454909|466384949|FG002|Overall Study|Others|0|||
129570150|NCT02996682|466384950|FG000|Overall Study|Death|0|||
129570151|NCT02996682|466384951|FG001|Overall Study|Death|3|||
129570152|NCT02457520|466384952|FG000|Active Treatment Phase|Adverse Event|10|||
129570153|NCT02457520|466384952|FG000|Active Treatment Phase|Lost to Follow-up|8|||
129570154|NCT02457520|466384952|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
129570155|NCT02457520|466384952|FG000|Active Treatment Phase|other|4|||
129570156|NCT02457520|466384952|FG000|Active Treatment Phase|Physician Decision|1|||
129570157|NCT02457520|466384952|FG000|Active Treatment Phase|Protocol Violation|1|||
129570158|NCT02457520|466384952|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
129570159|NCT02457520|466384952|FG000|Post-treatment Period|Other: Retreatment Required|7|||
129570160|NCT02457520|466384952|FG000|Post-treatment Period|Lost to Follow-up|23|||
129570161|NCT02457520|466384952|FG000|Post-treatment Period|Other|3|||
129570162|NCT02457520|466384952|FG000|Post-treatment Period|Physician Decision|1|||
129570163|NCT02457520|466384952|FG000|Post-treatment Period|Withdrawal by Subject|14|||
129570164|NCT00282048|466384953|FG000|Overall Study|Lack of Efficacy|30|||
129570165|NCT00282048|466384953|FG000|Overall Study|Adverse Event|22|||
129570166|NCT00282048|466384953|FG000|Overall Study|Withdrawal by Subject|1|||
129570167|NCT00282048|466384953|FG000|Overall Study|Other|8|||
129570168|NCT00282048|466384953|FG000|Overall Study|Ongoing|1|||
129570169|NCT02107092|466384954|FG000|Overall Study|Miscellaneous|3|||
129570170|NCT02107092|466384954|FG000|Overall Study|Subject compliance|3|||
129570171|NCT02107092|466384954|FG000|Overall Study|Hypo-or hyperkalemia|2|||
129570172|NCT02107092|466384954|FG000|Overall Study|Met ECG withdrawal criteria|3|||
129570173|NCT02107092|466384954|FG000|Overall Study|Physician Decision|3|||
129570174|NCT02107092|466384954|FG000|Overall Study|Lost to Follow-up|2|||
129570175|NCT02107092|466384954|FG000|Overall Study|Withdrawal by Subject|9|||
129570176|NCT02107092|466384954|FG000|Overall Study|Adverse Event|7|||
129570177|NCT02107092|466384954|FG000|Overall Study|Expected progression of CKD|12|||
129570178|NCT03522675|466384956|FG000|Overall Study|Screen fail|1|||
129570179|NCT03522675|466384956|FG000|Overall Study|Non-reactive to histamine|1|||
129570180|NCT00707161|466384957|FG000|Overall Study|Physician Decision|6|||
129570181|NCT00696020|466384960|FG000|Overall Study|Adverse Event|3|||
129570182|NCT00696020|466384961|FG001|Overall Study|Adverse Event|1|||
129570183|NCT00696020|466384962|FG002|Overall Study|Adverse Event|2|||
129570184|NCT00696020|466384963|FG003|Overall Study|Adverse Event|1|||
129570185|NCT00696020|466384960|FG000|Overall Study|Lack of Efficacy|1|||
129570186|NCT00696020|466384961|FG001|Overall Study|Lack of Efficacy|0|||
129570187|NCT00696020|466384962|FG002|Overall Study|Lack of Efficacy|0|||
129570188|NCT00696020|466384963|FG003|Overall Study|Lack of Efficacy|0|||
129690795|NCT01774370|466826447|FG000|Overall Study|Follow-up failure|34|||
129690796|NCT05436288|466826448|FG000|Overall Study|Lost to Follow-up|1|||
129690797|NCT05436288|466826448|FG000|Overall Study|Adverse Event|1|||
129690798|NCT01436500|466826452|FG000|Overall Study|Death|1|||
129690799|NCT01436500|466826453|FG001|Overall Study|Death|0|||
129690800|NCT01436500|466826454|FG002|Overall Study|Death|0|||
129690801|NCT01436500|466826455|FG003|Overall Study|Death|0|||
129690802|NCT01436500|466826456|FG004|Overall Study|Death|0|||
129690803|NCT01436500|466826452|FG000|Overall Study|Adverse Event|0|||
129690804|NCT01436500|466826453|FG001|Overall Study|Adverse Event|2|||
129690805|NCT01436500|466826454|FG002|Overall Study|Adverse Event|2|||
129690806|NCT01436500|466826455|FG003|Overall Study|Adverse Event|0|||
129690807|NCT01436500|466826456|FG004|Overall Study|Adverse Event|1|||
129690808|NCT01436500|466826452|FG000|Overall Study|Withdrawal by Subject|0|||
129690809|NCT01436500|466826453|FG001|Overall Study|Withdrawal by Subject|0|||
129690810|NCT01436500|466826454|FG002|Overall Study|Withdrawal by Subject|2|||
129690811|NCT01436500|466826455|FG003|Overall Study|Withdrawal by Subject|0|||
129690812|NCT01436500|466826456|FG004|Overall Study|Withdrawal by Subject|2|||
129690813|NCT01436500|466826452|FG000|Overall Study|Physician Decision|0|||
129690814|NCT01436500|466826453|FG001|Overall Study|Physician Decision|0|||
129690815|NCT01436500|466826454|FG002|Overall Study|Physician Decision|1|||
129690816|NCT01436500|466826455|FG003|Overall Study|Physician Decision|0|||
129690817|NCT01436500|466826456|FG004|Overall Study|Physician Decision|0|||
129570189|NCT00696020|466384960|FG000|Overall Study|Protocol Violation|0|||
129570190|NCT00696020|466384961|FG001|Overall Study|Protocol Violation|0|||
129570191|NCT00696020|466384962|FG002|Overall Study|Protocol Violation|0|||
129570192|NCT00696020|466384963|FG003|Overall Study|Protocol Violation|1|||
129570193|NCT00696020|466384960|FG000|Overall Study|Withdrawal by Subject|0|||
129570194|NCT00696020|466384961|FG001|Overall Study|Withdrawal by Subject|1|||
129570195|NCT00696020|466384962|FG002|Overall Study|Withdrawal by Subject|0|||
129570196|NCT00696020|466384963|FG003|Overall Study|Withdrawal by Subject|1|||
129690818|NCT01436500|466826452|FG000|Overall Study|liver transplant|1|||
129690819|NCT01436500|466826453|FG001|Overall Study|liver transplant|0|||
129781032|NCT00545272|467166030|FG004|Overall Study|Adverse Event|0|||
129781033|NCT00545272|467166031|FG005|Overall Study|Adverse Event|1|||
129781034|NCT00545272|467166026|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129781035|NCT00545272|467166027|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129781036|NCT00545272|467166028|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129781037|NCT00545272|467166029|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129781038|NCT00545272|467166030|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129781039|NCT00545272|467166031|FG005|Overall Study|Abnormal laboratory value(s)|1|||
129781040|NCT00545272|467166026|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129781041|NCT00545272|467166027|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129781042|NCT00545272|467166028|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129781043|NCT00545272|467166029|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129781044|NCT00545272|467166030|FG004|Overall Study|Abnormal test procedure result(s)|1|||
129781045|NCT00545272|467166031|FG005|Overall Study|Abnormal test procedure result(s)|0|||
129781046|NCT00545272|467166026|FG000|Overall Study|Lost to Follow-up|0|||
129781047|NCT00545272|467166027|FG001|Overall Study|Lost to Follow-up|0|||
129781048|NCT00545272|467166028|FG002|Overall Study|Lost to Follow-up|0|||
129781049|NCT00545272|467166029|FG003|Overall Study|Lost to Follow-up|0|||
129781050|NCT00545272|467166030|FG004|Overall Study|Lost to Follow-up|1|||
129781051|NCT00545272|467166031|FG005|Overall Study|Lost to Follow-up|0|||
129781052|NCT04491604|467166032|FG000|Overall Study|Withdrawal by Subject|3|||
129781053|NCT02934503|467166033|FG000|Overall Study|progression of disease|3|||
129781054|NCT02934503|467166033|FG000|Overall Study|Withdrawal by Subject|1|||
129781055|NCT00724867|467166034|FG000|Overall Study|Adverse Event|25|||
129781056|NCT00724867|467166034|FG000|Overall Study|Lack of Efficacy|14|||
129781057|NCT00724867|467166034|FG000|Overall Study|Lost to Follow-up|12|||
129781058|NCT00724867|467166034|FG000|Overall Study|Non-compliance with study drug|6|||
129781059|NCT00724867|467166034|FG000|Overall Study|Physician Decision|17|||
129781060|NCT00724867|467166034|FG000|Overall Study|Protocol Violation|1|||
129781061|NCT00724867|467166034|FG000|Overall Study|Withdrawal by Subject|31|||
129781062|NCT00724867|467166034|FG000|Overall Study|Sponsor decision to end study|14|||
129781063|NCT00724867|467166034|FG000|Overall Study|Subject incarcerated|1|||
129781064|NCT00724867|467166034|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
129781065|NCT00724867|467166034|FG000|Overall Study|Subject moved out of state|1|||
129781066|NCT00724867|467166034|FG000|Overall Study|Elected to exit due to site closure|2|||
129781067|NCT04335136|467166036|FG000|Overall Study|Death|8|||
129781068|NCT04335136|467166037|FG001|Overall Study|Death|4|||
129781069|NCT04335136|467166036|FG000|Overall Study|Lost to Follow-up|2|||
129781070|NCT04335136|467166037|FG001|Overall Study|Lost to Follow-up|0|||
129781071|NCT04335136|467166036|FG000|Overall Study|Protocol Violation|1|||
129690820|NCT01436500|466826454|FG002|Overall Study|liver transplant|0|||
129690821|NCT01436500|466826455|FG003|Overall Study|liver transplant|0|||
129690822|NCT01436500|466826456|FG004|Overall Study|liver transplant|0|||
129690823|NCT01436500|466826452|FG000|Overall Study|initiation of dialysis|0|||
129690824|NCT01436500|466826453|FG001|Overall Study|initiation of dialysis|0|||
129690825|NCT01436500|466826454|FG002|Overall Study|initiation of dialysis|0|||
129690826|NCT01436500|466826455|FG003|Overall Study|initiation of dialysis|0|||
129690827|NCT01436500|466826456|FG004|Overall Study|initiation of dialysis|1|||
129690828|NCT01436500|466826452|FG000|Overall Study|discontinued study drug|1|||
129690829|NCT01436500|466826453|FG001|Overall Study|discontinued study drug|0|||
129690830|NCT01436500|466826454|FG002|Overall Study|discontinued study drug|0|||
129690831|NCT01436500|466826455|FG003|Overall Study|discontinued study drug|0|||
129690832|NCT01436500|466826456|FG004|Overall Study|discontinued study drug|0|||
129690833|NCT01436500|466826452|FG000|Overall Study|Other|0|||
129690834|NCT01436500|466826453|FG001|Overall Study|Other|1|||
129690835|NCT01436500|466826454|FG002|Overall Study|Other|0|||
129690836|NCT01436500|466826455|FG003|Overall Study|Other|1|||
129690837|NCT01436500|466826456|FG004|Overall Study|Other|0|||
129690838|NCT01487161|466826458|FG000|Overall Study|Adverse Event|1|||
129690839|NCT01487161|466826459|FG001|Overall Study|Adverse Event|0|||
129690840|NCT01487161|466826460|FG002|Overall Study|Adverse Event|0|||
129690841|NCT01487161|466826461|FG003|Overall Study|Adverse Event|0|||
129690842|NCT01487161|466826458|FG000|Overall Study|Withdrawal by Subject|1|||
129690843|NCT01487161|466826459|FG001|Overall Study|Withdrawal by Subject|1|||
129690844|NCT01487161|466826460|FG002|Overall Study|Withdrawal by Subject|1|||
129781072|NCT04335136|467166037|FG001|Overall Study|Protocol Violation|0|||
129781073|NCT04335136|467166036|FG000|Overall Study|Withdrawal by Subject|1|||
129781074|NCT04335136|467166037|FG001|Overall Study|Withdrawal by Subject|1|||
129781075|NCT04335136|467166036|FG000|Overall Study|Health-threatening condition|0|||
129781076|NCT04335136|467166037|FG001|Overall Study|Health-threatening condition|1|||
129781077|NCT04335136|467166036|FG000|Overall Study|Adverse Event|0|||
129781078|NCT04335136|467166037|FG001|Overall Study|Adverse Event|1|||
129781079|NCT04335136|467166036|FG000|Overall Study|Erroneously randomized|2|||
129781080|NCT04335136|467166037|FG001|Overall Study|Erroneously randomized|0|||
129781081|NCT02834793|467166038|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
129781082|NCT02834793|467166039|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
129781083|NCT02834793|467166040|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
129690845|NCT01487161|466826461|FG003|Overall Study|Withdrawal by Subject|2|||
129690846|NCT01487161|466826458|FG000|Overall Study|missing data|0|||
129690847|NCT01487161|466826459|FG001|Overall Study|missing data|1|||
129690848|NCT01487161|466826460|FG002|Overall Study|missing data|0|||
129690849|NCT01487161|466826461|FG003|Overall Study|missing data|0|||
129690850|NCT02675452|466826465|FG000|Overall Study|Sponsor decision|0|||
129690851|NCT02675452|466826466|FG001|Overall Study|Sponsor decision|0|||
129690852|NCT02675452|466826467|FG002|Overall Study|Sponsor decision|0|||
129690853|NCT02675452|466826468|FG003|Overall Study|Sponsor decision|0|||
129690854|NCT02675452|466826469|FG004|Overall Study|Sponsor decision|0|||
129690855|NCT02675452|466826470|FG005|Overall Study|Sponsor decision|0|||
129690856|NCT02675452|466826471|FG006|Overall Study|Sponsor decision|0|||
129690857|NCT02675452|466826472|FG007|Overall Study|Sponsor decision|0|||
129690858|NCT02675452|466826473|FG008|Overall Study|Sponsor decision|0|||
129690859|NCT02675452|466826474|FG009|Overall Study|Sponsor decision|1|||
129690860|NCT02675452|466826475|FG010|Overall Study|Sponsor decision|0|||
129690861|NCT02675452|466826476|FG011|Overall Study|Sponsor decision|0|||
129690862|NCT02675452|466826477|FG012|Overall Study|Sponsor decision|0|||
129690863|NCT02675452|466826478|FG013|Overall Study|Sponsor decision|2|||
129690864|NCT02675452|466826479|FG014|Overall Study|Sponsor decision|1|||
129690865|NCT02675452|466826480|FG015|Overall Study|Sponsor decision|0|||
129690866|NCT02675452|466826481|FG016|Overall Study|Sponsor decision|1|||
129690867|NCT02675452|466826482|FG017|Overall Study|Sponsor decision|0|||
129690868|NCT02675452|466826483|FG018|Overall Study|Sponsor decision|0|||
129690869|NCT02675452|466826484|FG019|Overall Study|Sponsor decision|0|||
129690870|NCT02675452|466826485|FG020|Overall Study|Sponsor decision|0|||
129690871|NCT02675452|466826486|FG021|Overall Study|Sponsor decision|0|||
129690872|NCT02675452|466826487|FG022|Overall Study|Sponsor decision|0|||
129690873|NCT02675452|466826488|FG023|Overall Study|Sponsor decision|0|||
129690874|NCT02675452|466826489|FG024|Overall Study|Sponsor decision|0|||
129690875|NCT02675452|466826490|FG025|Overall Study|Sponsor decision|0|||
129690876|NCT02675452|466826491|FG026|Overall Study|Sponsor decision|2|||
129690877|NCT02675452|466826492|FG027|Overall Study|Sponsor decision|0|||
129690878|NCT02675452|466826493|FG028|Overall Study|Sponsor decision|0|||
129690879|NCT02675452|466826465|FG000|Overall Study|Withdrawal by Subject|0|||
129690880|NCT02675452|466826466|FG001|Overall Study|Withdrawal by Subject|0|||
129690881|NCT02675452|466826467|FG002|Overall Study|Withdrawal by Subject|0|||
129690882|NCT02675452|466826468|FG003|Overall Study|Withdrawal by Subject|0|||
129690883|NCT02675452|466826469|FG004|Overall Study|Withdrawal by Subject|0|||
129690884|NCT02675452|466826470|FG005|Overall Study|Withdrawal by Subject|0|||
129690885|NCT02675452|466826471|FG006|Overall Study|Withdrawal by Subject|0|||
129690886|NCT02675452|466826472|FG007|Overall Study|Withdrawal by Subject|0|||
129690887|NCT02675452|466826473|FG008|Overall Study|Withdrawal by Subject|0|||
129690888|NCT02675452|466826474|FG009|Overall Study|Withdrawal by Subject|1|||
129690889|NCT02675452|466826475|FG010|Overall Study|Withdrawal by Subject|0|||
129690890|NCT02675452|466826476|FG011|Overall Study|Withdrawal by Subject|1|||
129690891|NCT02675452|466826477|FG012|Overall Study|Withdrawal by Subject|0|||
129690892|NCT02675452|466826478|FG013|Overall Study|Withdrawal by Subject|1|||
129690893|NCT02675452|466826479|FG014|Overall Study|Withdrawal by Subject|1|||
129690894|NCT02675452|466826480|FG015|Overall Study|Withdrawal by Subject|0|||
129690895|NCT02675452|466826481|FG016|Overall Study|Withdrawal by Subject|2|||
129690896|NCT02675452|466826482|FG017|Overall Study|Withdrawal by Subject|0|||
129690897|NCT02675452|466826483|FG018|Overall Study|Withdrawal by Subject|0|||
129690898|NCT02675452|466826484|FG019|Overall Study|Withdrawal by Subject|0|||
129690899|NCT02675452|466826485|FG020|Overall Study|Withdrawal by Subject|0|||
129690900|NCT02675452|466826486|FG021|Overall Study|Withdrawal by Subject|0|||
129690901|NCT02675452|466826487|FG022|Overall Study|Withdrawal by Subject|3|||
129690902|NCT02675452|466826488|FG023|Overall Study|Withdrawal by Subject|0|||
129690903|NCT02675452|466826489|FG024|Overall Study|Withdrawal by Subject|1|||
129690904|NCT02675452|466826490|FG025|Overall Study|Withdrawal by Subject|0|||
129690905|NCT02675452|466826491|FG026|Overall Study|Withdrawal by Subject|1|||
129690906|NCT02675452|466826492|FG027|Overall Study|Withdrawal by Subject|3|||
129690907|NCT02675452|466826493|FG028|Overall Study|Withdrawal by Subject|4|||
129690908|NCT02675452|466826465|FG000|Overall Study|Death|0|||
129690909|NCT02675452|466826466|FG001|Overall Study|Death|0|||
129690910|NCT02675452|466826467|FG002|Overall Study|Death|1|||
129690911|NCT02675452|466826468|FG003|Overall Study|Death|0|||
129690912|NCT02675452|466826469|FG004|Overall Study|Death|0|||
129781084|NCT02834793|467166041|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
129690913|NCT02675452|466826470|FG005|Overall Study|Death|1|||
129690914|NCT02675452|466826471|FG006|Overall Study|Death|0|||
129690915|NCT02675452|466826472|FG007|Overall Study|Death|0|||
129690916|NCT02675452|466826473|FG008|Overall Study|Death|1|||
129781085|NCT02834793|467166038|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
129570197|NCT00696020|466384960|FG000|Overall Study|Other not stated above|0|||
129570198|NCT00696020|466384961|FG001|Overall Study|Other not stated above|0|||
129781086|NCT02834793|467166039|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
129781087|NCT02834793|467166040|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
129781088|NCT02834793|467166041|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
129570199|NCT00696020|466384962|FG002|Overall Study|Other not stated above|1|||
129690917|NCT02675452|466826474|FG009|Overall Study|Death|0|||
129690918|NCT02675452|466826475|FG010|Overall Study|Death|0|||
129690919|NCT02675452|466826476|FG011|Overall Study|Death|0|||
129690920|NCT02675452|466826477|FG012|Overall Study|Death|1|||
129690921|NCT02675452|466826478|FG013|Overall Study|Death|0|||
129690922|NCT02675452|466826479|FG014|Overall Study|Death|0|||
129690923|NCT02675452|466826480|FG015|Overall Study|Death|2|||
129690924|NCT02675452|466826481|FG016|Overall Study|Death|0|||
129690925|NCT02675452|466826482|FG017|Overall Study|Death|0|||
129690926|NCT02675452|466826483|FG018|Overall Study|Death|4|||
129690927|NCT02675452|466826484|FG019|Overall Study|Death|3|||
129690928|NCT02675452|466826485|FG020|Overall Study|Death|3|||
129690929|NCT02675452|466826486|FG021|Overall Study|Death|3|||
129690930|NCT02675452|466826487|FG022|Overall Study|Death|7|||
129690931|NCT02675452|466826488|FG023|Overall Study|Death|5|||
129690932|NCT02675452|466826489|FG024|Overall Study|Death|3|||
129570200|NCT00696020|466384963|FG003|Overall Study|Other not stated above|1|||
129690933|NCT02675452|466826490|FG025|Overall Study|Death|4|||
129690934|NCT02675452|466826491|FG026|Overall Study|Death|7|||
129690935|NCT02675452|466826492|FG027|Overall Study|Death|6|||
129690936|NCT02675452|466826493|FG028|Overall Study|Death|9|||
129690937|NCT02675452|466826465|FG000|Overall Study|Lost to Follow-up|0|||
129570201|NCT01387022|466384964|FG000|Overall Study|Death|1|||
129690938|NCT02675452|466826466|FG001|Overall Study|Lost to Follow-up|1|||
129690939|NCT02675452|466826467|FG002|Overall Study|Lost to Follow-up|0|||
129690940|NCT02675452|466826468|FG003|Overall Study|Lost to Follow-up|0|||
129781089|NCT02834793|467166038|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
129570202|NCT01387022|466384965|FG001|Overall Study|Death|1|||
129570203|NCT01387022|466384964|FG000|Overall Study|Lost to Follow-up|0|||
129570204|NCT01387022|466384965|FG001|Overall Study|Lost to Follow-up|3|||
129570205|NCT02076022|466384966|FG000|Overall Study|Withdrawal by Subject|2|||
129570206|NCT02076022|466384967|FG001|Overall Study|Withdrawal by Subject|0|||
129570207|NCT02661295|466384974|FG000|Overall Study|Death|1|||
129570208|NCT02661295|466384974|FG000|Overall Study|Transferred Out|1|||
129570209|NCT02661295|466384974|FG000|Overall Study|Kidney Transplant|1|||
129570210|NCT02661295|466384974|FG000|Overall Study|Withdrawn due to side effects|8|||
129570211|NCT02661295|466384974|FG000|Overall Study|Withdrawn due to access type|1|||
129570212|NCT02661295|466384974|FG000|Overall Study|Withdrawn due to allergies|1|||
129570213|NCT02661295|466384974|FG000|Overall Study|Withdrawn due to non-compliance|1|||
129570214|NCT02661295|466384974|FG000|Overall Study|Withdrawal by Subject|3|||
129570215|NCT02661295|466384974|FG000|Overall Study|Failed screening|2|||
129570216|NCT03627091|466384975|FG000|Overall Study|Adverse Event|0|||
129570217|NCT03627091|466384976|FG001|Overall Study|Adverse Event|0|||
129570218|NCT03627091|466384977|FG002|Overall Study|Adverse Event|2|||
129570219|NCT03627091|466384975|FG000|Overall Study|Withdrawal by Subject|2|||
129570220|NCT03627091|466384976|FG001|Overall Study|Withdrawal by Subject|0|||
129570221|NCT03627091|466384977|FG002|Overall Study|Withdrawal by Subject|2|||
129570222|NCT03627091|466384975|FG000|Overall Study|Physician Decision|2|||
129570223|NCT03627091|466384976|FG001|Overall Study|Physician Decision|0|||
129570224|NCT03627091|466384977|FG002|Overall Study|Physician Decision|0|||
129570225|NCT03627091|466384975|FG000|Overall Study|Site terminated by sponsor|0|||
129570226|NCT03627091|466384976|FG001|Overall Study|Site terminated by sponsor|1|||
129570227|NCT03627091|466384977|FG002|Overall Study|Site terminated by sponsor|0|||
129570228|NCT03627091|466384975|FG000|Overall Study|Disease relapse|7|||
129570229|NCT03627091|466384976|FG001|Overall Study|Disease relapse|5|||
129570230|NCT03627091|466384977|FG002|Overall Study|Disease relapse|1|||
129570231|NCT03627091|466384975|FG000|Overall Study|Other|1|||
129570232|NCT03627091|466384976|FG001|Overall Study|Other|0|||
129570233|NCT03627091|466384977|FG002|Overall Study|Other|0|||
129570234|NCT01376167|466384982|FG000|Overall Study|Lost to Follow-up|2|||
129570235|NCT01376167|466384983|FG001|Overall Study|Lost to Follow-up|4|||
129570236|NCT01376167|466384984|FG002|Overall Study|Lost to Follow-up|2|||
129570237|NCT01376167|466384982|FG000|Overall Study|Physician Decision|1|||
129570238|NCT01376167|466384983|FG001|Overall Study|Physician Decision|1|||
129570239|NCT01376167|466384984|FG002|Overall Study|Physician Decision|0|||
129570240|NCT01376167|466384982|FG000|Overall Study|Withdrawal by Subject|1|||
129570241|NCT01376167|466384983|FG001|Overall Study|Withdrawal by Subject|5|||
129570242|NCT01376167|466384984|FG002|Overall Study|Withdrawal by Subject|4|||
129690941|NCT02675452|466826469|FG004|Overall Study|Lost to Follow-up|0|||
129690942|NCT02675452|466826470|FG005|Overall Study|Lost to Follow-up|0|||
129690943|NCT02675452|466826471|FG006|Overall Study|Lost to Follow-up|0|||
129690944|NCT02675452|466826472|FG007|Overall Study|Lost to Follow-up|0|||
129690945|NCT02675452|466826473|FG008|Overall Study|Lost to Follow-up|0|||
129690946|NCT02675452|466826474|FG009|Overall Study|Lost to Follow-up|0|||
129690947|NCT02675452|466826475|FG010|Overall Study|Lost to Follow-up|0|||
129690948|NCT02675452|466826476|FG011|Overall Study|Lost to Follow-up|0|||
129690949|NCT02675452|466826477|FG012|Overall Study|Lost to Follow-up|1|||
129690950|NCT02675452|466826478|FG013|Overall Study|Lost to Follow-up|0|||
129690951|NCT02675452|466826479|FG014|Overall Study|Lost to Follow-up|0|||
129690952|NCT02675452|466826480|FG015|Overall Study|Lost to Follow-up|0|||
129690953|NCT02675452|466826481|FG016|Overall Study|Lost to Follow-up|0|||
129690954|NCT02675452|466826482|FG017|Overall Study|Lost to Follow-up|0|||
129690955|NCT02675452|466826483|FG018|Overall Study|Lost to Follow-up|0|||
129690956|NCT02675452|466826484|FG019|Overall Study|Lost to Follow-up|0|||
129690957|NCT02675452|466826485|FG020|Overall Study|Lost to Follow-up|0|||
129690958|NCT02675452|466826486|FG021|Overall Study|Lost to Follow-up|0|||
129690959|NCT02675452|466826487|FG022|Overall Study|Lost to Follow-up|0|||
129690960|NCT02675452|466826488|FG023|Overall Study|Lost to Follow-up|0|||
129690961|NCT02675452|466826489|FG024|Overall Study|Lost to Follow-up|0|||
129690962|NCT02675452|466826490|FG025|Overall Study|Lost to Follow-up|0|||
129690963|NCT02675452|466826491|FG026|Overall Study|Lost to Follow-up|1|||
129690964|NCT02675452|466826492|FG027|Overall Study|Lost to Follow-up|0|||
129690965|NCT02675452|466826493|FG028|Overall Study|Lost to Follow-up|0|||
129570243|NCT01173692|466384990|FG000|Overall Study|Adverse Event|1|||
129570244|NCT01173692|466384991|FG001|Overall Study|Adverse Event|2|||
129570245|NCT01173692|466384990|FG000|Overall Study|Withdrawal by Subject|1|||
129570246|NCT01173692|466384991|FG001|Overall Study|Withdrawal by Subject|3|||
129570247|NCT00678639|466384992|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
129570248|NCT00678639|466384993|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
129570249|NCT00986245|466384996|FG000|First Intervention|Poor compliance|8|||
129570250|NCT00986245|466384997|FG001|First Intervention|Poor compliance|4|||
129570251|NCT00986245|466384996|FG000|First Intervention|Lack of Efficacy|1|||
129690966|NCT02675452|466826465|FG000|Overall Study|Other|0|||
129570252|NCT00986245|466384997|FG001|First Intervention|Lack of Efficacy|2|||
129570253|NCT00986245|466384996|FG000|First Intervention|Withdrawal by Subject|0|||
129570254|NCT00986245|466384997|FG001|First Intervention|Withdrawal by Subject|1|||
129570255|NCT00986245|466384996|FG000|First Intervention|Protocol Violation|0|||
129570256|NCT00986245|466384997|FG001|First Intervention|Protocol Violation|1|||
129570257|NCT00986245|466384996|FG000|First Intervention|Out of indication|1|||
129570258|NCT00986245|466384997|FG001|First Intervention|Out of indication|0|||
129570259|NCT00986245|466384996|FG000|Second Intervention|Poor compliance|1|||
129570260|NCT00986245|466384997|FG001|Second Intervention|Poor compliance|0|||
129570261|NCT00986245|466384996|FG000|Second Intervention|Lost to Follow-up|1|||
129570262|NCT00986245|466384997|FG001|Second Intervention|Lost to Follow-up|0|||
129570263|NCT00986245|466384996|FG000|Second Intervention|Protocol Violation|0|||
129570264|NCT00986245|466384997|FG001|Second Intervention|Protocol Violation|1|||
129570265|NCT02849652|466385003|FG000|Overall Study|Lost to Follow-up|104|||
129570266|NCT02849652|466385004|FG001|Overall Study|Lost to Follow-up|35|||
129570267|NCT02849652|466385005|FG002|Overall Study|Lost to Follow-up|116|||
129570268|NCT02849652|466385006|FG003|Overall Study|Lost to Follow-up|22|||
129690967|NCT02675452|466826466|FG001|Overall Study|Other|0|||
129690968|NCT02675452|466826467|FG002|Overall Study|Other|0|||
129690969|NCT02675452|466826468|FG003|Overall Study|Other|0|||
129690970|NCT02675452|466826469|FG004|Overall Study|Other|0|||
129690971|NCT02675452|466826470|FG005|Overall Study|Other|0|||
129690972|NCT02675452|466826471|FG006|Overall Study|Other|0|||
129690973|NCT02675452|466826472|FG007|Overall Study|Other|0|||
129690974|NCT02675452|466826473|FG008|Overall Study|Other|0|||
129690975|NCT02675452|466826474|FG009|Overall Study|Other|0|||
129690976|NCT02675452|466826475|FG010|Overall Study|Other|0|||
129690977|NCT02675452|466826476|FG011|Overall Study|Other|0|||
129690978|NCT02675452|466826477|FG012|Overall Study|Other|0|||
129690979|NCT02675452|466826478|FG013|Overall Study|Other|0|||
129690980|NCT02675452|466826479|FG014|Overall Study|Other|0|||
129690981|NCT02675452|466826480|FG015|Overall Study|Other|0|||
129690982|NCT02675452|466826481|FG016|Overall Study|Other|0|||
129690983|NCT02675452|466826482|FG017|Overall Study|Other|0|||
129690984|NCT02675452|466826483|FG018|Overall Study|Other|0|||
129690985|NCT02675452|466826484|FG019|Overall Study|Other|0|||
129690986|NCT02675452|466826485|FG020|Overall Study|Other|0|||
129690987|NCT02675452|466826486|FG021|Overall Study|Other|0|||
129690988|NCT02675452|466826487|FG022|Overall Study|Other|0|||
129690989|NCT02675452|466826488|FG023|Overall Study|Other|0|||
129690990|NCT02675452|466826489|FG024|Overall Study|Other|0|||
129690991|NCT02675452|466826490|FG025|Overall Study|Other|0|||
129690992|NCT02675452|466826491|FG026|Overall Study|Other|1|||
129690993|NCT02675452|466826492|FG027|Overall Study|Other|0|||
129690994|NCT02675452|466826493|FG028|Overall Study|Other|0|||
129690995|NCT00541775|466826494|FG000|Overall Study|Adverse Event|3|||
129690996|NCT00541775|466826495|FG001|Overall Study|Adverse Event|2|||
129690997|NCT00541775|466826496|FG002|Overall Study|Adverse Event|1|||
129690998|NCT00541775|466826494|FG000|Overall Study|Lack of Efficacy|0|||
129690999|NCT00541775|466826495|FG001|Overall Study|Lack of Efficacy|0|||
129691000|NCT00541775|466826496|FG002|Overall Study|Lack of Efficacy|3|||
129691001|NCT00541775|466826494|FG000|Overall Study|Lost to Follow-up|0|||
129691002|NCT00541775|466826495|FG001|Overall Study|Lost to Follow-up|0|||
129691003|NCT00541775|466826496|FG002|Overall Study|Lost to Follow-up|2|||
129691004|NCT00541775|466826494|FG000|Overall Study|Protocol Violation|1|||
129691005|NCT00541775|466826495|FG001|Overall Study|Protocol Violation|0|||
129691006|NCT00541775|466826496|FG002|Overall Study|Protocol Violation|0|||
129691007|NCT00541775|466826494|FG000|Overall Study|Withdrawal by Subject and Other|5|||
129570269|NCT02849652|466385003|FG000|Overall Study|Withdrawal by Subject|10|||
129570270|NCT02849652|466385004|FG001|Overall Study|Withdrawal by Subject|2|||
129570271|NCT02849652|466385005|FG002|Overall Study|Withdrawal by Subject|8|||
129691008|NCT00541775|466826495|FG001|Overall Study|Withdrawal by Subject and Other|0|||
129691009|NCT00541775|466826496|FG002|Overall Study|Withdrawal by Subject and Other|2|||
129570272|NCT02849652|466385006|FG003|Overall Study|Withdrawal by Subject|4|||
129691010|NCT02939781|466826497|FG000|Overall Study|Protocol Violation|8|||
129691011|NCT02939781|466826497|FG000|Overall Study|Withdrawal by Subject|1|||
129691012|NCT00032487|466826498|FG000|Overall Study|Withdrawal by Subject|67|||
129691013|NCT00032487|466826499|FG001|Overall Study|Withdrawal by Subject|43|||
129691014|NCT00032487|466826498|FG000|Overall Study|Adverse Event|3|||
129691015|NCT00032487|466826499|FG001|Overall Study|Adverse Event|7|||
129691016|NCT00032487|466826498|FG000|Overall Study|Lost to Follow-up|57|||
129691017|NCT00032487|466826499|FG001|Overall Study|Lost to Follow-up|58|||
129691018|NCT00032487|466826498|FG000|Overall Study|Had other reason|12|||
129691019|NCT00032487|466826499|FG001|Overall Study|Had other reason|12|||
129691020|NCT02569242|466826501|FG000|Overall Study|Death|1|||
129691021|NCT02569242|466826502|FG001|Overall Study|Death|0|||
129691022|NCT02569242|466826501|FG000|Overall Study|Withdrawal by Subject|0|||
129691023|NCT02569242|466826502|FG001|Overall Study|Withdrawal by Subject|1|||
129691024|NCT00689052|466826503|FG000|Overall Study|Adverse Event|4|||
129691025|NCT00689052|466826504|FG001|Overall Study|Adverse Event|6|||
129691026|NCT00689052|466826503|FG000|Overall Study|Protocol Violation|1|||
129691027|NCT00689052|466826504|FG001|Overall Study|Protocol Violation|0|||
129691028|NCT00689052|466826503|FG000|Overall Study|Lost to Follow-up|2|||
129691029|NCT00689052|466826504|FG001|Overall Study|Lost to Follow-up|0|||
129691030|NCT00689052|466826503|FG000|Overall Study|Withdrawal by Subject|2|||
129691031|NCT00689052|466826504|FG001|Overall Study|Withdrawal by Subject|0|||
129691032|NCT00689052|466826503|FG000|Overall Study|Early termination of the trial|22|||
129691033|NCT00689052|466826504|FG001|Overall Study|Early termination of the trial|24|||
129691034|NCT03003468|466826505|FG000|Overall Study|Withdrawal by Subject|0|||
129691035|NCT03003468|466826506|FG001|Overall Study|Withdrawal by Subject|0|||
129691036|NCT03003468|466826507|FG002|Overall Study|Withdrawal by Subject|1|||
129691037|NCT03003468|466826505|FG000|Overall Study|No measurable lesions|0|||
129691038|NCT03003468|466826506|FG001|Overall Study|No measurable lesions|0|||
129691039|NCT03003468|466826507|FG002|Overall Study|No measurable lesions|1|||
129691040|NCT03259308|466826515|FG000|Overall Study|Adverse Event|5|||
129691041|NCT03259308|466826516|FG001|Overall Study|Adverse Event|4|||
129691042|NCT03259308|466826517|FG002|Overall Study|Adverse Event|1|||
129691043|NCT03259308|466826515|FG000|Overall Study|Withdrawal by Subject|2|||
129691044|NCT03259308|466826516|FG001|Overall Study|Withdrawal by Subject|1|||
129691045|NCT03259308|466826517|FG002|Overall Study|Withdrawal by Subject|3|||
129691046|NCT03259308|466826515|FG000|Overall Study|Lost to Follow-up|0|||
129691047|NCT03259308|466826516|FG001|Overall Study|Lost to Follow-up|0|||
129691048|NCT03259308|466826517|FG002|Overall Study|Lost to Follow-up|1|||
129691049|NCT03259308|466826515|FG000|Overall Study|Pregnancy|0|||
129691050|NCT03259308|466826516|FG001|Overall Study|Pregnancy|0|||
129691051|NCT03259308|466826517|FG002|Overall Study|Pregnancy|1|||
129691052|NCT03259308|466826515|FG000|Overall Study|Protocol Deviation|0|||
129691053|NCT03259308|466826516|FG001|Overall Study|Protocol Deviation|3|||
129691054|NCT03259308|466826517|FG002|Overall Study|Protocol Deviation|0|||
129691055|NCT03259308|466826515|FG000|Overall Study|Lack of Efficacy|0|||
129691056|NCT03259308|466826516|FG001|Overall Study|Lack of Efficacy|0|||
129691057|NCT03259308|466826517|FG002|Overall Study|Lack of Efficacy|1|||
129691058|NCT01727154|466826518|FG000|Overall Study|Death|17|||
129691059|NCT01727154|466826518|FG000|Overall Study|Withdrawal by Subject|14|||
129691060|NCT01727154|466826518|FG000|Overall Study|Subject Withdrew Consent|18|||
129691061|NCT01727154|466826518|FG000|Overall Study|Study Terminated|6|||
129691062|NCT01727154|466826518|FG000|Overall Study|No Discontinuation Documentation|4|||
129691063|NCT00003474|466826519|FG000|Overall Study|Not Evaluable|14|||
129691064|NCT06025695|466826520|FG000|Overall Study|Adverse Event|5|||
129691065|NCT06025695|466826521|FG001|Overall Study|Adverse Event|6|||
129691066|NCT06025695|466826520|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
129691067|NCT06025695|466826521|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
129691068|NCT06025695|466826520|FG000|Overall Study|Other|23|||
129691069|NCT06025695|466826521|FG001|Overall Study|Other|19|||
129691070|NCT06025695|466826520|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
129691071|NCT06025695|466826521|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
129691072|NCT03834883|466826522|FG000|Second Treatment|Withdrawal by Subject|1|||
129691073|NCT03834883|466826523|FG001|Second Treatment|Withdrawal by Subject|0|||
129691074|NCT03834883|466826524|FG002|Second Treatment|Withdrawal by Subject|0|||
129691075|NCT03834883|466826525|FG003|Second Treatment|Withdrawal by Subject|0|||
129691076|NCT03834883|466826522|FG000|Second Treatment|COVID-19 pandemic|1|||
129691077|NCT03834883|466826523|FG001|Second Treatment|COVID-19 pandemic|0|||
129691078|NCT03834883|466826524|FG002|Second Treatment|COVID-19 pandemic|1|||
129691079|NCT03834883|466826525|FG003|Second Treatment|COVID-19 pandemic|1|||
129691080|NCT01629563|466828130|FG000|Overall Study|Adverse Event|16|||
129691081|NCT01629563|466828131|FG001|Overall Study|Adverse Event|16|||
129691082|NCT01629563|466828130|FG000|Overall Study|Death|2|||
129691083|NCT01629563|466828131|FG001|Overall Study|Death|0|||
129691084|NCT01629563|466828130|FG000|Overall Study|Lack of Efficacy|2|||
129691085|NCT01629563|466828131|FG001|Overall Study|Lack of Efficacy|3|||
129691086|NCT01629563|466828130|FG000|Overall Study|Lost to Follow-up|1|||
129691087|NCT01629563|466828131|FG001|Overall Study|Lost to Follow-up|0|||
129691088|NCT01629563|466828130|FG000|Overall Study|Pregnancy|1|||
129691089|NCT01629563|466828131|FG001|Overall Study|Pregnancy|2|||
129691090|NCT01629563|466828130|FG000|Overall Study|Protocol Violation|0|||
129691091|NCT01629563|466828131|FG001|Overall Study|Protocol Violation|1|||
129691092|NCT01629563|466828130|FG000|Overall Study|Withdrawal by Subject|27|||
129691093|NCT01629563|466828131|FG001|Overall Study|Withdrawal by Subject|20|||
129691094|NCT01629563|466828130|FG000|Overall Study|surgery|0|||
129691095|NCT01629563|466828131|FG001|Overall Study|surgery|3|||
129691096|NCT01629563|466828130|FG000|Overall Study|Lack of return of menses|12|||
129691097|NCT01629563|466828131|FG001|Overall Study|Lack of return of menses|7|||
129691098|NCT01629563|466828130|FG000|Overall Study|Protocol Violation|0|||
129691099|NCT01629563|466828131|FG001|Overall Study|Protocol Violation|1|||
129691100|NCT00454142|466828132|FG000|Overall Study|Withdrawal by Subject|1|||
129691101|NCT02545127|466828135|FG000|Overall Study|Lost to Follow-up|1|||
129691102|NCT02545127|466828136|FG001|Overall Study|Lost to Follow-up|0|||
129691103|NCT02802865|466828137|FG000|Overall Study|Pregnancy|1|||
129691104|NCT02802865|466828138|FG001|Overall Study|Pregnancy|1|||
129691105|NCT02802865|466828137|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
129691106|NCT02802865|466828138|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
129691107|NCT01783015|466828139|FG000|Blinded Treatment|Adverse Event|0|||
129691108|NCT01783015|466828140|FG001|Blinded Treatment|Adverse Event|1|||
129691109|NCT01783015|466828141|FG002|Blinded Treatment|Adverse Event|0|||
129691110|NCT01783015|466828139|FG000|Blinded Treatment|Protocol Violation|0|||
129691111|NCT01783015|466828140|FG001|Blinded Treatment|Protocol Violation|1|||
129691112|NCT01783015|466828141|FG002|Blinded Treatment|Protocol Violation|0|||
129691113|NCT01783015|466828139|FG000|Blinded Treatment|Withdrawal by Subject|0|||
129691114|NCT01783015|466828140|FG001|Blinded Treatment|Withdrawal by Subject|1|||
129691115|NCT01783015|466828141|FG002|Blinded Treatment|Withdrawal by Subject|0|||
129691116|NCT01783015|466828139|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
129691117|NCT01783015|466828140|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
129691118|NCT01783015|466828141|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
129691119|NCT01783015|466828139|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
129691120|NCT01783015|466828140|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
129570273|NCT00565448|466385007|FG000|Overall Study|Adverse Event|1|||
129570274|NCT00565448|466385008|FG001|Overall Study|Adverse Event|2|||
129570275|NCT00565448|466385007|FG000|Overall Study|Disease progression|1|||
129570276|NCT00565448|466385008|FG001|Overall Study|Disease progression|0|||
129570277|NCT00565448|466385007|FG000|Overall Study|Withdrawal by Subject|1|||
129570278|NCT00565448|466385008|FG001|Overall Study|Withdrawal by Subject|0|||
129570279|NCT01863745|466385009|FG000|Overall Study|Disease Progression|9|||
129570280|NCT01863745|466385009|FG000|Overall Study|Adverse Event|2|||
129570281|NCT01863745|466385009|FG000|Overall Study|Death|1|||
129570282|NCT01863745|466385009|FG000|Overall Study|Withdrawal by Subject|1|||
129570283|NCT00302952|466385010|FG000|Overall Study|Physician Decision|1|||
129570284|NCT00302952|466385011|FG001|Overall Study|Physician Decision|1|||
129570285|NCT00302952|466385010|FG000|Overall Study|Withdrawal by Subject|2|||
129570286|NCT00302952|466385011|FG001|Overall Study|Withdrawal by Subject|3|||
129570287|NCT00302952|466385010|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
129570288|NCT00302952|466385011|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
129570289|NCT02373098|466385012|FG000|Overall Study|Lost to Follow-up|1|||
129570290|NCT02373098|466385013|FG001|Overall Study|Lost to Follow-up|0|||
129570291|NCT02373098|466385012|FG000|Overall Study|Protocol Violation|3|||
129570292|NCT02373098|466385013|FG001|Overall Study|Protocol Violation|0|||
129570293|NCT02373098|466385012|FG000|Overall Study|Withdrawal by Subject|5|||
129570294|NCT02373098|466385013|FG001|Overall Study|Withdrawal by Subject|0|||
129570295|NCT02373098|466385012|FG000|Overall Study|Adverse Event|3|||
129570296|NCT02373098|466385013|FG001|Overall Study|Adverse Event|0|||
129570297|NCT00420238|466385014|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
129570298|NCT00420238|466385015|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
129570299|NCT00420238|466385014|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
129570300|NCT00420238|466385015|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
129570301|NCT00420238|466385014|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
129570302|NCT00420238|466385015|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
129570303|NCT00420238|466385014|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
129570304|NCT00420238|466385015|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
129570305|NCT00420238|466385014|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
129570306|NCT00420238|466385015|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
129570307|NCT00420238|466385014|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
129570308|NCT00420238|466385015|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
129570309|NCT05214560|466385016|FG000|Overall Study|Screening Failure|1|||
129570310|NCT05214560|466385016|FG000|Overall Study|Physician Decision|4|||
129570311|NCT05214560|466385016|FG000|Overall Study|Withdrawal by Subject|1|||
129570312|NCT05214560|466385016|FG000|Overall Study|Lost to Follow-up|2|||
129570313|NCT05214560|466385016|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
129570314|NCT05214560|466385016|FG000|Overall Study|Study physician not available for the anesthesia|3|||
129570315|NCT05214560|466385016|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
129570316|NCT05214560|466385016|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
129691121|NCT01783015|466828141|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
129691122|NCT00509600|466828142|FG000|Overall Study|Adverse Event|1|||
129691123|NCT02930941|466828144|FG000|Overall Study|Lost to Follow-up|1|||
129691124|NCT02930941|466828145|FG001|Overall Study|Lost to Follow-up|2|||
129691125|NCT00289978|466828146|FG000|Overall Study|Withdrawal by Subject|31|||
129691126|NCT00289978|466828147|FG001|Overall Study|Withdrawal by Subject|17|||
129691127|NCT00289978|466828148|FG002|Overall Study|Withdrawal by Subject|28|||
129691128|NCT00289978|466828146|FG000|Overall Study|Adverse Event|22|||
129691129|NCT00289978|466828147|FG001|Overall Study|Adverse Event|13|||
129691130|NCT00289978|466828148|FG002|Overall Study|Adverse Event|18|||
129691131|NCT00289978|466828146|FG000|Overall Study|Lack of Efficacy|13|||
129691132|NCT00289978|466828147|FG001|Overall Study|Lack of Efficacy|6|||
129691133|NCT00289978|466828148|FG002|Overall Study|Lack of Efficacy|25|||
129691134|NCT00289978|466828146|FG000|Overall Study|Abnormal laboratory value(s)|20|||
129691135|NCT00289978|466828147|FG001|Overall Study|Abnormal laboratory value(s)|9|||
129691136|NCT00289978|466828148|FG002|Overall Study|Abnormal laboratory value(s)|1|||
129691137|NCT00289978|466828146|FG000|Overall Study|Lost to Follow-up|3|||
129691138|NCT00289978|466828147|FG001|Overall Study|Lost to Follow-up|5|||
129691139|NCT00289978|466828148|FG002|Overall Study|Lost to Follow-up|7|||
129691140|NCT00289978|466828146|FG000|Overall Study|Protocol Violation|5|||
129570317|NCT05214560|466385016|FG000|Overall Study|Surgery not performed|3|||
129570318|NCT03639311|466385017|FG000|Maintenance Phase|Lost to Follow-up|1|||
129570319|NCT03639311|466385018|FG001|Maintenance Phase|Lost to Follow-up|0|||
129691141|NCT00289978|466828147|FG001|Overall Study|Protocol Violation|5|||
129781090|NCT02834793|467166039|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
129570320|NCT03639311|466385019|FG002|Maintenance Phase|Lost to Follow-up|0|||
129691142|NCT00289978|466828148|FG002|Overall Study|Protocol Violation|4|||
129691143|NCT00289978|466828146|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129691144|NCT00289978|466828147|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129781091|NCT02834793|467166040|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
129570321|NCT03639311|466385017|FG000|Maintenance Phase|Adverse Event|1|||
129570322|NCT03639311|466385018|FG001|Maintenance Phase|Adverse Event|0|||
129570323|NCT03639311|466385019|FG002|Maintenance Phase|Adverse Event|0|||
129570324|NCT03639311|466385017|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
129570325|NCT03639311|466385018|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
129570326|NCT03639311|466385019|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
129570327|NCT03639311|466385017|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
129570328|NCT03639311|466385018|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
129570329|NCT03639311|466385019|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
129570330|NCT03639311|466385017|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
129570331|NCT03639311|466385018|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
129570332|NCT03639311|466385019|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
129570333|NCT03639311|466385017|FG000|Maintenance Phase|Lack of Efficacy|1|||
129570334|NCT03639311|466385018|FG001|Maintenance Phase|Lack of Efficacy|0|||
129570335|NCT03639311|466385019|FG002|Maintenance Phase|Lack of Efficacy|0|||
129570336|NCT03018249|466385026|FG000|Overall Study|Withdrawal by Subject|2|||
129570337|NCT03018249|466385027|FG001|Overall Study|Withdrawal by Subject|2|||
129570338|NCT00304083|466385029|FG000|Overall Study|Withdrawal by Subject|4|||
129570339|NCT00304083|466385030|FG001|Overall Study|Withdrawal by Subject|2|||
129570340|NCT00304083|466385029|FG000|Overall Study|Physician Decision|8|||
129570341|NCT00304083|466385030|FG001|Overall Study|Physician Decision|3|||
129570342|NCT00304083|466385029|FG000|Overall Study|Disease Progression|5|||
129570343|NCT00304083|466385030|FG001|Overall Study|Disease Progression|1|||
129570344|NCT00304083|466385029|FG000|Overall Study|Other|5|||
129570345|NCT00304083|466385030|FG001|Overall Study|Other|2|||
129570346|NCT03966365|466385033|FG000|Overall Study|Protocol Violation|1|||
129570347|NCT03966365|466385034|FG001|Overall Study|Protocol Violation|0|||
129570348|NCT01044732|466385035|FG000|Overall Study|Lost to Follow-up|2|||
129570349|NCT01044732|466385036|FG001|Overall Study|Lost to Follow-up|1|||
129570350|NCT01044732|466385035|FG000|Overall Study|Physician Decision|5|||
129570351|NCT01044732|466385036|FG001|Overall Study|Physician Decision|3|||
129570352|NCT01044732|466385035|FG000|Overall Study|Protocol Violation|11|||
129570353|NCT01044732|466385036|FG001|Overall Study|Protocol Violation|12|||
129570354|NCT01044732|466385035|FG000|Overall Study|Withdrawal by Subject|0|||
129570355|NCT01044732|466385036|FG001|Overall Study|Withdrawal by Subject|1|||
129570356|NCT01044732|466385035|FG000|Overall Study|Inadequate bowel preparation|11|||
129570357|NCT01044732|466385036|FG001|Overall Study|Inadequate bowel preparation|17|||
129570358|NCT01044732|466385035|FG000|Overall Study|Inability to reach cecum|5|||
129570359|NCT01044732|466385036|FG001|Overall Study|Inability to reach cecum|2|||
129570360|NCT01044732|466385035|FG000|Overall Study|Technical error or malfunction|15|||
129570361|NCT01044732|466385036|FG001|Overall Study|Technical error or malfunction|14|||
129570362|NCT01569152|466385037|FG000|Phase IIa, Period 1|Early Escape|5|||
129570363|NCT01569152|466385038|FG001|Phase IIa, Period 1|Early Escape|22|||
129570364|NCT01569152|466385039|FG002|Phase IIa, Period 1|Early Escape|0|||
129570365|NCT01569152|466385037|FG000|Phase IIa, Period 1|Adverse Event|4|||
129570366|NCT01569152|466385038|FG001|Phase IIa, Period 1|Adverse Event|0|||
129570367|NCT01569152|466385039|FG002|Phase IIa, Period 1|Adverse Event|0|||
129570368|NCT01569152|466385037|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
129570369|NCT01569152|466385038|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
129570370|NCT01569152|466385039|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
129570371|NCT01569152|466385037|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
129570372|NCT01569152|466385038|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
129570373|NCT01569152|466385039|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
129570374|NCT01569152|466385037|FG000|Phase IIa, Period 1|Protocol Violation|0|||
129570375|NCT01569152|466385038|FG001|Phase IIa, Period 1|Protocol Violation|1|||
129570376|NCT01569152|466385039|FG002|Phase IIa, Period 1|Protocol Violation|0|||
129570377|NCT01569152|466385037|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
129570378|NCT01569152|466385038|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
129570379|NCT01569152|466385039|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
129570380|NCT01569152|466385037|FG000|Safety Extension, Period 3|Adverse Event|0|||
129570381|NCT01569152|466385038|FG001|Safety Extension, Period 3|Adverse Event|0|||
129570382|NCT01569152|466385039|FG002|Safety Extension, Period 3|Adverse Event|4|||
129570383|NCT01569152|466385037|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
129570384|NCT01569152|466385038|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
129570385|NCT01569152|466385039|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
129570386|NCT01569152|466385037|FG000|Safety Extension, Period 3|Physician Decision|0|||
129570387|NCT01569152|466385038|FG001|Safety Extension, Period 3|Physician Decision|0|||
129570388|NCT01569152|466385039|FG002|Safety Extension, Period 3|Physician Decision|2|||
129570389|NCT01569152|466385037|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
129570390|NCT01569152|466385038|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
129570391|NCT01569152|466385039|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
129570392|NCT00824265|466385044|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
129570393|NCT00824265|466385045|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
129570394|NCT00824265|466385044|FG000|Treatment Phase|Protocol Violation|1|||
129570395|NCT00824265|466385045|FG001|Treatment Phase|Protocol Violation|0|||
129570396|NCT00824265|466385044|FG000|Treatment Phase|Lost to Follow-up|1|||
129570397|NCT00824265|466385045|FG001|Treatment Phase|Lost to Follow-up|1|||
129570398|NCT00824265|466385044|FG000|Treatment Phase|Physician Decision|6|||
129570399|NCT00824265|466385045|FG001|Treatment Phase|Physician Decision|12|||
129570400|NCT00824265|466385044|FG000|Treatment Phase|Withdrawal by Subject|6|||
129570401|NCT00824265|466385045|FG001|Treatment Phase|Withdrawal by Subject|15|||
129570402|NCT00824265|466385044|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
129570403|NCT00824265|466385045|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
129570404|NCT00824265|466385044|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
129570405|NCT00824265|466385045|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
129570406|NCT02801877|466385046|FG000|Overall Study|Lost to Follow-up|1|||
129570407|NCT02801877|466385047|FG001|Overall Study|Lost to Follow-up|1|||
129570408|NCT02801877|466385048|FG002|Overall Study|Lost to Follow-up|2|||
129570409|NCT02801877|466385049|FG003|Overall Study|Lost to Follow-up|0|||
129570410|NCT02801877|466385046|FG000|Overall Study|Never Started Treatment|2|||
129570411|NCT02801877|466385047|FG001|Overall Study|Never Started Treatment|0|||
129570412|NCT02801877|466385048|FG002|Overall Study|Never Started Treatment|4|||
129570413|NCT02801877|466385049|FG003|Overall Study|Never Started Treatment|0|||
129570414|NCT00705536|466386855|FG000|Start Period 1|Withdrawal by Subject|0|||
129570415|NCT00705536|466386856|FG001|Start Period 1|Withdrawal by Subject|0|||
129570416|NCT00705536|466386857|FG002|Start Period 1|Withdrawal by Subject|0|||
129570417|NCT00705536|466386858|FG003|Start Period 1|Withdrawal by Subject|1|||
129884562|NCT02696902|467536454|FG001|Overall Study|Death|3|||
129570418|NCT04188106|466386859|FG000|Overall Study|Lost to Follow-up|5|||
129570419|NCT04188106|466386859|FG000|Overall Study|Non-Compliance|1|||
129570420|NCT02289963|466386860|FG000|Overall Study|Adverse Event|1|||
129570421|NCT02289963|466386861|FG001|Overall Study|Adverse Event|2|||
129570422|NCT02289963|466386860|FG000|Overall Study|Poor compliance to protocol|1|||
129570423|NCT02289963|466386861|FG001|Overall Study|Poor compliance to protocol|0|||
129570424|NCT02289963|466386860|FG000|Overall Study|Withdrawal by Subject|1|||
129570425|NCT02289963|466386861|FG001|Overall Study|Withdrawal by Subject|0|||
129570426|NCT02289963|466386860|FG000|Overall Study|Last injection missed|2|||
129570427|NCT02289963|466386861|FG001|Overall Study|Last injection missed|2|||
129570428|NCT02289963|466386860|FG000|Overall Study|End treatment visit outside visit window|0|||
129570429|NCT02289963|466386861|FG001|Overall Study|End treatment visit outside visit window|4|||
129570430|NCT02289963|466386860|FG000|Overall Study|Other than specified above|0|||
129570431|NCT02289963|466386861|FG001|Overall Study|Other than specified above|2|||
129570432|NCT00549718|466386864|FG000|Overall Study|Insufficient clinical response|20|||
129570433|NCT00549718|466386865|FG001|Overall Study|Insufficient clinical response|7|||
129570434|NCT00549718|466386866|FG002|Overall Study|Insufficient clinical response|18|||
129570435|NCT00549718|466386867|FG003|Overall Study|Insufficient clinical response|32|||
129570436|NCT00549718|466386864|FG000|Overall Study|Adverse Event|6|||
129570437|NCT00549718|466386865|FG001|Overall Study|Adverse Event|8|||
129570438|NCT00549718|466386866|FG002|Overall Study|Adverse Event|7|||
129570439|NCT00549718|466386867|FG003|Overall Study|Adverse Event|3|||
129570440|NCT00549718|466386864|FG000|Overall Study|Lost to Follow-up|4|||
129570441|NCT00549718|466386865|FG001|Overall Study|Lost to Follow-up|2|||
129570442|NCT00549718|466386866|FG002|Overall Study|Lost to Follow-up|0|||
129570443|NCT00549718|466386867|FG003|Overall Study|Lost to Follow-up|6|||
129570444|NCT00549718|466386864|FG000|Overall Study|Withdrawal by Subject|9|||
129570445|NCT00549718|466386865|FG001|Overall Study|Withdrawal by Subject|18|||
129570446|NCT00549718|466386866|FG002|Overall Study|Withdrawal by Subject|12|||
129570447|NCT00549718|466386867|FG003|Overall Study|Withdrawal by Subject|13|||
129570448|NCT00549718|466386864|FG000|Overall Study|Administrative|2|||
129570449|NCT00549718|466386865|FG001|Overall Study|Administrative|2|||
129570450|NCT00549718|466386866|FG002|Overall Study|Administrative|2|||
129570451|NCT00549718|466386867|FG003|Overall Study|Administrative|1|||
129570452|NCT02880761|466386871|FG000|Overall Study|Death|6|||
129570453|NCT02880761|466386872|FG001|Overall Study|Death|8|||
129570454|NCT02880761|466386871|FG000|Overall Study|Withdrawal by Subject|3|||
129570455|NCT02880761|466386872|FG001|Overall Study|Withdrawal by Subject|6|||
129570456|NCT02880761|466386871|FG000|Overall Study|Protocol Violation|4|||
129570457|NCT02880761|466386872|FG001|Overall Study|Protocol Violation|3|||
129570458|NCT02880761|466386871|FG000|Overall Study|Lost to Follow-up|3|||
129570459|NCT02880761|466386872|FG001|Overall Study|Lost to Follow-up|4|||
129570460|NCT03075761|466386873|FG000|Overall Study|Lost to Follow-up|1|||
129570461|NCT03075761|466386874|FG001|Overall Study|Lost to Follow-up|6|||
129570462|NCT02311361|466386879|FG000|Overall Study|Did not receive treatment|0|||
129570463|NCT02311361|466386880|FG001|Overall Study|Did not receive treatment|1|||
129570464|NCT02311361|466386881|FG002|Overall Study|Did not receive treatment|0|||
129570465|NCT02311361|466386882|FG003|Overall Study|Did not receive treatment|1|||
129570466|NCT02653664|466386883|FG000|Post-Treatment|Withdrawal by Subject|6|||
129570467|NCT02653664|466386884|FG001|Post-Treatment|Withdrawal by Subject|5|||
129570468|NCT02653664|466386885|FG002|Post-Treatment|Withdrawal by Subject|7|||
129570469|NCT02653664|466386883|FG000|Post-Treatment|Lost to Follow-up|8|||
129570470|NCT02653664|466386884|FG001|Post-Treatment|Lost to Follow-up|1|||
129570471|NCT02653664|466386885|FG002|Post-Treatment|Lost to Follow-up|7|||
129570472|NCT02653664|466386883|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
129570473|NCT02653664|466386884|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
129570474|NCT02653664|466386885|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
129570475|NCT02653664|466386883|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
129570476|NCT02653664|466386884|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
129570477|NCT02653664|466386885|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
129570478|NCT02653664|466386883|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129570479|NCT02653664|466386884|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
129570480|NCT02653664|466386885|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129570481|NCT02653664|466386883|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
129570482|NCT02653664|466386884|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
129570483|NCT02653664|466386885|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
129570484|NCT02653664|466386883|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
129570485|NCT02653664|466386884|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
129570486|NCT02653664|466386885|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
129570487|NCT02653664|466386883|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
129570488|NCT02653664|466386884|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
129570489|NCT02653664|466386885|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
129570490|NCT02653664|466386883|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129570491|NCT02653664|466386884|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
129570492|NCT02653664|466386885|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
129570493|NCT02653664|466386883|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
129570494|NCT02653664|466386884|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
129570495|NCT02653664|466386885|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
129570496|NCT00633594|466386886|FG000|Overall Study|Adverse Event|0|||
129570497|NCT00633594|466386887|FG001|Overall Study|Adverse Event|4|||
129570498|NCT00633594|466386888|FG002|Overall Study|Adverse Event|7|||
129570499|NCT00633594|466386886|FG000|Overall Study|Death|0|||
129570500|NCT00633594|466386887|FG001|Overall Study|Death|1|||
129570501|NCT00633594|466386888|FG002|Overall Study|Death|2|||
129570502|NCT00633594|466386886|FG000|Overall Study|Disease Progression|0|||
129570503|NCT00633594|466386887|FG001|Overall Study|Disease Progression|0|||
129570504|NCT00633594|466386888|FG002|Overall Study|Disease Progression|1|||
129570505|NCT00365300|466386892|FG000|Open-label Phase|Adverse Event|4|||
129570506|NCT00365300|466386893|FG001|Open-label Phase|Adverse Event|0|||
129570507|NCT00365300|466386892|FG000|Open-label Phase|Failed to Return|1|||
129570508|NCT00365300|466386893|FG001|Open-label Phase|Failed to Return|0|||
129570509|NCT00365300|466386892|FG000|Open-label Phase|Physician Decision|1|||
129570510|NCT00365300|466386893|FG001|Open-label Phase|Physician Decision|0|||
129570511|NCT00365300|466386892|FG000|Open-label Phase|Noncompliance|9|||
129570512|NCT00365300|466386893|FG001|Open-label Phase|Noncompliance|0|||
129570513|NCT00365300|466386892|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
129570514|NCT00365300|466386893|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
129570515|NCT00365300|466386892|FG000|Open-label Phase|Protocol Violation|1|||
129570516|NCT00365300|466386893|FG001|Open-label Phase|Protocol Violation|0|||
129570517|NCT00365300|466386892|FG000|Open-label Phase|Lack of Efficacy|1|||
129570518|NCT00365300|466386893|FG001|Open-label Phase|Lack of Efficacy|0|||
129570519|NCT00365300|466386892|FG000|Open-label Phase|Patient skipped open label phase|1|||
129570520|NCT00365300|466386893|FG001|Open-label Phase|Patient skipped open label phase|0|||
129570521|NCT00365300|466386892|FG000|Double-blind Phase|Failed to return|1|||
129570522|NCT00365300|466386893|FG001|Double-blind Phase|Failed to return|0|||
129570523|NCT00365300|466386892|FG000|Double-blind Phase|Noncompliance|1|||
129570524|NCT00365300|466386893|FG001|Double-blind Phase|Noncompliance|1|||
129570525|NCT00365300|466386892|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129570526|NCT00365300|466386893|FG001|Double-blind Phase|Withdrawal by Subject|1|||
129570527|NCT00365300|466386892|FG000|Double-blind Phase|Protocol Violation|3|||
129570528|NCT00365300|466386893|FG001|Double-blind Phase|Protocol Violation|1|||
129570529|NCT00365300|466386892|FG000|Double-blind Phase|Lack of Efficacy|6|||
129570530|NCT00365300|466386893|FG001|Double-blind Phase|Lack of Efficacy|6|||
129570531|NCT01179048|466386894|FG000|Overall Study|Withdrawn - does not allow contact|4|||
129570532|NCT01179048|466386895|FG001|Overall Study|Withdrawn - does not allow contact|8|||
129570533|NCT01179048|466386894|FG000|Overall Study|Lost to Follow-up|8|||
129570534|NCT01179048|466386895|FG001|Overall Study|Lost to Follow-up|9|||
129570535|NCT01179048|466386894|FG000|Overall Study|Alive|127|||
129570536|NCT01179048|466386895|FG001|Overall Study|Alive|142|||
129570537|NCT01520909|466386907|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
129570538|NCT01520909|466386908|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
129570539|NCT01520909|466386909|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
129570540|NCT01520909|466386907|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
129570541|NCT01520909|466386908|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
129570542|NCT01520909|466386909|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
129570543|NCT01520909|466386907|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
129570544|NCT01520909|466386908|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
129570545|NCT01520909|466386909|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
129570546|NCT01520909|466386907|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
129570547|NCT01520909|466386908|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
129570548|NCT01520909|466386909|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
129570549|NCT01038856|466386916|FG000|Overall Study|Adverse Event|2|||
129570550|NCT03136380|466386920|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129570551|NCT03136380|466386921|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
129570552|NCT03136380|466386922|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129570553|NCT03136380|466386923|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129691145|NCT00289978|466828148|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129691146|NCT00289978|466828146|FG000|Overall Study|Death|1|||
129691147|NCT00289978|466828147|FG001|Overall Study|Death|0|||
129691148|NCT00289978|466828148|FG002|Overall Study|Death|2|||
129691149|NCT00720083|466828151|FG000|Overall Study|Ineligible|1|||
129570554|NCT03136380|466386924|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
129570555|NCT00553280|466386930|FG000|Overall Study|Adverse Event|19|||
129570556|NCT00553280|466386930|FG000|Overall Study|Lack of Efficacy|3|||
129570557|NCT00553280|466386930|FG000|Overall Study|Withdrawal by Subject|3|||
129570558|NCT00553280|466386930|FG000|Overall Study|Physician Decision|1|||
129570559|NCT01544127|466386931|FG000|Overall Study|Lost to Follow-up|4|||
129570560|NCT01544127|466386932|FG001|Overall Study|Lost to Follow-up|2|||
129570561|NCT01544127|466386933|FG002|Overall Study|Lost to Follow-up|9|||
129570562|NCT01544127|466386931|FG000|Overall Study|Withdrawal by Subject|2|||
129691150|NCT00720083|466828152|FG001|Overall Study|Ineligible|2|||
129570563|NCT01544127|466386932|FG001|Overall Study|Withdrawal by Subject|2|||
129570564|NCT01544127|466386933|FG002|Overall Study|Withdrawal by Subject|1|||
129570565|NCT01544127|466386931|FG000|Overall Study|Discharged out of catchment area|1|||
129570566|NCT01544127|466386932|FG001|Overall Study|Discharged out of catchment area|1|||
129570567|NCT01544127|466386933|FG002|Overall Study|Discharged out of catchment area|1|||
129570568|NCT01544127|466386931|FG000|Overall Study|Death|1|||
129570569|NCT01544127|466386932|FG001|Overall Study|Death|0|||
129570570|NCT01544127|466386933|FG002|Overall Study|Death|0|||
129570571|NCT01544127|466386931|FG000|Overall Study|Jail or Prison|1|||
129570572|NCT01544127|466386932|FG001|Overall Study|Jail or Prison|1|||
129570573|NCT01544127|466386933|FG002|Overall Study|Jail or Prison|2|||
129570574|NCT01544127|466386931|FG000|Overall Study|Became Psychotic|1|||
129570575|NCT01544127|466386932|FG001|Overall Study|Became Psychotic|0|||
129570576|NCT01544127|466386933|FG002|Overall Study|Became Psychotic|0|||
129570577|NCT01544127|466386931|FG000|Overall Study|Researcher withdrew|1|||
129570578|NCT01544127|466386932|FG001|Overall Study|Researcher withdrew|0|||
129570579|NCT01544127|466386933|FG002|Overall Study|Researcher withdrew|0|||
129570580|NCT01544127|466386931|FG000|Overall Study|Went active duty|0|||
129570581|NCT01544127|466386932|FG001|Overall Study|Went active duty|0|||
129570582|NCT01544127|466386933|FG002|Overall Study|Went active duty|1|||
129570583|NCT00533273|466386934|FG000|Double-blind|Withdrew consent|0|||
129570584|NCT00533273|466386935|FG001|Double-blind|Withdrew consent|2|||
129570585|NCT00533273|466386934|FG000|Open-label|Withdrawal by Subject|6|||
129570586|NCT00533273|466386935|FG001|Open-label|Withdrawal by Subject|0|||
129570587|NCT02794974|466386936|FG000|Overall Study|Physician Decision|0|||
129570588|NCT02794974|466386937|FG001|Overall Study|Physician Decision|1|||
129570589|NCT01873586|466386941|FG000|Overall Study|Lost to Follow-up|3|||
129570590|NCT02202850|466386942|FG000|Overall Study|Other|2|||
129691151|NCT01967277|466828154|FG000|Overall Study|Lost to Follow-up|1|||
129691152|NCT01967277|466828155|FG001|Overall Study|Lost to Follow-up|2|||
129691153|NCT01967277|466828154|FG000|Overall Study|Unrelated illness|0|||
129691154|NCT01967277|466828155|FG001|Overall Study|Unrelated illness|1|||
129691155|NCT00103506|466828158|FG000|Overall Study|Study closed by sponsor|34|||
129691156|NCT00103506|466828159|FG001|Overall Study|Study closed by sponsor|37|||
129691157|NCT00103506|466828158|FG000|Overall Study|Death|257|||
129691158|NCT00103506|466828159|FG001|Overall Study|Death|253|||
129570591|NCT02202850|466386943|FG001|Overall Study|Other|2|||
129570592|NCT02202850|466386942|FG000|Overall Study|Enbrel treatment discontinued|15|||
129570593|NCT02202850|466386943|FG001|Overall Study|Enbrel treatment discontinued|3|||
129570594|NCT02202850|466386942|FG000|Overall Study|Lost to Follow-up|7|||
129570595|NCT02202850|466386943|FG001|Overall Study|Lost to Follow-up|1|||
129570596|NCT00312663|466386944|FG000|Immunization Phase|Adverse Event|0|||
129570597|NCT00312663|466386945|FG001|Immunization Phase|Adverse Event|1|||
129691159|NCT00103506|466828158|FG000|Overall Study|Lost to Follow-up|13|||
129570598|NCT00312663|466386946|FG002|Immunization Phase|Adverse Event|0|||
129570599|NCT00301366|466386947|FG000|Overall Study|Adverse Event|1|||
129570600|NCT04213326|466386948|FG000|Overall Study|Consent withdrawn|51|||
129570601|NCT04213326|466386949|FG001|Overall Study|Consent withdrawn|241|||
129570602|NCT04213326|466386948|FG000|Overall Study|Lost to Follow-up|50|||
129570603|NCT04213326|466386949|FG001|Overall Study|Lost to Follow-up|902|||
129570604|NCT04213326|466386948|FG000|Overall Study|Protocol Violation|3|||
129570605|NCT04213326|466386949|FG001|Overall Study|Protocol Violation|25|||
129570606|NCT04213326|466386948|FG000|Overall Study|Participant eligibility changed|106|||
129570607|NCT04213326|466386949|FG001|Overall Study|Participant eligibility changed|19|||
129570608|NCT04213326|466386948|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
129570609|NCT04213326|466386949|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
129570610|NCT04213326|466386948|FG000|Overall Study|Incomplete study visit|0|||
129570611|NCT04213326|466386949|FG001|Overall Study|Incomplete study visit|367|||
129570612|NCT02549092|466386952|FG000|Treatment Period|Adverse Event|2|||
129781092|NCT02834793|467166041|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
129781093|NCT02834793|467166038|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
129781094|NCT02834793|467166039|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
129781095|NCT02834793|467166040|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
129781096|NCT02834793|467166041|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
129781097|NCT02834793|467166038|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
129781098|NCT02834793|467166039|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
129781099|NCT02834793|467166040|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
129781100|NCT02834793|467166041|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
129781101|NCT02834793|467166038|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
129781102|NCT02834793|467166039|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
129781103|NCT02834793|467166040|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
129781104|NCT02834793|467166041|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
129781105|NCT02834793|467166038|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
129570613|NCT02549092|466386953|FG001|Treatment Period|Adverse Event|2|||
129570614|NCT02549092|466386952|FG000|Treatment Period|Withdrawal by Subject|1|||
129570615|NCT02549092|466386953|FG001|Treatment Period|Withdrawal by Subject|3|||
129570616|NCT02549092|466386952|FG000|Treatment Period|Lack of Efficacy|0|||
129570617|NCT02549092|466386953|FG001|Treatment Period|Lack of Efficacy|2|||
129570618|NCT02549092|466386952|FG000|Extension/Transition Period|Adverse Event|1|||
129570619|NCT02549092|466386953|FG001|Extension/Transition Period|Adverse Event|1|||
129570620|NCT02549092|466386952|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
129570621|NCT02549092|466386953|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
129570622|NCT02549092|466386952|FG000|Extension/Transition Period|Other, Not Specified|4|||
129570623|NCT02549092|466386953|FG001|Extension/Transition Period|Other, Not Specified|2|||
129570624|NCT02511782|466386954|FG000|Overall Study|Withdrawal by Subject|1|||
129570625|NCT02511782|466386955|FG001|Overall Study|Withdrawal by Subject|0|||
129570626|NCT02511782|466386956|FG002|Overall Study|Withdrawal by Subject|0|||
129570627|NCT00450190|466386957|FG000|Overall Study|Withdrawal by Subject|2|||
129570628|NCT01536574|466386958|FG000|Overall Study|Adverse Event|4|||
129570629|NCT01536574|466386959|FG001|Overall Study|Adverse Event|5|||
129570630|NCT01536574|466386958|FG000|Overall Study|Withdrawal by Subject|1|||
129570631|NCT01536574|466386959|FG001|Overall Study|Withdrawal by Subject|2|||
129570632|NCT01536574|466386958|FG000|Overall Study|Lack of Efficacy|1|||
129570633|NCT01536574|466386959|FG001|Overall Study|Lack of Efficacy|0|||
129570634|NCT02193165|466386962|FG000|4 Week Product Use|Lost to Follow-up|1|||
129570635|NCT02193165|466386963|FG001|4 Week Product Use|Lost to Follow-up|1|||
129570636|NCT02193165|466386964|FG002|4 Week Product Use|Lost to Follow-up|1|||
129570637|NCT02193165|466386962|FG000|6 Week Product Use|Lost to Follow-up|0|||
129570638|NCT02193165|466386963|FG001|6 Week Product Use|Lost to Follow-up|1|||
129570639|NCT02193165|466386964|FG002|6 Week Product Use|Lost to Follow-up|0|||
129570640|NCT01498120|466386965|FG000|Overall Study|Lost to Follow-up|1|||
129570641|NCT01498120|466386965|FG000|Overall Study|Withdrawal by Subject|5|||
129570642|NCT01498120|466386965|FG000|Overall Study|AE, non-serious non-fatal|3|||
129570643|NCT01498120|466386965|FG000|Overall Study|Other|4|||
129691160|NCT00103506|466828159|FG001|Overall Study|Lost to Follow-up|13|||
129691161|NCT00103506|466828158|FG000|Overall Study|Withdrawal by Subject|18|||
129691162|NCT00103506|466828159|FG001|Overall Study|Withdrawal by Subject|21|||
129691163|NCT00585585|466828160|FG000|Overall Study|Adverse Event|1|||
129691164|NCT00585169|466828161|FG000|Overall Study|Withdrawal by Subject|1|||
129691165|NCT00710970|466828162|FG000|Overall Study|Never took drug|3|||
129691166|NCT01028560|466828163|FG000|Overall Study|Lack of Efficacy|3|||
129691167|NCT01028560|466828164|FG001|Overall Study|Lack of Efficacy|6|||
129691168|NCT01028560|466828163|FG000|Overall Study|Withdrawal by Subject|7|||
129691169|NCT01028560|466828164|FG001|Overall Study|Withdrawal by Subject|12|||
129691170|NCT03055221|466828165|FG000|Overall Study|Adverse Event|2|||
129570644|NCT01214850|466386968|FG000|Overall Study|Withdrawal by Subject|38|||
129691171|NCT03055221|466828165|FG000|Overall Study|Withdrawal by Subject|4|||
129781106|NCT02834793|467166039|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
129781107|NCT02834793|467166040|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
129570645|NCT01214850|466386969|FG001|Overall Study|Withdrawal by Subject|31|||
129570646|NCT01214850|466386970|FG002|Overall Study|Withdrawal by Subject|28|||
129570647|NCT01214850|466386968|FG000|Overall Study|Lost to Follow-up|124|||
129570648|NCT01214850|466386969|FG001|Overall Study|Lost to Follow-up|98|||
129570649|NCT01214850|466386970|FG002|Overall Study|Lost to Follow-up|123|||
129570650|NCT01214850|466386968|FG000|Overall Study|Protocol Violation|5|||
129570651|NCT01214850|466386969|FG001|Overall Study|Protocol Violation|5|||
129570652|NCT01214850|466386970|FG002|Overall Study|Protocol Violation|6|||
129570653|NCT01214850|466386968|FG000|Overall Study|Adverse event or death|11|||
129570654|NCT01214850|466386969|FG001|Overall Study|Adverse event or death|8|||
129570655|NCT01214850|466386970|FG002|Overall Study|Adverse event or death|3|||
129570656|NCT01214850|466386968|FG000|Overall Study|Inappropriate enrollment|2|||
129570657|NCT01214850|466386969|FG001|Overall Study|Inappropriate enrollment|1|||
129570658|NCT01214850|466386970|FG002|Overall Study|Inappropriate enrollment|0|||
129570659|NCT01214850|466386968|FG000|Overall Study|Administrative reason|1|||
129570660|NCT01214850|466386969|FG001|Overall Study|Administrative reason|0|||
129691172|NCT03055221|466828165|FG000|Overall Study|Death|6|||
129691173|NCT03055221|466828165|FG000|Overall Study|Physician Decision|1|||
129691174|NCT03055221|466828165|FG000|Overall Study|Study terminated by Sponsor|3|||
129691175|NCT03055221|466828165|FG000|Overall Study|Lost to Follow-up|4|||
129691176|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
129691177|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
129691178|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
129691179|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
129691180|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
129691181|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
129691182|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
129691183|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
129691184|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
129691185|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
129691186|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
129691187|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
129691188|NCT01243424|466828166|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
129691189|NCT01243424|466828167|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
129691190|NCT01243424|466828166|FG000|Discontinuation From Treatment|Not treated|5|||
129691191|NCT01243424|466828167|FG001|Discontinuation From Treatment|Not treated|4|||
129691192|NCT01243424|466828166|FG000|Discontinuation From Treatment|Adverse Event|457|||
129691193|NCT01243424|466828167|FG001|Discontinuation From Treatment|Adverse Event|523|||
129691194|NCT01243424|466828166|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
129691195|NCT01243424|466828167|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
129691196|NCT01243424|466828166|FG000|Discontinuation From Treatment|Protocol Violation|46|||
129691197|NCT01243424|466828167|FG001|Discontinuation From Treatment|Protocol Violation|47|||
129691198|NCT01243424|466828166|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
129691199|NCT01243424|466828167|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
129691200|NCT01243424|466828166|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
129691201|NCT01243424|466828167|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
129691202|NCT01243424|466828166|FG000|Discontinuation From Treatment|Other than listed above|230|||
129691203|NCT01243424|466828167|FG001|Discontinuation From Treatment|Other than listed above|211|||
129691204|NCT00397930|466828172|FG000|Overall Study|Personal reasons|14|||
129691205|NCT00397930|466828173|FG001|Overall Study|Personal reasons|8|||
129691206|NCT00397930|466828172|FG000|Overall Study|Other medical|9|||
129691207|NCT00397930|466828173|FG001|Overall Study|Other medical|4|||
129691208|NCT00397930|466828172|FG000|Overall Study|Unknown reasons|9|||
129691209|NCT00397930|466828173|FG001|Overall Study|Unknown reasons|14|||
129691210|NCT00397930|466828172|FG000|Overall Study|Noncompliant|3|||
129691211|NCT00397930|466828173|FG001|Overall Study|Noncompliant|2|||
129691212|NCT00397930|466828172|FG000|Overall Study|Too time-consuming|2|||
129691213|NCT00397930|466828173|FG001|Overall Study|Too time-consuming|9|||
129691214|NCT00397930|466828172|FG000|Overall Study|Started own yoga program|1|||
129691215|NCT00397930|466828173|FG001|Overall Study|Started own yoga program|1|||
129691216|NCT00397930|466828172|FG000|Overall Study|Did not want to be in control group|0|||
129691217|NCT00397930|466828173|FG001|Overall Study|Did not want to be in control group|1|||
129691218|NCT00397930|466828172|FG000|Overall Study|Withdrawal by Subject|0|||
129691219|NCT00397930|466828173|FG001|Overall Study|Withdrawal by Subject|8|||
129691220|NCT00397930|466828172|FG000|Overall Study|Missing data|0|||
129691221|NCT00397930|466828173|FG001|Overall Study|Missing data|4|||
129570661|NCT01214850|466386970|FG002|Overall Study|Administrative reason|0|||
129570662|NCT01214850|466386968|FG000|Overall Study|Unable to classify|2|||
129781108|NCT02834793|467166041|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
129781109|NCT02834793|467166038|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
129781110|NCT02834793|467166039|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
129781111|NCT02834793|467166040|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
129570663|NCT01214850|466386969|FG001|Overall Study|Unable to classify|1|||
129570664|NCT01214850|466386970|FG002|Overall Study|Unable to classify|1|||
129570665|NCT00193609|466386971|FG000|Overall Study|Lack of Efficacy|2|||
129570666|NCT00193609|466386971|FG000|Overall Study|Adverse Event|2|||
129570667|NCT00854308|466386974|FG000|Overall Study|Disease progression|42|||
129570668|NCT00854308|466386975|FG001|Overall Study|Disease progression|50|||
129570669|NCT00854308|466386974|FG000|Overall Study|Adverse Event|8|||
129570670|NCT00854308|466386975|FG001|Overall Study|Adverse Event|3|||
129570671|NCT00854308|466386974|FG000|Overall Study|Death|2|||
129781112|NCT02834793|467166041|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
129781113|NCT02834793|467166038|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
129570672|NCT00854308|466386975|FG001|Overall Study|Death|5|||
129570673|NCT00854308|466386974|FG000|Overall Study|Physician Decision|6|||
129570674|NCT00854308|466386975|FG001|Overall Study|Physician Decision|6|||
129570675|NCT00854308|466386974|FG000|Overall Study|Withdrawal by Subject|4|||
129570676|NCT00854308|466386975|FG001|Overall Study|Withdrawal by Subject|2|||
129570677|NCT00854308|466386974|FG000|Overall Study|Sponsor's decision to terminate study|0|||
129570678|NCT00854308|466386975|FG001|Overall Study|Sponsor's decision to terminate study|1|||
129570679|NCT03048500|466386976|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
129691222|NCT01960842|466828174|FG000|Overall Study|Adverse Event|1|||
129691223|NCT01960842|466828174|FG000|Overall Study|Withdrawal by Subject|2|||
129691224|NCT02391584|466828175|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
129691225|NCT02391584|466828176|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
129691226|NCT02391584|466828175|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
129691227|NCT02391584|466828176|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
129691228|NCT02391584|466828175|FG000|3 Month|Lost to Follow-up|1|||
129691229|NCT02391584|466828176|FG001|3 Month|Lost to Follow-up|0|||
129691230|NCT02391584|466828175|FG000|6 Month|Withdrawal by Subject|1|||
129691231|NCT02391584|466828176|FG001|6 Month|Withdrawal by Subject|0|||
129691232|NCT02391584|466828175|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
129691233|NCT02391584|466828176|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
129691234|NCT00710554|466828184|FG000|Overall Study|Adverse Event|24|||
129691235|NCT00710554|466828185|FG001|Overall Study|Adverse Event|7|||
129691236|NCT00710554|466828184|FG000|Overall Study|Withdrawal by Subject|7|||
129691237|NCT00710554|466828185|FG001|Overall Study|Withdrawal by Subject|3|||
129691238|NCT00710554|466828184|FG000|Overall Study|Lost to Follow-up|7|||
129691239|NCT00710554|466828185|FG001|Overall Study|Lost to Follow-up|1|||
129691240|NCT00710554|466828184|FG000|Overall Study|Lack of Efficacy|11|||
129691241|NCT00710554|466828185|FG001|Overall Study|Lack of Efficacy|12|||
129691242|NCT00710554|466828184|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
129691243|NCT00710554|466828185|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
129691244|NCT01301001|466828190|FG000|First Intervention|Lost to Follow-up|4|||
129691245|NCT01301001|466828191|FG001|First Intervention|Lost to Follow-up|4|||
129691246|NCT01301001|466828190|FG000|First Intervention|Withdrawal by Subject|1|||
129691247|NCT01301001|466828191|FG001|First Intervention|Withdrawal by Subject|4|||
129691248|NCT01301001|466828190|FG000|First Intervention|Adverse Event|5|||
129691249|NCT01301001|466828191|FG001|First Intervention|Adverse Event|0|||
129691250|NCT01301001|466828190|FG000|First Intervention|Protocol Violation|0|||
129691251|NCT01301001|466828191|FG001|First Intervention|Protocol Violation|1|||
129691252|NCT01301001|466828190|FG000|Second Intervention|Adverse Event|2|||
129691253|NCT01301001|466828191|FG001|Second Intervention|Adverse Event|0|||
129691254|NCT01301001|466828190|FG000|Second Intervention|Withdrawal by Subject|2|||
129691255|NCT01301001|466828191|FG001|Second Intervention|Withdrawal by Subject|0|||
129691256|NCT01433978|466828194|FG000|Core Study|Adverse Event, Non-Fatal|0|||
129691257|NCT01433978|466828195|FG001|Core Study|Adverse Event, Non-Fatal|1|||
129691258|NCT01433978|466828196|FG002|Core Study|Adverse Event, Non-Fatal|0|||
129691259|NCT01433978|466828194|FG000|Core Study|Lack of Efficacy|5|||
129781114|NCT02834793|467166039|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
129570680|NCT03048500|466386976|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
129570681|NCT03048500|466386976|FG000|Reached 1st Response/Continued Treatment|Death|1|||
129570682|NCT03048500|466386976|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
129570683|NCT03048500|466386976|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
129570684|NCT03048500|466386976|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
129691260|NCT01433978|466828195|FG001|Core Study|Lack of Efficacy|1|||
129691261|NCT01433978|466828196|FG002|Core Study|Lack of Efficacy|0|||
129691262|NCT01433978|466828194|FG000|Core Study|Study Terminated by Sponsor|6|||
129691263|NCT01433978|466828195|FG001|Core Study|Study Terminated by Sponsor|9|||
129570685|NCT03048500|466386976|FG000|Follow up for 3 Years|Death|12|||
129691264|NCT01433978|466828196|FG002|Core Study|Study Terminated by Sponsor|0|||
129570686|NCT00610363|466386977|FG000|Overall Study|Non-compliance with protocol|0|||
129570687|NCT00610363|466386978|FG001|Overall Study|Non-compliance with protocol|1|||
129691265|NCT01433978|466828194|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
129691266|NCT01433978|466828195|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
129691267|NCT01433978|466828196|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
129691268|NCT01433978|466828194|FG000|Extension Phase|Lack of Efficacy|0|||
129691269|NCT01433978|466828195|FG001|Extension Phase|Lack of Efficacy|0|||
129691270|NCT01433978|466828196|FG002|Extension Phase|Lack of Efficacy|1|||
129691271|NCT01433978|466828194|FG000|Extension Phase|Study Terminated by Sponsor|0|||
129691272|NCT01433978|466828195|FG001|Extension Phase|Study Terminated by Sponsor|0|||
129691273|NCT01433978|466828196|FG002|Extension Phase|Study Terminated by Sponsor|4|||
129691274|NCT01441414|466828197|FG000|Overall Study|Participant died|9|||
129691275|NCT01441414|466828197|FG000|Overall Study|Other reasons|3|||
129691276|NCT01441414|466828197|FG000|Overall Study|Study terminated by sponsor|2|||
129691277|NCT01441414|466828197|FG000|Overall Study|Subject refused further follow-up|1|||
129691278|NCT01773889|466828198|FG000|Overall Study|lack of funding|2|||
129691279|NCT02565186|466828199|FG000|Overall Study|Adverse Event|113|||
129691280|NCT02565186|466828200|FG001|Overall Study|Adverse Event|148|||
129691281|NCT02565186|466828199|FG000|Overall Study|Lost to Follow-up|102|||
129691282|NCT02565186|466828200|FG001|Overall Study|Lost to Follow-up|93|||
129691283|NCT02565186|466828199|FG000|Overall Study|Non-Compliance|57|||
129691284|NCT02565186|466828200|FG001|Overall Study|Non-Compliance|55|||
129691285|NCT02565186|466828199|FG000|Overall Study|Withdrawal by Subject|229|||
129691286|NCT02565186|466828200|FG001|Overall Study|Withdrawal by Subject|214|||
129691287|NCT02565186|466828199|FG000|Overall Study|Physician Decision|18|||
129691288|NCT02565186|466828200|FG001|Overall Study|Physician Decision|16|||
129691289|NCT02565186|466828199|FG000|Overall Study|Sponsor Request|5|||
129691290|NCT02565186|466828200|FG001|Overall Study|Sponsor Request|9|||
129691291|NCT02565186|466828199|FG000|Overall Study|Missing|1|||
129691292|NCT02565186|466828200|FG001|Overall Study|Missing|0|||
129691293|NCT02565186|466828199|FG000|Overall Study|Did Not Receive Study Drug|55|||
129691294|NCT02565186|466828200|FG001|Overall Study|Did Not Receive Study Drug|86|||
129691295|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
129691296|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
129691297|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
129691298|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
129691299|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
129691300|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
129691301|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
129691302|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
129691303|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
129691304|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
129691305|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
129691306|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
129691307|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
129691308|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
129691309|NCT00976391|466828201|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
129691310|NCT00976391|466828202|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
129691311|NCT00976391|466828201|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
129691312|NCT00976391|466828202|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
129691313|NCT00976391|466828201|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
129691314|NCT00976391|466828202|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
129691315|NCT00976391|466828201|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
129691316|NCT00976391|466828202|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
129691317|NCT00976391|466828201|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
129691318|NCT00976391|466828202|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
129691319|NCT00976391|466828201|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
129691320|NCT00976391|466828202|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
129691321|NCT00976391|466828201|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
129691322|NCT00976391|466828202|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
129691323|NCT05156125|466828203|FG000|Overall Study|Lack of Efficacy|1|||
129691324|NCT05156125|466828204|FG001|Overall Study|Lack of Efficacy|1|||
129691325|NCT05156125|466828205|FG002|Overall Study|Lack of Efficacy|1|||
129691326|NCT05156125|466828203|FG000|Overall Study|Physician Decision|0|||
129691327|NCT05156125|466828204|FG001|Overall Study|Physician Decision|0|||
129691328|NCT05156125|466828205|FG002|Overall Study|Physician Decision|1|||
129691329|NCT05156125|466828203|FG000|Overall Study|Non-compliance|0|||
129691330|NCT05156125|466828204|FG001|Overall Study|Non-compliance|1|||
129691331|NCT05156125|466828205|FG002|Overall Study|Non-compliance|1|||
129691332|NCT05156125|466828203|FG000|Overall Study|Withdrawal by Subject|0|||
129691333|NCT05156125|466828204|FG001|Overall Study|Withdrawal by Subject|0|||
129691334|NCT05156125|466828205|FG002|Overall Study|Withdrawal by Subject|1|||
129691335|NCT05156125|466828203|FG000|Overall Study|Adverse Event|2|||
129691336|NCT05156125|466828204|FG001|Overall Study|Adverse Event|1|||
129691337|NCT05156125|466828205|FG002|Overall Study|Adverse Event|0|||
129781115|NCT02834793|467166040|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
129781116|NCT02834793|467166041|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
129781117|NCT02834793|467166038|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
129781118|NCT02834793|467166039|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
129781119|NCT02834793|467166040|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
129781120|NCT02834793|467166041|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
129781121|NCT02834793|467166038|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
129781122|NCT02834793|467166039|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
129781123|NCT02834793|467166040|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
129781124|NCT02834793|467166041|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
129781125|NCT02834793|467166038|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
129781126|NCT02834793|467166039|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
129781127|NCT02834793|467166040|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
129781128|NCT02834793|467166041|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
129781129|NCT02834793|467166038|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
129781130|NCT02834793|467166039|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
129781131|NCT02834793|467166040|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
129570688|NCT00610363|466386977|FG000|Overall Study|Adverse Event|3|||
129570689|NCT00610363|466386978|FG001|Overall Study|Adverse Event|1|||
129570690|NCT00610363|466386977|FG000|Overall Study|Lack of Efficacy|2|||
129570691|NCT00610363|466386978|FG001|Overall Study|Lack of Efficacy|0|||
129570692|NCT00610363|466386977|FG000|Overall Study|Lost to Follow-up|4|||
129570693|NCT00610363|466386978|FG001|Overall Study|Lost to Follow-up|0|||
129570694|NCT00610363|466386977|FG000|Overall Study|Withdrawal by Subject|1|||
129570695|NCT00610363|466386978|FG001|Overall Study|Withdrawal by Subject|0|||
129570696|NCT00610363|466386977|FG000|Overall Study|Other than specified above|1|||
129570697|NCT00610363|466386978|FG001|Overall Study|Other than specified above|1|||
129781132|NCT02834793|467166041|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
129781133|NCT02834793|467166038|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
129781134|NCT02834793|467166039|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
129781135|NCT02834793|467166040|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
129781136|NCT02834793|467166041|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
129781137|NCT02834793|467166038|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
129781138|NCT02834793|467166039|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
129781139|NCT02834793|467166040|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
129781140|NCT02834793|467166041|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
129781141|NCT01049009|467166042|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
129781142|NCT01049009|467166043|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
129781143|NCT01049009|467166042|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129781144|NCT01049009|467166043|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129781145|NCT01049009|467166042|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
129781146|NCT01049009|467166043|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
129781147|NCT01049009|467166042|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
129781148|NCT01049009|467166043|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
129781149|NCT02423902|467166044|FG000|Overall Study|Disease progression|1|||
129570698|NCT02008565|466386992|FG000|Overall Study|Protocol Violation|1|||
129570699|NCT02008565|466386993|FG001|Overall Study|Protocol Violation|1|||
129781150|NCT02423902|467166045|FG001|Overall Study|Disease progression|4|||
129781151|NCT02136069|467166046|FG000|Overall Study|UC flare-up|1|||
129781152|NCT02136069|467166047|FG001|Overall Study|UC flare-up|0|||
129781153|NCT02136069|467166046|FG000|Overall Study|Adverse Event|6|||
129781154|NCT02136069|467166047|FG001|Overall Study|Adverse Event|8|||
129781155|NCT02136069|467166046|FG000|Overall Study|Death|0|||
129781156|NCT02136069|467166047|FG001|Overall Study|Death|1|||
129781157|NCT02136069|467166046|FG000|Overall Study|Lack of Efficacy|10|||
129781158|NCT02136069|467166047|FG001|Overall Study|Lack of Efficacy|4|||
129781159|NCT02136069|467166046|FG000|Overall Study|Lost to Follow-up|1|||
129781160|NCT02136069|467166047|FG001|Overall Study|Lost to Follow-up|0|||
129781161|NCT02136069|467166046|FG000|Overall Study|Non-Compliance|1|||
129781162|NCT02136069|467166047|FG001|Overall Study|Non-Compliance|0|||
129781163|NCT02136069|467166046|FG000|Overall Study|Physician Decision|5|||
129781164|NCT02136069|467166047|FG001|Overall Study|Physician Decision|4|||
129781165|NCT02136069|467166046|FG000|Overall Study|Withdrawal by Subject|10|||
129781166|NCT02136069|467166047|FG001|Overall Study|Withdrawal by Subject|11|||
129781167|NCT04538144|467166048|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
129781168|NCT04538144|467166049|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
129781169|NCT04538144|467166050|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
129781170|NCT04538144|467166051|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
129781171|NCT01092546|467166052|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
129781172|NCT00622440|467166053|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
129781173|NCT00622440|467166054|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
129781174|NCT00622440|467166053|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
129781175|NCT00622440|467166054|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
129781176|NCT00622440|467166053|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
129781177|NCT00622440|467166054|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
129570700|NCT02008565|466386994|FG002|Overall Study|Protocol Violation|2|||
129570701|NCT02008565|466386995|FG003|Overall Study|Protocol Violation|0|||
129570702|NCT02193178|466386996|FG000|Overall Study|Lost to Follow-up|1|||
129570703|NCT02193178|466386996|FG000|Overall Study|Dry eyes|1|||
129570704|NCT03435081|466386997|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
129570705|NCT03435081|466386998|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
129570706|NCT03435081|466386999|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
129570707|NCT03435081|466386997|FG000|Week 0 to Week 16|Adverse Event|2|||
129570708|NCT03435081|466386998|FG001|Week 0 to Week 16|Adverse Event|2|||
129570709|NCT03435081|466386999|FG002|Week 0 to Week 16|Adverse Event|2|||
129570710|NCT03435081|466386997|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
129781178|NCT00622440|467166053|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
129781179|NCT00622440|467166054|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
129781180|NCT01667419|467166059|FG000|Overall Study|Reason Not Specified|1|||
129781181|NCT01667419|467166060|FG001|Overall Study|Reason Not Specified|0|||
129781182|NCT01667419|467166061|FG002|Overall Study|Reason Not Specified|0|||
129781183|NCT01667419|467166062|FG003|Overall Study|Reason Not Specified|0|||
129781184|NCT01667419|467166059|FG000|Overall Study|Withdrawal by Subject|16|||
129781185|NCT01667419|467166060|FG001|Overall Study|Withdrawal by Subject|8|||
129781186|NCT01667419|467166061|FG002|Overall Study|Withdrawal by Subject|9|||
129781187|NCT01667419|467166062|FG003|Overall Study|Withdrawal by Subject|8|||
129781188|NCT01667419|467166059|FG000|Overall Study|Non-compliance|0|||
129781189|NCT01667419|467166060|FG001|Overall Study|Non-compliance|0|||
129781190|NCT01667419|467166061|FG002|Overall Study|Non-compliance|0|||
129781191|NCT01667419|467166062|FG003|Overall Study|Non-compliance|1|||
129781192|NCT01667419|467166059|FG000|Overall Study|Protocol Violation|1|||
129781193|NCT01667419|467166060|FG001|Overall Study|Protocol Violation|0|||
129781194|NCT01667419|467166061|FG002|Overall Study|Protocol Violation|0|||
129781195|NCT01667419|467166062|FG003|Overall Study|Protocol Violation|0|||
129781196|NCT01667419|467166059|FG000|Overall Study|Lost to Follow-up|7|||
129781197|NCT01667419|467166060|FG001|Overall Study|Lost to Follow-up|6|||
129781198|NCT01667419|467166061|FG002|Overall Study|Lost to Follow-up|2|||
129781199|NCT01667419|467166062|FG003|Overall Study|Lost to Follow-up|4|||
129781200|NCT01667419|467166059|FG000|Overall Study|Death|18|||
129781201|NCT01667419|467166060|FG001|Overall Study|Death|33|||
129781202|NCT01667419|467166061|FG002|Overall Study|Death|25|||
129781203|NCT01667419|467166062|FG003|Overall Study|Death|26|||
129781204|NCT04364984|467166063|FG000|Overall Study|Death|2|||
129781205|NCT04364984|467166064|FG001|Overall Study|Death|2|||
129781206|NCT04364984|467166065|FG002|Overall Study|Death|0|||
129781207|NCT01941186|467166066|FG000|Follow-up|Lost to Follow-up|1|||
129781208|NCT01941186|467166067|FG001|Follow-up|Lost to Follow-up|0|||
129781209|NCT02722304|467166068|FG000|Overall Study|Study Terminated by Sponsor|1|||
129781210|NCT02722304|467166069|FG001|Overall Study|Study Terminated by Sponsor|0|||
129781211|NCT02722304|467166070|FG002|Overall Study|Study Terminated by Sponsor|2|||
129781212|NCT02722304|467166071|FG003|Overall Study|Study Terminated by Sponsor|1|||
129781213|NCT02722304|467166072|FG004|Overall Study|Study Terminated by Sponsor|1|||
129781214|NCT02722304|467166068|FG000|Overall Study|Other|0|||
129781215|NCT02722304|467166069|FG001|Overall Study|Other|0|||
129781216|NCT02722304|467166070|FG002|Overall Study|Other|0|||
129781217|NCT02722304|467166071|FG003|Overall Study|Other|1|||
129781218|NCT02722304|467166072|FG004|Overall Study|Other|1|||
129781219|NCT01068600|467166073|FG000|Overall Study|Withdrawal by Subject|5|||
129781220|NCT01068600|467166074|FG001|Overall Study|Withdrawal by Subject|6|||
129781221|NCT01068600|467166073|FG000|Overall Study|Adverse Event|3|||
129570711|NCT03435081|466386998|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
129570712|NCT03435081|466386999|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
129570713|NCT03435081|466386997|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
129781222|NCT01068600|467166074|FG001|Overall Study|Adverse Event|3|||
129781223|NCT01068600|467166073|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129781224|NCT01068600|467166074|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129781225|NCT01068600|467166073|FG000|Overall Study|Lost to Follow-up|1|||
129781226|NCT01068600|467166074|FG001|Overall Study|Lost to Follow-up|2|||
129781227|NCT01068600|467166073|FG000|Overall Study|Protocol deviation|1|||
129781228|NCT01068600|467166074|FG001|Overall Study|Protocol deviation|1|||
129781229|NCT01068600|467166073|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129781230|NCT01068600|467166074|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129570714|NCT03435081|466386998|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
129781231|NCT01068600|467166073|FG000|Overall Study|Administrative problems|0|||
129781232|NCT01068600|467166074|FG001|Overall Study|Administrative problems|1|||
129781233|NCT02644109|467166075|FG000|Overall Study|Adverse Event|0|||
129781234|NCT02644109|467166076|FG001|Overall Study|Adverse Event|4|||
129781235|NCT01519869|467166079|FG000|Overall Study|Lost to Follow-up|1|||
129781236|NCT03023813|467166080|FG000|Overall Study|Lost to Follow-up|1|||
129781237|NCT03023813|467166081|FG001|Overall Study|Lost to Follow-up|2|||
129781238|NCT03023813|467166082|FG002|Overall Study|Lost to Follow-up|0|||
129781239|NCT00312195|467166089|FG000|Overall Study|Adverse Event|4|||
129781240|NCT00312195|467166090|FG001|Overall Study|Adverse Event|6|||
129781241|NCT00312195|467166089|FG000|Overall Study|Lost to Follow-up|1|||
129781242|NCT00312195|467166090|FG001|Overall Study|Lost to Follow-up|0|||
129781243|NCT00312195|467166089|FG000|Overall Study|Protocol Violation|1|||
129781244|NCT00312195|467166090|FG001|Overall Study|Protocol Violation|0|||
129781245|NCT00329797|467166093|FG000|Overall Study|Protocol Violation|1|||
129781246|NCT00329797|467166094|FG001|Overall Study|Protocol Violation|0|||
129781247|NCT00329797|467166093|FG000|Overall Study|Withdrawal by Subject|6|||
129781248|NCT00329797|467166094|FG001|Overall Study|Withdrawal by Subject|6|||
129781249|NCT04254913|467166097|FG000|Overall Study|Adverse Event|1|||
129781250|NCT01396057|467166098|FG000|Overall Study|Adverse Event|2|||
129781251|NCT01396057|467166099|FG001|Overall Study|Adverse Event|6|||
129781252|NCT01396057|467166098|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129781253|NCT01396057|467166099|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129781254|NCT01396057|467166098|FG000|Overall Study|Protocol deviation|4|||
129781255|NCT01396057|467166099|FG001|Overall Study|Protocol deviation|4|||
129781256|NCT01396057|467166098|FG000|Overall Study|Consent withdrawn|3|||
129781257|NCT01396057|467166099|FG001|Overall Study|Consent withdrawn|2|||
129781258|NCT04535453|467166100|FG000|Overall Study|Death|0|||
129781259|NCT04535453|467166101|FG001|Overall Study|Death|1|||
129781260|NCT04535453|467166102|FG002|Overall Study|Death|0|||
129781261|NCT04535453|467166103|FG003|Overall Study|Death|0|||
129781262|NCT04535453|467166104|FG004|Overall Study|Death|0|||
129781263|NCT04535453|467166105|FG005|Overall Study|Death|0|||
129781264|NCT04535453|467166106|FG006|Overall Study|Death|0|||
129781265|NCT04535453|467166107|FG007|Overall Study|Death|0|||
129781266|NCT04535453|467166108|FG008|Overall Study|Death|0|||
129781267|NCT04535453|467166109|FG009|Overall Study|Death|0|||
129781268|NCT04535453|467166110|FG010|Overall Study|Death|0|||
129781269|NCT04535453|467166111|FG011|Overall Study|Death|0|||
129781270|NCT04535453|467166100|FG000|Overall Study|Lost to Follow-up|1|||
129781271|NCT04535453|467166101|FG001|Overall Study|Lost to Follow-up|1|||
129781272|NCT04535453|467166102|FG002|Overall Study|Lost to Follow-up|1|||
129781273|NCT04535453|467166103|FG003|Overall Study|Lost to Follow-up|0|||
129781274|NCT04535453|467166104|FG004|Overall Study|Lost to Follow-up|3|||
129781275|NCT04535453|467166105|FG005|Overall Study|Lost to Follow-up|1|||
129781276|NCT04535453|467166106|FG006|Overall Study|Lost to Follow-up|0|||
129781277|NCT04535453|467166107|FG007|Overall Study|Lost to Follow-up|0|||
129781278|NCT04535453|467166108|FG008|Overall Study|Lost to Follow-up|1|||
129781279|NCT04535453|467166109|FG009|Overall Study|Lost to Follow-up|1|||
129781280|NCT04535453|467166110|FG010|Overall Study|Lost to Follow-up|0|||
129781281|NCT04535453|467166111|FG011|Overall Study|Lost to Follow-up|0|||
129781282|NCT04535453|467166100|FG000|Overall Study|Physician Decision|0|||
129781283|NCT04535453|467166101|FG001|Overall Study|Physician Decision|0|||
129781284|NCT04535453|467166102|FG002|Overall Study|Physician Decision|0|||
129781285|NCT04535453|467166103|FG003|Overall Study|Physician Decision|1|||
129781286|NCT04535453|467166104|FG004|Overall Study|Physician Decision|0|||
129781287|NCT04535453|467166105|FG005|Overall Study|Physician Decision|0|||
129781288|NCT04535453|467166106|FG006|Overall Study|Physician Decision|0|||
129781289|NCT04535453|467166107|FG007|Overall Study|Physician Decision|0|||
129781290|NCT04535453|467166108|FG008|Overall Study|Physician Decision|0|||
129781291|NCT04535453|467166109|FG009|Overall Study|Physician Decision|0|||
129781292|NCT04535453|467166110|FG010|Overall Study|Physician Decision|0|||
129781293|NCT04535453|467166111|FG011|Overall Study|Physician Decision|0|||
129781294|NCT04535453|467166100|FG000|Overall Study|Withdrawal by Subject|3|||
129781295|NCT04535453|467166101|FG001|Overall Study|Withdrawal by Subject|6|||
129781296|NCT04535453|467166102|FG002|Overall Study|Withdrawal by Subject|3|||
129781297|NCT04535453|467166103|FG003|Overall Study|Withdrawal by Subject|3|||
129781298|NCT04535453|467166104|FG004|Overall Study|Withdrawal by Subject|2|||
129781299|NCT04535453|467166105|FG005|Overall Study|Withdrawal by Subject|1|||
129781300|NCT04535453|467166106|FG006|Overall Study|Withdrawal by Subject|1|||
129781301|NCT04535453|467166107|FG007|Overall Study|Withdrawal by Subject|1|||
129781302|NCT04535453|467166108|FG008|Overall Study|Withdrawal by Subject|1|||
129781303|NCT04535453|467166109|FG009|Overall Study|Withdrawal by Subject|1|||
129781304|NCT04535453|467166110|FG010|Overall Study|Withdrawal by Subject|0|||
129781305|NCT04535453|467166111|FG011|Overall Study|Withdrawal by Subject|1|||
129781306|NCT04535453|467166100|FG000|Overall Study|Other|0|||
129781307|NCT04535453|467166101|FG001|Overall Study|Other|0|||
129781308|NCT04535453|467166102|FG002|Overall Study|Other|1|||
129781309|NCT04535453|467166103|FG003|Overall Study|Other|0|||
129781310|NCT04535453|467166104|FG004|Overall Study|Other|1|||
129781311|NCT04535453|467166105|FG005|Overall Study|Other|0|||
129781312|NCT04535453|467166106|FG006|Overall Study|Other|1|||
129781313|NCT04535453|467166107|FG007|Overall Study|Other|1|||
129781314|NCT04535453|467166108|FG008|Overall Study|Other|1|||
129781315|NCT04535453|467166109|FG009|Overall Study|Other|0|||
129781316|NCT04535453|467166110|FG010|Overall Study|Other|0|||
129781317|NCT04535453|467166111|FG011|Overall Study|Other|0|||
129781318|NCT02695420|467166112|FG000|Overall Study|Death|0|||
129570715|NCT03435081|466386999|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
129570716|NCT03435081|466386997|FG000|Week 0 to Week 16|Pregnancy|1|||
129570717|NCT03435081|466386998|FG001|Week 0 to Week 16|Pregnancy|0|||
129570718|NCT03435081|466386999|FG002|Week 0 to Week 16|Pregnancy|0|||
129570719|NCT03435081|466386997|FG000|Week 0 to Week 16|Non-compliance|1|||
129570720|NCT03435081|466386998|FG001|Week 0 to Week 16|Non-compliance|0|||
129570721|NCT03435081|466386999|FG002|Week 0 to Week 16|Non-compliance|2|||
129570722|NCT03435081|466386997|FG000|Week 0 to Week 16|Inadequate Response|0|||
129570723|NCT03435081|466386998|FG001|Week 0 to Week 16|Inadequate Response|1|||
129570724|NCT03435081|466386999|FG002|Week 0 to Week 16|Inadequate Response|0|||
129570725|NCT03435081|466386997|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
129570726|NCT03435081|466386998|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
129570727|NCT03435081|466386999|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
129570728|NCT03435081|466386997|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
129570729|NCT03435081|466386998|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
129570730|NCT03435081|466386999|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
129570731|NCT03435081|466386997|FG000|Week 16 to Week 104|Adverse Event|1|||
129570732|NCT03435081|466386998|FG001|Week 16 to Week 104|Adverse Event|0|||
129570733|NCT03435081|466386999|FG002|Week 16 to Week 104|Adverse Event|2|||
129570734|NCT03435081|466386997|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
129570735|NCT03435081|466386998|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
129570736|NCT03435081|466386999|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
129570737|NCT03435081|466386997|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
129570738|NCT03435081|466386998|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
129570739|NCT03435081|466386999|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
129570740|NCT03435081|466386997|FG000|Week 16 to Week 104|Non--Compliance|0|||
129570741|NCT03435081|466386998|FG001|Week 16 to Week 104|Non--Compliance|0|||
129570742|NCT03435081|466386999|FG002|Week 16 to Week 104|Non--Compliance|1|||
129570743|NCT04320849|466387002|FG000|Overall Study|Withdrawal by Subject|4|||
129570744|NCT04320849|466387002|FG000|Overall Study|Imaging data unavailable|2|||
129570745|NCT04320849|466387002|FG000|Overall Study|Incomplete imaging|2|||
129570746|NCT00214422|466387003|FG000|Overall Study|Physician Decision|2|||
129570747|NCT00214422|466387004|FG001|Overall Study|Physician Decision|0|||
129570748|NCT00214422|466387005|FG002|Overall Study|Physician Decision|0|||
129570749|NCT00214422|466387003|FG000|Overall Study|Developed esophageal ca|1|||
129570750|NCT00214422|466387004|FG001|Overall Study|Developed esophageal ca|0|||
129570751|NCT00214422|466387005|FG002|Overall Study|Developed esophageal ca|0|||
129570752|NCT00214422|466387003|FG000|Overall Study|Pt taken off study|1|||
129570753|NCT00214422|466387004|FG001|Overall Study|Pt taken off study|1|||
129570754|NCT00214422|466387005|FG002|Overall Study|Pt taken off study|0|||
129570755|NCT00214422|466387003|FG000|Overall Study|Disease progression on study|1|||
129570756|NCT00214422|466387004|FG001|Overall Study|Disease progression on study|0|||
129570757|NCT00214422|466387005|FG002|Overall Study|Disease progression on study|0|||
129570758|NCT00214422|466387003|FG000|Overall Study|Unable to make a radiation treatment|0|||
129570759|NCT00214422|466387004|FG001|Overall Study|Unable to make a radiation treatment|0|||
129570760|NCT00214422|466387005|FG002|Overall Study|Unable to make a radiation treatment|1|||
129570761|NCT03929393|466387006|FG000|Overall Study|Death|1|||
129570762|NCT03929393|466387007|FG001|Overall Study|Death|0|||
129570763|NCT03929393|466387006|FG000|Overall Study|Time Commitment|2|||
129570764|NCT03929393|466387007|FG001|Overall Study|Time Commitment|5|||
129570765|NCT03929393|466387006|FG000|Overall Study|Motor Vehicle Accident|0|||
129570766|NCT03929393|466387007|FG001|Overall Study|Motor Vehicle Accident|1|||
129570767|NCT03929393|466387006|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
129570768|NCT03929393|466387007|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
129570769|NCT03929393|466387006|FG000|Overall Study|Other|1|||
129570770|NCT03929393|466387007|FG001|Overall Study|Other|3|||
129570771|NCT02424097|466388817|FG000|Overall Study|Lost to Follow-up|1|||
129570772|NCT02424097|466388818|FG001|Overall Study|Lost to Follow-up|2|||
129570773|NCT01675622|466388819|FG000|Overall Study|Withdrawal by Subject|2|||
129570774|NCT01675622|466388820|FG001|Overall Study|Withdrawal by Subject|2|||
129570775|NCT01675622|466388819|FG000|Overall Study|Adverse Event|12|||
129570776|NCT01675622|466388820|FG001|Overall Study|Adverse Event|10|||
129570777|NCT01675622|466388819|FG000|Overall Study|Protocol Violation|4|||
129570778|NCT01675622|466388820|FG001|Overall Study|Protocol Violation|1|||
129570779|NCT01675622|466388819|FG000|Overall Study|Lack of Efficacy|2|||
129570780|NCT01675622|466388820|FG001|Overall Study|Lack of Efficacy|4|||
129691338|NCT02852434|466828206|FG000|Overall Study|Withdrawal by Subject|0|||
129691339|NCT02852434|466828207|FG001|Overall Study|Withdrawal by Subject|1|||
129570781|NCT01675622|466388819|FG000|Overall Study|Lost to Follow-up|1|||
129691340|NCT02852434|466828206|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
129691341|NCT02852434|466828207|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
129691342|NCT02018887|466828210|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
129691343|NCT02018887|466828211|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691344|NCT02018887|466828212|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129570782|NCT01675622|466388820|FG001|Overall Study|Lost to Follow-up|3|||
129570783|NCT01675622|466388819|FG000|Overall Study|Other|5|||
129570784|NCT01675622|466388820|FG001|Overall Study|Other|4|||
129570785|NCT04032977|466388821|FG000|Overall Study|Withdrawal by Subject|6|||
129570786|NCT04032977|466388822|FG001|Overall Study|Withdrawal by Subject|1|||
129570787|NCT04032977|466388821|FG000|Overall Study|Lost to Follow-up|2|||
129570788|NCT04032977|466388822|FG001|Overall Study|Lost to Follow-up|7|||
129570789|NCT04032977|466388821|FG000|Overall Study|Pregnancy|1|||
129570790|NCT04032977|466388822|FG001|Overall Study|Pregnancy|0|||
129570791|NCT03597256|466388823|FG000|Overall Study|Lost to Follow-up|3|||
129570792|NCT03597256|466388824|FG001|Overall Study|Lost to Follow-up|1|||
129570793|NCT03597256|466388823|FG000|Overall Study|Withdrawal by Subject|0|||
129570794|NCT03597256|466388824|FG001|Overall Study|Withdrawal by Subject|1|||
129570795|NCT03597256|466388823|FG000|Overall Study|Could not return for treatment|0|||
129570796|NCT03597256|466388824|FG001|Overall Study|Could not return for treatment|1|||
129570797|NCT03597256|466388823|FG000|Overall Study|Moved from location|0|||
129570798|NCT03597256|466388824|FG001|Overall Study|Moved from location|1|||
129570799|NCT03597256|466388823|FG000|Overall Study|Not accepted the treatment|0|||
129570800|NCT03597256|466388824|FG001|Overall Study|Not accepted the treatment|1|||
129570801|NCT02106156|466388825|FG000|Overall Study|Patient Died|19|||
129570802|NCT02106156|466388826|FG001|Overall Study|Patient Died|0|||
129570803|NCT02106156|466388827|FG002|Overall Study|Patient Died|0|||
129570804|NCT02106156|466388825|FG000|Overall Study|Lack of Tolerability|305|||
129570805|NCT02106156|466388826|FG001|Overall Study|Lack of Tolerability|3|||
129570806|NCT02106156|466388827|FG002|Overall Study|Lack of Tolerability|0|||
129570807|NCT02106156|466388825|FG000|Overall Study|Lack of Virological Response|1044|||
129570808|NCT02106156|466388826|FG001|Overall Study|Lack of Virological Response|8|||
129570809|NCT02106156|466388827|FG002|Overall Study|Lack of Virological Response|0|||
129570810|NCT02106156|466388825|FG000|Overall Study|Concomitant Disease|74|||
129570811|NCT02106156|466388826|FG001|Overall Study|Concomitant Disease|2|||
129570812|NCT02106156|466388827|FG002|Overall Study|Concomitant Disease|0|||
129570813|NCT02106156|466388825|FG000|Overall Study|Lack of Compliance|211|||
129570814|NCT02106156|466388826|FG001|Overall Study|Lack of Compliance|7|||
129570815|NCT02106156|466388827|FG002|Overall Study|Lack of Compliance|0|||
129570816|NCT02106156|466388825|FG000|Overall Study|Patients Request|307|||
129570817|NCT02106156|466388826|FG001|Overall Study|Patients Request|9|||
129570818|NCT02106156|466388827|FG002|Overall Study|Patients Request|0|||
129570819|NCT02106156|466388825|FG000|Overall Study|Lost to Follow-up|451|||
129570820|NCT02106156|466388826|FG001|Overall Study|Lost to Follow-up|8|||
129570821|NCT02106156|466388827|FG002|Overall Study|Lost to Follow-up|0|||
129570822|NCT02106156|466388825|FG000|Overall Study|Unplanned Event|82|||
129570823|NCT02106156|466388826|FG001|Overall Study|Unplanned Event|2|||
129570824|NCT02106156|466388827|FG002|Overall Study|Unplanned Event|0|||
129570825|NCT02106156|466388825|FG000|Overall Study|Change of Laboratory Parameter|10|||
129570826|NCT02106156|466388826|FG001|Overall Study|Change of Laboratory Parameter|0|||
129570827|NCT02106156|466388827|FG002|Overall Study|Change of Laboratory Parameter|0|||
129570828|NCT02106156|466388825|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
129691345|NCT02018887|466828213|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691346|NCT02018887|466828214|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691347|NCT02018887|466828215|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129570829|NCT02106156|466388826|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
129691348|NCT02018887|466828216|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691349|NCT02018887|466828217|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691350|NCT02018887|466828218|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691351|NCT02018887|466828219|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691352|NCT02018887|466828220|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
129691353|NCT02018887|466828210|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691354|NCT02018887|466828211|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691355|NCT02018887|466828212|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691356|NCT02018887|466828213|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691357|NCT02018887|466828214|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
129691358|NCT02018887|466828215|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129570830|NCT02106156|466388827|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
129570831|NCT02106156|466388825|FG000|Overall Study|Relocation/Change of Physician|40|||
129570832|NCT02106156|466388826|FG001|Overall Study|Relocation/Change of Physician|1|||
129570833|NCT02106156|466388827|FG002|Overall Study|Relocation/Change of Physician|0|||
129570834|NCT05017480|466388833|FG000|Stage 1 Study|Withdrawal by Subject|8|||
129570835|NCT05017480|466388834|FG001|Stage 1 Study|Withdrawal by Subject|6|||
129570836|NCT05017480|466388835|FG002|Stage 1 Study|Withdrawal by Subject|0|||
129570837|NCT05017480|466388836|FG003|Stage 1 Study|Withdrawal by Subject|0|||
129570838|NCT05017480|466388837|FG004|Stage 1 Study|Withdrawal by Subject|0|||
129570839|NCT05017480|466388833|FG000|Stage 1 Study|Adverse Event|1|||
129570840|NCT05017480|466388834|FG001|Stage 1 Study|Adverse Event|1|||
129570841|NCT05017480|466388835|FG002|Stage 1 Study|Adverse Event|0|||
129570842|NCT05017480|466388836|FG003|Stage 1 Study|Adverse Event|0|||
129570843|NCT05017480|466388837|FG004|Stage 1 Study|Adverse Event|0|||
129570844|NCT05017480|466388833|FG000|Stage 1 Study|Poor Compliance|1|||
129570845|NCT05017480|466388834|FG001|Stage 1 Study|Poor Compliance|1|||
129570846|NCT05017480|466388835|FG002|Stage 1 Study|Poor Compliance|0|||
129570847|NCT05017480|466388836|FG003|Stage 1 Study|Poor Compliance|0|||
129570848|NCT05017480|466388837|FG004|Stage 1 Study|Poor Compliance|0|||
129570849|NCT05017480|466388833|FG000|Stage 1 Study|Physician Decision|0|||
129570850|NCT05017480|466388834|FG001|Stage 1 Study|Physician Decision|1|||
129570851|NCT05017480|466388835|FG002|Stage 1 Study|Physician Decision|0|||
129570852|NCT05017480|466388836|FG003|Stage 1 Study|Physician Decision|0|||
129570853|NCT05017480|466388837|FG004|Stage 1 Study|Physician Decision|0|||
129570854|NCT05017480|466388833|FG000|Stage 2 Study|Withdrawal by Subject|0|||
129570855|NCT05017480|466388834|FG001|Stage 2 Study|Withdrawal by Subject|0|||
129570856|NCT05017480|466388835|FG002|Stage 2 Study|Withdrawal by Subject|6|||
129570857|NCT05017480|466388836|FG003|Stage 2 Study|Withdrawal by Subject|9|||
129570858|NCT05017480|466388837|FG004|Stage 2 Study|Withdrawal by Subject|11|||
129570859|NCT05017480|466388833|FG000|Stage 2 Study|Lost to Follow-up|0|||
129570860|NCT05017480|466388834|FG001|Stage 2 Study|Lost to Follow-up|0|||
129570861|NCT05017480|466388835|FG002|Stage 2 Study|Lost to Follow-up|0|||
129570862|NCT05017480|466388836|FG003|Stage 2 Study|Lost to Follow-up|2|||
129570863|NCT05017480|466388837|FG004|Stage 2 Study|Lost to Follow-up|1|||
129570864|NCT05017480|466388833|FG000|Stage 2 Study|Adverse Event|0|||
129570865|NCT05017480|466388834|FG001|Stage 2 Study|Adverse Event|0|||
129570866|NCT05017480|466388835|FG002|Stage 2 Study|Adverse Event|0|||
129570867|NCT05017480|466388836|FG003|Stage 2 Study|Adverse Event|1|||
129570868|NCT05017480|466388837|FG004|Stage 2 Study|Adverse Event|0|||
129570869|NCT05017480|466388833|FG000|Stage 2 Study|COVID-19|0|||
129570870|NCT05017480|466388834|FG001|Stage 2 Study|COVID-19|0|||
129570871|NCT05017480|466388835|FG002|Stage 2 Study|COVID-19|0|||
129570872|NCT05017480|466388836|FG003|Stage 2 Study|COVID-19|1|||
129570873|NCT05017480|466388837|FG004|Stage 2 Study|COVID-19|0|||
129570874|NCT05017480|466388833|FG000|Stage 2 Study|Pregnancy|0|||
129570875|NCT05017480|466388834|FG001|Stage 2 Study|Pregnancy|0|||
129570876|NCT05017480|466388835|FG002|Stage 2 Study|Pregnancy|0|||
129570877|NCT05017480|466388836|FG003|Stage 2 Study|Pregnancy|0|||
129570878|NCT05017480|466388837|FG004|Stage 2 Study|Pregnancy|1|||
129570879|NCT01136382|466388842|FG000|Overall Study|Other|8|||
129570880|NCT01136382|466388843|FG001|Overall Study|Other|3|||
129570881|NCT01136382|466388842|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
129570882|NCT01136382|466388843|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
129570883|NCT01136382|466388842|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
129570884|NCT01136382|466388843|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
129570885|NCT01136382|466388842|FG000|Overall Study|Withdrawal by Subject|4|||
129570886|NCT01136382|466388843|FG001|Overall Study|Withdrawal by Subject|1|||
129570887|NCT00746798|466388844|FG000|Overall Study|Protocol Violation|0|||
129570888|NCT00746798|466388845|FG001|Overall Study|Protocol Violation|1|||
129570889|NCT00746798|466388846|FG002|Overall Study|Protocol Violation|0|||
129570890|NCT00746798|466388847|FG003|Overall Study|Protocol Violation|0|||
129570891|NCT00746798|466388844|FG000|Overall Study|Withdrawal by Subject|0|||
129570892|NCT00746798|466388845|FG001|Overall Study|Withdrawal by Subject|1|||
129570893|NCT00746798|466388846|FG002|Overall Study|Withdrawal by Subject|1|||
129570894|NCT00746798|466388847|FG003|Overall Study|Withdrawal by Subject|0|||
129570895|NCT00746798|466388844|FG000|Overall Study|Death|0|||
129781319|NCT02695420|467166113|FG001|Overall Study|Death|1|||
129781320|NCT02695420|467166114|FG002|Overall Study|Death|0|||
129781321|NCT02695420|467166115|FG003|Overall Study|Death|0|||
129781322|NCT00916929|467166118|FG000|Overall Study|Lost to Follow-up|1|||
129781323|NCT00916929|467166119|FG001|Overall Study|Lost to Follow-up|3|||
129781324|NCT00916929|467166118|FG000|Overall Study|Death|5|||
129781325|NCT00916929|467166119|FG001|Overall Study|Death|10|||
129781326|NCT00916929|467166118|FG000|Overall Study|Withdrawal by Subject|1|||
129781327|NCT00916929|467166119|FG001|Overall Study|Withdrawal by Subject|5|||
129570896|NCT00746798|466388845|FG001|Overall Study|Death|0|||
129570897|NCT00746798|466388846|FG002|Overall Study|Death|2|||
129781328|NCT00916929|467166118|FG000|Overall Study|Left ventricular epicardial lead|1|||
129570898|NCT00746798|466388847|FG003|Overall Study|Death|0|||
129570899|NCT00746798|466388844|FG000|Overall Study|Participant unable to return for visit|1|||
129570900|NCT00746798|466388845|FG001|Overall Study|Participant unable to return for visit|0|||
129570901|NCT00746798|466388846|FG002|Overall Study|Participant unable to return for visit|0|||
129570902|NCT00746798|466388847|FG003|Overall Study|Participant unable to return for visit|0|||
129570903|NCT02896361|466388848|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
129570904|NCT02896361|466388849|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
129781329|NCT00916929|467166119|FG001|Overall Study|Left ventricular epicardial lead|2|||
129884563|NCT02696902|467536455|FG002|Overall Study|Death|24|||
129570905|NCT02896361|466388850|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
129570906|NCT02896361|466388848|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
129570907|NCT02896361|466388849|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
129570908|NCT02896361|466388850|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
129570909|NCT01045096|466388852|FG000|Overall Study|Withdrawal by Subject|2|||
129570910|NCT01045096|466388853|FG001|Overall Study|Withdrawal by Subject|0|||
129570911|NCT01045096|466388854|FG002|Overall Study|Withdrawal by Subject|0|||
129570912|NCT01045096|466388852|FG000|Overall Study|Other|1|||
129570913|NCT01045096|466388853|FG001|Overall Study|Other|0|||
129570914|NCT01045096|466388854|FG002|Overall Study|Other|0|||
129570915|NCT01511939|466388856|FG000|Overall Study|Withdrawal by Subject|2|||
129570916|NCT01511939|466388857|FG001|Overall Study|Withdrawal by Subject|1|||
129570917|NCT01511939|466388858|FG002|Overall Study|Withdrawal by Subject|0|||
129570918|NCT00324168|466388863|FG000|Overall Study|Lost to Follow-up|19|||
129570919|NCT00324168|466388864|FG001|Overall Study|Lost to Follow-up|18|||
129570920|NCT00324168|466388863|FG000|Overall Study|Death|3|||
129570921|NCT00324168|466388864|FG001|Overall Study|Death|3|||
129570922|NCT00324168|466388863|FG000|Overall Study|Patient did not visit in f/u window|6|||
129570923|NCT00324168|466388864|FG001|Overall Study|Patient did not visit in f/u window|9|||
129570924|NCT03497897|466388865|FG000|Overall Study|Adverse Event|1|||
129570925|NCT03497897|466388866|FG001|Overall Study|Adverse Event|1|||
129570926|NCT03497897|466388867|FG002|Overall Study|Adverse Event|1|||
129570927|NCT03497897|466388865|FG000|Overall Study|Lost to Follow-up|2|||
129570928|NCT03497897|466388866|FG001|Overall Study|Lost to Follow-up|0|||
129570929|NCT03497897|466388867|FG002|Overall Study|Lost to Follow-up|2|||
129570930|NCT03497897|466388865|FG000|Overall Study|Physician Decision|1|||
129570931|NCT03497897|466388866|FG001|Overall Study|Physician Decision|0|||
129691359|NCT02018887|466828216|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
129691360|NCT02018887|466828217|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
129691361|NCT02018887|466828218|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691362|NCT02018887|466828219|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691363|NCT02018887|466828220|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
129691364|NCT02018887|466828210|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
129691365|NCT02018887|466828211|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
129691366|NCT02018887|466828212|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
129691367|NCT02018887|466828213|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
129691368|NCT02018887|466828214|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
129691369|NCT02018887|466828215|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
129691370|NCT02018887|466828216|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
129691371|NCT02018887|466828217|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
129691372|NCT02018887|466828218|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
129691373|NCT02018887|466828219|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
129691374|NCT02018887|466828220|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
129691375|NCT02018887|466828210|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
129691376|NCT02018887|466828211|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
129691377|NCT02018887|466828212|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
129691378|NCT02018887|466828213|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
129691379|NCT02018887|466828214|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
129691380|NCT02018887|466828215|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
129691381|NCT02018887|466828216|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
129691382|NCT02018887|466828217|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
129691383|NCT02018887|466828218|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
129691384|NCT02018887|466828219|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
129691385|NCT02018887|466828220|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
129691386|NCT00927186|466828221|FG000|12 Months Primary Study|Adverse Event|5|||
129691387|NCT00927186|466828222|FG001|12 Months Primary Study|Adverse Event|2|||
129691388|NCT00927186|466828221|FG000|12 Months Primary Study|Lost to Follow-up|1|||
129691389|NCT00927186|466828222|FG001|12 Months Primary Study|Lost to Follow-up|0|||
129691390|NCT00927186|466828221|FG000|12 Months Primary Study|Protocol Violation|0|||
129691391|NCT00927186|466828222|FG001|12 Months Primary Study|Protocol Violation|1|||
129691392|NCT00927186|466828221|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
129691393|NCT00927186|466828222|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
129691394|NCT01145222|466828223|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
129691395|NCT01145222|466828224|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
129691396|NCT01145222|466828225|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
129691397|NCT01145222|466828226|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
129570932|NCT03497897|466388867|FG002|Overall Study|Physician Decision|0|||
129570933|NCT03497897|466388865|FG000|Overall Study|Subject/Guardian Decision|2|||
129570934|NCT03497897|466388866|FG001|Overall Study|Subject/Guardian Decision|1|||
129570935|NCT03497897|466388867|FG002|Overall Study|Subject/Guardian Decision|3|||
129570936|NCT00358449|466388873|FG000|Overall Study|Adverse Event|1|||
129570937|NCT00358449|466388874|FG001|Overall Study|Adverse Event|0|||
129570938|NCT00358449|466388875|FG002|Overall Study|Adverse Event|1|||
129570939|NCT00358449|466388873|FG000|Overall Study|Lost to Follow-up|1|||
129570940|NCT00358449|466388874|FG001|Overall Study|Lost to Follow-up|0|||
129570941|NCT00358449|466388875|FG002|Overall Study|Lost to Follow-up|0|||
129570942|NCT00358449|466388873|FG000|Overall Study|Withdrawal by Subject|2|||
129781330|NCT00916929|467166118|FG000|Overall Study|Transferred to hospice care|1|||
129570943|NCT00358449|466388874|FG001|Overall Study|Withdrawal by Subject|0|||
129570944|NCT00358449|466388875|FG002|Overall Study|Withdrawal by Subject|0|||
129570945|NCT00358449|466388873|FG000|Overall Study|Lack of Efficacy|0|||
129570946|NCT00358449|466388874|FG001|Overall Study|Lack of Efficacy|1|||
129570947|NCT00358449|466388875|FG002|Overall Study|Lack of Efficacy|0|||
129570948|NCT00358449|466388873|FG000|Overall Study|Steriod Inhaler was Increased|0|||
129570949|NCT00358449|466388874|FG001|Overall Study|Steriod Inhaler was Increased|0|||
129570950|NCT00358449|466388875|FG002|Overall Study|Steriod Inhaler was Increased|1|||
129570951|NCT01367457|466388876|FG000|Overall Study|Death|2|||
129570952|NCT01367457|466388877|FG001|Overall Study|Death|0|||
129570953|NCT01367457|466388878|FG002|Overall Study|Death|0|||
129570954|NCT01367457|466388876|FG000|Overall Study|Investigator's decision|2|||
129570955|NCT01367457|466388877|FG001|Overall Study|Investigator's decision|0|||
129570956|NCT01367457|466388878|FG002|Overall Study|Investigator's decision|0|||
129570957|NCT01367457|466388876|FG000|Overall Study|Clinical decline (CD)|2|||
129570958|NCT01367457|466388877|FG001|Overall Study|Clinical decline (CD)|0|||
129570959|NCT01367457|466388878|FG002|Overall Study|Clinical decline (CD)|0|||
129570960|NCT01367457|466388876|FG000|Overall Study|Progression and death|8|||
129570961|NCT01367457|466388877|FG001|Overall Study|Progression and death|0|||
129570962|NCT01367457|466388878|FG002|Overall Study|Progression and death|0|||
129570963|NCT01367457|466388876|FG000|Overall Study|Toxicity|16|||
129570964|NCT01367457|466388877|FG001|Overall Study|Toxicity|0|||
129570965|NCT01367457|466388878|FG002|Overall Study|Toxicity|0|||
129570966|NCT01367457|466388876|FG000|Overall Study|Progression|137|||
129570967|NCT01367457|466388877|FG001|Overall Study|Progression|0|||
129570968|NCT01367457|466388878|FG002|Overall Study|Progression|0|||
129570969|NCT01367457|466388876|FG000|Overall Study|Patient asks for rest + slow progression|1|||
129570970|NCT01367457|466388877|FG001|Overall Study|Patient asks for rest + slow progression|0|||
129570971|NCT01367457|466388878|FG002|Overall Study|Patient asks for rest + slow progression|0|||
129570972|NCT01367457|466388876|FG000|Overall Study|Investigator's opinion, stable disease|1|||
129781331|NCT00916929|467166119|FG001|Overall Study|Transferred to hospice care|1|||
129781332|NCT00916929|467166118|FG000|Overall Study|System explant|1|||
129781333|NCT00916929|467166119|FG001|Overall Study|System explant|0|||
129781334|NCT00916929|467166118|FG000|Overall Study|Moved to another state|0|||
129781335|NCT00916929|467166119|FG001|Overall Study|Moved to another state|1|||
129781336|NCT00916929|467166118|FG000|Overall Study|Device unable to process impedance data|0|||
129781337|NCT00916929|467166119|FG001|Overall Study|Device unable to process impedance data|7|||
129781338|NCT01742286|467166121|FG000|Escalation Phase|Administrative problems|1|||
129781339|NCT01742286|467166122|FG001|Escalation Phase|Administrative problems|1|||
129781340|NCT01742286|467166123|FG002|Escalation Phase|Administrative problems|0|||
129781341|NCT01742286|467166124|FG003|Escalation Phase|Administrative problems|0|||
129781342|NCT01742286|467166125|FG004|Escalation Phase|Administrative problems|0|||
129781343|NCT01742286|467166126|FG005|Escalation Phase|Administrative problems|0|||
129781344|NCT01742286|467166127|FG006|Escalation Phase|Administrative problems|2|||
129781345|NCT01742286|467166121|FG000|Escalation Phase|Adverse Event|0|||
129781346|NCT01742286|467166122|FG001|Escalation Phase|Adverse Event|1|||
129781347|NCT01742286|467166123|FG002|Escalation Phase|Adverse Event|2|||
129781348|NCT01742286|467166124|FG003|Escalation Phase|Adverse Event|0|||
129781349|NCT01742286|467166125|FG004|Escalation Phase|Adverse Event|0|||
129570973|NCT01367457|466388877|FG001|Overall Study|Investigator's opinion, stable disease|0|||
129570974|NCT01367457|466388878|FG002|Overall Study|Investigator's opinion, stable disease|0|||
129570975|NCT01367457|466388876|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
129781350|NCT01742286|467166126|FG005|Escalation Phase|Adverse Event|1|||
129781351|NCT01742286|467166127|FG006|Escalation Phase|Adverse Event|0|||
129781352|NCT01742286|467166121|FG000|Escalation Phase|Disease progression|3|||
129781353|NCT01742286|467166122|FG001|Escalation Phase|Disease progression|7|||
129781354|NCT01742286|467166123|FG002|Escalation Phase|Disease progression|4|||
129781355|NCT01742286|467166124|FG003|Escalation Phase|Disease progression|1|||
129781356|NCT01742286|467166125|FG004|Escalation Phase|Disease progression|4|||
129781357|NCT01742286|467166126|FG005|Escalation Phase|Disease progression|3|||
129781358|NCT01742286|467166127|FG006|Escalation Phase|Disease progression|2|||
129570976|NCT01367457|466388877|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
129570977|NCT01367457|466388878|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
129570978|NCT01367457|466388876|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
129570979|NCT01367457|466388877|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
129570980|NCT01367457|466388878|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
129781359|NCT01742286|467166121|FG000|Escalation Phase|Death|0|||
129570981|NCT01367457|466388876|FG000|Overall Study|low grade toxicities + stable disease|1|||
129570982|NCT01367457|466388877|FG001|Overall Study|low grade toxicities + stable disease|0|||
129570983|NCT01367457|466388878|FG002|Overall Study|low grade toxicities + stable disease|0|||
129570984|NCT01367457|466388876|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
129570985|NCT01367457|466388877|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
129570986|NCT01367457|466388878|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
129781360|NCT01742286|467166122|FG001|Escalation Phase|Death|0|||
129781361|NCT01742286|467166123|FG002|Escalation Phase|Death|0|||
129781362|NCT01742286|467166124|FG003|Escalation Phase|Death|0|||
129570987|NCT01367457|466388876|FG000|Overall Study|Withdrawal by Subject|1|||
129570988|NCT01367457|466388877|FG001|Overall Study|Withdrawal by Subject|0|||
129570989|NCT01367457|466388878|FG002|Overall Study|Withdrawal by Subject|0|||
129570990|NCT01367457|466388876|FG000|Overall Study|CD, associated leukaemia|1|||
129570991|NCT01367457|466388877|FG001|Overall Study|CD, associated leukaemia|0|||
129570992|NCT01367457|466388878|FG002|Overall Study|CD, associated leukaemia|0|||
129570993|NCT01367457|466388876|FG000|Overall Study|Uncontrolled pain|1|||
129570994|NCT01367457|466388877|FG001|Overall Study|Uncontrolled pain|0|||
129570995|NCT01367457|466388878|FG002|Overall Study|Uncontrolled pain|0|||
129570996|NCT01367457|466388876|FG000|Overall Study|Overall status worsens to grade 4|1|||
129570997|NCT01367457|466388877|FG001|Overall Study|Overall status worsens to grade 4|0|||
129570998|NCT01367457|466388878|FG002|Overall Study|Overall status worsens to grade 4|0|||
129570999|NCT01367457|466388876|FG000|Overall Study|Stabilisation + frequent infections|1|||
129571000|NCT01367457|466388877|FG001|Overall Study|Stabilisation + frequent infections|0|||
129571001|NCT01367457|466388878|FG002|Overall Study|Stabilisation + frequent infections|0|||
129571002|NCT01367457|466388876|FG000|Overall Study|No clinical benefit|1|||
129781363|NCT01742286|467166125|FG004|Escalation Phase|Death|0|||
129781364|NCT01742286|467166126|FG005|Escalation Phase|Death|1|||
129571003|NCT01367457|466388877|FG001|Overall Study|No clinical benefit|0|||
129571004|NCT01367457|466388878|FG002|Overall Study|No clinical benefit|0|||
129571005|NCT01367457|466388876|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
129571006|NCT01367457|466388877|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
129571007|NCT01367457|466388878|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
129571008|NCT01367457|466388876|FG000|Overall Study|Overall decline|1|||
129571009|NCT01367457|466388877|FG001|Overall Study|Overall decline|0|||
129571010|NCT01367457|466388878|FG002|Overall Study|Overall decline|0|||
129571011|NCT01367457|466388876|FG000|Overall Study|Rejection of treatment|1|||
129571012|NCT01367457|466388877|FG001|Overall Study|Rejection of treatment|0|||
129571013|NCT01367457|466388878|FG002|Overall Study|Rejection of treatment|0|||
129571014|NCT01367457|466388876|FG000|Overall Study|Lost to Follow-up|1|||
129571015|NCT01367457|466388877|FG001|Overall Study|Lost to Follow-up|0|||
129571016|NCT01367457|466388878|FG002|Overall Study|Lost to Follow-up|0|||
129781365|NCT01742286|467166127|FG006|Escalation Phase|Death|0|||
129781366|NCT01742286|467166121|FG000|Escalation Phase|Physician Decision|0|||
129781367|NCT01742286|467166122|FG001|Escalation Phase|Physician Decision|3|||
129781368|NCT01742286|467166123|FG002|Escalation Phase|Physician Decision|0|||
129781369|NCT01742286|467166124|FG003|Escalation Phase|Physician Decision|1|||
129571017|NCT01367457|466388876|FG000|Overall Study|Death from septic shock|1|||
129571018|NCT01367457|466388877|FG001|Overall Study|Death from septic shock|0|||
129571019|NCT01367457|466388878|FG002|Overall Study|Death from septic shock|0|||
129571020|NCT01367457|466388876|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
129571021|NCT01367457|466388877|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
129571022|NCT01367457|466388878|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
129571023|NCT01367457|466388876|FG000|Overall Study|Patient's Wish|1|||
129571024|NCT01367457|466388877|FG001|Overall Study|Patient's Wish|0|||
129571025|NCT01367457|466388878|FG002|Overall Study|Patient's Wish|0|||
129571026|NCT01367457|466388876|FG000|Overall Study|Palliative. Overall decline|1|||
129571027|NCT01367457|466388877|FG001|Overall Study|Palliative. Overall decline|0|||
129571028|NCT01367457|466388878|FG002|Overall Study|Palliative. Overall decline|0|||
129781370|NCT01742286|467166125|FG004|Escalation Phase|Physician Decision|0|||
129781371|NCT01742286|467166126|FG005|Escalation Phase|Physician Decision|0|||
129571029|NCT01367457|466388876|FG000|Overall Study|Suspected DP/suspected active infection|1|||
129571030|NCT01367457|466388877|FG001|Overall Study|Suspected DP/suspected active infection|0|||
129571031|NCT01367457|466388878|FG002|Overall Study|Suspected DP/suspected active infection|0|||
129571032|NCT01391793|466388882|FG000|Overall Study|Ineligible|3|||
129571033|NCT01391793|466388883|FG001|Overall Study|Ineligible|0|||
129571034|NCT01391793|466388882|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
129571035|NCT01391793|466388883|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
129571036|NCT01391793|466388882|FG000|Overall Study|No DMSA|73|||
129571037|NCT01391793|466388883|FG001|Overall Study|No DMSA|57|||
129571038|NCT01666730|466388885|FG000|Overall Study|Adverse Event|16|||
129781372|NCT01742286|467166127|FG006|Escalation Phase|Physician Decision|2|||
129571039|NCT01666730|466388885|FG000|Overall Study|Death|2|||
129571040|NCT01666730|466388885|FG000|Overall Study|Physician Decision|5|||
129571041|NCT01666730|466388885|FG000|Overall Study|Withdrawal by Subject|9|||
129781373|NCT01742286|467166121|FG000|Escalation Phase|Subject/guardian decision|1|||
129571042|NCT01666730|466388885|FG000|Overall Study|Disease progression/relapse|18|||
129571043|NCT02087904|466388888|FG000|Overall Study|Did Not Receive Study Drug|0|||
129571044|NCT02087904|466388889|FG001|Overall Study|Did Not Receive Study Drug|0|||
129571045|NCT02087904|466388890|FG002|Overall Study|Did Not Receive Study Drug|2|||
129571046|NCT02087904|466388891|FG003|Overall Study|Did Not Receive Study Drug|1|||
129571047|NCT02087904|466388888|FG000|Overall Study|Adverse Event|8|||
129571048|NCT02087904|466388889|FG001|Overall Study|Adverse Event|4|||
129571049|NCT02087904|466388890|FG002|Overall Study|Adverse Event|4|||
129571050|NCT02087904|466388891|FG003|Overall Study|Adverse Event|12|||
129571051|NCT02087904|466388888|FG000|Overall Study|Lack of Efficacy|3|||
129571052|NCT02087904|466388889|FG001|Overall Study|Lack of Efficacy|6|||
129571053|NCT02087904|466388890|FG002|Overall Study|Lack of Efficacy|3|||
129571054|NCT02087904|466388891|FG003|Overall Study|Lack of Efficacy|2|||
129571055|NCT02087904|466388888|FG000|Overall Study|Other|6|||
129571056|NCT02087904|466388889|FG001|Overall Study|Other|2|||
129571057|NCT02087904|466388890|FG002|Overall Study|Other|4|||
129571058|NCT02087904|466388891|FG003|Overall Study|Other|4|||
129571059|NCT02087904|466388888|FG000|Overall Study|Withdrawal by Subject|8|||
129571060|NCT02087904|466388889|FG001|Overall Study|Withdrawal by Subject|3|||
129571061|NCT02087904|466388890|FG002|Overall Study|Withdrawal by Subject|7|||
129571062|NCT02087904|466388891|FG003|Overall Study|Withdrawal by Subject|4|||
129571063|NCT02087904|466388888|FG000|Overall Study|Lost to Follow-up|0|||
129571064|NCT02087904|466388889|FG001|Overall Study|Lost to Follow-up|4|||
129571065|NCT02087904|466388890|FG002|Overall Study|Lost to Follow-up|2|||
129571066|NCT02087904|466388891|FG003|Overall Study|Lost to Follow-up|2|||
129571067|NCT03025880|466388893|FG000|Overall Study|Adverse Event|1|||
129571068|NCT03025880|466388894|FG001|Overall Study|Adverse Event|0|||
129571069|NCT03025880|466388893|FG000|Overall Study|Death|1|||
129571070|NCT03025880|466388894|FG001|Overall Study|Death|1|||
129571071|NCT03025880|466388893|FG000|Overall Study|Withdrawal by Subject|0|||
129571072|NCT03025880|466388894|FG001|Overall Study|Withdrawal by Subject|1|||
129571073|NCT03025880|466388893|FG000|Overall Study|Physician Decision|0|||
129571074|NCT03025880|466388894|FG001|Overall Study|Physician Decision|1|||
129571075|NCT03025880|466388893|FG000|Overall Study|Progressive Disease|12|||
129571076|NCT03025880|466388894|FG001|Overall Study|Progressive Disease|19|||
129571077|NCT01389102|466388895|FG000|Overall Study|Adverse Event|1|||
129571078|NCT01389102|466388896|FG001|Overall Study|Adverse Event|3|||
129571079|NCT01389102|466388897|FG002|Overall Study|Adverse Event|2|||
129571080|NCT01389102|466388898|FG003|Overall Study|Adverse Event|2|||
129571081|NCT01389102|466388899|FG004|Overall Study|Adverse Event|2|||
129571082|NCT01389102|466388900|FG005|Overall Study|Adverse Event|2|||
129571083|NCT01389102|466388895|FG000|Overall Study|Hurricane Katrina|4|||
129571084|NCT01389102|466388896|FG001|Overall Study|Hurricane Katrina|2|||
129571085|NCT01389102|466388897|FG002|Overall Study|Hurricane Katrina|3|||
129571086|NCT01389102|466388898|FG003|Overall Study|Hurricane Katrina|0|||
129571087|NCT01389102|466388899|FG004|Overall Study|Hurricane Katrina|3|||
129691398|NCT01145222|466828223|FG000|Overall Study|Poor bowel preparation|0|||
129691399|NCT01145222|466828224|FG001|Overall Study|Poor bowel preparation|0|||
129691400|NCT01145222|466828225|FG002|Overall Study|Poor bowel preparation|0|||
129691401|NCT01145222|466828226|FG003|Overall Study|Poor bowel preparation|1|||
129691402|NCT01698008|466828227|FG000|Overall Study|Withdrawal by Subject|1|||
129691403|NCT01698008|466828228|FG001|Overall Study|Withdrawal by Subject|2|||
129691404|NCT01011283|466828230|FG000|Overall Study|Adverse Event|4|||
129691405|NCT01011283|466828231|FG001|Overall Study|Adverse Event|2|||
129691406|NCT01011283|466828230|FG000|Overall Study|Progressive Disease|0|||
129691407|NCT01011283|466828231|FG001|Overall Study|Progressive Disease|2|||
129691408|NCT01011283|466828230|FG000|Overall Study|Terminated by Sponsor|5|||
129691409|NCT01011283|466828231|FG001|Overall Study|Terminated by Sponsor|5|||
129691410|NCT01011283|466828230|FG000|Overall Study|Other|2|||
129691411|NCT01011283|466828231|FG001|Overall Study|Other|2|||
129691412|NCT02959892|466828235|FG000|Overall Study|PET tracer synthesis failure|1|||
129571088|NCT01389102|466388900|FG005|Overall Study|Hurricane Katrina|1|||
129691413|NCT02959892|466828236|FG001|Overall Study|PET tracer synthesis failure|0|||
129571089|NCT01389102|466388895|FG000|Overall Study|Lost to Follow-up|4|||
129691414|NCT02959892|466828235|FG000|Overall Study|Study termination|0|||
129571090|NCT01389102|466388896|FG001|Overall Study|Lost to Follow-up|1|||
129571091|NCT01389102|466388897|FG002|Overall Study|Lost to Follow-up|1|||
129571092|NCT01389102|466388898|FG003|Overall Study|Lost to Follow-up|2|||
129571093|NCT01389102|466388899|FG004|Overall Study|Lost to Follow-up|4|||
129571094|NCT01389102|466388900|FG005|Overall Study|Lost to Follow-up|1|||
129571095|NCT01389102|466388895|FG000|Overall Study|Protocol Violation|0|||
129571096|NCT01389102|466388896|FG001|Overall Study|Protocol Violation|0|||
129571097|NCT01389102|466388897|FG002|Overall Study|Protocol Violation|3|||
129571098|NCT01389102|466388898|FG003|Overall Study|Protocol Violation|0|||
129571099|NCT01389102|466388899|FG004|Overall Study|Protocol Violation|1|||
129691415|NCT02959892|466828236|FG001|Overall Study|Study termination|1|||
129691416|NCT00799864|466828240|FG000|Overall Study|Participant reached a virologic endpoint|9|||
129781374|NCT01742286|467166122|FG001|Escalation Phase|Subject/guardian decision|0|||
129781375|NCT01742286|467166123|FG002|Escalation Phase|Subject/guardian decision|0|||
129781376|NCT01742286|467166124|FG003|Escalation Phase|Subject/guardian decision|0|||
129781377|NCT01742286|467166125|FG004|Escalation Phase|Subject/guardian decision|0|||
129781378|NCT01742286|467166126|FG005|Escalation Phase|Subject/guardian decision|0|||
129781379|NCT01742286|467166127|FG006|Escalation Phase|Subject/guardian decision|0|||
129781380|NCT01742286|467166121|FG000|Expansion Phase|Administrative problems|0|||
129781381|NCT01742286|467166122|FG001|Expansion Phase|Administrative problems|0|||
129781382|NCT01742286|467166123|FG002|Expansion Phase|Administrative problems|0|||
129781383|NCT01742286|467166124|FG003|Expansion Phase|Administrative problems|0|||
129781384|NCT01742286|467166125|FG004|Expansion Phase|Administrative problems|0|||
129781385|NCT01742286|467166126|FG005|Expansion Phase|Administrative problems|0|||
129781386|NCT01742286|467166127|FG006|Expansion Phase|Administrative problems|5|||
129781387|NCT01742286|467166121|FG000|Expansion Phase|Physician Decision|0|||
129781388|NCT01742286|467166122|FG001|Expansion Phase|Physician Decision|0|||
129781389|NCT01742286|467166123|FG002|Expansion Phase|Physician Decision|4|||
129781390|NCT01742286|467166124|FG003|Expansion Phase|Physician Decision|0|||
129781391|NCT01742286|467166125|FG004|Expansion Phase|Physician Decision|0|||
129781392|NCT01742286|467166126|FG005|Expansion Phase|Physician Decision|0|||
129781393|NCT01742286|467166127|FG006|Expansion Phase|Physician Decision|9|||
129781394|NCT01742286|467166121|FG000|Expansion Phase|Adverse Event|0|||
129781395|NCT01742286|467166122|FG001|Expansion Phase|Adverse Event|0|||
129781396|NCT01742286|467166123|FG002|Expansion Phase|Adverse Event|0|||
129781397|NCT01742286|467166124|FG003|Expansion Phase|Adverse Event|0|||
129781398|NCT01742286|467166125|FG004|Expansion Phase|Adverse Event|0|||
129781399|NCT01742286|467166126|FG005|Expansion Phase|Adverse Event|0|||
129781400|NCT01742286|467166127|FG006|Expansion Phase|Adverse Event|6|||
129781401|NCT01742286|467166121|FG000|Expansion Phase|Disease progression|0|||
129781402|NCT01742286|467166122|FG001|Expansion Phase|Disease progression|0|||
129781403|NCT01742286|467166123|FG002|Expansion Phase|Disease progression|3|||
129781404|NCT01742286|467166124|FG003|Expansion Phase|Disease progression|0|||
129781405|NCT01742286|467166125|FG004|Expansion Phase|Disease progression|0|||
129781406|NCT01742286|467166126|FG005|Expansion Phase|Disease progression|0|||
129781407|NCT01742286|467166127|FG006|Expansion Phase|Disease progression|15|||
129781408|NCT01742286|467166121|FG000|Expansion Phase|Withdrawal by Subject|0|||
129781409|NCT01742286|467166122|FG001|Expansion Phase|Withdrawal by Subject|0|||
129781410|NCT01742286|467166123|FG002|Expansion Phase|Withdrawal by Subject|0|||
129781411|NCT01742286|467166124|FG003|Expansion Phase|Withdrawal by Subject|0|||
129781412|NCT01742286|467166125|FG004|Expansion Phase|Withdrawal by Subject|0|||
129781413|NCT01742286|467166126|FG005|Expansion Phase|Withdrawal by Subject|0|||
129781414|NCT01742286|467166127|FG006|Expansion Phase|Withdrawal by Subject|1|||
129781415|NCT04530136|467166128|FG000|Overall Study|Lost to Follow-up|2|||
129781416|NCT04530136|467166129|FG001|Overall Study|Lost to Follow-up|3|||
129781417|NCT04530136|467166128|FG000|Overall Study|Withdrawal by Subject|1|||
129781418|NCT04530136|467166129|FG001|Overall Study|Withdrawal by Subject|0|||
129781419|NCT04530136|467166128|FG000|Overall Study|Death|0|||
129781420|NCT04530136|467166129|FG001|Overall Study|Death|1|||
129781421|NCT02087423|467166130|FG000|Overall Study|Withdrawal by Subject|20|||
129781422|NCT02087423|467166131|FG001|Overall Study|Withdrawal by Subject|20|||
129781423|NCT02087423|467166132|FG002|Overall Study|Withdrawal by Subject|3|||
129781424|NCT02087423|467166130|FG000|Overall Study|Death|68|||
129781425|NCT02087423|467166131|FG001|Overall Study|Death|207|||
129781426|NCT02087423|467166132|FG002|Overall Study|Death|40|||
129781427|NCT02087423|467166130|FG000|Overall Study|Lost to Follow-up|0|||
129781428|NCT02087423|467166131|FG001|Overall Study|Lost to Follow-up|2|||
129781429|NCT02087423|467166132|FG002|Overall Study|Lost to Follow-up|0|||
129781430|NCT02087423|467166130|FG000|Overall Study|Terminated from study at final DCO|23|||
129781431|NCT02087423|467166131|FG001|Overall Study|Terminated from study at final DCO|36|||
129781432|NCT02087423|467166132|FG002|Overall Study|Terminated from study at final DCO|25|||
129781433|NCT01387542|467166133|FG000|Overall Study|Adverse Event|3|||
129781434|NCT01387542|467166133|FG000|Overall Study|Withdrawal by Subject|1|||
129781435|NCT01387542|467166133|FG000|Overall Study|Changed diagnosis|1|||
129781436|NCT01387542|467166133|FG000|Overall Study|Insufficient response|1|||
129781437|NCT01387542|467166133|FG000|Overall Study|Non-compliant|1|||
129781438|NCT01387542|467166133|FG000|Overall Study|Lost to Follow-up|1|||
129781439|NCT01010867|467166136|FG000|Overall Study|< 50% adherence to probiotic|1|||
129781440|NCT01233232|467166137|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
129781441|NCT01233232|467166138|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
129781442|NCT01233232|467166139|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
129781443|NCT02762370|467166140|FG000|Overall Study|Protocol Violation|1|||
129781444|NCT02762370|467166141|FG001|Overall Study|Protocol Violation|0|||
129781445|NCT03500224|467166142|FG000|Overall Study|Withdrawal by Subject|2|||
129781446|NCT01324401|467166145|FG000|Overall Study|Withdrawn before any treatment|0|||
129781447|NCT01324401|467166146|FG001|Overall Study|Withdrawn before any treatment|3|||
129781448|NCT01324401|467166145|FG000|Overall Study|Adverse Event|1|||
129781449|NCT01324401|467166146|FG001|Overall Study|Adverse Event|3|||
129571100|NCT01389102|466388900|FG005|Overall Study|Protocol Violation|1|||
129781450|NCT01708902|467166148|FG000|Overall Study|Adverse Event|3|||
129781451|NCT01708902|467166149|FG001|Overall Study|Adverse Event|4|||
129781452|NCT01708902|467166150|FG002|Overall Study|Adverse Event|9|||
129781453|NCT01708902|467166151|FG003|Overall Study|Adverse Event|2|||
129781454|NCT01708902|467166152|FG004|Overall Study|Adverse Event|7|||
129781455|NCT01708902|467166153|FG005|Overall Study|Adverse Event|3|||
129781456|NCT01708902|467166154|FG006|Overall Study|Adverse Event|5|||
129781457|NCT01708902|467166148|FG000|Overall Study|Lack of Efficacy|3|||
129781458|NCT01708902|467166149|FG001|Overall Study|Lack of Efficacy|1|||
129781459|NCT01708902|467166150|FG002|Overall Study|Lack of Efficacy|0|||
129781460|NCT01708902|467166151|FG003|Overall Study|Lack of Efficacy|0|||
129781461|NCT01708902|467166152|FG004|Overall Study|Lack of Efficacy|0|||
129781462|NCT01708902|467166153|FG005|Overall Study|Lack of Efficacy|1|||
129571101|NCT01389102|466388895|FG000|Overall Study|Withdrawal by Subject|7|||
129571102|NCT01389102|466388896|FG001|Overall Study|Withdrawal by Subject|4|||
129571103|NCT01389102|466388897|FG002|Overall Study|Withdrawal by Subject|9|||
129571104|NCT01389102|466388898|FG003|Overall Study|Withdrawal by Subject|2|||
129571105|NCT01389102|466388899|FG004|Overall Study|Withdrawal by Subject|3|||
129571106|NCT01389102|466388900|FG005|Overall Study|Withdrawal by Subject|3|||
129571107|NCT01389102|466388895|FG000|Overall Study|Subject Traveling Out of Country|0|||
129571108|NCT01389102|466388896|FG001|Overall Study|Subject Traveling Out of Country|0|||
129571109|NCT01389102|466388897|FG002|Overall Study|Subject Traveling Out of Country|0|||
129571110|NCT01389102|466388898|FG003|Overall Study|Subject Traveling Out of Country|1|||
129571111|NCT01389102|466388899|FG004|Overall Study|Subject Traveling Out of Country|0|||
129571112|NCT01389102|466388900|FG005|Overall Study|Subject Traveling Out of Country|0|||
129571113|NCT01389102|466388895|FG000|Overall Study|Subject Moved|2|||
129571114|NCT01389102|466388896|FG001|Overall Study|Subject Moved|0|||
129571115|NCT01389102|466388897|FG002|Overall Study|Subject Moved|1|||
129571116|NCT01389102|466388898|FG003|Overall Study|Subject Moved|0|||
129571117|NCT01389102|466388899|FG004|Overall Study|Subject Moved|0|||
129571118|NCT01389102|466388900|FG005|Overall Study|Subject Moved|0|||
129571119|NCT01389102|466388895|FG000|Overall Study|Unavailable due to husband's illness|0|||
129571120|NCT01389102|466388896|FG001|Overall Study|Unavailable due to husband's illness|1|||
129571121|NCT01389102|466388897|FG002|Overall Study|Unavailable due to husband's illness|0|||
129571122|NCT01389102|466388898|FG003|Overall Study|Unavailable due to husband's illness|0|||
129571123|NCT01389102|466388899|FG004|Overall Study|Unavailable due to husband's illness|0|||
129571124|NCT01389102|466388900|FG005|Overall Study|Unavailable due to husband's illness|0|||
129571125|NCT01389102|466388895|FG000|Overall Study|Investigator Judgement|0|||
129571126|NCT01389102|466388896|FG001|Overall Study|Investigator Judgement|1|||
129571127|NCT01389102|466388897|FG002|Overall Study|Investigator Judgement|0|||
129571128|NCT01389102|466388898|FG003|Overall Study|Investigator Judgement|0|||
129571129|NCT01389102|466388899|FG004|Overall Study|Investigator Judgement|0|||
129571130|NCT01389102|466388900|FG005|Overall Study|Investigator Judgement|0|||
129571131|NCT00893464|466388901|FG000|Overall Study|Did not complete therapy/experience PD|0|||
129571132|NCT00893464|466388902|FG001|Overall Study|Did not complete therapy/experience PD|0|||
129571133|NCT00893464|466388903|FG002|Overall Study|Did not complete therapy/experience PD|0|||
129571134|NCT00893464|466388904|FG003|Overall Study|Did not complete therapy/experience PD|0|||
129571135|NCT00893464|466388905|FG004|Overall Study|Did not complete therapy/experience PD|0|||
129571136|NCT00893464|466388906|FG005|Overall Study|Did not complete therapy/experience PD|0|||
129571137|NCT00893464|466388907|FG006|Overall Study|Did not complete therapy/experience PD|2|||
129571138|NCT00893464|466388908|FG007|Overall Study|Did not complete therapy/experience PD|2|||
129571139|NCT02910037|466388909|FG000|Overall Study|Withdrawal by Subject|4|||
129571140|NCT02910037|466388909|FG000|Overall Study|Lost to Follow-up|6|||
129571141|NCT00436553|466388910|FG000|Overall Study|Adverse Event|4|||
129571142|NCT00436553|466388911|FG001|Overall Study|Adverse Event|3|||
129571143|NCT00436553|466388912|FG002|Overall Study|Adverse Event|4|||
129571144|NCT00436553|466388910|FG000|Overall Study|Death|3|||
129571145|NCT00436553|466388911|FG001|Overall Study|Death|1|||
129571146|NCT00436553|466388912|FG002|Overall Study|Death|3|||
129571147|NCT00436553|466388910|FG000|Overall Study|Lost to Follow-up|0|||
129571148|NCT00436553|466388911|FG001|Overall Study|Lost to Follow-up|2|||
129781463|NCT01708902|467166154|FG006|Overall Study|Lack of Efficacy|0|||
129781464|NCT01708902|467166148|FG000|Overall Study|Non compliance with protocol|0|||
129571149|NCT00436553|466388912|FG002|Overall Study|Lost to Follow-up|0|||
129571150|NCT00436553|466388910|FG000|Overall Study|Protocol Violation|1|||
129571151|NCT00436553|466388911|FG001|Overall Study|Protocol Violation|0|||
129781465|NCT01708902|467166149|FG001|Overall Study|Non compliance with protocol|2|||
129571152|NCT00436553|466388912|FG002|Overall Study|Protocol Violation|0|||
129571153|NCT00436553|466388910|FG000|Overall Study|Withdrawal by Subject|5|||
129571154|NCT00436553|466388911|FG001|Overall Study|Withdrawal by Subject|6|||
129781466|NCT01708902|467166150|FG002|Overall Study|Non compliance with protocol|1|||
129781467|NCT01708902|467166151|FG003|Overall Study|Non compliance with protocol|3|||
129781468|NCT01708902|467166152|FG004|Overall Study|Non compliance with protocol|0|||
129781469|NCT01708902|467166153|FG005|Overall Study|Non compliance with protocol|0|||
129571155|NCT00436553|466388912|FG002|Overall Study|Withdrawal by Subject|3|||
129571156|NCT01035060|466388917|FG000|Overall Study|Lost to Follow-up|0|||
129571157|NCT01035060|466388918|FG001|Overall Study|Lost to Follow-up|7|||
129571158|NCT01035060|466388917|FG000|Overall Study|Did not quality after 2nd screening|14|||
129571159|NCT01035060|466388918|FG001|Overall Study|Did not quality after 2nd screening|1|||
129571160|NCT01035060|466388917|FG000|Overall Study|Withdrawal by Subject|8|||
129571161|NCT01035060|466388918|FG001|Overall Study|Withdrawal by Subject|6|||
129571162|NCT01035060|466388917|FG000|Overall Study|Physician Decision|2|||
129571163|NCT01035060|466388918|FG001|Overall Study|Physician Decision|0|||
129571164|NCT02015390|466388923|FG000|Overall Study|Lost to Follow-up|1|||
129571165|NCT02015390|466388924|FG001|Overall Study|Lost to Follow-up|0|||
129571166|NCT02015390|466388923|FG000|Overall Study|Adverse Event|0|||
129571167|NCT02015390|466388924|FG001|Overall Study|Adverse Event|3|||
129571168|NCT02015390|466388923|FG000|Overall Study|Physician Decision|0|||
129571169|NCT02015390|466388924|FG001|Overall Study|Physician Decision|1|||
129571170|NCT02193880|466388925|FG000|Overall Study|patients did not collect enough HPC|3|||
129571171|NCT01661686|466388926|FG000|Overall Study|Lost to Follow-up|2|||
129571172|NCT01661686|466388927|FG001|Overall Study|Lost to Follow-up|1|||
129571173|NCT01661686|466388926|FG000|Overall Study|did not receive allocated intervention|0|||
129571174|NCT01661686|466388927|FG001|Overall Study|did not receive allocated intervention|1|||
129571175|NCT02419937|466388930|FG000|Overall Study|Lost to Follow-up|1|||
129571176|NCT02419937|466388931|FG001|Overall Study|Lost to Follow-up|0|||
129571177|NCT02674477|466388933|FG000|Overall Study|Protocol Violation|8|||
129571178|NCT02674477|466388934|FG001|Overall Study|Protocol Violation|2|||
129571179|NCT00624065|466388935|FG000|Overall Study|Adverse Event|5|||
129571180|NCT00624065|466388936|FG001|Overall Study|Adverse Event|6|||
129571181|NCT00624065|466388935|FG000|Overall Study|Lost to Follow-up|4|||
129571182|NCT00624065|466388936|FG001|Overall Study|Lost to Follow-up|1|||
129571183|NCT00624065|466388935|FG000|Overall Study|Consent withdrawn|6|||
129571184|NCT00624065|466388936|FG001|Overall Study|Consent withdrawn|5|||
129571185|NCT00624065|466388935|FG000|Overall Study|Lack of Efficacy|0|||
129571186|NCT00624065|466388936|FG001|Overall Study|Lack of Efficacy|3|||
129691417|NCT00799864|466828241|FG001|Overall Study|Participant reached a virologic endpoint|2|||
129691418|NCT00799864|466828242|FG002|Overall Study|Participant reached a virologic endpoint|2|||
129691419|NCT00799864|466828243|FG003|Overall Study|Participant reached a virologic endpoint|0|||
129691420|NCT00799864|466828244|FG004|Overall Study|Participant reached a virologic endpoint|0|||
129691421|NCT00799864|466828240|FG000|Overall Study|Other|2|||
129691422|NCT00799864|466828241|FG001|Overall Study|Other|1|||
129571187|NCT00624065|466388935|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
129571188|NCT00624065|466388936|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
129691423|NCT00799864|466828242|FG002|Overall Study|Other|0|||
129691424|NCT00799864|466828243|FG003|Overall Study|Other|0|||
129691425|NCT00799864|466828244|FG004|Overall Study|Other|0|||
129691426|NCT03364686|466828245|FG000|Overall Study|Physician Decision|2|||
129691427|NCT01210443|466828248|FG000|Overall Study|Study terminated by sponsor|2|||
129691428|NCT01936974|466828249|FG000|Overall Study|Physician Decision|2|||
129691429|NCT01936974|466828250|FG001|Overall Study|Physician Decision|5|||
129691430|NCT04584554|466828253|FG000|Overall Study|Withdrawal by Subject|2|||
129691431|NCT04584554|466828254|FG001|Overall Study|Withdrawal by Subject|2|||
129691432|NCT02807181|466828255|FG000|Overall Study|Death|28|||
129691433|NCT02807181|466828256|FG001|Overall Study|Death|24|||
129691434|NCT02807181|466828255|FG000|Overall Study|Withdrawal by Subject|1|||
129691435|NCT02807181|466828256|FG001|Overall Study|Withdrawal by Subject|1|||
129691436|NCT02807181|466828255|FG000|Overall Study|Lost to Follow-up|0|||
129691437|NCT02807181|466828256|FG001|Overall Study|Lost to Follow-up|2|||
129691438|NCT02807181|466828255|FG000|Overall Study|Subject decision|1|||
129691439|NCT02807181|466828256|FG001|Overall Study|Subject decision|0|||
129781470|NCT01708902|467166154|FG006|Overall Study|Non compliance with protocol|0|||
129781471|NCT01708902|467166148|FG000|Overall Study|Lost to Follow-up|2|||
129571189|NCT02514122|466388939|FG000|Overall Study|Withdrawal by Subject|2|||
129571190|NCT02514122|466388940|FG001|Overall Study|Withdrawal by Subject|0|||
129571191|NCT04239872|466388941|FG000|Overall Study|Lost to Follow-up|0|||
129571192|NCT04239872|466388942|FG001|Overall Study|Lost to Follow-up|1|||
129571193|NCT01472341|466388943|FG000|Overall Study|Started insulin therapy|55|||
129571194|NCT01472341|466388943|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
129571195|NCT01472341|466388943|FG000|Overall Study|Withdrawal by Subject|39|||
129571196|NCT01472341|466388943|FG000|Overall Study|Lost to Follow-up|52|||
129571197|NCT01472341|466388943|FG000|Overall Study|Laboratory parameters unavailable|25|||
129571198|NCT01472341|466388943|FG000|Overall Study|Death|9|||
129571199|NCT00112463|466388946|FG000|Overall Study|Physician Decision|1|||
129571200|NCT00112463|466388946|FG000|Overall Study|Progression|30|||
129571201|NCT00112463|466388946|FG000|Overall Study|Second Primary|1|||
129691440|NCT02807181|466828255|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
129691441|NCT02807181|466828256|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
129691442|NCT02807181|466828255|FG000|Overall Study|In Study|3|||
129571202|NCT00112463|466388946|FG000|Overall Study|Toxicity|3|||
129571203|NCT00112463|466388946|FG000|Overall Study|Withdrawal by Subject|2|||
129571204|NCT00112463|466388946|FG000|Overall Study|Never started treatment|2|||
129571205|NCT01118312|466388953|FG000|Overall Study|Lost to Follow-up|33|||
129571206|NCT01118312|466388954|FG001|Overall Study|Lost to Follow-up|32|||
129571207|NCT01118312|466388953|FG000|Overall Study|Withdrawal by Subject|1|||
129571208|NCT01118312|466388954|FG001|Overall Study|Withdrawal by Subject|3|||
129571209|NCT00296647|466388955|FG000|Overall Study|Death|4|||
129571210|NCT00296647|466388956|FG001|Overall Study|Death|1|||
129571211|NCT00296647|466388957|FG002|Overall Study|Death|2|||
129571212|NCT00296647|466388958|FG003|Overall Study|Death|1|||
129571213|NCT00296647|466388959|FG004|Overall Study|Death|1|||
129571214|NCT00296647|466388955|FG000|Overall Study|Withdrawal by Subject|28|||
129571215|NCT00296647|466388956|FG001|Overall Study|Withdrawal by Subject|27|||
129571216|NCT00296647|466388957|FG002|Overall Study|Withdrawal by Subject|32|||
129571217|NCT00296647|466388958|FG003|Overall Study|Withdrawal by Subject|16|||
129571218|NCT00296647|466388959|FG004|Overall Study|Withdrawal by Subject|19|||
129571219|NCT01629381|466388960|FG000|Overall Study|Withdrawal by Subject|2|||
129571220|NCT01629381|466388961|FG001|Overall Study|Withdrawal by Subject|5|||
129571221|NCT00735904|466388962|FG000|Overall Study|Adverse Event|3|||
129571222|NCT00735904|466388962|FG000|Overall Study|Death|20|||
129571223|NCT00735904|466388962|FG000|Overall Study|Protocol Violation|1|||
129781472|NCT01708902|467166149|FG001|Overall Study|Lost to Follow-up|1|||
129781473|NCT01708902|467166150|FG002|Overall Study|Lost to Follow-up|2|||
129781474|NCT01708902|467166151|FG003|Overall Study|Lost to Follow-up|2|||
129781475|NCT01708902|467166152|FG004|Overall Study|Lost to Follow-up|0|||
129781476|NCT01708902|467166153|FG005|Overall Study|Lost to Follow-up|0|||
129781477|NCT01708902|467166154|FG006|Overall Study|Lost to Follow-up|1|||
129781478|NCT01708902|467166148|FG000|Overall Study|Refused to continue trial medication|8|||
129781479|NCT01708902|467166149|FG001|Overall Study|Refused to continue trial medication|0|||
129781480|NCT01708902|467166150|FG002|Overall Study|Refused to continue trial medication|4|||
129781481|NCT01708902|467166151|FG003|Overall Study|Refused to continue trial medication|2|||
129781482|NCT01708902|467166152|FG004|Overall Study|Refused to continue trial medication|8|||
129781483|NCT01708902|467166153|FG005|Overall Study|Refused to continue trial medication|1|||
129781484|NCT01708902|467166154|FG006|Overall Study|Refused to continue trial medication|1|||
129781485|NCT01708902|467166148|FG000|Overall Study|Other Reason|1|||
129781486|NCT01708902|467166149|FG001|Overall Study|Other Reason|0|||
129781487|NCT01708902|467166150|FG002|Overall Study|Other Reason|1|||
129781488|NCT01708902|467166151|FG003|Overall Study|Other Reason|1|||
129781489|NCT01708902|467166152|FG004|Overall Study|Other Reason|1|||
129781490|NCT01708902|467166153|FG005|Overall Study|Other Reason|2|||
129781491|NCT01708902|467166154|FG006|Overall Study|Other Reason|0|||
129781492|NCT02633020|467166156|FG000|Overall Study|Adverse Event|1|||
129781493|NCT02633020|467166157|FG001|Overall Study|Adverse Event|0|||
129781494|NCT00530816|467166158|FG000|Overall Study|Progressive Disease|16|||
129781495|NCT00530816|467166159|FG001|Overall Study|Progressive Disease|24|||
129781496|NCT00530816|467166160|FG002|Overall Study|Progressive Disease|24|||
129781497|NCT00530816|467166158|FG000|Overall Study|Adverse Event|6|||
129781498|NCT00530816|467166159|FG001|Overall Study|Adverse Event|13|||
129781499|NCT00530816|467166160|FG002|Overall Study|Adverse Event|7|||
129781500|NCT00530816|467166158|FG000|Overall Study|Other|3|||
129781501|NCT00530816|467166159|FG001|Overall Study|Other|3|||
129781502|NCT00530816|467166160|FG002|Overall Study|Other|4|||
129781503|NCT00530816|467166158|FG000|Overall Study|Withdrawal by Subject|1|||
129781504|NCT00530816|467166159|FG001|Overall Study|Withdrawal by Subject|2|||
129781505|NCT00530816|467166160|FG002|Overall Study|Withdrawal by Subject|6|||
129781506|NCT01136785|467166161|FG000|Overall Study|Protocol Violation|2|||
129781507|NCT01136785|467166162|FG001|Overall Study|Protocol Violation|1|||
129571224|NCT00735904|466388962|FG000|Overall Study|Withdrawal by Subject|1|||
129571225|NCT00735904|466388962|FG000|Overall Study|Study Terminated by Sponsor|5|||
129571226|NCT00735904|466388962|FG000|Overall Study|Other|8|||
129571227|NCT01390844|466388963|FG000|Treatment Phase|Adverse Event|12|||
129571228|NCT01390844|466388964|FG001|Treatment Phase|Adverse Event|2|||
129571229|NCT01390844|466388965|FG002|Treatment Phase|Adverse Event|3|||
129781508|NCT01388985|467166165|FG000|Overall Study|Death|0|||
129781509|NCT01388985|467166166|FG001|Overall Study|Death|1|||
129781510|NCT01388985|467166165|FG000|Overall Study|Lost to Follow-up|30|||
129781511|NCT01388985|467166166|FG001|Overall Study|Lost to Follow-up|30|||
129571230|NCT01390844|466388966|FG003|Treatment Phase|Adverse Event|2|||
129571231|NCT01390844|466388963|FG000|Treatment Phase|Treatment Failure|23|||
129691443|NCT02807181|466828256|FG001|Overall Study|In Study|3|||
129691444|NCT02807181|466828255|FG000|Overall Study|Post Progression|3|||
129691445|NCT02807181|466828256|FG001|Overall Study|Post Progression|2|||
129691446|NCT00063999|466828257|FG000|Overall Study|Withdrawal by Subject|1|||
129691447|NCT00063999|466828258|FG001|Overall Study|Withdrawal by Subject|0|||
129691448|NCT00063999|466828257|FG000|Overall Study|Ineligible|44|||
129691449|NCT00063999|466828258|FG001|Overall Study|Ineligible|24|||
129691450|NCT03767894|466828259|FG000|Overall Study|Withdrawal by Subject|1|||
129691451|NCT04243837|466828263|FG000|Overall Study|Adverse Event|2|||
129691452|NCT04243837|466828264|FG001|Overall Study|Adverse Event|1|||
129691453|NCT04243837|466828263|FG000|Overall Study|Withdrawal by Subject|4|||
129691454|NCT04243837|466828264|FG001|Overall Study|Withdrawal by Subject|2|||
129691455|NCT04243837|466828263|FG000|Overall Study|Covid-19 lock down|1|||
129691456|NCT04243837|466828264|FG001|Overall Study|Covid-19 lock down|0|||
129691457|NCT04243837|466828263|FG000|Overall Study|Study Terminated by Sponsor|11|||
129691458|NCT04243837|466828264|FG001|Overall Study|Study Terminated by Sponsor|12|||
129691459|NCT02280499|466828268|FG000|Overall Study|Death|14|||
129691460|NCT02280499|466828268|FG000|Overall Study|Lost to Follow-up|42|||
129691461|NCT02280499|466828268|FG000|Overall Study|Adverse Event|5|||
129691462|NCT00977561|466828275|FG000|Overall Study|Death|3|||
129691463|NCT00977561|466828276|FG001|Overall Study|Death|2|||
129691464|NCT00977561|466828275|FG000|Overall Study|Study terminated|0|||
129691465|NCT00977561|466828276|FG001|Overall Study|Study terminated|2|||
129691466|NCT00977561|466828275|FG000|Overall Study|Other|2|||
129691467|NCT00977561|466828276|FG001|Overall Study|Other|0|||
129691468|NCT04689009|466828280|FG000|Overall Study|Adverse Event|1|||
129691469|NCT04689009|466828281|FG001|Overall Study|Adverse Event|0|||
129691470|NCT04689009|466828280|FG000|Overall Study|Lost to Follow-up|1|||
129691471|NCT04689009|466828281|FG001|Overall Study|Lost to Follow-up|2|||
129691472|NCT04689009|466828280|FG000|Overall Study|Withdrawal by Subject|4|||
129691473|NCT04689009|466828281|FG001|Overall Study|Withdrawal by Subject|3|||
129691474|NCT04689009|466828280|FG000|Overall Study|Protocol Violation|1|||
129691475|NCT04689009|466828281|FG001|Overall Study|Protocol Violation|0|||
129691476|NCT02187055|466828282|FG000|Overall Study|Lack of Efficacy|10|||
129691477|NCT02187055|466828283|FG001|Overall Study|Lack of Efficacy|3|||
129691478|NCT02187055|466828284|FG002|Overall Study|Lack of Efficacy|7|||
129691479|NCT02187055|466828282|FG000|Overall Study|Lost to Follow-up|2|||
129691480|NCT02187055|466828283|FG001|Overall Study|Lost to Follow-up|7|||
129691481|NCT02187055|466828284|FG002|Overall Study|Lost to Follow-up|3|||
129691482|NCT02187055|466828282|FG000|Overall Study|No longer meets eligibility criteria|0|||
129691483|NCT02187055|466828283|FG001|Overall Study|No longer meets eligibility criteria|2|||
129691484|NCT02187055|466828284|FG002|Overall Study|No longer meets eligibility criteria|0|||
129691485|NCT02187055|466828282|FG000|Overall Study|No longer willing to participate|6|||
129691486|NCT02187055|466828283|FG001|Overall Study|No longer willing to participate|8|||
129691487|NCT02187055|466828284|FG002|Overall Study|No longer willing to participate|10|||
129691488|NCT02187055|466828282|FG000|Overall Study|Other|5|||
129691489|NCT02187055|466828283|FG001|Overall Study|Other|6|||
129691490|NCT02187055|466828284|FG002|Overall Study|Other|3|||
129691491|NCT02187055|466828282|FG000|Overall Study|Protocol Violation|9|||
129691492|NCT02187055|466828283|FG001|Overall Study|Protocol Violation|9|||
129691493|NCT02187055|466828284|FG002|Overall Study|Protocol Violation|4|||
129691494|NCT02187055|466828282|FG000|Overall Study|Pregnancy|3|||
129691495|NCT02187055|466828283|FG001|Overall Study|Pregnancy|1|||
129691496|NCT02187055|466828284|FG002|Overall Study|Pregnancy|0|||
129571232|NCT01390844|466388964|FG001|Treatment Phase|Treatment Failure|25|||
129691497|NCT02187055|466828282|FG000|Overall Study|Withdrawal by Subject|11|||
129691498|NCT02187055|466828283|FG001|Overall Study|Withdrawal by Subject|11|||
129691499|NCT02187055|466828284|FG002|Overall Study|Withdrawal by Subject|11|||
129691500|NCT02187055|466828282|FG000|Overall Study|Adverse Event|21|||
129691501|NCT02187055|466828283|FG001|Overall Study|Adverse Event|26|||
129691502|NCT02187055|466828284|FG002|Overall Study|Adverse Event|36|||
129691503|NCT02187055|466828282|FG000|Overall Study|Death|2|||
129691504|NCT02187055|466828283|FG001|Overall Study|Death|0|||
129691505|NCT02187055|466828284|FG002|Overall Study|Death|0|||
129691506|NCT05737745|466828285|FG000|Overall Study|Withdrawal by Subject|0|||
129691507|NCT05737745|466828286|FG001|Overall Study|Withdrawal by Subject|6|||
129571233|NCT01390844|466388965|FG002|Treatment Phase|Treatment Failure|10|||
129691508|NCT05737745|466828287|FG002|Overall Study|Withdrawal by Subject|1|||
129691509|NCT02547935|466828288|FG000|Overall Study|Other|0|||
129691510|NCT02547935|466828289|FG001|Overall Study|Other|1|||
129691511|NCT02547935|466828290|FG002|Overall Study|Other|0|||
129691512|NCT02547935|466828288|FG000|Overall Study|Withdrawal by Subject|2|||
129691513|NCT02547935|466828289|FG001|Overall Study|Withdrawal by Subject|3|||
129691514|NCT02547935|466828290|FG002|Overall Study|Withdrawal by Subject|4|||
129691515|NCT02547935|466828288|FG000|Overall Study|Screen Failure|2|||
129691516|NCT02547935|466828289|FG001|Overall Study|Screen Failure|0|||
129691517|NCT02547935|466828290|FG002|Overall Study|Screen Failure|0|||
129691518|NCT02547935|466828288|FG000|Overall Study|Physician Decision|0|||
129691519|NCT02547935|466828289|FG001|Overall Study|Physician Decision|1|||
129691520|NCT02547935|466828290|FG002|Overall Study|Physician Decision|0|||
129691521|NCT02547935|466828288|FG000|Overall Study|Lost to Follow-up|0|||
129691522|NCT02547935|466828289|FG001|Overall Study|Lost to Follow-up|2|||
129691523|NCT02547935|466828290|FG002|Overall Study|Lost to Follow-up|1|||
129691524|NCT02547935|466828288|FG000|Overall Study|Death|1|||
129691525|NCT02547935|466828289|FG001|Overall Study|Death|1|||
129691526|NCT02547935|466828290|FG002|Overall Study|Death|0|||
129691527|NCT02487199|466828293|FG000|Overall Study|Withdrew Consent|0|||
129691528|NCT02487199|466828294|FG001|Overall Study|Withdrew Consent|1|||
129691529|NCT05206604|466830467|FG000|Overall Study|Non-compliance with study drug|0|||
129691530|NCT05206604|466830468|FG001|Overall Study|Non-compliance with study drug|0|||
129691531|NCT05206604|466830469|FG002|Overall Study|Non-compliance with study drug|0|||
129691532|NCT05206604|466830470|FG003|Overall Study|Non-compliance with study drug|0|||
129691533|NCT05206604|466830471|FG004|Overall Study|Non-compliance with study drug|0|||
129691534|NCT05206604|466830472|FG005|Overall Study|Non-compliance with study drug|1|||
129691535|NCT05206604|466830473|FG006|Overall Study|Non-compliance with study drug|0|||
129691536|NCT05206604|466830474|FG007|Overall Study|Non-compliance with study drug|0|||
129691537|NCT03735498|466830475|FG000|Overall Study|Withdrawal by Subject|3|||
129691538|NCT03735498|466830475|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
129691539|NCT02014103|466830476|FG000|Overall Study|Protocol Violation|7|||
129691540|NCT02014103|466830477|FG001|Overall Study|Protocol Violation|7|||
129691541|NCT02014103|466830476|FG000|Overall Study|Adverse Event|1|||
129691542|NCT02014103|466830477|FG001|Overall Study|Adverse Event|0|||
129691543|NCT02014103|466830476|FG000|Overall Study|Lost venous access|1|||
129691544|NCT02014103|466830477|FG001|Overall Study|Lost venous access|0|||
129691545|NCT02014103|466830476|FG000|Overall Study|Withdrawal by Subject|0|||
129691546|NCT02014103|466830477|FG001|Overall Study|Withdrawal by Subject|2|||
129691547|NCT04289298|466830479|FG000|Overall Study|Lost to Follow-up|5|||
129691548|NCT04289298|466830480|FG001|Overall Study|Lost to Follow-up|0|||
129691549|NCT04289298|466830479|FG000|Overall Study|Withdrawal by Subject|2|||
129691550|NCT04289298|466830480|FG001|Overall Study|Withdrawal by Subject|0|||
129691551|NCT00620035|466830481|FG000|Overall Study|Adverse Event|106|||
129691552|NCT00620035|466830481|FG000|Overall Study|Withdrawal of Informed Consent|1|||
129691553|NCT00620035|466830481|FG000|Overall Study|Other Reason|38|||
129691554|NCT01108796|466830484|FG000|Overall Study|Adverse Event|0|||
129691555|NCT01108796|466830485|FG001|Overall Study|Adverse Event|1|||
129691556|NCT01108796|466830484|FG000|Overall Study|Lost to Follow-up|7|||
129691557|NCT01108796|466830485|FG001|Overall Study|Lost to Follow-up|6|||
129691558|NCT01245751|466830487|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
129691559|NCT01245751|466830488|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
129691560|NCT01245751|466830489|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
129691561|NCT01245751|466830490|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
129691562|NCT01245751|466830487|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
129691563|NCT01245751|466830488|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
129691564|NCT01245751|466830489|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
129691565|NCT01245751|466830490|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
129691566|NCT01245751|466830487|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
129691567|NCT01245751|466830488|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
129691568|NCT01245751|466830489|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
129691569|NCT01245751|466830490|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
129691570|NCT00985192|466830491|FG000|Overall Study|Withdrawal by Subject|1|||
129691571|NCT00985192|466830491|FG000|Overall Study|Disease Progression|1|||
129691572|NCT00985192|466830491|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
129691573|NCT00676052|466830494|FG000|Overall Study|Adverse Event|0|||
129691574|NCT00676052|466830495|FG001|Overall Study|Adverse Event|1|||
129691575|NCT00676052|466830496|FG002|Overall Study|Adverse Event|1|||
129691576|NCT00676052|466830497|FG003|Overall Study|Adverse Event|2|||
129691577|NCT00676052|466830498|FG004|Overall Study|Adverse Event|2|||
129781512|NCT01388985|467166165|FG000|Overall Study|Withdrawal by Subject|13|||
129781513|NCT01388985|467166166|FG001|Overall Study|Withdrawal by Subject|4|||
129781514|NCT01388985|467166165|FG000|Overall Study|Subject unavailable|1|||
129781515|NCT01388985|467166166|FG001|Overall Study|Subject unavailable|1|||
129781516|NCT01388985|467166165|FG000|Overall Study|Other (no reason)|0|||
129781517|NCT01388985|467166166|FG001|Overall Study|Other (no reason)|1|||
129781518|NCT01388985|467166165|FG000|Overall Study|Error of nurse|5|||
129781519|NCT01388985|467166166|FG001|Overall Study|Error of nurse|1|||
129781520|NCT01057589|467166167|FG000|Overall Study|Disease Progression|35|||
129781521|NCT01057589|467166167|FG000|Overall Study|Adverse Event|10|||
129781522|NCT01057589|467166167|FG000|Overall Study|Physician Decision|8|||
129781523|NCT01057589|467166167|FG000|Overall Study|Withdrawal by Subject|3|||
129781524|NCT01057589|467166167|FG000|Overall Study|Sponsor Decision|1|||
129781525|NCT01057589|467166167|FG000|Overall Study|Death|8|||
129781526|NCT01057589|467166167|FG000|Overall Study|Lost to Follow-up|1|||
129781527|NCT02954172|467166172|FG000|Overall Study|Protocol Violation|3|||
129781528|NCT02954172|467166173|FG001|Overall Study|Protocol Violation|0|||
129781529|NCT02954172|467166172|FG000|Overall Study|allergic reaction|2|||
129781530|NCT02954172|467166173|FG001|Overall Study|allergic reaction|1|||
129781531|NCT02954172|467166172|FG000|Overall Study|non-measurable lesions at baseline|1|||
129781532|NCT02954172|467166173|FG001|Overall Study|non-measurable lesions at baseline|2|||
129781533|NCT00853567|467166174|FG000|Overall Study|Study prematurely terminated|71|||
129781534|NCT01497366|467166178|FG000|Overall Study|Virologic failure|2|||
129781535|NCT01497366|467166179|FG001|Overall Study|Virologic failure|50|||
129781536|NCT01497366|467166178|FG000|Overall Study|Lost to Follow-up|11|||
129781537|NCT01497366|467166179|FG001|Overall Study|Lost to Follow-up|10|||
129781538|NCT01497366|467166178|FG000|Overall Study|Withdrawal by Subject|6|||
129781539|NCT01497366|467166179|FG001|Overall Study|Withdrawal by Subject|6|||
129781540|NCT01497366|467166178|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
129781541|NCT01497366|467166179|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
129781542|NCT01497366|467166178|FG000|Overall Study|Other|5|||
129781543|NCT01497366|467166179|FG001|Overall Study|Other|0|||
129781544|NCT01497366|467166178|FG000|Overall Study|Death|1|||
129781545|NCT01497366|467166179|FG001|Overall Study|Death|1|||
129781546|NCT01497366|467166178|FG000|Overall Study|Randomized but not treated|7|||
129781547|NCT01497366|467166179|FG001|Overall Study|Randomized but not treated|21|||
129781548|NCT02745080|467166193|FG000|Overall Study|Adverse Event|13|||
129781549|NCT02745080|467166194|FG001|Overall Study|Adverse Event|21|||
129781550|NCT02745080|467166193|FG000|Overall Study|Lack of Efficacy|11|||
129781551|NCT02745080|467166194|FG001|Overall Study|Lack of Efficacy|23|||
129781552|NCT02745080|467166193|FG000|Overall Study|Lost to Follow-up|3|||
129781553|NCT02745080|467166194|FG001|Overall Study|Lost to Follow-up|3|||
129571234|NCT01390844|466388966|FG003|Treatment Phase|Treatment Failure|13|||
129571235|NCT01390844|466388963|FG000|Treatment Phase|Non-Medical Reasons|5|||
129781554|NCT02745080|467166193|FG000|Overall Study|Physician Decision|3|||
129781555|NCT02745080|467166194|FG001|Overall Study|Physician Decision|0|||
129781556|NCT02745080|467166193|FG000|Overall Study|Protocol Violation|3|||
129781557|NCT02745080|467166194|FG001|Overall Study|Protocol Violation|1|||
129781558|NCT02745080|467166193|FG000|Overall Study|Withdrawal by Subject|22|||
129781559|NCT02745080|467166194|FG001|Overall Study|Withdrawal by Subject|41|||
129781560|NCT00531427|467166197|FG000|Overall Study|Withdrawal by Subject|7|||
129781561|NCT00531427|467166198|FG001|Overall Study|Withdrawal by Subject|13|||
129781562|NCT00531427|467166197|FG000|Overall Study|Adverse Event|44|||
129781563|NCT00531427|467166198|FG001|Overall Study|Adverse Event|30|||
129781564|NCT00531427|467166197|FG000|Overall Study|Lost to Follow-up|4|||
129781565|NCT00531427|467166198|FG001|Overall Study|Lost to Follow-up|3|||
129781566|NCT00531427|467166197|FG000|Overall Study|Lack of Efficacy|14|||
129781567|NCT00531427|467166198|FG001|Overall Study|Lack of Efficacy|39|||
129781568|NCT00531427|467166197|FG000|Overall Study|Administrative|4|||
129781569|NCT00531427|467166198|FG001|Overall Study|Administrative|9|||
129781570|NCT00843284|467167977|FG000|Overall Study|Adverse Event|39|||
129781571|NCT00843284|467167977|FG000|Overall Study|Lack of Efficacy|5|||
129781572|NCT00843284|467167977|FG000|Overall Study|Lost to Follow-up|11|||
129781573|NCT00843284|467167977|FG000|Overall Study|Other|10|||
129781574|NCT00843284|467167977|FG000|Overall Study|Withdrawal by Subject|4|||
129781575|NCT00843284|467167977|FG000|Overall Study|Death|3|||
129781576|NCT00798759|467167981|FG000|Overall Study|Adverse Event|3|||
129781577|NCT00798759|467167982|FG001|Overall Study|Adverse Event|3|||
129781578|NCT00798759|467167981|FG000|Overall Study|Lost to Follow-up|1|||
129781579|NCT00798759|467167982|FG001|Overall Study|Lost to Follow-up|1|||
129781580|NCT00798759|467167981|FG000|Overall Study|Protocol Violation|4|||
129781581|NCT00798759|467167982|FG001|Overall Study|Protocol Violation|8|||
129781582|NCT00798759|467167981|FG000|Overall Study|Other|0|||
129781583|NCT00798759|467167982|FG001|Overall Study|Other|1|||
129781584|NCT00724711|467167983|FG000|Overall Study|Adverse Event|7|||
129781585|NCT00724711|467167984|FG001|Overall Study|Adverse Event|3|||
129781586|NCT00724711|467167983|FG000|Overall Study|Pregnancy|0|||
129781587|NCT00724711|467167984|FG001|Overall Study|Pregnancy|1|||
129781588|NCT00724711|467167983|FG000|Overall Study|Lack of Efficacy|0|||
129781589|NCT00724711|467167984|FG001|Overall Study|Lack of Efficacy|1|||
129781590|NCT00724711|467167983|FG000|Overall Study|Physician Decision|0|||
129781591|NCT00724711|467167984|FG001|Overall Study|Physician Decision|3|||
129781592|NCT00724711|467167983|FG000|Overall Study|Withdrawal by Subject|5|||
129781593|NCT00724711|467167984|FG001|Overall Study|Withdrawal by Subject|4|||
129781594|NCT00724711|467167983|FG000|Overall Study|Lost to Follow-up|4|||
129781595|NCT00724711|467167984|FG001|Overall Study|Lost to Follow-up|5|||
129781596|NCT00724711|467167983|FG000|Overall Study|Protocol Violation|1|||
129781597|NCT00724711|467167984|FG001|Overall Study|Protocol Violation|0|||
129781598|NCT01945710|467167985|FG000|Overall Study|Progressive Disease|5|||
129781599|NCT01945710|467167986|FG001|Overall Study|Progressive Disease|4|||
129781600|NCT01945710|467167987|FG002|Overall Study|Progressive Disease|3|||
129781601|NCT01945710|467167988|FG003|Overall Study|Progressive Disease|2|||
129781602|NCT01945710|467167989|FG004|Overall Study|Progressive Disease|7|||
129781603|NCT01945710|467167990|FG005|Overall Study|Progressive Disease|3|||
129781604|NCT01945710|467167991|FG006|Overall Study|Progressive Disease|19|||
129781605|NCT01945710|467167985|FG000|Overall Study|Adverse Event|0|||
129781606|NCT01945710|467167986|FG001|Overall Study|Adverse Event|1|||
129781607|NCT01945710|467167987|FG002|Overall Study|Adverse Event|0|||
129781608|NCT01945710|467167988|FG003|Overall Study|Adverse Event|0|||
129781609|NCT01945710|467167989|FG004|Overall Study|Adverse Event|0|||
129781610|NCT01945710|467167990|FG005|Overall Study|Adverse Event|0|||
129781611|NCT01945710|467167991|FG006|Overall Study|Adverse Event|0|||
129781612|NCT01945710|467167985|FG000|Overall Study|Other|2|||
129781613|NCT01945710|467167986|FG001|Overall Study|Other|0|||
129781614|NCT01945710|467167987|FG002|Overall Study|Other|3|||
129781615|NCT01945710|467167988|FG003|Overall Study|Other|1|||
129781616|NCT01945710|467167989|FG004|Overall Study|Other|1|||
129781617|NCT01945710|467167990|FG005|Overall Study|Other|0|||
129781618|NCT01945710|467167991|FG006|Overall Study|Other|4|||
129781619|NCT01945710|467167985|FG000|Overall Study|Withdrawal by Subject|0|||
129781620|NCT01945710|467167986|FG001|Overall Study|Withdrawal by Subject|1|||
129781621|NCT01945710|467167987|FG002|Overall Study|Withdrawal by Subject|1|||
129781622|NCT01945710|467167988|FG003|Overall Study|Withdrawal by Subject|0|||
129781623|NCT01945710|467167989|FG004|Overall Study|Withdrawal by Subject|1|||
129781624|NCT01945710|467167990|FG005|Overall Study|Withdrawal by Subject|0|||
129781625|NCT01945710|467167991|FG006|Overall Study|Withdrawal by Subject|0|||
129781626|NCT00375609|467167992|FG000|Overall Study|Did not receive treatment|1|||
129781627|NCT00375609|467167993|FG001|Overall Study|Did not receive treatment|0|||
129781628|NCT00375609|467167994|FG002|Overall Study|Did not receive treatment|0|||
129781629|NCT00375609|467167992|FG000|Overall Study|Adverse Event|0|||
129781630|NCT00375609|467167993|FG001|Overall Study|Adverse Event|3|||
129781631|NCT00375609|467167994|FG002|Overall Study|Adverse Event|0|||
129781632|NCT00375609|467167992|FG000|Overall Study|Lost to Follow-up|1|||
129781633|NCT00375609|467167993|FG001|Overall Study|Lost to Follow-up|0|||
129781634|NCT00375609|467167994|FG002|Overall Study|Lost to Follow-up|0|||
129781635|NCT00375609|467167992|FG000|Overall Study|Physician Decision|0|||
129781636|NCT00375609|467167993|FG001|Overall Study|Physician Decision|0|||
129781637|NCT00375609|467167994|FG002|Overall Study|Physician Decision|1|||
129781638|NCT00375609|467167992|FG000|Overall Study|Withdrawal by Subject|1|||
129781639|NCT00375609|467167993|FG001|Overall Study|Withdrawal by Subject|4|||
129781640|NCT00375609|467167994|FG002|Overall Study|Withdrawal by Subject|0|||
129781641|NCT00375609|467167992|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
129571236|NCT01390844|466388964|FG001|Treatment Phase|Non-Medical Reasons|1|||
129781642|NCT00375609|467167993|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
129781643|NCT00375609|467167994|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
129781644|NCT02338882|467167999|FG000|Overall Study|Death|1|||
129781645|NCT02338882|467168000|FG001|Overall Study|Death|0|||
129781646|NCT02338882|467167999|FG000|Overall Study|Lost to Follow-up|6|||
129781647|NCT02338882|467168000|FG001|Overall Study|Lost to Follow-up|3|||
129781648|NCT04838977|467168003|FG000|Overall Study|Lost to Follow-up|2|||
129781649|NCT04838977|467168004|FG001|Overall Study|Lost to Follow-up|3|||
129781650|NCT04838977|467168003|FG000|Overall Study|Withdrawal by Subject|1|||
129781651|NCT04838977|467168004|FG001|Overall Study|Withdrawal by Subject|1|||
129781652|NCT00095940|467168006|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
129781653|NCT00095940|467168007|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
129781654|NCT00095940|467168008|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
129571237|NCT01390844|466388965|FG002|Treatment Phase|Non-Medical Reasons|8|||
129571238|NCT01390844|466388966|FG003|Treatment Phase|Non-Medical Reasons|1|||
129571239|NCT01390844|466388963|FG000|Treatment Phase|Non-GCP Compliant|0|||
129571240|NCT01390844|466388964|FG001|Treatment Phase|Non-GCP Compliant|0|||
129571241|NCT01390844|466388965|FG002|Treatment Phase|Non-GCP Compliant|10|||
129571242|NCT01390844|466388966|FG003|Treatment Phase|Non-GCP Compliant|3|||
129571243|NCT01390844|466388963|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
129571244|NCT01390844|466388964|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
129571245|NCT01390844|466388965|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
129571246|NCT01390844|466388966|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
129571247|NCT03204539|466388971|FG000|Overall Study|Loss of funding|0|||
129571248|NCT03204539|466388972|FG001|Overall Study|Loss of funding|1|||
129781655|NCT00095940|467168009|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
129781656|NCT00095940|467168010|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
129781657|NCT00095940|467168011|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
129781658|NCT00095940|467168012|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
129781659|NCT00095940|467168013|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
129781660|NCT00095940|467168014|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
129781661|NCT00095940|467168006|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
129781662|NCT00095940|467168007|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
129781663|NCT00095940|467168008|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
129781664|NCT00095940|467168009|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
129781665|NCT00095940|467168010|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
129781666|NCT00095940|467168011|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
129781667|NCT00095940|467168012|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
129781668|NCT00095940|467168013|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
129781669|NCT00095940|467168014|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
129781670|NCT00095940|467168006|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781671|NCT00095940|467168007|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781672|NCT00095940|467168008|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781673|NCT00095940|467168009|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781674|NCT00095940|467168010|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781675|NCT00095940|467168011|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781676|NCT00095940|467168012|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781677|NCT00095940|467168013|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
129781678|NCT00095940|467168014|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
129781679|NCT02350478|467168015|FG000|Overall Study|Lost to Follow-up|5|||
129781680|NCT02350478|467168016|FG001|Overall Study|Lost to Follow-up|1|||
129781681|NCT03646123|467168029|FG000|Overall Study|Withdrawal by Subject|2|||
129781682|NCT03646123|467168030|FG001|Overall Study|Withdrawal by Subject|2|||
129781683|NCT03646123|467168031|FG002|Overall Study|Withdrawal by Subject|3|||
129781684|NCT03646123|467168029|FG000|Overall Study|Study termination by sponsor|0|||
129781685|NCT03646123|467168030|FG001|Overall Study|Study termination by sponsor|45|||
129781686|NCT03646123|467168031|FG002|Overall Study|Study termination by sponsor|139|||
129781687|NCT03646123|467168029|FG000|Overall Study|Lost to Follow-up|4|||
129781688|NCT03646123|467168030|FG001|Overall Study|Lost to Follow-up|10|||
129781689|NCT03646123|467168031|FG002|Overall Study|Lost to Follow-up|10|||
129781690|NCT03646123|467168029|FG000|Overall Study|Death|2|||
129781691|NCT03646123|467168030|FG001|Overall Study|Death|1|||
129571249|NCT01171963|466388973|FG000|Overall Study|Adverse Event|10|||
129571250|NCT01171963|466388974|FG001|Overall Study|Adverse Event|15|||
129571251|NCT01171963|466388973|FG000|Overall Study|Lost to Follow-up|23|||
129781692|NCT03646123|467168031|FG002|Overall Study|Death|1|||
129781693|NCT03646123|467168029|FG000|Overall Study|Other|2|||
129781694|NCT03646123|467168030|FG001|Overall Study|Other|0|||
129781695|NCT03646123|467168031|FG002|Overall Study|Other|2|||
129781696|NCT04195893|467168038|FG000|Second Intervention|Withdrawal by Subject|1|||
129781697|NCT04195893|467168039|FG001|Second Intervention|Withdrawal by Subject|0|||
129781698|NCT03679754|467168042|FG000|Overall Study|Investigator request|1|||
129571252|NCT01171963|466388974|FG001|Overall Study|Lost to Follow-up|24|||
129781699|NCT00964171|467168043|FG000|Overall Study|Death|5|||
129781700|NCT03037580|467168047|FG000|Overall Study|Withdrawal by Subject|3|||
129781701|NCT03037580|467168048|FG001|Overall Study|Withdrawal by Subject|0|||
129781702|NCT03037580|467168047|FG000|Overall Study|Adverse Event|1|||
129781703|NCT03037580|467168048|FG001|Overall Study|Adverse Event|0|||
129781704|NCT03037580|467168047|FG000|Overall Study|Study Terminated by Sponsor|12|||
129781705|NCT03037580|467168048|FG001|Overall Study|Study Terminated by Sponsor|15|||
129781706|NCT03037580|467168047|FG000|Overall Study|Death|0|||
129781707|NCT03037580|467168048|FG001|Overall Study|Death|1|||
129781708|NCT02442804|467168049|FG000|Overall Study|Withdrawal by Subject|0|||
129781709|NCT02442804|467168050|FG001|Overall Study|Withdrawal by Subject|1|||
129781710|NCT02442804|467168049|FG000|Overall Study|Adverse Event|1|||
129781711|NCT02442804|467168050|FG001|Overall Study|Adverse Event|0|||
129781712|NCT02036853|467168051|FG000|Overall Study|Adverse Event|0|||
129781713|NCT02036853|467168052|FG001|Overall Study|Adverse Event|2|||
129781714|NCT02036853|467168051|FG000|Overall Study|Lack of Efficacy|0|||
129781715|NCT02036853|467168052|FG001|Overall Study|Lack of Efficacy|2|||
129781716|NCT02036853|467168051|FG000|Overall Study|Physician Decision|0|||
129781717|NCT02036853|467168052|FG001|Overall Study|Physician Decision|1|||
129781718|NCT02036853|467168051|FG000|Overall Study|Withdrawal by Subject|0|||
129781719|NCT02036853|467168052|FG001|Overall Study|Withdrawal by Subject|1|||
129781720|NCT01309282|467168056|FG000|Overall Study|Lost to Follow-up|1|||
129781721|NCT00499590|467168059|FG000|Overall Study|Study Terminated|112|||
129781722|NCT00499590|467168060|FG001|Overall Study|Study Terminated|112|||
129781723|NCT00499590|467168061|FG002|Overall Study|Study Terminated|112|||
129781724|NCT00499590|467168059|FG000|Overall Study|Not treated|1|||
129781725|NCT00499590|467168060|FG001|Overall Study|Not treated|0|||
129781726|NCT00499590|467168061|FG002|Overall Study|Not treated|1|||
129781727|NCT05661851|467168063|FG000|Overall Study|Protocol Violation|1|||
129781728|NCT05661851|467168064|FG001|Overall Study|Protocol Violation|1|||
129781729|NCT05661851|467168063|FG000|Overall Study|Covid-19 Related|3|||
129781730|NCT05661851|467168064|FG001|Overall Study|Covid-19 Related|4|||
129781731|NCT05661851|467168063|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
129781732|NCT05661851|467168064|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
129781733|NCT05661851|467168063|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
129781734|NCT05661851|467168064|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
129781735|NCT00612807|467168065|FG000|Overall Study|Withdrawal by Subject|2|||
129781736|NCT00612807|467168066|FG001|Overall Study|Withdrawal by Subject|0|||
129781737|NCT02055118|467168073|FG000|Overall Study|Withdrawal by Subject|0|||
129781738|NCT02055118|467168074|FG001|Overall Study|Withdrawal by Subject|2|||
129781739|NCT02055118|467168075|FG002|Overall Study|Withdrawal by Subject|0|||
129781740|NCT02281383|467168076|FG000|Overall Study|Progressive Disease|1|||
129781741|NCT02281383|467168076|FG000|Overall Study|Withdrawal by Subject|6|||
129781742|NCT02281383|467168076|FG000|Overall Study|Protocol Violation|2|||
129781743|NCT02281383|467168076|FG000|Overall Study|Death|1|||
129781744|NCT02281383|467168076|FG000|Overall Study|Adverse Event|2|||
129781745|NCT02259088|467168077|FG000|Overall Study|Adverse Event|6|||
129781746|NCT02259088|467168078|FG001|Overall Study|Adverse Event|4|||
129781747|NCT02259088|467168077|FG000|Overall Study|Lost to Follow-up|2|||
129781748|NCT02259088|467168078|FG001|Overall Study|Lost to Follow-up|0|||
129781749|NCT02259088|467168077|FG000|Overall Study|Death|2|||
129781750|NCT02259088|467168078|FG001|Overall Study|Death|0|||
129781751|NCT02259088|467168077|FG000|Overall Study|Physician Decision|5|||
129781752|NCT02259088|467168078|FG001|Overall Study|Physician Decision|2|||
129781753|NCT02259088|467168077|FG000|Overall Study|Protocol deviation|5|||
129571253|NCT01171963|466388973|FG000|Overall Study|Other - diarrhoea|1|||
129571254|NCT01171963|466388974|FG001|Overall Study|Other - diarrhoea|0|||
129571255|NCT01171963|466388973|FG000|Overall Study|Withdrawal by Subject|114|||
129571256|NCT01171963|466388974|FG001|Overall Study|Withdrawal by Subject|129|||
129571257|NCT05093205|466388975|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
129571258|NCT05093205|466388976|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
129781754|NCT02259088|467168078|FG001|Overall Study|Protocol deviation|0|||
129781755|NCT02259088|467168077|FG000|Overall Study|Subject/guardian decision|8|||
129781756|NCT02259088|467168078|FG001|Overall Study|Subject/guardian decision|8|||
129571259|NCT05093205|466388977|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
129571260|NCT05093205|466388978|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
129571261|NCT05093205|466388979|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
129781757|NCT01001325|467168081|FG000|Overall Study|Lost to Follow-up|16|||
129781758|NCT01001325|467168082|FG001|Overall Study|Lost to Follow-up|10|||
129781759|NCT01001325|467168081|FG000|Overall Study|Protocol Violation|2|||
129781760|NCT01001325|467168082|FG001|Overall Study|Protocol Violation|0|||
129781761|NCT01584440|467168083|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
129781762|NCT01584440|467168084|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
129781763|NCT01584440|467168085|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
129781764|NCT01584440|467168086|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
129781765|NCT01584440|467168087|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
129781766|NCT01584440|467168083|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
129781767|NCT01584440|467168084|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
129781768|NCT01584440|467168085|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
129781769|NCT01584440|467168086|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
129781770|NCT01584440|467168087|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
129781771|NCT01584440|467168083|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
129781772|NCT01584440|467168084|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
129781773|NCT01584440|467168085|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
129781774|NCT01584440|467168086|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
129781775|NCT01584440|467168087|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
129781776|NCT01584440|467168083|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
129781777|NCT01584440|467168084|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
129781778|NCT01584440|467168085|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
129781779|NCT01584440|467168086|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
129781780|NCT01584440|467168087|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
129781781|NCT01584440|467168083|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
129781782|NCT01584440|467168084|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
129781783|NCT01584440|467168085|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
129781784|NCT01584440|467168086|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
129781785|NCT01584440|467168087|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
129781786|NCT01584440|467168083|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
129781787|NCT01584440|467168084|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
129781788|NCT01584440|467168085|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
129781789|NCT01584440|467168086|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
129781790|NCT01584440|467168087|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
129781791|NCT01584440|467168083|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
129781792|NCT01584440|467168084|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
129781793|NCT01584440|467168085|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
129781794|NCT01584440|467168086|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
129781795|NCT01584440|467168087|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
129781796|NCT01584440|467168083|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
129781797|NCT01584440|467168084|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
129781798|NCT01584440|467168085|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
129781799|NCT01584440|467168086|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
129781800|NCT01584440|467168087|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
129781801|NCT01584440|467168083|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
129781802|NCT01584440|467168084|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
129781803|NCT01584440|467168085|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
129781804|NCT01584440|467168086|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
129781805|NCT01584440|467168087|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
129781806|NCT00899431|467168088|FG000|Overall Study|Physician Decision|1|||
129781807|NCT00899431|467168089|FG001|Overall Study|Physician Decision|0|||
129781808|NCT00899431|467168090|FG002|Overall Study|Physician Decision|0|||
129781809|NCT00661427|467168091|FG000|Overall Study|Adverse Event|5|||
129781810|NCT00661427|467168092|FG001|Overall Study|Adverse Event|5|||
129781811|NCT00661427|467168091|FG000|Overall Study|Patient not treated|0|||
129781812|NCT00661427|467168092|FG001|Overall Study|Patient not treated|2|||
129781813|NCT01821560|467168093|FG000|Overall Study|Lost to Follow-up|5|||
129781814|NCT01821560|467168094|FG001|Overall Study|Lost to Follow-up|5|||
129781815|NCT01821560|467168093|FG000|Overall Study|Withdrawal by Subject|1|||
129781816|NCT01821560|467168094|FG001|Overall Study|Withdrawal by Subject|1|||
129781817|NCT01821560|467168093|FG000|Overall Study|Protocol Violation|0|||
129781818|NCT01821560|467168094|FG001|Overall Study|Protocol Violation|1|||
129781819|NCT01338298|467168095|FG000|Overall Study|Withdrawal by Subject|1|||
129781820|NCT01338298|467168096|FG001|Overall Study|Withdrawal by Subject|1|||
129781821|NCT01338298|467168095|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
129781822|NCT01338298|467168096|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
129781823|NCT01338298|467168095|FG000|Overall Study|Administrative error|0|||
129781824|NCT01338298|467168096|FG001|Overall Study|Administrative error|1|||
129781825|NCT01338298|467168095|FG000|Overall Study|Positive symptom worsening|1|||
129781826|NCT01338298|467168096|FG001|Overall Study|Positive symptom worsening|0|||
129781827|NCT01338298|467168095|FG000|Overall Study|Depressive symptoms and nausea|1|||
129781828|NCT01338298|467168096|FG001|Overall Study|Depressive symptoms and nausea|0|||
129781829|NCT01338298|467168095|FG000|Overall Study|Non-adherence|1|||
129781830|NCT01338298|467168096|FG001|Overall Study|Non-adherence|0|||
129781831|NCT02872285|467168097|FG000|Overall Study|Withdrawal by Subject|2|||
129781832|NCT02872285|467168098|FG001|Overall Study|Withdrawal by Subject|0|||
129781833|NCT02872285|467168097|FG000|Overall Study|Lost to Follow-up|2|||
129781834|NCT02872285|467168098|FG001|Overall Study|Lost to Follow-up|2|||
129781835|NCT02872285|467168097|FG000|Overall Study|Discontinued due to back surgery|1|||
129781836|NCT02872285|467168098|FG001|Overall Study|Discontinued due to back surgery|0|||
129781837|NCT01253577|467168101|FG000|Overall Study|Lost to Follow-up|3|||
129781838|NCT00334113|467168102|FG000|Overall Study|Lost to Follow-up|2|||
129781839|NCT00334113|467168103|FG001|Overall Study|Lost to Follow-up|2|||
129781840|NCT00334113|467168102|FG000|Overall Study|Withdrawal by Subject|0|||
129781841|NCT00334113|467168103|FG001|Overall Study|Withdrawal by Subject|1|||
129781842|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
129781843|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
129781844|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
129781845|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
129781846|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Other|2|||
129781847|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
129781848|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
129781849|NCT02509026|467168104|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
129781850|NCT02509026|467168104|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
129781851|NCT02509026|467168104|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
129781852|NCT02509026|467168104|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
129781853|NCT02509026|467168104|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
129781854|NCT02509026|467168104|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
129781855|NCT00721968|467168105|FG000|Overall Study|Lost to Follow-up|2|||
129781856|NCT00721968|467168106|FG001|Overall Study|Lost to Follow-up|0|||
129781857|NCT05601544|467168107|FG000|Phase 2 Period 1|Adverse Event|0|||
129781858|NCT05601544|467168108|FG001|Phase 2 Period 1|Adverse Event|1|||
129781859|NCT05601544|467168109|FG002|Phase 2 Period 1|Adverse Event|0|||
129781860|NCT05601544|467168110|FG003|Phase 2 Period 1|Adverse Event|0|||
129781861|NCT05601544|467168111|FG004|Phase 2 Period 1|Adverse Event|0|||
129781862|NCT05601544|467168112|FG005|Phase 2 Period 1|Adverse Event|0|||
129781863|NCT02626624|467168125|FG000|Overall Study|Adverse Event|1|||
129781864|NCT02626624|467168125|FG000|Overall Study|Lost to Follow-up|3|||
129781865|NCT02626624|467168125|FG000|Overall Study|Protocol Violation|4|||
129781866|NCT02626624|467168125|FG000|Overall Study|Death|2|||
129781867|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
129781868|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
129781869|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
129781870|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
129781871|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
129781872|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
129781873|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
129781874|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
129781875|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
129781876|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
129781877|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
129781878|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
129781879|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
129781880|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
129781881|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
129781882|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
129781883|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
129781884|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
129781885|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
129781886|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
129781887|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
129781888|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
129781889|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
129781890|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
129781891|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
129781892|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
129781893|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
129781894|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
129781895|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
129781896|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
129781897|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
129781898|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
129781899|NCT03818035|467168128|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
129781900|NCT03818035|467168129|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
129781901|NCT03818035|467168130|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
129781902|NCT03818035|467168131|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
129781903|NCT03818035|467168128|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
129781904|NCT03818035|467168129|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
129691578|NCT00676052|466830499|FG005|Overall Study|Adverse Event|2|||
129691579|NCT00676052|466830494|FG000|Overall Study|Lack of Efficacy|2|||
129691580|NCT00676052|466830495|FG001|Overall Study|Lack of Efficacy|2|||
129691581|NCT00676052|466830496|FG002|Overall Study|Lack of Efficacy|1|||
129691582|NCT00676052|466830497|FG003|Overall Study|Lack of Efficacy|1|||
129691583|NCT00676052|466830498|FG004|Overall Study|Lack of Efficacy|2|||
129691584|NCT00676052|466830499|FG005|Overall Study|Lack of Efficacy|1|||
129691585|NCT00676052|466830494|FG000|Overall Study|Protocol Violation|5|||
129571262|NCT05093205|466388980|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
129571263|NCT05093205|466388981|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
129691586|NCT00676052|466830495|FG001|Overall Study|Protocol Violation|3|||
129691587|NCT00676052|466830496|FG002|Overall Study|Protocol Violation|2|||
129691588|NCT00676052|466830497|FG003|Overall Study|Protocol Violation|2|||
129691589|NCT00676052|466830498|FG004|Overall Study|Protocol Violation|1|||
129691590|NCT00676052|466830499|FG005|Overall Study|Protocol Violation|2|||
129691591|NCT00676052|466830494|FG000|Overall Study|Lost to Follow-up|0|||
129691592|NCT00676052|466830495|FG001|Overall Study|Lost to Follow-up|0|||
129691593|NCT00676052|466830496|FG002|Overall Study|Lost to Follow-up|0|||
129691594|NCT00676052|466830497|FG003|Overall Study|Lost to Follow-up|0|||
129691595|NCT00676052|466830498|FG004|Overall Study|Lost to Follow-up|1|||
129691596|NCT00676052|466830499|FG005|Overall Study|Lost to Follow-up|0|||
129691597|NCT00676052|466830494|FG000|Overall Study|Physician Decision|1|||
129691598|NCT00676052|466830495|FG001|Overall Study|Physician Decision|1|||
129691599|NCT00676052|466830496|FG002|Overall Study|Physician Decision|1|||
129691600|NCT00676052|466830497|FG003|Overall Study|Physician Decision|0|||
129691601|NCT00676052|466830498|FG004|Overall Study|Physician Decision|0|||
129691602|NCT00676052|466830499|FG005|Overall Study|Physician Decision|1|||
129691603|NCT00676052|466830494|FG000|Overall Study|Withdrawal by Subject|1|||
129691604|NCT00676052|466830495|FG001|Overall Study|Withdrawal by Subject|0|||
129691605|NCT00676052|466830496|FG002|Overall Study|Withdrawal by Subject|1|||
129691606|NCT00676052|466830497|FG003|Overall Study|Withdrawal by Subject|0|||
129691607|NCT00676052|466830498|FG004|Overall Study|Withdrawal by Subject|0|||
129691608|NCT00676052|466830499|FG005|Overall Study|Withdrawal by Subject|0|||
129691609|NCT00120250|466830500|FG000|Overall Study|Lost to Follow-up|1|||
129691610|NCT00120250|466830501|FG001|Overall Study|Lost to Follow-up|1|||
129691611|NCT00120250|466830500|FG000|Overall Study|Protocol Violation|0|||
129691612|NCT00120250|466830501|FG001|Overall Study|Protocol Violation|1|||
129691613|NCT01964560|466830517|FG000|Overall Study|Adverse Event|23|||
129691614|NCT01964560|466830517|FG000|Overall Study|Lack of Efficacy|46|||
129691615|NCT01964560|466830517|FG000|Overall Study|Protocol deviation|2|||
129691616|NCT01964560|466830517|FG000|Overall Study|Lost to Follow-up|4|||
129691617|NCT01964560|466830517|FG000|Overall Study|Withdrawal by Subject|64|||
129691618|NCT01964560|466830517|FG000|Overall Study|Surgery-hemispherotomy|1|||
129691619|NCT01964560|466830517|FG000|Overall Study|Surgery|1|||
129691620|NCT01964560|466830517|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
129691621|NCT01964560|466830517|FG000|Overall Study|Patient and Investigator choice|1|||
129691622|NCT01964560|466830517|FG000|Overall Study|Patient was prescribed CBD|1|||
129691623|NCT01964560|466830517|FG000|Overall Study|Participant moved to another country|1|||
129691624|NCT00378560|466830518|FG000|Overall Study|Adverse Event|1|||
129691625|NCT00378560|466830519|FG001|Overall Study|Adverse Event|0|||
129691626|NCT00378560|466830518|FG000|Overall Study|Lost to Follow-up|24|||
129691627|NCT00378560|466830519|FG001|Overall Study|Lost to Follow-up|29|||
129691628|NCT00378560|466830518|FG000|Overall Study|Protocol Violation|2|||
129691629|NCT00378560|466830519|FG001|Overall Study|Protocol Violation|0|||
129691630|NCT00378560|466830518|FG000|Overall Study|Withdrawal by Subject|17|||
129691631|NCT00378560|466830519|FG001|Overall Study|Withdrawal by Subject|21|||
129691632|NCT00378560|466830518|FG000|Overall Study|Moved|4|||
129691633|NCT00378560|466830519|FG001|Overall Study|Moved|3|||
129691634|NCT00378560|466830518|FG000|Overall Study|Pregnancy|7|||
129691635|NCT00378560|466830519|FG001|Overall Study|Pregnancy|5|||
129691636|NCT00378560|466830518|FG000|Overall Study|Laboratory test values abnormal|1|||
129691637|NCT00378560|466830519|FG001|Overall Study|Laboratory test values abnormal|0|||
129691638|NCT04389671|466830520|FG000|Overall Study|Death|7|||
129691639|NCT04865978|466830522|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
129691640|NCT04865978|466830523|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
129691641|NCT03835117|466830524|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
129691642|NCT03835117|466830525|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
129691643|NCT01543503|466830529|FG000|Overall Study|Lost to Follow-up|32|||
129691644|NCT01543503|466830530|FG001|Overall Study|Lost to Follow-up|36|||
129691645|NCT01543503|466830529|FG000|Overall Study|Adverse Event|9|||
129691646|NCT01543503|466830530|FG001|Overall Study|Adverse Event|13|||
129691647|NCT01543503|466830529|FG000|Overall Study|Lack of Efficacy|4|||
129691648|NCT01543503|466830530|FG001|Overall Study|Lack of Efficacy|16|||
129571264|NCT05093205|466388982|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
129691649|NCT01543503|466830529|FG000|Overall Study|Participant withdrew informed consent|8|||
129691650|NCT01543503|466830530|FG001|Overall Study|Participant withdrew informed consent|10|||
129691651|NCT01543503|466830529|FG000|Overall Study|Change of jobs|0|||
129691652|NCT01543503|466830530|FG001|Overall Study|Change of jobs|1|||
129691653|NCT01543503|466830529|FG000|Overall Study|Intolerance to the biologic treatment|0|||
129691654|NCT01543503|466830530|FG001|Overall Study|Intolerance to the biologic treatment|1|||
129691655|NCT01543503|466830529|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
129691656|NCT01543503|466830530|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
129691657|NCT01543503|466830529|FG000|Overall Study|Participant did not complete last visit|0|||
129691658|NCT01543503|466830530|FG001|Overall Study|Participant did not complete last visit|2|||
129781905|NCT03818035|467168130|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
129781906|NCT03818035|467168131|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
129781907|NCT03818035|467168128|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
129781908|NCT03818035|467168129|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
129781909|NCT03818035|467168130|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
129781910|NCT03818035|467168131|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
129781911|NCT03818035|467168128|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
129781912|NCT03818035|467168129|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
129781913|NCT03818035|467168130|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
129781914|NCT03818035|467168131|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
129781915|NCT03818035|467168128|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
129781916|NCT03818035|467168129|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
129781917|NCT03818035|467168130|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
129781918|NCT03818035|467168131|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
129781919|NCT03818035|467168128|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
129781920|NCT03818035|467168129|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
129781921|NCT03818035|467168130|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
129781922|NCT03818035|467168131|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
129781923|NCT03818035|467168128|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
129781924|NCT03818035|467168129|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
129781925|NCT03818035|467168130|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
129781926|NCT03818035|467168131|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
129781927|NCT03374202|467168134|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
129781928|NCT03374202|467168135|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
129781929|NCT03374202|467168136|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
129781930|NCT03374202|467168134|FG000|Five Year Long Term Follow Up|Death|0|||
129781931|NCT03374202|467168135|FG001|Five Year Long Term Follow Up|Death|1|||
129781932|NCT03374202|467168136|FG002|Five Year Long Term Follow Up|Death|0|||
129781933|NCT01868542|467169848|FG000|Overall Study|Protocol Violation|0|||
129781934|NCT01868542|467169849|FG001|Overall Study|Protocol Violation|1|||
129781935|NCT01868542|467169848|FG000|Overall Study|Unclassified|0|||
129781936|NCT01868542|467169849|FG001|Overall Study|Unclassified|1|||
129781937|NCT00122980|467169856|FG000|Overall Study|Death|0|||
129781938|NCT00122980|467169857|FG001|Overall Study|Death|1|||
129781939|NCT00122980|467169856|FG000|Overall Study|Physician Decision|2|||
129781940|NCT00122980|467169857|FG001|Overall Study|Physician Decision|0|||
129781941|NCT00122980|467169856|FG000|Overall Study|Protocol Violation|5|||
129781942|NCT00122980|467169857|FG001|Overall Study|Protocol Violation|1|||
129781943|NCT00122980|467169856|FG000|Overall Study|Withdrawal by Subject|2|||
129781944|NCT00122980|467169857|FG001|Overall Study|Withdrawal by Subject|3|||
129781945|NCT00122980|467169856|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
129781946|NCT00122980|467169857|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
129781947|NCT00122980|467169856|FG000|Overall Study|Study termination|27|||
129781948|NCT00122980|467169857|FG001|Overall Study|Study termination|35|||
129781949|NCT01124864|467169858|FG000|Overall Study|Follow up phase competed as per protocol|18|||
129781950|NCT01124864|467169859|FG001|Overall Study|Follow up phase competed as per protocol|22|||
129781951|NCT01124864|467169860|FG002|Overall Study|Follow up phase competed as per protocol|24|||
129781952|NCT01124864|467169861|FG003|Overall Study|Follow up phase competed as per protocol|18|||
129781953|NCT01124864|467169862|FG004|Overall Study|Follow up phase competed as per protocol|26|||
129781954|NCT01124864|467169863|FG005|Overall Study|Follow up phase competed as per protocol|2|||
129781955|NCT01124864|467169858|FG000|Overall Study|Death|6|||
129781956|NCT01124864|467169859|FG001|Overall Study|Death|9|||
129781957|NCT01124864|467169860|FG002|Overall Study|Death|6|||
129781958|NCT01124864|467169861|FG003|Overall Study|Death|2|||
129781959|NCT01124864|467169862|FG004|Overall Study|Death|1|||
129781960|NCT01124864|467169863|FG005|Overall Study|Death|0|||
129781961|NCT01124864|467169858|FG000|Overall Study|Withdrawal by Subject|2|||
129781962|NCT01124864|467169859|FG001|Overall Study|Withdrawal by Subject|3|||
129781963|NCT01124864|467169860|FG002|Overall Study|Withdrawal by Subject|4|||
129781964|NCT01124864|467169861|FG003|Overall Study|Withdrawal by Subject|0|||
129781965|NCT01124864|467169862|FG004|Overall Study|Withdrawal by Subject|2|||
129781966|NCT01124864|467169863|FG005|Overall Study|Withdrawal by Subject|1|||
129781967|NCT01124864|467169858|FG000|Overall Study|Lost to Follow-up|1|||
129781968|NCT01124864|467169859|FG001|Overall Study|Lost to Follow-up|1|||
129781969|NCT01124864|467169860|FG002|Overall Study|Lost to Follow-up|0|||
129781970|NCT01124864|467169861|FG003|Overall Study|Lost to Follow-up|1|||
129781971|NCT01124864|467169862|FG004|Overall Study|Lost to Follow-up|0|||
129781972|NCT01124864|467169863|FG005|Overall Study|Lost to Follow-up|0|||
129781973|NCT01124864|467169858|FG000|Overall Study|Protocol Violation|1|||
129781974|NCT01124864|467169859|FG001|Overall Study|Protocol Violation|0|||
129781975|NCT01124864|467169860|FG002|Overall Study|Protocol Violation|0|||
129781976|NCT01124864|467169861|FG003|Overall Study|Protocol Violation|0|||
129781977|NCT01124864|467169862|FG004|Overall Study|Protocol Violation|1|||
129781978|NCT01124864|467169863|FG005|Overall Study|Protocol Violation|0|||
129571265|NCT05093205|466388983|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
129571266|NCT05093205|466388984|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
129571267|NCT05093205|466388985|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
129571268|NCT05093205|466388986|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
129571269|NCT05093205|466388987|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
129571270|NCT05093205|466388975|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129884564|NCT02696902|467536453|FG000|Overall Study|Participant not fit post-randomization|0|||
129691659|NCT01543503|466830529|FG000|Overall Study|Refused to continue treatment|7|||
129884565|NCT02696902|467536454|FG001|Overall Study|Participant not fit post-randomization|0|||
129691660|NCT01543503|466830530|FG001|Overall Study|Refused to continue treatment|0|||
129691661|NCT01543503|466830529|FG000|Overall Study|Incorrect medication received|1|||
129691662|NCT01543503|466830530|FG001|Overall Study|Incorrect medication received|0|||
129691663|NCT01543503|466830529|FG000|Overall Study|Participant moved to another city|2|||
129691664|NCT01543503|466830530|FG001|Overall Study|Participant moved to another city|0|||
129691665|NCT01543503|466830529|FG000|Overall Study|Participant will not return for visits|0|||
129691666|NCT01543503|466830530|FG001|Overall Study|Participant will not return for visits|2|||
129691667|NCT01543503|466830529|FG000|Overall Study|Participant transferred to another city|1|||
129691668|NCT01543503|466830530|FG001|Overall Study|Participant transferred to another city|0|||
129691669|NCT01543503|466830529|FG000|Overall Study|Participant moved to Scotland|1|||
129691670|NCT01543503|466830530|FG001|Overall Study|Participant moved to Scotland|0|||
129691671|NCT01543503|466830529|FG000|Overall Study|Participant decision to stop treatment|1|||
129691672|NCT01543503|466830530|FG001|Overall Study|Participant decision to stop treatment|0|||
129691673|NCT01543503|466830529|FG000|Overall Study|Investigator did not wish to participate|1|||
129691674|NCT01543503|466830530|FG001|Overall Study|Investigator did not wish to participate|1|||
129691675|NCT01543503|466830529|FG000|Overall Study|Participant recruited after closing date|0|||
129884566|NCT02696902|467536455|FG002|Overall Study|Participant not fit post-randomization|1|||
129781979|NCT01243242|467169864|FG000|Overall Study|Adverse Event|1|||
129781980|NCT01243242|467169865|FG001|Overall Study|Adverse Event|1|||
129781981|NCT01243242|467169864|FG000|Overall Study|Withdrawal by Subject|1|||
129781982|NCT01243242|467169865|FG001|Overall Study|Withdrawal by Subject|1|||
129781983|NCT01243242|467169864|FG000|Overall Study|Physician Decision|0|||
129781984|NCT01243242|467169865|FG001|Overall Study|Physician Decision|1|||
129781985|NCT01243242|467169864|FG000|Overall Study|sponsor decision|0|||
129781986|NCT01243242|467169865|FG001|Overall Study|sponsor decision|1|||
129781987|NCT01243242|467169864|FG000|Overall Study|non compliance|1|||
129781988|NCT01243242|467169865|FG001|Overall Study|non compliance|0|||
129781989|NCT01256294|467169875|FG000|Overall Study|Adverse Event|1|||
129781990|NCT01256294|467169876|FG001|Overall Study|Adverse Event|0|||
129781991|NCT01256294|467169875|FG000|Overall Study|Withdrawal by Subject|1|||
129781992|NCT01256294|467169876|FG001|Overall Study|Withdrawal by Subject|1|||
129884567|NCT02696902|467536453|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
129884568|NCT02696902|467536454|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
129884569|NCT02696902|467536455|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
129884570|NCT02696902|467536453|FG000|Overall Study|Principal investigator's decision|1|||
129884571|NCT02696902|467536454|FG001|Overall Study|Principal investigator's decision|0|||
129884572|NCT02696902|467536455|FG002|Overall Study|Principal investigator's decision|0|||
129884573|NCT02696902|467536453|FG000|Overall Study|Sponsor's decision|1|||
129884574|NCT02696902|467536454|FG001|Overall Study|Sponsor's decision|0|||
129884575|NCT02696902|467536455|FG002|Overall Study|Sponsor's decision|0|||
129884576|NCT02696902|467536453|FG000|Overall Study|Transferred to other hospital|1|||
129884577|NCT02696902|467536454|FG001|Overall Study|Transferred to other hospital|0|||
129884578|NCT02696902|467536455|FG002|Overall Study|Transferred to other hospital|0|||
129884579|NCT03918239|467538559|FG000|Overall Study|Lost to Follow-up|3|||
129884580|NCT03918239|467538560|FG001|Overall Study|Lost to Follow-up|1|||
129884581|NCT03918239|467538559|FG000|Overall Study|Pregnancy|0|||
129884582|NCT03918239|467538560|FG001|Overall Study|Pregnancy|2|||
129884583|NCT03918239|467538559|FG000|Overall Study|Withdrawal by Subject|3|||
129884584|NCT03918239|467538560|FG001|Overall Study|Withdrawal by Subject|3|||
129884585|NCT03918239|467538559|FG000|Overall Study|positive urine drug screening results|4|||
129884586|NCT03918239|467538560|FG001|Overall Study|positive urine drug screening results|1|||
129884587|NCT00593554|467538563|FG000|Overall Study|Death|1|||
129884588|NCT00593554|467538564|FG001|Overall Study|Death|2|||
129884589|NCT00593554|467538563|FG000|Overall Study|Physician Decision|0|||
129884590|NCT00593554|467538564|FG001|Overall Study|Physician Decision|1|||
129884591|NCT00593554|467538563|FG000|Overall Study|Withdrawal by Subject|1|||
129884592|NCT00593554|467538564|FG001|Overall Study|Withdrawal by Subject|0|||
129884593|NCT00593554|467538563|FG000|Overall Study|Disease Progression|1|||
129884594|NCT00593554|467538564|FG001|Overall Study|Disease Progression|2|||
129884595|NCT02086552|467538566|FG000|Overall Study|Withdrawal by Subject|1|||
129884596|NCT02080520|467538572|FG000|Overall Study|Self-reported symptoms|5|||
129884597|NCT02080520|467538573|FG001|Overall Study|Self-reported symptoms|6|||
129884598|NCT02080520|467538572|FG000|Overall Study|Unable to contact|2|||
129884599|NCT02080520|467538573|FG001|Overall Study|Unable to contact|1|||
129884600|NCT02080520|467538572|FG000|Overall Study|Initiated aspirin|2|||
129884601|NCT02080520|467538573|FG001|Overall Study|Initiated aspirin|0|||
129884602|NCT02080520|467538572|FG000|Overall Study|Atrial fibrillation|1|||
129884603|NCT02080520|467538573|FG001|Overall Study|Atrial fibrillation|1|||
129571271|NCT05093205|466388976|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571272|NCT05093205|466388977|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
129691676|NCT01543503|466830530|FG001|Overall Study|Participant recruited after closing date|1|||
129691677|NCT01543503|466830529|FG000|Overall Study|Site stopped participation|5|||
129691678|NCT01543503|466830530|FG001|Overall Study|Site stopped participation|1|||
129691679|NCT01543503|466830529|FG000|Overall Study|Participant did not attend a visit|1|||
129691680|NCT01543503|466830530|FG001|Overall Study|Participant did not attend a visit|0|||
129691681|NCT01543503|466830529|FG000|Overall Study|Moved to other rheumatologic site|0|||
129691682|NCT01543503|466830530|FG001|Overall Study|Moved to other rheumatologic site|1|||
129691683|NCT01543503|466830529|FG000|Overall Study|Participant consented to another study|0|||
129691684|NCT01543503|466830530|FG001|Overall Study|Participant consented to another study|2|||
129691685|NCT01543503|466830529|FG000|Overall Study|Participant went to United States|1|||
129691686|NCT01543503|466830530|FG001|Overall Study|Participant went to United States|0|||
129691687|NCT01543503|466830529|FG000|Overall Study|Screen failure|1|||
129691688|NCT01543503|466830530|FG001|Overall Study|Screen failure|0|||
129691689|NCT01309100|466830533|FG000|Overall Study|Protocol Violation|1|||
129691690|NCT01309100|466830533|FG000|Overall Study|Positive Slit lamp finding|1|||
129691691|NCT01968785|466830536|FG000|Overall Study|Withdrawal by Subject|1|||
129691692|NCT01968785|466830537|FG001|Overall Study|Withdrawal by Subject|0|||
129781993|NCT01256294|467169875|FG000|Overall Study|Protocol deviation|2|||
129781994|NCT01256294|467169876|FG001|Overall Study|Protocol deviation|1|||
129781995|NCT02160899|467169877|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
129781996|NCT02160899|467169878|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
129781997|NCT02160899|467169879|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
129781998|NCT02160899|467169880|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
129781999|NCT02160899|467169881|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
129782000|NCT02160899|467169882|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
129782001|NCT01368562|467169883|FG000|Overall Study|Adverse Event|1|||
129782002|NCT01368562|467169883|FG000|Overall Study|Disease progression|1|||
129782003|NCT01368562|467169883|FG000|Overall Study|Lost to Follow-up|1|||
129782004|NCT01368562|467169883|FG000|Overall Study|Death|6|||
129782005|NCT01368562|467169883|FG000|Overall Study|Unresponsive to treatment|5|||
129782006|NCT01368562|467169883|FG000|Overall Study|Other|3|||
129782007|NCT01368562|467169883|FG000|Overall Study|Other than specified|2|||
129782008|NCT01754727|467169884|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
129782009|NCT00669409|467169887|FG000|Part 2|Withdrawal by Subject|0|||
129782010|NCT00669409|467169888|FG001|Part 2|Withdrawal by Subject|0|||
129571273|NCT05093205|466388978|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571274|NCT05093205|466388979|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571275|NCT05093205|466388980|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571276|NCT05093205|466388981|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571277|NCT05093205|466388982|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571278|NCT05093205|466388983|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571279|NCT05093205|466388984|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571280|NCT05093205|466388985|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571281|NCT05093205|466388986|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571282|NCT05093205|466388987|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
129571283|NCT05093205|466388975|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
129571284|NCT05093205|466388976|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
129571285|NCT05093205|466388977|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
129571286|NCT05093205|466388978|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
129571287|NCT05093205|466388979|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
129571288|NCT05093205|466388980|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
129571289|NCT05093205|466388981|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
129571290|NCT05093205|466388982|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
129571291|NCT05093205|466388983|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
129571292|NCT05093205|466388984|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
129571293|NCT05093205|466388985|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
129571294|NCT05093205|466388986|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
129571295|NCT05093205|466388987|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
129571296|NCT05093205|466388975|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
129571297|NCT05093205|466388976|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
129571298|NCT05093205|466388977|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
129691693|NCT04560309|466830541|FG000|Overall Study|Meet drop out criteria|1|||
129691694|NCT04560309|466830542|FG001|Overall Study|Meet drop out criteria|1|||
129691695|NCT04146909|466830543|FG000|Overall Study|Withdrawal by Subject|3|||
129691696|NCT04146909|466830543|FG000|Overall Study|Did not qualify after consented|1|||
129691697|NCT05085405|466830544|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129691698|NCT05085405|466830545|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129691699|NCT05085405|466830546|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
129691700|NCT05085405|466830547|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
129691701|NCT05085405|466830548|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129691702|NCT05085405|466830549|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
129691703|NCT05085405|466830544|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129691704|NCT05085405|466830545|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129691705|NCT05085405|466830546|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129691706|NCT05085405|466830547|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
129691707|NCT05085405|466830548|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129691708|NCT05085405|466830549|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
129691709|NCT04000724|466830557|FG000|Overall Study|Withdrawal by Subject|5|||
129691710|NCT04000724|466830558|FG001|Overall Study|Withdrawal by Subject|3|||
129691711|NCT04000724|466830559|FG002|Overall Study|Withdrawal by Subject|4|||
129691712|NCT04000724|466830557|FG000|Overall Study|Lost to Follow-up|11|||
129691713|NCT04000724|466830558|FG001|Overall Study|Lost to Follow-up|7|||
129691714|NCT04000724|466830559|FG002|Overall Study|Lost to Follow-up|13|||
129691715|NCT00455455|466830560|FG000|Washout|Withdrawal by Subject|0|||
129691716|NCT00455455|466830561|FG001|Washout|Withdrawal by Subject|1|||
129691717|NCT00455455|466830560|FG000|Washout|Withdrawal by Subject|1|||
129691718|NCT00455455|466830561|FG001|Washout|Withdrawal by Subject|0|||
129691719|NCT03808909|466830562|FG000|Overall Study|Lost to Follow-up|3|||
129691720|NCT03808909|466830563|FG001|Overall Study|Lost to Follow-up|0|||
129691721|NCT01827943|466830564|FG000|Overall Study|Protocol Violation|8|||
129691722|NCT01827943|466830564|FG000|Overall Study|Never treated because of an rapid progression|1|||
129691723|NCT03335566|466830565|FG000|Overall Study|Adverse Event|0|||
129691724|NCT03335566|466830566|FG001|Overall Study|Adverse Event|1|||
129691725|NCT03335566|466830565|FG000|Overall Study|Lost to Follow-up|1|||
129691726|NCT03335566|466830566|FG001|Overall Study|Lost to Follow-up|0|||
129691727|NCT03335566|466830565|FG000|Overall Study|Technical Problems|1|||
129691728|NCT03335566|466830566|FG001|Overall Study|Technical Problems|0|||
129691729|NCT03335566|466830565|FG000|Overall Study|Protocol Violation|1|||
129691730|NCT03335566|466830566|FG001|Overall Study|Protocol Violation|0|||
129691731|NCT03335566|466830565|FG000|Overall Study|Other than specified above|1|||
129571299|NCT05093205|466388978|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
129571300|NCT05093205|466388979|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
129571301|NCT05093205|466388980|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
129571302|NCT05093205|466388981|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
129571303|NCT05093205|466388982|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
129571304|NCT05093205|466388983|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
129571305|NCT05093205|466388984|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
129571306|NCT05093205|466388985|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
129571307|NCT05093205|466388986|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
129782011|NCT00669409|467169889|FG002|Part 2|Withdrawal by Subject|0|||
129782012|NCT00669409|467169890|FG003|Part 2|Withdrawal by Subject|0|||
129782013|NCT00669409|467169891|FG004|Part 2|Withdrawal by Subject|0|||
129782014|NCT00669409|467169892|FG005|Part 2|Withdrawal by Subject|0|||
129782015|NCT00669409|467169893|FG006|Part 2|Withdrawal by Subject|0|||
129782016|NCT00669409|467169894|FG007|Part 2|Withdrawal by Subject|0|||
129782017|NCT00669409|467169895|FG008|Part 2|Withdrawal by Subject|0|||
129782018|NCT00669409|467169896|FG009|Part 2|Withdrawal by Subject|1|||
129782019|NCT00669409|467169897|FG010|Part 2|Withdrawal by Subject|0|||
129782020|NCT02314637|467169898|FG000|Overall Study|Adverse Event|4|||
129782021|NCT02314637|467169899|FG001|Overall Study|Adverse Event|8|||
129782022|NCT02314637|467169898|FG000|Overall Study|Lack of Efficacy|1|||
129782023|NCT02314637|467169899|FG001|Overall Study|Lack of Efficacy|0|||
129782024|NCT02314637|467169898|FG000|Overall Study|Physician Decision|5|||
129782025|NCT02314637|467169899|FG001|Overall Study|Physician Decision|2|||
129782026|NCT02314637|467169898|FG000|Overall Study|Withdrawal by Subject|5|||
129782027|NCT02314637|467169899|FG001|Overall Study|Withdrawal by Subject|4|||
129782028|NCT02314637|467169898|FG000|Overall Study|Other Reason|1|||
129782029|NCT02314637|467169899|FG001|Overall Study|Other Reason|0|||
129782030|NCT03539549|467169900|FG000|Overall Study|Adverse Event|12|||
129782031|NCT03539549|467169900|FG000|Overall Study|Lost to Follow-up|1|||
129782032|NCT03539549|467169900|FG000|Overall Study|Death|2|||
129782033|NCT03539549|467169900|FG000|Overall Study|Progressive Disease|1|||
129571308|NCT05093205|466388987|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
129571309|NCT05093205|466388975|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
129571310|NCT05093205|466388976|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
129571311|NCT05093205|466388977|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
129571312|NCT05093205|466388978|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
129571313|NCT05093205|466388979|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
129571314|NCT05093205|466388980|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
129571315|NCT05093205|466388981|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
129571316|NCT05093205|466388982|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
129571317|NCT05093205|466388983|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
129571318|NCT05093205|466388984|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
129571319|NCT05093205|466388985|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
129571320|NCT05093205|466388986|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
129571321|NCT05093205|466388987|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
129571322|NCT05093205|466388975|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
129571323|NCT05093205|466388976|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
129782034|NCT03539549|467169900|FG000|Overall Study|Reason not Specified|1|||
129782035|NCT02864862|467169901|FG000|Overall Study|Lost to Follow-up|1|||
129782036|NCT02864862|467169902|FG001|Overall Study|Lost to Follow-up|0|||
129782037|NCT02864862|467169903|FG002|Overall Study|Lost to Follow-up|1|||
129782038|NCT02864862|467169901|FG000|Overall Study|Protocol Violation|0|||
129782039|NCT02864862|467169902|FG001|Overall Study|Protocol Violation|0|||
129782040|NCT02864862|467169903|FG002|Overall Study|Protocol Violation|1|||
129782041|NCT01536067|467169910|FG000|Overall Study|Disease Progression|1|||
129782042|NCT03120351|467169911|FG000|Overall Study|Physician Decision|1|||
129782043|NCT03120351|467169912|FG001|Overall Study|Physician Decision|1|||
129782044|NCT01256190|467169913|FG000|Overall Study|Lost to Follow-up|2|||
129782045|NCT01256190|467169914|FG001|Overall Study|Lost to Follow-up|0|||
129782046|NCT04693234|467169915|FG000|Overall Study|Death|79|||
129782047|NCT04693234|467169916|FG001|Overall Study|Death|19|||
129782048|NCT04693234|467169915|FG000|Overall Study|Sponsor Ended Study|47|||
129782049|NCT04693234|467169916|FG001|Overall Study|Sponsor Ended Study|18|||
129571324|NCT05093205|466388977|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
129782050|NCT04693234|467169915|FG000|Overall Study|Withdrawal by Subject|10|||
129782051|NCT04693234|467169916|FG001|Overall Study|Withdrawal by Subject|2|||
129782052|NCT04693234|467169915|FG000|Overall Study|Lost to Follow-up|2|||
129782053|NCT04693234|467169916|FG001|Overall Study|Lost to Follow-up|1|||
129782054|NCT04643158|467169917|FG000|Overall Study|Study terminated by sponsor|0|||
129782055|NCT04643158|467169918|FG001|Overall Study|Study terminated by sponsor|0|||
129782056|NCT04643158|467169919|FG002|Overall Study|Study terminated by sponsor|1|||
129571325|NCT05093205|466388978|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
129571326|NCT05093205|466388979|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
129571327|NCT05093205|466388980|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
129782057|NCT04643158|467169920|FG003|Overall Study|Study terminated by sponsor|0|||
129571328|NCT05093205|466388981|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
129571329|NCT05093205|466388982|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
129571330|NCT05093205|466388983|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
129571331|NCT05093205|466388984|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
129571332|NCT05093205|466388985|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
129571333|NCT05093205|466388986|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
129571334|NCT05093205|466388987|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
129571335|NCT05093205|466388975|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
129571336|NCT05093205|466388976|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
129571337|NCT05093205|466388977|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
129571338|NCT05093205|466388978|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
129571339|NCT05093205|466388979|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
129571340|NCT05093205|466388980|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
129571341|NCT05093205|466388981|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
129571342|NCT05093205|466388982|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
129571343|NCT05093205|466388983|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
129571344|NCT05093205|466388984|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
129571345|NCT05093205|466388985|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
129571346|NCT05093205|466388986|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
129571347|NCT05093205|466388987|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
129571348|NCT05093205|466388975|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
129571349|NCT05093205|466388976|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
129571350|NCT05093205|466388977|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
129571351|NCT05093205|466388978|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
129571352|NCT05093205|466388979|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
129571353|NCT05093205|466388980|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
129571354|NCT05093205|466388981|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
129571355|NCT05093205|466388982|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
129571356|NCT05093205|466388983|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
129571357|NCT05093205|466388984|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
129571358|NCT05093205|466388985|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
129571359|NCT05093205|466388986|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
129571360|NCT05093205|466388987|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
129571361|NCT05093205|466388975|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571362|NCT05093205|466388976|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571363|NCT05093205|466388977|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571364|NCT05093205|466388978|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571365|NCT05093205|466388979|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571366|NCT05093205|466388980|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571367|NCT05093205|466388981|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571368|NCT05093205|466388982|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571369|NCT05093205|466388983|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571370|NCT05093205|466388984|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
129691732|NCT03335566|466830566|FG001|Overall Study|Other than specified above|2|||
129691733|NCT01084135|466830567|FG000|20 Week|Physician Decision|0|||
129691734|NCT01084135|466830568|FG001|20 Week|Physician Decision|1|||
129691735|NCT00663351|466830569|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
129691736|NCT00663351|466830570|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
129691737|NCT00663351|466830569|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
129691738|NCT00663351|466830570|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
129691739|NCT00663351|466830569|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
129691740|NCT00663351|466830570|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
129691741|NCT00663351|466830569|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
129691742|NCT00663351|466830570|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
129691743|NCT00663351|466830569|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
129691744|NCT00663351|466830570|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
129691745|NCT00663351|466830569|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
129691746|NCT00663351|466830570|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
129691747|NCT00567112|466830571|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
129691748|NCT00567112|466830572|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
129691749|NCT00567112|466830573|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
129691750|NCT00567112|466830571|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
129691751|NCT00567112|466830572|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
129691752|NCT00567112|466830573|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
129691753|NCT00567112|466830571|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
129691754|NCT00567112|466830572|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
129691755|NCT00567112|466830573|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
129571371|NCT05093205|466388985|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571372|NCT05093205|466388986|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129571373|NCT05093205|466388987|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
129691756|NCT00545948|466830576|FG000|Overall Study|Not Treated|1|||
129571374|NCT05093205|466388975|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
129691757|NCT00545948|466830577|FG001|Overall Study|Not Treated|1|||
129691758|NCT00545948|466830578|FG002|Overall Study|Not Treated|7|||
129691759|NCT03467945|466830579|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129691760|NCT03467945|466830580|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129691761|NCT03467945|466830581|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129691762|NCT03467945|466830582|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129691763|NCT03467945|466830579|FG000|Treatment Period 3|Withdrawal by Subject|1|||
129691764|NCT03467945|466830580|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129691765|NCT03467945|466830581|FG002|Treatment Period 3|Withdrawal by Subject|2|||
129691766|NCT03467945|466830582|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129691767|NCT03520387|466830597|FG000|Pre-Randomization|Withdrawal by Subject|1|||
129691768|NCT03520387|466830598|FG001|Pre-Randomization|Withdrawal by Subject|0|||
129691769|NCT03520387|466830599|FG002|Pre-Randomization|Withdrawal by Subject|0|||
129691770|NCT03520387|466830600|FG003|Pre-Randomization|Withdrawal by Subject|0|||
129691771|NCT03520387|466830601|FG004|Pre-Randomization|Withdrawal by Subject|0|||
129691772|NCT03520387|466830597|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
129691773|NCT03520387|466830598|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129691774|NCT03520387|466830599|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129691775|NCT03520387|466830600|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129691776|NCT03520387|466830601|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
129691777|NCT03336866|466830602|FG000|Overall Study|Lost to Follow-up|2|||
129691778|NCT03336866|466830603|FG001|Overall Study|Lost to Follow-up|0|||
129691779|NCT03336866|466830604|FG002|Overall Study|Lost to Follow-up|3|||
129691780|NCT03336866|466830602|FG000|Overall Study|Withdrawal by Subject|1|||
129691781|NCT03336866|466830603|FG001|Overall Study|Withdrawal by Subject|1|||
129691782|NCT03336866|466830604|FG002|Overall Study|Withdrawal by Subject|0|||
129691783|NCT03336866|466830602|FG000|Overall Study|Noncompliance with clinic house rules|0|||
129691784|NCT03336866|466830603|FG001|Overall Study|Noncompliance with clinic house rules|0|||
129691785|NCT03336866|466830604|FG002|Overall Study|Noncompliance with clinic house rules|1|||
129571375|NCT05093205|466388976|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
129571376|NCT05093205|466388977|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
129571377|NCT05093205|466388978|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
129571378|NCT05093205|466388979|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
129571379|NCT05093205|466388980|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
129571380|NCT05093205|466388981|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
129571381|NCT05093205|466388982|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
129571382|NCT05093205|466388983|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
129571383|NCT05093205|466388984|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
129571384|NCT05093205|466388985|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
129571385|NCT05093205|466388986|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
129571386|NCT05093205|466388987|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
129571387|NCT05093205|466388975|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571388|NCT05093205|466388976|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571389|NCT05093205|466388977|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571390|NCT05093205|466388978|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571391|NCT05093205|466388979|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571392|NCT05093205|466388980|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129691786|NCT04913675|466830605|FG000|Main Study (Up to Week 36)|Death|0|||
129691787|NCT04913675|466830606|FG001|Main Study (Up to Week 36)|Death|2|||
129691788|NCT04913675|466830607|FG002|Main Study (Up to Week 36)|Death|2|||
129691789|NCT04913675|466830608|FG003|Main Study (Up to Week 36)|Death|0|||
129691790|NCT04913675|466830605|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
129691791|NCT04913675|466830606|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
129691792|NCT04913675|466830607|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
129691793|NCT04913675|466830608|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
129691794|NCT04913675|466830605|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
129691795|NCT04913675|466830606|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
129691796|NCT04913675|466830607|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
129691797|NCT04913675|466830608|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
129691798|NCT04913675|466830605|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
129691799|NCT04913675|466830606|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
129691800|NCT04913675|466830607|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
129691801|NCT04913675|466830608|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
129691802|NCT04913675|466830605|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
129691803|NCT04913675|466830606|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
129691804|NCT04913675|466830607|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
129691805|NCT04913675|466830608|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
129691806|NCT02975700|466830609|FG000|Overall Study|Adverse Event|1|||
129691807|NCT02975700|466830609|FG000|Overall Study|Progressive disease|3|||
129691808|NCT02975700|466830609|FG000|Overall Study|Failed screening criteria|2|||
129691809|NCT05660538|466830611|FG000|Overall Study|Adverse Event|0|||
129691810|NCT05660538|466830612|FG001|Overall Study|Adverse Event|0|||
129691811|NCT05660538|466830613|FG002|Overall Study|Adverse Event|1|||
129691812|NCT05660538|466830614|FG003|Overall Study|Adverse Event|0|||
129691813|NCT05660538|466830611|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129691814|NCT05660538|466830612|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129691815|NCT05660538|466830613|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
129691816|NCT05660538|466830614|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
129691817|NCT05660538|466830611|FG000|Overall Study|Lost to Follow-up|0|||
129691818|NCT05660538|466830612|FG001|Overall Study|Lost to Follow-up|0|||
129691819|NCT05660538|466830613|FG002|Overall Study|Lost to Follow-up|1|||
129691820|NCT05660538|466830614|FG003|Overall Study|Lost to Follow-up|1|||
129691821|NCT05660538|466830611|FG000|Overall Study|Death|0|||
129691822|NCT05660538|466830612|FG001|Overall Study|Death|0|||
129691823|NCT05660538|466830613|FG002|Overall Study|Death|1|||
129691824|NCT05660538|466830614|FG003|Overall Study|Death|0|||
129691825|NCT05660538|466830611|FG000|Overall Study|Physician Decision|0|||
129691826|NCT05660538|466830612|FG001|Overall Study|Physician Decision|0|||
129691827|NCT05660538|466830613|FG002|Overall Study|Physician Decision|0|||
129691828|NCT05660538|466830614|FG003|Overall Study|Physician Decision|1|||
129691829|NCT05660538|466830611|FG000|Overall Study|Sponsor Decision|1|||
129691830|NCT05660538|466830612|FG001|Overall Study|Sponsor Decision|0|||
129691831|NCT05660538|466830613|FG002|Overall Study|Sponsor Decision|0|||
129691832|NCT05660538|466830614|FG003|Overall Study|Sponsor Decision|0|||
129691833|NCT05660538|466830611|FG000|Overall Study|Other|1|||
129691834|NCT05660538|466830612|FG001|Overall Study|Other|0|||
129691835|NCT05660538|466830613|FG002|Overall Study|Other|0|||
129691836|NCT05660538|466830614|FG003|Overall Study|Other|1|||
129782058|NCT04643158|467169921|FG004|Overall Study|Study terminated by sponsor|0|||
129571393|NCT05093205|466388981|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571394|NCT05093205|466388982|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129782059|NCT04643158|467169922|FG005|Overall Study|Study terminated by sponsor|1|||
129571395|NCT05093205|466388983|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129782060|NCT04643158|467169923|FG006|Overall Study|Study terminated by sponsor|0|||
129782061|NCT04643158|467169917|FG000|Overall Study|Global/country situation|0|||
129782062|NCT04643158|467169918|FG001|Overall Study|Global/country situation|0|||
129782063|NCT04643158|467169919|FG002|Overall Study|Global/country situation|1|||
129782064|NCT04643158|467169920|FG003|Overall Study|Global/country situation|0|||
129782065|NCT04643158|467169921|FG004|Overall Study|Global/country situation|0|||
129782066|NCT04643158|467169922|FG005|Overall Study|Global/country situation|0|||
129782067|NCT04643158|467169923|FG006|Overall Study|Global/country situation|0|||
129782068|NCT04643158|467169917|FG000|Overall Study|Withdrawal by Subject|0|||
129782069|NCT04643158|467169918|FG001|Overall Study|Withdrawal by Subject|0|||
129782070|NCT04643158|467169919|FG002|Overall Study|Withdrawal by Subject|0|||
129782071|NCT04643158|467169920|FG003|Overall Study|Withdrawal by Subject|0|||
129782072|NCT04643158|467169921|FG004|Overall Study|Withdrawal by Subject|0|||
129782073|NCT04643158|467169922|FG005|Overall Study|Withdrawal by Subject|1|||
129782074|NCT04643158|467169923|FG006|Overall Study|Withdrawal by Subject|0|||
129782075|NCT04540198|467169924|FG000|Overall Study|Lost to Follow-up|25|||
129782076|NCT04540198|467169925|FG001|Overall Study|Lost to Follow-up|23|||
129782077|NCT04540198|467169924|FG000|Overall Study|Withdrawal by Subject|15|||
129782078|NCT04540198|467169925|FG001|Overall Study|Withdrawal by Subject|9|||
129782079|NCT04540198|467169924|FG000|Overall Study|Discontinued|1|||
129782080|NCT04540198|467169925|FG001|Overall Study|Discontinued|0|||
129782081|NCT02888119|467169926|FG000|Overall Study|Lost to Follow-up|5|||
129782082|NCT02888119|467169927|FG001|Overall Study|Lost to Follow-up|4|||
129782083|NCT02888119|467169928|FG002|Overall Study|Lost to Follow-up|0|||
129782084|NCT02123472|467169930|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
129782085|NCT02123472|467169931|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
129571396|NCT05093205|466388984|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571397|NCT05093205|466388985|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
129571398|NCT05093205|466388986|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571399|NCT05093205|466388987|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
129571400|NCT05093205|466388975|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571401|NCT05093205|466388976|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571402|NCT05093205|466388977|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571403|NCT05093205|466388978|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571404|NCT05093205|466388979|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571405|NCT05093205|466388980|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571406|NCT05093205|466388981|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571407|NCT05093205|466388982|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571408|NCT05093205|466388983|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571409|NCT05093205|466388984|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571410|NCT05093205|466388985|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571411|NCT05093205|466388986|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
129571412|NCT05093205|466388987|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
129571413|NCT05093205|466388975|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
129571414|NCT05093205|466388976|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
129571415|NCT05093205|466388977|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
129571416|NCT05093205|466388978|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
129571417|NCT05093205|466388979|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
129571418|NCT05093205|466388980|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
129571419|NCT05093205|466388981|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
129571420|NCT05093205|466388982|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
129571421|NCT05093205|466388983|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
129571422|NCT05093205|466388984|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
129571423|NCT05093205|466388985|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
129571424|NCT05093205|466388986|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
129571425|NCT05093205|466388987|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
129571426|NCT05093205|466388975|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571427|NCT05093205|466388976|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571428|NCT05093205|466388977|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571429|NCT05093205|466388978|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571430|NCT05093205|466388979|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571431|NCT05093205|466388980|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571432|NCT05093205|466388981|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571433|NCT05093205|466388982|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571434|NCT05093205|466388983|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129782086|NCT01474018|467169932|FG000|Overall Study|Lost to Follow-up|0|||
129782087|NCT01474018|467169933|FG001|Overall Study|Lost to Follow-up|1|||
129782088|NCT01474018|467169932|FG000|Overall Study|Withdrawal by Subject|0|||
129782089|NCT01474018|467169933|FG001|Overall Study|Withdrawal by Subject|2|||
129782090|NCT02433080|467169934|FG000|Overall Study|Lost to Follow-up|1|||
129782091|NCT02433080|467169935|FG001|Overall Study|Lost to Follow-up|2|||
129782092|NCT02433080|467169934|FG000|Overall Study|Withdrawal by Subject|0|||
129884604|NCT02080520|467538572|FG000|Overall Study|Cancer|1|||
129884605|NCT02080520|467538573|FG001|Overall Study|Cancer|2|||
129884606|NCT02080520|467538572|FG000|Overall Study|Not interested in study|1|||
129884607|NCT02080520|467538573|FG001|Overall Study|Not interested in study|3|||
129884608|NCT02080520|467538572|FG000|Overall Study|Too busy|1|||
129884609|NCT02080520|467538573|FG001|Overall Study|Too busy|1|||
129884610|NCT02080520|467538572|FG000|Overall Study|Work-related injury|1|||
129884611|NCT02080520|467538573|FG001|Overall Study|Work-related injury|0|||
129884612|NCT02080520|467538572|FG000|Overall Study|Personal reasons|0|||
129884613|NCT02080520|467538573|FG001|Overall Study|Personal reasons|3|||
129884614|NCT04397523|467538574|FG000|Overall Study|Lost to Follow-up|3|||
129782093|NCT02433080|467169935|FG001|Overall Study|Withdrawal by Subject|2|||
129782094|NCT01015638|467169938|FG000|Overall Study|Withdrawal by Subject|1|||
129571435|NCT05093205|466388984|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571436|NCT05093205|466388985|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571437|NCT05093205|466388986|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
129782095|NCT01015638|467169939|FG001|Overall Study|Withdrawal by Subject|0|||
129782096|NCT00910299|467169945|FG000|Overall Study|Withdrawal by Subject|16|||
129782097|NCT00910299|467169946|FG001|Overall Study|Withdrawal by Subject|13|||
129782098|NCT00910299|467169945|FG000|Overall Study|Sponsor Decision|58|||
129782099|NCT00910299|467169946|FG001|Overall Study|Sponsor Decision|60|||
129884615|NCT04397523|467538574|FG000|Overall Study|Transfer from/to other hospital|8|||
129571438|NCT05093205|466388987|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
129571439|NCT03361228|466388989|FG000|Overall Study|Other|1|||
129782100|NCT00910299|467169945|FG000|Overall Study|Didn't receive any study drug|2|||
129571440|NCT03361228|466388990|FG001|Overall Study|Other|1|||
129571441|NCT03361228|466388989|FG000|Overall Study|Death|3|||
129571442|NCT03361228|466388990|FG001|Overall Study|Death|0|||
129571443|NCT04149964|466388994|FG000|Overall Study|Lost to Follow-up|19|||
129571444|NCT04149964|466388995|FG001|Overall Study|Lost to Follow-up|18|||
129571445|NCT04753437|466388996|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129571446|NCT04753437|466388997|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129571447|NCT04753437|466388996|FG000|Overall Study|Liver Function Test Abnormalities|2|||
129571448|NCT04753437|466388997|FG001|Overall Study|Liver Function Test Abnormalities|4|||
129571449|NCT01223365|466388998|FG000|Open-label Titration Period|Enrolled but not treated|1|||
129571450|NCT01223365|466388998|FG000|Open-label Titration Period|Adverse Event|23|||
129571451|NCT01223365|466388998|FG000|Open-label Titration Period|Lack of Efficacy|3|||
129571452|NCT01223365|466388998|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
129571453|NCT01223365|466388998|FG000|Open-label Titration Period|Protocol Violation|1|||
129571454|NCT01223365|466388998|FG000|Open-label Titration Period|Lost to Follow-up|2|||
129571455|NCT01223365|466388998|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
129571456|NCT01223365|466388998|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
129571457|NCT01223365|466388998|FG000|Open-label Titration Period|Starting physical therapy|1|||
129571458|NCT01223365|466388998|FG000|Open-label Treatment Period|Adverse Event|39|||
129571459|NCT01223365|466388998|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
129571460|NCT01223365|466388998|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
129571461|NCT01223365|466388998|FG000|Open-label Treatment Period|Protocol Violation|15|||
129571462|NCT01223365|466388998|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
129571463|NCT01223365|466388998|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
129571464|NCT01223365|466388998|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
129571465|NCT01223365|466388998|FG000|Open-label Treatment Period|Moved out of area|2|||
129571466|NCT01223365|466388998|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
129782101|NCT00910299|467169946|FG001|Overall Study|Didn't receive any study drug|1|||
129782102|NCT00711477|467169947|FG000|Overall Study|Adverse Event|3|||
129782103|NCT00711477|467169948|FG001|Overall Study|Adverse Event|1|||
129782104|NCT00711477|467169947|FG000|Overall Study|Lost to Follow-up|0|||
129782105|NCT00711477|467169948|FG001|Overall Study|Lost to Follow-up|1|||
129782106|NCT00711477|467169947|FG000|Overall Study|Noncompliance|0|||
129782107|NCT00711477|467169948|FG001|Overall Study|Noncompliance|1|||
129782108|NCT02929407|467169950|FG000|Overall Study|Adverse Event|1|||
129782109|NCT00884741|467169951|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
129782110|NCT00884741|467169952|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
129782111|NCT00884741|467169953|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
129782112|NCT00884741|467169954|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
129782113|NCT00884741|467169951|FG000|Step 1 Registration: Tissue Screening|Death|3|||
129782114|NCT00884741|467169952|FG001|Step 1 Registration: Tissue Screening|Death|0|||
129782115|NCT00884741|467169953|FG002|Step 1 Registration: Tissue Screening|Death|0|||
129782116|NCT00884741|467169954|FG003|Step 1 Registration: Tissue Screening|Death|0|||
129782117|NCT00884741|467169951|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
129782118|NCT00884741|467169952|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
129782119|NCT00884741|467169953|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
129782120|NCT00884741|467169954|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
129571467|NCT01223365|466388998|FG000|Open-label Treatment Period|"Out of window"|1|||
129782121|NCT00884741|467169951|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
129782122|NCT00884741|467169952|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
129782123|NCT00884741|467169953|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
129782124|NCT00884741|467169954|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
129782125|NCT00884741|467169951|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
129782126|NCT00884741|467169952|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
129782127|NCT00884741|467169953|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
129782128|NCT00884741|467169954|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
129782129|NCT00884741|467169951|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
129782130|NCT00884741|467169952|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
129782131|NCT00884741|467169953|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
129782132|NCT00884741|467169954|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
129782133|NCT00884741|467169951|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
129782134|NCT00884741|467169952|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
129782135|NCT00884741|467169953|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
129782136|NCT00884741|467169954|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
129571468|NCT01223365|466388998|FG000|Open-label Treatment Period|Starting physical therapy|1|||
129571469|NCT01223365|466388998|FG000|Open-label Treatment Period|Physician Decision|2|||
129782137|NCT00884741|467169951|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
129571470|NCT03567174|466388999|FG000|Overall Study|Death|24|||
129571471|NCT03567174|466389000|FG001|Overall Study|Death|31|||
129782138|NCT00884741|467169952|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
129782139|NCT00884741|467169953|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
129571472|NCT03567174|466388999|FG000|Overall Study|Lost to Follow-up|165|||
129571473|NCT03567174|466389000|FG001|Overall Study|Lost to Follow-up|174|||
129782140|NCT00884741|467169954|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
129782141|NCT00884741|467169951|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
129782142|NCT00884741|467169952|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
129782143|NCT00884741|467169953|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
129782144|NCT00884741|467169954|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
129782145|NCT00884741|467169951|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
129782146|NCT00884741|467169952|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
129782147|NCT00884741|467169953|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
129782148|NCT00884741|467169954|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
129782149|NCT00884741|467169951|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
129782150|NCT00884741|467169952|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
129782151|NCT00884741|467169953|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
129782152|NCT00884741|467169954|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
129782153|NCT00884741|467169951|FG000|Randomization|Protocol Violation|0|||
129782154|NCT00884741|467169952|FG001|Randomization|Protocol Violation|0|||
129782155|NCT00884741|467169953|FG002|Randomization|Protocol Violation|8|||
129782156|NCT00884741|467169954|FG003|Randomization|Protocol Violation|8|||
129782157|NCT01014910|467169955|FG000|Overall Study|Withdrawal by Subject|0|||
129782158|NCT01014910|467169956|FG001|Overall Study|Withdrawal by Subject|2|||
129782159|NCT00145977|467169957|FG000|Overall Study|Lack of Efficacy|0|||
129782160|NCT00145977|467169958|FG001|Overall Study|Lack of Efficacy|4|||
129782161|NCT00145977|467169957|FG000|Overall Study|Lost to Follow-up|1|||
129782162|NCT00145977|467169958|FG001|Overall Study|Lost to Follow-up|0|||
129571474|NCT03243630|466389001|FG000|Overall Study|Protocol Violation|1|||
129571475|NCT03243630|466389001|FG000|Overall Study|Physician Decision|1|||
129782163|NCT00145977|467169957|FG000|Overall Study|Withdrawal by Subject|1|||
129782164|NCT00145977|467169958|FG001|Overall Study|Withdrawal by Subject|0|||
129782165|NCT00782834|467169959|FG000|Treatment Phase|fibrous tumor not GIST|1|||
129782166|NCT01215097|467169961|FG000|Overall Study|Adverse Event|1|||
129782167|NCT01215097|467169962|FG001|Overall Study|Adverse Event|3|||
129782168|NCT01215097|467169961|FG000|Overall Study|Protocol Violation|0|||
129782169|NCT01215097|467169962|FG001|Overall Study|Protocol Violation|2|||
129782170|NCT01215097|467169961|FG000|Overall Study|Lost to Follow-up|2|||
129782171|NCT01215097|467169962|FG001|Overall Study|Lost to Follow-up|0|||
129782172|NCT01215097|467169961|FG000|Overall Study|Withdrawal by Subject|6|||
129782173|NCT01215097|467169962|FG001|Overall Study|Withdrawal by Subject|3|||
129782174|NCT01215097|467169961|FG000|Overall Study|Lack of Efficacy|0|||
129782175|NCT01215097|467169962|FG001|Overall Study|Lack of Efficacy|3|||
129782176|NCT01215097|467169961|FG000|Overall Study|patient's refusal to come|2|||
129782177|NCT01215097|467169962|FG001|Overall Study|patient's refusal to come|2|||
129782178|NCT01215097|467169961|FG000|Overall Study|patient's private reason|1|||
129782179|NCT01215097|467169962|FG001|Overall Study|patient's private reason|1|||
129782180|NCT02252939|467169963|FG000|Overall Study|Lost to Follow-up|3|||
129782181|NCT01818752|467169965|FG000|Overall Study|Adverse Event|64|||
129782182|NCT01818752|467169966|FG001|Overall Study|Adverse Event|74|||
129782183|NCT01818752|467169965|FG000|Overall Study|Death|14|||
129782184|NCT01818752|467169966|FG001|Overall Study|Death|18|||
129782185|NCT01818752|467169965|FG000|Overall Study|Non-compliance|16|||
129782186|NCT01818752|467169966|FG001|Overall Study|Non-compliance|20|||
129782187|NCT01818752|467169965|FG000|Overall Study|Withdrawal by Subject|15|||
129782188|NCT01818752|467169966|FG001|Overall Study|Withdrawal by Subject|14|||
129782189|NCT01818752|467169965|FG000|Overall Study|Physician Decision|9|||
129782190|NCT01818752|467169966|FG001|Overall Study|Physician Decision|8|||
129782191|NCT01818752|467169965|FG000|Overall Study|Disease Progression|54|||
129782192|NCT01818752|467169966|FG001|Overall Study|Disease Progression|48|||
129782193|NCT01818752|467169965|FG000|Overall Study|Other|7|||
129782194|NCT01818752|467169966|FG001|Overall Study|Other|8|||
129782195|NCT01818752|467169965|FG000|Overall Study|Continuing Treatment|1|||
129782196|NCT01818752|467169966|FG001|Overall Study|Continuing Treatment|4|||
129782197|NCT01818752|467169965|FG000|Overall Study|Randomized but not Dosed|7|||
129782198|NCT01818752|467169966|FG001|Overall Study|Randomized but not Dosed|4|||
129782199|NCT01033448|467169967|FG000|Overall Study|Withdrawal by Subject|4|||
129782200|NCT01033448|467169967|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
129782201|NCT01033448|467169967|FG000|Overall Study|Lost to Follow-up|3|||
129782202|NCT01033448|467169967|FG000|Overall Study|Withdrew due to other reasons|3|||
129782203|NCT01033448|467169967|FG000|Overall Study|Unknown disposition|1|||
129782204|NCT04270370|467169968|FG000|Overall Study|Lost to Follow-up|1|||
129782205|NCT04270370|467169969|FG001|Overall Study|Lost to Follow-up|0|||
129782206|NCT04270370|467169970|FG002|Overall Study|Lost to Follow-up|0|||
129782207|NCT04270370|467169971|FG003|Overall Study|Lost to Follow-up|0|||
129782208|NCT04270370|467169972|FG004|Overall Study|Lost to Follow-up|0|||
129782209|NCT04270370|467169973|FG005|Overall Study|Lost to Follow-up|0|||
129782210|NCT04270370|467169974|FG006|Overall Study|Lost to Follow-up|0|||
129782211|NCT04270370|467169975|FG007|Overall Study|Lost to Follow-up|0|||
129571476|NCT02140060|466389002|FG000|Overall Study|Adverse Event|0|||
129782212|NCT04270370|467169976|FG008|Overall Study|Lost to Follow-up|1|||
129782213|NCT04270370|467169977|FG009|Overall Study|Lost to Follow-up|0|||
129571477|NCT02140060|466389003|FG001|Overall Study|Adverse Event|0|||
129571478|NCT02140060|466389004|FG002|Overall Study|Adverse Event|0|||
129571479|NCT02140060|466389005|FG003|Overall Study|Adverse Event|1|||
129571480|NCT02140060|466389006|FG004|Overall Study|Adverse Event|1|||
129571481|NCT02140060|466389007|FG005|Overall Study|Adverse Event|1|||
129571482|NCT02140060|466389002|FG000|Overall Study|Lack of Efficacy|0|||
129571483|NCT02140060|466389003|FG001|Overall Study|Lack of Efficacy|0|||
129571484|NCT02140060|466389004|FG002|Overall Study|Lack of Efficacy|0|||
129571485|NCT02140060|466389005|FG003|Overall Study|Lack of Efficacy|1|||
129571486|NCT02140060|466389006|FG004|Overall Study|Lack of Efficacy|0|||
129571487|NCT02140060|466389007|FG005|Overall Study|Lack of Efficacy|0|||
129571488|NCT02817841|466390764|FG000|Overall Study|Lost to Follow-up|287|||
129571489|NCT02817841|466390764|FG000|Overall Study|Withdrawal by Subject|183|||
129571490|NCT02817841|466390764|FG000|Overall Study|Adverse event not related to bleeding|131|||
129571491|NCT02817841|466390764|FG000|Overall Study|Adverse event related to bleeding|51|||
129571492|NCT02817841|466390764|FG000|Overall Study|Pregnancy|32|||
129571493|NCT02817841|466390764|FG000|Overall Study|Pregnancy wish|17|||
129571494|NCT02817841|466390764|FG000|Overall Study|Other reasons|53|||
129571495|NCT02817841|466390764|FG000|Overall Study|Protocol Violation|94|||
129571496|NCT01746017|466390773|FG000|Period 1|Withdrawal by Subject|0|||
129571497|NCT01746017|466390774|FG001|Period 1|Withdrawal by Subject|0|||
129571498|NCT01746017|466390775|FG002|Period 1|Withdrawal by Subject|0|||
129571499|NCT01746017|466390776|FG003|Period 1|Withdrawal by Subject|0|||
129571500|NCT01746017|466390777|FG004|Period 1|Withdrawal by Subject|0|||
129571501|NCT01746017|466390778|FG005|Period 1|Withdrawal by Subject|0|||
129571502|NCT01746017|466390779|FG006|Period 1|Withdrawal by Subject|1|||
129571503|NCT01746017|466390780|FG007|Period 1|Withdrawal by Subject|0|||
129571504|NCT01746017|466390781|FG008|Period 1|Withdrawal by Subject|0|||
129571505|NCT01746017|466390782|FG009|Period 1|Withdrawal by Subject|0|||
129571506|NCT01746017|466390783|FG010|Period 1|Withdrawal by Subject|0|||
129571507|NCT01746017|466390773|FG000|Period 3|Withdrawal by Subject|0|||
129571508|NCT01746017|466390774|FG001|Period 3|Withdrawal by Subject|0|||
129571509|NCT01746017|466390775|FG002|Period 3|Withdrawal by Subject|0|||
129571510|NCT01746017|466390776|FG003|Period 3|Withdrawal by Subject|0|||
129571511|NCT01746017|466390777|FG004|Period 3|Withdrawal by Subject|0|||
129571512|NCT01746017|466390778|FG005|Period 3|Withdrawal by Subject|1|||
129571513|NCT01746017|466390779|FG006|Period 3|Withdrawal by Subject|0|||
129571514|NCT01746017|466390780|FG007|Period 3|Withdrawal by Subject|0|||
129571515|NCT01746017|466390781|FG008|Period 3|Withdrawal by Subject|0|||
129571516|NCT01746017|466390782|FG009|Period 3|Withdrawal by Subject|0|||
129571517|NCT01746017|466390783|FG010|Period 3|Withdrawal by Subject|0|||
129691837|NCT05660538|466830611|FG000|Overall Study|Randomized but did not receive study drug|1|||
129691838|NCT05660538|466830612|FG001|Overall Study|Randomized but did not receive study drug|0|||
129691839|NCT05660538|466830613|FG002|Overall Study|Randomized but did not receive study drug|0|||
129691840|NCT05660538|466830614|FG003|Overall Study|Randomized but did not receive study drug|1|||
129691841|NCT05660538|466830611|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
129691842|NCT05660538|466830612|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
129691843|NCT05660538|466830613|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
129691844|NCT05660538|466830614|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
129691845|NCT04518410|466830616|FG000|Overall Study|Lost to Follow-up|1|||
129691846|NCT04518410|466830617|FG001|Overall Study|Lost to Follow-up|1|||
129691847|NCT04518410|466830618|FG002|Overall Study|Lost to Follow-up|8|||
129691848|NCT04518410|466830619|FG003|Overall Study|Lost to Follow-up|5|||
129691849|NCT04518410|466830620|FG004|Overall Study|Lost to Follow-up|92|||
129691850|NCT04518410|466830621|FG005|Overall Study|Lost to Follow-up|25|||
129691851|NCT04518410|466830622|FG006|Overall Study|Lost to Follow-up|25|||
129691852|NCT04518410|466830623|FG007|Overall Study|Lost to Follow-up|3|||
129691853|NCT04518410|466830624|FG008|Overall Study|Lost to Follow-up|2|||
129691854|NCT04518410|466830625|FG009|Overall Study|Lost to Follow-up|13|||
129691855|NCT04518410|466830626|FG010|Overall Study|Lost to Follow-up|9|||
129691856|NCT04518410|466830627|FG011|Overall Study|Lost to Follow-up|13|||
129691857|NCT04518410|466830628|FG012|Overall Study|Lost to Follow-up|9|||
129691858|NCT04518410|466830629|FG013|Overall Study|Lost to Follow-up|13|||
129782214|NCT04270370|467169978|FG010|Overall Study|Lost to Follow-up|0|||
129782215|NCT04270370|467169979|FG011|Overall Study|Lost to Follow-up|0|||
129571518|NCT00397488|466390784|FG000|Overall Study|Withdrawal by Subject|3|||
129571519|NCT00397488|466390784|FG000|Overall Study|Adverse Event|3|||
129571520|NCT00397488|466390784|FG000|Overall Study|Death|1|||
129571521|NCT02943447|466390785|FG000|Blinded Study Phase|Withdrew Consent|1|||
129571522|NCT02943447|466390786|FG001|Blinded Study Phase|Withdrew Consent|2|||
129571523|NCT02943447|466390787|FG002|Blinded Study Phase|Withdrew Consent|1|||
129571524|NCT02943447|466390785|FG000|Blinded Study Phase|Adverse Event|3|||
129571525|NCT02943447|466390786|FG001|Blinded Study Phase|Adverse Event|0|||
129571526|NCT02943447|466390787|FG002|Blinded Study Phase|Adverse Event|0|||
129571527|NCT02943447|466390785|FG000|Blinded Study Phase|Investigator's discretion|1|||
129571528|NCT02943447|466390786|FG001|Blinded Study Phase|Investigator's discretion|0|||
129571529|NCT02943447|466390787|FG002|Blinded Study Phase|Investigator's discretion|0|||
129571530|NCT02943447|466390785|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
129571531|NCT02943447|466390786|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
129571532|NCT02943447|466390787|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
129571533|NCT02943447|466390785|FG000|Open-Label Extension Phase|Adverse Event|4|||
129571534|NCT02943447|466390786|FG001|Open-Label Extension Phase|Adverse Event|7|||
129691859|NCT04518410|466830630|FG014|Overall Study|Lost to Follow-up|8|||
129691860|NCT04518410|466830631|FG015|Overall Study|Lost to Follow-up|10|||
129691861|NCT04518410|466830632|FG016|Overall Study|Lost to Follow-up|6|||
129691862|NCT04518410|466830633|FG017|Overall Study|Lost to Follow-up|13|||
129691863|NCT04518410|466830634|FG018|Overall Study|Lost to Follow-up|21|||
129691864|NCT04518410|466830635|FG019|Overall Study|Lost to Follow-up|6|||
129691865|NCT04518410|466830636|FG020|Overall Study|Lost to Follow-up|7|||
129691866|NCT04518410|466830637|FG021|Overall Study|Lost to Follow-up|21|||
129691867|NCT04518410|466830638|FG022|Overall Study|Lost to Follow-up|1|||
129691868|NCT04518410|466830639|FG023|Overall Study|Lost to Follow-up|7|||
129691869|NCT04518410|466830640|FG024|Overall Study|Lost to Follow-up|6|||
129691870|NCT04518410|466830616|FG000|Overall Study|Withdrawal by Subject|1|||
129691871|NCT04518410|466830617|FG001|Overall Study|Withdrawal by Subject|2|||
129691872|NCT04518410|466830618|FG002|Overall Study|Withdrawal by Subject|2|||
129691873|NCT04518410|466830619|FG003|Overall Study|Withdrawal by Subject|3|||
129691874|NCT04518410|466830620|FG004|Overall Study|Withdrawal by Subject|20|||
129691875|NCT04518410|466830621|FG005|Overall Study|Withdrawal by Subject|20|||
129691876|NCT04518410|466830622|FG006|Overall Study|Withdrawal by Subject|25|||
129691877|NCT04518410|466830623|FG007|Overall Study|Withdrawal by Subject|6|||
129691878|NCT04518410|466830624|FG008|Overall Study|Withdrawal by Subject|1|||
129691879|NCT04518410|466830625|FG009|Overall Study|Withdrawal by Subject|12|||
129691880|NCT04518410|466830626|FG010|Overall Study|Withdrawal by Subject|5|||
129691881|NCT04518410|466830627|FG011|Overall Study|Withdrawal by Subject|7|||
129691882|NCT04518410|466830628|FG012|Overall Study|Withdrawal by Subject|2|||
129691883|NCT04518410|466830629|FG013|Overall Study|Withdrawal by Subject|13|||
129691884|NCT04518410|466830630|FG014|Overall Study|Withdrawal by Subject|4|||
129691885|NCT04518410|466830631|FG015|Overall Study|Withdrawal by Subject|9|||
129691886|NCT04518410|466830632|FG016|Overall Study|Withdrawal by Subject|0|||
129691887|NCT04518410|466830633|FG017|Overall Study|Withdrawal by Subject|15|||
129691888|NCT04518410|466830634|FG018|Overall Study|Withdrawal by Subject|12|||
129691889|NCT04518410|466830635|FG019|Overall Study|Withdrawal by Subject|9|||
129691890|NCT04518410|466830636|FG020|Overall Study|Withdrawal by Subject|14|||
129691891|NCT04518410|466830637|FG021|Overall Study|Withdrawal by Subject|3|||
129691892|NCT04518410|466830638|FG022|Overall Study|Withdrawal by Subject|2|||
129691893|NCT04518410|466830639|FG023|Overall Study|Withdrawal by Subject|9|||
129691894|NCT04518410|466830640|FG024|Overall Study|Withdrawal by Subject|8|||
129691895|NCT04518410|466830616|FG000|Overall Study|Other|1|||
129691896|NCT04518410|466830617|FG001|Overall Study|Other|0|||
129691897|NCT04518410|466830618|FG002|Overall Study|Other|0|||
129691898|NCT04518410|466830619|FG003|Overall Study|Other|1|||
129691899|NCT04518410|466830620|FG004|Overall Study|Other|6|||
129691900|NCT04518410|466830621|FG005|Overall Study|Other|6|||
129691901|NCT04518410|466830622|FG006|Overall Study|Other|5|||
129691902|NCT04518410|466830623|FG007|Overall Study|Other|2|||
129691903|NCT04518410|466830624|FG008|Overall Study|Other|0|||
129691904|NCT04518410|466830625|FG009|Overall Study|Other|1|||
129691905|NCT04518410|466830626|FG010|Overall Study|Other|0|||
129691906|NCT04518410|466830627|FG011|Overall Study|Other|2|||
129691907|NCT04518410|466830628|FG012|Overall Study|Other|0|||
129691908|NCT04518410|466830629|FG013|Overall Study|Other|0|||
129691909|NCT04518410|466830630|FG014|Overall Study|Other|0|||
129691910|NCT04518410|466830631|FG015|Overall Study|Other|3|||
129691911|NCT04518410|466830632|FG016|Overall Study|Other|1|||
129691912|NCT04518410|466830633|FG017|Overall Study|Other|1|||
129691913|NCT04518410|466830634|FG018|Overall Study|Other|1|||
129691914|NCT04518410|466830635|FG019|Overall Study|Other|0|||
129691915|NCT04518410|466830636|FG020|Overall Study|Other|1|||
129691916|NCT04518410|466830637|FG021|Overall Study|Other|0|||
129691917|NCT04518410|466830638|FG022|Overall Study|Other|1|||
129691918|NCT04518410|466830639|FG023|Overall Study|Other|2|||
129691919|NCT04518410|466830640|FG024|Overall Study|Other|2|||
129691920|NCT04518410|466830616|FG000|Overall Study|Protocol Violation|0|||
129691921|NCT04518410|466830617|FG001|Overall Study|Protocol Violation|0|||
129691922|NCT04518410|466830618|FG002|Overall Study|Protocol Violation|0|||
129691923|NCT04518410|466830619|FG003|Overall Study|Protocol Violation|2|||
129691924|NCT04518410|466830620|FG004|Overall Study|Protocol Violation|17|||
129691925|NCT04518410|466830621|FG005|Overall Study|Protocol Violation|1|||
129691926|NCT04518410|466830622|FG006|Overall Study|Protocol Violation|2|||
129691927|NCT04518410|466830623|FG007|Overall Study|Protocol Violation|1|||
129571535|NCT02943447|466390787|FG002|Open-Label Extension Phase|Adverse Event|3|||
129571536|NCT02943447|466390785|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
129571537|NCT02943447|466390786|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
129571538|NCT02943447|466390787|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
129571539|NCT02943447|466390785|FG000|Open-Label Extension Phase|Withdrew consent|1|||
129571540|NCT02943447|466390786|FG001|Open-Label Extension Phase|Withdrew consent|1|||
129571541|NCT02943447|466390787|FG002|Open-Label Extension Phase|Withdrew consent|1|||
129571542|NCT02943447|466390785|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129571543|NCT02943447|466390786|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
129571544|NCT02943447|466390787|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129571545|NCT01294787|466390788|FG000|Period 1|Adverse Event|0|||
129571546|NCT01294787|466390789|FG001|Period 1|Adverse Event|0|||
129571547|NCT01294787|466390790|FG002|Period 1|Adverse Event|0|||
129571548|NCT01294787|466390791|FG003|Period 1|Adverse Event|0|||
129571549|NCT01294787|466390792|FG004|Period 1|Adverse Event|1|||
129571550|NCT01294787|466390793|FG005|Period 1|Adverse Event|0|||
129571551|NCT01294787|466390788|FG000|Period 1|Withdrawal by Subject|0|||
129571552|NCT01294787|466390789|FG001|Period 1|Withdrawal by Subject|0|||
129571553|NCT01294787|466390790|FG002|Period 1|Withdrawal by Subject|0|||
129571554|NCT01294787|466390791|FG003|Period 1|Withdrawal by Subject|1|||
129571555|NCT01294787|466390792|FG004|Period 1|Withdrawal by Subject|1|||
129571556|NCT01294787|466390793|FG005|Period 1|Withdrawal by Subject|1|||
129571557|NCT01294787|466390788|FG000|Period 1|Administrative problem|0|||
129571558|NCT01294787|466390789|FG001|Period 1|Administrative problem|0|||
129571559|NCT01294787|466390790|FG002|Period 1|Administrative problem|1|||
129571560|NCT01294787|466390791|FG003|Period 1|Administrative problem|0|||
129571561|NCT01294787|466390792|FG004|Period 1|Administrative problem|0|||
129571562|NCT01294787|466390793|FG005|Period 1|Administrative problem|1|||
129571563|NCT01294787|466390788|FG000|Period 2|Adverse Event|0|||
129571564|NCT01294787|466390789|FG001|Period 2|Adverse Event|3|||
129691928|NCT04518410|466830624|FG008|Overall Study|Protocol Violation|0|||
129691929|NCT04518410|466830625|FG009|Overall Study|Protocol Violation|0|||
129691930|NCT04518410|466830626|FG010|Overall Study|Protocol Violation|0|||
129691931|NCT04518410|466830627|FG011|Overall Study|Protocol Violation|0|||
129691932|NCT04518410|466830628|FG012|Overall Study|Protocol Violation|0|||
129691933|NCT04518410|466830629|FG013|Overall Study|Protocol Violation|0|||
129691934|NCT04518410|466830630|FG014|Overall Study|Protocol Violation|0|||
129691935|NCT04518410|466830631|FG015|Overall Study|Protocol Violation|0|||
129691936|NCT04518410|466830632|FG016|Overall Study|Protocol Violation|1|||
129691937|NCT04518410|466830633|FG017|Overall Study|Protocol Violation|1|||
129691938|NCT04518410|466830634|FG018|Overall Study|Protocol Violation|0|||
129691939|NCT04518410|466830635|FG019|Overall Study|Protocol Violation|0|||
129691940|NCT04518410|466830636|FG020|Overall Study|Protocol Violation|1|||
129691941|NCT04518410|466830637|FG021|Overall Study|Protocol Violation|2|||
129691942|NCT04518410|466830638|FG022|Overall Study|Protocol Violation|0|||
129691943|NCT04518410|466830639|FG023|Overall Study|Protocol Violation|3|||
129691944|NCT04518410|466830640|FG024|Overall Study|Protocol Violation|0|||
129691945|NCT04518410|466830616|FG000|Overall Study|Death|0|||
129691946|NCT04518410|466830617|FG001|Overall Study|Death|0|||
129691947|NCT04518410|466830618|FG002|Overall Study|Death|0|||
129691948|NCT04518410|466830619|FG003|Overall Study|Death|0|||
129691949|NCT04518410|466830620|FG004|Overall Study|Death|12|||
129691950|NCT04518410|466830621|FG005|Overall Study|Death|2|||
129691951|NCT04518410|466830622|FG006|Overall Study|Death|11|||
129691952|NCT04518410|466830623|FG007|Overall Study|Death|0|||
129691953|NCT04518410|466830624|FG008|Overall Study|Death|1|||
129691954|NCT04518410|466830625|FG009|Overall Study|Death|0|||
129691955|NCT04518410|466830626|FG010|Overall Study|Death|0|||
129691956|NCT04518410|466830627|FG011|Overall Study|Death|0|||
129691957|NCT04518410|466830628|FG012|Overall Study|Death|0|||
129691958|NCT04518410|466830629|FG013|Overall Study|Death|1|||
129691959|NCT04518410|466830630|FG014|Overall Study|Death|1|||
129691960|NCT04518410|466830631|FG015|Overall Study|Death|0|||
129691961|NCT04518410|466830632|FG016|Overall Study|Death|0|||
129691962|NCT04518410|466830633|FG017|Overall Study|Death|1|||
129691963|NCT04518410|466830634|FG018|Overall Study|Death|4|||
129571565|NCT01294787|466390790|FG002|Period 2|Adverse Event|0|||
129691964|NCT04518410|466830635|FG019|Overall Study|Death|4|||
129691965|NCT04518410|466830636|FG020|Overall Study|Death|1|||
129691966|NCT04518410|466830637|FG021|Overall Study|Death|0|||
129691967|NCT04518410|466830638|FG022|Overall Study|Death|0|||
129691968|NCT04518410|466830639|FG023|Overall Study|Death|0|||
129691969|NCT04518410|466830640|FG024|Overall Study|Death|0|||
129691970|NCT04518410|466830616|FG000|Overall Study|Requirement to start alternative therapy|0|||
129691971|NCT04518410|466830617|FG001|Overall Study|Requirement to start alternative therapy|0|||
129691972|NCT04518410|466830618|FG002|Overall Study|Requirement to start alternative therapy|1|||
129571566|NCT01294787|466390791|FG003|Period 2|Adverse Event|1|||
129571567|NCT01294787|466390792|FG004|Period 2|Adverse Event|0|||
129571568|NCT01294787|466390793|FG005|Period 2|Adverse Event|0|||
129571569|NCT01294787|466390788|FG000|Period 2|No longer needs study drug|0|||
129571570|NCT01294787|466390789|FG001|Period 2|No longer needs study drug|0|||
129571571|NCT01294787|466390790|FG002|Period 2|No longer needs study drug|0|||
129571572|NCT01294787|466390791|FG003|Period 2|No longer needs study drug|1|||
129571573|NCT01294787|466390792|FG004|Period 2|No longer needs study drug|0|||
129571574|NCT01294787|466390793|FG005|Period 2|No longer needs study drug|0|||
129571575|NCT01294787|466390788|FG000|Period 3|Adverse Event|0|||
129571576|NCT01294787|466390789|FG001|Period 3|Adverse Event|0|||
129571577|NCT01294787|466390790|FG002|Period 3|Adverse Event|0|||
129571578|NCT01294787|466390791|FG003|Period 3|Adverse Event|0|||
129571579|NCT01294787|466390792|FG004|Period 3|Adverse Event|1|||
129571580|NCT01294787|466390793|FG005|Period 3|Adverse Event|0|||
129571581|NCT04657770|466390796|FG000|Overall Study|Withdrawal by Subject|3|||
129571582|NCT04657770|466390796|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
129571583|NCT03655106|466390797|FG000|Overall Study|Withdrawal by Subject|3|||
129571584|NCT03655106|466390798|FG001|Overall Study|Withdrawal by Subject|2|||
129571585|NCT03655106|466390797|FG000|Overall Study|Lost to Follow-up|2|||
129571586|NCT03655106|466390798|FG001|Overall Study|Lost to Follow-up|1|||
129571587|NCT03655106|466390797|FG000|Overall Study|Duplicate Enrollment|1|||
129571588|NCT03655106|466390798|FG001|Overall Study|Duplicate Enrollment|1|||
129571589|NCT03655106|466390797|FG000|Overall Study|Protocol Violation|3|||
129571590|NCT03655106|466390798|FG001|Overall Study|Protocol Violation|0|||
129571591|NCT03785548|466390799|FG000|Overall Study|age > 80|1|||
129571592|NCT03785548|466390800|FG001|Overall Study|age > 80|0|||
129571593|NCT03785548|466390799|FG000|Overall Study|no Postop queries|1|||
129571594|NCT03785548|466390800|FG001|Overall Study|no Postop queries|0|||
129571595|NCT05327491|466390803|FG000|Periods 1 & 2|Miscellaneous|0|||
129571596|NCT05327491|466390804|FG001|Periods 1 & 2|Miscellaneous|1|||
129571597|NCT05327491|466390805|FG002|Periods 1 & 2|Miscellaneous|0|||
129571598|NCT05327491|466390806|FG003|Periods 1 & 2|Miscellaneous|0|||
129571599|NCT05327491|466390803|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
129571600|NCT05327491|466390804|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
129571601|NCT05327491|466390805|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
129571602|NCT05327491|466390806|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
129571603|NCT05038293|466390807|FG000|Overall Study|device was not operating properly for one subject.|1|||
129571604|NCT05038293|466390808|FG001|Overall Study|device was not operating properly for one subject.|0|||
129571605|NCT05038293|466390807|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
129571606|NCT05038293|466390808|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
129571607|NCT01171989|466390809|FG000|Overall Study|Lost to Follow-up|0|||
129571608|NCT01171989|466390810|FG001|Overall Study|Lost to Follow-up|0|||
129571609|NCT01171989|466390811|FG002|Overall Study|Lost to Follow-up|1|||
129571610|NCT01247701|466390814|FG000|Overall Study|Death|2|||
129571611|NCT01247701|466390814|FG000|Overall Study|Relapsed|8|||
129571612|NCT04166630|466390815|FG000|Overall Study|Withdrawal by Subject|0|||
129571613|NCT04166630|466390816|FG001|Overall Study|Withdrawal by Subject|1|||
129571614|NCT00096447|466390817|FG000|Overall Study|Never treated|1|||
129571615|NCT04088760|466390818|FG000|Overall Study|Physician Decision|1|||
129571616|NCT02300103|466390819|FG000|Overall Study|Lack of Efficacy|3|||
129571617|NCT02300103|466390819|FG000|Overall Study|Protocol Violation|1|||
129571618|NCT02300103|466390819|FG000|Overall Study|Withdrew Consent|2|||
129571619|NCT04091971|466390820|FG000|Overall Study|Withdrawal by Subject|1|||
129571620|NCT04091971|466390820|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
129691973|NCT04518410|466830619|FG003|Overall Study|Requirement to start alternative therapy|0|||
129691974|NCT04518410|466830620|FG004|Overall Study|Requirement to start alternative therapy|0|||
129691975|NCT04518410|466830621|FG005|Overall Study|Requirement to start alternative therapy|0|||
129691976|NCT04518410|466830622|FG006|Overall Study|Requirement to start alternative therapy|0|||
129691977|NCT04518410|466830623|FG007|Overall Study|Requirement to start alternative therapy|0|||
129571621|NCT04091971|466390820|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
129571622|NCT04466111|466390822|FG000|Prior to Trial Phase|Physician Decision|1|||
129571623|NCT00105196|466390823|FG000|Overall Study|Lack of Efficacy|2|||
129571624|NCT00105196|466390824|FG001|Overall Study|Lack of Efficacy|3|||
129571625|NCT00105196|466390823|FG000|Overall Study|Adverse Event|11|||
129571626|NCT00105196|466390824|FG001|Overall Study|Adverse Event|3|||
129571627|NCT00105196|466390823|FG000|Overall Study|Withdrawal by Subject|6|||
129571628|NCT00105196|466390824|FG001|Overall Study|Withdrawal by Subject|6|||
129571629|NCT00105196|466390823|FG000|Overall Study|Lost to Follow-up|3|||
129571630|NCT00105196|466390824|FG001|Overall Study|Lost to Follow-up|2|||
129571631|NCT00105196|466390823|FG000|Overall Study|Poor/noncompliance|3|||
129571632|NCT00105196|466390824|FG001|Overall Study|Poor/noncompliance|4|||
129571633|NCT00105196|466390823|FG000|Overall Study|Protocol Violation|5|||
129571634|NCT00105196|466390824|FG001|Overall Study|Protocol Violation|2|||
129782216|NCT01324141|467169980|FG000|Overall Study|Declined to participate before treatment started|1|||
129782217|NCT01324141|467169980|FG000|Overall Study|Disease progression on study|1|||
129782218|NCT00870584|467169983|FG000|Overall Study|Adverse Event|3|||
129782219|NCT00870584|467169984|FG001|Overall Study|Adverse Event|3|||
129782220|NCT00870584|467169983|FG000|Overall Study|Withdrawal by Subject|6|||
129782221|NCT00870584|467169984|FG001|Overall Study|Withdrawal by Subject|7|||
129782222|NCT00870584|467169983|FG000|Overall Study|Lost to Follow-up|5|||
129782223|NCT00870584|467169984|FG001|Overall Study|Lost to Follow-up|1|||
129782224|NCT00870584|467169983|FG000|Overall Study|Protocol Deviation|2|||
129782225|NCT00870584|467169984|FG001|Overall Study|Protocol Deviation|2|||
129782226|NCT02560025|467169985|FG000|Overall Study|Ineligible after consent/ registration|3|||
129782227|NCT02703337|467169986|FG000|Period One (Part A)|Withdrawal by Subject|0|||
129782228|NCT02703337|467169987|FG001|Period One (Part A)|Withdrawal by Subject|0|||
129782229|NCT02703337|467169988|FG002|Period One (Part A)|Withdrawal by Subject|0|||
129782230|NCT02703337|467169989|FG003|Period One (Part A)|Withdrawal by Subject|0|||
129782231|NCT02703337|467169990|FG004|Period One (Part A)|Withdrawal by Subject|1|||
129782232|NCT02703337|467169991|FG005|Period One (Part A)|Withdrawal by Subject|0|||
129782233|NCT02703337|467169992|FG006|Period One (Part A)|Withdrawal by Subject|0|||
129782234|NCT02703337|467169993|FG007|Period One (Part A)|Withdrawal by Subject|0|||
129782235|NCT00282308|467169994|FG000|Treatment Period|Lost to Follow-up|1|||
129782236|NCT00282308|467169995|FG001|Treatment Period|Lost to Follow-up|0|||
129782237|NCT00282308|467169996|FG002|Treatment Period|Lost to Follow-up|0|||
129782238|NCT00282308|467169994|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
129782239|NCT00282308|467169995|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
129782240|NCT00282308|467169996|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
129782241|NCT00282308|467169994|FG000|Treatment Period|Adverse Event|0|||
129782242|NCT00282308|467169995|FG001|Treatment Period|Adverse Event|2|||
129782243|NCT00282308|467169996|FG002|Treatment Period|Adverse Event|0|||
129782244|NCT00282308|467169994|FG000|Treatment Period|Not Treated with Study Drug|1|||
129782245|NCT00282308|467169995|FG001|Treatment Period|Not Treated with Study Drug|0|||
129782246|NCT00282308|467169996|FG002|Treatment Period|Not Treated with Study Drug|0|||
129782247|NCT00282308|467169994|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
129782248|NCT00282308|467169995|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
129782249|NCT00282308|467169996|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
129782250|NCT00282308|467169994|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
129782251|NCT00282308|467169995|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
129782252|NCT00282308|467169996|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
129782253|NCT00282308|467169994|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
129782254|NCT00282308|467169995|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
129782255|NCT00282308|467169996|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
129782256|NCT00282308|467169994|FG000|Safety Follow-up Period|Adverse Event|0|||
129782257|NCT00282308|467169995|FG001|Safety Follow-up Period|Adverse Event|0|||
129782258|NCT00282308|467169996|FG002|Safety Follow-up Period|Adverse Event|1|||
129782259|NCT00282308|467169994|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
129782260|NCT00282308|467169995|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
129782261|NCT00282308|467169996|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
129782262|NCT00282308|467169994|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
129782263|NCT00282308|467169995|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
129782264|NCT00282308|467169996|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
129782265|NCT00282308|467169994|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
129782266|NCT00282308|467169995|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
129782267|NCT00282308|467169996|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
129782268|NCT04303195|467169997|FG000|Overall Study|Adverse Event|1|||
129782269|NCT04303195|467169998|FG001|Overall Study|Adverse Event|3|||
129571635|NCT00105196|466390823|FG000|Overall Study|pending surgery|0|||
129782270|NCT04303195|467169999|FG002|Overall Study|Adverse Event|7|||
129782271|NCT04303195|467170000|FG003|Overall Study|Adverse Event|0|||
129782272|NCT04303195|467169997|FG000|Overall Study|Lost to Follow-up|1|||
129782273|NCT04303195|467169998|FG001|Overall Study|Lost to Follow-up|0|||
129782274|NCT04303195|467169999|FG002|Overall Study|Lost to Follow-up|1|||
129782275|NCT04303195|467170000|FG003|Overall Study|Lost to Follow-up|4|||
129782276|NCT04303195|467169997|FG000|Overall Study|Withdrawal by Subject|3|||
129782277|NCT04303195|467169998|FG001|Overall Study|Withdrawal by Subject|1|||
129782278|NCT04303195|467169999|FG002|Overall Study|Withdrawal by Subject|1|||
129571636|NCT00105196|466390824|FG001|Overall Study|pending surgery|1|||
129571637|NCT00105196|466390823|FG000|Overall Study|marijuana use|0|||
129782279|NCT04303195|467170000|FG003|Overall Study|Withdrawal by Subject|1|||
129571638|NCT00105196|466390824|FG001|Overall Study|marijuana use|1|||
129571639|NCT00105196|466390823|FG000|Overall Study|Subject became unblinded|0|||
129571640|NCT00105196|466390824|FG001|Overall Study|Subject became unblinded|1|||
129571641|NCT01981720|466390827|FG000|Overall Study|Adverse Event|1|||
129571642|NCT01981720|466390827|FG000|Overall Study|Withdrawal by Subject|3|||
129571643|NCT01981720|466390827|FG000|Overall Study|Pregnancy|1|||
129571644|NCT00184600|466390828|FG000|Overall Study|Adverse Event|9|||
129571645|NCT00184600|466390829|FG001|Overall Study|Adverse Event|0|||
129571646|NCT00184600|466390830|FG002|Overall Study|Adverse Event|5|||
129571647|NCT00184600|466390828|FG000|Overall Study|Death|3|||
129571648|NCT00184600|466390829|FG001|Overall Study|Death|9|||
129571649|NCT00184600|466390830|FG002|Overall Study|Death|7|||
129571650|NCT00184600|466390828|FG000|Overall Study|Lack of Efficacy|3|||
129571651|NCT00184600|466390829|FG001|Overall Study|Lack of Efficacy|1|||
129571652|NCT00184600|466390830|FG002|Overall Study|Lack of Efficacy|3|||
129571653|NCT00184600|466390828|FG000|Overall Study|Lost to Follow-up|4|||
129571654|NCT00184600|466390829|FG001|Overall Study|Lost to Follow-up|6|||
129571655|NCT00184600|466390830|FG002|Overall Study|Lost to Follow-up|1|||
129571656|NCT00184600|466390828|FG000|Overall Study|Protocol Violation|2|||
129571657|NCT00184600|466390829|FG001|Overall Study|Protocol Violation|2|||
129571658|NCT00184600|466390830|FG002|Overall Study|Protocol Violation|3|||
129571659|NCT00184600|466390828|FG000|Overall Study|Withdrawal by Subject|20|||
129571660|NCT00184600|466390829|FG001|Overall Study|Withdrawal by Subject|28|||
129571661|NCT00184600|466390830|FG002|Overall Study|Withdrawal by Subject|12|||
129571662|NCT00184600|466390828|FG000|Overall Study|Unclassified|4|||
129571663|NCT00184600|466390829|FG001|Overall Study|Unclassified|5|||
129571664|NCT00184600|466390830|FG002|Overall Study|Unclassified|3|||
129571665|NCT00286754|466390831|FG000|Overall Study|Adverse Event|2|||
129571666|NCT00286754|466390832|FG001|Overall Study|Adverse Event|2|||
129571667|NCT00286754|466390833|FG002|Overall Study|Adverse Event|3|||
129571668|NCT00286754|466390831|FG000|Overall Study|Withdrawal by Subject|6|||
129571669|NCT00286754|466390832|FG001|Overall Study|Withdrawal by Subject|2|||
129571670|NCT00286754|466390833|FG002|Overall Study|Withdrawal by Subject|0|||
129571671|NCT00286754|466390831|FG000|Overall Study|Lost to Follow-up|12|||
129571672|NCT00286754|466390832|FG001|Overall Study|Lost to Follow-up|14|||
129571673|NCT00286754|466390833|FG002|Overall Study|Lost to Follow-up|6|||
129571674|NCT00286754|466390831|FG000|Overall Study|Moved out of state|0|||
129571675|NCT00286754|466390832|FG001|Overall Study|Moved out of state|0|||
129571676|NCT00286754|466390833|FG002|Overall Study|Moved out of state|1|||
129571677|NCT01536405|466390834|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
129571678|NCT01536405|466390835|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
129571679|NCT01536405|466390834|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
129571680|NCT01536405|466390835|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
129571681|NCT01536405|466390834|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
129571682|NCT01536405|466390835|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
129571683|NCT01536405|466390834|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
129571684|NCT01536405|466390835|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
129571685|NCT01536405|466390834|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
129571686|NCT01536405|466390835|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
129571687|NCT01536405|466390834|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
129571688|NCT01536405|466390835|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
129571689|NCT01536405|466390834|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
129571690|NCT01536405|466390835|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
129571691|NCT01536405|466390834|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
129571692|NCT01536405|466390835|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
129571693|NCT01536405|466390834|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
129571694|NCT01536405|466390835|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
129691978|NCT04518410|466830624|FG008|Overall Study|Requirement to start alternative therapy|0|||
129691979|NCT04518410|466830625|FG009|Overall Study|Requirement to start alternative therapy|0|||
129691980|NCT04518410|466830626|FG010|Overall Study|Requirement to start alternative therapy|0|||
129691981|NCT04518410|466830627|FG011|Overall Study|Requirement to start alternative therapy|0|||
129691982|NCT04518410|466830628|FG012|Overall Study|Requirement to start alternative therapy|0|||
129691983|NCT04518410|466830629|FG013|Overall Study|Requirement to start alternative therapy|0|||
129691984|NCT04518410|466830630|FG014|Overall Study|Requirement to start alternative therapy|0|||
129691985|NCT04518410|466830631|FG015|Overall Study|Requirement to start alternative therapy|0|||
129691986|NCT04518410|466830632|FG016|Overall Study|Requirement to start alternative therapy|0|||
129691987|NCT04518410|466830633|FG017|Overall Study|Requirement to start alternative therapy|0|||
129691988|NCT04518410|466830634|FG018|Overall Study|Requirement to start alternative therapy|0|||
129571695|NCT01536405|466390834|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
129571696|NCT01536405|466390835|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
129571697|NCT01536405|466390834|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
129571698|NCT01536405|466390835|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
129782280|NCT04303195|467169997|FG000|Overall Study|No study drug administered or protocol deviation|0|||
129782281|NCT04303195|467169998|FG001|Overall Study|No study drug administered or protocol deviation|2|||
129782282|NCT04303195|467169999|FG002|Overall Study|No study drug administered or protocol deviation|0|||
129782283|NCT04303195|467170000|FG003|Overall Study|No study drug administered or protocol deviation|2|||
129782284|NCT06457204|467170001|FG000|Washout|Adverse Event|0|||
129782285|NCT06457204|467170002|FG001|Washout|Adverse Event|2|||
129782286|NCT01065454|467170003|FG000|Treatment|Adverse Event|7|||
129782287|NCT01065454|467170004|FG001|Treatment|Adverse Event|4|||
129782288|NCT01065454|467170005|FG002|Treatment|Adverse Event|3|||
129782289|NCT01065454|467170006|FG003|Treatment|Adverse Event|6|||
129782290|NCT01065454|467170003|FG000|Treatment|Death|1|||
129782291|NCT01065454|467170004|FG001|Treatment|Death|0|||
129782292|NCT01065454|467170005|FG002|Treatment|Death|0|||
129782293|NCT01065454|467170006|FG003|Treatment|Death|0|||
129782294|NCT01065454|467170003|FG000|Treatment|Non-compliance|1|||
129782295|NCT01065454|467170004|FG001|Treatment|Non-compliance|0|||
129782296|NCT01065454|467170005|FG002|Treatment|Non-compliance|0|||
129782297|NCT01065454|467170006|FG003|Treatment|Non-compliance|1|||
129782298|NCT01065454|467170003|FG000|Treatment|Protocol Decision|0|||
129782299|NCT01065454|467170004|FG001|Treatment|Protocol Decision|0|||
129782300|NCT01065454|467170005|FG002|Treatment|Protocol Decision|3|||
129782301|NCT01065454|467170006|FG003|Treatment|Protocol Decision|2|||
129782302|NCT01065454|467170003|FG000|Treatment|Protocol Violation|1|||
129782303|NCT01065454|467170004|FG001|Treatment|Protocol Violation|0|||
129782304|NCT01065454|467170005|FG002|Treatment|Protocol Violation|1|||
129571699|NCT01536405|466390834|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
129571700|NCT01536405|466390835|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
129571701|NCT01536405|466390834|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
129571702|NCT01536405|466390835|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
129571703|NCT02336165|466390836|FG000|Overall Study|Death|3|||
129571704|NCT02336165|466390837|FG001|Overall Study|Death|0|||
129571705|NCT02336165|466390838|FG002|Overall Study|Death|0|||
129571706|NCT02336165|466390839|FG003|Overall Study|Death|0|||
129571707|NCT02336165|466390840|FG004|Overall Study|Death|1|||
129571708|NCT02336165|466390836|FG000|Overall Study|Physician Decision|2|||
129782305|NCT01065454|467170006|FG003|Treatment|Protocol Violation|0|||
129782306|NCT01065454|467170003|FG000|Treatment|Withdrawal by Subject|3|||
129782307|NCT01065454|467170004|FG001|Treatment|Withdrawal by Subject|1|||
129782308|NCT01065454|467170005|FG002|Treatment|Withdrawal by Subject|2|||
129782309|NCT01065454|467170006|FG003|Treatment|Withdrawal by Subject|3|||
129782310|NCT01065454|467170003|FG000|Follow up|Adverse Event|1|||
129782311|NCT01065454|467170004|FG001|Follow up|Adverse Event|0|||
129782312|NCT01065454|467170005|FG002|Follow up|Adverse Event|0|||
129782313|NCT01065454|467170006|FG003|Follow up|Adverse Event|1|||
129782314|NCT01065454|467170003|FG000|Follow up|Death|0|||
129782315|NCT01065454|467170004|FG001|Follow up|Death|1|||
129571709|NCT02336165|466390837|FG001|Overall Study|Physician Decision|2|||
129571710|NCT02336165|466390838|FG002|Overall Study|Physician Decision|1|||
129571711|NCT02336165|466390839|FG003|Overall Study|Physician Decision|1|||
129571712|NCT02336165|466390840|FG004|Overall Study|Physician Decision|0|||
129571713|NCT02336165|466390836|FG000|Overall Study|Withdrawal by Subject|0|||
129571714|NCT02336165|466390837|FG001|Overall Study|Withdrawal by Subject|0|||
129571715|NCT02336165|466390838|FG002|Overall Study|Withdrawal by Subject|1|||
129571716|NCT02336165|466390839|FG003|Overall Study|Withdrawal by Subject|0|||
129571717|NCT02336165|466390840|FG004|Overall Study|Withdrawal by Subject|1|||
129571718|NCT02336165|466390836|FG000|Overall Study|Adverse Event|4|||
129782316|NCT01065454|467170005|FG002|Follow up|Death|1|||
129571719|NCT02336165|466390837|FG001|Overall Study|Adverse Event|1|||
129571720|NCT02336165|466390838|FG002|Overall Study|Adverse Event|2|||
129571721|NCT02336165|466390839|FG003|Overall Study|Adverse Event|4|||
129782317|NCT01065454|467170006|FG003|Follow up|Death|0|||
129782318|NCT01065454|467170003|FG000|Follow up|Lost to Follow-up|0|||
129571722|NCT02336165|466390840|FG004|Overall Study|Adverse Event|1|||
129571723|NCT02336165|466390836|FG000|Overall Study|Progressive disease|23|||
129571724|NCT02336165|466390837|FG001|Overall Study|Progressive disease|22|||
129571725|NCT02336165|466390838|FG002|Overall Study|Progressive disease|27|||
129571726|NCT02336165|466390839|FG003|Overall Study|Progressive disease|24|||
129571727|NCT02336165|466390840|FG004|Overall Study|Progressive disease|19|||
129782319|NCT01065454|467170004|FG001|Follow up|Lost to Follow-up|0|||
129782320|NCT01065454|467170005|FG002|Follow up|Lost to Follow-up|0|||
129782321|NCT01065454|467170006|FG003|Follow up|Lost to Follow-up|1|||
129782322|NCT01065454|467170003|FG000|Follow up|Progressive disease|0|||
129782323|NCT01065454|467170004|FG001|Follow up|Progressive disease|0|||
129782324|NCT01065454|467170005|FG002|Follow up|Progressive disease|0|||
129782325|NCT01065454|467170006|FG003|Follow up|Progressive disease|1|||
129571728|NCT02336165|466390836|FG000|Overall Study|Non-compliance|1|||
129571729|NCT02336165|466390837|FG001|Overall Study|Non-compliance|0|||
129571730|NCT02336165|466390838|FG002|Overall Study|Non-compliance|0|||
129571731|NCT02336165|466390839|FG003|Overall Study|Non-compliance|1|||
129571732|NCT02336165|466390840|FG004|Overall Study|Non-compliance|0|||
129571733|NCT02336165|466390836|FG000|Overall Study|Other|1|||
129571734|NCT02336165|466390837|FG001|Overall Study|Other|0|||
129571735|NCT02336165|466390838|FG002|Overall Study|Other|0|||
129571736|NCT02336165|466390839|FG003|Overall Study|Other|1|||
129571737|NCT02336165|466390840|FG004|Overall Study|Other|0|||
129571738|NCT02726581|466390843|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129571739|NCT02726581|466390844|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
129571740|NCT02726581|466390845|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129571741|NCT02726581|466390843|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
129571742|NCT02726581|466390844|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
129571743|NCT02726581|466390845|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
129571744|NCT02726581|466390843|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129571745|NCT02726581|466390844|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129571746|NCT02726581|466390845|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129571747|NCT02726581|466390843|FG000|Treatment Period|Disease progression|47|||
129571748|NCT02726581|466390844|FG001|Treatment Period|Disease progression|50|||
129571749|NCT02726581|466390845|FG002|Treatment Period|Disease progression|16|||
129571750|NCT02726581|466390843|FG000|Treatment Period|Other reasons|9|||
129571751|NCT02726581|466390844|FG001|Treatment Period|Other reasons|8|||
129571752|NCT02726581|466390845|FG002|Treatment Period|Other reasons|2|||
129571753|NCT02726581|466390843|FG000|Treatment Period|Study drug toxicity|6|||
129782326|NCT01065454|467170003|FG000|Follow up|Withdrawal by Subject|1|||
129782327|NCT01065454|467170004|FG001|Follow up|Withdrawal by Subject|1|||
129782328|NCT01065454|467170005|FG002|Follow up|Withdrawal by Subject|1|||
129782329|NCT01065454|467170006|FG003|Follow up|Withdrawal by Subject|0|||
129571754|NCT02726581|466390844|FG001|Treatment Period|Study drug toxicity|3|||
129571755|NCT02726581|466390845|FG002|Treatment Period|Study drug toxicity|2|||
129571756|NCT02726581|466390843|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
129571757|NCT02726581|466390844|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
129571758|NCT02726581|466390845|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
129571759|NCT02726581|466390843|FG000|Treatment Period|Participant withdrew consent|3|||
129571760|NCT02726581|466390844|FG001|Treatment Period|Participant withdrew consent|1|||
129571761|NCT02726581|466390845|FG002|Treatment Period|Participant withdrew consent|1|||
129571762|NCT02726581|466390843|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
129571763|NCT02726581|466390844|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
129571764|NCT02726581|466390845|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
129571765|NCT02726581|466390843|FG000|Treatment Period|Maximum clinical benefit|0|||
129571766|NCT02726581|466390844|FG001|Treatment Period|Maximum clinical benefit|2|||
129571767|NCT02726581|466390845|FG002|Treatment Period|Maximum clinical benefit|0|||
129571768|NCT02726581|466390843|FG000|Treatment Period|Death|1|||
129571769|NCT02726581|466390844|FG001|Treatment Period|Death|0|||
129782330|NCT01065454|467170003|FG000|Follow up|study ongoing|37|||
129782331|NCT01065454|467170004|FG001|Follow up|study ongoing|22|||
129782332|NCT01065454|467170005|FG002|Follow up|study ongoing|15|||
129782333|NCT01065454|467170006|FG003|Follow up|study ongoing|41|||
129571770|NCT02726581|466390845|FG002|Treatment Period|Death|0|||
129571771|NCT02726581|466390843|FG000|Treatment Period|Poor/non-compliance|1|||
129571772|NCT02726581|466390844|FG001|Treatment Period|Poor/non-compliance|0|||
129571773|NCT02726581|466390845|FG002|Treatment Period|Poor/non-compliance|0|||
129571774|NCT02726581|466390843|FG000|Treatment Period|Participant no longer meets study criteria|0|||
129571775|NCT02726581|466390844|FG001|Treatment Period|Participant no longer meets study criteria|1|||
129571776|NCT02726581|466390845|FG002|Treatment Period|Participant no longer meets study criteria|0|||
129782334|NCT01601652|467170007|FG000|Overall Study|Death|1|||
129782335|NCT01097005|467170017|FG000|Overall Study|Case Report Form not collected|18|||
129782336|NCT01097005|467170017|FG000|Overall Study|Subjects cannot visit the hospital|1|||
129571777|NCT00552669|466390849|FG000|Overall Study|Death|3|||
129571778|NCT00552669|466390850|FG001|Overall Study|Death|7|||
129571779|NCT01844375|466390851|FG000|Overall Study|Protocol Violation|1|||
129571780|NCT01844375|466390852|FG001|Overall Study|Protocol Violation|1|||
129571781|NCT03020615|466390853|FG000|Overall Study|Physician Decision|3|||
129571782|NCT03020615|466390854|FG001|Overall Study|Physician Decision|1|||
129782337|NCT01097005|467170017|FG000|Overall Study|Poor medication compliance|1|||
129782338|NCT01097005|467170017|FG000|Overall Study|No examination data available|244|||
129782339|NCT01097005|467170017|FG000|Overall Study|Deviation from exclusion criteria|37|||
129571783|NCT03020615|466390855|FG002|Overall Study|Physician Decision|2|||
129782340|NCT01097005|467170017|FG000|Overall Study|Adverse Event|14|||
129782341|NCT01097005|467170017|FG000|Overall Study|Discontinuance by complication|50|||
129571784|NCT03020615|466390853|FG000|Overall Study|Parent/guardian/patient choice|3|||
129571785|NCT03020615|466390854|FG001|Overall Study|Parent/guardian/patient choice|0|||
129571786|NCT03020615|466390855|FG002|Overall Study|Parent/guardian/patient choice|4|||
129571787|NCT03020615|466390853|FG000|Overall Study|Screen failure|0|||
129571788|NCT03020615|466390854|FG001|Overall Study|Screen failure|0|||
129571789|NCT03020615|466390855|FG002|Overall Study|Screen failure|1|||
129571790|NCT03020615|466390853|FG000|Overall Study|Death|1|||
129571791|NCT03020615|466390854|FG001|Overall Study|Death|0|||
129571792|NCT03020615|466390855|FG002|Overall Study|Death|0|||
129571793|NCT03020615|466390853|FG000|Overall Study|Lost to Follow-up|0|||
129571794|NCT03020615|466390854|FG001|Overall Study|Lost to Follow-up|1|||
129571795|NCT03020615|466390855|FG002|Overall Study|Lost to Follow-up|0|||
129571796|NCT00252720|466390857|FG000|Overall Study|Withdrawal by Subject|95|||
129571797|NCT00252720|466390858|FG001|Overall Study|Withdrawal by Subject|97|||
129571798|NCT00252720|466390857|FG000|Overall Study|Death|7|||
129571799|NCT00252720|466390858|FG001|Overall Study|Death|8|||
129571800|NCT00252720|466390857|FG000|Overall Study|Moving|23|||
129571801|NCT00252720|466390858|FG001|Overall Study|Moving|42|||
129571802|NCT00252720|466390857|FG000|Overall Study|Mainly patients lost to follow-up|7|||
129571803|NCT00252720|466390858|FG001|Overall Study|Mainly patients lost to follow-up|18|||
129571804|NCT03693430|466390864|FG000|Overall Study|Lost to Follow-up|3|||
129571805|NCT03693430|466390865|FG001|Overall Study|Lost to Follow-up|14|||
129571806|NCT03693430|466390864|FG000|Overall Study|Death|1|||
129571807|NCT03693430|466390865|FG001|Overall Study|Death|0|||
129571808|NCT03693430|466390864|FG000|Overall Study|Withdrawal by Subject|0|||
129571809|NCT03693430|466390865|FG001|Overall Study|Withdrawal by Subject|4|||
129571810|NCT00585689|466390866|FG000|Overall Study|Received different ABI-007 schedule|3|||
129571811|NCT00585689|466390866|FG000|Overall Study|Adverse Event|1|||
129571812|NCT00585689|466390866|FG000|Overall Study|Patient Declined Surgery|1|||
129571813|NCT00585689|466390866|FG000|Overall Study|Patient had unresectable disease|1|||
129571814|NCT00585689|466390866|FG000|Overall Study|Death|1|||
129571815|NCT04185909|466390867|FG000|Overall Study|Lost to Follow-up|1|||
129571816|NCT01417078|466390868|FG000|Overall Study|Withdrawal by Subject|1|||
129571817|NCT00626548|466390869|FG000|Overall Study|Adverse Event|164|||
129571818|NCT00626548|466390870|FG001|Overall Study|Adverse Event|44|||
129571819|NCT00626548|466390869|FG000|Overall Study|Withdrawal by Subject|42|||
129571820|NCT00626548|466390870|FG001|Overall Study|Withdrawal by Subject|46|||
129571821|NCT00626548|466390869|FG000|Overall Study|Protocol Violation|4|||
129571822|NCT00626548|466390870|FG001|Overall Study|Protocol Violation|11|||
129571823|NCT00626548|466390869|FG000|Overall Study|Lost to Follow-up|2|||
129571824|NCT00626548|466390870|FG001|Overall Study|Lost to Follow-up|2|||
129571825|NCT00626548|466390869|FG000|Overall Study|Other termination reason|493|||
129571826|NCT00626548|466390870|FG001|Overall Study|Other termination reason|613|||
129571827|NCT00048581|466390871|FG000|Double-Blind Period|Adverse Event|9|||
129571828|NCT00048581|466390872|FG001|Double-Blind Period|Adverse Event|5|||
129571829|NCT00048581|466390873|FG002|Double-Blind Period|Adverse Event|0|||
129571830|NCT00048581|466390871|FG000|Double-Blind Period|Lack of Efficacy|14|||
129571831|NCT00048581|466390872|FG001|Double-Blind Period|Lack of Efficacy|27|||
129571832|NCT00048581|466390873|FG002|Double-Blind Period|Lack of Efficacy|0|||
129571833|NCT00048581|466390871|FG000|Double-Blind Period|Lost to Follow-up|5|||
129571834|NCT00048581|466390872|FG001|Double-Blind Period|Lost to Follow-up|0|||
129571835|NCT00048581|466390873|FG002|Double-Blind Period|Lost to Follow-up|0|||
129571836|NCT00048581|466390871|FG000|Double-Blind Period|Withdrawal by Subject|5|||
129571837|NCT00048581|466390872|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129571838|NCT00048581|466390873|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129571839|NCT00048581|466390871|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
129571840|NCT00048581|466390872|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
129571841|NCT00048581|466390873|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
129571842|NCT00048581|466390871|FG000|Double-Blind Period|Investigator Decision|1|||
129782342|NCT01395524|467171286|FG000|Overall Study|Non-compliance with study schedule|1|||
129782343|NCT01395524|467171287|FG001|Overall Study|Non-compliance with study schedule|0|||
129571843|NCT00048581|466390872|FG001|Double-Blind Period|Investigator Decision|0|||
129571844|NCT00048581|466390873|FG002|Double-Blind Period|Investigator Decision|0|||
129571845|NCT00048581|466390871|FG000|Open-Label Period|Death|0|||
129571846|NCT00048581|466390872|FG001|Open-Label Period|Death|0|||
129571847|NCT00048581|466390873|FG002|Open-Label Period|Death|4|||
129571848|NCT00048581|466390871|FG000|Open-Label Period|Adverse Event|0|||
129782344|NCT01395524|467171288|FG002|Overall Study|Non-compliance with study schedule|1|||
129571849|NCT00048581|466390872|FG001|Open-Label Period|Adverse Event|0|||
129571850|NCT00048581|466390873|FG002|Open-Label Period|Adverse Event|37|||
129571851|NCT00048581|466390871|FG000|Open-Label Period|Lack of Efficacy|0|||
129571852|NCT00048581|466390872|FG001|Open-Label Period|Lack of Efficacy|0|||
129571853|NCT00048581|466390873|FG002|Open-Label Period|Lack of Efficacy|69|||
129571854|NCT00048581|466390871|FG000|Open-Label Period|Lost to Follow-up|0|||
129571855|NCT00048581|466390872|FG001|Open-Label Period|Lost to Follow-up|0|||
129571856|NCT00048581|466390873|FG002|Open-Label Period|Lost to Follow-up|14|||
129571857|NCT00048581|466390871|FG000|Open-Label Period|Withdrawal by Subject|0|||
129782345|NCT01395524|467171286|FG000|Overall Study|Lost to Follow-up|3|||
129782346|NCT01395524|467171287|FG001|Overall Study|Lost to Follow-up|1|||
129782347|NCT01395524|467171288|FG002|Overall Study|Lost to Follow-up|1|||
129782348|NCT01395524|467171286|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
129782349|NCT01395524|467171287|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
129782350|NCT01395524|467171288|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
129782351|NCT01395524|467171286|FG000|Overall Study|Severe noncompliance with protocol|1|||
129782352|NCT01395524|467171287|FG001|Overall Study|Severe noncompliance with protocol|0|||
129782353|NCT01395524|467171288|FG002|Overall Study|Severe noncompliance with protocol|0|||
129782354|NCT01395524|467171286|FG000|Overall Study|Adverse Event|4|||
129782355|NCT01395524|467171287|FG001|Overall Study|Adverse Event|4|||
129782356|NCT01395524|467171288|FG002|Overall Study|Adverse Event|3|||
129884616|NCT00684762|467538600|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
129884617|NCT00684762|467538601|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
129782357|NCT01395524|467171286|FG000|Overall Study|Death|1|||
129782358|NCT01395524|467171287|FG001|Overall Study|Death|0|||
129782359|NCT01395524|467171288|FG002|Overall Study|Death|0|||
129782360|NCT01395524|467171286|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129782361|NCT01395524|467171287|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129782362|NCT01395524|467171288|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129782363|NCT01395524|467171286|FG000|Overall Study|Withdrawal by Subject|4|||
129782364|NCT01395524|467171287|FG001|Overall Study|Withdrawal by Subject|8|||
129782365|NCT01395524|467171288|FG002|Overall Study|Withdrawal by Subject|8|||
129782366|NCT01395524|467171286|FG000|Overall Study|Did not receive treatment|1|||
129782367|NCT01395524|467171287|FG001|Overall Study|Did not receive treatment|1|||
129782368|NCT01395524|467171288|FG002|Overall Study|Did not receive treatment|3|||
129782369|NCT01395524|467171286|FG000|Overall Study|Subject had spinal surgery|0|||
129782370|NCT01395524|467171287|FG001|Overall Study|Subject had spinal surgery|0|||
129782371|NCT01395524|467171288|FG002|Overall Study|Subject had spinal surgery|1|||
129782372|NCT01657461|467171289|FG000|Overall Study|Death|9|||
129782373|NCT01657461|467171290|FG001|Overall Study|Death|12|||
129782374|NCT01657461|467171289|FG000|Overall Study|Lost to Follow-up|0|||
129782375|NCT01657461|467171290|FG001|Overall Study|Lost to Follow-up|3|||
129782376|NCT01657461|467171289|FG000|Overall Study|Physician Decision|0|||
129782377|NCT01657461|467171290|FG001|Overall Study|Physician Decision|2|||
129782378|NCT01657461|467171289|FG000|Overall Study|Withdrawal by Subject|1|||
129782379|NCT01657461|467171290|FG001|Overall Study|Withdrawal by Subject|3|||
129782380|NCT03583385|467171293|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129782381|NCT03583385|467171294|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129782382|NCT03583385|467171293|FG000|Treatment Period 2|Adverse Event|1|||
129571858|NCT00048581|466390872|FG001|Open-Label Period|Withdrawal by Subject|0|||
129571859|NCT00048581|466390873|FG002|Open-Label Period|Withdrawal by Subject|20|||
129571860|NCT00048581|466390871|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
129571861|NCT00048581|466390872|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
129571862|NCT00048581|466390873|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
129782383|NCT03583385|467171294|FG001|Treatment Period 2|Adverse Event|0|||
129782384|NCT01311024|467171306|FG000|Overall Study|Protocol Violation|35|||
129782385|NCT01311024|467171307|FG001|Overall Study|Protocol Violation|22|||
129782386|NCT01523275|467171308|FG000|Overall Study|Lost to Follow-up|1|||
129782387|NCT01523275|467171309|FG001|Overall Study|Lost to Follow-up|2|||
129782388|NCT01523275|467171308|FG000|Overall Study|Withdrawal by Subject|1|||
129782389|NCT01523275|467171309|FG001|Overall Study|Withdrawal by Subject|0|||
129782390|NCT05573386|467171310|FG000|Overall Study|Withdrawal by Subject|3|||
129782391|NCT05573386|467171311|FG001|Overall Study|Withdrawal by Subject|2|||
129782392|NCT01802073|467171312|FG000|Overall Study|Lost to Follow-up|0|||
129782393|NCT01802073|467171313|FG001|Overall Study|Lost to Follow-up|1|||
129782394|NCT01802073|467171312|FG000|Overall Study|Non-compliant|4|||
129782395|NCT01802073|467171313|FG001|Overall Study|Non-compliant|2|||
129782396|NCT01802073|467171312|FG000|Overall Study|Withdrawal by Subject|1|||
129782397|NCT01802073|467171313|FG001|Overall Study|Withdrawal by Subject|1|||
129782398|NCT01802073|467171312|FG000|Overall Study|Physician Decision|0|||
129782399|NCT01802073|467171313|FG001|Overall Study|Physician Decision|7|||
129782400|NCT00918736|467171316|FG000|Overall Study|Withdrawal by Subject|4|||
129782401|NCT01137604|467171317|FG000|Overall Study|Adverse Event|3|||
129782402|NCT01137604|467171318|FG001|Overall Study|Adverse Event|6|||
129782403|NCT01137604|467171319|FG002|Overall Study|Adverse Event|9|||
129782404|NCT01137604|467171320|FG003|Overall Study|Adverse Event|9|||
129782405|NCT01137604|467171317|FG000|Overall Study|Participant Choice|0|||
129782406|NCT01137604|467171318|FG001|Overall Study|Participant Choice|2|||
129782407|NCT01137604|467171319|FG002|Overall Study|Participant Choice|2|||
129571863|NCT00048581|466390871|FG000|Open-Label Period|Poor/Non-compliance|0|||
129571864|NCT00048581|466390872|FG001|Open-Label Period|Poor/Non-compliance|0|||
129571865|NCT00048581|466390873|FG002|Open-Label Period|Poor/Non-compliance|5|||
129571866|NCT00048581|466390871|FG000|Open-Label Period|Pregnancy|0|||
129571867|NCT00048581|466390872|FG001|Open-Label Period|Pregnancy|0|||
129782408|NCT01137604|467171320|FG003|Overall Study|Participant Choice|0|||
129782409|NCT01137604|467171317|FG000|Overall Study|Withdrawal of consent|0|||
129571868|NCT00048581|466390873|FG002|Open-Label Period|Pregnancy|7|||
129782410|NCT01137604|467171318|FG001|Overall Study|Withdrawal of consent|0|||
129782411|NCT01137604|467171319|FG002|Overall Study|Withdrawal of consent|0|||
129782412|NCT01137604|467171320|FG003|Overall Study|Withdrawal of consent|2|||
129782413|NCT01137604|467171317|FG000|Overall Study|Clinical progression/deterioration|1|||
129782414|NCT01137604|467171318|FG001|Overall Study|Clinical progression/deterioration|2|||
129782415|NCT01137604|467171319|FG002|Overall Study|Clinical progression/deterioration|2|||
129782416|NCT01137604|467171320|FG003|Overall Study|Clinical progression/deterioration|0|||
129782417|NCT03462511|467171324|FG000|Overall Study|Withdrawal by Subject|2|||
129782418|NCT03462511|467171325|FG001|Overall Study|Withdrawal by Subject|3|||
129782419|NCT02925416|467171326|FG000|Overall Study|Adverse Event|2|||
129782420|NCT02925416|467171327|FG001|Overall Study|Adverse Event|0|||
129782421|NCT00200356|467171328|FG000|Overall Study|Lack of Efficacy|3|||
129782422|NCT00200356|467171329|FG001|Overall Study|Lack of Efficacy|3|||
129782423|NCT00200356|467171328|FG000|Overall Study|Protocol Violation|4|||
129782424|NCT00200356|467171329|FG001|Overall Study|Protocol Violation|4|||
129782425|NCT00200356|467171328|FG000|Overall Study|Nontreatment|1|||
129782426|NCT00200356|467171329|FG001|Overall Study|Nontreatment|0|||
129782427|NCT01297491|467171330|FG000|Overall Study|Adverse Event|11|||
129782428|NCT01297491|467171331|FG001|Overall Study|Adverse Event|6|||
129782429|NCT01297491|467171330|FG000|Overall Study|Physician Decision|3|||
129782430|NCT01297491|467171331|FG001|Overall Study|Physician Decision|2|||
129782431|NCT01297491|467171330|FG000|Overall Study|Progressive disease|11|||
129571869|NCT00048581|466390871|FG000|Open-Label Period|Study Site Closure|0|||
129571870|NCT00048581|466390872|FG001|Open-Label Period|Study Site Closure|0|||
129571871|NCT00048581|466390873|FG002|Open-Label Period|Study Site Closure|2|||
129571872|NCT00048581|466390871|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
129571873|NCT00048581|466390872|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
129571874|NCT00048581|466390873|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
129571875|NCT00048581|466390871|FG000|Open-Label Period|Problem With Transportation To Site|0|||
129571876|NCT00048581|466390872|FG001|Open-Label Period|Problem With Transportation To Site|0|||
129571877|NCT00048581|466390873|FG002|Open-Label Period|Problem With Transportation To Site|1|||
129571878|NCT00048581|466390871|FG000|Open-Label Period|Primary Investigator Retired|0|||
129691989|NCT04518410|466830635|FG019|Overall Study|Requirement to start alternative therapy|0|||
129691990|NCT04518410|466830636|FG020|Overall Study|Requirement to start alternative therapy|0|||
129691991|NCT04518410|466830637|FG021|Overall Study|Requirement to start alternative therapy|0|||
129691992|NCT04518410|466830638|FG022|Overall Study|Requirement to start alternative therapy|0|||
129691993|NCT04518410|466830639|FG023|Overall Study|Requirement to start alternative therapy|0|||
129691994|NCT04518410|466830640|FG024|Overall Study|Requirement to start alternative therapy|0|||
129691995|NCT04518410|466830616|FG000|Overall Study|Randomized but not treated|0|||
129691996|NCT04518410|466830617|FG001|Overall Study|Randomized but not treated|0|||
129691997|NCT04518410|466830618|FG002|Overall Study|Randomized but not treated|0|||
129691998|NCT04518410|466830619|FG003|Overall Study|Randomized but not treated|2|||
129691999|NCT04518410|466830620|FG004|Overall Study|Randomized but not treated|6|||
129692000|NCT04518410|466830621|FG005|Overall Study|Randomized but not treated|4|||
129692001|NCT04518410|466830622|FG006|Overall Study|Randomized but not treated|3|||
129692002|NCT04518410|466830623|FG007|Overall Study|Randomized but not treated|3|||
129692003|NCT04518410|466830624|FG008|Overall Study|Randomized but not treated|0|||
129692004|NCT04518410|466830625|FG009|Overall Study|Randomized but not treated|4|||
129692005|NCT04518410|466830626|FG010|Overall Study|Randomized but not treated|0|||
129692006|NCT04518410|466830627|FG011|Overall Study|Randomized but not treated|0|||
129692007|NCT04518410|466830628|FG012|Overall Study|Randomized but not treated|1|||
129692008|NCT04518410|466830629|FG013|Overall Study|Randomized but not treated|3|||
129692009|NCT04518410|466830630|FG014|Overall Study|Randomized but not treated|3|||
129692010|NCT04518410|466830631|FG015|Overall Study|Randomized but not treated|3|||
129692011|NCT04518410|466830632|FG016|Overall Study|Randomized but not treated|4|||
129692012|NCT04518410|466830633|FG017|Overall Study|Randomized but not treated|5|||
129692013|NCT04518410|466830634|FG018|Overall Study|Randomized but not treated|4|||
129692014|NCT04518410|466830635|FG019|Overall Study|Randomized but not treated|0|||
129692015|NCT04518410|466830636|FG020|Overall Study|Randomized but not treated|0|||
129692016|NCT04518410|466830637|FG021|Overall Study|Randomized but not treated|5|||
129692017|NCT04518410|466830638|FG022|Overall Study|Randomized but not treated|0|||
129692018|NCT04518410|466830639|FG023|Overall Study|Randomized but not treated|3|||
129692019|NCT04518410|466830640|FG024|Overall Study|Randomized but not treated|1|||
129692020|NCT04518410|466830616|FG000|Overall Study|Screen Fail but Randomized|0|||
129692021|NCT04518410|466830617|FG001|Overall Study|Screen Fail but Randomized|0|||
129692022|NCT04518410|466830618|FG002|Overall Study|Screen Fail but Randomized|0|||
129692023|NCT04518410|466830619|FG003|Overall Study|Screen Fail but Randomized|0|||
129692024|NCT04518410|466830620|FG004|Overall Study|Screen Fail but Randomized|2|||
129692025|NCT04518410|466830621|FG005|Overall Study|Screen Fail but Randomized|0|||
129692026|NCT04518410|466830622|FG006|Overall Study|Screen Fail but Randomized|0|||
129692027|NCT04518410|466830623|FG007|Overall Study|Screen Fail but Randomized|0|||
129692028|NCT04518410|466830624|FG008|Overall Study|Screen Fail but Randomized|0|||
129692029|NCT04518410|466830625|FG009|Overall Study|Screen Fail but Randomized|0|||
129692030|NCT04518410|466830626|FG010|Overall Study|Screen Fail but Randomized|0|||
129692031|NCT04518410|466830627|FG011|Overall Study|Screen Fail but Randomized|0|||
129692032|NCT04518410|466830628|FG012|Overall Study|Screen Fail but Randomized|0|||
129782432|NCT01297491|467171331|FG001|Overall Study|Progressive disease|20|||
129571879|NCT00048581|466390872|FG001|Open-Label Period|Primary Investigator Retired|0|||
129571880|NCT00048581|466390873|FG002|Open-Label Period|Primary Investigator Retired|2|||
129692033|NCT04518410|466830629|FG013|Overall Study|Screen Fail but Randomized|0|||
129692034|NCT04518410|466830630|FG014|Overall Study|Screen Fail but Randomized|0|||
129692035|NCT04518410|466830631|FG015|Overall Study|Screen Fail but Randomized|0|||
129692036|NCT04518410|466830632|FG016|Overall Study|Screen Fail but Randomized|0|||
129692037|NCT04518410|466830633|FG017|Overall Study|Screen Fail but Randomized|0|||
129692038|NCT04518410|466830634|FG018|Overall Study|Screen Fail but Randomized|0|||
129692039|NCT04518410|466830635|FG019|Overall Study|Screen Fail but Randomized|0|||
129692040|NCT04518410|466830636|FG020|Overall Study|Screen Fail but Randomized|0|||
129782433|NCT01297491|467171330|FG000|Overall Study|Patient/Guardian decision|3|||
129782434|NCT01297491|467171331|FG001|Overall Study|Patient/Guardian decision|4|||
129571881|NCT00048581|466390871|FG000|Open-Label Period|Study Ended By Sponsor|0|||
129571882|NCT00048581|466390872|FG001|Open-Label Period|Study Ended By Sponsor|0|||
129571883|NCT00048581|466390873|FG002|Open-Label Period|Study Ended By Sponsor|1|||
129571884|NCT01059903|466390875|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
129571885|NCT01059903|466390876|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
129571886|NCT00385593|466390883|FG000|Overall Study|Adverse Event|3|||
129571887|NCT00385593|466390884|FG001|Overall Study|Adverse Event|2|||
129571888|NCT00385593|466390883|FG000|Overall Study|Withdrawal by Subject|17|||
129571889|NCT00385593|466390884|FG001|Overall Study|Withdrawal by Subject|7|||
129571890|NCT00385593|466390883|FG000|Overall Study|Lost to Follow-up|12|||
129571891|NCT00385593|466390884|FG001|Overall Study|Lost to Follow-up|8|||
129571892|NCT00385593|466390883|FG000|Overall Study|Protocol Violation|7|||
129571893|NCT00385593|466390884|FG001|Overall Study|Protocol Violation|4|||
129571894|NCT00385593|466390883|FG000|Overall Study|Several reasons|17|||
129571895|NCT00385593|466390884|FG001|Overall Study|Several reasons|15|||
129571896|NCT00385593|466390883|FG000|Overall Study|Incorrect inclusion|2|||
129571897|NCT00385593|466390884|FG001|Overall Study|Incorrect inclusion|0|||
129571898|NCT00385593|466390883|FG000|Overall Study|Incorrect randomization|0|||
129571899|NCT00385593|466390884|FG001|Overall Study|Incorrect randomization|1|||
129571900|NCT02100228|466390885|FG000|Overall Study|Other|19|||
129571901|NCT02100228|466390886|FG001|Overall Study|Other|19|||
129571902|NCT02100228|466390885|FG000|Overall Study|Administrative reason|0|||
129571903|NCT02100228|466390886|FG001|Overall Study|Administrative reason|1|||
129571904|NCT02100228|466390885|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
129571905|NCT02100228|466390886|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
129571906|NCT02100228|466390885|FG000|Overall Study|Non-compliance|0|||
129571907|NCT02100228|466390886|FG001|Overall Study|Non-compliance|3|||
129571908|NCT02100228|466390885|FG000|Overall Study|Lost to Follow-up|0|||
129571909|NCT02100228|466390886|FG001|Overall Study|Lost to Follow-up|1|||
129571910|NCT02100228|466390885|FG000|Overall Study|Withdrawal by Subject|27|||
129571911|NCT02100228|466390886|FG001|Overall Study|Withdrawal by Subject|37|||
129571912|NCT02100228|466390885|FG000|Overall Study|Adverse Event|16|||
129571913|NCT02100228|466390886|FG001|Overall Study|Adverse Event|12|||
129571914|NCT02100228|466390885|FG000|Overall Study|Death|1|||
129571915|NCT02100228|466390886|FG001|Overall Study|Death|1|||
129571916|NCT00319735|466390887|FG000|Overall Study|Death|2|||
129571917|NCT02421952|466390894|FG000|Overall Study|Diary Not Returned|93|||
129571918|NCT02421952|466390894|FG000|Overall Study|Failed seriation task|13|||
129571919|NCT02421952|466390894|FG000|Overall Study|Subject uncooperative for baseline test|2|||
129571920|NCT02421952|466390894|FG000|Overall Study|Surgery cancelled|1|||
129571921|NCT00854100|466390895|FG000|Overall Study|Inability to complete the study visits|0|||
129571922|NCT00854100|466390896|FG001|Overall Study|Inability to complete the study visits|0|||
129571923|NCT00854100|466390897|FG002|Overall Study|Inability to complete the study visits|1|||
129571924|NCT00854100|466390895|FG000|Overall Study|Lost to Follow-up|2|||
129571925|NCT00854100|466390896|FG001|Overall Study|Lost to Follow-up|0|||
129571926|NCT00854100|466390897|FG002|Overall Study|Lost to Follow-up|3|||
129571927|NCT00854100|466390895|FG000|Overall Study|Withdrawal by Subject|3|||
129571928|NCT00854100|466390896|FG001|Overall Study|Withdrawal by Subject|1|||
129571929|NCT00854100|466390897|FG002|Overall Study|Withdrawal by Subject|2|||
129571930|NCT00854100|466390895|FG000|Overall Study|Protocol Violation|2|||
129571931|NCT00854100|466390896|FG001|Overall Study|Protocol Violation|4|||
129571932|NCT00854100|466390897|FG002|Overall Study|Protocol Violation|3|||
129571933|NCT00854100|466390895|FG000|Overall Study|Adverse Event|2|||
129571934|NCT00854100|466390896|FG001|Overall Study|Adverse Event|1|||
129571935|NCT00854100|466390897|FG002|Overall Study|Adverse Event|2|||
129571936|NCT02216071|466390907|FG000|Overall Study|Withdrawal by Subject|7|||
129571937|NCT02216071|466390908|FG001|Overall Study|Withdrawal by Subject|2|||
129571938|NCT02216071|466390907|FG000|Overall Study|Lost to Follow-up|3|||
129571939|NCT02216071|466390908|FG001|Overall Study|Lost to Follow-up|3|||
129571940|NCT02216071|466390907|FG000|Overall Study|Protocol Violation|3|||
129571941|NCT02216071|466390908|FG001|Overall Study|Protocol Violation|5|||
129571942|NCT02216071|466390907|FG000|Overall Study|Other|2|||
129782435|NCT01297491|467171330|FG000|Overall Study|Death|2|||
129571943|NCT02216071|466390908|FG001|Overall Study|Other|2|||
129571944|NCT00389064|466390909|FG000|Overall Study|Adverse Event|11|||
129571945|NCT00389064|466390910|FG001|Overall Study|Adverse Event|3|||
129571946|NCT00389064|466390909|FG000|Overall Study|Lack of Efficacy|3|||
129571947|NCT00389064|466390910|FG001|Overall Study|Lack of Efficacy|14|||
129571948|NCT00389064|466390909|FG000|Overall Study|Withdrawal by Subject|17|||
129571949|NCT00389064|466390910|FG001|Overall Study|Withdrawal by Subject|27|||
129571950|NCT00389064|466390909|FG000|Overall Study|Physician Decision|2|||
129571951|NCT00389064|466390910|FG001|Overall Study|Physician Decision|2|||
129571952|NCT00389064|466390909|FG000|Overall Study|Lost to Follow-up|1|||
129571953|NCT00389064|466390910|FG001|Overall Study|Lost to Follow-up|2|||
129571954|NCT00389064|466390909|FG000|Overall Study|Protocol Violation|2|||
129782436|NCT01297491|467171331|FG001|Overall Study|Death|1|||
129571955|NCT00389064|466390910|FG001|Overall Study|Protocol Violation|0|||
129571956|NCT00389064|466390909|FG000|Overall Study|Multiple Reasons|9|||
129571957|NCT00389064|466390910|FG001|Overall Study|Multiple Reasons|11|||
129571958|NCT01387737|466392152|FG000|Overall Study|Adverse Event|20|||
129571959|NCT01387737|466392153|FG001|Overall Study|Adverse Event|30|||
129571960|NCT01387737|466392152|FG000|Overall Study|Lack of Efficacy|1|||
129571961|NCT01387737|466392153|FG001|Overall Study|Lack of Efficacy|0|||
129571962|NCT01387737|466392152|FG000|Overall Study|Physician Decision|3|||
129571963|NCT01387737|466392153|FG001|Overall Study|Physician Decision|10|||
129571964|NCT01387737|466392152|FG000|Overall Study|Withdrawal by Subject|27|||
129571965|NCT01387737|466392153|FG001|Overall Study|Withdrawal by Subject|31|||
129571966|NCT01387737|466392152|FG000|Overall Study|Clearly not eligible for the study|1|||
129571967|NCT01387737|466392153|FG001|Overall Study|Clearly not eligible for the study|3|||
129571968|NCT01215981|466392156|FG000|Overall Study|Physician Decision|0|||
129571969|NCT01215981|466392157|FG001|Overall Study|Physician Decision|1|||
129571970|NCT01215981|466392156|FG000|Overall Study|Protocol Violation|1|||
129571971|NCT01215981|466392157|FG001|Overall Study|Protocol Violation|0|||
129571972|NCT01215981|466392156|FG000|Overall Study|Withdrawal by Subject|1|||
129571973|NCT01215981|466392157|FG001|Overall Study|Withdrawal by Subject|0|||
129571974|NCT00840632|466392163|FG000|First Intervention|Withdrawal by Subject|0|||
129571975|NCT00840632|466392164|FG001|First Intervention|Withdrawal by Subject|1|||
129571976|NCT00840632|466392163|FG000|Washout|Withdrawal by Subject|1|||
129571977|NCT00840632|466392164|FG001|Washout|Withdrawal by Subject|1|||
129571978|NCT01725529|466392168|FG000|Overall Study|Adverse Event|1|||
129571979|NCT01725529|466392169|FG001|Overall Study|Adverse Event|0|||
129571980|NCT01725529|466392170|FG002|Overall Study|Adverse Event|0|||
129571981|NCT01725529|466392168|FG000|Overall Study|Lost to Follow-up|2|||
129571982|NCT01725529|466392169|FG001|Overall Study|Lost to Follow-up|1|||
129571983|NCT01725529|466392170|FG002|Overall Study|Lost to Follow-up|1|||
129571984|NCT01725529|466392168|FG000|Overall Study|Protocol Violation|0|||
129571985|NCT01725529|466392169|FG001|Overall Study|Protocol Violation|1|||
129571986|NCT01725529|466392170|FG002|Overall Study|Protocol Violation|1|||
129571987|NCT01725529|466392168|FG000|Overall Study|Withdrawal by Subject|12|||
129571988|NCT01725529|466392169|FG001|Overall Study|Withdrawal by Subject|14|||
129571989|NCT01725529|466392170|FG002|Overall Study|Withdrawal by Subject|8|||
129571990|NCT01948258|466392176|FG000|Overall Study|Pregnancy|41|||
129571991|NCT01948258|466392176|FG000|Overall Study|Did not complete by cut-off date|35|||
129571992|NCT01948258|466392176|FG000|Overall Study|Lost to Follow-up|27|||
129571993|NCT01948258|466392176|FG000|Overall Study|Withdrawal by SPD|8|||
129571994|NCT01948258|466392176|FG000|Overall Study|Withdrawal by Subject|6|||
129692041|NCT04518410|466830637|FG021|Overall Study|Screen Fail but Randomized|0|||
129692042|NCT04518410|466830638|FG022|Overall Study|Screen Fail but Randomized|0|||
129692043|NCT04518410|466830639|FG023|Overall Study|Screen Fail but Randomized|0|||
129692044|NCT04518410|466830640|FG024|Overall Study|Screen Fail but Randomized|0|||
129692045|NCT04518410|466830616|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692046|NCT04518410|466830617|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692047|NCT04518410|466830618|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692048|NCT04518410|466830619|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692049|NCT04518410|466830620|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
129692050|NCT04518410|466830621|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
129692051|NCT04518410|466830622|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
129692052|NCT04518410|466830623|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129692053|NCT04518410|466830624|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
129692054|NCT04518410|466830625|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
129692055|NCT04518410|466830626|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129692056|NCT04518410|466830627|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692057|NCT04518410|466830628|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692058|NCT04518410|466830629|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129692059|NCT04518410|466830630|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
129692060|NCT04518410|466830631|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
129692061|NCT04518410|466830632|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
129571995|NCT01948258|466392176|FG000|Overall Study|Health Care Professional|43|||
129571996|NCT01948258|466392176|FG000|Overall Study|Removed from statistical analysis|2|||
129571997|NCT01049334|466392179|FG000|Overall Study|Withdrawal by Subject|5|||
129571998|NCT01049334|466392180|FG001|Overall Study|Withdrawal by Subject|3|||
129571999|NCT01049334|466392179|FG000|Overall Study|Adverse Event|2|||
129572000|NCT01049334|466392180|FG001|Overall Study|Adverse Event|3|||
129572001|NCT01049334|466392179|FG000|Overall Study|Physician Decision|2|||
129572002|NCT01049334|466392180|FG001|Overall Study|Physician Decision|0|||
129572003|NCT01049334|466392179|FG000|Overall Study|Protocol Violation|0|||
129572004|NCT01049334|466392180|FG001|Overall Study|Protocol Violation|1|||
129572005|NCT00667095|466392193|FG000|Overall Study|Withdrawal by Subject|0|||
129572006|NCT00667095|466392194|FG001|Overall Study|Withdrawal by Subject|1|||
129572007|NCT03447262|466392195|FG000|Overall Study|Adverse Event|7|||
129572008|NCT03447262|466392195|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
129572009|NCT03447262|466392195|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
129572010|NCT03447262|466392195|FG000|Overall Study|Death|2|||
129572011|NCT03447262|466392195|FG000|Overall Study|Study Termination by Sponsor|455|||
129572012|NCT03447262|466392195|FG000|Overall Study|Other|4|||
129572013|NCT01882257|466392197|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
129572014|NCT01882257|466392198|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
129572015|NCT01882257|466392199|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
129572016|NCT01882257|466392197|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
129572017|NCT01882257|466392198|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
129572018|NCT01882257|466392199|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
129572019|NCT00496964|466392205|FG000|Overall Study|Withdrawal by Subject|0|||
129572020|NCT00496964|466392206|FG001|Overall Study|Withdrawal by Subject|1|||
129572021|NCT02058498|466392207|FG000|Overall Study|Withdrawal by Subject|4|||
129572022|NCT03351335|466392209|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
129572023|NCT03351335|466392210|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
129572024|NCT03351335|466392211|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
129572025|NCT00469417|466392212|FG000|Overall Study|Treatment failure all lesions|18|||
129572026|NCT00469417|466392213|FG001|Overall Study|Treatment failure all lesions|11|||
129572027|NCT00469417|466392212|FG000|Overall Study|Consent withdrawn|1|||
129572028|NCT00469417|466392213|FG001|Overall Study|Consent withdrawn|1|||
129572029|NCT00469417|466392212|FG000|Overall Study|Adverse Event|8|||
129572030|NCT00469417|466392213|FG001|Overall Study|Adverse Event|2|||
129572031|NCT00469417|466392212|FG000|Overall Study|Lost to Follow-up|1|||
129572032|NCT00469417|466392213|FG001|Overall Study|Lost to Follow-up|2|||
129572033|NCT00469417|466392212|FG000|Overall Study|Intercurrent disease|0|||
129572034|NCT00469417|466392213|FG001|Overall Study|Intercurrent disease|1|||
129572035|NCT00469417|466392212|FG000|Overall Study|Randomized but not treated|2|||
129572036|NCT00469417|466392213|FG001|Overall Study|Randomized but not treated|0|||
129572037|NCT00834743|466392216|FG000|Second Intervention|Withdrawal by Subject|1|||
129572038|NCT00834743|466392217|FG001|Second Intervention|Withdrawal by Subject|0|||
129572039|NCT00086996|466392219|FG000|Overall Study|Adverse Event|29|||
129572040|NCT00086996|466392219|FG000|Overall Study|Death|4|||
129572041|NCT00086996|466392219|FG000|Overall Study|progression/relapse|7|||
129572042|NCT00086996|466392219|FG000|Overall Study|Withdrawal by Subject|13|||
129572043|NCT00086996|466392219|FG000|Overall Study|Other|6|||
129572044|NCT00086996|466392219|FG000|Overall Study|not eligible|5|||
129572045|NCT00004562|466392220|FG000|Overall Study|Lost to Follow-up|102|||
129572046|NCT00004562|466392221|FG001|Overall Study|Lost to Follow-up|91|||
129572047|NCT04274686|466392223|FG000|Overall Study|Physician Decision|1|||
129692062|NCT04518410|466830633|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
129692063|NCT04518410|466830634|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
129692064|NCT04518410|466830635|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
129692065|NCT04518410|466830636|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
129692066|NCT04518410|466830637|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
129572048|NCT04274686|466392224|FG001|Overall Study|Physician Decision|0|||
129572049|NCT00376623|466392225|FG000|Overall Study|Progressive disease|35|||
129692067|NCT04518410|466830638|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
129572050|NCT00376623|466392226|FG001|Overall Study|Progressive disease|22|||
129572051|NCT00376623|466392227|FG002|Overall Study|Progressive disease|17|||
129572052|NCT00376623|466392225|FG000|Overall Study|Lost to Follow-up|0|||
129572053|NCT00376623|466392226|FG001|Overall Study|Lost to Follow-up|1|||
129572054|NCT00376623|466392227|FG002|Overall Study|Lost to Follow-up|0|||
129572055|NCT00376623|466392225|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
129572056|NCT00376623|466392226|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
129572057|NCT00376623|466392227|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
129572058|NCT00376623|466392225|FG000|Overall Study|Not treated with BI 2536|1|||
129572059|NCT00376623|466392226|FG001|Overall Study|Not treated with BI 2536|0|||
129572060|NCT00376623|466392227|FG002|Overall Study|Not treated with BI 2536|0|||
129572061|NCT00376623|466392225|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
129572062|NCT00376623|466392226|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129572063|NCT00376623|466392227|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129572064|NCT00376623|466392225|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
129572065|NCT00376623|466392226|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
129572066|NCT00376623|466392227|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
129572067|NCT00376623|466392225|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
129572068|NCT00376623|466392226|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
129572069|NCT00376623|466392227|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
129572070|NCT00376623|466392225|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
129572071|NCT00376623|466392226|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
129572072|NCT00376623|466392227|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
129572073|NCT00376623|466392225|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129572074|NCT00376623|466392226|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
129572075|NCT00376623|466392227|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
129572076|NCT00376623|466392225|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
129572077|NCT00376623|466392226|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
129572078|NCT00376623|466392227|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
129572079|NCT00376623|466392225|FG000|Overall Study|Increase of tumour markers|0|||
129572080|NCT00376623|466392226|FG001|Overall Study|Increase of tumour markers|1|||
129572081|NCT00376623|466392227|FG002|Overall Study|Increase of tumour markers|0|||
129572082|NCT00376623|466392225|FG000|Overall Study|Bone metastasis|1|||
129572083|NCT00376623|466392226|FG001|Overall Study|Bone metastasis|0|||
129572084|NCT00376623|466392227|FG002|Overall Study|Bone metastasis|0|||
129572085|NCT00910663|466392232|FG000|Period 1|Withdrawal by Subject|0|||
129572086|NCT00910663|466392233|FG001|Period 1|Withdrawal by Subject|1|||
129572087|NCT02865850|466392234|FG000|Overall Study|Death|15|||
129572088|NCT02865850|466392235|FG001|Overall Study|Death|19|||
129572089|NCT02865850|466392234|FG000|Overall Study|Withdrawal by Subject|3|||
129572090|NCT02865850|466392235|FG001|Overall Study|Withdrawal by Subject|2|||
129572091|NCT02865850|466392234|FG000|Overall Study|Lost to Follow-up|3|||
129572092|NCT02865850|466392235|FG001|Overall Study|Lost to Follow-up|2|||
129572093|NCT01772537|466392237|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
129572094|NCT01772537|466392238|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
129572095|NCT01772537|466392239|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
129692068|NCT04518410|466830639|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
129692069|NCT04518410|466830640|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
129692070|NCT04518410|466830616|FG000|Overall Study|Dual Enrolled Subject|0|||
129692071|NCT04518410|466830617|FG001|Overall Study|Dual Enrolled Subject|0|||
129692072|NCT04518410|466830618|FG002|Overall Study|Dual Enrolled Subject|0|||
129692073|NCT04518410|466830619|FG003|Overall Study|Dual Enrolled Subject|0|||
129692074|NCT04518410|466830620|FG004|Overall Study|Dual Enrolled Subject|0|||
129692075|NCT04518410|466830621|FG005|Overall Study|Dual Enrolled Subject|0|||
129692076|NCT04518410|466830622|FG006|Overall Study|Dual Enrolled Subject|0|||
129692077|NCT04518410|466830623|FG007|Overall Study|Dual Enrolled Subject|0|||
129692078|NCT04518410|466830624|FG008|Overall Study|Dual Enrolled Subject|0|||
129692079|NCT04518410|466830625|FG009|Overall Study|Dual Enrolled Subject|0|||
129692080|NCT04518410|466830626|FG010|Overall Study|Dual Enrolled Subject|0|||
129692081|NCT04518410|466830627|FG011|Overall Study|Dual Enrolled Subject|0|||
129692082|NCT04518410|466830628|FG012|Overall Study|Dual Enrolled Subject|0|||
129692083|NCT04518410|466830629|FG013|Overall Study|Dual Enrolled Subject|0|||
129692084|NCT04518410|466830630|FG014|Overall Study|Dual Enrolled Subject|0|||
129692085|NCT04518410|466830631|FG015|Overall Study|Dual Enrolled Subject|0|||
129692086|NCT04518410|466830632|FG016|Overall Study|Dual Enrolled Subject|0|||
129692087|NCT04518410|466830633|FG017|Overall Study|Dual Enrolled Subject|1|||
129692088|NCT04518410|466830634|FG018|Overall Study|Dual Enrolled Subject|0|||
129692089|NCT04518410|466830635|FG019|Overall Study|Dual Enrolled Subject|0|||
129692090|NCT04518410|466830636|FG020|Overall Study|Dual Enrolled Subject|0|||
129782437|NCT02424578|467171335|FG000|Overall Study|Withdrawal by Subject|0|||
129572096|NCT03195491|466392240|FG000|Overall Study|Study drug toxicity|25|||
129692091|NCT04518410|466830637|FG021|Overall Study|Dual Enrolled Subject|0|||
129692092|NCT04518410|466830638|FG022|Overall Study|Dual Enrolled Subject|0|||
129692093|NCT04518410|466830639|FG023|Overall Study|Dual Enrolled Subject|0|||
129692094|NCT04518410|466830640|FG024|Overall Study|Dual Enrolled Subject|0|||
129782438|NCT02424578|467171336|FG001|Overall Study|Withdrawal by Subject|1|||
129782439|NCT01703754|467171341|FG000|Overall Study|Clinically significant disease progression|2|||
129782440|NCT01703754|467171342|FG001|Overall Study|Clinically significant disease progression|2|||
129782441|NCT01703754|467171343|FG002|Overall Study|Clinically significant disease progression|1|||
129782442|NCT01703754|467171341|FG000|Overall Study|Adverse Event|1|||
129782443|NCT01703754|467171342|FG001|Overall Study|Adverse Event|1|||
129782444|NCT01703754|467171343|FG002|Overall Study|Adverse Event|0|||
129782445|NCT01703754|467171341|FG000|Overall Study|Withdrawal by Subject|2|||
129782446|NCT01703754|467171342|FG001|Overall Study|Withdrawal by Subject|0|||
129782447|NCT01703754|467171343|FG002|Overall Study|Withdrawal by Subject|0|||
129782448|NCT01989208|467171344|FG000|200 mg (7 Days)|Protocol Violation|0|||
129782449|NCT01989208|467171345|FG001|200 mg (7 Days)|Protocol Violation|1|||
129782450|NCT04973436|467171346|FG000|Overall Study|Lost to Follow-up|3|||
129782451|NCT04973436|467171346|FG000|Overall Study|Withdrawal by Subject|1|||
129782452|NCT04973436|467171346|FG000|Overall Study|Death|2|||
129782453|NCT00566696|467171347|FG000|Overall Study|Met Exclusion Criteria|2|||
129782454|NCT00566696|467171347|FG000|Overall Study|Muromonab not available|1|||
129782455|NCT00566696|467171347|FG000|Overall Study|Health Status Change|1|||
129782456|NCT00566696|467171347|FG000|Overall Study|Physician Decision|1|||
129782457|NCT00566696|467171347|FG000|Overall Study|Non-Patient Donors|37|||
129782458|NCT02872935|467171348|FG000|Overall Study|Other|0|||
129782459|NCT02872935|467171349|FG001|Overall Study|Other|1|||
129782460|NCT01276054|467171353|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
129782461|NCT01276054|467171354|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
129782462|NCT02640508|467171355|FG000|Overall Study|Death|19|||
129782463|NCT02640508|467171355|FG000|Overall Study|Withdrawal by Subject|8|||
129782464|NCT02640508|467171355|FG000|Overall Study|Physician Decision|1|||
129782465|NCT02640508|467171355|FG000|Overall Study|Lost to Follow-up|1|||
129782466|NCT02792829|467171356|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782467|NCT02792829|467171357|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
129782468|NCT02792829|467171358|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782469|NCT02792829|467171359|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782470|NCT02792829|467171360|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782471|NCT02792829|467171361|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782472|NCT02792829|467171362|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782473|NCT02792829|467171363|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
129782474|NCT02792829|467171356|FG000|Treatment Period 2|Adverse Event|0|||
129782475|NCT02792829|467171357|FG001|Treatment Period 2|Adverse Event|0|||
129782476|NCT02792829|467171358|FG002|Treatment Period 2|Adverse Event|0|||
129782477|NCT02792829|467171359|FG003|Treatment Period 2|Adverse Event|0|||
129782478|NCT02792829|467171360|FG004|Treatment Period 2|Adverse Event|1|||
129782479|NCT02792829|467171361|FG005|Treatment Period 2|Adverse Event|0|||
129782480|NCT02792829|467171362|FG006|Treatment Period 2|Adverse Event|1|||
129782481|NCT02792829|467171363|FG007|Treatment Period 2|Adverse Event|1|||
129782482|NCT02792829|467171356|FG000|Treatment Period 2|Use of proscribed medications|0|||
129782483|NCT02792829|467171357|FG001|Treatment Period 2|Use of proscribed medications|0|||
129782484|NCT02792829|467171358|FG002|Treatment Period 2|Use of proscribed medications|0|||
129782485|NCT02792829|467171359|FG003|Treatment Period 2|Use of proscribed medications|0|||
129782486|NCT02792829|467171360|FG004|Treatment Period 2|Use of proscribed medications|0|||
129782487|NCT02792829|467171361|FG005|Treatment Period 2|Use of proscribed medications|0|||
129782488|NCT02792829|467171362|FG006|Treatment Period 2|Use of proscribed medications|0|||
129782489|NCT02792829|467171363|FG007|Treatment Period 2|Use of proscribed medications|1|||
129782490|NCT05405257|467171364|FG000|Overall Study|Withdrawal by Subject|1|||
129782491|NCT00452361|467171365|FG000|Overall Study|Adverse Event|8|||
129782492|NCT00452361|467171366|FG001|Overall Study|Adverse Event|0|||
129782493|NCT00452361|467171365|FG000|Overall Study|Withdrawal by Subject|0|||
129782494|NCT00452361|467171366|FG001|Overall Study|Withdrawal by Subject|1|||
129782495|NCT00452361|467171365|FG000|Overall Study|Premature termination|13|||
129782496|NCT00452361|467171366|FG001|Overall Study|Premature termination|9|||
129782497|NCT00776919|467171367|FG000|Overall Study|Withdrawal by Subject|16|||
129782498|NCT00776919|467171368|FG001|Overall Study|Withdrawal by Subject|14|||
129782499|NCT00776919|467171369|FG002|Overall Study|Withdrawal by Subject|15|||
129782500|NCT00776919|467171370|FG003|Overall Study|Withdrawal by Subject|26|||
129782501|NCT00776919|467171367|FG000|Overall Study|Lost to Follow-up|8|||
129782502|NCT00776919|467171368|FG001|Overall Study|Lost to Follow-up|12|||
129782503|NCT00776919|467171369|FG002|Overall Study|Lost to Follow-up|11|||
129782504|NCT00776919|467171370|FG003|Overall Study|Lost to Follow-up|8|||
129782505|NCT00776919|467171367|FG000|Overall Study|Adverse Event|1|||
129782506|NCT00776919|467171368|FG001|Overall Study|Adverse Event|0|||
129782507|NCT00776919|467171369|FG002|Overall Study|Adverse Event|2|||
129782508|NCT00776919|467171370|FG003|Overall Study|Adverse Event|2|||
129782509|NCT00776919|467171367|FG000|Overall Study|Protocol Violation|1|||
129782510|NCT00776919|467171368|FG001|Overall Study|Protocol Violation|2|||
129782511|NCT00776919|467171369|FG002|Overall Study|Protocol Violation|0|||
129782512|NCT00776919|467171370|FG003|Overall Study|Protocol Violation|1|||
129782513|NCT00776919|467171367|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
129782514|NCT00776919|467171368|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
129782515|NCT00776919|467171369|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
129782516|NCT00776919|467171370|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
129782517|NCT03116152|467171373|FG000|Overall Study|Disease Progression|49|||
129782518|NCT03116152|467171374|FG001|Overall Study|Disease Progression|47|||
129572097|NCT03195491|466392241|FG001|Overall Study|Study drug toxicity|3|||
129572098|NCT03195491|466392240|FG000|Overall Study|Maximum clinical benefit|5|||
129572099|NCT03195491|466392241|FG001|Overall Study|Maximum clinical benefit|0|||
129572100|NCT03195491|466392240|FG000|Overall Study|Lost to Follow-up|1|||
129572101|NCT03195491|466392241|FG001|Overall Study|Lost to Follow-up|0|||
129572102|NCT03195491|466392240|FG000|Overall Study|Death|3|||
129572103|NCT03195491|466392241|FG001|Overall Study|Death|0|||
129572104|NCT03195491|466392240|FG000|Overall Study|Adverse event unrelated to study drug|19|||
129572105|NCT03195491|466392241|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129572106|NCT03195491|466392240|FG000|Overall Study|Disease progression|266|||
129572107|NCT03195491|466392241|FG001|Overall Study|Disease progression|8|||
129572108|NCT03195491|466392240|FG000|Overall Study|Other reasons|10|||
129572109|NCT03195491|466392241|FG001|Overall Study|Other reasons|0|||
129572110|NCT03195491|466392240|FG000|Overall Study|Participant withdrew consent|8|||
129572111|NCT03195491|466392241|FG001|Overall Study|Participant withdrew consent|1|||
129572112|NCT03195491|466392240|FG000|Overall Study|Participant no longer meets study criteria|0|||
129572113|NCT03195491|466392241|FG001|Overall Study|Participant no longer meets study criteria|1|||
129572114|NCT03195491|466392240|FG000|Overall Study|Participant request to discontinue study treatment|10|||
129572115|NCT03195491|466392241|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129572116|NCT01263704|466392242|FG000|Overall Study|Progressive disease|18|||
129572117|NCT01263704|466392242|FG000|Overall Study|Adverse Event|3|||
129572118|NCT01263704|466392242|FG000|Overall Study|Death|2|||
129572119|NCT01263704|466392242|FG000|Overall Study|Patient withdrew consent|2|||
129572120|NCT01263704|466392242|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
129572121|NCT01263704|466392242|FG000|Overall Study|Lost to Follow-up|1|||
129572122|NCT01263704|466392242|FG000|Overall Study|Colon metastases|1|||
129572123|NCT01263704|466392242|FG000|Overall Study|Principal Investigator (PI) decision|1|||
129692095|NCT03462563|466830641|FG000|Overall Study|Death|1|||
129692096|NCT03462563|466830642|FG001|Overall Study|Death|1|||
129692097|NCT03462563|466830641|FG000|Overall Study|Termination of study|2|||
129692098|NCT03462563|466830642|FG001|Overall Study|Termination of study|1|||
129692099|NCT03462563|466830641|FG000|Overall Study|Adverse Event|1|||
129692100|NCT03462563|466830642|FG001|Overall Study|Adverse Event|3|||
129692101|NCT03462563|466830641|FG000|Overall Study|Unspecified reason|10|||
129692102|NCT03462563|466830642|FG001|Overall Study|Unspecified reason|12|||
129692103|NCT03462563|466830641|FG000|Overall Study|Physician Decision|1|||
129692104|NCT03462563|466830642|FG001|Overall Study|Physician Decision|0|||
129692105|NCT01740427|466830643|FG000|Overall Study|Objective Progression or Relapse|286|||
129692106|NCT01740427|466830644|FG001|Overall Study|Objective Progression or Relapse|172|||
129692107|NCT01740427|466830643|FG000|Overall Study|Adverse Event|32|||
129692108|NCT01740427|466830644|FG001|Overall Study|Adverse Event|9|||
129692109|NCT01740427|466830643|FG000|Overall Study|Global Deterioration of Health Status|28|||
129692110|NCT01740427|466830644|FG001|Overall Study|Global Deterioration of Health Status|12|||
129692111|NCT01740427|466830643|FG000|Overall Study|Participant Refused Continued Treatment|27|||
129692112|NCT01740427|466830644|FG001|Overall Study|Participant Refused Continued Treatment|15|||
129692113|NCT01740427|466830643|FG000|Overall Study|Unspecified reasons|52|||
129692114|NCT01740427|466830644|FG001|Overall Study|Unspecified reasons|8|||
129692115|NCT01740427|466830643|FG000|Overall Study|Death|10|||
129692116|NCT01740427|466830644|FG001|Overall Study|Death|3|||
129692117|NCT01740427|466830643|FG000|Overall Study|Protocol Violation|5|||
129692118|NCT01740427|466830644|FG001|Overall Study|Protocol Violation|3|||
129692119|NCT01740427|466830643|FG000|Overall Study|Lost to Follow-up|3|||
129692120|NCT01740427|466830644|FG001|Overall Study|Lost to Follow-up|0|||
129782519|NCT03116152|467171373|FG000|Overall Study|Death|5|||
129572124|NCT01185821|466392248|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129692121|NCT01740427|466830643|FG000|Overall Study|Site Terminated by Sponsor|1|||
129692122|NCT01740427|466830644|FG001|Overall Study|Site Terminated by Sponsor|0|||
129782520|NCT03116152|467171374|FG001|Overall Study|Death|2|||
129572125|NCT01185821|466392249|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129572126|NCT01185821|466392250|FG002|Overall Study|Abnormal laboratory value(s)|1|||
129572127|NCT01185821|466392251|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129692123|NCT04796207|466830645|FG000|Overall Study|Lost to Follow-up|7|||
129692124|NCT04796207|466830646|FG001|Overall Study|Lost to Follow-up|2|||
129692125|NCT02405962|466830649|FG000|Overall Study|Lost to Follow-up|1|||
129572128|NCT01185821|466392252|FG004|Overall Study|Abnormal laboratory value(s)|0|||
129572129|NCT01185821|466392248|FG000|Overall Study|Protocol Violation|0|||
129572130|NCT01185821|466392249|FG001|Overall Study|Protocol Violation|0|||
129572131|NCT01185821|466392250|FG002|Overall Study|Protocol Violation|0|||
129572132|NCT01185821|466392251|FG003|Overall Study|Protocol Violation|1|||
129572133|NCT01185821|466392252|FG004|Overall Study|Protocol Violation|1|||
129572134|NCT01185821|466392248|FG000|Overall Study|Abnormal test procedure result|0|||
129572135|NCT01185821|466392249|FG001|Overall Study|Abnormal test procedure result|0|||
129572136|NCT01185821|466392250|FG002|Overall Study|Abnormal test procedure result|0|||
129572137|NCT01185821|466392251|FG003|Overall Study|Abnormal test procedure result|0|||
129572138|NCT01185821|466392252|FG004|Overall Study|Abnormal test procedure result|1|||
129572139|NCT01185821|466392248|FG000|Overall Study|Death|0|||
129572140|NCT01185821|466392249|FG001|Overall Study|Death|1|||
129572141|NCT01185821|466392250|FG002|Overall Study|Death|0|||
129572142|NCT01185821|466392251|FG003|Overall Study|Death|0|||
129572143|NCT01185821|466392252|FG004|Overall Study|Death|0|||
129572144|NCT01185821|466392248|FG000|Overall Study|Condition no longer required study drug|0|||
129572145|NCT01185821|466392249|FG001|Overall Study|Condition no longer required study drug|0|||
129572146|NCT01185821|466392250|FG002|Overall Study|Condition no longer required study drug|0|||
129572147|NCT01185821|466392251|FG003|Overall Study|Condition no longer required study drug|0|||
129572148|NCT01185821|466392252|FG004|Overall Study|Condition no longer required study drug|1|||
129572149|NCT01185821|466392248|FG000|Overall Study|Adverse Event|2|||
129572150|NCT01185821|466392249|FG001|Overall Study|Adverse Event|3|||
129572151|NCT01185821|466392250|FG002|Overall Study|Adverse Event|1|||
129572152|NCT01185821|466392251|FG003|Overall Study|Adverse Event|2|||
129572153|NCT01185821|466392252|FG004|Overall Study|Adverse Event|5|||
129572154|NCT01185821|466392248|FG000|Overall Study|Lack of Efficacy|0|||
129572155|NCT01185821|466392249|FG001|Overall Study|Lack of Efficacy|0|||
129572156|NCT01185821|466392250|FG002|Overall Study|Lack of Efficacy|3|||
129572157|NCT01185821|466392251|FG003|Overall Study|Lack of Efficacy|0|||
129572158|NCT01185821|466392252|FG004|Overall Study|Lack of Efficacy|9|||
129572159|NCT01185821|466392248|FG000|Overall Study|Withdrawal by Subject|3|||
129572160|NCT01185821|466392249|FG001|Overall Study|Withdrawal by Subject|2|||
129572161|NCT01185821|466392250|FG002|Overall Study|Withdrawal by Subject|2|||
129572162|NCT01185821|466392251|FG003|Overall Study|Withdrawal by Subject|1|||
129572163|NCT01185821|466392252|FG004|Overall Study|Withdrawal by Subject|3|||
129572164|NCT01185821|466392248|FG000|Overall Study|Lost to Follow-up|1|||
129572165|NCT01185821|466392249|FG001|Overall Study|Lost to Follow-up|1|||
129572166|NCT01185821|466392250|FG002|Overall Study|Lost to Follow-up|2|||
129572167|NCT01185821|466392251|FG003|Overall Study|Lost to Follow-up|1|||
129572168|NCT01185821|466392252|FG004|Overall Study|Lost to Follow-up|2|||
129572169|NCT01185821|466392248|FG000|Overall Study|Administrative problems|0|||
129572170|NCT01185821|466392249|FG001|Overall Study|Administrative problems|0|||
129572171|NCT01185821|466392250|FG002|Overall Study|Administrative problems|1|||
129572172|NCT01185821|466392251|FG003|Overall Study|Administrative problems|1|||
129782521|NCT03116152|467171373|FG000|Overall Study|Adverse Event|21|||
129782522|NCT03116152|467171374|FG001|Overall Study|Adverse Event|7|||
129782523|NCT03116152|467171373|FG000|Overall Study|Protocol Violation|2|||
129782524|NCT03116152|467171374|FG001|Overall Study|Protocol Violation|2|||
129782525|NCT03116152|467171373|FG000|Overall Study|Withdrawal by Subject|0|||
129782526|NCT03116152|467171374|FG001|Overall Study|Withdrawal by Subject|1|||
129782527|NCT03116152|467171373|FG000|Overall Study|Physician Decision|3|||
129782528|NCT03116152|467171374|FG001|Overall Study|Physician Decision|2|||
129782529|NCT03116152|467171373|FG000|Overall Study|other|11|||
129782530|NCT03116152|467171374|FG001|Overall Study|other|34|||
129782531|NCT02379637|467171378|FG000|Overall Study|Protocol Violation|0|||
129782532|NCT02379637|467171379|FG001|Overall Study|Protocol Violation|1|||
129572173|NCT01185821|466392252|FG004|Overall Study|Administrative problems|2|||
129782533|NCT02379637|467171378|FG000|Overall Study|Adverse Event|1|||
129572174|NCT01546545|466392254|FG000|Overall Study|Withdrawal by Subject|1|||
129572175|NCT04060147|466392255|FG000|Overall Study|Withdrew consent|1|||
129572176|NCT02057458|466392259|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
129572177|NCT02057458|466392260|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
129572178|NCT02057458|466392261|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
129572179|NCT02057458|466392259|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
129572180|NCT02057458|466392260|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
129572181|NCT02057458|466392261|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
129572182|NCT02057458|466392259|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
129782534|NCT02379637|467171379|FG001|Overall Study|Adverse Event|0|||
129782535|NCT02379637|467171378|FG000|Overall Study|Withdrawal by Subject|1|||
129782536|NCT02379637|467171379|FG001|Overall Study|Withdrawal by Subject|0|||
129782537|NCT02791763|467171380|FG000|Overall Study|Protocol Violation|0|||
129572183|NCT02057458|466392260|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
129572184|NCT02057458|466392261|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
129572185|NCT00550537|466392262|FG000|Overall Study|Death|18|||
129572186|NCT00550537|466392262|FG000|Overall Study|Adverse Event|20|||
129572187|NCT00550537|466392262|FG000|Overall Study|Disease progression before|46|||
129572188|NCT00550537|466392262|FG000|Overall Study|Withdrawal by Subject|7|||
129572189|NCT00550537|466392262|FG000|Overall Study|Change in treatment plan|4|||
129572190|NCT00550537|466392262|FG000|Overall Study|Other complicating ilness|3|||
129572191|NCT00550537|466392262|FG000|Overall Study|Declining performance status|2|||
129572192|NCT00550537|466392262|FG000|Overall Study|Treated closer to home|4|||
129572193|NCT00617305|466392263|FG000|Overall Study|Adverse Event|4|||
129572194|NCT00617305|466392264|FG001|Overall Study|Adverse Event|0|||
129572195|NCT00617305|466392265|FG002|Overall Study|Adverse Event|0|||
129572196|NCT00617305|466392263|FG000|Overall Study|Death|1|||
129572197|NCT00617305|466392264|FG001|Overall Study|Death|0|||
129572198|NCT00617305|466392265|FG002|Overall Study|Death|0|||
129572199|NCT00617305|466392263|FG000|Overall Study|Physician Decision|1|||
129572200|NCT00617305|466392264|FG001|Overall Study|Physician Decision|0|||
129572201|NCT00617305|466392265|FG002|Overall Study|Physician Decision|0|||
129572202|NCT00617305|466392263|FG000|Overall Study|Protocol Violation|1|||
129572203|NCT00617305|466392264|FG001|Overall Study|Protocol Violation|0|||
129572204|NCT00617305|466392265|FG002|Overall Study|Protocol Violation|1|||
129572205|NCT00617305|466392263|FG000|Overall Study|Withdrawal by Subject|1|||
129572206|NCT00617305|466392264|FG001|Overall Study|Withdrawal by Subject|0|||
129572207|NCT00617305|466392265|FG002|Overall Study|Withdrawal by Subject|0|||
129572208|NCT04510285|466392266|FG000|Overall Study|Death|1|||
129572209|NCT03555305|466392269|FG000|Period 1|Physician Decision|0|||
129572210|NCT03555305|466392270|FG001|Period 1|Physician Decision|1|||
129572211|NCT03555305|466392269|FG000|Period 1|Adverse Event|0|||
129572212|NCT03555305|466392270|FG001|Period 1|Adverse Event|1|||
129572213|NCT03586726|466392271|FG000|Overall Study|Withdrawal by Subject|1|||
129572214|NCT03420300|466392274|FG000|Overall Study|Death|2|||
129572215|NCT01811953|466393590|FG000|Overall Study|Adverse Event|0|||
129572216|NCT01811953|466393591|FG001|Overall Study|Adverse Event|0|||
129572217|NCT01811953|466393592|FG002|Overall Study|Adverse Event|0|||
129572218|NCT01811953|466393593|FG003|Overall Study|Adverse Event|1|||
129572219|NCT01811953|466393594|FG004|Overall Study|Adverse Event|0|||
129572220|NCT01811953|466393595|FG005|Overall Study|Adverse Event|1|||
129572221|NCT01811953|466393590|FG000|Overall Study|Protocol Violation|0|||
129572222|NCT01811953|466393591|FG001|Overall Study|Protocol Violation|0|||
129572223|NCT01811953|466393592|FG002|Overall Study|Protocol Violation|0|||
129572224|NCT01811953|466393593|FG003|Overall Study|Protocol Violation|0|||
129572225|NCT01811953|466393594|FG004|Overall Study|Protocol Violation|1|||
129572226|NCT01811953|466393595|FG005|Overall Study|Protocol Violation|0|||
129572227|NCT02262377|466393597|FG000|Overall Study|Lost to Follow-up|5|||
129572228|NCT02262377|466393598|FG001|Overall Study|Lost to Follow-up|6|||
129572229|NCT02262377|466393597|FG000|Overall Study|Found ineligible after enrollment|3|||
129572230|NCT02262377|466393598|FG001|Overall Study|Found ineligible after enrollment|0|||
129572231|NCT02262377|466393597|FG000|Overall Study|Withdrawal by Subject|4|||
129572232|NCT02262377|466393598|FG001|Overall Study|Withdrawal by Subject|0|||
129572233|NCT00371839|466393600|FG000|Overall Study|Death|4|||
129572234|NCT00371839|466393601|FG001|Overall Study|Death|0|||
129572235|NCT00371839|466393602|FG002|Overall Study|Death|0|||
129572236|NCT00371839|466393600|FG000|Overall Study|Withdrawal by Subject|7|||
129572237|NCT00371839|466393601|FG001|Overall Study|Withdrawal by Subject|4|||
129572238|NCT00371839|466393602|FG002|Overall Study|Withdrawal by Subject|0|||
129782538|NCT02791763|467171381|FG001|Overall Study|Protocol Violation|0|||
129782539|NCT02791763|467171382|FG002|Overall Study|Protocol Violation|1|||
129782540|NCT02791763|467171380|FG000|Overall Study|Withdrawal by Subject|5|||
129572239|NCT00371839|466393600|FG000|Overall Study|Lost to Follow-up|6|||
129782541|NCT02791763|467171381|FG001|Overall Study|Withdrawal by Subject|1|||
129572240|NCT00371839|466393601|FG001|Overall Study|Lost to Follow-up|3|||
129572241|NCT00371839|466393602|FG002|Overall Study|Lost to Follow-up|2|||
129572242|NCT00723528|466393603|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
129572243|NCT00723528|466393604|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
129572244|NCT00723528|466393605|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
129572245|NCT00723528|466393606|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
129572246|NCT00723528|466393607|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
129572247|NCT00723528|466393608|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
129572248|NCT00723528|466393609|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
129572249|NCT00723528|466393603|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
129572250|NCT00723528|466393604|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129782542|NCT02791763|467171382|FG002|Overall Study|Withdrawal by Subject|0|||
129692126|NCT02405962|466830650|FG001|Overall Study|Lost to Follow-up|4|||
129692127|NCT02405962|466830649|FG000|Overall Study|A participant has moved to another place|0|||
129692128|NCT02405962|466830650|FG001|Overall Study|A participant has moved to another place|1|||
129692129|NCT00165698|466830651|FG000|Overall Study|Adverse Event|2|||
129692130|NCT00165698|466830652|FG001|Overall Study|Adverse Event|10|||
129692131|NCT00165698|466830651|FG000|Overall Study|Lost to Follow-up|2|||
129692132|NCT00165698|466830652|FG001|Overall Study|Lost to Follow-up|2|||
129692133|NCT00165698|466830651|FG000|Overall Study|Withdrawal by Subject|2|||
129692134|NCT00165698|466830652|FG001|Overall Study|Withdrawal by Subject|1|||
129782543|NCT02791763|467171380|FG000|Overall Study|Physician Decision|0|||
129782544|NCT02791763|467171381|FG001|Overall Study|Physician Decision|1|||
129572251|NCT00723528|466393605|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129572252|NCT00723528|466393606|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129572253|NCT00723528|466393607|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129572254|NCT00723528|466393608|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129572255|NCT00723528|466393609|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
129572256|NCT00723528|466393603|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
129572257|NCT00723528|466393604|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
129572258|NCT00723528|466393605|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
129572259|NCT00723528|466393606|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
129572260|NCT00723528|466393607|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
129572261|NCT00723528|466393608|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
129572262|NCT00723528|466393609|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
129572263|NCT00723528|466393603|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129572264|NCT00723528|466393604|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129572265|NCT00723528|466393605|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
129572266|NCT00723528|466393606|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129572267|NCT00723528|466393607|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129572268|NCT00723528|466393608|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129572269|NCT00723528|466393609|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
129572270|NCT00723528|466393603|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
129572271|NCT00723528|466393604|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129572272|NCT00723528|466393605|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
129572273|NCT00723528|466393606|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129572274|NCT00723528|466393607|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129572275|NCT00723528|466393608|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129782545|NCT02791763|467171382|FG002|Overall Study|Physician Decision|0|||
129782546|NCT02791763|467171380|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
129572276|NCT00723528|466393609|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
129572277|NCT00723528|466393603|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129572278|NCT00723528|466393604|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129572279|NCT00723528|466393605|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129572280|NCT00723528|466393606|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
129782547|NCT02791763|467171381|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
129782548|NCT02791763|467171382|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
129782549|NCT02791763|467171380|FG000|Overall Study|Cancer event|1|||
129782550|NCT02791763|467171381|FG001|Overall Study|Cancer event|3|||
129782551|NCT02791763|467171382|FG002|Overall Study|Cancer event|0|||
129782552|NCT02791763|467171380|FG000|Overall Study|Participant had renal transplant|3|||
129782553|NCT02791763|467171381|FG001|Overall Study|Participant had renal transplant|0|||
129782554|NCT02791763|467171382|FG002|Overall Study|Participant had renal transplant|0|||
129782555|NCT02791763|467171380|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
129572281|NCT00723528|466393607|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
129572282|NCT00723528|466393608|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
129572283|NCT00723528|466393609|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
129572284|NCT00723528|466393603|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129572285|NCT00723528|466393604|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129782556|NCT02791763|467171381|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
129782557|NCT02791763|467171382|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
129782558|NCT02791763|467171380|FG000|Overall Study|Adverse Event|12|||
129782559|NCT02791763|467171381|FG001|Overall Study|Adverse Event|13|||
129782560|NCT02791763|467171382|FG002|Overall Study|Adverse Event|7|||
129782561|NCT03179605|467171383|FG000|Overall Study|Withdrawal by Subject|1|||
129782562|NCT00635999|467171384|FG000|Overall Study|Withdrawal by Subject|4|||
129692135|NCT00165698|466830651|FG000|Overall Study|Protocol Violation|1|||
129692136|NCT00165698|466830652|FG001|Overall Study|Protocol Violation|0|||
129692137|NCT00165698|466830651|FG000|Overall Study|Not Taken/Lost the medicine|1|||
129692138|NCT00165698|466830652|FG001|Overall Study|Not Taken/Lost the medicine|2|||
129692139|NCT03679884|466830653|FG000|Overall Study|Other|12|||
129692140|NCT03679884|466830654|FG001|Overall Study|Other|12|||
129692141|NCT03679884|466830655|FG002|Overall Study|Other|12|||
129692142|NCT03679884|466830656|FG003|Overall Study|Other|7|||
129692143|NCT03679884|466830657|FG004|Overall Study|Other|8|||
129782563|NCT00635999|467171385|FG001|Overall Study|Withdrawal by Subject|2|||
129782564|NCT00635999|467171386|FG002|Overall Study|Withdrawal by Subject|1|||
129782565|NCT02410343|467171390|FG000|Core Period (24 Weeks)|Adverse Event|1|||
129782566|NCT02410343|467171391|FG001|Core Period (24 Weeks)|Adverse Event|0|||
129782567|NCT02410343|467171390|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
129782568|NCT02410343|467171391|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
129782569|NCT02410343|467171390|FG000|Extension Period (12 Months)|Adverse Event|1|||
129782570|NCT02410343|467171391|FG001|Extension Period (12 Months)|Adverse Event|0|||
129782571|NCT02410343|467171390|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
129572286|NCT00723528|466393605|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129572287|NCT00723528|466393606|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129572288|NCT00723528|466393607|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129572289|NCT00723528|466393608|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
129572290|NCT00723528|466393609|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
129572291|NCT00723528|466393603|FG000|Period 2: After Controlled Period|Other|0|||
129572292|NCT00723528|466393604|FG001|Period 2: After Controlled Period|Other|0|||
129572293|NCT00723528|466393605|FG002|Period 2: After Controlled Period|Other|0|||
129572294|NCT00723528|466393606|FG003|Period 2: After Controlled Period|Other|0|||
129572295|NCT00723528|466393607|FG004|Period 2: After Controlled Period|Other|1|||
129572296|NCT00723528|466393608|FG005|Period 2: After Controlled Period|Other|4|||
129572297|NCT00723528|466393609|FG006|Period 2: After Controlled Period|Other|0|||
129572298|NCT00723528|466393603|FG000|Period 2: After Controlled Period|Adverse Event|0|||
129572299|NCT00723528|466393604|FG001|Period 2: After Controlled Period|Adverse Event|0|||
129572300|NCT00723528|466393605|FG002|Period 2: After Controlled Period|Adverse Event|0|||
129572301|NCT00723528|466393606|FG003|Period 2: After Controlled Period|Adverse Event|0|||
129572302|NCT00723528|466393607|FG004|Period 2: After Controlled Period|Adverse Event|1|||
129572303|NCT00723528|466393608|FG005|Period 2: After Controlled Period|Adverse Event|0|||
129572304|NCT00723528|466393609|FG006|Period 2: After Controlled Period|Adverse Event|1|||
129782572|NCT02410343|467171391|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
129782573|NCT00228553|467171392|FG000|Overall Study|Adverse Event|112|||
129782574|NCT00228553|467171392|FG000|Overall Study|Lack of Efficacy|34|||
129782575|NCT00228553|467171392|FG000|Overall Study|Lost to Follow-up|67|||
129782576|NCT00228553|467171392|FG000|Overall Study|Physician Decision|48|||
129782577|NCT00228553|467171392|FG000|Overall Study|Protocol Violation|6|||
129782578|NCT00228553|467171392|FG000|Overall Study|Withdrawal by Subject|115|||
129782579|NCT00228553|467171392|FG000|Overall Study|Pregnancy|2|||
129572305|NCT00723528|466393603|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129572306|NCT00723528|466393604|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129692144|NCT03679884|466830653|FG000|Overall Study|Lack of Efficacy|15|||
129692145|NCT03679884|466830654|FG001|Overall Study|Lack of Efficacy|29|||
129692146|NCT03679884|466830655|FG002|Overall Study|Lack of Efficacy|13|||
129692147|NCT03679884|466830656|FG003|Overall Study|Lack of Efficacy|29|||
129692148|NCT03679884|466830657|FG004|Overall Study|Lack of Efficacy|10|||
129692149|NCT03679884|466830653|FG000|Overall Study|Death|1|||
129692150|NCT03679884|466830654|FG001|Overall Study|Death|0|||
129692151|NCT03679884|466830655|FG002|Overall Study|Death|0|||
129572307|NCT00723528|466393605|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129692152|NCT03679884|466830656|FG003|Overall Study|Death|0|||
129692153|NCT03679884|466830657|FG004|Overall Study|Death|0|||
129692154|NCT03679884|466830653|FG000|Overall Study|Adverse Event|2|||
129692155|NCT03679884|466830654|FG001|Overall Study|Adverse Event|10|||
129692156|NCT03679884|466830655|FG002|Overall Study|Adverse Event|9|||
129692157|NCT03679884|466830656|FG003|Overall Study|Adverse Event|6|||
129692158|NCT03679884|466830657|FG004|Overall Study|Adverse Event|6|||
129692159|NCT03679884|466830653|FG000|Overall Study|Withdrawal by Subject|12|||
129692160|NCT03679884|466830654|FG001|Overall Study|Withdrawal by Subject|23|||
129692161|NCT03679884|466830655|FG002|Overall Study|Withdrawal by Subject|8|||
129692162|NCT03679884|466830656|FG003|Overall Study|Withdrawal by Subject|8|||
129692163|NCT03679884|466830657|FG004|Overall Study|Withdrawal by Subject|9|||
129692164|NCT03679884|466830653|FG000|Overall Study|Lost to Follow-up|1|||
129692165|NCT03679884|466830654|FG001|Overall Study|Lost to Follow-up|4|||
129692166|NCT03679884|466830655|FG002|Overall Study|Lost to Follow-up|2|||
129692167|NCT03679884|466830656|FG003|Overall Study|Lost to Follow-up|0|||
129692168|NCT03679884|466830657|FG004|Overall Study|Lost to Follow-up|3|||
129692169|NCT01107457|466830658|FG000|Part A|Adverse Event|1|||
129692170|NCT01107457|466830659|FG001|Part A|Adverse Event|2|||
129692171|NCT01107457|466830660|FG002|Part A|Adverse Event|1|||
129692172|NCT01107457|466830661|FG003|Part A|Adverse Event|0|||
129692173|NCT01107457|466830662|FG004|Part A|Adverse Event|0|||
129692174|NCT01107457|466830663|FG005|Part A|Adverse Event|0|||
129692175|NCT01107457|466830658|FG000|Part A|Withdrawal by Subject|3|||
129692176|NCT01107457|466830659|FG001|Part A|Withdrawal by Subject|3|||
129692177|NCT01107457|466830660|FG002|Part A|Withdrawal by Subject|0|||
129692178|NCT01107457|466830661|FG003|Part A|Withdrawal by Subject|3|||
129692179|NCT01107457|466830662|FG004|Part A|Withdrawal by Subject|1|||
129692180|NCT01107457|466830663|FG005|Part A|Withdrawal by Subject|0|||
129692181|NCT01107457|466830658|FG000|Part A|Lost to Follow-up|0|||
129692182|NCT01107457|466830659|FG001|Part A|Lost to Follow-up|1|||
129692183|NCT01107457|466830660|FG002|Part A|Lost to Follow-up|0|||
129692184|NCT01107457|466830661|FG003|Part A|Lost to Follow-up|0|||
129692185|NCT01107457|466830662|FG004|Part A|Lost to Follow-up|0|||
129692186|NCT01107457|466830663|FG005|Part A|Lost to Follow-up|0|||
129692187|NCT01107457|466830658|FG000|Part A|Lack of Efficacy|1|||
129692188|NCT01107457|466830659|FG001|Part A|Lack of Efficacy|0|||
129692189|NCT01107457|466830660|FG002|Part A|Lack of Efficacy|0|||
129692190|NCT01107457|466830661|FG003|Part A|Lack of Efficacy|0|||
129692191|NCT01107457|466830662|FG004|Part A|Lack of Efficacy|0|||
129692192|NCT01107457|466830663|FG005|Part A|Lack of Efficacy|0|||
129692193|NCT01107457|466830658|FG000|Part A|Protocol Violation|0|||
129692194|NCT01107457|466830659|FG001|Part A|Protocol Violation|1|||
129692195|NCT01107457|466830660|FG002|Part A|Protocol Violation|0|||
129692196|NCT01107457|466830661|FG003|Part A|Protocol Violation|0|||
129692197|NCT01107457|466830662|FG004|Part A|Protocol Violation|0|||
129692198|NCT01107457|466830663|FG005|Part A|Protocol Violation|0|||
129692199|NCT01107457|466830658|FG000|Part B and C|Adverse Event|0|||
129692200|NCT01107457|466830659|FG001|Part B and C|Adverse Event|0|||
129692201|NCT01107457|466830660|FG002|Part B and C|Adverse Event|0|||
129692202|NCT01107457|466830661|FG003|Part B and C|Adverse Event|0|||
129692203|NCT01107457|466830662|FG004|Part B and C|Adverse Event|0|||
129692204|NCT01107457|466830663|FG005|Part B and C|Adverse Event|12|||
129692205|NCT01107457|466830658|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129692206|NCT01107457|466830659|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129692207|NCT01107457|466830660|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129692208|NCT01107457|466830661|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129782580|NCT00228553|467171392|FG000|Overall Study|Miscellaneous|46|||
129782581|NCT02878798|467171393|FG000|Overall Study|Withdrawal by Subject|5|||
129692209|NCT01107457|466830662|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
129692210|NCT01107457|466830663|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
129692211|NCT01107457|466830658|FG000|Part B and C|Physician Decision|0|||
129692212|NCT01107457|466830659|FG001|Part B and C|Physician Decision|0|||
129692213|NCT01107457|466830660|FG002|Part B and C|Physician Decision|0|||
129692214|NCT01107457|466830661|FG003|Part B and C|Physician Decision|0|||
129692215|NCT01107457|466830662|FG004|Part B and C|Physician Decision|0|||
129692216|NCT01107457|466830663|FG005|Part B and C|Physician Decision|3|||
129692217|NCT01107457|466830658|FG000|Part B and C|Lack of Efficacy|0|||
129692218|NCT01107457|466830659|FG001|Part B and C|Lack of Efficacy|0|||
129692219|NCT01107457|466830660|FG002|Part B and C|Lack of Efficacy|0|||
129692220|NCT01107457|466830661|FG003|Part B and C|Lack of Efficacy|0|||
129692221|NCT01107457|466830662|FG004|Part B and C|Lack of Efficacy|0|||
129692222|NCT01107457|466830663|FG005|Part B and C|Lack of Efficacy|7|||
129692223|NCT01107457|466830658|FG000|Part B and C|Lost to Follow-up|0|||
129692224|NCT01107457|466830659|FG001|Part B and C|Lost to Follow-up|0|||
129692225|NCT01107457|466830660|FG002|Part B and C|Lost to Follow-up|0|||
129782582|NCT02878798|467171394|FG001|Overall Study|Withdrawal by Subject|4|||
129782583|NCT02878798|467171393|FG000|Overall Study|Lost to Follow-up|2|||
129782584|NCT02878798|467171394|FG001|Overall Study|Lost to Follow-up|2|||
129782585|NCT02878798|467171393|FG000|Overall Study|Protocol Violation|0|||
129782586|NCT02878798|467171394|FG001|Overall Study|Protocol Violation|1|||
129782587|NCT02720042|467171395|FG000|Overall Study|Death|3|||
129782588|NCT02720042|467171395|FG000|Overall Study|Lost to Follow-up|4|||
129782589|NCT02720042|467171395|FG000|Overall Study|Withdrawal by Subject|1|||
129782590|NCT02720042|467171395|FG000|Overall Study|Physician Decision|3|||
129782591|NCT02720042|467171395|FG000|Overall Study|Phasix Mesh explanted|1|||
129782592|NCT02720042|467171395|FG000|Overall Study|unable due to non-study-related illness|3|||
129782593|NCT00101452|467171398|FG000|Overall Study|Adverse Event|2|||
129782594|NCT00101452|467171399|FG001|Overall Study|Adverse Event|0|||
129782595|NCT00101452|467171400|FG002|Overall Study|Adverse Event|1|||
129782596|NCT00101452|467171398|FG000|Overall Study|Lost to Follow-up|13|||
129782597|NCT00101452|467171399|FG001|Overall Study|Lost to Follow-up|8|||
129782598|NCT00101452|467171400|FG002|Overall Study|Lost to Follow-up|14|||
129782599|NCT00101452|467171398|FG000|Overall Study|Withdrawal by Subject|10|||
129782600|NCT00101452|467171399|FG001|Overall Study|Withdrawal by Subject|14|||
129782601|NCT00101452|467171400|FG002|Overall Study|Withdrawal by Subject|9|||
129782602|NCT00101452|467171398|FG000|Overall Study|Baseline Fail|2|||
129782603|NCT00101452|467171399|FG001|Overall Study|Baseline Fail|1|||
129782604|NCT00101452|467171400|FG002|Overall Study|Baseline Fail|2|||
129782605|NCT00101452|467171398|FG000|Overall Study|Physician Decision|0|||
129782606|NCT00101452|467171399|FG001|Overall Study|Physician Decision|3|||
129782607|NCT00101452|467171400|FG002|Overall Study|Physician Decision|2|||
129782608|NCT00101452|467171398|FG000|Overall Study|Protocol Violation|2|||
129782609|NCT00101452|467171399|FG001|Overall Study|Protocol Violation|1|||
129782610|NCT00101452|467171400|FG002|Overall Study|Protocol Violation|3|||
129782611|NCT00101452|467171398|FG000|Overall Study|Other|15|||
129782612|NCT00101452|467171399|FG001|Overall Study|Other|16|||
129782613|NCT00101452|467171400|FG002|Overall Study|Other|12|||
129782614|NCT01516034|467171403|FG000|Overall Study|Physician Decision|1|||
129782615|NCT01516034|467171403|FG000|Overall Study|Lack of Efficacy|7|||
129782616|NCT05477108|467171408|FG000|Overall Study|Participants randomized, not treated|1|||
129782617|NCT05477108|467171409|FG001|Overall Study|Participants randomized, not treated|1|||
129782618|NCT05477108|467171410|FG002|Overall Study|Participants randomized, not treated|1|||
129782619|NCT05477108|467171408|FG000|Overall Study|Physician Decision|0|||
129782620|NCT05477108|467171409|FG001|Overall Study|Physician Decision|0|||
129782621|NCT05477108|467171410|FG002|Overall Study|Physician Decision|1|||
129782622|NCT05477108|467171408|FG000|Overall Study|withdrawn from study|0|||
129782623|NCT05477108|467171409|FG001|Overall Study|withdrawn from study|0|||
129782624|NCT05477108|467171410|FG002|Overall Study|withdrawn from study|1|||
129782625|NCT02660983|467171411|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
129782626|NCT02660983|467171412|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
129782627|NCT02660983|467171411|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
129782628|NCT02660983|467171412|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
129782629|NCT02660983|467171411|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
129782630|NCT02660983|467171412|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
129782631|NCT02660983|467171411|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
129782632|NCT02660983|467171412|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
129782633|NCT02660983|467171411|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
129782634|NCT02660983|467171412|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
129782635|NCT02660983|467171411|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
129782636|NCT02660983|467171412|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
129782637|NCT02660983|467171411|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
129782638|NCT02660983|467171412|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
129782639|NCT01165216|467171420|FG000|Overall Study|Adverse Event|6|||
129782640|NCT01165216|467171421|FG001|Overall Study|Adverse Event|3|||
129782641|NCT01165216|467171420|FG000|Overall Study|Withdrawal by Subject|1|||
129782642|NCT01165216|467171421|FG001|Overall Study|Withdrawal by Subject|1|||
129782643|NCT01165216|467171420|FG000|Overall Study|Disease progression|1|||
129782644|NCT01165216|467171421|FG001|Overall Study|Disease progression|3|||
129782645|NCT05688670|467171423|FG000|Overall Study|Change in surgery plan|1|||
129782646|NCT05688670|467171424|FG001|Overall Study|Change in surgery plan|4|||
129782647|NCT05688670|467171423|FG000|Overall Study|Inability to extubate|1|||
129782648|NCT05688670|467171424|FG001|Overall Study|Inability to extubate|2|||
129782649|NCT05688670|467171423|FG000|Overall Study|Day of surgery cancellation|0|||
129782650|NCT05688670|467171424|FG001|Overall Study|Day of surgery cancellation|1|||
129782651|NCT05688670|467171423|FG000|Overall Study|Reintubated on PCICU arrival|0|||
129782652|NCT05688670|467171424|FG001|Overall Study|Reintubated on PCICU arrival|1|||
129782653|NCT03425253|467171425|FG000|Overall Study|Adverse Event|2|||
129782654|NCT03425253|467171425|FG000|Overall Study|Lost to Follow-up|3|||
129782655|NCT03425253|467171425|FG000|Overall Study|Withdrew Consent|6|||
129782656|NCT03425253|467171425|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
129782657|NCT01217307|467173262|FG000|Overall Study|Withdrawal by Subject|0|||
129782658|NCT01217307|467173263|FG001|Overall Study|Withdrawal by Subject|1|||
129782659|NCT04129151|467173266|FG000|Overall Study|Adverse Event|1|||
129782660|NCT04129151|467173266|FG000|Overall Study|Disease Progression|7|||
129782661|NCT04129151|467173266|FG000|Overall Study|Study closure|1|||
129782662|NCT02730195|467173267|FG000|Overall Study|Withdrawal by Subject|1|||
129782663|NCT01463007|467173269|FG000|Overall Study|Physician Decision|1|||
129782664|NCT00942994|467173270|FG000|Overall Study|Adverse Event|7|||
129782665|NCT00942994|467173271|FG001|Overall Study|Adverse Event|4|||
129782666|NCT00942994|467173270|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129782667|NCT00942994|467173271|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129782668|NCT00942994|467173270|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129782669|NCT00942994|467173271|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129782670|NCT00942994|467173270|FG000|Overall Study|Patient withdrew consent|5|||
129782671|NCT00942994|467173271|FG001|Overall Study|Patient withdrew consent|8|||
129782672|NCT00942994|467173270|FG000|Overall Study|Lost to Follow-up|1|||
129782673|NCT00942994|467173271|FG001|Overall Study|Lost to Follow-up|4|||
129782674|NCT00942994|467173270|FG000|Overall Study|Protocol deviation|1|||
129782675|NCT00942994|467173271|FG001|Overall Study|Protocol deviation|2|||
129782676|NCT00689117|467173272|FG000|Overall Study|Adverse Event|6|||
129782677|NCT00689117|467173273|FG001|Overall Study|Adverse Event|0|||
129782678|NCT00689117|467173274|FG002|Overall Study|Adverse Event|5|||
129782679|NCT00689117|467173275|FG003|Overall Study|Adverse Event|0|||
129782680|NCT00689117|467173272|FG000|Overall Study|Lost to Follow-up|26|||
129782681|NCT00689117|467173273|FG001|Overall Study|Lost to Follow-up|19|||
129782682|NCT00689117|467173274|FG002|Overall Study|Lost to Follow-up|17|||
129782683|NCT00689117|467173275|FG003|Overall Study|Lost to Follow-up|11|||
129782684|NCT00689117|467173272|FG000|Overall Study|Lack of Efficacy|1|||
129782685|NCT00689117|467173273|FG001|Overall Study|Lack of Efficacy|2|||
129782686|NCT00689117|467173274|FG002|Overall Study|Lack of Efficacy|2|||
129782687|NCT00689117|467173275|FG003|Overall Study|Lack of Efficacy|2|||
129782688|NCT00689117|467173272|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
129782689|NCT00689117|467173273|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
129782690|NCT00689117|467173274|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
129782691|NCT00689117|467173275|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
129782692|NCT00689117|467173272|FG000|Overall Study|Withdrawal by Subject|19|||
129782693|NCT00689117|467173273|FG001|Overall Study|Withdrawal by Subject|18|||
129782694|NCT00689117|467173274|FG002|Overall Study|Withdrawal by Subject|26|||
129782695|NCT00689117|467173275|FG003|Overall Study|Withdrawal by Subject|13|||
129782696|NCT00689117|467173272|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
129782697|NCT00689117|467173273|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
129782698|NCT00689117|467173274|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
129782699|NCT00689117|467173275|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
129782700|NCT00689117|467173272|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129782701|NCT00689117|467173273|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
129782702|NCT00689117|467173274|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129782703|NCT00689117|467173275|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129782704|NCT00689117|467173272|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
129782705|NCT00689117|467173273|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
129782706|NCT00689117|467173274|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
129782707|NCT00689117|467173275|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
129782708|NCT00689117|467173272|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
129782709|NCT00689117|467173273|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
129782710|NCT00689117|467173274|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
129572308|NCT00723528|466393606|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129572309|NCT00723528|466393607|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129572310|NCT00723528|466393608|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
129572311|NCT00723528|466393609|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
129572312|NCT00723528|466393603|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129572313|NCT00723528|466393604|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129572314|NCT00723528|466393605|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129572315|NCT00723528|466393606|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129572316|NCT00723528|466393607|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129572317|NCT00723528|466393608|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
129572318|NCT00723528|466393609|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
129572319|NCT01993030|466393610|FG000|Overall Study|Adverse Event|0|||
129572320|NCT01993030|466393611|FG001|Overall Study|Adverse Event|4|||
129572321|NCT01710657|466393612|FG000|Overall Study|Lost to Follow-up|2|||
129572322|NCT01710657|466393613|FG001|Overall Study|Lost to Follow-up|0|||
129572323|NCT01710657|466393614|FG002|Overall Study|Lost to Follow-up|1|||
129572324|NCT01710657|466393612|FG000|Overall Study|Protocol Violation|2|||
129572325|NCT01710657|466393613|FG001|Overall Study|Protocol Violation|2|||
129572326|NCT01710657|466393614|FG002|Overall Study|Protocol Violation|0|||
129572327|NCT01710657|466393612|FG000|Overall Study|Adverse Event|14|||
129572328|NCT01710657|466393613|FG001|Overall Study|Adverse Event|8|||
129572329|NCT01710657|466393614|FG002|Overall Study|Adverse Event|28|||
129572330|NCT01710657|466393612|FG000|Overall Study|Withdrawal by Subject|0|||
129572331|NCT01710657|466393613|FG001|Overall Study|Withdrawal by Subject|1|||
129572332|NCT01710657|466393614|FG002|Overall Study|Withdrawal by Subject|2|||
129572333|NCT01710657|466393612|FG000|Overall Study|Lack of Efficacy|0|||
129572334|NCT01710657|466393613|FG001|Overall Study|Lack of Efficacy|1|||
129572335|NCT01710657|466393614|FG002|Overall Study|Lack of Efficacy|1|||
129572336|NCT01591785|466393617|FG000|Overall Study|worsening condition|1|||
129572337|NCT01591785|466393618|FG001|Overall Study|worsening condition|2|||
129572338|NCT01591785|466393617|FG000|Overall Study|Protocol Violation|2|||
129572339|NCT01591785|466393618|FG001|Overall Study|Protocol Violation|0|||
129572340|NCT01591785|466393617|FG000|Overall Study|Lost to Follow-up|1|||
129692226|NCT01107457|466830661|FG003|Part B and C|Lost to Follow-up|0|||
129692227|NCT01107457|466830662|FG004|Part B and C|Lost to Follow-up|0|||
129692228|NCT01107457|466830663|FG005|Part B and C|Lost to Follow-up|10|||
129692229|NCT01107457|466830658|FG000|Part B and C|Protocol Violation|0|||
129692230|NCT01107457|466830659|FG001|Part B and C|Protocol Violation|0|||
129692231|NCT01107457|466830660|FG002|Part B and C|Protocol Violation|0|||
129692232|NCT01107457|466830661|FG003|Part B and C|Protocol Violation|0|||
129692233|NCT01107457|466830662|FG004|Part B and C|Protocol Violation|0|||
129692234|NCT01107457|466830663|FG005|Part B and C|Protocol Violation|1|||
129692235|NCT01107457|466830658|FG000|Part B and C|Sponsor Decision|0|||
129692236|NCT01107457|466830659|FG001|Part B and C|Sponsor Decision|0|||
129692237|NCT01107457|466830660|FG002|Part B and C|Sponsor Decision|0|||
129692238|NCT01107457|466830661|FG003|Part B and C|Sponsor Decision|0|||
129692239|NCT01107457|466830662|FG004|Part B and C|Sponsor Decision|0|||
129692240|NCT01107457|466830663|FG005|Part B and C|Sponsor Decision|66|||
129692241|NCT01107457|466830658|FG000|Part B and C|Withdrawal by Subject|0|||
129692242|NCT01107457|466830659|FG001|Part B and C|Withdrawal by Subject|0|||
129692243|NCT01107457|466830660|FG002|Part B and C|Withdrawal by Subject|0|||
129692244|NCT01107457|466830661|FG003|Part B and C|Withdrawal by Subject|0|||
129692245|NCT01107457|466830662|FG004|Part B and C|Withdrawal by Subject|0|||
129692246|NCT01107457|466830663|FG005|Part B and C|Withdrawal by Subject|16|||
129692247|NCT01107457|466830658|FG000|Part B and C|Clinical Relapse|0|||
129692248|NCT01107457|466830659|FG001|Part B and C|Clinical Relapse|0|||
129692249|NCT01107457|466830660|FG002|Part B and C|Clinical Relapse|0|||
129692250|NCT01107457|466830661|FG003|Part B and C|Clinical Relapse|0|||
129692251|NCT01107457|466830662|FG004|Part B and C|Clinical Relapse|0|||
129692252|NCT01107457|466830663|FG005|Part B and C|Clinical Relapse|4|||
129692253|NCT00362609|466830664|FG000|Overall Study|Withdrawal by Subject|0|||
129692254|NCT00362609|466830665|FG001|Overall Study|Withdrawal by Subject|1|||
129692255|NCT00362609|466830664|FG000|Overall Study|Protocol Violation|0|||
129692256|NCT00362609|466830665|FG001|Overall Study|Protocol Violation|1|||
129692257|NCT01800058|466830667|FG000|Overall Study|Lost to Follow-up|1|||
129692258|NCT03787212|466832355|FG000|Period 1|Study Termination|2|||
129692259|NCT03787212|466832356|FG001|Period 1|Study Termination|2|||
129572341|NCT01591785|466393618|FG001|Overall Study|Lost to Follow-up|0|||
129692260|NCT04193176|466832357|FG000|Overall Study|Withdrawal by Subject|6|||
129692261|NCT04193176|466832358|FG001|Overall Study|Withdrawal by Subject|10|||
129692262|NCT02370394|466832359|FG000|Overall Study|Lost to Follow-up|2|||
129692263|NCT02370394|466832360|FG001|Overall Study|Lost to Follow-up|1|||
129692264|NCT02370394|466832359|FG000|Overall Study|Withdrawal by Subject|0|||
129692265|NCT02370394|466832360|FG001|Overall Study|Withdrawal by Subject|1|||
129692266|NCT00520572|466832362|FG000|Overall Study|Adverse Event|9|||
129572342|NCT00909610|466393622|FG000|Period: First Intervention|Adverse Event|0|||
129572343|NCT00909610|466393623|FG001|Period: First Intervention|Adverse Event|1|||
129572344|NCT00909610|466393622|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
129572345|NCT00909610|466393623|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
129572346|NCT00909610|466393622|FG000|Period: Second Intervention|Adverse Event|1|||
129692267|NCT00520572|466832363|FG001|Overall Study|Adverse Event|3|||
129692268|NCT00520572|466832364|FG002|Overall Study|Adverse Event|6|||
129692269|NCT00520572|466832365|FG003|Overall Study|Adverse Event|9|||
129692270|NCT00520572|466832366|FG004|Overall Study|Adverse Event|7|||
129692271|NCT00520572|466832367|FG005|Overall Study|Adverse Event|2|||
129692272|NCT00520572|466832362|FG000|Overall Study|Withdrawal by Subject|0|||
129692273|NCT00520572|466832363|FG001|Overall Study|Withdrawal by Subject|9|||
129692274|NCT00520572|466832364|FG002|Overall Study|Withdrawal by Subject|5|||
129692275|NCT00520572|466832365|FG003|Overall Study|Withdrawal by Subject|2|||
129692276|NCT00520572|466832366|FG004|Overall Study|Withdrawal by Subject|2|||
129692277|NCT00520572|466832367|FG005|Overall Study|Withdrawal by Subject|0|||
129692278|NCT00520572|466832362|FG000|Overall Study|Protocol Violation|0|||
129692279|NCT00520572|466832363|FG001|Overall Study|Protocol Violation|0|||
129692280|NCT00520572|466832364|FG002|Overall Study|Protocol Violation|1|||
129692281|NCT00520572|466832365|FG003|Overall Study|Protocol Violation|0|||
129692282|NCT00520572|466832366|FG004|Overall Study|Protocol Violation|0|||
129692283|NCT00520572|466832367|FG005|Overall Study|Protocol Violation|0|||
129692284|NCT00520572|466832362|FG000|Overall Study|Lack of Efficacy|1|||
129692285|NCT00520572|466832363|FG001|Overall Study|Lack of Efficacy|1|||
129692286|NCT00520572|466832364|FG002|Overall Study|Lack of Efficacy|1|||
129692287|NCT00520572|466832365|FG003|Overall Study|Lack of Efficacy|2|||
129692288|NCT00520572|466832366|FG004|Overall Study|Lack of Efficacy|1|||
129692289|NCT00520572|466832367|FG005|Overall Study|Lack of Efficacy|0|||
129692290|NCT00520572|466832362|FG000|Overall Study|Lost to Follow-up|0|||
129692291|NCT00520572|466832363|FG001|Overall Study|Lost to Follow-up|0|||
129692292|NCT00520572|466832364|FG002|Overall Study|Lost to Follow-up|0|||
129692293|NCT00520572|466832365|FG003|Overall Study|Lost to Follow-up|0|||
129692294|NCT00520572|466832366|FG004|Overall Study|Lost to Follow-up|1|||
129692295|NCT00520572|466832367|FG005|Overall Study|Lost to Follow-up|0|||
129692296|NCT00520572|466832362|FG000|Overall Study|Incorrect enrollment|1|||
129692297|NCT00520572|466832363|FG001|Overall Study|Incorrect enrollment|0|||
129692298|NCT00520572|466832364|FG002|Overall Study|Incorrect enrollment|1|||
129692299|NCT00520572|466832365|FG003|Overall Study|Incorrect enrollment|0|||
129692300|NCT00520572|466832366|FG004|Overall Study|Incorrect enrollment|1|||
129692301|NCT00520572|466832367|FG005|Overall Study|Incorrect enrollment|0|||
129692302|NCT00520572|466832362|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
129692303|NCT00520572|466832363|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
129692304|NCT00520572|466832364|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
129692305|NCT00520572|466832365|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
129692306|NCT00520572|466832366|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
129692307|NCT00520572|466832367|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
129692308|NCT00520572|466832362|FG000|Overall Study|Long break in taking Medication|0|||
129692309|NCT00520572|466832363|FG001|Overall Study|Long break in taking Medication|0|||
129692310|NCT00520572|466832364|FG002|Overall Study|Long break in taking Medication|0|||
129692311|NCT00520572|466832365|FG003|Overall Study|Long break in taking Medication|1|||
129692312|NCT00520572|466832366|FG004|Overall Study|Long break in taking Medication|0|||
129692313|NCT00520572|466832367|FG005|Overall Study|Long break in taking Medication|0|||
129692314|NCT00520572|466832362|FG000|Overall Study|Did not receive Treatment|1|||
129692315|NCT00520572|466832363|FG001|Overall Study|Did not receive Treatment|0|||
129692316|NCT00520572|466832364|FG002|Overall Study|Did not receive Treatment|1|||
129692317|NCT00520572|466832365|FG003|Overall Study|Did not receive Treatment|0|||
129692318|NCT00520572|466832366|FG004|Overall Study|Did not receive Treatment|0|||
129692319|NCT00520572|466832367|FG005|Overall Study|Did not receive Treatment|0|||
129692320|NCT02181621|466832368|FG000|Overall Study|Adverse Event|1|||
129692321|NCT02181621|466832369|FG001|Overall Study|Adverse Event|0|||
129692322|NCT02181621|466832368|FG000|Overall Study|Previously Enrolled|0|||
129692323|NCT02181621|466832369|FG001|Overall Study|Previously Enrolled|1|||
129692324|NCT02181621|466832368|FG000|Overall Study|Enrollment Hold|1|||
129692325|NCT02181621|466832369|FG001|Overall Study|Enrollment Hold|1|||
129692326|NCT00960856|466832370|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129692327|NCT00960856|466832371|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
129692328|NCT00960856|466832372|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
129692329|NCT00960856|466832373|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
129692330|NCT00960856|466832370|FG000|Washout Period of 7 Days|Adverse Event|0|||
129692331|NCT00960856|466832371|FG001|Washout Period of 7 Days|Adverse Event|0|||
129692332|NCT00960856|466832372|FG002|Washout Period of 7 Days|Adverse Event|1|||
129692333|NCT00960856|466832373|FG003|Washout Period of 7 Days|Adverse Event|0|||
129692334|NCT03387046|466832375|FG000|Overall Study|Adverse Event|1|||
129692335|NCT03387046|466832376|FG001|Overall Study|Adverse Event|1|||
129692336|NCT03794544|466832378|FG000|Overall Study|Withdrawal by Subject|1|||
129692337|NCT03794544|466832379|FG001|Overall Study|Withdrawal by Subject|1|||
129572347|NCT00909610|466393623|FG001|Period: Second Intervention|Adverse Event|0|||
129572348|NCT05612724|466393629|FG000|Overall Study|Lost to Follow-up|4|||
129692338|NCT03794544|466832380|FG002|Overall Study|Withdrawal by Subject|0|||
129692339|NCT03794544|466832381|FG003|Overall Study|Withdrawal by Subject|0|||
129692340|NCT03794544|466832378|FG000|Overall Study|Death|0|||
129692341|NCT03794544|466832379|FG001|Overall Study|Death|0|||
129692342|NCT03794544|466832380|FG002|Overall Study|Death|0|||
129692343|NCT03794544|466832381|FG003|Overall Study|Death|1|||
129692344|NCT03794544|466832378|FG000|Overall Study|Lost to Follow-up|0|||
129692345|NCT03794544|466832379|FG001|Overall Study|Lost to Follow-up|1|||
129692346|NCT03794544|466832380|FG002|Overall Study|Lost to Follow-up|1|||
129692347|NCT03794544|466832381|FG003|Overall Study|Lost to Follow-up|0|||
129692348|NCT03794544|466832378|FG000|Overall Study|Other|0|||
129692349|NCT03794544|466832379|FG001|Overall Study|Other|1|||
129692350|NCT03794544|466832380|FG002|Overall Study|Other|0|||
129692351|NCT03794544|466832381|FG003|Overall Study|Other|0|||
129692352|NCT00337194|466832384|FG000|Overall Study|Adverse Event|5|||
129692353|NCT00337194|466832385|FG001|Overall Study|Adverse Event|1|||
129692354|NCT00337194|466832384|FG000|Overall Study|Death|2|||
129692355|NCT00337194|466832385|FG001|Overall Study|Death|0|||
129692356|NCT00337194|466832384|FG000|Overall Study|Withdrawal by Subject|1|||
129692357|NCT00337194|466832385|FG001|Overall Study|Withdrawal by Subject|0|||
129692358|NCT00337194|466832384|FG000|Overall Study|Disease progression|1|||
129692359|NCT00337194|466832385|FG001|Overall Study|Disease progression|2|||
129692360|NCT00337194|466832384|FG000|Overall Study|Subsequent non-protocol therapy|3|||
129692361|NCT00337194|466832385|FG001|Overall Study|Subsequent non-protocol therapy|1|||
129692362|NCT03188705|466832386|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
129692363|NCT03188705|466832386|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
129692364|NCT01174459|466832387|FG000|Overall Study|case report form (CRF) not collected|5|||
129692365|NCT01717859|466832389|FG000|Overall Study|Adverse Event|5|||
129692366|NCT01717859|466832389|FG000|Overall Study|Moved out of state|1|||
129692367|NCT01717859|466832389|FG000|Overall Study|Patient concerned about mental health|1|||
129692368|NCT01717859|466832389|FG000|Overall Study|Lost to Follow-up|1|||
129692369|NCT01717859|466832389|FG000|Overall Study|Withdrawal by Subject|2|||
129692370|NCT01623752|466832390|FG000|Phase 1 (78 Weeks)|No Data|249|||
129692371|NCT01623752|466832391|FG001|Phase 1 (78 Weeks)|No Data|66|||
129692372|NCT01623752|466832392|FG002|Phase 1 (78 Weeks)|No Data|2|||
129692373|NCT01623752|466832390|FG000|Phase 1 (78 Weeks)|Other|33|||
129692374|NCT01623752|466832391|FG001|Phase 1 (78 Weeks)|Other|20|||
129692375|NCT01623752|466832392|FG002|Phase 1 (78 Weeks)|Other|0|||
129692376|NCT01623752|466832390|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
129692377|NCT01623752|466832391|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
129692378|NCT01623752|466832392|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
129692379|NCT01623752|466832390|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
129692380|NCT01623752|466832391|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
129692381|NCT01623752|466832392|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
129692382|NCT01623752|466832390|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
129692383|NCT01623752|466832391|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
129692384|NCT01623752|466832392|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
129692385|NCT01623752|466832390|FG000|Phase 2 (78 Weeks)|Other|5|||
129692386|NCT01623752|466832391|FG001|Phase 2 (78 Weeks)|Other|1|||
129692387|NCT01623752|466832392|FG002|Phase 2 (78 Weeks)|Other|0|||
129692388|NCT01623752|466832390|FG000|Phase 2 (78 Weeks)|No Data|43|||
129692389|NCT01623752|466832391|FG001|Phase 2 (78 Weeks)|No Data|11|||
129692390|NCT01623752|466832392|FG002|Phase 2 (78 Weeks)|No Data|0|||
129692391|NCT01623752|466832390|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
129692392|NCT01623752|466832391|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
129692393|NCT01623752|466832392|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
129572349|NCT02128997|466393631|FG000|Overall Study|Lost to Follow-up|6|||
129692394|NCT03994120|466832393|FG000|Overall Study|Lost to Follow-up|3|||
129692395|NCT03994120|466832394|FG001|Overall Study|Lost to Follow-up|1|||
129692396|NCT01111292|466832395|FG000|Treatment|Physician Decision|1|||
129692397|NCT01111292|466832396|FG001|Treatment|Physician Decision|1|||
129692398|NCT05529173|466832399|FG000|Overall Study|Physician Decision|3|||
129692399|NCT05529173|466832400|FG001|Overall Study|Physician Decision|6|||
129692400|NCT05529173|466832399|FG000|Overall Study|Sample shipment delay more than one day|4|||
129692401|NCT05529173|466832400|FG001|Overall Study|Sample shipment delay more than one day|0|||
129692402|NCT00609973|466832406|FG000|Overall Study|Adverse Event|2|||
129692403|NCT00609973|466832407|FG001|Overall Study|Adverse Event|1|||
129692404|NCT00609973|466832406|FG000|Overall Study|Protocol Violation|4|||
129692405|NCT00609973|466832407|FG001|Overall Study|Protocol Violation|3|||
129692406|NCT00609973|466832406|FG000|Overall Study|Lost to Follow-up|2|||
129782711|NCT00689117|467173275|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
129782712|NCT00689117|467173272|FG000|Overall Study|Use of Prohibitive Medication|2|||
129782713|NCT00689117|467173273|FG001|Overall Study|Use of Prohibitive Medication|1|||
129782714|NCT00689117|467173274|FG002|Overall Study|Use of Prohibitive Medication|3|||
129782715|NCT00689117|467173275|FG003|Overall Study|Use of Prohibitive Medication|0|||
129782716|NCT00689117|467173272|FG000|Overall Study|Pregnancy|0|||
129782717|NCT00689117|467173273|FG001|Overall Study|Pregnancy|2|||
129782718|NCT00689117|467173274|FG002|Overall Study|Pregnancy|0|||
129782719|NCT00689117|467173275|FG003|Overall Study|Pregnancy|2|||
129782720|NCT00689117|467173272|FG000|Overall Study|Incarceration|2|||
129782721|NCT00689117|467173273|FG001|Overall Study|Incarceration|0|||
129782722|NCT00689117|467173274|FG002|Overall Study|Incarceration|0|||
129782723|NCT00689117|467173275|FG003|Overall Study|Incarceration|0|||
129782724|NCT00689117|467173272|FG000|Overall Study|Fear of Birth Defects|0|||
129782725|NCT00689117|467173273|FG001|Overall Study|Fear of Birth Defects|0|||
129782726|NCT00689117|467173274|FG002|Overall Study|Fear of Birth Defects|1|||
129782727|NCT00689117|467173275|FG003|Overall Study|Fear of Birth Defects|0|||
129782728|NCT00689117|467173272|FG000|Overall Study|Transportation|1|||
129782729|NCT00689117|467173273|FG001|Overall Study|Transportation|0|||
129782730|NCT00689117|467173274|FG002|Overall Study|Transportation|0|||
129782731|NCT00689117|467173275|FG003|Overall Study|Transportation|0|||
129782732|NCT00689117|467173272|FG000|Overall Study|Patient Withdrew from Study|0|||
129782733|NCT00689117|467173273|FG001|Overall Study|Patient Withdrew from Study|0|||
129782734|NCT00689117|467173274|FG002|Overall Study|Patient Withdrew from Study|0|||
129782735|NCT00689117|467173275|FG003|Overall Study|Patient Withdrew from Study|1|||
129782736|NCT00689117|467173272|FG000|Overall Study|Personal Reason|0|||
129782737|NCT00689117|467173273|FG001|Overall Study|Personal Reason|1|||
129782738|NCT00689117|467173274|FG002|Overall Study|Personal Reason|0|||
129782739|NCT00689117|467173275|FG003|Overall Study|Personal Reason|0|||
129782740|NCT00689117|467173272|FG000|Overall Study|Dispensing Error|0|||
129782741|NCT00689117|467173273|FG001|Overall Study|Dispensing Error|1|||
129782742|NCT00689117|467173274|FG002|Overall Study|Dispensing Error|0|||
129782743|NCT00689117|467173275|FG003|Overall Study|Dispensing Error|0|||
129782744|NCT01206322|467173276|FG000|Overall Study|Adverse Event|0|||
129782745|NCT01206322|467173277|FG001|Overall Study|Adverse Event|0|||
129782746|NCT01206322|467173278|FG002|Overall Study|Adverse Event|0|||
129782747|NCT01206322|467173279|FG003|Overall Study|Adverse Event|1|||
129782748|NCT00859638|467173282|FG000|Overall Study|Lost to Follow-up|6|||
129782749|NCT00859638|467173283|FG001|Overall Study|Lost to Follow-up|1|||
129782750|NCT00859638|467173282|FG000|Overall Study|Withdrawal by Subject|3|||
129782751|NCT00859638|467173283|FG001|Overall Study|Withdrawal by Subject|2|||
129782752|NCT00859638|467173282|FG000|Overall Study|Ill health|1|||
129782753|NCT00859638|467173283|FG001|Overall Study|Ill health|1|||
129782754|NCT02969408|467173284|FG000|Overall Study|Adverse Event|2|||
129782755|NCT02969408|467173284|FG000|Overall Study|Withdrawal by Subject|8|||
129782756|NCT02969408|467173284|FG000|Overall Study|Lost to Follow-up|4|||
129782757|NCT02969408|467173284|FG000|Overall Study|Protocol Violation|1|||
129782758|NCT02969408|467173284|FG000|Overall Study|Other than specified|1|||
129782759|NCT02779556|467173285|FG000|Baseline|Partial baseline interview completed|1|||
129782760|NCT02779556|467173286|FG001|Baseline|Partial baseline interview completed|0|||
129782761|NCT02779556|467173285|FG000|3 Months|Lost to Follow-up|40|||
129782762|NCT02779556|467173286|FG001|3 Months|Lost to Follow-up|29|||
129782763|NCT02779556|467173285|FG000|3 Months|Missed 3 month clinic visit|27|||
129782764|NCT02779556|467173286|FG001|3 Months|Missed 3 month clinic visit|19|||
129782765|NCT02779556|467173285|FG000|6 Month|Lost to Follow-up|33|||
129782766|NCT02779556|467173286|FG001|6 Month|Lost to Follow-up|39|||
129782767|NCT02779556|467173285|FG000|6 Month HbA1c|No value collected during window|69|||
129782768|NCT02779556|467173286|FG001|6 Month HbA1c|No value collected during window|50|||
129782769|NCT02779556|467173285|FG000|12 Month HbA1c|No value collected during window|138|||
129782770|NCT02779556|467173286|FG001|12 Month HbA1c|No value collected during window|102|||
129782771|NCT03110770|467173290|FG000|Overall Study|Death|1|||
129782772|NCT03110770|467173291|FG001|Overall Study|Death|0|||
129782773|NCT03110770|467173292|FG002|Overall Study|Death|0|||
129782774|NCT03110770|467173293|FG003|Overall Study|Death|1|||
129782775|NCT03110770|467173294|FG004|Overall Study|Death|0|||
129782776|NCT03110770|467173290|FG000|Overall Study|Enrolled but did not receive product|0|||
129782777|NCT03110770|467173291|FG001|Overall Study|Enrolled but did not receive product|0|||
129782778|NCT03110770|467173292|FG002|Overall Study|Enrolled but did not receive product|0|||
129782779|NCT03110770|467173293|FG003|Overall Study|Enrolled but did not receive product|8|||
129782780|NCT03110770|467173294|FG004|Overall Study|Enrolled but did not receive product|7|||
129782781|NCT03110770|467173290|FG000|Overall Study|Lost to Follow-up|0|||
129782782|NCT03110770|467173291|FG001|Overall Study|Lost to Follow-up|0|||
129782783|NCT03110770|467173292|FG002|Overall Study|Lost to Follow-up|0|||
129782784|NCT03110770|467173293|FG003|Overall Study|Lost to Follow-up|53|||
129782785|NCT03110770|467173294|FG004|Overall Study|Lost to Follow-up|45|||
129782786|NCT03110770|467173290|FG000|Overall Study|Investigator Decision|0|||
129782787|NCT03110770|467173291|FG001|Overall Study|Investigator Decision|0|||
129782788|NCT03110770|467173292|FG002|Overall Study|Investigator Decision|0|||
129782789|NCT03110770|467173293|FG003|Overall Study|Investigator Decision|5|||
129782790|NCT03110770|467173294|FG004|Overall Study|Investigator Decision|3|||
129782791|NCT03110770|467173290|FG000|Overall Study|Withdrawal by Subject|0|||
129782792|NCT03110770|467173291|FG001|Overall Study|Withdrawal by Subject|0|||
129782793|NCT03110770|467173292|FG002|Overall Study|Withdrawal by Subject|0|||
129782794|NCT03110770|467173293|FG003|Overall Study|Withdrawal by Subject|24|||
129782795|NCT03110770|467173294|FG004|Overall Study|Withdrawal by Subject|24|||
129782796|NCT03110770|467173290|FG000|Overall Study|Moved from area|5|||
129782797|NCT03110770|467173291|FG001|Overall Study|Moved from area|0|||
129782798|NCT03110770|467173292|FG002|Overall Study|Moved from area|2|||
129782799|NCT03110770|467173293|FG003|Overall Study|Moved from area|42|||
129782800|NCT03110770|467173294|FG004|Overall Study|Moved from area|43|||
129782801|NCT03110770|467173290|FG000|Overall Study|Illness/Injury unrelated to product|0|||
129782802|NCT03110770|467173291|FG001|Overall Study|Illness/Injury unrelated to product|0|||
129782803|NCT03110770|467173292|FG002|Overall Study|Illness/Injury unrelated to product|0|||
129782804|NCT03110770|467173293|FG003|Overall Study|Illness/Injury unrelated to product|0|||
129782805|NCT03110770|467173294|FG004|Overall Study|Illness/Injury unrelated to product|1|||
129782806|NCT01086358|467173297|FG000|First Intervention|Lost to Follow-up|9|||
129782807|NCT01086358|467173298|FG001|First Intervention|Lost to Follow-up|4|||
129782808|NCT01086358|467173297|FG000|First Intervention|Withdrawal by Subject|0|||
129782809|NCT01086358|467173298|FG001|First Intervention|Withdrawal by Subject|1|||
129782810|NCT01086358|467173297|FG000|Second Intervention|Lost to Follow-up|4|||
129782811|NCT01086358|467173298|FG001|Second Intervention|Lost to Follow-up|4|||
129782812|NCT01767142|467173299|FG000|Overall Study|Lost to Follow-up|3|||
129782813|NCT03206788|467173302|FG000|Overall Study|Withdrawal by Subject|0|||
129782814|NCT03206788|467173303|FG001|Overall Study|Withdrawal by Subject|1|||
129782815|NCT03206788|467173302|FG000|Overall Study|Adverse Event|0|||
129782816|NCT03206788|467173303|FG001|Overall Study|Adverse Event|1|||
129782817|NCT03206788|467173302|FG000|Overall Study|Physician Decision|0|||
129782818|NCT03206788|467173303|FG001|Overall Study|Physician Decision|1|||
129782819|NCT02471612|467173304|FG000|Overall Study|Lost to Follow-up|2|||
129782820|NCT02082340|467173305|FG000|Overall Study|Lost to Follow-up|1|||
129782821|NCT02082340|467173306|FG001|Overall Study|Lost to Follow-up|1|||
129782822|NCT03595228|467173311|FG000|Overall Study|Death|2|||
129782823|NCT03595228|467173311|FG000|Overall Study|Lack of Efficacy|13|||
129782824|NCT03595228|467173311|FG000|Overall Study|Withdrawal by Subject|3|||
129782825|NCT03595228|467173311|FG000|Overall Study|Withdrawal by Sponsor|1|||
129782826|NCT00435045|467173313|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
129782827|NCT00435045|467173314|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
129782828|NCT00435045|467173313|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
129782829|NCT00435045|467173314|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
129782830|NCT00435045|467173313|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
129782831|NCT00435045|467173314|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
129782832|NCT00435045|467173313|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
129782833|NCT00435045|467173314|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
129782834|NCT00435045|467173313|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
129782835|NCT00435045|467173314|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
129782836|NCT00435045|467173313|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
129782837|NCT00435045|467173314|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
129782838|NCT00435045|467173313|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
129782839|NCT00435045|467173314|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
129782840|NCT00435045|467173313|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
129782841|NCT00435045|467173314|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
129572350|NCT02128997|466393632|FG001|Overall Study|Lost to Follow-up|11|||
129572351|NCT04000815|466393635|FG000|Overall Study|Lost to Follow-up|9|||
129572352|NCT04000815|466393636|FG001|Overall Study|Lost to Follow-up|2|||
129572353|NCT04000815|466393637|FG002|Overall Study|Lost to Follow-up|3|||
129572354|NCT04000815|466393635|FG000|Overall Study|Withdrawal by Subject|4|||
129572355|NCT04000815|466393636|FG001|Overall Study|Withdrawal by Subject|3|||
129572356|NCT04000815|466393637|FG002|Overall Study|Withdrawal by Subject|2|||
129572357|NCT04000815|466393635|FG000|Overall Study|Right ovarian cyst occured|1|||
129782842|NCT00435045|467173313|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
129782843|NCT00435045|467173314|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
129782844|NCT00435045|467173313|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
129572358|NCT04000815|466393636|FG001|Overall Study|Right ovarian cyst occured|0|||
129572359|NCT04000815|466393637|FG002|Overall Study|Right ovarian cyst occured|0|||
129572360|NCT04000815|466393635|FG000|Overall Study|Hypertension occured on follow up|0|||
129572361|NCT04000815|466393636|FG001|Overall Study|Hypertension occured on follow up|0|||
129782845|NCT00435045|467173314|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
129782846|NCT00435045|467173313|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
129782847|NCT00435045|467173314|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
129782848|NCT03083990|467173317|FG000|Overall Study|Adverse Event|1|||
129572362|NCT04000815|466393637|FG002|Overall Study|Hypertension occured on follow up|2|||
129572363|NCT00239577|466393638|FG000|Primary Phase|Adverse Event|0|||
129572364|NCT00239577|466393639|FG001|Primary Phase|Adverse Event|0|||
129572365|NCT00239577|466393640|FG002|Primary Phase|Adverse Event|1|||
129572366|NCT00239577|466393641|FG003|Primary Phase|Adverse Event|0|||
129572367|NCT00239577|466393638|FG000|Primary Phase|Other|5|||
129572368|NCT00239577|466393639|FG001|Primary Phase|Other|3|||
129572369|NCT00239577|466393640|FG002|Primary Phase|Other|2|||
129572370|NCT00239577|466393641|FG003|Primary Phase|Other|0|||
129572371|NCT03988803|466393644|FG000|Period 2|Prematurely discontinued from medication|2|||
129572372|NCT03988803|466393644|FG000|Period 2|Adverse Event|1|||
129572373|NCT02736721|466393645|FG000|Overall Study|Adverse Event|8|||
129572374|NCT02736721|466393645|FG000|Overall Study|Lost to Follow-up|3|||
129572375|NCT02736721|466393645|FG000|Overall Study|Other|5|||
129572376|NCT03021018|466393647|FG000|Overall Study|Adverse Event|1|||
129572377|NCT03021018|466393648|FG001|Overall Study|Adverse Event|0|||
129572378|NCT03021018|466393649|FG002|Overall Study|Adverse Event|0|||
129572379|NCT03021018|466393647|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
129572380|NCT03021018|466393648|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
129572381|NCT03021018|466393649|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
129572382|NCT04123548|466393660|FG000|Overall Study|Withdrawal by Subject|1|||
129572383|NCT04123548|466393660|FG000|Overall Study|Lost to Follow-up|8|||
129572384|NCT04123548|466393660|FG000|Overall Study|Death|4|||
129572385|NCT04123548|466393660|FG000|Overall Study|Reason Not Specified|1|||
129572386|NCT00418184|466393663|FG000|Double-blind Phase|Withdrawal by Subject|22|||
129572387|NCT00418184|466393664|FG001|Double-blind Phase|Withdrawal by Subject|9|||
129572388|NCT00418184|466393663|FG000|Double-blind Phase|Adverse Event|2|||
129572389|NCT00418184|466393664|FG001|Double-blind Phase|Adverse Event|1|||
129572390|NCT00418184|466393663|FG000|Double-blind Phase|Poor compliance|3|||
129572391|NCT00418184|466393664|FG001|Double-blind Phase|Poor compliance|1|||
129572392|NCT02472366|466393665|FG000|Overall Study|Lost to Follow-up|1|||
129572393|NCT02472366|466393666|FG001|Overall Study|Lost to Follow-up|0|||
129572394|NCT02728102|466393667|FG000|Overall Study|Death|3|||
129572395|NCT02728102|466393668|FG001|Overall Study|Death|0|||
129572396|NCT02728102|466393669|FG002|Overall Study|Death|1|||
129572397|NCT02728102|466393667|FG000|Overall Study|Withdrawal by Subject|0|||
129572398|NCT02728102|466393668|FG001|Overall Study|Withdrawal by Subject|2|||
129572399|NCT02728102|466393669|FG002|Overall Study|Withdrawal by Subject|3|||
129572400|NCT02728102|466393667|FG000|Overall Study|Physician Decision|1|||
129572401|NCT02728102|466393668|FG001|Overall Study|Physician Decision|1|||
129572402|NCT02728102|466393669|FG002|Overall Study|Physician Decision|0|||
129572403|NCT02728102|466393667|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
129572404|NCT02728102|466393668|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
129572405|NCT02728102|466393669|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
129572406|NCT02728102|466393667|FG000|Overall Study|Covid|0|||
129572407|NCT02728102|466393668|FG001|Overall Study|Covid|0|||
129572408|NCT02728102|466393669|FG002|Overall Study|Covid|1|||
129572409|NCT01182415|466393670|FG000|Overall Study|Lost to Follow-up|1|||
129572410|NCT02587962|466393672|FG000|Overall Study|Adverse Event|0|||
129572411|NCT02587962|466393673|FG001|Overall Study|Adverse Event|0|||
129572412|NCT02587962|466393674|FG002|Overall Study|Adverse Event|1|||
129572413|NCT02587962|466393675|FG003|Overall Study|Adverse Event|0|||
129572414|NCT02587962|466393676|FG004|Overall Study|Adverse Event|0|||
129572415|NCT02587962|466393672|FG000|Overall Study|Withdrawal by Subject|0|||
129572416|NCT02587962|466393673|FG001|Overall Study|Withdrawal by Subject|0|||
129572417|NCT02587962|466393674|FG002|Overall Study|Withdrawal by Subject|1|||
129572418|NCT02587962|466393675|FG003|Overall Study|Withdrawal by Subject|1|||
129572419|NCT02587962|466393676|FG004|Overall Study|Withdrawal by Subject|4|||
129572420|NCT02587962|466393672|FG000|Overall Study|Radiological progression|2|||
129572421|NCT02587962|466393673|FG001|Overall Study|Radiological progression|2|||
129572422|NCT02587962|466393674|FG002|Overall Study|Radiological progression|2|||
129572423|NCT02587962|466393675|FG003|Overall Study|Radiological progression|5|||
129572424|NCT02587962|466393676|FG004|Overall Study|Radiological progression|10|||
129572425|NCT02587962|466393672|FG000|Overall Study|Clinical progression|0|||
129572426|NCT02587962|466393673|FG001|Overall Study|Clinical progression|1|||
129572427|NCT02587962|466393674|FG002|Overall Study|Clinical progression|2|||
129572428|NCT02587962|466393675|FG003|Overall Study|Clinical progression|0|||
129572429|NCT02587962|466393676|FG004|Overall Study|Clinical progression|1|||
129572430|NCT01422538|466393680|FG000|Overall Study|Lost to Follow-up|0|||
129572431|NCT01422538|466393681|FG001|Overall Study|Lost to Follow-up|1|||
129572432|NCT01422538|466393682|FG002|Overall Study|Lost to Follow-up|1|||
129572433|NCT01422538|466393680|FG000|Overall Study|Missed visit|0|||
129572434|NCT01422538|466393681|FG001|Overall Study|Missed visit|1|||
129572435|NCT01422538|466393682|FG002|Overall Study|Missed visit|1|||
129572436|NCT02770820|466393683|FG000|Overall Study|Death|1|||
129572437|NCT02770820|466393683|FG000|Overall Study|Physician Decision|2|||
129572438|NCT02098876|466393686|FG000|Overall Study|Withdrawal by Subject|5|||
129572439|NCT02098876|466393687|FG001|Overall Study|Withdrawal by Subject|5|||
129572440|NCT01061866|466393688|FG000|Overall Study|Adverse Event|2|||
129572441|NCT00834756|466393689|FG000|First Intervention|Adverse Event|1|||
129572442|NCT00834756|466393690|FG001|First Intervention|Adverse Event|0|||
129572443|NCT00834756|466393689|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
129572444|NCT00834756|466393690|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
129572445|NCT02979353|466393696|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
129572446|NCT02979353|466393697|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
129572447|NCT02979353|466393696|FG000|Overall Study|Withdrawal by Subject|16|||
129572448|NCT02979353|466393697|FG001|Overall Study|Withdrawal by Subject|12|||
129572449|NCT02979353|466393696|FG000|Overall Study|Death|10|||
129572450|NCT02979353|466393697|FG001|Overall Study|Death|11|||
129572451|NCT02979353|466393696|FG000|Overall Study|Transfer to Hospice Care|19|||
129572452|NCT02979353|466393697|FG001|Overall Study|Transfer to Hospice Care|14|||
129572453|NCT02979353|466393696|FG000|Overall Study|Lost to Follow-up|1|||
129572454|NCT02979353|466393697|FG001|Overall Study|Lost to Follow-up|5|||
129572455|NCT01079988|466393698|FG000|Overall Study|Lost to Follow-up|0|||
129572456|NCT01079988|466393699|FG001|Overall Study|Lost to Follow-up|0|||
129572457|NCT01079988|466393700|FG002|Overall Study|Lost to Follow-up|0|||
129572458|NCT01079988|466393701|FG003|Overall Study|Lost to Follow-up|1|||
129572459|NCT01079988|466393702|FG004|Overall Study|Lost to Follow-up|0|||
129572460|NCT01079988|466393698|FG000|Overall Study|Lack of Efficacy|1|||
129572461|NCT01079988|466393699|FG001|Overall Study|Lack of Efficacy|0|||
129572462|NCT01079988|466393700|FG002|Overall Study|Lack of Efficacy|0|||
129572463|NCT01079988|466393701|FG003|Overall Study|Lack of Efficacy|0|||
129572464|NCT01079988|466393702|FG004|Overall Study|Lack of Efficacy|0|||
129572465|NCT01079988|466393698|FG000|Overall Study|Other|0|||
129572466|NCT01079988|466393699|FG001|Overall Study|Other|0|||
129572467|NCT01079988|466393700|FG002|Overall Study|Other|0|||
129572468|NCT01079988|466393701|FG003|Overall Study|Other|2|||
129572469|NCT01079988|466393702|FG004|Overall Study|Other|1|||
129572470|NCT00268905|466393703|FG000|Overall Study|Adverse Event|3|||
129572471|NCT00268905|466393704|FG001|Overall Study|Adverse Event|0|||
129572472|NCT00268905|466393705|FG002|Overall Study|Adverse Event|4|||
129572473|NCT00268905|466393703|FG000|Overall Study|Lost to Follow-up|0|||
129572474|NCT00268905|466393704|FG001|Overall Study|Lost to Follow-up|1|||
129572475|NCT00268905|466393705|FG002|Overall Study|Lost to Follow-up|0|||
129572476|NCT00268905|466393703|FG000|Overall Study|Withdrawal by Subject|0|||
129572477|NCT00268905|466393704|FG001|Overall Study|Withdrawal by Subject|0|||
129572478|NCT00268905|466393705|FG002|Overall Study|Withdrawal by Subject|3|||
129572479|NCT00268905|466393703|FG000|Overall Study|Progressive Disease|28|||
129572480|NCT00268905|466393704|FG001|Overall Study|Progressive Disease|4|||
129572481|NCT00268905|466393705|FG002|Overall Study|Progressive Disease|3|||
129572482|NCT00268905|466393703|FG000|Overall Study|Physician Decision|3|||
129572483|NCT00268905|466393704|FG001|Overall Study|Physician Decision|0|||
129572484|NCT00268905|466393705|FG002|Overall Study|Physician Decision|1|||
129572485|NCT00268905|466393703|FG000|Overall Study|Clinical Progression|9|||
129572486|NCT00268905|466393704|FG001|Overall Study|Clinical Progression|4|||
129572487|NCT00268905|466393705|FG002|Overall Study|Clinical Progression|1|||
129572488|NCT01406795|466393706|FG000|Overall Study|Withdrawal by Subject|1|||
129572489|NCT03897088|466393711|FG000|Overall Study|Withdrawal by Subject|12|||
129572490|NCT03897088|466393712|FG001|Overall Study|Withdrawal by Subject|12|||
129572491|NCT03897088|466393711|FG000|Overall Study|Lost to Follow-up|7|||
129572492|NCT03897088|466393712|FG001|Overall Study|Lost to Follow-up|15|||
129572493|NCT03897088|466393711|FG000|Overall Study|Sponsor Decision|1|||
129572494|NCT03897088|466393712|FG001|Overall Study|Sponsor Decision|2|||
129572495|NCT03897088|466393711|FG000|Overall Study|COVID-19|2|||
129572496|NCT03897088|466393712|FG001|Overall Study|COVID-19|0|||
129572497|NCT03897088|466393711|FG000|Overall Study|Other|3|||
129572498|NCT03897088|466393712|FG001|Overall Study|Other|0|||
129572499|NCT03897088|466393711|FG000|Overall Study|Non-compliance with Study Drug|1|||
129572500|NCT03897088|466393712|FG001|Overall Study|Non-compliance with Study Drug|1|||
129572501|NCT03897088|466393711|FG000|Overall Study|Pregnancy|0|||
129572502|NCT03897088|466393712|FG001|Overall Study|Pregnancy|1|||
129572503|NCT00855738|466393713|FG000|Overall Study|Lost to Follow-up|2|||
129572504|NCT00855738|466393713|FG000|Overall Study|Adverse Event|1|||
129572505|NCT00855738|466393713|FG000|Overall Study|Subject Defaulted|1|||
129572506|NCT00855738|466393713|FG000|Overall Study|Death|1|||
129572507|NCT02392000|466393714|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
129572508|NCT02392000|466393714|FG000|Overall Study|Withdrawal by Subject|1|||
129572509|NCT02392000|466393714|FG000|Overall Study|Lost to Follow-up|8|||
129572510|NCT04384978|466393715|FG000|Overall Study|Withdrawal by Subject|4|||
129572511|NCT04384978|466393716|FG001|Overall Study|Withdrawal by Subject|0|||
129572512|NCT03500692|466393733|FG000|Overall Study|Death|163|||
129572513|NCT03500692|466393733|FG000|Overall Study|Lost to Follow-up|75|||
129572514|NCT03500692|466393733|FG000|Overall Study|Termination Reasons|3|||
129572515|NCT06358820|466395252|FG000|Overall Study|Adverse Event|11|||
129572516|NCT06358820|466395252|FG000|Overall Study|kidney transplantation|3|||
129572517|NCT06358820|466395252|FG000|Overall Study|patient voluntary withdrawal|6|||
129572518|NCT06358820|466395252|FG000|Overall Study|Physician Decision|1|||
129572519|NCT01066143|466395253|FG000|Overall Study|ineligible for the study|8|||
129572520|NCT05376319|466395254|FG000|Overall Study|Funding termination|2|||
129572521|NCT05376319|466395255|FG001|Overall Study|Funding termination|4|||
129572522|NCT01124175|466395256|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129572523|NCT01124175|466395257|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
129572524|NCT00942968|466395260|FG000|Overall Study|Adverse Event|60|||
129572525|NCT00942968|466395260|FG000|Overall Study|Death|76|||
129572526|NCT00942968|466395260|FG000|Overall Study|Protocol Violation|9|||
129572527|NCT00942968|466395260|FG000|Overall Study|Lost to Follow-up|4|||
129572528|NCT00942968|466395260|FG000|Overall Study|Withdrawal by Subject|44|||
129572529|NCT00942968|466395260|FG000|Overall Study|Sponsor request|5|||
129572530|NCT00942968|466395260|FG000|Overall Study|Physician Decision|11|||
129572531|NCT00942968|466395260|FG000|Overall Study|Progression of disease|12|||
129572532|NCT00942968|466395260|FG000|Overall Study|Inferior vena cava filter placement|4|||
129572533|NCT00942968|466395260|FG000|Overall Study|Pulmonary embolism (PE)|1|||
129572534|NCT00942968|466395260|FG000|Overall Study|Participant required pancreatic biopsy|1|||
129572535|NCT00942968|466395260|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
129572536|NCT00218257|466395264|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
129572537|NCT00218257|466395265|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
129572538|NCT01466166|466395268|FG000|Overall Study|Death|1|||
129572539|NCT01466166|466395268|FG000|Overall Study|Lost to Follow-up|7|||
129692407|NCT00609973|466832407|FG001|Overall Study|Lost to Follow-up|1|||
129572540|NCT01466166|466395268|FG000|Overall Study|Infusion Reaction (IR)|27|||
129572541|NCT01466166|466395268|FG000|Overall Study|Adverse Event (Other than IR)|11|||
129572542|NCT01466166|466395268|FG000|Overall Study|Elevated Serum Uric Acid|78|||
129572543|NCT01466166|466395268|FG000|Overall Study|Withdrawal by Subject|13|||
129572544|NCT01466166|466395268|FG000|Overall Study|Sponsor Decision|4|||
129572545|NCT01466166|466395268|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
129572546|NCT01466166|466395268|FG000|Overall Study|Other|20|||
129572547|NCT01340495|466395275|FG000|Overall Study|Withdrawal by Subject|1|||
129572548|NCT00070291|466395276|FG000|Step 1|Withdrawal by Subject|1|||
129572549|NCT00070291|466395276|FG000|Step 1|Adverse Event|1|||
129572550|NCT00070291|466395276|FG000|Step 2|Adverse Event|1|||
129572551|NCT02028715|466395279|FG000|Overall Study|Adverse Event|2|||
129572552|NCT02028715|466395280|FG001|Overall Study|Adverse Event|2|||
129572553|NCT02028715|466395279|FG000|Overall Study|Physician Decision|1|||
129572554|NCT02028715|466395280|FG001|Overall Study|Physician Decision|0|||
129572555|NCT02028715|466395279|FG000|Overall Study|Did not complete satisfaction surveys|2|||
129572556|NCT02028715|466395280|FG001|Overall Study|Did not complete satisfaction surveys|2|||
129572557|NCT00520130|466395281|FG000|Overall Study|Disease progression on study|4|||
129572558|NCT00520130|466395282|FG001|Overall Study|Disease progression on study|0|||
129572559|NCT00520130|466395281|FG000|Overall Study|Physician Decision|1|||
129572560|NCT00520130|466395282|FG001|Overall Study|Physician Decision|1|||
129572561|NCT00667862|466395283|FG000|Overall Study|Adverse Event|9|||
129572562|NCT00667862|466395283|FG000|Overall Study|Death|1|||
129572563|NCT00667862|466395283|FG000|Overall Study|Disease Progression|22|||
129572564|NCT00667862|466395283|FG000|Overall Study|Withdrawal by Subject|3|||
129572565|NCT02495857|466395285|FG000|Overall Study|Adverse Event|5|||
129572566|NCT02495857|466395286|FG001|Overall Study|Adverse Event|0|||
129572567|NCT02495857|466395287|FG002|Overall Study|Adverse Event|1|||
129572568|NCT02495857|466395285|FG000|Overall Study|Withdrawal by Subject|9|||
129572569|NCT02495857|466395286|FG001|Overall Study|Withdrawal by Subject|6|||
129572570|NCT02495857|466395287|FG002|Overall Study|Withdrawal by Subject|10|||
129572571|NCT02495857|466395285|FG000|Overall Study|Physician Decision|0|||
129572572|NCT02495857|466395286|FG001|Overall Study|Physician Decision|1|||
129572573|NCT02495857|466395287|FG002|Overall Study|Physician Decision|0|||
129572574|NCT02495857|466395285|FG000|Overall Study|Protocol Violation|1|||
129572575|NCT02495857|466395286|FG001|Overall Study|Protocol Violation|1|||
129572576|NCT02495857|466395287|FG002|Overall Study|Protocol Violation|2|||
129572577|NCT02495857|466395285|FG000|Overall Study|Lost to Follow-up|4|||
129572578|NCT02495857|466395286|FG001|Overall Study|Lost to Follow-up|5|||
129572579|NCT02495857|466395287|FG002|Overall Study|Lost to Follow-up|3|||
129572580|NCT02495857|466395285|FG000|Overall Study|Other|3|||
129572581|NCT02495857|466395286|FG001|Overall Study|Other|3|||
129572582|NCT02495857|466395287|FG002|Overall Study|Other|2|||
129572583|NCT00396279|466395288|FG000|Overall Study|Ongoing in study|26|||
129572584|NCT00396279|466395288|FG000|Overall Study|Disease progression|2|||
129572585|NCT00396279|466395288|FG000|Overall Study|Withdrawal by Subject|1|||
129572586|NCT00396279|466395288|FG000|Overall Study|Physician Decision|1|||
129572587|NCT02883452|466395289|FG000|Overall Study|Withdrawal by Subject|1|||
129572588|NCT02883452|466395290|FG001|Overall Study|Withdrawal by Subject|1|||
129572589|NCT02883452|466395291|FG002|Overall Study|Withdrawal by Subject|3|||
129572590|NCT02883452|466395292|FG003|Overall Study|Withdrawal by Subject|0|||
129572591|NCT02883452|466395293|FG004|Overall Study|Withdrawal by Subject|2|||
129572592|NCT02883452|466395294|FG005|Overall Study|Withdrawal by Subject|5|||
129572593|NCT02883452|466395289|FG000|Overall Study|Disease progression|1|||
129572594|NCT02883452|466395290|FG001|Overall Study|Disease progression|0|||
129572595|NCT02883452|466395291|FG002|Overall Study|Disease progression|0|||
129692408|NCT00609973|466832406|FG000|Overall Study|Withdrawal by Subject|0|||
129692409|NCT00609973|466832407|FG001|Overall Study|Withdrawal by Subject|1|||
129692410|NCT00191152|466832408|FG000|Initial Treatment|Adverse Event|43|||
129572596|NCT02883452|466395292|FG003|Overall Study|Disease progression|1|||
129572597|NCT02883452|466395293|FG004|Overall Study|Disease progression|4|||
129572598|NCT02883452|466395294|FG005|Overall Study|Disease progression|5|||
129572599|NCT02883452|466395289|FG000|Overall Study|Adverse Event|2|||
129572600|NCT02883452|466395290|FG001|Overall Study|Adverse Event|1|||
129572601|NCT02883452|466395291|FG002|Overall Study|Adverse Event|1|||
129572602|NCT02883452|466395292|FG003|Overall Study|Adverse Event|1|||
129572603|NCT02883452|466395293|FG004|Overall Study|Adverse Event|1|||
129572604|NCT02883452|466395294|FG005|Overall Study|Adverse Event|3|||
129572605|NCT02883452|466395289|FG000|Overall Study|Physician Decision|0|||
129692411|NCT00191152|466832409|FG001|Initial Treatment|Adverse Event|67|||
129692412|NCT00191152|466832408|FG000|Initial Treatment|Physician Decision|40|||
129692413|NCT00191152|466832409|FG001|Initial Treatment|Physician Decision|31|||
129692414|NCT00191152|466832408|FG000|Initial Treatment|Withdrawal by Subject|40|||
129572606|NCT02883452|466395290|FG001|Overall Study|Physician Decision|0|||
129572607|NCT02883452|466395291|FG002|Overall Study|Physician Decision|0|||
129572608|NCT02883452|466395292|FG003|Overall Study|Physician Decision|0|||
129572609|NCT02883452|466395293|FG004|Overall Study|Physician Decision|4|||
129572610|NCT02883452|466395294|FG005|Overall Study|Physician Decision|1|||
129692415|NCT00191152|466832409|FG001|Initial Treatment|Withdrawal by Subject|28|||
129572611|NCT02883452|466395289|FG000|Overall Study|Death|1|||
129572612|NCT02883452|466395290|FG001|Overall Study|Death|0|||
129572613|NCT02883452|466395291|FG002|Overall Study|Death|1|||
129572614|NCT02883452|466395292|FG003|Overall Study|Death|0|||
129572615|NCT02883452|466395293|FG004|Overall Study|Death|0|||
129572616|NCT02883452|466395294|FG005|Overall Study|Death|0|||
129572617|NCT02883452|466395289|FG000|Overall Study|Other|0|||
129572618|NCT02883452|466395290|FG001|Overall Study|Other|0|||
129572619|NCT02883452|466395291|FG002|Overall Study|Other|0|||
129572620|NCT02883452|466395292|FG003|Overall Study|Other|0|||
129572621|NCT02883452|466395293|FG004|Overall Study|Other|0|||
129572622|NCT02883452|466395294|FG005|Overall Study|Other|1|||
129572623|NCT00830206|466395295|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
129572624|NCT00830206|466395296|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
129572625|NCT00905346|466395298|FG000|Period 1|Withdrawal by Subject|1|||
129572626|NCT00905346|466395299|FG001|Period 1|Withdrawal by Subject|0|||
129572627|NCT01435265|466395300|FG000|Overall Study|Lost to Follow-up|0|||
129572628|NCT01435265|466395301|FG001|Overall Study|Lost to Follow-up|1|||
129572629|NCT04605094|466395302|FG000|Overall Study|Adverse Event|2|||
129572630|NCT04605094|466395303|FG001|Overall Study|Adverse Event|2|||
129572631|NCT04605094|466395302|FG000|Overall Study|Lost to Follow-up|1|||
129572632|NCT04605094|466395303|FG001|Overall Study|Lost to Follow-up|4|||
129572633|NCT04605094|466395302|FG000|Overall Study|Physician Decision|2|||
129572634|NCT04605094|466395303|FG001|Overall Study|Physician Decision|2|||
129572635|NCT04605094|466395302|FG000|Overall Study|Study terminated by Sponsor|31|||
129572636|NCT04605094|466395303|FG001|Overall Study|Study terminated by Sponsor|33|||
129572637|NCT04605094|466395302|FG000|Overall Study|Withdrawal by Subject|22|||
129572638|NCT04605094|466395303|FG001|Overall Study|Withdrawal by Subject|19|||
129572639|NCT04605094|466395302|FG000|Overall Study|Other|1|||
129572640|NCT04605094|466395303|FG001|Overall Study|Other|1|||
129572641|NCT02724462|466395304|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
129572642|NCT02724462|466395305|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
129572643|NCT02724462|466395304|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
129572644|NCT02724462|466395305|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
129572645|NCT02724462|466395304|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
129572646|NCT02724462|466395305|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
129572647|NCT02724462|466395304|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
129572648|NCT02724462|466395305|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
129572649|NCT02724462|466395304|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
129572650|NCT02724462|466395305|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
129572651|NCT02724462|466395304|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
129572652|NCT02724462|466395305|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
129572653|NCT01900691|466395306|FG000|Overall Study|Death|7|||
129572654|NCT01900691|466395306|FG000|Overall Study|Lost to Follow-up|4|||
129572655|NCT01900691|466395306|FG000|Overall Study|Study Device Not Placed|3|||
129572656|NCT01900691|466395306|FG000|Overall Study|Non study stent placed|2|||
129572657|NCT01900691|466395306|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
129572658|NCT01900691|466395306|FG000|Overall Study|Complete stent migration through digestive tract|1|||
129572659|NCT01954394|466395311|FG000|Overall Study|Enrolled but not treated|1|||
129572660|NCT01954394|466395312|FG001|Overall Study|Enrolled but not treated|0|||
129572661|NCT01954394|466395311|FG000|Overall Study|Adverse Event|10|||
129572662|NCT01954394|466395312|FG001|Overall Study|Adverse Event|23|||
129572663|NCT01954394|466395311|FG000|Overall Study|Poor compliance to protocol|7|||
129572664|NCT01954394|466395312|FG001|Overall Study|Poor compliance to protocol|7|||
129572665|NCT01954394|466395311|FG000|Overall Study|Participant Moved|0|||
129572666|NCT01954394|466395312|FG001|Overall Study|Participant Moved|4|||
129572667|NCT01954394|466395311|FG000|Overall Study|Related to Study Drug administration|2|||
129572668|NCT01954394|466395312|FG001|Overall Study|Related to Study Drug administration|2|||
129572669|NCT01954394|466395311|FG000|Overall Study|Other than specified above|10|||
129572670|NCT01954394|466395312|FG001|Overall Study|Other than specified above|21|||
129572671|NCT02422264|466395326|FG000|Overall Study|Serious Adverse Event|1|||
129572672|NCT02422264|466395327|FG001|Overall Study|Serious Adverse Event|0|||
129572673|NCT02422264|466395326|FG000|Overall Study|Withdrawal by Subject|1|||
129572674|NCT02422264|466395327|FG001|Overall Study|Withdrawal by Subject|2|||
129572675|NCT02422264|466395326|FG000|Overall Study|Migrated/moved from study area|3|||
129572676|NCT02422264|466395327|FG001|Overall Study|Migrated/moved from study area|1|||
129572677|NCT02422264|466395326|FG000|Overall Study|Subject vaccinated outside of the study|0|||
129572678|NCT02422264|466395327|FG001|Overall Study|Subject vaccinated outside of the study|1|||
129572679|NCT00328926|466395328|FG000|Overall Study|Pregnancy|2|||
129572680|NCT00328926|466395329|FG001|Overall Study|Pregnancy|1|||
129572681|NCT00328926|466395330|FG002|Overall Study|Pregnancy|0|||
129572682|NCT00328926|466395328|FG000|Overall Study|Lost to Follow-up|0|||
129572683|NCT00328926|466395329|FG001|Overall Study|Lost to Follow-up|1|||
129572684|NCT00328926|466395330|FG002|Overall Study|Lost to Follow-up|0|||
129572685|NCT00328926|466395328|FG000|Overall Study|Death|0|||
129572686|NCT00328926|466395329|FG001|Overall Study|Death|0|||
129572687|NCT00328926|466395330|FG002|Overall Study|Death|1|||
129572688|NCT00328926|466395328|FG000|Overall Study|In vitro fertilization treatment|0|||
129572689|NCT00328926|466395329|FG001|Overall Study|In vitro fertilization treatment|0|||
129572690|NCT00328926|466395330|FG002|Overall Study|In vitro fertilization treatment|1|||
129572691|NCT00328926|466395328|FG000|Overall Study|Lack of ovarian response|0|||
129572692|NCT00328926|466395329|FG001|Overall Study|Lack of ovarian response|1|||
129572693|NCT00328926|466395330|FG002|Overall Study|Lack of ovarian response|0|||
129572694|NCT02269657|466395333|FG000|Overall Study|Protocol Violation|3|||
129572695|NCT00620074|466395334|FG000|Overall Study|Adverse Event|1|||
129572696|NCT00573066|466395335|FG000|Overall Study|Exclusion criteria|18|||
129572697|NCT00573066|466395335|FG000|Overall Study|IV malfunction|1|||
129572698|NCT00573066|466395335|FG000|Overall Study|Postoperative bleeding|1|||
129572699|NCT01838941|466395336|FG000|Overall Study|Adverse Event|1|||
129572700|NCT01838941|466395336|FG000|Overall Study|Withdrawal by Subject|1|||
129572701|NCT02822235|466395337|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
129572702|NCT02822235|466395338|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
129572703|NCT02822235|466395337|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
129572704|NCT02822235|466395338|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
129572705|NCT02822235|466395337|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
129572706|NCT02822235|466395338|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
129572707|NCT02822235|466395337|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
129572708|NCT02822235|466395338|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
129572709|NCT02822235|466395337|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
129572710|NCT02822235|466395338|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
129572711|NCT02822235|466395337|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
129572712|NCT02822235|466395338|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
129572713|NCT03214952|466395339|FG000|Overall Study|Protocol Deviation|45|||
129572714|NCT03214952|466395339|FG000|Overall Study|Case Report Forms Uncollected|13|||
129572715|NCT03769896|466395342|FG000|Open-label Phase|Lack of Efficacy|5|||
129572716|NCT03769896|466395343|FG001|Open-label Phase|Lack of Efficacy|0|||
129572717|NCT03769896|466395342|FG000|Open-label Phase|Adverse Event|3|||
129572718|NCT03769896|466395343|FG001|Open-label Phase|Adverse Event|0|||
129572719|NCT03769896|466395342|FG000|Open-label Phase|Withdrawal by Subject|1|||
129572720|NCT03769896|466395343|FG001|Open-label Phase|Withdrawal by Subject|0|||
129572721|NCT00377260|466395344|FG000|Overall Study|Lost to Follow-up|0|||
129572722|NCT00377260|466395345|FG001|Overall Study|Lost to Follow-up|1|||
129572723|NCT00377260|466395344|FG000|Overall Study|Withdrawal by Subject|2|||
129572724|NCT00377260|466395345|FG001|Overall Study|Withdrawal by Subject|4|||
129572725|NCT00829530|466395346|FG000|First Intervention|Adverse Event|0|||
129572726|NCT00829530|466395347|FG001|First Intervention|Adverse Event|1|||
129572727|NCT00829530|466395346|FG000|First Intervention|Intolerance to Venopuncture|0|||
129572728|NCT00829530|466395347|FG001|First Intervention|Intolerance to Venopuncture|1|||
129572729|NCT00829530|466395346|FG000|Second Intervention|Intolerance to Venopuncture|1|||
129572730|NCT00829530|466395347|FG001|Second Intervention|Intolerance to Venopuncture|0|||
129572731|NCT01015625|466395350|FG000|Overall Study|Lost to Follow-up|3|||
129572732|NCT01015625|466395351|FG001|Overall Study|Lost to Follow-up|1|||
129572733|NCT01015625|466395350|FG000|Overall Study|Withdrawal by Subject|2|||
129572734|NCT01015625|466395351|FG001|Overall Study|Withdrawal by Subject|3|||
129572735|NCT01015625|466395350|FG000|Overall Study|Physician Decision|2|||
129572736|NCT01015625|466395351|FG001|Overall Study|Physician Decision|0|||
129572737|NCT01015625|466395350|FG000|Overall Study|Death|30|||
129572738|NCT01015625|466395351|FG001|Overall Study|Death|22|||
129572739|NCT04112823|466395352|FG000|Overall Study|Lost to Follow-up|2|||
129572740|NCT04112823|466395353|FG001|Overall Study|Lost to Follow-up|3|||
129572741|NCT00625443|466395354|FG000|Overall Study|Adverse Event|1|||
129572742|NCT00625443|466395355|FG001|Overall Study|Adverse Event|4|||
129572743|NCT00625443|466395356|FG002|Overall Study|Adverse Event|0|||
129572744|NCT00625443|466395354|FG000|Overall Study|Non-compliance with protocol|0|||
129572745|NCT00625443|466395355|FG001|Overall Study|Non-compliance with protocol|1|||
129572746|NCT00625443|466395356|FG002|Overall Study|Non-compliance with protocol|0|||
129572747|NCT00625443|466395354|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
129572748|NCT00625443|466395355|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
129572749|NCT00625443|466395356|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
129572750|NCT00625443|466395354|FG000|Overall Study|Withdrawal by Subject|0|||
129572751|NCT00625443|466395355|FG001|Overall Study|Withdrawal by Subject|1|||
129572752|NCT00625443|466395356|FG002|Overall Study|Withdrawal by Subject|2|||
129572753|NCT00625443|466395354|FG000|Overall Study|Physician Decision|0|||
129572754|NCT00625443|466395355|FG001|Overall Study|Physician Decision|4|||
129572755|NCT00625443|466395356|FG002|Overall Study|Physician Decision|2|||
129572756|NCT00625443|466395354|FG000|Overall Study|Other|0|||
129572757|NCT00625443|466395355|FG001|Overall Study|Other|1|||
129572758|NCT00625443|466395356|FG002|Overall Study|Other|1|||
129572759|NCT02924883|466395357|FG000|Overall Study|Death|39|||
129572760|NCT02924883|466395358|FG001|Overall Study|Death|20|||
129572761|NCT02924883|466395357|FG000|Overall Study|Lost to Follow-up|1|||
129572762|NCT02924883|466395358|FG001|Overall Study|Lost to Follow-up|0|||
129572763|NCT02924883|466395357|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
129572764|NCT02924883|466395358|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
129572765|NCT02924883|466395357|FG000|Overall Study|Protocol Violation|1|||
129572766|NCT02924883|466395358|FG001|Overall Study|Protocol Violation|0|||
129572767|NCT02924883|466395357|FG000|Overall Study|Withdrawal by Subject|22|||
129572768|NCT02924883|466395358|FG001|Overall Study|Withdrawal by Subject|16|||
129572769|NCT02924883|466395357|FG000|Overall Study|Progressive Disease|1|||
129572770|NCT02924883|466395358|FG001|Overall Study|Progressive Disease|0|||
129572771|NCT02924883|466395357|FG000|Overall Study|Study Terminated by Sponsor|69|||
129572772|NCT02924883|466395358|FG001|Overall Study|Study Terminated by Sponsor|32|||
129572773|NCT00772941|466395361|FG000|Overall Study|CRFs not available|195|||
129572774|NCT00772941|466395361|FG000|Overall Study|Study not completed|16|||
129572775|NCT00772941|466395361|FG000|Overall Study|Missed Visits|374|||
129572776|NCT00772941|466395361|FG000|Overall Study|Poor Compliance|7|||
129572777|NCT00772941|466395361|FG000|Overall Study|GPSP Violation|90|||
129572778|NCT04786184|466395362|FG000|Overall Study|Adverse Event|4|||
129572779|NCT04786184|466395363|FG001|Overall Study|Adverse Event|0|||
129572780|NCT04786184|466395362|FG000|Overall Study|Withdrawal by Subject|3|||
129572781|NCT04786184|466395363|FG001|Overall Study|Withdrawal by Subject|1|||
129572782|NCT04786184|466395362|FG000|Overall Study|Lost to Follow-up|4|||
129572783|NCT04786184|466395363|FG001|Overall Study|Lost to Follow-up|2|||
129572784|NCT01702987|466395373|FG000|Overall Study|Withdrawal by Subject|1|||
129572785|NCT01702987|466395374|FG001|Overall Study|Withdrawal by Subject|0|||
129572786|NCT02017223|466395375|FG000|Overall Study|Algorithm problems|2|||
129572787|NCT04263649|466395377|FG000|Overall Study|Adverse Event|53|||
129572788|NCT04263649|466395377|FG000|Overall Study|Lost to Follow-up|3|||
129572789|NCT04263649|466395377|FG000|Overall Study|Death|29|||
129572790|NCT04263649|466395377|FG000|Overall Study|Device deficiency|19|||
129572791|NCT04263649|466395377|FG000|Overall Study|other reasons|11|||
129572792|NCT01534520|466395378|FG000|Overall Study|Adverse Event|0|||
129572793|NCT01534520|466395379|FG001|Overall Study|Adverse Event|1|||
129572794|NCT05169710|466395382|FG000|Overall Study|Adverse Event|1|||
129572795|NCT05169710|466395383|FG001|Overall Study|Adverse Event|2|||
129572796|NCT05169710|466395384|FG002|Overall Study|Adverse Event|2|||
129572797|NCT05169710|466395382|FG000|Overall Study|Lost to Follow-up|0|||
129572798|NCT05169710|466395383|FG001|Overall Study|Lost to Follow-up|0|||
129572799|NCT05169710|466395384|FG002|Overall Study|Lost to Follow-up|1|||
129572800|NCT05169710|466395382|FG000|Overall Study|Withdrawal by Subject|2|||
129572801|NCT05169710|466395383|FG001|Overall Study|Withdrawal by Subject|1|||
129572802|NCT05169710|466395384|FG002|Overall Study|Withdrawal by Subject|0|||
129572803|NCT05169710|466395382|FG000|Overall Study|Other Study Discontinuation Reason|0|||
129572804|NCT05169710|466395383|FG001|Overall Study|Other Study Discontinuation Reason|2|||
129572805|NCT05169710|466395384|FG002|Overall Study|Other Study Discontinuation Reason|0|||
129572806|NCT01686438|466395389|FG000|Overall Study|Lost to Follow-up|8|||
129572807|NCT01686438|466395390|FG001|Overall Study|Lost to Follow-up|9|||
129572808|NCT01686438|466395391|FG002|Overall Study|Lost to Follow-up|10|||
129572809|NCT01686438|466395389|FG000|Overall Study|Adverse Event|0|||
129572810|NCT01686438|466395390|FG001|Overall Study|Adverse Event|0|||
129572811|NCT01686438|466395391|FG002|Overall Study|Adverse Event|1|||
129572812|NCT01686438|466395389|FG000|Overall Study|Protocol Violation|0|||
129572813|NCT01686438|466395390|FG001|Overall Study|Protocol Violation|0|||
129572814|NCT01686438|466395391|FG002|Overall Study|Protocol Violation|1|||
129572815|NCT01686438|466395389|FG000|Overall Study|Withdrawal by Subject|0|||
129572816|NCT01686438|466395390|FG001|Overall Study|Withdrawal by Subject|0|||
129572817|NCT01686438|466395391|FG002|Overall Study|Withdrawal by Subject|1|||
129572818|NCT02601560|466395395|FG000|Overall Study|Other|0|||
129572819|NCT02601560|466395396|FG001|Overall Study|Other|0|||
129572820|NCT02601560|466395397|FG002|Overall Study|Other|0|||
129572821|NCT02601560|466395398|FG003|Overall Study|Other|0|||
129572822|NCT02601560|466395399|FG004|Overall Study|Other|0|||
129572823|NCT02601560|466395400|FG005|Overall Study|Other|0|||
129572824|NCT02601560|466395401|FG006|Overall Study|Other|1|||
129572825|NCT02601560|466395402|FG007|Overall Study|Other|0|||
129572826|NCT03459807|466395403|FG000|Overall Study|Withdrawal due to transplant|0|||
129572827|NCT03459807|466395404|FG001|Overall Study|Withdrawal due to transplant|1|||
129572828|NCT03707912|466395407|FG000|Overall Study|Violation of inclusion criteria|1|||
129692416|NCT00191152|466832408|FG000|Initial Treatment|Lost to Follow-up|0|||
129692417|NCT00191152|466832409|FG001|Initial Treatment|Lost to Follow-up|6|||
129572829|NCT03707912|466395408|FG001|Overall Study|Violation of inclusion criteria|0|||
129572830|NCT01802320|466395409|FG000|Overall Study|Death|1|||
129572831|NCT01802320|466395409|FG000|Overall Study|Withdrawal by Subject|1|||
129572832|NCT04915755|466396757|FG000|Overall Study|Physician Decision|3|||
129572833|NCT04915755|466396758|FG001|Overall Study|Physician Decision|2|||
129572834|NCT04915755|466396757|FG000|Overall Study|Withdrawal by Subject|1|||
129572835|NCT04915755|466396758|FG001|Overall Study|Withdrawal by Subject|1|||
129572836|NCT04915755|466396757|FG000|Overall Study|Ongoing for PACT|3|||
129572837|NCT04915755|466396758|FG001|Overall Study|Ongoing for PACT|2|||
129692418|NCT00191152|466832408|FG000|Initial Treatment|Other|18|||
129572838|NCT04915755|466396757|FG000|Overall Study|Other|7|||
129572839|NCT04915755|466396758|FG001|Overall Study|Other|11|||
129572840|NCT02533258|466396759|FG000|Overall Study|Adverse Event|1|||
129572841|NCT02533258|466396759|FG000|Overall Study|Death|2|||
129572842|NCT02533258|466396759|FG000|Overall Study|Other|1|||
129572843|NCT02533258|466396759|FG000|Overall Study|Economic factor|1|||
129572844|NCT02533258|466396759|FG000|Overall Study|Progression of pleural effusion|1|||
129572845|NCT02533258|466396759|FG000|Overall Study|Lack of Efficacy|2|||
129572846|NCT00851877|466396760|FG000|Phase I-1|Death|1|||
129572847|NCT00851877|466396761|FG001|Phase I-1|Death|0|||
129572848|NCT00851877|466396762|FG002|Phase I-1|Death|0|||
129572849|NCT00851877|466396760|FG000|Phase II|Withdrawal by Subject|0|||
129572850|NCT00851877|466396761|FG001|Phase II|Withdrawal by Subject|0|||
129572851|NCT00851877|466396762|FG002|Phase II|Withdrawal by Subject|3|||
129572852|NCT00829673|466396763|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129572853|NCT00829673|466396764|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129572854|NCT03450057|466396765|FG000|Overall Study|Death|17|||
129572855|NCT03450057|466396765|FG000|Overall Study|ICF withdrawal|4|||
129572856|NCT03450057|466396765|FG000|Overall Study|Lost to Follow-up|2|||
129572857|NCT01034358|466396766|FG000|Overall Study|Withdrawal by Subject|1|||
129572858|NCT01034358|466396766|FG000|Overall Study|Protocol Violation|1|||
129572859|NCT00829790|466396769|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
129572860|NCT00829790|466396770|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
129572861|NCT02246166|466396771|FG000|Overall Study|Protocol Violation|1|||
129572862|NCT02246166|466396772|FG001|Overall Study|Protocol Violation|0|||
129572863|NCT00627016|466396773|FG000|Overall Study|Adverse Event|1|||
129572864|NCT00627016|466396774|FG001|Overall Study|Adverse Event|1|||
129572865|NCT00627016|466396773|FG000|Overall Study|Protocol Violation|0|||
129572866|NCT00627016|466396774|FG001|Overall Study|Protocol Violation|2|||
129572867|NCT00627016|466396773|FG000|Overall Study|Lost to Follow-up|0|||
129572868|NCT00627016|466396774|FG001|Overall Study|Lost to Follow-up|1|||
129572869|NCT00627016|466396773|FG000|Overall Study|Withdrawal by Subject|2|||
129572870|NCT00627016|466396774|FG001|Overall Study|Withdrawal by Subject|1|||
129572871|NCT00627016|466396773|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129572872|NCT00627016|466396774|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
129572873|NCT00627016|466396773|FG000|Overall Study|Lack of Efficacy|1|||
129572874|NCT00627016|466396774|FG001|Overall Study|Lack of Efficacy|0|||
129572875|NCT00627016|466396773|FG000|Overall Study|Placed on Excluded Drugs|1|||
129572876|NCT00627016|466396774|FG001|Overall Study|Placed on Excluded Drugs|0|||
129572877|NCT00627016|466396773|FG000|Overall Study|Pregnancy|1|||
129572878|NCT00627016|466396774|FG001|Overall Study|Pregnancy|0|||
129572879|NCT01534663|466396775|FG000|Overall Study|Lost to Follow-up|0|||
129572880|NCT01534663|466396776|FG001|Overall Study|Lost to Follow-up|2|||
129572881|NCT01534663|466396775|FG000|Overall Study|Adverse Event|2|||
129572882|NCT01534663|466396776|FG001|Overall Study|Adverse Event|1|||
129572883|NCT03107091|466396777|FG000|Overall Study|Physician Decision|1|||
129572884|NCT04567186|466396782|FG000|Period 1|COVID-19 related|1|||
129572885|NCT04567186|466396783|FG001|Period 1|COVID-19 related|0|||
129572886|NCT04567186|466396782|FG000|Period 1|Protocol Violation|0|||
129572887|NCT04567186|466396783|FG001|Period 1|Protocol Violation|1|||
129572888|NCT04567186|466396782|FG000|Period 1|Adverse Event|0|||
129572889|NCT04567186|466396783|FG001|Period 1|Adverse Event|2|||
129572890|NCT04567186|466396782|FG000|Period 2|COVID-19 Related|0|||
129572891|NCT04567186|466396783|FG001|Period 2|COVID-19 Related|1|||
129572892|NCT04567186|466396782|FG000|Period 2|Protocol Violation|0|||
129572893|NCT04567186|466396783|FG001|Period 2|Protocol Violation|1|||
129572894|NCT04567186|466396782|FG000|Period 2|Lost to Follow-up|0|||
129572895|NCT04567186|466396783|FG001|Period 2|Lost to Follow-up|1|||
129572896|NCT04567186|466396782|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
129572897|NCT04567186|466396783|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
129572898|NCT01256684|466396788|FG000|Overall Study|Adverse Event|1|||
129572899|NCT01256684|466396789|FG001|Overall Study|Adverse Event|4|||
129572900|NCT01256684|466396790|FG002|Overall Study|Adverse Event|2|||
129572901|NCT01256684|466396788|FG000|Overall Study|Withdrawal by Subject|4|||
129572902|NCT01256684|466396789|FG001|Overall Study|Withdrawal by Subject|0|||
129572903|NCT01256684|466396790|FG002|Overall Study|Withdrawal by Subject|2|||
129572904|NCT01256684|466396788|FG000|Overall Study|Physician Decision|0|||
129572905|NCT01256684|466396789|FG001|Overall Study|Physician Decision|1|||
129572906|NCT01256684|466396790|FG002|Overall Study|Physician Decision|0|||
129572907|NCT01256684|466396788|FG000|Overall Study|Lack of Efficacy|0|||
129572908|NCT01256684|466396789|FG001|Overall Study|Lack of Efficacy|1|||
129572909|NCT01256684|466396790|FG002|Overall Study|Lack of Efficacy|1|||
129572910|NCT01256684|466396788|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
129572911|NCT01256684|466396789|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
129572912|NCT01256684|466396790|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
129572913|NCT01185548|466396792|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
129572914|NCT02678286|466396793|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
129572915|NCT02678286|466396794|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
129572916|NCT02678286|466396793|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
129572917|NCT02678286|466396794|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
129572918|NCT02678286|466396793|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
129572919|NCT02678286|466396794|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
129572920|NCT02678286|466396793|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
129572921|NCT02678286|466396794|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
129572922|NCT02678286|466396793|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
129572923|NCT02678286|466396794|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
129572924|NCT02331394|466396795|FG000|Overall Study|Disease progression|1|||
129572925|NCT01313273|466396796|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
129572926|NCT01313273|466396797|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
129572927|NCT01313273|466396796|FG000|Overall Study|Withdrawal by Subject|1|||
129572928|NCT01313273|466396797|FG001|Overall Study|Withdrawal by Subject|0|||
129572929|NCT01313273|466396796|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
129572930|NCT01313273|466396797|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
129572931|NCT03687736|466396798|FG000|Overall Study|Lost to Follow-up|7|||
129572932|NCT03687736|466396798|FG000|Overall Study|Withdrawal by Subject|3|||
129572933|NCT01270503|466396799|FG000|Overall Study|Lost to Follow-up|1|||
129572934|NCT02459951|466396800|FG000|Overall Study|Unable to meet holding requirement|1|||
129572935|NCT02481830|466396804|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
129572936|NCT02481830|466396805|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
129572937|NCT02481830|466396804|FG000|Pre-treatment|Withdrawal by Subject|0|||
129572938|NCT02481830|466396805|FG001|Pre-treatment|Withdrawal by Subject|10|||
129572939|NCT02481830|466396804|FG000|Pre-treatment|Disease Progression|1|||
129572940|NCT02481830|466396805|FG001|Pre-treatment|Disease Progression|1|||
129572941|NCT02481830|466396804|FG000|Pre-treatment|Other reasons|0|||
129572942|NCT02481830|466396805|FG001|Pre-treatment|Other reasons|1|||
129572943|NCT02481830|466396804|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
129572944|NCT02481830|466396805|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
129572945|NCT02481830|466396804|FG000|Treatment|Disease Progression|233|||
129572946|NCT02481830|466396805|FG001|Treatment|Disease Progression|171|||
129572947|NCT02481830|466396804|FG000|Treatment|Study drug toxicity|18|||
129572948|NCT02481830|466396805|FG001|Treatment|Study drug toxicity|38|||
129572949|NCT02481830|466396804|FG000|Treatment|Death|1|||
129572950|NCT02481830|466396805|FG001|Treatment|Death|1|||
129572951|NCT02481830|466396804|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
129572952|NCT02481830|466396805|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
129572953|NCT02481830|466396804|FG000|Treatment|Participants request to discontinue Study treatment|6|||
129572954|NCT02481830|466396805|FG001|Treatment|Participants request to discontinue Study treatment|34|||
129572955|NCT02481830|466396804|FG000|Treatment|Withdrawal by Subject|2|||
129572956|NCT02481830|466396805|FG001|Treatment|Withdrawal by Subject|3|||
129572957|NCT02481830|466396804|FG000|Treatment|Lost to Follow-up|1|||
129572958|NCT02481830|466396805|FG001|Treatment|Lost to Follow-up|0|||
129572959|NCT02481830|466396804|FG000|Treatment|Maximum Clinical Benefit|0|||
129572960|NCT02481830|466396805|FG001|Treatment|Maximum Clinical Benefit|5|||
129572961|NCT02481830|466396804|FG000|Treatment|Administrative reason by sponsor|1|||
129572962|NCT02481830|466396805|FG001|Treatment|Administrative reason by sponsor|1|||
129572963|NCT02481830|466396804|FG000|Treatment|Other reasons|6|||
129572964|NCT02481830|466396805|FG001|Treatment|Other reasons|1|||
129572965|NCT00102440|466396806|FG000|Overall Study|Lost to Follow-up|25|||
129572966|NCT00102440|466396807|FG001|Overall Study|Lost to Follow-up|18|||
129572967|NCT00102440|466396808|FG002|Overall Study|Lost to Follow-up|21|||
129572968|NCT00102440|466396806|FG000|Overall Study|Adverse Event|16|||
129572969|NCT00102440|466396807|FG001|Overall Study|Adverse Event|23|||
129572970|NCT00102440|466396808|FG002|Overall Study|Adverse Event|8|||
129572971|NCT00102440|466396806|FG000|Overall Study|Gout Flare|10|||
129572972|NCT00102440|466396807|FG001|Overall Study|Gout Flare|28|||
129572973|NCT00102440|466396808|FG002|Overall Study|Gout Flare|9|||
129572974|NCT00102440|466396806|FG000|Overall Study|Personal Reason(s)|19|||
129572975|NCT00102440|466396807|FG001|Overall Study|Personal Reason(s)|13|||
129572976|NCT00102440|466396808|FG002|Overall Study|Personal Reason(s)|13|||
129572977|NCT00102440|466396806|FG000|Overall Study|Other|11|||
129572978|NCT00102440|466396807|FG001|Overall Study|Other|14|||
129572979|NCT00102440|466396808|FG002|Overall Study|Other|14|||
129572980|NCT00102440|466396806|FG000|Overall Study|Protocol Violation|7|||
129572981|NCT00102440|466396807|FG001|Overall Study|Protocol Violation|2|||
129782849|NCT03083990|467173318|FG001|Overall Study|Adverse Event|0|||
129572982|NCT00102440|466396808|FG002|Overall Study|Protocol Violation|1|||
129782850|NCT00984620|467173319|FG000|Overall Study|Adverse Event|5|||
129572983|NCT04627038|466396809|FG000|Overall Study|Adverse Event|36|||
129782851|NCT00984620|467173320|FG001|Overall Study|Adverse Event|5|||
129572984|NCT04627038|466396810|FG001|Overall Study|Adverse Event|8|||
129572985|NCT04627038|466396809|FG000|Overall Study|Lost to Follow-up|1|||
129572986|NCT04627038|466396810|FG001|Overall Study|Lost to Follow-up|0|||
129572987|NCT04627038|466396809|FG000|Overall Study|Physician Decision|0|||
129572988|NCT04627038|466396810|FG001|Overall Study|Physician Decision|1|||
129572989|NCT04627038|466396809|FG000|Overall Study|Protocol Violation|3|||
129572990|NCT04627038|466396810|FG001|Overall Study|Protocol Violation|1|||
129572991|NCT04627038|466396809|FG000|Overall Study|Withdrawal by Subject|13|||
129572992|NCT04627038|466396810|FG001|Overall Study|Withdrawal by Subject|3|||
129572993|NCT04627038|466396809|FG000|Overall Study|Non-compliance with study drug|0|||
129572994|NCT04627038|466396810|FG001|Overall Study|Non-compliance with study drug|1|||
129572995|NCT04627038|466396809|FG000|Overall Study|Prohibited Concomitant Medication|1|||
129572996|NCT04627038|466396810|FG001|Overall Study|Prohibited Concomitant Medication|0|||
129572997|NCT02255097|466396811|FG000|Overall Study|Death|151|||
129572998|NCT02255097|466396811|FG000|Overall Study|Lost to Follow-up|5|||
129572999|NCT02255097|466396811|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
129573000|NCT02255097|466396811|FG000|Overall Study|Withdrawal by Subject|7|||
129573001|NCT02255097|466396811|FG000|Overall Study|Allocated but not treated|1|||
129573002|NCT01010542|466396817|FG000|Overall Study|Adverse Event|0|||
129573003|NCT01010542|466396818|FG001|Overall Study|Adverse Event|1|||
129573004|NCT01010542|466396819|FG002|Overall Study|Adverse Event|0|||
129573005|NCT01010542|466396817|FG000|Overall Study|Lost to Follow-up|0|||
129573006|NCT01010542|466396818|FG001|Overall Study|Lost to Follow-up|1|||
129573007|NCT01010542|466396819|FG002|Overall Study|Lost to Follow-up|0|||
129573008|NCT01010542|466396817|FG000|Overall Study|Withdrawal by Subject|0|||
129573009|NCT01010542|466396818|FG001|Overall Study|Withdrawal by Subject|3|||
129573010|NCT01010542|466396819|FG002|Overall Study|Withdrawal by Subject|2|||
129573011|NCT01745120|466396820|FG000|Overall Study|Investigator decision|1|||
129573012|NCT01745120|466396821|FG001|Overall Study|Investigator decision|0|||
129573013|NCT03956862|466396822|FG000|Overall Study|Lost to Follow-up|1|||
129573014|NCT03956862|466396823|FG001|Overall Study|Lost to Follow-up|1|||
129573015|NCT03956862|466396822|FG000|Overall Study|Withdrawal by Subject|1|||
129573016|NCT03956862|466396823|FG001|Overall Study|Withdrawal by Subject|1|||
129573017|NCT00579670|466396827|FG000|Overall Study|Death|1|||
129573018|NCT00579670|466396828|FG001|Overall Study|Death|0|||
129573019|NCT00579670|466396829|FG002|Overall Study|Death|0|||
129573020|NCT00579670|466396830|FG003|Overall Study|Death|0|||
129573021|NCT00579670|466396831|FG004|Overall Study|Death|0|||
129573022|NCT00579670|466396827|FG000|Overall Study|Adverse Event|1|||
129573023|NCT00579670|466396828|FG001|Overall Study|Adverse Event|0|||
129573024|NCT00579670|466396829|FG002|Overall Study|Adverse Event|1|||
129573025|NCT00579670|466396830|FG003|Overall Study|Adverse Event|2|||
129573026|NCT00579670|466396831|FG004|Overall Study|Adverse Event|0|||
129573027|NCT00579670|466396827|FG000|Overall Study|Lack of Efficacy|0|||
129573028|NCT00579670|466396828|FG001|Overall Study|Lack of Efficacy|0|||
129573029|NCT00579670|466396829|FG002|Overall Study|Lack of Efficacy|1|||
129573030|NCT00579670|466396830|FG003|Overall Study|Lack of Efficacy|14|||
129573031|NCT00579670|466396831|FG004|Overall Study|Lack of Efficacy|0|||
129573032|NCT00579670|466396827|FG000|Overall Study|Lost to Follow-up|0|||
129573033|NCT00579670|466396828|FG001|Overall Study|Lost to Follow-up|1|||
129573034|NCT00579670|466396829|FG002|Overall Study|Lost to Follow-up|0|||
129573035|NCT00579670|466396830|FG003|Overall Study|Lost to Follow-up|4|||
129573036|NCT00579670|466396831|FG004|Overall Study|Lost to Follow-up|0|||
129573037|NCT00579670|466396827|FG000|Overall Study|Other|0|||
129573038|NCT00579670|466396828|FG001|Overall Study|Other|0|||
129573039|NCT00579670|466396829|FG002|Overall Study|Other|1|||
129573040|NCT00579670|466396830|FG003|Overall Study|Other|2|||
129573041|NCT00579670|466396831|FG004|Overall Study|Other|0|||
129573042|NCT00579670|466396827|FG000|Overall Study|Withdrawal by Subject|0|||
129573043|NCT00579670|466396828|FG001|Overall Study|Withdrawal by Subject|0|||
129573044|NCT00579670|466396829|FG002|Overall Study|Withdrawal by Subject|1|||
129573045|NCT00579670|466396830|FG003|Overall Study|Withdrawal by Subject|0|||
129573046|NCT00579670|466396831|FG004|Overall Study|Withdrawal by Subject|0|||
129573047|NCT00850174|466396835|FG000|Washout: One Week|Withdrawal by Subject|0|||
129573048|NCT00850174|466396836|FG001|Washout: One Week|Withdrawal by Subject|2|||
129573049|NCT00850174|466396835|FG000|Second Intervention|Withdrawal by Subject|1|||
129573050|NCT00850174|466396836|FG001|Second Intervention|Withdrawal by Subject|0|||
129573051|NCT01363765|466396839|FG000|Overall Study|non-diagnostic|2621|||
129573052|NCT01363765|466396840|FG001|Overall Study|non-diagnostic|1124|||
129573053|NCT01363765|466396839|FG000|Overall Study|duplicate records|736|||
129573054|NCT01363765|466396840|FG001|Overall Study|duplicate records|3177|||
129573055|NCT01363765|466396839|FG000|Overall Study|non-resident|156|||
129573056|NCT01363765|466396840|FG001|Overall Study|non-resident|76|||
129573057|NCT01363765|466396839|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
129573058|NCT01363765|466396840|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
129573059|NCT01363765|466396839|FG000|Overall Study|smear during intervention|2170|||
129573060|NCT01363765|466396840|FG001|Overall Study|smear during intervention|0|||
129573061|NCT01900626|466396841|FG000|Overall Study|study was closed due to low enrollment|1|||
129573062|NCT01900626|466396842|FG001|Overall Study|study was closed due to low enrollment|1|||
129573063|NCT00635492|466396843|FG000|Overall Study|Death|12|||
129573064|NCT00635492|466396844|FG001|Overall Study|Death|40|||
129573065|NCT00635492|466396843|FG000|Overall Study|Lost to Follow-up|151|||
129573066|NCT00635492|466396844|FG001|Overall Study|Lost to Follow-up|172|||
129573067|NCT00635492|466396843|FG000|Overall Study|Physician Decision|32|||
129573068|NCT00635492|466396844|FG001|Overall Study|Physician Decision|22|||
129573069|NCT00635492|466396843|FG000|Overall Study|Sponsor decision|2|||
129573070|NCT00635492|466396844|FG001|Overall Study|Sponsor decision|3|||
129573071|NCT00635492|466396843|FG000|Overall Study|Withdrawal by Subject|82|||
129573072|NCT00635492|466396844|FG001|Overall Study|Withdrawal by Subject|45|||
129573073|NCT02682784|466396845|FG000|Overall Study|Withdrawal by Subject|0|||
129573074|NCT02682784|466396846|FG001|Overall Study|Withdrawal by Subject|2|||
129573075|NCT02682784|466396847|FG002|Overall Study|Withdrawal by Subject|1|||
129573076|NCT02682784|466396848|FG003|Overall Study|Withdrawal by Subject|2|||
129573077|NCT02682784|466396845|FG000|Overall Study|Physician Decision|1|||
129573078|NCT02682784|466396846|FG001|Overall Study|Physician Decision|0|||
129573079|NCT02682784|466396847|FG002|Overall Study|Physician Decision|1|||
129573080|NCT02682784|466396848|FG003|Overall Study|Physician Decision|1|||
129573081|NCT00836056|466396858|FG000|First Intervention|Adverse Event|1|||
129573082|NCT00836056|466396859|FG001|First Intervention|Adverse Event|0|||
129573083|NCT00846495|466396860|FG000|Overall Study|Lost to Follow-up|1|||
129573084|NCT00846495|466396861|FG001|Overall Study|Lost to Follow-up|0|||
129573085|NCT00846495|466396860|FG000|Overall Study|Adverse Event|5|||
129573086|NCT00846495|466396861|FG001|Overall Study|Adverse Event|1|||
129573087|NCT00846495|466396860|FG000|Overall Study|Lack of Efficacy|1|||
129573088|NCT00846495|466396861|FG001|Overall Study|Lack of Efficacy|2|||
129573089|NCT00846495|466396860|FG000|Overall Study|Physician Decision|1|||
129573090|NCT00846495|466396861|FG001|Overall Study|Physician Decision|0|||
129573091|NCT01265056|466396862|FG000|Initial Study Period|Withdrawal by Subject|1|||
129573092|NCT01265056|466396863|FG001|Initial Study Period|Withdrawal by Subject|1|||
129573093|NCT01265056|466396862|FG000|Initial Study Period|Withdrawal by Subject|1|||
129573094|NCT01265056|466396863|FG001|Initial Study Period|Withdrawal by Subject|1|||
129573095|NCT01265056|466396862|FG000|Follow up|Lost to Follow-up|7|||
129573096|NCT01265056|466396863|FG001|Follow up|Lost to Follow-up|3|||
129573097|NCT03725605|466396867|FG000|Overall Study|Unsuccessful TIL expansion|2|||
129573098|NCT00965185|466396868|FG000|Overall Study|Lost to Follow-up|2|||
129573099|NCT00965185|466396869|FG001|Overall Study|Lost to Follow-up|0|||
129573100|NCT00965185|466396868|FG000|Overall Study|Withdrawal by Subject|0|||
129573101|NCT00965185|466396869|FG001|Overall Study|Withdrawal by Subject|1|||
129573102|NCT02272777|466396871|FG000|Overall Study|Adverse Event|0|||
129573103|NCT02272777|466396872|FG001|Overall Study|Adverse Event|1|||
129573104|NCT02272777|466396871|FG000|Overall Study|Withdrawal by Subject|0|||
129573105|NCT02272777|466396872|FG001|Overall Study|Withdrawal by Subject|3|||
129573106|NCT02272777|466396871|FG000|Overall Study|Lost to Follow-up|2|||
129573107|NCT02272777|466396872|FG001|Overall Study|Lost to Follow-up|0|||
129573108|NCT02272777|466396871|FG000|Overall Study|Other|2|||
129573109|NCT02272777|466396872|FG001|Overall Study|Other|0|||
129573110|NCT05275205|466396873|FG000|Overall Study|Adverse Event|1|||
129573111|NCT05275205|466396874|FG001|Overall Study|Adverse Event|2|||
129573112|NCT05275205|466396873|FG000|Overall Study|Physician Decision|1|||
129573113|NCT05275205|466396874|FG001|Overall Study|Physician Decision|1|||
129573114|NCT05275205|466396873|FG000|Overall Study|Withdrawal by Subject|2|||
129573115|NCT05275205|466396874|FG001|Overall Study|Withdrawal by Subject|3|||
129573116|NCT05275205|466396873|FG000|Overall Study|Death|1|||
129573117|NCT05275205|466396874|FG001|Overall Study|Death|0|||
129573118|NCT05275205|466396873|FG000|Overall Study|Patient unable to attend visits|1|||
129573119|NCT05275205|466396874|FG001|Overall Study|Patient unable to attend visits|0|||
129573120|NCT02066922|466396875|FG000|Overall Study|Adverse Event|1|||
129573121|NCT00440297|466396876|FG000|Overall Study|Adverse Event|8|||
129573122|NCT00440297|466396877|FG001|Overall Study|Adverse Event|5|||
129692419|NCT00191152|466832409|FG001|Initial Treatment|Other|21|||
129692420|NCT00191152|466832408|FG000|Crossover Treatment|Adverse Event|8|||
129692421|NCT00191152|466832409|FG001|Crossover Treatment|Adverse Event|8|||
129692422|NCT00191152|466832408|FG000|Crossover Treatment|Physician Decision|7|||
129692423|NCT00191152|466832409|FG001|Crossover Treatment|Physician Decision|7|||
129692424|NCT00191152|466832408|FG000|Crossover Treatment|Withdrawal by Subject|6|||
129692425|NCT00191152|466832409|FG001|Crossover Treatment|Withdrawal by Subject|9|||
129782852|NCT00984620|467173319|FG000|Overall Study|Lost to Follow-up|1|||
129782853|NCT00984620|467173320|FG001|Overall Study|Lost to Follow-up|1|||
129573123|NCT00440297|466396876|FG000|Overall Study|Lost to Follow-up|1|||
129573124|NCT00440297|466396877|FG001|Overall Study|Lost to Follow-up|0|||
129573125|NCT00440297|466396876|FG000|Overall Study|Physician Decision|1|||
129573126|NCT00440297|466396877|FG001|Overall Study|Physician Decision|0|||
129573127|NCT00440297|466396876|FG000|Overall Study|Protocol Violation|11|||
129573128|NCT00440297|466396877|FG001|Overall Study|Protocol Violation|7|||
129573129|NCT00440297|466396876|FG000|Overall Study|Withdrawal by Subject|1|||
129573130|NCT00440297|466396877|FG001|Overall Study|Withdrawal by Subject|6|||
129573131|NCT00440297|466396876|FG000|Overall Study|Randomized by mistake|1|||
129573132|NCT00440297|466396877|FG001|Overall Study|Randomized by mistake|0|||
129692426|NCT00191152|466832408|FG000|Crossover Treatment|Lost to Follow-up|2|||
129692427|NCT00191152|466832409|FG001|Crossover Treatment|Lost to Follow-up|1|||
129692428|NCT00191152|466832408|FG000|Crossover Treatment|Other|4|||
129692429|NCT00191152|466832409|FG001|Crossover Treatment|Other|3|||
129692430|NCT00114777|466832410|FG000|Randomization to Month 36|Death|10|||
129692431|NCT00114777|466832411|FG001|Randomization to Month 36|Death|4|||
129692432|NCT00114777|466832412|FG002|Randomization to Month 36|Death|3|||
129692433|NCT00114777|466832410|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
129692434|NCT00114777|466832411|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
129692435|NCT00114777|466832412|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
129692436|NCT00114777|466832410|FG000|Randomization to Month 36|Lack of Efficacy|19|||
129692437|NCT00114777|466832411|FG001|Randomization to Month 36|Lack of Efficacy|15|||
129692438|NCT00114777|466832412|FG002|Randomization to Month 36|Lack of Efficacy|17|||
129692439|NCT00114777|466832410|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
129692440|NCT00114777|466832411|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
129692441|NCT00114777|466832412|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
129692442|NCT00114777|466832410|FG000|Randomization to Month 36|Adverse Event|34|||
129692443|NCT00114777|466832411|FG001|Randomization to Month 36|Adverse Event|35|||
129692444|NCT00114777|466832412|FG002|Randomization to Month 36|Adverse Event|44|||
129692445|NCT00114777|466832410|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
129692446|NCT00114777|466832411|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
129692447|NCT00114777|466832412|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
129692448|NCT00114777|466832410|FG000|Randomization to Month 36|Other|9|||
129692449|NCT00114777|466832411|FG001|Randomization to Month 36|Other|3|||
129692450|NCT00114777|466832412|FG002|Randomization to Month 36|Other|12|||
129573133|NCT03020641|466396878|FG000|Overall Study|Lost to Follow-up|0|||
129573134|NCT03020641|466396879|FG001|Overall Study|Lost to Follow-up|1|||
129692451|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Death|8|||
129692452|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Death|13|||
129692453|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Death|7|||
129692454|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
129692455|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
129692456|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
129692457|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
129692458|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
129573135|NCT03020641|466396878|FG000|Overall Study|Converted to open surgery|2|||
129573136|NCT03020641|466396879|FG001|Overall Study|Converted to open surgery|1|||
129573137|NCT03020641|466396878|FG000|Overall Study|for surgery not performed|0|||
129573138|NCT03020641|466396879|FG001|Overall Study|for surgery not performed|1|||
129573139|NCT02039908|466396883|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
129573140|NCT02039908|466396884|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
129573141|NCT02039908|466396885|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
129573142|NCT02039908|466396886|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
129573143|NCT02039908|466396883|FG000|Phase 1-Summer|Protocol Violation|6|||
129573144|NCT02039908|466396884|FG001|Phase 1-Summer|Protocol Violation|0|||
129573145|NCT02039908|466396885|FG002|Phase 1-Summer|Protocol Violation|0|||
129573146|NCT02039908|466396886|FG003|Phase 1-Summer|Protocol Violation|0|||
129573147|NCT02039908|466396883|FG000|Phase 2-School Year|Lost to Follow-up|0|||
129573148|NCT02039908|466396884|FG001|Phase 2-School Year|Lost to Follow-up|0|||
129573149|NCT02039908|466396885|FG002|Phase 2-School Year|Lost to Follow-up|1|||
129573150|NCT02039908|466396886|FG003|Phase 2-School Year|Lost to Follow-up|3|||
129692459|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
129692460|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
129692461|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
129692462|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
129573151|NCT02039908|466396883|FG000|Phase 2-School Year|Protocol Violation|0|||
129573152|NCT02039908|466396884|FG001|Phase 2-School Year|Protocol Violation|0|||
129573153|NCT02039908|466396885|FG002|Phase 2-School Year|Protocol Violation|3|||
129573154|NCT02039908|466396886|FG003|Phase 2-School Year|Protocol Violation|0|||
129692463|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
129692464|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
129573155|NCT02039908|466396883|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
129573156|NCT02039908|466396884|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
129573157|NCT02039908|466396885|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
129573158|NCT02039908|466396886|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
129573159|NCT03375463|466398906|FG000|Period 1|Lost to Follow-up|0|||
129573160|NCT03375463|466398907|FG001|Period 1|Lost to Follow-up|0|||
129573161|NCT03375463|466398908|FG002|Period 1|Lost to Follow-up|1|||
129573162|NCT03375463|466398909|FG003|Period 1|Lost to Follow-up|0|||
129573163|NCT03375463|466398910|FG004|Period 1|Lost to Follow-up|0|||
129573164|NCT03375463|466398911|FG005|Period 1|Lost to Follow-up|0|||
129573165|NCT03375463|466398906|FG000|Period 1|Adverse Event|0|||
129573166|NCT03375463|466398907|FG001|Period 1|Adverse Event|0|||
129573167|NCT03375463|466398908|FG002|Period 1|Adverse Event|0|||
129692465|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
129692466|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
129692467|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
129573168|NCT03375463|466398909|FG003|Period 1|Adverse Event|0|||
129573169|NCT03375463|466398910|FG004|Period 1|Adverse Event|1|||
129573170|NCT03375463|466398911|FG005|Period 1|Adverse Event|0|||
129573171|NCT03375463|466398906|FG000|Period 2|Lost to Follow-up|1|||
129692468|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
129692469|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
129573172|NCT03375463|466398907|FG001|Period 2|Lost to Follow-up|1|||
129573173|NCT03375463|466398908|FG002|Period 2|Lost to Follow-up|0|||
129573174|NCT03375463|466398909|FG003|Period 2|Lost to Follow-up|0|||
129573175|NCT03375463|466398910|FG004|Period 2|Lost to Follow-up|0|||
129573176|NCT03375463|466398911|FG005|Period 2|Lost to Follow-up|0|||
129573177|NCT01602419|466398912|FG000|Overall Study|Not treated with Wilate|9|||
129573178|NCT01602419|466398912|FG000|Overall Study|Adverse Drug Reaction|4|||
129573179|NCT01602419|466398912|FG000|Overall Study|Insurance issues|3|||
129573180|NCT01602419|466398912|FG000|Overall Study|Changed treatment centre|1|||
129573181|NCT01602419|466398912|FG000|Overall Study|Treatment centre closed|1|||
129573182|NCT01602419|466398912|FG000|Overall Study|Withdrawal by Subject|5|||
129573183|NCT01602419|466398912|FG000|Overall Study|Lost to Follow-up|6|||
129573184|NCT01792635|466398913|FG000|Part B|Adverse Event|0|||
129573185|NCT01792635|466398914|FG001|Part B|Adverse Event|0|||
129573186|NCT01792635|466398915|FG002|Part B|Adverse Event|1|||
129573187|NCT01792635|466398913|FG000|Part B|Study terminated|0|||
129573188|NCT01792635|466398914|FG001|Part B|Study terminated|4|||
129573189|NCT01792635|466398915|FG002|Part B|Study terminated|3|||
129573190|NCT01513174|466398918|FG000|Overall Study|Inclusion Error|1|||
129573191|NCT01513174|466398919|FG001|Overall Study|Inclusion Error|7|||
129573192|NCT01513174|466398918|FG000|Overall Study|Not receive study treatment|3|||
129573193|NCT01513174|466398919|FG001|Overall Study|Not receive study treatment|1|||
129573194|NCT00467363|466398920|FG000|Overall Study|Lost to Follow-up|80|||
129573195|NCT00467363|466398921|FG001|Overall Study|Lost to Follow-up|70|||
129573196|NCT04533594|466398922|FG000|Overall Study|Death|26|||
129573197|NCT03138967|466398926|FG000|Overall Study|Death|0|||
129573198|NCT03138967|466398927|FG001|Overall Study|Death|1|||
129573199|NCT03138967|466398926|FG000|Overall Study|Physician Decision|1|||
129573200|NCT03138967|466398927|FG001|Overall Study|Physician Decision|3|||
129573201|NCT01029340|466398929|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
129573202|NCT01029340|466398930|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
129573203|NCT01029340|466398931|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
129573204|NCT01029340|466398932|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
129573205|NCT01029340|466398933|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
129573206|NCT01029340|466398934|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
129573207|NCT01029340|466398929|FG000|Part B Treatment Period|Protocol Violation|0|||
129573208|NCT01029340|466398930|FG001|Part B Treatment Period|Protocol Violation|0|||
129573209|NCT01029340|466398931|FG002|Part B Treatment Period|Protocol Violation|1|||
129573210|NCT01029340|466398932|FG003|Part B Treatment Period|Protocol Violation|0|||
129573211|NCT01029340|466398933|FG004|Part B Treatment Period|Protocol Violation|0|||
129573212|NCT01029340|466398934|FG005|Part B Treatment Period|Protocol Violation|0|||
129573213|NCT01029340|466398929|FG000|Extension Period|Adverse Event|0|||
129573214|NCT01029340|466398930|FG001|Extension Period|Adverse Event|0|||
129573215|NCT01029340|466398931|FG002|Extension Period|Adverse Event|0|||
129573216|NCT01029340|466398932|FG003|Extension Period|Adverse Event|0|||
129573217|NCT01029340|466398933|FG004|Extension Period|Adverse Event|0|||
129573218|NCT01029340|466398934|FG005|Extension Period|Adverse Event|1|||
129573219|NCT01029340|466398929|FG000|Extension Period|starting another study|0|||
129573220|NCT01029340|466398930|FG001|Extension Period|starting another study|0|||
129573221|NCT01029340|466398931|FG002|Extension Period|starting another study|0|||
129573222|NCT01029340|466398932|FG003|Extension Period|starting another study|0|||
129573223|NCT01029340|466398933|FG004|Extension Period|starting another study|0|||
129573224|NCT01029340|466398934|FG005|Extension Period|starting another study|8|||
129573225|NCT01029340|466398929|FG000|Extension Period|non-compliance|0|||
129692470|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
129573226|NCT01029340|466398930|FG001|Extension Period|non-compliance|0|||
129573227|NCT01029340|466398931|FG002|Extension Period|non-compliance|0|||
129573228|NCT01029340|466398932|FG003|Extension Period|non-compliance|0|||
129573229|NCT01029340|466398933|FG004|Extension Period|non-compliance|0|||
129692471|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
129692472|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
129692473|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
129692474|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
129692475|NCT00114777|466832410|FG000|Long-Term Extension to Month 84|Other|2|||
129573230|NCT01029340|466398934|FG005|Extension Period|non-compliance|1|||
129573231|NCT01029340|466398929|FG000|Extension Period|Withdrawal by Subject|0|||
129573232|NCT01029340|466398930|FG001|Extension Period|Withdrawal by Subject|0|||
129573233|NCT01029340|466398931|FG002|Extension Period|Withdrawal by Subject|0|||
129573234|NCT01029340|466398932|FG003|Extension Period|Withdrawal by Subject|0|||
129573235|NCT01029340|466398933|FG004|Extension Period|Withdrawal by Subject|0|||
129573236|NCT01029340|466398934|FG005|Extension Period|Withdrawal by Subject|1|||
129573237|NCT01029340|466398929|FG000|Extension Period|Physician Decision|0|||
129573238|NCT01029340|466398930|FG001|Extension Period|Physician Decision|0|||
129573239|NCT01029340|466398931|FG002|Extension Period|Physician Decision|0|||
129573240|NCT01029340|466398932|FG003|Extension Period|Physician Decision|0|||
129573241|NCT01029340|466398933|FG004|Extension Period|Physician Decision|0|||
129573242|NCT01029340|466398934|FG005|Extension Period|Physician Decision|1|||
129573243|NCT02648347|466398935|FG000|Overall Study|Death|174|||
129573244|NCT02648347|466398936|FG001|Overall Study|Death|167|||
129573245|NCT02648347|466398935|FG000|Overall Study|Withdrawal by Subject|16|||
129573246|NCT02648347|466398936|FG001|Overall Study|Withdrawal by Subject|9|||
129573247|NCT02648347|466398935|FG000|Overall Study|Lost to Follow-up|18|||
129573248|NCT02648347|466398936|FG001|Overall Study|Lost to Follow-up|21|||
129573249|NCT02648347|466398935|FG000|Overall Study|Missing|1|||
129573250|NCT02648347|466398936|FG001|Overall Study|Missing|0|||
129573251|NCT03546842|466398938|FG000|Overall Study|Protocol Violation|1|||
129573252|NCT03546842|466398938|FG000|Overall Study|Withdrawal by Subject|2|||
129573253|NCT02711852|466398950|FG000|Overall Study|Death|5|||
129573254|NCT02711852|466398950|FG000|Overall Study|Lost to Follow-up|1|||
129573255|NCT02711852|466398950|FG000|Overall Study|Completed follow-up|3|||
129573256|NCT02711852|466398950|FG000|Overall Study|Withdrawal by Subject|1|||
129573257|NCT02453386|466398956|FG000|Overall Study|Adverse Event|22|||
129573258|NCT02453386|466398957|FG001|Overall Study|Adverse Event|30|||
129573259|NCT02453386|466398958|FG002|Overall Study|Adverse Event|15|||
129573260|NCT02453386|466398956|FG000|Overall Study|Protocol Violation|1|||
129573261|NCT02453386|466398957|FG001|Overall Study|Protocol Violation|0|||
129573262|NCT02453386|466398958|FG002|Overall Study|Protocol Violation|1|||
129573263|NCT02453386|466398956|FG000|Overall Study|Withdrawal by Subject|10|||
129573264|NCT02453386|466398957|FG001|Overall Study|Withdrawal by Subject|9|||
129573265|NCT02453386|466398958|FG002|Overall Study|Withdrawal by Subject|9|||
129573266|NCT02453386|466398956|FG000|Overall Study|Sponsor Terminated Study|14|||
129573267|NCT02453386|466398957|FG001|Overall Study|Sponsor Terminated Study|8|||
129573268|NCT02453386|466398958|FG002|Overall Study|Sponsor Terminated Study|11|||
129573269|NCT02453386|466398956|FG000|Overall Study|Subject Terminated by Sponsor|1|||
129573270|NCT02453386|466398957|FG001|Overall Study|Subject Terminated by Sponsor|1|||
129573271|NCT02453386|466398958|FG002|Overall Study|Subject Terminated by Sponsor|1|||
129573272|NCT02453386|466398956|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
129573273|NCT02453386|466398957|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
129573274|NCT02453386|466398958|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
129573275|NCT02453386|466398956|FG000|Overall Study|Lost to Follow-up|0|||
129573276|NCT02453386|466398957|FG001|Overall Study|Lost to Follow-up|0|||
129573277|NCT02453386|466398958|FG002|Overall Study|Lost to Follow-up|1|||
129573278|NCT02453386|466398956|FG000|Overall Study|Other|1|||
129573279|NCT02453386|466398957|FG001|Overall Study|Other|0|||
129573280|NCT02453386|466398958|FG002|Overall Study|Other|1|||
129573281|NCT00833937|466398961|FG000|Washout|Withdrawal by Subject|1|||
129573282|NCT00833937|466398962|FG001|Washout|Withdrawal by Subject|0|||
129573283|NCT03233724|466398970|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129573284|NCT03233724|466398971|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129573285|NCT03233724|466398972|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129573286|NCT03233724|466398973|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
129573287|NCT03233724|466398974|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
129573288|NCT03233724|466398970|FG000|Phase I Dose Escalation|Best interest of participant|1|||
129573289|NCT03233724|466398971|FG001|Phase I Dose Escalation|Best interest of participant|1|||
129573290|NCT03233724|466398972|FG002|Phase I Dose Escalation|Best interest of participant|1|||
129573291|NCT03233724|466398973|FG003|Phase I Dose Escalation|Best interest of participant|0|||
129573292|NCT03233724|466398974|FG004|Phase I Dose Escalation|Best interest of participant|0|||
129573293|NCT03233724|466398970|FG000|Phase I Dose Escalation|Physician Decision|0|||
129573294|NCT03233724|466398971|FG001|Phase I Dose Escalation|Physician Decision|0|||
129573295|NCT03233724|466398972|FG002|Phase I Dose Escalation|Physician Decision|1|||
129573296|NCT03233724|466398973|FG003|Phase I Dose Escalation|Physician Decision|0|||
129573297|NCT03233724|466398974|FG004|Phase I Dose Escalation|Physician Decision|0|||
129573298|NCT03233724|466398970|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129573299|NCT03233724|466398971|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129573300|NCT03233724|466398972|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
129573301|NCT03233724|466398973|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129573302|NCT03233724|466398974|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
129573303|NCT02388191|466398976|FG000|Overall Study|Patient did not receive IUD|1|||
129573304|NCT02388191|466398977|FG001|Overall Study|Patient did not receive IUD|0|||
129573305|NCT03135834|466398978|FG000|Stage 1|Adverse Event|1|||
129573306|NCT03135834|466398979|FG001|Stage 1|Adverse Event|2|||
129573307|NCT03135834|466398980|FG002|Stage 1|Adverse Event|2|||
129573308|NCT03135834|466398981|FG003|Stage 1|Adverse Event|1|||
129573309|NCT03135834|466398978|FG000|Stage 1|Death|1|||
129573310|NCT03135834|466398979|FG001|Stage 1|Death|0|||
129573311|NCT03135834|466398980|FG002|Stage 1|Death|0|||
129573312|NCT03135834|466398981|FG003|Stage 1|Death|0|||
129573313|NCT03135834|466398978|FG000|Stage 1|Lost to Follow-up|17|||
129573314|NCT03135834|466398979|FG001|Stage 1|Lost to Follow-up|24|||
129573315|NCT03135834|466398980|FG002|Stage 1|Lost to Follow-up|21|||
129573316|NCT03135834|466398981|FG003|Stage 1|Lost to Follow-up|38|||
129573317|NCT03135834|466398978|FG000|Stage 1|No longer met eligibility criteria|1|||
129573318|NCT03135834|466398979|FG001|Stage 1|No longer met eligibility criteria|6|||
129573319|NCT03135834|466398980|FG002|Stage 1|No longer met eligibility criteria|2|||
129573320|NCT03135834|466398981|FG003|Stage 1|No longer met eligibility criteria|5|||
129573321|NCT03135834|466398978|FG000|Stage 1|Other|0|||
129573322|NCT03135834|466398979|FG001|Stage 1|Other|2|||
129573323|NCT03135834|466398980|FG002|Stage 1|Other|1|||
129573324|NCT03135834|466398981|FG003|Stage 1|Other|0|||
129573325|NCT03135834|466398978|FG000|Stage 1|Physician Decision|0|||
129573326|NCT03135834|466398979|FG001|Stage 1|Physician Decision|1|||
129573327|NCT03135834|466398980|FG002|Stage 1|Physician Decision|0|||
129573328|NCT03135834|466398981|FG003|Stage 1|Physician Decision|0|||
129573329|NCT03135834|466398978|FG000|Stage 1|Pregnancy|0|||
129573330|NCT03135834|466398979|FG001|Stage 1|Pregnancy|4|||
129573331|NCT03135834|466398980|FG002|Stage 1|Pregnancy|2|||
129573332|NCT03135834|466398981|FG003|Stage 1|Pregnancy|4|||
129573333|NCT03135834|466398978|FG000|Stage 1|Protocol Violation|1|||
129573334|NCT03135834|466398979|FG001|Stage 1|Protocol Violation|1|||
129573335|NCT03135834|466398980|FG002|Stage 1|Protocol Violation|2|||
129573336|NCT03135834|466398981|FG003|Stage 1|Protocol Violation|1|||
129573337|NCT03135834|466398978|FG000|Stage 1|Withdrawal by parent/guardian|2|||
129573338|NCT03135834|466398979|FG001|Stage 1|Withdrawal by parent/guardian|10|||
129573339|NCT03135834|466398980|FG002|Stage 1|Withdrawal by parent/guardian|2|||
129573340|NCT03135834|466398981|FG003|Stage 1|Withdrawal by parent/guardian|1|||
129573341|NCT03135834|466398978|FG000|Stage 1|Withdrawal by Subject|16|||
129573342|NCT03135834|466398979|FG001|Stage 1|Withdrawal by Subject|22|||
129573343|NCT03135834|466398980|FG002|Stage 1|Withdrawal by Subject|7|||
129573344|NCT03135834|466398981|FG003|Stage 1|Withdrawal by Subject|10|||
129573345|NCT03135834|466398978|FG000|Stage 1|Randomized but not Vaccinated|0|||
129573346|NCT03135834|466398979|FG001|Stage 1|Randomized but not Vaccinated|3|||
129573347|NCT03135834|466398980|FG002|Stage 1|Randomized but not Vaccinated|1|||
129573348|NCT03135834|466398981|FG003|Stage 1|Randomized but not Vaccinated|6|||
129573349|NCT03135834|466398978|FG000|Stage 2|Lost to Follow-up|0|||
129573350|NCT03135834|466398979|FG001|Stage 2|Lost to Follow-up|1|||
129573351|NCT03135834|466398980|FG002|Stage 2|Lost to Follow-up|0|||
129573352|NCT03135834|466398981|FG003|Stage 2|Lost to Follow-up|0|||
129573353|NCT03135834|466398978|FG000|Stage 2|Withdrawal by Subject|0|||
129573354|NCT03135834|466398979|FG001|Stage 2|Withdrawal by Subject|1|||
129573355|NCT03135834|466398980|FG002|Stage 2|Withdrawal by Subject|0|||
129573356|NCT03135834|466398981|FG003|Stage 2|Withdrawal by Subject|0|||
129573357|NCT03135834|466398978|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
129573358|NCT03135834|466398979|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
129573359|NCT03135834|466398980|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
129573360|NCT03135834|466398981|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
129573361|NCT03135834|466398978|FG000|Stage 2|Did not receive Booster Vaccination|1|||
129573362|NCT03135834|466398979|FG001|Stage 2|Did not receive Booster Vaccination|1|||
129573363|NCT03135834|466398980|FG002|Stage 2|Did not receive Booster Vaccination|0|||
129573364|NCT03135834|466398981|FG003|Stage 2|Did not receive Booster Vaccination|0|||
129692476|NCT00114777|466832411|FG001|Long-Term Extension to Month 84|Other|0|||
129692477|NCT00114777|466832412|FG002|Long-Term Extension to Month 84|Other|2|||
129692478|NCT00629239|466832417|FG000|Overall Study|Adverse Event|7|||
129692479|NCT00629239|466832418|FG001|Overall Study|Adverse Event|4|||
129692480|NCT00629239|466832417|FG000|Overall Study|Physician Decision|1|||
129692481|NCT00629239|466832418|FG001|Overall Study|Physician Decision|0|||
129692482|NCT01851369|466832419|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692483|NCT01851369|466832420|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692484|NCT01851369|466832421|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129573365|NCT03197883|466398982|FG000|Overall Study|Adverse Event|1|||
129573366|NCT03197883|466398983|FG001|Overall Study|Adverse Event|1|||
129573367|NCT03197883|466398982|FG000|Overall Study|Lost to Follow-up|1|||
129573368|NCT03197883|466398983|FG001|Overall Study|Lost to Follow-up|0|||
129573369|NCT03197883|466398982|FG000|Overall Study|Protocol Violation|1|||
129573370|NCT03197883|466398983|FG001|Overall Study|Protocol Violation|0|||
129573371|NCT03197883|466398982|FG000|Overall Study|Other (Not Specified)|0|||
129573372|NCT03197883|466398983|FG001|Overall Study|Other (Not Specified)|5|||
129573373|NCT03686033|466398984|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
129573374|NCT03686033|466398985|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
129573375|NCT03686033|466398986|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
129573376|NCT03686033|466398987|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
129573377|NCT03686033|466398988|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
129573378|NCT03686033|466398989|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
129573379|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
129573380|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
129573381|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
129573382|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
129573383|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
129573384|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
129573385|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
129573386|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
129573387|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
129573388|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
129573389|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
129573390|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
129573391|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
129573392|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
129573393|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
129573394|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
129573395|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
129573396|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
129573397|NCT01045161|466398990|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
129692485|NCT01851369|466832422|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692486|NCT01851369|466832423|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692487|NCT01851369|466832424|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
129692488|NCT01851369|466832425|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692489|NCT01851369|466832426|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692490|NCT01851369|466832427|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692491|NCT01851369|466832428|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692492|NCT01851369|466832429|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692493|NCT01851369|466832430|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692494|NCT01851369|466832431|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
129692495|NCT02453191|466832434|FG000|Overall Study|Withdrawal by Subject|1|||
129692496|NCT01520714|466832435|FG000|Overall Study|Protocol Violation|0|||
129692497|NCT01520714|466832436|FG001|Overall Study|Protocol Violation|3|||
129692498|NCT01520714|466832435|FG000|Overall Study|Adverse Event|0|||
129692499|NCT01520714|466832436|FG001|Overall Study|Adverse Event|2|||
129692500|NCT01520714|466832435|FG000|Overall Study|Lack of Efficacy|0|||
129692501|NCT01520714|466832436|FG001|Overall Study|Lack of Efficacy|1|||
129692502|NCT00183391|466832437|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
129692503|NCT00183391|466832438|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
129692504|NCT00183391|466832437|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
129692505|NCT00183391|466832438|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
129692506|NCT02336503|466832440|FG000|Overall Study|Lost to Follow-up|0|||
129692507|NCT02336503|466832441|FG001|Overall Study|Lost to Follow-up|3|||
129692508|NCT02336503|466832442|FG002|Overall Study|Lost to Follow-up|0|||
129692509|NCT02336503|466832443|FG003|Overall Study|Lost to Follow-up|2|||
129692510|NCT02336503|466832440|FG000|Overall Study|Withdrawal by Subject|2|||
129692511|NCT02336503|466832441|FG001|Overall Study|Withdrawal by Subject|0|||
129692512|NCT02336503|466832442|FG002|Overall Study|Withdrawal by Subject|0|||
129692513|NCT02336503|466832443|FG003|Overall Study|Withdrawal by Subject|4|||
129692514|NCT02336503|466832440|FG000|Overall Study|Adverse Event|0|||
129692515|NCT02336503|466832441|FG001|Overall Study|Adverse Event|0|||
129692516|NCT02336503|466832442|FG002|Overall Study|Adverse Event|1|||
129692517|NCT02336503|466832443|FG003|Overall Study|Adverse Event|0|||
129692518|NCT02460380|466832444|FG000|Overall Study|Withdrawal by Subject|10|||
129692519|NCT02460380|466832445|FG001|Overall Study|Withdrawal by Subject|5|||
129692520|NCT00395512|466832446|FG000|Overall Study|Adverse Event|3|||
129692521|NCT00395512|466832447|FG001|Overall Study|Adverse Event|8|||
129692522|NCT00395512|466832448|FG002|Overall Study|Adverse Event|6|||
129692523|NCT00395512|466832449|FG003|Overall Study|Adverse Event|6|||
129692524|NCT00395512|466832446|FG000|Overall Study|Protocol Violation|2|||
129692525|NCT00395512|466832447|FG001|Overall Study|Protocol Violation|3|||
129692526|NCT00395512|466832448|FG002|Overall Study|Protocol Violation|6|||
129692527|NCT00395512|466832449|FG003|Overall Study|Protocol Violation|7|||
129692528|NCT00395512|466832446|FG000|Overall Study|Lost to Follow-up|2|||
129692529|NCT00395512|466832447|FG001|Overall Study|Lost to Follow-up|6|||
129692530|NCT00395512|466832448|FG002|Overall Study|Lost to Follow-up|5|||
129692531|NCT00395512|466832449|FG003|Overall Study|Lost to Follow-up|5|||
129692532|NCT00395512|466832446|FG000|Overall Study|Withdrawal by Subject|6|||
129692533|NCT00395512|466832447|FG001|Overall Study|Withdrawal by Subject|5|||
129692534|NCT00395512|466832448|FG002|Overall Study|Withdrawal by Subject|5|||
129573398|NCT01045161|466398991|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
129573399|NCT01045161|466398992|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
129573400|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
129573401|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
129573402|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
129573403|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
129573404|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
129573405|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
129573406|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
129573407|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
129573408|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
129573409|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
129573410|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
129573411|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
129573412|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
129573413|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
129573414|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
129573415|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
129573416|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
129573417|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
129573418|NCT01045161|466398990|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
129573419|NCT01045161|466398991|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
129573420|NCT01045161|466398992|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
129573421|NCT03031847|466398993|FG000|Overall Study|Death|1|||
129573422|NCT03031847|466398994|FG001|Overall Study|Death|1|||
129573423|NCT03031847|466398995|FG002|Overall Study|Death|2|||
129573424|NCT03031847|466398996|FG003|Overall Study|Death|3|||
129573425|NCT03031847|466398993|FG000|Overall Study|Lost to Follow-up|1|||
129573426|NCT03031847|466398994|FG001|Overall Study|Lost to Follow-up|1|||
129573427|NCT03031847|466398995|FG002|Overall Study|Lost to Follow-up|2|||
129573428|NCT03031847|466398996|FG003|Overall Study|Lost to Follow-up|3|||
129573429|NCT00858845|466398998|FG000|Overall Study|Patient underwent heart transplant.|0|||
129573430|NCT00858845|466398999|FG001|Overall Study|Patient underwent heart transplant.|1|||
129573431|NCT01353664|466399001|FG000|Overall Study|Other|3|||
129573432|NCT01353664|466399001|FG000|Overall Study|Disease Progression|16|||
129573433|NCT02605928|466399004|FG000|Overall Study|Model tuning phase|28|||
129573434|NCT02605928|466399004|FG000|Overall Study|Lack of Efficacy|5|||
129573435|NCT02612337|466399012|FG000|Overall Study|Lack of Efficacy|1|||
129573436|NCT02612337|466399013|FG001|Overall Study|Lack of Efficacy|0|||
129573437|NCT02612337|466399012|FG000|Overall Study|Withdrawal by Subject|2|||
129573438|NCT02612337|466399013|FG001|Overall Study|Withdrawal by Subject|2|||
129573439|NCT02612337|466399012|FG000|Overall Study|Did not receive study drug|0|||
129573440|NCT02612337|466399013|FG001|Overall Study|Did not receive study drug|1|||
129573441|NCT02242201|466399014|FG000|Overall Study|preoperative identified neuropathy|2|||
129573442|NCT02242201|466399015|FG001|Overall Study|preoperative identified neuropathy|0|||
129573443|NCT02242201|466399016|FG002|Overall Study|preoperative identified neuropathy|0|||
129573444|NCT02242201|466399014|FG000|Overall Study|planned post-op anticoagulation|1|||
129573445|NCT02242201|466399015|FG001|Overall Study|planned post-op anticoagulation|0|||
129573446|NCT02242201|466399016|FG002|Overall Study|planned post-op anticoagulation|0|||
129573447|NCT02242201|466399014|FG000|Overall Study|changed surgical procedure|1|||
129573448|NCT02242201|466399015|FG001|Overall Study|changed surgical procedure|0|||
129573449|NCT02242201|466399016|FG002|Overall Study|changed surgical procedure|0|||
129782854|NCT00984620|467173319|FG000|Overall Study|Withdrawal by Subject|0|||
129782855|NCT00984620|467173320|FG001|Overall Study|Withdrawal by Subject|2|||
129782856|NCT00984620|467173319|FG000|Overall Study|reason other than listed above|0|||
129782857|NCT00984620|467173320|FG001|Overall Study|reason other than listed above|4|||
129782858|NCT01018810|467173321|FG000|Overall Study|Withdrawal by Subject|0|||
129782859|NCT01018810|467173322|FG001|Overall Study|Withdrawal by Subject|1|||
129782860|NCT01018810|467173323|FG002|Overall Study|Withdrawal by Subject|0|||
129782861|NCT01018810|467173324|FG003|Overall Study|Withdrawal by Subject|0|||
129782862|NCT01018810|467173325|FG004|Overall Study|Withdrawal by Subject|0|||
129782863|NCT01018810|467173321|FG000|Overall Study|Sponsor Decision|2|||
129573450|NCT02242201|466399014|FG000|Overall Study|postponed surgery|0|||
129573451|NCT02242201|466399015|FG001|Overall Study|postponed surgery|0|||
129573452|NCT02242201|466399016|FG002|Overall Study|postponed surgery|1|||
129573453|NCT02242201|466399014|FG000|Overall Study|preoperative opioid consumption|0|||
129573454|NCT02242201|466399015|FG001|Overall Study|preoperative opioid consumption|1|||
129782864|NCT01018810|467173322|FG001|Overall Study|Sponsor Decision|0|||
129782865|NCT01018810|467173323|FG002|Overall Study|Sponsor Decision|1|||
129782866|NCT01018810|467173324|FG003|Overall Study|Sponsor Decision|1|||
129573455|NCT02242201|466399016|FG002|Overall Study|preoperative opioid consumption|0|||
129573456|NCT02374853|466399020|FG000|Overall Study|Surgery Cancelled|5|||
129573457|NCT02374853|466399021|FG001|Overall Study|Surgery Cancelled|11|||
129573458|NCT02281084|466399022|FG000|Overall Study|Death|21|||
129573459|NCT02281084|466399023|FG001|Overall Study|Death|18|||
129573460|NCT02281084|466399024|FG002|Overall Study|Death|3|||
129573461|NCT02281084|466399025|FG003|Overall Study|Death|5|||
129573462|NCT02281084|466399022|FG000|Overall Study|Adverse Event|1|||
129573463|NCT02281084|466399023|FG001|Overall Study|Adverse Event|0|||
129573464|NCT02281084|466399024|FG002|Overall Study|Adverse Event|0|||
129573465|NCT02281084|466399025|FG003|Overall Study|Adverse Event|0|||
129573466|NCT02281084|466399022|FG000|Overall Study|Withdrawal by Subject|2|||
129573467|NCT02281084|466399023|FG001|Overall Study|Withdrawal by Subject|2|||
129573468|NCT02281084|466399024|FG002|Overall Study|Withdrawal by Subject|0|||
129573469|NCT02281084|466399025|FG003|Overall Study|Withdrawal by Subject|0|||
129573470|NCT02281084|466399022|FG000|Overall Study|Site Closure by Sponsor|5|||
129573471|NCT02281084|466399023|FG001|Overall Study|Site Closure by Sponsor|1|||
129573472|NCT02281084|466399024|FG002|Overall Study|Site Closure by Sponsor|2|||
129573473|NCT02281084|466399025|FG003|Overall Study|Site Closure by Sponsor|0|||
129573474|NCT01697696|466399026|FG000|Overall Study|Study terminated by sponsor|0|||
129573475|NCT01697696|466399027|FG001|Overall Study|Study terminated by sponsor|3|||
129573476|NCT01697696|466399026|FG000|Overall Study|Protocol deviation|1|||
129573477|NCT01697696|466399027|FG001|Overall Study|Protocol deviation|0|||
129573478|NCT01697696|466399026|FG000|Overall Study|Physician Decision|1|||
129573479|NCT01697696|466399027|FG001|Overall Study|Physician Decision|0|||
129573480|NCT01697696|466399026|FG000|Overall Study|Death|4|||
129573481|NCT01697696|466399027|FG001|Overall Study|Death|2|||
129573482|NCT01697696|466399026|FG000|Overall Study|Lost to Follow-up|10|||
129573483|NCT01697696|466399027|FG001|Overall Study|Lost to Follow-up|7|||
129573484|NCT01697696|466399026|FG000|Overall Study|Subject/guardian decision|31|||
129573485|NCT01697696|466399027|FG001|Overall Study|Subject/guardian decision|35|||
129573486|NCT01424644|466399028|FG000|Overall Study|Adverse Event|2|||
129573487|NCT01424644|466399029|FG001|Overall Study|Adverse Event|0|||
129573488|NCT01424644|466399028|FG000|Overall Study|Withdrawal by Subject|9|||
129573489|NCT01424644|466399029|FG001|Overall Study|Withdrawal by Subject|12|||
129573490|NCT01424644|466399028|FG000|Overall Study|Lost to Follow-up|16|||
129573491|NCT01424644|466399029|FG001|Overall Study|Lost to Follow-up|12|||
129573492|NCT01424644|466399028|FG000|Overall Study|Protocol Violation|4|||
129573493|NCT01424644|466399029|FG001|Overall Study|Protocol Violation|3|||
129573494|NCT01424644|466399028|FG000|Overall Study|Administrative Reason|1|||
129573495|NCT01424644|466399029|FG001|Overall Study|Administrative Reason|0|||
129573496|NCT01424644|466399028|FG000|Overall Study|Unable to Classify|1|||
129573497|NCT01424644|466399029|FG001|Overall Study|Unable to Classify|0|||
129573498|NCT05593965|466399030|FG000|1st Intervention (1 Day)|Technical error|1|||
129573499|NCT05593965|466399031|FG001|1st Intervention (1 Day)|Technical error|0|||
129573500|NCT01880593|466399044|FG000|Overall Study|Adverse Event|1|||
129573501|NCT01880593|466399045|FG001|Overall Study|Adverse Event|0|||
129573502|NCT01880593|466399044|FG000|Overall Study|Lack of Efficacy|1|||
129573503|NCT01880593|466399045|FG001|Overall Study|Lack of Efficacy|5|||
129573504|NCT01880593|466399044|FG000|Overall Study|Withdrawal by Subject|6|||
129573505|NCT01880593|466399045|FG001|Overall Study|Withdrawal by Subject|1|||
129573506|NCT02445339|466399053|FG000|Overall Study|Physician Decision|1|||
129573507|NCT02445339|466399054|FG001|Overall Study|Physician Decision|0|||
129573508|NCT02445339|466399053|FG000|Overall Study|Lost to Follow-up|11|||
129573509|NCT02445339|466399054|FG001|Overall Study|Lost to Follow-up|15|||
129573510|NCT02024932|466399055|FG000|Overall Study|Adverse Event|2|||
129573511|NCT02024932|466399056|FG001|Overall Study|Adverse Event|3|||
129573512|NCT02024932|466399057|FG002|Overall Study|Adverse Event|0|||
129573513|NCT02024932|466399058|FG003|Overall Study|Adverse Event|0|||
129573514|NCT02024932|466399059|FG004|Overall Study|Adverse Event|2|||
129573515|NCT02024932|466399060|FG005|Overall Study|Adverse Event|0|||
129573516|NCT02024932|466399055|FG000|Overall Study|Abnormal laboratory value|0|||
129573517|NCT02024932|466399056|FG001|Overall Study|Abnormal laboratory value|0|||
129573518|NCT02024932|466399057|FG002|Overall Study|Abnormal laboratory value|0|||
129573519|NCT02024932|466399058|FG003|Overall Study|Abnormal laboratory value|2|||
129573520|NCT02024932|466399059|FG004|Overall Study|Abnormal laboratory value|0|||
129573521|NCT02024932|466399060|FG005|Overall Study|Abnormal laboratory value|0|||
129573522|NCT03041025|466399061|FG000|Overall Study|Adverse Event|0|||
129573523|NCT03041025|466399062|FG001|Overall Study|Adverse Event|0|||
129782867|NCT01018810|467173325|FG004|Overall Study|Sponsor Decision|1|||
129782868|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
129573524|NCT03041025|466399063|FG002|Overall Study|Adverse Event|1|||
129573525|NCT03041025|466399061|FG000|Overall Study|Lost to Follow-up|1|||
129573526|NCT03041025|466399062|FG001|Overall Study|Lost to Follow-up|0|||
129573527|NCT03041025|466399063|FG002|Overall Study|Lost to Follow-up|0|||
129573528|NCT03041025|466399061|FG000|Overall Study|Withdrawal by Subject|0|||
129573529|NCT03041025|466399062|FG001|Overall Study|Withdrawal by Subject|0|||
129573530|NCT03041025|466399063|FG002|Overall Study|Withdrawal by Subject|1|||
129573531|NCT00939003|466399066|FG000|Double-blind Treatment Period|Adverse Event|1|||
129573532|NCT00939003|466399067|FG001|Double-blind Treatment Period|Adverse Event|1|||
129573533|NCT00939003|466399066|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129573534|NCT00939003|466399067|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
129573535|NCT00939003|466399066|FG000|Double-blind Treatment Period|Pregnancy|0|||
129573536|NCT00939003|466399067|FG001|Double-blind Treatment Period|Pregnancy|1|||
129573537|NCT00939003|466399066|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
129573538|NCT00939003|466399067|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
129573539|NCT00939003|466399066|FG000|Open-label Treatment Period|Adverse Event|4|||
129573540|NCT00939003|466399067|FG001|Open-label Treatment Period|Adverse Event|8|||
129573541|NCT00939003|466399066|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
129573542|NCT00939003|466399067|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
129573543|NCT00939003|466399066|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
129573544|NCT00939003|466399067|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
129573545|NCT00939003|466399066|FG000|Open-label Treatment Period|Pregnancy|1|||
129573546|NCT00939003|466399067|FG001|Open-label Treatment Period|Pregnancy|1|||
129573547|NCT00939003|466399066|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
129573548|NCT00939003|466399067|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
129573549|NCT00939003|466399066|FG000|Open-label Treatment Period|Site Closure|3|||
129573550|NCT00939003|466399067|FG001|Open-label Treatment Period|Site Closure|4|||
129573551|NCT00727961|466399068|FG000|Overall Study|Lost to Follow-up|1|||
129573552|NCT00727961|466399068|FG000|Overall Study|Adverse Event|4|||
129573553|NCT00727961|466399068|FG000|Overall Study|Patient's refusal|2|||
129573554|NCT00727961|466399068|FG000|Overall Study|Progression|30|||
129573555|NCT02131129|466399069|FG000|Overall Study|Withdrawal by Subject|1|||
129573556|NCT02131129|466399070|FG001|Overall Study|Withdrawal by Subject|0|||
129573557|NCT02865122|466399071|FG000|Overall Study|Adverse Event|1|||
129573558|NCT02865122|466399072|FG001|Overall Study|Adverse Event|0|||
129573559|NCT02865122|466399073|FG002|Overall Study|Adverse Event|0|||
129573560|NCT03880266|466399074|FG000|Overall Study|Withdrawal by Subject|0|||
129573561|NCT03880266|466399075|FG001|Overall Study|Withdrawal by Subject|1|||
129573562|NCT03880266|466399076|FG002|Overall Study|Withdrawal by Subject|1|||
129573563|NCT03880266|466399077|FG003|Overall Study|Withdrawal by Subject|0|||
129573564|NCT03880266|466399078|FG004|Overall Study|Withdrawal by Subject|0|||
129573565|NCT03880266|466399079|FG005|Overall Study|Withdrawal by Subject|0|||
129573566|NCT03880266|466399080|FG006|Overall Study|Withdrawal by Subject|0|||
129573567|NCT03880266|466399081|FG007|Overall Study|Withdrawal by Subject|0|||
129573568|NCT03161405|466399082|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
129573569|NCT00837486|466399085|FG000|Blinded-treatment Phase|Physician Decision|1|||
129573570|NCT00837486|466399086|FG001|Blinded-treatment Phase|Physician Decision|0|||
129573571|NCT00837486|466399085|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
129573572|NCT00837486|466399086|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
129573573|NCT00837486|466399085|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
129573574|NCT00837486|466399086|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
129573575|NCT00837486|466399085|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
129573576|NCT00837486|466399086|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
129573577|NCT01577381|466399088|FG000|Overall Study|Discontinued|2|||
129573578|NCT01577381|466399089|FG001|Overall Study|Discontinued|1|||
129573579|NCT01577381|466399090|FG002|Overall Study|Discontinued|2|||
129573580|NCT01577381|466399091|FG003|Overall Study|Discontinued|2|||
129573581|NCT01577381|466399088|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
129573582|NCT01577381|466399089|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
129573583|NCT01577381|466399090|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
129573584|NCT01577381|466399091|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
129573585|NCT01421277|466399092|FG000|Overall Study|Lack of qualifying event|0|||
129573586|NCT01421277|466399093|FG001|Overall Study|Lack of qualifying event|61|||
129573587|NCT01421277|466399092|FG000|Overall Study|Incomplete baseline data|0|||
129573588|NCT01421277|466399093|FG001|Overall Study|Incomplete baseline data|31|||
129573589|NCT02186821|466399094|FG000|Overall Study|Adverse Event|9|||
129573590|NCT02186821|466399094|FG000|Overall Study|Death|2|||
129573591|NCT02186821|466399094|FG000|Overall Study|Disease progression|32|||
129573592|NCT02186821|466399094|FG000|Overall Study|Protocol Violation|1|||
129573593|NCT02186821|466399094|FG000|Overall Study|Physician Decision|1|||
129573594|NCT02186821|466399094|FG000|Overall Study|Study terminated by sponsor|2|||
129573595|NCT00819741|466399101|FG000|Overall Study|Adverse Event|5|||
129573596|NCT00819741|466399102|FG001|Overall Study|Adverse Event|2|||
129573597|NCT00819741|466399101|FG000|Overall Study|Lack of Efficacy|0|||
129573598|NCT00819741|466399102|FG001|Overall Study|Lack of Efficacy|2|||
129573599|NCT00819741|466399101|FG000|Overall Study|Lost to Follow-up|3|||
129573600|NCT00819741|466399102|FG001|Overall Study|Lost to Follow-up|1|||
129573601|NCT00819741|466399101|FG000|Overall Study|Protocol Violation|3|||
129573602|NCT00819741|466399102|FG001|Overall Study|Protocol Violation|4|||
129573603|NCT00819741|466399101|FG000|Overall Study|Withdrawal by Subject|2|||
129573604|NCT00819741|466399102|FG001|Overall Study|Withdrawal by Subject|2|||
129573605|NCT00819741|466399101|FG000|Overall Study|Unclassified|6|||
129573606|NCT00819741|466399102|FG001|Overall Study|Unclassified|0|||
129573607|NCT00819741|466399101|FG000|Overall Study|Reasons unknown|3|||
129573608|NCT00819741|466399102|FG001|Overall Study|Reasons unknown|3|||
129573609|NCT00119015|466399103|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
129573610|NCT00119015|466399104|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
129573611|NCT00119015|466399105|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
129573612|NCT01597245|466399106|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
129573613|NCT01597245|466399107|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
129573614|NCT01597245|466399108|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
129573615|NCT01597245|466399109|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
129573616|NCT01597245|466399110|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573617|NCT01597245|466399111|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573618|NCT01597245|466399112|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573619|NCT01597245|466399113|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573620|NCT01597245|466399114|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573621|NCT01597245|466399115|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573622|NCT01597245|466399116|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573623|NCT01597245|466399117|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573624|NCT01597245|466399118|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573625|NCT01597245|466399119|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573626|NCT01597245|466399120|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573627|NCT01597245|466399121|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573628|NCT01597245|466399122|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573629|NCT01597245|466399123|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573630|NCT01597245|466399124|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573631|NCT01597245|466399125|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573632|NCT01597245|466399126|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
129573633|NCT01597245|466399106|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
129573634|NCT01597245|466399107|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
129573635|NCT01597245|466399108|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
129573636|NCT01597245|466399109|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
129573637|NCT01597245|466399110|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573638|NCT01597245|466399111|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573639|NCT01597245|466399112|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573640|NCT01597245|466399113|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573641|NCT01597245|466399114|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573642|NCT01597245|466399115|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573643|NCT01597245|466399116|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573644|NCT01597245|466399117|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573645|NCT01597245|466399118|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573646|NCT01597245|466399119|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573647|NCT01597245|466399120|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573648|NCT01597245|466399121|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573649|NCT01597245|466399122|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573650|NCT01597245|466399123|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573651|NCT01597245|466399124|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573652|NCT01597245|466399125|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573653|NCT01597245|466399126|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
129573654|NCT01597245|466399106|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
129573655|NCT01597245|466399107|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
129573656|NCT01597245|466399108|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
129573657|NCT01597245|466399109|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
129573658|NCT01597245|466399110|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573659|NCT01597245|466399111|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573660|NCT01597245|466399112|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573661|NCT01597245|466399113|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573662|NCT01597245|466399114|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573663|NCT01597245|466399115|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573664|NCT01597245|466399116|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573665|NCT01597245|466399117|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129782869|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
129573666|NCT01597245|466399118|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573667|NCT01597245|466399119|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573668|NCT01597245|466399120|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573669|NCT01597245|466399121|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573670|NCT01597245|466399122|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129782870|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Adverse Event|7|||
129573671|NCT01597245|466399123|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573672|NCT01597245|466399124|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573673|NCT01597245|466399125|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573674|NCT01597245|466399126|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
129573675|NCT01597245|466399106|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
129573676|NCT01597245|466399107|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
129573677|NCT01597245|466399108|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
129573678|NCT01597245|466399109|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573679|NCT01597245|466399110|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573680|NCT01597245|466399111|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573681|NCT01597245|466399112|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573682|NCT01597245|466399113|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573683|NCT01597245|466399114|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573684|NCT01597245|466399115|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573685|NCT01597245|466399116|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573686|NCT01597245|466399117|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573687|NCT01597245|466399118|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573688|NCT01597245|466399119|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573689|NCT01597245|466399120|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573690|NCT01597245|466399121|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573691|NCT01597245|466399122|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573692|NCT01597245|466399123|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573693|NCT01597245|466399124|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573694|NCT01597245|466399125|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573695|NCT01597245|466399126|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
129573696|NCT01597245|466399106|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
129573697|NCT01597245|466399107|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573698|NCT01597245|466399108|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573699|NCT01597245|466399109|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
129573700|NCT01597245|466399110|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573701|NCT01597245|466399111|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573702|NCT01597245|466399112|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573703|NCT01597245|466399113|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573704|NCT01597245|466399114|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573705|NCT01597245|466399115|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573706|NCT01597245|466399116|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573707|NCT01597245|466399117|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573708|NCT01597245|466399118|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573709|NCT01597245|466399119|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573710|NCT01597245|466399120|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573711|NCT01597245|466399121|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573712|NCT01597245|466399122|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573713|NCT01597245|466399123|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573714|NCT01597245|466399124|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573715|NCT01597245|466399125|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573716|NCT01597245|466399126|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
129573717|NCT01597245|466399106|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
129573718|NCT01597245|466399107|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
129573719|NCT01597245|466399108|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
129573720|NCT01597245|466399109|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573721|NCT01597245|466399110|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573722|NCT01597245|466399111|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573723|NCT01597245|466399112|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573724|NCT01597245|466399113|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573725|NCT01597245|466399114|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573726|NCT01597245|466399115|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573727|NCT01597245|466399116|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573728|NCT01597245|466399117|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573729|NCT01597245|466399118|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573730|NCT01597245|466399119|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573731|NCT01597245|466399120|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573732|NCT01597245|466399121|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573733|NCT01597245|466399122|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573734|NCT01597245|466399123|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573735|NCT01597245|466399124|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573736|NCT01597245|466399125|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573737|NCT01597245|466399126|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
129573738|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573739|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573740|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573741|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573742|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573743|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
129573744|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
129573745|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573746|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573747|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573748|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573749|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573750|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573751|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573752|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573753|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573754|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573755|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573756|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573757|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573758|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
129573759|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573760|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573761|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573762|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573763|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
129573764|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
129573765|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
129782871|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Adverse Event|6|||
129782872|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
129782873|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
129782874|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Physician Decision|4|||
129782875|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Physician Decision|4|||
129782876|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
129782877|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
129782878|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
129782879|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
129782880|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
129782881|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
129782882|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Non-compliance|1|||
129782883|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Non-compliance|0|||
129782884|NCT00470834|467173326|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
129782885|NCT00470834|467173327|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
129782886|NCT00470834|467173326|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
129782887|NCT00470834|467173327|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
129782888|NCT00470834|467173326|FG000|Extension Period (24 Months)|Adverse Event|3|||
129782889|NCT00470834|467173327|FG001|Extension Period (24 Months)|Adverse Event|4|||
129782890|NCT00470834|467173326|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
129782891|NCT00470834|467173327|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
129782892|NCT00470834|467173326|FG000|Extension Period (24 Months)|Physician Decision|4|||
129782893|NCT00470834|467173327|FG001|Extension Period (24 Months)|Physician Decision|3|||
129573766|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
129782894|NCT00470834|467173326|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
129573767|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573768|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
129573769|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573770|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573771|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573772|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573773|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573774|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573775|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573776|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573777|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573778|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573779|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
129573780|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573781|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573782|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573783|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573784|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573785|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
129573786|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573787|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573788|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
129573789|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573790|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
129573791|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
129573792|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
129573793|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573794|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573795|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573796|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573797|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573798|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573799|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573800|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
129573801|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573802|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573803|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573804|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573805|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
129573806|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
129573807|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
129573808|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
129573809|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
129573810|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
129573811|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
129573812|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
129573813|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
129573814|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573815|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573816|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573817|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573818|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573819|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129782895|NCT00470834|467173327|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
129782896|NCT00470834|467173326|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
129782897|NCT00470834|467173327|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
129782898|NCT00470834|467173326|FG000|Extension Period (24 Months)|Non-compliance|0|||
129782899|NCT00470834|467173327|FG001|Extension Period (24 Months)|Non-compliance|1|||
129782900|NCT00470834|467173326|FG000|Extension Period (24 Months)|Disease Progression|0|||
129782901|NCT00470834|467173327|FG001|Extension Period (24 Months)|Disease Progression|1|||
129782902|NCT00862641|467173330|FG000|Overall Study|Randomized, but drug not received|1|||
129782903|NCT00862641|467173331|FG001|Overall Study|Randomized, but drug not received|4|||
129782904|NCT00862641|467173332|FG002|Overall Study|Randomized, but drug not received|1|||
129884618|NCT01394250|467538602|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
129573820|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129573821|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
129884619|NCT01394250|467538603|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
129573822|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573823|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573824|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573825|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573826|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
129573827|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
129573828|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
129573829|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573830|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
129573831|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
129573832|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
129573833|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
129573834|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
129573835|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573836|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573837|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573838|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573839|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573840|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573841|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573842|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
129573843|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573844|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573845|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573846|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573847|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
129573848|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573849|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573850|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573851|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
129573852|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
129573853|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
129573854|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573855|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
129573856|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573857|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573858|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573859|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573860|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573861|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573862|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573863|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
129573864|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573865|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573866|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573867|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573868|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
129573869|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
129573870|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
129573871|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573872|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
129573873|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
129692535|NCT00395512|466832449|FG003|Overall Study|Withdrawal by Subject|12|||
129692536|NCT00395512|466832446|FG000|Overall Study|Physician Decision|6|||
129692537|NCT00395512|466832447|FG001|Overall Study|Physician Decision|4|||
129692538|NCT00395512|466832448|FG002|Overall Study|Physician Decision|2|||
129692539|NCT00395512|466832449|FG003|Overall Study|Physician Decision|2|||
129692540|NCT00395512|466832446|FG000|Overall Study|Other|1|||
129692541|NCT00395512|466832447|FG001|Overall Study|Other|1|||
129692542|NCT00395512|466832448|FG002|Overall Study|Other|0|||
129692543|NCT00395512|466832449|FG003|Overall Study|Other|0|||
129573874|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
129573875|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
129573876|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
129573877|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573878|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573879|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573880|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573881|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573882|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573883|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573884|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
129573885|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573886|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573887|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573888|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573889|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573890|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129573891|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129782905|NCT00862641|467173333|FG003|Overall Study|Randomized, but drug not received|4|||
129573892|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573893|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129573894|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129573895|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129782906|NCT02365480|467173334|FG000|Overall Study|Withdrawal by Subject|2|||
129782907|NCT02365480|467173335|FG001|Overall Study|Withdrawal by Subject|0|||
129782908|NCT04534686|467173336|FG000|Baseline Measurement|Lost to Follow-up|4|||
129782909|NCT04534686|467173337|FG001|Baseline Measurement|Lost to Follow-up|6|||
129782910|NCT04534686|467173336|FG000|Baseline Measurement|Withdrawal by Subject|3|||
129782911|NCT04534686|467173337|FG001|Baseline Measurement|Withdrawal by Subject|1|||
129782912|NCT04534686|467173336|FG000|Intervention|Withdrawal by Subject|2|||
129782913|NCT04534686|467173337|FG001|Intervention|Withdrawal by Subject|2|||
129573896|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
129573897|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573898|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573899|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573900|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573901|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573902|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573903|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573904|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573905|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
129573906|NCT01597245|466399106|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573907|NCT01597245|466399107|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573908|NCT01597245|466399108|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573909|NCT01597245|466399109|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573910|NCT01597245|466399110|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573911|NCT01597245|466399111|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573912|NCT01597245|466399112|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573913|NCT01597245|466399113|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573914|NCT01597245|466399114|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573915|NCT01597245|466399115|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573916|NCT01597245|466399116|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
129573917|NCT01597245|466399117|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573918|NCT01597245|466399118|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573919|NCT01597245|466399119|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573920|NCT01597245|466399120|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573921|NCT01597245|466399121|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573922|NCT01597245|466399122|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573923|NCT01597245|466399123|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573924|NCT01597245|466399124|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129782914|NCT01781299|467173341|FG000|Overall Study|Withdrawal by Subject|0|||
129782915|NCT01781299|467173342|FG001|Overall Study|Withdrawal by Subject|1|||
129782916|NCT01798849|467173346|FG000|Overall Study|Physician Decision|0|||
129782917|NCT01798849|467173347|FG001|Overall Study|Physician Decision|0|||
129573925|NCT01597245|466399125|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573926|NCT01597245|466399126|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
129573927|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573928|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573929|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573930|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573931|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573932|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573933|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573934|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573935|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573936|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573937|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573938|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573939|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573940|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
129573941|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
129573942|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
129573943|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573944|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573945|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573946|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573947|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
129573948|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573949|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573950|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573951|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573952|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573953|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573954|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573955|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573956|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573957|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573958|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573959|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573960|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573961|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
129573962|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
129573963|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
129573964|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573965|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573966|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573967|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573968|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
129573969|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573970|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573971|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573972|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573973|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573974|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573975|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573976|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573977|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573978|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573979|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573980|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573981|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573982|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573983|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
129573984|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
129573985|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129782918|NCT01798849|467173348|FG002|Overall Study|Physician Decision|1|||
129782919|NCT02636361|467173349|FG000|Period 4|Physician Decision|0|||
129782920|NCT02636361|467173350|FG001|Period 4|Physician Decision|0|||
129573986|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573987|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573988|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573989|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
129573990|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573991|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573992|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573993|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573994|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573995|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573996|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573997|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573998|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129573999|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574000|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574001|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574002|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574003|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574004|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
129574005|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
129574006|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574007|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574008|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574009|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574010|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
129574011|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574012|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574013|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574014|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574015|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574016|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574017|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574018|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574019|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574020|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574021|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574022|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574023|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574024|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
129574025|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
129574026|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
129574027|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574028|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574029|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574030|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574031|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
129574032|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574033|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574034|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574035|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574036|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574037|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574038|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574039|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574040|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574041|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574042|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574043|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574044|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
129692544|NCT00395512|466832446|FG000|Overall Study|Hyperglycemic Rescue|18|||
129692545|NCT00395512|466832447|FG001|Overall Study|Hyperglycemic Rescue|10|||
129692546|NCT00395512|466832448|FG002|Overall Study|Hyperglycemic Rescue|4|||
129692547|NCT00395512|466832449|FG003|Overall Study|Hyperglycemic Rescue|6|||
129692548|NCT01986751|466832454|FG000|Overall Study|improperly consented|10|||
129692549|NCT01986751|466832455|FG001|Overall Study|improperly consented|2|||
129782921|NCT02636361|467173351|FG002|Period 4|Physician Decision|0|||
129574045|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574046|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
129574047|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
129574048|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574049|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574050|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574051|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574052|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
129574053|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574054|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574055|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574056|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574057|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574058|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574059|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574060|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574061|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574062|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574063|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574064|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574065|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574066|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574067|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
129574068|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
129574069|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574070|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574071|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574072|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574073|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
129574074|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574075|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574076|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129692550|NCT01478087|466832456|FG000|Overall Study|due to sponsor closing study|1|||
129692551|NCT03566550|466832457|FG000|Overall Study|Withdrawal by Subject|0|||
129692552|NCT03566550|466832458|FG001|Overall Study|Withdrawal by Subject|1|||
129692553|NCT04576949|466832464|FG000|Overall Study|Adverse Event|1|||
129692554|NCT04576949|466832465|FG001|Overall Study|Adverse Event|3|||
129692555|NCT04576949|466832466|FG002|Overall Study|Adverse Event|2|||
129692556|NCT04576949|466832464|FG000|Overall Study|Withdrawal by Subject|41|||
129692557|NCT04576949|466832465|FG001|Overall Study|Withdrawal by Subject|26|||
129692558|NCT04576949|466832466|FG002|Overall Study|Withdrawal by Subject|18|||
129692559|NCT04576949|466832464|FG000|Overall Study|Physician Decision|3|||
129692560|NCT04576949|466832465|FG001|Overall Study|Physician Decision|0|||
129692561|NCT04576949|466832466|FG002|Overall Study|Physician Decision|0|||
129692562|NCT04576949|466832464|FG000|Overall Study|Death|0|||
129692563|NCT04576949|466832465|FG001|Overall Study|Death|1|||
129692564|NCT04576949|466832466|FG002|Overall Study|Death|0|||
129692565|NCT04576949|466832464|FG000|Overall Study|Lost to Follow-up|29|||
129692566|NCT04576949|466832465|FG001|Overall Study|Lost to Follow-up|37|||
129692567|NCT04576949|466832466|FG002|Overall Study|Lost to Follow-up|24|||
129692568|NCT04576949|466832464|FG000|Overall Study|Other, Not Specified|2|||
129692569|NCT04576949|466832465|FG001|Overall Study|Other, Not Specified|3|||
129692570|NCT04576949|466832466|FG002|Overall Study|Other, Not Specified|1|||
129692571|NCT04576949|466832464|FG000|Overall Study|Other|1|||
129692572|NCT04576949|466832465|FG001|Overall Study|Other|0|||
129692573|NCT04576949|466832466|FG002|Overall Study|Other|0|||
129692574|NCT00052715|466832467|FG000|Overall Study|wrong histology|1|||
129692575|NCT01063881|466832468|FG000|Overall Study|Adverse Event|12|||
129574077|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574078|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574079|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574080|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574081|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574082|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574083|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574084|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574085|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574086|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574087|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574088|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
129574089|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
129574090|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574091|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574092|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574093|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574094|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
129574095|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574096|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574097|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574098|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574099|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574100|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574101|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574102|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574103|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574104|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574105|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574106|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574107|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129692576|NCT01063881|466832469|FG001|Overall Study|Adverse Event|2|||
129692577|NCT01063881|466832470|FG002|Overall Study|Adverse Event|0|||
129692578|NCT01063881|466832468|FG000|Overall Study|Lost to Follow-up|13|||
129692579|NCT01063881|466832469|FG001|Overall Study|Lost to Follow-up|7|||
129692580|NCT01063881|466832470|FG002|Overall Study|Lost to Follow-up|1|||
129692581|NCT01063881|466832468|FG000|Overall Study|Withdrawal by Subject|25|||
129692582|NCT01063881|466832469|FG001|Overall Study|Withdrawal by Subject|1|||
129692583|NCT01063881|466832470|FG002|Overall Study|Withdrawal by Subject|0|||
129692584|NCT01063881|466832468|FG000|Overall Study|Reason for not completed not specified|5|||
129692585|NCT01063881|466832469|FG001|Overall Study|Reason for not completed not specified|1|||
129692586|NCT01063881|466832470|FG002|Overall Study|Reason for not completed not specified|0|||
129692587|NCT01489358|466832471|FG000|Overall Study|Lost to Follow-up|0|||
129692588|NCT01489358|466832472|FG001|Overall Study|Lost to Follow-up|0|||
129692589|NCT01489358|466832473|FG002|Overall Study|Lost to Follow-up|2|||
129692590|NCT00736476|466832474|FG000|Overall Study|Adverse Event|1|||
129692591|NCT00736476|466832475|FG001|Overall Study|Adverse Event|0|||
129692592|NCT03518203|466832480|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
129692593|NCT03518203|466832480|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
129692594|NCT03511066|466832483|FG000|Overall Study|Withdrawal by Subject|1|||
129692595|NCT03511066|466832484|FG001|Overall Study|Withdrawal by Subject|2|||
129692596|NCT03511066|466832485|FG002|Overall Study|Withdrawal by Subject|3|||
129692597|NCT03511066|466832483|FG000|Overall Study|Lost to Follow-up|2|||
129692598|NCT03511066|466832484|FG001|Overall Study|Lost to Follow-up|3|||
129692599|NCT03511066|466832485|FG002|Overall Study|Lost to Follow-up|0|||
129692600|NCT02362412|466832486|FG000|Treatment Period III|Lost to Follow-up|0|||
129692601|NCT02362412|466832487|FG001|Treatment Period III|Lost to Follow-up|1|||
129692602|NCT01541254|466832488|FG000|Overall Study|Withdrawal by Subject|1|||
129692603|NCT01541254|466832488|FG000|Overall Study|excluded - metal allergy|1|||
129692604|NCT01541254|466832488|FG000|Overall Study|enrolled after study closed|1|||
129574108|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574109|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
129692605|NCT01541254|466832488|FG000|Overall Study|GI bleed prior to procedure|1|||
129692606|NCT01541254|466832488|FG000|Overall Study|stent not required|1|||
129692607|NCT01541254|466832488|FG000|Overall Study|alternate stent used|1|||
129692608|NCT05103332|466832491|FG000|Overall Study|Lost to Follow-up|0|||
129692609|NCT05103332|466832492|FG001|Overall Study|Lost to Follow-up|2|||
129692610|NCT05103332|466832493|FG002|Overall Study|Lost to Follow-up|1|||
129692611|NCT05103332|466832494|FG003|Overall Study|Lost to Follow-up|0|||
129692612|NCT05103332|466832495|FG004|Overall Study|Lost to Follow-up|0|||
129574110|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
129574111|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574112|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574113|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574114|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574115|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
129574116|NCT01597245|466399106|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574117|NCT01597245|466399107|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574118|NCT01597245|466399108|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574119|NCT01597245|466399109|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574120|NCT01597245|466399110|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574121|NCT01597245|466399111|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574122|NCT01597245|466399112|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574123|NCT01597245|466399113|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574124|NCT01597245|466399114|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574125|NCT01597245|466399115|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574126|NCT01597245|466399116|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574127|NCT01597245|466399117|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574128|NCT01597245|466399118|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574129|NCT01597245|466399119|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
129574130|NCT01597245|466399120|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574131|NCT01597245|466399121|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574132|NCT01597245|466399122|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574133|NCT01597245|466399123|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574134|NCT01597245|466399124|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574135|NCT01597245|466399125|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574136|NCT01597245|466399126|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
129574137|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574138|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574139|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574140|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574141|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574142|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574143|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574144|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574145|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574146|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574147|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574148|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574149|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574150|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574151|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574152|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
129574153|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
129574154|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
129574155|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
129574156|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
129574157|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
129574158|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574159|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574160|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574161|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574162|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574163|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129692613|NCT05103332|466832496|FG005|Overall Study|Lost to Follow-up|2|||
129692614|NCT05103332|466832491|FG000|Overall Study|Physician Decision|0|||
129692615|NCT05103332|466832492|FG001|Overall Study|Physician Decision|1|||
129692616|NCT05103332|466832493|FG002|Overall Study|Physician Decision|0|||
129692617|NCT05103332|466832494|FG003|Overall Study|Physician Decision|1|||
129692618|NCT05103332|466832495|FG004|Overall Study|Physician Decision|0|||
129692619|NCT05103332|466832496|FG005|Overall Study|Physician Decision|0|||
129692620|NCT05103332|466832491|FG000|Overall Study|Participant Stopped Participation in the Study|2|||
129692621|NCT05103332|466832492|FG001|Overall Study|Participant Stopped Participation in the Study|3|||
129692622|NCT05103332|466832493|FG002|Overall Study|Participant Stopped Participation in the Study|5|||
129692623|NCT05103332|466832494|FG003|Overall Study|Participant Stopped Participation in the Study|3|||
129782922|NCT02636361|467173352|FG003|Period 4|Physician Decision|1|||
129782923|NCT02636361|467173353|FG004|Period 4|Physician Decision|0|||
129782924|NCT02032238|467173354|FG000|Overall Study|Lost to Follow-up|2|||
129782925|NCT02032238|467173355|FG001|Overall Study|Lost to Follow-up|0|||
129782926|NCT00246740|467173364|FG000|Initial Enrollment|Death|1|||
129782927|NCT00246740|467173365|FG001|Initial Enrollment|Death|0|||
129782928|NCT00246740|467173364|FG000|Initial Enrollment|Additional surgery scheduled|0|||
129782929|NCT00246740|467173365|FG001|Initial Enrollment|Additional surgery scheduled|2|||
129782930|NCT00246740|467173364|FG000|Initial Enrollment|Surgery schedule change|4|||
129782931|NCT00246740|467173365|FG001|Initial Enrollment|Surgery schedule change|4|||
129782932|NCT00246740|467173364|FG000|Initial Enrollment|Other|1|||
129782933|NCT00246740|467173365|FG001|Initial Enrollment|Other|2|||
129782934|NCT02969655|467173367|FG000|Overall Study|Withdrawal by Subject|3|||
129782935|NCT02969655|467173368|FG001|Overall Study|Withdrawal by Subject|2|||
129782936|NCT02969655|467173367|FG000|Overall Study|Physician Decision|4|||
129782937|NCT02969655|467173368|FG001|Overall Study|Physician Decision|3|||
129782938|NCT02969655|467173367|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
129782939|NCT02969655|467173368|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
129782940|NCT02969655|467173367|FG000|Overall Study|Adverse Event|10|||
129782941|NCT02969655|467173368|FG001|Overall Study|Adverse Event|8|||
129782942|NCT01510769|467173369|FG000|Overall Study|Adverse Event|7|||
129782943|NCT01510769|467173370|FG001|Overall Study|Adverse Event|6|||
129782944|NCT01510769|467173371|FG002|Overall Study|Adverse Event|4|||
129782945|NCT01510769|467173369|FG000|Overall Study|Gout Flare|0|||
129782946|NCT01510769|467173370|FG001|Overall Study|Gout Flare|3|||
129782947|NCT01510769|467173371|FG002|Overall Study|Gout Flare|1|||
129782948|NCT01510769|467173369|FG000|Overall Study|Protocol Violation|11|||
129782949|NCT01510769|467173370|FG001|Overall Study|Protocol Violation|10|||
129782950|NCT01510769|467173371|FG002|Overall Study|Protocol Violation|9|||
129782951|NCT01510769|467173369|FG000|Overall Study|Lost to Follow-up|5|||
129782952|NCT01510769|467173370|FG001|Overall Study|Lost to Follow-up|1|||
129782953|NCT01510769|467173371|FG002|Overall Study|Lost to Follow-up|5|||
129782954|NCT01510769|467173369|FG000|Overall Study|Withdrawal by Subject|3|||
129782955|NCT01510769|467173370|FG001|Overall Study|Withdrawal by Subject|4|||
129782956|NCT01510769|467173371|FG002|Overall Study|Withdrawal by Subject|3|||
129782957|NCT01510769|467173369|FG000|Overall Study|Death|1|||
129782958|NCT01510769|467173370|FG001|Overall Study|Death|1|||
129782959|NCT01510769|467173371|FG002|Overall Study|Death|0|||
129782960|NCT00335764|467173374|FG000|Overall Study|wrong histology|1|||
129782961|NCT00335764|467173375|FG001|Overall Study|wrong histology|0|||
129782962|NCT00335764|467173376|FG002|Overall Study|wrong histology|0|||
129782963|NCT00335764|467173377|FG003|Overall Study|wrong histology|0|||
129782964|NCT00335764|467173378|FG004|Overall Study|wrong histology|1|||
129782965|NCT02466659|467173379|FG000|Overall Study|Lost to Follow-up|5|||
129782966|NCT02466659|467173380|FG001|Overall Study|Lost to Follow-up|2|||
129692624|NCT05103332|466832495|FG004|Overall Study|Participant Stopped Participation in the Study|3|||
129692625|NCT05103332|466832496|FG005|Overall Study|Participant Stopped Participation in the Study|7|||
129692626|NCT05103332|466832491|FG000|Overall Study|Unspeccified|0|||
129692627|NCT05103332|466832492|FG001|Overall Study|Unspeccified|0|||
129692628|NCT05103332|466832493|FG002|Overall Study|Unspeccified|0|||
129692629|NCT05103332|466832494|FG003|Overall Study|Unspeccified|1|||
129692630|NCT05103332|466832495|FG004|Overall Study|Unspeccified|0|||
129692631|NCT05103332|466832496|FG005|Overall Study|Unspeccified|0|||
129692632|NCT02218268|466832497|FG000|24 Hour Washout|Physician Decision|11|||
129692633|NCT02218268|466832498|FG001|24 Hour Washout|Physician Decision|9|||
129692634|NCT03651336|466832499|FG000|Overall Study|Withdrawal by Subject|4|||
129692635|NCT01125748|466832502|FG000|Overall Study|Adverse Event|0|||
129692636|NCT01125748|466832503|FG001|Overall Study|Adverse Event|2|||
129692637|NCT01125748|466832502|FG000|Overall Study|Lost to Follow-up|0|||
129692638|NCT01125748|466832503|FG001|Overall Study|Lost to Follow-up|1|||
129692639|NCT01125748|466832502|FG000|Overall Study|Physician Decision|8|||
129692640|NCT01125748|466832503|FG001|Overall Study|Physician Decision|7|||
129692641|NCT01125748|466832502|FG000|Overall Study|Patient Decision to Withdraw|2|||
129692642|NCT01125748|466832503|FG001|Overall Study|Patient Decision to Withdraw|4|||
129692643|NCT01028391|466832504|FG000|Overall Study|Adverse Event|4|||
129692644|NCT01028391|466832505|FG001|Overall Study|Adverse Event|0|||
129782967|NCT01536392|467173383|FG000|Overall Study|Adverse Event|2|||
129782968|NCT01536392|467173384|FG001|Overall Study|Adverse Event|2|||
129782969|NCT01536392|467173383|FG000|Overall Study|Physician Decision|2|||
129782970|NCT01536392|467173384|FG001|Overall Study|Physician Decision|3|||
129692645|NCT01028391|466832504|FG000|Overall Study|Lack of Efficacy|0|||
129692646|NCT01028391|466832505|FG001|Overall Study|Lack of Efficacy|2|||
129692647|NCT01028391|466832504|FG000|Overall Study|Lost to Follow-up|3|||
129782971|NCT01536392|467173383|FG000|Overall Study|Withdrawal by Subject|3|||
129692648|NCT01028391|466832505|FG001|Overall Study|Lost to Follow-up|4|||
129692649|NCT01028391|466832504|FG000|Overall Study|Physician Decision|0|||
129782972|NCT01536392|467173384|FG001|Overall Study|Withdrawal by Subject|6|||
129782973|NCT01536392|467173383|FG000|Overall Study|Non Compliance|3|||
129574164|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574165|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574166|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574167|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574168|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574169|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574170|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574171|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574172|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574173|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574174|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
129574175|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
129574176|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
129574177|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
129574178|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
129574179|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574180|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574181|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574182|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574183|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574184|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574185|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574186|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574187|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574188|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574189|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574190|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574191|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574192|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574193|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574194|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574195|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
129574196|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574197|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
129574198|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
129574199|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
129574200|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574201|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574202|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574203|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574204|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574205|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574206|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574207|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574208|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574209|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574210|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574211|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574212|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574213|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574214|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574215|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574216|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574217|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
129574218|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
129574219|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
129574220|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
129574221|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129692650|NCT01028391|466832505|FG001|Overall Study|Physician Decision|1|||
129692651|NCT01028391|466832504|FG000|Overall Study|Withdrawal by Subject|6|||
129692652|NCT01028391|466832505|FG001|Overall Study|Withdrawal by Subject|3|||
129692653|NCT01028391|466832504|FG000|Overall Study|Needed excluded medication|1|||
129692654|NCT01028391|466832505|FG001|Overall Study|Needed excluded medication|1|||
129692655|NCT01227395|466832506|FG000|Overall Study|Protocol Violation|0|||
129574222|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574223|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574224|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574225|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574226|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574227|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574228|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574229|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574230|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574231|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574232|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574233|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574234|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574235|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574236|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574237|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
129574238|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574239|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
129574240|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
129574241|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
129574242|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574243|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574244|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574245|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574246|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574247|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574248|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574249|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574250|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574251|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574252|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574253|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129692656|NCT01227395|466832507|FG001|Overall Study|Protocol Violation|1|||
129692657|NCT00086307|466832512|FG000|Overall Study|Lack of Efficacy|1|||
129692658|NCT00086307|466832513|FG001|Overall Study|Lack of Efficacy|1|||
129692659|NCT00086307|466832514|FG002|Overall Study|Lack of Efficacy|2|||
129692660|NCT00086307|466832512|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
129692661|NCT00086307|466832513|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
129692662|NCT00086307|466832514|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
129692663|NCT00086307|466832512|FG000|Overall Study|Nausea and headaches|0|||
129692664|NCT00086307|466832513|FG001|Overall Study|Nausea and headaches|0|||
129692665|NCT00086307|466832514|FG002|Overall Study|Nausea and headaches|1|||
129692666|NCT00086307|466832512|FG000|Overall Study|Constipation and sleepiness|0|||
129692667|NCT00086307|466832513|FG001|Overall Study|Constipation and sleepiness|0|||
129692668|NCT00086307|466832514|FG002|Overall Study|Constipation and sleepiness|1|||
129692669|NCT00086307|466832512|FG000|Overall Study|Suicidal ideation|0|||
129692670|NCT00086307|466832513|FG001|Overall Study|Suicidal ideation|0|||
129692671|NCT00086307|466832514|FG002|Overall Study|Suicidal ideation|1|||
129692672|NCT00086307|466832512|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
129692673|NCT00086307|466832513|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
129692674|NCT00086307|466832514|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
129692675|NCT00086307|466832512|FG000|Overall Study|Withdrawal by Subject|0|||
129692676|NCT00086307|466832513|FG001|Overall Study|Withdrawal by Subject|0|||
129692677|NCT00086307|466832514|FG002|Overall Study|Withdrawal by Subject|2|||
129692678|NCT00105508|466832515|FG000|Overall Study|Prephase Dropout|1|||
129692679|NCT00105508|466832516|FG001|Overall Study|Prephase Dropout|0|||
129692680|NCT00105508|466832515|FG000|Overall Study|Adverse Event|16|||
129692681|NCT00105508|466832516|FG001|Overall Study|Adverse Event|19|||
129692682|NCT00105508|466832515|FG000|Overall Study|Insufficient Efficacy|1|||
129692683|NCT00105508|466832516|FG001|Overall Study|Insufficient Efficacy|0|||
129692684|NCT00105508|466832515|FG000|Overall Study|Withdrawal by Subject|10|||
129574254|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574255|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574256|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574257|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574258|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
129574259|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574260|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
129574261|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
129574262|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
129574263|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574264|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574265|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574266|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574267|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574268|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574269|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574270|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574271|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574272|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574273|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574274|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574275|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574276|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574277|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574278|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574279|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
129574280|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574281|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574282|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
129574283|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
129574284|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574285|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574286|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574287|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574288|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574289|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574290|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574291|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574292|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574293|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574294|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574295|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574296|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574297|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574298|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574299|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574300|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
129574301|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574302|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574303|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
129574304|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
129574305|NCT01597245|466399106|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574306|NCT01597245|466399107|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574307|NCT01597245|466399108|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574308|NCT01597245|466399109|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574309|NCT01597245|466399110|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129782974|NCT01536392|467173384|FG001|Overall Study|Non Compliance|4|||
129574310|NCT01597245|466399111|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574311|NCT01597245|466399112|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574312|NCT01597245|466399113|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574313|NCT01597245|466399114|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574314|NCT01597245|466399115|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574315|NCT01597245|466399116|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574316|NCT01597245|466399117|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574317|NCT01597245|466399118|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574318|NCT01597245|466399119|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574319|NCT01597245|466399120|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574320|NCT01597245|466399121|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574321|NCT01597245|466399122|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574322|NCT01597245|466399123|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574323|NCT01597245|466399124|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574324|NCT01597245|466399125|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
129574325|NCT01597245|466399126|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
129574326|NCT01313780|466399127|FG000|Overall Study|Lack of Efficacy|4|||
129574327|NCT01313780|466399128|FG001|Overall Study|Lack of Efficacy|2|||
129574328|NCT01313780|466399127|FG000|Overall Study|Adverse Event|6|||
129574329|NCT01313780|466399128|FG001|Overall Study|Adverse Event|11|||
129574330|NCT01313780|466399127|FG000|Overall Study|Withdrawal by Subject|2|||
129574331|NCT01313780|466399128|FG001|Overall Study|Withdrawal by Subject|8|||
129574332|NCT01313780|466399127|FG000|Overall Study|Protocol Violation|10|||
129574333|NCT01313780|466399128|FG001|Overall Study|Protocol Violation|4|||
129574334|NCT01313780|466399127|FG000|Overall Study|missing data|3|||
129574335|NCT01313780|466399128|FG001|Overall Study|missing data|3|||
129574336|NCT00731783|466399129|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
129574337|NCT00731783|466399130|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
129574338|NCT00731783|466399129|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
129692685|NCT00105508|466832516|FG001|Overall Study|Withdrawal by Subject|6|||
129692686|NCT00105508|466832515|FG000|Overall Study|Lost to Follow-up|3|||
129692687|NCT00105508|466832516|FG001|Overall Study|Lost to Follow-up|0|||
129692688|NCT00105508|466832515|FG000|Overall Study|Protocol Violation|1|||
129692689|NCT00105508|466832516|FG001|Overall Study|Protocol Violation|2|||
129692690|NCT00105508|466832515|FG000|Overall Study|Other|8|||
129692691|NCT00105508|466832516|FG001|Overall Study|Other|9|||
129692692|NCT00683384|466832517|FG000|Overall Study|Death|1|||
129692693|NCT00683384|466832517|FG000|Overall Study|Adverse Event|1|||
129692694|NCT00120874|466832519|FG000|Overall Study|Death|0|||
129692695|NCT00120874|466832520|FG001|Overall Study|Death|1|||
129692696|NCT03882801|466834178|FG000|Period 1|Adverse Event|0|||
129692697|NCT03882801|466834179|FG001|Period 1|Adverse Event|1|||
129692698|NCT03882801|466834178|FG000|Period 1|Non-compliance with study drug|1|||
129692699|NCT03882801|466834179|FG001|Period 1|Non-compliance with study drug|1|||
129692700|NCT03882801|466834178|FG000|Period 1|Never treated with study drug|1|||
129692701|NCT03882801|466834179|FG001|Period 1|Never treated with study drug|0|||
129692702|NCT03882801|466834178|FG000|Washout Period|Physician Decision|0|||
129692703|NCT03882801|466834179|FG001|Washout Period|Physician Decision|1|||
129692704|NCT03882801|466834178|FG000|Period 2|Non-compliance with study drug|0|||
129574339|NCT00731783|466399130|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
129574340|NCT00731783|466399129|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
129574341|NCT00731783|466399130|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
129574342|NCT00731783|466399129|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
129574343|NCT00731783|466399130|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
129574344|NCT03818581|466400704|FG000|Overall Study|Adverse Event|1|||
129574345|NCT03818581|466400705|FG001|Overall Study|Adverse Event|0|||
129574346|NCT03818581|466400706|FG002|Overall Study|Adverse Event|0|||
129574347|NCT03818581|466400707|FG003|Overall Study|Adverse Event|0|||
129574348|NCT03818581|466400708|FG004|Overall Study|Adverse Event|0|||
129574349|NCT03818581|466400704|FG000|Overall Study|Covid-19|2|||
129574350|NCT03818581|466400705|FG001|Overall Study|Covid-19|0|||
129574351|NCT03818581|466400706|FG002|Overall Study|Covid-19|0|||
129574352|NCT03818581|466400707|FG003|Overall Study|Covid-19|0|||
129574353|NCT03818581|466400708|FG004|Overall Study|Covid-19|1|||
129574354|NCT03818581|466400704|FG000|Overall Study|Withdrawal by Subject|0|||
129574355|NCT03818581|466400705|FG001|Overall Study|Withdrawal by Subject|0|||
129574356|NCT03818581|466400706|FG002|Overall Study|Withdrawal by Subject|0|||
129574357|NCT03818581|466400707|FG003|Overall Study|Withdrawal by Subject|0|||
129574358|NCT03818581|466400708|FG004|Overall Study|Withdrawal by Subject|1|||
129574359|NCT03818581|466400704|FG000|Overall Study|No longer met study criteria|0|||
129574360|NCT03818581|466400705|FG001|Overall Study|No longer met study criteria|0|||
129574361|NCT03818581|466400706|FG002|Overall Study|No longer met study criteria|0|||
129574362|NCT03818581|466400707|FG003|Overall Study|No longer met study criteria|0|||
129574363|NCT03818581|466400708|FG004|Overall Study|No longer met study criteria|1|||
129574364|NCT00462345|466400709|FG000|Overall Study|Withdrawal by Subject|2|||
129692705|NCT03882801|466834179|FG001|Period 2|Non-compliance with study drug|1|||
129692706|NCT03548415|466834186|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
129692707|NCT03548415|466834187|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
129692708|NCT03548415|466834188|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
129692709|NCT03548415|466834189|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
129692710|NCT03548415|466834190|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
129692711|NCT01803737|466834191|FG000|Overall Study|Lack of Time|1|||
129692712|NCT01803737|466834192|FG001|Overall Study|Lack of Time|0|||
129692713|NCT01803737|466834191|FG000|Overall Study|Medical Reason|0|||
129692714|NCT01803737|466834192|FG001|Overall Study|Medical Reason|1|||
129692715|NCT01803737|466834191|FG000|Overall Study|Lost to Follow-up|0|||
129692716|NCT01803737|466834192|FG001|Overall Study|Lost to Follow-up|2|||
129692717|NCT01529112|466834193|FG000|Overall Study|Adverse Event|2|||
129692718|NCT01529112|466834194|FG001|Overall Study|Adverse Event|0|||
129692719|NCT01529112|466834193|FG000|Overall Study|Death|59|||
129692720|NCT01529112|466834194|FG001|Overall Study|Death|38|||
129692721|NCT01529112|466834193|FG000|Overall Study|Protocol Violation|1|||
129692722|NCT01529112|466834194|FG001|Overall Study|Protocol Violation|0|||
129692723|NCT01529112|466834193|FG000|Overall Study|Withdrawal by Subject|7|||
129692724|NCT01529112|466834194|FG001|Overall Study|Withdrawal by Subject|3|||
129692725|NCT03607695|466834195|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
129692726|NCT03607695|466834195|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
129692727|NCT02741193|466834196|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
129692728|NCT02741193|466834196|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
129692729|NCT02502383|466834197|FG000|Overall Study|Lost to Follow-up|130|||
129692730|NCT02502383|466834198|FG001|Overall Study|Lost to Follow-up|131|||
129692731|NCT02502383|466834197|FG000|Overall Study|Withdrawal by Subject|31|||
129692732|NCT02502383|466834198|FG001|Overall Study|Withdrawal by Subject|24|||
129692733|NCT01122680|466834201|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
129692734|NCT01122680|466834202|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
129692735|NCT01122680|466834203|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
129692736|NCT01122680|466834204|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
129692737|NCT01122680|466834201|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
129692738|NCT01122680|466834202|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
129692739|NCT01122680|466834203|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
129692740|NCT01122680|466834204|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
129692741|NCT01122680|466834201|FG000|Period 1 (4 Weeks)|Other|1|||
129692742|NCT01122680|466834202|FG001|Period 1 (4 Weeks)|Other|1|||
129692743|NCT01122680|466834203|FG002|Period 1 (4 Weeks)|Other|0|||
129692744|NCT01122680|466834204|FG003|Period 1 (4 Weeks)|Other|0|||
129692745|NCT01122680|466834201|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
129692746|NCT01122680|466834202|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
129692747|NCT01122680|466834203|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
129692748|NCT01122680|466834204|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
129692749|NCT01122680|466834201|FG000|Period 2 (4 Weeks)|Other|1|||
129692750|NCT01122680|466834202|FG001|Period 2 (4 Weeks)|Other|0|||
129692751|NCT01122680|466834203|FG002|Period 2 (4 Weeks)|Other|0|||
129692752|NCT01122680|466834204|FG003|Period 2 (4 Weeks)|Other|0|||
129692753|NCT01122680|466834201|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
129692754|NCT01122680|466834202|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
129574365|NCT00462345|466400709|FG000|Overall Study|Did not complete second course|1|||
129574366|NCT01149473|466400710|FG000|First Intervention|Adverse Event|1|||
129574367|NCT01149473|466400711|FG001|First Intervention|Adverse Event|1|||
129574368|NCT01149473|466400710|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129574369|NCT01149473|466400711|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129574370|NCT04089735|466400712|FG000|Overall Study|Adverse Event|1|||
129574371|NCT04089735|466400713|FG001|Overall Study|Adverse Event|0|||
129574372|NCT04089735|466400714|FG002|Overall Study|Adverse Event|1|||
129574373|NCT04089735|466400715|FG003|Overall Study|Adverse Event|1|||
129574374|NCT04089735|466400716|FG004|Overall Study|Adverse Event|0|||
129574375|NCT04089735|466400717|FG005|Overall Study|Adverse Event|0|||
129574376|NCT04089735|466400712|FG000|Overall Study|Physician Decision|0|||
129574377|NCT04089735|466400713|FG001|Overall Study|Physician Decision|3|||
129782975|NCT01536392|467173383|FG000|Overall Study|Completed therapy early|3|||
129782976|NCT01536392|467173384|FG001|Overall Study|Completed therapy early|0|||
129782977|NCT00934440|467173385|FG000|Overall Study|Lost to Follow-up|1|||
129782978|NCT03060551|467173386|FG000|Overall Study|Withdrawal by Subject|1|||
129782979|NCT03060551|467173386|FG000|Overall Study|Adverse Event|1|||
129782980|NCT04614324|467173391|FG000|Overall Study|Lost to Follow-up|3|||
129782981|NCT04614324|467173391|FG000|Overall Study|Physician Decision|1|||
129782982|NCT04614324|467173391|FG000|Overall Study|Withdrawal by Subject|2|||
129782983|NCT04614324|467173391|FG000|Overall Study|Remaining in Follow up|123|||
129782984|NCT05289037|467173392|FG000|Overall Study|Withdrawal by Subject|7|||
129782985|NCT05289037|467173393|FG001|Overall Study|Withdrawal by Subject|0|||
129782986|NCT05289037|467173394|FG002|Overall Study|Withdrawal by Subject|3|||
129782987|NCT05289037|467173395|FG003|Overall Study|Withdrawal by Subject|3|||
129782988|NCT05289037|467173396|FG004|Overall Study|Withdrawal by Subject|1|||
129782989|NCT05289037|467173397|FG005|Overall Study|Withdrawal by Subject|5|||
129782990|NCT05289037|467173398|FG006|Overall Study|Withdrawal by Subject|2|||
129782991|NCT05289037|467173399|FG007|Overall Study|Withdrawal by Subject|1|||
129782992|NCT05289037|467173400|FG008|Overall Study|Withdrawal by Subject|2|||
129782993|NCT05289037|467173401|FG009|Overall Study|Withdrawal by Subject|2|||
129782994|NCT05289037|467173402|FG010|Overall Study|Withdrawal by Subject|1|||
129782995|NCT05289037|467173403|FG011|Overall Study|Withdrawal by Subject|0|||
129782996|NCT05289037|467173404|FG012|Overall Study|Withdrawal by Subject|1|||
129782997|NCT05289037|467173405|FG013|Overall Study|Withdrawal by Subject|2|||
129782998|NCT05289037|467173406|FG014|Overall Study|Withdrawal by Subject|0|||
129782999|NCT05289037|467173407|FG015|Overall Study|Withdrawal by Subject|3|||
129783000|NCT05289037|467173408|FG016|Overall Study|Withdrawal by Subject|3|||
129783001|NCT05289037|467173392|FG000|Overall Study|Lost to Follow-up|1|||
129783002|NCT05289037|467173393|FG001|Overall Study|Lost to Follow-up|4|||
129783003|NCT05289037|467173394|FG002|Overall Study|Lost to Follow-up|3|||
129783004|NCT05289037|467173395|FG003|Overall Study|Lost to Follow-up|3|||
129783005|NCT05289037|467173396|FG004|Overall Study|Lost to Follow-up|3|||
129783006|NCT05289037|467173397|FG005|Overall Study|Lost to Follow-up|2|||
129783007|NCT05289037|467173398|FG006|Overall Study|Lost to Follow-up|3|||
129783008|NCT05289037|467173399|FG007|Overall Study|Lost to Follow-up|2|||
129783009|NCT05289037|467173400|FG008|Overall Study|Lost to Follow-up|2|||
129783010|NCT05289037|467173401|FG009|Overall Study|Lost to Follow-up|1|||
129783011|NCT05289037|467173402|FG010|Overall Study|Lost to Follow-up|3|||
129783012|NCT05289037|467173403|FG011|Overall Study|Lost to Follow-up|4|||
129783013|NCT05289037|467173404|FG012|Overall Study|Lost to Follow-up|2|||
129783014|NCT05289037|467173405|FG013|Overall Study|Lost to Follow-up|7|||
129783015|NCT05289037|467173406|FG014|Overall Study|Lost to Follow-up|4|||
129783016|NCT05289037|467173407|FG015|Overall Study|Lost to Follow-up|6|||
129783017|NCT05289037|467173408|FG016|Overall Study|Lost to Follow-up|4|||
129783018|NCT05289037|467173392|FG000|Overall Study|Death|0|||
129783019|NCT05289037|467173393|FG001|Overall Study|Death|0|||
129783020|NCT05289037|467173394|FG002|Overall Study|Death|0|||
129783021|NCT05289037|467173395|FG003|Overall Study|Death|0|||
129783022|NCT05289037|467173396|FG004|Overall Study|Death|0|||
129783023|NCT05289037|467173397|FG005|Overall Study|Death|1|||
129574378|NCT04089735|466400714|FG002|Overall Study|Physician Decision|0|||
129574379|NCT04089735|466400715|FG003|Overall Study|Physician Decision|0|||
129574380|NCT04089735|466400716|FG004|Overall Study|Physician Decision|0|||
129574381|NCT04089735|466400717|FG005|Overall Study|Physician Decision|0|||
129783024|NCT05289037|467173398|FG006|Overall Study|Death|0|||
129783025|NCT05289037|467173399|FG007|Overall Study|Death|0|||
129692755|NCT01122680|466834203|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
129692756|NCT01122680|466834204|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
129692757|NCT01122680|466834201|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129692758|NCT01122680|466834202|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
129692759|NCT01122680|466834203|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129692760|NCT01122680|466834204|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
129692761|NCT00225758|466834205|FG000|Overall Study|Adverse Event|4|||
129692762|NCT00564070|466834206|FG000|Overall Study|Lost to Follow-up|9|||
129692763|NCT00564070|466834207|FG001|Overall Study|Lost to Follow-up|7|||
129692764|NCT00564070|466834206|FG000|Overall Study|Worsening depression, referred to care|3|||
129692765|NCT00564070|466834207|FG001|Overall Study|Worsening depression, referred to care|0|||
129692766|NCT03142334|466834211|FG000|Overall Study|Death|18|||
129692767|NCT03142334|466834212|FG001|Overall Study|Death|33|||
129692768|NCT03142334|466834211|FG000|Overall Study|Withdrawal by Subject|15|||
129692769|NCT03142334|466834212|FG001|Overall Study|Withdrawal by Subject|11|||
129692770|NCT03142334|466834211|FG000|Overall Study|Ongoing on trial follow up|463|||
129692771|NCT03142334|466834212|FG001|Overall Study|Ongoing on trial follow up|454|||
129692772|NCT01217047|466834213|FG000|Overall Study|Lost to Follow-up|0|||
129692773|NCT01217047|466834214|FG001|Overall Study|Lost to Follow-up|1|||
129692774|NCT01217047|466834215|FG002|Overall Study|Lost to Follow-up|0|||
129692775|NCT01530997|466834222|FG000|Overall Study|Physician Decision|1|||
129692776|NCT01530997|466834222|FG000|Overall Study|Withdrawal by Subject|1|||
129692777|NCT03892915|466834223|FG000|Overall Study|Lost to Follow-up|6|||
129692778|NCT03892915|466834224|FG001|Overall Study|Lost to Follow-up|12|||
129692779|NCT03892915|466834223|FG000|Overall Study|Death|0|||
129692780|NCT03892915|466834224|FG001|Overall Study|Death|2|||
129692781|NCT03892915|466834223|FG000|Overall Study|Withdrawal by Subject|1|||
129692782|NCT03892915|466834224|FG001|Overall Study|Withdrawal by Subject|1|||
129692783|NCT03892915|466834223|FG000|Overall Study|unsuccessful delivery|13|||
129692784|NCT03892915|466834224|FG001|Overall Study|unsuccessful delivery|18|||
129692785|NCT02181738|466834227|FG000|Overall Study|Participant Withdrew Consent|2|||
129692786|NCT02181738|466834228|FG001|Overall Study|Participant Withdrew Consent|1|||
129692787|NCT02181738|466834229|FG002|Overall Study|Participant Withdrew Consent|1|||
129692788|NCT02181738|466834230|FG003|Overall Study|Participant Withdrew Consent|1|||
129692789|NCT02181738|466834227|FG000|Overall Study|Lost to Follow-up|1|||
129692790|NCT02181738|466834228|FG001|Overall Study|Lost to Follow-up|2|||
129692791|NCT02181738|466834229|FG002|Overall Study|Lost to Follow-up|1|||
129692792|NCT02181738|466834230|FG003|Overall Study|Lost to Follow-up|1|||
129692793|NCT02181738|466834227|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
129692794|NCT02181738|466834228|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
129692795|NCT02181738|466834229|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
129692796|NCT02181738|466834230|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
129692797|NCT02181738|466834227|FG000|Overall Study|Poor/Non-Compliance|1|||
129692798|NCT02181738|466834228|FG001|Overall Study|Poor/Non-Compliance|0|||
129692799|NCT02181738|466834229|FG002|Overall Study|Poor/Non-Compliance|2|||
129692800|NCT02181738|466834230|FG003|Overall Study|Poor/Non-Compliance|1|||
129692801|NCT02181738|466834227|FG000|Overall Study|Disease Progression|28|||
129692802|NCT02181738|466834228|FG001|Overall Study|Disease Progression|35|||
129692803|NCT02181738|466834229|FG002|Overall Study|Disease Progression|40|||
129692804|NCT02181738|466834230|FG003|Overall Study|Disease Progression|0|||
129692805|NCT02181738|466834227|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
129692806|NCT02181738|466834228|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
129692807|NCT02181738|466834229|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
129692808|NCT02181738|466834230|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
129692809|NCT02181738|466834227|FG000|Overall Study|Study Drug Toxicity|6|||
129692810|NCT02181738|466834228|FG001|Overall Study|Study Drug Toxicity|11|||
129692811|NCT02181738|466834229|FG002|Overall Study|Study Drug Toxicity|8|||
129692812|NCT02181738|466834230|FG003|Overall Study|Study Drug Toxicity|1|||
129692813|NCT02181738|466834227|FG000|Overall Study|Other Reasons|14|||
129692814|NCT02181738|466834228|FG001|Overall Study|Other Reasons|16|||
129692815|NCT02181738|466834229|FG002|Overall Study|Other Reasons|28|||
129692816|NCT02181738|466834230|FG003|Overall Study|Other Reasons|0|||
129783026|NCT05289037|467173400|FG008|Overall Study|Death|0|||
129783027|NCT05289037|467173401|FG009|Overall Study|Death|0|||
129783028|NCT05289037|467173402|FG010|Overall Study|Death|0|||
129783029|NCT05289037|467173403|FG011|Overall Study|Death|0|||
129783030|NCT05289037|467173404|FG012|Overall Study|Death|0|||
129783031|NCT05289037|467173405|FG013|Overall Study|Death|0|||
129783032|NCT05289037|467173406|FG014|Overall Study|Death|1|||
129783033|NCT05289037|467173407|FG015|Overall Study|Death|0|||
129783034|NCT05289037|467173408|FG016|Overall Study|Death|0|||
129783035|NCT05289037|467173392|FG000|Overall Study|Did not receive vaccine|0|||
129783036|NCT05289037|467173393|FG001|Overall Study|Did not receive vaccine|3|||
129783037|NCT05289037|467173394|FG002|Overall Study|Did not receive vaccine|0|||
129783038|NCT05289037|467173395|FG003|Overall Study|Did not receive vaccine|0|||
129783039|NCT05289037|467173396|FG004|Overall Study|Did not receive vaccine|1|||
129783040|NCT05289037|467173397|FG005|Overall Study|Did not receive vaccine|1|||
129783041|NCT05289037|467173398|FG006|Overall Study|Did not receive vaccine|1|||
129783042|NCT05289037|467173399|FG007|Overall Study|Did not receive vaccine|0|||
129783043|NCT05289037|467173400|FG008|Overall Study|Did not receive vaccine|0|||
129783044|NCT05289037|467173401|FG009|Overall Study|Did not receive vaccine|0|||
129783045|NCT05289037|467173402|FG010|Overall Study|Did not receive vaccine|0|||
129783046|NCT05289037|467173403|FG011|Overall Study|Did not receive vaccine|0|||
129783047|NCT05289037|467173404|FG012|Overall Study|Did not receive vaccine|0|||
129783048|NCT05289037|467173405|FG013|Overall Study|Did not receive vaccine|0|||
129783049|NCT05289037|467173406|FG014|Overall Study|Did not receive vaccine|1|||
129783050|NCT05289037|467173407|FG015|Overall Study|Did not receive vaccine|0|||
129783051|NCT05289037|467173408|FG016|Overall Study|Did not receive vaccine|0|||
129783052|NCT05289037|467173392|FG000|Overall Study|Unable to make last visit|0|||
129783053|NCT05289037|467173393|FG001|Overall Study|Unable to make last visit|0|||
129783054|NCT05289037|467173394|FG002|Overall Study|Unable to make last visit|1|||
129783055|NCT05289037|467173395|FG003|Overall Study|Unable to make last visit|0|||
129783056|NCT05289037|467173396|FG004|Overall Study|Unable to make last visit|0|||
129783057|NCT05289037|467173397|FG005|Overall Study|Unable to make last visit|0|||
129783058|NCT05289037|467173398|FG006|Overall Study|Unable to make last visit|0|||
129783059|NCT05289037|467173399|FG007|Overall Study|Unable to make last visit|0|||
129574382|NCT04089735|466400712|FG000|Overall Study|Withdrawal by Subject|0|||
129574383|NCT04089735|466400713|FG001|Overall Study|Withdrawal by Subject|0|||
129574384|NCT04089735|466400714|FG002|Overall Study|Withdrawal by Subject|1|||
129692817|NCT02181738|466834227|FG000|Overall Study|Maximum Clinical Benefit|3|||
129692818|NCT02181738|466834228|FG001|Overall Study|Maximum Clinical Benefit|0|||
129692819|NCT02181738|466834229|FG002|Overall Study|Maximum Clinical Benefit|1|||
129692820|NCT02181738|466834230|FG003|Overall Study|Maximum Clinical Benefit|0|||
129692821|NCT02181738|466834227|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129692822|NCT02181738|466834228|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129692823|NCT02181738|466834229|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
129692824|NCT02181738|466834230|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129692825|NCT02318277|466834233|FG000|Overall Study|Physician Decision|0|||
129692826|NCT02318277|466834234|FG001|Overall Study|Physician Decision|0|||
129692827|NCT02318277|466834235|FG002|Overall Study|Physician Decision|0|||
129692828|NCT02318277|466834236|FG003|Overall Study|Physician Decision|0|||
129692829|NCT02318277|466834237|FG004|Overall Study|Physician Decision|0|||
129692830|NCT02318277|466834238|FG005|Overall Study|Physician Decision|0|||
129692831|NCT02318277|466834239|FG006|Overall Study|Physician Decision|0|||
129692832|NCT02318277|466834240|FG007|Overall Study|Physician Decision|1|||
129692833|NCT02318277|466834233|FG000|Overall Study|Other|0|||
129692834|NCT02318277|466834234|FG001|Overall Study|Other|0|||
129692835|NCT02318277|466834235|FG002|Overall Study|Other|0|||
129692836|NCT02318277|466834236|FG003|Overall Study|Other|0|||
129692837|NCT02318277|466834237|FG004|Overall Study|Other|0|||
129692838|NCT02318277|466834238|FG005|Overall Study|Other|0|||
129692839|NCT02318277|466834239|FG006|Overall Study|Other|1|||
129692840|NCT02318277|466834240|FG007|Overall Study|Other|0|||
129692841|NCT02318277|466834233|FG000|Overall Study|Withdrawal by Subject|0|||
129692842|NCT02318277|466834234|FG001|Overall Study|Withdrawal by Subject|0|||
129692843|NCT02318277|466834235|FG002|Overall Study|Withdrawal by Subject|1|||
129692844|NCT02318277|466834236|FG003|Overall Study|Withdrawal by Subject|0|||
129692845|NCT02318277|466834237|FG004|Overall Study|Withdrawal by Subject|1|||
129692846|NCT02318277|466834238|FG005|Overall Study|Withdrawal by Subject|1|||
129692847|NCT02318277|466834239|FG006|Overall Study|Withdrawal by Subject|6|||
129692848|NCT02318277|466834240|FG007|Overall Study|Withdrawal by Subject|14|||
129692849|NCT02318277|466834233|FG000|Overall Study|Participant trial terminated by sponsor|0|||
129692850|NCT02318277|466834234|FG001|Overall Study|Participant trial terminated by sponsor|0|||
129692851|NCT02318277|466834235|FG002|Overall Study|Participant trial terminated by sponsor|1|||
129692852|NCT02318277|466834236|FG003|Overall Study|Participant trial terminated by sponsor|0|||
129692853|NCT02318277|466834237|FG004|Overall Study|Participant trial terminated by sponsor|1|||
129783060|NCT05289037|467173400|FG008|Overall Study|Unable to make last visit|0|||
129783061|NCT05289037|467173401|FG009|Overall Study|Unable to make last visit|0|||
129692854|NCT02318277|466834238|FG005|Overall Study|Participant trial terminated by sponsor|2|||
129692855|NCT02318277|466834239|FG006|Overall Study|Participant trial terminated by sponsor|5|||
129692856|NCT02318277|466834240|FG007|Overall Study|Participant trial terminated by sponsor|16|||
129692857|NCT02318277|466834233|FG000|Overall Study|Lost to Follow-up|1|||
129692858|NCT02318277|466834234|FG001|Overall Study|Lost to Follow-up|0|||
129692859|NCT02318277|466834235|FG002|Overall Study|Lost to Follow-up|1|||
129692860|NCT02318277|466834236|FG003|Overall Study|Lost to Follow-up|0|||
129692861|NCT02318277|466834237|FG004|Overall Study|Lost to Follow-up|0|||
129692862|NCT02318277|466834238|FG005|Overall Study|Lost to Follow-up|0|||
129692863|NCT02318277|466834239|FG006|Overall Study|Lost to Follow-up|3|||
129692864|NCT02318277|466834240|FG007|Overall Study|Lost to Follow-up|4|||
129692865|NCT02318277|466834233|FG000|Overall Study|Death|5|||
129692866|NCT02318277|466834234|FG001|Overall Study|Death|3|||
129692867|NCT02318277|466834235|FG002|Overall Study|Death|1|||
129692868|NCT02318277|466834236|FG003|Overall Study|Death|4|||
129692869|NCT02318277|466834237|FG004|Overall Study|Death|6|||
129692870|NCT02318277|466834238|FG005|Overall Study|Death|5|||
129692871|NCT02318277|466834239|FG006|Overall Study|Death|34|||
129692872|NCT02318277|466834240|FG007|Overall Study|Death|58|||
129692873|NCT02318277|466834233|FG000|Overall Study|Transitioned to Hospice|0|||
129692874|NCT02318277|466834234|FG001|Overall Study|Transitioned to Hospice|0|||
129692875|NCT02318277|466834235|FG002|Overall Study|Transitioned to Hospice|0|||
129692876|NCT02318277|466834236|FG003|Overall Study|Transitioned to Hospice|0|||
129692877|NCT02318277|466834237|FG004|Overall Study|Transitioned to Hospice|0|||
129692878|NCT02318277|466834238|FG005|Overall Study|Transitioned to Hospice|1|||
129692879|NCT02318277|466834239|FG006|Overall Study|Transitioned to Hospice|0|||
129692880|NCT02318277|466834240|FG007|Overall Study|Transitioned to Hospice|0|||
129692881|NCT01691482|466834241|FG000|Treatment Period 2|Adverse Event|0|||
129692882|NCT01691482|466834242|FG001|Treatment Period 2|Adverse Event|1|||
129692883|NCT01691482|466834241|FG000|Treatment Period 2|Protocol Violation|1|||
129692884|NCT01691482|466834242|FG001|Treatment Period 2|Protocol Violation|1|||
129692885|NCT00407030|466834243|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
129692886|NCT00407030|466834244|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
129692887|NCT00407030|466834245|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
129692888|NCT00407030|466834243|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
129692889|NCT00407030|466834244|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
129574385|NCT04089735|466400715|FG003|Overall Study|Withdrawal by Subject|0|||
129692890|NCT00407030|466834245|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
129783062|NCT05289037|467173402|FG010|Overall Study|Unable to make last visit|0|||
129783063|NCT05289037|467173403|FG011|Overall Study|Unable to make last visit|0|||
129783064|NCT05289037|467173404|FG012|Overall Study|Unable to make last visit|0|||
129783065|NCT05289037|467173405|FG013|Overall Study|Unable to make last visit|0|||
129783066|NCT05289037|467173406|FG014|Overall Study|Unable to make last visit|0|||
129783067|NCT05289037|467173407|FG015|Overall Study|Unable to make last visit|0|||
129783068|NCT05289037|467173408|FG016|Overall Study|Unable to make last visit|0|||
129783069|NCT05289037|467173392|FG000|Overall Study|Protocol deviation|0|||
129783070|NCT05289037|467173393|FG001|Overall Study|Protocol deviation|0|||
129783071|NCT05289037|467173394|FG002|Overall Study|Protocol deviation|0|||
129783072|NCT05289037|467173395|FG003|Overall Study|Protocol deviation|0|||
129783073|NCT05289037|467173396|FG004|Overall Study|Protocol deviation|0|||
129783074|NCT05289037|467173397|FG005|Overall Study|Protocol deviation|0|||
129783075|NCT05289037|467173398|FG006|Overall Study|Protocol deviation|0|||
129783076|NCT05289037|467173399|FG007|Overall Study|Protocol deviation|0|||
129783077|NCT05289037|467173400|FG008|Overall Study|Protocol deviation|0|||
129783078|NCT05289037|467173401|FG009|Overall Study|Protocol deviation|0|||
129783079|NCT05289037|467173402|FG010|Overall Study|Protocol deviation|0|||
129783080|NCT05289037|467173403|FG011|Overall Study|Protocol deviation|0|||
129783081|NCT05289037|467173404|FG012|Overall Study|Protocol deviation|0|||
129783082|NCT05289037|467173405|FG013|Overall Study|Protocol deviation|0|||
129783083|NCT05289037|467173406|FG014|Overall Study|Protocol deviation|0|||
129783084|NCT05289037|467173407|FG015|Overall Study|Protocol deviation|1|||
129783085|NCT05289037|467173408|FG016|Overall Study|Protocol deviation|0|||
129783086|NCT05141448|467173409|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129783087|NCT05141448|467173410|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
129783088|NCT05141448|467173411|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129783089|NCT05141448|467173412|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129783090|NCT05141448|467173413|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129783091|NCT05141448|467173414|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129783092|NCT05141448|467173409|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129783093|NCT05141448|467173410|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129783094|NCT05141448|467173411|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129783095|NCT05141448|467173412|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129783096|NCT05141448|467173413|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
129783097|NCT05141448|467173414|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129783098|NCT05141448|467173409|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129783099|NCT05141448|467173410|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
129783100|NCT05141448|467173411|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129783101|NCT05141448|467173412|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129783102|NCT05141448|467173413|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129783103|NCT05141448|467173414|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129783104|NCT05141448|467173409|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129783105|NCT05141448|467173410|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129783106|NCT05141448|467173411|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129783107|NCT05141448|467173412|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129783108|NCT05141448|467173413|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129783109|NCT05141448|467173414|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
129783110|NCT05141448|467173409|FG000|Period 2|COVID-19 Related|0|||
129783111|NCT05141448|467173410|FG001|Period 2|COVID-19 Related|0|||
129783112|NCT05141448|467173411|FG002|Period 2|COVID-19 Related|0|||
129783113|NCT05141448|467173412|FG003|Period 2|COVID-19 Related|1|||
129783114|NCT05141448|467173413|FG004|Period 2|COVID-19 Related|0|||
129783115|NCT05141448|467173414|FG005|Period 2|COVID-19 Related|1|||
129783116|NCT05141448|467173409|FG000|3|Covid-19 related|2|||
129783117|NCT05141448|467173410|FG001|3|Covid-19 related|0|||
129783118|NCT05141448|467173411|FG002|3|Covid-19 related|0|||
129783119|NCT05141448|467173412|FG003|3|Covid-19 related|0|||
129783120|NCT05141448|467173413|FG004|3|Covid-19 related|0|||
129783121|NCT05141448|467173414|FG005|3|Covid-19 related|1|||
129783122|NCT05141448|467173409|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
129783123|NCT05141448|467173410|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
129783124|NCT05141448|467173411|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
129783125|NCT05141448|467173412|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
129783126|NCT05141448|467173413|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
129783127|NCT05141448|467173414|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
129783128|NCT04627285|467173415|FG000|Overall Study|Adverse Event|0|||
129783129|NCT04627285|467173416|FG001|Overall Study|Adverse Event|2|||
129783130|NCT04627285|467173415|FG000|Overall Study|Lost to Follow-up|1|||
129783131|NCT04627285|467173416|FG001|Overall Study|Lost to Follow-up|0|||
129783132|NCT04627285|467173415|FG000|Overall Study|Withdrawal by Subject|1|||
129783133|NCT04627285|467173416|FG001|Overall Study|Withdrawal by Subject|1|||
129692891|NCT00407030|466834243|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
129692892|NCT00407030|466834244|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
129692893|NCT00407030|466834245|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
129692894|NCT00407030|466834243|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
129692895|NCT00407030|466834244|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
129692896|NCT00407030|466834245|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
129692897|NCT00407030|466834243|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
129692898|NCT00407030|466834244|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
129692899|NCT00407030|466834245|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
129692900|NCT00407030|466834243|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
129692901|NCT00407030|466834244|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
129692902|NCT00407030|466834245|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
129692903|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
129692904|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
129692905|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
129692906|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
129692907|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
129692908|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
129692909|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
129692910|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
129692911|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
129884620|NCT01394250|467538602|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
129692912|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
129692913|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
129692914|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
129692915|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
129692916|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
129692917|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
129692918|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
129692919|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
129692920|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
129692921|NCT00407030|466834243|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
129692922|NCT00407030|466834244|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
129692923|NCT00407030|466834245|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
129692924|NCT02829957|466834247|FG000|Overall Study|Lost to Follow-up|2|||
129692925|NCT02829957|466834248|FG001|Overall Study|Lost to Follow-up|1|||
129692926|NCT00754559|466834249|FG000|Overall Study|Adverse Event|15|||
129692927|NCT00754559|466834249|FG000|Overall Study|Protocol Violation|11|||
129692928|NCT00754559|466834249|FG000|Overall Study|Lack of Efficacy|10|||
129692929|NCT00754559|466834249|FG000|Overall Study|Lost to Follow-up|2|||
129692930|NCT00754559|466834249|FG000|Overall Study|Administrative reason|1|||
129692931|NCT00754559|466834249|FG000|Overall Study|Other|5|||
129692932|NCT00754559|466834249|FG000|Overall Study|Withdrawal by Subject|3|||
129692933|NCT01663987|466834250|FG000|Overall Study|Adverse Event|7|||
129692934|NCT01663987|466834251|FG001|Overall Study|Adverse Event|2|||
129692935|NCT01663987|466834250|FG000|Overall Study|Lost to Follow-up|1|||
129692936|NCT01663987|466834251|FG001|Overall Study|Lost to Follow-up|1|||
129692937|NCT01663987|466834250|FG000|Overall Study|Withdrawal by Subject|2|||
129692938|NCT01663987|466834251|FG001|Overall Study|Withdrawal by Subject|3|||
129692939|NCT01663987|466834250|FG000|Overall Study|Other reason not defined above|3|||
129692940|NCT01663987|466834251|FG001|Overall Study|Other reason not defined above|0|||
129692941|NCT01370538|466834253|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
129692942|NCT01370538|466834254|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
129692943|NCT01370538|466834253|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129692944|NCT01370538|466834254|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129692945|NCT01370538|466834253|FG000|Overall Study|Adverse Event|1|||
129692946|NCT01370538|466834254|FG001|Overall Study|Adverse Event|0|||
129692947|NCT01370538|466834253|FG000|Overall Study|Protocol Violation|8|||
129692948|NCT01370538|466834254|FG001|Overall Study|Protocol Violation|5|||
129692949|NCT01370538|466834253|FG000|Overall Study|Development of study specific withdrawal|1|||
129692950|NCT01370538|466834254|FG001|Overall Study|Development of study specific withdrawal|1|||
129692951|NCT01370538|466834253|FG000|Overall Study|Lost to follow up|6|||
129692952|NCT01370538|466834254|FG001|Overall Study|Lost to follow up|10|||
129692953|NCT04193527|466834255|FG000|Overall Study|Other|1|||
129692954|NCT04193527|466834256|FG001|Overall Study|Other|1|||
129692955|NCT04193527|466834257|FG002|Overall Study|Other|0|||
129692956|NCT00676689|466834258|FG000|Overall Study|Screen Failure|2|||
129692957|NCT00676689|466834258|FG000|Overall Study|Death|2|||
129692958|NCT00676689|466834258|FG000|Overall Study|Lost to Follow-up|4|||
129692959|NCT00676689|466834258|FG000|Overall Study|Physician Decision|1|||
129692960|NCT00676689|466834258|FG000|Overall Study|Withdrawal by Subject|3|||
129692961|NCT00676689|466834258|FG000|Overall Study|Continuing FU|49|||
129692962|NCT02366130|466834259|FG000|Overall Study|Withdrawal by Subject|3|||
129692963|NCT02366130|466834259|FG000|Overall Study|Ineligible|6|||
129692964|NCT01945242|466834260|FG000|Overall Study|Physician Decision|3|||
129692965|NCT01945242|466834261|FG001|Overall Study|Physician Decision|3|||
129692966|NCT05661734|466834262|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
129692967|NCT05661734|466834262|FG000|Overall Study|Lost to Follow-up|13|||
129692968|NCT05661734|466834262|FG000|Overall Study|Enrolled but not dosed|2|||
129692969|NCT01026038|466834263|FG000|Overall Study|Lost to Follow-up|1|||
129692970|NCT01026038|466834264|FG001|Overall Study|Lost to Follow-up|1|||
129692971|NCT01026038|466834265|FG002|Overall Study|Lost to Follow-up|0|||
129692972|NCT03601052|466834266|FG000|Overall Study|Lost to Follow-up|2|||
129692973|NCT01348490|466834267|FG000|Overall Study|Death|1|||
129692974|NCT01348490|466834267|FG000|Overall Study|Adverse Event|3|||
129692975|NCT01348490|466834267|FG000|Overall Study|Consent withdrawn|7|||
129692976|NCT01348490|466834267|FG000|Overall Study|Disease progression|3|||
129692977|NCT01348490|466834267|FG000|Overall Study|Lost to Follow-up|1|||
129884621|NCT01394250|467538603|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
129692978|NCT01348490|466834267|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
129692979|NCT01348490|466834267|FG000|Overall Study|Other Unspecified|8|||
129692980|NCT00300495|466834268|FG000|Overall Study|Protocol Violation|4|||
129692981|NCT00300495|466834269|FG001|Overall Study|Protocol Violation|1|||
129692982|NCT01184118|466834270|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
129692983|NCT01184118|466834270|FG000|Overall Study|No physiologic confirmation of asthma|8|||
129692984|NCT01184118|466834270|FG000|Overall Study|FEV1 <60% predicted|2|||
129692985|NCT01184118|466834270|FG000|Overall Study|Exclusionary medical condition|2|||
129692986|NCT01184118|466834270|FG000|Overall Study|Withdrawal by Subject|5|||
129692987|NCT03632720|466834271|FG000|Overall Study|Adverse Event|2|||
129692988|NCT03632720|466834272|FG001|Overall Study|Adverse Event|0|||
129692989|NCT03632720|466834273|FG002|Overall Study|Adverse Event|0|||
129692990|NCT03632720|466834271|FG000|Overall Study|Lost to Follow-up|0|||
129692991|NCT03632720|466834272|FG001|Overall Study|Lost to Follow-up|1|||
129692992|NCT03632720|466834273|FG002|Overall Study|Lost to Follow-up|0|||
129692993|NCT03632720|466834271|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
129692994|NCT03632720|466834272|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
129692995|NCT03632720|466834273|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
129692996|NCT03632720|466834271|FG000|Overall Study|Screen failure|0|||
129692997|NCT03632720|466834272|FG001|Overall Study|Screen failure|1|||
129692998|NCT03632720|466834273|FG002|Overall Study|Screen failure|0|||
129692999|NCT00682435|466834274|FG000|Overall Study|Insufficient data|5|||
129693000|NCT00682435|466834274|FG000|Overall Study|Erroneously enrolled twice|2|||
129693001|NCT01049828|466834276|FG000|Overall Study|Claustrophibia and Frustration|2|||
129693002|NCT00290238|466834277|FG000|Overall Study|Study terminated|27|||
129693003|NCT00290238|466834278|FG001|Overall Study|Study terminated|27|||
129693004|NCT00290238|466834277|FG000|Overall Study|Lost to Follow-up|0|||
129693005|NCT00290238|466834278|FG001|Overall Study|Lost to Follow-up|1|||
129693006|NCT00290238|466834277|FG000|Overall Study|Withdrawal by Subject|15|||
129693007|NCT00290238|466834278|FG001|Overall Study|Withdrawal by Subject|13|||
129693008|NCT02186171|466834279|FG000|Overall Study|Withdrawal by Subject|1|||
129693009|NCT02186171|466834280|FG001|Overall Study|Withdrawal by Subject|9|||
129693010|NCT02186171|466834279|FG000|Overall Study|Lost to Follow-up|2|||
129693011|NCT02186171|466834280|FG001|Overall Study|Lost to Follow-up|2|||
129693012|NCT02186171|466834279|FG000|Overall Study|Death|1|||
129693013|NCT02186171|466834280|FG001|Overall Study|Death|2|||
129693014|NCT02186171|466834279|FG000|Overall Study|Protocol-specified Criteria|0|||
129693015|NCT02186171|466834280|FG001|Overall Study|Protocol-specified Criteria|2|||
129693016|NCT02946996|466834281|FG000|Overall Study|non-evaluable|3|||
129693017|NCT02946996|466834282|FG001|Overall Study|non-evaluable|6|||
129693018|NCT02946996|466834283|FG002|Overall Study|non-evaluable|5|||
129693019|NCT06868667|466834287|FG000|Overall Study|Death|0|||
129693020|NCT06868667|466834288|FG001|Overall Study|Death|4|||
129693021|NCT06868667|466834287|FG000|Overall Study|Lost to Follow-up|0|||
129693022|NCT06868667|466834288|FG001|Overall Study|Lost to Follow-up|1|||
129693023|NCT06868667|466834287|FG000|Overall Study|Withdrawal by Subject|1|||
129693024|NCT06868667|466834288|FG001|Overall Study|Withdrawal by Subject|0|||
129693025|NCT06868667|466834287|FG000|Overall Study|Ongoing|9|||
129693026|NCT06868667|466834288|FG001|Overall Study|Ongoing|9|||
129693027|NCT05330429|466834291|FG000|Overall Study|Study Terminated by Sponsor|4|||
129693028|NCT05330429|466834292|FG001|Overall Study|Study Terminated by Sponsor|33|||
129693029|NCT05330429|466834293|FG002|Overall Study|Study Terminated by Sponsor|12|||
129693030|NCT05330429|466834291|FG000|Overall Study|Death|5|||
129693031|NCT05330429|466834292|FG001|Overall Study|Death|2|||
129693032|NCT05330429|466834293|FG002|Overall Study|Death|4|||
129693033|NCT05330429|466834291|FG000|Overall Study|Withdrew Consent|0|||
129693034|NCT05330429|466834292|FG001|Overall Study|Withdrew Consent|5|||
129693035|NCT05330429|466834293|FG002|Overall Study|Withdrew Consent|4|||
129693036|NCT05330429|466834291|FG000|Overall Study|Investigator's Discretion|0|||
129693037|NCT05330429|466834292|FG001|Overall Study|Investigator's Discretion|1|||
129693038|NCT05330429|466834293|FG002|Overall Study|Investigator's Discretion|3|||
129693039|NCT05330429|466834291|FG000|Overall Study|Subject Decision|1|||
129693040|NCT05330429|466834292|FG001|Overall Study|Subject Decision|2|||
129693041|NCT05330429|466834293|FG002|Overall Study|Subject Decision|0|||
129693042|NCT05330429|466834291|FG000|Overall Study|Lost to Follow-up|0|||
129693043|NCT05330429|466834292|FG001|Overall Study|Lost to Follow-up|1|||
129693044|NCT05330429|466834293|FG002|Overall Study|Lost to Follow-up|0|||
129693045|NCT03572218|466834294|FG000|Overall Study|Lost to Follow-up|3|||
129693046|NCT03572218|466834295|FG001|Overall Study|Lost to Follow-up|2|||
129693047|NCT03572218|466834294|FG000|Overall Study|No longer available for study visits|2|||
129693048|NCT03572218|466834295|FG001|Overall Study|No longer available for study visits|1|||
129693049|NCT03572218|466834294|FG000|Overall Study|No longer interested|1|||
129693050|NCT03572218|466834295|FG001|Overall Study|No longer interested|2|||
129693051|NCT00286455|466834296|FG000|Overall Study|Hyperglycemia rescue|19|||
129693052|NCT00286455|466834297|FG001|Overall Study|Hyperglycemia rescue|13|||
129693053|NCT00286455|466834298|FG002|Overall Study|Hyperglycemia rescue|10|||
129693054|NCT00286455|466834296|FG000|Overall Study|Adverse Event|1|||
129693055|NCT00286455|466834297|FG001|Overall Study|Adverse Event|3|||
129693056|NCT00286455|466834298|FG002|Overall Study|Adverse Event|2|||
129693057|NCT00286455|466834296|FG000|Overall Study|Lost to Follow-up|0|||
129693058|NCT00286455|466834297|FG001|Overall Study|Lost to Follow-up|3|||
129693059|NCT00286455|466834298|FG002|Overall Study|Lost to Follow-up|3|||
129693060|NCT00286455|466834296|FG000|Overall Study|Physician Decision|3|||
129693061|NCT00286455|466834297|FG001|Overall Study|Physician Decision|0|||
129693062|NCT00286455|466834298|FG002|Overall Study|Physician Decision|2|||
129693063|NCT00286455|466834296|FG000|Overall Study|Protocol Violation|1|||
129693064|NCT00286455|466834297|FG001|Overall Study|Protocol Violation|1|||
129693065|NCT00286455|466834298|FG002|Overall Study|Protocol Violation|0|||
129693066|NCT00286455|466834296|FG000|Overall Study|Participant Non-compliance|1|||
129693067|NCT00286455|466834297|FG001|Overall Study|Participant Non-compliance|0|||
129693068|NCT00286455|466834298|FG002|Overall Study|Participant Non-compliance|0|||
129693069|NCT00286455|466834296|FG000|Overall Study|Withdrawal by Subject|0|||
129693070|NCT00286455|466834297|FG001|Overall Study|Withdrawal by Subject|8|||
129693071|NCT00286455|466834298|FG002|Overall Study|Withdrawal by Subject|7|||
129693072|NCT06097273|466834299|FG000|Overall Study|Death|2|||
129693073|NCT06097273|466834300|FG001|Overall Study|Death|1|||
129693074|NCT06097273|466834301|FG002|Overall Study|Death|2|||
129693075|NCT06097273|466834302|FG003|Overall Study|Death|2|||
129693076|NCT06097273|466834299|FG000|Overall Study|Lost to Follow-up|27|||
129693077|NCT06097273|466834300|FG001|Overall Study|Lost to Follow-up|18|||
129693078|NCT06097273|466834301|FG002|Overall Study|Lost to Follow-up|36|||
129693079|NCT06097273|466834302|FG003|Overall Study|Lost to Follow-up|31|||
129693080|NCT06097273|466834299|FG000|Overall Study|Physician Decision|0|||
129693081|NCT06097273|466834300|FG001|Overall Study|Physician Decision|1|||
129693082|NCT06097273|466834301|FG002|Overall Study|Physician Decision|0|||
129693083|NCT06097273|466834302|FG003|Overall Study|Physician Decision|3|||
129693084|NCT06097273|466834299|FG000|Overall Study|Protocol Violation|1|||
129693085|NCT06097273|466834300|FG001|Overall Study|Protocol Violation|1|||
129693086|NCT06097273|466834301|FG002|Overall Study|Protocol Violation|2|||
129693087|NCT06097273|466834302|FG003|Overall Study|Protocol Violation|1|||
129693088|NCT06097273|466834299|FG000|Overall Study|Withdrawal by Subject|14|||
129693089|NCT06097273|466834300|FG001|Overall Study|Withdrawal by Subject|11|||
129693090|NCT06097273|466834301|FG002|Overall Study|Withdrawal by Subject|14|||
129693091|NCT06097273|466834302|FG003|Overall Study|Withdrawal by Subject|15|||
129693092|NCT06097273|466834299|FG000|Overall Study|Other Than Specified|7|||
129693093|NCT06097273|466834300|FG001|Overall Study|Other Than Specified|3|||
129693094|NCT06097273|466834301|FG002|Overall Study|Other Than Specified|11|||
129693095|NCT06097273|466834302|FG003|Overall Study|Other Than Specified|6|||
129693096|NCT00394472|466835687|FG000|Overall Study|Protocol Violation|1|||
129693097|NCT00394472|466835688|FG001|Overall Study|Protocol Violation|3|||
129693098|NCT00394472|466835687|FG000|Overall Study|incorrect enrolment|4|||
129693099|NCT00394472|466835688|FG001|Overall Study|incorrect enrolment|2|||
129693100|NCT00394472|466835687|FG000|Overall Study|Adverse Event|4|||
129693101|NCT00394472|466835688|FG001|Overall Study|Adverse Event|2|||
129693102|NCT00394472|466835687|FG000|Overall Study|Withdrawal by Subject|0|||
129693103|NCT00394472|466835688|FG001|Overall Study|Withdrawal by Subject|2|||
129693104|NCT00394472|466835687|FG000|Overall Study|Physician Decision|0|||
129693105|NCT00394472|466835688|FG001|Overall Study|Physician Decision|1|||
129693106|NCT00394472|466835687|FG000|Overall Study|Lost to Follow-up|0|||
129693107|NCT00394472|466835688|FG001|Overall Study|Lost to Follow-up|1|||
129693108|NCT03931785|466835690|FG000|Overall Study|Lost to Follow-up|4|||
129693109|NCT03931785|466835691|FG001|Overall Study|Lost to Follow-up|1|||
129693110|NCT03931785|466835692|FG002|Overall Study|Lost to Follow-up|4|||
129693111|NCT03931785|466835693|FG003|Overall Study|Lost to Follow-up|3|||
129693112|NCT03931785|466835690|FG000|Overall Study|Adverse Event|1|||
129693113|NCT03931785|466835691|FG001|Overall Study|Adverse Event|0|||
129693114|NCT03931785|466835692|FG002|Overall Study|Adverse Event|3|||
129693115|NCT03931785|466835693|FG003|Overall Study|Adverse Event|4|||
129693116|NCT03931785|466835690|FG000|Overall Study|Protocol Violation|0|||
129693117|NCT03931785|466835691|FG001|Overall Study|Protocol Violation|1|||
129693118|NCT03931785|466835692|FG002|Overall Study|Protocol Violation|0|||
129693119|NCT03931785|466835693|FG003|Overall Study|Protocol Violation|0|||
129693120|NCT03931785|466835690|FG000|Overall Study|Noncompliance With Study drug|0|||
129693121|NCT03931785|466835691|FG001|Overall Study|Noncompliance With Study drug|1|||
129693122|NCT03931785|466835692|FG002|Overall Study|Noncompliance With Study drug|0|||
129693123|NCT03931785|466835693|FG003|Overall Study|Noncompliance With Study drug|0|||
129693124|NCT03931785|466835690|FG000|Overall Study|Other Not specified|0|||
129693125|NCT03931785|466835691|FG001|Overall Study|Other Not specified|2|||
129693126|NCT03931785|466835692|FG002|Overall Study|Other Not specified|2|||
129693127|NCT03931785|466835693|FG003|Overall Study|Other Not specified|2|||
129693128|NCT03931785|466835690|FG000|Overall Study|Withdrawal by Subject|0|||
129693129|NCT03931785|466835691|FG001|Overall Study|Withdrawal by Subject|2|||
129693130|NCT03931785|466835692|FG002|Overall Study|Withdrawal by Subject|4|||
129783134|NCT04627285|467173415|FG000|Overall Study|Sponsor decision|5|||
129693131|NCT03931785|466835693|FG003|Overall Study|Withdrawal by Subject|1|||
129693132|NCT03931785|466835690|FG000|Overall Study|Pregnancy|0|||
129693133|NCT03931785|466835691|FG001|Overall Study|Pregnancy|0|||
129693134|NCT03931785|466835692|FG002|Overall Study|Pregnancy|0|||
129693135|NCT03931785|466835693|FG003|Overall Study|Pregnancy|1|||
129693136|NCT04605588|466835696|FG000|Overall Study|Withdrawal by Subject|1|||
129693137|NCT04605588|466835697|FG001|Overall Study|Withdrawal by Subject|0|||
129693138|NCT01230814|466835698|FG000|Overall Study|Lost to Follow-up|11|||
129693139|NCT01230814|466835699|FG001|Overall Study|Lost to Follow-up|3|||
129693140|NCT01230814|466835698|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
129693141|NCT01230814|466835699|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
129693142|NCT01748552|466835704|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
129693143|NCT01748552|466835705|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
129693144|NCT01748552|466835706|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
129693145|NCT01748552|466835707|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
129693146|NCT01748552|466835708|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
129693147|NCT01748552|466835709|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
129693148|NCT01748552|466835710|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
129693149|NCT01748552|466835711|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
129693150|NCT01748552|466835712|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
129693151|NCT01748552|466835713|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
129693152|NCT01748552|466835714|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
129693153|NCT01748552|466835715|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
129693154|NCT01748552|466835704|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693155|NCT01748552|466835705|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693156|NCT01748552|466835706|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693157|NCT01748552|466835707|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693158|NCT01748552|466835708|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693159|NCT01748552|466835709|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693160|NCT01748552|466835710|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
129693161|NCT01748552|466835711|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
129693162|NCT01748552|466835712|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
129693163|NCT01748552|466835713|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693164|NCT01748552|466835714|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693165|NCT01748552|466835715|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
129693166|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
129693167|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
129693168|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
129693169|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
129693170|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
129693171|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
129693172|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
129693173|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
129693174|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
129693175|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
129693176|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
129693177|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
129693178|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
129693179|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
129693180|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
129693181|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
129693182|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
129693183|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
129693184|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
129693185|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
129693186|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
129693187|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
129693188|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
129693189|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
129693190|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
129693191|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
129693192|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
129693193|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
129693194|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
129693195|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
129693196|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
129783135|NCT04627285|467173416|FG001|Overall Study|Sponsor decision|0|||
129783136|NCT04627285|467173415|FG000|Overall Study|Participant left country; aunt informed the site|0|||
129783137|NCT04627285|467173416|FG001|Overall Study|Participant left country; aunt informed the site|1|||
129783138|NCT01904773|467175620|FG000|Screen|Screen failure|3|||
129783139|NCT01904773|467175621|FG001|Screen|Screen failure|0|||
129783140|NCT01904773|467175622|FG002|Screen|Screen failure|0|||
129783141|NCT01904773|467175623|FG003|Screen|Screen failure|0|||
129783142|NCT01904773|467175624|FG004|Screen|Screen failure|0|||
129783143|NCT01904773|467175625|FG005|Screen|Screen failure|0|||
129783144|NCT01904773|467175626|FG006|Screen|Screen failure|0|||
129783145|NCT01904773|467175627|FG007|Screen|Screen failure|0|||
129783146|NCT01904773|467175628|FG008|Screen|Screen failure|0|||
129783147|NCT01904773|467175620|FG000|Screen|Withdrawal by Subject|1|||
129783148|NCT01904773|467175621|FG001|Screen|Withdrawal by Subject|0|||
129783149|NCT01904773|467175622|FG002|Screen|Withdrawal by Subject|0|||
129783150|NCT01904773|467175623|FG003|Screen|Withdrawal by Subject|0|||
129783151|NCT01904773|467175624|FG004|Screen|Withdrawal by Subject|0|||
129783152|NCT01904773|467175625|FG005|Screen|Withdrawal by Subject|0|||
129783153|NCT01904773|467175626|FG006|Screen|Withdrawal by Subject|0|||
129783154|NCT01904773|467175627|FG007|Screen|Withdrawal by Subject|0|||
129783155|NCT01904773|467175628|FG008|Screen|Withdrawal by Subject|0|||
129783156|NCT01904773|467175620|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
129783157|NCT01904773|467175621|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783158|NCT01904773|467175622|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783159|NCT01904773|467175623|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783160|NCT01904773|467175624|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783161|NCT01904773|467175625|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783162|NCT01904773|467175626|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783163|NCT01904773|467175627|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783164|NCT01904773|467175628|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
129783165|NCT01904773|467175620|FG000|First Intervention|Adverse Event|0|||
129783166|NCT01904773|467175621|FG001|First Intervention|Adverse Event|0|||
129783167|NCT01904773|467175622|FG002|First Intervention|Adverse Event|0|||
129783168|NCT01904773|467175623|FG003|First Intervention|Adverse Event|0|||
129783169|NCT01904773|467175624|FG004|First Intervention|Adverse Event|0|||
129783170|NCT01904773|467175625|FG005|First Intervention|Adverse Event|0|||
129783171|NCT01904773|467175626|FG006|First Intervention|Adverse Event|1|||
129783172|NCT01904773|467175627|FG007|First Intervention|Adverse Event|0|||
129783173|NCT01904773|467175628|FG008|First Intervention|Adverse Event|0|||
129783174|NCT01904773|467175620|FG000|Placebo Washout First Intervention|Condition worsened|0|||
129783175|NCT01904773|467175621|FG001|Placebo Washout First Intervention|Condition worsened|1|||
129783176|NCT01904773|467175622|FG002|Placebo Washout First Intervention|Condition worsened|0|||
129783177|NCT01904773|467175623|FG003|Placebo Washout First Intervention|Condition worsened|0|||
129783178|NCT01904773|467175624|FG004|Placebo Washout First Intervention|Condition worsened|0|||
129783179|NCT01904773|467175625|FG005|Placebo Washout First Intervention|Condition worsened|0|||
129783180|NCT01904773|467175626|FG006|Placebo Washout First Intervention|Condition worsened|0|||
129783181|NCT01904773|467175627|FG007|Placebo Washout First Intervention|Condition worsened|0|||
129783182|NCT01904773|467175628|FG008|Placebo Washout First Intervention|Condition worsened|0|||
129783183|NCT01904773|467175620|FG000|Fifth Intervention|Adverse Event|0|||
129783184|NCT01904773|467175621|FG001|Fifth Intervention|Adverse Event|0|||
129783185|NCT01904773|467175622|FG002|Fifth Intervention|Adverse Event|0|||
129783186|NCT01904773|467175623|FG003|Fifth Intervention|Adverse Event|0|||
129783187|NCT01904773|467175624|FG004|Fifth Intervention|Adverse Event|0|||
129783188|NCT01904773|467175625|FG005|Fifth Intervention|Adverse Event|0|||
129783189|NCT01904773|467175626|FG006|Fifth Intervention|Adverse Event|0|||
129783190|NCT01904773|467175627|FG007|Fifth Intervention|Adverse Event|1|||
129783191|NCT01904773|467175628|FG008|Fifth Intervention|Adverse Event|0|||
129783192|NCT01904773|467175620|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783193|NCT01904773|467175621|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
129783194|NCT01904773|467175622|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783195|NCT01904773|467175623|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783196|NCT01904773|467175624|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783197|NCT01904773|467175625|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783198|NCT01904773|467175626|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783199|NCT01904773|467175627|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129800238|NCT04755283|467236269|FG001|Overall Study|Withdrawal by Subject|3|||
129783200|NCT01904773|467175628|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
129783201|NCT00220779|467175632|FG000|Overall Study|Adverse Event|1|||
129783202|NCT00220779|467175633|FG001|Overall Study|Adverse Event|0|||
129783203|NCT00220779|467175634|FG002|Overall Study|Adverse Event|0|||
129783204|NCT00220779|467175632|FG000|Overall Study|Withdrawal by Subject|1|||
129783205|NCT00220779|467175633|FG001|Overall Study|Withdrawal by Subject|4|||
129783206|NCT00220779|467175634|FG002|Overall Study|Withdrawal by Subject|1|||
129783207|NCT00220779|467175632|FG000|Overall Study|Non-compliance|1|||
129783208|NCT00220779|467175633|FG001|Overall Study|Non-compliance|0|||
129783209|NCT00220779|467175634|FG002|Overall Study|Non-compliance|0|||
129783210|NCT00220779|467175632|FG000|Overall Study|Too time consuming|1|||
129783211|NCT00220779|467175633|FG001|Overall Study|Too time consuming|0|||
129783212|NCT00220779|467175634|FG002|Overall Study|Too time consuming|0|||
129783213|NCT00220779|467175632|FG000|Overall Study|Pregnancy|0|||
129783214|NCT00220779|467175633|FG001|Overall Study|Pregnancy|0|||
129783215|NCT00220779|467175634|FG002|Overall Study|Pregnancy|2|||
129783216|NCT00220779|467175632|FG000|Overall Study|Lack of Efficacy|3|||
129783217|NCT00220779|467175633|FG001|Overall Study|Lack of Efficacy|0|||
129783218|NCT00220779|467175634|FG002|Overall Study|Lack of Efficacy|1|||
129783219|NCT02248675|467175635|FG000|Overall Study|Lost to Follow-up|3|||
129783220|NCT02248675|467175636|FG001|Overall Study|Lost to Follow-up|1|||
129783221|NCT03390101|467175639|FG000|Weeks 0-12|Withdrawal by Subject|0|||
129783222|NCT03390101|467175640|FG001|Weeks 0-12|Withdrawal by Subject|1|||
129783223|NCT03390101|467175641|FG002|Weeks 0-12|Withdrawal by Subject|1|||
129783224|NCT03390101|467175639|FG000|Weeks 0-12|Lost to Follow-up|0|||
129783225|NCT03390101|467175640|FG001|Weeks 0-12|Lost to Follow-up|1|||
129574386|NCT04089735|466400716|FG004|Overall Study|Withdrawal by Subject|0|||
129574387|NCT04089735|466400717|FG005|Overall Study|Withdrawal by Subject|0|||
129574388|NCT04089735|466400712|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
129783226|NCT03390101|467175641|FG002|Weeks 0-12|Lost to Follow-up|0|||
129783227|NCT03390101|467175639|FG000|Weeks 12-54|Withdrawal by Subject|0|||
129783228|NCT03390101|467175640|FG001|Weeks 12-54|Withdrawal by Subject|3|||
129783229|NCT03390101|467175641|FG002|Weeks 12-54|Withdrawal by Subject|1|||
129783230|NCT03390101|467175639|FG000|Weeks 12-54|Pregnancy|1|||
129783231|NCT03390101|467175640|FG001|Weeks 12-54|Pregnancy|0|||
129783232|NCT03390101|467175641|FG002|Weeks 12-54|Pregnancy|0|||
129783233|NCT03390101|467175639|FG000|Weeks 12-54|Adverse Event|2|||
129783234|NCT03390101|467175640|FG001|Weeks 12-54|Adverse Event|1|||
129783235|NCT03390101|467175641|FG002|Weeks 12-54|Adverse Event|1|||
129783236|NCT00281658|467175646|FG000|Randomized Phase|Adverse Event|0|||
129783237|NCT00281658|467175647|FG001|Randomized Phase|Adverse Event|2|||
129783238|NCT00281658|467175648|FG002|Randomized Phase|Adverse Event|0|||
129783239|NCT00281658|467175649|FG003|Randomized Phase|Adverse Event|0|||
129783240|NCT00281658|467175646|FG000|Randomized Phase|Lost to Follow-up|34|||
129783241|NCT00281658|467175647|FG001|Randomized Phase|Lost to Follow-up|27|||
129783242|NCT00281658|467175648|FG002|Randomized Phase|Lost to Follow-up|0|||
129783243|NCT00281658|467175649|FG003|Randomized Phase|Lost to Follow-up|0|||
129783244|NCT00281658|467175646|FG000|Randomized Phase|Withdrawal by Subject|8|||
129783245|NCT00281658|467175647|FG001|Randomized Phase|Withdrawal by Subject|7|||
129783246|NCT00281658|467175648|FG002|Randomized Phase|Withdrawal by Subject|0|||
129783247|NCT00281658|467175649|FG003|Randomized Phase|Withdrawal by Subject|0|||
129783248|NCT00281658|467175646|FG000|Randomized Phase|Study closed/terminated|1|||
129783249|NCT00281658|467175647|FG001|Randomized Phase|Study closed/terminated|1|||
129783250|NCT00281658|467175648|FG002|Randomized Phase|Study closed/terminated|0|||
129783251|NCT00281658|467175649|FG003|Randomized Phase|Study closed/terminated|0|||
129783252|NCT00281658|467175646|FG000|Randomized Phase|Disease progression|36|||
129783253|NCT00281658|467175647|FG001|Randomized Phase|Disease progression|27|||
129783254|NCT00281658|467175648|FG002|Randomized Phase|Disease progression|0|||
129783255|NCT00281658|467175649|FG003|Randomized Phase|Disease progression|0|||
129783256|NCT00281658|467175646|FG000|Randomized Phase|Physician Decision|1|||
129574389|NCT04089735|466400713|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
129783257|NCT00281658|467175647|FG001|Randomized Phase|Physician Decision|1|||
129783258|NCT00281658|467175648|FG002|Randomized Phase|Physician Decision|0|||
129783259|NCT00281658|467175649|FG003|Randomized Phase|Physician Decision|0|||
129783260|NCT00281658|467175646|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
129783261|NCT00281658|467175647|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
129574390|NCT04089735|466400714|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
129783262|NCT00281658|467175648|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
129783263|NCT00281658|467175649|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
129783264|NCT00281658|467175646|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
129783265|NCT00281658|467175647|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
129783266|NCT00281658|467175648|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
129884622|NCT02310126|467538604|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
129783267|NCT00281658|467175649|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
129783268|NCT00281658|467175646|FG000|Randomized Phase|Treatment ongoing|1|||
129783269|NCT00281658|467175647|FG001|Randomized Phase|Treatment ongoing|0|||
129783270|NCT00281658|467175648|FG002|Randomized Phase|Treatment ongoing|0|||
129693197|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
129693198|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
129693199|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
129693200|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
129693201|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
129693202|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
129693203|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
129693204|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
129693205|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
129693206|NCT02596893|466835718|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
129693207|NCT02596893|466835719|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
129693208|NCT02596893|466835720|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
129693209|NCT02596893|466835721|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
129693210|NCT00004228|466835724|FG000|Overall Study|Adverse Event|0|||
129693211|NCT00004228|466835725|FG001|Overall Study|Adverse Event|1|||
129693212|NCT00004228|466835726|FG002|Overall Study|Adverse Event|0|||
129693213|NCT00004228|466835727|FG003|Overall Study|Adverse Event|0|||
129693214|NCT00004228|466835728|FG004|Overall Study|Adverse Event|1|||
129693215|NCT00004228|466835729|FG005|Overall Study|Adverse Event|0|||
129693216|NCT00004228|466835730|FG006|Overall Study|Adverse Event|0|||
129693217|NCT00004228|466835724|FG000|Overall Study|Death|0|||
129693218|NCT00004228|466835725|FG001|Overall Study|Death|1|||
129693219|NCT00004228|466835726|FG002|Overall Study|Death|2|||
129693220|NCT00004228|466835727|FG003|Overall Study|Death|0|||
129693221|NCT00004228|466835728|FG004|Overall Study|Death|1|||
129693222|NCT00004228|466835729|FG005|Overall Study|Death|0|||
129693223|NCT00004228|466835730|FG006|Overall Study|Death|0|||
129693224|NCT00004228|466835724|FG000|Overall Study|Lack of Efficacy|1|||
129693225|NCT00004228|466835725|FG001|Overall Study|Lack of Efficacy|6|||
129693226|NCT00004228|466835726|FG002|Overall Study|Lack of Efficacy|5|||
129693227|NCT00004228|466835727|FG003|Overall Study|Lack of Efficacy|3|||
129693228|NCT00004228|466835728|FG004|Overall Study|Lack of Efficacy|9|||
129693229|NCT00004228|466835729|FG005|Overall Study|Lack of Efficacy|8|||
129693230|NCT00004228|466835730|FG006|Overall Study|Lack of Efficacy|4|||
129693231|NCT00004228|466835724|FG000|Overall Study|Lost to Follow-up|0|||
129693232|NCT00004228|466835725|FG001|Overall Study|Lost to Follow-up|0|||
129693233|NCT00004228|466835726|FG002|Overall Study|Lost to Follow-up|1|||
129693234|NCT00004228|466835727|FG003|Overall Study|Lost to Follow-up|0|||
129693235|NCT00004228|466835728|FG004|Overall Study|Lost to Follow-up|0|||
129693236|NCT00004228|466835729|FG005|Overall Study|Lost to Follow-up|0|||
129693237|NCT00004228|466835730|FG006|Overall Study|Lost to Follow-up|0|||
129693238|NCT00004228|466835724|FG000|Overall Study|Physician Decision|1|||
129693239|NCT00004228|466835725|FG001|Overall Study|Physician Decision|0|||
129693240|NCT00004228|466835726|FG002|Overall Study|Physician Decision|3|||
129693241|NCT00004228|466835727|FG003|Overall Study|Physician Decision|2|||
129693242|NCT00004228|466835728|FG004|Overall Study|Physician Decision|1|||
129693243|NCT00004228|466835729|FG005|Overall Study|Physician Decision|1|||
129693244|NCT00004228|466835730|FG006|Overall Study|Physician Decision|1|||
129693245|NCT00004228|466835724|FG000|Overall Study|Protocol Violation|0|||
129693246|NCT00004228|466835725|FG001|Overall Study|Protocol Violation|5|||
129693247|NCT00004228|466835726|FG002|Overall Study|Protocol Violation|2|||
129693248|NCT00004228|466835727|FG003|Overall Study|Protocol Violation|1|||
129693249|NCT00004228|466835728|FG004|Overall Study|Protocol Violation|1|||
129693250|NCT00004228|466835729|FG005|Overall Study|Protocol Violation|2|||
129693251|NCT00004228|466835730|FG006|Overall Study|Protocol Violation|0|||
129693252|NCT00004228|466835724|FG000|Overall Study|Withdrawal by Subject|3|||
129693253|NCT00004228|466835725|FG001|Overall Study|Withdrawal by Subject|0|||
129693254|NCT00004228|466835726|FG002|Overall Study|Withdrawal by Subject|1|||
129693255|NCT00004228|466835727|FG003|Overall Study|Withdrawal by Subject|0|||
129693256|NCT00004228|466835728|FG004|Overall Study|Withdrawal by Subject|2|||
129693257|NCT00004228|466835729|FG005|Overall Study|Withdrawal by Subject|1|||
129783271|NCT00281658|467175649|FG003|Randomized Phase|Treatment ongoing|0|||
129693258|NCT00004228|466835730|FG006|Overall Study|Withdrawal by Subject|2|||
129783272|NCT00281658|467175646|FG000|Open Label Phase|Adverse Event|0|||
129693259|NCT00004228|466835724|FG000|Overall Study|Other|0|||
129693260|NCT00004228|466835725|FG001|Overall Study|Other|0|||
129783273|NCT00281658|467175647|FG001|Open Label Phase|Adverse Event|0|||
129693261|NCT00004228|466835726|FG002|Overall Study|Other|1|||
129693262|NCT00004228|466835727|FG003|Overall Study|Other|0|||
129693263|NCT00004228|466835728|FG004|Overall Study|Other|0|||
129693264|NCT00004228|466835729|FG005|Overall Study|Other|0|||
129693265|NCT00004228|466835730|FG006|Overall Study|Other|0|||
129693266|NCT00004228|466835724|FG000|Overall Study|ineligible|4|||
129693267|NCT00004228|466835725|FG001|Overall Study|ineligible|2|||
129693268|NCT00004228|466835726|FG002|Overall Study|ineligible|4|||
129783274|NCT00281658|467175648|FG002|Open Label Phase|Adverse Event|1|||
129783275|NCT00281658|467175649|FG003|Open Label Phase|Adverse Event|0|||
129783276|NCT00281658|467175646|FG000|Open Label Phase|Lost to Follow-up|0|||
129783277|NCT00281658|467175647|FG001|Open Label Phase|Lost to Follow-up|0|||
129783278|NCT00281658|467175648|FG002|Open Label Phase|Lost to Follow-up|16|||
129783279|NCT00281658|467175649|FG003|Open Label Phase|Lost to Follow-up|2|||
129783280|NCT00281658|467175646|FG000|Open Label Phase|Withdrawal by Subject|0|||
129783281|NCT00281658|467175647|FG001|Open Label Phase|Withdrawal by Subject|0|||
129783282|NCT00281658|467175648|FG002|Open Label Phase|Withdrawal by Subject|3|||
129783283|NCT00281658|467175649|FG003|Open Label Phase|Withdrawal by Subject|2|||
129693269|NCT00004228|466835727|FG003|Overall Study|ineligible|1|||
129693270|NCT00004228|466835728|FG004|Overall Study|ineligible|1|||
129693271|NCT00004228|466835729|FG005|Overall Study|ineligible|2|||
129693272|NCT00004228|466835730|FG006|Overall Study|ineligible|5|||
129693273|NCT02255279|466835731|FG000|Overall Study|Lost to Follow-up|2|||
129693274|NCT02255279|466835732|FG001|Overall Study|Lost to Follow-up|2|||
129693275|NCT02255279|466835731|FG000|Overall Study|Protocol Violation|0|||
129693276|NCT02255279|466835732|FG001|Overall Study|Protocol Violation|1|||
129693277|NCT02255279|466835731|FG000|Overall Study|Withdrawal by Subject|3|||
129693278|NCT02255279|466835732|FG001|Overall Study|Withdrawal by Subject|6|||
129693279|NCT00363467|466835733|FG000|Overall Study|Physician Decision|1|||
129693280|NCT00903344|466835734|FG000|Overall Study|Pregnancy|2|||
129693281|NCT00903344|466835735|FG001|Overall Study|Pregnancy|3|||
129693282|NCT00903344|466835734|FG000|Overall Study|Lost to Follow-up|3|||
129693283|NCT00903344|466835735|FG001|Overall Study|Lost to Follow-up|0|||
129693284|NCT01524705|466835736|FG000|Overall Study|Adverse Event|2|||
129693285|NCT01524705|466835737|FG001|Overall Study|Adverse Event|0|||
129693286|NCT01524705|466835736|FG000|Overall Study|Death|1|||
129693287|NCT01524705|466835737|FG001|Overall Study|Death|0|||
129693288|NCT01524705|466835736|FG000|Overall Study|Lost to Follow-up|0|||
129693289|NCT01524705|466835737|FG001|Overall Study|Lost to Follow-up|1|||
129693290|NCT01524705|466835736|FG000|Overall Study|Withdrawal by Subject|0|||
129693291|NCT01524705|466835737|FG001|Overall Study|Withdrawal by Subject|1|||
129693292|NCT01524705|466835736|FG000|Overall Study|Pancreatic Cancer|0|||
129693293|NCT01524705|466835737|FG001|Overall Study|Pancreatic Cancer|1|||
129693294|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
129693295|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
129693296|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
129693297|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
129693298|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
129693299|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
129693300|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
129693301|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
129693302|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
129693303|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
129693304|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
129693305|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
129693306|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
129693307|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
129693308|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
129693309|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
129693310|NCT01755156|466835738|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
129693311|NCT01755156|466835739|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
129693312|NCT01755156|466835738|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
129693313|NCT01755156|466835739|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
129693314|NCT01755156|466835738|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
129693315|NCT01755156|466835739|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
129693316|NCT00527748|466835742|FG000|Overall Study|Other|3|||
129693317|NCT01093885|466835744|FG000|Overall Study|Adverse Event|4|||
129693318|NCT01093885|466835744|FG000|Overall Study|Lost to Follow-up|1|||
129693319|NCT00292370|466835745|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
129693320|NCT00292370|466835746|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
129693321|NCT00292370|466835747|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
129693322|NCT00292370|466835745|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
129693323|NCT00292370|466835746|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
129693324|NCT00292370|466835747|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
129783284|NCT00281658|467175646|FG000|Open Label Phase|Disease progression|0|||
129783285|NCT00281658|467175647|FG001|Open Label Phase|Disease progression|0|||
129693325|NCT00292370|466835745|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
129693326|NCT00292370|466835746|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
129693327|NCT00292370|466835747|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
129693328|NCT00292370|466835745|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
129693329|NCT00292370|466835746|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
129693330|NCT00292370|466835747|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
129693331|NCT00292370|466835745|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
129783286|NCT00281658|467175648|FG002|Open Label Phase|Disease progression|18|||
129783287|NCT00281658|467175649|FG003|Open Label Phase|Disease progression|0|||
129783288|NCT00281658|467175646|FG000|Open Label Phase|Physician Decision|0|||
129783289|NCT00281658|467175647|FG001|Open Label Phase|Physician Decision|0|||
129783290|NCT00281658|467175648|FG002|Open Label Phase|Physician Decision|1|||
129783291|NCT00281658|467175649|FG003|Open Label Phase|Physician Decision|0|||
129783292|NCT00281658|467175646|FG000|Open Label Phase|Relocation of patient|0|||
129783293|NCT00281658|467175647|FG001|Open Label Phase|Relocation of patient|0|||
129783294|NCT00281658|467175648|FG002|Open Label Phase|Relocation of patient|1|||
129783295|NCT00281658|467175649|FG003|Open Label Phase|Relocation of patient|0|||
129783296|NCT00281658|467175646|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
129783297|NCT00281658|467175647|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
129783298|NCT00281658|467175648|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
129783299|NCT00281658|467175649|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
129783300|NCT00813943|467175653|FG000|Overall Study|Ongoing at cut-off date|5|||
129783301|NCT00813943|467175654|FG001|Overall Study|Ongoing at cut-off date|5|||
129783302|NCT00813943|467175655|FG002|Overall Study|Ongoing at cut-off date|3|||
129783303|NCT01343693|467175656|FG000|Overall Study|Lost to Follow-up|9|||
129783304|NCT01235598|467175657|FG000|Overall Study|Adverse Event|0|||
129783305|NCT01235598|467175658|FG001|Overall Study|Adverse Event|3|||
129783306|NCT01235598|467175657|FG000|Overall Study|Lack of Efficacy|0|||
129783307|NCT01235598|467175658|FG001|Overall Study|Lack of Efficacy|1|||
129783308|NCT01235598|467175657|FG000|Overall Study|Withdrawal by Subject|1|||
129783309|NCT01235598|467175658|FG001|Overall Study|Withdrawal by Subject|0|||
129783310|NCT02551991|467175659|FG000|Overall Study|Death|5|||
129783311|NCT02551991|467175660|FG001|Overall Study|Death|7|||
129783312|NCT02551991|467175661|FG002|Overall Study|Death|8|||
129783313|NCT02551991|467175662|FG003|Overall Study|Death|7|||
129783314|NCT02551991|467175663|FG004|Overall Study|Death|17|||
129783315|NCT02551991|467175659|FG000|Overall Study|Withdrawal by Subject|1|||
129783316|NCT02551991|467175660|FG001|Overall Study|Withdrawal by Subject|0|||
129783317|NCT02551991|467175661|FG002|Overall Study|Withdrawal by Subject|0|||
129783318|NCT02551991|467175662|FG003|Overall Study|Withdrawal by Subject|0|||
129783319|NCT02551991|467175663|FG004|Overall Study|Withdrawal by Subject|2|||
129783320|NCT02551991|467175659|FG000|Overall Study|Lost to Follow-up|0|||
129783321|NCT02551991|467175660|FG001|Overall Study|Lost to Follow-up|0|||
129783322|NCT02551991|467175661|FG002|Overall Study|Lost to Follow-up|1|||
129783323|NCT02551991|467175662|FG003|Overall Study|Lost to Follow-up|0|||
129783324|NCT02551991|467175663|FG004|Overall Study|Lost to Follow-up|0|||
129783325|NCT02551991|467175659|FG000|Overall Study|Sponsor Decision|1|||
129783326|NCT02551991|467175660|FG001|Overall Study|Sponsor Decision|0|||
129783327|NCT02551991|467175661|FG002|Overall Study|Sponsor Decision|1|||
129783328|NCT02551991|467175662|FG003|Overall Study|Sponsor Decision|0|||
129783329|NCT02551991|467175663|FG004|Overall Study|Sponsor Decision|5|||
129783330|NCT02551991|467175659|FG000|Overall Study|Other|0|||
129783331|NCT02551991|467175660|FG001|Overall Study|Other|0|||
129783332|NCT02551991|467175661|FG002|Overall Study|Other|0|||
129783333|NCT02551991|467175662|FG003|Overall Study|Other|0|||
129783334|NCT02551991|467175663|FG004|Overall Study|Other|1|||
129783335|NCT00265148|467175664|FG000|Overall Study|Adverse Event|2|||
129783336|NCT00265148|467175665|FG001|Overall Study|Adverse Event|2|||
129783337|NCT00265148|467175664|FG000|Overall Study|Lack of Efficacy|0|||
129783338|NCT00265148|467175665|FG001|Overall Study|Lack of Efficacy|2|||
129783339|NCT00265148|467175664|FG000|Overall Study|Protocol Violation|3|||
129783340|NCT00265148|467175665|FG001|Overall Study|Protocol Violation|2|||
129783341|NCT00265148|467175664|FG000|Overall Study|Lost to Follow-up|0|||
129783342|NCT00265148|467175665|FG001|Overall Study|Lost to Follow-up|1|||
129783343|NCT00265148|467175664|FG000|Overall Study|Withdrawal by Subject|2|||
129783344|NCT00265148|467175665|FG001|Overall Study|Withdrawal by Subject|1|||
129783345|NCT00265148|467175664|FG000|Overall Study|Physician Decision|1|||
129783346|NCT00265148|467175665|FG001|Overall Study|Physician Decision|0|||
129783347|NCT00265148|467175664|FG000|Overall Study|Increasing frailty|0|||
129783348|NCT00265148|467175665|FG001|Overall Study|Increasing frailty|1|||
129783349|NCT00265148|467175664|FG000|Overall Study|Subject chose to change of the dose|1|||
129783350|NCT00265148|467175665|FG001|Overall Study|Subject chose to change of the dose|0|||
129783351|NCT00387790|467175670|FG000|Overall Study|Adverse Event|5|||
129783352|NCT00387790|467175670|FG000|Overall Study|Lack of Efficacy|2|||
129783353|NCT00387790|467175670|FG000|Overall Study|Physician Decision|2|||
129783354|NCT00387790|467175670|FG000|Overall Study|Withdrawal by Subject|3|||
129783355|NCT00387790|467175670|FG000|Overall Study|Ineligible for study|2|||
129783356|NCT01874340|467175673|FG000|Overall Study|Study terminated by Sponsor|6|||
129783357|NCT01874340|467175674|FG001|Overall Study|Study terminated by Sponsor|8|||
129783358|NCT01874340|467175675|FG002|Overall Study|Study terminated by Sponsor|8|||
129783359|NCT01874340|467175676|FG003|Overall Study|Study terminated by Sponsor|4|||
129783360|NCT01874340|467175673|FG000|Overall Study|Withdrawal by Subject|0|||
129783361|NCT01874340|467175674|FG001|Overall Study|Withdrawal by Subject|0|||
129783362|NCT01874340|467175675|FG002|Overall Study|Withdrawal by Subject|0|||
129783363|NCT01874340|467175676|FG003|Overall Study|Withdrawal by Subject|1|||
129783364|NCT00444678|467175685|FG000|Overall Study|Toxicity|11|||
129783365|NCT00444678|467175685|FG000|Overall Study|Disease Progression|12|||
129693332|NCT00292370|466835746|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
129693333|NCT00292370|466835747|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
129693334|NCT00292370|466835745|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
129693335|NCT00292370|466835746|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
129693336|NCT00292370|466835747|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
129693337|NCT02533674|466835748|FG000|Dose Level I|Progressive disease|1|||
129693338|NCT02533674|466835749|FG001|Dose Level I|Progressive disease|0|||
129693339|NCT02533674|466835750|FG002|Dose Level I|Progressive disease|0|||
129693340|NCT02533674|466835751|FG003|Dose Level I|Progressive disease|0|||
129693341|NCT02533674|466835752|FG004|Dose Level I|Progressive disease|0|||
129693342|NCT02533674|466835753|FG005|Dose Level I|Progressive disease|0|||
129693343|NCT02533674|466835754|FG006|Dose Level I|Progressive disease|0|||
129693344|NCT02533674|466835755|FG007|Dose Level I|Progressive disease|0|||
129693345|NCT02533674|466835748|FG000|Dose Level I|Withdrawal by Subject|1|||
129693346|NCT02533674|466835749|FG001|Dose Level I|Withdrawal by Subject|0|||
129693347|NCT02533674|466835750|FG002|Dose Level I|Withdrawal by Subject|0|||
129693348|NCT02533674|466835751|FG003|Dose Level I|Withdrawal by Subject|0|||
129693349|NCT02533674|466835752|FG004|Dose Level I|Withdrawal by Subject|0|||
129693350|NCT02533674|466835753|FG005|Dose Level I|Withdrawal by Subject|0|||
129693351|NCT02533674|466835754|FG006|Dose Level I|Withdrawal by Subject|0|||
129693352|NCT02533674|466835755|FG007|Dose Level I|Withdrawal by Subject|0|||
129693353|NCT02533674|466835748|FG000|Dose Level I|Physician Decision|1|||
129693354|NCT02533674|466835749|FG001|Dose Level I|Physician Decision|0|||
129693355|NCT02533674|466835750|FG002|Dose Level I|Physician Decision|0|||
129693356|NCT02533674|466835751|FG003|Dose Level I|Physician Decision|0|||
129693357|NCT02533674|466835752|FG004|Dose Level I|Physician Decision|0|||
129693358|NCT02533674|466835753|FG005|Dose Level I|Physician Decision|0|||
129693359|NCT02533674|466835754|FG006|Dose Level I|Physician Decision|0|||
129693360|NCT02533674|466835755|FG007|Dose Level I|Physician Decision|0|||
129693361|NCT02533674|466835748|FG000|Dose Level I|Death|1|||
129693362|NCT02533674|466835749|FG001|Dose Level I|Death|0|||
129693363|NCT02533674|466835750|FG002|Dose Level I|Death|0|||
129693364|NCT02533674|466835751|FG003|Dose Level I|Death|0|||
129693365|NCT02533674|466835752|FG004|Dose Level I|Death|0|||
129693366|NCT02533674|466835753|FG005|Dose Level I|Death|0|||
129693367|NCT02533674|466835754|FG006|Dose Level I|Death|0|||
129693368|NCT02533674|466835755|FG007|Dose Level I|Death|0|||
129693369|NCT02533674|466835748|FG000|Dose Level I|Never Treated|1|||
129693370|NCT02533674|466835749|FG001|Dose Level I|Never Treated|0|||
129693371|NCT02533674|466835750|FG002|Dose Level I|Never Treated|0|||
129693372|NCT02533674|466835751|FG003|Dose Level I|Never Treated|0|||
129693373|NCT02533674|466835752|FG004|Dose Level I|Never Treated|0|||
129693374|NCT02533674|466835753|FG005|Dose Level I|Never Treated|0|||
129693375|NCT02533674|466835754|FG006|Dose Level I|Never Treated|0|||
129693376|NCT02533674|466835755|FG007|Dose Level I|Never Treated|0|||
129693377|NCT02533674|466835748|FG000|Dose Level II|Progressive disease|0|||
129693378|NCT02533674|466835749|FG001|Dose Level II|Progressive disease|3|||
129693379|NCT02533674|466835750|FG002|Dose Level II|Progressive disease|0|||
129693380|NCT02533674|466835751|FG003|Dose Level II|Progressive disease|0|||
129693381|NCT02533674|466835752|FG004|Dose Level II|Progressive disease|0|||
129693382|NCT02533674|466835753|FG005|Dose Level II|Progressive disease|0|||
129783366|NCT00444678|467175685|FG000|Overall Study|Death|3|||
129783367|NCT00444678|467175685|FG000|Overall Study|Physician Decision|3|||
129693383|NCT02533674|466835754|FG006|Dose Level II|Progressive disease|0|||
129693384|NCT02533674|466835755|FG007|Dose Level II|Progressive disease|0|||
129693385|NCT02533674|466835748|FG000|Dose Level II|Withdrawal by Subject|0|||
129693386|NCT02533674|466835749|FG001|Dose Level II|Withdrawal by Subject|1|||
129693387|NCT02533674|466835750|FG002|Dose Level II|Withdrawal by Subject|0|||
129693388|NCT02533674|466835751|FG003|Dose Level II|Withdrawal by Subject|0|||
129693389|NCT02533674|466835752|FG004|Dose Level II|Withdrawal by Subject|0|||
129693390|NCT02533674|466835753|FG005|Dose Level II|Withdrawal by Subject|0|||
129693391|NCT02533674|466835754|FG006|Dose Level II|Withdrawal by Subject|0|||
129693392|NCT02533674|466835755|FG007|Dose Level II|Withdrawal by Subject|0|||
129693393|NCT02533674|466835748|FG000|Dose Level II|Treatment-related AE|0|||
129693394|NCT02533674|466835749|FG001|Dose Level II|Treatment-related AE|1|||
129693395|NCT02533674|466835750|FG002|Dose Level II|Treatment-related AE|0|||
129693396|NCT02533674|466835751|FG003|Dose Level II|Treatment-related AE|0|||
129693397|NCT02533674|466835752|FG004|Dose Level II|Treatment-related AE|0|||
129693398|NCT02533674|466835753|FG005|Dose Level II|Treatment-related AE|0|||
129693399|NCT02533674|466835754|FG006|Dose Level II|Treatment-related AE|0|||
129693400|NCT02533674|466835755|FG007|Dose Level II|Treatment-related AE|0|||
129693401|NCT02533674|466835748|FG000|Dose Level II|Physician Decision|0|||
129693402|NCT02533674|466835749|FG001|Dose Level II|Physician Decision|1|||
129693403|NCT02533674|466835750|FG002|Dose Level II|Physician Decision|0|||
129693404|NCT02533674|466835751|FG003|Dose Level II|Physician Decision|0|||
129693405|NCT02533674|466835752|FG004|Dose Level II|Physician Decision|0|||
129693406|NCT02533674|466835753|FG005|Dose Level II|Physician Decision|0|||
129693407|NCT02533674|466835754|FG006|Dose Level II|Physician Decision|0|||
129693408|NCT02533674|466835755|FG007|Dose Level II|Physician Decision|0|||
129693409|NCT02533674|466835748|FG000|Dose Level II|Non-treatment-related AE|0|||
129693410|NCT02533674|466835749|FG001|Dose Level II|Non-treatment-related AE|1|||
129693411|NCT02533674|466835750|FG002|Dose Level II|Non-treatment-related AE|0|||
129693412|NCT02533674|466835751|FG003|Dose Level II|Non-treatment-related AE|0|||
129693413|NCT02533674|466835752|FG004|Dose Level II|Non-treatment-related AE|0|||
129693414|NCT02533674|466835753|FG005|Dose Level II|Non-treatment-related AE|0|||
129693415|NCT02533674|466835754|FG006|Dose Level II|Non-treatment-related AE|0|||
129693416|NCT02533674|466835755|FG007|Dose Level II|Non-treatment-related AE|0|||
129693417|NCT02533674|466835748|FG000|Dose Level III|Progressive disease|0|||
129693418|NCT02533674|466835749|FG001|Dose Level III|Progressive disease|0|||
129693419|NCT02533674|466835750|FG002|Dose Level III|Progressive disease|2|||
129693420|NCT02533674|466835751|FG003|Dose Level III|Progressive disease|0|||
129693421|NCT02533674|466835752|FG004|Dose Level III|Progressive disease|0|||
129693422|NCT02533674|466835753|FG005|Dose Level III|Progressive disease|0|||
129693423|NCT02533674|466835754|FG006|Dose Level III|Progressive disease|0|||
129693424|NCT02533674|466835755|FG007|Dose Level III|Progressive disease|0|||
129693425|NCT02533674|466835748|FG000|Dose Level III|Withdrawal by Subject|0|||
129693426|NCT02533674|466835749|FG001|Dose Level III|Withdrawal by Subject|0|||
129693427|NCT02533674|466835750|FG002|Dose Level III|Withdrawal by Subject|1|||
129693428|NCT02533674|466835751|FG003|Dose Level III|Withdrawal by Subject|0|||
129693429|NCT02533674|466835752|FG004|Dose Level III|Withdrawal by Subject|0|||
129693430|NCT02533674|466835753|FG005|Dose Level III|Withdrawal by Subject|0|||
129693431|NCT02533674|466835754|FG006|Dose Level III|Withdrawal by Subject|0|||
129693432|NCT02533674|466835755|FG007|Dose Level III|Withdrawal by Subject|0|||
129693433|NCT02533674|466835748|FG000|Dose Level III|Treatment-related AE|0|||
129693434|NCT02533674|466835749|FG001|Dose Level III|Treatment-related AE|0|||
129693435|NCT02533674|466835750|FG002|Dose Level III|Treatment-related AE|1|||
129693436|NCT02533674|466835751|FG003|Dose Level III|Treatment-related AE|0|||
129693437|NCT02533674|466835752|FG004|Dose Level III|Treatment-related AE|0|||
129693438|NCT02533674|466835753|FG005|Dose Level III|Treatment-related AE|0|||
129693439|NCT02533674|466835754|FG006|Dose Level III|Treatment-related AE|0|||
129693440|NCT02533674|466835755|FG007|Dose Level III|Treatment-related AE|0|||
129693441|NCT02533674|466835748|FG000|Dose Level IV|Progressive disease|0|||
129693442|NCT02533674|466835749|FG001|Dose Level IV|Progressive disease|0|||
129693443|NCT02533674|466835750|FG002|Dose Level IV|Progressive disease|0|||
129693444|NCT02533674|466835751|FG003|Dose Level IV|Progressive disease|3|||
129693445|NCT02533674|466835752|FG004|Dose Level IV|Progressive disease|0|||
129693446|NCT02533674|466835753|FG005|Dose Level IV|Progressive disease|0|||
129693447|NCT02533674|466835754|FG006|Dose Level IV|Progressive disease|0|||
129693448|NCT02533674|466835755|FG007|Dose Level IV|Progressive disease|0|||
129693449|NCT02533674|466835748|FG000|Dose Level IV|Withdrawal by Subject|0|||
129693450|NCT02533674|466835749|FG001|Dose Level IV|Withdrawal by Subject|0|||
129693451|NCT02533674|466835750|FG002|Dose Level IV|Withdrawal by Subject|0|||
129693452|NCT02533674|466835751|FG003|Dose Level IV|Withdrawal by Subject|1|||
129693453|NCT02533674|466835752|FG004|Dose Level IV|Withdrawal by Subject|0|||
129693454|NCT02533674|466835753|FG005|Dose Level IV|Withdrawal by Subject|0|||
129693455|NCT02533674|466835754|FG006|Dose Level IV|Withdrawal by Subject|0|||
129693456|NCT02533674|466835755|FG007|Dose Level IV|Withdrawal by Subject|0|||
129693457|NCT02533674|466835748|FG000|Dose Level IV|Physician Decision|0|||
129884623|NCT02310126|467538605|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
129693458|NCT02533674|466835749|FG001|Dose Level IV|Physician Decision|0|||
129693459|NCT02533674|466835750|FG002|Dose Level IV|Physician Decision|0|||
129693460|NCT02533674|466835751|FG003|Dose Level IV|Physician Decision|1|||
129693461|NCT02533674|466835752|FG004|Dose Level IV|Physician Decision|0|||
129693462|NCT02533674|466835753|FG005|Dose Level IV|Physician Decision|0|||
129693463|NCT02533674|466835754|FG006|Dose Level IV|Physician Decision|0|||
129693464|NCT02533674|466835755|FG007|Dose Level IV|Physician Decision|0|||
129783368|NCT00444678|467175685|FG000|Overall Study|Withdrawal by Subject|2|||
129783369|NCT00606905|467175688|FG000|Overall Study|No Pregnancy|9|||
129783370|NCT00606905|467175689|FG001|Overall Study|No Pregnancy|6|||
129574391|NCT04089735|466400715|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
129574392|NCT04089735|466400716|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
129574393|NCT04089735|466400717|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
129574394|NCT01439880|466400719|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
129574395|NCT01439880|466400720|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
129574396|NCT01439880|466400719|FG000|SOC-controlled Period (Year 1)|Death|2|||
129574397|NCT01439880|466400720|FG001|SOC-controlled Period (Year 1)|Death|1|||
129574398|NCT01439880|466400719|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
129574399|NCT01439880|466400720|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
129574400|NCT01439880|466400719|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
129574401|NCT01439880|466400720|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
129574402|NCT01439880|466400719|FG000|SOC-controlled Period (Year 1)|Other|8|||
129574403|NCT01439880|466400720|FG001|SOC-controlled Period (Year 1)|Other|13|||
129574404|NCT01439880|466400719|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
129574405|NCT01439880|466400720|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
129574406|NCT01439880|466400719|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
129574407|NCT01439880|466400720|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
129574408|NCT01439880|466400719|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
129574409|NCT01439880|466400720|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
129574410|NCT01439880|466400719|FG000|All-IP Period (Years 2 to 5)|Death|3|||
129574411|NCT01439880|466400720|FG001|All-IP Period (Years 2 to 5)|Death|13|||
129574412|NCT01439880|466400719|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
129574413|NCT01439880|466400720|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
129574414|NCT01439880|466400719|FG000|All-IP Period (Years 2 to 5)|Other|14|||
129574415|NCT01439880|466400720|FG001|All-IP Period (Years 2 to 5)|Other|31|||
129574416|NCT01439880|466400719|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
129574417|NCT01439880|466400720|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
129574418|NCT03874715|466400722|FG000|Overall Study|Adverse Event|2|||
129574419|NCT03874715|466400723|FG001|Overall Study|Adverse Event|0|||
129574420|NCT03874715|466400722|FG000|Overall Study|Poor compliance to protocol|5|||
129574421|NCT03874715|466400723|FG001|Overall Study|Poor compliance to protocol|1|||
129574422|NCT03874715|466400722|FG000|Overall Study|Withdrawal by Subject|1|||
129574423|NCT03874715|466400723|FG001|Overall Study|Withdrawal by Subject|0|||
129574424|NCT03874715|466400722|FG000|Overall Study|Other-unspecified|1|||
129574425|NCT03874715|466400723|FG001|Overall Study|Other-unspecified|0|||
129574426|NCT02956460|466400726|FG000|Lens 1|Lost to Follow-up|1|||
129574427|NCT02956460|466400727|FG001|Lens 1|Lost to Follow-up|0|||
129574428|NCT00834067|466400730|FG000|Washout of 21 Days|Protocol Violation|0|||
129574429|NCT00834067|466400731|FG001|Washout of 21 Days|Protocol Violation|1|||
129574430|NCT04129346|466400732|FG000|Overall Study|Death|1|||
129574431|NCT04129346|466400733|FG001|Overall Study|Death|0|||
129574432|NCT01083693|466400734|FG000|Overall Study|Adverse Event|1|||
129574433|NCT01083693|466400735|FG001|Overall Study|Adverse Event|1|||
129574434|NCT01083693|466400736|FG002|Overall Study|Adverse Event|0|||
129574435|NCT01083693|466400734|FG000|Overall Study|Lost to Follow-up|2|||
129574436|NCT01083693|466400735|FG001|Overall Study|Lost to Follow-up|0|||
129574437|NCT01083693|466400736|FG002|Overall Study|Lost to Follow-up|2|||
129574438|NCT01083693|466400734|FG000|Overall Study|Lack of effectiveness|13|||
129693465|NCT02533674|466835748|FG000|Dose Level V|Progressive disease|0|||
129693466|NCT02533674|466835749|FG001|Dose Level V|Progressive disease|0|||
129693467|NCT02533674|466835750|FG002|Dose Level V|Progressive disease|0|||
129693468|NCT02533674|466835751|FG003|Dose Level V|Progressive disease|0|||
129693469|NCT02533674|466835752|FG004|Dose Level V|Progressive disease|3|||
129693470|NCT02533674|466835753|FG005|Dose Level V|Progressive disease|0|||
129693471|NCT02533674|466835754|FG006|Dose Level V|Progressive disease|0|||
129693472|NCT02533674|466835755|FG007|Dose Level V|Progressive disease|0|||
129783371|NCT00606905|467175688|FG000|Overall Study|Non-Index Pregnancy|1|||
129783372|NCT00606905|467175689|FG001|Overall Study|Non-Index Pregnancy|4|||
129574439|NCT01083693|466400735|FG001|Overall Study|Lack of effectiveness|2|||
129574440|NCT01083693|466400736|FG002|Overall Study|Lack of effectiveness|2|||
129574441|NCT01083693|466400734|FG000|Overall Study|Patient Moved|0|||
129574442|NCT01083693|466400735|FG001|Overall Study|Patient Moved|1|||
129574443|NCT01083693|466400736|FG002|Overall Study|Patient Moved|0|||
129574444|NCT01083693|466400734|FG000|Overall Study|Complete remission|0|||
129574445|NCT01083693|466400735|FG001|Overall Study|Complete remission|1|||
129783373|NCT00606905|467175688|FG000|Overall Study|Withdrew|5|||
129574446|NCT01083693|466400736|FG002|Overall Study|Complete remission|0|||
129574447|NCT01083693|466400734|FG000|Overall Study|Other medical condition/surgery|1|||
129693473|NCT02533674|466835748|FG000|Dose Level V|Withdrawal by Subject|0|||
129783374|NCT00606905|467175689|FG001|Overall Study|Withdrew|5|||
129574448|NCT01083693|466400735|FG001|Overall Study|Other medical condition/surgery|1|||
129574449|NCT01083693|466400736|FG002|Overall Study|Other medical condition/surgery|0|||
129574450|NCT01083693|466400734|FG000|Overall Study|Withdrawal by Subject|3|||
129574451|NCT01083693|466400735|FG001|Overall Study|Withdrawal by Subject|0|||
129574452|NCT01083693|466400736|FG002|Overall Study|Withdrawal by Subject|2|||
129574453|NCT01083693|466400734|FG000|Overall Study|Reason unknown|0|||
129574454|NCT01083693|466400735|FG001|Overall Study|Reason unknown|0|||
129574455|NCT01083693|466400736|FG002|Overall Study|Reason unknown|1|||
129574456|NCT01705574|466400737|FG000|Double-Blind Phase|Lost to Follow-up|12|||
129574457|NCT01705574|466400738|FG001|Double-Blind Phase|Lost to Follow-up|16|||
129574458|NCT01705574|466400739|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129574459|NCT01705574|466400740|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129574460|NCT01705574|466400737|FG000|Double-Blind Phase|Adverse Event|3|||
129574461|NCT01705574|466400738|FG001|Double-Blind Phase|Adverse Event|10|||
129574462|NCT01705574|466400739|FG002|Double-Blind Phase|Adverse Event|0|||
129574463|NCT01705574|466400740|FG003|Double-Blind Phase|Adverse Event|0|||
129574464|NCT01705574|466400737|FG000|Double-Blind Phase|Withdrew Consent|8|||
129574465|NCT01705574|466400738|FG001|Double-Blind Phase|Withdrew Consent|5|||
129574466|NCT01705574|466400739|FG002|Double-Blind Phase|Withdrew Consent|0|||
129574467|NCT01705574|466400740|FG003|Double-Blind Phase|Withdrew Consent|0|||
129574468|NCT01705574|466400737|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
129574469|NCT01705574|466400738|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
129574470|NCT01705574|466400739|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
129574471|NCT01705574|466400740|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
129574472|NCT01705574|466400737|FG000|Double-Blind Phase|Pregnancy|1|||
129574473|NCT01705574|466400738|FG001|Double-Blind Phase|Pregnancy|1|||
129574474|NCT01705574|466400739|FG002|Double-Blind Phase|Pregnancy|0|||
129574475|NCT01705574|466400740|FG003|Double-Blind Phase|Pregnancy|0|||
129574476|NCT01705574|466400737|FG000|Double-Blind Phase|Protocol Violation|1|||
129574477|NCT01705574|466400738|FG001|Double-Blind Phase|Protocol Violation|0|||
129574478|NCT01705574|466400739|FG002|Double-Blind Phase|Protocol Violation|0|||
129574479|NCT01705574|466400740|FG003|Double-Blind Phase|Protocol Violation|0|||
129574480|NCT01705574|466400737|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
129574481|NCT01705574|466400738|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
129574482|NCT01705574|466400739|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
129574483|NCT01705574|466400740|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
129574484|NCT01705574|466400737|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
129574485|NCT01705574|466400738|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129693474|NCT02533674|466835749|FG001|Dose Level V|Withdrawal by Subject|0|||
129693475|NCT02533674|466835750|FG002|Dose Level V|Withdrawal by Subject|0|||
129693476|NCT02533674|466835751|FG003|Dose Level V|Withdrawal by Subject|0|||
129693477|NCT02533674|466835752|FG004|Dose Level V|Withdrawal by Subject|1|||
129693478|NCT02533674|466835753|FG005|Dose Level V|Withdrawal by Subject|0|||
129693479|NCT02533674|466835754|FG006|Dose Level V|Withdrawal by Subject|0|||
129693480|NCT02533674|466835755|FG007|Dose Level V|Withdrawal by Subject|0|||
129693481|NCT02533674|466835748|FG000|Dose Level V|Physician Decision|0|||
129693482|NCT02533674|466835749|FG001|Dose Level V|Physician Decision|0|||
129693483|NCT02533674|466835750|FG002|Dose Level V|Physician Decision|0|||
129693484|NCT02533674|466835751|FG003|Dose Level V|Physician Decision|0|||
129693485|NCT02533674|466835752|FG004|Dose Level V|Physician Decision|1|||
129693486|NCT02533674|466835753|FG005|Dose Level V|Physician Decision|0|||
129693487|NCT02533674|466835754|FG006|Dose Level V|Physician Decision|0|||
129693488|NCT02533674|466835755|FG007|Dose Level V|Physician Decision|0|||
129693489|NCT02533674|466835748|FG000|Dose Level VI|Progressive disease|0|||
129693490|NCT02533674|466835749|FG001|Dose Level VI|Progressive disease|0|||
129693491|NCT02533674|466835750|FG002|Dose Level VI|Progressive disease|0|||
129693492|NCT02533674|466835751|FG003|Dose Level VI|Progressive disease|0|||
129693493|NCT02533674|466835752|FG004|Dose Level VI|Progressive disease|0|||
129693494|NCT02533674|466835753|FG005|Dose Level VI|Progressive disease|7|||
129693495|NCT02533674|466835754|FG006|Dose Level VI|Progressive disease|0|||
129693496|NCT02533674|466835755|FG007|Dose Level VI|Progressive disease|0|||
129574486|NCT01705574|466400739|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
129574487|NCT01705574|466400740|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
129574488|NCT01705574|466400737|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
129574489|NCT01705574|466400738|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
129574490|NCT01705574|466400739|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
129574491|NCT01705574|466400740|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
129574492|NCT01705574|466400737|FG000|Open-Label Extension Phase|Adverse Event|3|||
129693497|NCT02533674|466835748|FG000|Dose Level VI|Withdrawal by Subject|0|||
129693498|NCT02533674|466835749|FG001|Dose Level VI|Withdrawal by Subject|0|||
129693499|NCT02533674|466835750|FG002|Dose Level VI|Withdrawal by Subject|0|||
129693500|NCT02533674|466835751|FG003|Dose Level VI|Withdrawal by Subject|0|||
129693501|NCT02533674|466835752|FG004|Dose Level VI|Withdrawal by Subject|0|||
129693502|NCT02533674|466835753|FG005|Dose Level VI|Withdrawal by Subject|1|||
129574493|NCT01705574|466400738|FG001|Open-Label Extension Phase|Adverse Event|0|||
129574494|NCT01705574|466400739|FG002|Open-Label Extension Phase|Adverse Event|0|||
129574495|NCT01705574|466400740|FG003|Open-Label Extension Phase|Adverse Event|1|||
129574496|NCT01705574|466400737|FG000|Open-Label Extension Phase|Death|2|||
129574497|NCT01705574|466400738|FG001|Open-Label Extension Phase|Death|0|||
129574498|NCT01705574|466400739|FG002|Open-Label Extension Phase|Death|1|||
129574499|NCT01705574|466400740|FG003|Open-Label Extension Phase|Death|0|||
129574500|NCT01705574|466400737|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
129574501|NCT01705574|466400738|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
129574502|NCT01705574|466400739|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
129574503|NCT01705574|466400740|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
129574504|NCT01705574|466400737|FG000|Open-Label Extension Phase|Physician Decision|0|||
129574505|NCT01705574|466400738|FG001|Open-Label Extension Phase|Physician Decision|0|||
129574506|NCT01705574|466400739|FG002|Open-Label Extension Phase|Physician Decision|2|||
129574507|NCT01705574|466400740|FG003|Open-Label Extension Phase|Physician Decision|0|||
129574508|NCT01705574|466400737|FG000|Open-Label Extension Phase|Pregnancy|0|||
129574509|NCT01705574|466400738|FG001|Open-Label Extension Phase|Pregnancy|0|||
129574510|NCT01705574|466400739|FG002|Open-Label Extension Phase|Pregnancy|1|||
129574511|NCT01705574|466400740|FG003|Open-Label Extension Phase|Pregnancy|1|||
129574512|NCT02543203|466400741|FG000|Overall Study|Unpalatable Fragrance|2|||
129574513|NCT02543203|466400742|FG001|Overall Study|Unpalatable Fragrance|2|||
129574514|NCT02543203|466400741|FG000|Overall Study|Lost to Follow-up|1|||
129693503|NCT02533674|466835754|FG006|Dose Level VI|Withdrawal by Subject|0|||
129693504|NCT02533674|466835755|FG007|Dose Level VI|Withdrawal by Subject|0|||
129693505|NCT02533674|466835748|FG000|Dose Level VI|Treatment-related AE|0|||
129693506|NCT02533674|466835749|FG001|Dose Level VI|Treatment-related AE|0|||
129693507|NCT02533674|466835750|FG002|Dose Level VI|Treatment-related AE|0|||
129693508|NCT02533674|466835751|FG003|Dose Level VI|Treatment-related AE|0|||
129693509|NCT02533674|466835752|FG004|Dose Level VI|Treatment-related AE|0|||
129693510|NCT02533674|466835753|FG005|Dose Level VI|Treatment-related AE|1|||
129693511|NCT02533674|466835754|FG006|Dose Level VI|Treatment-related AE|0|||
129693512|NCT02533674|466835755|FG007|Dose Level VI|Treatment-related AE|0|||
129693513|NCT02533674|466835748|FG000|Dose Level VII|Progressive disease|0|||
129693514|NCT02533674|466835749|FG001|Dose Level VII|Progressive disease|0|||
129693515|NCT02533674|466835750|FG002|Dose Level VII|Progressive disease|0|||
129693516|NCT02533674|466835751|FG003|Dose Level VII|Progressive disease|0|||
129693517|NCT02533674|466835752|FG004|Dose Level VII|Progressive disease|0|||
129693518|NCT02533674|466835753|FG005|Dose Level VII|Progressive disease|0|||
129693519|NCT02533674|466835754|FG006|Dose Level VII|Progressive disease|10|||
129693520|NCT02533674|466835755|FG007|Dose Level VII|Progressive disease|0|||
129693521|NCT02533674|466835748|FG000|Dose Level VII|Withdrawal by Subject|0|||
129693522|NCT02533674|466835749|FG001|Dose Level VII|Withdrawal by Subject|0|||
129693523|NCT02533674|466835750|FG002|Dose Level VII|Withdrawal by Subject|0|||
129693524|NCT02533674|466835751|FG003|Dose Level VII|Withdrawal by Subject|0|||
129693525|NCT02533674|466835752|FG004|Dose Level VII|Withdrawal by Subject|0|||
129693526|NCT02533674|466835753|FG005|Dose Level VII|Withdrawal by Subject|0|||
129693527|NCT02533674|466835754|FG006|Dose Level VII|Withdrawal by Subject|3|||
129693528|NCT02533674|466835755|FG007|Dose Level VII|Withdrawal by Subject|0|||
129693529|NCT02533674|466835748|FG000|Dose Level VII|Treatment-related AE|0|||
129693530|NCT02533674|466835749|FG001|Dose Level VII|Treatment-related AE|0|||
129693531|NCT02533674|466835750|FG002|Dose Level VII|Treatment-related AE|0|||
129693532|NCT02533674|466835751|FG003|Dose Level VII|Treatment-related AE|0|||
129693533|NCT02533674|466835752|FG004|Dose Level VII|Treatment-related AE|0|||
129693534|NCT02533674|466835753|FG005|Dose Level VII|Treatment-related AE|0|||
129693535|NCT02533674|466835754|FG006|Dose Level VII|Treatment-related AE|1|||
129693536|NCT02533674|466835755|FG007|Dose Level VII|Treatment-related AE|0|||
129693537|NCT02533674|466835748|FG000|Dose Level VII|Death|0|||
129693538|NCT02533674|466835749|FG001|Dose Level VII|Death|0|||
129693539|NCT02533674|466835750|FG002|Dose Level VII|Death|0|||
129693540|NCT02533674|466835751|FG003|Dose Level VII|Death|0|||
129693541|NCT02533674|466835752|FG004|Dose Level VII|Death|0|||
129693542|NCT02533674|466835753|FG005|Dose Level VII|Death|0|||
129693543|NCT02533674|466835754|FG006|Dose Level VII|Death|2|||
129693544|NCT02533674|466835755|FG007|Dose Level VII|Death|0|||
129693545|NCT02533674|466835748|FG000|Dose Level VIII|Progressive disease|0|||
129693546|NCT02533674|466835749|FG001|Dose Level VIII|Progressive disease|0|||
129693547|NCT02533674|466835750|FG002|Dose Level VIII|Progressive disease|0|||
129693548|NCT02533674|466835751|FG003|Dose Level VIII|Progressive disease|0|||
129693549|NCT02533674|466835752|FG004|Dose Level VIII|Progressive disease|0|||
129693550|NCT02533674|466835753|FG005|Dose Level VIII|Progressive disease|0|||
129693551|NCT02533674|466835754|FG006|Dose Level VIII|Progressive disease|0|||
129693552|NCT02533674|466835755|FG007|Dose Level VIII|Progressive disease|3|||
129693553|NCT02533674|466835748|FG000|Dose Level VIII|Withdrawal by Subject|0|||
129693554|NCT02533674|466835749|FG001|Dose Level VIII|Withdrawal by Subject|0|||
129693555|NCT02533674|466835750|FG002|Dose Level VIII|Withdrawal by Subject|0|||
129693556|NCT02533674|466835751|FG003|Dose Level VIII|Withdrawal by Subject|0|||
129783375|NCT03179202|467175690|FG000|Overall Study|Screen Failure|67|||
129783376|NCT03179202|467175690|FG000|Overall Study|Subject Lost to Follow Up|12|||
129783377|NCT03179202|467175690|FG000|Overall Study|Withdrawal by Subject|7|||
129783378|NCT03179202|467175690|FG000|Overall Study|Adverse Event|3|||
129783379|NCT03179202|467175690|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
129783380|NCT03179202|467175690|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
129783381|NCT03255629|467175691|FG000|Overall Study|Adverse Event|1|||
129783382|NCT03255629|467175692|FG001|Overall Study|Adverse Event|0|||
129783383|NCT03255629|467175691|FG000|Overall Study|did not experience hypoglycemia|2|||
129783384|NCT03255629|467175692|FG001|Overall Study|did not experience hypoglycemia|1|||
129783385|NCT01625260|467175700|FG000|Overall Study|Adverse Event|3|||
129783386|NCT01625260|467175701|FG001|Overall Study|Adverse Event|0|||
129783387|NCT01625260|467175700|FG000|Overall Study|Study Terminated by Investigator|2|||
129783388|NCT01625260|467175701|FG001|Overall Study|Study Terminated by Investigator|0|||
129783389|NCT01625260|467175700|FG000|Overall Study|Disease Progression|2|||
129783390|NCT01625260|467175701|FG001|Overall Study|Disease Progression|0|||
129783391|NCT01625260|467175700|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
129783392|NCT01625260|467175701|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
129783393|NCT03899805|467175702|FG000|Overall Study|Physician Decision|3|||
129783394|NCT03899805|467175703|FG001|Overall Study|Physician Decision|0|||
129783395|NCT03899805|467175704|FG002|Overall Study|Physician Decision|2|||
129783396|NCT03899805|467175702|FG000|Overall Study|Withdrawal by Subject|1|||
129783397|NCT03899805|467175703|FG001|Overall Study|Withdrawal by Subject|0|||
129783398|NCT03899805|467175704|FG002|Overall Study|Withdrawal by Subject|2|||
129783399|NCT03899805|467175702|FG000|Overall Study|Progressive Disease|10|||
129783400|NCT03899805|467175703|FG001|Overall Study|Progressive Disease|18|||
129783401|NCT03899805|467175704|FG002|Overall Study|Progressive Disease|12|||
129783402|NCT03899805|467175702|FG000|Overall Study|Adverse Event|3|||
129783403|NCT03899805|467175703|FG001|Overall Study|Adverse Event|1|||
129783404|NCT03899805|467175704|FG002|Overall Study|Adverse Event|0|||
129783405|NCT03899805|467175702|FG000|Overall Study|Death|2|||
129783406|NCT03899805|467175703|FG001|Overall Study|Death|0|||
129783407|NCT03899805|467175704|FG002|Overall Study|Death|0|||
129783408|NCT03899805|467175702|FG000|Overall Study|Came off for surgery|0|||
129783409|NCT03899805|467175703|FG001|Overall Study|Came off for surgery|0|||
129783410|NCT03899805|467175704|FG002|Overall Study|Came off for surgery|1|||
129783411|NCT03317405|467175705|FG000|Overall Study|Withdrawal by Subject|1|||
129783412|NCT03317405|467175706|FG001|Overall Study|Withdrawal by Subject|0|||
129783413|NCT03317405|467175707|FG002|Overall Study|Withdrawal by Subject|0|||
129574515|NCT02543203|466400742|FG001|Overall Study|Lost to Follow-up|0|||
129574516|NCT02543203|466400741|FG000|Overall Study|Increased Irritability|1|||
129574517|NCT02543203|466400742|FG001|Overall Study|Increased Irritability|0|||
129574518|NCT02543203|466400741|FG000|Overall Study|Family|1|||
129574519|NCT02543203|466400742|FG001|Overall Study|Family|2|||
129574520|NCT02543203|466400741|FG000|Overall Study|Negative Behavior|1|||
129574521|NCT02543203|466400742|FG001|Overall Study|Negative Behavior|0|||
129693557|NCT02533674|466835752|FG004|Dose Level VIII|Withdrawal by Subject|0|||
129693558|NCT02533674|466835753|FG005|Dose Level VIII|Withdrawal by Subject|0|||
129693559|NCT02533674|466835754|FG006|Dose Level VIII|Withdrawal by Subject|0|||
129693560|NCT02533674|466835755|FG007|Dose Level VIII|Withdrawal by Subject|1|||
129693561|NCT02533674|466835748|FG000|Dose Level VIII|Treatment-related AE|0|||
129693562|NCT02533674|466835749|FG001|Dose Level VIII|Treatment-related AE|0|||
129693563|NCT02533674|466835750|FG002|Dose Level VIII|Treatment-related AE|0|||
129693564|NCT02533674|466835751|FG003|Dose Level VIII|Treatment-related AE|0|||
129693565|NCT02533674|466835752|FG004|Dose Level VIII|Treatment-related AE|0|||
129693566|NCT02533674|466835753|FG005|Dose Level VIII|Treatment-related AE|0|||
129693567|NCT02533674|466835754|FG006|Dose Level VIII|Treatment-related AE|0|||
129693568|NCT02533674|466835755|FG007|Dose Level VIII|Treatment-related AE|1|||
129693569|NCT02533674|466835748|FG000|Dose Level VIII|Never treated|0|||
129693570|NCT02533674|466835749|FG001|Dose Level VIII|Never treated|0|||
129693571|NCT02533674|466835750|FG002|Dose Level VIII|Never treated|0|||
129693572|NCT02533674|466835751|FG003|Dose Level VIII|Never treated|0|||
129693573|NCT02533674|466835752|FG004|Dose Level VIII|Never treated|0|||
129693574|NCT02533674|466835753|FG005|Dose Level VIII|Never treated|0|||
129783414|NCT03317405|467175705|FG000|Overall Study|Physician Decision|0|||
129783415|NCT03317405|467175706|FG001|Overall Study|Physician Decision|0|||
129783416|NCT03317405|467175707|FG002|Overall Study|Physician Decision|1|||
129783417|NCT03317405|467175705|FG000|Overall Study|Surgery Rescheduled|0|||
129783418|NCT03317405|467175706|FG001|Overall Study|Surgery Rescheduled|1|||
129783419|NCT03317405|467175707|FG002|Overall Study|Surgery Rescheduled|0|||
129783420|NCT01024309|467175710|FG000|Overall Study|Physician Decision|4|||
129783421|NCT01024309|467175711|FG001|Overall Study|Physician Decision|0|||
129574522|NCT02543203|466400741|FG000|Overall Study|Withdrawal by Subject|0|||
129693575|NCT02533674|466835754|FG006|Dose Level VIII|Never treated|0|||
129693576|NCT02533674|466835755|FG007|Dose Level VIII|Never treated|1|||
129693577|NCT01560988|466835756|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
129574523|NCT02543203|466400742|FG001|Overall Study|Withdrawal by Subject|1|||
129574524|NCT00089661|466400743|FG000|Overall Study|Adverse Event|0|||
129574525|NCT00089661|466400744|FG001|Overall Study|Adverse Event|2|||
129574526|NCT00089661|466400743|FG000|Overall Study|Death|1|||
129574527|NCT00089661|466400744|FG001|Overall Study|Death|0|||
129574528|NCT00089661|466400743|FG000|Overall Study|Lost to Follow-up|0|||
129574529|NCT00089661|466400744|FG001|Overall Study|Lost to Follow-up|3|||
129574530|NCT00089661|466400743|FG000|Overall Study|Withdrawal by Subject|11|||
129574531|NCT00089661|466400744|FG001|Overall Study|Withdrawal by Subject|9|||
129574532|NCT00089661|466400743|FG000|Overall Study|Disease progression|1|||
129574533|NCT00089661|466400744|FG001|Overall Study|Disease progression|3|||
129574534|NCT00089661|466400743|FG000|Overall Study|Ineligibility determined|4|||
129574535|NCT00089661|466400744|FG001|Overall Study|Ineligibility determined|4|||
129574536|NCT00089661|466400743|FG000|Overall Study|Noncompliance|2|||
129574537|NCT00089661|466400744|FG001|Overall Study|Noncompliance|4|||
129574538|NCT00089661|466400743|FG000|Overall Study|Other|2|||
129574539|NCT00089661|466400744|FG001|Overall Study|Other|1|||
129574540|NCT01273805|466400745|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
129574541|NCT01273805|466400746|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
129574542|NCT02647944|466400747|FG000|Overall Study|Withdrawal by Subject|0|||
129574543|NCT02647944|466400748|FG001|Overall Study|Withdrawal by Subject|3|||
129574544|NCT02647944|466400747|FG000|Overall Study|Adverse Event|2|||
129574545|NCT02647944|466400748|FG001|Overall Study|Adverse Event|0|||
129574546|NCT02077465|466400749|FG000|Overall Study|Withdrew Consent|0|||
129574547|NCT02077465|466400750|FG001|Overall Study|Withdrew Consent|1|||
129574548|NCT02077465|466400749|FG000|Overall Study|Lost to Follow-up|1|||
129574549|NCT02077465|466400750|FG001|Overall Study|Lost to Follow-up|0|||
129574550|NCT02760368|466400752|FG000|Overall Study|Withdrawal by Subject|8|||
129574551|NCT02760368|466400753|FG001|Overall Study|Withdrawal by Subject|12|||
129574552|NCT02760368|466400754|FG002|Overall Study|Withdrawal by Subject|9|||
129574553|NCT02760368|466400752|FG000|Overall Study|Screen Failure|0|||
129574554|NCT02760368|466400753|FG001|Overall Study|Screen Failure|0|||
129574555|NCT02760368|466400754|FG002|Overall Study|Screen Failure|1|||
129574556|NCT02760368|466400752|FG000|Overall Study|Death|0|||
129574557|NCT02760368|466400753|FG001|Overall Study|Death|1|||
129574558|NCT02760368|466400754|FG002|Overall Study|Death|0|||
129574559|NCT02760368|466400752|FG000|Overall Study|Withdrawal by Sponsor|0|||
129574560|NCT02760368|466400753|FG001|Overall Study|Withdrawal by Sponsor|0|||
129574561|NCT02760368|466400754|FG002|Overall Study|Withdrawal by Sponsor|1|||
129574562|NCT01827163|466400755|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
129574563|NCT01827163|466400755|FG000|Overall Study|Adverse Event|9|||
129574564|NCT02294604|466400756|FG000|Overall Study|Did not provide samples for culture|0|||
129574565|NCT02294604|466400757|FG001|Overall Study|Did not provide samples for culture|1|||
129574566|NCT02294604|466400758|FG002|Overall Study|Did not provide samples for culture|0|||
129574567|NCT02294604|466400756|FG000|Overall Study|Culture contamination|1|||
129574568|NCT02294604|466400757|FG001|Overall Study|Culture contamination|2|||
129574569|NCT02294604|466400758|FG002|Overall Study|Culture contamination|0|||
129574570|NCT02902211|466400761|FG000|First Three Months|Withdrawal by Subject|7|||
129574571|NCT02902211|466400762|FG001|First Three Months|Withdrawal by Subject|3|||
129574572|NCT01401647|466400770|FG000|Overall Study|Withdrawal by Subject|1|||
129574573|NCT01401647|466400771|FG001|Overall Study|Withdrawal by Subject|5|||
129574574|NCT01401647|466400772|FG002|Overall Study|Withdrawal by Subject|2|||
129574575|NCT01401647|466400770|FG000|Overall Study|Lost to Follow-up|3|||
129574576|NCT01401647|466400771|FG001|Overall Study|Lost to Follow-up|3|||
129574577|NCT01401647|466400772|FG002|Overall Study|Lost to Follow-up|1|||
129574578|NCT00473330|466400776|FG000|Core Study|Adverse Event|4|||
129574579|NCT00473330|466400777|FG001|Core Study|Adverse Event|4|||
129574580|NCT00473330|466400778|FG002|Core Study|Adverse Event|1|||
129574581|NCT00473330|466400776|FG000|Core Study|Death|6|||
129574582|NCT00473330|466400777|FG001|Core Study|Death|4|||
129574583|NCT00473330|466400778|FG002|Core Study|Death|4|||
129574584|NCT00473330|466400776|FG000|Core Study|Lost to Follow-up|5|||
129574585|NCT00473330|466400777|FG001|Core Study|Lost to Follow-up|5|||
129574586|NCT00473330|466400778|FG002|Core Study|Lost to Follow-up|10|||
129574587|NCT00473330|466400776|FG000|Core Study|Physician Decision|2|||
129574588|NCT00473330|466400777|FG001|Core Study|Physician Decision|1|||
129574589|NCT00473330|466400778|FG002|Core Study|Physician Decision|3|||
129574590|NCT00473330|466400776|FG000|Core Study|Subject Non-compliance|1|||
129574591|NCT00473330|466400777|FG001|Core Study|Subject Non-compliance|2|||
129574592|NCT00473330|466400778|FG002|Core Study|Subject Non-compliance|1|||
129574593|NCT00473330|466400776|FG000|Core Study|Subject Required Other Therapy|0|||
129574594|NCT00473330|466400777|FG001|Core Study|Subject Required Other Therapy|1|||
129574595|NCT00473330|466400778|FG002|Core Study|Subject Required Other Therapy|3|||
129574596|NCT00473330|466400776|FG000|Core Study|Subject's Decision|9|||
129574597|NCT00473330|466400777|FG001|Core Study|Subject's Decision|8|||
129574598|NCT00473330|466400778|FG002|Core Study|Subject's Decision|19|||
129693578|NCT01560988|466835757|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
129693579|NCT01560988|466835756|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
129693580|NCT01560988|466835757|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
129693581|NCT01560988|466835756|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
129693582|NCT01560988|466835757|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
129693583|NCT01346709|466835758|FG000|Overall Study|Protocol Violation|35|||
129693584|NCT01346709|466835758|FG000|Overall Study|Lost to Follow-up|31|||
129693585|NCT01346709|466835758|FG000|Overall Study|Missing data in candidate risk factor|285|||
129693586|NCT01292473|466835762|FG000|Overall Study|Adverse Event|1|||
129693587|NCT01292473|466835763|FG001|Overall Study|Adverse Event|0|||
129693588|NCT01292473|466835764|FG002|Overall Study|Adverse Event|1|||
129693589|NCT01292473|466835765|FG003|Overall Study|Adverse Event|1|||
129693590|NCT01292473|466835762|FG000|Overall Study|Lost to Follow-up|1|||
129693591|NCT01292473|466835763|FG001|Overall Study|Lost to Follow-up|1|||
129693592|NCT01292473|466835764|FG002|Overall Study|Lost to Follow-up|2|||
129693593|NCT01292473|466835765|FG003|Overall Study|Lost to Follow-up|2|||
129693594|NCT01292473|466835762|FG000|Overall Study|Withdrawal by Subject|3|||
129693595|NCT01292473|466835763|FG001|Overall Study|Withdrawal by Subject|4|||
129693596|NCT01292473|466835764|FG002|Overall Study|Withdrawal by Subject|3|||
129693597|NCT01292473|466835765|FG003|Overall Study|Withdrawal by Subject|3|||
129693598|NCT01292473|466835762|FG000|Overall Study|Physician Decision|0|||
129693599|NCT01292473|466835763|FG001|Overall Study|Physician Decision|1|||
129693600|NCT01292473|466835764|FG002|Overall Study|Physician Decision|0|||
129693601|NCT01292473|466835765|FG003|Overall Study|Physician Decision|0|||
129693602|NCT01292473|466835762|FG000|Overall Study|Disease Progression|0|||
129693603|NCT01292473|466835763|FG001|Overall Study|Disease Progression|1|||
129693604|NCT01292473|466835764|FG002|Overall Study|Disease Progression|3|||
129693605|NCT01292473|466835765|FG003|Overall Study|Disease Progression|6|||
129693606|NCT02123511|466835770|FG000|Overall Study|Cancelled treatment|1|||
129693607|NCT02123511|466835771|FG001|Overall Study|Cancelled treatment|0|||
129693608|NCT02123511|466835770|FG000|Overall Study|Incomplete data|1|||
129693609|NCT02123511|466835771|FG001|Overall Study|Incomplete data|3|||
129693610|NCT02123511|466835770|FG000|Overall Study|Ineligible|0|||
129693611|NCT02123511|466835771|FG001|Overall Study|Ineligible|1|||
129693612|NCT04821245|466835772|FG000|Overall Study|Withdrawal by Subject|3|||
129693613|NCT04821245|466835772|FG000|Overall Study|Physician Decision|1|||
129693614|NCT04821245|466835772|FG000|Overall Study|Protocol Violation|5|||
129693615|NCT00458705|466835773|FG000|Overall Study|Adverse Event|4|||
129693616|NCT00458705|466835773|FG000|Overall Study|Not Treated|1|||
129693617|NCT00604383|466835778|FG000|Overall Study|Withdrawal by Subject|33|||
129693618|NCT00604383|466835779|FG001|Overall Study|Withdrawal by Subject|31|||
129693619|NCT00604383|466835778|FG000|Overall Study|Lost to Follow-up|24|||
129693620|NCT00604383|466835779|FG001|Overall Study|Lost to Follow-up|19|||
129693621|NCT00604383|466835778|FG000|Overall Study|Death|14|||
129693622|NCT00604383|466835779|FG001|Overall Study|Death|22|||
129693623|NCT00604383|466835778|FG000|Overall Study|Adverse Event|16|||
129693624|NCT00604383|466835779|FG001|Overall Study|Adverse Event|9|||
129693625|NCT00604383|466835778|FG000|Overall Study|Physician Decision|0|||
129693626|NCT00604383|466835779|FG001|Overall Study|Physician Decision|3|||
129693627|NCT00576407|466835782|FG000|Overall Study|Death|7|||
129693628|NCT00576407|466835782|FG000|Overall Study|Physician Decision|1|||
129693629|NCT00756444|466835783|FG000|Overall Study|Adverse Event|1|||
129693630|NCT00756444|466835784|FG001|Overall Study|Adverse Event|1|||
129693631|NCT00756444|466835783|FG000|Overall Study|Withdrawal by Subject|6|||
129693632|NCT00756444|466835784|FG001|Overall Study|Withdrawal by Subject|8|||
129693633|NCT00756444|466835783|FG000|Overall Study|Lost to Follow-up|0|||
129693634|NCT00756444|466835784|FG001|Overall Study|Lost to Follow-up|1|||
129693635|NCT00756444|466835783|FG000|Overall Study|Death|5|||
129693636|NCT00756444|466835784|FG001|Overall Study|Death|4|||
129693637|NCT00756444|466835783|FG000|Overall Study|Disease Progression|2|||
129693638|NCT00756444|466835784|FG001|Overall Study|Disease Progression|7|||
129693639|NCT00756444|466835783|FG000|Overall Study|Ineligibility Determined|1|||
129693640|NCT00756444|466835784|FG001|Overall Study|Ineligibility Determined|0|||
129693641|NCT03071965|466835785|FG000|Overall Study|Adverse Event|0|||
129693642|NCT03071965|466835786|FG001|Overall Study|Adverse Event|0|||
129693643|NCT03071965|466835787|FG002|Overall Study|Adverse Event|1|||
129693644|NCT03071965|466835788|FG003|Overall Study|Adverse Event|0|||
129693645|NCT03071965|466835785|FG000|Overall Study|Death|0|||
129693646|NCT03071965|466835786|FG001|Overall Study|Death|0|||
129693647|NCT03071965|466835787|FG002|Overall Study|Death|1|||
129693648|NCT03071965|466835788|FG003|Overall Study|Death|1|||
129693649|NCT03071965|466835785|FG000|Overall Study|COVID-19|0|||
129693650|NCT03071965|466835786|FG001|Overall Study|COVID-19|1|||
129693651|NCT03071965|466835787|FG002|Overall Study|COVID-19|0|||
129574599|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
129574600|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
129574601|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
129574602|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Death|2|||
129574603|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Death|0|||
129574604|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Death|0|||
129574605|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
129574606|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
129574607|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
129574608|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
129574609|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
129574610|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
129574611|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
129574612|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
129574613|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
129574614|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
129574615|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
129574616|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
129574617|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
129574618|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
129574619|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
129574620|NCT00473330|466400776|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
129574621|NCT00473330|466400777|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
129574622|NCT00473330|466400778|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
129574623|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
129574624|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
129693652|NCT03071965|466835788|FG003|Overall Study|COVID-19|1|||
129693653|NCT03071965|466835785|FG000|Overall Study|Other Health Reason|0|||
129693654|NCT03071965|466835786|FG001|Overall Study|Other Health Reason|0|||
129693655|NCT03071965|466835787|FG002|Overall Study|Other Health Reason|0|||
129693656|NCT03071965|466835788|FG003|Overall Study|Other Health Reason|1|||
129574625|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
129574626|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Death|2|||
129574627|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Death|2|||
129574628|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Death|1|||
129574629|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
129574630|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
129574631|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
129574632|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
129574633|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
129574634|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
129574635|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
129574636|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
129574637|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
129574638|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
129574639|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
129574640|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
129574641|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
129574642|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
129574643|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
129574644|NCT00473330|466400776|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
129574645|NCT00473330|466400777|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
129574646|NCT00473330|466400778|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
129574647|NCT01975948|466400779|FG000|Overall Study|Withdrawal by Subject|17|||
129574648|NCT01975948|466400780|FG001|Overall Study|Withdrawal by Subject|21|||
129574649|NCT01975948|466400781|FG002|Overall Study|Withdrawal by Subject|7|||
129574650|NCT01975948|466400782|FG003|Overall Study|Withdrawal by Subject|6|||
129574651|NCT01675765|466400783|FG000|Overall Study|Progressive disease|4|||
129574652|NCT01675765|466400784|FG001|Overall Study|Progressive disease|4|||
129574653|NCT01675765|466400783|FG000|Overall Study|Adverse Event|1|||
129574654|NCT01675765|466400784|FG001|Overall Study|Adverse Event|2|||
129574655|NCT01675765|466400783|FG000|Overall Study|Withdrawal by Subject|2|||
129574656|NCT01675765|466400784|FG001|Overall Study|Withdrawal by Subject|0|||
129574657|NCT01675765|466400783|FG000|Overall Study|Death|1|||
129574658|NCT01675765|466400784|FG001|Overall Study|Death|0|||
129693657|NCT05587998|466835789|FG000|Overall Study|Withdrawal by Subject|1|||
129574659|NCT01675765|466400783|FG000|Overall Study|Clinical progression|3|||
129574660|NCT01675765|466400784|FG001|Overall Study|Clinical progression|2|||
129574661|NCT00365846|466400786|FG000|Overall Study|Lost to Follow-up|1|||
129574662|NCT04400890|466400787|FG000|Overall Study|Withdrawal by Subject|3|||
129574663|NCT04400890|466400788|FG001|Overall Study|Withdrawal by Subject|2|||
129574664|NCT04405570|466400789|FG000|Overall Study|Adverse Event|0|||
129574665|NCT04405570|466400790|FG001|Overall Study|Adverse Event|1|||
129574666|NCT04405570|466400791|FG002|Overall Study|Adverse Event|1|||
129574667|NCT04405570|466400792|FG003|Overall Study|Adverse Event|1|||
129574668|NCT04405570|466400789|FG000|Overall Study|Lost to Follow-up|0|||
129574669|NCT04405570|466400790|FG001|Overall Study|Lost to Follow-up|1|||
129574670|NCT04405570|466400791|FG002|Overall Study|Lost to Follow-up|0|||
129574671|NCT04405570|466400792|FG003|Overall Study|Lost to Follow-up|0|||
129574672|NCT04405570|466400789|FG000|Overall Study|Physician Decision|0|||
129574673|NCT04405570|466400790|FG001|Overall Study|Physician Decision|0|||
129574674|NCT04405570|466400791|FG002|Overall Study|Physician Decision|1|||
129574675|NCT04405570|466400792|FG003|Overall Study|Physician Decision|0|||
129574676|NCT04405570|466400789|FG000|Overall Study|Withdrawal by Subject|0|||
129574677|NCT04405570|466400790|FG001|Overall Study|Withdrawal by Subject|1|||
129574678|NCT04405570|466400791|FG002|Overall Study|Withdrawal by Subject|1|||
129574679|NCT04405570|466400792|FG003|Overall Study|Withdrawal by Subject|0|||
129574680|NCT04405570|466400789|FG000|Overall Study|Randomized not dosed|0|||
129574681|NCT04405570|466400790|FG001|Overall Study|Randomized not dosed|2|||
129574682|NCT04405570|466400791|FG002|Overall Study|Randomized not dosed|0|||
129574683|NCT04405570|466400792|FG003|Overall Study|Randomized not dosed|0|||
129574684|NCT00723710|466400793|FG000|Overall Study|Disease progression|48|||
129574685|NCT00723710|466400793|FG000|Overall Study|Adverse Event|88|||
129574686|NCT00723710|466400793|FG000|Overall Study|Withdrawal by Subject|36|||
129574687|NCT00723710|466400793|FG000|Overall Study|Physician Decision|2|||
129574688|NCT04499963|466400794|FG000|Overall Study|Adverse Event|3|||
129574689|NCT04499963|466400795|FG001|Overall Study|Adverse Event|0|||
129574690|NCT04499963|466400794|FG000|Overall Study|Death|3|||
129574691|NCT04499963|466400795|FG001|Overall Study|Death|0|||
129574692|NCT04499963|466400794|FG000|Overall Study|Lack of Efficacy|7|||
129574693|NCT04499963|466400795|FG001|Overall Study|Lack of Efficacy|0|||
129574694|NCT04499963|466400794|FG000|Overall Study|Lost to Follow-up|2|||
129574695|NCT04499963|466400795|FG001|Overall Study|Lost to Follow-up|0|||
129574696|NCT00984126|466400803|FG000|Overall Study|Protocol Violation|0|||
129574697|NCT00984126|466400804|FG001|Overall Study|Protocol Violation|0|||
129574698|NCT00984126|466400805|FG002|Overall Study|Protocol Violation|1|||
129574699|NCT00984126|466400806|FG003|Overall Study|Protocol Violation|2|||
129574700|NCT00984126|466400803|FG000|Overall Study|Adverse Event|0|||
129574701|NCT00984126|466400804|FG001|Overall Study|Adverse Event|0|||
129574702|NCT00984126|466400805|FG002|Overall Study|Adverse Event|0|||
129574703|NCT00984126|466400806|FG003|Overall Study|Adverse Event|2|||
129574704|NCT00984126|466400803|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
129574705|NCT00984126|466400804|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
129574706|NCT00984126|466400805|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
129574707|NCT00984126|466400806|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
129574708|NCT00984126|466400803|FG000|Overall Study|Withdrawal criteria|0|||
129574709|NCT00984126|466400804|FG001|Overall Study|Withdrawal criteria|1|||
129574710|NCT00984126|466400805|FG002|Overall Study|Withdrawal criteria|3|||
129574711|NCT00984126|466400806|FG003|Overall Study|Withdrawal criteria|9|||
129574712|NCT01001208|466400807|FG000|Overall Study|Adverse Event|10|||
129574713|NCT01001208|466400808|FG001|Overall Study|Adverse Event|5|||
129574714|NCT01001208|466400807|FG000|Overall Study|Lost to Follow-up|5|||
129574715|NCT01001208|466400808|FG001|Overall Study|Lost to Follow-up|9|||
129574716|NCT01001208|466400807|FG000|Overall Study|Physician Decision|1|||
129574717|NCT01001208|466400808|FG001|Overall Study|Physician Decision|0|||
129574718|NCT01001208|466400807|FG000|Overall Study|Withdrawal by Subject|4|||
129574719|NCT01001208|466400808|FG001|Overall Study|Withdrawal by Subject|5|||
129574720|NCT01001208|466400807|FG000|Overall Study|Ineligibility Determined|4|||
129574721|NCT01001208|466400808|FG001|Overall Study|Ineligibility Determined|2|||
129574722|NCT01001208|466400807|FG000|Overall Study|Noncompliance|4|||
129574723|NCT01001208|466400808|FG001|Overall Study|Noncompliance|7|||
129574724|NCT01001208|466400807|FG000|Overall Study|Disease Progression|0|||
129574725|NCT01001208|466400808|FG001|Overall Study|Disease Progression|3|||
129574726|NCT01001208|466400807|FG000|Overall Study|Other|0|||
129574727|NCT01001208|466400808|FG001|Overall Study|Other|2|||
129574728|NCT01864174|466400809|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
129574729|NCT01864174|466400810|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
129574730|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
129574731|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
129574732|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
129574733|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
129574734|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
129574735|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
129574736|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Death|1|||
129574737|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Death|0|||
129574738|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
129574739|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
129574740|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
129574741|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
129574742|NCT01864174|466400809|FG000|Double Blind - Compliant Randomized|Other|6|||
129574743|NCT01864174|466400810|FG001|Double Blind - Compliant Randomized|Other|10|||
129574744|NCT01864174|466400809|FG000|Off Treatment Follow-Up|Other|2|||
129574745|NCT01864174|466400810|FG001|Off Treatment Follow-Up|Other|0|||
129574746|NCT01864174|466400809|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
129574747|NCT01864174|466400810|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
129574748|NCT01723397|466400814|FG000|Study Period 1|Protocol Violation|0|||
129574749|NCT01723397|466400815|FG001|Study Period 1|Protocol Violation|1|||
129574750|NCT01723397|466400814|FG000|Study Period 2|Protocol Violation|0|||
129574751|NCT01723397|466400815|FG001|Study Period 2|Protocol Violation|1|||
129574752|NCT00468286|466400816|FG000|Overall Study|Adverse Event|1|||
129574753|NCT00468286|466400817|FG001|Overall Study|Adverse Event|6|||
129574754|NCT00468286|466400816|FG000|Overall Study|Protocol Violation|2|||
129574755|NCT00468286|466400817|FG001|Overall Study|Protocol Violation|2|||
129574756|NCT00468286|466400816|FG000|Overall Study|Withdrawal by Subject|4|||
129574757|NCT00468286|466400817|FG001|Overall Study|Withdrawal by Subject|3|||
129574758|NCT00468286|466400816|FG000|Overall Study|Physician Decision|0|||
129574759|NCT00468286|466400817|FG001|Overall Study|Physician Decision|1|||
129574760|NCT02196675|466400818|FG000|Overall Study|Withdrawal by Subject|1|||
129574761|NCT02196675|466400819|FG001|Overall Study|Withdrawal by Subject|0|||
129574762|NCT02196675|466400820|FG002|Overall Study|Withdrawal by Subject|0|||
129574763|NCT02196675|466400818|FG000|Overall Study|Intra-operative surgical exclusion|1|||
129574764|NCT02196675|466400819|FG001|Overall Study|Intra-operative surgical exclusion|1|||
129574765|NCT02196675|466400820|FG002|Overall Study|Intra-operative surgical exclusion|0|||
129574766|NCT02196675|466400818|FG000|Overall Study|Protocol Violation|0|||
129574767|NCT02196675|466400819|FG001|Overall Study|Protocol Violation|1|||
129574768|NCT02196675|466400820|FG002|Overall Study|Protocol Violation|0|||
129574769|NCT02196675|466400818|FG000|Overall Study|Death|0|||
129574770|NCT02196675|466400819|FG001|Overall Study|Death|0|||
129574771|NCT02196675|466400820|FG002|Overall Study|Death|1|||
129574772|NCT02158663|466400821|FG000|Overall Study|Withdrawal by Subject|5|||
129574773|NCT02158663|466400822|FG001|Overall Study|Withdrawal by Subject|4|||
129574774|NCT00537979|466400823|FG000|Overall Study|Adverse Event|2|||
129574775|NCT00537979|466400824|FG001|Overall Study|Adverse Event|2|||
129574776|NCT00537979|466400823|FG000|Overall Study|Withdrawal by Subject|1|||
129574777|NCT00537979|466400824|FG001|Overall Study|Withdrawal by Subject|4|||
129574778|NCT00537979|466400823|FG000|Overall Study|Lost to Follow-up|1|||
129574779|NCT00537979|466400824|FG001|Overall Study|Lost to Follow-up|4|||
129574780|NCT00537979|466400823|FG000|Overall Study|Lack of Efficacy|0|||
129574781|NCT00537979|466400824|FG001|Overall Study|Lack of Efficacy|1|||
129574782|NCT00537979|466400823|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
129574783|NCT00537979|466400824|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
129574784|NCT00537979|466400823|FG000|Overall Study|Death|0|||
129783422|NCT01024309|467175710|FG000|Overall Study|Withdrawal by Subject|4|||
129574785|NCT00537979|466400824|FG001|Overall Study|Death|3|||
129574786|NCT00537979|466400823|FG000|Overall Study|Kidney transplant|0|||
129693658|NCT05587998|466835790|FG001|Overall Study|Withdrawal by Subject|1|||
129693659|NCT05587998|466835789|FG000|Overall Study|Not treated|3|||
129693660|NCT05587998|466835790|FG001|Overall Study|Not treated|1|||
129693661|NCT05587998|466835789|FG000|Overall Study|Non-compliance with study procedures|0|||
129693662|NCT05587998|466835790|FG001|Overall Study|Non-compliance with study procedures|1|||
129693663|NCT03225989|466835791|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
129693664|NCT03225989|466835792|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
129693665|NCT03225989|466835793|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
129693666|NCT03225989|466835791|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
129693667|NCT03225989|466835792|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
129693668|NCT03225989|466835793|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
129693669|NCT03225989|466835791|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
129693670|NCT03225989|466835792|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
129693671|NCT03225989|466835793|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
129693672|NCT03225989|466835791|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
129783423|NCT01024309|467175711|FG001|Overall Study|Withdrawal by Subject|4|||
129574787|NCT00537979|466400824|FG001|Overall Study|Kidney transplant|3|||
129574788|NCT00537979|466400823|FG000|Overall Study|Heart failure|0|||
129574789|NCT00537979|466400824|FG001|Overall Study|Heart failure|1|||
129574790|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
129693673|NCT03225989|466835792|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
129574791|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
129574792|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
129574793|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
129574794|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
129574795|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
129574796|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
129574797|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
129574798|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
129574799|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
129574800|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
129574801|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
129574802|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
129574803|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
129574804|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
129574805|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
129574806|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
129574807|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
129574808|NCT02009163|466400825|FG000|Open-label Period (Non-randomized)|Other|13|||
129574809|NCT02009163|466400826|FG001|Open-label Period (Non-randomized)|Other|0|||
129574810|NCT02009163|466400827|FG002|Open-label Period (Non-randomized)|Other|0|||
129574811|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
129574812|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
129574813|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
129574814|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
129574815|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
129574816|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
129574817|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Adverse Event|0|||
129783424|NCT05194579|467175714|FG000|Overall Study|Lost to Follow-up|2|||
129783425|NCT05194579|467175715|FG001|Overall Study|Lost to Follow-up|3|||
129783426|NCT05194579|467175714|FG000|Overall Study|Withdrawal by Subject|3|||
129783427|NCT05194579|467175715|FG001|Overall Study|Withdrawal by Subject|4|||
129783428|NCT05194579|467175714|FG000|Overall Study|Refused further study procedures|0|||
129783429|NCT05194579|467175715|FG001|Overall Study|Refused further study procedures|1|||
129783430|NCT05194579|467175714|FG000|Overall Study|Protocol deviation|1|||
129783431|NCT05194579|467175715|FG001|Overall Study|Protocol deviation|0|||
129783432|NCT01639729|467175716|FG000|Overall Study|Withdrawal by Subject|1|||
129783433|NCT01639729|467175717|FG001|Overall Study|Withdrawal by Subject|0|||
129783434|NCT01639729|467175718|FG002|Overall Study|Withdrawal by Subject|1|||
129783435|NCT01639729|467175719|FG003|Overall Study|Withdrawal by Subject|1|||
129783436|NCT01639729|467175720|FG004|Overall Study|Withdrawal by Subject|0|||
129783437|NCT01639729|467175721|FG005|Overall Study|Withdrawal by Subject|0|||
129783438|NCT00567255|467175725|FG000|Overall Study|Adverse Event|241|||
129783439|NCT00567255|467175726|FG001|Overall Study|Adverse Event|68|||
129574818|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Adverse Event|0|||
129574819|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Adverse Event|6|||
129783440|NCT00567255|467175725|FG000|Overall Study|Lost to Follow-up|77|||
129783441|NCT00567255|467175726|FG001|Overall Study|Lost to Follow-up|48|||
129783442|NCT00567255|467175725|FG000|Overall Study|Withdrawal by Subject|75|||
129783443|NCT00567255|467175726|FG001|Overall Study|Withdrawal by Subject|56|||
129783444|NCT00567255|467175725|FG000|Overall Study|Lack of Efficacy|19|||
129783445|NCT00567255|467175726|FG001|Overall Study|Lack of Efficacy|33|||
129783446|NCT00567255|467175725|FG000|Overall Study|Protocol Violation|20|||
129783447|NCT00567255|467175726|FG001|Overall Study|Protocol Violation|8|||
129783448|NCT00567255|467175725|FG000|Overall Study|Pregnancy|6|||
129783449|NCT00567255|467175726|FG001|Overall Study|Pregnancy|0|||
129783450|NCT00567255|467175725|FG000|Overall Study|Drug noncompliance,moved,other|25|||
129783451|NCT00567255|467175726|FG001|Overall Study|Drug noncompliance,moved,other|15|||
129783452|NCT01640314|467175729|FG000|Overall Study|Protocol Violation|0|||
129783453|NCT01640314|467175730|FG001|Overall Study|Protocol Violation|1|||
129783454|NCT03672097|467175731|FG000|Period 1|Withdrawal by Subject|2|||
129783455|NCT03672097|467175731|FG000|Period 1|Adverse Event|1|||
129783456|NCT03672097|467175731|FG000|Period 1|Did not receive treatment|1|||
129783457|NCT03672097|467175731|FG000|Period 2|Withdrawal by Subject|3|||
129783458|NCT03672097|467175731|FG000|Period 2|Other|1|||
129783459|NCT01290796|467175732|FG000|Overall Study|Lost to Follow-up|21|||
129783460|NCT01290796|467175732|FG000|Overall Study|Withdrawal by Subject|4|||
129783461|NCT01290796|467175732|FG000|Overall Study|Physician Decision|2|||
129884624|NCT02310126|467538604|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
129574820|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
129783462|NCT01290796|467175732|FG000|Overall Study|Secondary Surgical Intervention|2|||
129783463|NCT01290796|467175732|FG000|Overall Study|Withdrawal by Sponsor|1|||
129783464|NCT03087617|467175733|FG000|Overall Study|Lost to Follow-up|32|||
129783465|NCT03087617|467175734|FG001|Overall Study|Lost to Follow-up|30|||
129783466|NCT03087617|467175735|FG002|Overall Study|Lost to Follow-up|30|||
129783467|NCT03087617|467175736|FG003|Overall Study|Lost to Follow-up|39|||
129574821|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
129574822|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
129574823|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
129574824|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
129574825|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
129574826|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Pregnancy|0|||
129574827|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Pregnancy|0|||
129574828|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Pregnancy|2|||
129574829|NCT02009163|466400825|FG000|Randomized-withdrawal Period|Other|0|||
129574830|NCT02009163|466400826|FG001|Randomized-withdrawal Period|Other|9|||
129574831|NCT02009163|466400827|FG002|Randomized-withdrawal Period|Other|5|||
129574832|NCT01218867|466400830|FG000|Overall Study|Death during treatment|0|||
129693674|NCT03225989|466835793|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
129693675|NCT03225989|466835791|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
129693676|NCT03225989|466835792|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
129693677|NCT03225989|466835793|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
129693678|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
129693679|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
129693680|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
129693681|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
129693682|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
129693683|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
129574833|NCT01218867|466400831|FG001|Overall Study|Death during treatment|0|||
129574834|NCT01218867|466400832|FG002|Overall Study|Death during treatment|0|||
129574835|NCT01218867|466400833|FG003|Overall Study|Death during treatment|0|||
129574836|NCT01218867|466400834|FG004|Overall Study|Death during treatment|0|||
129574837|NCT01218867|466400835|FG005|Overall Study|Death during treatment|0|||
129574838|NCT01218867|466400836|FG006|Overall Study|Death during treatment|1|||
129574839|NCT01218867|466400837|FG007|Overall Study|Death during treatment|0|||
129574840|NCT01218867|466400838|FG008|Overall Study|Death during treatment|0|||
129574841|NCT01218867|466400839|FG009|Overall Study|Death during treatment|0|||
129574842|NCT01218867|466400840|FG010|Overall Study|Death during treatment|0|||
129574843|NCT01474551|466400842|FG000|Overall Study|Death|1|||
129574844|NCT04419311|466400844|FG000|Overall Study|Lost to Follow-up|1|||
129574845|NCT04419311|466400845|FG001|Overall Study|Lost to Follow-up|0|||
129574846|NCT00465270|466400848|FG000|Overall Study|Death|7|||
129574847|NCT00465270|466400849|FG001|Overall Study|Death|11|||
129574848|NCT00465270|466400848|FG000|Overall Study|Withdrawal by Subject|34|||
129574849|NCT00465270|466400849|FG001|Overall Study|Withdrawal by Subject|78|||
129574850|NCT00465270|466400848|FG000|Overall Study|Lost to Follow-up|60|||
129574851|NCT00465270|466400849|FG001|Overall Study|Lost to Follow-up|67|||
129574852|NCT00465270|466400848|FG000|Overall Study|Investigator request|3|||
129574853|NCT00465270|466400849|FG001|Overall Study|Investigator request|4|||
129574854|NCT02089997|466400865|FG000|Overall Study|Case report forms uncollected|99|||
129574855|NCT02089997|466400865|FG000|Overall Study|Protocol Violation|147|||
129574856|NCT02441309|466400866|FG000|Overall Study|Disease progression|2|||
129574857|NCT02441309|466400867|FG001|Overall Study|Disease progression|1|||
129574858|NCT02441309|466400868|FG002|Overall Study|Disease progression|2|||
129574859|NCT02441309|466400866|FG000|Overall Study|Adverse Event|0|||
129574860|NCT02441309|466400867|FG001|Overall Study|Adverse Event|1|||
129574861|NCT02441309|466400868|FG002|Overall Study|Adverse Event|0|||
129574862|NCT02441309|466400866|FG000|Overall Study|Withdrawal by Subject|1|||
129574863|NCT02441309|466400867|FG001|Overall Study|Withdrawal by Subject|0|||
129574864|NCT02441309|466400868|FG002|Overall Study|Withdrawal by Subject|1|||
129783468|NCT04450381|467175738|FG000|Overall Study|Protocol Violation|4|||
129783469|NCT04450381|467175738|FG000|Overall Study|Wrong device setting|2|||
129783470|NCT04556383|467175746|FG000|PCP|Lack of Efficacy|28|||
129783471|NCT04556383|467175747|FG001|PCP|Lack of Efficacy|23|||
129783472|NCT04556383|467175748|FG002|PCP|Lack of Efficacy|23|||
129783473|NCT04556383|467175749|FG003|PCP|Lack of Efficacy|0|||
129783474|NCT04556383|467175746|FG000|PCP|Study terminated by sponsor|15|||
129783475|NCT04556383|467175747|FG001|PCP|Study terminated by sponsor|13|||
129783476|NCT04556383|467175748|FG002|PCP|Study terminated by sponsor|16|||
129783477|NCT04556383|467175749|FG003|PCP|Study terminated by sponsor|0|||
129783478|NCT04556383|467175746|FG000|PCP|Withdrawal by Subject|8|||
129574865|NCT02335658|466400873|FG000|Overall Study|Adverse Event|18|||
129574866|NCT02335658|466400874|FG001|Overall Study|Adverse Event|12|||
129574867|NCT02335658|466400873|FG000|Overall Study|Lack of Efficacy|4|||
129574868|NCT02335658|466400874|FG001|Overall Study|Lack of Efficacy|5|||
129574869|NCT02335658|466400873|FG000|Overall Study|Pregnancy|1|||
129574870|NCT02335658|466400874|FG001|Overall Study|Pregnancy|0|||
129574871|NCT02335658|466400873|FG000|Overall Study|Withdrawal by Subject|13|||
129574872|NCT02335658|466400874|FG001|Overall Study|Withdrawal by Subject|21|||
129574873|NCT02335658|466400873|FG000|Overall Study|non-compliance|2|||
129783479|NCT04556383|467175747|FG001|PCP|Withdrawal by Subject|6|||
129783480|NCT04556383|467175748|FG002|PCP|Withdrawal by Subject|6|||
129783481|NCT04556383|467175749|FG003|PCP|Withdrawal by Subject|0|||
129783482|NCT04556383|467175746|FG000|PCP|Adverse Event|1|||
129783483|NCT04556383|467175747|FG001|PCP|Adverse Event|7|||
129783484|NCT04556383|467175748|FG002|PCP|Adverse Event|7|||
129783485|NCT04556383|467175749|FG003|PCP|Adverse Event|0|||
129783486|NCT04556383|467175746|FG000|PCP|Other, Not Specified|1|||
129783487|NCT04556383|467175747|FG001|PCP|Other, Not Specified|2|||
129783488|NCT04556383|467175748|FG002|PCP|Other, Not Specified|1|||
129783489|NCT04556383|467175749|FG003|PCP|Other, Not Specified|0|||
129783490|NCT04556383|467175746|FG000|PCP|Protocol Violation|1|||
129783491|NCT04556383|467175747|FG001|PCP|Protocol Violation|0|||
129783492|NCT04556383|467175748|FG002|PCP|Protocol Violation|1|||
129783493|NCT04556383|467175749|FG003|PCP|Protocol Violation|0|||
129783494|NCT04556383|467175746|FG000|PCP|Lost to Follow-up|1|||
129783495|NCT04556383|467175747|FG001|PCP|Lost to Follow-up|0|||
129783496|NCT04556383|467175748|FG002|PCP|Lost to Follow-up|0|||
129783497|NCT04556383|467175749|FG003|PCP|Lost to Follow-up|0|||
129783498|NCT04556383|467175746|FG000|PCP|Physician Decision|0|||
129783499|NCT04556383|467175747|FG001|PCP|Physician Decision|1|||
129783500|NCT04556383|467175748|FG002|PCP|Physician Decision|0|||
129574874|NCT02335658|466400874|FG001|Overall Study|non-compliance|3|||
129574875|NCT02335658|466400873|FG000|Overall Study|other reason|2|||
129574876|NCT02335658|466400874|FG001|Overall Study|other reason|3|||
129693684|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
129693685|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
129693686|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
129693687|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
129693688|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
129693689|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
129693690|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
129693691|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
129693692|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
129693693|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
129693694|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
129693695|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
129693696|NCT03225989|466835791|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
129693697|NCT03225989|466835792|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
129693698|NCT03225989|466835793|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
129693699|NCT00601107|466835794|FG000|Overall Study|Adverse Event|0|||
129693700|NCT00601107|466835795|FG001|Overall Study|Adverse Event|1|||
129693701|NCT00601107|466835796|FG002|Overall Study|Adverse Event|3|||
129693702|NCT00601107|466835797|FG003|Overall Study|Adverse Event|0|||
129693703|NCT00601107|466835794|FG000|Overall Study|Withdrawal by Subject|5|||
129693704|NCT00601107|466835795|FG001|Overall Study|Withdrawal by Subject|4|||
129693705|NCT00601107|466835796|FG002|Overall Study|Withdrawal by Subject|7|||
129693706|NCT00601107|466835797|FG003|Overall Study|Withdrawal by Subject|4|||
129693707|NCT00601107|466835794|FG000|Overall Study|Lost to Follow-up|3|||
129693708|NCT00601107|466835795|FG001|Overall Study|Lost to Follow-up|3|||
129693709|NCT00601107|466835796|FG002|Overall Study|Lost to Follow-up|0|||
129693710|NCT00601107|466835797|FG003|Overall Study|Lost to Follow-up|3|||
129693711|NCT00601107|466835794|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
129693712|NCT00601107|466835795|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
129693713|NCT00601107|466835796|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
129693714|NCT00601107|466835797|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
129693715|NCT00601107|466835794|FG000|Overall Study|Worsening of Psoriasis|4|||
129693716|NCT00601107|466835795|FG001|Overall Study|Worsening of Psoriasis|1|||
129693717|NCT00601107|466835796|FG002|Overall Study|Worsening of Psoriasis|1|||
129693718|NCT00601107|466835797|FG003|Overall Study|Worsening of Psoriasis|4|||
129693719|NCT00601107|466835794|FG000|Overall Study|Undefined|1|||
129693720|NCT00601107|466835795|FG001|Overall Study|Undefined|0|||
129693721|NCT00601107|466835796|FG002|Overall Study|Undefined|1|||
129693722|NCT00601107|466835797|FG003|Overall Study|Undefined|0|||
129693723|NCT01181128|466835798|FG000|Overall Study|Withdrawal by Subject|2|||
129693724|NCT01181128|466835799|FG001|Overall Study|Withdrawal by Subject|2|||
129693725|NCT01181128|466835800|FG002|Overall Study|Withdrawal by Subject|0|||
129693726|NCT01181128|466835798|FG000|Overall Study|Death|1|||
129693727|NCT01181128|466835799|FG001|Overall Study|Death|0|||
129693728|NCT01181128|466835800|FG002|Overall Study|Death|0|||
129693729|NCT01181128|466835798|FG000|Overall Study|Physician Decision|2|||
129693730|NCT01181128|466835799|FG001|Overall Study|Physician Decision|0|||
129693731|NCT01181128|466835800|FG002|Overall Study|Physician Decision|0|||
129693732|NCT01181128|466835798|FG000|Overall Study|Adverse Event|0|||
129693733|NCT01181128|466835799|FG001|Overall Study|Adverse Event|2|||
129693734|NCT01181128|466835800|FG002|Overall Study|Adverse Event|0|||
129693735|NCT01181128|466835798|FG000|Overall Study|Other|1|||
129693736|NCT01181128|466835799|FG001|Overall Study|Other|1|||
129693737|NCT01181128|466835800|FG002|Overall Study|Other|1|||
129693738|NCT01362270|466835801|FG000|Overall Study|Withdrawal by Subject|1|||
129693739|NCT01362270|466835802|FG001|Overall Study|Withdrawal by Subject|0|||
129693740|NCT01362270|466835801|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
129693741|NCT01362270|466835802|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
129783501|NCT04556383|467175749|FG003|PCP|Physician Decision|0|||
129783502|NCT04556383|467175746|FG000|PCP|Site terminated by sponsor|0|||
129783503|NCT04556383|467175747|FG001|PCP|Site terminated by sponsor|1|||
129783504|NCT04556383|467175748|FG002|PCP|Site terminated by sponsor|0|||
129783505|NCT04556383|467175749|FG003|PCP|Site terminated by sponsor|0|||
129783506|NCT04556383|467175746|FG000|OLE|Study terminated by sponsor|0|||
129783507|NCT04556383|467175747|FG001|OLE|Study terminated by sponsor|0|||
129783508|NCT04556383|467175748|FG002|OLE|Study terminated by sponsor|0|||
129783509|NCT04556383|467175749|FG003|OLE|Study terminated by sponsor|68|||
129574877|NCT02305758|466400875|FG000|Overall Study|Death|27|||
129783510|NCT04556383|467175746|FG000|OLE|Withdrawal by Subject|0|||
129783511|NCT04556383|467175747|FG001|OLE|Withdrawal by Subject|0|||
129783512|NCT04556383|467175748|FG002|OLE|Withdrawal by Subject|0|||
129783513|NCT04556383|467175749|FG003|OLE|Withdrawal by Subject|10|||
129783514|NCT04556383|467175746|FG000|OLE|Lack of Efficacy|0|||
129783515|NCT04556383|467175747|FG001|OLE|Lack of Efficacy|0|||
129783516|NCT04556383|467175748|FG002|OLE|Lack of Efficacy|0|||
129783517|NCT04556383|467175749|FG003|OLE|Lack of Efficacy|7|||
129783518|NCT04556383|467175746|FG000|OLE|Adverse Event|0|||
129783519|NCT04556383|467175747|FG001|OLE|Adverse Event|0|||
129783520|NCT04556383|467175748|FG002|OLE|Adverse Event|0|||
129783521|NCT04556383|467175749|FG003|OLE|Adverse Event|2|||
129783522|NCT04556383|467175746|FG000|OLE|Other, Not Specified|0|||
129783523|NCT04556383|467175747|FG001|OLE|Other, Not Specified|0|||
129783524|NCT04556383|467175748|FG002|OLE|Other, Not Specified|0|||
129783525|NCT04556383|467175749|FG003|OLE|Other, Not Specified|2|||
129783526|NCT04556383|467175746|FG000|OLE|Death|0|||
129574878|NCT02305758|466400876|FG001|Overall Study|Death|27|||
129783527|NCT04556383|467175747|FG001|OLE|Death|0|||
129783528|NCT04556383|467175748|FG002|OLE|Death|0|||
129783529|NCT04556383|467175749|FG003|OLE|Death|1|||
129783530|NCT04556383|467175746|FG000|OLE|Lost to Follow-up|0|||
129783531|NCT04556383|467175747|FG001|OLE|Lost to Follow-up|0|||
129783532|NCT04556383|467175748|FG002|OLE|Lost to Follow-up|0|||
129783533|NCT04556383|467175749|FG003|OLE|Lost to Follow-up|1|||
129783534|NCT01994889|467175755|FG000|Overall Study|Adverse Event|5|||
129783535|NCT01994889|467175756|FG001|Overall Study|Adverse Event|12|||
129783536|NCT01994889|467175757|FG002|Overall Study|Adverse Event|11|||
129783537|NCT01994889|467175755|FG000|Overall Study|Cardiac Device Implantation|0|||
129783538|NCT01994889|467175756|FG001|Overall Study|Cardiac Device Implantation|2|||
129783539|NCT01994889|467175757|FG002|Overall Study|Cardiac Device Implantation|0|||
129783540|NCT01994889|467175755|FG000|Overall Study|Organ Transplantation|1|||
129783541|NCT01994889|467175756|FG001|Overall Study|Organ Transplantation|5|||
129783542|NCT01994889|467175757|FG002|Overall Study|Organ Transplantation|5|||
129783543|NCT01994889|467175755|FG000|Overall Study|No longer willing to participate|8|||
129783544|NCT01994889|467175756|FG001|Overall Study|No longer willing to participate|17|||
129783545|NCT01994889|467175757|FG002|Overall Study|No longer willing to participate|37|||
129783546|NCT01994889|467175755|FG000|Overall Study|Lost to Follow-up|0|||
129783547|NCT01994889|467175756|FG001|Overall Study|Lost to Follow-up|1|||
129783548|NCT01994889|467175757|FG002|Overall Study|Lost to Follow-up|0|||
129783549|NCT01994889|467175755|FG000|Overall Study|Protocol Violation|0|||
129783550|NCT01994889|467175756|FG001|Overall Study|Protocol Violation|1|||
129783551|NCT01994889|467175757|FG002|Overall Study|Protocol Violation|1|||
129783552|NCT01994889|467175755|FG000|Overall Study|Death|14|||
129783553|NCT01994889|467175756|FG001|Overall Study|Death|25|||
129783554|NCT01994889|467175757|FG002|Overall Study|Death|38|||
129783555|NCT00929643|467175758|FG000|Overall Study|Protocol Violation|2|||
129783556|NCT02873429|467175761|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
129783557|NCT02873429|467175762|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
129783558|NCT02873429|467175761|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
129783559|NCT02873429|467175762|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
129783560|NCT02873429|467175761|FG000|16 Weeks|Lost to Follow-up|3|||
129783561|NCT02873429|467175762|FG001|16 Weeks|Lost to Follow-up|0|||
129783562|NCT00744042|467175763|FG000|Overall Study|Withdrawal by Subject|1|||
129783563|NCT03158285|467175767|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
129783564|NCT03158285|467175768|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
129783565|NCT03158285|467175769|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
129783566|NCT03158285|467175767|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
129783567|NCT03158285|467175768|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
129783568|NCT03158285|467175769|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
129783569|NCT03158285|467175767|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
129783570|NCT03158285|467175768|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
129783571|NCT03158285|467175769|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
129783572|NCT03158285|467175767|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
129783573|NCT03158285|467175768|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
129783574|NCT03158285|467175769|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
129783575|NCT03158285|467175767|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
129783576|NCT03158285|467175768|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
129783577|NCT03158285|467175769|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
129783578|NCT03158285|467175767|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
129783579|NCT03158285|467175768|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
129783580|NCT03158285|467175769|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
129783581|NCT03158285|467175767|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
129783582|NCT03158285|467175768|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
129574879|NCT02305758|466400875|FG000|Overall Study|Withdrew consent|9|||
129783583|NCT03158285|467175769|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
129783584|NCT03158285|467175767|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
129783585|NCT03158285|467175768|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
129783586|NCT03158285|467175769|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
129783587|NCT03158285|467175767|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
129783588|NCT03158285|467175768|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
129783589|NCT03158285|467175769|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
129783590|NCT03158285|467175767|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
129783591|NCT03158285|467175768|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
129783592|NCT03158285|467175769|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
129574880|NCT02305758|466400876|FG001|Overall Study|Withdrew consent|2|||
129574881|NCT02305758|466400875|FG000|Overall Study|Lost to Follow-up|6|||
129574882|NCT02305758|466400876|FG001|Overall Study|Lost to Follow-up|1|||
129574883|NCT02305758|466400875|FG000|Overall Study|Study Terminated by Sponsor|21|||
129574884|NCT02305758|466400876|FG001|Overall Study|Study Terminated by Sponsor|34|||
129574885|NCT02305758|466400875|FG000|Overall Study|Other, not specified|2|||
129574886|NCT02305758|466400876|FG001|Overall Study|Other, not specified|1|||
129574887|NCT02032888|466400879|FG000|Treatment Period|Poor compliance/noncompliance|1|||
129574888|NCT02032888|466400880|FG001|Treatment Period|Poor compliance/noncompliance|1|||
129574889|NCT02032888|466400881|FG002|Treatment Period|Poor compliance/noncompliance|0|||
129574890|NCT02032888|466400879|FG000|Treatment Period|Other|1|||
129574891|NCT02032888|466400880|FG001|Treatment Period|Other|1|||
129574892|NCT02032888|466400881|FG002|Treatment Period|Other|0|||
129574893|NCT02032888|466400879|FG000|Follow-up Period|Lost to Follow-up|1|||
129574894|NCT02032888|466400880|FG001|Follow-up Period|Lost to Follow-up|1|||
129574895|NCT02032888|466400881|FG002|Follow-up Period|Lost to Follow-up|0|||
129574896|NCT02032888|466400879|FG000|Follow-up Period|Death|1|||
129574897|NCT02032888|466400880|FG001|Follow-up Period|Death|1|||
129574898|NCT02032888|466400881|FG002|Follow-up Period|Death|0|||
129574899|NCT02032888|466400879|FG000|Follow-up Period|Other|1|||
129574900|NCT02032888|466400880|FG001|Follow-up Period|Other|0|||
129574901|NCT02032888|466400881|FG002|Follow-up Period|Other|0|||
129574902|NCT03616106|466400884|FG000|Overall Study|Removed by PI|6|||
129574903|NCT03616106|466400885|FG001|Overall Study|Removed by PI|0|||
129574904|NCT03616106|466400884|FG000|Overall Study|Withdrawal by Subject|1|||
129574905|NCT03616106|466400885|FG001|Overall Study|Withdrawal by Subject|1|||
129574906|NCT03616106|466400884|FG000|Overall Study|Lost to Follow-up|7|||
129574907|NCT03616106|466400885|FG001|Overall Study|Lost to Follow-up|0|||
129574908|NCT03206177|466400886|FG000|Overall Study|Withdrawal by Subject|1|||
129574909|NCT02963259|466400887|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
129574910|NCT02963259|466400887|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
129574911|NCT02963259|466400887|FG000|Overall Study|Death|1|||
129574912|NCT02963259|466400887|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
129574913|NCT04611789|466400888|FG000|Overall Study|Lost to Follow-up|1|||
129574914|NCT04611789|466400889|FG001|Overall Study|Lost to Follow-up|0|||
129574915|NCT04611789|466400890|FG002|Overall Study|Lost to Follow-up|0|||
129574916|NCT02655679|466400891|FG000|Overall Study|Adverse Event|0|||
129574917|NCT02655679|466400892|FG001|Overall Study|Adverse Event|1|||
129574918|NCT02655679|466400893|FG002|Overall Study|Adverse Event|0|||
129574919|NCT02655679|466400894|FG003|Overall Study|Adverse Event|0|||
129574920|NCT02655679|466400895|FG004|Overall Study|Adverse Event|0|||
129574921|NCT02655679|466400891|FG000|Overall Study|Withdrawal by Subject|1|||
129574922|NCT02655679|466400892|FG001|Overall Study|Withdrawal by Subject|1|||
129574923|NCT02655679|466400893|FG002|Overall Study|Withdrawal by Subject|0|||
129574924|NCT02655679|466400894|FG003|Overall Study|Withdrawal by Subject|3|||
129574925|NCT02655679|466400895|FG004|Overall Study|Withdrawal by Subject|1|||
129574926|NCT02655679|466400891|FG000|Overall Study|Inability to Comply with the Protocol|1|||
129574927|NCT02655679|466400892|FG001|Overall Study|Inability to Comply with the Protocol|0|||
129574928|NCT02655679|466400893|FG002|Overall Study|Inability to Comply with the Protocol|0|||
129574929|NCT02655679|466400894|FG003|Overall Study|Inability to Comply with the Protocol|0|||
129574930|NCT02655679|466400895|FG004|Overall Study|Inability to Comply with the Protocol|0|||
129574931|NCT02655679|466400891|FG000|Overall Study|Lost to Follow-up|0|||
129574932|NCT02655679|466400892|FG001|Overall Study|Lost to Follow-up|1|||
129574933|NCT02655679|466400893|FG002|Overall Study|Lost to Follow-up|1|||
129574934|NCT02655679|466400894|FG003|Overall Study|Lost to Follow-up|1|||
129783593|NCT03158285|467175767|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
129783594|NCT03158285|467175768|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
129783595|NCT03158285|467175769|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
129783596|NCT03158285|467175767|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
129783597|NCT03158285|467175768|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
129783598|NCT03158285|467175769|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
129783599|NCT03158285|467175767|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
129783600|NCT03158285|467175768|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
129783601|NCT03158285|467175769|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
129783602|NCT03158285|467175767|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
129783603|NCT03158285|467175768|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
129783604|NCT03158285|467175769|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
129783605|NCT03158285|467175767|FG000|Active Treatment Period: Week 52-100|Death|1|||
129783606|NCT03158285|467175768|FG001|Active Treatment Period: Week 52-100|Death|0|||
129783607|NCT03158285|467175769|FG002|Active Treatment Period: Week 52-100|Death|0|||
129783608|NCT03158285|467175767|FG000|Active Treatment Period: Week 52-100|Other|4|||
129783609|NCT03158285|467175768|FG001|Active Treatment Period: Week 52-100|Other|1|||
129783610|NCT03158285|467175769|FG002|Active Treatment Period: Week 52-100|Other|0|||
129783611|NCT02228980|467175770|FG000|Overall Study|Adverse Event|14|||
129783612|NCT02228980|467175771|FG001|Overall Study|Adverse Event|0|||
129783613|NCT02228980|467175772|FG002|Overall Study|Adverse Event|0|||
129783614|NCT02228980|467175773|FG003|Overall Study|Adverse Event|0|||
129783615|NCT02228980|467175770|FG000|Overall Study|Protocol Violation|7|||
129783616|NCT02228980|467175771|FG001|Overall Study|Protocol Violation|0|||
129783617|NCT02228980|467175772|FG002|Overall Study|Protocol Violation|0|||
129783618|NCT02228980|467175773|FG003|Overall Study|Protocol Violation|0|||
129783619|NCT02228980|467175770|FG000|Overall Study|Withdrawal by Subject|3|||
129783620|NCT02228980|467175771|FG001|Overall Study|Withdrawal by Subject|3|||
129783621|NCT02228980|467175772|FG002|Overall Study|Withdrawal by Subject|2|||
129783622|NCT02228980|467175773|FG003|Overall Study|Withdrawal by Subject|3|||
129783623|NCT04629066|467175774|FG000|Overall Study|Lost to Follow-up|3|||
129783624|NCT04629066|467175775|FG001|Overall Study|Lost to Follow-up|2|||
129783625|NCT00530504|467175778|FG000|Overall Study|Death|54|||
129783626|NCT00530504|467175778|FG000|Overall Study|Lost to Follow-up|26|||
129783627|NCT00530504|467175778|FG000|Overall Study|Withdrawal by Subject|39|||
129783628|NCT00530504|467175778|FG000|Overall Study|Exited study due to other reasons|33|||
129783629|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
129783630|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
129574935|NCT02655679|466400895|FG004|Overall Study|Lost to Follow-up|0|||
129783631|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
129783632|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
129783633|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
129783634|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
129574936|NCT02655679|466400891|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129574937|NCT02655679|466400892|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129574938|NCT02655679|466400893|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129574939|NCT02655679|466400894|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129574940|NCT02655679|466400895|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129574941|NCT05472038|466402391|FG000|Overall Study|Adverse Event|0|||
129574942|NCT05472038|466402392|FG001|Overall Study|Adverse Event|0|||
129574943|NCT05472038|466402393|FG002|Overall Study|Adverse Event|1|||
129574944|NCT05472038|466402394|FG003|Overall Study|Adverse Event|0|||
129574945|NCT05472038|466402395|FG004|Overall Study|Adverse Event|0|||
129574946|NCT05472038|466402396|FG005|Overall Study|Adverse Event|0|||
129574947|NCT05472038|466402397|FG006|Overall Study|Adverse Event|0|||
129574948|NCT05472038|466402398|FG007|Overall Study|Adverse Event|0|||
129574949|NCT05472038|466402399|FG008|Overall Study|Adverse Event|0|||
129574950|NCT05472038|466402400|FG009|Overall Study|Adverse Event|0|||
129574951|NCT05472038|466402401|FG010|Overall Study|Adverse Event|0|||
129574952|NCT05472038|466402402|FG011|Overall Study|Adverse Event|0|||
129574953|NCT05472038|466402391|FG000|Overall Study|Death|0|||
129574954|NCT05472038|466402392|FG001|Overall Study|Death|0|||
129574955|NCT05472038|466402393|FG002|Overall Study|Death|0|||
129574956|NCT05472038|466402394|FG003|Overall Study|Death|0|||
129574957|NCT05472038|466402395|FG004|Overall Study|Death|0|||
129574958|NCT05472038|466402396|FG005|Overall Study|Death|1|||
129574959|NCT05472038|466402397|FG006|Overall Study|Death|0|||
129574960|NCT05472038|466402398|FG007|Overall Study|Death|0|||
129574961|NCT05472038|466402399|FG008|Overall Study|Death|0|||
129574962|NCT05472038|466402400|FG009|Overall Study|Death|0|||
129574963|NCT05472038|466402401|FG010|Overall Study|Death|0|||
129574964|NCT05472038|466402402|FG011|Overall Study|Death|0|||
129693742|NCT01362270|466835801|FG000|Overall Study|Met excl. criteria before 1st session|1|||
129693743|NCT01362270|466835802|FG001|Overall Study|Met excl. criteria before 1st session|1|||
129783635|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
129783636|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
129574965|NCT05472038|466402391|FG000|Overall Study|Lost to Follow-up|1|||
129693744|NCT04595370|466835805|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
129693745|NCT04595370|466835806|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129693746|NCT04595370|466835807|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129693747|NCT04595370|466835808|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129693748|NCT04595370|466835809|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129693749|NCT04595370|466835810|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
129783637|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
129574966|NCT05472038|466402392|FG001|Overall Study|Lost to Follow-up|3|||
129574967|NCT05472038|466402393|FG002|Overall Study|Lost to Follow-up|3|||
129574968|NCT05472038|466402394|FG003|Overall Study|Lost to Follow-up|9|||
129783638|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
129574969|NCT05472038|466402395|FG004|Overall Study|Lost to Follow-up|2|||
129574970|NCT05472038|466402396|FG005|Overall Study|Lost to Follow-up|2|||
129574971|NCT05472038|466402397|FG006|Overall Study|Lost to Follow-up|1|||
129574972|NCT05472038|466402398|FG007|Overall Study|Lost to Follow-up|0|||
129574973|NCT05472038|466402399|FG008|Overall Study|Lost to Follow-up|1|||
129574974|NCT05472038|466402400|FG009|Overall Study|Lost to Follow-up|0|||
129574975|NCT05472038|466402401|FG010|Overall Study|Lost to Follow-up|2|||
129574976|NCT05472038|466402402|FG011|Overall Study|Lost to Follow-up|1|||
129574977|NCT05472038|466402391|FG000|Overall Study|Physician Decision|0|||
129574978|NCT05472038|466402392|FG001|Overall Study|Physician Decision|0|||
129574979|NCT05472038|466402393|FG002|Overall Study|Physician Decision|0|||
129574980|NCT05472038|466402394|FG003|Overall Study|Physician Decision|0|||
129574981|NCT05472038|466402395|FG004|Overall Study|Physician Decision|1|||
129574982|NCT05472038|466402396|FG005|Overall Study|Physician Decision|0|||
129574983|NCT05472038|466402397|FG006|Overall Study|Physician Decision|0|||
129574984|NCT05472038|466402398|FG007|Overall Study|Physician Decision|0|||
129693750|NCT04595370|466835805|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129693751|NCT04595370|466835806|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129693752|NCT04595370|466835807|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
129693753|NCT04595370|466835808|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129693754|NCT04595370|466835809|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129693755|NCT04595370|466835810|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
129693756|NCT04595370|466835805|FG000|Overall Study|Adverse Event|0|||
129693757|NCT04595370|466835806|FG001|Overall Study|Adverse Event|4|||
129693758|NCT04595370|466835807|FG002|Overall Study|Adverse Event|3|||
129693759|NCT04595370|466835808|FG003|Overall Study|Adverse Event|1|||
129693760|NCT04595370|466835809|FG004|Overall Study|Adverse Event|1|||
129693761|NCT04595370|466835810|FG005|Overall Study|Adverse Event|1|||
129693762|NCT04595370|466835805|FG000|Overall Study|Withdrawal of Consent|1|||
129574985|NCT05472038|466402399|FG008|Overall Study|Physician Decision|0|||
129574986|NCT05472038|466402400|FG009|Overall Study|Physician Decision|0|||
129574987|NCT05472038|466402401|FG010|Overall Study|Physician Decision|0|||
129693763|NCT04595370|466835806|FG001|Overall Study|Withdrawal of Consent|1|||
129693764|NCT04595370|466835807|FG002|Overall Study|Withdrawal of Consent|1|||
129574988|NCT05472038|466402402|FG011|Overall Study|Physician Decision|0|||
129574989|NCT05472038|466402391|FG000|Overall Study|Withdrawal by Subject|1|||
129574990|NCT05472038|466402392|FG001|Overall Study|Withdrawal by Subject|3|||
129574991|NCT05472038|466402393|FG002|Overall Study|Withdrawal by Subject|1|||
129574992|NCT05472038|466402394|FG003|Overall Study|Withdrawal by Subject|6|||
129574993|NCT05472038|466402395|FG004|Overall Study|Withdrawal by Subject|1|||
129574994|NCT05472038|466402396|FG005|Overall Study|Withdrawal by Subject|3|||
129574995|NCT05472038|466402397|FG006|Overall Study|Withdrawal by Subject|0|||
129574996|NCT05472038|466402398|FG007|Overall Study|Withdrawal by Subject|2|||
129574997|NCT05472038|466402399|FG008|Overall Study|Withdrawal by Subject|3|||
129574998|NCT05472038|466402400|FG009|Overall Study|Withdrawal by Subject|1|||
129574999|NCT05472038|466402401|FG010|Overall Study|Withdrawal by Subject|2|||
129575000|NCT05472038|466402402|FG011|Overall Study|Withdrawal by Subject|2|||
129575001|NCT05472038|466402391|FG000|Overall Study|Protocol Violation|0|||
129693765|NCT04595370|466835808|FG003|Overall Study|Withdrawal of Consent|0|||
129693766|NCT04595370|466835809|FG004|Overall Study|Withdrawal of Consent|0|||
129693767|NCT04595370|466835810|FG005|Overall Study|Withdrawal of Consent|0|||
129693768|NCT04595370|466835805|FG000|Overall Study|Death|0|||
129693769|NCT04595370|466835806|FG001|Overall Study|Death|1|||
129693770|NCT04595370|466835807|FG002|Overall Study|Death|0|||
129693771|NCT04595370|466835808|FG003|Overall Study|Death|0|||
129693772|NCT04595370|466835809|FG004|Overall Study|Death|1|||
129693773|NCT04595370|466835810|FG005|Overall Study|Death|0|||
129693774|NCT04595370|466835805|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129693775|NCT04595370|466835806|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129693776|NCT04595370|466835807|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129693777|NCT04595370|466835808|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129693778|NCT04595370|466835809|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129693779|NCT04595370|466835810|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129693780|NCT04595370|466835805|FG000|Overall Study|Withdrawal by Subject|0|||
129693781|NCT04595370|466835806|FG001|Overall Study|Withdrawal by Subject|0|||
129693782|NCT04595370|466835807|FG002|Overall Study|Withdrawal by Subject|1|||
129693783|NCT04595370|466835808|FG003|Overall Study|Withdrawal by Subject|0|||
129693784|NCT04595370|466835809|FG004|Overall Study|Withdrawal by Subject|2|||
129693785|NCT04595370|466835810|FG005|Overall Study|Withdrawal by Subject|0|||
129693786|NCT04595370|466835805|FG000|Overall Study|Lost to Follow-up|0|||
129693787|NCT04595370|466835806|FG001|Overall Study|Lost to Follow-up|0|||
129693788|NCT04595370|466835807|FG002|Overall Study|Lost to Follow-up|0|||
129693789|NCT04595370|466835808|FG003|Overall Study|Lost to Follow-up|0|||
129693790|NCT04595370|466835809|FG004|Overall Study|Lost to Follow-up|1|||
129575002|NCT05472038|466402392|FG001|Overall Study|Protocol Violation|0|||
129693791|NCT04595370|466835810|FG005|Overall Study|Lost to Follow-up|0|||
129693792|NCT04595370|466835805|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
129693793|NCT04595370|466835806|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
129575003|NCT05472038|466402393|FG002|Overall Study|Protocol Violation|0|||
129693794|NCT04595370|466835807|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
129783639|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783640|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
129783641|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783642|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783643|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783644|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783645|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783646|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
129783647|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
129783648|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
129783649|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
129783650|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
129783651|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
129783652|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
129783653|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
129783654|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
129783655|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
129783656|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|Other|0|||
129783657|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|Other|0|||
129783658|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|Other|1|||
129783659|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|Other|1|||
129783660|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|Other|0|||
129783661|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|Other|0|||
129783662|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|Other|0|||
129783663|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|Other|1|||
129783664|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|Other|0|||
129783665|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|Death|0|||
129783666|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|Death|0|||
129783667|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|Death|0|||
129783668|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|Death|0|||
129783669|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|Death|0|||
129783670|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|Death|1|||
129783671|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|Death|0|||
129783672|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|Death|0|||
129783673|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|Death|0|||
129783674|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783675|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783676|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783677|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783678|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783679|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
129783680|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
129783681|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783682|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
129783683|NCT00557856|467175787|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
129783684|NCT00557856|467175788|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129783685|NCT00557856|467175789|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129783686|NCT00557856|467175790|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129783687|NCT00557856|467175791|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129693795|NCT04595370|466835808|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
129693796|NCT04595370|466835809|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
129693797|NCT04595370|466835810|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
129693798|NCT01341990|466835811|FG000|Overall Study|Adverse Event|0|||
129693799|NCT01341990|466835812|FG001|Overall Study|Adverse Event|1|||
129693800|NCT01341990|466835811|FG000|Overall Study|Torn Study Lens|1|||
129693801|NCT01341990|466835812|FG001|Overall Study|Torn Study Lens|0|||
129693802|NCT01341990|466835811|FG000|Overall Study|Withdrawal by Subject|2|||
129693803|NCT01341990|466835812|FG001|Overall Study|Withdrawal by Subject|0|||
129693804|NCT01751685|466835814|FG000|6-mo Followup|Missed study visit|1|||
129693805|NCT01751685|466835815|FG001|6-mo Followup|Missed study visit|0|||
129693806|NCT01751685|466835814|FG000|6-mo Followup|Withdrawal by Subject|2|||
129693807|NCT01751685|466835815|FG001|6-mo Followup|Withdrawal by Subject|2|||
129693808|NCT01751685|466835814|FG000|6-mo Followup|Lost to Follow-up|0|||
129693809|NCT01751685|466835815|FG001|6-mo Followup|Lost to Follow-up|1|||
129693810|NCT01751685|466835814|FG000|12-mo Followup|Lost to Follow-up|5|||
129693811|NCT01751685|466835815|FG001|12-mo Followup|Lost to Follow-up|0|||
129693812|NCT04401293|466835816|FG000|Overall Study|Withdrawal by Subject|1|||
129693813|NCT04401293|466835817|FG001|Overall Study|Withdrawal by Subject|3|||
129693814|NCT00694161|466835818|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
129693815|NCT00694161|466835818|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
129693816|NCT00694161|466835818|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
129693817|NCT00837330|466835819|FG000|Overall Study|Lost to Follow-up|1|||
129693818|NCT00837330|466835820|FG001|Overall Study|Lost to Follow-up|3|||
129693819|NCT01117350|466835828|FG000|Comparative Period|Not Treated|5|||
129693820|NCT01117350|466835829|FG001|Comparative Period|Not Treated|8|||
129693821|NCT01117350|466835828|FG000|Comparative Period|Adverse Event|6|||
129693822|NCT01117350|466835829|FG001|Comparative Period|Adverse Event|33|||
129693823|NCT01117350|466835828|FG000|Comparative Period|Lost to Follow-up|11|||
129693824|NCT01117350|466835829|FG001|Comparative Period|Lost to Follow-up|7|||
129693825|NCT01117350|466835828|FG000|Comparative Period|Withdrawal by Subject|9|||
129693826|NCT01117350|466835829|FG001|Comparative Period|Withdrawal by Subject|13|||
129693827|NCT01117350|466835828|FG000|Comparative Period|Protocol Violation|8|||
129693828|NCT01117350|466835829|FG001|Comparative Period|Protocol Violation|12|||
129693829|NCT01117350|466835828|FG000|Comparative Period|Lack of Efficacy|1|||
129693830|NCT01117350|466835829|FG001|Comparative Period|Lack of Efficacy|0|||
129693831|NCT01117350|466835828|FG000|Comparative Period|Physician Decision|0|||
129693832|NCT01117350|466835829|FG001|Comparative Period|Physician Decision|1|||
129693833|NCT01117350|466835828|FG000|Comparative Period|Move to another city/country|2|||
129693834|NCT01117350|466835829|FG001|Comparative Period|Move to another city/country|1|||
129693835|NCT01117350|466835828|FG000|Extension Period|Not included in extension, not treated|0|||
129693836|NCT01117350|466835829|FG001|Extension Period|Not included in extension, not treated|50|||
129693837|NCT01117350|466835828|FG000|Extension Period|Adverse Event|0|||
129693838|NCT01117350|466835829|FG001|Extension Period|Adverse Event|2|||
129693839|NCT01117350|466835828|FG000|Extension Period|Protocol Violation|0|||
129693840|NCT01117350|466835829|FG001|Extension Period|Protocol Violation|2|||
129693841|NCT01117350|466835828|FG000|Extension Period|Lost to Follow-up|0|||
129693842|NCT01117350|466835829|FG001|Extension Period|Lost to Follow-up|2|||
129693843|NCT01117350|466835828|FG000|Extension Period|Withdrawal by Subject|0|||
129575004|NCT05472038|466402394|FG003|Overall Study|Protocol Violation|0|||
129693844|NCT01117350|466835829|FG001|Extension Period|Withdrawal by Subject|3|||
129783688|NCT00557856|467175792|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129693845|NCT01117350|466835828|FG000|Extension Period|Lack of Efficacy|0|||
129693846|NCT01117350|466835829|FG001|Extension Period|Lack of Efficacy|2|||
129693847|NCT01117350|466835828|FG000|Extension Period|Inclusion criteria not respected|0|||
129693848|NCT01117350|466835829|FG001|Extension Period|Inclusion criteria not respected|1|||
129693849|NCT01117350|466835828|FG000|Extension Period|Prohibited medication|0|||
129693850|NCT01117350|466835829|FG001|Extension Period|Prohibited medication|1|||
129693851|NCT00450749|466835838|FG000|Overall Study|Withdrawal by Subject|0|||
129783689|NCT00557856|467175793|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129783690|NCT00557856|467175794|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129783691|NCT00557856|467175795|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
129783692|NCT00557856|467175787|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783693|NCT00557856|467175788|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783694|NCT00557856|467175789|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783695|NCT00557856|467175790|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783696|NCT00557856|467175791|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783697|NCT00557856|467175792|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783698|NCT00557856|467175793|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783699|NCT00557856|467175794|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
129783700|NCT00557856|467175795|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
129783701|NCT00557856|467175787|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783702|NCT00557856|467175788|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783703|NCT00557856|467175789|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783704|NCT00557856|467175790|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783705|NCT00557856|467175791|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783706|NCT00557856|467175792|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783707|NCT00557856|467175793|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783708|NCT00557856|467175794|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
129783709|NCT00557856|467175795|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
129783710|NCT00557856|467175787|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
129783711|NCT00557856|467175788|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
129783712|NCT00557856|467175789|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
129783713|NCT00557856|467175790|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
129783714|NCT00557856|467175791|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
129783715|NCT00557856|467175792|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
129783716|NCT00557856|467175793|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
129783717|NCT00557856|467175794|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
129783718|NCT00557856|467175795|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
129783719|NCT00557856|467175787|FG000|Part 2: Exploratory Phase|Other|0|||
129783720|NCT00557856|467175788|FG001|Part 2: Exploratory Phase|Other|0|||
129783721|NCT00557856|467175789|FG002|Part 2: Exploratory Phase|Other|0|||
129783722|NCT00557856|467175790|FG003|Part 2: Exploratory Phase|Other|0|||
129783723|NCT00557856|467175791|FG004|Part 2: Exploratory Phase|Other|0|||
129783724|NCT00557856|467175792|FG005|Part 2: Exploratory Phase|Other|0|||
129783725|NCT00557856|467175793|FG006|Part 2: Exploratory Phase|Other|0|||
129783726|NCT00557856|467175794|FG007|Part 2: Exploratory Phase|Other|0|||
129783727|NCT00557856|467175795|FG008|Part 2: Exploratory Phase|Other|1|||
129783728|NCT00557856|467175787|FG000|Part 2: Exploratory Phase|Death|0|||
129783729|NCT00557856|467175788|FG001|Part 2: Exploratory Phase|Death|0|||
129783730|NCT00557856|467175789|FG002|Part 2: Exploratory Phase|Death|0|||
129783731|NCT00557856|467175790|FG003|Part 2: Exploratory Phase|Death|0|||
129783732|NCT00557856|467175791|FG004|Part 2: Exploratory Phase|Death|0|||
129783733|NCT00557856|467175792|FG005|Part 2: Exploratory Phase|Death|0|||
129783734|NCT00557856|467175793|FG006|Part 2: Exploratory Phase|Death|0|||
129783735|NCT00557856|467175794|FG007|Part 2: Exploratory Phase|Death|0|||
129783736|NCT00557856|467175795|FG008|Part 2: Exploratory Phase|Death|2|||
129783737|NCT00557856|467175787|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
129783738|NCT00557856|467175788|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
129783739|NCT00557856|467175789|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
129575005|NCT05472038|466402395|FG004|Overall Study|Protocol Violation|0|||
129783740|NCT00557856|467175790|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
129783741|NCT00557856|467175791|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
129783742|NCT00557856|467175792|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
129783743|NCT00557856|467175793|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
129783744|NCT00557856|467175794|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
129575006|NCT05472038|466402396|FG005|Overall Study|Protocol Violation|0|||
129575007|NCT05472038|466402397|FG006|Overall Study|Protocol Violation|0|||
129575008|NCT05472038|466402398|FG007|Overall Study|Protocol Violation|1|||
129575009|NCT05472038|466402399|FG008|Overall Study|Protocol Violation|1|||
129575010|NCT05472038|466402400|FG009|Overall Study|Protocol Violation|1|||
129575011|NCT05472038|466402401|FG010|Overall Study|Protocol Violation|1|||
129575012|NCT05472038|466402402|FG011|Overall Study|Protocol Violation|1|||
129575013|NCT05472038|466402391|FG000|Overall Study|Not vaccinated|0|||
129575014|NCT05472038|466402392|FG001|Overall Study|Not vaccinated|0|||
129575015|NCT05472038|466402393|FG002|Overall Study|Not vaccinated|0|||
129575016|NCT05472038|466402394|FG003|Overall Study|Not vaccinated|1|||
129575017|NCT05472038|466402395|FG004|Overall Study|Not vaccinated|0|||
129575018|NCT05472038|466402396|FG005|Overall Study|Not vaccinated|0|||
129575019|NCT05472038|466402397|FG006|Overall Study|Not vaccinated|0|||
129575020|NCT05472038|466402398|FG007|Overall Study|Not vaccinated|0|||
129575021|NCT05472038|466402399|FG008|Overall Study|Not vaccinated|0|||
129575022|NCT05472038|466402400|FG009|Overall Study|Not vaccinated|0|||
129575023|NCT05472038|466402401|FG010|Overall Study|Not vaccinated|0|||
129575024|NCT05472038|466402402|FG011|Overall Study|Not vaccinated|0|||
129575025|NCT05369208|466402405|FG000|Core Phase|Prohibited Medication Required|2|||
129575026|NCT05369208|466402405|FG000|Core Phase|Adverse Event|1|||
129575027|NCT05369208|466402405|FG000|Core Phase|Lack of Efficacy|1|||
129575028|NCT03235739|466402408|FG000|Overall Study|Withdrawal by Subject|2|||
129575029|NCT03235739|466402409|FG001|Overall Study|Withdrawal by Subject|2|||
129575030|NCT03235739|466402408|FG000|Overall Study|Physician Decision|0|||
129575031|NCT03235739|466402409|FG001|Overall Study|Physician Decision|1|||
129575032|NCT02847650|466402410|FG000|Overall Study|Adverse Event|2|||
129575033|NCT02847650|466402411|FG001|Overall Study|Adverse Event|4|||
129575034|NCT02847650|466402410|FG000|Overall Study|Lost to Follow-up|1|||
129575035|NCT02847650|466402411|FG001|Overall Study|Lost to Follow-up|0|||
129575036|NCT02847650|466402410|FG000|Overall Study|Protocol Violation|0|||
129575037|NCT02847650|466402411|FG001|Overall Study|Protocol Violation|1|||
129575038|NCT02847650|466402410|FG000|Overall Study|Withdrawal by Subject|1|||
129575039|NCT02847650|466402411|FG001|Overall Study|Withdrawal by Subject|1|||
129575040|NCT00467896|466402412|FG000|Overall Study|Consent Withdrawal|18|||
129575041|NCT00467896|466402412|FG000|Overall Study|Adverse Event|7|||
129575042|NCT00467896|466402412|FG000|Overall Study|Serious Adverse Event|13|||
129575043|NCT00467896|466402412|FG000|Overall Study|Non-compliance|3|||
129575044|NCT00467896|466402412|FG000|Overall Study|Changed therapy|2|||
129575045|NCT00467896|466402412|FG000|Overall Study|Patient received transplant|2|||
129575046|NCT00467896|466402412|FG000|Overall Study|Patient had atrial septostomy|1|||
129575047|NCT00467896|466402412|FG000|Overall Study|Patient weaned off iloprost|1|||
129575048|NCT00467896|466402412|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
129693852|NCT00450749|466835839|FG001|Overall Study|Withdrawal by Subject|0|||
129693853|NCT00450749|466835840|FG002|Overall Study|Withdrawal by Subject|2|||
129693854|NCT00450749|466835838|FG000|Overall Study|Noncompliant|0|||
129575049|NCT00467896|466402412|FG000|Overall Study|Started intravenous prostacyclin|1|||
129575050|NCT00467896|466402412|FG000|Overall Study|Started inhaled Remodulin|1|||
129575051|NCT00467896|466402412|FG000|Overall Study|Patient had no improvement|1|||
129575052|NCT03772522|466402413|FG000|Pre-intervention|Withdrawal by Subject|3|||
129575053|NCT03772522|466402414|FG001|Pre-intervention|Withdrawal by Subject|4|||
129575054|NCT03772522|466402413|FG000|Intervention|Withdrawal by Subject|1|||
129575055|NCT03772522|466402414|FG001|Intervention|Withdrawal by Subject|0|||
129575056|NCT03772522|466402413|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
129575057|NCT03772522|466402414|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
129575058|NCT00834249|466402417|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129575059|NCT00834249|466402418|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
129575060|NCT00834249|466402417|FG000|Second Intervention|Adverse Event|1|||
129575061|NCT00834249|466402418|FG001|Second Intervention|Adverse Event|0|||
129575062|NCT01015703|466402421|FG000|Overall Study|Withdrawal by Subject|0|||
129575063|NCT01015703|466402422|FG001|Overall Study|Withdrawal by Subject|1|||
129575064|NCT01015703|466402423|FG002|Overall Study|Withdrawal by Subject|0|||
129575065|NCT01015703|466402424|FG003|Overall Study|Withdrawal by Subject|0|||
129575066|NCT01015703|466402425|FG004|Overall Study|Withdrawal by Subject|0|||
129575067|NCT01015703|466402421|FG000|Overall Study|Adverse Event|1|||
129575068|NCT01015703|466402422|FG001|Overall Study|Adverse Event|0|||
129575069|NCT01015703|466402423|FG002|Overall Study|Adverse Event|0|||
129575070|NCT01015703|466402424|FG003|Overall Study|Adverse Event|0|||
129575071|NCT01015703|466402425|FG004|Overall Study|Adverse Event|0|||
129575072|NCT01015703|466402421|FG000|Overall Study|Protocol Violation|1|||
129575073|NCT01015703|466402422|FG001|Overall Study|Protocol Violation|0|||
129575074|NCT01015703|466402423|FG002|Overall Study|Protocol Violation|0|||
129575075|NCT01015703|466402424|FG003|Overall Study|Protocol Violation|0|||
129575076|NCT01015703|466402425|FG004|Overall Study|Protocol Violation|0|||
129575077|NCT03122535|466402426|FG000|Overall Study|Lost to Follow-up|68|||
129575078|NCT03122535|466402427|FG001|Overall Study|Lost to Follow-up|68|||
129575079|NCT03122535|466402426|FG000|Overall Study|Physician Decision|3|||
129575080|NCT03122535|466402427|FG001|Overall Study|Physician Decision|3|||
129575081|NCT03122535|466402426|FG000|Overall Study|Withdrawal by Subject|2|||
129575082|NCT03122535|466402427|FG001|Overall Study|Withdrawal by Subject|2|||
129575083|NCT02718326|466402428|FG000|Overall Study|Adverse Event|4|||
129575084|NCT02718326|466402429|FG001|Overall Study|Adverse Event|9|||
129575085|NCT02718326|466402430|FG002|Overall Study|Adverse Event|0|||
129575086|NCT02718326|466402428|FG000|Overall Study|Death|8|||
129575087|NCT02718326|466402429|FG001|Overall Study|Death|1|||
129575088|NCT02718326|466402430|FG002|Overall Study|Death|2|||
129575089|NCT02718326|466402428|FG000|Overall Study|Withdrawal by Subject|4|||
129575090|NCT02718326|466402429|FG001|Overall Study|Withdrawal by Subject|9|||
129575091|NCT02718326|466402430|FG002|Overall Study|Withdrawal by Subject|6|||
129575092|NCT02718326|466402428|FG000|Overall Study|Lost to Follow-up|18|||
129575093|NCT02718326|466402429|FG001|Overall Study|Lost to Follow-up|5|||
129575094|NCT02718326|466402430|FG002|Overall Study|Lost to Follow-up|14|||
129575095|NCT02718326|466402428|FG000|Overall Study|Protocol Deviation|1|||
129575096|NCT02718326|466402429|FG001|Overall Study|Protocol Deviation|0|||
129575097|NCT02718326|466402430|FG002|Overall Study|Protocol Deviation|0|||
129575098|NCT02718326|466402428|FG000|Overall Study|Pregnancy|1|||
129575099|NCT02718326|466402429|FG001|Overall Study|Pregnancy|0|||
129575100|NCT02718326|466402430|FG002|Overall Study|Pregnancy|0|||
129693855|NCT00450749|466835839|FG001|Overall Study|Noncompliant|1|||
129693856|NCT00450749|466835840|FG002|Overall Study|Noncompliant|0|||
129693857|NCT01245049|466835843|FG000|Overall Study|Migrated/moved from study area|0|||
129693858|NCT01245049|466835844|FG001|Overall Study|Migrated/moved from study area|1|||
129693859|NCT01245049|466835843|FG000|Overall Study|Withdrawal by Subject|0|||
129693860|NCT01245049|466835844|FG001|Overall Study|Withdrawal by Subject|1|||
129693861|NCT01245049|466835843|FG000|Overall Study|Lost to Follow-up|1|||
129575101|NCT00834418|466402436|FG000|Overall Study|Adverse Event|0|||
129575102|NCT00834418|466402437|FG001|Overall Study|Adverse Event|2|||
129575103|NCT00777023|466402438|FG000|Overall Study|Adverse Event|15|||
129575104|NCT00777023|466402439|FG001|Overall Study|Adverse Event|21|||
129575105|NCT00777023|466402440|FG002|Overall Study|Adverse Event|8|||
129693862|NCT01245049|466835844|FG001|Overall Study|Lost to Follow-up|2|||
129693863|NCT01213251|466837420|FG000|Overall Study|Death|2|||
129575106|NCT00777023|466402438|FG000|Overall Study|Lack of Efficacy|1|||
129575107|NCT00777023|466402439|FG001|Overall Study|Lack of Efficacy|0|||
129575108|NCT00777023|466402440|FG002|Overall Study|Lack of Efficacy|14|||
129575109|NCT00777023|466402438|FG000|Overall Study|Protocol Violation|2|||
129575110|NCT00777023|466402439|FG001|Overall Study|Protocol Violation|1|||
129575111|NCT00777023|466402440|FG002|Overall Study|Protocol Violation|1|||
129693864|NCT01213251|466837421|FG001|Overall Study|Death|1|||
129693865|NCT01213251|466837422|FG002|Overall Study|Death|2|||
129693866|NCT01213251|466837420|FG000|Overall Study|Exit|3|||
129693867|NCT01213251|466837421|FG001|Overall Study|Exit|2|||
129693868|NCT01213251|466837422|FG002|Overall Study|Exit|8|||
129693869|NCT01213251|466837420|FG000|Overall Study|Protocol Violation|1|||
129693870|NCT01213251|466837421|FG001|Overall Study|Protocol Violation|1|||
129693871|NCT01213251|466837422|FG002|Overall Study|Protocol Violation|0|||
129693872|NCT01213251|466837420|FG000|Overall Study|Missed 18-Month Follow-up|0|||
129693873|NCT01213251|466837421|FG001|Overall Study|Missed 18-Month Follow-up|0|||
129693874|NCT01213251|466837422|FG002|Overall Study|Missed 18-Month Follow-up|1|||
129693875|NCT01313676|466837423|FG000|Overall Study|Adverse Event|395|||
129693876|NCT01313676|466837424|FG001|Overall Study|Adverse Event|365|||
129575112|NCT00777023|466402438|FG000|Overall Study|Lost to Follow-up|2|||
129575113|NCT00777023|466402439|FG001|Overall Study|Lost to Follow-up|3|||
129575114|NCT00777023|466402440|FG002|Overall Study|Lost to Follow-up|3|||
129575115|NCT00777023|466402438|FG000|Overall Study|Death|0|||
129575116|NCT00777023|466402439|FG001|Overall Study|Death|1|||
129575117|NCT00777023|466402440|FG002|Overall Study|Death|0|||
129575118|NCT00777023|466402438|FG000|Overall Study|Withdrawal by Subject|7|||
129575119|NCT00777023|466402439|FG001|Overall Study|Withdrawal by Subject|7|||
129575120|NCT00777023|466402440|FG002|Overall Study|Withdrawal by Subject|8|||
129575121|NCT00777023|466402438|FG000|Overall Study|Missing data|1|||
129575122|NCT00777023|466402439|FG001|Overall Study|Missing data|1|||
129783745|NCT00557856|467175795|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
129783746|NCT02537015|467175796|FG000|Overall Study|Adverse Event|3|||
129783747|NCT02537015|467175796|FG000|Overall Study|Withdrawal by Subject|2|||
129783748|NCT02537015|467175796|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129783749|NCT01808092|467175797|FG000|Overall Study|Death|39|||
129783750|NCT01808092|467175798|FG001|Overall Study|Death|29|||
129783751|NCT01808092|467175797|FG000|Overall Study|Lost to Follow-up|3|||
129783752|NCT01808092|467175798|FG001|Overall Study|Lost to Follow-up|7|||
129783753|NCT01808092|467175797|FG000|Overall Study|Withdrawal by Subject|9|||
129783754|NCT01808092|467175798|FG001|Overall Study|Withdrawal by Subject|4|||
129783755|NCT01808092|467175797|FG000|Overall Study|Other Eligibility criteria|3|||
129783756|NCT01808092|467175798|FG001|Overall Study|Other Eligibility criteria|5|||
129783757|NCT03952039|467175799|FG000|Overall Study|Adverse Event|22|||
129783758|NCT03952039|467175800|FG001|Overall Study|Adverse Event|8|||
129783759|NCT03952039|467175799|FG000|Overall Study|Withdrawal by Participant|17|||
129783760|NCT03952039|467175800|FG001|Overall Study|Withdrawal by Participant|12|||
129783761|NCT03952039|467175799|FG000|Overall Study|Death|13|||
129783762|NCT03952039|467175800|FG001|Overall Study|Death|6|||
129783763|NCT03952039|467175799|FG000|Overall Study|Lack of Efficacy|12|||
129783764|NCT03952039|467175800|FG001|Overall Study|Lack of Efficacy|2|||
129783765|NCT03952039|467175799|FG000|Overall Study|Physician Decision|9|||
129783766|NCT03952039|467175800|FG001|Overall Study|Physician Decision|3|||
129783767|NCT03952039|467175799|FG000|Overall Study|Progressive Disease|6|||
129783768|NCT03952039|467175800|FG001|Overall Study|Progressive Disease|4|||
129783769|NCT03952039|467175799|FG000|Overall Study|Other Reasons|12|||
129783770|NCT03952039|467175800|FG001|Overall Study|Other Reasons|4|||
129783771|NCT05009979|467175801|FG000|Overall Study|Withdrawal by Subject|1|||
129783772|NCT01888432|467177452|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
129783773|NCT01888432|467177453|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
129575123|NCT00777023|466402440|FG002|Overall Study|Missing data|0|||
129575124|NCT00777023|466402438|FG000|Overall Study|Reasons not specified|4|||
129575125|NCT00777023|466402439|FG001|Overall Study|Reasons not specified|4|||
129575126|NCT00777023|466402440|FG002|Overall Study|Reasons not specified|2|||
129575127|NCT00777023|466402438|FG000|Overall Study|Last dose date unknown|3|||
129575128|NCT00777023|466402439|FG001|Overall Study|Last dose date unknown|3|||
129575129|NCT00777023|466402440|FG002|Overall Study|Last dose date unknown|1|||
129693877|NCT01313676|466837425|FG002|Overall Study|Adverse Event|372|||
129693878|NCT01313676|466837426|FG003|Overall Study|Adverse Event|333|||
129693879|NCT01313676|466837423|FG000|Overall Study|Lack of Efficacy|98|||
129693880|NCT01313676|466837424|FG001|Overall Study|Lack of Efficacy|90|||
129693881|NCT01313676|466837425|FG002|Overall Study|Lack of Efficacy|65|||
129693882|NCT01313676|466837426|FG003|Overall Study|Lack of Efficacy|46|||
129693883|NCT01313676|466837423|FG000|Overall Study|Protocol Violation|37|||
129693884|NCT01313676|466837424|FG001|Overall Study|Protocol Violation|44|||
129693885|NCT01313676|466837425|FG002|Overall Study|Protocol Violation|46|||
129693886|NCT01313676|466837426|FG003|Overall Study|Protocol Violation|44|||
129693887|NCT01313676|466837423|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
129693888|NCT01313676|466837424|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
129693889|NCT01313676|466837425|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
129693890|NCT01313676|466837426|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
129693891|NCT01313676|466837423|FG000|Overall Study|Study Closed/terminated|7|||
129693892|NCT01313676|466837424|FG001|Overall Study|Study Closed/terminated|6|||
129693893|NCT01313676|466837425|FG002|Overall Study|Study Closed/terminated|9|||
129693894|NCT01313676|466837426|FG003|Overall Study|Study Closed/terminated|9|||
129693895|NCT01313676|466837423|FG000|Overall Study|Lost to Follow-up|0|||
129693896|NCT01313676|466837424|FG001|Overall Study|Lost to Follow-up|0|||
129693897|NCT01313676|466837425|FG002|Overall Study|Lost to Follow-up|1|||
129693898|NCT01313676|466837426|FG003|Overall Study|Lost to Follow-up|0|||
129783774|NCT01888432|467177452|FG000|12-month Analysis (FAS)|Physician Decision|1|||
129783775|NCT01888432|467177453|FG001|12-month Analysis (FAS)|Physician Decision|1|||
129783776|NCT01888432|467177452|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
129575130|NCT02659150|466402443|FG000|Subject Enrollment|Physician Decision|3|||
129575131|NCT02659150|466402443|FG000|Subject Enrollment|Withdrawal by Subject|2|||
129575132|NCT02659150|466402443|FG000|Baseline Imaging|Withdrawal by Subject|1|||
129693899|NCT01313676|466837423|FG000|Overall Study|Physician Decision|53|||
129575133|NCT02659150|466402443|FG000|Baseline Imaging|Physician Decision|1|||
129575134|NCT02659150|466402443|FG000|Study Drug Dosing|Adverse Event|1|||
129575135|NCT01200810|466402448|FG000|Overall Study|Physician Decision|1|||
129575136|NCT01200810|466402449|FG001|Overall Study|Physician Decision|0|||
129575137|NCT01200810|466402448|FG000|Overall Study|Withdrawal by Subject|1|||
129575138|NCT01200810|466402449|FG001|Overall Study|Withdrawal by Subject|2|||
129575139|NCT01200810|466402448|FG000|Overall Study|Sponsor stopped making study drug|3|||
129575140|NCT01200810|466402449|FG001|Overall Study|Sponsor stopped making study drug|3|||
129575141|NCT00960297|466402451|FG000|Overall Study|Physician Decision|1|||
129575142|NCT00960297|466402451|FG000|Overall Study|Venous port infection|1|||
129575143|NCT00960297|466402451|FG000|Overall Study|Disease progression|1|||
129575144|NCT03965091|466402459|FG000|Overall Study|Adverse Event|0|||
129575145|NCT03965091|466402460|FG001|Overall Study|Adverse Event|2|||
129575146|NCT03965091|466402461|FG002|Overall Study|Adverse Event|3|||
129575147|NCT03965091|466402459|FG000|Overall Study|Withdrawal by Subject|11|||
129575148|NCT03965091|466402460|FG001|Overall Study|Withdrawal by Subject|3|||
129575149|NCT03965091|466402461|FG002|Overall Study|Withdrawal by Subject|5|||
129783777|NCT01888432|467177453|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
129783778|NCT01888432|467177452|FG000|12-month Analysis (FAS)|Death|4|||
129783779|NCT01888432|467177453|FG001|12-month Analysis (FAS)|Death|3|||
129783780|NCT01888432|467177452|FG000|24-month Analysis (FAS)|Graft loss|0|||
129783781|NCT01888432|467177453|FG001|24-month Analysis (FAS)|Graft loss|1|||
129575150|NCT03965091|466402459|FG000|Overall Study|Non-compliance with study drug|0|||
129575151|NCT03965091|466402460|FG001|Overall Study|Non-compliance with study drug|0|||
129575152|NCT03965091|466402461|FG002|Overall Study|Non-compliance with study drug|1|||
129575153|NCT03965091|466402459|FG000|Overall Study|Lost to Follow-up|1|||
129575154|NCT03965091|466402460|FG001|Overall Study|Lost to Follow-up|1|||
129783782|NCT01888432|467177452|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
129575155|NCT03965091|466402461|FG002|Overall Study|Lost to Follow-up|1|||
129575156|NCT03965091|466402459|FG000|Overall Study|Lack of Efficacy|2|||
129575157|NCT03965091|466402460|FG001|Overall Study|Lack of Efficacy|0|||
129693900|NCT01313676|466837424|FG001|Overall Study|Physician Decision|64|||
129693901|NCT01313676|466837425|FG002|Overall Study|Physician Decision|62|||
129575158|NCT03965091|466402461|FG002|Overall Study|Lack of Efficacy|0|||
129693902|NCT01313676|466837426|FG003|Overall Study|Physician Decision|48|||
129693903|NCT01313676|466837423|FG000|Overall Study|Decision by Participant or Proxy|643|||
129693904|NCT01313676|466837424|FG001|Overall Study|Decision by Participant or Proxy|527|||
129693905|NCT01313676|466837425|FG002|Overall Study|Decision by Participant or Proxy|515|||
129693906|NCT01313676|466837426|FG003|Overall Study|Decision by Participant or Proxy|492|||
129693907|NCT01313676|466837423|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
129693908|NCT01313676|466837424|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
129693909|NCT01313676|466837425|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
129693910|NCT01313676|466837426|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
129693911|NCT01313676|466837423|FG000|Overall Study|Investigator Site Closed|12|||
129693912|NCT01313676|466837424|FG001|Overall Study|Investigator Site Closed|11|||
129693913|NCT01313676|466837425|FG002|Overall Study|Investigator Site Closed|15|||
129693914|NCT01313676|466837426|FG003|Overall Study|Investigator Site Closed|10|||
129693915|NCT01313676|466837423|FG000|Overall Study|Missing|1|||
129693916|NCT01313676|466837424|FG001|Overall Study|Missing|1|||
129693917|NCT01313676|466837425|FG002|Overall Study|Missing|1|||
129575159|NCT03965091|466402459|FG000|Overall Study|Other than specified|9|||
129693918|NCT01313676|466837426|FG003|Overall Study|Missing|0|||
129693919|NCT03312114|466837427|FG000|Overall Study|All the five enrolled dropped out of the|5|||
129693920|NCT00944645|466837428|FG000|Period 2|Adverse Event|1|||
129693921|NCT00944645|466837429|FG001|Period 2|Adverse Event|0|||
129575160|NCT03965091|466402460|FG001|Overall Study|Other than specified|11|||
129783783|NCT01888432|467177453|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
129783784|NCT01888432|467177452|FG000|24-month Analysis (FAS)|Physician Decision|2|||
129783785|NCT01888432|467177453|FG001|24-month Analysis (FAS)|Physician Decision|4|||
129783786|NCT01888432|467177452|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
129783787|NCT01888432|467177453|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
129783788|NCT01888432|467177452|FG000|24-month Analysis (FAS)|Death|8|||
129783789|NCT01888432|467177453|FG001|24-month Analysis (FAS)|Death|4|||
129783790|NCT01888432|467177452|FG000|36-month Analysis (Extension)|Death|1|||
129783791|NCT01888432|467177453|FG001|36-month Analysis (Extension)|Death|0|||
129783792|NCT00130247|467177456|FG000|Overall Study|Pregnancy|1|||
129783793|NCT00130247|467177457|FG001|Overall Study|Pregnancy|0|||
129783794|NCT00130247|467177456|FG000|Overall Study|Post-randomization exclusion|1|||
129783795|NCT00130247|467177457|FG001|Overall Study|Post-randomization exclusion|2|||
129783796|NCT00130247|467177456|FG000|Overall Study|Not compliant with DOT|0|||
129783797|NCT00130247|467177457|FG001|Overall Study|Not compliant with DOT|2|||
129783798|NCT03844945|467177458|FG000|Overall Study|Adverse Event|1|||
129783799|NCT03844945|467177459|FG001|Overall Study|Adverse Event|1|||
129783800|NCT03844945|467177460|FG002|Overall Study|Adverse Event|4|||
129783801|NCT03844945|467177461|FG003|Overall Study|Adverse Event|0|||
129783802|NCT03844945|467177458|FG000|Overall Study|Withdrawal by Subject|0|||
129783803|NCT03844945|467177459|FG001|Overall Study|Withdrawal by Subject|0|||
129693922|NCT00944645|466837428|FG000|Period 2|Lost to Follow-up|0|||
129693923|NCT00944645|466837429|FG001|Period 2|Lost to Follow-up|3|||
129693924|NCT00944645|466837428|FG000|Period 2|Withdrawal by Subject|7|||
129693925|NCT00944645|466837429|FG001|Period 2|Withdrawal by Subject|6|||
129693926|NCT03537729|466837430|FG000|Overall Study|Death|2|||
129693927|NCT03537729|466837431|FG001|Overall Study|Death|2|||
129693928|NCT03537729|466837432|FG002|Overall Study|Death|7|||
129693929|NCT03537729|466837430|FG000|Overall Study|Withdrawal by Subject|3|||
129693930|NCT03537729|466837431|FG001|Overall Study|Withdrawal by Subject|3|||
129693931|NCT03537729|466837432|FG002|Overall Study|Withdrawal by Subject|0|||
129693932|NCT03537729|466837430|FG000|Overall Study|Subject Moved|8|||
129693933|NCT03537729|466837431|FG001|Overall Study|Subject Moved|5|||
129693934|NCT03537729|466837432|FG002|Overall Study|Subject Moved|4|||
129693935|NCT03537729|466837430|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
129693936|NCT03537729|466837431|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
129693937|NCT03537729|466837432|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
129693938|NCT03537729|466837430|FG000|Overall Study|COVID-19 Site Restrictions|11|||
129693939|NCT03537729|466837431|FG001|Overall Study|COVID-19 Site Restrictions|15|||
129693940|NCT03537729|466837432|FG002|Overall Study|COVID-19 Site Restrictions|18|||
129693941|NCT03537729|466837430|FG000|Overall Study|Decline in Health|5|||
129693942|NCT03537729|466837431|FG001|Overall Study|Decline in Health|9|||
129693943|NCT03537729|466837432|FG002|Overall Study|Decline in Health|4|||
129693944|NCT03537729|466837430|FG000|Overall Study|Determined Ineligible|0|||
129693945|NCT03537729|466837431|FG001|Overall Study|Determined Ineligible|0|||
129693946|NCT03537729|466837432|FG002|Overall Study|Determined Ineligible|1|||
129693947|NCT02562040|466837434|FG000|Overall Study|Lost to Follow-up|20|||
129693948|NCT02562040|466837435|FG001|Overall Study|Lost to Follow-up|28|||
129693949|NCT02562040|466837434|FG000|Overall Study|Withdrawal by Subject|8|||
129693950|NCT02562040|466837435|FG001|Overall Study|Withdrawal by Subject|7|||
129693951|NCT02562040|466837434|FG000|Overall Study|Adverse Event|1|||
129693952|NCT02562040|466837435|FG001|Overall Study|Adverse Event|0|||
129693953|NCT01902303|466837436|FG000|Overall Study|Adverse Event|0|||
129783804|NCT03844945|467177460|FG002|Overall Study|Withdrawal by Subject|1|||
129783805|NCT03844945|467177461|FG003|Overall Study|Withdrawal by Subject|0|||
129693954|NCT01902303|466837437|FG001|Overall Study|Adverse Event|1|||
129575161|NCT03965091|466402461|FG002|Overall Study|Other than specified|8|||
129575162|NCT02576938|466402463|FG000|Overall Study|Adverse Event|5|||
129575163|NCT02576938|466402464|FG001|Overall Study|Adverse Event|3|||
129575164|NCT02576938|466402465|FG002|Overall Study|Adverse Event|6|||
129575165|NCT02576938|466402463|FG000|Overall Study|Protocol Violation|1|||
129575166|NCT02576938|466402464|FG001|Overall Study|Protocol Violation|1|||
129575167|NCT02576938|466402465|FG002|Overall Study|Protocol Violation|1|||
129575168|NCT02576938|466402463|FG000|Overall Study|Withdrawal by Subject|3|||
129575169|NCT02576938|466402464|FG001|Overall Study|Withdrawal by Subject|2|||
129575170|NCT02576938|466402465|FG002|Overall Study|Withdrawal by Subject|4|||
129575171|NCT02576938|466402463|FG000|Overall Study|Lack of Efficacy|9|||
129575172|NCT02576938|466402464|FG001|Overall Study|Lack of Efficacy|4|||
129575173|NCT02576938|466402465|FG002|Overall Study|Lack of Efficacy|0|||
129575174|NCT02576938|466402463|FG000|Overall Study|Lost to Follow-up|2|||
129575175|NCT02576938|466402464|FG001|Overall Study|Lost to Follow-up|0|||
129575176|NCT02576938|466402465|FG002|Overall Study|Lost to Follow-up|1|||
129575177|NCT02576938|466402463|FG000|Overall Study|Physician Decision|0|||
129693955|NCT01902303|466837436|FG000|Overall Study|Lost to Follow-up|0|||
129693956|NCT01902303|466837437|FG001|Overall Study|Lost to Follow-up|1|||
129693957|NCT01902303|466837436|FG000|Overall Study|Protocol Violation|2|||
129693958|NCT01902303|466837437|FG001|Overall Study|Protocol Violation|2|||
129693959|NCT01902303|466837436|FG000|Overall Study|subject lost investigational product|0|||
129693960|NCT01902303|466837437|FG001|Overall Study|subject lost investigational product|1|||
129693961|NCT01902303|466837436|FG000|Overall Study|Did not develop a cold sore|21|||
129693962|NCT01902303|466837437|FG001|Overall Study|Did not develop a cold sore|19|||
129693963|NCT02821000|466837438|FG000|Overall Study|Death|89|||
129693964|NCT02821000|466837438|FG000|Overall Study|Sponsor Decision|12|||
129693965|NCT02821000|466837438|FG000|Overall Study|Withdrawal by Subject|2|||
129693966|NCT04359680|466837439|FG000|Overall Study|Withdrawal by Subject|29|||
129693967|NCT04359680|466837440|FG001|Overall Study|Withdrawal by Subject|24|||
129693968|NCT04359680|466837439|FG000|Overall Study|Adverse Event|6|||
129693969|NCT04359680|466837440|FG001|Overall Study|Adverse Event|2|||
129693970|NCT04359680|466837439|FG000|Overall Study|Lost to Follow-up|56|||
129575178|NCT02576938|466402464|FG001|Overall Study|Physician Decision|1|||
129575179|NCT02576938|466402465|FG002|Overall Study|Physician Decision|0|||
129575180|NCT02576938|466402463|FG000|Overall Study|Met Exclusion Criteria|0|||
129575181|NCT02576938|466402464|FG001|Overall Study|Met Exclusion Criteria|1|||
129575182|NCT02576938|466402465|FG002|Overall Study|Met Exclusion Criteria|0|||
129575183|NCT03500341|466402466|FG000|Overall Study|Withdrawn prior to Completion|2|||
129575184|NCT00838630|466402470|FG000|First Intervention|Adverse Event|1|||
129575185|NCT00838630|466402471|FG001|First Intervention|Adverse Event|0|||
129575186|NCT00838630|466402470|FG000|Washout: 7 Days|Protocol Violation|1|||
129575187|NCT00838630|466402471|FG001|Washout: 7 Days|Protocol Violation|0|||
129575188|NCT02159950|466402485|FG000|Overall Study|Adverse Event|0|||
129575189|NCT02159950|466402486|FG001|Overall Study|Adverse Event|1|||
129575190|NCT02159950|466402485|FG000|Overall Study|Progression|0|||
129575191|NCT02159950|466402486|FG001|Overall Study|Progression|1|||
129575192|NCT00003659|466402487|FG000|Overall Study|Withdrawal by Subject|3|||
129575193|NCT04022954|466402488|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
129575194|NCT04022954|466402488|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
129575195|NCT04022954|466402488|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
129575196|NCT03017885|466402489|FG000|Overall Study|Adverse Event|2|||
129575197|NCT03017885|466402490|FG001|Overall Study|Adverse Event|0|||
129575198|NCT03017885|466402491|FG002|Overall Study|Adverse Event|0|||
129575199|NCT03017885|466402492|FG003|Overall Study|Adverse Event|0|||
129575200|NCT03017885|466402493|FG004|Overall Study|Adverse Event|0|||
129575201|NCT03017885|466402494|FG005|Overall Study|Adverse Event|0|||
129575202|NCT03017885|466402489|FG000|Overall Study|Progression of disease|4|||
129575203|NCT03017885|466402490|FG001|Overall Study|Progression of disease|3|||
129575204|NCT03017885|466402491|FG002|Overall Study|Progression of disease|4|||
129575205|NCT03017885|466402492|FG003|Overall Study|Progression of disease|0|||
129575206|NCT03017885|466402493|FG004|Overall Study|Progression of disease|0|||
129575207|NCT03017885|466402494|FG005|Overall Study|Progression of disease|0|||
129575208|NCT03017885|466402489|FG000|Overall Study|Other than listed|1|||
129575209|NCT03017885|466402490|FG001|Overall Study|Other than listed|2|||
129575210|NCT03017885|466402491|FG002|Overall Study|Other than listed|1|||
129575211|NCT03017885|466402492|FG003|Overall Study|Other than listed|0|||
129575212|NCT03017885|466402493|FG004|Overall Study|Other than listed|0|||
129575213|NCT03017885|466402494|FG005|Overall Study|Other than listed|0|||
129575214|NCT03017885|466402489|FG000|Overall Study|Lost to Follow-up|2|||
129575215|NCT03017885|466402490|FG001|Overall Study|Lost to Follow-up|0|||
129575216|NCT03017885|466402491|FG002|Overall Study|Lost to Follow-up|3|||
129575217|NCT03017885|466402492|FG003|Overall Study|Lost to Follow-up|0|||
129575218|NCT03017885|466402493|FG004|Overall Study|Lost to Follow-up|0|||
129575219|NCT03017885|466402494|FG005|Overall Study|Lost to Follow-up|0|||
129575220|NCT03017885|466402489|FG000|Overall Study|Change to other anti-cancer therapy|0|||
129575221|NCT03017885|466402490|FG001|Overall Study|Change to other anti-cancer therapy|0|||
129575222|NCT03017885|466402491|FG002|Overall Study|Change to other anti-cancer therapy|1|||
129575223|NCT03017885|466402492|FG003|Overall Study|Change to other anti-cancer therapy|0|||
129575224|NCT03017885|466402493|FG004|Overall Study|Change to other anti-cancer therapy|0|||
129783806|NCT03844945|467177458|FG000|Overall Study|Lack of Efficacy|0|||
129693971|NCT04359680|466837440|FG001|Overall Study|Lost to Follow-up|59|||
129693972|NCT04359680|466837439|FG000|Overall Study|Protocol Violation|3|||
129693973|NCT04359680|466837440|FG001|Overall Study|Protocol Violation|5|||
129693974|NCT04359680|466837439|FG000|Overall Study|Physician Decision|1|||
129693975|NCT04359680|466837440|FG001|Overall Study|Physician Decision|1|||
129693976|NCT04359680|466837439|FG000|Overall Study|Sponsor Decision|0|||
129693977|NCT04359680|466837440|FG001|Overall Study|Sponsor Decision|1|||
129693978|NCT01654250|466837441|FG000|Overall Study|Lost to Follow-up|1|||
129693979|NCT01654250|466837442|FG001|Overall Study|Lost to Follow-up|0|||
129693980|NCT01862029|466837443|FG000|Overall Study|Physician Decision|1|||
129693981|NCT01530256|466837445|FG000|Overall Study|Death|2|||
129575225|NCT03017885|466402494|FG005|Overall Study|Change to other anti-cancer therapy|0|||
129575226|NCT03925532|466402495|FG000|Overall Study|Lost to Follow-up|1|||
129575227|NCT01208337|466402496|FG000|Overall Study|Death|3|||
129575228|NCT03663179|466402500|FG000|Overall Study|Withdrawal by Subject|2|||
129575229|NCT03663179|466402501|FG001|Overall Study|Withdrawal by Subject|0|||
129575230|NCT03663179|466402500|FG000|Overall Study|Lost to Follow-up|1|||
129783807|NCT03844945|467177459|FG001|Overall Study|Lack of Efficacy|0|||
129783808|NCT03844945|467177460|FG002|Overall Study|Lack of Efficacy|0|||
129783809|NCT03844945|467177461|FG003|Overall Study|Lack of Efficacy|1|||
129783810|NCT04473235|467177464|FG000|Overall Study|Lost to Follow-up|6|||
129783811|NCT04473235|467177465|FG001|Overall Study|Lost to Follow-up|5|||
129783812|NCT04473235|467177464|FG000|Overall Study|Declined continuation|2|||
129783813|NCT04473235|467177465|FG001|Overall Study|Declined continuation|0|||
129783814|NCT04473235|467177464|FG000|Overall Study|Physician Decision|1|||
129783815|NCT04473235|467177465|FG001|Overall Study|Physician Decision|1|||
129783816|NCT04473235|467177464|FG000|Overall Study|Protocol Violation|10|||
129783817|NCT04473235|467177465|FG001|Overall Study|Protocol Violation|6|||
129783818|NCT01754402|467177466|FG000|Overall Study|Death|0|||
129783819|NCT01754402|467177467|FG001|Overall Study|Death|0|||
129783820|NCT01754402|467177468|FG002|Overall Study|Death|1|||
129783821|NCT01754402|467177466|FG000|Overall Study|Adverse Event|2|||
129783822|NCT01754402|467177467|FG001|Overall Study|Adverse Event|2|||
129783823|NCT01754402|467177468|FG002|Overall Study|Adverse Event|1|||
129783824|NCT01754402|467177466|FG000|Overall Study|Withdrawal by Subject|0|||
129783825|NCT01754402|467177467|FG001|Overall Study|Withdrawal by Subject|0|||
129783826|NCT01754402|467177468|FG002|Overall Study|Withdrawal by Subject|1|||
129783827|NCT01754402|467177466|FG000|Overall Study|Lack of Efficacy|0|||
129783828|NCT01754402|467177467|FG001|Overall Study|Lack of Efficacy|0|||
129783829|NCT01754402|467177468|FG002|Overall Study|Lack of Efficacy|1|||
129783830|NCT01282463|467177469|FG000|Overall Study|Lost to Follow-up|1|||
129783831|NCT01282463|467177470|FG001|Overall Study|Lost to Follow-up|0|||
129783832|NCT01282463|467177471|FG002|Overall Study|Lost to Follow-up|0|||
129783833|NCT01282463|467177469|FG000|Overall Study|Withdrawal by Subject|6|||
129783834|NCT01282463|467177470|FG001|Overall Study|Withdrawal by Subject|2|||
129783835|NCT01282463|467177471|FG002|Overall Study|Withdrawal by Subject|3|||
129783836|NCT01282463|467177469|FG000|Overall Study|"Never Treated Death"|0|||
129783837|NCT01282463|467177470|FG001|Overall Study|"Never Treated Death"|1|||
129575231|NCT03663179|466402501|FG001|Overall Study|Lost to Follow-up|1|||
129783838|NCT01282463|467177471|FG002|Overall Study|"Never Treated Death"|0|||
129783839|NCT01282463|467177469|FG000|Overall Study|"Never Treated PD"|0|||
129783840|NCT01282463|467177470|FG001|Overall Study|"Never Treated PD"|1|||
129783841|NCT01282463|467177471|FG002|Overall Study|"Never Treated PD"|0|||
129783842|NCT01282463|467177469|FG000|Overall Study|Protocol Violation|0|||
129783843|NCT01282463|467177470|FG001|Overall Study|Protocol Violation|0|||
129783844|NCT01282463|467177471|FG002|Overall Study|Protocol Violation|1|||
129783845|NCT01282463|467177469|FG000|Overall Study|Physician Decision|1|||
129783846|NCT01282463|467177470|FG001|Overall Study|Physician Decision|0|||
129783847|NCT01282463|467177471|FG002|Overall Study|Physician Decision|0|||
129575232|NCT03663179|466402500|FG000|Overall Study|Revealed exclusionary condition|1|||
129575233|NCT03663179|466402501|FG001|Overall Study|Revealed exclusionary condition|0|||
129575234|NCT01615198|466402502|FG000|Overall Study|Withdrawal by Subject|5|||
129783848|NCT02051933|467177474|FG000|Overall Study|Physician Decision|0|||
129783849|NCT02051933|467177475|FG001|Overall Study|Physician Decision|1|||
129783850|NCT02123251|467177476|FG000|Overall Study|Death|1|||
129783851|NCT02123251|467177477|FG001|Overall Study|Death|1|||
129783852|NCT02123251|467177476|FG000|Overall Study|Withdrawal by Subject|0|||
129783853|NCT02123251|467177477|FG001|Overall Study|Withdrawal by Subject|3|||
129783854|NCT02123251|467177476|FG000|Overall Study|Lost Medicaid eligibility|29|||
129783855|NCT02123251|467177477|FG001|Overall Study|Lost Medicaid eligibility|22|||
129783856|NCT02123251|467177476|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
129783857|NCT02123251|467177477|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
129783858|NCT01221285|467177478|FG000|Overall Study|Withdrawal by Subject|1|||
129783859|NCT00588861|467177482|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
129783860|NCT00588861|467177483|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
129783861|NCT00588861|467177482|FG000|6 Months|Patients did not return for follow-up|98|||
129783862|NCT00588861|467177483|FG001|6 Months|Patients did not return for follow-up|73|||
129783863|NCT00588861|467177482|FG000|1 Year|Patients did not return for follow-up|89|||
129783864|NCT00588861|467177483|FG001|1 Year|Patients did not return for follow-up|82|||
129783865|NCT00588861|467177482|FG000|2 Years|Patients did not return for follow-up|92|||
129783866|NCT00588861|467177483|FG001|2 Years|Patients did not return for follow-up|87|||
129783867|NCT00588861|467177482|FG000|4 Years|Patients did not return for follow-up|91|||
129783868|NCT00588861|467177483|FG001|4 Years|Patients did not return for follow-up|103|||
129783869|NCT00588861|467177482|FG000|6 Years|Patients did not return for follow-up|104|||
129783870|NCT00588861|467177483|FG001|6 Years|Patients did not return for follow-up|109|||
129783871|NCT00588861|467177482|FG000|8 Years|Patients did not return for follow-up|105|||
129783872|NCT00588861|467177483|FG001|8 Years|Patients did not return for follow-up|114|||
129783873|NCT00588861|467177482|FG000|10 Years|Incomplete due to study termination|107|||
129783874|NCT00588861|467177483|FG001|10 Years|Incomplete due to study termination|114|||
129783875|NCT01239992|467177484|FG000|Overall Study|Withdrawal by Subject|2|||
129783876|NCT02848729|467177487|FG000|Overall Study|Withdrawal by Subject|1|||
129783877|NCT02848729|467177488|FG001|Overall Study|Withdrawal by Subject|0|||
129783878|NCT02848729|467177487|FG000|Overall Study|Emesis|15|||
129783879|NCT02848729|467177488|FG001|Overall Study|Emesis|11|||
129783880|NCT00791076|467177489|FG000|Overall Study|Study was terminated,PI left institution|8|||
129783881|NCT02052414|467177492|FG000|Overall Study|Adverse Event|12|||
129783882|NCT02052414|467177492|FG000|Overall Study|Lack of Efficacy|2|||
129783883|NCT02052414|467177492|FG000|Overall Study|Withdrawal by Subject|3|||
129575235|NCT01615198|466402503|FG001|Overall Study|Withdrawal by Subject|5|||
129575236|NCT01615198|466402502|FG000|Overall Study|Protocol deviation|1|||
129575237|NCT01615198|466402503|FG001|Overall Study|Protocol deviation|1|||
129783884|NCT02704143|467177495|FG000|Overall Study|disease progression|10|||
129783885|NCT02151773|467177496|FG000|Overall Study|Protocol Deviation|64|||
129783886|NCT00395343|467177497|FG000|Overall Study|Adverse Event|13|||
129575238|NCT01615198|466402502|FG000|Overall Study|Physician Decision|5|||
129783887|NCT00395343|467177498|FG001|Overall Study|Adverse Event|5|||
129783888|NCT00395343|467177497|FG000|Overall Study|Lack of Efficacy|0|||
129783889|NCT00395343|467177498|FG001|Overall Study|Lack of Efficacy|1|||
129783890|NCT00395343|467177497|FG000|Overall Study|Lost to Follow-up|4|||
129783891|NCT00395343|467177498|FG001|Overall Study|Lost to Follow-up|4|||
129575239|NCT01615198|466402503|FG001|Overall Study|Physician Decision|1|||
129783892|NCT00395343|467177497|FG000|Overall Study|Physician Decision|2|||
129783893|NCT00395343|467177498|FG001|Overall Study|Physician Decision|4|||
129783894|NCT00395343|467177497|FG000|Overall Study|Protocol Violation|6|||
129783895|NCT00395343|467177498|FG001|Overall Study|Protocol Violation|8|||
129783896|NCT00395343|467177497|FG000|Overall Study|Withdrawal by Subject|11|||
129783897|NCT00395343|467177498|FG001|Overall Study|Withdrawal by Subject|12|||
129783898|NCT00395343|467177497|FG000|Overall Study|Other|5|||
129783899|NCT00395343|467177498|FG001|Overall Study|Other|2|||
129783900|NCT04605991|467177501|FG000|Overall Study|Adverse Event|5|||
129783901|NCT04605991|467177501|FG000|Overall Study|Lack of Efficacy|1|||
129783902|NCT04605991|467177501|FG000|Overall Study|Lost to Follow-up|8|||
129783903|NCT04605991|467177501|FG000|Overall Study|Physician Decision|4|||
129783904|NCT04605991|467177501|FG000|Overall Study|Withdrawal by Subject|14|||
129783905|NCT04605991|467177501|FG000|Overall Study|Non-compliance with study|1|||
129783906|NCT03263702|467177502|FG000|Overall Study|Lost to Follow-up|2|||
129783907|NCT03263702|467177503|FG001|Overall Study|Lost to Follow-up|2|||
129783908|NCT03263702|467177502|FG000|Overall Study|Withdrawal by Subject|1|||
129783909|NCT03263702|467177503|FG001|Overall Study|Withdrawal by Subject|2|||
129783910|NCT00966875|467177505|FG000|Part A|Adverse Event|2|||
129783911|NCT00966875|467177506|FG001|Part A|Adverse Event|1|||
129783912|NCT00966875|467177507|FG002|Part A|Adverse Event|0|||
129783913|NCT00966875|467177508|FG003|Part A|Adverse Event|1|||
129575240|NCT01615198|466402502|FG000|Overall Study|Lost to Follow-up|1|||
129575241|NCT01615198|466402503|FG001|Overall Study|Lost to Follow-up|1|||
129575242|NCT01615198|466402502|FG000|Overall Study|Lack of Efficacy|1|||
129575243|NCT01615198|466402503|FG001|Overall Study|Lack of Efficacy|6|||
129575244|NCT01615198|466402502|FG000|Overall Study|Adverse Event|11|||
129575245|NCT01615198|466402503|FG001|Overall Study|Adverse Event|5|||
129575246|NCT02414152|466402504|FG000|Overall Study|Withdrawal by Subject|1|||
129575247|NCT02414152|466402504|FG000|Overall Study|Lack of Efficacy|1|||
129575248|NCT01289262|466402505|FG000|Overall Study|Lost to Follow-up|29|||
129575249|NCT01289262|466402506|FG001|Overall Study|Lost to Follow-up|16|||
129575250|NCT01289262|466402505|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
129783914|NCT00966875|467177509|FG004|Part A|Adverse Event|0|||
129783915|NCT00966875|467177510|FG005|Part A|Adverse Event|1|||
129783916|NCT00966875|467177511|FG006|Part A|Adverse Event|0|||
129575251|NCT01289262|466402506|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
129575252|NCT00838279|466402507|FG000|Washout|Protocol Violation|1|||
129575253|NCT00838279|466402508|FG001|Washout|Protocol Violation|0|||
129783917|NCT00966875|467177512|FG007|Part A|Adverse Event|3|||
129783918|NCT00966875|467177513|FG008|Part A|Adverse Event|3|||
129783919|NCT00966875|467177505|FG000|Part A|Entry Criteria|0|||
129783920|NCT00966875|467177506|FG001|Part A|Entry Criteria|0|||
129783921|NCT00966875|467177507|FG002|Part A|Entry Criteria|0|||
129783922|NCT00966875|467177508|FG003|Part A|Entry Criteria|0|||
129783923|NCT00966875|467177509|FG004|Part A|Entry Criteria|0|||
129783924|NCT00966875|467177510|FG005|Part A|Entry Criteria|2|||
129783925|NCT00966875|467177511|FG006|Part A|Entry Criteria|0|||
129783926|NCT00966875|467177512|FG007|Part A|Entry Criteria|0|||
129575254|NCT00838279|466402507|FG000|Washout|Withdrawal by Subject|0|||
129693982|NCT02004275|466837446|FG000|Phase 1|Ineligible|0|||
129693983|NCT02004275|466837447|FG001|Phase 1|Ineligible|0|||
129693984|NCT02004275|466837448|FG002|Phase 1|Ineligible|0|||
129693985|NCT02004275|466837449|FG003|Phase 1|Ineligible|1|||
129693986|NCT02004275|466837450|FG004|Phase 1|Ineligible|1|||
129693987|NCT02004275|466837451|FG005|Phase 1|Ineligible|0|||
129693988|NCT02004275|466837446|FG000|Phase 1|Protocol Violation|0|||
129693989|NCT02004275|466837447|FG001|Phase 1|Protocol Violation|0|||
129693990|NCT02004275|466837448|FG002|Phase 1|Protocol Violation|0|||
129693991|NCT02004275|466837449|FG003|Phase 1|Protocol Violation|1|||
129693992|NCT02004275|466837450|FG004|Phase 1|Protocol Violation|0|||
129693993|NCT02004275|466837451|FG005|Phase 1|Protocol Violation|5|||
129693994|NCT02004275|466837446|FG000|Phase 2 Part 1|Ineligible|6|||
129693995|NCT02004275|466837447|FG001|Phase 2 Part 1|Ineligible|9|||
129693996|NCT02004275|466837448|FG002|Phase 2 Part 1|Ineligible|0|||
129693997|NCT02004275|466837449|FG003|Phase 2 Part 1|Ineligible|0|||
129693998|NCT02004275|466837450|FG004|Phase 2 Part 1|Ineligible|0|||
129693999|NCT02004275|466837451|FG005|Phase 2 Part 1|Ineligible|0|||
129694000|NCT02004275|466837446|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
129694001|NCT02004275|466837447|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
129694002|NCT02004275|466837448|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
129694003|NCT02004275|466837449|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
129694004|NCT02004275|466837450|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
129694005|NCT02004275|466837451|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
129694006|NCT02595437|466837453|FG000|Triferic Via IV|Withdrawal by Subject|1|||
129694007|NCT01975285|466837469|FG000|Overall Study|Failed Block and follow up|2|||
129694008|NCT01975285|466837470|FG001|Overall Study|Failed Block and follow up|2|||
129694009|NCT04914000|466837471|FG000|Overall Study|Lost to Follow-up|8|||
129694010|NCT04914000|466837471|FG000|Overall Study|Withdrawal by Subject|1|||
129694011|NCT01429623|466837472|FG000|Overall Study|Death|1|||
129694012|NCT01429623|466837473|FG001|Overall Study|Death|0|||
129694013|NCT01429623|466837472|FG000|Overall Study|Adverse Event|7|||
129694014|NCT01429623|466837473|FG001|Overall Study|Adverse Event|14|||
129694015|NCT01429623|466837472|FG000|Overall Study|Withdrawal by Subject|19|||
129694016|NCT01429623|466837473|FG001|Overall Study|Withdrawal by Subject|13|||
129694017|NCT01429623|466837472|FG000|Overall Study|Physician Decision|2|||
129694018|NCT01429623|466837473|FG001|Overall Study|Physician Decision|3|||
129694019|NCT01429623|466837472|FG000|Overall Study|Protocol Violation|3|||
129694020|NCT01429623|466837473|FG001|Overall Study|Protocol Violation|2|||
129694021|NCT01429623|466837472|FG000|Overall Study|Assorted|1|||
129694022|NCT01429623|466837473|FG001|Overall Study|Assorted|2|||
129694023|NCT01429623|466837472|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
129783927|NCT00966875|467177513|FG008|Part A|Entry Criteria|0|||
129694024|NCT01429623|466837473|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
129783928|NCT00966875|467177505|FG000|Part A|Lack of Efficacy|0|||
129783929|NCT00966875|467177506|FG001|Part A|Lack of Efficacy|1|||
129694025|NCT01429623|466837472|FG000|Overall Study|No post baseline data|4|||
129694026|NCT01429623|466837473|FG001|Overall Study|No post baseline data|4|||
129694027|NCT01750281|466837474|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
129694028|NCT01750281|466837475|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
129694029|NCT01750281|466837476|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
129694030|NCT01750281|466837474|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
129783930|NCT00966875|467177507|FG002|Part A|Lack of Efficacy|0|||
129783931|NCT00966875|467177508|FG003|Part A|Lack of Efficacy|0|||
129783932|NCT00966875|467177509|FG004|Part A|Lack of Efficacy|0|||
129783933|NCT00966875|467177510|FG005|Part A|Lack of Efficacy|0|||
129783934|NCT00966875|467177511|FG006|Part A|Lack of Efficacy|4|||
129783935|NCT00966875|467177512|FG007|Part A|Lack of Efficacy|0|||
129783936|NCT00966875|467177513|FG008|Part A|Lack of Efficacy|0|||
129783937|NCT00966875|467177505|FG000|Part A|Lost to Follow-up|2|||
129783938|NCT00966875|467177506|FG001|Part A|Lost to Follow-up|0|||
129783939|NCT00966875|467177507|FG002|Part A|Lost to Follow-up|0|||
129783940|NCT00966875|467177508|FG003|Part A|Lost to Follow-up|0|||
129783941|NCT00966875|467177509|FG004|Part A|Lost to Follow-up|0|||
129783942|NCT00966875|467177510|FG005|Part A|Lost to Follow-up|1|||
129783943|NCT00966875|467177511|FG006|Part A|Lost to Follow-up|0|||
129783944|NCT00966875|467177512|FG007|Part A|Lost to Follow-up|0|||
129783945|NCT00966875|467177513|FG008|Part A|Lost to Follow-up|0|||
129783946|NCT00966875|467177505|FG000|Part A|Parent/Caregiver Decision|0|||
129783947|NCT00966875|467177506|FG001|Part A|Parent/Caregiver Decision|0|||
129783948|NCT00966875|467177507|FG002|Part A|Parent/Caregiver Decision|0|||
129783949|NCT00966875|467177508|FG003|Part A|Parent/Caregiver Decision|1|||
129783950|NCT00966875|467177509|FG004|Part A|Parent/Caregiver Decision|0|||
129783951|NCT00966875|467177510|FG005|Part A|Parent/Caregiver Decision|0|||
129783952|NCT00966875|467177511|FG006|Part A|Parent/Caregiver Decision|0|||
129783953|NCT00966875|467177512|FG007|Part A|Parent/Caregiver Decision|0|||
129783954|NCT00966875|467177513|FG008|Part A|Parent/Caregiver Decision|0|||
129783955|NCT00966875|467177505|FG000|Part A|Physician Decision|0|||
129783956|NCT00966875|467177506|FG001|Part A|Physician Decision|0|||
129783957|NCT00966875|467177507|FG002|Part A|Physician Decision|0|||
129783958|NCT00966875|467177508|FG003|Part A|Physician Decision|0|||
129783959|NCT00966875|467177509|FG004|Part A|Physician Decision|1|||
129783960|NCT00966875|467177510|FG005|Part A|Physician Decision|0|||
129783961|NCT00966875|467177511|FG006|Part A|Physician Decision|1|||
129783962|NCT00966875|467177512|FG007|Part A|Physician Decision|0|||
129783963|NCT00966875|467177513|FG008|Part A|Physician Decision|2|||
129783964|NCT00966875|467177505|FG000|Part A|Sponsor Decision|0|||
129783965|NCT00966875|467177506|FG001|Part A|Sponsor Decision|0|||
129783966|NCT00966875|467177507|FG002|Part A|Sponsor Decision|1|||
129783967|NCT00966875|467177508|FG003|Part A|Sponsor Decision|0|||
129783968|NCT00966875|467177509|FG004|Part A|Sponsor Decision|1|||
129783969|NCT00966875|467177510|FG005|Part A|Sponsor Decision|0|||
129783970|NCT00966875|467177511|FG006|Part A|Sponsor Decision|0|||
129783971|NCT00966875|467177512|FG007|Part A|Sponsor Decision|2|||
129783972|NCT00966875|467177513|FG008|Part A|Sponsor Decision|1|||
129783973|NCT00966875|467177505|FG000|Part A|Withdrawal by Subject|2|||
129783974|NCT00966875|467177506|FG001|Part A|Withdrawal by Subject|2|||
129783975|NCT00966875|467177507|FG002|Part A|Withdrawal by Subject|1|||
129783976|NCT00966875|467177508|FG003|Part A|Withdrawal by Subject|1|||
129783977|NCT00966875|467177509|FG004|Part A|Withdrawal by Subject|3|||
129783978|NCT00966875|467177510|FG005|Part A|Withdrawal by Subject|0|||
129783979|NCT00966875|467177511|FG006|Part A|Withdrawal by Subject|5|||
129783980|NCT00966875|467177512|FG007|Part A|Withdrawal by Subject|1|||
129783981|NCT00966875|467177513|FG008|Part A|Withdrawal by Subject|1|||
129783982|NCT00966875|467177505|FG000|Part A|Protocol Violation|0|||
129783983|NCT00966875|467177506|FG001|Part A|Protocol Violation|0|||
129783984|NCT00966875|467177507|FG002|Part A|Protocol Violation|0|||
129783985|NCT00966875|467177508|FG003|Part A|Protocol Violation|0|||
129783986|NCT00966875|467177509|FG004|Part A|Protocol Violation|0|||
129783987|NCT00966875|467177510|FG005|Part A|Protocol Violation|0|||
129783988|NCT00966875|467177511|FG006|Part A|Protocol Violation|2|||
129783989|NCT00966875|467177512|FG007|Part A|Protocol Violation|1|||
129783990|NCT00966875|467177513|FG008|Part A|Protocol Violation|1|||
129783991|NCT00966875|467177505|FG000|Part B|Adverse Event|0|||
129783992|NCT00966875|467177506|FG001|Part B|Adverse Event|1|||
129783993|NCT00966875|467177507|FG002|Part B|Adverse Event|1|||
129783994|NCT00966875|467177508|FG003|Part B|Adverse Event|0|||
129783995|NCT00966875|467177509|FG004|Part B|Adverse Event|1|||
129783996|NCT00966875|467177510|FG005|Part B|Adverse Event|0|||
129783997|NCT00966875|467177511|FG006|Part B|Adverse Event|5|||
129783998|NCT00966875|467177512|FG007|Part B|Adverse Event|2|||
129783999|NCT00966875|467177513|FG008|Part B|Adverse Event|2|||
129784000|NCT00966875|467177505|FG000|Part B|Death|0|||
129784001|NCT00966875|467177506|FG001|Part B|Death|0|||
129784002|NCT00966875|467177507|FG002|Part B|Death|1|||
129784003|NCT00966875|467177508|FG003|Part B|Death|0|||
129784004|NCT00966875|467177509|FG004|Part B|Death|0|||
129784005|NCT00966875|467177510|FG005|Part B|Death|0|||
129784006|NCT00966875|467177511|FG006|Part B|Death|0|||
129784007|NCT00966875|467177512|FG007|Part B|Death|1|||
129784008|NCT00966875|467177513|FG008|Part B|Death|0|||
129784009|NCT00966875|467177505|FG000|Part B|Lack of Efficacy|2|||
129784010|NCT00966875|467177506|FG001|Part B|Lack of Efficacy|1|||
129784011|NCT00966875|467177507|FG002|Part B|Lack of Efficacy|1|||
129784012|NCT00966875|467177508|FG003|Part B|Lack of Efficacy|1|||
129784013|NCT00966875|467177509|FG004|Part B|Lack of Efficacy|2|||
129784014|NCT00966875|467177510|FG005|Part B|Lack of Efficacy|3|||
129784015|NCT00966875|467177511|FG006|Part B|Lack of Efficacy|12|||
129784016|NCT00966875|467177512|FG007|Part B|Lack of Efficacy|9|||
129784017|NCT00966875|467177513|FG008|Part B|Lack of Efficacy|6|||
129784018|NCT00966875|467177505|FG000|Part B|Lost to Follow-up|0|||
129784019|NCT00966875|467177506|FG001|Part B|Lost to Follow-up|0|||
129784020|NCT00966875|467177507|FG002|Part B|Lost to Follow-up|0|||
129784021|NCT00966875|467177508|FG003|Part B|Lost to Follow-up|1|||
129784022|NCT00966875|467177509|FG004|Part B|Lost to Follow-up|0|||
129784023|NCT00966875|467177510|FG005|Part B|Lost to Follow-up|0|||
129784024|NCT00966875|467177511|FG006|Part B|Lost to Follow-up|0|||
129784025|NCT00966875|467177512|FG007|Part B|Lost to Follow-up|0|||
129784026|NCT00966875|467177513|FG008|Part B|Lost to Follow-up|1|||
129784027|NCT00966875|467177505|FG000|Part B|Physician Decision|0|||
129784028|NCT00966875|467177506|FG001|Part B|Physician Decision|0|||
129784029|NCT00966875|467177507|FG002|Part B|Physician Decision|1|||
129784030|NCT00966875|467177508|FG003|Part B|Physician Decision|0|||
129784031|NCT00966875|467177509|FG004|Part B|Physician Decision|2|||
129784032|NCT00966875|467177510|FG005|Part B|Physician Decision|1|||
129784033|NCT00966875|467177511|FG006|Part B|Physician Decision|0|||
129784034|NCT00966875|467177512|FG007|Part B|Physician Decision|0|||
129784035|NCT00966875|467177513|FG008|Part B|Physician Decision|2|||
129784036|NCT00966875|467177505|FG000|Part B|Sponsor Decision|1|||
129784037|NCT00966875|467177506|FG001|Part B|Sponsor Decision|0|||
129784038|NCT00966875|467177507|FG002|Part B|Sponsor Decision|0|||
129784039|NCT00966875|467177508|FG003|Part B|Sponsor Decision|0|||
129784040|NCT00966875|467177509|FG004|Part B|Sponsor Decision|0|||
129784041|NCT00966875|467177510|FG005|Part B|Sponsor Decision|1|||
129784042|NCT00966875|467177511|FG006|Part B|Sponsor Decision|0|||
129784043|NCT00966875|467177512|FG007|Part B|Sponsor Decision|2|||
129784044|NCT00966875|467177513|FG008|Part B|Sponsor Decision|1|||
129784045|NCT00966875|467177505|FG000|Part B|Withdrawal by Subject|2|||
129784046|NCT00966875|467177506|FG001|Part B|Withdrawal by Subject|1|||
129784047|NCT00966875|467177507|FG002|Part B|Withdrawal by Subject|2|||
129784048|NCT00966875|467177508|FG003|Part B|Withdrawal by Subject|1|||
129784049|NCT00966875|467177509|FG004|Part B|Withdrawal by Subject|2|||
129784050|NCT00966875|467177510|FG005|Part B|Withdrawal by Subject|1|||
129784051|NCT00966875|467177511|FG006|Part B|Withdrawal by Subject|4|||
129784052|NCT00966875|467177512|FG007|Part B|Withdrawal by Subject|5|||
129784053|NCT00966875|467177513|FG008|Part B|Withdrawal by Subject|5|||
129784054|NCT00966875|467177505|FG000|Part B|Entry Criteria|0|||
129784055|NCT00966875|467177506|FG001|Part B|Entry Criteria|0|||
129784056|NCT00966875|467177507|FG002|Part B|Entry Criteria|0|||
129784057|NCT00966875|467177508|FG003|Part B|Entry Criteria|0|||
129784058|NCT00966875|467177509|FG004|Part B|Entry Criteria|0|||
129784059|NCT00966875|467177510|FG005|Part B|Entry Criteria|0|||
129784060|NCT00966875|467177511|FG006|Part B|Entry Criteria|1|||
129694031|NCT01750281|466837475|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
129694032|NCT01750281|466837476|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
129694033|NCT01750281|466837474|FG000|Overall Study|Did not receive treatment|0|||
129694034|NCT01750281|466837475|FG001|Overall Study|Did not receive treatment|1|||
129694035|NCT01750281|466837476|FG002|Overall Study|Did not receive treatment|0|||
129694036|NCT01896986|466837477|FG000|Overall Study|samples lost|14|||
129694037|NCT01896986|466837478|FG001|Overall Study|samples lost|23|||
129694038|NCT01061710|466837484|FG000|Overall Study|Protocol Violation|14|||
129694039|NCT03757715|466837486|FG000|Overall Study|Lost to Follow-up|4|||
129694040|NCT03757715|466837487|FG001|Overall Study|Lost to Follow-up|9|||
129694041|NCT03757715|466837486|FG000|Overall Study|Withdrawal by Subject|1|||
129694042|NCT03757715|466837487|FG001|Overall Study|Withdrawal by Subject|1|||
129694043|NCT00281580|466837488|FG000|Overall Study|Adverse Event|2|||
129694044|NCT00281580|466837489|FG001|Overall Study|Adverse Event|0|||
129694045|NCT00281580|466837490|FG002|Overall Study|Adverse Event|2|||
129694046|NCT00281580|466837491|FG003|Overall Study|Adverse Event|4|||
129694047|NCT00281580|466837492|FG004|Overall Study|Adverse Event|1|||
129694048|NCT00281580|466837493|FG005|Overall Study|Adverse Event|0|||
129694049|NCT00281580|466837494|FG006|Overall Study|Adverse Event|1|||
129694050|NCT00281580|466837495|FG007|Overall Study|Adverse Event|0|||
129694051|NCT00281580|466837496|FG008|Overall Study|Adverse Event|1|||
129694052|NCT00281580|466837497|FG009|Overall Study|Adverse Event|6|||
129694053|NCT00281580|466837498|FG010|Overall Study|Adverse Event|0|||
129694054|NCT00281580|466837499|FG011|Overall Study|Adverse Event|5|||
129694055|NCT00281580|466837500|FG012|Overall Study|Adverse Event|8|||
129694056|NCT00281580|466837501|FG013|Overall Study|Adverse Event|2|||
129694057|NCT00281580|466837502|FG014|Overall Study|Adverse Event|3|||
129694058|NCT00281580|466837503|FG015|Overall Study|Adverse Event|3|||
129694059|NCT00281580|466837488|FG000|Overall Study|Protocol Violation|0|||
129694060|NCT00281580|466837489|FG001|Overall Study|Protocol Violation|0|||
129694061|NCT00281580|466837490|FG002|Overall Study|Protocol Violation|1|||
129694062|NCT00281580|466837491|FG003|Overall Study|Protocol Violation|1|||
129694063|NCT00281580|466837492|FG004|Overall Study|Protocol Violation|0|||
129694064|NCT00281580|466837493|FG005|Overall Study|Protocol Violation|0|||
129694065|NCT00281580|466837494|FG006|Overall Study|Protocol Violation|1|||
129694066|NCT00281580|466837495|FG007|Overall Study|Protocol Violation|0|||
129694067|NCT00281580|466837496|FG008|Overall Study|Protocol Violation|2|||
129694068|NCT00281580|466837497|FG009|Overall Study|Protocol Violation|0|||
129694069|NCT00281580|466837498|FG010|Overall Study|Protocol Violation|1|||
129694070|NCT00281580|466837499|FG011|Overall Study|Protocol Violation|2|||
129784061|NCT00966875|467177512|FG007|Part B|Entry Criteria|0|||
129694071|NCT00281580|466837500|FG012|Overall Study|Protocol Violation|0|||
129694072|NCT00281580|466837501|FG013|Overall Study|Protocol Violation|1|||
129694073|NCT00281580|466837502|FG014|Overall Study|Protocol Violation|1|||
129694074|NCT00281580|466837503|FG015|Overall Study|Protocol Violation|3|||
129694075|NCT00281580|466837488|FG000|Overall Study|Withdrawal by Subject|3|||
129694076|NCT00281580|466837489|FG001|Overall Study|Withdrawal by Subject|0|||
129694077|NCT00281580|466837490|FG002|Overall Study|Withdrawal by Subject|1|||
129784062|NCT00966875|467177513|FG008|Part B|Entry Criteria|1|||
129784063|NCT01589653|467177514|FG000|Overall Study|Protocol Violation|3|||
129784064|NCT01589653|467177515|FG001|Overall Study|Protocol Violation|1|||
129784065|NCT01589653|467177514|FG000|Overall Study|Withdrawal criteria|4|||
129784066|NCT01589653|467177515|FG001|Overall Study|Withdrawal criteria|7|||
129784067|NCT01589653|467177514|FG000|Overall Study|Unclassified|0|||
129784068|NCT01589653|467177515|FG001|Overall Study|Unclassified|3|||
129784069|NCT02386189|467177516|FG000|Overall Study|Lost to Follow-up|2|||
129784070|NCT02386189|467177517|FG001|Overall Study|Lost to Follow-up|3|||
129784071|NCT02386189|467177516|FG000|Overall Study|Withdrawal by Subject|1|||
129784072|NCT02386189|467177517|FG001|Overall Study|Withdrawal by Subject|0|||
129784073|NCT02386189|467177516|FG000|Overall Study|Death|1|||
129784074|NCT02386189|467177517|FG001|Overall Study|Death|0|||
129784075|NCT04657666|467177518|FG000|Period 1|Withdrawal of participant consent|2|||
129784076|NCT04657666|467177519|FG001|Period 1|Withdrawal of participant consent|1|||
129784077|NCT04657666|467177518|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
129575255|NCT00838279|466402508|FG001|Washout|Withdrawal by Subject|1|||
129575256|NCT03792477|466402509|FG000|Overall Study|Adverse Event|0|||
129575257|NCT03792477|466402510|FG001|Overall Study|Adverse Event|0|||
129575258|NCT03792477|466402511|FG002|Overall Study|Adverse Event|0|||
129575259|NCT03792477|466402512|FG003|Overall Study|Adverse Event|1|||
129575260|NCT03792477|466402513|FG004|Overall Study|Adverse Event|0|||
129575261|NCT03792477|466402509|FG000|Overall Study|Lost to Follow-up|0|||
129575262|NCT03792477|466402510|FG001|Overall Study|Lost to Follow-up|0|||
129575263|NCT03792477|466402511|FG002|Overall Study|Lost to Follow-up|2|||
129784078|NCT04657666|467177519|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
129784079|NCT04657666|467177518|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
129784080|NCT04657666|467177519|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
129784081|NCT04657666|467177518|FG000|Period 2|Other|2|||
129784082|NCT04657666|467177519|FG001|Period 2|Other|0|||
129784083|NCT04657666|467177518|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
129784084|NCT04657666|467177519|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
129784085|NCT03700684|467177528|FG000|Overall Study|COVID-19|0|||
129784086|NCT03700684|467177529|FG001|Overall Study|COVID-19|0|||
129784087|NCT03700684|467177530|FG002|Overall Study|COVID-19|2|||
129575264|NCT03792477|466402512|FG003|Overall Study|Lost to Follow-up|0|||
129575265|NCT03792477|466402513|FG004|Overall Study|Lost to Follow-up|0|||
129575266|NCT03792477|466402509|FG000|Overall Study|Other|0|||
129575267|NCT03792477|466402510|FG001|Overall Study|Other|0|||
129575268|NCT03792477|466402511|FG002|Overall Study|Other|0|||
129694078|NCT00281580|466837491|FG003|Overall Study|Withdrawal by Subject|1|||
129694079|NCT00281580|466837492|FG004|Overall Study|Withdrawal by Subject|1|||
129694080|NCT00281580|466837493|FG005|Overall Study|Withdrawal by Subject|2|||
129694081|NCT00281580|466837494|FG006|Overall Study|Withdrawal by Subject|2|||
129694082|NCT00281580|466837495|FG007|Overall Study|Withdrawal by Subject|0|||
129694083|NCT00281580|466837496|FG008|Overall Study|Withdrawal by Subject|1|||
129694084|NCT00281580|466837497|FG009|Overall Study|Withdrawal by Subject|4|||
129694085|NCT00281580|466837498|FG010|Overall Study|Withdrawal by Subject|1|||
129694086|NCT00281580|466837499|FG011|Overall Study|Withdrawal by Subject|1|||
129694087|NCT00281580|466837500|FG012|Overall Study|Withdrawal by Subject|2|||
129694088|NCT00281580|466837501|FG013|Overall Study|Withdrawal by Subject|2|||
129694089|NCT00281580|466837502|FG014|Overall Study|Withdrawal by Subject|1|||
129694090|NCT00281580|466837503|FG015|Overall Study|Withdrawal by Subject|5|||
129694091|NCT00281580|466837488|FG000|Overall Study|Lack of Efficacy|2|||
129694092|NCT00281580|466837489|FG001|Overall Study|Lack of Efficacy|1|||
129694093|NCT00281580|466837490|FG002|Overall Study|Lack of Efficacy|1|||
129694094|NCT00281580|466837491|FG003|Overall Study|Lack of Efficacy|6|||
129694095|NCT00281580|466837492|FG004|Overall Study|Lack of Efficacy|2|||
129694096|NCT00281580|466837493|FG005|Overall Study|Lack of Efficacy|0|||
129694097|NCT00281580|466837494|FG006|Overall Study|Lack of Efficacy|0|||
129694098|NCT00281580|466837495|FG007|Overall Study|Lack of Efficacy|0|||
129694099|NCT00281580|466837496|FG008|Overall Study|Lack of Efficacy|0|||
129694100|NCT00281580|466837497|FG009|Overall Study|Lack of Efficacy|0|||
129694101|NCT00281580|466837498|FG010|Overall Study|Lack of Efficacy|0|||
129694102|NCT00281580|466837499|FG011|Overall Study|Lack of Efficacy|1|||
129694103|NCT00281580|466837500|FG012|Overall Study|Lack of Efficacy|0|||
129694104|NCT00281580|466837501|FG013|Overall Study|Lack of Efficacy|2|||
129694105|NCT00281580|466837502|FG014|Overall Study|Lack of Efficacy|1|||
129694106|NCT00281580|466837503|FG015|Overall Study|Lack of Efficacy|0|||
129694107|NCT00281580|466837488|FG000|Overall Study|Lost to Follow-up|0|||
129694108|NCT00281580|466837489|FG001|Overall Study|Lost to Follow-up|0|||
129694109|NCT00281580|466837490|FG002|Overall Study|Lost to Follow-up|0|||
129694110|NCT00281580|466837491|FG003|Overall Study|Lost to Follow-up|3|||
129694111|NCT00281580|466837492|FG004|Overall Study|Lost to Follow-up|0|||
129694112|NCT00281580|466837493|FG005|Overall Study|Lost to Follow-up|1|||
129694113|NCT00281580|466837494|FG006|Overall Study|Lost to Follow-up|0|||
129694114|NCT00281580|466837495|FG007|Overall Study|Lost to Follow-up|1|||
129694115|NCT00281580|466837496|FG008|Overall Study|Lost to Follow-up|2|||
129694116|NCT00281580|466837497|FG009|Overall Study|Lost to Follow-up|1|||
129694117|NCT00281580|466837498|FG010|Overall Study|Lost to Follow-up|1|||
129694118|NCT00281580|466837499|FG011|Overall Study|Lost to Follow-up|0|||
129694119|NCT00281580|466837500|FG012|Overall Study|Lost to Follow-up|1|||
129694120|NCT00281580|466837501|FG013|Overall Study|Lost to Follow-up|0|||
129694121|NCT00281580|466837502|FG014|Overall Study|Lost to Follow-up|0|||
129694122|NCT00281580|466837503|FG015|Overall Study|Lost to Follow-up|0|||
129694123|NCT00281580|466837488|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
129694124|NCT00281580|466837489|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
129694125|NCT00281580|466837490|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
129784088|NCT03319745|467177532|FG000|Overall Study|Death|1|||
129575269|NCT03792477|466402512|FG003|Overall Study|Other|0|||
129575270|NCT03792477|466402513|FG004|Overall Study|Other|1|||
129575271|NCT01921062|466402514|FG000|Overall Study|Withdrawal by Subject|0|||
129575272|NCT01921062|466402515|FG001|Overall Study|Withdrawal by Subject|7|||
129575273|NCT01921062|466402514|FG000|Overall Study|Adverse Event|5|||
129575274|NCT01921062|466402515|FG001|Overall Study|Adverse Event|6|||
129575275|NCT01921062|466402514|FG000|Overall Study|Protocol Violation|0|||
129575276|NCT01921062|466402515|FG001|Overall Study|Protocol Violation|1|||
129575277|NCT01921062|466402514|FG000|Overall Study|VMIQ score > 72|4|||
129575278|NCT01921062|466402515|FG001|Overall Study|VMIQ score > 72|1|||
129575279|NCT01921062|466402514|FG000|Overall Study|Logistic error|0|||
129575280|NCT01921062|466402515|FG001|Overall Study|Logistic error|1|||
129575281|NCT00576056|466402516|FG000|Overall Study|Adverse Event|1|||
129575282|NCT00576056|466402516|FG000|Overall Study|Death|1|||
129575283|NCT00576056|466402516|FG000|Overall Study|Lack of Efficacy|1|||
129575284|NCT00576056|466402516|FG000|Overall Study|Withdrawal by Subject|2|||
129784089|NCT03319745|467177532|FG000|Overall Study|Toxicity Precluding Surgery|1|||
129784090|NCT00870103|467177533|FG000|Overall Study|Physician Decision|2|||
129784091|NCT00870103|467177533|FG000|Overall Study|Lost to Follow-up|2|||
129784092|NCT01317550|467177534|FG000|Overall Study|Withdrawal by Subject|1|||
129784093|NCT01317550|467177535|FG001|Overall Study|Withdrawal by Subject|0|||
129784094|NCT01317550|467177536|FG002|Overall Study|Withdrawal by Subject|0|||
129784095|NCT01317550|467177537|FG003|Overall Study|Withdrawal by Subject|0|||
129784096|NCT01317550|467177534|FG000|Overall Study|Lack of compliance study med|1|||
129784097|NCT01317550|467177535|FG001|Overall Study|Lack of compliance study med|0|||
129784098|NCT01317550|467177536|FG002|Overall Study|Lack of compliance study med|0|||
129784099|NCT01317550|467177537|FG003|Overall Study|Lack of compliance study med|0|||
129784100|NCT01120782|467177538|FG000|Overall Study|Test article shipping error|11|||
129784101|NCT04975438|467177539|FG000|Overall Study|Lost to Follow-up|1|||
129784102|NCT04975438|467177540|FG001|Overall Study|Lost to Follow-up|0|||
129784103|NCT04975438|467177541|FG002|Overall Study|Lost to Follow-up|1|||
129784104|NCT04975438|467177542|FG003|Overall Study|Lost to Follow-up|0|||
129784105|NCT04975438|467177539|FG000|Overall Study|Withdrawal by Subject|1|||
129784106|NCT04975438|467177540|FG001|Overall Study|Withdrawal by Subject|0|||
129784107|NCT04975438|467177541|FG002|Overall Study|Withdrawal by Subject|0|||
129784108|NCT04975438|467177542|FG003|Overall Study|Withdrawal by Subject|0|||
129784109|NCT01950013|467177549|FG000|Overall Study|Withdrawal by Subject|0|||
129784110|NCT01950013|467177550|FG001|Overall Study|Withdrawal by Subject|2|||
129784111|NCT01950013|467177551|FG002|Overall Study|Withdrawal by Subject|0|||
129784112|NCT03091348|467177554|FG000|Overall Study|Lost to Follow-up|2|||
129784113|NCT03091348|467177555|FG001|Overall Study|Lost to Follow-up|1|||
129784114|NCT00706342|467177556|FG000|Overall Study|Adverse Event|3|||
129784115|NCT00706342|467177556|FG000|Overall Study|Not responding to treatment|2|||
129784116|NCT00706342|467177556|FG000|Overall Study|Withdrawn due to failure to respond|1|||
129784117|NCT00706342|467177556|FG000|Overall Study|Death|1|||
129784118|NCT00706342|467177556|FG000|Overall Study|Withdrew from the study on his own.|1|||
129784119|NCT00706342|467177556|FG000|Overall Study|Investigator discretion|2|||
129784120|NCT00706342|467177556|FG000|Overall Study|Non-responder Week 12|1|||
129784121|NCT00706342|467177556|FG000|Overall Study|Ongoing|6|||
129784122|NCT00706342|467177556|FG000|Overall Study|WIthdrawal of consent|1|||
129784123|NCT01419197|467177558|FG000|Overall Study|Death|247|||
129784124|NCT01419197|467177559|FG001|Overall Study|Death|122|||
129784125|NCT01419197|467177558|FG000|Overall Study|Physician Decision|4|||
129784126|NCT01419197|467177559|FG001|Overall Study|Physician Decision|4|||
129784127|NCT01419197|467177558|FG000|Overall Study|Non-compliance|3|||
129784128|NCT01419197|467177559|FG001|Overall Study|Non-compliance|1|||
129784129|NCT01419197|467177558|FG000|Overall Study|Withdrawal by Subject|33|||
129784130|NCT01419197|467177559|FG001|Overall Study|Withdrawal by Subject|32|||
129784131|NCT01419197|467177558|FG000|Overall Study|Study Completed by Sponsor|103|||
129784132|NCT01419197|467177559|FG001|Overall Study|Study Completed by Sponsor|34|||
129784133|NCT01419197|467177558|FG000|Overall Study|Reason Not Specified|0|||
129784134|NCT01419197|467177559|FG001|Overall Study|Reason Not Specified|1|||
129784135|NCT01419197|467177558|FG000|Overall Study|Lost to Follow-up|14|||
129784136|NCT01419197|467177559|FG001|Overall Study|Lost to Follow-up|4|||
129784137|NCT00146848|467177560|FG000|Pre-randomization|Death|19|||
129784138|NCT00146848|467177561|FG001|Pre-randomization|Death|0|||
129784139|NCT00146848|467177562|FG002|Pre-randomization|Death|0|||
129784140|NCT00146848|467177560|FG000|Pre-randomization|Lost to Follow-up|70|||
129784141|NCT00146848|467177561|FG001|Pre-randomization|Lost to Follow-up|0|||
129784142|NCT00146848|467177562|FG002|Pre-randomization|Lost to Follow-up|0|||
129784143|NCT00146848|467177560|FG000|Pre-randomization|Physician Decision|8|||
129784144|NCT00146848|467177561|FG001|Pre-randomization|Physician Decision|0|||
129784145|NCT00146848|467177562|FG002|Pre-randomization|Physician Decision|0|||
129784146|NCT00146848|467177560|FG000|Pre-randomization|Protocol Violation|172|||
129784147|NCT00146848|467177561|FG001|Pre-randomization|Protocol Violation|0|||
129784148|NCT00146848|467177562|FG002|Pre-randomization|Protocol Violation|0|||
129784149|NCT00146848|467177560|FG000|Pre-randomization|Withdrawal by Subject|40|||
129784150|NCT00146848|467177561|FG001|Pre-randomization|Withdrawal by Subject|0|||
129784151|NCT00146848|467177562|FG002|Pre-randomization|Withdrawal by Subject|0|||
129784152|NCT00146848|467177560|FG000|Post-randomization|Lost to Follow-up|12|||
129784153|NCT00146848|467177561|FG001|Post-randomization|Lost to Follow-up|15|||
129784154|NCT00146848|467177562|FG002|Post-randomization|Lost to Follow-up|12|||
129784155|NCT00146848|467177560|FG000|Post-randomization|Withdrawn|26|||
129784156|NCT00146848|467177561|FG001|Post-randomization|Withdrawn|32|||
129694126|NCT00281580|466837491|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
129694127|NCT00281580|466837492|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
129694128|NCT00281580|466837493|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
129694129|NCT00281580|466837494|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
129694130|NCT00281580|466837495|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
129694131|NCT00281580|466837496|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
129694132|NCT00281580|466837497|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
129694133|NCT00281580|466837498|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
129694134|NCT00281580|466837499|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
129694135|NCT00281580|466837500|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
129694136|NCT00281580|466837501|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
129694137|NCT00281580|466837502|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
129694138|NCT00281580|466837503|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
129694139|NCT03302936|466837504|FG000|Overall Study|Protocol Violation|3|||
129694140|NCT03302936|466837505|FG001|Overall Study|Protocol Violation|4|||
129784157|NCT00146848|467177562|FG002|Post-randomization|Withdrawn|27|||
129694141|NCT01550965|466837506|FG000|Overall Study|Adverse Event|26|||
129694142|NCT01550965|466837506|FG000|Overall Study|Withdrawal by Subject|10|||
129784158|NCT00119678|467177563|FG000|Double-blind Treatment Period|Death|1|||
129784159|NCT00119678|467177564|FG001|Double-blind Treatment Period|Death|0|||
129784160|NCT00119678|467177563|FG000|Double-blind Treatment Period|Adverse Event|7|||
129784161|NCT00119678|467177564|FG001|Double-blind Treatment Period|Adverse Event|1|||
129784162|NCT00119678|467177563|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
129784163|NCT00119678|467177564|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
129694143|NCT01550965|466837506|FG000|Overall Study|Lost to Follow-up|2|||
129694144|NCT01550965|466837506|FG000|Overall Study|Lack of Efficacy|59|||
129694145|NCT01550965|466837506|FG000|Overall Study|Other|13|||
129694146|NCT03016403|466837509|FG000|Baseline|Death|5|||
129694147|NCT03016403|466837510|FG001|Baseline|Death|8|||
129784164|NCT00119678|467177563|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129784165|NCT00119678|467177564|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
129784166|NCT00119678|467177563|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
129784167|NCT00119678|467177564|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
129784168|NCT00119678|467177563|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
129784169|NCT00119678|467177564|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
129784170|NCT00119678|467177563|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
129784171|NCT00119678|467177564|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
129784172|NCT00119678|467177563|FG000|Double-blind Treatment Period|Pregnancy|0|||
129784173|NCT00119678|467177564|FG001|Double-blind Treatment Period|Pregnancy|2|||
129784174|NCT00119678|467177563|FG000|Double-blind Treatment Period|Not treated|1|||
129784175|NCT00119678|467177564|FG001|Double-blind Treatment Period|Not treated|2|||
129784176|NCT00119678|467177563|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
129784177|NCT00119678|467177564|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
129784178|NCT00119678|467177563|FG000|Open-label Treatment Period|Death|1|||
129784179|NCT00119678|467177564|FG001|Open-label Treatment Period|Death|0|||
129784180|NCT00119678|467177563|FG000|Open-label Treatment Period|Adverse Event|3|||
129784181|NCT00119678|467177564|FG001|Open-label Treatment Period|Adverse Event|0|||
129784182|NCT00119678|467177563|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
129784183|NCT00119678|467177564|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
129784184|NCT00119678|467177563|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
129784185|NCT00119678|467177564|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129784186|NCT00119678|467177563|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
129784187|NCT00119678|467177564|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
129784188|NCT00119678|467177563|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
129784189|NCT00119678|467177564|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
129784190|NCT00119678|467177563|FG000|Open-label Treatment Period|Pregnancy|1|||
129784191|NCT00119678|467177564|FG001|Open-label Treatment Period|Pregnancy|0|||
129784192|NCT00119678|467177563|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
129784193|NCT00119678|467177564|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
129784194|NCT01761240|467177565|FG000|Overall Study|Progressive disease:radiology assessment|3|||
129784195|NCT01761240|467177566|FG001|Overall Study|Progressive disease:radiology assessment|3|||
129784196|NCT01761240|467177567|FG002|Overall Study|Progressive disease:radiology assessment|0|||
129784197|NCT01761240|467177568|FG003|Overall Study|Progressive disease:radiology assessment|0|||
129784198|NCT01761240|467177569|FG004|Overall Study|Progressive disease:radiology assessment|0|||
129784199|NCT01761240|467177565|FG000|Overall Study|Progressive disease:clinical assessment|0|||
129784200|NCT01761240|467177566|FG001|Overall Study|Progressive disease:clinical assessment|0|||
129784201|NCT01761240|467177567|FG002|Overall Study|Progressive disease:clinical assessment|3|||
129784202|NCT01761240|467177568|FG003|Overall Study|Progressive disease:clinical assessment|1|||
129784203|NCT01761240|467177569|FG004|Overall Study|Progressive disease:clinical assessment|0|||
129784204|NCT01761240|467177565|FG000|Overall Study|Withdrawal by Subject|0|||
129784205|NCT01761240|467177566|FG001|Overall Study|Withdrawal by Subject|0|||
129784206|NCT01761240|467177567|FG002|Overall Study|Withdrawal by Subject|0|||
129784207|NCT01761240|467177568|FG003|Overall Study|Withdrawal by Subject|3|||
129784208|NCT01761240|467177569|FG004|Overall Study|Withdrawal by Subject|1|||
129784209|NCT01761240|467177565|FG000|Overall Study|Adverse Event|0|||
129784210|NCT01761240|467177566|FG001|Overall Study|Adverse Event|0|||
129784211|NCT01761240|467177567|FG002|Overall Study|Adverse Event|0|||
129784212|NCT01761240|467177568|FG003|Overall Study|Adverse Event|1|||
129784213|NCT01761240|467177569|FG004|Overall Study|Adverse Event|6|||
129784214|NCT01761240|467177565|FG000|Overall Study|Death|0|||
129784215|NCT01761240|467177566|FG001|Overall Study|Death|1|||
129784216|NCT01761240|467177567|FG002|Overall Study|Death|1|||
129784217|NCT01761240|467177568|FG003|Overall Study|Death|2|||
129784218|NCT01761240|467177569|FG004|Overall Study|Death|1|||
129784219|NCT01761240|467177565|FG000|Overall Study|Non-compliance|0|||
129784220|NCT01761240|467177566|FG001|Overall Study|Non-compliance|0|||
129784221|NCT01761240|467177567|FG002|Overall Study|Non-compliance|1|||
129784222|NCT01761240|467177568|FG003|Overall Study|Non-compliance|0|||
129784223|NCT01761240|467177569|FG004|Overall Study|Non-compliance|0|||
129784224|NCT00509145|467177570|FG000|Overall Study|Death|0|||
129784225|NCT00509145|467177571|FG001|Overall Study|Death|2|||
129784226|NCT00509145|467177570|FG000|Overall Study|Adverse Event|42|||
129784227|NCT00509145|467177571|FG001|Overall Study|Adverse Event|28|||
129784228|NCT00509145|467177570|FG000|Overall Study|Withdrawal by Subject|32|||
129784229|NCT00509145|467177571|FG001|Overall Study|Withdrawal by Subject|38|||
129784230|NCT00509145|467177570|FG000|Overall Study|Physician Decision|11|||
129784231|NCT00509145|467177571|FG001|Overall Study|Physician Decision|14|||
129784232|NCT00509145|467177570|FG000|Overall Study|Protocol Violation|1|||
129784233|NCT00509145|467177571|FG001|Overall Study|Protocol Violation|6|||
129784234|NCT00509145|467177570|FG000|Overall Study|Pregnancy|3|||
129784235|NCT00509145|467177571|FG001|Overall Study|Pregnancy|8|||
129784236|NCT00509145|467177570|FG000|Overall Study|Lost to Follow-up|6|||
129784237|NCT00509145|467177571|FG001|Overall Study|Lost to Follow-up|5|||
129784238|NCT00509145|467177570|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
129575285|NCT00576056|466402516|FG000|Overall Study|did not meet eligibility criteria|8|||
129575286|NCT00576056|466402516|FG000|Overall Study|Physician Decision|1|||
129784239|NCT00509145|467177571|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
129784240|NCT00509145|467177570|FG000|Overall Study|Other|6|||
129784241|NCT00509145|467177571|FG001|Overall Study|Other|6|||
129784242|NCT00750152|467177572|FG000|Overall Study|Adverse Event|2|||
129784243|NCT00750152|467177573|FG001|Overall Study|Adverse Event|1|||
129784244|NCT00750152|467177572|FG000|Overall Study|Lost to Follow-up|8|||
129784245|NCT00750152|467177573|FG001|Overall Study|Lost to Follow-up|13|||
129784246|NCT00750152|467177572|FG000|Overall Study|Withdrawal by Subject|3|||
129784247|NCT00750152|467177573|FG001|Overall Study|Withdrawal by Subject|3|||
129784248|NCT00750152|467177572|FG000|Overall Study|Physician Decision|1|||
129784249|NCT00750152|467177573|FG001|Overall Study|Physician Decision|1|||
129694148|NCT03016403|466837511|FG002|Baseline|Death|1|||
129694149|NCT03016403|466837512|FG003|Baseline|Death|0|||
129694150|NCT03016403|466837509|FG000|Baseline|Withdrawal by Subject|2|||
129694151|NCT03016403|466837510|FG001|Baseline|Withdrawal by Subject|8|||
129694152|NCT03016403|466837511|FG002|Baseline|Withdrawal by Subject|4|||
129694153|NCT03016403|466837512|FG003|Baseline|Withdrawal by Subject|10|||
129694154|NCT03016403|466837509|FG000|Baseline|Lost to Follow-up|9|||
129784250|NCT00750152|467177572|FG000|Overall Study|Non-compliance|0|||
129784251|NCT00750152|467177573|FG001|Overall Study|Non-compliance|1|||
129784252|NCT00750152|467177572|FG000|Overall Study|Termination by sponsor|1|||
129784253|NCT00750152|467177573|FG001|Overall Study|Termination by sponsor|0|||
129784254|NCT00750152|467177572|FG000|Overall Study|Other|7|||
129784255|NCT00750152|467177573|FG001|Overall Study|Other|8|||
129784256|NCT01642615|467177574|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
129784257|NCT01642615|467177575|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
129784258|NCT01642615|467177576|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
129784259|NCT01642615|467177574|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
129575287|NCT01854047|466402517|FG000|Overall Study|Lack of Efficacy|1|||
129694155|NCT03016403|466837510|FG001|Baseline|Lost to Follow-up|11|||
129694156|NCT03016403|466837511|FG002|Baseline|Lost to Follow-up|6|||
129694157|NCT03016403|466837512|FG003|Baseline|Lost to Follow-up|24|||
129694158|NCT03016403|466837509|FG000|6-week Follow-up|Death|1|||
129694159|NCT03016403|466837510|FG001|6-week Follow-up|Death|4|||
129694160|NCT03016403|466837511|FG002|6-week Follow-up|Death|0|||
129694161|NCT03016403|466837512|FG003|6-week Follow-up|Death|0|||
129694162|NCT03016403|466837509|FG000|6-week Follow-up|Lost to Follow-up|2|||
129694163|NCT03016403|466837510|FG001|6-week Follow-up|Lost to Follow-up|7|||
129694164|NCT03016403|466837511|FG002|6-week Follow-up|Lost to Follow-up|4|||
129694165|NCT03016403|466837512|FG003|6-week Follow-up|Lost to Follow-up|8|||
129694166|NCT03016403|466837509|FG000|6-week Follow-up|Withdrawal by Subject|0|||
129784260|NCT01642615|467177575|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
129694167|NCT03016403|466837510|FG001|6-week Follow-up|Withdrawal by Subject|2|||
129694168|NCT03016403|466837511|FG002|6-week Follow-up|Withdrawal by Subject|0|||
129694169|NCT03016403|466837512|FG003|6-week Follow-up|Withdrawal by Subject|1|||
129694170|NCT03016403|466837509|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
129694171|NCT03016403|466837510|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
129694172|NCT03016403|466837511|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
129694173|NCT03016403|466837512|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
129694174|NCT03016403|466837509|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
129694175|NCT03016403|466837510|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
129784261|NCT01642615|467177576|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
129784262|NCT01642615|467177574|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
129784263|NCT01642615|467177575|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
129784264|NCT01642615|467177576|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
129784265|NCT01642615|467177574|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
129784266|NCT01642615|467177575|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
129784267|NCT01642615|467177576|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
129784268|NCT01642615|467177574|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
129784269|NCT01642615|467177575|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
129784270|NCT01642615|467177576|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
129694176|NCT03016403|466837511|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
129784271|NCT01642615|467177574|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
129784272|NCT01642615|467177575|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
129784273|NCT01642615|467177576|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
129784274|NCT01642615|467177574|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
129784275|NCT01642615|467177575|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
129784276|NCT01642615|467177576|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
129784277|NCT01642615|467177574|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
129784278|NCT01642615|467177575|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
129784279|NCT01642615|467177576|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
129784280|NCT01642615|467177574|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
129784281|NCT01642615|467177575|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
129784282|NCT01642615|467177576|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
129784283|NCT01028300|467177579|FG000|Overall Study|Study Terminated|4|||
129784284|NCT01214395|467177582|FG000|Overall Study|All patients had infection|5|||
129784285|NCT00715910|467177583|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
129784286|NCT00715910|467177584|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
129784287|NCT00715910|467177585|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
129784288|NCT00715910|467177586|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
129784289|NCT00715910|467177587|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
129784290|NCT00715910|467177588|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
129784291|NCT00715910|467177583|FG000|Booster and ESFU Phase|Other|0|||
129784292|NCT00715910|467177584|FG001|Booster and ESFU Phase|Other|0|||
129784293|NCT00715910|467177585|FG002|Booster and ESFU Phase|Other|0|||
129784294|NCT00715910|467177586|FG003|Booster and ESFU Phase|Other|5|||
129784295|NCT00715910|467177587|FG004|Booster and ESFU Phase|Other|1|||
129784296|NCT00715910|467177588|FG005|Booster and ESFU Phase|Other|0|||
129784297|NCT02034409|467177592|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
129784298|NCT02034409|467177593|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
129784299|NCT02034409|467177592|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
129784300|NCT02034409|467177593|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
129784301|NCT02034409|467177592|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
129784302|NCT02034409|467177593|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
129694177|NCT03016403|466837512|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
129694178|NCT03016403|466837509|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
129694179|NCT03016403|466837510|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
129694180|NCT03016403|466837511|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
129694181|NCT03016403|466837512|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
129694182|NCT05463705|466837513|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
129694183|NCT05463705|466837514|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
129694184|NCT05463705|466837515|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
129694185|NCT05463705|466837516|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
129694186|NCT05463705|466837517|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
129694187|NCT05463705|466837518|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
129694188|NCT00621322|466837519|FG000|Overall Study|Lost to Follow-up|0|||
129694189|NCT00621322|466837520|FG001|Overall Study|Lost to Follow-up|0|||
129694190|NCT00621322|466837521|FG002|Overall Study|Lost to Follow-up|0|||
129694191|NCT00621322|466837522|FG003|Overall Study|Lost to Follow-up|0|||
129694192|NCT00621322|466837523|FG004|Overall Study|Lost to Follow-up|1|||
129694193|NCT00621322|466837524|FG005|Overall Study|Lost to Follow-up|0|||
129694194|NCT00621322|466837519|FG000|Overall Study|Physician Decision|0|||
129694195|NCT00621322|466837520|FG001|Overall Study|Physician Decision|0|||
129694196|NCT00621322|466837521|FG002|Overall Study|Physician Decision|1|||
129694197|NCT00621322|466837522|FG003|Overall Study|Physician Decision|1|||
129694198|NCT00621322|466837523|FG004|Overall Study|Physician Decision|0|||
129694199|NCT00621322|466837524|FG005|Overall Study|Physician Decision|0|||
129694200|NCT00621322|466837519|FG000|Overall Study|Withdrawal by Subject|0|||
129694201|NCT00621322|466837520|FG001|Overall Study|Withdrawal by Subject|0|||
129694202|NCT00621322|466837521|FG002|Overall Study|Withdrawal by Subject|0|||
129694203|NCT00621322|466837522|FG003|Overall Study|Withdrawal by Subject|1|||
129694204|NCT00621322|466837523|FG004|Overall Study|Withdrawal by Subject|0|||
129694205|NCT00621322|466837524|FG005|Overall Study|Withdrawal by Subject|2|||
129694206|NCT00621322|466837519|FG000|Overall Study|Migrated/moved from study area|1|||
129694207|NCT00621322|466837520|FG001|Overall Study|Migrated/moved from study area|0|||
129694208|NCT00621322|466837521|FG002|Overall Study|Migrated/moved from study area|1|||
129694209|NCT00621322|466837522|FG003|Overall Study|Migrated/moved from study area|1|||
129694210|NCT00621322|466837523|FG004|Overall Study|Migrated/moved from study area|0|||
129694211|NCT00621322|466837524|FG005|Overall Study|Migrated/moved from study area|2|||
129694212|NCT01655069|466837530|FG000|Overall Study|Physician Decision|0|||
129694213|NCT01655069|466837531|FG001|Overall Study|Physician Decision|0|||
129694214|NCT01655069|466837532|FG002|Overall Study|Physician Decision|0|||
129694215|NCT01655069|466837533|FG003|Overall Study|Physician Decision|1|||
129694216|NCT01655069|466837530|FG000|Overall Study|Adverse Event|6|||
129575288|NCT01854047|466402518|FG001|Overall Study|Lack of Efficacy|0|||
129694217|NCT01655069|466837531|FG001|Overall Study|Adverse Event|7|||
129694218|NCT01655069|466837532|FG002|Overall Study|Adverse Event|2|||
129694219|NCT01655069|466837533|FG003|Overall Study|Adverse Event|3|||
129694220|NCT01655069|466837530|FG000|Overall Study|Lack of Efficacy|0|||
129575289|NCT01854047|466402519|FG002|Overall Study|Lack of Efficacy|0|||
129694221|NCT01655069|466837531|FG001|Overall Study|Lack of Efficacy|1|||
129694222|NCT01655069|466837532|FG002|Overall Study|Lack of Efficacy|0|||
129694223|NCT01655069|466837533|FG003|Overall Study|Lack of Efficacy|0|||
129694224|NCT01655069|466837530|FG000|Overall Study|No Treatment Needed|0|||
129694225|NCT01655069|466837531|FG001|Overall Study|No Treatment Needed|1|||
129694226|NCT01655069|466837532|FG002|Overall Study|No Treatment Needed|0|||
129694227|NCT01655069|466837533|FG003|Overall Study|No Treatment Needed|0|||
129694228|NCT01655069|466837530|FG000|Overall Study|Withdrawal by Subject|2|||
129694229|NCT01655069|466837531|FG001|Overall Study|Withdrawal by Subject|3|||
129694230|NCT01655069|466837532|FG002|Overall Study|Withdrawal by Subject|0|||
129694231|NCT01655069|466837533|FG003|Overall Study|Withdrawal by Subject|0|||
129694232|NCT06399471|466837534|FG000|Overall Study|Withdrawal by Subject|1|||
129694233|NCT00986102|466837535|FG000|Overall Study|Lost to Follow-up|0|||
129694234|NCT00986102|466837536|FG001|Overall Study|Lost to Follow-up|1|||
129694235|NCT00986102|466837537|FG002|Overall Study|Lost to Follow-up|0|||
129694236|NCT00986102|466837538|FG003|Overall Study|Lost to Follow-up|1|||
129694237|NCT00986102|466837535|FG000|Overall Study|Withdrawal by Subject|1|||
129694238|NCT00986102|466837536|FG001|Overall Study|Withdrawal by Subject|1|||
129694239|NCT00986102|466837537|FG002|Overall Study|Withdrawal by Subject|0|||
129694240|NCT00986102|466837538|FG003|Overall Study|Withdrawal by Subject|0|||
129694241|NCT06083493|466837539|FG000|Overall Study|Technical issues with the interventional device|2|||
129694242|NCT06083493|466837540|FG001|Overall Study|Technical issues with the interventional device|2|||
129694243|NCT06083493|466837539|FG000|Overall Study|Performed incorrect visual task|1|||
129694244|NCT06083493|466837540|FG001|Overall Study|Performed incorrect visual task|0|||
129694245|NCT06083493|466837539|FG000|Overall Study|Insufficient baseline performance|0|||
129694246|NCT06083493|466837540|FG001|Overall Study|Insufficient baseline performance|1|||
129694247|NCT00147537|466837541|FG000|Phase 1b|Death|0|||
129694248|NCT00147537|466837542|FG001|Phase 1b|Death|1|||
129694249|NCT00147537|466837543|FG002|Phase 1b|Death|2|||
129694250|NCT00147537|466837544|FG003|Phase 1b|Death|1|||
129694251|NCT00147537|466837545|FG004|Phase 1b|Death|2|||
129694252|NCT00147537|466837546|FG005|Phase 1b|Death|2|||
129694253|NCT00147537|466837547|FG006|Phase 1b|Death|1|||
129575290|NCT01854047|466402520|FG003|Overall Study|Lack of Efficacy|0|||
129575291|NCT01854047|466402521|FG004|Overall Study|Lack of Efficacy|0|||
129575292|NCT01854047|466402517|FG000|Overall Study|Poor compliance to protocol|3|||
129575293|NCT01854047|466402518|FG001|Overall Study|Poor compliance to protocol|0|||
129575294|NCT01854047|466402519|FG002|Overall Study|Poor compliance to protocol|2|||
129575295|NCT01854047|466402520|FG003|Overall Study|Poor compliance to protocol|0|||
129575296|NCT01854047|466402521|FG004|Overall Study|Poor compliance to protocol|0|||
129575297|NCT01854047|466402517|FG000|Overall Study|Adverse Event|5|||
129575298|NCT01854047|466402518|FG001|Overall Study|Adverse Event|4|||
129575299|NCT01854047|466402519|FG002|Overall Study|Adverse Event|6|||
129575300|NCT01854047|466402520|FG003|Overall Study|Adverse Event|10|||
129575301|NCT01854047|466402521|FG004|Overall Study|Adverse Event|7|||
129575302|NCT01854047|466402517|FG000|Overall Study|Randomized but not treated|0|||
129575303|NCT01854047|466402518|FG001|Overall Study|Randomized but not treated|1|||
129575304|NCT01854047|466402519|FG002|Overall Study|Randomized but not treated|2|||
129694254|NCT00147537|466837548|FG007|Phase 1b|Death|3|||
129694255|NCT00147537|466837549|FG008|Phase 1b|Death|9|||
129694256|NCT00147537|466837550|FG009|Phase 1b|Death|0|||
129694257|NCT00147537|466837551|FG010|Phase 1b|Death|0|||
129694258|NCT00147537|466837541|FG000|Phase 1b|Lost to Follow-up|2|||
129694259|NCT00147537|466837542|FG001|Phase 1b|Lost to Follow-up|1|||
129694260|NCT00147537|466837543|FG002|Phase 1b|Lost to Follow-up|0|||
129694261|NCT00147537|466837544|FG003|Phase 1b|Lost to Follow-up|0|||
129694262|NCT00147537|466837545|FG004|Phase 1b|Lost to Follow-up|0|||
129694263|NCT00147537|466837546|FG005|Phase 1b|Lost to Follow-up|0|||
129694264|NCT00147537|466837547|FG006|Phase 1b|Lost to Follow-up|2|||
129694265|NCT00147537|466837548|FG007|Phase 1b|Lost to Follow-up|0|||
129694266|NCT00147537|466837549|FG008|Phase 1b|Lost to Follow-up|1|||
129694267|NCT00147537|466837550|FG009|Phase 1b|Lost to Follow-up|0|||
129694268|NCT00147537|466837551|FG010|Phase 1b|Lost to Follow-up|0|||
129694269|NCT00147537|466837541|FG000|Phase 1b|Other|0|||
129694270|NCT00147537|466837542|FG001|Phase 1b|Other|0|||
129694271|NCT00147537|466837543|FG002|Phase 1b|Other|2|||
129694272|NCT00147537|466837544|FG003|Phase 1b|Other|1|||
129694273|NCT00147537|466837545|FG004|Phase 1b|Other|1|||
129694274|NCT00147537|466837546|FG005|Phase 1b|Other|1|||
129694275|NCT00147537|466837547|FG006|Phase 1b|Other|14|||
129694276|NCT00147537|466837548|FG007|Phase 1b|Other|4|||
129694277|NCT00147537|466837549|FG008|Phase 1b|Other|4|||
129575305|NCT01854047|466402520|FG003|Overall Study|Randomized but not treated|0|||
129694278|NCT00147537|466837550|FG009|Phase 1b|Other|0|||
129694279|NCT00147537|466837551|FG010|Phase 1b|Other|0|||
129694280|NCT00147537|466837541|FG000|Phase 1b|Withdrawal by Subject|0|||
129694281|NCT00147537|466837542|FG001|Phase 1b|Withdrawal by Subject|0|||
129694282|NCT00147537|466837543|FG002|Phase 1b|Withdrawal by Subject|0|||
129694283|NCT00147537|466837544|FG003|Phase 1b|Withdrawal by Subject|0|||
129694284|NCT00147537|466837545|FG004|Phase 1b|Withdrawal by Subject|0|||
129694285|NCT00147537|466837546|FG005|Phase 1b|Withdrawal by Subject|0|||
129694286|NCT00147537|466837547|FG006|Phase 1b|Withdrawal by Subject|0|||
129694287|NCT00147537|466837548|FG007|Phase 1b|Withdrawal by Subject|0|||
129694288|NCT00147537|466837549|FG008|Phase 1b|Withdrawal by Subject|2|||
129694289|NCT00147537|466837550|FG009|Phase 1b|Withdrawal by Subject|0|||
129694290|NCT00147537|466837551|FG010|Phase 1b|Withdrawal by Subject|0|||
129784303|NCT02034409|467177592|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
129784304|NCT02034409|467177593|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
129784305|NCT02034409|467177592|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
129784306|NCT02034409|467177593|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
129784307|NCT02034409|467177592|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
129784308|NCT02034409|467177593|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
129784309|NCT01699867|467177594|FG000|Overall Study|Screening Failure|3|||
129784310|NCT00006289|467177595|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
129784311|NCT00006289|467177596|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
129784312|NCT00006289|467177595|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
129784313|NCT00006289|467177596|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
129784314|NCT03703297|467177603|FG000|Overall Study|Death|115|||
129784315|NCT03703297|467177604|FG001|Overall Study|Death|0|||
129784316|NCT03703297|467177605|FG002|Overall Study|Death|144|||
129784317|NCT03703297|467177603|FG000|Overall Study|Withdrawal by Subject|9|||
129575306|NCT01854047|466402521|FG004|Overall Study|Randomized but not treated|4|||
129575307|NCT01854047|466402517|FG000|Overall Study|Other than specified above|3|||
129575308|NCT01854047|466402518|FG001|Overall Study|Other than specified above|3|||
129575309|NCT01854047|466402519|FG002|Overall Study|Other than specified above|3|||
129575310|NCT01854047|466402520|FG003|Overall Study|Other than specified above|5|||
129575311|NCT01854047|466402521|FG004|Overall Study|Other than specified above|8|||
129575312|NCT03273153|466402522|FG000|Overall Study|Adverse Event|1|||
129575313|NCT03273153|466402523|FG001|Overall Study|Adverse Event|2|||
129575314|NCT03273153|466402522|FG000|Overall Study|Missing|0|||
129575315|NCT03273153|466402523|FG001|Overall Study|Missing|2|||
129575316|NCT03273153|466402522|FG000|Overall Study|Other|3|||
129575317|NCT03273153|466402523|FG001|Overall Study|Other|2|||
129575318|NCT03273153|466402522|FG000|Overall Study|Symptomatic Deterioration|0|||
129575319|NCT03273153|466402523|FG001|Overall Study|Symptomatic Deterioration|1|||
129575320|NCT03273153|466402522|FG000|Overall Study|Progressive Disease|6|||
129575321|NCT03273153|466402523|FG001|Overall Study|Progressive Disease|5|||
129575322|NCT03273153|466402522|FG000|Overall Study|Physician Decision|1|||
129575323|NCT03273153|466402523|FG001|Overall Study|Physician Decision|3|||
129575324|NCT03273153|466402522|FG000|Overall Study|Study Terminated by Sponsor|112|||
129575325|NCT03273153|466402523|FG001|Overall Study|Study Terminated by Sponsor|102|||
129575326|NCT03273153|466402522|FG000|Overall Study|Withdrawal by Subject|26|||
129575327|NCT03273153|466402523|FG001|Overall Study|Withdrawal by Subject|25|||
129575328|NCT03273153|466402522|FG000|Overall Study|Protocol Deviation|3|||
129575329|NCT03273153|466402523|FG001|Overall Study|Protocol Deviation|0|||
129575330|NCT03273153|466402522|FG000|Overall Study|Lost to Follow-up|6|||
129575331|NCT03273153|466402523|FG001|Overall Study|Lost to Follow-up|11|||
129575332|NCT03273153|466402522|FG000|Overall Study|Death|66|||
129575333|NCT03273153|466402523|FG001|Overall Study|Death|69|||
129575334|NCT05323396|466402524|FG000|Overall Study|Lost to Follow-up|1|||
129575335|NCT05323396|466402525|FG001|Overall Study|Lost to Follow-up|35|||
129575336|NCT05323396|466402524|FG000|Overall Study|Pregnancy|1|||
129575337|NCT05323396|466402525|FG001|Overall Study|Pregnancy|0|||
129575338|NCT04646213|466402526|FG000|Overall Study|Physician Decision|3|||
129575339|NCT04646213|466402526|FG000|Overall Study|Withdrawal by Subject|2|||
129575340|NCT00415363|466402531|FG000|Overall Study|Withdrawal by Subject|4|||
129575341|NCT00415363|466402532|FG001|Overall Study|Withdrawal by Subject|4|||
129575342|NCT00415363|466402531|FG000|Overall Study|Adverse Event|4|||
129575343|NCT00415363|466402532|FG001|Overall Study|Adverse Event|4|||
129575344|NCT00415363|466402531|FG000|Overall Study|Lost to Follow-up|2|||
129575345|NCT00415363|466402532|FG001|Overall Study|Lost to Follow-up|1|||
129575346|NCT00415363|466402531|FG000|Overall Study|Physician Decision|3|||
129575347|NCT00415363|466402532|FG001|Overall Study|Physician Decision|1|||
129575348|NCT00415363|466402531|FG000|Overall Study|Death|16|||
129575349|NCT00415363|466402532|FG001|Overall Study|Death|12|||
129575350|NCT00415363|466402531|FG000|Overall Study|Progressive disease|26|||
129575351|NCT00415363|466402532|FG001|Overall Study|Progressive disease|32|||
129575352|NCT00095212|466402533|FG000|Overall Study|Withdrawal by Subject|1|||
129575353|NCT00095212|466402534|FG001|Overall Study|Withdrawal by Subject|3|||
129575354|NCT05341622|466402535|FG000|Overall Study|Death|0|||
129575355|NCT05341622|466402536|FG001|Overall Study|Death|0|||
129575356|NCT05341622|466402537|FG002|Overall Study|Death|0|||
129575357|NCT05341622|466402538|FG003|Overall Study|Death|0|||
129575358|NCT05341622|466402539|FG004|Overall Study|Death|1|||
129575359|NCT05341622|466402540|FG005|Overall Study|Death|0|||
129575360|NCT05341622|466402541|FG006|Overall Study|Death|0|||
129575361|NCT05341622|466402542|FG007|Overall Study|Death|1|||
129575362|NCT05341622|466402535|FG000|Overall Study|Invalid Address|0|||
129575363|NCT05341622|466402536|FG001|Overall Study|Invalid Address|1|||
129575364|NCT05341622|466402537|FG002|Overall Study|Invalid Address|0|||
129575365|NCT05341622|466402538|FG003|Overall Study|Invalid Address|0|||
129575366|NCT05341622|466402539|FG004|Overall Study|Invalid Address|0|||
129575367|NCT05341622|466402540|FG005|Overall Study|Invalid Address|0|||
129575368|NCT05341622|466402541|FG006|Overall Study|Invalid Address|0|||
129575369|NCT05341622|466402542|FG007|Overall Study|Invalid Address|0|||
129575370|NCT05341622|466402535|FG000|Overall Study|Ineligible|26|||
129575371|NCT05341622|466402536|FG001|Overall Study|Ineligible|21|||
129575372|NCT05341622|466402537|FG002|Overall Study|Ineligible|28|||
129575373|NCT05341622|466402538|FG003|Overall Study|Ineligible|24|||
129575374|NCT05341622|466402539|FG004|Overall Study|Ineligible|29|||
129575375|NCT05341622|466402540|FG005|Overall Study|Ineligible|31|||
129575376|NCT05341622|466402541|FG006|Overall Study|Ineligible|28|||
129575377|NCT05341622|466402542|FG007|Overall Study|Ineligible|26|||
129575378|NCT02658084|466402543|FG000|Overall Study|Withdrawal by Subject|1|||
129575379|NCT02658084|466402544|FG001|Overall Study|Withdrawal by Subject|0|||
129575380|NCT02658084|466402543|FG000|Overall Study|Study Termination|1|||
129575381|NCT02658084|466402544|FG001|Overall Study|Study Termination|0|||
129575382|NCT02175095|466404046|FG000|Overall Study|Withdrawal by Subject|3|||
129575383|NCT02096211|466404047|FG000|Overall Study|Death|2|||
129575384|NCT02096211|466404047|FG000|Overall Study|Withdrawal by Subject|8|||
129575385|NCT02096211|466404047|FG000|Overall Study|Revision of implant|7|||
129575386|NCT02096211|466404047|FG000|Overall Study|Lost to Follow-up|43|||
129575387|NCT00519194|466404050|FG000|Overall Study|Withdrawal by Subject|9|||
129575388|NCT00519194|466404050|FG000|Overall Study|Death|9|||
129575389|NCT00519194|466404050|FG000|Overall Study|Lost to Follow-up|3|||
129575390|NCT03165994|466404051|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
129575391|NCT03165994|466404051|FG000|Overall Study|Death|2|||
129575392|NCT03165994|466404051|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
129575393|NCT03165994|466404051|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
129575394|NCT03165994|466404051|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
129575395|NCT03165994|466404051|FG000|Overall Study|Miscellaneous|1|||
129575396|NCT00934050|466404058|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
129575397|NCT00934050|466404059|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129575398|NCT00934050|466404060|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129575399|NCT00934050|466404061|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
129575400|NCT00934050|466404062|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129575401|NCT00934050|466404063|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
129575402|NCT00934050|466404058|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
129575403|NCT00934050|466404059|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
129575404|NCT00934050|466404060|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
129575405|NCT00934050|466404061|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
129575406|NCT00934050|466404062|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
129575407|NCT00934050|466404063|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
129575408|NCT00934050|466404058|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129575409|NCT00934050|466404059|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129575410|NCT00934050|466404060|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
129575411|NCT00934050|466404061|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129575412|NCT00934050|466404062|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129575413|NCT00934050|466404063|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
129575414|NCT00934050|466404058|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
129575415|NCT00934050|466404059|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
129575416|NCT00934050|466404060|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
129575417|NCT00934050|466404061|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
129575418|NCT00934050|466404062|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
129575419|NCT00934050|466404063|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
129575420|NCT00934050|466404058|FG000|Enrolled After 15 Dec 2009|Death|0|||
129575421|NCT00934050|466404059|FG001|Enrolled After 15 Dec 2009|Death|0|||
129575422|NCT00934050|466404060|FG002|Enrolled After 15 Dec 2009|Death|0|||
129575423|NCT00934050|466404061|FG003|Enrolled After 15 Dec 2009|Death|0|||
129575424|NCT00934050|466404062|FG004|Enrolled After 15 Dec 2009|Death|0|||
129575425|NCT00934050|466404063|FG005|Enrolled After 15 Dec 2009|Death|1|||
129784318|NCT03703297|467177604|FG001|Overall Study|Withdrawal by Subject|0|||
129784319|NCT03703297|467177605|FG002|Overall Study|Withdrawal by Subject|11|||
129784320|NCT03703297|467177603|FG000|Overall Study|Ongoing at the time of DCO|140|||
129784321|NCT03703297|467177604|FG001|Overall Study|Ongoing at the time of DCO|200|||
129784322|NCT03703297|467177605|FG002|Overall Study|Ongoing at the time of DCO|111|||
129784323|NCT02156271|467179914|FG000|Overall Study|Physician Decision|4|||
129784324|NCT02156271|467179915|FG001|Overall Study|Physician Decision|3|||
129784325|NCT03320824|467179916|FG000|Overall Study|Withdrawal by Subject|8|||
129575426|NCT00934050|466404058|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129784326|NCT03320824|467179917|FG001|Overall Study|Withdrawal by Subject|1|||
129784327|NCT03320824|467179916|FG000|Overall Study|Lost to Follow-up|10|||
129784328|NCT03320824|467179917|FG001|Overall Study|Lost to Follow-up|1|||
129784329|NCT03320824|467179916|FG000|Overall Study|moved out of state|0|||
129784330|NCT03320824|467179917|FG001|Overall Study|moved out of state|1|||
129784331|NCT03320824|467179916|FG000|Overall Study|could not complete final visit|0|||
129784332|NCT03320824|467179917|FG001|Overall Study|could not complete final visit|1|||
129784333|NCT03387111|467179918|FG000|Overall Study|Progressive Disease|3|||
129784334|NCT03387111|467179918|FG000|Overall Study|Other|1|||
129784335|NCT02617485|467179919|FG000|Treatment and Observation Period|Adverse Event|9|||
129784336|NCT02617485|467179920|FG001|Treatment and Observation Period|Adverse Event|1|||
129784337|NCT02617485|467179919|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
129575427|NCT00934050|466404059|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129784338|NCT02617485|467179920|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
129784339|NCT02617485|467179919|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
129575428|NCT00934050|466404060|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129575429|NCT00934050|466404061|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129784340|NCT02617485|467179920|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
129575430|NCT00934050|466404062|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
129575431|NCT00934050|466404063|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
129784341|NCT02617485|467179919|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
129784342|NCT02617485|467179920|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
129784343|NCT02617485|467179919|FG000|Treatment and Observation Period|Physician Decision|0|||
129784344|NCT02617485|467179920|FG001|Treatment and Observation Period|Physician Decision|1|||
129784345|NCT02617485|467179919|FG000|Follow-up Period|Adverse Event|1|||
129784346|NCT02617485|467179920|FG001|Follow-up Period|Adverse Event|0|||
129784347|NCT02617485|467179919|FG000|Follow-up Period|Withdrawal by Subject|1|||
129784348|NCT02617485|467179920|FG001|Follow-up Period|Withdrawal by Subject|0|||
129784349|NCT02617485|467179919|FG000|Follow-up Period|Disease progression|2|||
129784350|NCT02617485|467179920|FG001|Follow-up Period|Disease progression|1|||
129784351|NCT02617485|467179919|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
129575432|NCT00934050|466404058|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129575433|NCT00934050|466404059|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129575434|NCT00934050|466404060|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129575435|NCT00934050|466404061|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
129575436|NCT00934050|466404062|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
129575437|NCT00934050|466404063|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
129575438|NCT00461786|466404064|FG000|Overall Study|Entry Criteria Not Met|2|||
129575439|NCT00461786|466404064|FG000|Overall Study|Inevaluable (Never Treated)|1|||
129575440|NCT00835991|466404065|FG000|First Intervention|Adverse Event|0|||
129575441|NCT00835991|466404066|FG001|First Intervention|Adverse Event|1|||
129575442|NCT00835991|466404065|FG000|Washout|Protocol Violation|0|||
129575443|NCT00835991|466404066|FG001|Washout|Protocol Violation|2|||
129575444|NCT00835991|466404065|FG000|Washout|Withdrawal by Subject|3|||
129575445|NCT00835991|466404066|FG001|Washout|Withdrawal by Subject|1|||
129575446|NCT02149420|466404067|FG000|Core Study|Administrative problems|0|||
129575447|NCT02149420|466404068|FG001|Core Study|Administrative problems|1|||
129575448|NCT02149420|466404069|FG002|Core Study|Administrative problems|2|||
129575449|NCT02149420|466404067|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
129575450|NCT02149420|466404068|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
129575451|NCT02149420|466404069|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
129575452|NCT01111461|466404070|FG000|Overall Study|Adverse Event|32|||
129575453|NCT01111461|466404070|FG000|Overall Study|Participant choice|11|||
129575454|NCT01111461|466404070|FG000|Overall Study|Lost to Follow-up|1|||
129575455|NCT01111461|466404070|FG000|Overall Study|Withdrawal by Subject|1|||
129575456|NCT01111461|466404070|FG000|Overall Study|Other|6|||
129575457|NCT02378935|466404071|FG000|Overall Study|Lack of Efficacy|10|||
129575458|NCT02378935|466404072|FG001|Overall Study|Lack of Efficacy|0|||
129575459|NCT02378935|466404073|FG002|Overall Study|Lack of Efficacy|2|||
129575460|NCT02378935|466404074|FG003|Overall Study|Lack of Efficacy|6|||
129575461|NCT02378935|466404075|FG004|Overall Study|Lack of Efficacy|0|||
129575462|NCT02378935|466404076|FG005|Overall Study|Lack of Efficacy|0|||
129575463|NCT02378935|466404077|FG006|Overall Study|Lack of Efficacy|0|||
129575464|NCT02378935|466404071|FG000|Overall Study|Death|0|||
129575465|NCT02378935|466404072|FG001|Overall Study|Death|0|||
129575466|NCT02378935|466404073|FG002|Overall Study|Death|1|||
129575467|NCT02378935|466404074|FG003|Overall Study|Death|0|||
129575468|NCT02378935|466404075|FG004|Overall Study|Death|0|||
129575469|NCT02378935|466404076|FG005|Overall Study|Death|0|||
129575470|NCT02378935|466404077|FG006|Overall Study|Death|0|||
129575471|NCT03616535|466404078|FG000|Overall Study|Death|2|||
129575472|NCT03616535|466404079|FG001|Overall Study|Death|0|||
129575473|NCT03616535|466404080|FG002|Overall Study|Death|0|||
129575474|NCT03616535|466404081|FG003|Overall Study|Death|1|||
129575475|NCT03616535|466404078|FG000|Overall Study|Lost to Follow-up|2|||
129575476|NCT03616535|466404079|FG001|Overall Study|Lost to Follow-up|1|||
129575477|NCT03616535|466404080|FG002|Overall Study|Lost to Follow-up|0|||
129575478|NCT03616535|466404081|FG003|Overall Study|Lost to Follow-up|2|||
129575479|NCT03616535|466404078|FG000|Overall Study|Withdrawal by Subject|1|||
129575480|NCT03616535|466404079|FG001|Overall Study|Withdrawal by Subject|2|||
129575481|NCT03616535|466404080|FG002|Overall Study|Withdrawal by Subject|5|||
129575482|NCT03616535|466404081|FG003|Overall Study|Withdrawal by Subject|1|||
129575483|NCT03616535|466404078|FG000|Overall Study|Not specified or change in eligibility|2|||
129575484|NCT03616535|466404079|FG001|Overall Study|Not specified or change in eligibility|3|||
129575485|NCT03616535|466404080|FG002|Overall Study|Not specified or change in eligibility|3|||
129575486|NCT03616535|466404081|FG003|Overall Study|Not specified or change in eligibility|1|||
129575487|NCT02146105|466404084|FG000|Overall Study|Adverse Event|1|||
129575488|NCT02146105|466404084|FG000|Overall Study|Withdrawal by Subject|5|||
129575489|NCT05755282|466404085|FG000|Overall Study|Protocol Violation|0|||
129575490|NCT05755282|466404086|FG001|Overall Study|Protocol Violation|1|||
129575491|NCT03935880|466404088|FG000|Overall Study|Lost to Follow-up|0|||
129575492|NCT03935880|466404089|FG001|Overall Study|Lost to Follow-up|1|||
129575493|NCT02476994|466404090|FG000|Overall Study|Based on feedback from FDA|1|||
129575494|NCT02476994|466404091|FG001|Overall Study|Based on feedback from FDA|0|||
129575495|NCT02563561|466404092|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
129575496|NCT02563561|466404093|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
129575497|NCT02563561|466404094|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
129575498|NCT02563561|466404092|FG000|Overall Study|Withdrew of Consent|1|||
129575499|NCT02563561|466404093|FG001|Overall Study|Withdrew of Consent|1|||
129575500|NCT02563561|466404094|FG002|Overall Study|Withdrew of Consent|2|||
129575501|NCT02563561|466404092|FG000|Overall Study|Lost to Follow-up|1|||
129575502|NCT02563561|466404093|FG001|Overall Study|Lost to Follow-up|1|||
129575503|NCT02563561|466404094|FG002|Overall Study|Lost to Follow-up|0|||
129575504|NCT02563561|466404092|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
129575505|NCT02563561|466404093|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
129575506|NCT02563561|466404094|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
129575507|NCT02563561|466404092|FG000|Overall Study|Investigator Decision|3|||
129575508|NCT02563561|466404093|FG001|Overall Study|Investigator Decision|4|||
129575509|NCT02563561|466404094|FG002|Overall Study|Investigator Decision|2|||
129575510|NCT02563561|466404092|FG000|Overall Study|Sponsor Decision|5|||
129575511|NCT02563561|466404093|FG001|Overall Study|Sponsor Decision|2|||
129575512|NCT02563561|466404094|FG002|Overall Study|Sponsor Decision|4|||
129575513|NCT02563561|466404092|FG000|Overall Study|Other|1|||
129575514|NCT02563561|466404093|FG001|Overall Study|Other|5|||
129575515|NCT02563561|466404094|FG002|Overall Study|Other|2|||
129575516|NCT02646124|466404097|FG000|Overall Study|Lost to Follow-up|0|||
129575517|NCT02646124|466404098|FG001|Overall Study|Lost to Follow-up|2|||
129575518|NCT03154047|466404099|FG000|Overall Study|Death|1|||
129575519|NCT03154047|466404099|FG000|Overall Study|Study terminated by sponsor|76|||
129575520|NCT03154047|466404099|FG000|Overall Study|Withdrawal by Subject|3|||
129575521|NCT00857454|466404100|FG000|Overall Study|Withdrawal by Subject|2|||
129575522|NCT00857454|466404100|FG000|Overall Study|Lost to Follow-up|1|||
129575523|NCT00857454|466404100|FG000|Overall Study|Adverse Event|2|||
129575524|NCT00857454|466404100|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
129575525|NCT00857454|466404100|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
129575526|NCT00857454|466404100|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
129575527|NCT00365365|466404101|FG000|Overall Study|Randomized but not treated|0|||
129575528|NCT00365365|466404102|FG001|Overall Study|Randomized but not treated|2|||
129575529|NCT00365365|466404103|FG002|Overall Study|Randomized but not treated|0|||
129575530|NCT00365365|466404101|FG000|Overall Study|Poor compliance to protocol|0|||
129575531|NCT00365365|466404102|FG001|Overall Study|Poor compliance to protocol|1|||
129575532|NCT00365365|466404103|FG002|Overall Study|Poor compliance to protocol|0|||
129575533|NCT00365365|466404101|FG000|Overall Study|Lost to Follow-up|3|||
129575534|NCT00365365|466404102|FG001|Overall Study|Lost to Follow-up|3|||
129575535|NCT00365365|466404103|FG002|Overall Study|Lost to Follow-up|3|||
129575536|NCT00365365|466404101|FG000|Overall Study|Death|1|||
129575537|NCT00365365|466404102|FG001|Overall Study|Death|3|||
129575538|NCT00365365|466404103|FG002|Overall Study|Death|0|||
129575539|NCT00365365|466404101|FG000|Overall Study|Subject's request|11|||
129575540|NCT00365365|466404102|FG001|Overall Study|Subject's request|13|||
129575541|NCT00365365|466404103|FG002|Overall Study|Subject's request|1|||
129575542|NCT00365365|466404101|FG000|Overall Study|Disease progression/relapse|9|||
129575543|NCT00365365|466404102|FG001|Overall Study|Disease progression/relapse|6|||
129575544|NCT00365365|466404103|FG002|Overall Study|Disease progression/relapse|7|||
129575545|NCT00365365|466404101|FG000|Overall Study|Adverse Event|6|||
129575546|NCT00365365|466404102|FG001|Overall Study|Adverse Event|6|||
129575547|NCT00365365|466404103|FG002|Overall Study|Adverse Event|3|||
129575548|NCT00365365|466404101|FG000|Overall Study|Moved|2|||
129575549|NCT00365365|466404102|FG001|Overall Study|Moved|0|||
129575550|NCT00365365|466404103|FG002|Overall Study|Moved|0|||
129575551|NCT00365365|466404101|FG000|Overall Study|New cancer|1|||
129575552|NCT00365365|466404102|FG001|Overall Study|New cancer|0|||
129575553|NCT00365365|466404103|FG002|Overall Study|New cancer|0|||
129575554|NCT00365365|466404101|FG000|Overall Study|Withdrew consent|1|||
129575555|NCT00365365|466404102|FG001|Overall Study|Withdrew consent|1|||
129575556|NCT00365365|466404103|FG002|Overall Study|Withdrew consent|0|||
129575557|NCT00365365|466404101|FG000|Overall Study|Second malignancy|0|||
129575558|NCT00365365|466404102|FG001|Overall Study|Second malignancy|1|||
129575559|NCT00365365|466404103|FG002|Overall Study|Second malignancy|0|||
129575560|NCT00365365|466404101|FG000|Overall Study|Patient/physician decision|0|||
129575561|NCT00365365|466404102|FG001|Overall Study|Patient/physician decision|0|||
129694291|NCT00147537|466837541|FG000|Phase 1b|Randomized but not treated|0|||
129694292|NCT00147537|466837542|FG001|Phase 1b|Randomized but not treated|0|||
129694293|NCT00147537|466837543|FG002|Phase 1b|Randomized but not treated|0|||
129694294|NCT00147537|466837544|FG003|Phase 1b|Randomized but not treated|0|||
129694295|NCT00147537|466837545|FG004|Phase 1b|Randomized but not treated|0|||
129694296|NCT00147537|466837546|FG005|Phase 1b|Randomized but not treated|0|||
129694297|NCT00147537|466837547|FG006|Phase 1b|Randomized but not treated|1|||
129694298|NCT00147537|466837548|FG007|Phase 1b|Randomized but not treated|0|||
129694299|NCT00147537|466837549|FG008|Phase 1b|Randomized but not treated|1|||
129694300|NCT00147537|466837550|FG009|Phase 1b|Randomized but not treated|0|||
129575562|NCT00365365|466404103|FG002|Overall Study|Patient/physician decision|1|||
129575563|NCT00984022|466404104|FG000|Overall Study|Lost to Follow-up|10|||
129575564|NCT00984022|466404105|FG001|Overall Study|Lost to Follow-up|14|||
129694301|NCT00147537|466837551|FG010|Phase 1b|Randomized but not treated|0|||
129575565|NCT00573443|466404109|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129575566|NCT00573443|466404110|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129575567|NCT00573443|466404111|FG002|Double-Blind Phase|Lost to Follow-up|2|||
129575568|NCT00573443|466404109|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
129575569|NCT00573443|466404110|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
129575570|NCT00573443|466404111|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
129575571|NCT00573443|466404109|FG000|Double-Blind Phase|Adverse Event|1|||
129575572|NCT00573443|466404110|FG001|Double-Blind Phase|Adverse Event|5|||
129575573|NCT00573443|466404111|FG002|Double-Blind Phase|Adverse Event|0|||
129694302|NCT00147537|466837541|FG000|Phase 2|Death|0|||
129575574|NCT00573443|466404109|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
129575575|NCT00573443|466404110|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
129575576|NCT00573443|466404111|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
129575577|NCT00573443|466404109|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
129575578|NCT00573443|466404110|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
129575579|NCT00573443|466404111|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
129575580|NCT00573443|466404109|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129575581|NCT00573443|466404110|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
129575582|NCT00573443|466404111|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
129575583|NCT00573443|466404109|FG000|Double-Blind Phase|Protocol Violation|0|||
129575584|NCT00573443|466404110|FG001|Double-Blind Phase|Protocol Violation|2|||
129575585|NCT00573443|466404111|FG002|Double-Blind Phase|Protocol Violation|1|||
129575586|NCT00573443|466404109|FG000|Double-Blind Phase|Other|0|||
129575587|NCT00573443|466404110|FG001|Double-Blind Phase|Other|2|||
129575588|NCT00573443|466404111|FG002|Double-Blind Phase|Other|3|||
129575589|NCT00573443|466404109|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
129575590|NCT00573443|466404110|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129575591|NCT00573443|466404111|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129575592|NCT00573443|466404109|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
129575593|NCT00573443|466404110|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
129575594|NCT00573443|466404111|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
129575595|NCT00573443|466404109|FG000|Open-Label Extension Phase|Adverse Event|3|||
129575596|NCT00573443|466404110|FG001|Open-Label Extension Phase|Adverse Event|0|||
129575597|NCT00573443|466404111|FG002|Open-Label Extension Phase|Adverse Event|0|||
129575598|NCT00573443|466404109|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
129575599|NCT00573443|466404110|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
129575600|NCT00573443|466404111|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
129575601|NCT00573443|466404109|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
129575602|NCT00573443|466404110|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
129575603|NCT00573443|466404111|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
129575604|NCT00573443|466404109|FG000|Open-Label Extension Phase|Protocol Violation|2|||
129575605|NCT00573443|466404110|FG001|Open-Label Extension Phase|Protocol Violation|0|||
129575606|NCT00573443|466404111|FG002|Open-Label Extension Phase|Protocol Violation|0|||
129575607|NCT00573443|466404109|FG000|Open-Label Extension Phase|Other|2|||
129575608|NCT00573443|466404110|FG001|Open-Label Extension Phase|Other|0|||
129575609|NCT00573443|466404111|FG002|Open-Label Extension Phase|Other|0|||
129575610|NCT00905606|466404112|FG000|Period 1|Adverse Event|0|||
129575611|NCT00905606|466404113|FG001|Period 1|Adverse Event|1|||
129575612|NCT00905606|466404112|FG000|Washout|Withdrawal by Subject|1|||
129575613|NCT00905606|466404113|FG001|Washout|Withdrawal by Subject|0|||
129575614|NCT00804856|466404116|FG000|Overall Study|Progressive Disease|3|||
129575615|NCT00804856|466404117|FG001|Overall Study|Progressive Disease|2|||
129575616|NCT00804856|466404118|FG002|Overall Study|Progressive Disease|4|||
129575617|NCT00804856|466404119|FG003|Overall Study|Progressive Disease|6|||
129575618|NCT00804856|466404120|FG004|Overall Study|Progressive Disease|4|||
129575619|NCT00804856|466404121|FG005|Overall Study|Progressive Disease|1|||
129575620|NCT00804856|466404122|FG006|Overall Study|Progressive Disease|8|||
129575621|NCT00804856|466404123|FG007|Overall Study|Progressive Disease|2|||
129575622|NCT00804856|466404124|FG008|Overall Study|Progressive Disease|4|||
129575623|NCT00804856|466404125|FG009|Overall Study|Progressive Disease|5|||
129575624|NCT00804856|466404126|FG010|Overall Study|Progressive Disease|12|||
129575625|NCT00804856|466404127|FG011|Overall Study|Progressive Disease|2|||
129575626|NCT00804856|466404128|FG012|Overall Study|Progressive Disease|2|||
129575627|NCT00804856|466404129|FG013|Overall Study|Progressive Disease|26|||
129575628|NCT00804856|466404130|FG014|Overall Study|Progressive Disease|20|||
129575629|NCT00804856|466404116|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575630|NCT00804856|466404117|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575631|NCT00804856|466404118|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575632|NCT00804856|466404119|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575633|NCT00804856|466404120|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129575634|NCT00804856|466404121|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575635|NCT00804856|466404122|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129694303|NCT00147537|466837542|FG001|Phase 2|Death|0|||
129694304|NCT00147537|466837543|FG002|Phase 2|Death|0|||
129694305|NCT00147537|466837544|FG003|Phase 2|Death|0|||
129694306|NCT00147537|466837545|FG004|Phase 2|Death|0|||
129575636|NCT00804856|466404123|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575637|NCT00804856|466404124|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575638|NCT00804856|466404125|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575639|NCT00804856|466404126|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575640|NCT00804856|466404127|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575641|NCT00804856|466404128|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129694307|NCT00147537|466837546|FG005|Phase 2|Death|0|||
129694308|NCT00147537|466837547|FG006|Phase 2|Death|0|||
129575642|NCT00804856|466404129|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129575643|NCT00804856|466404130|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129575644|NCT00804856|466404116|FG000|Overall Study|Other Adverse Event|1|||
129575645|NCT00804856|466404117|FG001|Overall Study|Other Adverse Event|1|||
129575646|NCT00804856|466404118|FG002|Overall Study|Other Adverse Event|1|||
129575647|NCT00804856|466404119|FG003|Overall Study|Other Adverse Event|2|||
129575648|NCT00804856|466404120|FG004|Overall Study|Other Adverse Event|2|||
129575649|NCT00804856|466404121|FG005|Overall Study|Other Adverse Event|1|||
129575650|NCT00804856|466404122|FG006|Overall Study|Other Adverse Event|3|||
129575651|NCT00804856|466404123|FG007|Overall Study|Other Adverse Event|0|||
129575652|NCT00804856|466404124|FG008|Overall Study|Other Adverse Event|0|||
129575653|NCT00804856|466404125|FG009|Overall Study|Other Adverse Event|1|||
129575654|NCT00804856|466404126|FG010|Overall Study|Other Adverse Event|5|||
129575655|NCT00804856|466404127|FG011|Overall Study|Other Adverse Event|2|||
129575656|NCT00804856|466404128|FG012|Overall Study|Other Adverse Event|0|||
129575657|NCT00804856|466404129|FG013|Overall Study|Other Adverse Event|6|||
129575658|NCT00804856|466404130|FG014|Overall Study|Other Adverse Event|13|||
129575659|NCT00804856|466404116|FG000|Overall Study|Non compliance with protocol|0|||
129575660|NCT00804856|466404117|FG001|Overall Study|Non compliance with protocol|0|||
129575661|NCT00804856|466404118|FG002|Overall Study|Non compliance with protocol|0|||
129575662|NCT00804856|466404119|FG003|Overall Study|Non compliance with protocol|0|||
129575663|NCT00804856|466404120|FG004|Overall Study|Non compliance with protocol|0|||
129575664|NCT00804856|466404121|FG005|Overall Study|Non compliance with protocol|0|||
129575665|NCT00804856|466404122|FG006|Overall Study|Non compliance with protocol|0|||
129575666|NCT00804856|466404123|FG007|Overall Study|Non compliance with protocol|0|||
129575667|NCT00804856|466404124|FG008|Overall Study|Non compliance with protocol|0|||
129575668|NCT00804856|466404125|FG009|Overall Study|Non compliance with protocol|0|||
129575669|NCT00804856|466404126|FG010|Overall Study|Non compliance with protocol|0|||
129575670|NCT00804856|466404127|FG011|Overall Study|Non compliance with protocol|0|||
129575671|NCT00804856|466404128|FG012|Overall Study|Non compliance with protocol|0|||
129575672|NCT00804856|466404129|FG013|Overall Study|Non compliance with protocol|2|||
129575673|NCT00804856|466404130|FG014|Overall Study|Non compliance with protocol|0|||
129575674|NCT00804856|466404116|FG000|Overall Study|Refused to continue medication|0|||
129575675|NCT00804856|466404117|FG001|Overall Study|Refused to continue medication|0|||
129575676|NCT00804856|466404118|FG002|Overall Study|Refused to continue medication|0|||
129575677|NCT00804856|466404119|FG003|Overall Study|Refused to continue medication|1|||
129575678|NCT00804856|466404120|FG004|Overall Study|Refused to continue medication|1|||
129575679|NCT00804856|466404121|FG005|Overall Study|Refused to continue medication|0|||
129575680|NCT00804856|466404122|FG006|Overall Study|Refused to continue medication|0|||
129575681|NCT00804856|466404123|FG007|Overall Study|Refused to continue medication|0|||
129575682|NCT00804856|466404124|FG008|Overall Study|Refused to continue medication|0|||
129575683|NCT00804856|466404125|FG009|Overall Study|Refused to continue medication|0|||
129575684|NCT00804856|466404126|FG010|Overall Study|Refused to continue medication|3|||
129575685|NCT00804856|466404127|FG011|Overall Study|Refused to continue medication|0|||
129575686|NCT00804856|466404128|FG012|Overall Study|Refused to continue medication|1|||
129575687|NCT00804856|466404129|FG013|Overall Study|Refused to continue medication|1|||
129575688|NCT00804856|466404130|FG014|Overall Study|Refused to continue medication|5|||
129575689|NCT00804856|466404116|FG000|Overall Study|Other reason than listed above|0|||
129575690|NCT00804856|466404117|FG001|Overall Study|Other reason than listed above|0|||
129694309|NCT00147537|466837548|FG007|Phase 2|Death|0|||
129694310|NCT00147537|466837549|FG008|Phase 2|Death|0|||
129694311|NCT00147537|466837550|FG009|Phase 2|Death|85|||
129694312|NCT00147537|466837551|FG010|Phase 2|Death|31|||
129694313|NCT00147537|466837541|FG000|Phase 2|Lost to Follow-up|0|||
129694314|NCT00147537|466837542|FG001|Phase 2|Lost to Follow-up|0|||
129694315|NCT00147537|466837543|FG002|Phase 2|Lost to Follow-up|0|||
129694316|NCT00147537|466837544|FG003|Phase 2|Lost to Follow-up|0|||
129694317|NCT00147537|466837545|FG004|Phase 2|Lost to Follow-up|0|||
129694318|NCT00147537|466837546|FG005|Phase 2|Lost to Follow-up|0|||
129694319|NCT00147537|466837547|FG006|Phase 2|Lost to Follow-up|0|||
129694320|NCT00147537|466837548|FG007|Phase 2|Lost to Follow-up|0|||
129694321|NCT00147537|466837549|FG008|Phase 2|Lost to Follow-up|0|||
129694322|NCT00147537|466837550|FG009|Phase 2|Lost to Follow-up|12|||
129694323|NCT00147537|466837551|FG010|Phase 2|Lost to Follow-up|4|||
129694324|NCT00147537|466837541|FG000|Phase 2|Other|0|||
129694325|NCT00147537|466837542|FG001|Phase 2|Other|0|||
129694326|NCT00147537|466837543|FG002|Phase 2|Other|0|||
129694327|NCT00147537|466837544|FG003|Phase 2|Other|0|||
129694328|NCT00147537|466837545|FG004|Phase 2|Other|0|||
129694329|NCT00147537|466837546|FG005|Phase 2|Other|0|||
129694330|NCT00147537|466837547|FG006|Phase 2|Other|0|||
129694331|NCT00147537|466837548|FG007|Phase 2|Other|0|||
129694332|NCT00147537|466837549|FG008|Phase 2|Other|0|||
129694333|NCT00147537|466837550|FG009|Phase 2|Other|47|||
129694334|NCT00147537|466837551|FG010|Phase 2|Other|12|||
129575691|NCT00804856|466404118|FG002|Overall Study|Other reason than listed above|0|||
129575692|NCT00804856|466404119|FG003|Overall Study|Other reason than listed above|0|||
129575693|NCT00804856|466404120|FG004|Overall Study|Other reason than listed above|0|||
129575694|NCT00804856|466404121|FG005|Overall Study|Other reason than listed above|1|||
129575695|NCT00804856|466404122|FG006|Overall Study|Other reason than listed above|0|||
129575696|NCT00804856|466404123|FG007|Overall Study|Other reason than listed above|0|||
129575697|NCT00804856|466404124|FG008|Overall Study|Other reason than listed above|1|||
129575698|NCT00804856|466404125|FG009|Overall Study|Other reason than listed above|0|||
129575699|NCT00804856|466404126|FG010|Overall Study|Other reason than listed above|3|||
129575700|NCT00804856|466404127|FG011|Overall Study|Other reason than listed above|1|||
129575701|NCT00804856|466404128|FG012|Overall Study|Other reason than listed above|1|||
129575702|NCT00804856|466404129|FG013|Overall Study|Other reason than listed above|10|||
129575703|NCT00804856|466404130|FG014|Overall Study|Other reason than listed above|3|||
129575704|NCT00418561|466404131|FG000|Overall Study|Participant's (guardian's) decision|0|||
129575705|NCT00418561|466404132|FG001|Overall Study|Participant's (guardian's) decision|1|||
129575706|NCT00418561|466404133|FG002|Overall Study|Participant's (guardian's) decision|0|||
129575707|NCT01796171|466404134|FG000|Enrolled|Death|0|||
129575708|NCT01796171|466404135|FG001|Enrolled|Death|0|||
129575709|NCT01796171|466404136|FG002|Enrolled|Death|0|||
129575710|NCT01796171|466404137|FG003|Enrolled|Death|0|||
129575711|NCT01796171|466404138|FG004|Enrolled|Death|0|||
129575712|NCT01796171|466404139|FG005|Enrolled|Death|0|||
129575713|NCT01796171|466404140|FG006|Enrolled|Death|0|||
129575714|NCT01796171|466404141|FG007|Enrolled|Death|0|||
129575715|NCT01796171|466404142|FG008|Enrolled|Death|0|||
129575716|NCT01796171|466404143|FG009|Enrolled|Death|0|||
129575717|NCT01796171|466404144|FG010|Enrolled|Death|0|||
129575718|NCT01796171|466404145|FG011|Enrolled|Death|0|||
129575719|NCT01796171|466404146|FG012|Enrolled|Death|0|||
129575720|NCT01796171|466404147|FG013|Enrolled|Death|0|||
129575721|NCT01796171|466404148|FG014|Enrolled|Death|1|||
129575722|NCT01796171|466404134|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
129575723|NCT01796171|466404135|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
129575724|NCT01796171|466404136|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
129575725|NCT01796171|466404137|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
129575726|NCT01796171|466404138|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
129575727|NCT01796171|466404139|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
129575728|NCT01796171|466404140|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
129575729|NCT01796171|466404141|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
129575730|NCT01796171|466404142|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
129575731|NCT01796171|466404143|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
129575732|NCT01796171|466404144|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
129575733|NCT01796171|466404145|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
129575734|NCT01796171|466404146|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
129575735|NCT01796171|466404147|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
129575736|NCT01796171|466404148|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
129575737|NCT01796171|466404134|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575738|NCT01796171|466404135|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575739|NCT01796171|466404136|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575740|NCT01796171|466404137|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575741|NCT01796171|466404138|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575742|NCT01796171|466404139|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575743|NCT01796171|466404140|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575744|NCT01796171|466404141|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575745|NCT01796171|466404142|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575746|NCT01796171|466404143|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575747|NCT01796171|466404144|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575748|NCT01796171|466404145|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575749|NCT01796171|466404146|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575750|NCT01796171|466404147|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
129575751|NCT01796171|466404148|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
129575752|NCT01796171|466404134|FG000|Treatment Period With Betalutin|Progressive disease|0|||
129575753|NCT01796171|466404135|FG001|Treatment Period With Betalutin|Progressive disease|1|||
129575754|NCT01796171|466404136|FG002|Treatment Period With Betalutin|Progressive disease|0|||
129575755|NCT01796171|466404137|FG003|Treatment Period With Betalutin|Progressive disease|0|||
129575756|NCT01796171|466404138|FG004|Treatment Period With Betalutin|Progressive disease|0|||
129575757|NCT01796171|466404139|FG005|Treatment Period With Betalutin|Progressive disease|0|||
129575758|NCT01796171|466404140|FG006|Treatment Period With Betalutin|Progressive disease|0|||
129575759|NCT01796171|466404141|FG007|Treatment Period With Betalutin|Progressive disease|0|||
129694335|NCT00147537|466837541|FG000|Phase 2|Withdrawal by Subject|0|||
129694336|NCT00147537|466837542|FG001|Phase 2|Withdrawal by Subject|0|||
129694337|NCT00147537|466837543|FG002|Phase 2|Withdrawal by Subject|0|||
129694338|NCT00147537|466837544|FG003|Phase 2|Withdrawal by Subject|0|||
129694339|NCT00147537|466837545|FG004|Phase 2|Withdrawal by Subject|0|||
129784352|NCT02617485|467179920|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
129784353|NCT02617485|467179919|FG000|Follow-up Period|Patient needed radiotherapy|9|||
129784354|NCT02617485|467179920|FG001|Follow-up Period|Patient needed radiotherapy|5|||
129784355|NCT02617485|467179919|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
129784356|NCT02617485|467179920|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
129784357|NCT04590248|467179922|FG000|Overall Study|Lost to Follow-up|1|||
129784358|NCT04590248|467179922|FG000|Overall Study|Withdrawal by Subject|16|||
129784359|NCT04590248|467179922|FG000|Overall Study|Other|2|||
129784360|NCT03598114|467179923|FG000|Overall Study|Staff turnover/left the program|3|||
129784361|NCT03598114|467179924|FG001|Overall Study|Staff turnover/left the program|39|||
129784362|NCT04250077|467179928|FG000|Overall Study|Withdrawal by Subject|0|||
129784363|NCT04250077|467179929|FG001|Overall Study|Withdrawal by Subject|1|||
129784364|NCT04250077|467179930|FG002|Overall Study|Withdrawal by Subject|0|||
129784365|NCT04250077|467179928|FG000|Overall Study|Lost to Follow-up|2|||
129784366|NCT04250077|467179929|FG001|Overall Study|Lost to Follow-up|3|||
129784367|NCT04250077|467179930|FG002|Overall Study|Lost to Follow-up|0|||
129784368|NCT01022398|467179931|FG000|Overall Study|Study terminated|2|||
129784369|NCT01022398|467179932|FG001|Overall Study|Study terminated|2|||
129784370|NCT00640224|467179933|FG000|Overall Study|Lost to Follow-up|5|||
129784371|NCT00640224|467179934|FG001|Overall Study|Lost to Follow-up|2|||
129784372|NCT00640224|467179935|FG002|Overall Study|Lost to Follow-up|0|||
129784373|NCT00640224|467179936|FG003|Overall Study|Lost to Follow-up|0|||
129784374|NCT00640224|467179933|FG000|Overall Study|Withdrawal by Subject|1|||
129784375|NCT00640224|467179934|FG001|Overall Study|Withdrawal by Subject|0|||
129784376|NCT00640224|467179935|FG002|Overall Study|Withdrawal by Subject|0|||
129784377|NCT00640224|467179936|FG003|Overall Study|Withdrawal by Subject|0|||
129784378|NCT00640224|467179933|FG000|Overall Study|Headaches|0|||
129784379|NCT00640224|467179934|FG001|Overall Study|Headaches|1|||
129784380|NCT00640224|467179935|FG002|Overall Study|Headaches|0|||
129784381|NCT00640224|467179936|FG003|Overall Study|Headaches|0|||
129784382|NCT02937584|467179941|FG000|Period 1|Adverse Event|1|||
129784383|NCT02937584|467179942|FG001|Period 1|Adverse Event|2|||
129784384|NCT02937584|467179941|FG000|Washout|Adverse Event|0|||
129784385|NCT02937584|467179942|FG001|Washout|Adverse Event|1|||
129784386|NCT04075734|467179951|FG000|Overall Study|Lost to Follow-up|1|||
129784387|NCT04075734|467179952|FG001|Overall Study|Lost to Follow-up|1|||
129784388|NCT04075734|467179953|FG002|Overall Study|Lost to Follow-up|0|||
129784389|NCT04075734|467179951|FG000|Overall Study|Withdrawal by Subject|3|||
129784390|NCT04075734|467179952|FG001|Overall Study|Withdrawal by Subject|0|||
129784391|NCT04075734|467179953|FG002|Overall Study|Withdrawal by Subject|0|||
129784392|NCT03615040|467179954|FG000|Overall Study|Withdrawal by Subject|2|||
129784393|NCT03615040|467179955|FG001|Overall Study|Withdrawal by Subject|1|||
129784394|NCT03615040|467179954|FG000|Overall Study|Physician Decision|2|||
129784395|NCT03615040|467179955|FG001|Overall Study|Physician Decision|2|||
129784396|NCT03615040|467179954|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
129784397|NCT03615040|467179955|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
129784398|NCT03615040|467179954|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
129784399|NCT03615040|467179955|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
129784400|NCT03615040|467179954|FG000|Overall Study|Death|0|||
129784401|NCT03615040|467179955|FG001|Overall Study|Death|2|||
129784402|NCT01776307|467179956|FG000|Overall Study|Not dosed|0|||
129784403|NCT01776307|467179957|FG001|Overall Study|Not dosed|0|||
129784404|NCT01776307|467179958|FG002|Overall Study|Not dosed|1|||
129784405|NCT04074161|467179961|FG000|Overall Study|Withdrawal by Subject|2|||
129784406|NCT04074161|467179962|FG001|Overall Study|Withdrawal by Subject|4|||
129784407|NCT04074161|467179963|FG002|Overall Study|Withdrawal by Subject|1|||
129784408|NCT04074161|467179961|FG000|Overall Study|Lost to Follow-up|4|||
129784409|NCT04074161|467179962|FG001|Overall Study|Lost to Follow-up|5|||
129784410|NCT04074161|467179963|FG002|Overall Study|Lost to Follow-up|3|||
129784411|NCT03890666|467179975|FG000|Overall Study|Withdrawal by Subject|0|||
129784412|NCT03890666|467179976|FG001|Overall Study|Withdrawal by Subject|1|||
129784413|NCT03890666|467179975|FG000|Overall Study|Protocol deviation|1|||
129784414|NCT03890666|467179976|FG001|Overall Study|Protocol deviation|4|||
129784415|NCT03890666|467179975|FG000|Overall Study|Lost to Follow-up|2|||
129784416|NCT03890666|467179976|FG001|Overall Study|Lost to Follow-up|5|||
129784417|NCT03890666|467179975|FG000|Overall Study|Other than specified|1|||
129784418|NCT03890666|467179976|FG001|Overall Study|Other than specified|8|||
129784419|NCT03232333|467179977|FG000|Overall Study|Infection or Osteomyelitis|9|||
129784420|NCT03232333|467179977|FG000|Overall Study|Lost to Follow-up|4|||
129784421|NCT03232333|467179977|FG000|Overall Study|Withdrawal by Subject|2|||
129784422|NCT03052426|467179978|FG000|Overall Study|Withdrawal by Subject|0|||
129784423|NCT03052426|467179979|FG001|Overall Study|Withdrawal by Subject|1|||
129784424|NCT03052426|467179980|FG002|Overall Study|Withdrawal by Subject|0|||
129784425|NCT03052426|467179978|FG000|Overall Study|Lost to Follow-up|2|||
129575760|NCT01796171|466404142|FG008|Treatment Period With Betalutin|Progressive disease|0|||
129575761|NCT01796171|466404143|FG009|Treatment Period With Betalutin|Progressive disease|0|||
129575762|NCT01796171|466404144|FG010|Treatment Period With Betalutin|Progressive disease|0|||
129575763|NCT01796171|466404145|FG011|Treatment Period With Betalutin|Progressive disease|0|||
129575764|NCT01796171|466404146|FG012|Treatment Period With Betalutin|Progressive disease|0|||
129575765|NCT01796171|466404147|FG013|Treatment Period With Betalutin|Progressive disease|0|||
129575766|NCT01796171|466404148|FG014|Treatment Period With Betalutin|Progressive disease|0|||
129575767|NCT01796171|466404134|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575768|NCT01796171|466404135|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575769|NCT01796171|466404136|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575770|NCT01796171|466404137|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575771|NCT01796171|466404138|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575772|NCT01796171|466404139|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575773|NCT01796171|466404140|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575774|NCT01796171|466404141|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575775|NCT01796171|466404142|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
129575776|NCT01796171|466404143|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575777|NCT01796171|466404144|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
129575778|NCT01796171|466404145|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
129575779|NCT01796171|466404146|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575780|NCT01796171|466404147|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575781|NCT01796171|466404148|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
129575782|NCT01796171|466404134|FG000|Treatment Period With Betalutin|Physician Decision|0|||
129575783|NCT01796171|466404135|FG001|Treatment Period With Betalutin|Physician Decision|0|||
129575784|NCT01796171|466404136|FG002|Treatment Period With Betalutin|Physician Decision|0|||
129575785|NCT01796171|466404137|FG003|Treatment Period With Betalutin|Physician Decision|0|||
129575786|NCT01796171|466404138|FG004|Treatment Period With Betalutin|Physician Decision|0|||
129575787|NCT01796171|466404139|FG005|Treatment Period With Betalutin|Physician Decision|0|||
129575788|NCT01796171|466404140|FG006|Treatment Period With Betalutin|Physician Decision|0|||
129575789|NCT01796171|466404141|FG007|Treatment Period With Betalutin|Physician Decision|0|||
129575790|NCT01796171|466404142|FG008|Treatment Period With Betalutin|Physician Decision|0|||
129575791|NCT01796171|466404143|FG009|Treatment Period With Betalutin|Physician Decision|0|||
129575792|NCT01796171|466404144|FG010|Treatment Period With Betalutin|Physician Decision|5|||
129575793|NCT01796171|466404145|FG011|Treatment Period With Betalutin|Physician Decision|1|||
129575794|NCT01796171|466404146|FG012|Treatment Period With Betalutin|Physician Decision|1|||
129575795|NCT01796171|466404147|FG013|Treatment Period With Betalutin|Physician Decision|0|||
129575796|NCT01796171|466404148|FG014|Treatment Period With Betalutin|Physician Decision|0|||
129575797|NCT01796171|466404134|FG000|Treatment Period With Betalutin|Death|0|||
129575798|NCT01796171|466404135|FG001|Treatment Period With Betalutin|Death|0|||
129575799|NCT01796171|466404136|FG002|Treatment Period With Betalutin|Death|0|||
129575800|NCT01796171|466404137|FG003|Treatment Period With Betalutin|Death|0|||
129694340|NCT00147537|466837546|FG005|Phase 2|Withdrawal by Subject|0|||
129694341|NCT00147537|466837547|FG006|Phase 2|Withdrawal by Subject|0|||
129694342|NCT00147537|466837548|FG007|Phase 2|Withdrawal by Subject|0|||
129694343|NCT00147537|466837549|FG008|Phase 2|Withdrawal by Subject|0|||
129694344|NCT00147537|466837550|FG009|Phase 2|Withdrawal by Subject|16|||
129694345|NCT00147537|466837551|FG010|Phase 2|Withdrawal by Subject|4|||
129694346|NCT00147537|466837541|FG000|Phase 2|Randomized but not treated|0|||
129694347|NCT00147537|466837542|FG001|Phase 2|Randomized but not treated|0|||
129694348|NCT00147537|466837543|FG002|Phase 2|Randomized but not treated|0|||
129694349|NCT00147537|466837544|FG003|Phase 2|Randomized but not treated|0|||
129694350|NCT00147537|466837545|FG004|Phase 2|Randomized but not treated|0|||
129694351|NCT00147537|466837546|FG005|Phase 2|Randomized but not treated|0|||
129694352|NCT00147537|466837547|FG006|Phase 2|Randomized but not treated|0|||
129694353|NCT00147537|466837548|FG007|Phase 2|Randomized but not treated|0|||
129694354|NCT00147537|466837549|FG008|Phase 2|Randomized but not treated|0|||
129694355|NCT00147537|466837550|FG009|Phase 2|Randomized but not treated|1|||
129694356|NCT00147537|466837551|FG010|Phase 2|Randomized but not treated|1|||
129694357|NCT00345592|466837552|FG000|Overall Study|Death|14|||
129694358|NCT00345592|466837553|FG001|Overall Study|Death|16|||
129694359|NCT00345592|466837552|FG000|Overall Study|Withdrawal by Subject|11|||
129694360|NCT00345592|466837553|FG001|Overall Study|Withdrawal by Subject|8|||
129694361|NCT02006654|466837555|FG000|Overall Study|Withdrawal before treatment|4|||
129694362|NCT02006654|466837556|FG001|Overall Study|Withdrawal before treatment|2|||
129694363|NCT02006654|466837555|FG000|Overall Study|Adverse Event|16|||
129694364|NCT02006654|466837556|FG001|Overall Study|Adverse Event|17|||
129694365|NCT02006654|466837555|FG000|Overall Study|Death|1|||
129575801|NCT01796171|466404138|FG004|Treatment Period With Betalutin|Death|0|||
129575802|NCT01796171|466404139|FG005|Treatment Period With Betalutin|Death|0|||
129575803|NCT01796171|466404140|FG006|Treatment Period With Betalutin|Death|0|||
129575804|NCT01796171|466404141|FG007|Treatment Period With Betalutin|Death|0|||
129575805|NCT01796171|466404142|FG008|Treatment Period With Betalutin|Death|0|||
129575806|NCT01796171|466404143|FG009|Treatment Period With Betalutin|Death|0|||
129575807|NCT01796171|466404144|FG010|Treatment Period With Betalutin|Death|2|||
129575808|NCT01796171|466404145|FG011|Treatment Period With Betalutin|Death|0|||
129575809|NCT01796171|466404146|FG012|Treatment Period With Betalutin|Death|0|||
129575810|NCT01796171|466404147|FG013|Treatment Period With Betalutin|Death|0|||
129575811|NCT01796171|466404148|FG014|Treatment Period With Betalutin|Death|0|||
129575812|NCT01796171|466404134|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
129575813|NCT01796171|466404135|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
129575814|NCT01796171|466404136|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
129575815|NCT01796171|466404137|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
129575816|NCT01796171|466404138|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
129575817|NCT01796171|466404139|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
129575818|NCT01796171|466404140|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
129575819|NCT01796171|466404141|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
129575820|NCT01796171|466404142|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
129575821|NCT01796171|466404143|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
129575822|NCT01796171|466404144|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
129575823|NCT01796171|466404145|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
129575824|NCT01796171|466404146|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
129575825|NCT01796171|466404147|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
129575826|NCT01796171|466404148|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
129575827|NCT01796171|466404134|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575828|NCT01796171|466404135|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575829|NCT01796171|466404136|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575830|NCT01796171|466404137|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575831|NCT01796171|466404138|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575832|NCT01796171|466404139|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575833|NCT01796171|466404140|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575834|NCT01796171|466404141|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575835|NCT01796171|466404142|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575836|NCT01796171|466404143|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129694366|NCT02006654|466837556|FG001|Overall Study|Death|0|||
129694367|NCT02006654|466837555|FG000|Overall Study|Withdrawal by Subject|14|||
129694368|NCT02006654|466837556|FG001|Overall Study|Withdrawal by Subject|12|||
129694369|NCT02006654|466837555|FG000|Overall Study|Protocol Violation|5|||
129694370|NCT02006654|466837556|FG001|Overall Study|Protocol Violation|8|||
129694371|NCT02006654|466837555|FG000|Overall Study|Lost to Follow-up|1|||
129784426|NCT03052426|467179979|FG001|Overall Study|Lost to Follow-up|0|||
129784427|NCT03052426|467179980|FG002|Overall Study|Lost to Follow-up|1|||
129784428|NCT01853839|467179982|FG000|Overall Study|Violated inclusion criteria|2|||
129784429|NCT01853839|467179982|FG000|Overall Study|Not meet ITT population definition|58|||
129784430|NCT01853839|467179982|FG000|Overall Study|End of treatment visit too early|33|||
129784431|NCT01853839|467179982|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
129784432|NCT04145219|467179983|FG000|Overall Study|Adverse Event|18|||
129784433|NCT04145219|467179984|FG001|Overall Study|Adverse Event|6|||
129784434|NCT04145219|467179983|FG000|Overall Study|Lost to Follow-up|2|||
129784435|NCT04145219|467179984|FG001|Overall Study|Lost to Follow-up|3|||
129784436|NCT04145219|467179983|FG000|Overall Study|Physician Decision|0|||
129784437|NCT04145219|467179984|FG001|Overall Study|Physician Decision|2|||
129784438|NCT04145219|467179983|FG000|Overall Study|Withdrawal by Subject|12|||
129784439|NCT04145219|467179984|FG001|Overall Study|Withdrawal by Subject|8|||
129784440|NCT04145219|467179983|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
129784441|NCT04145219|467179984|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
129784442|NCT02709538|467179985|FG000|Overall Study|Adverse Event|13|||
129784443|NCT02709538|467179986|FG001|Overall Study|Adverse Event|2|||
129575837|NCT01796171|466404144|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
129694372|NCT02006654|466837556|FG001|Overall Study|Lost to Follow-up|0|||
129575838|NCT01796171|466404145|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
129575839|NCT01796171|466404146|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575840|NCT01796171|466404147|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129784444|NCT02709538|467179987|FG002|Overall Study|Adverse Event|3|||
129694373|NCT02006654|466837555|FG000|Overall Study|patient's will|2|||
129784445|NCT02709538|467179985|FG000|Overall Study|Lack of Efficacy|1|||
129784446|NCT02709538|467179986|FG001|Overall Study|Lack of Efficacy|0|||
129694374|NCT02006654|466837556|FG001|Overall Study|patient's will|1|||
129784447|NCT02709538|467179987|FG002|Overall Study|Lack of Efficacy|0|||
129784448|NCT02709538|467179985|FG000|Overall Study|Lost to Follow-up|24|||
129784449|NCT02709538|467179986|FG001|Overall Study|Lost to Follow-up|8|||
129784450|NCT02709538|467179987|FG002|Overall Study|Lost to Follow-up|4|||
129784451|NCT02709538|467179985|FG000|Overall Study|Physician Decision|1|||
129784452|NCT02709538|467179986|FG001|Overall Study|Physician Decision|0|||
129784453|NCT02709538|467179987|FG002|Overall Study|Physician Decision|0|||
129784454|NCT02709538|467179985|FG000|Overall Study|Withdrawal by Subject|40|||
129784455|NCT02709538|467179986|FG001|Overall Study|Withdrawal by Subject|7|||
129784456|NCT02709538|467179987|FG002|Overall Study|Withdrawal by Subject|4|||
129784457|NCT02709538|467179985|FG000|Overall Study|Non-compliance with study procedures|5|||
129784458|NCT02709538|467179986|FG001|Overall Study|Non-compliance with study procedures|0|||
129784459|NCT02709538|467179987|FG002|Overall Study|Non-compliance with study procedures|0|||
129784460|NCT02709538|467179985|FG000|Overall Study|Non-compliance with study drug|2|||
129784461|NCT02709538|467179986|FG001|Overall Study|Non-compliance with study drug|0|||
129784462|NCT02709538|467179987|FG002|Overall Study|Non-compliance with study drug|0|||
129784463|NCT02709538|467179985|FG000|Overall Study|Protocol deviation|10|||
129784464|NCT02709538|467179986|FG001|Overall Study|Protocol deviation|4|||
129784465|NCT02709538|467179987|FG002|Overall Study|Protocol deviation|4|||
129575841|NCT01796171|466404148|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
129575842|NCT01796171|466404134|FG000|Follow-up Period|Start of further anticancer therapy|4|||
129575843|NCT01796171|466404135|FG001|Follow-up Period|Start of further anticancer therapy|25|||
129575844|NCT01796171|466404136|FG002|Follow-up Period|Start of further anticancer therapy|2|||
129575845|NCT01796171|466404137|FG003|Follow-up Period|Start of further anticancer therapy|1|||
129575846|NCT01796171|466404138|FG004|Follow-up Period|Start of further anticancer therapy|2|||
129575847|NCT01796171|466404139|FG005|Follow-up Period|Start of further anticancer therapy|2|||
129575848|NCT01796171|466404140|FG006|Follow-up Period|Start of further anticancer therapy|1|||
129784466|NCT02709538|467179985|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
129784467|NCT02709538|467179986|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
129784468|NCT02709538|467179987|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
129784469|NCT02709538|467179985|FG000|Overall Study|Other|16|||
129784470|NCT02709538|467179986|FG001|Overall Study|Other|7|||
129784471|NCT02709538|467179987|FG002|Overall Study|Other|5|||
129784472|NCT02059291|467179988|FG000|Epoch 2|Lack of Efficacy|0|||
129784473|NCT02059291|467179989|FG001|Epoch 2|Lack of Efficacy|0|||
129784474|NCT02059291|467179990|FG002|Epoch 2|Lack of Efficacy|0|||
129784475|NCT02059291|467179991|FG003|Epoch 2|Lack of Efficacy|1|||
129784476|NCT02059291|467179992|FG004|Epoch 2|Lack of Efficacy|0|||
129784477|NCT02059291|467179993|FG005|Epoch 2|Lack of Efficacy|1|||
129784478|NCT02059291|467179994|FG006|Epoch 2|Lack of Efficacy|0|||
129784479|NCT02059291|467179995|FG007|Epoch 2|Lack of Efficacy|0|||
129784480|NCT02059291|467179996|FG008|Epoch 2|Lack of Efficacy|0|||
129784481|NCT02059291|467179997|FG009|Epoch 2|Lack of Efficacy|0|||
129784482|NCT02059291|467179998|FG010|Epoch 2|Lack of Efficacy|0|||
129784483|NCT02059291|467179999|FG011|Epoch 2|Lack of Efficacy|0|||
129784484|NCT02059291|467180000|FG012|Epoch 2|Lack of Efficacy|0|||
129784485|NCT02059291|467180001|FG013|Epoch 2|Lack of Efficacy|0|||
129575849|NCT01796171|466404141|FG007|Follow-up Period|Start of further anticancer therapy|15|||
129575850|NCT01796171|466404142|FG008|Follow-up Period|Start of further anticancer therapy|2|||
129575851|NCT01796171|466404143|FG009|Follow-up Period|Start of further anticancer therapy|0|||
129575852|NCT01796171|466404144|FG010|Follow-up Period|Start of further anticancer therapy|0|||
129575853|NCT01796171|466404145|FG011|Follow-up Period|Start of further anticancer therapy|0|||
129575854|NCT01796171|466404146|FG012|Follow-up Period|Start of further anticancer therapy|0|||
129575855|NCT01796171|466404147|FG013|Follow-up Period|Start of further anticancer therapy|0|||
129575856|NCT01796171|466404148|FG014|Follow-up Period|Start of further anticancer therapy|0|||
129575857|NCT01796171|466404134|FG000|Follow-up Period|Progressive disease|0|||
129575858|NCT01796171|466404135|FG001|Follow-up Period|Progressive disease|1|||
129575859|NCT01796171|466404136|FG002|Follow-up Period|Progressive disease|0|||
129575860|NCT01796171|466404137|FG003|Follow-up Period|Progressive disease|0|||
129575861|NCT01796171|466404138|FG004|Follow-up Period|Progressive disease|0|||
129575862|NCT01796171|466404139|FG005|Follow-up Period|Progressive disease|0|||
129575863|NCT01796171|466404140|FG006|Follow-up Period|Progressive disease|0|||
129575864|NCT01796171|466404141|FG007|Follow-up Period|Progressive disease|3|||
129575865|NCT01796171|466404142|FG008|Follow-up Period|Progressive disease|0|||
129575866|NCT01796171|466404143|FG009|Follow-up Period|Progressive disease|0|||
129575867|NCT01796171|466404144|FG010|Follow-up Period|Progressive disease|0|||
129575868|NCT01796171|466404145|FG011|Follow-up Period|Progressive disease|0|||
129575869|NCT01796171|466404146|FG012|Follow-up Period|Progressive disease|0|||
129575870|NCT01796171|466404147|FG013|Follow-up Period|Progressive disease|0|||
129575871|NCT01796171|466404148|FG014|Follow-up Period|Progressive disease|0|||
129575872|NCT01796171|466404134|FG000|Follow-up Period|Physician Decision|0|||
129575873|NCT01796171|466404135|FG001|Follow-up Period|Physician Decision|2|||
129575874|NCT01796171|466404136|FG002|Follow-up Period|Physician Decision|0|||
129575875|NCT01796171|466404137|FG003|Follow-up Period|Physician Decision|0|||
129575876|NCT01796171|466404138|FG004|Follow-up Period|Physician Decision|0|||
129575877|NCT01796171|466404139|FG005|Follow-up Period|Physician Decision|0|||
129575878|NCT01796171|466404140|FG006|Follow-up Period|Physician Decision|0|||
129575879|NCT01796171|466404141|FG007|Follow-up Period|Physician Decision|0|||
129575880|NCT01796171|466404142|FG008|Follow-up Period|Physician Decision|0|||
129575881|NCT01796171|466404143|FG009|Follow-up Period|Physician Decision|0|||
129575882|NCT01796171|466404144|FG010|Follow-up Period|Physician Decision|5|||
129575883|NCT01796171|466404145|FG011|Follow-up Period|Physician Decision|0|||
129575884|NCT01796171|466404146|FG012|Follow-up Period|Physician Decision|0|||
129575885|NCT01796171|466404147|FG013|Follow-up Period|Physician Decision|0|||
129575886|NCT01796171|466404148|FG014|Follow-up Period|Physician Decision|0|||
129575887|NCT01796171|466404134|FG000|Follow-up Period|Withdrawal by Subject|0|||
129575888|NCT01796171|466404135|FG001|Follow-up Period|Withdrawal by Subject|1|||
129575889|NCT01796171|466404136|FG002|Follow-up Period|Withdrawal by Subject|0|||
129575890|NCT01796171|466404137|FG003|Follow-up Period|Withdrawal by Subject|0|||
129784486|NCT02059291|467180002|FG014|Epoch 2|Lack of Efficacy|0|||
129784487|NCT02059291|467180003|FG015|Epoch 2|Lack of Efficacy|0|||
129784488|NCT02059291|467180004|FG016|Epoch 2|Lack of Efficacy|0|||
129784489|NCT02059291|467180005|FG017|Epoch 2|Lack of Efficacy|0|||
129784490|NCT02059291|467180006|FG018|Epoch 2|Lack of Efficacy|0|||
129784491|NCT02059291|467180007|FG019|Epoch 2|Lack of Efficacy|0|||
129784492|NCT02059291|467180008|FG020|Epoch 2|Lack of Efficacy|0|||
129784493|NCT02059291|467180009|FG021|Epoch 2|Lack of Efficacy|0|||
129784494|NCT02059291|467180010|FG022|Epoch 2|Lack of Efficacy|0|||
129784495|NCT02059291|467180011|FG023|Epoch 2|Lack of Efficacy|0|||
129784496|NCT02059291|467180012|FG024|Epoch 2|Lack of Efficacy|0|||
129784497|NCT02059291|467179988|FG000|Epoch 2|Adverse Event|0|||
129784498|NCT02059291|467179989|FG001|Epoch 2|Adverse Event|0|||
129784499|NCT02059291|467179990|FG002|Epoch 2|Adverse Event|1|||
129784500|NCT02059291|467179991|FG003|Epoch 2|Adverse Event|1|||
129784501|NCT02059291|467179992|FG004|Epoch 2|Adverse Event|0|||
129784502|NCT02059291|467179993|FG005|Epoch 2|Adverse Event|0|||
129784503|NCT02059291|467179994|FG006|Epoch 2|Adverse Event|0|||
129784504|NCT02059291|467179995|FG007|Epoch 2|Adverse Event|1|||
129784505|NCT02059291|467179996|FG008|Epoch 2|Adverse Event|1|||
129784506|NCT02059291|467179997|FG009|Epoch 2|Adverse Event|0|||
129784507|NCT02059291|467179998|FG010|Epoch 2|Adverse Event|0|||
129575891|NCT01796171|466404138|FG004|Follow-up Period|Withdrawal by Subject|0|||
129575892|NCT01796171|466404139|FG005|Follow-up Period|Withdrawal by Subject|1|||
129575893|NCT01796171|466404140|FG006|Follow-up Period|Withdrawal by Subject|0|||
129575894|NCT01796171|466404141|FG007|Follow-up Period|Withdrawal by Subject|0|||
129575895|NCT01796171|466404142|FG008|Follow-up Period|Withdrawal by Subject|0|||
129575896|NCT01796171|466404143|FG009|Follow-up Period|Withdrawal by Subject|0|||
129784508|NCT02059291|467179999|FG011|Epoch 2|Adverse Event|0|||
129784509|NCT02059291|467180000|FG012|Epoch 2|Adverse Event|0|||
129784510|NCT02059291|467180001|FG013|Epoch 2|Adverse Event|0|||
129784511|NCT02059291|467180002|FG014|Epoch 2|Adverse Event|0|||
129784512|NCT02059291|467180003|FG015|Epoch 2|Adverse Event|0|||
129784513|NCT02059291|467180004|FG016|Epoch 2|Adverse Event|0|||
129784514|NCT02059291|467180005|FG017|Epoch 2|Adverse Event|0|||
129784515|NCT02059291|467180006|FG018|Epoch 2|Adverse Event|0|||
129784516|NCT02059291|467180007|FG019|Epoch 2|Adverse Event|0|||
129575897|NCT01796171|466404144|FG010|Follow-up Period|Withdrawal by Subject|3|||
129575898|NCT01796171|466404145|FG011|Follow-up Period|Withdrawal by Subject|1|||
129575899|NCT01796171|466404146|FG012|Follow-up Period|Withdrawal by Subject|0|||
129575900|NCT01796171|466404147|FG013|Follow-up Period|Withdrawal by Subject|0|||
129575901|NCT01796171|466404148|FG014|Follow-up Period|Withdrawal by Subject|0|||
129575902|NCT01796171|466404134|FG000|Follow-up Period|Death|0|||
129575903|NCT01796171|466404135|FG001|Follow-up Period|Death|0|||
129575904|NCT01796171|466404136|FG002|Follow-up Period|Death|0|||
129575905|NCT01796171|466404137|FG003|Follow-up Period|Death|0|||
129575906|NCT01796171|466404138|FG004|Follow-up Period|Death|0|||
129575907|NCT01796171|466404139|FG005|Follow-up Period|Death|0|||
129575908|NCT01796171|466404140|FG006|Follow-up Period|Death|1|||
129575909|NCT01796171|466404141|FG007|Follow-up Period|Death|0|||
129575910|NCT01796171|466404142|FG008|Follow-up Period|Death|0|||
129575911|NCT01796171|466404143|FG009|Follow-up Period|Death|0|||
129575912|NCT01796171|466404144|FG010|Follow-up Period|Death|17|||
129575913|NCT01796171|466404145|FG011|Follow-up Period|Death|9|||
129575914|NCT01796171|466404146|FG012|Follow-up Period|Death|1|||
129575915|NCT01796171|466404147|FG013|Follow-up Period|Death|0|||
129575916|NCT01796171|466404148|FG014|Follow-up Period|Death|0|||
129575917|NCT01796171|466404134|FG000|Follow-up Period|Patient transferred to other hospital|0|||
129575918|NCT01796171|466404135|FG001|Follow-up Period|Patient transferred to other hospital|1|||
129575919|NCT01796171|466404136|FG002|Follow-up Period|Patient transferred to other hospital|0|||
129575920|NCT01796171|466404137|FG003|Follow-up Period|Patient transferred to other hospital|0|||
129575921|NCT01796171|466404138|FG004|Follow-up Period|Patient transferred to other hospital|0|||
129575922|NCT01796171|466404139|FG005|Follow-up Period|Patient transferred to other hospital|0|||
129575923|NCT01796171|466404140|FG006|Follow-up Period|Patient transferred to other hospital|0|||
129575924|NCT01796171|466404141|FG007|Follow-up Period|Patient transferred to other hospital|0|||
129575925|NCT01796171|466404142|FG008|Follow-up Period|Patient transferred to other hospital|0|||
129575926|NCT01796171|466404143|FG009|Follow-up Period|Patient transferred to other hospital|0|||
129575927|NCT01796171|466404144|FG010|Follow-up Period|Patient transferred to other hospital|0|||
129575928|NCT01796171|466404145|FG011|Follow-up Period|Patient transferred to other hospital|0|||
129575929|NCT01796171|466404146|FG012|Follow-up Period|Patient transferred to other hospital|0|||
129575930|NCT01796171|466404147|FG013|Follow-up Period|Patient transferred to other hospital|0|||
129575931|NCT01796171|466404148|FG014|Follow-up Period|Patient transferred to other hospital|0|||
129575932|NCT01796171|466404134|FG000|Follow-up Period|Sponsor Decision|0|||
129575933|NCT01796171|466404135|FG001|Follow-up Period|Sponsor Decision|0|||
129575934|NCT01796171|466404136|FG002|Follow-up Period|Sponsor Decision|0|||
129575935|NCT01796171|466404137|FG003|Follow-up Period|Sponsor Decision|0|||
129575936|NCT01796171|466404138|FG004|Follow-up Period|Sponsor Decision|0|||
129575937|NCT01796171|466404139|FG005|Follow-up Period|Sponsor Decision|0|||
129575938|NCT01796171|466404140|FG006|Follow-up Period|Sponsor Decision|0|||
129575939|NCT01796171|466404141|FG007|Follow-up Period|Sponsor Decision|0|||
129575940|NCT01796171|466404142|FG008|Follow-up Period|Sponsor Decision|0|||
129575941|NCT01796171|466404143|FG009|Follow-up Period|Sponsor Decision|0|||
129575942|NCT01796171|466404144|FG010|Follow-up Period|Sponsor Decision|40|||
129694375|NCT02006654|466837555|FG000|Overall Study|insufficient compliance|1|||
129694376|NCT02006654|466837556|FG001|Overall Study|insufficient compliance|0|||
129694377|NCT02006654|466837555|FG000|Overall Study|worsening cognitive condition|0|||
129694378|NCT02006654|466837556|FG001|Overall Study|worsening cognitive condition|1|||
129694379|NCT02006654|466837555|FG000|Overall Study|faecal incontinence|0|||
129694380|NCT02006654|466837556|FG001|Overall Study|faecal incontinence|1|||
129575943|NCT01796171|466404145|FG011|Follow-up Period|Sponsor Decision|15|||
129575944|NCT01796171|466404146|FG012|Follow-up Period|Sponsor Decision|7|||
129575945|NCT01796171|466404147|FG013|Follow-up Period|Sponsor Decision|0|||
129575946|NCT01796171|466404148|FG014|Follow-up Period|Sponsor Decision|0|||
129575947|NCT00829309|466404149|FG000|Washout: 7 Days|Protocol Violation|1|||
129575948|NCT00829309|466404150|FG001|Washout: 7 Days|Protocol Violation|0|||
129575949|NCT01558635|466404153|FG000|Overall Study|Death|1|||
129575950|NCT01558635|466404153|FG000|Overall Study|Withdrawal by Subject|2|||
129575951|NCT01558635|466404153|FG000|Overall Study|Physician Decision|1|||
129575952|NCT01558635|466404153|FG000|Overall Study|Subject received other treatment|1|||
129575953|NCT01558635|466404153|FG000|Overall Study|Reveal XT was explanted|1|||
129575954|NCT00455312|466404154|FG000|Overall Study|Death|0|||
129575955|NCT00455312|466404155|FG001|Overall Study|Death|1|||
129575956|NCT01693523|466404156|FG000|Overall Study|Adverse Event|2|||
129575957|NCT01693523|466404157|FG001|Overall Study|Adverse Event|1|||
129575958|NCT01693523|466404158|FG002|Overall Study|Adverse Event|0|||
129694381|NCT02006654|466837555|FG000|Overall Study|mood disorder|0|||
129575959|NCT01693523|466404156|FG000|Overall Study|Death|0|||
129575960|NCT01693523|466404157|FG001|Overall Study|Death|1|||
129575961|NCT01693523|466404158|FG002|Overall Study|Death|1|||
129575962|NCT01693523|466404156|FG000|Overall Study|Lost to Follow-up|0|||
129575963|NCT01693523|466404157|FG001|Overall Study|Lost to Follow-up|0|||
129575964|NCT01693523|466404158|FG002|Overall Study|Lost to Follow-up|4|||
129575965|NCT01693523|466404156|FG000|Overall Study|Physician Decision|0|||
129575966|NCT01693523|466404157|FG001|Overall Study|Physician Decision|0|||
129575967|NCT01693523|466404158|FG002|Overall Study|Physician Decision|1|||
129575968|NCT01693523|466404156|FG000|Overall Study|Withdrawal by Subject|1|||
129575969|NCT01693523|466404157|FG001|Overall Study|Withdrawal by Subject|2|||
129575970|NCT01693523|466404158|FG002|Overall Study|Withdrawal by Subject|2|||
129784517|NCT02059291|467180008|FG020|Epoch 2|Adverse Event|0|||
129784518|NCT02059291|467180009|FG021|Epoch 2|Adverse Event|0|||
129784519|NCT02059291|467180010|FG022|Epoch 2|Adverse Event|0|||
129784520|NCT02059291|467180011|FG023|Epoch 2|Adverse Event|0|||
129784521|NCT02059291|467180012|FG024|Epoch 2|Adverse Event|0|||
129784522|NCT02059291|467179988|FG000|Epoch 2|Withdrawal by Subject|0|||
129784523|NCT02059291|467179989|FG001|Epoch 2|Withdrawal by Subject|1|||
129784524|NCT02059291|467179990|FG002|Epoch 2|Withdrawal by Subject|0|||
129784525|NCT02059291|467179991|FG003|Epoch 2|Withdrawal by Subject|0|||
129784526|NCT02059291|467179992|FG004|Epoch 2|Withdrawal by Subject|0|||
129784527|NCT02059291|467179993|FG005|Epoch 2|Withdrawal by Subject|1|||
129784528|NCT02059291|467179994|FG006|Epoch 2|Withdrawal by Subject|0|||
129784529|NCT02059291|467179995|FG007|Epoch 2|Withdrawal by Subject|0|||
129784530|NCT02059291|467179996|FG008|Epoch 2|Withdrawal by Subject|1|||
129784531|NCT02059291|467179997|FG009|Epoch 2|Withdrawal by Subject|0|||
129784532|NCT02059291|467179998|FG010|Epoch 2|Withdrawal by Subject|0|||
129784533|NCT02059291|467179999|FG011|Epoch 2|Withdrawal by Subject|0|||
129784534|NCT02059291|467180000|FG012|Epoch 2|Withdrawal by Subject|0|||
129784535|NCT02059291|467180001|FG013|Epoch 2|Withdrawal by Subject|0|||
129784536|NCT02059291|467180002|FG014|Epoch 2|Withdrawal by Subject|0|||
129784537|NCT02059291|467180003|FG015|Epoch 2|Withdrawal by Subject|0|||
129784538|NCT02059291|467180004|FG016|Epoch 2|Withdrawal by Subject|0|||
129784539|NCT02059291|467180005|FG017|Epoch 2|Withdrawal by Subject|0|||
129784540|NCT02059291|467180006|FG018|Epoch 2|Withdrawal by Subject|0|||
129784541|NCT02059291|467180007|FG019|Epoch 2|Withdrawal by Subject|0|||
129784542|NCT02059291|467180008|FG020|Epoch 2|Withdrawal by Subject|0|||
129784543|NCT02059291|467180009|FG021|Epoch 2|Withdrawal by Subject|0|||
129784544|NCT02059291|467180010|FG022|Epoch 2|Withdrawal by Subject|0|||
129784545|NCT02059291|467180011|FG023|Epoch 2|Withdrawal by Subject|0|||
129784546|NCT02059291|467180012|FG024|Epoch 2|Withdrawal by Subject|0|||
129784547|NCT02059291|467179988|FG000|Epoch 3|Physician Decision|0|||
129784548|NCT02059291|467179989|FG001|Epoch 3|Physician Decision|0|||
129784549|NCT02059291|467179990|FG002|Epoch 3|Physician Decision|0|||
129784550|NCT02059291|467179991|FG003|Epoch 3|Physician Decision|0|||
129784551|NCT02059291|467179992|FG004|Epoch 3|Physician Decision|0|||
129784552|NCT02059291|467179993|FG005|Epoch 3|Physician Decision|0|||
129784553|NCT02059291|467179994|FG006|Epoch 3|Physician Decision|0|||
129784554|NCT02059291|467179995|FG007|Epoch 3|Physician Decision|0|||
129784555|NCT02059291|467179996|FG008|Epoch 3|Physician Decision|0|||
129784556|NCT02059291|467179997|FG009|Epoch 3|Physician Decision|0|||
129784557|NCT02059291|467179998|FG010|Epoch 3|Physician Decision|0|||
129784558|NCT02059291|467179999|FG011|Epoch 3|Physician Decision|0|||
129784559|NCT02059291|467180000|FG012|Epoch 3|Physician Decision|0|||
129575971|NCT01693523|466404156|FG000|Overall Study|Lack of compliance study medication|1|||
129784560|NCT02059291|467180001|FG013|Epoch 3|Physician Decision|1|||
129575972|NCT01693523|466404157|FG001|Overall Study|Lack of compliance study medication|2|||
129575973|NCT01693523|466404158|FG002|Overall Study|Lack of compliance study medication|0|||
129575974|NCT01693523|466404156|FG000|Overall Study|Chemotherapy was held|1|||
129575975|NCT01693523|466404157|FG001|Overall Study|Chemotherapy was held|2|||
129575976|NCT01693523|466404158|FG002|Overall Study|Chemotherapy was held|0|||
129575977|NCT03343535|466404159|FG000|Overall Study|Lost to Follow-up|1|||
129575978|NCT03343535|466404159|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
129575979|NCT03343535|466404159|FG000|Overall Study|Death|12|||
129784561|NCT02059291|467180002|FG014|Epoch 3|Physician Decision|0|||
129784562|NCT02059291|467180003|FG015|Epoch 3|Physician Decision|1|||
129784563|NCT02059291|467180004|FG016|Epoch 3|Physician Decision|0|||
129784564|NCT02059291|467180005|FG017|Epoch 3|Physician Decision|0|||
129784565|NCT02059291|467180006|FG018|Epoch 3|Physician Decision|0|||
129784566|NCT02059291|467180007|FG019|Epoch 3|Physician Decision|0|||
129784567|NCT02059291|467180008|FG020|Epoch 3|Physician Decision|0|||
129784568|NCT02059291|467180009|FG021|Epoch 3|Physician Decision|0|||
129784569|NCT02059291|467180010|FG022|Epoch 3|Physician Decision|0|||
129784570|NCT02059291|467180011|FG023|Epoch 3|Physician Decision|0|||
129784571|NCT02059291|467180012|FG024|Epoch 3|Physician Decision|0|||
129784572|NCT02059291|467179988|FG000|Epoch 3|Adverse Event|0|||
129784573|NCT02059291|467179989|FG001|Epoch 3|Adverse Event|0|||
129784574|NCT02059291|467179990|FG002|Epoch 3|Adverse Event|0|||
129784575|NCT02059291|467179991|FG003|Epoch 3|Adverse Event|0|||
129784576|NCT02059291|467179992|FG004|Epoch 3|Adverse Event|0|||
129784577|NCT02059291|467179993|FG005|Epoch 3|Adverse Event|0|||
129784578|NCT02059291|467179994|FG006|Epoch 3|Adverse Event|0|||
129784579|NCT02059291|467179995|FG007|Epoch 3|Adverse Event|0|||
129784580|NCT02059291|467179996|FG008|Epoch 3|Adverse Event|0|||
129784581|NCT02059291|467179997|FG009|Epoch 3|Adverse Event|0|||
129784582|NCT02059291|467179998|FG010|Epoch 3|Adverse Event|0|||
129784583|NCT02059291|467179999|FG011|Epoch 3|Adverse Event|0|||
129784584|NCT02059291|467180000|FG012|Epoch 3|Adverse Event|0|||
129784585|NCT02059291|467180001|FG013|Epoch 3|Adverse Event|0|||
129784586|NCT02059291|467180002|FG014|Epoch 3|Adverse Event|0|||
129784587|NCT02059291|467180003|FG015|Epoch 3|Adverse Event|1|||
129784588|NCT02059291|467180004|FG016|Epoch 3|Adverse Event|0|||
129784589|NCT02059291|467180005|FG017|Epoch 3|Adverse Event|0|||
129784590|NCT02059291|467180006|FG018|Epoch 3|Adverse Event|0|||
129784591|NCT02059291|467180007|FG019|Epoch 3|Adverse Event|0|||
129784592|NCT02059291|467180008|FG020|Epoch 3|Adverse Event|0|||
129784593|NCT02059291|467180009|FG021|Epoch 3|Adverse Event|0|||
129784594|NCT02059291|467180010|FG022|Epoch 3|Adverse Event|0|||
129784595|NCT02059291|467180011|FG023|Epoch 3|Adverse Event|0|||
129784596|NCT02059291|467180012|FG024|Epoch 3|Adverse Event|0|||
129784597|NCT02059291|467179988|FG000|Epoch 3|Lack of Efficacy|0|||
129784598|NCT02059291|467179989|FG001|Epoch 3|Lack of Efficacy|0|||
129784599|NCT02059291|467179990|FG002|Epoch 3|Lack of Efficacy|0|||
129784600|NCT02059291|467179991|FG003|Epoch 3|Lack of Efficacy|0|||
129784601|NCT02059291|467179992|FG004|Epoch 3|Lack of Efficacy|0|||
129784602|NCT02059291|467179993|FG005|Epoch 3|Lack of Efficacy|0|||
129784603|NCT02059291|467179994|FG006|Epoch 3|Lack of Efficacy|0|||
129784604|NCT02059291|467179995|FG007|Epoch 3|Lack of Efficacy|0|||
129784605|NCT02059291|467179996|FG008|Epoch 3|Lack of Efficacy|0|||
129784606|NCT02059291|467179997|FG009|Epoch 3|Lack of Efficacy|0|||
129784607|NCT02059291|467179998|FG010|Epoch 3|Lack of Efficacy|0|||
129784608|NCT02059291|467179999|FG011|Epoch 3|Lack of Efficacy|0|||
129784609|NCT02059291|467180000|FG012|Epoch 3|Lack of Efficacy|0|||
129784610|NCT02059291|467180001|FG013|Epoch 3|Lack of Efficacy|0|||
129784611|NCT02059291|467180002|FG014|Epoch 3|Lack of Efficacy|0|||
129784612|NCT02059291|467180003|FG015|Epoch 3|Lack of Efficacy|3|||
129784613|NCT02059291|467180004|FG016|Epoch 3|Lack of Efficacy|0|||
129784614|NCT02059291|467180005|FG017|Epoch 3|Lack of Efficacy|0|||
129784615|NCT02059291|467180006|FG018|Epoch 3|Lack of Efficacy|0|||
129784616|NCT02059291|467180007|FG019|Epoch 3|Lack of Efficacy|0|||
129784617|NCT02059291|467180008|FG020|Epoch 3|Lack of Efficacy|0|||
129784618|NCT02059291|467180009|FG021|Epoch 3|Lack of Efficacy|0|||
129784619|NCT02059291|467180010|FG022|Epoch 3|Lack of Efficacy|0|||
129784620|NCT02059291|467180011|FG023|Epoch 3|Lack of Efficacy|0|||
129784621|NCT02059291|467180012|FG024|Epoch 3|Lack of Efficacy|0|||
129784622|NCT02059291|467179988|FG000|Epoch 3|Withdrawal by Subject|0|||
129784623|NCT02059291|467179989|FG001|Epoch 3|Withdrawal by Subject|0|||
129784624|NCT02059291|467179990|FG002|Epoch 3|Withdrawal by Subject|0|||
129784625|NCT02059291|467179991|FG003|Epoch 3|Withdrawal by Subject|0|||
129784626|NCT02059291|467179992|FG004|Epoch 3|Withdrawal by Subject|0|||
129784627|NCT02059291|467179993|FG005|Epoch 3|Withdrawal by Subject|0|||
129784628|NCT02059291|467179994|FG006|Epoch 3|Withdrawal by Subject|0|||
129784629|NCT02059291|467179995|FG007|Epoch 3|Withdrawal by Subject|0|||
129784630|NCT02059291|467179996|FG008|Epoch 3|Withdrawal by Subject|0|||
129784631|NCT02059291|467179997|FG009|Epoch 3|Withdrawal by Subject|0|||
129784632|NCT02059291|467179998|FG010|Epoch 3|Withdrawal by Subject|0|||
129784633|NCT02059291|467179999|FG011|Epoch 3|Withdrawal by Subject|0|||
129784634|NCT02059291|467180000|FG012|Epoch 3|Withdrawal by Subject|0|||
129784635|NCT02059291|467180001|FG013|Epoch 3|Withdrawal by Subject|0|||
129784636|NCT02059291|467180002|FG014|Epoch 3|Withdrawal by Subject|0|||
129784637|NCT02059291|467180003|FG015|Epoch 3|Withdrawal by Subject|1|||
129784638|NCT02059291|467180004|FG016|Epoch 3|Withdrawal by Subject|0|||
129784639|NCT02059291|467180005|FG017|Epoch 3|Withdrawal by Subject|0|||
129784640|NCT02059291|467180006|FG018|Epoch 3|Withdrawal by Subject|0|||
129784641|NCT02059291|467180007|FG019|Epoch 3|Withdrawal by Subject|0|||
129784642|NCT02059291|467180008|FG020|Epoch 3|Withdrawal by Subject|0|||
129784643|NCT02059291|467180009|FG021|Epoch 3|Withdrawal by Subject|0|||
129784644|NCT02059291|467180010|FG022|Epoch 3|Withdrawal by Subject|0|||
129784645|NCT02059291|467180011|FG023|Epoch 3|Withdrawal by Subject|0|||
129784646|NCT02059291|467180012|FG024|Epoch 3|Withdrawal by Subject|0|||
129784647|NCT02059291|467179988|FG000|Epoch 4|Adverse Event|0|||
129784648|NCT02059291|467179989|FG001|Epoch 4|Adverse Event|0|||
129784649|NCT02059291|467179990|FG002|Epoch 4|Adverse Event|0|||
129784650|NCT02059291|467179991|FG003|Epoch 4|Adverse Event|0|||
129784651|NCT02059291|467179992|FG004|Epoch 4|Adverse Event|0|||
129784652|NCT02059291|467179993|FG005|Epoch 4|Adverse Event|0|||
129784653|NCT02059291|467179994|FG006|Epoch 4|Adverse Event|0|||
129784654|NCT02059291|467179995|FG007|Epoch 4|Adverse Event|0|||
129784655|NCT02059291|467179996|FG008|Epoch 4|Adverse Event|0|||
129784656|NCT02059291|467179997|FG009|Epoch 4|Adverse Event|0|||
129784657|NCT02059291|467179998|FG010|Epoch 4|Adverse Event|0|||
129575980|NCT03699020|466404161|FG000|Overall Study|Withdrawal by Subject|3|||
129575981|NCT03699020|466404162|FG001|Overall Study|Withdrawal by Subject|2|||
129575982|NCT02246920|466404163|FG000|Overall Study|Adverse Event|3|||
129575983|NCT02246920|466404164|FG001|Overall Study|Adverse Event|1|||
129575984|NCT02246920|466404165|FG002|Overall Study|Adverse Event|1|||
129575985|NCT02246920|466404163|FG000|Overall Study|Lost to Follow-up|2|||
129575986|NCT02246920|466404164|FG001|Overall Study|Lost to Follow-up|1|||
129575987|NCT02246920|466404165|FG002|Overall Study|Lost to Follow-up|0|||
129575988|NCT02246920|466404163|FG000|Overall Study|Protocol Violation|2|||
129575989|NCT02246920|466404164|FG001|Overall Study|Protocol Violation|5|||
129575990|NCT02246920|466404165|FG002|Overall Study|Protocol Violation|1|||
129694382|NCT02006654|466837556|FG001|Overall Study|mood disorder|1|||
129694383|NCT02006654|466837555|FG000|Overall Study|disallowed medication|1|||
129694384|NCT02006654|466837556|FG001|Overall Study|disallowed medication|0|||
129694385|NCT02006654|466837555|FG000|Overall Study|moving out of state|0|||
129694386|NCT02006654|466837556|FG001|Overall Study|moving out of state|1|||
129694387|NCT03438656|466837557|FG000|Overall Study|Lost to Follow-up|2|||
129694388|NCT03721965|466837558|FG000|Overall Study|Death|1|||
129694389|NCT03721965|466837558|FG000|Overall Study|Study Terminated by Sponsor|1|||
129694390|NCT00563316|466837559|FG000|Overall Study|Adverse Event|2|||
129694391|NCT00563316|466837559|FG000|Overall Study|Physician Decision|1|||
129694392|NCT00563316|466837559|FG000|Overall Study|Lost to Follow-up|2|||
129694393|NCT00563316|466837559|FG000|Overall Study|Death|1|||
129694394|NCT00563316|466837559|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
129694395|NCT00563316|466837559|FG000|Overall Study|Other|1|||
129694396|NCT01108055|466837566|FG000|Overall Study|Ineligible|11|||
129694397|NCT01108055|466837566|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
129694398|NCT03339453|466837568|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
129694399|NCT03339453|466837569|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
129694400|NCT00800384|466837572|FG000|Overall Study|Withdrawal by Subject|24|||
129694401|NCT00800384|466837573|FG001|Overall Study|Withdrawal by Subject|17|||
129694402|NCT00800384|466837572|FG000|Overall Study|Lost to Follow-up|17|||
129694403|NCT00800384|466837573|FG001|Overall Study|Lost to Follow-up|26|||
129694404|NCT01027754|466839550|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
129575991|NCT02246920|466404163|FG000|Overall Study|Withdrawal by Subject|0|||
129575992|NCT02246920|466404164|FG001|Overall Study|Withdrawal by Subject|0|||
129694405|NCT01027754|466839551|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
129694406|NCT01027754|466839550|FG000|Overall Study|Withdrawal by Subject|0|||
129694407|NCT01027754|466839551|FG001|Overall Study|Withdrawal by Subject|5|||
129694408|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
129694409|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129694410|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129694411|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129694412|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129694413|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
129694414|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
129694415|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
129694416|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129694417|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
129694418|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129694419|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129694420|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129694421|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
129694422|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
129694423|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129694424|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129694425|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129694426|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129694427|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129694428|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
129694429|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
129694430|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129694431|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129694432|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129694433|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129694434|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
129694435|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
129694436|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129575993|NCT02246920|466404165|FG002|Overall Study|Withdrawal by Subject|1|||
129575994|NCT00448019|466404168|FG000|Overall Study|Withdrawal by Subject|3|||
129575995|NCT00448019|466404168|FG000|Overall Study|Disease progression|1|||
129575996|NCT00448019|466404168|FG000|Overall Study|Death|2|||
129575997|NCT00448019|466404168|FG000|Overall Study|Insurance Issues|1|||
129575998|NCT03620747|466404170|FG000|Overall Study|Participant decision|7|||
129575999|NCT03620747|466404170|FG000|Overall Study|Adverse Event|6|||
129576000|NCT03620747|466404170|FG000|Overall Study|Lack of Efficacy|1|||
129576001|NCT03620747|466404170|FG000|Overall Study|Poor compliance to protocol|2|||
129576002|NCT03620747|466404170|FG000|Overall Study|Other-unspecified|3|||
129576003|NCT02714062|466404171|FG000|Overall Study|Adverse Event|0|||
129576004|NCT02714062|466404172|FG001|Overall Study|Adverse Event|0|||
129576005|NCT02714062|466404173|FG002|Overall Study|Adverse Event|2|||
129576006|NCT02714062|466404171|FG000|Overall Study|Withdrawal by Subject|1|||
129576007|NCT02714062|466404172|FG001|Overall Study|Withdrawal by Subject|0|||
129576008|NCT02714062|466404173|FG002|Overall Study|Withdrawal by Subject|1|||
129576009|NCT02714062|466404171|FG000|Overall Study|Protocol Violation|0|||
129576010|NCT02714062|466404172|FG001|Overall Study|Protocol Violation|1|||
129576011|NCT02714062|466404173|FG002|Overall Study|Protocol Violation|0|||
129576012|NCT00904215|466404175|FG000|Overall Study|Adverse Event|25|||
129576013|NCT00904215|466404175|FG000|Overall Study|Protocol Violation|10|||
129576014|NCT00904215|466404175|FG000|Overall Study|Lost to Follow-up|63|||
129576015|NCT00904215|466404175|FG000|Overall Study|Withdrawal by Subject|9|||
129576016|NCT00904215|466404175|FG000|Overall Study|Other|28|||
129576017|NCT00571064|466404177|FG000|Overall Study|Adverse Event|13|||
129576018|NCT00571064|466404177|FG000|Overall Study|Protocol Violation|4|||
129576019|NCT00571064|466404177|FG000|Overall Study|Withdrawal by Subject|2|||
129576020|NCT00571064|466404177|FG000|Overall Study|Other|2|||
129576021|NCT00244764|466404178|FG000|Overall Study|Adverse Event|37|||
129576022|NCT00244764|466404178|FG000|Overall Study|Lost to Follow-up|23|||
129576023|NCT00244764|466404178|FG000|Overall Study|Withdrawal by Subject|12|||
129576024|NCT00244764|466404178|FG000|Overall Study|Disease Progression|13|||
129576025|NCT00244764|466404178|FG000|Overall Study|Protocol Violation|2|||
129576026|NCT00244764|466404178|FG000|Overall Study|Death|1|||
129576027|NCT00244764|466404178|FG000|Overall Study|Off Study Medication for >21 Days|1|||
129576028|NCT00244764|466404178|FG000|Overall Study|Declining Performance Status|1|||
129576029|NCT00244764|466404178|FG000|Overall Study|Participant was Hospitalized until Death|1|||
129576030|NCT00244764|466404178|FG000|Overall Study|Primary Investigator Discretion|2|||
129576031|NCT00244764|466404178|FG000|Overall Study|Sponsor Terminated Study|2|||
129576032|NCT00244764|466404178|FG000|Overall Study|Developed Secondary Malignancy|1|||
129694437|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
129694438|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129694439|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129694440|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129694441|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129694442|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
129694443|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129694444|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129694445|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129694446|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129694447|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
129694448|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
129694449|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
129694450|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129694451|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
129694452|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
129694453|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129694454|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129694455|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
129694456|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
129694457|NCT01557244|466839552|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
129694458|NCT01557244|466839553|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129576033|NCT03872128|466404181|FG000|Overall Study|Dropped out before treatment|1|||
129576034|NCT03872128|466404182|FG001|Overall Study|Dropped out before treatment|0|||
129576035|NCT03872128|466404183|FG002|Overall Study|Dropped out before treatment|4|||
129576036|NCT03872128|466404181|FG000|Overall Study|Lost to Follow-up|2|||
129576037|NCT03872128|466404182|FG001|Overall Study|Lost to Follow-up|5|||
129576038|NCT03872128|466404183|FG002|Overall Study|Lost to Follow-up|8|||
129576039|NCT03285594|466404185|FG000|Overall Study|At the Participant's Own Request|10|||
129576040|NCT03285594|466404186|FG001|Overall Study|At the Participant's Own Request|5|||
129576041|NCT03285594|466404187|FG002|Overall Study|At the Participant's Own Request|21|||
129576042|NCT03285594|466404185|FG000|Overall Study|Adverse Event|2|||
129576043|NCT03285594|466404186|FG001|Overall Study|Adverse Event|2|||
129576044|NCT03285594|466404187|FG002|Overall Study|Adverse Event|6|||
129576045|NCT03285594|466404185|FG000|Overall Study|Poor Compliance to Protocol|0|||
129576046|NCT03285594|466404186|FG001|Overall Study|Poor Compliance to Protocol|0|||
129576047|NCT03285594|466404187|FG002|Overall Study|Poor Compliance to Protocol|1|||
129576048|NCT03285594|466404185|FG000|Overall Study|Lost to Follow-up|0|||
129576049|NCT03285594|466404186|FG001|Overall Study|Lost to Follow-up|0|||
129576050|NCT03285594|466404187|FG002|Overall Study|Lost to Follow-up|1|||
129576051|NCT03285594|466404185|FG000|Overall Study|Reason Not Specified|3|||
129576052|NCT03285594|466404186|FG001|Overall Study|Reason Not Specified|4|||
129576053|NCT03285594|466404187|FG002|Overall Study|Reason Not Specified|8|||
129576054|NCT02648438|466404191|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129576055|NCT02648438|466404192|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
129576056|NCT02648438|466404193|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129576057|NCT02648438|466404191|FG000|Overall Study|Protocol Violation|2|||
129576058|NCT02648438|466404192|FG001|Overall Study|Protocol Violation|0|||
129576059|NCT02648438|466404193|FG002|Overall Study|Protocol Violation|0|||
129576060|NCT02648438|466404191|FG000|Overall Study|Withdrawal by Subject|1|||
129576061|NCT02648438|466404192|FG001|Overall Study|Withdrawal by Subject|1|||
129576062|NCT02648438|466404193|FG002|Overall Study|Withdrawal by Subject|0|||
129576063|NCT02258074|466404194|FG000|Overall Study|Withdrawal by Subject|1|||
129576064|NCT02258074|466404195|FG001|Overall Study|Withdrawal by Subject|0|||
129576065|NCT02258074|466404196|FG002|Overall Study|Withdrawal by Subject|0|||
129576066|NCT02258074|466404197|FG003|Overall Study|Withdrawal by Subject|0|||
129576067|NCT02739997|466404198|FG000|Overall Study|Death|1|||
129576068|NCT02739997|466404198|FG000|Overall Study|Withdrawal by Subject|1|||
129576069|NCT03552393|466404201|FG000|Core Period|Kidney Transplant|1|||
129576070|NCT03552393|466404201|FG000|Core Period|Prohibited Medication|1|||
129576071|NCT03552393|466404201|FG000|Safety Extension Period|Kidney Transplant|4|||
129576072|NCT02601625|466404202|FG000|Overall Study|Lost to Follow-up|0|||
129576073|NCT02601625|466404203|FG001|Overall Study|Lost to Follow-up|0|||
129576074|NCT02601625|466404204|FG002|Overall Study|Lost to Follow-up|1|||
129694459|NCT01557244|466839554|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
129694460|NCT01557244|466839555|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129694461|NCT01557244|466839556|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129694462|NCT01557244|466839557|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129694463|NCT01557244|466839558|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
129694464|NCT01557244|466839552|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
129694465|NCT01557244|466839553|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
129694466|NCT01557244|466839554|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129694467|NCT01557244|466839555|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129694468|NCT01557244|466839556|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129694469|NCT01557244|466839557|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
129694470|NCT01557244|466839558|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
129694471|NCT01557244|466839552|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
129694472|NCT01557244|466839553|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
129694473|NCT01557244|466839554|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129694474|NCT01557244|466839555|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129694475|NCT01557244|466839556|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129694476|NCT01557244|466839557|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129694477|NCT01557244|466839558|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
129694478|NCT01557244|466839552|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129694479|NCT01557244|466839553|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129694480|NCT01557244|466839554|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129784658|NCT02059291|467179999|FG011|Epoch 4|Adverse Event|0|||
129784659|NCT02059291|467180000|FG012|Epoch 4|Adverse Event|0|||
129784660|NCT02059291|467180001|FG013|Epoch 4|Adverse Event|0|||
129784661|NCT02059291|467180002|FG014|Epoch 4|Adverse Event|0|||
129576075|NCT02601625|466404205|FG003|Overall Study|Lost to Follow-up|1|||
129576076|NCT00359281|466404207|FG000|Overall Study|Adverse Event|1|||
129576077|NCT00359281|466404208|FG001|Overall Study|Adverse Event|0|||
129576078|NCT00359281|466404209|FG002|Overall Study|Adverse Event|0|||
129576079|NCT00359281|466404210|FG003|Overall Study|Adverse Event|0|||
129576080|NCT00359281|466404211|FG004|Overall Study|Adverse Event|0|||
129576081|NCT00359281|466404212|FG005|Overall Study|Adverse Event|0|||
129576082|NCT00359281|466404213|FG006|Overall Study|Adverse Event|1|||
129576083|NCT00359281|466404214|FG007|Overall Study|Adverse Event|0|||
129576084|NCT00359281|466404215|FG008|Overall Study|Adverse Event|0|||
129576085|NCT00359281|466404207|FG000|Overall Study|Withdrawal by Subject|0|||
129576086|NCT00359281|466404208|FG001|Overall Study|Withdrawal by Subject|0|||
129784662|NCT02059291|467180003|FG015|Epoch 4|Adverse Event|0|||
129784663|NCT02059291|467180004|FG016|Epoch 4|Adverse Event|1|||
129784664|NCT02059291|467180005|FG017|Epoch 4|Adverse Event|0|||
129784665|NCT02059291|467180006|FG018|Epoch 4|Adverse Event|0|||
129784666|NCT02059291|467180007|FG019|Epoch 4|Adverse Event|0|||
129784667|NCT02059291|467180008|FG020|Epoch 4|Adverse Event|0|||
129784668|NCT02059291|467180009|FG021|Epoch 4|Adverse Event|0|||
129784669|NCT02059291|467180010|FG022|Epoch 4|Adverse Event|1|||
129576087|NCT00359281|466404209|FG002|Overall Study|Withdrawal by Subject|0|||
129576088|NCT00359281|466404210|FG003|Overall Study|Withdrawal by Subject|0|||
129576089|NCT00359281|466404211|FG004|Overall Study|Withdrawal by Subject|0|||
129576090|NCT00359281|466404212|FG005|Overall Study|Withdrawal by Subject|0|||
129576091|NCT00359281|466404213|FG006|Overall Study|Withdrawal by Subject|1|||
129576092|NCT00359281|466404214|FG007|Overall Study|Withdrawal by Subject|0|||
129576093|NCT00359281|466404215|FG008|Overall Study|Withdrawal by Subject|0|||
129576094|NCT04887415|466404216|FG000|Overall Study|Lost to Follow-up|2|||
129576095|NCT04608188|466404217|FG000|Overall Study|Withdrawal by Subject|4|||
129576096|NCT04608188|466404218|FG001|Overall Study|Withdrawal by Subject|8|||
129576097|NCT01250912|466404222|FG000|Overall Study|Lost to Follow-up|1|||
129576098|NCT00840411|466404225|FG000|First Intervention|Adverse Event|1|||
129694481|NCT01557244|466839555|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
129694482|NCT01557244|466839556|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129694483|NCT01557244|466839557|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129694484|NCT01557244|466839558|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
129694485|NCT01557244|466839552|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
129576099|NCT00840411|466404226|FG001|First Intervention|Adverse Event|0|||
129576100|NCT00840411|466404225|FG000|Washout|Withdrawal by Subject|1|||
129694486|NCT01557244|466839553|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
129694487|NCT01557244|466839554|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129694488|NCT01557244|466839555|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129694489|NCT01557244|466839556|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129694490|NCT01557244|466839557|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129694491|NCT01557244|466839558|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
129694492|NCT00326495|466839559|FG000|Overall Study|Switched to alternative treatment|1|||
129694493|NCT00326495|466839559|FG000|Overall Study|Disease progression before treatment|1|||
129694494|NCT00326495|466839559|FG000|Overall Study|Refused further treatment|2|||
129694495|NCT00326495|466839559|FG000|Overall Study|Subject off study before assessment|1|||
129694496|NCT00504556|466839560|FG000|Overall Study|Adverse Event|11|||
129694497|NCT00504556|466839561|FG001|Overall Study|Adverse Event|11|||
129694498|NCT00504556|466839562|FG002|Overall Study|Adverse Event|14|||
129694499|NCT00504556|466839563|FG003|Overall Study|Adverse Event|13|||
129694500|NCT00504556|466839564|FG004|Overall Study|Adverse Event|5|||
129694501|NCT00504556|466839560|FG000|Overall Study|Death|3|||
129694502|NCT00504556|466839561|FG001|Overall Study|Death|3|||
129694503|NCT00504556|466839562|FG002|Overall Study|Death|1|||
129694504|NCT00504556|466839563|FG003|Overall Study|Death|0|||
129694505|NCT00504556|466839564|FG004|Overall Study|Death|2|||
129694506|NCT00504556|466839560|FG000|Overall Study|Protocol Violation|1|||
129694507|NCT00504556|466839561|FG001|Overall Study|Protocol Violation|3|||
129694508|NCT00504556|466839562|FG002|Overall Study|Protocol Violation|2|||
129694509|NCT00504556|466839563|FG003|Overall Study|Protocol Violation|1|||
129694510|NCT00504556|466839564|FG004|Overall Study|Protocol Violation|2|||
129694511|NCT00504556|466839560|FG000|Overall Study|Lost to Follow-up|0|||
129694512|NCT00504556|466839561|FG001|Overall Study|Lost to Follow-up|0|||
129694513|NCT00504556|466839562|FG002|Overall Study|Lost to Follow-up|1|||
129694514|NCT00504556|466839563|FG003|Overall Study|Lost to Follow-up|1|||
129694515|NCT00504556|466839564|FG004|Overall Study|Lost to Follow-up|1|||
129694516|NCT00504556|466839560|FG000|Overall Study|Withdrawal by Subject|16|||
129694517|NCT00504556|466839561|FG001|Overall Study|Withdrawal by Subject|16|||
129694518|NCT00504556|466839562|FG002|Overall Study|Withdrawal by Subject|7|||
129694519|NCT00504556|466839563|FG003|Overall Study|Withdrawal by Subject|8|||
129694520|NCT00504556|466839564|FG004|Overall Study|Withdrawal by Subject|12|||
129694521|NCT00504556|466839560|FG000|Overall Study|administrative reasons|0|||
129694522|NCT00504556|466839561|FG001|Overall Study|administrative reasons|2|||
129784670|NCT02059291|467180011|FG023|Epoch 4|Adverse Event|0|||
129784671|NCT02059291|467180012|FG024|Epoch 4|Adverse Event|0|||
129784672|NCT02059291|467179988|FG000|Epoch 4|Pregnancy|0|||
129784673|NCT02059291|467179989|FG001|Epoch 4|Pregnancy|0|||
129576101|NCT00840411|466404226|FG001|Washout|Withdrawal by Subject|0|||
129576102|NCT02674152|466405641|FG000|Overall Study|Personal Reasons|1|||
129576103|NCT02674152|466405642|FG001|Overall Study|Personal Reasons|0|||
129784674|NCT02059291|467179990|FG002|Epoch 4|Pregnancy|0|||
129784675|NCT02059291|467179991|FG003|Epoch 4|Pregnancy|0|||
129784676|NCT02059291|467179992|FG004|Epoch 4|Pregnancy|0|||
129784677|NCT02059291|467179993|FG005|Epoch 4|Pregnancy|0|||
129784678|NCT02059291|467179994|FG006|Epoch 4|Pregnancy|0|||
129784679|NCT02059291|467179995|FG007|Epoch 4|Pregnancy|0|||
129784680|NCT02059291|467179996|FG008|Epoch 4|Pregnancy|0|||
129784681|NCT02059291|467179997|FG009|Epoch 4|Pregnancy|0|||
129784682|NCT02059291|467179998|FG010|Epoch 4|Pregnancy|0|||
129784683|NCT02059291|467179999|FG011|Epoch 4|Pregnancy|0|||
129784684|NCT02059291|467180000|FG012|Epoch 4|Pregnancy|0|||
129784685|NCT02059291|467180001|FG013|Epoch 4|Pregnancy|0|||
129784686|NCT02059291|467180002|FG014|Epoch 4|Pregnancy|0|||
129784687|NCT02059291|467180003|FG015|Epoch 4|Pregnancy|0|||
129784688|NCT02059291|467180004|FG016|Epoch 4|Pregnancy|1|||
129784689|NCT02059291|467180005|FG017|Epoch 4|Pregnancy|0|||
129784690|NCT02059291|467180006|FG018|Epoch 4|Pregnancy|0|||
129784691|NCT02059291|467180007|FG019|Epoch 4|Pregnancy|0|||
129784692|NCT02059291|467180008|FG020|Epoch 4|Pregnancy|0|||
129784693|NCT02059291|467180009|FG021|Epoch 4|Pregnancy|0|||
129784694|NCT02059291|467180010|FG022|Epoch 4|Pregnancy|0|||
129784695|NCT02059291|467180011|FG023|Epoch 4|Pregnancy|0|||
129784696|NCT02059291|467180012|FG024|Epoch 4|Pregnancy|0|||
129784697|NCT02059291|467179988|FG000|Epoch 4|Withdrawal by Subject|0|||
129784698|NCT02059291|467179989|FG001|Epoch 4|Withdrawal by Subject|0|||
129784699|NCT02059291|467179990|FG002|Epoch 4|Withdrawal by Subject|0|||
129784700|NCT02059291|467179991|FG003|Epoch 4|Withdrawal by Subject|0|||
129784701|NCT02059291|467179992|FG004|Epoch 4|Withdrawal by Subject|0|||
129784702|NCT02059291|467179993|FG005|Epoch 4|Withdrawal by Subject|0|||
129784703|NCT02059291|467179994|FG006|Epoch 4|Withdrawal by Subject|0|||
129784704|NCT02059291|467179995|FG007|Epoch 4|Withdrawal by Subject|0|||
129784705|NCT02059291|467179996|FG008|Epoch 4|Withdrawal by Subject|0|||
129784706|NCT02059291|467179997|FG009|Epoch 4|Withdrawal by Subject|0|||
129784707|NCT02059291|467179998|FG010|Epoch 4|Withdrawal by Subject|0|||
129784708|NCT02059291|467179999|FG011|Epoch 4|Withdrawal by Subject|0|||
129784709|NCT02059291|467180000|FG012|Epoch 4|Withdrawal by Subject|0|||
129784710|NCT02059291|467180001|FG013|Epoch 4|Withdrawal by Subject|0|||
129784711|NCT02059291|467180002|FG014|Epoch 4|Withdrawal by Subject|0|||
129784712|NCT02059291|467180003|FG015|Epoch 4|Withdrawal by Subject|0|||
129784713|NCT02059291|467180004|FG016|Epoch 4|Withdrawal by Subject|0|||
129784714|NCT02059291|467180005|FG017|Epoch 4|Withdrawal by Subject|0|||
129784715|NCT02059291|467180006|FG018|Epoch 4|Withdrawal by Subject|0|||
129784716|NCT02059291|467180007|FG019|Epoch 4|Withdrawal by Subject|0|||
129784717|NCT02059291|467180008|FG020|Epoch 4|Withdrawal by Subject|1|||
129784718|NCT02059291|467180009|FG021|Epoch 4|Withdrawal by Subject|0|||
129784719|NCT02059291|467180010|FG022|Epoch 4|Withdrawal by Subject|0|||
129784720|NCT02059291|467180011|FG023|Epoch 4|Withdrawal by Subject|0|||
129784721|NCT02059291|467180012|FG024|Epoch 4|Withdrawal by Subject|0|||
129784722|NCT02059291|467179988|FG000|Epoch 4|Lack of Efficacy|0|||
129784723|NCT02059291|467179989|FG001|Epoch 4|Lack of Efficacy|0|||
129784724|NCT02059291|467179990|FG002|Epoch 4|Lack of Efficacy|0|||
129784725|NCT02059291|467179991|FG003|Epoch 4|Lack of Efficacy|0|||
129784726|NCT02059291|467179992|FG004|Epoch 4|Lack of Efficacy|0|||
129784727|NCT02059291|467179993|FG005|Epoch 4|Lack of Efficacy|0|||
129784728|NCT02059291|467179994|FG006|Epoch 4|Lack of Efficacy|0|||
129784729|NCT02059291|467179995|FG007|Epoch 4|Lack of Efficacy|0|||
129784730|NCT02059291|467179996|FG008|Epoch 4|Lack of Efficacy|0|||
129784731|NCT02059291|467179997|FG009|Epoch 4|Lack of Efficacy|0|||
129784732|NCT02059291|467179998|FG010|Epoch 4|Lack of Efficacy|0|||
129784733|NCT02059291|467179999|FG011|Epoch 4|Lack of Efficacy|0|||
129784734|NCT02059291|467180000|FG012|Epoch 4|Lack of Efficacy|0|||
129784735|NCT02059291|467180001|FG013|Epoch 4|Lack of Efficacy|0|||
129784736|NCT02059291|467180002|FG014|Epoch 4|Lack of Efficacy|0|||
129784737|NCT02059291|467180003|FG015|Epoch 4|Lack of Efficacy|0|||
129784738|NCT02059291|467180004|FG016|Epoch 4|Lack of Efficacy|0|||
129784739|NCT02059291|467180005|FG017|Epoch 4|Lack of Efficacy|0|||
129784740|NCT02059291|467180006|FG018|Epoch 4|Lack of Efficacy|0|||
129784741|NCT02059291|467180007|FG019|Epoch 4|Lack of Efficacy|0|||
129784742|NCT02059291|467180008|FG020|Epoch 4|Lack of Efficacy|0|||
129784743|NCT02059291|467180009|FG021|Epoch 4|Lack of Efficacy|0|||
129784744|NCT02059291|467180010|FG022|Epoch 4|Lack of Efficacy|0|||
129784745|NCT02059291|467180011|FG023|Epoch 4|Lack of Efficacy|1|||
129784746|NCT02059291|467180012|FG024|Epoch 4|Lack of Efficacy|0|||
129784747|NCT01433289|467180013|FG000|Overall Study|Pregnancy|0|||
129784748|NCT01433289|467180014|FG001|Overall Study|Pregnancy|1|||
129784749|NCT01433289|467180015|FG002|Overall Study|Pregnancy|0|||
129784750|NCT01433289|467180016|FG003|Overall Study|Pregnancy|0|||
129784751|NCT04343235|467180018|FG000|Overall Study|Lost to Follow-up|3|||
129784752|NCT04343235|467180019|FG001|Overall Study|Lost to Follow-up|2|||
129784753|NCT00787267|467180020|FG000|Overall Study|Screen failure/Ineligible|10|||
129784754|NCT00787267|467180020|FG000|Overall Study|No Reason Provided|1|||
129784755|NCT00787267|467180020|FG000|Overall Study|Withdrawal by Subject|1|||
129784756|NCT01763996|467180021|FG000|Treatment Period 2|Adverse Event|0|||
129784757|NCT01763996|467180022|FG001|Treatment Period 2|Adverse Event|1|||
129784758|NCT00865280|467180023|FG000|Overall Study|Withdrawal by Subject|4|||
129784759|NCT00865280|467180024|FG001|Overall Study|Withdrawal by Subject|1|||
129784760|NCT00865280|467180023|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
129576104|NCT02674152|466405643|FG002|Overall Study|Personal Reasons|0|||
129576105|NCT02674152|466405644|FG003|Overall Study|Personal Reasons|1|||
129576106|NCT02674152|466405645|FG004|Overall Study|Personal Reasons|1|||
129576107|NCT02674152|466405641|FG000|Overall Study|Other adverse event or clinical progression|0|||
129576108|NCT02674152|466405642|FG001|Overall Study|Other adverse event or clinical progression|1|||
129694523|NCT00504556|466839562|FG002|Overall Study|administrative reasons|2|||
129694524|NCT00504556|466839563|FG003|Overall Study|administrative reasons|1|||
129694525|NCT00504556|466839564|FG004|Overall Study|administrative reasons|2|||
129694526|NCT00504556|466839560|FG000|Overall Study|did not meet entry criteria|2|||
129694527|NCT00504556|466839561|FG001|Overall Study|did not meet entry criteria|0|||
129694528|NCT00504556|466839562|FG002|Overall Study|did not meet entry criteria|1|||
129694529|NCT00504556|466839563|FG003|Overall Study|did not meet entry criteria|1|||
129694530|NCT00504556|466839564|FG004|Overall Study|did not meet entry criteria|0|||
129694531|NCT00504556|466839560|FG000|Overall Study|data monitor committee decision|0|||
129694532|NCT00504556|466839561|FG001|Overall Study|data monitor committee decision|0|||
129694533|NCT00504556|466839562|FG002|Overall Study|data monitor committee decision|0|||
129694534|NCT00504556|466839563|FG003|Overall Study|data monitor committee decision|100|||
129694535|NCT00504556|466839564|FG004|Overall Study|data monitor committee decision|0|||
129694536|NCT00504556|466839560|FG000|Overall Study|Other|2|||
129694537|NCT00504556|466839561|FG001|Overall Study|Other|2|||
129694538|NCT00504556|466839562|FG002|Overall Study|Other|2|||
129694539|NCT00504556|466839563|FG003|Overall Study|Other|3|||
129694540|NCT00504556|466839564|FG004|Overall Study|Other|0|||
129694541|NCT00504556|466839560|FG000|Overall Study|not in safety analysis set|0|||
129694542|NCT00504556|466839561|FG001|Overall Study|not in safety analysis set|1|||
129694543|NCT00504556|466839562|FG002|Overall Study|not in safety analysis set|1|||
129694544|NCT00504556|466839563|FG003|Overall Study|not in safety analysis set|0|||
129694545|NCT00504556|466839564|FG004|Overall Study|not in safety analysis set|1|||
129694546|NCT03280615|466839565|FG000|Overall Study|Lost to Follow-up|1|||
129694547|NCT03280615|466839566|FG001|Overall Study|Lost to Follow-up|2|||
129694548|NCT03280615|466839565|FG000|Overall Study|Adverse Event|1|||
129694549|NCT03280615|466839566|FG001|Overall Study|Adverse Event|1|||
129694550|NCT03280615|466839565|FG000|Overall Study|Withdrawal by Subject|2|||
129694551|NCT03280615|466839566|FG001|Overall Study|Withdrawal by Subject|2|||
129694552|NCT01013870|466839569|FG000|Overall Study|Lost to Follow-up|1|||
129694553|NCT01013870|466839570|FG001|Overall Study|Lost to Follow-up|3|||
129694554|NCT01386645|466839571|FG000|Overall Study|Physician Decision|0|||
129694555|NCT01386645|466839572|FG001|Overall Study|Physician Decision|0|||
129694556|NCT01386645|466839573|FG002|Overall Study|Physician Decision|1|||
129694557|NCT01386645|466839571|FG000|Overall Study|Withdrawal by Subject|0|||
129694558|NCT01386645|466839572|FG001|Overall Study|Withdrawal by Subject|1|||
129694559|NCT01386645|466839573|FG002|Overall Study|Withdrawal by Subject|1|||
129694560|NCT00432991|466839574|FG000|Overall Study|Protocol Violation|7|||
129694561|NCT00432991|466839575|FG001|Overall Study|Protocol Violation|12|||
129694562|NCT03142451|466839585|FG000|Overall Study|Adverse Event|5|||
129694563|NCT03142451|466839586|FG001|Overall Study|Adverse Event|2|||
129576109|NCT02674152|466405643|FG002|Overall Study|Other adverse event or clinical progression|0|||
129576110|NCT02674152|466405644|FG003|Overall Study|Other adverse event or clinical progression|3|||
129694564|NCT03142451|466839585|FG000|Overall Study|Lost to Follow-up|25|||
129694565|NCT03142451|466839586|FG001|Overall Study|Lost to Follow-up|8|||
129694566|NCT03142451|466839585|FG000|Overall Study|Participant request|24|||
129694567|NCT03142451|466839586|FG001|Overall Study|Participant request|12|||
129694568|NCT03142451|466839585|FG000|Overall Study|Protocol Violation|3|||
129694569|NCT03142451|466839586|FG001|Overall Study|Protocol Violation|1|||
129694570|NCT03142451|466839585|FG000|Overall Study|Other|1|||
129694571|NCT03142451|466839586|FG001|Overall Study|Other|1|||
129694572|NCT00090402|466839587|FG000|Overall Study|Death|1|||
129694573|NCT00090402|466839588|FG001|Overall Study|Death|1|||
129694574|NCT00090402|466839589|FG002|Overall Study|Death|0|||
129694575|NCT00090402|466839587|FG000|Overall Study|subject moved|0|||
129694576|NCT00090402|466839588|FG001|Overall Study|subject moved|1|||
129694577|NCT00090402|466839589|FG002|Overall Study|subject moved|0|||
129694578|NCT00090402|466839587|FG000|Overall Study|stopped taking study medication|1|||
129694579|NCT00090402|466839588|FG001|Overall Study|stopped taking study medication|0|||
129694580|NCT00090402|466839589|FG002|Overall Study|stopped taking study medication|1|||
129694581|NCT04621786|466839600|FG000|Overall Study|Lost to Follow-up|9|||
129694582|NCT04621786|466839600|FG000|Overall Study|Protocol Violation|3|||
129694583|NCT02365064|466839603|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
129694584|NCT02365064|466839604|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
129694585|NCT02365064|466839603|FG000|Overall Study|Withdrawal by Subject|6|||
129694586|NCT02365064|466839604|FG001|Overall Study|Withdrawal by Subject|9|||
129694587|NCT02365064|466839603|FG000|Overall Study|Treatment intolerance|2|||
129694588|NCT02365064|466839604|FG001|Overall Study|Treatment intolerance|4|||
129694589|NCT01716559|466839605|FG000|Overall Study|Adverse Event|11|||
129576111|NCT02674152|466405645|FG004|Overall Study|Other adverse event or clinical progression|0|||
129694590|NCT01716559|466839605|FG000|Overall Study|Death|21|||
129694591|NCT01716559|466839605|FG000|Overall Study|Withdrawal by Subject|4|||
129784761|NCT00865280|467180024|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
129784762|NCT00865280|467180023|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
129784763|NCT00865280|467180024|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
129784764|NCT00865280|467180023|FG000|Overall Study|Exclusion Condition|1|||
129784765|NCT00865280|467180024|FG001|Overall Study|Exclusion Condition|0|||
129784766|NCT00865280|467180023|FG000|Overall Study|Adverse Event|0|||
129784767|NCT00865280|467180024|FG001|Overall Study|Adverse Event|1|||
129784768|NCT01788215|467180027|FG000|Overall Study|Withdrawal by Subject|0|||
129784769|NCT01788215|467180028|FG001|Overall Study|Withdrawal by Subject|1|||
129784770|NCT01788215|467180027|FG000|Overall Study|Lost to Follow-up|2|||
129784771|NCT01788215|467180028|FG001|Overall Study|Lost to Follow-up|0|||
129784772|NCT00275340|467180029|FG000|Overall Study|Lost to Follow-up|2|||
129784773|NCT00275340|467180030|FG001|Overall Study|Lost to Follow-up|4|||
129784774|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
129784775|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
129784776|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
129784777|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
129784778|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
129784779|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
129784780|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
129784781|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
129784782|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
129784783|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
129784784|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
129784785|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
129784786|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
129784787|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
129784788|NCT00612105|467180034|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
129784789|NCT00612105|467180035|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
129784790|NCT00612105|467180034|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
129784791|NCT00612105|467180035|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
129784792|NCT00612105|467180034|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
129784793|NCT00612105|467180035|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
129784794|NCT00612105|467180034|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
129784795|NCT00612105|467180035|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
129784796|NCT00612105|467180034|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
129784797|NCT00612105|467180035|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
129784798|NCT01105767|467180036|FG000|Overall Study|Lost to Follow-up|1160|||
129784799|NCT01105767|467180037|FG001|Overall Study|Lost to Follow-up|1614|||
129784800|NCT01105767|467180038|FG002|Overall Study|Lost to Follow-up|1184|||
129784801|NCT00743106|467180039|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
129784802|NCT00743106|467180040|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
129784803|NCT02674204|467180042|FG000|Overall Study|Adverse Event|1|||
129784804|NCT02674204|467180043|FG001|Overall Study|Adverse Event|0|||
129784805|NCT02874144|467180046|FG000|Overall Study|Lost to Follow-up|3|||
129784806|NCT02874144|467180047|FG001|Overall Study|Lost to Follow-up|5|||
129784807|NCT00486811|467180048|FG000|Overall Study|Adverse Event|28|||
129784808|NCT00486811|467180049|FG001|Overall Study|Adverse Event|60|||
129784809|NCT00486811|467180050|FG002|Overall Study|Adverse Event|135|||
129784810|NCT00486811|467180048|FG000|Overall Study|Lack of Efficacy|34|||
129784811|NCT00486811|467180049|FG001|Overall Study|Lack of Efficacy|14|||
129784812|NCT00486811|467180050|FG002|Overall Study|Lack of Efficacy|7|||
129784813|NCT00486811|467180048|FG000|Overall Study|Lost to Follow-up|4|||
129784814|NCT00486811|467180049|FG001|Overall Study|Lost to Follow-up|6|||
129784815|NCT00486811|467180050|FG002|Overall Study|Lost to Follow-up|4|||
129784816|NCT00486811|467180048|FG000|Overall Study|Withdrawal by Subject|33|||
129784817|NCT00486811|467180049|FG001|Overall Study|Withdrawal by Subject|44|||
129784818|NCT00486811|467180050|FG002|Overall Study|Withdrawal by Subject|58|||
129784819|NCT00486811|467180048|FG000|Overall Study|Study drug non-compliant|5|||
129784820|NCT00486811|467180049|FG001|Overall Study|Study drug non-compliant|6|||
129784821|NCT00486811|467180050|FG002|Overall Study|Study drug non-compliant|3|||
129784822|NCT00486811|467180048|FG000|Overall Study|All other|18|||
129784823|NCT00486811|467180049|FG001|Overall Study|All other|11|||
129784824|NCT00486811|467180050|FG002|Overall Study|All other|7|||
129784825|NCT03753789|467180051|FG000|Overall Study|Withdrawal by Subject|2|||
129784826|NCT01578850|467180056|FG000|Period 1|Insufficient Clinical Response|1|||
129784827|NCT01578850|467180057|FG001|Period 1|Insufficient Clinical Response|0|||
129784828|NCT01578850|467180058|FG002|Period 1|Insufficient Clinical Response|0|||
129784829|NCT01578850|467180056|FG000|Period 1|Adverse Event|11|||
129784830|NCT01578850|467180057|FG001|Period 1|Adverse Event|0|||
129784831|NCT01578850|467180058|FG002|Period 1|Adverse Event|0|||
129784832|NCT01578850|467180056|FG000|Period 1|Death|1|||
129784833|NCT01578850|467180057|FG001|Period 1|Death|0|||
129784834|NCT01578850|467180058|FG002|Period 1|Death|0|||
129784835|NCT01578850|467180056|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
129784836|NCT01578850|467180057|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
129784837|NCT01578850|467180058|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
129784838|NCT01578850|467180056|FG000|Period 1|Withdrawal by Subject|9|||
129784839|NCT01578850|467180057|FG001|Period 1|Withdrawal by Subject|0|||
129784840|NCT01578850|467180058|FG002|Period 1|Withdrawal by Subject|0|||
129784841|NCT01578850|467180056|FG000|Period 1|Study Terminated by Sponsor|3|||
129784842|NCT01578850|467180057|FG001|Period 1|Study Terminated by Sponsor|0|||
129784843|NCT01578850|467180058|FG002|Period 1|Study Terminated by Sponsor|0|||
129784844|NCT01578850|467180056|FG000|Period 2|Insufficient Clinical Response|0|||
129784845|NCT01578850|467180057|FG001|Period 2|Insufficient Clinical Response|1|||
129784846|NCT01578850|467180058|FG002|Period 2|Insufficient Clinical Response|0|||
129784847|NCT01578850|467180056|FG000|Period 2|Adverse Event|0|||
129784848|NCT01578850|467180057|FG001|Period 2|Adverse Event|3|||
129784849|NCT01578850|467180058|FG002|Period 2|Adverse Event|6|||
129784850|NCT01578850|467180056|FG000|Period 2|Lost to Follow-up|0|||
129784851|NCT01578850|467180057|FG001|Period 2|Lost to Follow-up|1|||
129784852|NCT01578850|467180058|FG002|Period 2|Lost to Follow-up|2|||
129784853|NCT01578850|467180056|FG000|Period 2|Withdrawal by Subject|0|||
129784854|NCT01578850|467180057|FG001|Period 2|Withdrawal by Subject|2|||
129784855|NCT01578850|467180058|FG002|Period 2|Withdrawal by Subject|2|||
129784856|NCT01578850|467180056|FG000|Period 2|Study Terminated by Sponsor|0|||
129784857|NCT01578850|467180057|FG001|Period 2|Study Terminated by Sponsor|5|||
129784858|NCT01578850|467180058|FG002|Period 2|Study Terminated by Sponsor|4|||
129784859|NCT01578850|467180056|FG000|Period 2|Unspecified Reasons|0|||
129784860|NCT01578850|467180057|FG001|Period 2|Unspecified Reasons|1|||
129784861|NCT01578850|467180058|FG002|Period 2|Unspecified Reasons|0|||
129784862|NCT01711216|467180061|FG000|Overall Study|Adverse Event|4|||
129784863|NCT01711216|467180061|FG000|Overall Study|Pregnancy|56|||
129784864|NCT01711216|467180061|FG000|Overall Study|Withdrawal by Subject|6|||
129784865|NCT01711216|467180061|FG000|Overall Study|Lost to Follow-up|46|||
129784866|NCT01711216|467180061|FG000|Overall Study|variety of other minor reasons|83|||
129784867|NCT01711216|467180061|FG000|Overall Study|no reason specified|22|||
129784868|NCT02929498|467180062|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
129784869|NCT02929498|467180063|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
129784870|NCT02929498|467180064|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
129784871|NCT02929498|467180062|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
129784872|NCT02929498|467180063|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
129784873|NCT02929498|467180064|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
129784874|NCT02744040|467180065|FG000|Overall Study|Withdrawal by Subject|3|||
129784875|NCT02744040|467180066|FG001|Overall Study|Withdrawal by Subject|2|||
129784876|NCT02744040|467180067|FG002|Overall Study|Withdrawal by Subject|2|||
129784877|NCT02744040|467180065|FG000|Overall Study|Physician Decision|0|||
129784878|NCT02744040|467180066|FG001|Overall Study|Physician Decision|8|||
129784879|NCT02744040|467180067|FG002|Overall Study|Physician Decision|13|||
129784880|NCT02744040|467180065|FG000|Overall Study|Lost to Follow-up|3|||
129784881|NCT02744040|467180066|FG001|Overall Study|Lost to Follow-up|1|||
129784882|NCT02744040|467180067|FG002|Overall Study|Lost to Follow-up|7|||
129784883|NCT00096356|467180068|FG000|Overall Study|Adverse Event|11|||
129784884|NCT00096356|467180069|FG001|Overall Study|Adverse Event|9|||
129784885|NCT00096356|467180068|FG000|Overall Study|Physician Decision|5|||
129784886|NCT00096356|467180069|FG001|Overall Study|Physician Decision|3|||
129784887|NCT00096356|467180068|FG000|Overall Study|Withdrawal by Subject|17|||
129784888|NCT00096356|467180069|FG001|Overall Study|Withdrawal by Subject|23|||
129784889|NCT00096356|467180068|FG000|Overall Study|Lack of Efficacy|1|||
129784890|NCT00096356|467180069|FG001|Overall Study|Lack of Efficacy|0|||
129784891|NCT00096356|467180068|FG000|Overall Study|multiple reasons|10|||
129784892|NCT00096356|467180069|FG001|Overall Study|multiple reasons|18|||
129784893|NCT01030666|467180071|FG000|Overall Study|Lost to Follow-up|3|||
129784894|NCT01030666|467180072|FG001|Overall Study|Lost to Follow-up|2|||
129784895|NCT04002908|467180075|FG000|Overall Study|Death|41|||
129784896|NCT04002908|467180076|FG001|Overall Study|Death|0|||
129784897|NCT04002908|467180077|FG002|Overall Study|Death|0|||
129784898|NCT04002908|467180078|FG003|Overall Study|Death|0|||
129784899|NCT04002908|467180075|FG000|Overall Study|Withdrawal by Subject|112|||
129784900|NCT04002908|467180076|FG001|Overall Study|Withdrawal by Subject|0|||
129784901|NCT04002908|467180077|FG002|Overall Study|Withdrawal by Subject|0|||
129784902|NCT04002908|467180078|FG003|Overall Study|Withdrawal by Subject|0|||
129784903|NCT04002908|467180075|FG000|Overall Study|Lost to Follow-up|72|||
129784904|NCT04002908|467180076|FG001|Overall Study|Lost to Follow-up|0|||
129784905|NCT04002908|467180077|FG002|Overall Study|Lost to Follow-up|0|||
129784906|NCT04002908|467180078|FG003|Overall Study|Lost to Follow-up|0|||
129784907|NCT04002908|467180075|FG000|Overall Study|Infant died, so mother withdrawn|34|||
129784908|NCT04002908|467180076|FG001|Overall Study|Infant died, so mother withdrawn|0|||
129784909|NCT04002908|467180077|FG002|Overall Study|Infant died, so mother withdrawn|0|||
129784910|NCT04002908|467180078|FG003|Overall Study|Infant died, so mother withdrawn|0|||
129784911|NCT04359901|467180083|FG000|Overall Study|Withdrawal by Subject|0|||
129784912|NCT04359901|467180084|FG001|Overall Study|Withdrawal by Subject|1|||
129784913|NCT04359901|467180083|FG000|Overall Study|Death|6|||
129784914|NCT04359901|467180084|FG001|Overall Study|Death|2|||
129784915|NCT05092360|467180085|FG000|Overall Study|Withdrawal by Subject|21|||
129784916|NCT05092360|467180086|FG001|Overall Study|Withdrawal by Subject|4|||
129784917|NCT05092360|467180087|FG002|Overall Study|Withdrawal by Subject|9|||
129784918|NCT05092360|467180088|FG003|Overall Study|Withdrawal by Subject|26|||
129784919|NCT05092360|467180085|FG000|Overall Study|Death|97|||
129784920|NCT05092360|467180086|FG001|Overall Study|Death|14|||
129784921|NCT05092360|467180087|FG002|Overall Study|Death|31|||
129784922|NCT05092360|467180088|FG003|Overall Study|Death|101|||
129784923|NCT05092360|467180085|FG000|Overall Study|Lost to Follow-up|1|||
129784924|NCT05092360|467180086|FG001|Overall Study|Lost to Follow-up|2|||
129784925|NCT05092360|467180087|FG002|Overall Study|Lost to Follow-up|2|||
129784926|NCT05092360|467180088|FG003|Overall Study|Lost to Follow-up|2|||
129784927|NCT05092360|467180085|FG000|Overall Study|Study terminated by sponsor|65|||
129784928|NCT05092360|467180086|FG001|Overall Study|Study terminated by sponsor|7|||
129784929|NCT05092360|467180087|FG002|Overall Study|Study terminated by sponsor|13|||
129784930|NCT05092360|467180088|FG003|Overall Study|Study terminated by sponsor|61|||
129784931|NCT01525225|467180089|FG000|Enrollment|No longer met study criteria|1|||
129784932|NCT01525225|467180089|FG000|Enrollment|Other|1|||
129784933|NCT00243841|467180092|FG000|Overall Study|Physician Decision|0|||
129784934|NCT00243841|467180093|FG001|Overall Study|Physician Decision|0|||
129784935|NCT00243841|467180094|FG002|Overall Study|Physician Decision|1|||
129784936|NCT00243841|467180095|FG003|Overall Study|Physician Decision|0|||
129784937|NCT00243841|467180096|FG004|Overall Study|Physician Decision|0|||
129784938|NCT00243841|467180097|FG005|Overall Study|Physician Decision|2|||
129784939|NCT00363545|467180098|FG000|Overall Study|Serious Adverse Event|0|||
129784940|NCT00363545|467180099|FG001|Overall Study|Serious Adverse Event|1|||
129784941|NCT00363545|467180098|FG000|Overall Study|Withdrawal by Subject|12|||
129784942|NCT00363545|467180099|FG001|Overall Study|Withdrawal by Subject|15|||
129784943|NCT00363545|467180098|FG000|Overall Study|Migrated/moved from study area|3|||
129784944|NCT00363545|467180099|FG001|Overall Study|Migrated/moved from study area|6|||
129784945|NCT00363545|467180098|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
129784946|NCT00363545|467180099|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
129784947|NCT00363545|467180098|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
129784948|NCT00363545|467180099|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
129784949|NCT00363545|467180098|FG000|Overall Study|Others|1|||
129784950|NCT00363545|467180099|FG001|Overall Study|Others|0|||
129784951|NCT01379508|467180100|FG000|Treatment to Week 104|Adverse Event|2|||
129784952|NCT01379508|467180101|FG001|Treatment to Week 104|Adverse Event|0|||
129784953|NCT01379508|467180102|FG002|Treatment to Week 104|Adverse Event|5|||
129784954|NCT01379508|467180103|FG003|Treatment to Week 104|Adverse Event|0|||
129784955|NCT01379508|467180100|FG000|Treatment to Week 104|Abnormal lab value|1|||
129784956|NCT01379508|467180101|FG001|Treatment to Week 104|Abnormal lab value|0|||
129784957|NCT01379508|467180102|FG002|Treatment to Week 104|Abnormal lab value|0|||
129784958|NCT01379508|467180103|FG003|Treatment to Week 104|Abnormal lab value|0|||
129784959|NCT01379508|467180100|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
129784960|NCT01379508|467180101|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
129784961|NCT01379508|467180102|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
129784962|NCT01379508|467180103|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
129784963|NCT01379508|467180100|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
129784964|NCT01379508|467180101|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
129784965|NCT01379508|467180102|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
129784966|NCT01379508|467180103|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
129784967|NCT01379508|467180100|FG000|Treatment to Week 104|Lost to Follow-up|5|||
129784968|NCT01379508|467180101|FG001|Treatment to Week 104|Lost to Follow-up|0|||
129784969|NCT01379508|467180102|FG002|Treatment to Week 104|Lost to Follow-up|3|||
129784970|NCT01379508|467180103|FG003|Treatment to Week 104|Lost to Follow-up|0|||
129784971|NCT01379508|467180100|FG000|Treatment to Week 104|Administrative problems|3|||
129784972|NCT01379508|467180101|FG001|Treatment to Week 104|Administrative problems|1|||
129784973|NCT01379508|467180102|FG002|Treatment to Week 104|Administrative problems|0|||
129784974|NCT01379508|467180103|FG003|Treatment to Week 104|Administrative problems|0|||
129784975|NCT01379508|467180100|FG000|Treatment to Week 104|Protocol Violation|1|||
129784976|NCT01379508|467180101|FG001|Treatment to Week 104|Protocol Violation|1|||
129784977|NCT01379508|467180102|FG002|Treatment to Week 104|Protocol Violation|1|||
129784978|NCT01379508|467180103|FG003|Treatment to Week 104|Protocol Violation|0|||
129784979|NCT01379508|467180100|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
129784980|NCT01379508|467180101|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
129784981|NCT01379508|467180102|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
129576112|NCT02674152|466405641|FG000|Overall Study|Dose-limiting toxicity|0|||
129576113|NCT02674152|466405642|FG001|Overall Study|Dose-limiting toxicity|0|||
129576114|NCT02674152|466405643|FG002|Overall Study|Dose-limiting toxicity|0|||
129576115|NCT02674152|466405644|FG003|Overall Study|Dose-limiting toxicity|0|||
129576116|NCT02674152|466405645|FG004|Overall Study|Dose-limiting toxicity|1|||
129576117|NCT02674152|466405641|FG000|Overall Study|Progressive Disease|2|||
129784982|NCT01379508|467180103|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
129784983|NCT01379508|467180100|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
129576118|NCT02674152|466405642|FG001|Overall Study|Progressive Disease|1|||
129576119|NCT02674152|466405643|FG002|Overall Study|Progressive Disease|1|||
129576120|NCT02674152|466405644|FG003|Overall Study|Progressive Disease|13|||
129576121|NCT02674152|466405645|FG004|Overall Study|Progressive Disease|2|||
129576122|NCT02674152|466405641|FG000|Overall Study|Adverse Event|0|||
129576123|NCT02674152|466405642|FG001|Overall Study|Adverse Event|0|||
129576124|NCT02674152|466405643|FG002|Overall Study|Adverse Event|1|||
129784984|NCT01379508|467180101|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
129784985|NCT01379508|467180102|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
129784986|NCT01379508|467180103|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
129784987|NCT01379508|467180100|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
129784988|NCT01379508|467180101|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
129784989|NCT01379508|467180102|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
129784990|NCT01379508|467180103|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
129784991|NCT01379508|467180100|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
129784992|NCT01379508|467180101|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
129784993|NCT01379508|467180102|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
129784994|NCT01379508|467180103|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
129784995|NCT04236141|467181955|FG000|Overall Study|Death|18|||
129784996|NCT04236141|467181956|FG001|Overall Study|Death|10|||
129784997|NCT04236141|467181955|FG000|Overall Study|Withdrawal by Participant|1|||
129784998|NCT04236141|467181956|FG001|Overall Study|Withdrawal by Participant|0|||
129784999|NCT04236141|467181955|FG000|Overall Study|Reason not Specified|1|||
129785000|NCT04236141|467181956|FG001|Overall Study|Reason not Specified|0|||
129576125|NCT02674152|466405644|FG003|Overall Study|Adverse Event|0|||
129576126|NCT02674152|466405645|FG004|Overall Study|Adverse Event|1|||
129576127|NCT04934722|466405646|FG000|Overall Study|Death|4|||
129576128|NCT04934722|466405647|FG001|Overall Study|Death|3|||
129576129|NCT04934722|466405646|FG000|Overall Study|Participants Ongoing|88|||
129576130|NCT04934722|466405647|FG001|Overall Study|Participants Ongoing|91|||
129576131|NCT05265624|466405648|FG000|Overall Study|Lost to Follow-up|3|||
129785001|NCT04236141|467181955|FG000|Overall Study|Study terminated by Sponsor|8|||
129785002|NCT04236141|467181956|FG001|Overall Study|Study terminated by Sponsor|4|||
129785003|NCT01925131|467181957|FG000|Overall Study|Death|0|||
129785004|NCT01925131|467181958|FG001|Overall Study|Death|0|||
129785005|NCT01925131|467181959|FG002|Overall Study|Death|1|||
129785006|NCT01925131|467181960|FG003|Overall Study|Death|0|||
129785007|NCT01925131|467181961|FG004|Overall Study|Death|0|||
129785008|NCT01925131|467181962|FG005|Overall Study|Death|0|||
129785009|NCT01925131|467181957|FG000|Overall Study|Progression/Relapse|1|||
129785010|NCT01925131|467181958|FG001|Overall Study|Progression/Relapse|1|||
129785011|NCT01925131|467181959|FG002|Overall Study|Progression/Relapse|4|||
129785012|NCT01925131|467181960|FG003|Overall Study|Progression/Relapse|0|||
129785013|NCT01925131|467181961|FG004|Overall Study|Progression/Relapse|0|||
129785014|NCT01925131|467181962|FG005|Overall Study|Progression/Relapse|1|||
129576132|NCT05265624|466405649|FG001|Overall Study|Lost to Follow-up|0|||
129785015|NCT01925131|467181957|FG000|Overall Study|Patient Refusal|1|||
129785016|NCT01925131|467181958|FG001|Overall Study|Patient Refusal|0|||
129785017|NCT01925131|467181959|FG002|Overall Study|Patient Refusal|0|||
129785018|NCT01925131|467181960|FG003|Overall Study|Patient Refusal|0|||
129785019|NCT01925131|467181961|FG004|Overall Study|Patient Refusal|0|||
129785020|NCT01925131|467181962|FG005|Overall Study|Patient Refusal|0|||
129785021|NCT01925131|467181957|FG000|Overall Study|Adverse Event|0|||
129576133|NCT05265624|466405648|FG000|Overall Study|Withdrawal by Subject|1|||
129576134|NCT05265624|466405649|FG001|Overall Study|Withdrawal by Subject|0|||
129576135|NCT03071575|466405650|FG000|Overall Study|Death|0|||
129576136|NCT03071575|466405651|FG001|Overall Study|Death|1|||
129785022|NCT01925131|467181958|FG001|Overall Study|Adverse Event|0|||
129785023|NCT01925131|467181959|FG002|Overall Study|Adverse Event|2|||
129785024|NCT01925131|467181960|FG003|Overall Study|Adverse Event|0|||
129785025|NCT01925131|467181961|FG004|Overall Study|Adverse Event|1|||
129785026|NCT01925131|467181962|FG005|Overall Study|Adverse Event|3|||
129576137|NCT03071575|466405650|FG000|Overall Study|Lost to Follow-up|5|||
129576138|NCT03071575|466405651|FG001|Overall Study|Lost to Follow-up|11|||
129576139|NCT03071575|466405650|FG000|Overall Study|Withdrawal by Subject|4|||
129576140|NCT03071575|466405651|FG001|Overall Study|Withdrawal by Subject|2|||
129576141|NCT00834795|466405652|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
129576142|NCT00834795|466405653|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
129576143|NCT00834795|466405652|FG000|Second Intervention|Adverse Event|1|||
129576144|NCT00834795|466405653|FG001|Second Intervention|Adverse Event|0|||
129576145|NCT00579345|466405654|FG000|Overall Study|Withdrawal by Subject|2|||
129576146|NCT00579345|466405655|FG001|Overall Study|Withdrawal by Subject|0|||
129576147|NCT00579345|466405656|FG002|Overall Study|Withdrawal by Subject|0|||
129576148|NCT00579345|466405657|FG003|Overall Study|Withdrawal by Subject|0|||
129576149|NCT00579345|466405658|FG004|Overall Study|Withdrawal by Subject|0|||
129576150|NCT00579345|466405659|FG005|Overall Study|Withdrawal by Subject|0|||
129576151|NCT00579345|466405660|FG006|Overall Study|Withdrawal by Subject|0|||
129576152|NCT00579345|466405661|FG007|Overall Study|Withdrawal by Subject|1|||
129576153|NCT00579345|466405654|FG000|Overall Study|Lost to Follow-up|1|||
129576154|NCT00579345|466405655|FG001|Overall Study|Lost to Follow-up|0|||
129576155|NCT00579345|466405656|FG002|Overall Study|Lost to Follow-up|0|||
129576156|NCT00579345|466405657|FG003|Overall Study|Lost to Follow-up|0|||
129576157|NCT00579345|466405658|FG004|Overall Study|Lost to Follow-up|0|||
129576158|NCT00579345|466405659|FG005|Overall Study|Lost to Follow-up|0|||
129576159|NCT00579345|466405660|FG006|Overall Study|Lost to Follow-up|0|||
129576160|NCT00579345|466405661|FG007|Overall Study|Lost to Follow-up|0|||
129576161|NCT00579345|466405654|FG000|Overall Study|Adverse Event|0|||
129576162|NCT00579345|466405655|FG001|Overall Study|Adverse Event|0|||
129576163|NCT00579345|466405656|FG002|Overall Study|Adverse Event|1|||
129576164|NCT00579345|466405657|FG003|Overall Study|Adverse Event|0|||
129576165|NCT00579345|466405658|FG004|Overall Study|Adverse Event|0|||
129576166|NCT00579345|466405659|FG005|Overall Study|Adverse Event|0|||
129576167|NCT00579345|466405660|FG006|Overall Study|Adverse Event|0|||
129576168|NCT00579345|466405661|FG007|Overall Study|Adverse Event|0|||
129576169|NCT00579345|466405654|FG000|Overall Study|Protocol Violation|1|||
129576170|NCT00579345|466405655|FG001|Overall Study|Protocol Violation|0|||
129576171|NCT00579345|466405656|FG002|Overall Study|Protocol Violation|0|||
129576172|NCT00579345|466405657|FG003|Overall Study|Protocol Violation|0|||
129576173|NCT00579345|466405658|FG004|Overall Study|Protocol Violation|0|||
129576174|NCT00579345|466405659|FG005|Overall Study|Protocol Violation|0|||
129576175|NCT00579345|466405660|FG006|Overall Study|Protocol Violation|0|||
129576176|NCT00579345|466405661|FG007|Overall Study|Protocol Violation|1|||
129576177|NCT00579345|466405654|FG000|Overall Study|Death|1|||
129576178|NCT00579345|466405655|FG001|Overall Study|Death|1|||
129576179|NCT00579345|466405656|FG002|Overall Study|Death|1|||
129576180|NCT00579345|466405657|FG003|Overall Study|Death|1|||
129576181|NCT00579345|466405658|FG004|Overall Study|Death|0|||
129576182|NCT00579345|466405659|FG005|Overall Study|Death|0|||
129576183|NCT00579345|466405660|FG006|Overall Study|Death|0|||
129576184|NCT00579345|466405661|FG007|Overall Study|Death|0|||
129576185|NCT03255733|466405665|FG000|Overall Study|Lost to Follow-up|4|||
129576186|NCT03653507|466405667|FG000|Overall Study|Miscellaneous|28|||
129576187|NCT03653507|466405668|FG001|Overall Study|Miscellaneous|19|||
129576188|NCT03653507|466405667|FG000|Overall Study|Withdrawal by Subject|37|||
129576189|NCT03653507|466405668|FG001|Overall Study|Withdrawal by Subject|22|||
129576190|NCT03653507|466405667|FG000|Overall Study|Protocol Deviation|2|||
129576191|NCT03653507|466405668|FG001|Overall Study|Protocol Deviation|1|||
129576192|NCT03653507|466405667|FG000|Overall Study|Progressive disease|117|||
129576193|NCT03653507|466405668|FG001|Overall Study|Progressive disease|168|||
129576194|NCT03653507|466405667|FG000|Overall Study|Lost to Follow-up|1|||
129576195|NCT03653507|466405668|FG001|Overall Study|Lost to Follow-up|1|||
129576196|NCT03653507|466405667|FG000|Overall Study|Death|25|||
129576197|NCT03653507|466405668|FG001|Overall Study|Death|22|||
129576198|NCT03653507|466405667|FG000|Overall Study|Adverse Event|35|||
129576199|NCT03653507|466405668|FG001|Overall Study|Adverse Event|14|||
129576200|NCT03697109|466405669|FG000|Open-label (OL) Phase|Adverse Event|24|||
129576201|NCT03697109|466405670|FG001|Open-label (OL) Phase|Adverse Event|0|||
129785027|NCT01925131|467181957|FG000|Overall Study|Other - Not Protocol Specified|3|||
129576202|NCT03697109|466405671|FG002|Open-label (OL) Phase|Adverse Event|0|||
129576203|NCT03697109|466405669|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
129576204|NCT03697109|466405670|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
129576205|NCT03697109|466405671|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
129576206|NCT03697109|466405669|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
129576207|NCT03697109|466405670|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
129576208|NCT03697109|466405671|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
129576209|NCT03697109|466405669|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
129576210|NCT03697109|466405670|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
129576211|NCT03697109|466405671|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
129576212|NCT03697109|466405669|FG000|Open-label (OL) Phase|Physician Decision|2|||
129576213|NCT03697109|466405670|FG001|Open-label (OL) Phase|Physician Decision|0|||
129576214|NCT03697109|466405671|FG002|Open-label (OL) Phase|Physician Decision|0|||
129576215|NCT03697109|466405669|FG000|Open-label (OL) Phase|Death|2|||
129576216|NCT03697109|466405670|FG001|Open-label (OL) Phase|Death|0|||
129576217|NCT03697109|466405671|FG002|Open-label (OL) Phase|Death|0|||
129576218|NCT03697109|466405669|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
129576219|NCT03697109|466405670|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
129576220|NCT03697109|466405671|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
129576221|NCT03697109|466405669|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
129576222|NCT03697109|466405670|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
129576223|NCT03697109|466405671|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
129576224|NCT03697109|466405669|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
129576225|NCT03697109|466405670|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
129576226|NCT03697109|466405671|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
129576227|NCT00834522|466405672|FG000|Washout|Adverse Event|1|||
129576228|NCT00834522|466405673|FG001|Washout|Adverse Event|0|||
129576229|NCT00834522|466405672|FG000|Washout|Withdrawal by Subject|2|||
129576230|NCT00834522|466405673|FG001|Washout|Withdrawal by Subject|1|||
129576231|NCT04516967|466405674|FG000|Core Phase|Adverse Event|2|||
129576232|NCT04516967|466405675|FG001|Core Phase|Adverse Event|1|||
129576233|NCT04516967|466405676|FG002|Core Phase|Adverse Event|0|||
129576234|NCT04516967|466405674|FG000|Core Phase|Physician Decision|1|||
129576235|NCT04516967|466405675|FG001|Core Phase|Physician Decision|1|||
129576236|NCT04516967|466405676|FG002|Core Phase|Physician Decision|0|||
129576237|NCT04516967|466405674|FG000|Core Phase|Lack of Efficacy|7|||
129576238|NCT04516967|466405675|FG001|Core Phase|Lack of Efficacy|18|||
129576239|NCT04516967|466405676|FG002|Core Phase|Lack of Efficacy|0|||
129576240|NCT00440518|466405679|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
129576241|NCT00440518|466405680|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
129576242|NCT00440518|466405681|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
129576243|NCT00440518|466405679|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
129576244|NCT00440518|466405680|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
129576245|NCT00440518|466405681|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
129576246|NCT00440518|466405679|FG000|Randomized /Titration Period|Protocol Deviation|1|||
129576247|NCT00440518|466405680|FG001|Randomized /Titration Period|Protocol Deviation|0|||
129576248|NCT00440518|466405681|FG002|Randomized /Titration Period|Protocol Deviation|0|||
129576249|NCT00440518|466405679|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
129576250|NCT00440518|466405680|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
129576251|NCT00440518|466405681|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
129576252|NCT00440518|466405679|FG000|Randomized /Titration Period|Other|1|||
129576253|NCT00440518|466405680|FG001|Randomized /Titration Period|Other|0|||
129576254|NCT00440518|466405681|FG002|Randomized /Titration Period|Other|0|||
129576255|NCT00440518|466405679|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
129576256|NCT00440518|466405680|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
129576257|NCT00440518|466405681|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
129576258|NCT00440518|466405679|FG000|Randomized /Titration Period|Adverse Event|2|||
129576259|NCT00440518|466405680|FG001|Randomized /Titration Period|Adverse Event|3|||
129576260|NCT00440518|466405681|FG002|Randomized /Titration Period|Adverse Event|0|||
129576261|NCT00440518|466405679|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
129576262|NCT00440518|466405680|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
129576263|NCT00440518|466405681|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
129576264|NCT00440518|466405679|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
129576265|NCT00440518|466405680|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
129576266|NCT00440518|466405681|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
129576267|NCT00440518|466405679|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
129576268|NCT00440518|466405680|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
129576269|NCT00440518|466405681|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
129576270|NCT00440518|466405679|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
129576271|NCT00440518|466405680|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
129576272|NCT00440518|466405681|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
129576273|NCT00440518|466405679|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
129576274|NCT00440518|466405680|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
129576275|NCT00440518|466405681|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
129576276|NCT00440518|466405679|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
129576277|NCT00440518|466405680|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
129576278|NCT00440518|466405681|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
129576279|NCT00272779|466405682|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
129576280|NCT00272779|466405683|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
129576281|NCT00272779|466405682|FG000|Baseline Through Week 48|Death before Week 48|4|||
129576282|NCT00272779|466405683|FG001|Baseline Through Week 48|Death before Week 48|4|||
129576283|NCT00272779|466405682|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
129576284|NCT00272779|466405683|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
129576285|NCT00272779|466405682|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
129576286|NCT00272779|466405683|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
129576287|NCT00272779|466405682|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
129576288|NCT00272779|466405683|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
129576289|NCT00272779|466405682|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
129576290|NCT00272779|466405683|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
129576291|NCT00272779|466405682|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
129576292|NCT00272779|466405683|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
129576293|NCT00272779|466405682|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
129576294|NCT00272779|466405683|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
129576295|NCT00272779|466405682|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
129576296|NCT00272779|466405683|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
129576297|NCT00272779|466405682|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
129576298|NCT00272779|466405683|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
129576299|NCT00272779|466405682|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
129576300|NCT00272779|466405683|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
129576301|NCT00272779|466405682|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
129576302|NCT00272779|466405683|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
129576303|NCT00272779|466405682|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
129576304|NCT00272779|466405683|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
129576305|NCT00272779|466405682|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
129576306|NCT00272779|466405683|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
129576307|NCT00272779|466405682|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
129576308|NCT00272779|466405683|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
129576309|NCT00272779|466405682|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
129576310|NCT00272779|466405683|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
129576311|NCT00272779|466405682|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
129576312|NCT00272779|466405683|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
129576313|NCT00272779|466405682|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
129576314|NCT00272779|466405683|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
129576315|NCT00272779|466405682|FG000|Baseline Through Week 48|Continuing treatment|385|||
129576316|NCT00272779|466405683|FG001|Baseline Through Week 48|Continuing treatment|368|||
129576317|NCT00272779|466405682|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
129576318|NCT00272779|466405683|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
129576319|NCT00272779|466405682|FG000|Baseline Through Week 48|Never treated|2|||
129576320|NCT00272779|466405683|FG001|Baseline Through Week 48|Never treated|3|||
129576321|NCT00272779|466405682|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
129576322|NCT00272779|466405683|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
129576323|NCT00272779|466405682|FG000|Baseline Through Week 96|Death before Week 96|6|||
129576324|NCT00272779|466405683|FG001|Baseline Through Week 96|Death before Week 96|5|||
129576325|NCT00272779|466405682|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
129576326|NCT00272779|466405683|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
129576327|NCT00272779|466405682|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
129576328|NCT00272779|466405683|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
129694592|NCT01716559|466839605|FG000|Overall Study|Other withdrawal reason|75|||
129694593|NCT01133977|466839608|FG000|Overall Study|Adverse Event|0|||
129576329|NCT00272779|466405682|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
129576330|NCT00272779|466405683|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
129576331|NCT00272779|466405682|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
129576332|NCT00272779|466405683|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
129576333|NCT00272779|466405682|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
129576334|NCT00272779|466405683|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
129576335|NCT00272779|466405682|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
129576336|NCT00272779|466405683|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
129576337|NCT00272779|466405682|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
129576338|NCT00272779|466405683|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
129576339|NCT00272779|466405682|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
129576340|NCT00272779|466405683|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
129576341|NCT00272779|466405682|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
129576342|NCT00272779|466405683|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
129576343|NCT00272779|466405682|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
129694594|NCT01133977|466839609|FG001|Overall Study|Adverse Event|0|||
129694595|NCT01133977|466839610|FG002|Overall Study|Adverse Event|1|||
129694596|NCT01133977|466839611|FG003|Overall Study|Adverse Event|0|||
129694597|NCT01133977|466839612|FG004|Overall Study|Adverse Event|0|||
129694598|NCT01133977|466839608|FG000|Overall Study|Death|1|||
129694599|NCT01133977|466839609|FG001|Overall Study|Death|1|||
129694600|NCT01133977|466839610|FG002|Overall Study|Death|1|||
129694601|NCT01133977|466839611|FG003|Overall Study|Death|7|||
129694602|NCT01133977|466839612|FG004|Overall Study|Death|3|||
129694603|NCT01133977|466839608|FG000|Overall Study|Started a New Line of Therapy|2|||
129694604|NCT01133977|466839609|FG001|Overall Study|Started a New Line of Therapy|6|||
129694605|NCT01133977|466839610|FG002|Overall Study|Started a New Line of Therapy|4|||
129694606|NCT01133977|466839611|FG003|Overall Study|Started a New Line of Therapy|25|||
129694607|NCT01133977|466839612|FG004|Overall Study|Started a New Line of Therapy|33|||
129694608|NCT01133977|466839608|FG000|Overall Study|Lost to Follow-up|0|||
129694609|NCT01133977|466839609|FG001|Overall Study|Lost to Follow-up|0|||
129694610|NCT01133977|466839610|FG002|Overall Study|Lost to Follow-up|0|||
129694611|NCT01133977|466839611|FG003|Overall Study|Lost to Follow-up|2|||
129694612|NCT01133977|466839612|FG004|Overall Study|Lost to Follow-up|1|||
129694613|NCT01133977|466839608|FG000|Overall Study|Withdrawal by Subject|0|||
129694614|NCT01133977|466839609|FG001|Overall Study|Withdrawal by Subject|0|||
129694615|NCT01133977|466839610|FG002|Overall Study|Withdrawal by Subject|0|||
129694616|NCT01133977|466839611|FG003|Overall Study|Withdrawal by Subject|5|||
129694617|NCT01133977|466839612|FG004|Overall Study|Withdrawal by Subject|1|||
129694618|NCT02773537|466839613|FG000|Overall Study|Lost to Follow-up|0|||
129694619|NCT02773537|466839614|FG001|Overall Study|Lost to Follow-up|1|||
129694620|NCT02773537|466839615|FG002|Overall Study|Lost to Follow-up|4|||
129694621|NCT01840163|466839616|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
129694622|NCT01840163|466839617|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
129694623|NCT01840163|466839616|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
129694624|NCT01840163|466839617|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
129694625|NCT01840163|466839616|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
129694626|NCT01840163|466839617|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
129694627|NCT00662038|466839618|FG000|Overall Study|Reason not specified|3|||
129694628|NCT00662038|466839618|FG000|Overall Study|Withdrawn consent|22|||
129694629|NCT00662038|466839618|FG000|Overall Study|Withdrawal by Subject|83|||
129694630|NCT00662038|466839618|FG000|Overall Study|Sponsor decision|1|||
129694631|NCT00662038|466839618|FG000|Overall Study|Physician Decision|19|||
129694632|NCT00662038|466839618|FG000|Overall Study|Lung transplantation|44|||
129694633|NCT00662038|466839618|FG000|Overall Study|Lost to Follow-up|1|||
129694634|NCT00662038|466839618|FG000|Overall Study|Death|95|||
129694635|NCT00662038|466839618|FG000|Overall Study|Adverse Event|358|||
129694636|NCT00662038|466839618|FG000|Overall Study|Continued treatment|5|||
129694637|NCT00397046|466839619|FG000|Overall Study|Disease Progression|3|||
129694638|NCT00397046|466839620|FG001|Overall Study|Disease Progression|3|||
129694639|NCT00397046|466839621|FG002|Overall Study|Disease Progression|10|||
129694640|NCT00397046|466839622|FG003|Overall Study|Disease Progression|5|||
129694641|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
129694642|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
129694643|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
129694644|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
129694645|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
129694646|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
129694647|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
129707769|NCT00542178|466892119|FG000|Overall Study|did not complete year 4 follow-up|75|||
129707770|NCT00542178|466892120|FG001|Overall Study|did not complete year 4 follow-up|80|||
129707771|NCT00542178|466892121|FG002|Overall Study|did not complete year 4 follow-up|74|||
129707772|NCT00542178|466892122|FG003|Overall Study|did not complete year 4 follow-up|62|||
129576344|NCT00272779|466405683|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
129576345|NCT00272779|466405682|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
129576346|NCT00272779|466405683|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
129576347|NCT00272779|466405682|FG000|Baseline Through Week 96|Never treated|2|||
129576348|NCT00272779|466405683|FG001|Baseline Through Week 96|Never treated|3|||
129576349|NCT00272779|466405682|FG000|Baseline Through Week 96|Continuing on treatment|61|||
129576350|NCT00272779|466405683|FG001|Baseline Through Week 96|Continuing on treatment|38|||
129576351|NCT03570749|466405685|FG000|Overall Study|Ongoing|26|||
129576352|NCT03570749|466405686|FG001|Overall Study|Ongoing|25|||
129576353|NCT03570749|466405687|FG002|Overall Study|Ongoing|25|||
129576354|NCT03570749|466405688|FG003|Overall Study|Ongoing|26|||
129785028|NCT01925131|467181958|FG001|Overall Study|Other - Not Protocol Specified|1|||
129785029|NCT01925131|467181959|FG002|Overall Study|Other - Not Protocol Specified|2|||
129785030|NCT01925131|467181960|FG003|Overall Study|Other - Not Protocol Specified|5|||
129785031|NCT01925131|467181961|FG004|Overall Study|Other - Not Protocol Specified|10|||
129785032|NCT01925131|467181962|FG005|Overall Study|Other - Not Protocol Specified|6|||
129576355|NCT03570749|466405689|FG004|Overall Study|Ongoing|140|||
129576356|NCT03570749|466405690|FG005|Overall Study|Ongoing|142|||
129576357|NCT03570749|466405691|FG006|Overall Study|Ongoing|220|||
129576358|NCT03570749|466405685|FG000|Overall Study|Adverse Event|0|||
129576359|NCT03570749|466405686|FG001|Overall Study|Adverse Event|0|||
129576360|NCT03570749|466405687|FG002|Overall Study|Adverse Event|0|||
129576361|NCT03570749|466405688|FG003|Overall Study|Adverse Event|0|||
129576362|NCT03570749|466405689|FG004|Overall Study|Adverse Event|2|||
129576363|NCT03570749|466405690|FG005|Overall Study|Adverse Event|3|||
129576364|NCT03570749|466405691|FG006|Overall Study|Adverse Event|6|||
129576365|NCT03570749|466405685|FG000|Overall Study|Lack of Efficacy|0|||
129576366|NCT03570749|466405686|FG001|Overall Study|Lack of Efficacy|0|||
129576367|NCT03570749|466405687|FG002|Overall Study|Lack of Efficacy|0|||
129576368|NCT03570749|466405688|FG003|Overall Study|Lack of Efficacy|0|||
129576369|NCT03570749|466405689|FG004|Overall Study|Lack of Efficacy|8|||
129576370|NCT03570749|466405690|FG005|Overall Study|Lack of Efficacy|2|||
129576371|NCT03570749|466405691|FG006|Overall Study|Lack of Efficacy|7|||
129576372|NCT03570749|466405685|FG000|Overall Study|Lost to Follow-up|0|||
129576373|NCT03570749|466405686|FG001|Overall Study|Lost to Follow-up|0|||
129576374|NCT03570749|466405687|FG002|Overall Study|Lost to Follow-up|0|||
129576375|NCT03570749|466405688|FG003|Overall Study|Lost to Follow-up|0|||
129576376|NCT03570749|466405689|FG004|Overall Study|Lost to Follow-up|5|||
129576377|NCT03570749|466405690|FG005|Overall Study|Lost to Follow-up|10|||
129576378|NCT03570749|466405691|FG006|Overall Study|Lost to Follow-up|10|||
129576379|NCT03570749|466405685|FG000|Overall Study|Pregnancy|0|||
129785033|NCT01696929|467181963|FG000|Overall Study|Physician Decision|1|||
129785034|NCT01794338|467181964|FG000|Overall Study|Death|2|||
129785035|NCT01794338|467181965|FG001|Overall Study|Death|0|||
129785036|NCT01794338|467181964|FG000|Overall Study|Lost to Follow-up|6|||
129785037|NCT01794338|467181965|FG001|Overall Study|Lost to Follow-up|9|||
129785038|NCT01954927|467181966|FG000|Overall Study|Withdrawal by Subject|3|||
129785039|NCT01954927|467181967|FG001|Overall Study|Withdrawal by Subject|1|||
129785040|NCT00955305|467181968|FG000|Overall Study|Disease progression|39|||
129785041|NCT00955305|467181969|FG001|Overall Study|Disease progression|41|||
129785042|NCT00955305|467181968|FG000|Overall Study|Adverse Event|22|||
129785043|NCT00955305|467181969|FG001|Overall Study|Adverse Event|22|||
129785044|NCT00955305|467181968|FG000|Overall Study|Death|2|||
129785045|NCT00955305|467181969|FG001|Overall Study|Death|1|||
129576380|NCT03570749|466405686|FG001|Overall Study|Pregnancy|0|||
129576381|NCT03570749|466405687|FG002|Overall Study|Pregnancy|0|||
129576382|NCT03570749|466405688|FG003|Overall Study|Pregnancy|0|||
129576383|NCT03570749|466405689|FG004|Overall Study|Pregnancy|0|||
129576384|NCT03570749|466405690|FG005|Overall Study|Pregnancy|1|||
129576385|NCT03570749|466405691|FG006|Overall Study|Pregnancy|1|||
129576386|NCT03570749|466405685|FG000|Overall Study|Screen Fail|0|||
129576387|NCT03570749|466405686|FG001|Overall Study|Screen Fail|0|||
129576388|NCT03570749|466405687|FG002|Overall Study|Screen Fail|0|||
129576389|NCT03570749|466405688|FG003|Overall Study|Screen Fail|0|||
129576390|NCT03570749|466405689|FG004|Overall Study|Screen Fail|0|||
129576391|NCT03570749|466405690|FG005|Overall Study|Screen Fail|0|||
129576392|NCT03570749|466405691|FG006|Overall Study|Screen Fail|1|||
129576393|NCT03570749|466405685|FG000|Overall Study|Withdrawal by Subject|2|||
129576394|NCT03570749|466405686|FG001|Overall Study|Withdrawal by Subject|3|||
129576395|NCT03570749|466405687|FG002|Overall Study|Withdrawal by Subject|2|||
129576396|NCT03570749|466405688|FG003|Overall Study|Withdrawal by Subject|1|||
129576397|NCT03570749|466405689|FG004|Overall Study|Withdrawal by Subject|17|||
129576398|NCT03570749|466405690|FG005|Overall Study|Withdrawal by Subject|12|||
129576399|NCT03570749|466405691|FG006|Overall Study|Withdrawal by Subject|15|||
129576400|NCT03570749|466405685|FG000|Overall Study|Other|0|||
129576401|NCT03570749|466405686|FG001|Overall Study|Other|0|||
129576402|NCT03570749|466405687|FG002|Overall Study|Other|0|||
129785046|NCT00955305|467181968|FG000|Overall Study|Withdrawal by Subject|5|||
129785047|NCT00955305|467181969|FG001|Overall Study|Withdrawal by Subject|4|||
129785048|NCT00955305|467181968|FG000|Overall Study|Alternative therapy|4|||
129785049|NCT00955305|467181969|FG001|Overall Study|Alternative therapy|0|||
129576403|NCT03570749|466405688|FG003|Overall Study|Other|0|||
129576404|NCT03570749|466405689|FG004|Overall Study|Other|17|||
129576405|NCT03570749|466405690|FG005|Overall Study|Other|14|||
129576406|NCT03570749|466405691|FG006|Overall Study|Other|21|||
129576407|NCT00561015|466405692|FG000|Overall Study|Adverse Event|0|||
129576408|NCT00561015|466405693|FG001|Overall Study|Adverse Event|0|||
129576409|NCT00561015|466405694|FG002|Overall Study|Adverse Event|0|||
129576410|NCT00561015|466405695|FG003|Overall Study|Adverse Event|0|||
129576411|NCT00561015|466405696|FG004|Overall Study|Adverse Event|1|||
129576412|NCT00561015|466405697|FG005|Overall Study|Adverse Event|0|||
129576413|NCT00561015|466405692|FG000|Overall Study|Lost to Follow-up|2|||
129576414|NCT00561015|466405693|FG001|Overall Study|Lost to Follow-up|0|||
129576415|NCT00561015|466405694|FG002|Overall Study|Lost to Follow-up|0|||
129576416|NCT00561015|466405695|FG003|Overall Study|Lost to Follow-up|1|||
129576417|NCT00561015|466405696|FG004|Overall Study|Lost to Follow-up|0|||
129576418|NCT00561015|466405697|FG005|Overall Study|Lost to Follow-up|3|||
129576419|NCT00561015|466405692|FG000|Overall Study|Participant non-compliance|2|||
129576420|NCT00561015|466405693|FG001|Overall Study|Participant non-compliance|0|||
129576421|NCT00561015|466405694|FG002|Overall Study|Participant non-compliance|0|||
129576422|NCT00561015|466405695|FG003|Overall Study|Participant non-compliance|0|||
129576423|NCT00561015|466405696|FG004|Overall Study|Participant non-compliance|0|||
129576424|NCT00561015|466405697|FG005|Overall Study|Participant non-compliance|0|||
129576425|NCT02440711|466405698|FG000|Second Intervention|Lost to Follow-up|1|||
129576426|NCT02440711|466405699|FG001|Second Intervention|Lost to Follow-up|0|||
129576427|NCT00163657|466405702|FG000|Overall Study|Death|12|||
129576428|NCT00163657|466405703|FG001|Overall Study|Death|14|||
129576429|NCT00163657|466405704|FG002|Overall Study|Death|19|||
129576430|NCT00163657|466405702|FG000|Overall Study|graft loss|4|||
129576431|NCT00163657|466405703|FG001|Overall Study|graft loss|1|||
129576432|NCT00163657|466405704|FG002|Overall Study|graft loss|2|||
129576433|NCT00163657|466405702|FG000|Overall Study|Withdrawal by Subject|2|||
129576434|NCT00163657|466405703|FG001|Overall Study|Withdrawal by Subject|3|||
129576435|NCT00163657|466405704|FG002|Overall Study|Withdrawal by Subject|2|||
129576436|NCT00163657|466405702|FG000|Overall Study|Physician Decision|0|||
129576437|NCT00163657|466405703|FG001|Overall Study|Physician Decision|1|||
129576438|NCT00163657|466405704|FG002|Overall Study|Physician Decision|1|||
129576439|NCT00163657|466405702|FG000|Overall Study|Non Compliance|1|||
129576440|NCT00163657|466405703|FG001|Overall Study|Non Compliance|0|||
129576441|NCT00163657|466405704|FG002|Overall Study|Non Compliance|0|||
129576442|NCT00163657|466405702|FG000|Overall Study|Lost to Follow-up|1|||
129576443|NCT00163657|466405703|FG001|Overall Study|Lost to Follow-up|3|||
129576444|NCT00163657|466405704|FG002|Overall Study|Lost to Follow-up|10|||
129576445|NCT00163657|466405702|FG000|Overall Study|Other reason|0|||
129576446|NCT00163657|466405703|FG001|Overall Study|Other reason|1|||
129576447|NCT00163657|466405704|FG002|Overall Study|Other reason|3|||
129576448|NCT02436005|466405705|FG000|Second Intervention|Adverse Event|0|||
129576449|NCT02436005|466405706|FG001|Second Intervention|Adverse Event|1|||
129576450|NCT04247282|466405710|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
129576451|NCT04247282|466405711|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
129576452|NCT04247282|466405712|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
129576453|NCT04247282|466405713|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
129576454|NCT04247282|466405710|FG000|Overall Study|Refused further treatment|0|||
129576455|NCT04247282|466405711|FG001|Overall Study|Refused further treatment|1|||
129576456|NCT04247282|466405712|FG002|Overall Study|Refused further treatment|0|||
129576457|NCT04247282|466405713|FG003|Overall Study|Refused further treatment|0|||
129576458|NCT01037114|466405720|FG000|Year 20|Others|1|||
129576459|NCT00968812|466405728|FG000|Overall Study|Adverse Event|30|||
129576460|NCT00968812|466405729|FG001|Overall Study|Adverse Event|46|||
129576461|NCT00968812|466405730|FG002|Overall Study|Adverse Event|33|||
129576462|NCT00968812|466405728|FG000|Overall Study|Death|2|||
129576463|NCT00968812|466405729|FG001|Overall Study|Death|2|||
129576464|NCT00968812|466405730|FG002|Overall Study|Death|1|||
129576465|NCT00968812|466405728|FG000|Overall Study|Lack of Efficacy|9|||
129576466|NCT00968812|466405729|FG001|Overall Study|Lack of Efficacy|7|||
129576467|NCT00968812|466405730|FG002|Overall Study|Lack of Efficacy|16|||
129576468|NCT00968812|466405728|FG000|Overall Study|Lost to Follow-up|17|||
129576469|NCT00968812|466405729|FG001|Overall Study|Lost to Follow-up|12|||
129576470|NCT00968812|466405730|FG002|Overall Study|Lost to Follow-up|11|||
129576471|NCT00968812|466405728|FG000|Overall Study|Physician Decision|8|||
129576472|NCT00968812|466405729|FG001|Overall Study|Physician Decision|5|||
129576473|NCT00968812|466405730|FG002|Overall Study|Physician Decision|9|||
129576474|NCT00968812|466405728|FG000|Overall Study|Protocol Violation|7|||
129576475|NCT00968812|466405729|FG001|Overall Study|Protocol Violation|4|||
129576476|NCT00968812|466405730|FG002|Overall Study|Protocol Violation|3|||
129576477|NCT00968812|466405728|FG000|Overall Study|Withdrawal by Subject|17|||
129576478|NCT00968812|466405729|FG001|Overall Study|Withdrawal by Subject|23|||
129576479|NCT00968812|466405730|FG002|Overall Study|Withdrawal by Subject|25|||
129576480|NCT00968812|466405728|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
129576481|NCT00968812|466405729|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
129785050|NCT00955305|467181968|FG000|Overall Study|Other complicating disease|2|||
129785051|NCT00955305|467181969|FG001|Overall Study|Other complicating disease|4|||
129576482|NCT00968812|466405730|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
129576483|NCT00968812|466405728|FG000|Overall Study|Noncompliance with study drug|4|||
129576484|NCT00968812|466405729|FG001|Overall Study|Noncompliance with study drug|1|||
129576485|NCT00968812|466405730|FG002|Overall Study|Noncompliance with study drug|6|||
129576486|NCT00968812|466405728|FG000|Overall Study|Unable to take rescue therapy|12|||
129576487|NCT00968812|466405729|FG001|Overall Study|Unable to take rescue therapy|12|||
129576488|NCT00968812|466405730|FG002|Overall Study|Unable to take rescue therapy|17|||
129576489|NCT00968812|466405728|FG000|Overall Study|Other|25|||
129576490|NCT00968812|466405729|FG001|Overall Study|Other|37|||
129576491|NCT00968812|466405730|FG002|Overall Study|Other|40|||
129576492|NCT00448591|466405733|FG000|Overall Study|Withdrawal by Subject|178|||
129576493|NCT00448591|466405733|FG000|Overall Study|Progressive Disease|1382|||
129576494|NCT00448591|466405733|FG000|Overall Study|Adverse Event|382|||
129576495|NCT00448591|466405733|FG000|Overall Study|Protocol Violation|41|||
129576496|NCT00448591|466405733|FG000|Overall Study|Lost to Follow-up|19|||
129576497|NCT00448591|466405733|FG000|Overall Study|Treatment Regimen Completed|70|||
129576498|NCT00448591|466405733|FG000|Overall Study|Other|154|||
129576499|NCT00448591|466405733|FG000|Overall Study|Termination of Study|70|||
129576500|NCT00640562|466405734|FG000|Overall Study|Adverse Event|8|||
129576501|NCT00640562|466405735|FG001|Overall Study|Adverse Event|5|||
129576502|NCT00640562|466405734|FG000|Overall Study|Lack of Efficacy|1|||
129576503|NCT00640562|466405735|FG001|Overall Study|Lack of Efficacy|4|||
129576504|NCT00640562|466405734|FG000|Overall Study|Protocol Violation|2|||
129576505|NCT00640562|466405735|FG001|Overall Study|Protocol Violation|4|||
129576506|NCT00640562|466405734|FG000|Overall Study|Withdrawal by Subject|6|||
129576507|NCT00640562|466405735|FG001|Overall Study|Withdrawal by Subject|10|||
129576508|NCT00640562|466405734|FG000|Overall Study|Known risperidone intolerance|0|||
129576509|NCT00640562|466405735|FG001|Overall Study|Known risperidone intolerance|1|||
129576510|NCT00640562|466405734|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
129576511|NCT00640562|466405735|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
129576512|NCT00640562|466405734|FG000|Overall Study|Low study drug dose|0|||
129576513|NCT00640562|466405735|FG001|Overall Study|Low study drug dose|1|||
129576514|NCT00640562|466405734|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
129576515|NCT00640562|466405735|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
129785052|NCT00955305|467181968|FG000|Overall Study|Physician Decision|1|||
129785053|NCT00955305|467181969|FG001|Overall Study|Physician Decision|0|||
129785054|NCT00955305|467181968|FG000|Overall Study|Continued presence of residual disease|0|||
129785055|NCT00955305|467181969|FG001|Overall Study|Continued presence of residual disease|1|||
129785056|NCT00955305|467181968|FG000|Overall Study|Functional decline|2|||
129785057|NCT00955305|467181969|FG001|Overall Study|Functional decline|0|||
129785058|NCT00955305|467181968|FG000|Overall Study|Maximum response achieved|0|||
129785059|NCT00955305|467181969|FG001|Overall Study|Maximum response achieved|1|||
129785060|NCT00955305|467181968|FG000|Overall Study|Lost to Follow-up|0|||
129576516|NCT02937870|466405736|FG000|Overall Study|Adverse Event|1|||
129576517|NCT02937870|466405736|FG000|Overall Study|Protocol Deviation|2|||
129576518|NCT00609674|466405740|FG000|Overall Study|Adverse Event|1|||
129576519|NCT00609674|466405741|FG001|Overall Study|Adverse Event|1|||
129576520|NCT00609674|466405740|FG000|Overall Study|Protocol Violation|3|||
129576521|NCT00609674|466405741|FG001|Overall Study|Protocol Violation|5|||
129576522|NCT00609674|466405740|FG000|Overall Study|Lost to Follow-up|1|||
129576523|NCT00609674|466405741|FG001|Overall Study|Lost to Follow-up|0|||
129576524|NCT00609674|466405740|FG000|Overall Study|Withdrew consent|2|||
129576525|NCT00609674|466405741|FG001|Overall Study|Withdrew consent|1|||
129576526|NCT03098394|466405742|FG000|Overall Study|Pregnancy|0|||
129576527|NCT03098394|466405743|FG001|Overall Study|Pregnancy|1|||
129576528|NCT04604275|466405744|FG000|Washout-1 Week|Withdrawal by Subject|1|||
129576529|NCT04604275|466405745|FG001|Washout-1 Week|Withdrawal by Subject|0|||
129576530|NCT05615935|466405746|FG000|Overall Study|Lost to Follow-up|1|||
129576531|NCT05615935|466405747|FG001|Overall Study|Lost to Follow-up|1|||
129576532|NCT05446870|466405748|FG000|Overall Study|Death|6|||
129576533|NCT05446870|466405749|FG001|Overall Study|Death|5|||
129576534|NCT05446870|466405748|FG000|Overall Study|Lost to Follow-up|0|||
129785061|NCT00955305|467181969|FG001|Overall Study|Lost to Follow-up|1|||
129576535|NCT05446870|466405749|FG001|Overall Study|Lost to Follow-up|1|||
129576536|NCT05446870|466405748|FG000|Overall Study|Physician Decision|52|||
129576537|NCT05446870|466405749|FG001|Overall Study|Physician Decision|53|||
129576538|NCT05446870|466405748|FG000|Overall Study|Withdrawal by Subject|3|||
129576539|NCT05446870|466405749|FG001|Overall Study|Withdrawal by Subject|3|||
129576540|NCT02689505|466405751|FG000|Overall Study|Progressive disease|2|||
129576541|NCT02689505|466405752|FG001|Overall Study|Progressive disease|2|||
129576542|NCT02689505|466405753|FG002|Overall Study|Progressive disease|3|||
129576543|NCT02689505|466405754|FG003|Overall Study|Progressive disease|9|||
129576544|NCT02689505|466405755|FG004|Overall Study|Progressive disease|1|||
129576545|NCT02689505|466405751|FG000|Overall Study|Dose Limiting Toxicity|0|||
129576546|NCT02689505|466405752|FG001|Overall Study|Dose Limiting Toxicity|1|||
129576547|NCT02689505|466405753|FG002|Overall Study|Dose Limiting Toxicity|0|||
129576548|NCT02689505|466405754|FG003|Overall Study|Dose Limiting Toxicity|0|||
129576549|NCT02689505|466405755|FG004|Overall Study|Dose Limiting Toxicity|2|||
129576550|NCT02689505|466405751|FG000|Overall Study|Other AE or clinical progression|0|||
129576551|NCT02689505|466405752|FG001|Overall Study|Other AE or clinical progression|2|||
129576552|NCT02689505|466405753|FG002|Overall Study|Other AE or clinical progression|0|||
129576553|NCT02689505|466405754|FG003|Overall Study|Other AE or clinical progression|2|||
129576554|NCT02689505|466405755|FG004|Overall Study|Other AE or clinical progression|0|||
129576555|NCT02446600|466405756|FG000|Overall Study|Never treated|20|||
129576556|NCT02446600|466405757|FG001|Overall Study|Never treated|2|||
129576557|NCT02446600|466405758|FG002|Overall Study|Never treated|6|||
129576558|NCT02446600|466405759|FG003|Overall Study|Never treated|0|||
129576559|NCT02446600|466405756|FG000|Overall Study|Withdrawal by Subject|19|||
129576560|NCT02446600|466405757|FG001|Overall Study|Withdrawal by Subject|5|||
129576561|NCT02446600|466405758|FG002|Overall Study|Withdrawal by Subject|17|||
129576562|NCT02446600|466405759|FG003|Overall Study|Withdrawal by Subject|0|||
129576563|NCT02446600|466405756|FG000|Overall Study|Ineligible|1|||
129576564|NCT02446600|466405757|FG001|Overall Study|Ineligible|4|||
129576565|NCT02446600|466405758|FG002|Overall Study|Ineligible|4|||
129576566|NCT02446600|466405759|FG003|Overall Study|Ineligible|1|||
129576567|NCT02446600|466405756|FG000|Overall Study|Duplicate Enrollment|0|||
129576568|NCT02446600|466405757|FG001|Overall Study|Duplicate Enrollment|1|||
129576569|NCT02446600|466405758|FG002|Overall Study|Duplicate Enrollment|0|||
129576570|NCT02446600|466405759|FG003|Overall Study|Duplicate Enrollment|0|||
129576571|NCT04108858|466405760|FG000|Overall Study|Adverse Event|1|||
129576572|NCT01415986|466405762|FG000|Overall Study|Lost to Follow-up|1|||
129576573|NCT03122457|466405763|FG000|Overall Study|Withdrawal by Subject|6|||
129785062|NCT00955305|467181968|FG000|Overall Study|No off-treatment reason submitted|1|||
129785063|NCT00955305|467181969|FG001|Overall Study|No off-treatment reason submitted|0|||
129785064|NCT00955305|467181968|FG000|Overall Study|Never started protocol treatment|5|||
129785065|NCT00955305|467181969|FG001|Overall Study|Never started protocol treatment|5|||
129785066|NCT00955305|467181968|FG000|Overall Study|Ineligible|5|||
129785067|NCT00955305|467181969|FG001|Overall Study|Ineligible|7|||
129785068|NCT00109590|467181970|FG000|Overall Study|Lost to Follow-up|1|||
129785069|NCT00109590|467181971|FG001|Overall Study|Lost to Follow-up|0|||
129785070|NCT00109590|467181972|FG002|Overall Study|Lost to Follow-up|1|||
129785071|NCT00109590|467181970|FG000|Overall Study|Never Started Treatment|1|||
129785072|NCT00109590|467181971|FG001|Overall Study|Never Started Treatment|2|||
129785073|NCT00109590|467181972|FG002|Overall Study|Never Started Treatment|3|||
129785074|NCT03254108|467181976|FG000|Overall Study|Adverse Event|0|||
129785075|NCT03254108|467181977|FG001|Overall Study|Adverse Event|2|||
129785076|NCT03254108|467181978|FG002|Overall Study|Adverse Event|0|||
129576574|NCT01701674|466406375|FG000|Overall Study|Unable to safely complete treatment|1|||
129576575|NCT05604170|466406376|FG000|Overall Study|Lack of Efficacy|5|||
129576576|NCT05604170|466406376|FG000|Overall Study|Adverse Event|6|||
129576577|NCT05604170|466406376|FG000|Overall Study|Physician Decision|6|||
129576578|NCT05604170|466406376|FG000|Overall Study|Lost to Follow-up|6|||
129576579|NCT05604170|466406376|FG000|Overall Study|Withdrawal by Subject|11|||
129576580|NCT05604170|466406376|FG000|Overall Study|Early study termination by sponsor|77|||
129576581|NCT05604170|466406376|FG000|Overall Study|Other|6|||
129576582|NCT03032172|466406377|FG000|Treatment Period|Adverse Event|0|||
129576583|NCT03032172|466406378|FG001|Treatment Period|Adverse Event|1|||
129576584|NCT03032172|466406379|FG002|Treatment Period|Adverse Event|0|||
129576585|NCT03032172|466406380|FG003|Treatment Period|Adverse Event|0|||
129576586|NCT03032172|466406381|FG004|Treatment Period|Adverse Event|0|||
129576587|NCT03032172|466406382|FG005|Treatment Period|Adverse Event|0|||
129576588|NCT03032172|466406383|FG006|Treatment Period|Adverse Event|0|||
129576589|NCT03032172|466406384|FG007|Treatment Period|Adverse Event|0|||
129785077|NCT03254108|467181979|FG003|Overall Study|Adverse Event|1|||
129785078|NCT03254108|467181980|FG004|Overall Study|Adverse Event|1|||
129576590|NCT03032172|466406377|FG000|Treatment Period|Lack of Efficacy|0|||
129576591|NCT03032172|466406378|FG001|Treatment Period|Lack of Efficacy|1|||
129576592|NCT03032172|466406379|FG002|Treatment Period|Lack of Efficacy|0|||
129576593|NCT03032172|466406380|FG003|Treatment Period|Lack of Efficacy|0|||
129576594|NCT03032172|466406381|FG004|Treatment Period|Lack of Efficacy|0|||
129576595|NCT03032172|466406382|FG005|Treatment Period|Lack of Efficacy|0|||
129576596|NCT03032172|466406383|FG006|Treatment Period|Lack of Efficacy|0|||
129576597|NCT03032172|466406384|FG007|Treatment Period|Lack of Efficacy|0|||
129576598|NCT03032172|466406377|FG000|Treatment Period|Non-compliance With Study Drug|0|||
129576599|NCT03032172|466406378|FG001|Treatment Period|Non-compliance With Study Drug|1|||
129576600|NCT03032172|466406379|FG002|Treatment Period|Non-compliance With Study Drug|0|||
129576601|NCT03032172|466406380|FG003|Treatment Period|Non-compliance With Study Drug|0|||
129576602|NCT03032172|466406381|FG004|Treatment Period|Non-compliance With Study Drug|0|||
129576603|NCT03032172|466406382|FG005|Treatment Period|Non-compliance With Study Drug|0|||
129576604|NCT03032172|466406383|FG006|Treatment Period|Non-compliance With Study Drug|0|||
129576605|NCT03032172|466406384|FG007|Treatment Period|Non-compliance With Study Drug|0|||
129576606|NCT03032172|466406377|FG000|Treatment Period|Reason Not Specified|0|||
129576607|NCT03032172|466406378|FG001|Treatment Period|Reason Not Specified|4|||
129576608|NCT03032172|466406379|FG002|Treatment Period|Reason Not Specified|1|||
129576609|NCT03032172|466406380|FG003|Treatment Period|Reason Not Specified|0|||
129576610|NCT03032172|466406381|FG004|Treatment Period|Reason Not Specified|0|||
129576611|NCT03032172|466406382|FG005|Treatment Period|Reason Not Specified|0|||
129576612|NCT03032172|466406383|FG006|Treatment Period|Reason Not Specified|0|||
129576613|NCT03032172|466406384|FG007|Treatment Period|Reason Not Specified|0|||
129576614|NCT03032172|466406377|FG000|Treatment Period|Physician Decision|0|||
129576615|NCT03032172|466406378|FG001|Treatment Period|Physician Decision|2|||
129576616|NCT03032172|466406379|FG002|Treatment Period|Physician Decision|1|||
129576617|NCT03032172|466406380|FG003|Treatment Period|Physician Decision|0|||
129576618|NCT03032172|466406381|FG004|Treatment Period|Physician Decision|0|||
129576619|NCT03032172|466406382|FG005|Treatment Period|Physician Decision|0|||
129576620|NCT03032172|466406383|FG006|Treatment Period|Physician Decision|0|||
129576621|NCT03032172|466406384|FG007|Treatment Period|Physician Decision|0|||
129576622|NCT03032172|466406377|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129576623|NCT03032172|466406378|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
129576624|NCT03032172|466406379|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
129576625|NCT03032172|466406380|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
129576626|NCT03032172|466406381|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129576627|NCT03032172|466406382|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129576628|NCT03032172|466406383|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129576629|NCT03032172|466406384|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
129576630|NCT03032172|466406377|FG000|Treatment Period|Withdrawal by Subject|2|||
129576631|NCT03032172|466406378|FG001|Treatment Period|Withdrawal by Subject|0|||
129576632|NCT03032172|466406379|FG002|Treatment Period|Withdrawal by Subject|3|||
129576633|NCT03032172|466406380|FG003|Treatment Period|Withdrawal by Subject|0|||
129576634|NCT03032172|466406381|FG004|Treatment Period|Withdrawal by Subject|0|||
129694648|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
129694649|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
129694650|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
129694651|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
129694652|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
129694653|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Other|6|||
129694654|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Other|3|||
129694655|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Other|0|||
129694656|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
129694657|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129694658|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129694659|NCT03636269|466839624|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
129694660|NCT03636269|466839625|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
129694661|NCT03636269|466839626|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
129694662|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Adverse Event|0|||
129694663|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Adverse Event|0|||
129694664|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Adverse Event|21|||
129694665|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
129694666|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
129694667|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
129694668|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
129694669|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
129694670|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
129576635|NCT03032172|466406382|FG005|Treatment Period|Withdrawal by Subject|0|||
129576636|NCT03032172|466406383|FG006|Treatment Period|Withdrawal by Subject|0|||
129576637|NCT03032172|466406384|FG007|Treatment Period|Withdrawal by Subject|0|||
129576638|NCT03032172|466406377|FG000|Open-label Extension Period|Death|0|||
129576639|NCT03032172|466406378|FG001|Open-label Extension Period|Death|0|||
129576640|NCT03032172|466406379|FG002|Open-label Extension Period|Death|0|||
129576641|NCT03032172|466406380|FG003|Open-label Extension Period|Death|0|||
129576642|NCT03032172|466406381|FG004|Open-label Extension Period|Death|0|||
129576643|NCT03032172|466406382|FG005|Open-label Extension Period|Death|0|||
129576644|NCT03032172|466406383|FG006|Open-label Extension Period|Death|0|||
129576645|NCT03032172|466406384|FG007|Open-label Extension Period|Death|2|||
129576646|NCT03032172|466406377|FG000|Open-label Extension Period|Reason Not Specified|0|||
129576647|NCT03032172|466406378|FG001|Open-label Extension Period|Reason Not Specified|0|||
129576648|NCT03032172|466406379|FG002|Open-label Extension Period|Reason Not Specified|0|||
129576649|NCT03032172|466406380|FG003|Open-label Extension Period|Reason Not Specified|0|||
129576650|NCT03032172|466406381|FG004|Open-label Extension Period|Reason Not Specified|0|||
129576651|NCT03032172|466406382|FG005|Open-label Extension Period|Reason Not Specified|5|||
129576652|NCT03032172|466406383|FG006|Open-label Extension Period|Reason Not Specified|3|||
129576653|NCT03032172|466406384|FG007|Open-label Extension Period|Reason Not Specified|0|||
129576654|NCT03032172|466406377|FG000|Open-label Extension Period|Pregnancy|0|||
129576655|NCT03032172|466406378|FG001|Open-label Extension Period|Pregnancy|0|||
129576656|NCT03032172|466406379|FG002|Open-label Extension Period|Pregnancy|0|||
129576657|NCT03032172|466406380|FG003|Open-label Extension Period|Pregnancy|0|||
129576658|NCT03032172|466406381|FG004|Open-label Extension Period|Pregnancy|0|||
129576659|NCT03032172|466406382|FG005|Open-label Extension Period|Pregnancy|0|||
129576660|NCT03032172|466406383|FG006|Open-label Extension Period|Pregnancy|1|||
129576661|NCT03032172|466406384|FG007|Open-label Extension Period|Pregnancy|0|||
129576662|NCT03032172|466406377|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129576663|NCT03032172|466406378|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129576664|NCT03032172|466406379|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
129576665|NCT03032172|466406380|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
129576666|NCT03032172|466406381|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
129576667|NCT03032172|466406382|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
129576668|NCT03032172|466406383|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
129576669|NCT03032172|466406384|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
129576670|NCT02869867|466406387|FG000|Overall Study|Protocol Violation|1|||
129576671|NCT02869867|466406388|FG001|Overall Study|Protocol Violation|0|||
129576672|NCT02869867|466406387|FG000|Overall Study|Lost to Follow-up|5|||
129576673|NCT02869867|466406388|FG001|Overall Study|Lost to Follow-up|5|||
129576674|NCT01005745|466406389|FG000|Overall Study|No TIL growth|1|||
129576675|NCT01005745|466406389|FG000|Overall Study|Disease progressed during TIL growth|3|||
129576676|NCT01005745|466406389|FG000|Overall Study|Death prior to treatment|1|||
129576677|NCT01005745|466406389|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
129576678|NCT05646251|466406394|FG000|Overall Study|Physician Decision|1|||
129576679|NCT05646251|466406395|FG001|Overall Study|Physician Decision|0|||
129576680|NCT05646251|466406396|FG002|Overall Study|Physician Decision|2|||
129576681|NCT04659603|466406398|FG000|Overall Study|Study terminated by sponsor|0|||
129576682|NCT04659603|466406399|FG001|Overall Study|Study terminated by sponsor|0|||
129576683|NCT04659603|466406400|FG002|Overall Study|Study terminated by sponsor|2|||
129576684|NCT04659603|466406398|FG000|Overall Study|Withdrawal by Subject|0|||
129576685|NCT04659603|466406399|FG001|Overall Study|Withdrawal by Subject|5|||
129576686|NCT04659603|466406400|FG002|Overall Study|Withdrawal by Subject|0|||
129576687|NCT04659603|466406398|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
129576688|NCT04659603|466406399|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
129576689|NCT04659603|466406400|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
129576690|NCT01231906|466406403|FG000|Overall Study|Lack of Efficacy|75|||
129576691|NCT01231906|466406404|FG001|Overall Study|Lack of Efficacy|68|||
129576692|NCT01231906|466406403|FG000|Overall Study|Lost to Follow-up|1|||
129576693|NCT01231906|466406404|FG001|Overall Study|Lost to Follow-up|0|||
129576694|NCT01231906|466406403|FG000|Overall Study|Physician Decision|34|||
129576695|NCT01231906|466406404|FG001|Overall Study|Physician Decision|24|||
129576696|NCT01231906|466406403|FG000|Overall Study|Withdrawal by Subject|0|||
129694671|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
129694672|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
129694673|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
129694674|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Administrative|0|||
129694675|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Administrative|0|||
129694676|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Administrative|36|||
129694677|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Other|0|||
129785079|NCT03254108|467181976|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
129576697|NCT01231906|466406404|FG001|Overall Study|Withdrawal by Subject|4|||
129576698|NCT01231906|466406403|FG000|Overall Study|Ineligible|10|||
129576699|NCT01231906|466406404|FG001|Overall Study|Ineligible|3|||
129576700|NCT01231906|466406403|FG000|Overall Study|No treatment|1|||
129694678|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Other|0|||
129576701|NCT01231906|466406404|FG001|Overall Study|No treatment|2|||
129576702|NCT02957942|466406412|FG000|Overall Study|Withdrawal by Subject|0|||
129576703|NCT02957942|466406413|FG001|Overall Study|Withdrawal by Subject|1|||
129576704|NCT02957942|466406412|FG000|Overall Study|Practicing experiment protocol|0|||
129576705|NCT02957942|466406413|FG001|Overall Study|Practicing experiment protocol|6|||
129576706|NCT01136174|466406414|FG000|Overall Study|Adverse Event|0|||
129576707|NCT01136174|466406415|FG001|Overall Study|Adverse Event|0|||
129576708|NCT01136174|466406416|FG002|Overall Study|Adverse Event|0|||
129576709|NCT01136174|466406417|FG003|Overall Study|Adverse Event|4|||
129576710|NCT03238781|466406418|FG000|Overall Study|Adverse Event|1|||
129576711|NCT03238781|466406419|FG001|Overall Study|Adverse Event|1|||
129576712|NCT03238781|466406420|FG002|Overall Study|Adverse Event|2|||
129576713|NCT03238781|466406418|FG000|Overall Study|Lost to Follow-up|2|||
129576714|NCT03238781|466406419|FG001|Overall Study|Lost to Follow-up|1|||
129576715|NCT03238781|466406420|FG002|Overall Study|Lost to Follow-up|2|||
129576716|NCT03238781|466406418|FG000|Overall Study|Withdrawal by Subject|23|||
129576717|NCT03238781|466406419|FG001|Overall Study|Withdrawal by Subject|14|||
129576718|NCT03238781|466406420|FG002|Overall Study|Withdrawal by Subject|16|||
129576719|NCT03238781|466406418|FG000|Overall Study|Decision by sponsor|0|||
129576720|NCT03238781|466406419|FG001|Overall Study|Decision by sponsor|1|||
129576721|NCT03238781|466406420|FG002|Overall Study|Decision by sponsor|0|||
129576722|NCT01754597|466406423|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
129576723|NCT01754597|466406424|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
129576724|NCT01588236|466406425|FG000|Overall Study|Adverse Event|5|||
129576725|NCT01588236|466406426|FG001|Overall Study|Adverse Event|4|||
129576726|NCT01588236|466406427|FG002|Overall Study|Adverse Event|1|||
129576727|NCT01588236|466406425|FG000|Overall Study|Lost to Follow-up|8|||
129576728|NCT01588236|466406426|FG001|Overall Study|Lost to Follow-up|13|||
129576729|NCT01588236|466406427|FG002|Overall Study|Lost to Follow-up|6|||
129576730|NCT01588236|466406425|FG000|Overall Study|Physician Decision|1|||
129576731|NCT01588236|466406426|FG001|Overall Study|Physician Decision|2|||
129576732|NCT01588236|466406427|FG002|Overall Study|Physician Decision|0|||
129576733|NCT01588236|466406425|FG000|Overall Study|Protocol Violation|0|||
129576734|NCT01588236|466406426|FG001|Overall Study|Protocol Violation|1|||
129576735|NCT01588236|466406427|FG002|Overall Study|Protocol Violation|1|||
129576736|NCT01588236|466406425|FG000|Overall Study|Withdrawal by Subject|14|||
129576737|NCT01588236|466406426|FG001|Overall Study|Withdrawal by Subject|16|||
129576738|NCT01588236|466406427|FG002|Overall Study|Withdrawal by Subject|18|||
129576739|NCT01588236|466406425|FG000|Overall Study|Exclusion Criteria met during study|2|||
129576740|NCT01588236|466406426|FG001|Overall Study|Exclusion Criteria met during study|1|||
129576741|NCT01588236|466406427|FG002|Overall Study|Exclusion Criteria met during study|0|||
129576742|NCT01588236|466406425|FG000|Overall Study|sponsor decision|1|||
129576743|NCT01588236|466406426|FG001|Overall Study|sponsor decision|6|||
129576744|NCT01588236|466406427|FG002|Overall Study|sponsor decision|2|||
129576745|NCT04544410|466406428|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129576746|NCT04544410|466406429|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129576747|NCT04544410|466406428|FG000|Double-blind Treatment Period|Adverse Event|1|||
129576748|NCT04544410|466406429|FG001|Double-blind Treatment Period|Adverse Event|0|||
129576749|NCT04544410|466406428|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129576750|NCT04544410|466406429|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129576751|NCT04544410|466406428|FG000|Double-blind Treatment Period|Protocol Violation|1|||
129576752|NCT04544410|466406429|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129576753|NCT04544410|466406428|FG000|Open-Label Treatment Period|Study Terminated|15|||
129576754|NCT04544410|466406429|FG001|Open-Label Treatment Period|Study Terminated|19|||
129576755|NCT04544410|466406428|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
129576756|NCT04544410|466406429|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
129576757|NCT04544410|466406428|FG000|Open-Label Treatment Period|Adverse Event|0|||
129576758|NCT04544410|466406429|FG001|Open-Label Treatment Period|Adverse Event|1|||
129576759|NCT04544410|466406428|FG000|Open-Label Treatment Period|Physician Decision|1|||
129576760|NCT04544410|466406429|FG001|Open-Label Treatment Period|Physician Decision|0|||
129576761|NCT04544410|466406428|FG000|Open-Label Treatment Period|Other|0|||
129576762|NCT04544410|466406429|FG001|Open-Label Treatment Period|Other|1|||
129576763|NCT04299087|466407827|FG000|Overall Study|Lost to Follow-up|2|||
129576764|NCT04299087|466407828|FG001|Overall Study|Lost to Follow-up|1|||
129800239|NCT04755283|467236270|FG002|Overall Study|Withdrawal by Subject|6|||
129576765|NCT00594035|466407829|FG000|Overall Study|Lost to Follow-up|1|||
129576766|NCT00594035|466407830|FG001|Overall Study|Lost to Follow-up|1|||
129576767|NCT00594035|466407829|FG000|Overall Study|Withdrawal by Subject|1|||
129576768|NCT00594035|466407830|FG001|Overall Study|Withdrawal by Subject|0|||
129576769|NCT00594035|466407829|FG000|Overall Study|Subject transferred to nursing home|0|||
129576770|NCT00594035|466407830|FG001|Overall Study|Subject transferred to nursing home|1|||
129576771|NCT00594035|466407829|FG000|Overall Study|Subject couldn't return due to job|0|||
129576772|NCT00594035|466407830|FG001|Overall Study|Subject couldn't return due to job|1|||
129576773|NCT00795821|466407831|FG000|Acute Treatment Phase|Adverse Event|23|||
129576774|NCT00795821|466407832|FG001|Acute Treatment Phase|Adverse Event|4|||
129576775|NCT00795821|466407831|FG000|Acute Treatment Phase|Death|1|||
129576776|NCT00795821|466407832|FG001|Acute Treatment Phase|Death|0|||
129576777|NCT00795821|466407831|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
129576778|NCT00795821|466407832|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
129576779|NCT00795821|466407831|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
129576780|NCT00795821|466407832|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
129576781|NCT00795821|466407831|FG000|Acute Treatment Phase|Physician Decision|1|||
129576782|NCT00795821|466407832|FG001|Acute Treatment Phase|Physician Decision|1|||
129576783|NCT00795821|466407831|FG000|Acute Treatment Phase|Protocol Violation|1|||
129576784|NCT00795821|466407832|FG001|Acute Treatment Phase|Protocol Violation|2|||
129576785|NCT00795821|466407831|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
129576786|NCT00795821|466407832|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
129576787|NCT00795821|466407831|FG000|Long-term Extension Phase|Adverse Event|25|||
129576788|NCT00795821|466407832|FG001|Long-term Extension Phase|Adverse Event|32|||
129576789|NCT00795821|466407831|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
129576790|NCT00795821|466407832|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
129576791|NCT00795821|466407831|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
129576792|NCT00795821|466407832|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
129576793|NCT00795821|466407831|FG000|Long-term Extension Phase|Physician Decision|1|||
129576794|NCT00795821|466407832|FG001|Long-term Extension Phase|Physician Decision|2|||
129576795|NCT00795821|466407831|FG000|Long-term Extension Phase|Protocol Violation|3|||
129576796|NCT00795821|466407832|FG001|Long-term Extension Phase|Protocol Violation|5|||
129576797|NCT00795821|466407831|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
129576798|NCT00795821|466407832|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
129576799|NCT00795821|466407831|FG000|Taper Phase|Adverse Event|2|||
129576800|NCT00795821|466407832|FG001|Taper Phase|Adverse Event|0|||
129576801|NCT00795821|466407831|FG000|Taper Phase|Lost to Follow-up|1|||
129576802|NCT00795821|466407832|FG001|Taper Phase|Lost to Follow-up|0|||
129576803|NCT00795821|466407831|FG000|Taper Phase|Physician Decision|2|||
129576804|NCT00795821|466407832|FG001|Taper Phase|Physician Decision|0|||
129576805|NCT00795821|466407831|FG000|Taper Phase|Withdrawal by Subject|4|||
129576806|NCT00795821|466407832|FG001|Taper Phase|Withdrawal by Subject|0|||
129576807|NCT06284525|466407837|FG000|Overall Study|Withdrawal by Subject|1|||
129576808|NCT00583453|466407842|FG000|Overall Study|discontinued intervention|0|||
129576809|NCT00583453|466407843|FG001|Overall Study|discontinued intervention|2|||
129576810|NCT03868891|466407846|FG000|Overall Study|Adverse Event|1|||
129576811|NCT03868891|466407847|FG001|Overall Study|Adverse Event|0|||
129576812|NCT03868891|466407846|FG000|Overall Study|Lost to Follow-up|2|||
129576813|NCT03868891|466407847|FG001|Overall Study|Lost to Follow-up|1|||
129576814|NCT03868891|466407846|FG000|Overall Study|COVID-19 Restrictions|1|||
129576815|NCT03868891|466407847|FG001|Overall Study|COVID-19 Restrictions|2|||
129576816|NCT03123094|466407849|FG000|Overall Study|Withdrawal by Subject|0|||
129576817|NCT03123094|466407850|FG001|Overall Study|Withdrawal by Subject|2|||
129576818|NCT03123094|466407851|FG002|Overall Study|Withdrawal by Subject|1|||
129576819|NCT03123094|466407852|FG003|Overall Study|Withdrawal by Subject|0|||
129576820|NCT03123094|466407853|FG004|Overall Study|Withdrawal by Subject|1|||
129576821|NCT00794963|466407854|FG000|Overall Study|Withdrawal by Subject|1|||
129576822|NCT00794963|466407855|FG001|Overall Study|Withdrawal by Subject|4|||
129694679|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Other|9|||
129694680|NCT03636269|466839624|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
129576823|NCT03181594|466407861|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
129576824|NCT03181594|466407861|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
129576825|NCT03181594|466407861|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
129576826|NCT03181594|466407861|FG000|Initial Study Protocol (12-month FU)|Death|1|||
129576827|NCT03181594|466407861|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
129576828|NCT03181594|466407861|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
129576829|NCT03247972|466407862|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
129576830|NCT03247972|466407862|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
129576831|NCT02838420|466407863|FG000|Overall Study|Ongoing in Study|113|||
129576832|NCT02838420|466407864|FG001|Overall Study|Ongoing in Study|45|||
129576833|NCT02838420|466407863|FG000|Overall Study|Lost to Follow-up|1|||
129576834|NCT02838420|466407864|FG001|Overall Study|Lost to Follow-up|0|||
129576835|NCT02838420|466407863|FG000|Overall Study|Withdrawal by Subject|3|||
129576836|NCT02838420|466407864|FG001|Overall Study|Withdrawal by Subject|4|||
129576837|NCT02838420|466407863|FG000|Overall Study|Death|8|||
129576838|NCT02838420|466407864|FG001|Overall Study|Death|13|||
129576839|NCT00185458|466407865|FG000|Contraception Phase|Adverse Event|37|||
129576840|NCT00185458|466407865|FG000|Contraception Phase|Lost to Follow-up|10|||
129576841|NCT00185458|466407865|FG000|Contraception Phase|Protocol Violation|2|||
129576842|NCT00185458|466407865|FG000|Contraception Phase|Physician Decision|2|||
129576843|NCT00185458|466407865|FG000|Contraception Phase|Withdrawal by Subject|7|||
129576844|NCT00185458|466407865|FG000|HRT Phase|Adverse Event|18|||
129576845|NCT00185458|466407865|FG000|HRT Phase|Lost to Follow-up|4|||
129576846|NCT00185458|466407865|FG000|HRT Phase|Protocol Violation|2|||
129576847|NCT00185458|466407865|FG000|HRT Phase|Withdrawal by Subject|3|||
129576848|NCT00251979|466407866|FG000|Overall Study|Protocol Violation|3|||
129576849|NCT00251979|466407867|FG001|Overall Study|Protocol Violation|5|||
129576850|NCT00251979|466407866|FG000|Overall Study|Adverse Event|11|||
129576851|NCT00251979|466407867|FG001|Overall Study|Adverse Event|17|||
129576852|NCT00251979|466407866|FG000|Overall Study|Withdrawal by Subject|13|||
129576853|NCT00251979|466407867|FG001|Overall Study|Withdrawal by Subject|7|||
129576854|NCT00251979|466407866|FG000|Overall Study|Lost to Follow-up|8|||
129576855|NCT00251979|466407867|FG001|Overall Study|Lost to Follow-up|6|||
129576856|NCT00251979|466407866|FG000|Overall Study|Death|3|||
129576857|NCT00251979|466407867|FG001|Overall Study|Death|5|||
129576858|NCT01576042|466407868|FG000|Overall Study|Physician Decision|2|||
129576859|NCT01576042|466407869|FG001|Overall Study|Physician Decision|0|||
129576860|NCT00835536|466407876|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
129576861|NCT00835536|466407877|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
129576862|NCT03173547|466407878|FG000|Overall Study|Adverse Event|2|||
129576863|NCT03173547|466407879|FG001|Overall Study|Adverse Event|0|||
129576864|NCT03173547|466407878|FG000|Overall Study|Withdrawal by Subject|2|||
129576865|NCT03173547|466407879|FG001|Overall Study|Withdrawal by Subject|2|||
129576866|NCT00657553|466407880|FG000|Overall Study|low accrual, no analysis run|5|||
129576867|NCT00657553|466407881|FG001|Overall Study|low accrual, no analysis run|5|||
129576868|NCT00446563|466407882|FG000|Overall Study|Adverse Event|4|||
129576869|NCT00446563|466407883|FG001|Overall Study|Adverse Event|3|||
129576870|NCT00446563|466407882|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129576871|NCT00446563|466407883|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129576872|NCT00446563|466407882|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129576873|NCT00446563|466407883|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129576874|NCT00446563|466407882|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129576875|NCT00446563|466407883|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129576876|NCT00446563|466407882|FG000|Overall Study|Withdrawal by Subject|2|||
129576877|NCT00446563|466407883|FG001|Overall Study|Withdrawal by Subject|1|||
129576878|NCT00446563|466407882|FG000|Overall Study|Administrative problems|0|||
129576879|NCT00446563|466407883|FG001|Overall Study|Administrative problems|1|||
129576880|NCT03769025|466407884|FG000|Overall Study|Withdrawal by Subject|1|||
129576881|NCT03769025|466407885|FG001|Overall Study|Withdrawal by Subject|1|||
129576882|NCT03769025|466407884|FG000|Overall Study|Lost to Follow-up|4|||
129576883|NCT03769025|466407885|FG001|Overall Study|Lost to Follow-up|3|||
129576884|NCT01169558|466407886|FG000|Overall Study|Disease progression|98|||
129576885|NCT01169558|466407886|FG000|Overall Study|Adverse Event|25|||
129576886|NCT01169558|466407886|FG000|Overall Study|Withdrawal of Consent|8|||
129576887|NCT01169558|466407886|FG000|Overall Study|Medical Decision|7|||
129576888|NCT01169558|466407886|FG000|Overall Study|Stable Disease|4|||
129576889|NCT01169558|466407886|FG000|Overall Study|Lost to Follow-up|4|||
129576890|NCT01169558|466407886|FG000|Overall Study|Need for Surgery|4|||
129576891|NCT01169558|466407886|FG000|Overall Study|Non-compliance|2|||
129576892|NCT01169558|466407886|FG000|Overall Study|Protocol Violation|2|||
129576893|NCT01169558|466407886|FG000|Overall Study|Partial response|2|||
129576894|NCT02409355|466407892|FG000|Overall Study|Withdrawal by Subject|1|||
129576895|NCT02409355|466407893|FG001|Overall Study|Withdrawal by Subject|0|||
129576896|NCT02409355|466407892|FG000|Overall Study|Death|1|||
129576897|NCT02409355|466407893|FG001|Overall Study|Death|1|||
129576898|NCT02409355|466407892|FG000|Overall Study|Study terminated by Sponsor|2|||
129576899|NCT02409355|466407893|FG001|Overall Study|Study terminated by Sponsor|3|||
129576900|NCT00838539|466407894|FG000|Overall Study|Disease Progression|2|||
129576901|NCT00838539|466407895|FG001|Overall Study|Disease Progression|4|||
129576902|NCT00838539|466407896|FG002|Overall Study|Disease Progression|3|||
129576903|NCT00838539|466407897|FG003|Overall Study|Disease Progression|2|||
129576904|NCT00838539|466407898|FG004|Overall Study|Disease Progression|4|||
129576905|NCT00838539|466407899|FG005|Overall Study|Disease Progression|2|||
129576906|NCT00838539|466407900|FG006|Overall Study|Disease Progression|3|||
129576907|NCT00838539|466407901|FG007|Overall Study|Disease Progression|4|||
129576908|NCT00838539|466407902|FG008|Overall Study|Disease Progression|4|||
129576909|NCT00838539|466407903|FG009|Overall Study|Disease Progression|5|||
129576910|NCT00838539|466407904|FG010|Overall Study|Disease Progression|1|||
129576911|NCT00838539|466407905|FG011|Overall Study|Disease Progression|4|||
129576912|NCT00838539|466407894|FG000|Overall Study|Adverse Event|1|||
129576913|NCT00838539|466407895|FG001|Overall Study|Adverse Event|1|||
129576914|NCT00838539|466407896|FG002|Overall Study|Adverse Event|1|||
129576915|NCT00838539|466407897|FG003|Overall Study|Adverse Event|1|||
129576916|NCT00838539|466407898|FG004|Overall Study|Adverse Event|2|||
129576917|NCT00838539|466407899|FG005|Overall Study|Adverse Event|1|||
129576918|NCT00838539|466407900|FG006|Overall Study|Adverse Event|0|||
129576919|NCT00838539|466407901|FG007|Overall Study|Adverse Event|2|||
129576920|NCT00838539|466407902|FG008|Overall Study|Adverse Event|0|||
129576921|NCT00838539|466407903|FG009|Overall Study|Adverse Event|1|||
129576922|NCT00838539|466407904|FG010|Overall Study|Adverse Event|2|||
129576923|NCT00838539|466407905|FG011|Overall Study|Adverse Event|0|||
129576924|NCT00838539|466407894|FG000|Overall Study|Withdrawal by Subject|0|||
129576925|NCT00838539|466407895|FG001|Overall Study|Withdrawal by Subject|1|||
129576926|NCT00838539|466407896|FG002|Overall Study|Withdrawal by Subject|0|||
129576927|NCT00838539|466407897|FG003|Overall Study|Withdrawal by Subject|0|||
129576928|NCT00838539|466407898|FG004|Overall Study|Withdrawal by Subject|0|||
129576929|NCT00838539|466407899|FG005|Overall Study|Withdrawal by Subject|0|||
129576930|NCT00838539|466407900|FG006|Overall Study|Withdrawal by Subject|0|||
129576931|NCT00838539|466407901|FG007|Overall Study|Withdrawal by Subject|0|||
129576932|NCT00838539|466407902|FG008|Overall Study|Withdrawal by Subject|0|||
129576933|NCT00838539|466407903|FG009|Overall Study|Withdrawal by Subject|1|||
129576934|NCT00838539|466407904|FG010|Overall Study|Withdrawal by Subject|2|||
129576935|NCT00838539|466407905|FG011|Overall Study|Withdrawal by Subject|0|||
129576936|NCT00838539|466407894|FG000|Overall Study|Death|0|||
129576937|NCT00838539|466407895|FG001|Overall Study|Death|0|||
129576938|NCT00838539|466407896|FG002|Overall Study|Death|0|||
129576939|NCT00838539|466407897|FG003|Overall Study|Death|0|||
129576940|NCT00838539|466407898|FG004|Overall Study|Death|0|||
129576941|NCT00838539|466407899|FG005|Overall Study|Death|0|||
129576942|NCT00838539|466407900|FG006|Overall Study|Death|1|||
129576943|NCT00838539|466407901|FG007|Overall Study|Death|0|||
129576944|NCT00838539|466407902|FG008|Overall Study|Death|0|||
129576945|NCT00838539|466407903|FG009|Overall Study|Death|0|||
129694681|NCT03636269|466839625|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
129694682|NCT03636269|466839626|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
129694683|NCT00493285|466839636|FG000|Overall Study|Lost to Follow-up|0|||
129576946|NCT00838539|466407904|FG010|Overall Study|Death|0|||
129576947|NCT00838539|466407905|FG011|Overall Study|Death|0|||
129576948|NCT00838539|466407894|FG000|Overall Study|Physician Decision|0|||
129576949|NCT00838539|466407895|FG001|Overall Study|Physician Decision|0|||
129576950|NCT00838539|466407896|FG002|Overall Study|Physician Decision|0|||
129576951|NCT00838539|466407897|FG003|Overall Study|Physician Decision|0|||
129576952|NCT00838539|466407898|FG004|Overall Study|Physician Decision|0|||
129694684|NCT00493285|466839637|FG001|Overall Study|Lost to Follow-up|0|||
129694685|NCT00493285|466839638|FG002|Overall Study|Lost to Follow-up|0|||
129576953|NCT00838539|466407899|FG005|Overall Study|Physician Decision|0|||
129576954|NCT00838539|466407900|FG006|Overall Study|Physician Decision|0|||
129576955|NCT00838539|466407901|FG007|Overall Study|Physician Decision|0|||
129576956|NCT00838539|466407902|FG008|Overall Study|Physician Decision|1|||
129576957|NCT00838539|466407903|FG009|Overall Study|Physician Decision|0|||
129576958|NCT00838539|466407904|FG010|Overall Study|Physician Decision|0|||
129576959|NCT00838539|466407905|FG011|Overall Study|Physician Decision|0|||
129576960|NCT00838539|466407894|FG000|Overall Study|Clinical Progression|0|||
129576961|NCT00838539|466407895|FG001|Overall Study|Clinical Progression|0|||
129576962|NCT00838539|466407896|FG002|Overall Study|Clinical Progression|0|||
129576963|NCT00838539|466407897|FG003|Overall Study|Clinical Progression|0|||
129576964|NCT00838539|466407898|FG004|Overall Study|Clinical Progression|0|||
129576965|NCT00838539|466407899|FG005|Overall Study|Clinical Progression|0|||
129576966|NCT00838539|466407900|FG006|Overall Study|Clinical Progression|1|||
129576967|NCT00838539|466407901|FG007|Overall Study|Clinical Progression|0|||
129576968|NCT00838539|466407902|FG008|Overall Study|Clinical Progression|0|||
129694686|NCT00493285|466839639|FG003|Overall Study|Lost to Follow-up|0|||
129576969|NCT00838539|466407903|FG009|Overall Study|Clinical Progression|0|||
129576970|NCT00838539|466407904|FG010|Overall Study|Clinical Progression|0|||
129576971|NCT00838539|466407905|FG011|Overall Study|Clinical Progression|0|||
129694687|NCT00493285|466839640|FG004|Overall Study|Lost to Follow-up|1|||
129576972|NCT00838539|466407894|FG000|Overall Study|Symptomatic Deterioration|0|||
129576973|NCT00838539|466407895|FG001|Overall Study|Symptomatic Deterioration|0|||
129576974|NCT00838539|466407896|FG002|Overall Study|Symptomatic Deterioration|1|||
129576975|NCT00838539|466407897|FG003|Overall Study|Symptomatic Deterioration|1|||
129576976|NCT00838539|466407898|FG004|Overall Study|Symptomatic Deterioration|0|||
129576977|NCT00838539|466407899|FG005|Overall Study|Symptomatic Deterioration|1|||
129694688|NCT00493285|466839641|FG005|Overall Study|Lost to Follow-up|0|||
129694689|NCT04535362|466839642|FG000|Overall Study|Lost to Follow-up|3|||
129576978|NCT00838539|466407900|FG006|Overall Study|Symptomatic Deterioration|0|||
129576979|NCT00838539|466407901|FG007|Overall Study|Symptomatic Deterioration|0|||
129576980|NCT00838539|466407902|FG008|Overall Study|Symptomatic Deterioration|0|||
129576981|NCT00838539|466407903|FG009|Overall Study|Symptomatic Deterioration|1|||
129576982|NCT00838539|466407904|FG010|Overall Study|Symptomatic Deterioration|0|||
129576983|NCT00838539|466407905|FG011|Overall Study|Symptomatic Deterioration|0|||
129576984|NCT01908205|466407906|FG000|Overall Study|Lost to Follow-up|2|||
129576985|NCT01908205|466407907|FG001|Overall Study|Lost to Follow-up|0|||
129576986|NCT01908205|466407906|FG000|Overall Study|Withdrawal by Subject|3|||
129576987|NCT01908205|466407907|FG001|Overall Study|Withdrawal by Subject|1|||
129576988|NCT03134222|466407912|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
129576989|NCT03134222|466407913|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
129576990|NCT03134222|466407914|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
129576991|NCT03134222|466407915|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
129576992|NCT03134222|466407916|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
129576993|NCT03134222|466407912|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
129576994|NCT03134222|466407913|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
129576995|NCT03134222|466407914|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
129576996|NCT03134222|466407915|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
129576997|NCT03134222|466407916|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
129576998|NCT03134222|466407912|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129576999|NCT03134222|466407913|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
129577000|NCT03134222|466407914|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129577001|NCT03134222|466407915|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129577002|NCT03134222|466407916|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
129577003|NCT03134222|466407912|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
129577004|NCT03134222|466407913|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
129577005|NCT03134222|466407914|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
129577006|NCT03134222|466407915|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
129577007|NCT03134222|466407916|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
129577008|NCT03134222|466407912|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
129577009|NCT03134222|466407913|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
129577010|NCT03134222|466407914|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
129577011|NCT03134222|466407915|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
129694690|NCT04535362|466839643|FG001|Overall Study|Lost to Follow-up|1|||
129694691|NCT03791060|466839644|FG000|Overall Study|Withdrawal by Subject|1|||
129694692|NCT03774810|466839645|FG000|Phase 1|Lack of Efficacy|21|||
129694693|NCT03774810|466839646|FG001|Phase 1|Lack of Efficacy|0|||
129694694|NCT03774810|466839647|FG002|Phase 1|Lack of Efficacy|0|||
129694695|NCT03774810|466839648|FG003|Phase 1|Lack of Efficacy|0|||
129694696|NCT03774810|466839649|FG004|Phase 1|Lack of Efficacy|0|||
129694697|NCT03774810|466839645|FG000|Phase 1|Withdrawal by Subject|9|||
129694698|NCT03774810|466839646|FG001|Phase 1|Withdrawal by Subject|0|||
129694699|NCT03774810|466839647|FG002|Phase 1|Withdrawal by Subject|0|||
129694700|NCT03774810|466839648|FG003|Phase 1|Withdrawal by Subject|0|||
129694701|NCT03774810|466839649|FG004|Phase 1|Withdrawal by Subject|0|||
129694702|NCT03774810|466839645|FG000|Phase 1|Lost to Follow-up|2|||
129694703|NCT03774810|466839646|FG001|Phase 1|Lost to Follow-up|0|||
129694704|NCT03774810|466839647|FG002|Phase 1|Lost to Follow-up|0|||
129694705|NCT03774810|466839648|FG003|Phase 1|Lost to Follow-up|0|||
129694706|NCT03774810|466839649|FG004|Phase 1|Lost to Follow-up|0|||
129694707|NCT03774810|466839645|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
129694708|NCT03774810|466839646|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
129694709|NCT03774810|466839647|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
129694710|NCT03774810|466839648|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
129694711|NCT03774810|466839649|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
129694712|NCT03774810|466839645|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
129694713|NCT03774810|466839646|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
129694714|NCT03774810|466839647|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
129694715|NCT03774810|466839648|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
129694716|NCT03774810|466839649|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
129694717|NCT03774810|466839645|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
129694718|NCT03774810|466839646|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
129694719|NCT03774810|466839647|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
129694720|NCT03774810|466839648|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
129694721|NCT03774810|466839649|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
129694722|NCT03774810|466839645|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
129785080|NCT03254108|467181977|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
129785081|NCT03254108|467181978|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
129785082|NCT03254108|467181979|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
129785083|NCT03254108|467181980|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
129785084|NCT00745849|467181987|FG000|First Intervention|Withdrawal by Subject|0|||
129785085|NCT00745849|467181988|FG001|First Intervention|Withdrawal by Subject|1|||
129785086|NCT00745849|467181987|FG000|First Intervention|Lost to Follow-up|1|||
129577012|NCT03134222|466407916|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
129577013|NCT03134222|466407912|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
129577014|NCT03134222|466407913|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129577015|NCT03134222|466407914|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129577016|NCT03134222|466407915|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129577017|NCT03134222|466407916|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
129577018|NCT03134222|466407912|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129577019|NCT03134222|466407913|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129577020|NCT03134222|466407914|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129577021|NCT03134222|466407915|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
129577022|NCT03134222|466407916|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
129577023|NCT03134222|466407912|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
129577024|NCT03134222|466407913|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
129577025|NCT03134222|466407914|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
129577026|NCT03134222|466407915|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
129577027|NCT03134222|466407916|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
129577028|NCT03482882|466407919|FG000|Overall Study|Adverse Event|3|||
129577029|NCT03482882|466407919|FG000|Overall Study|Lost to Follow-up|1|||
129577030|NCT03482882|466407919|FG000|Overall Study|Protocol Violation|2|||
129577031|NCT03482882|466407919|FG000|Overall Study|Not further specified|1|||
129577032|NCT01110005|466407924|FG000|Overall Study|ineligible|1|||
129577033|NCT01110005|466407925|FG001|Overall Study|ineligible|2|||
129577034|NCT01110005|466407924|FG000|Overall Study|missing consent|3|||
129577035|NCT01110005|466407925|FG001|Overall Study|missing consent|2|||
129694723|NCT03774810|466839646|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
129694724|NCT03774810|466839647|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
129694725|NCT03774810|466839648|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
129694726|NCT03774810|466839649|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
129694727|NCT03774810|466839645|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
129694728|NCT03774810|466839646|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
129694729|NCT03774810|466839647|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
129694730|NCT03774810|466839648|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
129694731|NCT03774810|466839649|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
129694732|NCT03774810|466839645|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
129694733|NCT03774810|466839646|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
129694734|NCT03774810|466839647|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
129694735|NCT03774810|466839648|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
129694736|NCT03774810|466839649|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
129694737|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
129694738|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
129694739|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
129694740|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
129694741|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
129694742|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
129694743|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
129694744|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
129694745|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
129694746|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
129694747|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
129694748|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
129694749|NCT00290758|466839659|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
129694750|NCT00290758|466839660|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
129577036|NCT01110005|466407924|FG000|Overall Study|Withdrawal by Subject|0|||
129785087|NCT00745849|467181988|FG001|First Intervention|Lost to Follow-up|1|||
129785088|NCT00745849|467181987|FG000|Second Intervention|Lost to Follow-up|2|||
129785089|NCT00745849|467181988|FG001|Second Intervention|Lost to Follow-up|1|||
129785090|NCT00409331|467181995|FG000|Overall Study|Physician Decision|1|||
129785091|NCT01511055|467182000|FG000|Overall Study|Withdrawal by Subject|6|||
129785092|NCT00830869|467182001|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
129785093|NCT00830869|467182002|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
129785094|NCT00830869|467182003|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
129785095|NCT00830869|467182004|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
129785096|NCT00830869|467182005|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
129785097|NCT00830869|467182006|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
129785098|NCT00830869|467182007|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
129785099|NCT00830869|467182008|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
129785100|NCT00830869|467182009|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
129785101|NCT00830869|467182010|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
129785102|NCT00830869|467182011|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
129785103|NCT00830869|467182012|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
129785104|NCT00830869|467182001|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
129785105|NCT00830869|467182002|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
129785106|NCT00830869|467182003|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
129785107|NCT00830869|467182004|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
129785108|NCT00830869|467182005|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
129785109|NCT00830869|467182006|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
129785110|NCT00830869|467182007|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
129785111|NCT00830869|467182008|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
129785112|NCT00830869|467182009|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
129785113|NCT00830869|467182010|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
129785114|NCT00830869|467182011|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
129785115|NCT00830869|467182012|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
129785116|NCT00830869|467182001|FG000|Period 1: Part 1|Adverse Event|0|||
129785117|NCT00830869|467182002|FG001|Period 1: Part 1|Adverse Event|0|||
129785118|NCT00830869|467182003|FG002|Period 1: Part 1|Adverse Event|0|||
129785119|NCT00830869|467182004|FG003|Period 1: Part 1|Adverse Event|0|||
129785120|NCT00830869|467182005|FG004|Period 1: Part 1|Adverse Event|0|||
129785121|NCT00830869|467182006|FG005|Period 1: Part 1|Adverse Event|1|||
129785122|NCT00830869|467182007|FG006|Period 1: Part 1|Adverse Event|1|||
129785123|NCT00830869|467182008|FG007|Period 1: Part 1|Adverse Event|0|||
129785124|NCT00830869|467182009|FG008|Period 1: Part 1|Adverse Event|0|||
129785125|NCT00830869|467182010|FG009|Period 1: Part 1|Adverse Event|0|||
129785126|NCT00830869|467182011|FG010|Period 1: Part 1|Adverse Event|0|||
129785127|NCT00830869|467182012|FG011|Period 1: Part 1|Adverse Event|0|||
129785128|NCT00830869|467182001|FG000|Period 1: Part 1|Progressive disease|1|||
129785129|NCT00830869|467182002|FG001|Period 1: Part 1|Progressive disease|0|||
129785130|NCT00830869|467182003|FG002|Period 1: Part 1|Progressive disease|1|||
129785131|NCT00830869|467182004|FG003|Period 1: Part 1|Progressive disease|6|||
129785132|NCT00830869|467182005|FG004|Period 1: Part 1|Progressive disease|4|||
129785133|NCT00830869|467182006|FG005|Period 1: Part 1|Progressive disease|4|||
129785134|NCT00830869|467182007|FG006|Period 1: Part 1|Progressive disease|1|||
129785135|NCT00830869|467182008|FG007|Period 1: Part 1|Progressive disease|0|||
129785136|NCT00830869|467182009|FG008|Period 1: Part 1|Progressive disease|0|||
129785137|NCT00830869|467182010|FG009|Period 1: Part 1|Progressive disease|0|||
129785138|NCT00830869|467182011|FG010|Period 1: Part 1|Progressive disease|0|||
129785139|NCT00830869|467182012|FG011|Period 1: Part 1|Progressive disease|0|||
129785140|NCT00830869|467182001|FG000|Period 2: Part 2|Protocol Violation|0|||
129785141|NCT00830869|467182002|FG001|Period 2: Part 2|Protocol Violation|0|||
129785142|NCT00830869|467182003|FG002|Period 2: Part 2|Protocol Violation|0|||
129785143|NCT00830869|467182004|FG003|Period 2: Part 2|Protocol Violation|0|||
129785144|NCT00830869|467182005|FG004|Period 2: Part 2|Protocol Violation|0|||
129785145|NCT00830869|467182006|FG005|Period 2: Part 2|Protocol Violation|0|||
129785146|NCT00830869|467182007|FG006|Period 2: Part 2|Protocol Violation|0|||
129785147|NCT00830869|467182008|FG007|Period 2: Part 2|Protocol Violation|1|||
129785148|NCT00830869|467182009|FG008|Period 2: Part 2|Protocol Violation|0|||
129785149|NCT00830869|467182010|FG009|Period 2: Part 2|Protocol Violation|1|||
129785150|NCT00830869|467182011|FG010|Period 2: Part 2|Protocol Violation|0|||
129785151|NCT00830869|467182012|FG011|Period 2: Part 2|Protocol Violation|0|||
129785152|NCT00830869|467182001|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
129785153|NCT00830869|467182002|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
129785154|NCT00830869|467182003|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
129785155|NCT00830869|467182004|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
129785156|NCT00830869|467182005|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
129785157|NCT00830869|467182006|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
129577037|NCT01110005|466407925|FG001|Overall Study|Withdrawal by Subject|1|||
129577038|NCT03123471|466407926|FG000|Placebo-controlled Phase|Adverse Event|3|||
129577039|NCT03123471|466407927|FG001|Placebo-controlled Phase|Adverse Event|8|||
129577040|NCT03123471|466407926|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
129577041|NCT03123471|466407927|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
129577042|NCT03123471|466407926|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
129577043|NCT03123471|466407927|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
129577044|NCT03123471|466407926|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
129577045|NCT03123471|466407927|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
129577046|NCT03123471|466407926|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
129577047|NCT03123471|466407927|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
129577048|NCT03123471|466407926|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
129577049|NCT03123471|466407927|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
129577050|NCT03123471|466407926|FG000|Placebo-controlled Phase|Miscellaneous|0|||
129577051|NCT03123471|466407927|FG001|Placebo-controlled Phase|Miscellaneous|1|||
129577052|NCT03123471|466407926|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
129577053|NCT03123471|466407927|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
129577054|NCT03123471|466407926|FG000|Apremilast Extension Phase|Adverse Event|1|||
129577055|NCT03123471|466407927|FG001|Apremilast Extension Phase|Adverse Event|5|||
129577056|NCT03123471|466407926|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
129577057|NCT03123471|466407927|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
129577058|NCT03123471|466407926|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
129577059|NCT03123471|466407927|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
129577060|NCT03681470|466407930|FG000|Overall Study|Lack of Efficacy|3|||
129577061|NCT03681470|466407930|FG000|Overall Study|Lost to Follow-up|1|||
129577062|NCT03681470|466407930|FG000|Overall Study|Protocol Violation|3|||
129577063|NCT03681470|466407930|FG000|Overall Study|Withdrawal by Subject|1|||
129577064|NCT01686477|466407931|FG000|Feeding Intervention|Death|1|||
129577065|NCT01686477|466407932|FG001|Feeding Intervention|Death|0|||
129577066|NCT01686477|466407933|FG002|Feeding Intervention|Death|1|||
129577067|NCT01686477|466407931|FG000|Feeding Intervention|Withdrawal by Subject|0|||
129577068|NCT01686477|466407932|FG001|Feeding Intervention|Withdrawal by Subject|6|||
129577069|NCT01686477|466407933|FG002|Feeding Intervention|Withdrawal by Subject|0|||
129577070|NCT01686477|466407931|FG000|Feeding Intervention|Physician Decision|1|||
129577071|NCT01686477|466407932|FG001|Feeding Intervention|Physician Decision|2|||
129577072|NCT01686477|466407933|FG002|Feeding Intervention|Physician Decision|0|||
129577073|NCT01686477|466407931|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
129577074|NCT01686477|466407932|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
129577075|NCT01686477|466407933|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
129577076|NCT01686477|466407931|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
129577077|NCT01686477|466407932|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
129577078|NCT01686477|466407933|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
129577079|NCT01686477|466407931|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
129577080|NCT01686477|466407932|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
129577081|NCT01686477|466407933|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
129577082|NCT01686477|466407931|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
129577083|NCT01686477|466407932|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
129577084|NCT01686477|466407933|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
129577085|NCT01686477|466407931|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
129577086|NCT01686477|466407932|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
129577087|NCT01686477|466407933|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
129577088|NCT01686477|466407931|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
129577089|NCT01686477|466407932|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
129577090|NCT01686477|466407933|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
129577091|NCT01686477|466407931|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
129577092|NCT01686477|466407932|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
129577093|NCT01686477|466407933|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
129577094|NCT03290781|466407934|FG000|Overall Study|Adverse Event|5|||
129577095|NCT03290781|466407935|FG001|Overall Study|Adverse Event|7|||
129577096|NCT03290781|466407936|FG002|Overall Study|Adverse Event|4|||
129577097|NCT03290781|466407937|FG003|Overall Study|Adverse Event|1|||
129577098|NCT03290781|466407938|FG004|Overall Study|Adverse Event|0|||
129577099|NCT03290781|466407939|FG005|Overall Study|Adverse Event|0|||
129577100|NCT03290781|466407940|FG006|Overall Study|Adverse Event|0|||
129577101|NCT03290781|466407934|FG000|Overall Study|Death|0|||
129577102|NCT03290781|466407935|FG001|Overall Study|Death|0|||
129577103|NCT03290781|466407936|FG002|Overall Study|Death|1|||
129577104|NCT03290781|466407937|FG003|Overall Study|Death|0|||
129577105|NCT03290781|466407938|FG004|Overall Study|Death|1|||
129577106|NCT03290781|466407939|FG005|Overall Study|Death|0|||
129577107|NCT03290781|466407940|FG006|Overall Study|Death|0|||
129577108|NCT03290781|466407934|FG000|Overall Study|Withdrawal by Subject|6|||
129577109|NCT03290781|466407935|FG001|Overall Study|Withdrawal by Subject|5|||
129577110|NCT03290781|466407936|FG002|Overall Study|Withdrawal by Subject|9|||
129577111|NCT03290781|466407937|FG003|Overall Study|Withdrawal by Subject|10|||
129577112|NCT03290781|466407938|FG004|Overall Study|Withdrawal by Subject|1|||
129577113|NCT03290781|466407939|FG005|Overall Study|Withdrawal by Subject|2|||
129577114|NCT03290781|466407940|FG006|Overall Study|Withdrawal by Subject|0|||
129577115|NCT03290781|466407934|FG000|Overall Study|Physician Decision|0|||
129577116|NCT03290781|466407935|FG001|Overall Study|Physician Decision|1|||
129577117|NCT03290781|466407936|FG002|Overall Study|Physician Decision|0|||
129577118|NCT03290781|466407937|FG003|Overall Study|Physician Decision|0|||
129577119|NCT03290781|466407938|FG004|Overall Study|Physician Decision|0|||
129577120|NCT03290781|466407939|FG005|Overall Study|Physician Decision|0|||
129577121|NCT03290781|466407940|FG006|Overall Study|Physician Decision|0|||
129577122|NCT03290781|466407934|FG000|Overall Study|Site Terminated by Sponsor|1|||
129577123|NCT03290781|466407935|FG001|Overall Study|Site Terminated by Sponsor|0|||
129577124|NCT03290781|466407936|FG002|Overall Study|Site Terminated by Sponsor|2|||
129577125|NCT03290781|466407937|FG003|Overall Study|Site Terminated by Sponsor|1|||
129577126|NCT03290781|466407938|FG004|Overall Study|Site Terminated by Sponsor|0|||
129577127|NCT03290781|466407939|FG005|Overall Study|Site Terminated by Sponsor|0|||
129577128|NCT03290781|466407940|FG006|Overall Study|Site Terminated by Sponsor|0|||
129577129|NCT03290781|466407934|FG000|Overall Study|Lost to Follow-up|0|||
129577130|NCT03290781|466407935|FG001|Overall Study|Lost to Follow-up|0|||
129577131|NCT03290781|466407936|FG002|Overall Study|Lost to Follow-up|0|||
129577132|NCT03290781|466407937|FG003|Overall Study|Lost to Follow-up|1|||
129577133|NCT03290781|466407938|FG004|Overall Study|Lost to Follow-up|0|||
129577134|NCT03290781|466407939|FG005|Overall Study|Lost to Follow-up|0|||
129577135|NCT03290781|466407940|FG006|Overall Study|Lost to Follow-up|0|||
129577136|NCT03290781|466407934|FG000|Overall Study|Protocol Deviation|2|||
129577137|NCT03290781|466407935|FG001|Overall Study|Protocol Deviation|0|||
129577138|NCT03290781|466407936|FG002|Overall Study|Protocol Deviation|0|||
129577139|NCT03290781|466407937|FG003|Overall Study|Protocol Deviation|1|||
129577140|NCT03290781|466407938|FG004|Overall Study|Protocol Deviation|0|||
129577141|NCT03290781|466407939|FG005|Overall Study|Protocol Deviation|0|||
129577142|NCT03290781|466407940|FG006|Overall Study|Protocol Deviation|0|||
129800240|NCT04755283|467236268|FG000|Overall Study|Lost to Follow-up|0|||
129577143|NCT03290781|466407934|FG000|Overall Study|Disease Relapse|32|||
129577144|NCT03290781|466407935|FG001|Overall Study|Disease Relapse|5|||
129577145|NCT03290781|466407936|FG002|Overall Study|Disease Relapse|38|||
129577146|NCT03290781|466407937|FG003|Overall Study|Disease Relapse|7|||
129577147|NCT03290781|466407938|FG004|Overall Study|Disease Relapse|3|||
129577148|NCT03290781|466407939|FG005|Overall Study|Disease Relapse|1|||
129577149|NCT03290781|466407940|FG006|Overall Study|Disease Relapse|4|||
129577150|NCT03290781|466407934|FG000|Overall Study|Other|3|||
129577151|NCT03290781|466407935|FG001|Overall Study|Other|0|||
129577152|NCT03290781|466407936|FG002|Overall Study|Other|2|||
129577153|NCT03290781|466407937|FG003|Overall Study|Other|2|||
129577154|NCT03290781|466407938|FG004|Overall Study|Other|0|||
129577155|NCT03290781|466407939|FG005|Overall Study|Other|0|||
129577156|NCT03290781|466407940|FG006|Overall Study|Other|0|||
129577157|NCT00811655|466407952|FG000|Overall Study|Physician Decision|1|||
129577158|NCT00813592|466407953|FG000|Overall Study|Disease assessment was not completed per|2|||
129577159|NCT03761173|466407957|FG000|Overall Study|Lost to Follow-up|93|||
129577160|NCT03761173|466407957|FG000|Overall Study|Withdrawal by Subject|74|||
129577161|NCT03761173|466407957|FG000|Overall Study|Death|45|||
129577162|NCT03761173|466407957|FG000|Overall Study|Withdrawal for Other Reasons|29|||
129577163|NCT03761173|466407957|FG000|Overall Study|Protocol Violation|1|||
129577164|NCT04852978|466407963|FG000|Overall Study|Physician Decision|0|||
129577165|NCT04852978|466407964|FG001|Overall Study|Physician Decision|1|||
129577166|NCT04852978|466407965|FG002|Overall Study|Physician Decision|0|||
129577167|NCT04852978|466407966|FG003|Overall Study|Physician Decision|0|||
129577168|NCT04852978|466407967|FG004|Overall Study|Physician Decision|0|||
129577169|NCT04852978|466407968|FG005|Overall Study|Physician Decision|0|||
129577170|NCT04852978|466407969|FG006|Overall Study|Physician Decision|0|||
129577171|NCT04852978|466407970|FG007|Overall Study|Physician Decision|2|||
129577172|NCT04852978|466407971|FG008|Overall Study|Physician Decision|0|||
129577173|NCT04852978|466407963|FG000|Overall Study|Sponsor request|0|||
129577174|NCT04852978|466407964|FG001|Overall Study|Sponsor request|0|||
129577175|NCT04852978|466407965|FG002|Overall Study|Sponsor request|1|||
129577176|NCT04852978|466407966|FG003|Overall Study|Sponsor request|0|||
129577177|NCT04852978|466407967|FG004|Overall Study|Sponsor request|0|||
129577178|NCT04852978|466407968|FG005|Overall Study|Sponsor request|0|||
129577179|NCT04852978|466407969|FG006|Overall Study|Sponsor request|0|||
129577180|NCT04852978|466407970|FG007|Overall Study|Sponsor request|0|||
129577181|NCT04852978|466407971|FG008|Overall Study|Sponsor request|0|||
129577182|NCT04852978|466407963|FG000|Overall Study|Death|0|||
129577183|NCT04852978|466407964|FG001|Overall Study|Death|0|||
129577184|NCT04852978|466407965|FG002|Overall Study|Death|0|||
129577185|NCT04852978|466407966|FG003|Overall Study|Death|0|||
129577186|NCT04852978|466407967|FG004|Overall Study|Death|0|||
129577187|NCT04852978|466407968|FG005|Overall Study|Death|0|||
129577188|NCT04852978|466407969|FG006|Overall Study|Death|1|||
129577189|NCT04852978|466407970|FG007|Overall Study|Death|0|||
129577190|NCT04852978|466407971|FG008|Overall Study|Death|0|||
129577191|NCT04852978|466407963|FG000|Overall Study|Lost to Follow-up|3|||
129577192|NCT04852978|466407964|FG001|Overall Study|Lost to Follow-up|2|||
129577193|NCT04852978|466407965|FG002|Overall Study|Lost to Follow-up|2|||
129577194|NCT04852978|466407966|FG003|Overall Study|Lost to Follow-up|0|||
129577195|NCT04852978|466407967|FG004|Overall Study|Lost to Follow-up|2|||
129577196|NCT04852978|466407968|FG005|Overall Study|Lost to Follow-up|4|||
129577197|NCT04852978|466407969|FG006|Overall Study|Lost to Follow-up|1|||
129577198|NCT04852978|466407970|FG007|Overall Study|Lost to Follow-up|2|||
129577199|NCT04852978|466407971|FG008|Overall Study|Lost to Follow-up|2|||
129577200|NCT04852978|466407963|FG000|Overall Study|Withdrawal by Subject|4|||
129577201|NCT04852978|466407964|FG001|Overall Study|Withdrawal by Subject|2|||
129577202|NCT04852978|466407965|FG002|Overall Study|Withdrawal by Subject|2|||
129577203|NCT04852978|466407966|FG003|Overall Study|Withdrawal by Subject|1|||
129577204|NCT04852978|466407967|FG004|Overall Study|Withdrawal by Subject|5|||
129577205|NCT04852978|466407968|FG005|Overall Study|Withdrawal by Subject|3|||
129577206|NCT04852978|466407969|FG006|Overall Study|Withdrawal by Subject|2|||
129577207|NCT04852978|466407970|FG007|Overall Study|Withdrawal by Subject|2|||
129577208|NCT04852978|466407971|FG008|Overall Study|Withdrawal by Subject|1|||
129577209|NCT02301975|466409562|FG000|Overall Study|Adverse Event|8|||
129577210|NCT02301975|466409563|FG001|Overall Study|Adverse Event|3|||
129577211|NCT02301975|466409564|FG002|Overall Study|Adverse Event|2|||
129785158|NCT00830869|467182007|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
129577212|NCT02301975|466409562|FG000|Overall Study|Lack of Efficacy|1|||
129785159|NCT00830869|467182008|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
129577213|NCT02301975|466409563|FG001|Overall Study|Lack of Efficacy|1|||
129577214|NCT02301975|466409564|FG002|Overall Study|Lack of Efficacy|1|||
129577215|NCT02301975|466409562|FG000|Overall Study|Protocol Violation|3|||
129577216|NCT02301975|466409563|FG001|Overall Study|Protocol Violation|5|||
129577217|NCT02301975|466409564|FG002|Overall Study|Protocol Violation|3|||
129577218|NCT02301975|466409562|FG000|Overall Study|Lost to Follow-up|0|||
129577219|NCT02301975|466409563|FG001|Overall Study|Lost to Follow-up|2|||
129577220|NCT02301975|466409564|FG002|Overall Study|Lost to Follow-up|2|||
129577221|NCT02301975|466409562|FG000|Overall Study|Physician Decision|4|||
129577222|NCT02301975|466409563|FG001|Overall Study|Physician Decision|2|||
129577223|NCT02301975|466409564|FG002|Overall Study|Physician Decision|3|||
129577224|NCT02301975|466409562|FG000|Overall Study|Withdrawal by Subject|15|||
129577225|NCT02301975|466409563|FG001|Overall Study|Withdrawal by Subject|12|||
129577226|NCT02301975|466409564|FG002|Overall Study|Withdrawal by Subject|11|||
129577227|NCT03606174|466409567|FG000|Overall Study|Death|37|||
129577228|NCT03606174|466409568|FG001|Overall Study|Death|15|||
129577229|NCT03606174|466409569|FG002|Overall Study|Death|15|||
129577230|NCT03606174|466409570|FG003|Overall Study|Death|7|||
129577231|NCT03606174|466409571|FG004|Overall Study|Death|35|||
129577232|NCT03606174|466409572|FG005|Overall Study|Death|12|||
129577233|NCT03606174|466409573|FG006|Overall Study|Death|35|||
129577234|NCT03606174|466409574|FG007|Overall Study|Death|8|||
129577235|NCT03606174|466409575|FG008|Overall Study|Death|5|||
129577236|NCT03606174|466409576|FG009|Overall Study|Death|3|||
129577237|NCT03606174|466409577|FG010|Overall Study|Death|0|||
129577238|NCT03606174|466409567|FG000|Overall Study|Lost to Follow-up|0|||
129577239|NCT03606174|466409568|FG001|Overall Study|Lost to Follow-up|0|||
129577240|NCT03606174|466409569|FG002|Overall Study|Lost to Follow-up|0|||
129577241|NCT03606174|466409570|FG003|Overall Study|Lost to Follow-up|0|||
129577242|NCT03606174|466409571|FG004|Overall Study|Lost to Follow-up|1|||
129577243|NCT03606174|466409572|FG005|Overall Study|Lost to Follow-up|1|||
129694751|NCT00290758|466839659|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
129694752|NCT00290758|466839660|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
129694753|NCT00474968|466839661|FG000|Overall Study|Withdrawal by Subject|8|||
129694754|NCT00474968|466839662|FG001|Overall Study|Withdrawal by Subject|7|||
129694755|NCT00474968|466839661|FG000|Overall Study|Protocol Violation|9|||
129694756|NCT00474968|466839662|FG001|Overall Study|Protocol Violation|8|||
129694757|NCT00474968|466839661|FG000|Overall Study|Sample not collected|1|||
129694758|NCT00474968|466839662|FG001|Overall Study|Sample not collected|1|||
129694759|NCT00981175|466839663|FG000|Primary Dose Vaccination|Adverse Event|1|||
129694760|NCT00981175|466839664|FG001|Primary Dose Vaccination|Adverse Event|0|||
129694761|NCT00981175|466839663|FG000|Primary Dose Vaccination|Protocol Violation|0|||
129694762|NCT00981175|466839664|FG001|Primary Dose Vaccination|Protocol Violation|1|||
129694763|NCT00981175|466839663|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
129694764|NCT00981175|466839664|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
129694765|NCT00981175|466839663|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
129694766|NCT00981175|466839664|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
129694767|NCT02619812|466839665|FG000|Overall Study|Withdrawal by Subject|0|||
129694768|NCT02619812|466839666|FG001|Overall Study|Withdrawal by Subject|0|||
129694769|NCT02619812|466839667|FG002|Overall Study|Withdrawal by Subject|1|||
129694770|NCT02619812|466839668|FG003|Overall Study|Withdrawal by Subject|2|||
129694771|NCT04189588|466839669|FG000|Overall Study|Death|0|||
129694772|NCT04189588|466839670|FG001|Overall Study|Death|1|||
129694773|NCT04189588|466839669|FG000|Overall Study|Lost to Follow-up|0|||
129694774|NCT04189588|466839670|FG001|Overall Study|Lost to Follow-up|1|||
129694775|NCT01658735|466839671|FG000|Overall Study|Lack of Efficacy|1|||
129694776|NCT01658735|466839672|FG001|Overall Study|Lack of Efficacy|0|||
129694777|NCT01658735|466839673|FG002|Overall Study|Lack of Efficacy|1|||
129694778|NCT01658735|466839671|FG000|Overall Study|Lost to Follow-up|1|||
129694779|NCT01658735|466839672|FG001|Overall Study|Lost to Follow-up|1|||
129694780|NCT01658735|466839673|FG002|Overall Study|Lost to Follow-up|0|||
129694781|NCT01658735|466839671|FG000|Overall Study|Protocol Violation|0|||
129694782|NCT01658735|466839672|FG001|Overall Study|Protocol Violation|1|||
129694783|NCT01658735|466839673|FG002|Overall Study|Protocol Violation|0|||
129694784|NCT01658735|466839671|FG000|Overall Study|Withdrawal by Subject|3|||
129694785|NCT01658735|466839672|FG001|Overall Study|Withdrawal by Subject|5|||
129694786|NCT01658735|466839673|FG002|Overall Study|Withdrawal by Subject|3|||
129694787|NCT03156621|466839674|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
129694788|NCT03156621|466839675|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
129694789|NCT03156621|466839674|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
129694790|NCT03156621|466839675|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
129694791|NCT01379937|466839676|FG000|Overall Study|Protocol Violation|0|||
129694792|NCT01379937|466839677|FG001|Overall Study|Protocol Violation|0|||
129694793|NCT01379937|466839678|FG002|Overall Study|Protocol Violation|0|||
129694794|NCT01379937|466839679|FG003|Overall Study|Protocol Violation|1|||
129694795|NCT01379937|466839676|FG000|Overall Study|Consent withdrawal|0|||
129694796|NCT01379937|466839677|FG001|Overall Study|Consent withdrawal|1|||
129694797|NCT01379937|466839678|FG002|Overall Study|Consent withdrawal|0|||
129694798|NCT01379937|466839679|FG003|Overall Study|Consent withdrawal|0|||
129577244|NCT03606174|466409573|FG006|Overall Study|Lost to Follow-up|0|||
129694799|NCT01379937|466839676|FG000|Overall Study|Lost to Follow-up|1|||
129694800|NCT01379937|466839677|FG001|Overall Study|Lost to Follow-up|2|||
129694801|NCT01379937|466839678|FG002|Overall Study|Lost to Follow-up|2|||
129577245|NCT03606174|466409574|FG007|Overall Study|Lost to Follow-up|0|||
129577246|NCT03606174|466409575|FG008|Overall Study|Lost to Follow-up|0|||
129577247|NCT03606174|466409576|FG009|Overall Study|Lost to Follow-up|0|||
129577248|NCT03606174|466409577|FG010|Overall Study|Lost to Follow-up|0|||
129577249|NCT03606174|466409567|FG000|Overall Study|Withdrawal by Subject|6|||
129577250|NCT03606174|466409568|FG001|Overall Study|Withdrawal by Subject|0|||
129577251|NCT03606174|466409569|FG002|Overall Study|Withdrawal by Subject|0|||
129577252|NCT03606174|466409570|FG003|Overall Study|Withdrawal by Subject|1|||
129577253|NCT03606174|466409571|FG004|Overall Study|Withdrawal by Subject|2|||
129577254|NCT03606174|466409572|FG005|Overall Study|Withdrawal by Subject|1|||
129577255|NCT03606174|466409573|FG006|Overall Study|Withdrawal by Subject|4|||
129577256|NCT03606174|466409574|FG007|Overall Study|Withdrawal by Subject|0|||
129577257|NCT03606174|466409575|FG008|Overall Study|Withdrawal by Subject|0|||
129577258|NCT03606174|466409576|FG009|Overall Study|Withdrawal by Subject|0|||
129577259|NCT03606174|466409577|FG010|Overall Study|Withdrawal by Subject|1|||
129577260|NCT03606174|466409567|FG000|Overall Study|Study Terminated by Sponsor|5|||
129577261|NCT03606174|466409568|FG001|Overall Study|Study Terminated by Sponsor|7|||
129577262|NCT03606174|466409569|FG002|Overall Study|Study Terminated by Sponsor|3|||
129577263|NCT03606174|466409570|FG003|Overall Study|Study Terminated by Sponsor|0|||
129577264|NCT03606174|466409571|FG004|Overall Study|Study Terminated by Sponsor|11|||
129577265|NCT03606174|466409572|FG005|Overall Study|Study Terminated by Sponsor|6|||
129577266|NCT03606174|466409573|FG006|Overall Study|Study Terminated by Sponsor|12|||
129577267|NCT03606174|466409574|FG007|Overall Study|Study Terminated by Sponsor|1|||
129577268|NCT03606174|466409575|FG008|Overall Study|Study Terminated by Sponsor|3|||
129577269|NCT03606174|466409576|FG009|Overall Study|Study Terminated by Sponsor|1|||
129577270|NCT03606174|466409577|FG010|Overall Study|Study Terminated by Sponsor|2|||
129577271|NCT03606174|466409567|FG000|Overall Study|Miscellaneous|1|||
129577272|NCT03606174|466409568|FG001|Overall Study|Miscellaneous|1|||
129577273|NCT03606174|466409569|FG002|Overall Study|Miscellaneous|0|||
129577274|NCT03606174|466409570|FG003|Overall Study|Miscellaneous|1|||
129577275|NCT03606174|466409571|FG004|Overall Study|Miscellaneous|4|||
129577276|NCT03606174|466409572|FG005|Overall Study|Miscellaneous|7|||
129577277|NCT03606174|466409573|FG006|Overall Study|Miscellaneous|5|||
129577278|NCT03606174|466409574|FG007|Overall Study|Miscellaneous|0|||
129577279|NCT03606174|466409575|FG008|Overall Study|Miscellaneous|0|||
129577280|NCT03606174|466409576|FG009|Overall Study|Miscellaneous|0|||
129577281|NCT03606174|466409577|FG010|Overall Study|Miscellaneous|1|||
129577282|NCT03049748|466409578|FG000|Overall Study|Lost to Follow-up|1|||
129577283|NCT03049748|466409579|FG001|Overall Study|Lost to Follow-up|0|||
129577284|NCT03049748|466409578|FG000|Overall Study|Death|3|||
129577285|NCT03049748|466409579|FG001|Overall Study|Death|0|||
129577286|NCT03049748|466409578|FG000|Overall Study|Withdrawal by Subject|0|||
129577287|NCT03049748|466409579|FG001|Overall Study|Withdrawal by Subject|3|||
129577288|NCT03049748|466409578|FG000|Overall Study|Protocol Violation|0|||
129577289|NCT03049748|466409579|FG001|Overall Study|Protocol Violation|2|||
129577290|NCT03049748|466409578|FG000|Overall Study|Moved out of state (relocation)|0|||
129577291|NCT03049748|466409579|FG001|Overall Study|Moved out of state (relocation)|1|||
129577292|NCT00905840|466409582|FG000|Overall Study|Lost to Follow-up|11|||
129577293|NCT00905840|466409582|FG000|Overall Study|Death|3|||
129577294|NCT00905840|466409582|FG000|Overall Study|Withdrawal by Subject|1|||
129577295|NCT00905840|466409582|FG000|Overall Study|Adverse Event|1|||
129577296|NCT03496623|466409583|FG000|Run-In Period (2 Weeks)|Death|1|||
129577297|NCT03496623|466409584|FG001|Run-In Period (2 Weeks)|Death|0|||
129577298|NCT03496623|466409585|FG002|Run-In Period (2 Weeks)|Death|0|||
129577299|NCT03496623|466409586|FG003|Run-In Period (2 Weeks)|Death|0|||
129577300|NCT03496623|466409587|FG004|Run-In Period (2 Weeks)|Death|0|||
129577301|NCT03496623|466409583|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
129577302|NCT03496623|466409584|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129577303|NCT03496623|466409585|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129577304|NCT03496623|466409586|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129577305|NCT03496623|466409587|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
129577306|NCT03496623|466409583|FG000|Period 1 (12 Weeks)|Death|0|||
129577307|NCT03496623|466409584|FG001|Period 1 (12 Weeks)|Death|3|||
129577308|NCT03496623|466409585|FG002|Period 1 (12 Weeks)|Death|0|||
129577309|NCT03496623|466409586|FG003|Period 1 (12 Weeks)|Death|0|||
129577310|NCT03496623|466409587|FG004|Period 1 (12 Weeks)|Death|0|||
129577311|NCT03496623|466409583|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
129577312|NCT03496623|466409584|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
129577313|NCT03496623|466409585|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
129577314|NCT03496623|466409586|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
129577315|NCT03496623|466409587|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
129577316|NCT03496623|466409583|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129577317|NCT03496623|466409584|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129577318|NCT03496623|466409585|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129577319|NCT03496623|466409586|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129577320|NCT03496623|466409587|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129577321|NCT03496623|466409583|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
129577322|NCT03496623|466409584|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
129577323|NCT03496623|466409585|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
129577324|NCT03496623|466409586|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
129577325|NCT03496623|466409587|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
129577326|NCT03496623|466409583|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129577327|NCT03496623|466409584|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129577328|NCT03496623|466409585|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
129577329|NCT03496623|466409586|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129577330|NCT03496623|466409587|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129577331|NCT03496623|466409583|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129577332|NCT03496623|466409584|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129577333|NCT03496623|466409585|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
129577334|NCT03496623|466409586|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129577335|NCT03496623|466409587|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
129577336|NCT03496623|466409583|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129577337|NCT03496623|466409584|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
129577338|NCT03496623|466409585|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129577339|NCT03496623|466409586|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129577340|NCT03496623|466409587|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129577341|NCT01527006|466409591|FG000|Core Study|Adverse Event|0|||
129577342|NCT01527006|466409592|FG001|Core Study|Adverse Event|2|||
129577343|NCT01527006|466409591|FG000|Core Study|Lost to Follow-up|0|||
129577344|NCT01527006|466409592|FG001|Core Study|Lost to Follow-up|1|||
129577345|NCT01527006|466409591|FG000|Core Study|Subject Choice|1|||
129577346|NCT01527006|466409592|FG001|Core Study|Subject Choice|0|||
129577347|NCT01527006|466409591|FG000|Core Study|Inadequate Therapeutic Effect|1|||
129577348|NCT01527006|466409592|FG001|Core Study|Inadequate Therapeutic Effect|0|||
129577349|NCT01527006|466409591|FG000|Core Study|Withdrawal by Subject|0|||
129577350|NCT01527006|466409592|FG001|Core Study|Withdrawal by Subject|1|||
129577351|NCT01527006|466409591|FG000|Core Study|Other|0|||
129577352|NCT01527006|466409592|FG001|Core Study|Other|2|||
129577353|NCT01527006|466409591|FG000|Extension Phase|Adverse Event|4|||
129577354|NCT01527006|466409592|FG001|Extension Phase|Adverse Event|2|||
129577355|NCT01527006|466409591|FG000|Extension Phase|Lost to Follow-up|0|||
129577356|NCT01527006|466409592|FG001|Extension Phase|Lost to Follow-up|1|||
129577357|NCT01527006|466409591|FG000|Extension Phase|Subject Choice|1|||
129577358|NCT01527006|466409592|FG001|Extension Phase|Subject Choice|1|||
129577359|NCT01527006|466409591|FG000|Extension Phase|Inadequate therapeutic effect|1|||
129577360|NCT01527006|466409592|FG001|Extension Phase|Inadequate therapeutic effect|1|||
129577361|NCT01527006|466409591|FG000|Extension Phase|Other|0|||
129577362|NCT01527006|466409592|FG001|Extension Phase|Other|3|||
129577363|NCT00123734|466409597|FG000|Overall Study|Death|3|||
129577364|NCT00123734|466409597|FG000|Overall Study|Lost to Follow-up|3|||
129694802|NCT01379937|466839679|FG003|Overall Study|Lost to Follow-up|0|||
129694803|NCT01260311|466839688|FG000|Overall Study|Adverse Event|11|||
129694804|NCT01260311|466839688|FG000|Overall Study|Lack of Efficacy|4|||
129577365|NCT00123734|466409597|FG000|Overall Study|Dropout|1|||
129577366|NCT00123734|466409597|FG000|Overall Study|Withdrawal by Subject|1|||
129577367|NCT00834340|466409598|FG000|Washout|Adverse Event|1|||
129577368|NCT00834340|466409599|FG001|Washout|Adverse Event|0|||
129694805|NCT01260311|466839688|FG000|Overall Study|Lost to Follow-up|25|||
129694806|NCT01260311|466839688|FG000|Overall Study|Withdrawal by Subject|6|||
129577369|NCT00834340|466409598|FG000|Washout|Withdrawal by Subject|1|||
129577370|NCT00834340|466409599|FG001|Washout|Withdrawal by Subject|0|||
129577371|NCT04238754|466409605|FG000|Washout - 1 Week|Lost to Follow-up|1|||
129577372|NCT04238754|466409606|FG001|Washout - 1 Week|Lost to Follow-up|0|||
129577373|NCT01175018|466409607|FG000|Overall Study|Adverse Event|3|||
129577374|NCT01175018|466409608|FG001|Overall Study|Adverse Event|1|||
129577375|NCT00840073|466409612|FG000|Second Intervention|Missed 72 hour blood draw|1|||
129577376|NCT00840073|466409613|FG001|Second Intervention|Missed 72 hour blood draw|1|||
129694807|NCT01260311|466839688|FG000|Overall Study|Financial Constraints|77|||
129577377|NCT02964039|466409617|FG000|Overall Study|Medical reason unrelated to study participation|1|||
129577378|NCT02964039|466409618|FG001|Overall Study|Medical reason unrelated to study participation|0|||
129785160|NCT00830869|467182009|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
129785161|NCT00830869|467182010|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
129577379|NCT02964039|466409619|FG002|Overall Study|Medical reason unrelated to study participation|3|||
129577380|NCT02964039|466409617|FG000|Overall Study|Research shutdown due to pandemic|2|||
129577381|NCT02964039|466409618|FG001|Overall Study|Research shutdown due to pandemic|0|||
129785162|NCT00830869|467182011|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
129785163|NCT00830869|467182012|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
129785164|NCT00830869|467182001|FG000|Period 2: Part 2|Adverse Event|0|||
129785165|NCT00830869|467182002|FG001|Period 2: Part 2|Adverse Event|0|||
129785166|NCT00830869|467182003|FG002|Period 2: Part 2|Adverse Event|0|||
129785167|NCT00830869|467182004|FG003|Period 2: Part 2|Adverse Event|0|||
129785168|NCT00830869|467182005|FG004|Period 2: Part 2|Adverse Event|0|||
129785169|NCT00830869|467182006|FG005|Period 2: Part 2|Adverse Event|0|||
129785170|NCT00830869|467182007|FG006|Period 2: Part 2|Adverse Event|0|||
129785171|NCT00830869|467182008|FG007|Period 2: Part 2|Adverse Event|4|||
129785172|NCT00830869|467182009|FG008|Period 2: Part 2|Adverse Event|3|||
129785173|NCT00830869|467182010|FG009|Period 2: Part 2|Adverse Event|2|||
129577382|NCT02964039|466409619|FG002|Overall Study|Research shutdown due to pandemic|1|||
129577383|NCT02964039|466409617|FG000|Overall Study|Withdrawal by Subject|0|||
129577384|NCT02964039|466409618|FG001|Overall Study|Withdrawal by Subject|1|||
129577385|NCT02964039|466409619|FG002|Overall Study|Withdrawal by Subject|0|||
129577386|NCT02964039|466409617|FG000|Overall Study|Lost to Follow-up|1|||
129577387|NCT02964039|466409618|FG001|Overall Study|Lost to Follow-up|0|||
129577388|NCT02964039|466409619|FG002|Overall Study|Lost to Follow-up|1|||
129577389|NCT01103713|466409623|FG000|Overall Study|Lost to Follow-up|2|||
129577390|NCT01103713|466409623|FG000|Overall Study|Withdrawal by Subject|8|||
129577391|NCT01103713|466409623|FG000|Overall Study|Study terminated by sponsor|2|||
129577392|NCT01103713|466409623|FG000|Overall Study|Other|1|||
129577393|NCT00505622|466409626|FG000|Overall Study|Adverse Event|5|||
129577394|NCT00505622|466409627|FG001|Overall Study|Adverse Event|6|||
129577395|NCT00505622|466409628|FG002|Overall Study|Adverse Event|4|||
129577396|NCT00505622|466409626|FG000|Overall Study|Protocol Violation|1|||
129785174|NCT00830869|467182011|FG010|Period 2: Part 2|Adverse Event|2|||
129785175|NCT00830869|467182012|FG011|Period 2: Part 2|Adverse Event|0|||
129785176|NCT00830869|467182001|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
129785177|NCT00830869|467182002|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
129785178|NCT00830869|467182003|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
129785179|NCT00830869|467182004|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
129785180|NCT00830869|467182005|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
129785181|NCT00830869|467182006|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
129785182|NCT00830869|467182007|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
129785183|NCT00830869|467182008|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
129577397|NCT00505622|466409627|FG001|Overall Study|Protocol Violation|1|||
129577398|NCT00505622|466409628|FG002|Overall Study|Protocol Violation|0|||
129577399|NCT00505622|466409626|FG000|Overall Study|Withdrawal by Subject|0|||
129577400|NCT00505622|466409627|FG001|Overall Study|Withdrawal by Subject|3|||
129577401|NCT00505622|466409628|FG002|Overall Study|Withdrawal by Subject|2|||
129577402|NCT00505622|466409626|FG000|Overall Study|Study termination by sponsor|115|||
129577403|NCT00505622|466409627|FG001|Overall Study|Study termination by sponsor|98|||
129577404|NCT00505622|466409628|FG002|Overall Study|Study termination by sponsor|90|||
129577405|NCT03084471|466409631|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
129577406|NCT03084471|466409631|FG000|Overall Study|Condition under investigation worsened|84|||
129577407|NCT03084471|466409631|FG000|Overall Study|Lack of therapeutic response|2|||
129577408|NCT03084471|466409631|FG000|Overall Study|Protocol Violation|1|||
129577409|NCT03084471|466409631|FG000|Overall Study|Adverse Event|73|||
129577410|NCT03084471|466409631|FG000|Overall Study|Withdrawal by Subject|12|||
129577411|NCT03084471|466409631|FG000|Overall Study|Disease relapse|181|||
129577412|NCT03084471|466409631|FG000|Overall Study|Subjective disease progression|359|||
129577413|NCT03084471|466409631|FG000|Overall Study|Other (as recorded)|33|||
129577414|NCT03084471|466409631|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
129577415|NCT00796653|466409632|FG000|Overall Study|Adverse Event|19|||
129785184|NCT00830869|467182009|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
129785185|NCT00830869|467182010|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
129577416|NCT00796653|466409633|FG001|Overall Study|Adverse Event|16|||
129577417|NCT00796653|466409634|FG002|Overall Study|Adverse Event|16|||
129577418|NCT00796653|466409635|FG003|Overall Study|Adverse Event|16|||
129577419|NCT00796653|466409632|FG000|Overall Study|Lost to Follow-up|2|||
129577420|NCT00796653|466409633|FG001|Overall Study|Lost to Follow-up|1|||
129577421|NCT00796653|466409634|FG002|Overall Study|Lost to Follow-up|2|||
129785186|NCT00830869|467182011|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
129785187|NCT00830869|467182012|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
129785188|NCT00830869|467182001|FG000|Period 2: Part 2|Progressive disease|0|||
129785189|NCT00830869|467182002|FG001|Period 2: Part 2|Progressive disease|0|||
129577422|NCT00796653|466409635|FG003|Overall Study|Lost to Follow-up|3|||
129577423|NCT00796653|466409632|FG000|Overall Study|Withdrawal by Subject|16|||
129577424|NCT00796653|466409633|FG001|Overall Study|Withdrawal by Subject|8|||
129577425|NCT00796653|466409634|FG002|Overall Study|Withdrawal by Subject|8|||
129577426|NCT00796653|466409635|FG003|Overall Study|Withdrawal by Subject|13|||
129577427|NCT00796653|466409632|FG000|Overall Study|Lack of Efficacy|8|||
129577428|NCT00796653|466409633|FG001|Overall Study|Lack of Efficacy|1|||
129577429|NCT00796653|466409634|FG002|Overall Study|Lack of Efficacy|3|||
129577430|NCT00796653|466409635|FG003|Overall Study|Lack of Efficacy|2|||
129577431|NCT00796653|466409632|FG000|Overall Study|Non compliance with protocol|2|||
129577432|NCT00796653|466409633|FG001|Overall Study|Non compliance with protocol|2|||
129577433|NCT00796653|466409634|FG002|Overall Study|Non compliance with protocol|0|||
129577434|NCT00796653|466409635|FG003|Overall Study|Non compliance with protocol|2|||
129577435|NCT00796653|466409632|FG000|Overall Study|Other reason not described above|4|||
129577436|NCT00796653|466409633|FG001|Overall Study|Other reason not described above|9|||
129577437|NCT00796653|466409634|FG002|Overall Study|Other reason not described above|7|||
129577438|NCT00796653|466409635|FG003|Overall Study|Other reason not described above|4|||
129577439|NCT01848938|466409646|FG000|Overall Study|Lost to Follow-up|1|||
129577440|NCT01848938|466409647|FG001|Overall Study|Lost to Follow-up|1|||
129577441|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
129577442|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
129577443|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
129577444|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
129577445|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
129577446|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
129577447|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129577448|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129577449|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
129577450|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
129577451|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
129577452|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
129577453|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
129577454|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
129577455|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
129577456|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
129577457|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
129577458|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
129577459|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
129577460|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
129577461|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Death|0|||
129577462|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Death|1|||
129577463|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Death|0|||
129577464|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Death|0|||
129577465|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
129577466|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
129577467|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
129577468|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
129577469|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
129577470|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
129577471|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
129577472|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
129577473|NCT01940341|466409648|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129577474|NCT01940341|466409649|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
129577475|NCT01940341|466409650|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129577476|NCT01940341|466409651|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129694808|NCT01260311|466839688|FG000|Overall Study|Gone to Province|2|||
129694809|NCT01260311|466839688|FG000|Overall Study|Medication Stopped|1|||
129694810|NCT01260311|466839688|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
129694811|NCT01089543|466839695|FG000|Overall Study|Withdrawal by Subject|2|||
129694812|NCT01089543|466839696|FG001|Overall Study|Withdrawal by Subject|3|||
129694813|NCT01089543|466839697|FG002|Overall Study|Withdrawal by Subject|3|||
129694814|NCT01089543|466839698|FG003|Overall Study|Withdrawal by Subject|1|||
129694815|NCT01089543|466839695|FG000|Overall Study|Physician Decision|1|||
129694816|NCT01089543|466839696|FG001|Overall Study|Physician Decision|0|||
129577477|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
129577478|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
129577479|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
129577480|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
129694817|NCT01089543|466839697|FG002|Overall Study|Physician Decision|0|||
129694818|NCT01089543|466839698|FG003|Overall Study|Physician Decision|1|||
129694819|NCT01089543|466839695|FG000|Overall Study|Adverse Event|0|||
129577481|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
129577482|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
129577483|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
129577484|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
129577485|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129577486|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129577487|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
129577488|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129577489|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
129577490|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
129577491|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
129577492|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
129577493|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129577494|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129577495|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
129577496|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129577497|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
129577498|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
129577499|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
129577500|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
129577501|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129577502|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129694820|NCT01089543|466839696|FG001|Overall Study|Adverse Event|1|||
129694821|NCT01089543|466839697|FG002|Overall Study|Adverse Event|0|||
129694822|NCT01089543|466839698|FG003|Overall Study|Adverse Event|0|||
129694823|NCT01248468|466839700|FG000|Overall Study|Administrative problem|1|||
129694824|NCT01248468|466839701|FG001|Overall Study|Administrative problem|0|||
129694825|NCT01248468|466839702|FG002|Overall Study|Administrative problem|0|||
129694826|NCT01248468|466839700|FG000|Overall Study|Lost to Follow-up|9|||
129694827|NCT01248468|466839701|FG001|Overall Study|Lost to Follow-up|12|||
129694828|NCT01248468|466839702|FG002|Overall Study|Lost to Follow-up|4|||
129694829|NCT01248468|466839700|FG000|Overall Study|Pregnancy|1|||
129577503|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
129577504|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129577505|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129577506|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129577507|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129577508|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
129577509|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129577510|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129577511|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129577512|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
129577513|NCT01940341|466409648|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
129577514|NCT01940341|466409649|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
129577515|NCT01940341|466409650|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
129577516|NCT01940341|466409651|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
129694830|NCT01248468|466839701|FG001|Overall Study|Pregnancy|0|||
129694831|NCT01248468|466839702|FG002|Overall Study|Pregnancy|0|||
129694832|NCT01248468|466839700|FG000|Overall Study|Withdrawal by Subject|4|||
129694833|NCT01248468|466839701|FG001|Overall Study|Withdrawal by Subject|2|||
129577517|NCT01757392|466409654|FG000|Overall Study|Withdrawal by Subject|1|||
129577518|NCT01757392|466409654|FG000|Overall Study|Screen Fail|3|||
129577519|NCT00207090|466409659|FG000|Overall Study|Study drug toxicity|3|||
129577520|NCT00207090|466409659|FG000|Overall Study|Chest wall mass larger|1|||
129577521|NCT00207090|466409659|FG000|Overall Study|Disease progression/relapse|2|||
129694834|NCT01248468|466839702|FG002|Overall Study|Withdrawal by Subject|0|||
129694835|NCT00468546|466839704|FG000|Week 24 Analysis|Lack of Efficacy|83|||
129694836|NCT00468546|466839705|FG001|Week 24 Analysis|Lack of Efficacy|37|||
129577522|NCT00207090|466409659|FG000|Overall Study|Physician Decision|1|||
129694837|NCT00468546|466839704|FG000|Week 24 Analysis|Refused treatment|5|||
129694838|NCT00468546|466839705|FG001|Week 24 Analysis|Refused treatment|5|||
129577523|NCT00841698|466409662|FG000|First Intervention|Withdrawal by Subject|1|||
129577524|NCT00841698|466409663|FG001|First Intervention|Withdrawal by Subject|0|||
129694839|NCT00468546|466839704|FG000|Week 24 Analysis|Adverse Event|1|||
129577525|NCT00651820|466409674|FG000|Overall Study|Lost to Follow-up|2|||
129694840|NCT00468546|466839705|FG001|Week 24 Analysis|Adverse Event|8|||
129694841|NCT00468546|466839704|FG000|Week 24 Analysis|Failure to return|3|||
129800241|NCT04755283|467236269|FG001|Overall Study|Lost to Follow-up|0|||
129577526|NCT00773253|466409676|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
129577527|NCT00773253|466409677|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
129577528|NCT01878292|466409678|FG000|Randomized|Protocol Violation|1|||
129577529|NCT01878292|466409679|FG001|Randomized|Protocol Violation|0|||
129577530|NCT01878292|466409680|FG002|Randomized|Protocol Violation|0|||
129577531|NCT01878292|466409678|FG000|Randomized|Lost to Follow-up|1|||
129577532|NCT01878292|466409679|FG001|Randomized|Lost to Follow-up|0|||
129577533|NCT01878292|466409680|FG002|Randomized|Lost to Follow-up|0|||
129577534|NCT01878292|466409678|FG000|Randomized|Adverse Event|1|||
129577535|NCT01878292|466409679|FG001|Randomized|Adverse Event|0|||
129577536|NCT01878292|466409680|FG002|Randomized|Adverse Event|0|||
129577537|NCT01878292|466409678|FG000|Double-blind Treatment Period|Other Reasons|2|||
129577538|NCT01878292|466409679|FG001|Double-blind Treatment Period|Other Reasons|0|||
129577539|NCT01878292|466409680|FG002|Double-blind Treatment Period|Other Reasons|0|||
129577540|NCT01878292|466409678|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
129577541|NCT01878292|466409679|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
129577542|NCT01878292|466409680|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129577543|NCT01878292|466409678|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
129577544|NCT01878292|466409679|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
129577545|NCT01878292|466409680|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
129577546|NCT01878292|466409678|FG000|Double-blind Treatment Period|Protocol Violation|3|||
129577547|NCT01878292|466409679|FG001|Double-blind Treatment Period|Protocol Violation|4|||
129577548|NCT01878292|466409680|FG002|Double-blind Treatment Period|Protocol Violation|2|||
129577549|NCT01878292|466409678|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
129577550|NCT01878292|466409679|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
129577551|NCT01878292|466409680|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129577552|NCT01878292|466409678|FG000|Double-blind Treatment Period|Adverse Event|4|||
129577553|NCT01878292|466409679|FG001|Double-blind Treatment Period|Adverse Event|9|||
129577554|NCT01878292|466409680|FG002|Double-blind Treatment Period|Adverse Event|8|||
129577555|NCT01878292|466409678|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
129577556|NCT01878292|466409679|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
129577557|NCT01878292|466409680|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
129577558|NCT01302548|466409685|FG000|Overall Study|Lost to Follow-up|2|||
129577559|NCT01302548|466409686|FG001|Overall Study|Lost to Follow-up|1|||
129577560|NCT01249651|466409688|FG000|Overall Study|Withdrawal by Subject|4|||
129577561|NCT01249651|466409688|FG000|Overall Study|Adverse Event|1|||
129577562|NCT01249651|466409688|FG000|Overall Study|Protocol Violation|1|||
129577563|NCT01249651|466409688|FG000|Overall Study|Sponsor Decision|1|||
129577564|NCT02820350|466409689|FG000|Overall Study|Withdrawal by Subject|3|||
129577565|NCT02820350|466409689|FG000|Overall Study|Death|4|||
129577566|NCT03801707|466409692|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
129577567|NCT03873272|466409693|FG000|Overall Study|Withdrawal by Subject|2|||
129577568|NCT03873272|466409694|FG001|Overall Study|Withdrawal by Subject|0|||
129577569|NCT03873272|466409695|FG002|Overall Study|Withdrawal by Subject|1|||
129577570|NCT03873272|466409693|FG000|Overall Study|Death|0|||
129577571|NCT03873272|466409694|FG001|Overall Study|Death|2|||
129577572|NCT03873272|466409695|FG002|Overall Study|Death|1|||
129577573|NCT00787254|466409696|FG000|Overall Study|Adverse Event|24|||
129577574|NCT00787254|466409697|FG001|Overall Study|Adverse Event|23|||
129577575|NCT00787254|466409696|FG000|Overall Study|Protocol Violation|26|||
129577576|NCT00787254|466409697|FG001|Overall Study|Protocol Violation|23|||
129577577|NCT00787254|466409696|FG000|Overall Study|Withdrawal by Subject|16|||
129577578|NCT00787254|466409697|FG001|Overall Study|Withdrawal by Subject|11|||
129577579|NCT00787254|466409696|FG000|Overall Study|Lack of Efficacy|4|||
129577580|NCT00787254|466409697|FG001|Overall Study|Lack of Efficacy|15|||
129577581|NCT00787254|466409696|FG000|Overall Study|NSAIDs discontinuation|1|||
129577582|NCT00787254|466409697|FG001|Overall Study|NSAIDs discontinuation|2|||
129577583|NCT00787254|466409696|FG000|Overall Study|Institution closed|1|||
129577584|NCT00787254|466409697|FG001|Overall Study|Institution closed|0|||
129694842|NCT00468546|466839705|FG001|Week 24 Analysis|Failure to return|4|||
129577585|NCT00787254|466409696|FG000|Overall Study|Physician Decision|4|||
129694843|NCT00468546|466839704|FG000|Week 24 Analysis|Rescue therapy|2|||
129694844|NCT00468546|466839705|FG001|Week 24 Analysis|Rescue therapy|0|||
129694845|NCT00468546|466839704|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
129694846|NCT00468546|466839705|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
129577586|NCT00787254|466409697|FG001|Overall Study|Physician Decision|8|||
129577587|NCT00859430|466409698|FG000|First Intervention|Withdrawal by Subject|0|||
129577588|NCT00859430|466409699|FG001|First Intervention|Withdrawal by Subject|1|||
129577589|NCT03733730|466411854|FG000|Overall Study|Lost to Follow-up|1|||
129577590|NCT03733730|466411855|FG001|Overall Study|Lost to Follow-up|32|||
129577591|NCT03733730|466411854|FG000|Overall Study|Other|1|||
129577592|NCT03733730|466411855|FG001|Overall Study|Other|0|||
129577593|NCT03733730|466411854|FG000|Overall Study|Adverse Event|0|||
129577594|NCT03733730|466411855|FG001|Overall Study|Adverse Event|4|||
129577595|NCT03733730|466411854|FG000|Overall Study|Death|0|||
129577596|NCT03733730|466411855|FG001|Overall Study|Death|5|||
129577597|NCT03733730|466411854|FG000|Overall Study|Withdrawal by Subject|0|||
129577598|NCT03733730|466411855|FG001|Overall Study|Withdrawal by Subject|8|||
129577599|NCT01531894|466411860|FG000|Overall Study|Physician Decision|8|||
129577600|NCT01531894|466411860|FG000|Overall Study|Death|1|||
129577601|NCT03086460|466411861|FG000|Study Participants|Lost to Follow-up|2|||
129577602|NCT03086460|466411861|FG000|Study Participants|Protocol Violation|1|||
129577603|NCT03086460|466411861|FG000|Study Participants|Withdrawal by Subject|6|||
129577604|NCT03086460|466411861|FG000|Treatment A|Lost to Follow-up|1|||
129577605|NCT03086460|466411861|FG000|Treatment A|Protocol Violation|1|||
129577606|NCT03086460|466411861|FG000|Treatment A|Withdrawal by Subject|2|||
129577607|NCT03086460|466411861|FG000|Treatment C|Withdrawal by Subject|2|||
129577608|NCT03086460|466411861|FG000|Treatment E|Lost to Follow-up|1|||
129577609|NCT03086460|466411861|FG000|Treatment E|Withdrawal by Subject|3|||
129577610|NCT03635320|466411862|FG000|Overall Study|not implanted the device|1|||
129577611|NCT03635320|466411863|FG001|Overall Study|not implanted the device|2|||
129577612|NCT03635320|466411862|FG000|Overall Study|Withdrawal by Subject|11|||
129577613|NCT03635320|466411863|FG001|Overall Study|Withdrawal by Subject|6|||
129577614|NCT00835575|466411866|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
129577615|NCT00835575|466411867|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
129577616|NCT01440803|466411868|FG000|Overall Study|Met study stopping rule|2|||
129577617|NCT01440803|466411869|FG001|Overall Study|Met study stopping rule|1|||
129577618|NCT01440803|466411868|FG000|Overall Study|Lost to Follow-up|0|||
129577619|NCT01440803|466411869|FG001|Overall Study|Lost to Follow-up|2|||
129577620|NCT01440803|466411868|FG000|Overall Study|Withdrawal by Subject|0|||
129577621|NCT01440803|466411869|FG001|Overall Study|Withdrawal by Subject|1|||
129577622|NCT01609257|466411870|FG000|Overall Study|Lost to Follow-up|2|||
129577623|NCT01609257|466411871|FG001|Overall Study|Lost to Follow-up|1|||
129577624|NCT01609257|466411870|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
129577625|NCT01609257|466411871|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
129577626|NCT01609257|466411870|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
129577627|NCT01609257|466411871|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
129577628|NCT02125461|466411874|FG000|Overall Study|Withdrawal by Subject|30|||
129577629|NCT02125461|466411875|FG001|Overall Study|Withdrawal by Subject|16|||
129577630|NCT02125461|466411874|FG000|Overall Study|Lost to Follow-up|8|||
129577631|NCT02125461|466411875|FG001|Overall Study|Lost to Follow-up|3|||
129577632|NCT02125461|466411874|FG000|Overall Study|Death|260|||
129577633|NCT02125461|466411875|FG001|Overall Study|Death|149|||
129577634|NCT02125461|466411874|FG000|Overall Study|Missing Termination Reason|0|||
129577635|NCT02125461|466411875|FG001|Overall Study|Missing Termination Reason|1|||
129577636|NCT03502811|466411879|FG000|Overall Study|Death|157|||
129577637|NCT03502811|466411879|FG000|Overall Study|Withdrawal by Subject|105|||
129577638|NCT03502811|466411879|FG000|Overall Study|Lost to Follow-up|26|||
129577639|NCT03502811|466411879|FG000|Overall Study|No Visits (Missed)|31|||
129577640|NCT01735994|466411880|FG000|Overall Study|Withdrawal by Subject|6|||
129577641|NCT01735994|466411881|FG001|Overall Study|Withdrawal by Subject|4|||
129800242|NCT04755283|467236270|FG002|Overall Study|Lost to Follow-up|1|||
129577642|NCT01735994|466411880|FG000|Overall Study|Injury|2|||
129577643|NCT01735994|466411881|FG001|Overall Study|Injury|0|||
129577644|NCT01735994|466411880|FG000|Overall Study|Kicked off team|5|||
129577645|NCT01735994|466411881|FG001|Overall Study|Kicked off team|0|||
129577646|NCT01735994|466411880|FG000|Overall Study|Lost to Follow-up|50|||
129577647|NCT01735994|466411881|FG001|Overall Study|Lost to Follow-up|62|||
129577648|NCT01158118|466411882|FG000|Overall Study|Screen failure|1|||
129577649|NCT01158118|466411883|FG001|Overall Study|Screen failure|0|||
129577650|NCT01158118|466411882|FG000|Overall Study|Donor match was a screen failure|0|||
129577651|NCT01158118|466411883|FG001|Overall Study|Donor match was a screen failure|1|||
129577652|NCT01158118|466411882|FG000|Overall Study|Suffered stroke prior to transplant|0|||
129577653|NCT01158118|466411883|FG001|Overall Study|Suffered stroke prior to transplant|1|||
129577654|NCT01158118|466411882|FG000|Overall Study|Death|0|||
129577655|NCT01158118|466411883|FG001|Overall Study|Death|1|||
129577656|NCT04994535|466411884|FG000|Overall Study|Lost to Follow-up|7|||
129577657|NCT04994535|466411885|FG001|Overall Study|Lost to Follow-up|7|||
129577658|NCT04994535|466411884|FG000|Overall Study|Withdrawal by Subject|10|||
129577659|NCT04994535|466411885|FG001|Overall Study|Withdrawal by Subject|7|||
129577660|NCT04994535|466411884|FG000|Overall Study|Other|1|||
129577661|NCT04994535|466411885|FG001|Overall Study|Other|1|||
129577662|NCT00604162|466411886|FG000|Overall Study|Physician Decision|3|||
129577663|NCT00604162|466411886|FG000|Overall Study|Withdrawal by Subject|1|||
129577664|NCT02241551|466411887|FG000|Overall Study|Adverse Event|1|||
129577665|NCT02241551|466411888|FG001|Overall Study|Adverse Event|0|||
129577666|NCT01015287|466411889|FG000|Overall Study|Death|21|||
129577667|NCT01015287|466411890|FG001|Overall Study|Death|16|||
129577668|NCT01015287|466411889|FG000|Overall Study|Adverse Event|1|||
129577669|NCT01015287|466411890|FG001|Overall Study|Adverse Event|0|||
129577670|NCT01015287|466411889|FG000|Overall Study|Sponsor Decision|3|||
129577671|NCT01015287|466411890|FG001|Overall Study|Sponsor Decision|7|||
129577672|NCT01015287|466411889|FG000|Overall Study|Physician Decision|19|||
129577673|NCT01015287|466411890|FG001|Overall Study|Physician Decision|21|||
129577674|NCT01015287|466411889|FG000|Overall Study|Withdrawal by Subject|14|||
129577675|NCT01015287|466411890|FG001|Overall Study|Withdrawal by Subject|19|||
129577676|NCT01015287|466411889|FG000|Overall Study|Entry Criteria not Met|11|||
129577677|NCT01015287|466411890|FG001|Overall Study|Entry Criteria not Met|14|||
129577678|NCT01015287|466411889|FG000|Overall Study|Lost to Follow-up|2|||
129577679|NCT01015287|466411890|FG001|Overall Study|Lost to Follow-up|1|||
129577680|NCT01015287|466411889|FG000|Overall Study|Protocol Violation|1|||
129577681|NCT01015287|466411890|FG001|Overall Study|Protocol Violation|1|||
129577682|NCT00469898|466411891|FG000|Overall Study|Adverse Event|7|||
129577683|NCT00469898|466411891|FG000|Overall Study|Withdrawal by Subject|4|||
129577684|NCT00469898|466411891|FG000|Overall Study|Death|4|||
129577685|NCT00469898|466411891|FG000|Overall Study|Disease progression|9|||
129577686|NCT00469898|466411891|FG000|Overall Study|Decreased performance status|1|||
129577687|NCT01370317|466411892|FG000|Overall Study|Participant withdrew consent|1|||
129577688|NCT01370317|466411893|FG001|Overall Study|Participant withdrew consent|0|||
129577689|NCT01370317|466411892|FG000|Overall Study|Protocol deviation|0|||
129577690|NCT01370317|466411893|FG001|Overall Study|Protocol deviation|1|||
129577691|NCT00113386|466411898|FG000|Overall Study|Withdrawal by Subject|1|||
129577692|NCT00113386|466411899|FG001|Overall Study|Withdrawal by Subject|0|||
129577693|NCT00113386|466411898|FG000|Overall Study|Physician Decision|0|||
129577694|NCT00113386|466411899|FG001|Overall Study|Physician Decision|1|||
129577695|NCT00113386|466411898|FG000|Overall Study|Toxicity|3|||
129577696|NCT00113386|466411899|FG001|Overall Study|Toxicity|0|||
129577697|NCT00113386|466411898|FG000|Overall Study|Ineligible|1|||
129577698|NCT00113386|466411899|FG001|Overall Study|Ineligible|2|||
129577699|NCT00113386|466411898|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
129577700|NCT00113386|466411899|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
129577701|NCT02849457|466411900|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
129577702|NCT02849457|466411901|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
129577703|NCT02849457|466411902|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
129577704|NCT02849457|466411903|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
129577705|NCT00392665|466411904|FG000|Overall Study|Death|16|||
129577706|NCT00392665|466411905|FG001|Overall Study|Death|14|||
129577707|NCT00392665|466411904|FG000|Overall Study|Lost to Follow-up|1|||
129577708|NCT00392665|466411905|FG001|Overall Study|Lost to Follow-up|1|||
129577709|NCT03673670|466411908|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
129577710|NCT03673670|466411909|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129785190|NCT00830869|467182003|FG002|Period 2: Part 2|Progressive disease|0|||
129785191|NCT00830869|467182004|FG003|Period 2: Part 2|Progressive disease|0|||
129785192|NCT00830869|467182005|FG004|Period 2: Part 2|Progressive disease|0|||
129785193|NCT00830869|467182006|FG005|Period 2: Part 2|Progressive disease|0|||
129577711|NCT03673670|466411910|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129577712|NCT03673670|466411911|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129577713|NCT03673670|466411912|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129577714|NCT03673670|466411913|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
129577715|NCT03673670|466411908|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
129577716|NCT03673670|466411909|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
129577717|NCT03673670|466411910|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
129785194|NCT00830869|467182007|FG006|Period 2: Part 2|Progressive disease|0|||
129785195|NCT00830869|467182008|FG007|Period 2: Part 2|Progressive disease|14|||
129785196|NCT00830869|467182009|FG008|Period 2: Part 2|Progressive disease|11|||
129785197|NCT00830869|467182010|FG009|Period 2: Part 2|Progressive disease|12|||
129785198|NCT00830869|467182011|FG010|Period 2: Part 2|Progressive disease|8|||
129785199|NCT00830869|467182012|FG011|Period 2: Part 2|Progressive disease|15|||
129577718|NCT03673670|466411911|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
129577719|NCT03673670|466411912|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
129577720|NCT03673670|466411913|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
129577721|NCT03673670|466411908|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
129577722|NCT03673670|466411909|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
129577723|NCT03673670|466411910|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
129577724|NCT03673670|466411911|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
129577725|NCT03673670|466411912|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
129577726|NCT03673670|466411913|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
129577727|NCT03673670|466411908|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129577728|NCT03673670|466411909|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129577729|NCT03673670|466411910|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129577730|NCT03673670|466411911|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129577731|NCT03673670|466411912|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
129577732|NCT03673670|466411913|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
129577733|NCT03673670|466411908|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
129577734|NCT03673670|466411909|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
129577735|NCT03673670|466411910|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
129577736|NCT03673670|466411911|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
129577737|NCT03673670|466411912|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
129577738|NCT03673670|466411913|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
129577739|NCT03673670|466411908|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129577740|NCT03673670|466411909|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129577741|NCT03673670|466411910|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129577742|NCT03673670|466411911|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129577743|NCT03673670|466411912|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
129577744|NCT03673670|466411913|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
129577745|NCT03673670|466411908|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
129577746|NCT03673670|466411909|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
129577747|NCT03673670|466411910|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
129577748|NCT03673670|466411911|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
129577749|NCT03673670|466411912|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
129577750|NCT03673670|466411913|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
129577751|NCT03733444|466411918|FG000|Overall Study|Adverse Event|8|||
129577752|NCT03733444|466411919|FG001|Overall Study|Adverse Event|10|||
129577753|NCT03733444|466411920|FG002|Overall Study|Adverse Event|5|||
129577754|NCT03733444|466411918|FG000|Overall Study|Death|20|||
129577755|NCT03733444|466411919|FG001|Overall Study|Death|19|||
129577756|NCT03733444|466411920|FG002|Overall Study|Death|11|||
129577757|NCT03733444|466411918|FG000|Overall Study|Lost to Follow-up|3|||
129577758|NCT03733444|466411919|FG001|Overall Study|Lost to Follow-up|0|||
129577759|NCT03733444|466411920|FG002|Overall Study|Lost to Follow-up|1|||
129577760|NCT03733444|466411918|FG000|Overall Study|Lack of Efficacy|0|||
129577761|NCT03733444|466411919|FG001|Overall Study|Lack of Efficacy|1|||
129577762|NCT03733444|466411920|FG002|Overall Study|Lack of Efficacy|1|||
129577763|NCT03733444|466411918|FG000|Overall Study|Physician Decision|2|||
129577764|NCT03733444|466411919|FG001|Overall Study|Physician Decision|1|||
129785200|NCT00830869|467182001|FG000|Period 2: Part 2|Other|0|||
129577765|NCT03733444|466411920|FG002|Overall Study|Physician Decision|0|||
129785201|NCT00830869|467182002|FG001|Period 2: Part 2|Other|0|||
129785202|NCT00830869|467182003|FG002|Period 2: Part 2|Other|0|||
129577766|NCT03733444|466411918|FG000|Overall Study|Protocol Violation|2|||
129577767|NCT03733444|466411919|FG001|Overall Study|Protocol Violation|1|||
129577768|NCT03733444|466411920|FG002|Overall Study|Protocol Violation|0|||
129577769|NCT03733444|466411918|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
129577770|NCT03733444|466411919|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
129577771|NCT03733444|466411920|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
129785203|NCT00830869|467182004|FG003|Period 2: Part 2|Other|0|||
129785204|NCT00830869|467182005|FG004|Period 2: Part 2|Other|0|||
129577772|NCT03733444|466411918|FG000|Overall Study|Study Terminated by Sponsor|203|||
129577773|NCT03733444|466411919|FG001|Overall Study|Study Terminated by Sponsor|209|||
129577774|NCT03733444|466411920|FG002|Overall Study|Study Terminated by Sponsor|221|||
129577775|NCT03733444|466411918|FG000|Overall Study|Withdrawal by Subject|19|||
129577776|NCT03733444|466411919|FG001|Overall Study|Withdrawal by Subject|18|||
129577777|NCT03733444|466411920|FG002|Overall Study|Withdrawal by Subject|16|||
129577778|NCT03733444|466411918|FG000|Overall Study|Miscellaneous|1|||
129577779|NCT03733444|466411919|FG001|Overall Study|Miscellaneous|0|||
129577780|NCT03733444|466411920|FG002|Overall Study|Miscellaneous|1|||
129577781|NCT03733444|466411918|FG000|Overall Study|Not Treated|1|||
129577782|NCT03733444|466411919|FG001|Overall Study|Not Treated|2|||
129577783|NCT03733444|466411920|FG002|Overall Study|Not Treated|1|||
129577784|NCT00556322|466411921|FG000|Overall Study|Insufficient therapeutic response|158|||
129577785|NCT00556322|466411922|FG001|Overall Study|Insufficient therapeutic response|168|||
129577786|NCT00556322|466411921|FG000|Overall Study|Adverse Event|7|||
129577787|NCT00556322|466411922|FG001|Overall Study|Adverse Event|4|||
129577788|NCT00556322|466411921|FG000|Overall Study|Other|4|||
129577789|NCT00556322|466411922|FG001|Overall Study|Other|1|||
129577790|NCT00556322|466411921|FG000|Overall Study|Lost to Follow-up|5|||
129577791|NCT00556322|466411922|FG001|Overall Study|Lost to Follow-up|3|||
129577792|NCT00556322|466411921|FG000|Overall Study|Withdrawal by Subject|19|||
129577793|NCT00556322|466411922|FG001|Overall Study|Withdrawal by Subject|7|||
129577794|NCT00556322|466411921|FG000|Overall Study|Protocol Violation|5|||
129577795|NCT00556322|466411922|FG001|Overall Study|Protocol Violation|1|||
129577796|NCT00556322|466411921|FG000|Overall Study|Ongoing at data cutoff|3|||
129577797|NCT00556322|466411922|FG001|Overall Study|Ongoing at data cutoff|5|||
129577798|NCT00556322|466411921|FG000|Overall Study|Death|20|||
129577799|NCT00556322|466411922|FG001|Overall Study|Death|14|||
129577800|NCT01788423|466411923|FG000|Overall Study|See Comments in Completed (above)|0|||
129577801|NCT01788423|466411924|FG001|Overall Study|See Comments in Completed (above)|4|||
129577802|NCT01788423|466411925|FG002|Overall Study|See Comments in Completed (above)|5|||
129577803|NCT03637764|466411926|FG000|Overall Study|Adverse Event|2|||
129577804|NCT03637764|466411927|FG001|Overall Study|Adverse Event|0|||
129577805|NCT03637764|466411928|FG002|Overall Study|Adverse Event|0|||
129577806|NCT03637764|466411929|FG003|Overall Study|Adverse Event|1|||
129577807|NCT03637764|466411926|FG000|Overall Study|Progressive Disease|23|||
129577808|NCT03637764|466411927|FG001|Overall Study|Progressive Disease|23|||
129577809|NCT03637764|466411928|FG002|Overall Study|Progressive Disease|18|||
129577810|NCT03637764|466411929|FG003|Overall Study|Progressive Disease|31|||
129577811|NCT03637764|466411926|FG000|Overall Study|Withdrawal by Subject|1|||
129577812|NCT03637764|466411927|FG001|Overall Study|Withdrawal by Subject|3|||
129577813|NCT03637764|466411928|FG002|Overall Study|Withdrawal by Subject|0|||
129577814|NCT03637764|466411929|FG003|Overall Study|Withdrawal by Subject|1|||
129577815|NCT02760927|466411934|FG000|Overall Study|Tube Slippage from Device|1|||
129577816|NCT02105272|466411935|FG000|Overall Study|Adverse Event|1|||
129577817|NCT02105272|466411936|FG001|Overall Study|Adverse Event|2|||
129577818|NCT02105272|466411935|FG000|Overall Study|Physician Decision|0|||
129577819|NCT02105272|466411936|FG001|Overall Study|Physician Decision|1|||
129577820|NCT02105272|466411935|FG000|Overall Study|Protocol Violation|2|||
129577821|NCT02105272|466411936|FG001|Overall Study|Protocol Violation|0|||
129577822|NCT02105272|466411935|FG000|Overall Study|Withdrawal by Subject|2|||
129577823|NCT02105272|466411936|FG001|Overall Study|Withdrawal by Subject|0|||
129577824|NCT03190915|466411938|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
129577825|NCT03190915|466411938|FG000|Overall Study|Progressive Disease|3|||
129577826|NCT01911676|466411939|FG000|Period 1 of Study|Withdrawal by Subject|4|||
129577827|NCT01911676|466411940|FG001|Period 1 of Study|Withdrawal by Subject|2|||
129577828|NCT01911676|466411941|FG002|Period 1 of Study|Withdrawal by Subject|1|||
129577829|NCT01911676|466411942|FG003|Period 1 of Study|Withdrawal by Subject|2|||
129577830|NCT01911676|466411939|FG000|Period 1 of Study|Physician Decision|2|||
129577831|NCT01911676|466411940|FG001|Period 1 of Study|Physician Decision|0|||
129577832|NCT01911676|466411941|FG002|Period 1 of Study|Physician Decision|0|||
129577833|NCT01911676|466411942|FG003|Period 1 of Study|Physician Decision|1|||
129577834|NCT01911676|466411939|FG000|Period 2 of Study|Physician Decision|2|||
129577835|NCT01911676|466411940|FG001|Period 2 of Study|Physician Decision|0|||
129577836|NCT01911676|466411941|FG002|Period 2 of Study|Physician Decision|0|||
129577837|NCT01911676|466411942|FG003|Period 2 of Study|Physician Decision|1|||
129577838|NCT01911676|466411939|FG000|Period 2 of Study|Lost to Follow-up|0|||
129577839|NCT01911676|466411940|FG001|Period 2 of Study|Lost to Follow-up|0|||
129577840|NCT01911676|466411941|FG002|Period 2 of Study|Lost to Follow-up|0|||
129577841|NCT01911676|466411942|FG003|Period 2 of Study|Lost to Follow-up|1|||
129577842|NCT01566721|466411943|FG000|Treatment Period|Withdrawal by Subject|35|||
129577843|NCT01566721|466411944|FG001|Treatment Period|Withdrawal by Subject|9|||
129577844|NCT01566721|466411943|FG000|Treatment Period|Disease Progression/Recurrence|37|||
129577845|NCT01566721|466411944|FG001|Treatment Period|Disease Progression/Recurrence|13|||
129577846|NCT01566721|466411943|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
129577847|NCT01566721|466411944|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
129577848|NCT01566721|466411943|FG000|Treatment Period|Other|13|||
129785205|NCT00830869|467182006|FG005|Period 2: Part 2|Other|0|||
129785206|NCT00830869|467182007|FG006|Period 2: Part 2|Other|0|||
129785207|NCT00830869|467182008|FG007|Period 2: Part 2|Other|0|||
129785208|NCT00830869|467182009|FG008|Period 2: Part 2|Other|0|||
129785209|NCT00830869|467182010|FG009|Period 2: Part 2|Other|1|||
129785210|NCT00830869|467182011|FG010|Period 2: Part 2|Other|0|||
129785211|NCT00830869|467182012|FG011|Period 2: Part 2|Other|0|||
129785212|NCT00617669|467182013|FG000|Overall Study|Withdrawal by Subject|71|||
129785213|NCT00617669|467182014|FG001|Overall Study|Withdrawal by Subject|77|||
129785214|NCT00617669|467182013|FG000|Overall Study|Lost to Follow-up|3|||
129785215|NCT00617669|467182014|FG001|Overall Study|Lost to Follow-up|2|||
129785216|NCT00617669|467182013|FG000|Overall Study|Adverse Event|87|||
129785217|NCT00617669|467182014|FG001|Overall Study|Adverse Event|76|||
129785218|NCT00617669|467182013|FG000|Overall Study|Protocol Violation|2|||
129785219|NCT00617669|467182014|FG001|Overall Study|Protocol Violation|3|||
129785220|NCT00617669|467182013|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
129785221|NCT00617669|467182014|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
129785222|NCT00617669|467182013|FG000|Overall Study|Patients randomized but not treated|2|||
129785223|NCT00617669|467182014|FG001|Overall Study|Patients randomized but not treated|3|||
129785224|NCT03745820|467182015|FG000|Overall Study|Adverse Event|0|||
129785225|NCT03745820|467182016|FG001|Overall Study|Adverse Event|3|||
129785226|NCT03745820|467182017|FG002|Overall Study|Adverse Event|2|||
129785227|NCT03745820|467182015|FG000|Overall Study|Non-Compliance with Study Drug|4|||
129785228|NCT03745820|467182016|FG001|Overall Study|Non-Compliance with Study Drug|3|||
129785229|NCT03745820|467182017|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129785230|NCT03745820|467182015|FG000|Overall Study|Withdrawal by Subject|4|||
129785231|NCT03745820|467182016|FG001|Overall Study|Withdrawal by Subject|4|||
129785232|NCT03745820|467182017|FG002|Overall Study|Withdrawal by Subject|4|||
129785233|NCT03745820|467182015|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
129785234|NCT03745820|467182016|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
129785235|NCT03745820|467182017|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
129785236|NCT03745820|467182015|FG000|Overall Study|Lost to Follow-up|2|||
129785237|NCT03745820|467182016|FG001|Overall Study|Lost to Follow-up|0|||
129785238|NCT03745820|467182017|FG002|Overall Study|Lost to Follow-up|3|||
129785239|NCT03745820|467182015|FG000|Overall Study|Reason not Specified|2|||
129785240|NCT03745820|467182016|FG001|Overall Study|Reason not Specified|4|||
129785241|NCT03745820|467182017|FG002|Overall Study|Reason not Specified|1|||
129785242|NCT00507728|467182018|FG000|Randomization to Month 3|Lost to Follow-up|15|||
129785243|NCT00507728|467182019|FG001|Randomization to Month 3|Lost to Follow-up|14|||
129785244|NCT00507728|467182020|FG002|Randomization to Month 3|Lost to Follow-up|20|||
129785245|NCT00507728|467182018|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
129785246|NCT00507728|467182019|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
129785247|NCT00507728|467182020|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
129785248|NCT03680742|467182021|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
129785249|NCT00615901|467182022|FG000|Overall Study|Withdrawal by Subject|2|||
129785250|NCT00615901|467182022|FG000|Overall Study|Adverse Event|7|||
129785251|NCT02527200|467182023|FG000|Overall Study|Withdrawal by Subject|3|||
129785252|NCT02527200|467182024|FG001|Overall Study|Withdrawal by Subject|2|||
129785253|NCT02527200|467182025|FG002|Overall Study|Withdrawal by Subject|1|||
129785254|NCT02527200|467182026|FG003|Overall Study|Withdrawal by Subject|0|||
129785255|NCT02527200|467182023|FG000|Overall Study|Unclassified|0|||
129785256|NCT02527200|467182024|FG001|Overall Study|Unclassified|1|||
129785257|NCT02527200|467182025|FG002|Overall Study|Unclassified|0|||
129785258|NCT02527200|467182026|FG003|Overall Study|Unclassified|0|||
129785259|NCT02527200|467182023|FG000|Overall Study|Lost to Follow-up|0|||
129785260|NCT02527200|467182024|FG001|Overall Study|Lost to Follow-up|0|||
129785261|NCT02527200|467182025|FG002|Overall Study|Lost to Follow-up|1|||
129577849|NCT01566721|466411944|FG001|Treatment Period|Other|2|||
129785262|NCT02527200|467182026|FG003|Overall Study|Lost to Follow-up|0|||
129785263|NCT00668733|467182027|FG000|Overall Study|Lost to Follow-up|2|||
129785264|NCT00668733|467182028|FG001|Overall Study|Lost to Follow-up|3|||
129785265|NCT00668733|467182027|FG000|Overall Study|Withdrawal by Subject|0|||
129785266|NCT00668733|467182028|FG001|Overall Study|Withdrawal by Subject|4|||
129785267|NCT01909791|467182029|FG000|Overall Study|Death|9|||
129785268|NCT01909791|467182030|FG001|Overall Study|Death|8|||
129785269|NCT01909791|467182031|FG002|Overall Study|Death|4|||
129785270|NCT01909791|467182029|FG000|Overall Study|Withdrawal by Subject|5|||
129785271|NCT01909791|467182030|FG001|Overall Study|Withdrawal by Subject|9|||
129785272|NCT01909791|467182031|FG002|Overall Study|Withdrawal by Subject|13|||
129785273|NCT01909791|467182029|FG000|Overall Study|Lost to Follow-up|5|||
129785274|NCT01909791|467182030|FG001|Overall Study|Lost to Follow-up|11|||
129577850|NCT01566721|466411943|FG000|Treatment Period|Lack of Compliance|5|||
129577851|NCT01566721|466411944|FG001|Treatment Period|Lack of Compliance|1|||
129577852|NCT01566721|466411943|FG000|Treatment Period|Adverse Event|100|||
129577853|NCT01566721|466411944|FG001|Treatment Period|Adverse Event|30|||
129577854|NCT01566721|466411943|FG000|Treatment Period|Pregnancy|1|||
129577855|NCT01566721|466411944|FG001|Treatment Period|Pregnancy|0|||
129577856|NCT01566721|466411943|FG000|Safety Follow-up|Physician Decision|6|||
129577857|NCT01566721|466411944|FG001|Safety Follow-up|Physician Decision|4|||
129577858|NCT01566721|466411943|FG000|Safety Follow-up|Lost to Follow-up|101|||
129577859|NCT01566721|466411944|FG001|Safety Follow-up|Lost to Follow-up|48|||
129577860|NCT01566721|466411943|FG000|Safety Follow-up|Withdrawal by Subject|155|||
129577861|NCT01566721|466411944|FG001|Safety Follow-up|Withdrawal by Subject|49|||
129577862|NCT01566721|466411943|FG000|Safety Follow-up|Death|28|||
129577863|NCT01566721|466411944|FG001|Safety Follow-up|Death|4|||
129577864|NCT01566721|466411943|FG000|Safety Follow-up|Non-compliance|7|||
129577865|NCT01566721|466411944|FG001|Safety Follow-up|Non-compliance|3|||
129577866|NCT01566721|466411943|FG000|Safety Follow-up|Protocol Violation|7|||
129577867|NCT01566721|466411944|FG001|Safety Follow-up|Protocol Violation|0|||
129577868|NCT01566721|466411943|FG000|Safety Follow-up|Site closure|2|||
129577869|NCT01566721|466411944|FG001|Safety Follow-up|Site closure|3|||
129577870|NCT01566721|466411943|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
129577871|NCT01566721|466411944|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
129577872|NCT01566721|466411943|FG000|Safety Follow-up|Missing|7|||
129577873|NCT01566721|466411944|FG001|Safety Follow-up|Missing|2|||
129577874|NCT01566721|466411943|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
129577875|NCT01566721|466411944|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
129577876|NCT01566721|466411943|FG000|Safety Follow-up|Sponsor decision|1|||
129577877|NCT01566721|466411944|FG001|Safety Follow-up|Sponsor decision|0|||
129577878|NCT01566721|466411943|FG000|Safety Follow-up|Adverse Event|8|||
129577879|NCT01566721|466411944|FG001|Safety Follow-up|Adverse Event|4|||
129577880|NCT01237054|466411945|FG000|Overall Study|imaging 10C0096|1|||
129577881|NCT02619682|466411946|FG000|Overall Study|Withdrawal by Subject|3|||
129577882|NCT02619682|466411946|FG000|Overall Study|Lack of Efficacy|8|||
129577883|NCT02619682|466411946|FG000|Overall Study|new secondary cancer|1|||
129577884|NCT02619682|466411946|FG000|Overall Study|post surgery complications|2|||
129577885|NCT00268203|466411949|FG000|Overall Study|Lost to Follow-up|92|||
129577886|NCT00268203|466411949|FG000|Overall Study|Withdrawal by Subject|9|||
129577887|NCT00268203|466411949|FG000|Overall Study|Received Other NHL Therapy|7|||
129577888|NCT00268203|466411949|FG000|Overall Study|Progressive Disease|359|||
129577889|NCT00268203|466411949|FG000|Overall Study|Death|84|||
129577890|NCT00268203|466411949|FG000|Overall Study|Reason Not Specified|34|||
129577891|NCT00268203|466411949|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
129577892|NCT00730691|466411956|FG000|Overall Study|Adverse Event|4|||
129577893|NCT00730691|466411957|FG001|Overall Study|Adverse Event|8|||
129577894|NCT00730691|466411958|FG002|Overall Study|Adverse Event|11|||
129577895|NCT00730691|466411959|FG003|Overall Study|Adverse Event|11|||
129577896|NCT00730691|466411960|FG004|Overall Study|Adverse Event|23|||
129577897|NCT00730691|466411956|FG000|Overall Study|Lack of Efficacy|4|||
129577898|NCT00730691|466411957|FG001|Overall Study|Lack of Efficacy|4|||
129577899|NCT00730691|466411958|FG002|Overall Study|Lack of Efficacy|2|||
129577900|NCT00730691|466411959|FG003|Overall Study|Lack of Efficacy|1|||
129577901|NCT00730691|466411960|FG004|Overall Study|Lack of Efficacy|1|||
129577902|NCT00730691|466411956|FG000|Overall Study|Non-compliance with Study Drug|6|||
129577903|NCT00730691|466411957|FG001|Overall Study|Non-compliance with Study Drug|1|||
129577904|NCT00730691|466411958|FG002|Overall Study|Non-compliance with Study Drug|6|||
129577905|NCT00730691|466411959|FG003|Overall Study|Non-compliance with Study Drug|3|||
129577906|NCT00730691|466411960|FG004|Overall Study|Non-compliance with Study Drug|3|||
129577907|NCT00730691|466411956|FG000|Overall Study|Protocol Deviations|3|||
129577908|NCT00730691|466411957|FG001|Overall Study|Protocol Deviations|5|||
129694847|NCT00468546|466839704|FG000|Week 24 Analysis|Due to clinical hold|1|||
129694848|NCT00468546|466839705|FG001|Week 24 Analysis|Due to clinical hold|0|||
129694849|NCT00468546|466839704|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
129694850|NCT00468546|466839705|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
129694851|NCT00468546|466839704|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
129577909|NCT00730691|466411958|FG002|Overall Study|Protocol Deviations|3|||
129577910|NCT00730691|466411959|FG003|Overall Study|Protocol Deviations|7|||
129577911|NCT00730691|466411960|FG004|Overall Study|Protocol Deviations|5|||
129577912|NCT00730691|466411956|FG000|Overall Study|Withdrawal of Consent|7|||
129577913|NCT00730691|466411957|FG001|Overall Study|Withdrawal of Consent|9|||
129694852|NCT00468546|466839705|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
129577914|NCT00730691|466411958|FG002|Overall Study|Withdrawal of Consent|3|||
129577915|NCT00730691|466411959|FG003|Overall Study|Withdrawal of Consent|6|||
129577916|NCT00730691|466411960|FG004|Overall Study|Withdrawal of Consent|3|||
129577917|NCT00730691|466411956|FG000|Overall Study|Lost to Follow-up|11|||
129577918|NCT00730691|466411957|FG001|Overall Study|Lost to Follow-up|8|||
129577919|NCT00730691|466411958|FG002|Overall Study|Lost to Follow-up|13|||
129694853|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
129577920|NCT00730691|466411959|FG003|Overall Study|Lost to Follow-up|15|||
129577921|NCT00730691|466411960|FG004|Overall Study|Lost to Follow-up|13|||
129577922|NCT00730691|466411956|FG000|Overall Study|Other|1|||
129577923|NCT00730691|466411957|FG001|Overall Study|Other|1|||
129577924|NCT00730691|466411958|FG002|Overall Study|Other|1|||
129577925|NCT00730691|466411959|FG003|Overall Study|Other|2|||
129577926|NCT00730691|466411960|FG004|Overall Study|Other|2|||
129577927|NCT02178787|466411961|FG000|Overall Study|Lost to Follow-up|1|||
129577928|NCT02178787|466411962|FG001|Overall Study|Lost to Follow-up|0|||
129577929|NCT02178787|466411961|FG000|Overall Study|Withdrawal by Subject|0|||
129577930|NCT02178787|466411962|FG001|Overall Study|Withdrawal by Subject|2|||
129577931|NCT02178787|466411961|FG000|Overall Study|No TCD window|3|||
129577932|NCT02178787|466411962|FG001|Overall Study|No TCD window|7|||
129577933|NCT02178787|466411961|FG000|Overall Study|Physician Decision|1|||
129577934|NCT02178787|466411962|FG001|Overall Study|Physician Decision|0|||
129577935|NCT02554890|466411963|FG000|Double-blind|Adverse Event|45|||
129577936|NCT02554890|466411964|FG001|Double-blind|Adverse Event|51|||
129577937|NCT02554890|466411963|FG000|Double-blind|Death|6|||
129577938|NCT02554890|466411964|FG001|Double-blind|Death|4|||
129577939|NCT02554890|466411963|FG000|Double-blind|Protocol Violation|1|||
129577940|NCT02554890|466411964|FG001|Double-blind|Protocol Violation|1|||
129577941|NCT02554890|466411963|FG000|Double-blind|Physician Decision|4|||
129577942|NCT02554890|466411964|FG001|Double-blind|Physician Decision|3|||
129577943|NCT02554890|466411963|FG000|Double-blind|Subject/Guardian decision|21|||
129577944|NCT02554890|466411964|FG001|Double-blind|Subject/Guardian decision|16|||
129577945|NCT02554890|466411963|FG000|Double-blind|Lost to Follow-up|7|||
129577946|NCT02554890|466411964|FG001|Double-blind|Lost to Follow-up|5|||
129577947|NCT02554890|466411963|FG000|Double-blind|Technical problems|1|||
129577948|NCT02554890|466411964|FG001|Double-blind|Technical problems|0|||
129577949|NCT02554890|466411963|FG000|Double-blind|Withdrawal by Subject|5|||
129577950|NCT02554890|466411964|FG001|Double-blind|Withdrawal by Subject|6|||
129577951|NCT02554890|466411963|FG000|Double-blind|Noncompliance with study treatment|6|||
129577952|NCT02554890|466411964|FG001|Double-blind|Noncompliance with study treatment|5|||
129577953|NCT02554890|466411963|FG000|Open-label|Adverse Event|0|||
129577954|NCT02554890|466411964|FG001|Open-label|Adverse Event|30|||
129577955|NCT02554890|466411963|FG000|Open-label|Death|0|||
129577956|NCT02554890|466411964|FG001|Open-label|Death|1|||
129577957|NCT02554890|466411963|FG000|Open-label|Physician Decision|0|||
129577958|NCT02554890|466411964|FG001|Open-label|Physician Decision|1|||
129577959|NCT02554890|466411963|FG000|Open-label|Subject/Guardian decision|0|||
129577960|NCT02554890|466411964|FG001|Open-label|Subject/Guardian decision|11|||
129577961|NCT02554890|466411963|FG000|Open-label|Lost to Follow-up|0|||
129577962|NCT02554890|466411964|FG001|Open-label|Lost to Follow-up|7|||
129577963|NCT02554890|466411963|FG000|Open-label|Technical problems|0|||
129577964|NCT02554890|466411964|FG001|Open-label|Technical problems|1|||
129577965|NCT02554890|466411963|FG000|Open-label|Withdrawal by Subject|0|||
129577966|NCT02554890|466411964|FG001|Open-label|Withdrawal by Subject|1|||
129577967|NCT03649477|466411965|FG000|Overall Study|Adverse Event|2|||
129577968|NCT03649477|466411966|FG001|Overall Study|Adverse Event|0|||
129577969|NCT03649477|466411967|FG002|Overall Study|Adverse Event|0|||
129577970|NCT02430480|466411970|FG000|Overall Study|Death|1|||
129694854|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
129577971|NCT02430480|466411970|FG000|Overall Study|Anesthesia concerns|1|||
129577972|NCT02430480|466411970|FG000|Overall Study|Progressed on treatment|1|||
129577973|NCT01097577|466411978|FG000|Overall Study|Adverse Event|0|||
129577974|NCT01097577|466411979|FG001|Overall Study|Adverse Event|1|||
129577975|NCT00316186|466411980|FG000|Overall Study|Adverse Event|6|||
129577976|NCT00316186|466411980|FG000|Overall Study|Disease Progression|4|||
129577977|NCT00316186|466411980|FG000|Overall Study|Lost to Follow-up|1|||
129577978|NCT00316186|466411980|FG000|Overall Study|Other|1|||
129577979|NCT04493684|466411983|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
129577980|NCT04493684|466411984|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577981|NCT04493684|466411985|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
129577982|NCT04493684|466411986|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577983|NCT04493684|466411987|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577984|NCT04493684|466411988|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
129577985|NCT04493684|466411989|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577986|NCT04493684|466411990|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129694855|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Death|1|||
129785275|NCT01909791|467182031|FG002|Overall Study|Lost to Follow-up|10|||
129785276|NCT01909791|467182029|FG000|Overall Study|Missed Visit|2|||
129785277|NCT01909791|467182030|FG001|Overall Study|Missed Visit|0|||
129785278|NCT01909791|467182031|FG002|Overall Study|Missed Visit|1|||
129785279|NCT01659554|467182032|FG000|Overall Study|Study Termination|4|||
129785280|NCT00945906|467182035|FG000|Overall Study|Withdrawal by Subject|1|||
129785281|NCT00945906|467182035|FG000|Overall Study|Did not want to return for last visit|2|||
129785282|NCT00945906|467182035|FG000|Overall Study|Unable to return for last visit|2|||
129785283|NCT00945906|467182035|FG000|Overall Study|Moved to another country|2|||
129785284|NCT03330002|467182038|FG000|Overall Study|Lost to Follow-up|15|||
129785285|NCT03330002|467182038|FG000|Overall Study|Death|7|||
129785286|NCT00635219|467182039|FG000|Overall Study|Adverse Event|12|||
129785287|NCT00635219|467182040|FG001|Overall Study|Adverse Event|10|||
129785288|NCT00635219|467182041|FG002|Overall Study|Adverse Event|18|||
129785289|NCT00635219|467182042|FG003|Overall Study|Adverse Event|15|||
129785290|NCT00635219|467182043|FG004|Overall Study|Adverse Event|19|||
129785291|NCT00635219|467182039|FG000|Overall Study|Lack of Efficacy|5|||
129785292|NCT00635219|467182040|FG001|Overall Study|Lack of Efficacy|6|||
129785293|NCT00635219|467182041|FG002|Overall Study|Lack of Efficacy|3|||
129785294|NCT00635219|467182042|FG003|Overall Study|Lack of Efficacy|4|||
129785295|NCT00635219|467182043|FG004|Overall Study|Lack of Efficacy|6|||
129785296|NCT00635219|467182039|FG000|Overall Study|Non-compliance With Study Product|0|||
129785297|NCT00635219|467182040|FG001|Overall Study|Non-compliance With Study Product|0|||
129785298|NCT00635219|467182041|FG002|Overall Study|Non-compliance With Study Product|0|||
129785299|NCT00635219|467182042|FG003|Overall Study|Non-compliance With Study Product|2|||
129785300|NCT00635219|467182043|FG004|Overall Study|Non-compliance With Study Product|1|||
129785301|NCT00635219|467182039|FG000|Overall Study|Protocol Violation|0|||
129785302|NCT00635219|467182040|FG001|Overall Study|Protocol Violation|2|||
129785303|NCT00635219|467182041|FG002|Overall Study|Protocol Violation|3|||
129785304|NCT00635219|467182042|FG003|Overall Study|Protocol Violation|2|||
129785305|NCT00635219|467182043|FG004|Overall Study|Protocol Violation|4|||
129785306|NCT00635219|467182039|FG000|Overall Study|Withdrawal of Consent|8|||
129785307|NCT00635219|467182040|FG001|Overall Study|Withdrawal of Consent|6|||
129577987|NCT04493684|466411991|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577988|NCT04493684|466411992|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577989|NCT04493684|466411993|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577990|NCT04493684|466411994|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577991|NCT04493684|466411995|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577992|NCT04493684|466411996|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577993|NCT04493684|466411997|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577994|NCT04493684|466411998|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577995|NCT04493684|466411999|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
129577996|NCT04493684|466411983|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
129577997|NCT04493684|466411984|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129577998|NCT04493684|466411985|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129577999|NCT04493684|466411986|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578000|NCT04493684|466411987|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129785308|NCT00635219|467182041|FG002|Overall Study|Withdrawal of Consent|8|||
129785309|NCT00635219|467182042|FG003|Overall Study|Withdrawal of Consent|11|||
129785310|NCT00635219|467182043|FG004|Overall Study|Withdrawal of Consent|8|||
129785311|NCT00635219|467182039|FG000|Overall Study|Lost to Follow-up|0|||
129785312|NCT00635219|467182040|FG001|Overall Study|Lost to Follow-up|0|||
129785313|NCT00635219|467182041|FG002|Overall Study|Lost to Follow-up|2|||
129785314|NCT00635219|467182042|FG003|Overall Study|Lost to Follow-up|0|||
129785315|NCT00635219|467182043|FG004|Overall Study|Lost to Follow-up|3|||
129785316|NCT00635219|467182039|FG000|Overall Study|Administrative or Other Reasons|0|||
129785317|NCT00635219|467182040|FG001|Overall Study|Administrative or Other Reasons|1|||
129785318|NCT00635219|467182041|FG002|Overall Study|Administrative or Other Reasons|1|||
129785319|NCT00635219|467182042|FG003|Overall Study|Administrative or Other Reasons|0|||
129785320|NCT00635219|467182043|FG004|Overall Study|Administrative or Other Reasons|1|||
129785321|NCT01598129|467182044|FG000|Overall Study|Disease progression|6|||
129785322|NCT01598129|467182044|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
129785323|NCT01598129|467182044|FG000|Overall Study|Withdrawal by Subject|1|||
129785324|NCT00505076|467182045|FG000|Overall Study|Adverse Event|1|||
129785325|NCT00505076|467182046|FG001|Overall Study|Adverse Event|0|||
129785326|NCT00505076|467182047|FG002|Overall Study|Adverse Event|1|||
129785327|NCT00505076|467182045|FG000|Overall Study|Protocol Violation|2|||
129785328|NCT00505076|467182046|FG001|Overall Study|Protocol Violation|1|||
129785329|NCT00505076|467182047|FG002|Overall Study|Protocol Violation|2|||
129785330|NCT00505076|467182045|FG000|Overall Study|Withdrawal by Subject|0|||
129785331|NCT00505076|467182046|FG001|Overall Study|Withdrawal by Subject|1|||
129785332|NCT00505076|467182047|FG002|Overall Study|Withdrawal by Subject|2|||
129785333|NCT00591318|467182050|FG000|Overall Study|Lack of Efficacy|2|||
129578001|NCT04493684|466411988|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578002|NCT04493684|466411989|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578003|NCT04493684|466411990|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578004|NCT04493684|466411991|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578005|NCT04493684|466411992|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578006|NCT04493684|466411993|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578007|NCT04493684|466411994|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578008|NCT04493684|466411995|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578009|NCT04493684|466411996|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578010|NCT04493684|466411997|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578011|NCT04493684|466411998|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578012|NCT04493684|466411999|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
129578013|NCT04493684|466411983|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578014|NCT04493684|466411984|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578015|NCT04493684|466411985|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578016|NCT04493684|466411986|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578017|NCT04493684|466411987|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578018|NCT04493684|466411988|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578019|NCT04493684|466411989|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
129578020|NCT04493684|466411990|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578021|NCT04493684|466411991|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578022|NCT04493684|466411992|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578023|NCT04493684|466411993|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578024|NCT04493684|466411994|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578025|NCT04493684|466411995|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578026|NCT04493684|466411996|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578027|NCT04493684|466411997|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578028|NCT04493684|466411998|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578029|NCT04493684|466411999|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
129578030|NCT04493684|466411983|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
129578031|NCT04493684|466411984|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578032|NCT04493684|466411985|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578033|NCT04493684|466411986|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578034|NCT04493684|466411987|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578035|NCT04493684|466411988|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578036|NCT04493684|466411989|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578037|NCT04493684|466411990|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578038|NCT04493684|466411991|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578039|NCT04493684|466411992|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578040|NCT04493684|466411993|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578041|NCT04493684|466411994|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578042|NCT04493684|466411995|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578043|NCT04493684|466411996|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578044|NCT04493684|466411997|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578045|NCT04493684|466411998|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578046|NCT04493684|466411999|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
129578047|NCT04493684|466411983|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578048|NCT04493684|466411984|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578049|NCT04493684|466411985|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578050|NCT04493684|466411986|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578051|NCT04493684|466411987|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578052|NCT04493684|466411988|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
129578053|NCT04493684|466411989|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578054|NCT04493684|466411990|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578055|NCT04493684|466411991|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578056|NCT04493684|466411992|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578057|NCT04493684|466411993|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578058|NCT04493684|466411994|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578059|NCT04493684|466411995|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578060|NCT04493684|466411996|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578061|NCT04493684|466411997|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578062|NCT04493684|466411998|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578063|NCT04493684|466411999|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
129578064|NCT04493684|466411983|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578065|NCT04493684|466411984|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578066|NCT04493684|466411985|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578067|NCT04493684|466411986|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578068|NCT04493684|466411987|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578069|NCT04493684|466411988|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578070|NCT04493684|466411989|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578071|NCT04493684|466411990|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578072|NCT04493684|466411991|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578073|NCT04493684|466411992|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578074|NCT04493684|466411993|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578075|NCT04493684|466411994|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
129578076|NCT04493684|466411995|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578077|NCT04493684|466411996|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578078|NCT04493684|466411997|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578079|NCT04493684|466411998|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578080|NCT04493684|466411999|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
129578081|NCT04493684|466411983|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578082|NCT04493684|466411984|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578083|NCT04493684|466411985|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578084|NCT04493684|466411986|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578085|NCT04493684|466411987|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578086|NCT04493684|466411988|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578087|NCT04493684|466411989|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578088|NCT04493684|466411990|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578089|NCT04493684|466411991|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578090|NCT04493684|466411992|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578091|NCT04493684|466411993|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578092|NCT04493684|466411994|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578093|NCT04493684|466411995|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578094|NCT04493684|466411996|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578095|NCT04493684|466411997|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578096|NCT04493684|466411998|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
129578097|NCT04493684|466411999|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
129578098|NCT04493684|466411983|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578099|NCT04493684|466411984|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578100|NCT04493684|466411985|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578101|NCT04493684|466411986|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578102|NCT04493684|466411987|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578103|NCT04493684|466411988|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578104|NCT04493684|466411989|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578105|NCT04493684|466411990|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578106|NCT04493684|466411991|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578107|NCT04493684|466411992|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578108|NCT04493684|466411993|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578109|NCT04493684|466411994|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578110|NCT04493684|466411995|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578111|NCT04493684|466411996|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578112|NCT04493684|466411997|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578113|NCT04493684|466411998|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
129578114|NCT04493684|466411999|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
129578115|NCT01963728|466412000|FG000|Overall Study|Study terminated early|0|||
129785334|NCT00591318|467182051|FG001|Overall Study|Lack of Efficacy|0|||
129785335|NCT00591318|467182050|FG000|Overall Study|Adverse Event|2|||
129578116|NCT01963728|466412001|FG001|Overall Study|Study terminated early|1|||
129578117|NCT05152576|466412004|FG000|Overall Study|Lost to Follow-up|3|||
129578118|NCT05152576|466412005|FG001|Overall Study|Lost to Follow-up|0|||
129578119|NCT05152576|466412006|FG002|Overall Study|Lost to Follow-up|0|||
129578120|NCT05152576|466412007|FG003|Overall Study|Lost to Follow-up|1|||
129578121|NCT05152576|466412004|FG000|Overall Study|Withdrawal by Subject|0|||
129578122|NCT05152576|466412005|FG001|Overall Study|Withdrawal by Subject|1|||
129578123|NCT05152576|466412006|FG002|Overall Study|Withdrawal by Subject|0|||
129578124|NCT05152576|466412007|FG003|Overall Study|Withdrawal by Subject|1|||
129578125|NCT05152576|466412004|FG000|Overall Study|Other|2|||
129578126|NCT05152576|466412005|FG001|Overall Study|Other|0|||
129578127|NCT05152576|466412006|FG002|Overall Study|Other|0|||
129578128|NCT05152576|466412007|FG003|Overall Study|Other|0|||
129578129|NCT04115293|466414061|FG000|Overall Study|Adverse Event|0|||
129578130|NCT04115293|466414062|FG001|Overall Study|Adverse Event|2|||
129578131|NCT04115293|466414061|FG000|Overall Study|Withdrawal by Subject|2|||
129578132|NCT04115293|466414062|FG001|Overall Study|Withdrawal by Subject|1|||
129578133|NCT04115293|466414061|FG000|Overall Study|Physician Decision|1|||
129578134|NCT04115293|466414062|FG001|Overall Study|Physician Decision|0|||
129578135|NCT04115293|466414061|FG000|Overall Study|Death|1|||
129578136|NCT04115293|466414062|FG001|Overall Study|Death|1|||
129578137|NCT00001703|466414063|FG000|Overall Study|progressed disease|2|||
129578138|NCT00001703|466414063|FG000|Overall Study|No evidence of disease|1|||
129578139|NCT00001703|466414063|FG000|Overall Study|recurrent disease|2|||
129578140|NCT02057835|466414064|FG000|Overall Study|Withdrawal by Subject|0|||
129578141|NCT02057835|466414065|FG001|Overall Study|Withdrawal by Subject|2|||
129578142|NCT02057835|466414066|FG002|Overall Study|Withdrawal by Subject|0|||
129578143|NCT02057835|466414067|FG003|Overall Study|Withdrawal by Subject|0|||
129578144|NCT02057835|466414068|FG004|Overall Study|Withdrawal by Subject|0|||
129578145|NCT02057835|466414069|FG005|Overall Study|Withdrawal by Subject|0|||
129578146|NCT02057835|466414070|FG006|Overall Study|Withdrawal by Subject|0|||
129578147|NCT02057835|466414071|FG007|Overall Study|Withdrawal by Subject|0|||
129578148|NCT02057835|466414072|FG008|Overall Study|Withdrawal by Subject|0|||
129578149|NCT02057835|466414073|FG009|Overall Study|Withdrawal by Subject|0|||
129578150|NCT01660243|466414074|FG000|Overall Study|Adverse Event|1|||
129578151|NCT01660243|466414075|FG001|Overall Study|Adverse Event|0|||
129578152|NCT01660243|466414076|FG002|Overall Study|Adverse Event|1|||
129578153|NCT01660243|466414077|FG003|Overall Study|Adverse Event|0|||
129578154|NCT01660243|466414074|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
129578155|NCT01660243|466414075|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
129578156|NCT01660243|466414076|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
129578157|NCT01660243|466414077|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
129578158|NCT01660243|466414074|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
129578159|NCT01660243|466414075|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
129578160|NCT01660243|466414076|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
129578161|NCT01660243|466414077|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
129578162|NCT01660243|466414074|FG000|Overall Study|Randomization error|0|||
129578163|NCT01660243|466414075|FG001|Overall Study|Randomization error|0|||
129578164|NCT01660243|466414076|FG002|Overall Study|Randomization error|0|||
129578165|NCT01660243|466414077|FG003|Overall Study|Randomization error|1|||
129578166|NCT00712959|466414084|FG000|Overall Study|Protocol Violation|3|||
129578167|NCT00712959|466414085|FG001|Overall Study|Protocol Violation|1|||
129578168|NCT00712959|466414084|FG000|Overall Study|Lost to Follow-up|13|||
129578169|NCT00712959|466414085|FG001|Overall Study|Lost to Follow-up|2|||
129578170|NCT00712959|466414084|FG000|Overall Study|Withdrawal by Subject|3|||
129578171|NCT00712959|466414085|FG001|Overall Study|Withdrawal by Subject|0|||
129578172|NCT00508651|466414086|FG000|Overall Study|Lost to Follow-up|3|||
129578173|NCT00508651|466414087|FG001|Overall Study|Lost to Follow-up|1|||
129578174|NCT00508651|466414086|FG000|Overall Study|Withdrawal by Subject|1|||
129578175|NCT00508651|466414087|FG001|Overall Study|Withdrawal by Subject|1|||
129578176|NCT02328040|466414089|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
129578177|NCT02328040|466414090|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
129578178|NCT03121586|466414095|FG000|Overall Study|Study terminated by sponsor|0|||
129578179|NCT03121586|466414096|FG001|Overall Study|Study terminated by sponsor|0|||
129578180|NCT03121586|466414097|FG002|Overall Study|Study terminated by sponsor|99|||
129578181|NCT03121586|466414095|FG000|Overall Study|Withdrawal by Subject|37|||
129578182|NCT03121586|466414096|FG001|Overall Study|Withdrawal by Subject|14|||
129578183|NCT03121586|466414097|FG002|Overall Study|Withdrawal by Subject|9|||
129578184|NCT03121586|466414095|FG000|Overall Study|Not further specified|6|||
129578185|NCT03121586|466414096|FG001|Overall Study|Not further specified|11|||
129578186|NCT03121586|466414097|FG002|Overall Study|Not further specified|10|||
129578187|NCT03121586|466414095|FG000|Overall Study|Adverse Event|16|||
129578188|NCT03121586|466414096|FG001|Overall Study|Adverse Event|5|||
129578189|NCT03121586|466414097|FG002|Overall Study|Adverse Event|6|||
129578190|NCT03121586|466414095|FG000|Overall Study|Protocol Violation|0|||
129578191|NCT03121586|466414096|FG001|Overall Study|Protocol Violation|5|||
129578192|NCT03121586|466414097|FG002|Overall Study|Protocol Violation|0|||
129578193|NCT03121586|466414095|FG000|Overall Study|Lack of Efficacy|3|||
129578194|NCT03121586|466414096|FG001|Overall Study|Lack of Efficacy|3|||
129578195|NCT03121586|466414097|FG002|Overall Study|Lack of Efficacy|1|||
129578196|NCT03121586|466414095|FG000|Overall Study|Physician Decision|2|||
129578197|NCT03121586|466414096|FG001|Overall Study|Physician Decision|2|||
129578198|NCT03121586|466414097|FG002|Overall Study|Physician Decision|0|||
129578199|NCT03121586|466414095|FG000|Overall Study|Noncompliance with study drug|5|||
129578200|NCT03121586|466414096|FG001|Overall Study|Noncompliance with study drug|3|||
129578201|NCT03121586|466414097|FG002|Overall Study|Noncompliance with study drug|5|||
129578202|NCT03121586|466414095|FG000|Overall Study|Lost to Follow-up|4|||
129578203|NCT03121586|466414096|FG001|Overall Study|Lost to Follow-up|2|||
129578204|NCT03121586|466414097|FG002|Overall Study|Lost to Follow-up|0|||
129578205|NCT03121586|466414095|FG000|Overall Study|Death|2|||
129578206|NCT03121586|466414096|FG001|Overall Study|Death|0|||
129578207|NCT03121586|466414097|FG002|Overall Study|Death|0|||
129578208|NCT06381102|466414098|FG000|Washout 5 Days|Withdrawal by Subject|0|||
129578209|NCT06381102|466414099|FG001|Washout 5 Days|Withdrawal by Subject|2|||
129578210|NCT04278560|466414100|FG000|Overall Study|Adverse Event|1|||
129578211|NCT04278560|466414101|FG001|Overall Study|Adverse Event|2|||
129578212|NCT04278560|466414100|FG000|Overall Study|Withdrawal by Subject|0|||
129578213|NCT04278560|466414101|FG001|Overall Study|Withdrawal by Subject|1|||
129578214|NCT02832063|466414102|FG000|Overall Study|Adverse Event|2|||
129578215|NCT02832063|466414103|FG001|Overall Study|Adverse Event|1|||
129578216|NCT02832063|466414102|FG000|Overall Study|Physician Decision|5|||
129578217|NCT02832063|466414103|FG001|Overall Study|Physician Decision|7|||
129578218|NCT02832063|466414102|FG000|Overall Study|Lost to Follow-up|15|||
129578219|NCT02832063|466414103|FG001|Overall Study|Lost to Follow-up|8|||
129578220|NCT02832063|466414102|FG000|Overall Study|Withdrawal by Subject|10|||
129578221|NCT02832063|466414103|FG001|Overall Study|Withdrawal by Subject|21|||
129578222|NCT02832063|466414102|FG000|Overall Study|Other|2|||
129578223|NCT02832063|466414103|FG001|Overall Study|Other|1|||
129578224|NCT04408794|466414104|FG000|Overall Study|Adverse Event|43|||
129578225|NCT04408794|466414104|FG000|Overall Study|Infrequent study drug usage|43|||
129578226|NCT04408794|466414104|FG000|Overall Study|Lack of Efficacy|61|||
129578227|NCT04408794|466414104|FG000|Overall Study|Lost to Follow-up|33|||
129578228|NCT04408794|466414104|FG000|Overall Study|Non-compliance|6|||
129578229|NCT04408794|466414104|FG000|Overall Study|Physician Decision|1|||
129578230|NCT04408794|466414104|FG000|Overall Study|Pregnancy|6|||
129578231|NCT04408794|466414104|FG000|Overall Study|Protocol Deviation|9|||
129578232|NCT04408794|466414104|FG000|Overall Study|Sheehan-STS Result|1|||
129578233|NCT04408794|466414104|FG000|Overall Study|Withdrawal by Subject|57|||
129578234|NCT04408794|466414104|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
129578235|NCT04408794|466414104|FG000|Overall Study|Never Treated Migraine|5|||
129578236|NCT02294786|466414109|FG000|Overall Study|Withdrawal by Subject|0|||
129578237|NCT02294786|466414110|FG001|Overall Study|Withdrawal by Subject|1|||
129578238|NCT02294786|466414109|FG000|Overall Study|Physician Decision|6|||
129578239|NCT02294786|466414110|FG001|Overall Study|Physician Decision|7|||
129578240|NCT02294786|466414109|FG000|Overall Study|Lost to Follow-up|1|||
129578241|NCT02294786|466414110|FG001|Overall Study|Lost to Follow-up|2|||
129578242|NCT02294786|466414109|FG000|Overall Study|Protocol Violation|1|||
129578243|NCT02294786|466414110|FG001|Overall Study|Protocol Violation|0|||
129578244|NCT02294786|466414109|FG000|Overall Study|Adverse Event|1|||
129578245|NCT02294786|466414110|FG001|Overall Study|Adverse Event|1|||
129578246|NCT02294786|466414109|FG000|Overall Study|Death|2|||
129578247|NCT02294786|466414110|FG001|Overall Study|Death|3|||
129578248|NCT01778010|466414111|FG000|Overall Study|Withdrawal by Subject|2|||
129578249|NCT01778010|466414111|FG000|Overall Study|abnormal ECG before meds|1|||
129578250|NCT01778010|466414111|FG000|Overall Study|Arrested|1|||
129578251|NCT01778010|466414111|FG000|Overall Study|rash while on placebo|1|||
129578252|NCT01518972|466414112|FG000|Overall Study|Lost to Follow-up|2|||
129578253|NCT01518972|466414113|FG001|Overall Study|Lost to Follow-up|1|||
129578254|NCT01518972|466414112|FG000|Overall Study|Withdrawal by Subject|1|||
129578255|NCT01518972|466414113|FG001|Overall Study|Withdrawal by Subject|0|||
129578256|NCT01518972|466414112|FG000|Overall Study|Moved from area|1|||
129578257|NCT01518972|466414113|FG001|Overall Study|Moved from area|0|||
129578258|NCT01518972|466414112|FG000|Overall Study|Transportation problems|1|||
129578259|NCT01518972|466414113|FG001|Overall Study|Transportation problems|0|||
129694856|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Death|0|||
129694857|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
129578260|NCT01518972|466414112|FG000|Overall Study|Exclusionary medical condition|1|||
129694858|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
129694859|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
129578261|NCT01518972|466414113|FG001|Overall Study|Exclusionary medical condition|0|||
129578262|NCT01518972|466414112|FG000|Overall Study|Missed safety visits|0|||
129578263|NCT01518972|466414113|FG001|Overall Study|Missed safety visits|1|||
129578264|NCT01518972|466414112|FG000|Overall Study|Exclusionary medication|0|||
129578265|NCT01518972|466414113|FG001|Overall Study|Exclusionary medication|1|||
129578266|NCT01518972|466414112|FG000|Overall Study|Declined medication starting on day 12|0|||
129578267|NCT01518972|466414113|FG001|Overall Study|Declined medication starting on day 12|1|||
129578268|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
129694860|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
129578269|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
129578270|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
129578271|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
129578272|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
129578273|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
129578274|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
129578275|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
129578276|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
129578277|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
129578278|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
129578279|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
129578280|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
129578281|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
129578282|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
129578283|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
129578284|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
129578285|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
129578286|NCT01667679|466414114|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
129578287|NCT01667679|466414115|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
129578288|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
129578289|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
129578290|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
129578291|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
129578292|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
129578293|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
129578294|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
129578295|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
129578296|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
129578297|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
129578298|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
129578299|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
129578300|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
129578301|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
129578302|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
129578303|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
129578304|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
129578305|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
129578306|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
129578307|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
129578308|NCT01667679|466414114|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
129578309|NCT01667679|466414115|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
129578310|NCT02159183|466414116|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
129578311|NCT02159183|466414117|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
129578312|NCT02159183|466414116|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
129578313|NCT02159183|466414117|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
129578314|NCT02159183|466414116|FG000|Analysis After the 36 Months Follow-up|Death|0|||
129578315|NCT02159183|466414117|FG001|Analysis After the 36 Months Follow-up|Death|1|||
129578316|NCT02159183|466414116|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
129578317|NCT02159183|466414117|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
129578318|NCT02159183|466414116|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
129578319|NCT02159183|466414117|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
129578320|NCT01294917|466414121|FG000|Overall Study|Relocation|5|||
129578321|NCT01294917|466414121|FG000|Overall Study|Inconvenience|1|||
129578322|NCT02519348|466414122|FG000|Overall Study|Death|31|||
129578323|NCT02519348|466414123|FG001|Overall Study|Death|74|||
129578324|NCT02519348|466414124|FG002|Overall Study|Death|47|||
129578325|NCT02519348|466414125|FG003|Overall Study|Death|54|||
129578326|NCT02519348|466414126|FG004|Overall Study|Death|63|||
129694861|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
129694862|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
129578327|NCT02519348|466414127|FG005|Overall Study|Death|18|||
129694863|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
129578328|NCT02519348|466414128|FG006|Overall Study|Death|2|||
129578329|NCT02519348|466414129|FG007|Overall Study|Death|5|||
129578330|NCT02519348|466414130|FG008|Overall Study|Death|5|||
129578331|NCT02519348|466414122|FG000|Overall Study|Withdrawal by Subject|4|||
129694864|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
129694865|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
129785336|NCT00591318|467182051|FG001|Overall Study|Adverse Event|0|||
129578332|NCT02519348|466414123|FG001|Overall Study|Withdrawal by Subject|7|||
129578333|NCT02519348|466414124|FG002|Overall Study|Withdrawal by Subject|4|||
129578334|NCT02519348|466414125|FG003|Overall Study|Withdrawal by Subject|3|||
129578335|NCT02519348|466414126|FG004|Overall Study|Withdrawal by Subject|3|||
129578336|NCT02519348|466414127|FG005|Overall Study|Withdrawal by Subject|2|||
129578337|NCT02519348|466414128|FG006|Overall Study|Withdrawal by Subject|0|||
129578338|NCT02519348|466414129|FG007|Overall Study|Withdrawal by Subject|0|||
129578339|NCT02519348|466414130|FG008|Overall Study|Withdrawal by Subject|1|||
129578340|NCT02519348|466414122|FG000|Overall Study|Lost to Follow-up|0|||
129578341|NCT02519348|466414123|FG001|Overall Study|Lost to Follow-up|0|||
129578342|NCT02519348|466414124|FG002|Overall Study|Lost to Follow-up|1|||
129785337|NCT04224688|467182057|FG000|Overall Study|Withdrawal by Subject|1|||
129785338|NCT04224688|467182058|FG001|Overall Study|Withdrawal by Subject|3|||
129785339|NCT04224688|467182057|FG000|Overall Study|Lack of Efficacy|1|||
129785340|NCT04224688|467182058|FG001|Overall Study|Lack of Efficacy|1|||
129785341|NCT04224688|467182057|FG000|Overall Study|Adverse event, not fatal|0|||
129785342|NCT04224688|467182058|FG001|Overall Study|Adverse event, not fatal|2|||
129785343|NCT04224688|467182057|FG000|Overall Study|COVID-19|0|||
129785344|NCT04224688|467182058|FG001|Overall Study|COVID-19|1|||
129785345|NCT02745145|467182061|FG000|Overall Study|Adverse Event|1|||
129785346|NCT02745145|467182062|FG001|Overall Study|Adverse Event|0|||
129785347|NCT02745145|467182063|FG002|Overall Study|Adverse Event|0|||
129785348|NCT02745145|467182061|FG000|Overall Study|Death|0|||
129578343|NCT02519348|466414125|FG003|Overall Study|Lost to Follow-up|0|||
129578344|NCT02519348|466414126|FG004|Overall Study|Lost to Follow-up|2|||
129578345|NCT02519348|466414127|FG005|Overall Study|Lost to Follow-up|1|||
129785349|NCT02745145|467182062|FG001|Overall Study|Death|1|||
129694866|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
129694867|NCT00468546|466839704|FG000|Week 24 to Week 104 Analysis|Other|17|||
129694868|NCT00468546|466839705|FG001|Week 24 to Week 104 Analysis|Other|14|||
129694869|NCT00472641|466839706|FG000|Overall Study|Lack of Efficacy|3|||
129694870|NCT00472641|466839706|FG000|Overall Study|Adverse Event|3|||
129694871|NCT00472641|466839706|FG000|Overall Study|Lost to Follow-up|1|||
129694872|NCT00478140|466839707|FG000|Overall Study|Clinical Disease Progression|1|||
129694873|NCT01189227|466839710|FG000|Overall Study|Study terminated due to low accrual|6|||
129694874|NCT01189227|466839711|FG001|Overall Study|Study terminated due to low accrual|3|||
129694875|NCT03211832|466839712|FG000|Overall Study|No longer with agency|32|||
129694876|NCT03211832|466839713|FG001|Overall Study|No longer with agency|49|||
129694877|NCT03211832|466839714|FG002|Overall Study|No longer with agency|30|||
129694878|NCT03211832|466839712|FG000|Overall Study|Declined survey|3|||
129694879|NCT03211832|466839713|FG001|Overall Study|Declined survey|3|||
129694880|NCT03211832|466839714|FG002|Overall Study|Declined survey|2|||
129694881|NCT03211832|466839712|FG000|Overall Study|Not available during data collection|1|||
129694882|NCT03211832|466839713|FG001|Overall Study|Not available during data collection|0|||
129694883|NCT03211832|466839714|FG002|Overall Study|Not available during data collection|2|||
129694884|NCT02489045|466839722|FG000|Overall Study|unable to collect usable data|53|||
129694885|NCT02489045|466839722|FG000|Follow-up|Lost to Follow-up|10|||
129694886|NCT03111732|466839725|FG000|Overall Study|Enrolled in different study|1|||
129694887|NCT03111732|466839725|FG000|Overall Study|Progressive disease|3|||
129694888|NCT03111732|466839725|FG000|Overall Study|Withdrawal by Subject|1|||
129694889|NCT02151604|466839727|FG000|Overall Study|Lost to Follow-up|3|||
129694890|NCT02151604|466839727|FG000|Overall Study|Withdrawal by Subject|2|||
129578346|NCT02519348|466414128|FG006|Overall Study|Lost to Follow-up|1|||
129578347|NCT02519348|466414129|FG007|Overall Study|Lost to Follow-up|0|||
129578348|NCT02519348|466414130|FG008|Overall Study|Lost to Follow-up|0|||
129578349|NCT02519348|466414122|FG000|Overall Study|Other|0|||
129578350|NCT02519348|466414123|FG001|Overall Study|Other|3|||
129578351|NCT02519348|466414124|FG002|Overall Study|Other|0|||
129578352|NCT02519348|466414125|FG003|Overall Study|Other|0|||
129578353|NCT02519348|466414126|FG004|Overall Study|Other|1|||
129578354|NCT02519348|466414127|FG005|Overall Study|Other|0|||
129578355|NCT02519348|466414128|FG006|Overall Study|Other|0|||
129578356|NCT02519348|466414129|FG007|Overall Study|Other|0|||
129578357|NCT02519348|466414130|FG008|Overall Study|Other|0|||
129578358|NCT02519348|466414122|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
129578359|NCT02519348|466414123|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
129578360|NCT02519348|466414124|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
129578361|NCT02519348|466414125|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
129578362|NCT02519348|466414126|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
129578363|NCT02519348|466414127|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
129578364|NCT02519348|466414128|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
129578365|NCT02519348|466414129|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
129578366|NCT02519348|466414130|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
129578367|NCT01444378|466414131|FG000|Overall Study|Lost to Follow-up|1|||
129578368|NCT01444378|466414131|FG000|Overall Study|Withdrawal by Subject|1|||
129578369|NCT01444378|466414131|FG000|Overall Study|Death|3|||
129578370|NCT01444378|466414131|FG000|Overall Study|Administrative Closure Of The Study|2|||
129578371|NCT01444378|466414131|FG000|Overall Study|Missed Visits|10|||
129578372|NCT00927069|466414132|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
129578373|NCT00927069|466414133|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
129578374|NCT00927069|466414134|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
129578375|NCT00927069|466414135|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
129578376|NCT00927069|466414132|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
129578377|NCT00927069|466414133|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
129694891|NCT02151604|466839727|FG000|Overall Study|Physician Decision|3|||
129578378|NCT00927069|466414134|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
129578379|NCT00927069|466414135|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
129694892|NCT02151604|466839727|FG000|Overall Study|Death|1|||
129578380|NCT00927069|466414132|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
129578381|NCT00927069|466414133|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
129578382|NCT00927069|466414134|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
129578383|NCT00927069|466414135|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
129578384|NCT00927069|466414132|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
129578385|NCT00927069|466414133|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
129694893|NCT04495478|466839728|FG000|Overall Study|Withdrawal by Subject|0|||
129694894|NCT04495478|466839729|FG001|Overall Study|Withdrawal by Subject|0|||
129578386|NCT00927069|466414134|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
129578387|NCT00927069|466414135|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
129578388|NCT00927069|466414132|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
129578389|NCT00927069|466414133|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
129578390|NCT00927069|466414134|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
129578391|NCT00927069|466414135|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
129578392|NCT02911792|466414136|FG000|Overall Study|Lost to Follow-up|3|||
129578393|NCT02911792|466414137|FG001|Overall Study|Lost to Follow-up|3|||
129578394|NCT02911792|466414138|FG002|Overall Study|Lost to Follow-up|3|||
129578395|NCT02911792|466414139|FG003|Overall Study|Lost to Follow-up|3|||
129578396|NCT01244620|466414142|FG000|Overall Study|Study terminated|4|||
129578397|NCT01244620|466414143|FG001|Overall Study|Study terminated|4|||
129578398|NCT01244620|466414144|FG002|Overall Study|Study terminated|4|||
129578399|NCT01244620|466414145|FG003|Overall Study|Study terminated|4|||
129578400|NCT02321098|466414147|FG000|12 Weeks Treament|Lost to Follow-up|1|||
129578401|NCT02321098|466414148|FG001|12 Weeks Treament|Lost to Follow-up|1|||
129578402|NCT02321098|466414149|FG002|12 Weeks Treament|Lost to Follow-up|0|||
129578403|NCT02321098|466414147|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
129578404|NCT02321098|466414148|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
129578405|NCT02321098|466414149|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
129578406|NCT02321098|466414147|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
129578407|NCT02321098|466414148|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
129578408|NCT02321098|466414149|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
129578409|NCT02321098|466414147|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
129578410|NCT02321098|466414148|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
129578411|NCT02321098|466414149|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
129578412|NCT01663233|466414150|FG000|Overall Study|Withdrawal by Subject|3|||
129578413|NCT01663233|466414151|FG001|Overall Study|Withdrawal by Subject|2|||
129578414|NCT01663233|466414150|FG000|Overall Study|Protocol Deviation|1|||
129578415|NCT01663233|466414151|FG001|Overall Study|Protocol Deviation|4|||
129578416|NCT01663233|466414150|FG000|Overall Study|Lost to Follow-up|0|||
129578417|NCT01663233|466414151|FG001|Overall Study|Lost to Follow-up|1|||
129785350|NCT02745145|467182063|FG002|Overall Study|Death|0|||
129785351|NCT02745145|467182061|FG000|Overall Study|Progressive disease|0|||
129785352|NCT02745145|467182062|FG001|Overall Study|Progressive disease|0|||
129785353|NCT02745145|467182063|FG002|Overall Study|Progressive disease|1|||
129785354|NCT02745145|467182061|FG000|Overall Study|Withdrew consent|1|||
129578418|NCT02558491|466414152|FG000|First Invention|Withdrawal by Subject|3|||
129578419|NCT02558491|466414153|FG001|First Invention|Withdrawal by Subject|1|||
129578420|NCT02558491|466414152|FG000|First Invention|Data collection issues|1|||
129578421|NCT02558491|466414153|FG001|First Invention|Data collection issues|0|||
129578422|NCT02558491|466414152|FG000|First Invention|Stopping criteria|0|||
129578423|NCT02558491|466414153|FG001|First Invention|Stopping criteria|1|||
129578424|NCT02558491|466414152|FG000|First Invention|Changed parameters during trial|1|||
129578425|NCT02558491|466414153|FG001|First Invention|Changed parameters during trial|0|||
129578426|NCT02558491|466414152|FG000|Second Intervention|Withdrawal by Subject|1|||
129578427|NCT02558491|466414153|FG001|Second Intervention|Withdrawal by Subject|0|||
129578428|NCT02558491|466414152|FG000|Second Intervention|Stopping Criteria|1|||
129578429|NCT02558491|466414153|FG001|Second Intervention|Stopping Criteria|0|||
129785355|NCT02745145|467182062|FG001|Overall Study|Withdrew consent|1|||
129578430|NCT00834431|466414156|FG000|First Intervention|Adverse Event|0|||
129578431|NCT00834431|466414157|FG001|First Intervention|Adverse Event|1|||
129578432|NCT00834431|466414156|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129578433|NCT00834431|466414157|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129578434|NCT05630885|466414161|FG000|Study Completion|Took prohibited medications|2|||
129578435|NCT05630885|466414162|FG001|Study Completion|Took prohibited medications|0|||
129578436|NCT05630885|466414161|FG000|Study Completion|Non-compliance with study drug|1|||
129578437|NCT05630885|466414162|FG001|Study Completion|Non-compliance with study drug|0|||
129578438|NCT05630885|466414161|FG000|Study Completion|Adverse Event|1|||
129578439|NCT05630885|466414162|FG001|Study Completion|Adverse Event|0|||
129578440|NCT05630885|466414161|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
129578441|NCT05630885|466414162|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
129578442|NCT05630885|466414161|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
129578443|NCT05630885|466414162|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
129578444|NCT06539676|466414163|FG000|Overall Study|Early study termination|1|||
129578445|NCT06539676|466414164|FG001|Overall Study|Early study termination|0|||
129578446|NCT06539676|466414165|FG002|Overall Study|Early study termination|6|||
129578447|NCT02645409|466414166|FG000|Overall Study|Withdrawal by Subject|3|||
129578448|NCT02645409|466414167|FG001|Overall Study|Withdrawal by Subject|0|||
129578449|NCT02645409|466414166|FG000|Overall Study|Physician Decision|1|||
129578450|NCT02645409|466414167|FG001|Overall Study|Physician Decision|0|||
129578451|NCT03419403|466414168|FG000|Overall Study|Withdrawal by Subject|5|||
129578452|NCT03419403|466414169|FG001|Overall Study|Withdrawal by Subject|2|||
129578453|NCT03419403|466414170|FG002|Overall Study|Withdrawal by Subject|5|||
129578454|NCT03419403|466414171|FG003|Overall Study|Withdrawal by Subject|1|||
129578455|NCT03419403|466414168|FG000|Overall Study|Progressive disease (per protocol)|0|||
129578456|NCT03419403|466414169|FG001|Overall Study|Progressive disease (per protocol)|2|||
129578457|NCT03419403|466414170|FG002|Overall Study|Progressive disease (per protocol)|2|||
129578458|NCT03419403|466414171|FG003|Overall Study|Progressive disease (per protocol)|0|||
129578459|NCT03419403|466414168|FG000|Overall Study|Other, not specified|6|||
129578460|NCT03419403|466414169|FG001|Overall Study|Other, not specified|4|||
129578461|NCT03419403|466414170|FG002|Overall Study|Other, not specified|5|||
129578462|NCT03419403|466414171|FG003|Overall Study|Other, not specified|1|||
129578463|NCT03419403|466414168|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
129578464|NCT03419403|466414169|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
129578465|NCT03419403|466414170|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
129578466|NCT03419403|466414171|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
129578467|NCT02089685|466414176|FG000|Overall Study|Adverse Event|1|||
129578468|NCT02089685|466414177|FG001|Overall Study|Adverse Event|0|||
129578469|NCT02089685|466414178|FG002|Overall Study|Adverse Event|0|||
129578470|NCT02089685|466414179|FG003|Overall Study|Adverse Event|0|||
129578471|NCT02089685|466414180|FG004|Overall Study|Adverse Event|1|||
129578472|NCT02089685|466414181|FG005|Overall Study|Adverse Event|0|||
129578473|NCT02089685|466414176|FG000|Overall Study|Clinical Progression|4|||
129578474|NCT02089685|466414177|FG001|Overall Study|Clinical Progression|0|||
129578475|NCT02089685|466414178|FG002|Overall Study|Clinical Progression|0|||
129578476|NCT02089685|466414179|FG003|Overall Study|Clinical Progression|5|||
129578477|NCT02089685|466414180|FG004|Overall Study|Clinical Progression|1|||
129578478|NCT02089685|466414181|FG005|Overall Study|Clinical Progression|2|||
129578479|NCT02089685|466414176|FG000|Overall Study|Excluded Medication|1|||
129578480|NCT02089685|466414177|FG001|Overall Study|Excluded Medication|0|||
129578481|NCT02089685|466414178|FG002|Overall Study|Excluded Medication|0|||
129694895|NCT04495478|466839730|FG002|Overall Study|Withdrawal by Subject|0|||
129694896|NCT04495478|466839731|FG003|Overall Study|Withdrawal by Subject|1|||
129694897|NCT04495478|466839732|FG004|Overall Study|Withdrawal by Subject|0|||
129694898|NCT04495478|466839733|FG005|Overall Study|Withdrawal by Subject|0|||
129694899|NCT04495478|466839734|FG006|Overall Study|Withdrawal by Subject|0|||
129694900|NCT04495478|466839728|FG000|Overall Study|Physician Decision|0|||
129694901|NCT04495478|466839729|FG001|Overall Study|Physician Decision|1|||
129694902|NCT04495478|466839730|FG002|Overall Study|Physician Decision|0|||
129694903|NCT04495478|466839731|FG003|Overall Study|Physician Decision|0|||
129694904|NCT04495478|466839732|FG004|Overall Study|Physician Decision|1|||
129694905|NCT04495478|466839733|FG005|Overall Study|Physician Decision|0|||
129694906|NCT04495478|466839734|FG006|Overall Study|Physician Decision|0|||
129694907|NCT03004183|466841626|FG000|Overall Study|Adverse Event|7|||
129694908|NCT03004183|466841626|FG000|Overall Study|Lost to Follow-up|1|||
129578482|NCT02089685|466414179|FG003|Overall Study|Excluded Medication|11|||
129578483|NCT02089685|466414180|FG004|Overall Study|Excluded Medication|2|||
129578484|NCT02089685|466414181|FG005|Overall Study|Excluded Medication|1|||
129578485|NCT02089685|466414176|FG000|Overall Study|Progressive disease|13|||
129578486|NCT02089685|466414177|FG001|Overall Study|Progressive disease|10|||
129578487|NCT02089685|466414178|FG002|Overall Study|Progressive disease|3|||
129578488|NCT02089685|466414179|FG003|Overall Study|Progressive disease|51|||
129578489|NCT02089685|466414180|FG004|Overall Study|Progressive disease|17|||
129578490|NCT02089685|466414181|FG005|Overall Study|Progressive disease|12|||
129694909|NCT03004183|466841626|FG000|Overall Study|Physician Decision|40|||
129694910|NCT03004183|466841626|FG000|Overall Study|Withdrawal by Subject|1|||
129578491|NCT02089685|466414176|FG000|Overall Study|Follow up ended by sponsor|2|||
129578492|NCT02089685|466414177|FG001|Overall Study|Follow up ended by sponsor|2|||
129578493|NCT02089685|466414178|FG002|Overall Study|Follow up ended by sponsor|0|||
129578494|NCT02089685|466414179|FG003|Overall Study|Follow up ended by sponsor|70|||
129578495|NCT02089685|466414180|FG004|Overall Study|Follow up ended by sponsor|26|||
129578496|NCT02089685|466414181|FG005|Overall Study|Follow up ended by sponsor|26|||
129578497|NCT02089685|466414176|FG000|Overall Study|Withdrawal by Subject|0|||
129578498|NCT02089685|466414177|FG001|Overall Study|Withdrawal by Subject|2|||
129578499|NCT02089685|466414178|FG002|Overall Study|Withdrawal by Subject|0|||
129578500|NCT02089685|466414179|FG003|Overall Study|Withdrawal by Subject|8|||
129578501|NCT02089685|466414180|FG004|Overall Study|Withdrawal by Subject|1|||
129578502|NCT02089685|466414181|FG005|Overall Study|Withdrawal by Subject|1|||
129578503|NCT02089685|466414176|FG000|Overall Study|Status not recorded|1|||
129578504|NCT02089685|466414177|FG001|Overall Study|Status not recorded|0|||
129578505|NCT02089685|466414178|FG002|Overall Study|Status not recorded|0|||
129578506|NCT02089685|466414179|FG003|Overall Study|Status not recorded|0|||
129578507|NCT02089685|466414180|FG004|Overall Study|Status not recorded|1|||
129578508|NCT02089685|466414181|FG005|Overall Study|Status not recorded|0|||
129578509|NCT02089685|466414176|FG000|Overall Study|Death|0|||
129578510|NCT02089685|466414177|FG001|Overall Study|Death|0|||
129578511|NCT02089685|466414178|FG002|Overall Study|Death|0|||
129578512|NCT02089685|466414179|FG003|Overall Study|Death|7|||
129578513|NCT02089685|466414180|FG004|Overall Study|Death|2|||
129578514|NCT02089685|466414181|FG005|Overall Study|Death|5|||
129578515|NCT02089685|466414176|FG000|Overall Study|Lost to Follow-up|0|||
129578516|NCT02089685|466414177|FG001|Overall Study|Lost to Follow-up|0|||
129578517|NCT02089685|466414178|FG002|Overall Study|Lost to Follow-up|0|||
129578518|NCT02089685|466414179|FG003|Overall Study|Lost to Follow-up|1|||
129578519|NCT02089685|466414180|FG004|Overall Study|Lost to Follow-up|0|||
129578520|NCT02089685|466414181|FG005|Overall Study|Lost to Follow-up|0|||
129578521|NCT02089685|466414176|FG000|Overall Study|Physician Decision|0|||
129578522|NCT02089685|466414177|FG001|Overall Study|Physician Decision|0|||
129578523|NCT02089685|466414178|FG002|Overall Study|Physician Decision|0|||
129578524|NCT02089685|466414179|FG003|Overall Study|Physician Decision|0|||
129578525|NCT02089685|466414180|FG004|Overall Study|Physician Decision|0|||
129578526|NCT02089685|466414181|FG005|Overall Study|Physician Decision|4|||
129578527|NCT02089685|466414176|FG000|Overall Study|Screen failure|1|||
129578528|NCT02089685|466414177|FG001|Overall Study|Screen failure|0|||
129578529|NCT02089685|466414178|FG002|Overall Study|Screen failure|0|||
129578530|NCT02089685|466414179|FG003|Overall Study|Screen failure|0|||
129578531|NCT02089685|466414180|FG004|Overall Study|Screen failure|0|||
129578532|NCT02089685|466414181|FG005|Overall Study|Screen failure|0|||
129578533|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Adverse Event|11|||
129578534|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Adverse Event|23|||
129578535|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Adverse Event|29|||
129578536|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Adverse Event|2|||
129578537|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Adverse Event|8|||
129578538|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
129578539|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
129578540|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
129578541|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
129578542|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
129785356|NCT02745145|467182063|FG002|Overall Study|Withdrew consent|1|||
129785357|NCT02745145|467182061|FG000|Overall Study|Study Termination|8|||
129578543|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
129578544|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
129578545|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
129578546|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
129578547|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
129578548|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
129578549|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
129578550|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
129578551|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
129578552|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
129578553|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129578554|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
129785358|NCT02745145|467182062|FG001|Overall Study|Study Termination|3|||
129578555|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129578556|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129578557|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
129578558|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
129578559|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
129578560|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
129578561|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
129578562|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
129578563|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
129578564|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
129785359|NCT02745145|467182063|FG002|Overall Study|Study Termination|7|||
129578565|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
129578566|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
129578567|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
129578568|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Move|0|||
129578569|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Move|1|||
129578570|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Move|0|||
129578571|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Move|0|||
129578572|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Move|0|||
129578573|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129578574|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129578575|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129578576|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
129578577|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
129578578|NCT00318461|466414182|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
129694911|NCT03004183|466841626|FG000|Overall Study|COVID-19|1|||
129694912|NCT02529488|466841627|FG000|Overall Study|Adverse Event|1|||
129694913|NCT02529488|466841627|FG000|Overall Study|Death|3|||
129694914|NCT02698787|466841628|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
129578579|NCT00318461|466414183|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
129578580|NCT00318461|466414184|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
129578581|NCT00318461|466414185|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
129578582|NCT00318461|466414186|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
129578583|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Work commitment|0|||
129578584|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Work commitment|0|||
129578585|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Work commitment|0|||
129578586|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Work commitment|0|||
129578587|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Work commitment|1|||
129578588|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Investigator decision|0|||
129578589|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Investigator decision|0|||
129578590|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Investigator decision|0|||
129578591|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Investigator decision|0|||
129578592|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Investigator decision|1|||
129578593|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Lack of time|1|||
129578594|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Lack of time|0|||
129578595|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Lack of time|0|||
129578596|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Lack of time|0|||
129578597|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Lack of time|0|||
129578598|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129578599|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129578600|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129578601|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
129578602|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
129578603|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
129578604|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
129578605|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
129578606|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
129578607|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
129578608|NCT00318461|466414182|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129578609|NCT00318461|466414183|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129578610|NCT00318461|466414184|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129578611|NCT00318461|466414185|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
129578612|NCT00318461|466414186|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
129578613|NCT00318461|466414182|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129578614|NCT00318461|466414183|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
129578615|NCT00318461|466414184|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129578616|NCT00318461|466414185|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129578617|NCT00318461|466414186|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
129578618|NCT00318461|466414182|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
129578619|NCT00318461|466414183|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
129578620|NCT00318461|466414184|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
129578621|NCT00318461|466414185|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
129578622|NCT00318461|466414186|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
129578623|NCT00318461|466414182|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
129578624|NCT00318461|466414183|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
129578625|NCT00318461|466414184|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
129578626|NCT00318461|466414185|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
129578627|NCT00318461|466414186|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
129578628|NCT00318461|466414182|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
129578629|NCT00318461|466414183|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
129578630|NCT00318461|466414184|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
129578631|NCT00318461|466414185|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
129578632|NCT00318461|466414186|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
129578633|NCT00318461|466414182|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
129578634|NCT00318461|466414183|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
129694915|NCT02698787|466841629|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
129694916|NCT02933151|466841638|FG000|Overall Study|Lost to Follow-up|19|||
129694917|NCT02933151|466841639|FG001|Overall Study|Lost to Follow-up|18|||
129694918|NCT02933151|466841638|FG000|Overall Study|Death|1732|||
129694919|NCT02933151|466841639|FG001|Overall Study|Death|1827|||
129694920|NCT02933151|466841638|FG000|Overall Study|Transplant|210|||
129694921|NCT02933151|466841639|FG001|Overall Study|Transplant|278|||
129694922|NCT02933151|466841638|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
129694923|NCT02933151|466841639|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
129694924|NCT02933151|466841638|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
129694925|NCT02933151|466841639|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
129578635|NCT00318461|466414184|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
129578636|NCT00318461|466414185|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
129578637|NCT00318461|466414186|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
129578638|NCT01929863|466414193|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
129578639|NCT01929863|466414194|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
129578640|NCT01929863|466414193|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
129578641|NCT01929863|466414194|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
129578642|NCT01929863|466414193|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
129578643|NCT01929863|466414194|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
129578644|NCT02911701|466414195|FG000|Overall Study|Withdrawal by Subject|2|||
129578645|NCT02911701|466414196|FG001|Overall Study|Withdrawal by Subject|4|||
129578646|NCT02911701|466414195|FG000|Overall Study|Adverse Event|1|||
129578647|NCT02911701|466414196|FG001|Overall Study|Adverse Event|0|||
129578648|NCT00830024|466414197|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129578649|NCT00830024|466414198|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129578650|NCT00429416|466414199|FG000|Overall Study|Death|1|||
129578651|NCT01983969|466414200|FG000|Overall Study|Disease Progression|0|||
129578652|NCT01983969|466414201|FG001|Overall Study|Disease Progression|1|||
129578653|NCT01983969|466414202|FG002|Overall Study|Disease Progression|0|||
129578654|NCT00436163|466414203|FG000|Overall Study|Lost to Follow-up|2|||
129578655|NCT00436163|466414203|FG000|Overall Study|Adverse Event|1|||
129578656|NCT02530905|466414204|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
129578657|NCT02530905|466414205|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
129578658|NCT02530905|466414206|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
129578659|NCT00950989|466414208|FG000|Overall Study|Death|0|||
129578660|NCT00950989|466414209|FG001|Overall Study|Death|0|||
129578661|NCT00950989|466414210|FG002|Overall Study|Death|1|||
129578662|NCT00950989|466414211|FG003|Overall Study|Death|0|||
129578663|NCT00950989|466414208|FG000|Overall Study|Administrative Decision|0|||
129578664|NCT00950989|466414209|FG001|Overall Study|Administrative Decision|1|||
129578665|NCT00950989|466414210|FG002|Overall Study|Administrative Decision|0|||
129578666|NCT00950989|466414211|FG003|Overall Study|Administrative Decision|0|||
129578667|NCT00950989|466414208|FG000|Overall Study|Disease Progression|0|||
129578668|NCT00950989|466414209|FG001|Overall Study|Disease Progression|0|||
129578669|NCT00950989|466414210|FG002|Overall Study|Disease Progression|1|||
129578670|NCT00950989|466414211|FG003|Overall Study|Disease Progression|0|||
129578671|NCT00950989|466414208|FG000|Overall Study|Withdrawal by Subject|2|||
129578672|NCT00950989|466414209|FG001|Overall Study|Withdrawal by Subject|1|||
129578673|NCT00950989|466414210|FG002|Overall Study|Withdrawal by Subject|0|||
129578674|NCT00950989|466414211|FG003|Overall Study|Withdrawal by Subject|0|||
129578675|NCT00950989|466414208|FG000|Overall Study|Adverse Event|2|||
129578676|NCT00950989|466414209|FG001|Overall Study|Adverse Event|1|||
129578677|NCT00950989|466414210|FG002|Overall Study|Adverse Event|1|||
129578678|NCT00950989|466414211|FG003|Overall Study|Adverse Event|0|||
129578679|NCT01841554|466414212|FG000|Overall Study|Death|7|||
129578680|NCT01841554|466414212|FG000|Overall Study|No Implantation|1|||
129578681|NCT01841554|466414212|FG000|Overall Study|Discontinued Follow Up|5|||
129578682|NCT01841554|466414212|FG000|Overall Study|Study exit due to secondary intervention|6|||
129578683|NCT03804983|466414216|FG000|Overall Study|Adverse Event|0|||
129578684|NCT03804983|466414217|FG001|Overall Study|Adverse Event|1|||
129578685|NCT03804983|466414216|FG000|Overall Study|Family Obligation|1|||
129578686|NCT03804983|466414217|FG001|Overall Study|Family Obligation|0|||
129578687|NCT03600376|466414218|FG000|Overall Study|Adverse Event|1|||
129578688|NCT03600376|466414219|FG001|Overall Study|Adverse Event|1|||
129578689|NCT03600376|466414218|FG000|Overall Study|Transferred to other facility|1|||
129578690|NCT03600376|466414219|FG001|Overall Study|Transferred to other facility|0|||
129578691|NCT03600376|466414218|FG000|Overall Study|Investigator Decision|0|||
129578692|NCT03600376|466414219|FG001|Overall Study|Investigator Decision|4|||
129578693|NCT03600376|466414218|FG000|Overall Study|Determined to be ineligible for study|0|||
129578694|NCT03600376|466414219|FG001|Overall Study|Determined to be ineligible for study|1|||
129578695|NCT02152163|466414220|FG000|Overall Study|Physician Decision|12|||
129578696|NCT02152163|466414221|FG001|Overall Study|Physician Decision|13|||
129785360|NCT00388583|467182064|FG000|Overall Study|Protocol Violation|1|||
129785361|NCT00388583|467182065|FG001|Overall Study|Protocol Violation|0|||
129578697|NCT00796562|466414222|FG000|Overall Study|Death|49|||
129578698|NCT00424047|466414223|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
129800243|NCT04755283|467236268|FG000|Overall Study|Death|31|||
129785362|NCT00388583|467182064|FG000|Overall Study|Withdrawal by Subject|3|||
129785363|NCT00388583|467182065|FG001|Overall Study|Withdrawal by Subject|3|||
129785364|NCT00388583|467182064|FG000|Overall Study|Serious Adverse Event|2|||
129785365|NCT00388583|467182065|FG001|Overall Study|Serious Adverse Event|0|||
129785366|NCT00388583|467182064|FG000|Overall Study|Did not receive vaccine|0|||
129785367|NCT00388583|467182065|FG001|Overall Study|Did not receive vaccine|1|||
129785368|NCT01155011|467182067|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
129785369|NCT01155011|467182068|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
129785370|NCT01155011|467182067|FG000|Baseline to 6 Months|investigator decision, moved|4|||
129785371|NCT01155011|467182068|FG001|Baseline to 6 Months|investigator decision, moved|5|||
129785372|NCT01155011|467182067|FG000|Baseline to 6 Months|Death|0|||
129785373|NCT01155011|467182068|FG001|Baseline to 6 Months|Death|1|||
129785374|NCT01155011|467182067|FG000|6 to 12 Months|Withdrawal by Subject|8|||
129785375|NCT01155011|467182068|FG001|6 to 12 Months|Withdrawal by Subject|5|||
129785376|NCT01155011|467182067|FG000|6 to 12 Months|Death|1|||
129785377|NCT01155011|467182068|FG001|6 to 12 Months|Death|5|||
129785378|NCT00322621|467182069|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
129785379|NCT00322621|467182070|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
129785380|NCT00322621|467182071|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
129785381|NCT00322621|467182069|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
129785382|NCT00322621|467182070|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
129785383|NCT00322621|467182071|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
129785384|NCT00322621|467182069|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
129785385|NCT00322621|467182070|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
129785386|NCT00322621|467182071|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
129785387|NCT00322621|467182069|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
129785388|NCT00322621|467182070|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
129785389|NCT00322621|467182071|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
129785390|NCT00322621|467182069|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
129785391|NCT00322621|467182070|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
129785392|NCT00322621|467182071|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
129785393|NCT00322621|467182069|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
129785394|NCT00322621|467182070|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
129785395|NCT00322621|467182071|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
129785396|NCT00322621|467182069|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
129785397|NCT00322621|467182070|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
129785398|NCT00322621|467182071|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
129785399|NCT00322621|467182069|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
129785400|NCT00322621|467182070|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
129785401|NCT00322621|467182071|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
129785402|NCT00322621|467182069|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
129785403|NCT00322621|467182070|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
129785404|NCT00322621|467182071|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
129785405|NCT00322621|467182069|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
129785406|NCT00322621|467182070|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
129785407|NCT00322621|467182071|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
129785408|NCT00322621|467182069|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
129785409|NCT00322621|467182070|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
129785410|NCT00322621|467182071|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
129785411|NCT01743001|467182072|FG000|Overall Study|Physician Decision|1|||
129785412|NCT01743001|467182073|FG001|Overall Study|Physician Decision|0|||
129785413|NCT01743001|467182072|FG000|Overall Study|Pregnancy|1|||
129785414|NCT01743001|467182073|FG001|Overall Study|Pregnancy|0|||
129785415|NCT01743001|467182072|FG000|Overall Study|Death|1|||
129785416|NCT01743001|467182073|FG001|Overall Study|Death|0|||
129785417|NCT01565343|467182076|FG000|Overall Study|Administrative decision/technical issues|1|||
129785418|NCT01565343|467182077|FG001|Overall Study|Administrative decision/technical issues|0|||
129785419|NCT01565343|467182078|FG002|Overall Study|Administrative decision/technical issues|0|||
129785420|NCT00271505|467182091|FG000|Overall Study|Screen Failure|3|||
129578699|NCT00424047|466414224|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
129785421|NCT00271505|467182091|FG000|Overall Study|Adverse Event|1|||
129785422|NCT00271505|467182091|FG000|Overall Study|Death|1|||
129785423|NCT03288142|467182097|FG000|Overall Study|Lost to Follow-up|22|||
129785424|NCT03288142|467182098|FG001|Overall Study|Lost to Follow-up|15|||
129785425|NCT00946153|467182099|FG000|Phase 2|Adverse Event|0|||
129785426|NCT00946153|467182100|FG001|Phase 2|Adverse Event|0|||
129785427|NCT00946153|467182101|FG002|Phase 2|Adverse Event|0|||
129785428|NCT00946153|467182102|FG003|Phase 2|Adverse Event|0|||
129785429|NCT00946153|467182103|FG004|Phase 2|Adverse Event|6|||
129785430|NCT00946153|467182099|FG000|Phase 2|Need more reduction of dose|0|||
129785431|NCT00946153|467182100|FG001|Phase 2|Need more reduction of dose|0|||
129785432|NCT00946153|467182101|FG002|Phase 2|Need more reduction of dose|0|||
129578700|NCT00424047|466414223|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
129578701|NCT00424047|466414224|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
129578702|NCT00424047|466414223|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
129578703|NCT00424047|466414224|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
129578704|NCT00424047|466414223|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
129578705|NCT00424047|466414224|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
129578706|NCT00424047|466414223|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
129578707|NCT00424047|466414224|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
129578708|NCT00424047|466414223|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
129578709|NCT00424047|466414224|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
129578710|NCT00424047|466414223|FG000|On Study at Time of Unblinding|Adverse Event|22|||
129578711|NCT00424047|466414224|FG001|On Study at Time of Unblinding|Adverse Event|12|||
129578712|NCT00424047|466414223|FG000|On Study at Time of Unblinding|Progression of disease|92|||
129578713|NCT00424047|466414224|FG001|On Study at Time of Unblinding|Progression of disease|128|||
129578714|NCT00424047|466414223|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
129578715|NCT00424047|466414224|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
129578716|NCT00424047|466414223|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
129578717|NCT00424047|466414224|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
129578718|NCT00424047|466414223|FG000|On Study at Time of Unblinding|Death|11|||
129578719|NCT00424047|466414224|FG001|On Study at Time of Unblinding|Death|11|||
129578720|NCT00424047|466414223|FG000|On Study at Time of Unblinding|Other|5|||
129578721|NCT00424047|466414224|FG001|On Study at Time of Unblinding|Other|4|||
129578722|NCT00424047|466414223|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
129578723|NCT00424047|466414224|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
129578724|NCT00424047|466414223|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
129578725|NCT00424047|466414224|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
129578726|NCT00424047|466414223|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
129578727|NCT00424047|466414224|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
129578728|NCT00424047|466414223|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
129785433|NCT00946153|467182102|FG003|Phase 2|Need more reduction of dose|0|||
129785434|NCT00946153|467182103|FG004|Phase 2|Need more reduction of dose|2|||
129785435|NCT00946153|467182099|FG000|Phase 2|Physician Decision|0|||
129785436|NCT00946153|467182100|FG001|Phase 2|Physician Decision|0|||
129785437|NCT00946153|467182101|FG002|Phase 2|Physician Decision|0|||
129785438|NCT00946153|467182102|FG003|Phase 2|Physician Decision|0|||
129785439|NCT00946153|467182103|FG004|Phase 2|Physician Decision|1|||
129785440|NCT00946153|467182099|FG000|Phase 2|14 days washout for recovery due to AE|0|||
129785441|NCT00946153|467182100|FG001|Phase 2|14 days washout for recovery due to AE|0|||
129785442|NCT00946153|467182101|FG002|Phase 2|14 days washout for recovery due to AE|0|||
129785443|NCT00946153|467182102|FG003|Phase 2|14 days washout for recovery due to AE|0|||
129785444|NCT00946153|467182103|FG004|Phase 2|14 days washout for recovery due to AE|4|||
129785445|NCT01948193|467183513|FG000|Overall Study|Serious event|2|||
129785446|NCT01948193|467183513|FG000|Overall Study|Lost to Follow-up|7|||
129785447|NCT02522624|467183514|FG000|Overall Study|Technical failure|1|||
129785448|NCT02522624|467183515|FG001|Overall Study|Technical failure|0|||
129785449|NCT00490529|467183517|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
129785450|NCT00490529|467183517|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
129785451|NCT00490529|467183517|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
129785452|NCT00490529|467183517|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
129785453|NCT00490529|467183517|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
129785454|NCT00490529|467183517|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
129785455|NCT03254459|467183518|FG000|Overall Study|Adverse Event|7|||
129785456|NCT03254459|467183519|FG001|Overall Study|Adverse Event|20|||
129785457|NCT03254459|467183518|FG000|Overall Study|Withdrawal by Subject Consent|3|||
129785458|NCT03254459|467183519|FG001|Overall Study|Withdrawal by Subject Consent|1|||
129785459|NCT03254459|467183518|FG000|Overall Study|Lost to Follow-up|0|||
129785460|NCT03254459|467183519|FG001|Overall Study|Lost to Follow-up|1|||
129785461|NCT03254459|467183518|FG000|Overall Study|Miscellaneous|0|||
129785462|NCT03254459|467183519|FG001|Overall Study|Miscellaneous|1|||
129785463|NCT00727441|467183520|FG000|Overall Study|Disease Progression|11|||
129785464|NCT00727441|467183521|FG001|Overall Study|Disease Progression|14|||
129785465|NCT00727441|467183522|FG002|Overall Study|Disease Progression|17|||
129785466|NCT00727441|467183520|FG000|Overall Study|Eligibility|7|||
129785467|NCT00727441|467183521|FG001|Overall Study|Eligibility|5|||
129785468|NCT00727441|467183522|FG002|Overall Study|Eligibility|7|||
129785469|NCT00727441|467183520|FG000|Overall Study|Death|0|||
129785470|NCT00727441|467183521|FG001|Overall Study|Death|1|||
129785471|NCT00727441|467183522|FG002|Overall Study|Death|1|||
129785472|NCT00727441|467183520|FG000|Overall Study|Physician Decision|0|||
129578729|NCT00424047|466414224|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
129578730|NCT00424047|466414223|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
129578731|NCT00424047|466414224|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
129578732|NCT00312897|466414227|FG000|Overall Study|Adverse Event|1|||
129578733|NCT00312897|466414228|FG001|Overall Study|Adverse Event|0|||
129578734|NCT00312897|466414227|FG000|Overall Study|Lost to Follow-up|2|||
129578735|NCT00312897|466414228|FG001|Overall Study|Lost to Follow-up|0|||
129578736|NCT00312897|466414227|FG000|Overall Study|Physician Decision|1|||
129578737|NCT00312897|466414228|FG001|Overall Study|Physician Decision|0|||
129578738|NCT00312897|466414227|FG000|Overall Study|Withdrawal by Subject|1|||
129578739|NCT00312897|466414228|FG001|Overall Study|Withdrawal by Subject|3|||
129578740|NCT00312897|466414227|FG000|Overall Study|Pregnancy|1|||
129578741|NCT00312897|466414228|FG001|Overall Study|Pregnancy|0|||
129578742|NCT00312897|466414227|FG000|Overall Study|discontinued prior to getting treatment|0|||
129578743|NCT00312897|466414228|FG001|Overall Study|discontinued prior to getting treatment|3|||
129578744|NCT03100344|466414229|FG000|Overall Study|Adverse Event|0|||
129578745|NCT03100344|466414230|FG001|Overall Study|Adverse Event|3|||
129578746|NCT03100344|466414231|FG002|Overall Study|Adverse Event|2|||
129578747|NCT03100344|466414232|FG003|Overall Study|Adverse Event|3|||
129578748|NCT03100344|466414229|FG000|Overall Study|Lack of Efficacy|2|||
129578749|NCT03100344|466414230|FG001|Overall Study|Lack of Efficacy|0|||
129578750|NCT03100344|466414231|FG002|Overall Study|Lack of Efficacy|0|||
129578751|NCT03100344|466414232|FG003|Overall Study|Lack of Efficacy|0|||
129578752|NCT03100344|466414229|FG000|Overall Study|Protocol Violation|1|||
129578753|NCT03100344|466414230|FG001|Overall Study|Protocol Violation|0|||
129578754|NCT03100344|466414231|FG002|Overall Study|Protocol Violation|0|||
129578755|NCT03100344|466414232|FG003|Overall Study|Protocol Violation|0|||
129578756|NCT03100344|466414229|FG000|Overall Study|Withdrawal by Subject|10|||
129578757|NCT03100344|466414230|FG001|Overall Study|Withdrawal by Subject|7|||
129578758|NCT03100344|466414231|FG002|Overall Study|Withdrawal by Subject|4|||
129578759|NCT03100344|466414232|FG003|Overall Study|Withdrawal by Subject|8|||
129578760|NCT03100344|466414229|FG000|Overall Study|Lost to Follow-up|1|||
129578761|NCT03100344|466414230|FG001|Overall Study|Lost to Follow-up|1|||
129578762|NCT03100344|466414231|FG002|Overall Study|Lost to Follow-up|1|||
129578763|NCT03100344|466414232|FG003|Overall Study|Lost to Follow-up|1|||
129578764|NCT01010503|466414233|FG000|Overall Study|Adverse Event|1|||
129578765|NCT01010503|466414233|FG000|Overall Study|Death|1|||
129578766|NCT04633564|466414234|FG000|Period 1|Adverse Event|28|||
129578767|NCT04633564|466414235|FG001|Period 1|Adverse Event|19|||
129578768|NCT04633564|466414234|FG000|Period 1|Death|8|||
129578769|NCT04633564|466414235|FG001|Period 1|Death|7|||
129578770|NCT04633564|466414234|FG000|Period 1|Lost to Follow-up|3|||
129578771|NCT04633564|466414235|FG001|Period 1|Lost to Follow-up|5|||
129578772|NCT04633564|466414234|FG000|Period 1|Physician Decision|4|||
129578773|NCT04633564|466414235|FG001|Period 1|Physician Decision|12|||
129578774|NCT04633564|466414234|FG000|Period 1|Protocol Violation|0|||
129578775|NCT04633564|466414235|FG001|Period 1|Protocol Violation|1|||
129578776|NCT04633564|466414234|FG000|Period 1|Withdrawal by Subject|10|||
129578777|NCT04633564|466414235|FG001|Period 1|Withdrawal by Subject|8|||
129578778|NCT04633564|466414234|FG000|Period 1|Progressive disease|47|||
129578779|NCT04633564|466414235|FG001|Period 1|Progressive disease|51|||
129578780|NCT04633564|466414234|FG000|Period 1|Terminated by Sponsor|8|||
129578781|NCT04633564|466414235|FG001|Period 1|Terminated by Sponsor|6|||
129578782|NCT04633564|466414234|FG000|Period 2|Adverse Event|3|||
129578783|NCT04633564|466414235|FG001|Period 2|Adverse Event|4|||
129578784|NCT04633564|466414234|FG000|Period 2|Death|0|||
129694926|NCT02933151|466841638|FG000|Overall Study|Recovered Kidney Function|47|||
129694927|NCT02933151|466841639|FG001|Overall Study|Recovered Kidney Function|29|||
129694928|NCT03048019|466841640|FG000|Overall Study|Adverse Event|1|||
129694929|NCT03048019|466841641|FG001|Overall Study|Adverse Event|0|||
129694930|NCT03400787|466841642|FG000|Overall Study|Lost to Follow-up|1|||
129694931|NCT03400787|466841643|FG001|Overall Study|Lost to Follow-up|0|||
129694932|NCT03400787|466841642|FG000|Overall Study|Death|1|||
129694933|NCT03400787|466841643|FG001|Overall Study|Death|0|||
129694934|NCT03400787|466841642|FG000|Overall Study|Protocol Violation|0|||
129694935|NCT03400787|466841643|FG001|Overall Study|Protocol Violation|2|||
129694936|NCT03400787|466841642|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
129578785|NCT04633564|466414235|FG001|Period 2|Death|2|||
129578786|NCT04633564|466414234|FG000|Period 2|Lost to Follow-up|0|||
129578787|NCT04633564|466414235|FG001|Period 2|Lost to Follow-up|1|||
129578788|NCT04633564|466414234|FG000|Period 2|Physician Decision|2|||
129578789|NCT04633564|466414235|FG001|Period 2|Physician Decision|4|||
129578790|NCT04633564|466414234|FG000|Period 2|Withdrawal by Subject|5|||
129578791|NCT04633564|466414235|FG001|Period 2|Withdrawal by Subject|1|||
129578792|NCT04633564|466414234|FG000|Period 2|Progressive Disease|74|||
129578793|NCT04633564|466414235|FG001|Period 2|Progressive Disease|82|||
129578794|NCT04633564|466414234|FG000|Period 2|Terminated by Sponsor|9|||
129578795|NCT04633564|466414235|FG001|Period 2|Terminated by Sponsor|3|||
129578796|NCT03043872|466414241|FG000|Overall Study|Withdrawal by Subject|6|||
129578797|NCT03043872|466414242|FG001|Overall Study|Withdrawal by Subject|6|||
129578798|NCT03043872|466414243|FG002|Overall Study|Withdrawal by Subject|15|||
129578799|NCT03043872|466414241|FG000|Overall Study|Lost to Follow-up|2|||
129785473|NCT00727441|467183521|FG001|Overall Study|Physician Decision|1|||
129578800|NCT03043872|466414242|FG001|Overall Study|Lost to Follow-up|1|||
129578801|NCT03043872|466414243|FG002|Overall Study|Lost to Follow-up|1|||
129578802|NCT03043872|466414241|FG000|Overall Study|Death|270|||
129578803|NCT03043872|466414242|FG001|Overall Study|Death|269|||
129578804|NCT03043872|466414243|FG002|Overall Study|Death|296|||
129578805|NCT01154231|466414244|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
129578806|NCT01154231|466414244|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
129578807|NCT03447353|466415461|FG000|Overall Study|Failure at Screening Visit|2|||
129578808|NCT03447353|466415461|FG000|Overall Study|Lost to Follow-up|4|||
129578809|NCT03447353|466415461|FG000|Overall Study|Scheduling Conflicts|3|||
129578810|NCT03447353|466415461|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
129578811|NCT02642653|466415464|FG000|Overall Study|Adverse Event|2|||
129578812|NCT02642653|466415465|FG001|Overall Study|Adverse Event|0|||
129578813|NCT02267187|466415466|FG000|Overall Study|Physician Decision|2|||
129578814|NCT02267187|466415466|FG000|Overall Study|Screen fail|3|||
129578815|NCT02222818|466415472|FG000|Period 1|Eligibility criteria not met|0|||
129578816|NCT02222818|466415473|FG001|Period 1|Eligibility criteria not met|3|||
129578817|NCT03025087|466415474|FG000|Overall Study|Physician Decision|3|||
129578818|NCT03025087|466415475|FG001|Overall Study|Physician Decision|3|||
129578819|NCT03025087|466415476|FG002|Overall Study|Physician Decision|0|||
129578820|NCT03025087|466415477|FG003|Overall Study|Physician Decision|0|||
129578821|NCT03025087|466415478|FG004|Overall Study|Physician Decision|0|||
129578822|NCT03025087|466415474|FG000|Overall Study|Withdrawal by Subject|1|||
129578823|NCT03025087|466415475|FG001|Overall Study|Withdrawal by Subject|1|||
129578824|NCT03025087|466415476|FG002|Overall Study|Withdrawal by Subject|0|||
129578825|NCT03025087|466415477|FG003|Overall Study|Withdrawal by Subject|0|||
129578826|NCT03025087|466415478|FG004|Overall Study|Withdrawal by Subject|0|||
129578827|NCT03025087|466415474|FG000|Overall Study|Unable to complete MRI|2|||
129578828|NCT03025087|466415475|FG001|Overall Study|Unable to complete MRI|2|||
129578829|NCT03025087|466415476|FG002|Overall Study|Unable to complete MRI|0|||
129578830|NCT03025087|466415477|FG003|Overall Study|Unable to complete MRI|0|||
129578831|NCT03025087|466415478|FG004|Overall Study|Unable to complete MRI|0|||
129578832|NCT01376037|466415487|FG000|Overall Study|Lost to Follow-up|0|||
129578833|NCT01376037|466415488|FG001|Overall Study|Lost to Follow-up|2|||
129578834|NCT01987765|466415491|FG000|Overall Study|Protocol Violation|65|||
129578835|NCT01987765|466415491|FG000|Overall Study|Lost to Follow-up|37|||
129578836|NCT01528696|466415492|FG000|Overall Study|See detailed description|18|||
129578837|NCT01528696|466415493|FG001|Overall Study|See detailed description|19|||
129578838|NCT03600805|466415494|FG000|Overall Study|Adverse Event|2|||
129578839|NCT03600805|466415495|FG001|Overall Study|Adverse Event|1|||
129578840|NCT03600805|466415496|FG002|Overall Study|Adverse Event|1|||
129578841|NCT03600805|466415497|FG003|Overall Study|Adverse Event|7|||
129578842|NCT03600805|466415494|FG000|Overall Study|Lack of Efficacy|2|||
129578843|NCT03600805|466415495|FG001|Overall Study|Lack of Efficacy|1|||
129578844|NCT03600805|466415496|FG002|Overall Study|Lack of Efficacy|0|||
129578845|NCT03600805|466415497|FG003|Overall Study|Lack of Efficacy|0|||
129578846|NCT03600805|466415494|FG000|Overall Study|Withdrawal by Subject|1|||
129578847|NCT03600805|466415495|FG001|Overall Study|Withdrawal by Subject|0|||
129578848|NCT03600805|466415496|FG002|Overall Study|Withdrawal by Subject|0|||
129578849|NCT03600805|466415497|FG003|Overall Study|Withdrawal by Subject|1|||
129578850|NCT03600805|466415494|FG000|Overall Study|Other unspecified|14|||
129578851|NCT03600805|466415495|FG001|Overall Study|Other unspecified|6|||
129578852|NCT03600805|466415496|FG002|Overall Study|Other unspecified|7|||
129578853|NCT03600805|466415497|FG003|Overall Study|Other unspecified|11|||
129578854|NCT06195579|466415498|FG000|Overall Study|Withdrawal by Subject|1|||
129578855|NCT02545283|466415499|FG000|Overall Study|Lost to Follow-up|2|||
129578856|NCT02545283|466415500|FG001|Overall Study|Lost to Follow-up|4|||
129578857|NCT02545283|466415499|FG000|Overall Study|Withdrawal by Subject|5|||
129578858|NCT02545283|466415500|FG001|Overall Study|Withdrawal by Subject|9|||
129578859|NCT02545283|466415499|FG000|Overall Study|Death|109|||
129578860|NCT02545283|466415500|FG001|Overall Study|Death|211|||
129694937|NCT03400787|466841643|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
129578861|NCT02545283|466415499|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
129578862|NCT02545283|466415500|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
129578863|NCT02545283|466415499|FG000|Overall Study|Study Terminated By Sponsor|33|||
129578864|NCT02545283|466415500|FG001|Overall Study|Study Terminated By Sponsor|71|||
129578865|NCT01205035|466415516|FG000|Overall Study|Withdrawal by Subject|1|||
129578866|NCT01205035|466415517|FG001|Overall Study|Withdrawal by Subject|0|||
129578867|NCT01205035|466415516|FG000|Overall Study|Physician Decision|1|||
129578868|NCT01205035|466415517|FG001|Overall Study|Physician Decision|0|||
129578869|NCT02663349|466415518|FG000|Overall Study|Withdrawal by Subject|6|||
129578870|NCT00488774|466415520|FG000|Overall Study|Withdrawal of consent|2|||
129578871|NCT00488774|466415521|FG001|Overall Study|Withdrawal of consent|2|||
129578872|NCT00488774|466415522|FG002|Overall Study|Withdrawal of consent|2|||
129578873|NCT00488774|466415523|FG003|Overall Study|Withdrawal of consent|0|||
129578874|NCT00488774|466415520|FG000|Overall Study|Other|6|||
129578875|NCT00488774|466415521|FG001|Overall Study|Other|3|||
129785474|NCT00727441|467183522|FG002|Overall Study|Physician Decision|0|||
129785475|NCT00727441|467183520|FG000|Overall Study|Withdrawal by Subject|0|||
129785476|NCT00727441|467183521|FG001|Overall Study|Withdrawal by Subject|1|||
129785477|NCT00727441|467183522|FG002|Overall Study|Withdrawal by Subject|0|||
129785478|NCT00535288|467183523|FG000|Overall Study|Adverse Event|20|||
129785479|NCT00535288|467183524|FG001|Overall Study|Adverse Event|19|||
129785480|NCT00535288|467183525|FG002|Overall Study|Adverse Event|25|||
129785481|NCT00535288|467183526|FG003|Overall Study|Adverse Event|20|||
129785482|NCT00535288|467183527|FG004|Overall Study|Adverse Event|30|||
129785483|NCT00535288|467183523|FG000|Overall Study|Lost to Follow-up|0|||
129785484|NCT00535288|467183524|FG001|Overall Study|Lost to Follow-up|3|||
129785485|NCT00535288|467183525|FG002|Overall Study|Lost to Follow-up|0|||
129785486|NCT00535288|467183526|FG003|Overall Study|Lost to Follow-up|0|||
129785487|NCT00535288|467183527|FG004|Overall Study|Lost to Follow-up|0|||
129785488|NCT00535288|467183523|FG000|Overall Study|Lack of Efficacy|26|||
129785489|NCT00535288|467183524|FG001|Overall Study|Lack of Efficacy|3|||
129785490|NCT00535288|467183525|FG002|Overall Study|Lack of Efficacy|4|||
129785491|NCT00535288|467183526|FG003|Overall Study|Lack of Efficacy|4|||
129785492|NCT00535288|467183527|FG004|Overall Study|Lack of Efficacy|7|||
129785493|NCT00535288|467183523|FG000|Overall Study|Unwilling to cooperate|6|||
129785494|NCT00535288|467183524|FG001|Overall Study|Unwilling to cooperate|6|||
129785495|NCT00535288|467183525|FG002|Overall Study|Unwilling to cooperate|3|||
129785496|NCT00535288|467183526|FG003|Overall Study|Unwilling to cooperate|3|||
129785497|NCT00535288|467183527|FG004|Overall Study|Unwilling to cooperate|4|||
129785498|NCT00535288|467183523|FG000|Overall Study|Other|2|||
129785499|NCT00535288|467183524|FG001|Overall Study|Other|1|||
129785500|NCT00535288|467183525|FG002|Overall Study|Other|1|||
129785501|NCT00535288|467183526|FG003|Overall Study|Other|2|||
129785502|NCT00535288|467183527|FG004|Overall Study|Other|1|||
129785503|NCT01129583|467183533|FG000|Overall Study|Death|1|||
129785504|NCT01129583|467183534|FG001|Overall Study|Death|0|||
129785505|NCT01129583|467183533|FG000|Overall Study|Lost to Follow-up|1|||
129785506|NCT01129583|467183534|FG001|Overall Study|Lost to Follow-up|1|||
129785507|NCT01129583|467183533|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
129785508|NCT01129583|467183534|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
129785509|NCT02600871|467183535|FG000|Overall Study|Lost to Follow-up|13|||
129785510|NCT02600871|467183536|FG001|Overall Study|Lost to Follow-up|10|||
129785511|NCT01410357|467183552|FG000|Overall Study|Death|2|||
129785512|NCT01410357|467183553|FG001|Overall Study|Death|1|||
129785513|NCT01410357|467183552|FG000|Overall Study|Withdrawal by Subject|1|||
129785514|NCT01410357|467183553|FG001|Overall Study|Withdrawal by Subject|2|||
129785515|NCT01410357|467183552|FG000|Overall Study|Lost to Follow-up|23|||
129785516|NCT01410357|467183553|FG001|Overall Study|Lost to Follow-up|21|||
129785517|NCT03135119|467183554|FG000|Overall Study|Lost to Follow-up|2|||
129785518|NCT03135119|467183555|FG001|Overall Study|Lost to Follow-up|0|||
129785519|NCT03135119|467183554|FG000|Overall Study|Physician Decision|1|||
129785520|NCT03135119|467183555|FG001|Overall Study|Physician Decision|1|||
129785521|NCT03135119|467183554|FG000|Overall Study|COVID-19 Shutdown|2|||
129785522|NCT03135119|467183555|FG001|Overall Study|COVID-19 Shutdown|2|||
129785523|NCT00361634|467183560|FG000|Overall Study|Lost to Follow-up|1|||
129785524|NCT00361634|467183560|FG000|Overall Study|Withdrawal by Subject|1|||
129785525|NCT00833417|467183561|FG000|Overall Study|Adverse Event|5|||
129785526|NCT00833417|467183562|FG001|Overall Study|Adverse Event|16|||
129785527|NCT00833417|467183561|FG000|Overall Study|Death|1|||
129785528|NCT00833417|467183562|FG001|Overall Study|Death|3|||
129785529|NCT00833417|467183561|FG000|Overall Study|Lost to Follow-up|1|||
129785530|NCT00833417|467183562|FG001|Overall Study|Lost to Follow-up|2|||
129785531|NCT00833417|467183561|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
129785532|NCT00833417|467183562|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
129785533|NCT00833417|467183561|FG000|Overall Study|Patient Decision to Withdraw|4|||
129785534|NCT00833417|467183562|FG001|Overall Study|Patient Decision to Withdraw|23|||
129785535|NCT00833417|467183561|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
129785536|NCT00833417|467183562|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
129785537|NCT00833417|467183561|FG000|Overall Study|Disease Progression|18|||
129785538|NCT00833417|467183562|FG001|Overall Study|Disease Progression|17|||
129785539|NCT00833417|467183561|FG000|Overall Study|Reason Not Specified|0|||
129785540|NCT00833417|467183562|FG001|Overall Study|Reason Not Specified|1|||
129785541|NCT05315908|467183563|FG000|Overall Study|Lost to Follow-up|4477|||
129785542|NCT05315908|467183564|FG001|Overall Study|Lost to Follow-up|4606|||
129578876|NCT00488774|466415522|FG002|Overall Study|Other|2|||
129578877|NCT00488774|466415523|FG003|Overall Study|Other|2|||
129578878|NCT00488774|466415520|FG000|Overall Study|Lost to Follow-up|0|||
129578879|NCT00488774|466415521|FG001|Overall Study|Lost to Follow-up|0|||
129578880|NCT00488774|466415522|FG002|Overall Study|Lost to Follow-up|1|||
129578881|NCT00488774|466415523|FG003|Overall Study|Lost to Follow-up|1|||
129578882|NCT01204294|466415524|FG000|Overall Study|Adverse Event|2|||
129578883|NCT01204294|466415525|FG001|Overall Study|Adverse Event|6|||
129578884|NCT01204294|466415526|FG002|Overall Study|Adverse Event|0|||
129578885|NCT01204294|466415527|FG003|Overall Study|Adverse Event|7|||
129578886|NCT01204294|466415528|FG004|Overall Study|Adverse Event|1|||
129578887|NCT01204294|466415529|FG005|Overall Study|Adverse Event|4|||
129694938|NCT04432298|466841647|FG000|Overall Study|Other than specified|1|||
129694939|NCT04432298|466841648|FG001|Overall Study|Other than specified|0|||
129694940|NCT04432298|466841647|FG000|Overall Study|Lost to Follow-up|0|||
129694941|NCT04432298|466841648|FG001|Overall Study|Lost to Follow-up|1|||
129694942|NCT04432298|466841647|FG000|Overall Study|Death|3|||
129694943|NCT04432298|466841648|FG001|Overall Study|Death|2|||
129694944|NCT04432298|466841647|FG000|Overall Study|Withdrawal by Subject|2|||
129694945|NCT04432298|466841648|FG001|Overall Study|Withdrawal by Subject|0|||
129694946|NCT02451007|466841653|FG000|Overall Study|Withdrawal by Subject|4|||
129694947|NCT02451007|466841653|FG000|Overall Study|Adverse Event|1|||
129694948|NCT02451007|466841653|FG000|Overall Study|Disease Progression|2|||
129694949|NCT00348374|466841654|FG000|Overall Study|Adverse Event|1|||
129694950|NCT00348374|466841655|FG001|Overall Study|Adverse Event|4|||
129694951|NCT00348374|466841654|FG000|Overall Study|Lost to Follow-up|1|||
129694952|NCT00348374|466841655|FG001|Overall Study|Lost to Follow-up|3|||
129694953|NCT00348374|466841654|FG000|Overall Study|Withdrawal by Subject|5|||
129694954|NCT00348374|466841655|FG001|Overall Study|Withdrawal by Subject|5|||
129694955|NCT00348374|466841654|FG000|Overall Study|Other|11|||
129694956|NCT00348374|466841655|FG001|Overall Study|Other|12|||
129694957|NCT00348374|466841654|FG000|Overall Study|ongoing at date of cutoff|1|||
129694958|NCT00348374|466841655|FG001|Overall Study|ongoing at date of cutoff|1|||
129694959|NCT00348374|466841654|FG000|Overall Study|randomized but did not receive treatment|0|||
129694960|NCT00348374|466841655|FG001|Overall Study|randomized but did not receive treatment|7|||
129694961|NCT02070380|466841664|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
129694962|NCT02070380|466841665|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
129694963|NCT02070380|466841666|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
129694964|NCT02070380|466841667|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
129694965|NCT02070380|466841664|FG000|Second Injection|Image sets missing or technically inadeq|0|||
129694966|NCT02070380|466841665|FG001|Second Injection|Image sets missing or technically inadeq|1|||
129694967|NCT02070380|466841666|FG002|Second Injection|Image sets missing or technically inadeq|0|||
129694968|NCT02070380|466841667|FG003|Second Injection|Image sets missing or technically inadeq|0|||
129694969|NCT02070380|466841664|FG000|Second Injection|Protocol Violation|0|||
129694970|NCT02070380|466841665|FG001|Second Injection|Protocol Violation|1|||
129694971|NCT02070380|466841666|FG002|Second Injection|Protocol Violation|1|||
129694972|NCT02070380|466841667|FG003|Second Injection|Protocol Violation|5|||
129694973|NCT02105012|466841680|FG000|Overall Study|Withdrawal by Subject|11|||
129694974|NCT02105012|466841680|FG000|Overall Study|Protocol Specified Criteria|9|||
129694975|NCT02105012|466841680|FG000|Overall Study|Lost to Follow-up|4|||
129694976|NCT02105012|466841680|FG000|Overall Study|Protocol Violation|4|||
129694977|NCT02105012|466841680|FG000|Overall Study|Physician Decision|3|||
129694978|NCT02105012|466841680|FG000|Overall Study|Adverse Event|1|||
129694979|NCT02105012|466841680|FG000|Overall Study|Lack of Efficacy|1|||
129694980|NCT03436420|466841681|FG000|Overall Study|Lack of Efficacy|3|||
129694981|NCT01104870|466841685|FG000|Overall Study|Adverse Event|1|||
129694982|NCT01104870|466841686|FG001|Overall Study|Adverse Event|1|||
129694983|NCT01104870|466841687|FG002|Overall Study|Adverse Event|0|||
129694984|NCT01104870|466841685|FG000|Overall Study|Death|0|||
129694985|NCT01104870|466841686|FG001|Overall Study|Death|0|||
129694986|NCT01104870|466841687|FG002|Overall Study|Death|1|||
129694987|NCT01104870|466841685|FG000|Overall Study|Withdrawal by Subject|0|||
129694988|NCT01104870|466841686|FG001|Overall Study|Withdrawal by Subject|0|||
129578888|NCT01204294|466415530|FG006|Overall Study|Adverse Event|0|||
129694989|NCT01104870|466841687|FG002|Overall Study|Withdrawal by Subject|1|||
129694990|NCT04985682|466841688|FG000|Overall Study|Withdrawal by Subject|1|||
129578889|NCT01204294|466415524|FG000|Overall Study|Protocol Violation|1|||
129578890|NCT01204294|466415525|FG001|Overall Study|Protocol Violation|0|||
129578891|NCT01204294|466415526|FG002|Overall Study|Protocol Violation|2|||
129694991|NCT00079781|466841700|FG000|Pre-implant Period|Withdrawal by Subject|2|||
129694992|NCT00079781|466841701|FG001|Pre-implant Period|Withdrawal by Subject|0|||
129694993|NCT00079781|466841702|FG002|Pre-implant Period|Withdrawal by Subject|0|||
129578892|NCT01204294|466415527|FG003|Overall Study|Protocol Violation|1|||
129578893|NCT01204294|466415528|FG004|Overall Study|Protocol Violation|0|||
129578894|NCT01204294|466415529|FG005|Overall Study|Protocol Violation|0|||
129578895|NCT01204294|466415530|FG006|Overall Study|Protocol Violation|0|||
129578896|NCT01204294|466415524|FG000|Overall Study|Withdrawal by Subject|0|||
129578897|NCT01204294|466415525|FG001|Overall Study|Withdrawal by Subject|2|||
129578898|NCT01204294|466415526|FG002|Overall Study|Withdrawal by Subject|2|||
129578899|NCT01204294|466415527|FG003|Overall Study|Withdrawal by Subject|1|||
129578900|NCT01204294|466415528|FG004|Overall Study|Withdrawal by Subject|1|||
129578901|NCT01204294|466415529|FG005|Overall Study|Withdrawal by Subject|1|||
129578902|NCT01204294|466415530|FG006|Overall Study|Withdrawal by Subject|2|||
129578903|NCT01204294|466415524|FG000|Overall Study|Lack of Efficacy|0|||
129578904|NCT01204294|466415525|FG001|Overall Study|Lack of Efficacy|0|||
129578905|NCT01204294|466415526|FG002|Overall Study|Lack of Efficacy|0|||
129578906|NCT01204294|466415527|FG003|Overall Study|Lack of Efficacy|2|||
129578907|NCT01204294|466415528|FG004|Overall Study|Lack of Efficacy|0|||
129578908|NCT01204294|466415529|FG005|Overall Study|Lack of Efficacy|0|||
129578909|NCT01204294|466415530|FG006|Overall Study|Lack of Efficacy|0|||
129578910|NCT01204294|466415524|FG000|Overall Study|Other (house moving)|0|||
129578911|NCT01204294|466415525|FG001|Overall Study|Other (house moving)|0|||
129578912|NCT01204294|466415526|FG002|Overall Study|Other (house moving)|1|||
129578913|NCT01204294|466415527|FG003|Overall Study|Other (house moving)|0|||
129578914|NCT01204294|466415528|FG004|Overall Study|Other (house moving)|0|||
129578915|NCT01204294|466415529|FG005|Overall Study|Other (house moving)|0|||
129785543|NCT01561898|467183565|FG000|Overall Study|Withdrawal by Subject|0|||
129785544|NCT01561898|467183566|FG001|Overall Study|Withdrawal by Subject|8|||
129785545|NCT01561898|467183567|FG002|Overall Study|Withdrawal by Subject|12|||
129785546|NCT01561898|467183568|FG003|Overall Study|Withdrawal by Subject|5|||
129785547|NCT01561898|467183565|FG000|Overall Study|Lack of Efficacy|0|||
129785548|NCT01561898|467183566|FG001|Overall Study|Lack of Efficacy|8|||
129785549|NCT01561898|467183567|FG002|Overall Study|Lack of Efficacy|10|||
129785550|NCT01561898|467183568|FG003|Overall Study|Lack of Efficacy|5|||
129785551|NCT01561898|467183565|FG000|Overall Study|Worsening of complications|0|||
129785552|NCT01561898|467183566|FG001|Overall Study|Worsening of complications|1|||
129785553|NCT01561898|467183567|FG002|Overall Study|Worsening of complications|0|||
129785554|NCT01561898|467183568|FG003|Overall Study|Worsening of complications|0|||
129785555|NCT01561898|467183565|FG000|Overall Study|Lost to Follow-up|0|||
129785556|NCT01561898|467183566|FG001|Overall Study|Lost to Follow-up|0|||
129785557|NCT01561898|467183567|FG002|Overall Study|Lost to Follow-up|1|||
129785558|NCT01561898|467183568|FG003|Overall Study|Lost to Follow-up|0|||
129785559|NCT01561898|467183565|FG000|Overall Study|Adverse Event|1|||
129785560|NCT01561898|467183566|FG001|Overall Study|Adverse Event|19|||
129578916|NCT01204294|466415530|FG006|Overall Study|Other (house moving)|0|||
129578917|NCT04590027|466415531|FG000|Overall Study|Lost to Follow-up|17|||
129578918|NCT04590027|466415532|FG001|Overall Study|Lost to Follow-up|14|||
129785561|NCT01561898|467183567|FG002|Overall Study|Adverse Event|14|||
129785562|NCT01561898|467183568|FG003|Overall Study|Adverse Event|9|||
129785563|NCT01561898|467183565|FG000|Overall Study|Physician Decision|1|||
129578919|NCT04590027|466415531|FG000|Overall Study|Protocol Violation|0|||
129785564|NCT01561898|467183566|FG001|Overall Study|Physician Decision|5|||
129785565|NCT01561898|467183567|FG002|Overall Study|Physician Decision|7|||
129884625|NCT02310126|467538605|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
129884626|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
129884627|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
129884628|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
129884629|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
129884630|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
129884631|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
129884632|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129884633|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
129884634|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129884635|NCT02441946|467538615|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
129884636|NCT02441946|467538616|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
129884637|NCT02441946|467538617|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
129884638|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
129884639|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
129884640|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
129884641|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
129884642|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
129884643|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
129884644|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
129884645|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
129884646|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
129884647|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
129884648|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
129884649|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
129884650|NCT02441946|467538615|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
129884651|NCT02441946|467538616|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
129884652|NCT02441946|467538617|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
129884653|NCT02441946|467538615|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
129884654|NCT02441946|467538616|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
129884655|NCT02441946|467538617|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
129884656|NCT02441946|467538615|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
129884657|NCT02441946|467538616|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129884658|NCT02441946|467538617|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
129884659|NCT03537261|467538619|FG000|Overall Study|Lost to Follow-up|4|||
129884660|NCT03537261|467538620|FG001|Overall Study|Lost to Follow-up|5|||
129884661|NCT03537261|467538619|FG000|Overall Study|Withdrawal by Subject|4|||
129884662|NCT03537261|467538620|FG001|Overall Study|Withdrawal by Subject|6|||
129884663|NCT03537261|467538619|FG000|Overall Study|Did not return study questionnaires|0|||
129884664|NCT03537261|467538620|FG001|Overall Study|Did not return study questionnaires|1|||
129884665|NCT03237013|467538621|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
129884666|NCT03237013|467538622|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
129884667|NCT03237013|467538623|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
129884668|NCT00502996|467538626|FG000|Overall Study|Lost to Follow-up|9|||
129884669|NCT00502996|467538626|FG000|Overall Study|Protocol Violation|2|||
129884670|NCT00502996|467538626|FG000|Overall Study|Treatment failure|25|||
129884671|NCT00502996|467538626|FG000|Overall Study|Withdrawal Informed Consent|6|||
129884672|NCT00502996|467538626|FG000|Overall Study|Adverse Event|2|||
129884673|NCT01729728|467538627|FG000|Overall Study|Adverse Event|0|||
129884674|NCT01729728|467538628|FG001|Overall Study|Adverse Event|6|||
129578920|NCT04590027|466415532|FG001|Overall Study|Protocol Violation|3|||
129578921|NCT03128723|466415535|FG000|Overall Study|Withdrawal by Subject|2|||
129694994|NCT00079781|466841700|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
129578922|NCT00075478|466415536|FG000|Overall Study|not eligible|1|||
129578923|NCT00075478|466415537|FG001|Overall Study|not eligible|0|||
129578924|NCT00075478|466415536|FG000|Overall Study|Physician Decision|0|||
129578925|NCT00075478|466415537|FG001|Overall Study|Physician Decision|1|||
129578926|NCT00673660|466415538|FG000|Overall Study|Lost to Follow-up|107|||
129578927|NCT00245063|466415539|FG000|Overall Study|Adverse Event|6|||
129694995|NCT00079781|466841701|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
129694996|NCT00079781|466841702|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
129694997|NCT00079781|466841700|FG000|Follow-up Period|Withdrawal by Subject|3|||
129884675|NCT01729728|467538629|FG002|Overall Study|Adverse Event|0|||
129884676|NCT01729728|467538627|FG000|Overall Study|Protocol Violation|1|||
129884677|NCT01729728|467538628|FG001|Overall Study|Protocol Violation|0|||
129884678|NCT01729728|467538629|FG002|Overall Study|Protocol Violation|1|||
129884679|NCT04267614|467538630|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
129884680|NCT04267614|467538630|FG000|Overall Study|Lost to Follow-up|115|||
129884681|NCT00988351|467538631|FG000|Overall Study|Withdrawal by Subject|8|||
129578928|NCT00245063|466415540|FG001|Overall Study|Adverse Event|5|||
129578929|NCT00245063|466415539|FG000|Overall Study|Death|1|||
129578930|NCT00245063|466415540|FG001|Overall Study|Death|0|||
129578931|NCT05099380|466415541|FG000|Overall Study|Subject enrolled in error|1|||
129578932|NCT05099380|466415542|FG001|Overall Study|Subject enrolled in error|0|||
129578933|NCT05099380|466415541|FG000|Overall Study|Study Procedure|1|||
129578934|NCT05099380|466415542|FG001|Overall Study|Study Procedure|0|||
129578935|NCT05099380|466415541|FG000|Overall Study|Protocol Violation|1|||
129578936|NCT05099380|466415542|FG001|Overall Study|Protocol Violation|0|||
129578937|NCT05099380|466415541|FG000|Overall Study|Adverse Event|1|||
129578938|NCT05099380|466415542|FG001|Overall Study|Adverse Event|1|||
129578939|NCT05099380|466415541|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
129578940|NCT05099380|466415542|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
129578941|NCT03276754|466415543|FG000|Overall Study|Withdrawal of informed consent|4|||
129578942|NCT03276754|466415543|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
129578943|NCT03276754|466415543|FG000|Overall Study|Lost to Follow-up|27|||
129578944|NCT03276754|466415543|FG000|Overall Study|No data reported at Month 24|31|||
129578945|NCT03276754|466415543|FG000|Overall Study|Death|39|||
129578946|NCT00835263|466415544|FG000|Second Intervention|Adverse Event|1|||
129578947|NCT00835263|466415545|FG001|Second Intervention|Adverse Event|0|||
129578948|NCT03249454|466415546|FG000|Overall Study|Withdrawal by Subject|0|||
129578949|NCT03249454|466415547|FG001|Overall Study|Withdrawal by Subject|0|||
129578950|NCT03249454|466415548|FG002|Overall Study|Withdrawal by Subject|0|||
129578951|NCT03249454|466415549|FG003|Overall Study|Withdrawal by Subject|0|||
129578952|NCT03249454|466415550|FG004|Overall Study|Withdrawal by Subject|0|||
129578953|NCT03249454|466415551|FG005|Overall Study|Withdrawal by Subject|0|||
129578954|NCT03249454|466415552|FG006|Overall Study|Withdrawal by Subject|0|||
129578955|NCT03249454|466415553|FG007|Overall Study|Withdrawal by Subject|0|||
129578956|NCT03249454|466415554|FG008|Overall Study|Withdrawal by Subject|0|||
129578957|NCT03249454|466415555|FG009|Overall Study|Withdrawal by Subject|1|||
129578958|NCT03249454|466415556|FG010|Overall Study|Withdrawal by Subject|1|||
129578959|NCT01913405|466415557|FG000|Overall Study|Withdrawal by Subject|1|||
129578960|NCT01913405|466415557|FG000|Overall Study|Adverse Event|1|||
129578961|NCT01020474|466415560|FG000|Overall Study|Adverse Event|4|||
129578962|NCT01020474|466415561|FG001|Overall Study|Adverse Event|4|||
129578963|NCT01020474|466415560|FG000|Overall Study|Protocol Violation|0|||
129578964|NCT01020474|466415561|FG001|Overall Study|Protocol Violation|2|||
129578965|NCT01020474|466415560|FG000|Overall Study|Withdrawal by Subject|5|||
129578966|NCT01020474|466415561|FG001|Overall Study|Withdrawal by Subject|7|||
129578967|NCT01020474|466415560|FG000|Overall Study|Other Reasons|1|||
129578968|NCT01020474|466415561|FG001|Overall Study|Other Reasons|1|||
129578969|NCT01020474|466415560|FG000|Overall Study|Insufficient Clinical Response|0|||
129578970|NCT01020474|466415561|FG001|Overall Study|Insufficient Clinical Response|3|||
129578971|NCT03199963|466415564|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
129578972|NCT03199963|466415565|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
129578973|NCT03199963|466415564|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
129578974|NCT03199963|466415565|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
129578975|NCT03199963|466415564|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
129578976|NCT03199963|466415565|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
129578977|NCT03199963|466415564|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
129578978|NCT03199963|466415565|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
129578979|NCT03199963|466415564|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
129578980|NCT03199963|466415565|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
129578981|NCT03199963|466415564|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
129578982|NCT03199963|466415565|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
129578983|NCT00466167|466415566|FG000|Overall Study|Adverse Event|8|||
129578984|NCT00466167|466415567|FG001|Overall Study|Adverse Event|8|||
129578985|NCT00466167|466415568|FG002|Overall Study|Adverse Event|7|||
129578986|NCT00466167|466415566|FG000|Overall Study|Lack of Efficacy|2|||
129578987|NCT00466167|466415567|FG001|Overall Study|Lack of Efficacy|0|||
129578988|NCT00466167|466415568|FG002|Overall Study|Lack of Efficacy|3|||
129578989|NCT00466167|466415566|FG000|Overall Study|Protocol Violation|1|||
129578990|NCT00466167|466415567|FG001|Overall Study|Protocol Violation|1|||
129578991|NCT00466167|466415568|FG002|Overall Study|Protocol Violation|2|||
129578992|NCT00466167|466415566|FG000|Overall Study|Lost to Follow-up|3|||
129578993|NCT00466167|466415567|FG001|Overall Study|Lost to Follow-up|2|||
129578994|NCT00466167|466415568|FG002|Overall Study|Lost to Follow-up|2|||
129578995|NCT00466167|466415566|FG000|Overall Study|Withdrawal by Subject|4|||
129578996|NCT00466167|466415567|FG001|Overall Study|Withdrawal by Subject|1|||
129578997|NCT00466167|466415568|FG002|Overall Study|Withdrawal by Subject|6|||
129785566|NCT01561898|467183568|FG003|Overall Study|Physician Decision|1|||
129578998|NCT00466167|466415566|FG000|Overall Study|patient did not meet inclusion criteria|1|||
129578999|NCT00466167|466415567|FG001|Overall Study|patient did not meet inclusion criteria|0|||
129579000|NCT00466167|466415568|FG002|Overall Study|patient did not meet inclusion criteria|1|||
129579001|NCT00466167|466415566|FG000|Overall Study|Not treated|1|||
129579002|NCT00466167|466415567|FG001|Overall Study|Not treated|0|||
129579003|NCT00466167|466415568|FG002|Overall Study|Not treated|0|||
129579004|NCT03669861|466415571|FG000|Overall Study|Disease Flare|5|||
129579005|NCT03669861|466415571|FG000|Overall Study|Lack of Efficacy|2|||
129579006|NCT05479058|466415581|FG000|Overall Study|Withdrawal by Subject|1|||
129579007|NCT05479058|466415582|FG001|Overall Study|Withdrawal by Subject|1|||
129579008|NCT05479058|466415581|FG000|Overall Study|Study terminated by sponsor|10|||
129579009|NCT05479058|466415582|FG001|Overall Study|Study terminated by sponsor|10|||
129785567|NCT00294762|467183569|FG000|Overall Study|Did not receive study treatment|3|||
129785568|NCT00294762|467183570|FG001|Overall Study|Did not receive study treatment|3|||
129785569|NCT02238080|467183571|FG000|Overall Study|Death|13|||
129785570|NCT02238080|467183571|FG000|Overall Study|Treatment interrupted|6|||
129785571|NCT02238080|467183571|FG000|Overall Study|Withdrawal by Subject|2|||
129785572|NCT02238080|467183571|FG000|Overall Study|Other|4|||
129785573|NCT01738646|467183572|FG000|Overall Study|Still Receiving Treatment|2|||
129785574|NCT04093024|467183573|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
129785575|NCT04093024|467183574|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
129785576|NCT04093024|467183573|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
129785577|NCT04093024|467183574|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
129785578|NCT04093024|467183573|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
129785579|NCT04093024|467183574|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
129785580|NCT04093024|467183573|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
129785581|NCT04093024|467183574|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
129785582|NCT00647270|467183581|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
129785583|NCT00647270|467183582|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
129785584|NCT00647270|467183583|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
129785585|NCT00647270|467183581|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
129785586|NCT00647270|467183582|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
129785587|NCT00647270|467183583|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
129785588|NCT00647270|467183581|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
129785589|NCT00647270|467183582|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
129785590|NCT00647270|467183583|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
129785591|NCT00647270|467183581|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
129785592|NCT00647270|467183582|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
129785593|NCT00647270|467183583|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
129785594|NCT00647270|467183581|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
129785595|NCT00647270|467183582|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
129785596|NCT00647270|467183583|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
129785597|NCT00647270|467183581|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
129785598|NCT00647270|467183582|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
129785599|NCT00647270|467183583|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
129785600|NCT00647270|467183581|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
129785601|NCT00647270|467183582|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
129785602|NCT00647270|467183583|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
129785603|NCT04493892|467183584|FG000|Overall Study|Withdrawal by Subject|15|||
129785604|NCT00233454|467183589|FG000|Overall Study|Death|6|||
129785605|NCT02366091|467183590|FG000|Overall Study|Withdrawal by Subject|3|||
129785606|NCT02366091|467183591|FG001|Overall Study|Withdrawal by Subject|7|||
129785607|NCT02366091|467183592|FG002|Overall Study|Withdrawal by Subject|3|||
129785608|NCT02366091|467183593|FG003|Overall Study|Withdrawal by Subject|1|||
129785609|NCT02160041|467183594|FG000|Overall Study|Adverse Event|11|||
129785610|NCT02160041|467183594|FG000|Overall Study|Death|2|||
129785611|NCT02160041|467183594|FG000|Overall Study|disease progression|57|||
129785612|NCT02160041|467183594|FG000|Overall Study|Protocol Violation|1|||
129785613|NCT02160041|467183594|FG000|Overall Study|non-compliance with study|1|||
129785614|NCT02160041|467183594|FG000|Overall Study|Physician Decision|3|||
129785615|NCT02160041|467183594|FG000|Overall Study|Withdrawal by Subject|8|||
129785616|NCT02160041|467183594|FG000|Overall Study|study terminated by by sponsor|1|||
129785617|NCT01403948|467183595|FG000|Overall Study|Progressive disease|0|||
129785618|NCT01403948|467183596|FG001|Overall Study|Progressive disease|2|||
129785619|NCT01403948|467183597|FG002|Overall Study|Progressive disease|2|||
129785620|NCT01403948|467183598|FG003|Overall Study|Progressive disease|4|||
129785621|NCT01403948|467183599|FG004|Overall Study|Progressive disease|2|||
129579010|NCT01370733|466415583|FG000|Overall Study|Withdrawal by Subject|8|||
129579011|NCT01370733|466415584|FG001|Overall Study|Withdrawal by Subject|8|||
129579012|NCT01370733|466415583|FG000|Overall Study|Lost to Follow-up|3|||
129579013|NCT01370733|466415584|FG001|Overall Study|Lost to Follow-up|0|||
129579014|NCT01370733|466415583|FG000|Overall Study|Adverse Event|2|||
129579015|NCT01370733|466415584|FG001|Overall Study|Adverse Event|4|||
129579016|NCT01370733|466415583|FG000|Overall Study|Lack of Efficacy|3|||
129579017|NCT01370733|466415584|FG001|Overall Study|Lack of Efficacy|5|||
129579018|NCT01370733|466415583|FG000|Overall Study|Physician Decision|0|||
129579019|NCT01370733|466415584|FG001|Overall Study|Physician Decision|2|||
129579020|NCT01370733|466415583|FG000|Overall Study|Protocol Violation|1|||
129579021|NCT01370733|466415584|FG001|Overall Study|Protocol Violation|3|||
129579022|NCT00463684|466415587|FG000|Overall Study|Withdrawal by Subject|1|||
129579023|NCT00463684|466415587|FG000|Overall Study|Lost to Follow-up|3|||
129579024|NCT03644550|466415588|FG000|Overall Study|Withdrawal by Subject|3|||
129579025|NCT03644550|466415588|FG000|Overall Study|Progressive disease|15|||
129579026|NCT00323882|466415589|FG000|Overall Study|Adverse Event|2|||
129579027|NCT00323882|466415590|FG001|Overall Study|Adverse Event|1|||
129579028|NCT00323882|466415591|FG002|Overall Study|Adverse Event|1|||
129579029|NCT00323882|466415592|FG003|Overall Study|Adverse Event|1|||
129579030|NCT00323882|466415593|FG004|Overall Study|Adverse Event|3|||
129579031|NCT00323882|466415589|FG000|Overall Study|Disease Progression|6|||
129579032|NCT00323882|466415590|FG001|Overall Study|Disease Progression|4|||
129579033|NCT00323882|466415591|FG002|Overall Study|Disease Progression|10|||
129579034|NCT00323882|466415592|FG003|Overall Study|Disease Progression|5|||
129579035|NCT00323882|466415593|FG004|Overall Study|Disease Progression|22|||
129579036|NCT00323882|466415589|FG000|Overall Study|Death|0|||
129579037|NCT00323882|466415590|FG001|Overall Study|Death|1|||
129579038|NCT00323882|466415591|FG002|Overall Study|Death|1|||
129579039|NCT00323882|466415592|FG003|Overall Study|Death|0|||
129579040|NCT00323882|466415593|FG004|Overall Study|Death|5|||
129579041|NCT00323882|466415589|FG000|Overall Study|Lost to Follow-up|0|||
129579042|NCT00323882|466415590|FG001|Overall Study|Lost to Follow-up|0|||
129579043|NCT00323882|466415591|FG002|Overall Study|Lost to Follow-up|1|||
129579044|NCT00323882|466415592|FG003|Overall Study|Lost to Follow-up|0|||
129579045|NCT00323882|466415593|FG004|Overall Study|Lost to Follow-up|1|||
129579046|NCT00323882|466415589|FG000|Overall Study|Other|0|||
129579047|NCT00323882|466415590|FG001|Overall Study|Other|0|||
129579048|NCT00323882|466415591|FG002|Overall Study|Other|0|||
129579049|NCT00323882|466415592|FG003|Overall Study|Other|1|||
129579050|NCT00323882|466415593|FG004|Overall Study|Other|1|||
129579051|NCT01794845|466415594|FG000|Overall Study|Withdrawal by Subject|1|||
129579052|NCT06647173|466415595|FG000|Overall Study|Lost to Follow-up|24|||
129579053|NCT06999265|466415596|FG000|Overall Study|Lost to Follow-up|1|||
129579054|NCT06999265|466415597|FG001|Overall Study|Lost to Follow-up|1|||
129579055|NCT04025229|466416950|FG000|Overall Study|Adverse Event|1|||
129579056|NCT04025229|466416951|FG001|Overall Study|Adverse Event|0|||
129579057|NCT04025229|466416950|FG000|Overall Study|Withdrawal by Subject|0|||
129579058|NCT04025229|466416951|FG001|Overall Study|Withdrawal by Subject|2|||
129579059|NCT04025229|466416950|FG000|Overall Study|Death|0|||
129579060|NCT04025229|466416951|FG001|Overall Study|Death|1|||
129579061|NCT04025229|466416950|FG000|Overall Study|Physician Decision|0|||
129579062|NCT04025229|466416951|FG001|Overall Study|Physician Decision|1|||
129579063|NCT02571907|466416952|FG000|Overall Study|Death|4|||
129579064|NCT02571907|466416952|FG000|Overall Study|Lost to Follow-up|3|||
129579065|NCT02571907|466416952|FG000|Overall Study|Withdrawal by Subject|3|||
129579066|NCT02286739|466416957|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
129579067|NCT02286739|466416958|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
129579068|NCT02286739|466416957|FG000|Overall Study|No Verasense type documented|0|||
129579069|NCT02286739|466416958|FG001|Overall Study|No Verasense type documented|23|||
129579070|NCT02286739|466416957|FG000|Overall Study|Adverse Event|1|||
129579071|NCT02286739|466416958|FG001|Overall Study|Adverse Event|2|||
129579072|NCT02286739|466416957|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
129579073|NCT02286739|466416958|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
129579074|NCT00834717|466416959|FG000|First Intervention|Adverse Event|1|||
129579075|NCT00834717|466416960|FG001|First Intervention|Adverse Event|0|||
129579076|NCT00834717|466416959|FG000|First Intervention|Withdrawal by Subject|0|||
129579077|NCT00834717|466416960|FG001|First Intervention|Withdrawal by Subject|1|||
129579078|NCT02255149|466416963|FG000|Overall Study|Lost to Follow-up|2|||
129579079|NCT02255149|466416963|FG000|Overall Study|Withdrawal by Subject|1|||
129579080|NCT02255149|466416963|FG000|Overall Study|Withdrawal by PI|1|||
129579081|NCT02255149|466416963|FG000|Overall Study|Implant Failure|1|||
129579082|NCT05710718|466416969|FG000|Overall Study|Withdrawal by Subject|5|||
129579083|NCT05710718|466416970|FG001|Overall Study|Withdrawal by Subject|1|||
129579084|NCT05710718|466416969|FG000|Overall Study|Lost to Follow-up|0|||
129579085|NCT05710718|466416970|FG001|Overall Study|Lost to Follow-up|1|||
129579086|NCT05710718|466416969|FG000|Overall Study|Death|0|||
129579087|NCT05710718|466416970|FG001|Overall Study|Death|1|||
129579088|NCT01319383|466416971|FG000|Overall Study|No ex vivo or in vivo response|4|||
129579089|NCT01319383|466416972|FG001|Overall Study|No ex vivo or in vivo response|0|||
129579090|NCT01319383|466416971|FG000|Overall Study|Physician Decision|3|||
129579091|NCT01319383|466416972|FG001|Overall Study|Physician Decision|0|||
129884682|NCT00988351|467538632|FG001|Overall Study|Withdrawal by Subject|0|||
129884683|NCT00988351|467538631|FG000|Overall Study|Lost to Follow-up|6|||
129884684|NCT00988351|467538632|FG001|Overall Study|Lost to Follow-up|9|||
129884685|NCT00988351|467538631|FG000|Overall Study|not using CPAP|5|||
129884686|NCT00988351|467538632|FG001|Overall Study|not using CPAP|3|||
129884687|NCT00363896|467538640|FG000|Overall Study|Withdrawal by Subject|29|||
129884688|NCT00363896|467538641|FG001|Overall Study|Withdrawal by Subject|16|||
129884689|NCT00363896|467538640|FG000|Overall Study|Adverse Event|24|||
129884690|NCT00363896|467538641|FG001|Overall Study|Adverse Event|13|||
129884691|NCT00363896|467538640|FG000|Overall Study|COPD exacerbation|13|||
129884692|NCT00363896|467538641|FG001|Overall Study|COPD exacerbation|7|||
129884693|NCT00363896|467538640|FG000|Overall Study|Lack of Efficacy|12|||
129884694|NCT00363896|467538641|FG001|Overall Study|Lack of Efficacy|8|||
129884695|NCT00363896|467538640|FG000|Overall Study|Protocol Violation|6|||
129884696|NCT00363896|467538641|FG001|Overall Study|Protocol Violation|1|||
129884697|NCT00363896|467538640|FG000|Overall Study|Lost to Follow-up|3|||
129884698|NCT00363896|467538641|FG001|Overall Study|Lost to Follow-up|0|||
129884699|NCT00363896|467538640|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
129884700|NCT00363896|467538641|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
129884701|NCT00363896|467538640|FG000|Overall Study|Other|1|||
129884702|NCT00363896|467538641|FG001|Overall Study|Other|2|||
129884703|NCT00924469|467538646|FG000|Overall Study|Adverse Event|2|||
129884704|NCT00924469|467538647|FG001|Overall Study|Adverse Event|0|||
129884705|NCT00924469|467538646|FG000|Overall Study|Withdrawal by Subject|0|||
129884706|NCT00924469|467538647|FG001|Overall Study|Withdrawal by Subject|1|||
129884707|NCT00924469|467538646|FG000|Overall Study|Lost to Follow-up|0|||
129884708|NCT00924469|467538647|FG001|Overall Study|Lost to Follow-up|1|||
129884709|NCT00630058|467538648|FG000|Overall Study|Adverse Event|1|||
129884710|NCT00630058|467538649|FG001|Overall Study|Adverse Event|1|||
129884711|NCT00630058|467538648|FG000|Overall Study|Withdrawal by Subject|0|||
129884712|NCT00630058|467538649|FG001|Overall Study|Withdrawal by Subject|1|||
129884713|NCT00630058|467538648|FG000|Overall Study|stopping criteria|3|||
129884714|NCT00630058|467538649|FG001|Overall Study|stopping criteria|2|||
129884715|NCT01651936|467538650|FG000|Base Study|Adverse Event|3|||
129579092|NCT01319383|466416971|FG000|Overall Study|Lack of Efficacy|5|||
129579093|NCT01319383|466416972|FG001|Overall Study|Lack of Efficacy|9|||
129579094|NCT01319383|466416971|FG000|Overall Study|No in vivo response to interval doses|0|||
129579095|NCT01319383|466416972|FG001|Overall Study|No in vivo response to interval doses|1|||
129579096|NCT01056484|466416981|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
129579097|NCT01056484|466416982|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
129579098|NCT01056484|466416981|FG000|Randomized Controlled Trial|Physician Decision|1|||
129579099|NCT01056484|466416982|FG001|Randomized Controlled Trial|Physician Decision|0|||
129579100|NCT01056484|466416981|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
129579101|NCT01056484|466416982|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
129579102|NCT00446966|466416983|FG000|Overall Study|Lost to Follow-up|10|||
129579103|NCT00446966|466416984|FG001|Overall Study|Lost to Follow-up|7|||
129579104|NCT01564394|466416985|FG000|Overall Study|Withdrawal by Subject|6|||
129579105|NCT01564394|466416986|FG001|Overall Study|Withdrawal by Subject|10|||
129579106|NCT00443651|466416989|FG000|Overall Study|Death|1|||
129579107|NCT00443651|466416990|FG001|Overall Study|Death|5|||
129579108|NCT00443651|466416989|FG000|Overall Study|Adverse Event|5|||
129579109|NCT00443651|466416990|FG001|Overall Study|Adverse Event|6|||
129579110|NCT00443651|466416989|FG000|Overall Study|Lost to Follow-up|18|||
129579111|NCT00443651|466416990|FG001|Overall Study|Lost to Follow-up|12|||
129579112|NCT00443651|466416989|FG000|Overall Study|Patient's/Guardian's Decision|58|||
129579113|NCT00443651|466416990|FG001|Overall Study|Patient's/Guardian's Decision|30|||
129579114|NCT00443651|466416989|FG000|Overall Study|Physician Decision|13|||
129579115|NCT00443651|466416990|FG001|Overall Study|Physician Decision|4|||
129579116|NCT00443651|466416989|FG000|Overall Study|Pregnancy|0|||
129579117|NCT00443651|466416990|FG001|Overall Study|Pregnancy|1|||
129579118|NCT00859521|466416991|FG000|Washout|Withdrawal by Subject|0|||
129579119|NCT00859521|466416992|FG001|Washout|Withdrawal by Subject|1|||
129579120|NCT01547286|466417000|FG000|Overall Study|Did not meet all eligibility criteria|1|||
129579121|NCT01547286|466417000|FG000|Overall Study|Physician Decision|1|||
129694998|NCT00079781|466841701|FG001|Follow-up Period|Withdrawal by Subject|0|||
129694999|NCT00079781|466841702|FG002|Follow-up Period|Withdrawal by Subject|1|||
129884716|NCT01651936|467538651|FG001|Base Study|Adverse Event|0|||
129884717|NCT01651936|467538652|FG002|Base Study|Adverse Event|0|||
129884718|NCT01651936|467538650|FG000|Base Study|Withdrawal by Subject|1|||
129884719|NCT01651936|467538651|FG001|Base Study|Withdrawal by Subject|1|||
129884720|NCT01651936|467538652|FG002|Base Study|Withdrawal by Subject|0|||
129884721|NCT01651936|467538650|FG000|Base Study|Early Escape|2|||
129884722|NCT01651936|467538651|FG001|Base Study|Early Escape|8|||
129884723|NCT01651936|467538652|FG002|Base Study|Early Escape|0|||
129884724|NCT01651936|467538650|FG000|Base Study|Study terminated by sponsor|21|||
129884725|NCT01651936|467538651|FG001|Base Study|Study terminated by sponsor|16|||
129579122|NCT03415308|466417003|FG000|Overall Study|Lost to Follow-up|0|||
129579123|NCT03415308|466417004|FG001|Overall Study|Lost to Follow-up|0|||
129579124|NCT03415308|466417005|FG002|Overall Study|Lost to Follow-up|1|||
129579125|NCT03415308|466417003|FG000|Overall Study|Scheduling Conflicts|0|||
129579126|NCT03415308|466417004|FG001|Overall Study|Scheduling Conflicts|0|||
129579127|NCT03415308|466417005|FG002|Overall Study|Scheduling Conflicts|7|||
129579128|NCT01471353|466417006|FG000|Overall Study|remain on study|3|||
129579129|NCT00836472|466417007|FG000|Washout|Adverse Event|1|||
129579130|NCT00836472|466417008|FG001|Washout|Adverse Event|2|||
129579131|NCT00836472|466417007|FG000|Washout|Withdrawal by Subject|1|||
129579132|NCT00836472|466417008|FG001|Washout|Withdrawal by Subject|1|||
129579133|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
129579134|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
129579135|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
129579136|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
129579137|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579138|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579139|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579140|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579141|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579142|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579143|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579144|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579145|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579146|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
129579147|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
129579148|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
129579149|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
129579150|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
129579151|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579152|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579153|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579154|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579155|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579156|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579157|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579158|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579159|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579160|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129579161|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
129579162|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579163|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
129579164|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579165|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579166|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579167|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579168|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579169|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579170|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579171|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579172|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579173|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579174|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129579175|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
129579176|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
129579177|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
129579178|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579179|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129695000|NCT00079781|466841700|FG000|Follow-up Period|Lost to Follow-up|1|||
129579180|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579181|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579182|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579183|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579184|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579185|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579186|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579187|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579188|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129579189|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
129695001|NCT00079781|466841701|FG001|Follow-up Period|Lost to Follow-up|0|||
129695002|NCT00079781|466841702|FG002|Follow-up Period|Lost to Follow-up|0|||
129695003|NCT00079781|466841700|FG000|Follow-up Period|Death|0|||
129695004|NCT00079781|466841701|FG001|Follow-up Period|Death|0|||
129695005|NCT00079781|466841702|FG002|Follow-up Period|Death|1|||
129695006|NCT04641975|466841703|FG000|Overall Study|Protocol Violation|1|||
129695007|NCT04641975|466841704|FG001|Overall Study|Protocol Violation|2|||
129695008|NCT04641975|466841705|FG002|Overall Study|Protocol Violation|0|||
129695009|NCT04641975|466841706|FG003|Overall Study|Protocol Violation|0|||
129695010|NCT04641975|466841703|FG000|Overall Study|Adverse Event|0|||
129695011|NCT04641975|466841704|FG001|Overall Study|Adverse Event|0|||
129695012|NCT04641975|466841705|FG002|Overall Study|Adverse Event|1|||
129695013|NCT04641975|466841706|FG003|Overall Study|Adverse Event|1|||
129695014|NCT04641975|466841703|FG000|Overall Study|Withdrawal by Subject|1|||
129695015|NCT04641975|466841704|FG001|Overall Study|Withdrawal by Subject|0|||
129695016|NCT04641975|466841705|FG002|Overall Study|Withdrawal by Subject|0|||
129695017|NCT04641975|466841706|FG003|Overall Study|Withdrawal by Subject|0|||
129695018|NCT01259024|466841708|FG000|Overall Study|Physician Decision|1|||
129695019|NCT01657500|466841709|FG000|Overall Study|set impropperly matched|3|||
129695020|NCT01657500|466841710|FG001|Overall Study|set impropperly matched|3|||
129695021|NCT01657500|466841709|FG000|Overall Study|Lost to Follow-up|2|||
129695022|NCT01657500|466841710|FG001|Overall Study|Lost to Follow-up|2|||
129695023|NCT02067156|466841711|FG000|Overall Study|Lost to Follow-up|4|||
129695024|NCT03596983|466841712|FG000|Overall Study|Withdrawal by Subject|3|||
129695025|NCT04034056|466841713|FG000|Overall Study|Withdrawal by Subject|2|||
129695026|NCT04034056|466841713|FG000|Overall Study|Reason Not Specified|13|||
129695027|NCT04034056|466841713|FG000|Overall Study|Adverse Event|56|||
129695028|NCT04008069|466841714|FG000|Open-Label Period|Adverse Event|1|||
129695029|NCT04008069|466841715|FG001|Open-Label Period|Adverse Event|0|||
129695030|NCT04008069|466841716|FG002|Open-Label Period|Adverse Event|0|||
129695031|NCT04008069|466841714|FG000|Open-Label Period|Lack of Efficacy|4|||
129695032|NCT04008069|466841715|FG001|Open-Label Period|Lack of Efficacy|0|||
129695033|NCT04008069|466841716|FG002|Open-Label Period|Lack of Efficacy|0|||
129695034|NCT04008069|466841714|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
129695035|NCT04008069|466841715|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
129695036|NCT04008069|466841716|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
129695037|NCT04008069|466841714|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
129695038|NCT04008069|466841715|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
129695039|NCT04008069|466841716|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
129695040|NCT02134028|466841718|FG000|Overall Study|Lack of Efficacy|1|||
129695041|NCT02134028|466841719|FG001|Overall Study|Lack of Efficacy|0|||
129695042|NCT02134028|466841720|FG002|Overall Study|Lack of Efficacy|3|||
129695043|NCT02134028|466841721|FG003|Overall Study|Lack of Efficacy|2|||
129695044|NCT02134028|466841722|FG004|Overall Study|Lack of Efficacy|1|||
129695045|NCT02134028|466841723|FG005|Overall Study|Lack of Efficacy|2|||
129695046|NCT02134028|466841724|FG006|Overall Study|Lack of Efficacy|1|||
129695047|NCT02134028|466841725|FG007|Overall Study|Lack of Efficacy|0|||
129695048|NCT02134028|466841718|FG000|Overall Study|Poor compliance to protocol|1|||
129695049|NCT02134028|466841719|FG001|Overall Study|Poor compliance to protocol|1|||
129695050|NCT02134028|466841720|FG002|Overall Study|Poor compliance to protocol|3|||
129695051|NCT02134028|466841721|FG003|Overall Study|Poor compliance to protocol|7|||
129695052|NCT02134028|466841722|FG004|Overall Study|Poor compliance to protocol|1|||
129695053|NCT02134028|466841723|FG005|Overall Study|Poor compliance to protocol|1|||
129695054|NCT02134028|466841724|FG006|Overall Study|Poor compliance to protocol|0|||
129695055|NCT02134028|466841725|FG007|Overall Study|Poor compliance to protocol|0|||
129695056|NCT02134028|466841718|FG000|Overall Study|Other unspecified|4|||
129695057|NCT02134028|466841719|FG001|Overall Study|Other unspecified|22|||
129695058|NCT02134028|466841720|FG002|Overall Study|Other unspecified|33|||
129695059|NCT02134028|466841721|FG003|Overall Study|Other unspecified|64|||
129695060|NCT02134028|466841722|FG004|Overall Study|Other unspecified|8|||
129695061|NCT02134028|466841723|FG005|Overall Study|Other unspecified|6|||
129695062|NCT02134028|466841724|FG006|Overall Study|Other unspecified|2|||
129695063|NCT02134028|466841725|FG007|Overall Study|Other unspecified|1|||
129695064|NCT02134028|466841718|FG000|Overall Study|Adverse Event|3|||
129695065|NCT02134028|466841719|FG001|Overall Study|Adverse Event|19|||
129695066|NCT02134028|466841720|FG002|Overall Study|Adverse Event|13|||
129579190|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579191|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
129579192|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579193|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579194|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579195|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579196|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579197|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579198|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579199|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579200|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579201|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579202|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
129579203|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129579204|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579205|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129579206|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579207|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579208|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579209|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579210|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579211|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579212|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579213|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579214|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579215|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579216|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129579217|NCT01695239|466417009|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
129579218|NCT01695239|466417010|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579219|NCT01695239|466417011|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579220|NCT01695239|466417012|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579221|NCT01695239|466417013|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579222|NCT01695239|466417014|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579223|NCT01695239|466417015|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579224|NCT01695239|466417016|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579225|NCT01695239|466417017|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579226|NCT01695239|466417018|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579227|NCT01695239|466417019|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579228|NCT01695239|466417020|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579229|NCT01695239|466417021|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579230|NCT01695239|466417022|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129579231|NCT01695239|466417009|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579232|NCT01695239|466417010|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579233|NCT01695239|466417011|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579234|NCT01695239|466417012|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579235|NCT01695239|466417013|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579236|NCT01695239|466417014|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579237|NCT01695239|466417015|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579238|NCT01695239|466417016|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
129579239|NCT01695239|466417017|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579240|NCT01695239|466417018|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579241|NCT01695239|466417019|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579242|NCT01695239|466417020|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579243|NCT01695239|466417021|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579244|NCT01695239|466417022|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
129579245|NCT01695239|466417009|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579246|NCT01695239|466417010|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129695067|NCT02134028|466841721|FG003|Overall Study|Adverse Event|32|||
129695068|NCT02134028|466841722|FG004|Overall Study|Adverse Event|4|||
129695069|NCT02134028|466841723|FG005|Overall Study|Adverse Event|5|||
129695070|NCT02134028|466841724|FG006|Overall Study|Adverse Event|1|||
129695071|NCT02134028|466841725|FG007|Overall Study|Adverse Event|2|||
129695072|NCT00819832|466841728|FG000|Overall Study|Sponsor Termination of Study|3|||
129579247|NCT01695239|466417011|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129695073|NCT00819832|466841729|FG001|Overall Study|Sponsor Termination of Study|0|||
129695074|NCT00819832|466841730|FG002|Overall Study|Sponsor Termination of Study|0|||
129579248|NCT01695239|466417012|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579249|NCT01695239|466417013|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579250|NCT01695239|466417014|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579251|NCT01695239|466417015|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579252|NCT01695239|466417016|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
129579253|NCT01695239|466417017|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579254|NCT01695239|466417018|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579255|NCT01695239|466417019|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579256|NCT01695239|466417020|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579257|NCT01695239|466417021|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579258|NCT01695239|466417022|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
129579259|NCT01695239|466417009|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579260|NCT01695239|466417010|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579261|NCT01695239|466417011|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579262|NCT01695239|466417012|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579263|NCT01695239|466417013|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579264|NCT01695239|466417014|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579265|NCT01695239|466417015|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579266|NCT01695239|466417016|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
129579267|NCT01695239|466417017|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579268|NCT01695239|466417018|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579269|NCT01695239|466417019|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579270|NCT01695239|466417020|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579271|NCT01695239|466417021|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579272|NCT01695239|466417022|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
129579273|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579274|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579275|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579276|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579277|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579278|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579279|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579280|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579281|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
129579282|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
129579283|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579284|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579285|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579286|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
129579287|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
129579288|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
129579289|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
129579290|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
129579291|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
129579292|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
129579293|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
129579294|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
129579295|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
129579296|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
129579297|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
129579298|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
129579299|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
129579300|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
129579301|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579302|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129785622|NCT01403948|467183600|FG005|Overall Study|Progressive disease|6|||
129785623|NCT01403948|467183601|FG006|Overall Study|Progressive disease|2|||
129579303|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579304|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579305|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579306|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579307|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579308|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579309|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
129579310|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
129579311|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579312|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579313|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579314|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
129579315|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
129579316|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
129579317|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
129579318|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
129579319|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
129579320|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
129579321|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
129579322|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
129579323|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
129579324|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
129579325|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
129579326|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
129579327|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
129579328|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
129579329|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579330|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579331|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579332|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579333|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579334|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579335|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579336|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579337|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
129579338|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
129579339|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579340|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579341|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579342|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
129579343|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579344|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579345|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579346|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579347|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579348|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579349|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579350|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579351|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
129695075|NCT00819832|466841731|FG003|Overall Study|Sponsor Termination of Study|0|||
129695076|NCT00819832|466841732|FG004|Overall Study|Sponsor Termination of Study|0|||
129695077|NCT00819832|466841733|FG005|Overall Study|Sponsor Termination of Study|0|||
129695078|NCT01452789|466841742|FG000|Overall Study|Withdrawal by Subject|3|||
129695079|NCT01452789|466841743|FG001|Overall Study|Withdrawal by Subject|2|||
129695080|NCT01340170|466841744|FG000|Overall Study|Lost to Follow-up|2|||
129695081|NCT01340170|466841745|FG001|Overall Study|Lost to Follow-up|4|||
129695082|NCT01340170|466841746|FG002|Overall Study|Lost to Follow-up|0|||
129695083|NCT01340170|466841744|FG000|Overall Study|Implant failure|1|||
129695084|NCT01340170|466841745|FG001|Overall Study|Implant failure|3|||
129695085|NCT01340170|466841746|FG002|Overall Study|Implant failure|0|||
129695086|NCT03878602|466841747|FG000|Overall Study|cord blood donation|7|||
129695087|NCT03878602|466841748|FG001|Overall Study|cord blood donation|1|||
129695088|NCT03878602|466841747|FG000|Overall Study|incomplete data collection|2|||
129785624|NCT01403948|467183602|FG007|Overall Study|Progressive disease|4|||
129785625|NCT01403948|467183603|FG008|Overall Study|Progressive disease|5|||
129785626|NCT01403948|467183604|FG009|Overall Study|Progressive disease|5|||
129785627|NCT01403948|467183595|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
129800244|NCT04755283|467236269|FG001|Overall Study|Death|36|||
129579352|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
129579353|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579354|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579355|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579356|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
129579357|NCT01695239|466417009|FG000|Extension Long-Term Extension Periods|Death|0|||
129579358|NCT01695239|466417010|FG001|Extension Long-Term Extension Periods|Death|0|||
129579359|NCT01695239|466417011|FG002|Extension Long-Term Extension Periods|Death|0|||
129579360|NCT01695239|466417012|FG003|Extension Long-Term Extension Periods|Death|0|||
129579361|NCT01695239|466417013|FG004|Extension Long-Term Extension Periods|Death|0|||
129579362|NCT01695239|466417014|FG005|Extension Long-Term Extension Periods|Death|0|||
129579363|NCT01695239|466417015|FG006|Extension Long-Term Extension Periods|Death|0|||
129579364|NCT01695239|466417016|FG007|Extension Long-Term Extension Periods|Death|0|||
129579365|NCT01695239|466417017|FG008|Extension Long-Term Extension Periods|Death|1|||
129579366|NCT01695239|466417018|FG009|Extension Long-Term Extension Periods|Death|0|||
129579367|NCT01695239|466417019|FG010|Extension Long-Term Extension Periods|Death|0|||
129579368|NCT01695239|466417020|FG011|Extension Long-Term Extension Periods|Death|0|||
129579369|NCT01695239|466417021|FG012|Extension Long-Term Extension Periods|Death|0|||
129579370|NCT01695239|466417022|FG013|Extension Long-Term Extension Periods|Death|0|||
129579371|NCT01695239|466417009|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579372|NCT01695239|466417010|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579373|NCT01695239|466417011|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579374|NCT01695239|466417012|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579375|NCT01695239|466417013|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579376|NCT01695239|466417014|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579377|NCT01695239|466417015|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579378|NCT01695239|466417016|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579379|NCT01695239|466417017|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579380|NCT01695239|466417018|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579381|NCT01695239|466417019|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129579382|NCT01695239|466417020|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
129579383|NCT01695239|466417021|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
129579384|NCT01695239|466417022|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
129579385|NCT01695239|466417009|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579386|NCT01695239|466417010|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579387|NCT01695239|466417011|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579388|NCT01695239|466417012|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579389|NCT01695239|466417013|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579390|NCT01695239|466417014|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579391|NCT01695239|466417015|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579392|NCT01695239|466417016|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579393|NCT01695239|466417017|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579394|NCT01695239|466417018|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579395|NCT01695239|466417019|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579396|NCT01695239|466417020|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129579397|NCT01695239|466417021|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
129579398|NCT01695239|466417022|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
129579399|NCT01695239|466417009|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579400|NCT01695239|466417010|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579401|NCT01695239|466417011|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579402|NCT01695239|466417012|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579403|NCT01695239|466417013|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579404|NCT01695239|466417014|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579405|NCT01695239|466417015|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579406|NCT01695239|466417016|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579407|NCT01695239|466417017|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579408|NCT01695239|466417018|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579409|NCT01695239|466417019|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579410|NCT01695239|466417020|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579411|NCT01695239|466417021|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
129785628|NCT01403948|467183596|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
129785629|NCT01403948|467183597|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
129785630|NCT01403948|467183598|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
129785631|NCT01403948|467183599|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
129785632|NCT01403948|467183600|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
129785633|NCT01403948|467183601|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
129785634|NCT01403948|467183602|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
129579412|NCT01695239|466417022|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
129579413|NCT01695239|466417009|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579414|NCT01695239|466417010|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579415|NCT01695239|466417011|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579416|NCT01695239|466417012|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579417|NCT01695239|466417013|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579418|NCT01695239|466417014|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579419|NCT01695239|466417015|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579420|NCT01695239|466417016|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579421|NCT01695239|466417017|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579422|NCT01695239|466417018|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579423|NCT01695239|466417019|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579424|NCT01695239|466417020|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579425|NCT01695239|466417021|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129579426|NCT01695239|466417022|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
129579427|NCT05239195|466417024|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
129579428|NCT05239195|466417025|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
129579429|NCT03552484|466417026|FG000|Overall Study|Death|6|||
129579430|NCT03552484|466417027|FG001|Overall Study|Death|4|||
129579431|NCT03552484|466417026|FG000|Overall Study|Lost to Follow-up|0|||
129579432|NCT03552484|466417027|FG001|Overall Study|Lost to Follow-up|16|||
129579433|NCT02682238|466417028|FG000|Overall Study|Lost to Follow-up|0|||
129579434|NCT02682238|466417029|FG001|Overall Study|Lost to Follow-up|2|||
129579435|NCT02682238|466417028|FG000|Overall Study|Withdrawal by Subject|1|||
129579436|NCT02682238|466417029|FG001|Overall Study|Withdrawal by Subject|0|||
129579437|NCT02682238|466417028|FG000|Overall Study|Adverse Event|1|||
129579438|NCT02682238|466417029|FG001|Overall Study|Adverse Event|0|||
129579439|NCT02682238|466417028|FG000|Overall Study|Non-compliance with Study Drug|1|||
129579440|NCT02682238|466417029|FG001|Overall Study|Non-compliance with Study Drug|0|||
129579441|NCT02682238|466417028|FG000|Overall Study|Non-compliance with Protocol|0|||
129579442|NCT02682238|466417029|FG001|Overall Study|Non-compliance with Protocol|2|||
129579443|NCT02075463|466417031|FG000|Overall Study|Adverse Event|3|||
129579444|NCT02075463|466417031|FG000|Overall Study|Par. reached stopping criteria|4|||
129579445|NCT02075463|466417031|FG000|Overall Study|Withdrawal by Subject|1|||
129579446|NCT01383486|466417033|FG000|Overall Study|Lost to Follow-up|10|||
129579447|NCT01383486|466417033|FG000|Overall Study|Incomplete information for analysis|2|||
129579448|NCT01383486|466417033|FG000|Overall Study|Did not take any product|6|||
129579449|NCT01839279|466417035|FG000|Overall Study|Adverse Event|4|||
129579450|NCT01839279|466417036|FG001|Overall Study|Adverse Event|1|||
129579451|NCT01839279|466417037|FG002|Overall Study|Adverse Event|1|||
129579452|NCT01839279|466417035|FG000|Overall Study|Withdrawal by Subject|4|||
129579453|NCT01839279|466417036|FG001|Overall Study|Withdrawal by Subject|1|||
129579454|NCT01839279|466417037|FG002|Overall Study|Withdrawal by Subject|1|||
129579455|NCT01839279|466417035|FG000|Overall Study|Classified as 'Other'|5|||
129579456|NCT01839279|466417036|FG001|Overall Study|Classified as 'Other'|0|||
129579457|NCT01839279|466417037|FG002|Overall Study|Classified as 'Other'|0|||
129579458|NCT03437265|466417038|FG000|Overall Study|Protocol Violation|6|||
129579459|NCT00316277|466417040|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
129579460|NCT00316277|466417041|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
129579461|NCT00316277|466417040|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
129579462|NCT00316277|466417041|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
129579463|NCT00316277|466417040|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
129579464|NCT00316277|466417041|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
129579465|NCT00316277|466417040|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
129579466|NCT00316277|466417041|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
129579467|NCT00316277|466417040|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
129579468|NCT00316277|466417041|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
129579469|NCT00848536|466417044|FG000|Overall Study|Adverse Event|2|||
129579470|NCT00848536|466417045|FG001|Overall Study|Adverse Event|2|||
129579471|NCT00848536|466417044|FG000|Overall Study|Withdrawal by Subject|0|||
129579472|NCT00848536|466417045|FG001|Overall Study|Withdrawal by Subject|1|||
129579473|NCT00848536|466417044|FG000|Overall Study|Protocol Violation|0|||
129579474|NCT00848536|466417045|FG001|Overall Study|Protocol Violation|1|||
129579475|NCT00848536|466417044|FG000|Overall Study|Noncompliance|1|||
129579476|NCT00848536|466417045|FG001|Overall Study|Noncompliance|0|||
129579477|NCT00848536|466417044|FG000|Overall Study|Inadequate Control of IOP|1|||
129579478|NCT00848536|466417045|FG001|Overall Study|Inadequate Control of IOP|1|||
129579479|NCT00848536|466417044|FG000|Overall Study|Patient Moved|0|||
129579480|NCT00848536|466417045|FG001|Overall Study|Patient Moved|2|||
129579481|NCT01572662|466417046|FG000|Overall Study|Withdrawal by Subject|1|||
129579482|NCT01572662|466417047|FG001|Overall Study|Withdrawal by Subject|0|||
129579483|NCT01572662|466417046|FG000|Overall Study|Physician Decision|0|||
129579484|NCT01572662|466417047|FG001|Overall Study|Physician Decision|1|||
129579485|NCT03364192|466417048|FG000|Overall Study|Ineligible|10|||
129579486|NCT03364192|466417048|FG000|Overall Study|Withdrawal by Subject|5|||
129579487|NCT03364192|466417048|FG000|Overall Study|Lost to Follow-up|1|||
129579488|NCT00918645|466417049|FG000|Overall Study|Withdrawal by Subject|1|||
129579489|NCT03446768|466417050|FG000|Overall Study|Withdrawal by Subject|0|||
129579490|NCT03446768|466417051|FG001|Overall Study|Withdrawal by Subject|1|||
129579491|NCT05133180|466417052|FG000|Overall Study|Withdrawal of consent|1|||
129579492|NCT05133180|466417053|FG001|Overall Study|Withdrawal of consent|1|||
129579493|NCT05133180|466417052|FG000|Overall Study|Lost to Follow-up|1|||
129579494|NCT05133180|466417053|FG001|Overall Study|Lost to Follow-up|1|||
129579495|NCT05133180|466417052|FG000|Overall Study|Documented disease progression|0|||
129579496|NCT05133180|466417053|FG001|Overall Study|Documented disease progression|1|||
129579497|NCT01604941|466417056|FG000|Overall Study|Adverse Event|1|||
129579498|NCT01604941|466417057|FG001|Overall Study|Adverse Event|2|||
129579499|NCT01604941|466417058|FG002|Overall Study|Adverse Event|0|||
129579500|NCT01604941|466417059|FG003|Overall Study|Adverse Event|0|||
129579501|NCT01604941|466417060|FG004|Overall Study|Adverse Event|1|||
129579502|NCT01604941|466417061|FG005|Overall Study|Adverse Event|5|||
129579503|NCT01604941|466417056|FG000|Overall Study|Non-compliance|1|||
129579504|NCT01604941|466417057|FG001|Overall Study|Non-compliance|0|||
129579505|NCT01604941|466417058|FG002|Overall Study|Non-compliance|0|||
129579506|NCT01604941|466417059|FG003|Overall Study|Non-compliance|0|||
129579507|NCT01604941|466417060|FG004|Overall Study|Non-compliance|0|||
129579508|NCT01604941|466417061|FG005|Overall Study|Non-compliance|0|||
129579509|NCT01604941|466417056|FG000|Overall Study|Participant Decision|0|||
129579510|NCT01604941|466417057|FG001|Overall Study|Participant Decision|0|||
129579511|NCT01604941|466417058|FG002|Overall Study|Participant Decision|0|||
129579512|NCT01604941|466417059|FG003|Overall Study|Participant Decision|0|||
129579513|NCT01604941|466417060|FG004|Overall Study|Participant Decision|0|||
129579514|NCT01604941|466417061|FG005|Overall Study|Participant Decision|2|||
129579515|NCT01604941|466417056|FG000|Overall Study|Early Study Termination|9|||
129579516|NCT01604941|466417057|FG001|Overall Study|Early Study Termination|2|||
129579517|NCT01604941|466417058|FG002|Overall Study|Early Study Termination|3|||
129579518|NCT01604941|466417059|FG003|Overall Study|Early Study Termination|3|||
129579519|NCT01604941|466417060|FG004|Overall Study|Early Study Termination|0|||
129579520|NCT01604941|466417061|FG005|Overall Study|Early Study Termination|0|||
129579521|NCT04078022|466417064|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
129579522|NCT04078022|466417065|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
129579523|NCT01895335|466417066|FG000|Overall Study|Adverse Event|106|||
129579524|NCT01895335|466417066|FG000|Overall Study|Lack of Efficacy|53|||
129579525|NCT01895335|466417066|FG000|Overall Study|Poor Compliance to Protocol|11|||
129579526|NCT01895335|466417066|FG000|Overall Study|Included But Not treated|1|||
129579527|NCT01895335|466417066|FG000|Overall Study|Other than Specified Above|44|||
129579528|NCT00115063|466417067|FG000|Overall Study|Lost to Follow-up|98|||
129579529|NCT00115063|466417068|FG001|Overall Study|Lost to Follow-up|104|||
129579530|NCT00115063|466417067|FG000|Overall Study|Death|1|||
129579531|NCT00115063|466417068|FG001|Overall Study|Death|0|||
129579532|NCT00191815|466417069|FG000|Overall Study|Adverse Event|2|||
129579533|NCT00191815|466417069|FG000|Overall Study|Disease progression or relapse|24|||
129579534|NCT00191815|466417069|FG000|Overall Study|Death|2|||
129579535|NCT00191815|466417069|FG000|Overall Study|Protocol Violation|3|||
129579536|NCT00191815|466417069|FG000|Overall Study|Physician Decision|2|||
129579537|NCT00191815|466417069|FG000|Overall Study|Withdrawal by Subject|7|||
129579538|NCT03808376|466417070|FG000|Overall Study|Withdrawal by Subject|10|||
129579539|NCT01075282|466417071|FG000|Overall Study|Withdrawal by Subject|11|||
129579540|NCT01075282|466417072|FG001|Overall Study|Withdrawal by Subject|7|||
129579541|NCT01075282|466417073|FG002|Overall Study|Withdrawal by Subject|11|||
129579542|NCT01075282|466417071|FG000|Overall Study|Adverse Event|9|||
129579543|NCT01075282|466417072|FG001|Overall Study|Adverse Event|8|||
129579544|NCT01075282|466417073|FG002|Overall Study|Adverse Event|5|||
129579545|NCT01075282|466417071|FG000|Overall Study|Entry Criteria Not Met|3|||
129579546|NCT01075282|466417072|FG001|Overall Study|Entry Criteria Not Met|2|||
129579547|NCT01075282|466417073|FG002|Overall Study|Entry Criteria Not Met|0|||
129579548|NCT01075282|466417071|FG000|Overall Study|Lost to Follow-up|3|||
129579549|NCT01075282|466417072|FG001|Overall Study|Lost to Follow-up|3|||
129579550|NCT01075282|466417073|FG002|Overall Study|Lost to Follow-up|3|||
129579551|NCT01075282|466417071|FG000|Overall Study|Physician Decision|3|||
129579552|NCT01075282|466417072|FG001|Overall Study|Physician Decision|3|||
129579553|NCT01075282|466417073|FG002|Overall Study|Physician Decision|3|||
129579554|NCT01075282|466417071|FG000|Overall Study|Lack of Efficacy|1|||
129579555|NCT01075282|466417072|FG001|Overall Study|Lack of Efficacy|1|||
129579556|NCT01075282|466417073|FG002|Overall Study|Lack of Efficacy|0|||
129579557|NCT01075282|466417071|FG000|Overall Study|Treatment Non-compliance|1|||
129579558|NCT01075282|466417072|FG001|Overall Study|Treatment Non-compliance|2|||
129579559|NCT01075282|466417073|FG002|Overall Study|Treatment Non-compliance|2|||
129579560|NCT01075282|466417071|FG000|Overall Study|Protocol Violation|0|||
129579561|NCT01075282|466417072|FG001|Overall Study|Protocol Violation|2|||
129579562|NCT01075282|466417073|FG002|Overall Study|Protocol Violation|1|||
129579563|NCT01075282|466417071|FG000|Overall Study|Death|0|||
129579564|NCT01075282|466417072|FG001|Overall Study|Death|1|||
129579565|NCT01075282|466417073|FG002|Overall Study|Death|2|||
129579566|NCT00003470|466417074|FG000|Overall Study|Not evaluable|6|||
129579567|NCT03503318|466417075|FG000|Overall Study|Death|1|||
129579568|NCT03503318|466417076|FG001|Overall Study|Death|0|||
129579569|NCT03503318|466417077|FG002|Overall Study|Death|4|||
129579570|NCT03503318|466417075|FG000|Overall Study|Adverse Event|3|||
129579571|NCT03503318|466417076|FG001|Overall Study|Adverse Event|4|||
129579572|NCT03503318|466417077|FG002|Overall Study|Adverse Event|2|||
129579573|NCT03503318|466417075|FG000|Overall Study|Withdrawal by Subject|12|||
129579574|NCT03503318|466417076|FG001|Overall Study|Withdrawal by Subject|17|||
129579575|NCT03503318|466417077|FG002|Overall Study|Withdrawal by Subject|16|||
129579576|NCT03503318|466417075|FG000|Overall Study|Protocol Violation|5|||
129579577|NCT03503318|466417076|FG001|Overall Study|Protocol Violation|0|||
129579578|NCT03503318|466417077|FG002|Overall Study|Protocol Violation|3|||
129579579|NCT03503318|466417075|FG000|Overall Study|Lost to Follow-up|17|||
129579580|NCT03503318|466417076|FG001|Overall Study|Lost to Follow-up|15|||
129579581|NCT03503318|466417077|FG002|Overall Study|Lost to Follow-up|12|||
129579582|NCT03503318|466417075|FG000|Overall Study|Other than specified|1|||
129579583|NCT03503318|466417076|FG001|Overall Study|Other than specified|3|||
129579584|NCT03503318|466417077|FG002|Overall Study|Other than specified|3|||
129579585|NCT02139826|466417080|FG000|Overall Study|Adverse Event|1|||
129579586|NCT01456221|466417082|FG000|Overall Study|Withdrawal by Subject|56|||
129579587|NCT01456221|466417083|FG001|Overall Study|Withdrawal by Subject|49|||
129579588|NCT01456221|466417082|FG000|Overall Study|Lost to Follow-up|1|||
129579589|NCT01456221|466417083|FG001|Overall Study|Lost to Follow-up|4|||
129579590|NCT01456221|466417082|FG000|Overall Study|Received medication|3|||
129579591|NCT01456221|466417083|FG001|Overall Study|Received medication|2|||
129579592|NCT01456221|466417082|FG000|Overall Study|Incomplete data|4|||
129579593|NCT01456221|466417083|FG001|Overall Study|Incomplete data|2|||
129579594|NCT01473953|466417086|FG000|Overall Study|Other|1|||
129579595|NCT01473953|466417087|FG001|Overall Study|Other|0|||
129579596|NCT01473953|466417088|FG002|Overall Study|Other|0|||
129579597|NCT01473953|466417089|FG003|Overall Study|Other|0|||
129579598|NCT01473953|466417090|FG004|Overall Study|Other|0|||
129579599|NCT01494532|466417091|FG000|Overall Study|Adverse Event|4|||
129579600|NCT01494532|466417092|FG001|Overall Study|Adverse Event|1|||
129579601|NCT01494532|466417093|FG002|Overall Study|Adverse Event|8|||
129579602|NCT01494532|466417094|FG003|Overall Study|Adverse Event|6|||
129579603|NCT01494532|466417095|FG004|Overall Study|Adverse Event|5|||
129579604|NCT01494532|466417096|FG005|Overall Study|Adverse Event|0|||
129579605|NCT01494532|466417091|FG000|Overall Study|Lack of Efficacy|0|||
129579606|NCT01494532|466417092|FG001|Overall Study|Lack of Efficacy|0|||
129579607|NCT01494532|466417093|FG002|Overall Study|Lack of Efficacy|0|||
129579608|NCT01494532|466417094|FG003|Overall Study|Lack of Efficacy|0|||
129579609|NCT01494532|466417095|FG004|Overall Study|Lack of Efficacy|2|||
129579610|NCT01494532|466417096|FG005|Overall Study|Lack of Efficacy|0|||
129579611|NCT01494532|466417091|FG000|Overall Study|Protocol deviation|2|||
129579612|NCT01494532|466417092|FG001|Overall Study|Protocol deviation|1|||
129579613|NCT01494532|466417093|FG002|Overall Study|Protocol deviation|3|||
129579614|NCT01494532|466417094|FG003|Overall Study|Protocol deviation|2|||
129579615|NCT01494532|466417095|FG004|Overall Study|Protocol deviation|3|||
129579616|NCT01494532|466417096|FG005|Overall Study|Protocol deviation|0|||
129579617|NCT01494532|466417091|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129579618|NCT01494532|466417092|FG001|Overall Study|Protocol-defined stopping criteria|0|||
129579619|NCT01494532|466417093|FG002|Overall Study|Protocol-defined stopping criteria|1|||
129579620|NCT01494532|466417094|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129579621|NCT01494532|466417095|FG004|Overall Study|Protocol-defined stopping criteria|0|||
129579622|NCT01494532|466417096|FG005|Overall Study|Protocol-defined stopping criteria|0|||
129579623|NCT01494532|466417091|FG000|Overall Study|Lost to Follow-up|1|||
129579624|NCT01494532|466417092|FG001|Overall Study|Lost to Follow-up|0|||
129579625|NCT01494532|466417093|FG002|Overall Study|Lost to Follow-up|0|||
129579626|NCT01494532|466417094|FG003|Overall Study|Lost to Follow-up|2|||
129695089|NCT03878602|466841748|FG001|Overall Study|incomplete data collection|0|||
129695090|NCT00066170|466841749|FG000|Overall Study|Adverse Event|2|||
129695091|NCT00066170|466841750|FG001|Overall Study|Adverse Event|4|||
129695092|NCT00066170|466841751|FG002|Overall Study|Adverse Event|1|||
129695093|NCT00066170|466841752|FG003|Overall Study|Adverse Event|7|||
129695094|NCT00066170|466841749|FG000|Overall Study|Serious Adverse Event|0|||
129579627|NCT01494532|466417095|FG004|Overall Study|Lost to Follow-up|0|||
129579628|NCT01494532|466417096|FG005|Overall Study|Lost to Follow-up|0|||
129579629|NCT01494532|466417091|FG000|Overall Study|Physician Decision|0|||
129579630|NCT01494532|466417092|FG001|Overall Study|Physician Decision|1|||
129579631|NCT01494532|466417093|FG002|Overall Study|Physician Decision|1|||
129579632|NCT01494532|466417094|FG003|Overall Study|Physician Decision|2|||
129579633|NCT01494532|466417095|FG004|Overall Study|Physician Decision|0|||
129579634|NCT01494532|466417096|FG005|Overall Study|Physician Decision|0|||
129695095|NCT00066170|466841750|FG001|Overall Study|Serious Adverse Event|0|||
129579635|NCT01494532|466417091|FG000|Overall Study|Withdrawal by Subject|3|||
129579636|NCT01494532|466417092|FG001|Overall Study|Withdrawal by Subject|1|||
129579637|NCT01494532|466417093|FG002|Overall Study|Withdrawal by Subject|4|||
129579638|NCT01494532|466417094|FG003|Overall Study|Withdrawal by Subject|3|||
129579639|NCT01494532|466417095|FG004|Overall Study|Withdrawal by Subject|2|||
129579640|NCT01494532|466417096|FG005|Overall Study|Withdrawal by Subject|0|||
129579641|NCT03114891|466417101|FG000|First Treatment Round|Lost to Follow-up|0|||
129579642|NCT03114891|466417102|FG001|First Treatment Round|Lost to Follow-up|1|||
129579643|NCT03114891|466417103|FG002|First Treatment Round|Lost to Follow-up|1|||
129579644|NCT03114891|466417104|FG003|First Treatment Round|Lost to Follow-up|0|||
129579645|NCT03114891|466417101|FG000|First Treatment Round|Withdrawal by Subject|0|||
129579646|NCT03114891|466417102|FG001|First Treatment Round|Withdrawal by Subject|2|||
129579647|NCT03114891|466417103|FG002|First Treatment Round|Withdrawal by Subject|0|||
129579648|NCT03114891|466417104|FG003|First Treatment Round|Withdrawal by Subject|1|||
129579649|NCT03114891|466417101|FG000|3 Week Break|Lost to Follow-up|1|||
129579650|NCT03114891|466417102|FG001|3 Week Break|Lost to Follow-up|0|||
129579651|NCT03114891|466417103|FG002|3 Week Break|Lost to Follow-up|0|||
129579652|NCT03114891|466417104|FG003|3 Week Break|Lost to Follow-up|1|||
129579653|NCT03114891|466417101|FG000|3 Week Break|Withdrawal by Subject|0|||
129579654|NCT03114891|466417102|FG001|3 Week Break|Withdrawal by Subject|1|||
129579655|NCT03114891|466417103|FG002|3 Week Break|Withdrawal by Subject|0|||
129579656|NCT03114891|466417104|FG003|3 Week Break|Withdrawal by Subject|0|||
129579657|NCT03114891|466417101|FG000|Second Treatment Round|Lost to Follow-up|1|||
129579658|NCT03114891|466417102|FG001|Second Treatment Round|Lost to Follow-up|0|||
129579659|NCT03114891|466417103|FG002|Second Treatment Round|Lost to Follow-up|0|||
129579660|NCT03114891|466417104|FG003|Second Treatment Round|Lost to Follow-up|0|||
129579661|NCT03114891|466417101|FG000|Second Treatment Round|Physician Decision|1|||
129579662|NCT03114891|466417102|FG001|Second Treatment Round|Physician Decision|0|||
129579663|NCT03114891|466417103|FG002|Second Treatment Round|Physician Decision|0|||
129579664|NCT03114891|466417104|FG003|Second Treatment Round|Physician Decision|0|||
129579665|NCT00772603|466418411|FG000|Overall Study|Withdrawal by Subject|11|||
129579666|NCT00772603|466418412|FG001|Overall Study|Withdrawal by Subject|10|||
129579667|NCT00772603|466418413|FG002|Overall Study|Withdrawal by Subject|6|||
129579668|NCT00772603|466418411|FG000|Overall Study|Adverse Event|37|||
129579669|NCT00772603|466418412|FG001|Overall Study|Adverse Event|18|||
129579670|NCT00772603|466418413|FG002|Overall Study|Adverse Event|10|||
129579671|NCT00772603|466418411|FG000|Overall Study|Subject Non-compliance|1|||
129579672|NCT00772603|466418412|FG001|Overall Study|Subject Non-compliance|6|||
129579673|NCT00772603|466418413|FG002|Overall Study|Subject Non-compliance|4|||
129579674|NCT00772603|466418411|FG000|Overall Study|Protocol Violation|0|||
129579675|NCT00772603|466418412|FG001|Overall Study|Protocol Violation|1|||
129579676|NCT00772603|466418413|FG002|Overall Study|Protocol Violation|1|||
129579677|NCT00772603|466418411|FG000|Overall Study|Lost to Follow-up|1|||
129579678|NCT00772603|466418412|FG001|Overall Study|Lost to Follow-up|5|||
129579679|NCT00772603|466418413|FG002|Overall Study|Lost to Follow-up|2|||
129579680|NCT00772603|466418411|FG000|Overall Study|Physician Decision|0|||
129579681|NCT00772603|466418412|FG001|Overall Study|Physician Decision|0|||
129579682|NCT00772603|466418413|FG002|Overall Study|Physician Decision|1|||
129579683|NCT00772603|466418411|FG000|Overall Study|Other|2|||
129579684|NCT00772603|466418412|FG001|Overall Study|Other|0|||
129579685|NCT00772603|466418413|FG002|Overall Study|Other|2|||
129579686|NCT02888756|466418418|FG000|Analytical Treatment Interruption|Physician Decision|10|||
129579687|NCT02888756|466418419|FG001|Analytical Treatment Interruption|Physician Decision|6|||
129579688|NCT02888756|466418420|FG002|Analytical Treatment Interruption|Physician Decision|5|||
129579689|NCT03246503|466418423|FG000|Overall Study|Lost to Follow-up|23|||
129579690|NCT03246503|466418423|FG000|Overall Study|Withdrawal by Subject|20|||
129579691|NCT03246503|466418423|FG000|Overall Study|Physician Decision|5|||
129579692|NCT03246503|466418423|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
129579693|NCT00736190|466418424|FG000|Overall Study|Pregnancy|1|||
129579694|NCT00736190|466418424|FG000|Overall Study|Withdrawal by Subject|1|||
129579695|NCT00736190|466418424|FG000|Overall Study|Adverse Event|1|||
129579696|NCT01492439|466418426|FG000|Overall Study|Withdrew from RTE|4|||
129579697|NCT01492439|466418427|FG001|Overall Study|Withdrew from RTE|9|||
129579698|NCT00716625|466418428|FG000|Overall Study|Safety was not Assessable|1|||
129579699|NCT02909907|466418429|FG000|Overall Study|Withdrawal by Subject|0|||
129579700|NCT02909907|466418430|FG001|Overall Study|Withdrawal by Subject|1|||
129579701|NCT00824291|466418431|FG000|Overall Study|Adverse Event|15|||
129579702|NCT00824291|466418432|FG001|Overall Study|Adverse Event|6|||
129579703|NCT00824291|466418431|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
129579704|NCT00824291|466418432|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
129579705|NCT00824291|466418431|FG000|Overall Study|Lost to Follow-up|11|||
129579706|NCT00824291|466418432|FG001|Overall Study|Lost to Follow-up|9|||
129579707|NCT00824291|466418431|FG000|Overall Study|Non-compliance|1|||
129579708|NCT00824291|466418432|FG001|Overall Study|Non-compliance|1|||
129579709|NCT00824291|466418431|FG000|Overall Study|Protocol Violation|4|||
129579710|NCT00824291|466418432|FG001|Overall Study|Protocol Violation|1|||
129579711|NCT00824291|466418431|FG000|Overall Study|Withdrawal by Subject|14|||
129579712|NCT00824291|466418432|FG001|Overall Study|Withdrawal by Subject|8|||
129579713|NCT00824291|466418431|FG000|Overall Study|Lack of Efficacy|7|||
129579714|NCT00824291|466418432|FG001|Overall Study|Lack of Efficacy|8|||
129579715|NCT00824291|466418431|FG000|Overall Study|Participant on prohibited medication|1|||
129579716|NCT00824291|466418432|FG001|Overall Study|Participant on prohibited medication|0|||
129579717|NCT00933686|466418433|FG000|Overall Study|Protocol Violation|0|||
129579718|NCT00933686|466418434|FG001|Overall Study|Protocol Violation|1|||
129579719|NCT00933686|466418433|FG000|Overall Study|Lost to Follow-up|2|||
129579720|NCT00933686|466418434|FG001|Overall Study|Lost to Follow-up|2|||
129579721|NCT00933686|466418433|FG000|Overall Study|Withdrawal by Subject|6|||
129579722|NCT00933686|466418434|FG001|Overall Study|Withdrawal by Subject|5|||
129579723|NCT00933686|466418433|FG000|Overall Study|Adverse Event|1|||
129579724|NCT00933686|466418434|FG001|Overall Study|Adverse Event|1|||
129579725|NCT00933686|466418433|FG000|Overall Study|Physician Decision|1|||
129579726|NCT00933686|466418434|FG001|Overall Study|Physician Decision|0|||
129579727|NCT00933686|466418433|FG000|Overall Study|Failure to show up at endpoint visits|0|||
129579728|NCT00933686|466418434|FG001|Overall Study|Failure to show up at endpoint visits|2|||
129579729|NCT01648582|466418437|FG000|Overall Study|Adverse Event|6|||
129579730|NCT01648582|466418438|FG001|Overall Study|Adverse Event|11|||
129579731|NCT01648582|466418439|FG002|Overall Study|Adverse Event|2|||
129579732|NCT01648582|466418437|FG000|Overall Study|Lost to Follow-up|9|||
129579733|NCT01648582|466418438|FG001|Overall Study|Lost to Follow-up|6|||
129579734|NCT01648582|466418439|FG002|Overall Study|Lost to Follow-up|8|||
129579735|NCT01648582|466418437|FG000|Overall Study|Protocol Violation|1|||
129579736|NCT01648582|466418438|FG001|Overall Study|Protocol Violation|2|||
129579737|NCT01648582|466418439|FG002|Overall Study|Protocol Violation|1|||
129579738|NCT01648582|466418437|FG000|Overall Study|Withdrawal by Subject|15|||
129579739|NCT01648582|466418438|FG001|Overall Study|Withdrawal by Subject|17|||
129579740|NCT01648582|466418439|FG002|Overall Study|Withdrawal by Subject|17|||
129579741|NCT01648582|466418437|FG000|Overall Study|Physician Decision|0|||
129579742|NCT01648582|466418438|FG001|Overall Study|Physician Decision|1|||
129579743|NCT01648582|466418439|FG002|Overall Study|Physician Decision|3|||
129579744|NCT01648582|466418437|FG000|Overall Study|Death|1|||
129579745|NCT01648582|466418438|FG001|Overall Study|Death|0|||
129579746|NCT01648582|466418439|FG002|Overall Study|Death|0|||
129579747|NCT01648582|466418437|FG000|Overall Study|Sponsor Decision|0|||
129579748|NCT01648582|466418438|FG001|Overall Study|Sponsor Decision|1|||
129579749|NCT01648582|466418439|FG002|Overall Study|Sponsor Decision|1|||
129579750|NCT02699866|466418440|FG000|Overall Study|Withdrawal by Subject|3|||
129579751|NCT02699866|466418440|FG000|Overall Study|Physician Decision|2|||
129579752|NCT02699866|466418440|FG000|Overall Study|Adverse Event|3|||
129579753|NCT03987191|466418447|FG000|Overall Study|COVID-19 related research disruption|0|||
129579754|NCT03987191|466418448|FG001|Overall Study|COVID-19 related research disruption|2|||
129579755|NCT03261167|466418449|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
129579756|NCT03261167|466418450|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
129579757|NCT03261167|466418449|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
129579758|NCT03261167|466418450|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
129579759|NCT03261167|466418449|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
129579760|NCT03261167|466418450|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
129579761|NCT03261167|466418449|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
129579762|NCT03261167|466418450|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
129579763|NCT03261167|466418449|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
129579764|NCT03261167|466418450|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
129579765|NCT01535222|466418451|FG000|Overall Study|Inclusion/exclusion|0|||
129579766|NCT01535222|466418452|FG001|Overall Study|Inclusion/exclusion|0|||
129579767|NCT01535222|466418453|FG002|Overall Study|Inclusion/exclusion|1|||
129579768|NCT01535222|466418454|FG003|Overall Study|Inclusion/exclusion|0|||
129785635|NCT01403948|467183603|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
129785636|NCT01403948|467183604|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
129785637|NCT01403948|467183595|FG000|Overall Study|Lost to Follow-up|0|||
129785638|NCT01403948|467183596|FG001|Overall Study|Lost to Follow-up|0|||
129785639|NCT01403948|467183597|FG002|Overall Study|Lost to Follow-up|0|||
129785640|NCT01403948|467183598|FG003|Overall Study|Lost to Follow-up|0|||
129785641|NCT01403948|467183599|FG004|Overall Study|Lost to Follow-up|0|||
129785642|NCT01403948|467183600|FG005|Overall Study|Lost to Follow-up|0|||
129785643|NCT01403948|467183601|FG006|Overall Study|Lost to Follow-up|0|||
129785644|NCT01403948|467183602|FG007|Overall Study|Lost to Follow-up|0|||
129785645|NCT01403948|467183603|FG008|Overall Study|Lost to Follow-up|0|||
129785646|NCT01403948|467183604|FG009|Overall Study|Lost to Follow-up|1|||
129785647|NCT01403948|467183595|FG000|Overall Study|Refused cont. medication|0|||
129785648|NCT01403948|467183596|FG001|Overall Study|Refused cont. medication|0|||
129785649|NCT01403948|467183597|FG002|Overall Study|Refused cont. medication|0|||
129785650|NCT01403948|467183598|FG003|Overall Study|Refused cont. medication|0|||
129785651|NCT01403948|467183599|FG004|Overall Study|Refused cont. medication|1|||
129579769|NCT01535222|466418455|FG004|Overall Study|Inclusion/exclusion|0|||
129579770|NCT01535222|466418456|FG005|Overall Study|Inclusion/exclusion|0|||
129579771|NCT00935012|466418457|FG000|Overall Study|Death|19|||
129579772|NCT00935012|466418457|FG000|Overall Study|Withdrawal by Subject|3|||
129579773|NCT00935012|466418457|FG000|Overall Study|Other|5|||
129579774|NCT00935012|466418457|FG000|Overall Study|Adverse Event|2|||
129785652|NCT01403948|467183600|FG005|Overall Study|Refused cont. medication|0|||
129785653|NCT01403948|467183601|FG006|Overall Study|Refused cont. medication|0|||
129579775|NCT01442155|466418458|FG000|Overall Study|Complete remission|35|||
129579776|NCT01442155|466418458|FG000|Overall Study|Recurrence|26|||
129579777|NCT01442155|466418458|FG000|Overall Study|Adverse Event|2|||
129579778|NCT01442155|466418458|FG000|Overall Study|Lost to Follow-up|2|||
129579779|NCT00705666|466418459|FG000|Overall Study|No post-treatment questionnaire|279|||
129579780|NCT00705666|466418459|FG000|Overall Study|Withdrawal by Subject|21|||
129579781|NCT00705666|466418459|FG000|Overall Study|Physician Decision|7|||
129579782|NCT00705666|466418459|FG000|Overall Study|Lost to Follow-up|5|||
129579783|NCT00705666|466418459|FG000|Overall Study|Death|1|||
129579784|NCT00705666|466418459|FG000|Overall Study|Adverse Event|4|||
129579785|NCT00705666|466418459|FG000|Overall Study|Other|12|||
129579786|NCT00705666|466418459|FG000|Overall Study|Other|2|||
129579787|NCT00705666|466418459|FG000|Overall Study|Lack of data|3|||
129579788|NCT00705666|466418459|FG000|Overall Study|Untreated|5|||
129579789|NCT01590563|466418468|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
129579790|NCT03256695|466418469|FG000|Overall Study|Adverse Event|8|||
129579791|NCT03256695|466418469|FG000|Overall Study|Death|2|||
129579792|NCT03256695|466418469|FG000|Overall Study|Withdrawal by Subject|14|||
129579793|NCT03256695|466418469|FG000|Overall Study|Non-compliance with study drug|1|||
129579794|NCT03256695|466418469|FG000|Overall Study|Lost to Follow-up|3|||
129785654|NCT01403948|467183602|FG007|Overall Study|Refused cont. medication|0|||
129579795|NCT03256695|466418469|FG000|Overall Study|Lack of Efficacy|3|||
129579796|NCT03256695|466418469|FG000|Overall Study|Protocol Violation|5|||
129579797|NCT03256695|466418469|FG000|Overall Study|Other than specified|3|||
129579798|NCT03930732|466418470|FG000|Overall Study|Adverse Event|9|||
129579799|NCT03930732|466418471|FG001|Overall Study|Adverse Event|7|||
129579800|NCT03930732|466418470|FG000|Overall Study|Poor compliance to protocol|0|||
129579801|NCT03930732|466418471|FG001|Overall Study|Poor compliance to protocol|1|||
129579802|NCT03930732|466418470|FG000|Overall Study|Withdrawal by Subject|23|||
129579803|NCT03930732|466418471|FG001|Overall Study|Withdrawal by Subject|11|||
129579804|NCT03930732|466418470|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
129579805|NCT03930732|466418471|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
129579806|NCT03930732|466418470|FG000|Overall Study|Other reason not related to COVID-19|5|||
129579807|NCT03930732|466418471|FG001|Overall Study|Other reason not related to COVID-19|8|||
129579808|NCT03406156|466418472|FG000|Overall Study|Death|9|||
129579809|NCT03406156|466418473|FG001|Overall Study|Death|3|||
129579810|NCT03406156|466418472|FG000|Overall Study|Withdrawal by Subject|1|||
129579811|NCT03406156|466418473|FG001|Overall Study|Withdrawal by Subject|2|||
129579812|NCT03406156|466418472|FG000|Overall Study|COVID-19 infection|1|||
129579813|NCT03406156|466418473|FG001|Overall Study|COVID-19 infection|0|||
129579814|NCT03406156|466418472|FG000|Overall Study|Non-compliance with study procedures|1|||
129579815|NCT03406156|466418473|FG001|Overall Study|Non-compliance with study procedures|1|||
129579816|NCT03406156|466418472|FG000|Overall Study|Lost to Follow-up|0|||
129579817|NCT03406156|466418473|FG001|Overall Study|Lost to Follow-up|2|||
129579818|NCT03406156|466418472|FG000|Overall Study|Other, not specified|72|||
129579819|NCT03406156|466418473|FG001|Overall Study|Other, not specified|28|||
129579820|NCT03366792|466418476|FG000|Overall Study|Withdrawal by Subject|7|||
129579821|NCT03366792|466418476|FG000|Overall Study|Lost to Follow-up|2|||
129579822|NCT03366792|466418476|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
129579823|NCT03366792|466418476|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
129579824|NCT02450539|466418477|FG000|Overall Study|Withdrawal by Subject|12|||
129579825|NCT02450539|466418478|FG001|Overall Study|Withdrawal by Subject|6|||
129579826|NCT02450539|466418477|FG000|Overall Study|Lost to Follow-up|4|||
129579827|NCT02450539|466418478|FG001|Overall Study|Lost to Follow-up|1|||
129579828|NCT02699463|466418479|FG000|Overall Study|Lost to Follow-up|11|||
129579829|NCT02699463|466418480|FG001|Overall Study|Lost to Follow-up|8|||
129579830|NCT02699463|466418479|FG000|Overall Study|Withdrawal by Subject|4|||
129579831|NCT02699463|466418480|FG001|Overall Study|Withdrawal by Subject|1|||
129579832|NCT01808651|466418481|FG000|Study Period 1|Lost to Follow-up|1|||
129579833|NCT01808651|466418482|FG001|Study Period 1|Lost to Follow-up|3|||
129579834|NCT01808651|466418483|FG002|Study Period 1|Lost to Follow-up|0|||
129579835|NCT01808651|466418481|FG000|Study Period 1|Protocol Violation|1|||
129785655|NCT01403948|467183603|FG008|Overall Study|Refused cont. medication|0|||
129785656|NCT01403948|467183604|FG009|Overall Study|Refused cont. medication|1|||
129579836|NCT01808651|466418482|FG001|Study Period 1|Protocol Violation|0|||
129579837|NCT01808651|466418483|FG002|Study Period 1|Protocol Violation|1|||
129579838|NCT01808651|466418481|FG000|Study Period 1|Physician Decision|3|||
129579839|NCT01808651|466418482|FG001|Study Period 1|Physician Decision|2|||
129579840|NCT01808651|466418483|FG002|Study Period 1|Physician Decision|0|||
129579841|NCT01808651|466418481|FG000|Study Period 1|Lack of Efficacy|2|||
129579842|NCT01808651|466418482|FG001|Study Period 1|Lack of Efficacy|1|||
129579843|NCT01808651|466418483|FG002|Study Period 1|Lack of Efficacy|0|||
129579844|NCT01808651|466418481|FG000|Study Period 1|Adverse Event|10|||
129579845|NCT01808651|466418482|FG001|Study Period 1|Adverse Event|4|||
129579846|NCT01808651|466418483|FG002|Study Period 1|Adverse Event|1|||
129579847|NCT01808651|466418481|FG000|Study Period 1|Participant Decision|9|||
129579848|NCT01808651|466418482|FG001|Study Period 1|Participant Decision|7|||
129579849|NCT01808651|466418483|FG002|Study Period 1|Participant Decision|3|||
129579850|NCT00585286|466418487|FG000|Overall Study|Lost to Follow-up|1|||
129579851|NCT03957551|466418488|FG000|Overall Study|Adverse Event|2|||
129579852|NCT03957551|466418489|FG001|Overall Study|Adverse Event|2|||
129579853|NCT03957551|466418490|FG002|Overall Study|Adverse Event|6|||
129579854|NCT03957551|466418488|FG000|Overall Study|Physician Decision|1|||
129579855|NCT03957551|466418489|FG001|Overall Study|Physician Decision|0|||
129579856|NCT03957551|466418490|FG002|Overall Study|Physician Decision|2|||
129579857|NCT03957551|466418488|FG000|Overall Study|Withdrawal by Subject|1|||
129579858|NCT03957551|466418489|FG001|Overall Study|Withdrawal by Subject|0|||
129579859|NCT03957551|466418490|FG002|Overall Study|Withdrawal by Subject|2|||
129579860|NCT03957551|466418488|FG000|Overall Study|Disease progression|1|||
129579861|NCT03957551|466418489|FG001|Overall Study|Disease progression|0|||
129579862|NCT03957551|466418490|FG002|Overall Study|Disease progression|8|||
129579863|NCT00918684|466418496|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
129579864|NCT00918684|466418496|FG000|Treatment Phase|Lack of Efficacy|6|||
129579865|NCT00918684|466418496|FG000|Treatment Phase|Lost to Follow-up|2|||
129579866|NCT00918684|466418496|FG000|Treatment Phase|Physician Decision|8|||
129579867|NCT00918684|466418496|FG000|Treatment Phase|Protocol Violation|1|||
129579868|NCT00918684|466418496|FG000|Treatment Phase|Withdrawal by Subject|8|||
129579869|NCT00909038|466418497|FG000|Overall Study|Protocol Violation|187|||
129579870|NCT00909038|466418497|FG000|Overall Study|Non-evaluable Subjects|230|||
129579871|NCT00484679|466418498|FG000|Overall Study|Withdrawal by Subject|3|||
129579872|NCT00402103|466418499|FG000|Overall Study|Adverse Event|60|||
129579873|NCT00402103|466418500|FG001|Overall Study|Adverse Event|7|||
129579874|NCT00402103|466418499|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129579875|NCT00402103|466418500|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129579876|NCT00402103|466418499|FG000|Overall Study|Condition no longer requires study drug|2|||
129579877|NCT00402103|466418500|FG001|Overall Study|Condition no longer requires study drug|0|||
129579878|NCT00402103|466418499|FG000|Overall Study|Protocol Deviation|8|||
129579879|NCT00402103|466418500|FG001|Overall Study|Protocol Deviation|0|||
129579880|NCT00402103|466418499|FG000|Overall Study|Patient withdrew consent|12|||
129785657|NCT01403948|467183595|FG000|Overall Study|other than above|1|||
129785658|NCT01403948|467183596|FG001|Overall Study|other than above|2|||
129785659|NCT01403948|467183597|FG002|Overall Study|other than above|1|||
129785660|NCT01403948|467183598|FG003|Overall Study|other than above|0|||
129785661|NCT01403948|467183599|FG004|Overall Study|other than above|1|||
129785662|NCT01403948|467183600|FG005|Overall Study|other than above|1|||
129785663|NCT01403948|467183601|FG006|Overall Study|other than above|2|||
129785664|NCT01403948|467183602|FG007|Overall Study|other than above|0|||
129785665|NCT01403948|467183603|FG008|Overall Study|other than above|0|||
129785666|NCT01403948|467183604|FG009|Overall Study|other than above|0|||
129785667|NCT00763698|467183605|FG000|Overall Study|Unsuccessful Implant|5|||
129785668|NCT00763698|467183605|FG000|Overall Study|Death|4|||
129785669|NCT00763698|467183605|FG000|Overall Study|Withdrawal by Subject|1|||
129785670|NCT01960907|467183608|FG000|Overall Study|Death|4|||
129785671|NCT01960907|467183609|FG001|Overall Study|Death|3|||
129785672|NCT01960907|467183608|FG000|Overall Study|Withdrawal by Subject|32|||
129785673|NCT01960907|467183609|FG001|Overall Study|Withdrawal by Subject|42|||
129785674|NCT00080899|467183610|FG000|Overall Study|Adverse Event|1|||
129785675|NCT00717236|467183611|FG000|Double-Blind Period|Adverse Event|33|||
129579881|NCT00402103|466418500|FG001|Overall Study|Patient withdrew consent|1|||
129785676|NCT00717236|467183612|FG001|Double-Blind Period|Adverse Event|6|||
129785677|NCT00717236|467183611|FG000|Double-Blind Period|Lack of Efficacy|6|||
129785678|NCT00717236|467183612|FG001|Double-Blind Period|Lack of Efficacy|6|||
129785679|NCT00717236|467183611|FG000|Double-Blind Period|Lost to Follow-up|3|||
129785680|NCT00717236|467183612|FG001|Double-Blind Period|Lost to Follow-up|5|||
129785681|NCT00717236|467183611|FG000|Double-Blind Period|Withdrawal by Subject|10|||
129785682|NCT00717236|467183612|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129579882|NCT00402103|466418499|FG000|Overall Study|Lost to Follow-up|6|||
129579883|NCT00402103|466418500|FG001|Overall Study|Lost to Follow-up|3|||
129579884|NCT00402103|466418499|FG000|Overall Study|Administrative problems|2|||
129579885|NCT00402103|466418500|FG001|Overall Study|Administrative problems|0|||
129579886|NCT00835692|466418501|FG000|First Intervention|Withdrawal by Subject|1|||
129785683|NCT00717236|467183611|FG000|Double-Blind Period|Loss of efficacy|3|||
129884726|NCT01651936|467538652|FG002|Base Study|Study terminated by sponsor|0|||
129579887|NCT00835692|466418502|FG001|First Intervention|Withdrawal by Subject|0|||
129579888|NCT04345653|466418505|FG000|Overall Study|Withdrawal by Subject|2|||
129579889|NCT00418938|466418510|FG000|Overall Study|Reimbursement|1|||
129579890|NCT00418938|466418511|FG001|Overall Study|Reimbursement|0|||
129579891|NCT00418938|466418510|FG000|Overall Study|Administrative decision|3|||
129884727|NCT01651936|467538650|FG000|Extension Study|Lack of Efficacy|0|||
129884728|NCT01651936|467538651|FG001|Extension Study|Lack of Efficacy|0|||
129884729|NCT01651936|467538652|FG002|Extension Study|Lack of Efficacy|1|||
129884730|NCT01651936|467538650|FG000|Extension Study|Study terminated by sponsor|0|||
129884731|NCT01651936|467538651|FG001|Extension Study|Study terminated by sponsor|0|||
129884732|NCT01651936|467538652|FG002|Extension Study|Study terminated by sponsor|13|||
129884733|NCT03044353|467538653|FG000|Overall Study|Adverse Event|0|||
129884734|NCT03044353|467538654|FG001|Overall Study|Adverse Event|1|||
129884735|NCT03044353|467538655|FG002|Overall Study|Adverse Event|0|||
129884736|NCT02141659|467538662|FG000|Overall Study|Major Protocol Deviation|0|||
129884737|NCT02141659|467538663|FG001|Overall Study|Major Protocol Deviation|1|||
129884738|NCT02141659|467538664|FG002|Overall Study|Major Protocol Deviation|0|||
129884739|NCT02141659|467538665|FG003|Overall Study|Major Protocol Deviation|0|||
129884740|NCT02141659|467538666|FG004|Overall Study|Major Protocol Deviation|0|||
129884741|NCT02141659|467538667|FG005|Overall Study|Major Protocol Deviation|0|||
129884742|NCT02141659|467538662|FG000|Overall Study|Lack of Efficacy|0|||
129884743|NCT02141659|467538663|FG001|Overall Study|Lack of Efficacy|0|||
129884744|NCT02141659|467538664|FG002|Overall Study|Lack of Efficacy|0|||
129579892|NCT00418938|466418511|FG001|Overall Study|Administrative decision|3|||
129579893|NCT00418938|466418510|FG000|Overall Study|Withdrawal by Subject|16|||
129579894|NCT00418938|466418511|FG001|Overall Study|Withdrawal by Subject|15|||
129579895|NCT00418938|466418510|FG000|Overall Study|Lost to Follow-up|1|||
129579896|NCT00418938|466418511|FG001|Overall Study|Lost to Follow-up|3|||
129579897|NCT00418938|466418510|FG000|Overall Study|Adverse Event|1|||
129579898|NCT00418938|466418511|FG001|Overall Study|Adverse Event|1|||
129579899|NCT00418938|466418510|FG000|Overall Study|On-going|1|||
129579900|NCT00418938|466418511|FG001|Overall Study|On-going|1|||
129579901|NCT00418938|466418510|FG000|Overall Study|Ineligibility Determined|1|||
129579902|NCT00418938|466418511|FG001|Overall Study|Ineligibility Determined|0|||
129579903|NCT00700739|466418512|FG000|Overall Study|Lost to Follow-up|4|||
129884745|NCT02141659|467538665|FG003|Overall Study|Lack of Efficacy|0|||
129884746|NCT02141659|467538666|FG004|Overall Study|Lack of Efficacy|0|||
129579904|NCT00700739|466418513|FG001|Overall Study|Lost to Follow-up|4|||
129579905|NCT01316055|466418521|FG000|Overall Study|Lost to Follow-up|1|||
129579906|NCT01316055|466418522|FG001|Overall Study|Lost to Follow-up|0|||
129579907|NCT01316055|466418523|FG002|Overall Study|Lost to Follow-up|0|||
129579908|NCT01348789|466418524|FG000|Overall Study|Protocol Violation|2|||
129884747|NCT02141659|467538667|FG005|Overall Study|Lack of Efficacy|1|||
129884748|NCT02141659|467538662|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
129884749|NCT02141659|467538663|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
129884750|NCT02141659|467538664|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
129884751|NCT02141659|467538665|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
129579909|NCT01348789|466418524|FG000|Overall Study|Withdrawal by Subject|2|||
129579910|NCT01825798|466418531|FG000|Overall Study|Adverse Event|1|||
129579911|NCT01825798|466418532|FG001|Overall Study|Adverse Event|5|||
129579912|NCT01825798|466418531|FG000|Overall Study|Lost to Follow-up|1|||
129579913|NCT01825798|466418532|FG001|Overall Study|Lost to Follow-up|0|||
129579914|NCT00834873|466418533|FG000|First Intervention|Adverse Event|0|||
129579915|NCT00834873|466418534|FG001|First Intervention|Adverse Event|1|||
129579916|NCT02358538|466418537|FG000|Through Week 26|Adverse Event|0|||
129579917|NCT02358538|466418538|FG001|Through Week 26|Adverse Event|1|||
129579918|NCT02358538|466418539|FG002|Through Week 26|Adverse Event|1|||
129579919|NCT02358538|466418540|FG003|Through Week 26|Adverse Event|2|||
129579920|NCT02358538|466418537|FG000|Through Week 26|Lack of Efficacy|1|||
129579921|NCT02358538|466418538|FG001|Through Week 26|Lack of Efficacy|1|||
129579922|NCT02358538|466418539|FG002|Through Week 26|Lack of Efficacy|3|||
129579923|NCT02358538|466418540|FG003|Through Week 26|Lack of Efficacy|3|||
129579924|NCT02358538|466418537|FG000|Through Week 26|Withdrawal by Subject|1|||
129579925|NCT02358538|466418538|FG001|Through Week 26|Withdrawal by Subject|0|||
129579926|NCT02358538|466418539|FG002|Through Week 26|Withdrawal by Subject|0|||
129579927|NCT02358538|466418540|FG003|Through Week 26|Withdrawal by Subject|0|||
129579928|NCT02358538|466418537|FG000|Through Week 26|Non-Compliance|0|||
129579929|NCT02358538|466418538|FG001|Through Week 26|Non-Compliance|0|||
129579930|NCT02358538|466418539|FG002|Through Week 26|Non-Compliance|1|||
129579931|NCT02358538|466418540|FG003|Through Week 26|Non-Compliance|0|||
129579932|NCT02358538|466418537|FG000|Through Week 26|Family did not see benefit from IP|1|||
129579933|NCT02358538|466418538|FG001|Through Week 26|Family did not see benefit from IP|0|||
129579934|NCT02358538|466418539|FG002|Through Week 26|Family did not see benefit from IP|0|||
129579935|NCT02358538|466418540|FG003|Through Week 26|Family did not see benefit from IP|0|||
129695096|NCT00066170|466841751|FG002|Overall Study|Serious Adverse Event|1|||
129695097|NCT00066170|466841752|FG003|Overall Study|Serious Adverse Event|1|||
129695098|NCT00066170|466841749|FG000|Overall Study|Lost to Follow-up|0|||
129695099|NCT00066170|466841750|FG001|Overall Study|Lost to Follow-up|1|||
129695100|NCT00066170|466841751|FG002|Overall Study|Lost to Follow-up|0|||
129695101|NCT00066170|466841752|FG003|Overall Study|Lost to Follow-up|0|||
129695102|NCT00066170|466841749|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
129695103|NCT00066170|466841750|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
129695104|NCT00066170|466841751|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
129695105|NCT00066170|466841752|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
129695106|NCT00066170|466841749|FG000|Overall Study|Protocol Violation|3|||
129695107|NCT00066170|466841750|FG001|Overall Study|Protocol Violation|0|||
129695108|NCT00066170|466841751|FG002|Overall Study|Protocol Violation|0|||
129695109|NCT00066170|466841752|FG003|Overall Study|Protocol Violation|0|||
129695110|NCT00066170|466841749|FG000|Overall Study|Other|1|||
129695111|NCT00066170|466841750|FG001|Overall Study|Other|5|||
129695112|NCT00066170|466841751|FG002|Overall Study|Other|2|||
129695113|NCT00066170|466841752|FG003|Overall Study|Other|0|||
129695114|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Adverse Event|14|||
129695115|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Adverse Event|27|||
129695116|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Adverse Event|60|||
129695117|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Adverse Event|0|||
129695118|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Adverse Event|0|||
129695119|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Pregnancy|0|||
129695120|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Pregnancy|7|||
129695121|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Pregnancy|9|||
129695122|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Pregnancy|0|||
129695123|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Pregnancy|0|||
129695124|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
129695125|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
129695126|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
129695127|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
129695128|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
129695129|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
129884752|NCT02141659|467538666|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
129579936|NCT02358538|466418537|FG000|52 Week Extension Period|Lack of Efficacy|0|||
129579937|NCT02358538|466418538|FG001|52 Week Extension Period|Lack of Efficacy|0|||
129579938|NCT02358538|466418539|FG002|52 Week Extension Period|Lack of Efficacy|2|||
129695130|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
129695131|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
129695132|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
129695133|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
129695134|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Death|1|||
129695135|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Death|2|||
129695136|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Death|2|||
129579939|NCT02358538|466418540|FG003|52 Week Extension Period|Lack of Efficacy|4|||
129579940|NCT04827394|466418544|FG000|Overall Study|Physician Decision|0|||
129579941|NCT04827394|466418545|FG001|Overall Study|Physician Decision|2|||
129579942|NCT03500094|466418546|FG000|Overall Study|Withdrawal by Subject|1|||
129579943|NCT03500094|466418546|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
129579944|NCT03500094|466418546|FG000|Overall Study|Lost to Follow-up|1|||
129579945|NCT01030133|466418549|FG000|Overall Study|failed to experience pain at level 7/10|2|||
129579946|NCT01030133|466418550|FG001|Overall Study|failed to experience pain at level 7/10|2|||
129579947|NCT00477594|466418551|FG000|Year 1 and Year 2|Adverse Event|4|||
129579948|NCT00477594|466418552|FG001|Year 1 and Year 2|Adverse Event|2|||
129579949|NCT00477594|466418551|FG000|Year 1 and Year 2|Physician Decision|2|||
129579950|NCT00477594|466418552|FG001|Year 1 and Year 2|Physician Decision|1|||
129579951|NCT00477594|466418551|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
129579952|NCT00477594|466418552|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
129579953|NCT00477594|466418551|FG000|Year 1 and Year 2|Other|1|||
129579954|NCT00477594|466418552|FG001|Year 1 and Year 2|Other|0|||
129579955|NCT00477594|466418551|FG000|Year 3|Adverse Event|1|||
129579956|NCT00477594|466418552|FG001|Year 3|Adverse Event|0|||
129579957|NCT00477594|466418551|FG000|Year 3|Withdrawal by Subject|1|||
129579958|NCT00477594|466418552|FG001|Year 3|Withdrawal by Subject|0|||
129579959|NCT00477594|466418551|FG000|Follow-up Period|Withdrawal by Subject|2|||
129579960|NCT00477594|466418552|FG001|Follow-up Period|Withdrawal by Subject|1|||
129579961|NCT00477594|466418551|FG000|Follow-up Period|Other|1|||
129579962|NCT00477594|466418552|FG001|Follow-up Period|Other|0|||
129579963|NCT02068794|466420280|FG000|Overall Study|Withdrawal by Subject|0|||
129579964|NCT02068794|466420281|FG001|Overall Study|Withdrawal by Subject|1|||
129579965|NCT02068794|466420282|FG002|Overall Study|Withdrawal by Subject|2|||
129579966|NCT02068794|466420280|FG000|Overall Study|Early Progression|1|||
129579967|NCT02068794|466420281|FG001|Overall Study|Early Progression|0|||
129579968|NCT02068794|466420282|FG002|Overall Study|Early Progression|1|||
129579969|NCT02068794|466420280|FG000|Overall Study|Ineligible|0|||
129579970|NCT02068794|466420281|FG001|Overall Study|Ineligible|0|||
129579971|NCT02068794|466420282|FG002|Overall Study|Ineligible|1|||
129579972|NCT02316548|466420284|FG000|Overall Study|Protocol Violation|0|||
129579973|NCT02316548|466420285|FG001|Overall Study|Protocol Violation|1|||
129579974|NCT01958294|466420286|FG000|Overall Study|Clinical Circumstances|2|||
129579975|NCT02566850|466420288|FG000|Overall Study|Protocol Violation|1|||
129579976|NCT02635750|466420289|FG000|Part 1, Period 2|Adverse Event|1|||
129579977|NCT02635750|466420290|FG001|Part 1, Period 2|Adverse Event|0|||
129579978|NCT02635750|466420291|FG002|Part 1, Period 2|Adverse Event|0|||
129579979|NCT00830258|466420294|FG000|First Intervention|Adverse Event|1|||
129579980|NCT00830258|466420295|FG001|First Intervention|Adverse Event|0|||
129785684|NCT00717236|467183612|FG001|Double-Blind Period|Loss of efficacy|0|||
129785685|NCT00717236|467183611|FG000|Double-Blind Period|Other: Death|1|||
129785686|NCT00717236|467183612|FG001|Double-Blind Period|Other: Death|0|||
129785687|NCT00717236|467183611|FG000|Double-Blind Period|Other: Pregnancy|1|||
129785688|NCT00717236|467183612|FG001|Double-Blind Period|Other: Pregnancy|0|||
129785689|NCT00717236|467183611|FG000|Double-Blind Period|Other: Protocol Violation|2|||
129785690|NCT00717236|467183612|FG001|Double-Blind Period|Other: Protocol Violation|0|||
129785691|NCT00717236|467183611|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
129785692|NCT00717236|467183612|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
129785693|NCT00717236|467183611|FG000|Double-Blind Period|Other: Site withdrew|2|||
129785694|NCT00717236|467183612|FG001|Double-Blind Period|Other: Site withdrew|0|||
129785695|NCT00717236|467183611|FG000|Double-Blind Period|Other: Screening failure|1|||
129785696|NCT00717236|467183612|FG001|Double-Blind Period|Other: Screening failure|0|||
129785697|NCT00717236|467183611|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
129785698|NCT00717236|467183612|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
129785699|NCT00717236|467183611|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
129785700|NCT00717236|467183612|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
129785701|NCT00717236|467183611|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
129785702|NCT00717236|467183612|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
129800245|NCT04755283|467236270|FG002|Overall Study|Death|34|||
129579981|NCT00830258|466420294|FG000|Washout: 7 Days|Protocol Violation|1|||
129579982|NCT00830258|466420295|FG001|Washout: 7 Days|Protocol Violation|0|||
129579983|NCT00682461|466420299|FG000|Overall Study|Adverse Event|5|||
129579984|NCT00682461|466420300|FG001|Overall Study|Adverse Event|7|||
129579985|NCT00682461|466420299|FG000|Overall Study|Lost to Follow-up|8|||
129579986|NCT00682461|466420300|FG001|Overall Study|Lost to Follow-up|5|||
129579987|NCT00682461|466420299|FG000|Overall Study|Withdrawal by Subject|12|||
129579988|NCT00682461|466420300|FG001|Overall Study|Withdrawal by Subject|19|||
129579989|NCT04035187|466420304|FG000|Overall Study|Withdrawal by Subject|2|||
129579990|NCT04035187|466420305|FG001|Overall Study|Withdrawal by Subject|1|||
129579991|NCT04035187|466420306|FG002|Overall Study|Withdrawal by Subject|0|||
129579992|NCT04035187|466420307|FG003|Overall Study|Withdrawal by Subject|0|||
129579993|NCT04035187|466420304|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
129579994|NCT04035187|466420305|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
129579995|NCT04035187|466420306|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
129579996|NCT04035187|466420307|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
129579997|NCT01116739|466420308|FG000|Overall Study|Child had 2 years of HS|110|||
129579998|NCT01116739|466420309|FG001|Overall Study|Child had 2 years of HS|128|||
129579999|NCT01116739|466420308|FG000|Overall Study|Withdrawal by Subject|6|||
129580000|NCT01116739|466420309|FG001|Overall Study|Withdrawal by Subject|0|||
129580001|NCT01116739|466420308|FG000|Overall Study|child too young|2|||
129580002|NCT01116739|466420309|FG001|Overall Study|child too young|6|||
129580003|NCT01116739|466420308|FG000|Overall Study|child not enrolled in head start|10|||
129580004|NCT01116739|466420309|FG001|Overall Study|child not enrolled in head start|2|||
129580005|NCT01116739|466420308|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
129580006|NCT01116739|466420309|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
129580007|NCT05511935|466420310|FG000|Overall Study|Lost to Follow-up|9|||
129580008|NCT05511935|466420311|FG001|Overall Study|Lost to Follow-up|27|||
129785703|NCT00717236|467183611|FG000|Double-Blind Period|Other: History of cancer|1|||
129785704|NCT00717236|467183612|FG001|Double-Blind Period|Other: History of cancer|0|||
129785705|NCT00717236|467183611|FG000|Double-Blind Period|Other: Sponsor request|1|||
129785706|NCT00717236|467183612|FG001|Double-Blind Period|Other: Sponsor request|0|||
129785707|NCT00717236|467183611|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
129785708|NCT00717236|467183612|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
129785709|NCT00717236|467183611|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
129785710|NCT00717236|467183612|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
129785711|NCT00717236|467183611|FG000|Double-Blind Period|Other: Subject moved|1|||
129785712|NCT00717236|467183612|FG001|Double-Blind Period|Other: Subject moved|1|||
129785713|NCT00717236|467183611|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
129785714|NCT00717236|467183612|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
129785715|NCT00717236|467183611|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
129785716|NCT00717236|467183612|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
129785717|NCT00717236|467183611|FG000|Double-Blind Period|Other: Transportation problems|0|||
129785718|NCT00717236|467183612|FG001|Double-Blind Period|Other: Transportation problems|1|||
129785719|NCT00717236|467183611|FG000|Double-Blind Period|Other: Investigator Decision|0|||
129785720|NCT00717236|467183612|FG001|Double-Blind Period|Other: Investigator Decision|1|||
129785721|NCT00717236|467183611|FG000|Open-Label Period|Adverse Event|29|||
129785722|NCT00717236|467183612|FG001|Open-Label Period|Adverse Event|4|||
129785723|NCT00717236|467183611|FG000|Open-Label Period|Lack of Efficacy|30|||
129785724|NCT00717236|467183612|FG001|Open-Label Period|Lack of Efficacy|8|||
129785725|NCT00717236|467183611|FG000|Open-Label Period|Lost to Follow-up|28|||
129785726|NCT00717236|467183612|FG001|Open-Label Period|Lost to Follow-up|4|||
129785727|NCT00717236|467183611|FG000|Open-Label Period|Withdrawal by Subject|20|||
129785728|NCT00717236|467183612|FG001|Open-Label Period|Withdrawal by Subject|2|||
129785729|NCT00717236|467183611|FG000|Open-Label Period|Loss of Efficacy|6|||
129785730|NCT00717236|467183612|FG001|Open-Label Period|Loss of Efficacy|1|||
129785731|NCT00717236|467183611|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
129785732|NCT00717236|467183612|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
129785733|NCT00717236|467183611|FG000|Open-Label Period|Other: Lack of Compliance|1|||
129785734|NCT00717236|467183612|FG001|Open-Label Period|Other: Lack of Compliance|1|||
129785735|NCT00717236|467183611|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
129785736|NCT00717236|467183612|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
129785737|NCT00717236|467183611|FG000|Open-Label Period|Other: Moved|1|||
129785738|NCT00717236|467183612|FG001|Open-Label Period|Other: Moved|0|||
129785739|NCT00717236|467183611|FG000|Open-Label Period|Other: Investigator Decision|1|||
129785740|NCT00717236|467183612|FG001|Open-Label Period|Other: Investigator Decision|0|||
129785741|NCT00717236|467183611|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
129785742|NCT00717236|467183612|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
129785743|NCT00717236|467183611|FG000|Open-Label Period|Other: Sponsor Request|3|||
129785744|NCT00717236|467183612|FG001|Open-Label Period|Other: Sponsor Request|0|||
129580009|NCT05090839|466420314|FG000|Overall Study|Lost to Follow-up|2|||
129785745|NCT00717236|467183611|FG000|Open-Label Period|Other: Cataract Surgery|1|||
129580010|NCT05090839|466420315|FG001|Overall Study|Lost to Follow-up|3|||
129580011|NCT05090839|466420316|FG002|Overall Study|Lost to Follow-up|1|||
129580012|NCT05090839|466420317|FG003|Overall Study|Lost to Follow-up|1|||
129580013|NCT03913377|466420318|FG000|Period 1|Test Article no longer available|0|||
129580014|NCT03913377|466420319|FG001|Period 1|Test Article no longer available|1|||
129580015|NCT03913377|466420320|FG002|Period 1|Test Article no longer available|0|||
129580016|NCT03913377|466420318|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
129580017|NCT03913377|466420319|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
129580018|NCT03913377|466420320|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
129580019|NCT03499353|466420321|FG000|Treatment|Adverse Event|3|||
129580020|NCT03499353|466420321|FG000|Treatment|Progressive Disease|10|||
129580021|NCT03499353|466420321|FG000|Treatment|Other|1|||
129580022|NCT03499353|466420321|FG000|Treatment|Withdrawal by Subject|2|||
129580023|NCT03499353|466420321|FG000|Long-Term Follow-up|Death|2|||
129580024|NCT03499353|466420321|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
129580025|NCT03499353|466420321|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
129580026|NCT01117623|466420322|FG000|Overall Study|Adverse Event|0|||
129580027|NCT01117623|466420323|FG001|Overall Study|Adverse Event|2|||
129580028|NCT01117623|466420324|FG002|Overall Study|Adverse Event|4|||
129580029|NCT01117623|466420325|FG003|Overall Study|Adverse Event|0|||
129580030|NCT01117623|466420326|FG004|Overall Study|Adverse Event|2|||
129580031|NCT01117623|466420327|FG005|Overall Study|Adverse Event|0|||
129580032|NCT01117623|466420328|FG006|Overall Study|Adverse Event|0|||
129580033|NCT01117623|466420329|FG007|Overall Study|Adverse Event|2|||
129580034|NCT01117623|466420322|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
129580035|NCT01117623|466420323|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
129580036|NCT01117623|466420324|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
129580037|NCT01117623|466420325|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
129580038|NCT01117623|466420326|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
129580039|NCT01117623|466420327|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
129580040|NCT01117623|466420328|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
129580041|NCT01117623|466420329|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
129580042|NCT01117623|466420322|FG000|Overall Study|Withdrawal by Subject|0|||
129580043|NCT01117623|466420323|FG001|Overall Study|Withdrawal by Subject|0|||
129580044|NCT01117623|466420324|FG002|Overall Study|Withdrawal by Subject|2|||
129695137|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Death|0|||
129695138|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Death|0|||
129695139|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
129695140|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
129695141|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
129695142|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
129695143|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
129695144|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
129695145|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
129695146|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
129695147|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
129695148|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
129695149|NCT00098293|466841753|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
129695150|NCT00098293|466841754|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
129695151|NCT00098293|466841755|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
129695152|NCT00098293|466841756|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
129695153|NCT00098293|466841757|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
129695154|NCT00098293|466841753|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129695155|NCT00098293|466841754|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129695156|NCT00098293|466841755|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
129695157|NCT00098293|466841756|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129695158|NCT00098293|466841757|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
129695159|NCT00098293|466841753|FG000|Open-label (OL) Phase|Adverse Event|0|||
129695160|NCT00098293|466841754|FG001|Open-label (OL) Phase|Adverse Event|3|||
129695161|NCT00098293|466841755|FG002|Open-label (OL) Phase|Adverse Event|7|||
129695162|NCT00098293|466841756|FG003|Open-label (OL) Phase|Adverse Event|6|||
129695163|NCT00098293|466841757|FG004|Open-label (OL) Phase|Adverse Event|0|||
129785746|NCT00717236|467183612|FG001|Open-Label Period|Other: Cataract Surgery|0|||
129785747|NCT00717236|467183611|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
129580045|NCT01117623|466420325|FG003|Overall Study|Withdrawal by Subject|0|||
129580046|NCT01117623|466420326|FG004|Overall Study|Withdrawal by Subject|0|||
129580047|NCT01117623|466420327|FG005|Overall Study|Withdrawal by Subject|1|||
129580048|NCT01117623|466420328|FG006|Overall Study|Withdrawal by Subject|1|||
129580049|NCT01117623|466420329|FG007|Overall Study|Withdrawal by Subject|1|||
129580050|NCT01117623|466420322|FG000|Overall Study|Non-compliance with study medication|0|||
129580051|NCT01117623|466420323|FG001|Overall Study|Non-compliance with study medication|0|||
129695164|NCT00098293|466841753|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
129695165|NCT00098293|466841754|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
129580052|NCT01117623|466420324|FG002|Overall Study|Non-compliance with study medication|0|||
129580053|NCT01117623|466420325|FG003|Overall Study|Non-compliance with study medication|0|||
129580054|NCT01117623|466420326|FG004|Overall Study|Non-compliance with study medication|0|||
129580055|NCT01117623|466420327|FG005|Overall Study|Non-compliance with study medication|0|||
129580056|NCT01117623|466420328|FG006|Overall Study|Non-compliance with study medication|0|||
129580057|NCT01117623|466420329|FG007|Overall Study|Non-compliance with study medication|1|||
129580058|NCT01117623|466420322|FG000|Overall Study|Invest. text: completed all planned txs|0|||
129580059|NCT01117623|466420323|FG001|Overall Study|Invest. text: completed all planned txs|0|||
129580060|NCT01117623|466420324|FG002|Overall Study|Invest. text: completed all planned txs|0|||
129580061|NCT01117623|466420325|FG003|Overall Study|Invest. text: completed all planned txs|0|||
129580062|NCT01117623|466420326|FG004|Overall Study|Invest. text: completed all planned txs|0|||
129580063|NCT01117623|466420327|FG005|Overall Study|Invest. text: completed all planned txs|1|||
129580064|NCT01117623|466420328|FG006|Overall Study|Invest. text: completed all planned txs|0|||
129580065|NCT01117623|466420329|FG007|Overall Study|Invest. text: completed all planned txs|0|||
129580066|NCT01896934|466420334|FG000|Overall Study|Adverse Event|1|||
129580067|NCT01896934|466420334|FG000|Overall Study|Withdrawal by Subject|1|||
129580068|NCT00395694|466420336|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
129580069|NCT00395694|466420337|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
129580070|NCT00395694|466420336|FG000|Continuation Phase|Adverse Event|1|||
129580071|NCT00395694|466420337|FG001|Continuation Phase|Adverse Event|0|||
129580072|NCT00395694|466420336|FG000|Continuation Phase|Lack of Efficacy|12|||
129580073|NCT00395694|466420337|FG001|Continuation Phase|Lack of Efficacy|11|||
129580074|NCT00395694|466420336|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
129580075|NCT00395694|466420337|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
129580076|NCT00395694|466420336|FG000|Continuation Phase|Poor Compliance|1|||
129580077|NCT00395694|466420337|FG001|Continuation Phase|Poor Compliance|0|||
129580078|NCT00395694|466420336|FG000|Continuation Phase|Withdrawal by Subject|0|||
129580079|NCT00395694|466420337|FG001|Continuation Phase|Withdrawal by Subject|2|||
129580080|NCT01959672|466420341|FG000|Overall Study|Death|1|||
129580081|NCT00840216|466420342|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129580082|NCT00840216|466420343|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129580083|NCT01058668|466420344|FG000|Double-blind Treatment Phase|Adverse Event|8|||
129580084|NCT01058668|466420345|FG001|Double-blind Treatment Phase|Adverse Event|15|||
129580085|NCT01058668|466420346|FG002|Double-blind Treatment Phase|Adverse Event|25|||
129580086|NCT01058668|466420344|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
129580087|NCT01058668|466420345|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
129580088|NCT01058668|466420346|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
129580089|NCT01058668|466420344|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
129580090|NCT01058668|466420345|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
129580091|NCT01058668|466420346|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
129580092|NCT01058668|466420344|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
129580093|NCT01058668|466420345|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
129580094|NCT01058668|466420346|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
129580095|NCT01058668|466420344|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129580096|NCT01058668|466420345|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
129580097|NCT01058668|466420346|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
129580098|NCT01058668|466420344|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
129695166|NCT00098293|466841755|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
129695167|NCT00098293|466841756|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
129695168|NCT00098293|466841757|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
129695169|NCT00098293|466841753|FG000|Open-label (OL) Phase|Pregnancy|0|||
129695170|NCT00098293|466841754|FG001|Open-label (OL) Phase|Pregnancy|1|||
129695171|NCT00098293|466841755|FG002|Open-label (OL) Phase|Pregnancy|0|||
129695172|NCT00098293|466841756|FG003|Open-label (OL) Phase|Pregnancy|3|||
129695173|NCT00098293|466841757|FG004|Open-label (OL) Phase|Pregnancy|0|||
129695174|NCT00098293|466841753|FG000|Open-label (OL) Phase|Protocol Violation|0|||
129695175|NCT00098293|466841754|FG001|Open-label (OL) Phase|Protocol Violation|6|||
129695176|NCT00098293|466841755|FG002|Open-label (OL) Phase|Protocol Violation|13|||
129695177|NCT00098293|466841756|FG003|Open-label (OL) Phase|Protocol Violation|16|||
129695178|NCT00098293|466841757|FG004|Open-label (OL) Phase|Protocol Violation|0|||
129695179|NCT00098293|466841753|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
129695180|NCT00098293|466841754|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
129695181|NCT00098293|466841755|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
129695182|NCT00098293|466841756|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
129695183|NCT00098293|466841757|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
129580099|NCT01058668|466420345|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
129580100|NCT01058668|466420346|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
129695184|NCT00098293|466841753|FG000|Open-label (OL) Phase|Death|0|||
129695185|NCT00098293|466841754|FG001|Open-label (OL) Phase|Death|2|||
129884753|NCT02141659|467538667|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
129884754|NCT01927731|467538668|FG000|Overall Study|Graft Failure|1|||
129884755|NCT01927731|467538669|FG001|Overall Study|Graft Failure|2|||
129884756|NCT01927731|467538668|FG000|Overall Study|Physician Decision|2|||
129884757|NCT01927731|467538669|FG001|Overall Study|Physician Decision|3|||
129884758|NCT01927731|467538668|FG000|Overall Study|Withdrawal by Subject|0|||
129884759|NCT01927731|467538669|FG001|Overall Study|Withdrawal by Subject|2|||
129884760|NCT01927731|467538668|FG000|Overall Study|Death|0|||
129884761|NCT01927731|467538669|FG001|Overall Study|Death|3|||
129884762|NCT01388530|467538672|FG000|Overall Study|Lost to Follow-up|5|||
129884763|NCT00305864|467538673|FG000|Overall Study|Ineligible / No protocol treatment|0|||
129884764|NCT00305864|467538674|FG001|Overall Study|Ineligible / No protocol treatment|1|||
129884765|NCT00305864|467538675|FG002|Overall Study|Ineligible / No protocol treatment|1|||
129884766|NCT00305864|467538676|FG003|Overall Study|Ineligible / No protocol treatment|13|||
129884767|NCT02836613|467538677|FG000|Overall Study|Accidental drowning|1|||
129884768|NCT02836613|467538678|FG001|Overall Study|Accidental drowning|0|||
129884769|NCT02836613|467538677|FG000|Overall Study|Lost to Follow-up|0|||
129884770|NCT02836613|467538678|FG001|Overall Study|Lost to Follow-up|1|||
129884771|NCT02836613|467538677|FG000|Overall Study|Withdrawal by Subject|0|||
129884772|NCT02836613|467538678|FG001|Overall Study|Withdrawal by Subject|2|||
129884773|NCT03881059|467538679|FG000|Treatment Period - Part A|Adverse Event|1|||
129884774|NCT03881059|467538680|FG001|Treatment Period - Part A|Adverse Event|3|||
129884775|NCT03881059|467538681|FG002|Treatment Period - Part A|Adverse Event|4|||
129884776|NCT03881059|467538679|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
129884777|NCT03881059|467538680|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
129884778|NCT03881059|467538681|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
129884779|NCT03881059|467538679|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
129884780|NCT03881059|467538680|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
129884781|NCT03881059|467538681|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
129884782|NCT03881059|467538679|FG000|Treatment Period - Part A|Other reasons|2|||
129884783|NCT03881059|467538680|FG001|Treatment Period - Part A|Other reasons|1|||
129884784|NCT03881059|467538681|FG002|Treatment Period - Part A|Other reasons|0|||
129884785|NCT03881059|467538679|FG000|Treatment Period - Part B|Adverse Event|0|||
129884786|NCT03881059|467538680|FG001|Treatment Period - Part B|Adverse Event|0|||
129884787|NCT03881059|467538681|FG002|Treatment Period - Part B|Adverse Event|3|||
129884788|NCT03881059|467538679|FG000|Treatment Period - Part B|Death|0|||
129884789|NCT03881059|467538680|FG001|Treatment Period - Part B|Death|1|||
129884790|NCT03881059|467538681|FG002|Treatment Period - Part B|Death|1|||
129884791|NCT03881059|467538679|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
129884792|NCT03881059|467538680|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
129884793|NCT03881059|467538681|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
129884794|NCT03881059|467538679|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
129884795|NCT03881059|467538680|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
129884796|NCT03881059|467538681|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
129884797|NCT03881059|467538679|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
129884798|NCT03881059|467538680|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
129884799|NCT03881059|467538681|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
129884800|NCT03881059|467538679|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
129884801|NCT03881059|467538680|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
129884802|NCT03881059|467538681|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
129884803|NCT03881059|467538679|FG000|Treatment Period - Part B|Other reasons|4|||
129884804|NCT03881059|467538680|FG001|Treatment Period - Part B|Other reasons|3|||
129884805|NCT03881059|467538681|FG002|Treatment Period - Part B|Other reasons|3|||
129884806|NCT05284019|467538682|FG000|Overall Study|Study terminated|2|||
129884807|NCT05284019|467538683|FG001|Overall Study|Study terminated|2|||
129884808|NCT05284019|467538684|FG002|Overall Study|Study terminated|2|||
129884809|NCT05284019|467538685|FG003|Overall Study|Study terminated|5|||
129884810|NCT05284019|467538686|FG004|Overall Study|Study terminated|15|||
129884811|NCT05284019|467538682|FG000|Overall Study|Withdrawal by Subject|0|||
129884812|NCT05284019|467538683|FG001|Overall Study|Withdrawal by Subject|0|||
129884813|NCT05284019|467538684|FG002|Overall Study|Withdrawal by Subject|0|||
129884814|NCT05284019|467538685|FG003|Overall Study|Withdrawal by Subject|1|||
129884815|NCT05284019|467538686|FG004|Overall Study|Withdrawal by Subject|1|||
129884816|NCT05284019|467538682|FG000|Overall Study|Lost to Follow-up|1|||
129884817|NCT05284019|467538683|FG001|Overall Study|Lost to Follow-up|0|||
129884818|NCT05284019|467538684|FG002|Overall Study|Lost to Follow-up|0|||
129884819|NCT05284019|467538685|FG003|Overall Study|Lost to Follow-up|2|||
129884820|NCT05284019|467538686|FG004|Overall Study|Lost to Follow-up|1|||
129884821|NCT02065570|467538687|FG000|Induction Study|Adverse Event|5|||
129884822|NCT02065570|467538688|FG001|Induction Study|Adverse Event|12|||
129884823|NCT02065570|467538689|FG002|Induction Study|Adverse Event|0|||
129884824|NCT02065570|467538690|FG003|Induction Study|Adverse Event|0|||
129884825|NCT02065570|467538687|FG000|Induction Study|Withdrawal by Subject|2|||
129884826|NCT02065570|467538688|FG001|Induction Study|Withdrawal by Subject|3|||
129884827|NCT02065570|467538689|FG002|Induction Study|Withdrawal by Subject|0|||
129884828|NCT02065570|467538690|FG003|Induction Study|Withdrawal by Subject|0|||
129884829|NCT02065570|467538687|FG000|Induction Study|Lost to Follow-up|1|||
129884830|NCT02065570|467538688|FG001|Induction Study|Lost to Follow-up|1|||
129884831|NCT02065570|467538689|FG002|Induction Study|Lost to Follow-up|0|||
129884832|NCT02065570|467538690|FG003|Induction Study|Lost to Follow-up|0|||
129884833|NCT02065570|467538687|FG000|Induction Study|Other, Not Specified|6|||
129884834|NCT02065570|467538688|FG001|Induction Study|Other, Not Specified|5|||
129884835|NCT02065570|467538689|FG002|Induction Study|Other, Not Specified|0|||
129884836|NCT02065570|467538690|FG003|Induction Study|Other, Not Specified|0|||
129884837|NCT02065570|467538687|FG000|Maintenance Study|Adverse Event|0|||
129884838|NCT02065570|467538688|FG001|Maintenance Study|Adverse Event|0|||
129884839|NCT02065570|467538689|FG002|Maintenance Study|Adverse Event|8|||
129884840|NCT02065570|467538690|FG003|Maintenance Study|Adverse Event|8|||
129884841|NCT02065570|467538687|FG000|Maintenance Study|Withdrawal by Subject|0|||
129884842|NCT02065570|467538688|FG001|Maintenance Study|Withdrawal by Subject|0|||
129884843|NCT02065570|467538689|FG002|Maintenance Study|Withdrawal by Subject|1|||
129884844|NCT02065570|467538690|FG003|Maintenance Study|Withdrawal by Subject|4|||
129884845|NCT02065570|467538687|FG000|Maintenance Study|Lost to Follow-up|0|||
129884846|NCT02065570|467538688|FG001|Maintenance Study|Lost to Follow-up|0|||
129884847|NCT02065570|467538689|FG002|Maintenance Study|Lost to Follow-up|2|||
129884848|NCT02065570|467538690|FG003|Maintenance Study|Lost to Follow-up|2|||
129884849|NCT02065570|467538687|FG000|Maintenance Study|Other, Not Specified|0|||
129884850|NCT02065570|467538688|FG001|Maintenance Study|Other, Not Specified|0|||
129884851|NCT02065570|467538689|FG002|Maintenance Study|Other, Not Specified|11|||
129884852|NCT02065570|467538690|FG003|Maintenance Study|Other, Not Specified|5|||
129884853|NCT03382600|467538694|FG000|Overall Study|Adverse Event|3|||
129884854|NCT03382600|467538695|FG001|Overall Study|Adverse Event|3|||
129580101|NCT03605342|466420353|FG000|Overall Study|Withdrawal by Subject|9|||
129580102|NCT03605342|466420354|FG001|Overall Study|Withdrawal by Subject|7|||
129580103|NCT03605342|466420353|FG000|Overall Study|Lost to Follow-up|1|||
129580104|NCT03605342|466420354|FG001|Overall Study|Lost to Follow-up|1|||
129580105|NCT00796328|466420355|FG000|Overall Study|experienced hypotension requiring tx|6|||
129580106|NCT02842853|466420358|FG000|Overall Study|Non-compliance with the protocol|3|||
129580107|NCT02842853|466420359|FG001|Overall Study|Non-compliance with the protocol|7|||
129580108|NCT02842853|466420360|FG002|Overall Study|Non-compliance with the protocol|2|||
129580109|NCT02842853|466420361|FG003|Overall Study|Non-compliance with the protocol|5|||
129580110|NCT02842853|466420358|FG000|Overall Study|Subject met exclusion criteria|0|||
129580111|NCT02842853|466420359|FG001|Overall Study|Subject met exclusion criteria|1|||
129785748|NCT00717236|467183612|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
129785749|NCT00717236|467183611|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
129785750|NCT00717236|467183612|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
129785751|NCT00717236|467183611|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
129785752|NCT00717236|467183612|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
129785753|NCT00475982|467183613|FG000|Overall Study|surgery rescheduled|7|||
129785754|NCT00475982|467183614|FG001|Overall Study|surgery rescheduled|3|||
129785755|NCT00783198|467183619|FG000|Overall Study|Adverse Event|15|||
129785756|NCT00783198|467183620|FG001|Overall Study|Adverse Event|19|||
129785757|NCT00783198|467183621|FG002|Overall Study|Adverse Event|3|||
129580112|NCT02842853|466420360|FG002|Overall Study|Subject met exclusion criteria|0|||
129580113|NCT02842853|466420361|FG003|Overall Study|Subject met exclusion criteria|0|||
129580114|NCT02842853|466420358|FG000|Overall Study|Withdrawal by Subject|11|||
129580115|NCT02842853|466420359|FG001|Overall Study|Withdrawal by Subject|13|||
129580116|NCT02842853|466420360|FG002|Overall Study|Withdrawal by Subject|9|||
129580117|NCT02842853|466420361|FG003|Overall Study|Withdrawal by Subject|8|||
129580118|NCT02842853|466420358|FG000|Overall Study|Lost to Follow-up|9|||
129580119|NCT02842853|466420359|FG001|Overall Study|Lost to Follow-up|13|||
129580120|NCT02842853|466420360|FG002|Overall Study|Lost to Follow-up|10|||
129580121|NCT02842853|466420361|FG003|Overall Study|Lost to Follow-up|11|||
129884855|NCT03382600|467538694|FG000|Overall Study|Clinical Disease Progression|2|||
129884856|NCT03382600|467538695|FG001|Overall Study|Clinical Disease Progression|4|||
129884857|NCT03382600|467538694|FG000|Overall Study|Radiological Progression|40|||
129884858|NCT03382600|467538695|FG001|Overall Study|Radiological Progression|31|||
129580122|NCT04089553|466420362|FG000|Overall Study|Death|1|||
129884859|NCT03382600|467538694|FG000|Overall Study|Withdrawal by Subject|0|||
129884860|NCT03382600|467538695|FG001|Overall Study|Withdrawal by Subject|1|||
129580123|NCT04089553|466420363|FG001|Overall Study|Death|1|||
129580124|NCT04089553|466420362|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
129580125|NCT04089553|466420363|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
129580126|NCT04089553|466420362|FG000|Overall Study|Withdrawal by Subject|3|||
129884861|NCT03382600|467538694|FG000|Overall Study|Other|9|||
129785758|NCT00783198|467183619|FG000|Overall Study|Lost to Follow-up|11|||
129884862|NCT03382600|467538695|FG001|Overall Study|Other|7|||
129884863|NCT01000376|467538696|FG000|Cycle 1 Day 1|Adverse Event|1|||
129884864|NCT01000376|467538697|FG001|Cycle 1 Day 1|Adverse Event|0|||
129884865|NCT01000376|467538696|FG000|Cycle 1 Day 1|Progressive Disease|1|||
129785759|NCT00783198|467183620|FG001|Overall Study|Lost to Follow-up|1|||
129785760|NCT00783198|467183621|FG002|Overall Study|Lost to Follow-up|7|||
129785761|NCT00783198|467183619|FG000|Overall Study|Withdrawal by Subject|22|||
129785762|NCT00783198|467183620|FG001|Overall Study|Withdrawal by Subject|14|||
129785763|NCT00783198|467183621|FG002|Overall Study|Withdrawal by Subject|20|||
129785764|NCT00783198|467183619|FG000|Overall Study|Noncompliance with protocol|7|||
129785765|NCT00783198|467183620|FG001|Overall Study|Noncompliance with protocol|7|||
129785766|NCT00783198|467183621|FG002|Overall Study|Noncompliance with protocol|10|||
129785767|NCT00783198|467183619|FG000|Overall Study|Did not meet protocol eligibility|0|||
129785768|NCT00783198|467183620|FG001|Overall Study|Did not meet protocol eligibility|1|||
129785769|NCT00783198|467183621|FG002|Overall Study|Did not meet protocol eligibility|0|||
129785770|NCT00783198|467183619|FG000|Overall Study|Administrative|2|||
129785771|NCT00783198|467183620|FG001|Overall Study|Administrative|1|||
129785772|NCT00783198|467183621|FG002|Overall Study|Administrative|2|||
129785773|NCT03704636|467183622|FG000|Overall Study|Inadequate Venous Flow|3|||
129785774|NCT00539188|467183625|FG000|Overall Study|Withdrawal by Subject|1|||
129785775|NCT00539188|467183626|FG001|Overall Study|Withdrawal by Subject|0|||
129785776|NCT00539188|467183625|FG000|Overall Study|Lost to Follow-up|2|||
129785777|NCT00539188|467183626|FG001|Overall Study|Lost to Follow-up|1|||
129785778|NCT04784442|467183627|FG000|Overall Study|Adverse Event|1|||
129785779|NCT04784442|467183628|FG001|Overall Study|Adverse Event|0|||
129785780|NCT04784442|467183629|FG002|Overall Study|Adverse Event|2|||
129785781|NCT04784442|467183630|FG003|Overall Study|Adverse Event|1|||
129785782|NCT04784442|467183627|FG000|Overall Study|Protocol Violation|1|||
129785783|NCT04784442|467183628|FG001|Overall Study|Protocol Violation|0|||
129785784|NCT04784442|467183629|FG002|Overall Study|Protocol Violation|0|||
129785785|NCT04784442|467183630|FG003|Overall Study|Protocol Violation|0|||
129785786|NCT04784442|467183627|FG000|Overall Study|Non-compliance with study drug|1|||
129785787|NCT04784442|467183628|FG001|Overall Study|Non-compliance with study drug|0|||
129785788|NCT04784442|467183629|FG002|Overall Study|Non-compliance with study drug|0|||
129785789|NCT04784442|467183630|FG003|Overall Study|Non-compliance with study drug|0|||
129785790|NCT01590758|467183631|FG000|Overall Study|Withdrawal by Subject|0|||
129785791|NCT01590758|467183632|FG001|Overall Study|Withdrawal by Subject|3|||
129785792|NCT01590758|467183631|FG000|Overall Study|Physician Decision|1|||
129785793|NCT01590758|467183632|FG001|Overall Study|Physician Decision|2|||
129785794|NCT01590758|467183631|FG000|Overall Study|Lost to Follow-up|4|||
129785795|NCT01590758|467183632|FG001|Overall Study|Lost to Follow-up|2|||
129785796|NCT04525885|467183633|FG000|Overall Study|Screen Failure|1|||
129785797|NCT04525885|467183634|FG001|Overall Study|Screen Failure|0|||
129785798|NCT04525885|467183635|FG002|Overall Study|Screen Failure|0|||
129785799|NCT04525885|467183633|FG000|Overall Study|Withdrawal by Subject|14|||
129785800|NCT04525885|467183634|FG001|Overall Study|Withdrawal by Subject|6|||
129785801|NCT04525885|467183635|FG002|Overall Study|Withdrawal by Subject|20|||
129785802|NCT04525885|467183633|FG000|Overall Study|Physician Decision|1|||
129785803|NCT04525885|467183634|FG001|Overall Study|Physician Decision|0|||
129785804|NCT04525885|467183635|FG002|Overall Study|Physician Decision|1|||
129580127|NCT04089553|466420363|FG001|Overall Study|Withdrawal by Subject|3|||
129580128|NCT04089553|466420362|FG000|Overall Study|Physician Decision|1|||
129580129|NCT04089553|466420363|FG001|Overall Study|Physician Decision|0|||
129580130|NCT04089553|466420362|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
129580131|NCT04089553|466420363|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
129580132|NCT04089553|466420362|FG000|Overall Study|Other|1|||
129580133|NCT04089553|466420363|FG001|Overall Study|Other|0|||
129580134|NCT04089553|466420362|FG000|Overall Study|Adverse Event|1|||
129580135|NCT04089553|466420363|FG001|Overall Study|Adverse Event|1|||
129580136|NCT01403194|466420371|FG000|Overall Study|Screen Failure|2|||
129580137|NCT01403194|466420371|FG000|Overall Study|Lost to Follow-up|8|||
129580138|NCT00107991|466420376|FG000|Eligibility Assessment|Disease not severe enough|7|||
129580139|NCT00107991|466420376|FG000|Eligibility Assessment|Unwilling to participate|7|||
129580140|NCT00107991|466420376|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
129580141|NCT00107991|466420376|FG000|Eligibility Assessment|Abnormal labs|2|||
129785805|NCT02756806|467183636|FG000|Overall Study|Study terminated early|5|||
129785806|NCT02717832|467183637|FG000|Overall Study|Inability to place IV|3|||
129785807|NCT01008423|467183638|FG000|Overall Study|Adverse Event|13|||
129785808|NCT01008423|467183639|FG001|Overall Study|Adverse Event|6|||
129785809|NCT01008423|467183638|FG000|Overall Study|Withdrawal by Subject|4|||
129580142|NCT00107991|466420376|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
129580143|NCT00107991|466420376|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
129785810|NCT01008423|467183639|FG001|Overall Study|Withdrawal by Subject|7|||
129785811|NCT01008423|467183638|FG000|Overall Study|Lost to Follow-up|0|||
129785812|NCT01008423|467183639|FG001|Overall Study|Lost to Follow-up|2|||
129785813|NCT01008423|467183638|FG000|Overall Study|Low Cortisol|0|||
129785814|NCT01008423|467183639|FG001|Overall Study|Low Cortisol|1|||
129580144|NCT00107991|466420376|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
129580145|NCT00107991|466420376|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
129580146|NCT00107991|466420376|FG000|12 Week Treatment Period|Adverse Event|1|||
129580147|NCT00107991|466420376|FG000|12 Week Treatment Period|Protocol Violation|1|||
129580148|NCT00107991|466420376|FG000|12 Week Treatment Period|Incarcerated|1|||
129580149|NCT00107991|466420376|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
129580150|NCT00506831|466420383|FG000|Overall Study|Death|1|||
129580151|NCT00506831|466420383|FG000|Overall Study|Withdrawal by Subject|1|||
129580152|NCT02488239|466420387|FG000|Overall Study|Death|3|||
129580153|NCT02488239|466420387|FG000|Overall Study|Withdrawal by Subject|3|||
129580154|NCT02488239|466420387|FG000|Overall Study|Physician Decision|2|||
129580155|NCT02488239|466420387|FG000|Overall Study|Consent ineligible|1|||
129580156|NCT02488239|466420387|FG000|Overall Study|Did not undergo implant procedure|1|||
129580157|NCT00608322|466420390|FG000|Overall Study|Death|2|||
129580158|NCT00608322|466420391|FG001|Overall Study|Death|1|||
129580159|NCT00834444|466420392|FG000|First Intervention|Adverse Event|1|||
129580160|NCT00834444|466420393|FG001|First Intervention|Adverse Event|0|||
129580161|NCT00834444|466420392|FG000|First Intervention|Intolerance to Venopuncture|0|||
129580162|NCT00834444|466420393|FG001|First Intervention|Intolerance to Venopuncture|1|||
129580163|NCT00834444|466420392|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129580164|NCT00834444|466420393|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129580165|NCT00834444|466420392|FG000|Second Intervention|Adverse Event|1|||
129580166|NCT00834444|466420393|FG001|Second Intervention|Adverse Event|0|||
129580167|NCT00606281|466420396|FG000|Overall Study|Adverse Event|11|||
129580168|NCT00606281|466420397|FG001|Overall Study|Adverse Event|12|||
129580169|NCT00606281|466420396|FG000|Overall Study|Death|1|||
129580170|NCT00606281|466420397|FG001|Overall Study|Death|0|||
129580171|NCT00606281|466420396|FG000|Overall Study|Lack of Efficacy|28|||
129580172|NCT00606281|466420397|FG001|Overall Study|Lack of Efficacy|35|||
129580173|NCT00606281|466420396|FG000|Overall Study|Physician Decision|0|||
129580174|NCT00606281|466420397|FG001|Overall Study|Physician Decision|1|||
129580175|NCT00606281|466420396|FG000|Overall Study|Protocol Violation|3|||
129580176|NCT00606281|466420397|FG001|Overall Study|Protocol Violation|3|||
129580177|NCT00606281|466420396|FG000|Overall Study|Withdrawal by Subject|11|||
129580178|NCT00606281|466420397|FG001|Overall Study|Withdrawal by Subject|13|||
129580179|NCT00606281|466420396|FG000|Overall Study|Progression to depressive phase|1|||
129580180|NCT00606281|466420397|FG001|Overall Study|Progression to depressive phase|1|||
129580181|NCT00606281|466420396|FG000|Overall Study|Change of residence or other commitments|1|||
129580182|NCT00606281|466420397|FG001|Overall Study|Change of residence or other commitments|1|||
129580183|NCT02294981|466420398|FG000|Overall Study|Lost to Follow-up|1|||
129580184|NCT00829712|466420399|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
129580185|NCT00829712|466420400|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
129580186|NCT00263588|466420401|FG000|Overall Study|Death|54|||
129580187|NCT00263588|466420402|FG001|Overall Study|Death|90|||
129580188|NCT00263588|466420401|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
129580189|NCT00263588|466420402|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
129580190|NCT00263588|466420401|FG000|Overall Study|Lost to Follow-up|7|||
129580191|NCT00263588|466420402|FG001|Overall Study|Lost to Follow-up|10|||
129580192|NCT00263588|466420401|FG000|Overall Study|Withdrawal by Subject|3|||
129580193|NCT00263588|466420402|FG001|Overall Study|Withdrawal by Subject|4|||
129580194|NCT00263588|466420401|FG000|Overall Study|Protocol Violation|0|||
129580195|NCT00263588|466420402|FG001|Overall Study|Protocol Violation|1|||
129580196|NCT00263588|466420401|FG000|Overall Study|Investigator decision|7|||
129580197|NCT00263588|466420402|FG001|Overall Study|Investigator decision|15|||
129695186|NCT00098293|466841755|FG002|Open-label (OL) Phase|Death|3|||
129695187|NCT00098293|466841756|FG003|Open-label (OL) Phase|Death|0|||
129695188|NCT00098293|466841757|FG004|Open-label (OL) Phase|Death|0|||
129695189|NCT00098293|466841753|FG000|Supplemental Phase (SP)|Death|0|||
129695190|NCT00098293|466841754|FG001|Supplemental Phase (SP)|Death|0|||
129695191|NCT00098293|466841755|FG002|Supplemental Phase (SP)|Death|0|||
129695192|NCT00098293|466841756|FG003|Supplemental Phase (SP)|Death|0|||
129695193|NCT00098293|466841757|FG004|Supplemental Phase (SP)|Death|1|||
129695194|NCT00098293|466841753|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
129695195|NCT00098293|466841754|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
129695196|NCT00098293|466841755|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
129695197|NCT00098293|466841756|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
129695198|NCT00098293|466841757|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
129695199|NCT00098293|466841753|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129580198|NCT00263588|466420401|FG000|Overall Study|Sponsor terminated study|0|||
129580199|NCT00263588|466420402|FG001|Overall Study|Sponsor terminated study|1|||
129580200|NCT02622386|466420403|FG000|First Assignment|Withdrawal by Subject|3|||
129580201|NCT02622386|466420404|FG001|First Assignment|Withdrawal by Subject|2|||
129580202|NCT02622386|466420403|FG000|Washout|Withdrawal by Subject|4|||
129580203|NCT02622386|466420404|FG001|Washout|Withdrawal by Subject|4|||
129580204|NCT02622386|466420403|FG000|Second Assignment|Withdrawal by Subject|0|||
129580205|NCT02622386|466420404|FG001|Second Assignment|Withdrawal by Subject|2|||
129580206|NCT02336074|466420405|FG000|Overall Study|Adverse Event|0|||
129580207|NCT02336074|466420406|FG001|Overall Study|Adverse Event|2|||
129580208|NCT02679729|466420407|FG000|Overall Study|Lost to Follow-up|0|||
129580209|NCT02679729|466420408|FG001|Overall Study|Lost to Follow-up|1|||
129580210|NCT02679729|466420409|FG002|Overall Study|Lost to Follow-up|0|||
129580211|NCT02679729|466420410|FG003|Overall Study|Lost to Follow-up|0|||
129580212|NCT02679729|466420411|FG004|Overall Study|Lost to Follow-up|1|||
129580213|NCT02679729|466420412|FG005|Overall Study|Lost to Follow-up|0|||
129580214|NCT02679729|466420413|FG006|Overall Study|Lost to Follow-up|0|||
129580215|NCT02679729|466420414|FG007|Overall Study|Lost to Follow-up|0|||
129580216|NCT02679729|466420415|FG008|Overall Study|Lost to Follow-up|0|||
129580217|NCT02679729|466420407|FG000|Overall Study|Participant decision|0|||
129580218|NCT02679729|466420408|FG001|Overall Study|Participant decision|1|||
129580219|NCT02679729|466420409|FG002|Overall Study|Participant decision|0|||
129580220|NCT02679729|466420410|FG003|Overall Study|Participant decision|0|||
129580221|NCT02679729|466420411|FG004|Overall Study|Participant decision|0|||
129580222|NCT02679729|466420412|FG005|Overall Study|Participant decision|0|||
129580223|NCT02679729|466420413|FG006|Overall Study|Participant decision|1|||
129580224|NCT02679729|466420414|FG007|Overall Study|Participant decision|0|||
129580225|NCT02679729|466420415|FG008|Overall Study|Participant decision|0|||
129580226|NCT03488108|466420422|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129580227|NCT03488108|466420423|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129580228|NCT03488108|466420422|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
129580229|NCT03488108|466420423|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
129580230|NCT00858780|466420428|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
129580231|NCT00858780|466420429|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129580232|NCT00858780|466420430|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129580233|NCT00858780|466420431|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129580234|NCT00858780|466420432|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
129580235|NCT00858780|466420428|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129580236|NCT00858780|466420429|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129580237|NCT00858780|466420430|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
129580238|NCT00858780|466420431|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129580239|NCT00858780|466420432|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
129580240|NCT00858780|466420428|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
129580241|NCT00858780|466420429|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
129580242|NCT00858780|466420430|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
129580243|NCT00858780|466420431|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
129580244|NCT00858780|466420432|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
129580245|NCT00858780|466420428|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129580246|NCT00858780|466420429|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
129580247|NCT00858780|466420430|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129580248|NCT00858780|466420431|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129580249|NCT00858780|466420432|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
129580250|NCT00858780|466420428|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129580251|NCT00858780|466420429|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129785815|NCT01008423|467183638|FG000|Overall Study|Lack of Efficacy|0|||
129785816|NCT01008423|467183639|FG001|Overall Study|Lack of Efficacy|5|||
129785817|NCT01008423|467183638|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
129785818|NCT01008423|467183639|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
129785819|NCT01008423|467183638|FG000|Overall Study|Personal Conflict|1|||
129785820|NCT01008423|467183639|FG001|Overall Study|Personal Conflict|0|||
129785821|NCT01008423|467183638|FG000|Overall Study|Other|0|||
129785822|NCT01008423|467183639|FG001|Overall Study|Other|1|||
129785823|NCT00934843|467183640|FG000|Overall Study|Protocol Violation|0|||
129785824|NCT00934843|467183641|FG001|Overall Study|Protocol Violation|1|||
129785825|NCT01144299|467183642|FG000|Overall Study|Lost to Follow-up|1|||
129785826|NCT01144299|467183643|FG001|Overall Study|Lost to Follow-up|0|||
129785827|NCT01144299|467183642|FG000|Overall Study|Withdrawal by Subject|1|||
129785828|NCT01144299|467183643|FG001|Overall Study|Withdrawal by Subject|0|||
129785829|NCT03698591|467183646|FG000|Overall Study|Withdrawal by Subject|2|||
129785830|NCT03698591|467183647|FG001|Overall Study|Withdrawal by Subject|2|||
129785831|NCT03698591|467183646|FG000|Overall Study|Failed drug screen|1|||
129580252|NCT00858780|466420430|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129580253|NCT00858780|466420431|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
129785832|NCT03698591|467183647|FG001|Overall Study|Failed drug screen|1|||
129580254|NCT00858780|466420432|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
129580255|NCT00858780|466420428|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
129580256|NCT00858780|466420429|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
129580257|NCT00858780|466420430|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
129580258|NCT00858780|466420431|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
129580259|NCT00858780|466420432|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
129580260|NCT00863330|466420433|FG000|Overall Study|study terminated early due to administra|6|||
129580261|NCT03602339|466420434|FG000|Overall Study|Withdrawal by Subject|9|||
129580262|NCT03602339|466420434|FG000|Overall Study|Physician Decision|2|||
129580263|NCT03602339|466420434|FG000|Overall Study|Other reason|4|||
129580264|NCT05098743|466420436|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
129580265|NCT05098743|466420437|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
129580266|NCT05098743|466420436|FG000|Overall Study|Lost to Follow-up|1|||
129580267|NCT05098743|466420437|FG001|Overall Study|Lost to Follow-up|2|||
129580268|NCT02911025|466420446|FG000|Overall Study|Lost to Follow-up|3|||
129580269|NCT03719040|466420447|FG000|Overall Study|Withdrawal by Subject|177|||
129580270|NCT03719040|466420447|FG000|Overall Study|Lost to Follow-up|26|||
129580271|NCT02923349|466420448|FG000|Overall Study|Other|1|||
129580272|NCT02923349|466420449|FG001|Overall Study|Other|2|||
129580273|NCT02923349|466420450|FG002|Overall Study|Other|4|||
129695200|NCT00098293|466841754|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129695201|NCT00098293|466841755|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129695202|NCT00098293|466841756|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
129695203|NCT00098293|466841757|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
129695204|NCT00098293|466841753|FG000|Supplemental Phase (SP)|Other|0|||
129695205|NCT00098293|466841754|FG001|Supplemental Phase (SP)|Other|0|||
129695206|NCT00098293|466841755|FG002|Supplemental Phase (SP)|Other|0|||
129695207|NCT00098293|466841756|FG003|Supplemental Phase (SP)|Other|0|||
129695208|NCT00098293|466841757|FG004|Supplemental Phase (SP)|Other|22|||
129695209|NCT01370642|466841758|FG000|Overall Study|Adverse Event|2|||
129695210|NCT01370642|466841759|FG001|Overall Study|Adverse Event|1|||
129695211|NCT01370642|466841760|FG002|Overall Study|Adverse Event|1|||
129695212|NCT01370642|466841758|FG000|Overall Study|Detectable HCV RNA|0|||
129695213|NCT01370642|466841759|FG001|Overall Study|Detectable HCV RNA|0|||
129695214|NCT01370642|466841760|FG002|Overall Study|Detectable HCV RNA|22|||
129695215|NCT01370642|466841758|FG000|Overall Study|Lost to Follow-up|0|||
129695216|NCT01370642|466841759|FG001|Overall Study|Lost to Follow-up|0|||
129695217|NCT01370642|466841760|FG002|Overall Study|Lost to Follow-up|1|||
129695218|NCT01370642|466841758|FG000|Overall Study|Physician Decision|4|||
129695219|NCT01370642|466841759|FG001|Overall Study|Physician Decision|1|||
129695220|NCT01370642|466841760|FG002|Overall Study|Physician Decision|2|||
129695221|NCT01370642|466841758|FG000|Overall Study|Withdrawal by Subject|2|||
129695222|NCT01370642|466841759|FG001|Overall Study|Withdrawal by Subject|4|||
129695223|NCT01370642|466841760|FG002|Overall Study|Withdrawal by Subject|3|||
129695224|NCT01796470|466841761|FG000|Overall Study|Adverse Event|4|||
129695225|NCT01796470|466841762|FG001|Overall Study|Adverse Event|2|||
129695226|NCT01796470|466841763|FG002|Overall Study|Adverse Event|2|||
129695227|NCT01796470|466841764|FG003|Overall Study|Adverse Event|1|||
129695228|NCT01796470|466841765|FG004|Overall Study|Adverse Event|3|||
129695229|NCT01796470|466841761|FG000|Overall Study|Death|2|||
129695230|NCT01796470|466841762|FG001|Overall Study|Death|0|||
129695231|NCT01796470|466841763|FG002|Overall Study|Death|0|||
129695232|NCT01796470|466841764|FG003|Overall Study|Death|0|||
129695233|NCT01796470|466841765|FG004|Overall Study|Death|1|||
129695234|NCT01796470|466841761|FG000|Overall Study|Initiated New Therapy|9|||
129695235|NCT01796470|466841762|FG001|Overall Study|Initiated New Therapy|0|||
129695236|NCT01796470|466841763|FG002|Overall Study|Initiated New Therapy|0|||
129695237|NCT01796470|466841764|FG003|Overall Study|Initiated New Therapy|0|||
129695238|NCT01796470|466841765|FG004|Overall Study|Initiated New Therapy|2|||
129695239|NCT01796470|466841761|FG000|Overall Study|Lost to Follow-up|0|||
129695240|NCT01796470|466841762|FG001|Overall Study|Lost to Follow-up|1|||
129695241|NCT01796470|466841763|FG002|Overall Study|Lost to Follow-up|0|||
129695242|NCT01796470|466841764|FG003|Overall Study|Lost to Follow-up|0|||
129695243|NCT01796470|466841765|FG004|Overall Study|Lost to Follow-up|0|||
129695244|NCT01796470|466841761|FG000|Overall Study|Physician Decision|5|||
129695245|NCT01796470|466841762|FG001|Overall Study|Physician Decision|4|||
129695246|NCT01796470|466841763|FG002|Overall Study|Physician Decision|1|||
129695247|NCT01796470|466841764|FG003|Overall Study|Physician Decision|0|||
129695248|NCT01796470|466841765|FG004|Overall Study|Physician Decision|1|||
129580274|NCT02923349|466420451|FG003|Overall Study|Other|1|||
129580275|NCT02923349|466420452|FG004|Overall Study|Other|3|||
129580276|NCT02923349|466420453|FG005|Overall Study|Other|0|||
129580277|NCT02923349|466420454|FG006|Overall Study|Other|1|||
129580278|NCT02923349|466420448|FG000|Overall Study|Withdrawal by Subject|2|||
129580279|NCT02923349|466420449|FG001|Overall Study|Withdrawal by Subject|2|||
129580280|NCT02923349|466420450|FG002|Overall Study|Withdrawal by Subject|8|||
129580281|NCT02923349|466420451|FG003|Overall Study|Withdrawal by Subject|10|||
129580282|NCT02923349|466420452|FG004|Overall Study|Withdrawal by Subject|12|||
129580283|NCT02923349|466420453|FG005|Overall Study|Withdrawal by Subject|3|||
129580284|NCT02923349|466420454|FG006|Overall Study|Withdrawal by Subject|0|||
129580285|NCT02923349|466420448|FG000|Overall Study|Physician Decision|0|||
129580286|NCT02923349|466420449|FG001|Overall Study|Physician Decision|0|||
129580287|NCT02923349|466420450|FG002|Overall Study|Physician Decision|0|||
129580288|NCT02923349|466420451|FG003|Overall Study|Physician Decision|1|||
129580289|NCT02923349|466420452|FG004|Overall Study|Physician Decision|1|||
129580290|NCT02923349|466420453|FG005|Overall Study|Physician Decision|0|||
129580291|NCT02923349|466420454|FG006|Overall Study|Physician Decision|2|||
129580292|NCT02923349|466420448|FG000|Overall Study|Lost to Follow-up|0|||
129580293|NCT02923349|466420449|FG001|Overall Study|Lost to Follow-up|0|||
129580294|NCT02923349|466420450|FG002|Overall Study|Lost to Follow-up|3|||
129580295|NCT02923349|466420451|FG003|Overall Study|Lost to Follow-up|0|||
129580296|NCT02923349|466420452|FG004|Overall Study|Lost to Follow-up|1|||
129580297|NCT02923349|466420453|FG005|Overall Study|Lost to Follow-up|1|||
129580298|NCT02923349|466420454|FG006|Overall Study|Lost to Follow-up|0|||
129580299|NCT02923349|466420448|FG000|Overall Study|Death|1|||
129580300|NCT02923349|466420449|FG001|Overall Study|Death|0|||
129580301|NCT02923349|466420450|FG002|Overall Study|Death|2|||
129580302|NCT02923349|466420451|FG003|Overall Study|Death|4|||
129580303|NCT02923349|466420452|FG004|Overall Study|Death|2|||
129580304|NCT02923349|466420453|FG005|Overall Study|Death|3|||
129785833|NCT03698591|467183646|FG000|Overall Study|Failed health screen|0|||
129785834|NCT03698591|467183647|FG001|Overall Study|Failed health screen|1|||
129785835|NCT03698591|467183646|FG000|Overall Study|Ineligible for financial compensation|1|||
129785836|NCT03698591|467183647|FG001|Overall Study|Ineligible for financial compensation|0|||
129785837|NCT03698591|467183646|FG000|Overall Study|Equipment Error|1|||
129785838|NCT03698591|467183647|FG001|Overall Study|Equipment Error|0|||
129785839|NCT03698591|467183646|FG000|Overall Study|Could not establish TMS dosage|0|||
129785840|NCT03698591|467183647|FG001|Overall Study|Could not establish TMS dosage|1|||
129785841|NCT01675167|467183649|FG000|Open-label Titration Phase|Adverse Event|81|||
129785842|NCT01675167|467183650|FG001|Open-label Titration Phase|Adverse Event|0|||
129785843|NCT01675167|467183651|FG002|Open-label Titration Phase|Adverse Event|0|||
129785844|NCT01675167|467183649|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
129785845|NCT01675167|467183650|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
129785846|NCT01675167|467183651|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
129785847|NCT01675167|467183649|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
129785848|NCT01675167|467183650|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
129785849|NCT01675167|467183651|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
129785850|NCT01675167|467183649|FG000|Open-label Titration Phase|Protocol Violation|43|||
129785851|NCT01675167|467183650|FG001|Open-label Titration Phase|Protocol Violation|0|||
129785852|NCT01675167|467183651|FG002|Open-label Titration Phase|Protocol Violation|0|||
129785853|NCT01675167|467183649|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
129785854|NCT01675167|467183650|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
129580305|NCT02923349|466420454|FG006|Overall Study|Death|0|||
129580306|NCT04063878|466420455|FG000|Overall Study|Withdrawal by Subject|2|||
129580307|NCT04063878|466420455|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
129580308|NCT02751827|466420456|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
129580309|NCT02751827|466420457|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
129580310|NCT02751827|466420458|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
129580311|NCT02875392|466422942|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
129580312|NCT02875392|466422943|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
129580313|NCT03599193|466422944|FG000|Overall Study|Adverse Event|0|||
129785855|NCT01675167|467183651|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
129580314|NCT03599193|466422945|FG001|Overall Study|Adverse Event|2|||
129785856|NCT01675167|467183649|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
129785857|NCT01675167|467183650|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
129785858|NCT01675167|467183651|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
129580315|NCT03599193|466422944|FG000|Overall Study|Withdrawal by Subject|1|||
129580316|NCT03599193|466422945|FG001|Overall Study|Withdrawal by Subject|0|||
129580317|NCT03599193|466422944|FG000|Overall Study|Protocol Violation|1|||
129580318|NCT03599193|466422945|FG001|Overall Study|Protocol Violation|0|||
129580319|NCT03599193|466422944|FG000|Overall Study|Lost to Follow-up|0|||
129580320|NCT03599193|466422945|FG001|Overall Study|Lost to Follow-up|1|||
129580321|NCT00835705|466422946|FG000|First Intervention|Difficulty with vein|1|||
129580322|NCT00835705|466422947|FG001|First Intervention|Difficulty with vein|0|||
129580323|NCT00835705|466422946|FG000|Second Intervention|Difficulty with vein|1|||
129580324|NCT00835705|466422947|FG001|Second Intervention|Difficulty with vein|0|||
129580325|NCT01750294|466422948|FG000|Overall Study|Withdrawal by Subject|1|||
129580326|NCT01750294|466422948|FG000|Overall Study|Safety Endpoint|1|||
129580327|NCT00665925|466422949|FG000|Overall Study|Lack of Efficacy|10|||
129580328|NCT00665925|466422950|FG001|Overall Study|Lack of Efficacy|8|||
129580329|NCT00665925|466422951|FG002|Overall Study|Lack of Efficacy|9|||
129580330|NCT00665925|466422952|FG003|Overall Study|Lack of Efficacy|8|||
129580331|NCT00665925|466422949|FG000|Overall Study|Lost to Follow-up|1|||
129580332|NCT00665925|466422950|FG001|Overall Study|Lost to Follow-up|2|||
129580333|NCT00665925|466422951|FG002|Overall Study|Lost to Follow-up|2|||
129580334|NCT00665925|466422952|FG003|Overall Study|Lost to Follow-up|2|||
129580335|NCT00665925|466422949|FG000|Overall Study|Withdrawal by Subject|2|||
129580336|NCT00665925|466422950|FG001|Overall Study|Withdrawal by Subject|2|||
129580337|NCT00665925|466422951|FG002|Overall Study|Withdrawal by Subject|3|||
129580338|NCT00665925|466422952|FG003|Overall Study|Withdrawal by Subject|2|||
129580339|NCT00665925|466422949|FG000|Overall Study|Physician Decision|0|||
129580340|NCT00665925|466422950|FG001|Overall Study|Physician Decision|0|||
129580341|NCT00665925|466422951|FG002|Overall Study|Physician Decision|1|||
129580342|NCT00665925|466422952|FG003|Overall Study|Physician Decision|2|||
129580343|NCT00665925|466422949|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
129580344|NCT00665925|466422950|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
129580345|NCT00665925|466422951|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
129580346|NCT00665925|466422952|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
129580347|NCT00665925|466422949|FG000|Overall Study|Adverse Event|1|||
129580348|NCT00665925|466422950|FG001|Overall Study|Adverse Event|5|||
129580349|NCT00665925|466422951|FG002|Overall Study|Adverse Event|10|||
129580350|NCT00665925|466422952|FG003|Overall Study|Adverse Event|5|||
129580351|NCT00665925|466422949|FG000|Overall Study|Enrolled by mistake|0|||
129580352|NCT00665925|466422950|FG001|Overall Study|Enrolled by mistake|0|||
129580353|NCT00665925|466422951|FG002|Overall Study|Enrolled by mistake|0|||
129580354|NCT00665925|466422952|FG003|Overall Study|Enrolled by mistake|1|||
129580355|NCT00665925|466422949|FG000|Overall Study|Due to exclusion criteria|1|||
129580356|NCT00665925|466422950|FG001|Overall Study|Due to exclusion criteria|0|||
129580357|NCT00665925|466422951|FG002|Overall Study|Due to exclusion criteria|0|||
129580358|NCT00665925|466422952|FG003|Overall Study|Due to exclusion criteria|0|||
129580359|NCT04372238|466422955|FG000|Overall Study|Duplicate|3|||
129580360|NCT04372238|466422956|FG001|Overall Study|Duplicate|3|||
129580361|NCT04372238|466422955|FG000|Overall Study|Did not consent for data linkage|6|||
129580362|NCT04372238|466422956|FG001|Overall Study|Did not consent for data linkage|10|||
129580363|NCT00334815|466422957|FG000|Overall Study|Adverse Event|3|||
129580364|NCT00334815|466422958|FG001|Overall Study|Adverse Event|2|||
129580365|NCT00334815|466422957|FG000|Overall Study|Death|0|||
129580366|NCT00334815|466422958|FG001|Overall Study|Death|2|||
129580367|NCT00334815|466422957|FG000|Overall Study|Progression|1|||
129580368|NCT00334815|466422958|FG001|Overall Study|Progression|0|||
129580369|NCT00334815|466422957|FG000|Overall Study|ineligible|1|||
129580370|NCT00334815|466422958|FG001|Overall Study|ineligible|1|||
129580371|NCT00334815|466422957|FG000|Overall Study|patient refused treatment|0|||
129580372|NCT00334815|466422958|FG001|Overall Study|patient refused treatment|1|||
129580373|NCT00334815|466422957|FG000|Overall Study|Physician Decision|2|||
129580374|NCT00334815|466422958|FG001|Overall Study|Physician Decision|4|||
129580375|NCT01592240|466422959|FG000|Overall Study|Adverse Event|1|||
129580376|NCT01592240|466422960|FG001|Overall Study|Adverse Event|0|||
129580377|NCT01592240|466422961|FG002|Overall Study|Adverse Event|0|||
129580378|NCT01592240|466422962|FG003|Overall Study|Adverse Event|1|||
129580379|NCT01592240|466422963|FG004|Overall Study|Adverse Event|1|||
129580380|NCT01592240|466422964|FG005|Overall Study|Adverse Event|0|||
129580381|NCT01592240|466422965|FG006|Overall Study|Adverse Event|0|||
129695249|NCT01796470|466841761|FG000|Overall Study|Progressive Disease|7|||
129695250|NCT01796470|466841762|FG001|Overall Study|Progressive Disease|7|||
129580382|NCT01592240|466422959|FG000|Overall Study|Death|0|||
129580383|NCT01592240|466422960|FG001|Overall Study|Death|1|||
129580384|NCT01592240|466422961|FG002|Overall Study|Death|0|||
129580385|NCT01592240|466422962|FG003|Overall Study|Death|0|||
129580386|NCT01592240|466422963|FG004|Overall Study|Death|0|||
129695251|NCT01796470|466841763|FG002|Overall Study|Progressive Disease|3|||
129580387|NCT01592240|466422964|FG005|Overall Study|Death|0|||
129580388|NCT01592240|466422965|FG006|Overall Study|Death|0|||
129695252|NCT01796470|466841764|FG003|Overall Study|Progressive Disease|2|||
129580389|NCT01592240|466422959|FG000|Overall Study|Lost to Follow-up|1|||
129580390|NCT01592240|466422960|FG001|Overall Study|Lost to Follow-up|3|||
129580391|NCT01592240|466422961|FG002|Overall Study|Lost to Follow-up|1|||
129580392|NCT01592240|466422962|FG003|Overall Study|Lost to Follow-up|0|||
129695253|NCT01796470|466841765|FG004|Overall Study|Progressive Disease|0|||
129695254|NCT01796470|466841761|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
129580393|NCT01592240|466422963|FG004|Overall Study|Lost to Follow-up|3|||
129580394|NCT01592240|466422964|FG005|Overall Study|Lost to Follow-up|2|||
129580395|NCT01592240|466422965|FG006|Overall Study|Lost to Follow-up|0|||
129580396|NCT01592240|466422959|FG000|Overall Study|Protocol Violation|0|||
129580397|NCT01592240|466422960|FG001|Overall Study|Protocol Violation|0|||
129580398|NCT01592240|466422961|FG002|Overall Study|Protocol Violation|0|||
129580399|NCT01592240|466422962|FG003|Overall Study|Protocol Violation|0|||
129580400|NCT01592240|466422963|FG004|Overall Study|Protocol Violation|0|||
129580401|NCT01592240|466422964|FG005|Overall Study|Protocol Violation|1|||
129580402|NCT01592240|466422965|FG006|Overall Study|Protocol Violation|0|||
129580403|NCT01592240|466422959|FG000|Overall Study|Withdrawal by Subject|0|||
129580404|NCT01592240|466422960|FG001|Overall Study|Withdrawal by Subject|4|||
129580405|NCT01592240|466422961|FG002|Overall Study|Withdrawal by Subject|4|||
129580406|NCT01592240|466422962|FG003|Overall Study|Withdrawal by Subject|1|||
129580407|NCT01592240|466422963|FG004|Overall Study|Withdrawal by Subject|3|||
129580408|NCT01592240|466422964|FG005|Overall Study|Withdrawal by Subject|0|||
129580409|NCT01592240|466422965|FG006|Overall Study|Withdrawal by Subject|2|||
129580410|NCT01592240|466422959|FG000|Overall Study|Other|0|||
129580411|NCT01592240|466422960|FG001|Overall Study|Other|3|||
129580412|NCT01592240|466422961|FG002|Overall Study|Other|1|||
129580413|NCT01592240|466422962|FG003|Overall Study|Other|1|||
129580414|NCT01592240|466422963|FG004|Overall Study|Other|0|||
129580415|NCT01592240|466422964|FG005|Overall Study|Other|0|||
129580416|NCT01592240|466422965|FG006|Overall Study|Other|1|||
129580417|NCT01592240|466422959|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129580418|NCT01592240|466422960|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
129580419|NCT01592240|466422961|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
129580420|NCT01592240|466422962|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
129580421|NCT01592240|466422963|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
129580422|NCT01592240|466422964|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
129580423|NCT01592240|466422965|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
129580424|NCT02751424|466422969|FG000|Part 2|Adverse Event|0|||
129580425|NCT02751424|466422970|FG001|Part 2|Adverse Event|0|||
129580426|NCT02751424|466422971|FG002|Part 2|Adverse Event|0|||
129580427|NCT02751424|466422972|FG003|Part 2|Adverse Event|0|||
129580428|NCT02751424|466422973|FG004|Part 2|Adverse Event|0|||
129580429|NCT02751424|466422974|FG005|Part 2|Adverse Event|0|||
129580430|NCT02751424|466422975|FG006|Part 2|Adverse Event|0|||
129580431|NCT02751424|466422976|FG007|Part 2|Adverse Event|5|||
129580432|NCT02751424|466422977|FG008|Part 2|Adverse Event|0|||
129580433|NCT03206749|466422978|FG000|Overall Study|Withdrawal of consent|5|||
129580434|NCT03206749|466422979|FG001|Overall Study|Withdrawal of consent|3|||
129580435|NCT03206749|466422980|FG002|Overall Study|Withdrawal of consent|6|||
129580436|NCT03206749|466422978|FG000|Overall Study|Lost to Follow-up|0|||
129580437|NCT03206749|466422979|FG001|Overall Study|Lost to Follow-up|0|||
129580438|NCT03206749|466422980|FG002|Overall Study|Lost to Follow-up|1|||
129580439|NCT02197416|466422981|FG000|Overall Study|Other reasons|0|||
129580440|NCT02197416|466422982|FG001|Overall Study|Other reasons|2|||
129580441|NCT02197416|466422983|FG002|Overall Study|Other reasons|5|||
129580442|NCT02197416|466422981|FG000|Overall Study|Withdrawal by Subject|0|||
129580443|NCT02197416|466422982|FG001|Overall Study|Withdrawal by Subject|2|||
129580444|NCT02197416|466422983|FG002|Overall Study|Withdrawal by Subject|1|||
129580445|NCT02197416|466422981|FG000|Overall Study|Protocol Violation|1|||
129580446|NCT02197416|466422982|FG001|Overall Study|Protocol Violation|0|||
129580447|NCT02197416|466422983|FG002|Overall Study|Protocol Violation|1|||
129580448|NCT02197416|466422981|FG000|Overall Study|Adverse Event|0|||
129580449|NCT02197416|466422982|FG001|Overall Study|Adverse Event|0|||
129580450|NCT02197416|466422983|FG002|Overall Study|Adverse Event|1|||
129580451|NCT02451696|466422984|FG000|Overall Study|Surgery postponed|1|||
129785859|NCT01675167|467183649|FG000|Open-label Titration Phase|Other|55|||
129785860|NCT01675167|467183650|FG001|Open-label Titration Phase|Other|0|||
129785861|NCT01675167|467183651|FG002|Open-label Titration Phase|Other|0|||
129785862|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
129785863|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
129785864|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
129785865|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129785866|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
129785867|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
129785868|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129580452|NCT02451696|466422985|FG001|Overall Study|Surgery postponed|0|||
129580453|NCT05014828|466422987|FG000|Overall Study|Study Completed by Sponsor|16|||
129580454|NCT05014828|466422988|FG001|Overall Study|Study Completed by Sponsor|16|||
129580455|NCT05014828|466422989|FG002|Overall Study|Study Completed by Sponsor|3|||
129785869|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Adverse Event|5|||
129580456|NCT05014828|466422990|FG003|Overall Study|Study Completed by Sponsor|3|||
129580457|NCT05014828|466422987|FG000|Overall Study|Death|11|||
129580458|NCT05014828|466422988|FG001|Overall Study|Death|6|||
129580459|NCT05014828|466422989|FG002|Overall Study|Death|0|||
129580460|NCT05014828|466422990|FG003|Overall Study|Death|0|||
129580461|NCT05014828|466422987|FG000|Overall Study|Lost to Follow-up|0|||
129580462|NCT05014828|466422988|FG001|Overall Study|Lost to Follow-up|0|||
129580463|NCT05014828|466422989|FG002|Overall Study|Lost to Follow-up|2|||
129580464|NCT05014828|466422990|FG003|Overall Study|Lost to Follow-up|0|||
129580465|NCT05014828|466422987|FG000|Overall Study|Miscellaneous.|0|||
129580466|NCT05014828|466422988|FG001|Overall Study|Miscellaneous.|1|||
129580467|NCT05014828|466422989|FG002|Overall Study|Miscellaneous.|0|||
129580468|NCT05014828|466422990|FG003|Overall Study|Miscellaneous.|0|||
129580469|NCT05523895|466422991|FG000|Overall Study|Adverse Event|2|||
129580470|NCT05523895|466422992|FG001|Overall Study|Adverse Event|1|||
129580471|NCT05523895|466422993|FG002|Overall Study|Adverse Event|1|||
129580472|NCT05523895|466422991|FG000|Overall Study|Lost to Follow-up|0|||
129580473|NCT05523895|466422992|FG001|Overall Study|Lost to Follow-up|1|||
129580474|NCT05523895|466422993|FG002|Overall Study|Lost to Follow-up|2|||
129580475|NCT05523895|466422991|FG000|Overall Study|Noncompliance with study drug|1|||
129580476|NCT05523895|466422992|FG001|Overall Study|Noncompliance with study drug|1|||
129580477|NCT05523895|466422993|FG002|Overall Study|Noncompliance with study drug|1|||
129580478|NCT05523895|466422991|FG000|Overall Study|Protocol Violation|0|||
129580479|NCT05523895|466422992|FG001|Overall Study|Protocol Violation|2|||
129580480|NCT05523895|466422993|FG002|Overall Study|Protocol Violation|0|||
129580481|NCT05523895|466422991|FG000|Overall Study|Withdrawal by Subject|1|||
129580482|NCT05523895|466422992|FG001|Overall Study|Withdrawal by Subject|3|||
129580483|NCT05523895|466422993|FG002|Overall Study|Withdrawal by Subject|1|||
129580484|NCT05523895|466422991|FG000|Overall Study|Not further specified|0|||
129580485|NCT05523895|466422992|FG001|Overall Study|Not further specified|3|||
129580486|NCT05523895|466422993|FG002|Overall Study|Not further specified|1|||
129580487|NCT03674892|466422994|FG000|Overall Study|Lack of Efficacy|5|||
129580488|NCT03674892|466422994|FG000|Overall Study|Lost to Follow-up|3|||
129580489|NCT03674892|466422994|FG000|Overall Study|Migraine|2|||
129695255|NCT01796470|466841762|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
129695256|NCT01796470|466841763|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
129695257|NCT01796470|466841764|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
129695258|NCT01796470|466841765|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
129695259|NCT01796470|466841761|FG000|Overall Study|Withdrawal by Subject|7|||
129695260|NCT01796470|466841762|FG001|Overall Study|Withdrawal by Subject|0|||
129695261|NCT01796470|466841763|FG002|Overall Study|Withdrawal by Subject|0|||
129695262|NCT01796470|466841764|FG003|Overall Study|Withdrawal by Subject|0|||
129695263|NCT01796470|466841765|FG004|Overall Study|Withdrawal by Subject|1|||
129695264|NCT01927861|466841766|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
129695265|NCT01927861|466841767|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
129695266|NCT01927861|466841766|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
129695267|NCT01927861|466841767|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
129695268|NCT00987935|466841768|FG000|Overall Study|Progressive disease|3|||
129695269|NCT00987935|466841769|FG001|Overall Study|Progressive disease|2|||
129695270|NCT00987935|466841770|FG002|Overall Study|Progressive disease|3|||
129695271|NCT00987935|466841771|FG003|Overall Study|Progressive disease|2|||
129695272|NCT00987935|466841772|FG004|Overall Study|Progressive disease|5|||
129695273|NCT00987935|466841773|FG005|Overall Study|Progressive disease|3|||
129695274|NCT00987935|466841774|FG006|Overall Study|Progressive disease|9|||
129695275|NCT00987935|466841775|FG007|Overall Study|Progressive disease|48|||
129695276|NCT00987935|466841776|FG008|Overall Study|Progressive disease|23|||
129695277|NCT00987935|466841768|FG000|Overall Study|Adverse Event|0|||
129695278|NCT00987935|466841769|FG001|Overall Study|Adverse Event|1|||
129695279|NCT00987935|466841770|FG002|Overall Study|Adverse Event|0|||
129695280|NCT00987935|466841771|FG003|Overall Study|Adverse Event|1|||
129695281|NCT00987935|466841772|FG004|Overall Study|Adverse Event|1|||
129695282|NCT00987935|466841773|FG005|Overall Study|Adverse Event|0|||
129580490|NCT03674892|466422994|FG000|Overall Study|Excessive Tearing|1|||
129580491|NCT03674892|466422994|FG000|Overall Study|Increased Eye Pain|1|||
129580492|NCT03674892|466422994|FG000|Overall Study|Increased Facial Pain|1|||
129580493|NCT03674892|466422994|FG000|Overall Study|Sinus Irritation|1|||
129580494|NCT03674892|466422994|FG000|Overall Study|Sinus Infection|1|||
129695283|NCT00987935|466841774|FG006|Overall Study|Adverse Event|2|||
129695284|NCT00987935|466841775|FG007|Overall Study|Adverse Event|10|||
129695285|NCT00987935|466841776|FG008|Overall Study|Adverse Event|6|||
129695286|NCT00987935|466841768|FG000|Overall Study|Refused to continue taking trial med.|1|||
129695287|NCT00987935|466841769|FG001|Overall Study|Refused to continue taking trial med.|0|||
129580495|NCT05041361|466422996|FG000|Overall Study|Lost to Follow-up|1|||
129580496|NCT05041361|466422997|FG001|Overall Study|Lost to Follow-up|3|||
129580497|NCT01642277|466422998|FG000|Overall Study|Adverse Event|10|||
129580498|NCT01642277|466422999|FG001|Overall Study|Adverse Event|0|||
129580499|NCT01642277|466422998|FG000|Overall Study|Physician Decision|2|||
129580500|NCT01642277|466422999|FG001|Overall Study|Physician Decision|0|||
129580501|NCT01642277|466422998|FG000|Overall Study|Protocol Violation|1|||
129580502|NCT01642277|466422999|FG001|Overall Study|Protocol Violation|0|||
129580503|NCT01642277|466422998|FG000|Overall Study|Withdrawal by Subject|11|||
129695288|NCT00987935|466841770|FG002|Overall Study|Refused to continue taking trial med.|0|||
129695289|NCT00987935|466841771|FG003|Overall Study|Refused to continue taking trial med.|0|||
129695290|NCT00987935|466841772|FG004|Overall Study|Refused to continue taking trial med.|1|||
129695291|NCT00987935|466841773|FG005|Overall Study|Refused to continue taking trial med.|0|||
129695292|NCT00987935|466841774|FG006|Overall Study|Refused to continue taking trial med.|4|||
129695293|NCT00987935|466841775|FG007|Overall Study|Refused to continue taking trial med.|4|||
129695294|NCT00987935|466841776|FG008|Overall Study|Refused to continue taking trial med.|2|||
129695295|NCT00987935|466841768|FG000|Overall Study|Reason other than those specified above|0|||
129695296|NCT00987935|466841769|FG001|Overall Study|Reason other than those specified above|0|||
129695297|NCT00987935|466841770|FG002|Overall Study|Reason other than those specified above|0|||
129695298|NCT00987935|466841771|FG003|Overall Study|Reason other than those specified above|0|||
129695299|NCT00987935|466841772|FG004|Overall Study|Reason other than those specified above|0|||
129695300|NCT00987935|466841773|FG005|Overall Study|Reason other than those specified above|0|||
129695301|NCT00987935|466841774|FG006|Overall Study|Reason other than those specified above|0|||
129695302|NCT00987935|466841775|FG007|Overall Study|Reason other than those specified above|0|||
129695303|NCT00987935|466841776|FG008|Overall Study|Reason other than those specified above|1|||
129695304|NCT02176525|466841777|FG000|Overall Study|Adverse Event|0|||
129695305|NCT02176525|466841778|FG001|Overall Study|Adverse Event|0|||
129695306|NCT02176525|466841779|FG002|Overall Study|Adverse Event|0|||
129695307|NCT02176525|466841780|FG003|Overall Study|Adverse Event|1|||
129695308|NCT02176525|466841781|FG004|Overall Study|Adverse Event|1|||
129695309|NCT02176525|466841782|FG005|Overall Study|Adverse Event|0|||
129695310|NCT02176525|466841783|FG006|Overall Study|Adverse Event|1|||
129695311|NCT02176525|466841784|FG007|Overall Study|Adverse Event|0|||
129695312|NCT02176525|466841777|FG000|Overall Study|not treated|1|||
129695313|NCT02176525|466841778|FG001|Overall Study|not treated|0|||
129695314|NCT02176525|466841779|FG002|Overall Study|not treated|0|||
129695315|NCT02176525|466841780|FG003|Overall Study|not treated|0|||
129695316|NCT02176525|466841781|FG004|Overall Study|not treated|0|||
129695317|NCT02176525|466841782|FG005|Overall Study|not treated|1|||
129695318|NCT02176525|466841783|FG006|Overall Study|not treated|0|||
129695319|NCT02176525|466841784|FG007|Overall Study|not treated|0|||
129695320|NCT01905267|466841785|FG000|Overall Study|Physician Decision|2|||
129695321|NCT01905267|466841786|FG001|Overall Study|Physician Decision|2|||
129695322|NCT01608308|466841787|FG000|Overall Study|pretreatment medical and billing reasons|0|||
129695323|NCT01608308|466841788|FG001|Overall Study|pretreatment medical and billing reasons|2|||
129695324|NCT05652140|466841791|FG000|Overall Study|Lost to Follow-up|7|||
129695325|NCT05652140|466841792|FG001|Overall Study|Lost to Follow-up|16|||
129695326|NCT05652140|466841793|FG002|Overall Study|Lost to Follow-up|22|||
129695327|NCT05652140|466841794|FG003|Overall Study|Lost to Follow-up|31|||
129695328|NCT06048705|466841795|FG000|Overall Study|Physician Decision|1|||
129695329|NCT06048705|466841796|FG001|Overall Study|Physician Decision|0|||
129695330|NCT06048705|466841797|FG002|Overall Study|Physician Decision|0|||
129695331|NCT06048705|466841795|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
129695332|NCT06048705|466841796|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
129695333|NCT06048705|466841797|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
129695334|NCT06048705|466841795|FG000|Overall Study|Death prior to lymphodepletion|0|||
129695335|NCT06048705|466841796|FG001|Overall Study|Death prior to lymphodepletion|0|||
129695336|NCT06048705|466841797|FG002|Overall Study|Death prior to lymphodepletion|1|||
129695337|NCT01016015|466841798|FG000|Overall Study|Not Treated|3|||
129695338|NCT01016015|466841798|FG000|Overall Study|Withdrawal by Subject|1|||
129695339|NCT01016015|466841798|FG000|Overall Study|Adverse Event|15|||
129695340|NCT04648241|466841799|FG000|Overall Study|Lost to Follow-up|1|||
129695341|NCT04648241|466841800|FG001|Overall Study|Lost to Follow-up|0|||
129580504|NCT01642277|466422999|FG001|Overall Study|Withdrawal by Subject|0|||
129580505|NCT03779334|466423002|FG000|Overall Study|Withdrawal by Subject|3|||
129580506|NCT03779334|466423003|FG001|Overall Study|Withdrawal by Subject|0|||
129695342|NCT02057666|466841801|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
129695343|NCT02057666|466841802|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
129695344|NCT02057666|466841801|FG000|Double Blind Treatment Period|Poor tolerability|7|||
129695345|NCT02057666|466841802|FG001|Double Blind Treatment Period|Poor tolerability|2|||
129695346|NCT02057666|466841801|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
129695347|NCT02057666|466841802|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
129695348|NCT02057666|466841801|FG000|Double Blind Treatment Period|Physician Decision|1|||
129580507|NCT03779334|466423004|FG002|Overall Study|Withdrawal by Subject|0|||
129884866|NCT01000376|467538697|FG001|Cycle 1 Day 1|Progressive Disease|0|||
129884867|NCT00896454|467538698|FG000|Overall Study|Death|10|||
129884868|NCT00896454|467538698|FG000|Overall Study|Adverse Event|8|||
129580508|NCT03779334|466423002|FG000|Overall Study|Ongoing in Study|5|||
129695349|NCT02057666|466841802|FG001|Double Blind Treatment Period|Physician Decision|0|||
129695350|NCT02057666|466841801|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
129695351|NCT02057666|466841802|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
129695352|NCT02057666|466841801|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
129695353|NCT02057666|466841802|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
129695354|NCT02057666|466841801|FG000|Double Blind Treatment Period|Sponsor's request|70|||
129695355|NCT02057666|466841802|FG001|Double Blind Treatment Period|Sponsor's request|34|||
129695356|NCT02057666|466841801|FG000|Open-Label Treatment Period|Poor tolerability|0|||
129695357|NCT02057666|466841802|FG001|Open-Label Treatment Period|Poor tolerability|1|||
129695358|NCT02057666|466841801|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
129695359|NCT02057666|466841802|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
129695360|NCT02057666|466841801|FG000|Open-Label Treatment Period|Sponsor's request|0|||
129695361|NCT02057666|466841802|FG001|Open-Label Treatment Period|Sponsor's request|4|||
129695362|NCT01793129|466843814|FG000|Overall Study|Lost to Follow-up|3|||
129695363|NCT01793129|466843815|FG001|Overall Study|Lost to Follow-up|7|||
129695364|NCT01793129|466843814|FG000|Overall Study|Withdrawal by Subject|0|||
129695365|NCT01793129|466843815|FG001|Overall Study|Withdrawal by Subject|2|||
129695366|NCT01428713|466843818|FG000|Overall Study|Non-compliance|2|||
129695367|NCT01428713|466843819|FG001|Overall Study|Non-compliance|2|||
129695368|NCT01428713|466843818|FG000|Overall Study|Withdrawal by Subject|1|||
129695369|NCT01428713|466843819|FG001|Overall Study|Withdrawal by Subject|1|||
129695370|NCT01428713|466843818|FG000|Overall Study|Adverse Event|0|||
129695371|NCT01428713|466843819|FG001|Overall Study|Adverse Event|2|||
129695372|NCT00862277|466843820|FG000|Overall Study|Protocol Violation|1|||
129695373|NCT00862277|466843821|FG001|Overall Study|Protocol Violation|2|||
129695374|NCT00862277|466843822|FG002|Overall Study|Protocol Violation|5|||
129695375|NCT00871000|466843823|FG000|Overall Study|Withdrawal by Subject|1|||
129695376|NCT00871000|466843824|FG001|Overall Study|Withdrawal by Subject|0|||
129695377|NCT01052428|466843825|FG000|Overall Study|Death|1|||
129695378|NCT01052428|466843826|FG001|Overall Study|Death|0|||
129695379|NCT01052428|466843825|FG000|Overall Study|Withdrawal by Subject|0|||
129695380|NCT01052428|466843826|FG001|Overall Study|Withdrawal by Subject|1|||
129695381|NCT00605657|466843828|FG000|Overall Study|Adverse Event|1|||
129695382|NCT00605657|466843828|FG000|Overall Study|Protocol Violation|1|||
129695383|NCT01034657|466843830|FG000|Core Phase|Withdrawal by Subject|1|||
129695384|NCT01034657|466843831|FG001|Core Phase|Withdrawal by Subject|0|||
129695385|NCT01034657|466843832|FG002|Core Phase|Withdrawal by Subject|0|||
129695386|NCT01034657|466843830|FG000|Core Phase|Lack of Efficacy|2|||
129695387|NCT01034657|466843831|FG001|Core Phase|Lack of Efficacy|0|||
129695388|NCT01034657|466843832|FG002|Core Phase|Lack of Efficacy|0|||
129695389|NCT01034657|466843830|FG000|Core Phase|Abnormal laboratory value|1|||
129695390|NCT01034657|466843831|FG001|Core Phase|Abnormal laboratory value|0|||
129695391|NCT01034657|466843832|FG002|Core Phase|Abnormal laboratory value|0|||
129695392|NCT01034657|466843830|FG000|Core Phase|Adverse Event|8|||
129695393|NCT01034657|466843831|FG001|Core Phase|Adverse Event|0|||
129695394|NCT01034657|466843832|FG002|Core Phase|Adverse Event|0|||
129695395|NCT01034657|466843830|FG000|Core Phase|Protocol Violation|2|||
129695396|NCT01034657|466843831|FG001|Core Phase|Protocol Violation|0|||
129695397|NCT01034657|466843832|FG002|Core Phase|Protocol Violation|0|||
129695398|NCT01034657|466843830|FG000|Randomized Phase|Withdrawal by Subject|0|||
129695399|NCT01034657|466843831|FG001|Randomized Phase|Withdrawal by Subject|2|||
129695400|NCT01034657|466843832|FG002|Randomized Phase|Withdrawal by Subject|0|||
129695401|NCT01034657|466843830|FG000|Randomized Phase|Lack of Efficacy|5|||
129695402|NCT01034657|466843831|FG001|Randomized Phase|Lack of Efficacy|1|||
129695403|NCT01034657|466843832|FG002|Randomized Phase|Lack of Efficacy|0|||
129695404|NCT01034657|466843830|FG000|Randomized Phase|Abnormal laboratory value|0|||
129695405|NCT01034657|466843831|FG001|Randomized Phase|Abnormal laboratory value|1|||
129695406|NCT01034657|466843832|FG002|Randomized Phase|Abnormal laboratory value|0|||
129695407|NCT01034657|466843830|FG000|Randomized Phase|Adverse Event|0|||
129695408|NCT01034657|466843831|FG001|Randomized Phase|Adverse Event|2|||
129695409|NCT01034657|466843832|FG002|Randomized Phase|Adverse Event|1|||
129695410|NCT01791205|466843833|FG000|Phase II|Lack of Efficacy|6|||
129695411|NCT01791205|466843834|FG001|Phase II|Lack of Efficacy|0|||
129695412|NCT01791205|466843833|FG000|Phase II|Adverse Event|2|||
129695413|NCT01791205|466843834|FG001|Phase II|Adverse Event|0|||
129695414|NCT01791205|466843833|FG000|Phase II|Safety|1|||
129695415|NCT01791205|466843834|FG001|Phase II|Safety|0|||
129695416|NCT01791205|466843833|FG000|Phase II|Lost to Follow-up|1|||
129695417|NCT01791205|466843834|FG001|Phase II|Lost to Follow-up|0|||
129695418|NCT01791205|466843833|FG000|Phase II|Remission of disease|1|||
129695419|NCT01791205|466843834|FG001|Phase II|Remission of disease|0|||
129695420|NCT01791205|466843833|FG000|Phase II|Physician's decision|1|||
129884869|NCT00896454|467538698|FG000|Overall Study|Disease Progression|5|||
129884870|NCT00896454|467538698|FG000|Overall Study|Other|4|||
129580509|NCT03779334|466423003|FG001|Overall Study|Ongoing in Study|13|||
129580510|NCT03779334|466423004|FG002|Overall Study|Ongoing in Study|5|||
129580511|NCT01175135|466423005|FG000|Overall Study|Adverse Event|2|||
129580512|NCT01175135|466423006|FG001|Overall Study|Adverse Event|5|||
129580513|NCT01175135|466423007|FG002|Overall Study|Adverse Event|3|||
129580514|NCT01175135|466423008|FG003|Overall Study|Adverse Event|4|||
129580515|NCT01175135|466423005|FG000|Overall Study|Death|1|||
129785870|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Adverse Event|13|||
129785871|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
129785872|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
129785873|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
129785874|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129785875|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
129785876|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
129785877|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
129785878|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
129785879|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
129785880|NCT01675167|467183649|FG000|Double-blind Treatment Phase|Other|0|||
129785881|NCT01675167|467183650|FG001|Double-blind Treatment Phase|Other|7|||
129785882|NCT01675167|467183651|FG002|Double-blind Treatment Phase|Other|5|||
129785883|NCT00881868|467183652|FG000|Overall Study|Adverse Event|0|||
129785884|NCT00881868|467183653|FG001|Overall Study|Adverse Event|1|||
129785885|NCT00881868|467183652|FG000|Overall Study|Lost to Follow-up|2|||
129785886|NCT00881868|467183653|FG001|Overall Study|Lost to Follow-up|1|||
129785887|NCT00881868|467183652|FG000|Overall Study|Physician Decision|4|||
129785888|NCT00881868|467183653|FG001|Overall Study|Physician Decision|0|||
129785889|NCT00881868|467183652|FG000|Overall Study|Protocol Violation|2|||
129785890|NCT00881868|467183653|FG001|Overall Study|Protocol Violation|0|||
129785891|NCT03255083|467183654|FG000|Overall Study|Clinical progression|1|||
129785892|NCT03255083|467183655|FG001|Overall Study|Clinical progression|0|||
129785893|NCT03255083|467183656|FG002|Overall Study|Clinical progression|0|||
129785894|NCT03255083|467183657|FG003|Overall Study|Clinical progression|0|||
129785895|NCT03255083|467183654|FG000|Overall Study|Adverse Event|0|||
129785896|NCT03255083|467183655|FG001|Overall Study|Adverse Event|1|||
129785897|NCT03255083|467183656|FG002|Overall Study|Adverse Event|0|||
129785898|NCT03255083|467183657|FG003|Overall Study|Adverse Event|0|||
129785899|NCT03255083|467183654|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
129785900|NCT03255083|467183655|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
129785901|NCT03255083|467183656|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
129785902|NCT03255083|467183657|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
129785903|NCT03255083|467183654|FG000|Overall Study|Withdrawal by Subject|1|||
129785904|NCT03255083|467183655|FG001|Overall Study|Withdrawal by Subject|1|||
129785905|NCT03255083|467183656|FG002|Overall Study|Withdrawal by Subject|1|||
129785906|NCT03255083|467183657|FG003|Overall Study|Withdrawal by Subject|0|||
129785907|NCT01182844|467183658|FG000|Overall Study|Withdrawal by Subject|0|||
129785908|NCT01182844|467183659|FG001|Overall Study|Withdrawal by Subject|2|||
129785909|NCT01457352|467183660|FG000|Period 1|Adverse Event|2|||
129785910|NCT01457352|467183661|FG001|Period 1|Adverse Event|0|||
129785911|NCT01457352|467183660|FG000|Period 1|Withdrawal by Subject|2|||
129785912|NCT01457352|467183661|FG001|Period 1|Withdrawal by Subject|0|||
129785913|NCT01457352|467183660|FG000|Period 1|Physician Decision|2|||
129785914|NCT01457352|467183661|FG001|Period 1|Physician Decision|0|||
129785915|NCT01457352|467183660|FG000|Period 1|MS related disease progression|1|||
129785916|NCT01457352|467183661|FG001|Period 1|MS related disease progression|0|||
129785917|NCT01457352|467183660|FG000|Period 1|Withdrawn|1|||
129785918|NCT01457352|467183661|FG001|Period 1|Withdrawn|0|||
129785919|NCT01457352|467183660|FG000|Period 1|withdrew per sponsor|1|||
129785920|NCT01457352|467183661|FG001|Period 1|withdrew per sponsor|0|||
129785921|NCT01457352|467183660|FG000|Period 1|Protocol Violation|4|||
129785922|NCT01457352|467183661|FG001|Period 1|Protocol Violation|0|||
129785923|NCT01457352|467183660|FG000|Period 1|Did not meet eligibility criteria|3|||
129785924|NCT01457352|467183661|FG001|Period 1|Did not meet eligibility criteria|0|||
129785925|NCT01457352|467183660|FG000|Period 2|Withdrawal by Subject|23|||
129785926|NCT01457352|467183661|FG001|Period 2|Withdrawal by Subject|0|||
129785927|NCT01457352|467183660|FG000|Period 2|Adverse Event|22|||
129785928|NCT01457352|467183661|FG001|Period 2|Adverse Event|0|||
129785929|NCT01457352|467183660|FG000|Period 2|no analysis|10|||
129785930|NCT01457352|467183661|FG001|Period 2|no analysis|0|||
129785931|NCT01457352|467183660|FG000|Period 2|Lack of Efficacy|8|||
129785932|NCT01457352|467183661|FG001|Period 2|Lack of Efficacy|0|||
129785933|NCT01457352|467183660|FG000|Period 2|Protocol Violation|4|||
129785934|NCT01457352|467183661|FG001|Period 2|Protocol Violation|0|||
129785935|NCT01457352|467183660|FG000|Period 2|Sponsor's withdrawal|7|||
129785936|NCT01457352|467183661|FG001|Period 2|Sponsor's withdrawal|0|||
129785937|NCT01457352|467183660|FG000|Period 2|Lost to Follow-up|1|||
129785938|NCT01457352|467183661|FG001|Period 2|Lost to Follow-up|0|||
129785939|NCT01457352|467183660|FG000|Period 2|dose change|1|||
129580516|NCT01175135|466423006|FG001|Overall Study|Death|0|||
129580517|NCT01175135|466423007|FG002|Overall Study|Death|0|||
129580518|NCT01175135|466423008|FG003|Overall Study|Death|0|||
129580519|NCT01175135|466423005|FG000|Overall Study|Lack of Efficacy|4|||
129580520|NCT01175135|466423006|FG001|Overall Study|Lack of Efficacy|5|||
129580521|NCT01175135|466423007|FG002|Overall Study|Lack of Efficacy|0|||
129580522|NCT01175135|466423008|FG003|Overall Study|Lack of Efficacy|5|||
129785940|NCT01457352|467183661|FG001|Period 2|dose change|0|||
129785941|NCT01457352|467183660|FG000|Period 2|Physician Decision|1|||
129785942|NCT01457352|467183661|FG001|Period 2|Physician Decision|0|||
129785943|NCT01457352|467183660|FG000|Period 2|Did not meet eligibility criteria|3|||
129785944|NCT01457352|467183661|FG001|Period 2|Did not meet eligibility criteria|0|||
129785945|NCT01457352|467183660|FG000|Period 3|Adverse Event|1|||
129785946|NCT01457352|467183661|FG001|Period 3|Adverse Event|1|||
129785947|NCT01457352|467183660|FG000|Period 3|Withdrawal by Subject|0|||
129785948|NCT01457352|467183661|FG001|Period 3|Withdrawal by Subject|2|||
129785949|NCT01457352|467183660|FG000|Period 3|incorrect treatment|0|||
129785950|NCT01457352|467183661|FG001|Period 3|incorrect treatment|1|||
129785951|NCT01457352|467183660|FG000|Period 3|Sponsor's withdrawal|0|||
129785952|NCT01457352|467183661|FG001|Period 3|Sponsor's withdrawal|1|||
129785953|NCT04174365|467183662|FG000|Overall Study|Lost to Follow-up|1|||
129785954|NCT04174365|467183663|FG001|Overall Study|Lost to Follow-up|2|||
129785955|NCT04174365|467183662|FG000|Overall Study|Adverse Event|2|||
129785956|NCT04174365|467183663|FG001|Overall Study|Adverse Event|1|||
129785957|NCT04174365|467183662|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
129785958|NCT04174365|467183663|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
129785959|NCT04174365|467183662|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
129785960|NCT04174365|467183663|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
129785961|NCT04174365|467183662|FG000|Overall Study|Protocol Deviation|1|||
129785962|NCT04174365|467183663|FG001|Overall Study|Protocol Deviation|0|||
129785963|NCT04174365|467183662|FG000|Overall Study|Lack of Efficacy|0|||
129785964|NCT04174365|467183663|FG001|Overall Study|Lack of Efficacy|2|||
129785965|NCT04174365|467183662|FG000|Overall Study|Disease Relapse|1|||
129785966|NCT04174365|467183663|FG001|Overall Study|Disease Relapse|0|||
129785967|NCT04174365|467183662|FG000|Overall Study|Reason Not Specified|0|||
129785968|NCT04174365|467183663|FG001|Overall Study|Reason Not Specified|1|||
129785969|NCT01031836|467185542|FG000|Stage I|Adverse Event|1|||
129785970|NCT01031836|467185543|FG001|Stage I|Adverse Event|1|||
129785971|NCT01031836|467185544|FG002|Stage I|Adverse Event|0|||
129785972|NCT01031836|467185545|FG003|Stage I|Adverse Event|0|||
129785973|NCT01031836|467185546|FG004|Stage I|Adverse Event|0|||
129785974|NCT01031836|467185547|FG005|Stage I|Adverse Event|0|||
129785975|NCT01031836|467185542|FG000|Stage I|Other|0|||
129785976|NCT01031836|467185543|FG001|Stage I|Other|1|||
129785977|NCT01031836|467185544|FG002|Stage I|Other|0|||
129785978|NCT01031836|467185545|FG003|Stage I|Other|0|||
129785979|NCT01031836|467185546|FG004|Stage I|Other|0|||
129785980|NCT01031836|467185547|FG005|Stage I|Other|1|||
129785981|NCT01031836|467185542|FG000|Stage II|Adverse Event|0|||
129785982|NCT01031836|467185543|FG001|Stage II|Adverse Event|0|||
129785983|NCT01031836|467185544|FG002|Stage II|Adverse Event|2|||
129580523|NCT01175135|466423005|FG000|Overall Study|Lost to Follow-up|1|||
129580524|NCT01175135|466423006|FG001|Overall Study|Lost to Follow-up|2|||
129580525|NCT01175135|466423007|FG002|Overall Study|Lost to Follow-up|0|||
129580526|NCT01175135|466423008|FG003|Overall Study|Lost to Follow-up|0|||
129580527|NCT01175135|466423005|FG000|Overall Study|Protocol Violation|1|||
129580528|NCT01175135|466423006|FG001|Overall Study|Protocol Violation|1|||
129580529|NCT01175135|466423007|FG002|Overall Study|Protocol Violation|0|||
129580530|NCT01175135|466423008|FG003|Overall Study|Protocol Violation|0|||
129580531|NCT01175135|466423005|FG000|Overall Study|Withdrawal by Subject|4|||
129580532|NCT01175135|466423006|FG001|Overall Study|Withdrawal by Subject|8|||
129785984|NCT01031836|467185545|FG003|Stage II|Adverse Event|2|||
129785985|NCT01031836|467185546|FG004|Stage II|Adverse Event|1|||
129785986|NCT01031836|467185547|FG005|Stage II|Adverse Event|1|||
129785987|NCT01031836|467185542|FG000|Stage II|Other|2|||
129785988|NCT01031836|467185543|FG001|Stage II|Other|0|||
129785989|NCT01031836|467185544|FG002|Stage II|Other|0|||
129785990|NCT01031836|467185545|FG003|Stage II|Other|1|||
129785991|NCT01031836|467185546|FG004|Stage II|Other|1|||
129580533|NCT01175135|466423007|FG002|Overall Study|Withdrawal by Subject|5|||
129785992|NCT01031836|467185547|FG005|Stage II|Other|0|||
129785993|NCT03859973|467185555|FG000|Overall Study|Other reason than listed|3|||
129785994|NCT03859973|467185556|FG001|Overall Study|Other reason than listed|2|||
129785995|NCT03859973|467185555|FG000|Overall Study|COVID-19 related, not due to AE|3|||
129785996|NCT03859973|467185556|FG001|Overall Study|COVID-19 related, not due to AE|4|||
129785997|NCT03859973|467185555|FG000|Overall Study|Withdrawal by Subject|8|||
129785998|NCT03859973|467185556|FG001|Overall Study|Withdrawal by Subject|9|||
129580534|NCT01175135|466423008|FG003|Overall Study|Withdrawal by Subject|5|||
129785999|NCT03859973|467185555|FG000|Overall Study|Lost to Follow-up|2|||
129786000|NCT03859973|467185556|FG001|Overall Study|Lost to Follow-up|3|||
129580535|NCT01175135|466423005|FG000|Overall Study|Other|3|||
129580536|NCT01175135|466423006|FG001|Overall Study|Other|1|||
129580537|NCT01175135|466423007|FG002|Overall Study|Other|3|||
129580538|NCT01175135|466423008|FG003|Overall Study|Other|0|||
129580539|NCT01175135|466423005|FG000|Overall Study|Randomized But Not Treated|0|||
129580540|NCT01175135|466423006|FG001|Overall Study|Randomized But Not Treated|0|||
129580541|NCT01175135|466423007|FG002|Overall Study|Randomized But Not Treated|1|||
129580542|NCT01175135|466423008|FG003|Overall Study|Randomized But Not Treated|0|||
129580543|NCT04692155|466423012|FG000|Overall Study|Death|1|||
129580544|NCT02213263|466423017|FG000|Overall Study|Insufficient clinical response|4|||
129580545|NCT02213263|466423018|FG001|Overall Study|Insufficient clinical response|3|||
129580546|NCT02213263|466423017|FG000|Overall Study|Lost to Follow-up|0|||
129580547|NCT02213263|466423018|FG001|Overall Study|Lost to Follow-up|1|||
129580548|NCT02213263|466423017|FG000|Overall Study|No longer willing to participate|3|||
129580549|NCT02213263|466423018|FG001|Overall Study|No longer willing to participate|4|||
129580550|NCT02213263|466423017|FG000|Overall Study|Progressive disease|20|||
129580551|NCT02213263|466423018|FG001|Overall Study|Progressive disease|14|||
129580552|NCT02213263|466423017|FG000|Overall Study|Protocol Violation|0|||
129580553|NCT02213263|466423018|FG001|Overall Study|Protocol Violation|1|||
129580554|NCT02213263|466423017|FG000|Overall Study|Adverse Event|1|||
129580555|NCT02213263|466423018|FG001|Overall Study|Adverse Event|3|||
129580556|NCT05752721|466423019|FG000|Overall Study|Lost to Follow-up|22|||
129580557|NCT05752721|466423020|FG001|Overall Study|Lost to Follow-up|20|||
129580558|NCT05752721|466423019|FG000|Overall Study|Withdrawal by Subject|15|||
129580559|NCT05752721|466423020|FG001|Overall Study|Withdrawal by Subject|12|||
129580560|NCT01188681|466423021|FG000|Overall Study|bladder cancer|0|||
129580561|NCT01188681|466423022|FG001|Overall Study|bladder cancer|0|||
129695421|NCT01791205|466843834|FG001|Phase II|Physician's decision|0|||
129695422|NCT02242903|466843845|FG000|Overall Study|Withdrawal by Subject|1|||
129695423|NCT02242903|466843846|FG001|Overall Study|Withdrawal by Subject|0|||
129695424|NCT02242903|466843847|FG002|Overall Study|Withdrawal by Subject|0|||
129695425|NCT02242903|466843848|FG003|Overall Study|Withdrawal by Subject|0|||
129695426|NCT02242903|466843849|FG004|Overall Study|Withdrawal by Subject|0|||
129695427|NCT02242903|466843850|FG005|Overall Study|Withdrawal by Subject|0|||
129695428|NCT02242903|466843851|FG006|Overall Study|Withdrawal by Subject|0|||
129695429|NCT01546987|466843856|FG000|Overall Study|Protocol Violation|3|||
129695430|NCT01546987|466843857|FG001|Overall Study|Protocol Violation|4|||
129695431|NCT03473301|466843860|FG000|Overall Study|Protocol Violation|4|||
129695432|NCT03473301|466843861|FG001|Overall Study|Protocol Violation|0|||
129695433|NCT03473301|466843862|FG002|Overall Study|Protocol Violation|0|||
129695434|NCT03473301|466843860|FG000|Overall Study|Withdrawal by Subject|0|||
129695435|NCT03473301|466843861|FG001|Overall Study|Withdrawal by Subject|1|||
129695436|NCT03473301|466843862|FG002|Overall Study|Withdrawal by Subject|0|||
129695437|NCT03473301|466843860|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
129695438|NCT03473301|466843861|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
129695439|NCT03473301|466843862|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
129695440|NCT05287685|466843863|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
129695441|NCT05287685|466843864|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
129695442|NCT05287685|466843863|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
129695443|NCT05287685|466843864|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
129695444|NCT03093870|466843865|FG000|Overall Study|Withdrawal by Subject|2|||
129695445|NCT03093870|466843866|FG001|Overall Study|Withdrawal by Subject|6|||
129695446|NCT03093870|466843867|FG002|Overall Study|Withdrawal by Subject|5|||
129695447|NCT03093870|466843865|FG000|Overall Study|Death|1|||
129695448|NCT03093870|466843866|FG001|Overall Study|Death|35|||
129695449|NCT03093870|466843867|FG002|Overall Study|Death|35|||
129695450|NCT03093870|466843865|FG000|Overall Study|Radiographic disease progression|10|||
129695451|NCT03093870|466843866|FG001|Overall Study|Radiographic disease progression|0|||
129695452|NCT03093870|466843867|FG002|Overall Study|Radiographic disease progression|0|||
129695453|NCT03093870|466843865|FG000|Overall Study|Clinical disease progression|1|||
129695454|NCT03093870|466843866|FG001|Overall Study|Clinical disease progression|0|||
129695455|NCT03093870|466843867|FG002|Overall Study|Clinical disease progression|0|||
129695456|NCT03093870|466843865|FG000|Overall Study|Physician Decision|2|||
129695457|NCT03093870|466843866|FG001|Overall Study|Physician Decision|0|||
129695458|NCT03093870|466843867|FG002|Overall Study|Physician Decision|0|||
129695459|NCT03093870|466843865|FG000|Overall Study|Adverse Event|7|||
129695460|NCT03093870|466843866|FG001|Overall Study|Adverse Event|0|||
129695461|NCT03093870|466843867|FG002|Overall Study|Adverse Event|0|||
129695462|NCT03093870|466843865|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
129580562|NCT01188681|466423023|FG002|Overall Study|bladder cancer|1|||
129580563|NCT01188681|466423024|FG003|Overall Study|bladder cancer|0|||
129695463|NCT03093870|466843866|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
129695464|NCT03093870|466843867|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
129580564|NCT01188681|466423021|FG000|Overall Study|Withdrawal by Subject|0|||
129580565|NCT01188681|466423022|FG001|Overall Study|Withdrawal by Subject|0|||
129695465|NCT03093870|466843865|FG000|Overall Study|Lost to Follow-up|0|||
129580566|NCT01188681|466423023|FG002|Overall Study|Withdrawal by Subject|0|||
129580567|NCT01188681|466423024|FG003|Overall Study|Withdrawal by Subject|1|||
129580568|NCT02280863|466423025|FG000|Integrated Platform|Met stopping criteria|0|||
129580569|NCT02280863|466423026|FG001|Integrated Platform|Met stopping criteria|1|||
129580570|NCT02890992|466423029|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580571|NCT02890992|466423030|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
129580572|NCT02890992|466423031|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580573|NCT02890992|466423032|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580574|NCT02890992|466423033|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580575|NCT02890992|466423034|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580576|NCT02890992|466423035|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580577|NCT02890992|466423036|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
129580578|NCT02890992|466423029|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129580579|NCT02890992|466423030|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129580580|NCT02890992|466423031|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129580581|NCT02890992|466423032|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129580582|NCT02890992|466423033|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129580583|NCT02890992|466423034|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
129786001|NCT03859973|467185555|FG000|Overall Study|Protocol Violation|1|||
129580584|NCT02890992|466423035|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
129695466|NCT03093870|466843866|FG001|Overall Study|Lost to Follow-up|0|||
129695467|NCT03093870|466843867|FG002|Overall Study|Lost to Follow-up|1|||
129695468|NCT03722030|466843873|FG000|Overall Study|Withdrawal by Subject|1|||
129695469|NCT03722030|466843874|FG001|Overall Study|Withdrawal by Subject|0|||
129695470|NCT02191397|466843876|FG000|Overall Study|Adverse Event|28|||
129695471|NCT02191397|466843877|FG001|Overall Study|Adverse Event|17|||
129695472|NCT02191397|466843876|FG000|Overall Study|Lack of Efficacy|10|||
129695473|NCT02191397|466843877|FG001|Overall Study|Lack of Efficacy|5|||
129695474|NCT02191397|466843876|FG000|Overall Study|Protocol Violation|0|||
129695475|NCT02191397|466843877|FG001|Overall Study|Protocol Violation|3|||
129695476|NCT02191397|466843876|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
129695477|NCT02191397|466843877|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
129695478|NCT02191397|466843876|FG000|Overall Study|Lost to Follow-up|10|||
129695479|NCT02191397|466843877|FG001|Overall Study|Lost to Follow-up|11|||
129695480|NCT02191397|466843876|FG000|Overall Study|Physician Decision|8|||
129695481|NCT02191397|466843877|FG001|Overall Study|Physician Decision|3|||
129695482|NCT02191397|466843876|FG000|Overall Study|Withdrawal by Subject|22|||
129695483|NCT02191397|466843877|FG001|Overall Study|Withdrawal by Subject|27|||
129695484|NCT03721107|466843878|FG000|Overall Study|Adverse Event|1|||
129695485|NCT03721107|466843879|FG001|Overall Study|Adverse Event|1|||
129695486|NCT03721107|466843880|FG002|Overall Study|Adverse Event|6|||
129695487|NCT03721107|466843881|FG003|Overall Study|Adverse Event|5|||
129695488|NCT03721107|466843878|FG000|Overall Study|Lost to Follow-up|2|||
129695489|NCT03721107|466843879|FG001|Overall Study|Lost to Follow-up|0|||
129695490|NCT03721107|466843880|FG002|Overall Study|Lost to Follow-up|3|||
129695491|NCT03721107|466843881|FG003|Overall Study|Lost to Follow-up|0|||
129695492|NCT03721107|466843878|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
129695493|NCT03721107|466843879|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
129695494|NCT03721107|466843880|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
129695495|NCT03721107|466843881|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
129695496|NCT03721107|466843878|FG000|Overall Study|Physician Decision|0|||
129695497|NCT03721107|466843879|FG001|Overall Study|Physician Decision|1|||
129695498|NCT03721107|466843880|FG002|Overall Study|Physician Decision|0|||
129695499|NCT03721107|466843881|FG003|Overall Study|Physician Decision|0|||
129695500|NCT03721107|466843878|FG000|Overall Study|Pregnancy|0|||
129695501|NCT03721107|466843879|FG001|Overall Study|Pregnancy|0|||
129695502|NCT03721107|466843880|FG002|Overall Study|Pregnancy|1|||
129695503|NCT03721107|466843881|FG003|Overall Study|Pregnancy|0|||
129695504|NCT03721107|466843878|FG000|Overall Study|Withdrawal by Subject|1|||
129695505|NCT03721107|466843879|FG001|Overall Study|Withdrawal by Subject|1|||
129695506|NCT03721107|466843880|FG002|Overall Study|Withdrawal by Subject|5|||
129695507|NCT03721107|466843881|FG003|Overall Study|Withdrawal by Subject|5|||
129695508|NCT03721107|466843878|FG000|Overall Study|Other|1|||
129695509|NCT03721107|466843879|FG001|Overall Study|Other|0|||
129695510|NCT03721107|466843880|FG002|Overall Study|Other|0|||
129695511|NCT03721107|466843881|FG003|Overall Study|Other|1|||
129695512|NCT03888482|466843882|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
129695513|NCT03888482|466843883|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
129695514|NCT03888482|466843882|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
129695515|NCT03888482|466843883|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
129695516|NCT02554474|466843884|FG000|Overall Study|Protocol Violation|1|||
129695517|NCT02554474|466843885|FG001|Overall Study|Protocol Violation|1|||
129695518|NCT02554474|466843884|FG000|Overall Study|Health issue not related to the study|1|||
129695519|NCT02554474|466843885|FG001|Overall Study|Health issue not related to the study|0|||
129884871|NCT00896454|467538698|FG000|Overall Study|Requirement for alternative therapy|3|||
129884872|NCT00896454|467538698|FG000|Overall Study|Ongoing in study|2|||
129884873|NCT00896454|467538698|FG000|Overall Study|Withdrawal by Subject|1|||
129884874|NCT03688711|467538699|FG000|Overall Study|Withdrawal by Subject|0|||
129580585|NCT02890992|466423036|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
129580586|NCT02890992|466423029|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
129580587|NCT02890992|466423030|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
129580588|NCT02890992|466423031|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
129580589|NCT02890992|466423032|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
129580590|NCT02890992|466423033|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
129884875|NCT03688711|467538700|FG001|Overall Study|Withdrawal by Subject|1|||
129884876|NCT05033080|467538702|FG000|Overall Study|Adverse Event|4|||
129884877|NCT05033080|467538703|FG001|Overall Study|Adverse Event|4|||
129884878|NCT05033080|467538702|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
129884879|NCT05033080|467538703|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
129884880|NCT05033080|467538702|FG000|Overall Study|Lost to Follow-up|1|||
129884881|NCT05033080|467538703|FG001|Overall Study|Lost to Follow-up|0|||
129884882|NCT05033080|467538702|FG000|Overall Study|Other non-compliance|0|||
129884883|NCT05033080|467538703|FG001|Overall Study|Other non-compliance|1|||
129884884|NCT05033080|467538702|FG000|Overall Study|Physician Decision|0|||
129884885|NCT05033080|467538703|FG001|Overall Study|Physician Decision|1|||
129884886|NCT05033080|467538702|FG000|Overall Study|Other|1|||
129884887|NCT05033080|467538703|FG001|Overall Study|Other|1|||
129884888|NCT01263106|467538704|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
129884889|NCT01263106|467538705|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
129884890|NCT02058290|467538710|FG000|Overall Study|Protocol Violation|2|||
129884891|NCT02058290|467538711|FG001|Overall Study|Protocol Violation|1|||
129884892|NCT02058290|467538710|FG000|Overall Study|Physician Decision|1|||
129884893|NCT02058290|467538711|FG001|Overall Study|Physician Decision|0|||
129884894|NCT02058290|467538710|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
129884895|NCT02058290|467538711|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
129884896|NCT02058290|467538710|FG000|Overall Study|Withdrawal by Subject|0|||
129884897|NCT02058290|467538711|FG001|Overall Study|Withdrawal by Subject|1|||
129884898|NCT05822921|467538714|FG000|Overall Study|Lost to Follow-up|1|||
129884899|NCT05822921|467538715|FG001|Overall Study|Lost to Follow-up|1|||
129884900|NCT00544544|467538716|FG000|Overall Study|Withdrawal by Subject|1|||
129884901|NCT00544544|467538716|FG000|Overall Study|Adverse Event|1|||
129884902|NCT00544544|467538716|FG000|Overall Study|Lost to Follow-up|1|||
129884903|NCT03406702|467538717|FG000|Overall Study|Missed Day 27 Dosing|1|||
129884904|NCT01857622|467538722|FG000|Overall Study|Adverse Event|5|||
129884905|NCT01857622|467538723|FG001|Overall Study|Adverse Event|0|||
129884906|NCT01857622|467538724|FG002|Overall Study|Adverse Event|2|||
129884907|NCT01857622|467538722|FG000|Overall Study|Physician Decision|1|||
129884908|NCT01857622|467538723|FG001|Overall Study|Physician Decision|0|||
129884909|NCT01857622|467538724|FG002|Overall Study|Physician Decision|0|||
129884910|NCT01857622|467538722|FG000|Overall Study|Protocol Violation|4|||
129884911|NCT01857622|467538723|FG001|Overall Study|Protocol Violation|1|||
129884912|NCT01857622|467538724|FG002|Overall Study|Protocol Violation|0|||
129884913|NCT01857622|467538722|FG000|Overall Study|Withdrawal by Subject|1|||
129884914|NCT01857622|467538723|FG001|Overall Study|Withdrawal by Subject|0|||
129580591|NCT02890992|466423034|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
129580592|NCT02890992|466423035|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
129580593|NCT02890992|466423036|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
129580594|NCT03236311|466423037|FG000|Overall Study|Study terminated by sponsor|0|||
129580595|NCT03236311|466423038|FG001|Overall Study|Study terminated by sponsor|2|||
129580596|NCT03236311|466423037|FG000|Overall Study|Adverse Event|0|||
129884915|NCT01857622|467538724|FG002|Overall Study|Withdrawal by Subject|0|||
129884916|NCT01291225|467538726|FG000|Overall Study|Lost to Follow-up|85|||
129884917|NCT01291225|467538727|FG001|Overall Study|Lost to Follow-up|39|||
129884918|NCT01267253|467538728|FG000|Overall Study|Ineligible - required test not done|1|||
129580597|NCT03236311|466423038|FG001|Overall Study|Adverse Event|1|||
129580598|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
129580599|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
129884919|NCT01267253|467538728|FG000|Overall Study|Inevaluable-never received study treatme|2|||
129884920|NCT04318093|467538729|FG000|Overall Study|Adverse Event|2|||
129884921|NCT04318093|467538730|FG001|Overall Study|Adverse Event|2|||
129884922|NCT04318093|467538729|FG000|Overall Study|Participant withdrew consent|1|||
129884923|NCT04318093|467538730|FG001|Overall Study|Participant withdrew consent|0|||
129884924|NCT04318093|467538729|FG000|Overall Study|Other reasons|0|||
129884925|NCT04318093|467538730|FG001|Overall Study|Other reasons|1|||
129884926|NCT00876460|467538733|FG000|Combination Therapy Phase|Progressive disease|2|||
129884927|NCT00876460|467538734|FG001|Combination Therapy Phase|Progressive disease|3|||
129884928|NCT00876460|467538735|FG002|Combination Therapy Phase|Progressive disease|3|||
129580600|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
129580601|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
129580602|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
129580603|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
129580604|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Death|9|||
129580605|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Death|7|||
129580606|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Death|14|||
129580607|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Death|7|||
129580608|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Death|0|||
129580609|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Death|0|||
129580610|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
129580611|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
129580612|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
129580613|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
129580614|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
129580615|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
129580616|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Other Event|49|||
129580617|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Other Event|52|||
129580618|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Other Event|41|||
129580619|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Other Event|58|||
129580620|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Other Event|0|||
129580621|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Other Event|0|||
129580622|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
129580623|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
129580624|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
129580625|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
129580626|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
129580627|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
129580628|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
129580629|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
129580630|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
129580631|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
129580632|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
129580633|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
129580634|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
129580635|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
129580636|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
129580637|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
129580638|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
129580639|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
129580640|NCT00205777|466423043|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
129580641|NCT00205777|466423044|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
129580642|NCT00205777|466423045|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
129580643|NCT00205777|466423046|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
129580644|NCT00205777|466423047|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
129580645|NCT00205777|466423048|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
129580646|NCT00205777|466423043|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
129580647|NCT00205777|466423044|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
129580648|NCT00205777|466423045|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
129580649|NCT00205777|466423046|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
129580650|NCT00205777|466423047|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
129580651|NCT00205777|466423048|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
129580652|NCT00205777|466423043|FG000|Completed Core Study, Entered SE I|Other Event|52|||
129580653|NCT00205777|466423044|FG001|Completed Core Study, Entered SE I|Other Event|46|||
129580654|NCT00205777|466423045|FG002|Completed Core Study, Entered SE I|Other Event|47|||
129580655|NCT00205777|466423046|FG003|Completed Core Study, Entered SE I|Other Event|50|||
129580656|NCT00205777|466423047|FG004|Completed Core Study, Entered SE I|Other Event|0|||
129580657|NCT00205777|466423048|FG005|Completed Core Study, Entered SE I|Other Event|0|||
129580658|NCT00205777|466423043|FG000|Study Extension I|Adverse Event|57|||
129580659|NCT00205777|466423044|FG001|Study Extension I|Adverse Event|0|||
129580660|NCT00205777|466423045|FG002|Study Extension I|Adverse Event|0|||
129580661|NCT00205777|466423046|FG003|Study Extension I|Adverse Event|61|||
129580662|NCT00205777|466423047|FG004|Study Extension I|Adverse Event|58|||
129580663|NCT00205777|466423048|FG005|Study Extension I|Adverse Event|0|||
129580664|NCT00205777|466423043|FG000|Study Extension I|Death|5|||
129580665|NCT00205777|466423044|FG001|Study Extension I|Death|0|||
129580666|NCT00205777|466423045|FG002|Study Extension I|Death|0|||
129580667|NCT00205777|466423046|FG003|Study Extension I|Death|1|||
129580668|NCT00205777|466423047|FG004|Study Extension I|Death|2|||
129580669|NCT00205777|466423048|FG005|Study Extension I|Death|0|||
129580670|NCT00205777|466423043|FG000|Study Extension I|Withdrawal by Subject|99|||
129580671|NCT00205777|466423044|FG001|Study Extension I|Withdrawal by Subject|0|||
129580672|NCT00205777|466423045|FG002|Study Extension I|Withdrawal by Subject|0|||
129580673|NCT00205777|466423046|FG003|Study Extension I|Withdrawal by Subject|106|||
129580674|NCT00205777|466423047|FG004|Study Extension I|Withdrawal by Subject|89|||
129580675|NCT00205777|466423048|FG005|Study Extension I|Withdrawal by Subject|0|||
129580676|NCT00205777|466423043|FG000|Study Extension I|Protocol Violation|4|||
129580677|NCT00205777|466423044|FG001|Study Extension I|Protocol Violation|0|||
129580678|NCT00205777|466423045|FG002|Study Extension I|Protocol Violation|0|||
129580679|NCT00205777|466423046|FG003|Study Extension I|Protocol Violation|8|||
129580680|NCT00205777|466423047|FG004|Study Extension I|Protocol Violation|8|||
129580681|NCT00205777|466423048|FG005|Study Extension I|Protocol Violation|0|||
129580682|NCT00205777|466423043|FG000|Study Extension I|Lack of Efficacy|0|||
129580683|NCT00205777|466423044|FG001|Study Extension I|Lack of Efficacy|0|||
129580684|NCT00205777|466423045|FG002|Study Extension I|Lack of Efficacy|0|||
129580685|NCT00205777|466423046|FG003|Study Extension I|Lack of Efficacy|1|||
129580686|NCT00205777|466423047|FG004|Study Extension I|Lack of Efficacy|2|||
129580687|NCT00205777|466423048|FG005|Study Extension I|Lack of Efficacy|0|||
129580688|NCT00205777|466423043|FG000|Study Extension I|Failed to return|15|||
129580689|NCT00205777|466423044|FG001|Study Extension I|Failed to return|0|||
129580690|NCT00205777|466423045|FG002|Study Extension I|Failed to return|0|||
129580691|NCT00205777|466423046|FG003|Study Extension I|Failed to return|17|||
129580692|NCT00205777|466423047|FG004|Study Extension I|Failed to return|13|||
129580693|NCT00205777|466423048|FG005|Study Extension I|Failed to return|0|||
129580694|NCT00205777|466423043|FG000|Study Extension I|Other Event|34|||
129580695|NCT00205777|466423044|FG001|Study Extension I|Other Event|0|||
129580696|NCT00205777|466423045|FG002|Study Extension I|Other Event|0|||
129580697|NCT00205777|466423046|FG003|Study Extension I|Other Event|34|||
129580698|NCT00205777|466423047|FG004|Study Extension I|Other Event|29|||
129580699|NCT00205777|466423048|FG005|Study Extension I|Other Event|0|||
129580700|NCT00205777|466423043|FG000|Study Extension I|Withdrawn as per protocol|0|||
129580701|NCT00205777|466423044|FG001|Study Extension I|Withdrawn as per protocol|0|||
129580702|NCT00205777|466423045|FG002|Study Extension I|Withdrawn as per protocol|1070|||
129580703|NCT00205777|466423046|FG003|Study Extension I|Withdrawn as per protocol|0|||
129580704|NCT00205777|466423047|FG004|Study Extension I|Withdrawn as per protocol|0|||
129580705|NCT00205777|466423048|FG005|Study Extension I|Withdrawn as per protocol|0|||
129580706|NCT00205777|466423043|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
129580707|NCT00205777|466423044|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129580708|NCT00205777|466423045|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129580709|NCT00205777|466423046|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
129580710|NCT00205777|466423047|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
129580711|NCT00205777|466423048|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
129580712|NCT00205777|466423043|FG000|Study Extension II|Adverse Event|0|||
129580713|NCT00205777|466423044|FG001|Study Extension II|Adverse Event|0|||
129580714|NCT00205777|466423045|FG002|Study Extension II|Adverse Event|0|||
129580715|NCT00205777|466423046|FG003|Study Extension II|Adverse Event|14|||
129580716|NCT00205777|466423047|FG004|Study Extension II|Adverse Event|0|||
129580717|NCT00205777|466423048|FG005|Study Extension II|Adverse Event|30|||
129580718|NCT00205777|466423043|FG000|Study Extension II|Death|0|||
129580719|NCT00205777|466423044|FG001|Study Extension II|Death|0|||
129580720|NCT00205777|466423045|FG002|Study Extension II|Death|0|||
129695520|NCT02554474|466843884|FG000|Overall Study|Withdrawal by Subject|1|||
129695521|NCT02554474|466843885|FG001|Overall Study|Withdrawal by Subject|1|||
129695522|NCT02991859|466843886|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695523|NCT02991859|466843887|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
129695524|NCT02991859|466843888|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695525|NCT02991859|466843889|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695526|NCT02991859|466843890|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
129695527|NCT02991859|466843891|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695528|NCT02991859|466843892|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695529|NCT02991859|466843893|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695530|NCT02991859|466843894|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695531|NCT02991859|466843895|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695532|NCT02991859|466843896|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695533|NCT02991859|466843897|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695534|NCT02991859|466843898|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695535|NCT02991859|466843899|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695536|NCT02991859|466843900|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695537|NCT02991859|466843901|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695538|NCT02991859|466843902|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
129695539|NCT02991859|466843886|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695540|NCT02991859|466843887|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129786002|NCT03859973|467185556|FG001|Overall Study|Protocol Violation|3|||
129580721|NCT00205777|466423046|FG003|Study Extension II|Death|2|||
129580722|NCT00205777|466423047|FG004|Study Extension II|Death|0|||
129580723|NCT00205777|466423048|FG005|Study Extension II|Death|5|||
129580724|NCT00205777|466423043|FG000|Study Extension II|Withdrawal by Subject|0|||
129580725|NCT00205777|466423044|FG001|Study Extension II|Withdrawal by Subject|0|||
129580726|NCT00205777|466423045|FG002|Study Extension II|Withdrawal by Subject|0|||
129580727|NCT00205777|466423046|FG003|Study Extension II|Withdrawal by Subject|35|||
129580728|NCT00205777|466423047|FG004|Study Extension II|Withdrawal by Subject|0|||
129580729|NCT00205777|466423048|FG005|Study Extension II|Withdrawal by Subject|59|||
129580730|NCT00205777|466423043|FG000|Study Extension II|Protocol Violation|0|||
129580731|NCT00205777|466423044|FG001|Study Extension II|Protocol Violation|0|||
129580732|NCT00205777|466423045|FG002|Study Extension II|Protocol Violation|0|||
129580733|NCT00205777|466423046|FG003|Study Extension II|Protocol Violation|1|||
129580734|NCT00205777|466423047|FG004|Study Extension II|Protocol Violation|0|||
129580735|NCT00205777|466423048|FG005|Study Extension II|Protocol Violation|10|||
129580736|NCT00205777|466423043|FG000|Study Extension II|Lack of Efficacy|0|||
129580737|NCT00205777|466423044|FG001|Study Extension II|Lack of Efficacy|0|||
129580738|NCT00205777|466423045|FG002|Study Extension II|Lack of Efficacy|0|||
129580739|NCT00205777|466423046|FG003|Study Extension II|Lack of Efficacy|0|||
129580740|NCT00205777|466423047|FG004|Study Extension II|Lack of Efficacy|0|||
129580741|NCT00205777|466423048|FG005|Study Extension II|Lack of Efficacy|1|||
129580742|NCT00205777|466423043|FG000|Study Extension II|Failed to return|0|||
129580743|NCT00205777|466423044|FG001|Study Extension II|Failed to return|0|||
129580744|NCT00205777|466423045|FG002|Study Extension II|Failed to return|0|||
129580745|NCT00205777|466423046|FG003|Study Extension II|Failed to return|14|||
129580746|NCT00205777|466423047|FG004|Study Extension II|Failed to return|0|||
129580747|NCT00205777|466423048|FG005|Study Extension II|Failed to return|26|||
129580748|NCT00205777|466423043|FG000|Study Extension II|Other Event|0|||
129580749|NCT00205777|466423044|FG001|Study Extension II|Other Event|0|||
129580750|NCT00205777|466423045|FG002|Study Extension II|Other Event|0|||
129580751|NCT00205777|466423046|FG003|Study Extension II|Other Event|12|||
129580752|NCT00205777|466423047|FG004|Study Extension II|Other Event|0|||
129580753|NCT00205777|466423048|FG005|Study Extension II|Other Event|20|||
129580754|NCT00205777|466423043|FG000|Study Extension II|Enrolled but not treated|0|||
129580755|NCT00205777|466423044|FG001|Study Extension II|Enrolled but not treated|0|||
129580756|NCT00205777|466423045|FG002|Study Extension II|Enrolled but not treated|0|||
129580757|NCT00205777|466423046|FG003|Study Extension II|Enrolled but not treated|71|||
129580758|NCT00205777|466423047|FG004|Study Extension II|Enrolled but not treated|0|||
129580759|NCT00205777|466423048|FG005|Study Extension II|Enrolled but not treated|131|||
129580760|NCT00367133|466423051|FG000|2 Years|Death|20|||
129580761|NCT00367133|466423052|FG001|2 Years|Death|12|||
129580762|NCT00367133|466423053|FG002|2 Years|Death|12|||
129580763|NCT00367133|466423051|FG000|2 Years|Dropped|34|||
129580764|NCT00367133|466423052|FG001|2 Years|Dropped|19|||
129580765|NCT00367133|466423053|FG002|2 Years|Dropped|33|||
129580766|NCT00367133|466423051|FG000|2 Years|Missed visit|4|||
129580767|NCT00367133|466423052|FG001|2 Years|Missed visit|5|||
129580768|NCT00367133|466423053|FG002|2 Years|Missed visit|4|||
129580769|NCT00906399|466423054|FG000|Year 1|Randomized But Not Treated|0|||
129695541|NCT02991859|466843888|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695542|NCT02991859|466843889|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695543|NCT02991859|466843890|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695544|NCT02991859|466843891|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695545|NCT02991859|466843892|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695546|NCT02991859|466843893|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695547|NCT02991859|466843894|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695548|NCT02991859|466843895|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695549|NCT02991859|466843896|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695550|NCT02991859|466843897|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695551|NCT02991859|466843898|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
129695552|NCT02991859|466843899|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
129695553|NCT02991859|466843900|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695554|NCT02991859|466843901|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695555|NCT02991859|466843902|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
129695556|NCT02991859|466843886|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695557|NCT02991859|466843887|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129580770|NCT00906399|466423055|FG001|Year 1|Randomized But Not Treated|1|||
129580771|NCT00906399|466423056|FG002|Year 1|Randomized But Not Treated|3|||
129580772|NCT00906399|466423057|FG003|Year 1|Randomized But Not Treated|0|||
129695558|NCT02991859|466843888|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129580773|NCT00906399|466423058|FG004|Year 1|Randomized But Not Treated|0|||
129580774|NCT00906399|466423059|FG005|Year 1|Randomized But Not Treated|0|||
129580775|NCT00906399|466423060|FG006|Year 1|Randomized But Not Treated|0|||
129580776|NCT00906399|466423054|FG000|Year 1|Adverse Event|4|||
129786003|NCT03859973|467185555|FG000|Overall Study|Adverse Event|3|||
129786004|NCT03859973|467185556|FG001|Overall Study|Adverse Event|5|||
129786005|NCT02855541|467185557|FG000|Overall Study|Change in health status|2|||
129786006|NCT02855541|467185557|FG000|Overall Study|Withdrawal by Subject|2|||
129786007|NCT00422513|467185558|FG000|Overall Study|Lack of Efficacy|4|||
129786008|NCT00422513|467185559|FG001|Overall Study|Lack of Efficacy|5|||
129580777|NCT00906399|466423055|FG001|Year 1|Adverse Event|22|||
129580778|NCT00906399|466423056|FG002|Year 1|Adverse Event|24|||
129580779|NCT00906399|466423057|FG003|Year 1|Adverse Event|0|||
129580780|NCT00906399|466423058|FG004|Year 1|Adverse Event|0|||
129580781|NCT00906399|466423059|FG005|Year 1|Adverse Event|0|||
129580782|NCT00906399|466423060|FG006|Year 1|Adverse Event|0|||
129580783|NCT00906399|466423054|FG000|Year 1|Lost to Follow-up|4|||
129580784|NCT00906399|466423055|FG001|Year 1|Lost to Follow-up|4|||
129580785|NCT00906399|466423056|FG002|Year 1|Lost to Follow-up|2|||
129580786|NCT00906399|466423057|FG003|Year 1|Lost to Follow-up|0|||
129580787|NCT00906399|466423058|FG004|Year 1|Lost to Follow-up|0|||
129580788|NCT00906399|466423059|FG005|Year 1|Lost to Follow-up|0|||
129580789|NCT00906399|466423060|FG006|Year 1|Lost to Follow-up|0|||
129580790|NCT00906399|466423054|FG000|Year 1|Withdrawal by Subject|30|||
129580791|NCT00906399|466423055|FG001|Year 1|Withdrawal by Subject|32|||
129580792|NCT00906399|466423056|FG002|Year 1|Withdrawal by Subject|36|||
129580793|NCT00906399|466423057|FG003|Year 1|Withdrawal by Subject|0|||
129580794|NCT00906399|466423058|FG004|Year 1|Withdrawal by Subject|0|||
129580795|NCT00906399|466423059|FG005|Year 1|Withdrawal by Subject|0|||
129580796|NCT00906399|466423060|FG006|Year 1|Withdrawal by Subject|0|||
129580797|NCT00906399|466423054|FG000|Year 1|Physician Decision|0|||
129580798|NCT00906399|466423055|FG001|Year 1|Physician Decision|1|||
129580799|NCT00906399|466423056|FG002|Year 1|Physician Decision|3|||
129580800|NCT00906399|466423057|FG003|Year 1|Physician Decision|0|||
129580801|NCT00906399|466423058|FG004|Year 1|Physician Decision|0|||
129580802|NCT00906399|466423059|FG005|Year 1|Physician Decision|0|||
129580803|NCT00906399|466423060|FG006|Year 1|Physician Decision|0|||
129580804|NCT00906399|466423054|FG000|Year 1|Death|2|||
129580805|NCT00906399|466423055|FG001|Year 1|Death|1|||
129580806|NCT00906399|466423056|FG002|Year 1|Death|1|||
129580807|NCT00906399|466423057|FG003|Year 1|Death|0|||
129580808|NCT00906399|466423058|FG004|Year 1|Death|0|||
129580809|NCT00906399|466423059|FG005|Year 1|Death|0|||
129580810|NCT00906399|466423060|FG006|Year 1|Death|0|||
129580811|NCT00906399|466423054|FG000|Year 1|Other|4|||
129580812|NCT00906399|466423055|FG001|Year 1|Other|2|||
129580813|NCT00906399|466423056|FG002|Year 1|Other|7|||
129580814|NCT00906399|466423057|FG003|Year 1|Other|0|||
129580815|NCT00906399|466423058|FG004|Year 1|Other|0|||
129580816|NCT00906399|466423059|FG005|Year 1|Other|0|||
129580817|NCT00906399|466423060|FG006|Year 1|Other|0|||
129580818|NCT00906399|466423054|FG000|Year 2|Adverse Event|0|||
129580819|NCT00906399|466423055|FG001|Year 2|Adverse Event|0|||
129580820|NCT00906399|466423056|FG002|Year 2|Adverse Event|0|||
129580821|NCT00906399|466423057|FG003|Year 2|Adverse Event|9|||
129580822|NCT00906399|466423058|FG004|Year 2|Adverse Event|8|||
129580823|NCT00906399|466423059|FG005|Year 2|Adverse Event|11|||
129786009|NCT00422513|467185558|FG000|Overall Study|Protocol Violation|23|||
129786010|NCT00422513|467185559|FG001|Overall Study|Protocol Violation|7|||
129786011|NCT00422513|467185558|FG000|Overall Study|Refused Treatment|4|||
129786012|NCT00422513|467185559|FG001|Overall Study|Refused Treatment|2|||
129786013|NCT00422513|467185558|FG000|Overall Study|Withdrawal by Subject|2|||
129580824|NCT00906399|466423060|FG006|Year 2|Adverse Event|6|||
129580825|NCT00906399|466423054|FG000|Year 2|Lost to Follow-up|0|||
129580826|NCT00906399|466423055|FG001|Year 2|Lost to Follow-up|0|||
129580827|NCT00906399|466423056|FG002|Year 2|Lost to Follow-up|0|||
129580828|NCT00906399|466423057|FG003|Year 2|Lost to Follow-up|1|||
129580829|NCT00906399|466423058|FG004|Year 2|Lost to Follow-up|4|||
129580830|NCT00906399|466423059|FG005|Year 2|Lost to Follow-up|2|||
129580831|NCT00906399|466423060|FG006|Year 2|Lost to Follow-up|4|||
129580832|NCT00906399|466423054|FG000|Year 2|Withdrawal by Subject|0|||
129580833|NCT00906399|466423055|FG001|Year 2|Withdrawal by Subject|0|||
129580834|NCT00906399|466423056|FG002|Year 2|Withdrawal by Subject|0|||
129580835|NCT00906399|466423057|FG003|Year 2|Withdrawal by Subject|17|||
129580836|NCT00906399|466423058|FG004|Year 2|Withdrawal by Subject|18|||
129580837|NCT00906399|466423059|FG005|Year 2|Withdrawal by Subject|27|||
129580838|NCT00906399|466423060|FG006|Year 2|Withdrawal by Subject|13|||
129580839|NCT00906399|466423054|FG000|Year 2|Physician Decision|0|||
129580840|NCT00906399|466423055|FG001|Year 2|Physician Decision|0|||
129580841|NCT00906399|466423056|FG002|Year 2|Physician Decision|0|||
129580842|NCT00906399|466423057|FG003|Year 2|Physician Decision|0|||
129580843|NCT00906399|466423058|FG004|Year 2|Physician Decision|2|||
129580844|NCT00906399|466423059|FG005|Year 2|Physician Decision|6|||
129580845|NCT00906399|466423060|FG006|Year 2|Physician Decision|3|||
129580846|NCT00906399|466423054|FG000|Year 2|Death|0|||
129580847|NCT00906399|466423055|FG001|Year 2|Death|0|||
129580848|NCT00906399|466423056|FG002|Year 2|Death|0|||
129580849|NCT00906399|466423057|FG003|Year 2|Death|1|||
129580850|NCT00906399|466423058|FG004|Year 2|Death|0|||
129580851|NCT00906399|466423059|FG005|Year 2|Death|0|||
129580852|NCT00906399|466423060|FG006|Year 2|Death|3|||
129580853|NCT00906399|466423054|FG000|Year 2|Other|0|||
129580854|NCT00906399|466423055|FG001|Year 2|Other|0|||
129580855|NCT00906399|466423056|FG002|Year 2|Other|0|||
129580856|NCT00906399|466423057|FG003|Year 2|Other|2|||
129580857|NCT00906399|466423058|FG004|Year 2|Other|3|||
129580858|NCT00906399|466423059|FG005|Year 2|Other|1|||
129580859|NCT00906399|466423060|FG006|Year 2|Other|0|||
129580860|NCT01297504|466423072|FG000|Overall Study|Invalid Consent|1|||
129580861|NCT01297504|466423072|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
129580862|NCT01297504|466423072|FG000|Overall Study|No Study Visits|4|||
129580863|NCT01297504|466423072|FG000|Overall Study|Death|3|||
129580864|NCT01297504|466423072|FG000|Overall Study|Lost to Follow-up|43|||
129580865|NCT01297504|466423072|FG000|Overall Study|Withdrawal by Subject|9|||
129580866|NCT01297504|466423072|FG000|Overall Study|Site Closure|3|||
129580867|NCT01297504|466423072|FG000|Overall Study|Protocol Violation|3|||
129580868|NCT02615249|466423073|FG000|Overall Study|Withdrawal by Subject|1|||
129580869|NCT00574847|466423074|FG000|Overall Study|Adverse Event|2|||
129580870|NCT00574847|466423075|FG001|Overall Study|Adverse Event|0|||
129580871|NCT00574847|466423074|FG000|Overall Study|Death|1|||
129580872|NCT00574847|466423075|FG001|Overall Study|Death|0|||
129580873|NCT00574847|466423074|FG000|Overall Study|Withdrawal by Subject|2|||
129580874|NCT00574847|466423075|FG001|Overall Study|Withdrawal by Subject|2|||
129580875|NCT00574847|466423074|FG000|Overall Study|Physician Decision|1|||
129580876|NCT00574847|466423075|FG001|Overall Study|Physician Decision|0|||
129580877|NCT00574847|466423074|FG000|Overall Study|Did not receive medication (declined)|2|||
129580878|NCT00574847|466423075|FG001|Overall Study|Did not receive medication (declined)|5|||
129580879|NCT02055547|466423076|FG000|Overall Study|Protocol Violation|0|||
129580880|NCT02055547|466423077|FG001|Overall Study|Protocol Violation|0|||
129580881|NCT02055547|466423078|FG002|Overall Study|Protocol Violation|1|||
129580882|NCT02055547|466423079|FG003|Overall Study|Protocol Violation|0|||
129580883|NCT02055547|466423080|FG004|Overall Study|Protocol Violation|0|||
129580884|NCT02055547|466423081|FG005|Overall Study|Protocol Violation|0|||
129580885|NCT02055547|466423082|FG006|Overall Study|Protocol Violation|1|||
129580886|NCT02055547|466423083|FG007|Overall Study|Protocol Violation|0|||
129580887|NCT02055547|466423084|FG008|Overall Study|Protocol Violation|0|||
129580888|NCT02055547|466423085|FG009|Overall Study|Protocol Violation|0|||
129580889|NCT02055547|466423086|FG010|Overall Study|Protocol Violation|0|||
129580890|NCT02055547|466423087|FG011|Overall Study|Protocol Violation|0|||
129580891|NCT02055547|466423088|FG012|Overall Study|Protocol Violation|0|||
129786014|NCT00422513|467185559|FG001|Overall Study|Withdrawal by Subject|1|||
129786015|NCT00422513|467185558|FG000|Overall Study|early termination of the study|67|||
129786016|NCT00422513|467185559|FG001|Overall Study|early termination of the study|80|||
129580892|NCT02055547|466423089|FG013|Overall Study|Protocol Violation|0|||
129580893|NCT02055547|466423090|FG014|Overall Study|Protocol Violation|0|||
129580894|NCT02055547|466423091|FG015|Overall Study|Protocol Violation|0|||
129580895|NCT02055547|466423092|FG016|Overall Study|Protocol Violation|0|||
129580896|NCT02055547|466423093|FG017|Overall Study|Protocol Violation|0|||
129580897|NCT02055547|466423094|FG018|Overall Study|Protocol Violation|0|||
129580898|NCT02055547|466423076|FG000|Overall Study|Physician Decision|0|||
129580899|NCT02055547|466423077|FG001|Overall Study|Physician Decision|1|||
129580900|NCT02055547|466423078|FG002|Overall Study|Physician Decision|1|||
129580901|NCT02055547|466423079|FG003|Overall Study|Physician Decision|0|||
129580902|NCT02055547|466423080|FG004|Overall Study|Physician Decision|1|||
129580903|NCT02055547|466423081|FG005|Overall Study|Physician Decision|0|||
129580904|NCT02055547|466423082|FG006|Overall Study|Physician Decision|0|||
129580905|NCT02055547|466423083|FG007|Overall Study|Physician Decision|0|||
129580906|NCT02055547|466423084|FG008|Overall Study|Physician Decision|0|||
129786017|NCT00422513|467185558|FG000|Overall Study|Adverse Event|4|||
129786018|NCT00422513|467185559|FG001|Overall Study|Adverse Event|4|||
129786019|NCT00422513|467185558|FG000|Overall Study|Death|3|||
129786020|NCT00422513|467185559|FG001|Overall Study|Death|7|||
129580907|NCT02055547|466423085|FG009|Overall Study|Physician Decision|1|||
129580908|NCT02055547|466423086|FG010|Overall Study|Physician Decision|1|||
129580909|NCT02055547|466423087|FG011|Overall Study|Physician Decision|0|||
129580910|NCT02055547|466423088|FG012|Overall Study|Physician Decision|0|||
129580911|NCT02055547|466423089|FG013|Overall Study|Physician Decision|0|||
129580912|NCT02055547|466423090|FG014|Overall Study|Physician Decision|0|||
129580913|NCT02055547|466423091|FG015|Overall Study|Physician Decision|0|||
129580914|NCT02055547|466423092|FG016|Overall Study|Physician Decision|0|||
129580915|NCT02055547|466423093|FG017|Overall Study|Physician Decision|0|||
129580916|NCT02055547|466423094|FG018|Overall Study|Physician Decision|0|||
129580917|NCT02055547|466423076|FG000|Overall Study|Adverse Event|0|||
129580918|NCT02055547|466423077|FG001|Overall Study|Adverse Event|0|||
129580919|NCT02055547|466423078|FG002|Overall Study|Adverse Event|0|||
129580920|NCT02055547|466423079|FG003|Overall Study|Adverse Event|0|||
129580921|NCT02055547|466423080|FG004|Overall Study|Adverse Event|0|||
129695559|NCT02991859|466843889|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695560|NCT02991859|466843890|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129580922|NCT02055547|466423081|FG005|Overall Study|Adverse Event|0|||
129580923|NCT02055547|466423082|FG006|Overall Study|Adverse Event|1|||
129580924|NCT02055547|466423083|FG007|Overall Study|Adverse Event|0|||
129580925|NCT02055547|466423084|FG008|Overall Study|Adverse Event|1|||
129580926|NCT02055547|466423085|FG009|Overall Study|Adverse Event|0|||
129580927|NCT02055547|466423086|FG010|Overall Study|Adverse Event|0|||
129580928|NCT02055547|466423087|FG011|Overall Study|Adverse Event|0|||
129580929|NCT02055547|466423088|FG012|Overall Study|Adverse Event|0|||
129580930|NCT02055547|466423089|FG013|Overall Study|Adverse Event|0|||
129580931|NCT02055547|466423090|FG014|Overall Study|Adverse Event|0|||
129695561|NCT02991859|466843891|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
129695562|NCT02991859|466843892|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695563|NCT02991859|466843893|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695564|NCT02991859|466843894|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695565|NCT02991859|466843895|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695566|NCT02991859|466843896|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695567|NCT02991859|466843897|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695568|NCT02991859|466843898|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695569|NCT02991859|466843899|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129580932|NCT02055547|466423091|FG015|Overall Study|Adverse Event|0|||
129580933|NCT02055547|466423092|FG016|Overall Study|Adverse Event|0|||
129695570|NCT02991859|466843900|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129786021|NCT03032380|467185560|FG000|Overall Study|Adverse Event|0|||
129786022|NCT03032380|467185561|FG001|Overall Study|Adverse Event|1|||
129580934|NCT02055547|466423093|FG017|Overall Study|Adverse Event|0|||
129786023|NCT03032380|467185560|FG000|Overall Study|Lack of Efficacy|1|||
129786024|NCT03032380|467185561|FG001|Overall Study|Lack of Efficacy|0|||
129786025|NCT03032380|467185560|FG000|Overall Study|Withdrawal by Subject|2|||
129580935|NCT02055547|466423094|FG018|Overall Study|Adverse Event|0|||
129580936|NCT02055547|466423076|FG000|Overall Study|Withdrawal by Subject|0|||
129580937|NCT02055547|466423077|FG001|Overall Study|Withdrawal by Subject|0|||
129580938|NCT02055547|466423078|FG002|Overall Study|Withdrawal by Subject|0|||
129580939|NCT02055547|466423079|FG003|Overall Study|Withdrawal by Subject|0|||
129580940|NCT02055547|466423080|FG004|Overall Study|Withdrawal by Subject|0|||
129580941|NCT02055547|466423081|FG005|Overall Study|Withdrawal by Subject|1|||
129580942|NCT02055547|466423082|FG006|Overall Study|Withdrawal by Subject|0|||
129580943|NCT02055547|466423083|FG007|Overall Study|Withdrawal by Subject|0|||
129695571|NCT02991859|466843901|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129786026|NCT03032380|467185561|FG001|Overall Study|Withdrawal by Subject|3|||
129786027|NCT03032380|467185560|FG000|Overall Study|Recovery|0|||
129786028|NCT03032380|467185561|FG001|Overall Study|Recovery|1|||
129786029|NCT03032380|467185560|FG000|Overall Study|Death|39|||
129786030|NCT03032380|467185561|FG001|Overall Study|Death|34|||
129786031|NCT03032380|467185560|FG000|Overall Study|Other - Miscellaneous|0|||
129786032|NCT03032380|467185561|FG001|Overall Study|Other - Miscellaneous|1|||
129786033|NCT02267317|467185562|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
129786034|NCT02267317|467185563|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
129786035|NCT02267317|467185564|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
129786036|NCT02267317|467185565|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
129786037|NCT02267317|467185566|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
129786038|NCT02267317|467185567|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
129786039|NCT02267317|467185562|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
129786040|NCT02267317|467185563|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
129786041|NCT02267317|467185564|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
129786042|NCT02267317|467185565|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
129786043|NCT02267317|467185566|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
129786044|NCT02267317|467185567|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
129786045|NCT01128621|467185568|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
129786046|NCT01128621|467185569|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
129786047|NCT00796445|467185570|FG000|Overall Study|Protocol Violation|5|||
129884929|NCT00876460|467538736|FG003|Combination Therapy Phase|Progressive disease|3|||
129580944|NCT02055547|466423084|FG008|Overall Study|Withdrawal by Subject|1|||
129580945|NCT02055547|466423085|FG009|Overall Study|Withdrawal by Subject|0|||
129580946|NCT02055547|466423086|FG010|Overall Study|Withdrawal by Subject|0|||
129695572|NCT02991859|466843902|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
129695573|NCT02991859|466843886|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695574|NCT02991859|466843887|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695575|NCT02991859|466843888|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695576|NCT02991859|466843889|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129580947|NCT02055547|466423087|FG011|Overall Study|Withdrawal by Subject|0|||
129580948|NCT02055547|466423088|FG012|Overall Study|Withdrawal by Subject|0|||
129695577|NCT02991859|466843890|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695578|NCT02991859|466843891|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695579|NCT02991859|466843892|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695580|NCT02991859|466843893|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695581|NCT02991859|466843894|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695582|NCT02991859|466843895|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
129695583|NCT02991859|466843896|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695584|NCT02991859|466843897|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695585|NCT02991859|466843898|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695586|NCT02991859|466843899|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695587|NCT02991859|466843900|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695588|NCT02991859|466843901|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695589|NCT02991859|466843902|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
129695590|NCT02991859|466843886|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695591|NCT02991859|466843887|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695592|NCT02991859|466843888|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695593|NCT02991859|466843889|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695594|NCT02991859|466843890|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695595|NCT02991859|466843891|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695596|NCT02991859|466843892|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695597|NCT02991859|466843893|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695598|NCT02991859|466843894|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
129695599|NCT02991859|466843895|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695600|NCT02991859|466843896|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695601|NCT02991859|466843897|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695602|NCT02991859|466843898|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695603|NCT02991859|466843899|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695604|NCT02991859|466843900|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695605|NCT02991859|466843901|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695606|NCT02991859|466843902|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
129695607|NCT04223687|466843908|FG000|Overall Study|Missing primary outcome|1|||
129695608|NCT04223687|466843909|FG001|Overall Study|Missing primary outcome|0|||
129695609|NCT00425854|466843910|FG000|Overall Study|Progressive Disease|19|||
129695610|NCT00425854|466843911|FG001|Overall Study|Progressive Disease|12|||
129695611|NCT00425854|466843910|FG000|Overall Study|Dose reduction toxicity AE|8|||
129695612|NCT00425854|466843911|FG001|Overall Study|Dose reduction toxicity AE|7|||
129695613|NCT00425854|466843910|FG000|Overall Study|Other Adverse Event|2|||
129695614|NCT00425854|466843911|FG001|Overall Study|Other Adverse Event|2|||
129695615|NCT03163264|466843917|FG000|Overall Study|Withdrawal by Subject|13|||
129786048|NCT00796445|467185571|FG001|Overall Study|Protocol Violation|3|||
129786049|NCT00796445|467185570|FG000|Overall Study|Adverse event, serious fatal|10|||
129786050|NCT00796445|467185571|FG001|Overall Study|Adverse event, serious fatal|5|||
129786051|NCT00796445|467185570|FG000|Overall Study|Adverse event, non-fatal|4|||
129786052|NCT00796445|467185571|FG001|Overall Study|Adverse event, non-fatal|0|||
129786053|NCT00796445|467185570|FG000|Overall Study|Disease progression/recurrence|537|||
129786054|NCT00796445|467185571|FG001|Overall Study|Disease progression/recurrence|268|||
129786055|NCT00796445|467185570|FG000|Overall Study|Other|10|||
129695616|NCT03163264|466843918|FG001|Overall Study|Withdrawal by Subject|3|||
129695617|NCT03163264|466843919|FG002|Overall Study|Withdrawal by Subject|4|||
129695618|NCT03163264|466843920|FG003|Overall Study|Withdrawal by Subject|2|||
129695619|NCT03163264|466843917|FG000|Overall Study|Lost to Follow-up|17|||
129695620|NCT03163264|466843918|FG001|Overall Study|Lost to Follow-up|20|||
129695621|NCT03163264|466843919|FG002|Overall Study|Lost to Follow-up|0|||
129695622|NCT03163264|466843920|FG003|Overall Study|Lost to Follow-up|0|||
129695623|NCT03163264|466843917|FG000|Overall Study|Death|0|||
129695624|NCT03163264|466843918|FG001|Overall Study|Death|2|||
129695625|NCT03163264|466843919|FG002|Overall Study|Death|0|||
129695626|NCT03163264|466843920|FG003|Overall Study|Death|0|||
129695627|NCT02614066|466843921|FG000|Overall Study|Death|6|||
129695628|NCT02614066|466843922|FG001|Overall Study|Death|14|||
129695629|NCT02614066|466843923|FG002|Overall Study|Death|11|||
129695630|NCT02614066|466843924|FG003|Overall Study|Death|29|||
129695631|NCT02614066|466843921|FG000|Overall Study|Full consent withdrawn|0|||
129695632|NCT02614066|466843922|FG001|Overall Study|Full consent withdrawn|1|||
129786056|NCT00796445|467185571|FG001|Overall Study|Other|7|||
129786057|NCT00796445|467185570|FG000|Overall Study|Withdrawal by Subject|18|||
129786058|NCT00796445|467185571|FG001|Overall Study|Withdrawal by Subject|9|||
129786059|NCT00796445|467185570|FG000|Overall Study|Invalid Informed Consent Form|1|||
129580949|NCT02055547|466423089|FG013|Overall Study|Withdrawal by Subject|1|||
129580950|NCT02055547|466423090|FG014|Overall Study|Withdrawal by Subject|0|||
129580951|NCT02055547|466423091|FG015|Overall Study|Withdrawal by Subject|1|||
129580952|NCT02055547|466423092|FG016|Overall Study|Withdrawal by Subject|0|||
129580953|NCT02055547|466423093|FG017|Overall Study|Withdrawal by Subject|0|||
129580954|NCT02055547|466423094|FG018|Overall Study|Withdrawal by Subject|0|||
129580955|NCT02055547|466423076|FG000|Overall Study|Lost to Follow-up|0|||
129580956|NCT02055547|466423077|FG001|Overall Study|Lost to Follow-up|0|||
129580957|NCT02055547|466423078|FG002|Overall Study|Lost to Follow-up|1|||
129580958|NCT02055547|466423079|FG003|Overall Study|Lost to Follow-up|0|||
129580959|NCT02055547|466423080|FG004|Overall Study|Lost to Follow-up|0|||
129580960|NCT02055547|466423081|FG005|Overall Study|Lost to Follow-up|0|||
129580961|NCT02055547|466423082|FG006|Overall Study|Lost to Follow-up|0|||
129580962|NCT02055547|466423083|FG007|Overall Study|Lost to Follow-up|0|||
129580963|NCT02055547|466423084|FG008|Overall Study|Lost to Follow-up|0|||
129580964|NCT02055547|466423085|FG009|Overall Study|Lost to Follow-up|0|||
129580965|NCT02055547|466423086|FG010|Overall Study|Lost to Follow-up|0|||
129580966|NCT02055547|466423087|FG011|Overall Study|Lost to Follow-up|0|||
129580967|NCT02055547|466423088|FG012|Overall Study|Lost to Follow-up|0|||
129580968|NCT02055547|466423089|FG013|Overall Study|Lost to Follow-up|0|||
129580969|NCT02055547|466423090|FG014|Overall Study|Lost to Follow-up|0|||
129580970|NCT02055547|466423091|FG015|Overall Study|Lost to Follow-up|0|||
129580971|NCT02055547|466423092|FG016|Overall Study|Lost to Follow-up|0|||
129580972|NCT02055547|466423093|FG017|Overall Study|Lost to Follow-up|0|||
129580973|NCT02055547|466423094|FG018|Overall Study|Lost to Follow-up|0|||
129580974|NCT01248728|466423099|FG000|Overall Study|Adverse Event|1|||
129580975|NCT01248728|466423100|FG001|Overall Study|Adverse Event|1|||
129580976|NCT01248728|466423099|FG000|Overall Study|Withdrawal by Subject|2|||
129580977|NCT01248728|466423100|FG001|Overall Study|Withdrawal by Subject|1|||
129580978|NCT01248728|466423099|FG000|Overall Study|Lack of Efficacy|1|||
129580979|NCT01248728|466423100|FG001|Overall Study|Lack of Efficacy|0|||
129580980|NCT00147498|466423101|FG000|Overall Study|Adverse Event|1|||
129580981|NCT00147498|466423102|FG001|Overall Study|Adverse Event|6|||
129580982|NCT00147498|466423103|FG002|Overall Study|Adverse Event|7|||
129580983|NCT00147498|466423104|FG003|Overall Study|Adverse Event|3|||
129580984|NCT00147498|466423101|FG000|Overall Study|Lack of Efficacy|1|||
129580985|NCT00147498|466423102|FG001|Overall Study|Lack of Efficacy|1|||
129580986|NCT00147498|466423103|FG002|Overall Study|Lack of Efficacy|1|||
129580987|NCT00147498|466423104|FG003|Overall Study|Lack of Efficacy|8|||
129580988|NCT00147498|466423101|FG000|Overall Study|Laboratory abnormality|0|||
129580989|NCT00147498|466423102|FG001|Overall Study|Laboratory abnormality|0|||
129580990|NCT00147498|466423103|FG002|Overall Study|Laboratory abnormality|2|||
129580991|NCT00147498|466423104|FG003|Overall Study|Laboratory abnormality|0|||
129580992|NCT00147498|466423101|FG000|Overall Study|Participant defaulted|0|||
129580993|NCT00147498|466423102|FG001|Overall Study|Participant defaulted|1|||
129580994|NCT00147498|466423103|FG002|Overall Study|Participant defaulted|4|||
129580995|NCT00147498|466423104|FG003|Overall Study|Participant defaulted|3|||
129580996|NCT00147498|466423101|FG000|Overall Study|Other|1|||
129580997|NCT00147498|466423102|FG001|Overall Study|Other|1|||
129580998|NCT00147498|466423103|FG002|Overall Study|Other|3|||
129580999|NCT00147498|466423104|FG003|Overall Study|Other|3|||
129581000|NCT01229150|466423105|FG000|Overall Study|Toxicity|2|||
129581001|NCT01229150|466423106|FG001|Overall Study|Toxicity|2|||
129581002|NCT01229150|466423107|FG002|Overall Study|Toxicity|0|||
129581003|NCT01229150|466423108|FG003|Overall Study|Toxicity|0|||
129581004|NCT00902538|466423109|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
129581005|NCT00902538|466423110|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129581006|NCT00902538|466423111|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129581007|NCT00902538|466423112|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129581008|NCT00902538|466423113|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129581009|NCT00902538|466423114|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
129786060|NCT00796445|467185571|FG001|Overall Study|Invalid Informed Consent Form|0|||
129786061|NCT02208063|467185572|FG000|Overall Study|Death|3|||
129786062|NCT02208063|467185573|FG001|Overall Study|Death|5|||
129581010|NCT00902538|466423109|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
129581011|NCT00902538|466423110|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129581012|NCT00902538|466423111|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129581013|NCT00902538|466423112|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129581014|NCT00902538|466423113|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129581015|NCT00902538|466423114|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
129581016|NCT00902538|466423109|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
129581017|NCT00902538|466423110|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129581018|NCT00902538|466423111|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129786063|NCT02208063|467185572|FG000|Overall Study|Not Specified in report|3|||
129786064|NCT02208063|467185573|FG001|Overall Study|Not Specified in report|4|||
129786065|NCT02208063|467185572|FG000|Overall Study|Withdrawal by Subject|5|||
129695633|NCT02614066|466843923|FG002|Overall Study|Full consent withdrawn|0|||
129695634|NCT02614066|466843924|FG003|Overall Study|Full consent withdrawn|8|||
129695635|NCT02614066|466843921|FG000|Overall Study|Lost to Follow-up|0|||
129695636|NCT02614066|466843922|FG001|Overall Study|Lost to Follow-up|2|||
129695637|NCT02614066|466843923|FG002|Overall Study|Lost to Follow-up|2|||
129695638|NCT02614066|466843924|FG003|Overall Study|Lost to Follow-up|2|||
129695639|NCT02614066|466843921|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
129695640|NCT02614066|466843922|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
129695641|NCT02614066|466843923|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
129695642|NCT02614066|466843924|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
129695643|NCT02614066|466843921|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
129695644|NCT02614066|466843922|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
129695645|NCT02614066|466843923|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
129695646|NCT02614066|466843924|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
129695647|NCT02614066|466843921|FG000|Overall Study|Reason not specified|0|||
129695648|NCT02614066|466843922|FG001|Overall Study|Reason not specified|2|||
129695649|NCT02614066|466843923|FG002|Overall Study|Reason not specified|1|||
129695650|NCT02614066|466843924|FG003|Overall Study|Reason not specified|1|||
129695651|NCT05259722|466843931|FG000|Overall Study|Adverse Event|2|||
129695652|NCT05259722|466843932|FG001|Overall Study|Adverse Event|24|||
129695653|NCT05259722|466843931|FG000|Overall Study|Lost to Follow-up|5|||
129695654|NCT05259722|466843932|FG001|Overall Study|Lost to Follow-up|1|||
129695655|NCT05259722|466843931|FG000|Overall Study|Lack of Efficacy|8|||
129695656|NCT05259722|466843932|FG001|Overall Study|Lack of Efficacy|26|||
129695657|NCT05259722|466843931|FG000|Overall Study|Withdrawal by Subject|15|||
129695658|NCT05259722|466843932|FG001|Overall Study|Withdrawal by Subject|33|||
129695659|NCT05259722|466843931|FG000|Overall Study|Various reasons|3|||
129695660|NCT05259722|466843932|FG001|Overall Study|Various reasons|9|||
129695661|NCT05259722|466843931|FG000|Overall Study|Not exposed to IMP|1|||
129695662|NCT05259722|466843932|FG001|Overall Study|Not exposed to IMP|12|||
129695663|NCT05259722|466843931|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
129695664|NCT05259722|466843932|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
129695665|NCT03069937|466843933|FG000|Overall Study|Second primary malignancy noted|1|||
129695666|NCT00962650|466843934|FG000|Overall Study|Transgastric DP was not completed|2|||
129695667|NCT00231465|466843936|FG000|Overall Study|Completed only one cycle|1|||
129695668|NCT00231465|466843936|FG000|Overall Study|Did not have follow up CT scans|1|||
129695669|NCT01185366|466843937|FG000|First Line Therapy|Insurance Coverage Denied|1|||
129695670|NCT01185366|466843938|FG001|First Line Therapy|Insurance Coverage Denied|1|||
129695671|NCT01185366|466843937|FG000|First Line Therapy|Withdrawal by Subject|1|||
129695672|NCT01185366|466843938|FG001|First Line Therapy|Withdrawal by Subject|0|||
129695673|NCT01185366|466843937|FG000|First Line Therapy|Lack of Metastatic Site|1|||
129695674|NCT01185366|466843938|FG001|First Line Therapy|Lack of Metastatic Site|0|||
129695675|NCT01185366|466843937|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
129695676|NCT01185366|466843938|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
129786066|NCT02208063|467185573|FG001|Overall Study|Withdrawal by Subject|2|||
129786067|NCT02208063|467185572|FG000|Overall Study|Lost to Follow-up|1|||
129786068|NCT02208063|467185573|FG001|Overall Study|Lost to Follow-up|0|||
129695677|NCT01185366|466843937|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
129695678|NCT01185366|466843938|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
129695679|NCT01185366|466843937|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
129695680|NCT01185366|466843938|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
129695681|NCT01185366|466843937|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
129786069|NCT00422084|467185578|FG000|Overall Study|Adverse Event|21|||
129786070|NCT00422084|467185579|FG001|Overall Study|Adverse Event|7|||
129581019|NCT00902538|466423112|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129581020|NCT00902538|466423113|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129581021|NCT00902538|466423114|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
129581022|NCT00902538|466423109|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
129581023|NCT00902538|466423110|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129581024|NCT00902538|466423111|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129581025|NCT00902538|466423112|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129581026|NCT00902538|466423113|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129581027|NCT00902538|466423114|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
129581028|NCT00902538|466423109|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
129581029|NCT00902538|466423110|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129581030|NCT00902538|466423111|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129581031|NCT00902538|466423112|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129581032|NCT00902538|466423113|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129581033|NCT00902538|466423114|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
129581034|NCT00902538|466423109|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
129581035|NCT00902538|466423110|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
129581036|NCT00902538|466423111|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
129581037|NCT00902538|466423112|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
129581038|NCT00902538|466423113|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
129581039|NCT00902538|466423114|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
129581040|NCT00902538|466423109|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
129581041|NCT00902538|466423110|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
129581042|NCT00902538|466423111|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
129581043|NCT00902538|466423112|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
129581044|NCT00902538|466423113|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
129581045|NCT00902538|466423114|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
129581046|NCT00902538|466423109|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
129581047|NCT00902538|466423110|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129581048|NCT00902538|466423111|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
129581049|NCT00902538|466423112|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129581050|NCT00902538|466423113|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129581051|NCT00902538|466423114|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
129581052|NCT00902538|466423109|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
129581053|NCT00902538|466423110|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
129581054|NCT00902538|466423111|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
129581055|NCT00902538|466423112|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
129581056|NCT00902538|466423113|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
129581057|NCT00902538|466423114|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
129581058|NCT00902538|466423109|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
129581059|NCT00902538|466423110|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
129581060|NCT00902538|466423111|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
129581061|NCT00902538|466423112|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
129581062|NCT00902538|466423113|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
129581063|NCT00902538|466423114|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
129581064|NCT00902538|466423109|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
129695682|NCT01185366|466843938|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
129695683|NCT02774278|466843939|FG000|Overall Study|Lack of Efficacy|199|||
129695684|NCT02774278|466843939|FG000|Overall Study|Death|29|||
129695685|NCT02774278|466843939|FG000|Overall Study|Adverse event/intercurrent illness|16|||
129581065|NCT00902538|466423110|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
129581066|NCT00902538|466423111|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
129581067|NCT00902538|466423112|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
129581068|NCT00902538|466423113|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
129581069|NCT00902538|466423114|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
129581070|NCT00902538|466423109|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
129581071|NCT00902538|466423110|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
129581072|NCT00902538|466423111|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
129581073|NCT00902538|466423112|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
129581074|NCT00902538|466423113|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
129581075|NCT00902538|466423114|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
129581076|NCT00902538|466423109|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129581077|NCT00902538|466423110|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
129581078|NCT00902538|466423111|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129581079|NCT00902538|466423112|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129581080|NCT00902538|466423113|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129581081|NCT00902538|466423114|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
129581082|NCT00902538|466423109|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129581083|NCT00902538|466423110|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
129581084|NCT00902538|466423111|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129581085|NCT00902538|466423112|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129581086|NCT00902538|466423113|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129581087|NCT00902538|466423114|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
129581088|NCT00902538|466423109|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
129581089|NCT00902538|466423110|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
129581090|NCT00902538|466423111|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
129581091|NCT00902538|466423112|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
129581092|NCT00902538|466423113|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
129581093|NCT00902538|466423114|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
129581094|NCT00902538|466423109|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129581095|NCT00902538|466423110|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129581096|NCT00902538|466423111|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129581097|NCT00902538|466423112|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
129581098|NCT00902538|466423113|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
129581099|NCT00902538|466423114|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
129581100|NCT00902538|466423109|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129581101|NCT00902538|466423110|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129581102|NCT00902538|466423111|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129581103|NCT00902538|466423112|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
129581104|NCT00902538|466423113|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129581105|NCT00902538|466423114|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
129581106|NCT03531827|466423115|FG000|Overall Study|Adverse Event|2|||
129581107|NCT03531827|466423116|FG001|Overall Study|Adverse Event|0|||
129581108|NCT03531827|466423115|FG000|Overall Study|Progressive disease|1|||
129581109|NCT03531827|466423116|FG001|Overall Study|Progressive disease|0|||
129581110|NCT03578809|466424866|FG000|Overall Study|Death|0|||
129581111|NCT03578809|466424867|FG001|Overall Study|Death|2|||
129786071|NCT00422084|467185578|FG000|Overall Study|Withdrawal by Subject|12|||
129786072|NCT00422084|467185579|FG001|Overall Study|Withdrawal by Subject|9|||
129786073|NCT00422084|467185578|FG000|Overall Study|Lost to Follow-up|14|||
129786074|NCT00422084|467185579|FG001|Overall Study|Lost to Follow-up|9|||
129786075|NCT00422084|467185578|FG000|Overall Study|Protocol Violation|4|||
129786076|NCT00422084|467185579|FG001|Overall Study|Protocol Violation|1|||
129786077|NCT00422084|467185578|FG000|Overall Study|Lack of Efficacy|40|||
129786078|NCT00422084|467185579|FG001|Overall Study|Lack of Efficacy|42|||
129786079|NCT00422084|467185578|FG000|Overall Study|P. vivax infection|3|||
129786080|NCT00422084|467185579|FG001|Overall Study|P. vivax infection|6|||
129786081|NCT00422084|467185578|FG000|Overall Study|Cyesis|1|||
129786082|NCT00422084|467185579|FG001|Overall Study|Cyesis|0|||
129581112|NCT03578809|466424868|FG002|Overall Study|Death|0|||
129581113|NCT03578809|466424869|FG003|Overall Study|Death|1|||
129581114|NCT03578809|466424866|FG000|Overall Study|Lost to Follow-up|0|||
129581115|NCT03578809|466424867|FG001|Overall Study|Lost to Follow-up|1|||
129786083|NCT00422084|467185578|FG000|Overall Study|Withdrawn from study accidentally|1|||
129786084|NCT00422084|467185579|FG001|Overall Study|Withdrawn from study accidentally|0|||
129786085|NCT00422084|467185578|FG000|Overall Study|Non-compliance|1|||
129786086|NCT00422084|467185579|FG001|Overall Study|Non-compliance|0|||
129786087|NCT00422084|467185578|FG000|Overall Study|Re-location|0|||
129786088|NCT00422084|467185579|FG001|Overall Study|Re-location|1|||
129786089|NCT00422084|467185578|FG000|Overall Study|Not defined|1|||
129786090|NCT00422084|467185579|FG001|Overall Study|Not defined|1|||
129581116|NCT03578809|466424868|FG002|Overall Study|Lost to Follow-up|0|||
129581117|NCT03578809|466424869|FG003|Overall Study|Lost to Follow-up|0|||
129581118|NCT03578809|466424866|FG000|Overall Study|Withdrawal by Subject|3|||
129581119|NCT03578809|466424867|FG001|Overall Study|Withdrawal by Subject|5|||
129581120|NCT03578809|466424868|FG002|Overall Study|Withdrawal by Subject|2|||
129581121|NCT03578809|466424869|FG003|Overall Study|Withdrawal by Subject|0|||
129581122|NCT03578809|466424866|FG000|Overall Study|Other|3|||
129581123|NCT03578809|466424867|FG001|Overall Study|Other|6|||
129581124|NCT03578809|466424868|FG002|Overall Study|Other|2|||
129581125|NCT03578809|466424869|FG003|Overall Study|Other|8|||
129581126|NCT01624233|466424872|FG000|Period 2 - Induction|Adverse Event|1|||
129581127|NCT01624233|466424872|FG000|Period 3 - Maintenance|Adverse Event|2|||
129581128|NCT01624233|466424872|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
129581129|NCT01624233|466424872|FG000|Period 3 - Maintenance|Physician Decision|2|||
129581130|NCT01624233|466424872|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
129581131|NCT01624233|466424872|FG000|Period 4 - Drug Free Period|Relapsed|61|||
129581132|NCT01624233|466424872|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
129581133|NCT01624233|466424872|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
129581134|NCT01624233|466424872|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
129581135|NCT01624233|466424872|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
129581136|NCT01624233|466424872|FG000|Period 6: Follow-up|Adverse Event|3|||
129581137|NCT01624233|466424872|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
129581138|NCT01624233|466424872|FG000|Period 6: Follow-up|Physician Decision|1|||
129581139|NCT01624233|466424872|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
129581140|NCT04241458|466424873|FG000|Overall Study|Withdrawal by Subject|0|||
129581141|NCT04241458|466424874|FG001|Overall Study|Withdrawal by Subject|0|||
129581142|NCT04241458|466424875|FG002|Overall Study|Withdrawal by Subject|0|||
129581143|NCT04241458|466424876|FG003|Overall Study|Withdrawal by Subject|0|||
129581144|NCT04241458|466424877|FG004|Overall Study|Withdrawal by Subject|1|||
129581145|NCT03325881|466424891|FG000|Overall Study|Protocol Violation|0|||
129581146|NCT03325881|466424892|FG001|Overall Study|Protocol Violation|1|||
129581147|NCT03325881|466424891|FG000|Overall Study|Withdrawal by Subject|0|||
129581148|NCT03325881|466424892|FG001|Overall Study|Withdrawal by Subject|2|||
129581149|NCT03325881|466424891|FG000|Overall Study|Lack of Efficacy|2|||
129581150|NCT03325881|466424892|FG001|Overall Study|Lack of Efficacy|0|||
129581151|NCT03325881|466424891|FG000|Overall Study|Not treated|1|||
129581152|NCT03325881|466424892|FG001|Overall Study|Not treated|0|||
129581153|NCT03676634|466424895|FG000|Overall Study|Red blood cell loss|1|||
129581154|NCT03676634|466424895|FG000|Overall Study|Out-of-limit pulse|2|||
129581155|NCT03131895|466424901|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
129581156|NCT03131895|466424902|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
129581157|NCT03131895|466424903|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
129581158|NCT03131895|466424904|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
129581159|NCT03131895|466424901|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129581160|NCT03131895|466424902|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
129581161|NCT03131895|466424903|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
129581162|NCT03131895|466424904|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
129695686|NCT02774278|466843939|FG000|Overall Study|Refused treatment/did not cooperate|9|||
129581163|NCT03131895|466424901|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129581164|NCT03131895|466424902|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
129581165|NCT03131895|466424903|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129695687|NCT02774278|466843939|FG000|Overall Study|Administrative reasons|6|||
129695688|NCT02774278|466843939|FG000|Overall Study|Withdrawal by Subject|3|||
129695689|NCT02774278|466843939|FG000|Overall Study|Protocol Violation|2|||
129695690|NCT00127933|466843946|FG000|Overall Study|Randomized but not dosed|1|||
129695691|NCT00127933|466843947|FG001|Overall Study|Randomized but not dosed|0|||
129695692|NCT01783938|466843949|FG000|Overall Study|Disease Progression|18|||
129581166|NCT03131895|466424904|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129581167|NCT03131895|466424901|FG000|Washout Period (at Least 5 Days)|Other|0|||
129581168|NCT03131895|466424902|FG001|Washout Period (at Least 5 Days)|Other|0|||
129581169|NCT03131895|466424903|FG002|Washout Period (at Least 5 Days)|Other|2|||
129581170|NCT03131895|466424904|FG003|Washout Period (at Least 5 Days)|Other|0|||
129581171|NCT03131895|466424901|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
129581172|NCT03131895|466424902|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
129581173|NCT03131895|466424903|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
129581174|NCT03131895|466424904|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
129581175|NCT03131895|466424901|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
129581176|NCT03131895|466424902|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
129581177|NCT03131895|466424903|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
129581178|NCT03131895|466424904|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
129581179|NCT00540423|466424905|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129581180|NCT00540423|466424906|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129581181|NCT00540423|466424907|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129581182|NCT00540423|466424905|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
129581183|NCT00540423|466424906|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129695693|NCT01783938|466843950|FG001|Overall Study|Disease Progression|41|||
129695694|NCT01783938|466843949|FG000|Overall Study|Study Drug Toxicity|27|||
129695695|NCT01783938|466843950|FG001|Overall Study|Study Drug Toxicity|14|||
129695696|NCT01783938|466843949|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
129695697|NCT01783938|466843950|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129695698|NCT01783938|466843949|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
129695699|NCT01783938|466843950|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
129695700|NCT01783938|466843949|FG000|Overall Study|Participant Withdrew Consent|2|||
129695701|NCT01783938|466843950|FG001|Overall Study|Participant Withdrew Consent|0|||
129695702|NCT01783938|466843949|FG000|Overall Study|Maximum Clinical Benefit|1|||
129695703|NCT01783938|466843950|FG001|Overall Study|Maximum Clinical Benefit|0|||
129695704|NCT01783938|466843949|FG000|Overall Study|Other Reasons|3|||
129695705|NCT01783938|466843950|FG001|Overall Study|Other Reasons|1|||
129695706|NCT00498485|466843951|FG000|Overall Study|Adverse Event|1|||
129695707|NCT00498485|466843952|FG001|Overall Study|Adverse Event|5|||
129695708|NCT03072875|466843957|FG000|Overall Study|Lost to Follow-up|1|||
129695709|NCT03478787|466843958|FG000|Overall Study|Adverse Event|5|||
129695710|NCT03478787|466843959|FG001|Overall Study|Adverse Event|1|||
129695711|NCT03478787|466843958|FG000|Overall Study|Protocol Violation|3|||
129695712|NCT03478787|466843959|FG001|Overall Study|Protocol Violation|0|||
129695713|NCT03478787|466843958|FG000|Overall Study|Lack of Efficacy|7|||
129581184|NCT00540423|466424907|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
129581185|NCT00216736|466424914|FG000|Overall Study|Lost to Follow-up|1|||
129581186|NCT00216736|466424915|FG001|Overall Study|Lost to Follow-up|1|||
129581187|NCT00807495|466424916|FG000|Overall Study|Adverse Event|6|||
129581188|NCT00807495|466424917|FG001|Overall Study|Adverse Event|3|||
129695714|NCT03478787|466843959|FG001|Overall Study|Lack of Efficacy|1|||
129695715|NCT03478787|466843958|FG000|Overall Study|Lost to Follow-up|9|||
129581189|NCT00807495|466424918|FG002|Overall Study|Adverse Event|1|||
129581190|NCT00807495|466424919|FG003|Overall Study|Adverse Event|1|||
129581191|NCT00807495|466424920|FG004|Overall Study|Adverse Event|2|||
129581192|NCT00807495|466424916|FG000|Overall Study|Withdrawal by Patient|2|||
129581193|NCT00807495|466424917|FG001|Overall Study|Withdrawal by Patient|0|||
129581194|NCT00807495|466424918|FG002|Overall Study|Withdrawal by Patient|1|||
129581195|NCT00807495|466424919|FG003|Overall Study|Withdrawal by Patient|0|||
129581196|NCT00807495|466424920|FG004|Overall Study|Withdrawal by Patient|0|||
129581197|NCT00807495|466424916|FG000|Overall Study|Reason Not Specified|0|||
129581198|NCT00807495|466424917|FG001|Overall Study|Reason Not Specified|3|||
129581199|NCT00807495|466424918|FG002|Overall Study|Reason Not Specified|2|||
129581200|NCT00807495|466424919|FG003|Overall Study|Reason Not Specified|0|||
129581201|NCT00807495|466424920|FG004|Overall Study|Reason Not Specified|3|||
129581202|NCT01174186|466424924|FG000|Overall Study|Lost to Follow-up|0|||
129581203|NCT01174186|466424925|FG001|Overall Study|Lost to Follow-up|1|||
129581204|NCT01174186|466424924|FG000|Overall Study|Withdrawal by Subject|0|||
129581205|NCT01174186|466424925|FG001|Overall Study|Withdrawal by Subject|2|||
129581206|NCT05274763|466424926|FG000|Overall Study|Lost to Follow-up|1|||
129581207|NCT00909753|466424928|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
129581208|NCT00909753|466424929|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
129581209|NCT00909753|466424928|FG000|Period: Second Intervention|Protocol Violation|1|||
129581210|NCT00909753|466424929|FG001|Period: Second Intervention|Protocol Violation|0|||
129581211|NCT00418145|466424932|FG000|Overall Study|study terminated|6|||
129581212|NCT03214588|466424933|FG000|Overall Study|Adverse Event|1|||
129581213|NCT03214588|466424934|FG001|Overall Study|Adverse Event|0|||
129581214|NCT03214588|466424935|FG002|Overall Study|Adverse Event|2|||
129581215|NCT03214588|466424933|FG000|Overall Study|Reason Not Specified|0|||
129581216|NCT03214588|466424934|FG001|Overall Study|Reason Not Specified|1|||
129581217|NCT03214588|466424935|FG002|Overall Study|Reason Not Specified|0|||
129581218|NCT03480763|466424940|FG000|Overall Study|Withdrawal by Subject|18|||
129581219|NCT03480763|466424941|FG001|Overall Study|Withdrawal by Subject|10|||
129581220|NCT03480763|466424940|FG000|Overall Study|Lost to Follow-up|4|||
129581221|NCT03480763|466424941|FG001|Overall Study|Lost to Follow-up|7|||
129581222|NCT03480763|466424940|FG000|Overall Study|non-study pneumococcal vaccine|1|||
129581223|NCT03480763|466424941|FG001|Overall Study|non-study pneumococcal vaccine|0|||
129581224|NCT03480763|466424940|FG000|Overall Study|oncological treatment|0|||
129581225|NCT03480763|466424941|FG001|Overall Study|oncological treatment|2|||
129581226|NCT03480763|466424940|FG000|Overall Study|pain with vaccination|1|||
129581227|NCT03480763|466424941|FG001|Overall Study|pain with vaccination|0|||
129581228|NCT01647828|466424942|FG000|Overall Study|Death|3|||
129581229|NCT01647828|466424943|FG001|Overall Study|Death|4|||
129581230|NCT01647828|466424944|FG002|Overall Study|Death|4|||
129581231|NCT01647828|466424945|FG003|Overall Study|Death|5|||
129581232|NCT01647828|466424946|FG004|Overall Study|Death|6|||
129581233|NCT01647828|466424947|FG005|Overall Study|Death|3|||
129581234|NCT01647828|466424948|FG006|Overall Study|Death|10|||
129581235|NCT01647828|466424949|FG007|Overall Study|Death|60|||
129581236|NCT01647828|466424950|FG008|Overall Study|Death|71|||
129581237|NCT01647828|466424942|FG000|Overall Study|Withdrawal by Subject|2|||
129581238|NCT01647828|466424943|FG001|Overall Study|Withdrawal by Subject|0|||
129581239|NCT01647828|466424944|FG002|Overall Study|Withdrawal by Subject|0|||
129581240|NCT01647828|466424945|FG003|Overall Study|Withdrawal by Subject|1|||
129581241|NCT01647828|466424946|FG004|Overall Study|Withdrawal by Subject|0|||
129581242|NCT01647828|466424947|FG005|Overall Study|Withdrawal by Subject|0|||
129884930|NCT00876460|467538737|FG004|Combination Therapy Phase|Progressive disease|3|||
129884931|NCT00876460|467538738|FG005|Combination Therapy Phase|Progressive disease|1|||
129884932|NCT00876460|467538739|FG006|Combination Therapy Phase|Progressive disease|1|||
129884933|NCT00876460|467538740|FG007|Combination Therapy Phase|Progressive disease|1|||
129884934|NCT00876460|467538733|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
129884935|NCT00876460|467538734|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
129581243|NCT01647828|466424948|FG006|Overall Study|Withdrawal by Subject|1|||
129581244|NCT01647828|466424949|FG007|Overall Study|Withdrawal by Subject|0|||
129581245|NCT01647828|466424950|FG008|Overall Study|Withdrawal by Subject|2|||
129581246|NCT01647828|466424942|FG000|Overall Study|Study terminated by Sponsor|0|||
129581247|NCT01647828|466424943|FG001|Overall Study|Study terminated by Sponsor|0|||
129581248|NCT01647828|466424944|FG002|Overall Study|Study terminated by Sponsor|0|||
129581249|NCT01647828|466424945|FG003|Overall Study|Study terminated by Sponsor|0|||
129581250|NCT01647828|466424946|FG004|Overall Study|Study terminated by Sponsor|0|||
129581251|NCT01647828|466424947|FG005|Overall Study|Study terminated by Sponsor|0|||
129581252|NCT01647828|466424948|FG006|Overall Study|Study terminated by Sponsor|1|||
129581253|NCT01647828|466424949|FG007|Overall Study|Study terminated by Sponsor|26|||
129581254|NCT01647828|466424950|FG008|Overall Study|Study terminated by Sponsor|16|||
129581255|NCT01647828|466424942|FG000|Overall Study|Lost to Follow-up|0|||
129884936|NCT00876460|467538735|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
129581256|NCT01647828|466424943|FG001|Overall Study|Lost to Follow-up|0|||
129581257|NCT01647828|466424944|FG002|Overall Study|Lost to Follow-up|0|||
129581258|NCT01647828|466424945|FG003|Overall Study|Lost to Follow-up|0|||
129581259|NCT01647828|466424946|FG004|Overall Study|Lost to Follow-up|0|||
129581260|NCT01647828|466424947|FG005|Overall Study|Lost to Follow-up|0|||
129581261|NCT01647828|466424948|FG006|Overall Study|Lost to Follow-up|0|||
129581262|NCT01647828|466424949|FG007|Overall Study|Lost to Follow-up|2|||
129581263|NCT01647828|466424950|FG008|Overall Study|Lost to Follow-up|0|||
129581264|NCT01906372|466424951|FG000|Overall Study|Withdrawal by Subject|2|||
129581265|NCT03629054|466424953|FG000|Period 2 (4 Days)|Not treated|0|||
129581266|NCT03629054|466424954|FG001|Period 2 (4 Days)|Not treated|1|||
129581267|NCT00624286|466424961|FG000|Overall Study|Protocol Deviation|7|||
129581268|NCT00624286|466424962|FG001|Overall Study|Protocol Deviation|9|||
129581269|NCT00624286|466424961|FG000|Overall Study|Adverse Event|6|||
129581270|NCT00624286|466424962|FG001|Overall Study|Adverse Event|3|||
129581271|NCT00624286|466424961|FG000|Overall Study|Withdrawal by Subject|5|||
129581272|NCT00624286|466424962|FG001|Overall Study|Withdrawal by Subject|4|||
129581273|NCT00624286|466424961|FG000|Overall Study|Lost to Follow-up|3|||
129581274|NCT00624286|466424962|FG001|Overall Study|Lost to Follow-up|2|||
129581275|NCT00624286|466424961|FG000|Overall Study|Administrative problems|3|||
129581276|NCT00624286|466424962|FG001|Overall Study|Administrative problems|0|||
129581277|NCT00624286|466424961|FG000|Overall Study|Lack of Efficacy|1|||
129581278|NCT00624286|466424962|FG001|Overall Study|Lack of Efficacy|6|||
129581279|NCT00624286|466424961|FG000|Overall Study|Not stated|0|||
129581280|NCT00624286|466424962|FG001|Overall Study|Not stated|1|||
129581281|NCT00624286|466424961|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129581282|NCT00624286|466424962|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129581283|NCT00624286|466424961|FG000|Overall Study|Death|0|||
129581284|NCT00624286|466424962|FG001|Overall Study|Death|1|||
129581285|NCT04404725|466424963|FG000|First Intervention|Withdrawal by Subject|0|||
129581286|NCT04404725|466424964|FG001|First Intervention|Withdrawal by Subject|2|||
129581287|NCT04404725|466424963|FG000|Second Intervention|Adverse Event|1|||
129581288|NCT04404725|466424964|FG001|Second Intervention|Adverse Event|1|||
129581289|NCT04404725|466424963|FG000|Second Intervention|Withdrawal by Subject|0|||
129581290|NCT04404725|466424964|FG001|Second Intervention|Withdrawal by Subject|1|||
129581291|NCT01075516|466424965|FG000|Overall Study|Death|5|||
129581292|NCT01075516|466424966|FG001|Overall Study|Death|9|||
129581293|NCT01075516|466424965|FG000|Overall Study|Lost to Follow-up|10|||
129581294|NCT01075516|466424966|FG001|Overall Study|Lost to Follow-up|2|||
129581295|NCT01075516|466424965|FG000|Overall Study|Withdrawal by Subject|3|||
129581296|NCT01075516|466424966|FG001|Overall Study|Withdrawal by Subject|5|||
129581297|NCT02252016|466424967|FG000|Overall Study|Lost to Follow-up|2|||
129581298|NCT02252016|466424968|FG001|Overall Study|Lost to Follow-up|1|||
129581299|NCT02252016|466424967|FG000|Overall Study|Physician Decision|1|||
129581300|NCT02252016|466424968|FG001|Overall Study|Physician Decision|0|||
129581301|NCT02252016|466424967|FG000|Overall Study|Withdrawal by Subject|0|||
129581302|NCT02252016|466424968|FG001|Overall Study|Withdrawal by Subject|2|||
129581303|NCT04631562|466424971|FG000|Overall Study|Withdrawal by Subject|0|||
129581304|NCT04631562|466424972|FG001|Overall Study|Withdrawal by Subject|0|||
129581305|NCT04631562|466424973|FG002|Overall Study|Withdrawal by Subject|0|||
129581306|NCT04631562|466424974|FG003|Overall Study|Withdrawal by Subject|0|||
129581307|NCT04631562|466424975|FG004|Overall Study|Withdrawal by Subject|0|||
129581308|NCT04631562|466424976|FG005|Overall Study|Withdrawal by Subject|0|||
129581309|NCT04631562|466424977|FG006|Overall Study|Withdrawal by Subject|0|||
129581310|NCT04631562|466424978|FG007|Overall Study|Withdrawal by Subject|1|||
129581311|NCT04631562|466424979|FG008|Overall Study|Withdrawal by Subject|0|||
129581312|NCT04631562|466424971|FG000|Overall Study|Other|0|||
129581313|NCT04631562|466424972|FG001|Overall Study|Other|0|||
129581314|NCT04631562|466424973|FG002|Overall Study|Other|0|||
129581315|NCT04631562|466424974|FG003|Overall Study|Other|0|||
129581316|NCT04631562|466424975|FG004|Overall Study|Other|0|||
129581317|NCT04631562|466424976|FG005|Overall Study|Other|0|||
129581318|NCT04631562|466424977|FG006|Overall Study|Other|0|||
129581319|NCT04631562|466424978|FG007|Overall Study|Other|0|||
129581320|NCT04631562|466424979|FG008|Overall Study|Other|1|||
129581321|NCT04631562|466424971|FG000|Overall Study|Lost to Follow-up|0|||
129581322|NCT04631562|466424972|FG001|Overall Study|Lost to Follow-up|0|||
129581323|NCT04631562|466424973|FG002|Overall Study|Lost to Follow-up|0|||
129581324|NCT04631562|466424974|FG003|Overall Study|Lost to Follow-up|1|||
129581325|NCT04631562|466424975|FG004|Overall Study|Lost to Follow-up|0|||
129581326|NCT04631562|466424976|FG005|Overall Study|Lost to Follow-up|0|||
129581327|NCT04631562|466424977|FG006|Overall Study|Lost to Follow-up|0|||
129581328|NCT04631562|466424978|FG007|Overall Study|Lost to Follow-up|0|||
129581329|NCT04631562|466424979|FG008|Overall Study|Lost to Follow-up|0|||
129581330|NCT04631562|466424971|FG000|Overall Study|Adverse Event|0|||
129581331|NCT04631562|466424972|FG001|Overall Study|Adverse Event|0|||
129581332|NCT04631562|466424973|FG002|Overall Study|Adverse Event|0|||
129581333|NCT04631562|466424974|FG003|Overall Study|Adverse Event|0|||
129581334|NCT04631562|466424975|FG004|Overall Study|Adverse Event|0|||
129581335|NCT04631562|466424976|FG005|Overall Study|Adverse Event|0|||
129581336|NCT04631562|466424977|FG006|Overall Study|Adverse Event|1|||
129581337|NCT04631562|466424978|FG007|Overall Study|Adverse Event|0|||
129581338|NCT04631562|466424979|FG008|Overall Study|Adverse Event|0|||
129581339|NCT01190865|466424985|FG000|Overall Study|Withdrawal by Subject|1|||
129581340|NCT01190865|466424985|FG000|Overall Study|Non-compliance|2|||
129581341|NCT02436200|466424987|FG000|Overall Study|Significant outlier|1|||
129581342|NCT01483820|466425007|FG000|Overall Study|Lack of Efficacy|6|||
129581343|NCT01483820|466425007|FG000|Overall Study|Adverse Event|1|||
129581344|NCT01483820|466425007|FG000|Overall Study|Death|1|||
129581345|NCT00867360|466425008|FG000|Overall Study|Withdrawal by Subject|1|||
129581346|NCT00867360|466425009|FG001|Overall Study|Withdrawal by Subject|0|||
129581347|NCT00867360|466425008|FG000|Overall Study|Physician Decision|0|||
129581348|NCT00867360|466425009|FG001|Overall Study|Physician Decision|1|||
129581349|NCT00842309|466425010|FG000|Overall Study|Withdrawal by Subject|3|||
129581350|NCT00842309|466425011|FG001|Overall Study|Withdrawal by Subject|1|||
129581351|NCT03218787|466425012|FG000|Overall Study|Lost to Follow-up|12|||
129581352|NCT03218787|466425012|FG000|Overall Study|Withdrawal by Subject|72|||
129581353|NCT03218787|466425012|FG000|Overall Study|Physician Decision|11|||
129581354|NCT03218787|466425012|FG000|Overall Study|Death|111|||
129581355|NCT02264977|466425013|FG000|Overall Study|Death|3|||
129581356|NCT02264977|466425013|FG000|Overall Study|Physician Decision|1|||
129581357|NCT02264977|466425013|FG000|Overall Study|Refuse to return|1|||
129581358|NCT03573544|466425014|FG000|Overall Study|Adverse Event|0|||
129581359|NCT03573544|466425015|FG001|Overall Study|Adverse Event|0|||
129581360|NCT03573544|466425016|FG002|Overall Study|Adverse Event|0|||
129581361|NCT03573544|466425017|FG003|Overall Study|Adverse Event|3|||
129581362|NCT03573544|466425018|FG004|Overall Study|Adverse Event|1|||
129581363|NCT03573544|466425019|FG005|Overall Study|Adverse Event|0|||
129581364|NCT03573544|466425020|FG006|Overall Study|Adverse Event|2|||
129581365|NCT03573544|466425021|FG007|Overall Study|Adverse Event|0|||
129581366|NCT03573544|466425014|FG000|Overall Study|Physician Decision|0|||
129581367|NCT03573544|466425015|FG001|Overall Study|Physician Decision|0|||
129581368|NCT03573544|466425016|FG002|Overall Study|Physician Decision|0|||
129581369|NCT03573544|466425017|FG003|Overall Study|Physician Decision|0|||
129581370|NCT03573544|466425018|FG004|Overall Study|Physician Decision|0|||
129581371|NCT03573544|466425019|FG005|Overall Study|Physician Decision|0|||
129581372|NCT03573544|466425020|FG006|Overall Study|Physician Decision|1|||
129581373|NCT03573544|466425021|FG007|Overall Study|Physician Decision|0|||
129581374|NCT03573544|466425014|FG000|Overall Study|Withdrawal by Subject|2|||
129581375|NCT03573544|466425015|FG001|Overall Study|Withdrawal by Subject|0|||
129581376|NCT03573544|466425016|FG002|Overall Study|Withdrawal by Subject|0|||
129581377|NCT03573544|466425017|FG003|Overall Study|Withdrawal by Subject|1|||
129581378|NCT03573544|466425018|FG004|Overall Study|Withdrawal by Subject|1|||
129581379|NCT03573544|466425019|FG005|Overall Study|Withdrawal by Subject|1|||
129581380|NCT03573544|466425020|FG006|Overall Study|Withdrawal by Subject|0|||
129581381|NCT03573544|466425021|FG007|Overall Study|Withdrawal by Subject|1|||
129581382|NCT03573544|466425014|FG000|Overall Study|Disease progression|3|||
129581383|NCT03573544|466425015|FG001|Overall Study|Disease progression|3|||
129581384|NCT03573544|466425016|FG002|Overall Study|Disease progression|6|||
129581385|NCT03573544|466425017|FG003|Overall Study|Disease progression|4|||
129581386|NCT03573544|466425018|FG004|Overall Study|Disease progression|5|||
129581387|NCT03573544|466425019|FG005|Overall Study|Disease progression|7|||
129581388|NCT03573544|466425020|FG006|Overall Study|Disease progression|6|||
129581389|NCT03573544|466425021|FG007|Overall Study|Disease progression|7|||
129581390|NCT01838681|466425022|FG000|Period A|Adverse Event|39|||
129581391|NCT01838681|466425023|FG001|Period A|Adverse Event|0|||
129581392|NCT01838681|466425024|FG002|Period A|Adverse Event|0|||
129581393|NCT01838681|466425025|FG003|Period A|Adverse Event|0|||
129581394|NCT01838681|466425022|FG000|Period A|Lack of Efficacy|21|||
129695716|NCT03478787|466843959|FG001|Overall Study|Lost to Follow-up|5|||
129695717|NCT03478787|466843958|FG000|Overall Study|Withdrawal by Subject|2|||
129581395|NCT01838681|466425023|FG001|Period A|Lack of Efficacy|0|||
129581396|NCT01838681|466425024|FG002|Period A|Lack of Efficacy|0|||
129581397|NCT01838681|466425025|FG003|Period A|Lack of Efficacy|0|||
129581398|NCT01838681|466425022|FG000|Period A|Early response|148|||
129581399|NCT01838681|466425023|FG001|Period A|Early response|0|||
129581400|NCT01838681|466425024|FG002|Period A|Early response|0|||
129581401|NCT01838681|466425025|FG003|Period A|Early response|0|||
129695718|NCT03478787|466843959|FG001|Overall Study|Withdrawal by Subject|6|||
129695719|NCT03478787|466843958|FG000|Overall Study|Other, Not Specified|3|||
129695720|NCT03478787|466843959|FG001|Overall Study|Other, Not Specified|0|||
129581402|NCT01838681|466425022|FG000|Period A|Withdrawal by Subject|70|||
129581403|NCT01838681|466425023|FG001|Period A|Withdrawal by Subject|0|||
129581404|NCT01838681|466425024|FG002|Period A|Withdrawal by Subject|0|||
129581405|NCT01838681|466425025|FG003|Period A|Withdrawal by Subject|0|||
129581406|NCT01838681|466425022|FG000|Period A|Protocol Violation|16|||
129581407|NCT01838681|466425023|FG001|Period A|Protocol Violation|0|||
129581408|NCT01838681|466425024|FG002|Period A|Protocol Violation|0|||
129581409|NCT01838681|466425025|FG003|Period A|Protocol Violation|0|||
129695721|NCT01539525|466843960|FG000|Overall Study|Lost to Follow-up|19|||
129581410|NCT01838681|466425022|FG000|Period A|Non-compliance with IMP|6|||
129581411|NCT01838681|466425023|FG001|Period A|Non-compliance with IMP|0|||
129581412|NCT01838681|466425024|FG002|Period A|Non-compliance with IMP|0|||
129581413|NCT01838681|466425025|FG003|Period A|Non-compliance with IMP|0|||
129581414|NCT01838681|466425022|FG000|Period A|Lost to Follow-up|4|||
129581415|NCT01838681|466425023|FG001|Period A|Lost to Follow-up|0|||
129581416|NCT01838681|466425024|FG002|Period A|Lost to Follow-up|0|||
129581417|NCT01838681|466425025|FG003|Period A|Lost to Follow-up|0|||
129581418|NCT01838681|466425022|FG000|Period A|Withdrawal before treatment|4|||
129581419|NCT01838681|466425023|FG001|Period A|Withdrawal before treatment|0|||
129581420|NCT01838681|466425024|FG002|Period A|Withdrawal before treatment|0|||
129581421|NCT01838681|466425025|FG003|Period A|Withdrawal before treatment|0|||
129581422|NCT01838681|466425022|FG000|Period A|Administrative or other reasons|17|||
129581423|NCT01838681|466425023|FG001|Period A|Administrative or other reasons|0|||
129581424|NCT01838681|466425024|FG002|Period A|Administrative or other reasons|0|||
129581425|NCT01838681|466425025|FG003|Period A|Administrative or other reasons|0|||
129581426|NCT01838681|466425022|FG000|Period B/A+|Adverse Event|0|||
129581427|NCT01838681|466425023|FG001|Period B/A+|Adverse Event|13|||
129581428|NCT01838681|466425024|FG002|Period B/A+|Adverse Event|27|||
129581429|NCT01838681|466425025|FG003|Period B/A+|Adverse Event|16|||
129581430|NCT01838681|466425022|FG000|Period B/A+|Lack of Efficacy|0|||
129581431|NCT01838681|466425023|FG001|Period B/A+|Lack of Efficacy|9|||
129581432|NCT01838681|466425024|FG002|Period B/A+|Lack of Efficacy|11|||
129581433|NCT01838681|466425025|FG003|Period B/A+|Lack of Efficacy|6|||
129581434|NCT01838681|466425022|FG000|Period B/A+|Withdrawal by Subject|0|||
129581435|NCT01838681|466425023|FG001|Period B/A+|Withdrawal by Subject|28|||
129581436|NCT01838681|466425024|FG002|Period B/A+|Withdrawal by Subject|35|||
129695722|NCT01539525|466843961|FG001|Overall Study|Lost to Follow-up|12|||
129695723|NCT01539525|466843962|FG002|Overall Study|Lost to Follow-up|11|||
129695724|NCT01539525|466843960|FG000|Overall Study|Withdrawal by Subject|0|||
129581437|NCT01838681|466425025|FG003|Period B/A+|Withdrawal by Subject|47|||
129581438|NCT01838681|466425022|FG000|Period B/A+|Protocol Violation|0|||
129581439|NCT01838681|466425023|FG001|Period B/A+|Protocol Violation|1|||
129581440|NCT01838681|466425024|FG002|Period B/A+|Protocol Violation|4|||
129581441|NCT01838681|466425025|FG003|Period B/A+|Protocol Violation|6|||
129581442|NCT01838681|466425022|FG000|Period B/A+|Non-compliance with IMP|0|||
129581443|NCT01838681|466425023|FG001|Period B/A+|Non-compliance with IMP|2|||
129695725|NCT01539525|466843961|FG001|Overall Study|Withdrawal by Subject|3|||
129695726|NCT01539525|466843962|FG002|Overall Study|Withdrawal by Subject|2|||
129581444|NCT01838681|466425024|FG002|Period B/A+|Non-compliance with IMP|3|||
129581445|NCT01838681|466425025|FG003|Period B/A+|Non-compliance with IMP|3|||
129581446|NCT01838681|466425022|FG000|Period B/A+|Lost to Follow-up|0|||
129581447|NCT01838681|466425023|FG001|Period B/A+|Lost to Follow-up|2|||
129581448|NCT01838681|466425024|FG002|Period B/A+|Lost to Follow-up|5|||
129581449|NCT01838681|466425025|FG003|Period B/A+|Lost to Follow-up|11|||
129581450|NCT01838681|466425022|FG000|Period B/A+|Withdrawal before treatment|0|||
129581451|NCT01838681|466425023|FG001|Period B/A+|Withdrawal before treatment|1|||
129581452|NCT01838681|466425024|FG002|Period B/A+|Withdrawal before treatment|0|||
129581453|NCT01838681|466425025|FG003|Period B/A+|Withdrawal before treatment|0|||
129581454|NCT01838681|466425022|FG000|Period B/A+|Administrative or other reasons|0|||
129581455|NCT01838681|466425023|FG001|Period B/A+|Administrative or other reasons|6|||
129581456|NCT01838681|466425024|FG002|Period B/A+|Administrative or other reasons|10|||
129581457|NCT01838681|466425025|FG003|Period B/A+|Administrative or other reasons|28|||
129581458|NCT02011945|466425026|FG000|Overall Study|Participant requested to Discontinue|0|||
129581459|NCT02011945|466425027|FG001|Overall Study|Participant requested to Discontinue|1|||
129581460|NCT02011945|466425028|FG002|Overall Study|Participant requested to Discontinue|1|||
129581461|NCT02011945|466425026|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
129581462|NCT02011945|466425027|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
129581463|NCT02011945|466425028|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
129581464|NCT02011945|466425026|FG000|Overall Study|Study Drug Toxicity|0|||
129581465|NCT02011945|466425027|FG001|Overall Study|Study Drug Toxicity|0|||
129581466|NCT02011945|466425028|FG002|Overall Study|Study Drug Toxicity|1|||
129581467|NCT02011945|466425026|FG000|Overall Study|Treatment Failure|0|||
129581468|NCT02011945|466425027|FG001|Overall Study|Treatment Failure|7|||
129581469|NCT02011945|466425028|FG002|Overall Study|Treatment Failure|6|||
129581470|NCT02011945|466425026|FG000|Overall Study|No Longer Meets Study Criteria|1|||
129581471|NCT02011945|466425027|FG001|Overall Study|No Longer Meets Study Criteria|0|||
129581472|NCT02011945|466425028|FG002|Overall Study|No Longer Meets Study Criteria|0|||
129581473|NCT02011945|466425026|FG000|Overall Study|Proceeded to stem cell transplant|0|||
129581474|NCT02011945|466425027|FG001|Overall Study|Proceeded to stem cell transplant|0|||
129581475|NCT02011945|466425028|FG002|Overall Study|Proceeded to stem cell transplant|1|||
129581476|NCT02011945|466425026|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
129581477|NCT02011945|466425027|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
129581478|NCT02011945|466425028|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
129581479|NCT00849797|466425029|FG000|First Intervention|bad veins|1|||
129581480|NCT00849797|466425030|FG001|First Intervention|bad veins|0|||
129695727|NCT01539525|466843960|FG000|Overall Study|Protocol Violation|1|||
129695728|NCT01539525|466843961|FG001|Overall Study|Protocol Violation|1|||
129695729|NCT01539525|466843962|FG002|Overall Study|Protocol Violation|4|||
129695730|NCT01712074|466843963|FG000|Placebo Run-in Period|Adverse Event|2|||
129695731|NCT01712074|466843964|FG001|Placebo Run-in Period|Adverse Event|0|||
129695732|NCT01712074|466843965|FG002|Placebo Run-in Period|Adverse Event|0|||
129695733|NCT01712074|466843963|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
129695734|NCT01712074|466843964|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
129695735|NCT01712074|466843965|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
129695736|NCT01712074|466843963|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
129695737|NCT01712074|466843964|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
129695738|NCT01712074|466843965|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
129695739|NCT01712074|466843963|FG000|Placebo Run-in Period|Other|1|||
129695740|NCT01712074|466843964|FG001|Placebo Run-in Period|Other|0|||
129695741|NCT01712074|466843965|FG002|Placebo Run-in Period|Other|0|||
129695742|NCT01712074|466843963|FG000|Placebo Run-in Period|No longer willing to participate|1|||
129695743|NCT01712074|466843964|FG001|Placebo Run-in Period|No longer willing to participate|0|||
129695744|NCT01712074|466843965|FG002|Placebo Run-in Period|No longer willing to participate|0|||
129695745|NCT01712074|466843963|FG000|Double Blind Period|Adverse Event|0|||
129695746|NCT01712074|466843964|FG001|Double Blind Period|Adverse Event|2|||
129695747|NCT01712074|466843965|FG002|Double Blind Period|Adverse Event|1|||
129695748|NCT01712074|466843963|FG000|Double Blind Period|No longer willing to participate|0|||
129695749|NCT01712074|466843964|FG001|Double Blind Period|No longer willing to participate|2|||
129695750|NCT01712074|466843965|FG002|Double Blind Period|No longer willing to participate|4|||
129695751|NCT01712074|466843963|FG000|Double Blind Period|Death|0|||
129695752|NCT01712074|466843964|FG001|Double Blind Period|Death|1|||
129695753|NCT01712074|466843965|FG002|Double Blind Period|Death|0|||
129695754|NCT01712074|466843963|FG000|Double Blind Period|Lost to Follow-up|0|||
129786091|NCT01253811|467185582|FG000|Overall Study|Withdrawal criteria|1|||
129581481|NCT00849797|466425029|FG000|First Intervention|Adverse Event|0|||
129581482|NCT00849797|466425030|FG001|First Intervention|Adverse Event|1|||
129581483|NCT00849797|466425029|FG000|Washout: One Week|Withdrawal by Subject|0|||
129581484|NCT00849797|466425030|FG001|Washout: One Week|Withdrawal by Subject|2|||
129695755|NCT01712074|466843964|FG001|Double Blind Period|Lost to Follow-up|2|||
129695756|NCT01712074|466843965|FG002|Double Blind Period|Lost to Follow-up|1|||
129695757|NCT01712074|466843963|FG000|Double Blind Period|Other|0|||
129695758|NCT01712074|466843964|FG001|Double Blind Period|Other|4|||
129786092|NCT03774823|467185583|FG000|Overall Study|Withdrawal by Subject|1|||
129786093|NCT03774823|467185584|FG001|Overall Study|Withdrawal by Subject|1|||
129786094|NCT01087736|467185585|FG000|Overall Study|Lost to Follow-up|1|||
129786095|NCT01087736|467185586|FG001|Overall Study|Lost to Follow-up|0|||
129786096|NCT01087736|467185585|FG000|Overall Study|Death|0|||
129786097|NCT01087736|467185586|FG001|Overall Study|Death|1|||
129786098|NCT01087736|467185585|FG000|Overall Study|Withdrawal by Subject|0|||
129786099|NCT01087736|467185586|FG001|Overall Study|Withdrawal by Subject|1|||
129786100|NCT00759564|467185590|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
129786101|NCT00759564|467185591|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
129786102|NCT00759564|467185592|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
129581485|NCT00679081|466425031|FG000|Overall Study|Lost to Follow-up|1|||
129581486|NCT00725322|466425032|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
129581487|NCT00725322|466425033|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
129581488|NCT00725322|466425032|FG000|Washout (28 Days)|Protocol Violation|0|||
129581489|NCT00725322|466425033|FG001|Washout (28 Days)|Protocol Violation|1|||
129581490|NCT01279486|466425034|FG000|Overall Study|Lost to Follow-up|1|||
129581491|NCT04198363|466425037|FG000|Overall Study|Adverse Event|1|||
129581492|NCT04198363|466425038|FG001|Overall Study|Adverse Event|1|||
129581493|NCT04198363|466425037|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
129581494|NCT04198363|466425038|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
129581495|NCT04198363|466425037|FG000|Overall Study|Reason not Specified|1|||
129581496|NCT04198363|466425038|FG001|Overall Study|Reason not Specified|0|||
129581497|NCT03067987|466425041|FG000|Overall Study|Lost to Follow-up|7|||
129581498|NCT03067987|466425042|FG001|Overall Study|Lost to Follow-up|10|||
129581499|NCT03067987|466425041|FG000|Overall Study|Protocol Violation|1|||
129581500|NCT03067987|466425042|FG001|Overall Study|Protocol Violation|2|||
129581501|NCT03067987|466425041|FG000|Overall Study|Withdrawal by Subject|2|||
129581502|NCT03067987|466425042|FG001|Overall Study|Withdrawal by Subject|1|||
129581503|NCT01404988|466425045|FG000|Overall Study|Death|2|||
129581504|NCT01404988|466425046|FG001|Overall Study|Death|0|||
129581505|NCT01404988|466425047|FG002|Overall Study|Death|2|||
129581506|NCT01404988|466425045|FG000|Overall Study|Adverse Event|1|||
129581507|NCT01404988|466425046|FG001|Overall Study|Adverse Event|0|||
129581508|NCT01404988|466425047|FG002|Overall Study|Adverse Event|0|||
129581509|NCT01404988|466425045|FG000|Overall Study|Withdrawal by Subject|2|||
129581510|NCT01404988|466425046|FG001|Overall Study|Withdrawal by Subject|2|||
129581511|NCT01404988|466425047|FG002|Overall Study|Withdrawal by Subject|0|||
129581512|NCT01404988|466425045|FG000|Overall Study|Lost to Follow-up|1|||
129581513|NCT01404988|466425046|FG001|Overall Study|Lost to Follow-up|2|||
129581514|NCT01404988|466425047|FG002|Overall Study|Lost to Follow-up|1|||
129581515|NCT00829764|466425048|FG000|First Intervention|Adverse Event|1|||
129581516|NCT00829764|466425049|FG001|First Intervention|Adverse Event|0|||
129581517|NCT00829764|466425048|FG000|First Intervention|Withdrawal by Subject|1|||
129581518|NCT00829764|466425049|FG001|First Intervention|Withdrawal by Subject|1|||
129581519|NCT04594252|466425050|FG000|Overall Study|Adverse Event|0|||
129581520|NCT04594252|466425051|FG001|Overall Study|Adverse Event|2|||
129581521|NCT01952691|466427099|FG000|Overall Study|Lost to Follow-up|2|||
129581522|NCT00199901|466427100|FG000|Overall Study|Protocol Violation|2|||
129581523|NCT00199901|466427101|FG001|Overall Study|Protocol Violation|0|||
129581524|NCT00199901|466427100|FG000|Overall Study|Withdrawal by Subject|1|||
129581525|NCT00199901|466427101|FG001|Overall Study|Withdrawal by Subject|0|||
129581526|NCT00199901|466427100|FG000|Overall Study|Progressive Disease|24|||
129581527|NCT00199901|466427101|FG001|Overall Study|Progressive Disease|24|||
129581528|NCT05776901|466427104|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
129581529|NCT02997176|466427107|FG000|Overall Study|Adverse Event|0|||
129581530|NCT02997176|466427108|FG001|Overall Study|Adverse Event|0|||
129581531|NCT02997176|466427109|FG002|Overall Study|Adverse Event|0|||
129581532|NCT02997176|466427110|FG003|Overall Study|Adverse Event|8|||
129581533|NCT02997176|466427107|FG000|Overall Study|Progressive Disease|1|||
129786103|NCT00759564|467185593|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
129786104|NCT00759564|467185594|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
129786105|NCT00958438|467185595|FG000|Overall Study|Protocol Violation|3|||
129581534|NCT02997176|466427108|FG001|Overall Study|Progressive Disease|0|||
129581535|NCT02997176|466427109|FG002|Overall Study|Progressive Disease|1|||
129581536|NCT02997176|466427110|FG003|Overall Study|Progressive Disease|1|||
129581537|NCT02997176|466427107|FG000|Overall Study|Death|0|||
129786106|NCT00958438|467185596|FG001|Overall Study|Protocol Violation|2|||
129786107|NCT00958438|467185597|FG002|Overall Study|Protocol Violation|2|||
129786108|NCT00958438|467185595|FG000|Overall Study|Withdrawal by Subject|4|||
129581538|NCT02997176|466427108|FG001|Overall Study|Death|0|||
129581539|NCT02997176|466427109|FG002|Overall Study|Death|1|||
129581540|NCT02997176|466427110|FG003|Overall Study|Death|1|||
129581541|NCT02997176|466427107|FG000|Overall Study|Withdrawal by Subject|0|||
129581542|NCT02997176|466427108|FG001|Overall Study|Withdrawal by Subject|2|||
129581543|NCT02997176|466427109|FG002|Overall Study|Withdrawal by Subject|0|||
129581544|NCT02997176|466427110|FG003|Overall Study|Withdrawal by Subject|1|||
129581545|NCT00373256|466427111|FG000|Overall Study|Adverse Event (AE)|1|||
129581546|NCT00373256|466427112|FG001|Overall Study|Adverse Event (AE)|5|||
129581547|NCT00373256|466427111|FG000|Overall Study|Lost to Follow-up|2|||
129581548|NCT00373256|466427112|FG001|Overall Study|Lost to Follow-up|1|||
129581549|NCT00373256|466427111|FG000|Overall Study|Death|9|||
129581550|NCT00373256|466427112|FG001|Overall Study|Death|8|||
129581551|NCT00373256|466427111|FG000|Overall Study|Objective Progression or Relapse|111|||
129581552|NCT00373256|466427112|FG001|Overall Study|Objective Progression or Relapse|104|||
129581553|NCT00373256|466427111|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
129581554|NCT00373256|466427112|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
129581555|NCT00373256|466427111|FG000|Overall Study|Other|73|||
129581556|NCT00373256|466427112|FG001|Overall Study|Other|107|||
129581557|NCT00373256|466427111|FG000|Overall Study|Protocol Violation|0|||
129581558|NCT00373256|466427112|FG001|Overall Study|Protocol Violation|2|||
129581559|NCT00373256|466427111|FG000|Overall Study|Study Terminated by Sponsor|41|||
129581560|NCT00373256|466427112|FG001|Overall Study|Study Terminated by Sponsor|13|||
129581561|NCT06144424|466427113|FG000|Overall Study|Withdrawal by Subject|2|||
129581562|NCT06144424|466427114|FG001|Overall Study|Withdrawal by Subject|0|||
129581563|NCT06144424|466427113|FG000|Overall Study|Incarceration|1|||
129581564|NCT06144424|466427114|FG001|Overall Study|Incarceration|0|||
129581565|NCT02727192|466427115|FG000|Overall Study|Lost to Follow-up|1|||
129581566|NCT02727192|466427116|FG001|Overall Study|Lost to Follow-up|0|||
129581567|NCT02727192|466427117|FG002|Overall Study|Lost to Follow-up|0|||
129581568|NCT00928057|466427118|FG000|Overall Study|Adverse Event|1|||
129581569|NCT00928057|466427119|FG001|Overall Study|Adverse Event|2|||
129581570|NCT00928057|466427118|FG000|Overall Study|Withdrawal by Subject|1|||
129581571|NCT00928057|466427119|FG001|Overall Study|Withdrawal by Subject|0|||
129581572|NCT00928057|466427118|FG000|Overall Study|Lost to Follow-up|0|||
129581573|NCT00928057|466427119|FG001|Overall Study|Lost to Follow-up|1|||
129581574|NCT00928057|466427118|FG000|Overall Study|Protocol Violation|0|||
129581575|NCT00928057|466427119|FG001|Overall Study|Protocol Violation|1|||
129581576|NCT05497557|466427120|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
129581577|NCT05497557|466427121|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
129581578|NCT05497557|466427122|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
129581579|NCT02752074|466427125|FG000|Overall Study|Lost to Follow-up|1|||
129581580|NCT02752074|466427126|FG001|Overall Study|Lost to Follow-up|4|||
129581581|NCT02752074|466427125|FG000|Overall Study|Death|146|||
129581582|NCT02752074|466427126|FG001|Overall Study|Death|129|||
129581583|NCT02752074|466427125|FG000|Overall Study|Withdrawal by Subject|9|||
129581584|NCT02752074|466427126|FG001|Overall Study|Withdrawal by Subject|10|||
129581585|NCT02392195|466427129|FG000|Overall Study|Lost to Follow-up|4|||
129581586|NCT02392195|466427129|FG000|Overall Study|Withdrawal by Subject|4|||
129581587|NCT00545792|466427132|FG000|Overall Study|Withdrawal by Subject|1|||
129581588|NCT03679598|466427134|FG000|Overall Study|Adverse Event|2|||
129581589|NCT03679598|466427135|FG001|Overall Study|Adverse Event|0|||
129581590|NCT01380782|466427140|FG000|Overall Study|Adverse Event|0|||
129581591|NCT01380782|466427141|FG001|Overall Study|Adverse Event|1|||
129581592|NCT01380782|466427142|FG002|Overall Study|Adverse Event|0|||
129581593|NCT01380782|466427143|FG003|Overall Study|Adverse Event|0|||
129581594|NCT01380782|466427140|FG000|Overall Study|Death|1|||
129581595|NCT01380782|466427141|FG001|Overall Study|Death|0|||
129581596|NCT01380782|466427142|FG002|Overall Study|Death|0|||
129581597|NCT01380782|466427143|FG003|Overall Study|Death|0|||
129581598|NCT01380782|466427140|FG000|Overall Study|Lack of Efficacy|10|||
129581599|NCT01380782|466427141|FG001|Overall Study|Lack of Efficacy|9|||
129581600|NCT01380782|466427142|FG002|Overall Study|Lack of Efficacy|10|||
129581601|NCT01380782|466427143|FG003|Overall Study|Lack of Efficacy|3|||
129581602|NCT01380782|466427140|FG000|Overall Study|Physician Decision|1|||
129581603|NCT01380782|466427141|FG001|Overall Study|Physician Decision|0|||
129581604|NCT01380782|466427142|FG002|Overall Study|Physician Decision|0|||
129581605|NCT01380782|466427143|FG003|Overall Study|Physician Decision|0|||
129581606|NCT01380782|466427140|FG000|Overall Study|Withdrawal by Subject|0|||
129581607|NCT01380782|466427141|FG001|Overall Study|Withdrawal by Subject|0|||
129581608|NCT01380782|466427142|FG002|Overall Study|Withdrawal by Subject|1|||
129581609|NCT01380782|466427143|FG003|Overall Study|Withdrawal by Subject|1|||
129581610|NCT05387408|466427146|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
129695759|NCT01712074|466843965|FG002|Double Blind Period|Other|1|||
129695760|NCT01712074|466843963|FG000|Double Blind Period|Protocol Violation|0|||
129695761|NCT01712074|466843964|FG001|Double Blind Period|Protocol Violation|0|||
129695762|NCT01712074|466843965|FG002|Double Blind Period|Protocol Violation|1|||
129695763|NCT01712074|466843963|FG000|Double Blind Period|No longer met eligibility criteria|0|||
129695764|NCT01712074|466843964|FG001|Double Blind Period|No longer met eligibility criteria|3|||
129695765|NCT01712074|466843965|FG002|Double Blind Period|No longer met eligibility criteria|0|||
129695766|NCT02268851|466843966|FG000|Overall Study|Death|0|||
129695767|NCT02268851|466843967|FG001|Overall Study|Death|0|||
129695768|NCT02268851|466843968|FG002|Overall Study|Death|0|||
129695769|NCT02268851|466843969|FG003|Overall Study|Death|1|||
129581611|NCT03428750|466427147|FG000|Overall Study|Withdrawal by Subject|11|||
129581612|NCT03428750|466427148|FG001|Overall Study|Withdrawal by Subject|10|||
129581613|NCT03428750|466427147|FG000|Overall Study|Lost to Follow-up|3|||
129581614|NCT03428750|466427148|FG001|Overall Study|Lost to Follow-up|9|||
129581615|NCT03428750|466427147|FG000|Overall Study|Adverse Event|9|||
129581616|NCT03428750|466427148|FG001|Overall Study|Adverse Event|1|||
129581617|NCT03428750|466427147|FG000|Overall Study|Protocol Violation|1|||
129581618|NCT03428750|466427148|FG001|Overall Study|Protocol Violation|0|||
129581619|NCT03428750|466427147|FG000|Overall Study|Administrative|0|||
129581620|NCT03428750|466427148|FG001|Overall Study|Administrative|1|||
129581621|NCT01919112|466427149|FG000|Secondary Analysis-day 30|Death|1|||
129581622|NCT01919112|466427150|FG001|Secondary Analysis-day 30|Death|1|||
129581623|NCT01919112|466427151|FG002|Secondary Analysis-day 30|Death|1|||
129581624|NCT01919112|466427149|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
129581625|NCT01919112|466427150|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
129581626|NCT01919112|466427151|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
129581627|NCT02554877|466427152|FG000|Overall Study|Adverse Event|2|||
129581628|NCT02554877|466427153|FG001|Overall Study|Adverse Event|0|||
129581629|NCT02554877|466427154|FG002|Overall Study|Adverse Event|0|||
129581630|NCT02554877|466427155|FG003|Overall Study|Adverse Event|1|||
129581631|NCT02554877|466427152|FG000|Overall Study|Lost to Follow-up|1|||
129581632|NCT02554877|466427153|FG001|Overall Study|Lost to Follow-up|1|||
129581633|NCT02554877|466427154|FG002|Overall Study|Lost to Follow-up|1|||
129581634|NCT02554877|466427155|FG003|Overall Study|Lost to Follow-up|2|||
129581635|NCT02554877|466427152|FG000|Overall Study|Did not meet entrance criteria|0|||
129581636|NCT02554877|466427153|FG001|Overall Study|Did not meet entrance criteria|0|||
129581637|NCT02554877|466427154|FG002|Overall Study|Did not meet entrance criteria|1|||
129581638|NCT02554877|466427155|FG003|Overall Study|Did not meet entrance criteria|0|||
129581639|NCT02554877|466427152|FG000|Overall Study|No longer met eligibility criteria|1|||
129581640|NCT02554877|466427153|FG001|Overall Study|No longer met eligibility criteria|0|||
129581641|NCT02554877|466427154|FG002|Overall Study|No longer met eligibility criteria|1|||
129581642|NCT02554877|466427155|FG003|Overall Study|No longer met eligibility criteria|1|||
129581643|NCT02554877|466427152|FG000|Overall Study|Protocol Violation|3|||
129581644|NCT02554877|466427153|FG001|Overall Study|Protocol Violation|1|||
129581645|NCT02554877|466427154|FG002|Overall Study|Protocol Violation|1|||
129581646|NCT02554877|466427155|FG003|Overall Study|Protocol Violation|0|||
129581647|NCT02554877|466427152|FG000|Overall Study|Other|1|||
129581648|NCT02554877|466427153|FG001|Overall Study|Other|3|||
129581649|NCT02554877|466427154|FG002|Overall Study|Other|0|||
129581650|NCT02554877|466427155|FG003|Overall Study|Other|3|||
129581651|NCT02554877|466427152|FG000|Overall Study|Insufficient clinical response|4|||
129581652|NCT02554877|466427153|FG001|Overall Study|Insufficient clinical response|0|||
129581653|NCT02554877|466427154|FG002|Overall Study|Insufficient clinical response|0|||
129581654|NCT02554877|466427155|FG003|Overall Study|Insufficient clinical response|0|||
129581655|NCT02554877|466427152|FG000|Overall Study|No longer willing to participate|0|||
129581656|NCT02554877|466427153|FG001|Overall Study|No longer willing to participate|2|||
129581657|NCT02554877|466427154|FG002|Overall Study|No longer willing to participate|2|||
129581658|NCT02554877|466427155|FG003|Overall Study|No longer willing to participate|0|||
129581659|NCT04474405|466427156|FG000|Overall Study|Withdrawal by Subject|0|||
129695770|NCT02268851|466843970|FG004|Overall Study|Death|2|||
129695771|NCT02268851|466843971|FG005|Overall Study|Death|1|||
129695772|NCT02268851|466843966|FG000|Overall Study|Adverse Event|0|||
129695773|NCT02268851|466843967|FG001|Overall Study|Adverse Event|0|||
129695774|NCT02268851|466843968|FG002|Overall Study|Adverse Event|0|||
129695775|NCT02268851|466843969|FG003|Overall Study|Adverse Event|0|||
129695776|NCT02268851|466843970|FG004|Overall Study|Adverse Event|2|||
129695777|NCT02268851|466843971|FG005|Overall Study|Adverse Event|2|||
129695778|NCT02268851|466843966|FG000|Overall Study|Withdrawal by Subject|0|||
129695779|NCT02268851|466843967|FG001|Overall Study|Withdrawal by Subject|0|||
129695780|NCT02268851|466843968|FG002|Overall Study|Withdrawal by Subject|0|||
129695781|NCT02268851|466843969|FG003|Overall Study|Withdrawal by Subject|2|||
129695782|NCT02268851|466843970|FG004|Overall Study|Withdrawal by Subject|0|||
129581660|NCT04474405|466427157|FG001|Overall Study|Withdrawal by Subject|0|||
129695783|NCT02268851|466843971|FG005|Overall Study|Withdrawal by Subject|1|||
129695784|NCT02268851|466843966|FG000|Overall Study|Progressive Disease|1|||
129581661|NCT04474405|466427158|FG002|Overall Study|Withdrawal by Subject|1|||
129581662|NCT04474405|466427159|FG003|Overall Study|Withdrawal by Subject|0|||
129581663|NCT04474405|466427160|FG004|Overall Study|Withdrawal by Subject|1|||
129581664|NCT04474405|466427161|FG005|Overall Study|Withdrawal by Subject|0|||
129581665|NCT04474405|466427156|FG000|Overall Study|Other|0|||
129581666|NCT04474405|466427157|FG001|Overall Study|Other|0|||
129581667|NCT04474405|466427158|FG002|Overall Study|Other|0|||
129581668|NCT04474405|466427159|FG003|Overall Study|Other|0|||
129581669|NCT04474405|466427160|FG004|Overall Study|Other|3|||
129581670|NCT04474405|466427161|FG005|Overall Study|Other|0|||
129695785|NCT02268851|466843967|FG001|Overall Study|Progressive Disease|3|||
129695786|NCT02268851|466843968|FG002|Overall Study|Progressive Disease|0|||
129581671|NCT00274651|466427162|FG000|Overall Study|Adverse Event|6|||
129581672|NCT00274651|466427163|FG001|Overall Study|Adverse Event|3|||
129581673|NCT00274651|466427162|FG000|Overall Study|Lack of Efficacy|13|||
129581674|NCT00274651|466427163|FG001|Overall Study|Lack of Efficacy|6|||
129581675|NCT00274651|466427162|FG000|Overall Study|Death|1|||
129581676|NCT00274651|466427163|FG001|Overall Study|Death|3|||
129581677|NCT00274651|466427162|FG000|Overall Study|Withdrawal by Subject|0|||
129581678|NCT00274651|466427163|FG001|Overall Study|Withdrawal by Subject|1|||
129581679|NCT00274651|466427162|FG000|Overall Study|Physician Decision|8|||
129581680|NCT00274651|466427163|FG001|Overall Study|Physician Decision|7|||
129581681|NCT00635648|466427164|FG000|Overall Study|Adverse Event|12|||
129581682|NCT00635648|466427164|FG000|Overall Study|Withdrawal by Subject|9|||
129581683|NCT00635648|466427164|FG000|Overall Study|Physician Decision|4|||
129581684|NCT00635648|466427164|FG000|Overall Study|Rapid progression of baseline disease|4|||
129581685|NCT00635648|466427164|FG000|Overall Study|Use of other antifungal agent needed|1|||
129581686|NCT00635648|466427164|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
129581687|NCT00635648|466427164|FG000|Overall Study|Noncompliance with protocol|1|||
129581688|NCT00635648|466427164|FG000|Overall Study|Other reason|2|||
129581689|NCT04547192|466427165|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
129581690|NCT04547192|466427166|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
129581691|NCT04547192|466427167|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
129581692|NCT04547192|466427168|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
129581693|NCT04547192|466427165|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
129581694|NCT04547192|466427166|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
129786109|NCT00958438|467185596|FG001|Overall Study|Withdrawal by Subject|2|||
129786110|NCT00958438|467185597|FG002|Overall Study|Withdrawal by Subject|1|||
129786111|NCT00958438|467185595|FG000|Overall Study|Adverse Event|0|||
129786112|NCT00958438|467185596|FG001|Overall Study|Adverse Event|3|||
129786113|NCT00958438|467185597|FG002|Overall Study|Adverse Event|0|||
129786114|NCT00958438|467185595|FG000|Overall Study|Physician Decision|1|||
129786115|NCT00958438|467185596|FG001|Overall Study|Physician Decision|0|||
129786116|NCT00958438|467185597|FG002|Overall Study|Physician Decision|1|||
129786117|NCT00958438|467185595|FG000|Overall Study|Other than specified above|2|||
129786118|NCT00958438|467185596|FG001|Overall Study|Other than specified above|3|||
129786119|NCT00958438|467185597|FG002|Overall Study|Other than specified above|2|||
129786120|NCT02788279|467185598|FG000|Overall Study|Death|62|||
129786121|NCT02788279|467185599|FG001|Overall Study|Death|136|||
129786122|NCT02788279|467185600|FG002|Overall Study|Death|72|||
129786123|NCT02788279|467185598|FG000|Overall Study|Withdrawal by Subject|10|||
129786124|NCT02788279|467185599|FG001|Overall Study|Withdrawal by Subject|15|||
129786125|NCT02788279|467185600|FG002|Overall Study|Withdrawal by Subject|5|||
129786126|NCT02788279|467185598|FG000|Overall Study|Lost to Follow-up|0|||
129786127|NCT02788279|467185599|FG001|Overall Study|Lost to Follow-up|3|||
129786128|NCT02788279|467185600|FG002|Overall Study|Lost to Follow-up|2|||
129786129|NCT02788279|467185598|FG000|Overall Study|Sponsor decision|18|||
129786130|NCT02788279|467185599|FG001|Overall Study|Sponsor decision|29|||
129786131|NCT02788279|467185600|FG002|Overall Study|Sponsor decision|11|||
129786132|NCT00329849|467185601|FG000|Overall Study|Withdrawal by Subject|6|||
129786133|NCT00329849|467185602|FG001|Overall Study|Withdrawal by Subject|4|||
129786134|NCT00653432|467185603|FG000|Overall Study|Adverse Event|4|||
129786135|NCT00653432|467185604|FG001|Overall Study|Adverse Event|1|||
129786136|NCT00653432|467185603|FG000|Overall Study|Withdrawal by Subject|4|||
129786137|NCT00653432|467185604|FG001|Overall Study|Withdrawal by Subject|5|||
129786138|NCT00653432|467185603|FG000|Overall Study|Lost to Follow-up|7|||
129581695|NCT04547192|466427167|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
129786139|NCT00653432|467185604|FG001|Overall Study|Lost to Follow-up|6|||
129581696|NCT04547192|466427168|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
129581697|NCT04547192|466427165|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
129581698|NCT04547192|466427166|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
129581699|NCT04547192|466427167|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
129581700|NCT04547192|466427168|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
129581701|NCT04547192|466427165|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
129581702|NCT04547192|466427166|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
129786140|NCT00653432|467185603|FG000|Overall Study|Use/Need of Con Therapy|2|||
129786141|NCT00653432|467185604|FG001|Overall Study|Use/Need of Con Therapy|1|||
129786142|NCT00653432|467185603|FG000|Overall Study|Other - Reason Not Provided|5|||
129786143|NCT00653432|467185604|FG001|Overall Study|Other - Reason Not Provided|3|||
129786144|NCT01782469|467185605|FG000|Overall Study|Lost to Follow-up|1|||
129786145|NCT00835211|467185609|FG000|First Intervention|Withdrawal by Subject|0|||
129786146|NCT00835211|467185610|FG001|First Intervention|Withdrawal by Subject|1|||
129581703|NCT04547192|466427167|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
129581704|NCT04547192|466427168|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
129581705|NCT04547192|466427165|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
129581706|NCT04547192|466427166|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
129581707|NCT04547192|466427167|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
129581708|NCT04547192|466427168|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
129581709|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
129581710|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
129884937|NCT00876460|467538736|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
129581711|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
129695787|NCT02268851|466843969|FG003|Overall Study|Progressive Disease|0|||
129581712|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
129581713|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
129581714|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
129581715|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
129581716|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
129581717|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
129581718|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
129581719|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
129581720|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
129581721|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
129581722|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
129581723|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
129581724|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
129581725|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
129581726|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
129581727|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
129581728|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
129581729|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
129581730|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
129581731|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
129581732|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
129581733|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
129581734|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
129581735|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
129581736|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
129581737|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
129581738|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
129581739|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
129581740|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
129581741|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
129581742|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
129581743|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
129581744|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
129581745|NCT04194801|466427169|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
129581746|NCT04194801|466427170|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
129581747|NCT04194801|466427171|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
129581748|NCT04194801|466427169|FG000|Part Ib/II End of Study|Death|2|||
129581749|NCT04194801|466427170|FG001|Part Ib/II End of Study|Death|3|||
129581750|NCT04194801|466427171|FG002|Part Ib/II End of Study|Death|3|||
129581751|NCT04194801|466427169|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
129581752|NCT04194801|466427170|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
129581753|NCT04194801|466427171|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
129581754|NCT04194801|466427169|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
129581755|NCT04194801|466427170|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
129581756|NCT04194801|466427171|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
129581757|NCT04194801|466427169|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
129581758|NCT04194801|466427170|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
129581759|NCT04194801|466427171|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
129581760|NCT04194801|466427169|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
129581761|NCT04194801|466427170|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
129581762|NCT04194801|466427171|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
129581763|NCT01923740|466427172|FG000|Overall Study|Lost to Follow-up|4|||
129581764|NCT01923740|466427173|FG001|Overall Study|Lost to Follow-up|9|||
129581765|NCT01923740|466427172|FG000|Overall Study|Withdrawal by Subject|2|||
129581766|NCT01923740|466427173|FG001|Overall Study|Withdrawal by Subject|0|||
129581767|NCT04723693|466427174|FG000|Overall Study|Withdrawal by Subject|2|||
129581768|NCT01410227|466427175|FG000|Overall Study|Adverse Event|1|||
129581769|NCT01410227|466427176|FG001|Overall Study|Adverse Event|0|||
129581770|NCT01410227|466427177|FG002|Overall Study|Adverse Event|0|||
129581771|NCT01410227|466427178|FG003|Overall Study|Adverse Event|0|||
129581772|NCT01410227|466427175|FG000|Overall Study|Withdrawal by Subject|3|||
129581773|NCT01410227|466427176|FG001|Overall Study|Withdrawal by Subject|0|||
129581774|NCT01410227|466427177|FG002|Overall Study|Withdrawal by Subject|1|||
129695788|NCT02268851|466843970|FG004|Overall Study|Progressive Disease|1|||
129581775|NCT01410227|466427178|FG003|Overall Study|Withdrawal by Subject|0|||
129581776|NCT01410227|466427175|FG000|Overall Study|Pregnancy|0|||
129581777|NCT01410227|466427176|FG001|Overall Study|Pregnancy|0|||
129581778|NCT01410227|466427177|FG002|Overall Study|Pregnancy|0|||
129581779|NCT01410227|466427178|FG003|Overall Study|Pregnancy|1|||
129581780|NCT01410227|466427175|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
129581781|NCT01410227|466427176|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
129581782|NCT01410227|466427177|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
129581783|NCT01410227|466427178|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
129581784|NCT03497130|466427179|FG000|Overall Study|Lost to Follow-up|1|||
129581785|NCT03497130|466427180|FG001|Overall Study|Lost to Follow-up|1|||
129581786|NCT04002648|466427181|FG000|Overall Study|Lost to Follow-up|2|||
129581787|NCT04002648|466427182|FG001|Overall Study|Lost to Follow-up|0|||
129581788|NCT00669162|466427186|FG000|Overall Study|Withdrawal by Subject|1|||
129581789|NCT02412852|466427187|FG000|Overall Study|Withdrawal by Subject|0|||
129581790|NCT02412852|466427188|FG001|Overall Study|Withdrawal by Subject|1|||
129581791|NCT02412852|466427189|FG002|Overall Study|Withdrawal by Subject|0|||
129581792|NCT02412852|466427190|FG003|Overall Study|Withdrawal by Subject|0|||
129581793|NCT02412852|466427187|FG000|Overall Study|Physician Decision|0|||
129581794|NCT02412852|466427188|FG001|Overall Study|Physician Decision|0|||
129581795|NCT02412852|466427189|FG002|Overall Study|Physician Decision|0|||
129581796|NCT02412852|466427190|FG003|Overall Study|Physician Decision|1|||
129581797|NCT01051349|466427191|FG000|Overall Study|Adverse Event|88|||
129581798|NCT01051349|466427191|FG000|Overall Study|Consent Withdrawn|54|||
129581799|NCT01051349|466427191|FG000|Overall Study|Investigator Decision|6|||
129581800|NCT01051349|466427191|FG000|Overall Study|Lost to Follow-up|6|||
129581801|NCT01051349|466427191|FG000|Overall Study|Subject non-compliance|7|||
129581802|NCT01051349|466427191|FG000|Overall Study|Reason not Specified|12|||
129581803|NCT00841542|466427192|FG000|Period 1|Adverse Event|1|||
129581804|NCT00841542|466427193|FG001|Period 1|Adverse Event|0|||
129581805|NCT00472212|466427194|FG000|Overall Study|Lost to Follow-up|6|||
129581806|NCT00472212|466427195|FG001|Overall Study|Lost to Follow-up|4|||
129581807|NCT02462837|466427196|FG000|Overall Study|pt developed hives|1|||
129581808|NCT02462837|466427197|FG001|Overall Study|pt developed hives|0|||
129581809|NCT02462837|466427196|FG000|Overall Study|Withdrawal by Subject|1|||
129581810|NCT02462837|466427197|FG001|Overall Study|Withdrawal by Subject|0|||
129581811|NCT05562011|466427202|FG000|Overall Study|Withdrawal by Subject|3|||
129581812|NCT05562011|466427202|FG000|Overall Study|Lost to Follow-up|1|||
129581813|NCT05562011|466427202|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
129581814|NCT05562011|466427202|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
129581815|NCT05562011|466427202|FG000|Overall Study|Device malfunction|13|||
129581816|NCT00841659|466427205|FG000|Washout: 2 Weeks|Protocol Violation|1|||
129581817|NCT00841659|466427206|FG001|Washout: 2 Weeks|Protocol Violation|0|||
129581818|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Refused|1|||
129581819|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Refused|3|||
129581820|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Medical|0|||
129581821|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Medical|1|||
129581822|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
129581823|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
129581824|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
129581825|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
129581826|NCT02054715|466427207|FG000|Baseline/Follow-up 1|No Reason|0|||
129581827|NCT02054715|466427208|FG001|Baseline/Follow-up 1|No Reason|1|||
129581828|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
129581829|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
129581830|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Ineligible|3|||
129581831|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Ineligible|0|||
129581832|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Hospitalization|1|||
129581833|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Hospitalization|0|||
129581834|NCT02054715|466427207|FG000|Baseline/Follow-up 1|Changed Mind|1|||
129581835|NCT02054715|466427208|FG001|Baseline/Follow-up 1|Changed Mind|0|||
129581836|NCT02054715|466427207|FG000|Follow-up 2|Lost to Followup|3|||
129581837|NCT02054715|466427208|FG001|Follow-up 2|Lost to Followup|1|||
129581838|NCT02054715|466427207|FG000|Follow-up 2|Refused|3|||
129581839|NCT02054715|466427208|FG001|Follow-up 2|Refused|2|||
129581840|NCT02054715|466427207|FG000|Follow-up 2|Followup Not Completed|3|||
129581841|NCT02054715|466427208|FG001|Follow-up 2|Followup Not Completed|4|||
129786147|NCT00835211|467185609|FG000|Washout: 7 Days|Adverse Event|2|||
129581842|NCT02054715|466427207|FG000|Follow-up 2|Ineligible|4|||
129581843|NCT02054715|466427208|FG001|Follow-up 2|Ineligible|5|||
129581844|NCT02054715|466427207|FG000|Follow-up 2|Death|3|||
129581845|NCT02054715|466427208|FG001|Follow-up 2|Death|3|||
129581846|NCT02054715|466427207|FG000|Follow-up 2|Hospitalization|0|||
129786148|NCT00835211|467185610|FG001|Washout: 7 Days|Adverse Event|1|||
129581847|NCT02054715|466427208|FG001|Follow-up 2|Hospitalization|2|||
129581848|NCT02054715|466427207|FG000|Follow-up 2|Changed MD/Facility|0|||
129581849|NCT02054715|466427208|FG001|Follow-up 2|Changed MD/Facility|1|||
129581850|NCT02054715|466427207|FG000|Follow-up 2|Changed Mind|0|||
129581851|NCT02054715|466427208|FG001|Follow-up 2|Changed Mind|1|||
129581852|NCT02054715|466427207|FG000|Follow-up 2|No Reason|2|||
129581853|NCT02054715|466427208|FG001|Follow-up 2|No Reason|0|||
129581854|NCT02054715|466427207|FG000|Follow-up 2|Treatment Change or Delay|1|||
129581855|NCT02054715|466427208|FG001|Follow-up 2|Treatment Change or Delay|0|||
129581856|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
129581857|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
129581858|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
129581859|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
129581860|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
129581861|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
129581862|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
129581863|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
129581864|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
129581865|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
129581866|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
129581867|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
129581868|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
129581869|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
129581870|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
129581871|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
129581872|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
129581873|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
129581874|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
129581875|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
129581876|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
129581877|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
129581878|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
129581879|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
129581880|NCT00073307|466427216|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
129581881|NCT00073307|466427217|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
129581882|NCT00073307|466427218|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
129581883|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
129581884|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
129581885|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
129884938|NCT00876460|467538737|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
129581886|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
129581887|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
129581888|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
129581889|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
129581890|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
129581891|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
129581892|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
129581893|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
129581894|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
129581895|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
129581896|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
129581897|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
129581898|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
129581899|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
129581900|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
129581901|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
129581902|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
129581903|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
129581904|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
129581905|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
129581906|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
129581907|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
129581908|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
129581909|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
129581910|NCT00073307|466427216|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
129581911|NCT00073307|466427217|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
129581912|NCT00073307|466427218|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
129581913|NCT01438060|466427219|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
129581914|NCT01438060|466427220|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
129581915|NCT01438060|466427219|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
129581916|NCT01438060|466427220|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
129581917|NCT01438060|466427219|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
129581918|NCT01438060|466427220|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
129581919|NCT01438060|466427219|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
129581920|NCT01438060|466427220|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
129581921|NCT01438060|466427219|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
129581922|NCT01438060|466427220|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
129581923|NCT01438060|466427219|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
129581924|NCT01438060|466427220|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
129581925|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
129581926|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
129581927|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
129581928|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
129581929|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
129581930|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
129581931|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
129581932|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
129581933|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
129581934|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
129581935|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
129581936|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
129581937|NCT01438060|466427219|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
129581938|NCT01438060|466427220|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
129581939|NCT01438060|466427219|FG000|On Study Beyond Week 140|Adverse Event|0|||
129581940|NCT01438060|466427220|FG001|On Study Beyond Week 140|Adverse Event|2|||
129581941|NCT01438060|466427219|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
129581942|NCT01438060|466427220|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
129581943|NCT01438060|466427219|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
129581944|NCT01438060|466427220|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
129581945|NCT01438060|466427219|FG000|On Study Beyond Week 140|Death|0|||
129581946|NCT01438060|466427220|FG001|On Study Beyond Week 140|Death|1|||
129581947|NCT01438060|466427219|FG000|On Study Beyond Week 140|Other Reason|0|||
129581948|NCT01438060|466427220|FG001|On Study Beyond Week 140|Other Reason|3|||
129581949|NCT01442376|466427222|FG000|Overall Study|Adverse Event|0|||
129581950|NCT01442376|466427223|FG001|Overall Study|Adverse Event|3|||
129581951|NCT01442376|466427224|FG002|Overall Study|Adverse Event|2|||
129581952|NCT01442376|466427222|FG000|Overall Study|Death|0|||
129581953|NCT01442376|466427223|FG001|Overall Study|Death|1|||
129581954|NCT01442376|466427224|FG002|Overall Study|Death|1|||
129581955|NCT01442376|466427222|FG000|Overall Study|Withdrawal of consent|0|||
129581956|NCT01442376|466427223|FG001|Overall Study|Withdrawal of consent|0|||
129581957|NCT01442376|466427224|FG002|Overall Study|Withdrawal of consent|1|||
129581958|NCT01442376|466427222|FG000|Overall Study|Patients not treated|2|||
129581959|NCT01442376|466427223|FG001|Overall Study|Patients not treated|3|||
129581960|NCT01442376|466427224|FG002|Overall Study|Patients not treated|1|||
129581961|NCT01442376|466427222|FG000|Overall Study|Not eligible for subsequent cycles|1|||
129581962|NCT01442376|466427223|FG001|Overall Study|Not eligible for subsequent cycles|2|||
129581963|NCT01442376|466427224|FG002|Overall Study|Not eligible for subsequent cycles|0|||
129581964|NCT01964950|466427225|FG000|Overall Study|Protocol Violation|25|||
129581965|NCT03499873|466427226|FG000|Overall Study|Withdrawal by Subject|4|||
129581966|NCT03499873|466427227|FG001|Overall Study|Withdrawal by Subject|6|||
129581967|NCT03499873|466427228|FG002|Overall Study|Withdrawal by Subject|1|||
129695789|NCT02268851|466843971|FG005|Overall Study|Progressive Disease|4|||
129581968|NCT03499873|466427226|FG000|Overall Study|Subjects condition worsened|0|||
129581969|NCT03499873|466427227|FG001|Overall Study|Subjects condition worsened|3|||
129581970|NCT03499873|466427228|FG002|Overall Study|Subjects condition worsened|11|||
129581971|NCT03499873|466427226|FG000|Overall Study|Adverse Event|8|||
129581972|NCT03499873|466427227|FG001|Overall Study|Adverse Event|3|||
129581973|NCT03499873|466427228|FG002|Overall Study|Adverse Event|6|||
129581974|NCT03499873|466427226|FG000|Overall Study|Physician Decision|1|||
129581975|NCT03499873|466427227|FG001|Overall Study|Physician Decision|0|||
129581976|NCT03499873|466427228|FG002|Overall Study|Physician Decision|0|||
129581977|NCT03499873|466427226|FG000|Overall Study|Administrative reasons|0|||
129581978|NCT03499873|466427227|FG001|Overall Study|Administrative reasons|1|||
129581979|NCT03499873|466427228|FG002|Overall Study|Administrative reasons|0|||
129581980|NCT03499873|466427226|FG000|Overall Study|Concomitant therapy|5|||
129581981|NCT03499873|466427227|FG001|Overall Study|Concomitant therapy|4|||
129581982|NCT03499873|466427228|FG002|Overall Study|Concomitant therapy|7|||
129581983|NCT03499873|466427226|FG000|Overall Study|Miscellaneous|1|||
129581984|NCT03499873|466427227|FG001|Overall Study|Miscellaneous|2|||
129581985|NCT03499873|466427228|FG002|Overall Study|Miscellaneous|2|||
129581986|NCT03499873|466427226|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
129581987|NCT03499873|466427227|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
129581988|NCT03499873|466427228|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
129581989|NCT02471807|466427239|FG000|Overall Study|Death|14|||
129581990|NCT02471807|466427239|FG000|Overall Study|Withdrawal by Subject|2|||
129581991|NCT02471807|466427239|FG000|Overall Study|Explant|5|||
129581992|NCT02471807|466427239|FG000|Overall Study|Lost to Follow-up|1|||
129581993|NCT00957021|466427240|FG000|Overall Study|Death|5|||
129581994|NCT00957021|466427240|FG000|Overall Study|Lost to Follow-up|8|||
129581995|NCT00957021|466427240|FG000|Overall Study|Withdrawal by Subject|34|||
129581996|NCT00957021|466427240|FG000|Overall Study|No 2 yr ROM data|35|||
129581997|NCT00957021|466427240|FG000|Overall Study|Revised study component by 2 yr visit|8|||
129581998|NCT00957021|466427240|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
129581999|NCT00957021|466427240|FG000|Overall Study|Surgery Cancelled|9|||
129582000|NCT00957021|466427240|FG000|Overall Study|Termination due to language issue|2|||
129582001|NCT00868998|466427242|FG000|Overall Study|Screen Failure|1|||
129582002|NCT00868998|466427242|FG000|Overall Study|Withdrawal by Subject|1|||
129582003|NCT00868998|466427242|FG000|Overall Study|Progression of disease|2|||
129582004|NCT00868998|466427242|FG000|Overall Study|Death|1|||
129582005|NCT01986647|466427243|FG000|Overall Study|Lost to Follow-up|4|||
129582006|NCT01986647|466427244|FG001|Overall Study|Lost to Follow-up|1|||
129582007|NCT01986647|466427245|FG002|Overall Study|Lost to Follow-up|4|||
129582008|NCT01986647|466427246|FG003|Overall Study|Lost to Follow-up|4|||
129582009|NCT01986647|466427243|FG000|Overall Study|Withdrawal by Subject|1|||
129582010|NCT01986647|466427244|FG001|Overall Study|Withdrawal by Subject|3|||
129582011|NCT01986647|466427245|FG002|Overall Study|Withdrawal by Subject|2|||
129582012|NCT01986647|466427246|FG003|Overall Study|Withdrawal by Subject|3|||
129582013|NCT01986647|466427243|FG000|Overall Study|Health|5|||
129582014|NCT01986647|466427244|FG001|Overall Study|Health|3|||
129582015|NCT01986647|466427245|FG002|Overall Study|Health|6|||
129582016|NCT01986647|466427246|FG003|Overall Study|Health|4|||
129582017|NCT02905435|466427247|FG000|Overall Study|Death|2|||
129582018|NCT02905435|466427247|FG000|Overall Study|Physician Decision|1|||
129582019|NCT02905435|466427247|FG000|Overall Study|Lost to Follow-up|4|||
129582020|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
129582021|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
129582022|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
129582023|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
129582024|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
129582025|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582026|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582027|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582028|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582029|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582030|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582031|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582032|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582033|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582034|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582035|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582036|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582037|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582038|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582039|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582040|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582041|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582042|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582043|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582044|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582045|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
129582046|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582047|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
129582048|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582049|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582050|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582051|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582052|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582053|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582054|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582055|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582056|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582057|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582058|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582059|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582060|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582061|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582062|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582063|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582064|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582065|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582066|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582067|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582068|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582069|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582070|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582071|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
129582072|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582073|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
129582074|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582075|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582076|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582077|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582078|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582079|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582080|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582081|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582082|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582083|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582084|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582085|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582086|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582087|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582088|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582089|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582090|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582091|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582092|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582093|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129786149|NCT00835211|467185609|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129786150|NCT00835211|467185610|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129582094|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582095|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582096|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582097|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
129582098|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
129582099|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582100|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
129582101|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
129582102|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
129582103|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582104|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582105|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582106|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582107|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582108|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582109|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582110|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582111|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582112|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582113|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582114|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582115|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582116|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582117|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582118|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582119|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582120|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582121|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582122|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582123|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
129582124|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
129582125|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
129582126|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
129582127|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
129582128|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
129582129|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582130|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582131|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582132|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582133|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582134|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582135|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582136|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582137|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582138|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582139|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582140|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582141|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582142|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582143|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582144|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582145|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582146|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582147|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582148|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582149|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
129582150|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|moved|0|||
129582151|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|moved|1|||
129582152|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|moved|1|||
129582153|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|moved|0|||
129582154|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|moved|0|||
129582155|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|moved|0|||
129582156|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|moved|0|||
129582157|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|moved|0|||
129582158|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|moved|0|||
129582159|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|moved|0|||
129582160|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|moved|0|||
129582161|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|moved|0|||
129582162|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|moved|0|||
129582163|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|moved|0|||
129582164|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|moved|0|||
129582165|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|moved|0|||
129582166|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|moved|0|||
129582167|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|moved|0|||
129582168|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|moved|0|||
129582169|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|moved|0|||
129582170|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|moved|0|||
129582171|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|moved|0|||
129582172|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|moved|0|||
129582173|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|moved|0|||
129582174|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|moved|0|||
129582175|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|moved|0|||
129582176|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582177|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582178|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582179|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
129582180|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582181|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582182|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582183|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582184|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582185|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582186|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582187|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582188|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582189|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582190|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582191|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582192|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582193|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582194|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582195|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582196|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582197|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582198|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582199|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582200|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582201|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
129582202|NCT00112437|466427254|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582203|NCT00112437|466427255|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582204|NCT00112437|466427256|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582205|NCT00112437|466427257|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582206|NCT00112437|466427258|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
129582207|NCT00112437|466427259|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582208|NCT00112437|466427260|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582209|NCT00112437|466427261|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582210|NCT00112437|466427262|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582211|NCT00112437|466427263|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582212|NCT00112437|466427264|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582213|NCT00112437|466427265|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582214|NCT00112437|466427266|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582215|NCT00112437|466427267|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582216|NCT00112437|466427268|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582217|NCT00112437|466427269|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582218|NCT00112437|466427270|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582219|NCT00112437|466427271|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582220|NCT00112437|466427272|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582221|NCT00112437|466427273|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582222|NCT00112437|466427274|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582223|NCT00112437|466427275|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582224|NCT00112437|466427276|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582225|NCT00112437|466427277|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582226|NCT00112437|466427278|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582227|NCT00112437|466427279|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
129582228|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
129786151|NCT02343549|467185611|FG000|Overall Study|Death|11|||
129786152|NCT02343549|467185611|FG000|Overall Study|Withdrawal by Subject|2|||
129786153|NCT01090323|467185612|FG000|Overall Study|Adverse Event|12|||
129786154|NCT01090323|467185613|FG001|Overall Study|Adverse Event|2|||
129582229|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
129582230|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
129582231|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
129582232|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
129582233|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
129582234|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
129582235|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
129582236|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
129582237|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
129582238|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
129582239|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
129582240|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
129582241|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
129582242|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
129582243|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
129582244|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
129582245|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
129582246|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
129582247|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
129582248|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
129582249|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
129582250|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
129582251|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
129582252|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
129582253|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
129582254|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582255|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582256|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582257|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582258|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582259|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
129582260|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
129582261|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582262|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582263|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
129582264|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582265|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582266|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582267|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582268|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582269|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582270|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582271|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582272|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582273|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582274|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582275|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582276|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582277|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582278|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582279|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
129582280|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582281|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582282|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582283|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582284|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582285|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582286|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582287|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582288|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
129582289|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129695790|NCT02268851|466843966|FG000|Overall Study|Physician Decision|0|||
129695791|NCT02268851|466843967|FG001|Overall Study|Physician Decision|0|||
129695792|NCT02268851|466843968|FG002|Overall Study|Physician Decision|1|||
129695793|NCT02268851|466843969|FG003|Overall Study|Physician Decision|0|||
129695794|NCT02268851|466843970|FG004|Overall Study|Physician Decision|0|||
129695795|NCT02268851|466843971|FG005|Overall Study|Physician Decision|1|||
129695796|NCT02268851|466843966|FG000|Overall Study|Patient Compliance|0|||
129695797|NCT02268851|466843967|FG001|Overall Study|Patient Compliance|0|||
129695798|NCT02268851|466843968|FG002|Overall Study|Patient Compliance|0|||
129582290|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582291|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582292|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582293|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582294|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582295|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582296|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582297|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582298|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582299|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582300|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582301|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582302|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582303|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582304|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582305|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
129582306|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582307|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582308|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582309|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582310|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582311|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582312|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582313|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582314|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
129582315|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582316|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582317|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582318|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582319|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582320|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582321|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582322|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582323|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582324|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582325|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582326|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582327|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582328|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582329|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
129786155|NCT01090323|467185612|FG000|Overall Study|Abnormal Lab Values|3|||
129786156|NCT01090323|467185613|FG001|Overall Study|Abnormal Lab Values|1|||
129786157|NCT01090323|467185612|FG000|Overall Study|Abnormal Test Procedure Results|2|||
129786158|NCT01090323|467185613|FG001|Overall Study|Abnormal Test Procedure Results|0|||
129786159|NCT01090323|467185612|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129786160|NCT01090323|467185613|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129786161|NCT01090323|467185612|FG000|Overall Study|Condition no longer requires drug|5|||
129786162|NCT01090323|467185613|FG001|Overall Study|Condition no longer requires drug|4|||
129786163|NCT01090323|467185612|FG000|Overall Study|Protocol Violation|2|||
129786164|NCT01090323|467185613|FG001|Overall Study|Protocol Violation|1|||
129786165|NCT01090323|467185612|FG000|Overall Study|Withdrew consent|33|||
129786166|NCT01090323|467185613|FG001|Overall Study|Withdrew consent|11|||
129786167|NCT01090323|467185612|FG000|Overall Study|Lost to Follow-up|11|||
129786168|NCT01090323|467185613|FG001|Overall Study|Lost to Follow-up|6|||
129786169|NCT01090323|467185612|FG000|Overall Study|Administrative problems|6|||
129786170|NCT01090323|467185613|FG001|Overall Study|Administrative problems|4|||
129786171|NCT01090323|467185612|FG000|Overall Study|Death|1|||
129786172|NCT01090323|467185613|FG001|Overall Study|Death|2|||
129786173|NCT01090323|467185612|FG000|Overall Study|Stopped end of core|7|||
129786174|NCT01090323|467185613|FG001|Overall Study|Stopped end of core|0|||
129582330|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
129786175|NCT01090323|467185612|FG000|Overall Study|Stopped end of extension 1#|3|||
129786176|NCT01090323|467185613|FG001|Overall Study|Stopped end of extension 1#|1|||
129786177|NCT05498701|467185614|FG000|Period 3|Adverse Event|1|||
129786178|NCT05498701|467185615|FG001|Period 3|Adverse Event|0|||
129582331|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
129582332|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582333|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129786179|NCT01864005|467185616|FG000|Overall Study|Protocol Violation|0|||
129786180|NCT01864005|467185617|FG001|Overall Study|Protocol Violation|1|||
129786181|NCT01864005|467185616|FG000|Overall Study|Withdrawal by Subject|0|||
129786182|NCT01864005|467185617|FG001|Overall Study|Withdrawal by Subject|1|||
129786183|NCT01864005|467185616|FG000|Overall Study|Incorrect enrolment|1|||
129582334|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582335|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582336|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582337|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
129582338|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
129582339|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
129582340|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
129582341|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
129582342|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582343|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582344|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582345|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582346|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582347|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582348|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582349|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582350|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582351|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582352|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582353|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582354|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582355|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582356|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582357|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
129582358|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582359|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582360|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582361|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582362|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582363|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582364|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582365|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582366|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582367|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
129582368|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582369|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582370|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582371|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582372|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582373|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582374|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582375|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582376|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582377|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582378|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582379|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582380|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129884939|NCT00876460|467538738|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
129582381|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129884940|NCT00876460|467538739|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
129582382|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582383|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
129582384|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582385|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582386|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582387|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582388|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582389|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582390|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582391|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582392|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582393|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
129582394|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582395|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582396|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582397|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582398|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582399|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582400|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582401|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582402|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582403|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582404|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582405|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582406|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582407|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582408|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582409|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
129582410|NCT00112437|466427254|FG000|Year 2 (12-Month Extension)|Moved|0|||
129582411|NCT00112437|466427255|FG001|Year 2 (12-Month Extension)|Moved|0|||
129582412|NCT00112437|466427256|FG002|Year 2 (12-Month Extension)|Moved|0|||
129582413|NCT00112437|466427257|FG003|Year 2 (12-Month Extension)|Moved|0|||
129582414|NCT00112437|466427258|FG004|Year 2 (12-Month Extension)|Moved|0|||
129582415|NCT00112437|466427259|FG005|Year 2 (12-Month Extension)|Moved|0|||
129582416|NCT00112437|466427260|FG006|Year 2 (12-Month Extension)|Moved|0|||
129582417|NCT00112437|466427261|FG007|Year 2 (12-Month Extension)|Moved|0|||
129582418|NCT00112437|466427262|FG008|Year 2 (12-Month Extension)|Moved|0|||
129582419|NCT00112437|466427263|FG009|Year 2 (12-Month Extension)|Moved|1|||
129582420|NCT00112437|466427264|FG010|Year 2 (12-Month Extension)|Moved|0|||
129582421|NCT00112437|466427265|FG011|Year 2 (12-Month Extension)|Moved|0|||
129582422|NCT00112437|466427266|FG012|Year 2 (12-Month Extension)|Moved|0|||
129582423|NCT00112437|466427267|FG013|Year 2 (12-Month Extension)|Moved|0|||
129582424|NCT00112437|466427268|FG014|Year 2 (12-Month Extension)|Moved|0|||
129582425|NCT00112437|466427269|FG015|Year 2 (12-Month Extension)|Moved|0|||
129582426|NCT00112437|466427270|FG016|Year 2 (12-Month Extension)|Moved|0|||
129582427|NCT00112437|466427271|FG017|Year 2 (12-Month Extension)|Moved|0|||
129582428|NCT00112437|466427272|FG018|Year 2 (12-Month Extension)|Moved|0|||
129582429|NCT00112437|466427273|FG019|Year 2 (12-Month Extension)|Moved|0|||
129582430|NCT00112437|466427274|FG020|Year 2 (12-Month Extension)|Moved|0|||
129582431|NCT00112437|466427275|FG021|Year 2 (12-Month Extension)|Moved|0|||
129582432|NCT00112437|466427276|FG022|Year 2 (12-Month Extension)|Moved|0|||
129582433|NCT00112437|466427277|FG023|Year 2 (12-Month Extension)|Moved|0|||
129582434|NCT00112437|466427278|FG024|Year 2 (12-Month Extension)|Moved|0|||
129582435|NCT00112437|466427279|FG025|Year 2 (12-Month Extension)|Moved|0|||
129582436|NCT00112437|466427254|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
129582437|NCT00112437|466427255|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
129582438|NCT00112437|466427256|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
129582439|NCT00112437|466427257|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
129582440|NCT00112437|466427258|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
129582441|NCT00112437|466427259|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
129582442|NCT00112437|466427260|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
129582443|NCT00112437|466427261|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
129582444|NCT00112437|466427262|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
129582445|NCT00112437|466427263|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
129582446|NCT00112437|466427264|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
129582447|NCT00112437|466427265|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
129582448|NCT00112437|466427266|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
129582449|NCT00112437|466427267|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
129582450|NCT00112437|466427268|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
129582451|NCT00112437|466427269|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
129582452|NCT00112437|466427270|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
129582453|NCT00112437|466427271|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
129582454|NCT00112437|466427272|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
129582455|NCT00112437|466427273|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
129582456|NCT00112437|466427274|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
129582457|NCT00112437|466427275|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
129582458|NCT00112437|466427276|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
129582459|NCT00112437|466427277|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
129582460|NCT00112437|466427278|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
129582461|NCT00112437|466427279|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
129582462|NCT00112437|466427254|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582463|NCT00112437|466427255|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582464|NCT00112437|466427256|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582465|NCT00112437|466427257|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582466|NCT00112437|466427258|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582467|NCT00112437|466427259|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582468|NCT00112437|466427260|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582469|NCT00112437|466427261|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582470|NCT00112437|466427262|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582471|NCT00112437|466427263|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582472|NCT00112437|466427264|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582473|NCT00112437|466427265|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
129582474|NCT00112437|466427266|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582475|NCT00112437|466427267|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
129582476|NCT00112437|466427268|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582477|NCT00112437|466427269|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
129582478|NCT00112437|466427270|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582479|NCT00112437|466427271|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582480|NCT00112437|466427272|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
129582481|NCT00112437|466427273|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582482|NCT00112437|466427274|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582483|NCT00112437|466427275|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582484|NCT00112437|466427276|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582485|NCT00112437|466427277|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582486|NCT00112437|466427278|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582487|NCT00112437|466427279|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
129582488|NCT00112437|466427254|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582489|NCT00112437|466427255|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582490|NCT00112437|466427256|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582491|NCT00112437|466427257|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582492|NCT00112437|466427258|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582493|NCT00112437|466427259|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582494|NCT00112437|466427260|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582495|NCT00112437|466427261|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582496|NCT00112437|466427262|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582497|NCT00112437|466427263|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129786184|NCT01864005|467185617|FG001|Overall Study|Incorrect enrolment|0|||
129786185|NCT01864005|467185616|FG000|Overall Study|Disease need|1|||
129786186|NCT01864005|467185617|FG001|Overall Study|Disease need|1|||
129786187|NCT01864005|467185616|FG000|Overall Study|Need GP IIb/IIIa|1|||
129786188|NCT01864005|467185617|FG001|Overall Study|Need GP IIb/IIIa|3|||
129786189|NCT00006409|467185621|FG000|Baseline|Protocol Violation|48|||
129786190|NCT00006409|467185622|FG001|Baseline|Protocol Violation|70|||
129786191|NCT00006409|467185623|FG002|Baseline|Protocol Violation|0|||
129786192|NCT00006409|467185624|FG003|Baseline|Protocol Violation|0|||
129582498|NCT00112437|466427264|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582499|NCT00112437|466427265|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582500|NCT00112437|466427266|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582501|NCT00112437|466427267|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582502|NCT00112437|466427268|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582503|NCT00112437|466427269|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
129582504|NCT00112437|466427270|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582505|NCT00112437|466427271|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582506|NCT00112437|466427272|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129786193|NCT00006409|467185625|FG004|Baseline|Protocol Violation|0|||
129786194|NCT00006409|467185626|FG005|Baseline|Protocol Violation|0|||
129786195|NCT00006409|467185621|FG000|Post-2 Year Intervention|Protocol Violation|0|||
129582507|NCT00112437|466427273|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582508|NCT00112437|466427274|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582509|NCT00112437|466427275|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582510|NCT00112437|466427276|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582511|NCT00112437|466427277|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582512|NCT00112437|466427278|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582513|NCT00112437|466427279|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
129582514|NCT00112437|466427254|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582515|NCT00112437|466427255|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582516|NCT00112437|466427256|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582517|NCT00112437|466427257|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582518|NCT00112437|466427258|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582519|NCT00112437|466427259|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582520|NCT00112437|466427260|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582521|NCT00112437|466427261|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582522|NCT00112437|466427262|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582523|NCT00112437|466427263|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582524|NCT00112437|466427264|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582525|NCT00112437|466427265|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582526|NCT00112437|466427266|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582527|NCT00112437|466427267|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582528|NCT00112437|466427268|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582529|NCT00112437|466427269|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
129582530|NCT00112437|466427270|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582531|NCT00112437|466427271|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582532|NCT00112437|466427272|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582533|NCT00112437|466427273|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582534|NCT00112437|466427274|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582535|NCT00112437|466427275|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582536|NCT00112437|466427276|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582537|NCT00112437|466427277|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582538|NCT00112437|466427278|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582539|NCT00112437|466427279|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
129582540|NCT00112437|466427254|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582541|NCT00112437|466427255|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582542|NCT00112437|466427256|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582543|NCT00112437|466427257|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582544|NCT00112437|466427258|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582545|NCT00112437|466427259|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582546|NCT00112437|466427260|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582547|NCT00112437|466427261|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582548|NCT00112437|466427262|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582549|NCT00112437|466427263|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582550|NCT00112437|466427264|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582551|NCT00112437|466427265|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
129582552|NCT00112437|466427266|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582553|NCT00112437|466427267|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582554|NCT00112437|466427268|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
129582555|NCT00112437|466427269|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582556|NCT00112437|466427270|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129695799|NCT02268851|466843969|FG003|Overall Study|Patient Compliance|0|||
129582557|NCT00112437|466427271|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582558|NCT00112437|466427272|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582559|NCT00112437|466427273|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582560|NCT00112437|466427274|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582561|NCT00112437|466427275|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582562|NCT00112437|466427276|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582563|NCT00112437|466427277|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582564|NCT00112437|466427278|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582565|NCT00112437|466427279|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
129582566|NCT00112437|466427254|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582567|NCT00112437|466427255|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582568|NCT00112437|466427256|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582569|NCT00112437|466427257|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582570|NCT00112437|466427258|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582571|NCT00112437|466427259|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582572|NCT00112437|466427260|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582573|NCT00112437|466427261|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582574|NCT00112437|466427262|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582575|NCT00112437|466427263|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582576|NCT00112437|466427264|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
129582577|NCT00112437|466427265|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
129582578|NCT00112437|466427266|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582579|NCT00112437|466427267|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582580|NCT00112437|466427268|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582581|NCT00112437|466427269|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582582|NCT00112437|466427270|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582583|NCT00112437|466427271|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582584|NCT00112437|466427272|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582585|NCT00112437|466427273|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582586|NCT00112437|466427274|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582587|NCT00112437|466427275|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582588|NCT00112437|466427276|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582589|NCT00112437|466427277|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582590|NCT00112437|466427278|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582591|NCT00112437|466427279|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
129582592|NCT00112437|466427254|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582593|NCT00112437|466427255|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582594|NCT00112437|466427256|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582595|NCT00112437|466427257|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582596|NCT00112437|466427258|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582597|NCT00112437|466427259|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582598|NCT00112437|466427260|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582599|NCT00112437|466427261|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582600|NCT00112437|466427262|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582601|NCT00112437|466427263|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582602|NCT00112437|466427264|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582603|NCT00112437|466427265|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582604|NCT00112437|466427266|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582605|NCT00112437|466427267|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582606|NCT00112437|466427268|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582607|NCT00112437|466427269|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582608|NCT00112437|466427270|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582609|NCT00112437|466427271|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582610|NCT00112437|466427272|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582611|NCT00112437|466427273|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582612|NCT00112437|466427274|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
129582613|NCT00112437|466427275|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
129582614|NCT00112437|466427276|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582615|NCT00112437|466427277|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582616|NCT00112437|466427278|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582617|NCT00112437|466427279|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
129582618|NCT00112437|466427254|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582619|NCT00112437|466427255|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129786196|NCT00006409|467185622|FG001|Post-2 Year Intervention|Protocol Violation|0|||
129786197|NCT00006409|467185623|FG002|Post-2 Year Intervention|Protocol Violation|251|||
129786198|NCT00006409|467185624|FG003|Post-2 Year Intervention|Protocol Violation|168|||
129786199|NCT00006409|467185625|FG004|Post-2 Year Intervention|Protocol Violation|0|||
129786200|NCT00006409|467185626|FG005|Post-2 Year Intervention|Protocol Violation|0|||
129800246|NCT05597020|467236278|FG000|Washout|Forbidden medication|2|||
129786201|NCT00006409|467185621|FG000|Post-3 Year Intervention|Protocol Violation|0|||
129786202|NCT00006409|467185622|FG001|Post-3 Year Intervention|Protocol Violation|0|||
129786203|NCT00006409|467185623|FG002|Post-3 Year Intervention|Protocol Violation|0|||
129786204|NCT00006409|467185624|FG003|Post-3 Year Intervention|Protocol Violation|0|||
129786205|NCT00006409|467185625|FG004|Post-3 Year Intervention|Protocol Violation|62|||
129786206|NCT00006409|467185626|FG005|Post-3 Year Intervention|Protocol Violation|62|||
129786207|NCT00638183|467185627|FG000|Overall Study|Adverse Event|23|||
129786208|NCT00638183|467185627|FG000|Overall Study|Lack of Efficacy|14|||
129786209|NCT00638183|467185627|FG000|Overall Study|Physician Decision|9|||
129786210|NCT00638183|467185627|FG000|Overall Study|Lost to Follow-up|46|||
129786211|NCT00638183|467185627|FG000|Overall Study|Other reason not defined above|27|||
129786212|NCT02350764|467185628|FG000|Overall Study|Adverse Event|4|||
129786213|NCT02350764|467185628|FG000|Overall Study|Death|3|||
129786214|NCT02350764|467185628|FG000|Overall Study|Physician Decision|2|||
129786215|NCT02350764|467185628|FG000|Overall Study|Withdrawal by Subject|2|||
129786216|NCT01328444|467185629|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
129786217|NCT01328444|467185630|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129786218|NCT01328444|467185631|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129786219|NCT01328444|467185632|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
129786220|NCT01328444|467185633|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
129786221|NCT01328444|467185634|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
129786222|NCT01328444|467185629|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
129786223|NCT01328444|467185630|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
129786224|NCT01328444|467185631|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
129786225|NCT01328444|467185632|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
129786226|NCT01328444|467185633|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
129786227|NCT01328444|467185634|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
129786228|NCT01328444|467185629|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
129786229|NCT01328444|467185630|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
129786230|NCT01328444|467185631|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
129786231|NCT01328444|467185632|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129786232|NCT01328444|467185633|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
129786233|NCT01328444|467185634|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129786234|NCT01328444|467185629|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
129786235|NCT01328444|467185630|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
129786236|NCT01328444|467185631|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
129786237|NCT01328444|467185632|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
129786238|NCT01328444|467185633|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
129786239|NCT01328444|467185634|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
129786240|NCT01328444|467185629|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
129786241|NCT01328444|467185630|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129786242|NCT01328444|467185631|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129786243|NCT01328444|467185632|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129786244|NCT01328444|467185633|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129786245|NCT01328444|467185634|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129786246|NCT01328444|467185629|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129786247|NCT01328444|467185630|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
129786248|NCT01328444|467185631|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129786249|NCT01328444|467185632|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
129786250|NCT01328444|467185633|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129786251|NCT01328444|467185634|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129786252|NCT01328444|467185629|FG000|Washout Period (14 Days)|Adverse Event|1|||
129786253|NCT01328444|467185630|FG001|Washout Period (14 Days)|Adverse Event|1|||
129582620|NCT00112437|466427256|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582621|NCT00112437|466427257|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582622|NCT00112437|466427258|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582623|NCT00112437|466427259|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582624|NCT00112437|466427260|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582625|NCT00112437|466427261|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582626|NCT00112437|466427262|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582627|NCT00112437|466427263|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582628|NCT00112437|466427264|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582629|NCT00112437|466427265|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129786254|NCT01328444|467185631|FG002|Washout Period (14 Days)|Adverse Event|0|||
129786255|NCT01328444|467185632|FG003|Washout Period (14 Days)|Adverse Event|1|||
129786256|NCT01328444|467185633|FG004|Washout Period (14 Days)|Adverse Event|1|||
129786257|NCT01328444|467185634|FG005|Washout Period (14 Days)|Adverse Event|2|||
129786258|NCT01328444|467185629|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
129786259|NCT01328444|467185630|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
129582630|NCT00112437|466427266|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582631|NCT00112437|466427267|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582632|NCT00112437|466427268|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582633|NCT00112437|466427269|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582634|NCT00112437|466427270|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129786260|NCT01328444|467185631|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
129786261|NCT01328444|467185632|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
129786262|NCT01328444|467185633|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
129786263|NCT01328444|467185634|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
129786264|NCT01328444|467185629|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
129786265|NCT01328444|467185630|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
129786266|NCT01328444|467185631|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
129786267|NCT01328444|467185632|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
129786268|NCT01328444|467185633|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
129786269|NCT01328444|467185634|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
129786270|NCT01328444|467185629|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
129786271|NCT01328444|467185630|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129786272|NCT01328444|467185631|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129786273|NCT01328444|467185632|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129786274|NCT01328444|467185633|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129786275|NCT01328444|467185634|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129786276|NCT01328444|467185629|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
129582635|NCT00112437|466427271|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582636|NCT00112437|466427272|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582637|NCT00112437|466427273|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582638|NCT00112437|466427274|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
129582639|NCT00112437|466427275|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582640|NCT00112437|466427276|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582641|NCT00112437|466427277|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582642|NCT00112437|466427278|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129786277|NCT01328444|467185630|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129786278|NCT01328444|467185631|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129786279|NCT01328444|467185632|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
129786280|NCT01328444|467185633|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
129582643|NCT00112437|466427279|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
129582644|NCT00112437|466427254|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582645|NCT00112437|466427255|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582646|NCT00112437|466427256|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582647|NCT00112437|466427257|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582648|NCT00112437|466427258|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582649|NCT00112437|466427259|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582650|NCT00112437|466427260|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582651|NCT00112437|466427261|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582652|NCT00112437|466427262|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582653|NCT00112437|466427263|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582654|NCT00112437|466427264|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582655|NCT00112437|466427265|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582656|NCT00112437|466427266|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582657|NCT00112437|466427267|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582658|NCT00112437|466427268|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582659|NCT00112437|466427269|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582660|NCT00112437|466427270|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582661|NCT00112437|466427271|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582662|NCT00112437|466427272|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582663|NCT00112437|466427273|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582664|NCT00112437|466427274|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582665|NCT00112437|466427275|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
129582666|NCT00112437|466427276|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582667|NCT00112437|466427277|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582668|NCT00112437|466427278|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582669|NCT00112437|466427279|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
129582670|NCT00112437|466427254|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582671|NCT00112437|466427255|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582672|NCT00112437|466427256|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582673|NCT00112437|466427257|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
129786281|NCT01328444|467185634|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
129884941|NCT00876460|467538740|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
129582674|NCT00112437|466427258|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582675|NCT00112437|466427259|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582676|NCT00112437|466427260|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582677|NCT00112437|466427261|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582678|NCT00112437|466427262|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582679|NCT00112437|466427263|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582680|NCT00112437|466427264|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582681|NCT00112437|466427265|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582682|NCT00112437|466427266|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582683|NCT00112437|466427267|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582684|NCT00112437|466427268|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582685|NCT00112437|466427269|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582686|NCT00112437|466427270|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582687|NCT00112437|466427271|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582688|NCT00112437|466427272|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582689|NCT00112437|466427273|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582690|NCT00112437|466427274|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582691|NCT00112437|466427275|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
129582692|NCT00112437|466427276|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582693|NCT00112437|466427277|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582694|NCT00112437|466427278|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582695|NCT00112437|466427279|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
129582696|NCT00112437|466427254|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582697|NCT00112437|466427255|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582698|NCT00112437|466427256|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582699|NCT00112437|466427257|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582700|NCT00112437|466427258|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582701|NCT00112437|466427259|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582702|NCT00112437|466427260|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582703|NCT00112437|466427261|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582704|NCT00112437|466427262|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582705|NCT00112437|466427263|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582706|NCT00112437|466427264|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582707|NCT00112437|466427265|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582708|NCT00112437|466427266|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129695800|NCT02268851|466843970|FG004|Overall Study|Patient Compliance|1|||
129582709|NCT00112437|466427267|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582710|NCT00112437|466427268|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582711|NCT00112437|466427269|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129695801|NCT02268851|466843971|FG005|Overall Study|Patient Compliance|1|||
129695802|NCT02268851|466843966|FG000|Overall Study|Co-Morbid Condition|0|||
129695803|NCT02268851|466843967|FG001|Overall Study|Co-Morbid Condition|0|||
129695804|NCT02268851|466843968|FG002|Overall Study|Co-Morbid Condition|0|||
129695805|NCT02268851|466843969|FG003|Overall Study|Co-Morbid Condition|0|||
129695806|NCT02268851|466843970|FG004|Overall Study|Co-Morbid Condition|1|||
129695807|NCT02268851|466843971|FG005|Overall Study|Co-Morbid Condition|1|||
129695808|NCT01472835|466843974|FG000|Overall Study|Lost to Follow-up|2|||
129695809|NCT01472835|466843975|FG001|Overall Study|Lost to Follow-up|0|||
129695810|NCT02539394|466843976|FG000|Overall Study|Protocol Violation|1|||
129695811|NCT02539394|466843977|FG001|Overall Study|Protocol Violation|3|||
129695812|NCT02539394|466843976|FG000|Overall Study|Lost to Follow-up|1|||
129695813|NCT02539394|466843977|FG001|Overall Study|Lost to Follow-up|2|||
129695814|NCT02539394|466843976|FG000|Overall Study|Incomplete dataset|6|||
129695815|NCT02539394|466843977|FG001|Overall Study|Incomplete dataset|6|||
129695816|NCT02205359|466843994|FG000|Overall Study|Death|293|||
129695817|NCT02205359|466843995|FG001|Overall Study|Death|327|||
129582712|NCT00112437|466427270|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582713|NCT00112437|466427271|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582714|NCT00112437|466427272|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582715|NCT00112437|466427273|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582716|NCT00112437|466427274|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
129582717|NCT00112437|466427275|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
129582718|NCT00112437|466427276|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582719|NCT00112437|466427277|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582720|NCT00112437|466427278|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582721|NCT00112437|466427279|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
129582722|NCT00112437|466427254|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582723|NCT00112437|466427255|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582724|NCT00112437|466427256|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582725|NCT00112437|466427257|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582726|NCT00112437|466427258|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582727|NCT00112437|466427259|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582728|NCT00112437|466427260|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582729|NCT00112437|466427261|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582730|NCT00112437|466427262|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582731|NCT00112437|466427263|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582732|NCT00112437|466427264|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582733|NCT00112437|466427265|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582734|NCT00112437|466427266|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582735|NCT00112437|466427267|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582736|NCT00112437|466427268|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582737|NCT00112437|466427269|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582738|NCT00112437|466427270|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582739|NCT00112437|466427271|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582740|NCT00112437|466427272|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582741|NCT00112437|466427273|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582742|NCT00112437|466427274|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582743|NCT00112437|466427275|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582744|NCT00112437|466427276|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
129582745|NCT00112437|466427277|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
129582746|NCT00112437|466427278|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
129582747|NCT00112437|466427279|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
129582748|NCT00112437|466427254|FG000|Years 6-10 (60-Month Extension)|Death|0|||
129582749|NCT00112437|466427255|FG001|Years 6-10 (60-Month Extension)|Death|0|||
129582750|NCT00112437|466427256|FG002|Years 6-10 (60-Month Extension)|Death|0|||
129582751|NCT00112437|466427257|FG003|Years 6-10 (60-Month Extension)|Death|0|||
129695818|NCT02205359|466843994|FG000|Overall Study|Lost to Follow-up|182|||
129695819|NCT02205359|466843995|FG001|Overall Study|Lost to Follow-up|162|||
129695820|NCT02205359|466843994|FG000|Overall Study|Physician Decision|51|||
129695821|NCT02205359|466843995|FG001|Overall Study|Physician Decision|53|||
129695822|NCT02205359|466843994|FG000|Overall Study|Withdrawal by Subject|167|||
129695823|NCT02205359|466843995|FG001|Overall Study|Withdrawal by Subject|169|||
129695824|NCT00236197|466843998|FG000|Overall Study|Withdrawal by Subject|3|||
129582752|NCT00112437|466427258|FG004|Years 6-10 (60-Month Extension)|Death|0|||
129582753|NCT00112437|466427259|FG005|Years 6-10 (60-Month Extension)|Death|0|||
129582754|NCT00112437|466427260|FG006|Years 6-10 (60-Month Extension)|Death|0|||
129582755|NCT00112437|466427261|FG007|Years 6-10 (60-Month Extension)|Death|0|||
129582756|NCT00112437|466427262|FG008|Years 6-10 (60-Month Extension)|Death|0|||
129695825|NCT00236197|466843999|FG001|Overall Study|Withdrawal by Subject|2|||
129582757|NCT00112437|466427263|FG009|Years 6-10 (60-Month Extension)|Death|0|||
129582758|NCT00112437|466427264|FG010|Years 6-10 (60-Month Extension)|Death|0|||
129582759|NCT00112437|466427265|FG011|Years 6-10 (60-Month Extension)|Death|0|||
129582760|NCT00112437|466427266|FG012|Years 6-10 (60-Month Extension)|Death|0|||
129582761|NCT00112437|466427267|FG013|Years 6-10 (60-Month Extension)|Death|0|||
129582762|NCT00112437|466427268|FG014|Years 6-10 (60-Month Extension)|Death|0|||
129582763|NCT00112437|466427269|FG015|Years 6-10 (60-Month Extension)|Death|0|||
129582764|NCT00112437|466427270|FG016|Years 6-10 (60-Month Extension)|Death|0|||
129582765|NCT00112437|466427271|FG017|Years 6-10 (60-Month Extension)|Death|0|||
129582766|NCT00112437|466427272|FG018|Years 6-10 (60-Month Extension)|Death|0|||
129582767|NCT00112437|466427273|FG019|Years 6-10 (60-Month Extension)|Death|0|||
129582768|NCT00112437|466427274|FG020|Years 6-10 (60-Month Extension)|Death|0|||
129582769|NCT00112437|466427275|FG021|Years 6-10 (60-Month Extension)|Death|0|||
129582770|NCT00112437|466427276|FG022|Years 6-10 (60-Month Extension)|Death|0|||
129582771|NCT00112437|466427277|FG023|Years 6-10 (60-Month Extension)|Death|2|||
129582772|NCT00112437|466427278|FG024|Years 6-10 (60-Month Extension)|Death|0|||
129582773|NCT00112437|466427279|FG025|Years 6-10 (60-Month Extension)|Death|0|||
129582774|NCT00112437|466427254|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582775|NCT00112437|466427255|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582776|NCT00112437|466427256|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582777|NCT00112437|466427257|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582778|NCT00112437|466427258|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582779|NCT00112437|466427259|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582780|NCT00112437|466427260|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582781|NCT00112437|466427261|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582782|NCT00112437|466427262|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582783|NCT00112437|466427263|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582784|NCT00112437|466427264|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582785|NCT00112437|466427265|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582786|NCT00112437|466427266|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582787|NCT00112437|466427267|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582788|NCT00112437|466427268|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582789|NCT00112437|466427269|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582790|NCT00112437|466427270|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582791|NCT00112437|466427271|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582792|NCT00112437|466427272|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582793|NCT00112437|466427273|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582794|NCT00112437|466427274|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582795|NCT00112437|466427275|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582796|NCT00112437|466427276|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582797|NCT00112437|466427277|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582798|NCT00112437|466427278|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
129582799|NCT00112437|466427279|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
129582800|NCT00112437|466427254|FG000|Years 6-10 (60-Month Extension)|Other|0|||
129582801|NCT00112437|466427255|FG001|Years 6-10 (60-Month Extension)|Other|0|||
129582802|NCT00112437|466427256|FG002|Years 6-10 (60-Month Extension)|Other|0|||
129582803|NCT00112437|466427257|FG003|Years 6-10 (60-Month Extension)|Other|0|||
129582804|NCT00112437|466427258|FG004|Years 6-10 (60-Month Extension)|Other|0|||
129582805|NCT00112437|466427259|FG005|Years 6-10 (60-Month Extension)|Other|0|||
129582806|NCT00112437|466427260|FG006|Years 6-10 (60-Month Extension)|Other|0|||
129582807|NCT00112437|466427261|FG007|Years 6-10 (60-Month Extension)|Other|0|||
129582808|NCT00112437|466427262|FG008|Years 6-10 (60-Month Extension)|Other|0|||
129582809|NCT00112437|466427263|FG009|Years 6-10 (60-Month Extension)|Other|0|||
129582810|NCT00112437|466427264|FG010|Years 6-10 (60-Month Extension)|Other|0|||
129582811|NCT00112437|466427265|FG011|Years 6-10 (60-Month Extension)|Other|0|||
129582812|NCT00112437|466427266|FG012|Years 6-10 (60-Month Extension)|Other|0|||
129582813|NCT00112437|466427267|FG013|Years 6-10 (60-Month Extension)|Other|0|||
129582814|NCT00112437|466427268|FG014|Years 6-10 (60-Month Extension)|Other|0|||
129582815|NCT00112437|466427269|FG015|Years 6-10 (60-Month Extension)|Other|0|||
129582816|NCT00112437|466427270|FG016|Years 6-10 (60-Month Extension)|Other|0|||
129582817|NCT00112437|466427271|FG017|Years 6-10 (60-Month Extension)|Other|0|||
129582818|NCT00112437|466427272|FG018|Years 6-10 (60-Month Extension)|Other|0|||
129884942|NCT00876460|467538733|FG000|Combination Therapy Phase|Adverse Event|0|||
129582819|NCT00112437|466427273|FG019|Years 6-10 (60-Month Extension)|Other|0|||
129582820|NCT00112437|466427274|FG020|Years 6-10 (60-Month Extension)|Other|0|||
129695826|NCT00236197|466843998|FG000|Overall Study|Lost to Follow-up|1|||
129582821|NCT00112437|466427275|FG021|Years 6-10 (60-Month Extension)|Other|0|||
129582822|NCT00112437|466427276|FG022|Years 6-10 (60-Month Extension)|Other|0|||
129582823|NCT00112437|466427277|FG023|Years 6-10 (60-Month Extension)|Other|0|||
129582824|NCT00112437|466427278|FG024|Years 6-10 (60-Month Extension)|Other|1|||
129582825|NCT00112437|466427279|FG025|Years 6-10 (60-Month Extension)|Other|0|||
129582826|NCT00112437|466427254|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582827|NCT00112437|466427255|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582828|NCT00112437|466427256|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582829|NCT00112437|466427257|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582830|NCT00112437|466427258|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582831|NCT00112437|466427259|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582832|NCT00112437|466427260|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582833|NCT00112437|466427261|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582834|NCT00112437|466427262|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582835|NCT00112437|466427263|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582836|NCT00112437|466427264|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582837|NCT00112437|466427265|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582838|NCT00112437|466427266|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582839|NCT00112437|466427267|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582840|NCT00112437|466427268|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582841|NCT00112437|466427269|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582842|NCT00112437|466427270|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582843|NCT00112437|466427271|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582844|NCT00112437|466427272|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582845|NCT00112437|466427273|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582846|NCT00112437|466427274|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582847|NCT00112437|466427275|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582848|NCT00112437|466427276|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582849|NCT00112437|466427277|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
129582850|NCT00112437|466427278|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582851|NCT00112437|466427279|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
129582852|NCT00112437|466427254|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582853|NCT00112437|466427255|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582854|NCT00112437|466427256|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582855|NCT00112437|466427257|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582856|NCT00112437|466427258|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582857|NCT00112437|466427259|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582858|NCT00112437|466427260|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129695827|NCT00236197|466843999|FG001|Overall Study|Lost to Follow-up|5|||
129582859|NCT00112437|466427261|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582860|NCT00112437|466427262|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582861|NCT00112437|466427263|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582862|NCT00112437|466427264|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582863|NCT00112437|466427265|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582864|NCT00112437|466427266|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582865|NCT00112437|466427267|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582866|NCT00112437|466427268|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582867|NCT00112437|466427269|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582868|NCT00112437|466427270|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582869|NCT00112437|466427271|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582870|NCT00112437|466427272|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582871|NCT00112437|466427273|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582872|NCT00112437|466427274|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582873|NCT00112437|466427275|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582874|NCT00112437|466427276|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
129582875|NCT00112437|466427277|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
129582876|NCT00112437|466427278|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
129582877|NCT00112437|466427279|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
129582878|NCT03541252|466427280|FG000|Overall Study|Withdrawal by Subject|1|||
129582879|NCT00227370|466427281|FG000|Overall Study|Withdrawal by Subject|1|||
129582880|NCT00227370|466427282|FG001|Overall Study|Withdrawal by Subject|2|||
129582881|NCT00227370|466427281|FG000|Overall Study|Death|3|||
129582882|NCT00227370|466427282|FG001|Overall Study|Death|4|||
129582883|NCT00227370|466427281|FG000|Overall Study|Adverse Event|6|||
129582884|NCT00227370|466427282|FG001|Overall Study|Adverse Event|11|||
129582885|NCT00227370|466427281|FG000|Overall Study|Physician Decision|9|||
129582886|NCT00227370|466427282|FG001|Overall Study|Physician Decision|6|||
129582887|NCT00227370|466427281|FG000|Overall Study|Other reasons|2|||
129582888|NCT00227370|466427282|FG001|Overall Study|Other reasons|1|||
129582889|NCT03846193|466427283|FG000|Overall Study|Physician Decision|0|||
129582890|NCT03846193|466427284|FG001|Overall Study|Physician Decision|0|||
129582891|NCT03846193|466427285|FG002|Overall Study|Physician Decision|1|||
129582892|NCT03846193|466427286|FG003|Overall Study|Physician Decision|0|||
129582893|NCT03846193|466427287|FG004|Overall Study|Physician Decision|0|||
129582894|NCT03846193|466427283|FG000|Overall Study|Lost to Follow-up|0|||
129582895|NCT03846193|466427284|FG001|Overall Study|Lost to Follow-up|0|||
129582896|NCT03846193|466427285|FG002|Overall Study|Lost to Follow-up|0|||
129582897|NCT03846193|466427286|FG003|Overall Study|Lost to Follow-up|0|||
129582898|NCT03846193|466427287|FG004|Overall Study|Lost to Follow-up|1|||
129582899|NCT03846193|466427283|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129582900|NCT03846193|466427284|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129582901|NCT03846193|466427285|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129582902|NCT03846193|466427286|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
129582903|NCT03846193|466427287|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
129582904|NCT02588339|466427289|FG000|Overall Study|Withdrawal by Subject|1|||
129582905|NCT02588339|466427289|FG000|Overall Study|GVHD Progression prior to treatment|2|||
129582906|NCT00660660|466428716|FG000|Overall Study|Adverse Event|1|||
129582907|NCT00660660|466428717|FG001|Overall Study|Adverse Event|0|||
129582908|NCT00660660|466428716|FG000|Overall Study|Lost to Follow-up|0|||
129582909|NCT00660660|466428717|FG001|Overall Study|Lost to Follow-up|6|||
129582910|NCT00660660|466428716|FG000|Overall Study|Lack of Efficacy|0|||
129582911|NCT00660660|466428717|FG001|Overall Study|Lack of Efficacy|2|||
129582912|NCT00660660|466428716|FG000|Overall Study|Withdrawal by Subject|3|||
129582913|NCT00660660|466428717|FG001|Overall Study|Withdrawal by Subject|0|||
129582914|NCT00660660|466428716|FG000|Overall Study|Incorrect enrollment and other|0|||
129582915|NCT00660660|466428717|FG001|Overall Study|Incorrect enrollment and other|1|||
129582916|NCT00660660|466428716|FG000|Overall Study|New medication after randomization|1|||
129582917|NCT00660660|466428717|FG001|Overall Study|New medication after randomization|0|||
129582918|NCT01701063|466428726|FG000|Overall Study|Lost to Follow-up|0|||
129582919|NCT01701063|466428727|FG001|Overall Study|Lost to Follow-up|1|||
129582920|NCT01701063|466428728|FG002|Overall Study|Lost to Follow-up|0|||
129582921|NCT01701063|466428726|FG000|Overall Study|Withdrawal by Subject|0|||
129582922|NCT01701063|466428727|FG001|Overall Study|Withdrawal by Subject|0|||
129582923|NCT01701063|466428728|FG002|Overall Study|Withdrawal by Subject|1|||
129582924|NCT01701063|466428726|FG000|Overall Study|Other|0|||
129582925|NCT01701063|466428727|FG001|Overall Study|Other|0|||
129582926|NCT01701063|466428728|FG002|Overall Study|Other|1|||
129582927|NCT02043132|466428729|FG000|Overall Study|Lost to Follow-up|1|||
129582928|NCT02043132|466428730|FG001|Overall Study|Lost to Follow-up|1|||
129582929|NCT02043132|466428729|FG000|Overall Study|screen failures|4|||
129582930|NCT02043132|466428730|FG001|Overall Study|screen failures|8|||
129582931|NCT03827395|466428731|FG000|Overall Study|Lost to Follow-up|1|||
129582932|NCT03827395|466428732|FG001|Overall Study|Lost to Follow-up|0|||
129582933|NCT03827395|466428731|FG000|Overall Study|Protocol Violation|1|||
129582934|NCT03827395|466428732|FG001|Overall Study|Protocol Violation|0|||
129582935|NCT03827395|466428731|FG000|Overall Study|Became ineligible after enrollment|1|||
129582936|NCT03827395|466428732|FG001|Overall Study|Became ineligible after enrollment|2|||
129582937|NCT00294047|466428733|FG000|Month 48|Adverse Event|28|||
129582938|NCT00294047|466428734|FG001|Month 48|Adverse Event|13|||
129582939|NCT00294047|466428733|FG000|Month 48|Protocol Violation|4|||
129582940|NCT00294047|466428734|FG001|Month 48|Protocol Violation|4|||
129582941|NCT00294047|466428733|FG000|Month 48|Withdrawal by Subject|111|||
129582942|NCT00294047|466428734|FG001|Month 48|Withdrawal by Subject|115|||
129582943|NCT00294047|466428733|FG000|Month 48|Lost to Follow-up|272|||
129582944|NCT00294047|466428734|FG001|Month 48|Lost to Follow-up|287|||
129582945|NCT00294047|466428733|FG000|Month 48|Other|10|||
129582946|NCT00294047|466428734|FG001|Month 48|Other|14|||
129582947|NCT00294047|466428733|FG000|Month 84|Adverse Event|4|||
129582948|NCT00294047|466428734|FG001|Month 84|Adverse Event|2|||
129582949|NCT00294047|466428733|FG000|Month 84|Protocol Violation|1|||
129582950|NCT00294047|466428734|FG001|Month 84|Protocol Violation|1|||
129582951|NCT00294047|466428733|FG000|Month 84|Withdrawal by Subject|33|||
129582952|NCT00294047|466428734|FG001|Month 84|Withdrawal by Subject|31|||
129582953|NCT00294047|466428733|FG000|Month 84|Lost to Follow-up|187|||
129582954|NCT00294047|466428734|FG001|Month 84|Lost to Follow-up|190|||
129582955|NCT00294047|466428733|FG000|Month 84|Absent Cervix|2|||
129582956|NCT00294047|466428734|FG001|Month 84|Absent Cervix|0|||
129582957|NCT00294047|466428733|FG000|Month 84|Work related reasons|4|||
129582958|NCT00294047|466428734|FG001|Month 84|Work related reasons|2|||
129582959|NCT00294047|466428733|FG000|Month 84|Center closed, subject did not transfer|1|||
129582960|NCT00294047|466428734|FG001|Month 84|Center closed, subject did not transfer|0|||
129582961|NCT00294047|466428733|FG000|Month 84|Family problems|2|||
129582962|NCT00294047|466428734|FG001|Month 84|Family problems|2|||
129582963|NCT00294047|466428733|FG000|Month 84|Lack of time|3|||
129582964|NCT00294047|466428734|FG001|Month 84|Lack of time|1|||
129582965|NCT00294047|466428733|FG000|Month 84|Personal reason|2|||
129582966|NCT00294047|466428734|FG001|Month 84|Personal reason|4|||
129582967|NCT00294047|466428733|FG000|Month 84|Subject does not want male physician|1|||
129582968|NCT00294047|466428734|FG001|Month 84|Subject does not want male physician|0|||
129582969|NCT00294047|466428733|FG000|Month 84|Transport reimbursement delayed|0|||
129582970|NCT00294047|466428734|FG001|Month 84|Transport reimbursement delayed|1|||
129582971|NCT00294047|466428733|FG000|Month 84|Unable to reach study site|1|||
129582972|NCT00294047|466428734|FG001|Month 84|Unable to reach study site|0|||
129582973|NCT00294047|466428733|FG000|Month 84|Under investigation locally|1|||
129582974|NCT00294047|466428734|FG001|Month 84|Under investigation locally|0|||
129582975|NCT00294047|466428733|FG000|Month 84|Visit missed|0|||
129582976|NCT00294047|466428734|FG001|Month 84|Visit missed|1|||
129582977|NCT00294047|466428733|FG000|Month 84|No consent for Month 84 Follow-up|731|||
129582978|NCT00294047|466428734|FG001|Month 84|No consent for Month 84 Follow-up|754|||
129582979|NCT02157974|466428735|FG000|Overall Study|Withdrawal by Subject|0|||
129582980|NCT02157974|466428736|FG001|Overall Study|Withdrawal by Subject|1|||
129582981|NCT02157974|466428737|FG002|Overall Study|Withdrawal by Subject|0|||
129582982|NCT02157974|466428738|FG003|Overall Study|Withdrawal by Subject|0|||
129582983|NCT02157974|466428739|FG004|Overall Study|Withdrawal by Subject|0|||
129582984|NCT02157974|466428735|FG000|Overall Study|Screen Failure|0|||
129582985|NCT02157974|466428736|FG001|Overall Study|Screen Failure|1|||
129582986|NCT02157974|466428737|FG002|Overall Study|Screen Failure|0|||
129582987|NCT02157974|466428738|FG003|Overall Study|Screen Failure|0|||
129582988|NCT02157974|466428739|FG004|Overall Study|Screen Failure|0|||
129582989|NCT02157974|466428735|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129582990|NCT02157974|466428736|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
129582991|NCT02157974|466428737|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129582992|NCT02157974|466428738|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129582993|NCT02157974|466428739|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
129582994|NCT01484912|466428742|FG000|Overall Study|Withdrawal by Subject|1|||
129695828|NCT00236197|466843998|FG000|Overall Study|Protocol Violation|0|||
129582995|NCT01484912|466428743|FG001|Overall Study|Withdrawal by Subject|0|||
129582996|NCT01484912|466428742|FG000|Overall Study|Physician Decision|0|||
129582997|NCT01484912|466428743|FG001|Overall Study|Physician Decision|1|||
129582998|NCT03158727|466428744|FG000|Overall Study|Withdrawal by Subject|2|||
129695829|NCT00236197|466843999|FG001|Overall Study|Protocol Violation|3|||
129582999|NCT03158727|466428745|FG001|Overall Study|Withdrawal by Subject|6|||
129583000|NCT03158727|466428744|FG000|Overall Study|Death|11|||
129583001|NCT03158727|466428745|FG001|Overall Study|Death|12|||
129583002|NCT03158727|466428744|FG000|Overall Study|Lost to Follow-up|1|||
129583003|NCT03158727|466428745|FG001|Overall Study|Lost to Follow-up|0|||
129583004|NCT03158727|466428744|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
129583005|NCT03158727|466428745|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
129583006|NCT03158727|466428744|FG000|Overall Study|Visit 11 not done by mistake|0|||
129583007|NCT03158727|466428745|FG001|Overall Study|Visit 11 not done by mistake|1|||
129583008|NCT03158727|466428744|FG000|Overall Study|Enrolled, not treated|1|||
129583009|NCT03158727|466428745|FG001|Overall Study|Enrolled, not treated|0|||
129583010|NCT00985439|466428746|FG000|Overall Study|Adverse Event|0|||
129583011|NCT00985439|466428747|FG001|Overall Study|Adverse Event|0|||
129583012|NCT00985439|466428748|FG002|Overall Study|Adverse Event|1|||
129583013|NCT00985439|466428749|FG003|Overall Study|Adverse Event|0|||
129583014|NCT00924638|466428756|FG000|Overall Study|Death|3|||
129583015|NCT00924638|466428757|FG001|Overall Study|Death|2|||
129583016|NCT00924638|466428756|FG000|Overall Study|Lost to Follow-up|1|||
129583017|NCT00924638|466428757|FG001|Overall Study|Lost to Follow-up|1|||
129583018|NCT00924638|466428756|FG000|Overall Study|Withdrawal by Subject|5|||
129583019|NCT00924638|466428757|FG001|Overall Study|Withdrawal by Subject|7|||
129583020|NCT00924638|466428756|FG000|Overall Study|Physician Decision|3|||
129583021|NCT00924638|466428757|FG001|Overall Study|Physician Decision|3|||
129583022|NCT00847535|466428758|FG000|Overall Study|Withdrawal by Subject|2|||
129583023|NCT00847535|466428759|FG001|Overall Study|Withdrawal by Subject|1|||
129583024|NCT00847535|466428760|FG002|Overall Study|Withdrawal by Subject|1|||
129583025|NCT00847535|466428758|FG000|Overall Study|Lost to Follow-up|0|||
129583026|NCT00847535|466428759|FG001|Overall Study|Lost to Follow-up|1|||
129583027|NCT00847535|466428760|FG002|Overall Study|Lost to Follow-up|0|||
129583028|NCT01252953|466428761|FG000|Overall Study|Withdrawal by Subject|16|||
129583029|NCT01252953|466428762|FG001|Overall Study|Withdrawal by Subject|17|||
129583030|NCT01252953|466428761|FG000|Overall Study|Lost to Follow-up|22|||
129583031|NCT01252953|466428762|FG001|Overall Study|Lost to Follow-up|21|||
129583032|NCT00958724|466428766|FG000|Overall Study|Disease Progression|6|||
129583033|NCT05604014|466428784|FG000|Overall Study|Lost to Follow-up|13|||
129583034|NCT02121184|466428785|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
129583035|NCT02121184|466428786|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
129583036|NCT02121184|466428785|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
129583037|NCT02121184|466428786|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
129583038|NCT02121184|466428785|FG000|Overall Study|Emergency cesarean section required|0|||
129583039|NCT02121184|466428786|FG001|Overall Study|Emergency cesarean section required|2|||
129583040|NCT02121184|466428785|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
129583041|NCT02121184|466428786|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
129583042|NCT00840203|466428787|FG000|First Intervention|Protocol Violation|1|||
129583043|NCT00840203|466428788|FG001|First Intervention|Protocol Violation|1|||
129583044|NCT00840203|466428787|FG000|Washout|Protocol Violation|1|||
129583045|NCT00840203|466428788|FG001|Washout|Protocol Violation|0|||
129583046|NCT04411680|466428791|FG000|Treatment Period|Adverse Event|3|||
129583047|NCT04411680|466428792|FG001|Treatment Period|Adverse Event|0|||
129583048|NCT04411680|466428791|FG000|Treatment Period|Discharged from hospital|18|||
129583049|NCT04411680|466428792|FG001|Treatment Period|Discharged from hospital|7|||
129786282|NCT01328444|467185629|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
129786283|NCT01328444|467185630|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
129786284|NCT01328444|467185631|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
129786285|NCT01328444|467185632|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
129786286|NCT01328444|467185633|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
129583050|NCT04411680|466428791|FG000|Treatment Period|Missed 1 or more doses|8|||
129583051|NCT04411680|466428792|FG001|Treatment Period|Missed 1 or more doses|0|||
129583052|NCT04411680|466428791|FG000|Treatment Period|Transferred to another hospital|0|||
129583053|NCT04411680|466428792|FG001|Treatment Period|Transferred to another hospital|1|||
129583054|NCT04411680|466428791|FG000|Follow up Period|Withdrawal by Subject|2|||
129786287|NCT01328444|467185634|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
129786288|NCT01328444|467185629|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
129786289|NCT01328444|467185630|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
129786290|NCT01328444|467185631|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
129884943|NCT00876460|467538734|FG001|Combination Therapy Phase|Adverse Event|2|||
129786291|NCT01328444|467185632|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
129884944|NCT00876460|467538735|FG002|Combination Therapy Phase|Adverse Event|0|||
129884945|NCT00876460|467538736|FG003|Combination Therapy Phase|Adverse Event|2|||
129884946|NCT00876460|467538737|FG004|Combination Therapy Phase|Adverse Event|2|||
129583055|NCT04411680|466428792|FG001|Follow up Period|Withdrawal by Subject|0|||
129583056|NCT04411680|466428791|FG000|Follow up Period|Lost to Follow-up|5|||
129583057|NCT04411680|466428792|FG001|Follow up Period|Lost to Follow-up|6|||
129583058|NCT04411680|466428791|FG000|Follow up Period|Death|11|||
129583059|NCT04411680|466428792|FG001|Follow up Period|Death|8|||
129583060|NCT00748566|466428793|FG000|Overall Study|Adverse Event|49|||
129583061|NCT00748566|466428793|FG000|Overall Study|Death|1|||
129583062|NCT00748566|466428793|FG000|Overall Study|Lack of Efficacy|12|||
129583063|NCT00748566|466428793|FG000|Overall Study|Lost to Follow-up|1|||
129583064|NCT00748566|466428793|FG000|Overall Study|Protocol Violation|13|||
129583065|NCT00748566|466428793|FG000|Overall Study|Withdrawal by Subject|22|||
129583066|NCT00748566|466428793|FG000|Overall Study|Study terminated by sponsor|5|||
129583067|NCT00748566|466428793|FG000|Overall Study|Other|9|||
129583068|NCT04025021|466428797|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
129583069|NCT04025021|466428798|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
129583070|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
129583071|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
129583072|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
129583073|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
129583074|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
129583075|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
129583076|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
129583077|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
129583078|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
129583079|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
129583080|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
129583081|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
129583082|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
129583083|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
129583084|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
129583085|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
129583086|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
129583087|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
129583088|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
129583089|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
129583090|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
129583091|NCT02227238|466428799|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
129583092|NCT02227238|466428800|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
129583093|NCT02227238|466428801|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
129583094|NCT02227238|466428799|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
129583095|NCT02227238|466428800|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
129583096|NCT02227238|466428801|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
129583097|NCT02227238|466428799|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
129583098|NCT02227238|466428800|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
129583099|NCT02227238|466428801|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
129583100|NCT02227238|466428799|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
129583101|NCT02227238|466428800|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
129583102|NCT02227238|466428801|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
129583103|NCT02227238|466428799|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
129583104|NCT02227238|466428800|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
129583105|NCT02227238|466428801|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
129583106|NCT02227238|466428799|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
129583107|NCT02227238|466428800|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
129583108|NCT02227238|466428801|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
129583109|NCT02227238|466428799|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
129583110|NCT02227238|466428800|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
129583111|NCT02227238|466428801|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
129800247|NCT05597020|467236279|FG001|Washout|Forbidden medication|0|||
129583112|NCT03966911|466428803|FG000|Overall Study|Adverse Event|1|||
129583113|NCT03966911|466428804|FG001|Overall Study|Adverse Event|1|||
129583114|NCT03966911|466428803|FG000|Overall Study|Withdrawal by Subject|8|||
129583115|NCT03966911|466428804|FG001|Overall Study|Withdrawal by Subject|2|||
129583116|NCT03966911|466428803|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
129583117|NCT03966911|466428804|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
129583118|NCT03498560|466428805|FG000|Overall Study|Found Ineligible|2|||
129583119|NCT03498560|466428805|FG000|Overall Study|Withdrawal by Subject|14|||
129583120|NCT03498560|466428805|FG000|Overall Study|Lost to Follow-up|4|||
129583121|NCT03498560|466428805|FG000|Overall Study|Death|1|||
129583122|NCT01507662|466428806|FG000|Overall Study|Death|26|||
129583123|NCT01507662|466428807|FG001|Overall Study|Death|18|||
129583124|NCT01507662|466428806|FG000|Overall Study|Withdrawal by Subject|290|||
129583125|NCT01507662|466428807|FG001|Overall Study|Withdrawal by Subject|287|||
129583126|NCT01507662|466428806|FG000|Overall Study|Lost to Follow-up|498|||
129583127|NCT01507662|466428807|FG001|Overall Study|Lost to Follow-up|523|||
129583128|NCT01507662|466428806|FG000|Overall Study|Proxy interview done|2|||
129583129|NCT01507662|466428807|FG001|Overall Study|Proxy interview done|3|||
129583130|NCT01395017|466428812|FG000|Overall Study|Lost to Follow-up|1|||
129583131|NCT01395017|466428813|FG001|Overall Study|Lost to Follow-up|0|||
129583132|NCT01395017|466428812|FG000|Overall Study|Adverse Event|26|||
129583133|NCT01395017|466428813|FG001|Overall Study|Adverse Event|12|||
129583134|NCT01395017|466428812|FG000|Overall Study|Physician Decision|11|||
129583135|NCT01395017|466428813|FG001|Overall Study|Physician Decision|15|||
129583136|NCT01395017|466428812|FG000|Overall Study|Withdrawal by Subject|14|||
129583137|NCT01395017|466428813|FG001|Overall Study|Withdrawal by Subject|8|||
129583138|NCT01395017|466428812|FG000|Overall Study|Protocol deviation|1|||
129583139|NCT01395017|466428813|FG001|Overall Study|Protocol deviation|2|||
129583140|NCT01395017|466428812|FG000|Overall Study|Death|4|||
129583141|NCT01395017|466428813|FG001|Overall Study|Death|3|||
129583142|NCT01395017|466428812|FG000|Overall Study|Disease progression|42|||
129583143|NCT01395017|466428813|FG001|Overall Study|Disease progression|58|||
129583144|NCT01395017|466428812|FG000|Overall Study|Sponsor discontinued study|1|||
129583145|NCT01395017|466428813|FG001|Overall Study|Sponsor discontinued study|4|||
129583146|NCT01004510|466428814|FG000|Overall Study|Adverse Event|1|||
129583147|NCT01960296|466428817|FG000|Overall Study|Postponed surgery|1|||
129583148|NCT01960296|466428818|FG001|Overall Study|Postponed surgery|0|||
129583149|NCT01960296|466428817|FG000|Overall Study|Received different procedure|1|||
129583150|NCT01960296|466428818|FG001|Overall Study|Received different procedure|3|||
129583151|NCT02003391|466428819|FG000|Overall Study|Withdrawal by Subject|2|||
129583152|NCT02003391|466428820|FG001|Overall Study|Withdrawal by Subject|1|||
129583153|NCT02003391|466428819|FG000|Overall Study|Protocol Violation|0|||
129583154|NCT02003391|466428820|FG001|Overall Study|Protocol Violation|1|||
129583155|NCT02003391|466428819|FG000|Overall Study|Adverse Event|1|||
129583156|NCT02003391|466428820|FG001|Overall Study|Adverse Event|0|||
129583157|NCT02272803|466428821|FG000|Overall Study|Disease progression|16|||
129583158|NCT02272803|466428822|FG001|Overall Study|Disease progression|8|||
129583159|NCT02272803|466428821|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
129583160|NCT02272803|466428822|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
129583161|NCT02272803|466428821|FG000|Overall Study|Study drug toxicity|4|||
129583162|NCT02272803|466428822|FG001|Overall Study|Study drug toxicity|9|||
129583163|NCT02272803|466428821|FG000|Overall Study|Participant request to discontinue study treatment|3|||
129583164|NCT02272803|466428822|FG001|Overall Study|Participant request to discontinue study treatment|7|||
129583165|NCT02272803|466428821|FG000|Overall Study|Maximum clinical benefit|4|||
129583166|NCT02272803|466428822|FG001|Overall Study|Maximum clinical benefit|2|||
129583167|NCT02272803|466428821|FG000|Overall Study|Poor/non-compliance|2|||
129583168|NCT02272803|466428822|FG001|Overall Study|Poor/non-compliance|2|||
129583169|NCT02272803|466428821|FG000|Overall Study|Withdrawal by Subject|2|||
129583170|NCT02272803|466428822|FG001|Overall Study|Withdrawal by Subject|1|||
129583171|NCT02272803|466428821|FG000|Overall Study|Death|0|||
129583172|NCT02272803|466428822|FG001|Overall Study|Death|1|||
129583173|NCT02272803|466428821|FG000|Overall Study|Other reasons|1|||
129583174|NCT02272803|466428822|FG001|Overall Study|Other reasons|3|||
129583175|NCT02272803|466428821|FG000|Overall Study|Administrative reason by sponsor|5|||
129583176|NCT02272803|466428822|FG001|Overall Study|Administrative reason by sponsor|4|||
129583177|NCT01566435|466428826|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
129583178|NCT03684928|466428827|FG000|First Intervention|Lost to Follow-up|0|||
129583179|NCT03684928|466428828|FG001|First Intervention|Lost to Follow-up|1|||
129583180|NCT03684928|466428827|FG000|First Intervention|Withdrawal by Subject|0|||
129583181|NCT03684928|466428828|FG001|First Intervention|Withdrawal by Subject|2|||
129583182|NCT03684928|466428827|FG000|Second Intervention|Soft Tissue Injury|1|||
129583183|NCT03684928|466428828|FG001|Second Intervention|Soft Tissue Injury|0|||
129583184|NCT03733145|466428832|FG000|Overall Study|screenfail|3|||
129583185|NCT03733145|466428833|FG001|Overall Study|screenfail|3|||
129583186|NCT03733145|466428834|FG002|Overall Study|screenfail|2|||
129583187|NCT02302716|466429792|FG000|Overall Study|Adverse Event|1|||
129583188|NCT02302716|466429793|FG001|Overall Study|Adverse Event|1|||
129583189|NCT02302716|466429792|FG000|Overall Study|Death|0|||
129583190|NCT02302716|466429793|FG001|Overall Study|Death|1|||
129695830|NCT00236197|466843998|FG000|Overall Study|Medication non-compliance|1|||
129695831|NCT00236197|466843999|FG001|Overall Study|Medication non-compliance|2|||
129695832|NCT00236197|466843998|FG000|Overall Study|Other|0|||
129695833|NCT00236197|466843999|FG001|Overall Study|Other|2|||
129695834|NCT02792257|466844004|FG000|Overall Study|Lost to Follow-up|3|||
129695835|NCT02792257|466844005|FG001|Overall Study|Lost to Follow-up|4|||
129695836|NCT02792257|466844004|FG000|Overall Study|Allergy|0|||
129695837|NCT02792257|466844005|FG001|Overall Study|Allergy|1|||
129583191|NCT02302716|466429792|FG000|Overall Study|Lack of Efficacy|0|||
129583192|NCT02302716|466429793|FG001|Overall Study|Lack of Efficacy|1|||
129583193|NCT02302716|466429792|FG000|Overall Study|Lost to Follow-up|2|||
129583194|NCT02302716|466429793|FG001|Overall Study|Lost to Follow-up|4|||
129583195|NCT02302716|466429792|FG000|Overall Study|Physician Decision|3|||
129583196|NCT02302716|466429793|FG001|Overall Study|Physician Decision|4|||
129583197|NCT02302716|466429792|FG000|Overall Study|Withdrawal by Subject|13|||
129583198|NCT02302716|466429793|FG001|Overall Study|Withdrawal by Subject|7|||
129583199|NCT02302716|466429792|FG000|Overall Study|Protocol Violation|0|||
129583200|NCT02302716|466429793|FG001|Overall Study|Protocol Violation|1|||
129583201|NCT00557245|466429797|FG000|Overall Study|Lost to Follow-up|7|||
129583202|NCT00557245|466429798|FG001|Overall Study|Lost to Follow-up|8|||
129583203|NCT00557245|466429799|FG002|Overall Study|Lost to Follow-up|10|||
129583204|NCT00557245|466429797|FG000|Overall Study|Ineligible|5|||
129583205|NCT00557245|466429798|FG001|Overall Study|Ineligible|4|||
129583206|NCT00557245|466429799|FG002|Overall Study|Ineligible|2|||
129583207|NCT00798603|466429802|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
129583208|NCT00798603|466429802|FG000|Overall Study|Withdrawal by Subject|10|||
129583209|NCT00798603|466429802|FG000|Overall Study|Adverse Event|22|||
129583210|NCT00798603|466429802|FG000|Overall Study|Physician Decision|1|||
129583211|NCT00798603|466429802|FG000|Overall Study|Lack of insurance coverage|1|||
129583212|NCT02316223|466429805|FG000|Overall Study|Lack of Efficacy|0|||
129583213|NCT02316223|466429806|FG001|Overall Study|Lack of Efficacy|1|||
129583214|NCT02316223|466429807|FG002|Overall Study|Lack of Efficacy|1|||
129583215|NCT02316223|466429805|FG000|Overall Study|Lost to Follow-up|27|||
129583216|NCT02316223|466429806|FG001|Overall Study|Lost to Follow-up|34|||
129583217|NCT02316223|466429807|FG002|Overall Study|Lost to Follow-up|36|||
129583218|NCT02316223|466429805|FG000|Overall Study|COPD Diagnosis|3|||
129583219|NCT02316223|466429806|FG001|Overall Study|COPD Diagnosis|2|||
129583220|NCT02316223|466429807|FG002|Overall Study|COPD Diagnosis|3|||
129583221|NCT02316223|466429805|FG000|Overall Study|Reside outside study area|1|||
129583222|NCT02316223|466429806|FG001|Overall Study|Reside outside study area|1|||
129583223|NCT02316223|466429807|FG002|Overall Study|Reside outside study area|1|||
129583224|NCT02316223|466429805|FG000|Overall Study|No asthma|2|||
129583225|NCT02316223|466429806|FG001|Overall Study|No asthma|0|||
129583226|NCT02316223|466429807|FG002|Overall Study|No asthma|0|||
129583227|NCT02316223|466429805|FG000|Overall Study|Discontinued by PI|11|||
129583228|NCT02316223|466429806|FG001|Overall Study|Discontinued by PI|19|||
129583229|NCT02316223|466429807|FG002|Overall Study|Discontinued by PI|3|||
129583230|NCT00529763|466429809|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
129583231|NCT00529763|466429810|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
129583232|NCT00529763|466429811|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129583233|NCT00529763|466429809|FG000|Overall Study|Death|1|||
129583234|NCT00529763|466429810|FG001|Overall Study|Death|1|||
129583235|NCT00529763|466429811|FG002|Overall Study|Death|1|||
129583236|NCT00529763|466429809|FG000|Overall Study|Disease Progression|10|||
129583237|NCT00529763|466429810|FG001|Overall Study|Disease Progression|16|||
129583238|NCT00529763|466429811|FG002|Overall Study|Disease Progression|11|||
129583239|NCT00529763|466429809|FG000|Overall Study|Lost to Follow-up|1|||
129583240|NCT00529763|466429810|FG001|Overall Study|Lost to Follow-up|2|||
129583241|NCT00529763|466429811|FG002|Overall Study|Lost to Follow-up|3|||
129583242|NCT00529763|466429809|FG000|Overall Study|Stem Cell Transplant|0|||
129583243|NCT00529763|466429810|FG001|Overall Study|Stem Cell Transplant|3|||
129583244|NCT00529763|466429811|FG002|Overall Study|Stem Cell Transplant|1|||
129583245|NCT00529763|466429809|FG000|Overall Study|Study Drug Toxicity|3|||
129583246|NCT00529763|466429810|FG001|Overall Study|Study Drug Toxicity|6|||
129583247|NCT00529763|466429811|FG002|Overall Study|Study Drug Toxicity|4|||
129583248|NCT00529763|466429809|FG000|Overall Study|Participant Withdrew Consent|2|||
129583249|NCT00529763|466429810|FG001|Overall Study|Participant Withdrew Consent|3|||
129583250|NCT00529763|466429811|FG002|Overall Study|Participant Withdrew Consent|4|||
129583251|NCT00529763|466429809|FG000|Overall Study|Other reasons|2|||
129583252|NCT00529763|466429810|FG001|Overall Study|Other reasons|0|||
129583253|NCT00529763|466429811|FG002|Overall Study|Other reasons|2|||
129583254|NCT00529763|466429809|FG000|Overall Study|Participant request to discontinue treatment|1|||
129583255|NCT00529763|466429810|FG001|Overall Study|Participant request to discontinue treatment|1|||
129583256|NCT00529763|466429811|FG002|Overall Study|Participant request to discontinue treatment|3|||
129583257|NCT03669250|466429812|FG000|Overall Study|Adverse Event|0|||
129583258|NCT03669250|466429813|FG001|Overall Study|Adverse Event|0|||
129583259|NCT03669250|466429814|FG002|Overall Study|Adverse Event|0|||
129583260|NCT03669250|466429815|FG003|Overall Study|Adverse Event|0|||
129583261|NCT03669250|466429816|FG004|Overall Study|Adverse Event|1|||
129583262|NCT03669250|466429817|FG005|Overall Study|Adverse Event|0|||
129583263|NCT03669250|466429812|FG000|Overall Study|Withdrawal by Subject|0|||
129583264|NCT03669250|466429813|FG001|Overall Study|Withdrawal by Subject|1|||
129583265|NCT03669250|466429814|FG002|Overall Study|Withdrawal by Subject|0|||
129695838|NCT02792257|466844004|FG000|Overall Study|Protocol Violation|2|||
129695839|NCT02792257|466844005|FG001|Overall Study|Protocol Violation|0|||
129695840|NCT02792257|466844004|FG000|Overall Study|Excessive Agitation|0|||
129695841|NCT02792257|466844005|FG001|Overall Study|Excessive Agitation|1|||
129695842|NCT02792257|466844004|FG000|Overall Study|Not Feeling Well|0|||
129695843|NCT02792257|466844005|FG001|Overall Study|Not Feeling Well|1|||
129695844|NCT00553475|466844006|FG000|Overall Study|Adverse Event|7|||
129695845|NCT00553475|466844007|FG001|Overall Study|Adverse Event|17|||
129695846|NCT00553475|466844008|FG002|Overall Study|Adverse Event|13|||
129695847|NCT00553475|466844006|FG000|Overall Study|Lack of Efficacy|7|||
129695848|NCT00553475|466844007|FG001|Overall Study|Lack of Efficacy|1|||
129695849|NCT00553475|466844008|FG002|Overall Study|Lack of Efficacy|0|||
129695850|NCT00553475|466844006|FG000|Overall Study|Withdrawal by Subject|1|||
129695851|NCT00553475|466844007|FG001|Overall Study|Withdrawal by Subject|1|||
129695852|NCT00553475|466844008|FG002|Overall Study|Withdrawal by Subject|0|||
129695853|NCT00553475|466844006|FG000|Overall Study|Physician Decision|1|||
129695854|NCT00553475|466844007|FG001|Overall Study|Physician Decision|0|||
129695855|NCT00553475|466844008|FG002|Overall Study|Physician Decision|0|||
129695856|NCT00553475|466844006|FG000|Overall Study|Due to moving|0|||
129695857|NCT00553475|466844007|FG001|Overall Study|Due to moving|1|||
129695858|NCT00553475|466844008|FG002|Overall Study|Due to moving|0|||
129695859|NCT01905683|466844011|FG000|Overall Study|Protocol Violation|1|||
129695860|NCT01905683|466844011|FG000|Overall Study|Re-injection criteria not met; others|13|||
129695861|NCT01905683|466844011|FG000|Overall Study|Physician Decision|1|||
129695862|NCT01905683|466844011|FG000|Overall Study|Lack of Efficacy|8|||
129695863|NCT01905683|466844011|FG000|Overall Study|Withdrawal by Subject|20|||
129695864|NCT01905683|466844011|FG000|Overall Study|Adverse Event|4|||
129695865|NCT01905683|466844011|FG000|Overall Study|Lost to Follow-up|4|||
129695866|NCT02568254|466844013|FG000|Period 2|Adverse Event|0|||
129695867|NCT02568254|466844014|FG001|Period 2|Adverse Event|0|||
129695868|NCT02568254|466844015|FG002|Period 2|Adverse Event|1|||
129695869|NCT02568254|466844016|FG003|Period 2|Adverse Event|0|||
129695870|NCT02568254|466844017|FG004|Period 2|Adverse Event|0|||
129695871|NCT02568254|466844018|FG005|Period 2|Adverse Event|0|||
129695872|NCT02568254|466844013|FG000|Period 3|Unstatisfactory Lens fitting|0|||
129695873|NCT02568254|466844014|FG001|Period 3|Unstatisfactory Lens fitting|0|||
129695874|NCT02568254|466844015|FG002|Period 3|Unstatisfactory Lens fitting|0|||
129695875|NCT02568254|466844016|FG003|Period 3|Unstatisfactory Lens fitting|0|||
129695876|NCT02568254|466844017|FG004|Period 3|Unstatisfactory Lens fitting|1|||
129695877|NCT02568254|466844018|FG005|Period 3|Unstatisfactory Lens fitting|0|||
129695878|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
129695879|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
129695880|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
129695881|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Adverse Event|5|||
129583266|NCT03669250|466429815|FG003|Overall Study|Withdrawal by Subject|1|||
129695882|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Adverse Event|1|||
129695883|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Adverse Event|0|||
129695884|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
129583267|NCT03669250|466429816|FG004|Overall Study|Withdrawal by Subject|0|||
129583268|NCT03669250|466429817|FG005|Overall Study|Withdrawal by Subject|0|||
129583269|NCT00828321|466429818|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
129583270|NCT00828321|466429819|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
129583271|NCT00828321|466429818|FG000|Second Intervention|Protocol Violation|0|||
129583272|NCT00828321|466429819|FG001|Second Intervention|Protocol Violation|1|||
129583273|NCT02034513|466429820|FG000|Overall Study|Adverse Event|11|||
129583274|NCT02034513|466429821|FG001|Overall Study|Adverse Event|10|||
129583275|NCT02034513|466429820|FG000|Overall Study|Lack of Efficacy|0|||
129583276|NCT02034513|466429821|FG001|Overall Study|Lack of Efficacy|1|||
129583277|NCT02034513|466429820|FG000|Overall Study|Lost to Follow-up|6|||
129583278|NCT02034513|466429821|FG001|Overall Study|Lost to Follow-up|7|||
129583279|NCT02034513|466429820|FG000|Overall Study|Pregnancy|0|||
129583280|NCT02034513|466429821|FG001|Overall Study|Pregnancy|3|||
129583281|NCT02034513|466429820|FG000|Overall Study|Protocol Violation|7|||
129583282|NCT02034513|466429821|FG001|Overall Study|Protocol Violation|10|||
129583283|NCT02034513|466429820|FG000|Overall Study|Withdrawal by Subject|25|||
129583284|NCT02034513|466429821|FG001|Overall Study|Withdrawal by Subject|25|||
129583285|NCT02034513|466429820|FG000|Overall Study|Unclassified|0|||
129583286|NCT02034513|466429821|FG001|Overall Study|Unclassified|1|||
129583287|NCT03119662|466429824|FG000|Overall Study|Withdrawal by Subject|0|||
129583288|NCT03119662|466429825|FG001|Overall Study|Withdrawal by Subject|1|||
129583289|NCT04523480|466429826|FG000|Overall Study|Lost to Follow-up|30|||
129583290|NCT04523480|466429827|FG001|Overall Study|Lost to Follow-up|35|||
129583291|NCT04523480|466429828|FG002|Overall Study|Lost to Follow-up|0|||
129583292|NCT00081653|466429832|FG000|Overall Study|Adverse Event|23|||
129583293|NCT00081653|466429833|FG001|Overall Study|Adverse Event|17|||
129583294|NCT00081653|466429832|FG000|Overall Study|Lost to Follow-up|2|||
129583295|NCT00081653|466429833|FG001|Overall Study|Lost to Follow-up|4|||
129583296|NCT00081653|466429832|FG000|Overall Study|Refused Treatment|18|||
129583297|NCT00081653|466429833|FG001|Overall Study|Refused Treatment|14|||
129583298|NCT00081653|466429832|FG000|Overall Study|Low bone mineral density|1|||
129583299|NCT00081653|466429833|FG001|Overall Study|Low bone mineral density|0|||
129583300|NCT00081653|466429832|FG000|Overall Study|Bone loss|2|||
129583301|NCT00081653|466429833|FG001|Overall Study|Bone loss|0|||
129583302|NCT00081653|466429832|FG000|Overall Study|Participant leaving country|1|||
129583303|NCT00081653|466429833|FG001|Overall Study|Participant leaving country|0|||
129583304|NCT00081653|466429832|FG000|Overall Study|Loss of bone mass|0|||
129583305|NCT00081653|466429833|FG001|Overall Study|Loss of bone mass|2|||
129583306|NCT02694536|466429839|FG000|Overall Study|Progressive Disease|40|||
129583307|NCT02694536|466429839|FG000|Overall Study|Lost to Follow-up|1|||
129583308|NCT02694536|466429839|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
129583309|NCT02694536|466429839|FG000|Overall Study|Withdrawal by Subject|8|||
129583310|NCT02694536|466429839|FG000|Overall Study|Death|8|||
129583311|NCT02694536|466429839|FG000|Overall Study|Other|22|||
129583312|NCT01911429|466429842|FG000|Overall Study|Adverse Event|5|||
129583313|NCT01911429|466429843|FG001|Overall Study|Adverse Event|3|||
129583314|NCT01911429|466429844|FG002|Overall Study|Adverse Event|9|||
129583315|NCT01911429|466429842|FG000|Overall Study|Lack of Efficacy|1|||
129583316|NCT01911429|466429843|FG001|Overall Study|Lack of Efficacy|2|||
129583317|NCT01911429|466429844|FG002|Overall Study|Lack of Efficacy|4|||
129583318|NCT01911429|466429842|FG000|Overall Study|Lost to Follow-up|0|||
129695885|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
129583319|NCT01911429|466429843|FG001|Overall Study|Lost to Follow-up|0|||
129583320|NCT01911429|466429844|FG002|Overall Study|Lost to Follow-up|1|||
129583321|NCT01911429|466429842|FG000|Overall Study|Protocol Violation|0|||
129583322|NCT01911429|466429843|FG001|Overall Study|Protocol Violation|0|||
129583323|NCT01911429|466429844|FG002|Overall Study|Protocol Violation|1|||
129583324|NCT01911429|466429842|FG000|Overall Study|Withdrawal by Subject|5|||
129583325|NCT01911429|466429843|FG001|Overall Study|Withdrawal by Subject|5|||
129583326|NCT01911429|466429844|FG002|Overall Study|Withdrawal by Subject|4|||
129583327|NCT01911429|466429842|FG000|Overall Study|Accidental randomization|0|||
129583328|NCT01911429|466429843|FG001|Overall Study|Accidental randomization|0|||
129583329|NCT01911429|466429844|FG002|Overall Study|Accidental randomization|1|||
129583330|NCT01911429|466429842|FG000|Overall Study|subject left study|1|||
129583331|NCT01911429|466429843|FG001|Overall Study|subject left study|0|||
129583332|NCT01911429|466429844|FG002|Overall Study|subject left study|0|||
129583333|NCT01168856|466429858|FG000|Overall Study|Lost to Follow-up|4|||
129583334|NCT01168856|466429859|FG001|Overall Study|Lost to Follow-up|34|||
129583335|NCT01168856|466429858|FG000|Overall Study|Withdrawal by Subject|6|||
129583336|NCT01168856|466429859|FG001|Overall Study|Withdrawal by Subject|8|||
129583337|NCT01168856|466429858|FG000|Overall Study|Physician Decision|2|||
129583338|NCT01168856|466429859|FG001|Overall Study|Physician Decision|1|||
129583339|NCT01168856|466429858|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
129583340|NCT01168856|466429859|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
129583341|NCT01168856|466429858|FG000|Overall Study|Participant received anti-HCV treatment|1|||
129583342|NCT01168856|466429859|FG001|Overall Study|Participant received anti-HCV treatment|0|||
129583343|NCT01168856|466429858|FG000|Overall Study|Death|0|||
129583344|NCT01168856|466429859|FG001|Overall Study|Death|2|||
129583345|NCT01168856|466429858|FG000|Overall Study|Other|1|||
129583346|NCT01168856|466429859|FG001|Overall Study|Other|291|||
129583347|NCT01168856|466429858|FG000|Overall Study|Protocol Violation|4|||
129583348|NCT01168856|466429859|FG001|Overall Study|Protocol Violation|6|||
129583349|NCT04567329|466429864|FG000|Overall Study|Withdrawal by Subject|5|||
129583350|NCT04567329|466429865|FG001|Overall Study|Withdrawal by Subject|6|||
129583351|NCT04567329|466429864|FG000|Overall Study|Protocol Violation|2|||
129583352|NCT04567329|466429865|FG001|Overall Study|Protocol Violation|3|||
129583353|NCT04567329|466429864|FG000|Overall Study|Discontinued|2|||
129583354|NCT04567329|466429865|FG001|Overall Study|Discontinued|2|||
129583355|NCT04567329|466429864|FG000|Overall Study|Lost to Follow-up|0|||
129583356|NCT04567329|466429865|FG001|Overall Study|Lost to Follow-up|1|||
129583357|NCT04567329|466429864|FG000|Overall Study|Lack of Efficacy|0|||
129583358|NCT04567329|466429865|FG001|Overall Study|Lack of Efficacy|1|||
129583359|NCT00674128|466429867|FG000|Overall Study|Withdrawal by Subject|25|||
129583360|NCT00674128|466429868|FG001|Overall Study|Withdrawal by Subject|23|||
129583361|NCT00829452|466429872|FG000|First Intervention|Withdrawal by Subject|0|||
129583362|NCT00829452|466429873|FG001|First Intervention|Withdrawal by Subject|1|||
129583363|NCT00829452|466429872|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
129583364|NCT00829452|466429873|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
129583365|NCT00829452|466429872|FG000|Second Intervention|Physician Decision|0|||
129583366|NCT00829452|466429873|FG001|Second Intervention|Physician Decision|1|||
129583367|NCT01559363|466429889|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
129583368|NCT01559363|466429890|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
129583369|NCT01559363|466429891|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
129583370|NCT01559363|466429892|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
129583371|NCT01559363|466429893|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
129583372|NCT01559363|466429894|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
129583373|NCT01559363|466429889|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
129583374|NCT01559363|466429890|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
129583375|NCT01559363|466429891|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
129583376|NCT01559363|466429892|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
129583377|NCT01559363|466429893|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
129583378|NCT01559363|466429894|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
129583379|NCT01559363|466429889|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
129583380|NCT01559363|466429890|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
129583381|NCT01559363|466429891|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129583382|NCT01559363|466429892|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129583383|NCT01559363|466429893|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129583384|NCT01559363|466429894|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
129583385|NCT01559363|466429889|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
129583386|NCT01559363|466429890|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
129583387|NCT01559363|466429891|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
129583388|NCT01559363|466429892|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
129583389|NCT01559363|466429893|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
129583390|NCT01559363|466429894|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
129583391|NCT01559363|466429889|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129583392|NCT01559363|466429890|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
129583393|NCT01559363|466429891|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129583394|NCT01559363|466429892|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129695886|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
129583395|NCT01559363|466429893|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129583396|NCT01559363|466429894|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
129583397|NCT01559363|466429889|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129583398|NCT01559363|466429890|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129583399|NCT01559363|466429891|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129583400|NCT01559363|466429892|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
129583401|NCT01559363|466429893|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
129583402|NCT01559363|466429894|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
129583403|NCT01559363|466429889|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129583404|NCT01559363|466429890|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129583405|NCT01559363|466429891|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129583406|NCT01559363|466429892|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
129583407|NCT01559363|466429893|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129583408|NCT01559363|466429894|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
129583409|NCT02705716|466429895|FG000|Overall Study|Adverse Event|0|||
129583410|NCT02705716|466429896|FG001|Overall Study|Adverse Event|1|||
129583411|NCT02705716|466429895|FG000|Overall Study|Protocol Violation|3|||
129583412|NCT02705716|466429896|FG001|Overall Study|Protocol Violation|0|||
129583413|NCT02705716|466429895|FG000|Overall Study|Withdrawal of Consent|1|||
129583414|NCT02705716|466429896|FG001|Overall Study|Withdrawal of Consent|1|||
129583415|NCT00562718|466429897|FG000|Overall Study|Death|1|||
129583416|NCT00562718|466429897|FG000|Overall Study|Withdrawal by Subject|3|||
129583417|NCT00562718|466429897|FG000|Overall Study|Adverse Event|4|||
129583418|NCT00562718|466429897|FG000|Overall Study|Lack of Efficacy|2|||
129583419|NCT00562718|466429897|FG000|Overall Study|not stated|1|||
129583420|NCT01868243|466429898|FG000|Overall Study|Death|0|||
129583421|NCT01868243|466429899|FG001|Overall Study|Death|1|||
129583422|NCT00999687|466429903|FG000|First Intervention|Withdrawal by Subject|1|||
129583423|NCT00999687|466429903|FG000|Second Intervention|Withdrawal by Subject|2|||
129583424|NCT00999687|466429903|FG000|Second Intervention|Lack of Efficacy|1|||
129583425|NCT00474188|466429904|FG000|Overall Study|Withdrawal by Subject|1|||
129583426|NCT00474188|466429904|FG000|Overall Study|Study discontinued by sponsor|5|||
129583427|NCT03961204|466429907|FG000|Overall Study|Withdrawal by Subject|2|||
129583428|NCT03961204|466429907|FG000|Overall Study|Lost to Follow-up|3|||
129583429|NCT03961204|466429907|FG000|Overall Study|Other|1|||
129583430|NCT03961204|466429907|FG000|Overall Study|Missing|1|||
129583431|NCT01968031|466429913|FG000|Overall Study|Adverse Event|13|||
129583432|NCT01968031|466429914|FG001|Overall Study|Adverse Event|10|||
129583433|NCT01968031|466429915|FG002|Overall Study|Adverse Event|22|||
129583434|NCT01968031|466429913|FG000|Overall Study|Withdrawal by Subject|3|||
129583435|NCT01968031|466429914|FG001|Overall Study|Withdrawal by Subject|7|||
129583436|NCT01968031|466429915|FG002|Overall Study|Withdrawal by Subject|3|||
129583437|NCT01968031|466429913|FG000|Overall Study|Did not meet entry criteria|1|||
129583438|NCT01968031|466429914|FG001|Overall Study|Did not meet entry criteria|1|||
129583439|NCT01968031|466429915|FG002|Overall Study|Did not meet entry criteria|1|||
129583440|NCT01968031|466429913|FG000|Overall Study|Noncompliance|0|||
129583441|NCT01968031|466429914|FG001|Overall Study|Noncompliance|0|||
129583442|NCT01968031|466429915|FG002|Overall Study|Noncompliance|2|||
129583443|NCT01968031|466429913|FG000|Overall Study|Failed inclusion criteria|0|||
129583444|NCT01968031|466429914|FG001|Overall Study|Failed inclusion criteria|2|||
129583445|NCT01968031|466429915|FG002|Overall Study|Failed inclusion criteria|0|||
129583446|NCT01968031|466429913|FG000|Overall Study|Death|0|||
129583447|NCT01968031|466429914|FG001|Overall Study|Death|0|||
129583448|NCT01968031|466429915|FG002|Overall Study|Death|1|||
129583449|NCT01968031|466429913|FG000|Overall Study|Prohibited concomitant medication|1|||
129583450|NCT01968031|466429914|FG001|Overall Study|Prohibited concomitant medication|0|||
129583451|NCT01968031|466429915|FG002|Overall Study|Prohibited concomitant medication|0|||
129583452|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Subject request|8|||
129583453|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Subject request|11|||
129583454|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
129583455|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
129583456|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
129583457|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
129583458|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
129583459|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
129583460|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
129583461|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
129583462|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
129583463|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
129583464|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Death|1|||
129583465|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Death|0|||
129583466|NCT00521586|466431706|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
129583467|NCT00521586|466431707|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
129583468|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
129583469|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
129583470|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
129583471|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
129583472|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
129583473|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
129583474|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
129583475|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
129583476|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
129583477|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
129583478|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
129583479|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
129695887|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Death|8|||
129695888|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Death|24|||
129695889|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Death|0|||
129695890|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
129583480|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
129583481|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
129583482|NCT00521586|466431706|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
129583483|NCT00521586|466431707|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
129583484|NCT00521586|466431706|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
129583485|NCT00521586|466431707|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
129583486|NCT00521586|466431706|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
129583487|NCT00521586|466431707|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
129583488|NCT00521586|466431706|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
129583489|NCT00521586|466431707|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
129583490|NCT03234907|466431708|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
129583491|NCT03234907|466431709|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
129583492|NCT03234907|466431710|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129583493|NCT03234907|466431711|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129583494|NCT03234907|466431712|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129583495|NCT03234907|466431713|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
129583496|NCT03234907|466431708|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
129583497|NCT03234907|466431709|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
129583498|NCT03234907|466431710|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129583499|NCT03234907|466431711|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129583500|NCT03234907|466431712|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129583501|NCT03234907|466431713|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
129583502|NCT03234907|466431708|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
129583503|NCT03234907|466431709|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129583504|NCT03234907|466431710|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129583505|NCT03234907|466431711|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129583506|NCT03234907|466431712|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129583507|NCT03234907|466431713|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
129583508|NCT03234907|466431708|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
129583509|NCT03234907|466431709|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
129583510|NCT03234907|466431710|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129583511|NCT03234907|466431711|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129583512|NCT03234907|466431712|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129583513|NCT03234907|466431713|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
129583514|NCT03234907|466431708|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
129583515|NCT03234907|466431709|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
129583516|NCT03234907|466431710|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
129583517|NCT03234907|466431711|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
129583518|NCT03234907|466431712|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
129583519|NCT03234907|466431713|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
129583520|NCT03234907|466431708|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
129583521|NCT03234907|466431709|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
129583522|NCT03234907|466431710|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
129583523|NCT03234907|466431711|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
129583524|NCT03234907|466431712|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
129583525|NCT03234907|466431713|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
129583526|NCT03234907|466431708|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
129583527|NCT03234907|466431709|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
129583528|NCT03234907|466431710|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
129583529|NCT03234907|466431711|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
129583530|NCT03234907|466431712|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
129583531|NCT03234907|466431713|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
129583532|NCT00642993|466431714|FG000|Overall Study|Adverse Event|85|||
129583533|NCT00642993|466431715|FG001|Overall Study|Adverse Event|4|||
129583534|NCT00642993|466431714|FG000|Overall Study|Lost to Follow-up|8|||
129583535|NCT00642993|466431715|FG001|Overall Study|Lost to Follow-up|4|||
129583536|NCT00642993|466431714|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
129583537|NCT00642993|466431715|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
129695891|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
129695892|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
129695893|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
129695894|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
129695895|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
129695896|NCT02931539|466844019|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
129695897|NCT02931539|466844020|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
129884947|NCT00876460|467538738|FG005|Combination Therapy Phase|Adverse Event|0|||
129884948|NCT00876460|467538739|FG006|Combination Therapy Phase|Adverse Event|3|||
129884949|NCT00876460|467538740|FG007|Combination Therapy Phase|Adverse Event|2|||
129884950|NCT00876460|467538733|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
129884951|NCT00876460|467538734|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
129884952|NCT00876460|467538735|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
129884953|NCT00876460|467538736|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
129884954|NCT00876460|467538737|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
129884955|NCT00876460|467538738|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
129884956|NCT00876460|467538739|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
129884957|NCT00876460|467538740|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
129884958|NCT00876460|467538733|FG000|Combination Therapy Phase|Other reason not defined above|0|||
129884959|NCT00876460|467538734|FG001|Combination Therapy Phase|Other reason not defined above|0|||
129884960|NCT00876460|467538735|FG002|Combination Therapy Phase|Other reason not defined above|0|||
129884961|NCT00876460|467538736|FG003|Combination Therapy Phase|Other reason not defined above|0|||
129884962|NCT00876460|467538737|FG004|Combination Therapy Phase|Other reason not defined above|0|||
129884963|NCT00876460|467538738|FG005|Combination Therapy Phase|Other reason not defined above|0|||
129884964|NCT00876460|467538739|FG006|Combination Therapy Phase|Other reason not defined above|1|||
129884965|NCT00876460|467538740|FG007|Combination Therapy Phase|Other reason not defined above|2|||
129884966|NCT00876460|467538733|FG000|Combination Therapy Phase|Not treated|0|||
129884967|NCT00876460|467538734|FG001|Combination Therapy Phase|Not treated|0|||
129884968|NCT00876460|467538735|FG002|Combination Therapy Phase|Not treated|0|||
129884969|NCT00876460|467538736|FG003|Combination Therapy Phase|Not treated|0|||
129884970|NCT00876460|467538737|FG004|Combination Therapy Phase|Not treated|0|||
129884971|NCT00876460|467538738|FG005|Combination Therapy Phase|Not treated|0|||
129884972|NCT00876460|467538739|FG006|Combination Therapy Phase|Not treated|1|||
129884973|NCT00876460|467538740|FG007|Combination Therapy Phase|Not treated|0|||
129884974|NCT00876460|467538733|FG000|Mono Therapy Phase|Progressive disease|0|||
129884975|NCT00876460|467538734|FG001|Mono Therapy Phase|Progressive disease|0|||
129884976|NCT00876460|467538735|FG002|Mono Therapy Phase|Progressive disease|0|||
129884977|NCT00876460|467538736|FG003|Mono Therapy Phase|Progressive disease|0|||
129884978|NCT00876460|467538737|FG004|Mono Therapy Phase|Progressive disease|2|||
129884979|NCT00876460|467538738|FG005|Mono Therapy Phase|Progressive disease|0|||
129884980|NCT00876460|467538739|FG006|Mono Therapy Phase|Progressive disease|1|||
129884981|NCT00876460|467538740|FG007|Mono Therapy Phase|Progressive disease|3|||
129884982|NCT00876460|467538733|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
129884983|NCT00876460|467538734|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
129884984|NCT00876460|467538735|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
129884985|NCT00876460|467538736|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
129884986|NCT00876460|467538737|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
129884987|NCT00876460|467538738|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
129884988|NCT00876460|467538739|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
129884989|NCT00876460|467538740|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
129884990|NCT00876460|467538733|FG000|Mono Therapy Phase|Adverse Event|0|||
129884991|NCT00876460|467538734|FG001|Mono Therapy Phase|Adverse Event|0|||
129884992|NCT00876460|467538735|FG002|Mono Therapy Phase|Adverse Event|0|||
129884993|NCT00876460|467538736|FG003|Mono Therapy Phase|Adverse Event|1|||
129884994|NCT00876460|467538737|FG004|Mono Therapy Phase|Adverse Event|0|||
129884995|NCT00876460|467538738|FG005|Mono Therapy Phase|Adverse Event|0|||
129884996|NCT00876460|467538739|FG006|Mono Therapy Phase|Adverse Event|0|||
129884997|NCT00876460|467538740|FG007|Mono Therapy Phase|Adverse Event|0|||
129884998|NCT00127413|467538742|FG000|Overall Study|Lost to Follow-up|6|||
129884999|NCT00127413|467538743|FG001|Overall Study|Lost to Follow-up|4|||
129885000|NCT00127413|467538744|FG002|Overall Study|Lost to Follow-up|8|||
129885001|NCT00127413|467538745|FG003|Overall Study|Lost to Follow-up|2|||
129885002|NCT00547911|467538748|FG000|Overall Study|Adverse Event|0|||
129885003|NCT00547911|467538749|FG001|Overall Study|Adverse Event|0|||
129885004|NCT00547911|467538750|FG002|Overall Study|Adverse Event|0|||
129885005|NCT00547911|467538751|FG003|Overall Study|Adverse Event|1|||
129885006|NCT00547911|467538752|FG004|Overall Study|Adverse Event|0|||
129583538|NCT00642993|466431714|FG000|Overall Study|Protocol Violation|1|||
129583539|NCT00642993|466431715|FG001|Overall Study|Protocol Violation|4|||
129885007|NCT00547911|467538753|FG005|Overall Study|Adverse Event|0|||
129885008|NCT01644474|467538754|FG000|Overall Study|Poor compliance to protocol|1|||
129885009|NCT01644474|467538755|FG001|Overall Study|Poor compliance to protocol|0|||
129583540|NCT00642993|466431714|FG000|Overall Study|Did not meet protocol eligibility|0|||
129583541|NCT00642993|466431715|FG001|Overall Study|Did not meet protocol eligibility|1|||
129885010|NCT01644474|467538754|FG000|Overall Study|Consent withdrawn by participant|0|||
129885011|NCT01644474|467538755|FG001|Overall Study|Consent withdrawn by participant|1|||
129885012|NCT01644474|467538754|FG000|Overall Study|Participant moved|0|||
129885013|NCT01644474|467538755|FG001|Overall Study|Participant moved|1|||
129885014|NCT01644474|467538754|FG000|Overall Study|Adverse Event|4|||
129885015|NCT01644474|467538755|FG001|Overall Study|Adverse Event|5|||
129885016|NCT01644474|467538754|FG000|Overall Study|Site scheduling error|1|||
129885017|NCT01644474|467538755|FG001|Overall Study|Site scheduling error|1|||
129583542|NCT00642993|466431714|FG000|Overall Study|Administrative|1|||
129583543|NCT00642993|466431715|FG001|Overall Study|Administrative|0|||
129583544|NCT02664415|466431716|FG000|Overall Study|Adverse Event|1|||
129583545|NCT02664415|466431717|FG001|Overall Study|Adverse Event|0|||
129583546|NCT02986139|466431721|FG000|Overall Study|Sponsor Decision|1|||
129583547|NCT02986139|466431722|FG001|Overall Study|Sponsor Decision|2|||
129885018|NCT01644474|467538754|FG000|Overall Study|Protocol Violation|1|||
129885019|NCT01644474|467538755|FG001|Overall Study|Protocol Violation|0|||
129885020|NCT02044458|467538759|FG000|Overall Study|Protocol Violation|3|||
129885021|NCT02044458|467538760|FG001|Overall Study|Protocol Violation|8|||
129885022|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885023|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885024|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885025|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885026|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885027|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
129885028|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885029|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885030|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885031|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885032|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
129885033|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
129885034|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885035|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885036|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885037|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885038|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885039|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
129885040|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885041|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885042|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885043|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
129885044|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885045|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885046|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
129885047|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885048|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885049|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885050|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885051|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885052|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885053|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885054|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
129885055|NCT02601937|467538761|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
129885056|NCT02601937|467538762|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885057|NCT02601937|467538763|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
129885058|NCT02601937|467538764|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885059|NCT02601937|467538765|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885060|NCT02601937|467538766|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
129885061|NCT02601937|467538767|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
129885062|NCT02601937|467538768|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
129583548|NCT02986139|466431721|FG000|Overall Study|Withdrawal by Subject|0|||
129583549|NCT02986139|466431722|FG001|Overall Study|Withdrawal by Subject|1|||
129583550|NCT02986139|466431721|FG000|Overall Study|Lost to Follow-up|0|||
129583551|NCT02986139|466431722|FG001|Overall Study|Lost to Follow-up|1|||
129583552|NCT00414726|466431723|FG000|Overall Study|Withdrawal by Subject|0|||
129583553|NCT00414726|466431724|FG001|Overall Study|Withdrawal by Subject|1|||
129583554|NCT02107196|466431725|FG000|12-week Treatment Period|Adverse Event|6|||
129583555|NCT02107196|466431726|FG001|12-week Treatment Period|Adverse Event|3|||
129583556|NCT02107196|466431725|FG000|12-week Treatment Period|Lack of Efficacy|2|||
129583557|NCT02107196|466431726|FG001|12-week Treatment Period|Lack of Efficacy|1|||
129583558|NCT02107196|466431725|FG000|12-week Treatment Period|Lost to Follow-up|3|||
129583559|NCT02107196|466431726|FG001|12-week Treatment Period|Lost to Follow-up|6|||
129583560|NCT02107196|466431725|FG000|12-week Treatment Period|Physician Decision|0|||
129583561|NCT02107196|466431726|FG001|12-week Treatment Period|Physician Decision|1|||
129583562|NCT02107196|466431725|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
129583563|NCT02107196|466431726|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
129583564|NCT02107196|466431725|FG000|12-week Treatment Period|Protocol Violation|7|||
129583565|NCT02107196|466431726|FG001|12-week Treatment Period|Protocol Violation|8|||
129583566|NCT02107196|466431725|FG000|12-week Treatment Period|Reason Missing|11|||
129583567|NCT02107196|466431726|FG001|12-week Treatment Period|Reason Missing|8|||
129583568|NCT02107196|466431725|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
129583569|NCT02107196|466431726|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
129583570|NCT02107196|466431725|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
129583571|NCT02107196|466431726|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129583572|NCT02107196|466431725|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
129583573|NCT02107196|466431726|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
129583574|NCT02107196|466431725|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
129583575|NCT02107196|466431726|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
129583576|NCT00516295|466431727|FG000|Overall Study|Lack of Efficacy|2|||
129583577|NCT00516295|466431728|FG001|Overall Study|Lack of Efficacy|0|||
129583578|NCT00516295|466431729|FG002|Overall Study|Lack of Efficacy|0|||
129583579|NCT00516295|466431727|FG000|Overall Study|Ineligible|1|||
129583580|NCT00516295|466431728|FG001|Overall Study|Ineligible|0|||
129583581|NCT00516295|466431729|FG002|Overall Study|Ineligible|0|||
129583582|NCT01630616|466431734|FG000|Overall Study|Adverse Event|0|||
129583583|NCT01630616|466431735|FG001|Overall Study|Adverse Event|0|||
129583584|NCT01630616|466431736|FG002|Overall Study|Adverse Event|0|||
129583585|NCT01630616|466431737|FG003|Overall Study|Adverse Event|1|||
129583586|NCT01630616|466431738|FG004|Overall Study|Adverse Event|0|||
129583587|NCT01630616|466431739|FG005|Overall Study|Adverse Event|0|||
129583588|NCT01630616|466431734|FG000|Overall Study|Withdrawal by Subject|0|||
129583589|NCT01630616|466431735|FG001|Overall Study|Withdrawal by Subject|0|||
129583590|NCT01630616|466431736|FG002|Overall Study|Withdrawal by Subject|0|||
129583591|NCT01630616|466431737|FG003|Overall Study|Withdrawal by Subject|2|||
129583592|NCT01630616|466431738|FG004|Overall Study|Withdrawal by Subject|0|||
129583593|NCT01630616|466431739|FG005|Overall Study|Withdrawal by Subject|0|||
129583594|NCT02218541|466431740|FG000|Overall Study|Lost to Follow-up|2|||
129583595|NCT02218541|466431741|FG001|Overall Study|Lost to Follow-up|1|||
129583596|NCT02218541|466431740|FG000|Overall Study|Implant Failure|4|||
129583597|NCT02218541|466431741|FG001|Overall Study|Implant Failure|1|||
129583598|NCT00691704|466431742|FG000|Induction Therapy|Disease Progression|1|||
129583599|NCT00691704|466431742|FG000|Induction Therapy|Active Hepatitis|1|||
129583600|NCT00691704|466431742|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
129583601|NCT00691704|466431742|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
129583602|NCT00691704|466431742|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
129583603|NCT01993186|466431744|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
129583604|NCT01993186|466431745|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
129583605|NCT01993186|466431744|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
129583606|NCT01993186|466431745|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
129583607|NCT01993186|466431744|FG000|Open-Label Extension Period|Other, Not Specified|0|||
129583608|NCT01993186|466431745|FG001|Open-Label Extension Period|Other, Not Specified|1|||
129583609|NCT01993186|466431744|FG000|Open-Label Extension Period|Adverse Event|1|||
129583610|NCT01993186|466431745|FG001|Open-Label Extension Period|Adverse Event|0|||
129583611|NCT01993186|466431744|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
129583612|NCT01993186|466431745|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
129583613|NCT01993186|466431744|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
129583614|NCT01993186|466431745|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
129583615|NCT01993186|466431744|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
129583616|NCT01993186|466431745|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
129583617|NCT04661202|466431746|FG000|Overall Study|Withdrawal by Subject|1|||
129583618|NCT04661202|466431747|FG001|Overall Study|Withdrawal by Subject|1|||
129583619|NCT04661202|466431746|FG000|Overall Study|Lack of Efficacy|2|||
129583620|NCT04661202|466431747|FG001|Overall Study|Lack of Efficacy|0|||
129583621|NCT02313558|466431749|FG000|Overall Study|Withdrawal by Subject|2|||
129583622|NCT02313558|466431750|FG001|Overall Study|Withdrawal by Subject|0|||
129583623|NCT02313558|466431749|FG000|Overall Study|Lost to Follow-up|4|||
129583624|NCT02313558|466431750|FG001|Overall Study|Lost to Follow-up|4|||
129583625|NCT04158687|466431751|FG000|Overall Study|Adverse Event|2|||
129583626|NCT04158687|466431752|FG001|Overall Study|Adverse Event|3|||
129583627|NCT04158687|466431753|FG002|Overall Study|Adverse Event|0|||
129583628|NCT04158687|466431754|FG003|Overall Study|Adverse Event|3|||
129583629|NCT04158687|466431751|FG000|Overall Study|Lost to Follow-up|5|||
129583630|NCT04158687|466431752|FG001|Overall Study|Lost to Follow-up|12|||
129583631|NCT04158687|466431753|FG002|Overall Study|Lost to Follow-up|4|||
129583632|NCT04158687|466431754|FG003|Overall Study|Lost to Follow-up|5|||
129583633|NCT04158687|466431751|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
129583634|NCT04158687|466431752|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
129583635|NCT04158687|466431753|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
129583636|NCT04158687|466431754|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
129583637|NCT04158687|466431751|FG000|Overall Study|Non-Compliance with Study Medication|2|||
129583638|NCT04158687|466431752|FG001|Overall Study|Non-Compliance with Study Medication|2|||
129583639|NCT04158687|466431753|FG002|Overall Study|Non-Compliance with Study Medication|3|||
129583640|NCT04158687|466431754|FG003|Overall Study|Non-Compliance with Study Medication|0|||
129583641|NCT04158687|466431751|FG000|Overall Study|Investigator Decision|0|||
129583642|NCT04158687|466431752|FG001|Overall Study|Investigator Decision|0|||
129583643|NCT04158687|466431753|FG002|Overall Study|Investigator Decision|2|||
129583644|NCT04158687|466431754|FG003|Overall Study|Investigator Decision|0|||
129583645|NCT04158687|466431751|FG000|Overall Study|Protocol Violation|0|||
129583646|NCT04158687|466431752|FG001|Overall Study|Protocol Violation|2|||
129583647|NCT04158687|466431753|FG002|Overall Study|Protocol Violation|1|||
129583648|NCT04158687|466431754|FG003|Overall Study|Protocol Violation|0|||
129583649|NCT04158687|466431751|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
129583650|NCT04158687|466431752|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
129583651|NCT04158687|466431753|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
129583652|NCT04158687|466431754|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
129583653|NCT04158687|466431751|FG000|Overall Study|Reason not Specified|3|||
129583654|NCT04158687|466431752|FG001|Overall Study|Reason not Specified|2|||
129583655|NCT04158687|466431753|FG002|Overall Study|Reason not Specified|4|||
129583656|NCT04158687|466431754|FG003|Overall Study|Reason not Specified|4|||
129583657|NCT04102345|466431755|FG000|Overall Study|Withdrawal by Subject|1|||
129583658|NCT04102345|466431756|FG001|Overall Study|Withdrawal by Subject|0|||
129583659|NCT00385736|466431757|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
129583660|NCT00385736|466431758|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
129583661|NCT00385736|466431759|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
129583662|NCT00385736|466431757|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
129583663|NCT00385736|466431758|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
129583664|NCT00385736|466431759|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
129583665|NCT00385736|466431757|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
129583666|NCT00385736|466431758|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
129583667|NCT00385736|466431759|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
129583668|NCT00385736|466431757|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
129583669|NCT00385736|466431758|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
129583670|NCT00385736|466431759|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
129583671|NCT00385736|466431757|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
129583672|NCT00385736|466431758|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
129583673|NCT00385736|466431759|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
129583674|NCT00385736|466431757|FG000|Efficacy Analysis Set - Induction|Other|0|||
129583675|NCT00385736|466431758|FG001|Efficacy Analysis Set - Induction|Other|0|||
129583676|NCT00385736|466431759|FG002|Efficacy Analysis Set - Induction|Other|1|||
129583677|NCT00385736|466431757|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
129583678|NCT00385736|466431758|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
129583679|NCT00385736|466431759|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
129583680|NCT00385736|466431757|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
129583681|NCT00385736|466431758|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
129583682|NCT00385736|466431759|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
129583683|NCT00385736|466431757|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
129583684|NCT00385736|466431758|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
129583685|NCT00385736|466431759|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
129885063|NCT02601937|467538769|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
129885064|NCT02601937|467538770|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
129885065|NCT02601937|467538771|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
129885066|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885067|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885068|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885069|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885070|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885071|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885072|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885073|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885074|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885075|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
129885076|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
129885077|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885078|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885079|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885080|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885081|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885082|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885083|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885084|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
129885085|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129583686|NCT00385736|466431757|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
129583687|NCT00385736|466431758|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
129583688|NCT00385736|466431759|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
129583689|NCT00385736|466431757|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
129583690|NCT00385736|466431758|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
129583691|NCT00385736|466431759|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
129583692|NCT00385736|466431757|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
129583693|NCT00385736|466431758|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
129583694|NCT00385736|466431759|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
129583695|NCT00385736|466431757|FG000|Safety Analysis Set|Adverse Event|23|||
129583696|NCT00385736|466431758|FG001|Safety Analysis Set|Adverse Event|15|||
129583697|NCT00385736|466431759|FG002|Safety Analysis Set|Adverse Event|23|||
129583698|NCT00385736|466431757|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
129583699|NCT00385736|466431758|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
129583700|NCT00385736|466431759|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
129583701|NCT00385736|466431757|FG000|Safety Analysis Set|Lost to Follow-up|0|||
129583702|NCT00385736|466431758|FG001|Safety Analysis Set|Lost to Follow-up|2|||
129583703|NCT00385736|466431759|FG002|Safety Analysis Set|Lost to Follow-up|2|||
129583704|NCT00385736|466431757|FG000|Safety Analysis Set|Lack of Efficacy|38|||
129583705|NCT00385736|466431758|FG001|Safety Analysis Set|Lack of Efficacy|16|||
129583706|NCT00385736|466431759|FG002|Safety Analysis Set|Lack of Efficacy|31|||
129583707|NCT00385736|466431757|FG000|Safety Analysis Set|Protocol Violation|2|||
129583708|NCT00385736|466431758|FG001|Safety Analysis Set|Protocol Violation|1|||
129583709|NCT00385736|466431759|FG002|Safety Analysis Set|Protocol Violation|6|||
129583710|NCT00385736|466431757|FG000|Safety Analysis Set|Other|1|||
129583711|NCT00385736|466431758|FG001|Safety Analysis Set|Other|4|||
129583712|NCT00385736|466431759|FG002|Safety Analysis Set|Other|4|||
129583713|NCT00198133|466431760|FG000|Overall Study|Disease progression|2|||
129583714|NCT00198133|466431761|FG001|Overall Study|Disease progression|5|||
129583715|NCT00198133|466431760|FG000|Overall Study|Adverse Event|1|||
129583716|NCT00198133|466431761|FG001|Overall Study|Adverse Event|3|||
129583717|NCT00198133|466431760|FG000|Overall Study|Withdrawal by Subject|1|||
129583718|NCT00198133|466431761|FG001|Overall Study|Withdrawal by Subject|0|||
129583719|NCT00198133|466431760|FG000|Overall Study|Physician Decision|1|||
129583720|NCT00198133|466431761|FG001|Overall Study|Physician Decision|0|||
129583721|NCT01557751|466431762|FG000|Overall Study|Physician Decision|3|||
129583722|NCT00835666|466431766|FG000|Washout|Protocol Violation|1|||
129583723|NCT00835666|466431767|FG001|Washout|Protocol Violation|0|||
129583724|NCT00835666|466431766|FG000|Washout|Withdrawal by Subject|1|||
129583725|NCT00835666|466431767|FG001|Washout|Withdrawal by Subject|0|||
129583726|NCT03599362|466431768|FG000|Overall Study|Screen Failure|3|||
129583727|NCT03707587|466431769|FG000|Overall Study|Death|0|||
129583728|NCT03707587|466431770|FG001|Overall Study|Death|1|||
129583729|NCT01537887|466431771|FG000|Period 1|Physician Decision|0|||
129583730|NCT01537887|466431772|FG001|Period 1|Physician Decision|0|||
129583731|NCT01537887|466431773|FG002|Period 1|Physician Decision|0|||
129583732|NCT01537887|466431774|FG003|Period 1|Physician Decision|0|||
129583733|NCT01537887|466431775|FG004|Period 1|Physician Decision|1|||
129583734|NCT01537887|466431776|FG005|Period 1|Physician Decision|1|||
129583735|NCT01537887|466431771|FG000|Period 1|Did not receive treatment|0|||
129583736|NCT01537887|466431772|FG001|Period 1|Did not receive treatment|0|||
129583737|NCT01537887|466431773|FG002|Period 1|Did not receive treatment|1|||
129583738|NCT01537887|466431774|FG003|Period 1|Did not receive treatment|0|||
129583739|NCT01537887|466431775|FG004|Period 1|Did not receive treatment|0|||
129583740|NCT01537887|466431776|FG005|Period 1|Did not receive treatment|0|||
129583741|NCT01537887|466431771|FG000|Period 2|Withdrawal by Subject|0|||
129583742|NCT01537887|466431772|FG001|Period 2|Withdrawal by Subject|1|||
129583743|NCT01537887|466431773|FG002|Period 2|Withdrawal by Subject|0|||
129583744|NCT01537887|466431774|FG003|Period 2|Withdrawal by Subject|0|||
129583745|NCT01537887|466431775|FG004|Period 2|Withdrawal by Subject|0|||
129583746|NCT01537887|466431776|FG005|Period 2|Withdrawal by Subject|0|||
129583747|NCT01537887|466431771|FG000|Period 3|Adverse Event|0|||
129583748|NCT01537887|466431772|FG001|Period 3|Adverse Event|0|||
129583749|NCT01537887|466431773|FG002|Period 3|Adverse Event|1|||
129583750|NCT01537887|466431774|FG003|Period 3|Adverse Event|0|||
129583751|NCT01537887|466431775|FG004|Period 3|Adverse Event|0|||
129583752|NCT01537887|466431776|FG005|Period 3|Adverse Event|0|||
129583753|NCT01537887|466431771|FG000|Period 3|Withdrawal by Subject|0|||
129583754|NCT01537887|466431772|FG001|Period 3|Withdrawal by Subject|1|||
129583755|NCT01537887|466431773|FG002|Period 3|Withdrawal by Subject|0|||
129583756|NCT01537887|466431774|FG003|Period 3|Withdrawal by Subject|0|||
129583757|NCT01537887|466431775|FG004|Period 3|Withdrawal by Subject|0|||
129583758|NCT01537887|466431776|FG005|Period 3|Withdrawal by Subject|0|||
129583759|NCT01634139|466431778|FG000|Overall Study|Non compliant with protocol|1|||
129583760|NCT01634139|466431779|FG001|Overall Study|Non compliant with protocol|0|||
129583761|NCT01634139|466431780|FG002|Overall Study|Non compliant with protocol|0|||
129583762|NCT01634139|466431778|FG000|Overall Study|Consent withdrawn not due to AE|4|||
129583763|NCT01634139|466431779|FG001|Overall Study|Consent withdrawn not due to AE|3|||
129583764|NCT01634139|466431780|FG002|Overall Study|Consent withdrawn not due to AE|2|||
129583765|NCT01634139|466431778|FG000|Overall Study|Other|4|||
129583766|NCT01634139|466431779|FG001|Overall Study|Other|0|||
129583767|NCT01634139|466431780|FG002|Overall Study|Other|3|||
129583768|NCT01634139|466431778|FG000|Overall Study|Lost to Follow-up|0|||
129583769|NCT01634139|466431779|FG001|Overall Study|Lost to Follow-up|2|||
129583770|NCT01634139|466431780|FG002|Overall Study|Lost to Follow-up|0|||
129583771|NCT01634139|466431778|FG000|Overall Study|Not treated|1|||
129583772|NCT01634139|466431779|FG001|Overall Study|Not treated|1|||
129583773|NCT01634139|466431780|FG002|Overall Study|Not treated|0|||
129583774|NCT00425308|466431788|FG000|Overall Study|Adverse Event|2|||
129583775|NCT00425308|466431789|FG001|Overall Study|Adverse Event|1|||
129583776|NCT00425308|466431788|FG000|Overall Study|Withdrawal by Subject|1|||
129583777|NCT00425308|466431789|FG001|Overall Study|Withdrawal by Subject|0|||
129583778|NCT00425308|466431788|FG000|Overall Study|Death|1|||
129583779|NCT00425308|466431789|FG001|Overall Study|Death|0|||
129583780|NCT04442503|466431792|FG000|Overall Study|Adverse Event|1|||
129583781|NCT04442503|466431793|FG001|Overall Study|Adverse Event|1|||
129583782|NCT04442503|466431792|FG000|Overall Study|Lost to Follow-up|8|||
129583783|NCT04442503|466431793|FG001|Overall Study|Lost to Follow-up|6|||
129583784|NCT04442503|466431792|FG000|Overall Study|Physician Decision|0|||
129583785|NCT04442503|466431793|FG001|Overall Study|Physician Decision|2|||
129583786|NCT04442503|466431792|FG000|Overall Study|Withdrawal by Subject|3|||
129583787|NCT04442503|466431793|FG001|Overall Study|Withdrawal by Subject|4|||
129583788|NCT04442503|466431792|FG000|Overall Study|Reason not Specified|0|||
129583789|NCT04442503|466431793|FG001|Overall Study|Reason not Specified|1|||
129583790|NCT04442503|466431792|FG000|Overall Study|Randomized but not Treated|3|||
129583791|NCT04442503|466431793|FG001|Overall Study|Randomized but not Treated|1|||
129583792|NCT01945580|466431794|FG000|Overall Study|Withdrawal by Subject|13|||
129583793|NCT01945580|466431795|FG001|Overall Study|Withdrawal by Subject|35|||
129583794|NCT01945580|466431794|FG000|Overall Study|Physician Decision|3|||
129583795|NCT01945580|466431795|FG001|Overall Study|Physician Decision|2|||
129583796|NCT01945580|466431794|FG000|Overall Study|Lost to Follow-up|26|||
129583797|NCT01945580|466431795|FG001|Overall Study|Lost to Follow-up|39|||
129583798|NCT01945580|466431794|FG000|Overall Study|Death|7|||
129583799|NCT01945580|466431795|FG001|Overall Study|Death|2|||
129583800|NCT01945580|466431794|FG000|Overall Study|Patient moved out of state|0|||
129583801|NCT01945580|466431795|FG001|Overall Study|Patient moved out of state|1|||
129583802|NCT01945580|466431794|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
129583803|NCT01945580|466431795|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
129583804|NCT01945580|466431794|FG000|Overall Study|Family illness - unable to return|0|||
129583805|NCT01945580|466431795|FG001|Overall Study|Family illness - unable to return|1|||
129583806|NCT01945580|466431794|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
129583807|NCT01945580|466431795|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
129583808|NCT01945580|466431794|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
129583809|NCT01945580|466431795|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
129583810|NCT01945580|466431794|FG000|Overall Study|Noncompliance with 36 month visit|1|||
129583811|NCT01945580|466431795|FG001|Overall Study|Noncompliance with 36 month visit|0|||
129583812|NCT01945580|466431794|FG000|Overall Study|The patient moved.|1|||
129583813|NCT01945580|466431795|FG001|Overall Study|The patient moved.|0|||
129583814|NCT01945580|466431794|FG000|Overall Study|No data available|0|||
129583815|NCT01945580|466431795|FG001|Overall Study|No data available|2|||
129583816|NCT02933060|466431796|FG000|Overall Study|Withdrawal by Subject|0|||
129583817|NCT02933060|466431797|FG001|Overall Study|Withdrawal by Subject|1|||
129583818|NCT05034874|466431800|FG000|Overall Study|Withdrawal by Subject|6|||
129583819|NCT05034874|466431801|FG001|Overall Study|Withdrawal by Subject|6|||
129583820|NCT05034874|466431800|FG000|Overall Study|Lost to Follow-up|18|||
129583821|NCT05034874|466431801|FG001|Overall Study|Lost to Follow-up|8|||
129583822|NCT05034874|466431800|FG000|Overall Study|Physician Decision|0|||
129583823|NCT05034874|466431801|FG001|Overall Study|Physician Decision|1|||
129583824|NCT05034874|466431800|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
129583825|NCT05034874|466431801|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
129583826|NCT00989950|466431802|FG000|Randomized Phase|Protocol Violation|1|||
129583827|NCT00989950|466431803|FG001|Randomized Phase|Protocol Violation|0|||
129583828|NCT00989950|466431804|FG002|Randomized Phase|Protocol Violation|0|||
129583829|NCT00989950|466431805|FG003|Randomized Phase|Protocol Violation|0|||
129583830|NCT00989950|466431802|FG000|Randomized Phase|Adverse Event|0|||
129583831|NCT00989950|466431803|FG001|Randomized Phase|Adverse Event|1|||
129583832|NCT00989950|466431804|FG002|Randomized Phase|Adverse Event|0|||
129583833|NCT00989950|466431805|FG003|Randomized Phase|Adverse Event|0|||
129583834|NCT00101439|466431806|FG000|Period 2|Withdrawal by Subject|0|||
129583835|NCT00101439|466431807|FG001|Period 2|Withdrawal by Subject|2|||
129583836|NCT01867658|466431809|FG000|Overall Study|Withdrawal by Subject|6|||
129583837|NCT01867658|466431809|FG000|Overall Study|Death|2|||
129583838|NCT01867658|466431809|FG000|Overall Study|Subject could not be contacted|1|||
129583839|NCT00840658|466431810|FG000|Overall Study|Death|2|||
129583840|NCT00840658|466431811|FG001|Overall Study|Death|2|||
129583841|NCT00840658|466431812|FG002|Overall Study|Death|3|||
129583842|NCT00840658|466431813|FG003|Overall Study|Death|3|||
129583843|NCT00840658|466431810|FG000|Overall Study|Lost to Follow-up|3|||
129583844|NCT00840658|466431811|FG001|Overall Study|Lost to Follow-up|1|||
129583845|NCT00840658|466431812|FG002|Overall Study|Lost to Follow-up|2|||
129583846|NCT00840658|466431813|FG003|Overall Study|Lost to Follow-up|1|||
129583847|NCT00474058|466431814|FG000|Overall Study|Adverse Event|11|||
129583848|NCT00474058|466431815|FG001|Overall Study|Adverse Event|6|||
129583849|NCT00474058|466431814|FG000|Overall Study|Lack of Efficacy|0|||
129583850|NCT00474058|466431815|FG001|Overall Study|Lack of Efficacy|4|||
129583851|NCT00474058|466431814|FG000|Overall Study|Withdrawal by Subject|11|||
129583852|NCT00474058|466431815|FG001|Overall Study|Withdrawal by Subject|7|||
129583853|NCT00474058|466431814|FG000|Overall Study|Other|2|||
129583854|NCT00474058|466431815|FG001|Overall Study|Other|0|||
129583855|NCT03101358|466431816|FG000|Overall Study|Non-compliance with study schedule|1|||
129583856|NCT03101358|466431817|FG001|Overall Study|Non-compliance with study schedule|0|||
129583857|NCT03101358|466431818|FG002|Overall Study|Non-compliance with study schedule|0|||
129583858|NCT03101358|466431819|FG003|Overall Study|Non-compliance with study schedule|1|||
129583859|NCT03101358|466431816|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
129583860|NCT03101358|466431817|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
129583861|NCT03101358|466431818|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
129583862|NCT03101358|466431819|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
129583863|NCT03101358|466431816|FG000|Overall Study|Physician Decision|1|||
129583864|NCT03101358|466431817|FG001|Overall Study|Physician Decision|0|||
129583865|NCT03101358|466431818|FG002|Overall Study|Physician Decision|0|||
129583866|NCT03101358|466431819|FG003|Overall Study|Physician Decision|3|||
129583867|NCT03101358|466431816|FG000|Overall Study|Adverse Event|0|||
129583868|NCT03101358|466431817|FG001|Overall Study|Adverse Event|0|||
129583869|NCT03101358|466431818|FG002|Overall Study|Adverse Event|1|||
129583870|NCT03101358|466431819|FG003|Overall Study|Adverse Event|0|||
129583871|NCT03101358|466431816|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
129583872|NCT03101358|466431817|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
129583873|NCT03101358|466431818|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
129583874|NCT03101358|466431819|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
129583875|NCT03101358|466431816|FG000|Overall Study|Lost to Follow-up|1|||
129583876|NCT03101358|466431817|FG001|Overall Study|Lost to Follow-up|0|||
129583877|NCT03101358|466431818|FG002|Overall Study|Lost to Follow-up|0|||
129583878|NCT03101358|466431819|FG003|Overall Study|Lost to Follow-up|1|||
129583879|NCT02426918|466431824|FG000|Overall Study|Adverse Event|2|||
129583880|NCT02426918|466431825|FG001|Overall Study|Adverse Event|2|||
129583881|NCT02426918|466431826|FG002|Overall Study|Adverse Event|0|||
129583882|NCT02426918|466431824|FG000|Overall Study|Physician Decision|1|||
129583883|NCT02426918|466431825|FG001|Overall Study|Physician Decision|1|||
129583884|NCT02426918|466431826|FG002|Overall Study|Physician Decision|1|||
129695898|NCT02931539|466844021|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
129695899|NCT02931539|466844019|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
129695900|NCT02931539|466844020|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
129695901|NCT02931539|466844021|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
129695902|NCT03178942|466844024|FG000|Overall Study|Withdrawal by Subject|2|||
129695903|NCT03178942|466844025|FG001|Overall Study|Withdrawal by Subject|0|||
129695904|NCT03178942|466844024|FG000|Overall Study|Lost to Follow-up|1|||
129695905|NCT03178942|466844025|FG001|Overall Study|Lost to Follow-up|2|||
129695906|NCT01926509|466845818|FG000|Overall Study|vital sign met discontinuation criteria|1|||
129695907|NCT01926509|466845819|FG001|Overall Study|vital sign met discontinuation criteria|0|||
129695908|NCT01926509|466845820|FG002|Overall Study|vital sign met discontinuation criteria|0|||
129695909|NCT01926509|466845821|FG003|Overall Study|vital sign met discontinuation criteria|0|||
129695910|NCT03681093|466845822|FG000|Overall Study|Subject decision|0|||
129583885|NCT02426918|466431824|FG000|Overall Study|Withdrawal by Subject|5|||
129583886|NCT02426918|466431825|FG001|Overall Study|Withdrawal by Subject|5|||
129583887|NCT02426918|466431826|FG002|Overall Study|Withdrawal by Subject|4|||
129583888|NCT02426918|466431824|FG000|Overall Study|Other|9|||
129583889|NCT02426918|466431825|FG001|Overall Study|Other|11|||
129583890|NCT02426918|466431826|FG002|Overall Study|Other|9|||
129583891|NCT02845336|466431827|FG000|Overall Study|Lost to Follow-up|3|||
129583892|NCT02845336|466431828|FG001|Overall Study|Lost to Follow-up|1|||
129583893|NCT02845336|466431827|FG000|Overall Study|Inability to get medication|2|||
129583894|NCT02845336|466431828|FG001|Overall Study|Inability to get medication|0|||
129583895|NCT01496118|466431829|FG000|Overall Study|Disease progression|3|||
129583896|NCT01496118|466431830|FG001|Overall Study|Disease progression|2|||
129583897|NCT01496118|466431831|FG002|Overall Study|Disease progression|3|||
129583898|NCT01496118|466431832|FG003|Overall Study|Disease progression|1|||
129583899|NCT01496118|466431833|FG004|Overall Study|Disease progression|2|||
129583900|NCT01496118|466431834|FG005|Overall Study|Disease progression|2|||
129583901|NCT01496118|466431835|FG006|Overall Study|Disease progression|14|||
129583902|NCT01496118|466431836|FG007|Overall Study|Disease progression|10|||
129583903|NCT01496118|466431829|FG000|Overall Study|Physician Decision|0|||
129583904|NCT01496118|466431830|FG001|Overall Study|Physician Decision|0|||
129583905|NCT01496118|466431831|FG002|Overall Study|Physician Decision|0|||
129583906|NCT01496118|466431832|FG003|Overall Study|Physician Decision|0|||
129583907|NCT01496118|466431833|FG004|Overall Study|Physician Decision|1|||
129583908|NCT01496118|466431834|FG005|Overall Study|Physician Decision|0|||
129583909|NCT01496118|466431835|FG006|Overall Study|Physician Decision|3|||
129583910|NCT01496118|466431836|FG007|Overall Study|Physician Decision|6|||
129583911|NCT01496118|466431829|FG000|Overall Study|Adverse Event|1|||
129583912|NCT01496118|466431830|FG001|Overall Study|Adverse Event|1|||
129583913|NCT01496118|466431831|FG002|Overall Study|Adverse Event|0|||
129583914|NCT01496118|466431832|FG003|Overall Study|Adverse Event|0|||
129583915|NCT01496118|466431833|FG004|Overall Study|Adverse Event|0|||
129583916|NCT01496118|466431834|FG005|Overall Study|Adverse Event|0|||
129583917|NCT01496118|466431835|FG006|Overall Study|Adverse Event|6|||
129583918|NCT01496118|466431836|FG007|Overall Study|Adverse Event|10|||
129583919|NCT01496118|466431829|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583920|NCT01496118|466431830|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583921|NCT01496118|466431831|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583922|NCT01496118|466431832|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583923|NCT01496118|466431833|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583924|NCT01496118|466431834|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583925|NCT01496118|466431835|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
129647341|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
129583926|NCT01496118|466431836|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
129583927|NCT01496118|466431829|FG000|Overall Study|Death|0|||
129583928|NCT01496118|466431830|FG001|Overall Study|Death|0|||
129583929|NCT01496118|466431831|FG002|Overall Study|Death|0|||
129583930|NCT01496118|466431832|FG003|Overall Study|Death|0|||
129583931|NCT01496118|466431833|FG004|Overall Study|Death|0|||
129583932|NCT01496118|466431834|FG005|Overall Study|Death|0|||
129583933|NCT01496118|466431835|FG006|Overall Study|Death|1|||
129583934|NCT01496118|466431836|FG007|Overall Study|Death|1|||
129583935|NCT01496118|466431829|FG000|Overall Study|Withdrawal by Subject|0|||
129583936|NCT01496118|466431830|FG001|Overall Study|Withdrawal by Subject|0|||
129583937|NCT01496118|466431831|FG002|Overall Study|Withdrawal by Subject|0|||
129583938|NCT01496118|466431832|FG003|Overall Study|Withdrawal by Subject|2|||
129583939|NCT01496118|466431833|FG004|Overall Study|Withdrawal by Subject|0|||
129583940|NCT01496118|466431834|FG005|Overall Study|Withdrawal by Subject|1|||
129583941|NCT01496118|466431835|FG006|Overall Study|Withdrawal by Subject|6|||
129583942|NCT01496118|466431836|FG007|Overall Study|Withdrawal by Subject|3|||
129583943|NCT05616728|466431843|FG000|Overall Study|Lost to Follow-up|0|||
129583944|NCT05616728|466431844|FG001|Overall Study|Lost to Follow-up|0|||
129583945|NCT05616728|466431845|FG002|Overall Study|Lost to Follow-up|1|||
129583946|NCT05616728|466431843|FG000|Overall Study|Withdrawal by Subject|1|||
129583947|NCT05616728|466431844|FG001|Overall Study|Withdrawal by Subject|1|||
129583948|NCT05616728|466431845|FG002|Overall Study|Withdrawal by Subject|0|||
129583949|NCT05616728|466431843|FG000|Overall Study|Physician Decision|1|||
129583950|NCT05616728|466431844|FG001|Overall Study|Physician Decision|1|||
129583951|NCT05616728|466431845|FG002|Overall Study|Physician Decision|1|||
129583952|NCT05616728|466431843|FG000|Overall Study|Other|0|||
129583953|NCT05616728|466431844|FG001|Overall Study|Other|2|||
129583954|NCT05616728|466431845|FG002|Overall Study|Other|0|||
129583955|NCT01024855|466431848|FG000|Overall Study|Inclusion/exclusion criteria|1|||
129695911|NCT03681093|466845823|FG001|Overall Study|Subject decision|2|||
129583956|NCT03306277|466431853|FG000|Overall Study|Death|1|||
129695912|NCT03681093|466845824|FG002|Overall Study|Subject decision|1|||
129695913|NCT01882829|466845828|FG000|Overall Study|Adverse Event|4|||
129695914|NCT01882829|466845828|FG000|Overall Study|Protocol Violation|1|||
129695915|NCT01882829|466845828|FG000|Overall Study|Withdrawal by Subject|1|||
129695916|NCT02469961|466845830|FG000|Overall Study|Physician Decision|4|||
129695917|NCT02469961|466845831|FG001|Overall Study|Physician Decision|1|||
129695918|NCT05130281|466845835|FG000|Overall Study|Withdrawal by Subject|0|||
129695919|NCT05130281|466845836|FG001|Overall Study|Withdrawal by Subject|0|||
129695920|NCT05130281|466845837|FG002|Overall Study|Withdrawal by Subject|1|||
129695921|NCT06844812|466845838|FG000|Overall Study|Lost to Follow-up|5|||
129695922|NCT06844812|466845838|FG000|Overall Study|stigmatization concerns|2|||
129695923|NCT06844812|466845838|FG000|Overall Study|medication refusal|2|||
129695924|NCT06844812|466845838|FG000|Overall Study|concerns about possible side effects|2|||
129695925|NCT06844812|466845838|FG000|Overall Study|wanting to seek another specialist opinion|2|||
129695926|NCT06844812|466845838|FG000|Overall Study|side effects (dizziness)|1|||
129695927|NCT00368849|466845841|FG000|Overall Study|Withdrawal by Subject|0|||
129695928|NCT00368849|466845842|FG001|Overall Study|Withdrawal by Subject|1|||
129695929|NCT00368849|466845841|FG000|Overall Study|Physician Decision|0|||
129695930|NCT00368849|466845842|FG001|Overall Study|Physician Decision|1|||
129695931|NCT01699685|466845846|FG000|Period 1|Adverse Event|1|||
129695932|NCT01699685|466845847|FG001|Period 1|Adverse Event|1|||
129695933|NCT01699685|466845846|FG000|Period 1|Medical or ethical, noncompliance|2|||
129695934|NCT01699685|466845847|FG001|Period 1|Medical or ethical, noncompliance|0|||
129695935|NCT01699685|466845846|FG000|Period 1|Other|0|||
129695936|NCT01699685|466845847|FG001|Period 1|Other|1|||
129695937|NCT01699685|466845846|FG000|Period 1|Patient request|0|||
129695938|NCT01699685|466845847|FG001|Period 1|Patient request|1|||
129695939|NCT01699685|466845846|FG000|Period 2|Lost to Follow-up|1|||
129695940|NCT01699685|466845847|FG001|Period 2|Lost to Follow-up|0|||
129695941|NCT03635996|466845848|FG000|Overall Study|Study terminated by Sponsor|94|||
129695942|NCT03635996|466845848|FG000|Overall Study|Withdrawal by Subject|20|||
129695943|NCT03635996|466845848|FG000|Overall Study|Ablation|26|||
129695944|NCT03635996|466845848|FG000|Overall Study|Adverse Event|7|||
129695945|NCT03635996|466845848|FG000|Overall Study|Physician Decision|3|||
129695946|NCT03635996|466845848|FG000|Overall Study|Prohibited medication|5|||
129695947|NCT03635996|466845848|FG000|Overall Study|Did not meet eligibility criteria|5|||
129695948|NCT03635996|466845848|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
129695949|NCT03635996|466845848|FG000|Overall Study|Protocol Violation|1|||
129695950|NCT03635996|466845848|FG000|Overall Study|Lost to Follow-up|1|||
129695951|NCT05058456|466845849|FG000|Overall Study|Death|1|||
129695952|NCT05058456|466845849|FG000|Overall Study|End of Study data not yet due for release|34|||
129583957|NCT03306277|466431853|FG000|Overall Study|Adverse Event|1|||
129583958|NCT03306277|466431853|FG000|Overall Study|Withdrawal by Subject|1|||
129583959|NCT00875524|466431854|FG000|Overall Study|Serious adverse event|0|||
129695953|NCT01832038|466845850|FG000|Overall Study|Death|5|||
129695954|NCT01832038|466845850|FG000|Overall Study|Adverse Event|50|||
129695955|NCT01832038|466845850|FG000|Overall Study|Lack of Efficacy|81|||
129583960|NCT00875524|466431855|FG001|Overall Study|Serious adverse event|1|||
129583961|NCT00875524|466431854|FG000|Overall Study|Protocol Violation|4|||
129583962|NCT00875524|466431855|FG001|Overall Study|Protocol Violation|0|||
129583963|NCT00875524|466431854|FG000|Overall Study|Lost to Follow-up|1|||
129583964|NCT00875524|466431855|FG001|Overall Study|Lost to Follow-up|0|||
129583965|NCT00875524|466431854|FG000|Overall Study|Withdrawal by Subject|3|||
129583966|NCT00875524|466431855|FG001|Overall Study|Withdrawal by Subject|5|||
129583967|NCT00881751|466431856|FG000|Overall Study|Physician Decision|0|||
129583968|NCT00881751|466431857|FG001|Overall Study|Physician Decision|1|||
129583969|NCT00881751|466431856|FG000|Overall Study|Adverse Event|0|||
129583970|NCT00881751|466431857|FG001|Overall Study|Adverse Event|2|||
129583971|NCT00881751|466431856|FG000|Overall Study|Withdrawal by Subject|0|||
129583972|NCT00881751|466431857|FG001|Overall Study|Withdrawal by Subject|2|||
129583973|NCT02385708|466431858|FG000|Overall Study|Withdrawal by Subject|0|||
129583974|NCT02385708|466431859|FG001|Overall Study|Withdrawal by Subject|2|||
129583975|NCT02385708|466431858|FG000|Overall Study|Withdrawn - surgery canceled|2|||
129583976|NCT02385708|466431859|FG001|Overall Study|Withdrawn - surgery canceled|5|||
129583977|NCT02385708|466431858|FG000|Overall Study|Investigator decision|5|||
129583978|NCT02385708|466431859|FG001|Overall Study|Investigator decision|7|||
129583979|NCT02385708|466431858|FG000|Overall Study|Protocol Violation|1|||
129583980|NCT02385708|466431859|FG001|Overall Study|Protocol Violation|1|||
129583981|NCT00672984|466431860|FG000|First Intervention|Adverse Event|5|||
129583982|NCT00672984|466431861|FG001|First Intervention|Adverse Event|0|||
129583983|NCT00672984|466431862|FG002|First Intervention|Adverse Event|0|||
129583984|NCT00672984|466431860|FG000|First Intervention|Withdrawal by Subject|1|||
129583985|NCT00672984|466431861|FG001|First Intervention|Withdrawal by Subject|2|||
129583986|NCT00672984|466431862|FG002|First Intervention|Withdrawal by Subject|2|||
129583987|NCT00672984|466431860|FG000|First Intervention|Sponsor decision|3|||
129583988|NCT00672984|466431861|FG001|First Intervention|Sponsor decision|0|||
129583989|NCT00672984|466431862|FG002|First Intervention|Sponsor decision|0|||
129583990|NCT00672984|466431860|FG000|Second Intervention|Non-compliance with facility policies|0|||
129583991|NCT00672984|466431861|FG001|Second Intervention|Non-compliance with facility policies|2|||
129583992|NCT00672984|466431862|FG002|Second Intervention|Non-compliance with facility policies|0|||
129583993|NCT00672984|466431860|FG000|Second Intervention|Withdrawal by Subject|0|||
129695956|NCT01832038|466845850|FG000|Overall Study|Protocol Violation|7|||
129695957|NCT01832038|466845850|FG000|Overall Study|Lost to Follow-up|10|||
129695958|NCT01832038|466845850|FG000|Overall Study|Withdrawal by Subject|49|||
129695959|NCT01832038|466845850|FG000|Overall Study|Visit non-compliance|2|||
129695960|NCT01832038|466845850|FG000|Overall Study|Subject refused to return visit|2|||
129695961|NCT01832038|466845850|FG000|Overall Study|Not convenient to come back to site|2|||
129695962|NCT01832038|466845850|FG000|Overall Study|Participant was asked to quit|5|||
129695963|NCT01832038|466845850|FG000|Overall Study|Back home|1|||
129695964|NCT01832038|466845850|FG000|Overall Study|Pregnancy|1|||
129695965|NCT01832038|466845850|FG000|Overall Study|Low compliance|3|||
129695966|NCT01832038|466845850|FG000|Overall Study|Prohibit procedure|2|||
129695967|NCT01832038|466845850|FG000|Overall Study|Not possible to visit the hospital|1|||
129695968|NCT01832038|466845850|FG000|Overall Study|Changes of implementation system|3|||
129695969|NCT01832038|466845850|FG000|Overall Study|Plan to pregnancy|7|||
129695970|NCT01832038|466845850|FG000|Overall Study|Bad mood and has suicidal thought|1|||
129695971|NCT01832038|466845850|FG000|Overall Study|Prohibited concomitant medication|1|||
129695972|NCT01832038|466845850|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
129695973|NCT01832038|466845850|FG000|Overall Study|Subject considered the efficacy was poor|1|||
129695974|NCT00107614|466845858|FG000|Overall Study|Physician Decision|10|||
129695975|NCT00107614|466845858|FG000|Overall Study|Death|2|||
129695976|NCT00101400|466845863|FG000|Survival Follow-Up|Alive|7|||
129695977|NCT05333965|466845884|FG000|First Intervention|Adverse Event|0|||
129695978|NCT05333965|466845885|FG001|First Intervention|Adverse Event|1|||
129695979|NCT05333965|466845884|FG000|First Intervention|Withdrawal by Subject|0|||
129695980|NCT05333965|466845885|FG001|First Intervention|Withdrawal by Subject|1|||
129695981|NCT00382863|466845886|FG000|Overall Study|Death|9|||
129695982|NCT00382863|466845887|FG001|Overall Study|Death|9|||
129695983|NCT00382863|466845886|FG000|Overall Study|Lost to Follow-up|1|||
129695984|NCT00382863|466845887|FG001|Overall Study|Lost to Follow-up|2|||
129695985|NCT00382863|466845886|FG000|Overall Study|Withdrawal by Subject|5|||
129695986|NCT00382863|466845887|FG001|Overall Study|Withdrawal by Subject|25|||
129695987|NCT02168439|466845888|FG000|Overall Study|Protocol Violation|0|||
129695988|NCT02168439|466845889|FG001|Overall Study|Protocol Violation|2|||
129695989|NCT02180672|466845892|FG000|Overall Study|Lost to Follow-up|5|||
129695990|NCT02180672|466845893|FG001|Overall Study|Lost to Follow-up|7|||
129695991|NCT02837952|466845894|FG000|Overall Study|Adverse Event|0|||
129583994|NCT00672984|466431861|FG001|Second Intervention|Withdrawal by Subject|3|||
129695992|NCT02837952|466845895|FG001|Overall Study|Adverse Event|1|||
129695993|NCT02837952|466845894|FG000|Overall Study|Withdrawal by Subject|4|||
129695994|NCT02837952|466845895|FG001|Overall Study|Withdrawal by Subject|5|||
129695995|NCT02837952|466845894|FG000|Overall Study|Medication Error|1|||
129695996|NCT02837952|466845895|FG001|Overall Study|Medication Error|0|||
129695997|NCT01362530|466845896|FG000|Base Study (Cycle 1)|Adverse Event|2|||
129583995|NCT00672984|466431862|FG002|Second Intervention|Withdrawal by Subject|0|||
129583996|NCT00672984|466431860|FG000|Second Intervention|Protocol Violation|0|||
129583997|NCT00672984|466431861|FG001|Second Intervention|Protocol Violation|1|||
129583998|NCT00672984|466431862|FG002|Second Intervention|Protocol Violation|1|||
129583999|NCT00672984|466431860|FG000|Third Intervention|Adverse Event|1|||
129584000|NCT00672984|466431861|FG001|Third Intervention|Adverse Event|0|||
129584001|NCT00672984|466431862|FG002|Third Intervention|Adverse Event|1|||
129584002|NCT00645853|466431863|FG000|Overall Study|Adverse Event|18|||
129584003|NCT00645853|466431864|FG001|Overall Study|Adverse Event|7|||
129584004|NCT00645853|466431863|FG000|Overall Study|AZ study closure in Hungary|60|||
129584005|NCT00645853|466431864|FG001|Overall Study|AZ study closure in Hungary|40|||
129584006|NCT00645853|466431863|FG000|Overall Study|Withdrawal by Subject|5|||
129584007|NCT00645853|466431864|FG001|Overall Study|Withdrawal by Subject|2|||
129584008|NCT00645853|466431863|FG000|Overall Study|Protocol Violation|0|||
129584009|NCT00645853|466431864|FG001|Overall Study|Protocol Violation|2|||
129584010|NCT00645853|466431863|FG000|Overall Study|Discontinuation criteria|2|||
129584011|NCT00645853|466431864|FG001|Overall Study|Discontinuation criteria|2|||
129584012|NCT00645853|466431863|FG000|Overall Study|recall of ICF, planned operation, death|7|||
129584013|NCT00645853|466431864|FG001|Overall Study|recall of ICF, planned operation, death|4|||
129584014|NCT04060251|466431865|FG000|Overall Study|Study terminated due to low enrollment.|7|||
129584015|NCT04060251|466431866|FG001|Overall Study|Study terminated due to low enrollment.|5|||
129584016|NCT04060251|466431867|FG002|Overall Study|Study terminated due to low enrollment.|7|||
129584017|NCT04060251|466431865|FG000|Overall Study|Adverse Event|1|||
129584018|NCT04060251|466431866|FG001|Overall Study|Adverse Event|1|||
129584019|NCT04060251|466431867|FG002|Overall Study|Adverse Event|0|||
129584020|NCT00487435|466431868|FG000|Overall Study|Adverse Event|146|||
129584021|NCT00487435|466431868|FG000|Overall Study|Death|2|||
129584022|NCT00487435|466431868|FG000|Overall Study|Lack of Efficacy|33|||
129584023|NCT00487435|466431868|FG000|Overall Study|Lost to Follow-up|54|||
129584024|NCT00487435|466431868|FG000|Overall Study|Pregnancy|2|||
129584025|NCT00487435|466431868|FG000|Overall Study|Withdrawal by Subject|132|||
129584026|NCT00487435|466431868|FG000|Overall Study|Resolution Of Pain|1|||
129584027|NCT00487435|466431868|FG000|Overall Study|Study Medication Non-Compliant|32|||
129584028|NCT00487435|466431868|FG000|Overall Study|Other|83|||
129584029|NCT00985751|466431869|FG000|Overall Study|Adverse Event|0|||
129584030|NCT00985751|466431870|FG001|Overall Study|Adverse Event|0|||
129584031|NCT00985751|466431871|FG002|Overall Study|Adverse Event|0|||
129584032|NCT00985751|466431872|FG003|Overall Study|Adverse Event|0|||
129584033|NCT00985751|466431873|FG004|Overall Study|Adverse Event|1|||
129584034|NCT00858403|466431880|FG000|Overall Study|Withdrawal by Subject|1|||
129584035|NCT00858403|466431880|FG000|Overall Study|Death|3|||
129584036|NCT00858403|466431880|FG000|Overall Study|Disease Progression|1|||
129584037|NCT03867760|466431883|FG000|Overall Study|Lost to Follow-up|2|||
129584038|NCT03867760|466431884|FG001|Overall Study|Lost to Follow-up|3|||
129584039|NCT03867760|466431883|FG000|Overall Study|Withdrawal by Subject|1|||
129584040|NCT03867760|466431884|FG001|Overall Study|Withdrawal by Subject|2|||
129584041|NCT03867760|466431883|FG000|Overall Study|subject could not meet study logistics|3|||
129584042|NCT03867760|466431884|FG001|Overall Study|subject could not meet study logistics|3|||
129584043|NCT01018862|466431889|FG000|Overall Study|Adverse Event|2|||
129584044|NCT01018862|466431890|FG001|Overall Study|Adverse Event|0|||
129584045|NCT01018862|466431891|FG002|Overall Study|Adverse Event|6|||
129584046|NCT01018862|466431889|FG000|Overall Study|Lack of Efficacy|1|||
129584047|NCT01018862|466431890|FG001|Overall Study|Lack of Efficacy|0|||
129584048|NCT01018862|466431891|FG002|Overall Study|Lack of Efficacy|2|||
129584049|NCT01018862|466431889|FG000|Overall Study|Lost to Follow-up|3|||
129584050|NCT01018862|466431890|FG001|Overall Study|Lost to Follow-up|1|||
129584051|NCT01018862|466431891|FG002|Overall Study|Lost to Follow-up|0|||
129695998|NCT01362530|466845897|FG001|Base Study (Cycle 1)|Adverse Event|0|||
129695999|NCT01362530|466845896|FG000|Base Study (Cycle 1)|Physician Decision|0|||
129696000|NCT01362530|466845897|FG001|Base Study (Cycle 1)|Physician Decision|1|||
129696001|NCT01362530|466845896|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
129696002|NCT01362530|466845897|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
129696003|NCT01362530|466845896|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
129696004|NCT01362530|466845897|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
129696005|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
129696006|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
129584052|NCT01018862|466431889|FG000|Overall Study|Protocol Violation|1|||
129584053|NCT01018862|466431890|FG001|Overall Study|Protocol Violation|3|||
129584054|NCT01018862|466431891|FG002|Overall Study|Protocol Violation|3|||
129584055|NCT01018862|466431889|FG000|Overall Study|Withdrawal by Subject|1|||
129584056|NCT01018862|466431890|FG001|Overall Study|Withdrawal by Subject|2|||
129584057|NCT01018862|466431891|FG002|Overall Study|Withdrawal by Subject|1|||
129584058|NCT01018862|466431889|FG000|Overall Study|administrative problems|5|||
129696007|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
129584059|NCT01018862|466431890|FG001|Overall Study|administrative problems|4|||
129584060|NCT01018862|466431891|FG002|Overall Study|administrative problems|4|||
129584061|NCT00840879|466431892|FG000|Second Intervention|Withdrawal by Subject|1|||
129584062|NCT00840879|466431893|FG001|Second Intervention|Withdrawal by Subject|0|||
129584063|NCT04236596|466431894|FG000|Overall Study|Withdrawal by Subject|1|||
129584064|NCT04236596|466431894|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
129584065|NCT04236596|466431894|FG000|Overall Study|Participants did not receive implant at all|4|||
129584066|NCT02957331|466431897|FG000|Overall Study|Protocol Violation|1|||
129584067|NCT02957331|466431898|FG001|Overall Study|Protocol Violation|0|||
129584068|NCT02583048|466433567|FG000|Overall Study|Withdrawal by Subject|0|||
129584069|NCT02583048|466433568|FG001|Overall Study|Withdrawal by Subject|1|||
129584070|NCT02583048|466433569|FG002|Overall Study|Withdrawal by Subject|0|||
129584071|NCT02583048|466433567|FG000|Overall Study|Failed to meet eligibility criterion|0|||
129584072|NCT02583048|466433568|FG001|Overall Study|Failed to meet eligibility criterion|0|||
129584073|NCT02583048|466433569|FG002|Overall Study|Failed to meet eligibility criterion|1|||
129584074|NCT01151280|466433575|FG000|Overall Study|Adverse Event|1|||
129584075|NCT01151280|466433575|FG000|Overall Study|Lack of Efficacy|3|||
129584076|NCT01243151|466433576|FG000|Overall Study|Adverse Event|0|||
129584077|NCT01243151|466433577|FG001|Overall Study|Adverse Event|1|||
129584078|NCT01243151|466433578|FG002|Overall Study|Adverse Event|0|||
129584079|NCT01243151|466433579|FG003|Overall Study|Adverse Event|0|||
129584080|NCT01243151|466433580|FG004|Overall Study|Adverse Event|0|||
129584081|NCT01243151|466433576|FG000|Overall Study|Protocol Violation|0|||
129584082|NCT01243151|466433577|FG001|Overall Study|Protocol Violation|0|||
129584083|NCT01243151|466433578|FG002|Overall Study|Protocol Violation|1|||
129584084|NCT01243151|466433579|FG003|Overall Study|Protocol Violation|0|||
129584085|NCT01243151|466433580|FG004|Overall Study|Protocol Violation|0|||
129584086|NCT01243151|466433576|FG000|Overall Study|Other|0|||
129584087|NCT01243151|466433577|FG001|Overall Study|Other|0|||
129584088|NCT01243151|466433578|FG002|Overall Study|Other|0|||
129584089|NCT01243151|466433579|FG003|Overall Study|Other|1|||
129584090|NCT01243151|466433580|FG004|Overall Study|Other|0|||
129584091|NCT01243151|466433576|FG000|Overall Study|Randomized but not treated|0|||
129584092|NCT01243151|466433577|FG001|Overall Study|Randomized but not treated|0|||
129584093|NCT01243151|466433578|FG002|Overall Study|Randomized but not treated|0|||
129584094|NCT01243151|466433579|FG003|Overall Study|Randomized but not treated|1|||
129584095|NCT01243151|466433580|FG004|Overall Study|Randomized but not treated|0|||
129584096|NCT02308241|466433583|FG000|Overall Study|Withdrawal by Subject|3|||
129584097|NCT04408924|466433584|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
129584098|NCT04408924|466433584|FG000|Overall Study|Lost to Follow-up|3|||
129584099|NCT04408924|466433584|FG000|Overall Study|Withdrawal by Subject|5|||
129584100|NCT04408924|466433584|FG000|Overall Study|Sponsor Decision|2|||
129584101|NCT02578641|466433585|FG000|Overall Study|Adverse Event|5|||
129584102|NCT02578641|466433586|FG001|Overall Study|Adverse Event|15|||
129584103|NCT02578641|466433585|FG000|Overall Study|Death|16|||
129584104|NCT02578641|466433586|FG001|Overall Study|Death|8|||
129584105|NCT02578641|466433585|FG000|Overall Study|Lost to Follow-up|0|||
129584106|NCT02578641|466433586|FG001|Overall Study|Lost to Follow-up|1|||
129584107|NCT02578641|466433585|FG000|Overall Study|Withdrawal by Subject|14|||
129584108|NCT02578641|466433586|FG001|Overall Study|Withdrawal by Subject|7|||
129584109|NCT02578641|466433585|FG000|Overall Study|Progressive Disease|69|||
129584110|NCT02578641|466433586|FG001|Overall Study|Progressive Disease|21|||
129584111|NCT02578641|466433585|FG000|Overall Study|No Study Drug|2|||
129584112|NCT02578641|466433586|FG001|Overall Study|No Study Drug|0|||
129584113|NCT02578641|466433585|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
129584114|NCT02578641|466433586|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
129584115|NCT02578641|466433585|FG000|Overall Study|Non-compliance with Study Schedule|1|||
129584116|NCT02578641|466433586|FG001|Overall Study|Non-compliance with Study Schedule|0|||
129584117|NCT02578641|466433585|FG000|Overall Study|Other|1|||
129584118|NCT02578641|466433586|FG001|Overall Study|Other|10|||
129584119|NCT02578641|466433585|FG000|Overall Study|Not treated|1|||
129584120|NCT02578641|466433586|FG001|Overall Study|Not treated|4|||
129584121|NCT00084864|466433589|FG000|Overall Study|Adverse Event|1|||
129584122|NCT00084864|466433590|FG001|Overall Study|Adverse Event|0|||
129584123|NCT00084864|466433591|FG002|Overall Study|Adverse Event|0|||
129584124|NCT00084864|466433592|FG003|Overall Study|Adverse Event|0|||
129584125|NCT01741545|466433593|FG000|Treatment Period|Lack of Efficacy|0|||
129584126|NCT01741545|466433594|FG001|Treatment Period|Lack of Efficacy|1|||
129584127|NCT01741545|466433593|FG000|Treatment Period|Adverse event, non-fatal|1|||
129584128|NCT01741545|466433594|FG001|Treatment Period|Adverse event, non-fatal|3|||
129584129|NCT01741545|466433593|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
129584130|NCT01741545|466433594|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
129584131|NCT01741545|466433593|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
129584132|NCT01741545|466433594|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
129584133|NCT01456962|466433595|FG000|Overall Study|Lost to Follow-up|2|||
129584134|NCT01456962|466433596|FG001|Overall Study|Lost to Follow-up|1|||
129584135|NCT01853176|466433597|FG000|Overall Study|Study terminated|4|||
129584136|NCT01853176|466433598|FG001|Overall Study|Study terminated|0|||
129584137|NCT01370083|466433601|FG000|Overall Study|Lost to Follow-up|2|||
129584138|NCT01370083|466433602|FG001|Overall Study|Lost to Follow-up|0|||
129584139|NCT01370083|466433601|FG000|Overall Study|Adverse Event|0|||
129584140|NCT01370083|466433602|FG001|Overall Study|Adverse Event|1|||
129584141|NCT00731939|466433604|FG000|Overall Study|Adverse Event|6|||
129584142|NCT00731939|466433604|FG000|Overall Study|Lost to Follow-up|15|||
129584143|NCT00731939|466433604|FG000|Overall Study|Not implanted with study device|9|||
129584144|NCT00731939|466433604|FG000|Overall Study|Withdrawal by Subject|2|||
129584145|NCT00731939|466433604|FG000|Overall Study|Did not meet enrollment criteria|2|||
129584146|NCT02072096|466433605|FG000|Overall Study|Lack of Efficacy|18|||
129584147|NCT02072096|466433606|FG001|Overall Study|Lack of Efficacy|29|||
129584148|NCT02072096|466433605|FG000|Overall Study|Protocol Violation|7|||
129584149|NCT02072096|466433606|FG001|Overall Study|Protocol Violation|7|||
129584150|NCT02072096|466433605|FG000|Overall Study|Withdrawal by Subject|5|||
129584151|NCT02072096|466433606|FG001|Overall Study|Withdrawal by Subject|7|||
129584152|NCT02072096|466433605|FG000|Overall Study|Adverse Event|5|||
129584153|NCT02072096|466433606|FG001|Overall Study|Adverse Event|2|||
129584154|NCT02072096|466433605|FG000|Overall Study|No Reason Provided|4|||
129584155|NCT02072096|466433606|FG001|Overall Study|No Reason Provided|2|||
129584156|NCT02072096|466433605|FG000|Overall Study|Death|2|||
129584157|NCT02072096|466433606|FG001|Overall Study|Death|0|||
129584158|NCT02072096|466433605|FG000|Overall Study|Physician Decision|0|||
129584159|NCT02072096|466433606|FG001|Overall Study|Physician Decision|1|||
129584160|NCT02072096|466433605|FG000|Overall Study|Study Terminated by Sponsor|43|||
129584161|NCT02072096|466433606|FG001|Overall Study|Study Terminated by Sponsor|30|||
129584162|NCT02072096|466433605|FG000|Overall Study|Lost to Follow-up|1|||
129584163|NCT02072096|466433606|FG001|Overall Study|Lost to Follow-up|0|||
129584164|NCT01266902|466433608|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
129584165|NCT01266902|466433609|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
129584166|NCT01266902|466433610|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
129584167|NCT01266902|466433608|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
129584168|NCT01266902|466433609|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
129584169|NCT01266902|466433610|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
129584170|NCT01266902|466433608|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
129584171|NCT01266902|466433609|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
129584172|NCT01266902|466433610|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
129584173|NCT01266902|466433608|FG000|Period 1 (Main Study)|Adverse Event|3|||
129584174|NCT01266902|466433609|FG001|Period 1 (Main Study)|Adverse Event|11|||
129584175|NCT01266902|466433610|FG002|Period 1 (Main Study)|Adverse Event|0|||
129584176|NCT01266902|466433608|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
129584177|NCT01266902|466433609|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
129584178|NCT01266902|466433610|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
129584179|NCT01266902|466433608|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
129584180|NCT01266902|466433609|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
129584181|NCT01266902|466433610|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
129584182|NCT01266902|466433608|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
129584183|NCT01266902|466433609|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
129584184|NCT01266902|466433610|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
129584185|NCT01266902|466433608|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
129584186|NCT01266902|466433609|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
129584187|NCT01266902|466433610|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
129584188|NCT01266902|466433608|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
129584189|NCT01266902|466433609|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
129584190|NCT01266902|466433610|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
129584191|NCT01266902|466433608|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
129584192|NCT01266902|466433609|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
129584193|NCT01266902|466433610|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
129584194|NCT00387153|466433611|FG000|Overall Study|Adverse Event|1|||
129584195|NCT00387153|466433611|FG000|Overall Study|Disease Progression|3|||
129584196|NCT00387153|466433611|FG000|Overall Study|Lack of Response|4|||
129584197|NCT02420353|466433614|FG000|Overall Study|Withdrawal by Subject|0|||
129584198|NCT02420353|466433615|FG001|Overall Study|Withdrawal by Subject|1|||
129584199|NCT01149057|466433616|FG000|Overall Study|Lack of Efficacy|16|||
129584200|NCT01149057|466433616|FG000|Overall Study|Adverse Event|13|||
129584201|NCT01149057|466433616|FG000|Overall Study|Withdrawal by Subject|9|||
129584202|NCT01149057|466433616|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
129584203|NCT01149057|466433616|FG000|Overall Study|B Cell Depletion|4|||
129584204|NCT01149057|466433616|FG000|Overall Study|Participant Non-Compliance|2|||
129584205|NCT01149057|466433616|FG000|Overall Study|Lost to Follow-up|1|||
129584206|NCT01149057|466433616|FG000|Overall Study|High Parathyroid Hormone Value|1|||
129584207|NCT01149057|466433616|FG000|Overall Study|Other|6|||
129584208|NCT04608448|466433617|FG000|Overall Study|Withdrawal by Subject|1|||
129584209|NCT04608448|466433617|FG000|Overall Study|Adverse Event|1|||
129584210|NCT00654186|466433618|FG000|Overall Study|Withdrawal by Subject|5|||
129584211|NCT00577655|466433619|FG000|Overall Study|Patient Request|0|||
129584212|NCT00577655|466433620|FG001|Overall Study|Patient Request|2|||
129584213|NCT00577655|466433619|FG000|Overall Study|Protocol Violation|0|||
129584214|NCT00577655|466433620|FG001|Overall Study|Protocol Violation|1|||
129584215|NCT00577655|466433619|FG000|Overall Study|Lost to Follow-up|1|||
129584216|NCT00577655|466433620|FG001|Overall Study|Lost to Follow-up|1|||
129584217|NCT01370863|466433622|FG000|Overall Study|Adverse Event|1|||
129584218|NCT01370863|466433623|FG001|Overall Study|Adverse Event|1|||
129584219|NCT01370863|466433622|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
129584220|NCT01370863|466433623|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
129584221|NCT01370863|466433622|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129584222|NCT01370863|466433623|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
129584223|NCT01143337|466433624|FG000|Overall Study|Adverse Event|3|||
129584224|NCT01143337|466433625|FG001|Overall Study|Adverse Event|9|||
129584225|NCT01143337|466433626|FG002|Overall Study|Adverse Event|5|||
129584226|NCT01143337|466433624|FG000|Overall Study|Lack of Efficacy|6|||
129584227|NCT01143337|466433625|FG001|Overall Study|Lack of Efficacy|2|||
129584228|NCT01143337|466433626|FG002|Overall Study|Lack of Efficacy|1|||
129584229|NCT01143337|466433624|FG000|Overall Study|Protocol Violation|1|||
129584230|NCT01143337|466433625|FG001|Overall Study|Protocol Violation|0|||
129584231|NCT01143337|466433626|FG002|Overall Study|Protocol Violation|0|||
129584232|NCT01143337|466433624|FG000|Overall Study|Withdrawal by Subject|0|||
129584233|NCT01143337|466433625|FG001|Overall Study|Withdrawal by Subject|0|||
129584234|NCT01143337|466433626|FG002|Overall Study|Withdrawal by Subject|1|||
129584235|NCT01143337|466433624|FG000|Overall Study|Other reason|0|||
129584236|NCT01143337|466433625|FG001|Overall Study|Other reason|0|||
129584237|NCT01143337|466433626|FG002|Overall Study|Other reason|5|||
129584238|NCT02761915|466433627|FG000|Overall Study|Death|3|||
129584239|NCT02761915|466433628|FG001|Overall Study|Death|1|||
129584240|NCT02761915|466433629|FG002|Overall Study|Death|1|||
129584241|NCT02761915|466433630|FG003|Overall Study|Death|1|||
129584242|NCT02761915|466433631|FG004|Overall Study|Death|0|||
129584243|NCT02761915|466433632|FG005|Overall Study|Death|1|||
129584244|NCT02761915|466433627|FG000|Overall Study|Withdrawal by Subject|1|||
129584245|NCT02761915|466433628|FG001|Overall Study|Withdrawal by Subject|0|||
129584246|NCT02761915|466433629|FG002|Overall Study|Withdrawal by Subject|0|||
129584247|NCT02761915|466433630|FG003|Overall Study|Withdrawal by Subject|0|||
129584248|NCT02761915|466433631|FG004|Overall Study|Withdrawal by Subject|1|||
129584249|NCT02761915|466433632|FG005|Overall Study|Withdrawal by Subject|2|||
129584250|NCT02761915|466433627|FG000|Overall Study|Disease Progression|0|||
129584251|NCT02761915|466433628|FG001|Overall Study|Disease Progression|0|||
129584252|NCT02761915|466433629|FG002|Overall Study|Disease Progression|0|||
129584253|NCT02761915|466433630|FG003|Overall Study|Disease Progression|2|||
129584254|NCT02761915|466433631|FG004|Overall Study|Disease Progression|2|||
129584255|NCT02761915|466433632|FG005|Overall Study|Disease Progression|2|||
129584256|NCT00406393|466433646|FG000|Overall Study|Did not undergo transplantation|2|||
129584257|NCT00406393|466433647|FG001|Overall Study|Did not undergo transplantation|1|||
129584258|NCT01597791|466433648|FG000|Overall Study|Physician Decision|2|||
129584259|NCT01597791|466433649|FG001|Overall Study|Physician Decision|1|||
129584260|NCT01597791|466433648|FG000|Overall Study|Cesarean Section|6|||
129584261|NCT01597791|466433649|FG001|Overall Study|Cesarean Section|7|||
129584262|NCT01597791|466433648|FG000|Overall Study|Subject withdrawal|0|||
129584263|NCT01597791|466433649|FG001|Overall Study|Subject withdrawal|1|||
129584264|NCT01597791|466433648|FG000|Overall Study|Protocol Violation|0|||
129584265|NCT01597791|466433649|FG001|Overall Study|Protocol Violation|1|||
129584266|NCT01087502|466433650|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
129584267|NCT01087502|466433651|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
129584268|NCT01087502|466433650|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
129584269|NCT01087502|466433651|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
129584270|NCT01087502|466433650|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
129584271|NCT01087502|466433651|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
129584272|NCT01087502|466433650|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
129584273|NCT01087502|466433651|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
129584274|NCT01087502|466433650|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
129584275|NCT01087502|466433651|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
129584276|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
129584277|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
129584278|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
129584279|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
129584280|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
129584281|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
129584282|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
129584283|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
129584284|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
129584285|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
129584286|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
129584287|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
129584288|NCT01087502|466433650|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
129584289|NCT01087502|466433651|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
129584290|NCT01151618|466433652|FG000|Overall Study|Adverse Event|2|||
129584291|NCT01151618|466433652|FG000|Overall Study|Withdrawal by Subject|7|||
129584292|NCT01632306|466433653|FG000|Overall Study|Protocol Violation|1|||
129584293|NCT01632306|466433654|FG001|Overall Study|Protocol Violation|0|||
129584294|NCT01632306|466433655|FG002|Overall Study|Protocol Violation|0|||
129584295|NCT00380588|466433658|FG000|Overall Study|Unequivocal Disease Progression|25|||
129584296|NCT00380588|466433659|FG001|Overall Study|Unequivocal Disease Progression|34|||
129584297|NCT00380588|466433658|FG000|Overall Study|Next Cycle Not Started|4|||
129584298|NCT00380588|466433659|FG001|Overall Study|Next Cycle Not Started|0|||
129584299|NCT00380588|466433658|FG000|Overall Study|Adverse Event|7|||
129584300|NCT00380588|466433659|FG001|Overall Study|Adverse Event|3|||
129584301|NCT00380588|466433658|FG000|Overall Study|Withdrawal by Subject|1|||
129584302|NCT00380588|466433659|FG001|Overall Study|Withdrawal by Subject|3|||
129584303|NCT00380588|466433658|FG000|Overall Study|Physician Decision|2|||
129584304|NCT00380588|466433659|FG001|Overall Study|Physician Decision|0|||
129584305|NCT01663896|466433660|FG000|Overall Study|Various reasons|43|||
129584306|NCT01451541|466433661|FG000|Overall Study|Adverse Event|4|||
129584307|NCT01451541|466433662|FG001|Overall Study|Adverse Event|3|||
129584308|NCT01451541|466433663|FG002|Overall Study|Adverse Event|6|||
129584309|NCT01451541|466433661|FG000|Overall Study|Lack of Efficacy|2|||
129584310|NCT01451541|466433662|FG001|Overall Study|Lack of Efficacy|0|||
129584311|NCT01451541|466433663|FG002|Overall Study|Lack of Efficacy|0|||
129584312|NCT01451541|466433661|FG000|Overall Study|Lost to Follow-up|4|||
129584313|NCT01451541|466433662|FG001|Overall Study|Lost to Follow-up|4|||
129584314|NCT01451541|466433663|FG002|Overall Study|Lost to Follow-up|7|||
129584315|NCT01451541|466433661|FG000|Overall Study|Withdrawal by Subject|15|||
129584316|NCT01451541|466433662|FG001|Overall Study|Withdrawal by Subject|8|||
129584317|NCT01451541|466433663|FG002|Overall Study|Withdrawal by Subject|6|||
129584318|NCT01451541|466433661|FG000|Overall Study|randomization error, noncompliance|11|||
129584319|NCT01451541|466433662|FG001|Overall Study|randomization error, noncompliance|10|||
129584320|NCT01451541|466433663|FG002|Overall Study|randomization error, noncompliance|8|||
129584321|NCT03366428|466433664|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
129584322|NCT03366428|466433664|FG000|Overall Study|Adverse Event|12|||
129584323|NCT03366428|466433664|FG000|Overall Study|Clinical progression|2|||
129584324|NCT03366428|466433664|FG000|Overall Study|Withdrawal by Subject|4|||
129584325|NCT01046084|466433669|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
129584326|NCT01046084|466433670|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
129584327|NCT03614728|466433671|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
129584328|NCT03614728|466433672|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
129584329|NCT03614728|466433673|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
129584330|NCT03614728|466433674|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
129584331|NCT03614728|466433671|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
129584332|NCT03614728|466433672|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
129584333|NCT03614728|466433673|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
129584334|NCT03614728|466433674|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
129584335|NCT00379353|466433675|FG000|Overall Study|Hospitalization|3|||
129584336|NCT00379353|466433676|FG001|Overall Study|Hospitalization|3|||
129584337|NCT00379353|466433675|FG000|Overall Study|Withdrawal by Subject|5|||
129584338|NCT00379353|466433676|FG001|Overall Study|Withdrawal by Subject|2|||
129584339|NCT00379353|466433675|FG000|Overall Study|Death|1|||
129584340|NCT00379353|466433676|FG001|Overall Study|Death|0|||
129584341|NCT00379353|466433675|FG000|Overall Study|Cardiac Tamponade|1|||
129584342|NCT00379353|466433676|FG001|Overall Study|Cardiac Tamponade|0|||
129584343|NCT00379353|466433675|FG000|Overall Study|Non-compliance|1|||
129584344|NCT00379353|466433676|FG001|Overall Study|Non-compliance|0|||
129584345|NCT00379353|466433675|FG000|Overall Study|Conflicting drug treatment|0|||
129584346|NCT00379353|466433676|FG001|Overall Study|Conflicting drug treatment|1|||
129584347|NCT01824576|466433677|FG000|Overall Study|Device deficiency|2|||
129584348|NCT01958476|466433678|FG000|Overall Study|Parent requested exclusion from analysis|1|||
129584349|NCT01958476|466433679|FG001|Overall Study|Parent requested exclusion from analysis|0|||
129584350|NCT03727139|466433682|FG000|Overall Study|Protocol Violation|60|||
129584351|NCT01120028|466433683|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
129584352|NCT01120028|466433684|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
129584353|NCT01120028|466433685|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
129584354|NCT01120028|466433686|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
129696008|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
129584355|NCT01120028|466433683|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
129584356|NCT01120028|466433684|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
129584357|NCT01120028|466433685|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
129584358|NCT01120028|466433686|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
129584359|NCT00556673|466433687|FG000|Overall Study|Protocol deviation|3|||
129584360|NCT00556673|466433688|FG001|Overall Study|Protocol deviation|2|||
129584361|NCT01401062|466433691|FG000|Overall Study|Death|9|||
129584362|NCT01401062|466433692|FG001|Overall Study|Death|7|||
129584363|NCT01401062|466433691|FG000|Overall Study|Physician Decision|1|||
129584364|NCT01401062|466433692|FG001|Overall Study|Physician Decision|0|||
129584365|NCT01401062|466433691|FG000|Overall Study|Withdrawal by Subject|1|||
129584366|NCT01401062|466433692|FG001|Overall Study|Withdrawal by Subject|1|||
129584367|NCT03555695|466433693|FG000|Overall Study|Withdrawal by Subject|1|||
129584368|NCT03555695|466433693|FG000|Overall Study|Lost to Follow-up|1|||
129584369|NCT03555695|466433693|FG000|Overall Study|appendicitis (unrelated)|1|||
129584370|NCT03555695|466433693|FG000|Overall Study|pre-existing sciatica|1|||
129584371|NCT01131260|466433694|FG000|Overall Study|Randomization error|5|||
129584372|NCT01131260|466433695|FG001|Overall Study|Randomization error|1|||
129584373|NCT01131260|466433694|FG000|Overall Study|Declined to continue participation|8|||
129584374|NCT01131260|466433695|FG001|Overall Study|Declined to continue participation|13|||
129584375|NCT01131260|466433694|FG000|Overall Study|Physician Decision|22|||
129584376|NCT01131260|466433695|FG001|Overall Study|Physician Decision|24|||
129584377|NCT01131260|466433694|FG000|Overall Study|Technical problems|7|||
129584378|NCT01131260|466433695|FG001|Overall Study|Technical problems|6|||
129584379|NCT01131260|466433694|FG000|Overall Study|Staff error|2|||
129584380|NCT01131260|466433695|FG001|Overall Study|Staff error|1|||
129584381|NCT01131260|466433694|FG000|Overall Study|Ineligible|0|||
129584382|NCT01131260|466433695|FG001|Overall Study|Ineligible|2|||
129584383|NCT00757172|466433696|FG000|Overall Study|Withdrawal by Subject|4|||
129584384|NCT00757172|466433696|FG000|Overall Study|Physician Decision|3|||
129584385|NCT00757172|466433696|FG000|Overall Study|Progression|4|||
129584386|NCT03247686|466435570|FG000|Overall Study|Withdrawal by Subject|1|||
129584387|NCT03247686|466435571|FG001|Overall Study|Withdrawal by Subject|2|||
129584388|NCT00754052|466435583|FG000|Overall Study|Study terminated by Sponsor|5|||
129584389|NCT00754052|466435584|FG001|Overall Study|Study terminated by Sponsor|3|||
129584390|NCT02658019|466435586|FG000|Overall Study|Adverse Event|1|||
129584391|NCT04364854|466435587|FG000|Overall Study|Withdrawal by Subject|1|||
129584392|NCT04364854|466435588|FG001|Overall Study|Withdrawal by Subject|0|||
129584393|NCT04364854|466435589|FG002|Overall Study|Withdrawal by Subject|1|||
129584394|NCT04364854|466435590|FG003|Overall Study|Withdrawal by Subject|3|||
129584395|NCT04364854|466435587|FG000|Overall Study|Death|1|||
129584396|NCT04364854|466435588|FG001|Overall Study|Death|0|||
129584397|NCT04364854|466435589|FG002|Overall Study|Death|0|||
129584398|NCT04364854|466435590|FG003|Overall Study|Death|0|||
129584399|NCT04364854|466435587|FG000|Overall Study|Lost to Follow-up|0|||
129584400|NCT04364854|466435588|FG001|Overall Study|Lost to Follow-up|0|||
129584401|NCT04364854|466435589|FG002|Overall Study|Lost to Follow-up|0|||
129584402|NCT04364854|466435590|FG003|Overall Study|Lost to Follow-up|1|||
129584403|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
129584404|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
129584405|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
129584406|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
129584407|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
129584408|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
129584409|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
129584410|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
129584411|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
129584412|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
129584413|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
129584414|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
129584415|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
129584416|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
129584417|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
129584418|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
129584419|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
129584420|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
129584421|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
129584422|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
129584423|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
129584424|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
129584425|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
129584426|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
129584427|NCT01710358|466435591|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
129584428|NCT01710358|466435592|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
129584429|NCT01710358|466435593|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
129584430|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
129584431|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
129584432|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
129584433|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
129584434|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
129584435|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
129584436|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
129584437|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
129584438|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
129584439|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
129584440|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
129584441|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
129584442|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
129584443|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
129584444|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
129584445|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
129584446|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
129584447|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
129584448|NCT01710358|466435591|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
129584449|NCT01710358|466435592|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
129885086|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885087|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
129885088|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885089|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885090|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885091|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885092|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885093|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885094|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885095|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885096|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
129885097|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
129885098|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
129885099|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885100|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885101|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885102|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885103|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885104|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129584450|NCT01710358|466435593|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
129584451|NCT01710358|466435591|FG000|Rescue Period|Adverse Event|0|||
129584452|NCT01710358|466435592|FG001|Rescue Period|Adverse Event|15|||
129584453|NCT01710358|466435593|FG002|Rescue Period|Adverse Event|0|||
129584454|NCT01710358|466435591|FG000|Rescue Period|Death|0|||
129584455|NCT01710358|466435592|FG001|Rescue Period|Death|1|||
129584456|NCT01710358|466435593|FG002|Rescue Period|Death|0|||
129584457|NCT01710358|466435591|FG000|Rescue Period|Lack of Efficacy|0|||
129584458|NCT01710358|466435592|FG001|Rescue Period|Lack of Efficacy|7|||
129584459|NCT01710358|466435593|FG002|Rescue Period|Lack of Efficacy|0|||
129584460|NCT01710358|466435591|FG000|Rescue Period|Withdrawal by Subject|0|||
129584461|NCT01710358|466435592|FG001|Rescue Period|Withdrawal by Subject|8|||
129584462|NCT01710358|466435593|FG002|Rescue Period|Withdrawal by Subject|0|||
129584463|NCT00396162|466435597|FG000|Overall Study|Withdrawal by Subject|2|||
129584464|NCT00396162|466435598|FG001|Overall Study|Withdrawal by Subject|3|||
129584465|NCT03540160|466435600|FG000|Overall Study|Protocol Violation|1|||
129584466|NCT03540160|466435600|FG000|Overall Study|Physician Decision|8|||
129584467|NCT03540160|466435600|FG000|Overall Study|Lack of Efficacy|60|||
129584468|NCT03540160|466435600|FG000|Overall Study|Pregnancy|1|||
129584469|NCT03540160|466435600|FG000|Overall Study|Adverse Event|20|||
129584470|NCT03540160|466435600|FG000|Overall Study|Withdrawal by Subject|68|||
129584471|NCT03540160|466435600|FG000|Overall Study|COVID-19|2|||
129584472|NCT03540160|466435600|FG000|Overall Study|Study Closure|10|||
129584473|NCT03540160|466435600|FG000|Overall Study|Lost to Follow-up|18|||
129584474|NCT03540160|466435600|FG000|Overall Study|Sponsor decision|191|||
129584475|NCT03358147|466435605|FG000|Overall Study|Withdrawal by Subject|13|||
129584476|NCT03358147|466435606|FG001|Overall Study|Withdrawal by Subject|19|||
129584477|NCT03358147|466435607|FG002|Overall Study|Withdrawal by Subject|16|||
129584478|NCT03358147|466435608|FG003|Overall Study|Withdrawal by Subject|10|||
129584479|NCT03358147|466435609|FG004|Overall Study|Withdrawal by Subject|5|||
129584480|NCT03358147|466435605|FG000|Overall Study|Adverse Event|3|||
129584481|NCT03358147|466435606|FG001|Overall Study|Adverse Event|9|||
129584482|NCT03358147|466435607|FG002|Overall Study|Adverse Event|7|||
129584483|NCT03358147|466435608|FG003|Overall Study|Adverse Event|5|||
129584484|NCT03358147|466435609|FG004|Overall Study|Adverse Event|2|||
129584485|NCT03358147|466435605|FG000|Overall Study|Lost to Follow-up|4|||
129584486|NCT03358147|466435606|FG001|Overall Study|Lost to Follow-up|3|||
129584487|NCT03358147|466435607|FG002|Overall Study|Lost to Follow-up|7|||
129584488|NCT03358147|466435608|FG003|Overall Study|Lost to Follow-up|6|||
129584489|NCT03358147|466435609|FG004|Overall Study|Lost to Follow-up|4|||
129584490|NCT03358147|466435605|FG000|Overall Study|Major Protocol Deviation|11|||
129584491|NCT03358147|466435606|FG001|Overall Study|Major Protocol Deviation|3|||
129584492|NCT03358147|466435607|FG002|Overall Study|Major Protocol Deviation|2|||
129584493|NCT03358147|466435608|FG003|Overall Study|Major Protocol Deviation|3|||
129584494|NCT03358147|466435609|FG004|Overall Study|Major Protocol Deviation|1|||
129584495|NCT03358147|466435605|FG000|Overall Study|Protocol specified criteria|2|||
129584496|NCT03358147|466435606|FG001|Overall Study|Protocol specified criteria|3|||
129584497|NCT03358147|466435607|FG002|Overall Study|Protocol specified criteria|0|||
129584498|NCT03358147|466435608|FG003|Overall Study|Protocol specified criteria|3|||
129584499|NCT03358147|466435609|FG004|Overall Study|Protocol specified criteria|1|||
129584500|NCT03358147|466435605|FG000|Overall Study|Physician Decision|1|||
129584501|NCT03358147|466435606|FG001|Overall Study|Physician Decision|0|||
129584502|NCT03358147|466435607|FG002|Overall Study|Physician Decision|1|||
129584503|NCT03358147|466435608|FG003|Overall Study|Physician Decision|6|||
129584504|NCT03358147|466435609|FG004|Overall Study|Physician Decision|1|||
129584505|NCT03358147|466435605|FG000|Overall Study|Administrative reasons|0|||
129584506|NCT03358147|466435606|FG001|Overall Study|Administrative reasons|1|||
129584507|NCT03358147|466435607|FG002|Overall Study|Administrative reasons|0|||
129584508|NCT03358147|466435608|FG003|Overall Study|Administrative reasons|3|||
129885105|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
129885106|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
129584509|NCT03358147|466435609|FG004|Overall Study|Administrative reasons|0|||
129584510|NCT03358147|466435605|FG000|Overall Study|Lack of Efficacy|0|||
129584511|NCT03358147|466435606|FG001|Overall Study|Lack of Efficacy|1|||
129584512|NCT03358147|466435607|FG002|Overall Study|Lack of Efficacy|1|||
129584513|NCT03358147|466435608|FG003|Overall Study|Lack of Efficacy|0|||
129584514|NCT03358147|466435609|FG004|Overall Study|Lack of Efficacy|0|||
129584515|NCT02704091|466435610|FG000|Overall Study|Adverse Event|4|||
129584516|NCT02704091|466435611|FG001|Overall Study|Adverse Event|3|||
129584517|NCT02704091|466435610|FG000|Overall Study|Protocol Violation|5|||
129584518|NCT02704091|466435611|FG001|Overall Study|Protocol Violation|3|||
129584519|NCT02704091|466435610|FG000|Overall Study|Consent withdrawn|4|||
129584520|NCT02704091|466435611|FG001|Overall Study|Consent withdrawn|4|||
129584521|NCT02704091|466435610|FG000|Overall Study|Lost to Follow-up|13|||
129584522|NCT02704091|466435611|FG001|Overall Study|Lost to Follow-up|5|||
129584523|NCT02704091|466435610|FG000|Overall Study|Other|2|||
129584524|NCT02704091|466435611|FG001|Overall Study|Other|8|||
129584525|NCT03073798|466435617|FG000|Overall Study|Adverse Event|1|||
129584526|NCT03073798|466435617|FG000|Overall Study|Withdrawal by Subject|1|||
129584527|NCT02640235|466435618|FG000|Overall Study|Withdrawal by Subject|7|||
129584528|NCT02640235|466435619|FG001|Overall Study|Withdrawal by Subject|6|||
129584529|NCT02640235|466435618|FG000|Overall Study|Lost to Follow-up|4|||
129584530|NCT02640235|466435619|FG001|Overall Study|Lost to Follow-up|3|||
129584531|NCT02640235|466435618|FG000|Overall Study|Death|2|||
129584532|NCT02640235|466435619|FG001|Overall Study|Death|3|||
129584533|NCT02640235|466435618|FG000|Overall Study|Other|1|||
129584534|NCT02640235|466435619|FG001|Overall Study|Other|2|||
129584535|NCT00301964|466435620|FG000|Overall Study|Second primary|2|||
129584536|NCT00301964|466435620|FG000|Overall Study|Wrong primary|1|||
129584537|NCT00301964|466435620|FG000|Overall Study|Inadequate pathology|1|||
129584538|NCT00819169|466435621|FG000|Overall Study|Withdrawal by Subject|2|||
129584539|NCT00819169|466435622|FG001|Overall Study|Withdrawal by Subject|0|||
129584540|NCT00819169|466435623|FG002|Overall Study|Withdrawal by Subject|0|||
129584541|NCT00819169|466435624|FG003|Overall Study|Withdrawal by Subject|1|||
129584542|NCT00819169|466435625|FG004|Overall Study|Withdrawal by Subject|1|||
129584543|NCT00819169|466435626|FG005|Overall Study|Withdrawal by Subject|1|||
129584544|NCT00819169|466435627|FG006|Overall Study|Withdrawal by Subject|5|||
129584545|NCT00819169|466435628|FG007|Overall Study|Withdrawal by Subject|1|||
129584546|NCT00819169|466435629|FG008|Overall Study|Withdrawal by Subject|4|||
129584547|NCT00819169|466435621|FG000|Overall Study|Lost to Follow-up|0|||
129584548|NCT00819169|466435622|FG001|Overall Study|Lost to Follow-up|2|||
129584549|NCT00819169|466435623|FG002|Overall Study|Lost to Follow-up|0|||
129584550|NCT00819169|466435624|FG003|Overall Study|Lost to Follow-up|1|||
129584551|NCT00819169|466435625|FG004|Overall Study|Lost to Follow-up|0|||
129584552|NCT00819169|466435626|FG005|Overall Study|Lost to Follow-up|6|||
129584553|NCT00819169|466435627|FG006|Overall Study|Lost to Follow-up|2|||
129584554|NCT00819169|466435628|FG007|Overall Study|Lost to Follow-up|2|||
129584555|NCT00819169|466435629|FG008|Overall Study|Lost to Follow-up|1|||
129584556|NCT00819169|466435621|FG000|Overall Study|Death|1|||
129584557|NCT00819169|466435622|FG001|Overall Study|Death|1|||
129584558|NCT00819169|466435623|FG002|Overall Study|Death|3|||
129584559|NCT00819169|466435624|FG003|Overall Study|Death|8|||
129584560|NCT00819169|466435625|FG004|Overall Study|Death|5|||
129584561|NCT00819169|466435626|FG005|Overall Study|Death|7|||
129584562|NCT00819169|466435627|FG006|Overall Study|Death|9|||
129584563|NCT00819169|466435628|FG007|Overall Study|Death|4|||
129584564|NCT00819169|466435629|FG008|Overall Study|Death|7|||
129584565|NCT00819169|466435621|FG000|Overall Study|Ineligibility determined|0|||
129584566|NCT00819169|466435622|FG001|Overall Study|Ineligibility determined|0|||
129584567|NCT00819169|466435623|FG002|Overall Study|Ineligibility determined|0|||
129584568|NCT00819169|466435624|FG003|Overall Study|Ineligibility determined|2|||
129584569|NCT00819169|466435625|FG004|Overall Study|Ineligibility determined|0|||
129584570|NCT00819169|466435626|FG005|Overall Study|Ineligibility determined|0|||
129584571|NCT00819169|466435627|FG006|Overall Study|Ineligibility determined|0|||
129584572|NCT00819169|466435628|FG007|Overall Study|Ineligibility determined|0|||
129584573|NCT00819169|466435629|FG008|Overall Study|Ineligibility determined|1|||
129584574|NCT00819169|466435621|FG000|Overall Study|Adverse Event|0|||
129584575|NCT00819169|466435622|FG001|Overall Study|Adverse Event|0|||
129584576|NCT00819169|466435623|FG002|Overall Study|Adverse Event|0|||
129584577|NCT00819169|466435624|FG003|Overall Study|Adverse Event|0|||
129584578|NCT00819169|466435625|FG004|Overall Study|Adverse Event|1|||
129584579|NCT00819169|466435626|FG005|Overall Study|Adverse Event|0|||
129584580|NCT00819169|466435627|FG006|Overall Study|Adverse Event|0|||
129584581|NCT00819169|466435628|FG007|Overall Study|Adverse Event|0|||
129584582|NCT00819169|466435629|FG008|Overall Study|Adverse Event|0|||
129584583|NCT00819169|466435621|FG000|Overall Study|Administrative Decision|0|||
129584584|NCT00819169|466435622|FG001|Overall Study|Administrative Decision|0|||
129584585|NCT00819169|466435623|FG002|Overall Study|Administrative Decision|0|||
129584586|NCT00819169|466435624|FG003|Overall Study|Administrative Decision|0|||
129584587|NCT00819169|466435625|FG004|Overall Study|Administrative Decision|1|||
129584588|NCT00819169|466435626|FG005|Overall Study|Administrative Decision|2|||
129584589|NCT00819169|466435627|FG006|Overall Study|Administrative Decision|0|||
129584590|NCT00819169|466435628|FG007|Overall Study|Administrative Decision|2|||
129584591|NCT00819169|466435629|FG008|Overall Study|Administrative Decision|0|||
129584592|NCT02096705|466435638|FG000|Treatment|Adverse Event|6|||
129584593|NCT02096705|466435639|FG001|Treatment|Adverse Event|3|||
129584594|NCT02096705|466435638|FG000|Treatment|Subject request to discontinue treatment|1|||
129584595|NCT02096705|466435639|FG001|Treatment|Subject request to discontinue treatment|1|||
129584596|NCT02096705|466435638|FG000|Treatment|Withdrawal by Subject|1|||
129584597|NCT02096705|466435639|FG001|Treatment|Withdrawal by Subject|0|||
129584598|NCT02096705|466435638|FG000|Treatment|Other|1|||
129584599|NCT02096705|466435639|FG001|Treatment|Other|1|||
129584600|NCT02096705|466435638|FG000|Follow-up|Withdrawal by Subject|1|||
129584601|NCT02096705|466435639|FG001|Follow-up|Withdrawal by Subject|0|||
129584602|NCT02096705|466435638|FG000|Follow-up|Adverse Event|2|||
129584603|NCT02096705|466435639|FG001|Follow-up|Adverse Event|2|||
129584604|NCT02096705|466435638|FG000|Follow-up|Subjects not reporting status|1|||
129584605|NCT02096705|466435639|FG001|Follow-up|Subjects not reporting status|2|||
129584606|NCT02166606|466435642|FG000|Overall Study|Adverse Event|3|||
129584607|NCT02166606|466435642|FG000|Overall Study|Death|31|||
129584608|NCT02166606|466435642|FG000|Overall Study|Protocol Violation|7|||
129584609|NCT02166606|466435642|FG000|Overall Study|Lost to Follow-up|30|||
129584610|NCT02166606|466435642|FG000|Overall Study|Withdrawal by Subject|1|||
129584611|NCT02166606|466435642|FG000|Overall Study|Physician Decision|1|||
129584612|NCT02166606|466435642|FG000|Overall Study|Device upgrade|1|||
129584613|NCT02166606|466435642|FG000|Overall Study|Enrolled after End of Enrollment|4|||
129584614|NCT05412121|466435645|FG000|Overall Study|Withdrawal by Subject|4|||
129584615|NCT05412121|466435645|FG000|Overall Study|Physician Decision|1|||
129584616|NCT05412121|466435645|FG000|Overall Study|Lost to Follow-up|5|||
129584617|NCT00537095|466435648|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
129584618|NCT00537095|466435649|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
129584619|NCT00537095|466435648|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
129584620|NCT00537095|466435649|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
129584621|NCT00537095|466435648|FG000|Randomized Treatment Period (433 Days)|Death|3|||
129584622|NCT00537095|466435649|FG001|Randomized Treatment Period (433 Days)|Death|1|||
129584623|NCT00537095|466435648|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
129584624|NCT00537095|466435649|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
129584625|NCT00537095|466435648|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
129584626|NCT00537095|466435649|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
129584627|NCT00537095|466435648|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
129584628|NCT00537095|466435649|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
129584629|NCT00537095|466435648|FG000|Open-label Period (590 Days)|Adverse Event|2|||
129584630|NCT00537095|466435649|FG001|Open-label Period (590 Days)|Adverse Event|11|||
129584631|NCT00537095|466435648|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
129584632|NCT00537095|466435649|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
129584633|NCT00537095|466435648|FG000|Open-label Period (590 Days)|Death|2|||
129584634|NCT00537095|466435649|FG001|Open-label Period (590 Days)|Death|2|||
129584635|NCT00537095|466435648|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
129584636|NCT00537095|466435649|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
129584637|NCT00537095|466435648|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
129584638|NCT00537095|466435649|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
129584639|NCT00566722|466435650|FG000|Overall Study|Adverse Event|0|||
129584640|NCT00566722|466435651|FG001|Overall Study|Adverse Event|1|||
129584641|NCT00566722|466435652|FG002|Overall Study|Adverse Event|0|||
129584642|NCT00566722|466435650|FG000|Overall Study|Withdrawal by Subject|0|||
129584643|NCT00566722|466435651|FG001|Overall Study|Withdrawal by Subject|0|||
129584644|NCT00566722|466435652|FG002|Overall Study|Withdrawal by Subject|1|||
129584645|NCT00566722|466435650|FG000|Overall Study|Lost to Follow-up|1|||
129584646|NCT00566722|466435651|FG001|Overall Study|Lost to Follow-up|1|||
129584647|NCT00566722|466435652|FG002|Overall Study|Lost to Follow-up|1|||
129584648|NCT00566722|466435650|FG000|Overall Study|Lack of Efficacy|1|||
129584649|NCT00566722|466435651|FG001|Overall Study|Lack of Efficacy|2|||
129584650|NCT00566722|466435652|FG002|Overall Study|Lack of Efficacy|4|||
129584651|NCT00566722|466435650|FG000|Overall Study|Did not meet exclusion criteria|0|||
129584652|NCT00566722|466435651|FG001|Overall Study|Did not meet exclusion criteria|0|||
129584653|NCT00566722|466435652|FG002|Overall Study|Did not meet exclusion criteria|2|||
129584654|NCT00566722|466435650|FG000|Overall Study|Serious adverse event|0|||
129584655|NCT00566722|466435651|FG001|Overall Study|Serious adverse event|1|||
129584656|NCT00566722|466435652|FG002|Overall Study|Serious adverse event|0|||
129584657|NCT00566722|466435650|FG000|Overall Study|Noncompliant with drug administration|0|||
129584658|NCT00566722|466435651|FG001|Overall Study|Noncompliant with drug administration|0|||
129584659|NCT00566722|466435652|FG002|Overall Study|Noncompliant with drug administration|1|||
129584660|NCT02611323|466435653|FG000|Overall Study|Death|3|||
129584661|NCT02611323|466435654|FG001|Overall Study|Death|1|||
129584662|NCT02611323|466435655|FG002|Overall Study|Death|0|||
129584663|NCT02611323|466435656|FG003|Overall Study|Death|0|||
129696009|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
129696010|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
129707773|NCT00542178|466892123|FG004|Overall Study|did not complete year 4 follow-up|64|||
129584664|NCT02611323|466435657|FG004|Overall Study|Death|1|||
129584665|NCT02611323|466435658|FG005|Overall Study|Death|1|||
129584666|NCT02611323|466435659|FG006|Overall Study|Death|8|||
129584667|NCT02611323|466435660|FG007|Overall Study|Death|0|||
129584668|NCT02611323|466435661|FG008|Overall Study|Death|4|||
129584669|NCT02611323|466435662|FG009|Overall Study|Death|6|||
129584670|NCT02611323|466435663|FG010|Overall Study|Death|26|||
129584671|NCT02611323|466435653|FG000|Overall Study|Lost to Follow-up|1|||
129584672|NCT02611323|466435654|FG001|Overall Study|Lost to Follow-up|0|||
129584673|NCT02611323|466435655|FG002|Overall Study|Lost to Follow-up|0|||
129584674|NCT02611323|466435656|FG003|Overall Study|Lost to Follow-up|0|||
129584675|NCT02611323|466435657|FG004|Overall Study|Lost to Follow-up|0|||
129584676|NCT02611323|466435658|FG005|Overall Study|Lost to Follow-up|0|||
129584677|NCT02611323|466435659|FG006|Overall Study|Lost to Follow-up|3|||
129584678|NCT02611323|466435660|FG007|Overall Study|Lost to Follow-up|0|||
129584679|NCT02611323|466435661|FG008|Overall Study|Lost to Follow-up|0|||
129584680|NCT02611323|466435662|FG009|Overall Study|Lost to Follow-up|0|||
129584681|NCT02611323|466435663|FG010|Overall Study|Lost to Follow-up|2|||
129584682|NCT02611323|466435653|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584683|NCT02611323|466435654|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584684|NCT02611323|466435655|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584685|NCT02611323|466435656|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584686|NCT02611323|466435657|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584687|NCT02611323|466435658|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584688|NCT02611323|466435659|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584689|NCT02611323|466435660|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584690|NCT02611323|466435661|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584691|NCT02611323|466435662|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
129584692|NCT02611323|466435663|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
129584693|NCT02611323|466435653|FG000|Overall Study|Progressive Disease|0|||
129584694|NCT02611323|466435654|FG001|Overall Study|Progressive Disease|0|||
129584695|NCT02611323|466435655|FG002|Overall Study|Progressive Disease|0|||
129584696|NCT02611323|466435656|FG003|Overall Study|Progressive Disease|0|||
129584697|NCT02611323|466435657|FG004|Overall Study|Progressive Disease|0|||
129584698|NCT02611323|466435658|FG005|Overall Study|Progressive Disease|0|||
129584699|NCT02611323|466435659|FG006|Overall Study|Progressive Disease|0|||
129584700|NCT02611323|466435660|FG007|Overall Study|Progressive Disease|0|||
129584701|NCT02611323|466435661|FG008|Overall Study|Progressive Disease|0|||
129584702|NCT02611323|466435662|FG009|Overall Study|Progressive Disease|0|||
129584703|NCT02611323|466435663|FG010|Overall Study|Progressive Disease|1|||
129584704|NCT02611323|466435653|FG000|Overall Study|Withdrawal by Subject|1|||
129584705|NCT02611323|466435654|FG001|Overall Study|Withdrawal by Subject|0|||
129584706|NCT02611323|466435655|FG002|Overall Study|Withdrawal by Subject|0|||
129584707|NCT02611323|466435656|FG003|Overall Study|Withdrawal by Subject|0|||
129584708|NCT02611323|466435657|FG004|Overall Study|Withdrawal by Subject|0|||
129584709|NCT02611323|466435658|FG005|Overall Study|Withdrawal by Subject|0|||
129584710|NCT02611323|466435659|FG006|Overall Study|Withdrawal by Subject|0|||
129584711|NCT02611323|466435660|FG007|Overall Study|Withdrawal by Subject|1|||
129584712|NCT02611323|466435661|FG008|Overall Study|Withdrawal by Subject|0|||
129584713|NCT02611323|466435662|FG009|Overall Study|Withdrawal by Subject|1|||
129584714|NCT02611323|466435663|FG010|Overall Study|Withdrawal by Subject|0|||
129584715|NCT02597049|466435664|FG000|Overall Study|Lost to Follow-up|0|||
129584716|NCT02597049|466435665|FG001|Overall Study|Lost to Follow-up|3|||
129584717|NCT02597049|466435666|FG002|Overall Study|Lost to Follow-up|2|||
129584718|NCT02597049|466435664|FG000|Overall Study|Withdrawal by Subject|2|||
129584719|NCT02597049|466435665|FG001|Overall Study|Withdrawal by Subject|2|||
129584720|NCT02597049|466435666|FG002|Overall Study|Withdrawal by Subject|1|||
129584721|NCT02597049|466435664|FG000|Overall Study|Adverse Event|2|||
129584722|NCT02597049|466435665|FG001|Overall Study|Adverse Event|0|||
129584723|NCT02597049|466435666|FG002|Overall Study|Adverse Event|0|||
129584724|NCT02597049|466435664|FG000|Overall Study|Death|2|||
129584725|NCT02597049|466435665|FG001|Overall Study|Death|0|||
129584726|NCT02597049|466435666|FG002|Overall Study|Death|0|||
129584727|NCT02597049|466435664|FG000|Overall Study|Noncompliant with Study Visits|1|||
129584728|NCT02597049|466435665|FG001|Overall Study|Noncompliant with Study Visits|0|||
129584729|NCT02597049|466435666|FG002|Overall Study|Noncompliant with Study Visits|0|||
129584730|NCT00243347|466435669|FG000|Overall Study|Lack of Efficacy|4|||
129584731|NCT00243347|466435669|FG000|Overall Study|Adverse Event|2|||
129584732|NCT00243347|466435669|FG000|Overall Study|Death|1|||
129584733|NCT00243347|466435669|FG000|Overall Study|Withdrawal by Subject|5|||
129584734|NCT00243347|466435669|FG000|Overall Study|Condition worsened|7|||
129584735|NCT01899053|466435672|FG000|Overall Study|Progressive Disease|4|||
129584736|NCT01899053|466435673|FG001|Overall Study|Progressive Disease|0|||
129584737|NCT01899053|466435674|FG002|Overall Study|Progressive Disease|3|||
129584738|NCT01899053|466435675|FG003|Overall Study|Progressive Disease|0|||
129584739|NCT01899053|466435676|FG004|Overall Study|Progressive Disease|3|||
129584740|NCT01899053|466435677|FG005|Overall Study|Progressive Disease|1|||
129584741|NCT01899053|466435678|FG006|Overall Study|Progressive Disease|1|||
129584742|NCT01899053|466435679|FG007|Overall Study|Progressive Disease|1|||
129584743|NCT01899053|466435680|FG008|Overall Study|Progressive Disease|4|||
129584744|NCT01899053|466435681|FG009|Overall Study|Progressive Disease|3|||
129584745|NCT01899053|466435682|FG010|Overall Study|Progressive Disease|12|||
129584746|NCT01899053|466435683|FG011|Overall Study|Progressive Disease|5|||
129584747|NCT01899053|466435684|FG012|Overall Study|Progressive Disease|8|||
129584748|NCT01899053|466435685|FG013|Overall Study|Progressive Disease|17|||
129584749|NCT01899053|466435672|FG000|Overall Study|Adverse Event|1|||
129584750|NCT01899053|466435673|FG001|Overall Study|Adverse Event|1|||
129584751|NCT01899053|466435674|FG002|Overall Study|Adverse Event|1|||
129584752|NCT01899053|466435675|FG003|Overall Study|Adverse Event|3|||
129584753|NCT01899053|466435676|FG004|Overall Study|Adverse Event|1|||
129584754|NCT01899053|466435677|FG005|Overall Study|Adverse Event|1|||
129584755|NCT01899053|466435678|FG006|Overall Study|Adverse Event|1|||
129584756|NCT01899053|466435679|FG007|Overall Study|Adverse Event|0|||
129584757|NCT01899053|466435680|FG008|Overall Study|Adverse Event|2|||
129584758|NCT01899053|466435681|FG009|Overall Study|Adverse Event|0|||
129584759|NCT01899053|466435682|FG010|Overall Study|Adverse Event|3|||
129584760|NCT01899053|466435683|FG011|Overall Study|Adverse Event|1|||
129584761|NCT01899053|466435684|FG012|Overall Study|Adverse Event|2|||
129584762|NCT01899053|466435685|FG013|Overall Study|Adverse Event|2|||
129584763|NCT01899053|466435672|FG000|Overall Study|Reason Not Specified|0|||
129584764|NCT01899053|466435673|FG001|Overall Study|Reason Not Specified|0|||
129584765|NCT01899053|466435674|FG002|Overall Study|Reason Not Specified|0|||
129584766|NCT01899053|466435675|FG003|Overall Study|Reason Not Specified|0|||
129584767|NCT01899053|466435676|FG004|Overall Study|Reason Not Specified|0|||
129584768|NCT01899053|466435677|FG005|Overall Study|Reason Not Specified|0|||
129584769|NCT01899053|466435678|FG006|Overall Study|Reason Not Specified|1|||
129584770|NCT01899053|466435679|FG007|Overall Study|Reason Not Specified|0|||
129584771|NCT01899053|466435680|FG008|Overall Study|Reason Not Specified|0|||
129584772|NCT01899053|466435681|FG009|Overall Study|Reason Not Specified|0|||
129584773|NCT01899053|466435682|FG010|Overall Study|Reason Not Specified|0|||
129584774|NCT01899053|466435683|FG011|Overall Study|Reason Not Specified|0|||
129584775|NCT01899053|466435684|FG012|Overall Study|Reason Not Specified|1|||
129584776|NCT01899053|466435685|FG013|Overall Study|Reason Not Specified|0|||
129584777|NCT01899053|466435672|FG000|Overall Study|Withdrawal by Subject|1|||
129584778|NCT01899053|466435673|FG001|Overall Study|Withdrawal by Subject|1|||
129584779|NCT01899053|466435674|FG002|Overall Study|Withdrawal by Subject|2|||
129584780|NCT01899053|466435675|FG003|Overall Study|Withdrawal by Subject|0|||
129584781|NCT01899053|466435676|FG004|Overall Study|Withdrawal by Subject|2|||
129584782|NCT01899053|466435677|FG005|Overall Study|Withdrawal by Subject|0|||
129584783|NCT01899053|466435678|FG006|Overall Study|Withdrawal by Subject|0|||
129584784|NCT01899053|466435679|FG007|Overall Study|Withdrawal by Subject|1|||
129584785|NCT01899053|466435680|FG008|Overall Study|Withdrawal by Subject|0|||
129584786|NCT01899053|466435681|FG009|Overall Study|Withdrawal by Subject|0|||
129584787|NCT01899053|466435682|FG010|Overall Study|Withdrawal by Subject|0|||
129584788|NCT01899053|466435683|FG011|Overall Study|Withdrawal by Subject|0|||
129584789|NCT01899053|466435684|FG012|Overall Study|Withdrawal by Subject|1|||
129885107|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
129584790|NCT01899053|466435685|FG013|Overall Study|Withdrawal by Subject|1|||
129584791|NCT01899053|466435672|FG000|Overall Study|Protocol Violation|0|||
129584792|NCT01899053|466435673|FG001|Overall Study|Protocol Violation|0|||
129584793|NCT01899053|466435674|FG002|Overall Study|Protocol Violation|1|||
129584794|NCT01899053|466435675|FG003|Overall Study|Protocol Violation|0|||
129584795|NCT01899053|466435676|FG004|Overall Study|Protocol Violation|0|||
129584796|NCT01899053|466435677|FG005|Overall Study|Protocol Violation|0|||
129584797|NCT01899053|466435678|FG006|Overall Study|Protocol Violation|0|||
129584798|NCT01899053|466435679|FG007|Overall Study|Protocol Violation|0|||
129584799|NCT01899053|466435680|FG008|Overall Study|Protocol Violation|0|||
129584800|NCT01899053|466435681|FG009|Overall Study|Protocol Violation|0|||
129584801|NCT01899053|466435682|FG010|Overall Study|Protocol Violation|0|||
129584802|NCT01899053|466435683|FG011|Overall Study|Protocol Violation|0|||
129584803|NCT01899053|466435684|FG012|Overall Study|Protocol Violation|0|||
129584804|NCT01899053|466435685|FG013|Overall Study|Protocol Violation|0|||
129584805|NCT01899053|466435672|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
129584806|NCT01899053|466435673|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
129584807|NCT01899053|466435674|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584808|NCT01899053|466435675|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584809|NCT01899053|466435676|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584810|NCT01899053|466435677|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584811|NCT01899053|466435678|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584812|NCT01899053|466435679|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584813|NCT01899053|466435680|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584814|NCT01899053|466435681|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584815|NCT01899053|466435682|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
129584816|NCT01899053|466435683|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584817|NCT01899053|466435684|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584818|NCT01899053|466435685|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
129584819|NCT01899053|466435672|FG000|Overall Study|Symptomatic Deterioration|0|||
129584820|NCT01899053|466435673|FG001|Overall Study|Symptomatic Deterioration|0|||
129584821|NCT01899053|466435674|FG002|Overall Study|Symptomatic Deterioration|0|||
129584822|NCT01899053|466435675|FG003|Overall Study|Symptomatic Deterioration|0|||
129584823|NCT01899053|466435676|FG004|Overall Study|Symptomatic Deterioration|0|||
129584824|NCT01899053|466435677|FG005|Overall Study|Symptomatic Deterioration|1|||
129584825|NCT01899053|466435678|FG006|Overall Study|Symptomatic Deterioration|0|||
129584826|NCT01899053|466435679|FG007|Overall Study|Symptomatic Deterioration|1|||
129584827|NCT01899053|466435680|FG008|Overall Study|Symptomatic Deterioration|0|||
129584828|NCT01899053|466435681|FG009|Overall Study|Symptomatic Deterioration|0|||
129584829|NCT01899053|466435682|FG010|Overall Study|Symptomatic Deterioration|0|||
129584830|NCT01899053|466435683|FG011|Overall Study|Symptomatic Deterioration|1|||
129584831|NCT01899053|466435684|FG012|Overall Study|Symptomatic Deterioration|2|||
129584832|NCT01899053|466435685|FG013|Overall Study|Symptomatic Deterioration|0|||
129584833|NCT03105297|466435686|FG000|Baseline Phase (Day 1)|Other|21|||
129584834|NCT03105297|466435686|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
129584835|NCT03105297|466435686|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
129584836|NCT01390948|466435687|FG000|Overall Study|End of Study|1|||
129584837|NCT01390948|466435688|FG001|Overall Study|End of Study|0|||
129584838|NCT01390948|466435689|FG002|Overall Study|End of Study|0|||
129584839|NCT01390948|466435687|FG000|Overall Study|Withdrew consent|2|||
129584840|NCT01390948|466435688|FG001|Overall Study|Withdrew consent|2|||
129584841|NCT01390948|466435689|FG002|Overall Study|Withdrew consent|0|||
129584842|NCT01390948|466435687|FG000|Overall Study|Progressive Disease|2|||
129584843|NCT01390948|466435688|FG001|Overall Study|Progressive Disease|5|||
129584844|NCT01390948|466435689|FG002|Overall Study|Progressive Disease|0|||
129696011|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
129696012|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
129696013|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
129696014|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
129696015|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
129696016|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
129696017|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
129696018|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
129696019|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
129696020|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
129696021|NCT01362530|466845896|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
129696022|NCT01362530|466845897|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
129696023|NCT03021005|466845899|FG000|Overall Study|Lost to Follow-up|39|||
129696024|NCT03021005|466845900|FG001|Overall Study|Lost to Follow-up|26|||
129696025|NCT00276380|466845907|FG000|Overall Study|Adverse Event|5|||
129696026|NCT00276380|466845908|FG001|Overall Study|Adverse Event|3|||
129696027|NCT00276380|466845907|FG000|Overall Study|Lost to Follow-up|1|||
129696028|NCT00276380|466845908|FG001|Overall Study|Lost to Follow-up|1|||
129696029|NCT00276380|466845907|FG000|Overall Study|Withdrawal by Subject|3|||
129696030|NCT00276380|466845908|FG001|Overall Study|Withdrawal by Subject|6|||
129696031|NCT00276380|466845907|FG000|Overall Study|Death|5|||
129696032|NCT00276380|466845908|FG001|Overall Study|Death|3|||
129696033|NCT00276380|466845907|FG000|Overall Study|Abnormal aPPT Levels|0|||
129696034|NCT00276380|466845908|FG001|Overall Study|Abnormal aPPT Levels|1|||
129696035|NCT04829214|466845909|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
129584845|NCT01390948|466435687|FG000|Overall Study|Death during follow-up|10|||
129584846|NCT01390948|466435688|FG001|Overall Study|Death during follow-up|11|||
129584847|NCT01390948|466435689|FG002|Overall Study|Death during follow-up|1|||
129584848|NCT05315713|466435691|FG000|Overall Study|Death|5|||
129584849|NCT05315713|466435691|FG000|Overall Study|Progressive disease|1|||
129584850|NCT05315713|466435691|FG000|Overall Study|Withdrawal by Subject|1|||
129584851|NCT05315713|466435691|FG000|Overall Study|Study terminated by sponsor|1|||
129584852|NCT03250117|466435694|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
129584853|NCT03250117|466435695|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
129584854|NCT03250117|466435696|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
129584855|NCT03250117|466435697|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
129584856|NCT04194151|466435699|FG000|Overall Study|Physician Decision|1|||
129584857|NCT04194151|466435700|FG001|Overall Study|Physician Decision|1|||
129584858|NCT04194151|466435701|FG002|Overall Study|Physician Decision|1|||
129584859|NCT04194151|466435702|FG003|Overall Study|Physician Decision|1|||
129584860|NCT04194151|466435703|FG004|Overall Study|Physician Decision|0|||
129584861|NCT04194151|466435704|FG005|Overall Study|Physician Decision|1|||
129584862|NCT04194151|466435699|FG000|Overall Study|Monitorization problem|0|||
129584863|NCT04194151|466435700|FG001|Overall Study|Monitorization problem|1|||
129584864|NCT04194151|466435701|FG002|Overall Study|Monitorization problem|0|||
129584865|NCT04194151|466435702|FG003|Overall Study|Monitorization problem|0|||
129584866|NCT04194151|466435703|FG004|Overall Study|Monitorization problem|0|||
129584867|NCT04194151|466435704|FG005|Overall Study|Monitorization problem|0|||
129584868|NCT04203823|466435706|FG000|Overall Study|Withdrawal by Subject|2|||
129584869|NCT04203823|466435707|FG001|Overall Study|Withdrawal by Subject|2|||
129584870|NCT04203823|466435706|FG000|Overall Study|Adverse Event|1|||
129584871|NCT04203823|466435707|FG001|Overall Study|Adverse Event|1|||
129584872|NCT04203823|466435706|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129584873|NCT04203823|466435707|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
129584874|NCT01499043|466435708|FG000|Overall Study|Progressive disease (radiographic)|2|||
129584875|NCT01499043|466435708|FG000|Overall Study|Progressive disease (clinical)|1|||
129584876|NCT01499043|466435708|FG000|Overall Study|Withdrawal by Subject|2|||
129584877|NCT01499043|466435708|FG000|Overall Study|Adverse Event|1|||
129584878|NCT00438633|466435709|FG000|Overall Study|Withdrawal by Subject|1|||
129584879|NCT00438633|466435710|FG001|Overall Study|Withdrawal by Subject|0|||
129584880|NCT00438633|466435709|FG000|Overall Study|Lost to Follow-up|15|||
129584881|NCT00438633|466435710|FG001|Overall Study|Lost to Follow-up|17|||
129584882|NCT02286466|466435711|FG000|Overall Study|Death|1|||
129584883|NCT02286466|466435712|FG001|Overall Study|Death|3|||
129584884|NCT02286466|466435711|FG000|Overall Study|Withdrawal by Subject|5|||
129584885|NCT02286466|466435712|FG001|Overall Study|Withdrawal by Subject|2|||
129584886|NCT02286466|466435711|FG000|Overall Study|Lost to Follow-up|1|||
129584887|NCT02286466|466435712|FG001|Overall Study|Lost to Follow-up|4|||
129584888|NCT02286466|466435711|FG000|Overall Study|Declined Clinician Assessment|0|||
129584889|NCT02286466|466435712|FG001|Overall Study|Declined Clinician Assessment|1|||
129584890|NCT00835081|466435713|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129584891|NCT00835081|466435714|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129584892|NCT00421304|466435715|FG000|Overall Study|Lost to Follow-up|5|||
129584893|NCT00421304|466435716|FG001|Overall Study|Lost to Follow-up|2|||
129584894|NCT00421304|466435717|FG002|Overall Study|Lost to Follow-up|5|||
129584895|NCT00421304|466435715|FG000|Overall Study|Withdrawal by Subject|2|||
129584896|NCT00421304|466435716|FG001|Overall Study|Withdrawal by Subject|2|||
129584897|NCT00421304|466435717|FG002|Overall Study|Withdrawal by Subject|2|||
129584898|NCT00421304|466435715|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
129584899|NCT00421304|466435716|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
129584900|NCT00421304|466435717|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
129584901|NCT00421304|466435715|FG000|Overall Study|Did not attend Day 360 visit|0|||
129584902|NCT00421304|466435716|FG001|Overall Study|Did not attend Day 360 visit|0|||
129584903|NCT00421304|466435717|FG002|Overall Study|Did not attend Day 360 visit|1|||
129584904|NCT03196284|466435718|FG000|Main Part|Withdrawal by Subject|0|||
129584905|NCT03196284|466435719|FG001|Main Part|Withdrawal by Subject|1|||
129584906|NCT03196284|466435720|FG002|Main Part|Withdrawal by Subject|0|||
129584907|NCT03196284|466435718|FG000|Extension Part|Lack of Efficacy|0|||
129584908|NCT03196284|466435719|FG001|Extension Part|Lack of Efficacy|0|||
129584909|NCT03196284|466435720|FG002|Extension Part|Lack of Efficacy|1|||
129584910|NCT03196284|466435718|FG000|Extension Part|Withdrawal by Subject|0|||
129584911|NCT03196284|466435719|FG001|Extension Part|Withdrawal by Subject|0|||
129584912|NCT03196284|466435720|FG002|Extension Part|Withdrawal by Subject|1|||
129584913|NCT03196284|466435718|FG000|Extension Part|Physician Decision|0|||
129584914|NCT03196284|466435719|FG001|Extension Part|Physician Decision|0|||
129584915|NCT03196284|466435720|FG002|Extension Part|Physician Decision|1|||
129584916|NCT01912807|466435721|FG000|Overall Study|Did not meet elegibility criteria|6|||
129584917|NCT01912807|466435722|FG001|Overall Study|Did not meet elegibility criteria|4|||
129584918|NCT01912807|466435721|FG000|Overall Study|Lost to Follow-up|36|||
129584919|NCT01912807|466435722|FG001|Overall Study|Lost to Follow-up|37|||
129584920|NCT02535923|466435724|FG000|Overall Study|Lost to Follow-up|5|||
129584921|NCT02535923|466435725|FG001|Overall Study|Lost to Follow-up|5|||
129584922|NCT02535923|466435724|FG000|Overall Study|Withdrawal by Subject|4|||
129584923|NCT02535923|466435725|FG001|Overall Study|Withdrawal by Subject|3|||
129584924|NCT00874276|466435731|FG000|Overall Study|Withdrawal by Subject|1|||
129584925|NCT00874276|466435732|FG001|Overall Study|Withdrawal by Subject|1|||
129584926|NCT01253564|466435735|FG000|Overall Study|Disease Progression|22|||
129584927|NCT01253564|466435735|FG000|Overall Study|Withdrawal by Subject|1|||
129584928|NCT01253564|466435735|FG000|Overall Study|Serious Adverse Event|1|||
129584929|NCT03694197|466435738|FG000|Overall Study|Adverse Event|9|||
129584930|NCT03694197|466435738|FG000|Overall Study|Protocol became inconvenient to participate|1|||
129584931|NCT03694197|466435738|FG000|Overall Study|Physician Decision|4|||
129584932|NCT03694197|466435738|FG000|Overall Study|Study terminated by sponsor|1350|||
129584933|NCT03694197|466435738|FG000|Overall Study|Participant moved|5|||
129584934|NCT03694197|466435738|FG000|Overall Study|Participant withdrew consent|10|||
129584935|NCT03694197|466435738|FG000|Overall Study|Related to IMP administration|1|||
129584936|NCT03694197|466435738|FG000|Overall Study|Not disclosed|5|||
129584937|NCT03506633|466437161|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
129584938|NCT03506633|466437162|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
129584939|NCT01109849|466437165|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
129584940|NCT01109849|466437166|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
129584941|NCT01109849|466437167|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
129584942|NCT01109849|466437168|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
129584943|NCT01109849|466437169|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
129584944|NCT01109849|466437165|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
129584945|NCT01109849|466437166|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129584946|NCT01109849|466437167|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129584947|NCT01109849|466437168|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129584948|NCT01109849|466437169|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
129584949|NCT01109849|466437165|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
129584950|NCT01109849|466437166|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
129584951|NCT01109849|466437167|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
129584952|NCT01109849|466437168|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
129584953|NCT01109849|466437169|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
129584954|NCT01109849|466437165|FG000|Initial Randomization: ADHD Treatment|move away|2|||
129584955|NCT01109849|466437166|FG001|Initial Randomization: ADHD Treatment|move away|7|||
129584956|NCT01109849|466437167|FG002|Initial Randomization: ADHD Treatment|move away|0|||
129584957|NCT01109849|466437168|FG003|Initial Randomization: ADHD Treatment|move away|0|||
129584958|NCT01109849|466437169|FG004|Initial Randomization: ADHD Treatment|move away|0|||
129584959|NCT01109849|466437165|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
129584960|NCT01109849|466437166|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
129584961|NCT01109849|466437167|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
129584962|NCT01109849|466437168|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
129584963|NCT01109849|466437169|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
129584964|NCT01109849|466437165|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
129584965|NCT01109849|466437166|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
129584966|NCT01109849|466437167|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
129584967|NCT01109849|466437168|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
129696036|NCT04829214|466845910|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
129696037|NCT04829214|466845909|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
129696038|NCT04829214|466845910|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
129584968|NCT01109849|466437169|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
129584969|NCT03969641|466437170|FG000|Overall Study|Lost to Follow-up|5|||
129584970|NCT03969641|466437171|FG001|Overall Study|Lost to Follow-up|3|||
129584971|NCT03969641|466437170|FG000|Overall Study|Withdrawal by Subject|1|||
129584972|NCT03969641|466437171|FG001|Overall Study|Withdrawal by Subject|2|||
129584973|NCT03969641|466437170|FG000|Overall Study|Found to be ineligible|1|||
129584974|NCT03969641|466437171|FG001|Overall Study|Found to be ineligible|1|||
129584975|NCT03969641|466437170|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
129584976|NCT03969641|466437171|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
129584977|NCT03969641|466437170|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
129584978|NCT03969641|466437171|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
129584979|NCT03969641|466437170|FG000|Overall Study|Elective termination|0|||
129584980|NCT03969641|466437171|FG001|Overall Study|Elective termination|1|||
129584981|NCT01541215|466437172|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
129584982|NCT01541215|466437173|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
129584983|NCT01541215|466437172|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
129584984|NCT01541215|466437173|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
129584985|NCT01541215|466437172|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
129584986|NCT01541215|466437173|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
129584987|NCT01541215|466437172|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
129584988|NCT01541215|466437173|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
129584989|NCT01541215|466437172|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
129584990|NCT01541215|466437173|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
129584991|NCT01541215|466437172|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
129584992|NCT01541215|466437173|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
129584993|NCT02435433|466437180|FG000|Overall Study|Withdrawal by Subject|2|||
129584994|NCT02435433|466437181|FG001|Overall Study|Withdrawal by Subject|3|||
129584995|NCT02435433|466437182|FG002|Overall Study|Withdrawal by Subject|1|||
129584996|NCT02435433|466437183|FG003|Overall Study|Withdrawal by Subject|0|||
129584997|NCT02435433|466437184|FG004|Overall Study|Withdrawal by Subject|0|||
129584998|NCT02435433|466437180|FG000|Overall Study|Lost to Follow-up|2|||
129584999|NCT02435433|466437181|FG001|Overall Study|Lost to Follow-up|2|||
129585000|NCT02435433|466437182|FG002|Overall Study|Lost to Follow-up|4|||
129585001|NCT02435433|466437183|FG003|Overall Study|Lost to Follow-up|1|||
129585002|NCT02435433|466437184|FG004|Overall Study|Lost to Follow-up|0|||
129585003|NCT00757705|466437185|FG000|Overall Study|Adverse Event|19|||
129585004|NCT00757705|466437185|FG000|Overall Study|Lost to Follow-up|16|||
129585005|NCT00757705|466437185|FG000|Overall Study|Withdrawal by Subject|25|||
129585006|NCT00757705|466437185|FG000|Overall Study|Insufficient Response|26|||
129585007|NCT00757705|466437185|FG000|Overall Study|Ineligible to continue|8|||
129585008|NCT00757705|466437185|FG000|Overall Study|Non-compliant|9|||
129585009|NCT00757705|466437185|FG000|Overall Study|Other|18|||
129585010|NCT00659815|466437186|FG000|Overall Study|Study related symptoms and complaints|2|||
129585011|NCT00659815|466437187|FG001|Overall Study|Study related symptoms and complaints|1|||
129585012|NCT00659815|466437186|FG000|Overall Study|Inability to maintain wearing schedule|1|||
129585013|NCT00659815|466437187|FG001|Overall Study|Inability to maintain wearing schedule|2|||
129585014|NCT00659815|466437186|FG000|Overall Study|Withdrawal by Subject|1|||
129585015|NCT00659815|466437187|FG001|Overall Study|Withdrawal by Subject|1|||
129585016|NCT00735696|466437192|FG000|Overall Study|Withdrawal by Subject|1|||
129585017|NCT00735696|466437192|FG000|Overall Study|Enrolled but never Treated|1|||
129585018|NCT00640393|466437193|FG000|Part 1|Lost to Follow-up|2|||
129585019|NCT00640393|466437194|FG001|Part 1|Lost to Follow-up|0|||
129585020|NCT00640393|466437195|FG002|Part 1|Lost to Follow-up|0|||
129585021|NCT00640393|466437193|FG000|Part 1|Withdrawal by Subject|3|||
129585022|NCT00640393|466437194|FG001|Part 1|Withdrawal by Subject|0|||
129585023|NCT00640393|466437195|FG002|Part 1|Withdrawal by Subject|0|||
129585024|NCT00640393|466437193|FG000|Randomization|Withdrawn per protocol|17|||
129585025|NCT00640393|466437194|FG001|Randomization|Withdrawn per protocol|0|||
129585026|NCT00640393|466437195|FG002|Randomization|Withdrawn per protocol|0|||
129585027|NCT00640393|466437193|FG000|Randomization|Never randomized by site|2|||
129585028|NCT00640393|466437194|FG001|Randomization|Never randomized by site|0|||
129585029|NCT00640393|466437195|FG002|Randomization|Never randomized by site|0|||
129585030|NCT00640393|466437193|FG000|Part 2|Lost to Follow-up|0|||
129585031|NCT00640393|466437194|FG001|Part 2|Lost to Follow-up|2|||
129585032|NCT00640393|466437195|FG002|Part 2|Lost to Follow-up|2|||
129585033|NCT00640393|466437193|FG000|Part 2|Withdrawal by Subject|0|||
129585034|NCT00640393|466437194|FG001|Part 2|Withdrawal by Subject|6|||
129585035|NCT00640393|466437195|FG002|Part 2|Withdrawal by Subject|1|||
129585036|NCT00640393|466437193|FG000|Part 2|Non-adherence|0|||
129585037|NCT00640393|466437194|FG001|Part 2|Non-adherence|1|||
129585038|NCT00640393|466437195|FG002|Part 2|Non-adherence|0|||
129585039|NCT00640393|466437193|FG000|Part 2|Adverse Event|0|||
129585040|NCT00640393|466437194|FG001|Part 2|Adverse Event|1|||
129585041|NCT00640393|466437195|FG002|Part 2|Adverse Event|0|||
129585042|NCT04406194|466437196|FG000|Period 1|Withdrawal by Subject|0|||
129585043|NCT04406194|466437197|FG001|Period 1|Withdrawal by Subject|1|||
129585044|NCT02998541|466437198|FG000|Overall Study|Adverse Event|4|||
129585045|NCT02998541|466437199|FG001|Overall Study|Adverse Event|5|||
129585046|NCT02998541|466437200|FG002|Overall Study|Adverse Event|1|||
129585047|NCT02998541|466437198|FG000|Overall Study|Protocol Violation|1|||
129585048|NCT02998541|466437199|FG001|Overall Study|Protocol Violation|0|||
129585049|NCT02998541|466437200|FG002|Overall Study|Protocol Violation|0|||
129585050|NCT02998541|466437198|FG000|Overall Study|Withdrawal by Subject|3|||
129585051|NCT02998541|466437199|FG001|Overall Study|Withdrawal by Subject|1|||
129585052|NCT02998541|466437200|FG002|Overall Study|Withdrawal by Subject|0|||
129585053|NCT02998541|466437198|FG000|Overall Study|Lost to Follow-up|0|||
129585054|NCT02998541|466437199|FG001|Overall Study|Lost to Follow-up|3|||
129585055|NCT02998541|466437200|FG002|Overall Study|Lost to Follow-up|1|||
129585056|NCT02998541|466437198|FG000|Overall Study|Physician Decision|0|||
129585057|NCT02998541|466437199|FG001|Overall Study|Physician Decision|0|||
129585058|NCT02998541|466437200|FG002|Overall Study|Physician Decision|3|||
129585059|NCT02998541|466437198|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129585060|NCT02998541|466437199|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129585061|NCT02998541|466437200|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
129585062|NCT01664039|466437202|FG000|Overall Study|Adverse Event|3|||
129585063|NCT01664039|466437203|FG001|Overall Study|Adverse Event|4|||
129585064|NCT01664039|466437202|FG000|Overall Study|Lost to Follow-up|1|||
129585065|NCT01664039|466437203|FG001|Overall Study|Lost to Follow-up|1|||
129585066|NCT01664039|466437202|FG000|Overall Study|Withdrawal by Subject|1|||
129585067|NCT01664039|466437203|FG001|Overall Study|Withdrawal by Subject|3|||
129585068|NCT01664039|466437202|FG000|Overall Study|Noncompliance|1|||
129585069|NCT01664039|466437203|FG001|Overall Study|Noncompliance|1|||
129585070|NCT01186458|466437207|FG000|Overall Study|Adverse Event|1|||
129585071|NCT00354835|466437208|FG000|Overall Study|Death|1|||
129585072|NCT00354835|466437209|FG001|Overall Study|Death|1|||
129585073|NCT00354835|466437208|FG000|Overall Study|Physician Decision|8|||
129585074|NCT00354835|466437209|FG001|Overall Study|Physician Decision|13|||
129585075|NCT00354835|466437208|FG000|Overall Study|Withdrawal by Subject|2|||
129585076|NCT00354835|466437209|FG001|Overall Study|Withdrawal by Subject|1|||
129585077|NCT00354835|466437208|FG000|Overall Study|Ineligible|17|||
129585078|NCT00354835|466437209|FG001|Overall Study|Ineligible|16|||
129585079|NCT00354835|466437208|FG000|Overall Study|Disease progression or relapse|15|||
129585080|NCT00354835|466437209|FG001|Overall Study|Disease progression or relapse|22|||
129585081|NCT00354835|466437208|FG000|Overall Study|Adverse Event|6|||
129585082|NCT00354835|466437209|FG001|Overall Study|Adverse Event|0|||
129585083|NCT00354835|466437208|FG000|Overall Study|Refusal of further therapy|3|||
129585084|NCT00354835|466437209|FG001|Overall Study|Refusal of further therapy|8|||
129585085|NCT01968551|466437214|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
129585086|NCT01968551|466437215|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
129585087|NCT01968551|466437216|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
129585088|NCT01968551|466437214|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
129585089|NCT01968551|466437215|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
129585090|NCT01968551|466437216|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
129585091|NCT01968551|466437214|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
129585092|NCT01968551|466437215|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
129585093|NCT01968551|466437216|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
129585094|NCT01968551|466437214|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
129585095|NCT01968551|466437215|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
129585096|NCT01968551|466437216|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
129585097|NCT01968551|466437214|FG000|Extension Phase|Adverse Event|0|||
129585098|NCT01968551|466437215|FG001|Extension Phase|Adverse Event|0|||
129585099|NCT01968551|466437216|FG002|Extension Phase|Adverse Event|2|||
129585100|NCT01968551|466437214|FG000|Extension Phase|Death|0|||
129585101|NCT01968551|466437215|FG001|Extension Phase|Death|1|||
129585102|NCT01968551|466437216|FG002|Extension Phase|Death|0|||
129585103|NCT01968551|466437214|FG000|Extension Phase|Withdrew Consent|0|||
129585104|NCT01968551|466437215|FG001|Extension Phase|Withdrew Consent|0|||
129585105|NCT01968551|466437216|FG002|Extension Phase|Withdrew Consent|1|||
129585106|NCT01968551|466437214|FG000|Extension Phase|Lost to Follow-up|1|||
129585107|NCT01968551|466437215|FG001|Extension Phase|Lost to Follow-up|0|||
129585108|NCT01968551|466437216|FG002|Extension Phase|Lost to Follow-up|1|||
129585109|NCT00573313|466437219|FG000|Overall Study|Protocol Violation|5|||
129585110|NCT00573313|466437220|FG001|Overall Study|Protocol Violation|0|||
129585111|NCT00573313|466437221|FG002|Overall Study|Protocol Violation|6|||
129585112|NCT00573313|466437222|FG003|Overall Study|Protocol Violation|0|||
129585113|NCT00467597|466437224|FG000|Overall Study|Withdrawal by Subject|2|||
129885108|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
129885109|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
129585114|NCT00467597|466437225|FG001|Overall Study|Withdrawal by Subject|0|||
129585115|NCT03277248|466437226|FG000|Overall Study|Adverse Event|3|||
129885110|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Other|0|||
129885111|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Other|0|||
129585116|NCT03277248|466437227|FG001|Overall Study|Adverse Event|1|||
129585117|NCT03277248|466437226|FG000|Overall Study|Subject Withdrawal of Consent|6|||
129585118|NCT03277248|466437227|FG001|Overall Study|Subject Withdrawal of Consent|23|||
129585119|NCT03277248|466437226|FG000|Overall Study|Investigator/Sponsor Decision|2|||
129585120|NCT03277248|466437227|FG001|Overall Study|Investigator/Sponsor Decision|2|||
129585121|NCT03277248|466437226|FG000|Overall Study|Pregnancy|4|||
129585122|NCT03277248|466437227|FG001|Overall Study|Pregnancy|1|||
129585123|NCT03277248|466437226|FG000|Overall Study|Lost to Follow-up|0|||
129585124|NCT03277248|466437227|FG001|Overall Study|Lost to Follow-up|2|||
129585125|NCT03277248|466437226|FG000|Overall Study|Lack of Efficacy|0|||
129585126|NCT03277248|466437227|FG001|Overall Study|Lack of Efficacy|2|||
129585127|NCT03277248|466437226|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
129585128|NCT03277248|466437227|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
129585129|NCT00884390|466437230|FG000|Overall Study|Adverse Event|0|||
129585130|NCT00884390|466437231|FG001|Overall Study|Adverse Event|1|||
129585131|NCT00884390|466437230|FG000|Overall Study|Lost to Follow-up|0|||
129585132|NCT00884390|466437231|FG001|Overall Study|Lost to Follow-up|1|||
129585133|NCT00884390|466437230|FG000|Overall Study|Physician Decision|2|||
129585134|NCT00884390|466437231|FG001|Overall Study|Physician Decision|1|||
129585135|NCT00884390|466437230|FG000|Overall Study|Protocol Violation|4|||
129585136|NCT00884390|466437231|FG001|Overall Study|Protocol Violation|1|||
129585137|NCT00884390|466437230|FG000|Overall Study|Withdrawal by Subject|4|||
129585138|NCT00884390|466437231|FG001|Overall Study|Withdrawal by Subject|1|||
129585139|NCT00884390|466437230|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
129585140|NCT00884390|466437231|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
129585141|NCT00884390|466437230|FG000|Overall Study|Other|11|||
129585142|NCT00884390|466437231|FG001|Overall Study|Other|1|||
129585143|NCT01691612|466437232|FG000|Overall Study|deemed ineligible after 1st visit|6|||
129585144|NCT01691612|466437232|FG000|Overall Study|Adverse Event|1|||
129585145|NCT02670551|466437236|FG000|Overall Study|Adverse Event|4|||
129585146|NCT02670551|466437237|FG001|Overall Study|Adverse Event|7|||
129585147|NCT02670551|466437238|FG002|Overall Study|Adverse Event|9|||
129585148|NCT02670551|466437236|FG000|Overall Study|Lack of Efficacy|2|||
129585149|NCT02670551|466437237|FG001|Overall Study|Lack of Efficacy|0|||
129585150|NCT02670551|466437238|FG002|Overall Study|Lack of Efficacy|3|||
129585151|NCT02670551|466437236|FG000|Overall Study|Withdrawal of Consent|6|||
129585152|NCT02670551|466437237|FG001|Overall Study|Withdrawal of Consent|3|||
129585153|NCT02670551|466437238|FG002|Overall Study|Withdrawal of Consent|8|||
129585154|NCT02670551|466437236|FG000|Overall Study|Lost to Follow-up|5|||
129585155|NCT02670551|466437237|FG001|Overall Study|Lost to Follow-up|7|||
129585156|NCT02670551|466437238|FG002|Overall Study|Lost to Follow-up|6|||
129585157|NCT02670551|466437236|FG000|Overall Study|Protocol Violation|1|||
129585158|NCT02670551|466437237|FG001|Overall Study|Protocol Violation|0|||
129585159|NCT02670551|466437238|FG002|Overall Study|Protocol Violation|0|||
129585160|NCT02670551|466437236|FG000|Overall Study|Noncompliance with study drug|3|||
129585161|NCT02670551|466437237|FG001|Overall Study|Noncompliance with study drug|3|||
129585162|NCT02670551|466437238|FG002|Overall Study|Noncompliance with study drug|2|||
129585163|NCT02670551|466437236|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129585164|NCT02670551|466437237|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129585165|NCT02670551|466437238|FG002|Overall Study|Other Miscellaneous Reasons|3|||
129585166|NCT02670551|466437236|FG000|Overall Study|Did Not Receive Treatment|5|||
129585167|NCT02670551|466437237|FG001|Overall Study|Did Not Receive Treatment|3|||
129585168|NCT02670551|466437238|FG002|Overall Study|Did Not Receive Treatment|0|||
129585169|NCT04476277|466437239|FG000|Overall Study|Withdrawal by Subject|0|||
129585170|NCT04476277|466437240|FG001|Overall Study|Withdrawal by Subject|0|||
129585171|NCT04476277|466437241|FG002|Overall Study|Withdrawal by Subject|1|||
129585172|NCT04476277|466437242|FG003|Overall Study|Withdrawal by Subject|0|||
129585173|NCT01971645|466437243|FG000|Overall Study|Adverse Event|1|||
129585174|NCT01971645|466437244|FG001|Overall Study|Adverse Event|0|||
129585175|NCT01971645|466437245|FG002|Overall Study|Adverse Event|0|||
129585176|NCT01971645|466437243|FG000|Overall Study|Lost to Follow-up|1|||
129585177|NCT01971645|466437244|FG001|Overall Study|Lost to Follow-up|0|||
129585178|NCT01971645|466437245|FG002|Overall Study|Lost to Follow-up|1|||
129585179|NCT01971645|466437243|FG000|Overall Study|Protocol Violation|0|||
129585180|NCT01971645|466437244|FG001|Overall Study|Protocol Violation|0|||
129585181|NCT01971645|466437245|FG002|Overall Study|Protocol Violation|1|||
129585182|NCT01962298|466437246|FG000|Overall Study|Protocol Violation|1|||
129585183|NCT01962298|466437247|FG001|Overall Study|Protocol Violation|0|||
129585184|NCT01962298|466437248|FG002|Overall Study|Protocol Violation|1|||
129585185|NCT01962298|466437249|FG003|Overall Study|Protocol Violation|1|||
129585186|NCT01962298|466437250|FG004|Overall Study|Protocol Violation|0|||
129885112|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Other|0|||
129585187|NCT01962298|466437246|FG000|Overall Study|Data quality insufficient|2|||
129585188|NCT01962298|466437247|FG001|Overall Study|Data quality insufficient|0|||
129585189|NCT01962298|466437248|FG002|Overall Study|Data quality insufficient|3|||
129585190|NCT01962298|466437249|FG003|Overall Study|Data quality insufficient|1|||
129585191|NCT01962298|466437250|FG004|Overall Study|Data quality insufficient|4|||
129585192|NCT01962298|466437246|FG000|Overall Study|Insufficient data|0|||
129585193|NCT01962298|466437247|FG001|Overall Study|Insufficient data|2|||
129585194|NCT01962298|466437248|FG002|Overall Study|Insufficient data|1|||
129585195|NCT01962298|466437249|FG003|Overall Study|Insufficient data|0|||
129585196|NCT01962298|466437250|FG004|Overall Study|Insufficient data|1|||
129585197|NCT01962298|466437246|FG000|Overall Study|Incorrect data recorded|0|||
129585198|NCT01962298|466437247|FG001|Overall Study|Incorrect data recorded|1|||
129585199|NCT01962298|466437248|FG002|Overall Study|Incorrect data recorded|0|||
129585200|NCT01962298|466437249|FG003|Overall Study|Incorrect data recorded|0|||
129585201|NCT01962298|466437250|FG004|Overall Study|Incorrect data recorded|0|||
129585202|NCT01962298|466437246|FG000|Overall Study|Physician Decision|0|||
129585203|NCT01962298|466437247|FG001|Overall Study|Physician Decision|1|||
129585204|NCT01962298|466437248|FG002|Overall Study|Physician Decision|0|||
129585205|NCT01962298|466437249|FG003|Overall Study|Physician Decision|0|||
129585206|NCT01962298|466437250|FG004|Overall Study|Physician Decision|1|||
129585207|NCT00533507|466437251|FG000|Overall Study|Withdrawal by Subject|1|||
129585208|NCT01576705|466437252|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
129585209|NCT01576705|466437253|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
129585210|NCT01576705|466437254|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
129585211|NCT01576705|466437255|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
129585212|NCT01576705|466437252|FG000|Overall Study|invalid ICF|0|||
129585213|NCT01576705|466437253|FG001|Overall Study|invalid ICF|1|||
129585214|NCT01576705|466437254|FG002|Overall Study|invalid ICF|0|||
129585215|NCT01576705|466437255|FG003|Overall Study|invalid ICF|0|||
129585216|NCT02896296|466437256|FG000|Overall Study|Adverse Event|1|||
129585217|NCT02896296|466437256|FG000|Overall Study|Lost to Follow-up|19|||
129585218|NCT02896296|466437256|FG000|Overall Study|Pregnancy|1|||
129585219|NCT02896296|466437256|FG000|Overall Study|Physician Decision|2|||
129585220|NCT02896296|466437256|FG000|Overall Study|Withdrawal by Subject|10|||
129585221|NCT02896296|466437256|FG000|Overall Study|Site closing|7|||
129585222|NCT02896296|466437256|FG000|Overall Study|Incarceration|1|||
129585223|NCT02896296|466437256|FG000|Overall Study|Relocation|1|||
129585224|NCT00045162|466437257|FG000|Overall Study|Ineligible|12|||
129585225|NCT00045162|466437258|FG001|Overall Study|Ineligible|8|||
129585226|NCT00045162|466437257|FG000|Overall Study|Not treated|7|||
129585227|NCT00045162|466437258|FG001|Overall Study|Not treated|2|||
129585228|NCT00045162|466437257|FG000|Overall Study|Adverse Event|55|||
129585229|NCT00045162|466437258|FG001|Overall Study|Adverse Event|50|||
129585230|NCT00045162|466437257|FG000|Overall Study|Lack of Efficacy|32|||
129585231|NCT00045162|466437258|FG001|Overall Study|Lack of Efficacy|29|||
129585232|NCT00045162|466437257|FG000|Overall Study|Death|10|||
129585233|NCT00045162|466437258|FG001|Overall Study|Death|10|||
129585234|NCT00045162|466437257|FG000|Overall Study|Withdrawal by Subject|5|||
129585235|NCT00045162|466437258|FG001|Overall Study|Withdrawal by Subject|3|||
129585236|NCT00045162|466437257|FG000|Overall Study|Other|21|||
129585237|NCT00045162|466437258|FG001|Overall Study|Other|16|||
129585238|NCT01044433|466437259|FG000|Overall Study|Lost to Follow-up|3|||
129585239|NCT01044433|466437259|FG000|Overall Study|Withdrawal by Subject|3|||
129585240|NCT05065619|466437260|FG000|Up to Day 42|Lost to Follow-up|1|||
129585241|NCT05065619|466437261|FG001|Up to Day 42|Lost to Follow-up|0|||
129585242|NCT05065619|466437260|FG000|Up to Day 42|Withdrawal by Subject|1|||
129585243|NCT05065619|466437261|FG001|Up to Day 42|Withdrawal by Subject|0|||
129585244|NCT05065619|466437260|FG000|After Day 43|Lost to Follow-up|1|||
129585245|NCT05065619|466437261|FG001|After Day 43|Lost to Follow-up|0|||
129585246|NCT05065619|466437260|FG000|After Day 43|Physician Decision|3|||
129585247|NCT05065619|466437261|FG001|After Day 43|Physician Decision|0|||
129585248|NCT05065619|466437260|FG000|After Day 43|Withdrawal by Subject|1|||
129585249|NCT05065619|466437261|FG001|After Day 43|Withdrawal by Subject|2|||
129585250|NCT05065619|466437260|FG000|After Day 43|Public vaccination|6|||
129585251|NCT05065619|466437261|FG001|After Day 43|Public vaccination|8|||
129585252|NCT05065619|466437260|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
129585253|NCT05065619|466437261|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
129585254|NCT05065619|466437260|FG000|After Day 43|Study Terminated by Sponsor|88|||
129585255|NCT05065619|466437261|FG001|After Day 43|Study Terminated by Sponsor|16|||
129585256|NCT00714051|466437266|FG000|Overall Study|Withdrawal by Subject|1|||
129585257|NCT00714051|466437267|FG001|Overall Study|Withdrawal by Subject|0|||
129585258|NCT00714051|466437266|FG000|Overall Study|Death|0|||
129585259|NCT00714051|466437267|FG001|Overall Study|Death|1|||
129585260|NCT03868631|466437268|FG000|Baseline to Week 6|Adverse Event|0|||
129585261|NCT03868631|466437269|FG001|Baseline to Week 6|Adverse Event|3|||
129585262|NCT03868631|466437268|FG000|Baseline to Week 6|Protocol Violation|1|||
129585263|NCT03868631|466437269|FG001|Baseline to Week 6|Protocol Violation|1|||
129585264|NCT03868631|466437268|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
129585265|NCT03868631|466437269|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
129585266|NCT03868631|466437268|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
129585267|NCT03868631|466437269|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
129585268|NCT03868631|466437268|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
129585269|NCT03868631|466437269|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
129585270|NCT03868631|466437268|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
129585271|NCT03868631|466437269|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
129585272|NCT01929681|466437271|FG000|Overall Study|Withdrawal by Subject|1|||
129585273|NCT01929681|466437272|FG001|Overall Study|Withdrawal by Subject|0|||
129585274|NCT01929681|466437271|FG000|Overall Study|Physician Decision|1|||
129585275|NCT01929681|466437272|FG001|Overall Study|Physician Decision|1|||
129585276|NCT02218216|466437273|FG000|Overall Study|Study terminated before completed|6|||
129585277|NCT02218216|466437274|FG001|Overall Study|Study terminated before completed|0|||
129585278|NCT02218216|466437275|FG002|Overall Study|Study terminated before completed|0|||
129585279|NCT05740098|466437280|FG000|Overall Study|Lost to Follow-up|26|||
129585280|NCT05740098|466437281|FG001|Overall Study|Lost to Follow-up|17|||
129585281|NCT05740098|466437282|FG002|Overall Study|Lost to Follow-up|21|||
129585282|NCT02452463|466437283|FG000|Overall Study|Death|1|||
129585283|NCT02452463|466437284|FG001|Overall Study|Death|0|||
129585284|NCT02452463|466437285|FG002|Overall Study|Death|0|||
129585285|NCT02452463|466437283|FG000|Overall Study|Study Suspended|1|||
129585286|NCT02452463|466437284|FG001|Overall Study|Study Suspended|0|||
129585287|NCT02452463|466437285|FG002|Overall Study|Study Suspended|0|||
129585288|NCT02452463|466437283|FG000|Overall Study|Recommended by DSMB|0|||
129585289|NCT02452463|466437284|FG001|Overall Study|Recommended by DSMB|1|||
129585290|NCT02452463|466437285|FG002|Overall Study|Recommended by DSMB|0|||
129585291|NCT02452463|466437283|FG000|Overall Study|Withdrawal by Subject|0|||
129585292|NCT02452463|466437284|FG001|Overall Study|Withdrawal by Subject|1|||
129585293|NCT02452463|466437285|FG002|Overall Study|Withdrawal by Subject|0|||
129585294|NCT01073631|466437286|FG000|Overall Study|Death|82|||
129585295|NCT01073631|466437286|FG000|Overall Study|Adverse Event|24|||
129585296|NCT01073631|466437286|FG000|Overall Study|Other|63|||
129585297|NCT01528735|466437287|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
129585298|NCT01528735|466437288|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
129585299|NCT01528735|466437287|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
129585300|NCT01528735|466437288|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
129585301|NCT01971554|466437289|FG000|Overall Study|Lost to Follow-up|1|||
129585302|NCT01971554|466437290|FG001|Overall Study|Lost to Follow-up|0|||
129585303|NCT01971554|466437291|FG002|Overall Study|Lost to Follow-up|0|||
129585304|NCT01971554|466437292|FG003|Overall Study|Lost to Follow-up|0|||
129585305|NCT01426854|466437295|FG000|Overall Study|Adverse Event|1|||
129585306|NCT01426854|466437296|FG001|Overall Study|Adverse Event|5|||
129585307|NCT01426854|466437295|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
129585308|NCT01426854|466437296|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
129585309|NCT01426854|466437295|FG000|Overall Study|Lost to Follow-up|3|||
129585310|NCT01426854|466437296|FG001|Overall Study|Lost to Follow-up|0|||
129585311|NCT01426854|466437295|FG000|Overall Study|Noncompliance|0|||
129585312|NCT01426854|466437296|FG001|Overall Study|Noncompliance|1|||
129585313|NCT01426854|466437295|FG000|Overall Study|Treatment Failure|0|||
129585314|NCT01426854|466437296|FG001|Overall Study|Treatment Failure|16|||
129585315|NCT01426854|466437295|FG000|Overall Study|Protocol Deviation|0|||
129585316|NCT01426854|466437296|FG001|Overall Study|Protocol Deviation|1|||
129585317|NCT01426854|466437295|FG000|Overall Study|Other|3|||
129585318|NCT01426854|466437296|FG001|Overall Study|Other|2|||
129585319|NCT01942135|466437300|FG000|Overall Study|Adverse Event|21|||
129585320|NCT01942135|466437301|FG001|Overall Study|Adverse Event|7|||
129585321|NCT01942135|466437300|FG000|Overall Study|Global Deterioration of Health Status|9|||
129585322|NCT01942135|466437301|FG001|Overall Study|Global Deterioration of Health Status|6|||
129585323|NCT01942135|466437300|FG000|Overall Study|Randomized Not Treated|2|||
129585324|NCT01942135|466437301|FG001|Overall Study|Randomized Not Treated|2|||
129585325|NCT01942135|466437300|FG000|Overall Study|Death|2|||
129585326|NCT01942135|466437301|FG001|Overall Study|Death|1|||
129585327|NCT01942135|466437300|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
129585328|NCT01942135|466437301|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
129585329|NCT01942135|466437300|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
129585330|NCT01942135|466437301|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
129585331|NCT01942135|466437300|FG000|Overall Study|Withdrawal by Subject|4|||
129585332|NCT01942135|466437301|FG001|Overall Study|Withdrawal by Subject|3|||
129585333|NCT01942135|466437300|FG000|Overall Study|Protocol Violation|1|||
129585334|NCT01942135|466437301|FG001|Overall Study|Protocol Violation|0|||
129585335|NCT01942135|466437300|FG000|Overall Study|Other|19|||
129585336|NCT01942135|466437301|FG001|Overall Study|Other|4|||
129585337|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
129585338|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
129585339|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
129585340|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
129585341|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
129585342|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
129585343|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
129585344|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
129585345|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
129585346|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
129585347|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
129585348|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
129585349|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
129585350|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
129585351|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
129585352|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
129585353|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
129585354|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
129585355|NCT00950300|466437302|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
129585356|NCT00950300|466437303|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
129585357|NCT00950300|466437302|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
129585358|NCT00950300|466437303|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
129585359|NCT00950300|466437302|FG000|TFFU Period|Death|4|||
129585360|NCT00950300|466437303|FG001|TFFU Period|Death|1|||
129585361|NCT00950300|466437302|FG000|TFFU Period|Refused Treatment|10|||
129585362|NCT00950300|466437303|FG001|TFFU Period|Refused Treatment|11|||
129585363|NCT00950300|466437302|FG000|TFFU Period|Failure to Return|16|||
129585364|NCT00950300|466437303|FG001|TFFU Period|Failure to Return|16|||
129585365|NCT00950300|466437302|FG000|TFFU Period|Recurrence of Disease|63|||
129585366|NCT00950300|466437303|FG001|TFFU Period|Recurrence of Disease|72|||
129585367|NCT00950300|466437302|FG000|TFFU Period|Other|4|||
129585368|NCT00950300|466437303|FG001|TFFU Period|Other|3|||
129585369|NCT00950300|466437302|FG000|SFU Period|Death|44|||
129585370|NCT00950300|466437303|FG001|SFU Period|Death|42|||
129585371|NCT00950300|466437302|FG000|SFU Period|Lost to Follow-up|30|||
129585372|NCT00950300|466437303|FG001|SFU Period|Lost to Follow-up|28|||
129585373|NCT00950300|466437302|FG000|SFU Period|Withdrawal by Subject|4|||
129585374|NCT00950300|466437303|FG001|SFU Period|Withdrawal by Subject|8|||
129585375|NCT01717040|466437304|FG000|Overall Study|Lost to Follow-up|2|||
129585376|NCT01717040|466437305|FG001|Overall Study|Lost to Follow-up|3|||
129585377|NCT01717040|466437304|FG000|Overall Study|Lack of Efficacy|1|||
129585378|NCT01717040|466437305|FG001|Overall Study|Lack of Efficacy|1|||
129585379|NCT01717040|466437304|FG000|Overall Study|Adverse Event|1|||
129585380|NCT01717040|466437305|FG001|Overall Study|Adverse Event|0|||
129585381|NCT01717040|466437304|FG000|Overall Study|Required Medication Change|0|||
129585382|NCT01717040|466437305|FG001|Overall Study|Required Medication Change|1|||
129585383|NCT01717040|466437304|FG000|Overall Study|New Substance Use Disorder|1|||
129585384|NCT01717040|466437305|FG001|Overall Study|New Substance Use Disorder|0|||
129585385|NCT00494013|466437306|FG000|Overall Study|Adverse Event|0|||
129585386|NCT00494013|466437307|FG001|Overall Study|Adverse Event|1|||
129585387|NCT00494013|466437306|FG000|Overall Study|Entry Criteria Not Met|1|||
129585388|NCT00494013|466437307|FG001|Overall Study|Entry Criteria Not Met|4|||
129585389|NCT00494013|466437306|FG000|Overall Study|Lost to Follow-up|5|||
129585390|NCT00494013|466437307|FG001|Overall Study|Lost to Follow-up|6|||
129585391|NCT00494013|466437306|FG000|Overall Study|Physician Decision|3|||
129585392|NCT00494013|466437307|FG001|Overall Study|Physician Decision|5|||
129585393|NCT00494013|466437306|FG000|Overall Study|Protocol Violation|8|||
129585394|NCT00494013|466437307|FG001|Overall Study|Protocol Violation|5|||
129585395|NCT00494013|466437306|FG000|Overall Study|Withdrawal by Subject|13|||
129585396|NCT00494013|466437307|FG001|Overall Study|Withdrawal by Subject|14|||
129585397|NCT00494013|466437306|FG000|Overall Study|Sponsor Decision|0|||
129585398|NCT00494013|466437307|FG001|Overall Study|Sponsor Decision|1|||
129585399|NCT04750239|466437308|FG000|Overall Study|Withdrawal by Subject|2|||
129585400|NCT04750239|466437308|FG000|Overall Study|Trial terminated by sponsor|1|||
129585401|NCT00903877|466437309|FG000|Overall Study|Did not meet study criteria|33|||
129585402|NCT00903877|466437309|FG000|Overall Study|Withdrawal by Subject|3|||
129585403|NCT00903877|466437309|FG000|Overall Study|Adverse Event|2|||
129585404|NCT00903877|466437309|FG000|Overall Study|Lost to Follow-up|1|||
129585405|NCT00903877|466437309|FG000|Overall Study|Participation put on hold|4|||
129585406|NCT00919711|466437310|FG000|Overall Study|Withdrawal by Subject|15|||
129585407|NCT00919711|466437311|FG001|Overall Study|Withdrawal by Subject|7|||
129585408|NCT00919711|466437310|FG000|Overall Study|Adverse Event|13|||
129585409|NCT00919711|466437311|FG001|Overall Study|Adverse Event|3|||
129585410|NCT00919711|466437310|FG000|Overall Study|Other|1|||
129585411|NCT00919711|466437311|FG001|Overall Study|Other|2|||
129585412|NCT00919711|466437310|FG000|Overall Study|Administrative Decision|0|||
129585413|NCT00919711|466437311|FG001|Overall Study|Administrative Decision|1|||
129585414|NCT00919711|466437310|FG000|Overall Study|Lost to Follow-up|2|||
129585415|NCT00919711|466437311|FG001|Overall Study|Lost to Follow-up|0|||
129585416|NCT00919711|466437310|FG000|Overall Study|Death|1|||
129585417|NCT00919711|466437311|FG001|Overall Study|Death|0|||
129585418|NCT00919711|466437310|FG000|Overall Study|Noncompliance|1|||
129585419|NCT00919711|466437311|FG001|Overall Study|Noncompliance|0|||
129585420|NCT00087529|466437312|FG000|Overall Study|Death|1|||
129585421|NCT00087529|466437313|FG001|Overall Study|Death|0|||
129585422|NCT00087529|466437312|FG000|Overall Study|Adverse Event|0|||
129585423|NCT00087529|466437313|FG001|Overall Study|Adverse Event|8|||
129585424|NCT00087529|466437312|FG000|Overall Study|Pregnancy|0|||
129585425|NCT00087529|466437313|FG001|Overall Study|Pregnancy|1|||
129585426|NCT00087529|466437312|FG000|Overall Study|Lost to Follow-up|2|||
129585427|NCT00087529|466437313|FG001|Overall Study|Lost to Follow-up|3|||
129585428|NCT00087529|466437312|FG000|Overall Study|Participant Decision|14|||
129585429|NCT00087529|466437313|FG001|Overall Study|Participant Decision|37|||
129585430|NCT00087529|466437312|FG000|Overall Study|Physician Decision|4|||
129585431|NCT00087529|466437313|FG001|Overall Study|Physician Decision|8|||
129585432|NCT00087529|466437312|FG000|Overall Study|Initiation of Excluded Therapy|0|||
129585433|NCT00087529|466437313|FG001|Overall Study|Initiation of Excluded Therapy|1|||
129585434|NCT00087529|466437312|FG000|Overall Study|Participant Noncompliance|0|||
129585435|NCT00087529|466437313|FG001|Overall Study|Participant Noncompliance|1|||
129585436|NCT00087529|466437312|FG000|Overall Study|Disease Progression|5|||
129585437|NCT00087529|466437313|FG001|Overall Study|Disease Progression|4|||
129585438|NCT00087529|466437312|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
129585439|NCT00087529|466437313|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
129585440|NCT04573309|466438614|FG000|Overall Study|Protocol Violation|1|||
129585441|NCT04573309|466438615|FG001|Overall Study|Protocol Violation|0|||
129585442|NCT01894230|466438616|FG000|Overall Study|Lost to Follow-up|2|||
129585443|NCT01894230|466438617|FG001|Overall Study|Lost to Follow-up|2|||
129585444|NCT01894230|466438616|FG000|Overall Study|Withdrawal by Subject|4|||
129585445|NCT01894230|466438617|FG001|Overall Study|Withdrawal by Subject|4|||
129585446|NCT01894230|466438616|FG000|Overall Study|Non-adherent|0|||
129585447|NCT01894230|466438617|FG001|Overall Study|Non-adherent|1|||
129585448|NCT01894230|466438616|FG000|Overall Study|Death|1|||
129585449|NCT01894230|466438617|FG001|Overall Study|Death|0|||
129585450|NCT02300987|466438618|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
129585451|NCT02300987|466438619|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
129585452|NCT02300987|466438618|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
129585453|NCT02300987|466438619|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
129585454|NCT02300987|466438618|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
129585455|NCT02300987|466438619|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
129585456|NCT02300987|466438618|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
129585457|NCT02300987|466438619|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
129585458|NCT02300987|466438618|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
129585459|NCT02300987|466438619|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
129585460|NCT02488109|466438620|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
129585461|NCT02488109|466438621|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
129585462|NCT02488109|466438620|FG000|12-month Follow-Up|Lost to Follow-up|4|||
129585463|NCT02488109|466438621|FG001|12-month Follow-Up|Lost to Follow-up|7|||
129585464|NCT02817828|466438628|FG000|Overall Study|Lost to Follow-up|41|||
129585465|NCT02817828|466438628|FG000|Overall Study|Adverse event not related to bleeding|104|||
129585466|NCT02817828|466438628|FG000|Overall Study|Adverse event related to bleeding|53|||
129585467|NCT02817828|466438628|FG000|Overall Study|Protocol Violation|11|||
129585468|NCT02817828|466438628|FG000|Overall Study|Pregnancy|7|||
129585469|NCT02817828|466438628|FG000|Overall Study|Pregnancy wish|15|||
129585470|NCT02817828|466438628|FG000|Overall Study|Withdrawal by Subject|78|||
129585471|NCT02817828|466438628|FG000|Overall Study|Other|26|||
129585472|NCT02651987|466438629|FG000|Overall Study|Adverse Event|2|||
129585473|NCT02651987|466438630|FG001|Overall Study|Adverse Event|2|||
129585474|NCT02651987|466438629|FG000|Overall Study|Consent Withdrawn|2|||
129585475|NCT02651987|466438630|FG001|Overall Study|Consent Withdrawn|0|||
129585476|NCT02651987|466438629|FG000|Overall Study|Local PD|0|||
129585477|NCT02651987|466438630|FG001|Overall Study|Local PD|2|||
129585478|NCT02651987|466438629|FG000|Overall Study|Investigator Decision|1|||
129585479|NCT02651987|466438630|FG001|Overall Study|Investigator Decision|1|||
129585480|NCT00522041|466438631|FG000|Overall Study|Adverse Event|9|||
129585481|NCT00522041|466438632|FG001|Overall Study|Adverse Event|3|||
129585482|NCT00522041|466438631|FG000|Overall Study|Protocol Violation|2|||
129585483|NCT00522041|466438632|FG001|Overall Study|Protocol Violation|0|||
129585484|NCT00522041|466438631|FG000|Overall Study|Lost to Follow-up|1|||
129585485|NCT00522041|466438632|FG001|Overall Study|Lost to Follow-up|4|||
129585486|NCT00522041|466438631|FG000|Overall Study|Voluntary withdrawal|5|||
129585487|NCT00522041|466438632|FG001|Overall Study|Voluntary withdrawal|4|||
129585488|NCT00522041|466438631|FG000|Overall Study|Did not receive treatment|0|||
129585489|NCT00522041|466438632|FG001|Overall Study|Did not receive treatment|1|||
129585490|NCT00486434|466438633|FG000|Overall Study|Withdrawal by Subject|34|||
129585491|NCT00486434|466438634|FG001|Overall Study|Withdrawal by Subject|39|||
129585492|NCT00486434|466438633|FG000|Overall Study|Adverse Event|118|||
129585493|NCT00486434|466438634|FG001|Overall Study|Adverse Event|44|||
129585494|NCT00486434|466438633|FG000|Overall Study|Protocol Violation|22|||
129585495|NCT00486434|466438634|FG001|Overall Study|Protocol Violation|21|||
129585496|NCT00486434|466438633|FG000|Overall Study|Lack of Efficacy|12|||
129585497|NCT00486434|466438634|FG001|Overall Study|Lack of Efficacy|19|||
129585498|NCT00486434|466438633|FG000|Overall Study|Lost to Follow-up|2|||
129585499|NCT00486434|466438634|FG001|Overall Study|Lost to Follow-up|3|||
129585500|NCT00486434|466438633|FG000|Overall Study|Death|1|||
129585501|NCT00486434|466438634|FG001|Overall Study|Death|2|||
129585502|NCT00486434|466438633|FG000|Overall Study|Personal reasons|5|||
129585503|NCT00486434|466438634|FG001|Overall Study|Personal reasons|6|||
129585504|NCT01944722|466438646|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
129585505|NCT01944722|466438646|FG000|Overall Study|Specimen Shipping Issues|34|||
129585506|NCT01944722|466438646|FG000|Overall Study|Improper Storage/Transport|5|||
129585507|NCT01944722|466438646|FG000|Overall Study|Insufficient Volume for Test|1|||
129585508|NCT01944722|466438646|FG000|Overall Study|Missing Specimens|3|||
129585509|NCT01944722|466438646|FG000|Overall Study|Specimens Mislabeled|2|||
129585510|NCT01944722|466438646|FG000|Overall Study|Withdrawal by Subject|8|||
129585511|NCT01944722|466438646|FG000|Overall Study|NILM Subjects <30 years old|8106|||
129585512|NCT01944722|466438646|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
129585513|NCT01944722|466438646|FG000|Overall Study|>ASCUS Cytology|1122|||
129585514|NCT02906917|466438647|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
129585515|NCT02906917|466438648|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
129585516|NCT02906917|466438647|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
129585517|NCT02906917|466438648|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
129585518|NCT02906917|466438647|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
129585519|NCT02906917|466438648|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
129585520|NCT02906917|466438647|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
129585521|NCT02906917|466438648|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
129585522|NCT02906917|466438647|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
129585523|NCT02906917|466438648|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
129585524|NCT02906917|466438647|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
129585525|NCT02906917|466438648|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
129585526|NCT02906917|466438647|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
129585527|NCT02906917|466438648|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
129585528|NCT02906917|466438647|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
129585529|NCT02906917|466438648|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
129585530|NCT00210639|466438649|FG000|Overall Study|Lost to Follow-up|37|||
129585531|NCT00210639|466438650|FG001|Overall Study|Lost to Follow-up|29|||
129585532|NCT00210639|466438649|FG000|Overall Study|Withdrawal by Subject|8|||
129585533|NCT00210639|466438650|FG001|Overall Study|Withdrawal by Subject|1|||
129585534|NCT00210639|466438649|FG000|Overall Study|Other|18|||
129585535|NCT00210639|466438650|FG001|Overall Study|Other|12|||
129585536|NCT02854800|466438652|FG000|Overall Study|Protocol Violation|16|||
129585537|NCT02854800|466438653|FG001|Overall Study|Protocol Violation|11|||
129585538|NCT02854800|466438654|FG002|Overall Study|Protocol Violation|3|||
129585539|NCT02854800|466438652|FG000|Overall Study|Withdrawal by Subject|4|||
129585540|NCT02854800|466438653|FG001|Overall Study|Withdrawal by Subject|2|||
129585541|NCT02854800|466438654|FG002|Overall Study|Withdrawal by Subject|3|||
129585542|NCT02627963|466438660|FG000|Overall Study|Randomized but not treated|2|||
129585543|NCT02627963|466438661|FG001|Overall Study|Randomized but not treated|6|||
129585544|NCT05278858|466438662|FG000|Overall Study|Withdrawal by Subject|1|||
129585545|NCT00503867|466438666|FG000|Overall Study|Lost to Follow-up|1|||
129585546|NCT00503867|466438666|FG000|Overall Study|Adverse Event|1|||
129585547|NCT00323258|466438669|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
129585548|NCT00323258|466438670|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
129585549|NCT00323258|466438669|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
129585550|NCT00323258|466438670|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
129585551|NCT00323258|466438669|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
129585552|NCT00323258|466438670|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
129585553|NCT00323258|466438669|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
129585554|NCT00323258|466438670|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
129585555|NCT00323258|466438669|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
129585556|NCT00323258|466438670|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
129585557|NCT00323258|466438669|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
129585558|NCT00323258|466438670|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
129585559|NCT00323258|466438669|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
129585560|NCT00323258|466438670|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
129696039|NCT04135352|466845911|FG000|Overall Study|Not treated-randomization error|0|||
129585561|NCT02372006|466438680|FG000|Overall Study|Progressive disease|8|||
129585562|NCT02372006|466438681|FG001|Overall Study|Progressive disease|7|||
129585563|NCT02372006|466438682|FG002|Overall Study|Progressive disease|34|||
129585564|NCT02372006|466438680|FG000|Overall Study|Dose limiting toxicity|0|||
129585565|NCT02372006|466438681|FG001|Overall Study|Dose limiting toxicity|1|||
129585566|NCT02372006|466438682|FG002|Overall Study|Dose limiting toxicity|0|||
129585567|NCT02372006|466438680|FG000|Overall Study|Adverse Event|0|||
129585568|NCT02372006|466438681|FG001|Overall Study|Adverse Event|0|||
129585569|NCT02372006|466438682|FG002|Overall Study|Adverse Event|3|||
129585570|NCT02372006|466438680|FG000|Overall Study|Withdrawal by Subject|0|||
129585571|NCT02372006|466438681|FG001|Overall Study|Withdrawal by Subject|1|||
129585572|NCT02372006|466438682|FG002|Overall Study|Withdrawal by Subject|1|||
129585573|NCT02372006|466438680|FG000|Overall Study|Other reason for not completing|0|||
129585574|NCT02372006|466438681|FG001|Overall Study|Other reason for not completing|0|||
129585575|NCT02372006|466438682|FG002|Overall Study|Other reason for not completing|1|||
129585576|NCT01859598|466438687|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
129585577|NCT03255980|466438692|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
129585578|NCT03255980|466438693|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
129585579|NCT03255980|466438694|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
129585580|NCT03255980|466438695|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
129585581|NCT03255980|466438692|FG000|Overall Study|Adverse Event|1|||
129585582|NCT03255980|466438693|FG001|Overall Study|Adverse Event|1|||
129585583|NCT03255980|466438694|FG002|Overall Study|Adverse Event|0|||
129585584|NCT03255980|466438695|FG003|Overall Study|Adverse Event|1|||
129585585|NCT03255980|466438692|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
129585586|NCT03255980|466438693|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
129585587|NCT03255980|466438694|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
129585588|NCT03255980|466438695|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
129585589|NCT03255980|466438692|FG000|Overall Study|Lost to Follow-up|1|||
129585590|NCT03255980|466438693|FG001|Overall Study|Lost to Follow-up|1|||
129585591|NCT03255980|466438694|FG002|Overall Study|Lost to Follow-up|0|||
129585592|NCT03255980|466438695|FG003|Overall Study|Lost to Follow-up|3|||
129585593|NCT03255980|466438692|FG000|Overall Study|Withdrawal by Subject|0|||
129585594|NCT03255980|466438693|FG001|Overall Study|Withdrawal by Subject|1|||
129585595|NCT03255980|466438694|FG002|Overall Study|Withdrawal by Subject|0|||
129585596|NCT03255980|466438695|FG003|Overall Study|Withdrawal by Subject|3|||
129585597|NCT02611362|466438696|FG000|Overall Study|Withdrawal by Subject|7|||
129585598|NCT02611362|466438697|FG001|Overall Study|Withdrawal by Subject|2|||
129585599|NCT02611362|466438696|FG000|Overall Study|Lost to Follow-up|2|||
129585600|NCT02611362|466438697|FG001|Overall Study|Lost to Follow-up|4|||
129585601|NCT01155531|466438698|FG000|Overall Study|Adverse Event|0|||
129585602|NCT01155531|466438699|FG001|Overall Study|Adverse Event|0|||
129585603|NCT01155531|466438700|FG002|Overall Study|Adverse Event|1|||
129585604|NCT01155531|466438701|FG003|Overall Study|Adverse Event|0|||
129585605|NCT01155531|466438698|FG000|Overall Study|Lost to Follow-up|0|||
129585606|NCT01155531|466438699|FG001|Overall Study|Lost to Follow-up|0|||
129585607|NCT01155531|466438700|FG002|Overall Study|Lost to Follow-up|0|||
129585608|NCT01155531|466438701|FG003|Overall Study|Lost to Follow-up|1|||
129585609|NCT01155531|466438698|FG000|Overall Study|Withdrawal by Subject|1|||
129585610|NCT01155531|466438699|FG001|Overall Study|Withdrawal by Subject|0|||
129585611|NCT01155531|466438700|FG002|Overall Study|Withdrawal by Subject|1|||
129585612|NCT01155531|466438701|FG003|Overall Study|Withdrawal by Subject|0|||
129585613|NCT00354159|466438702|FG000|Randomized Study Period|Withdrawal by Subject|5|||
129585614|NCT00354159|466438703|FG001|Randomized Study Period|Withdrawal by Subject|3|||
129585615|NCT00354159|466438702|FG000|Randomized Study Period|Physician Decision|6|||
129585616|NCT00354159|466438703|FG001|Randomized Study Period|Physician Decision|10|||
129585617|NCT00354159|466438702|FG000|Randomized Study Period|Lost to Follow-up|4|||
129585618|NCT00354159|466438703|FG001|Randomized Study Period|Lost to Follow-up|0|||
129585619|NCT00354159|466438702|FG000|Randomized Study Period|Death|7|||
129585620|NCT00354159|466438703|FG001|Randomized Study Period|Death|9|||
129585621|NCT00354159|466438702|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
129585622|NCT00354159|466438703|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
129585623|NCT00354159|466438702|FG000|Long-term Follow-up|Physician Decision|127|||
129585624|NCT00354159|466438703|FG001|Long-term Follow-up|Physician Decision|122|||
129585625|NCT00354159|466438702|FG000|Long-term Follow-up|Lost to Follow-up|1|||
129585626|NCT00354159|466438703|FG001|Long-term Follow-up|Lost to Follow-up|0|||
129585627|NCT00354159|466438702|FG000|Long-term Follow-up|Death|14|||
129585628|NCT00354159|466438703|FG001|Long-term Follow-up|Death|11|||
129585629|NCT00354159|466438702|FG000|Long-term Follow-up|Study Closed|29|||
129585630|NCT00354159|466438703|FG001|Long-term Follow-up|Study Closed|34|||
129585631|NCT01653704|466438704|FG000|Overall Study|Technical failure during recording|1|||
129585632|NCT01653704|466438705|FG001|Overall Study|Technical failure during recording|1|||
129585633|NCT01653704|466438704|FG000|Overall Study|Performance not reflective of training|1|||
129585634|NCT01653704|466438705|FG001|Overall Study|Performance not reflective of training|0|||
129585635|NCT01728116|466438706|FG000|Overall Study|Sponsor Terminated Study|106|||
129585636|NCT01728116|466438707|FG001|Overall Study|Sponsor Terminated Study|35|||
129585637|NCT01728116|466438706|FG000|Overall Study|Withdrawal by Subject|16|||
129585638|NCT01728116|466438707|FG001|Overall Study|Withdrawal by Subject|9|||
129585639|NCT01728116|466438706|FG000|Overall Study|Adverse Event|13|||
129585640|NCT01728116|466438707|FG001|Overall Study|Adverse Event|0|||
129585641|NCT01728116|466438706|FG000|Overall Study|Procedure/device failure|7|||
129585642|NCT01728116|466438707|FG001|Overall Study|Procedure/device failure|0|||
129585643|NCT01728116|466438706|FG000|Overall Study|Lost to Follow-up|9|||
129585644|NCT01728116|466438707|FG001|Overall Study|Lost to Follow-up|2|||
129585645|NCT01728116|466438706|FG000|Overall Study|Physician Decision|2|||
129585646|NCT01728116|466438707|FG001|Overall Study|Physician Decision|0|||
129585647|NCT01728116|466438706|FG000|Overall Study|Subject Non-Compliance|2|||
129585648|NCT01728116|466438707|FG001|Overall Study|Subject Non-Compliance|0|||
129585649|NCT01728116|466438706|FG000|Overall Study|Inter-current finding at procedure|1|||
129585650|NCT01728116|466438707|FG001|Overall Study|Inter-current finding at procedure|0|||
129585651|NCT01728116|466438706|FG000|Overall Study|Incorrectly enrolled in Study|0|||
129585652|NCT01728116|466438707|FG001|Overall Study|Incorrectly enrolled in Study|1|||
129585653|NCT01728116|466438706|FG000|Overall Study|various not noted previously|5|||
129585654|NCT01728116|466438707|FG001|Overall Study|various not noted previously|0|||
129585655|NCT03141151|466438720|FG000|Overall Study|Lost to Follow-up|3|||
129585656|NCT03141151|466438721|FG001|Overall Study|Lost to Follow-up|2|||
129585657|NCT03141151|466438720|FG000|Overall Study|Withdrawal by Subject|3|||
129585658|NCT03141151|466438721|FG001|Overall Study|Withdrawal by Subject|2|||
129585659|NCT01874535|466438722|FG000|Overall Study|Lost to Follow-up|10|||
129585660|NCT01874535|466438723|FG001|Overall Study|Lost to Follow-up|9|||
129585661|NCT01874535|466438722|FG000|Overall Study|incomplete symptom resolution|45|||
129585662|NCT01874535|466438723|FG001|Overall Study|incomplete symptom resolution|35|||
129585663|NCT01215721|466438724|FG000|Overall Study|Adverse Event|2|||
129585664|NCT02943096|466438725|FG000|Overall Study|Lack of Efficacy|0|||
129585665|NCT02943096|466438726|FG001|Overall Study|Lack of Efficacy|1|||
129585666|NCT02119936|466438736|FG000|Overall Study|Lost to Follow-up|10|||
129585667|NCT00570128|466438737|FG000|Overall Study|Adverse Event|1|||
129585668|NCT00570128|466438738|FG001|Overall Study|Adverse Event|0|||
129585669|NCT00570128|466438737|FG000|Overall Study|Lost to Follow-up|1|||
129585670|NCT00570128|466438738|FG001|Overall Study|Lost to Follow-up|0|||
129585671|NCT00570128|466438737|FG000|Overall Study|Withdrawal by Subject|2|||
129585672|NCT00570128|466438738|FG001|Overall Study|Withdrawal by Subject|0|||
129585673|NCT03193021|466438739|FG000|Overall Study|Lost to Follow-up|1|||
129585674|NCT03193021|466438740|FG001|Overall Study|Lost to Follow-up|1|||
129585675|NCT01139762|466438741|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
129585676|NCT01139762|466438742|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
129585677|NCT01139762|466438743|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
129585678|NCT01139762|466438741|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
129585679|NCT01139762|466438742|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
129585680|NCT01139762|466438743|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
129585681|NCT01139762|466438741|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
129585682|NCT01139762|466438742|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
129585683|NCT01139762|466438743|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
129585684|NCT01139762|466438741|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
129585685|NCT01139762|466438742|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
129585686|NCT01139762|466438743|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
129585687|NCT01139762|466438741|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
129585688|NCT01139762|466438742|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
129585689|NCT01139762|466438743|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
129585690|NCT01139762|466438741|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
129585691|NCT01139762|466438742|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
129585692|NCT01139762|466438743|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
129585693|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
129585694|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
129585695|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
129585696|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Death|0|||
129585697|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Death|1|||
129585698|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Death|1|||
129585699|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
129585700|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
129585701|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
129585702|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
129585703|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
129585704|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
129585705|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
129585706|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
129585707|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
129585708|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
129585709|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
129585710|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
129585711|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
129585712|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
129585713|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
129585714|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
129585715|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
129585716|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
129585717|NCT01139762|466438741|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
129585718|NCT01139762|466438742|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
129585719|NCT01139762|466438743|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
129585720|NCT00685334|466438746|FG000|Overall Study|Withdrawal by Subject|5|||
129585721|NCT00685334|466438747|FG001|Overall Study|Withdrawal by Subject|6|||
129585722|NCT00685334|466438746|FG000|Overall Study|Lost to Follow-up|4|||
129585723|NCT00685334|466438747|FG001|Overall Study|Lost to Follow-up|0|||
129585724|NCT00685334|466438746|FG000|Overall Study|Chose to enter hospital|1|||
129585725|NCT00685334|466438747|FG001|Overall Study|Chose to enter hospital|1|||
129585726|NCT01891357|466438748|FG000|Overall Study|Protocol Violation|3|||
129585727|NCT00640341|466440195|FG000|Overall Study|Adverse Event|0|||
129585728|NCT00640341|466440196|FG001|Overall Study|Adverse Event|0|||
129585729|NCT00640341|466440197|FG002|Overall Study|Adverse Event|1|||
129585730|NCT00640341|466440195|FG000|Overall Study|Positive Slit Lamp Findings|0|||
129585731|NCT00640341|466440196|FG001|Overall Study|Positive Slit Lamp Findings|0|||
129585732|NCT00640341|466440197|FG002|Overall Study|Positive Slit Lamp Findings|1|||
129585733|NCT00640341|466440195|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
129585734|NCT00640341|466440196|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
129585735|NCT00640341|466440197|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
129585736|NCT00640341|466440195|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
129585737|NCT00640341|466440196|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
129585738|NCT00640341|466440197|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
129585739|NCT00640341|466440195|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
129585740|NCT00640341|466440196|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
129585741|NCT00640341|466440197|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
129585742|NCT00640341|466440195|FG000|Overall Study|Lost to Follow-up|2|||
129585743|NCT00640341|466440196|FG001|Overall Study|Lost to Follow-up|0|||
129585744|NCT00640341|466440197|FG002|Overall Study|Lost to Follow-up|0|||
129585745|NCT00640341|466440195|FG000|Overall Study|Withdrawal by Subject|4|||
129585746|NCT00640341|466440196|FG001|Overall Study|Withdrawal by Subject|0|||
129585747|NCT00640341|466440197|FG002|Overall Study|Withdrawal by Subject|1|||
129585748|NCT00640341|466440195|FG000|Overall Study|Unacceptable Lens Movement|1|||
129585749|NCT00640341|466440196|FG001|Overall Study|Unacceptable Lens Movement|0|||
129585750|NCT00640341|466440197|FG002|Overall Study|Unacceptable Lens Movement|0|||
129585751|NCT00640341|466440195|FG000|Overall Study|Poor fit/Uncomfortable|4|||
129585752|NCT00640341|466440196|FG001|Overall Study|Poor fit/Uncomfortable|0|||
129585753|NCT00640341|466440197|FG002|Overall Study|Poor fit/Uncomfortable|0|||
129585754|NCT00640341|466440195|FG000|Overall Study|Ineligable at Baseline|5|||
129585755|NCT00640341|466440196|FG001|Overall Study|Ineligable at Baseline|3|||
129585756|NCT00640341|466440197|FG002|Overall Study|Ineligable at Baseline|2|||
129585757|NCT00640341|466440195|FG000|Overall Study|Adverse event and positive slit lamp|1|||
129585758|NCT00640341|466440196|FG001|Overall Study|Adverse event and positive slit lamp|0|||
129585759|NCT00640341|466440197|FG002|Overall Study|Adverse event and positive slit lamp|0|||
129585760|NCT00660387|466440201|FG000|Overall Study|Adverse Event|1|||
129585761|NCT00660387|466440202|FG001|Overall Study|Adverse Event|2|||
129585762|NCT00660387|466440201|FG000|Overall Study|Lack of Efficacy|0|||
129585763|NCT00660387|466440202|FG001|Overall Study|Lack of Efficacy|1|||
129585764|NCT00660387|466440201|FG000|Overall Study|Protocol Violation|1|||
129585765|NCT00660387|466440202|FG001|Overall Study|Protocol Violation|0|||
129585766|NCT01023061|466440207|FG000|Overall Study|Withdrawal prior to treatment|2|||
129585767|NCT02966340|466440208|FG000|Overall Study|Adverse Event|0|||
129585768|NCT02966340|466440209|FG001|Overall Study|Adverse Event|1|||
129585769|NCT02966340|466440208|FG000|Overall Study|Lost to Follow-up|0|||
129585770|NCT02966340|466440209|FG001|Overall Study|Lost to Follow-up|1|||
129585771|NCT02966340|466440208|FG000|Overall Study|Withdrawal by Subject|1|||
129585772|NCT02966340|466440209|FG001|Overall Study|Withdrawal by Subject|0|||
129585773|NCT02966340|466440208|FG000|Overall Study|data acquisition error|1|||
129585774|NCT02966340|466440209|FG001|Overall Study|data acquisition error|0|||
129585775|NCT02966340|466440208|FG000|Overall Study|startle non-responder|1|||
129585776|NCT02966340|466440209|FG001|Overall Study|startle non-responder|1|||
129585777|NCT00442351|466440210|FG000|Overall Study|Administrative|6|||
129585778|NCT00442351|466440211|FG001|Overall Study|Administrative|5|||
129585779|NCT00442351|466440210|FG000|Overall Study|Did not meet protocol eligibility|1|||
129585780|NCT00442351|466440211|FG001|Overall Study|Did not meet protocol eligibility|0|||
129585781|NCT00442351|466440210|FG000|Overall Study|Other|0|||
129585782|NCT00442351|466440211|FG001|Overall Study|Other|1|||
129585783|NCT03387462|466440215|FG000|Overall Study|Lost to Follow-up|1|||
129585784|NCT01460628|466440218|FG000|Overall Study|Adverse Event|3|||
129585785|NCT01460628|466440218|FG000|Overall Study|Withdrawal by Subject|2|||
129585786|NCT00874822|466440221|FG000|Overall Study|excluded by criteria|8|||
129585787|NCT04281472|466440223|FG000|Stage A|Lack of Efficacy|8|||
129585788|NCT04281472|466440224|FG001|Stage A|Lack of Efficacy|0|||
129585789|NCT04281472|466440225|FG002|Stage A|Lack of Efficacy|0|||
129585790|NCT04281472|466440223|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
129585791|NCT04281472|466440224|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
129585792|NCT04281472|466440225|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
129585793|NCT04281472|466440223|FG000|Stage A|Adverse Event|20|||
129585794|NCT04281472|466440224|FG001|Stage A|Adverse Event|0|||
129585795|NCT04281472|466440225|FG002|Stage A|Adverse Event|0|||
129585796|NCT04281472|466440223|FG000|Stage A|Death|1|||
129585797|NCT04281472|466440224|FG001|Stage A|Death|0|||
129585798|NCT04281472|466440225|FG002|Stage A|Death|0|||
129585799|NCT04281472|466440223|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
129585800|NCT04281472|466440224|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
129585801|NCT04281472|466440225|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
129585802|NCT04281472|466440223|FG000|Stage A|Lost to Follow-up|2|||
129585803|NCT04281472|466440224|FG001|Stage A|Lost to Follow-up|0|||
129585804|NCT04281472|466440225|FG002|Stage A|Lost to Follow-up|0|||
129585805|NCT04281472|466440223|FG000|Stage A|Non-compliance with study drug|1|||
129585806|NCT04281472|466440224|FG001|Stage A|Non-compliance with study drug|0|||
129585807|NCT04281472|466440225|FG002|Stage A|Non-compliance with study drug|0|||
129585808|NCT04281472|466440223|FG000|Stage A|Physician Decision|1|||
129585809|NCT04281472|466440224|FG001|Stage A|Physician Decision|0|||
129585810|NCT04281472|466440225|FG002|Stage A|Physician Decision|0|||
129585811|NCT04281472|466440223|FG000|Stage A|Prohibited medications|2|||
129585812|NCT04281472|466440224|FG001|Stage A|Prohibited medications|0|||
129585813|NCT04281472|466440225|FG002|Stage A|Prohibited medications|0|||
129585814|NCT04281472|466440223|FG000|Stage A|Withdrawal by Subject|11|||
129585815|NCT04281472|466440224|FG001|Stage A|Withdrawal by Subject|0|||
129585816|NCT04281472|466440225|FG002|Stage A|Withdrawal by Subject|0|||
129585817|NCT04281472|466440223|FG000|Stage A|Other|5|||
129585818|NCT04281472|466440224|FG001|Stage A|Other|0|||
129585819|NCT04281472|466440225|FG002|Stage A|Other|0|||
129585820|NCT04281472|466440223|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
129585821|NCT04281472|466440224|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
129585822|NCT04281472|466440225|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
129585823|NCT04281472|466440223|FG000|Stage B|Adverse Event|0|||
129585824|NCT04281472|466440224|FG001|Stage B|Adverse Event|3|||
129585825|NCT04281472|466440225|FG002|Stage B|Adverse Event|0|||
129585826|NCT04281472|466440223|FG000|Stage B|Death|0|||
129585827|NCT04281472|466440224|FG001|Stage B|Death|0|||
129585828|NCT04281472|466440225|FG002|Stage B|Death|1|||
129585829|NCT04281472|466440223|FG000|Stage B|Lack of Efficacy|0|||
129585830|NCT04281472|466440224|FG001|Stage B|Lack of Efficacy|0|||
129585831|NCT04281472|466440225|FG002|Stage B|Lack of Efficacy|1|||
129585832|NCT04281472|466440223|FG000|Stage B|Lost to Follow-up|0|||
129585833|NCT04281472|466440224|FG001|Stage B|Lost to Follow-up|0|||
129585834|NCT04281472|466440225|FG002|Stage B|Lost to Follow-up|2|||
129585835|NCT04281472|466440223|FG000|Stage B|Prohibited medications|0|||
129585836|NCT04281472|466440224|FG001|Stage B|Prohibited medications|2|||
129585837|NCT04281472|466440225|FG002|Stage B|Prohibited medications|1|||
129585838|NCT04281472|466440223|FG000|Stage B|Protocol Violation|0|||
129585839|NCT04281472|466440224|FG001|Stage B|Protocol Violation|1|||
129585840|NCT04281472|466440225|FG002|Stage B|Protocol Violation|1|||
129585841|NCT04281472|466440223|FG000|Stage B|Sponsor decision|0|||
129585842|NCT04281472|466440224|FG001|Stage B|Sponsor decision|0|||
129585843|NCT04281472|466440225|FG002|Stage B|Sponsor decision|1|||
129585844|NCT04281472|466440223|FG000|Stage B|Withdrawal by Subject|0|||
129585845|NCT04281472|466440224|FG001|Stage B|Withdrawal by Subject|3|||
129585846|NCT04281472|466440225|FG002|Stage B|Withdrawal by Subject|3|||
129585847|NCT04281472|466440223|FG000|Stage B|Other|0|||
129585848|NCT04281472|466440224|FG001|Stage B|Other|3|||
129585849|NCT04281472|466440225|FG002|Stage B|Other|0|||
129585850|NCT00152451|466440228|FG000|Overall Study|Adverse Event|4|||
129585851|NCT04697173|466440231|FG000|Overall Study|Withdrawal by Subject|34|||
129585852|NCT04697173|466440232|FG001|Overall Study|Withdrawal by Subject|38|||
129585853|NCT03807440|466440233|FG000|Overall Study|No documentation of index date 2|320|||
129585854|NCT03807440|466440233|FG000|Overall Study|No informed consent for index date 2|117|||
129585855|NCT01055834|466440235|FG000|Treatment Period I|Adverse Event|1|||
129585856|NCT01055834|466440236|FG001|Treatment Period I|Adverse Event|0|||
129585857|NCT05004649|466440240|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
129585858|NCT05004649|466440240|FG000|Overall Study|Lost to Follow-up|1|||
129585859|NCT05004649|466440240|FG000|Overall Study|Withdrawal by Subject|2|||
129585860|NCT05004649|466440240|FG000|Overall Study|COVID-19|1|||
129585861|NCT01717313|466440241|FG000|Phase A (Weeks 0 to 24)|Death|0|||
129585862|NCT01717313|466440242|FG001|Phase A (Weeks 0 to 24)|Death|1|||
129585863|NCT01717313|466440241|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
129585864|NCT01717313|466440242|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
129585865|NCT01717313|466440241|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
129585866|NCT01717313|466440242|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
129585867|NCT01717313|466440241|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
129585868|NCT01717313|466440242|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
129585869|NCT01717313|466440241|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
129585870|NCT01717313|466440242|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
129585871|NCT01717313|466440241|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
129585872|NCT01717313|466440242|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
129585873|NCT01717313|466440241|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
129585874|NCT01717313|466440242|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
129585875|NCT01717313|466440241|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
129585876|NCT01717313|466440242|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
129585877|NCT01717313|466440241|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
129585878|NCT01717313|466440242|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
129585879|NCT03504085|466440243|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
129585880|NCT03504085|466440244|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
129585881|NCT03504085|466440243|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
129585882|NCT03504085|466440244|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
129585883|NCT04133311|466440245|FG000|Period 1 Double Masked Treatment Period|Death|1|||
129585884|NCT04133311|466440246|FG001|Period 1 Double Masked Treatment Period|Death|0|||
129585885|NCT04133311|466440247|FG002|Period 1 Double Masked Treatment Period|Death|0|||
129585886|NCT04133311|466440248|FG003|Period 1 Double Masked Treatment Period|Death|0|||
129585887|NCT04133311|466440245|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
129585888|NCT04133311|466440246|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
129585889|NCT04133311|466440247|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
129585890|NCT04133311|466440248|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
129585891|NCT04133311|466440245|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
129585892|NCT04133311|466440246|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
129585893|NCT04133311|466440247|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
129585894|NCT04133311|466440248|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
129585895|NCT04133311|466440245|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
129885113|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Other|0|||
129885114|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Other|0|||
129585896|NCT04133311|466440246|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
129585897|NCT04133311|466440247|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
129585898|NCT04133311|466440248|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
129585899|NCT04133311|466440245|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
129585900|NCT04133311|466440246|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
129585901|NCT04133311|466440247|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
129585902|NCT04133311|466440248|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
129585903|NCT04133311|466440245|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
129585904|NCT04133311|466440246|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
129585905|NCT04133311|466440247|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
129585906|NCT04133311|466440248|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
129585907|NCT04133311|466440245|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
129585908|NCT04133311|466440246|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
129585909|NCT04133311|466440247|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
129585910|NCT04133311|466440248|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
129585911|NCT04133311|466440245|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
129585912|NCT04133311|466440246|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
129585913|NCT04133311|466440247|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
129585914|NCT04133311|466440248|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
129585915|NCT00728754|466440249|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
129585916|NCT00728754|466440250|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
129585917|NCT00728754|466440249|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
129585918|NCT00728754|466440250|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
129585919|NCT00728754|466440249|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
129585920|NCT00728754|466440250|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
129585921|NCT01926119|466440251|FG000|Overall Study|Withdrawal by Subject|1|||
129585922|NCT02654145|466440252|FG000|Overall Study|Lack of Efficacy|1|||
129585923|NCT02654145|466440252|FG000|Overall Study|Protocol Violation|1|||
129585924|NCT02654145|466440252|FG000|Overall Study|Withdrawal by Subject|5|||
129585925|NCT00009945|466440257|FG000|Overall Study|no follow up data|7|||
129585926|NCT00009945|466440258|FG001|Overall Study|no follow up data|5|||
129585927|NCT02637141|466440259|FG000|Overall Study|Adverse Event|1|||
129585928|NCT02637141|466440260|FG001|Overall Study|Adverse Event|1|||
129585929|NCT02637141|466440261|FG002|Overall Study|Adverse Event|0|||
129585930|NCT02637141|466440259|FG000|Overall Study|Withdrawal by Subject|1|||
129585931|NCT02637141|466440260|FG001|Overall Study|Withdrawal by Subject|1|||
129585932|NCT02637141|466440261|FG002|Overall Study|Withdrawal by Subject|1|||
129585933|NCT01943435|466440265|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
129585934|NCT01943435|466440266|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
129585935|NCT01943435|466440267|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
129585936|NCT01943435|466440265|FG000|Intervention Period|Withdrawal by Subject|3|||
129585937|NCT01943435|466440266|FG001|Intervention Period|Withdrawal by Subject|3|||
129585938|NCT01943435|466440267|FG002|Intervention Period|Withdrawal by Subject|4|||
129585939|NCT01943435|466440265|FG000|2 Month Follow up|Lost to Follow-up|2|||
129585940|NCT01943435|466440266|FG001|2 Month Follow up|Lost to Follow-up|3|||
129585941|NCT01943435|466440267|FG002|2 Month Follow up|Lost to Follow-up|0|||
129885115|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Other|0|||
129885116|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Other|0|||
129885117|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Other|0|||
129885118|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Other|2|||
129885119|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Other|2|||
129885120|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Other|0|||
129885121|NCT02601937|467538761|FG000|Period 2: Dose Expansion Cohort|Death|0|||
129885122|NCT02601937|467538762|FG001|Period 2: Dose Expansion Cohort|Death|0|||
129885123|NCT02601937|467538763|FG002|Period 2: Dose Expansion Cohort|Death|0|||
129885124|NCT02601937|467538764|FG003|Period 2: Dose Expansion Cohort|Death|0|||
129885125|NCT02601937|467538765|FG004|Period 2: Dose Expansion Cohort|Death|0|||
129885126|NCT02601937|467538766|FG005|Period 2: Dose Expansion Cohort|Death|0|||
129885127|NCT02601937|467538767|FG006|Period 2: Dose Expansion Cohort|Death|0|||
129885128|NCT02601937|467538768|FG007|Period 2: Dose Expansion Cohort|Death|0|||
129885129|NCT02601937|467538769|FG008|Period 2: Dose Expansion Cohort|Death|1|||
129885130|NCT02601937|467538770|FG009|Period 2: Dose Expansion Cohort|Death|0|||
129885131|NCT02601937|467538771|FG010|Period 2: Dose Expansion Cohort|Death|0|||
129885132|NCT01040780|467540580|FG000|Overall Study|Protocol Violation|1|||
129885133|NCT01040780|467540581|FG001|Overall Study|Protocol Violation|3|||
129885134|NCT00802737|467540582|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
129885135|NCT00802737|467540583|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
129885136|NCT00802737|467540584|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
129885137|NCT00802737|467540582|FG000|Overall Study|Death|6|||
129885138|NCT00802737|467540583|FG001|Overall Study|Death|5|||
129885139|NCT00802737|467540584|FG002|Overall Study|Death|1|||
129885140|NCT00802737|467540582|FG000|Overall Study|Adverse Event|1|||
129885141|NCT00802737|467540583|FG001|Overall Study|Adverse Event|0|||
129885142|NCT00802737|467540584|FG002|Overall Study|Adverse Event|0|||
129885143|NCT00802737|467540582|FG000|Overall Study|Received Prohibited Therapy|1|||
129885144|NCT00802737|467540583|FG001|Overall Study|Received Prohibited Therapy|0|||
129885145|NCT00802737|467540584|FG002|Overall Study|Received Prohibited Therapy|0|||
129885146|NCT00802737|467540582|FG000|Overall Study|Ongoing CLL-Treatment|0|||
129885147|NCT00802737|467540583|FG001|Overall Study|Ongoing CLL-Treatment|1|||
129885148|NCT00802737|467540584|FG002|Overall Study|Ongoing CLL-Treatment|0|||
129885149|NCT00802737|467540582|FG000|Overall Study|Participant too Unwell|0|||
129885150|NCT00802737|467540583|FG001|Overall Study|Participant too Unwell|2|||
129885151|NCT00802737|467540584|FG002|Overall Study|Participant too Unwell|0|||
129885152|NCT03864926|467540592|FG000|Overall Study|Death|0|||
129885153|NCT03864926|467540593|FG001|Overall Study|Death|2|||
129885154|NCT00445601|467540594|FG000|Overall Study|Withdrawal by Subject|11|||
129885155|NCT00445601|467540595|FG001|Overall Study|Withdrawal by Subject|11|||
129885156|NCT00445601|467540594|FG000|Overall Study|TURBT Complication|12|||
129885157|NCT00445601|467540595|FG001|Overall Study|TURBT Complication|8|||
129885158|NCT00445601|467540594|FG000|Overall Study|Incorrect Disease Status|6|||
129885159|NCT00445601|467540595|FG001|Overall Study|Incorrect Disease Status|6|||
129885160|NCT00445601|467540594|FG000|Overall Study|Drug Delivery Issue|2|||
129885161|NCT00445601|467540595|FG001|Overall Study|Drug Delivery Issue|2|||
129885162|NCT00445601|467540594|FG000|Overall Study|Adverse Event|2|||
129885163|NCT00445601|467540595|FG001|Overall Study|Adverse Event|0|||
129885164|NCT00445601|467540594|FG000|Overall Study|Death prior to TURBT|0|||
129885165|NCT00445601|467540595|FG001|Overall Study|Death prior to TURBT|1|||
129885166|NCT02391038|467540602|FG000|Overall Study|Progressive disease|3|||
129885167|NCT02391038|467540603|FG001|Overall Study|Progressive disease|3|||
129885168|NCT02391038|467540604|FG002|Overall Study|Progressive disease|6|||
129885169|NCT04213989|467540605|FG000|Overall Study|Withdrawal by Subject|3|||
129885170|NCT04213989|467540606|FG001|Overall Study|Withdrawal by Subject|2|||
129885171|NCT04213989|467540605|FG000|Overall Study|Physician Decision|1|||
129585942|NCT01943435|466440265|FG000|6 Month Follow up|Lost to Follow-up|12|||
129585943|NCT01943435|466440266|FG001|6 Month Follow up|Lost to Follow-up|7|||
129585944|NCT01943435|466440267|FG002|6 Month Follow up|Lost to Follow-up|15|||
129585945|NCT00295490|466440268|FG000|Overall Study|Protocol Violation|0|||
129885172|NCT04213989|467540606|FG001|Overall Study|Physician Decision|0|||
129585946|NCT00295490|466440269|FG001|Overall Study|Protocol Violation|0|||
129585947|NCT00295490|466440270|FG002|Overall Study|Protocol Violation|3|||
129885173|NCT04213989|467540605|FG000|Overall Study|Lost to Follow-up|0|||
129885174|NCT04213989|467540606|FG001|Overall Study|Lost to Follow-up|4|||
129885175|NCT02930122|467540608|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
129885176|NCT02930122|467540609|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
129885177|NCT01681368|467540610|FG000|Overall Study|Refused further treatment|1|||
129885178|NCT01681368|467540610|FG000|Overall Study|Refused further follow up|1|||
129885179|NCT01189890|467540611|FG000|Overall Study|Adverse Event|3|||
129885180|NCT01189890|467540612|FG001|Overall Study|Adverse Event|4|||
129585948|NCT00295490|466440271|FG003|Overall Study|Protocol Violation|3|||
129885181|NCT01189890|467540611|FG000|Overall Study|Lack of Efficacy|7|||
129885182|NCT01189890|467540612|FG001|Overall Study|Lack of Efficacy|2|||
129585949|NCT00295490|466440268|FG000|Overall Study|Withdrawal by Subject|0|||
129585950|NCT00295490|466440269|FG001|Overall Study|Withdrawal by Subject|2|||
129585951|NCT00295490|466440270|FG002|Overall Study|Withdrawal by Subject|0|||
129585952|NCT00295490|466440271|FG003|Overall Study|Withdrawal by Subject|1|||
129585953|NCT00295490|466440268|FG000|Overall Study|Lost to Follow-up|0|||
129585954|NCT00295490|466440269|FG001|Overall Study|Lost to Follow-up|0|||
129585955|NCT00295490|466440270|FG002|Overall Study|Lost to Follow-up|1|||
129585956|NCT00295490|466440271|FG003|Overall Study|Lost to Follow-up|0|||
129585957|NCT00295490|466440268|FG000|Overall Study|Adverse Event|1|||
129585958|NCT00295490|466440269|FG001|Overall Study|Adverse Event|0|||
129585959|NCT00295490|466440270|FG002|Overall Study|Adverse Event|0|||
129585960|NCT00295490|466440271|FG003|Overall Study|Adverse Event|0|||
129585961|NCT00295490|466440268|FG000|Overall Study|Other|0|||
129585962|NCT00295490|466440269|FG001|Overall Study|Other|2|||
129585963|NCT00295490|466440270|FG002|Overall Study|Other|0|||
129585964|NCT00295490|466440271|FG003|Overall Study|Other|1|||
129585965|NCT03885934|466440276|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
129585966|NCT03885934|466440277|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
129585967|NCT03885934|466440278|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
129585968|NCT03885934|466440279|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
129585969|NCT03885934|466440280|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
129585970|NCT03885934|466440281|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
129585971|NCT01617096|466440282|FG000|Overall Study|Withdrawal by Subject|96|||
129585972|NCT01617096|466440283|FG001|Overall Study|Withdrawal by Subject|81|||
129585973|NCT01617096|466440282|FG000|Overall Study|Lost to Follow-up|37|||
129585974|NCT01617096|466440283|FG001|Overall Study|Lost to Follow-up|32|||
129585975|NCT01617096|466440282|FG000|Overall Study|Physician Decision|10|||
129585976|NCT01617096|466440283|FG001|Overall Study|Physician Decision|18|||
129585977|NCT01617096|466440282|FG000|Overall Study|Death|4|||
129585978|NCT01617096|466440283|FG001|Overall Study|Death|3|||
129585979|NCT01617096|466440282|FG000|Overall Study|Other|1|||
129585980|NCT01617096|466440283|FG001|Overall Study|Other|3|||
129585981|NCT04473326|466440288|FG000|Overall Study|Death|0|||
129585982|NCT04473326|466440289|FG001|Overall Study|Death|1|||
129585983|NCT04473326|466440288|FG000|Overall Study|Withdrawal by Subject|1|||
129585984|NCT04473326|466440289|FG001|Overall Study|Withdrawal by Subject|2|||
129585985|NCT02046122|466440290|FG000|Overall Study|Physician Decision|8|||
129585986|NCT02046122|466440290|FG000|Overall Study|Withdrawal by Subject|1|||
129585987|NCT01559116|466440293|FG000|Overall Study|Adverse Event|10|||
129585988|NCT01559116|466440293|FG000|Overall Study|Lack of Efficacy|1|||
129585989|NCT01559116|466440293|FG000|Overall Study|Lost to Follow-up|1|||
129585990|NCT01559116|466440293|FG000|Overall Study|Protocol Violation|1|||
129585991|NCT01559116|466440293|FG000|Overall Study|Withdrawal by Subject|4|||
129585992|NCT01559116|466440293|FG000|Overall Study|other than stated above|9|||
129585993|NCT01196390|466440294|FG000|Overall Study|Protocol Violation|4|||
129585994|NCT01196390|466440295|FG001|Overall Study|Protocol Violation|5|||
129585995|NCT01532908|466440296|FG000|Overall Study|Not Transplanted|1|||
129585996|NCT01532908|466440297|FG001|Overall Study|Not Transplanted|0|||
129585997|NCT04610580|466440298|FG000|Two-way Crossover Period|Adverse Event|1|||
129585998|NCT04610580|466440299|FG001|Two-way Crossover Period|Adverse Event|0|||
129585999|NCT04610580|466440300|FG002|Two-way Crossover Period|Adverse Event|0|||
129586000|NCT04610580|466440301|FG003|Two-way Crossover Period|Adverse Event|0|||
129586001|NCT04610580|466440302|FG004|Two-way Crossover Period|Adverse Event|0|||
129586002|NCT04610580|466440303|FG005|Two-way Crossover Period|Adverse Event|0|||
129586003|NCT04610580|466440298|FG000|Two-way Crossover Period|Physician Decision|1|||
129586004|NCT04610580|466440299|FG001|Two-way Crossover Period|Physician Decision|0|||
129586005|NCT04610580|466440300|FG002|Two-way Crossover Period|Physician Decision|0|||
129586006|NCT04610580|466440301|FG003|Two-way Crossover Period|Physician Decision|0|||
129586007|NCT04610580|466440302|FG004|Two-way Crossover Period|Physician Decision|0|||
129586008|NCT04610580|466440303|FG005|Two-way Crossover Period|Physician Decision|0|||
129586009|NCT04610580|466440298|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
129586010|NCT04610580|466440299|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
129586011|NCT04610580|466440300|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
129586012|NCT04610580|466440301|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
129586013|NCT04610580|466440302|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
129586014|NCT04610580|466440303|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
129586015|NCT04610580|466440298|FG000|Two-way Crossover Period|Other than specified|0|||
129586016|NCT04610580|466440299|FG001|Two-way Crossover Period|Other than specified|1|||
129586017|NCT04610580|466440300|FG002|Two-way Crossover Period|Other than specified|0|||
129586018|NCT04610580|466440301|FG003|Two-way Crossover Period|Other than specified|0|||
129885183|NCT01189890|467540611|FG000|Overall Study|Lost to Follow-up|1|||
129586019|NCT04610580|466440302|FG004|Two-way Crossover Period|Other than specified|0|||
129586020|NCT04610580|466440303|FG005|Two-way Crossover Period|Other than specified|0|||
129586021|NCT04610580|466440298|FG000|Washout Before Extension Period|Other than specified|0|||
129586022|NCT04610580|466440299|FG001|Washout Before Extension Period|Other than specified|1|||
129586023|NCT04610580|466440300|FG002|Washout Before Extension Period|Other than specified|0|||
129586024|NCT04610580|466440301|FG003|Washout Before Extension Period|Other than specified|0|||
129586025|NCT04610580|466440302|FG004|Washout Before Extension Period|Other than specified|0|||
129586026|NCT04610580|466440303|FG005|Washout Before Extension Period|Other than specified|0|||
129586027|NCT04610580|466440298|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
129586028|NCT04610580|466440299|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
129586029|NCT04610580|466440300|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
129586030|NCT04610580|466440301|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
129586031|NCT04610580|466440302|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
129586032|NCT04610580|466440303|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
129586033|NCT04610580|466440298|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129586034|NCT04610580|466440299|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129586035|NCT04610580|466440300|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129586036|NCT04610580|466440301|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129586037|NCT04610580|466440302|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
129586038|NCT04610580|466440303|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
129586039|NCT01097694|466440304|FG000|Overall Study|Adverse Event|5|||
129586040|NCT01097694|466440305|FG001|Overall Study|Adverse Event|0|||
129586041|NCT01097694|466440304|FG000|Overall Study|Lost to Follow-up|0|||
129586042|NCT01097694|466440305|FG001|Overall Study|Lost to Follow-up|3|||
129586043|NCT01097694|466440304|FG000|Overall Study|Withdrawal by Subject|3|||
129586044|NCT01097694|466440305|FG001|Overall Study|Withdrawal by Subject|1|||
129586045|NCT02179190|466440306|FG000|Enrollment|Exit Prior to Device Attempt|11|||
129586046|NCT02179190|466440306|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
129586047|NCT02179190|466440306|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
129586048|NCT02179190|466440306|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
129586049|NCT02179190|466440306|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
129586050|NCT02179190|466440306|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
129586051|NCT02377349|466440307|FG000|Overall Study|Serious Adverse Event|1|||
129586052|NCT02377349|466440308|FG001|Overall Study|Serious Adverse Event|0|||
129586053|NCT02377349|466440307|FG000|Overall Study|Protocol Violation|3|||
129586054|NCT02377349|466440308|FG001|Overall Study|Protocol Violation|2|||
129586055|NCT02377349|466440307|FG000|Overall Study|Withdrawal by Subject|5|||
129586056|NCT02377349|466440308|FG001|Overall Study|Withdrawal by Subject|3|||
129586057|NCT02377349|466440307|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
129586058|NCT02377349|466440308|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
129586059|NCT02377349|466440307|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
129586060|NCT02377349|466440308|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
129586061|NCT02377349|466440307|FG000|Overall Study|Other|0|||
129586062|NCT02377349|466440308|FG001|Overall Study|Other|1|||
129586063|NCT01993940|466440311|FG000|Overall Study|Adverse Event|16|||
129586064|NCT01993940|466440312|FG001|Overall Study|Adverse Event|11|||
129586065|NCT01993940|466440311|FG000|Overall Study|Withdrawal by Subject|15|||
129586066|NCT01993940|466440312|FG001|Overall Study|Withdrawal by Subject|19|||
129586067|NCT01993940|466440311|FG000|Overall Study|Lost to Follow-up|2|||
129586068|NCT01993940|466440312|FG001|Overall Study|Lost to Follow-up|5|||
129586069|NCT01993940|466440311|FG000|Overall Study|Protocol Violation|5|||
129586070|NCT01993940|466440312|FG001|Overall Study|Protocol Violation|8|||
129586071|NCT01993940|466440311|FG000|Overall Study|Death|1|||
129586072|NCT01993940|466440312|FG001|Overall Study|Death|0|||
129586073|NCT01993940|466440311|FG000|Overall Study|Other - Miscellaneous|1|||
129586074|NCT01993940|466440312|FG001|Overall Study|Other - Miscellaneous|1|||
129586075|NCT03259165|466440313|FG000|Overall Study|COVID 19 pandemic|1|||
129586076|NCT03259165|466440314|FG001|Overall Study|COVID 19 pandemic|1|||
129586077|NCT01949532|466440315|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
129586078|NCT01949532|466440316|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
129586079|NCT00939523|466440321|FG000|Overall Study|Lack of Efficacy|1|||
129586080|NCT00939523|466440321|FG000|Overall Study|Physician Decision|2|||
129586081|NCT00024258|466440322|FG000|Overall Study|Withdrawal by Subject|1|||
129586082|NCT00024258|466440322|FG000|Overall Study|Disease Progression|8|||
129586083|NCT01050764|466440323|FG000|Overall Study|Death, before HSCT|1|||
129586084|NCT01050764|466440323|FG000|Overall Study|Donor mobilization failure, death|1|||
129586085|NCT01050764|466440323|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
129586086|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Adverse Event|8|||
129586087|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Adverse Event|5|||
129586088|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Adverse Event|9|||
129586089|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Adverse Event|0|||
129885184|NCT01189890|467540612|FG001|Overall Study|Lost to Follow-up|7|||
129885185|NCT01189890|467540611|FG000|Overall Study|Protocol Violation|1|||
129885186|NCT01189890|467540612|FG001|Overall Study|Protocol Violation|5|||
129885187|NCT01189890|467540611|FG000|Overall Study|Withdrawal by Subject|15|||
129586090|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Adverse Event|0|||
129885188|NCT01189890|467540612|FG001|Overall Study|Withdrawal by Subject|11|||
129586091|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Adverse Event|0|||
129586092|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
129586093|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
129586094|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
129586095|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
129586096|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
129586097|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
129586098|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
129586099|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
129586100|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
129885189|NCT01189890|467540611|FG000|Overall Study|Non Compliance|0|||
129885190|NCT01189890|467540612|FG001|Overall Study|Non Compliance|1|||
129885191|NCT01189890|467540611|FG000|Overall Study|Physician Decision|5|||
129885192|NCT01189890|467540612|FG001|Overall Study|Physician Decision|4|||
129885193|NCT01189890|467540611|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
129885194|NCT01189890|467540612|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
129885195|NCT01807221|467540613|FG000|Overall Study|Progressive disease|1|||
129885196|NCT01807221|467540614|FG001|Overall Study|Progressive disease|0|||
129885197|NCT01807221|467540615|FG002|Overall Study|Progressive disease|1|||
129885198|NCT01807221|467540616|FG003|Overall Study|Progressive disease|0|||
129885199|NCT01807221|467540617|FG004|Overall Study|Progressive disease|0|||
129885200|NCT01807221|467540618|FG005|Overall Study|Progressive disease|0|||
129885201|NCT01807221|467540613|FG000|Overall Study|Death|7|||
129885202|NCT01807221|467540614|FG001|Overall Study|Death|9|||
129885203|NCT01807221|467540615|FG002|Overall Study|Death|4|||
129885204|NCT01807221|467540616|FG003|Overall Study|Death|2|||
129885205|NCT01807221|467540617|FG004|Overall Study|Death|1|||
129885206|NCT01807221|467540618|FG005|Overall Study|Death|6|||
129885207|NCT01807221|467540613|FG000|Overall Study|Physician Decision|2|||
129885208|NCT01807221|467540614|FG001|Overall Study|Physician Decision|1|||
129885209|NCT01807221|467540615|FG002|Overall Study|Physician Decision|0|||
129885210|NCT01807221|467540616|FG003|Overall Study|Physician Decision|0|||
129885211|NCT01807221|467540617|FG004|Overall Study|Physician Decision|0|||
129586101|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
129586102|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
129586103|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
129586104|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Physician Decision|4|||
129586105|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Physician Decision|0|||
129586106|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Physician Decision|2|||
129586107|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Physician Decision|0|||
129586108|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Physician Decision|0|||
129586109|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Physician Decision|0|||
129885212|NCT01807221|467540618|FG005|Overall Study|Physician Decision|0|||
129885213|NCT01807221|467540613|FG000|Overall Study|Adverse Event|33|||
129586110|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Pregnancy|1|||
129586111|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Pregnancy|2|||
129885214|NCT01807221|467540614|FG001|Overall Study|Adverse Event|22|||
129885215|NCT01807221|467540615|FG002|Overall Study|Adverse Event|26|||
129885216|NCT01807221|467540616|FG003|Overall Study|Adverse Event|25|||
129885217|NCT01807221|467540617|FG004|Overall Study|Adverse Event|18|||
129885218|NCT01807221|467540618|FG005|Overall Study|Adverse Event|21|||
129885219|NCT01807221|467540613|FG000|Overall Study|Protocol Violation|0|||
129885220|NCT01807221|467540614|FG001|Overall Study|Protocol Violation|2|||
129885221|NCT01807221|467540615|FG002|Overall Study|Protocol Violation|1|||
129885222|NCT01807221|467540616|FG003|Overall Study|Protocol Violation|2|||
129885223|NCT01807221|467540617|FG004|Overall Study|Protocol Violation|0|||
129885224|NCT01807221|467540618|FG005|Overall Study|Protocol Violation|1|||
129885225|NCT01807221|467540613|FG000|Overall Study|Non-compliance|1|||
129586112|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Pregnancy|0|||
129885226|NCT01807221|467540614|FG001|Overall Study|Non-compliance|2|||
129586113|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Pregnancy|0|||
129885227|NCT01807221|467540615|FG002|Overall Study|Non-compliance|0|||
129586114|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Pregnancy|0|||
129586115|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Pregnancy|0|||
129586116|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
129586117|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
129586118|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
129586119|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
129586120|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
129586121|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
129586122|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
129586123|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
129586124|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
129586125|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
129586126|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
129586127|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
129586128|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
129586129|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
129586130|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
129586131|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
129586132|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129586133|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
129586134|NCT02614196|466440326|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
129586135|NCT02614196|466440327|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
129586136|NCT02614196|466440328|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
129586137|NCT02614196|466440329|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
129586138|NCT02614196|466440330|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
129586139|NCT02614196|466440331|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
129586140|NCT02614196|466440326|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
129586141|NCT02614196|466440327|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
129586142|NCT02614196|466440328|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
129586143|NCT02614196|466440329|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
129586144|NCT02614196|466440330|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
129586145|NCT02614196|466440331|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
129586146|NCT02614196|466440326|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
129586147|NCT02614196|466440327|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
129586148|NCT02614196|466440328|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
129586149|NCT02614196|466440329|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
129586150|NCT02614196|466440330|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
129586151|NCT02614196|466440331|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
129586152|NCT02614196|466440326|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
129586153|NCT02614196|466440327|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
129586154|NCT02614196|466440328|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
129586155|NCT02614196|466440329|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
129586156|NCT02614196|466440330|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
129586157|NCT02614196|466440331|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
129586158|NCT02614196|466440326|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
129586159|NCT02614196|466440327|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
129586160|NCT02614196|466440328|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
129586161|NCT02614196|466440329|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
129586162|NCT02614196|466440330|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
129586163|NCT02614196|466440331|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
129586164|NCT01691430|466441830|FG000|Overall Study|Death|17|||
129586165|NCT01691430|466441831|FG001|Overall Study|Death|16|||
129586166|NCT01691430|466441830|FG000|Overall Study|Withdrawal by Subject|5|||
129586167|NCT01691430|466441831|FG001|Overall Study|Withdrawal by Subject|1|||
129586168|NCT01691430|466441830|FG000|Overall Study|Lost to Follow-up|0|||
129586169|NCT01691430|466441831|FG001|Overall Study|Lost to Follow-up|3|||
129586170|NCT03086135|466441834|FG000|Overall Study|Adverse Event|1|||
129586171|NCT03086135|466441834|FG000|Overall Study|Lost to Follow-up|2|||
129586172|NCT01622660|466441835|FG000|Overall Study|Adverse Event|1|||
129586173|NCT04556734|466441836|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
129586174|NCT04556734|466441837|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129586175|NCT04556734|466441838|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
129586176|NCT04556734|466441839|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129586177|NCT04556734|466441840|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129586178|NCT04556734|466441841|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129586179|NCT04556734|466441842|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129586180|NCT04556734|466441843|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129586181|NCT04556734|466441836|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
129586182|NCT04556734|466441837|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586183|NCT04556734|466441838|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586184|NCT04556734|466441839|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586185|NCT04556734|466441840|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586186|NCT04556734|466441841|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586187|NCT04556734|466441842|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586188|NCT04556734|466441843|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129586189|NCT04556734|466441836|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129586190|NCT04556734|466441837|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129586191|NCT04556734|466441838|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129586192|NCT04556734|466441839|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129586193|NCT04556734|466441840|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129586194|NCT04556734|466441841|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129586195|NCT04556734|466441842|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129586196|NCT04556734|466441843|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129586197|NCT04556734|466441836|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
129586198|NCT04556734|466441837|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586199|NCT04556734|466441838|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586200|NCT04556734|466441839|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586201|NCT04556734|466441840|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586202|NCT04556734|466441841|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586203|NCT04556734|466441842|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586204|NCT04556734|466441843|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129586205|NCT04556734|466441836|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586206|NCT04556734|466441837|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586207|NCT04556734|466441838|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
129586208|NCT04556734|466441839|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586209|NCT04556734|466441840|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586210|NCT04556734|466441841|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586211|NCT04556734|466441842|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586212|NCT04556734|466441843|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
129586213|NCT04556734|466441836|FG000|OLE Period (28 Weeks)|Not reported|0|||
129586214|NCT04556734|466441837|FG001|OLE Period (28 Weeks)|Not reported|0|||
129586215|NCT04556734|466441838|FG002|OLE Period (28 Weeks)|Not reported|0|||
129586216|NCT04556734|466441839|FG003|OLE Period (28 Weeks)|Not reported|0|||
129586217|NCT04556734|466441840|FG004|OLE Period (28 Weeks)|Not reported|0|||
129586218|NCT04556734|466441841|FG005|OLE Period (28 Weeks)|Not reported|1|||
129586219|NCT04556734|466441842|FG006|OLE Period (28 Weeks)|Not reported|0|||
129586220|NCT04556734|466441843|FG007|OLE Period (28 Weeks)|Not reported|0|||
129586221|NCT04556734|466441836|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586222|NCT04556734|466441837|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586223|NCT04556734|466441838|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586224|NCT04556734|466441839|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586225|NCT04556734|466441840|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586226|NCT04556734|466441841|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586227|NCT04556734|466441842|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
129586228|NCT04556734|466441843|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
129586229|NCT04556734|466441836|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
129586230|NCT04556734|466441837|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
129586231|NCT04556734|466441838|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
129586232|NCT04556734|466441839|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
129586233|NCT04556734|466441840|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
129586234|NCT04556734|466441841|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
129586235|NCT04556734|466441842|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
129586236|NCT04556734|466441843|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
129586237|NCT04556734|466441836|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129586238|NCT04556734|466441837|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129586239|NCT04556734|466441838|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129586240|NCT04556734|466441839|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
129586241|NCT04556734|466441840|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
129586242|NCT04556734|466441841|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
129586243|NCT04556734|466441842|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
129586244|NCT04556734|466441843|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
129586245|NCT01120899|466441844|FG000|Overall Study|Withdrawal by Subject|3|||
129586246|NCT00820599|466441845|FG000|Overall Study|Death|129|||
129586247|NCT00820599|466441845|FG000|Overall Study|Withdrawal by Subject|2|||
129586248|NCT03686215|466441846|FG000|Overall Study|Adverse Event|0|||
129586249|NCT03686215|466441847|FG001|Overall Study|Adverse Event|0|||
129586250|NCT03686215|466441848|FG002|Overall Study|Adverse Event|7|||
129586251|NCT03686215|466441846|FG000|Overall Study|Physician Decision|0|||
129586252|NCT03686215|466441847|FG001|Overall Study|Physician Decision|0|||
129586253|NCT03686215|466441848|FG002|Overall Study|Physician Decision|1|||
129586254|NCT03686215|466441846|FG000|Overall Study|Protocol Violation|0|||
129586255|NCT03686215|466441847|FG001|Overall Study|Protocol Violation|0|||
129586256|NCT03686215|466441848|FG002|Overall Study|Protocol Violation|4|||
129586257|NCT03686215|466441846|FG000|Overall Study|Device issue|1|||
129586258|NCT03686215|466441847|FG001|Overall Study|Device issue|0|||
129586259|NCT03686215|466441848|FG002|Overall Study|Device issue|2|||
129586260|NCT00202839|466441851|FG000|Overall Study|Adverse Event|1|||
129586261|NCT00202839|466441852|FG001|Overall Study|Adverse Event|5|||
129586262|NCT00202839|466441851|FG000|Overall Study|Physician Decision|12|||
129586263|NCT00202839|466441852|FG001|Overall Study|Physician Decision|0|||
129586264|NCT00202839|466441851|FG000|Overall Study|Withdrawal by Subject|6|||
129586265|NCT00202839|466441852|FG001|Overall Study|Withdrawal by Subject|2|||
129586266|NCT00202839|466441851|FG000|Overall Study|Protocol Violation|2|||
129586267|NCT00202839|466441852|FG001|Overall Study|Protocol Violation|1|||
129586268|NCT00202839|466441851|FG000|Overall Study|Lost to Follow-up|3|||
129586269|NCT00202839|466441852|FG001|Overall Study|Lost to Follow-up|2|||
129586270|NCT01098851|466441855|FG000|Overall Study|Equipment failure|1|||
129586271|NCT01098851|466441856|FG001|Overall Study|Equipment failure|0|||
129586272|NCT01813435|466441862|FG000|Overall Study|did not finish experimental regimen|1902|||
129586273|NCT01813435|466441863|FG001|Overall Study|did not finish experimental regimen|770|||
129586274|NCT01813435|466441862|FG000|Overall Study|Lost to Follow-up|268|||
129586275|NCT01813435|466441863|FG001|Overall Study|Lost to Follow-up|237|||
129586276|NCT03035890|466441864|FG000|Overall Study|Death|1|||
129586277|NCT00452348|466441866|FG000|Overall Study|Adverse Event|6|||
129586278|NCT00452348|466441867|FG001|Overall Study|Adverse Event|9|||
129586279|NCT00452348|466441866|FG000|Overall Study|Lack of Efficacy|10|||
129586280|NCT00452348|466441867|FG001|Overall Study|Lack of Efficacy|9|||
129586281|NCT00452348|466441866|FG000|Overall Study|Lost to Follow-up|14|||
129586282|NCT00452348|466441867|FG001|Overall Study|Lost to Follow-up|8|||
129586283|NCT00452348|466441866|FG000|Overall Study|Protocol Violation|22|||
129586284|NCT00452348|466441867|FG001|Overall Study|Protocol Violation|28|||
129586285|NCT00452348|466441866|FG000|Overall Study|Withdrawal by Subject|18|||
129586286|NCT00452348|466441867|FG001|Overall Study|Withdrawal by Subject|21|||
129586287|NCT00452348|466441866|FG000|Overall Study|Other|9|||
129586288|NCT00452348|466441867|FG001|Overall Study|Other|9|||
129586289|NCT01490190|466441868|FG000|Overall Study|Withdrawal by Subject|9|||
129586290|NCT01490190|466441868|FG000|Overall Study|Adverse Event|17|||
129586291|NCT01490190|466441868|FG000|Overall Study|Protocol Violation|5|||
129586292|NCT01490190|466441868|FG000|Overall Study|Lost to Follow-up|13|||
129586293|NCT01490190|466441868|FG000|Overall Study|Relocation|1|||
129586294|NCT01490190|466441868|FG000|Overall Study|Inconvenience|1|||
129586295|NCT01490190|466441868|FG000|Overall Study|Ring expulsion|2|||
129586296|NCT00960154|466441874|FG000|Overall Study|Study termination|25|||
129586297|NCT00960154|466441875|FG001|Overall Study|Study termination|25|||
129586298|NCT00377156|466441879|FG000|Overall Study|Death|23|||
129586299|NCT00377156|466441880|FG001|Overall Study|Death|19|||
129586300|NCT00377156|466441879|FG000|Overall Study|Withdrawal by Subject|16|||
129586301|NCT00377156|466441880|FG001|Overall Study|Withdrawal by Subject|24|||
129586302|NCT00377156|466441879|FG000|Overall Study|Had follow-up <90 d|3|||
129586303|NCT00377156|466441880|FG001|Overall Study|Had follow-up <90 d|6|||
129586304|NCT00377156|466441879|FG000|Overall Study|Cancellation|1|||
129586305|NCT00377156|466441880|FG001|Overall Study|Cancellation|0|||
129586306|NCT00377156|466441879|FG000|Overall Study|Refused testing|0|||
129586307|NCT00377156|466441880|FG001|Overall Study|Refused testing|1|||
129586308|NCT00377156|466441879|FG000|Overall Study|Ineligible|0|||
129586309|NCT00377156|466441880|FG001|Overall Study|Ineligible|1|||
129586310|NCT00377156|466441879|FG000|Overall Study|Disability or language problem|0|||
129586311|NCT00377156|466441880|FG001|Overall Study|Disability or language problem|1|||
129586312|NCT00377156|466441879|FG000|Overall Study|Other|5|||
129586313|NCT00377156|466441880|FG001|Overall Study|Other|2|||
129586314|NCT00288704|466441881|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
129586315|NCT00288704|466441882|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
129885228|NCT01807221|467540616|FG003|Overall Study|Non-compliance|1|||
129586316|NCT00288704|466441883|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
129586317|NCT00288704|466441881|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
129586318|NCT00288704|466441882|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
129586319|NCT00288704|466441883|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
129586320|NCT00288704|466441881|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
129586321|NCT00288704|466441882|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
129586322|NCT00288704|466441883|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
129586323|NCT00288704|466441881|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
129586324|NCT00288704|466441882|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
129586325|NCT00288704|466441883|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
129586326|NCT00288704|466441881|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
129586327|NCT00288704|466441882|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
129586328|NCT00288704|466441883|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
129586329|NCT00288704|466441881|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
129586330|NCT00288704|466441882|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
129586331|NCT00288704|466441883|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
129586332|NCT00288704|466441881|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
129586333|NCT00288704|466441882|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
129586334|NCT00288704|466441883|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
129586335|NCT00544167|466441884|FG000|Overall Study|Adverse Event|21|||
129586336|NCT00544167|466441884|FG000|Overall Study|Physician Decision|8|||
129586337|NCT00856349|466441885|FG000|Overall Study|Death|418|||
129586338|NCT00856349|466441885|FG000|Overall Study|Withdrawal by Subject|116|||
129586339|NCT00856349|466441885|FG000|Overall Study|Lost to Follow-up|91|||
129586340|NCT00856349|466441885|FG000|Overall Study|Protocol Violation|38|||
129586341|NCT00856349|466441885|FG000|Overall Study|Physician Decision|13|||
129586342|NCT00856349|466441885|FG000|Overall Study|Subject relocation|104|||
129586343|NCT00856349|466441885|FG000|Overall Study|Device explant|33|||
129586344|NCT00856349|466441885|FG000|Overall Study|Site closure|78|||
129586345|NCT00856349|466441885|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
129586346|NCT02725515|466441886|FG000|Overall Study|Refused infusion (no study treatment)|1|||
129586347|NCT02725515|466441887|FG001|Overall Study|Refused infusion (no study treatment)|0|||
129586348|NCT02725515|466441886|FG000|Overall Study|Loss of Improvement per Protocol|14|||
129586349|NCT02725515|466441887|FG001|Overall Study|Loss of Improvement per Protocol|25|||
129586350|NCT02725515|466441886|FG000|Overall Study|Withdrawal by Subject|2|||
129586351|NCT02725515|466441887|FG001|Overall Study|Withdrawal by Subject|1|||
129696040|NCT04135352|466845912|FG001|Overall Study|Not treated-randomization error|0|||
129696041|NCT04135352|466845913|FG002|Overall Study|Not treated-randomization error|1|||
129586352|NCT02725515|466441886|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129586353|NCT02725515|466441887|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129586354|NCT02725515|466441886|FG000|Overall Study|Lost to Follow-up|1|||
129696042|NCT04135352|466845914|FG003|Overall Study|Not treated-randomization error|0|||
129586355|NCT02725515|466441887|FG001|Overall Study|Lost to Follow-up|1|||
129586356|NCT02725515|466441886|FG000|Overall Study|Adverse Event|7|||
129586357|NCT02725515|466441887|FG001|Overall Study|Adverse Event|2|||
129586358|NCT02725515|466441886|FG000|Overall Study|No Documented Disease Improvement|0|||
129586359|NCT02725515|466441887|FG001|Overall Study|No Documented Disease Improvement|1|||
129586360|NCT02725515|466441886|FG000|Overall Study|Completed Study Under Original Protocol|0|||
129586361|NCT02725515|466441887|FG001|Overall Study|Completed Study Under Original Protocol|1|||
129586362|NCT02725515|466441886|FG000|Overall Study|Lack of Response|0|||
129586363|NCT02725515|466441887|FG001|Overall Study|Lack of Response|1|||
129586364|NCT00874549|466441888|FG000|Overall Study|Adverse Event|0|||
129586365|NCT00874549|466441889|FG001|Overall Study|Adverse Event|0|||
129586366|NCT00874549|466441890|FG002|Overall Study|Adverse Event|1|||
129586367|NCT00874549|466441891|FG003|Overall Study|Adverse Event|0|||
129586368|NCT00874549|466441888|FG000|Overall Study|Protocol Violation|1|||
129586369|NCT00874549|466441889|FG001|Overall Study|Protocol Violation|0|||
129586370|NCT00874549|466441890|FG002|Overall Study|Protocol Violation|2|||
129586371|NCT00874549|466441891|FG003|Overall Study|Protocol Violation|1|||
129586372|NCT00874549|466441888|FG000|Overall Study|Lost to Follow-up|0|||
129586373|NCT00874549|466441889|FG001|Overall Study|Lost to Follow-up|0|||
129586374|NCT00874549|466441890|FG002|Overall Study|Lost to Follow-up|1|||
129586375|NCT00874549|466441891|FG003|Overall Study|Lost to Follow-up|0|||
129586376|NCT00874549|466441888|FG000|Overall Study|Withdrawal by Subject|0|||
129586377|NCT00874549|466441889|FG001|Overall Study|Withdrawal by Subject|1|||
129586378|NCT00874549|466441890|FG002|Overall Study|Withdrawal by Subject|0|||
129586379|NCT00874549|466441891|FG003|Overall Study|Withdrawal by Subject|1|||
129586380|NCT02697617|466441901|FG000|Overall Study|Withdrawal by Subject|0|||
129586381|NCT02697617|466441902|FG001|Overall Study|Withdrawal by Subject|2|||
129586382|NCT02697617|466441901|FG000|Overall Study|Pregnancy|1|||
129586383|NCT02697617|466441902|FG001|Overall Study|Pregnancy|0|||
129586384|NCT02460835|466441903|FG000|Overall Study|Disease progression prior to treatment|3|||
129586385|NCT02460835|466441903|FG000|Overall Study|Unable to complete planning scans|2|||
129586386|NCT02460835|466441903|FG000|Overall Study|Decrease in performance status|1|||
129586387|NCT02460835|466441903|FG000|Overall Study|Withdrawal by Subject|3|||
129586388|NCT02460835|466441903|FG000|Overall Study|Underwent fractionated RT|10|||
129586389|NCT02460835|466441903|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
129586390|NCT01157234|466441904|FG000|Overall Study|Withdrawal by Subject|1|||
129586391|NCT01157234|466441905|FG001|Overall Study|Withdrawal by Subject|0|||
129586392|NCT00517192|466441909|FG000|Overall Study|Adverse Event|1|||
129586393|NCT00517192|466441910|FG001|Overall Study|Adverse Event|1|||
129586394|NCT00517192|466441909|FG000|Overall Study|Lost to Follow-up|1|||
129586395|NCT00517192|466441910|FG001|Overall Study|Lost to Follow-up|1|||
129586396|NCT00517192|466441909|FG000|Overall Study|Withdrawal by Subject|1|||
129586397|NCT00517192|466441910|FG001|Overall Study|Withdrawal by Subject|0|||
129586398|NCT00517192|466441909|FG000|Overall Study|Early termination of the trial|16|||
129586399|NCT00517192|466441910|FG001|Overall Study|Early termination of the trial|18|||
129586400|NCT02733627|466441911|FG000|Overall Study|Adverse Event|0|||
129586401|NCT02733627|466441912|FG001|Overall Study|Adverse Event|1|||
129586402|NCT02733627|466441913|FG002|Overall Study|Adverse Event|1|||
129586403|NCT02733627|466441914|FG003|Overall Study|Adverse Event|0|||
129586404|NCT02733627|466441911|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
129586405|NCT02733627|466441912|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
129586406|NCT02733627|466441913|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
129586407|NCT02733627|466441914|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
129586408|NCT00183196|466441915|FG000|Overall Study|Withdrawal by Subject|18|||
129586409|NCT00183196|466441916|FG001|Overall Study|Withdrawal by Subject|11|||
129586410|NCT00183196|466441917|FG002|Overall Study|Withdrawal by Subject|13|||
129586411|NCT00183196|466441915|FG000|Overall Study|Adverse Event|1|||
129586412|NCT00183196|466441916|FG001|Overall Study|Adverse Event|2|||
129586413|NCT00183196|466441917|FG002|Overall Study|Adverse Event|2|||
129586414|NCT00183196|466441915|FG000|Overall Study|Legal event|1|||
129586415|NCT00183196|466441916|FG001|Overall Study|Legal event|1|||
129586416|NCT00183196|466441917|FG002|Overall Study|Legal event|1|||
129586417|NCT00183196|466441915|FG000|Overall Study|Required more intensive care|0|||
129586418|NCT00183196|466441916|FG001|Overall Study|Required more intensive care|1|||
129586419|NCT00183196|466441917|FG002|Overall Study|Required more intensive care|2|||
129586420|NCT01513239|466441918|FG000|Period 1: Main Phase|Adverse Event|1|||
129586421|NCT01513239|466441919|FG001|Period 1: Main Phase|Adverse Event|1|||
129586422|NCT01513239|466441920|FG002|Period 1: Main Phase|Adverse Event|2|||
129586423|NCT01513239|466441921|FG003|Period 1: Main Phase|Adverse Event|0|||
129586424|NCT01513239|466441922|FG004|Period 1: Main Phase|Adverse Event|0|||
129586425|NCT01513239|466441923|FG005|Period 1: Main Phase|Adverse Event|0|||
129586426|NCT01513239|466441918|FG000|Period 1: Main Phase|Death|29|||
129586427|NCT01513239|466441919|FG001|Period 1: Main Phase|Death|22|||
129586428|NCT01513239|466441920|FG002|Period 1: Main Phase|Death|32|||
129586429|NCT01513239|466441921|FG003|Period 1: Main Phase|Death|0|||
129586430|NCT01513239|466441922|FG004|Period 1: Main Phase|Death|0|||
129586431|NCT01513239|466441923|FG005|Period 1: Main Phase|Death|0|||
129586432|NCT01513239|466441918|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
129586433|NCT01513239|466441919|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
129586434|NCT01513239|466441920|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
129586435|NCT01513239|466441921|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
129586436|NCT01513239|466441922|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
129586437|NCT01513239|466441923|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
129586438|NCT01513239|466441918|FG000|Period 1: Main Phase|Physician Decision|4|||
129586439|NCT01513239|466441919|FG001|Period 1: Main Phase|Physician Decision|4|||
129586440|NCT01513239|466441920|FG002|Period 1: Main Phase|Physician Decision|4|||
129586441|NCT01513239|466441921|FG003|Period 1: Main Phase|Physician Decision|0|||
129586442|NCT01513239|466441922|FG004|Period 1: Main Phase|Physician Decision|0|||
129586443|NCT01513239|466441923|FG005|Period 1: Main Phase|Physician Decision|0|||
129586444|NCT01513239|466441918|FG000|Period 1: Main Phase|Protocol Violation|2|||
129586445|NCT01513239|466441919|FG001|Period 1: Main Phase|Protocol Violation|2|||
129586446|NCT01513239|466441920|FG002|Period 1: Main Phase|Protocol Violation|2|||
129586447|NCT01513239|466441921|FG003|Period 1: Main Phase|Protocol Violation|0|||
129586448|NCT01513239|466441922|FG004|Period 1: Main Phase|Protocol Violation|0|||
129586449|NCT01513239|466441923|FG005|Period 1: Main Phase|Protocol Violation|0|||
129586450|NCT01513239|466441918|FG000|Period 1: Main Phase|Technical Problems|1|||
129586451|NCT01513239|466441919|FG001|Period 1: Main Phase|Technical Problems|2|||
129586452|NCT01513239|466441920|FG002|Period 1: Main Phase|Technical Problems|0|||
129586453|NCT01513239|466441921|FG003|Period 1: Main Phase|Technical Problems|0|||
129586454|NCT01513239|466441922|FG004|Period 1: Main Phase|Technical Problems|0|||
129586455|NCT01513239|466441923|FG005|Period 1: Main Phase|Technical Problems|0|||
129586456|NCT01513239|466441918|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
129586457|NCT01513239|466441919|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
129586458|NCT01513239|466441920|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
129586459|NCT01513239|466441921|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
129586460|NCT01513239|466441922|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
129586461|NCT01513239|466441923|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
129586462|NCT01513239|466441918|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129586463|NCT01513239|466441919|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129586464|NCT01513239|466441920|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
129586465|NCT01513239|466441921|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
129586466|NCT01513239|466441922|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
129586467|NCT01513239|466441923|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
129586468|NCT01513239|466441918|FG000|Period 2: 9 Month Extension Phase|Death|0|||
129586469|NCT01513239|466441919|FG001|Period 2: 9 Month Extension Phase|Death|0|||
129586470|NCT01513239|466441920|FG002|Period 2: 9 Month Extension Phase|Death|0|||
129586471|NCT01513239|466441921|FG003|Period 2: 9 Month Extension Phase|Death|2|||
129586472|NCT01513239|466441922|FG004|Period 2: 9 Month Extension Phase|Death|5|||
129586473|NCT01513239|466441923|FG005|Period 2: 9 Month Extension Phase|Death|2|||
129586474|NCT01513239|466441918|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129586475|NCT01513239|466441919|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129586476|NCT01513239|466441920|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129586477|NCT01513239|466441921|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
129586478|NCT01513239|466441922|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
129586479|NCT01513239|466441923|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
129586480|NCT01513239|466441918|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129586481|NCT01513239|466441919|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129586482|NCT01513239|466441920|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129586483|NCT01513239|466441921|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
129586484|NCT01513239|466441922|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129586485|NCT01513239|466441923|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
129586486|NCT01513239|466441918|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
129586487|NCT01513239|466441919|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
129586488|NCT01513239|466441920|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
129586489|NCT01513239|466441921|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
129586490|NCT01513239|466441922|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
129586491|NCT01513239|466441923|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
129586492|NCT03167606|466441926|FG000|Overall Study|Lost to Follow-up|73|||
129586493|NCT03167606|466441927|FG001|Overall Study|Lost to Follow-up|64|||
129586494|NCT03167606|466441926|FG000|Overall Study|Withdrawal by Subject|6|||
129586495|NCT03167606|466441927|FG001|Overall Study|Withdrawal by Subject|5|||
129586496|NCT03167606|466441926|FG000|Overall Study|Withdrawal by Investigator|0|||
129586497|NCT03167606|466441927|FG001|Overall Study|Withdrawal by Investigator|2|||
129586498|NCT00059332|466441928|FG000|Overall Study|Withdrawal by Subject|2|||
129586499|NCT00059332|466441929|FG001|Overall Study|Withdrawal by Subject|1|||
129586500|NCT00059332|466441928|FG000|Overall Study|Lost to Follow-up|1|||
129586501|NCT00059332|466441929|FG001|Overall Study|Lost to Follow-up|1|||
129586502|NCT00413049|466441931|FG000|Overall Study|Adverse Event|10|||
129586503|NCT00413049|466441932|FG001|Overall Study|Adverse Event|8|||
129586504|NCT00413049|466441931|FG000|Overall Study|Withdrawal by Subject|7|||
129586505|NCT00413049|466441932|FG001|Overall Study|Withdrawal by Subject|5|||
129586506|NCT00413049|466441931|FG000|Overall Study|Lost to Follow-up|2|||
129586507|NCT00413049|466441932|FG001|Overall Study|Lost to Follow-up|3|||
129586508|NCT00413049|466441931|FG000|Overall Study|Protocol Violation|3|||
129586509|NCT00413049|466441932|FG001|Overall Study|Protocol Violation|1|||
129586510|NCT00413049|466441931|FG000|Overall Study|Subject no longer requires study drug|0|||
129586511|NCT00413049|466441932|FG001|Overall Study|Subject no longer requires study drug|1|||
129586512|NCT00413049|466441931|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129586513|NCT00413049|466441932|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129586514|NCT00413049|466441931|FG000|Overall Study|Lack of Efficacy|1|||
129586515|NCT00413049|466441932|FG001|Overall Study|Lack of Efficacy|0|||
129586516|NCT02587143|466441933|FG000|Overall Study|Adverse Event|1|||
129586517|NCT02587143|466441934|FG001|Overall Study|Adverse Event|0|||
129586518|NCT03314857|466441937|FG000|Overall Study|Death|4|||
129586519|NCT03314857|466441937|FG000|Overall Study|Physician Decision|1|||
129586520|NCT01119625|466441938|FG000|Overall Study|Lost to Follow-up|1|||
129586521|NCT01119625|466441939|FG001|Overall Study|Lost to Follow-up|2|||
129586522|NCT01119625|466441938|FG000|Overall Study|Withdrawal by Subject|2|||
129586523|NCT01119625|466441939|FG001|Overall Study|Withdrawal by Subject|1|||
129586524|NCT01119625|466441938|FG000|Overall Study|Other|0|||
129586525|NCT01119625|466441939|FG001|Overall Study|Other|1|||
129586526|NCT01721772|466441946|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
129586527|NCT01721772|466441947|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
129586528|NCT01721772|466441946|FG000|Pre-Treatment|Poor/non-compliance|0|||
129586529|NCT01721772|466441947|FG001|Pre-Treatment|Poor/non-compliance|1|||
129586530|NCT01721772|466441946|FG000|Pre-Treatment|Participant withdrew consent|0|||
129586531|NCT01721772|466441947|FG001|Pre-Treatment|Participant withdrew consent|1|||
129586532|NCT01721772|466441946|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
129586533|NCT01721772|466441947|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
129586534|NCT01721772|466441946|FG000|Treatment|Disease progression|119|||
129586535|NCT01721772|466441947|FG001|Treatment|Disease progression|168|||
129586536|NCT01721772|466441946|FG000|Treatment|Study drug toxicity|19|||
129586537|NCT01721772|466441947|FG001|Treatment|Study drug toxicity|10|||
129586538|NCT01721772|466441946|FG000|Treatment|Adverse event unrelated to study drug|7|||
129586539|NCT01721772|466441947|FG001|Treatment|Adverse event unrelated to study drug|7|||
129586540|NCT01721772|466441946|FG000|Treatment|Maximum clinical benefit|16|||
129586541|NCT01721772|466441947|FG001|Treatment|Maximum clinical benefit|4|||
129586542|NCT01721772|466441946|FG000|Treatment|Other|19|||
129586543|NCT01721772|466441947|FG001|Treatment|Other|2|||
129586544|NCT01721772|466441946|FG000|Treatment|Participant withdrew consent|2|||
129586545|NCT01721772|466441947|FG001|Treatment|Participant withdrew consent|5|||
129586546|NCT01721772|466441946|FG000|Treatment|Participant request to discontinue study treatment|21|||
129586547|NCT01721772|466441947|FG001|Treatment|Participant request to discontinue study treatment|8|||
129586548|NCT01721772|466441946|FG000|Treatment|Death|1|||
129586549|NCT01721772|466441947|FG001|Treatment|Death|0|||
129586550|NCT01721772|466441946|FG000|Treatment|Not reported|1|||
129586551|NCT01721772|466441947|FG001|Treatment|Not reported|0|||
129586552|NCT01721772|466441946|FG000|Treatment|Poor/non-compliance|1|||
129586553|NCT01721772|466441947|FG001|Treatment|Poor/non-compliance|0|||
129586554|NCT01721772|466441946|FG000|Treatment|Lost to Follow-up|0|||
129586555|NCT01721772|466441947|FG001|Treatment|Lost to Follow-up|1|||
129586556|NCT00397254|466441955|FG000|Overall Study|Lost to Follow-up|2|||
129586557|NCT00397254|466441956|FG001|Overall Study|Lost to Follow-up|2|||
129586558|NCT02340780|466441957|FG000|Overall Study|Ineligible|1|||
129586559|NCT04535986|466441961|FG000|Overall Study|Death|4|||
129586560|NCT04535986|466441962|FG001|Overall Study|Death|5|||
129586561|NCT04535986|466441961|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
129586562|NCT04535986|466441962|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
129586563|NCT04535986|466441961|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
129586564|NCT04535986|466441962|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
129586565|NCT04535986|466441961|FG000|Overall Study|Adverse Event|10|||
129586566|NCT04535986|466441962|FG001|Overall Study|Adverse Event|1|||
129586567|NCT04535986|466441961|FG000|Overall Study|Lack of Efficacy|3|||
129586568|NCT04535986|466441962|FG001|Overall Study|Lack of Efficacy|2|||
129586569|NCT04535986|466441961|FG000|Overall Study|Investigator discretion|3|||
129586570|NCT04535986|466441962|FG001|Overall Study|Investigator discretion|0|||
129586571|NCT04535986|466441961|FG000|Overall Study|Withdrawal by Subject|32|||
129586572|NCT04535986|466441962|FG001|Overall Study|Withdrawal by Subject|14|||
129586573|NCT04535986|466441961|FG000|Overall Study|Lost to Follow-up|5|||
129586574|NCT04535986|466441962|FG001|Overall Study|Lost to Follow-up|3|||
129586575|NCT04535986|466441961|FG000|Overall Study|Other|7|||
129586576|NCT04535986|466441962|FG001|Overall Study|Other|3|||
129586577|NCT01567527|466441963|FG000|Conversion Phase.|Protocol deviation|3|||
129586578|NCT01567527|466441964|FG001|Conversion Phase.|Protocol deviation|0|||
129586579|NCT01567527|466441965|FG002|Conversion Phase.|Protocol deviation|0|||
129586580|NCT01567527|466441966|FG003|Conversion Phase.|Protocol deviation|0|||
129586581|NCT01567527|466441967|FG004|Conversion Phase.|Protocol deviation|0|||
129586582|NCT01567527|466441963|FG000|Conversion Phase.|Met withdrawal criteria|10|||
129586583|NCT01567527|466441964|FG001|Conversion Phase.|Met withdrawal criteria|0|||
129586584|NCT01567527|466441965|FG002|Conversion Phase.|Met withdrawal criteria|0|||
129586585|NCT01567527|466441966|FG003|Conversion Phase.|Met withdrawal criteria|0|||
129586586|NCT01567527|466441967|FG004|Conversion Phase.|Met withdrawal criteria|0|||
129586587|NCT01567527|466441963|FG000|Conversion Phase.|Withdrawal by Subject|32|||
129586588|NCT01567527|466441964|FG001|Conversion Phase.|Withdrawal by Subject|0|||
129586589|NCT01567527|466441965|FG002|Conversion Phase.|Withdrawal by Subject|0|||
129586590|NCT01567527|466441966|FG003|Conversion Phase.|Withdrawal by Subject|0|||
129586591|NCT01567527|466441967|FG004|Conversion Phase.|Withdrawal by Subject|0|||
129586592|NCT01567527|466441963|FG000|Conversion Phase.|Lost to Follow-up|16|||
129586593|NCT01567527|466441964|FG001|Conversion Phase.|Lost to Follow-up|0|||
129586594|NCT01567527|466441965|FG002|Conversion Phase.|Lost to Follow-up|0|||
129586595|NCT01567527|466441966|FG003|Conversion Phase.|Lost to Follow-up|0|||
129586596|NCT01567527|466441967|FG004|Conversion Phase.|Lost to Follow-up|0|||
129586597|NCT01567527|466441963|FG000|Conversion Phase.|Lack of Efficacy|2|||
129586598|NCT01567527|466441964|FG001|Conversion Phase.|Lack of Efficacy|0|||
129586599|NCT01567527|466441965|FG002|Conversion Phase.|Lack of Efficacy|0|||
129586600|NCT01567527|466441966|FG003|Conversion Phase.|Lack of Efficacy|0|||
129586601|NCT01567527|466441967|FG004|Conversion Phase.|Lack of Efficacy|0|||
129586602|NCT01567527|466441963|FG000|Conversion Phase.|Adverse Event|33|||
129586603|NCT01567527|466441964|FG001|Conversion Phase.|Adverse Event|0|||
129586604|NCT01567527|466441965|FG002|Conversion Phase.|Adverse Event|0|||
129586605|NCT01567527|466441966|FG003|Conversion Phase.|Adverse Event|0|||
129586606|NCT01567527|466441967|FG004|Conversion Phase.|Adverse Event|0|||
129586607|NCT01567527|466441963|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
129586608|NCT01567527|466441964|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
129586609|NCT01567527|466441965|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
129586610|NCT01567527|466441966|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
129586611|NCT01567527|466441967|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
129586612|NCT01567527|466441963|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129586613|NCT01567527|466441964|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
129586614|NCT01567527|466441965|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129586615|NCT01567527|466441966|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129586616|NCT01567527|466441967|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
129586617|NCT01567527|466441963|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129586618|NCT01567527|466441964|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
129586619|NCT01567527|466441965|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129586620|NCT01567527|466441966|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129586621|NCT01567527|466441967|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
129586622|NCT01567527|466441963|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129586623|NCT01567527|466441964|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
129586624|NCT01567527|466441965|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129586625|NCT01567527|466441966|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129586626|NCT01567527|466441967|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
129586627|NCT01567527|466441963|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129586628|NCT01567527|466441964|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
129586629|NCT01567527|466441965|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129586630|NCT01567527|466441966|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129586631|NCT01567527|466441967|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
129586632|NCT01567527|466441963|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129586633|NCT01567527|466441964|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
129696043|NCT04135352|466845915|FG004|Overall Study|Not treated-randomization error|0|||
129696044|NCT04135352|466845916|FG005|Overall Study|Not treated-randomization error|0|||
129696045|NCT04135352|466845917|FG006|Overall Study|Not treated-randomization error|0|||
129696046|NCT04135352|466845918|FG007|Overall Study|Not treated-randomization error|0|||
129696047|NCT04135352|466845911|FG000|Overall Study|Withdrawal by Subject|0|||
129696048|NCT04135352|466845912|FG001|Overall Study|Withdrawal by Subject|0|||
129696049|NCT04135352|466845913|FG002|Overall Study|Withdrawal by Subject|2|||
129696050|NCT04135352|466845914|FG003|Overall Study|Withdrawal by Subject|0|||
129885229|NCT01807221|467540617|FG004|Overall Study|Non-compliance|0|||
129586634|NCT01567527|466441965|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129586635|NCT01567527|466441966|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129586636|NCT01567527|466441967|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
129586637|NCT01567527|466441963|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129696051|NCT04135352|466845915|FG004|Overall Study|Withdrawal by Subject|0|||
129586638|NCT01567527|466441964|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
129586639|NCT01567527|466441965|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129586640|NCT01567527|466441966|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129586641|NCT01567527|466441967|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
129586642|NCT01567527|466441963|FG000|IM Depot Stabilization.|Protocol deviation|0|||
129586643|NCT01567527|466441964|FG001|IM Depot Stabilization.|Protocol deviation|0|||
129586644|NCT01567527|466441965|FG002|IM Depot Stabilization.|Protocol deviation|5|||
129586645|NCT01567527|466441966|FG003|IM Depot Stabilization.|Protocol deviation|0|||
129586646|NCT01567527|466441967|FG004|IM Depot Stabilization.|Protocol deviation|0|||
129586647|NCT01567527|466441963|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
129586648|NCT01567527|466441964|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
129586649|NCT01567527|466441965|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
129586650|NCT01567527|466441966|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
129586651|NCT01567527|466441967|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
129586652|NCT01567527|466441963|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
129586653|NCT01567527|466441964|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
129586654|NCT01567527|466441965|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
129586655|NCT01567527|466441966|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
129586656|NCT01567527|466441967|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
129586657|NCT01567527|466441963|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
129586658|NCT01567527|466441964|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
129586659|NCT01567527|466441965|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
129586660|NCT01567527|466441966|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
129586661|NCT01567527|466441967|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
129586662|NCT01567527|466441963|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
129586663|NCT01567527|466441964|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
129586664|NCT01567527|466441965|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
129586665|NCT01567527|466441966|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
129586666|NCT01567527|466441967|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
129586667|NCT01567527|466441963|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
129586668|NCT01567527|466441964|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
129586669|NCT01567527|466441965|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
129586670|NCT01567527|466441966|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
129586671|NCT01567527|466441967|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
129586672|NCT01567527|466441963|FG000|IM Depot Stabilization.|Adverse Event|0|||
129586673|NCT01567527|466441964|FG001|IM Depot Stabilization.|Adverse Event|0|||
129586674|NCT01567527|466441965|FG002|IM Depot Stabilization.|Adverse Event|37|||
129586675|NCT01567527|466441966|FG003|IM Depot Stabilization.|Adverse Event|0|||
129586676|NCT01567527|466441967|FG004|IM Depot Stabilization.|Adverse Event|0|||
129586677|NCT01567527|466441963|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129586678|NCT01567527|466441964|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129586679|NCT01567527|466441965|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
129586680|NCT01567527|466441966|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129586681|NCT01567527|466441967|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
129586682|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
129586683|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
129586684|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
129586685|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
129586686|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
129586687|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
129586688|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
129586689|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
129586690|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
129586691|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
129586692|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
129586693|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
129586694|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
129586695|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
129586696|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
129586697|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
129586698|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
129586699|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
129586700|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
129586701|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
129586702|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129586703|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129586704|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129586705|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
129586706|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
129586707|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
129586708|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
129586709|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
129586710|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
129586711|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
129586712|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
129586713|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
129586714|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
129586715|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
129586716|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
129586717|NCT01567527|466441963|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129586718|NCT01567527|466441964|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129586719|NCT01567527|466441965|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129586720|NCT01567527|466441966|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
129586721|NCT01567527|466441967|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
129586722|NCT02004691|466441968|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
129586723|NCT02004691|466441969|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
129586724|NCT02004691|466441968|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
129586725|NCT02004691|466441969|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
129586726|NCT02004691|466441968|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
129586727|NCT02004691|466441969|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
129586728|NCT02004691|466441968|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
129586729|NCT02004691|466441969|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
129586730|NCT02004691|466441968|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
129586731|NCT02004691|466441969|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
129586732|NCT02004691|466441968|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
129586733|NCT02004691|466441969|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
129586734|NCT00021541|466441970|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
129586735|NCT00021541|466441971|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
129586736|NCT00021541|466441970|FG000|Period 1-First Treatment|Adverse Event|2|||
129586737|NCT00021541|466441971|FG001|Period 1-First Treatment|Adverse Event|1|||
129586738|NCT00021541|466441970|FG000|Period 1-First Treatment|non-adherence|3|||
129586739|NCT00021541|466441971|FG001|Period 1-First Treatment|non-adherence|0|||
129586740|NCT00021541|466441970|FG000|Period 1-First Treatment|Death|1|||
129586741|NCT00021541|466441971|FG001|Period 1-First Treatment|Death|0|||
129586742|NCT00021541|466441970|FG000|Period 1-First Treatment|Pts that did not progress|2|||
129586743|NCT00021541|466441971|FG001|Period 1-First Treatment|Pts that did not progress|2|||
129586744|NCT00021541|466441970|FG000|Period 1-First Treatment|Ineligible|0|||
129586745|NCT00021541|466441971|FG001|Period 1-First Treatment|Ineligible|2|||
129586746|NCT00021541|466441970|FG000|Period 2-crossover|refused phase B|2|||
129586747|NCT00021541|466441971|FG001|Period 2-crossover|refused phase B|2|||
129586748|NCT00021541|466441970|FG000|Period 2-crossover|Withdrawal by Subject|3|||
129586749|NCT00021541|466441971|FG001|Period 2-crossover|Withdrawal by Subject|4|||
129586750|NCT00021541|466441970|FG000|Period 2-crossover|Adverse Event|2|||
129586751|NCT00021541|466441971|FG001|Period 2-crossover|Adverse Event|2|||
129586752|NCT00021541|466441970|FG000|Period 2-crossover|non-adherence|1|||
129586753|NCT00021541|466441971|FG001|Period 2-crossover|non-adherence|0|||
129586754|NCT00021541|466441970|FG000|Period 2-crossover|Pts that did not progress|2|||
129586755|NCT00021541|466441971|FG001|Period 2-crossover|Pts that did not progress|3|||
129586756|NCT01547728|466441972|FG000|Overall Study|Change in procedure and equipment|1|||
129586757|NCT01547728|466441972|FG000|Overall Study|Drug not ready for subject|1|||
129586758|NCT01547728|466441972|FG000|Overall Study|Screen failure|39|||
129586759|NCT03828539|466441973|FG000|Overall Study|Adverse Event|3|||
129586760|NCT03828539|466441974|FG001|Overall Study|Adverse Event|12|||
129586761|NCT03828539|466441973|FG000|Overall Study|Patient's/guardian's decision|3|||
129586762|NCT03828539|466441974|FG001|Overall Study|Patient's/guardian's decision|5|||
129586763|NCT03828539|466441973|FG000|Overall Study|Lost to Follow-up|4|||
129586764|NCT03828539|466441974|FG001|Overall Study|Lost to Follow-up|2|||
129586765|NCT03828539|466441973|FG000|Overall Study|Protocol Violation|3|||
129586766|NCT03828539|466441974|FG001|Overall Study|Protocol Violation|2|||
129586767|NCT03828539|466441973|FG000|Overall Study|Withdrawal of informed consent|2|||
129586768|NCT03828539|466441974|FG001|Overall Study|Withdrawal of informed consent|1|||
129586769|NCT03828539|466441973|FG000|Overall Study|New therapy for study indication|1|||
129586770|NCT03828539|466441974|FG001|Overall Study|New therapy for study indication|0|||
129586771|NCT01341405|466441975|FG000|Overall Study|Adverse Event|0|||
129586772|NCT01341405|466441976|FG001|Overall Study|Adverse Event|1|||
129586773|NCT01341405|466441977|FG002|Overall Study|Adverse Event|1|||
129586774|NCT01341405|466441975|FG000|Overall Study|Withdrawal by Subject|3|||
129586775|NCT01341405|466441976|FG001|Overall Study|Withdrawal by Subject|2|||
129586776|NCT01341405|466441977|FG002|Overall Study|Withdrawal by Subject|1|||
129586777|NCT00826241|466441978|FG000|Overall Study|Withdrawal from Follow-up|1|||
129586778|NCT00826241|466441978|FG000|Overall Study|Withdrew consent|2|||
129885230|NCT01807221|467540618|FG005|Overall Study|Non-compliance|0|||
129885231|NCT01807221|467540613|FG000|Overall Study|Logistical difficulties|0|||
129885232|NCT01807221|467540614|FG001|Overall Study|Logistical difficulties|1|||
129885233|NCT01807221|467540615|FG002|Overall Study|Logistical difficulties|0|||
129586779|NCT00826241|466441978|FG000|Overall Study|Death|4|||
129586780|NCT00826241|466441978|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
129586781|NCT00826241|466441978|FG000|Overall Study|Non-compliance|1|||
129586782|NCT00826241|466441978|FG000|Overall Study|Progression of disease|1|||
129586783|NCT00826241|466441978|FG000|Overall Study|Patient refused follow-up|3|||
129586784|NCT00826241|466441978|FG000|Overall Study|Lost to Follow-up|9|||
129586785|NCT00826241|466441978|FG000|Overall Study|Could not obtain records|1|||
129586786|NCT00826241|466441978|FG000|Overall Study|Screen failure|2|||
129586787|NCT00826241|466441978|FG000|Overall Study|Pt unable to proceed to registration|1|||
129586788|NCT00826241|466441978|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
129586789|NCT04142658|466441979|FG000|Overall Study|Death|2|||
129586790|NCT04142658|466441980|FG001|Overall Study|Death|1|||
129586791|NCT04142658|466441979|FG000|Overall Study|Lost to Follow-up|4|||
129586792|NCT04142658|466441980|FG001|Overall Study|Lost to Follow-up|13|||
129586793|NCT04142658|466441979|FG000|Overall Study|Withdrawal by Subject|9|||
129586794|NCT04142658|466441980|FG001|Overall Study|Withdrawal by Subject|16|||
129586795|NCT04194008|466441985|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
129586796|NCT04194008|466441985|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
129586797|NCT04194008|466441985|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
129586798|NCT04194008|466441985|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
129586799|NCT04194008|466441985|FG000|Treatment Phase With Nerivio|Missing data|4|||
129586800|NCT04194008|466441985|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
129586801|NCT01539239|466441986|FG000|Overall Study|Death|5|||
129586802|NCT01539239|466441987|FG001|Overall Study|Death|5|||
129586803|NCT01539239|466441986|FG000|Overall Study|Lost to Follow-up|7|||
129586804|NCT01539239|466441987|FG001|Overall Study|Lost to Follow-up|12|||
129586805|NCT03201003|466441991|FG000|Overall Study|Adverse Event|14|||
129586806|NCT03201003|466441992|FG001|Overall Study|Adverse Event|1|||
129586807|NCT03201003|466441991|FG000|Overall Study|Other reasons|5|||
129586808|NCT03201003|466441992|FG001|Overall Study|Other reasons|1|||
129586809|NCT03201003|466441991|FG000|Overall Study|Withdrawal by Subject|4|||
129586810|NCT03201003|466441992|FG001|Overall Study|Withdrawal by Subject|1|||
129586811|NCT03201003|466441991|FG000|Overall Study|Lost to Follow-up|2|||
129586812|NCT03201003|466441992|FG001|Overall Study|Lost to Follow-up|0|||
129586813|NCT03201003|466441991|FG000|Overall Study|Protocol Violation|1|||
129586814|NCT03201003|466441992|FG001|Overall Study|Protocol Violation|0|||
129586815|NCT00834613|466441993|FG000|First Intervention|Protocol Violation|1|||
129586816|NCT00834613|466441994|FG001|First Intervention|Protocol Violation|0|||
129586817|NCT01751087|466441995|FG000|Overall Study|Withdrawal by Subject|1|||
129586818|NCT01751087|466441996|FG001|Overall Study|Withdrawal by Subject|0|||
129586819|NCT01751087|466441997|FG002|Overall Study|Withdrawal by Subject|0|||
129586820|NCT01751087|466441995|FG000|Overall Study|Physician Decision|0|||
129885234|NCT01807221|467540616|FG003|Overall Study|Logistical difficulties|0|||
129885235|NCT01807221|467540617|FG004|Overall Study|Logistical difficulties|1|||
129885236|NCT01807221|467540618|FG005|Overall Study|Logistical difficulties|0|||
129885237|NCT01807221|467540613|FG000|Overall Study|Withdrawal by Subject|33|||
129885238|NCT01807221|467540614|FG001|Overall Study|Withdrawal by Subject|15|||
129586821|NCT01751087|466441996|FG001|Overall Study|Physician Decision|0|||
129586822|NCT01751087|466441997|FG002|Overall Study|Physician Decision|1|||
129885239|NCT01807221|467540615|FG002|Overall Study|Withdrawal by Subject|8|||
129885240|NCT01807221|467540616|FG003|Overall Study|Withdrawal by Subject|14|||
129586823|NCT00697619|466441998|FG000|Overall Study|Lack of Efficacy|2|||
129586824|NCT00697619|466441999|FG001|Overall Study|Lack of Efficacy|2|||
129586825|NCT00697619|466441998|FG000|Overall Study|Adverse Event|4|||
129586826|NCT00697619|466441999|FG001|Overall Study|Adverse Event|6|||
129586827|NCT00258856|466443580|FG000|Overall Study|Lost to Follow-up|1|||
129586828|NCT00258856|466443581|FG001|Overall Study|Lost to Follow-up|0|||
129586829|NCT00258856|466443582|FG002|Overall Study|Lost to Follow-up|2|||
129586830|NCT00258856|466443583|FG003|Overall Study|Lost to Follow-up|0|||
129586831|NCT00258856|466443580|FG000|Overall Study|Non-compliance|2|||
129586832|NCT00258856|466443581|FG001|Overall Study|Non-compliance|0|||
129586833|NCT00258856|466443582|FG002|Overall Study|Non-compliance|0|||
129586834|NCT00258856|466443583|FG003|Overall Study|Non-compliance|1|||
129586835|NCT02219009|466443586|FG000|Overall Study|Withdrawal by Subject|5|||
129586836|NCT02219009|466443587|FG001|Overall Study|Withdrawal by Subject|1|||
129586837|NCT02219009|466443586|FG000|Overall Study|Adverse Event|2|||
129586838|NCT02219009|466443587|FG001|Overall Study|Adverse Event|4|||
129586839|NCT02219009|466443586|FG000|Overall Study|Lost to Follow-up|2|||
129586840|NCT02219009|466443587|FG001|Overall Study|Lost to Follow-up|2|||
129586841|NCT02219009|466443586|FG000|Overall Study|Protocol deviation|1|||
129586842|NCT02219009|466443587|FG001|Overall Study|Protocol deviation|0|||
129586843|NCT02219009|466443586|FG000|Overall Study|Physician Decision|0|||
129586844|NCT02219009|466443587|FG001|Overall Study|Physician Decision|1|||
129586845|NCT00762411|466443588|FG000|Initial Treatment|Death|7|||
129586846|NCT00762411|466443589|FG001|Initial Treatment|Death|6|||
129586847|NCT00762411|466443588|FG000|Initial Treatment|Adverse Event|132|||
129586848|NCT00762411|466443589|FG001|Initial Treatment|Adverse Event|40|||
129586849|NCT00762411|466443588|FG000|Initial Treatment|Protocol Violation|4|||
129586850|NCT00762411|466443589|FG001|Initial Treatment|Protocol Violation|1|||
129586851|NCT00762411|466443588|FG000|Initial Treatment|Withdrawal by Subject|65|||
129586852|NCT00762411|466443589|FG001|Initial Treatment|Withdrawal by Subject|52|||
129586853|NCT00762411|466443588|FG000|Initial Treatment|Physician Decision|1|||
129586854|NCT00762411|466443589|FG001|Initial Treatment|Physician Decision|0|||
129586855|NCT00762411|466443588|FG000|Initial Treatment|Sponsor Decision|293|||
129586856|NCT00762411|466443589|FG001|Initial Treatment|Sponsor Decision|401|||
129586857|NCT00762411|466443588|FG000|Initial Treatment|Lost to Follow-up|5|||
129586858|NCT00762411|466443589|FG001|Initial Treatment|Lost to Follow-up|0|||
129885241|NCT01807221|467540617|FG004|Overall Study|Withdrawal by Subject|16|||
129885242|NCT01807221|467540618|FG005|Overall Study|Withdrawal by Subject|13|||
129885243|NCT01807221|467540613|FG000|Overall Study|Sponsor decision|2|||
129885244|NCT01807221|467540614|FG001|Overall Study|Sponsor decision|0|||
129885245|NCT01807221|467540615|FG002|Overall Study|Sponsor decision|1|||
129885246|NCT01807221|467540616|FG003|Overall Study|Sponsor decision|1|||
129885247|NCT01807221|467540617|FG004|Overall Study|Sponsor decision|0|||
129885248|NCT01807221|467540618|FG005|Overall Study|Sponsor decision|0|||
129885249|NCT01807221|467540613|FG000|Overall Study|Lost to Follow-up|1|||
129885250|NCT01807221|467540614|FG001|Overall Study|Lost to Follow-up|0|||
129885251|NCT01807221|467540615|FG002|Overall Study|Lost to Follow-up|2|||
129885252|NCT01807221|467540616|FG003|Overall Study|Lost to Follow-up|1|||
129885253|NCT01807221|467540617|FG004|Overall Study|Lost to Follow-up|0|||
129885254|NCT01807221|467540618|FG005|Overall Study|Lost to Follow-up|0|||
129586859|NCT00762411|466443588|FG000|Initial Treatment|Caregiver Decision|21|||
129586860|NCT00762411|466443589|FG001|Initial Treatment|Caregiver Decision|16|||
129586861|NCT00762411|466443588|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
129586862|NCT00762411|466443589|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
129586863|NCT00762411|466443588|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
129586864|NCT00762411|466443589|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
129586865|NCT00762411|466443588|FG000|Delayed Start|Adverse Event|0|||
129586866|NCT00762411|466443589|FG001|Delayed Start|Adverse Event|4|||
129586867|NCT00762411|466443588|FG000|Delayed Start|Protocol Violation|0|||
129586868|NCT00762411|466443589|FG001|Delayed Start|Protocol Violation|1|||
129586869|NCT00762411|466443588|FG000|Delayed Start|Sponsor Decision|16|||
129586870|NCT00762411|466443589|FG001|Delayed Start|Sponsor Decision|20|||
129586871|NCT00762411|466443588|FG000|Delayed Start|Caregiver Decision|1|||
129586872|NCT00762411|466443589|FG001|Delayed Start|Caregiver Decision|1|||
129586873|NCT00762411|466443588|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
129586874|NCT00762411|466443589|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
129586875|NCT00762411|466443588|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
129586876|NCT00762411|466443589|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
129586877|NCT00762411|466443588|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
129586878|NCT00762411|466443589|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
129586879|NCT00762411|466443588|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
129586880|NCT00762411|466443589|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
129586881|NCT00762411|466443588|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
129586882|NCT00762411|466443589|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
129586883|NCT00762411|466443588|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
129586884|NCT00762411|466443589|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
129586885|NCT02259348|466443592|FG000|Overall Study|Donors|6|||
129586886|NCT02259348|466443592|FG000|Overall Study|Death|4|||
129586887|NCT04211766|466443593|FG000|Overall Study|Withdrawal by Subject|5|||
129586888|NCT04211766|466443594|FG001|Overall Study|Withdrawal by Subject|1|||
129586889|NCT04590781|466443596|FG000|Overall Study|Death|0|||
129586890|NCT04590781|466443597|FG001|Overall Study|Death|2|||
129586891|NCT04590781|466443596|FG000|Overall Study|Withdrawal by Subject|2|||
129586892|NCT04590781|466443597|FG001|Overall Study|Withdrawal by Subject|0|||
129586893|NCT01680016|466443600|FG000|Overall Study|Adverse Event|0|||
129586894|NCT01680016|466443601|FG001|Overall Study|Adverse Event|0|||
129586895|NCT01680016|466443602|FG002|Overall Study|Adverse Event|1|||
129586896|NCT01680016|466443603|FG003|Overall Study|Adverse Event|4|||
129586897|NCT01680016|466443600|FG000|Overall Study|The Subject went out of The Trial|1|||
129586898|NCT01680016|466443601|FG001|Overall Study|The Subject went out of The Trial|0|||
129586899|NCT01680016|466443602|FG002|Overall Study|The Subject went out of The Trial|3|||
129586900|NCT01680016|466443603|FG003|Overall Study|The Subject went out of The Trial|0|||
129586901|NCT01680016|466443600|FG000|Overall Study|Protocol Violation|0|||
129586902|NCT01680016|466443601|FG001|Overall Study|Protocol Violation|1|||
129586903|NCT01680016|466443602|FG002|Overall Study|Protocol Violation|0|||
129586904|NCT01680016|466443603|FG003|Overall Study|Protocol Violation|0|||
129586905|NCT01680016|466443600|FG000|Overall Study|Withdrawal by Subject|5|||
129586906|NCT01680016|466443601|FG001|Overall Study|Withdrawal by Subject|7|||
129586907|NCT01680016|466443602|FG002|Overall Study|Withdrawal by Subject|1|||
129586908|NCT01680016|466443603|FG003|Overall Study|Withdrawal by Subject|1|||
129586909|NCT02485158|466443604|FG000|Overall Study|Withdrawal by Subject|3|||
129586910|NCT02485158|466443604|FG000|Overall Study|expected drug side effect|1|||
129586911|NCT02846883|466443605|FG000|Overall Study|Death|0|||
129586912|NCT02846883|466443606|FG001|Overall Study|Death|1|||
129586913|NCT02846883|466443607|FG002|Overall Study|Death|1|||
129586914|NCT02846883|466443605|FG000|Overall Study|Lost to Follow-up|0|||
129586915|NCT02846883|466443606|FG001|Overall Study|Lost to Follow-up|0|||
129885255|NCT02609659|467540619|FG000|Overall Study|Adverse Event|1|||
129885256|NCT02609659|467540619|FG000|Overall Study|Lost to Follow-up|6|||
129586916|NCT02846883|466443607|FG002|Overall Study|Lost to Follow-up|1|||
129586917|NCT02846883|466443605|FG000|Overall Study|Withdrawal by Subject|1|||
129586918|NCT02846883|466443606|FG001|Overall Study|Withdrawal by Subject|0|||
129586919|NCT02846883|466443607|FG002|Overall Study|Withdrawal by Subject|0|||
129586920|NCT02846883|466443605|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
129586921|NCT02846883|466443606|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
129586922|NCT02846883|466443607|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
129586923|NCT02846883|466443605|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
129586924|NCT02846883|466443606|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
129586925|NCT02846883|466443607|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
129586926|NCT00927251|466443608|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
129586927|NCT01579006|466443611|FG000|Overall Study|Lack of Efficacy|10|||
129586928|NCT01579006|466443611|FG000|Overall Study|Adverse Event|13|||
129586929|NCT01579006|466443611|FG000|Overall Study|Withdrawal by Subject|5|||
129586930|NCT01579006|466443611|FG000|Overall Study|Non-compliance|3|||
129586931|NCT01579006|466443611|FG000|Overall Study|Due to participant's health fund|1|||
129586932|NCT01579006|466443611|FG000|Overall Study|Scheduled surgery|1|||
129586933|NCT00799708|466443614|FG000|Overall Study|non-compliance|1|||
129586934|NCT00799708|466443615|FG001|Overall Study|non-compliance|0|||
129586935|NCT00799708|466443616|FG002|Overall Study|non-compliance|0|||
129586936|NCT03343639|466443617|FG000|Overall Study|Withdrawal by Subject|10|||
129586937|NCT03343639|466443618|FG001|Overall Study|Withdrawal by Subject|6|||
129586938|NCT03343639|466443617|FG000|Overall Study|Lost to Follow-up|4|||
129586939|NCT03343639|466443618|FG001|Overall Study|Lost to Follow-up|5|||
129586940|NCT03343639|466443617|FG000|Overall Study|Protocol Violation|0|||
129586941|NCT03343639|466443618|FG001|Overall Study|Protocol Violation|1|||
129586942|NCT05061992|466443623|FG000|Overall Study|Excess bowel movements|1|||
129586943|NCT05061992|466443624|FG001|Overall Study|Excess bowel movements|0|||
129586944|NCT05061992|466443623|FG000|Overall Study|Complications of Medical Care|1|||
129586945|NCT05061992|466443624|FG001|Overall Study|Complications of Medical Care|0|||
129586946|NCT05061992|466443623|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
129586947|NCT05061992|466443624|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
129586948|NCT05061992|466443623|FG000|Overall Study|Withdrawal by Subject|0|||
129586949|NCT05061992|466443624|FG001|Overall Study|Withdrawal by Subject|1|||
129586950|NCT02473393|466443625|FG000|Overall Study|Adverse Event|0|||
129586951|NCT02473393|466443626|FG001|Overall Study|Adverse Event|0|||
129586952|NCT02473393|466443627|FG002|Overall Study|Adverse Event|1|||
129586953|NCT02473393|466443628|FG003|Overall Study|Adverse Event|0|||
129586954|NCT02473393|466443625|FG000|Overall Study|Withdrawal by Subject|0|||
129586955|NCT02473393|466443626|FG001|Overall Study|Withdrawal by Subject|0|||
129586956|NCT02473393|466443627|FG002|Overall Study|Withdrawal by Subject|1|||
129586957|NCT02473393|466443628|FG003|Overall Study|Withdrawal by Subject|1|||
129586958|NCT04968925|466443630|FG000|Phase I- Period 1|COVID-19 related|0|||
129586959|NCT04968925|466443631|FG001|Phase I- Period 1|COVID-19 related|1|||
129586960|NCT04968925|466443632|FG002|Phase I- Period 1|COVID-19 related|0|||
129586961|NCT04968925|466443633|FG003|Phase I- Period 1|COVID-19 related|0|||
129586962|NCT04968925|466443630|FG000|Phase I- Period 1|Subject enrolled in error|1|||
129586963|NCT04968925|466443631|FG001|Phase I- Period 1|Subject enrolled in error|1|||
129586964|NCT04968925|466443632|FG002|Phase I- Period 1|Subject enrolled in error|0|||
129586965|NCT04968925|466443633|FG003|Phase I- Period 1|Subject enrolled in error|0|||
129586966|NCT04968925|466443630|FG000|Phase II- Period 1|COVID-19 Related|0|||
129586967|NCT04968925|466443631|FG001|Phase II- Period 1|COVID-19 Related|0|||
129586968|NCT04968925|466443632|FG002|Phase II- Period 1|COVID-19 Related|6|||
129586969|NCT04968925|466443633|FG003|Phase II- Period 1|COVID-19 Related|6|||
129586970|NCT04968925|466443630|FG000|Phase II- Period 1|Subject enrolled in error|0|||
129586971|NCT04968925|466443631|FG001|Phase II- Period 1|Subject enrolled in error|0|||
129586972|NCT04968925|466443632|FG002|Phase II- Period 1|Subject enrolled in error|1|||
129586973|NCT04968925|466443633|FG003|Phase II- Period 1|Subject enrolled in error|0|||
129586974|NCT04968925|466443630|FG000|Phase II -Period 2|COVID-19 related|0|||
129586975|NCT04968925|466443631|FG001|Phase II -Period 2|COVID-19 related|0|||
129586976|NCT04968925|466443632|FG002|Phase II -Period 2|COVID-19 related|4|||
129586977|NCT04968925|466443633|FG003|Phase II -Period 2|COVID-19 related|3|||
129586978|NCT04968925|466443630|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
129586979|NCT04968925|466443631|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
129586980|NCT04968925|466443632|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
129586981|NCT04968925|466443633|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
129586982|NCT00876265|466443634|FG000|Overall Study|Miscellaneous reasons|4|||
129586983|NCT00876265|466443634|FG000|Overall Study|Lost to Follow-up|6|||
129586984|NCT00876265|466443634|FG000|Overall Study|Withdrawal by Subject|2|||
129586985|NCT00487695|466443635|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
129586986|NCT00487695|466443636|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
129586987|NCT00487695|466443635|FG000|First Procedure|active wheezing (did not have procedure)|1|||
129586988|NCT00487695|466443636|FG001|First Procedure|active wheezing (did not have procedure)|0|||
129586989|NCT00487695|466443635|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
129586990|NCT00487695|466443636|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
129586991|NCT00487695|466443635|FG000|Second Procedure|active wheezing|0|||
129586992|NCT00487695|466443636|FG001|Second Procedure|active wheezing|1|||
129586993|NCT00487695|466443635|FG000|Second Procedure|Withdrawal by Subject|1|||
129586994|NCT00487695|466443636|FG001|Second Procedure|Withdrawal by Subject|2|||
129586995|NCT01698554|466443639|FG000|Overall Study|Adverse Event|2|||
129586996|NCT01698554|466443640|FG001|Overall Study|Adverse Event|5|||
129586997|NCT01698554|466443641|FG002|Overall Study|Adverse Event|0|||
129586998|NCT01698554|466443642|FG003|Overall Study|Adverse Event|1|||
129586999|NCT01698554|466443639|FG000|Overall Study|Lost to Follow-up|1|||
129587000|NCT01698554|466443640|FG001|Overall Study|Lost to Follow-up|0|||
129885257|NCT02609659|467540619|FG000|Overall Study|Other|1|||
129885258|NCT01004250|467540620|FG000|Induction Therapy Period|Adverse Event|10|||
129885259|NCT01004250|467540620|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
129885260|NCT01004250|467540620|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
129885261|NCT01004250|467540620|FG000|Induction Therapy Period|Physician Decision|2|||
129885262|NCT01004250|467540620|FG000|Maintenance Therapy Period|Adverse Event|15|||
129885263|NCT01004250|467540620|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
129885264|NCT01004250|467540620|FG000|Maintenance Therapy Period|Protocol Violation|1|||
129885265|NCT01004250|467540620|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
129885266|NCT01004250|467540620|FG000|Maintenance Therapy Period|Physician Decision|4|||
129885267|NCT01004250|467540620|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
129885268|NCT03943589|467540621|FG000|Overall Study|Death|1|||
129885269|NCT03943589|467540621|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
129885270|NCT00900627|467540622|FG000|Overall Study|Condition under investigation worsened|4|||
129885271|NCT00900627|467540623|FG001|Overall Study|Condition under investigation worsened|0|||
129885272|NCT00900627|467540624|FG002|Overall Study|Condition under investigation worsened|5|||
129885273|NCT00900627|467540625|FG003|Overall Study|Condition under investigation worsened|3|||
129885274|NCT00900627|467540626|FG004|Overall Study|Condition under investigation worsened|0|||
129885275|NCT00900627|467540627|FG005|Overall Study|Condition under investigation worsened|0|||
129885276|NCT00900627|467540622|FG000|Overall Study|Withdrawal by Subject|1|||
129885277|NCT00900627|467540623|FG001|Overall Study|Withdrawal by Subject|0|||
129587001|NCT01698554|466443641|FG002|Overall Study|Lost to Follow-up|0|||
129587002|NCT01698554|466443642|FG003|Overall Study|Lost to Follow-up|0|||
129587003|NCT01698554|466443639|FG000|Overall Study|Personal Reasons|0|||
129885278|NCT00900627|467540624|FG002|Overall Study|Withdrawal by Subject|1|||
129885279|NCT00900627|467540625|FG003|Overall Study|Withdrawal by Subject|0|||
129885280|NCT00900627|467540626|FG004|Overall Study|Withdrawal by Subject|1|||
129696052|NCT04135352|466845916|FG005|Overall Study|Withdrawal by Subject|0|||
129696053|NCT04135352|466845917|FG006|Overall Study|Withdrawal by Subject|0|||
129696054|NCT04135352|466845918|FG007|Overall Study|Withdrawal by Subject|0|||
129696055|NCT04135352|466845911|FG000|Overall Study|Sponsor Decision|0|||
129696056|NCT04135352|466845912|FG001|Overall Study|Sponsor Decision|0|||
129696057|NCT04135352|466845913|FG002|Overall Study|Sponsor Decision|2|||
129696058|NCT04135352|466845914|FG003|Overall Study|Sponsor Decision|5|||
129696059|NCT04135352|466845915|FG004|Overall Study|Sponsor Decision|1|||
129696060|NCT04135352|466845916|FG005|Overall Study|Sponsor Decision|4|||
129696061|NCT04135352|466845917|FG006|Overall Study|Sponsor Decision|0|||
129696062|NCT04135352|466845918|FG007|Overall Study|Sponsor Decision|0|||
129696063|NCT04135352|466845911|FG000|Overall Study|Physician Decision|0|||
129696064|NCT04135352|466845912|FG001|Overall Study|Physician Decision|0|||
129696065|NCT04135352|466845913|FG002|Overall Study|Physician Decision|1|||
129696066|NCT04135352|466845914|FG003|Overall Study|Physician Decision|0|||
129696067|NCT04135352|466845915|FG004|Overall Study|Physician Decision|1|||
129696068|NCT04135352|466845916|FG005|Overall Study|Physician Decision|0|||
129696069|NCT04135352|466845917|FG006|Overall Study|Physician Decision|0|||
129696070|NCT04135352|466845918|FG007|Overall Study|Physician Decision|0|||
129696071|NCT04135352|466845911|FG000|Overall Study|Death|3|||
129696072|NCT04135352|466845912|FG001|Overall Study|Death|4|||
129696073|NCT04135352|466845913|FG002|Overall Study|Death|7|||
129587004|NCT01698554|466443640|FG001|Overall Study|Personal Reasons|5|||
129587005|NCT01698554|466443641|FG002|Overall Study|Personal Reasons|1|||
129587006|NCT01698554|466443642|FG003|Overall Study|Personal Reasons|1|||
129587007|NCT01698554|466443639|FG000|Overall Study|Protocol Violation|2|||
129587008|NCT01698554|466443640|FG001|Overall Study|Protocol Violation|0|||
129587009|NCT01698554|466443641|FG002|Overall Study|Protocol Violation|1|||
129587010|NCT01698554|466443642|FG003|Overall Study|Protocol Violation|0|||
129587011|NCT01698554|466443639|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129587012|NCT01698554|466443640|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129587013|NCT01698554|466443641|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129885281|NCT00900627|467540627|FG005|Overall Study|Withdrawal by Subject|2|||
129885282|NCT00900627|467540622|FG000|Overall Study|Adverse Event|1|||
129885283|NCT00900627|467540623|FG001|Overall Study|Adverse Event|2|||
129587014|NCT01698554|466443642|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129587015|NCT02229084|466443643|FG000|Overall Study|Adverse Event|1|||
129587016|NCT02229084|466443644|FG001|Overall Study|Adverse Event|0|||
129587017|NCT02229084|466443645|FG002|Overall Study|Adverse Event|0|||
129587018|NCT02229084|466443646|FG003|Overall Study|Adverse Event|0|||
129885284|NCT00900627|467540624|FG002|Overall Study|Adverse Event|0|||
129587019|NCT02229084|466443647|FG004|Overall Study|Adverse Event|0|||
129587020|NCT02229084|466443648|FG005|Overall Study|Adverse Event|0|||
129587021|NCT02229084|466443649|FG006|Overall Study|Adverse Event|0|||
129587022|NCT02229084|466443643|FG000|Overall Study|Lost to Follow-up|0|||
129587023|NCT02229084|466443644|FG001|Overall Study|Lost to Follow-up|0|||
129587024|NCT02229084|466443645|FG002|Overall Study|Lost to Follow-up|1|||
129587025|NCT02229084|466443646|FG003|Overall Study|Lost to Follow-up|1|||
129587026|NCT02229084|466443647|FG004|Overall Study|Lost to Follow-up|0|||
129587027|NCT02229084|466443648|FG005|Overall Study|Lost to Follow-up|0|||
129696074|NCT04135352|466845914|FG003|Overall Study|Death|0|||
129696075|NCT04135352|466845915|FG004|Overall Study|Death|3|||
129696076|NCT04135352|466845916|FG005|Overall Study|Death|1|||
129696077|NCT04135352|466845917|FG006|Overall Study|Death|0|||
129696078|NCT04135352|466845918|FG007|Overall Study|Death|0|||
129696079|NCT02739828|466845919|FG000|Overall Study|Adverse Event|1|||
129696080|NCT02739828|466845919|FG000|Overall Study|Lost to Follow-up|4|||
129696081|NCT01392495|466845920|FG000|Overall Study|Death|3|||
129696082|NCT01392495|466845920|FG000|Overall Study|Administrative problems|8|||
129696083|NCT01392495|466845920|FG000|Overall Study|Withdrawal by Subject|2|||
129696084|NCT01392495|466845920|FG000|Overall Study|Adverse Event|3|||
129696085|NCT02571244|466845921|FG000|Overall Study|Lost to Follow-up|0|||
129696086|NCT02571244|466845922|FG001|Overall Study|Lost to Follow-up|1|||
129696087|NCT02571244|466845921|FG000|Overall Study|Unable to reach out post discharge|3|||
129696088|NCT02571244|466845922|FG001|Overall Study|Unable to reach out post discharge|0|||
129696089|NCT04629521|466845923|FG000|Overall Study|Death|1|||
129696090|NCT04629521|466845923|FG000|Overall Study|Lost to Follow-up|3|||
129696091|NCT04629521|466845923|FG000|Overall Study|Subject withdrew consent|3|||
129696092|NCT04629521|466845923|FG000|Overall Study|Enrolled in error|1|||
129696093|NCT01065766|466845932|FG000|Overall Study|Assessed before the contracted date|1|||
129696094|NCT01065766|466845932|FG000|Overall Study|Contraindication to administration|6|||
129696095|NCT01065766|466845932|FG000|Overall Study|Violated dosage/administration|25|||
129696096|NCT04818086|466845935|FG000|Overall Study|Physician Decision|1|||
129696097|NCT04818086|466845936|FG001|Overall Study|Physician Decision|0|||
129696098|NCT04818086|466845935|FG000|Overall Study|Withdrawal by Subject|0|||
129696099|NCT04818086|466845936|FG001|Overall Study|Withdrawal by Subject|1|||
129696100|NCT04128228|466845938|FG000|Overall Study|Withdrawal by Subject|3|||
129696101|NCT04128228|466845939|FG001|Overall Study|Withdrawal by Subject|3|||
129696102|NCT04128228|466845940|FG002|Overall Study|Withdrawal by Subject|0|||
129696103|NCT04128228|466845941|FG003|Overall Study|Withdrawal by Subject|0|||
129696104|NCT04128228|466845938|FG000|Overall Study|noncompliance|2|||
129696105|NCT04128228|466845939|FG001|Overall Study|noncompliance|2|||
129696106|NCT04128228|466845940|FG002|Overall Study|noncompliance|0|||
129696107|NCT04128228|466845941|FG003|Overall Study|noncompliance|0|||
129696108|NCT01602666|466845942|FG000|Induction Chemotherapy|Death|2|||
129696109|NCT01602666|466845943|FG001|Induction Chemotherapy|Death|1|||
129696110|NCT01602666|466845942|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
129696111|NCT01602666|466845943|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
129696112|NCT01602666|466845942|FG000|Induction Chemotherapy|Physician Decision|12|||
129696113|NCT01602666|466845943|FG001|Induction Chemotherapy|Physician Decision|5|||
129696114|NCT01602666|466845942|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
129696115|NCT01602666|466845943|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
129696116|NCT01602666|466845942|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
129696117|NCT01602666|466845943|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
129696118|NCT01602666|466845942|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
129696119|NCT01602666|466845943|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
129696120|NCT01602666|466845942|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
129696121|NCT01602666|466845943|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
129696122|NCT01602666|466845942|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
129696123|NCT01602666|466845943|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
129696124|NCT01602666|466845942|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
129696125|NCT01602666|466845943|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
129696126|NCT01602666|466845942|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
129696127|NCT01602666|466845943|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
129696128|NCT01602666|466845942|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
129696129|NCT01602666|466845943|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
129696130|NCT00215657|466845948|FG000|Overall Study|Adverse Event|5|||
129696131|NCT00215657|466845949|FG001|Overall Study|Adverse Event|1|||
129696132|NCT00215657|466845950|FG002|Overall Study|Adverse Event|3|||
129696133|NCT00215657|466845951|FG003|Overall Study|Adverse Event|0|||
129696134|NCT00215657|466845952|FG004|Overall Study|Adverse Event|3|||
129696135|NCT00215657|466845953|FG005|Overall Study|Adverse Event|1|||
129696136|NCT00215657|466845954|FG006|Overall Study|Adverse Event|0|||
129696137|NCT00215657|466845955|FG007|Overall Study|Adverse Event|3|||
129696138|NCT00215657|466845948|FG000|Overall Study|Withdrawal by Subject|6|||
129696139|NCT00215657|466845949|FG001|Overall Study|Withdrawal by Subject|3|||
129587028|NCT02229084|466443649|FG006|Overall Study|Lost to Follow-up|1|||
129587029|NCT02229084|466443643|FG000|Overall Study|Physician Decision|0|||
129587030|NCT02229084|466443644|FG001|Overall Study|Physician Decision|0|||
129587031|NCT02229084|466443645|FG002|Overall Study|Physician Decision|0|||
129587032|NCT02229084|466443646|FG003|Overall Study|Physician Decision|1|||
129587033|NCT02229084|466443647|FG004|Overall Study|Physician Decision|3|||
129587034|NCT02229084|466443648|FG005|Overall Study|Physician Decision|0|||
129587035|NCT02229084|466443649|FG006|Overall Study|Physician Decision|1|||
129587036|NCT02229084|466443643|FG000|Overall Study|Withdrawal by Subject|0|||
129587037|NCT02229084|466443644|FG001|Overall Study|Withdrawal by Subject|0|||
129587038|NCT02229084|466443645|FG002|Overall Study|Withdrawal by Subject|1|||
129885285|NCT00900627|467540625|FG003|Overall Study|Adverse Event|3|||
129587039|NCT02229084|466443646|FG003|Overall Study|Withdrawal by Subject|0|||
129587040|NCT02229084|466443647|FG004|Overall Study|Withdrawal by Subject|1|||
129587041|NCT02229084|466443648|FG005|Overall Study|Withdrawal by Subject|1|||
129587042|NCT02229084|466443649|FG006|Overall Study|Withdrawal by Subject|1|||
129587043|NCT02229084|466443643|FG000|Overall Study|Death|0|||
129587044|NCT02229084|466443644|FG001|Overall Study|Death|0|||
129587045|NCT02229084|466443645|FG002|Overall Study|Death|0|||
129587046|NCT02229084|466443646|FG003|Overall Study|Death|0|||
129587047|NCT02229084|466443647|FG004|Overall Study|Death|0|||
129587048|NCT02229084|466443648|FG005|Overall Study|Death|0|||
129587049|NCT02229084|466443649|FG006|Overall Study|Death|1|||
129587050|NCT01745094|466443660|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
129587051|NCT01745094|466443661|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
129587052|NCT01745094|466443662|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
129587053|NCT01745094|466443663|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
129587054|NCT01745094|466443660|FG000|Overall Study|Adverse Event|0|||
129587055|NCT01745094|466443661|FG001|Overall Study|Adverse Event|0|||
129587056|NCT01745094|466443662|FG002|Overall Study|Adverse Event|3|||
129587057|NCT01745094|466443663|FG003|Overall Study|Adverse Event|0|||
129587058|NCT01745094|466443660|FG000|Overall Study|Withdrawal by Subject|2|||
129587059|NCT01745094|466443661|FG001|Overall Study|Withdrawal by Subject|0|||
129587060|NCT01745094|466443662|FG002|Overall Study|Withdrawal by Subject|1|||
129587061|NCT01745094|466443663|FG003|Overall Study|Withdrawal by Subject|2|||
129587062|NCT01745094|466443660|FG000|Overall Study|Protocol Violation|1|||
129587063|NCT01745094|466443661|FG001|Overall Study|Protocol Violation|0|||
129587064|NCT01745094|466443662|FG002|Overall Study|Protocol Violation|3|||
129587065|NCT01745094|466443663|FG003|Overall Study|Protocol Violation|1|||
129587066|NCT01745094|466443660|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
129587067|NCT01745094|466443661|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
129587068|NCT01745094|466443662|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
129587069|NCT01745094|466443663|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
129587070|NCT01745094|466443660|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
129587071|NCT01745094|466443661|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
129587072|NCT01745094|466443662|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
129587073|NCT01745094|466443663|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
129587074|NCT01745094|466443660|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
129587075|NCT01745094|466443661|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
129587076|NCT01745094|466443662|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
129587077|NCT01745094|466443663|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
129587078|NCT00881569|466443664|FG000|Overall Study|Disease progression|1|||
129587079|NCT00881569|466443665|FG001|Overall Study|Disease progression|1|||
129587080|NCT02623218|466443676|FG000|Overall Study|Lost to Follow-up|0|||
129587081|NCT02623218|466443677|FG001|Overall Study|Lost to Follow-up|1|||
129587082|NCT02623218|466443678|FG002|Overall Study|Lost to Follow-up|0|||
129587083|NCT02623218|466443679|FG003|Overall Study|Lost to Follow-up|0|||
129587084|NCT02623218|466443680|FG004|Overall Study|Lost to Follow-up|0|||
129587085|NCT01726803|466443681|FG000|Overall Study|Lost to Follow-up|6|||
129587086|NCT01726803|466443682|FG001|Overall Study|Lost to Follow-up|1|||
129587087|NCT01726803|466443681|FG000|Overall Study|Withdrawal by Subject|1|||
129587088|NCT01726803|466443682|FG001|Overall Study|Withdrawal by Subject|0|||
129587089|NCT01970592|466443684|FG000|Overall Study|Withdrawal by Subject|4|||
129587090|NCT01970592|466443684|FG000|Overall Study|Physician Decision|1|||
129587091|NCT01970592|466443684|FG000|Overall Study|Adverse Event|1|||
129587092|NCT01320722|466443685|FG000|Overall Study|Did not Receive Intervention|3|||
129587093|NCT01320722|466443686|FG001|Overall Study|Did not Receive Intervention|2|||
129587094|NCT01320722|466443687|FG002|Overall Study|Did not Receive Intervention|1|||
129587095|NCT01320722|466443688|FG003|Overall Study|Did not Receive Intervention|1|||
129587096|NCT01320722|466443689|FG004|Overall Study|Did not Receive Intervention|2|||
129587097|NCT01320722|466443685|FG000|Overall Study|Lost to Follow-up|0|||
129587098|NCT01320722|466443686|FG001|Overall Study|Lost to Follow-up|1|||
129587099|NCT01320722|466443687|FG002|Overall Study|Lost to Follow-up|0|||
129587100|NCT01320722|466443688|FG003|Overall Study|Lost to Follow-up|1|||
129587101|NCT01320722|466443689|FG004|Overall Study|Lost to Follow-up|3|||
129587102|NCT01320722|466443685|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
129587103|NCT01320722|466443686|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
129696140|NCT00215657|466845950|FG002|Overall Study|Withdrawal by Subject|3|||
129587104|NCT01320722|466443687|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
129587105|NCT01320722|466443688|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
129587106|NCT01320722|466443689|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
129587107|NCT01320722|466443685|FG000|Overall Study|Participant Developed a Rash|0|||
129587108|NCT01320722|466443686|FG001|Overall Study|Participant Developed a Rash|0|||
129587109|NCT01320722|466443687|FG002|Overall Study|Participant Developed a Rash|2|||
129587110|NCT01320722|466443688|FG003|Overall Study|Participant Developed a Rash|1|||
129587111|NCT01320722|466443689|FG004|Overall Study|Participant Developed a Rash|1|||
129587112|NCT01320722|466443685|FG000|Overall Study|Non-compliant with Medication|0|||
129587113|NCT01320722|466443686|FG001|Overall Study|Non-compliant with Medication|0|||
129587114|NCT01320722|466443687|FG002|Overall Study|Non-compliant with Medication|1|||
129587115|NCT01320722|466443688|FG003|Overall Study|Non-compliant with Medication|0|||
129587116|NCT01320722|466443689|FG004|Overall Study|Non-compliant with Medication|0|||
129587117|NCT01320722|466443685|FG000|Overall Study|Adverse Event|0|||
129587118|NCT01320722|466443686|FG001|Overall Study|Adverse Event|0|||
129587119|NCT01320722|466443687|FG002|Overall Study|Adverse Event|3|||
129587120|NCT01320722|466443688|FG003|Overall Study|Adverse Event|6|||
129587121|NCT01320722|466443689|FG004|Overall Study|Adverse Event|0|||
129587122|NCT01320722|466443685|FG000|Overall Study|Not Compliant with Study Procedures|0|||
129696141|NCT00215657|466845951|FG003|Overall Study|Withdrawal by Subject|1|||
129696142|NCT00215657|466845952|FG004|Overall Study|Withdrawal by Subject|6|||
129696143|NCT00215657|466845953|FG005|Overall Study|Withdrawal by Subject|1|||
129696144|NCT00215657|466845954|FG006|Overall Study|Withdrawal by Subject|10|||
129696145|NCT00215657|466845955|FG007|Overall Study|Withdrawal by Subject|3|||
129696146|NCT00215657|466845948|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
129696147|NCT00215657|466845949|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
129696148|NCT00215657|466845950|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
129696149|NCT00215657|466845951|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
129696150|NCT00215657|466845952|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
129696151|NCT00215657|466845953|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
129696152|NCT00215657|466845954|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
129696153|NCT00215657|466845955|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
129587123|NCT01320722|466443686|FG001|Overall Study|Not Compliant with Study Procedures|0|||
129587124|NCT01320722|466443687|FG002|Overall Study|Not Compliant with Study Procedures|0|||
129587125|NCT01320722|466443688|FG003|Overall Study|Not Compliant with Study Procedures|4|||
129587126|NCT01320722|466443689|FG004|Overall Study|Not Compliant with Study Procedures|0|||
129587127|NCT01320722|466443685|FG000|Overall Study|Pregnancy|0|||
129587128|NCT01320722|466443686|FG001|Overall Study|Pregnancy|0|||
129587129|NCT01320722|466443687|FG002|Overall Study|Pregnancy|0|||
129587130|NCT01320722|466443688|FG003|Overall Study|Pregnancy|1|||
129587131|NCT01320722|466443689|FG004|Overall Study|Pregnancy|0|||
129587132|NCT01320722|466443685|FG000|Overall Study|Started an Exclusionary Medication|0|||
129587133|NCT01320722|466443686|FG001|Overall Study|Started an Exclusionary Medication|0|||
129587134|NCT01320722|466443687|FG002|Overall Study|Started an Exclusionary Medication|0|||
129587135|NCT01320722|466443688|FG003|Overall Study|Started an Exclusionary Medication|0|||
129587136|NCT01320722|466443689|FG004|Overall Study|Started an Exclusionary Medication|1|||
129587137|NCT01320722|466443685|FG000|Overall Study|Withdrew due to Health Condition|0|||
129587138|NCT01320722|466443686|FG001|Overall Study|Withdrew due to Health Condition|0|||
129587139|NCT01320722|466443687|FG002|Overall Study|Withdrew due to Health Condition|0|||
129587140|NCT01320722|466443688|FG003|Overall Study|Withdrew due to Health Condition|0|||
129587141|NCT01320722|466443689|FG004|Overall Study|Withdrew due to Health Condition|1|||
129587142|NCT02616380|466443702|FG000|Overall Study|Lost to Follow-up|1|||
129587143|NCT02616380|466443702|FG000|Overall Study|Other|2|||
129587144|NCT00057941|466443703|FG000|Overall Study|Death|1|||
129587145|NCT00057941|466443704|FG001|Overall Study|Death|2|||
129587146|NCT00057941|466443703|FG000|Overall Study|Adverse Event|7|||
129587147|NCT00057941|466443704|FG001|Overall Study|Adverse Event|9|||
129587148|NCT00057941|466443703|FG000|Overall Study|Lack of Efficacy|54|||
129587149|NCT00057941|466443704|FG001|Overall Study|Lack of Efficacy|53|||
129587150|NCT00057941|466443703|FG000|Overall Study|Withdrawal by Subject|6|||
129587151|NCT00057941|466443704|FG001|Overall Study|Withdrawal by Subject|1|||
129587152|NCT00057941|466443703|FG000|Overall Study|still on treatment|3|||
129587153|NCT00057941|466443704|FG001|Overall Study|still on treatment|1|||
129587154|NCT00057941|466443703|FG000|Overall Study|insurance, symptomatic deterioration|1|||
129587155|NCT00057941|466443704|FG001|Overall Study|insurance, symptomatic deterioration|3|||
129587156|NCT00057941|466443703|FG000|Overall Study|Ineligible|2|||
129587157|NCT00057941|466443704|FG001|Overall Study|Ineligible|5|||
129587158|NCT03407729|466443705|FG000|Overall Study|Lost to Follow-up|2|||
129587159|NCT03407729|466443706|FG001|Overall Study|Lost to Follow-up|0|||
129587160|NCT03407729|466443705|FG000|Overall Study|Unable to schedule|0|||
129587161|NCT03407729|466443706|FG001|Overall Study|Unable to schedule|3|||
129587162|NCT03950674|466443707|FG000|Overall Study|Death|16|||
129587163|NCT03950674|466443708|FG001|Overall Study|Death|15|||
129587164|NCT03950674|466443707|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
129587165|NCT03950674|466443708|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
129587166|NCT00830167|466443711|FG000|Overall Study|Lack of Efficacy|26|||
129587167|NCT00830167|466443712|FG001|Overall Study|Lack of Efficacy|10|||
129587168|NCT00830167|466443711|FG000|Overall Study|Adverse Event|8|||
129587169|NCT00830167|466443712|FG001|Overall Study|Adverse Event|24|||
129587170|NCT00830167|466443711|FG000|Overall Study|Not meeting entrance criteria|2|||
129587171|NCT00830167|466443712|FG001|Overall Study|Not meeting entrance criteria|5|||
129587172|NCT00830167|466443711|FG000|Overall Study|Withdrawal by Subject|2|||
129587173|NCT00830167|466443712|FG001|Overall Study|Withdrawal by Subject|0|||
129587174|NCT00830167|466443711|FG000|Overall Study|Lost to Follow-up|0|||
129587175|NCT00830167|466443712|FG001|Overall Study|Lost to Follow-up|1|||
129587176|NCT00830167|466443711|FG000|Overall Study|Protocol Violation|0|||
129587177|NCT00830167|466443712|FG001|Overall Study|Protocol Violation|1|||
129587178|NCT00830167|466443711|FG000|Overall Study|Other|2|||
129587179|NCT00830167|466443712|FG001|Overall Study|Other|2|||
129587180|NCT00609154|466443713|FG000|Overall Study|Protocol Violation|1|||
129587181|NCT00609154|466443714|FG001|Overall Study|Protocol Violation|2|||
129587182|NCT00609154|466443713|FG000|Overall Study|Unable to establish IV access|0|||
129587183|NCT00609154|466443714|FG001|Overall Study|Unable to establish IV access|4|||
129587184|NCT00609154|466443713|FG000|Overall Study|Adverse Event|0|||
129587185|NCT00609154|466443714|FG001|Overall Study|Adverse Event|2|||
129587186|NCT02224053|466443715|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
129587187|NCT02224053|466443715|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
129587188|NCT02224053|466443715|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
129587189|NCT02224053|466443715|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
129587190|NCT02224053|466443715|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
129587191|NCT00860262|466443721|FG000|Overall Study|Adverse Event|9|||
129587192|NCT00860262|466443722|FG001|Overall Study|Adverse Event|6|||
129587193|NCT00860262|466443723|FG002|Overall Study|Adverse Event|7|||
129587194|NCT00860262|466443721|FG000|Overall Study|Protocol Violation|0|||
129587195|NCT00860262|466443722|FG001|Overall Study|Protocol Violation|1|||
129587196|NCT00860262|466443723|FG002|Overall Study|Protocol Violation|0|||
129587197|NCT00860262|466443721|FG000|Overall Study|Lost to Follow-up|2|||
129587198|NCT00860262|466443722|FG001|Overall Study|Lost to Follow-up|0|||
129587199|NCT00860262|466443723|FG002|Overall Study|Lost to Follow-up|1|||
129587200|NCT00860262|466443721|FG000|Overall Study|Withdrawal by Subject|4|||
129587201|NCT00860262|466443722|FG001|Overall Study|Withdrawal by Subject|8|||
129587202|NCT00860262|466443723|FG002|Overall Study|Withdrawal by Subject|6|||
129587203|NCT00860262|466443721|FG000|Overall Study|Lack of Efficacy|0|||
129587204|NCT00860262|466443722|FG001|Overall Study|Lack of Efficacy|4|||
129587205|NCT00860262|466443723|FG002|Overall Study|Lack of Efficacy|3|||
129587206|NCT00860262|466443721|FG000|Overall Study|Other|5|||
129587207|NCT00860262|466443722|FG001|Overall Study|Other|3|||
129587208|NCT00860262|466443723|FG002|Overall Study|Other|1|||
129587209|NCT00124618|466443724|FG000|Overall Study|Ineligible|1|||
129587210|NCT01596127|466443725|FG000|Overall Study|Patient Ineligible|1|||
129587211|NCT01675596|466443726|FG000|Overall Study|Death|6|||
129587212|NCT01675596|466443726|FG000|Overall Study|Exit with other reason|1|||
129587213|NCT01675596|466443726|FG000|Overall Study|Missed Visit|1|||
129587214|NCT00633022|466443727|FG000|Overall Study|Adverse Event|1|||
129587215|NCT00633022|466443728|FG001|Overall Study|Adverse Event|0|||
129587216|NCT00633022|466443729|FG002|Overall Study|Adverse Event|5|||
129587217|NCT00633022|466443727|FG000|Overall Study|Physician Decision|0|||
129587218|NCT00633022|466443728|FG001|Overall Study|Physician Decision|1|||
129587219|NCT00633022|466443729|FG002|Overall Study|Physician Decision|0|||
129587220|NCT04388787|466443731|FG000|Blinded Period|Patient could not follow instructions|1|||
129587221|NCT04388787|466443731|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
129587222|NCT00688844|466443732|FG000|Overall Study|Lost to Follow-up|10|||
129587223|NCT01374451|466443733|FG000|Overall Study|Administrative problems|1|||
129587224|NCT01374451|466443734|FG001|Overall Study|Administrative problems|0|||
129587225|NCT01223027|466443735|FG000|Overall Study|Adverse Event|20|||
129587226|NCT01223027|466443736|FG001|Overall Study|Adverse Event|10|||
129587227|NCT01223027|466443735|FG000|Overall Study|Death|42|||
129587228|NCT01223027|466443736|FG001|Overall Study|Death|42|||
129587229|NCT01223027|466443735|FG000|Overall Study|Lost to Follow-up|2|||
129587230|NCT01223027|466443736|FG001|Overall Study|Lost to Follow-up|1|||
129587231|NCT01223027|466443735|FG000|Overall Study|Physician Decision|4|||
129587232|NCT01223027|466443736|FG001|Overall Study|Physician Decision|8|||
129587233|NCT01223027|466443735|FG000|Overall Study|Progressive Disease|167|||
129587234|NCT01223027|466443736|FG001|Overall Study|Progressive Disease|183|||
129587235|NCT01223027|466443735|FG000|Overall Study|Protocol Violation|2|||
129587236|NCT01223027|466443736|FG001|Overall Study|Protocol Violation|1|||
129587237|NCT01223027|466443735|FG000|Overall Study|Subject/guardian decicion|18|||
129587238|NCT01223027|466443736|FG001|Overall Study|Subject/guardian decicion|16|||
129587239|NCT01223027|466443735|FG000|Overall Study|New therapy for study indication|17|||
129587240|NCT01223027|466443736|FG001|Overall Study|New therapy for study indication|8|||
129587241|NCT01223027|466443735|FG000|Overall Study|Study terminated by sponsor|2|||
129587242|NCT01223027|466443736|FG001|Overall Study|Study terminated by sponsor|8|||
129885286|NCT00900627|467540626|FG004|Overall Study|Adverse Event|0|||
129885287|NCT00900627|467540627|FG005|Overall Study|Adverse Event|0|||
129885288|NCT00900627|467540622|FG000|Overall Study|Death|0|||
129885289|NCT00900627|467540623|FG001|Overall Study|Death|0|||
129885290|NCT00900627|467540624|FG002|Overall Study|Death|0|||
129885291|NCT00900627|467540625|FG003|Overall Study|Death|0|||
129885292|NCT00900627|467540626|FG004|Overall Study|Death|28|||
129885293|NCT00900627|467540627|FG005|Overall Study|Death|24|||
129885294|NCT00373295|467540628|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129885295|NCT00373295|467540629|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
129885296|NCT00373295|467540630|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129885297|NCT00373295|467540631|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129885298|NCT00373295|467540632|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
129885299|NCT00373295|467540633|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129587243|NCT02061280|466443737|FG000|Overall Study|Protocol Violation|12|||
129587244|NCT02061280|466443738|FG001|Overall Study|Protocol Violation|8|||
129587245|NCT02061280|466443737|FG000|Overall Study|moved out of state|0|||
129587246|NCT02061280|466443738|FG001|Overall Study|moved out of state|1|||
129587247|NCT02061280|466443737|FG000|Overall Study|Withdrawal by Subject|1|||
129587248|NCT02061280|466443738|FG001|Overall Study|Withdrawal by Subject|2|||
129587249|NCT02061280|466443737|FG000|Overall Study|Lost to Follow-up|5|||
129587250|NCT02061280|466443738|FG001|Overall Study|Lost to Follow-up|1|||
129587251|NCT00724958|466443739|FG000|Overall Study|Adverse Event|28|||
129587252|NCT00724958|466443739|FG000|Overall Study|Loss of Response|40|||
129587253|NCT00724958|466443739|FG000|Overall Study|No Response|18|||
129587254|NCT00724958|466443739|FG000|Overall Study|Remission|7|||
129587255|NCT00724958|466443739|FG000|Overall Study|Other Reason|76|||
129587256|NCT00724958|466443739|FG000|Overall Study|No documentation for end of therapy|13|||
129587257|NCT01520987|466445425|FG000|Overall Study|Withdrawal by Subject|1|||
129587258|NCT01520987|466445426|FG001|Overall Study|Withdrawal by Subject|0|||
129587259|NCT01520987|466445427|FG002|Overall Study|Withdrawal by Subject|0|||
129587260|NCT01520987|466445428|FG003|Overall Study|Withdrawal by Subject|0|||
129587261|NCT01520987|466445429|FG004|Overall Study|Withdrawal by Subject|0|||
129885300|NCT00830947|467540634|FG000|Overall Study|Lost to Follow-up|4|||
129885301|NCT00830947|467540635|FG001|Overall Study|Lost to Follow-up|4|||
129885302|NCT00594906|467540636|FG000|Overall Study|Physician Decision|1|||
129885303|NCT00594906|467540637|FG001|Overall Study|Physician Decision|0|||
129885304|NCT00594906|467540636|FG000|Overall Study|Physician Decision|0|||
129587262|NCT01520987|466445430|FG005|Overall Study|Withdrawal by Subject|1|||
129587263|NCT01520987|466445431|FG006|Overall Study|Withdrawal by Subject|0|||
129587264|NCT01520987|466445432|FG007|Overall Study|Withdrawal by Subject|0|||
129587265|NCT02005562|466445433|FG000|Overall Study|Death|2|||
129587266|NCT02005562|466445434|FG001|Overall Study|Death|2|||
129587267|NCT02005562|466445433|FG000|Overall Study|Graft loss|7|||
129587268|NCT02005562|466445434|FG001|Overall Study|Graft loss|6|||
129587269|NCT02005562|466445433|FG000|Overall Study|Withdrawal by Subject|2|||
129587270|NCT02005562|466445434|FG001|Overall Study|Withdrawal by Subject|2|||
129587271|NCT02005562|466445433|FG000|Overall Study|No transplant|1|||
129587272|NCT02005562|466445434|FG001|Overall Study|No transplant|4|||
129587273|NCT02005562|466445433|FG000|Overall Study|Physician Decision|0|||
129587274|NCT02005562|466445434|FG001|Overall Study|Physician Decision|1|||
129587275|NCT04729101|466445435|FG000|Overall Study|Adverse Event|1|||
129587276|NCT04729101|466445436|FG001|Overall Study|Adverse Event|0|||
129587277|NCT04729101|466445435|FG000|Overall Study|Physician Decision|1|||
129587278|NCT04729101|466445436|FG001|Overall Study|Physician Decision|0|||
129587279|NCT04729101|466445435|FG000|Overall Study|Withdrawal by Subject|1|||
129587280|NCT04729101|466445436|FG001|Overall Study|Withdrawal by Subject|0|||
129587281|NCT00274625|466445437|FG000|Overall Study|Lost to Follow-up|46|||
129587282|NCT00274625|466445438|FG001|Overall Study|Lost to Follow-up|54|||
129587283|NCT00274625|466445437|FG000|Overall Study|Excluded from analysis|14|||
129587284|NCT00274625|466445438|FG001|Overall Study|Excluded from analysis|8|||
129587285|NCT02940522|466445439|FG000|Overall Study|Lost to Follow-up|1|||
129587286|NCT02940522|466445440|FG001|Overall Study|Lost to Follow-up|2|||
129587287|NCT02940522|466445439|FG000|Overall Study|Withdrawal by Subject|1|||
129587288|NCT02940522|466445440|FG001|Overall Study|Withdrawal by Subject|0|||
129587289|NCT01754376|466445444|FG000|Overall Study|Adverse Event|1|||
129587290|NCT01754376|466445444|FG000|Overall Study|Lack of Efficacy|2|||
129587291|NCT04264819|466445445|FG000|Overall Study|Physician Decision|19|||
129587292|NCT04264819|466445445|FG000|Overall Study|Adverse Event|12|||
129587293|NCT04264819|466445445|FG000|Overall Study|Withdrawal by Subject|11|||
129587294|NCT04264819|466445445|FG000|Overall Study|Lost to Follow-up|2|||
129587295|NCT04264819|466445445|FG000|Overall Study|Death|2|||
129587296|NCT04768296|466445446|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
129587297|NCT04768296|466445447|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
129587298|NCT03087786|466445448|FG000|Overall Study|Withdrawal by Subject|2|||
129587299|NCT03087786|466445449|FG001|Overall Study|Withdrawal by Subject|0|||
129587300|NCT01453153|466445454|FG000|Overall Study|Physician Decision|0|||
129587301|NCT01453153|466445455|FG001|Overall Study|Physician Decision|0|||
129587302|NCT01453153|466445456|FG002|Overall Study|Physician Decision|1|||
129587303|NCT01453153|466445454|FG000|Overall Study|Progressive Disease|3|||
129587304|NCT01453153|466445455|FG001|Overall Study|Progressive Disease|2|||
129587305|NCT01453153|466445456|FG002|Overall Study|Progressive Disease|16|||
129587306|NCT01453153|466445454|FG000|Overall Study|Withdrawal by Subject|0|||
129587307|NCT01453153|466445455|FG001|Overall Study|Withdrawal by Subject|1|||
129587308|NCT01453153|466445456|FG002|Overall Study|Withdrawal by Subject|2|||
129587309|NCT01453153|466445454|FG000|Overall Study|Adverse Event|1|||
129587310|NCT01453153|466445455|FG001|Overall Study|Adverse Event|1|||
129587311|NCT01453153|466445456|FG002|Overall Study|Adverse Event|1|||
129587312|NCT01802216|466445458|FG000|4 Month Visit|Participant did not show to visit|3|||
129587313|NCT01802216|466445459|FG001|4 Month Visit|Participant did not show to visit|4|||
129587314|NCT01802216|466445458|FG000|8 Month Visit|Participant did not show to visit|3|||
129587315|NCT01802216|466445459|FG001|8 Month Visit|Participant did not show to visit|5|||
129587316|NCT01802216|466445458|FG000|12 Month Visit|Participant did not show to visit|3|||
129587317|NCT01802216|466445459|FG001|12 Month Visit|Participant did not show to visit|4|||
129587318|NCT00880334|466445460|FG000|Randomized Phase|Physician Decision|1|||
129587319|NCT00880334|466445461|FG001|Randomized Phase|Physician Decision|0|||
129587320|NCT00880334|466445460|FG000|Randomized Phase|Withdrawal by Subject|2|||
129587321|NCT00880334|466445461|FG001|Randomized Phase|Withdrawal by Subject|1|||
129587322|NCT00880334|466445460|FG000|Randomized Phase|Inadequate Labs|1|||
129587323|NCT00880334|466445461|FG001|Randomized Phase|Inadequate Labs|1|||
129587324|NCT00880334|466445460|FG000|Randomized Phase|Brain Metastasis|0|||
129587325|NCT00880334|466445461|FG001|Randomized Phase|Brain Metastasis|1|||
129587326|NCT00880334|466445460|FG000|Randomized Phase|Crossover Participants|0|||
129587327|NCT00880334|466445461|FG001|Randomized Phase|Crossover Participants|37|||
129587328|NCT02274558|466445462|FG000|Overall Study|Adverse Event|2|||
129587329|NCT02274558|466445463|FG001|Overall Study|Adverse Event|4|||
129587330|NCT02274558|466445464|FG002|Overall Study|Adverse Event|2|||
129587331|NCT02274558|466445462|FG000|Overall Study|Non-compliance|2|||
129587332|NCT02274558|466445463|FG001|Overall Study|Non-compliance|1|||
129587333|NCT02274558|466445464|FG002|Overall Study|Non-compliance|0|||
129587334|NCT02274558|466445462|FG000|Overall Study|Withdrawal by Subject|1|||
129587335|NCT02274558|466445463|FG001|Overall Study|Withdrawal by Subject|5|||
129587336|NCT02274558|466445464|FG002|Overall Study|Withdrawal by Subject|4|||
129587337|NCT02274558|466445462|FG000|Overall Study|Death|0|||
129587338|NCT02274558|466445463|FG001|Overall Study|Death|0|||
129587339|NCT02274558|466445464|FG002|Overall Study|Death|1|||
129587340|NCT02274558|466445462|FG000|Overall Study|Lost to Follow-up|2|||
129587341|NCT02274558|466445463|FG001|Overall Study|Lost to Follow-up|1|||
129587342|NCT02274558|466445464|FG002|Overall Study|Lost to Follow-up|1|||
129587343|NCT02274558|466445462|FG000|Overall Study|Physician Decision|0|||
129587344|NCT02274558|466445463|FG001|Overall Study|Physician Decision|2|||
129587345|NCT02274558|466445464|FG002|Overall Study|Physician Decision|1|||
129587346|NCT05393271|466445474|FG000|Overall Study|Physician Decision|0|||
129587347|NCT05393271|466445475|FG001|Overall Study|Physician Decision|0|||
129587348|NCT05393271|466445476|FG002|Overall Study|Physician Decision|0|||
129587349|NCT05393271|466445477|FG003|Overall Study|Physician Decision|0|||
129587350|NCT05393271|466445478|FG004|Overall Study|Physician Decision|0|||
129587351|NCT05393271|466445479|FG005|Overall Study|Physician Decision|0|||
129587352|NCT05393271|466445480|FG006|Overall Study|Physician Decision|1|||
129587353|NCT05393271|466445481|FG007|Overall Study|Physician Decision|0|||
129587354|NCT05393271|466445482|FG008|Overall Study|Physician Decision|0|||
129587355|NCT05393271|466445483|FG009|Overall Study|Physician Decision|0|||
129587356|NCT05393271|466445484|FG010|Overall Study|Physician Decision|0|||
129587357|NCT02943993|466445487|FG000|Overall Study|Withdrawal by Subject|52|||
129587358|NCT02943993|466445487|FG000|Overall Study|Transfer to another institution|6|||
129587359|NCT02943993|466445487|FG000|Overall Study|Lost to Follow-up|135|||
129587360|NCT02943993|466445487|FG000|Overall Study|Death|98|||
129587361|NCT02943993|466445487|FG000|Overall Study|Other reason for premature termination|32|||
129587362|NCT02943993|466445487|FG000|Overall Study|Missing reason for termination|7|||
129587363|NCT02483416|466445491|FG000|Overall Study|Other reason|0|||
129587364|NCT02483416|466445492|FG001|Overall Study|Other reason|1|||
129587365|NCT02483416|466445491|FG000|Overall Study|Treatment stop|3|||
129587366|NCT02483416|466445492|FG001|Overall Study|Treatment stop|0|||
129587367|NCT04542694|466445497|FG000|Overall Study|The need for prohibited therapy|2|||
129587368|NCT04542694|466445498|FG001|Overall Study|The need for prohibited therapy|0|||
129587369|NCT04542694|466445497|FG000|Overall Study|Adverse Event|1|||
129587370|NCT04542694|466445498|FG001|Overall Study|Adverse Event|0|||
129587371|NCT04542694|466445497|FG000|Overall Study|Protocol Violation|1|||
129587372|NCT04542694|466445498|FG001|Overall Study|Protocol Violation|0|||
129587373|NCT03433703|466445501|FG000|Overall Study|Study terminated by Sponsor|2|||
129587374|NCT01957150|466445502|FG000|Overall Study|Adverse Event|23|||
129587375|NCT01957150|466445503|FG001|Overall Study|Adverse Event|20|||
129587376|NCT01957150|466445502|FG000|Overall Study|Withdrawal by Subject|13|||
129587377|NCT01957150|466445503|FG001|Overall Study|Withdrawal by Subject|17|||
129587378|NCT01957150|466445502|FG000|Overall Study|Physician Decision|3|||
129587379|NCT01957150|466445503|FG001|Overall Study|Physician Decision|6|||
129587380|NCT01957150|466445502|FG000|Overall Study|Lost to Follow-up|4|||
129587381|NCT01957150|466445503|FG001|Overall Study|Lost to Follow-up|4|||
129587382|NCT01957150|466445502|FG000|Overall Study|Protocol Violation|1|||
129587383|NCT01957150|466445503|FG001|Overall Study|Protocol Violation|0|||
129587384|NCT01957150|466445502|FG000|Overall Study|Lack of Efficacy|11|||
129587385|NCT01957150|466445503|FG001|Overall Study|Lack of Efficacy|11|||
129587386|NCT02786953|466445506|FG000|Overall Study|Withdrawal by Subject|3|||
129587387|NCT02786953|466445507|FG001|Overall Study|Withdrawal by Subject|0|||
129587388|NCT02786953|466445506|FG000|Overall Study|Physician Decision|0|||
129587389|NCT02786953|466445507|FG001|Overall Study|Physician Decision|1|||
129587390|NCT00252564|466445509|FG000|Overall Study|Adverse Event|17|||
129587391|NCT00252564|466445510|FG001|Overall Study|Adverse Event|13|||
129587392|NCT00252564|466445509|FG000|Overall Study|Unrelated Complication|2|||
129587393|NCT00252564|466445510|FG001|Overall Study|Unrelated Complication|1|||
129587394|NCT00252564|466445509|FG000|Overall Study|Disease Progression|14|||
129587395|NCT00252564|466445510|FG001|Overall Study|Disease Progression|20|||
129587396|NCT00252564|466445509|FG000|Overall Study|Death|0|||
129587397|NCT00252564|466445510|FG001|Overall Study|Death|3|||
129587398|NCT00252564|466445509|FG000|Overall Study|Physician Decision|1|||
129587399|NCT00252564|466445510|FG001|Overall Study|Physician Decision|0|||
129587400|NCT00252564|466445509|FG000|Overall Study|Lost to Follow-up|1|||
129587401|NCT00252564|466445510|FG001|Overall Study|Lost to Follow-up|0|||
129587402|NCT00252564|466445509|FG000|Overall Study|Patient Request|4|||
129587403|NCT00252564|466445510|FG001|Overall Study|Patient Request|5|||
129587404|NCT00252564|466445509|FG000|Overall Study|Withdrawal by Subject|0|||
129587405|NCT00252564|466445510|FG001|Overall Study|Withdrawal by Subject|2|||
129587406|NCT04561115|466445512|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
129587407|NCT04561115|466445513|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
129587408|NCT04561115|466445512|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
129587409|NCT04561115|466445513|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
129587410|NCT04561115|466445512|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
129587411|NCT04561115|466445513|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
129587412|NCT00743145|466445514|FG000|Overall Study|Withdrawal by Subject|1|||
129587413|NCT00743145|466445514|FG000|Overall Study|Adverse Event|2|||
129587414|NCT00743145|466445514|FG000|Overall Study|Pregnancy|1|||
129587415|NCT02416180|466445515|FG000|Overall Study|Withdrawal by Subject|1|||
129587416|NCT03414034|466445518|FG000|Overall Study|Adverse Event|6|||
129587417|NCT03414034|466445519|FG001|Overall Study|Adverse Event|1|||
129587418|NCT03414034|466445520|FG002|Overall Study|Adverse Event|1|||
129587419|NCT03414034|466445518|FG000|Overall Study|Death|0|||
129885305|NCT00594906|467540637|FG001|Overall Study|Physician Decision|1|||
129587420|NCT03414034|466445519|FG001|Overall Study|Death|0|||
129587421|NCT03414034|466445520|FG002|Overall Study|Death|1|||
129587422|NCT03414034|466445518|FG000|Overall Study|Non-compliance With Study Drug|0|||
129587423|NCT03414034|466445519|FG001|Overall Study|Non-compliance With Study Drug|0|||
129885306|NCT00594906|467540636|FG000|Overall Study|Death|0|||
129885307|NCT00594906|467540637|FG001|Overall Study|Death|1|||
129885308|NCT00839917|467540639|FG000|Overall Study|Lost to Follow-up|1|||
129885309|NCT00839917|467540640|FG001|Overall Study|Lost to Follow-up|0|||
129885310|NCT00839917|467540639|FG000|Overall Study|Did not receive vaccine|0|||
129885311|NCT00839917|467540640|FG001|Overall Study|Did not receive vaccine|1|||
129885312|NCT00867490|467540641|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
129885313|NCT00867490|467540641|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
129885314|NCT00867490|467540641|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
129885315|NCT00867490|467540641|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
129885316|NCT00867490|467540641|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
129885317|NCT01254565|467540642|FG000|Overall Study|Non-compliance to Study Procedures|0|||
129885318|NCT01254565|467540643|FG001|Overall Study|Non-compliance to Study Procedures|0|||
129885319|NCT01254565|467540644|FG002|Overall Study|Non-compliance to Study Procedures|0|||
129885320|NCT01254565|467540645|FG003|Overall Study|Non-compliance to Study Procedures|0|||
129885321|NCT01254565|467540646|FG004|Overall Study|Non-compliance to Study Procedures|1|||
129885322|NCT01254565|467540647|FG005|Overall Study|Non-compliance to Study Procedures|0|||
129885323|NCT01254565|467540642|FG000|Overall Study|Did not Receive Treatment|1|||
129885324|NCT01254565|467540643|FG001|Overall Study|Did not Receive Treatment|1|||
129885325|NCT01254565|467540644|FG002|Overall Study|Did not Receive Treatment|0|||
129885326|NCT01254565|467540645|FG003|Overall Study|Did not Receive Treatment|0|||
129885327|NCT01254565|467540646|FG004|Overall Study|Did not Receive Treatment|3|||
129885328|NCT01254565|467540647|FG005|Overall Study|Did not Receive Treatment|4|||
129885329|NCT01254565|467540642|FG000|Overall Study|Other|0|||
129885330|NCT01254565|467540643|FG001|Overall Study|Other|0|||
129885331|NCT01254565|467540644|FG002|Overall Study|Other|0|||
129885332|NCT01254565|467540645|FG003|Overall Study|Other|1|||
129885333|NCT01254565|467540646|FG004|Overall Study|Other|0|||
129885334|NCT01254565|467540647|FG005|Overall Study|Other|0|||
129885335|NCT00472186|467540648|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
129885336|NCT00472186|467540649|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
129885337|NCT04747275|467540650|FG000|Overall Study|Study terminated|0|||
129885338|NCT04747275|467540651|FG001|Overall Study|Study terminated|1|||
129885339|NCT03268590|467540655|FG000|Overall Study|Previously unknown exclusion criteria|1|||
129885340|NCT02139982|467540658|FG000|Overall Study|Lack of Efficacy|0|||
129885341|NCT02139982|467540659|FG001|Overall Study|Lack of Efficacy|1|||
129885342|NCT02139982|467540660|FG002|Overall Study|Lack of Efficacy|0|||
129885343|NCT02139982|467540661|FG003|Overall Study|Lack of Efficacy|1|||
129885344|NCT02139982|467540662|FG004|Overall Study|Lack of Efficacy|0|||
129885345|NCT02139982|467540663|FG005|Overall Study|Lack of Efficacy|0|||
129885346|NCT02139982|467540664|FG006|Overall Study|Lack of Efficacy|0|||
129885347|NCT02139982|467540665|FG007|Overall Study|Lack of Efficacy|0|||
129885348|NCT02139982|467540666|FG008|Overall Study|Lack of Efficacy|0|||
129885349|NCT02139982|467540667|FG009|Overall Study|Lack of Efficacy|0|||
129885350|NCT04254679|467540678|FG000|Overall Study|Protocol Violation|1|||
129885351|NCT04254679|467540679|FG001|Overall Study|Protocol Violation|1|||
129885352|NCT04254679|467540678|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
129885353|NCT04254679|467540679|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
129885354|NCT02823964|467540680|FG000|Overall Study|Adverse Event|2|||
129885355|NCT02823964|467540680|FG000|Overall Study|Physician Decision|1|||
129885356|NCT02823964|467540680|FG000|Overall Study|Lack of Efficacy|1|||
129885357|NCT02823964|467540680|FG000|Overall Study|Withdrawal by Subject|1|||
129885358|NCT00390455|467540685|FG000|Overall Study|Adverse Event|17|||
129885359|NCT00390455|467540686|FG001|Overall Study|Adverse Event|3|||
129885360|NCT00390455|467540685|FG000|Overall Study|Withdrawal by Subject|8|||
129885361|NCT00390455|467540686|FG001|Overall Study|Withdrawal by Subject|8|||
129885362|NCT00390455|467540685|FG000|Overall Study|Alternate Treatment|0|||
129885363|NCT00390455|467540686|FG001|Overall Study|Alternate Treatment|1|||
129885364|NCT00390455|467540685|FG000|Overall Study|Other Medical Reasons|7|||
129885365|NCT00390455|467540686|FG001|Overall Study|Other Medical Reasons|11|||
129885366|NCT00794820|467540692|FG000|Overall Study|Adverse Event|11|||
129885367|NCT00794820|467540692|FG000|Overall Study|Secondary Malignancies|2|||
129885368|NCT00794820|467540692|FG000|Overall Study|Resistant Disease|2|||
129885369|NCT00794820|467540692|FG000|Overall Study|Ineligible/Screen Failure|1|||
129885370|NCT04076020|467540694|FG000|Overall Study|Death|4|||
129885371|NCT04076020|467540695|FG001|Overall Study|Death|6|||
129885372|NCT04076020|467540694|FG000|Overall Study|Withdrawal by Subject|12|||
129885373|NCT04076020|467540695|FG001|Overall Study|Withdrawal by Subject|8|||
129885374|NCT02500979|467540696|FG000|Period 1|Hyperglycemia|1|||
129885375|NCT02500979|467540697|FG001|Period 1|Hyperglycemia|0|||
129885376|NCT02500979|467540696|FG000|Period 1|Severe non-compliance to protocol|0|||
129587424|NCT03414034|466445520|FG002|Overall Study|Non-compliance With Study Drug|1|||
129587425|NCT03414034|466445518|FG000|Overall Study|Physician Decision|1|||
129587426|NCT03414034|466445519|FG001|Overall Study|Physician Decision|3|||
129587427|NCT03414034|466445520|FG002|Overall Study|Physician Decision|2|||
129587428|NCT03414034|466445518|FG000|Overall Study|Withdrawal of Informed Consent|2|||
129587429|NCT03414034|466445519|FG001|Overall Study|Withdrawal of Informed Consent|1|||
129587430|NCT03414034|466445520|FG002|Overall Study|Withdrawal of Informed Consent|4|||
129587431|NCT03414034|466445518|FG000|Overall Study|Progressive Disease|15|||
129587432|NCT03414034|466445519|FG001|Overall Study|Progressive Disease|15|||
129587433|NCT03414034|466445520|FG002|Overall Study|Progressive Disease|17|||
129587434|NCT03414034|466445518|FG000|Overall Study|Miscellaneous|0|||
129587435|NCT03414034|466445519|FG001|Overall Study|Miscellaneous|0|||
129587436|NCT03414034|466445520|FG002|Overall Study|Miscellaneous|2|||
129587437|NCT04010227|466445522|FG000|Overall Study|Death|1|||
129587438|NCT04010227|466445523|FG001|Overall Study|Death|2|||
129587439|NCT04010227|466445522|FG000|Overall Study|Medical Reasons|4|||
129587440|NCT04010227|466445523|FG001|Overall Study|Medical Reasons|3|||
129587441|NCT04010227|466445522|FG000|Overall Study|Withdrawal by Subject|2|||
129587442|NCT04010227|466445523|FG001|Overall Study|Withdrawal by Subject|0|||
129587443|NCT04010227|466445522|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
129587444|NCT04010227|466445523|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
129885377|NCT02500979|467540697|FG001|Period 1|Severe non-compliance to protocol|1|||
129885378|NCT02500979|467540696|FG000|Period 1|Adverse Event|1|||
129885379|NCT02500979|467540697|FG001|Period 1|Adverse Event|0|||
129885380|NCT02500979|467540696|FG000|Period 1|Subject decision|2|||
129885381|NCT02500979|467540697|FG001|Period 1|Subject decision|0|||
129885382|NCT02500979|467540696|FG000|Period 2|Change in risk|1|||
129885383|NCT02500979|467540697|FG001|Period 2|Change in risk|0|||
129885384|NCT00672958|467540700|FG000|Overall Study|Adverse Event|11|||
129587445|NCT01841073|466445524|FG000|Overall Study|Adverse Event|1|||
129587446|NCT01841073|466445525|FG001|Overall Study|Adverse Event|1|||
129587447|NCT01841073|466445524|FG000|Overall Study|Physician Decision|1|||
129587448|NCT01841073|466445525|FG001|Overall Study|Physician Decision|0|||
129587449|NCT01841073|466445524|FG000|Overall Study|Lost to Follow-up|0|||
129587450|NCT01841073|466445525|FG001|Overall Study|Lost to Follow-up|2|||
129587451|NCT01670097|466445526|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
129587452|NCT01670097|466445527|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
129587453|NCT01670097|466445526|FG000|Overall Study|Study burden|1|||
129587454|NCT01670097|466445527|FG001|Overall Study|Study burden|0|||
129587455|NCT01670097|466445526|FG000|Overall Study|COPD exacerbation|0|||
129587456|NCT01670097|466445527|FG001|Overall Study|COPD exacerbation|1|||
129587457|NCT01670097|466445526|FG000|Overall Study|Neutropenia|0|||
129587458|NCT01670097|466445527|FG001|Overall Study|Neutropenia|1|||
129587459|NCT01670097|466445526|FG000|Overall Study|Clinical deterioration|0|||
129587460|NCT01670097|466445527|FG001|Overall Study|Clinical deterioration|1|||
129587461|NCT01670097|466445526|FG000|Overall Study|Disease progression|0|||
129587462|NCT01670097|466445527|FG001|Overall Study|Disease progression|1|||
129587463|NCT00550147|466445530|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
129587464|NCT00550147|466445530|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
129587465|NCT00550147|466445530|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
129587466|NCT00550147|466445530|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
129885385|NCT00672958|467540701|FG001|Overall Study|Adverse Event|9|||
129587467|NCT00550147|466445530|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
129587468|NCT04320745|466445531|FG000|Overall Study|Adverse Event|26|||
129587469|NCT04320745|466445531|FG000|Overall Study|Withdrawal by Subject|4|||
129587470|NCT04320745|466445531|FG000|Overall Study|Lost to Follow-up|12|||
129587471|NCT04320745|466445531|FG000|Overall Study|Protocol Deviation|2|||
129885386|NCT00672958|467540700|FG000|Overall Study|Lack of Efficacy|6|||
129885387|NCT00672958|467540701|FG001|Overall Study|Lack of Efficacy|11|||
129587472|NCT04320745|466445531|FG000|Overall Study|Non-compliance With Study Drug|2|||
129587473|NCT04320745|466445531|FG000|Overall Study|Reason Not Specified|1|||
129587474|NCT01824498|466445532|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
129587475|NCT01824498|466445533|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
129587476|NCT01824498|466445534|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
129587477|NCT01824498|466445535|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
129587478|NCT01824498|466445536|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
129587479|NCT01824498|466445537|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
129587480|NCT01277510|466445538|FG000|Double-blind Phase|Non-compliance|0|||
129587481|NCT01277510|466445539|FG001|Double-blind Phase|Non-compliance|1|||
129696154|NCT00215657|466845948|FG000|Overall Study|Insufficient testosterone response|5|||
129587482|NCT01277510|466445538|FG000|Double-blind Phase|Adverse Event|1|||
129587483|NCT01277510|466445539|FG001|Double-blind Phase|Adverse Event|0|||
129587484|NCT01277510|466445538|FG000|Double-blind Phase|Withdrawal by Subject|2|||
129587485|NCT01277510|466445539|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129587486|NCT01277510|466445538|FG000|Double-blind Phase|Administrative decision|7|||
129587487|NCT01277510|466445539|FG001|Double-blind Phase|Administrative decision|9|||
129587488|NCT01277510|466445538|FG000|Double-blind Phase|Death|0|||
129587489|NCT01277510|466445539|FG001|Double-blind Phase|Death|1|||
129587490|NCT01277510|466445538|FG000|Double-blind Phase|Protocol-specified criteria|2|||
129587491|NCT01277510|466445539|FG001|Double-blind Phase|Protocol-specified criteria|6|||
129587492|NCT01277510|466445538|FG000|Double-blind Phase|Other|1|||
129587493|NCT01277510|466445539|FG001|Double-blind Phase|Other|1|||
129587494|NCT01277510|466445538|FG000|Open-label Phase|Administrative decision|4|||
129587495|NCT01277510|466445539|FG001|Open-label Phase|Administrative decision|3|||
129587496|NCT01277510|466445538|FG000|Open-label Phase|Protocol-specified criteria|1|||
129587497|NCT01277510|466445539|FG001|Open-label Phase|Protocol-specified criteria|0|||
129587498|NCT01277510|466445538|FG000|Open-label Phase|Never received investigational product|2|||
129587499|NCT01277510|466445539|FG001|Open-label Phase|Never received investigational product|0|||
129587500|NCT01685008|466445540|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
129587501|NCT01685008|466445541|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
129587502|NCT01685008|466445542|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
129587503|NCT01685008|466445543|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
129587504|NCT01685008|466445540|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
129587505|NCT01685008|466445541|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
129587506|NCT01685008|466445542|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
129587507|NCT01685008|466445543|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
129587508|NCT01685008|466445540|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
129587509|NCT01685008|466445541|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
129587510|NCT01685008|466445542|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
129587511|NCT01685008|466445543|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
129696155|NCT00215657|466845949|FG001|Overall Study|Insufficient testosterone response|4|||
129696156|NCT00215657|466845950|FG002|Overall Study|Insufficient testosterone response|1|||
129696157|NCT00215657|466845951|FG003|Overall Study|Insufficient testosterone response|12|||
129696158|NCT00215657|466845952|FG004|Overall Study|Insufficient testosterone response|8|||
129587512|NCT01685008|466445540|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
129696159|NCT00215657|466845953|FG005|Overall Study|Insufficient testosterone response|12|||
129696160|NCT00215657|466845954|FG006|Overall Study|Insufficient testosterone response|4|||
129696161|NCT00215657|466845955|FG007|Overall Study|Insufficient testosterone response|7|||
129587513|NCT01685008|466445541|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
129587514|NCT01685008|466445542|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
129587515|NCT01685008|466445543|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
129587516|NCT01685008|466445540|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
129587517|NCT01685008|466445541|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
129587518|NCT01685008|466445542|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
129587519|NCT01685008|466445543|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
129587520|NCT00160524|466445546|FG000|Overall Study|Adverse Event|119|||
129587521|NCT00160524|466445546|FG000|Overall Study|Adverse Event and Other|94|||
129587522|NCT00160524|466445546|FG000|Overall Study|Protocol Violation|16|||
129587523|NCT00160524|466445546|FG000|Overall Study|Protocol Violation and Other|2|||
129587524|NCT00160524|466445546|FG000|Overall Study|Withdrawal by Subject|141|||
129587525|NCT00160524|466445546|FG000|Overall Study|Withdrawal by Subject and Other|17|||
129587526|NCT00160524|466445546|FG000|Overall Study|Physician Decision|27|||
129587527|NCT00160524|466445546|FG000|Overall Study|Physician Decision and Other|6|||
129587528|NCT00160524|466445546|FG000|Overall Study|Lost to Follow-up|13|||
129587529|NCT00160524|466445546|FG000|Overall Study|Lost to Follow-up and Other|1|||
129587530|NCT00160524|466445546|FG000|Overall Study|Lack of Efficacy|21|||
129587531|NCT00160524|466445546|FG000|Overall Study|Lack of Efficacy and Other|1|||
129587532|NCT00160524|466445546|FG000|Overall Study|Other|20|||
129587533|NCT05263505|466445547|FG000|Overall Study|Adverse Event|0|||
129587534|NCT05263505|466445548|FG001|Overall Study|Adverse Event|1|||
129587535|NCT01898598|466445550|FG000|Overall Study|Adverse Event|1|||
129696162|NCT00215657|466845948|FG000|Overall Study|Other|3|||
129696163|NCT00215657|466845949|FG001|Overall Study|Other|1|||
129587536|NCT01898598|466445551|FG001|Overall Study|Adverse Event|0|||
129587537|NCT01898598|466445550|FG000|Overall Study|Withdrawal by Subject|3|||
129587538|NCT01898598|466445551|FG001|Overall Study|Withdrawal by Subject|0|||
129587539|NCT01898598|466445550|FG000|Overall Study|Lost to Follow-up|0|||
129587540|NCT01898598|466445551|FG001|Overall Study|Lost to Follow-up|1|||
129587541|NCT01898598|466445550|FG000|Overall Study|Other|0|||
129587542|NCT01898598|466445551|FG001|Overall Study|Other|1|||
129587543|NCT03833427|466445552|FG000|Overall Study|Death|4|||
129587544|NCT03833427|466445553|FG001|Overall Study|Death|2|||
129587545|NCT03833427|466445554|FG002|Overall Study|Death|9|||
129587546|NCT03833427|466445555|FG003|Overall Study|Death|11|||
129587547|NCT03833427|466445556|FG004|Overall Study|Death|0|||
129587548|NCT03833427|466445557|FG005|Overall Study|Death|0|||
129587549|NCT03833427|466445558|FG006|Overall Study|Death|0|||
129587550|NCT03833427|466445552|FG000|Overall Study|Withdrawal by Subject|0|||
129587551|NCT03833427|466445553|FG001|Overall Study|Withdrawal by Subject|1|||
129587552|NCT03833427|466445554|FG002|Overall Study|Withdrawal by Subject|1|||
129587553|NCT03833427|466445555|FG003|Overall Study|Withdrawal by Subject|0|||
129587554|NCT03833427|466445556|FG004|Overall Study|Withdrawal by Subject|0|||
129587555|NCT03833427|466445557|FG005|Overall Study|Withdrawal by Subject|0|||
129587556|NCT03833427|466445558|FG006|Overall Study|Withdrawal by Subject|0|||
129587557|NCT03833427|466445552|FG000|Overall Study|Sponsor Decision|0|||
129587558|NCT03833427|466445553|FG001|Overall Study|Sponsor Decision|0|||
129587559|NCT03833427|466445554|FG002|Overall Study|Sponsor Decision|1|||
129587560|NCT03833427|466445555|FG003|Overall Study|Sponsor Decision|3|||
129587561|NCT03833427|466445556|FG004|Overall Study|Sponsor Decision|0|||
129587562|NCT03833427|466445557|FG005|Overall Study|Sponsor Decision|0|||
129587563|NCT03833427|466445558|FG006|Overall Study|Sponsor Decision|0|||
129587564|NCT01499160|466445563|FG000|Overall Study|Adverse Event|1|||
129587565|NCT01499160|466445563|FG000|Overall Study|Withdrawal by Subject|1|||
129587566|NCT03448692|466445564|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
129587567|NCT03448692|466445565|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
129587568|NCT03448692|466445564|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
129587569|NCT03448692|466445565|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
129587570|NCT03448692|466445564|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
129587571|NCT03448692|466445565|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
129587572|NCT03448692|466445564|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
129587573|NCT03448692|466445565|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
129587574|NCT03448692|466445564|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
129587575|NCT03448692|466445565|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
129587576|NCT00593827|466445568|FG000|Overall Study|On Active Treatment/Pending|0|||
129587577|NCT00593827|466445569|FG001|Overall Study|On Active Treatment/Pending|2|||
129587578|NCT00663234|466445570|FG000|Overall Study|Not willing to adhere to requirements|1|||
129587579|NCT01709903|466445573|FG000|Overall Study|administrative problems|2|||
129587580|NCT01709903|466445574|FG001|Overall Study|administrative problems|6|||
129587581|NCT01709903|466445573|FG000|Overall Study|Abnormal test procedure results|1|||
129587582|NCT01709903|466445574|FG001|Overall Study|Abnormal test procedure results|0|||
129587583|NCT01709903|466445573|FG000|Overall Study|In ability to use device|1|||
129587584|NCT01709903|466445574|FG001|Overall Study|In ability to use device|1|||
129587585|NCT01709903|466445573|FG000|Overall Study|no longer needed study drug|0|||
129587586|NCT01709903|466445574|FG001|Overall Study|no longer needed study drug|1|||
129587587|NCT01709903|466445573|FG000|Overall Study|Lost to Follow-up|0|||
129587588|NCT01709903|466445574|FG001|Overall Study|Lost to Follow-up|2|||
129587589|NCT01709903|466445573|FG000|Overall Study|Death|2|||
129587590|NCT01709903|466445574|FG001|Overall Study|Death|0|||
129587591|NCT01709903|466445573|FG000|Overall Study|Protocol Violation|3|||
129587592|NCT01709903|466445574|FG001|Overall Study|Protocol Violation|2|||
129587593|NCT01709903|466445573|FG000|Overall Study|Lack of Efficacy|3|||
129587594|NCT01709903|466445574|FG001|Overall Study|Lack of Efficacy|3|||
129587595|NCT01709903|466445573|FG000|Overall Study|Withdrawal by Subject|6|||
129587596|NCT01709903|466445574|FG001|Overall Study|Withdrawal by Subject|6|||
129587597|NCT01709903|466445573|FG000|Overall Study|Adverse Event|11|||
129587598|NCT01709903|466445574|FG001|Overall Study|Adverse Event|18|||
129587599|NCT02710214|466447505|FG000|Overall Study|Lost to Follow-up|1|||
129587600|NCT02710214|466447506|FG001|Overall Study|Lost to Follow-up|0|||
129587601|NCT02710214|466447505|FG000|Overall Study|Lack of Efficacy|0|||
129587602|NCT02710214|466447506|FG001|Overall Study|Lack of Efficacy|1|||
129587603|NCT02710214|466447505|FG000|Overall Study|Death|0|||
129587604|NCT02710214|466447506|FG001|Overall Study|Death|1|||
129587605|NCT01188226|466447510|FG000|Overall Study|Withdrawal by Subject|4|||
129587606|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
129587607|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
129587608|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
129587609|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
129587610|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
129587611|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
129587612|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
129587613|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
129587614|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
129587615|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
129587616|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
129587617|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
129587618|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
129587619|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
129587620|NCT04592419|466447514|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
129587621|NCT04592419|466447515|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
129587622|NCT04592419|466447514|FG000|Open-Label Extension Period|Adverse Event|1|||
129587623|NCT04592419|466447515|FG001|Open-Label Extension Period|Adverse Event|2|||
129587624|NCT04592419|466447514|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
129587625|NCT04592419|466447515|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
129587626|NCT04592419|466447514|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
129587627|NCT04592419|466447515|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
129587628|NCT04592419|466447514|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
129587629|NCT04592419|466447515|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
129587630|NCT04592419|466447514|FG000|Open-Label Extension Period|Sponsor Request|73|||
129587631|NCT04592419|466447515|FG001|Open-Label Extension Period|Sponsor Request|84|||
129587632|NCT01408888|466447532|FG000|First Intervention|Adverse Event|0|||
129587633|NCT01408888|466447533|FG001|First Intervention|Adverse Event|1|||
129587634|NCT01408888|466447532|FG000|First Intervention|Withdrawal by Subject|0|||
129587635|NCT01408888|466447533|FG001|First Intervention|Withdrawal by Subject|2|||
129587636|NCT01408888|466447532|FG000|Second Intervention|Withdrawal by Subject|1|||
129587637|NCT01408888|466447533|FG001|Second Intervention|Withdrawal by Subject|0|||
129587638|NCT01408888|466447532|FG000|Second Intervention|Adverse Event|1|||
129587639|NCT01408888|466447533|FG001|Second Intervention|Adverse Event|0|||
129587640|NCT00695110|466447536|FG000|Treatment Period 1|Adverse Event|1|||
129587641|NCT00695110|466447536|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129587642|NCT00695110|466447536|FG000|Treatment Period 3|Withdrawal by Subject|1|||
129587643|NCT00695110|466447536|FG000|Treatment Period 4|Adverse Event|1|||
129587644|NCT00969124|466447539|FG000|Overall Study|Protocol Violation|2|||
129587645|NCT00969124|466447539|FG000|Overall Study|Inadequate bowel preparation|15|||
129587646|NCT00969124|466447539|FG000|Overall Study|Inability to reach cecum|9|||
129587647|NCT00969124|466447539|FG000|Overall Study|Previously unrecognized disease|3|||
129587648|NCT00969124|466447539|FG000|Overall Study|Technical error|1|||
129587649|NCT00611884|466447540|FG000|Overall Study|Adverse Event|1|||
129587650|NCT00611884|466447541|FG001|Overall Study|Adverse Event|0|||
129587651|NCT00611884|466447542|FG002|Overall Study|Adverse Event|0|||
129587652|NCT00611884|466447543|FG003|Overall Study|Adverse Event|1|||
129587653|NCT00611884|466447540|FG000|Overall Study|Non-Compliance|1|||
129587654|NCT00611884|466447541|FG001|Overall Study|Non-Compliance|4|||
129587655|NCT00611884|466447542|FG002|Overall Study|Non-Compliance|2|||
129587656|NCT00611884|466447543|FG003|Overall Study|Non-Compliance|2|||
129587657|NCT00611884|466447540|FG000|Overall Study|Lack of Efficacy|0|||
129587658|NCT00611884|466447541|FG001|Overall Study|Lack of Efficacy|1|||
129587659|NCT00611884|466447542|FG002|Overall Study|Lack of Efficacy|0|||
129587660|NCT00611884|466447543|FG003|Overall Study|Lack of Efficacy|0|||
129587661|NCT00611884|466447540|FG000|Overall Study|Unclassified|7|||
129587662|NCT00611884|466447541|FG001|Overall Study|Unclassified|4|||
129587663|NCT00611884|466447542|FG002|Overall Study|Unclassified|2|||
129587664|NCT00611884|466447543|FG003|Overall Study|Unclassified|3|||
129587665|NCT00981799|466447544|FG000|Overall Study|Adverse Event|1|||
129587666|NCT00981799|466447545|FG001|Overall Study|Adverse Event|1|||
129587667|NCT00981799|466447546|FG002|Overall Study|Adverse Event|0|||
129587668|NCT00981799|466447547|FG003|Overall Study|Adverse Event|0|||
129587669|NCT00687739|466447548|FG000|Overall Study|Lost to Follow-up|2|||
129587670|NCT00687739|466447549|FG001|Overall Study|Lost to Follow-up|2|||
129587671|NCT00687739|466447550|FG002|Overall Study|Lost to Follow-up|1|||
129587672|NCT00687739|466447551|FG003|Overall Study|Lost to Follow-up|2|||
129587673|NCT00687739|466447548|FG000|Overall Study|Adverse Event|0|||
129587674|NCT00687739|466447549|FG001|Overall Study|Adverse Event|1|||
129587675|NCT00687739|466447550|FG002|Overall Study|Adverse Event|1|||
129587676|NCT00687739|466447551|FG003|Overall Study|Adverse Event|0|||
129587677|NCT01190930|466447553|FG000|Induction|Adverse Event|17|||
129587678|NCT01190930|466447554|FG001|Induction|Adverse Event|0|||
129587679|NCT01190930|466447555|FG002|Induction|Adverse Event|0|||
129587680|NCT01190930|466447556|FG003|Induction|Adverse Event|0|||
129587681|NCT01190930|466447557|FG004|Induction|Adverse Event|0|||
129587682|NCT01190930|466447558|FG005|Induction|Adverse Event|0|||
129587683|NCT01190930|466447559|FG006|Induction|Adverse Event|0|||
129587684|NCT01190930|466447560|FG007|Induction|Adverse Event|0|||
129587685|NCT01190930|466447561|FG008|Induction|Adverse Event|0|||
129587686|NCT01190930|466447562|FG009|Induction|Adverse Event|0|||
129587687|NCT01190930|466447553|FG000|Induction|Death|34|||
129587688|NCT01190930|466447554|FG001|Induction|Death|0|||
129587689|NCT01190930|466447555|FG002|Induction|Death|0|||
129587690|NCT01190930|466447556|FG003|Induction|Death|0|||
129587691|NCT01190930|466447557|FG004|Induction|Death|0|||
129587692|NCT01190930|466447558|FG005|Induction|Death|0|||
129587693|NCT01190930|466447559|FG006|Induction|Death|0|||
129587694|NCT01190930|466447560|FG007|Induction|Death|0|||
129587695|NCT01190930|466447561|FG008|Induction|Death|0|||
129587696|NCT01190930|466447562|FG009|Induction|Death|0|||
129587697|NCT01190930|466447553|FG000|Induction|Lost to Follow-up|1|||
129587698|NCT01190930|466447554|FG001|Induction|Lost to Follow-up|0|||
129587699|NCT01190930|466447555|FG002|Induction|Lost to Follow-up|0|||
129587700|NCT01190930|466447556|FG003|Induction|Lost to Follow-up|0|||
129587701|NCT01190930|466447557|FG004|Induction|Lost to Follow-up|0|||
129587702|NCT01190930|466447558|FG005|Induction|Lost to Follow-up|0|||
129587703|NCT01190930|466447559|FG006|Induction|Lost to Follow-up|0|||
129587704|NCT01190930|466447560|FG007|Induction|Lost to Follow-up|0|||
129587705|NCT01190930|466447561|FG008|Induction|Lost to Follow-up|0|||
129587706|NCT01190930|466447562|FG009|Induction|Lost to Follow-up|0|||
129587707|NCT01190930|466447553|FG000|Induction|Physician Decision|125|||
129587708|NCT01190930|466447554|FG001|Induction|Physician Decision|3|||
129587709|NCT01190930|466447555|FG002|Induction|Physician Decision|0|||
129587710|NCT01190930|466447556|FG003|Induction|Physician Decision|0|||
129587711|NCT01190930|466447557|FG004|Induction|Physician Decision|0|||
129587712|NCT01190930|466447558|FG005|Induction|Physician Decision|0|||
129587713|NCT01190930|466447559|FG006|Induction|Physician Decision|0|||
129587714|NCT01190930|466447560|FG007|Induction|Physician Decision|0|||
129587715|NCT01190930|466447561|FG008|Induction|Physician Decision|0|||
129587716|NCT01190930|466447562|FG009|Induction|Physician Decision|0|||
129587717|NCT01190930|466447553|FG000|Induction|Withdrawal by Subject|9|||
129587718|NCT01190930|466447554|FG001|Induction|Withdrawal by Subject|0|||
129587719|NCT01190930|466447555|FG002|Induction|Withdrawal by Subject|0|||
129587720|NCT01190930|466447556|FG003|Induction|Withdrawal by Subject|0|||
129587721|NCT01190930|466447557|FG004|Induction|Withdrawal by Subject|0|||
129587722|NCT01190930|466447558|FG005|Induction|Withdrawal by Subject|0|||
129587723|NCT01190930|466447559|FG006|Induction|Withdrawal by Subject|0|||
129587724|NCT01190930|466447560|FG007|Induction|Withdrawal by Subject|0|||
129587725|NCT01190930|466447561|FG008|Induction|Withdrawal by Subject|0|||
129587726|NCT01190930|466447562|FG009|Induction|Withdrawal by Subject|0|||
129587727|NCT01190930|466447553|FG000|Induction|Refusal|235|||
129587728|NCT01190930|466447554|FG001|Induction|Refusal|0|||
129587729|NCT01190930|466447555|FG002|Induction|Refusal|0|||
129587730|NCT01190930|466447556|FG003|Induction|Refusal|0|||
129587731|NCT01190930|466447557|FG004|Induction|Refusal|0|||
129587732|NCT01190930|466447558|FG005|Induction|Refusal|0|||
129587733|NCT01190930|466447559|FG006|Induction|Refusal|0|||
129587734|NCT01190930|466447560|FG007|Induction|Refusal|0|||
129587735|NCT01190930|466447561|FG008|Induction|Refusal|0|||
129587736|NCT01190930|466447562|FG009|Induction|Refusal|0|||
129587737|NCT01190930|466447553|FG000|Induction|Inevaluable|23|||
129587738|NCT01190930|466447554|FG001|Induction|Inevaluable|1|||
129587739|NCT01190930|466447555|FG002|Induction|Inevaluable|0|||
129587740|NCT01190930|466447556|FG003|Induction|Inevaluable|0|||
129587741|NCT01190930|466447557|FG004|Induction|Inevaluable|0|||
129587742|NCT01190930|466447558|FG005|Induction|Inevaluable|0|||
129587743|NCT01190930|466447559|FG006|Induction|Inevaluable|0|||
129587744|NCT01190930|466447560|FG007|Induction|Inevaluable|0|||
129587745|NCT01190930|466447561|FG008|Induction|Inevaluable|0|||
129587746|NCT01190930|466447562|FG009|Induction|Inevaluable|0|||
129587747|NCT01190930|466447553|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
129587748|NCT01190930|466447554|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587749|NCT01190930|466447555|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587750|NCT01190930|466447556|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587751|NCT01190930|466447557|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587752|NCT01190930|466447558|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587753|NCT01190930|466447559|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587754|NCT01190930|466447560|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587755|NCT01190930|466447561|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587756|NCT01190930|466447562|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
129587757|NCT01190930|466447553|FG000|Induction|High Risk Downs|80|||
129587758|NCT01190930|466447554|FG001|Induction|High Risk Downs|0|||
129587759|NCT01190930|466447555|FG002|Induction|High Risk Downs|0|||
129587760|NCT01190930|466447556|FG003|Induction|High Risk Downs|0|||
129587761|NCT01190930|466447557|FG004|Induction|High Risk Downs|0|||
129587762|NCT01190930|466447558|FG005|Induction|High Risk Downs|0|||
129587763|NCT01190930|466447559|FG006|Induction|High Risk Downs|0|||
129587764|NCT01190930|466447560|FG007|Induction|High Risk Downs|0|||
129587765|NCT01190930|466447561|FG008|Induction|High Risk Downs|0|||
129587766|NCT01190930|466447562|FG009|Induction|High Risk Downs|0|||
129587767|NCT01190930|466447553|FG000|Induction|Enrollment onto another COG Protocol|1|||
129587768|NCT01190930|466447554|FG001|Induction|Enrollment onto another COG Protocol|0|||
129587769|NCT01190930|466447555|FG002|Induction|Enrollment onto another COG Protocol|0|||
129587770|NCT01190930|466447556|FG003|Induction|Enrollment onto another COG Protocol|0|||
129587771|NCT01190930|466447557|FG004|Induction|Enrollment onto another COG Protocol|0|||
129587772|NCT01190930|466447558|FG005|Induction|Enrollment onto another COG Protocol|0|||
129587773|NCT01190930|466447559|FG006|Induction|Enrollment onto another COG Protocol|0|||
129587774|NCT01190930|466447560|FG007|Induction|Enrollment onto another COG Protocol|0|||
129587775|NCT01190930|466447561|FG008|Induction|Enrollment onto another COG Protocol|0|||
129587776|NCT01190930|466447562|FG009|Induction|Enrollment onto another COG Protocol|0|||
129587777|NCT01190930|466447553|FG000|Induction|Average Risk|1847|||
129587778|NCT01190930|466447554|FG001|Induction|Average Risk|0|||
129587779|NCT01190930|466447555|FG002|Induction|Average Risk|0|||
129587780|NCT01190930|466447556|FG003|Induction|Average Risk|0|||
129587781|NCT01190930|466447557|FG004|Induction|Average Risk|0|||
129587782|NCT01190930|466447558|FG005|Induction|Average Risk|0|||
129587783|NCT01190930|466447559|FG006|Induction|Average Risk|0|||
129587784|NCT01190930|466447560|FG007|Induction|Average Risk|0|||
129587785|NCT01190930|466447561|FG008|Induction|Average Risk|0|||
129587786|NCT01190930|466447562|FG009|Induction|Average Risk|0|||
129587787|NCT01190930|466447553|FG000|Induction|High Risk|1227|||
129587788|NCT01190930|466447554|FG001|Induction|High Risk|0|||
129587789|NCT01190930|466447555|FG002|Induction|High Risk|0|||
129587790|NCT01190930|466447556|FG003|Induction|High Risk|0|||
129587791|NCT01190930|466447557|FG004|Induction|High Risk|0|||
129587792|NCT01190930|466447558|FG005|Induction|High Risk|0|||
129587793|NCT01190930|466447559|FG006|Induction|High Risk|0|||
129587794|NCT01190930|466447560|FG007|Induction|High Risk|0|||
129587795|NCT01190930|466447561|FG008|Induction|High Risk|0|||
129587796|NCT01190930|466447562|FG009|Induction|High Risk|0|||
129587797|NCT01190930|466447553|FG000|Induction|Low Risk|443|||
129587798|NCT01190930|466447554|FG001|Induction|Low Risk|0|||
129587799|NCT01190930|466447555|FG002|Induction|Low Risk|0|||
129587800|NCT01190930|466447556|FG003|Induction|Low Risk|0|||
129587801|NCT01190930|466447557|FG004|Induction|Low Risk|0|||
129587802|NCT01190930|466447558|FG005|Induction|Low Risk|0|||
129587803|NCT01190930|466447559|FG006|Induction|Low Risk|0|||
129587804|NCT01190930|466447560|FG007|Induction|Low Risk|0|||
129587805|NCT01190930|466447561|FG008|Induction|Low Risk|0|||
129587806|NCT01190930|466447562|FG009|Induction|Low Risk|0|||
129587807|NCT01190930|466447553|FG000|Induction|Very High Risk|1012|||
129587808|NCT01190930|466447554|FG001|Induction|Very High Risk|0|||
129587809|NCT01190930|466447555|FG002|Induction|Very High Risk|0|||
129587810|NCT01190930|466447556|FG003|Induction|Very High Risk|0|||
129587811|NCT01190930|466447557|FG004|Induction|Very High Risk|0|||
129587812|NCT01190930|466447558|FG005|Induction|Very High Risk|0|||
129587813|NCT01190930|466447559|FG006|Induction|Very High Risk|0|||
129587814|NCT01190930|466447560|FG007|Induction|Very High Risk|0|||
129587815|NCT01190930|466447561|FG008|Induction|Very High Risk|0|||
129587816|NCT01190930|466447562|FG009|Induction|Very High Risk|0|||
129587817|NCT01190930|466447553|FG000|Induction|Philadelphia chromosome-positive|99|||
129587818|NCT01190930|466447554|FG001|Induction|Philadelphia chromosome-positive|0|||
129587819|NCT01190930|466447555|FG002|Induction|Philadelphia chromosome-positive|0|||
129587820|NCT01190930|466447556|FG003|Induction|Philadelphia chromosome-positive|0|||
129587821|NCT01190930|466447557|FG004|Induction|Philadelphia chromosome-positive|0|||
129587822|NCT01190930|466447558|FG005|Induction|Philadelphia chromosome-positive|0|||
129587823|NCT01190930|466447559|FG006|Induction|Philadelphia chromosome-positive|0|||
129587824|NCT01190930|466447560|FG007|Induction|Philadelphia chromosome-positive|0|||
129587825|NCT01190930|466447561|FG008|Induction|Philadelphia chromosome-positive|0|||
129587826|NCT01190930|466447562|FG009|Induction|Philadelphia chromosome-positive|0|||
129587827|NCT01190930|466447553|FG000|Induction|Incomplete Induction data|63|||
129587828|NCT01190930|466447554|FG001|Induction|Incomplete Induction data|0|||
129587829|NCT01190930|466447555|FG002|Induction|Incomplete Induction data|0|||
129587830|NCT01190930|466447556|FG003|Induction|Incomplete Induction data|0|||
129587831|NCT01190930|466447557|FG004|Induction|Incomplete Induction data|0|||
129587832|NCT01190930|466447558|FG005|Induction|Incomplete Induction data|0|||
129587833|NCT01190930|466447559|FG006|Induction|Incomplete Induction data|0|||
129587834|NCT01190930|466447560|FG007|Induction|Incomplete Induction data|0|||
129587835|NCT01190930|466447561|FG008|Induction|Incomplete Induction data|0|||
129587836|NCT01190930|466447562|FG009|Induction|Incomplete Induction data|0|||
129587837|NCT01190930|466447553|FG000|Induction|Progressive disease|0|||
129587838|NCT01190930|466447554|FG001|Induction|Progressive disease|1|||
129587839|NCT01190930|466447555|FG002|Induction|Progressive disease|0|||
129587840|NCT01190930|466447556|FG003|Induction|Progressive disease|0|||
129587841|NCT01190930|466447557|FG004|Induction|Progressive disease|0|||
129587842|NCT01190930|466447558|FG005|Induction|Progressive disease|0|||
129587843|NCT01190930|466447559|FG006|Induction|Progressive disease|0|||
129587844|NCT01190930|466447560|FG007|Induction|Progressive disease|0|||
129587845|NCT01190930|466447561|FG008|Induction|Progressive disease|0|||
129587846|NCT01190930|466447562|FG009|Induction|Progressive disease|0|||
129587847|NCT01190930|466447553|FG000|Induction|No treatment|3|||
129587848|NCT01190930|466447554|FG001|Induction|No treatment|0|||
129587849|NCT01190930|466447555|FG002|Induction|No treatment|0|||
129587850|NCT01190930|466447556|FG003|Induction|No treatment|0|||
129587851|NCT01190930|466447557|FG004|Induction|No treatment|0|||
129587852|NCT01190930|466447558|FG005|Induction|No treatment|0|||
129587853|NCT01190930|466447559|FG006|Induction|No treatment|0|||
129587854|NCT01190930|466447560|FG007|Induction|No treatment|0|||
129587855|NCT01190930|466447561|FG008|Induction|No treatment|0|||
129587856|NCT01190930|466447562|FG009|Induction|No treatment|0|||
129587857|NCT01190930|466447553|FG000|Induction|Ineligible|69|||
129587858|NCT01190930|466447554|FG001|Induction|Ineligible|4|||
129587859|NCT01190930|466447555|FG002|Induction|Ineligible|0|||
129587860|NCT01190930|466447556|FG003|Induction|Ineligible|0|||
129587861|NCT01190930|466447557|FG004|Induction|Ineligible|0|||
129587862|NCT01190930|466447558|FG005|Induction|Ineligible|0|||
129587863|NCT01190930|466447559|FG006|Induction|Ineligible|0|||
129587864|NCT01190930|466447560|FG007|Induction|Ineligible|0|||
129587865|NCT01190930|466447561|FG008|Induction|Ineligible|0|||
129587866|NCT01190930|466447562|FG009|Induction|Ineligible|0|||
129587867|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
129587868|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
129587869|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
129587870|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
129587871|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
129587872|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
129587873|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
129587874|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
129587875|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
129587876|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
129587877|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Death|0|||
129587878|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Death|0|||
129587879|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Death|8|||
129587880|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Death|4|||
129587881|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Death|0|||
129587882|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Death|0|||
129587883|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Death|0|||
129587884|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Death|0|||
129587885|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Death|0|||
129587886|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Death|0|||
129885388|NCT00672958|467540700|FG000|Overall Study|Non-compliance with study drug|2|||
129885389|NCT00672958|467540701|FG001|Overall Study|Non-compliance with study drug|3|||
129885390|NCT00672958|467540700|FG000|Overall Study|Protocol deviations|11|||
129885391|NCT00672958|467540701|FG001|Overall Study|Protocol deviations|5|||
129885392|NCT00672958|467540700|FG000|Overall Study|Voluntary withdrawal|12|||
129885393|NCT00672958|467540701|FG001|Overall Study|Voluntary withdrawal|8|||
129885394|NCT00672958|467540700|FG000|Overall Study|Lost to Follow-up|22|||
129885395|NCT00672958|467540701|FG001|Overall Study|Lost to Follow-up|17|||
129885396|NCT00672958|467540700|FG000|Overall Study|Reason not specified|0|||
129885397|NCT00672958|467540701|FG001|Overall Study|Reason not specified|3|||
129885398|NCT01380990|467540702|FG000|Overall Study|Treatment Failure|1|||
129885399|NCT01380990|467540703|FG001|Overall Study|Treatment Failure|0|||
129885400|NCT01380990|467540702|FG000|Overall Study|Death|0|||
129885401|NCT01380990|467540703|FG001|Overall Study|Death|1|||
129885402|NCT01313923|467540710|FG000|Overall Study|Physician Decision|3|||
129885403|NCT02471404|467540711|FG000|Overall Study|Adverse Event|7|||
129885404|NCT02471404|467540712|FG001|Overall Study|Adverse Event|1|||
129587887|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
129587888|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
129587889|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
129587890|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
129885405|NCT02471404|467540713|FG002|Overall Study|Adverse Event|2|||
129885406|NCT02471404|467540711|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
129885407|NCT02471404|467540712|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
129885408|NCT02471404|467540713|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
129885409|NCT02471404|467540711|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
129885410|NCT02471404|467540712|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129885411|NCT02471404|467540713|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
129587891|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
129587892|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
129587893|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
129587894|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
129587895|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
129587896|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
129587897|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587898|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
129587899|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
129587900|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
129587901|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587902|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587903|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587904|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587905|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587906|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
129587907|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Refusal|0|||
129587908|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Refusal|2|||
129587909|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Refusal|694|||
129587910|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Refusal|4|||
129587911|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Refusal|0|||
129587912|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Refusal|3|||
129587913|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Refusal|0|||
129587914|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Refusal|0|||
129587915|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Refusal|0|||
129587916|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Refusal|0|||
129587917|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
129587918|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
129587919|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
129587920|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
129587921|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
129587922|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
129587923|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
129587924|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
129587925|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
129587926|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
129587927|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587928|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
129587929|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587930|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587931|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587932|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587933|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587934|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587935|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587936|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
129587937|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
129587938|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
129587939|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
129587940|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
129587941|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
129587942|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
129587943|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
129587944|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
129587945|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
129885412|NCT02471404|467540711|FG000|Overall Study|Lost to Follow-up|1|||
129587946|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
129587947|NCT01190930|466447553|FG000|Post Induction Pre-Maintenance|Relapse|0|||
129587948|NCT01190930|466447554|FG001|Post Induction Pre-Maintenance|Relapse|0|||
129587949|NCT01190930|466447555|FG002|Post Induction Pre-Maintenance|Relapse|1|||
129587950|NCT01190930|466447556|FG003|Post Induction Pre-Maintenance|Relapse|0|||
129587951|NCT01190930|466447557|FG004|Post Induction Pre-Maintenance|Relapse|0|||
129587952|NCT01190930|466447558|FG005|Post Induction Pre-Maintenance|Relapse|0|||
129587953|NCT01190930|466447559|FG006|Post Induction Pre-Maintenance|Relapse|0|||
129587954|NCT01190930|466447560|FG007|Post Induction Pre-Maintenance|Relapse|0|||
129587955|NCT01190930|466447561|FG008|Post Induction Pre-Maintenance|Relapse|0|||
129587956|NCT01190930|466447562|FG009|Post Induction Pre-Maintenance|Relapse|0|||
129587957|NCT01190930|466447553|FG000|Maintenance|Adverse Event|0|||
129587958|NCT01190930|466447554|FG001|Maintenance|Adverse Event|0|||
129587959|NCT01190930|466447555|FG002|Maintenance|Adverse Event|0|||
129587960|NCT01190930|466447556|FG003|Maintenance|Adverse Event|0|||
129587961|NCT01190930|466447557|FG004|Maintenance|Adverse Event|0|||
129587962|NCT01190930|466447558|FG005|Maintenance|Adverse Event|1|||
129587963|NCT01190930|466447559|FG006|Maintenance|Adverse Event|1|||
129587964|NCT01190930|466447560|FG007|Maintenance|Adverse Event|3|||
129587965|NCT01190930|466447561|FG008|Maintenance|Adverse Event|3|||
129587966|NCT01190930|466447562|FG009|Maintenance|Adverse Event|0|||
129587967|NCT01190930|466447553|FG000|Maintenance|Death|0|||
129587968|NCT01190930|466447554|FG001|Maintenance|Death|0|||
129587969|NCT01190930|466447555|FG002|Maintenance|Death|0|||
129587970|NCT01190930|466447556|FG003|Maintenance|Death|1|||
129587971|NCT01190930|466447557|FG004|Maintenance|Death|0|||
129587972|NCT01190930|466447558|FG005|Maintenance|Death|0|||
129587973|NCT01190930|466447559|FG006|Maintenance|Death|2|||
129587974|NCT01190930|466447560|FG007|Maintenance|Death|2|||
129587975|NCT01190930|466447561|FG008|Maintenance|Death|2|||
129587976|NCT01190930|466447562|FG009|Maintenance|Death|2|||
129587977|NCT01190930|466447553|FG000|Maintenance|Lost to Follow-up|0|||
129587978|NCT01190930|466447554|FG001|Maintenance|Lost to Follow-up|0|||
129587979|NCT01190930|466447555|FG002|Maintenance|Lost to Follow-up|0|||
129587980|NCT01190930|466447556|FG003|Maintenance|Lost to Follow-up|0|||
129587981|NCT01190930|466447557|FG004|Maintenance|Lost to Follow-up|0|||
129587982|NCT01190930|466447558|FG005|Maintenance|Lost to Follow-up|0|||
129587983|NCT01190930|466447559|FG006|Maintenance|Lost to Follow-up|1|||
129587984|NCT01190930|466447560|FG007|Maintenance|Lost to Follow-up|1|||
129587985|NCT01190930|466447561|FG008|Maintenance|Lost to Follow-up|1|||
129587986|NCT01190930|466447562|FG009|Maintenance|Lost to Follow-up|0|||
129587987|NCT01190930|466447553|FG000|Maintenance|Physician Decision|0|||
129587988|NCT01190930|466447554|FG001|Maintenance|Physician Decision|1|||
129587989|NCT01190930|466447555|FG002|Maintenance|Physician Decision|0|||
129587990|NCT01190930|466447556|FG003|Maintenance|Physician Decision|5|||
129696164|NCT00215657|466845950|FG002|Overall Study|Other|2|||
129696165|NCT00215657|466845951|FG003|Overall Study|Other|3|||
129696166|NCT00215657|466845952|FG004|Overall Study|Other|5|||
129587991|NCT01190930|466447557|FG004|Maintenance|Physician Decision|9|||
129587992|NCT01190930|466447558|FG005|Maintenance|Physician Decision|4|||
129587993|NCT01190930|466447559|FG006|Maintenance|Physician Decision|8|||
129587994|NCT01190930|466447560|FG007|Maintenance|Physician Decision|8|||
129587995|NCT01190930|466447561|FG008|Maintenance|Physician Decision|10|||
129587996|NCT01190930|466447562|FG009|Maintenance|Physician Decision|17|||
129587997|NCT01190930|466447553|FG000|Maintenance|Withdrawal by Subject|0|||
129587998|NCT01190930|466447554|FG001|Maintenance|Withdrawal by Subject|0|||
129587999|NCT01190930|466447555|FG002|Maintenance|Withdrawal by Subject|0|||
129588000|NCT01190930|466447556|FG003|Maintenance|Withdrawal by Subject|0|||
129588001|NCT01190930|466447557|FG004|Maintenance|Withdrawal by Subject|0|||
129588002|NCT01190930|466447558|FG005|Maintenance|Withdrawal by Subject|0|||
129588003|NCT01190930|466447559|FG006|Maintenance|Withdrawal by Subject|2|||
129588004|NCT01190930|466447560|FG007|Maintenance|Withdrawal by Subject|1|||
129588005|NCT01190930|466447561|FG008|Maintenance|Withdrawal by Subject|4|||
129588006|NCT01190930|466447562|FG009|Maintenance|Withdrawal by Subject|1|||
129588007|NCT01190930|466447553|FG000|Maintenance|Refusal|0|||
129588008|NCT01190930|466447554|FG001|Maintenance|Refusal|1|||
129588009|NCT01190930|466447555|FG002|Maintenance|Refusal|0|||
129588010|NCT01190930|466447556|FG003|Maintenance|Refusal|2|||
129588011|NCT01190930|466447557|FG004|Maintenance|Refusal|0|||
129588012|NCT01190930|466447558|FG005|Maintenance|Refusal|4|||
129588013|NCT01190930|466447559|FG006|Maintenance|Refusal|5|||
129588014|NCT01190930|466447560|FG007|Maintenance|Refusal|17|||
129588015|NCT01190930|466447561|FG008|Maintenance|Refusal|13|||
129588016|NCT01190930|466447562|FG009|Maintenance|Refusal|6|||
129588017|NCT01190930|466447553|FG000|Maintenance|second malignant neoplasm|0|||
129588018|NCT01190930|466447554|FG001|Maintenance|second malignant neoplasm|0|||
129588019|NCT01190930|466447555|FG002|Maintenance|second malignant neoplasm|0|||
129588020|NCT01190930|466447556|FG003|Maintenance|second malignant neoplasm|1|||
129588021|NCT01190930|466447557|FG004|Maintenance|second malignant neoplasm|0|||
129588022|NCT01190930|466447558|FG005|Maintenance|second malignant neoplasm|1|||
129588023|NCT01190930|466447559|FG006|Maintenance|second malignant neoplasm|0|||
129588024|NCT01190930|466447560|FG007|Maintenance|second malignant neoplasm|0|||
129588025|NCT01190930|466447561|FG008|Maintenance|second malignant neoplasm|1|||
129588026|NCT01190930|466447562|FG009|Maintenance|second malignant neoplasm|0|||
129588027|NCT01190930|466447553|FG000|Maintenance|Inevaluable|0|||
129588028|NCT01190930|466447554|FG001|Maintenance|Inevaluable|0|||
129588029|NCT01190930|466447555|FG002|Maintenance|Inevaluable|0|||
129588030|NCT01190930|466447556|FG003|Maintenance|Inevaluable|0|||
129588031|NCT01190930|466447557|FG004|Maintenance|Inevaluable|0|||
129588032|NCT01190930|466447558|FG005|Maintenance|Inevaluable|1|||
129588033|NCT01190930|466447559|FG006|Maintenance|Inevaluable|1|||
129588034|NCT01190930|466447560|FG007|Maintenance|Inevaluable|1|||
129588035|NCT01190930|466447561|FG008|Maintenance|Inevaluable|0|||
129588036|NCT01190930|466447562|FG009|Maintenance|Inevaluable|0|||
129588037|NCT01190930|466447553|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
129588038|NCT01190930|466447554|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
129588039|NCT01190930|466447555|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
129588040|NCT01190930|466447556|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
129588041|NCT01190930|466447557|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
129588042|NCT01190930|466447558|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
129588043|NCT01190930|466447559|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
129588044|NCT01190930|466447560|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
129588045|NCT01190930|466447561|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
129588046|NCT01190930|466447562|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
129588047|NCT01190930|466447553|FG000|Maintenance|Relapse|0|||
129588048|NCT01190930|466447554|FG001|Maintenance|Relapse|0|||
129588049|NCT01190930|466447555|FG002|Maintenance|Relapse|0|||
129588050|NCT01190930|466447556|FG003|Maintenance|Relapse|2|||
129588051|NCT01190930|466447557|FG004|Maintenance|Relapse|0|||
129588052|NCT01190930|466447558|FG005|Maintenance|Relapse|1|||
129588053|NCT01190930|466447559|FG006|Maintenance|Relapse|6|||
129588054|NCT01190930|466447560|FG007|Maintenance|Relapse|13|||
129588055|NCT01190930|466447561|FG008|Maintenance|Relapse|11|||
129588056|NCT01190930|466447562|FG009|Maintenance|Relapse|11|||
129588057|NCT01190930|466447553|FG000|Maintenance|Still on therapy|0|||
129588058|NCT01190930|466447554|FG001|Maintenance|Still on therapy|8|||
129588059|NCT01190930|466447555|FG002|Maintenance|Still on therapy|0|||
129588060|NCT01190930|466447556|FG003|Maintenance|Still on therapy|29|||
129588061|NCT01190930|466447557|FG004|Maintenance|Still on therapy|0|||
129588062|NCT01190930|466447558|FG005|Maintenance|Still on therapy|0|||
129588063|NCT01190930|466447559|FG006|Maintenance|Still on therapy|0|||
129588064|NCT01190930|466447560|FG007|Maintenance|Still on therapy|0|||
129588065|NCT01190930|466447561|FG008|Maintenance|Still on therapy|0|||
129588066|NCT01190930|466447562|FG009|Maintenance|Still on therapy|0|||
129588067|NCT02167594|466447563|FG000|Overall Study|Withdrawal by Subject|2|||
129588068|NCT02167594|466447564|FG001|Overall Study|Withdrawal by Subject|0|||
129588069|NCT02167594|466447565|FG002|Overall Study|Withdrawal by Subject|0|||
129588070|NCT02167594|466447563|FG000|Overall Study|Death|0|||
129588071|NCT02167594|466447564|FG001|Overall Study|Death|1|||
129588072|NCT02167594|466447565|FG002|Overall Study|Death|0|||
129588073|NCT02161549|466447566|FG000|Overall Study|Physician Decision|6|||
129588074|NCT02161549|466447567|FG001|Overall Study|Physician Decision|2|||
129588075|NCT02451358|466447568|FG000|Overall Study|Withdrawal by Subject|1|||
129588076|NCT02451358|466447569|FG001|Overall Study|Withdrawal by Subject|1|||
129588077|NCT02451358|466447570|FG002|Overall Study|Withdrawal by Subject|0|||
129588078|NCT02451358|466447571|FG003|Overall Study|Withdrawal by Subject|0|||
129588079|NCT02451358|466447568|FG000|Overall Study|Protocol Violation|0|||
129588080|NCT02451358|466447569|FG001|Overall Study|Protocol Violation|1|||
129588081|NCT02451358|466447570|FG002|Overall Study|Protocol Violation|1|||
129588082|NCT02451358|466447571|FG003|Overall Study|Protocol Violation|0|||
129588083|NCT01583530|466447576|FG000|Overall Study|Adverse Event|0|||
129588084|NCT01583530|466447577|FG001|Overall Study|Adverse Event|0|||
129588085|NCT01583530|466447578|FG002|Overall Study|Adverse Event|0|||
129588086|NCT01583530|466447579|FG003|Overall Study|Adverse Event|0|||
129588087|NCT01583530|466447580|FG004|Overall Study|Adverse Event|0|||
129588088|NCT01583530|466447581|FG005|Overall Study|Adverse Event|1|||
129588089|NCT01583530|466447576|FG000|Overall Study|Withdrawal by Subject|0|||
129588090|NCT01583530|466447577|FG001|Overall Study|Withdrawal by Subject|3|||
129588091|NCT01583530|466447578|FG002|Overall Study|Withdrawal by Subject|0|||
129588092|NCT01583530|466447579|FG003|Overall Study|Withdrawal by Subject|1|||
129588093|NCT01583530|466447580|FG004|Overall Study|Withdrawal by Subject|1|||
129588094|NCT01583530|466447581|FG005|Overall Study|Withdrawal by Subject|2|||
129588095|NCT01583530|466447576|FG000|Overall Study|Lost to Follow-up|0|||
129588096|NCT01583530|466447577|FG001|Overall Study|Lost to Follow-up|0|||
129588097|NCT01583530|466447578|FG002|Overall Study|Lost to Follow-up|0|||
129588098|NCT01583530|466447579|FG003|Overall Study|Lost to Follow-up|0|||
129588099|NCT01583530|466447580|FG004|Overall Study|Lost to Follow-up|3|||
129588100|NCT01583530|466447581|FG005|Overall Study|Lost to Follow-up|0|||
129588101|NCT01583530|466447576|FG000|Overall Study|Lack of compliance|0|||
129588102|NCT01583530|466447577|FG001|Overall Study|Lack of compliance|0|||
129588103|NCT01583530|466447578|FG002|Overall Study|Lack of compliance|0|||
129588104|NCT01583530|466447579|FG003|Overall Study|Lack of compliance|0|||
129588105|NCT01583530|466447580|FG004|Overall Study|Lack of compliance|1|||
129588106|NCT01583530|466447581|FG005|Overall Study|Lack of compliance|0|||
129588107|NCT01332968|466447584|FG000|Induction Period|Adverse Event|23|||
129588108|NCT01332968|466447585|FG001|Induction Period|Adverse Event|26|||
129588109|NCT01332968|466447586|FG002|Induction Period|Adverse Event|0|||
129588110|NCT01332968|466447587|FG003|Induction Period|Adverse Event|0|||
129588111|NCT01332968|466447588|FG004|Induction Period|Adverse Event|0|||
129588112|NCT01332968|466447589|FG005|Induction Period|Adverse Event|0|||
129588113|NCT01332968|466447590|FG006|Induction Period|Adverse Event|0|||
129588114|NCT01332968|466447591|FG007|Induction Period|Adverse Event|0|||
129588115|NCT01332968|466447584|FG000|Induction Period|Death|1|||
129588116|NCT01332968|466447585|FG001|Induction Period|Death|4|||
129588117|NCT01332968|466447586|FG002|Induction Period|Death|0|||
129588118|NCT01332968|466447587|FG003|Induction Period|Death|0|||
129588119|NCT01332968|466447588|FG004|Induction Period|Death|0|||
129588120|NCT01332968|466447589|FG005|Induction Period|Death|0|||
129588121|NCT01332968|466447590|FG006|Induction Period|Death|0|||
129588122|NCT01332968|466447591|FG007|Induction Period|Death|0|||
129588123|NCT01332968|466447584|FG000|Induction Period|Non-compliance|1|||
129588124|NCT01332968|466447585|FG001|Induction Period|Non-compliance|0|||
129696167|NCT00215657|466845953|FG005|Overall Study|Other|4|||
129588125|NCT01332968|466447586|FG002|Induction Period|Non-compliance|0|||
129588126|NCT01332968|466447587|FG003|Induction Period|Non-compliance|0|||
129588127|NCT01332968|466447588|FG004|Induction Period|Non-compliance|0|||
129588128|NCT01332968|466447589|FG005|Induction Period|Non-compliance|0|||
129588129|NCT01332968|466447590|FG006|Induction Period|Non-compliance|0|||
129588130|NCT01332968|466447591|FG007|Induction Period|Non-compliance|0|||
129588131|NCT01332968|466447584|FG000|Induction Period|Other|2|||
129588132|NCT01332968|466447585|FG001|Induction Period|Other|2|||
129588133|NCT01332968|466447586|FG002|Induction Period|Other|0|||
129588134|NCT01332968|466447587|FG003|Induction Period|Other|0|||
129696168|NCT00215657|466845954|FG006|Overall Study|Other|6|||
129696169|NCT00215657|466845955|FG007|Overall Study|Other|1|||
129588135|NCT01332968|466447588|FG004|Induction Period|Other|0|||
129588136|NCT01332968|466447589|FG005|Induction Period|Other|0|||
129588137|NCT01332968|466447590|FG006|Induction Period|Other|0|||
129588138|NCT01332968|466447591|FG007|Induction Period|Other|0|||
129588139|NCT01332968|466447584|FG000|Induction Period|Physician Decision|6|||
129588140|NCT01332968|466447585|FG001|Induction Period|Physician Decision|1|||
129588141|NCT01332968|466447586|FG002|Induction Period|Physician Decision|0|||
129588142|NCT01332968|466447587|FG003|Induction Period|Physician Decision|0|||
129588143|NCT01332968|466447588|FG004|Induction Period|Physician Decision|0|||
129588144|NCT01332968|466447589|FG005|Induction Period|Physician Decision|0|||
129588145|NCT01332968|466447590|FG006|Induction Period|Physician Decision|0|||
129588146|NCT01332968|466447591|FG007|Induction Period|Physician Decision|0|||
129588147|NCT01332968|466447584|FG000|Induction Period|Progressive Disease|15|||
129885413|NCT02471404|467540712|FG001|Overall Study|Lost to Follow-up|1|||
129885414|NCT02471404|467540713|FG002|Overall Study|Lost to Follow-up|3|||
129885415|NCT02471404|467540711|FG000|Overall Study|Protocol Violation|1|||
129885416|NCT02471404|467540712|FG001|Overall Study|Protocol Violation|0|||
129588148|NCT01332968|466447585|FG001|Induction Period|Progressive Disease|7|||
129588149|NCT01332968|466447586|FG002|Induction Period|Progressive Disease|0|||
129588150|NCT01332968|466447587|FG003|Induction Period|Progressive Disease|0|||
129885417|NCT02471404|467540713|FG002|Overall Study|Protocol Violation|0|||
129885418|NCT02471404|467540711|FG000|Overall Study|Withdrawal by Subject|8|||
129885419|NCT02471404|467540712|FG001|Overall Study|Withdrawal by Subject|4|||
129885420|NCT02471404|467540713|FG002|Overall Study|Withdrawal by Subject|5|||
129885421|NCT02471404|467540711|FG000|Overall Study|Other reasons not specified|10|||
129885422|NCT02471404|467540712|FG001|Overall Study|Other reasons not specified|7|||
129885423|NCT02471404|467540713|FG002|Overall Study|Other reasons not specified|12|||
129885424|NCT00065468|467540716|FG000|Overall Study|Death|172|||
129885425|NCT00065468|467540717|FG001|Overall Study|Death|169|||
129885426|NCT00065468|467540718|FG002|Overall Study|Death|171|||
129885427|NCT00065468|467540716|FG000|Overall Study|Withdrawal by Subject|3|||
129885428|NCT00065468|467540717|FG001|Overall Study|Withdrawal by Subject|4|||
129885429|NCT00065468|467540718|FG002|Overall Study|Withdrawal by Subject|5|||
129885430|NCT00065468|467540716|FG000|Overall Study|Lost to Follow-up|5|||
129885431|NCT00065468|467540717|FG001|Overall Study|Lost to Follow-up|3|||
129885432|NCT00065468|467540718|FG002|Overall Study|Lost to Follow-up|2|||
129885433|NCT00065468|467540716|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
129588151|NCT01332968|466447588|FG004|Induction Period|Progressive Disease|0|||
129588152|NCT01332968|466447589|FG005|Induction Period|Progressive Disease|0|||
129885434|NCT00065468|467540717|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
129885435|NCT00065468|467540718|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
129588153|NCT01332968|466447590|FG006|Induction Period|Progressive Disease|0|||
129885436|NCT00065468|467540716|FG000|Overall Study|Disease progression|0|||
129885437|NCT00065468|467540717|FG001|Overall Study|Disease progression|0|||
129885438|NCT00065468|467540718|FG002|Overall Study|Disease progression|1|||
129885439|NCT00065468|467540716|FG000|Overall Study|Other|14|||
129588154|NCT01332968|466447591|FG007|Induction Period|Progressive Disease|0|||
129588155|NCT01332968|466447584|FG000|Induction Period|Protocol Violation|3|||
129588156|NCT01332968|466447585|FG001|Induction Period|Protocol Violation|4|||
129588157|NCT01332968|466447586|FG002|Induction Period|Protocol Violation|0|||
129588158|NCT01332968|466447587|FG003|Induction Period|Protocol Violation|0|||
129588159|NCT01332968|466447588|FG004|Induction Period|Protocol Violation|0|||
129588160|NCT01332968|466447589|FG005|Induction Period|Protocol Violation|0|||
129588161|NCT01332968|466447590|FG006|Induction Period|Protocol Violation|0|||
129696170|NCT03769467|466845956|FG000|Overall Study|Adverse Event|1|||
129885440|NCT00065468|467540717|FG001|Overall Study|Other|24|||
129885441|NCT00065468|467540718|FG002|Overall Study|Other|18|||
129885442|NCT01225835|467540719|FG000|Overall Study|Completed protocol|2|||
129885443|NCT01225835|467540720|FG001|Overall Study|Completed protocol|1|||
129588162|NCT01332968|466447591|FG007|Induction Period|Protocol Violation|0|||
129588163|NCT01332968|466447584|FG000|Induction Period|Withdrawal by Subject|3|||
129588164|NCT01332968|466447585|FG001|Induction Period|Withdrawal by Subject|5|||
129588165|NCT01332968|466447586|FG002|Induction Period|Withdrawal by Subject|0|||
129588166|NCT01332968|466447587|FG003|Induction Period|Withdrawal by Subject|0|||
129588167|NCT01332968|466447588|FG004|Induction Period|Withdrawal by Subject|0|||
129588168|NCT01332968|466447589|FG005|Induction Period|Withdrawal by Subject|0|||
129588169|NCT01332968|466447590|FG006|Induction Period|Withdrawal by Subject|0|||
129588170|NCT01332968|466447591|FG007|Induction Period|Withdrawal by Subject|0|||
129885444|NCT01225835|467540719|FG000|Overall Study|Did not meet hCG criterion|2|||
129885445|NCT01225835|467540720|FG001|Overall Study|Did not meet hCG criterion|0|||
129885446|NCT01225835|467540719|FG000|Overall Study|Adverse Event|2|||
129885447|NCT01225835|467540720|FG001|Overall Study|Adverse Event|1|||
129588171|NCT01332968|466447584|FG000|Induction Period|Randomised but not treated|4|||
129588172|NCT01332968|466447585|FG001|Induction Period|Randomised but not treated|7|||
129588173|NCT01332968|466447586|FG002|Induction Period|Randomised but not treated|0|||
129588174|NCT01332968|466447587|FG003|Induction Period|Randomised but not treated|0|||
129588175|NCT01332968|466447588|FG004|Induction Period|Randomised but not treated|0|||
129588176|NCT01332968|466447589|FG005|Induction Period|Randomised but not treated|0|||
129588177|NCT01332968|466447590|FG006|Induction Period|Randomised but not treated|0|||
129588178|NCT01332968|466447591|FG007|Induction Period|Randomised but not treated|0|||
129885448|NCT01225835|467540719|FG000|Overall Study|Other|1|||
129885449|NCT01225835|467540720|FG001|Overall Study|Other|1|||
129885450|NCT03285113|467540721|FG000|Overall Study|Unable to implant leads|2|||
129885451|NCT00849680|467540724|FG000|Overall Study|Adverse Event|0|||
129588179|NCT01332968|466447584|FG000|Maintenance/Observation Period|Adverse Event|0|||
129588180|NCT01332968|466447585|FG001|Maintenance/Observation Period|Adverse Event|0|||
129588181|NCT01332968|466447586|FG002|Maintenance/Observation Period|Adverse Event|53|||
129588182|NCT01332968|466447587|FG003|Maintenance/Observation Period|Adverse Event|66|||
129588183|NCT01332968|466447588|FG004|Maintenance/Observation Period|Adverse Event|0|||
129588184|NCT01332968|466447589|FG005|Maintenance/Observation Period|Adverse Event|0|||
129588185|NCT01332968|466447590|FG006|Maintenance/Observation Period|Adverse Event|0|||
129588186|NCT01332968|466447591|FG007|Maintenance/Observation Period|Adverse Event|0|||
129588187|NCT01332968|466447584|FG000|Maintenance/Observation Period|Death|0|||
129588188|NCT01332968|466447585|FG001|Maintenance/Observation Period|Death|0|||
129588189|NCT01332968|466447586|FG002|Maintenance/Observation Period|Death|5|||
129588190|NCT01332968|466447587|FG003|Maintenance/Observation Period|Death|6|||
129588191|NCT01332968|466447588|FG004|Maintenance/Observation Period|Death|0|||
129588192|NCT01332968|466447589|FG005|Maintenance/Observation Period|Death|0|||
129588193|NCT01332968|466447590|FG006|Maintenance/Observation Period|Death|0|||
129588194|NCT01332968|466447591|FG007|Maintenance/Observation Period|Death|0|||
129588195|NCT01332968|466447584|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
129588196|NCT01332968|466447585|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
129588197|NCT01332968|466447586|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
129588198|NCT01332968|466447587|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
129588199|NCT01332968|466447588|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
129588200|NCT01332968|466447589|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
129588201|NCT01332968|466447590|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
129588202|NCT01332968|466447591|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
129588203|NCT01332968|466447584|FG000|Maintenance/Observation Period|Non-compliance|0|||
129588204|NCT01332968|466447585|FG001|Maintenance/Observation Period|Non-compliance|0|||
129588205|NCT01332968|466447586|FG002|Maintenance/Observation Period|Non-compliance|4|||
129588206|NCT01332968|466447587|FG003|Maintenance/Observation Period|Non-compliance|3|||
129885452|NCT00849680|467540725|FG001|Overall Study|Adverse Event|0|||
129885453|NCT00849680|467540726|FG002|Overall Study|Adverse Event|0|||
129588207|NCT01332968|466447588|FG004|Maintenance/Observation Period|Non-compliance|0|||
129588208|NCT01332968|466447589|FG005|Maintenance/Observation Period|Non-compliance|0|||
129588209|NCT01332968|466447590|FG006|Maintenance/Observation Period|Non-compliance|0|||
129885454|NCT00849680|467540727|FG003|Overall Study|Adverse Event|0|||
129588210|NCT01332968|466447591|FG007|Maintenance/Observation Period|Non-compliance|0|||
129588211|NCT01332968|466447584|FG000|Maintenance/Observation Period|Other|0|||
129588212|NCT01332968|466447585|FG001|Maintenance/Observation Period|Other|0|||
129588213|NCT01332968|466447586|FG002|Maintenance/Observation Period|Other|4|||
129588214|NCT01332968|466447587|FG003|Maintenance/Observation Period|Other|7|||
129588215|NCT01332968|466447588|FG004|Maintenance/Observation Period|Other|0|||
129588216|NCT01332968|466447589|FG005|Maintenance/Observation Period|Other|0|||
129588217|NCT01332968|466447590|FG006|Maintenance/Observation Period|Other|0|||
129588218|NCT01332968|466447591|FG007|Maintenance/Observation Period|Other|0|||
129588219|NCT01332968|466447584|FG000|Maintenance/Observation Period|Physician Decision|0|||
129588220|NCT01332968|466447585|FG001|Maintenance/Observation Period|Physician Decision|0|||
129588221|NCT01332968|466447586|FG002|Maintenance/Observation Period|Physician Decision|14|||
129588222|NCT01332968|466447587|FG003|Maintenance/Observation Period|Physician Decision|19|||
129588223|NCT01332968|466447588|FG004|Maintenance/Observation Period|Physician Decision|0|||
129588224|NCT01332968|466447589|FG005|Maintenance/Observation Period|Physician Decision|1|||
129588225|NCT01332968|466447590|FG006|Maintenance/Observation Period|Physician Decision|0|||
129588226|NCT01332968|466447591|FG007|Maintenance/Observation Period|Physician Decision|0|||
129588227|NCT01332968|466447584|FG000|Maintenance/Observation Period|Progressive Disease|0|||
129588228|NCT01332968|466447585|FG001|Maintenance/Observation Period|Progressive Disease|0|||
129588229|NCT01332968|466447586|FG002|Maintenance/Observation Period|Progressive Disease|72|||
129588230|NCT01332968|466447587|FG003|Maintenance/Observation Period|Progressive Disease|40|||
129588231|NCT01332968|466447588|FG004|Maintenance/Observation Period|Progressive Disease|0|||
129588232|NCT01332968|466447589|FG005|Maintenance/Observation Period|Progressive Disease|0|||
129588233|NCT01332968|466447590|FG006|Maintenance/Observation Period|Progressive Disease|0|||
129588234|NCT01332968|466447591|FG007|Maintenance/Observation Period|Progressive Disease|0|||
129696171|NCT03769467|466845957|FG001|Overall Study|Adverse Event|1|||
129696172|NCT03769467|466845958|FG002|Overall Study|Adverse Event|0|||
129696173|NCT03769467|466845956|FG000|Overall Study|Death|3|||
129696174|NCT03769467|466845957|FG001|Overall Study|Death|3|||
129696175|NCT03769467|466845958|FG002|Overall Study|Death|0|||
129696176|NCT03769467|466845956|FG000|Overall Study|Study Terminated By Sponsor|2|||
129696177|NCT03769467|466845957|FG001|Overall Study|Study Terminated By Sponsor|1|||
129696178|NCT03769467|466845958|FG002|Overall Study|Study Terminated By Sponsor|0|||
129696179|NCT03769467|466845956|FG000|Overall Study|Withdrawal by Subject|0|||
129696180|NCT03769467|466845957|FG001|Overall Study|Withdrawal by Subject|1|||
129696181|NCT03769467|466845958|FG002|Overall Study|Withdrawal by Subject|0|||
129696182|NCT04754399|466845959|FG000|Overall Study|Adverse Event|5|||
129696183|NCT04754399|466845959|FG000|Overall Study|Withdrawal by Subject|6|||
129696184|NCT04565756|466845960|FG000|Overall Study|Withdrawal by Subject|0|||
129696185|NCT04565756|466845961|FG001|Overall Study|Withdrawal by Subject|0|||
129696186|NCT04565756|466845962|FG002|Overall Study|Withdrawal by Subject|0|||
129696187|NCT04565756|466845963|FG003|Overall Study|Withdrawal by Subject|0|||
129696188|NCT04565756|466845964|FG004|Overall Study|Withdrawal by Subject|1|||
129696189|NCT04565756|466845965|FG005|Overall Study|Withdrawal by Subject|0|||
129696190|NCT04565756|466845960|FG000|Overall Study|Protocol Violation|0|||
129696191|NCT04565756|466845961|FG001|Overall Study|Protocol Violation|0|||
129696192|NCT04565756|466845962|FG002|Overall Study|Protocol Violation|0|||
129696193|NCT04565756|466845963|FG003|Overall Study|Protocol Violation|0|||
129696194|NCT04565756|466845964|FG004|Overall Study|Protocol Violation|0|||
129696195|NCT04565756|466845965|FG005|Overall Study|Protocol Violation|1|||
129588235|NCT01332968|466447584|FG000|Maintenance/Observation Period|Protocol Violation|0|||
129588236|NCT01332968|466447585|FG001|Maintenance/Observation Period|Protocol Violation|0|||
129588237|NCT01332968|466447586|FG002|Maintenance/Observation Period|Protocol Violation|1|||
129588238|NCT01332968|466447587|FG003|Maintenance/Observation Period|Protocol Violation|1|||
129588239|NCT01332968|466447588|FG004|Maintenance/Observation Period|Protocol Violation|0|||
129588240|NCT01332968|466447589|FG005|Maintenance/Observation Period|Protocol Violation|0|||
129588241|NCT01332968|466447590|FG006|Maintenance/Observation Period|Protocol Violation|0|||
129588242|NCT01332968|466447591|FG007|Maintenance/Observation Period|Protocol Violation|0|||
129588243|NCT01332968|466447584|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
129588244|NCT01332968|466447585|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
129588245|NCT01332968|466447586|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
129588246|NCT01332968|466447587|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
129588247|NCT01332968|466447588|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
129588248|NCT01332968|466447589|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
129588249|NCT01332968|466447590|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
129588250|NCT01332968|466447591|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
129588251|NCT01332968|466447584|FG000|Follow-Up Period|Adverse Event|0|||
129588252|NCT01332968|466447585|FG001|Follow-Up Period|Adverse Event|0|||
129588253|NCT01332968|466447586|FG002|Follow-Up Period|Adverse Event|0|||
129588254|NCT01332968|466447587|FG003|Follow-Up Period|Adverse Event|0|||
129588255|NCT01332968|466447588|FG004|Follow-Up Period|Adverse Event|0|||
129588256|NCT01332968|466447589|FG005|Follow-Up Period|Adverse Event|0|||
129588257|NCT01332968|466447590|FG006|Follow-Up Period|Adverse Event|0|||
129588258|NCT01332968|466447591|FG007|Follow-Up Period|Adverse Event|4|||
129588259|NCT01332968|466447584|FG000|Follow-Up Period|Death|0|||
129588260|NCT01332968|466447585|FG001|Follow-Up Period|Death|0|||
129588261|NCT01332968|466447586|FG002|Follow-Up Period|Death|0|||
129588262|NCT01332968|466447587|FG003|Follow-Up Period|Death|0|||
129588263|NCT01332968|466447588|FG004|Follow-Up Period|Death|0|||
129588264|NCT01332968|466447589|FG005|Follow-Up Period|Death|0|||
129588265|NCT01332968|466447590|FG006|Follow-Up Period|Death|27|||
129588266|NCT01332968|466447591|FG007|Follow-Up Period|Death|30|||
129588267|NCT01332968|466447584|FG000|Follow-Up Period|Lost to Follow-up|0|||
129588268|NCT01332968|466447585|FG001|Follow-Up Period|Lost to Follow-up|0|||
129588269|NCT01332968|466447586|FG002|Follow-Up Period|Lost to Follow-up|0|||
129588270|NCT01332968|466447587|FG003|Follow-Up Period|Lost to Follow-up|0|||
129588271|NCT01332968|466447588|FG004|Follow-Up Period|Lost to Follow-up|0|||
129588272|NCT01332968|466447589|FG005|Follow-Up Period|Lost to Follow-up|0|||
129588273|NCT01332968|466447590|FG006|Follow-Up Period|Lost to Follow-up|11|||
129588274|NCT01332968|466447591|FG007|Follow-Up Period|Lost to Follow-up|15|||
129588275|NCT01332968|466447584|FG000|Follow-Up Period|Non-compliance|0|||
129588276|NCT01332968|466447585|FG001|Follow-Up Period|Non-compliance|0|||
129588277|NCT01332968|466447586|FG002|Follow-Up Period|Non-compliance|0|||
129588278|NCT01332968|466447587|FG003|Follow-Up Period|Non-compliance|0|||
129588279|NCT01332968|466447588|FG004|Follow-Up Period|Non-compliance|0|||
129588280|NCT01332968|466447589|FG005|Follow-Up Period|Non-compliance|0|||
129588281|NCT01332968|466447590|FG006|Follow-Up Period|Non-compliance|4|||
129588282|NCT01332968|466447591|FG007|Follow-Up Period|Non-compliance|9|||
129588283|NCT01332968|466447584|FG000|Follow-Up Period|Other|0|||
129588284|NCT01332968|466447585|FG001|Follow-Up Period|Other|0|||
129588285|NCT01332968|466447586|FG002|Follow-Up Period|Other|0|||
129588286|NCT01332968|466447587|FG003|Follow-Up Period|Other|0|||
129588287|NCT01332968|466447588|FG004|Follow-Up Period|Other|0|||
129588288|NCT01332968|466447589|FG005|Follow-Up Period|Other|0|||
129588289|NCT01332968|466447590|FG006|Follow-Up Period|Other|18|||
129588290|NCT01332968|466447591|FG007|Follow-Up Period|Other|21|||
129588291|NCT01332968|466447584|FG000|Follow-Up Period|Physician Decision|0|||
129588292|NCT01332968|466447585|FG001|Follow-Up Period|Physician Decision|0|||
129588293|NCT01332968|466447586|FG002|Follow-Up Period|Physician Decision|0|||
129696196|NCT00968968|466845968|FG000|Overall Study|Study closed/terminated|10|||
129696197|NCT00968968|466845969|FG001|Overall Study|Study closed/terminated|10|||
129696198|NCT00968968|466845968|FG000|Overall Study|Protocol defined stopping criteria|3|||
129696199|NCT00968968|466845969|FG001|Overall Study|Protocol defined stopping criteria|1|||
129696200|NCT00968968|466845968|FG000|Overall Study|Withdrawal by Subject|2|||
129696201|NCT00968968|466845969|FG001|Overall Study|Withdrawal by Subject|0|||
129696202|NCT00968968|466845968|FG000|Overall Study|Physician Decision|1|||
129696203|NCT00968968|466845969|FG001|Overall Study|Physician Decision|2|||
129588294|NCT01332968|466447587|FG003|Follow-Up Period|Physician Decision|0|||
129588295|NCT01332968|466447588|FG004|Follow-Up Period|Physician Decision|0|||
129588296|NCT01332968|466447589|FG005|Follow-Up Period|Physician Decision|0|||
129588297|NCT01332968|466447590|FG006|Follow-Up Period|Physician Decision|12|||
129588298|NCT01332968|466447591|FG007|Follow-Up Period|Physician Decision|15|||
129588299|NCT01332968|466447584|FG000|Follow-Up Period|Progressive Disease|0|||
129588300|NCT01332968|466447585|FG001|Follow-Up Period|Progressive Disease|0|||
129588301|NCT01332968|466447586|FG002|Follow-Up Period|Progressive Disease|0|||
129588302|NCT01332968|466447587|FG003|Follow-Up Period|Progressive Disease|0|||
129588303|NCT01332968|466447588|FG004|Follow-Up Period|Progressive Disease|0|||
129588304|NCT01332968|466447589|FG005|Follow-Up Period|Progressive Disease|0|||
129588305|NCT01332968|466447590|FG006|Follow-Up Period|Progressive Disease|126|||
129588306|NCT01332968|466447591|FG007|Follow-Up Period|Progressive Disease|106|||
129588307|NCT01332968|466447584|FG000|Follow-Up Period|Protocol Violation|0|||
129588308|NCT01332968|466447585|FG001|Follow-Up Period|Protocol Violation|0|||
129588309|NCT01332968|466447586|FG002|Follow-Up Period|Protocol Violation|0|||
129588310|NCT01332968|466447587|FG003|Follow-Up Period|Protocol Violation|0|||
129588311|NCT01332968|466447588|FG004|Follow-Up Period|Protocol Violation|0|||
129588312|NCT01332968|466447589|FG005|Follow-Up Period|Protocol Violation|0|||
129588313|NCT01332968|466447590|FG006|Follow-Up Period|Protocol Violation|1|||
129588314|NCT01332968|466447591|FG007|Follow-Up Period|Protocol Violation|0|||
129588315|NCT01332968|466447584|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129588316|NCT01332968|466447585|FG001|Follow-Up Period|Withdrawal by Subject|0|||
129588317|NCT01332968|466447586|FG002|Follow-Up Period|Withdrawal by Subject|0|||
129588318|NCT01332968|466447587|FG003|Follow-Up Period|Withdrawal by Subject|0|||
129588319|NCT01332968|466447588|FG004|Follow-Up Period|Withdrawal by Subject|0|||
129588320|NCT01332968|466447589|FG005|Follow-Up Period|Withdrawal by Subject|0|||
129588321|NCT01332968|466447590|FG006|Follow-Up Period|Withdrawal by Subject|29|||
129588322|NCT01332968|466447591|FG007|Follow-Up Period|Withdrawal by Subject|32|||
129588323|NCT01332968|466447584|FG000|Follow-Up Period|No reason provided|0|||
129588324|NCT01332968|466447585|FG001|Follow-Up Period|No reason provided|0|||
129588325|NCT01332968|466447586|FG002|Follow-Up Period|No reason provided|0|||
129588326|NCT01332968|466447587|FG003|Follow-Up Period|No reason provided|0|||
129588327|NCT01332968|466447588|FG004|Follow-Up Period|No reason provided|0|||
129588328|NCT01332968|466447589|FG005|Follow-Up Period|No reason provided|0|||
129588329|NCT01332968|466447590|FG006|Follow-Up Period|No reason provided|2|||
129588330|NCT01332968|466447591|FG007|Follow-Up Period|No reason provided|3|||
129588331|NCT03480022|466447592|FG000|Overall Study|Pregnancy|2|||
129588332|NCT03480022|466447593|FG001|Overall Study|Pregnancy|0|||
129588333|NCT03480022|466447592|FG000|Overall Study|Adverse Event|6|||
129588334|NCT03480022|466447593|FG001|Overall Study|Adverse Event|0|||
129588335|NCT03480022|466447592|FG000|Overall Study|Lack of Efficacy|0|||
129588336|NCT03480022|466447593|FG001|Overall Study|Lack of Efficacy|2|||
129588337|NCT03480022|466447592|FG000|Overall Study|Physician Decision|0|||
129588338|NCT03480022|466447593|FG001|Overall Study|Physician Decision|1|||
129588339|NCT03480022|466447592|FG000|Overall Study|Withdrawal by Subject|2|||
129588340|NCT03480022|466447593|FG001|Overall Study|Withdrawal by Subject|0|||
129588341|NCT03480022|466447592|FG000|Overall Study|Medication concerns|1|||
129588342|NCT03480022|466447593|FG001|Overall Study|Medication concerns|0|||
129588343|NCT03480022|466447592|FG000|Overall Study|Family member COVID exposure|0|||
129588344|NCT03480022|466447593|FG001|Overall Study|Family member COVID exposure|1|||
129588345|NCT00640926|466447594|FG000|Overall Study|Adverse Event|2|||
129588346|NCT00640926|466447595|FG001|Overall Study|Adverse Event|3|||
129588347|NCT00640926|466447596|FG002|Overall Study|Adverse Event|2|||
129588348|NCT00640926|466447594|FG000|Overall Study|Lack of Efficacy|0|||
129588349|NCT00640926|466447595|FG001|Overall Study|Lack of Efficacy|2|||
129588350|NCT00640926|466447596|FG002|Overall Study|Lack of Efficacy|1|||
129588351|NCT00640926|466447594|FG000|Overall Study|Protocol Violation|2|||
129588352|NCT00640926|466447595|FG001|Overall Study|Protocol Violation|0|||
129588353|NCT00640926|466447596|FG002|Overall Study|Protocol Violation|2|||
129588354|NCT00640926|466447594|FG000|Overall Study|Lost to Follow-up|3|||
129588355|NCT00640926|466447595|FG001|Overall Study|Lost to Follow-up|1|||
129588356|NCT00640926|466447596|FG002|Overall Study|Lost to Follow-up|2|||
129588357|NCT00640926|466447594|FG000|Overall Study|Withdrawal by Subject|1|||
129588358|NCT00640926|466447595|FG001|Overall Study|Withdrawal by Subject|0|||
129588359|NCT00640926|466447596|FG002|Overall Study|Withdrawal by Subject|1|||
129588360|NCT03922750|466447597|FG000|Overall Study|Unclassified|0|||
129588361|NCT03922750|466447598|FG001|Overall Study|Unclassified|0|||
129588362|NCT03922750|466447599|FG002|Overall Study|Unclassified|1|||
129588363|NCT03922750|466447597|FG000|Overall Study|Adverse Event|0|||
129588364|NCT03922750|466447598|FG001|Overall Study|Adverse Event|1|||
129588365|NCT03922750|466447599|FG002|Overall Study|Adverse Event|0|||
129588366|NCT02985398|466447600|FG000|Overall Study|Adverse Event|1|||
129588367|NCT02985398|466447600|FG000|Overall Study|Lost to Follow-up|4|||
129588368|NCT02985398|466447600|FG000|Overall Study|Withdrawal by Subject|8|||
129588369|NCT02985398|466447600|FG000|Overall Study|Study Burden|9|||
129588370|NCT04164758|466447601|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
129588371|NCT04164758|466447602|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
129588372|NCT04164758|466447603|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
129588373|NCT04164758|466447601|FG000|Overall Study|Adverse Event|0|||
129588374|NCT04164758|466447602|FG001|Overall Study|Adverse Event|1|||
129588375|NCT04164758|466447603|FG002|Overall Study|Adverse Event|0|||
129588376|NCT00697827|466447608|FG000|Overall Study|enrolled but not treated|2|||
129588377|NCT00697827|466447609|FG001|Overall Study|enrolled but not treated|1|||
129588378|NCT00283842|466447614|FG000|Overall Study|Adverse Event|8|||
129588379|NCT00283842|466447615|FG001|Overall Study|Adverse Event|7|||
129588380|NCT00283842|466447616|FG002|Overall Study|Adverse Event|21|||
129588381|NCT00283842|466447617|FG003|Overall Study|Adverse Event|21|||
129588382|NCT00283842|466447618|FG004|Overall Study|Adverse Event|5|||
129588383|NCT00283842|466447614|FG000|Overall Study|Protocol Violation|1|||
129588384|NCT00283842|466447615|FG001|Overall Study|Protocol Violation|5|||
129588385|NCT00283842|466447616|FG002|Overall Study|Protocol Violation|4|||
129588386|NCT00283842|466447617|FG003|Overall Study|Protocol Violation|0|||
129588387|NCT00283842|466447618|FG004|Overall Study|Protocol Violation|0|||
129588388|NCT00283842|466447614|FG000|Overall Study|Protocol deviation|0|||
129588389|NCT00283842|466447615|FG001|Overall Study|Protocol deviation|0|||
129588390|NCT00283842|466447616|FG002|Overall Study|Protocol deviation|0|||
129588391|NCT00283842|466447617|FG003|Overall Study|Protocol deviation|0|||
129588392|NCT00283842|466447618|FG004|Overall Study|Protocol deviation|2|||
129588393|NCT00283842|466447614|FG000|Overall Study|Withdrawal by Subject|2|||
129588394|NCT00283842|466447615|FG001|Overall Study|Withdrawal by Subject|1|||
129588395|NCT00283842|466447616|FG002|Overall Study|Withdrawal by Subject|1|||
129588396|NCT00283842|466447617|FG003|Overall Study|Withdrawal by Subject|5|||
129588397|NCT00283842|466447618|FG004|Overall Study|Withdrawal by Subject|4|||
129588398|NCT00283842|466447614|FG000|Overall Study|Lack of Efficacy|1|||
129588399|NCT00283842|466447615|FG001|Overall Study|Lack of Efficacy|3|||
129588400|NCT00283842|466447616|FG002|Overall Study|Lack of Efficacy|1|||
129588401|NCT00283842|466447617|FG003|Overall Study|Lack of Efficacy|0|||
129588402|NCT00283842|466447618|FG004|Overall Study|Lack of Efficacy|3|||
129588403|NCT00283842|466447614|FG000|Overall Study|Lost to Follow-up|0|||
129588404|NCT00283842|466447615|FG001|Overall Study|Lost to Follow-up|2|||
129588405|NCT00283842|466447616|FG002|Overall Study|Lost to Follow-up|4|||
129588406|NCT00283842|466447617|FG003|Overall Study|Lost to Follow-up|1|||
129588407|NCT00283842|466447618|FG004|Overall Study|Lost to Follow-up|1|||
129588408|NCT05665387|466447619|FG000|Overall Study|Withdrawal by Subject|1|||
129588409|NCT05665387|466447620|FG001|Overall Study|Withdrawal by Subject|0|||
129588410|NCT05665387|466447621|FG002|Overall Study|Withdrawal by Subject|1|||
129588411|NCT03732833|466447622|FG000|Overall Study|Adverse Event|0|||
129588412|NCT03732833|466447623|FG001|Overall Study|Adverse Event|3|||
129588413|NCT03732833|466447624|FG002|Overall Study|Adverse Event|1|||
129588414|NCT03732833|466447622|FG000|Overall Study|Withdrawal by Subject|11|||
129588415|NCT03732833|466447623|FG001|Overall Study|Withdrawal by Subject|13|||
129588416|NCT03732833|466447624|FG002|Overall Study|Withdrawal by Subject|8|||
129588417|NCT03732833|466447622|FG000|Overall Study|Lost to Follow-up|3|||
129588418|NCT03732833|466447623|FG001|Overall Study|Lost to Follow-up|5|||
129588419|NCT03732833|466447624|FG002|Overall Study|Lost to Follow-up|4|||
129588420|NCT03732833|466447622|FG000|Overall Study|Pregnancy|0|||
129588421|NCT03732833|466447623|FG001|Overall Study|Pregnancy|2|||
129588422|NCT03732833|466447624|FG002|Overall Study|Pregnancy|0|||
129588423|NCT03732833|466447622|FG000|Overall Study|Physician Decision|2|||
129588424|NCT03732833|466447623|FG001|Overall Study|Physician Decision|3|||
129588425|NCT03732833|466447624|FG002|Overall Study|Physician Decision|1|||
129588426|NCT03732833|466447622|FG000|Overall Study|Covid-19 related and other reasons|2|||
129588427|NCT03732833|466447623|FG001|Overall Study|Covid-19 related and other reasons|7|||
129588428|NCT03732833|466447624|FG002|Overall Study|Covid-19 related and other reasons|3|||
129588429|NCT02311894|466447628|FG000|Overall Study|Discontinued in error|1|||
129588430|NCT02311894|466447628|FG000|Overall Study|Lost to Follow-up|1|||
129588431|NCT02311894|466447628|FG000|Overall Study|Adverse Event|1|||
129588432|NCT02311894|466447628|FG000|Overall Study|Withdrawal by Subject|1|||
129588433|NCT02472639|466447630|FG000|Overall Study|Physician Decision|4|||
129588434|NCT02472639|466447631|FG001|Overall Study|Physician Decision|3|||
129588435|NCT00046839|466447632|FG000|Overall Study|Ineligible / No protocol treatment|0|||
129588436|NCT00046839|466447633|FG001|Overall Study|Ineligible / No protocol treatment|2|||
129588437|NCT00046839|466447632|FG000|Overall Study|Withdrawal of consent|1|||
129588438|NCT00046839|466447633|FG001|Overall Study|Withdrawal of consent|0|||
129588439|NCT00751023|466447634|FG000|Overall Study|Lost to Follow-up|11|||
129588440|NCT00751023|466447635|FG001|Overall Study|Lost to Follow-up|7|||
129588441|NCT00702507|466447639|FG000|Initial Treatment Phase|Adverse Event|2|||
129588442|NCT00702507|466447639|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
129588443|NCT00702507|466447639|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
129885455|NCT00849680|467540728|FG004|Overall Study|Adverse Event|0|||
129885456|NCT00849680|467540729|FG005|Overall Study|Adverse Event|0|||
129885457|NCT00849680|467540730|FG006|Overall Study|Adverse Event|2|||
129885458|NCT00849680|467540731|FG007|Overall Study|Adverse Event|0|||
129885459|NCT00849680|467540724|FG000|Overall Study|Lost to Follow-up|7|||
129588444|NCT00702507|466447639|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
129588445|NCT00702507|466447639|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
129588446|NCT00702507|466447639|FG000|Follow-up Phase|Protocol Violation|2|||
129588447|NCT00702507|466447639|FG000|Follow-up Phase|Lost to Follow-up|23|||
129588448|NCT00702507|466447639|FG000|Follow-up Phase|Late Enrollment|1|||
129588449|NCT02308696|466447641|FG000|Overall Study|Lost to Follow-up|28|||
129588450|NCT02308696|466447642|FG001|Overall Study|Lost to Follow-up|21|||
129588451|NCT02308696|466447641|FG000|Overall Study|Death|8|||
129588452|NCT02308696|466447642|FG001|Overall Study|Death|4|||
129588453|NCT02308696|466447641|FG000|Overall Study|Moved to a Higher Level of Care|17|||
129588454|NCT02308696|466447642|FG001|Overall Study|Moved to a Higher Level of Care|6|||
129588455|NCT01211262|466447646|FG000|Overall Study|Progressive Disease|18|||
129588456|NCT01211262|466447647|FG001|Overall Study|Progressive Disease|9|||
129588457|NCT01211262|466447646|FG000|Overall Study|Adverse Event|4|||
129588458|NCT01211262|466447647|FG001|Overall Study|Adverse Event|0|||
129588459|NCT01211262|466447646|FG000|Overall Study|Withdrawal of Consent|1|||
129588460|NCT01211262|466447647|FG001|Overall Study|Withdrawal of Consent|0|||
129588461|NCT01211262|466447646|FG000|Overall Study|Other|0|||
129588462|NCT01211262|466447647|FG001|Overall Study|Other|1|||
129588463|NCT04768114|466447648|FG000|Overall Study|Lost to Follow-up|5|||
129588464|NCT04768114|466447649|FG001|Overall Study|Lost to Follow-up|10|||
129588465|NCT04768114|466447648|FG000|Overall Study|Withdrawal by Subject|0|||
129885460|NCT00849680|467540725|FG001|Overall Study|Lost to Follow-up|3|||
129588466|NCT04768114|466447649|FG001|Overall Study|Withdrawal by Subject|1|||
129588467|NCT04049097|466447651|FG000|Overall Study|Adverse Event|18|||
129588468|NCT04049097|466447651|FG000|Overall Study|Death|2|||
129885461|NCT00849680|467540726|FG002|Overall Study|Lost to Follow-up|12|||
129885462|NCT00849680|467540727|FG003|Overall Study|Lost to Follow-up|11|||
129588469|NCT04049097|466447651|FG000|Overall Study|Lost to Follow-up|1|||
129588470|NCT04049097|466447651|FG000|Overall Study|Physician Decision|2|||
129588471|NCT04049097|466447651|FG000|Overall Study|Withdrawal by Subject|9|||
129588472|NCT04049097|466447651|FG000|Overall Study|Protocol Violation|2|||
129588473|NCT04049097|466447651|FG000|Overall Study|Other|1|||
129588474|NCT04049097|466447651|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
129885463|NCT00849680|467540728|FG004|Overall Study|Lost to Follow-up|8|||
129885464|NCT00849680|467540729|FG005|Overall Study|Lost to Follow-up|11|||
129885465|NCT00849680|467540730|FG006|Overall Study|Lost to Follow-up|12|||
129588475|NCT03980522|466447659|FG000|Treatment Period|Adverse Event|1|||
129588476|NCT03980522|466447660|FG001|Treatment Period|Adverse Event|0|||
129588477|NCT03980522|466447661|FG002|Treatment Period|Adverse Event|0|||
129588478|NCT03980522|466447662|FG003|Treatment Period|Adverse Event|0|||
129588479|NCT03980522|466447663|FG004|Treatment Period|Adverse Event|0|||
129588480|NCT04892147|466447664|FG000|Overall Study|Withdrawal by Subject|2|||
129588481|NCT04892147|466447665|FG001|Overall Study|Withdrawal by Subject|0|||
129588482|NCT02661022|466447666|FG000|Overall Study|Withdrawal by Subject|3|||
129588483|NCT02661022|466447667|FG001|Overall Study|Withdrawal by Subject|0|||
129588484|NCT02661022|466447666|FG000|Overall Study|Adverse Event|1|||
129588485|NCT02661022|466447667|FG001|Overall Study|Adverse Event|1|||
129588486|NCT02661022|466447666|FG000|Overall Study|Physician Decision|1|||
129588487|NCT02661022|466447667|FG001|Overall Study|Physician Decision|0|||
129588488|NCT02661022|466447666|FG000|Overall Study|Progressive Disease|2|||
129588489|NCT02661022|466447667|FG001|Overall Study|Progressive Disease|1|||
129696204|NCT00968968|466845968|FG000|Overall Study|Lost to Follow-up|0|||
129588490|NCT01785615|466447675|FG000|Dietary Phase|Lost to Follow-up|0|||
129588491|NCT01785615|466447676|FG001|Dietary Phase|Lost to Follow-up|0|||
129588492|NCT01785615|466447677|FG002|Dietary Phase|Lost to Follow-up|0|||
129588493|NCT01785615|466447678|FG003|Dietary Phase|Lost to Follow-up|24|||
129588494|NCT03428945|466447679|FG000|Overall Study|Lost to Follow-up|5|||
129588495|NCT03428945|466447680|FG001|Overall Study|Lost to Follow-up|3|||
129588496|NCT03428945|466447679|FG000|Overall Study|Withdrawal by Subject|10|||
129588497|NCT03428945|466447680|FG001|Overall Study|Withdrawal by Subject|10|||
129588498|NCT01266603|466447681|FG000|Overall Study|Adverse Event|1|||
129588499|NCT01266603|466447681|FG000|Overall Study|Lack of Efficacy|14|||
129588500|NCT01266603|466447681|FG000|Overall Study|Withdrawal by Subject|1|||
129588501|NCT01266603|466447681|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
129588502|NCT01598896|466447683|FG000|Overall Study|Withdrawal by Subject|0|||
129588503|NCT01598896|466447684|FG001|Overall Study|Withdrawal by Subject|1|||
129588504|NCT01598896|466447683|FG000|Overall Study|Lack of Efficacy|0|||
129588505|NCT01598896|466447684|FG001|Overall Study|Lack of Efficacy|1|||
129588506|NCT01120691|466447687|FG000|Overall Study|Adverse Event|59|||
129588507|NCT01120691|466447688|FG001|Overall Study|Adverse Event|67|||
129588508|NCT01120691|466447689|FG002|Overall Study|Adverse Event|47|||
129588509|NCT01120691|466447687|FG000|Overall Study|Subject withdrew consent|33|||
129588510|NCT01120691|466447688|FG001|Overall Study|Subject withdrew consent|50|||
129588511|NCT01120691|466447689|FG002|Overall Study|Subject withdrew consent|44|||
129588512|NCT01120691|466447687|FG000|Overall Study|Death|21|||
129696205|NCT00968968|466845969|FG001|Overall Study|Lost to Follow-up|1|||
129588513|NCT01120691|466447688|FG001|Overall Study|Death|22|||
129588514|NCT01120691|466447689|FG002|Overall Study|Death|24|||
129588515|NCT01120691|466447687|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
129588516|NCT01120691|466447688|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
129588517|NCT01120691|466447689|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
129588518|NCT01120691|466447687|FG000|Overall Study|Administrative problems|15|||
129588519|NCT01120691|466447688|FG001|Overall Study|Administrative problems|8|||
129588520|NCT01120691|466447689|FG002|Overall Study|Administrative problems|9|||
129588521|NCT01120691|466447687|FG000|Overall Study|Protocol deviation|13|||
129588522|NCT01120691|466447688|FG001|Overall Study|Protocol deviation|12|||
129588523|NCT01120691|466447689|FG002|Overall Study|Protocol deviation|12|||
129588524|NCT01120691|466447687|FG000|Overall Study|Lost to Follow-up|5|||
129588525|NCT01120691|466447688|FG001|Overall Study|Lost to Follow-up|6|||
129588526|NCT01120691|466447689|FG002|Overall Study|Lost to Follow-up|4|||
129588527|NCT01120691|466447687|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129588528|NCT01120691|466447688|FG001|Overall Study|Abnormal test procedure result(s)|2|||
129588529|NCT01120691|466447689|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129588530|NCT01120691|466447687|FG000|Overall Study|Patient's inability to use the device|3|||
129588531|NCT01120691|466447688|FG001|Overall Study|Patient's inability to use the device|1|||
129588532|NCT01120691|466447689|FG002|Overall Study|Patient's inability to use the device|0|||
129588533|NCT01120691|466447687|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129588534|NCT01120691|466447688|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129588535|NCT01120691|466447689|FG002|Overall Study|Abnormal laboratory value(s)|4|||
129588536|NCT04553406|466447690|FG000|Overall Study|Study Discontinuation|0|||
129588537|NCT04553406|466447691|FG001|Overall Study|Study Discontinuation|1|||
129588538|NCT03370510|466447692|FG000|Overall Study|COVID-19|2|||
129588539|NCT03370510|466447693|FG001|Overall Study|COVID-19|0|||
129588540|NCT00772148|466447694|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
129588541|NCT00772148|466447695|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
129588542|NCT00772148|466447694|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
129588543|NCT00772148|466447695|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
129588544|NCT00772148|466447694|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
129588545|NCT00772148|466447695|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
129588546|NCT00772148|466447694|FG000|Maintenance Phase (Week 52)|Death|2|||
129588547|NCT00772148|466447695|FG001|Maintenance Phase (Week 52)|Death|2|||
129588548|NCT00772148|466447694|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
129588549|NCT00772148|466447695|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
129588550|NCT00772148|466447694|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
129588551|NCT00772148|466447695|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
129588552|NCT00772148|466447694|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
129588553|NCT00772148|466447695|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
129588554|NCT01562613|466447696|FG000|Overall Study|Lost to Follow-up|2|||
129588555|NCT01562613|466447696|FG000|Overall Study|Withdrawal by Subject|2|||
129588556|NCT03573336|466447701|FG000|Overall Study|Study terminated|2|||
129588557|NCT03573336|466447702|FG001|Overall Study|Study terminated|4|||
129588558|NCT03573336|466447703|FG002|Overall Study|Study terminated|2|||
129588559|NCT01525628|466447704|FG000|Overall Study|Adverse Event|1|||
129588560|NCT01525628|466447705|FG001|Overall Study|Adverse Event|1|||
129588561|NCT01525628|466447706|FG002|Overall Study|Adverse Event|2|||
129588562|NCT01525628|466447707|FG003|Overall Study|Adverse Event|0|||
129588563|NCT01525628|466447708|FG004|Overall Study|Adverse Event|1|||
129588564|NCT01525628|466447704|FG000|Overall Study|Lack of Efficacy|0|||
129588565|NCT01525628|466447705|FG001|Overall Study|Lack of Efficacy|2|||
129588566|NCT01525628|466447706|FG002|Overall Study|Lack of Efficacy|2|||
129588567|NCT01525628|466447707|FG003|Overall Study|Lack of Efficacy|1|||
129588568|NCT01525628|466447708|FG004|Overall Study|Lack of Efficacy|2|||
129588569|NCT01525628|466447704|FG000|Overall Study|Protocol Violation|0|||
129588570|NCT01525628|466447705|FG001|Overall Study|Protocol Violation|0|||
129588571|NCT01525628|466447706|FG002|Overall Study|Protocol Violation|1|||
129588572|NCT01525628|466447707|FG003|Overall Study|Protocol Violation|0|||
129588573|NCT01525628|466447708|FG004|Overall Study|Protocol Violation|0|||
129588574|NCT01525628|466447704|FG000|Overall Study|Lost to Follow-up|1|||
129588575|NCT01525628|466447705|FG001|Overall Study|Lost to Follow-up|1|||
129588576|NCT01525628|466447706|FG002|Overall Study|Lost to Follow-up|0|||
129588577|NCT01525628|466447707|FG003|Overall Study|Lost to Follow-up|0|||
129588578|NCT01525628|466447708|FG004|Overall Study|Lost to Follow-up|0|||
129588579|NCT01525628|466447704|FG000|Overall Study|Withdrawal by Subject|0|||
129588580|NCT01525628|466447705|FG001|Overall Study|Withdrawal by Subject|1|||
129588581|NCT01525628|466447706|FG002|Overall Study|Withdrawal by Subject|0|||
129588582|NCT01525628|466447707|FG003|Overall Study|Withdrawal by Subject|0|||
129588583|NCT01525628|466447708|FG004|Overall Study|Withdrawal by Subject|0|||
129588584|NCT01525628|466447704|FG000|Overall Study|Other reason not defined above|0|||
129588585|NCT01525628|466447705|FG001|Overall Study|Other reason not defined above|0|||
129588586|NCT01525628|466447706|FG002|Overall Study|Other reason not defined above|0|||
129588587|NCT01525628|466447707|FG003|Overall Study|Other reason not defined above|3|||
129588588|NCT01525628|466447708|FG004|Overall Study|Other reason not defined above|0|||
129588589|NCT03493919|466447710|FG000|Overall Study|Other|2|||
129588590|NCT03493919|466447711|FG001|Overall Study|Other|0|||
129588591|NCT03493919|466447712|FG002|Overall Study|Other|1|||
129588592|NCT03493919|466447713|FG003|Overall Study|Other|0|||
129588593|NCT03493919|466447710|FG000|Overall Study|Withdrawal by Subject|9|||
129588594|NCT03493919|466447711|FG001|Overall Study|Withdrawal by Subject|3|||
129588595|NCT03493919|466447712|FG002|Overall Study|Withdrawal by Subject|1|||
129588596|NCT03493919|466447713|FG003|Overall Study|Withdrawal by Subject|1|||
129588597|NCT03493919|466447710|FG000|Overall Study|Lost to Follow-up|5|||
129588598|NCT03493919|466447711|FG001|Overall Study|Lost to Follow-up|0|||
129588599|NCT03493919|466447712|FG002|Overall Study|Lost to Follow-up|0|||
129588600|NCT03493919|466447713|FG003|Overall Study|Lost to Follow-up|3|||
129588601|NCT03493919|466447710|FG000|Overall Study|Adverse Event|0|||
129588602|NCT03493919|466447711|FG001|Overall Study|Adverse Event|1|||
129588603|NCT03493919|466447712|FG002|Overall Study|Adverse Event|0|||
129588604|NCT03493919|466447713|FG003|Overall Study|Adverse Event|0|||
129588605|NCT04640194|466447714|FG000|Overall Study|Adverse Event|3|||
129588606|NCT04640194|466447715|FG001|Overall Study|Adverse Event|7|||
129588607|NCT04640194|466447716|FG002|Overall Study|Adverse Event|0|||
129588608|NCT04640194|466447717|FG003|Overall Study|Adverse Event|5|||
129588609|NCT04640194|466447718|FG004|Overall Study|Adverse Event|0|||
129588610|NCT04640194|466447719|FG005|Overall Study|Adverse Event|4|||
129588611|NCT04640194|466447720|FG006|Overall Study|Adverse Event|0|||
129588612|NCT04640194|466447714|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
129588613|NCT04640194|466447715|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
129588614|NCT04640194|466447716|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
129588615|NCT04640194|466447717|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
129588616|NCT04640194|466447718|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
129588617|NCT04640194|466447719|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
129588618|NCT04640194|466447720|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
129588619|NCT04640194|466447714|FG000|Overall Study|fibrinogen level too low|0|||
129588620|NCT04640194|466447715|FG001|Overall Study|fibrinogen level too low|0|||
129588621|NCT04640194|466447716|FG002|Overall Study|fibrinogen level too low|0|||
129588622|NCT04640194|466447717|FG003|Overall Study|fibrinogen level too low|1|||
129588623|NCT04640194|466447718|FG004|Overall Study|fibrinogen level too low|0|||
129588624|NCT04640194|466447719|FG005|Overall Study|fibrinogen level too low|0|||
129588625|NCT04640194|466447720|FG006|Overall Study|fibrinogen level too low|0|||
129588626|NCT04640194|466447714|FG000|Overall Study|mild bleeding|0|||
129588627|NCT04640194|466447715|FG001|Overall Study|mild bleeding|0|||
129588628|NCT04640194|466447716|FG002|Overall Study|mild bleeding|0|||
129588629|NCT04640194|466447717|FG003|Overall Study|mild bleeding|1|||
129588630|NCT04640194|466447718|FG004|Overall Study|mild bleeding|0|||
129588631|NCT04640194|466447719|FG005|Overall Study|mild bleeding|0|||
129588632|NCT04640194|466447720|FG006|Overall Study|mild bleeding|0|||
129588633|NCT04640194|466447714|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129588634|NCT04640194|466447715|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
129588635|NCT04640194|466447716|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129588636|NCT04640194|466447717|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129588637|NCT04640194|466447718|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129588638|NCT04640194|466447719|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129588639|NCT04640194|466447720|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
129588640|NCT04773600|466447722|FG000|Overall Study|Withdrawal by Subject|15|||
129588641|NCT04773600|466447723|FG001|Overall Study|Withdrawal by Subject|9|||
129588642|NCT04773600|466447722|FG000|Overall Study|Lost to Follow-up|10|||
129588643|NCT04773600|466447723|FG001|Overall Study|Lost to Follow-up|6|||
129588644|NCT04773600|466447722|FG000|Overall Study|Adverse Event|8|||
129588645|NCT04773600|466447723|FG001|Overall Study|Adverse Event|2|||
129588646|NCT04773600|466447722|FG000|Overall Study|Lack of Efficacy|2|||
129588647|NCT04773600|466447723|FG001|Overall Study|Lack of Efficacy|3|||
129588648|NCT04773600|466447722|FG000|Overall Study|Noncompliance|2|||
129588649|NCT04773600|466447723|FG001|Overall Study|Noncompliance|0|||
129588650|NCT04773600|466447722|FG000|Overall Study|Protocol Violation|2|||
129588651|NCT04773600|466447723|FG001|Overall Study|Protocol Violation|0|||
129588652|NCT04773600|466447722|FG000|Overall Study|Physician Decision|0|||
129588653|NCT04773600|466447723|FG001|Overall Study|Physician Decision|1|||
129588654|NCT04773600|466447722|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
129588655|NCT04773600|466447723|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
129588656|NCT04773600|466447722|FG000|Overall Study|Emergency Travel Out of Country|1|||
129588657|NCT04773600|466447723|FG001|Overall Study|Emergency Travel Out of Country|0|||
129588658|NCT05135273|466449219|FG000|Overall Study|Recruited into the army|0|||
129588659|NCT05135273|466449220|FG001|Overall Study|Recruited into the army|0|||
129588660|NCT05135273|466449221|FG002|Overall Study|Recruited into the army|0|||
129588661|NCT05135273|466449222|FG003|Overall Study|Recruited into the army|0|||
129588662|NCT05135273|466449223|FG004|Overall Study|Recruited into the army|1|||
129588663|NCT05135273|466449224|FG005|Overall Study|Recruited into the army|0|||
129588664|NCT05135273|466449225|FG006|Overall Study|Recruited into the army|0|||
129588665|NCT05135273|466449226|FG007|Overall Study|Recruited into the army|0|||
129588666|NCT05135273|466449219|FG000|Overall Study|Moved away from study site|0|||
129588667|NCT05135273|466449220|FG001|Overall Study|Moved away from study site|0|||
129588668|NCT05135273|466449221|FG002|Overall Study|Moved away from study site|0|||
129588669|NCT05135273|466449222|FG003|Overall Study|Moved away from study site|0|||
129588670|NCT05135273|466449223|FG004|Overall Study|Moved away from study site|0|||
129588671|NCT05135273|466449224|FG005|Overall Study|Moved away from study site|1|||
129588672|NCT05135273|466449225|FG006|Overall Study|Moved away from study site|1|||
129588673|NCT05135273|466449226|FG007|Overall Study|Moved away from study site|0|||
129588674|NCT05135273|466449219|FG000|Overall Study|Travel|0|||
129588675|NCT05135273|466449220|FG001|Overall Study|Travel|0|||
129588676|NCT05135273|466449221|FG002|Overall Study|Travel|0|||
129588677|NCT05135273|466449222|FG003|Overall Study|Travel|0|||
129588678|NCT05135273|466449223|FG004|Overall Study|Travel|0|||
129588679|NCT05135273|466449224|FG005|Overall Study|Travel|0|||
129588680|NCT05135273|466449225|FG006|Overall Study|Travel|0|||
129588681|NCT05135273|466449226|FG007|Overall Study|Travel|1|||
129588682|NCT01705717|466449234|FG000|Overall Study|Adverse Event|2|||
129588683|NCT01705717|466449235|FG001|Overall Study|Adverse Event|2|||
129588684|NCT01705717|466449234|FG000|Overall Study|Lack of Efficacy|0|||
129588685|NCT01705717|466449235|FG001|Overall Study|Lack of Efficacy|1|||
129588686|NCT01705717|466449234|FG000|Overall Study|Other|0|||
129588687|NCT01705717|466449235|FG001|Overall Study|Other|2|||
129588688|NCT01662024|466449240|FG000|Overall Study|Pregnancy|2|||
129588689|NCT01662024|466449240|FG000|Overall Study|Withdrawal by Subject|3|||
129588690|NCT04980456|466449241|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
129588691|NCT04980456|466449242|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
129588692|NCT04980456|466449241|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
129588693|NCT04980456|466449242|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
129588694|NCT04980456|466449241|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
129588695|NCT04980456|466449242|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
129588696|NCT04980456|466449241|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
129588697|NCT04980456|466449242|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
129588698|NCT04832971|466449243|FG000|Overall Study|Death|1|||
129588699|NCT04832971|466449244|FG001|Overall Study|Death|0|||
129588700|NCT04832971|466449245|FG002|Overall Study|Death|0|||
129588701|NCT04832971|466449246|FG003|Overall Study|Death|0|||
129588702|NCT04832971|466449243|FG000|Overall Study|Lost to Follow-up|1|||
129588703|NCT04832971|466449244|FG001|Overall Study|Lost to Follow-up|1|||
129588704|NCT04832971|466449245|FG002|Overall Study|Lost to Follow-up|1|||
129588705|NCT04832971|466449246|FG003|Overall Study|Lost to Follow-up|0|||
129588706|NCT04832971|466449243|FG000|Overall Study|Withdrawal by Subject|1|||
129588707|NCT04832971|466449244|FG001|Overall Study|Withdrawal by Subject|3|||
129588708|NCT04832971|466449245|FG002|Overall Study|Withdrawal by Subject|2|||
129588709|NCT04832971|466449246|FG003|Overall Study|Withdrawal by Subject|2|||
129588710|NCT04832971|466449243|FG000|Overall Study|Other, Not Specified|0|||
129588711|NCT04832971|466449244|FG001|Overall Study|Other, Not Specified|0|||
129588712|NCT04832971|466449245|FG002|Overall Study|Other, Not Specified|1|||
129588713|NCT04832971|466449246|FG003|Overall Study|Other, Not Specified|0|||
129588714|NCT02293460|466449247|FG000|Overall Study|Protocol Violation|1|||
129588715|NCT02293460|466449247|FG000|Overall Study|Lack of Efficacy|2|||
129588716|NCT02293460|466449247|FG000|Overall Study|Adverse Event|2|||
129588717|NCT02293460|466449247|FG000|Overall Study|Withdrawal by Subject|1|||
129588718|NCT00500318|466449249|FG000|Overall Study|Adverse Event|3|||
129588719|NCT00500318|466449250|FG001|Overall Study|Adverse Event|8|||
129588720|NCT00500318|466449249|FG000|Overall Study|Protocol Violation|1|||
129588721|NCT00500318|466449250|FG001|Overall Study|Protocol Violation|3|||
129588722|NCT00500318|466449249|FG000|Overall Study|Withdrawal by Subject|1|||
129588723|NCT00500318|466449250|FG001|Overall Study|Withdrawal by Subject|2|||
129588724|NCT00500318|466449249|FG000|Overall Study|Lack of Efficacy|0|||
129588725|NCT00500318|466449250|FG001|Overall Study|Lack of Efficacy|3|||
129588726|NCT00500318|466449249|FG000|Overall Study|Other Reason|0|||
129588727|NCT00500318|466449250|FG001|Overall Study|Other Reason|1|||
129588728|NCT03243396|466449251|FG000|Overall Study|Lost to Follow-up|2|||
129588729|NCT03243396|466449252|FG001|Overall Study|Lost to Follow-up|3|||
129588730|NCT03243396|466449253|FG002|Overall Study|Lost to Follow-up|15|||
129588731|NCT03243396|466449254|FG003|Overall Study|Lost to Follow-up|8|||
129588732|NCT03243396|466449255|FG004|Overall Study|Lost to Follow-up|1|||
129588733|NCT03243396|466449256|FG005|Overall Study|Lost to Follow-up|4|||
129588734|NCT03243396|466449257|FG006|Overall Study|Lost to Follow-up|9|||
129588735|NCT03687242|466449258|FG000|Overall Study|Adverse Event|1|||
129588736|NCT01257581|466449259|FG000|Overall Study|Early Termination|3|||
129588737|NCT01257581|466449260|FG001|Overall Study|Early Termination|1|||
129588738|NCT01257581|466449261|FG002|Overall Study|Early Termination|2|||
129696206|NCT03624036|466845970|FG000|Overall Study|Death|2|||
129696207|NCT03624036|466845971|FG001|Overall Study|Death|3|||
129696208|NCT03624036|466845972|FG002|Overall Study|Death|0|||
129696209|NCT03624036|466845973|FG003|Overall Study|Death|1|||
129696210|NCT03624036|466845970|FG000|Overall Study|Withdrawal by Subject|1|||
129696211|NCT03624036|466845971|FG001|Overall Study|Withdrawal by Subject|0|||
129696212|NCT03624036|466845972|FG002|Overall Study|Withdrawal by Subject|1|||
129696213|NCT03624036|466845973|FG003|Overall Study|Withdrawal by Subject|0|||
129696214|NCT03624036|466845970|FG000|Overall Study|Enrolled but Never Treated|1|||
129696215|NCT03624036|466845971|FG001|Overall Study|Enrolled but Never Treated|0|||
129696216|NCT03624036|466845972|FG002|Overall Study|Enrolled but Never Treated|0|||
129696217|NCT03624036|466845973|FG003|Overall Study|Enrolled but Never Treated|0|||
129696218|NCT03624036|466845970|FG000|Overall Study|Reason not Specified|3|||
129696219|NCT03624036|466845971|FG001|Overall Study|Reason not Specified|0|||
129696220|NCT03624036|466845972|FG002|Overall Study|Reason not Specified|2|||
129696221|NCT03624036|466845973|FG003|Overall Study|Reason not Specified|2|||
129696222|NCT00930176|466845979|FG000|Overall Study|Death|1|||
129696223|NCT02413346|466845981|FG000|Overall Study|Adverse Event|6|||
129696224|NCT02413346|466845982|FG001|Overall Study|Adverse Event|6|||
129696225|NCT02413346|466845981|FG000|Overall Study|Withdrawal by Subject|30|||
129696226|NCT02413346|466845982|FG001|Overall Study|Withdrawal by Subject|40|||
129696227|NCT02413346|466845981|FG000|Overall Study|Lost to Follow-up|17|||
129696228|NCT02413346|466845982|FG001|Overall Study|Lost to Follow-up|21|||
129696229|NCT02413346|466845981|FG000|Overall Study|Protocol Violation|2|||
129588739|NCT01257581|466449259|FG000|Overall Study|Death|2|||
129588740|NCT01257581|466449260|FG001|Overall Study|Death|2|||
129588741|NCT01257581|466449261|FG002|Overall Study|Death|4|||
129588742|NCT02655224|466449262|FG000|Overall Study|Adverse Event|1|||
129696230|NCT02413346|466845982|FG001|Overall Study|Protocol Violation|0|||
129696231|NCT02413346|466845981|FG000|Overall Study|Other Miscellaneous Reasons|4|||
129588743|NCT02655224|466449263|FG001|Overall Study|Adverse Event|1|||
129588744|NCT04129944|466449267|FG000|Overall Study|Death|0|||
129588745|NCT04129944|466449268|FG001|Overall Study|Death|0|||
129588746|NCT04129944|466449269|FG002|Overall Study|Death|0|||
129588747|NCT04129944|466449270|FG003|Overall Study|Death|1|||
129588748|NCT04129944|466449267|FG000|Overall Study|Lost to Follow-up|1|||
129588749|NCT04129944|466449268|FG001|Overall Study|Lost to Follow-up|0|||
129588750|NCT04129944|466449269|FG002|Overall Study|Lost to Follow-up|0|||
129588751|NCT04129944|466449270|FG003|Overall Study|Lost to Follow-up|0|||
129588752|NCT04129944|466449267|FG000|Overall Study|Withdrawal by Subject|1|||
129588753|NCT04129944|466449268|FG001|Overall Study|Withdrawal by Subject|0|||
129588754|NCT04129944|466449269|FG002|Overall Study|Withdrawal by Subject|1|||
129588755|NCT04129944|466449270|FG003|Overall Study|Withdrawal by Subject|2|||
129588756|NCT02419573|466449271|FG000|Overall Study|Lost to Follow-up|3|||
129588757|NCT02419573|466449272|FG001|Overall Study|Lost to Follow-up|0|||
129588758|NCT02419573|466449271|FG000|Overall Study|Withdrawal by Subject|1|||
129588759|NCT02419573|466449272|FG001|Overall Study|Withdrawal by Subject|0|||
129588760|NCT00493792|466449273|FG000|Overall Study|Death|55|||
129588761|NCT00493792|466449274|FG001|Overall Study|Death|50|||
129588762|NCT00493792|466449273|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
129588763|NCT00493792|466449274|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
129588764|NCT02246764|466449275|FG000|Overall Study|Adverse Event|15|||
129588765|NCT02246764|466449276|FG001|Overall Study|Adverse Event|29|||
129588766|NCT02246764|466449277|FG002|Overall Study|Adverse Event|1|||
129588767|NCT02246764|466449275|FG000|Overall Study|Withdrawal by Subject|0|||
129588768|NCT02246764|466449276|FG001|Overall Study|Withdrawal by Subject|0|||
129588769|NCT02246764|466449277|FG002|Overall Study|Withdrawal by Subject|1|||
129588770|NCT02246764|466449275|FG000|Overall Study|Disallowed Concomitant Medication|1|||
129588771|NCT02246764|466449276|FG001|Overall Study|Disallowed Concomitant Medication|0|||
129588772|NCT02246764|466449277|FG002|Overall Study|Disallowed Concomitant Medication|0|||
129696232|NCT02413346|466845982|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129588773|NCT02246764|466449275|FG000|Overall Study|Physician Decision|0|||
129588774|NCT02246764|466449276|FG001|Overall Study|Physician Decision|2|||
129696233|NCT00954538|466845986|FG000|Part III|Withdrawal by Subject|0|||
129696234|NCT00954538|466845987|FG001|Part III|Withdrawal by Subject|0|||
129696235|NCT00954538|466845988|FG002|Part III|Withdrawal by Subject|0|||
129696236|NCT00954538|466845989|FG003|Part III|Withdrawal by Subject|0|||
129696237|NCT00954538|466845990|FG004|Part III|Withdrawal by Subject|1|||
129696238|NCT00954538|466845991|FG005|Part III|Withdrawal by Subject|0|||
129696239|NCT00992394|466845992|FG000|Overall Study|Lack of Efficacy|6|||
129696240|NCT00992394|466845993|FG001|Overall Study|Lack of Efficacy|3|||
129696241|NCT00992394|466845992|FG000|Overall Study|Adverse Event|4|||
129696242|NCT00992394|466845993|FG001|Overall Study|Adverse Event|5|||
129696243|NCT00992394|466845992|FG000|Overall Study|Withdrawal by Subject|8|||
129696244|NCT00992394|466845993|FG001|Overall Study|Withdrawal by Subject|2|||
129696245|NCT00992394|466845992|FG000|Overall Study|Physician Decision|1|||
129696246|NCT00992394|466845993|FG001|Overall Study|Physician Decision|0|||
129696247|NCT00992394|466845992|FG000|Overall Study|Protocol Violation|2|||
129696248|NCT00992394|466845993|FG001|Overall Study|Protocol Violation|4|||
129696249|NCT00992394|466845992|FG000|Overall Study|Lost to Follow-up|2|||
129696250|NCT00992394|466845993|FG001|Overall Study|Lost to Follow-up|0|||
129696251|NCT00992394|466845992|FG000|Overall Study|Other event|1|||
129696252|NCT00992394|466845993|FG001|Overall Study|Other event|0|||
129696253|NCT00537082|466845996|FG000|Overall Study|Adverse Event|6|||
129696254|NCT00537082|466845997|FG001|Overall Study|Adverse Event|6|||
129696255|NCT00537082|466845998|FG002|Overall Study|Adverse Event|3|||
129696256|NCT00537082|466845996|FG000|Overall Study|Protocol Violation|0|||
129696257|NCT00537082|466845997|FG001|Overall Study|Protocol Violation|2|||
129696258|NCT00537082|466845998|FG002|Overall Study|Protocol Violation|1|||
129696259|NCT00537082|466845996|FG000|Overall Study|Lack of Efficacy|0|||
129696260|NCT00537082|466845997|FG001|Overall Study|Lack of Efficacy|0|||
129696261|NCT00537082|466845998|FG002|Overall Study|Lack of Efficacy|2|||
129696262|NCT00537082|466845996|FG000|Overall Study|Withdrawal by Subject|0|||
129696263|NCT00537082|466845997|FG001|Overall Study|Withdrawal by Subject|1|||
129696264|NCT00537082|466845998|FG002|Overall Study|Withdrawal by Subject|0|||
129696265|NCT00537082|466845996|FG000|Overall Study|Discontinued before initiating treatment|3|||
129588775|NCT02246764|466449277|FG002|Overall Study|Physician Decision|1|||
129588776|NCT02246764|466449275|FG000|Overall Study|Protocol Violation|2|||
129588777|NCT02246764|466449276|FG001|Overall Study|Protocol Violation|1|||
129588778|NCT02246764|466449277|FG002|Overall Study|Protocol Violation|1|||
129588779|NCT02754492|466449278|FG000|Overall Study|Protocol Violation|2|||
129588780|NCT02754492|466449279|FG001|Overall Study|Protocol Violation|2|||
129588781|NCT02754492|466449280|FG002|Overall Study|Protocol Violation|0|||
129696266|NCT00537082|466845997|FG001|Overall Study|Discontinued before initiating treatment|0|||
129696267|NCT00537082|466845998|FG002|Overall Study|Discontinued before initiating treatment|0|||
129696268|NCT00655746|466845999|FG000|Overall Study|Withdrawal by Subject|1|||
129885466|NCT00849680|467540731|FG007|Overall Study|Lost to Follow-up|5|||
129588782|NCT02754492|466449281|FG003|Overall Study|Protocol Violation|1|||
129696269|NCT03061214|466846003|FG000|Overall Study|Withdrawal by Subject|21|||
129696270|NCT03061214|466846004|FG001|Overall Study|Withdrawal by Subject|26|||
129588783|NCT02754492|466449278|FG000|Overall Study|Withdrawal by Subject|2|||
129588784|NCT02754492|466449279|FG001|Overall Study|Withdrawal by Subject|0|||
129588785|NCT02754492|466449280|FG002|Overall Study|Withdrawal by Subject|0|||
129588786|NCT02754492|466449281|FG003|Overall Study|Withdrawal by Subject|0|||
129588787|NCT02754492|466449278|FG000|Overall Study|Equipment malfuntion|0|||
129588788|NCT02754492|466449279|FG001|Overall Study|Equipment malfuntion|0|||
129588789|NCT02754492|466449280|FG002|Overall Study|Equipment malfuntion|2|||
129588790|NCT02754492|466449281|FG003|Overall Study|Equipment malfuntion|5|||
129588791|NCT02754492|466449278|FG000|Overall Study|Adverse Event|0|||
129588792|NCT02754492|466449279|FG001|Overall Study|Adverse Event|0|||
129588793|NCT02754492|466449280|FG002|Overall Study|Adverse Event|0|||
129588794|NCT02754492|466449281|FG003|Overall Study|Adverse Event|13|||
129588795|NCT02754492|466449278|FG000|Overall Study|Venous access issues not resulting in AE|0|||
129588796|NCT02754492|466449279|FG001|Overall Study|Venous access issues not resulting in AE|0|||
129588797|NCT02754492|466449280|FG002|Overall Study|Venous access issues not resulting in AE|0|||
129588798|NCT02754492|466449281|FG003|Overall Study|Venous access issues not resulting in AE|4|||
129588799|NCT02104817|466449282|FG000|Overall Study|Death|363|||
129588800|NCT02104817|466449283|FG001|Overall Study|Death|330|||
129588801|NCT02104817|466449282|FG000|Overall Study|Lost to Follow-up|3|||
129588802|NCT02104817|466449283|FG001|Overall Study|Lost to Follow-up|2|||
129588803|NCT02104817|466449282|FG000|Overall Study|Protocol Violation|0|||
129588804|NCT02104817|466449283|FG001|Overall Study|Protocol Violation|1|||
129588805|NCT02104817|466449282|FG000|Overall Study|Study terminated by sponsor|5854|||
129588806|NCT02104817|466449283|FG001|Overall Study|Study terminated by sponsor|5901|||
129588807|NCT02104817|466449282|FG000|Overall Study|Withdrawal by Subject|111|||
129588808|NCT02104817|466449283|FG001|Overall Study|Withdrawal by Subject|78|||
129588809|NCT02104817|466449282|FG000|Overall Study|Other reasons|128|||
129588810|NCT02104817|466449283|FG001|Overall Study|Other reasons|135|||
129588811|NCT02575339|466449290|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
129588812|NCT02575339|466449291|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129588813|NCT02575339|466449292|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129588814|NCT02575339|466449290|FG000|Study Treatment|Disease Progression|5|||
129588815|NCT02575339|466449291|FG001|Study Treatment|Disease Progression|2|||
129588816|NCT02575339|466449292|FG002|Study Treatment|Disease Progression|0|||
129588817|NCT02575339|466449290|FG000|Study Treatment|Adverse Event|1|||
129588818|NCT02575339|466449291|FG001|Study Treatment|Adverse Event|2|||
129588819|NCT02575339|466449292|FG002|Study Treatment|Adverse Event|0|||
129588820|NCT02575339|466449290|FG000|Follow up|Death|6|||
129588821|NCT02575339|466449291|FG001|Follow up|Death|2|||
129588822|NCT02575339|466449292|FG002|Follow up|Death|0|||
129588823|NCT02575339|466449290|FG000|Follow up|Study Terminated|0|||
129588824|NCT02575339|466449291|FG001|Follow up|Study Terminated|2|||
129588825|NCT02575339|466449292|FG002|Follow up|Study Terminated|0|||
129588826|NCT02575339|466449290|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
129588827|NCT02575339|466449291|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
129588828|NCT02575339|466449292|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
129588829|NCT04675775|466449293|FG000|Overall Study|Withdrawal by Subject|7|||
129588830|NCT04633642|466449294|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
129588831|NCT04633642|466449295|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
129588832|NCT03223909|466449296|FG000|Overall Study|Protocol Violation|48|||
129588833|NCT03223909|466449297|FG001|Overall Study|Protocol Violation|45|||
129588834|NCT03223909|466449298|FG002|Overall Study|Protocol Violation|16|||
129588835|NCT01628549|466449303|FG000|Overall Study|Adverse Event|1|||
129588836|NCT01628549|466449304|FG001|Overall Study|Adverse Event|1|||
129588837|NCT01628549|466449305|FG002|Overall Study|Adverse Event|0|||
129588838|NCT01628549|466449306|FG003|Overall Study|Adverse Event|4|||
129588839|NCT01628549|466449303|FG000|Overall Study|Lost to Follow-up|3|||
129588840|NCT01628549|466449304|FG001|Overall Study|Lost to Follow-up|4|||
129588841|NCT01628549|466449305|FG002|Overall Study|Lost to Follow-up|3|||
129588842|NCT01628549|466449306|FG003|Overall Study|Lost to Follow-up|3|||
129588843|NCT01628549|466449303|FG000|Overall Study|Withdrawal by Subject|3|||
129588844|NCT01628549|466449304|FG001|Overall Study|Withdrawal by Subject|4|||
129588845|NCT01628549|466449305|FG002|Overall Study|Withdrawal by Subject|4|||
129588846|NCT01628549|466449306|FG003|Overall Study|Withdrawal by Subject|1|||
129588847|NCT01628549|466449303|FG000|Overall Study|Protocol Violation|2|||
129588848|NCT01628549|466449304|FG001|Overall Study|Protocol Violation|1|||
129588849|NCT01628549|466449305|FG002|Overall Study|Protocol Violation|1|||
129588850|NCT01628549|466449306|FG003|Overall Study|Protocol Violation|0|||
129588851|NCT01628549|466449303|FG000|Overall Study|withdrawn for noncompliance|0|||
129588852|NCT01628549|466449304|FG001|Overall Study|withdrawn for noncompliance|2|||
129588853|NCT01628549|466449305|FG002|Overall Study|withdrawn for noncompliance|1|||
129588854|NCT01628549|466449306|FG003|Overall Study|withdrawn for noncompliance|0|||
129588855|NCT01628549|466449303|FG000|Overall Study|abnormal laboratory test results|0|||
129588856|NCT01628549|466449304|FG001|Overall Study|abnormal laboratory test results|0|||
129588857|NCT01628549|466449305|FG002|Overall Study|abnormal laboratory test results|1|||
129588858|NCT01628549|466449306|FG003|Overall Study|abnormal laboratory test results|0|||
129588859|NCT01628549|466449303|FG000|Overall Study|positive pregnancy test|0|||
129588860|NCT01628549|466449304|FG001|Overall Study|positive pregnancy test|0|||
129588861|NCT01628549|466449305|FG002|Overall Study|positive pregnancy test|0|||
129588862|NCT01628549|466449306|FG003|Overall Study|positive pregnancy test|1|||
129588863|NCT00177164|466449310|FG000|Overall Study|Protocol Violation|0|||
129588864|NCT00177164|466449311|FG001|Overall Study|Protocol Violation|7|||
129588865|NCT00177164|466449310|FG000|Overall Study|Lost to Follow-up|4|||
129588866|NCT00177164|466449311|FG001|Overall Study|Lost to Follow-up|5|||
129588867|NCT00177164|466449310|FG000|Overall Study|increase in alcohol and drug use|1|||
129588868|NCT00177164|466449311|FG001|Overall Study|increase in alcohol and drug use|2|||
129588869|NCT00177164|466449310|FG000|Overall Study|Adverse Event|1|||
129588870|NCT00177164|466449311|FG001|Overall Study|Adverse Event|0|||
129588871|NCT00177164|466449310|FG000|Overall Study|discharge from hospital|1|||
129588872|NCT00177164|466449311|FG001|Overall Study|discharge from hospital|0|||
129588873|NCT00177164|466449310|FG000|Overall Study|Lack of Efficacy|2|||
129588874|NCT00177164|466449311|FG001|Overall Study|Lack of Efficacy|1|||
129588875|NCT00177164|466449310|FG000|Overall Study|Pregnancy|0|||
129588876|NCT00177164|466449311|FG001|Overall Study|Pregnancy|1|||
129588877|NCT00965757|466449312|FG000|Double-blind Phase|Progression of concomitant disease|1|||
129588878|NCT00965757|466449313|FG001|Double-blind Phase|Progression of concomitant disease|2|||
129588879|NCT00965757|466449314|FG002|Double-blind Phase|Progression of concomitant disease|0|||
129588880|NCT00965757|466449315|FG003|Double-blind Phase|Progression of concomitant disease|0|||
129588881|NCT00965757|466449312|FG000|Double-blind Phase|Adverse drug reaction|2|||
129588882|NCT00965757|466449313|FG001|Double-blind Phase|Adverse drug reaction|1|||
129588883|NCT00965757|466449314|FG002|Double-blind Phase|Adverse drug reaction|0|||
129588884|NCT00965757|466449315|FG003|Double-blind Phase|Adverse drug reaction|0|||
129588885|NCT00965757|466449312|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
129588886|NCT00965757|466449313|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
129588887|NCT00965757|466449314|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
129588888|NCT00965757|466449315|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
129885467|NCT00849680|467540724|FG000|Overall Study|Subject moved|1|||
129885468|NCT00849680|467540725|FG001|Overall Study|Subject moved|0|||
129885469|NCT00849680|467540726|FG002|Overall Study|Subject moved|3|||
129885470|NCT00849680|467540727|FG003|Overall Study|Subject moved|1|||
129885471|NCT00849680|467540728|FG004|Overall Study|Subject moved|0|||
129885472|NCT00849680|467540729|FG005|Overall Study|Subject moved|2|||
129885473|NCT00849680|467540730|FG006|Overall Study|Subject moved|2|||
129885474|NCT00849680|467540731|FG007|Overall Study|Subject moved|2|||
129885475|NCT00849680|467540724|FG000|Overall Study|Withdrawal by Subject|2|||
129885476|NCT00849680|467540725|FG001|Overall Study|Withdrawal by Subject|0|||
129885477|NCT00849680|467540726|FG002|Overall Study|Withdrawal by Subject|0|||
129885478|NCT00849680|467540727|FG003|Overall Study|Withdrawal by Subject|2|||
129885479|NCT00849680|467540728|FG004|Overall Study|Withdrawal by Subject|2|||
129885480|NCT00849680|467540729|FG005|Overall Study|Withdrawal by Subject|2|||
129885481|NCT00849680|467540730|FG006|Overall Study|Withdrawal by Subject|1|||
129885482|NCT00849680|467540731|FG007|Overall Study|Withdrawal by Subject|1|||
129885483|NCT00849680|467540724|FG000|Overall Study|Subject unable to comply with protocol|1|||
129885484|NCT00849680|467540725|FG001|Overall Study|Subject unable to comply with protocol|0|||
129885485|NCT00849680|467540726|FG002|Overall Study|Subject unable to comply with protocol|0|||
129885486|NCT00849680|467540727|FG003|Overall Study|Subject unable to comply with protocol|0|||
129885487|NCT00849680|467540728|FG004|Overall Study|Subject unable to comply with protocol|0|||
129885488|NCT00849680|467540729|FG005|Overall Study|Subject unable to comply with protocol|0|||
129885489|NCT00849680|467540730|FG006|Overall Study|Subject unable to comply with protocol|0|||
129885490|NCT00849680|467540731|FG007|Overall Study|Subject unable to comply with protocol|0|||
129885491|NCT02942004|467540734|FG000|Overall Study|Withdrawal by Subject|0|||
129885492|NCT02942004|467540735|FG001|Overall Study|Withdrawal by Subject|2|||
129885493|NCT02942004|467540736|FG002|Overall Study|Withdrawal by Subject|3|||
129885494|NCT02942004|467540734|FG000|Overall Study|Lost to Follow-up|1|||
129885495|NCT02942004|467540735|FG001|Overall Study|Lost to Follow-up|1|||
129885496|NCT02942004|467540736|FG002|Overall Study|Lost to Follow-up|2|||
129885497|NCT02942004|467540734|FG000|Overall Study|Randomized but not dosed|3|||
129885498|NCT02942004|467540735|FG001|Overall Study|Randomized but not dosed|9|||
129885499|NCT02942004|467540736|FG002|Overall Study|Randomized but not dosed|4|||
129885500|NCT02207374|467540737|FG000|Overall Study|Withdrawal by Subject|5|||
129885501|NCT02207374|467540738|FG001|Overall Study|Withdrawal by Subject|9|||
129885502|NCT02207374|467540739|FG002|Overall Study|Withdrawal by Subject|4|||
129885503|NCT02207374|467540737|FG000|Overall Study|Death|1|||
129885504|NCT02207374|467540738|FG001|Overall Study|Death|0|||
129885505|NCT02207374|467540739|FG002|Overall Study|Death|1|||
129885506|NCT02207374|467540737|FG000|Overall Study|Missing follow-up information|0|||
129885507|NCT02207374|467540738|FG001|Overall Study|Missing follow-up information|1|||
129885508|NCT02207374|467540739|FG002|Overall Study|Missing follow-up information|1|||
129885509|NCT02087150|467540740|FG000|Overall Study|Death|0|||
129885510|NCT02087150|467540741|FG001|Overall Study|Death|1|||
129885511|NCT02087150|467540742|FG002|Overall Study|Death|0|||
129885512|NCT02087150|467540740|FG000|Overall Study|Lost to Follow-up|6|||
129885513|NCT02087150|467540741|FG001|Overall Study|Lost to Follow-up|13|||
129885514|NCT02087150|467540742|FG002|Overall Study|Lost to Follow-up|7|||
129885515|NCT02087150|467540740|FG000|Overall Study|Withdrawal by Subject|2|||
129885516|NCT02087150|467540741|FG001|Overall Study|Withdrawal by Subject|5|||
129885517|NCT02087150|467540742|FG002|Overall Study|Withdrawal by Subject|3|||
129885518|NCT02087150|467540740|FG000|Overall Study|Physician Decision|0|||
129885519|NCT02087150|467540741|FG001|Overall Study|Physician Decision|1|||
129885520|NCT02087150|467540742|FG002|Overall Study|Physician Decision|0|||
129885521|NCT02087150|467540740|FG000|Overall Study|Procedure not done|1|||
129885522|NCT02087150|467540741|FG001|Overall Study|Procedure not done|13|||
129885523|NCT02087150|467540742|FG002|Overall Study|Procedure not done|0|||
129885524|NCT02087150|467540740|FG000|Overall Study|F/U not completed w/in study window|0|||
129885525|NCT02087150|467540741|FG001|Overall Study|F/U not completed w/in study window|0|||
129885526|NCT02087150|467540742|FG002|Overall Study|F/U not completed w/in study window|1|||
129885527|NCT02087150|467540740|FG000|Overall Study|Other|1|||
129885528|NCT02087150|467540741|FG001|Overall Study|Other|0|||
129885529|NCT02087150|467540742|FG002|Overall Study|Other|0|||
129885530|NCT02087150|467540740|FG000|Overall Study|Pt moved out of town|0|||
129588889|NCT00965757|466449312|FG000|Double-blind Phase|Lack of Efficacy|7|||
129885531|NCT02087150|467540741|FG001|Overall Study|Pt moved out of town|1|||
129885532|NCT02087150|467540742|FG002|Overall Study|Pt moved out of town|0|||
129885533|NCT01448044|467540743|FG000|Treatment Period|Adverse Event|4|||
129885534|NCT01448044|467540744|FG001|Treatment Period|Adverse Event|3|||
129885535|NCT01448044|467540743|FG000|Treatment Period|Lack of Efficacy|5|||
129885536|NCT01448044|467540744|FG001|Treatment Period|Lack of Efficacy|12|||
129885537|NCT01448044|467540743|FG000|Treatment Period|Subject requested discontinue study drug|1|||
129885538|NCT01448044|467540744|FG001|Treatment Period|Subject requested discontinue study drug|0|||
129588890|NCT00965757|466449313|FG001|Double-blind Phase|Lack of Efficacy|11|||
129588891|NCT00965757|466449314|FG002|Double-blind Phase|Lack of Efficacy|0|||
129588892|NCT00965757|466449315|FG003|Double-blind Phase|Lack of Efficacy|0|||
129588893|NCT00965757|466449312|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
129588894|NCT00965757|466449313|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
129588895|NCT00965757|466449314|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
129588896|NCT00965757|466449315|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
129588897|NCT00965757|466449312|FG000|Double-blind Phase|Lost to Follow-up|0|||
129588898|NCT00965757|466449313|FG001|Double-blind Phase|Lost to Follow-up|1|||
129588899|NCT00965757|466449314|FG002|Double-blind Phase|Lost to Follow-up|0|||
129588900|NCT00965757|466449315|FG003|Double-blind Phase|Lost to Follow-up|0|||
129588901|NCT00965757|466449312|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
129588902|NCT00965757|466449313|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
129588903|NCT00965757|466449314|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
129588904|NCT00965757|466449315|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
129588905|NCT00965757|466449312|FG000|Double-blind Phase|Other|1|||
129588906|NCT00965757|466449313|FG001|Double-blind Phase|Other|0|||
129588907|NCT00965757|466449314|FG002|Double-blind Phase|Other|0|||
129588908|NCT00965757|466449315|FG003|Double-blind Phase|Other|0|||
129588909|NCT00965757|466449312|FG000|Extension Phase|Progression of concomitant disease|0|||
129588910|NCT00965757|466449313|FG001|Extension Phase|Progression of concomitant disease|0|||
129588911|NCT00965757|466449314|FG002|Extension Phase|Progression of concomitant disease|4|||
129588912|NCT00965757|466449315|FG003|Extension Phase|Progression of concomitant disease|2|||
129588913|NCT00965757|466449312|FG000|Extension Phase|Adverse drug reaction|0|||
129588914|NCT00965757|466449313|FG001|Extension Phase|Adverse drug reaction|0|||
129588915|NCT00965757|466449314|FG002|Extension Phase|Adverse drug reaction|6|||
129588916|NCT00965757|466449315|FG003|Extension Phase|Adverse drug reaction|3|||
129588917|NCT00965757|466449312|FG000|Extension Phase|Abnormal Laboratory Value|0|||
129588918|NCT00965757|466449313|FG001|Extension Phase|Abnormal Laboratory Value|0|||
129588919|NCT00965757|466449314|FG002|Extension Phase|Abnormal Laboratory Value|6|||
129588920|NCT00965757|466449315|FG003|Extension Phase|Abnormal Laboratory Value|1|||
129588921|NCT00965757|466449312|FG000|Extension Phase|Lack of Efficacy|0|||
129588922|NCT00965757|466449313|FG001|Extension Phase|Lack of Efficacy|0|||
129588923|NCT00965757|466449314|FG002|Extension Phase|Lack of Efficacy|8|||
129588924|NCT00965757|466449315|FG003|Extension Phase|Lack of Efficacy|12|||
129588925|NCT00965757|466449312|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
129588926|NCT00965757|466449313|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
129588927|NCT00965757|466449314|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
129588928|NCT00965757|466449315|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
129588929|NCT00965757|466449312|FG000|Extension Phase|Lost to Follow-up|0|||
129588930|NCT00965757|466449313|FG001|Extension Phase|Lost to Follow-up|0|||
129588931|NCT00965757|466449314|FG002|Extension Phase|Lost to Follow-up|0|||
129588932|NCT00965757|466449315|FG003|Extension Phase|Lost to Follow-up|1|||
129588933|NCT00965757|466449312|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
129588934|NCT00965757|466449313|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
129588935|NCT00965757|466449314|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
129588936|NCT00965757|466449315|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
129588937|NCT00965757|466449312|FG000|Extension Phase|Protocol Violation|0|||
129588938|NCT00965757|466449313|FG001|Extension Phase|Protocol Violation|0|||
129588939|NCT00965757|466449314|FG002|Extension Phase|Protocol Violation|0|||
129588940|NCT00965757|466449315|FG003|Extension Phase|Protocol Violation|1|||
129588941|NCT00965757|466449312|FG000|Extension Phase|Other|0|||
129588942|NCT00965757|466449313|FG001|Extension Phase|Other|0|||
129588943|NCT00965757|466449314|FG002|Extension Phase|Other|2|||
129588944|NCT00965757|466449315|FG003|Extension Phase|Other|1|||
129588945|NCT01344018|466449321|FG000|Overall Study|Death|22|||
129588946|NCT01344018|466449322|FG001|Overall Study|Death|25|||
129588947|NCT01344018|466449321|FG000|Overall Study|Lost to Follow-up|4|||
129588948|NCT01344018|466449322|FG001|Overall Study|Lost to Follow-up|7|||
129588949|NCT05070754|466449323|FG000|Overall Study|Withdrawal by Subject|0|||
129588950|NCT05070754|466449324|FG001|Overall Study|Withdrawal by Subject|0|||
129588951|NCT05070754|466449325|FG002|Overall Study|Withdrawal by Subject|0|||
129588952|NCT05070754|466449326|FG003|Overall Study|Withdrawal by Subject|1|||
129588953|NCT05070754|466449323|FG000|Overall Study|Protocol Violation|0|||
129588954|NCT05070754|466449324|FG001|Overall Study|Protocol Violation|0|||
129588955|NCT05070754|466449325|FG002|Overall Study|Protocol Violation|0|||
129588956|NCT05070754|466449326|FG003|Overall Study|Protocol Violation|1|||
129588957|NCT01398787|466449327|FG000|Overall Study|Adverse Event|1|||
129588958|NCT02351167|466449328|FG000|Overall Study|Withdrawal by Subject|19|||
129588959|NCT02351167|466449329|FG001|Overall Study|Withdrawal by Subject|18|||
129588960|NCT02351167|466449330|FG002|Overall Study|Withdrawal by Subject|21|||
129588961|NCT00668395|466449333|FG000|Overall Study|Withdrawal by Subject|4|||
129588962|NCT00668395|466449334|FG001|Overall Study|Withdrawal by Subject|4|||
129588963|NCT00668395|466449335|FG002|Overall Study|Withdrawal by Subject|1|||
129588964|NCT00668395|466449333|FG000|Overall Study|Adverse Event|1|||
129588965|NCT00668395|466449334|FG001|Overall Study|Adverse Event|1|||
129588966|NCT00668395|466449335|FG002|Overall Study|Adverse Event|0|||
129588967|NCT00668395|466449333|FG000|Overall Study|Physician Decision|1|||
129588968|NCT00668395|466449334|FG001|Overall Study|Physician Decision|1|||
129588969|NCT00668395|466449335|FG002|Overall Study|Physician Decision|0|||
129588970|NCT02858037|466449338|FG000|Overall Study|Death|1|||
129885539|NCT01448044|467540743|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
129885540|NCT01448044|467540744|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
129885541|NCT01448044|467540743|FG000|Treatment Period|Participant does not meet study criteria|1|||
129885542|NCT01448044|467540744|FG001|Treatment Period|Participant does not meet study criteria|0|||
129885543|NCT01448044|467540743|FG000|Treatment Period|Lost to Follow-up|2|||
129885544|NCT01448044|467540744|FG001|Treatment Period|Lost to Follow-up|1|||
129885545|NCT01448044|467540743|FG000|Treatment Period|Other reason|2|||
129885546|NCT01448044|467540744|FG001|Treatment Period|Other reason|0|||
129885547|NCT01448044|467540743|FG000|Follow Up Period|Withdrawal by Subject|1|||
129885548|NCT01448044|467540744|FG001|Follow Up Period|Withdrawal by Subject|1|||
129885549|NCT01448044|467540743|FG000|Follow Up Period|Lost to Follow-up|6|||
129885550|NCT01448044|467540744|FG001|Follow Up Period|Lost to Follow-up|2|||
129885551|NCT01448044|467540743|FG000|Follow Up Period|Other|5|||
129885552|NCT01448044|467540744|FG001|Follow Up Period|Other|11|||
129885553|NCT02500316|467540754|FG000|Overall Study|Adverse Event|3|||
129885554|NCT02500316|467540754|FG000|Overall Study|Lost to Follow-up|2|||
129885555|NCT02500316|467540754|FG000|Overall Study|Protocol Violation|1|||
129885556|NCT02500316|467540754|FG000|Overall Study|Withdrawal by Subject|15|||
129885557|NCT02500316|467540754|FG000|Overall Study|Final height achieved|5|||
129885558|NCT02500316|467540754|FG000|Overall Study|Due to war activity|1|||
129885559|NCT03560245|467540755|FG000|Overall Study|Withdrawal by Subject|3|||
129885560|NCT03560245|467540756|FG001|Overall Study|Withdrawal by Subject|2|||
129885561|NCT03560245|467540755|FG000|Overall Study|Adverse Event|1|||
129885562|NCT03560245|467540756|FG001|Overall Study|Adverse Event|1|||
129885563|NCT03560245|467540755|FG000|Overall Study|Protocol Violation|1|||
129885564|NCT03560245|467540756|FG001|Overall Study|Protocol Violation|0|||
129885565|NCT03560245|467540755|FG000|Overall Study|Death|0|||
129885566|NCT03560245|467540756|FG001|Overall Study|Death|1|||
129885567|NCT03560245|467540755|FG000|Overall Study|Lost to Follow-up|0|||
129885568|NCT03560245|467540756|FG001|Overall Study|Lost to Follow-up|1|||
129885569|NCT03560245|467540755|FG000|Overall Study|Physician Decision|0|||
129588971|NCT02858037|466449338|FG000|Overall Study|Withdrawal by Subject|18|||
129885570|NCT03560245|467540756|FG001|Overall Study|Physician Decision|1|||
129588972|NCT02858037|466449338|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
129588973|NCT02858037|466449338|FG000|Overall Study|Lost to Follow-up|3|||
129588974|NCT02858037|466449338|FG000|Overall Study|Other|4|||
129885571|NCT03560245|467540755|FG000|Overall Study|Other|0|||
129885572|NCT03560245|467540756|FG001|Overall Study|Other|1|||
129885573|NCT02611830|467540767|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
129885574|NCT02611830|467540768|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
129588975|NCT00715676|466449344|FG000|Overall Study|Adverse Event|3|||
129588976|NCT00715676|466449345|FG001|Overall Study|Adverse Event|5|||
129588977|NCT00715676|466449346|FG002|Overall Study|Adverse Event|21|||
129588978|NCT00715676|466449344|FG000|Overall Study|Withdrawal by Subject|1|||
129588979|NCT00715676|466449345|FG001|Overall Study|Withdrawal by Subject|3|||
129885575|NCT02611830|467540769|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
129588980|NCT00715676|466449346|FG002|Overall Study|Withdrawal by Subject|8|||
129588981|NCT00715676|466449344|FG000|Overall Study|Lost to Follow-up|1|||
129588982|NCT00715676|466449345|FG001|Overall Study|Lost to Follow-up|2|||
129588983|NCT00715676|466449346|FG002|Overall Study|Lost to Follow-up|1|||
129588984|NCT00715676|466449344|FG000|Overall Study|Terminated by Sponsor|1|||
129588985|NCT00715676|466449345|FG001|Overall Study|Terminated by Sponsor|0|||
129588986|NCT00715676|466449346|FG002|Overall Study|Terminated by Sponsor|0|||
129588987|NCT00715676|466449344|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
129588988|NCT00715676|466449345|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
129588989|NCT00715676|466449346|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
129588990|NCT00715676|466449344|FG000|Overall Study|Use of Exclusionary Medication|0|||
129588991|NCT00715676|466449345|FG001|Overall Study|Use of Exclusionary Medication|0|||
129588992|NCT00715676|466449346|FG002|Overall Study|Use of Exclusionary Medication|1|||
129588993|NCT00715676|466449344|FG000|Overall Study|Elevated Blood Glucose|0|||
129588994|NCT00715676|466449345|FG001|Overall Study|Elevated Blood Glucose|1|||
129588995|NCT00715676|466449346|FG002|Overall Study|Elevated Blood Glucose|0|||
129588996|NCT01091363|466449347|FG000|Overall Study|Withdrawal by Subject|11|||
129588997|NCT01091363|466449348|FG001|Overall Study|Withdrawal by Subject|15|||
129588998|NCT01091363|466449347|FG000|Overall Study|Lost to Follow-up|2|||
129588999|NCT01091363|466449348|FG001|Overall Study|Lost to Follow-up|2|||
129589000|NCT01881737|466449351|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
129589001|NCT01881737|466449351|FG000|Overall Study|Withdrawal by Subject|1|||
129589002|NCT01881737|466449351|FG000|Overall Study|Worsening of baseline behavior|1|||
129589003|NCT04106817|466449356|FG000|Overall Study|Lost to Follow-up|1|||
129589004|NCT04106817|466449357|FG001|Overall Study|Lost to Follow-up|0|||
129589005|NCT04106817|466449358|FG002|Overall Study|Lost to Follow-up|0|||
129589006|NCT02260635|466449359|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
129589007|NCT02260635|466449360|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
129589008|NCT02260635|466449359|FG000|Open-Label Extension|Study Termination|25|||
129589009|NCT02260635|466449360|FG001|Open-Label Extension|Study Termination|25|||
129589010|NCT02260635|466449359|FG000|Open-Label Extension|Withdrawal by Subject|1|||
129589011|NCT02260635|466449360|FG001|Open-Label Extension|Withdrawal by Subject|0|||
129589012|NCT00152516|466449361|FG000|Overall Study|Adverse Event|18|||
129589013|NCT00152516|466449361|FG000|Overall Study|Lack and Loss of Efficacy|30|||
129589014|NCT00152516|466449361|FG000|Overall Study|Lost to Follow-up|5|||
129589015|NCT00152516|466449361|FG000|Overall Study|Withdrawal by Subject|8|||
129589016|NCT00152516|466449361|FG000|Overall Study|Protocol Violation|3|||
129589017|NCT00152516|466449361|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
129589018|NCT00152516|466449361|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
129589019|NCT00152516|466449361|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
129589020|NCT00152516|466449361|FG000|Overall Study|Other: Non-Compliance|2|||
129589021|NCT00152516|466449361|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
129589022|NCT00152516|466449361|FG000|Overall Study|Other: Moved Out Of State|1|||
129589023|NCT00152516|466449361|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
129589024|NCT00152516|466449361|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
129589025|NCT00360490|466449362|FG000|Overall Study|Adverse Event|4|||
129589026|NCT00360490|466449363|FG001|Overall Study|Adverse Event|2|||
129589027|NCT00360490|466449362|FG000|Overall Study|Lost to Follow-up|2|||
129589028|NCT00360490|466449363|FG001|Overall Study|Lost to Follow-up|1|||
129589029|NCT00360490|466449362|FG000|Overall Study|Physician Decision|2|||
129589030|NCT00360490|466449363|FG001|Overall Study|Physician Decision|1|||
129589031|NCT00360490|466449362|FG000|Overall Study|Protocol Violation|0|||
129589032|NCT00360490|466449363|FG001|Overall Study|Protocol Violation|4|||
129589033|NCT00360490|466449362|FG000|Overall Study|Withdrawal by Subject|1|||
129589034|NCT00360490|466449363|FG001|Overall Study|Withdrawal by Subject|3|||
129589035|NCT01517867|466449364|FG000|Overall Study|never started treatment|29|||
129589036|NCT01517867|466449365|FG001|Overall Study|never started treatment|32|||
129589037|NCT01517867|466449364|FG000|Overall Study|Withdrawal by Subject|34|||
129589038|NCT01517867|466449365|FG001|Overall Study|Withdrawal by Subject|30|||
129589039|NCT01517867|466449364|FG000|Overall Study|Still in treatment at study end|0|||
129589040|NCT01517867|466449365|FG001|Overall Study|Still in treatment at study end|3|||
129589041|NCT03294317|466449367|FG000|Overall Study|Physician Decision|1|||
129589042|NCT03294317|466449367|FG000|Overall Study|Withdrawal by Subject|6|||
129589043|NCT03294317|466449367|FG000|Overall Study|Lost to Follow-up|1|||
129589044|NCT03294317|466449367|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
129589045|NCT03294317|466449367|FG000|Overall Study|Failed HB lead implant|8|||
129589046|NCT03294317|466449367|FG000|Overall Study|Received CRT instead|1|||
129589047|NCT03294317|466449367|FG000|Overall Study|Exited after lead revision|2|||
129589048|NCT02466386|466449368|FG000|Overall Study|Adverse Event|5|||
129589049|NCT02466386|466449368|FG000|Overall Study|Protocol Violation|2|||
129589050|NCT02466386|466449368|FG000|Overall Study|Withdrawal by Subject|14|||
129589051|NCT02466386|466449368|FG000|Overall Study|Lost to Follow-up|5|||
129589052|NCT02466386|466449368|FG000|Overall Study|Lack of Efficacy|8|||
129589053|NCT02466386|466449368|FG000|Overall Study|Other|10|||
129589054|NCT05317195|466449369|FG000|Randomization|Withdrawal by Subject|1|||
129589055|NCT05317195|466449369|FG000|Randomization|Discontinued|6|||
129589056|NCT05317195|466449369|FG000|Admission|Withdrawal by Subject|2|||
129589057|NCT02387762|466449370|FG000|Overall Study|Withdrawal by Subject|1|||
129589058|NCT02387762|466449371|FG001|Overall Study|Withdrawal by Subject|0|||
129589059|NCT02614898|466449381|FG000|Overall Study|Participated until study termination|10|||
129589060|NCT02614898|466449382|FG001|Overall Study|Participated until study termination|26|||
129589061|NCT02614898|466449381|FG000|Overall Study|Lost to Follow-up|0|||
129589062|NCT02614898|466449382|FG001|Overall Study|Lost to Follow-up|2|||
129589063|NCT02614898|466449381|FG000|Overall Study|Physician Decision|1|||
129589064|NCT02614898|466449382|FG001|Overall Study|Physician Decision|8|||
129589065|NCT02614898|466449381|FG000|Overall Study|Study Terminated by Sponsor|3|||
129589066|NCT02614898|466449382|FG001|Overall Study|Study Terminated by Sponsor|0|||
129589067|NCT02614898|466449381|FG000|Overall Study|Withdrawal by Subject|0|||
129589068|NCT02614898|466449382|FG001|Overall Study|Withdrawal by Subject|2|||
129589069|NCT02614898|466449381|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129589070|NCT02614898|466449382|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129589071|NCT02614898|466449381|FG000|Overall Study|Other-Additional Information Unavailable|0|||
129589072|NCT02614898|466449382|FG001|Overall Study|Other-Additional Information Unavailable|11|||
129589073|NCT02614898|466449381|FG000|Overall Study|Missing|0|||
129589074|NCT02614898|466449382|FG001|Overall Study|Missing|1|||
129589075|NCT00239005|466449383|FG000|Overall Study|Adverse Event|6|||
129589076|NCT00239005|466449384|FG001|Overall Study|Adverse Event|6|||
129589077|NCT00239005|466449383|FG000|Overall Study|Withdrawal by Subject|3|||
129589078|NCT00239005|466449384|FG001|Overall Study|Withdrawal by Subject|4|||
129589079|NCT00239005|466449383|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
129589080|NCT00239005|466449384|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
129589081|NCT00239005|466449383|FG000|Overall Study|Protocol Violation|1|||
129589082|NCT00239005|466449384|FG001|Overall Study|Protocol Violation|0|||
129589083|NCT00239005|466449383|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
129589084|NCT00239005|466449384|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
129589085|NCT00239005|466449383|FG000|Overall Study|Lost to Follow-up|0|||
129589086|NCT00239005|466449384|FG001|Overall Study|Lost to Follow-up|1|||
129589087|NCT00787605|466449385|FG000|Overall Study|Administrative Problems|3|||
129589088|NCT00787605|466449386|FG001|Overall Study|Administrative Problems|0|||
129589089|NCT00787605|466449385|FG000|Overall Study|Adverse Event|14|||
129589090|NCT00787605|466449386|FG001|Overall Study|Adverse Event|25|||
129589091|NCT00787605|466449385|FG000|Overall Study|Lost to Follow-up|3|||
129589092|NCT00787605|466449386|FG001|Overall Study|Lost to Follow-up|6|||
129589093|NCT00787605|466449385|FG000|Overall Study|Protocol Violation|7|||
129589094|NCT00787605|466449386|FG001|Overall Study|Protocol Violation|3|||
129589095|NCT00787605|466449385|FG000|Overall Study|Withdrawal by Subject|6|||
129589096|NCT00787605|466449386|FG001|Overall Study|Withdrawal by Subject|13|||
129589097|NCT00787605|466449385|FG000|Overall Study|Lack of Efficacy|13|||
129589098|NCT00787605|466449386|FG001|Overall Study|Lack of Efficacy|9|||
129589099|NCT03382041|466449387|FG000|Overall Study|Consent Form Lost|2|||
129589100|NCT03382041|466449388|FG001|Overall Study|Consent Form Lost|1|||
129589101|NCT03382041|466449387|FG000|Overall Study|Withdrawal by Subject|1|||
129589102|NCT03382041|466449388|FG001|Overall Study|Withdrawal by Subject|4|||
129589103|NCT03382041|466449387|FG000|Overall Study|Lost to Follow-up|1|||
129589104|NCT03382041|466449388|FG001|Overall Study|Lost to Follow-up|4|||
129589105|NCT04428645|466449394|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
129589106|NCT00348816|466451342|FG000|Overall Study|Noncompliance with radiation treatment|1|||
129589107|NCT02050321|466451345|FG000|Overall Study|Withdrawal by Subject|1|||
129589108|NCT02050321|466451345|FG000|Overall Study|Adverse Event|1|||
129589109|NCT00113919|466451346|FG000|Overall Study|Physician Decision|8|||
129589110|NCT00113919|466451346|FG000|Overall Study|Death|6|||
129589111|NCT01963260|466451347|FG000|Overall Study|Withdrawal by Subject|2|||
129589112|NCT01963260|466451348|FG001|Overall Study|Withdrawal by Subject|0|||
129589113|NCT01963260|466451349|FG002|Overall Study|Withdrawal by Subject|0|||
129589114|NCT01963260|466451350|FG003|Overall Study|Withdrawal by Subject|1|||
129589115|NCT01963260|466451351|FG004|Overall Study|Withdrawal by Subject|2|||
129589116|NCT01963260|466451352|FG005|Overall Study|Withdrawal by Subject|0|||
129589117|NCT01963260|466451353|FG006|Overall Study|Withdrawal by Subject|0|||
129589118|NCT01963260|466451354|FG007|Overall Study|Withdrawal by Subject|0|||
129589119|NCT01963260|466451355|FG008|Overall Study|Withdrawal by Subject|0|||
129589120|NCT01963260|466451356|FG009|Overall Study|Withdrawal by Subject|0|||
129589121|NCT00372996|466451357|FG000|Overall Study|Death|11|||
129589122|NCT00372996|466451358|FG001|Overall Study|Death|4|||
129589123|NCT00372996|466451359|FG002|Overall Study|Death|8|||
129589124|NCT00372996|466451360|FG003|Overall Study|Death|7|||
129589125|NCT00372996|466451357|FG000|Overall Study|Lost to Follow-up|0|||
129589126|NCT00372996|466451358|FG001|Overall Study|Lost to Follow-up|2|||
129589127|NCT00372996|466451359|FG002|Overall Study|Lost to Follow-up|0|||
129589128|NCT00372996|466451360|FG003|Overall Study|Lost to Follow-up|1|||
129589129|NCT00372996|466451357|FG000|Overall Study|Withdrawal by Subject|12|||
129589130|NCT00372996|466451358|FG001|Overall Study|Withdrawal by Subject|6|||
129589131|NCT00372996|466451359|FG002|Overall Study|Withdrawal by Subject|9|||
129589132|NCT00372996|466451360|FG003|Overall Study|Withdrawal by Subject|5|||
129589133|NCT00372996|466451357|FG000|Overall Study|Study Terminated by Sponsor|4|||
129589134|NCT00372996|466451358|FG001|Overall Study|Study Terminated by Sponsor|0|||
129589135|NCT00372996|466451359|FG002|Overall Study|Study Terminated by Sponsor|4|||
129589136|NCT00372996|466451360|FG003|Overall Study|Study Terminated by Sponsor|0|||
129589137|NCT00372996|466451357|FG000|Overall Study|Other|10|||
129589138|NCT00372996|466451358|FG001|Overall Study|Other|2|||
129589139|NCT00372996|466451359|FG002|Overall Study|Other|7|||
129589140|NCT00372996|466451360|FG003|Overall Study|Other|7|||
129589141|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
129589142|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
129589143|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
129589144|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
129589145|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
129589146|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
129589147|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
129589148|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
129589149|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
129589150|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
129589151|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
129589152|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
129589153|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
129589154|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
129589155|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
129589156|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
129589157|NCT01067521|466451364|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
129589158|NCT01067521|466451365|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
129589159|NCT01067521|466451364|FG000|Open-Label Period|Death|3|||
129589160|NCT01067521|466451365|FG001|Open-Label Period|Death|1|||
129589161|NCT01067521|466451364|FG000|Open-Label Period|Adverse Event|30|||
129589162|NCT01067521|466451365|FG001|Open-Label Period|Adverse Event|28|||
129589163|NCT01067521|466451364|FG000|Open-Label Period|Withdrawal by Subject|160|||
129589164|NCT01067521|466451365|FG001|Open-Label Period|Withdrawal by Subject|88|||
129589165|NCT01067521|466451364|FG000|Open-Label Period|Physician Decision|13|||
129589166|NCT01067521|466451365|FG001|Open-Label Period|Physician Decision|11|||
129589167|NCT01067521|466451364|FG000|Open-Label Period|Non-compliance with study drug|5|||
129589168|NCT01067521|466451365|FG001|Open-Label Period|Non-compliance with study drug|0|||
129589169|NCT01067521|466451364|FG000|Open-Label Period|Protocol Violation|3|||
129589170|NCT01067521|466451365|FG001|Open-Label Period|Protocol Violation|0|||
129589171|NCT01067521|466451364|FG000|Open-Label Period|Pregnancy|14|||
129589172|NCT01067521|466451365|FG001|Open-Label Period|Pregnancy|8|||
129589173|NCT01067521|466451364|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
129589174|NCT01067521|466451365|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
129589175|NCT01067521|466451364|FG000|Open-Label Period|Lost to Follow-up|21|||
129589176|NCT01067521|466451365|FG001|Open-Label Period|Lost to Follow-up|20|||
129589177|NCT02151149|466451367|FG000|Treatment Period|Death|2|||
129589178|NCT02151149|466451368|FG001|Treatment Period|Death|3|||
129589179|NCT02151149|466451367|FG000|Treatment Period|Adverse Event|17|||
129589180|NCT02151149|466451368|FG001|Treatment Period|Adverse Event|14|||
129589181|NCT02151149|466451367|FG000|Treatment Period|Progressive Disease|25|||
129589182|NCT02151149|466451368|FG001|Treatment Period|Progressive Disease|24|||
129589183|NCT02151149|466451367|FG000|Treatment Period|Symptomatic Deterioration|2|||
129589184|NCT02151149|466451368|FG001|Treatment Period|Symptomatic Deterioration|10|||
129589185|NCT02151149|466451367|FG000|Treatment Period|Withdrawal by Subject|13|||
129589186|NCT02151149|466451368|FG001|Treatment Period|Withdrawal by Subject|11|||
129589187|NCT02151149|466451367|FG000|Treatment Period|Miscellaneous|8|||
129589188|NCT02151149|466451368|FG001|Treatment Period|Miscellaneous|7|||
129589189|NCT02151149|466451367|FG000|Treatment Period|Participants randomized but not treated|3|||
129589190|NCT02151149|466451368|FG001|Treatment Period|Participants randomized but not treated|2|||
129589191|NCT02151149|466451367|FG000|Follow-Up Period|Lost to Follow-up|2|||
129589192|NCT02151149|466451368|FG001|Follow-Up Period|Lost to Follow-up|3|||
129589193|NCT02151149|466451367|FG000|Follow-Up Period|Death|37|||
129589194|NCT02151149|466451368|FG001|Follow-Up Period|Death|34|||
129589195|NCT02760433|466451369|FG000|Overall Study|Lost to Follow-up|1|||
129589196|NCT02760433|466451370|FG001|Overall Study|Lost to Follow-up|0|||
129589197|NCT02760433|466451371|FG002|Overall Study|Lost to Follow-up|1|||
129589198|NCT02760433|466451372|FG003|Overall Study|Lost to Follow-up|0|||
129589199|NCT02760433|466451373|FG004|Overall Study|Lost to Follow-up|0|||
129589200|NCT02760433|466451369|FG000|Overall Study|Withdrawal by Subject|23|||
129589201|NCT02760433|466451370|FG001|Overall Study|Withdrawal by Subject|9|||
129589202|NCT02760433|466451371|FG002|Overall Study|Withdrawal by Subject|0|||
129589203|NCT02760433|466451372|FG003|Overall Study|Withdrawal by Subject|2|||
129589204|NCT02760433|466451373|FG004|Overall Study|Withdrawal by Subject|9|||
129589205|NCT02760433|466451369|FG000|Overall Study|Lack of Response At Week 14|0|||
129589206|NCT02760433|466451370|FG001|Overall Study|Lack of Response At Week 14|0|||
129589207|NCT02760433|466451371|FG002|Overall Study|Lack of Response At Week 14|0|||
129589208|NCT02760433|466451372|FG003|Overall Study|Lack of Response At Week 14|0|||
129589209|NCT02760433|466451373|FG004|Overall Study|Lack of Response At Week 14|1|||
129589210|NCT02760433|466451369|FG000|Overall Study|Subject refused to continue the study|1|||
129589211|NCT02760433|466451370|FG001|Overall Study|Subject refused to continue the study|0|||
129589212|NCT02760433|466451371|FG002|Overall Study|Subject refused to continue the study|0|||
129589213|NCT02760433|466451372|FG003|Overall Study|Subject refused to continue the study|0|||
129589214|NCT02760433|466451373|FG004|Overall Study|Subject refused to continue the study|0|||
129589215|NCT02760433|466451369|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
129589216|NCT02760433|466451370|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129589217|NCT02760433|466451371|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129589218|NCT02760433|466451372|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129589219|NCT02760433|466451373|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
129696271|NCT03061214|466846005|FG002|Overall Study|Withdrawal by Subject|9|||
129696272|NCT03061214|466846003|FG000|Overall Study|Lost to Follow-up|3|||
129696273|NCT03061214|466846004|FG001|Overall Study|Lost to Follow-up|1|||
129696274|NCT03061214|466846005|FG002|Overall Study|Lost to Follow-up|1|||
129696275|NCT03061214|466846003|FG000|Overall Study|Death|1|||
129696276|NCT03061214|466846004|FG001|Overall Study|Death|1|||
129696277|NCT03061214|466846005|FG002|Overall Study|Death|0|||
129696278|NCT03810365|466848029|FG000|Overall Study|Lost to Follow-up|2|||
129696279|NCT03810365|466848030|FG001|Overall Study|Lost to Follow-up|2|||
129696280|NCT03810365|466848029|FG000|Overall Study|Withdrawal by Subject|4|||
129696281|NCT03810365|466848030|FG001|Overall Study|Withdrawal by Subject|5|||
129696282|NCT02402907|466848039|FG000|Overall Study|Delivered vaginally|9|||
129589220|NCT02760433|466451369|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129696283|NCT02402907|466848040|FG001|Overall Study|Delivered vaginally|3|||
129696284|NCT02402907|466848039|FG000|Overall Study|Delivered outside of Sinai|1|||
129696285|NCT02402907|466848040|FG001|Overall Study|Delivered outside of Sinai|1|||
129696286|NCT02402907|466848039|FG000|Overall Study|Lost to follow up after C-Section|10|||
129589221|NCT02760433|466451370|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
129696287|NCT02402907|466848040|FG001|Overall Study|Lost to follow up after C-Section|23|||
129696288|NCT00449787|466848041|FG000|Overall Study|Lost to Follow-up|10|||
129696289|NCT00449787|466848042|FG001|Overall Study|Lost to Follow-up|8|||
129696290|NCT00449787|466848041|FG000|Overall Study|Did not require medication|95|||
129696291|NCT00449787|466848042|FG001|Overall Study|Did not require medication|92|||
129589222|NCT02760433|466451371|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129589223|NCT02760433|466451372|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129589224|NCT02760433|466451373|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
129589225|NCT00766493|466451374|FG000|30 Days Post-Procedure|Discontinued|7|||
129589226|NCT00766493|466451374|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
129589227|NCT00766493|466451374|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
129589228|NCT03419962|466451375|FG000|Overall Study|Change to other medication|1|||
129589229|NCT03419962|466451375|FG000|Overall Study|Refusal of continuing with trial drug|1|||
129589230|NCT03419962|466451375|FG000|Overall Study|Lost to Follow-up|3|||
129589231|NCT03419962|466451375|FG000|Overall Study|Difficulty in inhaling the doses|1|||
129589232|NCT03419962|466451375|FG000|Overall Study|Missing completion data|31|||
129589233|NCT01781234|466451381|FG000|Overall Study|Adverse Event|2|||
129589234|NCT01781234|466451382|FG001|Overall Study|Adverse Event|0|||
129589235|NCT01781234|466451381|FG000|Overall Study|Protocol Violation|3|||
129589236|NCT01781234|466451382|FG001|Overall Study|Protocol Violation|0|||
129589237|NCT01781234|466451381|FG000|Overall Study|Withdrawal by Subject|4|||
129589238|NCT01781234|466451382|FG001|Overall Study|Withdrawal by Subject|3|||
129589239|NCT03439085|466451383|FG000|Overall Study|Death|2|||
129589240|NCT03439085|466451383|FG000|Overall Study|Screen Failure|20|||
129589241|NCT01292837|466451384|FG000|Overall Study|Adverse Event|1|||
129589242|NCT01292837|466451384|FG000|Overall Study|Further treatment determined|1|||
129589243|NCT01206439|466451385|FG000|Overall Study|subject did not meet inclusion criteria|1|||
129589244|NCT05889039|466451386|FG000|Overall Study|error in completing survey|0|||
129589245|NCT05889039|466451387|FG001|Overall Study|error in completing survey|2|||
129589246|NCT05889039|466451388|FG002|Overall Study|error in completing survey|0|||
129589247|NCT05889039|466451389|FG003|Overall Study|error in completing survey|0|||
129589248|NCT05889039|466451386|FG000|Overall Study|Lost to Follow-up|4|||
129589249|NCT05889039|466451387|FG001|Overall Study|Lost to Follow-up|0|||
129589250|NCT05889039|466451388|FG002|Overall Study|Lost to Follow-up|0|||
129589251|NCT05889039|466451389|FG003|Overall Study|Lost to Follow-up|0|||
129589252|NCT04531527|466451392|FG000|Overall Study|Found to be Ineligible|3|||
129589253|NCT00982228|466451404|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
129589254|NCT00982228|466451405|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
129589255|NCT00982228|466451404|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
129589256|NCT00982228|466451405|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
129589257|NCT00982228|466451404|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
129589258|NCT00982228|466451405|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
129589259|NCT00982228|466451404|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
129589260|NCT00982228|466451405|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
129589261|NCT00982228|466451404|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
129589262|NCT00982228|466451405|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
129589263|NCT00982228|466451404|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
129589264|NCT00982228|466451405|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
129589265|NCT00982228|466451404|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
129589266|NCT00982228|466451405|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
129589267|NCT00982228|466451404|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
129589268|NCT00982228|466451405|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
129589269|NCT00982228|466451404|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
129589270|NCT00982228|466451405|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
129589271|NCT00982228|466451404|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
129589272|NCT00982228|466451405|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
129589273|NCT02250651|466451406|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
129589274|NCT02250651|466451407|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
129589275|NCT02250651|466451408|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
129885576|NCT02611830|467540770|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
129885577|NCT02611830|467540767|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
129885578|NCT02611830|467540768|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
129589276|NCT02250651|466451406|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
129589277|NCT02250651|466451407|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
129589278|NCT02250651|466451408|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
129589279|NCT02250651|466451406|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
129589280|NCT02250651|466451407|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
129589281|NCT02250651|466451408|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
129589282|NCT02250651|466451406|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
129589283|NCT02250651|466451407|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
129589284|NCT02250651|466451408|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
129589285|NCT02250651|466451406|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
129589286|NCT02250651|466451407|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
129589287|NCT02250651|466451408|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
129589288|NCT02250651|466451406|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
129589289|NCT02250651|466451407|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
129589290|NCT02250651|466451408|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
129589291|NCT02250651|466451406|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
129589292|NCT02250651|466451407|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
129589293|NCT02250651|466451408|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
129589294|NCT02250651|466451406|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
129589295|NCT02250651|466451407|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
129589296|NCT02250651|466451408|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
129589297|NCT02250651|466451406|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
129589298|NCT02250651|466451407|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
129589299|NCT02250651|466451408|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
129589300|NCT02250651|466451406|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
129589301|NCT02250651|466451407|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
129589302|NCT02250651|466451408|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
129589303|NCT02250651|466451406|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
129589304|NCT02250651|466451407|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
129589305|NCT02250651|466451408|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
129589306|NCT02250651|466451406|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
129589307|NCT02250651|466451407|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
129589308|NCT02250651|466451408|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
129589309|NCT02250651|466451406|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
129589310|NCT02250651|466451407|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
129589311|NCT02250651|466451408|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
129589312|NCT02250651|466451406|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
129885579|NCT02611830|467540769|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
129696292|NCT03701074|466848043|FG000|Overall Study|Physician Decision|1|||
129696293|NCT03701074|466848044|FG001|Overall Study|Physician Decision|0|||
129589313|NCT02250651|466451407|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
129589314|NCT02250651|466451408|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
129589315|NCT02250651|466451406|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
129589316|NCT02250651|466451407|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
129589317|NCT02250651|466451408|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
129589318|NCT03496298|466451409|FG000|Overall Study|Adverse Event|49|||
129589319|NCT03496298|466451410|FG001|Overall Study|Adverse Event|68|||
129589320|NCT03496298|466451411|FG002|Overall Study|Adverse Event|79|||
129589321|NCT03496298|466451409|FG000|Overall Study|Study terminated by Sponsor|1050|||
129589322|NCT03496298|466451410|FG001|Overall Study|Study terminated by Sponsor|1063|||
129589323|NCT03496298|466451411|FG002|Overall Study|Study terminated by Sponsor|1071|||
129589324|NCT03496298|466451409|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
129589325|NCT03496298|466451410|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
129589326|NCT03496298|466451411|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
129589327|NCT03496298|466451409|FG000|Overall Study|Withdrawal by Subject|176|||
129589328|NCT03496298|466451410|FG001|Overall Study|Withdrawal by Subject|154|||
129589329|NCT03496298|466451411|FG002|Overall Study|Withdrawal by Subject|151|||
129589330|NCT03496298|466451409|FG000|Overall Study|Other|29|||
129589331|NCT03496298|466451410|FG001|Overall Study|Other|20|||
129589332|NCT03496298|466451411|FG002|Overall Study|Other|23|||
129589333|NCT03496298|466451409|FG000|Overall Study|Randomized and not treated|1|||
129589334|NCT03496298|466451410|FG001|Overall Study|Randomized and not treated|1|||
129589335|NCT03496298|466451411|FG002|Overall Study|Randomized and not treated|1|||
129589336|NCT01438476|466451414|FG000|Overall Study|Protocol Violation|1|||
129589337|NCT01438476|466451415|FG001|Overall Study|Protocol Violation|0|||
129589338|NCT01438476|466451414|FG000|Overall Study|Withdrawal by Subject|1|||
129589339|NCT01438476|466451415|FG001|Overall Study|Withdrawal by Subject|0|||
129589340|NCT01438476|466451414|FG000|Overall Study|No Surgery- Disease|8|||
129589341|NCT01438476|466451415|FG001|Overall Study|No Surgery- Disease|10|||
129696294|NCT01423084|466848048|FG000|Overall Study|Adverse Event|0|||
129696295|NCT01423084|466848049|FG001|Overall Study|Adverse Event|1|||
129696296|NCT01423084|466848048|FG000|Overall Study|Withdrawal by Subject|2|||
129696297|NCT01423084|466848049|FG001|Overall Study|Withdrawal by Subject|3|||
129696298|NCT00661687|466848050|FG000|Overall Study|Study related symptoms and complaints|5|||
129696299|NCT00661687|466848050|FG000|Overall Study|Positive slit lamp findings|4|||
129696300|NCT00661687|466848050|FG000|Overall Study|Inability to maintain wearing schedule|3|||
129696301|NCT00661687|466848050|FG000|Overall Study|Physician Decision|1|||
129696302|NCT00661687|466848050|FG000|Overall Study|Adverse Event|2|||
129696303|NCT03574389|466848051|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
129696304|NCT03574389|466848052|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
129589342|NCT01438476|466451414|FG000|Overall Study|Communication barrier|0|||
129589343|NCT01438476|466451415|FG001|Overall Study|Communication barrier|1|||
129589344|NCT02522780|466451420|FG000|Overall Study|Consent withdrawn by subject|5|||
129589345|NCT02522780|466451421|FG001|Overall Study|Consent withdrawn by subject|7|||
129589346|NCT02522780|466451420|FG000|Overall Study|Protocol deviation|1|||
129589347|NCT02522780|466451421|FG001|Overall Study|Protocol deviation|3|||
129589348|NCT02522780|466451420|FG000|Overall Study|Subject refused endoscopic procedure|0|||
129589349|NCT02522780|466451421|FG001|Overall Study|Subject refused endoscopic procedure|1|||
129589350|NCT02522780|466451420|FG000|Overall Study|Adverse event, non-fatal|11|||
129589351|NCT02522780|466451421|FG001|Overall Study|Adverse event, non-fatal|16|||
129589352|NCT02058160|466451422|FG000|Overall Study|Randomized but not treated|2|||
129589353|NCT02058160|466451423|FG001|Overall Study|Randomized but not treated|4|||
129589354|NCT02058160|466451422|FG000|Overall Study|Poor compliance to protocol|4|||
129589355|NCT02058160|466451423|FG001|Overall Study|Poor compliance to protocol|1|||
129589356|NCT02058160|466451422|FG000|Overall Study|Adverse Event|12|||
129589357|NCT02058160|466451423|FG001|Overall Study|Adverse Event|3|||
129589358|NCT02058160|466451422|FG000|Overall Study|Lost to Follow-up|1|||
129589359|NCT02058160|466451423|FG001|Overall Study|Lost to Follow-up|0|||
129589360|NCT02058160|466451422|FG000|Overall Study|Other than specified above|12|||
129589361|NCT02058160|466451423|FG001|Overall Study|Other than specified above|6|||
129589362|NCT02289820|466451424|FG000|Overall Study|Withdrawal by Subject|2|||
129589363|NCT02289820|466451425|FG001|Overall Study|Withdrawal by Subject|1|||
129589364|NCT02289820|466451426|FG002|Overall Study|Withdrawal by Subject|2|||
129589365|NCT02289820|466451427|FG003|Overall Study|Withdrawal by Subject|1|||
129589366|NCT02289820|466451428|FG004|Overall Study|Withdrawal by Subject|0|||
129589367|NCT02289820|466451429|FG005|Overall Study|Withdrawal by Subject|0|||
129589368|NCT02289820|466451430|FG006|Overall Study|Withdrawal by Subject|1|||
129589369|NCT02289820|466451424|FG000|Overall Study|Death|0|||
129589370|NCT02289820|466451425|FG001|Overall Study|Death|0|||
129589371|NCT02289820|466451426|FG002|Overall Study|Death|1|||
129589372|NCT02289820|466451427|FG003|Overall Study|Death|0|||
129589373|NCT02289820|466451428|FG004|Overall Study|Death|0|||
129589374|NCT02289820|466451429|FG005|Overall Study|Death|0|||
129589375|NCT02289820|466451430|FG006|Overall Study|Death|0|||
129589376|NCT02289820|466451424|FG000|Overall Study|Lost to Follow-up|0|||
129589377|NCT02289820|466451425|FG001|Overall Study|Lost to Follow-up|0|||
129589378|NCT02289820|466451426|FG002|Overall Study|Lost to Follow-up|3|||
129589379|NCT02289820|466451427|FG003|Overall Study|Lost to Follow-up|1|||
129589380|NCT02289820|466451428|FG004|Overall Study|Lost to Follow-up|0|||
129589381|NCT02289820|466451429|FG005|Overall Study|Lost to Follow-up|1|||
129589382|NCT02289820|466451430|FG006|Overall Study|Lost to Follow-up|1|||
129589383|NCT02289820|466451424|FG000|Overall Study|withdrawal of consent|0|||
129589384|NCT02289820|466451425|FG001|Overall Study|withdrawal of consent|1|||
129589385|NCT02289820|466451426|FG002|Overall Study|withdrawal of consent|0|||
129589386|NCT02289820|466451427|FG003|Overall Study|withdrawal of consent|0|||
129589387|NCT02289820|466451428|FG004|Overall Study|withdrawal of consent|0|||
129589388|NCT02289820|466451429|FG005|Overall Study|withdrawal of consent|0|||
129589389|NCT02289820|466451430|FG006|Overall Study|withdrawal of consent|0|||
129589390|NCT00926367|466451433|FG000|Overall Study|Withdrawal by Subject|0|||
129589391|NCT00926367|466451434|FG001|Overall Study|Withdrawal by Subject|1|||
129589392|NCT00926367|466451433|FG000|Overall Study|Lost to Follow-up|1|||
129589393|NCT00926367|466451434|FG001|Overall Study|Lost to Follow-up|0|||
129589394|NCT00926367|466451433|FG000|Overall Study|Skin Irritation|1|||
129589395|NCT00926367|466451434|FG001|Overall Study|Skin Irritation|2|||
129589396|NCT02725411|466451441|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
129589397|NCT02725411|466451442|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
129589398|NCT02725411|466451443|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
129589399|NCT02725411|466451441|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
129589400|NCT02725411|466451442|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
129589401|NCT02725411|466451443|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
129589402|NCT02725411|466451441|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
129589403|NCT02725411|466451442|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
129589404|NCT02725411|466451443|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
129589405|NCT02725411|466451441|FG000|Treatment Period (56 Weeks)|Other|1|||
129589406|NCT02725411|466451442|FG001|Treatment Period (56 Weeks)|Other|4|||
129589407|NCT02725411|466451443|FG002|Treatment Period (56 Weeks)|Other|5|||
129589408|NCT02725411|466451441|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
129589409|NCT02725411|466451442|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
129589410|NCT02725411|466451443|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
129589411|NCT02725411|466451441|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
129589412|NCT02725411|466451442|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
129589413|NCT02725411|466451443|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
129589414|NCT02725411|466451441|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
129589415|NCT02725411|466451442|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
129589416|NCT02725411|466451443|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
129589417|NCT02725411|466451441|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
129589418|NCT02725411|466451442|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
129589419|NCT02725411|466451443|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
129589420|NCT02725411|466451441|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
129589421|NCT02725411|466451442|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
129589422|NCT02725411|466451443|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
129589423|NCT02725411|466451441|FG000|Follow-up Period (24 Weeks)|Other|1|||
129589424|NCT02725411|466451442|FG001|Follow-up Period (24 Weeks)|Other|4|||
129589425|NCT02725411|466451443|FG002|Follow-up Period (24 Weeks)|Other|2|||
129589426|NCT02725411|466451441|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
129589427|NCT02725411|466451442|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
129589428|NCT02725411|466451443|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
129589429|NCT03847974|466451444|FG000|Overall Study|relocated out of region|3|||
129696305|NCT03574389|466848053|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
129885580|NCT02611830|467540770|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
129885581|NCT02611830|467540767|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
129589430|NCT03847974|466451444|FG000|Overall Study|Withdrawal by Subject|2|||
129589431|NCT03847974|466451444|FG000|Overall Study|Adverse Event|1|||
129589432|NCT01924364|466451445|FG000|Overall Study|Physician Decision|3|||
129589433|NCT02911935|466451446|FG000|Overall Study|Lost to Follow-up|5|||
129589434|NCT02911935|466451447|FG001|Overall Study|Lost to Follow-up|7|||
129589435|NCT01685216|466451450|FG000|Overall Study|Did not receive study drug|1|||
129589436|NCT00756717|466451451|FG000|Overall Study|Withdrawal by Subject|2|||
129589437|NCT00685750|466451452|FG000|Overall Study|Tumor sampling failure|0|||
129589438|NCT00685750|466451453|FG001|Overall Study|Tumor sampling failure|0|||
129589439|NCT00685750|466451454|FG002|Overall Study|Tumor sampling failure|1|||
129589440|NCT00685750|466451455|FG003|Overall Study|Tumor sampling failure|0|||
129589441|NCT00685750|466451456|FG004|Overall Study|Tumor sampling failure|0|||
129589442|NCT00685750|466451457|FG005|Overall Study|Tumor sampling failure|0|||
129589443|NCT00685750|466451458|FG006|Overall Study|Tumor sampling failure|0|||
129589444|NCT00685750|466451452|FG000|Overall Study|Patient didn't receive the treatment|0|||
129589445|NCT00685750|466451453|FG001|Overall Study|Patient didn't receive the treatment|0|||
129589446|NCT00685750|466451454|FG002|Overall Study|Patient didn't receive the treatment|0|||
129589447|NCT00685750|466451455|FG003|Overall Study|Patient didn't receive the treatment|0|||
129589448|NCT00685750|466451456|FG004|Overall Study|Patient didn't receive the treatment|0|||
129589449|NCT00685750|466451457|FG005|Overall Study|Patient didn't receive the treatment|0|||
129589450|NCT00685750|466451458|FG006|Overall Study|Patient didn't receive the treatment|1|||
129589451|NCT00685750|466451452|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129589452|NCT00685750|466451453|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129589453|NCT00685750|466451454|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129589454|NCT00685750|466451455|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
129589455|NCT00685750|466451456|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129589456|NCT00685750|466451457|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
129589457|NCT00685750|466451458|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
129589458|NCT04979858|466451459|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
129589459|NCT04979858|466451460|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
129589460|NCT02654015|466451461|FG000|Overall Study|Death|12|||
129589461|NCT02654015|466451461|FG000|Overall Study|Lost to Follow-up|3|||
129589462|NCT02418754|466451464|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129589463|NCT02418754|466451465|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
129589464|NCT02418754|466451466|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129589465|NCT02418754|466451467|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129589466|NCT02418754|466451468|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
129589467|NCT02418754|466451464|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
129589468|NCT02418754|466451465|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
129589469|NCT02418754|466451466|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
129589470|NCT02418754|466451467|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
129589471|NCT02418754|466451468|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
129589472|NCT02418754|466451464|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
129589473|NCT02418754|466451465|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129589474|NCT02418754|466451466|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129589475|NCT02418754|466451467|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129589476|NCT02418754|466451468|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
129589477|NCT02418754|466451464|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
129696306|NCT03574389|466848054|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
129696307|NCT03574389|466848055|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
129696308|NCT03574389|466848056|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
129589478|NCT02418754|466451465|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
129589479|NCT02418754|466451466|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
129589480|NCT02418754|466451467|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
129589481|NCT02418754|466451468|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
129589482|NCT02418754|466451464|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129589483|NCT02418754|466451465|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129589484|NCT02418754|466451466|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
129589485|NCT02418754|466451467|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129589486|NCT02418754|466451468|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
129589487|NCT02418754|466451464|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
129589488|NCT02418754|466451465|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
129589489|NCT02418754|466451466|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
129589490|NCT02418754|466451467|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
129589491|NCT02418754|466451468|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
129589492|NCT02418754|466451464|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
129589493|NCT02418754|466451465|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129589494|NCT02418754|466451466|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129589495|NCT02418754|466451467|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129589496|NCT02418754|466451468|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
129589497|NCT02418754|466451464|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
129589498|NCT02418754|466451465|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
129589499|NCT02418754|466451466|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
129589500|NCT02418754|466451467|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
129589501|NCT02418754|466451468|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
129589502|NCT02418754|466451464|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
129589503|NCT02418754|466451465|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
129589504|NCT02418754|466451466|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
129589505|NCT02418754|466451467|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
129589506|NCT02418754|466451468|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
129589507|NCT02418754|466451464|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
129589508|NCT02418754|466451465|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
129589509|NCT02418754|466451466|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
129589510|NCT02418754|466451467|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
129589511|NCT02418754|466451468|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
129696309|NCT03574389|466848057|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
129696310|NCT03574389|466848051|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
129696311|NCT03574389|466848052|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
129696312|NCT03574389|466848053|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
129696313|NCT03574389|466848054|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
129696314|NCT03574389|466848055|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
129696315|NCT03574389|466848056|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
129696316|NCT03574389|466848057|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
129696317|NCT03574389|466848051|FG000|Vaccination Period|Other|6|||
129696318|NCT03574389|466848052|FG001|Vaccination Period|Other|0|||
129696319|NCT03574389|466848053|FG002|Vaccination Period|Other|0|||
129696320|NCT03574389|466848054|FG003|Vaccination Period|Other|0|||
129696321|NCT03574389|466848055|FG004|Vaccination Period|Other|0|||
129696322|NCT03574389|466848056|FG005|Vaccination Period|Other|0|||
129696323|NCT03574389|466848057|FG006|Vaccination Period|Other|0|||
129696324|NCT03574389|466848051|FG000|Vaccination Period|Adverse Event|0|||
129696325|NCT03574389|466848052|FG001|Vaccination Period|Adverse Event|1|||
129589512|NCT02418754|466451464|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
129589513|NCT02418754|466451465|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
129589514|NCT02418754|466451466|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
129589515|NCT02418754|466451467|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
129589516|NCT02418754|466451468|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
129589517|NCT01896505|466451469|FG000|Overall Study|Adverse Event|1|||
129589518|NCT01896505|466451470|FG001|Overall Study|Adverse Event|0|||
129589519|NCT01896505|466451471|FG002|Overall Study|Adverse Event|2|||
129589520|NCT01896505|466451472|FG003|Overall Study|Adverse Event|1|||
129589521|NCT01896505|466451473|FG004|Overall Study|Adverse Event|1|||
129589522|NCT01896505|466451474|FG005|Overall Study|Adverse Event|0|||
129589523|NCT01896505|466451469|FG000|Overall Study|Physician Decision|1|||
129589524|NCT01896505|466451470|FG001|Overall Study|Physician Decision|3|||
129589525|NCT01896505|466451471|FG002|Overall Study|Physician Decision|2|||
129589526|NCT01896505|466451472|FG003|Overall Study|Physician Decision|0|||
129589527|NCT01896505|466451473|FG004|Overall Study|Physician Decision|0|||
129589528|NCT01896505|466451474|FG005|Overall Study|Physician Decision|1|||
129589529|NCT01896505|466451469|FG000|Overall Study|Withdrawal by Subject|1|||
129589530|NCT01896505|466451470|FG001|Overall Study|Withdrawal by Subject|0|||
129589531|NCT01896505|466451471|FG002|Overall Study|Withdrawal by Subject|3|||
129589532|NCT01896505|466451472|FG003|Overall Study|Withdrawal by Subject|1|||
129589533|NCT01896505|466451473|FG004|Overall Study|Withdrawal by Subject|0|||
129589534|NCT01896505|466451474|FG005|Overall Study|Withdrawal by Subject|0|||
129589535|NCT01896505|466451469|FG000|Overall Study|Disease Progression|7|||
129589536|NCT01896505|466451470|FG001|Overall Study|Disease Progression|5|||
129589537|NCT01896505|466451471|FG002|Overall Study|Disease Progression|8|||
129589538|NCT01896505|466451472|FG003|Overall Study|Disease Progression|4|||
129589539|NCT01896505|466451473|FG004|Overall Study|Disease Progression|4|||
129589540|NCT01896505|466451474|FG005|Overall Study|Disease Progression|4|||
129589541|NCT01896505|466451469|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
129589542|NCT01896505|466451470|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
129589543|NCT01896505|466451471|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
129589544|NCT01896505|466451472|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
129589545|NCT01896505|466451473|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
129589546|NCT01896505|466451474|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
129589547|NCT01896505|466451469|FG000|Overall Study|Intercurrent illness|0|||
129589548|NCT01896505|466451470|FG001|Overall Study|Intercurrent illness|1|||
129589549|NCT01896505|466451471|FG002|Overall Study|Intercurrent illness|0|||
129589550|NCT01896505|466451472|FG003|Overall Study|Intercurrent illness|0|||
129589551|NCT01896505|466451473|FG004|Overall Study|Intercurrent illness|0|||
129589552|NCT01896505|466451474|FG005|Overall Study|Intercurrent illness|0|||
129589553|NCT01896505|466451469|FG000|Overall Study|Death|0|||
129589554|NCT01896505|466451470|FG001|Overall Study|Death|0|||
129589555|NCT01896505|466451471|FG002|Overall Study|Death|1|||
129589556|NCT01896505|466451472|FG003|Overall Study|Death|1|||
129589557|NCT01896505|466451473|FG004|Overall Study|Death|0|||
129589558|NCT01896505|466451474|FG005|Overall Study|Death|1|||
129589559|NCT04974580|466451475|FG000|Overall Study|Lost to Follow-up|33|||
129589560|NCT04974580|466451476|FG001|Overall Study|Lost to Follow-up|39|||
129589561|NCT04974580|466451477|FG002|Overall Study|Lost to Follow-up|30|||
129589562|NCT04974580|466451478|FG003|Overall Study|Lost to Follow-up|29|||
129589563|NCT00250705|466451479|FG000|Overall Study|Lack of Efficacy|2|||
129589564|NCT03919695|466451489|FG000|3-month Follow-up|Death|1|||
129589565|NCT03919695|466451490|FG001|3-month Follow-up|Death|1|||
129589566|NCT03919695|466451489|FG000|3-month Follow-up|unable to contact|0|||
129589567|NCT03919695|466451490|FG001|3-month Follow-up|unable to contact|3|||
129589568|NCT03919695|466451489|FG000|3-month Follow-up|in prison|0|||
129589569|NCT03919695|466451490|FG001|3-month Follow-up|in prison|1|||
129589570|NCT03919695|466451489|FG000|6-month Follow-up|Death|0|||
129589571|NCT03919695|466451490|FG001|6-month Follow-up|Death|1|||
129589572|NCT03919695|466451489|FG000|6-month Follow-up|Lost to Follow-up|1|||
129589573|NCT03919695|466451490|FG001|6-month Follow-up|Lost to Follow-up|2|||
129589574|NCT03919695|466451489|FG000|6-month Follow-up|in prison|0|||
129589575|NCT03919695|466451490|FG001|6-month Follow-up|in prison|2|||
129589576|NCT03919695|466451489|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
129589577|NCT03919695|466451490|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
129696326|NCT03574389|466848053|FG002|Vaccination Period|Adverse Event|0|||
129589578|NCT03919695|466451489|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
129589579|NCT03919695|466451490|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
129589580|NCT01688882|466451491|FG000|Overall Study|Adverse Event|1|||
129589581|NCT01688882|466451492|FG001|Overall Study|Adverse Event|0|||
129589582|NCT01688882|466451491|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129589583|NCT01688882|466451492|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129589584|NCT01688882|466451491|FG000|Overall Study|Administrative problems|1|||
129589585|NCT01688882|466451492|FG001|Overall Study|Administrative problems|0|||
129589586|NCT03259789|466451493|FG000|Overall Study|Adverse Event|3|||
129589587|NCT03259789|466451494|FG001|Overall Study|Adverse Event|2|||
129589588|NCT03259789|466451495|FG002|Overall Study|Adverse Event|1|||
129589589|NCT03259789|466451493|FG000|Overall Study|Withdrawal by Subject|9|||
129589590|NCT03259789|466451494|FG001|Overall Study|Withdrawal by Subject|5|||
129589591|NCT03259789|466451495|FG002|Overall Study|Withdrawal by Subject|1|||
129589592|NCT03259789|466451493|FG000|Overall Study|Lost to Follow-up|5|||
129589593|NCT03259789|466451494|FG001|Overall Study|Lost to Follow-up|9|||
129589594|NCT03259789|466451495|FG002|Overall Study|Lost to Follow-up|4|||
129589595|NCT03259789|466451493|FG000|Overall Study|Physician Decision|0|||
129589596|NCT03259789|466451494|FG001|Overall Study|Physician Decision|1|||
129589597|NCT03259789|466451495|FG002|Overall Study|Physician Decision|0|||
129589598|NCT02063217|466451497|FG000|Overall Study|Withdrawal by Subject|1|||
129696327|NCT03574389|466848054|FG003|Vaccination Period|Adverse Event|0|||
129589599|NCT02063217|466451498|FG001|Overall Study|Withdrawal by Subject|0|||
129589600|NCT02063217|466451499|FG002|Overall Study|Withdrawal by Subject|0|||
129589601|NCT00889252|466451500|FG000|Overall Study|Adverse Event|2|||
129589602|NCT00889252|466451501|FG001|Overall Study|Adverse Event|4|||
129696328|NCT03574389|466848055|FG004|Vaccination Period|Adverse Event|0|||
129696329|NCT03574389|466848056|FG005|Vaccination Period|Adverse Event|0|||
129696330|NCT03574389|466848057|FG006|Vaccination Period|Adverse Event|0|||
129589603|NCT00889252|466451500|FG000|Overall Study|Withdrawal by Subject|3|||
129589604|NCT00889252|466451501|FG001|Overall Study|Withdrawal by Subject|0|||
129589605|NCT00889252|466451500|FG000|Overall Study|Protocol Violation|2|||
129589606|NCT00889252|466451501|FG001|Overall Study|Protocol Violation|0|||
129589607|NCT01160640|466451505|FG000|Overall Study|Physician Decision|3|||
129589608|NCT01160640|466451506|FG001|Overall Study|Physician Decision|3|||
129589609|NCT01160640|466451505|FG000|Overall Study|Incarceration|1|||
129589610|NCT01160640|466451506|FG001|Overall Study|Incarceration|0|||
129589611|NCT01160640|466451505|FG000|Overall Study|Withdrawal by Subject|0|||
129589612|NCT01160640|466451506|FG001|Overall Study|Withdrawal by Subject|3|||
129589613|NCT00642811|466451507|FG000|Overall Study|Adverse Event|2|||
129589614|NCT00642811|466451508|FG001|Overall Study|Adverse Event|3|||
129589615|NCT00642811|466451509|FG002|Overall Study|Adverse Event|0|||
129589616|NCT00642811|466451510|FG003|Overall Study|Adverse Event|0|||
129589617|NCT00642811|466451511|FG004|Overall Study|Adverse Event|0|||
129589618|NCT00642811|466451512|FG005|Overall Study|Adverse Event|1|||
129589619|NCT00642811|466451507|FG000|Overall Study|Developement of discontinuation criteria|0|||
129589620|NCT00642811|466451508|FG001|Overall Study|Developement of discontinuation criteria|0|||
129589621|NCT00642811|466451509|FG002|Overall Study|Developement of discontinuation criteria|0|||
129589622|NCT00642811|466451510|FG003|Overall Study|Developement of discontinuation criteria|0|||
129589623|NCT00642811|466451511|FG004|Overall Study|Developement of discontinuation criteria|1|||
129589624|NCT00642811|466451512|FG005|Overall Study|Developement of discontinuation criteria|0|||
129589625|NCT00642811|466451507|FG000|Overall Study|Severe Non-compliance to protocol|1|||
129589626|NCT00642811|466451508|FG001|Overall Study|Severe Non-compliance to protocol|0|||
129589627|NCT00642811|466451509|FG002|Overall Study|Severe Non-compliance to protocol|0|||
129589628|NCT00642811|466451510|FG003|Overall Study|Severe Non-compliance to protocol|0|||
129589629|NCT00642811|466451511|FG004|Overall Study|Severe Non-compliance to protocol|0|||
129589630|NCT00642811|466451512|FG005|Overall Study|Severe Non-compliance to protocol|0|||
129589631|NCT00642811|466451507|FG000|Overall Study|Other|0|||
129589632|NCT00642811|466451508|FG001|Overall Study|Other|1|||
129589633|NCT00642811|466451509|FG002|Overall Study|Other|0|||
129589634|NCT00642811|466451510|FG003|Overall Study|Other|1|||
129589635|NCT00642811|466451511|FG004|Overall Study|Other|0|||
129589636|NCT00642811|466451512|FG005|Overall Study|Other|0|||
129589637|NCT03108820|466451516|FG000|Overall Study|Lost to Follow-up|30|||
129589638|NCT03108820|466451517|FG001|Overall Study|Lost to Follow-up|28|||
129589639|NCT03108820|466451516|FG000|Overall Study|Withdrawal by Subject|32|||
129589640|NCT03108820|466451517|FG001|Overall Study|Withdrawal by Subject|24|||
129589641|NCT03108820|466451516|FG000|Overall Study|Death|6|||
129589642|NCT03108820|466451517|FG001|Overall Study|Death|11|||
129589643|NCT00089973|466451520|FG000|Overall Study|Adverse Event|3|||
129589644|NCT00089973|466451520|FG000|Overall Study|Withdrawal by Subject|1|||
129589645|NCT00089973|466451520|FG000|Overall Study|Disease progression|45|||
129589646|NCT00089973|466451520|FG000|Overall Study|Death|1|||
129589647|NCT01992094|466451521|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
129589648|NCT01992094|466451522|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
129589649|NCT01992094|466451523|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
129589650|NCT01992094|466451521|FG000|Overall Study|Adverse Event|1|||
129589651|NCT01992094|466451522|FG001|Overall Study|Adverse Event|0|||
129589652|NCT01992094|466451523|FG002|Overall Study|Adverse Event|0|||
129589653|NCT01992094|466451521|FG000|Overall Study|Death|5|||
129589654|NCT01992094|466451522|FG001|Overall Study|Death|5|||
129589655|NCT01992094|466451523|FG002|Overall Study|Death|2|||
129589656|NCT01992094|466451521|FG000|Overall Study|Lost to Follow-up|26|||
129589657|NCT01992094|466451522|FG001|Overall Study|Lost to Follow-up|9|||
129589658|NCT01992094|466451523|FG002|Overall Study|Lost to Follow-up|13|||
129589659|NCT01992094|466451521|FG000|Overall Study|OTHER|4|||
129589660|NCT01992094|466451522|FG001|Overall Study|OTHER|0|||
129589661|NCT01992094|466451523|FG002|Overall Study|OTHER|0|||
129589662|NCT01992094|466451521|FG000|Overall Study|Protocol Violation|1|||
129589663|NCT01992094|466451522|FG001|Overall Study|Protocol Violation|0|||
129589664|NCT01992094|466451523|FG002|Overall Study|Protocol Violation|1|||
129589665|NCT01992094|466451521|FG000|Overall Study|Withdrawal by Subject|7|||
129589666|NCT01992094|466451522|FG001|Overall Study|Withdrawal by Subject|3|||
129589667|NCT01992094|466451523|FG002|Overall Study|Withdrawal by Subject|4|||
129589668|NCT01214239|466451524|FG000|Overall Study|Adverse Event|3|||
129589669|NCT01214239|466451525|FG001|Overall Study|Adverse Event|4|||
129696331|NCT03574389|466848051|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
129589670|NCT01214239|466451524|FG000|Overall Study|Protocol Violation|2|||
129589671|NCT01214239|466451525|FG001|Overall Study|Protocol Violation|1|||
129589672|NCT01214239|466451524|FG000|Overall Study|Lost to Follow-up|1|||
129589673|NCT01214239|466451525|FG001|Overall Study|Lost to Follow-up|1|||
129589674|NCT01214239|466451524|FG000|Overall Study|Withdrawal by Subject|4|||
129589675|NCT01214239|466451525|FG001|Overall Study|Withdrawal by Subject|9|||
129589676|NCT01214239|466451524|FG000|Overall Study|Lack of Efficacy|1|||
129589677|NCT01214239|466451525|FG001|Overall Study|Lack of Efficacy|2|||
129589678|NCT01214239|466451524|FG000|Overall Study|patient's private reason|1|||
129589679|NCT01214239|466451525|FG001|Overall Study|patient's private reason|1|||
129589680|NCT01049581|466451526|FG000|Overall Study|Lost to Follow-up|2|||
129589681|NCT01049581|466451527|FG001|Overall Study|Lost to Follow-up|1|||
129589682|NCT03203642|466451528|FG000|Overall Study|Adverse Event|3|||
129589683|NCT03203642|466451529|FG001|Overall Study|Adverse Event|1|||
129589684|NCT03203642|466451528|FG000|Overall Study|Withdrawal by Subject|6|||
129589685|NCT03203642|466451529|FG001|Overall Study|Withdrawal by Subject|6|||
129589686|NCT03203642|466451528|FG000|Overall Study|Lost to Follow-up|2|||
129589687|NCT03203642|466451529|FG001|Overall Study|Lost to Follow-up|1|||
129589688|NCT03203642|466451528|FG000|Overall Study|Termination of the study by sponsor|1|||
129589689|NCT03203642|466451529|FG001|Overall Study|Termination of the study by sponsor|1|||
129589690|NCT03203642|466451528|FG000|Overall Study|Participant moved|0|||
129589691|NCT03203642|466451529|FG001|Overall Study|Participant moved|1|||
129589692|NCT03203642|466451528|FG000|Overall Study|Investigator's decision|3|||
129589693|NCT03203642|466451529|FG001|Overall Study|Investigator's decision|0|||
129589694|NCT03203642|466451528|FG000|Overall Study|Other than above specified|0|||
129589695|NCT03203642|466451529|FG001|Overall Study|Other than above specified|1|||
129589696|NCT05068284|466451542|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
129589697|NCT05068284|466451543|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
129589698|NCT05068284|466451544|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129589699|NCT05068284|466451545|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129589700|NCT05068284|466451546|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129589701|NCT05068284|466451547|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129589702|NCT05068284|466451548|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129589703|NCT05068284|466451549|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
129589704|NCT05068284|466451542|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589705|NCT05068284|466451543|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589706|NCT05068284|466451544|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
129589707|NCT05068284|466451545|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589708|NCT05068284|466451546|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589709|NCT05068284|466451547|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589710|NCT05068284|466451548|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589711|NCT05068284|466451549|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
129589712|NCT05068284|466451542|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
129589713|NCT05068284|466451543|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
129589714|NCT05068284|466451544|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
129589715|NCT05068284|466451545|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
129589716|NCT05068284|466451546|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
129589717|NCT05068284|466451547|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
129589718|NCT05068284|466451548|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
129589719|NCT05068284|466451549|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
129589720|NCT05068284|466451542|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129589721|NCT05068284|466451543|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129589722|NCT05068284|466451544|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
129589723|NCT05068284|466451545|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129589724|NCT05068284|466451546|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
129589725|NCT05068284|466451547|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129589726|NCT05068284|466451548|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129589727|NCT05068284|466451549|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
129589728|NCT05068284|466451542|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589729|NCT05068284|466451543|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589730|NCT05068284|466451544|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589731|NCT05068284|466451545|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
129589732|NCT05068284|466451546|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589733|NCT05068284|466451547|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589734|NCT05068284|466451548|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589735|NCT05068284|466451549|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
129589736|NCT05068284|466451542|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129589737|NCT05068284|466451543|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129589738|NCT05068284|466451544|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
129589739|NCT05068284|466451545|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
129589740|NCT05068284|466451546|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129589741|NCT05068284|466451547|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129589742|NCT05068284|466451548|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129589743|NCT05068284|466451549|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
129589744|NCT05068284|466451542|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589745|NCT05068284|466451543|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589746|NCT05068284|466451544|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
129589747|NCT05068284|466451545|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589748|NCT05068284|466451546|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589749|NCT05068284|466451547|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589750|NCT05068284|466451548|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589751|NCT05068284|466451549|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
129589752|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
129589753|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589754|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589755|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589756|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589757|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589758|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589759|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
129589760|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
129589761|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129589762|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129589763|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129589764|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129589765|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
129589766|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
129589767|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
129589768|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
129589769|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129589770|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129589771|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129589772|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129589773|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129589774|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
129589775|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
129589776|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
129589777|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129696332|NCT03574389|466848052|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
129696333|NCT03574389|466848053|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
129696334|NCT03574389|466848054|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
129696335|NCT03574389|466848055|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
129696336|NCT03574389|466848056|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
129696337|NCT03574389|466848057|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
129696338|NCT02094885|466848060|FG000|Overall Study|Death|1|||
129696339|NCT02094885|466848061|FG001|Overall Study|Death|5|||
129696340|NCT02094885|466848060|FG000|Overall Study|Withdrawn due to age|1|||
129696341|NCT02094885|466848061|FG001|Overall Study|Withdrawn due to age|0|||
129696342|NCT03707821|466848064|FG000|Overall Study|Protocol Violation|0|||
129696343|NCT03707821|466848065|FG001|Overall Study|Protocol Violation|1|||
129696344|NCT03707821|466848064|FG000|Overall Study|Unsatisfactory Visual Response|1|||
129696345|NCT03707821|466848065|FG001|Overall Study|Unsatisfactory Visual Response|0|||
129696346|NCT03707821|466848064|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
129696347|NCT03707821|466848065|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
129696348|NCT00215553|466848066|FG000|Overall Study|Adverse Event|0|||
129696349|NCT00215553|466848067|FG001|Overall Study|Adverse Event|1|||
129696350|NCT00215553|466848068|FG002|Overall Study|Adverse Event|2|||
129696351|NCT00215553|466848069|FG003|Overall Study|Adverse Event|1|||
129696352|NCT00215553|466848070|FG004|Overall Study|Adverse Event|2|||
129696353|NCT00215553|466848071|FG005|Overall Study|Adverse Event|6|||
129696354|NCT00215553|466848072|FG006|Overall Study|Adverse Event|0|||
129696355|NCT00756314|466848073|FG000|Overall Study|Lost to Follow-up|2|||
129696356|NCT00756314|466848074|FG001|Overall Study|Lost to Follow-up|59|||
129696357|NCT02605967|466848076|FG000|Overall Study|subject / guardian decision|1|||
129696358|NCT02605967|466848077|FG001|Overall Study|subject / guardian decision|2|||
129696359|NCT02605967|466848076|FG000|Overall Study|Physician Decision|10|||
129696360|NCT02605967|466848077|FG001|Overall Study|Physician Decision|1|||
129885582|NCT02611830|467540768|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
129885583|NCT02611830|467540769|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
129696361|NCT02605967|466848076|FG000|Overall Study|Death|4|||
129589778|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129589779|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129589780|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129589781|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129589782|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129589783|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
129589784|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
129589785|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589786|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589787|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589788|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589789|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589790|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589791|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
129589792|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
129589793|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129589794|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129589795|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129589796|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
129589797|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
129589798|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
129589799|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
129589800|NCT05068284|466451542|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589801|NCT05068284|466451543|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589802|NCT05068284|466451544|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589803|NCT05068284|466451545|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589804|NCT05068284|466451546|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589805|NCT05068284|466451547|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589806|NCT05068284|466451548|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
129589807|NCT05068284|466451549|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
129589808|NCT00965731|466451550|FG000|Overall Study|Death|0|||
129589809|NCT00965731|466451551|FG001|Overall Study|Death|4|||
129589810|NCT00965731|466451550|FG000|Overall Study|Withdrawal by Subject|0|||
129589811|NCT00965731|466451551|FG001|Overall Study|Withdrawal by Subject|1|||
129589812|NCT00965731|466451550|FG000|Overall Study|Other|7|||
129589813|NCT00965731|466451551|FG001|Overall Study|Other|15|||
129589814|NCT00559637|466453827|FG000|Overall Study|Adverse Event|22|||
129589815|NCT00559637|466453827|FG000|Overall Study|Withdrawal by Subject|4|||
129589816|NCT00559637|466453827|FG000|Overall Study|Protocol Violation|6|||
129589817|NCT00559637|466453827|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
129589818|NCT00559637|466453827|FG000|Overall Study|Failure to return|6|||
129589819|NCT00559637|466453827|FG000|Overall Study|Insufficient response|3|||
129589820|NCT00559637|466453827|FG000|Overall Study|Started requiring dialysis after month 7|2|||
129589821|NCT00559637|466453827|FG000|Overall Study|Suspected lung cancer|1|||
129589822|NCT00559637|466453827|FG000|Overall Study|Participation in another study|1|||
129589823|NCT00559637|466453827|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
129589824|NCT00559637|466453827|FG000|Overall Study|Change of center|1|||
129589825|NCT00559637|466453827|FG000|Overall Study|Change of home|1|||
129589826|NCT00559637|466453827|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
129589827|NCT02832167|466453828|FG000|Treatment Period 1|Disease progression|90|||
129589828|NCT02832167|466453828|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
129589829|NCT02832167|466453828|FG000|Treatment Period 1|Death|2|||
129589830|NCT02832167|466453828|FG000|Treatment Period 1|Study Drug Toxicity|6|||
129589831|NCT02832167|466453828|FG000|Treatment Period 1|Participant request to discontinue|9|||
129589832|NCT02832167|466453828|FG000|Treatment Period 1|No longer meet study criteria|1|||
129589833|NCT02832167|466453828|FG000|Treatment Period 1|Participant withdrew consent|3|||
129589834|NCT02832167|466453828|FG000|Treatment Period 1|Other reasons|6|||
129589835|NCT02832167|466453828|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
129589836|NCT02832167|466453828|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
129589837|NCT02832167|466453828|FG000|Transition From Period 1 to Period 2|Death|2|||
129589838|NCT02832167|466453828|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
129589839|NCT02832167|466453828|FG000|Treatment Period 2|Disease progression|69|||
129589840|NCT02832167|466453828|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
129589841|NCT02832167|466453828|FG000|Treatment Period 2|Maximum clinical benefit|1|||
129589842|NCT02832167|466453828|FG000|Treatment Period 2|Study Drug Toxicity|5|||
129589843|NCT02832167|466453828|FG000|Treatment Period 2|Participant request to discontinue|2|||
129589844|NCT02832167|466453828|FG000|Treatment Period 2|Participant withdrew consent|3|||
129589845|NCT02832167|466453828|FG000|Treatment Period 2|Other reasons|3|||
129589846|NCT01958060|466453831|FG000|Overall Study|Not treated|2|||
129589847|NCT01958060|466453832|FG001|Overall Study|Not treated|0|||
129589848|NCT01958060|466453833|FG002|Overall Study|Not treated|0|||
129589849|NCT01958060|466453834|FG003|Overall Study|Not treated|0|||
129589850|NCT01958060|466453835|FG004|Overall Study|Not treated|1|||
129589851|NCT01958060|466453836|FG005|Overall Study|Not treated|0|||
129589852|NCT00224484|466453838|FG000|Overall Study|Serious Adverse Event|1|||
129589853|NCT00224484|466453839|FG001|Overall Study|Serious Adverse Event|1|||
129589854|NCT00224484|466453840|FG002|Overall Study|Serious Adverse Event|0|||
129589855|NCT00224484|466453838|FG000|Overall Study|Non-Serious Adverse Event|5|||
129589856|NCT00224484|466453839|FG001|Overall Study|Non-Serious Adverse Event|7|||
129589857|NCT00224484|466453840|FG002|Overall Study|Non-Serious Adverse Event|3|||
129589858|NCT00224484|466453838|FG000|Overall Study|Protocol Violation|2|||
129589859|NCT00224484|466453839|FG001|Overall Study|Protocol Violation|2|||
129589860|NCT00224484|466453840|FG002|Overall Study|Protocol Violation|0|||
129589861|NCT00224484|466453838|FG000|Overall Study|Withdrawal by Subject|49|||
129589862|NCT00224484|466453839|FG001|Overall Study|Withdrawal by Subject|18|||
129589863|NCT00224484|466453840|FG002|Overall Study|Withdrawal by Subject|16|||
129589864|NCT00224484|466453838|FG000|Overall Study|Migrated/moved from study area|18|||
129589865|NCT00224484|466453839|FG001|Overall Study|Migrated/moved from study area|5|||
129589866|NCT00224484|466453840|FG002|Overall Study|Migrated/moved from study area|5|||
129589867|NCT00224484|466453838|FG000|Overall Study|Lost to Follow-up|66|||
129589868|NCT00224484|466453839|FG001|Overall Study|Lost to Follow-up|28|||
129589869|NCT00224484|466453840|FG002|Overall Study|Lost to Follow-up|36|||
129589870|NCT00224484|466453838|FG000|Overall Study|Reason not specified|5|||
129589871|NCT00224484|466453839|FG001|Overall Study|Reason not specified|4|||
129589872|NCT00224484|466453840|FG002|Overall Study|Reason not specified|2|||
129589873|NCT01074008|466453841|FG000|Overall Study|Adverse Event|0|||
129589874|NCT01074008|466453842|FG001|Overall Study|Adverse Event|1|||
129589875|NCT01074008|466453843|FG002|Overall Study|Adverse Event|0|||
129589876|NCT01074008|466453844|FG003|Overall Study|Adverse Event|0|||
129589877|NCT01074008|466453845|FG004|Overall Study|Adverse Event|0|||
129589878|NCT01074008|466453846|FG005|Overall Study|Adverse Event|0|||
129589879|NCT01074008|466453847|FG006|Overall Study|Adverse Event|0|||
129589880|NCT01074008|466453848|FG007|Overall Study|Adverse Event|0|||
129589881|NCT01074008|466453849|FG008|Overall Study|Adverse Event|0|||
129589882|NCT01074008|466453841|FG000|Overall Study|Withdrawal by Subject|1|||
129589883|NCT01074008|466453842|FG001|Overall Study|Withdrawal by Subject|1|||
129589884|NCT01074008|466453843|FG002|Overall Study|Withdrawal by Subject|1|||
129589885|NCT01074008|466453844|FG003|Overall Study|Withdrawal by Subject|0|||
129589886|NCT01074008|466453845|FG004|Overall Study|Withdrawal by Subject|1|||
129589887|NCT01074008|466453846|FG005|Overall Study|Withdrawal by Subject|0|||
129589888|NCT01074008|466453847|FG006|Overall Study|Withdrawal by Subject|0|||
129589889|NCT01074008|466453848|FG007|Overall Study|Withdrawal by Subject|0|||
129589890|NCT01074008|466453849|FG008|Overall Study|Withdrawal by Subject|0|||
129589891|NCT01074008|466453841|FG000|Overall Study|Lost to Follow-up|0|||
129589892|NCT01074008|466453842|FG001|Overall Study|Lost to Follow-up|1|||
129589893|NCT01074008|466453843|FG002|Overall Study|Lost to Follow-up|1|||
129589894|NCT01074008|466453844|FG003|Overall Study|Lost to Follow-up|1|||
129589895|NCT01074008|466453845|FG004|Overall Study|Lost to Follow-up|1|||
129589896|NCT01074008|466453846|FG005|Overall Study|Lost to Follow-up|0|||
129885584|NCT02611830|467540770|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
129589897|NCT01074008|466453847|FG006|Overall Study|Lost to Follow-up|1|||
129589898|NCT01074008|466453848|FG007|Overall Study|Lost to Follow-up|0|||
129589899|NCT01074008|466453849|FG008|Overall Study|Lost to Follow-up|4|||
129589900|NCT02805309|466453850|FG000|Overall Study|Lost to Follow-up|2|||
129589901|NCT02805309|466453851|FG001|Overall Study|Lost to Follow-up|2|||
129589902|NCT02805309|466453852|FG002|Overall Study|Lost to Follow-up|2|||
129589903|NCT02805309|466453850|FG000|Overall Study|Post-Randomization Exclusion|0|||
129589904|NCT02805309|466453851|FG001|Overall Study|Post-Randomization Exclusion|2|||
129589905|NCT02805309|466453852|FG002|Overall Study|Post-Randomization Exclusion|1|||
129589906|NCT00108628|466453860|FG000|Overall Study|Withdrawal by Subject|17|||
129589907|NCT00108628|466453861|FG001|Overall Study|Withdrawal by Subject|9|||
129589908|NCT00108628|466453860|FG000|Overall Study|Lack of Efficacy|2|||
129589909|NCT00108628|466453861|FG001|Overall Study|Lack of Efficacy|1|||
129589910|NCT00108628|466453860|FG000|Overall Study|Death|1|||
129589911|NCT00108628|466453861|FG001|Overall Study|Death|0|||
129589912|NCT01350934|466453862|FG000|Base Study|Adverse Event|6|||
129589913|NCT01350934|466453863|FG001|Base Study|Adverse Event|0|||
129589914|NCT01350934|466453862|FG000|Base Study|Lost to Follow-up|1|||
129589915|NCT01350934|466453863|FG001|Base Study|Lost to Follow-up|0|||
129589916|NCT01350934|466453862|FG000|Base Study|Protocol Violation|1|||
129589917|NCT01350934|466453863|FG001|Base Study|Protocol Violation|1|||
129589918|NCT01350934|466453862|FG000|Base Study|Withdrawal by Subject|1|||
129589919|NCT01350934|466453863|FG001|Base Study|Withdrawal by Subject|2|||
129589920|NCT01350934|466453862|FG000|Base Study|Non-Compliance With Study Drug|2|||
129589921|NCT01350934|466453863|FG001|Base Study|Non-Compliance With Study Drug|0|||
129589922|NCT01350934|466453862|FG000|Extension Study|Adverse Event|2|||
129589923|NCT01350934|466453863|FG001|Extension Study|Adverse Event|1|||
129589924|NCT01350934|466453862|FG000|Extension Study|Lost to Follow-up|2|||
129589925|NCT01350934|466453863|FG001|Extension Study|Lost to Follow-up|0|||
129589926|NCT01350934|466453862|FG000|Extension Study|Protocol Violation|1|||
129589927|NCT01350934|466453863|FG001|Extension Study|Protocol Violation|1|||
129589928|NCT01350934|466453862|FG000|Extension Study|Lack of Efficacy|0|||
129589929|NCT01350934|466453863|FG001|Extension Study|Lack of Efficacy|1|||
129589930|NCT01350934|466453862|FG000|Extension Study|Withdrawal by Subject|0|||
129589931|NCT01350934|466453863|FG001|Extension Study|Withdrawal by Subject|1|||
129589932|NCT03547635|466453866|FG000|Overall Study|Adverse Event|5|||
129589933|NCT03547635|466453867|FG001|Overall Study|Adverse Event|2|||
129589934|NCT03547635|466453868|FG002|Overall Study|Adverse Event|3|||
129589935|NCT03547635|466453866|FG000|Overall Study|Lost to Follow-up|1|||
129589936|NCT03547635|466453867|FG001|Overall Study|Lost to Follow-up|3|||
129589937|NCT03547635|466453868|FG002|Overall Study|Lost to Follow-up|4|||
129589938|NCT03547635|466453866|FG000|Overall Study|Withdrawal by Subject|1|||
129589939|NCT03547635|466453867|FG001|Overall Study|Withdrawal by Subject|0|||
129589940|NCT03547635|466453868|FG002|Overall Study|Withdrawal by Subject|0|||
129589941|NCT03547635|466453866|FG000|Overall Study|Withdrawal By PI|0|||
129589942|NCT03547635|466453867|FG001|Overall Study|Withdrawal By PI|1|||
129589943|NCT03547635|466453868|FG002|Overall Study|Withdrawal By PI|0|||
129589944|NCT03547635|466453866|FG000|Overall Study|Withdrawal by Sponsor|0|||
129589945|NCT03547635|466453867|FG001|Overall Study|Withdrawal by Sponsor|0|||
129589946|NCT03547635|466453868|FG002|Overall Study|Withdrawal by Sponsor|1|||
129589947|NCT03547635|466453866|FG000|Overall Study|Errant Randomization before Treatment|0|||
129589948|NCT03547635|466453867|FG001|Overall Study|Errant Randomization before Treatment|1|||
129589949|NCT03547635|466453868|FG002|Overall Study|Errant Randomization before Treatment|0|||
129589950|NCT03547635|466453866|FG000|Overall Study|Withdrawal by Subject|1|||
129589951|NCT03547635|466453867|FG001|Overall Study|Withdrawal by Subject|0|||
129589952|NCT03547635|466453868|FG002|Overall Study|Withdrawal by Subject|0|||
129589953|NCT01765270|466453878|FG000|Overall Study|Physician Decision|1|||
129589954|NCT01765270|466453879|FG001|Overall Study|Physician Decision|0|||
129589955|NCT01765270|466453878|FG000|Overall Study|Withdrawal by Subject|0|||
129589956|NCT01765270|466453879|FG001|Overall Study|Withdrawal by Subject|1|||
129589957|NCT03431337|466453882|FG000|Overall Study|Lost to Follow-up|21|||
129589958|NCT03431337|466453883|FG001|Overall Study|Lost to Follow-up|19|||
129589959|NCT03431337|466453882|FG000|Overall Study|Withdrawal by Subject|8|||
129589960|NCT03431337|466453883|FG001|Overall Study|Withdrawal by Subject|3|||
129589961|NCT00329160|466453884|FG000|Overall Study|Adverse Event|27|||
129589962|NCT00329160|466453884|FG000|Overall Study|Withdrawal by Subject|13|||
129589963|NCT00329160|466453884|FG000|Overall Study|Protocol Violation|2|||
129589964|NCT00329160|466453884|FG000|Overall Study|Did not Receive Study Drug|1|||
129589965|NCT00329160|466453884|FG000|Overall Study|Incomplete IVUS|45|||
129589966|NCT04501094|466453885|FG000|Overall Study|Death (unrelated to research)|1|||
129696362|NCT02605967|466848077|FG001|Overall Study|Death|2|||
129589967|NCT04501094|466453886|FG001|Overall Study|Death (unrelated to research)|0|||
129589968|NCT00063258|466453890|FG000|Overall Study|Physician Decision|2|||
129589969|NCT00063258|466453891|FG001|Overall Study|Physician Decision|0|||
129589970|NCT00063258|466453890|FG000|Overall Study|Lack of Efficacy|2|||
129589971|NCT00063258|466453891|FG001|Overall Study|Lack of Efficacy|0|||
129589972|NCT00685035|466453892|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
129589973|NCT00685035|466453893|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
129589974|NCT04241133|466453896|FG000|Overall Study|COVID19 Precautions|14|||
129589975|NCT04241133|466453897|FG001|Overall Study|COVID19 Precautions|34|||
129589976|NCT04982445|466453898|FG000|Overall Study|Protocol Violation|1|||
129589977|NCT04982445|466453898|FG000|Overall Study|Withdrawal by Subject|4|||
129589978|NCT04982445|466453898|FG000|Overall Study|Lost to Follow-up|1|||
129589979|NCT03653026|466453899|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
129589980|NCT03653026|466453900|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
129589981|NCT03653026|466453901|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
129589982|NCT03653026|466453902|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
129589983|NCT03653026|466453899|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
129589984|NCT03653026|466453900|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
129589985|NCT03653026|466453901|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129589986|NCT03653026|466453902|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129589987|NCT03653026|466453899|FG000|Part 1: Placebo-controlled Period|Other|0|||
129589988|NCT03653026|466453900|FG001|Part 1: Placebo-controlled Period|Other|3|||
129589989|NCT03653026|466453901|FG002|Part 1: Placebo-controlled Period|Other|0|||
129589990|NCT03653026|466453902|FG003|Part 1: Placebo-controlled Period|Other|0|||
129589991|NCT03653026|466453899|FG000|Part 2: Open-label Extension|Adverse Event|0|||
129589992|NCT03653026|466453900|FG001|Part 2: Open-label Extension|Adverse Event|0|||
129589993|NCT03653026|466453901|FG002|Part 2: Open-label Extension|Adverse Event|1|||
129589994|NCT03653026|466453902|FG003|Part 2: Open-label Extension|Adverse Event|1|||
129589995|NCT03653026|466453899|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129589996|NCT03653026|466453900|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129589997|NCT03653026|466453901|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
129589998|NCT03653026|466453902|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
129589999|NCT03653026|466453899|FG000|Part 2: Open-label Extension|Other|0|||
129590000|NCT03653026|466453900|FG001|Part 2: Open-label Extension|Other|0|||
129590001|NCT03653026|466453901|FG002|Part 2: Open-label Extension|Other|1|||
129590002|NCT03653026|466453902|FG003|Part 2: Open-label Extension|Other|2|||
129590003|NCT02457819|466453903|FG000|Overall Study|reason not given|8|||
129590004|NCT02457819|466453903|FG000|Overall Study|Withdrawal by Subject|24|||
129590005|NCT02457819|466453903|FG000|Overall Study|Protocol Violation|1|||
129590006|NCT02457819|466453903|FG000|Overall Study|non compliance with study drug|4|||
129590007|NCT02457819|466453903|FG000|Overall Study|Lost to Follow-up|10|||
129590008|NCT02457819|466453903|FG000|Overall Study|Lack of Efficacy|19|||
129590009|NCT02457819|466453903|FG000|Overall Study|Adverse Event|33|||
129590010|NCT01045707|466453906|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
129590011|NCT01045707|466453907|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
129590012|NCT01045707|466453906|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
129590013|NCT01045707|466453907|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
129590014|NCT01045707|466453906|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
129590015|NCT01045707|466453907|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
129590016|NCT01045707|466453906|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
129590017|NCT01045707|466453907|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
129590018|NCT01045707|466453906|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
129590019|NCT01045707|466453907|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
129590020|NCT01045707|466453906|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
129590021|NCT01045707|466453907|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
129590022|NCT01045707|466453906|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
129590023|NCT01045707|466453907|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
129590024|NCT01045707|466453906|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
129590025|NCT01045707|466453907|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
129590026|NCT01045707|466453906|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
129590027|NCT01045707|466453907|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
129590028|NCT04886063|466453910|FG000|Overall Study|Adverse Event|50|||
129590029|NCT04886063|466453910|FG000|Overall Study|Lack of Efficacy|31|||
129590030|NCT04886063|466453910|FG000|Overall Study|Withdrawal by Subject|45|||
129590031|NCT04886063|466453910|FG000|Overall Study|Physician Decision|3|||
129590032|NCT04886063|466453910|FG000|Overall Study|Protocol Violation|3|||
129590033|NCT04886063|466453910|FG000|Overall Study|Site closure|4|||
129590034|NCT04886063|466453910|FG000|Overall Study|Nursing home replacement|3|||
129590035|NCT04886063|466453910|FG000|Overall Study|Lost to Follow-up|5|||
129590036|NCT04886063|466453910|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
129590037|NCT04886063|466453910|FG000|Overall Study|>1 reason|20|||
129590038|NCT02005276|466453912|FG000|Overall Study|No longer interested|5|||
129590039|NCT02005276|466453913|FG001|Overall Study|No longer interested|2|||
129590040|NCT02005276|466453914|FG002|Overall Study|No longer interested|3|||
129590041|NCT02005276|466453915|FG003|Overall Study|No longer interested|3|||
129590042|NCT04994431|466453916|FG000|Overall Study|Adverse Event|1|||
129590043|NCT04994431|466453917|FG001|Overall Study|Adverse Event|0|||
129590044|NCT02914457|466453920|FG000|Overall Study|Withdrawal by Subject|1|||
129590045|NCT02914457|466453920|FG000|Overall Study|Physician Decision|1|||
129590046|NCT02914457|466453920|FG000|Overall Study|No veins available for lead placement|1|||
129590047|NCT02914457|466453920|FG000|Overall Study|Electrical instability of patient|1|||
129590048|NCT02914457|466453920|FG000|Overall Study|ECG acquisition error due to sweating|1|||
129590049|NCT02914457|466453920|FG000|Overall Study|Protocol Violation|1|||
129590050|NCT01849458|466453923|FG000|Overall Study|Lost to Follow-up|4|||
129590051|NCT01863433|466453924|FG000|Overall Study|Protocol Violation|1|||
129590052|NCT03310619|466453927|FG000|Pre-Treatment Period|Death|1|||
129590053|NCT03310619|466453928|FG001|Pre-Treatment Period|Death|0|||
129590054|NCT03310619|466453929|FG002|Pre-Treatment Period|Death|0|||
129590055|NCT03310619|466453930|FG003|Pre-Treatment Period|Death|0|||
129590056|NCT03310619|466453931|FG004|Pre-Treatment Period|Death|1|||
129590057|NCT03310619|466453932|FG005|Pre-Treatment Period|Death|0|||
129590058|NCT03310619|466453933|FG006|Pre-Treatment Period|Death|0|||
129590059|NCT03310619|466453934|FG007|Pre-Treatment Period|Death|0|||
129590060|NCT03310619|466453927|FG000|Pre-Treatment Period|Other reasons|2|||
129590061|NCT03310619|466453928|FG001|Pre-Treatment Period|Other reasons|1|||
129590062|NCT03310619|466453929|FG002|Pre-Treatment Period|Other reasons|2|||
129590063|NCT03310619|466453930|FG003|Pre-Treatment Period|Other reasons|0|||
129590064|NCT03310619|466453931|FG004|Pre-Treatment Period|Other reasons|0|||
129590065|NCT03310619|466453932|FG005|Pre-Treatment Period|Other reasons|0|||
129590066|NCT03310619|466453933|FG006|Pre-Treatment Period|Other reasons|2|||
129590067|NCT03310619|466453934|FG007|Pre-Treatment Period|Other reasons|0|||
129590068|NCT03310619|466453927|FG000|Treatment Period|Death|1|||
129590069|NCT03310619|466453928|FG001|Treatment Period|Death|2|||
129590070|NCT03310619|466453929|FG002|Treatment Period|Death|0|||
129590071|NCT03310619|466453930|FG003|Treatment Period|Death|0|||
129590072|NCT03310619|466453931|FG004|Treatment Period|Death|1|||
129590073|NCT03310619|466453932|FG005|Treatment Period|Death|0|||
129590074|NCT03310619|466453933|FG006|Treatment Period|Death|2|||
129590075|NCT03310619|466453934|FG007|Treatment Period|Death|0|||
129590076|NCT03310619|466453927|FG000|Treatment Period|Adverse Event|0|||
129590077|NCT03310619|466453928|FG001|Treatment Period|Adverse Event|1|||
129590078|NCT03310619|466453929|FG002|Treatment Period|Adverse Event|4|||
129590079|NCT03310619|466453930|FG003|Treatment Period|Adverse Event|1|||
129590080|NCT03310619|466453931|FG004|Treatment Period|Adverse Event|0|||
129590081|NCT03310619|466453932|FG005|Treatment Period|Adverse Event|0|||
129590082|NCT03310619|466453933|FG006|Treatment Period|Adverse Event|0|||
129590083|NCT03310619|466453934|FG007|Treatment Period|Adverse Event|0|||
129590084|NCT03310619|466453927|FG000|Treatment Period|Withdrawal by participant|0|||
129590085|NCT03310619|466453928|FG001|Treatment Period|Withdrawal by participant|0|||
129590086|NCT03310619|466453929|FG002|Treatment Period|Withdrawal by participant|1|||
129590087|NCT03310619|466453930|FG003|Treatment Period|Withdrawal by participant|0|||
129590088|NCT03310619|466453931|FG004|Treatment Period|Withdrawal by participant|0|||
129590089|NCT03310619|466453932|FG005|Treatment Period|Withdrawal by participant|0|||
129590090|NCT03310619|466453933|FG006|Treatment Period|Withdrawal by participant|0|||
129590091|NCT03310619|466453934|FG007|Treatment Period|Withdrawal by participant|0|||
129590092|NCT03310619|466453927|FG000|Treatment Period|Lost to Follow-up|0|||
129590093|NCT03310619|466453928|FG001|Treatment Period|Lost to Follow-up|0|||
129590094|NCT03310619|466453929|FG002|Treatment Period|Lost to Follow-up|0|||
129590095|NCT03310619|466453930|FG003|Treatment Period|Lost to Follow-up|0|||
129590096|NCT03310619|466453931|FG004|Treatment Period|Lost to Follow-up|0|||
129590097|NCT03310619|466453932|FG005|Treatment Period|Lost to Follow-up|0|||
129590098|NCT03310619|466453933|FG006|Treatment Period|Lost to Follow-up|0|||
129590099|NCT03310619|466453934|FG007|Treatment Period|Lost to Follow-up|1|||
129590100|NCT03310619|466453927|FG000|Treatment Period|Study terminated by sponsor|0|||
129590101|NCT03310619|466453928|FG001|Treatment Period|Study terminated by sponsor|0|||
129590102|NCT03310619|466453929|FG002|Treatment Period|Study terminated by sponsor|0|||
129590103|NCT03310619|466453930|FG003|Treatment Period|Study terminated by sponsor|0|||
129590104|NCT03310619|466453931|FG004|Treatment Period|Study terminated by sponsor|0|||
129590105|NCT03310619|466453932|FG005|Treatment Period|Study terminated by sponsor|0|||
129590106|NCT03310619|466453933|FG006|Treatment Period|Study terminated by sponsor|0|||
129590107|NCT03310619|466453934|FG007|Treatment Period|Study terminated by sponsor|1|||
129590108|NCT03310619|466453927|FG000|Treatment Period|Physician Decision|0|||
129590109|NCT03310619|466453928|FG001|Treatment Period|Physician Decision|0|||
129590110|NCT03310619|466453929|FG002|Treatment Period|Physician Decision|0|||
129590111|NCT03310619|466453930|FG003|Treatment Period|Physician Decision|0|||
129590112|NCT03310619|466453931|FG004|Treatment Period|Physician Decision|3|||
129590113|NCT03310619|466453932|FG005|Treatment Period|Physician Decision|0|||
129590114|NCT03310619|466453933|FG006|Treatment Period|Physician Decision|0|||
129590115|NCT03310619|466453934|FG007|Treatment Period|Physician Decision|0|||
129590116|NCT03310619|466453927|FG000|Treatment Period|Other reasons|1|||
129590117|NCT03310619|466453928|FG001|Treatment Period|Other reasons|0|||
129590118|NCT03310619|466453929|FG002|Treatment Period|Other reasons|2|||
129590119|NCT03310619|466453930|FG003|Treatment Period|Other reasons|0|||
129590120|NCT03310619|466453931|FG004|Treatment Period|Other reasons|0|||
129590121|NCT03310619|466453932|FG005|Treatment Period|Other reasons|0|||
129590122|NCT03310619|466453933|FG006|Treatment Period|Other reasons|0|||
129590123|NCT03310619|466453934|FG007|Treatment Period|Other reasons|0|||
129590124|NCT02427399|466453935|FG000|Overall Study|Protocol Violation|14|||
129590125|NCT02427399|466453936|FG001|Overall Study|Protocol Violation|16|||
129590126|NCT02427399|466453937|FG002|Overall Study|Protocol Violation|12|||
129590127|NCT02427399|466453938|FG003|Overall Study|Protocol Violation|18|||
129590128|NCT02427399|466453939|FG004|Overall Study|Protocol Violation|15|||
129590129|NCT01115933|466453940|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
129590130|NCT01294449|466453941|FG000|Overall Study|Death|11|||
129590131|NCT01294449|466453942|FG001|Overall Study|Death|12|||
129590132|NCT01294449|466453941|FG000|Overall Study|Withdrawal by Subject|1|||
129590133|NCT01294449|466453942|FG001|Overall Study|Withdrawal by Subject|3|||
129590134|NCT00603512|466453943|FG000|Overall Study|Adverse Event|0|||
129590135|NCT00603512|466453944|FG001|Overall Study|Adverse Event|2|||
129590136|NCT00603512|466453945|FG002|Overall Study|Adverse Event|4|||
129590137|NCT00603512|466453946|FG003|Overall Study|Adverse Event|4|||
129590138|NCT00603512|466453947|FG004|Overall Study|Adverse Event|2|||
129590139|NCT00603512|466453943|FG000|Overall Study|Lack of Efficacy|0|||
129590140|NCT00603512|466453944|FG001|Overall Study|Lack of Efficacy|1|||
129590141|NCT00603512|466453945|FG002|Overall Study|Lack of Efficacy|0|||
129590142|NCT00603512|466453946|FG003|Overall Study|Lack of Efficacy|0|||
129590143|NCT00603512|466453947|FG004|Overall Study|Lack of Efficacy|1|||
129590144|NCT00603512|466453943|FG000|Overall Study|Other|2|||
129590145|NCT00603512|466453944|FG001|Overall Study|Other|1|||
129590146|NCT00603512|466453945|FG002|Overall Study|Other|0|||
129590147|NCT00603512|466453946|FG003|Overall Study|Other|1|||
129590148|NCT00603512|466453947|FG004|Overall Study|Other|1|||
129590149|NCT00603512|466453943|FG000|Overall Study|Withdrawal by Subject|0|||
129590150|NCT00603512|466453944|FG001|Overall Study|Withdrawal by Subject|0|||
129590151|NCT00603512|466453945|FG002|Overall Study|Withdrawal by Subject|0|||
129590152|NCT00603512|466453946|FG003|Overall Study|Withdrawal by Subject|0|||
129590153|NCT00603512|466453947|FG004|Overall Study|Withdrawal by Subject|1|||
129590154|NCT00603512|466453943|FG000|Overall Study|Randomized but not treated|0|||
129590155|NCT00603512|466453944|FG001|Overall Study|Randomized but not treated|1|||
129590156|NCT00603512|466453945|FG002|Overall Study|Randomized but not treated|1|||
129590157|NCT00603512|466453946|FG003|Overall Study|Randomized but not treated|2|||
129590158|NCT00603512|466453947|FG004|Overall Study|Randomized but not treated|0|||
129590159|NCT02416934|466453965|FG000|Overall Study|given steroids|1|||
129590160|NCT02416934|466453966|FG001|Overall Study|given steroids|2|||
129590161|NCT02416934|466453965|FG000|Overall Study|Lost to Follow-up|0|||
129590162|NCT02416934|466453966|FG001|Overall Study|Lost to Follow-up|2|||
129590163|NCT02416934|466453965|FG000|Overall Study|Withdrawal by Subject|1|||
129590164|NCT02416934|466453966|FG001|Overall Study|Withdrawal by Subject|0|||
129590165|NCT02416934|466453965|FG000|Overall Study|recruited during continuing renewal proc|0|||
129590166|NCT02416934|466453966|FG001|Overall Study|recruited during continuing renewal proc|1|||
129590167|NCT02416934|466453965|FG000|Overall Study|Protocol Violation|0|||
129590168|NCT02416934|466453966|FG001|Overall Study|Protocol Violation|1|||
129590169|NCT02416934|466453965|FG000|Overall Study|surgery started late|0|||
129590170|NCT02416934|466453966|FG001|Overall Study|surgery started late|1|||
129590171|NCT02416934|466453965|FG000|Overall Study|re-operation|1|||
129590172|NCT02416934|466453966|FG001|Overall Study|re-operation|0|||
129590173|NCT01020526|466453967|FG000|Overall Study|Withdrawal by Subject|5|||
129590174|NCT01020526|466453967|FG000|Overall Study|Other reasons|3|||
129590175|NCT01020526|466453967|FG000|Overall Study|Insufficient clinical response|3|||
129590176|NCT01020526|466453967|FG000|Overall Study|Lost to Follow-up|1|||
129590177|NCT01020526|466453967|FG000|Overall Study|Adverse Event|2|||
129590178|NCT00398073|466453968|FG000|Overall Study|Withdrawal by Subject|1|||
129590179|NCT00398073|466453969|FG001|Overall Study|Withdrawal by Subject|0|||
129590180|NCT00105157|466453974|FG000|Double-Blind (DB)|Never Treated|1|||
129590181|NCT00105157|466453975|FG001|Double-Blind (DB)|Never Treated|0|||
129590182|NCT00105157|466453976|FG002|Double-Blind (DB)|Never Treated|0|||
129590183|NCT00105157|466453977|FG003|Double-Blind (DB)|Never Treated|0|||
129590184|NCT00105157|466453974|FG000|Double-Blind (DB)|Adverse Event|2|||
129590185|NCT00105157|466453975|FG001|Double-Blind (DB)|Adverse Event|0|||
129590186|NCT00105157|466453976|FG002|Double-Blind (DB)|Adverse Event|1|||
129590187|NCT00105157|466453977|FG003|Double-Blind (DB)|Adverse Event|1|||
129590188|NCT00105157|466453974|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
129590189|NCT00105157|466453975|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
129590190|NCT00105157|466453976|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
129590191|NCT00105157|466453977|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
129590192|NCT00105157|466453974|FG000|Open-Label Continuation of DB|Adverse Event|3|||
129590193|NCT00105157|466453975|FG001|Open-Label Continuation of DB|Adverse Event|1|||
129590194|NCT00105157|466453976|FG002|Open-Label Continuation of DB|Adverse Event|0|||
129590195|NCT00105157|466453977|FG003|Open-Label Continuation of DB|Adverse Event|0|||
129590196|NCT00105157|466453974|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
129590197|NCT00105157|466453975|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
129590198|NCT00105157|466453976|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
129590199|NCT00105157|466453977|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
129590200|NCT00105157|466453974|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
129590201|NCT00105157|466453975|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
129590202|NCT00105157|466453976|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
129590203|NCT00105157|466453977|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
129590204|NCT00105157|466453974|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
129590205|NCT00105157|466453975|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
129590206|NCT00105157|466453976|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
129590207|NCT00105157|466453977|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
129590208|NCT00105157|466453974|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
129590209|NCT00105157|466453975|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129590210|NCT00105157|466453976|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129590211|NCT00105157|466453977|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
129590212|NCT00105157|466453974|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
129590213|NCT00105157|466453975|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
129590214|NCT00105157|466453976|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
129590215|NCT00105157|466453977|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
129590216|NCT00105157|466453974|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
129590217|NCT00105157|466453975|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
129590218|NCT00105157|466453976|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
129590219|NCT00105157|466453977|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
129590220|NCT00105157|466453974|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
129590221|NCT00105157|466453975|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
129590222|NCT00105157|466453976|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
129590223|NCT00105157|466453977|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
129590224|NCT00105157|466453974|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
129590225|NCT00105157|466453975|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
129590226|NCT00105157|466453976|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
129590227|NCT00105157|466453977|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
129590228|NCT00105157|466453974|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
129590229|NCT00105157|466453975|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
129590230|NCT00105157|466453976|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
129590231|NCT00105157|466453977|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
129696363|NCT02605967|466848076|FG000|Overall Study|Adverse Event|1|||
129696364|NCT02605967|466848077|FG001|Overall Study|Adverse Event|0|||
129590232|NCT00105157|466453974|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
129590233|NCT00105157|466453975|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
129696365|NCT02605967|466848076|FG000|Overall Study|progressive disease|66|||
129696366|NCT02605967|466848077|FG001|Overall Study|progressive disease|35|||
129590234|NCT00105157|466453976|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
129590235|NCT00105157|466453977|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
129590236|NCT02169336|466453982|FG000|Overall Study|Lack of Efficacy|1|||
129590237|NCT02169336|466453983|FG001|Overall Study|Lack of Efficacy|1|||
129590238|NCT02169336|466453984|FG002|Overall Study|Lack of Efficacy|0|||
129590239|NCT02169336|466453982|FG000|Overall Study|Adverse Event|2|||
129590240|NCT02169336|466453983|FG001|Overall Study|Adverse Event|3|||
129590241|NCT02169336|466453984|FG002|Overall Study|Adverse Event|1|||
129590242|NCT02169336|466453982|FG000|Overall Study|Withdrawal by Subject|1|||
129590243|NCT02169336|466453983|FG001|Overall Study|Withdrawal by Subject|0|||
129590244|NCT02169336|466453984|FG002|Overall Study|Withdrawal by Subject|0|||
129590245|NCT02169336|466453982|FG000|Overall Study|Physician Decision|0|||
129590246|NCT02169336|466453983|FG001|Overall Study|Physician Decision|0|||
129590247|NCT02169336|466453984|FG002|Overall Study|Physician Decision|1|||
129590248|NCT02169336|466453982|FG000|Overall Study|Subject declined to continue dosing|0|||
129590249|NCT02169336|466453983|FG001|Overall Study|Subject declined to continue dosing|0|||
129590250|NCT02169336|466453984|FG002|Overall Study|Subject declined to continue dosing|1|||
129590251|NCT01148225|466453985|FG000|Overall Study|Other|185|||
129590252|NCT02212457|466453986|FG000|Overall Study|Adverse Event|1|||
129590253|NCT02212457|466453987|FG001|Overall Study|Adverse Event|2|||
129590254|NCT02212457|466453988|FG002|Overall Study|Adverse Event|2|||
129590255|NCT02212457|466453989|FG003|Overall Study|Adverse Event|2|||
129590256|NCT02212457|466453990|FG004|Overall Study|Adverse Event|0|||
129590257|NCT02212457|466453991|FG005|Overall Study|Adverse Event|1|||
129590258|NCT02212457|466453986|FG000|Overall Study|Withdrawal by Subject|8|||
129590259|NCT02212457|466453987|FG001|Overall Study|Withdrawal by Subject|10|||
129590260|NCT02212457|466453988|FG002|Overall Study|Withdrawal by Subject|8|||
129590261|NCT02212457|466453989|FG003|Overall Study|Withdrawal by Subject|6|||
129590262|NCT02212457|466453990|FG004|Overall Study|Withdrawal by Subject|5|||
129590263|NCT02212457|466453991|FG005|Overall Study|Withdrawal by Subject|4|||
129590264|NCT02212457|466453986|FG000|Overall Study|Lost to Follow-up|6|||
129590265|NCT02212457|466453987|FG001|Overall Study|Lost to Follow-up|7|||
129590266|NCT02212457|466453988|FG002|Overall Study|Lost to Follow-up|4|||
129590267|NCT02212457|466453989|FG003|Overall Study|Lost to Follow-up|1|||
129590268|NCT02212457|466453990|FG004|Overall Study|Lost to Follow-up|8|||
129590269|NCT02212457|466453991|FG005|Overall Study|Lost to Follow-up|4|||
129590270|NCT02212457|466453986|FG000|Overall Study|Protocol Violation|2|||
129590271|NCT02212457|466453987|FG001|Overall Study|Protocol Violation|1|||
129590272|NCT02212457|466453988|FG002|Overall Study|Protocol Violation|0|||
129590273|NCT02212457|466453989|FG003|Overall Study|Protocol Violation|1|||
129590274|NCT02212457|466453990|FG004|Overall Study|Protocol Violation|2|||
129590275|NCT02212457|466453991|FG005|Overall Study|Protocol Violation|3|||
129590276|NCT02212457|466453986|FG000|Overall Study|Other|2|||
129590277|NCT02212457|466453987|FG001|Overall Study|Other|1|||
129590278|NCT02212457|466453988|FG002|Overall Study|Other|2|||
129590279|NCT02212457|466453989|FG003|Overall Study|Other|1|||
129590280|NCT02212457|466453990|FG004|Overall Study|Other|0|||
129590281|NCT02212457|466453991|FG005|Overall Study|Other|1|||
129590282|NCT02490800|466453992|FG000|Overall Study|Adverse Event|0|||
129590283|NCT02490800|466453993|FG001|Overall Study|Adverse Event|0|||
129590284|NCT02490800|466453994|FG002|Overall Study|Adverse Event|0|||
129590285|NCT02490800|466453995|FG003|Overall Study|Adverse Event|2|||
129590286|NCT02490800|466453996|FG004|Overall Study|Adverse Event|3|||
129590287|NCT02490800|466453997|FG005|Overall Study|Adverse Event|2|||
129590288|NCT02490800|466453998|FG006|Overall Study|Adverse Event|0|||
129590289|NCT02490800|466453999|FG007|Overall Study|Adverse Event|0|||
129590290|NCT02490800|466454000|FG008|Overall Study|Adverse Event|0|||
129590291|NCT02490800|466454001|FG009|Overall Study|Adverse Event|0|||
129590292|NCT02490800|466454002|FG010|Overall Study|Adverse Event|0|||
129590293|NCT02490800|466454003|FG011|Overall Study|Adverse Event|2|||
129590294|NCT02490800|466454004|FG012|Overall Study|Adverse Event|2|||
129590295|NCT02490800|466453992|FG000|Overall Study|Withdrawal by Subject|0|||
129590296|NCT02490800|466453993|FG001|Overall Study|Withdrawal by Subject|0|||
129590297|NCT02490800|466453994|FG002|Overall Study|Withdrawal by Subject|0|||
129590298|NCT02490800|466453995|FG003|Overall Study|Withdrawal by Subject|1|||
129590299|NCT02490800|466453996|FG004|Overall Study|Withdrawal by Subject|0|||
129590300|NCT02490800|466453997|FG005|Overall Study|Withdrawal by Subject|0|||
129590301|NCT02490800|466453998|FG006|Overall Study|Withdrawal by Subject|0|||
129590302|NCT02490800|466453999|FG007|Overall Study|Withdrawal by Subject|0|||
129590303|NCT02490800|466454000|FG008|Overall Study|Withdrawal by Subject|1|||
129590304|NCT02490800|466454001|FG009|Overall Study|Withdrawal by Subject|0|||
129590305|NCT02490800|466454002|FG010|Overall Study|Withdrawal by Subject|0|||
129590306|NCT02490800|466454003|FG011|Overall Study|Withdrawal by Subject|0|||
129590307|NCT02490800|466454004|FG012|Overall Study|Withdrawal by Subject|0|||
129590308|NCT02490800|466453992|FG000|Overall Study|Progressive disease|3|||
129590309|NCT02490800|466453993|FG001|Overall Study|Progressive disease|3|||
129590310|NCT02490800|466453994|FG002|Overall Study|Progressive disease|3|||
129590311|NCT02490800|466453995|FG003|Overall Study|Progressive disease|4|||
129590312|NCT02490800|466453996|FG004|Overall Study|Progressive disease|4|||
129590313|NCT02490800|466453997|FG005|Overall Study|Progressive disease|1|||
129590314|NCT02490800|466453998|FG006|Overall Study|Progressive disease|4|||
129590315|NCT02490800|466453999|FG007|Overall Study|Progressive disease|3|||
129590316|NCT02490800|466454000|FG008|Overall Study|Progressive disease|6|||
129590317|NCT02490800|466454001|FG009|Overall Study|Progressive disease|2|||
129590318|NCT02490800|466454002|FG010|Overall Study|Progressive disease|7|||
129590319|NCT02490800|466454003|FG011|Overall Study|Progressive disease|1|||
129590320|NCT02490800|466454004|FG012|Overall Study|Progressive disease|10|||
129590321|NCT02490800|466453992|FG000|Overall Study|Patient enrolled in post-trial access|0|||
129590322|NCT02490800|466453993|FG001|Overall Study|Patient enrolled in post-trial access|0|||
129590323|NCT02490800|466453994|FG002|Overall Study|Patient enrolled in post-trial access|0|||
129590324|NCT02490800|466453995|FG003|Overall Study|Patient enrolled in post-trial access|0|||
129590325|NCT02490800|466453996|FG004|Overall Study|Patient enrolled in post-trial access|0|||
129590326|NCT02490800|466453997|FG005|Overall Study|Patient enrolled in post-trial access|0|||
129590327|NCT02490800|466453998|FG006|Overall Study|Patient enrolled in post-trial access|0|||
129590328|NCT02490800|466453999|FG007|Overall Study|Patient enrolled in post-trial access|0|||
129590329|NCT02490800|466454000|FG008|Overall Study|Patient enrolled in post-trial access|0|||
129590330|NCT02490800|466454001|FG009|Overall Study|Patient enrolled in post-trial access|1|||
129590331|NCT02490800|466454002|FG010|Overall Study|Patient enrolled in post-trial access|1|||
129590332|NCT02490800|466454003|FG011|Overall Study|Patient enrolled in post-trial access|0|||
129590333|NCT02490800|466454004|FG012|Overall Study|Patient enrolled in post-trial access|6|||
129590334|NCT00654641|466454006|FG000|Overall Study|Lost to Follow-up|2|||
129590335|NCT00654641|466454007|FG001|Overall Study|Lost to Follow-up|3|||
129590336|NCT01337596|466454008|FG000|Overall Study|Withdrawal by Subject|0|||
129590337|NCT01337596|466454009|FG001|Overall Study|Withdrawal by Subject|0|||
129590338|NCT01337596|466454010|FG002|Overall Study|Withdrawal by Subject|0|||
129590339|NCT01337596|466454011|FG003|Overall Study|Withdrawal by Subject|0|||
129590340|NCT01337596|466454012|FG004|Overall Study|Withdrawal by Subject|2|||
129590341|NCT01337596|466454013|FG005|Overall Study|Withdrawal by Subject|0|||
129590342|NCT01337596|466454014|FG006|Overall Study|Withdrawal by Subject|0|||
129590343|NCT01337596|466454015|FG007|Overall Study|Withdrawal by Subject|0|||
129590344|NCT01337596|466454016|FG008|Overall Study|Withdrawal by Subject|0|||
129590345|NCT03693950|466454017|FG000|Overall Study|Withdrawal by Subject|1|||
129590346|NCT03693950|466454018|FG001|Overall Study|Withdrawal by Subject|0|||
129590347|NCT02415387|466455448|FG000|Overall Study|Withdrawal by Subject|6|||
129590348|NCT02415387|466455449|FG001|Overall Study|Withdrawal by Subject|1|||
129590349|NCT02415387|466455448|FG000|Overall Study|blood draw problem|0|||
129590350|NCT02415387|466455449|FG001|Overall Study|blood draw problem|1|||
129590351|NCT02415387|466455448|FG000|Overall Study|Protocol Violation|1|||
129590352|NCT02415387|466455449|FG001|Overall Study|Protocol Violation|0|||
129590353|NCT00676650|466455453|FG000|Overall Study|Death|45|||
129590354|NCT00676650|466455454|FG001|Overall Study|Death|14|||
129590355|NCT00676650|466455453|FG000|Overall Study|Adverse Event|159|||
129590356|NCT00676650|466455454|FG001|Overall Study|Adverse Event|21|||
129590357|NCT00676650|466455453|FG000|Overall Study|Global deterioration of health status|66|||
129590358|NCT00676650|466455454|FG001|Overall Study|Global deterioration of health status|31|||
129590359|NCT00676650|466455453|FG000|Overall Study|Lost to Follow-up|0|||
129590360|NCT00676650|466455454|FG001|Overall Study|Lost to Follow-up|1|||
129590361|NCT00676650|466455453|FG000|Overall Study|Objective progression or relapse|189|||
129590362|NCT00676650|466455454|FG001|Overall Study|Objective progression or relapse|140|||
129590363|NCT00676650|466455453|FG000|Overall Study|Other|14|||
129590364|NCT00676650|466455454|FG001|Overall Study|Other|10|||
129590365|NCT00676650|466455453|FG000|Overall Study|Protocol Violation|3|||
129590366|NCT00676650|466455454|FG001|Overall Study|Protocol Violation|1|||
129590367|NCT00676650|466455453|FG000|Overall Study|Study terminated by sponsor|57|||
129590368|NCT00676650|466455454|FG001|Overall Study|Study terminated by sponsor|43|||
129590369|NCT00676650|466455453|FG000|Overall Study|Withdrawal by Subject|48|||
129590370|NCT00676650|466455454|FG001|Overall Study|Withdrawal by Subject|24|||
129590371|NCT00676650|466455453|FG000|Overall Study|Randomized but not treated|3|||
129590372|NCT00676650|466455454|FG001|Overall Study|Randomized but not treated|4|||
129590373|NCT02297841|466455458|FG000|Overall Study|Withdrawal by Subject|1|||
129696367|NCT00159874|466848083|FG000|Overall Study|Adverse Event|2|||
129590374|NCT02297841|466455458|FG000|Overall Study|Protocol Violation|7|||
129590375|NCT00683592|466455459|FG000|Overall Study|Adverse Event|12|||
129590376|NCT00683592|466455460|FG001|Overall Study|Adverse Event|4|||
129590377|NCT00683592|466455459|FG000|Overall Study|Withdrawal by Subject|11|||
129590378|NCT00683592|466455460|FG001|Overall Study|Withdrawal by Subject|11|||
129590379|NCT00683592|466455459|FG000|Overall Study|Lost to Follow-up|17|||
129590380|NCT00683592|466455460|FG001|Overall Study|Lost to Follow-up|17|||
129590381|NCT00683592|466455459|FG000|Overall Study|Lack of Efficacy|3|||
129590382|NCT00683592|466455460|FG001|Overall Study|Lack of Efficacy|7|||
129590383|NCT00683592|466455459|FG000|Overall Study|Physician Decision|0|||
129590384|NCT00683592|466455460|FG001|Overall Study|Physician Decision|1|||
129590385|NCT00683592|466455459|FG000|Overall Study|Non-compliance|3|||
129590386|NCT00683592|466455460|FG001|Overall Study|Non-compliance|5|||
129590387|NCT00683592|466455459|FG000|Overall Study|Other|1|||
129590388|NCT00683592|466455460|FG001|Overall Study|Other|1|||
129590389|NCT00784979|466455461|FG000|Overall Study|incomplete data|6|||
129590390|NCT01235715|466455466|FG000|Overall Study|Physician Decision|0|||
129590391|NCT01235715|466455467|FG001|Overall Study|Physician Decision|2|||
129590392|NCT03619876|466455468|FG000|Overall Study|Withdrawal by Subject|1|||
129590393|NCT03619876|466455469|FG001|Overall Study|Withdrawal by Subject|2|||
129590394|NCT03619876|466455468|FG000|Overall Study|Withdrawal due to incidental finding|0|||
129590395|NCT03619876|466455469|FG001|Overall Study|Withdrawal due to incidental finding|2|||
129590396|NCT02994394|466455470|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
129590397|NCT02994394|466455471|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
129590398|NCT02994394|466455472|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
129590399|NCT02994394|466455473|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
129590400|NCT02994394|466455474|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
129590401|NCT02994394|466455475|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
129590402|NCT02994394|466455470|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
129590403|NCT02994394|466455471|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
129590404|NCT02994394|466455472|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
129590405|NCT02994394|466455473|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
129590406|NCT02994394|466455474|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
129590407|NCT02994394|466455475|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
129590408|NCT00396630|466455476|FG000|Overall Study|Lost to Follow-up|1|||
129590409|NCT00396630|466455477|FG001|Overall Study|Lost to Follow-up|1|||
129590410|NCT00396630|466455476|FG000|Overall Study|Withdrawal by Subject|1|||
129590411|NCT00396630|466455477|FG001|Overall Study|Withdrawal by Subject|1|||
129590412|NCT00396630|466455476|FG000|Overall Study|Not vaccinated at Visit 3|3|||
129590413|NCT00396630|466455477|FG001|Overall Study|Not vaccinated at Visit 3|3|||
129590414|NCT02327325|466455478|FG000|Overall Study|Withdrawal by Subject|1|||
129590415|NCT02327325|466455479|FG001|Overall Study|Withdrawal by Subject|4|||
129590416|NCT02327325|466455480|FG002|Overall Study|Withdrawal by Subject|4|||
129590417|NCT02327325|466455478|FG000|Overall Study|Excluded by Study Team|0|||
129590418|NCT02327325|466455479|FG001|Overall Study|Excluded by Study Team|0|||
129590419|NCT02327325|466455480|FG002|Overall Study|Excluded by Study Team|1|||
129590420|NCT01755975|466455483|FG000|Overall Study|Adverse Event|0|||
129590421|NCT01755975|466455484|FG001|Overall Study|Adverse Event|0|||
129590422|NCT01755975|466455485|FG002|Overall Study|Adverse Event|1|||
129590423|NCT01755975|466455486|FG003|Overall Study|Adverse Event|0|||
129590424|NCT01755975|466455487|FG004|Overall Study|Adverse Event|2|||
129590425|NCT03330236|466455491|FG000|Overall Study|Death|2|||
129590426|NCT03330236|466455492|FG001|Overall Study|Death|1|||
129590427|NCT03330236|466455491|FG000|Overall Study|Withdrawal by Subject|2|||
129590428|NCT03330236|466455492|FG001|Overall Study|Withdrawal by Subject|4|||
129590429|NCT03330236|466455491|FG000|Overall Study|Lost to Follow-up|0|||
129590430|NCT03330236|466455492|FG001|Overall Study|Lost to Follow-up|2|||
129590431|NCT03330236|466455491|FG000|Overall Study|Physician Decision|2|||
129590432|NCT03330236|466455492|FG001|Overall Study|Physician Decision|0|||
129590433|NCT03330236|466455491|FG000|Overall Study|Protocol Violation|4|||
129590434|NCT03330236|466455492|FG001|Overall Study|Protocol Violation|3|||
129590435|NCT03330236|466455491|FG000|Overall Study|SedLine malfunction/blinding|19|||
129590436|NCT03330236|466455492|FG001|Overall Study|SedLine malfunction/blinding|14|||
129590437|NCT03330236|466455491|FG000|Overall Study|Volatile anesthetics used|11|||
129590438|NCT03330236|466455492|FG001|Overall Study|Volatile anesthetics used|8|||
129590439|NCT03330236|466455491|FG000|Overall Study|Surgery aborted/converted to open|60|||
129590440|NCT03330236|466455492|FG001|Overall Study|Surgery aborted/converted to open|52|||
129590441|NCT01901848|466455493|FG000|Randomized and Treated|Lost to Follow-up|3|||
129590442|NCT01901848|466455494|FG001|Randomized and Treated|Lost to Follow-up|6|||
129590443|NCT01901848|466455493|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
129590444|NCT01901848|466455494|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
129590445|NCT00763555|466455495|FG000|Overall Study|Adverse Event|2|||
129590446|NCT00763555|466455496|FG001|Overall Study|Adverse Event|1|||
129590447|NCT00763555|466455495|FG000|Overall Study|Withdrawal by Subject|2|||
129590448|NCT00763555|466455496|FG001|Overall Study|Withdrawal by Subject|6|||
129590449|NCT00763555|466455495|FG000|Overall Study|Lost to Follow-up|0|||
129590450|NCT00763555|466455496|FG001|Overall Study|Lost to Follow-up|3|||
129590451|NCT01729026|466455497|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
129590452|NCT01729026|466455498|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
129590453|NCT01729026|466455497|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
129590454|NCT01729026|466455498|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
129590455|NCT00852917|466455499|FG000|Overall Study|Adverse Event|13|||
129590456|NCT00852917|466455500|FG001|Overall Study|Adverse Event|20|||
129590457|NCT00852917|466455501|FG002|Overall Study|Adverse Event|35|||
129590458|NCT00852917|466455502|FG003|Overall Study|Adverse Event|17|||
129590459|NCT00852917|466455499|FG000|Overall Study|Lack of Efficacy|21|||
129590460|NCT00852917|466455500|FG001|Overall Study|Lack of Efficacy|11|||
129590461|NCT00852917|466455501|FG002|Overall Study|Lack of Efficacy|11|||
129590462|NCT00852917|466455502|FG003|Overall Study|Lack of Efficacy|47|||
129590463|NCT00852917|466455499|FG000|Overall Study|Withdrawal by Subject|4|||
129590464|NCT00852917|466455500|FG001|Overall Study|Withdrawal by Subject|8|||
129590465|NCT00852917|466455501|FG002|Overall Study|Withdrawal by Subject|10|||
129590466|NCT00852917|466455502|FG003|Overall Study|Withdrawal by Subject|9|||
129590467|NCT00852917|466455499|FG000|Overall Study|Physician Decision|6|||
129590468|NCT00852917|466455500|FG001|Overall Study|Physician Decision|7|||
129590469|NCT00852917|466455501|FG002|Overall Study|Physician Decision|2|||
129590470|NCT00852917|466455502|FG003|Overall Study|Physician Decision|19|||
129590471|NCT00852917|466455499|FG000|Overall Study|Death|0|||
129590472|NCT00852917|466455500|FG001|Overall Study|Death|0|||
129590473|NCT00852917|466455501|FG002|Overall Study|Death|0|||
129590474|NCT00852917|466455502|FG003|Overall Study|Death|1|||
129590475|NCT03710590|466455503|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
129590476|NCT03710590|466455504|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
129590477|NCT02488824|466455505|FG000|Overall Study|Adverse Event|1|||
129590478|NCT02488824|466455506|FG001|Overall Study|Adverse Event|1|||
129590479|NCT01201759|466455508|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
129590480|NCT01201759|466455509|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
129590481|NCT01201759|466455508|FG000|Visit 3 - Washout|Adverse Event|0|||
129590482|NCT01201759|466455509|FG001|Visit 3 - Washout|Adverse Event|3|||
129590483|NCT01201759|466455508|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
129590484|NCT01201759|466455509|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
129590485|NCT01201759|466455508|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
129590486|NCT01201759|466455509|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
129590487|NCT00848042|466455510|FG000|Overall Study|Death|1|||
129590488|NCT00848042|466455511|FG001|Overall Study|Death|2|||
129590489|NCT00848042|466455512|FG002|Overall Study|Death|0|||
129590490|NCT00848042|466455510|FG000|Overall Study|Other Therapy|3|||
129590491|NCT00848042|466455511|FG001|Overall Study|Other Therapy|0|||
129590492|NCT00848042|466455512|FG002|Overall Study|Other Therapy|0|||
129590493|NCT00979212|466455515|FG000|Overall Study|Protocol Violation|1|||
129590494|NCT00979212|466455516|FG001|Overall Study|Protocol Violation|8|||
129590495|NCT00979212|466455515|FG000|Overall Study|No protocol therapy received|1|||
129590496|NCT00979212|466455516|FG001|Overall Study|No protocol therapy received|0|||
129590497|NCT02448563|466455523|FG000|Overall Study|Lost to Follow-up|16|||
129590498|NCT02448563|466455524|FG001|Overall Study|Lost to Follow-up|10|||
129590499|NCT02448563|466455523|FG000|Overall Study|Withdrawal by Subject|0|||
129590500|NCT02448563|466455524|FG001|Overall Study|Withdrawal by Subject|1|||
129590501|NCT02340962|466455525|FG000|Overall Study|Lost to Follow-up|1|||
129590502|NCT02340962|466455526|FG001|Overall Study|Lost to Follow-up|0|||
129590503|NCT02174276|466455527|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
129590504|NCT02174276|466455528|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
129590505|NCT02174276|466455529|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
129590506|NCT02174276|466455530|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
129590507|NCT02174276|466455527|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
129590508|NCT02174276|466455528|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
129590509|NCT02174276|466455529|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
129590510|NCT02174276|466455530|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
129590511|NCT02174276|466455527|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
129590512|NCT02174276|466455528|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
129590513|NCT02174276|466455529|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
129590514|NCT02174276|466455530|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
129590515|NCT02174276|466455527|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
129590516|NCT02174276|466455528|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
129590517|NCT02174276|466455529|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
129590518|NCT02174276|466455530|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
129590519|NCT02174276|466455527|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
129590520|NCT02174276|466455528|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
129590521|NCT02174276|466455529|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
129590522|NCT02174276|466455530|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
129590523|NCT02174276|466455527|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
129590524|NCT02174276|466455528|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
129696368|NCT00159874|466848084|FG001|Overall Study|Adverse Event|2|||
129590525|NCT02174276|466455529|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
129590526|NCT02174276|466455530|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
129590527|NCT00434837|466455538|FG000|Overall Study|Lost to Follow-up|20|||
129590528|NCT00434837|466455539|FG001|Overall Study|Lost to Follow-up|23|||
129590529|NCT00434837|466455540|FG002|Overall Study|Lost to Follow-up|30|||
129590530|NCT00515216|466455541|FG000|Overall Study|Withdrawal by Subject|1|||
129590531|NCT02786927|466455543|FG000|Overall Study|Adverse Event|1|||
129590532|NCT02786927|466455543|FG000|Overall Study|Protocol Violation|4|||
129590533|NCT01801917|466455544|FG000|Period 1 - Randomized|Adverse Event|1|||
129590534|NCT01801917|466455545|FG001|Period 1 - Randomized|Adverse Event|0|||
129590535|NCT01801917|466455546|FG002|Period 1 - Randomized|Adverse Event|1|||
129590536|NCT01801917|466455547|FG003|Period 1 - Randomized|Adverse Event|0|||
129590537|NCT04307849|466455548|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
129590538|NCT04307849|466455549|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
129590539|NCT04307849|466455550|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
129590540|NCT04307849|466455551|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
129590541|NCT04307849|466455552|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
129590542|NCT04307849|466455553|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
129590543|NCT04307849|466455548|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129590544|NCT04307849|466455549|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129590545|NCT04307849|466455550|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
129590546|NCT04307849|466455551|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129590547|NCT04307849|466455552|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129590548|NCT04307849|466455553|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
129590549|NCT04307849|466455548|FG000|Overall Study|Family member did not want them to continue|0|||
129590550|NCT04307849|466455549|FG001|Overall Study|Family member did not want them to continue|0|||
129590551|NCT04307849|466455550|FG002|Overall Study|Family member did not want them to continue|1|||
129590552|NCT04307849|466455551|FG003|Overall Study|Family member did not want them to continue|0|||
129590553|NCT04307849|466455552|FG004|Overall Study|Family member did not want them to continue|0|||
129590554|NCT04307849|466455553|FG005|Overall Study|Family member did not want them to continue|0|||
129590555|NCT04307849|466455548|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
129590556|NCT04307849|466455549|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
129590557|NCT04307849|466455550|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
129590558|NCT04307849|466455551|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
129590559|NCT04307849|466455552|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
129590560|NCT04307849|466455553|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
129590561|NCT05467982|466455556|FG000|Overall Study|Death|0|||
129590562|NCT05467982|466455557|FG001|Overall Study|Death|1|||
129590563|NCT05467982|466455556|FG000|Overall Study|Lost to Follow-up|3|||
129590564|NCT05467982|466455557|FG001|Overall Study|Lost to Follow-up|1|||
129590565|NCT01833169|466455561|FG000|Overall Study|Disease Progression|99|||
129590566|NCT01833169|466455561|FG000|Overall Study|Adverse Event|33|||
129590567|NCT01833169|466455561|FG000|Overall Study|Withdrawal by Subject|9|||
129590568|NCT01833169|466455561|FG000|Overall Study|Death|3|||
129590569|NCT01833169|466455561|FG000|Overall Study|Physician Decision|2|||
129590570|NCT00879684|466455565|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
129590571|NCT00879684|466455566|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
129590572|NCT00879684|466455567|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
129590573|NCT00879684|466455568|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
129590574|NCT00879684|466455569|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
129590575|NCT00879684|466455570|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
129590576|NCT00879684|466455571|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
129590577|NCT00879684|466455565|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
129590578|NCT00879684|466455566|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
129590579|NCT00879684|466455567|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
129590580|NCT00879684|466455568|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
129590581|NCT00879684|466455569|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
129590582|NCT00879684|466455570|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
129590583|NCT00879684|466455571|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
129590584|NCT00879684|466455565|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
129590585|NCT00879684|466455566|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
129590586|NCT00879684|466455567|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
129590587|NCT00879684|466455568|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
129590588|NCT00879684|466455569|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
129590589|NCT00879684|466455570|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
129590590|NCT00879684|466455571|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
129590591|NCT00879684|466455565|FG000|Stage 1: Dose Escalation|Death|0|||
129590592|NCT00879684|466455566|FG001|Stage 1: Dose Escalation|Death|0|||
129590593|NCT00879684|466455567|FG002|Stage 1: Dose Escalation|Death|1|||
129590594|NCT00879684|466455568|FG003|Stage 1: Dose Escalation|Death|0|||
129590595|NCT00879684|466455569|FG004|Stage 1: Dose Escalation|Death|0|||
129590596|NCT00879684|466455570|FG005|Stage 1: Dose Escalation|Death|0|||
129590597|NCT00879684|466455571|FG006|Stage 1: Dose Escalation|Death|0|||
129590598|NCT00879684|466455565|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129590599|NCT00879684|466455566|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129590600|NCT00879684|466455567|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129590601|NCT00879684|466455568|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129590602|NCT00879684|466455569|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129590603|NCT00879684|466455570|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
129590604|NCT00879684|466455571|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
129590605|NCT00879684|466455565|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
129590606|NCT00879684|466455566|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
129590607|NCT00879684|466455567|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
129590608|NCT00879684|466455568|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
129590609|NCT00879684|466455569|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
129590610|NCT00879684|466455570|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
129590611|NCT00879684|466455571|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
129590612|NCT00879684|466455565|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129590613|NCT00879684|466455566|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129590614|NCT00879684|466455567|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129590615|NCT00879684|466455568|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129590616|NCT00879684|466455569|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129590617|NCT00879684|466455570|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
129590618|NCT00879684|466455571|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
129590619|NCT00420095|466455572|FG000|Overall Study|Adverse Event|1|||
129590620|NCT00420095|466455573|FG001|Overall Study|Adverse Event|0|||
129590621|NCT00420095|466455572|FG000|Overall Study|Protocol Violation|1|||
129590622|NCT00420095|466455573|FG001|Overall Study|Protocol Violation|1|||
129590623|NCT00420095|466455572|FG000|Overall Study|Lost to Follow-up|1|||
129590624|NCT00420095|466455573|FG001|Overall Study|Lost to Follow-up|0|||
129590625|NCT00393705|466455574|FG000|Overall Study|Adverse Event|0|||
129590626|NCT00393705|466455575|FG001|Overall Study|Adverse Event|2|||
129590627|NCT00393705|466455574|FG000|Overall Study|Death|0|||
129590628|NCT00393705|466455575|FG001|Overall Study|Death|1|||
129590629|NCT00393705|466455574|FG000|Overall Study|Lost to Follow-up|2|||
129590630|NCT00393705|466455575|FG001|Overall Study|Lost to Follow-up|2|||
129590631|NCT00393705|466455574|FG000|Overall Study|Entry Criteria Not Met|10|||
129590632|NCT00393705|466455575|FG001|Overall Study|Entry Criteria Not Met|10|||
129590633|NCT00393705|466455574|FG000|Overall Study|Protocol Violation|4|||
129590634|NCT00393705|466455575|FG001|Overall Study|Protocol Violation|3|||
129590635|NCT00393705|466455574|FG000|Overall Study|Withdrawal by Subject|5|||
129885585|NCT02611830|467540767|FG000|OL Induction Phase|Lack of Efficacy|9|||
129590636|NCT00393705|466455575|FG001|Overall Study|Withdrawal by Subject|3|||
129590637|NCT00393705|466455574|FG000|Overall Study|Physician Decision|2|||
129590638|NCT00393705|466455575|FG001|Overall Study|Physician Decision|2|||
129590639|NCT03185741|466455576|FG000|Baseline|Withdrawal by Subject|1|||
129590640|NCT03185741|466455577|FG001|Baseline|Withdrawal by Subject|3|||
129590641|NCT03185741|466455578|FG002|Baseline|Withdrawal by Subject|2|||
129590642|NCT03185741|466455576|FG000|Baseline|Lost to Follow-up|1|||
129590643|NCT03185741|466455577|FG001|Baseline|Lost to Follow-up|2|||
129590644|NCT03185741|466455578|FG002|Baseline|Lost to Follow-up|3|||
129590645|NCT03185741|466455576|FG000|3Month|Death|1|||
129590646|NCT03185741|466455577|FG001|3Month|Death|1|||
129590647|NCT03185741|466455578|FG002|3Month|Death|2|||
129590648|NCT03185741|466455576|FG000|3Month|Withdrawal by Subject|1|||
129590649|NCT03185741|466455577|FG001|3Month|Withdrawal by Subject|5|||
129590650|NCT03185741|466455578|FG002|3Month|Withdrawal by Subject|1|||
129590651|NCT03185741|466455576|FG000|3Month|Lost to Follow-up|7|||
129590652|NCT03185741|466455577|FG001|3Month|Lost to Follow-up|9|||
129590653|NCT03185741|466455578|FG002|3Month|Lost to Follow-up|8|||
129590654|NCT03185741|466455576|FG000|3Month|Unavailable for 3Month|11|||
129590655|NCT03185741|466455577|FG001|3Month|Unavailable for 3Month|10|||
129590656|NCT03185741|466455578|FG002|3Month|Unavailable for 3Month|11|||
129590657|NCT03185741|466455576|FG000|3Month|Protocol Violation|0|||
129590658|NCT03185741|466455577|FG001|3Month|Protocol Violation|0|||
129590659|NCT03185741|466455578|FG002|3Month|Protocol Violation|3|||
129590660|NCT03185741|466455576|FG000|6Month|Death|1|||
129590661|NCT03185741|466455577|FG001|6Month|Death|1|||
129590662|NCT03185741|466455578|FG002|6Month|Death|2|||
129590663|NCT03185741|466455576|FG000|6Month|Withdrawal by Subject|2|||
129590664|NCT03185741|466455577|FG001|6Month|Withdrawal by Subject|3|||
129590665|NCT03185741|466455578|FG002|6Month|Withdrawal by Subject|1|||
129590666|NCT03185741|466455576|FG000|6Month|Lost to Follow-up|16|||
129590667|NCT03185741|466455577|FG001|6Month|Lost to Follow-up|15|||
129590668|NCT03185741|466455578|FG002|6Month|Lost to Follow-up|16|||
129590669|NCT03365791|466455579|FG000|Overall Study|Adverse Event|5|||
129590670|NCT03365791|466455579|FG000|Overall Study|Death|1|||
129590671|NCT03365791|466455579|FG000|Overall Study|Lost to Follow-up|1|||
129590672|NCT03365791|466455579|FG000|Overall Study|Physician Decision|9|||
129590673|NCT03365791|466455579|FG000|Overall Study|Progressive disease|51|||
129590674|NCT03365791|466455579|FG000|Overall Study|Subject/guardian decision|5|||
129590675|NCT01636934|466456830|FG000|Overall Study|Withdrawal by Subject|3|||
129590676|NCT01636934|466456831|FG001|Overall Study|Withdrawal by Subject|2|||
129590677|NCT01636934|466456830|FG000|Overall Study|Chemo cancel|1|||
129590678|NCT01636934|466456831|FG001|Overall Study|Chemo cancel|0|||
129590679|NCT01636934|466456830|FG000|Overall Study|Too ill to continue|1|||
129590680|NCT01636934|466456831|FG001|Overall Study|Too ill to continue|0|||
129590681|NCT01636934|466456830|FG000|Overall Study|Never started study medication|1|||
129590682|NCT01636934|466456831|FG001|Overall Study|Never started study medication|1|||
129590683|NCT01011335|466456832|FG000|Overall Study|Lost to Follow-up|0|||
129590684|NCT01011335|466456833|FG001|Overall Study|Lost to Follow-up|0|||
129590685|NCT01011335|466456834|FG002|Overall Study|Lost to Follow-up|1|||
129590686|NCT01011335|466456835|FG003|Overall Study|Lost to Follow-up|1|||
129590687|NCT01011335|466456836|FG004|Overall Study|Lost to Follow-up|1|||
129590688|NCT01011335|466456837|FG005|Overall Study|Lost to Follow-up|1|||
129590689|NCT01011335|466456838|FG006|Overall Study|Lost to Follow-up|2|||
129590690|NCT01011335|466456839|FG007|Overall Study|Lost to Follow-up|2|||
129590691|NCT01011335|466456840|FG008|Overall Study|Lost to Follow-up|1|||
129590692|NCT01011335|466456841|FG009|Overall Study|Lost to Follow-up|0|||
129590693|NCT01011335|466456842|FG010|Overall Study|Lost to Follow-up|0|||
129590694|NCT01011335|466456843|FG011|Overall Study|Lost to Follow-up|1|||
129590695|NCT01011335|466456844|FG012|Overall Study|Lost to Follow-up|2|||
129590696|NCT01011335|466456832|FG000|Overall Study|Protocol Violation|0|||
129590697|NCT01011335|466456833|FG001|Overall Study|Protocol Violation|1|||
129590698|NCT01011335|466456834|FG002|Overall Study|Protocol Violation|0|||
129590699|NCT01011335|466456835|FG003|Overall Study|Protocol Violation|0|||
129590700|NCT01011335|466456836|FG004|Overall Study|Protocol Violation|0|||
129590701|NCT01011335|466456837|FG005|Overall Study|Protocol Violation|0|||
129590702|NCT01011335|466456838|FG006|Overall Study|Protocol Violation|0|||
129590703|NCT01011335|466456839|FG007|Overall Study|Protocol Violation|0|||
129590704|NCT01011335|466456840|FG008|Overall Study|Protocol Violation|0|||
129590705|NCT01011335|466456841|FG009|Overall Study|Protocol Violation|0|||
129590706|NCT01011335|466456842|FG010|Overall Study|Protocol Violation|0|||
129590707|NCT01011335|466456843|FG011|Overall Study|Protocol Violation|0|||
129590708|NCT01011335|466456844|FG012|Overall Study|Protocol Violation|0|||
129590709|NCT01011335|466456832|FG000|Overall Study|Moved/deployed or no booster|1|||
129590710|NCT01011335|466456833|FG001|Overall Study|Moved/deployed or no booster|0|||
129590711|NCT01011335|466456834|FG002|Overall Study|Moved/deployed or no booster|0|||
129590712|NCT01011335|466456835|FG003|Overall Study|Moved/deployed or no booster|1|||
129590713|NCT01011335|466456836|FG004|Overall Study|Moved/deployed or no booster|0|||
129590714|NCT01011335|466456837|FG005|Overall Study|Moved/deployed or no booster|0|||
129590715|NCT01011335|466456838|FG006|Overall Study|Moved/deployed or no booster|1|||
129590716|NCT01011335|466456839|FG007|Overall Study|Moved/deployed or no booster|0|||
129590717|NCT01011335|466456840|FG008|Overall Study|Moved/deployed or no booster|1|||
129590718|NCT01011335|466456841|FG009|Overall Study|Moved/deployed or no booster|0|||
129590719|NCT01011335|466456842|FG010|Overall Study|Moved/deployed or no booster|2|||
129590720|NCT01011335|466456843|FG011|Overall Study|Moved/deployed or no booster|0|||
129590721|NCT01011335|466456844|FG012|Overall Study|Moved/deployed or no booster|0|||
129590722|NCT01011335|466456832|FG000|Overall Study|Adverse Event|0|||
129590723|NCT01011335|466456833|FG001|Overall Study|Adverse Event|0|||
129590724|NCT01011335|466456834|FG002|Overall Study|Adverse Event|0|||
129590725|NCT01011335|466456835|FG003|Overall Study|Adverse Event|0|||
129590726|NCT01011335|466456836|FG004|Overall Study|Adverse Event|0|||
129590727|NCT01011335|466456837|FG005|Overall Study|Adverse Event|0|||
129590728|NCT01011335|466456838|FG006|Overall Study|Adverse Event|0|||
129590729|NCT01011335|466456839|FG007|Overall Study|Adverse Event|0|||
129590730|NCT01011335|466456840|FG008|Overall Study|Adverse Event|0|||
129590731|NCT01011335|466456841|FG009|Overall Study|Adverse Event|0|||
129590732|NCT01011335|466456842|FG010|Overall Study|Adverse Event|4|||
129590733|NCT01011335|466456843|FG011|Overall Study|Adverse Event|0|||
129590734|NCT01011335|466456844|FG012|Overall Study|Adverse Event|1|||
129590735|NCT01765751|466456853|FG000|Overall Study|Lost to Follow-up|0|||
129590736|NCT01765751|466456854|FG001|Overall Study|Lost to Follow-up|2|||
129590737|NCT01765751|466456855|FG002|Overall Study|Lost to Follow-up|1|||
129590738|NCT03429049|466456856|FG000|Overall Study|Adverse Event|2|||
129590739|NCT03429049|466456857|FG001|Overall Study|Adverse Event|3|||
129590740|NCT03429049|466456856|FG000|Overall Study|Death|0|||
129590741|NCT03429049|466456857|FG001|Overall Study|Death|1|||
129590742|NCT03429049|466456856|FG000|Overall Study|Lack of Efficacy|4|||
129590743|NCT03429049|466456857|FG001|Overall Study|Lack of Efficacy|2|||
129590744|NCT03429049|466456856|FG000|Overall Study|Lost to Follow-up|9|||
129590745|NCT03429049|466456857|FG001|Overall Study|Lost to Follow-up|8|||
129590746|NCT03429049|466456856|FG000|Overall Study|Physician Decision|1|||
129590747|NCT03429049|466456857|FG001|Overall Study|Physician Decision|0|||
129590748|NCT03429049|466456856|FG000|Overall Study|Protocol Violation|3|||
129590749|NCT03429049|466456857|FG001|Overall Study|Protocol Violation|0|||
129590750|NCT03429049|466456856|FG000|Overall Study|Sponsor Decision|2|||
129590751|NCT03429049|466456857|FG001|Overall Study|Sponsor Decision|0|||
129590752|NCT03429049|466456856|FG000|Overall Study|Withdrawal by Subject|4|||
129590753|NCT03429049|466456857|FG001|Overall Study|Withdrawal by Subject|20|||
129590754|NCT03429049|466456856|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
129590755|NCT03429049|466456857|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
129590756|NCT02459418|466456861|FG000|Overall Study|Exclusion Criteria|4|||
129590757|NCT02459418|466456862|FG001|Overall Study|Exclusion Criteria|0|||
129590758|NCT02459418|466456861|FG000|Overall Study|Protocol Violation|0|||
129590759|NCT02459418|466456862|FG001|Overall Study|Protocol Violation|2|||
129590760|NCT02459418|466456861|FG000|Overall Study|Physician Decision|0|||
129590761|NCT02459418|466456862|FG001|Overall Study|Physician Decision|2|||
129590762|NCT02459418|466456861|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
129590763|NCT02459418|466456862|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
129590764|NCT02459418|466456861|FG000|Overall Study|Adverse Event|0|||
129590765|NCT02459418|466456862|FG001|Overall Study|Adverse Event|1|||
129590766|NCT02459418|466456861|FG000|Overall Study|Withdrawal by Subject|1|||
129590767|NCT02459418|466456862|FG001|Overall Study|Withdrawal by Subject|1|||
129590768|NCT02459418|466456861|FG000|Overall Study|Elevated Creatine Kinase|1|||
129590769|NCT02459418|466456862|FG001|Overall Study|Elevated Creatine Kinase|0|||
129590770|NCT02459418|466456861|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
129590771|NCT02459418|466456862|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
129590772|NCT01872715|466456863|FG000|Overall Study|Adverse Event|1|||
129590773|NCT01872715|466456863|FG000|Overall Study|Protocol Violation|1|||
129590774|NCT01872715|466456863|FG000|Overall Study|Withdrawal by Subject|2|||
129590775|NCT03303417|466456864|FG000|Overall Study|Withdrawal by Subject|1|||
129590776|NCT03303417|466456865|FG001|Overall Study|Withdrawal by Subject|1|||
129590777|NCT01848210|466456868|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
129590778|NCT01848210|466456869|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
129590779|NCT01848210|466456868|FG000|Overall Study|Lost to Follow-up|24|||
129590780|NCT01848210|466456869|FG001|Overall Study|Lost to Follow-up|12|||
129590781|NCT01848210|466456868|FG000|Overall Study|Protocol Violation|3|||
129590782|NCT01848210|466456869|FG001|Overall Study|Protocol Violation|5|||
129590783|NCT01848210|466456868|FG000|Overall Study|Use of Forbidden Drugs|9|||
129590784|NCT01848210|466456869|FG001|Overall Study|Use of Forbidden Drugs|10|||
129590785|NCT01848210|466456868|FG000|Overall Study|Impedition Condition|5|||
129590786|NCT01848210|466456869|FG001|Overall Study|Impedition Condition|9|||
129590787|NCT01848210|466456868|FG000|Overall Study|Adverse Event|7|||
129590788|NCT01848210|466456869|FG001|Overall Study|Adverse Event|9|||
129590789|NCT01848210|466456868|FG000|Overall Study|Discontinuation Criterion|5|||
129590790|NCT01848210|466456869|FG001|Overall Study|Discontinuation Criterion|7|||
129590791|NCT01848210|466456868|FG000|Overall Study|Hypesensitivity|1|||
129590792|NCT01848210|466456869|FG001|Overall Study|Hypesensitivity|0|||
129590793|NCT01848210|466456868|FG000|Overall Study|Hepatic Function Alteration|4|||
129590794|NCT01848210|466456869|FG001|Overall Study|Hepatic Function Alteration|0|||
129590795|NCT01848210|466456868|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
129590796|NCT01848210|466456869|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
129590797|NCT01848210|466456868|FG000|Overall Study|Administrative|1|||
129590798|NCT01848210|466456869|FG001|Overall Study|Administrative|0|||
129590799|NCT00894933|466456870|FG000|Overall Study|Lost to Follow-up|2|||
129590800|NCT00894933|466456870|FG000|Overall Study|Cancelled Procedure|1|||
129590801|NCT00894933|466456870|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
129590802|NCT00835796|466456874|FG000|First Intervention|Withdrawal by Subject|0|||
129590803|NCT00835796|466456875|FG001|First Intervention|Withdrawal by Subject|1|||
129590804|NCT00651183|466456878|FG000|Overall Study|Lack of Efficacy|1|||
129590805|NCT00651183|466456879|FG001|Overall Study|Lack of Efficacy|0|||
129590806|NCT00651183|466456878|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
129590807|NCT00651183|466456879|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
129590808|NCT00651183|466456878|FG000|Overall Study|Tolerability insufficient|5|||
129590809|NCT00651183|466456879|FG001|Overall Study|Tolerability insufficient|2|||
129590810|NCT00651183|466456878|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
129590811|NCT00651183|466456879|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
129590812|NCT00651183|466456878|FG000|Overall Study|Withdrawal by Subject|6|||
129590813|NCT00651183|466456879|FG001|Overall Study|Withdrawal by Subject|3|||
129590814|NCT00651183|466456878|FG000|Overall Study|Lost to Follow-up|3|||
129590815|NCT00651183|466456879|FG001|Overall Study|Lost to Follow-up|1|||
129590816|NCT00651183|466456878|FG000|Overall Study|Other reasons|4|||
129590817|NCT00651183|466456879|FG001|Overall Study|Other reasons|2|||
129590818|NCT00651183|466456878|FG000|Overall Study|missing|1|||
129590819|NCT00651183|466456879|FG001|Overall Study|missing|0|||
129590820|NCT00996437|466456882|FG000|Overall Study|Death|1|||
129590821|NCT00996437|466456883|FG001|Overall Study|Death|0|||
129590822|NCT00996437|466456882|FG000|Overall Study|Dropped|2|||
129590823|NCT00996437|466456883|FG001|Overall Study|Dropped|2|||
129590824|NCT00996437|466456882|FG000|Overall Study|Missed|2|||
129590825|NCT00996437|466456883|FG001|Overall Study|Missed|5|||
129590826|NCT02576717|466456886|FG000|Overall Study|Other Reasons|16|||
129590827|NCT02576717|466456887|FG001|Overall Study|Other Reasons|18|||
129590828|NCT02576717|466456888|FG002|Overall Study|Other Reasons|15|||
129590829|NCT02576717|466456886|FG000|Overall Study|Covid-19 Pandemic|0|||
129590830|NCT02576717|466456887|FG001|Overall Study|Covid-19 Pandemic|1|||
129590831|NCT02576717|466456888|FG002|Overall Study|Covid-19 Pandemic|1|||
129590832|NCT02576717|466456886|FG000|Overall Study|Sponsor Decision|0|||
129590833|NCT02576717|466456887|FG001|Overall Study|Sponsor Decision|0|||
129590834|NCT02576717|466456888|FG002|Overall Study|Sponsor Decision|1|||
129590835|NCT02576717|466456886|FG000|Overall Study|Physician Decision|3|||
129590836|NCT02576717|466456887|FG001|Overall Study|Physician Decision|8|||
129590837|NCT02576717|466456888|FG002|Overall Study|Physician Decision|9|||
129590838|NCT02576717|466456886|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
129590839|NCT02576717|466456887|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
129590840|NCT02576717|466456888|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
129590841|NCT02576717|466456886|FG000|Overall Study|Death|3|||
129590842|NCT02576717|466456887|FG001|Overall Study|Death|5|||
129590843|NCT02576717|466456888|FG002|Overall Study|Death|3|||
129590844|NCT02576717|466456886|FG000|Overall Study|Lost to Follow-up|9|||
129590845|NCT02576717|466456887|FG001|Overall Study|Lost to Follow-up|10|||
129590846|NCT02576717|466456888|FG002|Overall Study|Lost to Follow-up|19|||
129590847|NCT02576717|466456886|FG000|Overall Study|Protocol Violation|4|||
129590848|NCT02576717|466456887|FG001|Overall Study|Protocol Violation|0|||
129590849|NCT02576717|466456888|FG002|Overall Study|Protocol Violation|5|||
129590850|NCT02576717|466456886|FG000|Overall Study|Lack of Efficacy|24|||
129590851|NCT02576717|466456887|FG001|Overall Study|Lack of Efficacy|28|||
129590852|NCT02576717|466456888|FG002|Overall Study|Lack of Efficacy|20|||
129590853|NCT02576717|466456886|FG000|Overall Study|Adverse Event|26|||
129590854|NCT02576717|466456887|FG001|Overall Study|Adverse Event|32|||
129590855|NCT02576717|466456888|FG002|Overall Study|Adverse Event|26|||
129590856|NCT00399893|466456889|FG000|Overall Study|Withdrawal by Subject|1|||
129590857|NCT00399893|466456890|FG001|Overall Study|Withdrawal by Subject|0|||
129590858|NCT01363011|466456891|FG000|Main Study|Adverse Event|2|||
129590859|NCT01363011|466456892|FG001|Main Study|Adverse Event|3|||
129590860|NCT01363011|466456891|FG000|Main Study|Investigator's Discretion|1|||
129590861|NCT01363011|466456892|FG001|Main Study|Investigator's Discretion|1|||
129590862|NCT01363011|466456891|FG000|Main Study|Withdrew Consent|1|||
129590863|NCT01363011|466456892|FG001|Main Study|Withdrew Consent|4|||
129590864|NCT01363011|466456891|FG000|Main Study|Protocol Violation|0|||
129590865|NCT01363011|466456892|FG001|Main Study|Protocol Violation|1|||
129696369|NCT00159874|466848085|FG002|Overall Study|Adverse Event|5|||
129696370|NCT00159874|466848086|FG003|Overall Study|Adverse Event|1|||
129696371|NCT00159874|466848087|FG004|Overall Study|Adverse Event|1|||
129696372|NCT00159874|466848088|FG005|Overall Study|Adverse Event|2|||
129696373|NCT00159874|466848089|FG006|Overall Study|Adverse Event|0|||
129696374|NCT00159874|466848083|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
129696375|NCT00159874|466848084|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
129696376|NCT00159874|466848085|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
129696377|NCT00159874|466848086|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
129696378|NCT00159874|466848087|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
129696379|NCT00159874|466848088|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
129696380|NCT00159874|466848089|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
129696381|NCT00159874|466848083|FG000|Overall Study|Lack of Efficacy|2|||
129696382|NCT00159874|466848084|FG001|Overall Study|Lack of Efficacy|0|||
129696383|NCT00159874|466848085|FG002|Overall Study|Lack of Efficacy|1|||
129696384|NCT00159874|466848086|FG003|Overall Study|Lack of Efficacy|1|||
129590866|NCT01363011|466456891|FG000|Extension Phase|Adverse Event|1|||
129590867|NCT01363011|466456892|FG001|Extension Phase|Adverse Event|1|||
129696385|NCT00159874|466848087|FG004|Overall Study|Lack of Efficacy|0|||
129696386|NCT00159874|466848088|FG005|Overall Study|Lack of Efficacy|3|||
129696387|NCT00159874|466848089|FG006|Overall Study|Lack of Efficacy|0|||
129696388|NCT00159874|466848083|FG000|Overall Study|Lost to Follow-up|1|||
129696389|NCT00159874|466848084|FG001|Overall Study|Lost to Follow-up|0|||
129696390|NCT00159874|466848085|FG002|Overall Study|Lost to Follow-up|3|||
129696391|NCT00159874|466848086|FG003|Overall Study|Lost to Follow-up|0|||
129590868|NCT01363011|466456891|FG000|Extension Phase|Lack of Efficacy|0|||
129590869|NCT01363011|466456892|FG001|Extension Phase|Lack of Efficacy|1|||
129590870|NCT01363011|466456891|FG000|Extension Phase|Investigator's Discretion|2|||
129590871|NCT01363011|466456892|FG001|Extension Phase|Investigator's Discretion|2|||
129590872|NCT01363011|466456891|FG000|Extension Phase|Withdrew Consent|0|||
129590873|NCT01363011|466456892|FG001|Extension Phase|Withdrew Consent|1|||
129590874|NCT01363011|466456891|FG000|Extension Phase|Lost to Follow-up|0|||
129590875|NCT01363011|466456892|FG001|Extension Phase|Lost to Follow-up|2|||
129590876|NCT01363011|466456891|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
129590877|NCT01363011|466456892|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
129590878|NCT01961882|466456897|FG000|Overall Study|Adverse Event|3|||
129590879|NCT01961882|466456898|FG001|Overall Study|Adverse Event|2|||
129590880|NCT01961882|466456897|FG000|Overall Study|Physician Decision|1|||
129696392|NCT00159874|466848087|FG004|Overall Study|Lost to Follow-up|1|||
129696393|NCT00159874|466848088|FG005|Overall Study|Lost to Follow-up|2|||
129696394|NCT00159874|466848089|FG006|Overall Study|Lost to Follow-up|1|||
129696395|NCT00159874|466848083|FG000|Overall Study|Other|8|||
129696396|NCT00159874|466848084|FG001|Overall Study|Other|8|||
129696397|NCT00159874|466848085|FG002|Overall Study|Other|8|||
129696398|NCT00159874|466848086|FG003|Overall Study|Other|0|||
129696399|NCT00159874|466848087|FG004|Overall Study|Other|2|||
129696400|NCT00159874|466848088|FG005|Overall Study|Other|1|||
129696401|NCT00159874|466848089|FG006|Overall Study|Other|3|||
129696402|NCT00159874|466848083|FG000|Overall Study|Protocol Violation|0|||
129696403|NCT00159874|466848084|FG001|Overall Study|Protocol Violation|5|||
129696404|NCT00159874|466848085|FG002|Overall Study|Protocol Violation|2|||
129696405|NCT00159874|466848086|FG003|Overall Study|Protocol Violation|0|||
129696406|NCT00159874|466848087|FG004|Overall Study|Protocol Violation|0|||
129696407|NCT00159874|466848088|FG005|Overall Study|Protocol Violation|0|||
129696408|NCT00159874|466848089|FG006|Overall Study|Protocol Violation|0|||
129696409|NCT00159874|466848083|FG000|Overall Study|Death|3|||
129696410|NCT00159874|466848084|FG001|Overall Study|Death|8|||
129696411|NCT00159874|466848085|FG002|Overall Study|Death|15|||
129696412|NCT00159874|466848086|FG003|Overall Study|Death|0|||
129696413|NCT00159874|466848087|FG004|Overall Study|Death|1|||
129696414|NCT00159874|466848088|FG005|Overall Study|Death|2|||
129696415|NCT00159874|466848089|FG006|Overall Study|Death|0|||
129696416|NCT00159874|466848083|FG000|Overall Study|Withdrawal by Subject|2|||
129696417|NCT00159874|466848084|FG001|Overall Study|Withdrawal by Subject|6|||
129696418|NCT00159874|466848085|FG002|Overall Study|Withdrawal by Subject|8|||
129696419|NCT00159874|466848086|FG003|Overall Study|Withdrawal by Subject|4|||
129696420|NCT00159874|466848087|FG004|Overall Study|Withdrawal by Subject|3|||
129696421|NCT00159874|466848088|FG005|Overall Study|Withdrawal by Subject|2|||
129696422|NCT00159874|466848089|FG006|Overall Study|Withdrawal by Subject|1|||
129696423|NCT00159874|466848083|FG000|Overall Study|Pregnancy|1|||
129696424|NCT00159874|466848084|FG001|Overall Study|Pregnancy|1|||
129696425|NCT00159874|466848085|FG002|Overall Study|Pregnancy|0|||
129696426|NCT00159874|466848086|FG003|Overall Study|Pregnancy|0|||
129696427|NCT00159874|466848087|FG004|Overall Study|Pregnancy|0|||
129696428|NCT00159874|466848088|FG005|Overall Study|Pregnancy|0|||
129696429|NCT00159874|466848089|FG006|Overall Study|Pregnancy|0|||
129696430|NCT05122143|466848093|FG000|Overall Study|Adverse Event|1|||
129696431|NCT05122143|466848094|FG001|Overall Study|Adverse Event|0|||
129696432|NCT05122143|466848095|FG002|Overall Study|Adverse Event|0|||
129696433|NCT05122143|466848096|FG003|Overall Study|Adverse Event|0|||
129696434|NCT05122143|466848097|FG004|Overall Study|Adverse Event|1|||
129696435|NCT05122143|466848098|FG005|Overall Study|Adverse Event|0|||
129696436|NCT05122143|466848093|FG000|Overall Study|Protocol non-compliance|0|||
129696437|NCT05122143|466848094|FG001|Overall Study|Protocol non-compliance|0|||
129696438|NCT05122143|466848095|FG002|Overall Study|Protocol non-compliance|1|||
129696439|NCT05122143|466848096|FG003|Overall Study|Protocol non-compliance|0|||
129696440|NCT05122143|466848097|FG004|Overall Study|Protocol non-compliance|0|||
129590881|NCT01961882|466456898|FG001|Overall Study|Physician Decision|0|||
129590882|NCT01961882|466456897|FG000|Overall Study|Withdrawal by Subject|4|||
129590883|NCT01961882|466456898|FG001|Overall Study|Withdrawal by Subject|1|||
129590884|NCT01961882|466456897|FG000|Overall Study|Relapse of AML|39|||
129696441|NCT05122143|466848098|FG005|Overall Study|Protocol non-compliance|0|||
129696442|NCT05122143|466848093|FG000|Overall Study|Covid contact|0|||
129696443|NCT05122143|466848094|FG001|Overall Study|Covid contact|0|||
129696444|NCT05122143|466848095|FG002|Overall Study|Covid contact|0|||
129696445|NCT05122143|466848096|FG003|Overall Study|Covid contact|0|||
129696446|NCT05122143|466848097|FG004|Overall Study|Covid contact|1|||
129696447|NCT05122143|466848098|FG005|Overall Study|Covid contact|0|||
129590885|NCT01961882|466456898|FG001|Overall Study|Relapse of AML|37|||
129590886|NCT01961882|466456897|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
129590887|NCT01961882|466456898|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
129590888|NCT01961882|466456897|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
129590889|NCT01961882|466456898|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
129590890|NCT00407745|466456899|FG000|Overall Study|Lack of Efficacy|1|||
129590891|NCT00407745|466456900|FG001|Overall Study|Lack of Efficacy|2|||
129590892|NCT00407745|466456899|FG000|Overall Study|Withdrawal by Subject|3|||
129590893|NCT00407745|466456900|FG001|Overall Study|Withdrawal by Subject|3|||
129590894|NCT00407745|466456899|FG000|Overall Study|Protocol Violation|5|||
129590895|NCT00407745|466456900|FG001|Overall Study|Protocol Violation|3|||
129590896|NCT00407745|466456899|FG000|Overall Study|Adverse Event|8|||
129590897|NCT00407745|466456900|FG001|Overall Study|Adverse Event|8|||
129590898|NCT00407745|466456899|FG000|Overall Study|Other|2|||
129590899|NCT00407745|466456900|FG001|Overall Study|Other|0|||
129590900|NCT00407745|466456899|FG000|Overall Study|Randomized, unknown if treated|0|||
129590901|NCT00407745|466456900|FG001|Overall Study|Randomized, unknown if treated|1|||
129590902|NCT00108082|466456901|FG000|Overall Study|Adverse Event|14|||
129590903|NCT00108082|466456902|FG001|Overall Study|Adverse Event|12|||
129590904|NCT00108082|466456903|FG002|Overall Study|Adverse Event|17|||
129590905|NCT00108082|466456901|FG000|Overall Study|Lost to Follow-up|6|||
129590906|NCT00108082|466456902|FG001|Overall Study|Lost to Follow-up|3|||
129590907|NCT00108082|466456903|FG002|Overall Study|Lost to Follow-up|7|||
129590908|NCT00108082|466456901|FG000|Overall Study|Consent Withdrawn|3|||
129590909|NCT00108082|466456902|FG001|Overall Study|Consent Withdrawn|3|||
129590910|NCT00108082|466456903|FG002|Overall Study|Consent Withdrawn|5|||
129590911|NCT00108082|466456901|FG000|Overall Study|Protocol Violation|1|||
129590912|NCT00108082|466456902|FG001|Overall Study|Protocol Violation|2|||
129590913|NCT00108082|466456903|FG002|Overall Study|Protocol Violation|0|||
129590914|NCT00108082|466456901|FG000|Overall Study|Lack of Efficacy|3|||
129590915|NCT00108082|466456902|FG001|Overall Study|Lack of Efficacy|1|||
129590916|NCT00108082|466456903|FG002|Overall Study|Lack of Efficacy|2|||
129590917|NCT00108082|466456901|FG000|Overall Study|Amendment 4: > Month 12|5|||
129590918|NCT00108082|466456902|FG001|Overall Study|Amendment 4: > Month 12|7|||
129590919|NCT00108082|466456903|FG002|Overall Study|Amendment 4: > Month 12|5|||
129590920|NCT00108082|466456901|FG000|Overall Study|Woman of Child-bearing Potential|2|||
129590921|NCT00108082|466456902|FG001|Overall Study|Woman of Child-bearing Potential|0|||
129590922|NCT00108082|466456903|FG002|Overall Study|Woman of Child-bearing Potential|2|||
129590923|NCT00108082|466456901|FG000|Overall Study|Incorrectly Randomized|0|||
129590924|NCT00108082|466456902|FG001|Overall Study|Incorrectly Randomized|0|||
129590925|NCT00108082|466456903|FG002|Overall Study|Incorrectly Randomized|2|||
129590926|NCT00108082|466456901|FG000|Overall Study|Non-compliance|1|||
129590927|NCT00108082|466456902|FG001|Overall Study|Non-compliance|0|||
129590928|NCT00108082|466456903|FG002|Overall Study|Non-compliance|2|||
129590929|NCT00108082|466456901|FG000|Overall Study|Stopped Study Medication|0|||
129590930|NCT00108082|466456902|FG001|Overall Study|Stopped Study Medication|0|||
129590931|NCT00108082|466456903|FG002|Overall Study|Stopped Study Medication|1|||
129590932|NCT00108082|466456901|FG000|Overall Study|Site Closed Study|0|||
129590933|NCT00108082|466456902|FG001|Overall Study|Site Closed Study|2|||
129590934|NCT00108082|466456903|FG002|Overall Study|Site Closed Study|0|||
129590935|NCT00108082|466456901|FG000|Overall Study|Protocol Amendment|0|||
129590936|NCT00108082|466456902|FG001|Overall Study|Protocol Amendment|1|||
129590937|NCT00108082|466456903|FG002|Overall Study|Protocol Amendment|0|||
129590938|NCT00108082|466456901|FG000|Overall Study|Study Medication Not Tapered|0|||
129590939|NCT00108082|466456902|FG001|Overall Study|Study Medication Not Tapered|1|||
129590940|NCT00108082|466456903|FG002|Overall Study|Study Medication Not Tapered|0|||
129590941|NCT00108082|466456901|FG000|Overall Study|Subject Left Site Location|1|||
129590942|NCT00108082|466456902|FG001|Overall Study|Subject Left Site Location|0|||
129590943|NCT00108082|466456903|FG002|Overall Study|Subject Left Site Location|0|||
129590944|NCT00108082|466456901|FG000|Overall Study|Investigator Not at Site|1|||
129590945|NCT00108082|466456902|FG001|Overall Study|Investigator Not at Site|0|||
129590946|NCT00108082|466456903|FG002|Overall Study|Investigator Not at Site|0|||
129590947|NCT00108082|466456901|FG000|Overall Study|Blood Pressure Not Controlled|1|||
129590948|NCT00108082|466456902|FG001|Overall Study|Blood Pressure Not Controlled|0|||
129590949|NCT00108082|466456903|FG002|Overall Study|Blood Pressure Not Controlled|0|||
129590950|NCT00412737|466456904|FG000|Overall Study|Death|1|||
129590951|NCT00412737|466456905|FG001|Overall Study|Death|0|||
129590952|NCT00412737|466456904|FG000|Overall Study|Adverse Event|3|||
129590953|NCT00412737|466456905|FG001|Overall Study|Adverse Event|2|||
129590954|NCT00412737|466456904|FG000|Overall Study|Refused Treatment|6|||
129590955|NCT00412737|466456905|FG001|Overall Study|Refused Treatment|2|||
129590956|NCT00412737|466456904|FG000|Overall Study|Failure to Return|6|||
129590957|NCT00412737|466456905|FG001|Overall Study|Failure to Return|2|||
129590958|NCT00906373|466456907|FG000|Overall Study|Withdrawal by Subject|0|||
129590959|NCT00906373|466456908|FG001|Overall Study|Withdrawal by Subject|5|||
129590960|NCT00906373|466456907|FG000|Overall Study|Other|0|||
129590961|NCT00906373|466456908|FG001|Overall Study|Other|1|||
129590962|NCT00906373|466456907|FG000|Overall Study|Still on treatment at cutoff date|0|||
129590963|NCT00906373|466456908|FG001|Overall Study|Still on treatment at cutoff date|2|||
129590964|NCT01597479|466456909|FG000|Overall Study|Protocol Violation|1|||
129590965|NCT01597479|466456910|FG001|Overall Study|Protocol Violation|0|||
129590966|NCT01597479|466456909|FG000|Overall Study|Lost to Follow-up|1|||
129590967|NCT01597479|466456910|FG001|Overall Study|Lost to Follow-up|0|||
129590968|NCT04317599|466456915|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
129590969|NCT04317599|466456915|FG000|Overall Study|treatment outside standard of care|4|||
129590970|NCT01186016|466456916|FG000|Overall Study|Withdrawal by Subject|46|||
129590971|NCT01186016|466456917|FG001|Overall Study|Withdrawal by Subject|29|||
129590972|NCT01098539|466456918|FG000|Overall Study|Adverse Event|26|||
129590973|NCT01098539|466456919|FG001|Overall Study|Adverse Event|26|||
129590974|NCT01098539|466456918|FG000|Overall Study|Protocol Violation|1|||
129590975|NCT01098539|466456919|FG001|Overall Study|Protocol Violation|4|||
129590976|NCT01098539|466456918|FG000|Overall Study|Noncompliance|3|||
129590977|NCT01098539|466456919|FG001|Overall Study|Noncompliance|5|||
129590978|NCT01098539|466456918|FG000|Overall Study|Lost to Follow-up|4|||
129590979|NCT01098539|466456919|FG001|Overall Study|Lost to Follow-up|4|||
129590980|NCT01098539|466456918|FG000|Overall Study|Withdrawal by Subject|12|||
129590981|NCT01098539|466456919|FG001|Overall Study|Withdrawal by Subject|26|||
129590982|NCT01098539|466456918|FG000|Overall Study|Physician Decision|5|||
129590983|NCT01098539|466456919|FG001|Overall Study|Physician Decision|3|||
129590984|NCT00721955|466456920|FG000|Overall Study|Adverse Event|0|||
129590985|NCT00721955|466456921|FG001|Overall Study|Adverse Event|0|||
129590986|NCT00721955|466456922|FG002|Overall Study|Adverse Event|2|||
129590987|NCT01055886|466456924|FG000|Overall Study|Withdrawal by Subject|4|||
129590988|NCT01055886|466456925|FG001|Overall Study|Withdrawal by Subject|9|||
129590989|NCT01055886|466456924|FG000|Overall Study|Lost to Follow-up|1|||
129590990|NCT01055886|466456925|FG001|Overall Study|Lost to Follow-up|1|||
129590991|NCT01055886|466456924|FG000|Overall Study|Withdrawal by PI|0|||
129590992|NCT01055886|466456925|FG001|Overall Study|Withdrawal by PI|1|||
129590993|NCT01077258|466456928|FG000|Overall Study|Lost to Follow-up|1390|||
129590994|NCT01077258|466456928|FG000|Overall Study|Adverse drug reaction|218|||
129590995|NCT01077258|466456928|FG000|Overall Study|Lack of Efficacy|663|||
129590996|NCT01077258|466456928|FG000|Overall Study|Clinical remission|37|||
129590997|NCT01077258|466456928|FG000|Overall Study|Other reasons|260|||
129590998|NCT00726895|466456929|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129590999|NCT00726895|466456930|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129591000|NCT00265785|466456933|FG000|Overall Study|Adverse Event|4|||
129591001|NCT00265785|466456933|FG000|Overall Study|Withdrawal by Subject|3|||
129591002|NCT00265785|466456933|FG000|Overall Study|Progression/Relapse|15|||
129591003|NCT00265785|466456933|FG000|Overall Study|Not protocol specified|2|||
129591004|NCT00265785|466456933|FG000|Overall Study|Ineligible|1|||
129591005|NCT00265785|466456933|FG000|Overall Study|Did not receive protocol treatment|2|||
129591006|NCT00585312|466456949|FG000|Overall Study|Adverse Event|3|||
129591007|NCT00585312|466456950|FG001|Overall Study|Adverse Event|0|||
129591008|NCT00585312|466456949|FG000|Overall Study|Lack of Efficacy|6|||
129591009|NCT00585312|466456950|FG001|Overall Study|Lack of Efficacy|11|||
129591010|NCT00585312|466456949|FG000|Overall Study|Lost to Follow-up|1|||
129591011|NCT00585312|466456950|FG001|Overall Study|Lost to Follow-up|1|||
129591012|NCT00585312|466456949|FG000|Overall Study|Reason not specified|2|||
129591013|NCT00585312|466456950|FG001|Overall Study|Reason not specified|0|||
129591014|NCT00585312|466456949|FG000|Overall Study|Withdrawal by Subject|5|||
129591015|NCT00585312|466456950|FG001|Overall Study|Withdrawal by Subject|1|||
129591016|NCT00585312|466456949|FG000|Overall Study|Study terminated by the sponsor|34|||
129591017|NCT00585312|466456950|FG001|Overall Study|Study terminated by the sponsor|31|||
129591018|NCT01169038|466456956|FG000|Overall Study|Death|1|||
129591019|NCT01169038|466456956|FG000|Overall Study|Adverse Event|5|||
129591020|NCT01169038|466456956|FG000|Overall Study|Required antibiotic administration|1|||
129591021|NCT01634854|466456957|FG000|Overall Study|Cesarean delivery|2|||
129591022|NCT01634854|466456958|FG001|Overall Study|Cesarean delivery|7|||
129591023|NCT01488448|466456959|FG000|Overall Study|Withdrawal by Subject|3|||
129591024|NCT01488448|466456960|FG001|Overall Study|Withdrawal by Subject|1|||
129591025|NCT01488448|466456959|FG000|Overall Study|Adverse Event|9|||
129591026|NCT01488448|466456960|FG001|Overall Study|Adverse Event|4|||
129591027|NCT01488448|466456959|FG000|Overall Study|Physician Decision|4|||
129591028|NCT01488448|466456960|FG001|Overall Study|Physician Decision|9|||
129591029|NCT01488448|466456959|FG000|Overall Study|Protocol Violation|4|||
129591030|NCT01488448|466456960|FG001|Overall Study|Protocol Violation|3|||
129591031|NCT02329431|466456961|FG000|Overall Study|Lost to Follow-up|20|||
129591032|NCT02329431|466456962|FG001|Overall Study|Lost to Follow-up|13|||
129591033|NCT01475487|466456963|FG000|Overall Study|had to leave early for personal reasons|2|||
129591034|NCT01475487|466456964|FG001|Overall Study|had to leave early for personal reasons|1|||
129591035|NCT01977456|466456965|FG000|Overall Study|Death|5|||
129591036|NCT01142661|466456966|FG000|Overall Study|Adverse Event|2|||
129591037|NCT01142661|466456966|FG000|Overall Study|Withdrawal by Subject|1|||
129591038|NCT01142661|466456966|FG000|Overall Study|Physician Decision|1|||
129591039|NCT02129062|466458676|FG000|Overall Study|Death|1|||
129591040|NCT02129062|466458676|FG000|Overall Study|Disease Progression|2|||
129591041|NCT02722616|466458677|FG000|Overall Study|Sponsor closed study after one month|2|||
129591042|NCT02722616|466458678|FG001|Overall Study|Sponsor closed study after one month|0|||
129591043|NCT02722616|466458679|FG002|Overall Study|Sponsor closed study after one month|0|||
129591044|NCT01923311|466458680|FG000|Overall Study|Pregnancy|1|||
129591045|NCT01923311|466458681|FG001|Overall Study|Pregnancy|0|||
129591046|NCT01923311|466458680|FG000|Overall Study|Investigator's Discretion|1|||
129591047|NCT01923311|466458681|FG001|Overall Study|Investigator's Discretion|0|||
129591048|NCT01923311|466458680|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129591049|NCT01923311|466458681|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129591050|NCT01923311|466458680|FG000|Overall Study|Withdrew Consent|1|||
129591051|NCT01923311|466458681|FG001|Overall Study|Withdrew Consent|0|||
129591052|NCT01923311|466458680|FG000|Overall Study|Study Terminated by Sponsor|12|||
129591053|NCT01923311|466458681|FG001|Overall Study|Study Terminated by Sponsor|0|||
129591054|NCT02031237|466458682|FG000|Overall Study|Death|1|||
129591055|NCT02031237|466458683|FG001|Overall Study|Death|5|||
129591056|NCT02031237|466458684|FG002|Overall Study|Death|0|||
129591057|NCT02031237|466458682|FG000|Overall Study|Physician Decision|0|||
129591058|NCT02031237|466458683|FG001|Overall Study|Physician Decision|1|||
129591059|NCT02031237|466458684|FG002|Overall Study|Physician Decision|0|||
129591060|NCT02031237|466458682|FG000|Overall Study|Withdrawal by Subject|2|||
129591061|NCT02031237|466458683|FG001|Overall Study|Withdrawal by Subject|2|||
129591062|NCT02031237|466458684|FG002|Overall Study|Withdrawal by Subject|0|||
129591063|NCT02031237|466458682|FG000|Overall Study|Protocol Violation|2|||
129591064|NCT02031237|466458683|FG001|Overall Study|Protocol Violation|6|||
129591065|NCT02031237|466458684|FG002|Overall Study|Protocol Violation|0|||
129591066|NCT02031237|466458682|FG000|Overall Study|Alternate Treatment Given|0|||
129591067|NCT02031237|466458683|FG001|Overall Study|Alternate Treatment Given|0|||
129591068|NCT02031237|466458684|FG002|Overall Study|Alternate Treatment Given|3|||
129591069|NCT01841060|466458688|FG000|Overall Study|Protocol Violation|10|||
129591070|NCT00653159|466458689|FG000|Overall Study|Adverse Event|4|||
129591071|NCT00653159|466458690|FG001|Overall Study|Adverse Event|1|||
129591072|NCT00653159|466458689|FG000|Overall Study|Lost to Follow-up|1|||
129591073|NCT00653159|466458690|FG001|Overall Study|Lost to Follow-up|2|||
129591074|NCT05258630|466458691|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
129591075|NCT05258630|466458692|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
129591076|NCT05258630|466458691|FG000|Overall Study|Lost to Follow-up|0|||
129591077|NCT05258630|466458692|FG001|Overall Study|Lost to Follow-up|2|||
129591078|NCT00109837|466458693|FG000|Overall Study|Adverse Event|2|||
129591079|NCT00109837|466458693|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
129591080|NCT00109837|466458693|FG000|Overall Study|Death|1|||
129591081|NCT00109837|466458693|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
129591082|NCT00109837|466458693|FG000|Overall Study|Not treated|1|||
129591083|NCT00109837|466458693|FG000|Overall Study|Ineligible|1|||
129591084|NCT00381849|466458694|FG000|Wash Out|Withdrawal by Subject|0|||
129591085|NCT00381849|466458695|FG001|Wash Out|Withdrawal by Subject|1|||
129591086|NCT00631007|466458701|FG000|Overall Study|Adverse Event|0|||
129591087|NCT00631007|466458702|FG001|Overall Study|Adverse Event|2|||
129591088|NCT00631007|466458703|FG002|Overall Study|Adverse Event|0|||
129591089|NCT00631007|466458704|FG003|Overall Study|Adverse Event|2|||
129591090|NCT00631007|466458705|FG004|Overall Study|Adverse Event|3|||
129591091|NCT00631007|466458706|FG005|Overall Study|Adverse Event|2|||
129591092|NCT00631007|466458701|FG000|Overall Study|Lost to Follow-up|2|||
129591093|NCT00631007|466458702|FG001|Overall Study|Lost to Follow-up|1|||
129591094|NCT00631007|466458703|FG002|Overall Study|Lost to Follow-up|2|||
129591095|NCT00631007|466458704|FG003|Overall Study|Lost to Follow-up|4|||
129591096|NCT00631007|466458705|FG004|Overall Study|Lost to Follow-up|5|||
129591097|NCT00631007|466458706|FG005|Overall Study|Lost to Follow-up|3|||
129591098|NCT00631007|466458701|FG000|Overall Study|Physician Decision|1|||
129591099|NCT00631007|466458702|FG001|Overall Study|Physician Decision|0|||
129591100|NCT00631007|466458703|FG002|Overall Study|Physician Decision|1|||
129591101|NCT00631007|466458704|FG003|Overall Study|Physician Decision|0|||
129591102|NCT00631007|466458705|FG004|Overall Study|Physician Decision|0|||
129591103|NCT00631007|466458706|FG005|Overall Study|Physician Decision|2|||
129591104|NCT00631007|466458701|FG000|Overall Study|Persistent Hyperglycemia|2|||
129591105|NCT00631007|466458702|FG001|Overall Study|Persistent Hyperglycemia|2|||
129591106|NCT00631007|466458703|FG002|Overall Study|Persistent Hyperglycemia|5|||
129591107|NCT00631007|466458704|FG003|Overall Study|Persistent Hyperglycemia|1|||
129591108|NCT00631007|466458705|FG004|Overall Study|Persistent Hyperglycemia|2|||
129591109|NCT00631007|466458706|FG005|Overall Study|Persistent Hyperglycemia|5|||
129591110|NCT00631007|466458701|FG000|Overall Study|Withdrawal by Subject|4|||
129591111|NCT00631007|466458702|FG001|Overall Study|Withdrawal by Subject|5|||
129696448|NCT01475825|466848099|FG000|Overall Study|Adverse Event|41|||
129591112|NCT00631007|466458703|FG002|Overall Study|Withdrawal by Subject|2|||
129591113|NCT00631007|466458704|FG003|Overall Study|Withdrawal by Subject|2|||
129591114|NCT00631007|466458705|FG004|Overall Study|Withdrawal by Subject|1|||
129591115|NCT00631007|466458706|FG005|Overall Study|Withdrawal by Subject|3|||
129591116|NCT00631007|466458701|FG000|Overall Study|Other|2|||
129591117|NCT00631007|466458702|FG001|Overall Study|Other|1|||
129591118|NCT00631007|466458703|FG002|Overall Study|Other|0|||
129591119|NCT00631007|466458704|FG003|Overall Study|Other|0|||
129591120|NCT00631007|466458705|FG004|Overall Study|Other|1|||
129591121|NCT00631007|466458706|FG005|Overall Study|Other|0|||
129591122|NCT00683787|466458707|FG000|Overall Study|Progression|3|||
129591123|NCT00683787|466458708|FG001|Overall Study|Progression|3|||
129591124|NCT00683787|466458709|FG002|Overall Study|Progression|0|||
129591125|NCT00683787|466458707|FG000|Overall Study|Adverse Event|0|||
129591126|NCT00683787|466458708|FG001|Overall Study|Adverse Event|0|||
129591127|NCT00683787|466458709|FG002|Overall Study|Adverse Event|2|||
129591128|NCT04167618|466458710|FG000|Overall Study|Trial terminated by sponsor|1|||
129591129|NCT04167618|466458711|FG001|Overall Study|Trial terminated by sponsor|1|||
129591130|NCT02940730|466458716|FG000|Intervention 2|Physician Decision|7|||
129591131|NCT02940730|466458717|FG001|Intervention 2|Physician Decision|0|||
129591132|NCT03036839|466458718|FG000|Overall Study|Adverse Event|0|||
129591133|NCT03036839|466458719|FG001|Overall Study|Adverse Event|0|||
129591134|NCT03036839|466458720|FG002|Overall Study|Adverse Event|1|||
129591135|NCT03036839|466458718|FG000|Overall Study|Death|3|||
129591136|NCT03036839|466458719|FG001|Overall Study|Death|0|||
129591137|NCT03036839|466458720|FG002|Overall Study|Death|3|||
129591138|NCT03036839|466458718|FG000|Overall Study|Withdrew Consent|0|||
129591139|NCT03036839|466458719|FG001|Overall Study|Withdrew Consent|0|||
129591140|NCT03036839|466458720|FG002|Overall Study|Withdrew Consent|1|||
129591141|NCT01064531|466458721|FG000|Overall Study|Lost to Follow-up|0|||
129591142|NCT01064531|466458722|FG001|Overall Study|Lost to Follow-up|2|||
129591143|NCT01064531|466458721|FG000|Overall Study|Physician Decision|0|||
129591144|NCT01064531|466458722|FG001|Overall Study|Physician Decision|1|||
129591145|NCT01064531|466458721|FG000|Overall Study|Withdrawal by Subject|2|||
129885586|NCT02611830|467540768|FG001|OL Induction Phase|Lack of Efficacy|0|||
129591146|NCT01064531|466458722|FG001|Overall Study|Withdrawal by Subject|2|||
129591147|NCT01064531|466458721|FG000|Overall Study|Revision due to femoral stem loosening|1|||
129591148|NCT01064531|466458722|FG001|Overall Study|Revision due to femoral stem loosening|0|||
129591149|NCT01064531|466458721|FG000|Overall Study|Revision due to dislocation|0|||
129591150|NCT01064531|466458722|FG001|Overall Study|Revision due to dislocation|1|||
129591151|NCT01064531|466458721|FG000|Overall Study|Death|0|||
129591152|NCT01064531|466458722|FG001|Overall Study|Death|1|||
129591153|NCT00809965|466458727|FG000|Overall Study|Death|194|||
129591154|NCT00809965|466458728|FG001|Overall Study|Death|147|||
129591155|NCT00809965|466458729|FG002|Overall Study|Death|196|||
129591156|NCT00809965|466458727|FG000|Overall Study|Lost to Follow-up|17|||
129591157|NCT00809965|466458728|FG001|Overall Study|Lost to Follow-up|10|||
129591158|NCT00809965|466458729|FG002|Overall Study|Lost to Follow-up|18|||
129591159|NCT00809965|466458727|FG000|Overall Study|Withdrawal by Subject|405|||
129591160|NCT00809965|466458728|FG001|Overall Study|Withdrawal by Subject|448|||
129591161|NCT00809965|466458729|FG002|Overall Study|Withdrawal by Subject|441|||
129591162|NCT00809965|466458727|FG000|Overall Study|Other Reason|167|||
129591163|NCT00809965|466458728|FG001|Overall Study|Other Reason|170|||
129591164|NCT00809965|466458729|FG002|Overall Study|Other Reason|189|||
129591165|NCT02315066|466458730|FG000|Overall Study|Lost to Follow-up|0|||
129591166|NCT02315066|466458731|FG001|Overall Study|Lost to Follow-up|1|||
129591167|NCT02315066|466458732|FG002|Overall Study|Lost to Follow-up|1|||
129591168|NCT02315066|466458733|FG003|Overall Study|Lost to Follow-up|0|||
129591169|NCT02315066|466458734|FG004|Overall Study|Lost to Follow-up|1|||
129591170|NCT02315066|466458735|FG005|Overall Study|Lost to Follow-up|0|||
129591171|NCT02315066|466458736|FG006|Overall Study|Lost to Follow-up|2|||
129591172|NCT02315066|466458737|FG007|Overall Study|Lost to Follow-up|1|||
129591173|NCT02315066|466458738|FG008|Overall Study|Lost to Follow-up|0|||
129591174|NCT02315066|466458739|FG009|Overall Study|Lost to Follow-up|0|||
129591175|NCT02315066|466458740|FG010|Overall Study|Lost to Follow-up|1|||
129591176|NCT02315066|466458741|FG011|Overall Study|Lost to Follow-up|2|||
129591177|NCT02315066|466458742|FG012|Overall Study|Lost to Follow-up|0|||
129591178|NCT02315066|466458743|FG013|Overall Study|Lost to Follow-up|4|||
129591179|NCT02315066|466458730|FG000|Overall Study|Death|2|||
129591180|NCT02315066|466458731|FG001|Overall Study|Death|7|||
129591181|NCT02315066|466458732|FG002|Overall Study|Death|6|||
129591182|NCT02315066|466458733|FG003|Overall Study|Death|11|||
129591183|NCT02315066|466458734|FG004|Overall Study|Death|10|||
129591184|NCT02315066|466458735|FG005|Overall Study|Death|3|||
129591185|NCT02315066|466458736|FG006|Overall Study|Death|9|||
129591186|NCT02315066|466458737|FG007|Overall Study|Death|9|||
129591187|NCT02315066|466458738|FG008|Overall Study|Death|10|||
129591188|NCT02315066|466458739|FG009|Overall Study|Death|8|||
129591189|NCT02315066|466458740|FG010|Overall Study|Death|10|||
129591190|NCT02315066|466458741|FG011|Overall Study|Death|7|||
129591191|NCT02315066|466458742|FG012|Overall Study|Death|8|||
129591192|NCT02315066|466458743|FG013|Overall Study|Death|21|||
129591193|NCT02315066|466458730|FG000|Overall Study|Other|0|||
129591194|NCT02315066|466458731|FG001|Overall Study|Other|0|||
129591195|NCT02315066|466458732|FG002|Overall Study|Other|0|||
129591196|NCT02315066|466458733|FG003|Overall Study|Other|0|||
129591197|NCT02315066|466458734|FG004|Overall Study|Other|0|||
129591198|NCT02315066|466458735|FG005|Overall Study|Other|0|||
129591199|NCT02315066|466458736|FG006|Overall Study|Other|0|||
129591200|NCT02315066|466458737|FG007|Overall Study|Other|1|||
129591201|NCT02315066|466458738|FG008|Overall Study|Other|1|||
129591202|NCT02315066|466458739|FG009|Overall Study|Other|2|||
129591203|NCT02315066|466458740|FG010|Overall Study|Other|0|||
129591204|NCT02315066|466458741|FG011|Overall Study|Other|0|||
129591205|NCT02315066|466458742|FG012|Overall Study|Other|0|||
129591206|NCT02315066|466458743|FG013|Overall Study|Other|0|||
129591207|NCT02315066|466458730|FG000|Overall Study|Subject refused further follow-up|0|||
129591208|NCT02315066|466458731|FG001|Overall Study|Subject refused further follow-up|2|||
129591209|NCT02315066|466458732|FG002|Overall Study|Subject refused further follow-up|2|||
129591210|NCT02315066|466458733|FG003|Overall Study|Subject refused further follow-up|0|||
129591211|NCT02315066|466458734|FG004|Overall Study|Subject refused further follow-up|0|||
129591212|NCT02315066|466458735|FG005|Overall Study|Subject refused further follow-up|0|||
129591213|NCT02315066|466458736|FG006|Overall Study|Subject refused further follow-up|2|||
129591214|NCT02315066|466458737|FG007|Overall Study|Subject refused further follow-up|3|||
129591215|NCT02315066|466458738|FG008|Overall Study|Subject refused further follow-up|0|||
129591216|NCT02315066|466458739|FG009|Overall Study|Subject refused further follow-up|1|||
129591217|NCT02315066|466458740|FG010|Overall Study|Subject refused further follow-up|1|||
129591218|NCT02315066|466458741|FG011|Overall Study|Subject refused further follow-up|2|||
129591219|NCT02315066|466458742|FG012|Overall Study|Subject refused further follow-up|2|||
129591220|NCT02315066|466458743|FG013|Overall Study|Subject refused further follow-up|4|||
129591221|NCT02315066|466458730|FG000|Overall Study|Study ongoing at date of cut-off|0|||
129591222|NCT02315066|466458731|FG001|Overall Study|Study ongoing at date of cut-off|0|||
129591223|NCT02315066|466458732|FG002|Overall Study|Study ongoing at date of cut-off|0|||
129591224|NCT02315066|466458733|FG003|Overall Study|Study ongoing at date of cut-off|0|||
129591225|NCT02315066|466458734|FG004|Overall Study|Study ongoing at date of cut-off|0|||
129591226|NCT02315066|466458735|FG005|Overall Study|Study ongoing at date of cut-off|0|||
129591227|NCT02315066|466458736|FG006|Overall Study|Study ongoing at date of cut-off|0|||
129591228|NCT02315066|466458737|FG007|Overall Study|Study ongoing at date of cut-off|0|||
129591229|NCT02315066|466458738|FG008|Overall Study|Study ongoing at date of cut-off|0|||
129591230|NCT02315066|466458739|FG009|Overall Study|Study ongoing at date of cut-off|0|||
129591231|NCT02315066|466458740|FG010|Overall Study|Study ongoing at date of cut-off|0|||
129591232|NCT02315066|466458741|FG011|Overall Study|Study ongoing at date of cut-off|0|||
129591233|NCT02315066|466458742|FG012|Overall Study|Study ongoing at date of cut-off|0|||
129591234|NCT02315066|466458743|FG013|Overall Study|Study ongoing at date of cut-off|1|||
129591235|NCT00112294|466458744|FG000|Overall Study|Still on study|5|||
129591236|NCT00112294|466458745|FG001|Overall Study|Still on study|0|||
129591237|NCT01142908|466458746|FG000|Overall Study|Lost to Follow-up|19|||
129591238|NCT01142908|466458747|FG001|Overall Study|Lost to Follow-up|13|||
129591239|NCT01142908|466458746|FG000|Overall Study|Death|1|||
129591240|NCT01142908|466458747|FG001|Overall Study|Death|4|||
129591241|NCT01142908|466458746|FG000|Overall Study|Excluded - did not meet criteria|9|||
129591242|NCT01142908|466458747|FG001|Overall Study|Excluded - did not meet criteria|5|||
129591243|NCT01142908|466458746|FG000|Overall Study|Withdrawal by Subject|3|||
129591244|NCT01142908|466458747|FG001|Overall Study|Withdrawal by Subject|0|||
129591245|NCT00035555|466458748|FG000|Overall Study|Adverse Event|5|||
129591246|NCT00035555|466458749|FG001|Overall Study|Adverse Event|8|||
129591247|NCT00035555|466458750|FG002|Overall Study|Adverse Event|9|||
129591248|NCT00035555|466458748|FG000|Overall Study|Allograft loss|1|||
129591249|NCT00035555|466458749|FG001|Overall Study|Allograft loss|1|||
129591250|NCT00035555|466458750|FG002|Overall Study|Allograft loss|2|||
129591251|NCT00035555|466458748|FG000|Overall Study|Death|0|||
129591252|NCT00035555|466458749|FG001|Overall Study|Death|0|||
129591253|NCT00035555|466458750|FG002|Overall Study|Death|2|||
129591254|NCT00035555|466458748|FG000|Overall Study|Lost to Follow-up|0|||
129591255|NCT00035555|466458749|FG001|Overall Study|Lost to Follow-up|0|||
129591256|NCT00035555|466458750|FG002|Overall Study|Lost to Follow-up|1|||
129591257|NCT00035555|466458748|FG000|Overall Study|Noncompliance|0|||
129591258|NCT00035555|466458749|FG001|Overall Study|Noncompliance|1|||
129591259|NCT00035555|466458750|FG002|Overall Study|Noncompliance|1|||
129591260|NCT00035555|466458748|FG000|Overall Study|Prohibited medication|1|||
129591261|NCT00035555|466458749|FG001|Overall Study|Prohibited medication|1|||
129591262|NCT00035555|466458750|FG002|Overall Study|Prohibited medication|0|||
129591263|NCT00035555|466458748|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
129591264|NCT00035555|466458749|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
129591265|NCT00035555|466458750|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
129591266|NCT00035555|466458748|FG000|Overall Study|Withdrawal by Subject|2|||
129591267|NCT00035555|466458749|FG001|Overall Study|Withdrawal by Subject|0|||
129591268|NCT00035555|466458750|FG002|Overall Study|Withdrawal by Subject|2|||
129591269|NCT00035555|466458748|FG000|Overall Study|Investigator deemed not a good candidate|0|||
129591270|NCT00035555|466458749|FG001|Overall Study|Investigator deemed not a good candidate|0|||
129591271|NCT00035555|466458750|FG002|Overall Study|Investigator deemed not a good candidate|1|||
129591272|NCT00035555|466458748|FG000|Overall Study|Received cyclosporin in error|0|||
129591273|NCT00035555|466458749|FG001|Overall Study|Received cyclosporin in error|0|||
129591274|NCT00035555|466458750|FG002|Overall Study|Received cyclosporin in error|1|||
129591275|NCT02972515|466458753|FG000|Overall Study|Lost to Follow-up|78|||
129591276|NCT01450800|466458754|FG000|Overall Study|Protocol Violation|1|||
129591277|NCT01450800|466458755|FG001|Overall Study|Protocol Violation|3|||
129591278|NCT01086969|466458763|FG000|Overall Study|Withdrawal by Subject|1|||
129591279|NCT01086969|466458764|FG001|Overall Study|Withdrawal by Subject|2|||
129591280|NCT01086969|466458765|FG002|Overall Study|Withdrawal by Subject|0|||
129591281|NCT04253236|466458766|FG000|Overall Study|Adverse Event|1|||
129591282|NCT04253236|466458767|FG001|Overall Study|Adverse Event|0|||
129591283|NCT04253236|466458766|FG000|Overall Study|Safety Concerns|1|||
129591284|NCT04253236|466458767|FG001|Overall Study|Safety Concerns|0|||
129591285|NCT04253236|466458766|FG000|Overall Study|Study Terminated by Sponsor|1|||
129591286|NCT04253236|466458767|FG001|Overall Study|Study Terminated by Sponsor|0|||
129591287|NCT00587431|466458768|FG000|Overall Study|Adverse Event|1|||
129591288|NCT00587431|466458769|FG001|Overall Study|Adverse Event|0|||
129591289|NCT00587431|466458768|FG000|Overall Study|Withdrawal by Subject|0|||
129591290|NCT00587431|466458769|FG001|Overall Study|Withdrawal by Subject|1|||
129591291|NCT04291508|466458773|FG000|Overall Study|Withdrawal by Subject|1|||
129591292|NCT04291508|466458774|FG001|Overall Study|Withdrawal by Subject|0|||
129591293|NCT04291508|466458775|FG002|Overall Study|Withdrawal by Subject|1|||
129591294|NCT04291508|466458776|FG003|Overall Study|Withdrawal by Subject|0|||
129591295|NCT04291508|466458773|FG000|Overall Study|lost to follow up|4|||
129591296|NCT04291508|466458774|FG001|Overall Study|lost to follow up|0|||
129591297|NCT04291508|466458775|FG002|Overall Study|lost to follow up|1|||
129591298|NCT04291508|466458776|FG003|Overall Study|lost to follow up|0|||
129591299|NCT03566238|466458777|FG000|Overall Study|Adverse Event|0|||
129591300|NCT03566238|466458778|FG001|Overall Study|Adverse Event|1|||
129591301|NCT03566238|466458779|FG002|Overall Study|Adverse Event|0|||
129591302|NCT03566238|466458777|FG000|Overall Study|Lack of Efficacy|4|||
129591303|NCT03566238|466458778|FG001|Overall Study|Lack of Efficacy|2|||
129591304|NCT03566238|466458779|FG002|Overall Study|Lack of Efficacy|5|||
129591305|NCT03566238|466458777|FG000|Overall Study|Other|1|||
129591306|NCT03566238|466458778|FG001|Overall Study|Other|0|||
129591307|NCT03566238|466458779|FG002|Overall Study|Other|0|||
129591308|NCT04203667|466458787|FG000|Overall Study|Withdrawal by Subject|1|||
129591309|NCT04203667|466458787|FG000|Overall Study|Lost to Follow-up|1|||
129591310|NCT04203667|466458787|FG000|Overall Study|Death|1|||
129591311|NCT04203667|466458787|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
129591312|NCT01183884|466458788|FG000|Overall Study|Progressive Disease|26|||
129591313|NCT01183884|466458788|FG000|Overall Study|Adverse Event|3|||
129591314|NCT01183884|466458788|FG000|Overall Study|Withdrawal by Subject|1|||
129591315|NCT01183884|466458788|FG000|Overall Study|Other Complicating Disease|3|||
129591316|NCT01183884|466458788|FG000|Overall Study|Not Treated|1|||
129591317|NCT01183884|466458788|FG000|Overall Study|Other|4|||
129591318|NCT00127166|466458789|FG000|Period I|Protocol Violation|0|||
129591319|NCT00127166|466458790|FG001|Period I|Protocol Violation|2|||
129591320|NCT00127166|466458789|FG000|Period I|Withdrawal by Subject|2|||
129591321|NCT00127166|466458790|FG001|Period I|Withdrawal by Subject|0|||
129591322|NCT00127166|466458789|FG000|Period I|Patient did not meet inclusion criteria|1|||
129591323|NCT00127166|466458790|FG001|Period I|Patient did not meet inclusion criteria|0|||
129591324|NCT00127166|466458789|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
129591325|NCT00127166|466458790|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
129591326|NCT00127166|466458789|FG000|Period II|Withdrawal by Subject|2|||
129591327|NCT00127166|466458790|FG001|Period II|Withdrawal by Subject|0|||
129591328|NCT00127166|466458789|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
129591329|NCT00127166|466458790|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
129591330|NCT00708682|466458795|FG000|Infant Series|Adverse Event|1|||
129591331|NCT00708682|466458795|FG000|Infant Series|Lost to Follow-up|4|||
129591332|NCT00708682|466458795|FG000|Infant Series|Protocol Violation|1|||
129591333|NCT00708682|466458795|FG000|Infant Series|Parent/legal guardian request|6|||
129591334|NCT00708682|466458795|FG000|Infant Series|Failed to return|2|||
129591335|NCT00708682|466458795|FG000|Infant Series|Other|19|||
129591336|NCT00708682|466458795|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
129591337|NCT00708682|466458795|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
129591338|NCT00708682|466458795|FG000|Toddler Dose|Lost to Follow-up|3|||
129591339|NCT00708682|466458795|FG000|Toddler Dose|Failed to Return|4|||
129591340|NCT03689894|466458797|FG000|Overall Study|Adverse Event|1|||
129591341|NCT04718129|466458802|FG000|Overall Study|Lost to Follow-up|6|||
129591342|NCT04718129|466458803|FG001|Overall Study|Lost to Follow-up|7|||
129591343|NCT01588548|466458807|FG000|Overall Study|Withdrawal by Subject|0|||
129591344|NCT01588548|466458808|FG001|Overall Study|Withdrawal by Subject|1|||
129591345|NCT01588548|466458809|FG002|Overall Study|Withdrawal by Subject|1|||
129591346|NCT01588548|466458810|FG003|Overall Study|Withdrawal by Subject|1|||
129591347|NCT01588548|466458811|FG004|Overall Study|Withdrawal by Subject|2|||
129591348|NCT01588548|466458812|FG005|Overall Study|Withdrawal by Subject|3|||
129591349|NCT01588548|466458807|FG000|Overall Study|Adverse Event|0|||
129591350|NCT01588548|466458808|FG001|Overall Study|Adverse Event|0|||
129591351|NCT01588548|466458809|FG002|Overall Study|Adverse Event|1|||
129591352|NCT01588548|466458810|FG003|Overall Study|Adverse Event|2|||
129591353|NCT01588548|466458811|FG004|Overall Study|Adverse Event|1|||
129591354|NCT01588548|466458812|FG005|Overall Study|Adverse Event|0|||
129591355|NCT01588548|466458807|FG000|Overall Study|Condition Under Investigation Worsened|3|||
129591356|NCT01588548|466458808|FG001|Overall Study|Condition Under Investigation Worsened|6|||
129591357|NCT01588548|466458809|FG002|Overall Study|Condition Under Investigation Worsened|4|||
129591358|NCT01588548|466458810|FG003|Overall Study|Condition Under Investigation Worsened|4|||
129591359|NCT01588548|466458811|FG004|Overall Study|Condition Under Investigation Worsened|3|||
129591360|NCT01588548|466458812|FG005|Overall Study|Condition Under Investigation Worsened|3|||
129591361|NCT01835548|466458813|FG000|Dose Optimization Period|Adverse Event|0|||
129591362|NCT01835548|466458814|FG001|Dose Optimization Period|Adverse Event|0|||
129591363|NCT01835548|466458815|FG002|Dose Optimization Period|Adverse Event|1|||
129591364|NCT01835548|466458813|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
129591365|NCT01835548|466458814|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
129591366|NCT01835548|466458815|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
129591367|NCT01835548|466458813|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129591368|NCT01835548|466458814|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129591369|NCT01835548|466458815|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129591370|NCT01835548|466458813|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129591371|NCT01835548|466458814|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129591372|NCT01835548|466458815|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129591373|NCT03257254|466458816|FG000|Overall Study|Withdrawal by Subject|7|||
129591374|NCT03257254|466458816|FG000|Overall Study|Lost to Follow-up|9|||
129591375|NCT03257254|466458816|FG000|Overall Study|Study discontinued by sponsor|5|||
129591376|NCT00537017|466458817|FG000|Treatment Phase|Adverse Event|19|||
129591377|NCT00537017|466458817|FG000|Treatment Phase|Withdrawal by Subject|13|||
129591378|NCT00537017|466458817|FG000|Treatment Phase|Protocol Violation|2|||
129591379|NCT00537017|466458817|FG000|Follow-up Phase|Withdrawal by Subject|9|||
129591380|NCT01362296|466458818|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
129591381|NCT01362296|466458819|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
129591382|NCT01362296|466458820|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
129591383|NCT01362296|466458821|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
129591384|NCT01362296|466458818|FG000|Randomized Phase (RP)|Physician Decision|1|||
129591385|NCT01362296|466458819|FG001|Randomized Phase (RP)|Physician Decision|9|||
129591386|NCT01362296|466458820|FG002|Randomized Phase (RP)|Physician Decision|0|||
129591387|NCT01362296|466458821|FG003|Randomized Phase (RP)|Physician Decision|0|||
129591388|NCT01362296|466458818|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
129591389|NCT01362296|466458819|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
129591390|NCT01362296|466458820|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
129591391|NCT01362296|466458821|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
129591392|NCT01362296|466458818|FG000|Randomized Phase (RP)|Adverse Event|20|||
129591393|NCT01362296|466458819|FG001|Randomized Phase (RP)|Adverse Event|4|||
129591394|NCT01362296|466458820|FG002|Randomized Phase (RP)|Adverse Event|0|||
129591395|NCT01362296|466458821|FG003|Randomized Phase (RP)|Adverse Event|0|||
129591396|NCT01362296|466458818|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
129591397|NCT01362296|466458819|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
129591398|NCT01362296|466458820|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
129591399|NCT01362296|466458821|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
129591400|NCT01362296|466458818|FG000|Crossover Phase|PD including Death due to PD|0|||
129591401|NCT01362296|466458819|FG001|Crossover Phase|PD including Death due to PD|0|||
129591402|NCT01362296|466458820|FG002|Crossover Phase|PD including Death due to PD|16|||
129591403|NCT01362296|466458821|FG003|Crossover Phase|PD including Death due to PD|1|||
129591404|NCT01362296|466458818|FG000|Crossover Phase|Withdrawal by Subject|0|||
129591405|NCT01362296|466458819|FG001|Crossover Phase|Withdrawal by Subject|0|||
129591406|NCT01362296|466458820|FG002|Crossover Phase|Withdrawal by Subject|2|||
129591407|NCT01362296|466458821|FG003|Crossover Phase|Withdrawal by Subject|1|||
129591408|NCT01362296|466458818|FG000|Crossover Phase|Adverse Event|0|||
129591409|NCT01362296|466458819|FG001|Crossover Phase|Adverse Event|0|||
129696449|NCT01475825|466848100|FG001|Overall Study|Adverse Event|15|||
129696450|NCT01475825|466848101|FG002|Overall Study|Adverse Event|27|||
129591410|NCT01362296|466458820|FG002|Crossover Phase|Adverse Event|4|||
129591411|NCT01362296|466458821|FG003|Crossover Phase|Adverse Event|0|||
129591412|NCT01362296|466458818|FG000|Crossover Phase|Study Closed/Terminated|0|||
129591413|NCT01362296|466458819|FG001|Crossover Phase|Study Closed/Terminated|0|||
129591414|NCT01362296|466458820|FG002|Crossover Phase|Study Closed/Terminated|1|||
129591415|NCT01362296|466458821|FG003|Crossover Phase|Study Closed/Terminated|0|||
129591416|NCT03168906|466458824|FG000|Overall Study|Lack of Efficacy|6|||
129591417|NCT03168906|466458825|FG001|Overall Study|Lack of Efficacy|6|||
129591418|NCT01321697|466458826|FG000|Overall Study|Study Terminated|7|||
129591419|NCT00857818|466458829|FG000|Overall Study|Lack of Efficacy|1|||
129591420|NCT00857818|466458830|FG001|Overall Study|Lack of Efficacy|0|||
129591421|NCT00857818|466458829|FG000|Overall Study|Adverse Event|3|||
129591422|NCT00857818|466458830|FG001|Overall Study|Adverse Event|0|||
129591423|NCT00857818|466458829|FG000|Overall Study|Withdrawal by Subject|0|||
129591424|NCT00857818|466458830|FG001|Overall Study|Withdrawal by Subject|4|||
129591425|NCT00857818|466458829|FG000|Overall Study|Sponsor terminated study|6|||
129591426|NCT00857818|466458830|FG001|Overall Study|Sponsor terminated study|4|||
129591427|NCT00857818|466458829|FG000|Overall Study|Investigator decision|1|||
129591428|NCT00857818|466458830|FG001|Overall Study|Investigator decision|0|||
129591429|NCT02625974|466458832|FG000|Part 1|Lost to Follow-up|9|||
129591430|NCT02625974|466458833|FG001|Part 1|Lost to Follow-up|3|||
129591431|NCT02625974|466458832|FG000|Part 2|Lost to Follow-up|4|||
129591432|NCT02625974|466458833|FG001|Part 2|Lost to Follow-up|6|||
129591433|NCT02625974|466458832|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
129591434|NCT02625974|466458833|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
129591435|NCT00434590|466458834|FG000|Overall Study|Administrative problems|5|||
129591436|NCT00434590|466458835|FG001|Overall Study|Administrative problems|5|||
129591437|NCT04149535|466458837|FG000|Overall Study|Death|11|||
129591438|NCT04149535|466458838|FG001|Overall Study|Death|7|||
129591439|NCT04149535|466458837|FG000|Overall Study|Physician Decision|10|||
129591440|NCT04149535|466458838|FG001|Overall Study|Physician Decision|4|||
129591441|NCT04149535|466458837|FG000|Overall Study|Withdrawal by Subject|6|||
129591442|NCT04149535|466458838|FG001|Overall Study|Withdrawal by Subject|7|||
129591443|NCT04149535|466458837|FG000|Overall Study|Not described|2|||
129591444|NCT04149535|466458838|FG001|Overall Study|Not described|0|||
129591445|NCT02175368|466458839|FG000|Overall Study|Lost to Follow-up|1|||
129591446|NCT02875028|466458840|FG000|Washout Period|Withdrawal by Subject|0|||
129591447|NCT02875028|466458841|FG001|Washout Period|Withdrawal by Subject|1|||
129591448|NCT02426541|466460558|FG000|Overall Study|Protocol Violation|1|||
129591449|NCT02426541|466460559|FG001|Overall Study|Protocol Violation|0|||
129591450|NCT02674633|466460560|FG000|Overall Study|Lost to Follow-up|3|||
129591451|NCT02674633|466460561|FG001|Overall Study|Lost to Follow-up|2|||
129591452|NCT02674633|466460560|FG000|Overall Study|Physician Decision|1|||
129591453|NCT02674633|466460561|FG001|Overall Study|Physician Decision|0|||
129591454|NCT02674633|466460560|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129591455|NCT02674633|466460561|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129591456|NCT00460109|466460562|FG000|Overall Study|Death|1|||
129591457|NCT05996198|466460563|FG000|Overall Study|Withdrawal by Subject|1|||
129591458|NCT05996198|466460564|FG001|Overall Study|Withdrawal by Subject|0|||
129591459|NCT02014441|466460565|FG000|Overall Study|Withdrawal by Subject|12|||
129591460|NCT04412057|466460567|FG000|Overall Study|Death|3|||
129591461|NCT04412057|466460568|FG001|Overall Study|Death|7|||
129591462|NCT04412057|466460567|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
129591463|NCT04412057|466460568|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
129591464|NCT01091103|466460578|FG000|Overall Study|Adverse Event|1|||
129591465|NCT01091103|466460578|FG000|Overall Study|Progressive Disease|3|||
129591466|NCT03449199|466460579|FG000|Overall Study|Lost to Follow-up|1|||
129591467|NCT03449199|466460580|FG001|Overall Study|Lost to Follow-up|1|||
129591468|NCT03449199|466460581|FG002|Overall Study|Lost to Follow-up|0|||
129591469|NCT03449199|466460579|FG000|Overall Study|Protocol Deviation|0|||
129591470|NCT03449199|466460580|FG001|Overall Study|Protocol Deviation|0|||
129591471|NCT03449199|466460581|FG002|Overall Study|Protocol Deviation|1|||
129591472|NCT03449199|466460579|FG000|Overall Study|Withdrawal by Subject|0|||
129591473|NCT03449199|466460580|FG001|Overall Study|Withdrawal by Subject|0|||
129591474|NCT03449199|466460581|FG002|Overall Study|Withdrawal by Subject|1|||
129591475|NCT01270620|466460582|FG000|Overall Study|Withdrawal by Subject|1|||
129591476|NCT01270620|466460583|FG001|Overall Study|Withdrawal by Subject|3|||
129591477|NCT02780167|466460586|FG000|Overall Study|Adverse Event|9|||
129591478|NCT02780167|466460587|FG001|Overall Study|Adverse Event|8|||
129591479|NCT02780167|466460588|FG002|Overall Study|Adverse Event|8|||
129591480|NCT02780167|466460589|FG003|Overall Study|Adverse Event|12|||
129591481|NCT02780167|466460590|FG004|Overall Study|Adverse Event|8|||
129591482|NCT02780167|466460586|FG000|Overall Study|Lack of Efficacy|6|||
129591483|NCT02780167|466460587|FG001|Overall Study|Lack of Efficacy|5|||
129591484|NCT02780167|466460588|FG002|Overall Study|Lack of Efficacy|6|||
129591485|NCT02780167|466460589|FG003|Overall Study|Lack of Efficacy|1|||
129591486|NCT02780167|466460590|FG004|Overall Study|Lack of Efficacy|0|||
129591487|NCT02780167|466460586|FG000|Overall Study|Lost to Follow-up|2|||
129591488|NCT02780167|466460587|FG001|Overall Study|Lost to Follow-up|0|||
129591489|NCT02780167|466460588|FG002|Overall Study|Lost to Follow-up|1|||
129591490|NCT02780167|466460589|FG003|Overall Study|Lost to Follow-up|0|||
129591491|NCT02780167|466460590|FG004|Overall Study|Lost to Follow-up|0|||
129591492|NCT02780167|466460586|FG000|Overall Study|Does not meet entrance criteria|0|||
129591493|NCT02780167|466460587|FG001|Overall Study|Does not meet entrance criteria|0|||
129591494|NCT02780167|466460588|FG002|Overall Study|Does not meet entrance criteria|1|||
129591495|NCT02780167|466460589|FG003|Overall Study|Does not meet entrance criteria|0|||
129591496|NCT02780167|466460590|FG004|Overall Study|Does not meet entrance criteria|0|||
129591497|NCT02780167|466460586|FG000|Overall Study|No longer meets eligibility criteria|0|||
129591498|NCT02780167|466460587|FG001|Overall Study|No longer meets eligibility criteria|0|||
129591499|NCT02780167|466460588|FG002|Overall Study|No longer meets eligibility criteria|0|||
129591500|NCT02780167|466460589|FG003|Overall Study|No longer meets eligibility criteria|1|||
129591501|NCT02780167|466460590|FG004|Overall Study|No longer meets eligibility criteria|1|||
129591502|NCT02780167|466460586|FG000|Overall Study|Protocol Violation|5|||
129591503|NCT02780167|466460587|FG001|Overall Study|Protocol Violation|5|||
129591504|NCT02780167|466460588|FG002|Overall Study|Protocol Violation|1|||
129591505|NCT02780167|466460589|FG003|Overall Study|Protocol Violation|1|||
129591506|NCT02780167|466460590|FG004|Overall Study|Protocol Violation|2|||
129591507|NCT02780167|466460586|FG000|Overall Study|Withdrawal by Subject|6|||
129591508|NCT02780167|466460587|FG001|Overall Study|Withdrawal by Subject|4|||
129591509|NCT02780167|466460588|FG002|Overall Study|Withdrawal by Subject|4|||
129591510|NCT02780167|466460589|FG003|Overall Study|Withdrawal by Subject|3|||
129591511|NCT02780167|466460590|FG004|Overall Study|Withdrawal by Subject|4|||
129591512|NCT02780167|466460586|FG000|Overall Study|Other|0|||
129591513|NCT02780167|466460587|FG001|Overall Study|Other|0|||
129591514|NCT02780167|466460588|FG002|Overall Study|Other|3|||
129591515|NCT02780167|466460589|FG003|Overall Study|Other|1|||
129591516|NCT02780167|466460590|FG004|Overall Study|Other|2|||
129591517|NCT03180801|466460591|FG000|Overall Study|Physician Decision|3|||
129591518|NCT03180801|466460592|FG001|Overall Study|Physician Decision|3|||
129591519|NCT03180801|466460593|FG002|Overall Study|Physician Decision|1|||
129591520|NCT03180801|466460591|FG000|Overall Study|Non-compliance|1|||
129591521|NCT03180801|466460592|FG001|Overall Study|Non-compliance|4|||
129591522|NCT03180801|466460593|FG002|Overall Study|Non-compliance|0|||
129591523|NCT03180801|466460591|FG000|Overall Study|Inoculation Target Reached|1|||
129591524|NCT03180801|466460592|FG001|Overall Study|Inoculation Target Reached|1|||
129591525|NCT03180801|466460593|FG002|Overall Study|Inoculation Target Reached|3|||
129591526|NCT03180801|466460591|FG000|Overall Study|Adverse Event|1|||
129591527|NCT03180801|466460592|FG001|Overall Study|Adverse Event|0|||
129591528|NCT03180801|466460593|FG002|Overall Study|Adverse Event|2|||
129591529|NCT03180801|466460591|FG000|Overall Study|Withdrawal by Subject|2|||
129591530|NCT03180801|466460592|FG001|Overall Study|Withdrawal by Subject|2|||
129591531|NCT03180801|466460593|FG002|Overall Study|Withdrawal by Subject|1|||
129591532|NCT03180801|466460591|FG000|Overall Study|Lost to Follow-up|0|||
129591533|NCT03180801|466460592|FG001|Overall Study|Lost to Follow-up|2|||
129591534|NCT03180801|466460593|FG002|Overall Study|Lost to Follow-up|3|||
129591535|NCT02618382|466460596|FG000|Overall Study|Physician Decision|1|||
129591536|NCT02618382|466460596|FG000|Overall Study|Withdrawal by Subject|1|||
129591537|NCT02618382|466460596|FG000|Overall Study|Protocol Violation|1|||
129591538|NCT03235479|466460599|FG000|Overall Study|Lost to Follow-up|8|||
129591539|NCT03235479|466460600|FG001|Overall Study|Lost to Follow-up|11|||
129591540|NCT03235479|466460599|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
129591541|NCT03235479|466460600|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
129591542|NCT03235479|466460599|FG000|Overall Study|Pregnancy|1|||
129591543|NCT03235479|466460600|FG001|Overall Study|Pregnancy|0|||
129591544|NCT03235479|466460599|FG000|Overall Study|Protocol Deviation|1|||
129591545|NCT03235479|466460600|FG001|Overall Study|Protocol Deviation|3|||
129591546|NCT03235479|466460599|FG000|Overall Study|Technical Problems|3|||
129591547|NCT03235479|466460600|FG001|Overall Study|Technical Problems|2|||
129591548|NCT03235479|466460599|FG000|Overall Study|Withdrawal by Subject|2|||
129591549|NCT03235479|466460600|FG001|Overall Study|Withdrawal by Subject|2|||
129591550|NCT03235479|466460599|FG000|Overall Study|Other Reasons|3|||
129591551|NCT03235479|466460600|FG001|Overall Study|Other Reasons|5|||
129591552|NCT00309985|466460603|FG000|Overall Study|Disease progression|12|||
129591553|NCT00309985|466460604|FG001|Overall Study|Disease progression|0|||
129591554|NCT00309985|466460603|FG000|Overall Study|Adverse Event|30|||
129591555|NCT00309985|466460604|FG001|Overall Study|Adverse Event|0|||
129591556|NCT00309985|466460603|FG000|Overall Study|Death|2|||
129591557|NCT00309985|466460604|FG001|Overall Study|Death|0|||
129591558|NCT00309985|466460603|FG000|Overall Study|Withdrawal by Subject|5|||
129591559|NCT00309985|466460604|FG001|Overall Study|Withdrawal by Subject|1|||
129591560|NCT00309985|466460603|FG000|Overall Study|Physician Decision|3|||
129591561|NCT00309985|466460604|FG001|Overall Study|Physician Decision|0|||
129591562|NCT00309985|466460603|FG000|Overall Study|Never started treatment|7|||
129591563|NCT00309985|466460604|FG001|Overall Study|Never started treatment|0|||
129591564|NCT00309985|466460603|FG000|Overall Study|Complicating disease|1|||
129591565|NCT00309985|466460604|FG001|Overall Study|Complicating disease|0|||
129591566|NCT00309985|466460603|FG000|Overall Study|Non-compliance|1|||
129591567|NCT00309985|466460604|FG001|Overall Study|Non-compliance|0|||
129591568|NCT00309985|466460603|FG000|Overall Study|Chemotherapy discontinued only|1|||
129591569|NCT00309985|466460604|FG001|Overall Study|Chemotherapy discontinued only|0|||
129591570|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
129696451|NCT01475825|466848102|FG003|Overall Study|Adverse Event|11|||
129591571|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
129591572|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
129591573|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
129591574|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
129591575|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
129591576|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129591577|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129591578|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
129591579|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
129591580|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129591581|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129591582|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
129591583|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
129591584|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129591585|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129591586|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Death|2|||
129591587|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Death|1|||
129591588|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Death|0|||
129591589|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Death|0|||
129591590|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
129591591|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
129591592|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
129591593|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
129591594|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
129591595|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129591596|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129591597|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
129591598|NCT03110380|466460616|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
129591599|NCT03110380|466460617|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
129591600|NCT03110380|466460618|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
129591601|NCT03110380|466460619|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
129591602|NCT03110380|466460616|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129591603|NCT03110380|466460617|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129591604|NCT03110380|466460618|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
129591605|NCT03110380|466460619|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
129591606|NCT03110380|466460616|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
129591607|NCT03110380|466460617|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
129591608|NCT03110380|466460618|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
129591609|NCT03110380|466460619|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
129591610|NCT03110380|466460616|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
129591611|NCT03110380|466460617|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
129591612|NCT03110380|466460618|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
129591613|NCT03110380|466460619|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
129591614|NCT01355302|466460620|FG000|Phase 1b|Death|4|||
129591615|NCT01355302|466460621|FG001|Phase 1b|Death|0|||
129591616|NCT01355302|466460622|FG002|Phase 1b|Death|0|||
129591617|NCT01355302|466460620|FG000|Phase 1b|Study terminated by sponsor|2|||
129885587|NCT02611830|467540769|FG002|OL Induction Phase|Lack of Efficacy|0|||
129591618|NCT01355302|466460621|FG001|Phase 1b|Study terminated by sponsor|0|||
129591619|NCT01355302|466460622|FG002|Phase 1b|Study terminated by sponsor|0|||
129591620|NCT00693225|466460623|FG000|Overall Study|Lost to Follow-up|1|||
129591621|NCT00693225|466460624|FG001|Overall Study|Lost to Follow-up|2|||
129591622|NCT00693225|466460623|FG000|Overall Study|Adverse Event|1|||
129591623|NCT00693225|466460624|FG001|Overall Study|Adverse Event|3|||
129591624|NCT02531594|466460625|FG000|Overall Study|Withdrawal by Subject|7|||
129591625|NCT02531594|466460626|FG001|Overall Study|Withdrawal by Subject|8|||
129591626|NCT03750695|466460629|FG000|Overall Study|Lost to Follow-up|0|||
129591627|NCT03750695|466460630|FG001|Overall Study|Lost to Follow-up|1|||
129591628|NCT03843125|466460631|FG000|Overall Study|Adverse Event|17|||
129591629|NCT03843125|466460632|FG001|Overall Study|Adverse Event|13|||
129591630|NCT03843125|466460633|FG002|Overall Study|Adverse Event|5|||
129591631|NCT03843125|466460634|FG003|Overall Study|Adverse Event|9|||
129591632|NCT03843125|466460631|FG000|Overall Study|Death|0|||
129591633|NCT03843125|466460632|FG001|Overall Study|Death|6|||
129591634|NCT03843125|466460633|FG002|Overall Study|Death|2|||
129591635|NCT03843125|466460634|FG003|Overall Study|Death|0|||
129591636|NCT03843125|466460631|FG000|Overall Study|Lack of Efficacy|14|||
129591637|NCT03843125|466460632|FG001|Overall Study|Lack of Efficacy|11|||
129591638|NCT03843125|466460633|FG002|Overall Study|Lack of Efficacy|9|||
129591639|NCT03843125|466460634|FG003|Overall Study|Lack of Efficacy|4|||
129591640|NCT03843125|466460631|FG000|Overall Study|Lost to Follow-up|3|||
129591641|NCT03843125|466460632|FG001|Overall Study|Lost to Follow-up|4|||
129591642|NCT03843125|466460633|FG002|Overall Study|Lost to Follow-up|0|||
129591643|NCT03843125|466460634|FG003|Overall Study|Lost to Follow-up|2|||
129591644|NCT03843125|466460631|FG000|Overall Study|Other|12|||
129591645|NCT03843125|466460632|FG001|Overall Study|Other|14|||
129591646|NCT03843125|466460633|FG002|Overall Study|Other|3|||
129591647|NCT03843125|466460634|FG003|Overall Study|Other|4|||
129591648|NCT03843125|466460631|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
129591649|NCT03843125|466460632|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
129591650|NCT03843125|466460633|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
129591651|NCT03843125|466460634|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
129591652|NCT03843125|466460631|FG000|Overall Study|Study Terminated by Sponsor|318|||
129696452|NCT01475825|466848099|FG000|Overall Study|Death|1|||
129591653|NCT03843125|466460632|FG001|Overall Study|Study Terminated by Sponsor|318|||
129591654|NCT03843125|466460633|FG002|Overall Study|Study Terminated by Sponsor|163|||
129591655|NCT03843125|466460634|FG003|Overall Study|Study Terminated by Sponsor|163|||
129591656|NCT03843125|466460631|FG000|Overall Study|Withdrawal by Subject|23|||
129591657|NCT03843125|466460632|FG001|Overall Study|Withdrawal by Subject|12|||
129591658|NCT03843125|466460633|FG002|Overall Study|Withdrawal by Subject|6|||
129591659|NCT03843125|466460634|FG003|Overall Study|Withdrawal by Subject|9|||
129591660|NCT03843125|466460631|FG000|Overall Study|Missing data|0|||
129591661|NCT03843125|466460632|FG001|Overall Study|Missing data|1|||
129591662|NCT03843125|466460633|FG002|Overall Study|Missing data|1|||
129591663|NCT03843125|466460634|FG003|Overall Study|Missing data|0|||
129591664|NCT03173560|466460635|FG000|Overall Study|Death|70|||
129591665|NCT03173560|466460636|FG001|Overall Study|Death|60|||
129591666|NCT03173560|466460635|FG000|Overall Study|Lost to Follow-up|1|||
129591667|NCT03173560|466460636|FG001|Overall Study|Lost to Follow-up|4|||
129591668|NCT03173560|466460635|FG000|Overall Study|Withdrawal by Subject|10|||
129591669|NCT03173560|466460636|FG001|Overall Study|Withdrawal by Subject|5|||
129591670|NCT03173560|466460635|FG000|Overall Study|Other|0|||
129591671|NCT03173560|466460636|FG001|Overall Study|Other|1|||
129591672|NCT04480307|466460638|FG000|Overall Study|Withdrawal by Subject|0|||
129591673|NCT04480307|466460639|FG001|Overall Study|Withdrawal by Subject|1|||
129591674|NCT04480307|466460640|FG002|Overall Study|Withdrawal by Subject|0|||
129591675|NCT04480307|466460641|FG003|Overall Study|Withdrawal by Subject|0|||
129591676|NCT04480307|466460638|FG000|Overall Study|Adverse Event|0|||
129591677|NCT04480307|466460639|FG001|Overall Study|Adverse Event|0|||
129591678|NCT04480307|466460640|FG002|Overall Study|Adverse Event|0|||
129591679|NCT04480307|466460641|FG003|Overall Study|Adverse Event|1|||
129591680|NCT04254809|466460642|FG000|Overall Study|Lost to Follow-up|5|||
129591681|NCT04254809|466460643|FG001|Overall Study|Lost to Follow-up|10|||
129591682|NCT03023137|466460644|FG000|Overall Study|Multiple pregnancy|2|||
129591683|NCT03023137|466460645|FG001|Overall Study|Multiple pregnancy|4|||
129591684|NCT03023137|466460644|FG000|Overall Study|Lost to Follow-up|1|||
129591685|NCT03023137|466460645|FG001|Overall Study|Lost to Follow-up|1|||
129591686|NCT03023137|466460644|FG000|Overall Study|Protocol Violation|0|||
129591687|NCT03023137|466460645|FG001|Overall Study|Protocol Violation|4|||
129591688|NCT03023137|466460644|FG000|Overall Study|Lost the baby in a car accident|1|||
129591689|NCT03023137|466460645|FG001|Overall Study|Lost the baby in a car accident|0|||
129591690|NCT02608476|466460646|FG000|Overall Study|Withdrawal by Subject|30|||
129591691|NCT02608476|466460647|FG001|Overall Study|Withdrawal by Subject|37|||
129591692|NCT02608476|466460646|FG000|Overall Study|Lost to Follow-up|24|||
129591693|NCT02608476|466460647|FG001|Overall Study|Lost to Follow-up|24|||
129591694|NCT02608476|466460646|FG000|Overall Study|Adverse Event|2|||
129591695|NCT02608476|466460647|FG001|Overall Study|Adverse Event|8|||
129591696|NCT02608476|466460646|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
129591697|NCT02608476|466460647|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
129591698|NCT02608476|466460646|FG000|Overall Study|Noncompliance with treatment|1|||
129591699|NCT02608476|466460647|FG001|Overall Study|Noncompliance with treatment|5|||
129591700|NCT02608476|466460646|FG000|Overall Study|Lack of Efficacy|3|||
129591701|NCT02608476|466460647|FG001|Overall Study|Lack of Efficacy|1|||
129591702|NCT02608476|466460646|FG000|Overall Study|Other|0|||
129591703|NCT02608476|466460647|FG001|Overall Study|Other|1|||
129591704|NCT02608476|466460646|FG000|Overall Study|Physician Decision|1|||
129591705|NCT02608476|466460647|FG001|Overall Study|Physician Decision|0|||
129591706|NCT02608476|466460646|FG000|Overall Study|Pregnancy|0|||
129591707|NCT02608476|466460647|FG001|Overall Study|Pregnancy|1|||
129591708|NCT02608476|466460646|FG000|Overall Study|Progressive disease|1|||
129591709|NCT02608476|466460647|FG001|Overall Study|Progressive disease|0|||
129591710|NCT02795676|466460648|FG000|Overall Study|Adverse Event|2|||
129591711|NCT02795676|466460649|FG001|Overall Study|Adverse Event|0|||
129591712|NCT02795676|466460648|FG000|Overall Study|Withdrawal by Subject|3|||
129591713|NCT02795676|466460649|FG001|Overall Study|Withdrawal by Subject|1|||
129591714|NCT01203917|466460651|FG000|Overall Study|Death|29|||
129591715|NCT01203917|466460651|FG000|Overall Study|Lost to Follow-up|2|||
129591716|NCT01203917|466460651|FG000|Overall Study|Withdrawal by Subject|3|||
129591717|NCT01203917|466460651|FG000|Overall Study|Due to objective disease progression|1|||
129591718|NCT01203917|466460651|FG000|Overall Study|Due to EGFR M+I patient|1|||
129591719|NCT01609582|466460662|FG000|Overall Study|Adverse Event|20|||
129591720|NCT01609582|466460663|FG001|Overall Study|Adverse Event|18|||
129591721|NCT01609582|466460662|FG000|Overall Study|Lost to Follow-up|10|||
129591722|NCT01609582|466460663|FG001|Overall Study|Lost to Follow-up|10|||
129591723|NCT01609582|466460662|FG000|Overall Study|Withdrawal by Subject|21|||
129591724|NCT01609582|466460663|FG001|Overall Study|Withdrawal by Subject|15|||
129591725|NCT01609582|466460662|FG000|Overall Study|Study Terminated by Sponsor|1543|||
129885588|NCT02611830|467540770|FG003|OL Induction Phase|Lack of Efficacy|0|||
129885589|NCT02611830|467540767|FG000|OL Induction Phase|Reason not specified|3|||
129591726|NCT01609582|466460663|FG001|Overall Study|Study Terminated by Sponsor|1548|||
129591727|NCT01609582|466460662|FG000|Overall Study|Other|9|||
129591728|NCT01609582|466460663|FG001|Overall Study|Other|10|||
129591729|NCT01609582|466460662|FG000|Overall Study|Randomized, but not treated|0|||
129591730|NCT01609582|466460663|FG001|Overall Study|Randomized, but not treated|3|||
129591731|NCT00819767|466460664|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129591732|NCT00819767|466460665|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129591733|NCT00808509|466460675|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
129591734|NCT00808509|466460676|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
129591735|NCT00808509|466460675|FG000|Randomized Phase|Reduced methotrexate dose|1|||
129591736|NCT00808509|466460676|FG001|Randomized Phase|Reduced methotrexate dose|2|||
129591737|NCT00808509|466460675|FG000|Randomized Phase|Patient refused rescue therapy|0|||
129591738|NCT00808509|466460676|FG001|Randomized Phase|Patient refused rescue therapy|3|||
129591739|NCT02169791|466460677|FG000|Overall Study|Death|6|||
129591740|NCT02169791|466460677|FG000|Overall Study|patient withdrew consent|1|||
129591741|NCT02762994|466460680|FG000|Overall Study|Withdrawal by Subject|0|||
129591742|NCT02762994|466460681|FG001|Overall Study|Withdrawal by Subject|1|||
129591743|NCT02762994|466460682|FG002|Overall Study|Withdrawal by Subject|2|||
129591744|NCT02762994|466460683|FG003|Overall Study|Withdrawal by Subject|0|||
129591745|NCT02762994|466460680|FG000|Overall Study|Protocol Violation|1|||
129591746|NCT02762994|466460681|FG001|Overall Study|Protocol Violation|0|||
129591747|NCT02762994|466460682|FG002|Overall Study|Protocol Violation|0|||
129591748|NCT02762994|466460683|FG003|Overall Study|Protocol Violation|2|||
129591749|NCT04234464|466460684|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
129591750|NCT04234464|466460685|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
129591751|NCT01701973|466460686|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591752|NCT01701973|466460687|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
129591753|NCT01701973|466460688|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591754|NCT01701973|466460689|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591755|NCT01701973|466460690|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591756|NCT01701973|466460691|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591757|NCT01701973|466460692|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591758|NCT01701973|466460693|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
129591759|NCT04330157|466460696|FG000|Overall Study|Protocol Violation|4|||
129591760|NCT04330157|466460696|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
129591761|NCT01899326|466460697|FG000|Overall Study|Withdrawal by Subject|1|||
129591762|NCT01899326|466460697|FG000|Overall Study|Adverse Event|2|||
129591763|NCT01899326|466460697|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
129591764|NCT00373425|466460698|FG000|Overall Study|Relapse of NSCLC|116|||
129591765|NCT00373425|466460699|FG001|Overall Study|Relapse of NSCLC|104|||
129591766|NCT00373425|466460700|FG002|Overall Study|Relapse of NSCLC|19|||
129591767|NCT00373425|466460701|FG003|Overall Study|Relapse of NSCLC|2|||
129786292|NCT01328444|467185633|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
129786293|NCT01328444|467185634|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
129786294|NCT01328444|467185629|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129786295|NCT01328444|467185630|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129786296|NCT01328444|467185631|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129786297|NCT01328444|467185632|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129786298|NCT01328444|467185633|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129786299|NCT01328444|467185634|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
129591768|NCT00373425|466460702|FG004|Overall Study|Relapse of NSCLC|26|||
129591769|NCT00373425|466460698|FG000|Overall Study|Adverse Event|191|||
129591770|NCT00373425|466460699|FG001|Overall Study|Adverse Event|22|||
129591771|NCT00373425|466460700|FG002|Overall Study|Adverse Event|59|||
129591772|NCT00373425|466460701|FG003|Overall Study|Adverse Event|0|||
129786300|NCT01328444|467185629|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129591773|NCT00373425|466460702|FG004|Overall Study|Adverse Event|34|||
129591774|NCT00373425|466460698|FG000|Overall Study|Patient request|35|||
129591775|NCT00373425|466460699|FG001|Overall Study|Patient request|18|||
129591776|NCT00373425|466460700|FG002|Overall Study|Patient request|43|||
129591777|NCT00373425|466460701|FG003|Overall Study|Patient request|6|||
129591778|NCT00373425|466460702|FG004|Overall Study|Patient request|7|||
129591779|NCT00373425|466460698|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
129591780|NCT00373425|466460699|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
129591781|NCT00373425|466460700|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
129591782|NCT00373425|466460701|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
129786301|NCT01328444|467185630|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129591783|NCT00373425|466460702|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
129591784|NCT00373425|466460698|FG000|Overall Study|Death|7|||
129591785|NCT00373425|466460699|FG001|Overall Study|Death|0|||
129591786|NCT00373425|466460700|FG002|Overall Study|Death|3|||
129591787|NCT00373425|466460701|FG003|Overall Study|Death|1|||
129591788|NCT00373425|466460702|FG004|Overall Study|Death|0|||
129591789|NCT00551616|466460705|FG000|Overall Study|Lost to Follow-up|48|||
129786302|NCT01328444|467185631|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129786303|NCT01328444|467185632|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129786304|NCT01328444|467185633|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129786305|NCT01328444|467185634|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129786306|NCT03531632|467185635|FG000|Overall Study|Adverse Event|0|||
129786307|NCT03531632|467185636|FG001|Overall Study|Adverse Event|0|||
129786308|NCT03531632|467185637|FG002|Overall Study|Adverse Event|1|||
129786309|NCT03531632|467185635|FG000|Overall Study|Death|4|||
129786310|NCT03531632|467185636|FG001|Overall Study|Death|0|||
129786311|NCT03531632|467185637|FG002|Overall Study|Death|14|||
129786312|NCT03531632|467185635|FG000|Overall Study|Study Terminated|1|||
129786313|NCT03531632|467185636|FG001|Overall Study|Study Terminated|3|||
129786314|NCT03531632|467185637|FG002|Overall Study|Study Terminated|11|||
129786315|NCT00600119|467185638|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
129786316|NCT00600119|467185639|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
129786317|NCT00600119|467185640|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
129786318|NCT00600119|467185641|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
129786319|NCT00600119|467185642|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
129786320|NCT00600119|467185643|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
129786321|NCT00600119|467185638|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129786322|NCT00600119|467185639|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
129786323|NCT00600119|467185640|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
129786324|NCT00600119|467185641|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129786325|NCT00600119|467185642|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129786326|NCT00600119|467185643|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129786327|NCT00600119|467185638|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
129591790|NCT00551616|466460706|FG001|Overall Study|Lost to Follow-up|40|||
129591791|NCT01263561|466460707|FG000|Overall Study|Death|1|||
129591792|NCT01263561|466460708|FG001|Overall Study|Death|2|||
129591793|NCT03942211|466460709|FG000|Overall Study|Death|1|||
129591794|NCT03942211|466460710|FG001|Overall Study|Death|0|||
129591795|NCT03942211|466460709|FG000|Overall Study|Study terminated by sponsor|5|||
129591796|NCT03942211|466460710|FG001|Overall Study|Study terminated by sponsor|3|||
129591797|NCT03942211|466460709|FG000|Overall Study|Adverse Event|0|||
129591798|NCT03942211|466460710|FG001|Overall Study|Adverse Event|1|||
129591799|NCT01396421|466460711|FG000|Overall Study|Lost to Follow-up|0|||
129591800|NCT01396421|466460712|FG001|Overall Study|Lost to Follow-up|0|||
129591801|NCT01396421|466460713|FG002|Overall Study|Lost to Follow-up|0|||
129591802|NCT01396421|466460714|FG003|Overall Study|Lost to Follow-up|1|||
129591803|NCT01396421|466460711|FG000|Overall Study|Adverse Event|17|||
129591804|NCT01396421|466460712|FG001|Overall Study|Adverse Event|15|||
129591805|NCT01396421|466460713|FG002|Overall Study|Adverse Event|12|||
129591806|NCT01396421|466460714|FG003|Overall Study|Adverse Event|32|||
129591807|NCT01396421|466460711|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
129591808|NCT01396421|466460712|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
129591809|NCT01396421|466460713|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
129591810|NCT01396421|466460714|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
129591811|NCT01396421|466460711|FG000|Overall Study|Physician Decision|1|||
129591812|NCT01396421|466460712|FG001|Overall Study|Physician Decision|1|||
129591813|NCT01396421|466460713|FG002|Overall Study|Physician Decision|0|||
129591814|NCT01396421|466460714|FG003|Overall Study|Physician Decision|3|||
129591815|NCT01396421|466460711|FG000|Overall Study|Withdrawal by Subject|31|||
129591816|NCT01396421|466460712|FG001|Overall Study|Withdrawal by Subject|24|||
129591817|NCT01396421|466460713|FG002|Overall Study|Withdrawal by Subject|13|||
129591818|NCT01396421|466460714|FG003|Overall Study|Withdrawal by Subject|21|||
129591819|NCT01396421|466460711|FG000|Overall Study|Protocol Deviation|2|||
129591820|NCT01396421|466460712|FG001|Overall Study|Protocol Deviation|1|||
129591821|NCT01396421|466460713|FG002|Overall Study|Protocol Deviation|1|||
129591822|NCT01396421|466460714|FG003|Overall Study|Protocol Deviation|0|||
129591823|NCT01396421|466460711|FG000|Overall Study|Lack of Efficacy|7|||
129591824|NCT01396421|466460712|FG001|Overall Study|Lack of Efficacy|17|||
129591825|NCT01396421|466460713|FG002|Overall Study|Lack of Efficacy|7|||
129591826|NCT01396421|466460714|FG003|Overall Study|Lack of Efficacy|18|||
129591827|NCT00569777|466460718|FG000|Overall Study|Withdrawal by Subject|4|||
129591828|NCT00569777|466460719|FG001|Overall Study|Withdrawal by Subject|0|||
129591829|NCT00569777|466460718|FG000|Overall Study|Adverse Event|3|||
129591830|NCT00569777|466460719|FG001|Overall Study|Adverse Event|0|||
129591831|NCT00569777|466460718|FG000|Overall Study|Lost to Follow-up|1|||
129591832|NCT00569777|466460719|FG001|Overall Study|Lost to Follow-up|0|||
129591833|NCT00569777|466460718|FG000|Overall Study|scheduled eye surgery|0|||
129591834|NCT00569777|466460719|FG001|Overall Study|scheduled eye surgery|1|||
129591835|NCT00569777|466460718|FG000|Overall Study|did not meet exclusion criteria|1|||
129591836|NCT00569777|466460719|FG001|Overall Study|did not meet exclusion criteria|2|||
129591837|NCT00569777|466460718|FG000|Overall Study|pregnant|1|||
129591838|NCT00569777|466460719|FG001|Overall Study|pregnant|0|||
129591839|NCT02030535|466460720|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
129591840|NCT03180528|466462250|FG000|Overall Study|Adverse Event|1|||
129591841|NCT03180528|466462250|FG000|Overall Study|Withdrawal by Subject|1|||
129591842|NCT03180528|466462250|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
129591843|NCT02447887|466462251|FG000|Overall Study|Study was terminated|3|||
129591844|NCT02839798|466462252|FG000|Overall Study|Withdrawal by Subject|2|||
129591845|NCT04703855|466462253|FG000|Overall Study|Heart Transplant|1|||
129591846|NCT00401245|466462256|FG000|Double Blind Titration Phase|Adverse Event|3|||
129591847|NCT00401245|466462257|FG001|Double Blind Titration Phase|Adverse Event|2|||
129591848|NCT00401245|466462258|FG002|Double Blind Titration Phase|Adverse Event|5|||
129591849|NCT00401245|466462259|FG003|Double Blind Titration Phase|Adverse Event|12|||
129591850|NCT00401245|466462260|FG004|Double Blind Titration Phase|Adverse Event|0|||
129591851|NCT00401245|466462261|FG005|Double Blind Titration Phase|Adverse Event|0|||
129591852|NCT00401245|466462262|FG006|Double Blind Titration Phase|Adverse Event|0|||
129591853|NCT00401245|466462263|FG007|Double Blind Titration Phase|Adverse Event|0|||
129591854|NCT00401245|466462256|FG000|Double Blind Titration Phase|Other|0|||
129591855|NCT00401245|466462257|FG001|Double Blind Titration Phase|Other|0|||
129591856|NCT00401245|466462258|FG002|Double Blind Titration Phase|Other|1|||
129591857|NCT00401245|466462259|FG003|Double Blind Titration Phase|Other|0|||
129591858|NCT00401245|466462260|FG004|Double Blind Titration Phase|Other|0|||
129591859|NCT00401245|466462261|FG005|Double Blind Titration Phase|Other|0|||
129591860|NCT00401245|466462262|FG006|Double Blind Titration Phase|Other|0|||
129591861|NCT00401245|466462263|FG007|Double Blind Titration Phase|Other|0|||
129591862|NCT00401245|466462256|FG000|Double Blind Titration Phase|Protocol Violation|0|||
129591863|NCT00401245|466462257|FG001|Double Blind Titration Phase|Protocol Violation|0|||
129591864|NCT00401245|466462258|FG002|Double Blind Titration Phase|Protocol Violation|0|||
129591865|NCT00401245|466462259|FG003|Double Blind Titration Phase|Protocol Violation|1|||
129696453|NCT01475825|466848100|FG001|Overall Study|Death|0|||
129696454|NCT01475825|466848101|FG002|Overall Study|Death|1|||
129696455|NCT01475825|466848102|FG003|Overall Study|Death|0|||
129696456|NCT01475825|466848099|FG000|Overall Study|Lack of Efficacy|0|||
129696457|NCT01475825|466848100|FG001|Overall Study|Lack of Efficacy|0|||
129696458|NCT01475825|466848101|FG002|Overall Study|Lack of Efficacy|1|||
129696459|NCT01475825|466848102|FG003|Overall Study|Lack of Efficacy|0|||
129696460|NCT01475825|466848099|FG000|Overall Study|Lost to Follow-up|0|||
129696461|NCT01475825|466848100|FG001|Overall Study|Lost to Follow-up|0|||
129696462|NCT01475825|466848101|FG002|Overall Study|Lost to Follow-up|3|||
129696463|NCT01475825|466848102|FG003|Overall Study|Lost to Follow-up|1|||
129591866|NCT00401245|466462260|FG004|Double Blind Titration Phase|Protocol Violation|0|||
129591867|NCT00401245|466462261|FG005|Double Blind Titration Phase|Protocol Violation|0|||
129591868|NCT00401245|466462262|FG006|Double Blind Titration Phase|Protocol Violation|0|||
129591869|NCT00401245|466462263|FG007|Double Blind Titration Phase|Protocol Violation|0|||
129591870|NCT00401245|466462256|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
129591871|NCT00401245|466462257|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
129591872|NCT00401245|466462258|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
129591873|NCT00401245|466462259|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
129591874|NCT00401245|466462260|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
129591875|NCT00401245|466462261|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
129591876|NCT00401245|466462262|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
129591877|NCT00401245|466462263|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
129591878|NCT00401245|466462256|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129591879|NCT00401245|466462257|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
129591880|NCT00401245|466462258|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129591881|NCT00401245|466462259|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
129591882|NCT00401245|466462260|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129591883|NCT00401245|466462261|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129591884|NCT00401245|466462262|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129591885|NCT00401245|466462263|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
129591886|NCT00401245|466462256|FG000|Open Label Phase|Adverse Event|5|||
129591887|NCT00401245|466462257|FG001|Open Label Phase|Adverse Event|14|||
129591888|NCT00401245|466462258|FG002|Open Label Phase|Adverse Event|6|||
129591889|NCT00401245|466462259|FG003|Open Label Phase|Adverse Event|7|||
129591890|NCT00401245|466462260|FG004|Open Label Phase|Adverse Event|0|||
129591891|NCT00401245|466462261|FG005|Open Label Phase|Adverse Event|0|||
129591892|NCT00401245|466462262|FG006|Open Label Phase|Adverse Event|0|||
129591893|NCT00401245|466462263|FG007|Open Label Phase|Adverse Event|0|||
129591894|NCT00401245|466462256|FG000|Open Label Phase|Lost to Follow-up|5|||
129591895|NCT00401245|466462257|FG001|Open Label Phase|Lost to Follow-up|7|||
129591896|NCT00401245|466462258|FG002|Open Label Phase|Lost to Follow-up|5|||
129591897|NCT00401245|466462259|FG003|Open Label Phase|Lost to Follow-up|4|||
129591898|NCT00401245|466462260|FG004|Open Label Phase|Lost to Follow-up|0|||
129591899|NCT00401245|466462261|FG005|Open Label Phase|Lost to Follow-up|0|||
129591900|NCT00401245|466462262|FG006|Open Label Phase|Lost to Follow-up|0|||
129591901|NCT00401245|466462263|FG007|Open Label Phase|Lost to Follow-up|0|||
129591902|NCT00401245|466462256|FG000|Open Label Phase|Other|4|||
129591903|NCT00401245|466462257|FG001|Open Label Phase|Other|8|||
129591904|NCT00401245|466462258|FG002|Open Label Phase|Other|7|||
129591905|NCT00401245|466462259|FG003|Open Label Phase|Other|8|||
129591906|NCT00401245|466462260|FG004|Open Label Phase|Other|0|||
129786328|NCT00600119|467185639|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
129786329|NCT00600119|467185640|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
129591907|NCT00401245|466462261|FG005|Open Label Phase|Other|0|||
129591908|NCT00401245|466462262|FG006|Open Label Phase|Other|0|||
129591909|NCT00401245|466462263|FG007|Open Label Phase|Other|0|||
129591910|NCT00401245|466462256|FG000|Open Label Phase|Protocol Violation|0|||
129591911|NCT00401245|466462257|FG001|Open Label Phase|Protocol Violation|1|||
129591912|NCT00401245|466462258|FG002|Open Label Phase|Protocol Violation|0|||
129591913|NCT00401245|466462259|FG003|Open Label Phase|Protocol Violation|1|||
129591914|NCT00401245|466462260|FG004|Open Label Phase|Protocol Violation|0|||
129591915|NCT00401245|466462261|FG005|Open Label Phase|Protocol Violation|0|||
129591916|NCT00401245|466462262|FG006|Open Label Phase|Protocol Violation|0|||
129591917|NCT00401245|466462263|FG007|Open Label Phase|Protocol Violation|0|||
129591918|NCT00401245|466462256|FG000|Open Label Phase|Withdrawal by Subject|3|||
129591919|NCT00401245|466462257|FG001|Open Label Phase|Withdrawal by Subject|3|||
129591920|NCT00401245|466462258|FG002|Open Label Phase|Withdrawal by Subject|2|||
129591921|NCT00401245|466462259|FG003|Open Label Phase|Withdrawal by Subject|1|||
129591922|NCT00401245|466462260|FG004|Open Label Phase|Withdrawal by Subject|0|||
129591923|NCT00401245|466462261|FG005|Open Label Phase|Withdrawal by Subject|0|||
129591924|NCT00401245|466462262|FG006|Open Label Phase|Withdrawal by Subject|0|||
129591925|NCT00401245|466462263|FG007|Open Label Phase|Withdrawal by Subject|0|||
129591926|NCT00401245|466462256|FG000|Open Label Phase|Lack of Efficacy|4|||
129591927|NCT00401245|466462257|FG001|Open Label Phase|Lack of Efficacy|2|||
129591928|NCT00401245|466462258|FG002|Open Label Phase|Lack of Efficacy|3|||
129591929|NCT00401245|466462259|FG003|Open Label Phase|Lack of Efficacy|0|||
129591930|NCT00401245|466462260|FG004|Open Label Phase|Lack of Efficacy|0|||
129591931|NCT00401245|466462261|FG005|Open Label Phase|Lack of Efficacy|0|||
129591932|NCT00401245|466462262|FG006|Open Label Phase|Lack of Efficacy|0|||
129591933|NCT00401245|466462263|FG007|Open Label Phase|Lack of Efficacy|0|||
129591934|NCT00401245|466462256|FG000|Double Blind Tapering Phase|Adverse Event|0|||
129591935|NCT00401245|466462257|FG001|Double Blind Tapering Phase|Adverse Event|0|||
129591936|NCT00401245|466462258|FG002|Double Blind Tapering Phase|Adverse Event|0|||
129591937|NCT00401245|466462259|FG003|Double Blind Tapering Phase|Adverse Event|0|||
129591938|NCT00401245|466462260|FG004|Double Blind Tapering Phase|Adverse Event|1|||
129591939|NCT00401245|466462261|FG005|Double Blind Tapering Phase|Adverse Event|1|||
129591940|NCT00401245|466462262|FG006|Double Blind Tapering Phase|Adverse Event|2|||
129591941|NCT00401245|466462263|FG007|Double Blind Tapering Phase|Adverse Event|4|||
129591942|NCT00401245|466462256|FG000|Double Blind Tapering Phase|Investigator request|0|||
129591943|NCT00401245|466462257|FG001|Double Blind Tapering Phase|Investigator request|0|||
129591944|NCT00401245|466462258|FG002|Double Blind Tapering Phase|Investigator request|0|||
129591945|NCT00401245|466462259|FG003|Double Blind Tapering Phase|Investigator request|0|||
129591946|NCT00401245|466462260|FG004|Double Blind Tapering Phase|Investigator request|0|||
129591947|NCT00401245|466462261|FG005|Double Blind Tapering Phase|Investigator request|0|||
129591948|NCT00401245|466462262|FG006|Double Blind Tapering Phase|Investigator request|0|||
129591949|NCT00401245|466462263|FG007|Double Blind Tapering Phase|Investigator request|1|||
129591950|NCT00401245|466462256|FG000|Double Blind Tapering Phase|Other|0|||
129591951|NCT00401245|466462257|FG001|Double Blind Tapering Phase|Other|0|||
129591952|NCT00401245|466462258|FG002|Double Blind Tapering Phase|Other|0|||
129591953|NCT00401245|466462259|FG003|Double Blind Tapering Phase|Other|0|||
129591954|NCT00401245|466462260|FG004|Double Blind Tapering Phase|Other|1|||
129591955|NCT00401245|466462261|FG005|Double Blind Tapering Phase|Other|0|||
129591956|NCT00401245|466462262|FG006|Double Blind Tapering Phase|Other|2|||
129591957|NCT00401245|466462263|FG007|Double Blind Tapering Phase|Other|2|||
129591958|NCT00401245|466462256|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129591959|NCT00401245|466462257|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129591960|NCT00401245|466462258|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129591961|NCT00401245|466462259|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129591962|NCT00401245|466462260|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
129591963|NCT00401245|466462261|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
129591964|NCT00401245|466462262|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
129591965|NCT00401245|466462263|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
129591966|NCT00401245|466462256|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591967|NCT00401245|466462257|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591968|NCT00401245|466462258|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591969|NCT00401245|466462259|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591970|NCT00401245|466462260|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591971|NCT00401245|466462261|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
129591972|NCT00401245|466462262|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591973|NCT00401245|466462263|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
129591974|NCT01989676|466462264|FG000|Overall Study|Death|52|||
129591975|NCT01989676|466462265|FG001|Overall Study|Death|60|||
129591976|NCT01989676|466462264|FG000|Overall Study|Protocol Violation|2|||
129591977|NCT01989676|466462265|FG001|Overall Study|Protocol Violation|1|||
129591978|NCT01989676|466462264|FG000|Overall Study|Lost to Follow-up|8|||
129591979|NCT01989676|466462265|FG001|Overall Study|Lost to Follow-up|18|||
129591980|NCT01989676|466462264|FG000|Overall Study|No longer willing to participate in study|26|||
129591981|NCT01989676|466462265|FG001|Overall Study|No longer willing to participate in study|26|||
129591982|NCT01989676|466462264|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
129591983|NCT01989676|466462265|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
129591984|NCT01989676|466462264|FG000|Overall Study|Other|4|||
129591985|NCT01989676|466462265|FG001|Overall Study|Other|3|||
129591986|NCT03941834|466462266|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
129591987|NCT03941834|466462267|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
129591988|NCT03941834|466462268|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
129591989|NCT03941834|466462266|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
129591990|NCT03941834|466462267|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
129591991|NCT03941834|466462268|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
129591992|NCT03941834|466462266|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
129591993|NCT03941834|466462267|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
129591994|NCT03941834|466462268|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
129591995|NCT03941834|466462266|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
129591996|NCT03941834|466462267|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
129786330|NCT00600119|467185641|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
129786331|NCT00600119|467185642|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
129786332|NCT00600119|467185643|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
129786333|NCT00600119|467185638|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
129786334|NCT00600119|467185639|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
129786335|NCT00600119|467185640|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
129786336|NCT00600119|467185641|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
129786337|NCT00600119|467185642|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
129786338|NCT00600119|467185643|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
129786339|NCT00600119|467185638|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
129786340|NCT00600119|467185639|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
129786341|NCT00600119|467185640|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
129591997|NCT03941834|466462268|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
129591998|NCT03941834|466462266|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
129591999|NCT03941834|466462267|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
129592000|NCT03941834|466462268|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
129592001|NCT03941834|466462266|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
129592002|NCT03941834|466462267|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
129786342|NCT00600119|467185641|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
129786343|NCT00600119|467185642|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
129786344|NCT00600119|467185643|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
129786345|NCT00600119|467185638|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
129592003|NCT03941834|466462268|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
129592004|NCT01560819|466462272|FG000|Overall Study|Physician Decision|1|||
129592005|NCT01560819|466462273|FG001|Overall Study|Physician Decision|0|||
129592006|NCT02344745|466462274|FG000|Overall Study|Data collection sheets were lost|2|||
129592007|NCT02344745|466462275|FG001|Overall Study|Data collection sheets were lost|0|||
129592008|NCT02788513|466462276|FG000|Overall Study|Withdrawal by Subject|3|||
129592009|NCT02788513|466462277|FG001|Overall Study|Withdrawal by Subject|0|||
129592010|NCT02788513|466462278|FG002|Overall Study|Withdrawal by Subject|2|||
129592011|NCT02788513|466462279|FG003|Overall Study|Withdrawal by Subject|3|||
129786346|NCT00600119|467185639|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
129786347|NCT00600119|467185640|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
129786348|NCT00600119|467185641|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
129786349|NCT00600119|467185642|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
129786350|NCT00600119|467185643|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
129786351|NCT00600119|467185638|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
129786352|NCT00600119|467185639|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129786353|NCT00600119|467185640|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129786354|NCT00600119|467185641|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
129786355|NCT00600119|467185642|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
129786356|NCT00600119|467185643|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
129786357|NCT00600119|467185638|FG000|Double-blind Treatment Period|Other|0|||
129786358|NCT00600119|467185639|FG001|Double-blind Treatment Period|Other|0|||
129786359|NCT00600119|467185640|FG002|Double-blind Treatment Period|Other|0|||
129786360|NCT00600119|467185641|FG003|Double-blind Treatment Period|Other|0|||
129786361|NCT00600119|467185642|FG004|Double-blind Treatment Period|Other|2|||
129786362|NCT00600119|467185643|FG005|Double-blind Treatment Period|Other|1|||
129786363|NCT00600119|467185638|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
129786364|NCT00600119|467185639|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
129786365|NCT00600119|467185640|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
129786366|NCT00600119|467185641|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
129786367|NCT00600119|467185642|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
129592012|NCT02788513|466462280|FG004|Overall Study|Withdrawal by Subject|1|||
129786368|NCT00600119|467185643|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
129786369|NCT00600119|467185638|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
129786370|NCT00600119|467185639|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
129786371|NCT00600119|467185640|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
129592013|NCT02788513|466462276|FG000|Overall Study|Lost to Follow-up|1|||
129592014|NCT02788513|466462277|FG001|Overall Study|Lost to Follow-up|0|||
129592015|NCT02788513|466462278|FG002|Overall Study|Lost to Follow-up|0|||
129592016|NCT02788513|466462279|FG003|Overall Study|Lost to Follow-up|0|||
129592017|NCT02788513|466462280|FG004|Overall Study|Lost to Follow-up|1|||
129592018|NCT02788513|466462276|FG000|Overall Study|Adverse Event|5|||
129592019|NCT02788513|466462277|FG001|Overall Study|Adverse Event|8|||
129592020|NCT02788513|466462278|FG002|Overall Study|Adverse Event|4|||
129592021|NCT02788513|466462279|FG003|Overall Study|Adverse Event|2|||
129592022|NCT02788513|466462280|FG004|Overall Study|Adverse Event|2|||
129592023|NCT02788513|466462276|FG000|Overall Study|Protocol Violation|0|||
129592024|NCT02788513|466462277|FG001|Overall Study|Protocol Violation|0|||
129592025|NCT02788513|466462278|FG002|Overall Study|Protocol Violation|1|||
129592026|NCT02788513|466462279|FG003|Overall Study|Protocol Violation|1|||
129592027|NCT02788513|466462280|FG004|Overall Study|Protocol Violation|0|||
129592028|NCT02788513|466462276|FG000|Overall Study|Subject decided to stop taking treatment|0|||
129592029|NCT02788513|466462277|FG001|Overall Study|Subject decided to stop taking treatment|0|||
129592030|NCT02788513|466462278|FG002|Overall Study|Subject decided to stop taking treatment|1|||
129592031|NCT02788513|466462279|FG003|Overall Study|Subject decided to stop taking treatment|0|||
129592032|NCT02788513|466462280|FG004|Overall Study|Subject decided to stop taking treatment|0|||
129592033|NCT02788513|466462276|FG000|Overall Study|Decision by the study team|0|||
129592034|NCT02788513|466462277|FG001|Overall Study|Decision by the study team|0|||
129592035|NCT02788513|466462278|FG002|Overall Study|Decision by the study team|0|||
129592036|NCT02788513|466462279|FG003|Overall Study|Decision by the study team|0|||
129592037|NCT02788513|466462280|FG004|Overall Study|Decision by the study team|1|||
129592038|NCT00114231|466462282|FG000|Overall Study|No consent|2|||
129592039|NCT00114231|466462283|FG001|Overall Study|No consent|0|||
129592040|NCT00114231|466462282|FG000|Overall Study|QARC requirement not met|1|||
129592041|NCT00114231|466462283|FG001|Overall Study|QARC requirement not met|0|||
129592042|NCT00114231|466462282|FG000|Overall Study|Suspected metastatic disease|1|||
129592043|NCT00114231|466462283|FG001|Overall Study|Suspected metastatic disease|0|||
129592044|NCT00114231|466462282|FG000|Overall Study|No adenocarcinoma|1|||
129592045|NCT00114231|466462283|FG001|Overall Study|No adenocarcinoma|0|||
129592046|NCT00114231|466462282|FG000|Overall Study|Low creatinine clearance|0|||
129592047|NCT00114231|466462283|FG001|Overall Study|Low creatinine clearance|1|||
129592048|NCT00114231|466462282|FG000|Overall Study|Tumor size > 4cm|1|||
129592049|NCT00114231|466462283|FG001|Overall Study|Tumor size > 4cm|0|||
129592050|NCT00114231|466462282|FG000|Overall Study|Tumor fixed on digital exam|0|||
129592051|NCT00114231|466462283|FG001|Overall Study|Tumor fixed on digital exam|1|||
129592052|NCT00114231|466462282|FG000|Overall Study|No Absolute Neutrophil Count|2|||
129592053|NCT00114231|466462283|FG001|Overall Study|No Absolute Neutrophil Count|0|||
129592054|NCT00114231|466462282|FG000|Overall Study|Biopsy done after registration|1|||
129592055|NCT00114231|466462283|FG001|Overall Study|Biopsy done after registration|0|||
129592056|NCT01933919|466462284|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
129592057|NCT01933919|466462285|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
129592058|NCT01933919|466462284|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
129592059|NCT01933919|466462285|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
129592060|NCT01933919|466462284|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
129592061|NCT01933919|466462285|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
129592062|NCT01933919|466462284|FG000|Open-label Long-term Phase|Adverse Event|2|||
129592063|NCT01933919|466462285|FG001|Open-label Long-term Phase|Adverse Event|0|||
129592064|NCT01933919|466462284|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
129592065|NCT01933919|466462285|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
129592066|NCT01933919|466462284|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
129592067|NCT01933919|466462285|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
129592068|NCT01933919|466462284|FG000|Open-label Long-term Phase|Other|1|||
129592069|NCT01933919|466462285|FG001|Open-label Long-term Phase|Other|2|||
129592070|NCT02510261|466462292|FG000|Overall Study|Adverse Event|5|||
129592071|NCT02510261|466462293|FG001|Overall Study|Adverse Event|8|||
129592072|NCT02510261|466462294|FG002|Overall Study|Adverse Event|0|||
129592073|NCT02510261|466462292|FG000|Overall Study|Physician Decision|1|||
129592074|NCT02510261|466462293|FG001|Overall Study|Physician Decision|5|||
129592075|NCT02510261|466462294|FG002|Overall Study|Physician Decision|0|||
129592076|NCT02510261|466462292|FG000|Overall Study|Death|19|||
129592077|NCT02510261|466462293|FG001|Overall Study|Death|19|||
129592078|NCT02510261|466462294|FG002|Overall Study|Death|0|||
129592079|NCT02510261|466462292|FG000|Overall Study|Withdrawal by Subject|3|||
129592080|NCT02510261|466462293|FG001|Overall Study|Withdrawal by Subject|10|||
129592081|NCT02510261|466462294|FG002|Overall Study|Withdrawal by Subject|3|||
129592082|NCT01563237|466462295|FG000|Overall Study|Lost to Follow-up|6|||
129592083|NCT01563237|466462296|FG001|Overall Study|Lost to Follow-up|0|||
129592084|NCT01563237|466462295|FG000|Overall Study|Withdrawal by Subject|1|||
129592085|NCT01563237|466462296|FG001|Overall Study|Withdrawal by Subject|0|||
129592086|NCT01563237|466462295|FG000|Overall Study|Adverse Event|1|||
129592087|NCT01563237|466462296|FG001|Overall Study|Adverse Event|0|||
129592088|NCT01563237|466462295|FG000|Overall Study|Medical Reasons|1|||
129592089|NCT01563237|466462296|FG001|Overall Study|Medical Reasons|0|||
129592090|NCT01563237|466462295|FG000|Overall Study|Death|1|||
129592091|NCT01563237|466462296|FG001|Overall Study|Death|0|||
129592092|NCT01124695|466462297|FG000|Overall Study|Disease progression|77|||
129592093|NCT01124695|466462297|FG000|Overall Study|Adverse Event|11|||
129592094|NCT01124695|466462297|FG000|Overall Study|Death|1|||
129592095|NCT01124695|466462297|FG000|Overall Study|Withdrawal by Subject|7|||
129592096|NCT01124695|466462297|FG000|Overall Study|Physician Decision|3|||
129592097|NCT01124695|466462297|FG000|Overall Study|Alternative therapy|9|||
129592098|NCT01124695|466462297|FG000|Overall Study|No documentation that patient went off treatment|4|||
129592099|NCT01124695|466462297|FG000|Overall Study|Ineligible|9|||
129592100|NCT01124695|466462297|FG000|Overall Study|Ineligible and never start treatment|2|||
129592101|NCT02443324|466462301|FG000|Overall Study|Death|4|||
129592102|NCT02443324|466462302|FG001|Overall Study|Death|1|||
129592103|NCT02443324|466462303|FG002|Overall Study|Death|0|||
129592104|NCT02443324|466462304|FG003|Overall Study|Death|3|||
129592105|NCT02443324|466462305|FG004|Overall Study|Death|1|||
129592106|NCT02443324|466462306|FG005|Overall Study|Death|3|||
129592107|NCT02443324|466462307|FG006|Overall Study|Death|2|||
129592108|NCT02443324|466462301|FG000|Overall Study|Lost to Follow-up|0|||
129592109|NCT02443324|466462302|FG001|Overall Study|Lost to Follow-up|0|||
129592110|NCT02443324|466462303|FG002|Overall Study|Lost to Follow-up|0|||
129592111|NCT02443324|466462304|FG003|Overall Study|Lost to Follow-up|1|||
129592112|NCT02443324|466462305|FG004|Overall Study|Lost to Follow-up|0|||
129592113|NCT02443324|466462306|FG005|Overall Study|Lost to Follow-up|1|||
129592114|NCT02443324|466462307|FG006|Overall Study|Lost to Follow-up|0|||
129592115|NCT02443324|466462301|FG000|Overall Study|Physician Decision|0|||
129592116|NCT02443324|466462302|FG001|Overall Study|Physician Decision|3|||
129592117|NCT02443324|466462303|FG002|Overall Study|Physician Decision|5|||
129592118|NCT02443324|466462304|FG003|Overall Study|Physician Decision|1|||
129592119|NCT02443324|466462305|FG004|Overall Study|Physician Decision|1|||
129592120|NCT02443324|466462306|FG005|Overall Study|Physician Decision|0|||
129592121|NCT02443324|466462307|FG006|Overall Study|Physician Decision|2|||
129592122|NCT02443324|466462301|FG000|Overall Study|Progressive Disease|20|||
129592123|NCT02443324|466462302|FG001|Overall Study|Progressive Disease|20|||
129592124|NCT02443324|466462303|FG002|Overall Study|Progressive Disease|13|||
129592125|NCT02443324|466462304|FG003|Overall Study|Progressive Disease|10|||
129592126|NCT02443324|466462305|FG004|Overall Study|Progressive Disease|13|||
129592127|NCT02443324|466462306|FG005|Overall Study|Progressive Disease|17|||
129592128|NCT02443324|466462307|FG006|Overall Study|Progressive Disease|10|||
129592129|NCT02443324|466462301|FG000|Overall Study|Withdrawal by Subject|0|||
129592130|NCT02443324|466462302|FG001|Overall Study|Withdrawal by Subject|0|||
129592131|NCT02443324|466462303|FG002|Overall Study|Withdrawal by Subject|3|||
129592132|NCT02443324|466462304|FG003|Overall Study|Withdrawal by Subject|1|||
129592133|NCT02443324|466462305|FG004|Overall Study|Withdrawal by Subject|1|||
129592134|NCT02443324|466462306|FG005|Overall Study|Withdrawal by Subject|0|||
129592135|NCT02443324|466462307|FG006|Overall Study|Withdrawal by Subject|1|||
129592136|NCT02443324|466462301|FG000|Overall Study|Adverse Event|0|||
129592137|NCT02443324|466462302|FG001|Overall Study|Adverse Event|1|||
129592138|NCT02443324|466462303|FG002|Overall Study|Adverse Event|3|||
129592139|NCT02443324|466462304|FG003|Overall Study|Adverse Event|0|||
129592140|NCT02443324|466462305|FG004|Overall Study|Adverse Event|4|||
129592141|NCT02443324|466462306|FG005|Overall Study|Adverse Event|3|||
129592142|NCT02443324|466462307|FG006|Overall Study|Adverse Event|3|||
129592143|NCT02443324|466462301|FG000|Overall Study|Enrolled but Never Treated|0|||
129592144|NCT02443324|466462302|FG001|Overall Study|Enrolled but Never Treated|0|||
129592145|NCT02443324|466462303|FG002|Overall Study|Enrolled but Never Treated|1|||
129592146|NCT02443324|466462304|FG003|Overall Study|Enrolled but Never Treated|0|||
129592147|NCT02443324|466462305|FG004|Overall Study|Enrolled but Never Treated|1|||
129592148|NCT02443324|466462306|FG005|Overall Study|Enrolled but Never Treated|0|||
129592149|NCT02443324|466462307|FG006|Overall Study|Enrolled but Never Treated|1|||
129800248|NCT05597020|467236278|FG000|Treatment Period II|Advice from primary care physician|1|||
129592150|NCT00298740|466462308|FG000|Overall Study|Lack of Efficacy|6|||
129592151|NCT00298740|466462308|FG000|Overall Study|Withdrawal by Subject|3|||
129592152|NCT00684567|466462309|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
129592153|NCT00684567|466462309|FG000|Monotherapy Period|Adverse Event|2|||
129592154|NCT00684567|466462309|FG000|Monotherapy Period|Death|1|||
129592155|NCT00684567|466462309|FG000|Monotherapy Period|Progression of primary disease|11|||
129592156|NCT03136406|466462312|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
129592157|NCT00988208|466462318|FG000|Overall Study|Adverse Event|71|||
129592158|NCT00988208|466462319|FG001|Overall Study|Adverse Event|122|||
129592159|NCT00988208|466462318|FG000|Overall Study|Disease Progression|103|||
129592160|NCT00988208|466462319|FG001|Overall Study|Disease Progression|89|||
129592161|NCT00988208|466462318|FG000|Overall Study|Withdrawal by Subject|50|||
129592162|NCT00988208|466462319|FG001|Overall Study|Withdrawal by Subject|57|||
129592163|NCT00988208|466462318|FG000|Overall Study|Death|9|||
129592164|NCT00988208|466462319|FG001|Overall Study|Death|15|||
129592165|NCT00988208|466462318|FG000|Overall Study|Lost to Follow-up|2|||
129592166|NCT00988208|466462319|FG001|Overall Study|Lost to Follow-up|3|||
129592167|NCT00988208|466462318|FG000|Overall Study|Protocol Violation|9|||
129592168|NCT00988208|466462319|FG001|Overall Study|Protocol Violation|2|||
129592169|NCT00988208|466462318|FG000|Overall Study|Sponsor Decision|102|||
129592170|NCT00988208|466462319|FG001|Overall Study|Sponsor Decision|78|||
129592171|NCT00988208|466462318|FG000|Overall Study|Clinical Progression|17|||
129592172|NCT00988208|466462319|FG001|Overall Study|Clinical Progression|16|||
129592173|NCT00988208|466462318|FG000|Overall Study|Biochemical Progression|21|||
129592174|NCT00988208|466462319|FG001|Overall Study|Biochemical Progression|7|||
129592175|NCT00988208|466462318|FG000|Overall Study|Clinical Deterioration|7|||
129592176|NCT00988208|466462319|FG001|Overall Study|Clinical Deterioration|14|||
129592177|NCT00988208|466462318|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
129592178|NCT00988208|466462319|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
129592179|NCT00988208|466462318|FG000|Overall Study|Other|8|||
129592180|NCT00988208|466462319|FG001|Overall Study|Other|3|||
129592181|NCT01546519|466462323|FG000|Overall Study|Adverse Event|0|||
129592182|NCT01546519|466462324|FG001|Overall Study|Adverse Event|0|||
129592183|NCT01546519|466462325|FG002|Overall Study|Adverse Event|1|||
129592184|NCT01546519|466462326|FG003|Overall Study|Adverse Event|1|||
129592185|NCT01546519|466462323|FG000|Overall Study|Death|0|||
129592186|NCT01546519|466462324|FG001|Overall Study|Death|1|||
129592187|NCT01546519|466462325|FG002|Overall Study|Death|3|||
129786372|NCT00600119|467185641|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
129786373|NCT00600119|467185642|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
129592188|NCT01546519|466462326|FG003|Overall Study|Death|1|||
129592189|NCT01546519|466462323|FG000|Overall Study|related to disease progression|2|||
129592190|NCT01546519|466462324|FG001|Overall Study|related to disease progression|2|||
129592191|NCT01546519|466462325|FG002|Overall Study|related to disease progression|2|||
129592192|NCT01546519|466462326|FG003|Overall Study|related to disease progression|1|||
129592193|NCT01546519|466462323|FG000|Overall Study|Physician Decision|6|||
129592194|NCT01546519|466462324|FG001|Overall Study|Physician Decision|5|||
129592195|NCT01546519|466462325|FG002|Overall Study|Physician Decision|2|||
129592196|NCT01546519|466462326|FG003|Overall Study|Physician Decision|3|||
129592197|NCT01546519|466462323|FG000|Overall Study|Withdrawal by Subject|1|||
129592198|NCT01546519|466462324|FG001|Overall Study|Withdrawal by Subject|0|||
129592199|NCT01546519|466462325|FG002|Overall Study|Withdrawal by Subject|0|||
129592200|NCT01546519|466462326|FG003|Overall Study|Withdrawal by Subject|0|||
129592201|NCT01315028|466462327|FG000|Overall Study|Lost to Follow-up|1|||
129592202|NCT01315028|466462328|FG001|Overall Study|Lost to Follow-up|0|||
129592203|NCT01315028|466462327|FG000|Overall Study|Death|0|||
129592204|NCT01315028|466462328|FG001|Overall Study|Death|1|||
129592205|NCT00725764|466462330|FG000|Overall Study|Withdrawal by Subject|2|||
129592206|NCT00725764|466462330|FG000|Overall Study|Physician Decision|1|||
129592207|NCT00725764|466462330|FG000|Overall Study|Progressive Disease|7|||
129592208|NCT00725764|466462330|FG000|Overall Study|Lost to Follow-up|1|||
129592209|NCT00725764|466462330|FG000|Overall Study|Death|1|||
129592210|NCT00725764|466462330|FG000|Overall Study|Participant non compliant with protocol|1|||
129592211|NCT00725764|466462330|FG000|Overall Study|Decline in performance status|1|||
129592212|NCT01264835|466462332|FG000|Overall Study|Lost to Follow-up|1|||
129592213|NCT04660032|466462340|FG000|Overall Study|Protocol Violation|1|||
129592214|NCT04660032|466462341|FG001|Overall Study|Protocol Violation|1|||
129592215|NCT00090753|466462342|FG000|First Treatment Period|Adverse Event|20|||
129592216|NCT00090753|466462343|FG001|First Treatment Period|Adverse Event|8|||
129592217|NCT00090753|466462342|FG000|First Treatment Period|Death|88|||
129592218|NCT00090753|466462343|FG001|First Treatment Period|Death|62|||
129592219|NCT00090753|466462342|FG000|First Treatment Period|Lack of Efficacy|2|||
129592220|NCT00090753|466462343|FG001|First Treatment Period|Lack of Efficacy|1|||
129592221|NCT00090753|466462342|FG000|First Treatment Period|Refused Treatment|32|||
129592222|NCT00090753|466462343|FG001|First Treatment Period|Refused Treatment|25|||
129786374|NCT00600119|467185643|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
129786375|NCT00600119|467185638|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
129786376|NCT00600119|467185639|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
129786377|NCT00600119|467185640|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
129786378|NCT00600119|467185641|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
129786379|NCT00600119|467185642|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
129786380|NCT00600119|467185643|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
129786381|NCT00600119|467185638|FG000|Double-blind Treatment Period|Physician Decision|2|||
129592223|NCT00090753|466462342|FG000|First Treatment Period|Lost to Follow-up|4|||
129592224|NCT00090753|466462343|FG001|First Treatment Period|Lost to Follow-up|4|||
129592225|NCT00090753|466462342|FG000|First Treatment Period|Renal Transplant|70|||
129592226|NCT00090753|466462343|FG001|First Treatment Period|Renal Transplant|50|||
129592227|NCT00090753|466462342|FG000|First Treatment Period|Mircera Commercialization|1|||
129592228|NCT00090753|466462343|FG001|First Treatment Period|Mircera Commercialization|0|||
129592229|NCT00090753|466462342|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
129592230|NCT00090753|466462343|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
129592231|NCT00090753|466462342|FG000|Extended Treatment Period|Adverse Event|11|||
129592232|NCT00090753|466462343|FG001|Extended Treatment Period|Adverse Event|0|||
129592233|NCT00090753|466462342|FG000|Extended Treatment Period|Death|58|||
129592234|NCT00090753|466462343|FG001|Extended Treatment Period|Death|30|||
129592235|NCT00090753|466462342|FG000|Extended Treatment Period|Lack of Efficacy|1|||
129592236|NCT00090753|466462343|FG001|Extended Treatment Period|Lack of Efficacy|0|||
129592237|NCT00090753|466462342|FG000|Extended Treatment Period|Refused Treatment|18|||
129592238|NCT00090753|466462343|FG001|Extended Treatment Period|Refused Treatment|12|||
129592239|NCT00090753|466462342|FG000|Extended Treatment Period|Lost to Follow-up|3|||
129592240|NCT00090753|466462343|FG001|Extended Treatment Period|Lost to Follow-up|1|||
129592241|NCT00090753|466462342|FG000|Extended Treatment Period|Renal Transplant|15|||
129592242|NCT00090753|466462343|FG001|Extended Treatment Period|Renal Transplant|12|||
129592243|NCT00090753|466462342|FG000|Extended Treatment Period|Mircera Commercialization|188|||
129696464|NCT01475825|466848099|FG000|Overall Study|Non-compliance with Study Drug|1|||
129696465|NCT01475825|466848100|FG001|Overall Study|Non-compliance with Study Drug|2|||
129696466|NCT01475825|466848101|FG002|Overall Study|Non-compliance with Study Drug|4|||
129696467|NCT01475825|466848102|FG003|Overall Study|Non-compliance with Study Drug|0|||
129696468|NCT01475825|466848099|FG000|Overall Study|Other: Not available|0|||
129696469|NCT01475825|466848100|FG001|Overall Study|Other: Not available|0|||
129696470|NCT01475825|466848101|FG002|Overall Study|Other: Not available|2|||
129696471|NCT01475825|466848102|FG003|Overall Study|Other: Not available|0|||
129696472|NCT01475825|466848099|FG000|Overall Study|Protocol Violation|1|||
129592244|NCT00090753|466462343|FG001|Extended Treatment Period|Mircera Commercialization|93|||
129592245|NCT00090753|466462342|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
129592246|NCT00090753|466462343|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
129592247|NCT00605176|466462346|FG000|Overall Study|Adverse Event|2|||
129592248|NCT00605176|466462347|FG001|Overall Study|Adverse Event|1|||
129592249|NCT00605176|466462348|FG002|Overall Study|Adverse Event|3|||
129592250|NCT00605176|466462346|FG000|Overall Study|Withdrawal by Subject|4|||
129592251|NCT00605176|466462347|FG001|Overall Study|Withdrawal by Subject|2|||
129592252|NCT00605176|466462348|FG002|Overall Study|Withdrawal by Subject|4|||
129592253|NCT00605176|466462346|FG000|Overall Study|Lost to Follow-up|2|||
129592254|NCT00605176|466462347|FG001|Overall Study|Lost to Follow-up|2|||
129592255|NCT00605176|466462348|FG002|Overall Study|Lost to Follow-up|1|||
129592256|NCT00605176|466462346|FG000|Overall Study|Non-complicance with study procedures|1|||
129592257|NCT00605176|466462347|FG001|Overall Study|Non-complicance with study procedures|0|||
129592258|NCT00605176|466462348|FG002|Overall Study|Non-complicance with study procedures|0|||
129592259|NCT00605176|466462346|FG000|Overall Study|Use of concomitant therapy|1|||
129592260|NCT00605176|466462347|FG001|Overall Study|Use of concomitant therapy|0|||
129592261|NCT00605176|466462348|FG002|Overall Study|Use of concomitant therapy|1|||
129592262|NCT00605176|466462346|FG000|Overall Study|Other (not due to AE)|1|||
129592263|NCT00605176|466462347|FG001|Overall Study|Other (not due to AE)|1|||
129786382|NCT00600119|467185639|FG001|Double-blind Treatment Period|Physician Decision|0|||
129786383|NCT00600119|467185640|FG002|Double-blind Treatment Period|Physician Decision|0|||
129786384|NCT00600119|467185641|FG003|Double-blind Treatment Period|Physician Decision|0|||
129786385|NCT00600119|467185642|FG004|Double-blind Treatment Period|Physician Decision|0|||
129786386|NCT00600119|467185643|FG005|Double-blind Treatment Period|Physician Decision|0|||
129786387|NCT00600119|467185638|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129786388|NCT00600119|467185639|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
129786389|NCT00600119|467185640|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129786390|NCT00600119|467185641|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129786391|NCT00600119|467185642|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
129786392|NCT00600119|467185643|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
129786393|NCT00600119|467185638|FG000|Double-blind Treatment Period|Adverse Event|1|||
129786394|NCT00600119|467185639|FG001|Double-blind Treatment Period|Adverse Event|1|||
129786395|NCT00600119|467185640|FG002|Double-blind Treatment Period|Adverse Event|0|||
129786396|NCT00600119|467185641|FG003|Double-blind Treatment Period|Adverse Event|1|||
129786397|NCT00600119|467185642|FG004|Double-blind Treatment Period|Adverse Event|2|||
129786398|NCT00600119|467185643|FG005|Double-blind Treatment Period|Adverse Event|10|||
129786399|NCT00600119|467185638|FG000|Follow-up Period|Adverse Event|0|||
129786400|NCT00600119|467185639|FG001|Follow-up Period|Adverse Event|0|||
129786401|NCT00600119|467185640|FG002|Follow-up Period|Adverse Event|0|||
129786402|NCT00600119|467185641|FG003|Follow-up Period|Adverse Event|0|||
129786403|NCT00600119|467185642|FG004|Follow-up Period|Adverse Event|0|||
129786404|NCT00600119|467185643|FG005|Follow-up Period|Adverse Event|1|||
129786405|NCT00600119|467185638|FG000|Follow-up Period|Other|1|||
129786406|NCT00600119|467185639|FG001|Follow-up Period|Other|0|||
129786407|NCT00600119|467185640|FG002|Follow-up Period|Other|0|||
129786408|NCT00600119|467185641|FG003|Follow-up Period|Other|0|||
129786409|NCT00600119|467185642|FG004|Follow-up Period|Other|0|||
129786410|NCT00600119|467185643|FG005|Follow-up Period|Other|0|||
129786411|NCT03241368|467185644|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
129786412|NCT03241368|467185644|FG000|Overall Study|Lost to Follow-up|1|||
129786413|NCT03241368|467185644|FG000|Overall Study|Physician Decision|6|||
129786414|NCT03241368|467185644|FG000|Overall Study|Withdrawal by Subject|6|||
129786415|NCT03241368|467185644|FG000|Overall Study|Protocol Violation|1|||
129786416|NCT00729469|467185645|FG000|Overall Study|Adverse Event|14|||
129786417|NCT00729469|467185646|FG001|Overall Study|Adverse Event|25|||
129786418|NCT00729469|467185645|FG000|Overall Study|Lost to Follow-up|9|||
129786419|NCT00729469|467185646|FG001|Overall Study|Lost to Follow-up|9|||
129786420|NCT00729469|467185645|FG000|Overall Study|Protocol Violation|2|||
129786421|NCT00729469|467185646|FG001|Overall Study|Protocol Violation|1|||
129786422|NCT00729469|467185645|FG000|Overall Study|Withdrawal by Subject|19|||
129885590|NCT02611830|467540768|FG001|OL Induction Phase|Reason not specified|0|||
129592264|NCT00605176|466462348|FG002|Overall Study|Other (not due to AE)|0|||
129786423|NCT00729469|467185646|FG001|Overall Study|Withdrawal by Subject|8|||
129786424|NCT00729469|467185645|FG000|Overall Study|Other-Not mentioned|9|||
129786425|NCT00729469|467185646|FG001|Overall Study|Other-Not mentioned|4|||
129885591|NCT02611830|467540769|FG002|OL Induction Phase|Reason not specified|0|||
129885592|NCT02611830|467540770|FG003|OL Induction Phase|Reason not specified|0|||
129786426|NCT01270802|467185649|FG000|Overall Study|Withdrawal by Subject|1|||
129786427|NCT01270802|467185650|FG001|Overall Study|Withdrawal by Subject|0|||
129786428|NCT01270802|467185649|FG000|Overall Study|Adverse Event|1|||
129592265|NCT01466036|466462353|FG000|Overall Study|Death|1|||
129592266|NCT01466036|466462354|FG001|Overall Study|Death|1|||
129592267|NCT01466036|466462353|FG000|Overall Study|Physician Decision|0|||
129592268|NCT01466036|466462354|FG001|Overall Study|Physician Decision|4|||
129786429|NCT01270802|467185650|FG001|Overall Study|Adverse Event|0|||
129786430|NCT01270802|467185649|FG000|Overall Study|Lost to Follow-up|0|||
129592269|NCT01466036|466462353|FG000|Overall Study|Adverse Event|2|||
129592270|NCT01466036|466462354|FG001|Overall Study|Adverse Event|6|||
129592271|NCT01466036|466462353|FG000|Overall Study|Withdrawal by Subject|2|||
129592272|NCT01466036|466462354|FG001|Overall Study|Withdrawal by Subject|8|||
129592273|NCT01466036|466462353|FG000|Overall Study|progression/relapse|14|||
129592274|NCT01466036|466462354|FG001|Overall Study|progression/relapse|21|||
129592275|NCT01466036|466462353|FG000|Overall Study|prolonged treatment delay|1|||
129592276|NCT01466036|466462354|FG001|Overall Study|prolonged treatment delay|1|||
129592277|NCT00436917|466462361|FG000|Overall Study|Withdrawal by Subject|13|||
129592278|NCT00436917|466462361|FG000|Overall Study|Adverse Event|2|||
129592279|NCT00436917|466462361|FG000|Overall Study|Physician Decision|1|||
129592280|NCT00436917|466462361|FG000|Overall Study|Death|1|||
129592281|NCT00436917|466462361|FG000|Overall Study|Lost to Follow-up|1|||
129592282|NCT00436917|466462361|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
129592283|NCT00436917|466462361|FG000|Overall Study|Increased creatinine|1|||
129592284|NCT00436917|466462361|FG000|Overall Study|Personal conflicts of patient|1|||
129592285|NCT05103657|466462368|FG000|Overall Study|Other reasons than listed|9|||
129592286|NCT05103657|466462369|FG001|Overall Study|Other reasons than listed|8|||
129592287|NCT05103657|466462368|FG000|Overall Study|Protocol deviation|2|||
129592288|NCT05103657|466462369|FG001|Overall Study|Protocol deviation|2|||
129592289|NCT05103657|466462368|FG000|Overall Study|No reason available|5|||
129592290|NCT05103657|466462369|FG001|Overall Study|No reason available|4|||
129592291|NCT05103657|466462368|FG000|Overall Study|Burden of study procedures|3|||
129592292|NCT05103657|466462369|FG001|Overall Study|Burden of study procedures|1|||
129592293|NCT05103657|466462368|FG000|Overall Study|Perceived lack of efficacy|1|||
129592294|NCT05103657|466462369|FG001|Overall Study|Perceived lack of efficacy|1|||
129592295|NCT05103657|466462368|FG000|Overall Study|Adverse Event|6|||
129592296|NCT05103657|466462369|FG001|Overall Study|Adverse Event|14|||
129592297|NCT05103657|466462368|FG000|Overall Study|Not Treated|1|||
129592298|NCT05103657|466462369|FG001|Overall Study|Not Treated|1|||
129592299|NCT03635983|466462373|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
129592300|NCT03635983|466462374|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
129592301|NCT03635983|466462373|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129592302|NCT03635983|466462374|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129592303|NCT03635983|466462373|FG000|Pre-Treatment Period|Other reasons|0|||
129592304|NCT03635983|466462374|FG001|Pre-Treatment Period|Other reasons|1|||
129592305|NCT03635983|466462373|FG000|Pre-Treatment Period|Disease Progression|0|||
129592306|NCT03635983|466462374|FG001|Pre-Treatment Period|Disease Progression|1|||
129592307|NCT03635983|466462373|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
129592308|NCT03635983|466462374|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
129592309|NCT03635983|466462373|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
129592310|NCT03635983|466462374|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
129592311|NCT03635983|466462373|FG000|Treatment Period|Withdrawal by Subject|3|||
129592312|NCT03635983|466462374|FG001|Treatment Period|Withdrawal by Subject|5|||
129592313|NCT03635983|466462373|FG000|Treatment Period|Death|3|||
129592314|NCT03635983|466462374|FG001|Treatment Period|Death|5|||
129592315|NCT03635983|466462373|FG000|Treatment Period|Poor/Non-compliance|2|||
129592316|NCT03635983|466462374|FG001|Treatment Period|Poor/Non-compliance|1|||
129592317|NCT03635983|466462373|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
129592318|NCT03635983|466462374|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
129592319|NCT03635983|466462373|FG000|Treatment Period|Other reasons|7|||
129592320|NCT03635983|466462374|FG001|Treatment Period|Other reasons|4|||
129592321|NCT03635983|466462373|FG000|Treatment Period|Disease progression|230|||
129592322|NCT03635983|466462374|FG001|Treatment Period|Disease progression|201|||
129592323|NCT03635983|466462373|FG000|Treatment Period|Study drug toxicity|35|||
129592324|NCT03635983|466462374|FG001|Treatment Period|Study drug toxicity|36|||
129592325|NCT03635983|466462373|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
129592326|NCT03635983|466462374|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
129592327|NCT03635983|466462373|FG000|Treatment Period|Maximum clinical benefit|3|||
129592328|NCT03635983|466462374|FG001|Treatment Period|Maximum clinical benefit|5|||
129592329|NCT03635983|466462373|FG000|Treatment Period|Administrative reason by the sponsor|1|||
129592330|NCT03635983|466462374|FG001|Treatment Period|Administrative reason by the sponsor|2|||
129592331|NCT03635983|466462373|FG000|Treatment Period|Lost to Follow-up|0|||
129592332|NCT03635983|466462374|FG001|Treatment Period|Lost to Follow-up|1|||
129592333|NCT03430011|466462375|FG000|Pre-Treatment|Death|1|||
129592334|NCT03430011|466462376|FG001|Pre-Treatment|Death|0|||
129592335|NCT03430011|466462377|FG002|Pre-Treatment|Death|0|||
129592336|NCT03430011|466462378|FG003|Pre-Treatment|Death|0|||
129592337|NCT03430011|466462379|FG004|Pre-Treatment|Death|1|||
129592338|NCT03430011|466462380|FG005|Pre-Treatment|Death|0|||
129592339|NCT03430011|466462381|FG006|Pre-Treatment|Death|1|||
129592340|NCT03430011|466462382|FG007|Pre-Treatment|Death|0|||
129592341|NCT03430011|466462375|FG000|Pre-Treatment|Screen Fail|0|||
129592342|NCT03430011|466462376|FG001|Pre-Treatment|Screen Fail|0|||
129592343|NCT03430011|466462377|FG002|Pre-Treatment|Screen Fail|0|||
129592344|NCT03430011|466462378|FG003|Pre-Treatment|Screen Fail|0|||
129592345|NCT03430011|466462379|FG004|Pre-Treatment|Screen Fail|1|||
129592346|NCT03430011|466462380|FG005|Pre-Treatment|Screen Fail|0|||
129592347|NCT03430011|466462381|FG006|Pre-Treatment|Screen Fail|0|||
129592348|NCT03430011|466462382|FG007|Pre-Treatment|Screen Fail|0|||
129592349|NCT03430011|466462375|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592350|NCT03430011|466462376|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592351|NCT03430011|466462377|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
129592352|NCT03430011|466462378|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592353|NCT03430011|466462379|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592354|NCT03430011|466462380|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592355|NCT03430011|466462381|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592356|NCT03430011|466462382|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
129592357|NCT03430011|466462375|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
129592358|NCT03430011|466462376|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
129592359|NCT03430011|466462377|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
129592360|NCT03430011|466462378|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
129592361|NCT03430011|466462379|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
129592362|NCT03430011|466462380|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
129592363|NCT03430011|466462381|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
129592364|NCT03430011|466462382|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
129592365|NCT03430011|466462375|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
129592366|NCT03430011|466462376|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
129592367|NCT03430011|466462377|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
129592368|NCT03430011|466462378|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
129592369|NCT03430011|466462379|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
129592370|NCT03430011|466462380|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
129592371|NCT03430011|466462381|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
129592372|NCT03430011|466462382|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
129592373|NCT03430011|466462375|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
129592374|NCT03430011|466462376|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
129592375|NCT03430011|466462377|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
129592376|NCT03430011|466462378|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
129592377|NCT03430011|466462379|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
129592378|NCT03430011|466462380|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
129592379|NCT03430011|466462381|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
129592380|NCT03430011|466462382|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
129592381|NCT03430011|466462375|FG000|JCARH125 Treatment|Death|4|||
129592382|NCT03430011|466462376|FG001|JCARH125 Treatment|Death|19|||
129592383|NCT03430011|466462377|FG002|JCARH125 Treatment|Death|10|||
129592384|NCT03430011|466462378|FG003|JCARH125 Treatment|Death|8|||
129592385|NCT03430011|466462379|FG004|JCARH125 Treatment|Death|5|||
129592386|NCT03430011|466462380|FG005|JCARH125 Treatment|Death|3|||
129592387|NCT03430011|466462381|FG006|JCARH125 Treatment|Death|4|||
129592388|NCT03430011|466462382|FG007|JCARH125 Treatment|Death|2|||
129592389|NCT03430011|466462375|FG000|JCARH125 Treatment|Other reasons|1|||
129592390|NCT03430011|466462376|FG001|JCARH125 Treatment|Other reasons|0|||
129592391|NCT03430011|466462377|FG002|JCARH125 Treatment|Other reasons|4|||
129592392|NCT03430011|466462378|FG003|JCARH125 Treatment|Other reasons|2|||
129592393|NCT03430011|466462379|FG004|JCARH125 Treatment|Other reasons|2|||
129592394|NCT03430011|466462380|FG005|JCARH125 Treatment|Other reasons|1|||
129592395|NCT03430011|466462381|FG006|JCARH125 Treatment|Other reasons|3|||
129592396|NCT03430011|466462382|FG007|JCARH125 Treatment|Other reasons|2|||
129592397|NCT04126343|466462384|FG000|Overall Study|Adverse Event|0|||
129592398|NCT04126343|466462385|FG001|Overall Study|Adverse Event|0|||
129592399|NCT04126343|466462386|FG002|Overall Study|Adverse Event|0|||
129592400|NCT04126343|466462387|FG003|Overall Study|Adverse Event|0|||
129592401|NCT04126343|466462388|FG004|Overall Study|Adverse Event|0|||
129592402|NCT04126343|466462389|FG005|Overall Study|Adverse Event|1|||
129592403|NCT04126343|466462384|FG000|Overall Study|Withdrawal by Subject|0|||
129592404|NCT04126343|466462385|FG001|Overall Study|Withdrawal by Subject|0|||
129592405|NCT04126343|466462386|FG002|Overall Study|Withdrawal by Subject|0|||
129592406|NCT04126343|466462387|FG003|Overall Study|Withdrawal by Subject|1|||
129592407|NCT04126343|466462388|FG004|Overall Study|Withdrawal by Subject|0|||
129592408|NCT04126343|466462389|FG005|Overall Study|Withdrawal by Subject|0|||
129592409|NCT04126343|466462384|FG000|Overall Study|Related to COVID-19 pandemic|3|||
129592410|NCT04126343|466462385|FG001|Overall Study|Related to COVID-19 pandemic|4|||
129592411|NCT04126343|466462386|FG002|Overall Study|Related to COVID-19 pandemic|3|||
129592412|NCT04126343|466462387|FG003|Overall Study|Related to COVID-19 pandemic|3|||
129592413|NCT04126343|466462388|FG004|Overall Study|Related to COVID-19 pandemic|3|||
129592414|NCT04126343|466462389|FG005|Overall Study|Related to COVID-19 pandemic|3|||
129592415|NCT00084799|466462390|FG000|Overall Study|Disease Progression|1|||
129592416|NCT00084799|466462391|FG001|Overall Study|Disease Progression|0|||
129592417|NCT01235442|466462392|FG000|Overall Study|Lost to Follow-up|12|||
129592418|NCT01235442|466462393|FG001|Overall Study|Lost to Follow-up|10|||
129592419|NCT01235442|466462392|FG000|Overall Study|Death|0|||
129592420|NCT01235442|466462393|FG001|Overall Study|Death|2|||
129592421|NCT01235442|466462392|FG000|Overall Study|Pregnancy|1|||
129592422|NCT01235442|466462393|FG001|Overall Study|Pregnancy|1|||
129592423|NCT01235442|466462392|FG000|Overall Study|Ineligibility determined|5|||
129592424|NCT01235442|466462393|FG001|Overall Study|Ineligibility determined|4|||
129592425|NCT01235442|466462392|FG000|Overall Study|Protocol Violation|3|||
129592426|NCT01235442|466462393|FG001|Overall Study|Protocol Violation|3|||
129592427|NCT01235442|466462392|FG000|Overall Study|Adverse Event|4|||
129592428|NCT01235442|466462393|FG001|Overall Study|Adverse Event|6|||
129592429|NCT01235442|466462392|FG000|Overall Study|Withdrawal by Subject|15|||
129592430|NCT01235442|466462393|FG001|Overall Study|Withdrawal by Subject|9|||
129592431|NCT01235442|466462392|FG000|Overall Study|Lack of Efficacy|1|||
129592432|NCT01235442|466462393|FG001|Overall Study|Lack of Efficacy|3|||
129592433|NCT01235442|466462392|FG000|Overall Study|Noncompliance|1|||
129592434|NCT01235442|466462393|FG001|Overall Study|Noncompliance|2|||
129592435|NCT01235442|466462392|FG000|Overall Study|Administrative decision|1|||
129592436|NCT01235442|466462393|FG001|Overall Study|Administrative decision|2|||
129592437|NCT01235442|466462392|FG000|Overall Study|Other unspecified|1|||
129592438|NCT01235442|466462393|FG001|Overall Study|Other unspecified|2|||
129592439|NCT03712124|466462396|FG000|Overall Study|Protocol Violation|1|||
129592440|NCT03712124|466462397|FG001|Overall Study|Protocol Violation|0|||
129786431|NCT01270802|467185650|FG001|Overall Study|Lost to Follow-up|1|||
129786432|NCT01566214|467185651|FG000|Overall Study|Lost to Follow-up|3|||
129592441|NCT02412722|466462399|FG000|Overall Study|Adverse Event|0|||
129592442|NCT02412722|466462400|FG001|Overall Study|Adverse Event|2|||
129592443|NCT02412722|466462401|FG002|Overall Study|Adverse Event|0|||
129592444|NCT02412722|466462402|FG003|Overall Study|Adverse Event|3|||
129592445|NCT02412722|466462403|FG004|Overall Study|Adverse Event|0|||
129592446|NCT02412722|466462404|FG005|Overall Study|Adverse Event|3|||
129592447|NCT02412722|466462399|FG000|Overall Study|Progressive Disease|6|||
129592448|NCT02412722|466462400|FG001|Overall Study|Progressive Disease|4|||
129592449|NCT02412722|466462401|FG002|Overall Study|Progressive Disease|4|||
129592450|NCT02412722|466462402|FG003|Overall Study|Progressive Disease|9|||
129592451|NCT02412722|466462403|FG004|Overall Study|Progressive Disease|3|||
129592452|NCT02412722|466462404|FG005|Overall Study|Progressive Disease|3|||
129592453|NCT02412722|466462399|FG000|Overall Study|Withdrawal by Subject|2|||
129592454|NCT02412722|466462400|FG001|Overall Study|Withdrawal by Subject|0|||
129592455|NCT02412722|466462401|FG002|Overall Study|Withdrawal by Subject|1|||
129592456|NCT02412722|466462402|FG003|Overall Study|Withdrawal by Subject|2|||
129592457|NCT02412722|466462403|FG004|Overall Study|Withdrawal by Subject|1|||
129592458|NCT02412722|466462404|FG005|Overall Study|Withdrawal by Subject|1|||
129592459|NCT02412722|466462399|FG000|Overall Study|Lost to Follow-up|0|||
129592460|NCT02412722|466462400|FG001|Overall Study|Lost to Follow-up|0|||
129592461|NCT02412722|466462401|FG002|Overall Study|Lost to Follow-up|0|||
129592462|NCT02412722|466462402|FG003|Overall Study|Lost to Follow-up|0|||
129592463|NCT02412722|466462403|FG004|Overall Study|Lost to Follow-up|1|||
129592464|NCT02412722|466462404|FG005|Overall Study|Lost to Follow-up|0|||
129592465|NCT02412722|466462399|FG000|Overall Study|Received drug in run-in and discontinued|0|||
129592466|NCT02412722|466462400|FG001|Overall Study|Received drug in run-in and discontinued|2|||
129592467|NCT02412722|466462401|FG002|Overall Study|Received drug in run-in and discontinued|0|||
129592468|NCT02412722|466462402|FG003|Overall Study|Received drug in run-in and discontinued|0|||
129592469|NCT02412722|466462403|FG004|Overall Study|Received drug in run-in and discontinued|0|||
129592470|NCT02412722|466462404|FG005|Overall Study|Received drug in run-in and discontinued|0|||
129592471|NCT02412722|466462399|FG000|Overall Study|Reason not Specified|3|||
129592472|NCT02412722|466462400|FG001|Overall Study|Reason not Specified|0|||
129592473|NCT02412722|466462401|FG002|Overall Study|Reason not Specified|2|||
129592474|NCT02412722|466462402|FG003|Overall Study|Reason not Specified|1|||
129592475|NCT02412722|466462403|FG004|Overall Study|Reason not Specified|2|||
129592476|NCT02412722|466462404|FG005|Overall Study|Reason not Specified|6|||
129592477|NCT02941523|466462405|FG000|Monotherapy|Withdrawal by Subject|0|||
129592478|NCT02941523|466462406|FG001|Monotherapy|Withdrawal by Subject|1|||
129592479|NCT02941523|466462405|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
129592480|NCT02941523|466462406|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
129592481|NCT02941523|466462405|FG000|Carboplatin Combination Therapy|Death|1|||
129592482|NCT02941523|466462406|FG001|Carboplatin Combination Therapy|Death|2|||
129592483|NCT02941523|466462405|FG000|Carboplatin Combination Therapy|Disease progression|2|||
129592484|NCT02941523|466462406|FG001|Carboplatin Combination Therapy|Disease progression|0|||
129592485|NCT02941523|466462405|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
129592486|NCT02941523|466462406|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
129592487|NCT04449341|466462407|FG000|Overall Study|Protocol Violation|1|||
129592488|NCT04449341|466462408|FG001|Overall Study|Protocol Violation|0|||
129592489|NCT04499482|466462409|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
129592490|NCT01083680|466462410|FG000|Overall Study|Lost to Follow-up|2758|||
129592491|NCT01083680|466462410|FG000|Overall Study|Withdrawal by Subject|1086|||
129592492|NCT02219308|466462411|FG000|Overall Study|Withdrawal by Subject|1|||
129592493|NCT02219308|466462412|FG001|Overall Study|Withdrawal by Subject|2|||
129592494|NCT00991510|466463445|FG000|Period I (Days 1-14)|Adverse Event|1|||
129592495|NCT00991510|466463446|FG001|Period I (Days 1-14)|Adverse Event|0|||
129592496|NCT00991510|466463445|FG000|Period III (Days 29-112)|Adverse Event|1|||
129592497|NCT00991510|466463446|FG001|Period III (Days 29-112)|Adverse Event|1|||
129592498|NCT01976728|466463447|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
129592499|NCT01976728|466463448|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
129592500|NCT01976728|466463449|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
129592501|NCT01976728|466463450|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
129592502|NCT02356211|466463451|FG000|Overall Study|Withdrawal by Subject|2|||
129592503|NCT02356211|466463452|FG001|Overall Study|Withdrawal by Subject|2|||
129592504|NCT02356211|466463451|FG000|Overall Study|ineligible|1|||
129592505|NCT02356211|466463452|FG001|Overall Study|ineligible|8|||
129592506|NCT00966381|466463456|FG000|Overall Study|Withdrawal by Subject|2|||
129592507|NCT00966381|466463457|FG001|Overall Study|Withdrawal by Subject|2|||
129592508|NCT00097786|466463461|FG000|Overall Study|lost to follow-up for all-cause death|296|||
129592509|NCT00097786|466463462|FG001|Overall Study|lost to follow-up for all-cause death|292|||
129592510|NCT00097786|466463463|FG002|Overall Study|lost to follow-up for all-cause death|313|||
129592511|NCT00097786|466463464|FG003|Overall Study|lost to follow-up for all-cause death|310|||
129592512|NCT02668822|466463465|FG000|Overall Study|Protocol Violation|2|||
129885593|NCT02611830|467540767|FG000|Maintenance Phase|Lack of Efficacy|0|||
129592513|NCT02668822|466463466|FG001|Overall Study|Protocol Violation|0|||
129592514|NCT02668822|466463465|FG000|Overall Study|Study Terminated by Sponsor|7|||
129592515|NCT02668822|466463466|FG001|Overall Study|Study Terminated by Sponsor|9|||
129592516|NCT01522950|466463467|FG000|Overall Study|Withdrawal by Subject|3|||
129592517|NCT01522950|466463468|FG001|Overall Study|Withdrawal by Subject|2|||
129592518|NCT01522950|466463469|FG002|Overall Study|Withdrawal by Subject|1|||
129885594|NCT02611830|467540768|FG001|Maintenance Phase|Lack of Efficacy|29|||
129592519|NCT01522950|466463467|FG000|Overall Study|Adverse Event|3|||
129592520|NCT01522950|466463468|FG001|Overall Study|Adverse Event|1|||
129592521|NCT01522950|466463469|FG002|Overall Study|Adverse Event|1|||
129592522|NCT01522950|466463467|FG000|Overall Study|Protocol Violation|0|||
129592523|NCT01522950|466463468|FG001|Overall Study|Protocol Violation|0|||
129592524|NCT01522950|466463469|FG002|Overall Study|Protocol Violation|2|||
129592525|NCT01522950|466463467|FG000|Overall Study|Death|0|||
129592526|NCT01522950|466463468|FG001|Overall Study|Death|1|||
129592527|NCT01522950|466463469|FG002|Overall Study|Death|1|||
129592528|NCT01522950|466463467|FG000|Overall Study|Study Medication Sensitivity|0|||
129592529|NCT01522950|466463468|FG001|Overall Study|Study Medication Sensitivity|1|||
129592530|NCT01522950|466463469|FG002|Overall Study|Study Medication Sensitivity|0|||
129592531|NCT01844531|466463470|FG000|Overall Study|Withdrawal by Subject|0|||
129592532|NCT01844531|466463471|FG001|Overall Study|Withdrawal by Subject|1|||
129592533|NCT01844531|466463472|FG002|Overall Study|Withdrawal by Subject|0|||
129592534|NCT01844531|466463473|FG003|Overall Study|Withdrawal by Subject|0|||
129592535|NCT02000531|466463475|FG000|Overall Study|Lost to Follow-up|1|||
129592536|NCT02000531|466463476|FG001|Overall Study|Lost to Follow-up|0|||
129592537|NCT02000531|466463475|FG000|Overall Study|Discontinued due to data cut-off|3|||
129592538|NCT02000531|466463476|FG001|Overall Study|Discontinued due to data cut-off|8|||
129592539|NCT01345318|466463479|FG000|Overall Study|Adverse Event|16|||
129592540|NCT01345318|466463479|FG000|Overall Study|Lack of Efficacy|17|||
129592541|NCT01345318|466463479|FG000|Overall Study|Lost to Follow-up|2|||
129592542|NCT01345318|466463479|FG000|Overall Study|Protocol Violation|1|||
129592543|NCT01345318|466463479|FG000|Overall Study|Withdrawal by Subject|41|||
129592544|NCT01345318|466463479|FG000|Overall Study|Other|3|||
129592545|NCT00317642|466463480|FG000|Overall Study|Not Received Either Study Drug|1|||
129592546|NCT00317642|466463481|FG001|Overall Study|Not Received Either Study Drug|3|||
129592547|NCT00317642|466463480|FG000|Overall Study|Physician Decision|15|||
129592548|NCT00317642|466463481|FG001|Overall Study|Physician Decision|7|||
129592549|NCT00317642|466463480|FG000|Overall Study|Participant declined treatment|14|||
129592550|NCT00317642|466463481|FG001|Overall Study|Participant declined treatment|3|||
129592551|NCT00317642|466463480|FG000|Overall Study|Adverse Event|17|||
129592552|NCT00317642|466463481|FG001|Overall Study|Adverse Event|5|||
129592553|NCT00317642|466463480|FG000|Overall Study|Treatment Failure|56|||
129592554|NCT00317642|466463481|FG001|Overall Study|Treatment Failure|102|||
129592555|NCT00317642|466463480|FG000|Overall Study|Disease Recurrence|1|||
129592556|NCT00317642|466463481|FG001|Overall Study|Disease Recurrence|2|||
129592557|NCT00317642|466463480|FG000|Overall Study|Death|14|||
129592558|NCT00317642|466463481|FG001|Overall Study|Death|7|||
129592559|NCT00317642|466463480|FG000|Overall Study|Not Continue to Consolidation|2|||
129592560|NCT00317642|466463481|FG001|Overall Study|Not Continue to Consolidation|0|||
129592561|NCT00317642|466463480|FG000|Overall Study|Withdrawal by Subject|0|||
129592562|NCT00317642|466463481|FG001|Overall Study|Withdrawal by Subject|1|||
129592563|NCT00317642|466463480|FG000|Overall Study|Referred For Transplantation|1|||
129592564|NCT00317642|466463481|FG001|Overall Study|Referred For Transplantation|0|||
129592565|NCT00317642|466463480|FG000|Overall Study|AML Not Centrally Confirmed|1|||
129592566|NCT00317642|466463481|FG001|Overall Study|AML Not Centrally Confirmed|5|||
129592567|NCT01239472|466463486|FG000|Overall Study|Withdrawal by Subject|5|||
129592568|NCT01239472|466463487|FG001|Overall Study|Withdrawal by Subject|1|||
129592569|NCT01239472|466463486|FG000|Overall Study|Adverse Event|0|||
129592570|NCT01239472|466463487|FG001|Overall Study|Adverse Event|1|||
129592571|NCT01239472|466463486|FG000|Overall Study|Lack of Efficacy|0|||
129592572|NCT01239472|466463487|FG001|Overall Study|Lack of Efficacy|1|||
129592573|NCT01049412|466463491|FG000|Period I|Withdrawal by Subject|4|||
129592574|NCT01049412|466463492|FG001|Period I|Withdrawal by Subject|6|||
129592575|NCT01049412|466463491|FG000|Period I|Lost to Follow-up|2|||
129592576|NCT01049412|466463492|FG001|Period I|Lost to Follow-up|2|||
129592577|NCT01049412|466463491|FG000|Period I|Physician Decision|0|||
129592578|NCT01049412|466463492|FG001|Period I|Physician Decision|3|||
129592579|NCT01049412|466463491|FG000|Period I|Protocol Violation|1|||
129592580|NCT01049412|466463492|FG001|Period I|Protocol Violation|2|||
129592581|NCT01049412|466463491|FG000|Period I|Adverse Event|1|||
129592582|NCT01049412|466463492|FG001|Period I|Adverse Event|0|||
129592583|NCT01049412|466463491|FG000|Period II|Withdrawal by Subject|2|||
129592584|NCT01049412|466463492|FG001|Period II|Withdrawal by Subject|3|||
129592585|NCT01049412|466463491|FG000|Period II|Adverse Event|1|||
129592586|NCT01049412|466463492|FG001|Period II|Adverse Event|0|||
129592587|NCT01049412|466463491|FG000|Period II|Lost to Follow-up|1|||
129592588|NCT01049412|466463492|FG001|Period II|Lost to Follow-up|0|||
129592589|NCT01280617|466463493|FG000|Overall Study|Adverse Event|0|||
129592590|NCT01280617|466463494|FG001|Overall Study|Adverse Event|1|||
129592591|NCT05966090|466463495|FG000|Overall Study|Lost to Follow-up|6|||
129592592|NCT05966090|466463496|FG001|Overall Study|Lost to Follow-up|6|||
129592593|NCT05966090|466463495|FG000|Overall Study|Adverse Event|1|||
129592594|NCT05966090|466463496|FG001|Overall Study|Adverse Event|1|||
129592595|NCT05966090|466463495|FG000|Overall Study|Withdrawal by Subject|1|||
129592596|NCT05966090|466463496|FG001|Overall Study|Withdrawal by Subject|1|||
129696473|NCT01475825|466848100|FG001|Overall Study|Protocol Violation|0|||
129592597|NCT05966090|466463495|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129592598|NCT05966090|466463496|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129592599|NCT05966090|466463495|FG000|Overall Study|Other|1|||
129592600|NCT05966090|466463496|FG001|Overall Study|Other|1|||
129592601|NCT03756883|466463497|FG000|Overall Study|Adverse Event|2|||
129592602|NCT03756883|466463498|FG001|Overall Study|Adverse Event|2|||
129592603|NCT03756883|466463499|FG002|Overall Study|Adverse Event|2|||
129592604|NCT03756883|466463497|FG000|Overall Study|Lack of Efficacy|0|||
129592605|NCT03756883|466463498|FG001|Overall Study|Lack of Efficacy|1|||
129592606|NCT03756883|466463499|FG002|Overall Study|Lack of Efficacy|2|||
129592607|NCT03756883|466463497|FG000|Overall Study|Lost to Follow-up|3|||
129592608|NCT03756883|466463498|FG001|Overall Study|Lost to Follow-up|3|||
129592609|NCT03756883|466463499|FG002|Overall Study|Lost to Follow-up|0|||
129592610|NCT03756883|466463497|FG000|Overall Study|Protocol Violation|2|||
129592611|NCT03756883|466463498|FG001|Overall Study|Protocol Violation|0|||
129592612|NCT03756883|466463499|FG002|Overall Study|Protocol Violation|1|||
129592613|NCT03756883|466463497|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
129592614|NCT03756883|466463498|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
129592615|NCT03756883|466463499|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
129592616|NCT03756883|466463497|FG000|Overall Study|Withdrawal by Subject|4|||
129592617|NCT03756883|466463498|FG001|Overall Study|Withdrawal by Subject|1|||
129592618|NCT03756883|466463499|FG002|Overall Study|Withdrawal by Subject|0|||
129592619|NCT03756883|466463497|FG000|Overall Study|Other Reasons|2|||
129592620|NCT03756883|466463498|FG001|Overall Study|Other Reasons|4|||
129592621|NCT03756883|466463499|FG002|Overall Study|Other Reasons|0|||
129592622|NCT00337428|466463500|FG000|Overall Study|Withdrawal by Subject|1|||
129592623|NCT00337428|466463501|FG001|Overall Study|Withdrawal by Subject|2|||
129592624|NCT00337428|466463500|FG000|Overall Study|Lack of Time|1|||
129592625|NCT00337428|466463501|FG001|Overall Study|Lack of Time|1|||
129592626|NCT00337428|466463500|FG000|Overall Study|Unwilling to Continue|1|||
129592627|NCT00337428|466463501|FG001|Overall Study|Unwilling to Continue|0|||
129592628|NCT00337428|466463500|FG000|Overall Study|Anorexia|1|||
129592629|NCT00337428|466463501|FG001|Overall Study|Anorexia|0|||
129592630|NCT00529217|466463508|FG000|Overall Study|Lack of Efficacy|2|||
129592631|NCT00529217|466463508|FG000|Overall Study|Unable to adhere to study schedule|2|||
129592632|NCT01999894|466463509|FG000|Overall Study|Adverse Event|9|||
129592633|NCT01999894|466463509|FG000|Overall Study|Lack of Efficacy|5|||
129592634|NCT01999894|466463509|FG000|Overall Study|Protocol Violation|1|||
129592635|NCT01999894|466463509|FG000|Overall Study|Withdrawal by Subject|7|||
129592636|NCT01999894|466463509|FG000|Overall Study|Lost to Follow-up|10|||
129592637|NCT01999894|466463509|FG000|Overall Study|Other Reason|3|||
129592638|NCT01999894|466463509|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
129592639|NCT01098110|466463510|FG000|Overall Study|Withdrawal by Subject|14|||
129592640|NCT01098110|466463511|FG001|Overall Study|Withdrawal by Subject|24|||
129592641|NCT01098110|466463512|FG002|Overall Study|Withdrawal by Subject|19|||
129592642|NCT01098110|466463510|FG000|Overall Study|Adverse Event|30|||
129592643|NCT01098110|466463511|FG001|Overall Study|Adverse Event|32|||
129592644|NCT01098110|466463512|FG002|Overall Study|Adverse Event|43|||
129592645|NCT01098110|466463510|FG000|Overall Study|Lack of Efficacy|13|||
129592646|NCT01098110|466463511|FG001|Overall Study|Lack of Efficacy|9|||
129592647|NCT01098110|466463512|FG002|Overall Study|Lack of Efficacy|27|||
129592648|NCT01098110|466463510|FG000|Overall Study|Other|4|||
129592649|NCT01098110|466463511|FG001|Overall Study|Other|7|||
129592650|NCT01098110|466463512|FG002|Overall Study|Other|5|||
129592651|NCT01098110|466463510|FG000|Overall Study|Untreated|1|||
129592652|NCT01098110|466463511|FG001|Overall Study|Untreated|1|||
129592653|NCT01098110|466463512|FG002|Overall Study|Untreated|0|||
129592654|NCT00263887|466463515|FG000|Overall Study|Withdrawal by Subject|1|||
129592655|NCT00263887|466463516|FG001|Overall Study|Withdrawal by Subject|1|||
129592656|NCT00263887|466463515|FG000|Overall Study|Lung transplantation|1|||
129592657|NCT00263887|466463516|FG001|Overall Study|Lung transplantation|2|||
129592658|NCT00263887|466463515|FG000|Overall Study|Too ill to attend visit|1|||
129592659|NCT00263887|466463516|FG001|Overall Study|Too ill to attend visit|0|||
129592660|NCT00263887|466463515|FG000|Overall Study|Adverse Event|0|||
129592661|NCT00263887|466463516|FG001|Overall Study|Adverse Event|2|||
129592662|NCT00263887|466463515|FG000|Overall Study|Disease progression|0|||
129592663|NCT00263887|466463516|FG001|Overall Study|Disease progression|1|||
129592664|NCT00263887|466463515|FG000|Overall Study|Lack of Efficacy|0|||
129592665|NCT00263887|466463516|FG001|Overall Study|Lack of Efficacy|1|||
129592666|NCT00779402|466463517|FG000|Treatment Phase 1|Disease Progression|1|||
129592667|NCT00779402|466463518|FG001|Treatment Phase 1|Disease Progression|0|||
129592668|NCT00779402|466463517|FG000|Treatment Phase 1|Adverse Event|2|||
129592669|NCT00779402|466463518|FG001|Treatment Phase 1|Adverse Event|0|||
129592670|NCT00779402|466463517|FG000|Treatment Phase 1|Protocol Violation|1|||
129592671|NCT00779402|466463518|FG001|Treatment Phase 1|Protocol Violation|0|||
129592672|NCT00779402|466463517|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
129592673|NCT00779402|466463518|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
129592674|NCT00779402|466463517|FG000|Treatment Phase 1|Lost to Follow-up|0|||
129592675|NCT00779402|466463518|FG001|Treatment Phase 1|Lost to Follow-up|1|||
129592676|NCT00779402|466463517|FG000|Treatment Phase 1|Death|0|||
129592677|NCT00779402|466463518|FG001|Treatment Phase 1|Death|1|||
129592678|NCT00779402|466463517|FG000|Treatment Phase 1|Intercurrent Illness|1|||
129592679|NCT00779402|466463518|FG001|Treatment Phase 1|Intercurrent Illness|1|||
129592680|NCT00779402|466463517|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
129592681|NCT00779402|466463518|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
129592682|NCT00779402|466463517|FG000|Treatment Phase 1|Other|4|||
129592683|NCT00779402|466463518|FG001|Treatment Phase 1|Other|2|||
129592684|NCT00779402|466463517|FG000|Treatment Phase 1|Closure of Study|3|||
129592685|NCT00779402|466463518|FG001|Treatment Phase 1|Closure of Study|2|||
129592686|NCT00779402|466463517|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
129592687|NCT00779402|466463518|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
129592688|NCT00779402|466463517|FG000|Surveillance Phase|Protocol Violation|0|||
129592689|NCT00779402|466463518|FG001|Surveillance Phase|Protocol Violation|1|||
129592690|NCT00779402|466463517|FG000|Surveillance Phase|Patient refused to continue|22|||
129592691|NCT00779402|466463518|FG001|Surveillance Phase|Patient refused to continue|14|||
129592692|NCT00779402|466463517|FG000|Surveillance Phase|Lost to Follow-up|2|||
129592693|NCT00779402|466463518|FG001|Surveillance Phase|Lost to Follow-up|1|||
129592694|NCT00779402|466463517|FG000|Surveillance Phase|Death|0|||
129592695|NCT00779402|466463518|FG001|Surveillance Phase|Death|1|||
129592696|NCT00779402|466463517|FG000|Surveillance Phase|Intercurrent Illness|2|||
129592697|NCT00779402|466463518|FG001|Surveillance Phase|Intercurrent Illness|0|||
129592698|NCT00779402|466463517|FG000|Surveillance Phase|Other|5|||
129592699|NCT00779402|466463518|FG001|Surveillance Phase|Other|5|||
129592700|NCT00779402|466463517|FG000|Surveillance Phase|Withdrawal by Subject|4|||
129592701|NCT00779402|466463518|FG001|Surveillance Phase|Withdrawal by Subject|1|||
129592702|NCT00779402|466463517|FG000|Surveillance Phase|Closure of study|5|||
129592703|NCT00779402|466463518|FG001|Surveillance Phase|Closure of study|6|||
129592704|NCT00779402|466463517|FG000|Surveillance Phase|Completed Protocol Visits|3|||
129592705|NCT00779402|466463518|FG001|Surveillance Phase|Completed Protocol Visits|2|||
129592706|NCT00779402|466463517|FG000|Long-term Follow-up|Patient refused to continue|2|||
129592707|NCT00779402|466463518|FG001|Long-term Follow-up|Patient refused to continue|0|||
129592708|NCT00779402|466463517|FG000|Long-term Follow-up|Other|5|||
129592709|NCT00779402|466463518|FG001|Long-term Follow-up|Other|0|||
129592710|NCT00779402|466463517|FG000|Long-term Follow-up|Closure of Study|8|||
129592711|NCT00779402|466463518|FG001|Long-term Follow-up|Closure of Study|4|||
129592712|NCT00779402|466463517|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
129592713|NCT00779402|466463518|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
129592714|NCT01519947|466463523|FG000|Overall Study|Death|0|||
129592715|NCT01519947|466463524|FG001|Overall Study|Death|0|||
129592716|NCT01519947|466463525|FG002|Overall Study|Death|0|||
129592717|NCT01519947|466463526|FG003|Overall Study|Death|1|||
129592718|NCT01519947|466463523|FG000|Overall Study|Protocol Violation|0|||
129592719|NCT01519947|466463524|FG001|Overall Study|Protocol Violation|0|||
129592720|NCT01519947|466463525|FG002|Overall Study|Protocol Violation|2|||
129592721|NCT01519947|466463526|FG003|Overall Study|Protocol Violation|1|||
129592722|NCT01519947|466463523|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
129592723|NCT01519947|466463524|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
129592724|NCT01519947|466463525|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
129592725|NCT01519947|466463526|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
129592726|NCT01519947|466463523|FG000|Overall Study|Development of Anemia|0|||
129696474|NCT01475825|466848101|FG002|Overall Study|Protocol Violation|0|||
129592727|NCT01519947|466463524|FG001|Overall Study|Development of Anemia|1|||
129592728|NCT01519947|466463525|FG002|Overall Study|Development of Anemia|0|||
129592729|NCT01519947|466463526|FG003|Overall Study|Development of Anemia|1|||
129592730|NCT01519947|466463523|FG000|Overall Study|Blood Transfusion|0|||
129592731|NCT01519947|466463524|FG001|Overall Study|Blood Transfusion|1|||
129592732|NCT01519947|466463525|FG002|Overall Study|Blood Transfusion|1|||
129592733|NCT01519947|466463526|FG003|Overall Study|Blood Transfusion|0|||
129592734|NCT01519947|466463523|FG000|Overall Study|Withdrawal by Subject|0|||
129592735|NCT01519947|466463524|FG001|Overall Study|Withdrawal by Subject|1|||
129592736|NCT01519947|466463525|FG002|Overall Study|Withdrawal by Subject|0|||
129592737|NCT01519947|466463526|FG003|Overall Study|Withdrawal by Subject|1|||
129592738|NCT01519947|466463523|FG000|Overall Study|Lost to Follow-up|0|||
129592739|NCT01519947|466463524|FG001|Overall Study|Lost to Follow-up|0|||
129592740|NCT01519947|466463525|FG002|Overall Study|Lost to Follow-up|3|||
129592741|NCT01519947|466463526|FG003|Overall Study|Lost to Follow-up|2|||
129592742|NCT01519947|466463523|FG000|Overall Study|Poor Response|1|||
129592743|NCT01519947|466463524|FG001|Overall Study|Poor Response|0|||
129592744|NCT01519947|466463525|FG002|Overall Study|Poor Response|0|||
129592745|NCT01519947|466463526|FG003|Overall Study|Poor Response|1|||
129592746|NCT01519947|466463523|FG000|Overall Study|Adverse Event|1|||
129592747|NCT01519947|466463524|FG001|Overall Study|Adverse Event|0|||
129696475|NCT01475825|466848102|FG003|Overall Study|Protocol Violation|0|||
129592748|NCT01519947|466463525|FG002|Overall Study|Adverse Event|1|||
129592749|NCT01519947|466463526|FG003|Overall Study|Adverse Event|1|||
129592750|NCT02274948|466463531|FG000|Overall Study|Lost to Follow-up|28|||
129696476|NCT01475825|466848099|FG000|Overall Study|Physician Decision|0|||
129696477|NCT01475825|466848100|FG001|Overall Study|Physician Decision|1|||
129786433|NCT01566214|467185652|FG001|Overall Study|Lost to Follow-up|0|||
129786434|NCT00561977|467185653|FG000|Overall Study|Withdrawal by Subject|0|||
129786435|NCT00561977|467185654|FG001|Overall Study|Withdrawal by Subject|2|||
129786436|NCT00561977|467185655|FG002|Overall Study|Withdrawal by Subject|1|||
129786437|NCT00561977|467185653|FG000|Overall Study|Pregnancy|0|||
129786438|NCT00561977|467185654|FG001|Overall Study|Pregnancy|1|||
129786439|NCT00561977|467185655|FG002|Overall Study|Pregnancy|1|||
129786440|NCT04620798|467185658|FG000|Overall Study|Lost to Follow-up|126|||
129786441|NCT04620798|467185659|FG001|Overall Study|Lost to Follow-up|138|||
129786442|NCT01616693|467185663|FG000|Evaluated for Safety|Physician Decision|1|||
129592751|NCT02274948|466463532|FG001|Overall Study|Lost to Follow-up|25|||
129592752|NCT02274948|466463531|FG000|Overall Study|Withdrawal by Subject|64|||
129592753|NCT02274948|466463532|FG001|Overall Study|Withdrawal by Subject|58|||
129592754|NCT02274948|466463531|FG000|Overall Study|Stopped on family Practitioner advice|2|||
129592755|NCT02274948|466463532|FG001|Overall Study|Stopped on family Practitioner advice|5|||
129592756|NCT02274948|466463531|FG000|Overall Study|Left the area|4|||
129592757|NCT02274948|466463532|FG001|Overall Study|Left the area|3|||
129592758|NCT00707434|466463533|FG000|Overall Study|Adverse Event|1|||
129592759|NCT01386125|466463534|FG000|Overall Study|Lost to Follow-up|3|||
129592760|NCT01386125|466463535|FG001|Overall Study|Lost to Follow-up|9|||
129592761|NCT01386125|466463534|FG000|Overall Study|Physician Decision|0|||
129592762|NCT01386125|466463535|FG001|Overall Study|Physician Decision|1|||
129592763|NCT01386125|466463534|FG000|Overall Study|Protocol Violation|5|||
129592764|NCT01386125|466463535|FG001|Overall Study|Protocol Violation|7|||
129592765|NCT01386125|466463534|FG000|Overall Study|Disease Progress|1|||
129592766|NCT01386125|466463535|FG001|Overall Study|Disease Progress|2|||
129592767|NCT01386125|466463534|FG000|Overall Study|Withdrawal by Subject|13|||
129592768|NCT01386125|466463535|FG001|Overall Study|Withdrawal by Subject|12|||
129592769|NCT01386125|466463534|FG000|Overall Study|Adverse Event|2|||
129592770|NCT01386125|466463535|FG001|Overall Study|Adverse Event|5|||
129592771|NCT01386125|466463534|FG000|Overall Study|Lack of Efficacy|0|||
129592772|NCT01386125|466463535|FG001|Overall Study|Lack of Efficacy|1|||
129592773|NCT01386125|466463534|FG000|Overall Study|Participant Leaving Country|1|||
129592774|NCT01386125|466463535|FG001|Overall Study|Participant Leaving Country|0|||
129592775|NCT01928615|466463537|FG000|Overall Study|Study Terminated by Sponsor|2|||
129592776|NCT00676494|466463541|FG000|Overall Study|Missed Visit|8|||
129592777|NCT00676494|466463541|FG000|Overall Study|Withdrawal by Subject|6|||
129592778|NCT00732160|466463542|FG000|Overall Study|Adverse Event|1|||
129592779|NCT00732160|466463543|FG001|Overall Study|Adverse Event|0|||
129592780|NCT00732160|466463544|FG002|Overall Study|Adverse Event|1|||
129592781|NCT00732160|466463545|FG003|Overall Study|Adverse Event|1|||
129592782|NCT00732160|466463542|FG000|Overall Study|scheduling|4|||
129592783|NCT00732160|466463543|FG001|Overall Study|scheduling|4|||
129592784|NCT00732160|466463544|FG002|Overall Study|scheduling|2|||
129592785|NCT00732160|466463545|FG003|Overall Study|scheduling|1|||
129592786|NCT01256060|466463549|FG000|Overall Study|Lost to Follow-up|0|||
129592787|NCT01256060|466463550|FG001|Overall Study|Lost to Follow-up|1|||
129592788|NCT01256060|466463551|FG002|Overall Study|Lost to Follow-up|0|||
129592789|NCT01256060|466463552|FG003|Overall Study|Lost to Follow-up|0|||
129696478|NCT01475825|466848101|FG002|Overall Study|Physician Decision|0|||
129696479|NCT01475825|466848102|FG003|Overall Study|Physician Decision|0|||
129696480|NCT01475825|466848099|FG000|Overall Study|Withdrawal by Subject|8|||
129696481|NCT01475825|466848100|FG001|Overall Study|Withdrawal by Subject|3|||
129696482|NCT01475825|466848101|FG002|Overall Study|Withdrawal by Subject|11|||
129696483|NCT01475825|466848102|FG003|Overall Study|Withdrawal by Subject|7|||
129696484|NCT01475825|466848099|FG000|Overall Study|Did not enter OLC|15|||
129696485|NCT01475825|466848100|FG001|Overall Study|Did not enter OLC|11|||
129696486|NCT01475825|466848101|FG002|Overall Study|Did not enter OLC|15|||
129696487|NCT01475825|466848102|FG003|Overall Study|Did not enter OLC|11|||
129696488|NCT00309946|466848105|FG000|Overall Study|Withdrawal by Subject|1|||
129696489|NCT02624687|466848109|FG000|Overall Study|Withdrawal by Subject|1|||
129696490|NCT02624687|466848110|FG001|Overall Study|Withdrawal by Subject|1|||
129696491|NCT02624687|466848109|FG000|Overall Study|medical leave from work|0|||
129696492|NCT02624687|466848110|FG001|Overall Study|medical leave from work|1|||
129696493|NCT03111108|466848111|FG000|Overall Study|Death|0|||
129696494|NCT03111108|466848112|FG001|Overall Study|Death|1|||
129696495|NCT03111108|466848111|FG000|Overall Study|Withdrawal by Subject|1|||
129592790|NCT00985231|466463553|FG000|Overall Study|ineligible|1|||
129592791|NCT00985231|466463554|FG001|Overall Study|ineligible|0|||
129592792|NCT00985231|466463553|FG000|Overall Study|Protocol Violation|1|||
129592793|NCT00985231|466463554|FG001|Overall Study|Protocol Violation|0|||
129592794|NCT00985231|466463553|FG000|Overall Study|Withdrawal by Subject|1|||
129592795|NCT00985231|466463554|FG001|Overall Study|Withdrawal by Subject|0|||
129592796|NCT00985231|466463553|FG000|Overall Study|Lost to Follow-up|0|||
129592797|NCT00985231|466463554|FG001|Overall Study|Lost to Follow-up|1|||
129592798|NCT00985231|466463553|FG000|Overall Study|Study related symptoms & complaints|0|||
129592799|NCT00985231|466463554|FG001|Overall Study|Study related symptoms & complaints|2|||
129592800|NCT00220727|466463555|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
129592801|NCT00220727|466463556|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
129592802|NCT00761176|466463557|FG000|Overall Study|Death|1|||
129592803|NCT00761176|466463558|FG001|Overall Study|Death|0|||
129592804|NCT00761176|466463557|FG000|Overall Study|Withdrawal by Subject|1|||
129592805|NCT00761176|466463558|FG001|Overall Study|Withdrawal by Subject|1|||
129592806|NCT02508116|466463559|FG000|Overall Study|Lost to Follow-up|2|||
129592807|NCT02508116|466463560|FG001|Overall Study|Lost to Follow-up|3|||
129592808|NCT02508116|466463559|FG000|Overall Study|Withdrawal by Subject|3|||
129592809|NCT02508116|466463560|FG001|Overall Study|Withdrawal by Subject|2|||
129592810|NCT02508116|466463559|FG000|Overall Study|Protocol Violation|1|||
129592811|NCT02508116|466463560|FG001|Overall Study|Protocol Violation|2|||
129592812|NCT02508116|466463559|FG000|Overall Study|Physician Decision|2|||
129592813|NCT02508116|466463560|FG001|Overall Study|Physician Decision|0|||
129592814|NCT00109850|466463561|FG000|Overall Study|Adverse Event|1|||
129592815|NCT00109850|466463561|FG000|Overall Study|Death|2|||
129592816|NCT00109850|466463561|FG000|Overall Study|Ineligible|1|||
129592817|NCT00476593|466463562|FG000|Overall Study|Lost to Follow-up|10|||
129592818|NCT00476593|466463563|FG001|Overall Study|Lost to Follow-up|2|||
129592819|NCT00476593|466463564|FG002|Overall Study|Lost to Follow-up|8|||
129592820|NCT00476593|466463565|FG003|Overall Study|Lost to Follow-up|22|||
129592821|NCT00559364|466463566|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
129592822|NCT00559364|466463567|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
129592823|NCT04314843|466463568|FG000|Overall Study|Death|2|||
129592824|NCT04314843|466463569|FG001|Overall Study|Death|2|||
129592825|NCT04314843|466463568|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
129592826|NCT04314843|466463569|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
129592827|NCT03840382|466463570|FG000|Overall Study|Lost to Follow-up|11|||
129592828|NCT00802178|466465838|FG000|Overall Study|Lack of Efficacy|36|||
129592829|NCT00802178|466465838|FG000|Overall Study|Insufficient tolerability (IT)|17|||
129592830|NCT00802178|466465838|FG000|Overall Study|Withdrawal by Subject|18|||
129592831|NCT00802178|466465838|FG000|Overall Study|Other|32|||
129592832|NCT00802178|466465838|FG000|Overall Study|Lack of efficacy and patient wish|1|||
129592833|NCT00802178|466465838|FG000|Overall Study|IT and patient wish|8|||
129592834|NCT00802178|466465838|FG000|Overall Study|Patients wish and other reason|1|||
129592835|NCT00831233|466465842|FG000|Overall Study|Adverse Event|0|||
129592836|NCT00831233|466465843|FG001|Overall Study|Adverse Event|1|||
129592837|NCT00831233|466465842|FG000|Overall Study|Protocol Violation|1|||
129592838|NCT00831233|466465843|FG001|Overall Study|Protocol Violation|0|||
129592839|NCT00831233|466465842|FG000|Overall Study|Selection Criteria Not Met|2|||
129592840|NCT00831233|466465843|FG001|Overall Study|Selection Criteria Not Met|0|||
129592841|NCT02211014|466465844|FG000|Overall Study|Adverse Event|0|||
129592842|NCT02211014|466465845|FG001|Overall Study|Adverse Event|2|||
129592843|NCT02211014|466465844|FG000|Overall Study|Physician Decision|1|||
129592844|NCT02211014|466465845|FG001|Overall Study|Physician Decision|2|||
129592845|NCT02211014|466465844|FG000|Overall Study|Started another cancer therapy|1|||
129592846|NCT02211014|466465845|FG001|Overall Study|Started another cancer therapy|0|||
129592847|NCT02211014|466465844|FG000|Overall Study|Withdrawal by Subject|0|||
129592848|NCT02211014|466465845|FG001|Overall Study|Withdrawal by Subject|1|||
129592849|NCT02211014|466465844|FG000|Overall Study|In agreement with patient, no benefit|0|||
129592850|NCT02211014|466465845|FG001|Overall Study|In agreement with patient, no benefit|1|||
129592851|NCT02744755|466465846|FG000|Study Period 1|Protocol Violation|2|||
129592852|NCT02744755|466465847|FG001|Study Period 1|Protocol Violation|1|||
129592853|NCT02744755|466465846|FG000|Study Period 1|not defined|0|||
129592854|NCT02744755|466465847|FG001|Study Period 1|not defined|1|||
129592855|NCT02744755|466465846|FG000|Study Period 1|Pregnancy|1|||
129592856|NCT02744755|466465847|FG001|Study Period 1|Pregnancy|0|||
129592857|NCT02744755|466465846|FG000|Study Period 1|Adverse Event|1|||
129592858|NCT02744755|466465847|FG001|Study Period 1|Adverse Event|1|||
129592859|NCT02744755|466465846|FG000|Study Period 1|Lost to Follow-up|1|||
129592860|NCT02744755|466465847|FG001|Study Period 1|Lost to Follow-up|1|||
129592861|NCT02744755|466465846|FG000|Study Period 1|Lack of Efficacy|1|||
129592862|NCT02744755|466465847|FG001|Study Period 1|Lack of Efficacy|0|||
129592863|NCT02744755|466465846|FG000|Study Period 1|Withdrawal by Subject|8|||
129592864|NCT02744755|466465847|FG001|Study Period 1|Withdrawal by Subject|4|||
129592865|NCT02744755|466465846|FG000|Study Period 2|Adverse Event|5|||
129592866|NCT02744755|466465847|FG001|Study Period 2|Adverse Event|0|||
129592867|NCT02744755|466465846|FG000|Study Period 2|Protocol Violation|1|||
129592868|NCT02744755|466465847|FG001|Study Period 2|Protocol Violation|0|||
129592869|NCT02744755|466465846|FG000|Study Period 2|not defined|3|||
129592870|NCT02744755|466465847|FG001|Study Period 2|not defined|2|||
129592871|NCT02744755|466465846|FG000|Study Period 2|Lost to Follow-up|0|||
129592872|NCT02744755|466465847|FG001|Study Period 2|Lost to Follow-up|2|||
129592873|NCT02744755|466465846|FG000|Study Period 2|Withdrawal by Subject|2|||
129592874|NCT02744755|466465847|FG001|Study Period 2|Withdrawal by Subject|2|||
129592875|NCT02744755|466465846|FG000|Study Period 2|Lack of Efficacy|3|||
129592876|NCT02744755|466465847|FG001|Study Period 2|Lack of Efficacy|2|||
129592877|NCT02001051|466465850|FG000|Overall Study|Deemed not eligible following enrollment|0|||
129592878|NCT02001051|466465851|FG001|Overall Study|Deemed not eligible following enrollment|1|||
129592879|NCT02147587|466465853|FG000|Overall Study|Adverse Event|9|||
129592880|NCT02147587|466465854|FG001|Overall Study|Adverse Event|4|||
129592881|NCT02147587|466465853|FG000|Overall Study|Lack of Efficacy|2|||
129592882|NCT02147587|466465854|FG001|Overall Study|Lack of Efficacy|1|||
129592883|NCT00530348|466465857|FG000|Overall Study|Adverse Event|5|||
129592884|NCT00530348|466465858|FG001|Overall Study|Adverse Event|1|||
129592885|NCT00530348|466465857|FG000|Overall Study|Death|0|||
129592886|NCT00530348|466465858|FG001|Overall Study|Death|1|||
129592887|NCT00530348|466465857|FG000|Overall Study|Lack of Efficacy|2|||
129592888|NCT00530348|466465858|FG001|Overall Study|Lack of Efficacy|0|||
129592889|NCT00530348|466465857|FG000|Overall Study|Lost to Follow-up|0|||
129592890|NCT00530348|466465858|FG001|Overall Study|Lost to Follow-up|2|||
129592891|NCT00530348|466465857|FG000|Overall Study|Physician Decision|1|||
129696496|NCT03111108|466848112|FG001|Overall Study|Withdrawal by Subject|0|||
129592892|NCT00530348|466465858|FG001|Overall Study|Physician Decision|2|||
129592893|NCT00530348|466465857|FG000|Overall Study|Pregnancy|1|||
129592894|NCT00530348|466465858|FG001|Overall Study|Pregnancy|0|||
129696497|NCT02771145|466848113|FG000|Overall Study|Adverse Event|3|||
129696498|NCT02771145|466848113|FG000|Overall Study|Lost to Follow-up|1|||
129592895|NCT00530348|466465857|FG000|Overall Study|Withdrawal by Subject|12|||
129592896|NCT00530348|466465858|FG001|Overall Study|Withdrawal by Subject|12|||
129592897|NCT00530348|466465857|FG000|Overall Study|Randomised in error|1|||
129592898|NCT00530348|466465858|FG001|Overall Study|Randomised in error|0|||
129592899|NCT00530348|466465857|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
129592900|NCT00530348|466465858|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
129592901|NCT04364763|466465859|FG000|Overall Study|Death|1|||
129592902|NCT04364763|466465860|FG001|Overall Study|Death|2|||
129592903|NCT04364763|466465859|FG000|Overall Study|Lost to Follow-up|1|||
129592904|NCT04364763|466465860|FG001|Overall Study|Lost to Follow-up|0|||
129592905|NCT02359864|466465861|FG000|Overall Study|Withdrawal by Subject|1|||
129786443|NCT01616693|467185664|FG001|Evaluated for Safety|Physician Decision|0|||
129786444|NCT01616693|467185665|FG002|Evaluated for Safety|Physician Decision|1|||
129786445|NCT01616693|467185666|FG003|Evaluated for Safety|Physician Decision|0|||
129786446|NCT01616693|467185663|FG000|Received Both Vaccines|Adverse Event|2|||
129786447|NCT01616693|467185664|FG001|Received Both Vaccines|Adverse Event|0|||
129786448|NCT01616693|467185665|FG002|Received Both Vaccines|Adverse Event|0|||
129786449|NCT01616693|467185666|FG003|Received Both Vaccines|Adverse Event|0|||
129786450|NCT01616693|467185663|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
129786451|NCT01616693|467185664|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
129786452|NCT01616693|467185665|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
129786453|NCT01616693|467185666|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
129786454|NCT01616693|467185663|FG000|Received Both Vaccines|Lost to Follow-up|4|||
129592906|NCT02359864|466465862|FG001|Overall Study|Withdrawal by Subject|0|||
129592907|NCT01740791|466465863|FG000|Overall Study|Randomized but never treated|5|||
129592908|NCT01740791|466465864|FG001|Overall Study|Randomized but never treated|3|||
129592909|NCT01740791|466465865|FG002|Overall Study|Randomized but never treated|2|||
129592910|NCT01740791|466465866|FG003|Overall Study|Randomized but never treated|2|||
129592911|NCT01740791|466465867|FG004|Overall Study|Randomized but never treated|1|||
129592912|NCT01740791|466465868|FG005|Overall Study|Randomized but never treated|3|||
129592913|NCT01740791|466465863|FG000|Overall Study|Lost to Follow-up|2|||
129592914|NCT01740791|466465864|FG001|Overall Study|Lost to Follow-up|0|||
129592915|NCT01740791|466465865|FG002|Overall Study|Lost to Follow-up|2|||
129592916|NCT01740791|466465866|FG003|Overall Study|Lost to Follow-up|3|||
129592917|NCT01740791|466465867|FG004|Overall Study|Lost to Follow-up|2|||
129592918|NCT01740791|466465868|FG005|Overall Study|Lost to Follow-up|3|||
129592919|NCT01740791|466465863|FG000|Overall Study|Withdrew Consent|4|||
129592920|NCT01740791|466465864|FG001|Overall Study|Withdrew Consent|0|||
129592921|NCT01740791|466465865|FG002|Overall Study|Withdrew Consent|1|||
129592922|NCT01740791|466465866|FG003|Overall Study|Withdrew Consent|2|||
129592923|NCT01740791|466465867|FG004|Overall Study|Withdrew Consent|0|||
129592924|NCT01740791|466465868|FG005|Overall Study|Withdrew Consent|3|||
129592925|NCT01740791|466465863|FG000|Overall Study|Investigator's discretion|1|||
129592926|NCT01740791|466465864|FG001|Overall Study|Investigator's discretion|0|||
129592927|NCT01740791|466465865|FG002|Overall Study|Investigator's discretion|1|||
129592928|NCT01740791|466465866|FG003|Overall Study|Investigator's discretion|0|||
129592929|NCT01740791|466465867|FG004|Overall Study|Investigator's discretion|0|||
129592930|NCT01740791|466465868|FG005|Overall Study|Investigator's discretion|1|||
129592931|NCT01740791|466465863|FG000|Overall Study|Adverse Event|0|||
129592932|NCT01740791|466465864|FG001|Overall Study|Adverse Event|0|||
129592933|NCT01740791|466465865|FG002|Overall Study|Adverse Event|0|||
129592934|NCT01740791|466465866|FG003|Overall Study|Adverse Event|0|||
129592935|NCT01740791|466465867|FG004|Overall Study|Adverse Event|0|||
129592936|NCT01740791|466465868|FG005|Overall Study|Adverse Event|1|||
129592937|NCT01808248|466465869|FG000|Overall Study|Lack of Efficacy|3|||
129592938|NCT01808248|466465869|FG000|Overall Study|Withdrawal by Subject|1|||
129592939|NCT01808248|466465869|FG000|Overall Study|Lost to Follow-up|1|||
129592940|NCT02020967|466465871|FG000|Overall Study|Withdrawal by Subject|51|||
129592941|NCT03507686|466465872|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
129592942|NCT03507686|466465873|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
129592943|NCT03507686|466465872|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
129592944|NCT03507686|466465873|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
129592945|NCT03507686|466465872|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
129592946|NCT03507686|466465873|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
129592947|NCT03507686|466465872|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
129592948|NCT03507686|466465873|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
129592949|NCT03507686|466465872|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
129592950|NCT03507686|466465873|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
129592951|NCT03507686|466465872|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
129592952|NCT03507686|466465873|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
129592953|NCT00983528|466465876|FG000|Overall Study|Death|4|||
129592954|NCT00983528|466465876|FG000|Overall Study|Lost to Follow-up|1|||
129786455|NCT01616693|467185664|FG001|Received Both Vaccines|Lost to Follow-up|3|||
129786456|NCT01616693|467185665|FG002|Received Both Vaccines|Lost to Follow-up|4|||
129786457|NCT01616693|467185666|FG003|Received Both Vaccines|Lost to Follow-up|4|||
129786458|NCT01616693|467185663|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
129592955|NCT00983528|466465876|FG000|Overall Study|Study Terminated|1|||
129592956|NCT00575380|466465877|FG000|Overall Study|Withdrawal by Subject|1|||
129592957|NCT00575380|466465878|FG001|Overall Study|Withdrawal by Subject|0|||
129592958|NCT00575380|466465877|FG000|Overall Study|Adverse Event|0|||
129592959|NCT00575380|466465878|FG001|Overall Study|Adverse Event|1|||
129592960|NCT00575380|466465877|FG000|Overall Study|Various|0|||
129592961|NCT00575380|466465878|FG001|Overall Study|Various|2|||
129696499|NCT02264821|466848114|FG000|Overall Study|Protocol Violation|1|||
129696500|NCT02264821|466848115|FG001|Overall Study|Protocol Violation|3|||
129696501|NCT02264821|466848116|FG002|Overall Study|Protocol Violation|6|||
129696502|NCT00552279|466848117|FG000|Overall Study|Adverse Event|0|||
129696503|NCT00552279|466848118|FG001|Overall Study|Adverse Event|1|||
129696504|NCT00552279|466848117|FG000|Overall Study|Withdrawal by Subject|12|||
129696505|NCT00552279|466848118|FG001|Overall Study|Withdrawal by Subject|1|||
129696506|NCT00552279|466848117|FG000|Overall Study|Lost to Follow-up|1|||
129696507|NCT00552279|466848118|FG001|Overall Study|Lost to Follow-up|0|||
129696508|NCT00552279|466848117|FG000|Overall Study|Other|1|||
129696509|NCT00552279|466848118|FG001|Overall Study|Other|1|||
129696510|NCT02662582|466848120|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
129696511|NCT02662582|466848121|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
129696512|NCT02662582|466848120|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
129696513|NCT02662582|466848121|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
129696514|NCT02662582|466848120|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
129696515|NCT02662582|466848121|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
129696516|NCT02662582|466848120|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129696517|NCT02662582|466848121|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129696518|NCT00511199|466848123|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
129696519|NCT00511199|466848124|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
129696520|NCT00511199|466848123|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
129696521|NCT00511199|466848124|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
129696522|NCT00511199|466848123|FG000|Overall Study|Withdrawal of Informed Consent|19|||
129696523|NCT00511199|466848124|FG001|Overall Study|Withdrawal of Informed Consent|4|||
129696524|NCT00511199|466848123|FG000|Overall Study|Pregnancy|6|||
129696525|NCT00511199|466848124|FG001|Overall Study|Pregnancy|3|||
129696526|NCT00511199|466848123|FG000|Overall Study|Pregnancy Wish|16|||
129885595|NCT02611830|467540769|FG002|Maintenance Phase|Lack of Efficacy|18|||
129885596|NCT02611830|467540770|FG003|Maintenance Phase|Lack of Efficacy|6|||
129696527|NCT00511199|466848124|FG001|Overall Study|Pregnancy Wish|8|||
129696528|NCT00511199|466848123|FG000|Overall Study|Lost to Follow-up|40|||
129592962|NCT00330460|466465885|FG000|Overall Study|Physician Decision|1|||
129592963|NCT00330460|466465886|FG001|Overall Study|Physician Decision|0|||
129592964|NCT00330460|466465885|FG000|Overall Study|Adverse Event|10|||
129592965|NCT00330460|466465886|FG001|Overall Study|Adverse Event|8|||
129592966|NCT00330460|466465885|FG000|Overall Study|Withdrawal by Subject|18|||
129592967|NCT00330460|466465886|FG001|Overall Study|Withdrawal by Subject|17|||
129592968|NCT00330460|466465885|FG000|Overall Study|Death|1|||
129592969|NCT00330460|466465886|FG001|Overall Study|Death|1|||
129592970|NCT00330460|466465885|FG000|Overall Study|Ineligibility determined|1|||
129592971|NCT00330460|466465886|FG001|Overall Study|Ineligibility determined|3|||
129592972|NCT00330460|466465885|FG000|Overall Study|Lost to Follow-up|8|||
129592973|NCT00330460|466465886|FG001|Overall Study|Lost to Follow-up|3|||
129592974|NCT00330460|466465885|FG000|Overall Study|Noncompliance|2|||
129592975|NCT00330460|466465886|FG001|Overall Study|Noncompliance|1|||
129592976|NCT00330460|466465885|FG000|Overall Study|Other|1|||
129592977|NCT00330460|466465886|FG001|Overall Study|Other|0|||
129592978|NCT02663882|466465887|FG000|Overall Study|Lost to Follow-up|4|||
129592979|NCT02663882|466465888|FG001|Overall Study|Lost to Follow-up|2|||
129592980|NCT00388037|466465889|FG000|Overall Study|Protocol Violation|1|||
129592981|NCT00602537|466465890|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
129592982|NCT00602537|466465891|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
129592983|NCT00602537|466465890|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
129592984|NCT00602537|466465891|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
129592985|NCT00602537|466465890|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
129592986|NCT00602537|466465891|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
129592987|NCT00602537|466465890|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
129592988|NCT00602537|466465891|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
129592989|NCT00602537|466465890|FG000|Follow Up Study Comparison|Adverse Event|1|||
129592990|NCT00602537|466465891|FG001|Follow Up Study Comparison|Adverse Event|0|||
129592991|NCT00602537|466465890|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
129592992|NCT00602537|466465891|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
129592993|NCT00602537|466465890|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
129592994|NCT00602537|466465891|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
129592995|NCT00869440|466465898|FG000|Overall Study|Withdrawal by Subject|1|||
129592996|NCT00869440|466465899|FG001|Overall Study|Withdrawal by Subject|0|||
129592997|NCT00869440|466465900|FG002|Overall Study|Withdrawal by Subject|0|||
129592998|NCT00869440|466465901|FG003|Overall Study|Withdrawal by Subject|0|||
129592999|NCT00869440|466465898|FG000|Overall Study|Physician Decision|1|||
129593000|NCT00869440|466465899|FG001|Overall Study|Physician Decision|1|||
129593001|NCT00869440|466465900|FG002|Overall Study|Physician Decision|0|||
129593002|NCT00869440|466465901|FG003|Overall Study|Physician Decision|0|||
129593003|NCT04569786|466465908|FG000|Overall Study|Lost to Follow-up|1|||
129593004|NCT04569786|466465909|FG001|Overall Study|Lost to Follow-up|0|||
129593005|NCT04569786|466465910|FG002|Overall Study|Lost to Follow-up|4|||
129593006|NCT04569786|466465911|FG003|Overall Study|Lost to Follow-up|1|||
129593007|NCT04569786|466465912|FG004|Overall Study|Lost to Follow-up|0|||
129593008|NCT04569786|466465908|FG000|Overall Study|Withdrawal by Subject|0|||
129593009|NCT04569786|466465909|FG001|Overall Study|Withdrawal by Subject|0|||
129593010|NCT04569786|466465910|FG002|Overall Study|Withdrawal by Subject|0|||
129593011|NCT04569786|466465911|FG003|Overall Study|Withdrawal by Subject|5|||
129593012|NCT04569786|466465912|FG004|Overall Study|Withdrawal by Subject|1|||
129593013|NCT04569786|466465908|FG000|Overall Study|Physician Decision|0|||
129593014|NCT04569786|466465909|FG001|Overall Study|Physician Decision|0|||
129593015|NCT04569786|466465910|FG002|Overall Study|Physician Decision|0|||
129593016|NCT04569786|466465911|FG003|Overall Study|Physician Decision|1|||
129593017|NCT04569786|466465912|FG004|Overall Study|Physician Decision|0|||
129593018|NCT02692482|466465913|FG000|Overall Study|Death|2|||
129593019|NCT02692482|466465914|FG001|Overall Study|Death|2|||
129593020|NCT02692482|466465913|FG000|Overall Study|Withdrawal by Subject|1|||
129593021|NCT02692482|466465914|FG001|Overall Study|Withdrawal by Subject|2|||
129593022|NCT01435031|466465915|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
129593023|NCT01435031|466465915|FG000|ITT at 1 Month|Death|1|||
129593024|NCT01435031|466465915|FG000|ITT at 1 Month|Lost to Follow-up|4|||
129593025|NCT01435031|466465915|FG000|ITT at 6 Months|Death|2|||
129593026|NCT01435031|466465915|FG000|ITT at 6 Months|Lost to Follow-up|3|||
129593027|NCT01435031|466465915|FG000|ITT at 1 Year|Death|1|||
129593028|NCT01435031|466465915|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
129593029|NCT01435031|466465915|FG000|ITT at 1 Year|Lost to Follow-up|6|||
129593030|NCT01435031|466465915|FG000|ITT at 2 Years|Death|7|||
129593031|NCT01435031|466465915|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
129593032|NCT01435031|466465915|FG000|ITT at 2 Years|Lost to Follow-up|4|||
129593033|NCT01435031|466465915|FG000|ITT at 3 Years|Death|5|||
129593034|NCT01435031|466465915|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
129593035|NCT01435031|466465915|FG000|ITT at 3 Years|Lost to Follow-up|4|||
129593036|NCT01435031|466465915|FG000|ITT at 4 Years|Death|4|||
129696529|NCT00511199|466848124|FG001|Overall Study|Lost to Follow-up|17|||
129593037|NCT01435031|466465915|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
129593038|NCT01435031|466465915|FG000|ITT at 4 Years|Lost to Follow-up|1|||
129593039|NCT00613730|466465916|FG000|Overall Study|Disease progression|2|||
129593040|NCT00613730|466465916|FG000|Overall Study|Administrative decision|1|||
129593041|NCT00479388|466465917|FG000|Overall Study|Adverse Event|90|||
129593042|NCT00479388|466465918|FG001|Overall Study|Adverse Event|45|||
129593043|NCT00479388|466465917|FG000|Overall Study|Lost to Follow-up|0|||
129593044|NCT00479388|466465918|FG001|Overall Study|Lost to Follow-up|2|||
129593045|NCT00479388|466465917|FG000|Overall Study|Protocol Violation|10|||
129593046|NCT00479388|466465918|FG001|Overall Study|Protocol Violation|9|||
129593047|NCT00479388|466465917|FG000|Overall Study|Withdrawal by Subject|32|||
129593048|NCT00479388|466465918|FG001|Overall Study|Withdrawal by Subject|17|||
129593049|NCT01876368|466465921|FG000|Overall Study|Adverse Event|2|||
129593050|NCT01876368|466465922|FG001|Overall Study|Adverse Event|5|||
129593051|NCT01876368|466465921|FG000|Overall Study|Lack of Efficacy|1|||
129593052|NCT01876368|466465922|FG001|Overall Study|Lack of Efficacy|0|||
129593053|NCT01876368|466465921|FG000|Overall Study|Lost to Follow-up|0|||
129593054|NCT01876368|466465922|FG001|Overall Study|Lost to Follow-up|1|||
129593055|NCT01876368|466465921|FG000|Overall Study|Non-compliance with study treatment|0|||
129593056|NCT01876368|466465922|FG001|Overall Study|Non-compliance with study treatment|1|||
129593057|NCT01876368|466465921|FG000|Overall Study|Physician Decision|0|||
129593058|NCT01876368|466465922|FG001|Overall Study|Physician Decision|2|||
129593059|NCT01876368|466465921|FG000|Overall Study|Protocol deviation|3|||
129593060|NCT01876368|466465922|FG001|Overall Study|Protocol deviation|3|||
129593061|NCT01876368|466465921|FG000|Overall Study|Subject/guardian decision|3|||
129593062|NCT01876368|466465922|FG001|Overall Study|Subject/guardian decision|1|||
129593063|NCT01955044|466465923|FG000|Overall Study|Death|1|||
129593064|NCT01955044|466465924|FG001|Overall Study|Death|1|||
129593065|NCT01955044|466465925|FG002|Overall Study|Death|0|||
129593066|NCT01644149|466465926|FG000|Overall Study|Withdrawal by Subject|1|||
129593067|NCT01644149|466465927|FG001|Overall Study|Withdrawal by Subject|0|||
129593068|NCT01644149|466465926|FG000|Overall Study|Lost to Follow-up|3|||
129593069|NCT01644149|466465927|FG001|Overall Study|Lost to Follow-up|1|||
129593070|NCT05766787|466465928|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
129593071|NCT05766787|466465929|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
129593072|NCT05766787|466465928|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
129593073|NCT05766787|466465929|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
129593074|NCT05766787|466465928|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
129593075|NCT05766787|466465929|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
129593076|NCT01867606|466465930|FG000|Overall Study|Withdrawal by Subject|10|||
129593077|NCT01867606|466465931|FG001|Overall Study|Withdrawal by Subject|14|||
129593078|NCT01867606|466465930|FG000|Overall Study|Protocol Violation|0|||
129593079|NCT01867606|466465931|FG001|Overall Study|Protocol Violation|1|||
129593080|NCT01378962|466465932|FG000|Overall Study|Death|14|||
129593081|NCT01378962|466465932|FG000|Overall Study|Lost to Follow-up|1|||
129593082|NCT01378962|466465932|FG000|Overall Study|Other|2|||
129593083|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
129593084|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
129593085|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
129593086|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
129593087|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
129593088|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
129593089|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
129593090|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
129593091|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
129593092|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
129593093|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
129593094|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
129593095|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
129593096|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
129593097|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
129593098|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
129593099|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
129593100|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
129593101|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
129593102|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
129593103|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
129696530|NCT00511199|466848123|FG000|Overall Study|Other Reason|78|||
129593104|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
129593105|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
129593106|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
129593107|NCT01435928|466465934|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
129593108|NCT01435928|466465935|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
129593109|NCT01435928|466465936|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
129593110|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
129593111|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
129593112|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
129593113|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
129593114|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
129593115|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
129593116|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
129593117|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
129593118|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
129593119|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
129593120|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
129593121|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
129593122|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
129593123|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
129593124|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
129593125|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
129593126|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
129593127|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
129593128|NCT01435928|466465934|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
129593129|NCT01435928|466465935|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
129593130|NCT01435928|466465936|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
129593131|NCT00292227|466465938|FG000|Patch Period|Adverse Event|1|||
129593132|NCT00292227|466465939|FG001|Patch Period|Adverse Event|0|||
129593133|NCT00292227|466465940|FG002|Patch Period|Adverse Event|2|||
129593134|NCT00292227|466465938|FG000|Patch Period|Withdrawal by Subject|0|||
129593135|NCT00292227|466465939|FG001|Patch Period|Withdrawal by Subject|0|||
129593136|NCT00292227|466465940|FG002|Patch Period|Withdrawal by Subject|1|||
129593137|NCT02093923|466465941|FG000|Overall Study|Lost to Follow-up|0|||
129593138|NCT02093923|466465942|FG001|Overall Study|Lost to Follow-up|0|||
129593139|NCT02093923|466465943|FG002|Overall Study|Lost to Follow-up|0|||
129593140|NCT02093923|466465944|FG003|Overall Study|Lost to Follow-up|1|||
129593141|NCT02093923|466465945|FG004|Overall Study|Lost to Follow-up|0|||
129593142|NCT02093923|466465941|FG000|Overall Study|Screen failure after randomization|0|||
129593143|NCT02093923|466465942|FG001|Overall Study|Screen failure after randomization|0|||
129593144|NCT02093923|466465943|FG002|Overall Study|Screen failure after randomization|0|||
129593145|NCT02093923|466465944|FG003|Overall Study|Screen failure after randomization|1|||
129593146|NCT02093923|466465945|FG004|Overall Study|Screen failure after randomization|0|||
129593147|NCT00442546|466465948|FG000|Overall Study|Adverse Event|11|||
129593148|NCT00442546|466465949|FG001|Overall Study|Adverse Event|17|||
129593149|NCT00442546|466465950|FG002|Overall Study|Adverse Event|13|||
129593150|NCT00442546|466465948|FG000|Overall Study|Lost to Follow-up|1|||
129593151|NCT00442546|466465949|FG001|Overall Study|Lost to Follow-up|2|||
129593152|NCT00442546|466465950|FG002|Overall Study|Lost to Follow-up|1|||
129593153|NCT00442546|466465948|FG000|Overall Study|Other|4|||
129593154|NCT00442546|466465949|FG001|Overall Study|Other|9|||
129593155|NCT00442546|466465950|FG002|Overall Study|Other|6|||
129593156|NCT00442546|466465948|FG000|Overall Study|Withdrawal by Subject|5|||
129696531|NCT00511199|466848124|FG001|Overall Study|Other Reason|37|||
129696532|NCT01953354|466848130|FG000|Overall Study|Withdrawal by Subject|0|||
129593157|NCT00442546|466465949|FG001|Overall Study|Withdrawal by Subject|5|||
129593158|NCT00442546|466465950|FG002|Overall Study|Withdrawal by Subject|7|||
129593159|NCT00442546|466465948|FG000|Overall Study|Randomized But Not Treated|5|||
129593160|NCT00442546|466465949|FG001|Overall Study|Randomized But Not Treated|4|||
129593161|NCT00442546|466465950|FG002|Overall Study|Randomized But Not Treated|6|||
129593162|NCT00248170|466465951|FG000|Overall Study|Withdrawal by Subject|71|||
129593163|NCT00248170|466465952|FG001|Overall Study|Withdrawal by Subject|79|||
129696533|NCT01953354|466848131|FG001|Overall Study|Withdrawal by Subject|1|||
129593164|NCT00248170|466465951|FG000|Overall Study|Protocol Violation|35|||
129593165|NCT00248170|466465952|FG001|Overall Study|Protocol Violation|30|||
129593166|NCT00248170|466465951|FG000|Overall Study|Lost to Follow-up|28|||
129593167|NCT00248170|466465952|FG001|Overall Study|Lost to Follow-up|35|||
129593168|NCT00248170|466465951|FG000|Overall Study|Disease progression|196|||
129593169|NCT00248170|466465952|FG001|Overall Study|Disease progression|216|||
129593170|NCT00248170|466465951|FG000|Overall Study|Death|28|||
129593171|NCT00248170|466465952|FG001|Overall Study|Death|47|||
129593172|NCT00248170|466465951|FG000|Overall Study|Adverse Event|311|||
129593173|NCT00248170|466465952|FG001|Overall Study|Adverse Event|296|||
129593174|NCT00248170|466465951|FG000|Overall Study|Administrative problems|22|||
129593175|NCT00248170|466465952|FG001|Overall Study|Administrative problems|25|||
129593176|NCT00248170|466465951|FG000|Overall Study|Abnormal test procedure(s) result|49|||
129593177|NCT00248170|466465952|FG001|Overall Study|Abnormal test procedure(s) result|61|||
129593178|NCT00248170|466465951|FG000|Overall Study|Abnormal laboratory values|4|||
129593179|NCT00248170|466465952|FG001|Overall Study|Abnormal laboratory values|0|||
129593180|NCT00248170|466465951|FG000|Overall Study|Protocol deviation|17|||
129593181|NCT00248170|466465952|FG001|Overall Study|Protocol deviation|19|||
129593182|NCT01557582|466465955|FG000|Overall Study|Protocol Violation|4|||
129593183|NCT01557582|466465955|FG000|Overall Study|Operator error|2|||
129593184|NCT02843659|466465956|FG000|Overall Study|Subject Withdrew Consent|0|||
129593185|NCT02843659|466465957|FG001|Overall Study|Subject Withdrew Consent|0|||
129593186|NCT02843659|466465958|FG002|Overall Study|Subject Withdrew Consent|1|||
129696534|NCT01953354|466848130|FG000|Overall Study|Decision of Sponsor|0|||
129593187|NCT02843659|466465956|FG000|Overall Study|Administrative Reason by Sponsor|4|||
129593188|NCT02843659|466465957|FG001|Overall Study|Administrative Reason by Sponsor|5|||
129593189|NCT02843659|466465958|FG002|Overall Study|Administrative Reason by Sponsor|4|||
129593190|NCT02843659|466465956|FG000|Overall Study|Adverse Event|0|||
129593191|NCT02843659|466465957|FG001|Overall Study|Adverse Event|1|||
129593192|NCT02843659|466465958|FG002|Overall Study|Adverse Event|0|||
129593193|NCT02413294|466465962|FG000|Overall Study|Withdrawal by Subject|1|||
129593194|NCT01253317|466465972|FG000|Overall Study|Adverse Event|2|||
129593195|NCT04100096|466467955|FG000|Overall Study|Adverse Event|19|||
129593196|NCT04100096|466467956|FG001|Overall Study|Adverse Event|7|||
129593197|NCT04100096|466467955|FG000|Overall Study|Lack of Efficacy|0|||
129593198|NCT04100096|466467956|FG001|Overall Study|Lack of Efficacy|1|||
129593199|NCT04100096|466467955|FG000|Overall Study|Lost to Follow-up|13|||
129593200|NCT04100096|466467956|FG001|Overall Study|Lost to Follow-up|11|||
129593201|NCT04100096|466467955|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129593202|NCT04100096|466467956|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129593203|NCT04100096|466467955|FG000|Overall Study|Protocol Deviation|1|||
129593204|NCT04100096|466467956|FG001|Overall Study|Protocol Deviation|1|||
129593205|NCT04100096|466467955|FG000|Overall Study|Withdrawal by Participant|13|||
129593206|NCT04100096|466467956|FG001|Overall Study|Withdrawal by Participant|15|||
129593207|NCT01647711|466467958|FG000|Overall Study|Progressive disease|6|||
129593208|NCT01647711|466467959|FG001|Overall Study|Progressive disease|2|||
129593209|NCT01647711|466467960|FG002|Overall Study|Progressive disease|6|||
129593210|NCT01647711|466467961|FG003|Overall Study|Progressive disease|8|||
129593211|NCT01647711|466467962|FG004|Overall Study|Progressive disease|2|||
129593212|NCT01647711|466467958|FG000|Overall Study|Other adverse event|0|||
129593213|NCT01647711|466467959|FG001|Overall Study|Other adverse event|0|||
129593214|NCT01647711|466467960|FG002|Overall Study|Other adverse event|2|||
129593215|NCT01647711|466467961|FG003|Overall Study|Other adverse event|0|||
129593216|NCT01647711|466467962|FG004|Overall Study|Other adverse event|2|||
129593217|NCT01647711|466467958|FG000|Overall Study|Protocol Violation|0|||
129593218|NCT01647711|466467959|FG001|Overall Study|Protocol Violation|0|||
129593219|NCT01647711|466467960|FG002|Overall Study|Protocol Violation|0|||
129593220|NCT01647711|466467961|FG003|Overall Study|Protocol Violation|0|||
129593221|NCT01647711|466467962|FG004|Overall Study|Protocol Violation|1|||
129593222|NCT01647711|466467958|FG000|Overall Study|Refused to continue taking medication|0|||
129593223|NCT01647711|466467959|FG001|Overall Study|Refused to continue taking medication|0|||
129593224|NCT01647711|466467960|FG002|Overall Study|Refused to continue taking medication|0|||
129593225|NCT01647711|466467961|FG003|Overall Study|Refused to continue taking medication|2|||
129593226|NCT01647711|466467962|FG004|Overall Study|Refused to continue taking medication|1|||
129593227|NCT01647711|466467958|FG000|Overall Study|Other reason not defined|0|||
129593228|NCT01647711|466467959|FG001|Overall Study|Other reason not defined|1|||
129593229|NCT01647711|466467960|FG002|Overall Study|Other reason not defined|1|||
129593230|NCT01647711|466467961|FG003|Overall Study|Other reason not defined|1|||
129593231|NCT01647711|466467962|FG004|Overall Study|Other reason not defined|0|||
129593232|NCT01796964|466467976|FG000|Overall Study|Adverse Event|1|||
129593233|NCT01796964|466467977|FG001|Overall Study|Adverse Event|1|||
129593234|NCT01796964|466467976|FG000|Overall Study|Death|1|||
129593235|NCT01796964|466467977|FG001|Overall Study|Death|0|||
129593236|NCT01796964|466467976|FG000|Overall Study|Protocol Violation|0|||
129593237|NCT01796964|466467977|FG001|Overall Study|Protocol Violation|1|||
129593238|NCT01796964|466467976|FG000|Overall Study|Withdrawal by Subject|1|||
129593239|NCT01796964|466467977|FG001|Overall Study|Withdrawal by Subject|1|||
129593240|NCT04025684|466467978|FG000|Overall Study|Withdrawal by Subject|1|||
129593241|NCT04025684|466467979|FG001|Overall Study|Withdrawal by Subject|1|||
129593242|NCT04025684|466467980|FG002|Overall Study|Withdrawal by Subject|0|||
129593243|NCT04025684|466467981|FG003|Overall Study|Withdrawal by Subject|0|||
129593244|NCT04025684|466467978|FG000|Overall Study|Multiple reasons|1|||
129593245|NCT04025684|466467979|FG001|Overall Study|Multiple reasons|3|||
129593246|NCT04025684|466467980|FG002|Overall Study|Multiple reasons|0|||
129593247|NCT04025684|466467981|FG003|Overall Study|Multiple reasons|1|||
129593248|NCT02070757|466467982|FG000|Overall Study|Adverse Event|107|||
129593249|NCT02070757|466467983|FG001|Overall Study|Adverse Event|99|||
129593250|NCT02070757|466467982|FG000|Overall Study|Lost to Follow-up|7|||
129593251|NCT02070757|466467983|FG001|Overall Study|Lost to Follow-up|4|||
129593252|NCT02070757|466467982|FG000|Overall Study|Protocol Violation|0|||
129593253|NCT02070757|466467983|FG001|Overall Study|Protocol Violation|4|||
129885597|NCT02611830|467540767|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
129593254|NCT02070757|466467982|FG000|Overall Study|Withdrawal by Subject|1|||
129593255|NCT02070757|466467983|FG001|Overall Study|Withdrawal by Subject|3|||
129593256|NCT02070757|466467982|FG000|Overall Study|Investigator Decision|0|||
129593257|NCT02070757|466467983|FG001|Overall Study|Investigator Decision|2|||
129593258|NCT02070757|466467982|FG000|Overall Study|Discharged from Study Hospital|2|||
129593259|NCT02070757|466467983|FG001|Overall Study|Discharged from Study Hospital|2|||
129593260|NCT01546922|466467984|FG000|First Period of 10 Weeks|Protocol Violation|3|||
129885598|NCT02611830|467540768|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
129593261|NCT01546922|466467985|FG001|First Period of 10 Weeks|Protocol Violation|1|||
129593262|NCT01546922|466467984|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
129593263|NCT01546922|466467985|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
129593264|NCT01546922|466467984|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
129593265|NCT01546922|466467985|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
129593266|NCT01546922|466467984|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
129593267|NCT01546922|466467985|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
129593268|NCT01546922|466467984|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
129593269|NCT01546922|466467985|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
129593270|NCT01613378|466467989|FG000|Overall Study|Lack of Efficacy|13|||
129593271|NCT01613378|466467989|FG000|Overall Study|Adverse Event|11|||
129593272|NCT01613378|466467989|FG000|Overall Study|Withdrawal by Subject|8|||
129593273|NCT01613378|466467989|FG000|Overall Study|Death|2|||
129593274|NCT01613378|466467989|FG000|Overall Study|Lost to Follow-up|1|||
129593275|NCT01613378|466467989|FG000|Overall Study|Other Reason|4|||
129593276|NCT00792623|466467999|FG000|Overall Study|Adverse Event|2|||
129593277|NCT00792623|466467999|FG000|Overall Study|Withdrawal by Subject|5|||
129593278|NCT00880087|466468000|FG000|Overall Study|Lost to Follow-up|0|||
129593279|NCT00880087|466468001|FG001|Overall Study|Lost to Follow-up|2|||
129593280|NCT02916693|466468002|FG000|Overall Study|Lost to Follow-up|7|||
129593281|NCT04205162|466468007|FG000|Overall Study|Lost to Follow-up|1|||
129593282|NCT04205162|466468008|FG001|Overall Study|Lost to Follow-up|0|||
129593283|NCT04205162|466468007|FG000|Overall Study|Withdrawal by Subject|2|||
129593284|NCT04205162|466468008|FG001|Overall Study|Withdrawal by Subject|0|||
129593285|NCT04205162|466468007|FG000|Overall Study|University closure due to COVID-19|1|||
129593286|NCT04205162|466468008|FG001|Overall Study|University closure due to COVID-19|0|||
129593287|NCT01011556|466468009|FG000|Overall Study|Adverse Event|1|||
129593288|NCT01011556|466468010|FG001|Overall Study|Adverse Event|3|||
129593289|NCT01011556|466468011|FG002|Overall Study|Adverse Event|2|||
129593290|NCT01011556|466468012|FG003|Overall Study|Adverse Event|1|||
129593291|NCT01011556|466468009|FG000|Overall Study|Lost to Follow-up|1|||
129593292|NCT01011556|466468010|FG001|Overall Study|Lost to Follow-up|0|||
129593293|NCT01011556|466468011|FG002|Overall Study|Lost to Follow-up|0|||
129593294|NCT01011556|466468012|FG003|Overall Study|Lost to Follow-up|0|||
129593295|NCT01011556|466468009|FG000|Overall Study|Physician Decision|1|||
129593296|NCT01011556|466468010|FG001|Overall Study|Physician Decision|0|||
129593297|NCT01011556|466468011|FG002|Overall Study|Physician Decision|0|||
129593298|NCT01011556|466468012|FG003|Overall Study|Physician Decision|1|||
129593299|NCT01011556|466468009|FG000|Overall Study|Protocol Violation|0|||
129593300|NCT01011556|466468010|FG001|Overall Study|Protocol Violation|1|||
129593301|NCT01011556|466468011|FG002|Overall Study|Protocol Violation|0|||
129593302|NCT01011556|466468012|FG003|Overall Study|Protocol Violation|0|||
129593303|NCT01011556|466468009|FG000|Overall Study|Withdrawal by Subject|1|||
129593304|NCT01011556|466468010|FG001|Overall Study|Withdrawal by Subject|2|||
129593305|NCT01011556|466468011|FG002|Overall Study|Withdrawal by Subject|4|||
129593306|NCT01011556|466468012|FG003|Overall Study|Withdrawal by Subject|4|||
129593307|NCT01011556|466468009|FG000|Overall Study|Sponsor decision|0|||
129593308|NCT01011556|466468010|FG001|Overall Study|Sponsor decision|1|||
129593309|NCT01011556|466468011|FG002|Overall Study|Sponsor decision|1|||
129593310|NCT01011556|466468012|FG003|Overall Study|Sponsor decision|2|||
129593311|NCT01011556|466468009|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
129593312|NCT01011556|466468010|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
129593313|NCT01011556|466468011|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
129593314|NCT01011556|466468012|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
129593315|NCT01463982|466468014|FG000|Overall Study|Withdrawal by Subject|0|||
129593316|NCT01463982|466468015|FG001|Overall Study|Withdrawal by Subject|1|||
129593317|NCT01463982|466468016|FG002|Overall Study|Withdrawal by Subject|1|||
129593318|NCT01463982|466468017|FG003|Overall Study|Withdrawal by Subject|0|||
129593319|NCT01463982|466468014|FG000|Overall Study|Treatment delay over 5 week|0|||
129593320|NCT01463982|466468015|FG001|Overall Study|Treatment delay over 5 week|0|||
129593321|NCT01463982|466468016|FG002|Overall Study|Treatment delay over 5 week|1|||
129593322|NCT01463982|466468017|FG003|Overall Study|Treatment delay over 5 week|0|||
129593323|NCT04220775|466468020|FG000|Overall Study|Adverse Event|1|||
129593324|NCT04220775|466468021|FG001|Overall Study|Adverse Event|0|||
129593325|NCT04220775|466468020|FG000|Overall Study|Disease Progression|1|||
129593326|NCT04220775|466468021|FG001|Overall Study|Disease Progression|0|||
129593327|NCT00089076|466468022|FG000|Overall Study|Alternate Therapy|1|||
129593328|NCT00089076|466468022|FG000|Overall Study|Withdrawal by Subject|2|||
129593329|NCT00089076|466468022|FG000|Overall Study|Progression|7|||
129593330|NCT00931463|466468023|FG000|Overall Study|Death|8|||
129593331|NCT00931463|466468024|FG001|Overall Study|Death|4|||
129593332|NCT00931463|466468023|FG000|Overall Study|Withdrawal by Subject|5|||
129593333|NCT00931463|466468024|FG001|Overall Study|Withdrawal by Subject|0|||
129593334|NCT00931463|466468023|FG000|Overall Study|Lost to Follow-up|4|||
129593335|NCT00931463|466468024|FG001|Overall Study|Lost to Follow-up|1|||
129593336|NCT03170869|466468025|FG000|Overall Study|Protocol Violation|5|||
129593337|NCT03170869|466468025|FG000|Overall Study|Early study termination|3|||
129593338|NCT01009515|466468026|FG000|Overall Study|Withdrawal by Subject|3|||
129593339|NCT00983476|466468032|FG000|Overall Study|Did not receive intervention|17|||
129593340|NCT00983476|466468033|FG001|Overall Study|Did not receive intervention|22|||
129593341|NCT00983476|466468034|FG002|Overall Study|Did not receive intervention|0|||
129593342|NCT01175473|466468036|FG000|Overall Study|Adverse Event|2|||
129593343|NCT01175473|466468037|FG001|Overall Study|Adverse Event|2|||
129593344|NCT01857973|466468038|FG000|Overall Study|Subject did not meet required BG range|3|||
129593345|NCT01857973|466468038|FG000|Overall Study|drop out after 3 failed attempts|1|||
129593346|NCT01857973|466468038|FG000|Overall Study|Physician Decision|1|||
129593347|NCT00129116|466468043|FG000|Primary Phase|Lost to Follow-up|1|||
129593348|NCT00129116|466468044|FG001|Primary Phase|Lost to Follow-up|1|||
129593349|NCT00129116|466468045|FG002|Primary Phase|Lost to Follow-up|0|||
129593350|NCT00129116|466468046|FG003|Primary Phase|Lost to Follow-up|1|||
129593351|NCT00129116|466468047|FG004|Primary Phase|Lost to Follow-up|1|||
129593352|NCT00129116|466468043|FG000|Primary Phase|Protocol Violation|0|||
129593353|NCT00129116|466468044|FG001|Primary Phase|Protocol Violation|1|||
129593354|NCT00129116|466468045|FG002|Primary Phase|Protocol Violation|0|||
129593355|NCT00129116|466468046|FG003|Primary Phase|Protocol Violation|0|||
129593356|NCT00129116|466468047|FG004|Primary Phase|Protocol Violation|0|||
129593357|NCT00129116|466468043|FG000|Primary Phase|Adverse Event|1|||
129593358|NCT00129116|466468044|FG001|Primary Phase|Adverse Event|1|||
129593359|NCT00129116|466468045|FG002|Primary Phase|Adverse Event|0|||
129593360|NCT00129116|466468046|FG003|Primary Phase|Adverse Event|0|||
129593361|NCT00129116|466468047|FG004|Primary Phase|Adverse Event|0|||
129593362|NCT00129116|466468043|FG000|Primary Phase|Withdrawal by Subject|0|||
129593363|NCT00129116|466468044|FG001|Primary Phase|Withdrawal by Subject|1|||
129593364|NCT00129116|466468045|FG002|Primary Phase|Withdrawal by Subject|0|||
129593365|NCT00129116|466468046|FG003|Primary Phase|Withdrawal by Subject|0|||
129593366|NCT00129116|466468047|FG004|Primary Phase|Withdrawal by Subject|0|||
129593367|NCT00129116|466468043|FG000|Primary Phase|Other|0|||
129593368|NCT00129116|466468044|FG001|Primary Phase|Other|0|||
129593369|NCT00129116|466468045|FG002|Primary Phase|Other|1|||
129593370|NCT00129116|466468046|FG003|Primary Phase|Other|0|||
129593371|NCT00129116|466468047|FG004|Primary Phase|Other|0|||
129593372|NCT00129116|466468043|FG000|Booster Phase|Lost to Follow-up|2|||
129593373|NCT00129116|466468044|FG001|Booster Phase|Lost to Follow-up|0|||
129593374|NCT00129116|466468045|FG002|Booster Phase|Lost to Follow-up|0|||
129593375|NCT00129116|466468046|FG003|Booster Phase|Lost to Follow-up|0|||
129593376|NCT00129116|466468047|FG004|Booster Phase|Lost to Follow-up|1|||
129593377|NCT02539368|466468050|FG000|Overall Study|Death|4|||
129593378|NCT02539368|466468051|FG001|Overall Study|Death|2|||
129593379|NCT02539368|466468052|FG002|Overall Study|Death|1|||
129593380|NCT02539368|466468053|FG003|Overall Study|Death|0|||
129593381|NCT02539368|466468054|FG004|Overall Study|Death|0|||
129593382|NCT02539368|466468050|FG000|Overall Study|Withdrawal by Subject|44|||
129593383|NCT02539368|466468051|FG001|Overall Study|Withdrawal by Subject|35|||
129593384|NCT02539368|466468052|FG002|Overall Study|Withdrawal by Subject|9|||
129593385|NCT02539368|466468053|FG003|Overall Study|Withdrawal by Subject|1|||
129593386|NCT02539368|466468054|FG004|Overall Study|Withdrawal by Subject|3|||
129593387|NCT02539368|466468050|FG000|Overall Study|Physician Decision|49|||
129593388|NCT02539368|466468051|FG001|Overall Study|Physician Decision|15|||
129593389|NCT02539368|466468052|FG002|Overall Study|Physician Decision|7|||
129593390|NCT02539368|466468053|FG003|Overall Study|Physician Decision|0|||
129593391|NCT02539368|466468054|FG004|Overall Study|Physician Decision|2|||
129593392|NCT02539368|466468050|FG000|Overall Study|Lost to Follow-up|96|||
129593393|NCT02539368|466468051|FG001|Overall Study|Lost to Follow-up|21|||
129593394|NCT02539368|466468052|FG002|Overall Study|Lost to Follow-up|16|||
129593395|NCT02539368|466468053|FG003|Overall Study|Lost to Follow-up|4|||
129593396|NCT02539368|466468054|FG004|Overall Study|Lost to Follow-up|3|||
129593397|NCT02539368|466468050|FG000|Overall Study|Adverse Event|44|||
129593398|NCT02539368|466468051|FG001|Overall Study|Adverse Event|5|||
129593399|NCT02539368|466468052|FG002|Overall Study|Adverse Event|9|||
129593400|NCT02539368|466468053|FG003|Overall Study|Adverse Event|0|||
129593401|NCT02539368|466468054|FG004|Overall Study|Adverse Event|3|||
129593402|NCT02539368|466468050|FG000|Overall Study|Participant Non-compliant|13|||
129593403|NCT02539368|466468051|FG001|Overall Study|Participant Non-compliant|2|||
129593404|NCT02539368|466468052|FG002|Overall Study|Participant Non-compliant|1|||
129593405|NCT02539368|466468053|FG003|Overall Study|Participant Non-compliant|1|||
129593406|NCT02539368|466468054|FG004|Overall Study|Participant Non-compliant|0|||
129593407|NCT02539368|466468050|FG000|Overall Study|Other|145|||
129593408|NCT02539368|466468051|FG001|Overall Study|Other|18|||
129593409|NCT02539368|466468052|FG002|Overall Study|Other|24|||
129593410|NCT02539368|466468053|FG003|Overall Study|Other|1|||
129593411|NCT02539368|466468054|FG004|Overall Study|Other|3|||
129593412|NCT02539368|466468050|FG000|Overall Study|Missing|10|||
129593413|NCT02539368|466468051|FG001|Overall Study|Missing|3|||
129593414|NCT02539368|466468052|FG002|Overall Study|Missing|0|||
129593415|NCT02539368|466468053|FG003|Overall Study|Missing|0|||
129593416|NCT02539368|466468054|FG004|Overall Study|Missing|0|||
129593417|NCT03558139|466468056|FG000|Overall Study|Consent Withdrawn|1|||
129593418|NCT03558139|466468057|FG001|Overall Study|Consent Withdrawn|1|||
129593419|NCT03558139|466468058|FG002|Overall Study|Consent Withdrawn|4|||
129593420|NCT03558139|466468056|FG000|Overall Study|Death|5|||
129593421|NCT03558139|466468057|FG001|Overall Study|Death|3|||
129593422|NCT03558139|466468058|FG002|Overall Study|Death|8|||
129593423|NCT03558139|466468056|FG000|Overall Study|Lost to Follow-up|0|||
129593424|NCT03558139|466468057|FG001|Overall Study|Lost to Follow-up|0|||
129593425|NCT03558139|466468058|FG002|Overall Study|Lost to Follow-up|3|||
129593426|NCT03558139|466468056|FG000|Overall Study|Study Ended Per Protocol|0|||
129593427|NCT03558139|466468057|FG001|Overall Study|Study Ended Per Protocol|3|||
129593428|NCT03558139|466468058|FG002|Overall Study|Study Ended Per Protocol|6|||
129593429|NCT02752802|466468059|FG000|Overall Study|Contrast Volume Not Collected|1|||
129593430|NCT02752802|466468060|FG001|Overall Study|Contrast Volume Not Collected|0|||
129593431|NCT02808819|466468061|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
129593432|NCT02808819|466468062|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
129593433|NCT02808819|466468061|FG000|Overall Study|Withdrawal by Subject|10|||
129593434|NCT02808819|466468062|FG001|Overall Study|Withdrawal by Subject|13|||
129593435|NCT02808819|466468061|FG000|Overall Study|Site terminated by sponsor|2|||
129593436|NCT02808819|466468062|FG001|Overall Study|Site terminated by sponsor|0|||
129593437|NCT02808819|466468061|FG000|Overall Study|Pregnancy|1|||
129593438|NCT02808819|466468062|FG001|Overall Study|Pregnancy|0|||
129593439|NCT02808819|466468061|FG000|Overall Study|Lost to Follow-up|1|||
129593440|NCT02808819|466468062|FG001|Overall Study|Lost to Follow-up|6|||
129593441|NCT02808819|466468061|FG000|Overall Study|Protocol Violation|0|||
129593442|NCT02808819|466468062|FG001|Overall Study|Protocol Violation|1|||
129593443|NCT02808819|466468061|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
129593444|NCT02808819|466468062|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
129593445|NCT02808819|466468061|FG000|Overall Study|Death|1|||
129593446|NCT02808819|466468062|FG001|Overall Study|Death|0|||
129593447|NCT02808819|466468061|FG000|Overall Study|Adverse Event|3|||
129593448|NCT02808819|466468062|FG001|Overall Study|Adverse Event|4|||
129593449|NCT03573817|466468063|FG000|Overall Study|Adverse Event|0|||
129593450|NCT03573817|466468064|FG001|Overall Study|Adverse Event|2|||
129593451|NCT03573817|466468063|FG000|Overall Study|Protocol Violation|0|||
129593452|NCT03573817|466468064|FG001|Overall Study|Protocol Violation|1|||
129593453|NCT03573817|466468063|FG000|Overall Study|Withdrawal by Subject|1|||
129593454|NCT03573817|466468064|FG001|Overall Study|Withdrawal by Subject|1|||
129593455|NCT02013531|466468065|FG000|Overall Study|Lost to Follow-up|3|||
129593456|NCT02013531|466468065|FG000|Overall Study|Met Withdrawal Criteria|1|||
129593457|NCT02013531|466468065|FG000|Overall Study|Withdrawal by Subject|1|||
129593458|NCT03546647|466468066|FG000|Overall Study|Adverse Event|1|||
129593459|NCT03546647|466468067|FG001|Overall Study|Adverse Event|0|||
129593460|NCT02400476|466468068|FG000|Overall Study|Adverse Event|57|||
129593461|NCT02400476|466468069|FG001|Overall Study|Adverse Event|10|||
129593462|NCT02400476|466468070|FG002|Overall Study|Adverse Event|22|||
129593463|NCT02400476|466468071|FG003|Overall Study|Adverse Event|19|||
129593464|NCT02400476|466468072|FG004|Overall Study|Adverse Event|5|||
129593465|NCT02400476|466468073|FG005|Overall Study|Adverse Event|8|||
129593466|NCT02400476|466468068|FG000|Overall Study|Withdrawal by Subject|4|||
129593467|NCT02400476|466468069|FG001|Overall Study|Withdrawal by Subject|1|||
129593468|NCT02400476|466468070|FG002|Overall Study|Withdrawal by Subject|12|||
129593469|NCT02400476|466468071|FG003|Overall Study|Withdrawal by Subject|7|||
129593470|NCT02400476|466468072|FG004|Overall Study|Withdrawal by Subject|5|||
129593471|NCT02400476|466468073|FG005|Overall Study|Withdrawal by Subject|5|||
129593472|NCT02400476|466468068|FG000|Overall Study|Lost to Follow-up|0|||
129593473|NCT02400476|466468069|FG001|Overall Study|Lost to Follow-up|0|||
129696535|NCT01953354|466848131|FG001|Overall Study|Decision of Sponsor|1|||
129696536|NCT01953354|466848130|FG000|Overall Study|Disease Exacerbation|1|||
129696537|NCT01953354|466848131|FG001|Overall Study|Disease Exacerbation|0|||
129696538|NCT01696214|466848132|FG000|Overall Study|Lost to Follow-up|1|||
129696539|NCT01696214|466848133|FG001|Overall Study|Lost to Follow-up|0|||
129593474|NCT02400476|466468070|FG002|Overall Study|Lost to Follow-up|0|||
129593475|NCT02400476|466468071|FG003|Overall Study|Lost to Follow-up|1|||
129593476|NCT02400476|466468072|FG004|Overall Study|Lost to Follow-up|3|||
129593477|NCT02400476|466468073|FG005|Overall Study|Lost to Follow-up|1|||
129593478|NCT02400476|466468068|FG000|Overall Study|Physician Decision|0|||
129593479|NCT02400476|466468069|FG001|Overall Study|Physician Decision|0|||
129593480|NCT02400476|466468070|FG002|Overall Study|Physician Decision|1|||
129593481|NCT02400476|466468071|FG003|Overall Study|Physician Decision|1|||
129593482|NCT02400476|466468072|FG004|Overall Study|Physician Decision|0|||
129593483|NCT02400476|466468073|FG005|Overall Study|Physician Decision|1|||
129593484|NCT02400476|466468068|FG000|Overall Study|Other, Disease Progression|0|||
129593485|NCT02400476|466468069|FG001|Overall Study|Other, Disease Progression|1|||
129593486|NCT02400476|466468070|FG002|Overall Study|Other, Disease Progression|2|||
129593487|NCT02400476|466468071|FG003|Overall Study|Other, Disease Progression|1|||
129593488|NCT02400476|466468072|FG004|Overall Study|Other, Disease Progression|2|||
129593489|NCT02400476|466468073|FG005|Overall Study|Other, Disease Progression|1|||
129593490|NCT02400476|466468068|FG000|Overall Study|Other, Decreased Quality of Life|0|||
129593491|NCT02400476|466468069|FG001|Overall Study|Other, Decreased Quality of Life|0|||
129593492|NCT02400476|466468070|FG002|Overall Study|Other, Decreased Quality of Life|2|||
129593493|NCT02400476|466468071|FG003|Overall Study|Other, Decreased Quality of Life|0|||
129593494|NCT02400476|466468072|FG004|Overall Study|Other, Decreased Quality of Life|0|||
129593495|NCT02400476|466468073|FG005|Overall Study|Other, Decreased Quality of Life|0|||
129593496|NCT02400476|466468068|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
129593497|NCT02400476|466468069|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
129593498|NCT02400476|466468070|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
129885599|NCT02611830|467540769|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
129593499|NCT02400476|466468071|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
129593500|NCT02400476|466468072|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
129593501|NCT02400476|466468073|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
129593502|NCT00003531|466468074|FG000|Overall Study|Not evaluable|10|||
129593503|NCT00588731|466468077|FG000|Overall Study|Withdrawal by Subject|3|||
129593504|NCT00588731|466468078|FG001|Overall Study|Withdrawal by Subject|2|||
129593505|NCT00251316|466468079|FG000|Overall Study|Physician Decision|2|||
129593506|NCT00251316|466468080|FG001|Overall Study|Physician Decision|3|||
129593507|NCT00346164|466468081|FG000|Overall Study|Adverse Event|0|||
129593508|NCT00346164|466468082|FG001|Overall Study|Adverse Event|0|||
129593509|NCT00346164|466468083|FG002|Overall Study|Adverse Event|0|||
129593510|NCT00346164|466468084|FG003|Overall Study|Adverse Event|1|||
129593511|NCT00346164|466468081|FG000|Overall Study|Lack of Efficacy|0|||
129593512|NCT00346164|466468082|FG001|Overall Study|Lack of Efficacy|1|||
129593513|NCT00346164|466468083|FG002|Overall Study|Lack of Efficacy|7|||
129593514|NCT00346164|466468084|FG003|Overall Study|Lack of Efficacy|25|||
129593515|NCT00346164|466468081|FG000|Overall Study|Physician Decision|0|||
129593516|NCT00346164|466468082|FG001|Overall Study|Physician Decision|1|||
129593517|NCT00346164|466468083|FG002|Overall Study|Physician Decision|2|||
129593518|NCT00346164|466468084|FG003|Overall Study|Physician Decision|27|||
129593519|NCT00346164|466468081|FG000|Overall Study|Protocol Violation|6|||
129593520|NCT00346164|466468082|FG001|Overall Study|Protocol Violation|2|||
129593521|NCT00346164|466468083|FG002|Overall Study|Protocol Violation|10|||
129593522|NCT00346164|466468084|FG003|Overall Study|Protocol Violation|4|||
129593523|NCT00346164|466468081|FG000|Overall Study|Withdrawal by Subject|0|||
129593524|NCT00346164|466468082|FG001|Overall Study|Withdrawal by Subject|0|||
129593525|NCT00346164|466468083|FG002|Overall Study|Withdrawal by Subject|2|||
129593526|NCT00346164|466468084|FG003|Overall Study|Withdrawal by Subject|0|||
129593527|NCT00346164|466468081|FG000|Overall Study|Ineligible|11|||
129593528|NCT00346164|466468082|FG001|Overall Study|Ineligible|2|||
129593529|NCT00346164|466468083|FG002|Overall Study|Ineligible|2|||
129593530|NCT00346164|466468084|FG003|Overall Study|Ineligible|23|||
129593531|NCT00346164|466468081|FG000|Overall Study|Refusal of further protocol therapy|0|||
129593532|NCT00346164|466468082|FG001|Overall Study|Refusal of further protocol therapy|1|||
129593533|NCT00346164|466468083|FG002|Overall Study|Refusal of further protocol therapy|3|||
129593534|NCT00346164|466468084|FG003|Overall Study|Refusal of further protocol therapy|15|||
129593535|NCT00346164|466468081|FG000|Overall Study|Inability to start week 16 tx on time|0|||
129593536|NCT00346164|466468082|FG001|Overall Study|Inability to start week 16 tx on time|0|||
129593537|NCT00346164|466468083|FG002|Overall Study|Inability to start week 16 tx on time|0|||
129593538|NCT00346164|466468084|FG003|Overall Study|Inability to start week 16 tx on time|11|||
129593539|NCT00612677|466468087|FG000|Overall Study|study closed before treatment started|1|||
129593540|NCT03417830|466468088|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
129593541|NCT03417830|466468089|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
129593542|NCT01684878|466468095|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
129593543|NCT01684878|466468096|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
129593544|NCT01684878|466468097|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
129593545|NCT01684878|466468098|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
129593546|NCT01684878|466468095|FG000|Part 1: Safety Run in Phase|Death|15|||
129593547|NCT01684878|466468096|FG001|Part 1: Safety Run in Phase|Death|20|||
129593548|NCT01684878|466468097|FG002|Part 1: Safety Run in Phase|Death|0|||
129593549|NCT01684878|466468098|FG003|Part 1: Safety Run in Phase|Death|0|||
129593550|NCT01684878|466468095|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
129593551|NCT01684878|466468096|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
129593552|NCT01684878|466468097|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
129593553|NCT01684878|466468098|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
129593554|NCT01684878|466468095|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
129593555|NCT01684878|466468096|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
129593556|NCT01684878|466468097|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
129593557|NCT01684878|466468098|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
129593558|NCT01684878|466468095|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
129593559|NCT01684878|466468096|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
129593560|NCT01684878|466468097|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
129593561|NCT01684878|466468098|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
129593562|NCT01684878|466468095|FG000|Part 2: Randomized Phase|Death|0|||
129593563|NCT01684878|466468096|FG001|Part 2: Randomized Phase|Death|0|||
129593564|NCT01684878|466468097|FG002|Part 2: Randomized Phase|Death|62|||
129593565|NCT01684878|466468098|FG003|Part 2: Randomized Phase|Death|68|||
129593566|NCT01684878|466468095|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
129593567|NCT01684878|466468096|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
129593568|NCT01684878|466468097|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
129593569|NCT01684878|466468098|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
129593570|NCT01684878|466468095|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
129593571|NCT01684878|466468096|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
129593572|NCT01684878|466468097|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
129593573|NCT01684878|466468098|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
129593574|NCT02927834|466468099|FG000|Overall Study|Lost to Follow-up|1|||
129593575|NCT02927834|466468100|FG001|Overall Study|Lost to Follow-up|2|||
129593576|NCT02927834|466468101|FG002|Overall Study|Lost to Follow-up|2|||
129593577|NCT01662362|466468112|FG000|Overall Study|Lost to Follow-up|38|||
129593578|NCT01181531|466468117|FG000|Overall Study|Other|17|||
129593579|NCT01181531|466468118|FG001|Overall Study|Other|12|||
129593580|NCT01181531|466468117|FG000|Overall Study|Partial consent by subject withdrawn|0|||
129593581|NCT01181531|466468118|FG001|Overall Study|Partial consent by subject withdrawn|1|||
129593582|NCT01181531|466468117|FG000|Overall Study|Physician Decision|3|||
129593583|NCT01181531|466468118|FG001|Overall Study|Physician Decision|1|||
129593584|NCT01181531|466468117|FG000|Overall Study|Noncompliance|2|||
129593585|NCT01181531|466468118|FG001|Overall Study|Noncompliance|2|||
129593586|NCT01181531|466468117|FG000|Overall Study|Ineligibility determined|1|||
129593587|NCT01181531|466468118|FG001|Overall Study|Ineligibility determined|2|||
129593588|NCT01181531|466468117|FG000|Overall Study|Protocol Specified Criteria|15|||
129593589|NCT01181531|466468118|FG001|Overall Study|Protocol Specified Criteria|8|||
129593590|NCT01181531|466468117|FG000|Overall Study|Pregnancy|0|||
129593591|NCT01181531|466468118|FG001|Overall Study|Pregnancy|1|||
129593592|NCT01181531|466468117|FG000|Overall Study|Withdrawal by Subject|8|||
129593593|NCT01181531|466468118|FG001|Overall Study|Withdrawal by Subject|7|||
129593594|NCT01181531|466468117|FG000|Overall Study|Protocol Violation|6|||
129593595|NCT01181531|466468118|FG001|Overall Study|Protocol Violation|6|||
129593596|NCT01181531|466468117|FG000|Overall Study|Death|9|||
129593597|NCT01181531|466468118|FG001|Overall Study|Death|12|||
129593598|NCT01181531|466468117|FG000|Overall Study|Adverse Event|0|||
129593599|NCT01181531|466468118|FG001|Overall Study|Adverse Event|1|||
129593600|NCT00987831|466468119|FG000|Overall Study|Never flared in 12 months|1|||
129593601|NCT00987831|466468120|FG001|Overall Study|Never flared in 12 months|0|||
129593602|NCT00987831|466468121|FG002|Overall Study|Never flared in 12 months|0|||
129593603|NCT00987831|466468119|FG000|Overall Study|Lost to Follow-up|0|||
129593604|NCT00987831|466468120|FG001|Overall Study|Lost to Follow-up|3|||
129593605|NCT00987831|466468121|FG002|Overall Study|Lost to Follow-up|0|||
129593606|NCT00810602|466468123|FG000|Overall Study|Withdrawal by Subject|8|||
129593607|NCT00810602|466468124|FG001|Overall Study|Withdrawal by Subject|3|||
129593608|NCT02792218|466468125|FG000|Overall Study|Patient/guardian decision|15|||
129593609|NCT02792218|466468126|FG001|Overall Study|Patient/guardian decision|42|||
129593610|NCT02792218|466468125|FG000|Overall Study|Adverse Event|15|||
129593611|NCT02792218|466468126|FG001|Overall Study|Adverse Event|14|||
129593612|NCT02792218|466468125|FG000|Overall Study|Lost to Follow-up|10|||
129593613|NCT02792218|466468126|FG001|Overall Study|Lost to Follow-up|5|||
129593614|NCT02792218|466468125|FG000|Overall Study|Lack of Efficacy|1|||
129593615|NCT02792218|466468126|FG001|Overall Study|Lack of Efficacy|12|||
129593616|NCT02792218|466468125|FG000|Overall Study|Physician Decision|4|||
129593617|NCT02792218|466468126|FG001|Overall Study|Physician Decision|4|||
129593618|NCT02792218|466468125|FG000|Overall Study|Protocol deviation|3|||
129593619|NCT02792218|466468126|FG001|Overall Study|Protocol deviation|2|||
129593620|NCT02792218|466468125|FG000|Overall Study|New therapy for study indication|0|||
129593621|NCT02792218|466468126|FG001|Overall Study|New therapy for study indication|1|||
129593622|NCT02792218|466468125|FG000|Overall Study|Non-compliance with study treatment|0|||
129593623|NCT02792218|466468126|FG001|Overall Study|Non-compliance with study treatment|1|||
129593624|NCT02792218|466468125|FG000|Overall Study|Pregnancy|1|||
129593625|NCT02792218|466468126|FG001|Overall Study|Pregnancy|0|||
129593626|NCT00824369|466468127|FG000|Overall Study|Nolonger willing to participate in study|1|||
129593627|NCT00824369|466468128|FG001|Overall Study|Nolonger willing to participate in study|0|||
129593628|NCT00824369|466468129|FG002|Overall Study|Nolonger willing to participate in study|1|||
129593629|NCT00824369|466468130|FG003|Overall Study|Nolonger willing to participate in study|2|||
129593630|NCT00824369|466468131|FG004|Overall Study|Nolonger willing to participate in study|0|||
129593631|NCT00824369|466468132|FG005|Overall Study|Nolonger willing to participate in study|1|||
129593632|NCT00824369|466468127|FG000|Overall Study|Lost to Follow-up|0|||
129593633|NCT00824369|466468128|FG001|Overall Study|Lost to Follow-up|0|||
129593634|NCT00824369|466468129|FG002|Overall Study|Lost to Follow-up|0|||
129593635|NCT00824369|466468130|FG003|Overall Study|Lost to Follow-up|0|||
129593636|NCT00824369|466468131|FG004|Overall Study|Lost to Follow-up|1|||
129593637|NCT00824369|466468132|FG005|Overall Study|Lost to Follow-up|0|||
129593638|NCT01619579|466470691|FG000|Overall Study|Withdrawal by Subject|0|||
129593639|NCT01619579|466470692|FG001|Overall Study|Withdrawal by Subject|3|||
129593640|NCT02124902|466470693|FG000|Overall Study|Adverse Event|7|||
129593641|NCT02124902|466470694|FG001|Overall Study|Adverse Event|2|||
129593642|NCT02124902|466470693|FG000|Overall Study|Went to alternative treatment|4|||
129593643|NCT02124902|466470694|FG001|Overall Study|Went to alternative treatment|0|||
129593644|NCT02124902|466470693|FG000|Overall Study|Withdrawal by Subject|2|||
129593645|NCT02124902|466470694|FG001|Overall Study|Withdrawal by Subject|1|||
129593646|NCT02124902|466470693|FG000|Overall Study|Physician Decision|2|||
129593647|NCT02124902|466470694|FG001|Overall Study|Physician Decision|0|||
129593648|NCT02124902|466470693|FG000|Overall Study|Not eligible|1|||
129593649|NCT02124902|466470694|FG001|Overall Study|Not eligible|0|||
129593650|NCT02124902|466470693|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
129593651|NCT02124902|466470694|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
129593652|NCT02012452|466470698|FG000|Overall Study|Lost to Follow-up|2|||
129593653|NCT02012452|466470699|FG001|Overall Study|Lost to Follow-up|1|||
129593654|NCT02012452|466470698|FG000|Overall Study|Withdrawal by Subject|4|||
129593655|NCT02012452|466470699|FG001|Overall Study|Withdrawal by Subject|0|||
129593656|NCT02688387|466470700|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593657|NCT02688387|466470701|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593658|NCT02688387|466470702|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
129593659|NCT02688387|466470703|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593660|NCT02688387|466470704|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593661|NCT02688387|466470705|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593662|NCT02688387|466470706|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593663|NCT02688387|466470707|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593664|NCT02688387|466470708|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593665|NCT02688387|466470709|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593666|NCT02688387|466470710|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593667|NCT02688387|466470711|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593668|NCT02688387|466470712|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593669|NCT02688387|466470713|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593670|NCT02688387|466470714|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593671|NCT02688387|466470715|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593672|NCT02688387|466470716|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593673|NCT02688387|466470717|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593674|NCT02688387|466470718|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593675|NCT02688387|466470719|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593676|NCT02688387|466470720|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593677|NCT02688387|466470721|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
129593678|NCT02688387|466470700|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593679|NCT02688387|466470701|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593680|NCT02688387|466470702|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129696540|NCT01696214|466848134|FG002|Overall Study|Lost to Follow-up|0|||
129593681|NCT02688387|466470703|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
129593682|NCT02688387|466470704|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593683|NCT02688387|466470705|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593684|NCT02688387|466470706|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593685|NCT02688387|466470707|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593686|NCT02688387|466470708|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593687|NCT02688387|466470709|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593688|NCT02688387|466470710|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593689|NCT02688387|466470711|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593690|NCT02688387|466470712|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593691|NCT02688387|466470713|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593692|NCT02688387|466470714|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593693|NCT02688387|466470715|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593694|NCT02688387|466470716|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593695|NCT02688387|466470717|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593696|NCT02688387|466470718|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593697|NCT02688387|466470719|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593698|NCT02688387|466470720|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593699|NCT02688387|466470721|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593700|NCT02688387|466470700|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593701|NCT02688387|466470701|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
129593702|NCT02688387|466470702|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593703|NCT02688387|466470703|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593704|NCT02688387|466470704|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593705|NCT02688387|466470705|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593706|NCT02688387|466470706|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593707|NCT02688387|466470707|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593708|NCT02688387|466470708|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593709|NCT02688387|466470709|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593710|NCT02688387|466470710|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593711|NCT02688387|466470711|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593712|NCT02688387|466470712|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593713|NCT02688387|466470713|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593714|NCT02688387|466470714|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593715|NCT02688387|466470715|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593716|NCT02688387|466470716|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593717|NCT02688387|466470717|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593718|NCT02688387|466470718|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593719|NCT02688387|466470719|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593720|NCT02688387|466470720|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593721|NCT02688387|466470721|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
129593722|NCT02688387|466470700|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593723|NCT02688387|466470701|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593724|NCT02688387|466470702|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
129593725|NCT02688387|466470703|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593726|NCT02688387|466470704|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
129593727|NCT02688387|466470705|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593728|NCT02688387|466470706|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593729|NCT02688387|466470707|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593730|NCT02688387|466470708|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593731|NCT02688387|466470709|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593732|NCT02688387|466470710|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593733|NCT02688387|466470711|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593734|NCT02688387|466470712|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593735|NCT02688387|466470713|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593736|NCT02688387|466470714|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593737|NCT02688387|466470715|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593738|NCT02688387|466470716|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593739|NCT02688387|466470717|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593740|NCT02688387|466470718|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593741|NCT02688387|466470719|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593742|NCT02688387|466470720|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593743|NCT02688387|466470721|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
129593744|NCT02688387|466470700|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
129593745|NCT02688387|466470701|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593746|NCT02688387|466470702|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593747|NCT02688387|466470703|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593748|NCT02688387|466470704|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593749|NCT02688387|466470705|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593750|NCT02688387|466470706|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593751|NCT02688387|466470707|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593752|NCT02688387|466470708|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593753|NCT02688387|466470709|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593754|NCT02688387|466470710|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593755|NCT02688387|466470711|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593756|NCT02688387|466470712|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593757|NCT02688387|466470713|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593758|NCT02688387|466470714|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593759|NCT02688387|466470715|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593760|NCT02688387|466470716|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593761|NCT02688387|466470717|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593762|NCT02688387|466470718|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593763|NCT02688387|466470719|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593764|NCT02688387|466470720|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593765|NCT02688387|466470721|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
129593766|NCT02688387|466470700|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593767|NCT02688387|466470701|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593768|NCT02688387|466470702|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593769|NCT02688387|466470703|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593770|NCT02688387|466470704|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593771|NCT02688387|466470705|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593772|NCT02688387|466470706|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593773|NCT02688387|466470707|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593774|NCT02688387|466470708|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593775|NCT02688387|466470709|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593776|NCT02688387|466470710|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
129593777|NCT02688387|466470711|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593778|NCT02688387|466470712|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593779|NCT02688387|466470713|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593780|NCT02688387|466470714|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593781|NCT02688387|466470715|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593782|NCT02688387|466470716|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593783|NCT02688387|466470717|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593784|NCT02688387|466470718|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593785|NCT02688387|466470719|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593786|NCT02688387|466470720|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593787|NCT02688387|466470721|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
129593788|NCT02688387|466470700|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593789|NCT02688387|466470701|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593790|NCT02688387|466470702|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593791|NCT02688387|466470703|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593792|NCT02688387|466470704|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593793|NCT02688387|466470705|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593794|NCT02688387|466470706|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593795|NCT02688387|466470707|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593796|NCT02688387|466470708|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593797|NCT02688387|466470709|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593798|NCT02688387|466470710|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593799|NCT02688387|466470711|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593800|NCT02688387|466470712|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593801|NCT02688387|466470713|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593802|NCT02688387|466470714|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
129593803|NCT02688387|466470715|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593804|NCT02688387|466470716|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129696541|NCT01696214|466848135|FG003|Overall Study|Lost to Follow-up|0|||
129885600|NCT02611830|467540770|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
129593805|NCT02688387|466470717|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593806|NCT02688387|466470718|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593807|NCT02688387|466470719|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593808|NCT02688387|466470720|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593809|NCT02688387|466470721|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
129593810|NCT02688387|466470700|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593811|NCT02688387|466470701|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593812|NCT02688387|466470702|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593813|NCT02688387|466470703|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593814|NCT02688387|466470704|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593815|NCT02688387|466470705|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593816|NCT02688387|466470706|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593817|NCT02688387|466470707|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593818|NCT02688387|466470708|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593819|NCT02688387|466470709|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593820|NCT02688387|466470710|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593821|NCT02688387|466470711|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593822|NCT02688387|466470712|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593823|NCT02688387|466470713|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593824|NCT02688387|466470714|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593825|NCT02688387|466470715|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593826|NCT02688387|466470716|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593827|NCT02688387|466470717|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593828|NCT02688387|466470718|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593829|NCT02688387|466470719|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593830|NCT02688387|466470720|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
129593831|NCT02688387|466470721|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
129593832|NCT02688387|466470700|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593833|NCT02688387|466470701|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593834|NCT02688387|466470702|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593835|NCT02688387|466470703|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593836|NCT02688387|466470704|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593837|NCT02688387|466470705|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593838|NCT02688387|466470706|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593839|NCT02688387|466470707|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593840|NCT02688387|466470708|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593841|NCT02688387|466470709|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593842|NCT02688387|466470710|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593843|NCT02688387|466470711|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593844|NCT02688387|466470712|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593845|NCT02688387|466470713|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593846|NCT02688387|466470714|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593847|NCT02688387|466470715|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593848|NCT02688387|466470716|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593849|NCT02688387|466470717|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593850|NCT02688387|466470718|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
129593851|NCT02688387|466470719|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593852|NCT02688387|466470720|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
129593853|NCT02688387|466470721|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
129593854|NCT02688387|466470700|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593855|NCT02688387|466470701|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593856|NCT02688387|466470702|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593857|NCT02688387|466470703|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593858|NCT02688387|466470704|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593859|NCT02688387|466470705|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593860|NCT02688387|466470706|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593861|NCT02688387|466470707|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593862|NCT02688387|466470708|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593863|NCT02688387|466470709|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593864|NCT02688387|466470710|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593865|NCT02688387|466470711|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593866|NCT02688387|466470712|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593867|NCT02688387|466470713|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593868|NCT02688387|466470714|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593869|NCT02688387|466470715|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593870|NCT02688387|466470716|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593871|NCT02688387|466470717|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593872|NCT02688387|466470718|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593873|NCT02688387|466470719|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
129593874|NCT02688387|466470720|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593875|NCT02688387|466470721|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
129593876|NCT02938442|466470724|FG000|Overall Study|Death|0|||
129593877|NCT02938442|466470725|FG001|Overall Study|Death|1|||
129593878|NCT02938442|466470724|FG000|Overall Study|Lost to Follow-up|0|||
129593879|NCT02938442|466470725|FG001|Overall Study|Lost to Follow-up|1|||
129593880|NCT02938442|466470724|FG000|Overall Study|Physician Decision|0|||
129593881|NCT02938442|466470725|FG001|Overall Study|Physician Decision|1|||
129593882|NCT02938442|466470724|FG000|Overall Study|Withdrawal by Subject|2|||
129593883|NCT02938442|466470725|FG001|Overall Study|Withdrawal by Subject|0|||
129593884|NCT04403399|466470727|FG000|Period 2|Physician Decision|0|||
129593885|NCT04403399|466470728|FG001|Period 2|Physician Decision|1|||
129593886|NCT01606228|466470729|FG000|Overall Study|Lost to Follow-up|20|||
129593887|NCT01606228|466470729|FG000|Overall Study|Withdrawal by Subject|3|||
129593888|NCT01606228|466470729|FG000|Overall Study|Non-compliant|3|||
129593889|NCT01606228|466470729|FG000|Overall Study|Lack of Efficacy|2|||
129593890|NCT01606228|466470729|FG000|Overall Study|Adverse Event|1|||
129593891|NCT02960438|466470730|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
129593892|NCT02960438|466470731|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
129593893|NCT02960438|466470732|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
129593894|NCT02960438|466470733|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
129593895|NCT02960438|466470730|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
129593896|NCT02960438|466470731|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
129593897|NCT02960438|466470732|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
129593898|NCT02960438|466470733|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
129593899|NCT02960438|466470730|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
129593900|NCT02960438|466470731|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
129593901|NCT02960438|466470732|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
129593902|NCT02960438|466470733|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
129593903|NCT02960438|466470730|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
129593904|NCT02960438|466470731|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
129593905|NCT02960438|466470732|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
129593906|NCT02960438|466470733|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
129593907|NCT02960438|466470730|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
129593908|NCT02960438|466470731|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
129593909|NCT02960438|466470732|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
129593910|NCT02960438|466470733|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
129593911|NCT02960438|466470730|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
129593912|NCT02960438|466470731|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
129593913|NCT02960438|466470732|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
129593914|NCT02960438|466470733|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
129593915|NCT02960438|466470730|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
129593916|NCT02960438|466470731|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
129593917|NCT02960438|466470732|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
129593918|NCT02960438|466470733|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
129593919|NCT02960438|466470730|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
129593920|NCT02960438|466470731|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
129593921|NCT02960438|466470732|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
129593922|NCT02960438|466470733|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
129593923|NCT02960438|466470730|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
129593924|NCT02960438|466470731|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
129593925|NCT02960438|466470732|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
129593926|NCT02960438|466470733|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
129593927|NCT02960438|466470730|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
129593928|NCT02960438|466470731|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
129593929|NCT02960438|466470732|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
129593930|NCT02960438|466470733|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
129593931|NCT02960438|466470730|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
129593932|NCT02960438|466470731|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
129593933|NCT02960438|466470732|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
129593934|NCT02960438|466470733|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
129593935|NCT02960438|466470730|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
129593936|NCT02960438|466470731|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
129593937|NCT02960438|466470732|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
129593938|NCT02960438|466470733|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
129593939|NCT01316419|466470741|FG000|Overall Study|Not treated|103|||
129593940|NCT01316419|466470741|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
129593941|NCT01316419|466470741|FG000|Overall Study|Lost to Follow-up|19|||
129593942|NCT02310789|466470744|FG000|Overall Study|Adverse Event|1|||
129593943|NCT00794417|466470747|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
129593944|NCT00794417|466470748|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
129593945|NCT00794417|466470749|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
129593946|NCT00794417|466470750|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
129593947|NCT00794417|466470747|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
129593948|NCT00794417|466470748|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
129593949|NCT00794417|466470749|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
129593950|NCT00794417|466470750|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
129593951|NCT00794417|466470747|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
129593952|NCT00794417|466470748|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
129593953|NCT00794417|466470749|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
129593954|NCT00794417|466470750|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
129593955|NCT00794417|466470747|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
129593956|NCT00794417|466470748|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
129593957|NCT00794417|466470749|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
129593958|NCT00794417|466470750|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
129593959|NCT00794417|466470747|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
129593960|NCT00794417|466470748|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
129593961|NCT00794417|466470749|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
129593962|NCT00794417|466470750|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
129593963|NCT00794417|466470747|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
129593964|NCT00794417|466470748|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
129593965|NCT00794417|466470749|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
129593966|NCT00794417|466470750|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
129593967|NCT00804141|466470751|FG000|Overall Study|Adverse Event|157|||
129593968|NCT00804141|466470751|FG000|Overall Study|Death|4|||
129593969|NCT00804141|466470751|FG000|Overall Study|Failed to return|96|||
129593970|NCT00804141|466470751|FG000|Overall Study|Investigator request|8|||
129593971|NCT00804141|466470751|FG000|Overall Study|Protocol Violation|85|||
129593972|NCT00804141|466470751|FG000|Overall Study|Withdrawal by Subject|131|||
129593973|NCT00804141|466470751|FG000|Overall Study|Lack of Efficacy|46|||
129593974|NCT00804141|466470751|FG000|Overall Study|Other than specified|30|||
129593975|NCT00804141|466470751|FG000|Overall Study|Enrolled but not treated|6|||
129593976|NCT00572039|466470752|FG000|Overall Study|Withdrawal by Subject|9|||
129593977|NCT00572039|466470753|FG001|Overall Study|Withdrawal by Subject|6|||
129593978|NCT00572039|466470752|FG000|Overall Study|Death|2|||
129593979|NCT00572039|466470753|FG001|Overall Study|Death|3|||
129593980|NCT00572039|466470752|FG000|Overall Study|Ill|5|||
129593981|NCT00572039|466470753|FG001|Overall Study|Ill|1|||
129593982|NCT01470417|466470756|FG000|Overall Study|Disease progression|0|||
129593983|NCT01470417|466470757|FG001|Overall Study|Disease progression|2|||
129593984|NCT02973321|466470758|FG000|Overall Study|Other than specified|0|||
129593985|NCT02973321|466470759|FG001|Overall Study|Other than specified|5|||
129593986|NCT02973321|466470760|FG002|Overall Study|Other than specified|3|||
129593987|NCT02973321|466470761|FG003|Overall Study|Other than specified|3|||
129593988|NCT02973321|466470762|FG004|Overall Study|Other than specified|1|||
129593989|NCT02973321|466470758|FG000|Overall Study|Lack of Efficacy|0|||
129593990|NCT02973321|466470759|FG001|Overall Study|Lack of Efficacy|0|||
129593991|NCT02973321|466470760|FG002|Overall Study|Lack of Efficacy|0|||
129593992|NCT02973321|466470761|FG003|Overall Study|Lack of Efficacy|0|||
129593993|NCT02973321|466470762|FG004|Overall Study|Lack of Efficacy|1|||
129593994|NCT02973321|466470758|FG000|Overall Study|Adverse Event|1|||
129593995|NCT02973321|466470759|FG001|Overall Study|Adverse Event|10|||
129593996|NCT02973321|466470760|FG002|Overall Study|Adverse Event|11|||
129593997|NCT02973321|466470761|FG003|Overall Study|Adverse Event|13|||
129593998|NCT02973321|466470762|FG004|Overall Study|Adverse Event|3|||
129593999|NCT01790113|466470769|FG000|Overall Study|Adverse Event|2|||
129594000|NCT01790113|466470770|FG001|Overall Study|Adverse Event|7|||
129594001|NCT01790113|466470769|FG000|Overall Study|Study ended due to FDA clearance|1|||
129594002|NCT01790113|466470770|FG001|Overall Study|Study ended due to FDA clearance|68|||
129594003|NCT00194792|466470771|FG000|Overall Study|Withdrawal by Subject|1|||
129594004|NCT01714739|466470772|FG000|Overall Study|Disease progression|3|||
129594005|NCT01714739|466470773|FG001|Overall Study|Disease progression|5|||
129594006|NCT01714739|466470774|FG002|Overall Study|Disease progression|5|||
129594007|NCT01714739|466470775|FG003|Overall Study|Disease progression|204|||
129594008|NCT01714739|466470776|FG004|Overall Study|Disease progression|1|||
129594009|NCT01714739|466470777|FG005|Overall Study|Disease progression|3|||
129594010|NCT01714739|466470778|FG006|Overall Study|Disease progression|5|||
129594011|NCT01714739|466470772|FG000|Overall Study|Study drug toxicity|1|||
129594012|NCT01714739|466470773|FG001|Overall Study|Study drug toxicity|1|||
129594013|NCT01714739|466470774|FG002|Overall Study|Study drug toxicity|1|||
129594014|NCT01714739|466470775|FG003|Overall Study|Study drug toxicity|15|||
129594015|NCT01714739|466470776|FG004|Overall Study|Study drug toxicity|0|||
129594016|NCT01714739|466470777|FG005|Overall Study|Study drug toxicity|0|||
129594017|NCT01714739|466470778|FG006|Overall Study|Study drug toxicity|5|||
129594018|NCT01714739|466470772|FG000|Overall Study|Death|0|||
129594019|NCT01714739|466470773|FG001|Overall Study|Death|0|||
129594020|NCT01714739|466470774|FG002|Overall Study|Death|0|||
129594021|NCT01714739|466470775|FG003|Overall Study|Death|1|||
129594022|NCT01714739|466470776|FG004|Overall Study|Death|0|||
129594023|NCT01714739|466470777|FG005|Overall Study|Death|0|||
129594024|NCT01714739|466470778|FG006|Overall Study|Death|0|||
129594025|NCT01714739|466470772|FG000|Overall Study|Adverse Event unrelated to drug|0|||
129594026|NCT01714739|466470773|FG001|Overall Study|Adverse Event unrelated to drug|0|||
129594027|NCT01714739|466470774|FG002|Overall Study|Adverse Event unrelated to drug|3|||
129594028|NCT01714739|466470775|FG003|Overall Study|Adverse Event unrelated to drug|21|||
129594029|NCT01714739|466470776|FG004|Overall Study|Adverse Event unrelated to drug|0|||
129594030|NCT01714739|466470777|FG005|Overall Study|Adverse Event unrelated to drug|0|||
129594031|NCT01714739|466470778|FG006|Overall Study|Adverse Event unrelated to drug|0|||
129594032|NCT01714739|466470772|FG000|Overall Study|Participant request to stop therapy|0|||
129594033|NCT01714739|466470773|FG001|Overall Study|Participant request to stop therapy|1|||
129594034|NCT01714739|466470774|FG002|Overall Study|Participant request to stop therapy|0|||
129594035|NCT01714739|466470775|FG003|Overall Study|Participant request to stop therapy|6|||
129594036|NCT01714739|466470776|FG004|Overall Study|Participant request to stop therapy|0|||
129594037|NCT01714739|466470777|FG005|Overall Study|Participant request to stop therapy|0|||
129594038|NCT01714739|466470778|FG006|Overall Study|Participant request to stop therapy|0|||
129594039|NCT01714739|466470772|FG000|Overall Study|Participant withdrew consent|0|||
129594040|NCT01714739|466470773|FG001|Overall Study|Participant withdrew consent|1|||
129594041|NCT01714739|466470774|FG002|Overall Study|Participant withdrew consent|0|||
129594042|NCT01714739|466470775|FG003|Overall Study|Participant withdrew consent|8|||
129594043|NCT01714739|466470776|FG004|Overall Study|Participant withdrew consent|0|||
129594044|NCT01714739|466470777|FG005|Overall Study|Participant withdrew consent|0|||
129594045|NCT01714739|466470778|FG006|Overall Study|Participant withdrew consent|0|||
129594046|NCT01714739|466470772|FG000|Overall Study|Lost to Follow-up|0|||
129594047|NCT01714739|466470773|FG001|Overall Study|Lost to Follow-up|0|||
129696542|NCT01570192|466848136|FG000|Overall Study|no qualifying organism|6|||
129885601|NCT02611830|467540767|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
129594048|NCT01714739|466470774|FG002|Overall Study|Lost to Follow-up|0|||
129594049|NCT01714739|466470775|FG003|Overall Study|Lost to Follow-up|1|||
129594050|NCT01714739|466470776|FG004|Overall Study|Lost to Follow-up|0|||
129594051|NCT01714739|466470777|FG005|Overall Study|Lost to Follow-up|0|||
129594052|NCT01714739|466470778|FG006|Overall Study|Lost to Follow-up|0|||
129594053|NCT01714739|466470772|FG000|Overall Study|Maximum clinical benefit|0|||
129594054|NCT01714739|466470773|FG001|Overall Study|Maximum clinical benefit|1|||
129594055|NCT01714739|466470774|FG002|Overall Study|Maximum clinical benefit|1|||
129594056|NCT01714739|466470775|FG003|Overall Study|Maximum clinical benefit|3|||
129594057|NCT01714739|466470776|FG004|Overall Study|Maximum clinical benefit|0|||
129594058|NCT01714739|466470777|FG005|Overall Study|Maximum clinical benefit|0|||
129594059|NCT01714739|466470778|FG006|Overall Study|Maximum clinical benefit|0|||
129594060|NCT01714739|466470772|FG000|Overall Study|Poor/non-comliance|0|||
129594061|NCT01714739|466470773|FG001|Overall Study|Poor/non-comliance|1|||
129594062|NCT01714739|466470774|FG002|Overall Study|Poor/non-comliance|0|||
129594063|NCT01714739|466470775|FG003|Overall Study|Poor/non-comliance|1|||
129594064|NCT01714739|466470776|FG004|Overall Study|Poor/non-comliance|0|||
129594065|NCT01714739|466470777|FG005|Overall Study|Poor/non-comliance|0|||
129594066|NCT01714739|466470778|FG006|Overall Study|Poor/non-comliance|0|||
129594067|NCT01714739|466470772|FG000|Overall Study|No longer meets study criteria|0|||
129594068|NCT01714739|466470773|FG001|Overall Study|No longer meets study criteria|0|||
129594069|NCT01714739|466470774|FG002|Overall Study|No longer meets study criteria|0|||
129594070|NCT01714739|466470775|FG003|Overall Study|No longer meets study criteria|1|||
129594071|NCT01714739|466470776|FG004|Overall Study|No longer meets study criteria|0|||
129594072|NCT01714739|466470777|FG005|Overall Study|No longer meets study criteria|0|||
129594073|NCT01714739|466470778|FG006|Overall Study|No longer meets study criteria|0|||
129594074|NCT01714739|466470772|FG000|Overall Study|Other reason|0|||
129594075|NCT01714739|466470773|FG001|Overall Study|Other reason|0|||
129594076|NCT01714739|466470774|FG002|Overall Study|Other reason|0|||
129594077|NCT01714739|466470775|FG003|Overall Study|Other reason|3|||
129594078|NCT01714739|466470776|FG004|Overall Study|Other reason|1|||
129594079|NCT01714739|466470777|FG005|Overall Study|Other reason|0|||
129594080|NCT01714739|466470778|FG006|Overall Study|Other reason|0|||
129594081|NCT03585959|466470779|FG000|Overall Study|Physician Decision|1|||
129594082|NCT03585959|466470779|FG000|Overall Study|Unsuccessful Procedure|2|||
129594083|NCT00865514|466470780|FG000|Overall Study|Infusion cost exceeded funding|2|||
129594084|NCT03920280|466470781|FG000|Overall Study|Adverse Event|2|||
129594085|NCT03920280|466470782|FG001|Overall Study|Adverse Event|3|||
129594086|NCT03920280|466470781|FG000|Overall Study|Lost to Follow-up|0|||
129594087|NCT03920280|466470782|FG001|Overall Study|Lost to Follow-up|1|||
129594088|NCT03920280|466470781|FG000|Overall Study|Withdrawal by Subject|1|||
129594089|NCT03920280|466470782|FG001|Overall Study|Withdrawal by Subject|1|||
129594090|NCT03920280|466470781|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
129594091|NCT03920280|466470782|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
129594092|NCT01857206|466470783|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
129594093|NCT01857206|466470784|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
129594094|NCT01857206|466470783|FG000|Overall Study|Lost to Follow-up|9|||
129594095|NCT01857206|466470784|FG001|Overall Study|Lost to Follow-up|6|||
129594096|NCT01857206|466470783|FG000|Overall Study|Unclassified|3|||
129594097|NCT01857206|466470784|FG001|Overall Study|Unclassified|3|||
129594098|NCT01857206|466470783|FG000|Overall Study|Withdrawal by Subject|1|||
129594099|NCT01857206|466470784|FG001|Overall Study|Withdrawal by Subject|0|||
129594100|NCT01198873|466470785|FG000|Overall Study|Adverse Event|4|||
129594101|NCT01198873|466470786|FG001|Overall Study|Adverse Event|7|||
129594102|NCT01198873|466470785|FG000|Overall Study|Study closure|29|||
129594103|NCT01198873|466470786|FG001|Overall Study|Study closure|23|||
129594104|NCT01198873|466470785|FG000|Overall Study|Other than above|4|||
129594105|NCT01198873|466470786|FG001|Overall Study|Other than above|2|||
129594106|NCT03139240|466470787|FG000|Overall Study|Lost to Follow-up|0|||
129594107|NCT03139240|466470788|FG001|Overall Study|Lost to Follow-up|1|||
129594108|NCT03139240|466470789|FG002|Overall Study|Lost to Follow-up|1|||
129594109|NCT03139240|466470790|FG003|Overall Study|Lost to Follow-up|0|||
129885602|NCT02611830|467540768|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
129885603|NCT02611830|467540769|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
129594110|NCT00823199|466470791|FG000|Overall Study|Withdrawal by Subject|2|||
129594111|NCT01998243|466470792|FG000|Overall Study|Pregnancy|0|||
129594112|NCT01998243|466470793|FG001|Overall Study|Pregnancy|1|||
129594113|NCT01998243|466470792|FG000|Overall Study|Protocol Violation|5|||
129594114|NCT01998243|466470793|FG001|Overall Study|Protocol Violation|2|||
129594115|NCT01998243|466470792|FG000|Overall Study|Withdrawal by Subject|3|||
129594116|NCT01998243|466470793|FG001|Overall Study|Withdrawal by Subject|4|||
129594117|NCT00268892|466470794|FG000|Overall Study|Adverse Event|14|||
129594118|NCT00268892|466470795|FG001|Overall Study|Adverse Event|17|||
129594119|NCT00268892|466470796|FG002|Overall Study|Adverse Event|20|||
129594120|NCT00268892|466470794|FG000|Overall Study|Lack of Efficacy|1|||
129594121|NCT00268892|466470795|FG001|Overall Study|Lack of Efficacy|3|||
129594122|NCT00268892|466470796|FG002|Overall Study|Lack of Efficacy|0|||
129594123|NCT00268892|466470794|FG000|Overall Study|Withdrawal by Subject|14|||
129594124|NCT00268892|466470795|FG001|Overall Study|Withdrawal by Subject|15|||
129594125|NCT00268892|466470796|FG002|Overall Study|Withdrawal by Subject|13|||
129594126|NCT00268892|466470794|FG000|Overall Study|Physician Decision|0|||
129594127|NCT00268892|466470795|FG001|Overall Study|Physician Decision|1|||
129594128|NCT00268892|466470796|FG002|Overall Study|Physician Decision|0|||
129594129|NCT00268892|466470794|FG000|Overall Study|Lost to Follow-up|5|||
129594130|NCT00268892|466470795|FG001|Overall Study|Lost to Follow-up|2|||
129594131|NCT00268892|466470796|FG002|Overall Study|Lost to Follow-up|4|||
129594132|NCT00268892|466470794|FG000|Overall Study|Protocol Violation|0|||
129594133|NCT00268892|466470795|FG001|Overall Study|Protocol Violation|1|||
129594134|NCT00268892|466470796|FG002|Overall Study|Protocol Violation|0|||
129594135|NCT00268892|466470794|FG000|Overall Study|Disease Progression|1|||
129594136|NCT00268892|466470795|FG001|Overall Study|Disease Progression|1|||
129594137|NCT00268892|466470796|FG002|Overall Study|Disease Progression|0|||
129594138|NCT00268892|466470794|FG000|Overall Study|Trial Site Closed|4|||
129594139|NCT00268892|466470795|FG001|Overall Study|Trial Site Closed|2|||
129594140|NCT00268892|466470796|FG002|Overall Study|Trial Site Closed|2|||
129594141|NCT01640184|466470797|FG000|Overall Study|Death|1|||
129594142|NCT01640184|466470798|FG001|Overall Study|Death|0|||
129594143|NCT01640184|466470799|FG002|Overall Study|Death|0|||
129594144|NCT01640184|466470797|FG000|Overall Study|Lost to Follow-up|4|||
129594145|NCT01640184|466470798|FG001|Overall Study|Lost to Follow-up|1|||
129594146|NCT01640184|466470799|FG002|Overall Study|Lost to Follow-up|0|||
129594147|NCT01640184|466470797|FG000|Overall Study|Physician Decision|3|||
129594148|NCT01640184|466470798|FG001|Overall Study|Physician Decision|0|||
129594149|NCT01640184|466470799|FG002|Overall Study|Physician Decision|0|||
129594150|NCT01640184|466470797|FG000|Overall Study|Withdrawal by Subject|0|||
129594151|NCT01640184|466470798|FG001|Overall Study|Withdrawal by Subject|1|||
129594152|NCT01640184|466470799|FG002|Overall Study|Withdrawal by Subject|1|||
129594153|NCT01640184|466470797|FG000|Overall Study|Protocol Violation|0|||
129594154|NCT01640184|466470798|FG001|Overall Study|Protocol Violation|0|||
129594155|NCT01640184|466470799|FG002|Overall Study|Protocol Violation|1|||
129594156|NCT02260258|466470802|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
129594157|NCT02260258|466470803|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
129594158|NCT02563769|466470804|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
129594159|NCT02563769|466470805|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
129594160|NCT02563769|466470806|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
129594161|NCT00690482|466470807|FG000|Overall Study|Adverse Event|2|||
129594162|NCT00690482|466470808|FG001|Overall Study|Adverse Event|1|||
129594163|NCT00690482|466470807|FG000|Overall Study|Incorrect enrolment|0|||
129594164|NCT00690482|466470808|FG001|Overall Study|Incorrect enrolment|1|||
129594165|NCT00690482|466470807|FG000|Overall Study|Study-specific discontinuation criteria|1|||
129594166|NCT00690482|466470808|FG001|Overall Study|Study-specific discontinuation criteria|0|||
129594167|NCT00690482|466470807|FG000|Overall Study|Intake of prohibited medicine|1|||
129594168|NCT00690482|466470808|FG001|Overall Study|Intake of prohibited medicine|0|||
129594169|NCT00690482|466470807|FG000|Overall Study|withdrew consent at rand.day|0|||
129594170|NCT00690482|466470808|FG001|Overall Study|withdrew consent at rand.day|1|||
129594171|NCT01610063|466470811|FG000|Overall Study|Lost to Follow-up|42|||
129594172|NCT01610063|466470812|FG001|Overall Study|Lost to Follow-up|20|||
129594173|NCT04405739|466470813|FG000|Overall Study|Adverse Event|0|||
129594174|NCT04405739|466470814|FG001|Overall Study|Adverse Event|1|||
129594175|NCT04405739|466470815|FG002|Overall Study|Adverse Event|0|||
129594176|NCT04405739|466470816|FG003|Overall Study|Adverse Event|0|||
129594177|NCT04405739|466470813|FG000|Overall Study|Lost to Follow-up|0|||
129594178|NCT04405739|466470814|FG001|Overall Study|Lost to Follow-up|2|||
129594179|NCT04405739|466470815|FG002|Overall Study|Lost to Follow-up|1|||
129594180|NCT04405739|466470816|FG003|Overall Study|Lost to Follow-up|3|||
129786459|NCT01616693|467185664|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
129786460|NCT01616693|467185665|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
129594181|NCT04405739|466470813|FG000|Overall Study|Withdrawal by Subject|0|||
129594182|NCT04405739|466470814|FG001|Overall Study|Withdrawal by Subject|2|||
129786461|NCT01616693|467185666|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
129594183|NCT04405739|466470815|FG002|Overall Study|Withdrawal by Subject|1|||
129594184|NCT04405739|466470816|FG003|Overall Study|Withdrawal by Subject|1|||
129594185|NCT04405739|466470813|FG000|Overall Study|Death|0|||
129594186|NCT04405739|466470814|FG001|Overall Study|Death|0|||
129594187|NCT04405739|466470815|FG002|Overall Study|Death|1|||
129594188|NCT04405739|466470816|FG003|Overall Study|Death|0|||
129594189|NCT04405739|466470813|FG000|Overall Study|Transferred to rehab|0|||
129594190|NCT04405739|466470814|FG001|Overall Study|Transferred to rehab|0|||
129594191|NCT04405739|466470815|FG002|Overall Study|Transferred to rehab|0|||
129594192|NCT04405739|466470816|FG003|Overall Study|Transferred to rehab|1|||
129594193|NCT04405739|466470813|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
129594194|NCT04405739|466470814|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
129594195|NCT04405739|466470815|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
129594196|NCT04405739|466470816|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
129594197|NCT01436643|466470817|FG000|2-week Pre-treatment|Abnormal test result|0|||
129594198|NCT01436643|466470818|FG001|2-week Pre-treatment|Abnormal test result|0|||
129594199|NCT01436643|466470819|FG002|2-week Pre-treatment|Abnormal test result|0|||
129594200|NCT01436643|466470820|FG003|2-week Pre-treatment|Abnormal test result|1|||
129594201|NCT01436643|466470817|FG000|2-week Pre-treatment|Adverse Event|0|||
129594202|NCT01436643|466470818|FG001|2-week Pre-treatment|Adverse Event|0|||
129594203|NCT01436643|466470819|FG002|2-week Pre-treatment|Adverse Event|0|||
129594204|NCT01436643|466470820|FG003|2-week Pre-treatment|Adverse Event|5|||
129594205|NCT01436643|466470817|FG000|2-week Pre-treatment|Protocol Violation|0|||
129594206|NCT01436643|466470818|FG001|2-week Pre-treatment|Protocol Violation|0|||
129594207|NCT01436643|466470819|FG002|2-week Pre-treatment|Protocol Violation|0|||
129594208|NCT01436643|466470820|FG003|2-week Pre-treatment|Protocol Violation|4|||
129594209|NCT01436643|466470817|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
129594210|NCT01436643|466470818|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
129594211|NCT01436643|466470819|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
129594212|NCT01436643|466470820|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
129594213|NCT01436643|466470817|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
129594214|NCT01436643|466470818|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
129594215|NCT01436643|466470819|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
129594216|NCT01436643|466470820|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
129594217|NCT01436643|466470817|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
129594218|NCT01436643|466470818|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
129594219|NCT01436643|466470819|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
129594220|NCT01436643|466470820|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
129594221|NCT03718117|466470821|FG000|Overall Study|Death|12|||
129594222|NCT03718117|466470822|FG001|Overall Study|Death|11|||
129594223|NCT03718117|466470823|FG002|Overall Study|Death|0|||
129594224|NCT03718117|466470821|FG000|Overall Study|Other|0|||
129594225|NCT03718117|466470822|FG001|Overall Study|Other|1|||
129594226|NCT03718117|466470823|FG002|Overall Study|Other|0|||
129594227|NCT03718117|466470821|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
129594228|NCT03718117|466470822|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
129594229|NCT03718117|466470823|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
129594230|NCT03718117|466470821|FG000|Overall Study|Participant not met eligibility criteria|0|||
129594231|NCT03718117|466470822|FG001|Overall Study|Participant not met eligibility criteria|0|||
129594232|NCT03718117|466470823|FG002|Overall Study|Participant not met eligibility criteria|2|||
129594233|NCT02056652|466470829|FG000|Overall Study|Withdrawal by Subject|1|||
129594234|NCT02056652|466470830|FG001|Overall Study|Withdrawal by Subject|0|||
129594235|NCT02056652|466470829|FG000|Overall Study|Lost to Follow-up|0|||
129594236|NCT02056652|466470830|FG001|Overall Study|Lost to Follow-up|3|||
129594237|NCT04232540|466470833|FG000|Overall Study|Lost to Follow-up|1|||
129594238|NCT04232540|466470834|FG001|Overall Study|Lost to Follow-up|0|||
129594239|NCT03234608|466470835|FG000|Overall Study|Lost to Follow-up|23|||
129594240|NCT03234608|466470836|FG001|Overall Study|Lost to Follow-up|21|||
129594241|NCT02105701|466470837|FG000|Overall Study|Lost to Follow-up|1|||
129594242|NCT02105701|466470838|FG001|Overall Study|Lost to Follow-up|0|||
129594243|NCT02105701|466470839|FG002|Overall Study|Lost to Follow-up|2|||
129594244|NCT02105701|466470840|FG003|Overall Study|Lost to Follow-up|1|||
129594245|NCT02105701|466470837|FG000|Overall Study|Protocol Violation|0|||
129594246|NCT02105701|466470838|FG001|Overall Study|Protocol Violation|0|||
129594247|NCT02105701|466470839|FG002|Overall Study|Protocol Violation|1|||
129594248|NCT02105701|466470840|FG003|Overall Study|Protocol Violation|0|||
129594249|NCT02105701|466470837|FG000|Overall Study|Withdrawal by Subject|2|||
129594250|NCT02105701|466470838|FG001|Overall Study|Withdrawal by Subject|1|||
129594251|NCT02105701|466470839|FG002|Overall Study|Withdrawal by Subject|0|||
129594252|NCT02105701|466470840|FG003|Overall Study|Withdrawal by Subject|1|||
129594253|NCT02105701|466470837|FG000|Overall Study|Death|1|||
129594254|NCT02105701|466470838|FG001|Overall Study|Death|0|||
129594255|NCT02105701|466470839|FG002|Overall Study|Death|0|||
129594256|NCT02105701|466470840|FG003|Overall Study|Death|0|||
129786462|NCT00832624|467185670|FG000|Overall Study|Study Terminated|10|||
129786463|NCT02395172|467185671|FG000|Overall Study|Participants randomized but not treated|3|||
129594257|NCT02148445|466470841|FG000|Overall Study|Death|1|||
129786464|NCT02395172|467185672|FG001|Overall Study|Participants randomized but not treated|31|||
129594258|NCT02148445|466470842|FG001|Overall Study|Death|3|||
129594259|NCT03450629|466470843|FG000|Overall Study|Adverse Event|15|||
129786465|NCT00653939|467185673|FG000|Overall Study|Adverse Event|1|||
129594260|NCT03450629|466470844|FG001|Overall Study|Adverse Event|14|||
129594261|NCT03450629|466470843|FG000|Overall Study|Physician Decision|2|||
129594262|NCT03450629|466470844|FG001|Overall Study|Physician Decision|2|||
129594263|NCT03450629|466470843|FG000|Overall Study|Lack of Efficacy|2|||
129594264|NCT03450629|466470844|FG001|Overall Study|Lack of Efficacy|0|||
129594265|NCT03450629|466470843|FG000|Overall Study|Lost to Follow-up|4|||
129594266|NCT03450629|466470844|FG001|Overall Study|Lost to Follow-up|2|||
129594267|NCT03450629|466470843|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129594268|NCT03450629|466470844|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
129594269|NCT03450629|466470843|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129594270|NCT03450629|466470844|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129594271|NCT03450629|466470843|FG000|Overall Study|Protocol Violation|11|||
129594272|NCT03450629|466470844|FG001|Overall Study|Protocol Violation|8|||
129594273|NCT03450629|466470843|FG000|Overall Study|Withdrawal by Subject|12|||
129594274|NCT03450629|466470844|FG001|Overall Study|Withdrawal by Subject|6|||
129594275|NCT04230876|466470845|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
129594276|NCT04230876|466470846|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
129594277|NCT03438006|466470850|FG000|Overall Study|Adverse Event|1|||
129594278|NCT03438006|466470850|FG000|Overall Study|Lost to Follow-up|67|||
129594279|NCT03438006|466470850|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
129594280|NCT03438006|466470850|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
129594281|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
129594282|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594283|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594284|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594285|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594286|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594287|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594288|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594289|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
129594290|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
129594291|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594292|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594293|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594294|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594295|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594296|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594297|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594298|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
129594299|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
129594300|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129696543|NCT01570192|466848137|FG001|Overall Study|no qualifying organism|12|||
129696544|NCT01570192|466848136|FG000|Overall Study|changed to palliative care|1|||
129696545|NCT01570192|466848137|FG001|Overall Study|changed to palliative care|0|||
129885604|NCT02611830|467540770|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
129885605|NCT02611830|467540767|FG000|Maintenance Phase|Lost to Follow-up|0|||
129594301|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129885606|NCT02611830|467540768|FG001|Maintenance Phase|Lost to Follow-up|0|||
129885607|NCT02611830|467540769|FG002|Maintenance Phase|Lost to Follow-up|0|||
129594302|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129594303|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129594304|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129594305|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129594306|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129594307|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
129594308|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
129594309|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594310|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594311|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594312|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594313|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594314|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594315|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594316|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
129594317|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
129594318|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129885608|NCT02611830|467540770|FG003|Maintenance Phase|Lost to Follow-up|1|||
129885609|NCT02611830|467540767|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
129885610|NCT02611830|467540768|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
129885611|NCT02611830|467540769|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
129885612|NCT02611830|467540770|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
129885613|NCT02611830|467540767|FG000|Maintenance Phase|Pregnancy|0|||
129885614|NCT02611830|467540768|FG001|Maintenance Phase|Pregnancy|0|||
129885615|NCT02611830|467540769|FG002|Maintenance Phase|Pregnancy|1|||
129885616|NCT02611830|467540770|FG003|Maintenance Phase|Pregnancy|0|||
129885617|NCT02611830|467540767|FG000|Maintenance Phase|Reason not specified|0|||
129885618|NCT02611830|467540768|FG001|Maintenance Phase|Reason not specified|1|||
129885619|NCT02611830|467540769|FG002|Maintenance Phase|Reason not specified|4|||
129885620|NCT02611830|467540770|FG003|Maintenance Phase|Reason not specified|0|||
129885621|NCT02855164|467540771|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129885622|NCT02855164|467540772|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129885623|NCT02855164|467540773|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
129594319|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594320|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594321|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594322|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594323|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594324|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594325|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
129594326|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
129594327|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594328|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594329|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594330|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594331|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594332|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594333|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594334|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
129594335|NCT00739973|466470861|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
129594336|NCT00739973|466470862|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594337|NCT00739973|466470863|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594338|NCT00739973|466470864|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594339|NCT00739973|466470865|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594340|NCT00739973|466470866|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594341|NCT00739973|466470867|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594342|NCT00739973|466470868|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594343|NCT00739973|466470869|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
129594344|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
129594345|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
129594346|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
129594347|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
129594348|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
129594349|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
129594350|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
129594351|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
129594352|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
129594353|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594354|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594355|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594356|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594357|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
129594358|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594359|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594360|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
129594361|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
129594362|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
129594363|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
129594364|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594365|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594366|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594367|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594368|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594369|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594370|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
129594371|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
129594372|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
129594373|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
129594374|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
129594375|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
129594376|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
129594377|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
129594378|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
129696546|NCT01570192|466848136|FG000|Overall Study|Physician Decision|0|||
129594379|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
129594380|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594381|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594382|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
129594383|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594384|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594385|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594386|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594387|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594388|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
129594389|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129594390|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
129594391|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129594392|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
129594393|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129594394|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129594395|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
129594396|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
129594397|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
129594398|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
129594399|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
129594400|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
129594401|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
129594402|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
129594403|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
129594404|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
129594405|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
129594406|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
129696547|NCT01570192|466848137|FG001|Overall Study|Physician Decision|1|||
129696548|NCT00806026|466848138|FG000|Overall Study|Death|0|||
129696549|NCT00806026|466848139|FG001|Overall Study|Death|0|||
129696550|NCT00806026|466848140|FG002|Overall Study|Death|0|||
129594407|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594408|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594409|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594410|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594411|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594412|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594413|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
129594414|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594415|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
129594416|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
129594417|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
129594418|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
129594419|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
129594420|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
129594421|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
129594422|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
129594423|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
129594424|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
129594425|NCT00739973|466470861|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594426|NCT00739973|466470862|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
129594427|NCT00739973|466470863|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594428|NCT00739973|466470864|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594429|NCT00739973|466470865|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594430|NCT00739973|466470866|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594431|NCT00739973|466470867|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
129594432|NCT00739973|466470868|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594433|NCT00739973|466470869|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
129594434|NCT03078478|466470870|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
129594435|NCT03078478|466470871|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
129594436|NCT03078478|466470870|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
129594437|NCT03078478|466470871|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
129594438|NCT03078478|466470870|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
129594439|NCT03078478|466470871|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
129594440|NCT03078478|466470870|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
129594441|NCT03078478|466470871|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
129594442|NCT03078478|466470870|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
129594443|NCT03078478|466470871|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
129594444|NCT03078478|466470870|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
129594445|NCT03078478|466470871|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
129594446|NCT03078478|466470870|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
129594447|NCT03078478|466470871|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
129594448|NCT03078478|466470870|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
129594449|NCT03078478|466470871|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
129594450|NCT03253094|466470873|FG000|Overall Study|Adverse Event|2|||
129594451|NCT03253094|466470874|FG001|Overall Study|Adverse Event|0|||
129594452|NCT03253094|466470875|FG002|Overall Study|Adverse Event|0|||
129594453|NCT03253094|466470876|FG003|Overall Study|Adverse Event|0|||
129594454|NCT03253094|466470877|FG004|Overall Study|Adverse Event|0|||
129594455|NCT03253094|466470878|FG005|Overall Study|Adverse Event|0|||
129594456|NCT03253094|466470873|FG000|Overall Study|Lack of Efficacy|0|||
129594457|NCT03253094|466470874|FG001|Overall Study|Lack of Efficacy|0|||
129594458|NCT03253094|466470875|FG002|Overall Study|Lack of Efficacy|2|||
129594459|NCT03253094|466470876|FG003|Overall Study|Lack of Efficacy|1|||
129594460|NCT03253094|466470877|FG004|Overall Study|Lack of Efficacy|2|||
129594461|NCT03253094|466470878|FG005|Overall Study|Lack of Efficacy|1|||
129594462|NCT03253094|466470873|FG000|Overall Study|Lost to Follow-up|0|||
129594463|NCT03253094|466470874|FG001|Overall Study|Lost to Follow-up|0|||
129594464|NCT03253094|466470875|FG002|Overall Study|Lost to Follow-up|1|||
129594465|NCT03253094|466470876|FG003|Overall Study|Lost to Follow-up|1|||
129594466|NCT03253094|466470877|FG004|Overall Study|Lost to Follow-up|0|||
129594467|NCT03253094|466470878|FG005|Overall Study|Lost to Follow-up|1|||
129594468|NCT03253094|466470873|FG000|Overall Study|Physician Decision|1|||
129594469|NCT03253094|466470874|FG001|Overall Study|Physician Decision|0|||
129594470|NCT03253094|466470875|FG002|Overall Study|Physician Decision|0|||
129594471|NCT03253094|466470876|FG003|Overall Study|Physician Decision|1|||
129594472|NCT03253094|466470877|FG004|Overall Study|Physician Decision|0|||
129594473|NCT03253094|466470878|FG005|Overall Study|Physician Decision|2|||
129594474|NCT03253094|466470873|FG000|Overall Study|Withdrawal by Subject|1|||
129594475|NCT03253094|466470874|FG001|Overall Study|Withdrawal by Subject|2|||
129594476|NCT03253094|466470875|FG002|Overall Study|Withdrawal by Subject|1|||
129594477|NCT03253094|466470876|FG003|Overall Study|Withdrawal by Subject|0|||
129594478|NCT03253094|466470877|FG004|Overall Study|Withdrawal by Subject|3|||
129594479|NCT03253094|466470878|FG005|Overall Study|Withdrawal by Subject|0|||
129594480|NCT03253094|466470873|FG000|Overall Study|Other|0|||
129594481|NCT03253094|466470874|FG001|Overall Study|Other|1|||
129594482|NCT03253094|466470875|FG002|Overall Study|Other|2|||
129594483|NCT03253094|466470876|FG003|Overall Study|Other|1|||
129594484|NCT03253094|466470877|FG004|Overall Study|Other|0|||
129594485|NCT03253094|466470878|FG005|Overall Study|Other|0|||
129594486|NCT02339090|466470879|FG000|Overall Study|Adverse Event|1|||
129594487|NCT02339090|466470880|FG001|Overall Study|Adverse Event|0|||
129594488|NCT02339090|466470879|FG000|Overall Study|Lost to Follow-up|0|||
129594489|NCT02339090|466470880|FG001|Overall Study|Lost to Follow-up|1|||
129594490|NCT02339090|466470879|FG000|Overall Study|Non-compliance With Study Drug|0|||
129594491|NCT02339090|466470880|FG001|Overall Study|Non-compliance With Study Drug|1|||
129594492|NCT02339090|466470879|FG000|Overall Study|Withdrawal by Subject|2|||
129594493|NCT02339090|466470880|FG001|Overall Study|Withdrawal by Subject|1|||
129594494|NCT02339090|466470879|FG000|Overall Study|Poor Growth|3|||
129594495|NCT02339090|466470880|FG001|Overall Study|Poor Growth|0|||
129594496|NCT02339090|466470879|FG000|Overall Study|Randomized but not treated|0|||
129594497|NCT02339090|466470880|FG001|Overall Study|Randomized but not treated|2|||
129594498|NCT02737592|466470883|FG000|Overall Study|Withdrawal by Subject|1|||
129594499|NCT00576303|466470884|FG000|Dose Titration Period|Early withdrawal|17|||
129594500|NCT00576303|466470884|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
129594501|NCT00576303|466470884|FG000|Long Term Safety Period|Early withdrawal|16|||
129594502|NCT00955721|466470885|FG000|Overall Study|Physician Decision|1|||
129594503|NCT00955721|466470886|FG001|Overall Study|Physician Decision|0|||
129594504|NCT00955721|466470885|FG000|Overall Study|Death|1|||
129594505|NCT00955721|466470886|FG001|Overall Study|Death|0|||
129594506|NCT00955721|466470885|FG000|Overall Study|Withdrawal by Subject|1|||
129594507|NCT00955721|466470886|FG001|Overall Study|Withdrawal by Subject|0|||
129594508|NCT00749411|466470891|FG000|Overall Study|Adverse Event|0|||
129594509|NCT00749411|466470892|FG001|Overall Study|Adverse Event|2|||
129594510|NCT00749411|466470891|FG000|Overall Study|Lack of Efficacy|0|||
129594511|NCT00749411|466470892|FG001|Overall Study|Lack of Efficacy|1|||
129594512|NCT00749411|466470891|FG000|Overall Study|Protocol Violation|1|||
129594513|NCT00749411|466470892|FG001|Overall Study|Protocol Violation|1|||
129594514|NCT00749411|466470891|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129594515|NCT00749411|466470892|FG001|Overall Study|Protocol-defined stopping criteria|1|||
129594516|NCT03183141|466470893|FG000|Overall Study|Withdrawal by Subject|2|||
129594517|NCT03183141|466470894|FG001|Overall Study|Withdrawal by Subject|4|||
129594518|NCT03183141|466470893|FG000|Overall Study|Death|0|||
129594519|NCT03183141|466470894|FG001|Overall Study|Death|8|||
129594520|NCT02756637|466470896|FG000|Overall Study|Not eligible for initial SWOG study|10|||
129594521|NCT02756637|466470897|FG001|Overall Study|Not eligible for initial SWOG study|10|||
129594522|NCT02756637|466470896|FG000|Overall Study|No available NLR value|44|||
129594523|NCT02756637|466470897|FG001|Overall Study|No available NLR value|44|||
129594524|NCT02756637|466470896|FG000|Overall Study|Did not complete curative therapy|33|||
129594525|NCT02756637|466470897|FG001|Overall Study|Did not complete curative therapy|0|||
129594526|NCT04034355|466470900|FG000|Overall Study|Study terminated by Sponsor|10|||
129594527|NCT04034355|466470901|FG001|Overall Study|Study terminated by Sponsor|17|||
129594528|NCT04034355|466470900|FG000|Overall Study|Withdrawal by Subject|12|||
129594529|NCT04034355|466470901|FG001|Overall Study|Withdrawal by Subject|11|||
129594530|NCT04034355|466470900|FG000|Overall Study|Site terminated by Sponsor|4|||
129594531|NCT04034355|466470901|FG001|Overall Study|Site terminated by Sponsor|5|||
129594532|NCT04034355|466470900|FG000|Overall Study|Adverse Event|2|||
129594533|NCT04034355|466470901|FG001|Overall Study|Adverse Event|0|||
129594534|NCT04034355|466470900|FG000|Overall Study|Death|1|||
129594535|NCT04034355|466470901|FG001|Overall Study|Death|1|||
129594536|NCT04034355|466470900|FG000|Overall Study|Not reported|2|||
129594537|NCT04034355|466470901|FG001|Overall Study|Not reported|0|||
129594538|NCT04034355|466470900|FG000|Overall Study|Lost to Follow-up|1|||
129594539|NCT04034355|466470901|FG001|Overall Study|Lost to Follow-up|0|||
129594540|NCT04034355|466470900|FG000|Overall Study|Physician Decision|1|||
129594541|NCT04034355|466470901|FG001|Overall Study|Physician Decision|0|||
129594542|NCT04034355|466470900|FG000|Overall Study|Protocol Violation|0|||
129594543|NCT04034355|466470901|FG001|Overall Study|Protocol Violation|1|||
129594544|NCT04034355|466470900|FG000|Overall Study|Progressive disease|1|||
129594545|NCT04034355|466470901|FG001|Overall Study|Progressive disease|0|||
129594546|NCT02190279|466472400|FG000|Overall Study|Withdrawal consent|1|||
129594547|NCT02190279|466472401|FG001|Overall Study|Withdrawal consent|0|||
129594548|NCT02190279|466472402|FG002|Overall Study|Withdrawal consent|1|||
129594549|NCT02190279|466472400|FG000|Overall Study|Lost to Follow-up|2|||
129594550|NCT02190279|466472401|FG001|Overall Study|Lost to Follow-up|0|||
129594551|NCT02190279|466472402|FG002|Overall Study|Lost to Follow-up|0|||
129594552|NCT02190279|466472400|FG000|Overall Study|Refused further treatment|0|||
129594553|NCT02190279|466472401|FG001|Overall Study|Refused further treatment|0|||
129594554|NCT02190279|466472402|FG002|Overall Study|Refused further treatment|1|||
129594555|NCT02190279|466472400|FG000|Overall Study|Screening failure|0|||
129594556|NCT02190279|466472401|FG001|Overall Study|Screening failure|0|||
129594557|NCT02190279|466472402|FG002|Overall Study|Screening failure|1|||
129594558|NCT00546910|466472403|FG000|Overall Study|Adverse Event|2|||
129594559|NCT00546910|466472404|FG001|Overall Study|Adverse Event|3|||
129594560|NCT00546910|466472403|FG000|Overall Study|Lack of Efficacy|5|||
129594561|NCT00546910|466472404|FG001|Overall Study|Lack of Efficacy|7|||
129594562|NCT00546910|466472403|FG000|Overall Study|Physician Decision|0|||
129594563|NCT00546910|466472404|FG001|Overall Study|Physician Decision|1|||
129594564|NCT00546910|466472403|FG000|Overall Study|Withdrawal by Subject|2|||
129594565|NCT00546910|466472404|FG001|Overall Study|Withdrawal by Subject|0|||
129594566|NCT01115855|466472405|FG000|Overall Study|Adverse Event|16|||
129594567|NCT01115855|466472406|FG001|Overall Study|Adverse Event|18|||
129594568|NCT01115855|466472405|FG000|Overall Study|Death|6|||
129594569|NCT01115855|466472406|FG001|Overall Study|Death|5|||
129594570|NCT01115855|466472405|FG000|Overall Study|Lab Abnormality|1|||
129594571|NCT01115855|466472406|FG001|Overall Study|Lab Abnormality|1|||
129594572|NCT01115855|466472405|FG000|Overall Study|Protocol Violation|0|||
129594573|NCT01115855|466472406|FG001|Overall Study|Protocol Violation|1|||
129594574|NCT01115855|466472405|FG000|Overall Study|Withdrawal by Subject|5|||
129594575|NCT01115855|466472406|FG001|Overall Study|Withdrawal by Subject|5|||
129594576|NCT01115855|466472405|FG000|Overall Study|Other|8|||
129594577|NCT01115855|466472406|FG001|Overall Study|Other|6|||
129594578|NCT01467479|466472407|FG000|Overall Study|No Study Medication|1|||
129594579|NCT01467479|466472408|FG001|Overall Study|No Study Medication|0|||
129594580|NCT01467479|466472409|FG002|Overall Study|No Study Medication|2|||
129594581|NCT01467479|466472407|FG000|Overall Study|Adverse Event|1|||
129594582|NCT01467479|466472408|FG001|Overall Study|Adverse Event|2|||
129594583|NCT01467479|466472409|FG002|Overall Study|Adverse Event|0|||
129594584|NCT01467479|466472407|FG000|Overall Study|Death|0|||
129594585|NCT01467479|466472408|FG001|Overall Study|Death|0|||
129594586|NCT01467479|466472409|FG002|Overall Study|Death|1|||
129594587|NCT01467479|466472407|FG000|Overall Study|Lost to Follow-up|2|||
129594588|NCT01467479|466472408|FG001|Overall Study|Lost to Follow-up|5|||
129594589|NCT01467479|466472409|FG002|Overall Study|Lost to Follow-up|3|||
129594590|NCT01467479|466472407|FG000|Overall Study|Withdrawal of Consent|3|||
129594591|NCT01467479|466472408|FG001|Overall Study|Withdrawal of Consent|7|||
129594592|NCT01467479|466472409|FG002|Overall Study|Withdrawal of Consent|7|||
129594593|NCT01467479|466472407|FG000|Overall Study|Study Terminated by Sponsor|1|||
129594594|NCT01467479|466472408|FG001|Overall Study|Study Terminated by Sponsor|3|||
129594595|NCT01467479|466472409|FG002|Overall Study|Study Terminated by Sponsor|3|||
129594596|NCT01467479|466472407|FG000|Overall Study|Other|1|||
129594597|NCT01467479|466472408|FG001|Overall Study|Other|0|||
129594598|NCT01467479|466472409|FG002|Overall Study|Other|0|||
129594599|NCT02284347|466472419|FG000|Overall Study|Lost to Follow-up|2|||
129594600|NCT02284347|466472419|FG000|Overall Study|Withdrawn prior to treatment|1|||
129594601|NCT01915940|466472423|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
129594602|NCT01915940|466472424|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
129594603|NCT01915940|466472425|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
129594604|NCT01915940|466472423|FG000|Treatment Period|Decision of Participant|0|||
129786466|NCT00653939|467185674|FG001|Overall Study|Adverse Event|3|||
129786467|NCT00653939|467185673|FG000|Overall Study|Withdrawal by Subject|3|||
129786468|NCT00653939|467185674|FG001|Overall Study|Withdrawal by Subject|3|||
129786469|NCT00653939|467185673|FG000|Overall Study|Physician Decision|4|||
129786470|NCT00653939|467185674|FG001|Overall Study|Physician Decision|0|||
129786471|NCT00653939|467185673|FG000|Overall Study|Disease Progression|2|||
129786472|NCT00653939|467185674|FG001|Overall Study|Disease Progression|3|||
129786473|NCT00653939|467185673|FG000|Overall Study|Other|2|||
129594605|NCT01915940|466472424|FG001|Treatment Period|Decision of Participant|1|||
129786474|NCT00653939|467185674|FG001|Overall Study|Other|6|||
129786475|NCT01546623|467185675|FG000|Overall Study|Adverse Event|2|||
129594606|NCT01915940|466472425|FG002|Treatment Period|Decision of Participant|3|||
129594607|NCT01915940|466472423|FG000|Treatment Period|Adverse Event|0|||
129594608|NCT01915940|466472424|FG001|Treatment Period|Adverse Event|9|||
129786476|NCT01546623|467185676|FG001|Overall Study|Adverse Event|3|||
129594609|NCT01915940|466472425|FG002|Treatment Period|Adverse Event|1|||
129594610|NCT01915940|466472423|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
129594611|NCT01915940|466472424|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
129594612|NCT01915940|466472425|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
129594613|NCT02999984|466472426|FG000|Overall Study|Treatment Failure|1|||
129594614|NCT00754013|466472427|FG000|Overall Study|Lost to Follow-up|1|||
129594615|NCT00754013|466472428|FG001|Overall Study|Lost to Follow-up|1|||
129594616|NCT00754013|466472427|FG000|Overall Study|didn't return after study termed|3|||
129594617|NCT00754013|466472428|FG001|Overall Study|didn't return after study termed|4|||
129594618|NCT04039919|466472429|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129786477|NCT01546623|467185675|FG000|Overall Study|Major Protocol Deviation|1|||
129594619|NCT04039919|466472430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129594620|NCT04039919|466472431|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129594621|NCT04039919|466472432|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129594622|NCT04039919|466472433|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129594623|NCT04039919|466472429|FG000|Treatment Period 1|Sponsor's decision|0|||
129594624|NCT04039919|466472430|FG001|Treatment Period 1|Sponsor's decision|0|||
129594625|NCT04039919|466472431|FG002|Treatment Period 1|Sponsor's decision|0|||
129594626|NCT04039919|466472432|FG003|Treatment Period 1|Sponsor's decision|0|||
129594627|NCT04039919|466472433|FG004|Treatment Period 1|Sponsor's decision|16|||
129594628|NCT04039919|466472429|FG000|Treatment Period 5|Withdrawal by Subject|1|||
129696551|NCT00806026|466848141|FG003|Overall Study|Death|1|||
129696552|NCT00806026|466848142|FG004|Overall Study|Death|0|||
129696553|NCT00806026|466848143|FG005|Overall Study|Death|0|||
129696554|NCT00806026|466848138|FG000|Overall Study|Did not meet entrance criteria|4|||
129594629|NCT04039919|466472430|FG001|Treatment Period 5|Withdrawal by Subject|0|||
129594630|NCT04039919|466472431|FG002|Treatment Period 5|Withdrawal by Subject|0|||
129594631|NCT04039919|466472432|FG003|Treatment Period 5|Withdrawal by Subject|0|||
129594632|NCT04039919|466472433|FG004|Treatment Period 5|Withdrawal by Subject|0|||
129594633|NCT00983918|466472434|FG000|Overall Study|conversion to open cholecystectomy|0|||
129594634|NCT00983918|466472435|FG001|Overall Study|conversion to open cholecystectomy|2|||
129594635|NCT00983918|466472436|FG002|Overall Study|conversion to open cholecystectomy|2|||
129594636|NCT00983918|466472437|FG003|Overall Study|conversion to open cholecystectomy|2|||
129594637|NCT01197417|466472438|FG000|Overall Study|Physician Decision|3|||
129594638|NCT01197417|466472439|FG001|Overall Study|Physician Decision|2|||
129594639|NCT01197417|466472438|FG000|Overall Study|Withdrawal by Subject|2|||
129594640|NCT01197417|466472439|FG001|Overall Study|Withdrawal by Subject|4|||
129594641|NCT01197417|466472438|FG000|Overall Study|Site miscommunication|0|||
129594642|NCT01197417|466472439|FG001|Overall Study|Site miscommunication|1|||
129594643|NCT01197417|466472438|FG000|Overall Study|Subject transferred to intensive care|0|||
129594644|NCT01197417|466472439|FG001|Overall Study|Subject transferred to intensive care|1|||
129594645|NCT01197417|466472438|FG000|Overall Study|Not consented in time to receive drug|0|||
129594646|NCT01197417|466472439|FG001|Overall Study|Not consented in time to receive drug|1|||
129594647|NCT01197417|466472438|FG000|Overall Study|Hypotension|1|||
129594648|NCT01197417|466472439|FG001|Overall Study|Hypotension|2|||
129594649|NCT01197417|466472438|FG000|Overall Study|Found to be ineligible|2|||
129594650|NCT01197417|466472439|FG001|Overall Study|Found to be ineligible|5|||
129594651|NCT01197417|466472438|FG000|Overall Study|No 25-hour magnesium level|0|||
129594652|NCT01197417|466472439|FG001|Overall Study|No 25-hour magnesium level|2|||
129594653|NCT02065713|466472440|FG000|Overall Study|Adverse Event|0|||
129594654|NCT02065713|466472441|FG001|Overall Study|Adverse Event|1|||
129594655|NCT02065713|466472440|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129594656|NCT02065713|466472441|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129594657|NCT01652729|466472442|FG000|Overall Study|Withdrawal by Subject|14|||
129594658|NCT01652729|466472443|FG001|Overall Study|Withdrawal by Subject|7|||
129594659|NCT01652729|466472444|FG002|Overall Study|Withdrawal by Subject|7|||
129594660|NCT01652729|466472442|FG000|Overall Study|Adverse Event|4|||
129594661|NCT01652729|466472443|FG001|Overall Study|Adverse Event|0|||
129594662|NCT01652729|466472444|FG002|Overall Study|Adverse Event|3|||
129594663|NCT01652729|466472442|FG000|Overall Study|Physician Decision|1|||
129594664|NCT01652729|466472443|FG001|Overall Study|Physician Decision|0|||
129594665|NCT01652729|466472444|FG002|Overall Study|Physician Decision|1|||
129594666|NCT01652729|466472442|FG000|Overall Study|Protocol Violation|1|||
129696555|NCT00806026|466848139|FG001|Overall Study|Did not meet entrance criteria|1|||
129696556|NCT00806026|466848140|FG002|Overall Study|Did not meet entrance criteria|2|||
129696557|NCT00806026|466848141|FG003|Overall Study|Did not meet entrance criteria|1|||
129696558|NCT00806026|466848142|FG004|Overall Study|Did not meet entrance criteria|0|||
129696559|NCT00806026|466848143|FG005|Overall Study|Did not meet entrance criteria|0|||
129594667|NCT01652729|466472443|FG001|Overall Study|Protocol Violation|0|||
129594668|NCT01652729|466472444|FG002|Overall Study|Protocol Violation|0|||
129696560|NCT00806026|466848138|FG000|Overall Study|Lack of Efficacy|5|||
129696561|NCT00806026|466848139|FG001|Overall Study|Lack of Efficacy|18|||
129696562|NCT00806026|466848140|FG002|Overall Study|Lack of Efficacy|13|||
129696563|NCT00806026|466848141|FG003|Overall Study|Lack of Efficacy|4|||
129696564|NCT00806026|466848142|FG004|Overall Study|Lack of Efficacy|8|||
129594669|NCT01652729|466472442|FG000|Overall Study|Lost to Follow-up|6|||
129594670|NCT01652729|466472443|FG001|Overall Study|Lost to Follow-up|6|||
129594671|NCT01652729|466472444|FG002|Overall Study|Lost to Follow-up|3|||
129594672|NCT01652729|466472442|FG000|Overall Study|Administrative|1|||
129594673|NCT01652729|466472443|FG001|Overall Study|Administrative|0|||
129594674|NCT01652729|466472444|FG002|Overall Study|Administrative|0|||
129594675|NCT01223235|466472447|FG000|Overall Study|Withdrawal by Subject|1|||
129594676|NCT04364737|466472448|FG000|Overall Study|Withdrawal by Subject|4|||
129594677|NCT04364737|466472449|FG001|Overall Study|Withdrawal by Subject|9|||
129594678|NCT04364737|466472448|FG000|Overall Study|Lost to Follow-up|1|||
129594679|NCT04364737|466472449|FG001|Overall Study|Lost to Follow-up|1|||
129696565|NCT00806026|466848143|FG005|Overall Study|Lack of Efficacy|7|||
129594680|NCT01220609|466472450|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
129594681|NCT01220609|466472450|FG000|Overall Study|Ineligible- Wrong cell type|1|||
129594682|NCT01220609|466472450|FG000|Overall Study|Ineligible-Never treated|1|||
129594683|NCT02225665|466472451|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
129594684|NCT02225665|466472452|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
129594685|NCT02225665|466472451|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
129594686|NCT02225665|466472452|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
129594687|NCT01311557|466472453|FG000|Overall Study|Serious adverse event|0|||
129594688|NCT01311557|466472454|FG001|Overall Study|Serious adverse event|1|||
129594689|NCT01311557|466472453|FG000|Overall Study|Protocol Violation|4|||
129594690|NCT01311557|466472454|FG001|Overall Study|Protocol Violation|2|||
129594691|NCT01311557|466472453|FG000|Overall Study|Lost to Follow-up|0|||
129594692|NCT01311557|466472454|FG001|Overall Study|Lost to Follow-up|1|||
129594693|NCT01311557|466472453|FG000|Overall Study|Withdrawal by Subject|1|||
129594694|NCT01311557|466472454|FG001|Overall Study|Withdrawal by Subject|2|||
129594695|NCT02418455|466472457|FG000|48-Week Treatment Period|Other- Not Specified|1|||
129594696|NCT02418455|466472457|FG000|Continuation Period|Sponsor Decision|7|||
129594697|NCT00614822|466472461|FG000|Overall Study|Adverse Event|3|||
129594698|NCT01557920|466472462|FG000|Overall Study|Withdrawal by Subject|2|||
129594699|NCT01557920|466472463|FG001|Overall Study|Withdrawal by Subject|3|||
129594700|NCT01557920|466472462|FG000|Overall Study|Lack of Efficacy|1|||
129594701|NCT01557920|466472463|FG001|Overall Study|Lack of Efficacy|0|||
129594702|NCT02075606|466472466|FG000|Overall Study|Adverse Event|5|||
129594703|NCT02075606|466472466|FG000|Overall Study|Withdrawal by Subject|1|||
129594704|NCT02075606|466472466|FG000|Overall Study|Death|1|||
129594705|NCT02075606|466472466|FG000|Overall Study|Investigator's decision|1|||
129594706|NCT02075606|466472466|FG000|Overall Study|Symptom management|1|||
129594707|NCT02075606|466472466|FG000|Overall Study|Increasing Symptoms|1|||
129594708|NCT02310763|466472471|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
129594709|NCT02310763|466472472|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
129594710|NCT02310763|466472473|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
129594711|NCT02310763|466472471|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
129594712|NCT02310763|466472472|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
129594713|NCT02310763|466472473|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
129594714|NCT02310763|466472471|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
129594715|NCT02310763|466472472|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
129594716|NCT02310763|466472473|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
129594717|NCT02310763|466472471|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
129594718|NCT02310763|466472472|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
129594719|NCT02310763|466472473|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
129594720|NCT02310763|466472471|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
129594721|NCT02310763|466472472|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
129594722|NCT02310763|466472473|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
129594723|NCT01731886|466472479|FG000|Overall Study|Death|1|||
129594724|NCT01731886|466472480|FG001|Overall Study|Death|0|||
129594725|NCT01731886|466472479|FG000|Overall Study|Never started treatment|0|||
129594726|NCT01731886|466472480|FG001|Overall Study|Never started treatment|1|||
129594727|NCT01731886|466472479|FG000|Overall Study|Non-compliant|1|||
129594728|NCT01731886|466472480|FG001|Overall Study|Non-compliant|0|||
129594729|NCT00271024|466472481|FG000|Overall Study|Lost Interest|3|||
129594730|NCT00271024|466472482|FG001|Overall Study|Lost Interest|4|||
129594731|NCT00271024|466472483|FG002|Overall Study|Lost Interest|2|||
129594732|NCT00271024|466472484|FG003|Overall Study|Lost Interest|3|||
129696566|NCT00806026|466848138|FG000|Overall Study|Lost to Follow-up|8|||
129594733|NCT00271024|466472481|FG000|Overall Study|Unknown/Unspecified|11|||
129696567|NCT00806026|466848139|FG001|Overall Study|Lost to Follow-up|15|||
129594734|NCT00271024|466472482|FG001|Overall Study|Unknown/Unspecified|11|||
129696568|NCT00806026|466848140|FG002|Overall Study|Lost to Follow-up|8|||
129594735|NCT00271024|466472483|FG002|Overall Study|Unknown/Unspecified|8|||
129594736|NCT00271024|466472484|FG003|Overall Study|Unknown/Unspecified|4|||
129594737|NCT00271024|466472481|FG000|Overall Study|Protocol Violation|1|||
129594738|NCT00271024|466472482|FG001|Overall Study|Protocol Violation|6|||
129594739|NCT00271024|466472483|FG002|Overall Study|Protocol Violation|5|||
129594740|NCT00271024|466472484|FG003|Overall Study|Protocol Violation|11|||
129594741|NCT00271024|466472481|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
129594742|NCT00271024|466472482|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
129594743|NCT00271024|466472483|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
129594744|NCT00271024|466472484|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
129594745|NCT00271024|466472481|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
129594746|NCT00271024|466472482|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
129594747|NCT00271024|466472483|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
129594748|NCT00271024|466472484|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
129594749|NCT01040793|466472485|FG000|Overall Study|Adverse Event|5|||
129594750|NCT01040793|466472486|FG001|Overall Study|Adverse Event|3|||
129594751|NCT01040793|466472487|FG002|Overall Study|Adverse Event|0|||
129594752|NCT01040793|466472488|FG003|Overall Study|Adverse Event|2|||
129594753|NCT01040793|466472489|FG004|Overall Study|Adverse Event|2|||
129594754|NCT01040793|466472490|FG005|Overall Study|Adverse Event|1|||
129594755|NCT01040793|466472485|FG000|Overall Study|Protocol Violation|1|||
129594756|NCT01040793|466472486|FG001|Overall Study|Protocol Violation|1|||
129594757|NCT01040793|466472487|FG002|Overall Study|Protocol Violation|1|||
129594758|NCT01040793|466472488|FG003|Overall Study|Protocol Violation|0|||
129594759|NCT01040793|466472489|FG004|Overall Study|Protocol Violation|1|||
129594760|NCT01040793|466472490|FG005|Overall Study|Protocol Violation|0|||
129594761|NCT01040793|466472485|FG000|Overall Study|Lost to Follow-up|0|||
129594762|NCT01040793|466472486|FG001|Overall Study|Lost to Follow-up|1|||
129594763|NCT01040793|466472487|FG002|Overall Study|Lost to Follow-up|1|||
129594764|NCT01040793|466472488|FG003|Overall Study|Lost to Follow-up|0|||
129594765|NCT01040793|466472489|FG004|Overall Study|Lost to Follow-up|0|||
129594766|NCT01040793|466472490|FG005|Overall Study|Lost to Follow-up|0|||
129594767|NCT01040793|466472485|FG000|Overall Study|Withdrawal by Subject|0|||
129594768|NCT01040793|466472486|FG001|Overall Study|Withdrawal by Subject|0|||
129696569|NCT00806026|466848141|FG003|Overall Study|Lost to Follow-up|2|||
129594769|NCT01040793|466472487|FG002|Overall Study|Withdrawal by Subject|0|||
129594770|NCT01040793|466472488|FG003|Overall Study|Withdrawal by Subject|2|||
129594771|NCT01040793|466472489|FG004|Overall Study|Withdrawal by Subject|0|||
129594772|NCT01040793|466472490|FG005|Overall Study|Withdrawal by Subject|0|||
129594773|NCT01040793|466472485|FG000|Overall Study|Other reasons not listed above|0|||
129594774|NCT01040793|466472486|FG001|Overall Study|Other reasons not listed above|0|||
129594775|NCT01040793|466472487|FG002|Overall Study|Other reasons not listed above|1|||
129594776|NCT01040793|466472488|FG003|Overall Study|Other reasons not listed above|0|||
129594777|NCT01040793|466472489|FG004|Overall Study|Other reasons not listed above|1|||
129594778|NCT01040793|466472490|FG005|Overall Study|Other reasons not listed above|0|||
129594779|NCT00939627|466472501|FG000|Overall Study|Disease Progression|16|||
129696570|NCT00806026|466848142|FG004|Overall Study|Lost to Follow-up|6|||
129594780|NCT00939627|466472502|FG001|Overall Study|Disease Progression|12|||
129594781|NCT00939627|466472503|FG002|Overall Study|Disease Progression|0|||
129696571|NCT00806026|466848143|FG005|Overall Study|Lost to Follow-up|6|||
129594782|NCT00939627|466472501|FG000|Overall Study|Adverse Event|6|||
129594783|NCT00939627|466472502|FG001|Overall Study|Adverse Event|7|||
129594784|NCT00939627|466472503|FG002|Overall Study|Adverse Event|0|||
129594785|NCT00939627|466472501|FG000|Overall Study|Death|0|||
129594786|NCT00939627|466472502|FG001|Overall Study|Death|2|||
129594787|NCT00939627|466472503|FG002|Overall Study|Death|0|||
129594788|NCT00939627|466472501|FG000|Overall Study|Withdrawal by Subject|2|||
129594789|NCT00939627|466472502|FG001|Overall Study|Withdrawal by Subject|4|||
129696572|NCT00806026|466848138|FG000|Overall Study|Withdrawal by Subject|14|||
129594790|NCT00939627|466472503|FG002|Overall Study|Withdrawal by Subject|0|||
129594791|NCT00939627|466472501|FG000|Overall Study|Other complicating disease|1|||
129594792|NCT00939627|466472502|FG001|Overall Study|Other complicating disease|1|||
129594793|NCT00939627|466472503|FG002|Overall Study|Other complicating disease|0|||
129594794|NCT00939627|466472501|FG000|Overall Study|Not compliant|2|||
129594795|NCT00939627|466472502|FG001|Overall Study|Not compliant|0|||
129594796|NCT00939627|466472503|FG002|Overall Study|Not compliant|0|||
129594797|NCT00939627|466472501|FG000|Overall Study|No off-tx reason given|0|||
129594798|NCT00939627|466472502|FG001|Overall Study|No off-tx reason given|2|||
129594799|NCT00939627|466472503|FG002|Overall Study|No off-tx reason given|0|||
129594800|NCT00124462|466472504|FG000|Overall Study|Lost to Follow-up|3|||
129594801|NCT00124462|466472505|FG001|Overall Study|Lost to Follow-up|3|||
129594802|NCT00124462|466472504|FG000|Overall Study|Physician Decision|3|||
129594803|NCT00124462|466472505|FG001|Overall Study|Physician Decision|4|||
129594804|NCT00124462|466472504|FG000|Overall Study|Withdrawal by Subject|4|||
129594805|NCT00124462|466472505|FG001|Overall Study|Withdrawal by Subject|5|||
129594806|NCT00124462|466472504|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
129594807|NCT00124462|466472505|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
129594808|NCT02487082|466472506|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
129594809|NCT02487082|466472507|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
129594810|NCT02487082|466472506|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
129594811|NCT02487082|466472507|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
129594812|NCT03297294|466472508|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
129594813|NCT03297294|466472509|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
129594814|NCT03297294|466472510|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129594815|NCT03297294|466472511|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129594816|NCT03297294|466472512|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129594817|NCT03297294|466472508|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
129594818|NCT03297294|466472509|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
129594819|NCT03297294|466472510|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129594820|NCT03297294|466472511|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129594821|NCT03297294|466472512|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129594822|NCT03297294|466472508|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
129594823|NCT03297294|466472509|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
129594824|NCT03297294|466472510|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129594825|NCT03297294|466472511|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129594826|NCT03297294|466472512|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129594827|NCT03297294|466472508|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
129594828|NCT03297294|466472509|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
129594829|NCT03297294|466472510|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129594830|NCT03297294|466472511|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129594831|NCT03297294|466472512|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129594832|NCT03297294|466472508|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129594833|NCT03297294|466472509|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129594834|NCT03297294|466472510|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129594835|NCT03297294|466472511|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
129594836|NCT03297294|466472512|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
129594837|NCT02039063|466472515|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
129594838|NCT02039063|466472516|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
129594839|NCT02039063|466472517|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
129594840|NCT02039063|466472518|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
129594841|NCT02039063|466472515|FG000|Treatment Phase|Progression of disease|0|||
129594842|NCT02039063|466472516|FG001|Treatment Phase|Progression of disease|0|||
129594843|NCT02039063|466472517|FG002|Treatment Phase|Progression of disease|1|||
129594844|NCT02039063|466472518|FG003|Treatment Phase|Progression of disease|1|||
129594845|NCT02039063|466472515|FG000|Extension Phase|Inadequate therapeutic effect|0|||
129594846|NCT02039063|466472516|FG001|Extension Phase|Inadequate therapeutic effect|1|||
129594847|NCT02039063|466472517|FG002|Extension Phase|Inadequate therapeutic effect|2|||
129594848|NCT02039063|466472518|FG003|Extension Phase|Inadequate therapeutic effect|0|||
129594849|NCT02039063|466472515|FG000|Extension Phase|Progression of disease|0|||
129594850|NCT02039063|466472516|FG001|Extension Phase|Progression of disease|0|||
129594851|NCT02039063|466472517|FG002|Extension Phase|Progression of disease|0|||
129594852|NCT02039063|466472518|FG003|Extension Phase|Progression of disease|1|||
129594853|NCT02039063|466472515|FG000|Extension Phase|Adverse Event|0|||
129594854|NCT02039063|466472516|FG001|Extension Phase|Adverse Event|0|||
129594855|NCT02039063|466472517|FG002|Extension Phase|Adverse Event|1|||
129594856|NCT02039063|466472518|FG003|Extension Phase|Adverse Event|0|||
129594857|NCT02492841|466472520|FG000|Overall Study|Lost to Follow-up|34|||
129594858|NCT02492841|466472521|FG001|Overall Study|Lost to Follow-up|31|||
129594859|NCT02492841|466472522|FG002|Overall Study|Lost to Follow-up|35|||
129594860|NCT00104247|466472533|FG000|Overall Study|Withdrawal by Subject|1|||
129594861|NCT00104247|466472534|FG001|Overall Study|Withdrawal by Subject|0|||
129594862|NCT00104247|466472533|FG000|Overall Study|Noncompliant with dosing|0|||
129594863|NCT00104247|466472534|FG001|Overall Study|Noncompliant with dosing|1|||
129594864|NCT03069417|466472541|FG000|Overall Study|Lost to Follow-up|2|||
129594865|NCT03069417|466472542|FG001|Overall Study|Lost to Follow-up|0|||
129594866|NCT03069417|466472541|FG000|Overall Study|Reason Unknown|4|||
129594867|NCT03069417|466472542|FG001|Overall Study|Reason Unknown|7|||
129594868|NCT02244424|466472543|FG000|Overall Study|Lost to Follow-up|20|||
129594869|NCT02244424|466472544|FG001|Overall Study|Lost to Follow-up|10|||
129594870|NCT01917968|466472546|FG000|Overall Study|Death|3|||
129594871|NCT01917968|466472547|FG001|Overall Study|Death|2|||
129594872|NCT01917968|466472546|FG000|Overall Study|Lost to Follow-up|21|||
129594873|NCT01917968|466472547|FG001|Overall Study|Lost to Follow-up|39|||
129594874|NCT01917968|466472546|FG000|Overall Study|Physician Decision|1|||
129594875|NCT01917968|466472547|FG001|Overall Study|Physician Decision|2|||
129594876|NCT01917968|466472546|FG000|Overall Study|Withdrawal by Subject|20|||
129594877|NCT01917968|466472547|FG001|Overall Study|Withdrawal by Subject|35|||
129594878|NCT01917968|466472546|FG000|Overall Study|Subject Relocation|5|||
129594879|NCT01917968|466472547|FG001|Overall Study|Subject Relocation|1|||
129594880|NCT01917968|466472546|FG000|Overall Study|36M Missed Visit|3|||
129594881|NCT01917968|466472547|FG001|Overall Study|36M Missed Visit|2|||
129594882|NCT01917968|466472546|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
129594883|NCT01917968|466472547|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
129594884|NCT01917968|466472546|FG000|Overall Study|Change in Family Circumstances|0|||
129594885|NCT01917968|466472547|FG001|Overall Study|Change in Family Circumstances|1|||
129594886|NCT01917968|466472546|FG000|Overall Study|No Data Available|0|||
129594887|NCT01917968|466472547|FG001|Overall Study|No Data Available|2|||
129594888|NCT01507090|466472550|FG000|Overall Study|incomplete dataset|18|||
129594889|NCT03581188|466473875|FG000|Overall Study|Inclusion criteria not met|3|||
129594890|NCT03581188|466473876|FG001|Overall Study|Inclusion criteria not met|2|||
129594891|NCT03581188|466473875|FG000|Overall Study|Lost to Follow-up|5|||
129594892|NCT03581188|466473876|FG001|Overall Study|Lost to Follow-up|5|||
129594893|NCT03581188|466473875|FG000|Overall Study|Discontinued intervention|11|||
129594894|NCT03581188|466473876|FG001|Overall Study|Discontinued intervention|8|||
129594895|NCT03064438|466473881|FG000|Overall Study|Lost to Follow-up|1|||
129594896|NCT03064438|466473882|FG001|Overall Study|Lost to Follow-up|0|||
129594897|NCT03064438|466473881|FG000|Overall Study|Withdrawal by Subject|0|||
129594898|NCT03064438|466473882|FG001|Overall Study|Withdrawal by Subject|1|||
129594899|NCT01937351|466473883|FG000|Overall Study|Withdrawal by Subject|4|||
129594900|NCT01937351|466473884|FG001|Overall Study|Withdrawal by Subject|2|||
129594901|NCT01937351|466473883|FG000|Overall Study|Death|1|||
129594902|NCT01937351|466473884|FG001|Overall Study|Death|0|||
129594903|NCT01937351|466473883|FG000|Overall Study|Not treated w device, per protocol fail|4|||
129594904|NCT01937351|466473884|FG001|Overall Study|Not treated w device, per protocol fail|0|||
129594905|NCT01961687|466473885|FG000|Overall Study|Lost to Follow-up|19|||
129594906|NCT01961687|466473885|FG000|Overall Study|Re-operation|17|||
129594907|NCT01961687|466473885|FG000|Overall Study|Death|7|||
129594908|NCT01961687|466473885|FG000|Overall Study|Withdrawal by Subject|6|||
129594909|NCT01961687|466473885|FG000|Overall Study|Adverse Event|6|||
129594910|NCT01961687|466473885|FG000|Overall Study|Moved to area without study site|2|||
129594911|NCT01961687|466473885|FG000|Overall Study|Sponsor decision|2|||
129594912|NCT01961687|466473885|FG000|Overall Study|Physician Decision|1|||
129594913|NCT01961687|466473885|FG000|Overall Study|Unable to meet follow-up requirements|1|||
129594914|NCT03919448|466473890|FG000|Overall Study|Withdrawal by Subject|1|||
129594915|NCT03919448|466473891|FG001|Overall Study|Withdrawal by Subject|0|||
129594916|NCT03919448|466473892|FG002|Overall Study|Withdrawal by Subject|0|||
129594917|NCT03438539|466473893|FG000|Overall Study|Lost to Follow-up|8|||
129594918|NCT03438539|466473894|FG001|Overall Study|Lost to Follow-up|4|||
129594919|NCT03438539|466473895|FG002|Overall Study|Lost to Follow-up|10|||
129594920|NCT03438539|466473896|FG003|Overall Study|Lost to Follow-up|9|||
129594921|NCT03438539|466473897|FG004|Overall Study|Lost to Follow-up|3|||
129594922|NCT03438539|466473898|FG005|Overall Study|Lost to Follow-up|8|||
129594923|NCT04213209|466473899|FG000|Overall Study|Protocol Violation|1|||
129594924|NCT04213209|466473900|FG001|Overall Study|Protocol Violation|0|||
129594925|NCT04213209|466473901|FG002|Overall Study|Protocol Violation|0|||
129594926|NCT04213209|466473902|FG003|Overall Study|Protocol Violation|0|||
129594927|NCT04213209|466473903|FG004|Overall Study|Protocol Violation|0|||
129594928|NCT04213209|466473904|FG005|Overall Study|Protocol Violation|0|||
129594929|NCT00418522|466473912|FG000|Overall Study|Adverse Event|7|||
129594930|NCT00418522|466473913|FG001|Overall Study|Adverse Event|1|||
129594931|NCT00418522|466473912|FG000|Overall Study|Lack of Efficacy|1|||
129594932|NCT00418522|466473913|FG001|Overall Study|Lack of Efficacy|3|||
129594933|NCT00418522|466473912|FG000|Overall Study|Lost to Follow-up|10|||
129594934|NCT00418522|466473913|FG001|Overall Study|Lost to Follow-up|4|||
129594935|NCT00418522|466473912|FG000|Overall Study|Withdrawal by Subject|31|||
129594936|NCT00418522|466473913|FG001|Overall Study|Withdrawal by Subject|7|||
129594937|NCT00418522|466473912|FG000|Overall Study|Other|27|||
129594938|NCT00418522|466473913|FG001|Overall Study|Other|23|||
129594939|NCT00418522|466473912|FG000|Overall Study|Randomized but did not receive treatment|7|||
129594940|NCT00418522|466473913|FG001|Overall Study|Randomized but did not receive treatment|4|||
129594941|NCT02695719|466473914|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
129594942|NCT02695719|466473915|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
129594943|NCT02695719|466473914|FG000|Overall Study|Significant Protocol Deviation|0|||
129594944|NCT02695719|466473915|FG001|Overall Study|Significant Protocol Deviation|1|||
129594945|NCT02695719|466473914|FG000|Overall Study|Voluntary Withdrawal|1|||
129594946|NCT02695719|466473915|FG001|Overall Study|Voluntary Withdrawal|0|||
129594947|NCT00483548|466473916|FG000|Overall Study|Randomized; not treated with study drug|1|||
129594948|NCT00483548|466473917|FG001|Overall Study|Randomized; not treated with study drug|3|||
129594949|NCT00483548|466473916|FG000|Overall Study|Adverse Event|25|||
129594950|NCT00483548|466473917|FG001|Overall Study|Adverse Event|14|||
129594951|NCT00483548|466473916|FG000|Overall Study|Laboratory abnormality|1|||
129594952|NCT00483548|466473917|FG001|Overall Study|Laboratory abnormality|2|||
129594953|NCT00483548|466473916|FG000|Overall Study|Lack of Efficacy|4|||
129594954|NCT00483548|466473917|FG001|Overall Study|Lack of Efficacy|8|||
129594955|NCT00483548|466473916|FG000|Overall Study|Protocol Violation|11|||
129594956|NCT00483548|466473917|FG001|Overall Study|Protocol Violation|7|||
129594957|NCT00483548|466473916|FG000|Overall Study|Pregnancy|1|||
129594958|NCT00483548|466473917|FG001|Overall Study|Pregnancy|0|||
129594959|NCT00483548|466473916|FG000|Overall Study|Protocol required discontinuation|6|||
129594960|NCT00483548|466473917|FG001|Overall Study|Protocol required discontinuation|6|||
129594961|NCT00483548|466473916|FG000|Overall Study|Unable to comply with protocol schedule|1|||
129594962|NCT00483548|466473917|FG001|Overall Study|Unable to comply with protocol schedule|0|||
129594963|NCT00483548|466473916|FG000|Overall Study|Non-compliance with medication|2|||
129594964|NCT00483548|466473917|FG001|Overall Study|Non-compliance with medication|0|||
129594965|NCT00483548|466473916|FG000|Overall Study|Lost to Follow-up|3|||
129594966|NCT00483548|466473917|FG001|Overall Study|Lost to Follow-up|4|||
129594967|NCT00483548|466473916|FG000|Overall Study|Withdrawal by Subject|5|||
129594968|NCT00483548|466473917|FG001|Overall Study|Withdrawal by Subject|2|||
129594969|NCT00126126|466473918|FG000|Overall Study|Lost to Follow-up|0|||
129594970|NCT00126126|466473919|FG001|Overall Study|Lost to Follow-up|2|||
129594971|NCT02694549|466473920|FG000|Overall Study|screen failures|2|||
129594972|NCT01534078|466473921|FG000|Overall Study|Death|1|||
129594973|NCT01534078|466473921|FG000|Overall Study|Withdrawal by Subject|1|||
129594974|NCT02459665|466473922|FG000|Overall Study|Withdrawal by Subject|0|||
129594975|NCT02459665|466473923|FG001|Overall Study|Withdrawal by Subject|1|||
129594976|NCT02459665|466473924|FG002|Overall Study|Withdrawal by Subject|1|||
129594977|NCT02459665|466473925|FG003|Overall Study|Withdrawal by Subject|2|||
129594978|NCT00868296|466473929|FG000|Overall Study|Adverse Event|0|||
129594979|NCT00868296|466473930|FG001|Overall Study|Adverse Event|2|||
129594980|NCT00868296|466473929|FG000|Overall Study|Withdrawal by Subject|0|||
129594981|NCT00868296|466473930|FG001|Overall Study|Withdrawal by Subject|1|||
129594982|NCT00986570|466473935|FG000|Overall Study|Lost to Follow-up|6|||
129594983|NCT00986570|466473935|FG000|Overall Study|Potential bias for objective assessment|1|||
129594984|NCT01501110|466473936|FG000|Overall Study|Death|0|||
129594985|NCT01501110|466473937|FG001|Overall Study|Death|1|||
129594986|NCT02462486|466473942|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
129594987|NCT02462486|466473943|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
129594988|NCT02462486|466473944|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
129594989|NCT02462486|466473942|FG000|Overall Study|Adverse Event|53|||
129594990|NCT02462486|466473943|FG001|Overall Study|Adverse Event|48|||
129594991|NCT02462486|466473944|FG002|Overall Study|Adverse Event|21|||
129594992|NCT02462486|466473942|FG000|Overall Study|Lack of Efficacy|6|||
129594993|NCT02462486|466473943|FG001|Overall Study|Lack of Efficacy|12|||
129594994|NCT02462486|466473944|FG002|Overall Study|Lack of Efficacy|3|||
129594995|NCT02462486|466473942|FG000|Overall Study|Lost to Follow-up|3|||
129594996|NCT02462486|466473943|FG001|Overall Study|Lost to Follow-up|4|||
129594997|NCT02462486|466473944|FG002|Overall Study|Lost to Follow-up|2|||
129594998|NCT02462486|466473942|FG000|Overall Study|Withdrawal by Subject|25|||
129594999|NCT02462486|466473943|FG001|Overall Study|Withdrawal by Subject|22|||
129595000|NCT02462486|466473944|FG002|Overall Study|Withdrawal by Subject|19|||
129595001|NCT02462486|466473942|FG000|Overall Study|Protocol Violation|3|||
129595002|NCT02462486|466473943|FG001|Overall Study|Protocol Violation|1|||
129595003|NCT02462486|466473944|FG002|Overall Study|Protocol Violation|1|||
129595004|NCT02462486|466473942|FG000|Overall Study|Reason not Specified|3|||
129595005|NCT02462486|466473943|FG001|Overall Study|Reason not Specified|4|||
129595006|NCT02462486|466473944|FG002|Overall Study|Reason not Specified|3|||
129595007|NCT01439724|466473945|FG000|Overall Study|missing consultation|9|||
129595008|NCT01439724|466473946|FG001|Overall Study|missing consultation|8|||
129595009|NCT03877926|466473952|FG000|Overall Study|Adverse Event|1|||
129595010|NCT03877926|466473953|FG001|Overall Study|Adverse Event|0|||
129595011|NCT03877926|466473954|FG002|Overall Study|Adverse Event|0|||
129595012|NCT03877926|466473955|FG003|Overall Study|Adverse Event|0|||
129595013|NCT03877926|466473952|FG000|Overall Study|Death|2|||
129595014|NCT03877926|466473953|FG001|Overall Study|Death|2|||
129595015|NCT03877926|466473954|FG002|Overall Study|Death|2|||
129595016|NCT03877926|466473955|FG003|Overall Study|Death|0|||
129595017|NCT03877926|466473952|FG000|Overall Study|Lost to Follow-up|41|||
129595018|NCT03877926|466473953|FG001|Overall Study|Lost to Follow-up|52|||
129595019|NCT03877926|466473954|FG002|Overall Study|Lost to Follow-up|45|||
129595020|NCT03877926|466473955|FG003|Overall Study|Lost to Follow-up|17|||
129595021|NCT03877926|466473952|FG000|Overall Study|Physician Decision|2|||
129595022|NCT03877926|466473953|FG001|Overall Study|Physician Decision|0|||
129595023|NCT03877926|466473954|FG002|Overall Study|Physician Decision|2|||
129595024|NCT03877926|466473955|FG003|Overall Study|Physician Decision|0|||
129595025|NCT03877926|466473952|FG000|Overall Study|Withdrawal by Subject|18|||
129595026|NCT03877926|466473953|FG001|Overall Study|Withdrawal by Subject|21|||
129595027|NCT03877926|466473954|FG002|Overall Study|Withdrawal by Subject|12|||
129595028|NCT03877926|466473955|FG003|Overall Study|Withdrawal by Subject|4|||
129595029|NCT03877926|466473952|FG000|Overall Study|Other - Various|4|||
129595030|NCT03877926|466473953|FG001|Overall Study|Other - Various|1|||
129595031|NCT03877926|466473954|FG002|Overall Study|Other - Various|1|||
129595032|NCT03877926|466473955|FG003|Overall Study|Other - Various|0|||
129595033|NCT03877926|466473952|FG000|Overall Study|Not Treated|3|||
129595034|NCT03877926|466473953|FG001|Overall Study|Not Treated|1|||
129595035|NCT03877926|466473954|FG002|Overall Study|Not Treated|1|||
129595036|NCT03877926|466473955|FG003|Overall Study|Not Treated|0|||
129595037|NCT03554317|466473957|FG000|Overall Study|Withdrawal by Subject|1|||
129595038|NCT03554317|466473957|FG000|Overall Study|PSA Progression|3|||
129595039|NCT03554317|466473957|FG000|Overall Study|Radiographic Progression|4|||
129595040|NCT00537199|466473958|FG000|Overall Study|Study Terminated|1|||
129595041|NCT00467831|466473959|FG000|Overall Study|Death|2|||
129595042|NCT00467831|466473959|FG000|Overall Study|Withdrawal by Subject|1|||
129595043|NCT02776553|466473963|FG000|Overall Study|Lost to Follow-up|1|||
129885624|NCT02855164|467540774|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
129885625|NCT02855164|467540775|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
129595044|NCT02776553|466473964|FG001|Overall Study|Lost to Follow-up|0|||
129595045|NCT02776553|466473963|FG000|Overall Study|got liver transplant|1|||
129595046|NCT02776553|466473964|FG001|Overall Study|got liver transplant|2|||
129595047|NCT02776553|466473963|FG000|Overall Study|had other surgery|1|||
129595048|NCT02776553|466473964|FG001|Overall Study|had other surgery|0|||
129595049|NCT02776553|466473963|FG000|Overall Study|Protocol Violation|0|||
129595050|NCT02776553|466473964|FG001|Overall Study|Protocol Violation|1|||
129595051|NCT00171340|466473966|FG000|Overall Study|Adverse Event|46|||
129595052|NCT00171340|466473967|FG001|Overall Study|Adverse Event|42|||
129595053|NCT00171340|466473966|FG000|Overall Study|Lack of Efficacy|29|||
129595054|NCT00171340|466473967|FG001|Overall Study|Lack of Efficacy|41|||
129595055|NCT00171340|466473966|FG000|Overall Study|Protocol Violation|7|||
129595056|NCT00171340|466473967|FG001|Overall Study|Protocol Violation|8|||
129595057|NCT00171340|466473966|FG000|Overall Study|Withdrawal by Subject|22|||
129595058|NCT00171340|466473967|FG001|Overall Study|Withdrawal by Subject|19|||
129595059|NCT00171340|466473966|FG000|Overall Study|Lost to Follow-up|0|||
129595060|NCT00171340|466473967|FG001|Overall Study|Lost to Follow-up|5|||
129595061|NCT00171340|466473966|FG000|Overall Study|Abnormal Laboratory Results|2|||
129595062|NCT00171340|466473967|FG001|Overall Study|Abnormal Laboratory Results|0|||
129595063|NCT00171340|466473966|FG000|Overall Study|Abnormal Test Procedure Results|6|||
129595064|NCT00171340|466473967|FG001|Overall Study|Abnormal Test Procedure Results|11|||
129595065|NCT00171340|466473966|FG000|Overall Study|No Longer Required Study Drug|1|||
129595066|NCT00171340|466473967|FG001|Overall Study|No Longer Required Study Drug|1|||
129595067|NCT00171340|466473966|FG000|Overall Study|Administrative Problems|5|||
129595068|NCT00171340|466473967|FG001|Overall Study|Administrative Problems|2|||
129595069|NCT00171340|466473966|FG000|Overall Study|Death|6|||
129595070|NCT00171340|466473967|FG001|Overall Study|Death|6|||
129595071|NCT01056640|466473968|FG000|Overall Study|Withdrawal by Subject|11|||
129595072|NCT01056640|466473969|FG001|Overall Study|Withdrawal by Subject|8|||
129595073|NCT01056640|466473968|FG000|Overall Study|Death|15|||
129595074|NCT01056640|466473969|FG001|Overall Study|Death|4|||
129595075|NCT02087176|466473970|FG000|Overall Study|Withdrawal by Subject|1|||
129595076|NCT02087176|466473970|FG000|Overall Study|Death|10|||
129595077|NCT02087176|466473970|FG000|Overall Study|Censored|19|||
129595078|NCT02087176|466473970|FG000|Overall Study|Study Terminated by Sponsor|2|||
129595079|NCT03648879|466473971|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
129595080|NCT03812991|466473972|FG000|Overall Study|Lost to Follow-up|3|||
129595081|NCT03812991|466473973|FG001|Overall Study|Lost to Follow-up|1|||
129595082|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
129595083|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
129595084|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
129595085|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
129595086|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
129595087|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
129595088|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
129595089|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
129595090|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
129595091|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
129595092|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
129595093|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
129595094|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
129595095|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
129595096|NCT04740931|466473974|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
129595097|NCT04740931|466473975|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
129595098|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
129595099|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
129595100|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
129595101|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
129595102|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
129595103|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
129595104|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
129595105|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
129595106|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
129595107|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
129595108|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
129595109|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
129595110|NCT04740931|466473974|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
129595111|NCT04740931|466473975|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
129595112|NCT04099641|466473978|FG000|Overall Study|Death|46|||
129595113|NCT04099641|466473979|FG001|Overall Study|Death|12|||
129595114|NCT04099641|466473978|FG000|Overall Study|Lost to Follow-up|1|||
129595115|NCT04099641|466473979|FG001|Overall Study|Lost to Follow-up|0|||
129595116|NCT04099641|466473978|FG000|Overall Study|Withdrawal by Subject|2|||
129595117|NCT04099641|466473979|FG001|Overall Study|Withdrawal by Subject|0|||
129595118|NCT00895037|466473980|FG000|Overall Study|Death|0|||
129595119|NCT00895037|466473981|FG001|Overall Study|Death|2|||
129595120|NCT00895037|466473982|FG002|Overall Study|Death|1|||
129696573|NCT00806026|466848139|FG001|Overall Study|Withdrawal by Subject|17|||
129696574|NCT00806026|466848140|FG002|Overall Study|Withdrawal by Subject|9|||
129696575|NCT00806026|466848141|FG003|Overall Study|Withdrawal by Subject|2|||
129696576|NCT00806026|466848142|FG004|Overall Study|Withdrawal by Subject|5|||
129696577|NCT00806026|466848143|FG005|Overall Study|Withdrawal by Subject|3|||
129696578|NCT00806026|466848138|FG000|Overall Study|Other|3|||
129696579|NCT00806026|466848139|FG001|Overall Study|Other|6|||
129696580|NCT00806026|466848140|FG002|Overall Study|Other|8|||
129696581|NCT00806026|466848141|FG003|Overall Study|Other|2|||
129696582|NCT00806026|466848142|FG004|Overall Study|Other|0|||
129696583|NCT00806026|466848143|FG005|Overall Study|Other|4|||
129696584|NCT00806026|466848138|FG000|Overall Study|Protocol Violation|6|||
129595121|NCT04798482|466473998|FG000|Overall Study|Physician Decision|1|||
129595122|NCT04798482|466473998|FG000|Overall Study|Lost eligibility|1|||
129595123|NCT01192399|466473999|FG000|Overall Study|Lack of Efficacy|2|||
129595124|NCT01930175|466474000|FG000|Core Study|Lost to Follow-up|0|||
129595125|NCT01930175|466474001|FG001|Core Study|Lost to Follow-up|1|||
129595126|NCT01930175|466474002|FG002|Core Study|Lost to Follow-up|0|||
129696585|NCT00806026|466848139|FG001|Overall Study|Protocol Violation|9|||
129696586|NCT00806026|466848140|FG002|Overall Study|Protocol Violation|9|||
129696587|NCT00806026|466848141|FG003|Overall Study|Protocol Violation|0|||
129696588|NCT00806026|466848142|FG004|Overall Study|Protocol Violation|2|||
129696589|NCT00806026|466848143|FG005|Overall Study|Protocol Violation|3|||
129595127|NCT01930175|466474000|FG000|Core Study|Adverse Event|0|||
129696590|NCT00806026|466848138|FG000|Overall Study|Adverse Event|52|||
129696591|NCT00806026|466848139|FG001|Overall Study|Adverse Event|35|||
129696592|NCT00806026|466848140|FG002|Overall Study|Adverse Event|44|||
129595128|NCT01930175|466474001|FG001|Core Study|Adverse Event|0|||
129595129|NCT01930175|466474002|FG002|Core Study|Adverse Event|1|||
129595130|NCT02820740|466474003|FG000|Overall Study|Did not have procedure|2|||
129595131|NCT03314662|466474004|FG000|Overall Study|Withdrawal by Subject|1|||
129595132|NCT03314662|466474005|FG001|Overall Study|Withdrawal by Subject|1|||
129595133|NCT03314662|466474006|FG002|Overall Study|Withdrawal by Subject|1|||
129595134|NCT03314662|466474004|FG000|Overall Study|Lost to Follow-up|5|||
129595135|NCT03314662|466474005|FG001|Overall Study|Lost to Follow-up|4|||
129595136|NCT03314662|466474006|FG002|Overall Study|Lost to Follow-up|4|||
129595137|NCT03314662|466474004|FG000|Overall Study|Death|2|||
129595138|NCT03314662|466474005|FG001|Overall Study|Death|0|||
129595139|NCT03314662|466474006|FG002|Overall Study|Death|0|||
129696593|NCT00806026|466848141|FG003|Overall Study|Adverse Event|17|||
129696594|NCT00806026|466848142|FG004|Overall Study|Adverse Event|9|||
129696595|NCT00806026|466848143|FG005|Overall Study|Adverse Event|9|||
129696596|NCT03180138|466848144|FG000|Overall Study|Mobile-phone could not be verified|2|||
129696597|NCT03180138|466848145|FG001|Overall Study|Mobile-phone could not be verified|13|||
129595140|NCT00925301|466474014|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
129595141|NCT00925301|466474015|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
129595142|NCT00925301|466474016|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
129595143|NCT00925301|466474017|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
129595144|NCT00925301|466474014|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
129696598|NCT03180138|466848146|FG002|Overall Study|Mobile-phone could not be verified|15|||
129595145|NCT00925301|466474015|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
129595146|NCT00925301|466474016|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
129595147|NCT00925301|466474017|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
129595148|NCT00925301|466474014|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
129595149|NCT00925301|466474015|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
129595150|NCT00925301|466474016|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
129595151|NCT00925301|466474017|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
129595152|NCT00925301|466474014|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
129595153|NCT00925301|466474015|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
129595154|NCT00925301|466474016|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
129595155|NCT00925301|466474017|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
129595156|NCT00925301|466474014|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129595157|NCT00925301|466474015|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129595158|NCT00925301|466474016|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
129595159|NCT00925301|466474017|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
129595160|NCT00925301|466474014|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129595161|NCT00925301|466474015|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129595162|NCT00925301|466474016|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
129595163|NCT00925301|466474017|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
129595164|NCT00925301|466474014|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129595165|NCT00925301|466474015|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129595166|NCT00925301|466474016|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
129595167|NCT00925301|466474017|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
129595168|NCT03043560|466474018|FG000|Overall Study|Discontinued Intervention|1|||
129595169|NCT03043560|466474019|FG001|Overall Study|Discontinued Intervention|2|||
129595170|NCT03043560|466474018|FG000|Overall Study|Lost to Follow-up|0|||
129595171|NCT03043560|466474019|FG001|Overall Study|Lost to Follow-up|1|||
129595172|NCT01117766|466474020|FG000|First Intervention|Adverse Event|0|||
129595173|NCT01117766|466474021|FG001|First Intervention|Adverse Event|1|||
129595174|NCT01117766|466474020|FG000|First Intervention|Protocol Violation|1|||
129595175|NCT01117766|466474021|FG001|First Intervention|Protocol Violation|0|||
129595176|NCT01117766|466474020|FG000|Washout Period|Protocol Violation|0|||
129595177|NCT01117766|466474021|FG001|Washout Period|Protocol Violation|2|||
129595178|NCT01117766|466474020|FG000|Second Intervention|Lost to Follow-up|1|||
129595179|NCT01117766|466474021|FG001|Second Intervention|Lost to Follow-up|0|||
129595180|NCT01117766|466474020|FG000|Second Intervention|Other|1|||
129595181|NCT01117766|466474021|FG001|Second Intervention|Other|2|||
129595182|NCT01117766|466474020|FG000|Second Intervention|Adverse Event|0|||
129595183|NCT01117766|466474021|FG001|Second Intervention|Adverse Event|2|||
129595184|NCT01117766|466474020|FG000|Second Intervention|Withdrawal by Subject|0|||
129595185|NCT01117766|466474021|FG001|Second Intervention|Withdrawal by Subject|1|||
129595186|NCT00438659|466474022|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
129595187|NCT00438659|466474023|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
129595188|NCT00438659|466474022|FG000|Overall Study|Cancel|5|||
129595189|NCT00438659|466474023|FG001|Overall Study|Cancel|2|||
129595190|NCT00440115|466474024|FG000|Overall Study|Death|7|||
129595191|NCT00440115|466474025|FG001|Overall Study|Death|9|||
129595192|NCT00440115|466474026|FG002|Overall Study|Death|5|||
129595193|NCT00440115|466474024|FG000|Overall Study|Incarceration|0|||
129595194|NCT00440115|466474025|FG001|Overall Study|Incarceration|2|||
129595195|NCT00440115|466474026|FG002|Overall Study|Incarceration|1|||
129595196|NCT01117987|466474028|FG000|Overall Study|Protocol deviation|0|||
129595197|NCT01117987|466474029|FG001|Overall Study|Protocol deviation|1|||
129595198|NCT01117987|466474028|FG000|Overall Study|Subject no longer requires study drug|1|||
129595199|NCT01117987|466474029|FG001|Overall Study|Subject no longer requires study drug|0|||
129595200|NCT01117987|466474028|FG000|Overall Study|Lost to Follow-up|1|||
129595201|NCT01117987|466474029|FG001|Overall Study|Lost to Follow-up|1|||
129595202|NCT01117987|466474028|FG000|Overall Study|Abnormal test procedure result|2|||
129595203|NCT01117987|466474029|FG001|Overall Study|Abnormal test procedure result|0|||
129595204|NCT01117987|466474028|FG000|Overall Study|Lack of Efficacy|3|||
129595205|NCT01117987|466474029|FG001|Overall Study|Lack of Efficacy|4|||
129595206|NCT01117987|466474028|FG000|Overall Study|Death|5|||
129595207|NCT01117987|466474029|FG001|Overall Study|Death|10|||
129595208|NCT01117987|466474028|FG000|Overall Study|Withdrawal by Subject|5|||
129595209|NCT01117987|466474029|FG001|Overall Study|Withdrawal by Subject|10|||
129595210|NCT01117987|466474028|FG000|Overall Study|Adverse Event|19|||
129786478|NCT01546623|467185676|FG001|Overall Study|Major Protocol Deviation|1|||
129786479|NCT01546623|467185675|FG000|Overall Study|High Prostate specific antigen|2|||
129595211|NCT01117987|466474029|FG001|Overall Study|Adverse Event|26|||
129595212|NCT01117987|466474028|FG000|Overall Study|Administrative problems|25|||
129595213|NCT01117987|466474029|FG001|Overall Study|Administrative problems|22|||
129595214|NCT00206102|466474030|FG000|Overall Study|Adverse Event|119|||
129595215|NCT00206102|466474031|FG001|Overall Study|Adverse Event|82|||
129595216|NCT00206102|466474030|FG000|Overall Study|Protocol Violation|0|||
129595217|NCT00206102|466474031|FG001|Overall Study|Protocol Violation|2|||
129595218|NCT00206102|466474030|FG000|Overall Study|Lack of therapeutic response|16|||
129595219|NCT00206102|466474031|FG001|Overall Study|Lack of therapeutic response|11|||
129595220|NCT00206102|466474030|FG000|Overall Study|Lost to Follow-up|95|||
129595221|NCT00206102|466474031|FG001|Overall Study|Lost to Follow-up|66|||
129595222|NCT00206102|466474030|FG000|Overall Study|Withdrawal by Subject|118|||
129595223|NCT00206102|466474031|FG001|Overall Study|Withdrawal by Subject|101|||
129595224|NCT00206102|466474030|FG000|Overall Study|Study-specific discontinuation criteria|18|||
129595225|NCT00206102|466474031|FG001|Overall Study|Study-specific discontinuation criteria|17|||
129595226|NCT00206102|466474030|FG000|Overall Study|None of those categories|42|||
129595227|NCT00206102|466474031|FG001|Overall Study|None of those categories|36|||
129595228|NCT04117945|466474032|FG000|Overall Study|Death|1|||
129595229|NCT04117945|466474033|FG001|Overall Study|Death|0|||
129595230|NCT04117945|466474032|FG000|Overall Study|Withdrawal by Subject|3|||
129595231|NCT04117945|466474033|FG001|Overall Study|Withdrawal by Subject|1|||
129595232|NCT04117945|466474032|FG000|Overall Study|Disease Progression|0|||
129595233|NCT04117945|466474033|FG001|Overall Study|Disease Progression|2|||
129595234|NCT04117945|466474032|FG000|Overall Study|Ineligible|8|||
129595235|NCT04117945|466474033|FG001|Overall Study|Ineligible|7|||
129595236|NCT00402025|466474034|FG000|Overall Study|Adverse Event|0|||
129595237|NCT00402025|466474035|FG001|Overall Study|Adverse Event|0|||
129595238|NCT00402025|466474036|FG002|Overall Study|Adverse Event|2|||
129595239|NCT00402025|466474034|FG000|Overall Study|Death|0|||
129595240|NCT00402025|466474035|FG001|Overall Study|Death|1|||
129595241|NCT00402025|466474036|FG002|Overall Study|Death|5|||
129595242|NCT00402025|466474034|FG000|Overall Study|Disease Progression|1|||
129595243|NCT00402025|466474035|FG001|Overall Study|Disease Progression|1|||
129595244|NCT00402025|466474036|FG002|Overall Study|Disease Progression|2|||
129595245|NCT00402025|466474034|FG000|Overall Study|Physician Decision|1|||
129595246|NCT00402025|466474035|FG001|Overall Study|Physician Decision|1|||
129595247|NCT00402025|466474036|FG002|Overall Study|Physician Decision|0|||
129595248|NCT00402025|466474034|FG000|Overall Study|Participant Decision|0|||
129595249|NCT00402025|466474035|FG001|Overall Study|Participant Decision|0|||
129595250|NCT00402025|466474036|FG002|Overall Study|Participant Decision|1|||
129595251|NCT04678817|466475911|FG000|Overall Study|Lost to Follow-up|28|||
129595252|NCT04678817|466475912|FG001|Overall Study|Lost to Follow-up|0|||
129595253|NCT04678817|466475913|FG002|Overall Study|Lost to Follow-up|0|||
129595254|NCT01730040|466475916|FG000|Overall Study|Randomized but not treated|0|||
129595255|NCT01730040|466475917|FG001|Overall Study|Randomized but not treated|0|||
129595256|NCT01730040|466475918|FG002|Overall Study|Randomized but not treated|0|||
129595257|NCT01730040|466475919|FG003|Overall Study|Randomized but not treated|0|||
129595258|NCT01730040|466475920|FG004|Overall Study|Randomized but not treated|0|||
129595259|NCT01730040|466475921|FG005|Overall Study|Randomized but not treated|1|||
129595260|NCT01730040|466475922|FG006|Overall Study|Randomized but not treated|0|||
129595261|NCT01730040|466475916|FG000|Overall Study|Subject moved|0|||
129595262|NCT01730040|466475917|FG001|Overall Study|Subject moved|0|||
129595263|NCT01730040|466475918|FG002|Overall Study|Subject moved|1|||
129595264|NCT01730040|466475919|FG003|Overall Study|Subject moved|0|||
129595265|NCT01730040|466475920|FG004|Overall Study|Subject moved|0|||
129696599|NCT03180138|466848144|FG000|Overall Study|No prior immunization records|17|||
129696600|NCT03180138|466848145|FG001|Overall Study|No prior immunization records|0|||
129696601|NCT03180138|466848146|FG002|Overall Study|No prior immunization records|6|||
129885626|NCT02855164|467540776|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129595266|NCT01730040|466475921|FG005|Overall Study|Subject moved|0|||
129595267|NCT01730040|466475922|FG006|Overall Study|Subject moved|1|||
129595268|NCT01730040|466475916|FG000|Overall Study|Physician Decision|0|||
129595269|NCT01730040|466475917|FG001|Overall Study|Physician Decision|0|||
129696602|NCT03180138|466848144|FG000|Overall Study|Found to be >24 mon after randomization|3|||
129595270|NCT01730040|466475918|FG002|Overall Study|Physician Decision|0|||
129595271|NCT01730040|466475919|FG003|Overall Study|Physician Decision|0|||
129595272|NCT01730040|466475920|FG004|Overall Study|Physician Decision|0|||
129595273|NCT01730040|466475921|FG005|Overall Study|Physician Decision|1|||
129595274|NCT01730040|466475922|FG006|Overall Study|Physician Decision|1|||
129696603|NCT03180138|466848145|FG001|Overall Study|Found to be >24 mon after randomization|0|||
129595275|NCT01730040|466475916|FG000|Overall Study|Other than specified|7|||
129595276|NCT01730040|466475917|FG001|Overall Study|Other than specified|8|||
129595277|NCT01730040|466475918|FG002|Overall Study|Other than specified|5|||
129595278|NCT01730040|466475919|FG003|Overall Study|Other than specified|5|||
129595279|NCT01730040|466475920|FG004|Overall Study|Other than specified|5|||
129696604|NCT03180138|466848146|FG002|Overall Study|Found to be >24 mon after randomization|3|||
129696605|NCT00452530|466848148|FG000|Overall Study|Death|1|||
129696606|NCT00452530|466848149|FG001|Overall Study|Death|0|||
129696607|NCT00452530|466848148|FG000|Overall Study|Adverse Event|40|||
129595280|NCT01730040|466475921|FG005|Overall Study|Other than specified|4|||
129595281|NCT01730040|466475922|FG006|Overall Study|Other than specified|4|||
129595282|NCT01730040|466475916|FG000|Overall Study|Adverse Event|4|||
129595283|NCT01730040|466475917|FG001|Overall Study|Adverse Event|3|||
129595284|NCT01730040|466475918|FG002|Overall Study|Adverse Event|5|||
129595285|NCT01730040|466475919|FG003|Overall Study|Adverse Event|3|||
129595286|NCT01730040|466475920|FG004|Overall Study|Adverse Event|1|||
129595287|NCT01730040|466475921|FG005|Overall Study|Adverse Event|1|||
129595288|NCT01730040|466475922|FG006|Overall Study|Adverse Event|2|||
129595289|NCT01730040|466475916|FG000|Overall Study|Poor compliance to protocol|2|||
129595290|NCT01730040|466475917|FG001|Overall Study|Poor compliance to protocol|4|||
129595291|NCT01730040|466475918|FG002|Overall Study|Poor compliance to protocol|0|||
129595292|NCT01730040|466475919|FG003|Overall Study|Poor compliance to protocol|0|||
129595293|NCT01730040|466475920|FG004|Overall Study|Poor compliance to protocol|0|||
129696608|NCT00452530|466848149|FG001|Overall Study|Adverse Event|44|||
129696609|NCT00452530|466848148|FG000|Overall Study|Withdrawal by Subject|68|||
129696610|NCT00452530|466848149|FG001|Overall Study|Withdrawal by Subject|57|||
129595294|NCT01730040|466475921|FG005|Overall Study|Poor compliance to protocol|0|||
129595295|NCT01730040|466475922|FG006|Overall Study|Poor compliance to protocol|1|||
129595296|NCT01684215|466475923|FG000|Phase 1, Part 1|Adverse Event|1|||
129595297|NCT01684215|466475924|FG001|Phase 1, Part 1|Adverse Event|0|||
129595298|NCT01684215|466475925|FG002|Phase 1, Part 1|Adverse Event|0|||
129595299|NCT01684215|466475926|FG003|Phase 1, Part 1|Adverse Event|0|||
129595300|NCT01684215|466475923|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
129595301|NCT01684215|466475924|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
129595302|NCT01684215|466475925|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
129595303|NCT01684215|466475926|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
129595304|NCT01684215|466475923|FG000|Phase 1, Part 2|Adverse Event|0|||
129696611|NCT00452530|466848148|FG000|Overall Study|Lost to Follow-up|1|||
129696612|NCT00452530|466848149|FG001|Overall Study|Lost to Follow-up|0|||
129595305|NCT01684215|466475924|FG001|Phase 1, Part 2|Adverse Event|0|||
129595306|NCT01684215|466475925|FG002|Phase 1, Part 2|Adverse Event|1|||
129595307|NCT01684215|466475926|FG003|Phase 1, Part 2|Adverse Event|0|||
129595308|NCT01684215|466475923|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
129595309|NCT01684215|466475924|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
129595310|NCT01684215|466475925|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
129595311|NCT01684215|466475926|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
129595312|NCT01684215|466475923|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
129595313|NCT01684215|466475924|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
129595314|NCT01684215|466475925|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
129595315|NCT01684215|466475926|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
129595316|NCT01684215|466475923|FG000|Phase 2|Death|0|||
129595317|NCT01684215|466475924|FG001|Phase 2|Death|0|||
129595318|NCT01684215|466475925|FG002|Phase 2|Death|0|||
129595319|NCT01684215|466475926|FG003|Phase 2|Death|8|||
129595320|NCT01684215|466475923|FG000|Phase 2|Study terminated by sponsor|0|||
129595321|NCT01684215|466475924|FG001|Phase 2|Study terminated by sponsor|0|||
129595322|NCT01684215|466475925|FG002|Phase 2|Study terminated by sponsor|0|||
129595323|NCT01684215|466475926|FG003|Phase 2|Study terminated by sponsor|30|||
129696613|NCT00452530|466848148|FG000|Overall Study|Poor compliance/noncompliance|1|||
129595324|NCT01684215|466475923|FG000|Phase 2|Enrolled but not treated|0|||
129696614|NCT00452530|466848149|FG001|Overall Study|Poor compliance/noncompliance|2|||
129885627|NCT02855164|467540777|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129595325|NCT01684215|466475924|FG001|Phase 2|Enrolled but not treated|0|||
129595326|NCT01684215|466475925|FG002|Phase 2|Enrolled but not treated|0|||
129595327|NCT01684215|466475926|FG003|Phase 2|Enrolled but not treated|1|||
129595328|NCT01684215|466475923|FG000|Phase 2|Lost to Follow-up|0|||
129595329|NCT01684215|466475924|FG001|Phase 2|Lost to Follow-up|0|||
129595330|NCT01684215|466475925|FG002|Phase 2|Lost to Follow-up|0|||
129595331|NCT01684215|466475926|FG003|Phase 2|Lost to Follow-up|4|||
129595332|NCT01301482|466475927|FG000|Overall Study|Withdrawal by Subject|1|||
129595333|NCT00480324|466475928|FG000|Overall Study|Adverse Event|1|||
129595334|NCT00480324|466475929|FG001|Overall Study|Adverse Event|1|||
129595335|NCT00480324|466475928|FG000|Overall Study|Protocol Violation|0|||
129595336|NCT00480324|466475929|FG001|Overall Study|Protocol Violation|1|||
129595337|NCT00480324|466475928|FG000|Overall Study|Withdrawal by Subject|14|||
129595338|NCT00480324|466475929|FG001|Overall Study|Withdrawal by Subject|5|||
129595339|NCT00480324|466475928|FG000|Overall Study|Lost to Follow-up|17|||
129595340|NCT00480324|466475929|FG001|Overall Study|Lost to Follow-up|8|||
129595341|NCT00480324|466475928|FG000|Overall Study|Subject's mother pregnant|0|||
129595342|NCT00480324|466475929|FG001|Overall Study|Subject's mother pregnant|1|||
129595343|NCT00784134|466475930|FG000|Overall Study|Lost to Follow-up|3|||
129595344|NCT00784134|466475931|FG001|Overall Study|Lost to Follow-up|6|||
129595345|NCT03785145|466475932|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
129595346|NCT03785145|466475933|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
129595347|NCT03785145|466475932|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
129595348|NCT03785145|466475933|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
129595349|NCT03785145|466475932|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
129595350|NCT03785145|466475933|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
129595351|NCT03785145|466475932|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
129595352|NCT03785145|466475933|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
129595353|NCT03785145|466475932|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
129595354|NCT03785145|466475933|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
129595355|NCT03785145|466475932|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
129595356|NCT03785145|466475933|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
129595357|NCT03785145|466475932|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
129595358|NCT03785145|466475933|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
129595359|NCT03785145|466475932|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
129595360|NCT03785145|466475933|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
129595361|NCT03785145|466475932|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
129595362|NCT03785145|466475933|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
129595363|NCT03785145|466475932|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
129595364|NCT03785145|466475933|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
129595365|NCT03785145|466475932|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
129595366|NCT03785145|466475933|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
129595367|NCT01552369|466475934|FG000|Overall Study|Did not consent to extended follow up|8|||
129595368|NCT01552369|466475935|FG001|Overall Study|Did not consent to extended follow up|9|||
129595369|NCT03250299|466475939|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
129595370|NCT03250299|466475940|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
129595371|NCT03250299|466475941|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
129595372|NCT03250299|466475942|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
129595373|NCT03250299|466475943|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
129595374|NCT03250299|466475939|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
129595375|NCT03250299|466475940|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
129595376|NCT03250299|466475941|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
129595377|NCT03250299|466475942|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
129595378|NCT03250299|466475943|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
129595379|NCT03250299|466475939|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129595380|NCT03250299|466475940|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129595381|NCT03250299|466475941|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
129595382|NCT03250299|466475942|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129595383|NCT03250299|466475943|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
129595384|NCT03250299|466475939|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
129595385|NCT03250299|466475940|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
129595386|NCT03250299|466475941|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
129595387|NCT03250299|466475942|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
129595388|NCT03250299|466475943|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
129595389|NCT03346070|466475944|FG000|Overall Study|Death|0|||
129595390|NCT03346070|466475945|FG001|Overall Study|Death|0|||
129595391|NCT03346070|466475946|FG002|Overall Study|Death|0|||
129595392|NCT03346070|466475947|FG003|Overall Study|Death|0|||
129595393|NCT03346070|466475948|FG004|Overall Study|Death|1|||
129595394|NCT03346070|466475944|FG000|Overall Study|Lost to Follow-up|0|||
129595395|NCT03346070|466475945|FG001|Overall Study|Lost to Follow-up|1|||
129595396|NCT03346070|466475946|FG002|Overall Study|Lost to Follow-up|2|||
129696615|NCT00452530|466848148|FG000|Overall Study|No longer met study criteria|18|||
129696616|NCT00452530|466848149|FG001|Overall Study|No longer met study criteria|22|||
129595397|NCT03346070|466475947|FG003|Overall Study|Lost to Follow-up|0|||
129595398|NCT03346070|466475948|FG004|Overall Study|Lost to Follow-up|0|||
129595399|NCT03346070|466475944|FG000|Overall Study|Physician Decision|0|||
129696617|NCT00452530|466848148|FG000|Overall Study|Other|7|||
129595400|NCT03346070|466475945|FG001|Overall Study|Physician Decision|0|||
129595401|NCT03346070|466475946|FG002|Overall Study|Physician Decision|0|||
129595402|NCT03346070|466475947|FG003|Overall Study|Physician Decision|1|||
129595403|NCT03346070|466475948|FG004|Overall Study|Physician Decision|1|||
129595404|NCT03346070|466475944|FG000|Overall Study|Withdrawal by Subject|1|||
129595405|NCT03346070|466475945|FG001|Overall Study|Withdrawal by Subject|0|||
129595406|NCT03346070|466475946|FG002|Overall Study|Withdrawal by Subject|0|||
129595407|NCT03346070|466475947|FG003|Overall Study|Withdrawal by Subject|1|||
129595408|NCT03346070|466475948|FG004|Overall Study|Withdrawal by Subject|0|||
129595409|NCT03346070|466475944|FG000|Overall Study|Study medication not received as planned|2|||
129595410|NCT03346070|466475945|FG001|Overall Study|Study medication not received as planned|3|||
129595411|NCT03346070|466475946|FG002|Overall Study|Study medication not received as planned|2|||
129595412|NCT03346070|466475947|FG003|Overall Study|Study medication not received as planned|3|||
129595413|NCT03346070|466475948|FG004|Overall Study|Study medication not received as planned|2|||
129595414|NCT03346070|466475944|FG000|Overall Study|Screen Failure|0|||
129595415|NCT03346070|466475945|FG001|Overall Study|Screen Failure|0|||
129595416|NCT03346070|466475946|FG002|Overall Study|Screen Failure|0|||
129595417|NCT03346070|466475947|FG003|Overall Study|Screen Failure|1|||
129595418|NCT03346070|466475948|FG004|Overall Study|Screen Failure|1|||
129595419|NCT00977548|466475954|FG000|Overall Study|Ineligible|4|||
129595420|NCT00977548|466475954|FG000|Overall Study|Adverse Event|8|||
129595421|NCT00977548|466475954|FG000|Overall Study|Withdrawal by Subject|1|||
129595422|NCT04086641|466475955|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
129595423|NCT04086641|466475956|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
129595424|NCT01042535|466475959|FG000|Overall Study|disease progression prior to treatment|3|||
129595425|NCT01042535|466475959|FG000|Overall Study|disease progression during treatment|3|||
129595426|NCT01042535|466475959|FG000|Overall Study|complications from other disease|2|||
129595427|NCT01546142|466475960|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
129595428|NCT01546142|466475961|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
129595429|NCT01546142|466475960|FG000|Overall Study|Subject Noncompliance|1|||
129595430|NCT01546142|466475961|FG001|Overall Study|Subject Noncompliance|1|||
129595431|NCT01546142|466475960|FG000|Overall Study|Adverse Event|6|||
129595432|NCT01546142|466475961|FG001|Overall Study|Adverse Event|3|||
129595433|NCT01546142|466475960|FG000|Overall Study|Lost to Follow-up|20|||
129595434|NCT01546142|466475961|FG001|Overall Study|Lost to Follow-up|15|||
129595435|NCT01546142|466475960|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
129595436|NCT01546142|466475961|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
129595437|NCT01546142|466475960|FG000|Overall Study|Subject Randomized but Not Treated|1|||
129595438|NCT01546142|466475961|FG001|Overall Study|Subject Randomized but Not Treated|0|||
129595439|NCT00743509|466475968|FG000|Overall Study|Withdrawal by Subject|2|||
129595440|NCT00573170|466475972|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
129595441|NCT00573170|466475973|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
129595442|NCT00573170|466475974|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
129595443|NCT00573170|466475975|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
129595444|NCT00573170|466475976|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
129595445|NCT00573170|466475977|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
129595446|NCT00573170|466475972|FG000|First Washout Period|Adverse Event|1|||
129595447|NCT00573170|466475973|FG001|First Washout Period|Adverse Event|1|||
129595448|NCT00573170|466475974|FG002|First Washout Period|Adverse Event|0|||
129595449|NCT00573170|466475975|FG003|First Washout Period|Adverse Event|0|||
129595450|NCT00573170|466475976|FG004|First Washout Period|Adverse Event|0|||
129595451|NCT00573170|466475977|FG005|First Washout Period|Adverse Event|1|||
129595452|NCT00573170|466475972|FG000|First Washout Period|Lack of Efficacy|0|||
129595453|NCT00573170|466475973|FG001|First Washout Period|Lack of Efficacy|0|||
129595454|NCT00573170|466475974|FG002|First Washout Period|Lack of Efficacy|0|||
129595455|NCT00573170|466475975|FG003|First Washout Period|Lack of Efficacy|0|||
129595456|NCT00573170|466475976|FG004|First Washout Period|Lack of Efficacy|0|||
129595457|NCT00573170|466475977|FG005|First Washout Period|Lack of Efficacy|1|||
129595458|NCT00573170|466475972|FG000|First Washout Period|Lost to Follow-up|1|||
129595459|NCT00573170|466475973|FG001|First Washout Period|Lost to Follow-up|1|||
129595460|NCT00573170|466475974|FG002|First Washout Period|Lost to Follow-up|0|||
129595461|NCT00573170|466475975|FG003|First Washout Period|Lost to Follow-up|2|||
129595462|NCT00573170|466475976|FG004|First Washout Period|Lost to Follow-up|0|||
129595463|NCT00573170|466475977|FG005|First Washout Period|Lost to Follow-up|2|||
129595464|NCT00573170|466475972|FG000|First Washout Period|Withdrawal by Subject|2|||
129595465|NCT00573170|466475973|FG001|First Washout Period|Withdrawal by Subject|0|||
129595466|NCT00573170|466475974|FG002|First Washout Period|Withdrawal by Subject|0|||
129595467|NCT00573170|466475975|FG003|First Washout Period|Withdrawal by Subject|2|||
129595468|NCT00573170|466475976|FG004|First Washout Period|Withdrawal by Subject|3|||
129595469|NCT00573170|466475977|FG005|First Washout Period|Withdrawal by Subject|3|||
129595470|NCT00573170|466475972|FG000|First Washout Period|Other|4|||
129595471|NCT00573170|466475973|FG001|First Washout Period|Other|0|||
129696618|NCT00452530|466848149|FG001|Overall Study|Other|11|||
129595472|NCT00573170|466475974|FG002|First Washout Period|Other|1|||
129595473|NCT00573170|466475975|FG003|First Washout Period|Other|1|||
129595474|NCT00573170|466475976|FG004|First Washout Period|Other|0|||
129595475|NCT00573170|466475977|FG005|First Washout Period|Other|0|||
129595476|NCT00573170|466475972|FG000|Second Washout Period|Adverse Event|1|||
129595477|NCT00573170|466475973|FG001|Second Washout Period|Adverse Event|0|||
129595478|NCT00573170|466475974|FG002|Second Washout Period|Adverse Event|0|||
129595479|NCT00573170|466475975|FG003|Second Washout Period|Adverse Event|0|||
129595480|NCT00573170|466475976|FG004|Second Washout Period|Adverse Event|1|||
129595481|NCT00573170|466475977|FG005|Second Washout Period|Adverse Event|0|||
129595482|NCT00573170|466475972|FG000|Second Washout Period|Protocol Violation|2|||
129595483|NCT00573170|466475973|FG001|Second Washout Period|Protocol Violation|1|||
129595484|NCT00573170|466475974|FG002|Second Washout Period|Protocol Violation|1|||
129595485|NCT00573170|466475975|FG003|Second Washout Period|Protocol Violation|0|||
129595486|NCT00573170|466475976|FG004|Second Washout Period|Protocol Violation|0|||
129595487|NCT00573170|466475977|FG005|Second Washout Period|Protocol Violation|0|||
129595488|NCT00573170|466475972|FG000|Second Washout Period|Withdrawal by Subject|1|||
129595489|NCT00573170|466475973|FG001|Second Washout Period|Withdrawal by Subject|1|||
129595490|NCT00573170|466475974|FG002|Second Washout Period|Withdrawal by Subject|2|||
129595491|NCT00573170|466475975|FG003|Second Washout Period|Withdrawal by Subject|0|||
129595492|NCT00573170|466475976|FG004|Second Washout Period|Withdrawal by Subject|1|||
129595493|NCT00573170|466475977|FG005|Second Washout Period|Withdrawal by Subject|0|||
129595494|NCT00573170|466475972|FG000|Second Washout Period|Lost to Follow-up|0|||
129595495|NCT00573170|466475973|FG001|Second Washout Period|Lost to Follow-up|0|||
129595496|NCT00573170|466475974|FG002|Second Washout Period|Lost to Follow-up|0|||
129595497|NCT00573170|466475975|FG003|Second Washout Period|Lost to Follow-up|1|||
129595498|NCT00573170|466475976|FG004|Second Washout Period|Lost to Follow-up|0|||
129595499|NCT00573170|466475977|FG005|Second Washout Period|Lost to Follow-up|0|||
129595500|NCT00573170|466475972|FG000|Second Washout Period|Other|1|||
129595501|NCT00573170|466475973|FG001|Second Washout Period|Other|2|||
129595502|NCT00573170|466475974|FG002|Second Washout Period|Other|1|||
129595503|NCT00573170|466475975|FG003|Second Washout Period|Other|4|||
129595504|NCT00573170|466475976|FG004|Second Washout Period|Other|6|||
129595505|NCT00573170|466475977|FG005|Second Washout Period|Other|2|||
129595506|NCT00573170|466475972|FG000|Third Treatment Period|Withdrawal by Subject|1|||
129595507|NCT00573170|466475973|FG001|Third Treatment Period|Withdrawal by Subject|0|||
129595508|NCT00573170|466475974|FG002|Third Treatment Period|Withdrawal by Subject|0|||
129595509|NCT00573170|466475975|FG003|Third Treatment Period|Withdrawal by Subject|0|||
129595510|NCT00573170|466475976|FG004|Third Treatment Period|Withdrawal by Subject|0|||
129595511|NCT00573170|466475977|FG005|Third Treatment Period|Withdrawal by Subject|0|||
129595512|NCT00573170|466475972|FG000|Third Treatment Period|Lost to Follow-up|0|||
129595513|NCT00573170|466475973|FG001|Third Treatment Period|Lost to Follow-up|0|||
129595514|NCT00573170|466475974|FG002|Third Treatment Period|Lost to Follow-up|0|||
129595515|NCT00573170|466475975|FG003|Third Treatment Period|Lost to Follow-up|0|||
129595516|NCT00573170|466475976|FG004|Third Treatment Period|Lost to Follow-up|0|||
129595517|NCT00573170|466475977|FG005|Third Treatment Period|Lost to Follow-up|2|||
129595518|NCT00608517|466475978|FG000|Overall Study|Death|1|||
129595519|NCT00608517|466475979|FG001|Overall Study|Death|0|||
129595520|NCT00608517|466475980|FG002|Overall Study|Death|0|||
129595521|NCT00493454|466475982|FG000|Overall Study|Withdrawal by Subject|1|||
129595522|NCT00103038|466475983|FG000|Overall Study|Withdrawal by Subject|8|||
129595523|NCT00103038|466475983|FG000|Overall Study|Screen failure|3|||
129595524|NCT00103038|466475983|FG000|Overall Study|Death|1|||
129595525|NCT00103038|466475983|FG000|Overall Study|Physician Decision|1|||
129595526|NCT03649412|466475990|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
129595527|NCT03649412|466475991|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
129595528|NCT03649412|466475990|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
129595529|NCT03649412|466475991|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
129595530|NCT03649412|466475990|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
129595531|NCT03649412|466475991|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129786480|NCT01546623|467185676|FG001|Overall Study|High Prostate specific antigen|1|||
129595532|NCT03649412|466475990|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
129595533|NCT03649412|466475991|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
129595534|NCT03649412|466475990|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
129595535|NCT03649412|466475991|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
129595536|NCT03649412|466475990|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
129786481|NCT01546623|467185675|FG000|Overall Study|Did Not Receive Study Drug|1|||
129786482|NCT01546623|467185676|FG001|Overall Study|Did Not Receive Study Drug|1|||
129595537|NCT03649412|466475991|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
129595538|NCT02865395|466475992|FG000|Overall Study|Physician Decision|6|||
129595539|NCT02865395|466475993|FG001|Overall Study|Physician Decision|10|||
129595540|NCT02865395|466475994|FG002|Overall Study|Physician Decision|7|||
129595541|NCT02674386|466475997|FG000|Overall Study|Lost to Follow-up|0|||
129595542|NCT02674386|466475998|FG001|Overall Study|Lost to Follow-up|1|||
129595543|NCT02674386|466475999|FG002|Overall Study|Lost to Follow-up|1|||
129595544|NCT02674386|466475997|FG000|Overall Study|Withdrawal by Subject|0|||
129595545|NCT02674386|466475998|FG001|Overall Study|Withdrawal by Subject|4|||
129595546|NCT02674386|466475999|FG002|Overall Study|Withdrawal by Subject|0|||
129595547|NCT02674386|466475997|FG000|Overall Study|Other|0|||
129595548|NCT02674386|466475998|FG001|Overall Study|Other|1|||
129595549|NCT02674386|466475999|FG002|Overall Study|Other|0|||
129595550|NCT02674386|466475997|FG000|Overall Study|Enrolled but not evaluated|0|||
129595551|NCT02674386|466475998|FG001|Overall Study|Enrolled but not evaluated|4|||
129595552|NCT02674386|466475999|FG002|Overall Study|Enrolled but not evaluated|0|||
129595553|NCT04019054|466476000|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
129595554|NCT04019054|466476001|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
129595555|NCT04019054|466476000|FG000|Overall Study|Withdrawal by Subject|3|||
129595556|NCT04019054|466476001|FG001|Overall Study|Withdrawal by Subject|1|||
129595557|NCT02094261|466476004|FG000|Overall Study|Death|24|||
129595558|NCT02094261|466476004|FG000|Overall Study|Lost to Follow-up|1|||
129595559|NCT02094261|466476004|FG000|Overall Study|Withdrawal by Subject|4|||
129595560|NCT02094261|466476004|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
129595561|NCT02363439|466476005|FG000|Overall Study|Lack of Efficacy|4|||
129595562|NCT00860743|466476010|FG000|Overall Study|Withdrawal by Subject|3|||
129595563|NCT00860743|466476011|FG001|Overall Study|Withdrawal by Subject|0|||
129595564|NCT01682148|466476012|FG000|Overall Study|Withdrawal by Subject|2|||
129595565|NCT01682148|466476013|FG001|Overall Study|Withdrawal by Subject|0|||
129595566|NCT01682148|466476012|FG000|Overall Study|Lost to Follow-up|1|||
129595567|NCT01682148|466476013|FG001|Overall Study|Lost to Follow-up|2|||
129595568|NCT01682148|466476012|FG000|Overall Study|Protocol Violation|1|||
129595569|NCT01682148|466476013|FG001|Overall Study|Protocol Violation|1|||
129595570|NCT03827018|466476016|FG000|Overall Study|Adverse Event|1|||
129595571|NCT03827018|466476017|FG001|Overall Study|Adverse Event|0|||
129595572|NCT03827018|466476016|FG000|Overall Study|Withdrawal by Subject|2|||
129595573|NCT03827018|466476017|FG001|Overall Study|Withdrawal by Subject|2|||
129595574|NCT03827018|466476016|FG000|Overall Study|Lack of Efficacy|0|||
129595575|NCT03827018|466476017|FG001|Overall Study|Lack of Efficacy|1|||
129595576|NCT01029392|466476019|FG000|Overall Study|Withdrawal by Subject|18|||
129595577|NCT01029392|466476020|FG001|Overall Study|Withdrawal by Subject|11|||
129595578|NCT01029392|466476019|FG000|Overall Study|Physician Decision|2|||
129595579|NCT01029392|466476020|FG001|Overall Study|Physician Decision|0|||
129595580|NCT00063882|466476021|FG000|Overall Study|Protocol Violation|3|||
129595581|NCT00063882|466476022|FG001|Overall Study|Protocol Violation|3|||
129595582|NCT00063882|466476021|FG000|Overall Study|Withdrawal by Subject|2|||
129595583|NCT00063882|466476022|FG001|Overall Study|Withdrawal by Subject|1|||
129595584|NCT01103479|466476023|FG000|Overall Study|Up to date with CRC screening|1|||
129595585|NCT01103479|466476024|FG001|Overall Study|Up to date with CRC screening|9|||
129595586|NCT01103479|466476025|FG002|Overall Study|Up to date with CRC screening|12|||
129595587|NCT01103479|466476023|FG000|Overall Study|Family history of CRC|1|||
129595588|NCT01103479|466476024|FG001|Overall Study|Family history of CRC|0|||
129595589|NCT01103479|466476025|FG002|Overall Study|Family history of CRC|2|||
129595590|NCT01103479|466476023|FG000|Overall Study|Active cancer|1|||
129595591|NCT01103479|466476024|FG001|Overall Study|Active cancer|0|||
129595592|NCT01103479|466476025|FG002|Overall Study|Active cancer|0|||
129595593|NCT01103479|466476023|FG000|Overall Study|Saw non-study physician|2|||
129595594|NCT01103479|466476024|FG001|Overall Study|Saw non-study physician|0|||
129595595|NCT01103479|466476025|FG002|Overall Study|Saw non-study physician|0|||
129595596|NCT01534637|466476026|FG000|Overall Study|Physician Decision|3|||
129595597|NCT01534637|466476026|FG000|Overall Study|Lack of Efficacy|3|||
129595598|NCT01534637|466476026|FG000|Overall Study|Withdrawal by Subject|1|||
129595599|NCT01534637|466476026|FG000|Overall Study|Adverse Event|1|||
129595600|NCT01534637|466476026|FG000|Overall Study|Liver Mets before treatment|1|||
129595601|NCT00834899|466476027|FG000|Overall Study|Withdrawal by Subject|1|||
129595602|NCT00834899|466476028|FG001|Overall Study|Withdrawal by Subject|1|||
129595603|NCT00605917|466476029|FG000|Overall Study|Protocol Violation|79|||
129595604|NCT00890552|466476031|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
129595605|NCT00890552|466476031|FG000|On-treatment|Early prog disease/ death|10|||
129595606|NCT03903159|466476032|FG000|Overall Study|Discharged with Staff Approval|2|||
129595607|NCT03903159|466476032|FG000|Overall Study|Discharged at Staff Request|2|||
129595608|NCT03903159|466476032|FG000|Overall Study|Discharged Against Staff Advice|1|||
129595609|NCT02443545|466476035|FG000|Overall Study|Adverse Event|1|||
129595610|NCT02443545|466476036|FG001|Overall Study|Adverse Event|1|||
129595611|NCT02443545|466476035|FG000|Overall Study|Lost to Follow-up|0|||
129595612|NCT02443545|466476036|FG001|Overall Study|Lost to Follow-up|2|||
129595613|NCT02443545|466476035|FG000|Overall Study|Physician Decision|3|||
129595614|NCT02443545|466476036|FG001|Overall Study|Physician Decision|0|||
129595615|NCT02443545|466476035|FG000|Overall Study|Protocol Violation|8|||
129595616|NCT02443545|466476036|FG001|Overall Study|Protocol Violation|1|||
129595617|NCT02443545|466476035|FG000|Overall Study|Pregnancy|1|||
129595618|NCT02443545|466476036|FG001|Overall Study|Pregnancy|1|||
129595619|NCT02443545|466476035|FG000|Overall Study|Withdrawal by Subject|6|||
129595620|NCT02443545|466476036|FG001|Overall Study|Withdrawal by Subject|3|||
129595621|NCT02443545|466476035|FG000|Overall Study|Termination of study|20|||
129595622|NCT02443545|466476036|FG001|Overall Study|Termination of study|11|||
129696619|NCT02100644|466848150|FG000|LTG Escalation Phase|Adverse Event|9|||
129595623|NCT00724373|466476037|FG000|Overall Study|Adverse Event|41|||
129595624|NCT00724373|466476037|FG000|Overall Study|Lack of Efficacy|82|||
129595625|NCT00724373|466476037|FG000|Overall Study|Lost to Follow-up|7|||
129595626|NCT00724373|466476037|FG000|Overall Study|Non-compliance|2|||
129595627|NCT00724373|466476037|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
129595628|NCT00724373|466476037|FG000|Overall Study|Participant moved away|1|||
129595629|NCT00724373|466476037|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
129595630|NCT00724373|466476037|FG000|Overall Study|Only to have 24 week regimen|1|||
129595631|NCT00724373|466476037|FG000|Overall Study|Viral Relapse|1|||
129595632|NCT00724373|466476037|FG000|Overall Study|Acute HCV infection|1|||
129595633|NCT00724373|466476037|FG000|Overall Study|Drug Relapse|1|||
129595634|NCT00724373|466476037|FG000|Overall Study|Tolerability|23|||
129595635|NCT00536484|466476038|FG000|Overall Study|Adverse Event|21|||
129595636|NCT00536484|466476039|FG001|Overall Study|Adverse Event|34|||
129595637|NCT00536484|466476038|FG000|Overall Study|Withdrawal by Subject|11|||
129595638|NCT00536484|466476039|FG001|Overall Study|Withdrawal by Subject|11|||
129595639|NCT00536484|466476038|FG000|Overall Study|Lost to Follow-up|8|||
129595640|NCT00536484|466476039|FG001|Overall Study|Lost to Follow-up|6|||
129595641|NCT00536484|466476038|FG000|Overall Study|Lack of Efficacy|16|||
129595642|NCT00536484|466476039|FG001|Overall Study|Lack of Efficacy|5|||
129595643|NCT00536484|466476038|FG000|Overall Study|Other|4|||
129595644|NCT00536484|466476039|FG001|Overall Study|Other|0|||
129595645|NCT01506908|466476040|FG000|Overall Study|Adverse Event|1|||
129595646|NCT01506908|466476041|FG001|Overall Study|Adverse Event|0|||
129595647|NCT01382251|466476045|FG000|Overall Study|Surgeries cancelled or delayed|16|||
129595648|NCT01382251|466476046|FG001|Overall Study|Surgeries cancelled or delayed|16|||
129595649|NCT01382251|466476045|FG000|Overall Study|Lost to Follow-up|4|||
129595650|NCT01382251|466476046|FG001|Overall Study|Lost to Follow-up|4|||
129595651|NCT01382251|466476045|FG000|Overall Study|Contacted after study closed|1|||
129595652|NCT01382251|466476046|FG001|Overall Study|Contacted after study closed|1|||
129595653|NCT00562120|466476047|FG000|First Intervention Period|Adverse Event|1|||
129595654|NCT00562120|466476048|FG001|First Intervention Period|Adverse Event|0|||
129595655|NCT00562120|466476049|FG002|First Intervention Period|Adverse Event|0|||
129595656|NCT00562120|466476050|FG003|First Intervention Period|Adverse Event|0|||
129595657|NCT00562120|466476047|FG000|First Intervention Period|Randomized but not Treated|1|||
129595658|NCT00562120|466476048|FG001|First Intervention Period|Randomized but not Treated|0|||
129595659|NCT00562120|466476049|FG002|First Intervention Period|Randomized but not Treated|0|||
129595660|NCT00562120|466476050|FG003|First Intervention Period|Randomized but not Treated|0|||
129595661|NCT03366194|466476054|FG000|Overall Study|Lost to Follow-up|2|||
129595662|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
129595663|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
129595664|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
129696620|NCT02100644|466848151|FG001|LTG Escalation Phase|Adverse Event|0|||
129595665|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
129595666|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
129595667|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
129595668|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
129595669|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
129595670|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
129595671|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
129595672|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
129595673|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
129595674|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Death|0|||
129595675|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Death|1|||
129595676|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Death|0|||
129595677|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Death|0|||
129595678|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
129595679|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
129595680|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
129696621|NCT02100644|466848152|FG002|LTG Escalation Phase|Adverse Event|0|||
129696622|NCT02100644|466848150|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
129595681|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
129595682|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
129885628|NCT02855164|467540778|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
129696623|NCT02100644|466848151|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
129885629|NCT02855164|467540771|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
129595683|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
129595684|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
129595685|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
129595686|NCT00545688|466476057|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
129595687|NCT00545688|466476058|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
129595688|NCT00545688|466476059|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
129595689|NCT00545688|466476060|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
129595690|NCT00545688|466476057|FG000|Adjuvant Treatment Period|Disease Progression|3|||
129595691|NCT00545688|466476058|FG001|Adjuvant Treatment Period|Disease Progression|3|||
129595692|NCT00545688|466476059|FG002|Adjuvant Treatment Period|Disease Progression|0|||
129595693|NCT00545688|466476060|FG003|Adjuvant Treatment Period|Disease Progression|7|||
129595694|NCT00545688|466476057|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
129595695|NCT00545688|466476058|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
129595696|NCT00545688|466476059|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
129595697|NCT00545688|466476060|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
129595698|NCT00545688|466476057|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
129595699|NCT00545688|466476058|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
129595700|NCT00545688|466476059|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
129595701|NCT00545688|466476060|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
129595702|NCT00545688|466476057|FG000|Adjuvant Treatment Period|Adverse Event|0|||
129595703|NCT00545688|466476058|FG001|Adjuvant Treatment Period|Adverse Event|3|||
129595704|NCT00545688|466476059|FG002|Adjuvant Treatment Period|Adverse Event|2|||
129595705|NCT00545688|466476060|FG003|Adjuvant Treatment Period|Adverse Event|2|||
129595706|NCT00545688|466476057|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
129595707|NCT00545688|466476058|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
129595708|NCT00545688|466476059|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
129595709|NCT00545688|466476060|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
129595710|NCT00545688|466476057|FG000|Follow-Up Period|Death|4|||
129595711|NCT00545688|466476058|FG001|Follow-Up Period|Death|2|||
129595712|NCT00545688|466476059|FG002|Follow-Up Period|Death|2|||
129595713|NCT00545688|466476060|FG003|Follow-Up Period|Death|6|||
129595714|NCT00545688|466476057|FG000|Follow-Up Period|Disease Progression|6|||
129595715|NCT00545688|466476058|FG001|Follow-Up Period|Disease Progression|5|||
129595716|NCT00545688|466476059|FG002|Follow-Up Period|Disease Progression|9|||
129595717|NCT00545688|466476060|FG003|Follow-Up Period|Disease Progression|9|||
129595718|NCT00545688|466476057|FG000|Follow-Up Period|Refused Treatment|6|||
129595719|NCT00545688|466476058|FG001|Follow-Up Period|Refused Treatment|2|||
129595720|NCT00545688|466476059|FG002|Follow-Up Period|Refused Treatment|0|||
129595721|NCT00545688|466476060|FG003|Follow-Up Period|Refused Treatment|2|||
129595722|NCT00545688|466476057|FG000|Follow-Up Period|Lost to Follow-up|3|||
129595723|NCT00545688|466476058|FG001|Follow-Up Period|Lost to Follow-up|3|||
129595724|NCT00545688|466476059|FG002|Follow-Up Period|Lost to Follow-up|3|||
129595725|NCT00545688|466476060|FG003|Follow-Up Period|Lost to Follow-up|1|||
129595726|NCT00545688|466476057|FG000|Follow-Up Period|Unspecified Reason|2|||
129595727|NCT00545688|466476058|FG001|Follow-Up Period|Unspecified Reason|5|||
129595728|NCT00545688|466476059|FG002|Follow-Up Period|Unspecified Reason|6|||
129595729|NCT00545688|466476060|FG003|Follow-Up Period|Unspecified Reason|8|||
129595730|NCT00545688|466476057|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
129595731|NCT00545688|466476058|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
129595732|NCT00545688|466476059|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
129595733|NCT00545688|466476060|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
129595734|NCT03123783|466476061|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129595735|NCT03123783|466476062|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
129595736|NCT03123783|466476063|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129595737|NCT03123783|466476064|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129595738|NCT03123783|466476065|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129595739|NCT03123783|466476066|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129696624|NCT02100644|466848152|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
129696625|NCT02100644|466848150|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
129696626|NCT02100644|466848151|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
129595740|NCT03123783|466476067|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
129696627|NCT02100644|466848152|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
129696628|NCT00728182|466848153|FG000|Overall Study|Adverse Event|1|||
129595741|NCT03123783|466476061|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
129595742|NCT03123783|466476062|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
129595743|NCT03123783|466476063|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
129595744|NCT03123783|466476064|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
129595745|NCT03123783|466476065|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
129696629|NCT00728182|466848154|FG001|Overall Study|Adverse Event|0|||
129595746|NCT03123783|466476066|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
129696630|NCT00728182|466848153|FG000|Overall Study|Lost to Follow-up|2|||
129696631|NCT00728182|466848154|FG001|Overall Study|Lost to Follow-up|0|||
129595747|NCT03123783|466476067|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
129595748|NCT03123783|466476061|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
129595749|NCT03123783|466476062|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
129595750|NCT03123783|466476063|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
129595751|NCT03123783|466476064|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
129595752|NCT03123783|466476065|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
129595753|NCT03123783|466476066|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
129595754|NCT03123783|466476067|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
129595755|NCT03123783|466476061|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129595756|NCT03123783|466476062|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129595757|NCT03123783|466476063|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129595758|NCT03123783|466476064|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129696632|NCT00728182|466848153|FG000|Overall Study|Death|0|||
129696633|NCT00728182|466848154|FG001|Overall Study|Death|2|||
129696634|NCT00728182|466848153|FG000|Overall Study|Protocol Noncompliance|0|||
129595759|NCT03123783|466476065|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
129595760|NCT03123783|466476066|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129595761|NCT03123783|466476067|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
129595762|NCT02953678|466476073|FG000|Overall Study|Adverse Event|20|||
129595763|NCT02953678|466476073|FG000|Overall Study|Death|7|||
129595764|NCT02953678|466476073|FG000|Overall Study|Physician Decision|23|||
129595765|NCT02953678|466476073|FG000|Overall Study|Progressive Disease of GVHD|7|||
129595766|NCT02953678|466476073|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
129595767|NCT02953678|466476073|FG000|Overall Study|Withdrawal by participant|3|||
129595768|NCT02953678|466476073|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
129696635|NCT00728182|466848154|FG001|Overall Study|Protocol Noncompliance|1|||
129696636|NCT01898091|466848156|FG000|Overall Study|Lost to Follow-up|1|||
129696637|NCT01898091|466848157|FG001|Overall Study|Lost to Follow-up|1|||
129696638|NCT01898091|466848156|FG000|Overall Study|Withdrawal by Subject|1|||
129696639|NCT01898091|466848157|FG001|Overall Study|Withdrawal by Subject|5|||
129696640|NCT01618708|466848158|FG000|Overall Study|Adverse Event|10|||
129696641|NCT01618708|466848159|FG001|Overall Study|Adverse Event|10|||
129696642|NCT01618708|466848158|FG000|Overall Study|Lost to Follow-up|3|||
129696643|NCT01618708|466848159|FG001|Overall Study|Lost to Follow-up|3|||
129696644|NCT01618708|466848158|FG000|Overall Study|Withdrawal by Subject|17|||
129696645|NCT01618708|466848159|FG001|Overall Study|Withdrawal by Subject|22|||
129696646|NCT01618708|466848158|FG000|Overall Study|Lack of Efficacy|8|||
129696647|NCT01618708|466848159|FG001|Overall Study|Lack of Efficacy|8|||
129696648|NCT01618708|466848158|FG000|Overall Study|Technical problems|2|||
129696649|NCT01618708|466848159|FG001|Overall Study|Technical problems|0|||
129696650|NCT01618708|466848158|FG000|Overall Study|Other than specified above|1|||
129696651|NCT01618708|466848159|FG001|Overall Study|Other than specified above|1|||
129696652|NCT01618708|466848158|FG000|Overall Study|Randomized but not treated|3|||
129696653|NCT01618708|466848159|FG001|Overall Study|Randomized but not treated|2|||
129696654|NCT01630811|466848160|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
129696655|NCT01630811|466848161|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129696656|NCT01725308|466848164|FG000|Treatment Period I|Did Not Receive Drug|1|||
129696657|NCT01725308|466848165|FG001|Treatment Period I|Did Not Receive Drug|0|||
129696658|NCT01725308|466848166|FG002|Treatment Period I|Did Not Receive Drug|0|||
129696659|NCT01725308|466848164|FG000|Treatment Period I|Adverse Event|5|||
129696660|NCT01725308|466848165|FG001|Treatment Period I|Adverse Event|4|||
129696661|NCT01725308|466848166|FG002|Treatment Period I|Adverse Event|21|||
129696662|NCT01725308|466848164|FG000|Treatment Period I|Insufficient Response|7|||
129696663|NCT01725308|466848165|FG001|Treatment Period I|Insufficient Response|0|||
129696664|NCT01725308|466848166|FG002|Treatment Period I|Insufficient Response|5|||
129595769|NCT02953678|466476073|FG000|Overall Study|Participants were transferred to commercial product.|3|||
129595770|NCT00952276|466476074|FG000|Overall Study|Withdrawal by Subject|1|||
129595771|NCT00952276|466476075|FG001|Overall Study|Withdrawal by Subject|0|||
129595772|NCT00952276|466476076|FG002|Overall Study|Withdrawal by Subject|0|||
129595773|NCT00952276|466476077|FG003|Overall Study|Withdrawal by Subject|1|||
129595774|NCT00952276|466476078|FG004|Overall Study|Withdrawal by Subject|0|||
129595775|NCT01647958|466477573|FG000|Initial Study|Lost to Follow-up|2|||
129595776|NCT01647958|466477574|FG001|Initial Study|Lost to Follow-up|3|||
129595777|NCT01647958|466477573|FG000|Continuation Phase|treatment received during Overall Study|39|||
129595778|NCT01647958|466477574|FG001|Continuation Phase|treatment received during Overall Study|0|||
129595779|NCT01647958|466477573|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
129595780|NCT01647958|466477574|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
129595781|NCT00544817|466477575|FG000|Combined Modality|Lack of Efficacy|2|||
129595782|NCT00544817|466477575|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
129595783|NCT00544817|466477575|FG000|Combined Modality|Adverse Event|2|||
129595784|NCT00544817|466477575|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
129595785|NCT00544817|466477575|FG000|No Treatment Interval|Lack of Efficacy|8|||
129595786|NCT00544817|466477575|FG000|No Treatment Interval|Physician Decision|3|||
129595787|NCT00544817|466477575|FG000|No Treatment Interval|Adverse Event|1|||
129595788|NCT00544817|466477575|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
129595789|NCT00544817|466477575|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
129595790|NCT00544817|466477575|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
129595791|NCT01131299|466477576|FG000|Overall Study|Withdrawal by Subject|4|||
129595792|NCT01131299|466477577|FG001|Overall Study|Withdrawal by Subject|7|||
129595793|NCT01221090|466477578|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
129595794|NCT01221090|466477579|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
129696665|NCT01725308|466848164|FG000|Treatment Period I|Worsening of the Target Disease|8|||
129696666|NCT01725308|466848165|FG001|Treatment Period I|Worsening of the Target Disease|0|||
129595795|NCT01221090|466477580|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
129696667|NCT01725308|466848166|FG002|Treatment Period I|Worsening of the Target Disease|2|||
129696668|NCT01725308|466848164|FG000|Treatment Period I|Changes in the Episodes|3|||
129696669|NCT01725308|466848165|FG001|Treatment Period I|Changes in the Episodes|0|||
129595796|NCT01221090|466477581|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
129595797|NCT01221090|466477578|FG000|Overall Study|Withdrawal by Subject|0|||
129595798|NCT01221090|466477579|FG001|Overall Study|Withdrawal by Subject|22|||
129595799|NCT01221090|466477580|FG002|Overall Study|Withdrawal by Subject|27|||
129595800|NCT01221090|466477581|FG003|Overall Study|Withdrawal by Subject|2|||
129595801|NCT00708708|466477582|FG000|Overall Study|Another therapy instead of Enbrel|141|||
129696670|NCT01725308|466848166|FG002|Treatment Period I|Changes in the Episodes|2|||
129696671|NCT01725308|466848164|FG000|Treatment Period I|Withdrawal of Consent|12|||
129696672|NCT01725308|466848165|FG001|Treatment Period I|Withdrawal of Consent|7|||
129696673|NCT01725308|466848166|FG002|Treatment Period I|Withdrawal of Consent|5|||
129595802|NCT00708708|466477582|FG000|Overall Study|Lost to Follow-up|52|||
129595803|NCT00708708|466477582|FG000|Overall Study|Withdrawal by Subject|51|||
129595804|NCT00708708|466477582|FG000|Overall Study|Intolerance|42|||
129595805|NCT00708708|466477582|FG000|Overall Study|Another therapy along with Enbrel|15|||
129595806|NCT00708708|466477582|FG000|Overall Study|Other unspecified|11|||
129595807|NCT00708708|466477582|FG000|Overall Study|Good effectiveness|9|||
129595808|NCT00708708|466477582|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
129595809|NCT00708708|466477582|FG000|Overall Study|Administrative reasons|7|||
129595810|NCT00708708|466477582|FG000|Overall Study|Lack of effectiveness|4|||
129595811|NCT00708708|466477582|FG000|Overall Study|Lack of compliance|3|||
129595812|NCT00708708|466477582|FG000|Overall Study|Pregnancy|3|||
129595813|NCT00708708|466477582|FG000|Overall Study|Adverse Event|3|||
129595814|NCT00708708|466477582|FG000|Overall Study|Missing values|392|||
129595815|NCT04776746|466477589|FG000|Overall Study|Study terminated by sponsor|61|||
129595816|NCT04776746|466477589|FG000|Overall Study|Adverse Event|5|||
129595817|NCT04776746|466477589|FG000|Overall Study|Death|4|||
129595818|NCT04776746|466477589|FG000|Overall Study|Lack of Efficacy|3|||
129595819|NCT04776746|466477589|FG000|Overall Study|Noncompliance with study drug|2|||
129595820|NCT04776746|466477589|FG000|Overall Study|Not related to COVID-19|2|||
129595821|NCT00440466|466477590|FG000|Overall Study|Death|3|||
129595822|NCT00440466|466477591|FG001|Overall Study|Death|2|||
129595823|NCT00440466|466477592|FG002|Overall Study|Death|9|||
129595824|NCT00440466|466477590|FG000|Overall Study|Adverse Event|3|||
129595825|NCT00440466|466477591|FG001|Overall Study|Adverse Event|4|||
129595826|NCT00440466|466477592|FG002|Overall Study|Adverse Event|11|||
129595827|NCT00440466|466477590|FG000|Overall Study|Lost to Follow-up|1|||
129595828|NCT00440466|466477591|FG001|Overall Study|Lost to Follow-up|0|||
129595829|NCT00440466|466477592|FG002|Overall Study|Lost to Follow-up|2|||
129595830|NCT00440466|466477590|FG000|Overall Study|Physician Decision|2|||
129595831|NCT00440466|466477591|FG001|Overall Study|Physician Decision|0|||
129595832|NCT00440466|466477592|FG002|Overall Study|Physician Decision|1|||
129595833|NCT00440466|466477590|FG000|Overall Study|Protocol Violation|2|||
129595834|NCT00440466|466477591|FG001|Overall Study|Protocol Violation|0|||
129595835|NCT00440466|466477592|FG002|Overall Study|Protocol Violation|4|||
129595836|NCT00440466|466477590|FG000|Overall Study|Withdrawal by Subject|2|||
129595837|NCT00440466|466477591|FG001|Overall Study|Withdrawal by Subject|5|||
129595838|NCT00440466|466477592|FG002|Overall Study|Withdrawal by Subject|9|||
129595839|NCT00440466|466477590|FG000|Overall Study|Began Dialysis|0|||
129595840|NCT00440466|466477591|FG001|Overall Study|Began Dialysis|0|||
129595841|NCT00440466|466477592|FG002|Overall Study|Began Dialysis|1|||
129595842|NCT00440466|466477590|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
129595843|NCT00440466|466477591|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
129595844|NCT00440466|466477592|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
129595845|NCT03768726|466477597|FG000|Treatment Phase|Adverse Event|2|||
129595846|NCT03768726|466477598|FG001|Treatment Phase|Adverse Event|2|||
129595847|NCT03768726|466477597|FG000|Treatment Phase|Lost to Follow-up|1|||
129595848|NCT03768726|466477598|FG001|Treatment Phase|Lost to Follow-up|0|||
129595849|NCT03768726|466477597|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
129595850|NCT03768726|466477598|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
129595851|NCT03768726|466477597|FG000|Treatment Phase|Withdrawal by Subject|3|||
129595852|NCT03768726|466477598|FG001|Treatment Phase|Withdrawal by Subject|1|||
129696674|NCT01725308|466848164|FG000|Treatment Period I|Lost to Follow-up|3|||
129696675|NCT01725308|466848165|FG001|Treatment Period I|Lost to Follow-up|2|||
129696676|NCT01725308|466848166|FG002|Treatment Period I|Lost to Follow-up|2|||
129696677|NCT01725308|466848164|FG000|Treatment Period I|Protocol Deviations|3|||
129696678|NCT01725308|466848165|FG001|Treatment Period I|Protocol Deviations|1|||
129595853|NCT03768726|466477597|FG000|Follow-Up|Adverse Event|2|||
129595854|NCT03768726|466477598|FG001|Follow-Up|Adverse Event|2|||
129595855|NCT03768726|466477597|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
129595856|NCT03768726|466477598|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
129696679|NCT01725308|466848166|FG002|Treatment Period I|Protocol Deviations|1|||
129696680|NCT01725308|466848164|FG000|Treatment Period I|Miscellaneous|2|||
129595857|NCT03768726|466477597|FG000|Follow-Up|Withdrawal by Subject|2|||
129595858|NCT03768726|466477598|FG001|Follow-Up|Withdrawal by Subject|0|||
129595859|NCT03768726|466477597|FG000|Follow-Up|Other|1|||
129595860|NCT03768726|466477598|FG001|Follow-Up|Other|0|||
129696681|NCT01725308|466848165|FG001|Treatment Period I|Miscellaneous|0|||
129595861|NCT01286558|466477601|FG000|Overall Study|Adverse Event|1|||
129595862|NCT01286558|466477602|FG001|Overall Study|Adverse Event|1|||
129595863|NCT01286558|466477601|FG000|Overall Study|Withdrawal by Subject|0|||
129595864|NCT01286558|466477602|FG001|Overall Study|Withdrawal by Subject|1|||
129595865|NCT01787279|466477604|FG000|Overall Study|Lost to Follow-up|2|||
129595866|NCT01787279|466477604|FG000|Overall Study|Lack of Efficacy|1|||
129595867|NCT01005329|466477606|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
129595868|NCT04109313|466477611|FG000|Overall Study|Pregnancy|1|||
129595869|NCT04109313|466477611|FG000|Overall Study|Adverse Event|11|||
129595870|NCT04109313|466477611|FG000|Overall Study|Lack of Efficacy|11|||
129595871|NCT04109313|466477611|FG000|Overall Study|Lost to Follow-up|1|||
129595872|NCT04109313|466477611|FG000|Overall Study|Physician Decision|2|||
129595873|NCT04109313|466477611|FG000|Overall Study|Subject Decision|13|||
129595874|NCT04109313|466477611|FG000|Overall Study|Covid-19 situation|2|||
129595875|NCT01272921|466477612|FG000|Overall Study|Protocol Violation|2|||
129595876|NCT01272921|466477613|FG001|Overall Study|Protocol Violation|1|||
129595877|NCT01132664|466477614|FG000|Phase lb|Adverse Event|0|||
129595878|NCT01132664|466477615|FG001|Phase lb|Adverse Event|1|||
129595879|NCT01132664|466477616|FG002|Phase lb|Adverse Event|0|||
129595880|NCT01132664|466477617|FG003|Phase lb|Adverse Event|0|||
129595881|NCT01132664|466477618|FG004|Phase lb|Adverse Event|0|||
129595882|NCT01132664|466477614|FG000|Phase lb|Withdrawal by Subject|1|||
129595883|NCT01132664|466477615|FG001|Phase lb|Withdrawal by Subject|2|||
129595884|NCT01132664|466477616|FG002|Phase lb|Withdrawal by Subject|0|||
129595885|NCT01132664|466477617|FG003|Phase lb|Withdrawal by Subject|0|||
129595886|NCT01132664|466477618|FG004|Phase lb|Withdrawal by Subject|0|||
129595887|NCT01132664|466477614|FG000|Phase lb|Disease Progression|4|||
129595888|NCT01132664|466477615|FG001|Phase lb|Disease Progression|9|||
129595889|NCT01132664|466477616|FG002|Phase lb|Disease Progression|0|||
129595890|NCT01132664|466477617|FG003|Phase lb|Disease Progression|0|||
129595891|NCT01132664|466477618|FG004|Phase lb|Disease Progression|0|||
129595892|NCT01132664|466477614|FG000|Phase ll|Death|0|||
129595893|NCT01132664|466477615|FG001|Phase ll|Death|0|||
129595894|NCT01132664|466477616|FG002|Phase ll|Death|2|||
129595895|NCT01132664|466477617|FG003|Phase ll|Death|0|||
129595896|NCT01132664|466477618|FG004|Phase ll|Death|0|||
129595897|NCT01132664|466477614|FG000|Phase ll|Adverse Event|0|||
129595898|NCT01132664|466477615|FG001|Phase ll|Adverse Event|0|||
129595899|NCT01132664|466477616|FG002|Phase ll|Adverse Event|10|||
129595900|NCT01132664|466477617|FG003|Phase ll|Adverse Event|0|||
129595901|NCT01132664|466477618|FG004|Phase ll|Adverse Event|0|||
129595902|NCT01132664|466477614|FG000|Phase ll|Withdrawal by Subject|0|||
129595903|NCT01132664|466477615|FG001|Phase ll|Withdrawal by Subject|0|||
129595904|NCT01132664|466477616|FG002|Phase ll|Withdrawal by Subject|3|||
129595905|NCT01132664|466477617|FG003|Phase ll|Withdrawal by Subject|0|||
129595906|NCT01132664|466477618|FG004|Phase ll|Withdrawal by Subject|0|||
129595907|NCT01132664|466477614|FG000|Phase ll|Disease progression|0|||
129595908|NCT01132664|466477615|FG001|Phase ll|Disease progression|0|||
129595909|NCT01132664|466477616|FG002|Phase ll|Disease progression|35|||
129595910|NCT01132664|466477617|FG003|Phase ll|Disease progression|0|||
129595911|NCT01132664|466477618|FG004|Phase ll|Disease progression|0|||
129595912|NCT01132664|466477614|FG000|BM Cohort|Disease progression|0|||
129595913|NCT01132664|466477615|FG001|BM Cohort|Disease progression|0|||
129595914|NCT01132664|466477616|FG002|BM Cohort|Disease progression|0|||
129595915|NCT01132664|466477617|FG003|BM Cohort|Disease progression|3|||
129595916|NCT01132664|466477618|FG004|BM Cohort|Disease progression|4|||
129595917|NCT01132664|466477614|FG000|BM Cohort|Adverse Event|0|||
129595918|NCT01132664|466477615|FG001|BM Cohort|Adverse Event|0|||
129595919|NCT01132664|466477616|FG002|BM Cohort|Adverse Event|0|||
129595920|NCT01132664|466477617|FG003|BM Cohort|Adverse Event|0|||
129885630|NCT02855164|467540772|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
129885631|NCT02855164|467540773|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
129885632|NCT02855164|467540774|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
129595921|NCT01132664|466477618|FG004|BM Cohort|Adverse Event|1|||
129595922|NCT01132664|466477614|FG000|BM Cohort|Withdrawal by Subject|0|||
129595923|NCT01132664|466477615|FG001|BM Cohort|Withdrawal by Subject|0|||
129595924|NCT01132664|466477616|FG002|BM Cohort|Withdrawal by Subject|0|||
129595925|NCT01132664|466477617|FG003|BM Cohort|Withdrawal by Subject|0|||
129595926|NCT01132664|466477618|FG004|BM Cohort|Withdrawal by Subject|1|||
129595927|NCT00892281|466477622|FG000|Overall Study|Adverse Event|65|||
129885633|NCT02855164|467540775|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
129595928|NCT00892281|466477623|FG001|Overall Study|Adverse Event|8|||
129595929|NCT00892281|466477622|FG000|Overall Study|Lost to Follow-up|81|||
129595930|NCT00892281|466477623|FG001|Overall Study|Lost to Follow-up|8|||
129595931|NCT00892281|466477622|FG000|Overall Study|Pregnancy|1|||
129595932|NCT00892281|466477623|FG001|Overall Study|Pregnancy|0|||
129595933|NCT00892281|466477622|FG000|Overall Study|Protocol Violation|7|||
129595934|NCT00892281|466477623|FG001|Overall Study|Protocol Violation|2|||
129595935|NCT00892281|466477622|FG000|Overall Study|Withdrawal by Subject|86|||
129595936|NCT00892281|466477623|FG001|Overall Study|Withdrawal by Subject|14|||
129595937|NCT00892281|466477622|FG000|Overall Study|Subject failed to return for final visit|2|||
129595938|NCT00892281|466477623|FG001|Overall Study|Subject failed to return for final visit|0|||
129696682|NCT01725308|466848166|FG002|Treatment Period I|Miscellaneous|3|||
129595939|NCT00892281|466477622|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
129595940|NCT00892281|466477623|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
129595941|NCT00892281|466477622|FG000|Overall Study|Final visit completed 4 weeks late|0|||
129595942|NCT00892281|466477623|FG001|Overall Study|Final visit completed 4 weeks late|1|||
129595943|NCT00892281|466477622|FG000|Overall Study|Subject completed day after study closed|1|||
129595944|NCT00892281|466477623|FG001|Overall Study|Subject completed day after study closed|0|||
129595945|NCT00892281|466477622|FG000|Overall Study|Family emergency|1|||
129595946|NCT00892281|466477623|FG001|Overall Study|Family emergency|0|||
129595947|NCT00892281|466477622|FG000|Overall Study|Last visit not done - death in family|1|||
129595948|NCT00892281|466477623|FG001|Overall Study|Last visit not done - death in family|0|||
129595949|NCT00892281|466477622|FG000|Overall Study|Did not meet incl/excl criteria|1|||
129595950|NCT00892281|466477623|FG001|Overall Study|Did not meet incl/excl criteria|0|||
129595951|NCT00892281|466477622|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
129595952|NCT00892281|466477623|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
129595953|NCT00892281|466477622|FG000|Overall Study|Unable to redeem the drug voucher|1|||
129595954|NCT00892281|466477623|FG001|Overall Study|Unable to redeem the drug voucher|0|||
129595955|NCT00892281|466477622|FG000|Overall Study|Subject not good candidate for study|1|||
129595956|NCT00892281|466477623|FG001|Overall Study|Subject not good candidate for study|0|||
129595957|NCT00892281|466477622|FG000|Overall Study|Subject did not return for any visits|1|||
129595958|NCT00892281|466477623|FG001|Overall Study|Subject did not return for any visits|0|||
129595959|NCT00892281|466477622|FG000|Overall Study|Subject missed several visits/lost meds|1|||
129595960|NCT00892281|466477623|FG001|Overall Study|Subject missed several visits/lost meds|0|||
129595961|NCT00892281|466477622|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
129595962|NCT00892281|466477623|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
129595963|NCT00892281|466477622|FG000|Overall Study|Scheduled for knee replacement|0|||
129595964|NCT00892281|466477623|FG001|Overall Study|Scheduled for knee replacement|1|||
129595965|NCT00892281|466477622|FG000|Overall Study|PI complained of inadequate compensation|3|||
129595966|NCT00892281|466477623|FG001|Overall Study|PI complained of inadequate compensation|0|||
129595967|NCT00892281|466477622|FG000|Overall Study|Subject lost interest in program|0|||
129595968|NCT00892281|466477623|FG001|Overall Study|Subject lost interest in program|1|||
129595969|NCT00892281|466477622|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
129595970|NCT00892281|466477623|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
129595971|NCT00892281|466477622|FG000|Overall Study|Death in family|1|||
129595972|NCT00892281|466477623|FG001|Overall Study|Death in family|0|||
129595973|NCT00892281|466477622|FG000|Overall Study|Lack of efficacy of study product|2|||
129595974|NCT00892281|466477623|FG001|Overall Study|Lack of efficacy of study product|0|||
129595975|NCT00892281|466477622|FG000|Overall Study|Subject not seen by PI at final visit|1|||
129595976|NCT00892281|466477623|FG001|Overall Study|Subject not seen by PI at final visit|0|||
129595977|NCT00892281|466477622|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
129595978|NCT00892281|466477623|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
129595979|NCT00892281|466477622|FG000|Overall Study|Missed multiple visits|1|||
129595980|NCT00892281|466477623|FG001|Overall Study|Missed multiple visits|0|||
129595981|NCT00892281|466477622|FG000|Overall Study|Missed visits rescheduled out of window|1|||
129595982|NCT00892281|466477623|FG001|Overall Study|Missed visits rescheduled out of window|0|||
129595983|NCT00892281|466477622|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
129595984|NCT00892281|466477623|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
129595985|NCT00892281|466477622|FG000|Overall Study|Subject had history of drug abuse|1|||
129595986|NCT00892281|466477623|FG001|Overall Study|Subject had history of drug abuse|0|||
129595987|NCT00892281|466477622|FG000|Overall Study|Rash on hand|1|||
129595988|NCT00892281|466477623|FG001|Overall Study|Rash on hand|0|||
129595989|NCT00892281|466477622|FG000|Overall Study|Visit 4 date out of window|1|||
129595990|NCT00892281|466477623|FG001|Overall Study|Visit 4 date out of window|0|||
129595991|NCT00655850|466477624|FG000|Overall Study|Death|2|||
129595992|NCT00655850|466477624|FG000|Overall Study|Withdrawal by Subject|1|||
129595993|NCT01567826|466477627|FG000|Overall Study|Lost to Follow-up|3|||
129595994|NCT01567826|466477628|FG001|Overall Study|Lost to Follow-up|2|||
129595995|NCT05212883|466477636|FG000|Overall Study|Invalid test result|125|||
129595996|NCT02502734|466477637|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
129595997|NCT02502734|466477638|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
129595998|NCT02502734|466477637|FG000|Washout Period|Adverse Event|1|||
129595999|NCT02502734|466477638|FG001|Washout Period|Adverse Event|0|||
129596000|NCT05444543|466477644|FG000|Overall Study|Withdrawal by Subject|1|||
129596001|NCT05444543|466477645|FG001|Overall Study|Withdrawal by Subject|0|||
129596002|NCT05444543|466477644|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
129596003|NCT05444543|466477645|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
129596004|NCT05444543|466477644|FG000|Overall Study|Adverse Event|0|||
129596005|NCT05444543|466477645|FG001|Overall Study|Adverse Event|1|||
129596006|NCT05444543|466477644|FG000|Overall Study|Family relocating at a distance from study site|0|||
129596007|NCT05444543|466477645|FG001|Overall Study|Family relocating at a distance from study site|1|||
129596008|NCT01261624|466477646|FG000|Week 0 to Week 12|Disease Progression|1|||
129596009|NCT01261624|466477647|FG001|Week 0 to Week 12|Disease Progression|1|||
129596010|NCT01261624|466477646|FG000|Week 0 to Week 12|Insufficient Response|0|||
129596011|NCT01261624|466477647|FG001|Week 0 to Week 12|Insufficient Response|2|||
129596012|NCT01261624|466477646|FG000|Week 13 to Week 24|Insufficient Response|0|||
129596013|NCT01261624|466477647|FG001|Week 13 to Week 24|Insufficient Response|1|||
129596014|NCT02280187|466477648|FG000|Overall Study|Lost to Follow-up|218|||
129596015|NCT04668274|466477649|FG000|Part 1 Study Period 1|Adverse Event|3|||
129596016|NCT04668274|466477650|FG001|Part 1 Study Period 1|Adverse Event|0|||
129596017|NCT04668274|466477651|FG002|Part 1 Study Period 1|Adverse Event|0|||
129596018|NCT04668274|466477652|FG003|Part 1 Study Period 1|Adverse Event|0|||
129596019|NCT04668274|466477649|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
129596020|NCT04668274|466477650|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
129596021|NCT04668274|466477651|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
129596022|NCT04668274|466477652|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
129596023|NCT04668274|466477649|FG000|Part 1 Study Period 2|Other|0|||
129596024|NCT04668274|466477650|FG001|Part 1 Study Period 2|Other|1|||
129596025|NCT04668274|466477651|FG002|Part 1 Study Period 2|Other|0|||
129596026|NCT04668274|466477652|FG003|Part 1 Study Period 2|Other|0|||
129596027|NCT04668274|466477649|FG000|Part 1 Study Period 3|Adverse Event|0|||
129596028|NCT04668274|466477650|FG001|Part 1 Study Period 3|Adverse Event|0|||
129596029|NCT04668274|466477651|FG002|Part 1 Study Period 3|Adverse Event|1|||
129596030|NCT04668274|466477652|FG003|Part 1 Study Period 3|Adverse Event|0|||
129596031|NCT04668274|466477649|FG000|Part 1 Study Period 3|Other|0|||
129596032|NCT04668274|466477650|FG001|Part 1 Study Period 3|Other|0|||
129596033|NCT04668274|466477651|FG002|Part 1 Study Period 3|Other|2|||
129596034|NCT04668274|466477652|FG003|Part 1 Study Period 3|Other|0|||
129596035|NCT04668274|466477649|FG000|Part 2 Study Period 4|Other|0|||
129596036|NCT04668274|466477650|FG001|Part 2 Study Period 4|Other|0|||
129596037|NCT04668274|466477651|FG002|Part 2 Study Period 4|Other|0|||
129596038|NCT04668274|466477652|FG003|Part 2 Study Period 4|Other|1|||
129596039|NCT00508027|466477653|FG000|Dose Level 1|Lost to Follow-up|4|||
129596040|NCT00508027|466477653|FG000|Dose Level 1|Withdrawal by Subject|2|||
129596041|NCT00508027|466477653|FG000|Dose Level 1|Physician Decision|2|||
129596042|NCT00508027|466477653|FG000|Dose Level 2|Lost to Follow-up|2|||
129596043|NCT00508027|466477653|FG000|Dose Level 2|Withdrawal by Subject|2|||
129596044|NCT01719562|466477654|FG000|Overall Study|Lost to Follow-up|1|||
129596045|NCT01719562|466477655|FG001|Overall Study|Lost to Follow-up|0|||
129596046|NCT01719562|466477654|FG000|Overall Study|Death|1|||
129596047|NCT01719562|466477655|FG001|Overall Study|Death|0|||
129596048|NCT01719562|466477654|FG000|Overall Study|New cancer diagnosis|1|||
129596049|NCT01719562|466477655|FG001|Overall Study|New cancer diagnosis|0|||
129596050|NCT00941720|466477658|FG000|Overall Study|Withdrawal by Subject|1|||
129596051|NCT00941720|466477658|FG000|Overall Study|Insurance denied participation|11|||
129596052|NCT00941720|466477658|FG000|Overall Study|ineligible|2|||
129596053|NCT01202877|466477659|FG000|Overall Study|Disease Progression|0|||
129596054|NCT01202877|466477660|FG001|Overall Study|Disease Progression|1|||
129596055|NCT01202877|466477661|FG002|Overall Study|Disease Progression|2|||
129596056|NCT01202877|466477659|FG000|Overall Study|Adverse Event|0|||
129596057|NCT01202877|466477660|FG001|Overall Study|Adverse Event|0|||
129596058|NCT01202877|466477661|FG002|Overall Study|Adverse Event|2|||
129596059|NCT01202877|466477659|FG000|Overall Study|Withdrawal by Subject|0|||
129786483|NCT01134705|467185677|FG000|Overall Study|Adverse Event|1|||
129786484|NCT01134705|467185678|FG001|Overall Study|Adverse Event|7|||
129786485|NCT01134705|467185677|FG000|Overall Study|Withdrawal by Subject|6|||
129786486|NCT01134705|467185678|FG001|Overall Study|Withdrawal by Subject|6|||
129786487|NCT01134705|467185677|FG000|Overall Study|Pregnancy|1|||
129786488|NCT01134705|467185678|FG001|Overall Study|Pregnancy|0|||
129786489|NCT01134705|467185677|FG000|Overall Study|Lost to Follow-up|5|||
129786490|NCT01134705|467185678|FG001|Overall Study|Lost to Follow-up|2|||
129786491|NCT01134705|467185677|FG000|Overall Study|Protocol Violation|1|||
129786492|NCT01134705|467185678|FG001|Overall Study|Protocol Violation|1|||
129786493|NCT01134705|467185677|FG000|Overall Study|Other|1|||
129786494|NCT01134705|467185678|FG001|Overall Study|Other|6|||
129786495|NCT00852371|467185681|FG000|Overall Study|Lost to Follow-up|2|||
129596060|NCT01202877|466477660|FG001|Overall Study|Withdrawal by Subject|0|||
129596061|NCT01202877|466477661|FG002|Overall Study|Withdrawal by Subject|1|||
129596062|NCT01202877|466477659|FG000|Overall Study|Death|0|||
129596063|NCT01202877|466477660|FG001|Overall Study|Death|0|||
129596064|NCT01202877|466477661|FG002|Overall Study|Death|1|||
129596065|NCT00396331|466477662|FG000|Overall Study|Failed to mobilize - no transplant|8|||
129596066|NCT00396331|466477662|FG000|Overall Study|Did not go on to transplant|5|||
129596067|NCT00396331|466477662|FG000|Overall Study|Lost to Follow-up|3|||
129786496|NCT00852371|467185682|FG001|Overall Study|Lost to Follow-up|3|||
129786497|NCT00852371|467185683|FG002|Overall Study|Lost to Follow-up|4|||
129596068|NCT00396331|466477662|FG000|Overall Study|Death|16|||
129596069|NCT00775528|466477663|FG000|Overall Study|Protocol Violation|1|||
129596070|NCT00350402|466477666|FG000|Overall Study|Lost to Follow-up|1|||
129596071|NCT00350402|466477667|FG001|Overall Study|Lost to Follow-up|1|||
129596072|NCT01884688|466477668|FG000|Overall Study|Screen Failure|2|||
129596073|NCT04965389|466477678|FG000|Overall Study|Other reasons|1|||
129596074|NCT04965389|466477679|FG001|Overall Study|Other reasons|0|||
129596075|NCT04965389|466477680|FG002|Overall Study|Other reasons|0|||
129596076|NCT04965389|466477681|FG003|Overall Study|Other reasons|0|||
129596077|NCT04965389|466477678|FG000|Overall Study|Participant withdrew consent|0|||
129596078|NCT04965389|466477679|FG001|Overall Study|Participant withdrew consent|1|||
129596079|NCT04965389|466477680|FG002|Overall Study|Participant withdrew consent|0|||
129596080|NCT04965389|466477681|FG003|Overall Study|Participant withdrew consent|0|||
129596081|NCT04965389|466477678|FG000|Overall Study|Poor/Non-compliance|0|||
129596082|NCT04965389|466477679|FG001|Overall Study|Poor/Non-compliance|1|||
129596083|NCT04965389|466477680|FG002|Overall Study|Poor/Non-compliance|0|||
129596084|NCT04965389|466477681|FG003|Overall Study|Poor/Non-compliance|0|||
129596085|NCT02709486|466477684|FG000|Overall Study|Adverse Event|2|||
129596086|NCT02709486|466477685|FG001|Overall Study|Adverse Event|5|||
129596087|NCT02709486|466477686|FG002|Overall Study|Adverse Event|3|||
129596088|NCT02709486|466477684|FG000|Overall Study|Death|0|||
129596089|NCT02709486|466477685|FG001|Overall Study|Death|0|||
129596090|NCT02709486|466477686|FG002|Overall Study|Death|2|||
129596091|NCT02709486|466477684|FG000|Overall Study|Insufficient clinical response|7|||
129596092|NCT02709486|466477685|FG001|Overall Study|Insufficient clinical response|3|||
129596093|NCT02709486|466477686|FG002|Overall Study|Insufficient clinical response|3|||
129596094|NCT02709486|466477684|FG000|Overall Study|Lost to Follow-up|3|||
129596095|NCT02709486|466477685|FG001|Overall Study|Lost to Follow-up|2|||
129596096|NCT02709486|466477686|FG002|Overall Study|Lost to Follow-up|2|||
129596097|NCT02709486|466477684|FG000|Overall Study|Other|0|||
129596098|NCT02709486|466477685|FG001|Overall Study|Other|2|||
129596099|NCT02709486|466477686|FG002|Overall Study|Other|3|||
129596100|NCT02709486|466477684|FG000|Overall Study|Withdrawal by Subject|32|||
129596101|NCT02709486|466477685|FG001|Overall Study|Withdrawal by Subject|22|||
129596102|NCT02709486|466477686|FG002|Overall Study|Withdrawal by Subject|32|||
129596103|NCT02377921|466477690|FG000|Overall Study|Subject non-compliance|1|||
129596104|NCT02377921|466477691|FG001|Overall Study|Subject non-compliance|1|||
129596105|NCT02549573|466477694|FG000|Overall Study|Withdrawal by Subject|0|||
129596106|NCT02549573|466477695|FG001|Overall Study|Withdrawal by Subject|2|||
129596107|NCT02549573|466477694|FG000|Overall Study|Protocol Violation|0|||
129596108|NCT02549573|466477695|FG001|Overall Study|Protocol Violation|1|||
129647342|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
129647343|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
129647344|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
129647345|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
129647346|NCT04488419|466665282|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
129647347|NCT04488419|466665283|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
129647348|NCT04488419|466665284|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
129647349|NCT04488419|466665282|FG000|Primary Analysis Population|Adverse Event|6|||
129647350|NCT04488419|466665283|FG001|Primary Analysis Population|Adverse Event|9|||
129647351|NCT04488419|466665284|FG002|Primary Analysis Population|Adverse Event|0|||
129647352|NCT04488419|466665282|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
129647353|NCT04488419|466665283|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
129647354|NCT04488419|466665284|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
129647355|NCT04488419|466665282|FG000|Primary Analysis Population|Protocol Violation|1|||
129647356|NCT04488419|466665283|FG001|Primary Analysis Population|Protocol Violation|1|||
129647357|NCT04488419|466665284|FG002|Primary Analysis Population|Protocol Violation|0|||
129647358|NCT04488419|466665282|FG000|Primary Analysis Population|Undetermined|7|||
129647359|NCT04488419|466665283|FG001|Primary Analysis Population|Undetermined|3|||
129647360|NCT04488419|466665284|FG002|Primary Analysis Population|Undetermined|0|||
129647361|NCT04488419|466665282|FG000|Primary Analysis Population|>1 Reason|2|||
129647362|NCT04488419|466665283|FG001|Primary Analysis Population|>1 Reason|4|||
129647363|NCT04488419|466665284|FG002|Primary Analysis Population|>1 Reason|0|||
129647364|NCT04166591|466665285|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129647365|NCT04166591|466665286|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129647366|NCT04166591|466665287|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129647367|NCT04166591|466665288|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129647368|NCT04166591|466665285|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129647369|NCT04166591|466665286|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129647370|NCT04166591|466665287|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129647371|NCT04166591|466665288|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129647372|NCT04161079|466665291|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
129647373|NCT02515994|466665292|FG000|Overall Study|Protocol Violation|3|||
129596109|NCT01010126|466479295|FG000|Overall Study|Withdrawal by Subject|1|||
129596110|NCT01010126|466479296|FG001|Overall Study|Withdrawal by Subject|0|||
129596111|NCT01010126|466479297|FG002|Overall Study|Withdrawal by Subject|1|||
129596112|NCT01010126|466479298|FG003|Overall Study|Withdrawal by Subject|0|||
129596113|NCT01010126|466479299|FG004|Overall Study|Withdrawal by Subject|3|||
129596114|NCT01010126|466479300|FG005|Overall Study|Withdrawal by Subject|0|||
129596115|NCT00595335|466479303|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
129596116|NCT00595335|466479304|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
129596117|NCT00595335|466479303|FG000|Baseline to Six Months|Disease Progression|1|||
129596118|NCT00595335|466479304|FG001|Baseline to Six Months|Disease Progression|1|||
129596119|NCT00595335|466479303|FG000|Baseline to Six Months|Adverse Event|1|||
129596120|NCT00595335|466479304|FG001|Baseline to Six Months|Adverse Event|0|||
129596121|NCT00595335|466479303|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
129596122|NCT00595335|466479304|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
129596123|NCT00595335|466479303|FG000|Six Months to Twelve Months|Disease Progression|1|||
129596124|NCT00595335|466479304|FG001|Six Months to Twelve Months|Disease Progression|0|||
129596125|NCT03686150|466479316|FG000|Overall Study|Withdrawal by Subject|1|||
129596126|NCT03686150|466479317|FG001|Overall Study|Withdrawal by Subject|1|||
129596127|NCT03686150|466479318|FG002|Overall Study|Withdrawal by Subject|1|||
129596128|NCT03686150|466479319|FG003|Overall Study|Withdrawal by Subject|0|||
129596129|NCT03686150|466479320|FG004|Overall Study|Withdrawal by Subject|1|||
129596130|NCT03686150|466479321|FG005|Overall Study|Withdrawal by Subject|2|||
129596131|NCT03686150|466479316|FG000|Overall Study|Physician Decision|1|||
129596132|NCT03686150|466479317|FG001|Overall Study|Physician Decision|0|||
129596133|NCT03686150|466479318|FG002|Overall Study|Physician Decision|0|||
129596134|NCT03686150|466479319|FG003|Overall Study|Physician Decision|0|||
129596135|NCT03686150|466479320|FG004|Overall Study|Physician Decision|0|||
129596136|NCT03686150|466479321|FG005|Overall Study|Physician Decision|1|||
129596137|NCT03686150|466479316|FG000|Overall Study|Lost to Follow-up|0|||
129596138|NCT03686150|466479317|FG001|Overall Study|Lost to Follow-up|1|||
129596139|NCT03686150|466479318|FG002|Overall Study|Lost to Follow-up|0|||
129596140|NCT03686150|466479319|FG003|Overall Study|Lost to Follow-up|0|||
129596141|NCT03686150|466479320|FG004|Overall Study|Lost to Follow-up|0|||
129596142|NCT03686150|466479321|FG005|Overall Study|Lost to Follow-up|0|||
129596143|NCT02813421|466479324|FG000|Overall Study|Withdrawal by Subject|1|||
129596144|NCT02813421|466479325|FG001|Overall Study|Withdrawal by Subject|2|||
129596145|NCT02813421|466479324|FG000|Overall Study|Lost to Follow-up|1|||
129596146|NCT02813421|466479325|FG001|Overall Study|Lost to Follow-up|1|||
129596147|NCT01213836|466479337|FG000|Period 1, First Intervention|Adverse Event|2|||
129596148|NCT01213836|466479338|FG001|Period 1, First Intervention|Adverse Event|1|||
129596149|NCT01213836|466479337|FG000|Period 1, First Intervention|Protocol Violation|0|||
129596150|NCT01213836|466479338|FG001|Period 1, First Intervention|Protocol Violation|1|||
129596151|NCT01213836|466479337|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
129596152|NCT01213836|466479338|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
129596153|NCT00255151|466479345|FG000|Overall Study|Adverse Event|10|||
129596154|NCT00255151|466479346|FG001|Overall Study|Adverse Event|6|||
129596155|NCT00255151|466479347|FG002|Overall Study|Adverse Event|9|||
129596156|NCT00255151|466479345|FG000|Overall Study|Lost to Follow-up|4|||
129596157|NCT00255151|466479346|FG001|Overall Study|Lost to Follow-up|3|||
129596158|NCT00255151|466479347|FG002|Overall Study|Lost to Follow-up|4|||
129596159|NCT00255151|466479345|FG000|Overall Study|Withdrawal by Subject|18|||
129596160|NCT00255151|466479346|FG001|Overall Study|Withdrawal by Subject|17|||
129596161|NCT00255151|466479347|FG002|Overall Study|Withdrawal by Subject|8|||
129596162|NCT00255151|466479345|FG000|Overall Study|Noncompliance|0|||
129596163|NCT00255151|466479346|FG001|Overall Study|Noncompliance|1|||
129596164|NCT00255151|466479347|FG002|Overall Study|Noncompliance|2|||
129596165|NCT00255151|466479345|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
129596166|NCT00255151|466479346|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
129596167|NCT00255151|466479347|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
129596168|NCT00255151|466479345|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
129596169|NCT00255151|466479346|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
129596170|NCT00255151|466479347|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
129596171|NCT00255151|466479345|FG000|Overall Study|Possible Barrett's Esophagus|1|||
129596172|NCT00255151|466479346|FG001|Overall Study|Possible Barrett's Esophagus|3|||
129596173|NCT00255151|466479347|FG002|Overall Study|Possible Barrett's Esophagus|8|||
129596174|NCT00255151|466479345|FG000|Overall Study|Esophageal Stricture|0|||
129596175|NCT00255151|466479346|FG001|Overall Study|Esophageal Stricture|0|||
129596176|NCT00255151|466479347|FG002|Overall Study|Esophageal Stricture|1|||
129696683|NCT01725308|466848164|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
129786498|NCT00852371|467185684|FG003|Overall Study|Lost to Follow-up|2|||
129596177|NCT00255151|466479345|FG000|Overall Study|Therapeutic Failure|11|||
129596178|NCT00255151|466479346|FG001|Overall Study|Therapeutic Failure|2|||
129786499|NCT01375075|467185695|FG000|Overall Study|Adverse Event|0|||
129786500|NCT01375075|467185696|FG001|Overall Study|Adverse Event|0|||
129786501|NCT01375075|467185697|FG002|Overall Study|Adverse Event|3|||
129596179|NCT00255151|466479347|FG002|Overall Study|Therapeutic Failure|3|||
129596180|NCT00706095|466479348|FG000|Overall Study|Progressive Disease|4|||
129596181|NCT00706095|466479349|FG001|Overall Study|Progressive Disease|5|||
129596182|NCT00706095|466479350|FG002|Overall Study|Progressive Disease|3|||
129596183|NCT00706095|466479348|FG000|Overall Study|Clinical Progression|1|||
129596184|NCT00706095|466479349|FG001|Overall Study|Clinical Progression|2|||
129596185|NCT00706095|466479350|FG002|Overall Study|Clinical Progression|2|||
129596186|NCT00706095|466479348|FG000|Overall Study|Withdrawal by Subject|1|||
129596187|NCT00706095|466479349|FG001|Overall Study|Withdrawal by Subject|0|||
129596188|NCT00706095|466479350|FG002|Overall Study|Withdrawal by Subject|0|||
129596189|NCT02676284|466479351|FG000|Overall Study|Withdrawal by Subject|1|||
129596190|NCT01685073|466479352|FG000|Overall Study|Lost to Follow-up|6|||
129596191|NCT01685073|466479353|FG001|Overall Study|Lost to Follow-up|8|||
129596192|NCT01685073|466479352|FG000|Overall Study|Withdrawal by Subject|24|||
129596193|NCT01685073|466479353|FG001|Overall Study|Withdrawal by Subject|24|||
129596194|NCT00107042|466479358|FG000|Overall Study|Lost to Follow-up|9|||
129596195|NCT00107042|466479359|FG001|Overall Study|Lost to Follow-up|7|||
129596196|NCT00107042|466479358|FG000|Overall Study|Withdrawal by Subject|6|||
129596197|NCT00107042|466479359|FG001|Overall Study|Withdrawal by Subject|1|||
129596198|NCT00107042|466479358|FG000|Overall Study|Moved out of area|5|||
129596199|NCT00107042|466479359|FG001|Overall Study|Moved out of area|3|||
129596200|NCT00107042|466479358|FG000|Overall Study|Pregnancy|1|||
129596201|NCT00107042|466479359|FG001|Overall Study|Pregnancy|1|||
129596202|NCT00107042|466479358|FG000|Overall Study|Inadvertent enrollment|0|||
129596203|NCT00107042|466479359|FG001|Overall Study|Inadvertent enrollment|1|||
129596204|NCT00107042|466479358|FG000|Overall Study|vaccinated outside window|1|||
129596205|NCT00107042|466479359|FG001|Overall Study|vaccinated outside window|1|||
129596206|NCT00107042|466479358|FG000|Overall Study|Disallowed medications|0|||
129596207|NCT00107042|466479359|FG001|Overall Study|Disallowed medications|2|||
129596208|NCT00856830|466479361|FG000|Irinotecan & Bendamustine|Death|0|||
129596209|NCT00856830|466479362|FG001|Irinotecan & Bendamustine|Death|0|||
129596210|NCT00856830|466479363|FG002|Irinotecan & Bendamustine|Death|0|||
129596211|NCT00856830|466479364|FG003|Irinotecan & Bendamustine|Death|2|||
129596212|NCT00856830|466479361|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
129596213|NCT00856830|466479362|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
129596214|NCT00856830|466479363|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
129596215|NCT00856830|466479364|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
129596216|NCT00140413|466479365|FG000|Overall Study|Lost to Follow-up|1|||
129596217|NCT00140413|466479366|FG001|Overall Study|Lost to Follow-up|0|||
129596218|NCT00140413|466479365|FG000|Overall Study|Withdrawal by Subject|2|||
129596219|NCT00140413|466479366|FG001|Overall Study|Withdrawal by Subject|0|||
129596220|NCT00865098|466479367|FG000|Overall Study|Progressive disease|1|||
129596221|NCT01360866|466479375|FG000|Overall Study|Lost to Follow-up|11|||
129596222|NCT01360866|466479376|FG001|Overall Study|Lost to Follow-up|28|||
129596223|NCT01360866|466479377|FG002|Overall Study|Lost to Follow-up|41|||
129596224|NCT01360866|466479378|FG003|Overall Study|Lost to Follow-up|0|||
129596225|NCT01360866|466479375|FG000|Overall Study|Adverse Event|56|||
129596226|NCT01360866|466479376|FG001|Overall Study|Adverse Event|61|||
129596227|NCT01360866|466479377|FG002|Overall Study|Adverse Event|134|||
129596228|NCT01360866|466479378|FG003|Overall Study|Adverse Event|6|||
129596229|NCT01360866|466479375|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
129596230|NCT01360866|466479376|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
129596231|NCT01360866|466479377|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
129596232|NCT01360866|466479378|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
129596233|NCT01360866|466479375|FG000|Overall Study|Withdrawn by Investigator|9|||
129596234|NCT01360866|466479376|FG001|Overall Study|Withdrawn by Investigator|8|||
129596235|NCT01360866|466479377|FG002|Overall Study|Withdrawn by Investigator|31|||
129596236|NCT01360866|466479378|FG003|Overall Study|Withdrawn by Investigator|2|||
129596237|NCT01360866|466479375|FG000|Overall Study|Withdrawal by participant|79|||
129596238|NCT01360866|466479376|FG001|Overall Study|Withdrawal by participant|89|||
129596239|NCT01360866|466479377|FG002|Overall Study|Withdrawal by participant|168|||
129596240|NCT01360866|466479378|FG003|Overall Study|Withdrawal by participant|8|||
129596241|NCT01360866|466479375|FG000|Overall Study|Protocol Deviation|25|||
129596242|NCT01360866|466479376|FG001|Overall Study|Protocol Deviation|33|||
129596243|NCT01360866|466479377|FG002|Overall Study|Protocol Deviation|61|||
129596244|NCT01360866|466479378|FG003|Overall Study|Protocol Deviation|2|||
129596245|NCT01360866|466479375|FG000|Overall Study|Lack of Efficacy|30|||
129596246|NCT01360866|466479376|FG001|Overall Study|Lack of Efficacy|40|||
129596247|NCT01360866|466479377|FG002|Overall Study|Lack of Efficacy|30|||
129696684|NCT01725308|466848165|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
129596248|NCT01360866|466479378|FG003|Overall Study|Lack of Efficacy|4|||
129596249|NCT03702049|466479382|FG000|Overall Study|Lost to Follow-up|4|||
129596250|NCT03702049|466479382|FG000|Overall Study|Physician Decision|1|||
129596251|NCT01304693|466479383|FG000|Overall Study|Adverse Event|0|||
129596252|NCT01304693|466479384|FG001|Overall Study|Adverse Event|0|||
129596253|NCT01304693|466479385|FG002|Overall Study|Adverse Event|0|||
129596254|NCT01304693|466479386|FG003|Overall Study|Adverse Event|0|||
129596255|NCT01304693|466479387|FG004|Overall Study|Adverse Event|1|||
129596256|NCT01304693|466479383|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
129596257|NCT01304693|466479384|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
129596258|NCT01304693|466479385|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
129596259|NCT01304693|466479386|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
129596260|NCT01304693|466479387|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
129436097|NCT03938545|465895620|FG000|Overall Study|Lost to Follow-up|0|||
129436098|NCT03938545|465895621|FG001|Overall Study|Lost to Follow-up|0|||
129436099|NCT03938545|465895622|FG002|Overall Study|Lost to Follow-up|0|||
129436100|NCT03938545|465895623|FG003|Overall Study|Lost to Follow-up|1|||
129436101|NCT03938545|465895620|FG000|Overall Study|Non-compliance with study drug|0|||
129436102|NCT03938545|465895621|FG001|Overall Study|Non-compliance with study drug|0|||
129436103|NCT03938545|465895622|FG002|Overall Study|Non-compliance with study drug|1|||
129436104|NCT03938545|465895623|FG003|Overall Study|Non-compliance with study drug|0|||
129436105|NCT03938545|465895620|FG000|Overall Study|Pregnancy|1|||
129436106|NCT03938545|465895621|FG001|Overall Study|Pregnancy|0|||
129436107|NCT03938545|465895622|FG002|Overall Study|Pregnancy|0|||
129436108|NCT03938545|465895623|FG003|Overall Study|Pregnancy|0|||
129696685|NCT01725308|466848166|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
129696686|NCT01725308|466848164|FG000|Treatment Period II|Did Not Receive Drug|4|||
129696687|NCT01725308|466848165|FG001|Treatment Period II|Did Not Receive Drug|0|||
129596261|NCT02129647|466479388|FG000|Overall Study|Adverse Event|2|||
129596262|NCT02129647|466479388|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
129596263|NCT01715896|466479391|FG000|Overall Study|Lost to Follow-up|0|||
129596264|NCT01715896|466479392|FG001|Overall Study|Lost to Follow-up|2|||
129596265|NCT01715896|466479391|FG000|Overall Study|Withdrawal by Subject|1|||
129696688|NCT01725308|466848166|FG002|Treatment Period II|Did Not Receive Drug|0|||
129696689|NCT01725308|466848164|FG000|Treatment Period II|Adverse Event|13|||
129696690|NCT01725308|466848165|FG001|Treatment Period II|Adverse Event|8|||
129696691|NCT01725308|466848166|FG002|Treatment Period II|Adverse Event|20|||
129696692|NCT01725308|466848164|FG000|Treatment Period II|Insufficient Response|2|||
129436109|NCT03938545|465895620|FG000|Overall Study|Study terminated by sponsor|6|||
129436110|NCT03938545|465895621|FG001|Overall Study|Study terminated by sponsor|4|||
129436111|NCT03938545|465895622|FG002|Overall Study|Study terminated by sponsor|2|||
129596266|NCT01715896|466479392|FG001|Overall Study|Withdrawal by Subject|4|||
129696693|NCT01725308|466848165|FG001|Treatment Period II|Insufficient Response|4|||
129696694|NCT01725308|466848166|FG002|Treatment Period II|Insufficient Response|6|||
129786502|NCT01375075|467185698|FG003|Overall Study|Adverse Event|1|||
129596267|NCT01715896|466479391|FG000|Overall Study|Other|2|||
129596268|NCT01715896|466479392|FG001|Overall Study|Other|5|||
129596269|NCT01833533|466479396|FG000|Overall Study|Adverse Event|0|||
129596270|NCT01833533|466479397|FG001|Overall Study|Adverse Event|1|||
129596271|NCT01833533|466479396|FG000|Overall Study|Lost to Follow-up|4|||
129596272|NCT01833533|466479397|FG001|Overall Study|Lost to Follow-up|9|||
129596273|NCT01833533|466479396|FG000|Overall Study|To Enter an Extension Study|0|||
129596274|NCT01833533|466479397|FG001|Overall Study|To Enter an Extension Study|4|||
129596275|NCT01833533|466479396|FG000|Overall Study|Other|2|||
129696695|NCT01725308|466848164|FG000|Treatment Period II|Worsening of the Target Disease|1|||
129696696|NCT01725308|466848165|FG001|Treatment Period II|Worsening of the Target Disease|4|||
129436112|NCT03938545|465895623|FG003|Overall Study|Study terminated by sponsor|4|||
129436113|NCT03938545|465895620|FG000|Overall Study|Withdrawal by Subject|0|||
129436114|NCT03938545|465895621|FG001|Overall Study|Withdrawal by Subject|1|||
129436115|NCT03938545|465895622|FG002|Overall Study|Withdrawal by Subject|0|||
129436116|NCT03938545|465895623|FG003|Overall Study|Withdrawal by Subject|0|||
129436117|NCT03938545|465895620|FG000|Overall Study|Adverse Event|1|||
129596276|NCT01833533|466479397|FG001|Overall Study|Other|7|||
129596277|NCT01048502|466479398|FG000|Overall Study|Lost to Follow-up|2|||
129696697|NCT01725308|466848166|FG002|Treatment Period II|Worsening of the Target Disease|2|||
129596278|NCT01048502|466479399|FG001|Overall Study|Lost to Follow-up|0|||
129596279|NCT01048502|466479400|FG002|Overall Study|Lost to Follow-up|0|||
129596280|NCT01048502|466479401|FG003|Overall Study|Lost to Follow-up|0|||
129596281|NCT01048502|466479398|FG000|Overall Study|Adverse Event|1|||
129596282|NCT01048502|466479399|FG001|Overall Study|Adverse Event|0|||
129596283|NCT01048502|466479400|FG002|Overall Study|Adverse Event|0|||
129596284|NCT01048502|466479401|FG003|Overall Study|Adverse Event|0|||
129596285|NCT01048502|466479398|FG000|Overall Study|Withdrawal by Subject|1|||
129596286|NCT01048502|466479399|FG001|Overall Study|Withdrawal by Subject|4|||
129596287|NCT01048502|466479400|FG002|Overall Study|Withdrawal by Subject|5|||
129596288|NCT01048502|466479401|FG003|Overall Study|Withdrawal by Subject|3|||
129596289|NCT01048502|466479398|FG000|Overall Study|Physician Decision|0|||
129596290|NCT01048502|466479399|FG001|Overall Study|Physician Decision|3|||
129596291|NCT01048502|466479400|FG002|Overall Study|Physician Decision|0|||
129596292|NCT01048502|466479401|FG003|Overall Study|Physician Decision|1|||
129596293|NCT01138826|466479402|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
129596294|NCT01138826|466479403|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
129596295|NCT01138826|466479404|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
129596296|NCT01138826|466479405|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
129596297|NCT01138826|466479406|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
129596298|NCT01138826|466479407|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
129596299|NCT01333072|466479411|FG000|Overall Study|Lost to Follow-up|3|||
129596300|NCT01333072|466479412|FG001|Overall Study|Lost to Follow-up|0|||
129596301|NCT01333072|466479411|FG000|Overall Study|Adverse Event|2|||
129596302|NCT01333072|466479412|FG001|Overall Study|Adverse Event|4|||
129596303|NCT01333072|466479411|FG000|Overall Study|Physician Decision|1|||
129596304|NCT01333072|466479412|FG001|Overall Study|Physician Decision|0|||
129596305|NCT01557842|466479413|FG000|Overall Study|Lost to Follow-up|0|||
129596306|NCT01557842|466479414|FG001|Overall Study|Lost to Follow-up|1|||
129596307|NCT01557842|466479413|FG000|Overall Study|Death|1|||
129596308|NCT01557842|466479414|FG001|Overall Study|Death|0|||
129596309|NCT01557842|466479413|FG000|Overall Study|Lack of Efficacy|0|||
129596310|NCT01557842|466479414|FG001|Overall Study|Lack of Efficacy|1|||
129596311|NCT01557842|466479413|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
129596312|NCT01557842|466479414|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
129596313|NCT01557842|466479413|FG000|Overall Study|Study Terminated by Sponsor|3|||
129596314|NCT01557842|466479414|FG001|Overall Study|Study Terminated by Sponsor|4|||
129596315|NCT01557842|466479413|FG000|Overall Study|Not Ablated|2|||
129596316|NCT01557842|466479414|FG001|Overall Study|Not Ablated|0|||
129596317|NCT02457611|466479418|FG000|Overall Study|Lost to Follow-up|3|||
129596318|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
129596319|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
129596320|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
129596321|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
129596322|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
129596323|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
129596324|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
129596325|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
129596326|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
129596327|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
129596328|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
129596329|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
129596330|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
129596331|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
129596332|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
129596333|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
129596334|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
129596335|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
129596336|NCT00384293|466479419|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
129596337|NCT00384293|466479420|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
129596338|NCT00384293|466479421|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
129596339|NCT00384293|466479419|FG000|Post-randomization Period|Adverse Event|0|||
129596340|NCT00384293|466479420|FG001|Post-randomization Period|Adverse Event|23|||
129596341|NCT00384293|466479421|FG002|Post-randomization Period|Adverse Event|7|||
129596342|NCT00384293|466479419|FG000|Post-randomization Period|Lost to Follow-up|0|||
129596343|NCT00384293|466479420|FG001|Post-randomization Period|Lost to Follow-up|2|||
129596344|NCT00384293|466479421|FG002|Post-randomization Period|Lost to Follow-up|1|||
129596345|NCT00384293|466479419|FG000|Post-randomization Period|Protocol Violation|0|||
129596346|NCT00384293|466479420|FG001|Post-randomization Period|Protocol Violation|1|||
129596347|NCT00384293|466479421|FG002|Post-randomization Period|Protocol Violation|0|||
129596348|NCT00384293|466479419|FG000|Post-randomization Period|Withdrawal by Subject|0|||
129596349|NCT00384293|466479420|FG001|Post-randomization Period|Withdrawal by Subject|8|||
129596350|NCT00384293|466479421|FG002|Post-randomization Period|Withdrawal by Subject|6|||
129596351|NCT00384293|466479419|FG000|Post-randomization Period|Trial Termination|0|||
129596352|NCT00384293|466479420|FG001|Post-randomization Period|Trial Termination|180|||
129596353|NCT00384293|466479421|FG002|Post-randomization Period|Trial Termination|204|||
129596354|NCT00384293|466479419|FG000|Post-randomization Period|Patient Randomized in Error|0|||
129596355|NCT00384293|466479420|FG001|Post-randomization Period|Patient Randomized in Error|0|||
129596356|NCT00384293|466479421|FG002|Post-randomization Period|Patient Randomized in Error|1|||
129596357|NCT03005067|466479422|FG000|Overall Study|Withdrawal by Subject|3|||
129596358|NCT03005067|466479423|FG001|Overall Study|Withdrawal by Subject|2|||
129596359|NCT03005067|466479422|FG000|Overall Study|Adverse Event|4|||
129596360|NCT03005067|466479423|FG001|Overall Study|Adverse Event|3|||
129596361|NCT03005067|466479422|FG000|Overall Study|Other (reason not specified)|3|||
129596362|NCT03005067|466479423|FG001|Overall Study|Other (reason not specified)|1|||
129596363|NCT03005067|466479422|FG000|Overall Study|Protocol Violation|0|||
129596364|NCT03005067|466479423|FG001|Overall Study|Protocol Violation|1|||
129596365|NCT00619359|466479428|FG000|Overall Study|Adverse Event|32|||
129596366|NCT00619359|466479429|FG001|Overall Study|Adverse Event|36|||
129596367|NCT00619359|466479428|FG000|Overall Study|Lost to Follow-up|12|||
129596368|NCT00619359|466479429|FG001|Overall Study|Lost to Follow-up|16|||
129596369|NCT00619359|466479428|FG000|Overall Study|Physician Decision|0|||
129596370|NCT00619359|466479429|FG001|Overall Study|Physician Decision|7|||
129596371|NCT00619359|466479428|FG000|Overall Study|Protocol Violation|1|||
129596372|NCT00619359|466479429|FG001|Overall Study|Protocol Violation|1|||
129596373|NCT00619359|466479428|FG000|Overall Study|Withdrawal by Subject|19|||
129596374|NCT00619359|466479429|FG001|Overall Study|Withdrawal by Subject|20|||
129596375|NCT00619359|466479428|FG000|Overall Study|Progressive Disease|3|||
129596376|NCT00619359|466479429|FG001|Overall Study|Progressive Disease|1|||
129596377|NCT01483625|466479433|FG000|Overall Study|Adverse Event|1|||
129596378|NCT01483625|466479434|FG001|Overall Study|Adverse Event|1|||
129596379|NCT01483625|466479433|FG000|Overall Study|Refused to continue medication|2|||
129596380|NCT01483625|466479434|FG001|Overall Study|Refused to continue medication|1|||
129596381|NCT01483625|466479433|FG000|Overall Study|Due to other reason|1|||
129596382|NCT01483625|466479434|FG001|Overall Study|Due to other reason|0|||
129436118|NCT03938545|465895621|FG001|Overall Study|Adverse Event|0|||
129436119|NCT03938545|465895622|FG002|Overall Study|Adverse Event|0|||
129436120|NCT03938545|465895623|FG003|Overall Study|Adverse Event|0|||
129436121|NCT01060540|465895624|FG000|Overall Study|Withdrawal by Subject|10|||
129596383|NCT03891329|466479447|FG000|Overall Study|Death|5|||
129596384|NCT03891329|466479447|FG000|Overall Study|Lost to Follow-up|4|||
129596385|NCT03891329|466479447|FG000|Overall Study|Physician Decision|4|||
129596386|NCT03891329|466479447|FG000|Overall Study|Device explanted|3|||
129596387|NCT03891329|466479447|FG000|Overall Study|No study device implanted|3|||
129596388|NCT03176784|466479448|FG000|Overall Study|Lost to Follow-up|77|||
129596389|NCT03176784|466479449|FG001|Overall Study|Lost to Follow-up|79|||
129596390|NCT03176784|466479450|FG002|Overall Study|Lost to Follow-up|79|||
129596391|NCT03176784|466479451|FG003|Overall Study|Lost to Follow-up|49|||
129596392|NCT03176784|466479448|FG000|Overall Study|Withdrawal by Subject|28|||
129596393|NCT03176784|466479449|FG001|Overall Study|Withdrawal by Subject|34|||
129596394|NCT03176784|466479450|FG002|Overall Study|Withdrawal by Subject|34|||
129596395|NCT03176784|466479451|FG003|Overall Study|Withdrawal by Subject|21|||
129596396|NCT01832402|466479452|FG000|Overall Study|Lost to Follow-up|2|||
129596397|NCT01832402|466479453|FG001|Overall Study|Lost to Follow-up|0|||
129596398|NCT01832402|466479452|FG000|Overall Study|Withdrawal by Subject|3|||
129596399|NCT01832402|466479453|FG001|Overall Study|Withdrawal by Subject|3|||
129596400|NCT01832402|466479452|FG000|Overall Study|Declining Performance status|2|||
129436122|NCT01060540|465895625|FG001|Overall Study|Withdrawal by Subject|20|||
129596401|NCT01832402|466479453|FG001|Overall Study|Declining Performance status|1|||
129596402|NCT01803269|466479456|FG000|Overall Study|Withdrawal by Subject|3|||
129596403|NCT01803269|466479457|FG001|Overall Study|Withdrawal by Subject|0|||
129596404|NCT01803269|466479458|FG002|Overall Study|Withdrawal by Subject|0|||
129596405|NCT01351350|466479461|FG000|Overall Study|Disease Progression|5|||
129596406|NCT01351350|466479462|FG001|Overall Study|Disease Progression|13|||
129596407|NCT01351350|466479463|FG002|Overall Study|Disease Progression|6|||
129596408|NCT01351350|466479464|FG003|Overall Study|Disease Progression|8|||
129596409|NCT01351350|466479465|FG004|Overall Study|Disease Progression|5|||
129596410|NCT01351350|466479461|FG000|Overall Study|Adverse Event|1|||
129596411|NCT01351350|466479462|FG001|Overall Study|Adverse Event|10|||
129596412|NCT01351350|466479463|FG002|Overall Study|Adverse Event|1|||
129596413|NCT01351350|466479464|FG003|Overall Study|Adverse Event|2|||
129596414|NCT01351350|466479465|FG004|Overall Study|Adverse Event|0|||
129596415|NCT01351350|466479461|FG000|Overall Study|Participant Decision|2|||
129596416|NCT01351350|466479462|FG001|Overall Study|Participant Decision|6|||
129436123|NCT01060540|465895624|FG000|Overall Study|Lost to Follow-up|52|||
129596417|NCT01351350|466479463|FG002|Overall Study|Participant Decision|3|||
129596418|NCT01351350|466479464|FG003|Overall Study|Participant Decision|3|||
129596419|NCT01351350|466479465|FG004|Overall Study|Participant Decision|2|||
129436124|NCT01060540|465895625|FG001|Overall Study|Lost to Follow-up|43|||
129436125|NCT01060540|465895624|FG000|Overall Study|Death|2|||
129436126|NCT01060540|465895625|FG001|Overall Study|Death|1|||
129436127|NCT01060540|465895624|FG000|Overall Study|Physician Decision|0|||
129436128|NCT01060540|465895625|FG001|Overall Study|Physician Decision|1|||
129436129|NCT02401867|465895631|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
129436130|NCT02401867|465895631|FG000|Analysis|Cervical assay could not be conducted|9|||
129696698|NCT01725308|466848164|FG000|Treatment Period II|Changes in the Episodes|1|||
129696699|NCT01725308|466848165|FG001|Treatment Period II|Changes in the Episodes|0|||
129696700|NCT01725308|466848166|FG002|Treatment Period II|Changes in the Episodes|5|||
129436131|NCT01557283|465895632|FG000|Overall Study|Lost to Follow-up|7|||
129436132|NCT01557283|465895632|FG000|Overall Study|Non-responder|19|||
129436133|NCT01557283|465895632|FG000|Overall Study|Adverse Event|7|||
129436134|NCT01557283|465895632|FG000|Overall Study|Lack of Efficacy|1|||
129436135|NCT01557283|465895632|FG000|Overall Study|Non-compliance|1|||
129436136|NCT01557283|465895632|FG000|Overall Study|Withdrawal by Subject|1|||
129436137|NCT01557283|465895632|FG000|Overall Study|Participant's weight too high for dose|1|||
129436138|NCT01557283|465895632|FG000|Overall Study|Worsening of psoriasis|1|||
129596420|NCT01351350|466479461|FG000|Overall Study|Enrolled but not Treated|0|||
129596421|NCT01351350|466479462|FG001|Overall Study|Enrolled but not Treated|0|||
129596422|NCT01351350|466479463|FG002|Overall Study|Enrolled but not Treated|1|||
129596423|NCT01351350|466479464|FG003|Overall Study|Enrolled but not Treated|0|||
129596424|NCT01351350|466479465|FG004|Overall Study|Enrolled but not Treated|0|||
129596425|NCT04647383|466479468|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
129596426|NCT04647383|466479469|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
129596427|NCT04647383|466479470|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
129596428|NCT04647383|466479471|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
129596429|NCT01258101|466479473|FG000|Overall Study|Adverse Event|5|||
129596430|NCT01258101|466479474|FG001|Overall Study|Adverse Event|6|||
129596431|NCT01258101|466479475|FG002|Overall Study|Adverse Event|0|||
129596432|NCT01258101|466479476|FG003|Overall Study|Adverse Event|0|||
129596433|NCT01258101|466479473|FG000|Overall Study|Extra exclusion criterion amended|2|||
129596434|NCT01258101|466479474|FG001|Overall Study|Extra exclusion criterion amended|1|||
129596435|NCT01258101|466479475|FG002|Overall Study|Extra exclusion criterion amended|1|||
129596436|NCT01258101|466479476|FG003|Overall Study|Extra exclusion criterion amended|1|||
129596437|NCT01258101|466479473|FG000|Overall Study|Informed consent has been withdrawn|2|||
129596438|NCT01258101|466479474|FG001|Overall Study|Informed consent has been withdrawn|2|||
129596439|NCT01258101|466479475|FG002|Overall Study|Informed consent has been withdrawn|1|||
129596440|NCT01258101|466479476|FG003|Overall Study|Informed consent has been withdrawn|1|||
129596441|NCT01258101|466479473|FG000|Overall Study|Patient is not able to attend visits|8|||
129596442|NCT01258101|466479474|FG001|Overall Study|Patient is not able to attend visits|9|||
129596443|NCT01258101|466479475|FG002|Overall Study|Patient is not able to attend visits|7|||
129596444|NCT01258101|466479476|FG003|Overall Study|Patient is not able to attend visits|6|||
129596445|NCT01258101|466479473|FG000|Overall Study|Patient´s compliance|4|||
129596446|NCT01258101|466479474|FG001|Overall Study|Patient´s compliance|3|||
129436139|NCT01557283|465895632|FG000|Overall Study|Other|6|||
129436140|NCT00250679|465895635|FG000|Overall Study|Adverse Event|12|||
129436141|NCT00250679|465895636|FG001|Overall Study|Adverse Event|15|||
129436142|NCT00250679|465895637|FG002|Overall Study|Adverse Event|16|||
129596447|NCT01258101|466479475|FG002|Overall Study|Patient´s compliance|1|||
129596448|NCT01258101|466479476|FG003|Overall Study|Patient´s compliance|2|||
129596449|NCT01258101|466479473|FG000|Overall Study|Lost to Follow-up|5|||
129596450|NCT01258101|466479474|FG001|Overall Study|Lost to Follow-up|5|||
129596451|NCT01258101|466479475|FG002|Overall Study|Lost to Follow-up|0|||
129596452|NCT01258101|466479476|FG003|Overall Study|Lost to Follow-up|6|||
129596453|NCT01258101|466479473|FG000|Overall Study|PCR positive at week 24|0|||
129596454|NCT01258101|466479474|FG001|Overall Study|PCR positive at week 24|0|||
129596455|NCT01258101|466479475|FG002|Overall Study|PCR positive at week 24|0|||
129596456|NCT01258101|466479476|FG003|Overall Study|PCR positive at week 24|1|||
129596457|NCT01258101|466479473|FG000|Overall Study|Other reason|7|||
129596458|NCT01258101|466479474|FG001|Overall Study|Other reason|8|||
129596459|NCT01258101|466479475|FG002|Overall Study|Other reason|1|||
129596460|NCT01258101|466479476|FG003|Overall Study|Other reason|8|||
129596461|NCT00303667|466479477|FG000|Overall Study|Death|0|||
129596462|NCT00303667|466479478|FG001|Overall Study|Death|4|||
129596463|NCT01807117|466479479|FG000|Overall Study|Physician Decision|2|||
129596464|NCT01807117|466479479|FG000|Overall Study|Disease diagnosis not a study disease|1|||
129596465|NCT01298778|466479480|FG000|Overall Study|Lost to Follow-up|2|||
129596466|NCT01298778|466479481|FG001|Overall Study|Lost to Follow-up|3|||
129696701|NCT01725308|466848164|FG000|Treatment Period II|Withdrawal of Consent|28|||
129596467|NCT01298778|466479480|FG000|Overall Study|Incorrect use of VAS|1|||
129696702|NCT01725308|466848165|FG001|Treatment Period II|Withdrawal of Consent|2|||
129436143|NCT00250679|465895635|FG000|Overall Study|Protocol Violation|2|||
129436144|NCT00250679|465895636|FG001|Overall Study|Protocol Violation|4|||
129436145|NCT00250679|465895637|FG002|Overall Study|Protocol Violation|3|||
129436146|NCT00250679|465895635|FG000|Overall Study|Withdrawal by Subject|15|||
129436147|NCT00250679|465895636|FG001|Overall Study|Withdrawal by Subject|18|||
129436148|NCT00250679|465895637|FG002|Overall Study|Withdrawal by Subject|15|||
129436149|NCT00250679|465895635|FG000|Overall Study|Lost to Follow-up|3|||
129436150|NCT00250679|465895636|FG001|Overall Study|Lost to Follow-up|4|||
129436151|NCT00250679|465895637|FG002|Overall Study|Lost to Follow-up|2|||
129436152|NCT00250679|465895635|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
129436153|NCT00250679|465895636|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
129436154|NCT00250679|465895637|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
129436155|NCT00250679|465895635|FG000|Overall Study|Lack of Efficacy|0|||
129436156|NCT00250679|465895636|FG001|Overall Study|Lack of Efficacy|1|||
129436157|NCT00250679|465895637|FG002|Overall Study|Lack of Efficacy|3|||
129436158|NCT00250679|465895635|FG000|Overall Study|Technical Holter issues|1|||
129436159|NCT00250679|465895636|FG001|Overall Study|Technical Holter issues|0|||
129436160|NCT00250679|465895637|FG002|Overall Study|Technical Holter issues|2|||
129436161|NCT00250679|465895635|FG000|Overall Study|Moved|1|||
129436162|NCT00250679|465895636|FG001|Overall Study|Moved|1|||
129436163|NCT00250679|465895637|FG002|Overall Study|Moved|0|||
129436164|NCT00250679|465895635|FG000|Overall Study|Non-compliance|1|||
129436165|NCT00250679|465895636|FG001|Overall Study|Non-compliance|1|||
129436166|NCT00250679|465895637|FG002|Overall Study|Non-compliance|0|||
129436167|NCT00250679|465895635|FG000|Overall Study|various single events: hip surgery,diary|3|||
129436168|NCT00250679|465895636|FG001|Overall Study|various single events: hip surgery,diary|1|||
129436169|NCT00250679|465895637|FG002|Overall Study|various single events: hip surgery,diary|1|||
129436170|NCT00448279|465895639|FG000|Overall Study|Lost to Follow-up|2|||
129436171|NCT00448279|465895640|FG001|Overall Study|Lost to Follow-up|2|||
129436172|NCT00448279|465895639|FG000|Overall Study|Adverse Event|1|||
129436173|NCT00448279|465895640|FG001|Overall Study|Adverse Event|1|||
129436174|NCT00448279|465895639|FG000|Overall Study|Disease progression|16|||
129436175|NCT00448279|465895640|FG001|Overall Study|Disease progression|18|||
129596468|NCT01298778|466479481|FG001|Overall Study|Incorrect use of VAS|0|||
129596469|NCT01298778|466479480|FG000|Overall Study|Withdrawal by Subject|0|||
129596470|NCT01298778|466479481|FG001|Overall Study|Withdrawal by Subject|1|||
129596471|NCT01298778|466479480|FG000|Overall Study|Protocol Violation|0|||
129596472|NCT01298778|466479481|FG001|Overall Study|Protocol Violation|1|||
129596473|NCT01298778|466479480|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
129596474|NCT01298778|466479481|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
129596475|NCT00706355|466479485|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
129596476|NCT00706355|466479486|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
129596477|NCT00706355|466479487|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
129596478|NCT00706355|466479488|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
129596479|NCT00706355|466479485|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
129596480|NCT00706355|466479486|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
129596481|NCT00706355|466479487|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
129596482|NCT00706355|466479488|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
129596483|NCT00706355|466479485|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
129596484|NCT00706355|466479486|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
129596485|NCT00706355|466479487|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
129596486|NCT00706355|466479488|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
129596487|NCT00706355|466479485|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
129596488|NCT00706355|466479486|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
129596489|NCT00706355|466479487|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
129596490|NCT00706355|466479488|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
129596491|NCT00706355|466479485|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
129596492|NCT00706355|466479486|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
129596493|NCT00706355|466479487|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
129596494|NCT00706355|466479488|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
129596495|NCT00706355|466479485|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
129596496|NCT00706355|466479486|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
129596497|NCT00706355|466479487|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
129596498|NCT00706355|466479488|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
129596499|NCT00706355|466479485|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
129885634|NCT02855164|467540776|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
129436176|NCT00448279|465895639|FG000|Overall Study|Withdrawal by Subject|4|||
129436177|NCT00448279|465895640|FG001|Overall Study|Withdrawal by Subject|3|||
129436178|NCT00448279|465895639|FG000|Overall Study|Other|6|||
129436179|NCT00448279|465895640|FG001|Overall Study|Other|4|||
129436180|NCT00448279|465895639|FG000|Overall Study|Protocol Violation|0|||
129436181|NCT00448279|465895640|FG001|Overall Study|Protocol Violation|1|||
129436182|NCT03907410|465895641|FG000|Overall Study|Lost to Follow-up|4|||
129436183|NCT03907410|465895642|FG001|Overall Study|Lost to Follow-up|1|||
129436184|NCT03907410|465895643|FG002|Overall Study|Lost to Follow-up|1|||
129436185|NCT03907410|465895641|FG000|Overall Study|Lost to follow-up and research burden|0|||
129436186|NCT03907410|465895642|FG001|Overall Study|Lost to follow-up and research burden|0|||
129436187|NCT03907410|465895643|FG002|Overall Study|Lost to follow-up and research burden|1|||
129436188|NCT03718533|465895644|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
129436189|NCT03718533|465895644|FG000|Overall Study|Protocol deviation|1|||
129436190|NCT03718533|465895644|FG000|Overall Study|Disease progression|1|||
129436191|NCT03718533|465895644|FG000|Overall Study|Relapse|1|||
129436192|NCT03718533|465895644|FG000|Overall Study|Physician Decision|2|||
129436193|NCT03718533|465895644|FG000|Overall Study|Physician Decision and Adverse Event|1|||
129436194|NCT01853137|465895647|FG000|Overall Study|Lost to Follow-up|4|||
129436195|NCT01853137|465895648|FG001|Overall Study|Lost to Follow-up|1|||
129436196|NCT01037244|465895649|FG000|Overall Study|Adverse Event|3|||
129436197|NCT01037244|465895650|FG001|Overall Study|Adverse Event|2|||
129436198|NCT01037244|465895651|FG002|Overall Study|Adverse Event|6|||
129436199|NCT01037244|465895652|FG003|Overall Study|Adverse Event|3|||
129436200|NCT01037244|465895649|FG000|Overall Study|Lack of Efficacy|1|||
129436201|NCT01037244|465895650|FG001|Overall Study|Lack of Efficacy|1|||
129436202|NCT01037244|465895651|FG002|Overall Study|Lack of Efficacy|0|||
129436203|NCT01037244|465895652|FG003|Overall Study|Lack of Efficacy|1|||
129436204|NCT01037244|465895649|FG000|Overall Study|Lost to Follow-up|3|||
129436205|NCT01037244|465895650|FG001|Overall Study|Lost to Follow-up|3|||
129436206|NCT01037244|465895651|FG002|Overall Study|Lost to Follow-up|4|||
129436207|NCT01037244|465895652|FG003|Overall Study|Lost to Follow-up|4|||
129436208|NCT01037244|465895649|FG000|Overall Study|Withdrawal by Subject|1|||
129436209|NCT01037244|465895650|FG001|Overall Study|Withdrawal by Subject|5|||
129436210|NCT01037244|465895651|FG002|Overall Study|Withdrawal by Subject|3|||
129436211|NCT01037244|465895652|FG003|Overall Study|Withdrawal by Subject|5|||
129436212|NCT01037244|465895649|FG000|Overall Study|Partner Withdrew Consent|2|||
129436213|NCT01037244|465895650|FG001|Overall Study|Partner Withdrew Consent|1|||
129436214|NCT01037244|465895651|FG002|Overall Study|Partner Withdrew Consent|0|||
129436215|NCT01037244|465895652|FG003|Overall Study|Partner Withdrew Consent|0|||
129436216|NCT01037244|465895649|FG000|Overall Study|Various|3|||
129436217|NCT01037244|465895650|FG001|Overall Study|Various|2|||
129436218|NCT01037244|465895651|FG002|Overall Study|Various|1|||
129436219|NCT01037244|465895652|FG003|Overall Study|Various|1|||
129436220|NCT01411215|465895653|FG000|Overall Study|Adverse Event|1|||
129436221|NCT01411215|465895654|FG001|Overall Study|Adverse Event|2|||
129436222|NCT01411215|465895653|FG000|Overall Study|Lack of Efficacy|2|||
129436223|NCT01411215|465895654|FG001|Overall Study|Lack of Efficacy|4|||
129436224|NCT01411215|465895653|FG000|Overall Study|Lost to Follow-up|12|||
129436225|NCT01411215|465895654|FG001|Overall Study|Lost to Follow-up|18|||
129436226|NCT01411215|465895653|FG000|Overall Study|Did not meet entrance criteria|0|||
129436227|NCT01411215|465895654|FG001|Overall Study|Did not meet entrance criteria|1|||
129436228|NCT01411215|465895653|FG000|Overall Study|Study terminated by sponsor|2|||
129436229|NCT01411215|465895654|FG001|Overall Study|Study terminated by sponsor|15|||
129436230|NCT01411215|465895653|FG000|Overall Study|Protocol Violation|3|||
129436231|NCT01411215|465895654|FG001|Overall Study|Protocol Violation|5|||
129436232|NCT01411215|465895653|FG000|Overall Study|Withdrawal by Subject|34|||
129436233|NCT01411215|465895654|FG001|Overall Study|Withdrawal by Subject|21|||
129436234|NCT01411215|465895653|FG000|Overall Study|Other|12|||
129436235|NCT01411215|465895654|FG001|Overall Study|Other|17|||
129436236|NCT01411215|465895653|FG000|Overall Study|Screen failure|0|||
129436237|NCT01411215|465895654|FG001|Overall Study|Screen failure|1|||
129436238|NCT00848926|465895655|FG000|Treatment Period|Progressive disease|45|||
129436239|NCT00848926|465895655|FG000|Treatment Period|Adverse Event|20|||
129436240|NCT00848926|465895655|FG000|Treatment Period|Physician Decision|12|||
129436241|NCT00848926|465895655|FG000|Treatment Period|Withdrawal by Subject|7|||
129436242|NCT00848926|465895655|FG000|Follow-up Period|Lost to Follow-up|7|||
129436243|NCT00848926|465895655|FG000|Follow-up Period|Withdrawal by Subject|3|||
129436244|NCT00848926|465895655|FG000|Follow-up Period|Other|2|||
129436245|NCT04025580|465895656|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
129436246|NCT04025580|465895657|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
129436247|NCT04025580|465895658|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
129436248|NCT04507126|465895659|FG000|Overall Study|Withdrawal by Subject|1|||
129696703|NCT01725308|466848166|FG002|Treatment Period II|Withdrawal of Consent|16|||
129436249|NCT04507126|465895659|FG000|Overall Study|Protocol Violation|2|||
129436250|NCT04507126|465895659|FG000|Overall Study|Physician Decision|1|||
129436251|NCT02924064|465895660|FG000|Overall Study|Adverse Event|2|||
129436252|NCT02924064|465895661|FG001|Overall Study|Adverse Event|2|||
129436253|NCT02924064|465895660|FG000|Overall Study|Lost to Follow-up|0|||
129436254|NCT02924064|465895661|FG001|Overall Study|Lost to Follow-up|2|||
129436255|NCT02924064|465895660|FG000|Overall Study|Physician Decision|0|||
129436256|NCT02924064|465895661|FG001|Overall Study|Physician Decision|2|||
129436257|NCT02924064|465895660|FG000|Overall Study|Protocol Violation|1|||
129436258|NCT02924064|465895661|FG001|Overall Study|Protocol Violation|3|||
129436259|NCT02924064|465895660|FG000|Overall Study|Withdrawal by Subject|4|||
129436260|NCT02924064|465895661|FG001|Overall Study|Withdrawal by Subject|5|||
129436261|NCT02924064|465895660|FG000|Overall Study|Other|17|||
129436262|NCT02924064|465895661|FG001|Overall Study|Other|29|||
129596500|NCT00706355|466479486|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
129596501|NCT00706355|466479487|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
129596502|NCT00706355|466479488|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
129596503|NCT00706355|466479485|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
129596504|NCT00706355|466479486|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
129596505|NCT00706355|466479487|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
129596506|NCT00706355|466479488|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
129596507|NCT00706355|466479485|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
129596508|NCT00706355|466479486|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
129596509|NCT00706355|466479487|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
129596510|NCT00706355|466479488|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
129596511|NCT04179019|466479489|FG000|Overall Study|Lost to Follow-up|2|||
129596512|NCT04179019|466479489|FG000|Overall Study|Physician Decision|2|||
129596513|NCT04179019|466479489|FG000|Overall Study|Withdrawal by Subject|5|||
129596514|NCT04179019|466479489|FG000|Overall Study|Adverse Event|4|||
129596515|NCT02139124|466479492|FG000|Overall Study|Adverse Event|2|||
129596516|NCT02139124|466479493|FG001|Overall Study|Adverse Event|0|||
129596517|NCT02139124|466479494|FG002|Overall Study|Adverse Event|1|||
129596518|NCT02139124|466479495|FG003|Overall Study|Adverse Event|2|||
129596519|NCT02139124|466479496|FG004|Overall Study|Adverse Event|5|||
129596520|NCT02139124|466479492|FG000|Overall Study|Withdrawal by Subject|2|||
129596521|NCT02139124|466479493|FG001|Overall Study|Withdrawal by Subject|2|||
129596522|NCT02139124|466479494|FG002|Overall Study|Withdrawal by Subject|2|||
129596523|NCT02139124|466479495|FG003|Overall Study|Withdrawal by Subject|2|||
129596524|NCT02139124|466479496|FG004|Overall Study|Withdrawal by Subject|3|||
129596525|NCT02139124|466479492|FG000|Overall Study|Protocol Violation|0|||
129596526|NCT02139124|466479493|FG001|Overall Study|Protocol Violation|0|||
129596527|NCT02139124|466479494|FG002|Overall Study|Protocol Violation|0|||
129596528|NCT02139124|466479495|FG003|Overall Study|Protocol Violation|1|||
129596529|NCT02139124|466479496|FG004|Overall Study|Protocol Violation|1|||
129596530|NCT02139124|466479492|FG000|Overall Study|non-compliant|1|||
129596531|NCT02139124|466479493|FG001|Overall Study|non-compliant|0|||
129596532|NCT02139124|466479494|FG002|Overall Study|non-compliant|0|||
129596533|NCT02139124|466479495|FG003|Overall Study|non-compliant|2|||
129596534|NCT02139124|466479496|FG004|Overall Study|non-compliant|0|||
129596535|NCT02139124|466479492|FG000|Overall Study|incarceration|0|||
129596536|NCT02139124|466479493|FG001|Overall Study|incarceration|0|||
129596537|NCT02139124|466479494|FG002|Overall Study|incarceration|1|||
129596538|NCT02139124|466479495|FG003|Overall Study|incarceration|0|||
129596539|NCT02139124|466479496|FG004|Overall Study|incarceration|0|||
129596540|NCT02139124|466479492|FG000|Overall Study|subject moved|1|||
129596541|NCT02139124|466479493|FG001|Overall Study|subject moved|0|||
129596542|NCT02139124|466479494|FG002|Overall Study|subject moved|0|||
129596543|NCT02139124|466479495|FG003|Overall Study|subject moved|0|||
129596544|NCT02139124|466479496|FG004|Overall Study|subject moved|0|||
129596545|NCT02139124|466479492|FG000|Overall Study|Lost to Follow-up|3|||
129596546|NCT02139124|466479493|FG001|Overall Study|Lost to Follow-up|2|||
129596547|NCT02139124|466479494|FG002|Overall Study|Lost to Follow-up|0|||
129596548|NCT02139124|466479495|FG003|Overall Study|Lost to Follow-up|5|||
129596549|NCT02139124|466479496|FG004|Overall Study|Lost to Follow-up|4|||
129596550|NCT03465436|466479497|FG000|Period 1|Protocol Violation|0|||
129596551|NCT03465436|466479498|FG001|Period 1|Protocol Violation|0|||
129596552|NCT03465436|466479499|FG002|Period 1|Protocol Violation|1|||
129786503|NCT01375075|467185699|FG004|Overall Study|Adverse Event|0|||
129786504|NCT01375075|467185700|FG005|Overall Study|Adverse Event|1|||
129786505|NCT01375075|467185695|FG000|Overall Study|Entry Criterion Not Met|1|||
129786506|NCT01375075|467185696|FG001|Overall Study|Entry Criterion Not Met|0|||
129786507|NCT01375075|467185697|FG002|Overall Study|Entry Criterion Not Met|0|||
129786508|NCT01375075|467185698|FG003|Overall Study|Entry Criterion Not Met|0|||
129786509|NCT01375075|467185699|FG004|Overall Study|Entry Criterion Not Met|0|||
129786510|NCT01375075|467185700|FG005|Overall Study|Entry Criterion Not Met|1|||
129786511|NCT01375075|467185695|FG000|Overall Study|Withdrawal by Subject|0|||
129786512|NCT01375075|467185696|FG001|Overall Study|Withdrawal by Subject|1|||
129786513|NCT01375075|467185697|FG002|Overall Study|Withdrawal by Subject|0|||
129786514|NCT01375075|467185698|FG003|Overall Study|Withdrawal by Subject|0|||
129596553|NCT03465436|466479500|FG003|Period 1|Protocol Violation|0|||
129596554|NCT03465436|466479497|FG000|Period 2|Protocol Violation|0|||
129596555|NCT03465436|466479498|FG001|Period 2|Protocol Violation|1|||
129596556|NCT03465436|466479499|FG002|Period 2|Protocol Violation|0|||
129596557|NCT03465436|466479500|FG003|Period 2|Protocol Violation|0|||
129596558|NCT03465436|466479497|FG000|Period 3|Protocol Violation|1|||
129596559|NCT03465436|466479498|FG001|Period 3|Protocol Violation|1|||
129596560|NCT03465436|466479499|FG002|Period 3|Protocol Violation|0|||
129596561|NCT03465436|466479500|FG003|Period 3|Protocol Violation|0|||
129786515|NCT01375075|467185699|FG004|Overall Study|Withdrawal by Subject|0|||
129436263|NCT01249274|465895664|FG000|Overall Study|Lost to Follow-up|3|||
129596562|NCT03465436|466479497|FG000|Period 4|Protocol Violation|0|||
129596563|NCT03465436|466479498|FG001|Period 4|Protocol Violation|0|||
129596564|NCT03465436|466479499|FG002|Period 4|Protocol Violation|1|||
129596565|NCT03465436|466479500|FG003|Period 4|Protocol Violation|0|||
129596566|NCT02658487|466481376|FG000|Overall Study|Death|2|||
129596567|NCT02658487|466481376|FG000|Overall Study|Disease progression|10|||
129596568|NCT02658487|466481376|FG000|Overall Study|Alternative therapy|1|||
129596569|NCT02658487|466481376|FG000|Overall Study|Adverse Event|1|||
129596570|NCT02658487|466481376|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
129596571|NCT02658487|466481376|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
129596572|NCT00614926|466481377|FG000|Overall Study|Burden of travel|1|||
129596573|NCT00614926|466481378|FG001|Overall Study|Burden of travel|0|||
129596574|NCT00614926|466481377|FG000|Overall Study|Adverse Event|3|||
129596575|NCT00614926|466481378|FG001|Overall Study|Adverse Event|0|||
129596576|NCT03341000|466481379|FG000|Overall Study|Adverse Event|1|||
129596577|NCT00918463|466481382|FG000|Overall Study|Death|1|||
129596578|NCT00918463|466481382|FG000|Overall Study|Lack of Efficacy|1|||
129596579|NCT01014624|466481387|FG000|Overall Study|Adverse Event|0|||
129596580|NCT01014624|466481388|FG001|Overall Study|Adverse Event|1|||
129596581|NCT01014624|466481387|FG000|Overall Study|Protocol Violation|1|||
129596582|NCT01014624|466481388|FG001|Overall Study|Protocol Violation|0|||
129596583|NCT01014624|466481387|FG000|Overall Study|Withdrawal by Subject|1|||
129596584|NCT01014624|466481388|FG001|Overall Study|Withdrawal by Subject|0|||
129596585|NCT02954159|466481389|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
129596586|NCT02954159|466481390|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
129596587|NCT02954159|466481389|FG000|Overall Study|Withdrawal by Subject|0|||
129596588|NCT02954159|466481390|FG001|Overall Study|Withdrawal by Subject|1|||
129596589|NCT01117337|466481394|FG000|Overall Study|Lost to Follow-up|4|||
129596590|NCT01117337|466481395|FG001|Overall Study|Lost to Follow-up|0|||
129596591|NCT03575871|466481396|FG000|Overall Study|Adverse Event|5|||
129596592|NCT03575871|466481397|FG001|Overall Study|Adverse Event|5|||
129596593|NCT03575871|466481398|FG002|Overall Study|Adverse Event|8|||
129596594|NCT03575871|466481396|FG000|Overall Study|Death|1|||
129596595|NCT03575871|466481397|FG001|Overall Study|Death|0|||
129596596|NCT03575871|466481398|FG002|Overall Study|Death|0|||
129596597|NCT03575871|466481396|FG000|Overall Study|Lack of Efficacy|5|||
129596598|NCT03575871|466481397|FG001|Overall Study|Lack of Efficacy|4|||
129596599|NCT03575871|466481398|FG002|Overall Study|Lack of Efficacy|7|||
129596600|NCT03575871|466481396|FG000|Overall Study|Lost to Follow-up|1|||
129596601|NCT03575871|466481397|FG001|Overall Study|Lost to Follow-up|1|||
129596602|NCT03575871|466481398|FG002|Overall Study|Lost to Follow-up|1|||
129596603|NCT03575871|466481396|FG000|Overall Study|Protocol Deviation|1|||
129596604|NCT03575871|466481397|FG001|Overall Study|Protocol Deviation|1|||
129596605|NCT03575871|466481398|FG002|Overall Study|Protocol Deviation|1|||
129596606|NCT03575871|466481396|FG000|Overall Study|Withdrawal by Subject|6|||
129596607|NCT03575871|466481397|FG001|Overall Study|Withdrawal by Subject|1|||
129596608|NCT03575871|466481398|FG002|Overall Study|Withdrawal by Subject|9|||
129596609|NCT03575871|466481396|FG000|Overall Study|Other than specified|2|||
129596610|NCT03575871|466481397|FG001|Overall Study|Other than specified|2|||
129596611|NCT03575871|466481398|FG002|Overall Study|Other than specified|0|||
129596612|NCT01744093|466481402|FG000|Overall Study|Withdrawal by Subject|6|||
129596613|NCT01744093|466481403|FG001|Overall Study|Withdrawal by Subject|1|||
129596614|NCT01570283|466481404|FG000|Cohort 1: Dose Level 1|Death|0|||
129596615|NCT01570283|466481405|FG001|Cohort 1: Dose Level 1|Death|1|||
129596616|NCT01570283|466481406|FG002|Cohort 1: Dose Level 1|Death|0|||
129596617|NCT01570283|466481407|FG003|Cohort 1: Dose Level 1|Death|0|||
129596618|NCT01570283|466481408|FG004|Cohort 1: Dose Level 1|Death|0|||
129596619|NCT01570283|466481409|FG005|Cohort 1: Dose Level 1|Death|0|||
129596620|NCT01570283|466481404|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129596621|NCT01570283|466481405|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
129596622|NCT01570283|466481406|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129596623|NCT01570283|466481407|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129596624|NCT01570283|466481408|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129596625|NCT01570283|466481409|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
129596626|NCT01570283|466481404|FG000|Cohort 2: Dose Level 2|Death|0|||
129596627|NCT01570283|466481405|FG001|Cohort 2: Dose Level 2|Death|0|||
129596628|NCT01570283|466481406|FG002|Cohort 2: Dose Level 2|Death|1|||
129596629|NCT01570283|466481407|FG003|Cohort 2: Dose Level 2|Death|0|||
129596630|NCT01570283|466481408|FG004|Cohort 2: Dose Level 2|Death|0|||
129596631|NCT01570283|466481409|FG005|Cohort 2: Dose Level 2|Death|0|||
129596632|NCT01570283|466481404|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129596633|NCT01570283|466481405|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129596634|NCT01570283|466481406|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129596635|NCT01570283|466481407|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
129596636|NCT01570283|466481408|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129596637|NCT01570283|466481409|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
129596638|NCT01570283|466481404|FG000|Cohort 3: Dose Level 3|Death|0|||
129596639|NCT01570283|466481405|FG001|Cohort 3: Dose Level 3|Death|0|||
129596640|NCT01570283|466481406|FG002|Cohort 3: Dose Level 3|Death|0|||
129596641|NCT01570283|466481407|FG003|Cohort 3: Dose Level 3|Death|0|||
129596642|NCT01570283|466481408|FG004|Cohort 3: Dose Level 3|Death|0|||
129596643|NCT01570283|466481409|FG005|Cohort 3: Dose Level 3|Death|1|||
129596644|NCT01570283|466481404|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129596645|NCT01570283|466481405|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129596646|NCT01570283|466481406|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129596647|NCT01570283|466481407|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129596648|NCT01570283|466481408|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
129596649|NCT01570283|466481409|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
129596650|NCT01173471|466481412|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129596651|NCT01173471|466481413|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129596652|NCT01173471|466481414|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129596653|NCT01173471|466481415|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129596654|NCT01173471|466481412|FG000|Overall Study|Condition under investigation worsened|2|||
129596655|NCT01173471|466481413|FG001|Overall Study|Condition under investigation worsened|0|||
129596656|NCT01173471|466481414|FG002|Overall Study|Condition under investigation worsened|0|||
129596657|NCT01173471|466481415|FG003|Overall Study|Condition under investigation worsened|0|||
129596658|NCT01173471|466481412|FG000|Overall Study|Lost to Follow-up|0|||
129596659|NCT01173471|466481413|FG001|Overall Study|Lost to Follow-up|0|||
129596660|NCT01173471|466481414|FG002|Overall Study|Lost to Follow-up|1|||
129596661|NCT01173471|466481415|FG003|Overall Study|Lost to Follow-up|0|||
129596662|NCT01173471|466481412|FG000|Overall Study|Reason given as Other|0|||
129596663|NCT01173471|466481413|FG001|Overall Study|Reason given as Other|0|||
129596664|NCT01173471|466481414|FG002|Overall Study|Reason given as Other|1|||
129596665|NCT01173471|466481415|FG003|Overall Study|Reason given as Other|0|||
129596666|NCT03028740|466481416|FG000|Overall Study|Did not Receive Study Drug|4|||
129596667|NCT03028740|466481417|FG001|Overall Study|Did not Receive Study Drug|5|||
129596668|NCT03028740|466481416|FG000|Overall Study|Adverse Event|8|||
129596669|NCT03028740|466481417|FG001|Overall Study|Adverse Event|26|||
129596670|NCT03028740|466481416|FG000|Overall Study|Lack of Efficacy|0|||
129596671|NCT03028740|466481417|FG001|Overall Study|Lack of Efficacy|1|||
129596672|NCT03028740|466481416|FG000|Overall Study|Withdrawal by Subject|48|||
129596673|NCT03028740|466481417|FG001|Overall Study|Withdrawal by Subject|101|||
129596674|NCT03028740|466481416|FG000|Overall Study|Lost to Follow-up|30|||
129596675|NCT03028740|466481417|FG001|Overall Study|Lost to Follow-up|54|||
129596676|NCT03028740|466481416|FG000|Overall Study|Physician Decision|4|||
129596677|NCT03028740|466481417|FG001|Overall Study|Physician Decision|11|||
129596678|NCT03028740|466481416|FG000|Overall Study|Protocol Violation|4|||
129596679|NCT03028740|466481417|FG001|Overall Study|Protocol Violation|8|||
129596680|NCT03028740|466481416|FG000|Overall Study|Non-compliance with Study Drug|0|||
129596681|NCT03028740|466481417|FG001|Overall Study|Non-compliance with Study Drug|2|||
129596682|NCT03028740|466481416|FG000|Overall Study|Study Terminated by Sponsor|467|||
129596683|NCT03028740|466481417|FG001|Overall Study|Study Terminated by Sponsor|917|||
129596684|NCT03028740|466481416|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
129596685|NCT03028740|466481417|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
129596686|NCT03028740|466481416|FG000|Overall Study|Reason not Specified|1|||
129596687|NCT03028740|466481417|FG001|Overall Study|Reason not Specified|5|||
129596688|NCT00685802|466481425|FG000|Washout Period of 7 Days|Protocol Violation|2|||
129596689|NCT00685802|466481426|FG001|Washout Period of 7 Days|Protocol Violation|0|||
129596690|NCT00685802|466481425|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129596691|NCT00685802|466481426|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129596692|NCT03336242|466481430|FG000|Overall Study|Adverse Event|0|||
129596693|NCT03336242|466481431|FG001|Overall Study|Adverse Event|1|||
129596694|NCT02224573|466481433|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
129436264|NCT01249274|465895665|FG001|Overall Study|Lost to Follow-up|4|||
129596695|NCT02224573|466481434|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
129786516|NCT01375075|467185700|FG005|Overall Study|Withdrawal by Subject|1|||
129436265|NCT01249274|465895664|FG000|Overall Study|Received inpatient substance treatment|1|||
129596696|NCT02224573|466481433|FG000|Treatment Phase|Started on Other IMP|1|||
129596697|NCT02224573|466481434|FG001|Treatment Phase|Started on Other IMP|0|||
129596698|NCT02224573|466481433|FG000|Treatment Phase|Participant Discontinued IMP|0|||
129786517|NCT01011309|467185702|FG000|Overall Study|Adverse Event|2|||
129596699|NCT02224573|466481434|FG001|Treatment Phase|Participant Discontinued IMP|1|||
129596700|NCT02224573|466481433|FG000|Treatment Phase|Lack of Efficacy|15|||
129596701|NCT02224573|466481434|FG001|Treatment Phase|Lack of Efficacy|8|||
129596702|NCT02224573|466481433|FG000|Treatment Phase|Began Commercial Product|1|||
129596703|NCT02224573|466481434|FG001|Treatment Phase|Began Commercial Product|0|||
129596704|NCT02224573|466481433|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
129596705|NCT02224573|466481434|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
129596706|NCT02224573|466481433|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
129596707|NCT02224573|466481434|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
129596708|NCT02224573|466481433|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
129596709|NCT02224573|466481434|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
129596710|NCT02224573|466481433|FG000|Treatment Phase|Continued Compassionate Use|1|||
129596711|NCT02224573|466481434|FG001|Treatment Phase|Continued Compassionate Use|0|||
129596712|NCT02224573|466481433|FG000|Treatment Phase|Lack of Efficiency|2|||
129596713|NCT02224573|466481434|FG001|Treatment Phase|Lack of Efficiency|1|||
129596714|NCT02224573|466481433|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
129596715|NCT02224573|466481434|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
129596716|NCT02224573|466481433|FG000|Treatment Phase|Participant Moved|2|||
129596717|NCT02224573|466481434|FG001|Treatment Phase|Participant Moved|0|||
129596718|NCT02224573|466481433|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
129596719|NCT02224573|466481434|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
129596720|NCT02224573|466481433|FG000|Treatment Phase|Refused Medication|1|||
129596721|NCT02224573|466481434|FG001|Treatment Phase|Refused Medication|1|||
129596722|NCT02224573|466481433|FG000|Treatment Phase|Adverse Event|26|||
129596723|NCT02224573|466481434|FG001|Treatment Phase|Adverse Event|38|||
129596724|NCT02224573|466481433|FG000|Treatment Phase|Placed in Group Home|0|||
129596725|NCT02224573|466481434|FG001|Treatment Phase|Placed in Group Home|1|||
129596726|NCT02224573|466481433|FG000|Treatment Phase|Pursued Other Trials|1|||
129596727|NCT02224573|466481434|FG001|Treatment Phase|Pursued Other Trials|0|||
129596728|NCT02224573|466481433|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
129596729|NCT02224573|466481434|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
129596730|NCT02224573|466481433|FG000|Treatment Phase|Lost to Follow-up|2|||
129596731|NCT02224573|466481434|FG001|Treatment Phase|Lost to Follow-up|1|||
129596732|NCT02224573|466481433|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
129596733|NCT02224573|466481434|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
129596734|NCT02224573|466481433|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
129596735|NCT02224573|466481434|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
129596736|NCT02224573|466481433|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
129596737|NCT02224573|466481434|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
129596738|NCT02224573|466481433|FG000|Taper Phase|Adverse Event|1|||
129596739|NCT02224573|466481434|FG001|Taper Phase|Adverse Event|1|||
129596740|NCT02546362|466481435|FG000|4-week Treatment Period|Lost to Follow-up|1|||
129596741|NCT02546362|466481435|FG000|4-week Treatment Period|Change in medication|2|||
129596742|NCT02546362|466481435|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
129596743|NCT02546362|466481435|FG000|12-week Treatment Period|Lost to Follow-up|2|||
129596744|NCT02546362|466481435|FG000|12-week Treatment Period|Change in medication|1|||
129596745|NCT05206448|466481436|FG000|Overall Study|Lost to Follow-up|2|||
129596746|NCT05206448|466481437|FG001|Overall Study|Lost to Follow-up|2|||
129596747|NCT05206448|466481436|FG000|Overall Study|Withdrawal by Subject|2|||
129596748|NCT05206448|466481437|FG001|Overall Study|Withdrawal by Subject|0|||
129596749|NCT05206448|466481436|FG000|Overall Study|found ineligible after randomization|1|||
129596750|NCT05206448|466481437|FG001|Overall Study|found ineligible after randomization|1|||
129596751|NCT05206448|466481436|FG000|Overall Study|unable to complete study due to personal constraints|1|||
129596752|NCT05206448|466481437|FG001|Overall Study|unable to complete study due to personal constraints|0|||
129596753|NCT05206448|466481436|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
129596754|NCT05206448|466481437|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
129596755|NCT02025010|466481438|FG000|Overall Study|Symptomatic or radiographic progression|36|||
129596756|NCT02025010|466481438|FG000|Overall Study|Adverse Event|6|||
129596757|NCT02025010|466481438|FG000|Overall Study|Physician Decision|7|||
129596758|NCT02025010|466481438|FG000|Overall Study|Withdrawal by Subject|3|||
129596759|NCT02025010|466481438|FG000|Overall Study|Intercurrent illness|3|||
129596760|NCT02025010|466481438|FG000|Overall Study|Patients still on treatment|3|||
129596761|NCT02025010|466481438|FG000|Overall Study|Never initiate the treatment|2|||
129596762|NCT01661881|466481440|FG000|Overall Study|Disease Progression|1|||
129596763|NCT00949988|466481445|FG000|Overall Study|Withdrawal by Subject|3|||
129596764|NCT01144403|466481452|FG000|Overall Study|Lost to Follow-up|3|||
129596765|NCT01144403|466481452|FG000|Overall Study|Death|1|||
129596766|NCT01144403|466481452|FG000|Overall Study|Adverse Event|1|||
129596767|NCT00873119|466481462|FG000|Overall Study|Patient request|4|||
129696704|NCT01725308|466848164|FG000|Treatment Period II|Lost to Follow-up|1|||
129696705|NCT01725308|466848165|FG001|Treatment Period II|Lost to Follow-up|5|||
129596768|NCT00873119|466481463|FG001|Overall Study|Patient request|2|||
129596769|NCT00873119|466481462|FG000|Overall Study|Adverse Event|8|||
129596770|NCT00873119|466481463|FG001|Overall Study|Adverse Event|0|||
129596771|NCT00873119|466481462|FG000|Overall Study|Progressive disease|26|||
129596772|NCT00873119|466481463|FG001|Overall Study|Progressive disease|18|||
129596773|NCT00873119|466481462|FG000|Overall Study|Death|2|||
129596774|NCT00873119|466481463|FG001|Overall Study|Death|1|||
129596775|NCT00873119|466481462|FG000|Overall Study|Other|2|||
129596776|NCT00873119|466481463|FG001|Overall Study|Other|5|||
129596777|NCT00873119|466481462|FG000|Overall Study|Not treated|2|||
129596778|NCT00873119|466481463|FG001|Overall Study|Not treated|0|||
129596779|NCT00285584|466481464|FG000|Month 3|Lost to Follow-up|3|||
129596780|NCT00285584|466481465|FG001|Month 3|Lost to Follow-up|3|||
129596781|NCT00285584|466481464|FG000|Month 3|Withdrawal by Subject|1|||
129596782|NCT00285584|466481465|FG001|Month 3|Withdrawal by Subject|0|||
129596783|NCT00285584|466481464|FG000|Month 6|Lost to Follow-up|0|||
129596784|NCT00285584|466481465|FG001|Month 6|Lost to Follow-up|1|||
129596785|NCT00466726|466481466|FG000|Overall Study|Not evaluable for response|14|||
129596786|NCT01376310|466481467|FG000|Overall Study|Study closed/terminated|1|||
129596787|NCT01376310|466481468|FG001|Overall Study|Study closed/terminated|2|||
129596788|NCT01376310|466481467|FG000|Overall Study|Withdrawal by Subject|8|||
129596789|NCT01376310|466481468|FG001|Overall Study|Withdrawal by Subject|2|||
129596790|NCT01376310|466481467|FG000|Overall Study|Physician Decision|26|||
129596791|NCT01376310|466481468|FG001|Overall Study|Physician Decision|7|||
129596792|NCT01376310|466481467|FG000|Overall Study|Lost to Follow-up|1|||
129596793|NCT01376310|466481468|FG001|Overall Study|Lost to Follow-up|0|||
129596794|NCT00645944|466481471|FG000|Randomized|Withdrawal by Subject|1|||
129596795|NCT00645944|466481472|FG001|Randomized|Withdrawal by Subject|2|||
129596796|NCT00645944|466481471|FG000|Received Medication|Adverse Event|2|||
129596797|NCT00645944|466481472|FG001|Received Medication|Adverse Event|1|||
129596798|NCT00645944|466481471|FG000|Received Medication|Withdrawal by Subject|1|||
129596799|NCT00645944|466481472|FG001|Received Medication|Withdrawal by Subject|1|||
129596800|NCT00645944|466481471|FG000|Received Medication|Lost to Follow-up|1|||
129596801|NCT00645944|466481472|FG001|Received Medication|Lost to Follow-up|0|||
129596802|NCT00645944|466481471|FG000|Received Medication|Protocol Violation|2|||
129596803|NCT00645944|466481472|FG001|Received Medication|Protocol Violation|1|||
129596804|NCT02339740|466481473|FG000|Overall Study|Death|1|||
129596805|NCT02339740|466481474|FG001|Overall Study|Death|0|||
129596806|NCT02339740|466481473|FG000|Overall Study|Physician Decision|0|||
129596807|NCT02339740|466481474|FG001|Overall Study|Physician Decision|2|||
129596808|NCT02339740|466481473|FG000|Overall Study|Withdrawal by Subject|5|||
129596809|NCT02339740|466481474|FG001|Overall Study|Withdrawal by Subject|1|||
129596810|NCT02339740|466481473|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
129596811|NCT02339740|466481474|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
129596812|NCT02096588|466481475|FG000|Overall Study|Lack of Efficacy|2|||
129596813|NCT02096588|466481476|FG001|Overall Study|Lack of Efficacy|0|||
129596814|NCT02096588|466481475|FG000|Overall Study|Withdrawal by Subject|0|||
129596815|NCT02096588|466481476|FG001|Overall Study|Withdrawal by Subject|1|||
129596816|NCT01523587|466481477|FG000|Overall Study|Other than listed|5|||
129596817|NCT01523587|466481478|FG001|Overall Study|Other than listed|5|||
129596818|NCT01523587|466481477|FG000|Overall Study|Worsening of underlying cancer disease|19|||
129596819|NCT01523587|466481478|FG001|Overall Study|Worsening of underlying cancer disease|34|||
129596820|NCT01523587|466481477|FG000|Overall Study|Adverse Event|68|||
129596821|NCT01523587|466481478|FG001|Overall Study|Adverse Event|52|||
129596822|NCT01523587|466481477|FG000|Overall Study|Protocol Violation|5|||
129596823|NCT01523587|466481478|FG001|Overall Study|Protocol Violation|3|||
129596824|NCT01523587|466481477|FG000|Overall Study|Lost to Follow-up|2|||
129596825|NCT01523587|466481478|FG001|Overall Study|Lost to Follow-up|2|||
129596826|NCT01523587|466481477|FG000|Overall Study|Withdrawal by Subject|28|||
129596827|NCT01523587|466481478|FG001|Overall Study|Withdrawal by Subject|20|||
129596828|NCT01523587|466481477|FG000|Overall Study|Withdrew due to Progressive disease|265|||
129596829|NCT01523587|466481478|FG001|Overall Study|Withdrew due to Progressive disease|279|||
129596830|NCT01523587|466481477|FG000|Overall Study|Randomised but bot treated|6|||
129596831|NCT01523587|466481478|FG001|Overall Study|Randomised but bot treated|2|||
129596832|NCT01020799|466481494|FG000|Overall Study|Adverse Event|4|||
129596833|NCT01020799|466481495|FG001|Overall Study|Adverse Event|3|||
129596834|NCT01020799|466481496|FG002|Overall Study|Adverse Event|2|||
129596835|NCT01020799|466481494|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
129596836|NCT01020799|466481495|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
129596837|NCT01020799|466481496|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
129596838|NCT01020799|466481494|FG000|Overall Study|Protocol Violation|3|||
129596839|NCT01020799|466481495|FG001|Overall Study|Protocol Violation|2|||
129596840|NCT01020799|466481496|FG002|Overall Study|Protocol Violation|0|||
129596841|NCT01020799|466481494|FG000|Overall Study|Withdrawal by Subject|2|||
129596842|NCT01020799|466481495|FG001|Overall Study|Withdrawal by Subject|2|||
129596843|NCT01020799|466481496|FG002|Overall Study|Withdrawal by Subject|3|||
129596844|NCT01020799|466481494|FG000|Overall Study|Lost to Follow-up|6|||
129596845|NCT01020799|466481495|FG001|Overall Study|Lost to Follow-up|4|||
129596846|NCT01020799|466481496|FG002|Overall Study|Lost to Follow-up|2|||
129596847|NCT02610816|466481497|FG000|Phase 1|Withdrawal by Subject|2|||
129596848|NCT02610816|466481498|FG001|Phase 1|Withdrawal by Subject|6|||
129596849|NCT02610816|466481499|FG002|Phase 1|Withdrawal by Subject|0|||
129596850|NCT02610816|466481500|FG003|Phase 1|Withdrawal by Subject|0|||
129596851|NCT02610816|466481497|FG000|Phase 1|Lost to Follow-up|2|||
129596852|NCT02610816|466481498|FG001|Phase 1|Lost to Follow-up|1|||
129596853|NCT02610816|466481499|FG002|Phase 1|Lost to Follow-up|0|||
129596854|NCT02610816|466481500|FG003|Phase 1|Lost to Follow-up|0|||
129596855|NCT02610816|466481497|FG000|Phase 1|Physician Decision|0|||
129596856|NCT02610816|466481498|FG001|Phase 1|Physician Decision|1|||
129596857|NCT02610816|466481499|FG002|Phase 1|Physician Decision|0|||
129596858|NCT02610816|466481500|FG003|Phase 1|Physician Decision|0|||
129596859|NCT02610816|466481497|FG000|Phase 2|Withdrawal by Subject|0|||
129596860|NCT02610816|466481498|FG001|Phase 2|Withdrawal by Subject|0|||
129596861|NCT02610816|466481499|FG002|Phase 2|Withdrawal by Subject|9|||
129596862|NCT02610816|466481500|FG003|Phase 2|Withdrawal by Subject|3|||
129596863|NCT02610816|466481497|FG000|Phase 2|Lost to Follow-up|0|||
129596864|NCT02610816|466481498|FG001|Phase 2|Lost to Follow-up|0|||
129786518|NCT01011309|467185703|FG001|Overall Study|Adverse Event|1|||
129786519|NCT01011309|467185704|FG002|Overall Study|Adverse Event|2|||
129786520|NCT01011309|467185702|FG000|Overall Study|Lack of Efficacy|0|||
129786521|NCT01011309|467185703|FG001|Overall Study|Lack of Efficacy|1|||
129786522|NCT01011309|467185704|FG002|Overall Study|Lack of Efficacy|0|||
129596865|NCT02610816|466481499|FG002|Phase 2|Lost to Follow-up|2|||
129596866|NCT02610816|466481500|FG003|Phase 2|Lost to Follow-up|0|||
129436266|NCT01249274|465895665|FG001|Overall Study|Received inpatient substance treatment|2|||
129596867|NCT02610816|466481497|FG000|Phase 2|Physician Decision|0|||
129596868|NCT02610816|466481498|FG001|Phase 2|Physician Decision|0|||
129596869|NCT02610816|466481499|FG002|Phase 2|Physician Decision|0|||
129596870|NCT02610816|466481500|FG003|Phase 2|Physician Decision|2|||
129596871|NCT02610816|466481497|FG000|Phase 2|Pregnancy|0|||
129596872|NCT02610816|466481498|FG001|Phase 2|Pregnancy|0|||
129596873|NCT02610816|466481499|FG002|Phase 2|Pregnancy|0|||
129596874|NCT02610816|466481500|FG003|Phase 2|Pregnancy|1|||
129596875|NCT03438227|466481501|FG000|Overall Study|Withdrawal by Subject|10|||
129596876|NCT03438227|466481502|FG001|Overall Study|Withdrawal by Subject|5|||
129436267|NCT00138671|465895666|FG000|Overall Study|Death|0|||
129596877|NCT01855048|466481503|FG000|Overall Study|Withdrawal by Subject|0|||
129596878|NCT01855048|466481504|FG001|Overall Study|Withdrawal by Subject|1|||
129596879|NCT01855048|466481505|FG002|Overall Study|Withdrawal by Subject|0|||
129596880|NCT01855048|466481506|FG003|Overall Study|Withdrawal by Subject|0|||
129596881|NCT01855048|466481507|FG004|Overall Study|Withdrawal by Subject|1|||
129596882|NCT01855048|466481508|FG005|Overall Study|Withdrawal by Subject|0|||
129596883|NCT02691741|466481509|FG000|Overall Study|Adverse Event|0|||
129596884|NCT02691741|466481510|FG001|Overall Study|Adverse Event|2|||
129596885|NCT02691741|466481509|FG000|Overall Study|Lost to Follow-up|1|||
129596886|NCT02691741|466481510|FG001|Overall Study|Lost to Follow-up|0|||
129596887|NCT02691741|466481509|FG000|Overall Study|Physician Decision|0|||
129596888|NCT02691741|466481510|FG001|Overall Study|Physician Decision|1|||
129596889|NCT02691741|466481509|FG000|Overall Study|Withdrawal by Subject|0|||
129596890|NCT02691741|466481510|FG001|Overall Study|Withdrawal by Subject|4|||
129596891|NCT01813071|466481511|FG000|Overall Study|Protocol Violation|0|||
129596892|NCT01813071|466481512|FG001|Overall Study|Protocol Violation|0|||
129596893|NCT01813071|466481513|FG002|Overall Study|Protocol Violation|0|||
129596894|NCT01813071|466481514|FG003|Overall Study|Protocol Violation|0|||
129596895|NCT01813071|466481515|FG004|Overall Study|Protocol Violation|1|||
129596896|NCT01813071|466481516|FG005|Overall Study|Protocol Violation|4|||
129596897|NCT01813071|466481517|FG006|Overall Study|Protocol Violation|2|||
129596898|NCT01813071|466481518|FG007|Overall Study|Protocol Violation|4|||
129596899|NCT01813071|466481519|FG008|Overall Study|Protocol Violation|2|||
129596900|NCT01813071|466481511|FG000|Overall Study|Withdrawal by Subject|0|||
129596901|NCT01813071|466481512|FG001|Overall Study|Withdrawal by Subject|0|||
129596902|NCT01813071|466481513|FG002|Overall Study|Withdrawal by Subject|0|||
129596903|NCT01813071|466481514|FG003|Overall Study|Withdrawal by Subject|0|||
129596904|NCT01813071|466481515|FG004|Overall Study|Withdrawal by Subject|0|||
129596905|NCT01813071|466481516|FG005|Overall Study|Withdrawal by Subject|1|||
129596906|NCT01813071|466481517|FG006|Overall Study|Withdrawal by Subject|0|||
129596907|NCT01813071|466481518|FG007|Overall Study|Withdrawal by Subject|0|||
129596908|NCT01813071|466481519|FG008|Overall Study|Withdrawal by Subject|0|||
129596909|NCT01813071|466481511|FG000|Overall Study|Adverse Event|0|||
129596910|NCT01813071|466481512|FG001|Overall Study|Adverse Event|0|||
129596911|NCT01813071|466481513|FG002|Overall Study|Adverse Event|0|||
129596912|NCT01813071|466481514|FG003|Overall Study|Adverse Event|0|||
129596913|NCT01813071|466481515|FG004|Overall Study|Adverse Event|0|||
129596914|NCT01813071|466481516|FG005|Overall Study|Adverse Event|1|||
129596915|NCT01813071|466481517|FG006|Overall Study|Adverse Event|0|||
129596916|NCT01813071|466481518|FG007|Overall Study|Adverse Event|0|||
129596917|NCT01813071|466481519|FG008|Overall Study|Adverse Event|0|||
129596918|NCT01813071|466481511|FG000|Overall Study|Physician Decision|0|||
129596919|NCT01813071|466481512|FG001|Overall Study|Physician Decision|0|||
129596920|NCT01813071|466481513|FG002|Overall Study|Physician Decision|0|||
129596921|NCT01813071|466481514|FG003|Overall Study|Physician Decision|0|||
129596922|NCT01813071|466481515|FG004|Overall Study|Physician Decision|0|||
129596923|NCT01813071|466481516|FG005|Overall Study|Physician Decision|0|||
129596924|NCT01813071|466481517|FG006|Overall Study|Physician Decision|1|||
129596925|NCT01813071|466481518|FG007|Overall Study|Physician Decision|0|||
129596926|NCT01813071|466481519|FG008|Overall Study|Physician Decision|0|||
129596927|NCT01813071|466481511|FG000|Overall Study|Met inc/exc criteria|0|||
129596928|NCT01813071|466481512|FG001|Overall Study|Met inc/exc criteria|0|||
129596929|NCT01813071|466481513|FG002|Overall Study|Met inc/exc criteria|0|||
129596930|NCT01813071|466481514|FG003|Overall Study|Met inc/exc criteria|0|||
129596931|NCT01813071|466481515|FG004|Overall Study|Met inc/exc criteria|0|||
129596932|NCT01813071|466481516|FG005|Overall Study|Met inc/exc criteria|1|||
129786523|NCT01011309|467185702|FG000|Overall Study|Protocol Violation|0|||
129436268|NCT00138671|465895667|FG001|Overall Study|Death|3|||
129436269|NCT00138671|465895666|FG000|Overall Study|Adverse Event|6|||
129596933|NCT01813071|466481517|FG006|Overall Study|Met inc/exc criteria|0|||
129596934|NCT01813071|466481518|FG007|Overall Study|Met inc/exc criteria|1|||
129596935|NCT01813071|466481519|FG008|Overall Study|Met inc/exc criteria|1|||
129596936|NCT01425528|466481520|FG000|Overall Study|Withdrawal by Subject|1|||
129596937|NCT01425528|466481521|FG001|Overall Study|Withdrawal by Subject|1|||
129596938|NCT00842530|466481522|FG000|Overall Study|Serious adverse event|0|||
129596939|NCT00842530|466481523|FG001|Overall Study|Serious adverse event|6|||
129786524|NCT01011309|467185703|FG001|Overall Study|Protocol Violation|1|||
129786525|NCT01011309|467185704|FG002|Overall Study|Protocol Violation|3|||
129436270|NCT00138671|465895667|FG001|Overall Study|Adverse Event|3|||
129596940|NCT00842530|466481522|FG000|Overall Study|Other adverse event|6|||
129596941|NCT00842530|466481523|FG001|Overall Study|Other adverse event|1|||
129596942|NCT00842530|466481522|FG000|Overall Study|Protocol Violation|32|||
129596943|NCT00842530|466481523|FG001|Overall Study|Protocol Violation|14|||
129596944|NCT00842530|466481522|FG000|Overall Study|Lost to Follow-up|6|||
129596945|NCT00842530|466481523|FG001|Overall Study|Lost to Follow-up|8|||
129596946|NCT00842530|466481522|FG000|Overall Study|Withdrawal by Subject|73|||
129596947|NCT00842530|466481523|FG001|Overall Study|Withdrawal by Subject|28|||
129786526|NCT00831493|467185705|FG000|Overall Study|Intractable nausea and vomiting|1|||
129596948|NCT02939950|466481524|FG000|Overall Study|Lost to Follow-up|13|||
129596949|NCT02939950|466481525|FG001|Overall Study|Lost to Follow-up|16|||
129596950|NCT02939950|466481524|FG000|Overall Study|Positive slit lamp findings|0|||
129596951|NCT02939950|466481525|FG001|Overall Study|Positive slit lamp findings|1|||
129596952|NCT02939950|466481524|FG000|Overall Study|Chalazion upper lid|0|||
129596953|NCT02939950|466481525|FG001|Overall Study|Chalazion upper lid|1|||
129596954|NCT02939950|466481524|FG000|Overall Study|Lack of motivation|0|||
129596955|NCT02939950|466481525|FG001|Overall Study|Lack of motivation|2|||
129596956|NCT02939950|466481524|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
129596957|NCT02939950|466481525|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
129596958|NCT02939950|466481524|FG000|Overall Study|Military orders|1|||
129596959|NCT02939950|466481525|FG001|Overall Study|Military orders|0|||
129596960|NCT02939950|466481524|FG000|Overall Study|Participant Relocated|5|||
129596961|NCT02939950|466481525|FG001|Overall Study|Participant Relocated|3|||
129596962|NCT02939950|466481524|FG000|Overall Study|Study related symptoms|8|||
129596963|NCT02939950|466481525|FG001|Overall Study|Study related symptoms|8|||
129596964|NCT02939950|466481524|FG000|Overall Study|Unacceptable lens movement|2|||
129596965|NCT02939950|466481525|FG001|Overall Study|Unacceptable lens movement|0|||
129596966|NCT02939950|466481524|FG000|Overall Study|Protocol Violation|6|||
129596967|NCT02939950|466481525|FG001|Overall Study|Protocol Violation|3|||
129596968|NCT02939950|466481524|FG000|Overall Study|Physician Decision|2|||
129596969|NCT02939950|466481525|FG001|Overall Study|Physician Decision|0|||
129596970|NCT02939950|466481524|FG000|Overall Study|Pregnancy|6|||
129596971|NCT02939950|466481525|FG001|Overall Study|Pregnancy|7|||
129596972|NCT02939950|466481524|FG000|Overall Study|Withdrawal by Subject|12|||
129596973|NCT02939950|466481525|FG001|Overall Study|Withdrawal by Subject|28|||
129596974|NCT02939950|466481524|FG000|Overall Study|Adverse Event|7|||
129596975|NCT02939950|466481525|FG001|Overall Study|Adverse Event|3|||
129596976|NCT02939950|466481524|FG000|Overall Study|Randomized, not dispensed|1|||
129596977|NCT02939950|466481525|FG001|Overall Study|Randomized, not dispensed|0|||
129596978|NCT02939950|466481524|FG000|Overall Study|Ineligible at Baseline|2|||
129596979|NCT02939950|466481525|FG001|Overall Study|Ineligible at Baseline|8|||
129596980|NCT02243293|466481529|FG000|Overall Study|Adverse Event|1|||
129596981|NCT02243293|466481530|FG001|Overall Study|Adverse Event|0|||
129596982|NCT02243293|466481531|FG002|Overall Study|Adverse Event|0|||
129596983|NCT02243293|466481532|FG003|Overall Study|Adverse Event|0|||
129596984|NCT02243293|466481533|FG004|Overall Study|Adverse Event|0|||
129596985|NCT02243293|466481534|FG005|Overall Study|Adverse Event|0|||
129596986|NCT02243293|466481535|FG006|Overall Study|Adverse Event|0|||
129596987|NCT02243293|466481536|FG007|Overall Study|Adverse Event|0|||
129596988|NCT02243293|466481537|FG008|Overall Study|Adverse Event|0|||
129596989|NCT02243293|466481538|FG009|Overall Study|Adverse Event|0|||
129596990|NCT02243293|466481539|FG010|Overall Study|Adverse Event|0|||
129596991|NCT02243293|466481540|FG011|Overall Study|Adverse Event|0|||
129596992|NCT02243293|466481541|FG012|Overall Study|Adverse Event|0|||
129596993|NCT02243293|466481542|FG013|Overall Study|Adverse Event|0|||
129596994|NCT02243293|466481543|FG014|Overall Study|Adverse Event|0|||
129596995|NCT02243293|466481544|FG015|Overall Study|Adverse Event|1|||
129596996|NCT02243293|466481545|FG016|Overall Study|Adverse Event|0|||
129596997|NCT02243293|466481546|FG017|Overall Study|Adverse Event|0|||
129596998|NCT02243293|466481547|FG018|Overall Study|Adverse Event|0|||
129596999|NCT02243293|466481548|FG019|Overall Study|Adverse Event|0|||
129597000|NCT02243293|466481549|FG020|Overall Study|Adverse Event|1|||
129597001|NCT02243293|466481550|FG021|Overall Study|Adverse Event|0|||
129597002|NCT02243293|466481529|FG000|Overall Study|Withdrawal by Subject|1|||
129597003|NCT02243293|466481530|FG001|Overall Study|Withdrawal by Subject|0|||
129597004|NCT02243293|466481531|FG002|Overall Study|Withdrawal by Subject|0|||
129597005|NCT02243293|466481532|FG003|Overall Study|Withdrawal by Subject|0|||
129786527|NCT03976648|467185714|FG000|Overall Study|Adverse Event|0|||
129786528|NCT03976648|467185715|FG001|Overall Study|Adverse Event|2|||
129786529|NCT03976648|467185714|FG000|Overall Study|Study terminated by sponsor|21|||
129786530|NCT03976648|467185715|FG001|Overall Study|Study terminated by sponsor|8|||
129786531|NCT01981551|467185716|FG000|Overall Study|Refused further treatment|8|||
129786532|NCT01981551|467185716|FG000|Overall Study|Adverse Event|1|||
129786533|NCT00960570|467185717|FG000|21 Day Washout Period|Adverse Event|1|||
129885635|NCT02855164|467540777|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
129597006|NCT02243293|466481533|FG004|Overall Study|Withdrawal by Subject|0|||
129597007|NCT02243293|466481534|FG005|Overall Study|Withdrawal by Subject|0|||
129597008|NCT02243293|466481535|FG006|Overall Study|Withdrawal by Subject|0|||
129597009|NCT02243293|466481536|FG007|Overall Study|Withdrawal by Subject|0|||
129597010|NCT02243293|466481537|FG008|Overall Study|Withdrawal by Subject|0|||
129597011|NCT02243293|466481538|FG009|Overall Study|Withdrawal by Subject|1|||
129597012|NCT02243293|466481539|FG010|Overall Study|Withdrawal by Subject|0|||
129597013|NCT02243293|466481540|FG011|Overall Study|Withdrawal by Subject|1|||
129786534|NCT00960570|467185717|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
129597014|NCT02243293|466481541|FG012|Overall Study|Withdrawal by Subject|0|||
129597015|NCT02243293|466481542|FG013|Overall Study|Withdrawal by Subject|0|||
129786535|NCT00960570|467185717|FG000|1 Day Period Between Dosing|Adverse Event|2|||
129597016|NCT02243293|466481543|FG014|Overall Study|Withdrawal by Subject|0|||
129597017|NCT02243293|466481544|FG015|Overall Study|Withdrawal by Subject|0|||
129597018|NCT02243293|466481545|FG016|Overall Study|Withdrawal by Subject|0|||
129597019|NCT02243293|466481546|FG017|Overall Study|Withdrawal by Subject|0|||
129597020|NCT02243293|466481547|FG018|Overall Study|Withdrawal by Subject|0|||
129597021|NCT02243293|466481548|FG019|Overall Study|Withdrawal by Subject|0|||
129597022|NCT02243293|466481549|FG020|Overall Study|Withdrawal by Subject|0|||
129597023|NCT02243293|466481550|FG021|Overall Study|Withdrawal by Subject|1|||
129597024|NCT02243293|466481529|FG000|Overall Study|Lost to Follow-up|0|||
129597025|NCT02243293|466481530|FG001|Overall Study|Lost to Follow-up|1|||
129597026|NCT02243293|466481531|FG002|Overall Study|Lost to Follow-up|1|||
129597027|NCT02243293|466481532|FG003|Overall Study|Lost to Follow-up|1|||
129597028|NCT02243293|466481533|FG004|Overall Study|Lost to Follow-up|0|||
129597029|NCT02243293|466481534|FG005|Overall Study|Lost to Follow-up|0|||
129597030|NCT02243293|466481535|FG006|Overall Study|Lost to Follow-up|3|||
129597031|NCT02243293|466481536|FG007|Overall Study|Lost to Follow-up|0|||
129597032|NCT02243293|466481537|FG008|Overall Study|Lost to Follow-up|0|||
129597033|NCT02243293|466481538|FG009|Overall Study|Lost to Follow-up|0|||
129597034|NCT02243293|466481539|FG010|Overall Study|Lost to Follow-up|0|||
129597035|NCT02243293|466481540|FG011|Overall Study|Lost to Follow-up|2|||
129597036|NCT02243293|466481541|FG012|Overall Study|Lost to Follow-up|0|||
129597037|NCT02243293|466481542|FG013|Overall Study|Lost to Follow-up|0|||
129597038|NCT02243293|466481543|FG014|Overall Study|Lost to Follow-up|0|||
129597039|NCT02243293|466481544|FG015|Overall Study|Lost to Follow-up|0|||
129597040|NCT02243293|466481545|FG016|Overall Study|Lost to Follow-up|3|||
129597041|NCT02243293|466481546|FG017|Overall Study|Lost to Follow-up|1|||
129597042|NCT02243293|466481547|FG018|Overall Study|Lost to Follow-up|0|||
129597043|NCT02243293|466481548|FG019|Overall Study|Lost to Follow-up|0|||
129597044|NCT02243293|466481549|FG020|Overall Study|Lost to Follow-up|1|||
129597045|NCT02243293|466481550|FG021|Overall Study|Lost to Follow-up|2|||
129597046|NCT02243293|466481529|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
129597047|NCT02243293|466481530|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
129597048|NCT02243293|466481531|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
129597049|NCT02243293|466481532|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
129597050|NCT02243293|466481533|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
129597051|NCT02243293|466481534|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
129597052|NCT02243293|466481535|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
129597053|NCT02243293|466481536|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
129597054|NCT02243293|466481537|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
129597055|NCT02243293|466481538|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
129597056|NCT02243293|466481539|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
129597057|NCT02243293|466481540|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
129597058|NCT02243293|466481541|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
129597059|NCT02243293|466481542|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
129597060|NCT02243293|466481543|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
129597061|NCT02243293|466481544|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
129597062|NCT02243293|466481545|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
129597063|NCT02243293|466481546|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
129597064|NCT02243293|466481547|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
129597065|NCT02243293|466481548|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
129597066|NCT02243293|466481549|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
129597067|NCT02243293|466481550|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
129597068|NCT02243293|466481529|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
129597069|NCT02243293|466481530|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
129597070|NCT02243293|466481531|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
129597071|NCT02243293|466481532|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
129597072|NCT02243293|466481533|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
129597073|NCT02243293|466481534|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
129597074|NCT02243293|466481535|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
129597075|NCT02243293|466481536|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
129597076|NCT02243293|466481537|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
129597077|NCT02243293|466481538|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
129597078|NCT02243293|466481539|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
129597079|NCT02243293|466481540|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
129597080|NCT02243293|466481541|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
129597081|NCT02243293|466481542|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
129597082|NCT02243293|466481543|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
129597083|NCT02243293|466481544|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
129597084|NCT02243293|466481545|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
129597085|NCT02243293|466481546|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
129597086|NCT02243293|466481547|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
129597087|NCT02243293|466481548|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
129786536|NCT00960570|467185717|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
129436271|NCT00138671|465895666|FG000|Overall Study|Lost to Follow-up|1|||
129436272|NCT00138671|465895667|FG001|Overall Study|Lost to Follow-up|2|||
129436273|NCT00138671|465895666|FG000|Overall Study|Withdrawal by Subject|3|||
129436274|NCT00138671|465895667|FG001|Overall Study|Withdrawal by Subject|5|||
129436275|NCT00138671|465895666|FG000|Overall Study|Other|3|||
129436276|NCT00138671|465895667|FG001|Overall Study|Other|3|||
129597088|NCT02243293|466481549|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
129597089|NCT02243293|466481550|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
129597090|NCT02985879|466481555|FG000|Overall Study|Adverse Event|7|||
129597091|NCT02985879|466481556|FG001|Overall Study|Adverse Event|9|||
129597092|NCT02985879|466481557|FG002|Overall Study|Adverse Event|7|||
129597093|NCT02985879|466481555|FG000|Overall Study|Withdrew consent|6|||
129597094|NCT02985879|466481556|FG001|Overall Study|Withdrew consent|8|||
129597095|NCT02985879|466481557|FG002|Overall Study|Withdrew consent|10|||
129597096|NCT02985879|466481555|FG000|Overall Study|Lost to Follow-up|1|||
129597097|NCT02985879|466481556|FG001|Overall Study|Lost to Follow-up|0|||
129597098|NCT02985879|466481557|FG002|Overall Study|Lost to Follow-up|2|||
129597099|NCT02985879|466481555|FG000|Overall Study|Other, not specified|62|||
129597100|NCT02985879|466481556|FG001|Overall Study|Other, not specified|58|||
129597101|NCT02985879|466481557|FG002|Overall Study|Other, not specified|58|||
129597102|NCT04974619|466483068|FG000|Overall Study|Lost to Follow-up|0|||
129597103|NCT04974619|466483069|FG001|Overall Study|Lost to Follow-up|0|||
129436277|NCT01952054|465895668|FG000|Overall Study|Physician Decision|1|||
129436278|NCT01100034|465895669|FG000|Overall Study|Lost to Follow-up|11|||
129436279|NCT01100034|465895669|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
129436280|NCT01100034|465895669|FG000|Overall Study|Withdrawal by Subject|4|||
129436281|NCT01100034|465895669|FG000|Overall Study|Sponsor decision|21|||
129597104|NCT04974619|466483070|FG002|Overall Study|Lost to Follow-up|1|||
129597105|NCT04974619|466483068|FG000|Overall Study|Withdrawal by Subject|0|||
129597106|NCT04974619|466483069|FG001|Overall Study|Withdrawal by Subject|0|||
129597107|NCT04974619|466483070|FG002|Overall Study|Withdrawal by Subject|1|||
129597108|NCT04974619|466483068|FG000|Overall Study|Protocol Violation|0|||
129597109|NCT04974619|466483069|FG001|Overall Study|Protocol Violation|1|||
129597110|NCT04974619|466483070|FG002|Overall Study|Protocol Violation|0|||
129597111|NCT00493779|466483077|FG000|Overall Study|Logistical issue at site|1|||
129597112|NCT01885182|466483079|FG000|Overall Study|Adverse Event|11|||
129597113|NCT01885182|466483080|FG001|Overall Study|Adverse Event|13|||
129597114|NCT01885182|466483079|FG000|Overall Study|Withdrawal by Subject|13|||
129597115|NCT01885182|466483080|FG001|Overall Study|Withdrawal by Subject|6|||
129597116|NCT01885182|466483079|FG000|Overall Study|Lost to Follow-up|2|||
129597117|NCT01885182|466483080|FG001|Overall Study|Lost to Follow-up|2|||
129597118|NCT01885182|466483079|FG000|Overall Study|Lack of Efficacy|8|||
129597119|NCT01885182|466483080|FG001|Overall Study|Lack of Efficacy|1|||
129597120|NCT01207440|466483087|FG000|Overall Study|Adverse Event|46|||
129597121|NCT01207440|466483088|FG001|Overall Study|Adverse Event|11|||
129597122|NCT01207440|466483089|FG002|Overall Study|Adverse Event|7|||
129597123|NCT01207440|466483090|FG003|Overall Study|Adverse Event|2|||
129597124|NCT01207440|466483091|FG004|Overall Study|Adverse Event|6|||
129597125|NCT01207440|466483092|FG005|Overall Study|Adverse Event|6|||
129597126|NCT01207440|466483093|FG006|Overall Study|Adverse Event|2|||
129597127|NCT01207440|466483087|FG000|Overall Study|Death|6|||
129597128|NCT01207440|466483088|FG001|Overall Study|Death|3|||
129597129|NCT01207440|466483089|FG002|Overall Study|Death|2|||
129597130|NCT01207440|466483090|FG003|Overall Study|Death|2|||
129597131|NCT01207440|466483091|FG004|Overall Study|Death|7|||
129597132|NCT01207440|466483092|FG005|Overall Study|Death|5|||
129597133|NCT01207440|466483093|FG006|Overall Study|Death|1|||
129597134|NCT01207440|466483087|FG000|Overall Study|Lack of Efficacy|13|||
129597135|NCT01207440|466483088|FG001|Overall Study|Lack of Efficacy|2|||
129597136|NCT01207440|466483089|FG002|Overall Study|Lack of Efficacy|5|||
129597137|NCT01207440|466483090|FG003|Overall Study|Lack of Efficacy|1|||
129597138|NCT01207440|466483091|FG004|Overall Study|Lack of Efficacy|2|||
129597139|NCT01207440|466483092|FG005|Overall Study|Lack of Efficacy|3|||
129597140|NCT01207440|466483093|FG006|Overall Study|Lack of Efficacy|0|||
129597141|NCT01207440|466483087|FG000|Overall Study|Lost to Follow-up|0|||
129597142|NCT01207440|466483088|FG001|Overall Study|Lost to Follow-up|0|||
129597143|NCT01207440|466483089|FG002|Overall Study|Lost to Follow-up|2|||
129597144|NCT01207440|466483090|FG003|Overall Study|Lost to Follow-up|1|||
129597145|NCT01207440|466483091|FG004|Overall Study|Lost to Follow-up|0|||
129597146|NCT01207440|466483092|FG005|Overall Study|Lost to Follow-up|0|||
129597147|NCT01207440|466483093|FG006|Overall Study|Lost to Follow-up|0|||
129597148|NCT01207440|466483087|FG000|Overall Study|Non-compliance with Study Drug|3|||
129597149|NCT01207440|466483088|FG001|Overall Study|Non-compliance with Study Drug|0|||
129597150|NCT01207440|466483089|FG002|Overall Study|Non-compliance with Study Drug|1|||
129597151|NCT01207440|466483090|FG003|Overall Study|Non-compliance with Study Drug|0|||
129597152|NCT01207440|466483091|FG004|Overall Study|Non-compliance with Study Drug|0|||
129696706|NCT01725308|466848166|FG002|Treatment Period II|Lost to Follow-up|3|||
129696707|NCT01725308|466848164|FG000|Treatment Period II|Protocol Deviations|0|||
129696708|NCT01725308|466848165|FG001|Treatment Period II|Protocol Deviations|0|||
129696709|NCT01725308|466848166|FG002|Treatment Period II|Protocol Deviations|1|||
129696710|NCT01725308|466848164|FG000|Treatment Period II|Miscellaneous|5|||
129696711|NCT01725308|466848165|FG001|Treatment Period II|Miscellaneous|3|||
129696712|NCT01725308|466848166|FG002|Treatment Period II|Miscellaneous|7|||
129696713|NCT03511209|466848170|FG000|Overall Study|Withdrawal by Subject|2|||
129696714|NCT03511209|466848171|FG001|Overall Study|Withdrawal by Subject|4|||
129696715|NCT03511209|466848170|FG000|Overall Study|Death|1|||
129696716|NCT03511209|466848171|FG001|Overall Study|Death|0|||
129696717|NCT03511209|466848170|FG000|Overall Study|Lost to Follow-up|0|||
129696718|NCT03511209|466848171|FG001|Overall Study|Lost to Follow-up|2|||
129696719|NCT00401830|466848175|FG000|Overall Study|Adverse Event|10|||
129696720|NCT00401830|466848176|FG001|Overall Study|Adverse Event|18|||
129696721|NCT00401830|466848175|FG000|Overall Study|Lack of Efficacy|11|||
129696722|NCT00401830|466848176|FG001|Overall Study|Lack of Efficacy|5|||
129696723|NCT00401830|466848175|FG000|Overall Study|Withdrawal by Subject|4|||
129696724|NCT00401830|466848176|FG001|Overall Study|Withdrawal by Subject|3|||
129696725|NCT00401830|466848175|FG000|Overall Study|Protocol Violation|3|||
129696726|NCT00401830|466848176|FG001|Overall Study|Protocol Violation|3|||
129696727|NCT00401830|466848175|FG000|Overall Study|Non-compliance with drug study|1|||
129696728|NCT00401830|466848176|FG001|Overall Study|Non-compliance with drug study|0|||
129696729|NCT00401830|466848175|FG000|Overall Study|Lost to Follow-up|1|||
129696730|NCT00401830|466848176|FG001|Overall Study|Lost to Follow-up|3|||
129696731|NCT00401830|466848175|FG000|Overall Study|Other: Personal / Family problems|1|||
129696732|NCT00401830|466848176|FG001|Overall Study|Other: Personal / Family problems|0|||
129696733|NCT03378635|466848179|FG000|Overall Study|Adverse Event|1|||
129696734|NCT03378635|466848180|FG001|Overall Study|Adverse Event|0|||
129696735|NCT03378635|466848181|FG002|Overall Study|Adverse Event|0|||
129696736|NCT03378635|466848179|FG000|Overall Study|Withdrawal by Subject|1|||
129696737|NCT03378635|466848180|FG001|Overall Study|Withdrawal by Subject|0|||
129696738|NCT03378635|466848181|FG002|Overall Study|Withdrawal by Subject|0|||
129696739|NCT01316900|466848185|FG000|Overall Study|Adverse Event|10|||
129696740|NCT01316900|466848186|FG001|Overall Study|Adverse Event|10|||
129696741|NCT01316900|466848187|FG002|Overall Study|Adverse Event|15|||
129696742|NCT01316900|466848188|FG003|Overall Study|Adverse Event|9|||
129696743|NCT01316900|466848185|FG000|Overall Study|Lack of Efficacy|17|||
129696744|NCT01316900|466848186|FG001|Overall Study|Lack of Efficacy|9|||
129696745|NCT01316900|466848187|FG002|Overall Study|Lack of Efficacy|5|||
129696746|NCT01316900|466848188|FG003|Overall Study|Lack of Efficacy|7|||
129696747|NCT01316900|466848185|FG000|Overall Study|Protocol Violation|7|||
129696748|NCT01316900|466848186|FG001|Overall Study|Protocol Violation|1|||
129696749|NCT01316900|466848187|FG002|Overall Study|Protocol Violation|4|||
129696750|NCT01316900|466848188|FG003|Overall Study|Protocol Violation|0|||
129696751|NCT01316900|466848185|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
129696752|NCT01316900|466848186|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
129696753|NCT01316900|466848187|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
129696754|NCT01316900|466848188|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
129696755|NCT01316900|466848185|FG000|Overall Study|Lost to Follow-up|1|||
129696756|NCT01316900|466848186|FG001|Overall Study|Lost to Follow-up|0|||
129696757|NCT01316900|466848187|FG002|Overall Study|Lost to Follow-up|1|||
129696758|NCT01316900|466848188|FG003|Overall Study|Lost to Follow-up|1|||
129696759|NCT01316900|466848185|FG000|Overall Study|Withdrawal by Subject|7|||
129696760|NCT01316900|466848186|FG001|Overall Study|Withdrawal by Subject|8|||
129696761|NCT01316900|466848187|FG002|Overall Study|Withdrawal by Subject|6|||
129696762|NCT01316900|466848188|FG003|Overall Study|Withdrawal by Subject|9|||
129696763|NCT01684033|466848189|FG000|Period 1, First 30 Days|Adverse Event|1|||
129696764|NCT01684033|466848190|FG001|Period 1, First 30 Days|Adverse Event|1|||
129696765|NCT01684033|466848189|FG000|Period 1, First 30 Days|Noncompliance|1|||
129696766|NCT01684033|466848190|FG001|Period 1, First 30 Days|Noncompliance|0|||
129696767|NCT01684033|466848189|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
129696768|NCT01684033|466848190|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
129696769|NCT01684033|466848189|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
129696770|NCT01684033|466848190|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
129696771|NCT01684033|466848189|FG000|Period 2, Second 30 Days|Adverse Event|1|||
129696772|NCT01684033|466848190|FG001|Period 2, Second 30 Days|Adverse Event|0|||
129696773|NCT02496156|466848191|FG000|Overall Study|Lost to Follow-up|5|||
129696774|NCT02496156|466848192|FG001|Overall Study|Lost to Follow-up|0|||
129696775|NCT02496156|466848191|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
129696776|NCT02496156|466848192|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
129696777|NCT00089583|466848193|FG000|Overall Study|Adverse Event|0|||
129696778|NCT00089583|466848194|FG001|Overall Study|Adverse Event|3|||
129597153|NCT01207440|466483092|FG005|Overall Study|Non-compliance with Study Drug|0|||
129597154|NCT01207440|466483093|FG006|Overall Study|Non-compliance with Study Drug|0|||
129597155|NCT01207440|466483087|FG000|Overall Study|Physician Decision|6|||
129597156|NCT01207440|466483088|FG001|Overall Study|Physician Decision|5|||
129597157|NCT01207440|466483089|FG002|Overall Study|Physician Decision|5|||
129597158|NCT01207440|466483090|FG003|Overall Study|Physician Decision|0|||
129597159|NCT01207440|466483091|FG004|Overall Study|Physician Decision|1|||
129597160|NCT01207440|466483092|FG005|Overall Study|Physician Decision|0|||
129597161|NCT01207440|466483093|FG006|Overall Study|Physician Decision|0|||
129597162|NCT01207440|466483087|FG000|Overall Study|Progressive Disease|19|||
129597163|NCT01207440|466483088|FG001|Overall Study|Progressive Disease|10|||
129597164|NCT01207440|466483089|FG002|Overall Study|Progressive Disease|19|||
129597165|NCT01207440|466483090|FG003|Overall Study|Progressive Disease|7|||
129597166|NCT01207440|466483091|FG004|Overall Study|Progressive Disease|23|||
129597167|NCT01207440|466483092|FG005|Overall Study|Progressive Disease|27|||
129597168|NCT01207440|466483093|FG006|Overall Study|Progressive Disease|0|||
129597169|NCT01207440|466483087|FG000|Overall Study|Protocol Violation|2|||
129597170|NCT01207440|466483088|FG001|Overall Study|Protocol Violation|0|||
129597171|NCT01207440|466483089|FG002|Overall Study|Protocol Violation|0|||
129597172|NCT01207440|466483090|FG003|Overall Study|Protocol Violation|0|||
129597173|NCT01207440|466483091|FG004|Overall Study|Protocol Violation|0|||
129597174|NCT01207440|466483092|FG005|Overall Study|Protocol Violation|0|||
129597175|NCT01207440|466483093|FG006|Overall Study|Protocol Violation|0|||
129597176|NCT01207440|466483087|FG000|Overall Study|Site Terminated by Sponsor|69|||
129597177|NCT01207440|466483088|FG001|Overall Study|Site Terminated by Sponsor|19|||
129597178|NCT01207440|466483089|FG002|Overall Study|Site Terminated by Sponsor|12|||
129597179|NCT01207440|466483090|FG003|Overall Study|Site Terminated by Sponsor|2|||
129597180|NCT01207440|466483091|FG004|Overall Study|Site Terminated by Sponsor|3|||
129597181|NCT01207440|466483092|FG005|Overall Study|Site Terminated by Sponsor|0|||
129597182|NCT01207440|466483093|FG006|Overall Study|Site Terminated by Sponsor|2|||
129597183|NCT01207440|466483087|FG000|Overall Study|Withdrawal by Subject|29|||
129597184|NCT01207440|466483088|FG001|Overall Study|Withdrawal by Subject|4|||
129597185|NCT01207440|466483089|FG002|Overall Study|Withdrawal by Subject|5|||
129597186|NCT01207440|466483090|FG003|Overall Study|Withdrawal by Subject|3|||
129597187|NCT01207440|466483091|FG004|Overall Study|Withdrawal by Subject|2|||
129597188|NCT01207440|466483092|FG005|Overall Study|Withdrawal by Subject|2|||
129597189|NCT01207440|466483093|FG006|Overall Study|Withdrawal by Subject|0|||
129597190|NCT01207440|466483087|FG000|Overall Study|Reason Not Specified|10|||
129597191|NCT01207440|466483088|FG001|Overall Study|Reason Not Specified|10|||
129597192|NCT01207440|466483089|FG002|Overall Study|Reason Not Specified|7|||
129597193|NCT01207440|466483090|FG003|Overall Study|Reason Not Specified|0|||
129597194|NCT01207440|466483091|FG004|Overall Study|Reason Not Specified|4|||
129597195|NCT01207440|466483092|FG005|Overall Study|Reason Not Specified|3|||
129597196|NCT01207440|466483093|FG006|Overall Study|Reason Not Specified|0|||
129597197|NCT01592721|466483094|FG000|Long-term Follow-up|Death|1|||
129597198|NCT02516410|466483095|FG000|Overall Study|Adverse Event|0|||
129597199|NCT02516410|466483096|FG001|Overall Study|Adverse Event|1|||
129597200|NCT02516410|466483095|FG000|Overall Study|Withdrawal by Subject|0|||
129597201|NCT02516410|466483096|FG001|Overall Study|Withdrawal by Subject|1|||
129597202|NCT01432574|466483097|FG000|Overall Study|Moved|2|||
129597203|NCT01432574|466483097|FG000|Overall Study|Not interested|1|||
129597204|NCT01475253|466483103|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
129597205|NCT01475253|466483104|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
129597206|NCT01475253|466483105|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
129597207|NCT01475253|466483106|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
129597208|NCT01475253|466483103|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
129597209|NCT01475253|466483104|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
129597210|NCT01475253|466483105|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
129597211|NCT01475253|466483106|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
129597212|NCT03135899|466483107|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597213|NCT03135899|466483108|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597214|NCT03135899|466483109|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597215|NCT03135899|466483110|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597216|NCT03135899|466483111|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597217|NCT03135899|466483112|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597218|NCT03135899|466483113|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
129597219|NCT03135899|466483114|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
129597220|NCT03135899|466483107|FG000|Overall Study|Withdrawal by Subject|0|||
129597221|NCT03135899|466483108|FG001|Overall Study|Withdrawal by Subject|0|||
129885636|NCT02855164|467540778|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
129597222|NCT03135899|466483109|FG002|Overall Study|Withdrawal by Subject|0|||
129597223|NCT03135899|466483110|FG003|Overall Study|Withdrawal by Subject|0|||
129597224|NCT03135899|466483111|FG004|Overall Study|Withdrawal by Subject|0|||
129597225|NCT03135899|466483112|FG005|Overall Study|Withdrawal by Subject|2|||
129597226|NCT03135899|466483113|FG006|Overall Study|Withdrawal by Subject|0|||
129597227|NCT03135899|466483114|FG007|Overall Study|Withdrawal by Subject|0|||
129597228|NCT04146363|466483115|FG000|Induction Period|Adverse Event|1|||
129597229|NCT04146363|466483116|FG001|Induction Period|Adverse Event|2|||
129597230|NCT04146363|466483117|FG002|Induction Period|Adverse Event|0|||
129597231|NCT04146363|466483118|FG003|Induction Period|Adverse Event|0|||
129597232|NCT04146363|466483119|FG004|Induction Period|Adverse Event|0|||
129597233|NCT04146363|466483120|FG005|Induction Period|Adverse Event|0|||
129597234|NCT04146363|466483121|FG006|Induction Period|Adverse Event|0|||
129597235|NCT04146363|466483122|FG007|Induction Period|Adverse Event|0|||
129597236|NCT04146363|466483123|FG008|Induction Period|Adverse Event|0|||
129597237|NCT04146363|466483124|FG009|Induction Period|Adverse Event|0|||
129597238|NCT04146363|466483125|FG010|Induction Period|Adverse Event|0|||
129597239|NCT04146363|466483115|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
129597240|NCT04146363|466483116|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
129597241|NCT04146363|466483117|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
129597242|NCT04146363|466483118|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
129597243|NCT04146363|466483119|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
129597244|NCT04146363|466483120|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
129597245|NCT04146363|466483121|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
129597246|NCT04146363|466483122|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
129597247|NCT04146363|466483123|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
129597248|NCT04146363|466483124|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
129597249|NCT04146363|466483125|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
129597250|NCT04146363|466483115|FG000|Induction Period|Lack of Efficacy|7|||
129597251|NCT04146363|466483116|FG001|Induction Period|Lack of Efficacy|2|||
129597252|NCT04146363|466483117|FG002|Induction Period|Lack of Efficacy|0|||
129597253|NCT04146363|466483118|FG003|Induction Period|Lack of Efficacy|0|||
129597254|NCT04146363|466483119|FG004|Induction Period|Lack of Efficacy|0|||
129597255|NCT04146363|466483120|FG005|Induction Period|Lack of Efficacy|0|||
129597256|NCT04146363|466483121|FG006|Induction Period|Lack of Efficacy|0|||
129597257|NCT04146363|466483122|FG007|Induction Period|Lack of Efficacy|0|||
129597258|NCT04146363|466483123|FG008|Induction Period|Lack of Efficacy|0|||
129597259|NCT04146363|466483124|FG009|Induction Period|Lack of Efficacy|0|||
129597260|NCT04146363|466483125|FG010|Induction Period|Lack of Efficacy|0|||
129597261|NCT04146363|466483115|FG000|Induction Period|Lost to Follow-up|1|||
129597262|NCT04146363|466483116|FG001|Induction Period|Lost to Follow-up|4|||
129597263|NCT04146363|466483117|FG002|Induction Period|Lost to Follow-up|0|||
129597264|NCT04146363|466483118|FG003|Induction Period|Lost to Follow-up|0|||
129597265|NCT04146363|466483119|FG004|Induction Period|Lost to Follow-up|0|||
129597266|NCT04146363|466483120|FG005|Induction Period|Lost to Follow-up|0|||
129597267|NCT04146363|466483121|FG006|Induction Period|Lost to Follow-up|0|||
129597268|NCT04146363|466483122|FG007|Induction Period|Lost to Follow-up|0|||
129597269|NCT04146363|466483123|FG008|Induction Period|Lost to Follow-up|0|||
129597270|NCT04146363|466483124|FG009|Induction Period|Lost to Follow-up|0|||
129597271|NCT04146363|466483125|FG010|Induction Period|Lost to Follow-up|0|||
129597272|NCT04146363|466483115|FG000|Induction Period|Positive quantiferon test|0|||
129597273|NCT04146363|466483116|FG001|Induction Period|Positive quantiferon test|1|||
129597274|NCT04146363|466483117|FG002|Induction Period|Positive quantiferon test|0|||
129597275|NCT04146363|466483118|FG003|Induction Period|Positive quantiferon test|0|||
129597276|NCT04146363|466483119|FG004|Induction Period|Positive quantiferon test|0|||
129597277|NCT04146363|466483120|FG005|Induction Period|Positive quantiferon test|0|||
129597278|NCT04146363|466483121|FG006|Induction Period|Positive quantiferon test|0|||
129597279|NCT04146363|466483122|FG007|Induction Period|Positive quantiferon test|0|||
129597280|NCT04146363|466483123|FG008|Induction Period|Positive quantiferon test|0|||
129597281|NCT04146363|466483124|FG009|Induction Period|Positive quantiferon test|0|||
129597282|NCT04146363|466483125|FG010|Induction Period|Positive quantiferon test|0|||
129597283|NCT04146363|466483115|FG000|Induction Period|Protocol Deviation|5|||
129597284|NCT04146363|466483116|FG001|Induction Period|Protocol Deviation|6|||
129597285|NCT04146363|466483117|FG002|Induction Period|Protocol Deviation|0|||
129597286|NCT04146363|466483118|FG003|Induction Period|Protocol Deviation|0|||
129597287|NCT04146363|466483119|FG004|Induction Period|Protocol Deviation|0|||
129597288|NCT04146363|466483120|FG005|Induction Period|Protocol Deviation|0|||
129885637|NCT02855164|467540771|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
129597289|NCT04146363|466483121|FG006|Induction Period|Protocol Deviation|0|||
129597290|NCT04146363|466483122|FG007|Induction Period|Protocol Deviation|0|||
129597291|NCT04146363|466483123|FG008|Induction Period|Protocol Deviation|0|||
129597292|NCT04146363|466483124|FG009|Induction Period|Protocol Deviation|0|||
129597293|NCT04146363|466483125|FG010|Induction Period|Protocol Deviation|0|||
129597294|NCT04146363|466483115|FG000|Induction Period|Withdrawal by Subject|6|||
129597295|NCT04146363|466483116|FG001|Induction Period|Withdrawal by Subject|3|||
129597296|NCT04146363|466483117|FG002|Induction Period|Withdrawal by Subject|0|||
129597297|NCT04146363|466483118|FG003|Induction Period|Withdrawal by Subject|0|||
129597298|NCT04146363|466483119|FG004|Induction Period|Withdrawal by Subject|0|||
129597299|NCT04146363|466483120|FG005|Induction Period|Withdrawal by Subject|0|||
129597300|NCT04146363|466483121|FG006|Induction Period|Withdrawal by Subject|0|||
129597301|NCT04146363|466483122|FG007|Induction Period|Withdrawal by Subject|0|||
129597302|NCT04146363|466483123|FG008|Induction Period|Withdrawal by Subject|0|||
129597303|NCT04146363|466483124|FG009|Induction Period|Withdrawal by Subject|0|||
129597304|NCT04146363|466483125|FG010|Induction Period|Withdrawal by Subject|0|||
129597305|NCT04146363|466483115|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597306|NCT04146363|466483116|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597307|NCT04146363|466483117|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597308|NCT04146363|466483118|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597309|NCT04146363|466483119|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597310|NCT04146363|466483120|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597311|NCT04146363|466483121|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
129597312|NCT04146363|466483122|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
129597313|NCT04146363|466483123|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597314|NCT04146363|466483124|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597315|NCT04146363|466483125|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
129597316|NCT04146363|466483115|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597317|NCT04146363|466483116|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597318|NCT04146363|466483117|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597319|NCT04146363|466483118|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597320|NCT04146363|466483119|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597321|NCT04146363|466483120|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597322|NCT04146363|466483121|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597323|NCT04146363|466483122|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
129597324|NCT04146363|466483123|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597325|NCT04146363|466483124|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597326|NCT04146363|466483125|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129597327|NCT04146363|466483115|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597328|NCT04146363|466483116|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597329|NCT04146363|466483117|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597330|NCT04146363|466483118|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597331|NCT04146363|466483119|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597332|NCT04146363|466483120|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597333|NCT04146363|466483121|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
129597334|NCT04146363|466483122|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
129597335|NCT04146363|466483123|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597336|NCT04146363|466483124|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597337|NCT04146363|466483125|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129597338|NCT04146363|466483115|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597339|NCT04146363|466483116|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597340|NCT04146363|466483117|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
129597341|NCT04146363|466483118|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597342|NCT04146363|466483119|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597343|NCT04146363|466483120|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
129597344|NCT04146363|466483121|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597345|NCT04146363|466483122|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597346|NCT04146363|466483123|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597347|NCT04146363|466483124|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597348|NCT04146363|466483125|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
129597349|NCT04146363|466483115|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597350|NCT04146363|466483116|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597351|NCT04146363|466483117|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597352|NCT04146363|466483118|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597353|NCT04146363|466483119|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
129597354|NCT04146363|466483120|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
129597355|NCT04146363|466483121|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
129597356|NCT04146363|466483122|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
129597357|NCT04146363|466483123|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597358|NCT04146363|466483124|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597359|NCT04146363|466483125|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129597360|NCT04146363|466483115|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597361|NCT04146363|466483116|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597362|NCT04146363|466483117|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
129597363|NCT04146363|466483118|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597364|NCT04146363|466483119|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597365|NCT04146363|466483120|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
129597366|NCT04146363|466483121|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
129597367|NCT04146363|466483122|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
129597368|NCT04146363|466483123|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597369|NCT04146363|466483124|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597370|NCT04146363|466483125|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129597371|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597372|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597373|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597374|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597375|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597376|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597377|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597378|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597379|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
129597380|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
129597381|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
129597382|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597383|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597384|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597385|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597386|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597387|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597388|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597389|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129597390|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
129597391|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
129597392|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
129597393|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597394|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597395|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597396|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597397|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597398|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597399|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597400|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597401|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
129597402|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
129597403|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129597404|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597405|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597406|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597407|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597408|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597409|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597410|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597411|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597412|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
129597413|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
129597414|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
129597415|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597416|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597417|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597418|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597419|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597420|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597421|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597422|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129597423|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
129597424|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
129597425|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
129597426|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597427|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597428|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
129885638|NCT02855164|467540772|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
129597429|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597430|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597431|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597432|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597433|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597434|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597435|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
129597436|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
129597437|NCT04146363|466483115|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597438|NCT04146363|466483116|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597439|NCT04146363|466483117|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597440|NCT04146363|466483118|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597441|NCT04146363|466483119|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597442|NCT04146363|466483120|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597443|NCT04146363|466483121|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597444|NCT04146363|466483122|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597445|NCT04146363|466483123|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597446|NCT04146363|466483124|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
129597447|NCT04146363|466483125|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
129597448|NCT02914236|466483127|FG000|Overall Study|Lost to Follow-up|1|||
129597449|NCT02148913|466483132|FG000|Overall Study|Death|0|||
129597450|NCT02148913|466483133|FG001|Overall Study|Death|1|||
129597451|NCT02148913|466483134|FG002|Overall Study|Death|0|||
129597452|NCT02148913|466483135|FG003|Overall Study|Death|0|||
129597453|NCT01045993|466483143|FG000|Overall Study|Treated-later found eligibility not met|0|||
129597454|NCT01045993|466483144|FG001|Overall Study|Treated-later found eligibility not met|1|||
129597455|NCT01045993|466483145|FG002|Overall Study|Treated-later found eligibility not met|0|||
129597456|NCT01045993|466483146|FG003|Overall Study|Treated-later found eligibility not met|0|||
129597457|NCT05506358|466483147|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
129597458|NCT05506358|466483148|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129597459|NCT05506358|466483149|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129597460|NCT05506358|466483150|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129597461|NCT05506358|466483151|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
129597462|NCT05506358|466483147|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
129597463|NCT05506358|466483148|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129597464|NCT05506358|466483149|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129647374|NCT02515994|466665293|FG001|Overall Study|Protocol Violation|5|||
129647375|NCT02515994|466665292|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
129647376|NCT02515994|466665293|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
129647377|NCT02515994|466665292|FG000|Overall Study|Adverse Event|3|||
129647378|NCT02515994|466665293|FG001|Overall Study|Adverse Event|1|||
129647379|NCT02515994|466665292|FG000|Overall Study|Withdrawal by Subject|2|||
129647380|NCT02515994|466665293|FG001|Overall Study|Withdrawal by Subject|0|||
129647381|NCT03391232|466665298|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
129647382|NCT03391232|466665299|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
129647383|NCT03391232|466665298|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
129647384|NCT03391232|466665299|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
129647385|NCT04186806|466665306|FG000|Period 1: 7 Days|Adverse Event|1|||
129647386|NCT04186806|466665307|FG001|Period 1: 7 Days|Adverse Event|0|||
129647387|NCT04739722|466665315|FG000|Overall Study|Lost to Follow-up|5301|||
129647388|NCT04739722|466665315|FG000|Overall Study|Withdrawal by Subject|42|||
129647389|NCT04739722|466665315|FG000|Overall Study|Non Average-risk|1157|||
129647390|NCT03047720|466665319|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
129647391|NCT03047720|466665320|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
129647392|NCT00614120|466665321|FG000|Overall Study|Adverse Event|9|||
129647393|NCT00614120|466665322|FG001|Overall Study|Adverse Event|22|||
129647394|NCT00614120|466665323|FG002|Overall Study|Adverse Event|30|||
129647395|NCT00614120|466665324|FG003|Overall Study|Adverse Event|3|||
129647396|NCT00614120|466665321|FG000|Overall Study|Lack of Efficacy|3|||
129647397|NCT00614120|466665322|FG001|Overall Study|Lack of Efficacy|3|||
129647398|NCT00614120|466665323|FG002|Overall Study|Lack of Efficacy|2|||
129647399|NCT00614120|466665324|FG003|Overall Study|Lack of Efficacy|2|||
129647400|NCT00614120|466665321|FG000|Overall Study|Protocol Violation|2|||
129647401|NCT00614120|466665322|FG001|Overall Study|Protocol Violation|5|||
129647402|NCT00614120|466665323|FG002|Overall Study|Protocol Violation|3|||
129647403|NCT00614120|466665324|FG003|Overall Study|Protocol Violation|1|||
129597465|NCT05506358|466483150|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129597466|NCT05506358|466483151|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
129597467|NCT05506358|466483147|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129597468|NCT05506358|466483148|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129597469|NCT05506358|466483149|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129597470|NCT05506358|466483150|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
129597471|NCT05506358|466483151|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
129597472|NCT05506358|466483147|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
129597473|NCT05506358|466483148|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
129597474|NCT05506358|466483149|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
129597475|NCT05506358|466483150|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
129597476|NCT05506358|466483151|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
129597477|NCT05506358|466483147|FG000|Overall Study|HbE trait|0|||
129597478|NCT05506358|466483148|FG001|Overall Study|HbE trait|0|||
129597479|NCT05506358|466483149|FG002|Overall Study|HbE trait|0|||
129597480|NCT05506358|466483150|FG003|Overall Study|HbE trait|1|||
129597481|NCT05506358|466483151|FG004|Overall Study|HbE trait|0|||
129597482|NCT01659736|466483152|FG000|Treatment Period|Adverse Event|1|||
129597483|NCT01659736|466483153|FG001|Treatment Period|Adverse Event|1|||
129597484|NCT01659736|466483152|FG000|Treatment Period|Protocol Violation|3|||
129597485|NCT01659736|466483153|FG001|Treatment Period|Protocol Violation|1|||
129597486|NCT01659736|466483152|FG000|Treatment Period|Withdrawal by Subject|1|||
129597487|NCT01659736|466483153|FG001|Treatment Period|Withdrawal by Subject|0|||
129597488|NCT01659736|466483152|FG000|3-month Follow-up|Lost to Follow-up|0|||
129597489|NCT01659736|466483153|FG001|3-month Follow-up|Lost to Follow-up|1|||
129597490|NCT00252174|466483161|FG000|Overall Study|Withdrawal by Subject|0|||
129597491|NCT00252174|466483162|FG001|Overall Study|Withdrawal by Subject|1|||
129597492|NCT00252174|466483163|FG002|Overall Study|Withdrawal by Subject|0|||
129597493|NCT00484419|466483164|FG000|Overall Study|Adverse Event|3|||
129597494|NCT00484419|466483165|FG001|Overall Study|Adverse Event|0|||
129597495|NCT00484419|466483166|FG002|Overall Study|Adverse Event|0|||
129597496|NCT00484419|466483164|FG000|Overall Study|Lost to Follow-up|1|||
129597497|NCT00484419|466483165|FG001|Overall Study|Lost to Follow-up|0|||
129597498|NCT00484419|466483166|FG002|Overall Study|Lost to Follow-up|2|||
129597499|NCT00484419|466483164|FG000|Overall Study|Withdrawal by Subject|3|||
129597500|NCT00484419|466483165|FG001|Overall Study|Withdrawal by Subject|1|||
129597501|NCT00484419|466483166|FG002|Overall Study|Withdrawal by Subject|1|||
129597502|NCT00484419|466483164|FG000|Overall Study|subject met discontinuation criteria|2|||
129597503|NCT00484419|466483165|FG001|Overall Study|subject met discontinuation criteria|2|||
129597504|NCT00484419|466483166|FG002|Overall Study|subject met discontinuation criteria|4|||
129597505|NCT00484419|466483164|FG000|Overall Study|required restricted medication|1|||
129597506|NCT00484419|466483165|FG001|Overall Study|required restricted medication|0|||
129597507|NCT00484419|466483166|FG002|Overall Study|required restricted medication|1|||
129597508|NCT00484419|466483164|FG000|Overall Study|Physician Decision|1|||
129597509|NCT00484419|466483165|FG001|Overall Study|Physician Decision|1|||
129597510|NCT00484419|466483166|FG002|Overall Study|Physician Decision|1|||
129597511|NCT00484419|466483164|FG000|Overall Study|subject unable to receive medication|1|||
129597512|NCT00484419|466483165|FG001|Overall Study|subject unable to receive medication|0|||
129597513|NCT00484419|466483166|FG002|Overall Study|subject unable to receive medication|0|||
129597514|NCT00484419|466483164|FG000|Overall Study|subject relocated|0|||
129597515|NCT00484419|466483165|FG001|Overall Study|subject relocated|1|||
129597516|NCT00484419|466483166|FG002|Overall Study|subject relocated|0|||
129597517|NCT00484419|466483164|FG000|Overall Study|sponsor decision, randomized in error|0|||
129597518|NCT00484419|466483165|FG001|Overall Study|sponsor decision, randomized in error|0|||
129597519|NCT00484419|466483166|FG002|Overall Study|sponsor decision, randomized in error|2|||
129597520|NCT00102687|466483170|FG000|Initial Period|Withdrawal by Subject|6|||
129597521|NCT00102687|466483171|FG001|Initial Period|Withdrawal by Subject|3|||
129597522|NCT00102687|466483172|FG002|Initial Period|Withdrawal by Subject|5|||
129597523|NCT00102687|466483173|FG003|Initial Period|Withdrawal by Subject|0|||
129597524|NCT00102687|466483174|FG004|Initial Period|Withdrawal by Subject|0|||
129597525|NCT00102687|466483170|FG000|Initial Period|Adverse Event|4|||
129597526|NCT00102687|466483171|FG001|Initial Period|Adverse Event|7|||
129597527|NCT00102687|466483172|FG002|Initial Period|Adverse Event|9|||
129597528|NCT00102687|466483173|FG003|Initial Period|Adverse Event|0|||
129597529|NCT00102687|466483174|FG004|Initial Period|Adverse Event|0|||
129597530|NCT00102687|466483170|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
129597531|NCT00102687|466483171|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
129597532|NCT00102687|466483172|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
129597533|NCT00102687|466483173|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
129597534|NCT00102687|466483174|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
129597535|NCT00102687|466483170|FG000|Initial Period|Protocol Violation|0|||
129597536|NCT00102687|466483171|FG001|Initial Period|Protocol Violation|0|||
129597537|NCT00102687|466483172|FG002|Initial Period|Protocol Violation|2|||
129597538|NCT00102687|466483173|FG003|Initial Period|Protocol Violation|0|||
129597539|NCT00102687|466483174|FG004|Initial Period|Protocol Violation|0|||
129597540|NCT00102687|466483170|FG000|Initial Period|Physician Decision|2|||
129597541|NCT00102687|466483171|FG001|Initial Period|Physician Decision|9|||
129597542|NCT00102687|466483172|FG002|Initial Period|Physician Decision|6|||
129597543|NCT00102687|466483173|FG003|Initial Period|Physician Decision|0|||
129597544|NCT00102687|466483174|FG004|Initial Period|Physician Decision|0|||
129597545|NCT00102687|466483170|FG000|Initial Period|Sponsor's decision|0|||
129597546|NCT00102687|466483171|FG001|Initial Period|Sponsor's decision|1|||
129597547|NCT00102687|466483172|FG002|Initial Period|Sponsor's decision|1|||
129597548|NCT00102687|466483173|FG003|Initial Period|Sponsor's decision|0|||
129597549|NCT00102687|466483174|FG004|Initial Period|Sponsor's decision|0|||
129597550|NCT00102687|466483170|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
129597551|NCT00102687|466483171|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
129597552|NCT00102687|466483172|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
129597553|NCT00102687|466483173|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
129597554|NCT00102687|466483174|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
129597555|NCT00102687|466483170|FG000|Initial Period|Death|1|||
129597556|NCT00102687|466483171|FG001|Initial Period|Death|1|||
129597557|NCT00102687|466483172|FG002|Initial Period|Death|1|||
129597558|NCT00102687|466483173|FG003|Initial Period|Death|0|||
129597559|NCT00102687|466483174|FG004|Initial Period|Death|0|||
129597560|NCT00102687|466483170|FG000|Maintenance Period|Withdrawal by Subject|4|||
129597561|NCT00102687|466483171|FG001|Maintenance Period|Withdrawal by Subject|0|||
129597562|NCT00102687|466483172|FG002|Maintenance Period|Withdrawal by Subject|2|||
129597563|NCT00102687|466483173|FG003|Maintenance Period|Withdrawal by Subject|3|||
129597564|NCT00102687|466483174|FG004|Maintenance Period|Withdrawal by Subject|1|||
129597565|NCT00102687|466483170|FG000|Maintenance Period|Adverse Event|1|||
129597566|NCT00102687|466483171|FG001|Maintenance Period|Adverse Event|0|||
129597567|NCT00102687|466483172|FG002|Maintenance Period|Adverse Event|0|||
129597568|NCT00102687|466483173|FG003|Maintenance Period|Adverse Event|1|||
129597569|NCT00102687|466483174|FG004|Maintenance Period|Adverse Event|3|||
129597570|NCT00102687|466483170|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129597571|NCT00102687|466483171|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
129597572|NCT00102687|466483172|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129597573|NCT00102687|466483173|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
129597574|NCT00102687|466483174|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
129597575|NCT00102687|466483170|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
129597576|NCT00102687|466483171|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
129597577|NCT00102687|466483172|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
129597578|NCT00102687|466483173|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
129597579|NCT00102687|466483174|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
129597580|NCT00102687|466483170|FG000|Maintenance Period|Death|0|||
129597581|NCT00102687|466483171|FG001|Maintenance Period|Death|0|||
129597582|NCT00102687|466483172|FG002|Maintenance Period|Death|0|||
129597583|NCT00102687|466483173|FG003|Maintenance Period|Death|1|||
129597584|NCT00102687|466483174|FG004|Maintenance Period|Death|1|||
129597585|NCT00102687|466483170|FG000|Maintenance Period|Physician Decision|1|||
129597586|NCT00102687|466483171|FG001|Maintenance Period|Physician Decision|2|||
129597587|NCT00102687|466483172|FG002|Maintenance Period|Physician Decision|3|||
129597588|NCT00102687|466483173|FG003|Maintenance Period|Physician Decision|0|||
129597589|NCT00102687|466483174|FG004|Maintenance Period|Physician Decision|4|||
129597590|NCT00355472|466483175|FG000|Overall Study|Physician Decision|1|||
129597591|NCT03095118|466483176|FG000|Overall Study|Adverse Event|1|||
129597592|NCT03095118|466483176|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
129597593|NCT03847194|466483179|FG000|Overall Study|Lost to Follow-up|2|||
129597594|NCT03847194|466483180|FG001|Overall Study|Lost to Follow-up|5|||
129597595|NCT03847194|466483179|FG000|Overall Study|Withdrawal by Subject|1|||
129597596|NCT03847194|466483180|FG001|Overall Study|Withdrawal by Subject|2|||
129597597|NCT03847194|466483179|FG000|Overall Study|Death|0|||
129436282|NCT01100034|465895669|FG000|Overall Study|Participated in another clinical trial|1|||
129597598|NCT03847194|466483180|FG001|Overall Study|Death|1|||
129597599|NCT02408120|466483181|FG000|Overall Study|Withdrawal by Subject|0|||
129597600|NCT02408120|466483182|FG001|Overall Study|Withdrawal by Subject|1|||
129597601|NCT02408120|466483181|FG000|Overall Study|Treatment Refusal|1|||
129597602|NCT02408120|466483182|FG001|Overall Study|Treatment Refusal|0|||
129597603|NCT02408120|466483181|FG000|Overall Study|Received Steroids|1|||
129597604|NCT02408120|466483182|FG001|Overall Study|Received Steroids|1|||
129597605|NCT02408120|466483181|FG000|Overall Study|Discharged same day|1|||
129597606|NCT02408120|466483182|FG001|Overall Study|Discharged same day|1|||
129597607|NCT02408120|466483181|FG000|Overall Study|Did not receive insulin|1|||
129597608|NCT02408120|466483182|FG001|Overall Study|Did not receive insulin|2|||
129597609|NCT00351351|466483183|FG000|Overall Study|surgical access pbs; device issues|9|||
129696779|NCT00089583|466848193|FG000|Overall Study|Insufficient Viral Load Response|5|||
129597610|NCT00351351|466483184|FG001|Overall Study|surgical access pbs; device issues|4|||
129786537|NCT01451437|467185718|FG000|Overall Study|Adverse Event|0|||
129786538|NCT01451437|467185719|FG001|Overall Study|Adverse Event|0|||
129786539|NCT01451437|467185720|FG002|Overall Study|Adverse Event|0|||
129786540|NCT01451437|467185721|FG003|Overall Study|Adverse Event|0|||
129786541|NCT01451437|467185722|FG004|Overall Study|Adverse Event|0|||
129786542|NCT01451437|467185723|FG005|Overall Study|Adverse Event|1|||
129786543|NCT01451437|467185724|FG006|Overall Study|Adverse Event|1|||
129786544|NCT01451437|467185725|FG007|Overall Study|Adverse Event|2|||
129786545|NCT01451437|467185726|FG008|Overall Study|Adverse Event|1|||
129786546|NCT01451437|467185718|FG000|Overall Study|Physician Decision|1|||
129786547|NCT01451437|467185719|FG001|Overall Study|Physician Decision|1|||
129786548|NCT01451437|467185720|FG002|Overall Study|Physician Decision|2|||
129786549|NCT01451437|467185721|FG003|Overall Study|Physician Decision|0|||
129786550|NCT01451437|467185722|FG004|Overall Study|Physician Decision|0|||
129786551|NCT01451437|467185723|FG005|Overall Study|Physician Decision|0|||
129786552|NCT01451437|467185724|FG006|Overall Study|Physician Decision|0|||
129786553|NCT01451437|467185725|FG007|Overall Study|Physician Decision|0|||
129786554|NCT01451437|467185726|FG008|Overall Study|Physician Decision|0|||
129597611|NCT01341587|466483185|FG000|Overall Study|Lost to Follow-up|2|||
129597612|NCT01341587|466483186|FG001|Overall Study|Lost to Follow-up|0|||
129597613|NCT01341587|466483185|FG000|Overall Study|stopped using the meters|2|||
129597614|NCT01341587|466483186|FG001|Overall Study|stopped using the meters|10|||
129597615|NCT00680186|466483189|FG000|Overall Study|Adverse Event|47|||
129597616|NCT00680186|466483190|FG001|Overall Study|Adverse Event|44|||
129597617|NCT00680186|466483189|FG000|Overall Study|Protocol Violation|31|||
129597618|NCT00680186|466483190|FG001|Overall Study|Protocol Violation|26|||
129597619|NCT00680186|466483189|FG000|Overall Study|Lost to Follow-up|11|||
129597620|NCT00680186|466483190|FG001|Overall Study|Lost to Follow-up|6|||
129597621|NCT00680186|466483189|FG000|Overall Study|Withdrawal by Subject|32|||
129597622|NCT00680186|466483190|FG001|Overall Study|Withdrawal by Subject|39|||
129597623|NCT00680186|466483189|FG000|Overall Study|Other|4|||
129597624|NCT00680186|466483190|FG001|Overall Study|Other|1|||
129597625|NCT04403763|466483191|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
129597626|NCT04403763|466483192|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
129597627|NCT04403763|466483193|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
129597628|NCT04403763|466483194|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
129597629|NCT04403763|466483195|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
129597630|NCT04403763|466483196|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
129597631|NCT04403763|466483197|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
129597632|NCT04403763|466483191|FG000|Stage 1|Early termination due to PK tube failure|0|||
129597633|NCT04403763|466483192|FG001|Stage 1|Early termination due to PK tube failure|0|||
129597634|NCT04403763|466483193|FG002|Stage 1|Early termination due to PK tube failure|1|||
129597635|NCT04403763|466483194|FG003|Stage 1|Early termination due to PK tube failure|0|||
129597636|NCT04403763|466483195|FG004|Stage 1|Early termination due to PK tube failure|0|||
129597637|NCT04403763|466483196|FG005|Stage 1|Early termination due to PK tube failure|0|||
129597638|NCT04403763|466483197|FG006|Stage 1|Early termination due to PK tube failure|0|||
129597639|NCT04403763|466483191|FG000|Stage 2A|Adverse Event|0|||
129597640|NCT04403763|466483192|FG001|Stage 2A|Adverse Event|0|||
129597641|NCT04403763|466483193|FG002|Stage 2A|Adverse Event|0|||
129597642|NCT04403763|466483194|FG003|Stage 2A|Adverse Event|0|||
129597643|NCT04403763|466483195|FG004|Stage 2A|Adverse Event|0|||
129597644|NCT04403763|466483196|FG005|Stage 2A|Adverse Event|0|||
129597645|NCT04403763|466483197|FG006|Stage 2A|Adverse Event|1|||
129597646|NCT02470091|466483198|FG000|Overall Study|Withdrawal by Subject|1|||
129597647|NCT02470091|466483199|FG001|Overall Study|Withdrawal by Subject|0|||
129597648|NCT02470091|466483198|FG000|Overall Study|Ineligible|0|||
129597649|NCT02470091|466483199|FG001|Overall Study|Ineligible|2|||
129597650|NCT00606502|466483201|FG000|Randomization|Randomized but not treated|3|||
129597651|NCT00606502|466483202|FG001|Randomization|Randomized but not treated|0|||
129597652|NCT00606502|466483201|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
129597653|NCT00606502|466483202|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
129597654|NCT02083926|466483205|FG000|Overall Study|Withdrawal by Subject|1|||
129597655|NCT02083926|466483206|FG001|Overall Study|Withdrawal by Subject|0|||
129597656|NCT02697773|466483207|FG000|Overall Study|Adverse Event|2|||
129786555|NCT01451437|467185718|FG000|Overall Study|Disease Progression|0|||
129597657|NCT02697773|466483208|FG001|Overall Study|Adverse Event|1|||
129597658|NCT02697773|466483209|FG002|Overall Study|Adverse Event|2|||
129597659|NCT02697773|466483207|FG000|Overall Study|Death|0|||
129597660|NCT02697773|466483208|FG001|Overall Study|Death|0|||
129786556|NCT01451437|467185719|FG001|Overall Study|Disease Progression|0|||
129786557|NCT01451437|467185720|FG002|Overall Study|Disease Progression|1|||
129597661|NCT02697773|466483209|FG002|Overall Study|Death|2|||
129597662|NCT02697773|466483207|FG000|Overall Study|Lack of Efficacy|4|||
129597663|NCT02697773|466483208|FG001|Overall Study|Lack of Efficacy|6|||
129597664|NCT02697773|466483209|FG002|Overall Study|Lack of Efficacy|6|||
129597665|NCT02697773|466483207|FG000|Overall Study|Lost to Follow-up|5|||
129597666|NCT02697773|466483208|FG001|Overall Study|Lost to Follow-up|5|||
129597667|NCT02697773|466483209|FG002|Overall Study|Lost to Follow-up|7|||
129597668|NCT02697773|466483207|FG000|Overall Study|Other|15|||
129597669|NCT02697773|466483208|FG001|Overall Study|Other|11|||
129597670|NCT02697773|466483209|FG002|Overall Study|Other|10|||
129597671|NCT02697773|466483207|FG000|Overall Study|Protocol Violation|1|||
129597672|NCT02697773|466483208|FG001|Overall Study|Protocol Violation|1|||
129597673|NCT02697773|466483209|FG002|Overall Study|Protocol Violation|0|||
129597674|NCT02697773|466483207|FG000|Overall Study|Withdrawal by Subject|10|||
129597675|NCT02697773|466483208|FG001|Overall Study|Withdrawal by Subject|13|||
129597676|NCT02697773|466483209|FG002|Overall Study|Withdrawal by Subject|13|||
129597677|NCT02697773|466483207|FG000|Overall Study|Randomized but not treated|1|||
129597678|NCT02697773|466483208|FG001|Overall Study|Randomized but not treated|1|||
129597679|NCT02697773|466483209|FG002|Overall Study|Randomized but not treated|0|||
129597680|NCT00613834|466483210|FG000|Overall Study|Withdrawal by Subject|0|||
129597681|NCT00613834|466483211|FG001|Overall Study|Withdrawal by Subject|3|||
129597682|NCT01118117|466483214|FG000|Overall Study|Death|8|||
129597683|NCT01118117|466483215|FG001|Overall Study|Death|0|||
129597684|NCT01118117|466483214|FG000|Overall Study|Lost to Follow-up|6|||
129597685|NCT01118117|466483215|FG001|Overall Study|Lost to Follow-up|0|||
129597686|NCT01118117|466483214|FG000|Overall Study|Missed 12 Month Visit|7|||
129597687|NCT01118117|466483215|FG001|Overall Study|Missed 12 Month Visit|0|||
129786558|NCT01451437|467185721|FG003|Overall Study|Disease Progression|1|||
129786559|NCT01451437|467185722|FG004|Overall Study|Disease Progression|3|||
129786560|NCT01451437|467185723|FG005|Overall Study|Disease Progression|2|||
129786561|NCT01451437|467185724|FG006|Overall Study|Disease Progression|3|||
129786562|NCT01451437|467185725|FG007|Overall Study|Disease Progression|1|||
129597688|NCT02698865|466485818|FG000|Overall Study|Other|11|||
129597689|NCT02698865|466485819|FG001|Overall Study|Other|11|||
129597690|NCT02698865|466485818|FG000|Overall Study|Withdrawal by Subject|20|||
129597691|NCT02698865|466485819|FG001|Overall Study|Withdrawal by Subject|16|||
129597692|NCT02698865|466485818|FG000|Overall Study|Physician Decision|0|||
129597693|NCT02698865|466485819|FG001|Overall Study|Physician Decision|4|||
129597694|NCT02698865|466485818|FG000|Overall Study|Lost to Follow-up|4|||
129597695|NCT02698865|466485819|FG001|Overall Study|Lost to Follow-up|2|||
129597696|NCT03861481|466485820|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
129597697|NCT03861481|466485821|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
129597698|NCT03861481|466485820|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
129597699|NCT03861481|466485821|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
129597700|NCT03861481|466485820|FG000|Overall Study|Relapse|1|||
129597701|NCT03861481|466485821|FG001|Overall Study|Relapse|0|||
129597702|NCT03861481|466485820|FG000|Overall Study|Withdrawal by Subject|0|||
129597703|NCT03861481|466485821|FG001|Overall Study|Withdrawal by Subject|1|||
129597704|NCT03861481|466485820|FG000|Overall Study|Lack of Efficacy|4|||
129597705|NCT03861481|466485821|FG001|Overall Study|Lack of Efficacy|5|||
129597706|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
129597707|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
129597708|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
129597709|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
129597710|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
129597711|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
129597712|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
129597713|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
129597714|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
129597715|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
129597716|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
129597717|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
129597718|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
129597719|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
129597720|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
129597721|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
129597722|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129597723|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129597724|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
129597725|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129597726|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129597727|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129786563|NCT01451437|467185726|FG008|Overall Study|Disease Progression|3|||
129786564|NCT01451437|467185718|FG000|Overall Study|Protocol Violation|0|||
129786565|NCT01451437|467185719|FG001|Overall Study|Protocol Violation|0|||
129786566|NCT01451437|467185720|FG002|Overall Study|Protocol Violation|0|||
129786567|NCT01451437|467185721|FG003|Overall Study|Protocol Violation|0|||
129786568|NCT01451437|467185722|FG004|Overall Study|Protocol Violation|0|||
129786569|NCT01451437|467185723|FG005|Overall Study|Protocol Violation|0|||
129786570|NCT01451437|467185724|FG006|Overall Study|Protocol Violation|1|||
129786571|NCT01451437|467185725|FG007|Overall Study|Protocol Violation|0|||
129786572|NCT01451437|467185726|FG008|Overall Study|Protocol Violation|0|||
129597728|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129597729|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
129597730|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
129597731|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129597732|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129597733|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
129597734|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129597735|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
129597736|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
129597737|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
129597738|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
129597739|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
129597740|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
129597741|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
129597742|NCT00773734|466485822|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129597743|NCT00773734|466485823|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129597744|NCT00773734|466485824|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129597745|NCT00773734|466485825|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
129597746|NCT00773734|466485826|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
129597747|NCT00773734|466485827|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
129597748|NCT00773734|466485822|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
129597749|NCT00773734|466485823|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
129597750|NCT00773734|466485824|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
129597751|NCT00773734|466485825|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
129647404|NCT00614120|466665321|FG000|Overall Study|Withdrawal criteria|1|||
129647405|NCT00614120|466665322|FG001|Overall Study|Withdrawal criteria|0|||
129647406|NCT00614120|466665323|FG002|Overall Study|Withdrawal criteria|0|||
129647407|NCT00614120|466665324|FG003|Overall Study|Withdrawal criteria|0|||
129647408|NCT00614120|466665321|FG000|Overall Study|Withdrawal by Subject|9|||
129647409|NCT00614120|466665322|FG001|Overall Study|Withdrawal by Subject|10|||
129647410|NCT00614120|466665323|FG002|Overall Study|Withdrawal by Subject|16|||
129647411|NCT00614120|466665324|FG003|Overall Study|Withdrawal by Subject|3|||
129647412|NCT00614120|466665321|FG000|Overall Study|Did not meet trial criteria|0|||
129647413|NCT00614120|466665322|FG001|Overall Study|Did not meet trial criteria|1|||
129647414|NCT00614120|466665323|FG002|Overall Study|Did not meet trial criteria|1|||
129647415|NCT00614120|466665324|FG003|Overall Study|Did not meet trial criteria|1|||
129647416|NCT00614120|466665321|FG000|Overall Study|hCG positive (not pregnant)|0|||
129647417|NCT00614120|466665322|FG001|Overall Study|hCG positive (not pregnant)|0|||
129647418|NCT00614120|466665323|FG002|Overall Study|hCG positive (not pregnant)|1|||
129647419|NCT00614120|466665324|FG003|Overall Study|hCG positive (not pregnant)|0|||
129647420|NCT00614120|466665321|FG000|Overall Study|Hypoglycaemia|0|||
129647421|NCT00614120|466665322|FG001|Overall Study|Hypoglycaemia|0|||
129647422|NCT00614120|466665323|FG002|Overall Study|Hypoglycaemia|0|||
129647423|NCT00614120|466665324|FG003|Overall Study|Hypoglycaemia|1|||
129647424|NCT00614120|466665321|FG000|Overall Study|Lack of trial product|3|||
129647425|NCT00614120|466665322|FG001|Overall Study|Lack of trial product|3|||
129647426|NCT00614120|466665323|FG002|Overall Study|Lack of trial product|2|||
129647427|NCT00614120|466665324|FG003|Overall Study|Lack of trial product|0|||
129647428|NCT00614120|466665321|FG000|Overall Study|Late syphilis, latent|1|||
129647429|NCT00614120|466665322|FG001|Overall Study|Late syphilis, latent|0|||
129647430|NCT00614120|466665323|FG002|Overall Study|Late syphilis, latent|0|||
129647431|NCT00614120|466665324|FG003|Overall Study|Late syphilis, latent|0|||
129647432|NCT00614120|466665321|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
129647433|NCT00614120|466665322|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
129647434|NCT00614120|466665323|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
129647435|NCT00614120|466665324|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
129647436|NCT00614120|466665321|FG000|Overall Study|Lost to Follow-up|1|||
129647437|NCT00614120|466665322|FG001|Overall Study|Lost to Follow-up|2|||
129647438|NCT00614120|466665323|FG002|Overall Study|Lost to Follow-up|3|||
129647439|NCT00614120|466665324|FG003|Overall Study|Lost to Follow-up|4|||
129647440|NCT01185509|466665325|FG000|Overall Study|Progression/Relapse|9|||
129647441|NCT01185509|466665326|FG001|Overall Study|Progression/Relapse|15|||
129647442|NCT01185509|466665325|FG000|Overall Study|Physician Decision|2|||
129597752|NCT00773734|466485826|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
129597753|NCT00773734|466485827|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
129597754|NCT00773734|466485822|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
129597755|NCT00773734|466485823|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
129597756|NCT00773734|466485824|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
129597757|NCT00773734|466485825|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
129597758|NCT00773734|466485826|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
129597759|NCT00773734|466485827|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
129597760|NCT00773734|466485822|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
129597761|NCT00773734|466485823|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
129597762|NCT00773734|466485824|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
129597763|NCT00773734|466485825|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
129597764|NCT00773734|466485826|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
129597765|NCT00773734|466485827|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
129597766|NCT00773734|466485822|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129597767|NCT00773734|466485823|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
129597768|NCT00773734|466485824|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
129597769|NCT00773734|466485825|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129597770|NCT00773734|466485826|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129597771|NCT00773734|466485827|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
129597772|NCT00773734|466485822|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
129597773|NCT00773734|466485823|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129597774|NCT00773734|466485824|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129597775|NCT00773734|466485825|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129597776|NCT00773734|466485826|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
129597777|NCT00773734|466485827|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
129597778|NCT00773734|466485822|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
129597779|NCT00773734|466485823|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
129597780|NCT00773734|466485824|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
129597781|NCT00773734|466485825|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
129597782|NCT00773734|466485826|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
129597783|NCT00773734|466485827|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
129597784|NCT00773734|466485822|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129597785|NCT00773734|466485823|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129597786|NCT00773734|466485824|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129597787|NCT00773734|466485825|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
129597788|NCT00773734|466485826|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
129597789|NCT00773734|466485827|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
129597790|NCT00773734|466485822|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
129597791|NCT00773734|466485823|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
129597792|NCT00773734|466485824|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
129597793|NCT00773734|466485825|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
129597794|NCT00773734|466485826|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
129597795|NCT00773734|466485827|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
129597796|NCT00773734|466485822|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
129597797|NCT00773734|466485823|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
129597798|NCT00773734|466485824|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
129597799|NCT00773734|466485825|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
129647443|NCT01185509|466665326|FG001|Overall Study|Physician Decision|2|||
129786573|NCT01451437|467185718|FG000|Overall Study|Withdrawal by Subject|0|||
129786574|NCT01451437|467185719|FG001|Overall Study|Withdrawal by Subject|0|||
129786575|NCT01451437|467185720|FG002|Overall Study|Withdrawal by Subject|0|||
129786576|NCT01451437|467185721|FG003|Overall Study|Withdrawal by Subject|0|||
129786577|NCT01451437|467185722|FG004|Overall Study|Withdrawal by Subject|1|||
129786578|NCT01451437|467185723|FG005|Overall Study|Withdrawal by Subject|0|||
129786579|NCT01451437|467185724|FG006|Overall Study|Withdrawal by Subject|1|||
129786580|NCT01451437|467185725|FG007|Overall Study|Withdrawal by Subject|0|||
129786581|NCT01451437|467185726|FG008|Overall Study|Withdrawal by Subject|0|||
129786582|NCT03472547|467185732|FG000|Overall Study|Withdrawal by Subject|30|||
129786583|NCT02043899|467187102|FG000|Overall Study|Adverse Event|3|||
129786584|NCT02043899|467187102|FG000|Overall Study|Physician Decision|1|||
129786585|NCT02043899|467187102|FG000|Overall Study|Withdrawal by Subject|2|||
129786586|NCT02043899|467187102|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
129786587|NCT02043899|467187102|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
129786588|NCT02043899|467187102|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
129786589|NCT02043899|467187102|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
129597800|NCT00773734|466485826|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
129597801|NCT00773734|466485827|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
129597802|NCT00773734|466485822|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
129597803|NCT00773734|466485823|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
129597804|NCT00773734|466485824|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
129597805|NCT00773734|466485825|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
129597806|NCT00773734|466485826|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
129597807|NCT00773734|466485827|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
129597808|NCT00773734|466485822|FG000|Extension: Active Treatment Week 24-52|Other|0|||
129597809|NCT00773734|466485823|FG001|Extension: Active Treatment Week 24-52|Other|0|||
129597810|NCT00773734|466485824|FG002|Extension: Active Treatment Week 24-52|Other|1|||
129597811|NCT00773734|466485825|FG003|Extension: Active Treatment Week 24-52|Other|2|||
129597812|NCT00773734|466485826|FG004|Extension: Active Treatment Week 24-52|Other|0|||
129597813|NCT00773734|466485827|FG005|Extension: Active Treatment Week 24-52|Other|1|||
129597814|NCT00773734|466485822|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129597815|NCT00773734|466485823|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129597816|NCT00773734|466485824|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129597817|NCT00773734|466485825|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
129597818|NCT00773734|466485826|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129597819|NCT00773734|466485827|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
129597820|NCT00773734|466485822|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129597821|NCT00773734|466485823|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129597822|NCT00773734|466485824|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
129597823|NCT00773734|466485825|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
129597824|NCT00773734|466485826|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129597825|NCT00773734|466485827|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
129597826|NCT00773734|466485822|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129597827|NCT00773734|466485823|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129597828|NCT00773734|466485824|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
129597829|NCT00773734|466485825|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
129597830|NCT00773734|466485826|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129597831|NCT00773734|466485827|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
129597832|NCT00773734|466485822|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129597833|NCT00773734|466485823|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129597834|NCT00773734|466485824|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
129597835|NCT00773734|466485825|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
129597836|NCT00773734|466485826|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129597837|NCT00773734|466485827|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
129597838|NCT01220297|466485830|FG000|Overall Study|Death|2|||
129597839|NCT01220297|466485830|FG000|Overall Study|Lost to Follow-up|1|||
129597840|NCT02581163|466485833|FG000|Overall Study|Failure to return|15|||
129597841|NCT02581163|466485833|FG000|Overall Study|Insufficient virological response|3|||
129597842|NCT02581163|466485833|FG000|Overall Study|Withdrew consent|1|||
129597843|NCT02581163|466485833|FG000|Overall Study|Death|1|||
129597844|NCT02581163|466485833|FG000|Overall Study|Other, not specified|9|||
129597845|NCT02791893|466485834|FG000|Blinded Phase|Lost to Follow-up|2|||
129597846|NCT02791893|466485835|FG001|Blinded Phase|Lost to Follow-up|2|||
129597847|NCT02791893|466485834|FG000|Blinded Phase|Withdrawal by Subject|1|||
129597848|NCT02791893|466485835|FG001|Blinded Phase|Withdrawal by Subject|2|||
129597849|NCT02791893|466485834|FG000|Open Label Phase|Lost to Follow-up|3|||
129597850|NCT02791893|466485835|FG001|Open Label Phase|Lost to Follow-up|0|||
129597851|NCT02791893|466485834|FG000|Open Label Phase|Withdrawal by Subject|0|||
129597852|NCT02791893|466485835|FG001|Open Label Phase|Withdrawal by Subject|2|||
129597853|NCT03438396|466485836|FG000|Overall Study|Reason Not Specified|9|||
129597854|NCT03438396|466485836|FG000|Overall Study|Withdrawal by Subject|5|||
129597855|NCT03438396|466485836|FG000|Overall Study|Lost to Follow-up|2|||
129597856|NCT03438396|466485836|FG000|Overall Study|Death|85|||
129597857|NCT03438396|466485836|FG000|Overall Study|Not treated|1|||
129696780|NCT00089583|466848194|FG001|Overall Study|Insufficient Viral Load Response|5|||
129696781|NCT00089583|466848193|FG000|Overall Study|Withdrawal by Subject|0|||
129597858|NCT00262041|466485837|FG000|Overall Study|Withdrawal by Subject|0|||
129696782|NCT00089583|466848194|FG001|Overall Study|Withdrawal by Subject|4|||
129597859|NCT00262041|466485838|FG001|Overall Study|Withdrawal by Subject|3|||
129597860|NCT00262041|466485839|FG002|Overall Study|Withdrawal by Subject|1|||
129597861|NCT00262041|466485837|FG000|Overall Study|Lost to Follow-up|1|||
129597862|NCT00262041|466485838|FG001|Overall Study|Lost to Follow-up|1|||
129597863|NCT00262041|466485839|FG002|Overall Study|Lost to Follow-up|5|||
129597864|NCT00262041|466485837|FG000|Overall Study|Unable to classify|1|||
129597865|NCT00262041|466485838|FG001|Overall Study|Unable to classify|0|||
129597866|NCT00262041|466485839|FG002|Overall Study|Unable to classify|0|||
129597867|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
129597868|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
129597869|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
129597870|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
129597871|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
129597872|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
129597873|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
129597874|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
129597875|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
129597876|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
129597877|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
129597878|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
129597879|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
129597880|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
129597881|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
129597882|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
129597883|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
129597884|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
129597885|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
129597886|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
129597887|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
129597888|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
129597889|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
129597890|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
129597891|NCT01421342|466485840|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
129597892|NCT01421342|466485841|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
129597893|NCT01421342|466485842|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
129597894|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
129597895|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
129597896|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
129597897|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
129597898|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
129597899|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
129597900|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
129597901|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
129597902|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
129597903|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
129597904|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
129597905|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
129597906|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
129597907|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
129597908|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
129597909|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
129597910|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
129597911|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
129597912|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
129597913|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
129597914|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
129597915|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
129786590|NCT02043899|467187102|FG000|Overall Study|Treatment delayed|1|||
129786591|NCT01325337|467187103|FG000|Overall Study|Adverse Event|0|||
129786592|NCT01325337|467187104|FG001|Overall Study|Adverse Event|2|||
129786593|NCT01325337|467187105|FG002|Overall Study|Adverse Event|2|||
129786594|NCT01325337|467187106|FG003|Overall Study|Adverse Event|1|||
129436283|NCT01100034|465895669|FG000|Overall Study|Participants moved to another hospital|4|||
129597916|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
129597917|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
129597918|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
129786595|NCT01325337|467187107|FG004|Overall Study|Adverse Event|2|||
129786596|NCT01325337|467187103|FG000|Overall Study|Lost to Follow-up|2|||
129597919|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
129597920|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
129597921|NCT01421342|466485840|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
129597922|NCT01421342|466485841|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
129597923|NCT01421342|466485842|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
129597924|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
129597925|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
129597926|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
129597927|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
129597928|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
129597929|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
129597930|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
129597931|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
129597932|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
129597933|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
129597934|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
129597935|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
129597936|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
129597937|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
129597938|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
129597939|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
129597940|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
129597941|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
129597942|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
129597943|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
129597944|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
129597945|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
129597946|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
129597947|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
129597948|NCT01421342|466485840|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
129597949|NCT01421342|466485841|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
129597950|NCT01421342|466485842|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
129597951|NCT02017860|466485846|FG000|Overall Study|Adverse Event|1|||
129597952|NCT02017860|466485846|FG000|Overall Study|Withdrawal by Subject|1|||
129597953|NCT02488330|466485847|FG000|Overall Study|Adverse Event|1|||
129597954|NCT02488330|466485847|FG000|Overall Study|Physician Decision|2|||
129597955|NCT02488330|466485847|FG000|Overall Study|Death|2|||
129597956|NCT02488330|466485847|FG000|Overall Study|Disease Progression|3|||
129597957|NCT02488330|466485847|FG000|Overall Study|Study Termination by Sponsor|4|||
129597958|NCT01206816|466485851|FG000|Overall Study|Protocol Violation|0|||
129597959|NCT01206816|466485852|FG001|Overall Study|Protocol Violation|0|||
129597960|NCT01206816|466485853|FG002|Overall Study|Protocol Violation|1|||
129597961|NCT01206816|466485854|FG003|Overall Study|Protocol Violation|0|||
129597962|NCT01206816|466485855|FG004|Overall Study|Protocol Violation|0|||
129597963|NCT01206816|466485856|FG005|Overall Study|Protocol Violation|0|||
129597964|NCT01206816|466485857|FG006|Overall Study|Protocol Violation|0|||
129597965|NCT01206816|466485851|FG000|Overall Study|Withdrawal by Subject|0|||
129597966|NCT01206816|466485852|FG001|Overall Study|Withdrawal by Subject|0|||
129597967|NCT01206816|466485853|FG002|Overall Study|Withdrawal by Subject|1|||
129597968|NCT01206816|466485854|FG003|Overall Study|Withdrawal by Subject|0|||
129597969|NCT01206816|466485855|FG004|Overall Study|Withdrawal by Subject|0|||
129597970|NCT01206816|466485856|FG005|Overall Study|Withdrawal by Subject|0|||
129597971|NCT01206816|466485857|FG006|Overall Study|Withdrawal by Subject|0|||
129597972|NCT01206816|466485851|FG000|Overall Study|Progressive disease|3|||
129597973|NCT01206816|466485852|FG001|Overall Study|Progressive disease|3|||
129597974|NCT01206816|466485853|FG002|Overall Study|Progressive disease|13|||
129597975|NCT01206816|466485854|FG003|Overall Study|Progressive disease|3|||
129597976|NCT01206816|466485855|FG004|Overall Study|Progressive disease|3|||
129597977|NCT01206816|466485856|FG005|Overall Study|Progressive disease|16|||
129597978|NCT01206816|466485857|FG006|Overall Study|Progressive disease|3|||
129597979|NCT01206816|466485851|FG000|Overall Study|Other AE|0|||
129597980|NCT01206816|466485852|FG001|Overall Study|Other AE|0|||
129597981|NCT01206816|466485853|FG002|Overall Study|Other AE|4|||
129597982|NCT01206816|466485854|FG003|Overall Study|Other AE|0|||
129597983|NCT01206816|466485855|FG004|Overall Study|Other AE|0|||
129597984|NCT01206816|466485856|FG005|Overall Study|Other AE|3|||
129597985|NCT01206816|466485857|FG006|Overall Study|Other AE|2|||
129597986|NCT01206816|466485851|FG000|Overall Study|other than stated above|0|||
129597987|NCT01206816|466485852|FG001|Overall Study|other than stated above|0|||
129597988|NCT01206816|466485853|FG002|Overall Study|other than stated above|1|||
129597989|NCT01206816|466485854|FG003|Overall Study|other than stated above|0|||
129597990|NCT01206816|466485855|FG004|Overall Study|other than stated above|0|||
129597991|NCT01206816|466485856|FG005|Overall Study|other than stated above|0|||
129597992|NCT01206816|466485857|FG006|Overall Study|other than stated above|1|||
129597993|NCT02384941|466485860|FG000|Overall Study|Adverse Event|11|||
129597994|NCT02384941|466485861|FG001|Overall Study|Adverse Event|13|||
129597995|NCT02384941|466485862|FG002|Overall Study|Adverse Event|17|||
129597996|NCT02384941|466485860|FG000|Overall Study|Lost to Follow-up|3|||
129597997|NCT02384941|466485861|FG001|Overall Study|Lost to Follow-up|2|||
129597998|NCT02384941|466485862|FG002|Overall Study|Lost to Follow-up|1|||
129597999|NCT02384941|466485860|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129598000|NCT02384941|466485861|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129598001|NCT02384941|466485862|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129598002|NCT02384941|466485860|FG000|Overall Study|Physician Decision|1|||
129598003|NCT02384941|466485861|FG001|Overall Study|Physician Decision|1|||
129598004|NCT02384941|466485862|FG002|Overall Study|Physician Decision|0|||
129598005|NCT02384941|466485860|FG000|Overall Study|Protocol Violation|3|||
129598006|NCT02384941|466485861|FG001|Overall Study|Protocol Violation|0|||
129598007|NCT02384941|466485862|FG002|Overall Study|Protocol Violation|0|||
129598008|NCT02384941|466485860|FG000|Overall Study|Withdrawal by Subject|26|||
129598009|NCT02384941|466485861|FG001|Overall Study|Withdrawal by Subject|19|||
129598010|NCT02384941|466485862|FG002|Overall Study|Withdrawal by Subject|20|||
129598011|NCT02384941|466485860|FG000|Overall Study|Pregnancy|0|||
129598012|NCT02384941|466485861|FG001|Overall Study|Pregnancy|0|||
129598013|NCT02384941|466485862|FG002|Overall Study|Pregnancy|1|||
129598014|NCT02384941|466485860|FG000|Overall Study|Other than specified above|4|||
129598015|NCT02384941|466485861|FG001|Overall Study|Other than specified above|0|||
129598016|NCT02384941|466485862|FG002|Overall Study|Other than specified above|1|||
129598017|NCT02493777|466485863|FG000|Overall Study|Lost to Follow-up|0|||
129598018|NCT02493777|466485864|FG001|Overall Study|Lost to Follow-up|1|||
129598019|NCT01642914|466485865|FG000|Overall Study|Adverse Event|11|||
129598020|NCT01642914|466485866|FG001|Overall Study|Adverse Event|7|||
129598021|NCT01642914|466485867|FG002|Overall Study|Adverse Event|15|||
129598022|NCT01642914|466485865|FG000|Overall Study|Lack of Efficacy|9|||
129598023|NCT01642914|466485866|FG001|Overall Study|Lack of Efficacy|4|||
129598024|NCT01642914|466485867|FG002|Overall Study|Lack of Efficacy|2|||
129598025|NCT01642914|466485865|FG000|Overall Study|Protocol Violation|15|||
129598026|NCT01642914|466485866|FG001|Overall Study|Protocol Violation|13|||
129598027|NCT01642914|466485867|FG002|Overall Study|Protocol Violation|6|||
129598028|NCT01642914|466485865|FG000|Overall Study|Withdrawal by Subject|5|||
129598029|NCT01642914|466485866|FG001|Overall Study|Withdrawal by Subject|5|||
129598030|NCT01642914|466485867|FG002|Overall Study|Withdrawal by Subject|10|||
129598031|NCT01642914|466485865|FG000|Overall Study|Lost to Follow-up|5|||
129598032|NCT01642914|466485866|FG001|Overall Study|Lost to Follow-up|3|||
129598033|NCT01642914|466485867|FG002|Overall Study|Lost to Follow-up|7|||
129598034|NCT01642914|466485865|FG000|Overall Study|Other Reason|1|||
129598035|NCT01642914|466485866|FG001|Overall Study|Other Reason|0|||
129598036|NCT01642914|466485867|FG002|Overall Study|Other Reason|0|||
129598037|NCT02370914|466485868|FG000|Overall Study|Protocol Violation|2|||
129885639|NCT02855164|467540773|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
129598038|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
129598039|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
129598040|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
129598041|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
129598042|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
129598043|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
129598044|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
129598045|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
129598046|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
129598047|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
129598048|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
129598049|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
129598050|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129598051|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129598052|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129598053|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129598054|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
129598055|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
129598056|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
129598057|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
129598058|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
129598059|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
129598060|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
129598061|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
129598062|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
129598063|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
129598064|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
129598065|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
129598066|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Death|0|||
129598067|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Death|1|||
129598068|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Death|0|||
129598069|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Death|0|||
129598070|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
129598071|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
129598072|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
129598073|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
129598074|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
129598075|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
129598076|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
129598077|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
129598078|NCT02990806|466485872|FG000|Stage 1 (22 Weeks)|Other|1|||
129598079|NCT02990806|466485873|FG001|Stage 1 (22 Weeks)|Other|3|||
129598080|NCT02990806|466485874|FG002|Stage 1 (22 Weeks)|Other|0|||
129598081|NCT02990806|466485875|FG003|Stage 1 (22 Weeks)|Other|0|||
129598082|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
129598083|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
129598084|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
129598085|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
129598086|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Death|1|||
129598087|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Death|0|||
129598088|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Death|0|||
129598089|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Death|0|||
129598090|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
129598091|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
129598092|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
129598093|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
129598094|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
129598095|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
129598096|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
129598097|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
129598098|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
129598099|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
129598100|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
129598101|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
129598102|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
129598103|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
129598104|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
129598105|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
129598106|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129598107|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129598108|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
129598109|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
129598110|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
129598111|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
129598112|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
129598113|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
129598114|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
129598115|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
129598116|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
129598117|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
129598118|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
129598119|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
129598120|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
129598121|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
129598122|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
129598123|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
129598124|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
129598125|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
129598126|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Other|3|||
129598127|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Other|0|||
129598128|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Other|4|||
129598129|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Other|1|||
129598130|NCT02990806|466485872|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
129598131|NCT02990806|466485873|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
129598132|NCT02990806|466485874|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
129598133|NCT02990806|466485875|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
129598134|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
129598135|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
129598136|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
129598137|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
129598138|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
129598139|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
129598140|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
129598141|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
129696783|NCT00089583|466848193|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
129696784|NCT00089583|466848194|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
129696785|NCT00089583|466848193|FG000|Overall Study|Participant Refused Study Medication|0|||
129696786|NCT00089583|466848194|FG001|Overall Study|Participant Refused Study Medication|2|||
129696787|NCT00089583|466848193|FG000|Overall Study|Non-Compliance|0|||
129696788|NCT00089583|466848194|FG001|Overall Study|Non-Compliance|4|||
129696789|NCT00089583|466848193|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
129696790|NCT00089583|466848194|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
129696791|NCT00089583|466848193|FG000|Overall Study|Participant Management Criteria Met|0|||
129696792|NCT00089583|466848194|FG001|Overall Study|Participant Management Criteria Met|1|||
129696793|NCT00089583|466848193|FG000|Overall Study|Reason Not Provided|0|||
129696794|NCT00089583|466848194|FG001|Overall Study|Reason Not Provided|1|||
129696795|NCT00089583|466848193|FG000|Overall Study|Protocol Violation|0|||
129696796|NCT00089583|466848194|FG001|Overall Study|Protocol Violation|3|||
129696797|NCT00089583|466848193|FG000|Overall Study|Principal Investigator Decision|0|||
129696798|NCT00089583|466848194|FG001|Overall Study|Principal Investigator Decision|10|||
129696799|NCT00089583|466848193|FG000|Overall Study|Start of Disallowed Medication|0|||
129696800|NCT00089583|466848194|FG001|Overall Study|Start of Disallowed Medication|1|||
129696801|NCT00089583|466848193|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
129696802|NCT00089583|466848194|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
129696803|NCT00089583|466848193|FG000|Overall Study|Participant Incarcerated|0|||
129696804|NCT00089583|466848194|FG001|Overall Study|Participant Incarcerated|1|||
129696805|NCT00507507|466848195|FG000|Treatment Period|Lost to Follow-up|0|||
129696806|NCT00507507|466848196|FG001|Treatment Period|Lost to Follow-up|2|||
129696807|NCT00507507|466848195|FG000|Treatment Period|Physician Decision|4|||
129696808|NCT00507507|466848196|FG001|Treatment Period|Physician Decision|1|||
129696809|NCT00507507|466848195|FG000|Treatment Period|Protocol Violation|1|||
129696810|NCT00507507|466848196|FG001|Treatment Period|Protocol Violation|2|||
129696811|NCT00507507|466848195|FG000|Treatment Period|Adverse Event|1|||
129696812|NCT00507507|466848196|FG001|Treatment Period|Adverse Event|1|||
129696813|NCT00507507|466848195|FG000|Treatment Period|Withdrawal by Subject|46|||
129696814|NCT00507507|466848196|FG001|Treatment Period|Withdrawal by Subject|47|||
129696815|NCT00507507|466848195|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
129696816|NCT00507507|466848196|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
129696817|NCT00507507|466848195|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
129696818|NCT00507507|466848196|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
129696819|NCT00507507|466848195|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
129696820|NCT00507507|466848196|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
129696821|NCT02916433|466848197|FG000|Overall Study|Withdrawal by Subject|1|||
129696822|NCT02916433|466848198|FG001|Overall Study|Withdrawal by Subject|0|||
129696823|NCT02916433|466848197|FG000|Overall Study|Physician Decision|1|||
129696824|NCT02916433|466848198|FG001|Overall Study|Physician Decision|0|||
129696825|NCT03760666|466848199|FG000|Overall Study|Adverse Event|2|||
129696826|NCT03760666|466848200|FG001|Overall Study|Adverse Event|4|||
129696827|NCT03760666|466848201|FG002|Overall Study|Adverse Event|1|||
129696828|NCT03760666|466848199|FG000|Overall Study|AML Disease Progression|3|||
129696829|NCT03760666|466848200|FG001|Overall Study|AML Disease Progression|3|||
129696830|NCT03760666|466848201|FG002|Overall Study|AML Disease Progression|0|||
129696831|NCT03760666|466848199|FG000|Overall Study|Physician Decision|0|||
129696832|NCT03760666|466848200|FG001|Overall Study|Physician Decision|3|||
129696833|NCT03760666|466848201|FG002|Overall Study|Physician Decision|0|||
129696834|NCT03760666|466848199|FG000|Overall Study|Withdrawal by Subject|0|||
129598142|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129598143|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
129598144|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129598145|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
129598146|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
129598147|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
129598148|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
129598149|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
129598150|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
129598151|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
129598152|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
129598153|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
129598154|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
129598155|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
129598156|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
129598157|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
129598158|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
129598159|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
129598160|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
129598161|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
129598162|NCT02990806|466485872|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
129598163|NCT02990806|466485873|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
129598164|NCT02990806|466485874|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
129598165|NCT02990806|466485875|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
129598166|NCT00977431|466485876|FG000|Overall Study|Other than listed|1|||
129598167|NCT00977431|466485877|FG001|Overall Study|Other than listed|0|||
129696835|NCT03760666|466848200|FG001|Overall Study|Withdrawal by Subject|1|||
129696836|NCT03760666|466848201|FG002|Overall Study|Withdrawal by Subject|0|||
129696837|NCT01623154|466848202|FG000|Overall Study|Did not drink Pranactin Citric|4|||
129696838|NCT00890097|466848203|FG000|Overall Study|Adverse Event|21|||
129696839|NCT00890097|466848204|FG001|Overall Study|Adverse Event|32|||
129696840|NCT00890097|466848205|FG002|Overall Study|Adverse Event|28|||
129696841|NCT00890097|466848203|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
129696842|NCT00890097|466848204|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
129696843|NCT00890097|466848205|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
129696844|NCT00890097|466848203|FG000|Overall Study|Withdrew Consent|9|||
129696845|NCT00890097|466848204|FG001|Overall Study|Withdrew Consent|6|||
129696846|NCT00890097|466848205|FG002|Overall Study|Withdrew Consent|9|||
129696847|NCT00890097|466848203|FG000|Overall Study|Lost to Follow-up|5|||
129696848|NCT00890097|466848204|FG001|Overall Study|Lost to Follow-up|5|||
129696849|NCT00890097|466848205|FG002|Overall Study|Lost to Follow-up|5|||
129696850|NCT00890097|466848203|FG000|Overall Study|Noncompliance|0|||
129696851|NCT00890097|466848204|FG001|Overall Study|Noncompliance|4|||
129696852|NCT00890097|466848205|FG002|Overall Study|Noncompliance|4|||
129696853|NCT00890097|466848203|FG000|Overall Study|Sponsor Decision|7|||
129696854|NCT00890097|466848204|FG001|Overall Study|Sponsor Decision|11|||
129696855|NCT00890097|466848205|FG002|Overall Study|Sponsor Decision|7|||
129696856|NCT00890097|466848203|FG000|Overall Study|Did not attend final visit|2|||
129696857|NCT00890097|466848204|FG001|Overall Study|Did not attend final visit|3|||
129696858|NCT00890097|466848205|FG002|Overall Study|Did not attend final visit|0|||
129696859|NCT00890097|466848203|FG000|Overall Study|Subject Decision|3|||
129696860|NCT00890097|466848204|FG001|Overall Study|Subject Decision|2|||
129696861|NCT00890097|466848205|FG002|Overall Study|Subject Decision|6|||
129696862|NCT00890097|466848203|FG000|Overall Study|Randomization Error|2|||
129696863|NCT00890097|466848204|FG001|Overall Study|Randomization Error|0|||
129696864|NCT00890097|466848205|FG002|Overall Study|Randomization Error|0|||
129696865|NCT00890097|466848203|FG000|Overall Study|Failed inclusion criteria|3|||
129696866|NCT00890097|466848204|FG001|Overall Study|Failed inclusion criteria|4|||
129696867|NCT00890097|466848205|FG002|Overall Study|Failed inclusion criteria|0|||
129696868|NCT00890097|466848203|FG000|Overall Study|Transportation|0|||
129696869|NCT00890097|466848204|FG001|Overall Study|Transportation|2|||
129696870|NCT00890097|466848205|FG002|Overall Study|Transportation|0|||
129696871|NCT00890097|466848203|FG000|Overall Study|Subject Moved|0|||
129696872|NCT00890097|466848204|FG001|Overall Study|Subject Moved|4|||
129696873|NCT00890097|466848205|FG002|Overall Study|Subject Moved|0|||
129696874|NCT00890097|466848203|FG000|Overall Study|Protocol Deviation|1|||
129696875|NCT00890097|466848204|FG001|Overall Study|Protocol Deviation|1|||
129696876|NCT00890097|466848205|FG002|Overall Study|Protocol Deviation|1|||
129696877|NCT02656173|466848209|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
129696878|NCT02656173|466848210|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
129696879|NCT02656173|466848209|FG000|Overall Study|Adverse Event|7|||
129598168|NCT00977431|466485878|FG002|Overall Study|Other than listed|0|||
129598169|NCT00977431|466485879|FG003|Overall Study|Other than listed|0|||
129598170|NCT00977431|466485880|FG004|Overall Study|Other than listed|2|||
129598171|NCT00977431|466485876|FG000|Overall Study|Protocol Violation|0|||
129598172|NCT00977431|466485877|FG001|Overall Study|Protocol Violation|0|||
129598173|NCT00977431|466485878|FG002|Overall Study|Protocol Violation|1|||
129598174|NCT00977431|466485879|FG003|Overall Study|Protocol Violation|0|||
129598175|NCT00977431|466485880|FG004|Overall Study|Protocol Violation|0|||
129598176|NCT00977431|466485876|FG000|Overall Study|Adverse Event|3|||
129598177|NCT00977431|466485877|FG001|Overall Study|Adverse Event|0|||
129598178|NCT00977431|466485878|FG002|Overall Study|Adverse Event|4|||
129598179|NCT00977431|466485879|FG003|Overall Study|Adverse Event|0|||
129598180|NCT00977431|466485880|FG004|Overall Study|Adverse Event|6|||
129696880|NCT02656173|466848210|FG001|Overall Study|Adverse Event|5|||
129696881|NCT02656173|466848209|FG000|Overall Study|Withdrawal by Subject|1|||
129696882|NCT02656173|466848210|FG001|Overall Study|Withdrawal by Subject|3|||
129696883|NCT02656173|466848209|FG000|Overall Study|Protocol Violation|0|||
129696884|NCT02656173|466848210|FG001|Overall Study|Protocol Violation|1|||
129696885|NCT02656173|466848209|FG000|Overall Study|Miscellaneous|2|||
129696886|NCT02656173|466848210|FG001|Overall Study|Miscellaneous|0|||
129696887|NCT01064622|466848211|FG000|Randomized Phase II|Withdrawal by Subject|2|||
129696888|NCT01064622|466848212|FG001|Randomized Phase II|Withdrawal by Subject|2|||
129696889|NCT01064622|466848211|FG000|Randomized Phase II|Protocol Violation|0|||
129696890|NCT01064622|466848212|FG001|Randomized Phase II|Protocol Violation|1|||
129696891|NCT03449147|466848213|FG000|52-week Treatment Period|Death|0|||
129696892|NCT03449147|466848214|FG001|52-week Treatment Period|Death|1|||
129696893|NCT03449147|466848215|FG002|52-week Treatment Period|Death|0|||
129696894|NCT03449147|466848213|FG000|52-week Treatment Period|Lost to Follow-up|6|||
129696895|NCT03449147|466848214|FG001|52-week Treatment Period|Lost to Follow-up|2|||
129696896|NCT03449147|466848215|FG002|52-week Treatment Period|Lost to Follow-up|5|||
129696897|NCT03449147|466848213|FG000|52-week Treatment Period|Other|0|||
129696898|NCT03449147|466848214|FG001|52-week Treatment Period|Other|1|||
129696899|NCT03449147|466848215|FG002|52-week Treatment Period|Other|2|||
129696900|NCT03449147|466848213|FG000|52-week Treatment Period|Physician Decision|1|||
129696901|NCT03449147|466848214|FG001|52-week Treatment Period|Physician Decision|0|||
129696902|NCT03449147|466848215|FG002|52-week Treatment Period|Physician Decision|3|||
129696903|NCT03449147|466848213|FG000|52-week Treatment Period|Screen Failure|1|||
129696904|NCT03449147|466848214|FG001|52-week Treatment Period|Screen Failure|2|||
129696905|NCT03449147|466848215|FG002|52-week Treatment Period|Screen Failure|0|||
129696906|NCT03449147|466848213|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
129696907|NCT03449147|466848214|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
129696908|NCT03449147|466848215|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
129696909|NCT03449147|466848213|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
129696910|NCT03449147|466848214|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
129696911|NCT03449147|466848215|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
129696912|NCT03449147|466848213|FG000|12-Week Off-Treatment Durability Period|Other|0|||
129696913|NCT03449147|466848214|FG001|12-Week Off-Treatment Durability Period|Other|1|||
129696914|NCT03449147|466848215|FG002|12-Week Off-Treatment Durability Period|Other|0|||
129696915|NCT00974233|466848219|FG000|Induction Chemoimmunotherapy|Death|2|||
129696916|NCT00974233|466848219|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
129696917|NCT00974233|466848219|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
129696918|NCT00974233|466848219|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
129696919|NCT00974233|466848219|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
129696920|NCT00974233|466848219|FG000|Maintenance Lenalidomide|Adverse Event|8|||
129696921|NCT01691092|466848220|FG000|Overall Study|Lost to Follow-up|10|||
129696922|NCT01691092|466848220|FG000|Overall Study|Physician Decision|4|||
129696923|NCT01691092|466848220|FG000|Overall Study|Withdrawal by Subject|3|||
129696924|NCT01691092|466848220|FG000|Overall Study|non-compliance|3|||
129696925|NCT01691092|466848220|FG000|Overall Study|used for different study|2|||
129696926|NCT01691092|466848220|FG000|Overall Study|screen fail|19|||
129696927|NCT01657942|466848221|FG000|Overall Study|Alternative Treatment|7|||
129696928|NCT01657942|466848221|FG000|Overall Study|Lost to Follow-up|1|||
129696929|NCT01569763|466850039|FG000|Overall Study|Lack of Efficacy|2|||
129696930|NCT01569763|466850040|FG001|Overall Study|Lack of Efficacy|7|||
129696931|NCT01569763|466850039|FG000|Overall Study|Adverse Event|1|||
129696932|NCT01569763|466850040|FG001|Overall Study|Adverse Event|0|||
129696933|NCT02730169|466850041|FG000|Overall Study|Protocol Violation|1|||
129696934|NCT02730169|466850042|FG001|Overall Study|Protocol Violation|0|||
129786597|NCT01325337|467187104|FG001|Overall Study|Lost to Follow-up|2|||
129786598|NCT01325337|467187105|FG002|Overall Study|Lost to Follow-up|2|||
129786599|NCT01325337|467187106|FG003|Overall Study|Lost to Follow-up|1|||
129786600|NCT01325337|467187107|FG004|Overall Study|Lost to Follow-up|2|||
129786601|NCT01325337|467187103|FG000|Overall Study|Personal Reasons|2|||
129786602|NCT01325337|467187104|FG001|Overall Study|Personal Reasons|5|||
129786603|NCT01325337|467187105|FG002|Overall Study|Personal Reasons|4|||
129786604|NCT01325337|467187106|FG003|Overall Study|Personal Reasons|8|||
129598181|NCT00977431|466485876|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
129598182|NCT00977431|466485877|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
129598183|NCT00977431|466485878|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
129598184|NCT00977431|466485879|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
129598185|NCT00977431|466485880|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
129598186|NCT00977431|466485876|FG000|Overall Study|Progressive disease|2|||
129598187|NCT00977431|466485877|FG001|Overall Study|Progressive disease|6|||
129598188|NCT00977431|466485878|FG002|Overall Study|Progressive disease|1|||
129598189|NCT00977431|466485879|FG003|Overall Study|Progressive disease|3|||
129598190|NCT00977431|466485880|FG004|Overall Study|Progressive disease|5|||
129598191|NCT01010750|466485881|FG000|Second Intervention|Adverse Event|0|||
129598192|NCT01010750|466485882|FG001|Second Intervention|Adverse Event|1|||
129598193|NCT01010750|466485883|FG002|Second Intervention|Adverse Event|0|||
129598194|NCT01010750|466485884|FG003|Second Intervention|Adverse Event|0|||
129598195|NCT01010750|466485885|FG004|Second Intervention|Adverse Event|0|||
129598196|NCT01010750|466485886|FG005|Second Intervention|Adverse Event|0|||
129598197|NCT03739138|466485888|FG000|Overall Study|Death|0|||
129598198|NCT03739138|466485889|FG001|Overall Study|Death|7|||
129598199|NCT03739138|466485890|FG002|Overall Study|Death|4|||
129598200|NCT03739138|466485891|FG003|Overall Study|Death|13|||
129598201|NCT03739138|466485892|FG004|Overall Study|Death|0|||
129598202|NCT03739138|466485888|FG000|Overall Study|Lost to Follow-up|0|||
129598203|NCT03739138|466485889|FG001|Overall Study|Lost to Follow-up|0|||
129598204|NCT03739138|466485890|FG002|Overall Study|Lost to Follow-up|1|||
129598205|NCT03739138|466485891|FG003|Overall Study|Lost to Follow-up|0|||
129598206|NCT03739138|466485892|FG004|Overall Study|Lost to Follow-up|0|||
129598207|NCT03739138|466485888|FG000|Overall Study|Study Terminated By Sponsor|0|||
129598208|NCT03739138|466485889|FG001|Overall Study|Study Terminated By Sponsor|0|||
129598209|NCT03739138|466485890|FG002|Overall Study|Study Terminated By Sponsor|0|||
129598210|NCT03739138|466485891|FG003|Overall Study|Study Terminated By Sponsor|4|||
129598211|NCT03739138|466485892|FG004|Overall Study|Study Terminated By Sponsor|0|||
129598212|NCT03739138|466485888|FG000|Overall Study|Withdrawal by Subject|0|||
129598213|NCT03739138|466485889|FG001|Overall Study|Withdrawal by Subject|0|||
129598214|NCT03739138|466485890|FG002|Overall Study|Withdrawal by Subject|0|||
129598215|NCT03739138|466485891|FG003|Overall Study|Withdrawal by Subject|1|||
129598216|NCT03739138|466485892|FG004|Overall Study|Withdrawal by Subject|0|||
129598217|NCT02654587|466485893|FG000|Overall Study|patient alive at end of study|22|||
129786605|NCT01325337|467187107|FG004|Overall Study|Personal Reasons|3|||
129786606|NCT01325337|467187103|FG000|Overall Study|Withdrawal by Subject|1|||
129598218|NCT02654587|466485894|FG001|Overall Study|patient alive at end of study|8|||
129598219|NCT02654587|466485893|FG000|Overall Study|Withdrawal by Subject|1|||
129598220|NCT02654587|466485894|FG001|Overall Study|Withdrawal by Subject|7|||
129598221|NCT01825837|466485895|FG000|PART I|Withdrawal by Subject|0|||
129598222|NCT01825837|466485896|FG001|PART I|Withdrawal by Subject|0|||
129598223|NCT01825837|466485897|FG002|PART I|Withdrawal by Subject|0|||
129598224|NCT01825837|466485898|FG003|PART I|Withdrawal by Subject|6|||
129598225|NCT01825837|466485895|FG000|PART I|Patient non-compliance|0|||
129598226|NCT01825837|466485896|FG001|PART I|Patient non-compliance|0|||
129598227|NCT01825837|466485897|FG002|PART I|Patient non-compliance|0|||
129598228|NCT01825837|466485898|FG003|PART I|Patient non-compliance|1|||
129598229|NCT01825837|466485895|FG000|PART I|Treatment failure|0|||
129598230|NCT01825837|466485896|FG001|PART I|Treatment failure|0|||
129598231|NCT01825837|466485897|FG002|PART I|Treatment failure|0|||
129598232|NCT01825837|466485898|FG003|PART I|Treatment failure|7|||
129598233|NCT01825837|466485895|FG000|PART I|reason unspecified|0|||
129598234|NCT01825837|466485896|FG001|PART I|reason unspecified|0|||
129598235|NCT01825837|466485897|FG002|PART I|reason unspecified|0|||
129598236|NCT01825837|466485898|FG003|PART I|reason unspecified|3|||
129598237|NCT01825837|466485895|FG000|PART II|Withdrawal by Subject|3|||
129598238|NCT01825837|466485896|FG001|PART II|Withdrawal by Subject|3|||
129598239|NCT01825837|466485897|FG002|PART II|Withdrawal by Subject|7|||
129598240|NCT01825837|466485898|FG003|PART II|Withdrawal by Subject|0|||
129598241|NCT01825837|466485895|FG000|PART II|Patient non-compliance|5|||
129786607|NCT01325337|467187104|FG001|Overall Study|Withdrawal by Subject|0|||
129786608|NCT01325337|467187105|FG002|Overall Study|Withdrawal by Subject|1|||
129786609|NCT01325337|467187106|FG003|Overall Study|Withdrawal by Subject|0|||
129786610|NCT01325337|467187107|FG004|Overall Study|Withdrawal by Subject|1|||
129786611|NCT02184455|467187115|FG000|Overall Study|Lost to Follow-up|1|||
129786612|NCT01347580|467187116|FG000|Overall Study|Withdrawal by Subject|13|||
129786613|NCT01347580|467187117|FG001|Overall Study|Withdrawal by Subject|23|||
129786614|NCT01347580|467187116|FG000|Overall Study|Death|30|||
129598242|NCT01825837|466485896|FG001|PART II|Patient non-compliance|2|||
129598243|NCT01825837|466485897|FG002|PART II|Patient non-compliance|4|||
129598244|NCT01825837|466485898|FG003|PART II|Patient non-compliance|0|||
129598245|NCT01825837|466485895|FG000|PART II|Adverse Event|3|||
129598246|NCT01825837|466485896|FG001|PART II|Adverse Event|3|||
129598247|NCT01825837|466485897|FG002|PART II|Adverse Event|1|||
129598248|NCT01825837|466485898|FG003|PART II|Adverse Event|0|||
129598249|NCT01825837|466485895|FG000|PART II|Treatment failure|6|||
129598250|NCT01825837|466485896|FG001|PART II|Treatment failure|4|||
129786615|NCT01347580|467187117|FG001|Overall Study|Death|19|||
129786616|NCT01347580|467187116|FG000|Overall Study|Protocol Violation|10|||
129598251|NCT01825837|466485897|FG002|PART II|Treatment failure|5|||
129598252|NCT01825837|466485898|FG003|PART II|Treatment failure|0|||
129598253|NCT01825837|466485895|FG000|PART II|reason unspecified|2|||
129598254|NCT01825837|466485896|FG001|PART II|reason unspecified|2|||
129598255|NCT01825837|466485897|FG002|PART II|reason unspecified|2|||
129598256|NCT01825837|466485898|FG003|PART II|reason unspecified|0|||
129598257|NCT00904748|466485899|FG000|Overall Study|Withdrawal by Subject|1|||
129598258|NCT00904748|466485900|FG001|Overall Study|Withdrawal by Subject|1|||
129598259|NCT00904748|466485901|FG002|Overall Study|Withdrawal by Subject|1|||
129598260|NCT00904748|466485902|FG003|Overall Study|Withdrawal by Subject|2|||
129598261|NCT00904748|466485903|FG004|Overall Study|Withdrawal by Subject|0|||
129598262|NCT00904748|466485904|FG005|Overall Study|Withdrawal by Subject|0|||
129598263|NCT00904748|466485899|FG000|Overall Study|Adverse Event|0|||
129598264|NCT00904748|466485900|FG001|Overall Study|Adverse Event|0|||
129598265|NCT00904748|466485901|FG002|Overall Study|Adverse Event|0|||
129598266|NCT00904748|466485902|FG003|Overall Study|Adverse Event|0|||
129598267|NCT00904748|466485903|FG004|Overall Study|Adverse Event|1|||
129598268|NCT00904748|466485904|FG005|Overall Study|Adverse Event|0|||
129598269|NCT02903238|466485911|FG000|Overall Study|Lost to Follow-up|4|||
129598270|NCT00700817|466485915|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
129598271|NCT00700817|466485916|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
129598272|NCT00700817|466485917|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
129598273|NCT00700817|466485918|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
129598274|NCT00700817|466485919|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
129598275|NCT00700817|466485915|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
129598276|NCT00700817|466485916|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
129598277|NCT00700817|466485917|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
129598278|NCT00700817|466485918|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
129598279|NCT00700817|466485919|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
129598280|NCT00700817|466485915|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
129598281|NCT00700817|466485916|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
129598282|NCT00700817|466485917|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
129598283|NCT00700817|466485918|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
129598284|NCT00700817|466485919|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
129598285|NCT00700817|466485915|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
129786617|NCT01347580|467187117|FG001|Overall Study|Protocol Violation|7|||
129786618|NCT01347580|467187116|FG000|Overall Study|Lost to Follow-up|3|||
129786619|NCT01347580|467187117|FG001|Overall Study|Lost to Follow-up|1|||
129786620|NCT01347580|467187116|FG000|Overall Study|Had other reason|9|||
129786621|NCT01347580|467187117|FG001|Overall Study|Had other reason|6|||
129786622|NCT01964755|467187120|FG000|Overall Study|Death|2|||
129786623|NCT02894502|467187121|FG000|Baseline|Withdrawal by Subject|24|||
129786624|NCT02894502|467187122|FG001|Baseline|Withdrawal by Subject|31|||
129786625|NCT02894502|467187123|FG002|Baseline|Withdrawal by Subject|36|||
129786626|NCT02894502|467187121|FG000|Baseline|Death|3|||
129786627|NCT02894502|467187122|FG001|Baseline|Death|1|||
129786628|NCT02894502|467187123|FG002|Baseline|Death|9|||
129786629|NCT02894502|467187121|FG000|First Follow up|Withdrawal by Subject|32|||
129786630|NCT02894502|467187122|FG001|First Follow up|Withdrawal by Subject|29|||
129786631|NCT02894502|467187123|FG002|First Follow up|Withdrawal by Subject|37|||
129786632|NCT02894502|467187121|FG000|First Follow up|Death|2|||
129786633|NCT02894502|467187122|FG001|First Follow up|Death|2|||
129786634|NCT02894502|467187123|FG002|First Follow up|Death|3|||
129786635|NCT02894502|467187121|FG000|Second Follow up|Withdrawal by Subject|13|||
129786636|NCT02894502|467187122|FG001|Second Follow up|Withdrawal by Subject|15|||
129786637|NCT02894502|467187123|FG002|Second Follow up|Withdrawal by Subject|13|||
129786638|NCT02894502|467187121|FG000|Second Follow up|Death|2|||
129786639|NCT02894502|467187122|FG001|Second Follow up|Death|3|||
129786640|NCT02894502|467187123|FG002|Second Follow up|Death|1|||
129598286|NCT00700817|466485916|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
129598287|NCT00700817|466485917|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
129598288|NCT00700817|466485918|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
129598289|NCT00700817|466485919|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
129598290|NCT00700817|466485915|FG000|Week 0-26 (Main Period)|Unclassified|14|||
129598291|NCT00700817|466485916|FG001|Week 0-26 (Main Period)|Unclassified|4|||
129598292|NCT00700817|466485917|FG002|Week 0-26 (Main Period)|Unclassified|8|||
129598293|NCT00700817|466485918|FG003|Week 0-26 (Main Period)|Unclassified|0|||
129598294|NCT00700817|466485919|FG004|Week 0-26 (Main Period)|Unclassified|0|||
129786641|NCT02894502|467187121|FG000|Third Follow up|Withdrawal by Subject|5|||
129786642|NCT02894502|467187122|FG001|Third Follow up|Withdrawal by Subject|6|||
129786643|NCT02894502|467187123|FG002|Third Follow up|Withdrawal by Subject|3|||
129786644|NCT02894502|467187121|FG000|Third Follow up|Death|1|||
129786645|NCT02894502|467187122|FG001|Third Follow up|Death|1|||
129786646|NCT02894502|467187123|FG002|Third Follow up|Death|0|||
129786647|NCT01332799|467187127|FG000|Overall Study|Insufficient funding|10|||
129786648|NCT01332799|467187128|FG001|Overall Study|Insufficient funding|10|||
129598295|NCT00700817|466485915|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
129598296|NCT00700817|466485916|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
129598297|NCT00700817|466485917|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
129598298|NCT00700817|466485918|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
129598299|NCT00700817|466485919|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
129598300|NCT00700817|466485915|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
129598301|NCT00700817|466485916|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
129598302|NCT00700817|466485917|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
129598303|NCT00700817|466485918|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
129598304|NCT00700817|466485919|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
129598305|NCT00700817|466485915|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
129598306|NCT00700817|466485916|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
129598307|NCT00700817|466485917|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
129598308|NCT00700817|466485918|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
129598309|NCT00700817|466485919|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
129598310|NCT00700817|466485915|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
129598311|NCT00700817|466485916|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
129598312|NCT00700817|466485917|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
129598313|NCT00700817|466485918|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
129598314|NCT00700817|466485919|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
129598315|NCT00700817|466485915|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
129598316|NCT00700817|466485916|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
129598317|NCT00700817|466485917|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
129598318|NCT00700817|466485918|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
129598319|NCT00700817|466485919|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
129598320|NCT00700817|466485915|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
129598321|NCT00700817|466485916|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
129598322|NCT00700817|466485917|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
129598323|NCT00700817|466485918|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
129598324|NCT00700817|466485919|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
129598325|NCT00700817|466485915|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
129598326|NCT00700817|466485916|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
129598327|NCT00700817|466485917|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
129598328|NCT00700817|466485918|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
129786649|NCT02168387|467187131|FG000|Overall Study|Planned exubation|6|||
129786650|NCT02168387|467187132|FG001|Overall Study|Planned exubation|3|||
129786651|NCT02168387|467187131|FG000|Overall Study|Death|1|||
129786652|NCT02168387|467187132|FG001|Overall Study|Death|0|||
129786653|NCT03467152|467187133|FG000|Overall Study|Adverse Event|4|||
129786654|NCT03467152|467187134|FG001|Overall Study|Adverse Event|5|||
129786655|NCT03467152|467187135|FG002|Overall Study|Adverse Event|0|||
129786656|NCT03467152|467187133|FG000|Overall Study|Subject Choice|1|||
129786657|NCT03467152|467187134|FG001|Overall Study|Subject Choice|3|||
129786658|NCT03467152|467187135|FG002|Overall Study|Subject Choice|0|||
129786659|NCT03467152|467187133|FG000|Overall Study|Lost to Follow-up|1|||
129786660|NCT03467152|467187134|FG001|Overall Study|Lost to Follow-up|0|||
129786661|NCT03467152|467187135|FG002|Overall Study|Lost to Follow-up|0|||
129786662|NCT03467152|467187133|FG000|Overall Study|Withdrawal by Subject|4|||
129786663|NCT03467152|467187134|FG001|Overall Study|Withdrawal by Subject|2|||
129786664|NCT03467152|467187135|FG002|Overall Study|Withdrawal by Subject|0|||
129786665|NCT03467152|467187133|FG000|Overall Study|Others|3|||
129786666|NCT03467152|467187134|FG001|Overall Study|Others|0|||
129786667|NCT03467152|467187135|FG002|Overall Study|Others|0|||
129786668|NCT03467152|467187133|FG000|Overall Study|Not treated|3|||
129786669|NCT03467152|467187134|FG001|Overall Study|Not treated|1|||
129786670|NCT03467152|467187135|FG002|Overall Study|Not treated|6|||
129786671|NCT01236547|467187136|FG000|Overall Study|Protocol Violation|0|||
129786672|NCT01236547|467187137|FG001|Overall Study|Protocol Violation|1|||
129786673|NCT01236547|467187138|FG002|Overall Study|Protocol Violation|1|||
129598329|NCT00700817|466485919|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
129598330|NCT00700817|466485915|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
129598331|NCT00700817|466485916|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
129598332|NCT00700817|466485917|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
129598333|NCT00700817|466485918|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
129598334|NCT00700817|466485919|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
129786674|NCT01236547|467187139|FG003|Overall Study|Protocol Violation|6|||
129786675|NCT01236547|467187140|FG004|Overall Study|Protocol Violation|12|||
129786676|NCT00910624|467187142|FG000|Treatment Phase|Adverse Event|2|||
129786677|NCT00910624|467187143|FG001|Treatment Phase|Adverse Event|6|||
129786678|NCT00910624|467187144|FG002|Treatment Phase|Adverse Event|6|||
129786679|NCT00910624|467187145|FG003|Treatment Phase|Adverse Event|0|||
129786680|NCT00910624|467187142|FG000|Treatment Phase|Treatment Failure|23|||
129786681|NCT00910624|467187143|FG001|Treatment Phase|Treatment Failure|10|||
129786682|NCT00910624|467187144|FG002|Treatment Phase|Treatment Failure|0|||
129598335|NCT00700817|466485915|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
129598336|NCT00700817|466485916|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
129598337|NCT00700817|466485917|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
129598338|NCT00700817|466485918|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
129598339|NCT00700817|466485919|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
129598340|NCT00700817|466485915|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
129598341|NCT00700817|466485916|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
129598342|NCT00700817|466485917|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
129598343|NCT00700817|466485918|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
129598344|NCT00700817|466485919|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
129598345|NCT00767520|466485920|FG000|Overall Study|Participants still on treatment|11|||
129598346|NCT00767520|466485921|FG001|Overall Study|Participants still on treatment|15|||
129598347|NCT00767520|466485920|FG000|Overall Study|Randomized in error and Never treated|0|||
129598348|NCT00767520|466485921|FG001|Overall Study|Randomized in error and Never treated|2|||
129598349|NCT01338987|466485924|FG000|Overall Study|enrolled on new protocol|0|||
129598350|NCT01338987|466485925|FG001|Overall Study|enrolled on new protocol|0|||
129598351|NCT01338987|466485926|FG002|Overall Study|enrolled on new protocol|1|||
129598352|NCT01338987|466485927|FG003|Overall Study|enrolled on new protocol|0|||
129598353|NCT01338987|466485928|FG004|Overall Study|enrolled on new protocol|0|||
129598354|NCT01338987|466485924|FG000|Overall Study|Disease progression on study|2|||
129598355|NCT01338987|466485925|FG001|Overall Study|Disease progression on study|1|||
129598356|NCT01338987|466485926|FG002|Overall Study|Disease progression on study|1|||
129598357|NCT01338987|466485927|FG003|Overall Study|Disease progression on study|0|||
129598358|NCT01338987|466485928|FG004|Overall Study|Disease progression on study|0|||
129598359|NCT00958126|466485937|FG000|Overall Study|Serious Adverse Event|0|||
129598360|NCT00958126|466485938|FG001|Overall Study|Serious Adverse Event|2|||
129598361|NCT00958126|466485939|FG002|Overall Study|Serious Adverse Event|0|||
129598362|NCT00958126|466485940|FG003|Overall Study|Serious Adverse Event|0|||
129598363|NCT00958126|466485941|FG004|Overall Study|Serious Adverse Event|0|||
129598364|NCT00958126|466485942|FG005|Overall Study|Serious Adverse Event|0|||
129598365|NCT00958126|466485943|FG006|Overall Study|Serious Adverse Event|1|||
129598366|NCT00958126|466485944|FG007|Overall Study|Serious Adverse Event|0|||
129598367|NCT00958126|466485937|FG000|Overall Study|Withdrawal by Subject|0|||
129598368|NCT00958126|466485938|FG001|Overall Study|Withdrawal by Subject|2|||
129598369|NCT00958126|466485939|FG002|Overall Study|Withdrawal by Subject|0|||
129598370|NCT00958126|466485940|FG003|Overall Study|Withdrawal by Subject|0|||
129598371|NCT00958126|466485941|FG004|Overall Study|Withdrawal by Subject|0|||
129598372|NCT00958126|466485942|FG005|Overall Study|Withdrawal by Subject|0|||
129598373|NCT00958126|466485943|FG006|Overall Study|Withdrawal by Subject|0|||
129598374|NCT00958126|466485944|FG007|Overall Study|Withdrawal by Subject|0|||
129598375|NCT00958126|466485937|FG000|Overall Study|Moved away from study area|0|||
129598376|NCT00958126|466485938|FG001|Overall Study|Moved away from study area|0|||
129598377|NCT00958126|466485939|FG002|Overall Study|Moved away from study area|1|||
129598378|NCT00958126|466485940|FG003|Overall Study|Moved away from study area|1|||
129598379|NCT00958126|466485941|FG004|Overall Study|Moved away from study area|0|||
129598380|NCT00958126|466485942|FG005|Overall Study|Moved away from study area|0|||
129598381|NCT00958126|466485943|FG006|Overall Study|Moved away from study area|0|||
129598382|NCT00958126|466485944|FG007|Overall Study|Moved away from study area|0|||
129598383|NCT00958126|466485937|FG000|Overall Study|Lost to Follow-up|1|||
129598384|NCT00958126|466485938|FG001|Overall Study|Lost to Follow-up|5|||
129598385|NCT00958126|466485939|FG002|Overall Study|Lost to Follow-up|9|||
129598386|NCT00958126|466485940|FG003|Overall Study|Lost to Follow-up|8|||
129598387|NCT00958126|466485941|FG004|Overall Study|Lost to Follow-up|0|||
129598388|NCT00958126|466485942|FG005|Overall Study|Lost to Follow-up|0|||
129598389|NCT00958126|466485943|FG006|Overall Study|Lost to Follow-up|0|||
129598390|NCT00958126|466485944|FG007|Overall Study|Lost to Follow-up|0|||
129598391|NCT00958126|466485937|FG000|Overall Study|Sponsor/Investigator decision|0|||
129598392|NCT00958126|466485938|FG001|Overall Study|Sponsor/Investigator decision|0|||
129598393|NCT00958126|466485939|FG002|Overall Study|Sponsor/Investigator decision|0|||
129598394|NCT00958126|466485940|FG003|Overall Study|Sponsor/Investigator decision|1|||
129598395|NCT00958126|466485941|FG004|Overall Study|Sponsor/Investigator decision|0|||
129598396|NCT00958126|466485942|FG005|Overall Study|Sponsor/Investigator decision|0|||
129598397|NCT00958126|466485943|FG006|Overall Study|Sponsor/Investigator decision|0|||
129598398|NCT00958126|466485944|FG007|Overall Study|Sponsor/Investigator decision|0|||
129598399|NCT00958126|466485937|FG000|Overall Study|Other Reason|0|||
129598400|NCT00958126|466485938|FG001|Overall Study|Other Reason|0|||
129598401|NCT00958126|466485939|FG002|Overall Study|Other Reason|0|||
129598402|NCT00958126|466485940|FG003|Overall Study|Other Reason|1|||
129598403|NCT00958126|466485941|FG004|Overall Study|Other Reason|0|||
129598404|NCT00958126|466485942|FG005|Overall Study|Other Reason|1|||
129598405|NCT00958126|466485943|FG006|Overall Study|Other Reason|0|||
129598406|NCT00958126|466485944|FG007|Overall Study|Other Reason|0|||
129598407|NCT00720226|466485945|FG000|Overall Study|Withdrawal by Subject|7|||
129598408|NCT00720226|466485946|FG001|Overall Study|Withdrawal by Subject|4|||
129598409|NCT00733369|466485947|FG000|Overall Study|Lost to Follow-up|2|||
129598410|NCT00733369|466485948|FG001|Overall Study|Lost to Follow-up|1|||
129598411|NCT00733369|466485947|FG000|Overall Study|Adverse Event|4|||
129598412|NCT00733369|466485948|FG001|Overall Study|Adverse Event|4|||
129598413|NCT00733369|466485947|FG000|Overall Study|Protocol Violation|4|||
129598414|NCT00733369|466485948|FG001|Overall Study|Protocol Violation|4|||
129598415|NCT03401073|466485951|FG000|Overall Study|Lost to Follow-up|1|||
129598416|NCT03401073|466485952|FG001|Overall Study|Lost to Follow-up|2|||
129598417|NCT01470612|466485956|FG000|Overall Study|Adverse Event|20|||
129598418|NCT01470612|466485957|FG001|Overall Study|Adverse Event|80|||
129598419|NCT01470612|466485956|FG000|Overall Study|Death|0|||
129598420|NCT01470612|466485957|FG001|Overall Study|Death|1|||
129598421|NCT01470612|466485956|FG000|Overall Study|Lack of Efficacy|20|||
129598422|NCT01470612|466485957|FG001|Overall Study|Lack of Efficacy|326|||
129598423|NCT01470612|466485956|FG000|Overall Study|Lost to Follow-up|2|||
129598424|NCT01470612|466485957|FG001|Overall Study|Lost to Follow-up|5|||
129598425|NCT01470612|466485956|FG000|Overall Study|Did not meet entrance criteria|0|||
129598426|NCT01470612|466485957|FG001|Overall Study|Did not meet entrance criteria|1|||
129598427|NCT01470612|466485956|FG000|Overall Study|Pregnancy|2|||
129598428|NCT01470612|466485957|FG001|Overall Study|Pregnancy|10|||
129598429|NCT01470612|466485956|FG000|Overall Study|Protocol Violation|2|||
129598430|NCT01470612|466485957|FG001|Overall Study|Protocol Violation|7|||
129598431|NCT01470612|466485956|FG000|Overall Study|Withdrawal by Subject|24|||
129598432|NCT01470612|466485957|FG001|Overall Study|Withdrawal by Subject|79|||
129598433|NCT01470612|466485956|FG000|Overall Study|Other|14|||
129598434|NCT01470612|466485957|FG001|Overall Study|Other|156|||
129598435|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
129598436|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
129598437|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
129598438|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
129598439|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
129598440|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
129598441|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
129598442|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
129598443|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
129598444|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
129598445|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
129598446|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
129598447|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
129598448|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
129598449|NCT02510014|466485961|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
129598450|NCT02510014|466485962|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
129598451|NCT02510014|466485961|FG000|Treatment Period|Adverse Event|11|||
129598452|NCT02510014|466485962|FG001|Treatment Period|Adverse Event|4|||
129598453|NCT02510014|466485961|FG000|Treatment Period|Withdrawal symptoms|3|||
129598454|NCT02510014|466485962|FG001|Treatment Period|Withdrawal symptoms|0|||
129598455|NCT02510014|466485961|FG000|Treatment Period|Lost to Follow-up|80|||
129598456|NCT02510014|466485962|FG001|Treatment Period|Lost to Follow-up|19|||
129598457|NCT02510014|466485961|FG000|Treatment Period|Physician Decision|5|||
129598458|NCT02510014|466485962|FG001|Treatment Period|Physician Decision|0|||
129598459|NCT02510014|466485961|FG000|Treatment Period|Withdrawal by Subject|67|||
129598460|NCT02510014|466485962|FG001|Treatment Period|Withdrawal by Subject|24|||
129598461|NCT02510014|466485961|FG000|Treatment Period|Withdrawn by the investigator|7|||
129598462|NCT02510014|466485962|FG001|Treatment Period|Withdrawn by the investigator|1|||
129598463|NCT02510014|466485961|FG000|Treatment Period|Protocol Violation|4|||
129598464|NCT02510014|466485962|FG001|Treatment Period|Protocol Violation|4|||
129598465|NCT02510014|466485961|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
129696935|NCT02730169|466850043|FG002|Overall Study|Protocol Violation|0|||
129696936|NCT02730169|466850044|FG003|Overall Study|Protocol Violation|1|||
129696937|NCT02730169|466850041|FG000|Overall Study|Adverse Event|2|||
129598466|NCT02510014|466485962|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
129598467|NCT02556307|466485966|FG000|Overall Study|Premature treatment interruption|11|||
129598468|NCT02556307|466485966|FG000|Overall Study|Lost to Follow-up|36|||
129598469|NCT02556307|466485966|FG000|Overall Study|Change to triple therapy|4|||
129598470|NCT02556307|466485966|FG000|Overall Study|Enrolled but not treated|2|||
129598471|NCT00384176|466485970|FG000|Overall Study|Death|239|||
129598472|NCT00384176|466485971|FG001|Overall Study|Death|247|||
129598473|NCT00384176|466485972|FG002|Overall Study|Death|105|||
129598474|NCT00384176|466485970|FG000|Overall Study|Withdrawal by Subject|52|||
129598475|NCT00384176|466485971|FG001|Overall Study|Withdrawal by Subject|48|||
129696938|NCT02730169|466850042|FG001|Overall Study|Adverse Event|3|||
129696939|NCT02730169|466850043|FG002|Overall Study|Adverse Event|3|||
129696940|NCT02730169|466850044|FG003|Overall Study|Adverse Event|0|||
129696941|NCT02730169|466850041|FG000|Overall Study|Adverse Event of Special Interest|0|||
129696942|NCT02730169|466850042|FG001|Overall Study|Adverse Event of Special Interest|1|||
129696943|NCT02730169|466850043|FG002|Overall Study|Adverse Event of Special Interest|2|||
129696944|NCT02730169|466850044|FG003|Overall Study|Adverse Event of Special Interest|0|||
129696945|NCT02730169|466850041|FG000|Overall Study|Withdrawal by Subject|6|||
129696946|NCT02730169|466850042|FG001|Overall Study|Withdrawal by Subject|11|||
129696947|NCT02730169|466850043|FG002|Overall Study|Withdrawal by Subject|6|||
129696948|NCT02730169|466850044|FG003|Overall Study|Withdrawal by Subject|8|||
129696949|NCT02730169|466850041|FG000|Overall Study|Lost to Follow-up|5|||
129696950|NCT02730169|466850042|FG001|Overall Study|Lost to Follow-up|6|||
129696951|NCT02730169|466850043|FG002|Overall Study|Lost to Follow-up|5|||
129696952|NCT02730169|466850044|FG003|Overall Study|Lost to Follow-up|6|||
129696953|NCT02730169|466850041|FG000|Overall Study|Other|0|||
129696954|NCT02730169|466850042|FG001|Overall Study|Other|0|||
129696955|NCT02730169|466850043|FG002|Overall Study|Other|1|||
129696956|NCT02730169|466850044|FG003|Overall Study|Other|1|||
129786683|NCT00910624|467187145|FG003|Treatment Phase|Treatment Failure|0|||
129786684|NCT00910624|467187142|FG000|Treatment Phase|Lost to Follow-up|0|||
129786685|NCT00910624|467187143|FG001|Treatment Phase|Lost to Follow-up|0|||
129786686|NCT00910624|467187144|FG002|Treatment Phase|Lost to Follow-up|1|||
129786687|NCT00910624|467187145|FG003|Treatment Phase|Lost to Follow-up|0|||
129786688|NCT00910624|467187142|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
129786689|NCT00910624|467187143|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
129786690|NCT00910624|467187144|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
129786691|NCT00910624|467187145|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
129786692|NCT00910624|467187142|FG000|Treatment Phase|Withdrawal by Subject|2|||
129786693|NCT00910624|467187143|FG001|Treatment Phase|Withdrawal by Subject|1|||
129786694|NCT00910624|467187144|FG002|Treatment Phase|Withdrawal by Subject|0|||
129786695|NCT00910624|467187145|FG003|Treatment Phase|Withdrawal by Subject|0|||
129786696|NCT00910624|467187142|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
129786697|NCT00910624|467187143|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
129786698|NCT00910624|467187144|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
129786699|NCT00910624|467187145|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
129786700|NCT00910624|467187142|FG000|Follow-Up Phase|Adverse Event|0|||
129786701|NCT00910624|467187143|FG001|Follow-Up Phase|Adverse Event|0|||
129786702|NCT00910624|467187144|FG002|Follow-Up Phase|Adverse Event|1|||
129786703|NCT00910624|467187145|FG003|Follow-Up Phase|Adverse Event|0|||
129786704|NCT00910624|467187142|FG000|Follow-Up Phase|Lost to Follow-up|3|||
129786705|NCT00910624|467187143|FG001|Follow-Up Phase|Lost to Follow-up|1|||
129885640|NCT02855164|467540774|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
129598476|NCT00384176|466485972|FG002|Overall Study|Withdrawal by Subject|22|||
129598477|NCT00384176|466485970|FG000|Overall Study|Lost to Follow-up|16|||
129598478|NCT00384176|466485971|FG001|Overall Study|Lost to Follow-up|18|||
129598479|NCT00384176|466485972|FG002|Overall Study|Lost to Follow-up|4|||
129598480|NCT00384176|466485970|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
129598481|NCT00384176|466485971|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
129598482|NCT00384176|466485972|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
129598483|NCT00384176|466485970|FG000|Overall Study|Longer QTC as Visit 1|1|||
129598484|NCT00384176|466485971|FG001|Overall Study|Longer QTC as Visit 1|0|||
129598485|NCT00384176|466485972|FG002|Overall Study|Longer QTC as Visit 1|0|||
129598486|NCT00384176|466485970|FG000|Overall Study|Toxicity of treatment|1|||
129598487|NCT00384176|466485971|FG001|Overall Study|Toxicity of treatment|0|||
129598488|NCT00384176|466485972|FG002|Overall Study|Toxicity of treatment|0|||
129598489|NCT00384176|466485970|FG000|Overall Study|Did not receive study treatment|0|||
129598490|NCT00384176|466485971|FG001|Overall Study|Did not receive study treatment|1|||
129598491|NCT00384176|466485972|FG002|Overall Study|Did not receive study treatment|1|||
129598492|NCT00384176|466485970|FG000|Overall Study|Physician Decision|0|||
129598493|NCT00384176|466485971|FG001|Overall Study|Physician Decision|2|||
129598494|NCT00384176|466485972|FG002|Overall Study|Physician Decision|0|||
129598495|NCT00384176|466485970|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
129598496|NCT00384176|466485971|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
129598497|NCT00384176|466485972|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
129598498|NCT00049842|466485973|FG000|Treatment Phase|Adverse Event|47|||
129598499|NCT00049842|466485974|FG001|Treatment Phase|Adverse Event|12|||
129696957|NCT03211858|466850051|FG000|Overall Study|Adverse Event|8|||
129696958|NCT03211858|466850052|FG001|Overall Study|Adverse Event|6|||
129696959|NCT03211858|466850051|FG000|Overall Study|Lack of Efficacy|0|||
129696960|NCT03211858|466850052|FG001|Overall Study|Lack of Efficacy|4|||
129696961|NCT03211858|466850051|FG000|Overall Study|Poor compliance to protocol|6|||
129786706|NCT00910624|467187144|FG002|Follow-Up Phase|Lost to Follow-up|2|||
129786707|NCT00910624|467187145|FG003|Follow-Up Phase|Lost to Follow-up|0|||
129786708|NCT00910624|467187142|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
129786709|NCT00910624|467187143|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
129598500|NCT00049842|466485973|FG000|Treatment Phase|Withdrawal by Subject|35|||
129598501|NCT00049842|466485974|FG001|Treatment Phase|Withdrawal by Subject|46|||
129598502|NCT00049842|466485973|FG000|Treatment Phase|Non-compliance with protocol|7|||
129598503|NCT00049842|466485974|FG001|Treatment Phase|Non-compliance with protocol|8|||
129598504|NCT00049842|466485973|FG000|Treatment Phase|Lost to Follow-up|4|||
129598505|NCT00049842|466485974|FG001|Treatment Phase|Lost to Follow-up|8|||
129598506|NCT00049842|466485973|FG000|Treatment Phase|Administrative|0|||
129598507|NCT00049842|466485974|FG001|Treatment Phase|Administrative|3|||
129598508|NCT00049842|466485973|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
129598509|NCT00049842|466485974|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
129598510|NCT00049842|466485973|FG000|Follow-up Phase|Adverse Event|6|||
129598511|NCT00049842|466485974|FG001|Follow-up Phase|Adverse Event|1|||
129598512|NCT00049842|466485973|FG000|Follow-up Phase|Other|1|||
129598513|NCT00049842|466485974|FG001|Follow-up Phase|Other|4|||
129598514|NCT00307931|466485975|FG000|Overall Study|Adverse Event|1|||
129598515|NCT00854373|466485976|FG000|Overall Study|Withdrawal by Subject|1|||
129598516|NCT00854373|466485977|FG001|Overall Study|Withdrawal by Subject|3|||
129598517|NCT00854373|466485976|FG000|Overall Study|Forgot to take study drug|1|||
129598518|NCT00854373|466485977|FG001|Overall Study|Forgot to take study drug|1|||
129598519|NCT00293202|466485978|FG000|Overall Study|Withdrawal by Subject|1|||
129598520|NCT00293202|466485979|FG001|Overall Study|Withdrawal by Subject|2|||
129598521|NCT00293202|466485978|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
129598522|NCT00293202|466485979|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
129598523|NCT00293202|466485978|FG000|Overall Study|on-hold due to fistula maturation time|1|||
129598524|NCT00293202|466485979|FG001|Overall Study|on-hold due to fistula maturation time|0|||
129598525|NCT02442271|466485980|FG000|Overall Study|Adverse Event|1|||
129598526|NCT02442271|466485980|FG000|Overall Study|Withdrew Consent|1|||
129598527|NCT02442271|466485980|FG000|Overall Study|Lost to Follow-up|1|||
129598528|NCT02442271|466485980|FG000|Overall Study|Other|1|||
129598529|NCT02080832|466485981|FG000|Overall Study|Excluded from analysis by MRI|9|||
129598530|NCT02080832|466485982|FG001|Overall Study|Excluded from analysis by MRI|10|||
129598531|NCT02080832|466485983|FG002|Overall Study|Excluded from analysis by MRI|14|||
129598532|NCT02080832|466485981|FG000|Overall Study|Lost to Follow-up|0|||
129598533|NCT02080832|466485982|FG001|Overall Study|Lost to Follow-up|2|||
129598534|NCT02080832|466485983|FG002|Overall Study|Lost to Follow-up|2|||
129598535|NCT01560507|466485984|FG000|Overall Study|Lost to Follow-up|3|||
129598536|NCT01560507|466485985|FG001|Overall Study|Lost to Follow-up|1|||
129598537|NCT01560507|466485986|FG002|Overall Study|Lost to Follow-up|2|||
129598538|NCT01560507|466485984|FG000|Overall Study|Withdrawal by Subject|1|||
129598539|NCT01560507|466485985|FG001|Overall Study|Withdrawal by Subject|1|||
129598540|NCT01560507|466485986|FG002|Overall Study|Withdrawal by Subject|0|||
129598541|NCT02427984|466485987|FG000|Overall Study|Lost to Follow-up|13|||
129598542|NCT02427984|466485988|FG001|Overall Study|Lost to Follow-up|5|||
129598543|NCT02427984|466485989|FG002|Overall Study|Lost to Follow-up|18|||
129598544|NCT01660022|466485990|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
129598545|NCT01660022|466485991|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
129598546|NCT01660022|466485992|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
129598547|NCT01660022|466485993|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
129598548|NCT01660022|466485994|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
129598549|NCT01660022|466485995|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
129598550|NCT01660022|466485990|FG000|First Sequence (7 Days)|Adverse Event|0|||
129696962|NCT03211858|466850052|FG001|Overall Study|Poor compliance to protocol|2|||
129696963|NCT03211858|466850051|FG000|Overall Study|Non-serious Hypoglycemia|1|||
129696964|NCT03211858|466850052|FG001|Overall Study|Non-serious Hypoglycemia|0|||
129696965|NCT03211858|466850051|FG000|Overall Study|Other than specified above|22|||
129696966|NCT03211858|466850052|FG001|Overall Study|Other than specified above|21|||
129696967|NCT00185614|466850053|FG000|Inter-treatment Period|Physician Decision|1|||
129696968|NCT00185614|466850053|FG000|Inter-treatment Period|Relapse|2|||
129696969|NCT00185614|466850053|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
129696970|NCT03160573|466850054|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
129696971|NCT03160573|466850055|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
129696972|NCT03160573|466850056|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
129696973|NCT03160573|466850057|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
129696974|NCT02144337|466850058|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
129696975|NCT02144337|466850059|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
129696976|NCT02144337|466850058|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
129696977|NCT02144337|466850059|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
129696978|NCT02144337|466850058|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
129696979|NCT02144337|466850059|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
129696980|NCT02144337|466850058|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
129696981|NCT02144337|466850059|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
129696982|NCT02144337|466850058|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
129696983|NCT02144337|466850059|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
129696984|NCT01730729|466850062|FG000|Overall Study|Adverse Event|1|||
129696985|NCT01730729|466850062|FG000|Overall Study|Death|1|||
129696986|NCT01730729|466850062|FG000|Overall Study|Progressive Disease|12|||
129696987|NCT01661595|466850063|FG000|Phase 1: Week 0-4|Adverse Event|1|||
129696988|NCT01661595|466850064|FG001|Phase 1: Week 0-4|Adverse Event|0|||
129696989|NCT01661595|466850065|FG002|Phase 1: Week 0-4|Adverse Event|0|||
129696990|NCT01661595|466850066|FG003|Phase 1: Week 0-4|Adverse Event|0|||
129696991|NCT01661595|466850063|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
129696992|NCT01661595|466850064|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
129696993|NCT01661595|466850065|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
129696994|NCT01661595|466850066|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
129696995|NCT00912509|466850067|FG000|Overall Study|Lost to Follow-up|1|||
129696996|NCT00912509|466850068|FG001|Overall Study|Lost to Follow-up|0|||
129696997|NCT00912509|466850067|FG000|Overall Study|Lack of Efficacy|4|||
129696998|NCT00912509|466850068|FG001|Overall Study|Lack of Efficacy|3|||
129696999|NCT02715856|466850069|FG000|Overall Study|Software Issues|12|||
129697000|NCT02715856|466850070|FG001|Overall Study|Software Issues|7|||
129697001|NCT02715856|466850069|FG000|Overall Study|Death|6|||
129697002|NCT02715856|466850070|FG001|Overall Study|Death|5|||
129697003|NCT02715856|466850069|FG000|Overall Study|Non- Compliant|0|||
129697004|NCT02715856|466850070|FG001|Overall Study|Non- Compliant|40|||
129697005|NCT01682603|466850071|FG000|Overall Study|Lost to Follow-up|3|||
129697006|NCT02462057|466850072|FG000|Overall Study|Left Vitality|32|||
129697007|NCT02462057|466850073|FG001|Overall Study|Left Vitality|27|||
129697008|NCT02462057|466850074|FG002|Overall Study|Left Vitality|23|||
129697009|NCT02462057|466850075|FG003|Overall Study|Left Vitality|35|||
129697010|NCT02462057|466850076|FG004|Overall Study|Left Vitality|33|||
129697011|NCT02462057|466850072|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
129697012|NCT02462057|466850073|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
129697013|NCT02462057|466850074|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
129697014|NCT02462057|466850075|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
129697015|NCT02462057|466850076|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
129697016|NCT02336555|466850077|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129697017|NCT02336555|466850078|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129786710|NCT00910624|467187144|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
129786711|NCT00910624|467187145|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
129786712|NCT00910624|467187142|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
129786713|NCT00910624|467187143|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
129786714|NCT00910624|467187144|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
129786715|NCT00910624|467187145|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
129786716|NCT00910624|467187142|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
129786717|NCT00910624|467187143|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
129786718|NCT00910624|467187144|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
129786719|NCT00910624|467187145|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
129786720|NCT00910624|467187142|FG000|Follow-Up Phase|Administrative|0|||
129786721|NCT00910624|467187143|FG001|Follow-Up Phase|Administrative|1|||
129786722|NCT00910624|467187144|FG002|Follow-Up Phase|Administrative|1|||
129786723|NCT00910624|467187145|FG003|Follow-Up Phase|Administrative|0|||
129786724|NCT03005873|467187146|FG000|Overall Study|Prohibited medication use post radnomization|1|||
129786725|NCT03005873|467187147|FG001|Overall Study|Prohibited medication use post radnomization|1|||
129786726|NCT03005873|467187148|FG002|Overall Study|Prohibited medication use post radnomization|1|||
129786727|NCT03005873|467187146|FG000|Overall Study|Withdrew consent|0|||
129786728|NCT03005873|467187147|FG001|Overall Study|Withdrew consent|1|||
129786729|NCT03005873|467187148|FG002|Overall Study|Withdrew consent|2|||
129786730|NCT03005873|467187146|FG000|Overall Study|Lost to Follow-up|0|||
129786731|NCT03005873|467187147|FG001|Overall Study|Lost to Follow-up|1|||
129786732|NCT03005873|467187148|FG002|Overall Study|Lost to Follow-up|0|||
129786733|NCT03005873|467187146|FG000|Overall Study|Ineligible post randomization|0|||
129786734|NCT03005873|467187147|FG001|Overall Study|Ineligible post randomization|0|||
129786735|NCT03005873|467187148|FG002|Overall Study|Ineligible post randomization|1|||
129697018|NCT02336555|466850077|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
129697019|NCT02336555|466850078|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
129697020|NCT02336555|466850077|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
129786736|NCT04140227|467187149|FG000|Overall Study|Withdrawal by Subject|26|||
129697021|NCT02336555|466850078|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
129697022|NCT00993473|466850079|FG000|Overall Study|Adverse Event|0|||
129697023|NCT00993473|466850080|FG001|Overall Study|Adverse Event|2|||
129697024|NCT00993473|466850079|FG000|Overall Study|Protocol Violation|1|||
129697025|NCT00993473|466850080|FG001|Overall Study|Protocol Violation|2|||
129697026|NCT00993473|466850079|FG000|Overall Study|Lost to Follow-up|1|||
129697027|NCT00993473|466850080|FG001|Overall Study|Lost to Follow-up|0|||
129697028|NCT00993473|466850079|FG000|Overall Study|Withdrawal by Subject|1|||
129697029|NCT00993473|466850080|FG001|Overall Study|Withdrawal by Subject|5|||
129786737|NCT04140227|467187149|FG000|Overall Study|Lost to Follow-up|8|||
129786738|NCT04140227|467187149|FG000|Overall Study|Adverse Event|8|||
129786739|NCT04140227|467187149|FG000|Overall Study|Death|1|||
129786740|NCT04140227|467187149|FG000|Overall Study|Other|3|||
129598551|NCT01660022|466485991|FG001|First Sequence (7 Days)|Adverse Event|0|||
129598552|NCT01660022|466485992|FG002|First Sequence (7 Days)|Adverse Event|0|||
129598553|NCT01660022|466485993|FG003|First Sequence (7 Days)|Adverse Event|0|||
129598554|NCT01660022|466485994|FG004|First Sequence (7 Days)|Adverse Event|1|||
129598555|NCT01660022|466485995|FG005|First Sequence (7 Days)|Adverse Event|3|||
129598556|NCT01660022|466485990|FG000|First Sequence (7 Days)|Protocol Violation|0|||
129598557|NCT01660022|466485991|FG001|First Sequence (7 Days)|Protocol Violation|0|||
129598558|NCT01660022|466485992|FG002|First Sequence (7 Days)|Protocol Violation|0|||
129598559|NCT01660022|466485993|FG003|First Sequence (7 Days)|Protocol Violation|0|||
129786741|NCT04140227|467187149|FG000|Overall Study|Protocol Violation|2|||
129786742|NCT01713933|467187150|FG000|Overall Study|Lost to Follow-up|2|||
129786743|NCT01713933|467187150|FG000|Overall Study|Withdrawal by Subject|3|||
129786744|NCT01713933|467187150|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
129786745|NCT00412373|467187153|FG000|Overall Study|Adverse Event|8|||
129786746|NCT00412373|467187154|FG001|Overall Study|Adverse Event|13|||
129786747|NCT00412373|467187153|FG000|Overall Study|Lack of Efficacy|16|||
129786748|NCT00412373|467187154|FG001|Overall Study|Lack of Efficacy|22|||
129786749|NCT00412373|467187153|FG000|Overall Study|Lost to Follow-up|7|||
129786750|NCT00412373|467187154|FG001|Overall Study|Lost to Follow-up|13|||
129786751|NCT00412373|467187153|FG000|Overall Study|Withdrawal by Subject|8|||
129786752|NCT00412373|467187154|FG001|Overall Study|Withdrawal by Subject|27|||
129786753|NCT00412373|467187153|FG000|Overall Study|Other|2|||
129786754|NCT00412373|467187154|FG001|Overall Study|Other|2|||
129786755|NCT01009840|467187157|FG000|Overall Study|Lost to Follow-up|1|||
129786756|NCT01009840|467187157|FG000|Overall Study|Adverse Event|4|||
129786757|NCT01009840|467187157|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
129786758|NCT01009840|467187157|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
129786759|NCT01009840|467187157|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
129786760|NCT04022733|467187158|FG000|Overall Study|conversion to open surgery|3|||
129786761|NCT04022733|467187159|FG001|Overall Study|conversion to open surgery|2|||
129786762|NCT04022733|467187158|FG000|Overall Study|bradycardia|0|||
129786763|NCT04022733|467187159|FG001|Overall Study|bradycardia|1|||
129786764|NCT01104376|467187160|FG000|Overall Study|Withdrawal by Subject|15|||
129786765|NCT01104376|467187160|FG000|Overall Study|Consented but excluded after labs|13|||
129786766|NCT00797966|467187163|FG000|Phase A|Lost to Follow-up|0|||
129786767|NCT00797966|467187164|FG001|Phase A|Lost to Follow-up|0|||
129786768|NCT00797966|467187165|FG002|Phase A|Lost to Follow-up|0|||
129786769|NCT00797966|467187166|FG003|Phase A|Lost to Follow-up|0|||
129786770|NCT00797966|467187167|FG004|Phase A|Lost to Follow-up|33|||
129786771|NCT00797966|467187168|FG005|Phase A|Lost to Follow-up|0|||
129786772|NCT00797966|467187163|FG000|Phase A|Adverse Event|0|||
129786773|NCT00797966|467187164|FG001|Phase A|Adverse Event|0|||
129786774|NCT00797966|467187165|FG002|Phase A|Adverse Event|0|||
129786775|NCT00797966|467187166|FG003|Phase A|Adverse Event|0|||
129786776|NCT00797966|467187167|FG004|Phase A|Adverse Event|46|||
129786777|NCT00797966|467187168|FG005|Phase A|Adverse Event|0|||
129786778|NCT00797966|467187163|FG000|Phase A|Met withdrawal criteria|0|||
129786779|NCT00797966|467187164|FG001|Phase A|Met withdrawal criteria|0|||
129786780|NCT00797966|467187165|FG002|Phase A|Met withdrawal criteria|0|||
129786781|NCT00797966|467187166|FG003|Phase A|Met withdrawal criteria|0|||
129786782|NCT00797966|467187167|FG004|Phase A|Met withdrawal criteria|4|||
129786783|NCT00797966|467187168|FG005|Phase A|Met withdrawal criteria|0|||
129786784|NCT00797966|467187163|FG000|Phase A|Physician Decision|0|||
129786785|NCT00797966|467187164|FG001|Phase A|Physician Decision|0|||
129786786|NCT00797966|467187165|FG002|Phase A|Physician Decision|0|||
129786787|NCT00797966|467187166|FG003|Phase A|Physician Decision|0|||
129786788|NCT00797966|467187167|FG004|Phase A|Physician Decision|13|||
129786789|NCT00797966|467187168|FG005|Phase A|Physician Decision|0|||
129786790|NCT00797966|467187163|FG000|Phase A|Withdrawal by Subject|0|||
129786791|NCT00797966|467187164|FG001|Phase A|Withdrawal by Subject|0|||
129786792|NCT00797966|467187165|FG002|Phase A|Withdrawal by Subject|0|||
129598560|NCT01660022|466485994|FG004|First Sequence (7 Days)|Protocol Violation|0|||
129598561|NCT01660022|466485995|FG005|First Sequence (7 Days)|Protocol Violation|1|||
129598562|NCT03545191|466485997|FG000|Overall Study|Death|1|||
129598563|NCT03545191|466485998|FG001|Overall Study|Death|0|||
129598564|NCT03545191|466485999|FG002|Overall Study|Death|0|||
129598565|NCT03545191|466485997|FG000|Overall Study|Adverse Event|4|||
129598566|NCT03545191|466485998|FG001|Overall Study|Adverse Event|2|||
129598567|NCT03545191|466485999|FG002|Overall Study|Adverse Event|7|||
129786793|NCT00797966|467187166|FG003|Phase A|Withdrawal by Subject|0|||
129598568|NCT03545191|466485997|FG000|Overall Study|Other reasons|3|||
129598569|NCT03545191|466485998|FG001|Overall Study|Other reasons|11|||
129598570|NCT03545191|466485999|FG002|Overall Study|Other reasons|8|||
129598571|NCT03545191|466485997|FG000|Overall Study|Withdrawal by Subject|13|||
129598572|NCT03545191|466485998|FG001|Overall Study|Withdrawal by Subject|10|||
129786794|NCT00797966|467187167|FG004|Phase A|Withdrawal by Subject|33|||
129786795|NCT00797966|467187168|FG005|Phase A|Withdrawal by Subject|0|||
129786796|NCT00797966|467187163|FG000|Phase A|Protocol deviation|0|||
129786797|NCT00797966|467187164|FG001|Phase A|Protocol deviation|0|||
129786798|NCT00797966|467187165|FG002|Phase A|Protocol deviation|0|||
129786799|NCT00797966|467187166|FG003|Phase A|Protocol deviation|0|||
129786800|NCT00797966|467187167|FG004|Phase A|Protocol deviation|56|||
129786801|NCT00797966|467187168|FG005|Phase A|Protocol deviation|0|||
129786802|NCT00797966|467187163|FG000|Phase B|Lost to Follow-up|0|||
129786803|NCT00797966|467187164|FG001|Phase B|Lost to Follow-up|1|||
129786804|NCT00797966|467187165|FG002|Phase B|Lost to Follow-up|3|||
129786805|NCT00797966|467187166|FG003|Phase B|Lost to Follow-up|0|||
129786806|NCT00797966|467187167|FG004|Phase B|Lost to Follow-up|0|||
129598573|NCT03545191|466485999|FG002|Overall Study|Withdrawal by Subject|12|||
129598574|NCT03545191|466485997|FG000|Overall Study|Lost to Follow-up|1|||
129598575|NCT03545191|466485998|FG001|Overall Study|Lost to Follow-up|2|||
129598576|NCT03545191|466485999|FG002|Overall Study|Lost to Follow-up|3|||
129598577|NCT02181296|466486000|FG000|Overall Study|Lost to Follow-up|7|||
129598578|NCT02181296|466486001|FG001|Overall Study|Lost to Follow-up|6|||
129598579|NCT02149121|466486002|FG000|Main Study Period|Lack of Efficacy|2|||
129598580|NCT02149121|466486003|FG001|Main Study Period|Lack of Efficacy|2|||
129598581|NCT02149121|466486004|FG002|Main Study Period|Lack of Efficacy|1|||
129598582|NCT02149121|466486005|FG003|Main Study Period|Lack of Efficacy|0|||
129598583|NCT02149121|466486006|FG004|Main Study Period|Lack of Efficacy|0|||
129598584|NCT02149121|466486007|FG005|Main Study Period|Lack of Efficacy|0|||
129598585|NCT02149121|466486008|FG006|Main Study Period|Lack of Efficacy|0|||
129598586|NCT02149121|466486002|FG000|Main Study Period|Withdrawal by Subject|9|||
129598587|NCT02149121|466486003|FG001|Main Study Period|Withdrawal by Subject|5|||
129598588|NCT02149121|466486004|FG002|Main Study Period|Withdrawal by Subject|1|||
129598589|NCT02149121|466486005|FG003|Main Study Period|Withdrawal by Subject|0|||
129598590|NCT02149121|466486006|FG004|Main Study Period|Withdrawal by Subject|0|||
129598591|NCT02149121|466486007|FG005|Main Study Period|Withdrawal by Subject|0|||
129598592|NCT02149121|466486008|FG006|Main Study Period|Withdrawal by Subject|0|||
129598593|NCT02149121|466486002|FG000|Main Study Period|Adverse Event|2|||
129598594|NCT02149121|466486003|FG001|Main Study Period|Adverse Event|5|||
129598595|NCT02149121|466486004|FG002|Main Study Period|Adverse Event|1|||
129598596|NCT02149121|466486005|FG003|Main Study Period|Adverse Event|0|||
129598597|NCT02149121|466486006|FG004|Main Study Period|Adverse Event|0|||
129598598|NCT02149121|466486007|FG005|Main Study Period|Adverse Event|0|||
129598599|NCT02149121|466486008|FG006|Main Study Period|Adverse Event|0|||
129598600|NCT02149121|466486002|FG000|Main Study Period|Protocol Violation|2|||
129598601|NCT02149121|466486003|FG001|Main Study Period|Protocol Violation|0|||
129598602|NCT02149121|466486004|FG002|Main Study Period|Protocol Violation|0|||
129598603|NCT02149121|466486005|FG003|Main Study Period|Protocol Violation|0|||
129598604|NCT02149121|466486006|FG004|Main Study Period|Protocol Violation|0|||
129598605|NCT02149121|466486007|FG005|Main Study Period|Protocol Violation|0|||
129598606|NCT02149121|466486008|FG006|Main Study Period|Protocol Violation|0|||
129598607|NCT02149121|466486002|FG000|Main Study Period|Lost to Follow-up|2|||
129598608|NCT02149121|466486003|FG001|Main Study Period|Lost to Follow-up|1|||
129598609|NCT02149121|466486004|FG002|Main Study Period|Lost to Follow-up|0|||
129598610|NCT02149121|466486005|FG003|Main Study Period|Lost to Follow-up|0|||
129598611|NCT02149121|466486006|FG004|Main Study Period|Lost to Follow-up|0|||
129598612|NCT02149121|466486007|FG005|Main Study Period|Lost to Follow-up|0|||
129598613|NCT02149121|466486008|FG006|Main Study Period|Lost to Follow-up|0|||
129598614|NCT02149121|466486002|FG000|Main Study Period|Death|1|||
129598615|NCT02149121|466486003|FG001|Main Study Period|Death|0|||
129598616|NCT02149121|466486004|FG002|Main Study Period|Death|0|||
129598617|NCT02149121|466486005|FG003|Main Study Period|Death|0|||
129598618|NCT02149121|466486006|FG004|Main Study Period|Death|0|||
129598619|NCT02149121|466486007|FG005|Main Study Period|Death|0|||
129598620|NCT02149121|466486008|FG006|Main Study Period|Death|0|||
129598621|NCT02149121|466486002|FG000|Main Study Period|Physician Decision|1|||
129598622|NCT02149121|466486003|FG001|Main Study Period|Physician Decision|0|||
129598623|NCT02149121|466486004|FG002|Main Study Period|Physician Decision|0|||
129598624|NCT02149121|466486005|FG003|Main Study Period|Physician Decision|0|||
129598625|NCT02149121|466486006|FG004|Main Study Period|Physician Decision|0|||
129598626|NCT02149121|466486007|FG005|Main Study Period|Physician Decision|0|||
129598627|NCT02149121|466486008|FG006|Main Study Period|Physician Decision|0|||
129598628|NCT02149121|466486002|FG000|Main Study Period|Developed any malignancy|0|||
129598629|NCT02149121|466486003|FG001|Main Study Period|Developed any malignancy|1|||
129598630|NCT02149121|466486004|FG002|Main Study Period|Developed any malignancy|1|||
129598631|NCT02149121|466486005|FG003|Main Study Period|Developed any malignancy|0|||
129598632|NCT02149121|466486006|FG004|Main Study Period|Developed any malignancy|0|||
129598633|NCT02149121|466486007|FG005|Main Study Period|Developed any malignancy|0|||
129598634|NCT02149121|466486008|FG006|Main Study Period|Developed any malignancy|0|||
129598635|NCT02149121|466486002|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
129598636|NCT02149121|466486003|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
129598637|NCT02149121|466486004|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
129598638|NCT02149121|466486005|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
129598639|NCT02149121|466486006|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
129598640|NCT02149121|466486007|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
129598641|NCT02149121|466486008|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
129786807|NCT00797966|467187168|FG005|Phase B|Lost to Follow-up|0|||
129786808|NCT00797966|467187163|FG000|Phase B|Adverse Event|2|||
129786809|NCT00797966|467187164|FG001|Phase B|Adverse Event|1|||
129786810|NCT00797966|467187165|FG002|Phase B|Adverse Event|3|||
129786811|NCT00797966|467187166|FG003|Phase B|Adverse Event|1|||
129786812|NCT00797966|467187167|FG004|Phase B|Adverse Event|0|||
129786813|NCT00797966|467187168|FG005|Phase B|Adverse Event|0|||
129786814|NCT00797966|467187163|FG000|Phase B|Met Withdrawal Criteria|3|||
129786815|NCT00797966|467187164|FG001|Phase B|Met Withdrawal Criteria|3|||
129786816|NCT00797966|467187165|FG002|Phase B|Met Withdrawal Criteria|6|||
129786817|NCT00797966|467187166|FG003|Phase B|Met Withdrawal Criteria|1|||
129786818|NCT00797966|467187167|FG004|Phase B|Met Withdrawal Criteria|0|||
129786819|NCT00797966|467187168|FG005|Phase B|Met Withdrawal Criteria|0|||
129786820|NCT00797966|467187163|FG000|Phase B|Physician Decision|1|||
129786821|NCT00797966|467187164|FG001|Phase B|Physician Decision|0|||
129786822|NCT00797966|467187165|FG002|Phase B|Physician Decision|3|||
129786823|NCT00797966|467187166|FG003|Phase B|Physician Decision|1|||
129786824|NCT00797966|467187167|FG004|Phase B|Physician Decision|0|||
129786825|NCT00797966|467187168|FG005|Phase B|Physician Decision|0|||
129786826|NCT00797966|467187163|FG000|Phase B|Withdrawal by Subject|1|||
129786827|NCT00797966|467187164|FG001|Phase B|Withdrawal by Subject|4|||
129786828|NCT00797966|467187165|FG002|Phase B|Withdrawal by Subject|3|||
129786829|NCT00797966|467187166|FG003|Phase B|Withdrawal by Subject|3|||
129786830|NCT00797966|467187167|FG004|Phase B|Withdrawal by Subject|0|||
129786831|NCT00797966|467187168|FG005|Phase B|Withdrawal by Subject|0|||
129786832|NCT00797966|467187163|FG000|Phase B|Protocol Deviation|4|||
129786833|NCT00797966|467187164|FG001|Phase B|Protocol Deviation|8|||
129786834|NCT00797966|467187165|FG002|Phase B|Protocol Deviation|2|||
129786835|NCT00797966|467187166|FG003|Phase B|Protocol Deviation|6|||
129786836|NCT00797966|467187167|FG004|Phase B|Protocol Deviation|0|||
129786837|NCT00797966|467187168|FG005|Phase B|Protocol Deviation|0|||
129786838|NCT00797966|467187163|FG000|Phase B|Lack of Efficacy|0|||
129786839|NCT00797966|467187164|FG001|Phase B|Lack of Efficacy|1|||
129786840|NCT00797966|467187165|FG002|Phase B|Lack of Efficacy|1|||
129786841|NCT00797966|467187166|FG003|Phase B|Lack of Efficacy|4|||
129786842|NCT00797966|467187167|FG004|Phase B|Lack of Efficacy|0|||
129786843|NCT00797966|467187168|FG005|Phase B|Lack of Efficacy|0|||
129786844|NCT00797966|467187163|FG000|Phase A+|Lost to Follow-up|0|||
129786845|NCT00797966|467187164|FG001|Phase A+|Lost to Follow-up|0|||
129786846|NCT00797966|467187165|FG002|Phase A+|Lost to Follow-up|0|||
129786847|NCT00797966|467187166|FG003|Phase A+|Lost to Follow-up|0|||
129786848|NCT00797966|467187167|FG004|Phase A+|Lost to Follow-up|0|||
129786849|NCT00797966|467187168|FG005|Phase A+|Lost to Follow-up|9|||
129786850|NCT00797966|467187163|FG000|Phase A+|Met withdrawal criteria|0|||
129786851|NCT00797966|467187164|FG001|Phase A+|Met withdrawal criteria|0|||
129786852|NCT00797966|467187165|FG002|Phase A+|Met withdrawal criteria|0|||
129786853|NCT00797966|467187166|FG003|Phase A+|Met withdrawal criteria|0|||
129786854|NCT00797966|467187167|FG004|Phase A+|Met withdrawal criteria|0|||
129786855|NCT00797966|467187168|FG005|Phase A+|Met withdrawal criteria|5|||
129598642|NCT02149121|466486002|FG000|Main Study Period|Disease progression|0|||
129598643|NCT02149121|466486003|FG001|Main Study Period|Disease progression|1|||
129598644|NCT02149121|466486004|FG002|Main Study Period|Disease progression|0|||
129598645|NCT02149121|466486005|FG003|Main Study Period|Disease progression|0|||
129598646|NCT02149121|466486006|FG004|Main Study Period|Disease progression|0|||
129598647|NCT02149121|466486007|FG005|Main Study Period|Disease progression|0|||
129598648|NCT02149121|466486008|FG006|Main Study Period|Disease progression|0|||
129598649|NCT02149121|466486002|FG000|Extension Study Period|Withdrawal by Subject|0|||
129598650|NCT02149121|466486003|FG001|Extension Study Period|Withdrawal by Subject|0|||
129598651|NCT02149121|466486004|FG002|Extension Study Period|Withdrawal by Subject|0|||
129598652|NCT02149121|466486005|FG003|Extension Study Period|Withdrawal by Subject|1|||
129598653|NCT02149121|466486006|FG004|Extension Study Period|Withdrawal by Subject|0|||
129598654|NCT02149121|466486007|FG005|Extension Study Period|Withdrawal by Subject|2|||
129598655|NCT02149121|466486008|FG006|Extension Study Period|Withdrawal by Subject|0|||
129786856|NCT00797966|467187163|FG000|Phase A+|Withdrawal by Subject|0|||
129598656|NCT00766831|466486009|FG000|Overall Study|Withdrawal by Subject|4|||
129598657|NCT00766831|466486009|FG000|Overall Study|Lost to Follow-up|3|||
129786857|NCT00797966|467187164|FG001|Phase A+|Withdrawal by Subject|0|||
129786858|NCT00797966|467187165|FG002|Phase A+|Withdrawal by Subject|0|||
129786859|NCT00797966|467187166|FG003|Phase A+|Withdrawal by Subject|0|||
129786860|NCT00797966|467187167|FG004|Phase A+|Withdrawal by Subject|0|||
129786861|NCT00797966|467187168|FG005|Phase A+|Withdrawal by Subject|6|||
129786862|NCT00797966|467187163|FG000|Phase A+|Adverse Event|0|||
129786863|NCT00797966|467187164|FG001|Phase A+|Adverse Event|0|||
129786864|NCT00797966|467187165|FG002|Phase A+|Adverse Event|0|||
129786865|NCT00797966|467187166|FG003|Phase A+|Adverse Event|0|||
129786866|NCT00797966|467187167|FG004|Phase A+|Adverse Event|0|||
129786867|NCT00797966|467187168|FG005|Phase A+|Adverse Event|4|||
129697030|NCT00993473|466850079|FG000|Overall Study|Technical problem with CGM device|0|||
129697031|NCT00993473|466850080|FG001|Overall Study|Technical problem with CGM device|1|||
129697032|NCT00993473|466850079|FG000|Overall Study|Family event|1|||
129697033|NCT00993473|466850080|FG001|Overall Study|Family event|0|||
129697034|NCT01772693|466850081|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
129697035|NCT01772693|466850082|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
129697036|NCT01772693|466850081|FG000|Overall Study|Withdrawal by Subject|2|||
129697037|NCT01772693|466850082|FG001|Overall Study|Withdrawal by Subject|0|||
129697038|NCT01772693|466850081|FG000|Overall Study|Alternative Treatment|2|||
129697039|NCT01772693|466850082|FG001|Overall Study|Alternative Treatment|0|||
129697040|NCT01959919|466850083|FG000|Overall Study|Did not meet the eligibility criteria|2|||
129697041|NCT01697501|466850084|FG000|Overall Study|Protocol Violation|2|||
129697042|NCT00128492|466850085|FG000|Overall Study|AE unrelated to study|2|||
129697043|NCT00128492|466850086|FG001|Overall Study|AE unrelated to study|9|||
129697044|NCT00128492|466850085|FG000|Overall Study|Study drug intolerance (AE)|2|||
129697045|NCT00128492|466850086|FG001|Overall Study|Study drug intolerance (AE)|8|||
129697046|NCT00128492|466850085|FG000|Overall Study|AE related to study|1|||
129697047|NCT00128492|466850086|FG001|Overall Study|AE related to study|4|||
129697048|NCT00128492|466850085|FG000|Overall Study|Death|1|||
129697049|NCT00128492|466850086|FG001|Overall Study|Death|0|||
129697050|NCT00128492|466850085|FG000|Overall Study|Lost to Follow-up|1|||
129697051|NCT00128492|466850086|FG001|Overall Study|Lost to Follow-up|5|||
129697052|NCT00128492|466850085|FG000|Overall Study|Noncompliance|0|||
129697053|NCT00128492|466850086|FG001|Overall Study|Noncompliance|5|||
129697054|NCT00128492|466850085|FG000|Overall Study|Personal or administrative|10|||
129697055|NCT00128492|466850086|FG001|Overall Study|Personal or administrative|22|||
129697056|NCT00128492|466850085|FG000|Overall Study|Withdrawal by Subject|3|||
129697057|NCT00128492|466850086|FG001|Overall Study|Withdrawal by Subject|5|||
129697058|NCT00128492|466850085|FG000|Overall Study|Pregnancy|0|||
129697059|NCT00128492|466850086|FG001|Overall Study|Pregnancy|1|||
129697060|NCT00692237|466850088|FG000|Overall Study|Withdrawal by Subject|1|||
129697061|NCT00692237|466850089|FG001|Overall Study|Withdrawal by Subject|3|||
129697062|NCT00692237|466850088|FG000|Overall Study|Adverse Event|0|||
129697063|NCT00692237|466850089|FG001|Overall Study|Adverse Event|1|||
129697064|NCT01347086|466850090|FG000|Overall Study|failed screening visit|0|||
129697065|NCT01347086|466850091|FG001|Overall Study|failed screening visit|0|||
129697066|NCT01347086|466850092|FG002|Overall Study|failed screening visit|1|||
129697067|NCT01347086|466850093|FG003|Overall Study|failed screening visit|0|||
129697068|NCT01347086|466850094|FG004|Overall Study|failed screening visit|0|||
129697069|NCT01347086|466850095|FG005|Overall Study|failed screening visit|0|||
129697070|NCT01347086|466850096|FG006|Overall Study|failed screening visit|1|||
129697071|NCT01347086|466850097|FG007|Overall Study|failed screening visit|1|||
129697072|NCT01347086|466850098|FG008|Overall Study|failed screening visit|0|||
129697073|NCT01347086|466850099|FG009|Overall Study|failed screening visit|1|||
129786868|NCT00797966|467187163|FG000|Phase A+|Protocol deviation|0|||
129786869|NCT00797966|467187164|FG001|Phase A+|Protocol deviation|0|||
129786870|NCT00797966|467187165|FG002|Phase A+|Protocol deviation|0|||
129786871|NCT00797966|467187166|FG003|Phase A+|Protocol deviation|0|||
129786872|NCT00797966|467187167|FG004|Phase A+|Protocol deviation|0|||
129786873|NCT00797966|467187168|FG005|Phase A+|Protocol deviation|4|||
129786874|NCT01883453|467187174|FG000|Overall Study|No episode of common cold|25|||
129786875|NCT01883453|467187175|FG001|Overall Study|No episode of common cold|23|||
129786876|NCT00913458|467187184|FG000|Phase 1|Non-Responder|54|||
129786877|NCT00913458|467187185|FG001|Phase 1|Non-Responder|0|||
129786878|NCT00913458|467187186|FG002|Phase 1|Non-Responder|0|||
129786879|NCT00913458|467187187|FG003|Phase 1|Non-Responder|0|||
129786880|NCT00913458|467187188|FG004|Phase 1|Non-Responder|0|||
129786881|NCT00913458|467187189|FG005|Phase 1|Non-Responder|0|||
129786882|NCT00913458|467187190|FG006|Phase 1|Non-Responder|0|||
129786883|NCT00913458|467187184|FG000|Phase 1|Subject Request|17|||
129786884|NCT00913458|467187185|FG001|Phase 1|Subject Request|0|||
129786885|NCT00913458|467187186|FG002|Phase 1|Subject Request|0|||
129786886|NCT00913458|467187187|FG003|Phase 1|Subject Request|0|||
129697074|NCT00395447|466850100|FG000|Overall Study|Death|37|||
129697075|NCT00395447|466850101|FG001|Overall Study|Death|32|||
129697076|NCT00395447|466850100|FG000|Overall Study|Lost to Follow-up|52|||
129697077|NCT00395447|466850101|FG001|Overall Study|Lost to Follow-up|43|||
129697078|NCT00395447|466850100|FG000|Overall Study|Withdrawal by Subject|24|||
129697079|NCT00395447|466850101|FG001|Overall Study|Withdrawal by Subject|19|||
129697080|NCT00395447|466850100|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
129697081|NCT00395447|466850101|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
129786887|NCT00913458|467187188|FG004|Phase 1|Subject Request|0|||
129786888|NCT00913458|467187189|FG005|Phase 1|Subject Request|0|||
129786889|NCT00913458|467187190|FG006|Phase 1|Subject Request|0|||
129786890|NCT00913458|467187184|FG000|Phase 1|Adverse Event|20|||
129436284|NCT01100034|465895669|FG000|Overall Study|Site closed due to non-responsiveness|1|||
129598658|NCT00766831|466486009|FG000|Overall Study|Adverse Event|20|||
129598659|NCT00766831|466486009|FG000|Overall Study|Protocol Violation|15|||
129598660|NCT00766831|466486009|FG000|Overall Study|Physician Decision|5|||
129598661|NCT00766831|466486009|FG000|Overall Study|Withdrawal of consent|26|||
129598662|NCT00766831|466486009|FG000|Overall Study|Non cooperation by participants|14|||
129598663|NCT00766831|466486009|FG000|Overall Study|Other|28|||
129598664|NCT03166124|466486010|FG000|Treatment Period 1|Adverse Event|0|||
129598665|NCT03166124|466486011|FG001|Treatment Period 1|Adverse Event|0|||
129786891|NCT00913458|467187185|FG001|Phase 1|Adverse Event|0|||
129786892|NCT00913458|467187186|FG002|Phase 1|Adverse Event|0|||
129786893|NCT00913458|467187187|FG003|Phase 1|Adverse Event|0|||
129786894|NCT00913458|467187188|FG004|Phase 1|Adverse Event|0|||
129786895|NCT00913458|467187189|FG005|Phase 1|Adverse Event|0|||
129786896|NCT00913458|467187190|FG006|Phase 1|Adverse Event|0|||
129786897|NCT00913458|467187184|FG000|Phase 1|Lost to Follow-up|2|||
129786898|NCT00913458|467187185|FG001|Phase 1|Lost to Follow-up|0|||
129786899|NCT00913458|467187186|FG002|Phase 1|Lost to Follow-up|0|||
129786900|NCT00913458|467187187|FG003|Phase 1|Lost to Follow-up|0|||
129786901|NCT00913458|467187188|FG004|Phase 1|Lost to Follow-up|0|||
129786902|NCT00913458|467187189|FG005|Phase 1|Lost to Follow-up|0|||
129786903|NCT00913458|467187190|FG006|Phase 1|Lost to Follow-up|0|||
129786904|NCT00913458|467187184|FG000|Phase 1|Protocol Violation|10|||
129786905|NCT00913458|467187185|FG001|Phase 1|Protocol Violation|0|||
129786906|NCT00913458|467187186|FG002|Phase 1|Protocol Violation|0|||
129786907|NCT00913458|467187187|FG003|Phase 1|Protocol Violation|0|||
129786908|NCT00913458|467187188|FG004|Phase 1|Protocol Violation|0|||
129786909|NCT00913458|467187189|FG005|Phase 1|Protocol Violation|0|||
129786910|NCT00913458|467187190|FG006|Phase 1|Protocol Violation|0|||
129786911|NCT00913458|467187184|FG000|Phase 1|Sponsor|2|||
129786912|NCT00913458|467187185|FG001|Phase 1|Sponsor|0|||
129786913|NCT00913458|467187186|FG002|Phase 1|Sponsor|0|||
129786914|NCT00913458|467187187|FG003|Phase 1|Sponsor|0|||
129786915|NCT00913458|467187188|FG004|Phase 1|Sponsor|0|||
129786916|NCT00913458|467187189|FG005|Phase 1|Sponsor|0|||
129786917|NCT00913458|467187190|FG006|Phase 1|Sponsor|0|||
129786918|NCT00913458|467187184|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
129786919|NCT00913458|467187185|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
129786920|NCT00913458|467187186|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
129786921|NCT00913458|467187187|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
129786922|NCT00913458|467187188|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
129786923|NCT00913458|467187189|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
129786924|NCT00913458|467187190|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
129786925|NCT00913458|467187184|FG000|Phase 2|Non-Responder|0|||
129786926|NCT00913458|467187185|FG001|Phase 2|Non-Responder|5|||
129786927|NCT00913458|467187186|FG002|Phase 2|Non-Responder|7|||
129786928|NCT00913458|467187187|FG003|Phase 2|Non-Responder|12|||
129786929|NCT00913458|467187188|FG004|Phase 2|Non-Responder|0|||
129786930|NCT00913458|467187189|FG005|Phase 2|Non-Responder|0|||
129786931|NCT00913458|467187190|FG006|Phase 2|Non-Responder|0|||
129786932|NCT00913458|467187184|FG000|Phase 2|Subject Request|0|||
129786933|NCT00913458|467187185|FG001|Phase 2|Subject Request|0|||
129786934|NCT00913458|467187186|FG002|Phase 2|Subject Request|1|||
129786935|NCT00913458|467187187|FG003|Phase 2|Subject Request|2|||
129786936|NCT00913458|467187188|FG004|Phase 2|Subject Request|0|||
129786937|NCT00913458|467187189|FG005|Phase 2|Subject Request|0|||
129786938|NCT00913458|467187190|FG006|Phase 2|Subject Request|0|||
129786939|NCT00913458|467187184|FG000|Phase 2|Adverse Event|0|||
129786940|NCT00913458|467187185|FG001|Phase 2|Adverse Event|3|||
129786941|NCT00913458|467187186|FG002|Phase 2|Adverse Event|0|||
129786942|NCT00913458|467187187|FG003|Phase 2|Adverse Event|1|||
129786943|NCT00913458|467187188|FG004|Phase 2|Adverse Event|0|||
129436285|NCT01831856|465895670|FG000|Overall Study|Adverse Event|5|||
129786944|NCT00913458|467187189|FG005|Phase 2|Adverse Event|0|||
129786945|NCT00913458|467187190|FG006|Phase 2|Adverse Event|0|||
129786946|NCT00913458|467187184|FG000|Phase 2|Lost to Follow-up|0|||
129786947|NCT00913458|467187185|FG001|Phase 2|Lost to Follow-up|0|||
129598666|NCT03166124|466486012|FG002|Treatment Period 1|Adverse Event|1|||
129598667|NCT03166124|466486013|FG003|Treatment Period 1|Adverse Event|0|||
129598668|NCT03166124|466486010|FG000|Wash-out Period|Withdrawal by Subject|0|||
129598669|NCT03166124|466486011|FG001|Wash-out Period|Withdrawal by Subject|1|||
129786948|NCT00913458|467187186|FG002|Phase 2|Lost to Follow-up|0|||
129786949|NCT00913458|467187187|FG003|Phase 2|Lost to Follow-up|1|||
129786950|NCT00913458|467187188|FG004|Phase 2|Lost to Follow-up|0|||
129786951|NCT00913458|467187189|FG005|Phase 2|Lost to Follow-up|0|||
129786952|NCT00913458|467187190|FG006|Phase 2|Lost to Follow-up|0|||
129786953|NCT00913458|467187184|FG000|Phase 2|Protocol Violation|0|||
129786954|NCT00913458|467187185|FG001|Phase 2|Protocol Violation|2|||
129786955|NCT00913458|467187186|FG002|Phase 2|Protocol Violation|0|||
129786956|NCT00913458|467187187|FG003|Phase 2|Protocol Violation|0|||
129786957|NCT00913458|467187188|FG004|Phase 2|Protocol Violation|0|||
129786958|NCT00913458|467187189|FG005|Phase 2|Protocol Violation|0|||
129786959|NCT00913458|467187190|FG006|Phase 2|Protocol Violation|0|||
129786960|NCT00913458|467187184|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
129885641|NCT02855164|467540775|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
129885642|NCT02855164|467540776|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
129885643|NCT02855164|467540777|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
129885644|NCT02855164|467540778|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
129885645|NCT02855164|467540771|FG000|Part C (Randomized Set)|Adverse Event|0|||
129885646|NCT02855164|467540772|FG001|Part C (Randomized Set)|Adverse Event|0|||
129885647|NCT02855164|467540773|FG002|Part C (Randomized Set)|Adverse Event|0|||
129885648|NCT02855164|467540774|FG003|Part C (Randomized Set)|Adverse Event|0|||
129885649|NCT02855164|467540775|FG004|Part C (Randomized Set)|Adverse Event|0|||
129885650|NCT02855164|467540776|FG005|Part C (Randomized Set)|Adverse Event|5|||
129885651|NCT02855164|467540777|FG006|Part C (Randomized Set)|Adverse Event|9|||
129885652|NCT02855164|467540778|FG007|Part C (Randomized Set)|Adverse Event|2|||
129885653|NCT02855164|467540771|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
129885654|NCT02855164|467540772|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
129885655|NCT02855164|467540773|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
129885656|NCT02855164|467540774|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
129885657|NCT02855164|467540775|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
129885658|NCT02855164|467540776|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
129885659|NCT02855164|467540777|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
129885660|NCT02855164|467540778|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
129885661|NCT02855164|467540771|FG000|Part C (Randomized Set)|Physician Decision|0|||
129885662|NCT02855164|467540772|FG001|Part C (Randomized Set)|Physician Decision|0|||
129885663|NCT02855164|467540773|FG002|Part C (Randomized Set)|Physician Decision|0|||
129885664|NCT02855164|467540774|FG003|Part C (Randomized Set)|Physician Decision|0|||
129885665|NCT02855164|467540775|FG004|Part C (Randomized Set)|Physician Decision|0|||
129885666|NCT02855164|467540776|FG005|Part C (Randomized Set)|Physician Decision|1|||
129885667|NCT02855164|467540777|FG006|Part C (Randomized Set)|Physician Decision|0|||
129885668|NCT02855164|467540778|FG007|Part C (Randomized Set)|Physician Decision|1|||
129885669|NCT02855164|467540771|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885670|NCT02855164|467540772|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885671|NCT02855164|467540773|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885672|NCT02855164|467540774|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885673|NCT02855164|467540775|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
129885674|NCT02855164|467540776|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
129885675|NCT02855164|467540777|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
129885676|NCT02855164|467540778|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
129885677|NCT00581113|467542765|FG000|Overall Study|Withdrawal by Subject|0|||
129885678|NCT00581113|467542766|FG001|Overall Study|Withdrawal by Subject|1|||
129885679|NCT00619476|467542767|FG000|Overall Study|Adverse Event|12|||
129885680|NCT00619476|467542768|FG001|Overall Study|Adverse Event|6|||
129885681|NCT00619476|467542769|FG002|Overall Study|Adverse Event|12|||
129885682|NCT00619476|467542770|FG003|Overall Study|Adverse Event|16|||
129885683|NCT00619476|467542767|FG000|Overall Study|Lack of Efficacy|6|||
129885684|NCT00619476|467542768|FG001|Overall Study|Lack of Efficacy|1|||
129598670|NCT03166124|466486012|FG002|Wash-out Period|Withdrawal by Subject|0|||
129598671|NCT03166124|466486013|FG003|Wash-out Period|Withdrawal by Subject|1|||
129598672|NCT03166124|466486010|FG000|Wash-out Period|Adverse Event|0|||
129598673|NCT03166124|466486011|FG001|Wash-out Period|Adverse Event|1|||
129598674|NCT03166124|466486012|FG002|Wash-out Period|Adverse Event|1|||
129598675|NCT03166124|466486013|FG003|Wash-out Period|Adverse Event|0|||
129598676|NCT01172821|466486016|FG000|Overall Study|Adverse Event|5|||
129598677|NCT01172821|466486017|FG001|Overall Study|Adverse Event|2|||
129598678|NCT01172821|466486018|FG002|Overall Study|Adverse Event|2|||
129598679|NCT01172821|466486019|FG003|Overall Study|Adverse Event|7|||
129598680|NCT01172821|466486016|FG000|Overall Study|Protocol Violation|0|||
129598681|NCT01172821|466486017|FG001|Overall Study|Protocol Violation|2|||
129598682|NCT01172821|466486018|FG002|Overall Study|Protocol Violation|1|||
129598683|NCT01172821|466486019|FG003|Overall Study|Protocol Violation|2|||
129598684|NCT01172821|466486016|FG000|Overall Study|Lost to Follow-up|4|||
129598685|NCT01172821|466486017|FG001|Overall Study|Lost to Follow-up|1|||
129598686|NCT01172821|466486018|FG002|Overall Study|Lost to Follow-up|2|||
129598687|NCT01172821|466486019|FG003|Overall Study|Lost to Follow-up|2|||
129885685|NCT00619476|467542769|FG002|Overall Study|Lack of Efficacy|1|||
129885686|NCT00619476|467542770|FG003|Overall Study|Lack of Efficacy|4|||
129598688|NCT01172821|466486016|FG000|Overall Study|Withdrawal by Subject|2|||
129598689|NCT01172821|466486017|FG001|Overall Study|Withdrawal by Subject|3|||
129885687|NCT00619476|467542767|FG000|Overall Study|Protocol Violation|5|||
129885688|NCT00619476|467542768|FG001|Overall Study|Protocol Violation|4|||
129598690|NCT01172821|466486018|FG002|Overall Study|Withdrawal by Subject|3|||
129598691|NCT01172821|466486019|FG003|Overall Study|Withdrawal by Subject|3|||
129885689|NCT00619476|467542769|FG002|Overall Study|Protocol Violation|4|||
129885690|NCT00619476|467542770|FG003|Overall Study|Protocol Violation|9|||
129885691|NCT00619476|467542767|FG000|Overall Study|Lost to Follow-up|1|||
129598692|NCT01172821|466486016|FG000|Overall Study|Other|3|||
129885692|NCT00619476|467542768|FG001|Overall Study|Lost to Follow-up|2|||
129885693|NCT00619476|467542769|FG002|Overall Study|Lost to Follow-up|0|||
129697082|NCT02150863|466850103|FG000|Overall Study|Lost to Follow-up|0|||
129697083|NCT02150863|466850104|FG001|Overall Study|Lost to Follow-up|1|||
129697084|NCT02150863|466850105|FG002|Overall Study|Lost to Follow-up|0|||
129697085|NCT01651208|466850106|FG000|Overall Study|Lost to Follow-up|14|||
129697086|NCT01651208|466850107|FG001|Overall Study|Lost to Follow-up|16|||
129697087|NCT05071027|466850111|FG000|Overall Study|Lost to Follow-up|1|||
129697088|NCT05071027|466850112|FG001|Overall Study|Lost to Follow-up|4|||
129697089|NCT02314247|466850117|FG000|Overall Study|Adverse Event|2|||
129697090|NCT02314247|466850118|FG001|Overall Study|Adverse Event|1|||
129697091|NCT02314247|466850119|FG002|Overall Study|Adverse Event|0|||
129697092|NCT02314247|466850117|FG000|Overall Study|Withdrawal by Subject|1|||
129697093|NCT02314247|466850118|FG001|Overall Study|Withdrawal by Subject|3|||
129697094|NCT02314247|466850119|FG002|Overall Study|Withdrawal by Subject|1|||
129697095|NCT02314247|466850117|FG000|Overall Study|Progression of Disease|6|||
129697096|NCT02314247|466850118|FG001|Overall Study|Progression of Disease|2|||
129697097|NCT02314247|466850119|FG002|Overall Study|Progression of Disease|0|||
129697098|NCT02965976|466850120|FG000|Overall Study|Withdrawal by Subject|2|||
129697099|NCT02965976|466850121|FG001|Overall Study|Withdrawal by Subject|0|||
129697100|NCT01687595|466850122|FG000|Overall Study|Withdrawal by Subject|8|||
129697101|NCT01687595|466850123|FG001|Overall Study|Withdrawal by Subject|0|||
129697102|NCT01687595|466850122|FG000|Overall Study|Lost to Follow-up|3|||
129697103|NCT01687595|466850123|FG001|Overall Study|Lost to Follow-up|1|||
129697104|NCT01687595|466850122|FG000|Overall Study|Investigator's decision|1|||
129697105|NCT01687595|466850123|FG001|Overall Study|Investigator's decision|0|||
129697106|NCT01687595|466850122|FG000|Overall Study|Sponsor's decision|1|||
129697107|NCT01687595|466850123|FG001|Overall Study|Sponsor's decision|0|||
129697108|NCT01687595|466850122|FG000|Overall Study|Noncompliance|1|||
129697109|NCT01687595|466850123|FG001|Overall Study|Noncompliance|2|||
129697110|NCT01687595|466850122|FG000|Overall Study|Other than specified|56|||
129697111|NCT01687595|466850123|FG001|Overall Study|Other than specified|7|||
129697112|NCT00489359|466850126|FG000|Overall Study|Death|0|||
129697113|NCT00489359|466850127|FG001|Overall Study|Death|2|||
129697114|NCT00489359|466850126|FG000|Overall Study|Progressive Disease|5|||
129697115|NCT00489359|466850127|FG001|Overall Study|Progressive Disease|6|||
129697116|NCT00489359|466850126|FG000|Overall Study|Lost to Follow-up|1|||
129697117|NCT00489359|466850127|FG001|Overall Study|Lost to Follow-up|0|||
129697118|NCT00489359|466850126|FG000|Overall Study|Withdrawal by Subject|1|||
129697119|NCT00489359|466850127|FG001|Overall Study|Withdrawal by Subject|5|||
129697120|NCT00489359|466850126|FG000|Overall Study|Adverse Event|0|||
129786961|NCT00913458|467187185|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
129786962|NCT00913458|467187186|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
129786963|NCT00913458|467187187|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
129786964|NCT00913458|467187188|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
129786965|NCT00913458|467187189|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
129786966|NCT00913458|467187190|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
129786967|NCT00913458|467187184|FG000|Phase 3|Adverse Event|0|||
129786968|NCT00913458|467187185|FG001|Phase 3|Adverse Event|0|||
129786969|NCT00913458|467187186|FG002|Phase 3|Adverse Event|0|||
129786970|NCT00913458|467187187|FG003|Phase 3|Adverse Event|0|||
129786971|NCT00913458|467187188|FG004|Phase 3|Adverse Event|5|||
129786972|NCT00913458|467187189|FG005|Phase 3|Adverse Event|4|||
129786973|NCT00913458|467187190|FG006|Phase 3|Adverse Event|1|||
129786974|NCT00913458|467187184|FG000|Phase 3|Lost to Follow-up|0|||
129786975|NCT00913458|467187185|FG001|Phase 3|Lost to Follow-up|0|||
129697121|NCT00489359|466850127|FG001|Overall Study|Adverse Event|16|||
129697122|NCT04191733|466850129|FG000|Overall Study|Withdrawn due to study closure|13|||
129697123|NCT04191733|466850130|FG001|Overall Study|Withdrawn due to study closure|14|||
129697124|NCT04191733|466850129|FG000|Overall Study|Withdrawal by Subject|2|||
129697125|NCT04191733|466850130|FG001|Overall Study|Withdrawal by Subject|4|||
129697126|NCT04191733|466850129|FG000|Overall Study|Physician Decision|1|||
129697127|NCT04191733|466850130|FG001|Overall Study|Physician Decision|1|||
129697128|NCT04191733|466850129|FG000|Overall Study|Lost to Follow-up|5|||
129697129|NCT04191733|466850130|FG001|Overall Study|Lost to Follow-up|6|||
129697130|NCT04191733|466850129|FG000|Overall Study|Death|0|||
129697131|NCT04191733|466850130|FG001|Overall Study|Death|1|||
129786976|NCT00913458|467187186|FG002|Phase 3|Lost to Follow-up|0|||
129786977|NCT00913458|467187187|FG003|Phase 3|Lost to Follow-up|0|||
129697132|NCT01903733|466850133|FG000|Overall Study|Death|23|||
129697133|NCT01903733|466850134|FG001|Overall Study|Death|54|||
129697134|NCT01903733|466850135|FG002|Overall Study|Death|30|||
129697135|NCT01903733|466850136|FG003|Overall Study|Death|98|||
129697136|NCT01903733|466850133|FG000|Overall Study|Participant refused further follow-up|35|||
129786978|NCT00913458|467187188|FG004|Phase 3|Lost to Follow-up|2|||
129598693|NCT01172821|466486017|FG001|Overall Study|Other|4|||
129598694|NCT01172821|466486018|FG002|Overall Study|Other|5|||
129598695|NCT01172821|466486019|FG003|Overall Study|Other|3|||
129598696|NCT00094094|466486020|FG000|Overall Study|Death|2|||
129598697|NCT00094094|466486020|FG000|Overall Study|Lack of Efficacy|23|||
129598698|NCT00094094|466486020|FG000|Overall Study|Adverse Event|7|||
129598699|NCT00710749|466486021|FG000|First Intervention|Withdrawal by Subject|1|||
129598700|NCT00710749|466486022|FG001|First Intervention|Withdrawal by Subject|0|||
129598701|NCT05626803|466487777|FG000|Overall Study|Lost to Follow-up|0|||
129598702|NCT05626803|466487778|FG001|Overall Study|Lost to Follow-up|1|||
129598703|NCT05626803|466487779|FG002|Overall Study|Lost to Follow-up|0|||
129598704|NCT05626803|466487780|FG003|Overall Study|Lost to Follow-up|0|||
129598705|NCT01000610|466487788|FG000|Overall Study|Adverse Event|1|||
129598706|NCT01000610|466487788|FG000|Overall Study|Lost to Follow-up|4|||
129598707|NCT01000610|466487788|FG000|Overall Study|Treatment failure|1|||
129598708|NCT00493246|466487789|FG000|Overall Study|Withdrawal by Subject|0|||
129598709|NCT00493246|466487790|FG001|Overall Study|Withdrawal by Subject|0|||
129598710|NCT00493246|466487791|FG002|Overall Study|Withdrawal by Subject|0|||
129598711|NCT00493246|466487792|FG003|Overall Study|Withdrawal by Subject|0|||
129598712|NCT00493246|466487793|FG004|Overall Study|Withdrawal by Subject|1|||
129786979|NCT00913458|467187189|FG005|Phase 3|Lost to Follow-up|0|||
129786980|NCT00913458|467187190|FG006|Phase 3|Lost to Follow-up|0|||
129786981|NCT00913458|467187184|FG000|Phase 3|Non-Responder|0|||
129786982|NCT00913458|467187185|FG001|Phase 3|Non-Responder|0|||
129786983|NCT00913458|467187186|FG002|Phase 3|Non-Responder|0|||
129786984|NCT00913458|467187187|FG003|Phase 3|Non-Responder|0|||
129786985|NCT00913458|467187188|FG004|Phase 3|Non-Responder|0|||
129786986|NCT00913458|467187189|FG005|Phase 3|Non-Responder|1|||
129786987|NCT00913458|467187190|FG006|Phase 3|Non-Responder|3|||
129786988|NCT00913458|467187184|FG000|Phase 3|Withdrawal by Subject|0|||
129786989|NCT00913458|467187185|FG001|Phase 3|Withdrawal by Subject|0|||
129786990|NCT00913458|467187186|FG002|Phase 3|Withdrawal by Subject|0|||
129786991|NCT00913458|467187187|FG003|Phase 3|Withdrawal by Subject|0|||
129786992|NCT00913458|467187188|FG004|Phase 3|Withdrawal by Subject|1|||
129786993|NCT00913458|467187189|FG005|Phase 3|Withdrawal by Subject|2|||
129786994|NCT00913458|467187190|FG006|Phase 3|Withdrawal by Subject|0|||
129786995|NCT00913458|467187184|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
129786996|NCT00913458|467187185|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
129786997|NCT00913458|467187186|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
129786998|NCT00913458|467187187|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
129786999|NCT00913458|467187188|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
129787000|NCT00913458|467187189|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
129787001|NCT00913458|467187190|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
129787002|NCT00917644|467187191|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
129787003|NCT00917644|467187192|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
129787004|NCT00917644|467187191|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
129787005|NCT00917644|467187192|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
129787006|NCT00917644|467187191|FG000|Period 2: Second Intervention|family emergency|1|||
129787007|NCT00917644|467187192|FG001|Period 2: Second Intervention|family emergency|0|||
129787008|NCT00357760|467187195|FG000|Overall Study|Disease progression|44|||
129787009|NCT00357760|467187196|FG001|Overall Study|Disease progression|17|||
129787010|NCT00357760|467187195|FG000|Overall Study|Adverse Event|10|||
129787011|NCT00357760|467187196|FG001|Overall Study|Adverse Event|7|||
129787012|NCT00357760|467187195|FG000|Overall Study|Death|0|||
129787013|NCT00357760|467187196|FG001|Overall Study|Death|3|||
129787014|NCT00357760|467187195|FG000|Overall Study|Alternative therapy|1|||
129787015|NCT00357760|467187196|FG001|Overall Study|Alternative therapy|0|||
129598713|NCT00493246|466487794|FG005|Overall Study|Withdrawal by Subject|0|||
129598714|NCT00493246|466487795|FG006|Overall Study|Withdrawal by Subject|0|||
129598715|NCT00493246|466487796|FG007|Overall Study|Withdrawal by Subject|0|||
129598716|NCT00493246|466487789|FG000|Overall Study|No access to draw blood|0|||
129598717|NCT00493246|466487790|FG001|Overall Study|No access to draw blood|0|||
129598718|NCT00493246|466487791|FG002|Overall Study|No access to draw blood|0|||
129598719|NCT00493246|466487792|FG003|Overall Study|No access to draw blood|0|||
129598720|NCT00493246|466487793|FG004|Overall Study|No access to draw blood|0|||
129787016|NCT00357760|467187195|FG000|Overall Study|Withdrawal by Subject|0|||
129787017|NCT00357760|467187196|FG001|Overall Study|Withdrawal by Subject|2|||
129787018|NCT00357760|467187195|FG000|Overall Study|Never started treatment|2|||
129787019|NCT00357760|467187196|FG001|Overall Study|Never started treatment|1|||
129787020|NCT00357760|467187195|FG000|Overall Study|Ineligible|0|||
129598721|NCT00493246|466487794|FG005|Overall Study|No access to draw blood|1|||
129598722|NCT00493246|466487795|FG006|Overall Study|No access to draw blood|0|||
129598723|NCT00493246|466487796|FG007|Overall Study|No access to draw blood|0|||
129598724|NCT00493246|466487789|FG000|Overall Study|Lost to Follow-up|0|||
129787021|NCT00357760|467187196|FG001|Overall Study|Ineligible|2|||
129787022|NCT00357760|467187195|FG000|Overall Study|Physician Decision|2|||
129787023|NCT00357760|467187196|FG001|Overall Study|Physician Decision|1|||
129598725|NCT00493246|466487790|FG001|Overall Study|Lost to Follow-up|0|||
129598726|NCT00493246|466487791|FG002|Overall Study|Lost to Follow-up|0|||
129598727|NCT00493246|466487792|FG003|Overall Study|Lost to Follow-up|0|||
129598728|NCT00493246|466487793|FG004|Overall Study|Lost to Follow-up|0|||
129598729|NCT00493246|466487794|FG005|Overall Study|Lost to Follow-up|0|||
129598730|NCT00493246|466487795|FG006|Overall Study|Lost to Follow-up|1|||
129598731|NCT00493246|466487796|FG007|Overall Study|Lost to Follow-up|0|||
129598732|NCT01287039|466487797|FG000|Overall Study|Noncompliance with study procedures|0|||
129598733|NCT01287039|466487798|FG001|Overall Study|Noncompliance with study procedures|1|||
129598734|NCT01287039|466487797|FG000|Overall Study|Change of location/residence|0|||
129598735|NCT01287039|466487798|FG001|Overall Study|Change of location/residence|3|||
129598736|NCT01287039|466487797|FG000|Overall Study|Elective surgery|0|||
129598737|NCT01287039|466487798|FG001|Overall Study|Elective surgery|1|||
129598738|NCT01287039|466487797|FG000|Overall Study|Protocol Violation|2|||
129598739|NCT01287039|466487798|FG001|Overall Study|Protocol Violation|3|||
129598740|NCT01287039|466487797|FG000|Overall Study|Excluded medication taken|1|||
129598741|NCT01287039|466487798|FG001|Overall Study|Excluded medication taken|0|||
129598742|NCT01287039|466487797|FG000|Overall Study|Noncompliance with study medication|0|||
129598743|NCT01287039|466487798|FG001|Overall Study|Noncompliance with study medication|1|||
129598744|NCT01287039|466487797|FG000|Overall Study|Problem with travel|0|||
129598745|NCT01287039|466487798|FG001|Overall Study|Problem with travel|1|||
129598746|NCT01287039|466487797|FG000|Overall Study|Death|1|||
129598747|NCT01287039|466487798|FG001|Overall Study|Death|0|||
129598748|NCT01287039|466487797|FG000|Overall Study|Change of residence|1|||
129598749|NCT01287039|466487798|FG001|Overall Study|Change of residence|0|||
129598750|NCT01287039|466487797|FG000|Overall Study|Adverse Event|7|||
129598751|NCT01287039|466487798|FG001|Overall Study|Adverse Event|4|||
129598752|NCT01287039|466487797|FG000|Overall Study|Withdrawal by Subject|14|||
129598753|NCT01287039|466487798|FG001|Overall Study|Withdrawal by Subject|11|||
129598754|NCT01287039|466487797|FG000|Overall Study|Lost to Follow-up|3|||
129598755|NCT01287039|466487798|FG001|Overall Study|Lost to Follow-up|2|||
129598756|NCT00099268|466487799|FG000|Overall Study|Withdrawal by Subject|46|||
129598757|NCT00099268|466487800|FG001|Overall Study|Withdrawal by Subject|28|||
129598758|NCT00099268|466487799|FG000|Overall Study|Adverse Event|19|||
129598759|NCT00099268|466487800|FG001|Overall Study|Adverse Event|19|||
129598760|NCT00099268|466487799|FG000|Overall Study|Protocol Violation|9|||
129598761|NCT00099268|466487800|FG001|Overall Study|Protocol Violation|8|||
129598762|NCT00099268|466487799|FG000|Overall Study|Lost to Follow-up|6|||
129598763|NCT00099268|466487800|FG001|Overall Study|Lost to Follow-up|4|||
129598764|NCT00099268|466487799|FG000|Overall Study|Lack of Efficacy|5|||
129598765|NCT00099268|466487800|FG001|Overall Study|Lack of Efficacy|18|||
129598766|NCT00099268|466487799|FG000|Overall Study|Administrative problems|4|||
129787024|NCT00357760|467187195|FG000|Overall Study|Protocol Violation|0|||
129787025|NCT00357760|467187196|FG001|Overall Study|Protocol Violation|1|||
129787026|NCT00357760|467187195|FG000|Overall Study|To receive hospice care|0|||
129787027|NCT00357760|467187196|FG001|Overall Study|To receive hospice care|1|||
129787028|NCT04136444|467187197|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
129787029|NCT04136444|467187198|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
129787030|NCT02238067|467187199|FG000|Overall Study|Not completed survey at Month 6|45|||
129787031|NCT00869778|467187200|FG000|Overall Study|Adverse Event|2|||
129787032|NCT00869778|467187201|FG001|Overall Study|Adverse Event|0|||
129787033|NCT00869778|467187202|FG002|Overall Study|Adverse Event|0|||
129787034|NCT00869778|467187200|FG000|Overall Study|Withdrawal by Subject|3|||
129787035|NCT00869778|467187201|FG001|Overall Study|Withdrawal by Subject|4|||
129787036|NCT00869778|467187202|FG002|Overall Study|Withdrawal by Subject|5|||
129787037|NCT00869778|467187200|FG000|Overall Study|Pregnancy|1|||
129787038|NCT00869778|467187201|FG001|Overall Study|Pregnancy|0|||
129787039|NCT00869778|467187202|FG002|Overall Study|Pregnancy|0|||
129787040|NCT00869778|467187200|FG000|Overall Study|Protocol Violation|5|||
129787041|NCT00869778|467187201|FG001|Overall Study|Protocol Violation|3|||
129787042|NCT00869778|467187202|FG002|Overall Study|Protocol Violation|5|||
129787043|NCT00869778|467187200|FG000|Overall Study|Unblinding|1|||
129787044|NCT00869778|467187201|FG001|Overall Study|Unblinding|0|||
129787045|NCT00869778|467187202|FG002|Overall Study|Unblinding|0|||
129787046|NCT02184572|467187208|FG000|Overall Study|Lost to Follow-up|29|||
129787047|NCT02184572|467187209|FG001|Overall Study|Lost to Follow-up|21|||
129787048|NCT02184572|467187208|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
129598767|NCT00099268|466487800|FG001|Overall Study|Administrative problems|4|||
129598768|NCT00099268|466487799|FG000|Overall Study|Death|3|||
129598769|NCT00099268|466487800|FG001|Overall Study|Death|1|||
129598770|NCT05016622|466487801|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
129598771|NCT05016622|466487801|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
129787049|NCT02184572|467187209|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
129598772|NCT02006628|466487803|FG000|Overall Study|Adverse Event|1|||
129598773|NCT02006628|466487804|FG001|Overall Study|Adverse Event|1|||
129598774|NCT02006628|466487803|FG000|Overall Study|Withdrawal by Subject|2|||
129598775|NCT02006628|466487804|FG001|Overall Study|Withdrawal by Subject|1|||
129787050|NCT02184572|467187208|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
129787051|NCT02184572|467187209|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
129697137|NCT01903733|466850134|FG001|Overall Study|Participant refused further follow-up|38|||
129697138|NCT01903733|466850135|FG002|Overall Study|Participant refused further follow-up|13|||
129697139|NCT01903733|466850136|FG003|Overall Study|Participant refused further follow-up|9|||
129697140|NCT01903733|466850133|FG000|Overall Study|Lost to Follow-up|18|||
129697141|NCT01903733|466850134|FG001|Overall Study|Lost to Follow-up|19|||
129697142|NCT01903733|466850135|FG002|Overall Study|Lost to Follow-up|6|||
129697143|NCT01903733|466850136|FG003|Overall Study|Lost to Follow-up|9|||
129697144|NCT01903733|466850133|FG000|Overall Study|Other|10|||
129697145|NCT01903733|466850134|FG001|Overall Study|Other|15|||
129697146|NCT01903733|466850135|FG002|Overall Study|Other|12|||
129697147|NCT01903733|466850136|FG003|Overall Study|Other|3|||
129697148|NCT01903733|466850133|FG000|Overall Study|Missing|2|||
129697149|NCT01903733|466850134|FG001|Overall Study|Missing|0|||
129697150|NCT01903733|466850135|FG002|Overall Study|Missing|0|||
129697151|NCT01903733|466850136|FG003|Overall Study|Missing|0|||
129697152|NCT01903733|466850133|FG000|Overall Study|Investigator request|18|||
129697153|NCT01903733|466850134|FG001|Overall Study|Investigator request|0|||
129697154|NCT01903733|466850135|FG002|Overall Study|Investigator request|0|||
129697155|NCT01903733|466850136|FG003|Overall Study|Investigator request|0|||
129697156|NCT01714063|466850137|FG000|Overall Study|Equipment malfunction|2|||
129697157|NCT02294019|466850139|FG000|Overall Study|Adverse Event|2|||
129697158|NCT02294019|466850139|FG000|Overall Study|Protocol Violation|68|||
129697159|NCT02294019|466850139|FG000|Overall Study|Lost to Follow-up|31|||
129697160|NCT02294019|466850139|FG000|Overall Study|Other|1|||
129697161|NCT02294019|466850139|FG000|Overall Study|Withdrawal by Subject|1|||
129697162|NCT02369159|466850140|FG000|Overall Study|Adverse Event|0|||
129697163|NCT02369159|466850141|FG001|Overall Study|Adverse Event|1|||
129787052|NCT02184572|467187208|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
129787053|NCT02184572|467187209|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
129787054|NCT02184572|467187208|FG000|Overall Study|Traveling Outside The Country|1|||
129787055|NCT02184572|467187209|FG001|Overall Study|Traveling Outside The Country|0|||
129787056|NCT02184572|467187208|FG000|Overall Study|Withdrawal by Subject|14|||
129787057|NCT02184572|467187209|FG001|Overall Study|Withdrawal by Subject|9|||
129787058|NCT03726996|467187210|FG000|Overall Study|Parent's decision|2|||
129787059|NCT03726996|467187210|FG000|Overall Study|Study early termination|2|||
129787060|NCT03180619|467187211|FG000|Overall Study|Withdrew Consent|5|||
129787061|NCT03180619|467187212|FG001|Overall Study|Withdrew Consent|0|||
129787062|NCT03180619|467187213|FG002|Overall Study|Withdrew Consent|2|||
129787063|NCT03180619|467187211|FG000|Overall Study|Death|2|||
129787064|NCT03180619|467187212|FG001|Overall Study|Death|1|||
129787065|NCT03180619|467187213|FG002|Overall Study|Death|2|||
129787066|NCT03180619|467187211|FG000|Overall Study|Adverse Event|2|||
129787067|NCT03180619|467187212|FG001|Overall Study|Adverse Event|0|||
129787068|NCT03180619|467187213|FG002|Overall Study|Adverse Event|1|||
129787069|NCT03180619|467187211|FG000|Overall Study|Investigator's discretion|2|||
129787070|NCT03180619|467187212|FG001|Overall Study|Investigator's discretion|0|||
129787071|NCT03180619|467187213|FG002|Overall Study|Investigator's discretion|1|||
129787072|NCT02743611|467187214|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
129787073|NCT02743611|467187215|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
129787074|NCT02743611|467187216|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
129787075|NCT02743611|467187217|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
129787076|NCT00402740|467187226|FG000|Overall Study|Withdrawal by Subject|18|||
129787077|NCT00402740|467187226|FG000|Overall Study|Death|50|||
129787078|NCT00402740|467187226|FG000|Overall Study|Lost to Follow-up|6|||
129787079|NCT00402740|467187226|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
129787080|NCT00402740|467187226|FG000|Overall Study|Subject disposition unknown.|1|||
129787081|NCT02342418|467187229|FG000|Overall Study|Adverse Event|0|||
129787082|NCT02342418|467187230|FG001|Overall Study|Adverse Event|1|||
129787083|NCT04255394|467187231|FG000|Overall Study|Death|35|||
129787084|NCT04255394|467187232|FG001|Overall Study|Death|25|||
129787085|NCT04255394|467187231|FG000|Overall Study|Device removed|2|||
129787086|NCT04255394|467187232|FG001|Overall Study|Device removed|10|||
129787087|NCT04255394|467187231|FG000|Overall Study|Withdrawal by Subject|9|||
129787088|NCT04255394|467187232|FG001|Overall Study|Withdrawal by Subject|8|||
129787089|NCT04255394|467187231|FG000|Overall Study|Screen Failure/Not treated|12|||
129787090|NCT04255394|467187232|FG001|Overall Study|Screen Failure/Not treated|8|||
129885694|NCT00619476|467542770|FG003|Overall Study|Lost to Follow-up|1|||
129885695|NCT00619476|467542767|FG000|Overall Study|Investigator Discretion|2|||
129697164|NCT02369159|466850140|FG000|Overall Study|Lost to Follow-up|1|||
129697165|NCT02369159|466850141|FG001|Overall Study|Lost to Follow-up|1|||
129697166|NCT02369159|466850140|FG000|Overall Study|Withdrawal by Subject|7|||
129697167|NCT02369159|466850141|FG001|Overall Study|Withdrawal by Subject|0|||
129697168|NCT03769116|466850142|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
129697169|NCT03769116|466850143|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
129787091|NCT04255394|467187231|FG000|Overall Study|Lost to Follow-up|123|||
129787092|NCT04255394|467187232|FG001|Overall Study|Lost to Follow-up|265|||
129787093|NCT04255394|467187231|FG000|Overall Study|Adverse Event|1|||
129787094|NCT04255394|467187232|FG001|Overall Study|Adverse Event|3|||
129787095|NCT01159431|467187236|FG000|Overall Study|Adverse Event|1|||
129787096|NCT01159431|467187237|FG001|Overall Study|Adverse Event|2|||
129787097|NCT01159431|467187236|FG000|Overall Study|non-compliance|1|||
129787098|NCT01159431|467187237|FG001|Overall Study|non-compliance|1|||
129885696|NCT00619476|467542768|FG001|Overall Study|Investigator Discretion|2|||
129885697|NCT00619476|467542769|FG002|Overall Study|Investigator Discretion|2|||
129885698|NCT00619476|467542770|FG003|Overall Study|Investigator Discretion|0|||
129885699|NCT00619476|467542767|FG000|Overall Study|Withdrawal by Subject|5|||
129885700|NCT00619476|467542768|FG001|Overall Study|Withdrawal by Subject|7|||
129885701|NCT00619476|467542769|FG002|Overall Study|Withdrawal by Subject|5|||
129885702|NCT00619476|467542770|FG003|Overall Study|Withdrawal by Subject|4|||
129885703|NCT01625910|467542771|FG000|Overall Study|Lost to Follow-up|3|||
129885704|NCT01625910|467542772|FG001|Overall Study|Lost to Follow-up|4|||
129885705|NCT02959138|467542773|FG000|Overall Study|Enrolled but Never Treated|0|||
129885706|NCT02959138|467542774|FG001|Overall Study|Enrolled but Never Treated|1|||
129885707|NCT02959138|467542775|FG002|Overall Study|Enrolled but Never Treated|0|||
129885708|NCT01811563|467542776|FG000|Overall Study|Lost to Follow-up|5|||
129885709|NCT01811563|467542777|FG001|Overall Study|Lost to Follow-up|2|||
129885710|NCT01811563|467542776|FG000|Overall Study|Incorrect Randomization procedure|0|||
129885711|NCT01811563|467542777|FG001|Overall Study|Incorrect Randomization procedure|1|||
129885712|NCT01327547|467542778|FG000|Overall Study|Adverse Event|4|||
129885713|NCT01327547|467542779|FG001|Overall Study|Adverse Event|1|||
129885714|NCT01327547|467542778|FG000|Overall Study|Death|1|||
129885715|NCT01327547|467542779|FG001|Overall Study|Death|2|||
129885716|NCT01327547|467542778|FG000|Overall Study|Lost to Follow-up|6|||
129885717|NCT01327547|467542779|FG001|Overall Study|Lost to Follow-up|6|||
129885718|NCT01327547|467542778|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
129885719|NCT01327547|467542779|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
129885720|NCT01327547|467542778|FG000|Overall Study|Withdrawal by Subject|3|||
129885721|NCT01327547|467542779|FG001|Overall Study|Withdrawal by Subject|7|||
129885722|NCT01327547|467542778|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
129885723|NCT01327547|467542779|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
129885724|NCT01327547|467542778|FG000|Overall Study|Protocol Violation|1|||
129885725|NCT01327547|467542779|FG001|Overall Study|Protocol Violation|0|||
129885726|NCT01327547|467542778|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
129885727|NCT01327547|467542779|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
129885728|NCT01327547|467542778|FG000|Overall Study|Required prohibited medication|2|||
129885729|NCT01327547|467542779|FG001|Overall Study|Required prohibited medication|0|||
129885730|NCT01327547|467542778|FG000|Overall Study|Non-compliance with study procedures|1|||
129598776|NCT01705236|466487808|FG000|Overall Study|Lost to Follow-up|1|||
129598777|NCT01705236|466487808|FG000|Overall Study|Administrative problems|2|||
129598778|NCT01705236|466487808|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129787099|NCT01159431|467187236|FG000|Overall Study|Lack of Efficacy|0|||
129787100|NCT01159431|467187237|FG001|Overall Study|Lack of Efficacy|3|||
129787101|NCT00534599|467187243|FG000|Overall Study|Adverse Event|25|||
129787102|NCT00534599|467187244|FG001|Overall Study|Adverse Event|4|||
129787103|NCT00534599|467187243|FG000|Overall Study|Incorrect enrollment|2|||
129787104|NCT00534599|467187244|FG001|Overall Study|Incorrect enrollment|1|||
129787105|NCT00534599|467187243|FG000|Overall Study|Mis-randomization|2|||
129787106|NCT00534599|467187244|FG001|Overall Study|Mis-randomization|2|||
129787107|NCT00534599|467187243|FG000|Overall Study|Developed study-specific d/c criteria|5|||
129787108|NCT00534599|467187244|FG001|Overall Study|Developed study-specific d/c criteria|0|||
129787109|NCT00534599|467187243|FG000|Overall Study|Lack of Efficacy|0|||
129787110|NCT00534599|467187244|FG001|Overall Study|Lack of Efficacy|1|||
129787111|NCT00534599|467187243|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
129787112|NCT00534599|467187244|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
129787113|NCT00534599|467187243|FG000|Overall Study|Protocol Violation|1|||
129598779|NCT01705236|466487808|FG000|Overall Study|Protocol Violation|3|||
129598780|NCT01705236|466487808|FG000|Overall Study|Abnormal test procedure result(s)|4|||
129598781|NCT01705236|466487808|FG000|Overall Study|Abnormal laboratory value(s)|4|||
129598782|NCT01705236|466487808|FG000|Overall Study|Withdrawal by Subject|5|||
129598783|NCT01705236|466487808|FG000|Overall Study|Adverse Event|5|||
129787114|NCT00534599|467187244|FG001|Overall Study|Protocol Violation|3|||
129787115|NCT00534599|467187243|FG000|Overall Study|Lost to Follow-up|11|||
129787116|NCT00534599|467187244|FG001|Overall Study|Lost to Follow-up|14|||
129885731|NCT01327547|467542779|FG001|Overall Study|Non-compliance with study procedures|0|||
129885732|NCT01327547|467542778|FG000|Overall Study|By investigator in subject's interest|0|||
129885733|NCT01327547|467542779|FG001|Overall Study|By investigator in subject's interest|1|||
129885734|NCT00329719|467542780|FG000|Overall Study|Lost to Follow-up|0|||
129885735|NCT00329719|467542781|FG001|Overall Study|Lost to Follow-up|0|||
129885736|NCT00329719|467542782|FG002|Overall Study|Lost to Follow-up|0|||
129885737|NCT00329719|467542783|FG003|Overall Study|Lost to Follow-up|1|||
129598784|NCT00171301|466487809|FG000|Overall Study|Death|1|||
129787117|NCT00534599|467187243|FG000|Overall Study|Withdrawal by Subject|4|||
129598785|NCT00171301|466487810|FG001|Overall Study|Death|2|||
129885738|NCT01155388|467542790|FG000|Overall Study|Adverse Event|1|||
129885739|NCT01155388|467542791|FG001|Overall Study|Adverse Event|0|||
129885740|NCT02462083|467542792|FG000|Overall Study|Sponsor request|39|||
129885741|NCT02462083|467542792|FG000|Overall Study|Withdrawal by Subject|87|||
129885742|NCT02462083|467542792|FG000|Overall Study|Lost to Follow-up|41|||
129885743|NCT02462083|467542792|FG000|Overall Study|Lack of Efficacy|151|||
129885744|NCT02462083|467542792|FG000|Overall Study|Pregnancy|1|||
129885745|NCT02462083|467542792|FG000|Overall Study|Protocol Violation|6|||
129885746|NCT02462083|467542792|FG000|Overall Study|Adverse Event|33|||
129885747|NCT02462083|467542792|FG000|Overall Study|Worsening condition|16|||
129598786|NCT00171301|466487809|FG000|Overall Study|Adverse Event|1|||
129598787|NCT00171301|466487810|FG001|Overall Study|Adverse Event|2|||
129598788|NCT00171301|466487809|FG000|Overall Study|Lost to Follow-up|6|||
129598789|NCT00171301|466487810|FG001|Overall Study|Lost to Follow-up|2|||
129787118|NCT00534599|467187244|FG001|Overall Study|Withdrawal by Subject|6|||
129787119|NCT00534599|467187243|FG000|Overall Study|Other|7|||
129787120|NCT00534599|467187244|FG001|Overall Study|Other|0|||
129787121|NCT03645434|467187246|FG000|Period 1|Adverse Event|0|||
129787122|NCT03645434|467187247|FG001|Period 1|Adverse Event|0|||
129787123|NCT03645434|467187248|FG002|Period 1|Adverse Event|0|||
129787124|NCT03645434|467187249|FG003|Period 1|Adverse Event|1|||
129787125|NCT03645434|467187250|FG004|Period 1|Adverse Event|0|||
129787126|NCT03645434|467187251|FG005|Period 1|Adverse Event|0|||
129787127|NCT03645434|467187246|FG000|Period 1|COPD exacerbation|0|||
129787128|NCT03645434|467187247|FG001|Period 1|COPD exacerbation|0|||
129787129|NCT03645434|467187248|FG002|Period 1|COPD exacerbation|0|||
129787130|NCT03645434|467187249|FG003|Period 1|COPD exacerbation|0|||
129787131|NCT03645434|467187250|FG004|Period 1|COPD exacerbation|1|||
129787132|NCT03645434|467187251|FG005|Period 1|COPD exacerbation|0|||
129787133|NCT03865316|467189703|FG000|Overall Study|Procedure Cancelled|4|||
129787134|NCT03865316|467189703|FG000|Overall Study|Equipment failure|4|||
129787135|NCT03137069|467189708|FG000|Overall Study|Withdrawal by Subject|1|||
129885748|NCT02462083|467542792|FG000|Overall Study|Other than specified|45|||
129885749|NCT02291289|467542793|FG000|Induction Treatment|Withdrawal by Subject|0|||
129885750|NCT02291289|467542794|FG001|Induction Treatment|Withdrawal by Subject|0|||
129885751|NCT02291289|467542795|FG002|Induction Treatment|Withdrawal by Subject|0|||
129885752|NCT02291289|467542796|FG003|Induction Treatment|Withdrawal by Subject|24|||
129885753|NCT02291289|467542797|FG004|Induction Treatment|Withdrawal by Subject|0|||
129885754|NCT02291289|467542798|FG005|Induction Treatment|Withdrawal by Subject|0|||
129885755|NCT02291289|467542799|FG006|Induction Treatment|Withdrawal by Subject|0|||
129885756|NCT02291289|467542800|FG007|Induction Treatment|Withdrawal by Subject|0|||
129885757|NCT02291289|467542801|FG008|Induction Treatment|Withdrawal by Subject|0|||
129885758|NCT02291289|467542802|FG009|Induction Treatment|Withdrawal by Subject|18|||
129885759|NCT02291289|467542803|FG010|Induction Treatment|Withdrawal by Subject|0|||
129885760|NCT02291289|467542804|FG011|Induction Treatment|Withdrawal by Subject|0|||
129885761|NCT02291289|467542805|FG012|Induction Treatment|Withdrawal by Subject|0|||
129787136|NCT03137069|467189709|FG001|Overall Study|Withdrawal by Subject|2|||
129787137|NCT03137069|467189710|FG002|Overall Study|Withdrawal by Subject|2|||
129787138|NCT03137069|467189711|FG003|Overall Study|Withdrawal by Subject|2|||
129787139|NCT03137069|467189712|FG004|Overall Study|Withdrawal by Subject|0|||
129787140|NCT03137069|467189713|FG005|Overall Study|Withdrawal by Subject|0|||
129787141|NCT03137069|467189708|FG000|Overall Study|Adverse Event|0|||
129787142|NCT03137069|467189709|FG001|Overall Study|Adverse Event|3|||
129787143|NCT03137069|467189710|FG002|Overall Study|Adverse Event|1|||
129787144|NCT03137069|467189711|FG003|Overall Study|Adverse Event|1|||
129787145|NCT03137069|467189712|FG004|Overall Study|Adverse Event|0|||
129787146|NCT03137069|467189713|FG005|Overall Study|Adverse Event|1|||
129885762|NCT02291289|467542793|FG000|Induction Treatment|Adverse Event|0|||
129436286|NCT01831856|465895671|FG001|Overall Study|Adverse Event|8|||
129885763|NCT02291289|467542794|FG001|Induction Treatment|Adverse Event|0|||
129436287|NCT01831856|465895670|FG000|Overall Study|Lack of Efficacy|13|||
129787147|NCT03137069|467189708|FG000|Overall Study|Protocol Violation|0|||
129436288|NCT01831856|465895671|FG001|Overall Study|Lack of Efficacy|11|||
129598790|NCT00171301|466487809|FG000|Overall Study|Protocol Violation|0|||
129885764|NCT02291289|467542795|FG002|Induction Treatment|Adverse Event|0|||
129885765|NCT02291289|467542796|FG003|Induction Treatment|Adverse Event|3|||
129885766|NCT02291289|467542797|FG004|Induction Treatment|Adverse Event|0|||
129787148|NCT03137069|467189709|FG001|Overall Study|Protocol Violation|1|||
129787149|NCT03137069|467189710|FG002|Overall Study|Protocol Violation|0|||
129697170|NCT03769116|466850142|FG000|Part 3 - Open Label|Physician Decision|1|||
129697171|NCT03769116|466850143|FG001|Part 3 - Open Label|Physician Decision|0|||
129697172|NCT03769116|466850142|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
129697173|NCT03769116|466850143|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
129697174|NCT01887600|466850145|FG000|Overall Study|Death|39|||
129697175|NCT01887600|466850146|FG001|Overall Study|Death|16|||
129697176|NCT01887600|466850145|FG000|Overall Study|Lack of Efficacy|3|||
129697177|NCT01887600|466850146|FG001|Overall Study|Lack of Efficacy|26|||
129697178|NCT01887600|466850145|FG000|Overall Study|Lost to Follow-up|5|||
129697179|NCT01887600|466850146|FG001|Overall Study|Lost to Follow-up|1|||
129697180|NCT01887600|466850145|FG000|Overall Study|Physician Decision|7|||
129697181|NCT01887600|466850146|FG001|Overall Study|Physician Decision|8|||
129697182|NCT01887600|466850145|FG000|Overall Study|Protocol Deviation|3|||
129697183|NCT01887600|466850146|FG001|Overall Study|Protocol Deviation|0|||
129697184|NCT01887600|466850145|FG000|Overall Study|Withdrawal by Subject|58|||
129697185|NCT01887600|466850146|FG001|Overall Study|Withdrawal by Subject|52|||
129697186|NCT01887600|466850145|FG000|Overall Study|Adverse Event|21|||
129697187|NCT01887600|466850146|FG001|Overall Study|Adverse Event|9|||
129697188|NCT01887600|466850145|FG000|Overall Study|Non-compliance with study drug|3|||
129697189|NCT01887600|466850146|FG001|Overall Study|Non-compliance with study drug|0|||
129697190|NCT01887600|466850145|FG000|Overall Study|Miscellaneous|6|||
129697191|NCT01887600|466850146|FG001|Overall Study|Miscellaneous|2|||
129697192|NCT01887600|466850145|FG000|Overall Study|Progressive Disease|1|||
129697193|NCT01887600|466850146|FG001|Overall Study|Progressive Disease|0|||
129697194|NCT03688139|466850147|FG000|Overall Study|Lost to Follow-up|2|||
129697195|NCT03688139|466850148|FG001|Overall Study|Lost to Follow-up|0|||
129697196|NCT03688139|466850147|FG000|Overall Study|Physician Decision|0|||
129697197|NCT03688139|466850148|FG001|Overall Study|Physician Decision|1|||
129697198|NCT03688139|466850147|FG000|Overall Study|Withdrawal by Subject|2|||
129697199|NCT03688139|466850148|FG001|Overall Study|Withdrawal by Subject|3|||
129697200|NCT00025233|466850152|FG000|Overall Study|Ineligible: wrong cell type|1|||
129697201|NCT00025233|466850152|FG000|Overall Study|Ineligible: wrong primary|1|||
129697202|NCT00025233|466850152|FG000|Overall Study|Ineligible: improper prior treatment|1|||
129697203|NCT00025233|466850152|FG000|Overall Study|Never treated|1|||
129697204|NCT03425188|466850153|FG000|Overall Study|Withdrawal by Subject|1|||
129697205|NCT01412983|466850154|FG000|1st Period|Ineligible|0|||
129697206|NCT01412983|466850155|FG001|1st Period|Ineligible|1|||
129697207|NCT01412983|466850154|FG000|1st Period|Positive slit lamp finding|0|||
129697208|NCT01412983|466850155|FG001|1st Period|Positive slit lamp finding|1|||
129697209|NCT01412983|466850154|FG000|1st Period|Unacceptable lens movement|0|||
129697210|NCT01412983|466850155|FG001|1st Period|Unacceptable lens movement|1|||
129697211|NCT01412983|466850154|FG000|1st Period|Inability to maintain wear|0|||
129697212|NCT01412983|466850155|FG001|1st Period|Inability to maintain wear|1|||
129697213|NCT01694771|466850156|FG000|Overall Study|Adverse Event|18|||
129697214|NCT01694771|466850157|FG001|Overall Study|Adverse Event|16|||
129697215|NCT01694771|466850156|FG000|Overall Study|Lack of Efficacy|1|||
129697216|NCT01694771|466850157|FG001|Overall Study|Lack of Efficacy|0|||
129436289|NCT01831856|465895670|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
129436290|NCT01831856|465895671|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
129436291|NCT01498653|465895672|FG000|Overall Study|Adverse Event|2|||
129436292|NCT01498653|465895673|FG001|Overall Study|Adverse Event|2|||
129436293|NCT01498653|465895672|FG000|Overall Study|Lack of Efficacy|12|||
129436294|NCT01498653|465895673|FG001|Overall Study|Lack of Efficacy|26|||
129436295|NCT01498653|465895672|FG000|Overall Study|Protocol Violation|0|||
129436296|NCT01498653|465895673|FG001|Overall Study|Protocol Violation|4|||
129436297|NCT01498653|465895672|FG000|Overall Study|Lost to Follow-up|1|||
129436298|NCT01498653|465895673|FG001|Overall Study|Lost to Follow-up|0|||
129436299|NCT01498653|465895672|FG000|Overall Study|Physician Decision|2|||
129436300|NCT01498653|465895673|FG001|Overall Study|Physician Decision|0|||
129436301|NCT01498653|465895672|FG000|Overall Study|Withdrawal by Subject|2|||
129436302|NCT01498653|465895673|FG001|Overall Study|Withdrawal by Subject|3|||
129436303|NCT05208866|465895674|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
129436304|NCT02070588|465895675|FG000|Overall Study|Withdrawal by Subject|29|||
129436305|NCT02070588|465895676|FG001|Overall Study|Withdrawal by Subject|1|||
129436306|NCT02070588|465895677|FG002|Overall Study|Withdrawal by Subject|0|||
129697217|NCT01694771|466850156|FG000|Overall Study|Non compliance protocol|7|||
129697218|NCT01694771|466850157|FG001|Overall Study|Non compliance protocol|6|||
129697219|NCT01694771|466850156|FG000|Overall Study|Lost to Follow-up|2|||
129697220|NCT01694771|466850157|FG001|Overall Study|Lost to Follow-up|3|||
129697221|NCT01694771|466850156|FG000|Overall Study|Consent withdrawn|7|||
129697222|NCT01694771|466850157|FG001|Overall Study|Consent withdrawn|9|||
129697223|NCT01694771|466850156|FG000|Overall Study|Other reasons|5|||
129697224|NCT01694771|466850157|FG001|Overall Study|Other reasons|6|||
129697225|NCT00289900|466850158|FG000|Overall Study|Adverse Event|28|||
129697226|NCT00289900|466850159|FG001|Overall Study|Adverse Event|40|||
129697227|NCT00289900|466850160|FG002|Overall Study|Adverse Event|13|||
129697228|NCT00289900|466850161|FG003|Overall Study|Adverse Event|19|||
129697229|NCT00289900|466850162|FG004|Overall Study|Adverse Event|20|||
129598791|NCT00171301|466487810|FG001|Overall Study|Protocol Violation|2|||
129598792|NCT00171301|466487809|FG000|Overall Study|Withdrawal by Subject|0|||
129598793|NCT00171301|466487810|FG001|Overall Study|Withdrawal by Subject|1|||
129598794|NCT04319159|466487811|FG000|Overall Study|Screening failure|13|||
129598795|NCT04319159|466487811|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
129598796|NCT04319159|466487811|FG000|Overall Study|Withdrawal by Subject|1|||
129598797|NCT02100319|466487812|FG000|Overall Study|Case Report Forms Uncollected|11|||
129598798|NCT02100319|466487812|FG000|Overall Study|Protocol Deviation|5|||
129598799|NCT00754442|466487813|FG000|Overall Study|Withdrawal by Subject|5|||
129598800|NCT00754442|466487814|FG001|Overall Study|Withdrawal by Subject|3|||
129598801|NCT00296491|466487815|FG000|Overall Study|Low Pollen Counts|18|||
129598802|NCT00296491|466487816|FG001|Overall Study|Low Pollen Counts|26|||
129598803|NCT00296491|466487817|FG002|Overall Study|Low Pollen Counts|25|||
129598804|NCT00296491|466487818|FG003|Overall Study|Low Pollen Counts|16|||
129598805|NCT00296491|466487815|FG000|Overall Study|Protocol Violation|4|||
129598806|NCT00296491|466487816|FG001|Overall Study|Protocol Violation|6|||
129598807|NCT00296491|466487817|FG002|Overall Study|Protocol Violation|2|||
129598808|NCT00296491|466487818|FG003|Overall Study|Protocol Violation|3|||
129598809|NCT00296491|466487815|FG000|Overall Study|Adverse Event|1|||
129598810|NCT00296491|466487816|FG001|Overall Study|Adverse Event|3|||
129598811|NCT00296491|466487817|FG002|Overall Study|Adverse Event|1|||
129598812|NCT00296491|466487818|FG003|Overall Study|Adverse Event|4|||
129598813|NCT00296491|466487815|FG000|Overall Study|Withdrawn due to Asthma|0|||
129598814|NCT00296491|466487816|FG001|Overall Study|Withdrawn due to Asthma|0|||
129598815|NCT00296491|466487817|FG002|Overall Study|Withdrawn due to Asthma|0|||
129598816|NCT00296491|466487818|FG003|Overall Study|Withdrawn due to Asthma|4|||
129598817|NCT00296491|466487815|FG000|Overall Study|Withdrawal by Subject|7|||
129598818|NCT00296491|466487816|FG001|Overall Study|Withdrawal by Subject|3|||
129885767|NCT02291289|467542798|FG005|Induction Treatment|Adverse Event|0|||
129598819|NCT00296491|466487817|FG002|Overall Study|Withdrawal by Subject|3|||
129598820|NCT00296491|466487818|FG003|Overall Study|Withdrawal by Subject|2|||
129598821|NCT00296491|466487815|FG000|Overall Study|Non-Compliance|12|||
129598822|NCT00296491|466487816|FG001|Overall Study|Non-Compliance|13|||
129598823|NCT00296491|466487817|FG002|Overall Study|Non-Compliance|10|||
129598824|NCT00296491|466487818|FG003|Overall Study|Non-Compliance|14|||
129598825|NCT00296491|466487815|FG000|Overall Study|Lost to Follow-up|0|||
129598826|NCT00296491|466487816|FG001|Overall Study|Lost to Follow-up|2|||
129598827|NCT00296491|466487817|FG002|Overall Study|Lost to Follow-up|2|||
129598828|NCT00296491|466487818|FG003|Overall Study|Lost to Follow-up|0|||
129598829|NCT01300052|466487819|FG000|Overall Study|Adverse Event|3|||
129598830|NCT01300052|466487820|FG001|Overall Study|Adverse Event|0|||
129598831|NCT01300052|466487819|FG000|Overall Study|Withdrawal by Subject|2|||
129598832|NCT01300052|466487820|FG001|Overall Study|Withdrawal by Subject|2|||
129598833|NCT01300052|466487819|FG000|Overall Study|Protocol Violation|1|||
129598834|NCT01300052|466487820|FG001|Overall Study|Protocol Violation|1|||
129598835|NCT01231373|466487821|FG000|Overall Study|Withdrew consent prior to randomization|2|||
129598836|NCT01231373|466487822|FG001|Overall Study|Withdrew consent prior to randomization|1|||
129598837|NCT01231373|466487823|FG002|Overall Study|Withdrew consent prior to randomization|0|||
129598838|NCT01231373|466487824|FG003|Overall Study|Withdrew consent prior to randomization|0|||
129598839|NCT01231373|466487821|FG000|Overall Study|Lost to Follow-up|0|||
129598840|NCT01231373|466487822|FG001|Overall Study|Lost to Follow-up|0|||
129598841|NCT01231373|466487823|FG002|Overall Study|Lost to Follow-up|0|||
129598842|NCT01231373|466487824|FG003|Overall Study|Lost to Follow-up|1|||
129598843|NCT01231373|466487821|FG000|Overall Study|Withdrew Consent|1|||
129598844|NCT01231373|466487822|FG001|Overall Study|Withdrew Consent|0|||
129598845|NCT01231373|466487823|FG002|Overall Study|Withdrew Consent|0|||
129598846|NCT01231373|466487824|FG003|Overall Study|Withdrew Consent|0|||
129598847|NCT03451006|466487825|FG000|Overall Study|Withdrawal by Subject|2|||
129598848|NCT03451006|466487826|FG001|Overall Study|Withdrawal by Subject|2|||
129598849|NCT02547766|466487827|FG000|Overall Study|Withdrawal by Subject|1|||
129598850|NCT01929395|466487828|FG000|Overall Study|Did not complete - non-related toxicity|1|||
129598851|NCT01929395|466487829|FG001|Overall Study|Did not complete - non-related toxicity|0|||
129598852|NCT01929395|466487830|FG002|Overall Study|Did not complete - non-related toxicity|0|||
129598853|NCT01929395|466487828|FG000|Overall Study|Withdrawal by Subject|0|||
129598854|NCT01929395|466487829|FG001|Overall Study|Withdrawal by Subject|1|||
129598855|NCT01929395|466487830|FG002|Overall Study|Withdrawal by Subject|0|||
129598856|NCT01929395|466487828|FG000|Overall Study|Screen Fail|0|||
129598857|NCT01929395|466487829|FG001|Overall Study|Screen Fail|0|||
129598858|NCT01929395|466487830|FG002|Overall Study|Screen Fail|1|||
129598859|NCT03604341|466487831|FG000|Overall Study|Withdrawal by Subject|1|||
129598860|NCT03604341|466487832|FG001|Overall Study|Withdrawal by Subject|1|||
129598861|NCT03604341|466487831|FG000|Overall Study|Adverse Event|1|||
129598862|NCT03604341|466487832|FG001|Overall Study|Adverse Event|0|||
129598863|NCT03604341|466487831|FG000|Overall Study|Protocol Violation|0|||
129598864|NCT03604341|466487832|FG001|Overall Study|Protocol Violation|1|||
129598865|NCT01829113|466487836|FG000|Overall Study|Disease Progression|37|||
129598866|NCT01829113|466487837|FG001|Overall Study|Disease Progression|48|||
129787150|NCT03137069|467189711|FG003|Overall Study|Protocol Violation|1|||
129787151|NCT03137069|467189712|FG004|Overall Study|Protocol Violation|1|||
129787152|NCT03137069|467189713|FG005|Overall Study|Protocol Violation|1|||
129787153|NCT03137069|467189708|FG000|Overall Study|Physician Decision|0|||
129787154|NCT03137069|467189709|FG001|Overall Study|Physician Decision|0|||
129787155|NCT03137069|467189710|FG002|Overall Study|Physician Decision|0|||
129787156|NCT03137069|467189711|FG003|Overall Study|Physician Decision|1|||
129787157|NCT03137069|467189712|FG004|Overall Study|Physician Decision|0|||
129787158|NCT03137069|467189713|FG005|Overall Study|Physician Decision|0|||
129787159|NCT03137069|467189708|FG000|Overall Study|Study Terminated by Sponsor|0|||
129787160|NCT03137069|467189709|FG001|Overall Study|Study Terminated by Sponsor|0|||
129787161|NCT03137069|467189710|FG002|Overall Study|Study Terminated by Sponsor|0|||
129787162|NCT03137069|467189711|FG003|Overall Study|Study Terminated by Sponsor|0|||
129787163|NCT03137069|467189712|FG004|Overall Study|Study Terminated by Sponsor|1|||
129787164|NCT03137069|467189713|FG005|Overall Study|Study Terminated by Sponsor|0|||
129787165|NCT03137069|467189708|FG000|Overall Study|Data Entry Error|0|||
129787166|NCT03137069|467189709|FG001|Overall Study|Data Entry Error|0|||
129787167|NCT03137069|467189710|FG002|Overall Study|Data Entry Error|0|||
129787168|NCT03137069|467189711|FG003|Overall Study|Data Entry Error|1|||
129787169|NCT03137069|467189712|FG004|Overall Study|Data Entry Error|0|||
129787170|NCT03137069|467189713|FG005|Overall Study|Data Entry Error|0|||
129787171|NCT00336856|467189714|FG000|Overall Study|Withdrawal by Subject|3|||
129787172|NCT00336856|467189714|FG000|Overall Study|Found ineligible at time of analysis|1|||
129787173|NCT00362180|467189716|FG000|Treated Period|Withdrawal by Subject|1|||
129787174|NCT00362180|467189717|FG001|Treated Period|Withdrawal by Subject|0|||
129787175|NCT00362180|467189718|FG002|Treated Period|Withdrawal by Subject|0|||
129787176|NCT00362180|467189719|FG003|Treated Period|Withdrawal by Subject|0|||
129787177|NCT00362180|467189720|FG004|Treated Period|Withdrawal by Subject|0|||
129787178|NCT00362180|467189721|FG005|Treated Period|Withdrawal by Subject|0|||
129787179|NCT00362180|467189722|FG006|Treated Period|Withdrawal by Subject|0|||
129787180|NCT00362180|467189723|FG007|Treated Period|Withdrawal by Subject|0|||
129787181|NCT00362180|467189724|FG008|Treated Period|Withdrawal by Subject|0|||
129787182|NCT00362180|467189716|FG000|Treated Period|Adverse Event|0|||
129787183|NCT00362180|467189717|FG001|Treated Period|Adverse Event|0|||
129787184|NCT00362180|467189718|FG002|Treated Period|Adverse Event|0|||
129787185|NCT00362180|467189719|FG003|Treated Period|Adverse Event|0|||
129787186|NCT00362180|467189720|FG004|Treated Period|Adverse Event|0|||
129787187|NCT00362180|467189721|FG005|Treated Period|Adverse Event|1|||
129787188|NCT00362180|467189722|FG006|Treated Period|Adverse Event|0|||
129787189|NCT00362180|467189723|FG007|Treated Period|Adverse Event|1|||
129787190|NCT00362180|467189724|FG008|Treated Period|Adverse Event|0|||
129787191|NCT02434471|467189727|FG000|Overall Study|Physician Decision|9|||
129787192|NCT00843778|467189728|FG000|Overall Study|Adverse Event|15|||
129787193|NCT00843778|467189728|FG000|Overall Study|Lack of Efficacy|14|||
129787194|NCT00843778|467189728|FG000|Overall Study|Loss of efficacy|2|||
129787195|NCT00843778|467189728|FG000|Overall Study|Withdrawal by Subject|4|||
129787196|NCT00369629|467189729|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
129787197|NCT00369629|467189730|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
129787198|NCT00369629|467189731|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
129787199|NCT00369629|467189732|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
129787200|NCT00369629|467189729|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
129787201|NCT00369629|467189730|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
129787202|NCT00369629|467189731|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
129787203|NCT00369629|467189732|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
129787204|NCT00369629|467189729|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
129787205|NCT00369629|467189730|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
129787206|NCT00369629|467189731|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
129787207|NCT00369629|467189732|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
129787208|NCT00369629|467189729|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
129787209|NCT00369629|467189730|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
129787210|NCT00369629|467189731|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
129787211|NCT00369629|467189732|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
129787212|NCT00369629|467189729|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
129787213|NCT00369629|467189730|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
129787214|NCT00369629|467189731|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
129787215|NCT00369629|467189732|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
129885768|NCT02291289|467542799|FG006|Induction Treatment|Adverse Event|0|||
129787216|NCT00369629|467189729|FG000|Completed 4 More Cycles|Progressive disease|2|||
129787217|NCT00369629|467189730|FG001|Completed 4 More Cycles|Progressive disease|1|||
129697230|NCT00289900|466850163|FG005|Overall Study|Adverse Event|33|||
129697231|NCT00289900|466850158|FG000|Overall Study|Lost to Follow-up|7|||
129697232|NCT00289900|466850159|FG001|Overall Study|Lost to Follow-up|7|||
129697233|NCT00289900|466850160|FG002|Overall Study|Lost to Follow-up|8|||
129697234|NCT00289900|466850161|FG003|Overall Study|Lost to Follow-up|8|||
129697235|NCT00289900|466850162|FG004|Overall Study|Lost to Follow-up|4|||
129697236|NCT00289900|466850163|FG005|Overall Study|Lost to Follow-up|8|||
129697237|NCT00289900|466850158|FG000|Overall Study|Participant had flushing|18|||
129697238|NCT00289900|466850159|FG001|Overall Study|Participant had flushing|42|||
129697239|NCT00289900|466850160|FG002|Overall Study|Participant had flushing|1|||
129697240|NCT00289900|466850161|FG003|Overall Study|Participant had flushing|2|||
129697241|NCT00289900|466850162|FG004|Overall Study|Participant had flushing|0|||
129697242|NCT00289900|466850163|FG005|Overall Study|Participant had flushing|4|||
129697243|NCT00289900|466850158|FG000|Overall Study|Other|0|||
129697244|NCT00289900|466850159|FG001|Overall Study|Other|0|||
129697245|NCT00289900|466850160|FG002|Overall Study|Other|0|||
129885769|NCT02291289|467542800|FG007|Induction Treatment|Adverse Event|0|||
129885770|NCT02291289|467542801|FG008|Induction Treatment|Adverse Event|0|||
129697246|NCT00289900|466850161|FG003|Overall Study|Other|5|||
129697247|NCT00289900|466850162|FG004|Overall Study|Other|1|||
129697248|NCT00289900|466850163|FG005|Overall Study|Other|0|||
129697249|NCT00289900|466850158|FG000|Overall Study|Participant moved|1|||
129697250|NCT00289900|466850159|FG001|Overall Study|Participant moved|0|||
129787218|NCT00369629|467189731|FG002|Completed 4 More Cycles|Progressive disease|2|||
129787219|NCT00369629|467189732|FG003|Completed 4 More Cycles|Progressive disease|0|||
129787220|NCT00369629|467189729|FG000|Follow up for 1 Year|Death|2|||
129787221|NCT00369629|467189730|FG001|Follow up for 1 Year|Death|1|||
129787222|NCT00369629|467189731|FG002|Follow up for 1 Year|Death|1|||
129787223|NCT00369629|467189732|FG003|Follow up for 1 Year|Death|0|||
129787224|NCT00369629|467189729|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
129787225|NCT00369629|467189730|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
129787226|NCT00369629|467189731|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
129787227|NCT00369629|467189732|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
129787228|NCT00369629|467189729|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
129787229|NCT00369629|467189730|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
129787230|NCT00369629|467189731|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
129787231|NCT00369629|467189732|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
129787232|NCT00538785|467189734|FG000|Overall Study|Death|9|||
129787233|NCT00538785|467189735|FG001|Overall Study|Death|10|||
129787234|NCT00538785|467189734|FG000|Overall Study|Withdrawal of consent|9|||
129787235|NCT00538785|467189735|FG001|Overall Study|Withdrawal of consent|7|||
129787236|NCT00538785|467189734|FG000|Overall Study|Lost to Follow-up|1|||
129787237|NCT00538785|467189735|FG001|Overall Study|Lost to Follow-up|0|||
129787238|NCT01478048|467189736|FG000|Overall Study|Disease Progression|52|||
129787239|NCT01478048|467189737|FG001|Overall Study|Disease Progression|35|||
129787240|NCT01478048|467189736|FG000|Overall Study|study drug toxicity|11|||
129787241|NCT01478048|467189737|FG001|Overall Study|study drug toxicity|14|||
129787242|NCT01478048|467189736|FG000|Overall Study|Adverse Event|2|||
129787243|NCT01478048|467189737|FG001|Overall Study|Adverse Event|11|||
129787244|NCT01478048|467189736|FG000|Overall Study|subject request to discontinue treatment|3|||
129787245|NCT01478048|467189737|FG001|Overall Study|subject request to discontinue treatment|5|||
129787246|NCT01478048|467189736|FG000|Overall Study|Withdrawal by Subject|2|||
129787247|NCT01478048|467189737|FG001|Overall Study|Withdrawal by Subject|5|||
129787248|NCT01478048|467189736|FG000|Overall Study|non-specified|6|||
129787249|NCT01478048|467189737|FG001|Overall Study|non-specified|4|||
129787250|NCT01478048|467189736|FG000|Overall Study|poor/non-compliance|0|||
129787251|NCT01478048|467189737|FG001|Overall Study|poor/non-compliance|1|||
129787252|NCT01478048|467189736|FG000|Overall Study|no longer meets study criteria|1|||
129787253|NCT01478048|467189737|FG001|Overall Study|no longer meets study criteria|0|||
129787254|NCT03642132|467189743|FG000|Chemotherapy Period|Adverse Event|1|||
129787255|NCT03642132|467189744|FG001|Chemotherapy Period|Adverse Event|1|||
129787256|NCT03642132|467189745|FG002|Chemotherapy Period|Adverse Event|0|||
129787257|NCT03642132|467189743|FG000|Chemotherapy Period|Physician's decision|4|||
129787258|NCT03642132|467189744|FG001|Chemotherapy Period|Physician's decision|1|||
129787259|NCT03642132|467189745|FG002|Chemotherapy Period|Physician's decision|0|||
129787260|NCT03642132|467189743|FG000|Chemotherapy Period|Progressive disease|0|||
129787261|NCT03642132|467189744|FG001|Chemotherapy Period|Progressive disease|0|||
129787262|NCT03642132|467189745|FG002|Chemotherapy Period|Progressive disease|1|||
129787263|NCT03642132|467189743|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
129787264|NCT03642132|467189744|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
129787265|NCT03642132|467189745|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
129787266|NCT03642132|467189743|FG000|Chemotherapy Period|Other|1|||
129787267|NCT03642132|467189744|FG001|Chemotherapy Period|Other|0|||
129787268|NCT03642132|467189745|FG002|Chemotherapy Period|Other|2|||
129787269|NCT03642132|467189743|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
129787270|NCT03642132|467189744|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
129787271|NCT03642132|467189745|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
129787272|NCT03642132|467189743|FG000|Maintenance Period|Adverse Event|1|||
129787273|NCT03642132|467189744|FG001|Maintenance Period|Adverse Event|2|||
129787274|NCT03642132|467189745|FG002|Maintenance Period|Adverse Event|0|||
129787275|NCT03642132|467189743|FG000|Maintenance Period|Non-compliance with study drug|0|||
129787276|NCT03642132|467189744|FG001|Maintenance Period|Non-compliance with study drug|0|||
129787277|NCT03642132|467189745|FG002|Maintenance Period|Non-compliance with study drug|1|||
129787278|NCT03642132|467189743|FG000|Maintenance Period|Physician's decision|2|||
129787279|NCT03642132|467189744|FG001|Maintenance Period|Physician's decision|2|||
129787280|NCT03642132|467189745|FG002|Maintenance Period|Physician's decision|2|||
129787281|NCT03642132|467189743|FG000|Maintenance Period|Progressive disease|9|||
129787282|NCT03642132|467189744|FG001|Maintenance Period|Progressive disease|3|||
129787283|NCT03642132|467189745|FG002|Maintenance Period|Progressive disease|6|||
129598867|NCT01829113|466487836|FG000|Overall Study|Adverse Event|14|||
129787284|NCT03642132|467189743|FG000|Maintenance Period|Other|0|||
129787285|NCT03642132|467189744|FG001|Maintenance Period|Other|0|||
129787286|NCT03642132|467189745|FG002|Maintenance Period|Other|3|||
129787287|NCT03642132|467189743|FG000|Maintenance Period|Withdrawal by Subject|1|||
129787288|NCT03642132|467189744|FG001|Maintenance Period|Withdrawal by Subject|1|||
129885771|NCT02291289|467542802|FG009|Induction Treatment|Adverse Event|1|||
129787289|NCT03642132|467189745|FG002|Maintenance Period|Withdrawal by Subject|2|||
129787290|NCT03642132|467189743|FG000|Follow-up Period|Other|0|||
129787291|NCT03642132|467189744|FG001|Follow-up Period|Other|0|||
129787292|NCT03642132|467189745|FG002|Follow-up Period|Other|1|||
129598868|NCT01829113|466487837|FG001|Overall Study|Adverse Event|10|||
129598869|NCT01829113|466487836|FG000|Overall Study|Withdrawal by Subject|17|||
129598870|NCT01829113|466487837|FG001|Overall Study|Withdrawal by Subject|10|||
129598871|NCT01829113|466487836|FG000|Overall Study|Death|4|||
129598872|NCT01829113|466487837|FG001|Overall Study|Death|6|||
129598873|NCT01829113|466487836|FG000|Overall Study|Sponsor Decision|1|||
129787293|NCT03642132|467189743|FG000|Follow-up Period|Withdrawal by Subject|1|||
129787294|NCT03642132|467189744|FG001|Follow-up Period|Withdrawal by Subject|2|||
129787295|NCT03642132|467189745|FG002|Follow-up Period|Withdrawal by Subject|0|||
129598874|NCT01829113|466487837|FG001|Overall Study|Sponsor Decision|1|||
129598875|NCT01829113|466487836|FG000|Overall Study|No Study Treatment Received|3|||
129598876|NCT01829113|466487837|FG001|Overall Study|No Study Treatment Received|2|||
129598877|NCT01829113|466487836|FG000|Overall Study|Physician Decision|1|||
129598878|NCT01829113|466487837|FG001|Overall Study|Physician Decision|1|||
129598879|NCT02010255|466487842|FG000|Overall Study|Death|0|||
129598880|NCT02010255|466487843|FG001|Overall Study|Death|1|||
129598881|NCT02010255|466487844|FG002|Overall Study|Death|4|||
129598882|NCT02010255|466487845|FG003|Overall Study|Death|4|||
129598883|NCT02010255|466487846|FG004|Overall Study|Death|2|||
129598884|NCT02010255|466487847|FG005|Overall Study|Death|0|||
129598885|NCT02010255|466487848|FG006|Overall Study|Death|1|||
129598886|NCT02010255|466487849|FG007|Overall Study|Death|1|||
129598887|NCT02010255|466487850|FG008|Overall Study|Death|1|||
129598888|NCT02010255|466487851|FG009|Overall Study|Death|0|||
129598889|NCT02010255|466487852|FG010|Overall Study|Death|1|||
129598890|NCT02010255|466487853|FG011|Overall Study|Death|1|||
129787296|NCT03642132|467189743|FG000|Follow-up Period|Study terminated by sponsor|1|||
129787297|NCT03642132|467189744|FG001|Follow-up Period|Study terminated by sponsor|0|||
129787298|NCT03642132|467189745|FG002|Follow-up Period|Study terminated by sponsor|1|||
129787299|NCT03642132|467189743|FG000|Follow-up Period|Lack of Efficacy|1|||
129787300|NCT03642132|467189744|FG001|Follow-up Period|Lack of Efficacy|0|||
129787301|NCT03642132|467189745|FG002|Follow-up Period|Lack of Efficacy|0|||
129787302|NCT03642132|467189743|FG000|Follow-up Period|Death|1|||
129787303|NCT03642132|467189744|FG001|Follow-up Period|Death|0|||
129787304|NCT03642132|467189745|FG002|Follow-up Period|Death|2|||
129787305|NCT03642132|467189743|FG000|Follow-up Period|Adverse Event|1|||
129787306|NCT03642132|467189744|FG001|Follow-up Period|Adverse Event|0|||
129787307|NCT03642132|467189745|FG002|Follow-up Period|Adverse Event|0|||
129787308|NCT03337490|467189746|FG000|Overall Study|Withdrawal by Subject|1|||
129787309|NCT03337490|467189747|FG001|Overall Study|Withdrawal by Subject|0|||
129787310|NCT03337490|467189748|FG002|Overall Study|Withdrawal by Subject|0|||
129787311|NCT03337490|467189746|FG000|Overall Study|Lack of Efficacy|10|||
129787312|NCT03337490|467189747|FG001|Overall Study|Lack of Efficacy|12|||
129787313|NCT03337490|467189748|FG002|Overall Study|Lack of Efficacy|35|||
129787314|NCT03337490|467189746|FG000|Overall Study|Physician Decision|0|||
129787315|NCT03337490|467189747|FG001|Overall Study|Physician Decision|1|||
129787316|NCT03337490|467189748|FG002|Overall Study|Physician Decision|0|||
129787317|NCT03337490|467189746|FG000|Overall Study|Lost to Follow-up|0|||
129787318|NCT03337490|467189747|FG001|Overall Study|Lost to Follow-up|1|||
129787319|NCT03337490|467189748|FG002|Overall Study|Lost to Follow-up|0|||
129787320|NCT01541397|467189749|FG000|Overall Study|Study ended prior to data collection|4|||
129787321|NCT01541397|467189750|FG001|Overall Study|Study ended prior to data collection|2|||
129787322|NCT02577887|467189751|FG000|Overall Study|Death|93|||
129787323|NCT02577887|467189751|FG000|Overall Study|Protocol Violation|125|||
129787324|NCT02577887|467189751|FG000|Overall Study|Withdrawal by Subject|80|||
129787325|NCT03560518|467189752|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
129787326|NCT03560518|467189753|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
129787327|NCT03560518|467189754|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
129787328|NCT03560518|467189752|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
129787329|NCT03560518|467189753|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
129598891|NCT02010255|466487854|FG012|Overall Study|Death|0|||
129598892|NCT02010255|466487855|FG013|Overall Study|Death|0|||
129598893|NCT02010255|466487842|FG000|Overall Study|Lack of Efficacy|4|||
129787330|NCT03560518|467189754|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
129787331|NCT03560518|467189752|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129787332|NCT03560518|467189753|FG001|Double Blind Treatment Period|Protocol Violation|2|||
129787333|NCT03560518|467189754|FG002|Double Blind Treatment Period|Protocol Violation|0|||
129787334|NCT03560518|467189752|FG000|Double Blind Treatment Period|Pregnancy|0|||
129598894|NCT02010255|466487843|FG001|Overall Study|Lack of Efficacy|1|||
129598895|NCT02010255|466487844|FG002|Overall Study|Lack of Efficacy|2|||
129598896|NCT02010255|466487845|FG003|Overall Study|Lack of Efficacy|1|||
129598897|NCT02010255|466487846|FG004|Overall Study|Lack of Efficacy|1|||
129598898|NCT02010255|466487847|FG005|Overall Study|Lack of Efficacy|0|||
129598899|NCT02010255|466487848|FG006|Overall Study|Lack of Efficacy|0|||
129787335|NCT03560518|467189753|FG001|Double Blind Treatment Period|Pregnancy|2|||
129787336|NCT03560518|467189754|FG002|Double Blind Treatment Period|Pregnancy|0|||
129787337|NCT03560518|467189752|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
129787338|NCT03560518|467189753|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
129787339|NCT03560518|467189754|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
129787340|NCT03560518|467189752|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
129787341|NCT03560518|467189753|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
129787342|NCT03560518|467189754|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
129787343|NCT03560518|467189752|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
129787344|NCT03560518|467189753|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
129787345|NCT03560518|467189754|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
129885772|NCT02291289|467542803|FG010|Induction Treatment|Adverse Event|0|||
129885773|NCT02291289|467542804|FG011|Induction Treatment|Adverse Event|0|||
129598900|NCT02010255|466487849|FG007|Overall Study|Lack of Efficacy|0|||
129598901|NCT02010255|466487850|FG008|Overall Study|Lack of Efficacy|0|||
129598902|NCT02010255|466487851|FG009|Overall Study|Lack of Efficacy|0|||
129598903|NCT02010255|466487852|FG010|Overall Study|Lack of Efficacy|1|||
129885774|NCT02291289|467542805|FG012|Induction Treatment|Adverse Event|0|||
129885775|NCT02291289|467542793|FG000|Induction Treatment|Death|25|||
129885776|NCT02291289|467542794|FG001|Induction Treatment|Death|0|||
129885777|NCT02291289|467542795|FG002|Induction Treatment|Death|0|||
129885778|NCT02291289|467542796|FG003|Induction Treatment|Death|111|||
129885779|NCT02291289|467542797|FG004|Induction Treatment|Death|0|||
129885780|NCT02291289|467542798|FG005|Induction Treatment|Death|0|||
129885781|NCT02291289|467542799|FG006|Induction Treatment|Death|1|||
129885782|NCT02291289|467542800|FG007|Induction Treatment|Death|0|||
129885783|NCT02291289|467542801|FG008|Induction Treatment|Death|0|||
129885784|NCT02291289|467542802|FG009|Induction Treatment|Death|82|||
129885785|NCT02291289|467542803|FG010|Induction Treatment|Death|0|||
129885786|NCT02291289|467542804|FG011|Induction Treatment|Death|0|||
129885787|NCT02291289|467542805|FG012|Induction Treatment|Death|0|||
129598904|NCT02010255|466487853|FG011|Overall Study|Lack of Efficacy|0|||
129598905|NCT02010255|466487854|FG012|Overall Study|Lack of Efficacy|0|||
129598906|NCT02010255|466487855|FG013|Overall Study|Lack of Efficacy|0|||
129598907|NCT02010255|466487842|FG000|Overall Study|Withdrew Consent|1|||
129598908|NCT02010255|466487843|FG001|Overall Study|Withdrew Consent|0|||
129598909|NCT02010255|466487844|FG002|Overall Study|Withdrew Consent|0|||
129598910|NCT02010255|466487845|FG003|Overall Study|Withdrew Consent|1|||
129598911|NCT02010255|466487846|FG004|Overall Study|Withdrew Consent|0|||
129598912|NCT02010255|466487847|FG005|Overall Study|Withdrew Consent|0|||
129598913|NCT02010255|466487848|FG006|Overall Study|Withdrew Consent|0|||
129598914|NCT02010255|466487849|FG007|Overall Study|Withdrew Consent|0|||
129598915|NCT02010255|466487850|FG008|Overall Study|Withdrew Consent|0|||
129598916|NCT02010255|466487851|FG009|Overall Study|Withdrew Consent|0|||
129598917|NCT02010255|466487852|FG010|Overall Study|Withdrew Consent|0|||
129598918|NCT02010255|466487853|FG011|Overall Study|Withdrew Consent|0|||
129598919|NCT02010255|466487854|FG012|Overall Study|Withdrew Consent|0|||
129598920|NCT02010255|466487855|FG013|Overall Study|Withdrew Consent|0|||
129598921|NCT02010255|466487842|FG000|Overall Study|Adverse Event|1|||
129598922|NCT02010255|466487843|FG001|Overall Study|Adverse Event|0|||
129598923|NCT02010255|466487844|FG002|Overall Study|Adverse Event|0|||
129598924|NCT02010255|466487845|FG003|Overall Study|Adverse Event|0|||
129598925|NCT02010255|466487846|FG004|Overall Study|Adverse Event|0|||
129598926|NCT02010255|466487847|FG005|Overall Study|Adverse Event|0|||
129598927|NCT02010255|466487848|FG006|Overall Study|Adverse Event|0|||
129598928|NCT02010255|466487849|FG007|Overall Study|Adverse Event|0|||
129598929|NCT02010255|466487850|FG008|Overall Study|Adverse Event|0|||
129598930|NCT02010255|466487851|FG009|Overall Study|Adverse Event|0|||
129598931|NCT02010255|466487852|FG010|Overall Study|Adverse Event|0|||
129598932|NCT02010255|466487853|FG011|Overall Study|Adverse Event|0|||
129598933|NCT02010255|466487854|FG012|Overall Study|Adverse Event|0|||
129598934|NCT02010255|466487855|FG013|Overall Study|Adverse Event|0|||
129598935|NCT02010255|466487842|FG000|Overall Study|Lost to Follow-up|0|||
129885788|NCT02291289|467542793|FG000|Induction Treatment|Lost to Follow-up|1|||
129885789|NCT02291289|467542794|FG001|Induction Treatment|Lost to Follow-up|0|||
129885790|NCT02291289|467542795|FG002|Induction Treatment|Lost to Follow-up|0|||
129885791|NCT02291289|467542796|FG003|Induction Treatment|Lost to Follow-up|12|||
129885792|NCT02291289|467542797|FG004|Induction Treatment|Lost to Follow-up|0|||
129885793|NCT02291289|467542798|FG005|Induction Treatment|Lost to Follow-up|0|||
129885794|NCT02291289|467542799|FG006|Induction Treatment|Lost to Follow-up|0|||
129436307|NCT02070588|465895675|FG000|Overall Study|Writhdrawal due to early termination|9|||
129436308|NCT02070588|465895676|FG001|Overall Study|Writhdrawal due to early termination|0|||
129598936|NCT02010255|466487843|FG001|Overall Study|Lost to Follow-up|0|||
129598937|NCT02010255|466487844|FG002|Overall Study|Lost to Follow-up|1|||
129598938|NCT02010255|466487845|FG003|Overall Study|Lost to Follow-up|0|||
129598939|NCT02010255|466487846|FG004|Overall Study|Lost to Follow-up|1|||
129598940|NCT02010255|466487847|FG005|Overall Study|Lost to Follow-up|0|||
129598941|NCT02010255|466487848|FG006|Overall Study|Lost to Follow-up|0|||
129598942|NCT02010255|466487849|FG007|Overall Study|Lost to Follow-up|0|||
129598943|NCT02010255|466487850|FG008|Overall Study|Lost to Follow-up|0|||
129598944|NCT02010255|466487851|FG009|Overall Study|Lost to Follow-up|0|||
129885795|NCT02291289|467542800|FG007|Induction Treatment|Lost to Follow-up|0|||
129598945|NCT02010255|466487852|FG010|Overall Study|Lost to Follow-up|0|||
129598946|NCT02010255|466487853|FG011|Overall Study|Lost to Follow-up|0|||
129598947|NCT02010255|466487854|FG012|Overall Study|Lost to Follow-up|0|||
129598948|NCT02010255|466487855|FG013|Overall Study|Lost to Follow-up|0|||
129598949|NCT02010255|466487842|FG000|Overall Study|Randomized but Not Treated|0|||
129598950|NCT02010255|466487843|FG001|Overall Study|Randomized but Not Treated|0|||
129598951|NCT02010255|466487844|FG002|Overall Study|Randomized but Not Treated|0|||
129598952|NCT02010255|466487845|FG003|Overall Study|Randomized but Not Treated|0|||
129598953|NCT02010255|466487846|FG004|Overall Study|Randomized but Not Treated|0|||
129598954|NCT02010255|466487847|FG005|Overall Study|Randomized but Not Treated|0|||
129598955|NCT02010255|466487848|FG006|Overall Study|Randomized but Not Treated|0|||
129598956|NCT02010255|466487849|FG007|Overall Study|Randomized but Not Treated|0|||
129598957|NCT02010255|466487850|FG008|Overall Study|Randomized but Not Treated|0|||
129598958|NCT02010255|466487851|FG009|Overall Study|Randomized but Not Treated|0|||
129598959|NCT02010255|466487852|FG010|Overall Study|Randomized but Not Treated|0|||
129598960|NCT02010255|466487853|FG011|Overall Study|Randomized but Not Treated|0|||
129598961|NCT02010255|466487854|FG012|Overall Study|Randomized but Not Treated|0|||
129598962|NCT02010255|466487855|FG013|Overall Study|Randomized but Not Treated|1|||
129598963|NCT02777918|466487859|FG000|Overall Study|Medical reasons|1|||
129598964|NCT02777918|466487860|FG001|Overall Study|Medical reasons|2|||
129598965|NCT02777918|466487859|FG000|Overall Study|Too busy / stressed|1|||
129598966|NCT02777918|466487860|FG001|Overall Study|Too busy / stressed|1|||
129598967|NCT02777918|466487859|FG000|Overall Study|Withdrawal by Subject|1|||
129598968|NCT02777918|466487860|FG001|Overall Study|Withdrawal by Subject|1|||
129598969|NCT00757848|466487861|FG000|Overall Study|Voluntary discontinuation|1|||
129598970|NCT00757848|466487862|FG001|Overall Study|Voluntary discontinuation|0|||
129598971|NCT00757848|466487861|FG000|Overall Study|Adverse Event|1|||
129598972|NCT00757848|466487862|FG001|Overall Study|Adverse Event|2|||
129598973|NCT00757848|466487861|FG000|Overall Study|Incorrect enrolment|1|||
129598974|NCT00757848|466487862|FG001|Overall Study|Incorrect enrolment|0|||
129598975|NCT00058214|466487863|FG000|Overall Study|Adverse Event|1|||
129598976|NCT03856593|466487867|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
129598977|NCT03856593|466487868|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
129598978|NCT01949116|466487870|FG000|Overall Study|Death|2|||
129787346|NCT03560518|467189752|FG000|Double Blind Treatment Period|Adverse Event|0|||
129787347|NCT03560518|467189753|FG001|Double Blind Treatment Period|Adverse Event|3|||
129598979|NCT01949116|466487871|FG001|Overall Study|Death|0|||
129598980|NCT01949116|466487870|FG000|Overall Study|Lost to Follow-up|1|||
129787348|NCT03560518|467189754|FG002|Double Blind Treatment Period|Adverse Event|1|||
129787349|NCT01689532|467189755|FG000|Overall Study|Adverse Event|9|||
129787350|NCT01689532|467189756|FG001|Overall Study|Adverse Event|5|||
129787351|NCT01689532|467189755|FG000|Overall Study|Lack of Efficacy|2|||
129787352|NCT01689532|467189756|FG001|Overall Study|Lack of Efficacy|2|||
129787353|NCT01689532|467189755|FG000|Overall Study|Withdrawal by Subject|1|||
129787354|NCT01689532|467189756|FG001|Overall Study|Withdrawal by Subject|2|||
129787355|NCT01689532|467189755|FG000|Overall Study|Physician Decision|2|||
129787356|NCT01689532|467189756|FG001|Overall Study|Physician Decision|0|||
129787357|NCT01363349|467189757|FG000|Overall Study|Adverse Event|6|||
129787358|NCT01363349|467189758|FG001|Overall Study|Adverse Event|7|||
129787359|NCT01363349|467189757|FG000|Overall Study|Lack of Efficacy|3|||
129787360|NCT01363349|467189758|FG001|Overall Study|Lack of Efficacy|10|||
129787361|NCT01363349|467189757|FG000|Overall Study|Non compliance/Protocol deviations|2|||
129787362|NCT01363349|467189758|FG001|Overall Study|Non compliance/Protocol deviations|2|||
129787363|NCT01363349|467189757|FG000|Overall Study|Withdrawal by Subject|14|||
129787364|NCT01363349|467189758|FG001|Overall Study|Withdrawal by Subject|6|||
129787365|NCT01363349|467189757|FG000|Overall Study|Lost to Follow-up|5|||
129787366|NCT01363349|467189758|FG001|Overall Study|Lost to Follow-up|6|||
129787367|NCT01363349|467189757|FG000|Overall Study|Not reported|36|||
129787368|NCT01363349|467189758|FG001|Overall Study|Not reported|37|||
129787369|NCT01363349|467189757|FG000|Overall Study|missing|1|||
129787370|NCT01363349|467189758|FG001|Overall Study|missing|2|||
129787371|NCT01958489|467189759|FG000|Period 2|Adverse Event|0|||
129787372|NCT01958489|467189760|FG001|Period 2|Adverse Event|1|||
129787373|NCT03595618|467189761|FG000|Overall Study|Adverse Event|16|||
129787374|NCT03595618|467189762|FG001|Overall Study|Adverse Event|17|||
129598981|NCT01949116|466487871|FG001|Overall Study|Lost to Follow-up|3|||
129598982|NCT01949116|466487870|FG000|Overall Study|Withdrawal by Subject|5|||
129598983|NCT01949116|466487871|FG001|Overall Study|Withdrawal by Subject|3|||
129598984|NCT00706992|466487875|FG000|Overall Study|Study termination|5|||
129598985|NCT00706992|466487876|FG001|Overall Study|Study termination|5|||
129598986|NCT00706992|466487877|FG002|Overall Study|Study termination|6|||
129598987|NCT00706992|466487878|FG003|Overall Study|Study termination|2|||
129598988|NCT00706992|466487879|FG004|Overall Study|Study termination|3|||
129787375|NCT03595618|467189763|FG002|Overall Study|Adverse Event|20|||
129787376|NCT03595618|467189764|FG003|Overall Study|Adverse Event|8|||
129787377|NCT03595618|467189761|FG000|Overall Study|Withdrawal by Subject|12|||
129885796|NCT02291289|467542801|FG008|Induction Treatment|Lost to Follow-up|0|||
129885797|NCT02291289|467542802|FG009|Induction Treatment|Lost to Follow-up|9|||
129885798|NCT02291289|467542803|FG010|Induction Treatment|Lost to Follow-up|0|||
129885799|NCT02291289|467542804|FG011|Induction Treatment|Lost to Follow-up|0|||
129885800|NCT02291289|467542805|FG012|Induction Treatment|Lost to Follow-up|0|||
129885801|NCT02291289|467542793|FG000|Induction Treatment|Non-Compliance|0|||
129885802|NCT02291289|467542794|FG001|Induction Treatment|Non-Compliance|0|||
129885803|NCT02291289|467542795|FG002|Induction Treatment|Non-Compliance|0|||
129885804|NCT02291289|467542796|FG003|Induction Treatment|Non-Compliance|1|||
129885805|NCT02291289|467542797|FG004|Induction Treatment|Non-Compliance|0|||
129885806|NCT02291289|467542798|FG005|Induction Treatment|Non-Compliance|0|||
129885807|NCT02291289|467542799|FG006|Induction Treatment|Non-Compliance|0|||
129885808|NCT02291289|467542800|FG007|Induction Treatment|Non-Compliance|0|||
129885809|NCT02291289|467542801|FG008|Induction Treatment|Non-Compliance|0|||
129885810|NCT02291289|467542802|FG009|Induction Treatment|Non-Compliance|1|||
129885811|NCT02291289|467542803|FG010|Induction Treatment|Non-Compliance|0|||
129885812|NCT02291289|467542804|FG011|Induction Treatment|Non-Compliance|0|||
129885813|NCT02291289|467542805|FG012|Induction Treatment|Non-Compliance|0|||
129885814|NCT02291289|467542793|FG000|Induction Treatment|Reason Not Specified|0|||
129885815|NCT02291289|467542794|FG001|Induction Treatment|Reason Not Specified|0|||
129885816|NCT02291289|467542795|FG002|Induction Treatment|Reason Not Specified|0|||
129885817|NCT02291289|467542796|FG003|Induction Treatment|Reason Not Specified|4|||
129885818|NCT02291289|467542797|FG004|Induction Treatment|Reason Not Specified|0|||
129885819|NCT02291289|467542798|FG005|Induction Treatment|Reason Not Specified|0|||
129885820|NCT02291289|467542799|FG006|Induction Treatment|Reason Not Specified|0|||
129598989|NCT00706992|466487880|FG005|Overall Study|Study termination|2|||
129598990|NCT00706992|466487881|FG006|Overall Study|Study termination|3|||
129598991|NCT00706992|466487875|FG000|Overall Study|Disease progression before treatment|0|||
129598992|NCT00706992|466487876|FG001|Overall Study|Disease progression before treatment|0|||
129598993|NCT00706992|466487877|FG002|Overall Study|Disease progression before treatment|0|||
129598994|NCT00706992|466487878|FG003|Overall Study|Disease progression before treatment|0|||
129598995|NCT00706992|466487879|FG004|Overall Study|Disease progression before treatment|1|||
129598996|NCT00706992|466487880|FG005|Overall Study|Disease progression before treatment|0|||
129697251|NCT00289900|466850160|FG002|Overall Study|Participant moved|0|||
129697252|NCT00289900|466850161|FG003|Overall Study|Participant moved|1|||
129697253|NCT00289900|466850162|FG004|Overall Study|Participant moved|1|||
129697254|NCT00289900|466850163|FG005|Overall Study|Participant moved|1|||
129697255|NCT00289900|466850158|FG000|Overall Study|Withdrawal by Subject|10|||
129697256|NCT00289900|466850159|FG001|Overall Study|Withdrawal by Subject|21|||
129697257|NCT00289900|466850160|FG002|Overall Study|Withdrawal by Subject|8|||
129697258|NCT00289900|466850161|FG003|Overall Study|Withdrawal by Subject|18|||
129697259|NCT00289900|466850162|FG004|Overall Study|Withdrawal by Subject|12|||
129697260|NCT00289900|466850163|FG005|Overall Study|Withdrawal by Subject|11|||
129697261|NCT00289900|466850158|FG000|Overall Study|Protocol Violation|3|||
129697262|NCT00289900|466850159|FG001|Overall Study|Protocol Violation|9|||
129697263|NCT00289900|466850160|FG002|Overall Study|Protocol Violation|2|||
129697264|NCT00289900|466850161|FG003|Overall Study|Protocol Violation|6|||
129697265|NCT00289900|466850162|FG004|Overall Study|Protocol Violation|7|||
129697266|NCT00289900|466850163|FG005|Overall Study|Protocol Violation|4|||
129697267|NCT00289900|466850158|FG000|Overall Study|site terminated|1|||
129697268|NCT00289900|466850159|FG001|Overall Study|site terminated|0|||
129697269|NCT00289900|466850160|FG002|Overall Study|site terminated|1|||
129697270|NCT00289900|466850161|FG003|Overall Study|site terminated|0|||
129697271|NCT00289900|466850162|FG004|Overall Study|site terminated|0|||
129697272|NCT00289900|466850163|FG005|Overall Study|site terminated|0|||
129697273|NCT00289900|466850158|FG000|Overall Study|Not treated|0|||
129697274|NCT00289900|466850159|FG001|Overall Study|Not treated|1|||
129697275|NCT00289900|466850160|FG002|Overall Study|Not treated|0|||
129697276|NCT00289900|466850161|FG003|Overall Study|Not treated|0|||
129697277|NCT00289900|466850162|FG004|Overall Study|Not treated|0|||
129885821|NCT02291289|467542800|FG007|Induction Treatment|Reason Not Specified|0|||
129598997|NCT00706992|466487881|FG006|Overall Study|Disease progression before treatment|0|||
129598998|NCT02377063|466487885|FG000|Overall Study|Non-compliance|5|||
129697278|NCT00289900|466850163|FG005|Overall Study|Not treated|0|||
129697279|NCT01152385|466850164|FG000|Overall Study|Withdrawal by Subject|3|||
129885822|NCT02291289|467542801|FG008|Induction Treatment|Reason Not Specified|0|||
129598999|NCT01277718|466487887|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
129697280|NCT01152385|466850165|FG001|Overall Study|Withdrawal by Subject|1|||
129697281|NCT01152385|466850166|FG002|Overall Study|Withdrawal by Subject|1|||
129697282|NCT01152385|466850167|FG003|Overall Study|Withdrawal by Subject|1|||
129697283|NCT01152385|466850164|FG000|Overall Study|Protocol Violation|0|||
129697284|NCT01152385|466850165|FG001|Overall Study|Protocol Violation|0|||
129697285|NCT01152385|466850166|FG002|Overall Study|Protocol Violation|0|||
129885823|NCT02291289|467542802|FG009|Induction Treatment|Reason Not Specified|7|||
129697286|NCT01152385|466850167|FG003|Overall Study|Protocol Violation|1|||
129697287|NCT01152385|466850164|FG000|Overall Study|Adverse Event|1|||
129697288|NCT01152385|466850165|FG001|Overall Study|Adverse Event|1|||
129697289|NCT01152385|466850166|FG002|Overall Study|Adverse Event|0|||
129697290|NCT01152385|466850167|FG003|Overall Study|Adverse Event|0|||
129697291|NCT01152385|466850164|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129697292|NCT01152385|466850165|FG001|Overall Study|Study-specific withdrawal criteria|1|||
129697293|NCT01152385|466850166|FG002|Overall Study|Study-specific withdrawal criteria|2|||
129697294|NCT01152385|466850167|FG003|Overall Study|Study-specific withdrawal criteria|0|||
129697295|NCT01152385|466850164|FG000|Overall Study|Other|4|||
129697296|NCT01152385|466850165|FG001|Overall Study|Other|3|||
129697297|NCT01152385|466850166|FG002|Overall Study|Other|2|||
129697298|NCT01152385|466850167|FG003|Overall Study|Other|3|||
129697299|NCT05486065|466850168|FG000|Overall Study|Withdrawal by Subject|1|||
129697300|NCT05486065|466850169|FG001|Overall Study|Withdrawal by Subject|5|||
129697301|NCT05486065|466850170|FG002|Overall Study|Withdrawal by Subject|4|||
129697302|NCT05486065|466850171|FG003|Overall Study|Withdrawal by Subject|3|||
129697303|NCT05486065|466850168|FG000|Overall Study|Lost to Follow-up|4|||
129697304|NCT05486065|466850169|FG001|Overall Study|Lost to Follow-up|2|||
129697305|NCT05486065|466850170|FG002|Overall Study|Lost to Follow-up|2|||
129697306|NCT05486065|466850171|FG003|Overall Study|Lost to Follow-up|2|||
129697307|NCT05486065|466850168|FG000|Overall Study|Physician Decision|0|||
129697308|NCT05486065|466850169|FG001|Overall Study|Physician Decision|1|||
129697309|NCT05486065|466850170|FG002|Overall Study|Physician Decision|1|||
129697310|NCT05486065|466850171|FG003|Overall Study|Physician Decision|0|||
129697311|NCT05486065|466850168|FG000|Overall Study|Failure to meet randomization criteria|0|||
129697312|NCT05486065|466850169|FG001|Overall Study|Failure to meet randomization criteria|0|||
129697313|NCT05486065|466850170|FG002|Overall Study|Failure to meet randomization criteria|0|||
129697314|NCT05486065|466850171|FG003|Overall Study|Failure to meet randomization criteria|1|||
129697315|NCT03810495|466850176|FG000|Overall Study|Lost to Follow-up|2|||
129697316|NCT03810495|466850176|FG000|Overall Study|Withdrawal by Subject|1|||
129697317|NCT03289741|466850177|FG000|Overall Study|Adverse Event|1|||
129697318|NCT03289741|466850178|FG001|Overall Study|Adverse Event|1|||
129697319|NCT03289741|466850177|FG000|Overall Study|Physician Decision|2|||
129697320|NCT03289741|466850178|FG001|Overall Study|Physician Decision|2|||
129697321|NCT03289741|466850177|FG000|Overall Study|Withdrawal by Subject|1|||
129697322|NCT03289741|466850178|FG001|Overall Study|Withdrawal by Subject|0|||
129697323|NCT02536339|466850180|FG000|Overall Study|Death|20|||
129697324|NCT02536339|466850180|FG000|Overall Study|Withdrawal by Subject|3|||
129697325|NCT02536339|466850180|FG000|Overall Study|Lost to Follow-up|2|||
129697326|NCT02536339|466850180|FG000|Overall Study|Treatment discontinued|2|||
129697327|NCT02536339|466850180|FG000|Overall Study|Physician Decision|1|||
129697328|NCT02037984|466850181|FG000|Overall Study|Lack of Efficacy|0|||
129697329|NCT02037984|466850182|FG001|Overall Study|Lack of Efficacy|0|||
129697330|NCT02037984|466850183|FG002|Overall Study|Lack of Efficacy|3|||
129697331|NCT02037984|466850184|FG003|Overall Study|Lack of Efficacy|10|||
129697332|NCT02037984|466850185|FG004|Overall Study|Lack of Efficacy|2|||
129697333|NCT02037984|466850186|FG005|Overall Study|Lack of Efficacy|2|||
129697334|NCT02037984|466850187|FG006|Overall Study|Lack of Efficacy|4|||
129697335|NCT02037984|466850188|FG007|Overall Study|Lack of Efficacy|3|||
129697336|NCT02037984|466850181|FG000|Overall Study|Lost to Follow-up|1|||
129697337|NCT02037984|466850182|FG001|Overall Study|Lost to Follow-up|0|||
129697338|NCT02037984|466850183|FG002|Overall Study|Lost to Follow-up|3|||
129697339|NCT02037984|466850184|FG003|Overall Study|Lost to Follow-up|5|||
129697340|NCT02037984|466850185|FG004|Overall Study|Lost to Follow-up|2|||
129697341|NCT02037984|466850186|FG005|Overall Study|Lost to Follow-up|2|||
129787378|NCT03595618|467189762|FG001|Overall Study|Withdrawal by Subject|14|||
129787379|NCT03595618|467189763|FG002|Overall Study|Withdrawal by Subject|14|||
129787380|NCT03595618|467189764|FG003|Overall Study|Withdrawal by Subject|10|||
129787381|NCT03595618|467189761|FG000|Overall Study|Lost to Follow-up|6|||
129787382|NCT03595618|467189762|FG001|Overall Study|Lost to Follow-up|4|||
129787383|NCT03595618|467189763|FG002|Overall Study|Lost to Follow-up|5|||
129787384|NCT03595618|467189764|FG003|Overall Study|Lost to Follow-up|6|||
129697342|NCT02037984|466850187|FG006|Overall Study|Lost to Follow-up|2|||
129697343|NCT02037984|466850188|FG007|Overall Study|Lost to Follow-up|4|||
129697344|NCT02037984|466850181|FG000|Overall Study|Physician Decision|0|||
129697345|NCT02037984|466850182|FG001|Overall Study|Physician Decision|0|||
129697346|NCT02037984|466850183|FG002|Overall Study|Physician Decision|0|||
129697347|NCT02037984|466850184|FG003|Overall Study|Physician Decision|0|||
129697348|NCT02037984|466850185|FG004|Overall Study|Physician Decision|0|||
129697349|NCT02037984|466850186|FG005|Overall Study|Physician Decision|0|||
129697350|NCT02037984|466850187|FG006|Overall Study|Physician Decision|1|||
129697351|NCT02037984|466850188|FG007|Overall Study|Physician Decision|0|||
129697352|NCT02037984|466850181|FG000|Overall Study|Protocol Violation|0|||
129697353|NCT02037984|466850182|FG001|Overall Study|Protocol Violation|0|||
129697354|NCT02037984|466850183|FG002|Overall Study|Protocol Violation|0|||
129697355|NCT02037984|466850184|FG003|Overall Study|Protocol Violation|0|||
129697356|NCT02037984|466850185|FG004|Overall Study|Protocol Violation|0|||
129697357|NCT02037984|466850186|FG005|Overall Study|Protocol Violation|1|||
129697358|NCT02037984|466850187|FG006|Overall Study|Protocol Violation|2|||
129697359|NCT02037984|466850188|FG007|Overall Study|Protocol Violation|0|||
129697360|NCT02037984|466850181|FG000|Overall Study|Technical Problems|0|||
129697361|NCT02037984|466850182|FG001|Overall Study|Technical Problems|0|||
129697362|NCT02037984|466850183|FG002|Overall Study|Technical Problems|3|||
129697363|NCT02037984|466850184|FG003|Overall Study|Technical Problems|3|||
129697364|NCT02037984|466850185|FG004|Overall Study|Technical Problems|2|||
129697365|NCT02037984|466850186|FG005|Overall Study|Technical Problems|3|||
129697366|NCT02037984|466850187|FG006|Overall Study|Technical Problems|4|||
129697367|NCT02037984|466850188|FG007|Overall Study|Technical Problems|2|||
129697368|NCT02037984|466850181|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129697369|NCT02037984|466850182|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129697370|NCT02037984|466850183|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
129697371|NCT02037984|466850184|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
129697372|NCT02037984|466850185|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
129697373|NCT02037984|466850186|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
129697374|NCT02037984|466850187|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
129697375|NCT02037984|466850188|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
129697376|NCT02037984|466850181|FG000|Overall Study|Withdrawal by Subject|0|||
129697377|NCT02037984|466850182|FG001|Overall Study|Withdrawal by Subject|0|||
129697378|NCT02037984|466850183|FG002|Overall Study|Withdrawal by Subject|0|||
129697379|NCT02037984|466850184|FG003|Overall Study|Withdrawal by Subject|1|||
129697380|NCT02037984|466850185|FG004|Overall Study|Withdrawal by Subject|1|||
129697381|NCT02037984|466850186|FG005|Overall Study|Withdrawal by Subject|3|||
129697382|NCT02037984|466850187|FG006|Overall Study|Withdrawal by Subject|0|||
129697383|NCT02037984|466850188|FG007|Overall Study|Withdrawal by Subject|1|||
129697384|NCT02457546|466851785|FG000|Overall Study|Other reasons|4|||
129697385|NCT02457546|466851786|FG001|Overall Study|Other reasons|1|||
129697386|NCT02457546|466851785|FG000|Overall Study|Refused to complete study/procedures|1|||
129787385|NCT03595618|467189761|FG000|Overall Study|Protocol Violation|2|||
129787386|NCT03595618|467189762|FG001|Overall Study|Protocol Violation|0|||
129787387|NCT03595618|467189763|FG002|Overall Study|Protocol Violation|6|||
129436309|NCT02070588|465895677|FG002|Overall Study|Writhdrawal due to early termination|0|||
129436310|NCT02070588|465895675|FG000|Overall Study|Adverse Event|1|||
129436311|NCT02070588|465895676|FG001|Overall Study|Adverse Event|0|||
129436312|NCT02070588|465895677|FG002|Overall Study|Adverse Event|0|||
129436313|NCT02216357|465895679|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
129436314|NCT02216357|465895680|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
129436315|NCT00836095|465895682|FG000|Overall Study|Physician Decision|0|||
129436316|NCT00836095|465895683|FG001|Overall Study|Physician Decision|3|||
129436317|NCT04620811|465895686|FG000|Overall Study|Withdrawal by Subject|18|||
129436318|NCT04620811|465895687|FG001|Overall Study|Withdrawal by Subject|15|||
129436319|NCT04620811|465895686|FG000|Overall Study|Adverse Event|6|||
129436320|NCT04620811|465895687|FG001|Overall Study|Adverse Event|11|||
129436321|NCT04620811|465895686|FG000|Overall Study|Lost to Follow-up|4|||
129436322|NCT04620811|465895687|FG001|Overall Study|Lost to Follow-up|8|||
129436323|NCT04620811|465895686|FG000|Overall Study|Physician Decision|1|||
129436324|NCT04620811|465895687|FG001|Overall Study|Physician Decision|4|||
129436325|NCT04620811|465895686|FG000|Overall Study|Sponsor Decision|0|||
129436326|NCT04620811|465895687|FG001|Overall Study|Sponsor Decision|1|||
129436327|NCT04620811|465895686|FG000|Overall Study|Elevation of ALT or AST|1|||
129436328|NCT04620811|465895687|FG001|Overall Study|Elevation of ALT or AST|0|||
129436329|NCT04620811|465895686|FG000|Overall Study|Other|3|||
129436330|NCT04620811|465895687|FG001|Overall Study|Other|5|||
129436331|NCT01078675|465895688|FG000|Overall Study|Withdrawal by Subject|7|||
129436332|NCT01078675|465895689|FG001|Overall Study|Withdrawal by Subject|3|||
129436333|NCT01078675|465895688|FG000|Overall Study|Protocol Violation|56|||
129436334|NCT01078675|465895689|FG001|Overall Study|Protocol Violation|0|||
129436335|NCT01078675|465895688|FG000|Overall Study|Provided in CRF for specific reasons|2|||
129436336|NCT01078675|465895689|FG001|Overall Study|Provided in CRF for specific reasons|3|||
129436337|NCT01078675|465895688|FG000|Overall Study|Adverse Event|3|||
129436338|NCT01078675|465895689|FG001|Overall Study|Adverse Event|0|||
129436339|NCT01759368|465895692|FG000|Overall Study|Lost to Follow-up|1|||
129436340|NCT01759368|465895693|FG001|Overall Study|Lost to Follow-up|0|||
129697387|NCT02457546|466851786|FG001|Overall Study|Refused to complete study/procedures|1|||
129436341|NCT01191268|465895694|FG000|Overall Study|Withdrawal by Subject|19|||
129436342|NCT01191268|465895695|FG001|Overall Study|Withdrawal by Subject|25|||
129436343|NCT01191268|465895696|FG002|Overall Study|Withdrawal by Subject|21|||
129436344|NCT01191268|465895694|FG000|Overall Study|Adverse Event|21|||
129697388|NCT02457546|466851785|FG000|Overall Study|Lost to Follow-up|4|||
129436345|NCT01191268|465895695|FG001|Overall Study|Adverse Event|13|||
129697389|NCT02457546|466851786|FG001|Overall Study|Lost to Follow-up|1|||
129697390|NCT02457546|466851785|FG000|Overall Study|Adverse Event|0|||
129697391|NCT02457546|466851786|FG001|Overall Study|Adverse Event|1|||
129697392|NCT01633112|466851787|FG000|Overall Study|Lack of Efficacy|1|||
129697393|NCT01633112|466851788|FG001|Overall Study|Lack of Efficacy|6|||
129697394|NCT01633112|466851789|FG002|Overall Study|Lack of Efficacy|13|||
129599000|NCT01277718|466487888|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
129599001|NCT01277718|466487887|FG000|Period 2 - Second Intervention|Physician Decision|0|||
129599002|NCT01277718|466487888|FG001|Period 2 - Second Intervention|Physician Decision|2|||
129599003|NCT01524913|466487889|FG000|Overall Study|Lost to Follow-up|4|||
129599004|NCT01524913|466487890|FG001|Overall Study|Lost to Follow-up|0|||
129599005|NCT01524913|466487891|FG002|Overall Study|Lost to Follow-up|0|||
129599006|NCT00702208|466487892|FG000|Overall Study|Lost to Follow-up|28|||
129599007|NCT00702208|466487892|FG000|Overall Study|Did not self-lavage|1|||
129599008|NCT00702208|466487892|FG000|Overall Study|Unsatisfactory colposcopy|2|||
129599009|NCT02746627|466487893|FG000|Overall Study|Withdrawal by Subject|1|||
129599010|NCT02746627|466487894|FG001|Overall Study|Withdrawal by Subject|1|||
129599011|NCT02746627|466487895|FG002|Overall Study|Withdrawal by Subject|1|||
129599012|NCT00788593|466487898|FG000|Placebo Run-in Phase|Adverse Event|2|||
129599013|NCT00788593|466487899|FG001|Placebo Run-in Phase|Adverse Event|0|||
129599014|NCT00788593|466487900|FG002|Placebo Run-in Phase|Adverse Event|0|||
129599015|NCT00788593|466487898|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
129599016|NCT00788593|466487899|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
129599017|NCT00788593|466487900|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
129599018|NCT00788593|466487898|FG000|Placebo Run-in Phase|Protocol Violation|2|||
129599019|NCT00788593|466487899|FG001|Placebo Run-in Phase|Protocol Violation|0|||
129599020|NCT00788593|466487900|FG002|Placebo Run-in Phase|Protocol Violation|0|||
129599021|NCT00788593|466487898|FG000|First Intervention Period|Adverse Event|0|||
129599022|NCT00788593|466487899|FG001|First Intervention Period|Adverse Event|1|||
129599023|NCT00788593|466487900|FG002|First Intervention Period|Adverse Event|0|||
129599024|NCT00788593|466487898|FG000|Second Intervention Period|Lost to Follow-up|0|||
129599025|NCT00788593|466487899|FG001|Second Intervention Period|Lost to Follow-up|1|||
129599026|NCT00788593|466487900|FG002|Second Intervention Period|Lost to Follow-up|0|||
129599027|NCT00788593|466487898|FG000|Second Intervention Period|Other|0|||
129599028|NCT00788593|466487899|FG001|Second Intervention Period|Other|0|||
129599029|NCT00788593|466487900|FG002|Second Intervention Period|Other|1|||
129599030|NCT00515034|466487903|FG000|Overall Study|Adverse Event|2|||
129599031|NCT00515034|466487904|FG001|Overall Study|Adverse Event|0|||
129599032|NCT00515034|466487905|FG002|Overall Study|Adverse Event|1|||
129599033|NCT00515034|466487906|FG003|Overall Study|Adverse Event|0|||
129599034|NCT00515034|466487903|FG000|Overall Study|Death|4|||
129599035|NCT00515034|466487904|FG001|Overall Study|Death|2|||
129599036|NCT00515034|466487905|FG002|Overall Study|Death|1|||
129787388|NCT03595618|467189764|FG003|Overall Study|Protocol Violation|2|||
129787389|NCT03595618|467189761|FG000|Overall Study|Physician Decision|0|||
129787390|NCT03595618|467189762|FG001|Overall Study|Physician Decision|0|||
129787391|NCT03595618|467189763|FG002|Overall Study|Physician Decision|1|||
129787392|NCT03595618|467189764|FG003|Overall Study|Physician Decision|2|||
129787393|NCT03595618|467189761|FG000|Overall Study|Miscellaneous|7|||
129787394|NCT03595618|467189762|FG001|Overall Study|Miscellaneous|5|||
129787395|NCT03595618|467189763|FG002|Overall Study|Miscellaneous|10|||
129599037|NCT00515034|466487906|FG003|Overall Study|Death|3|||
129599038|NCT00515034|466487903|FG000|Overall Study|Withdrawal by Subject|1|||
129599039|NCT00515034|466487904|FG001|Overall Study|Withdrawal by Subject|0|||
129599040|NCT00515034|466487905|FG002|Overall Study|Withdrawal by Subject|3|||
129599041|NCT00515034|466487906|FG003|Overall Study|Withdrawal by Subject|0|||
129599042|NCT00515034|466487903|FG000|Overall Study|Physician Decision|0|||
129599043|NCT00515034|466487904|FG001|Overall Study|Physician Decision|0|||
129599044|NCT00515034|466487905|FG002|Overall Study|Physician Decision|1|||
129599045|NCT00515034|466487906|FG003|Overall Study|Physician Decision|1|||
129599046|NCT00515034|466487903|FG000|Overall Study|Other|1|||
129787396|NCT03595618|467189764|FG003|Overall Study|Miscellaneous|6|||
129787397|NCT02338232|467189765|FG000|Overall Study|Screen Failure|3|||
129599047|NCT00515034|466487904|FG001|Overall Study|Other|0|||
129599048|NCT00515034|466487905|FG002|Overall Study|Other|2|||
129599049|NCT00515034|466487906|FG003|Overall Study|Other|1|||
129599050|NCT02858726|466487907|FG000|Overall Study|Adverse Event|4|||
129599051|NCT02858726|466487908|FG001|Overall Study|Adverse Event|4|||
129599052|NCT02858726|466487909|FG002|Overall Study|Adverse Event|9|||
129599053|NCT02858726|466487910|FG003|Overall Study|Adverse Event|1|||
129787398|NCT02338232|467189765|FG000|Overall Study|Withdrawal by Subject|6|||
129787399|NCT02338232|467189765|FG000|Overall Study|Adverse Event|2|||
129787400|NCT02279407|467189766|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
129436346|NCT01191268|465895696|FG002|Overall Study|Adverse Event|8|||
129599054|NCT02858726|466487907|FG000|Overall Study|Physician Decision|0|||
129599055|NCT02858726|466487908|FG001|Overall Study|Physician Decision|0|||
129599056|NCT02858726|466487909|FG002|Overall Study|Physician Decision|1|||
129599057|NCT02858726|466487910|FG003|Overall Study|Physician Decision|0|||
129599058|NCT02858726|466487907|FG000|Overall Study|Protocol Violation|0|||
129599059|NCT02858726|466487908|FG001|Overall Study|Protocol Violation|0|||
129599060|NCT02858726|466487909|FG002|Overall Study|Protocol Violation|0|||
129599061|NCT02858726|466487910|FG003|Overall Study|Protocol Violation|1|||
129599062|NCT02858726|466487907|FG000|Overall Study|Study Terminated by Sponsor|0|||
129599063|NCT02858726|466487908|FG001|Overall Study|Study Terminated by Sponsor|0|||
129599064|NCT02858726|466487909|FG002|Overall Study|Study Terminated by Sponsor|0|||
129436347|NCT01191268|465895694|FG000|Overall Study|Physician Decision|6|||
129599065|NCT02858726|466487910|FG003|Overall Study|Study Terminated by Sponsor|1|||
129599066|NCT02858726|466487907|FG000|Overall Study|Withdrawal by Subject|1|||
129599067|NCT02858726|466487908|FG001|Overall Study|Withdrawal by Subject|2|||
129599068|NCT02858726|466487909|FG002|Overall Study|Withdrawal by Subject|1|||
129599069|NCT02858726|466487910|FG003|Overall Study|Withdrawal by Subject|0|||
129599070|NCT02858726|466487907|FG000|Overall Study|Noncompliance|0|||
129599071|NCT02858726|466487908|FG001|Overall Study|Noncompliance|1|||
129599072|NCT02858726|466487909|FG002|Overall Study|Noncompliance|0|||
129599073|NCT02858726|466487910|FG003|Overall Study|Noncompliance|0|||
129599074|NCT01392326|466487915|FG000|Overall Study|Death|2|||
129599075|NCT01392326|466487916|FG001|Overall Study|Death|0|||
129599076|NCT01392326|466487917|FG002|Overall Study|Death|0|||
129599077|NCT01392326|466487915|FG000|Overall Study|Withdrawal by Subject|12|||
129599078|NCT01392326|466487916|FG001|Overall Study|Withdrawal by Subject|11|||
129599079|NCT01392326|466487917|FG002|Overall Study|Withdrawal by Subject|15|||
129599080|NCT01392326|466487915|FG000|Overall Study|Protocol Violation|2|||
129599081|NCT01392326|466487916|FG001|Overall Study|Protocol Violation|0|||
129599082|NCT01392326|466487917|FG002|Overall Study|Protocol Violation|0|||
129599083|NCT01392326|466487915|FG000|Overall Study|Pregnancy|0|||
129599084|NCT01392326|466487916|FG001|Overall Study|Pregnancy|0|||
129599085|NCT01392326|466487917|FG002|Overall Study|Pregnancy|1|||
129599086|NCT01392326|466487915|FG000|Overall Study|Physician Decision|7|||
129599087|NCT01392326|466487916|FG001|Overall Study|Physician Decision|5|||
129599088|NCT01392326|466487917|FG002|Overall Study|Physician Decision|2|||
129436348|NCT01191268|465895695|FG001|Overall Study|Physician Decision|8|||
129599089|NCT01392326|466487915|FG000|Overall Study|Lost to Follow-up|1|||
129599090|NCT01392326|466487916|FG001|Overall Study|Lost to Follow-up|3|||
129599091|NCT01392326|466487917|FG002|Overall Study|Lost to Follow-up|4|||
129599092|NCT01392326|466487915|FG000|Overall Study|Lack of Efficacy|14|||
129599093|NCT01392326|466487916|FG001|Overall Study|Lack of Efficacy|10|||
129599094|NCT01392326|466487917|FG002|Overall Study|Lack of Efficacy|15|||
129599095|NCT01392326|466487915|FG000|Overall Study|Adverse Event|9|||
129599096|NCT01392326|466487916|FG001|Overall Study|Adverse Event|6|||
129599097|NCT01392326|466487917|FG002|Overall Study|Adverse Event|11|||
129599098|NCT00233987|466487922|FG000|Overall Study|Withdrawal by Subject|1|||
129599099|NCT00233987|466487922|FG000|Overall Study|Lack of Efficacy|2|||
129599100|NCT00233987|466487922|FG000|Overall Study|Reason Under Review|1|||
129599101|NCT00233987|466487922|FG000|Overall Study|Other - Not Protocol Specified|5|||
129599102|NCT00233987|466487922|FG000|Overall Study|Eligible but No Treatment Received|2|||
129599103|NCT00233987|466487922|FG000|Overall Study|Ineligible|4|||
129599104|NCT00518622|466487925|FG000|Overall Study|Lost to Follow-up|0|||
129599105|NCT00518622|466487926|FG001|Overall Study|Lost to Follow-up|0|||
129599106|NCT00518622|466487927|FG002|Overall Study|Lost to Follow-up|1|||
129599107|NCT00518622|466487928|FG003|Overall Study|Lost to Follow-up|0|||
129599108|NCT00518622|466487929|FG004|Overall Study|Lost to Follow-up|0|||
129599109|NCT00518622|466487930|FG005|Overall Study|Lost to Follow-up|0|||
129599110|NCT00518622|466487931|FG006|Overall Study|Lost to Follow-up|0|||
129599111|NCT00518622|466487932|FG007|Overall Study|Lost to Follow-up|0|||
129599112|NCT00518622|466487925|FG000|Overall Study|Study medication taken incorrectly|0|||
129599113|NCT00518622|466487926|FG001|Overall Study|Study medication taken incorrectly|1|||
129599114|NCT00518622|466487927|FG002|Overall Study|Study medication taken incorrectly|0|||
129599115|NCT00518622|466487928|FG003|Overall Study|Study medication taken incorrectly|0|||
129599116|NCT00518622|466487929|FG004|Overall Study|Study medication taken incorrectly|0|||
129599117|NCT00518622|466487930|FG005|Overall Study|Study medication taken incorrectly|0|||
129599118|NCT00518622|466487931|FG006|Overall Study|Study medication taken incorrectly|0|||
129436349|NCT01191268|465895696|FG002|Overall Study|Physician Decision|9|||
129599119|NCT00518622|466487932|FG007|Overall Study|Study medication taken incorrectly|0|||
129599120|NCT01688726|466487933|FG000|Overall Study|Adverse Event|1|||
129599121|NCT01688726|466487934|FG001|Overall Study|Adverse Event|0|||
129599122|NCT01688726|466487933|FG000|Overall Study|Relocated abroad|0|||
129599123|NCT01688726|466487934|FG001|Overall Study|Relocated abroad|1|||
129599124|NCT03499119|466487935|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
129599125|NCT03499119|466487936|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
129599126|NCT03499119|466487937|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
129599127|NCT03499119|466487938|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
129599128|NCT03499119|466487935|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
129787401|NCT02279407|467189767|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
129599129|NCT03499119|466487936|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
129599130|NCT03499119|466487937|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
129599131|NCT03499119|466487938|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
129599132|NCT03499119|466487935|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
129599133|NCT03499119|466487936|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
129599134|NCT03499119|466487937|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
129599135|NCT03499119|466487938|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
129599136|NCT03499119|466487935|FG000|Optional Extension Phase|Lost to Follow-up|0|||
129599137|NCT03499119|466487936|FG001|Optional Extension Phase|Lost to Follow-up|0|||
129599138|NCT03499119|466487937|FG002|Optional Extension Phase|Lost to Follow-up|0|||
129697395|NCT01633112|466851787|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129697396|NCT01633112|466851788|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129787402|NCT02279407|467189768|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
129787403|NCT02279407|467189769|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
129787404|NCT02279407|467189766|FG000|Overall Study|Withdrawal by Subject|1|||
129787405|NCT02279407|467189767|FG001|Overall Study|Withdrawal by Subject|0|||
129787406|NCT02279407|467189768|FG002|Overall Study|Withdrawal by Subject|1|||
129787407|NCT02279407|467189769|FG003|Overall Study|Withdrawal by Subject|1|||
129787408|NCT02279407|467189766|FG000|Overall Study|Adverse Event|1|||
129787409|NCT02279407|467189767|FG001|Overall Study|Adverse Event|1|||
129787410|NCT02279407|467189768|FG002|Overall Study|Adverse Event|2|||
129787411|NCT02279407|467189769|FG003|Overall Study|Adverse Event|0|||
129787412|NCT02500056|467189770|FG000|Overall Study|Lost to Follow-up|3|||
129787413|NCT02500056|467189771|FG001|Overall Study|Lost to Follow-up|7|||
129787414|NCT02500056|467189770|FG000|Overall Study|Recurrence|1|||
129787415|NCT02500056|467189771|FG001|Overall Study|Recurrence|0|||
129787416|NCT02500056|467189770|FG000|Overall Study|Death|3|||
129787417|NCT02500056|467189771|FG001|Overall Study|Death|1|||
129787418|NCT00864916|467189772|FG000|Overall Study|Lost to Follow-up|4|||
129787419|NCT00864916|467189773|FG001|Overall Study|Lost to Follow-up|4|||
129787420|NCT00864916|467189772|FG000|Overall Study|Protocol Violation|1|||
129787421|NCT00864916|467189773|FG001|Overall Study|Protocol Violation|0|||
129787422|NCT00864916|467189772|FG000|Overall Study|Withdrawal by Subject|1|||
129787423|NCT00864916|467189773|FG001|Overall Study|Withdrawal by Subject|0|||
129787424|NCT03996369|467189775|FG000|Overall Study|Protocol deviation|1|||
129787425|NCT03996369|467189776|FG001|Overall Study|Protocol deviation|1|||
129787426|NCT03996369|467189775|FG000|Overall Study|Physician Decision|4|||
129787427|NCT03996369|467189776|FG001|Overall Study|Physician Decision|2|||
129787428|NCT03996369|467189775|FG000|Overall Study|Participant decision|0|||
129787429|NCT03996369|467189776|FG001|Overall Study|Participant decision|1|||
129787430|NCT03996369|467189775|FG000|Overall Study|Lack of Efficacy|4|||
129787431|NCT03996369|467189776|FG001|Overall Study|Lack of Efficacy|0|||
129787432|NCT03996369|467189775|FG000|Overall Study|Adverse Event|9|||
129787433|NCT03996369|467189776|FG001|Overall Study|Adverse Event|0|||
129787434|NCT03996369|467189775|FG000|Overall Study|Withdrawal by Subject|6|||
129697397|NCT01633112|466851789|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129697398|NCT01633112|466851787|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129697399|NCT01633112|466851788|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129697400|NCT01633112|466851789|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129697401|NCT01633112|466851787|FG000|Overall Study|Administrative problems|1|||
129697402|NCT01633112|466851788|FG001|Overall Study|Administrative problems|2|||
129697403|NCT01633112|466851789|FG002|Overall Study|Administrative problems|5|||
129697404|NCT01633112|466851787|FG000|Overall Study|Adverse Event|16|||
129697405|NCT01633112|466851788|FG001|Overall Study|Adverse Event|18|||
129697406|NCT01633112|466851789|FG002|Overall Study|Adverse Event|20|||
129697407|NCT01633112|466851787|FG000|Overall Study|Lost to Follow-up|7|||
129697408|NCT01633112|466851788|FG001|Overall Study|Lost to Follow-up|19|||
129697409|NCT01633112|466851789|FG002|Overall Study|Lost to Follow-up|6|||
129697410|NCT01633112|466851787|FG000|Overall Study|Protocol Violation|4|||
129697411|NCT01633112|466851788|FG001|Overall Study|Protocol Violation|0|||
129697412|NCT01633112|466851789|FG002|Overall Study|Protocol Violation|2|||
129697413|NCT01633112|466851787|FG000|Overall Study|Subject no longer requires study drug|0|||
129697414|NCT01633112|466851788|FG001|Overall Study|Subject no longer requires study drug|0|||
129697415|NCT01633112|466851789|FG002|Overall Study|Subject no longer requires study drug|1|||
129787435|NCT03996369|467189776|FG001|Overall Study|Withdrawal by Subject|8|||
129787436|NCT03996369|467189775|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
129787437|NCT03996369|467189776|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
129787438|NCT03996369|467189775|FG000|Overall Study|Lost to Follow-up|0|||
129787439|NCT03996369|467189776|FG001|Overall Study|Lost to Follow-up|1|||
129787440|NCT01185301|467189780|FG000|Overall Study|Adverse Event|3|||
129787441|NCT01185301|467189781|FG001|Overall Study|Adverse Event|0|||
129787442|NCT01185301|467189782|FG002|Overall Study|Adverse Event|2|||
129599139|NCT03499119|466487938|FG003|Optional Extension Phase|Lost to Follow-up|1|||
129697416|NCT01633112|466851787|FG000|Overall Study|Withdrawal by Subject|20|||
129697417|NCT01633112|466851788|FG001|Overall Study|Withdrawal by Subject|12|||
129697418|NCT01633112|466851789|FG002|Overall Study|Withdrawal by Subject|41|||
129599140|NCT03499119|466487935|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
129787443|NCT01185301|467189783|FG003|Overall Study|Adverse Event|3|||
129787444|NCT01185301|467189780|FG000|Overall Study|Withdrawal by Subject|7|||
129787445|NCT01185301|467189781|FG001|Overall Study|Withdrawal by Subject|5|||
129787446|NCT01185301|467189782|FG002|Overall Study|Withdrawal by Subject|2|||
129787447|NCT01185301|467189783|FG003|Overall Study|Withdrawal by Subject|3|||
129787448|NCT01185301|467189780|FG000|Overall Study|Lost to Follow-up|2|||
129787449|NCT01185301|467189781|FG001|Overall Study|Lost to Follow-up|0|||
129787450|NCT01185301|467189782|FG002|Overall Study|Lost to Follow-up|0|||
129787451|NCT01185301|467189783|FG003|Overall Study|Lost to Follow-up|1|||
129787452|NCT01185301|467189780|FG000|Overall Study|Other Reason|3|||
129787453|NCT01185301|467189781|FG001|Overall Study|Other Reason|2|||
129787454|NCT01185301|467189782|FG002|Overall Study|Other Reason|2|||
129787455|NCT01185301|467189783|FG003|Overall Study|Other Reason|2|||
129787456|NCT02683746|467189784|FG000|Overall Study|Adverse Event|3|||
129787457|NCT02683746|467189785|FG001|Overall Study|Adverse Event|2|||
129787458|NCT02683746|467189784|FG000|Overall Study|Lost to Follow-up|5|||
129787459|NCT02683746|467189785|FG001|Overall Study|Lost to Follow-up|6|||
129787460|NCT02683746|467189784|FG000|Overall Study|Withdrawal by Subject|6|||
129787461|NCT02683746|467189785|FG001|Overall Study|Withdrawal by Subject|5|||
129787462|NCT02683746|467189784|FG000|Overall Study|Physician Decision|2|||
129787463|NCT02683746|467189785|FG001|Overall Study|Physician Decision|1|||
129787464|NCT04987944|467189786|FG000|Overall Study|Adverse Event|0|||
129787465|NCT04987944|467189787|FG001|Overall Study|Adverse Event|1|||
129787466|NCT04987944|467189786|FG000|Overall Study|Withdrawal by Subject|0|||
129787467|NCT04987944|467189787|FG001|Overall Study|Withdrawal by Subject|1|||
129787468|NCT03077087|467189794|FG000|Overall Study|Physician Decision|2|||
129787469|NCT01989468|467189795|FG000|Overall Study|Adverse Event|10|||
129787470|NCT01989468|467189796|FG001|Overall Study|Adverse Event|15|||
129787471|NCT01989468|467189797|FG002|Overall Study|Adverse Event|4|||
129787472|NCT01989468|467189798|FG003|Overall Study|Adverse Event|5|||
129787473|NCT01989468|467189799|FG004|Overall Study|Adverse Event|4|||
129599141|NCT03499119|466487936|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
129787474|NCT01989468|467189795|FG000|Overall Study|Lack of Efficacy|11|||
129787475|NCT01989468|467189796|FG001|Overall Study|Lack of Efficacy|11|||
129787476|NCT01989468|467189797|FG002|Overall Study|Lack of Efficacy|7|||
129787477|NCT01989468|467189798|FG003|Overall Study|Lack of Efficacy|4|||
129787478|NCT01989468|467189799|FG004|Overall Study|Lack of Efficacy|2|||
129787479|NCT01989468|467189795|FG000|Overall Study|Lost to Follow-up|5|||
129787480|NCT01989468|467189796|FG001|Overall Study|Lost to Follow-up|2|||
129787481|NCT01989468|467189797|FG002|Overall Study|Lost to Follow-up|0|||
129787482|NCT01989468|467189798|FG003|Overall Study|Lost to Follow-up|1|||
129787483|NCT01989468|467189799|FG004|Overall Study|Lost to Follow-up|1|||
129787484|NCT01989468|467189795|FG000|Overall Study|Physician Decision|4|||
129787485|NCT01989468|467189796|FG001|Overall Study|Physician Decision|1|||
129787486|NCT01989468|467189797|FG002|Overall Study|Physician Decision|0|||
129787487|NCT01989468|467189798|FG003|Overall Study|Physician Decision|1|||
129787488|NCT01989468|467189799|FG004|Overall Study|Physician Decision|0|||
129787489|NCT01989468|467189795|FG000|Overall Study|Pregnancy|0|||
129787490|NCT01989468|467189796|FG001|Overall Study|Pregnancy|1|||
129599142|NCT03499119|466487937|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
129599143|NCT03499119|466487938|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
129599144|NCT03499119|466487935|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
129599145|NCT03499119|466487936|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
129599146|NCT03499119|466487937|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
129599147|NCT03499119|466487938|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
129599148|NCT04553913|466487939|FG000|Overall Study|patient's block resolved prior to PACU|1|||
129436350|NCT01191268|465895694|FG000|Overall Study|Lost to Follow-up|8|||
129599149|NCT04553913|466487939|FG000|Overall Study|did not use the device properly|5|||
129599150|NCT01481324|466487941|FG000|Overall Study|Missing Data|0|||
129599151|NCT01481324|466487942|FG001|Overall Study|Missing Data|2|||
129599152|NCT01481324|466487943|FG002|Overall Study|Missing Data|2|||
129787491|NCT01989468|467189797|FG002|Overall Study|Pregnancy|0|||
129787492|NCT01989468|467189798|FG003|Overall Study|Pregnancy|0|||
129787493|NCT01989468|467189799|FG004|Overall Study|Pregnancy|0|||
129787494|NCT01989468|467189795|FG000|Overall Study|Technical Problems|3|||
129787495|NCT01989468|467189796|FG001|Overall Study|Technical Problems|1|||
129787496|NCT01989468|467189797|FG002|Overall Study|Technical Problems|3|||
129787497|NCT01989468|467189798|FG003|Overall Study|Technical Problems|1|||
129787498|NCT01989468|467189799|FG004|Overall Study|Technical Problems|0|||
129787499|NCT01989468|467189795|FG000|Overall Study|Subject Guardian Decision|11|||
129599153|NCT03821272|466490789|FG000|Overall Study|Death|1|||
129599154|NCT03821272|466490790|FG001|Overall Study|Death|0|||
129599155|NCT03821272|466490789|FG000|Overall Study|Physician Decision|1|||
129599156|NCT03821272|466490790|FG001|Overall Study|Physician Decision|0|||
129599157|NCT03821272|466490789|FG000|Overall Study|Withdrawal by Subject|1|||
129599158|NCT03821272|466490790|FG001|Overall Study|Withdrawal by Subject|0|||
129599159|NCT05904769|466490791|FG000|Overall Study|Physician Decision|0|||
129599160|NCT05904769|466490792|FG001|Overall Study|Physician Decision|6|||
129787500|NCT01989468|467189796|FG001|Overall Study|Subject Guardian Decision|6|||
129787501|NCT01989468|467189797|FG002|Overall Study|Subject Guardian Decision|4|||
129787502|NCT01989468|467189798|FG003|Overall Study|Subject Guardian Decision|4|||
129787503|NCT01989468|467189799|FG004|Overall Study|Subject Guardian Decision|1|||
129787504|NCT01989468|467189795|FG000|Overall Study|Death|3|||
129787505|NCT01989468|467189796|FG001|Overall Study|Death|0|||
129787506|NCT01989468|467189797|FG002|Overall Study|Death|1|||
129787507|NCT01989468|467189798|FG003|Overall Study|Death|0|||
129787508|NCT01989468|467189799|FG004|Overall Study|Death|0|||
129787509|NCT02112045|467189807|FG000|Overall Study|Withdrawal by Subject|1|||
129787510|NCT02112045|467189808|FG001|Overall Study|Withdrawal by Subject|0|||
129787511|NCT00977080|467189809|FG000|Overall Study|Adverse Event|2|||
129787512|NCT00977080|467189810|FG001|Overall Study|Adverse Event|7|||
129787513|NCT00977080|467189811|FG002|Overall Study|Adverse Event|7|||
129787514|NCT00977080|467189812|FG003|Overall Study|Adverse Event|7|||
129787515|NCT00977080|467189809|FG000|Overall Study|Withdrawal by Subject|1|||
129787516|NCT00977080|467189810|FG001|Overall Study|Withdrawal by Subject|5|||
129787517|NCT00977080|467189811|FG002|Overall Study|Withdrawal by Subject|1|||
129787518|NCT00977080|467189812|FG003|Overall Study|Withdrawal by Subject|5|||
129787519|NCT00977080|467189809|FG000|Overall Study|Protocol Violation|7|||
129787520|NCT00977080|467189810|FG001|Overall Study|Protocol Violation|3|||
129787521|NCT00977080|467189811|FG002|Overall Study|Protocol Violation|4|||
129787522|NCT00977080|467189812|FG003|Overall Study|Protocol Violation|3|||
129787523|NCT00977080|467189809|FG000|Overall Study|Noncompliance|0|||
129787524|NCT00977080|467189810|FG001|Overall Study|Noncompliance|2|||
129787525|NCT00977080|467189811|FG002|Overall Study|Noncompliance|1|||
129787526|NCT00977080|467189812|FG003|Overall Study|Noncompliance|0|||
129787527|NCT00977080|467189809|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
129787528|NCT00977080|467189810|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
129787529|NCT00977080|467189811|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
129787530|NCT00977080|467189812|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
129787531|NCT00977080|467189809|FG000|Overall Study|Required kidney transplantation|1|||
129787532|NCT00977080|467189810|FG001|Overall Study|Required kidney transplantation|3|||
129787533|NCT00977080|467189811|FG002|Overall Study|Required kidney transplantation|3|||
129787534|NCT00977080|467189812|FG003|Overall Study|Required kidney transplantation|1|||
129787535|NCT00977080|467189809|FG000|Overall Study|Travel for family reasons|1|||
129787536|NCT00977080|467189810|FG001|Overall Study|Travel for family reasons|0|||
129787537|NCT00977080|467189811|FG002|Overall Study|Travel for family reasons|0|||
129787538|NCT00977080|467189812|FG003|Overall Study|Travel for family reasons|0|||
129787539|NCT00441116|467189815|FG000|Overall Study|Adverse Event|1|||
129787540|NCT00441116|467189816|FG001|Overall Study|Adverse Event|1|||
129787541|NCT00441116|467189815|FG000|Overall Study|Withdrawal by Subject|1|||
129787542|NCT00441116|467189816|FG001|Overall Study|Withdrawal by Subject|0|||
129787543|NCT00441116|467189815|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
129787544|NCT00441116|467189816|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
129787545|NCT02509117|467189820|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787546|NCT02509117|467189821|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
129787547|NCT02509117|467189822|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787548|NCT02509117|467189823|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787549|NCT02509117|467189824|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787550|NCT02509117|467189825|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787551|NCT02509117|467189826|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787552|NCT02509117|467189827|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787553|NCT02509117|467189828|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787554|NCT02509117|467189829|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
129787555|NCT02509117|467189820|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787556|NCT02509117|467189821|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787557|NCT02509117|467189822|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787558|NCT02509117|467189823|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787559|NCT02509117|467189824|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787560|NCT02509117|467189825|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787561|NCT02509117|467189826|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787562|NCT02509117|467189827|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787563|NCT02509117|467189828|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
129787564|NCT02509117|467189829|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
129787565|NCT02509117|467189820|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787566|NCT02509117|467189821|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787567|NCT02509117|467189822|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787568|NCT02509117|467189823|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787569|NCT02509117|467189824|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787570|NCT02509117|467189825|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787571|NCT02509117|467189826|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787572|NCT02509117|467189827|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787573|NCT02509117|467189828|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
129787574|NCT02509117|467189829|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
129787575|NCT00548184|467189832|FG000|Overall Study|Adverse Event|3|||
129787576|NCT00548184|467189832|FG000|Overall Study|took other drug|1|||
129787577|NCT00548184|467189832|FG000|Overall Study|Found Her2 negative|1|||
129787578|NCT01765218|467189841|FG000|Overall Study|Protocol Violation|1|||
129787579|NCT01765218|467189842|FG001|Overall Study|Protocol Violation|2|||
129787580|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
129787581|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
129787582|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
129787583|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
129787584|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
129787585|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
129787586|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
129787587|NCT00946985|467189843|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
129787588|NCT00946985|467189843|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
129787589|NCT03148691|467189844|FG000|Overall Study|Protocol Violation|1|||
129787590|NCT03148691|467189845|FG001|Overall Study|Protocol Violation|2|||
129787591|NCT03148691|467189846|FG002|Overall Study|Protocol Violation|7|||
129787592|NCT03148691|467189844|FG000|Overall Study|Lost to Follow-up|0|||
129787593|NCT03148691|467189845|FG001|Overall Study|Lost to Follow-up|0|||
129787594|NCT03148691|467189846|FG002|Overall Study|Lost to Follow-up|1|||
129787595|NCT03148691|467189844|FG000|Overall Study|Other|1|||
129787596|NCT03148691|467189845|FG001|Overall Study|Other|0|||
129599192|NCT04189445|466490807|FG000|Overall Study|Withdrawal of consent|8|||
129599193|NCT04189445|466490808|FG001|Overall Study|Withdrawal of consent|1|||
129599194|NCT04189445|466490809|FG002|Overall Study|Withdrawal of consent|0|||
129599195|NCT04189445|466490807|FG000|Overall Study|Study Terminated by Sponsor|25|||
129599196|NCT04189445|466490808|FG001|Overall Study|Study Terminated by Sponsor|3|||
129599197|NCT04189445|466490809|FG002|Overall Study|Study Terminated by Sponsor|0|||
129599198|NCT04189445|466490807|FG000|Overall Study|Death|54|||
129599199|NCT04189445|466490808|FG001|Overall Study|Death|24|||
129599200|NCT04189445|466490809|FG002|Overall Study|Death|0|||
129436351|NCT01191268|465895695|FG001|Overall Study|Lost to Follow-up|5|||
129697419|NCT01633112|466851787|FG000|Overall Study|missing Study Completion CRF|1|||
129697420|NCT01633112|466851788|FG001|Overall Study|missing Study Completion CRF|1|||
129697421|NCT01633112|466851789|FG002|Overall Study|missing Study Completion CRF|4|||
129697422|NCT01908699|466851790|FG000|Overall Study|Adverse Event|8|||
129697423|NCT01908699|466851791|FG001|Overall Study|Adverse Event|12|||
129697424|NCT01908699|466851790|FG000|Overall Study|Lack of Efficacy|2|||
129697425|NCT01908699|466851791|FG001|Overall Study|Lack of Efficacy|2|||
129697426|NCT01908699|466851790|FG000|Overall Study|Lost to Follow-up|2|||
129787597|NCT03148691|467189846|FG002|Overall Study|Other|0|||
129787598|NCT03148691|467189844|FG000|Overall Study|Withdrawal by Subject|1|||
129697427|NCT01908699|466851791|FG001|Overall Study|Lost to Follow-up|4|||
129697428|NCT01908699|466851790|FG000|Overall Study|Physician Decision|8|||
129697429|NCT01908699|466851791|FG001|Overall Study|Physician Decision|8|||
129599327|NCT03959527|466490828|FG000|Overall Study|Withdrawal by Subject|8|||
129599328|NCT03959527|466490829|FG001|Overall Study|Withdrawal by Subject|3|||
129599329|NCT03959527|466490828|FG000|Overall Study|Lost to Follow-up|31|||
129599330|NCT03959527|466490829|FG001|Overall Study|Lost to Follow-up|15|||
129599331|NCT03959527|466490828|FG000|Overall Study|Did not meet eligibility criteria|1|||
129599332|NCT03959527|466490829|FG001|Overall Study|Did not meet eligibility criteria|1|||
129599333|NCT03959527|466490828|FG000|Overall Study|Protocol Violation|10|||
129787599|NCT03148691|467189845|FG001|Overall Study|Withdrawal by Subject|0|||
129787600|NCT03148691|467189846|FG002|Overall Study|Withdrawal by Subject|0|||
129787601|NCT00171834|467189847|FG000|Overall Study|Adverse Event|2|||
129787602|NCT00171834|467189848|FG001|Overall Study|Adverse Event|1|||
129787603|NCT00171834|467189849|FG002|Overall Study|Adverse Event|3|||
129787604|NCT00171834|467189850|FG003|Overall Study|Adverse Event|2|||
129787605|NCT00171834|467189851|FG004|Overall Study|Adverse Event|2|||
129787606|NCT00171834|467189852|FG005|Overall Study|Adverse Event|15|||
129787607|NCT00171834|467189853|FG006|Overall Study|Adverse Event|1|||
129787608|NCT00171834|467189847|FG000|Overall Study|Withdrawal by Subject|0|||
129787609|NCT00171834|467189848|FG001|Overall Study|Withdrawal by Subject|2|||
129787610|NCT00171834|467189849|FG002|Overall Study|Withdrawal by Subject|0|||
129787611|NCT00171834|467189850|FG003|Overall Study|Withdrawal by Subject|1|||
129787612|NCT00171834|467189851|FG004|Overall Study|Withdrawal by Subject|1|||
129787613|NCT00171834|467189852|FG005|Overall Study|Withdrawal by Subject|1|||
129787614|NCT00171834|467189853|FG006|Overall Study|Withdrawal by Subject|0|||
129436352|NCT01191268|465895696|FG002|Overall Study|Lost to Follow-up|9|||
129436353|NCT01191268|465895694|FG000|Overall Study|Entry Criteria Not Met|3|||
129436354|NCT01191268|465895695|FG001|Overall Study|Entry Criteria Not Met|1|||
129436355|NCT01191268|465895696|FG002|Overall Study|Entry Criteria Not Met|1|||
129599334|NCT03959527|466490829|FG001|Overall Study|Protocol Violation|5|||
129599343|NCT01688466|466490832|FG000|Overall Study|Withdrawal by Subject|2|||
129599344|NCT01688466|466490833|FG001|Overall Study|Withdrawal by Subject|1|||
129599345|NCT01688466|466490832|FG000|Overall Study|Death|0|||
129599346|NCT01688466|466490833|FG001|Overall Study|Death|1|||
129599347|NCT01688466|466490832|FG000|Overall Study|Adverse Event|0|||
129599348|NCT01688466|466490833|FG001|Overall Study|Adverse Event|4|||
129599349|NCT01688466|466490832|FG000|Overall Study|Not evaluable|0|||
129599350|NCT01688466|466490833|FG001|Overall Study|Not evaluable|1|||
129599351|NCT06029959|466490835|FG000|Overall Study|Physician Decision|6|||
129787615|NCT00171834|467189847|FG000|Overall Study|Death from study indication|0|||
129787616|NCT00171834|467189848|FG001|Overall Study|Death from study indication|1|||
129436356|NCT01191268|465895694|FG000|Overall Study|Death|0|||
129436357|NCT01191268|465895695|FG001|Overall Study|Death|1|||
129436358|NCT01191268|465895696|FG002|Overall Study|Death|3|||
129599408|NCT02960893|466490857|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
129599409|NCT02960893|466490858|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
129599410|NCT02960893|466490859|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
129599411|NCT02960893|466490860|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
129599412|NCT02960893|466490857|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
129599413|NCT02960893|466490858|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
129599414|NCT02960893|466490859|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
129599415|NCT02960893|466490860|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
129599416|NCT02960893|466490857|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
129599417|NCT02960893|466490858|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
129599418|NCT02960893|466490859|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
129599419|NCT02960893|466490860|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
129599420|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
129599421|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
129599422|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
129599423|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
129599424|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
129599425|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
129599426|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
129599427|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
129599428|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
129599429|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
129697430|NCT01908699|466851790|FG000|Overall Study|Withdrawal by Subject|15|||
129599430|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
129697431|NCT01908699|466851791|FG001|Overall Study|Withdrawal by Subject|10|||
129697432|NCT01908699|466851790|FG000|Overall Study|Pregnancy|0|||
129436359|NCT01191268|465895694|FG000|Overall Study|Protocol Violation|1|||
129436360|NCT01191268|465895695|FG001|Overall Study|Protocol Violation|0|||
129436361|NCT01191268|465895696|FG002|Overall Study|Protocol Violation|1|||
129436362|NCT01191268|465895694|FG000|Overall Study|Sponsor Decision|0|||
129436363|NCT01191268|465895695|FG001|Overall Study|Sponsor Decision|2|||
129436364|NCT01191268|465895696|FG002|Overall Study|Sponsor Decision|0|||
129436365|NCT02294227|465895699|FG000|Overall Study|Death|0|||
129436366|NCT02294227|465895700|FG001|Overall Study|Death|0|||
129436367|NCT02294227|465895701|FG002|Overall Study|Death|1|||
129436368|NCT02294227|465895699|FG000|Overall Study|Subject/Guardian Decision|6|||
129436369|NCT02294227|465895700|FG001|Overall Study|Subject/Guardian Decision|3|||
129436370|NCT02294227|465895701|FG002|Overall Study|Subject/Guardian Decision|7|||
129436371|NCT02294227|465895699|FG000|Overall Study|Physician Decision|1|||
129436372|NCT02294227|465895700|FG001|Overall Study|Physician Decision|2|||
129787617|NCT00171834|467189849|FG002|Overall Study|Death from study indication|0|||
129787618|NCT00171834|467189850|FG003|Overall Study|Death from study indication|0|||
129787619|NCT00171834|467189851|FG004|Overall Study|Death from study indication|1|||
129787620|NCT00171834|467189852|FG005|Overall Study|Death from study indication|0|||
129787621|NCT00171834|467189853|FG006|Overall Study|Death from study indication|0|||
129787622|NCT00171834|467189847|FG000|Overall Study|Disease Progression|4|||
129787623|NCT00171834|467189848|FG001|Overall Study|Disease Progression|8|||
129787624|NCT00171834|467189849|FG002|Overall Study|Disease Progression|8|||
129787625|NCT00171834|467189850|FG003|Overall Study|Disease Progression|9|||
129787626|NCT00171834|467189851|FG004|Overall Study|Disease Progression|2|||
129787627|NCT00171834|467189852|FG005|Overall Study|Disease Progression|18|||
129787628|NCT00171834|467189853|FG006|Overall Study|Disease Progression|3|||
129787629|NCT00171834|467189847|FG000|Overall Study|Treatment Duration Completed|0|||
129787630|NCT00171834|467189848|FG001|Overall Study|Treatment Duration Completed|0|||
129787631|NCT00171834|467189849|FG002|Overall Study|Treatment Duration Completed|1|||
129787632|NCT00171834|467189850|FG003|Overall Study|Treatment Duration Completed|0|||
129787633|NCT00171834|467189851|FG004|Overall Study|Treatment Duration Completed|2|||
129787634|NCT00171834|467189852|FG005|Overall Study|Treatment Duration Completed|1|||
129787635|NCT00171834|467189853|FG006|Overall Study|Treatment Duration Completed|0|||
129787636|NCT04345367|467189854|FG000|Overall Study|Other|3|||
129436373|NCT02294227|465895701|FG002|Overall Study|Physician Decision|1|||
129436374|NCT02294227|465895699|FG000|Overall Study|Lost to Follow-up|1|||
129436375|NCT02294227|465895700|FG001|Overall Study|Lost to Follow-up|0|||
129787637|NCT04345367|467189855|FG001|Overall Study|Other|4|||
129787638|NCT04345367|467189854|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
129787639|NCT04345367|467189855|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
129787640|NCT04345367|467189854|FG000|Overall Study|Withdrawal by Subject|11|||
129436376|NCT02294227|465895701|FG002|Overall Study|Lost to Follow-up|0|||
129599431|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
129599432|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
129436377|NCT02294227|465895699|FG000|Overall Study|Lack of Efficacy|11|||
129436378|NCT02294227|465895700|FG001|Overall Study|Lack of Efficacy|12|||
129599433|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
129599434|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
129599435|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
129599436|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
129599437|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
129599438|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
129599439|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
129436379|NCT02294227|465895701|FG002|Overall Study|Lack of Efficacy|8|||
129436380|NCT02294227|465895699|FG000|Overall Study|Adverse Event|6|||
129436381|NCT02294227|465895700|FG001|Overall Study|Adverse Event|8|||
129436382|NCT02294227|465895701|FG002|Overall Study|Adverse Event|2|||
129599440|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
129599441|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
129599442|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
129599443|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
129599444|NCT02960893|466490857|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
129599445|NCT02960893|466490858|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
129436383|NCT01768637|465895704|FG000|Overall Study|Lost to Follow-up|2|||
129436384|NCT01768637|465895705|FG001|Overall Study|Lost to Follow-up|7|||
129436385|NCT01768637|465895704|FG000|Overall Study|Difficult blood draw|1|||
129599446|NCT02960893|466490859|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
129599447|NCT02960893|466490860|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
129787641|NCT04345367|467189855|FG001|Overall Study|Withdrawal by Subject|11|||
129787642|NCT04345367|467189854|FG000|Overall Study|Protocol Violation|4|||
129787643|NCT04345367|467189855|FG001|Overall Study|Protocol Violation|3|||
129787644|NCT04345367|467189854|FG000|Overall Study|Lost to Follow-up|2|||
129787645|NCT04345367|467189855|FG001|Overall Study|Lost to Follow-up|4|||
129787646|NCT04345367|467189854|FG000|Overall Study|Lack of Efficacy|2|||
129787647|NCT04345367|467189855|FG001|Overall Study|Lack of Efficacy|0|||
129787648|NCT04345367|467189854|FG000|Overall Study|Death|2|||
129787649|NCT04345367|467189855|FG001|Overall Study|Death|0|||
129787650|NCT04345367|467189854|FG000|Overall Study|Adverse Event|10|||
129787651|NCT04345367|467189855|FG001|Overall Study|Adverse Event|9|||
129787652|NCT00796523|467189856|FG000|Overall Study|Lost to Follow-up|9|||
129787653|NCT00796523|467189857|FG001|Overall Study|Lost to Follow-up|7|||
129787654|NCT02431260|467189859|FG000|Overall Study|Subject Decision|0|||
129787655|NCT02431260|467189860|FG001|Overall Study|Subject Decision|1|||
129787656|NCT02431260|467189861|FG002|Overall Study|Subject Decision|1|||
129787657|NCT02431260|467189862|FG003|Overall Study|Subject Decision|0|||
129787658|NCT02431260|467189863|FG004|Overall Study|Subject Decision|0|||
129787659|NCT02431260|467189864|FG005|Overall Study|Subject Decision|0|||
129787660|NCT02431260|467189865|FG006|Overall Study|Subject Decision|0|||
129787661|NCT02431260|467189866|FG007|Overall Study|Subject Decision|0|||
129787662|NCT02431260|467189867|FG008|Overall Study|Subject Decision|1|||
129787663|NCT02431260|467189868|FG009|Overall Study|Subject Decision|1|||
129787664|NCT02431260|467189869|FG010|Overall Study|Subject Decision|0|||
129787665|NCT02431260|467189870|FG011|Overall Study|Subject Decision|1|||
129787666|NCT02431260|467189871|FG012|Overall Study|Subject Decision|0|||
129787667|NCT02431260|467189872|FG013|Overall Study|Subject Decision|0|||
129787668|NCT02431260|467189859|FG000|Overall Study|Death|4|||
129787669|NCT02431260|467189860|FG001|Overall Study|Death|4|||
129787670|NCT02431260|467189861|FG002|Overall Study|Death|3|||
129787671|NCT02431260|467189862|FG003|Overall Study|Death|4|||
129787672|NCT02431260|467189863|FG004|Overall Study|Death|2|||
129787673|NCT02431260|467189864|FG005|Overall Study|Death|2|||
129787674|NCT02431260|467189865|FG006|Overall Study|Death|3|||
129787675|NCT02431260|467189866|FG007|Overall Study|Death|1|||
129697433|NCT01908699|466851791|FG001|Overall Study|Pregnancy|1|||
129697434|NCT01908699|466851790|FG000|Overall Study|Randomized in Error|1|||
129697435|NCT01908699|466851791|FG001|Overall Study|Randomized in Error|0|||
129697436|NCT01908699|466851790|FG000|Overall Study|Death|9|||
129697437|NCT01908699|466851791|FG001|Overall Study|Death|12|||
129697438|NCT01908699|466851790|FG000|Overall Study|Progressive Disease|30|||
129697439|NCT01908699|466851791|FG001|Overall Study|Progressive Disease|29|||
129697440|NCT03439072|466851792|FG000|Overall Study|Withdrawal by Subject|2|||
129697441|NCT03439072|466851793|FG001|Overall Study|Withdrawal by Subject|3|||
129697442|NCT03439072|466851792|FG000|Overall Study|Physician Decision|0|||
129697443|NCT03439072|466851793|FG001|Overall Study|Physician Decision|1|||
129697444|NCT01537432|466851797|FG000|Overall Study|Lost to Follow-up|3|||
129697445|NCT01537432|466851798|FG001|Overall Study|Lost to Follow-up|1|||
129697446|NCT01537432|466851797|FG000|Overall Study|Withdrawal by Subject|0|||
129697447|NCT01537432|466851798|FG001|Overall Study|Withdrawal by Subject|1|||
129697448|NCT01537432|466851797|FG000|Overall Study|Administrative problems|1|||
129697449|NCT01537432|466851798|FG001|Overall Study|Administrative problems|0|||
129697450|NCT01537432|466851797|FG000|Overall Study|Adverse Event|1|||
129697451|NCT01537432|466851798|FG001|Overall Study|Adverse Event|0|||
129697452|NCT01537432|466851797|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129697453|NCT01537432|466851798|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129697454|NCT00889005|466851799|FG000|Overall Study|Lost to Follow-up|4|||
129697455|NCT00889005|466851800|FG001|Overall Study|Lost to Follow-up|2|||
129697456|NCT00889005|466851799|FG000|Overall Study|Withdrawal by Subject|4|||
129787676|NCT02431260|467189867|FG008|Overall Study|Death|6|||
129787677|NCT02431260|467189868|FG009|Overall Study|Death|6|||
129787678|NCT02431260|467189869|FG010|Overall Study|Death|3|||
129787679|NCT02431260|467189870|FG011|Overall Study|Death|2|||
129787680|NCT02431260|467189871|FG012|Overall Study|Death|5|||
129787681|NCT02431260|467189872|FG013|Overall Study|Death|1|||
129787682|NCT02431260|467189859|FG000|Overall Study|Lost to Follow-up|0|||
129787683|NCT02431260|467189860|FG001|Overall Study|Lost to Follow-up|0|||
129787684|NCT02431260|467189861|FG002|Overall Study|Lost to Follow-up|0|||
129697457|NCT00889005|466851800|FG001|Overall Study|Withdrawal by Subject|0|||
129697458|NCT05166902|466851801|FG000|First Intervention|Lost to Follow-up|0|||
129697459|NCT05166902|466851802|FG001|First Intervention|Lost to Follow-up|1|||
129697460|NCT01998477|466851803|FG000|Overall Study|Lost to Follow-up|4|||
129697461|NCT01998477|466851804|FG001|Overall Study|Lost to Follow-up|5|||
129787685|NCT02431260|467189862|FG003|Overall Study|Lost to Follow-up|0|||
129787686|NCT02431260|467189863|FG004|Overall Study|Lost to Follow-up|0|||
129787687|NCT02431260|467189864|FG005|Overall Study|Lost to Follow-up|1|||
129787688|NCT02431260|467189865|FG006|Overall Study|Lost to Follow-up|0|||
129787689|NCT02431260|467189866|FG007|Overall Study|Lost to Follow-up|0|||
129787690|NCT02431260|467189867|FG008|Overall Study|Lost to Follow-up|0|||
129787691|NCT02431260|467189868|FG009|Overall Study|Lost to Follow-up|0|||
129787692|NCT02431260|467189869|FG010|Overall Study|Lost to Follow-up|0|||
129787693|NCT02431260|467189870|FG011|Overall Study|Lost to Follow-up|0|||
129787694|NCT02431260|467189871|FG012|Overall Study|Lost to Follow-up|0|||
129787695|NCT02431260|467189872|FG013|Overall Study|Lost to Follow-up|0|||
129787696|NCT02431260|467189859|FG000|Overall Study|Study Terminated by the Sponsor|0|||
129787697|NCT02431260|467189860|FG001|Overall Study|Study Terminated by the Sponsor|0|||
129787698|NCT02431260|467189861|FG002|Overall Study|Study Terminated by the Sponsor|2|||
129787699|NCT02431260|467189862|FG003|Overall Study|Study Terminated by the Sponsor|1|||
129787700|NCT02431260|467189863|FG004|Overall Study|Study Terminated by the Sponsor|1|||
129787701|NCT02431260|467189864|FG005|Overall Study|Study Terminated by the Sponsor|0|||
129787702|NCT02431260|467189865|FG006|Overall Study|Study Terminated by the Sponsor|1|||
129787703|NCT02431260|467189866|FG007|Overall Study|Study Terminated by the Sponsor|2|||
129787704|NCT02431260|467189867|FG008|Overall Study|Study Terminated by the Sponsor|1|||
129787705|NCT02431260|467189868|FG009|Overall Study|Study Terminated by the Sponsor|1|||
129787706|NCT02431260|467189869|FG010|Overall Study|Study Terminated by the Sponsor|1|||
129787707|NCT02431260|467189870|FG011|Overall Study|Study Terminated by the Sponsor|0|||
129787708|NCT02431260|467189871|FG012|Overall Study|Study Terminated by the Sponsor|4|||
129787709|NCT02431260|467189872|FG013|Overall Study|Study Terminated by the Sponsor|0|||
129787710|NCT02431260|467189859|FG000|Overall Study|Physician Decision|0|||
129787711|NCT02431260|467189860|FG001|Overall Study|Physician Decision|0|||
129787712|NCT02431260|467189861|FG002|Overall Study|Physician Decision|0|||
129787713|NCT02431260|467189862|FG003|Overall Study|Physician Decision|0|||
129787714|NCT02431260|467189863|FG004|Overall Study|Physician Decision|0|||
129787715|NCT02431260|467189864|FG005|Overall Study|Physician Decision|1|||
129787716|NCT02431260|467189865|FG006|Overall Study|Physician Decision|0|||
129787717|NCT02431260|467189866|FG007|Overall Study|Physician Decision|0|||
129787718|NCT02431260|467189867|FG008|Overall Study|Physician Decision|0|||
129787719|NCT02431260|467189868|FG009|Overall Study|Physician Decision|0|||
129787720|NCT02431260|467189869|FG010|Overall Study|Physician Decision|0|||
129787721|NCT02431260|467189870|FG011|Overall Study|Physician Decision|0|||
129787722|NCT02431260|467189871|FG012|Overall Study|Physician Decision|0|||
129787723|NCT02431260|467189872|FG013|Overall Study|Physician Decision|0|||
129787724|NCT02431260|467189859|FG000|Overall Study|Other Unspecified|0|||
129787725|NCT02431260|467189860|FG001|Overall Study|Other Unspecified|0|||
129787726|NCT02431260|467189861|FG002|Overall Study|Other Unspecified|0|||
129787727|NCT02431260|467189862|FG003|Overall Study|Other Unspecified|0|||
129787728|NCT02431260|467189863|FG004|Overall Study|Other Unspecified|0|||
129787729|NCT02431260|467189864|FG005|Overall Study|Other Unspecified|0|||
129787730|NCT02431260|467189865|FG006|Overall Study|Other Unspecified|0|||
129787731|NCT02431260|467189866|FG007|Overall Study|Other Unspecified|0|||
129787732|NCT02431260|467189867|FG008|Overall Study|Other Unspecified|0|||
129787733|NCT02431260|467189868|FG009|Overall Study|Other Unspecified|0|||
129787734|NCT02431260|467189869|FG010|Overall Study|Other Unspecified|0|||
129787735|NCT02431260|467189870|FG011|Overall Study|Other Unspecified|1|||
129787736|NCT02431260|467189871|FG012|Overall Study|Other Unspecified|1|||
129787737|NCT02431260|467189872|FG013|Overall Study|Other Unspecified|0|||
129787738|NCT00439738|467189876|FG000|Overall Study|Withdrawal by Subject|16|||
129787739|NCT00439738|467189877|FG001|Overall Study|Withdrawal by Subject|13|||
129787740|NCT00439738|467189876|FG000|Overall Study|Adverse Event|6|||
129787741|NCT00439738|467189877|FG001|Overall Study|Adverse Event|4|||
129787742|NCT00439738|467189876|FG000|Overall Study|Lost to Follow-up|5|||
129787743|NCT00439738|467189877|FG001|Overall Study|Lost to Follow-up|6|||
129787744|NCT00439738|467189876|FG000|Overall Study|Protocol Violation|6|||
129787745|NCT00439738|467189877|FG001|Overall Study|Protocol Violation|3|||
129787746|NCT00439738|467189876|FG000|Overall Study|Lack of Efficacy|2|||
129787747|NCT00439738|467189877|FG001|Overall Study|Lack of Efficacy|2|||
129787748|NCT00439738|467189876|FG000|Overall Study|Abnormal Lab Values|1|||
129787749|NCT00439738|467189877|FG001|Overall Study|Abnormal Lab Values|0|||
129787750|NCT00978757|467189878|FG000|Overall Study|Physician Decision|1|||
129436386|NCT01768637|465895705|FG001|Overall Study|Difficult blood draw|0|||
129436387|NCT00887432|465895706|FG000|Overall Study|Start Excluded Therapy|3|||
129436388|NCT00887432|465895707|FG001|Overall Study|Start Excluded Therapy|0|||
129436389|NCT00887432|465895706|FG000|Overall Study|Did not complete treatment|6|||
129436390|NCT00887432|465895707|FG001|Overall Study|Did not complete treatment|8|||
129436391|NCT00887432|465895706|FG000|Overall Study|Protocol Violation|2|||
129436392|NCT00887432|465895707|FG001|Overall Study|Protocol Violation|3|||
129436393|NCT00887432|465895706|FG000|Overall Study|Withdrawal by Subject|3|||
129436394|NCT00887432|465895707|FG001|Overall Study|Withdrawal by Subject|2|||
129436395|NCT00887432|465895706|FG000|Overall Study|Lost to Follow-up|1|||
129436396|NCT00887432|465895707|FG001|Overall Study|Lost to Follow-up|0|||
129436397|NCT00887432|465895706|FG000|Overall Study|No reason provided|0|||
129436398|NCT00887432|465895707|FG001|Overall Study|No reason provided|1|||
129436399|NCT00899548|465895708|FG000|Overall Study|Physician Decision|3|||
129436400|NCT01636960|465895709|FG000|Induction Phase|Adverse Event|2|||
129436401|NCT01636960|465895709|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
129436402|NCT01636960|465895709|FG000|Maintenance Phase|Adverse Event|3|||
129436403|NCT01636960|465895709|FG000|Maintenance Phase|Progressive disease|1|||
129436404|NCT01209780|465895710|FG000|Overall Study|Adverse Event|0|||
129436405|NCT01209780|465895711|FG001|Overall Study|Adverse Event|1|||
129436406|NCT01209780|465895712|FG002|Overall Study|Adverse Event|0|||
129436407|NCT01209780|465895713|FG003|Overall Study|Adverse Event|0|||
129436408|NCT01209780|465895714|FG004|Overall Study|Adverse Event|0|||
129436409|NCT01209780|465895710|FG000|Overall Study|Withdrawal by Subject|9|||
129436410|NCT01209780|465895711|FG001|Overall Study|Withdrawal by Subject|2|||
129436411|NCT01209780|465895712|FG002|Overall Study|Withdrawal by Subject|1|||
129436412|NCT01209780|465895713|FG003|Overall Study|Withdrawal by Subject|1|||
129436413|NCT01209780|465895714|FG004|Overall Study|Withdrawal by Subject|0|||
129436414|NCT01209780|465895710|FG000|Overall Study|Lost to Follow-up|17|||
129436415|NCT01209780|465895711|FG001|Overall Study|Lost to Follow-up|12|||
129436416|NCT01209780|465895712|FG002|Overall Study|Lost to Follow-up|3|||
129436417|NCT01209780|465895713|FG003|Overall Study|Lost to Follow-up|9|||
129436418|NCT01209780|465895714|FG004|Overall Study|Lost to Follow-up|4|||
129436419|NCT01209780|465895710|FG000|Overall Study|Protocol Violation|0|||
129436420|NCT01209780|465895711|FG001|Overall Study|Protocol Violation|1|||
129436421|NCT01209780|465895712|FG002|Overall Study|Protocol Violation|0|||
129436422|NCT01209780|465895713|FG003|Overall Study|Protocol Violation|0|||
129787751|NCT00978757|467189879|FG001|Overall Study|Physician Decision|3|||
129787752|NCT01700387|467189880|FG000|Overall Study|Withdrawal by Subject|1|||
129885824|NCT02291289|467542803|FG010|Induction Treatment|Reason Not Specified|0|||
129885825|NCT02291289|467542804|FG011|Induction Treatment|Reason Not Specified|0|||
129885826|NCT02291289|467542805|FG012|Induction Treatment|Reason Not Specified|0|||
129885827|NCT02291289|467542793|FG000|Induction Treatment|Physician Decision|0|||
129885828|NCT02291289|467542794|FG001|Induction Treatment|Physician Decision|0|||
129885829|NCT02291289|467542795|FG002|Induction Treatment|Physician Decision|0|||
129885830|NCT02291289|467542796|FG003|Induction Treatment|Physician Decision|3|||
129885831|NCT02291289|467542797|FG004|Induction Treatment|Physician Decision|0|||
129885832|NCT02291289|467542798|FG005|Induction Treatment|Physician Decision|0|||
129885833|NCT02291289|467542799|FG006|Induction Treatment|Physician Decision|0|||
129885834|NCT02291289|467542800|FG007|Induction Treatment|Physician Decision|0|||
129885835|NCT02291289|467542801|FG008|Induction Treatment|Physician Decision|0|||
129885836|NCT02291289|467542802|FG009|Induction Treatment|Physician Decision|1|||
129885837|NCT02291289|467542803|FG010|Induction Treatment|Physician Decision|0|||
129885838|NCT02291289|467542804|FG011|Induction Treatment|Physician Decision|0|||
129885839|NCT02291289|467542805|FG012|Induction Treatment|Physician Decision|0|||
129436423|NCT01209780|465895714|FG004|Overall Study|Protocol Violation|0|||
129787753|NCT01700387|467189881|FG001|Overall Study|Withdrawal by Subject|2|||
129787754|NCT01700387|467189880|FG000|Overall Study|Adverse Event|1|||
129787755|NCT01700387|467189881|FG001|Overall Study|Adverse Event|1|||
129787756|NCT01700387|467189880|FG000|Overall Study|Lost to Follow-up|2|||
129787757|NCT01700387|467189881|FG001|Overall Study|Lost to Follow-up|1|||
129787758|NCT01185353|467189883|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
129787759|NCT01185353|467189884|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
129436424|NCT01209780|465895710|FG000|Overall Study|Inappropriate enrollment|0|||
129436425|NCT01209780|465895711|FG001|Overall Study|Inappropriate enrollment|2|||
129436426|NCT01209780|465895712|FG002|Overall Study|Inappropriate enrollment|0|||
129436427|NCT01209780|465895713|FG003|Overall Study|Inappropriate enrollment|0|||
129436428|NCT01209780|465895714|FG004|Overall Study|Inappropriate enrollment|1|||
129436429|NCT00511472|465895715|FG000|Overall Study|Clinical Adverse Event|1|||
129787760|NCT01185353|467189885|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
129787761|NCT01185353|467189886|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
129885840|NCT02291289|467542793|FG000|Induction Treatment|Protocol Violation|0|||
129885841|NCT02291289|467542794|FG001|Induction Treatment|Protocol Violation|0|||
129885842|NCT02291289|467542795|FG002|Induction Treatment|Protocol Violation|0|||
129885843|NCT02291289|467542796|FG003|Induction Treatment|Protocol Violation|3|||
129436430|NCT00511472|465895716|FG001|Overall Study|Clinical Adverse Event|2|||
129436431|NCT00511472|465895715|FG000|Overall Study|Laboratory Adverse Event|0|||
129787762|NCT01185353|467189887|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
129787763|NCT01185353|467189888|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
129787764|NCT01185353|467189889|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
129787765|NCT01185353|467189890|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
129787766|NCT01185353|467189891|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
129787767|NCT01185353|467189892|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
129787768|NCT01185353|467189883|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787769|NCT01185353|467189884|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787770|NCT01185353|467189885|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787771|NCT01185353|467189886|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787772|NCT01185353|467189887|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
129885844|NCT02291289|467542797|FG004|Induction Treatment|Protocol Violation|0|||
129885845|NCT02291289|467542798|FG005|Induction Treatment|Protocol Violation|0|||
129885846|NCT02291289|467542799|FG006|Induction Treatment|Protocol Violation|0|||
129885847|NCT02291289|467542800|FG007|Induction Treatment|Protocol Violation|0|||
129787773|NCT01185353|467189888|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787774|NCT01185353|467189889|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129885848|NCT02291289|467542801|FG008|Induction Treatment|Protocol Violation|0|||
129885849|NCT02291289|467542802|FG009|Induction Treatment|Protocol Violation|2|||
129885850|NCT02291289|467542803|FG010|Induction Treatment|Protocol Violation|0|||
129436432|NCT00511472|465895716|FG001|Overall Study|Laboratory Adverse Event|2|||
129787775|NCT01185353|467189890|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787776|NCT01185353|467189891|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787777|NCT01185353|467189892|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
129787778|NCT01185353|467189883|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
129787779|NCT01185353|467189884|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787780|NCT01185353|467189885|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787781|NCT01185353|467189886|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787782|NCT01185353|467189887|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
129787783|NCT01185353|467189888|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787784|NCT01185353|467189889|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787785|NCT01185353|467189890|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787786|NCT01185353|467189891|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787787|NCT01185353|467189892|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
129787788|NCT01185353|467189883|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787789|NCT01185353|467189884|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787790|NCT01185353|467189885|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
129787791|NCT01185353|467189886|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787792|NCT01185353|467189887|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
129787793|NCT01185353|467189888|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787794|NCT01185353|467189889|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787795|NCT01185353|467189890|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787796|NCT01185353|467189891|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787797|NCT01185353|467189892|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
129787798|NCT01185353|467189883|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787799|NCT01185353|467189884|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787800|NCT01185353|467189885|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787801|NCT01185353|467189886|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787802|NCT01185353|467189887|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
129787803|NCT01185353|467189888|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787804|NCT01185353|467189889|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787805|NCT01185353|467189890|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787806|NCT01185353|467189891|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787807|NCT01185353|467189892|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
129787808|NCT01185353|467189883|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
129787809|NCT01185353|467189884|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787810|NCT01185353|467189885|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787811|NCT01185353|467189886|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787812|NCT01185353|467189887|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
129787813|NCT01185353|467189888|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787814|NCT01185353|467189889|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787815|NCT01185353|467189890|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787816|NCT01185353|467189891|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787817|NCT01185353|467189892|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
129787818|NCT01185353|467189883|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787819|NCT01185353|467189884|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787820|NCT01185353|467189885|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
129787821|NCT01185353|467189886|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787822|NCT01185353|467189887|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787823|NCT01185353|467189888|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
129787824|NCT01185353|467189889|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787825|NCT01185353|467189890|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787826|NCT01185353|467189891|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787827|NCT01185353|467189892|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
129787828|NCT01185353|467189883|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129787829|NCT01185353|467189884|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
129787830|NCT01185353|467189885|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129787831|NCT01185353|467189886|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
129787832|NCT01185353|467189887|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129436433|NCT00511472|465895715|FG000|Overall Study|Not reported|2|||
129787833|NCT01185353|467189888|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129787834|NCT01185353|467189889|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129787835|NCT01185353|467189890|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129787836|NCT01185353|467189891|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129787837|NCT01185353|467189892|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
129697462|NCT01998477|466851803|FG000|Overall Study|Withdrawal by Subject|6|||
129697463|NCT01998477|466851804|FG001|Overall Study|Withdrawal by Subject|0|||
129697464|NCT00779909|466851805|FG000|Overall Study|Lost to Follow-up|1|||
129697465|NCT00779909|466851806|FG001|Overall Study|Lost to Follow-up|0|||
129697466|NCT00779909|466851807|FG002|Overall Study|Lost to Follow-up|0|||
129697467|NCT00779909|466851808|FG003|Overall Study|Lost to Follow-up|1|||
129697468|NCT00779909|466851805|FG000|Overall Study|Withdrawal by Subject|0|||
129697469|NCT00779909|466851806|FG001|Overall Study|Withdrawal by Subject|1|||
129697470|NCT00779909|466851807|FG002|Overall Study|Withdrawal by Subject|0|||
129697471|NCT00779909|466851808|FG003|Overall Study|Withdrawal by Subject|0|||
129697472|NCT03523585|466851809|FG000|Overall Study|Progressive Disease|174|||
129697473|NCT03523585|466851810|FG001|Overall Study|Progressive Disease|64|||
129697474|NCT03523585|466851811|FG002|Overall Study|Progressive Disease|77|||
129697475|NCT03523585|466851809|FG000|Overall Study|Adverse Event|74|||
129697476|NCT03523585|466851810|FG001|Overall Study|Adverse Event|5|||
129697477|NCT03523585|466851811|FG002|Overall Study|Adverse Event|9|||
129697478|NCT03523585|466851809|FG000|Overall Study|Withdrawal by Subject|30|||
129697479|NCT03523585|466851810|FG001|Overall Study|Withdrawal by Subject|11|||
129697480|NCT03523585|466851811|FG002|Overall Study|Withdrawal by Subject|6|||
129697481|NCT03523585|466851809|FG000|Overall Study|Clinical Progression|23|||
129697482|NCT03523585|466851810|FG001|Overall Study|Clinical Progression|5|||
129697483|NCT03523585|466851811|FG002|Overall Study|Clinical Progression|10|||
129697484|NCT03523585|466851809|FG000|Overall Study|Death|4|||
129697485|NCT03523585|466851810|FG001|Overall Study|Death|0|||
129697486|NCT03523585|466851811|FG002|Overall Study|Death|1|||
129697487|NCT03523585|466851809|FG000|Overall Study|Physician Decision|2|||
129697488|NCT03523585|466851810|FG001|Overall Study|Physician Decision|1|||
129697489|NCT03523585|466851811|FG002|Overall Study|Physician Decision|0|||
129697490|NCT03523585|466851809|FG000|Overall Study|Lost to Follow-up|1|||
129697491|NCT03523585|466851810|FG001|Overall Study|Lost to Follow-up|0|||
129697492|NCT03523585|466851811|FG002|Overall Study|Lost to Follow-up|0|||
129697493|NCT03523585|466851809|FG000|Overall Study|Miscellaneous|1|||
129697494|NCT03523585|466851810|FG001|Overall Study|Miscellaneous|0|||
129787838|NCT01185353|467189883|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787839|NCT01185353|467189884|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787840|NCT01185353|467189885|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787841|NCT01185353|467189886|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
129787842|NCT01185353|467189887|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787843|NCT01185353|467189888|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129885851|NCT02291289|467542804|FG011|Induction Treatment|Protocol Violation|0|||
129885852|NCT02291289|467542805|FG012|Induction Treatment|Protocol Violation|0|||
129885853|NCT02291289|467542793|FG000|Induction Treatment|Missing|4|||
129885854|NCT02291289|467542794|FG001|Induction Treatment|Missing|0|||
129436434|NCT00511472|465895716|FG001|Overall Study|Not reported|2|||
129436435|NCT02709096|465895717|FG000|Overall Study|non-compliance|1|||
129599591|NCT01013649|466490913|FG000|First Step|Withdrawal by Subject|36|||
129599592|NCT01013649|466490914|FG001|First Step|Withdrawal by Subject|19|||
129599593|NCT01013649|466490915|FG002|First Step|Withdrawal by Subject|0|||
129599594|NCT01013649|466490916|FG003|First Step|Withdrawal by Subject|0|||
129599595|NCT01013649|466490913|FG000|First Step|Progression|58|||
129599596|NCT01013649|466490914|FG001|First Step|Progression|23|||
129599597|NCT01013649|466490915|FG002|First Step|Progression|0|||
129599598|NCT01013649|466490916|FG003|First Step|Progression|0|||
129599599|NCT01013649|466490913|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
129599600|NCT01013649|466490914|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
129599601|NCT01013649|466490915|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
129599602|NCT01013649|466490916|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
129599603|NCT01013649|466490913|FG000|First Step|Death|3|||
129599604|NCT01013649|466490914|FG001|First Step|Death|4|||
129599605|NCT01013649|466490915|FG002|First Step|Death|0|||
129599606|NCT01013649|466490916|FG003|First Step|Death|0|||
129599607|NCT01013649|466490913|FG000|First Step|Adverse Event|9|||
129599608|NCT01013649|466490914|FG001|First Step|Adverse Event|5|||
129599609|NCT01013649|466490915|FG002|First Step|Adverse Event|0|||
129885855|NCT02291289|467542795|FG002|Induction Treatment|Missing|0|||
129885856|NCT02291289|467542796|FG003|Induction Treatment|Missing|14|||
129599610|NCT01013649|466490916|FG003|First Step|Adverse Event|0|||
129599611|NCT01013649|466490913|FG000|First Step|Other|4|||
129599612|NCT01013649|466490914|FG001|First Step|Other|6|||
129599613|NCT01013649|466490915|FG002|First Step|Other|0|||
129599614|NCT01013649|466490916|FG003|First Step|Other|0|||
129599615|NCT04285567|466490920|FG000|Overall Study|Death|3|||
129885857|NCT02291289|467542797|FG004|Induction Treatment|Missing|0|||
129885858|NCT02291289|467542798|FG005|Induction Treatment|Missing|0|||
129599616|NCT04285567|466490921|FG001|Overall Study|Death|3|||
129599617|NCT04285567|466490920|FG000|Overall Study|Lost to Follow-up|1|||
129599618|NCT04285567|466490921|FG001|Overall Study|Lost to Follow-up|1|||
129599619|NCT04285567|466490920|FG000|Overall Study|Reason Not Specified|1|||
129599620|NCT04285567|466490921|FG001|Overall Study|Reason Not Specified|1|||
129599621|NCT04285567|466490920|FG000|Overall Study|Physician Decision|2|||
129599622|NCT04285567|466490921|FG001|Overall Study|Physician Decision|1|||
129599623|NCT04285567|466490920|FG000|Overall Study|Withdrawal by Subject|2|||
129599624|NCT04285567|466490921|FG001|Overall Study|Withdrawal by Subject|6|||
129599625|NCT04285567|466490920|FG000|Overall Study|Adverse Event|1|||
129599626|NCT04285567|466490921|FG001|Overall Study|Adverse Event|0|||
129599627|NCT04285567|466490920|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
129599628|NCT04285567|466490921|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
129697495|NCT03523585|466851811|FG002|Overall Study|Miscellaneous|0|||
129787844|NCT01185353|467189889|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
129787845|NCT01185353|467189890|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787846|NCT01185353|467189891|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787847|NCT01185353|467189892|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
129787848|NCT01185353|467189883|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
129787849|NCT01185353|467189884|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
129787850|NCT01185353|467189885|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
129787851|NCT01185353|467189886|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
129787852|NCT01185353|467189887|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
129787853|NCT01185353|467189888|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
129787854|NCT01185353|467189889|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
129787855|NCT01185353|467189890|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
129787856|NCT01185353|467189891|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
129787857|NCT01185353|467189892|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
129787858|NCT01185353|467189883|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787859|NCT01185353|467189884|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787860|NCT01185353|467189885|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787861|NCT01185353|467189886|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787862|NCT01185353|467189887|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787863|NCT01185353|467189888|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787864|NCT01185353|467189889|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
129787865|NCT01185353|467189890|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787866|NCT01185353|467189891|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787867|NCT01185353|467189892|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
129787868|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787869|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787870|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787871|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787872|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787873|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787874|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
129787875|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
129787876|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
129787877|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
129787878|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787879|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787880|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787881|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787882|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787883|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787884|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
129787885|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
129787886|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
129787887|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
129787888|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129787889|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129885859|NCT02291289|467542799|FG006|Induction Treatment|Missing|0|||
129787890|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129787891|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129787892|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129787893|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129787894|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
129787895|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
129787896|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
129787897|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
129787898|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787899|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787900|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787901|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787902|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787903|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787904|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787905|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787906|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
129787907|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
129787908|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Death|0|||
129787909|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Death|0|||
129787910|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Death|0|||
129787911|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Death|0|||
129787912|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Death|0|||
129787913|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Death|0|||
129787914|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Death|0|||
129787915|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Death|0|||
129787916|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Death|0|||
129787917|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Death|1|||
129787918|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787919|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787920|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787921|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787922|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787923|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129436436|NCT02709096|465895718|FG001|Overall Study|non-compliance|1|||
129436437|NCT00505284|465895719|FG000|Overall Study|Adverse Event|3|||
129436438|NCT00505284|465895720|FG001|Overall Study|Adverse Event|7|||
129787924|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787925|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787926|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
129787927|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
129787928|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129436439|NCT00505284|465895721|FG002|Overall Study|Adverse Event|9|||
129436440|NCT00505284|465895722|FG003|Overall Study|Adverse Event|14|||
129436441|NCT00505284|465895723|FG004|Overall Study|Adverse Event|22|||
129436442|NCT00505284|465895719|FG000|Overall Study|Protocol Violation|0|||
129436443|NCT00505284|465895720|FG001|Overall Study|Protocol Violation|1|||
129436444|NCT00505284|465895721|FG002|Overall Study|Protocol Violation|1|||
129436445|NCT00505284|465895722|FG003|Overall Study|Protocol Violation|0|||
129436446|NCT00505284|465895723|FG004|Overall Study|Protocol Violation|0|||
129436447|NCT00505284|465895719|FG000|Overall Study|Withdrawal by Subject|2|||
129436448|NCT00505284|465895720|FG001|Overall Study|Withdrawal by Subject|6|||
129436449|NCT00505284|465895721|FG002|Overall Study|Withdrawal by Subject|1|||
129436450|NCT00505284|465895722|FG003|Overall Study|Withdrawal by Subject|0|||
129436451|NCT00505284|465895723|FG004|Overall Study|Withdrawal by Subject|6|||
129436452|NCT00505284|465895719|FG000|Overall Study|Lack of Efficacy|0|||
129436453|NCT00505284|465895720|FG001|Overall Study|Lack of Efficacy|1|||
129436454|NCT00505284|465895721|FG002|Overall Study|Lack of Efficacy|1|||
129436455|NCT00505284|465895722|FG003|Overall Study|Lack of Efficacy|1|||
129436456|NCT00505284|465895723|FG004|Overall Study|Lack of Efficacy|1|||
129436457|NCT00505284|465895719|FG000|Overall Study|Physician Decision|0|||
129436458|NCT00505284|465895720|FG001|Overall Study|Physician Decision|1|||
129436459|NCT00505284|465895721|FG002|Overall Study|Physician Decision|0|||
129436460|NCT00505284|465895722|FG003|Overall Study|Physician Decision|0|||
129436461|NCT00505284|465895723|FG004|Overall Study|Physician Decision|0|||
129436462|NCT00505284|465895719|FG000|Overall Study|Other|5|||
129436463|NCT00505284|465895720|FG001|Overall Study|Other|0|||
129436464|NCT00505284|465895721|FG002|Overall Study|Other|0|||
129436465|NCT00505284|465895722|FG003|Overall Study|Other|4|||
129436466|NCT00505284|465895723|FG004|Overall Study|Other|4|||
129436467|NCT00731120|465895724|FG000|Overall Study|Adverse Event|7|||
129436468|NCT00731120|465895725|FG001|Overall Study|Adverse Event|6|||
129436469|NCT00731120|465895726|FG002|Overall Study|Adverse Event|8|||
129436470|NCT00731120|465895724|FG000|Overall Study|Lack of Efficacy|4|||
129436471|NCT00731120|465895725|FG001|Overall Study|Lack of Efficacy|5|||
129436472|NCT00731120|465895726|FG002|Overall Study|Lack of Efficacy|4|||
129436473|NCT00731120|465895724|FG000|Overall Study|Noncompliance with Study Drug|3|||
129599768|NCT06005597|466490956|FG000|Overall Study|Lost to Follow-up|1|||
129599769|NCT06005597|466490957|FG001|Overall Study|Lost to Follow-up|2|||
129697496|NCT03523585|466851809|FG000|Overall Study|Protocol Deviation|1|||
129697497|NCT03523585|466851810|FG001|Overall Study|Protocol Deviation|0|||
129697498|NCT03523585|466851811|FG002|Overall Study|Protocol Deviation|1|||
129697499|NCT03523585|466851809|FG000|Overall Study|Randomized But Not Treated|2|||
129697500|NCT03523585|466851810|FG001|Overall Study|Randomized But Not Treated|4|||
129697501|NCT03523585|466851811|FG002|Overall Study|Randomized But Not Treated|3|||
129697502|NCT02872142|466851817|FG000|Overall Study|Adverse Event|2|||
129697503|NCT02872142|466851817|FG000|Overall Study|Death|1|||
129697504|NCT02872142|466851817|FG000|Overall Study|Participant Decision|3|||
129787929|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129787930|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129787931|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129787932|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129436474|NCT00731120|465895725|FG001|Overall Study|Noncompliance with Study Drug|3|||
129436475|NCT00731120|465895726|FG002|Overall Study|Noncompliance with Study Drug|1|||
129436476|NCT00731120|465895724|FG000|Overall Study|Protocol Deviations|1|||
129436477|NCT00731120|465895725|FG001|Overall Study|Protocol Deviations|6|||
129436478|NCT00731120|465895726|FG002|Overall Study|Protocol Deviations|1|||
129436479|NCT00731120|465895724|FG000|Overall Study|Withdrawal of Consent|13|||
129436480|NCT00731120|465895725|FG001|Overall Study|Withdrawal of Consent|8|||
129436481|NCT00731120|465895726|FG002|Overall Study|Withdrawal of Consent|4|||
129599770|NCT06005597|466490958|FG002|Overall Study|Lost to Follow-up|1|||
129599771|NCT06005597|466490959|FG003|Overall Study|Lost to Follow-up|2|||
129599772|NCT06005597|466490956|FG000|Overall Study|Death|1|||
129599773|NCT06005597|466490957|FG001|Overall Study|Death|1|||
129599774|NCT06005597|466490958|FG002|Overall Study|Death|1|||
129599775|NCT06005597|466490959|FG003|Overall Study|Death|0|||
129599776|NCT03375320|466490962|FG000|Overall Study|Adverse Event|34|||
129599777|NCT03375320|466490963|FG001|Overall Study|Adverse Event|9|||
129599778|NCT03375320|466490964|FG002|Overall Study|Adverse Event|10|||
129599779|NCT03375320|466490965|FG003|Overall Study|Adverse Event|0|||
129599780|NCT03375320|466490962|FG000|Overall Study|Death|6|||
129599781|NCT03375320|466490963|FG001|Overall Study|Death|3|||
129599782|NCT03375320|466490964|FG002|Overall Study|Death|0|||
129599783|NCT03375320|466490965|FG003|Overall Study|Death|0|||
129599784|NCT03375320|466490962|FG000|Overall Study|Withdrawal by Subject|7|||
129599785|NCT03375320|466490963|FG001|Overall Study|Withdrawal by Subject|4|||
129599786|NCT03375320|466490964|FG002|Overall Study|Withdrawal by Subject|5|||
129599787|NCT03375320|466490965|FG003|Overall Study|Withdrawal by Subject|4|||
129599788|NCT03375320|466490962|FG000|Overall Study|Progressive disease|55|||
129599789|NCT03375320|466490963|FG001|Overall Study|Progressive disease|41|||
129697505|NCT01903720|466851818|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
129436482|NCT00731120|465895724|FG000|Overall Study|Lost to Follow-up|10|||
129436483|NCT00731120|465895725|FG001|Overall Study|Lost to Follow-up|15|||
129599790|NCT03375320|466490964|FG002|Overall Study|Progressive disease|29|||
129599791|NCT03375320|466490965|FG003|Overall Study|Progressive disease|24|||
129599792|NCT03375320|466490962|FG000|Overall Study|Alternative treatment|6|||
129599793|NCT03375320|466490963|FG001|Overall Study|Alternative treatment|1|||
129697506|NCT01903720|466851818|FG000|Overall Study|Adverse Event|1|||
129787933|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129436484|NCT00731120|465895726|FG002|Overall Study|Lost to Follow-up|17|||
129436485|NCT00731120|465895724|FG000|Overall Study|Other|4|||
129436486|NCT00731120|465895725|FG001|Overall Study|Other|0|||
129599794|NCT03375320|466490964|FG002|Overall Study|Alternative treatment|1|||
129787934|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129436487|NCT00731120|465895726|FG002|Overall Study|Other|1|||
129787935|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129787936|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
129885860|NCT02291289|467542800|FG007|Induction Treatment|Missing|0|||
129697507|NCT01903720|466851818|FG000|Overall Study|Rescinding of informed consent|2|||
129697508|NCT01903720|466851818|FG000|Overall Study|Lost to Follow-up|2|||
129436506|NCT01575028|465895733|FG000|Overall Study|Physician Decision|0|||
129697509|NCT01903720|466851818|FG000|Overall Study|Treatment with alternative drug|1|||
129697510|NCT02244957|466851819|FG000|Overall Study|Lack of Efficacy|1|||
129697511|NCT02244957|466851820|FG001|Overall Study|Lack of Efficacy|0|||
129697512|NCT00836901|466851821|FG000|First Intervention|Withdrawal by Subject|1|||
129697513|NCT00836901|466851822|FG001|First Intervention|Withdrawal by Subject|0|||
129697514|NCT00830336|466851823|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
129697515|NCT00830336|466851824|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
129697516|NCT00104884|466851829|FG000|Overall Study|Disease progression|4|||
129436507|NCT01575028|465895734|FG001|Overall Study|Physician Decision|1|||
129697517|NCT03760081|466851830|FG000|Overall Study|Miscellaneous|0|||
129697518|NCT03760081|466851831|FG001|Overall Study|Miscellaneous|1|||
129697519|NCT03760081|466851830|FG000|Overall Study|Progressive Disease|5|||
129599795|NCT03375320|466490965|FG003|Overall Study|Alternative treatment|0|||
129599796|NCT03375320|466490962|FG000|Overall Study|Other disease|1|||
129599797|NCT03375320|466490963|FG001|Overall Study|Other disease|1|||
129599798|NCT03375320|466490964|FG002|Overall Study|Other disease|3|||
129599799|NCT03375320|466490965|FG003|Overall Study|Other disease|0|||
129599800|NCT03375320|466490962|FG000|Overall Study|Withdrawal prior to initiation|2|||
129599801|NCT03375320|466490963|FG001|Overall Study|Withdrawal prior to initiation|2|||
129599802|NCT03375320|466490964|FG002|Overall Study|Withdrawal prior to initiation|1|||
129599803|NCT03375320|466490965|FG003|Overall Study|Withdrawal prior to initiation|0|||
129599804|NCT03375320|466490962|FG000|Overall Study|Physician Decision|1|||
129599805|NCT03375320|466490963|FG001|Overall Study|Physician Decision|1|||
129599806|NCT03375320|466490964|FG002|Overall Study|Physician Decision|1|||
129599807|NCT03375320|466490965|FG003|Overall Study|Physician Decision|1|||
129599808|NCT03375320|466490962|FG000|Overall Study|Non-compliance|1|||
129599809|NCT03375320|466490963|FG001|Overall Study|Non-compliance|0|||
129599810|NCT03375320|466490964|FG002|Overall Study|Non-compliance|0|||
129599811|NCT03375320|466490965|FG003|Overall Study|Non-compliance|0|||
129599814|NCT02589522|466490970|FG000|Overall Study|Physician Decision|1|||
129599815|NCT02589522|466490971|FG001|Overall Study|Physician Decision|2|||
129599816|NCT02589522|466490972|FG002|Overall Study|Physician Decision|0|||
129599817|NCT02589522|466490970|FG000|Overall Study|Did not start treatment|1|||
129599818|NCT02589522|466490971|FG001|Overall Study|Did not start treatment|0|||
129599819|NCT02589522|466490972|FG002|Overall Study|Did not start treatment|0|||
129787937|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
129787938|NCT01185353|467189883|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787939|NCT01185353|467189884|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787940|NCT01185353|467189885|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787941|NCT01185353|467189886|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
129599888|NCT05611996|466490981|FG000|Overall Study|Ineligible|1|||
129599889|NCT05611996|466490981|FG000|Overall Study|Withdrawal by Subject|9|||
129599918|NCT04479475|466490992|FG000|Overall Study|Withdrawal by Subject|7|||
129599922|NCT05560763|466490996|FG000|Overall Study|Withdrawal by Subject|4|||
129599923|NCT03228537|466490997|FG000|Neoadjuvant|Adverse Event|2|||
129599924|NCT03228537|466490997|FG000|Neoadjuvant|Progression/Relapse|4|||
129599925|NCT03228537|466490997|FG000|Neoadjuvant|Death|1|||
129599926|NCT03228537|466490997|FG000|Surgery|Death|1|||
129599927|NCT03228537|466490997|FG000|Surgery|Other - Not Protocol Specified|2|||
129599928|NCT03228537|466490997|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
129599929|NCT03228537|466490997|FG000|Maintenance|Progression/Relapse|10|||
129599930|NCT06972251|466490999|FG000|Overall Study|Withdrawal by Subject|1|||
129599931|NCT06972251|466491000|FG001|Overall Study|Withdrawal by Subject|0|||
129599932|NCT06972251|466490999|FG000|Overall Study|Lost to Follow-up|10|||
129599933|NCT06972251|466491000|FG001|Overall Study|Lost to Follow-up|2|||
129599934|NCT04572243|466491005|FG000|Core Study: 14 Weeks|Adverse Event|1|||
129599935|NCT04572243|466491006|FG001|Core Study: 14 Weeks|Adverse Event|2|||
129599936|NCT04572243|466491007|FG002|Core Study: 14 Weeks|Adverse Event|0|||
129599937|NCT04572243|466491008|FG003|Core Study: 14 Weeks|Adverse Event|0|||
129599938|NCT04572243|466491005|FG000|Core Study: 14 Weeks|Subject choice|0|||
129599939|NCT04572243|466491006|FG001|Core Study: 14 Weeks|Subject choice|2|||
129599940|NCT04572243|466491007|FG002|Core Study: 14 Weeks|Subject choice|0|||
129599941|NCT04572243|466491008|FG003|Core Study: 14 Weeks|Subject choice|0|||
129599942|NCT04572243|466491005|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
129599943|NCT04572243|466491006|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
129599944|NCT04572243|466491007|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
129599945|NCT04572243|466491008|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
129599946|NCT04572243|466491005|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
129599947|NCT04572243|466491006|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
129599948|NCT04572243|466491007|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
129599949|NCT04572243|466491008|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
129697520|NCT03760081|466851831|FG001|Overall Study|Progressive Disease|10|||
129697521|NCT03760081|466851830|FG000|Overall Study|Death|1|||
129787942|NCT01185353|467189887|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787943|NCT01185353|467189888|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787944|NCT01185353|467189889|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787945|NCT01185353|467189890|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787946|NCT01185353|467189891|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
129787947|NCT01185353|467189892|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
129787948|NCT01185353|467189883|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787949|NCT01185353|467189884|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787950|NCT01185353|467189885|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787951|NCT01185353|467189886|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787952|NCT01185353|467189887|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787953|NCT01185353|467189888|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787954|NCT01185353|467189889|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787955|NCT01185353|467189890|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
129787956|NCT01185353|467189891|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
129787957|NCT01185353|467189892|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
129787958|NCT01185353|467189883|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787959|NCT01185353|467189884|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787960|NCT01185353|467189885|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787961|NCT01185353|467189886|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787962|NCT01185353|467189887|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787963|NCT01185353|467189888|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787964|NCT01185353|467189889|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
129787965|NCT01185353|467189890|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
129787966|NCT01185353|467189891|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
129787967|NCT01185353|467189892|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
129787968|NCT01185353|467189883|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787969|NCT01185353|467189884|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787970|NCT01185353|467189885|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787971|NCT01185353|467189886|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787972|NCT01185353|467189887|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787973|NCT01185353|467189888|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787974|NCT01185353|467189889|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787975|NCT01185353|467189890|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
129787976|NCT01185353|467189891|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
129787977|NCT01185353|467189892|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
129787978|NCT02270944|467189893|FG000|Overall Study|Lost to Follow-up|9|||
129787979|NCT02270944|467189894|FG001|Overall Study|Lost to Follow-up|4|||
129787980|NCT02270944|467189893|FG000|Overall Study|Withdrawal by Subject|2|||
129787981|NCT02270944|467189894|FG001|Overall Study|Withdrawal by Subject|1|||
129787982|NCT01978938|467189895|FG000|Overall Study|Lost to Follow-up|12|||
129787983|NCT01978938|467189896|FG001|Overall Study|Lost to Follow-up|6|||
129787984|NCT01978938|467189895|FG000|Overall Study|Withdrawal by Subject|8|||
129787985|NCT01978938|467189896|FG001|Overall Study|Withdrawal by Subject|4|||
129787986|NCT01978938|467189895|FG000|Overall Study|Adverse Event, non-fatal|2|||
129787987|NCT01978938|467189896|FG001|Overall Study|Adverse Event, non-fatal|1|||
129787988|NCT01978938|467189895|FG000|Overall Study|Participant noncompliance|1|||
129787989|NCT01978938|467189896|FG001|Overall Study|Participant noncompliance|1|||
129787990|NCT01978938|467189895|FG000|Overall Study|Did not meet inclusion criteria|0|||
129787991|NCT01978938|467189896|FG001|Overall Study|Did not meet inclusion criteria|1|||
129787992|NCT01978938|467189895|FG000|Overall Study|Previously scheduled procedure|0|||
129787993|NCT01978938|467189896|FG001|Overall Study|Previously scheduled procedure|1|||
129787994|NCT00095147|467189897|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
129787995|NCT00095147|467189898|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
129787996|NCT00095147|467189899|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
129787997|NCT00095147|467189900|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
129787998|NCT00095147|467189901|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
129787999|NCT00095147|467189897|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
129788000|NCT00095147|467189898|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
129788001|NCT00095147|467189899|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
129788002|NCT00095147|467189900|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
129788003|NCT00095147|467189901|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
129697522|NCT03760081|466851831|FG001|Overall Study|Death|1|||
129600030|NCT05420012|466491028|FG000|Overall Study|Lost to Follow-up|0|||
129600031|NCT05420012|466491029|FG001|Overall Study|Lost to Follow-up|1|||
129885861|NCT02291289|467542801|FG008|Induction Treatment|Missing|0|||
129885862|NCT02291289|467542802|FG009|Induction Treatment|Missing|54|||
129885863|NCT02291289|467542803|FG010|Induction Treatment|Missing|0|||
129885864|NCT02291289|467542804|FG011|Induction Treatment|Missing|0|||
129885865|NCT02291289|467542805|FG012|Induction Treatment|Missing|0|||
129885866|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885867|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885868|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885869|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885870|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
129885871|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
129885872|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885873|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885874|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885875|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885876|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
129885877|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
129885878|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129885879|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Death|0|||
129885880|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Death|29|||
129885881|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Death|16|||
129885882|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Death|0|||
129885883|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Death|188|||
129885884|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Death|107|||
129885885|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Death|0|||
129885886|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Death|1|||
129885887|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Death|1|||
129885888|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Death|0|||
129885889|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Death|46|||
129885890|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Death|19|||
129885891|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Death|0|||
129885892|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Adverse Event|0|||
129600052|NCT03253744|466491038|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
129600053|NCT03253744|466491039|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
129600054|NCT03253744|466491040|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
129600055|NCT03253744|466491041|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
129600056|NCT04134845|466491042|FG000|Overall Study|withdrawl by PI|5|||
129600057|NCT04134845|466491043|FG001|Overall Study|withdrawl by PI|12|||
129697523|NCT05261490|466851832|FG000|Overall Study|Other|1|||
129697524|NCT05261490|466851833|FG001|Overall Study|Other|0|||
129697525|NCT05261490|466851834|FG002|Overall Study|Other|0|||
129600081|NCT02999477|466492069|FG000|Overall Study|found ineligible after first dose|0|||
129600082|NCT02999477|466492070|FG001|Overall Study|found ineligible after first dose|1|||
129600083|NCT02999477|466492069|FG000|Overall Study|Withdrawal by Subject|1|||
129600084|NCT02999477|466492070|FG001|Overall Study|Withdrawal by Subject|1|||
129600085|NCT04266795|466492071|FG000|Overall Study|Adverse Event|10|||
129600086|NCT04266795|466492072|FG001|Overall Study|Adverse Event|19|||
129600087|NCT04266795|466492071|FG000|Overall Study|Death|7|||
129600088|NCT04266795|466492072|FG001|Overall Study|Death|8|||
129600089|NCT04266795|466492071|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
129600090|NCT04266795|466492072|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
129600091|NCT04266795|466492071|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129600092|NCT04266795|466492072|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129600093|NCT04266795|466492071|FG000|Overall Study|Progressive Disease|12|||
129788004|NCT00095147|467189897|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
129788005|NCT00095147|467189898|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
129788006|NCT00095147|467189899|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
129788007|NCT00095147|467189900|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
129600094|NCT04266795|466492072|FG001|Overall Study|Progressive Disease|9|||
129600095|NCT04266795|466492071|FG000|Overall Study|Withdrawal by Patient|5|||
129600096|NCT04266795|466492072|FG001|Overall Study|Withdrawal by Patient|6|||
129788008|NCT00095147|467189901|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
129788009|NCT00095147|467189897|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
129788010|NCT00095147|467189898|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
129788011|NCT00095147|467189899|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
129788012|NCT00095147|467189900|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
129788013|NCT00095147|467189901|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
129788014|NCT00095147|467189897|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
129788015|NCT00095147|467189898|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
129788016|NCT00095147|467189899|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
129788017|NCT00095147|467189900|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
129788018|NCT00095147|467189901|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
129788019|NCT00095147|467189897|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
129788020|NCT00095147|467189898|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
129788021|NCT00095147|467189899|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
129788022|NCT00095147|467189900|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
129788023|NCT00095147|467189901|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
129788024|NCT00095147|467189897|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
129788025|NCT00095147|467189898|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
129788026|NCT00095147|467189899|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
129788027|NCT00095147|467189900|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
129788028|NCT00095147|467189901|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
129788029|NCT00095147|467189897|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
129788030|NCT00095147|467189898|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
129788031|NCT00095147|467189899|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
129788032|NCT00095147|467189900|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
129788033|NCT00095147|467189901|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
129788034|NCT00095147|467189897|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
129788035|NCT00095147|467189898|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
129788036|NCT00095147|467189899|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
129788037|NCT00095147|467189900|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
129788038|NCT00095147|467189901|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
129788039|NCT00095147|467189897|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
129788040|NCT00095147|467189898|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
129788041|NCT00095147|467189899|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
129788042|NCT00095147|467189900|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
129788043|NCT00095147|467189901|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
129788044|NCT00095147|467189897|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
129788045|NCT00095147|467189898|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
129788046|NCT00095147|467189899|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
129788047|NCT00095147|467189900|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
129788048|NCT00095147|467189901|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
129788049|NCT00095147|467189897|FG000|Long-term Extension Period|Death|0|||
129788050|NCT00095147|467189898|FG001|Long-term Extension Period|Death|0|||
129788051|NCT00095147|467189899|FG002|Long-term Extension Period|Death|0|||
129788052|NCT00095147|467189900|FG003|Long-term Extension Period|Death|0|||
129788053|NCT00095147|467189901|FG004|Long-term Extension Period|Death|3|||
129788054|NCT00095147|467189897|FG000|Long-term Extension Period|Adverse Event|0|||
129788055|NCT00095147|467189898|FG001|Long-term Extension Period|Adverse Event|0|||
129788056|NCT00095147|467189899|FG002|Long-term Extension Period|Adverse Event|0|||
129788057|NCT00095147|467189900|FG003|Long-term Extension Period|Adverse Event|0|||
129788058|NCT00095147|467189901|FG004|Long-term Extension Period|Adverse Event|11|||
129788059|NCT00095147|467189897|FG000|Long-term Extension Period|Lack of Efficacy|0|||
129788060|NCT00095147|467189898|FG001|Long-term Extension Period|Lack of Efficacy|0|||
129788061|NCT00095147|467189899|FG002|Long-term Extension Period|Lack of Efficacy|0|||
129788062|NCT00095147|467189900|FG003|Long-term Extension Period|Lack of Efficacy|0|||
129788063|NCT00095147|467189901|FG004|Long-term Extension Period|Lack of Efficacy|9|||
129788064|NCT00095147|467189897|FG000|Long-term Extension Period|Lost to Follow-up|0|||
129788065|NCT00095147|467189898|FG001|Long-term Extension Period|Lost to Follow-up|0|||
129788066|NCT00095147|467189899|FG002|Long-term Extension Period|Lost to Follow-up|0|||
129788067|NCT00095147|467189900|FG003|Long-term Extension Period|Lost to Follow-up|0|||
129788068|NCT00095147|467189901|FG004|Long-term Extension Period|Lost to Follow-up|6|||
129788069|NCT00095147|467189897|FG000|Long-term Extension Period|Withdrawal of consent|0|||
129788070|NCT00095147|467189898|FG001|Long-term Extension Period|Withdrawal of consent|0|||
129788071|NCT00095147|467189899|FG002|Long-term Extension Period|Withdrawal of consent|0|||
129788072|NCT00095147|467189900|FG003|Long-term Extension Period|Withdrawal of consent|0|||
129788073|NCT00095147|467189901|FG004|Long-term Extension Period|Withdrawal of consent|12|||
129788074|NCT00095147|467189897|FG000|Long-term Extension Period|Pregnancy|0|||
129788075|NCT00095147|467189898|FG001|Long-term Extension Period|Pregnancy|0|||
129600097|NCT04266795|466492071|FG000|Overall Study|Disease Relapse|3|||
129600098|NCT04266795|466492072|FG001|Overall Study|Disease Relapse|6|||
129600099|NCT04266795|466492071|FG000|Overall Study|Reason not Specified|12|||
129600100|NCT04266795|466492072|FG001|Overall Study|Reason not Specified|10|||
129600101|NCT04266795|466492071|FG000|Overall Study|Participants Ongoing on Treatment|25|||
129600102|NCT04266795|466492072|FG001|Overall Study|Participants Ongoing on Treatment|23|||
129788076|NCT00095147|467189899|FG002|Long-term Extension Period|Pregnancy|0|||
129788077|NCT00095147|467189900|FG003|Long-term Extension Period|Pregnancy|0|||
129788078|NCT00095147|467189901|FG004|Long-term Extension Period|Pregnancy|1|||
129788079|NCT00095147|467189897|FG000|Long-term Extension Period|No longer meets study criteria|0|||
129788080|NCT00095147|467189898|FG001|Long-term Extension Period|No longer meets study criteria|0|||
129788081|NCT00095147|467189899|FG002|Long-term Extension Period|No longer meets study criteria|0|||
129788082|NCT00095147|467189900|FG003|Long-term Extension Period|No longer meets study criteria|0|||
129788083|NCT00095147|467189901|FG004|Long-term Extension Period|No longer meets study criteria|1|||
129788084|NCT00095147|467189897|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
129788085|NCT00095147|467189898|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
129788086|NCT00095147|467189899|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
129788087|NCT00095147|467189900|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
129788088|NCT00095147|467189901|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
129788089|NCT00095147|467189897|FG000|Long-term Extension Period|Leaving country|0|||
129788090|NCT00095147|467189898|FG001|Long-term Extension Period|Leaving country|0|||
129788091|NCT00095147|467189899|FG002|Long-term Extension Period|Leaving country|0|||
129788092|NCT00095147|467189900|FG003|Long-term Extension Period|Leaving country|0|||
129788093|NCT00095147|467189901|FG004|Long-term Extension Period|Leaving country|1|||
129788094|NCT03678870|467189905|FG000|Overall Study|prescribed non- protocol medications|10|||
129788095|NCT03678870|467189906|FG001|Overall Study|prescribed non- protocol medications|6|||
129788096|NCT03678870|467189905|FG000|Overall Study|Lost to Follow-up|3|||
129788097|NCT03678870|467189906|FG001|Overall Study|Lost to Follow-up|2|||
129788098|NCT03104816|467189908|FG000|Overall Study|Lack of Efficacy|0|||
129788099|NCT03104816|467189909|FG001|Overall Study|Lack of Efficacy|2|||
129788100|NCT03104816|467189910|FG002|Overall Study|Lack of Efficacy|0|||
129788101|NCT03104816|467189908|FG000|Overall Study|Protocol Violation|2|||
129788102|NCT03104816|467189909|FG001|Overall Study|Protocol Violation|0|||
129788103|NCT03104816|467189910|FG002|Overall Study|Protocol Violation|2|||
129788104|NCT01227629|467189912|FG000|Overall Study|Adverse Event|2|||
129788105|NCT01227629|467189913|FG001|Overall Study|Adverse Event|2|||
129788106|NCT01227629|467189914|FG002|Overall Study|Adverse Event|1|||
129788107|NCT01227629|467189915|FG003|Overall Study|Adverse Event|6|||
129788108|NCT01227629|467189916|FG004|Overall Study|Adverse Event|1|||
129788109|NCT01227629|467189917|FG005|Overall Study|Adverse Event|1|||
129788110|NCT01227629|467189918|FG006|Overall Study|Adverse Event|6|||
129788111|NCT01227629|467189919|FG007|Overall Study|Adverse Event|6|||
129788112|NCT01227629|467189920|FG008|Overall Study|Adverse Event|4|||
129788113|NCT01227629|467189921|FG009|Overall Study|Adverse Event|0|||
129788114|NCT01227629|467189912|FG000|Overall Study|Protocol Violation|0|||
129697526|NCT05261490|466851832|FG000|Overall Study|Study Terminated by Sponsor|1|||
129697527|NCT05261490|466851833|FG001|Overall Study|Study Terminated by Sponsor|1|||
129885893|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Adverse Event|0|||
129885894|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Adverse Event|0|||
129885895|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Adverse Event|0|||
129885896|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Adverse Event|1|||
129885897|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Adverse Event|1|||
129885898|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Adverse Event|0|||
129885899|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Adverse Event|0|||
129885900|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Adverse Event|0|||
129885901|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Adverse Event|0|||
129885902|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Adverse Event|0|||
129697528|NCT05261490|466851834|FG002|Overall Study|Study Terminated by Sponsor|4|||
129697529|NCT05261490|466851832|FG000|Overall Study|Death|1|||
129697530|NCT05261490|466851833|FG001|Overall Study|Death|2|||
129697531|NCT05261490|466851834|FG002|Overall Study|Death|0|||
129697532|NCT01646216|466851846|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
129697533|NCT01646216|466851847|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
129697534|NCT01646216|466851846|FG000|Overall Study|Did not complete training|0|||
129697535|NCT01646216|466851847|FG001|Overall Study|Did not complete training|2|||
129697536|NCT01646216|466851846|FG000|Overall Study|Investigator decision|1|||
129697537|NCT01646216|466851847|FG001|Overall Study|Investigator decision|1|||
129697538|NCT02395627|466851848|FG000|Overall Study|Withdrawal by Subject|0|||
129697539|NCT02395627|466851849|FG001|Overall Study|Withdrawal by Subject|2|||
129885903|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Adverse Event|0|||
129885904|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Adverse Event|0|||
129600141|NCT02655016|466492090|FG000|Overall Study|Disease progression|6|||
129600142|NCT02655016|466492091|FG001|Overall Study|Disease progression|4|||
129600143|NCT02655016|466492090|FG000|Overall Study|Site closed|0|||
129600144|NCT02655016|466492091|FG001|Overall Study|Site closed|1|||
129600145|NCT02655016|466492090|FG000|Overall Study|Death|30|||
129600146|NCT02655016|466492091|FG001|Overall Study|Death|48|||
129600147|NCT02655016|466492090|FG000|Overall Study|Lost to Follow-up|1|||
129600148|NCT02655016|466492091|FG001|Overall Study|Lost to Follow-up|1|||
129600149|NCT02655016|466492090|FG000|Overall Study|Withdrawal by Subject|18|||
129600150|NCT02655016|466492091|FG001|Overall Study|Withdrawal by Subject|36|||
129600171|NCT04459715|466492105|FG000|Overall Study|Adverse Event|3|||
129697540|NCT02395627|466851850|FG002|Overall Study|Withdrawal by Subject|0|||
129697541|NCT02395627|466851848|FG000|Overall Study|Did not receive pembrolizumab|3|||
129600172|NCT04459715|466492106|FG001|Overall Study|Adverse Event|3|||
129600173|NCT04459715|466492105|FG000|Overall Study|Death|111|||
129600174|NCT04459715|466492106|FG001|Overall Study|Death|93|||
129788115|NCT01227629|467189913|FG001|Overall Study|Protocol Violation|0|||
129788116|NCT01227629|467189914|FG002|Overall Study|Protocol Violation|0|||
129788117|NCT01227629|467189915|FG003|Overall Study|Protocol Violation|1|||
129788118|NCT01227629|467189916|FG004|Overall Study|Protocol Violation|0|||
129788119|NCT01227629|467189917|FG005|Overall Study|Protocol Violation|0|||
129788120|NCT01227629|467189918|FG006|Overall Study|Protocol Violation|0|||
129788121|NCT01227629|467189919|FG007|Overall Study|Protocol Violation|0|||
129788122|NCT01227629|467189920|FG008|Overall Study|Protocol Violation|0|||
129788123|NCT01227629|467189921|FG009|Overall Study|Protocol Violation|0|||
129788124|NCT01227629|467189912|FG000|Overall Study|Lost to Follow-up|0|||
129788125|NCT01227629|467189913|FG001|Overall Study|Lost to Follow-up|0|||
129788126|NCT01227629|467189914|FG002|Overall Study|Lost to Follow-up|0|||
129788127|NCT01227629|467189915|FG003|Overall Study|Lost to Follow-up|0|||
129788128|NCT01227629|467189916|FG004|Overall Study|Lost to Follow-up|1|||
129788129|NCT01227629|467189917|FG005|Overall Study|Lost to Follow-up|0|||
129788130|NCT01227629|467189918|FG006|Overall Study|Lost to Follow-up|0|||
129788131|NCT01227629|467189919|FG007|Overall Study|Lost to Follow-up|0|||
129788132|NCT01227629|467189920|FG008|Overall Study|Lost to Follow-up|0|||
129788133|NCT01227629|467189921|FG009|Overall Study|Lost to Follow-up|0|||
129788134|NCT01227629|467189912|FG000|Overall Study|Withdrawal by Subject|0|||
129788135|NCT01227629|467189913|FG001|Overall Study|Withdrawal by Subject|0|||
129788136|NCT01227629|467189914|FG002|Overall Study|Withdrawal by Subject|0|||
129788137|NCT01227629|467189915|FG003|Overall Study|Withdrawal by Subject|0|||
129788138|NCT01227629|467189916|FG004|Overall Study|Withdrawal by Subject|0|||
129788139|NCT01227629|467189917|FG005|Overall Study|Withdrawal by Subject|0|||
129788140|NCT01227629|467189918|FG006|Overall Study|Withdrawal by Subject|2|||
129788141|NCT01227629|467189919|FG007|Overall Study|Withdrawal by Subject|0|||
129788142|NCT01227629|467189920|FG008|Overall Study|Withdrawal by Subject|0|||
129788143|NCT01227629|467189921|FG009|Overall Study|Withdrawal by Subject|1|||
129788144|NCT01227629|467189912|FG000|Overall Study|Other|0|||
129788145|NCT01227629|467189913|FG001|Overall Study|Other|0|||
129788146|NCT01227629|467189914|FG002|Overall Study|Other|0|||
129788147|NCT01227629|467189915|FG003|Overall Study|Other|1|||
129788148|NCT01227629|467189916|FG004|Overall Study|Other|0|||
129788149|NCT01227629|467189917|FG005|Overall Study|Other|0|||
129788150|NCT01227629|467189918|FG006|Overall Study|Other|0|||
129788151|NCT01227629|467189919|FG007|Overall Study|Other|0|||
129788152|NCT01227629|467189920|FG008|Overall Study|Other|2|||
129788153|NCT01227629|467189921|FG009|Overall Study|Other|1|||
129788154|NCT03338959|467191607|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
129788155|NCT03338959|467191607|FG000|Overall Study|Physician Decision|1|||
129788156|NCT01604278|467191608|FG000|Overall Study|Lack of Efficacy|0|||
129788157|NCT01604278|467191609|FG001|Overall Study|Lack of Efficacy|1|||
129788158|NCT01604278|467191608|FG000|Overall Study|Lost to Follow-up|1|||
129788159|NCT01604278|467191609|FG001|Overall Study|Lost to Follow-up|0|||
129788160|NCT01604278|467191608|FG000|Overall Study|Administrative problems|2|||
129788161|NCT01604278|467191609|FG001|Overall Study|Administrative problems|1|||
129788162|NCT01604278|467191608|FG000|Overall Study|Withdrawal by Subject|3|||
129788163|NCT01604278|467191609|FG001|Overall Study|Withdrawal by Subject|3|||
129788164|NCT01604278|467191608|FG000|Overall Study|Adverse Event|3|||
129788165|NCT01604278|467191609|FG001|Overall Study|Adverse Event|5|||
129788166|NCT01604278|467191608|FG000|Overall Study|Protocol Deviation|5|||
129788167|NCT01604278|467191609|FG001|Overall Study|Protocol Deviation|3|||
129600175|NCT04459715|466492105|FG000|Overall Study|Lost to Follow-up|10|||
129600176|NCT04459715|466492106|FG001|Overall Study|Lost to Follow-up|9|||
129600177|NCT04459715|466492105|FG000|Overall Study|Other Reasons|4|||
129600178|NCT04459715|466492106|FG001|Overall Study|Other Reasons|5|||
129600179|NCT04459715|466492105|FG000|Overall Study|PROTOCOL DEVIATION|0|||
129600180|NCT04459715|466492106|FG001|Overall Study|PROTOCOL DEVIATION|1|||
129600181|NCT04459715|466492105|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
129600182|NCT04459715|466492106|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
129600183|NCT04459715|466492105|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
129600184|NCT04459715|466492106|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
129600185|NCT04459715|466492105|FG000|Overall Study|Withdrawal by Subject|22|||
129600186|NCT04459715|466492106|FG001|Overall Study|Withdrawal by Subject|22|||
129788168|NCT03328182|467191610|FG000|Overall Study|Withdrawal by Subject|1|||
129788169|NCT03328182|467191610|FG000|Overall Study|Protocol Violation|2|||
129788170|NCT03328182|467191610|FG000|Overall Study|No Product Evaluated|1|||
129788171|NCT00874939|467191614|FG000|Overall Study|Study terminated|4|||
129788172|NCT02870933|467191615|FG000|Overall Study|Death|2|||
129788173|NCT02870933|467191616|FG001|Overall Study|Death|1|||
129788174|NCT02870933|467191615|FG000|Overall Study|Withdrawal by Subject|0|||
129788175|NCT02870933|467191616|FG001|Overall Study|Withdrawal by Subject|1|||
129788176|NCT01250496|467191617|FG000|Overall Study|Study terminated|124|||
129788177|NCT01250496|467191618|FG001|Overall Study|Study terminated|124|||
129788178|NCT01425463|467191624|FG000|Overall Study|Adverse Event|5|||
129788179|NCT01425463|467191625|FG001|Overall Study|Adverse Event|7|||
129788180|NCT01425463|467191624|FG000|Overall Study|Lack of Efficacy|1|||
129788181|NCT01425463|467191625|FG001|Overall Study|Lack of Efficacy|1|||
129788182|NCT01425463|467191624|FG000|Overall Study|Protocol Violation|2|||
129788183|NCT01425463|467191625|FG001|Overall Study|Protocol Violation|2|||
129788184|NCT01425463|467191624|FG000|Overall Study|Lost to Follow-up|5|||
129788185|NCT01425463|467191625|FG001|Overall Study|Lost to Follow-up|2|||
129788186|NCT01425463|467191624|FG000|Overall Study|Withdrawal by Subject|7|||
129788187|NCT01425463|467191625|FG001|Overall Study|Withdrawal by Subject|5|||
129788188|NCT01425463|467191624|FG000|Overall Study|Unknown Reason|4|||
129788189|NCT01425463|467191625|FG001|Overall Study|Unknown Reason|7|||
129788190|NCT01328366|467191630|FG000|Overall Study|Death|1|||
129788191|NCT01328366|467191630|FG000|Overall Study|Withdrawal by Subject|2|||
129788192|NCT01328366|467191630|FG000|Overall Study|Lost to Follow-up|7|||
129788193|NCT01122264|467191631|FG000|Overall Study|Adverse Event|6|||
129788194|NCT01122264|467191632|FG001|Overall Study|Adverse Event|5|||
129788195|NCT01122264|467191633|FG002|Overall Study|Adverse Event|7|||
129788196|NCT01122264|467191631|FG000|Overall Study|Death|1|||
129788197|NCT01122264|467191632|FG001|Overall Study|Death|0|||
129788198|NCT01122264|467191633|FG002|Overall Study|Death|0|||
129788199|NCT01122264|467191631|FG000|Overall Study|Lost to Follow-up|5|||
129788200|NCT01122264|467191632|FG001|Overall Study|Lost to Follow-up|9|||
129647444|NCT01185509|466665325|FG000|Overall Study|Withdrawal by Subject|0|||
129647445|NCT01185509|466665326|FG001|Overall Study|Withdrawal by Subject|1|||
129647446|NCT01185509|466665325|FG000|Overall Study|Death|0|||
129647447|NCT01185509|466665326|FG001|Overall Study|Death|1|||
129647448|NCT01185509|466665325|FG000|Overall Study|Intercurrent Illness|0|||
129647449|NCT01185509|466665326|FG001|Overall Study|Intercurrent Illness|1|||
129647450|NCT03687372|466665327|FG000|Overall Study|Lost to Follow-up|12|||
129647451|NCT03687372|466665328|FG001|Overall Study|Lost to Follow-up|21|||
129647452|NCT03687372|466665327|FG000|Overall Study|Withdrawal by Subject|4|||
129647453|NCT03687372|466665328|FG001|Overall Study|Withdrawal by Subject|17|||
129647454|NCT03687372|466665327|FG000|Overall Study|Investigator Decision|1|||
129647455|NCT03687372|466665328|FG001|Overall Study|Investigator Decision|1|||
129647456|NCT00878969|466665333|FG000|Overall Study|Physician Decision|5|||
129647457|NCT00878969|466665334|FG001|Overall Study|Physician Decision|3|||
129647458|NCT00878969|466665335|FG002|Overall Study|Physician Decision|2|||
129647459|NCT00878969|466665333|FG000|Overall Study|Withdrawal by Subject|1|||
129647460|NCT00878969|466665334|FG001|Overall Study|Withdrawal by Subject|6|||
129647461|NCT00878969|466665335|FG002|Overall Study|Withdrawal by Subject|3|||
129647462|NCT00878969|466665333|FG000|Overall Study|kidney transplant|2|||
129647463|NCT00878969|466665334|FG001|Overall Study|kidney transplant|3|||
129647464|NCT00878969|466665335|FG002|Overall Study|kidney transplant|2|||
129647465|NCT00878969|466665333|FG000|Overall Study|Adverse Event|3|||
129647466|NCT00878969|466665334|FG001|Overall Study|Adverse Event|1|||
129788201|NCT01122264|467191633|FG002|Overall Study|Lost to Follow-up|13|||
129647467|NCT00878969|466665335|FG002|Overall Study|Adverse Event|2|||
129647468|NCT00878969|466665333|FG000|Overall Study|Lost to Follow-up|2|||
129647469|NCT00878969|466665334|FG001|Overall Study|Lost to Follow-up|1|||
129647470|NCT00878969|466665335|FG002|Overall Study|Lost to Follow-up|0|||
129647471|NCT00878969|466665333|FG000|Overall Study|Protocol Violation|2|||
129788202|NCT01122264|467191631|FG000|Overall Study|Entry Criteria Not Met|1|||
129788203|NCT01122264|467191632|FG001|Overall Study|Entry Criteria Not Met|0|||
129788204|NCT01122264|467191633|FG002|Overall Study|Entry Criteria Not Met|0|||
129647472|NCT00878969|466665334|FG001|Overall Study|Protocol Violation|0|||
129647473|NCT00878969|466665335|FG002|Overall Study|Protocol Violation|0|||
129647474|NCT00878969|466665333|FG000|Overall Study|Death|0|||
129647475|NCT00878969|466665334|FG001|Overall Study|Death|0|||
129647476|NCT00878969|466665335|FG002|Overall Study|Death|2|||
129647477|NCT00878969|466665333|FG000|Overall Study|Pregnancy|0|||
129647478|NCT00878969|466665334|FG001|Overall Study|Pregnancy|1|||
129647479|NCT00878969|466665335|FG002|Overall Study|Pregnancy|0|||
129647480|NCT03729570|466665336|FG000|Overall Study|Lost to Follow-up|16|||
129788205|NCT01122264|467191631|FG000|Overall Study|Protocol Violation|7|||
129788206|NCT01122264|467191632|FG001|Overall Study|Protocol Violation|7|||
129788207|NCT01122264|467191633|FG002|Overall Study|Protocol Violation|9|||
129697542|NCT02395627|466851849|FG001|Overall Study|Did not receive pembrolizumab|1|||
129697543|NCT02395627|466851850|FG002|Overall Study|Did not receive pembrolizumab|0|||
129697544|NCT02633527|466851851|FG000|Overall Study|Failed to meet eligibility|0|||
129697545|NCT02633527|466851852|FG001|Overall Study|Failed to meet eligibility|1|||
129697546|NCT02633527|466851853|FG002|Overall Study|Failed to meet eligibility|1|||
129697547|NCT02633527|466851854|FG003|Overall Study|Failed to meet eligibility|0|||
129697548|NCT02633527|466851855|FG004|Overall Study|Failed to meet eligibility|1|||
129697549|NCT02633527|466851851|FG000|Overall Study|Adverse Event|0|||
129697550|NCT02633527|466851852|FG001|Overall Study|Adverse Event|4|||
129697551|NCT02633527|466851853|FG002|Overall Study|Adverse Event|3|||
129697552|NCT02633527|466851854|FG003|Overall Study|Adverse Event|1|||
129697553|NCT02633527|466851855|FG004|Overall Study|Adverse Event|5|||
129697554|NCT02633527|466851851|FG000|Overall Study|Lost to Follow-up|1|||
129697555|NCT02633527|466851852|FG001|Overall Study|Lost to Follow-up|2|||
129697556|NCT02633527|466851853|FG002|Overall Study|Lost to Follow-up|5|||
129697557|NCT02633527|466851854|FG003|Overall Study|Lost to Follow-up|5|||
129697558|NCT02633527|466851855|FG004|Overall Study|Lost to Follow-up|4|||
129697559|NCT02633527|466851851|FG000|Overall Study|Withdrawal by Subject|0|||
129697560|NCT02633527|466851852|FG001|Overall Study|Withdrawal by Subject|3|||
129697561|NCT02633527|466851853|FG002|Overall Study|Withdrawal by Subject|5|||
129697562|NCT02633527|466851854|FG003|Overall Study|Withdrawal by Subject|4|||
129697563|NCT02633527|466851855|FG004|Overall Study|Withdrawal by Subject|4|||
129697564|NCT02633527|466851851|FG000|Overall Study|Protocol Violation|0|||
129697565|NCT02633527|466851852|FG001|Overall Study|Protocol Violation|1|||
129697566|NCT02633527|466851853|FG002|Overall Study|Protocol Violation|1|||
129697567|NCT02633527|466851854|FG003|Overall Study|Protocol Violation|1|||
129697568|NCT02633527|466851855|FG004|Overall Study|Protocol Violation|1|||
129697569|NCT02633527|466851851|FG000|Overall Study|Physician Decision|0|||
129697570|NCT02633527|466851852|FG001|Overall Study|Physician Decision|0|||
129697571|NCT02633527|466851853|FG002|Overall Study|Physician Decision|0|||
129697572|NCT02633527|466851854|FG003|Overall Study|Physician Decision|0|||
129697573|NCT02633527|466851855|FG004|Overall Study|Physician Decision|1|||
129697574|NCT02633527|466851851|FG000|Overall Study|Administrative reason|1|||
129788208|NCT01122264|467191631|FG000|Overall Study|Withdrawal by Subject|6|||
129788209|NCT01122264|467191632|FG001|Overall Study|Withdrawal by Subject|6|||
129788210|NCT01122264|467191633|FG002|Overall Study|Withdrawal by Subject|16|||
129788211|NCT01122264|467191631|FG000|Overall Study|Physician Decision|3|||
129788212|NCT01122264|467191632|FG001|Overall Study|Physician Decision|1|||
129788213|NCT01122264|467191633|FG002|Overall Study|Physician Decision|1|||
129788214|NCT01122264|467191631|FG000|Overall Study|Lack of Efficacy|3|||
129788215|NCT01122264|467191632|FG001|Overall Study|Lack of Efficacy|1|||
129788216|NCT01122264|467191633|FG002|Overall Study|Lack of Efficacy|1|||
129788217|NCT04585009|467191634|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
129788218|NCT04585009|467191635|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788219|NCT04585009|467191636|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788220|NCT04585009|467191637|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788221|NCT04585009|467191638|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788222|NCT04585009|467191639|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788223|NCT04585009|467191640|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788224|NCT04585009|467191641|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788225|NCT04585009|467191642|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788226|NCT04585009|467191643|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788227|NCT04585009|467191644|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788228|NCT04585009|467191645|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
129788229|NCT04585009|467191634|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
129788230|NCT04585009|467191635|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788231|NCT04585009|467191636|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788232|NCT04585009|467191637|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788233|NCT04585009|467191638|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788234|NCT04585009|467191639|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788235|NCT04585009|467191640|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788236|NCT04585009|467191641|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788237|NCT04585009|467191642|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129697575|NCT02633527|466851852|FG001|Overall Study|Administrative reason|0|||
129697576|NCT02633527|466851853|FG002|Overall Study|Administrative reason|0|||
129697577|NCT02633527|466851854|FG003|Overall Study|Administrative reason|1|||
129697578|NCT02633527|466851855|FG004|Overall Study|Administrative reason|0|||
129697579|NCT02633527|466851851|FG000|Overall Study|Multiple reasons|1|||
129697580|NCT02633527|466851852|FG001|Overall Study|Multiple reasons|0|||
129788238|NCT04585009|467191643|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788239|NCT04585009|467191644|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788240|NCT04585009|467191645|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
129788241|NCT04585009|467191634|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788242|NCT04585009|467191635|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788243|NCT04585009|467191636|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788244|NCT04585009|467191637|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788245|NCT04585009|467191638|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788246|NCT04585009|467191639|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788247|NCT04585009|467191640|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788248|NCT04585009|467191641|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
129788249|NCT04585009|467191642|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788250|NCT04585009|467191643|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788251|NCT04585009|467191644|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788252|NCT04585009|467191645|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
129788253|NCT04585009|467191634|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788254|NCT04585009|467191635|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788255|NCT04585009|467191636|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788256|NCT04585009|467191637|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788257|NCT04585009|467191638|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
129788258|NCT04585009|467191639|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788259|NCT04585009|467191640|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788260|NCT04585009|467191641|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788261|NCT04585009|467191642|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788262|NCT04585009|467191643|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788263|NCT04585009|467191644|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788264|NCT04585009|467191645|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
129788265|NCT04585009|467191634|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788266|NCT04585009|467191635|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788267|NCT04585009|467191636|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788268|NCT04585009|467191637|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788269|NCT04585009|467191638|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788270|NCT04585009|467191639|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788271|NCT04585009|467191640|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788272|NCT04585009|467191641|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788273|NCT04585009|467191642|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788274|NCT04585009|467191643|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
129788275|NCT04585009|467191644|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788276|NCT04585009|467191645|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
129788277|NCT04585009|467191634|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788278|NCT04585009|467191635|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788279|NCT04585009|467191636|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788280|NCT04585009|467191637|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788281|NCT04585009|467191638|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788282|NCT04585009|467191639|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788283|NCT04585009|467191640|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788284|NCT04585009|467191641|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788285|NCT04585009|467191642|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788286|NCT04585009|467191643|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788287|NCT04585009|467191644|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
129788288|NCT04585009|467191645|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
129788289|NCT00097981|467191654|FG000|Overall Study|Adverse Event|31|||
129788290|NCT00097981|467191655|FG001|Overall Study|Adverse Event|44|||
129788291|NCT00097981|467191654|FG000|Overall Study|Withdrawal by Subject|10|||
129788292|NCT00097981|467191655|FG001|Overall Study|Withdrawal by Subject|8|||
129788293|NCT00097981|467191654|FG000|Overall Study|Protocol Violation|1|||
129788294|NCT00097981|467191655|FG001|Overall Study|Protocol Violation|1|||
129788295|NCT00097981|467191654|FG000|Overall Study|Death|2|||
129788296|NCT00097981|467191655|FG001|Overall Study|Death|4|||
129788297|NCT00097981|467191654|FG000|Overall Study|Physician Decision|7|||
129788298|NCT00097981|467191655|FG001|Overall Study|Physician Decision|1|||
129788299|NCT00097981|467191654|FG000|Overall Study|Disease Progression|8|||
129788300|NCT00097981|467191655|FG001|Overall Study|Disease Progression|2|||
129788301|NCT00097981|467191654|FG000|Overall Study|Transplant planned|28|||
129788302|NCT00097981|467191655|FG001|Overall Study|Transplant planned|27|||
129788303|NCT00097981|467191654|FG000|Overall Study|Other|19|||
129788304|NCT00097981|467191655|FG001|Overall Study|Other|13|||
129600205|NCT04495283|466494101|FG000|Overall Study|Physician Decision|0|||
129600206|NCT04495283|466494102|FG001|Overall Study|Physician Decision|0|||
129600207|NCT04495283|466494103|FG002|Overall Study|Physician Decision|1|||
129600208|NCT04495283|466494101|FG000|Overall Study|Withdrawal by Subject|0|||
129600209|NCT04495283|466494102|FG001|Overall Study|Withdrawal by Subject|1|||
129600210|NCT04495283|466494103|FG002|Overall Study|Withdrawal by Subject|1|||
129600211|NCT04495283|466494101|FG000|Overall Study|Other|1|||
129600212|NCT04495283|466494102|FG001|Overall Study|Other|0|||
129600213|NCT04495283|466494103|FG002|Overall Study|Other|1|||
129600214|NCT02631876|466494108|FG000|Overall Study|Death|96|||
129600215|NCT02631876|466494109|FG001|Overall Study|Death|50|||
129600216|NCT02631876|466494108|FG000|Overall Study|Investigator's discretion|1|||
129600217|NCT02631876|466494109|FG001|Overall Study|Investigator's discretion|0|||
129600218|NCT02631876|466494108|FG000|Overall Study|Lost to Follow-up|2|||
129600219|NCT02631876|466494109|FG001|Overall Study|Lost to Follow-up|0|||
129600220|NCT02631876|466494108|FG000|Overall Study|Withdrawal by Subject|16|||
129600221|NCT02631876|466494109|FG001|Overall Study|Withdrawal by Subject|9|||
129600222|NCT02631876|466494108|FG000|Overall Study|Other than specified|4|||
129600223|NCT02631876|466494109|FG001|Overall Study|Other than specified|4|||
129600224|NCT01408563|466494114|FG000|Overall Study|Ineligible after consent/ registration|2|||
129600225|NCT00380692|466494115|FG000|Study Period II - Double Blind|Adverse Event|1|||
129600226|NCT00380692|466494116|FG001|Study Period II - Double Blind|Adverse Event|0|||
129600227|NCT00380692|466494115|FG000|Study Period II - Double Blind|Protocol Violation|2|||
129600228|NCT00380692|466494116|FG001|Study Period II - Double Blind|Protocol Violation|2|||
129600229|NCT00380692|466494115|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
129600230|NCT00380692|466494116|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
129600231|NCT00380692|466494115|FG000|Study Period II - Double Blind|Physician Decision|0|||
129600232|NCT00380692|466494116|FG001|Study Period II - Double Blind|Physician Decision|1|||
129600233|NCT00380692|466494115|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
129600234|NCT00380692|466494116|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
129600235|NCT00380692|466494115|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
129600236|NCT00380692|466494116|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
129600237|NCT00380692|466494115|FG000|Study Period III - Open Label|Adverse Event|5|||
129600238|NCT00380692|466494116|FG001|Study Period III - Open Label|Adverse Event|3|||
129600239|NCT00380692|466494115|FG000|Study Period III - Open Label|Protocol Violation|0|||
129600240|NCT00380692|466494116|FG001|Study Period III - Open Label|Protocol Violation|0|||
129600241|NCT00380692|466494115|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
129600242|NCT00380692|466494116|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
129600243|NCT00380692|466494115|FG000|Study Period III - Open Label|Physician Decision|0|||
129600244|NCT00380692|466494116|FG001|Study Period III - Open Label|Physician Decision|3|||
129600245|NCT00380692|466494115|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
129600246|NCT00380692|466494116|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
129600247|NCT00380692|466494115|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
129600248|NCT00380692|466494116|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
129600249|NCT02177136|466494125|FG000|DB Phase|Withdrawal by Subject|2|||
129600250|NCT02177136|466494126|FG001|DB Phase|Withdrawal by Subject|0|||
129600251|NCT02177136|466494127|FG002|DB Phase|Withdrawal by Subject|0|||
129600252|NCT02177136|466494128|FG003|DB Phase|Withdrawal by Subject|0|||
129600253|NCT02177136|466494125|FG000|DB Phase|Discontinued Due to Pruritus|1|||
129600254|NCT02177136|466494126|FG001|DB Phase|Discontinued Due to Pruritus|3|||
129600255|NCT02177136|466494127|FG002|DB Phase|Discontinued Due to Pruritus|0|||
129600256|NCT02177136|466494128|FG003|DB Phase|Discontinued Due to Pruritus|0|||
129600257|NCT02177136|466494125|FG000|DB Phase|Adverse Event|3|||
129600258|NCT02177136|466494126|FG001|DB Phase|Adverse Event|2|||
129600259|NCT02177136|466494127|FG002|DB Phase|Adverse Event|3|||
129600260|NCT02177136|466494128|FG003|DB Phase|Adverse Event|0|||
129600261|NCT02177136|466494125|FG000|DB Phase|Protocol Violation|0|||
129600262|NCT02177136|466494126|FG001|DB Phase|Protocol Violation|0|||
129600263|NCT02177136|466494127|FG002|DB Phase|Protocol Violation|1|||
129600264|NCT02177136|466494128|FG003|DB Phase|Protocol Violation|0|||
129600265|NCT02177136|466494125|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
129600266|NCT02177136|466494126|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
129600267|NCT02177136|466494127|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
129600268|NCT02177136|466494128|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
129600269|NCT02177136|466494125|FG000|LTSE Phase|Withdrawal by Subject|0|||
129600270|NCT02177136|466494126|FG001|LTSE Phase|Withdrawal by Subject|0|||
129600271|NCT02177136|466494127|FG002|LTSE Phase|Withdrawal by Subject|0|||
129600272|NCT02177136|466494128|FG003|LTSE Phase|Withdrawal by Subject|6|||
129600273|NCT02177136|466494125|FG000|LTSE Phase|Adverse Event|0|||
129600274|NCT02177136|466494126|FG001|LTSE Phase|Adverse Event|0|||
129600275|NCT02177136|466494127|FG002|LTSE Phase|Adverse Event|0|||
129600276|NCT02177136|466494128|FG003|LTSE Phase|Adverse Event|10|||
129600277|NCT02177136|466494125|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
129600278|NCT02177136|466494126|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
129600279|NCT02177136|466494127|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
129697581|NCT02633527|466851853|FG002|Overall Study|Multiple reasons|2|||
129697582|NCT02633527|466851854|FG003|Overall Study|Multiple reasons|2|||
129697583|NCT02633527|466851855|FG004|Overall Study|Multiple reasons|1|||
129697584|NCT01681849|466851856|FG000|Overall Study|Protocol Violation|2|||
129697585|NCT01681849|466851857|FG001|Overall Study|Protocol Violation|0|||
129697586|NCT01681849|466851858|FG002|Overall Study|Protocol Violation|0|||
129697587|NCT01681849|466851856|FG000|Overall Study|Withdrawal by Subject|3|||
129697588|NCT01681849|466851857|FG001|Overall Study|Withdrawal by Subject|5|||
129697589|NCT01681849|466851858|FG002|Overall Study|Withdrawal by Subject|33|||
129697590|NCT01681849|466851856|FG000|Overall Study|Lost to Follow-up|3|||
129697591|NCT01681849|466851857|FG001|Overall Study|Lost to Follow-up|2|||
129697592|NCT01681849|466851858|FG002|Overall Study|Lost to Follow-up|6|||
129697593|NCT02852005|466851861|FG000|Overall Study|Lost to Follow-up|0|||
129697594|NCT02852005|466851862|FG001|Overall Study|Lost to Follow-up|0|||
129697595|NCT02852005|466851863|FG002|Overall Study|Lost to Follow-up|0|||
129697596|NCT02852005|466851864|FG003|Overall Study|Lost to Follow-up|0|||
129697597|NCT02852005|466851865|FG004|Overall Study|Lost to Follow-up|1|||
129697598|NCT02852005|466851861|FG000|Overall Study|Withdrawal by Subject|1|||
129697599|NCT02852005|466851862|FG001|Overall Study|Withdrawal by Subject|0|||
129697600|NCT02852005|466851863|FG002|Overall Study|Withdrawal by Subject|0|||
129788305|NCT01002820|467191658|FG000|Overall Study|Adverse Event|1|||
129788306|NCT01002820|467191658|FG000|Overall Study|Withdrawal by Subject|2|||
129788307|NCT01002820|467191658|FG000|Overall Study|Lack of Efficacy|1|||
129788308|NCT01673347|467191660|FG000|Overall Study|failure of allograft|7|||
129788309|NCT00895011|467191664|FG000|Overall Study|Withdrawal by Subject|14|||
129788310|NCT00895011|467191665|FG001|Overall Study|Withdrawal by Subject|7|||
129788311|NCT00895011|467191666|FG002|Overall Study|Withdrawal by Subject|2|||
129788312|NCT00895011|467191664|FG000|Overall Study|Lost to Follow-up|5|||
129788313|NCT00895011|467191665|FG001|Overall Study|Lost to Follow-up|4|||
129788314|NCT00895011|467191666|FG002|Overall Study|Lost to Follow-up|1|||
129788315|NCT00895011|467191664|FG000|Overall Study|Protocol Violation|3|||
129788316|NCT00895011|467191665|FG001|Overall Study|Protocol Violation|1|||
129788317|NCT00895011|467191666|FG002|Overall Study|Protocol Violation|3|||
129788318|NCT00895011|467191664|FG000|Overall Study|Adverse Event|1|||
129788319|NCT00895011|467191665|FG001|Overall Study|Adverse Event|2|||
129788320|NCT00895011|467191666|FG002|Overall Study|Adverse Event|2|||
129788321|NCT00895011|467191664|FG000|Overall Study|schedule conflict|1|||
129788322|NCT00895011|467191665|FG001|Overall Study|schedule conflict|0|||
129788323|NCT00895011|467191666|FG002|Overall Study|schedule conflict|0|||
129788324|NCT02661178|467191669|FG000|Part 1|Protocol Violation|1|||
129788325|NCT02661178|467191670|FG001|Part 1|Protocol Violation|0|||
129788326|NCT02661178|467191671|FG002|Part 1|Protocol Violation|0|||
129788327|NCT02661178|467191672|FG003|Part 1|Protocol Violation|0|||
129788328|NCT02661178|467191673|FG004|Part 1|Protocol Violation|0|||
129788329|NCT02661178|467191674|FG005|Part 1|Protocol Violation|0|||
129788330|NCT02661178|467191675|FG006|Part 1|Protocol Violation|0|||
129788331|NCT02661178|467191676|FG007|Part 1|Protocol Violation|0|||
129788332|NCT02661178|467191677|FG008|Part 1|Protocol Violation|0|||
129788333|NCT02661178|467191678|FG009|Part 1|Protocol Violation|0|||
129788334|NCT02661178|467191679|FG010|Part 1|Protocol Violation|0|||
129788335|NCT02661178|467191680|FG011|Part 1|Protocol Violation|0|||
129788336|NCT02661178|467191681|FG012|Part 1|Protocol Violation|0|||
129788337|NCT02661178|467191682|FG013|Part 1|Protocol Violation|0|||
129788338|NCT02661178|467191683|FG014|Part 1|Protocol Violation|0|||
129788339|NCT01369329|467191685|FG000|Overall Study|Withdrawal by Subject|8|||
129788340|NCT01369329|467191686|FG001|Overall Study|Withdrawal by Subject|6|||
129788341|NCT01369329|467191687|FG002|Overall Study|Withdrawal by Subject|10|||
129788342|NCT01369329|467191685|FG000|Overall Study|Lost to Follow-up|2|||
129788343|NCT01369329|467191686|FG001|Overall Study|Lost to Follow-up|2|||
129697601|NCT02852005|466851864|FG003|Overall Study|Withdrawal by Subject|0|||
129697602|NCT02852005|466851865|FG004|Overall Study|Withdrawal by Subject|0|||
129697603|NCT02420314|466851868|FG000|Overall Study|Withdrawal by Subject|1|||
129697604|NCT02420314|466851868|FG000|Overall Study|Protocol Violation|1|||
129697605|NCT03760068|466851870|FG000|Overall Study|Withdrawal by Subject|7|||
129697606|NCT03760068|466851871|FG001|Overall Study|Withdrawal by Subject|8|||
129697607|NCT03760068|466851870|FG000|Overall Study|Adverse Event|1|||
129697608|NCT03760068|466851871|FG001|Overall Study|Adverse Event|2|||
129788344|NCT01369329|467191687|FG002|Overall Study|Lost to Follow-up|2|||
129788345|NCT01369329|467191685|FG000|Overall Study|Other|2|||
129788346|NCT01369329|467191686|FG001|Overall Study|Other|3|||
129788347|NCT01369329|467191687|FG002|Overall Study|Other|2|||
129788348|NCT01101308|467191688|FG000|Period 1|Adverse Event|2|||
129788349|NCT01101308|467191689|FG001|Period 1|Adverse Event|1|||
129788350|NCT01101308|467191688|FG000|Period 1|Positive for cotinine|1|||
129788351|NCT01101308|467191689|FG001|Period 1|Positive for cotinine|0|||
129788352|NCT01133990|467191692|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
129788353|NCT01133990|467191693|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129697609|NCT03760068|466851870|FG000|Overall Study|Administrative Decision by Sponsor|0|||
129697610|NCT03760068|466851871|FG001|Overall Study|Administrative Decision by Sponsor|2|||
129697611|NCT03760068|466851870|FG000|Overall Study|Physician Decision|1|||
129697612|NCT03760068|466851871|FG001|Overall Study|Physician Decision|2|||
129697613|NCT03760068|466851870|FG000|Overall Study|Lost to Follow-up|4|||
129697614|NCT03760068|466851871|FG001|Overall Study|Lost to Follow-up|9|||
129697615|NCT03760068|466851870|FG000|Overall Study|Subject Moved Out of State|1|||
129697616|NCT03760068|466851871|FG001|Overall Study|Subject Moved Out of State|0|||
129697617|NCT03460704|466851875|FG000|Overall Study|Withdrawal by Subject|11|||
129697618|NCT03460704|466851876|FG001|Overall Study|Withdrawal by Subject|14|||
129697619|NCT03460704|466851875|FG000|Overall Study|Study terminated by the Sponsor|29|||
129697620|NCT03460704|466851876|FG001|Overall Study|Study terminated by the Sponsor|19|||
129697621|NCT03460704|466851875|FG000|Overall Study|Adverse Event|10|||
129697622|NCT03460704|466851876|FG001|Overall Study|Adverse Event|5|||
129697623|NCT03460704|466851875|FG000|Overall Study|Death|3|||
129788354|NCT01133990|467191694|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129788355|NCT01133990|467191695|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129788356|NCT01133990|467191696|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129788357|NCT01133990|467191697|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129788358|NCT01133990|467191692|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
129788359|NCT01133990|467191693|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
129788360|NCT01133990|467191694|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
129788361|NCT01133990|467191695|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
129788362|NCT01133990|467191696|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
129788363|NCT01133990|467191697|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
129788364|NCT01133990|467191692|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129788365|NCT01133990|467191693|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129788366|NCT01133990|467191694|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129788367|NCT01133990|467191695|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129788368|NCT01133990|467191696|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129788369|NCT01133990|467191697|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129788370|NCT01133990|467191692|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
129788371|NCT01133990|467191693|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
129788372|NCT01133990|467191694|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
129788373|NCT01133990|467191695|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
129788374|NCT01133990|467191696|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
129788375|NCT01133990|467191697|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
129788376|NCT05277337|467191698|FG000|Overall Study|Lost to Follow-up|2|||
129788377|NCT05277337|467191699|FG001|Overall Study|Lost to Follow-up|0|||
129788378|NCT05277337|467191698|FG000|Overall Study|Withdrawal by Subject|1|||
129788379|NCT05277337|467191699|FG001|Overall Study|Withdrawal by Subject|0|||
129788380|NCT02282345|467191701|FG000|Overall Study|Progression|0|||
129788381|NCT02282345|467191702|FG001|Overall Study|Progression|1|||
129788382|NCT04905498|467191705|FG000|Overall Study|Lost to Follow-up|0|||
129788383|NCT04905498|467191706|FG001|Overall Study|Lost to Follow-up|2|||
129788384|NCT04905498|467191705|FG000|Overall Study|COVID lockdown|1|||
129788385|NCT04905498|467191706|FG001|Overall Study|COVID lockdown|0|||
129788386|NCT03222492|467191709|FG000|Overall Study|Withdrawal by Subject|0|||
129788387|NCT03222492|467191710|FG001|Overall Study|Withdrawal by Subject|0|||
129788388|NCT03222492|467191711|FG002|Overall Study|Withdrawal by Subject|1|||
129788389|NCT03222492|467191712|FG003|Overall Study|Withdrawal by Subject|0|||
129788390|NCT03222492|467191709|FG000|Overall Study|COVID-19 related|0|||
129788391|NCT03222492|467191710|FG001|Overall Study|COVID-19 related|0|||
129788392|NCT03222492|467191711|FG002|Overall Study|COVID-19 related|1|||
129788393|NCT03222492|467191712|FG003|Overall Study|COVID-19 related|0|||
129788394|NCT01224782|467191715|FG000|Overall Study|Lost to Follow-up|177|||
129697624|NCT03460704|466851876|FG001|Overall Study|Death|2|||
129788395|NCT01224782|467191715|FG000|Overall Study|Withdrawal by Subject|16|||
129788396|NCT01224782|467191715|FG000|Overall Study|Death|14|||
129788397|NCT01224782|467191715|FG000|Overall Study|Improvement|13|||
129788398|NCT01224782|467191715|FG000|Overall Study|Adverse Event|12|||
129788399|NCT01224782|467191715|FG000|Overall Study|Adverse Reaction|11|||
129788400|NCT01224782|467191715|FG000|Overall Study|Noncompliance|10|||
129788401|NCT01224782|467191715|FG000|Overall Study|Other|4|||
129697625|NCT03460704|466851875|FG000|Overall Study|Non-Compliance with Study Drug|3|||
129697626|NCT03460704|466851876|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129788402|NCT01224782|467191715|FG000|Overall Study|Start of Dialysis|3|||
129697627|NCT03460704|466851875|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129788403|NCT01224782|467191715|FG000|Overall Study|Change of Treatment|1|||
129788404|NCT01224782|467191715|FG000|Overall Study|Financial Reasons|1|||
129788405|NCT01224782|467191715|FG000|Overall Study|Deterioration|1|||
129788406|NCT01224782|467191715|FG000|Overall Study|Transplantation|1|||
129788407|NCT00065429|467191718|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
129600280|NCT02177136|466494128|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
129600281|NCT02177136|466494125|FG000|LTSE Phase|Physician Decision|0|||
129600282|NCT02177136|466494126|FG001|LTSE Phase|Physician Decision|0|||
129600283|NCT02177136|466494127|FG002|LTSE Phase|Physician Decision|0|||
129600284|NCT02177136|466494128|FG003|LTSE Phase|Physician Decision|2|||
129600285|NCT02177136|466494125|FG000|LTSE Phase|Lost to Follow-up|0|||
129600286|NCT02177136|466494126|FG001|LTSE Phase|Lost to Follow-up|0|||
129600287|NCT02177136|466494127|FG002|LTSE Phase|Lost to Follow-up|0|||
129600288|NCT02177136|466494128|FG003|LTSE Phase|Lost to Follow-up|1|||
129600289|NCT02177136|466494125|FG000|LTSE Phase|Participant Moved|0|||
129600290|NCT02177136|466494126|FG001|LTSE Phase|Participant Moved|0|||
129600291|NCT02177136|466494127|FG002|LTSE Phase|Participant Moved|0|||
129600292|NCT02177136|466494128|FG003|LTSE Phase|Participant Moved|1|||
129600293|NCT02054130|466494129|FG000|Overall Study|Withdrawal by Subject|4|||
129600294|NCT02054130|466494130|FG001|Overall Study|Withdrawal by Subject|4|||
129600295|NCT02054130|466494131|FG002|Overall Study|Withdrawal by Subject|7|||
129600296|NCT02054130|466494132|FG003|Overall Study|Withdrawal by Subject|10|||
129600297|NCT02054130|466494129|FG000|Overall Study|Death|0|||
129600298|NCT02054130|466494130|FG001|Overall Study|Death|1|||
129600299|NCT02054130|466494131|FG002|Overall Study|Death|0|||
129600300|NCT02054130|466494132|FG003|Overall Study|Death|0|||
129600301|NCT02054130|466494129|FG000|Overall Study|Lost to Follow-up|0|||
129600302|NCT02054130|466494130|FG001|Overall Study|Lost to Follow-up|0|||
129600303|NCT02054130|466494131|FG002|Overall Study|Lost to Follow-up|1|||
129600304|NCT02054130|466494132|FG003|Overall Study|Lost to Follow-up|2|||
129600305|NCT02054130|466494129|FG000|Overall Study|Missed dose|4|||
129600306|NCT02054130|466494130|FG001|Overall Study|Missed dose|6|||
129600307|NCT02054130|466494131|FG002|Overall Study|Missed dose|7|||
129600308|NCT02054130|466494132|FG003|Overall Study|Missed dose|10|||
129600309|NCT01386684|466494133|FG000|Overall Study|Lost to Follow-up|51|||
129600310|NCT01386684|466494133|FG000|Overall Study|Other|51|||
129600311|NCT01386684|466494133|FG000|Overall Study|Death|47|||
129600312|NCT01386684|466494133|FG000|Overall Study|Withdrawal of Consent|44|||
129600313|NCT01386684|466494133|FG000|Overall Study|Alternative Therapy Required|37|||
129600314|NCT01386684|466494133|FG000|Overall Study|Disease Progression|28|||
129600315|NCT01386684|466494133|FG000|Overall Study|Adverse Event|20|||
129600316|NCT01386684|466494133|FG000|Overall Study|Noncompliance|8|||
129600317|NCT01386684|466494133|FG000|Overall Study|Protocol Violation|4|||
129600318|NCT01386684|466494133|FG000|Overall Study|Missing|3|||
129600319|NCT01032018|466494134|FG000|Overall Study|Lost to Follow-up|6|||
129600320|NCT01032018|466494135|FG001|Overall Study|Lost to Follow-up|5|||
129600321|NCT01032018|466494134|FG000|Overall Study|Death|0|||
129600322|NCT01032018|466494135|FG001|Overall Study|Death|1|||
129600323|NCT00094458|466494136|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
129600324|NCT00094458|466494137|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
129600325|NCT00094458|466494138|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
129600326|NCT00094458|466494139|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
129600327|NCT00094458|466494140|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
129600328|NCT00094458|466494141|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
129600329|NCT00094458|466494136|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
129600330|NCT00094458|466494137|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
129600331|NCT00094458|466494138|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
129600332|NCT00094458|466494139|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
129600333|NCT00094458|466494140|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
129600334|NCT00094458|466494141|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
129600335|NCT00094458|466494136|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
129600336|NCT00094458|466494137|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
129600337|NCT00094458|466494138|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
129600338|NCT00094458|466494139|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
129600339|NCT00094458|466494140|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
129600340|NCT00094458|466494141|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
129600341|NCT00094458|466494136|FG000|Main Study: Through Week 30|Adverse Event|38|||
129885905|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885906|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
129885907|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885908|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
129600342|NCT00094458|466494137|FG001|Main Study: Through Week 30|Adverse Event|20|||
129600343|NCT00094458|466494138|FG002|Main Study: Through Week 30|Adverse Event|28|||
129600344|NCT00094458|466494139|FG003|Main Study: Through Week 30|Adverse Event|0|||
129600345|NCT00094458|466494140|FG004|Main Study: Through Week 30|Adverse Event|0|||
129600346|NCT00094458|466494141|FG005|Main Study: Through Week 30|Adverse Event|0|||
129600347|NCT00094458|466494136|FG000|Main Study: Through Week 30|Death|1|||
129600348|NCT00094458|466494137|FG001|Main Study: Through Week 30|Death|0|||
129600349|NCT00094458|466494138|FG002|Main Study: Through Week 30|Death|0|||
129600350|NCT00094458|466494139|FG003|Main Study: Through Week 30|Death|0|||
129600351|NCT00094458|466494140|FG004|Main Study: Through Week 30|Death|0|||
129600352|NCT00094458|466494141|FG005|Main Study: Through Week 30|Death|0|||
129600353|NCT00094458|466494136|FG000|Main Study: Through Week 30|Other|19|||
129600354|NCT00094458|466494137|FG001|Main Study: Through Week 30|Other|16|||
129600355|NCT00094458|466494138|FG002|Main Study: Through Week 30|Other|9|||
129600356|NCT00094458|466494139|FG003|Main Study: Through Week 30|Other|0|||
129600357|NCT00094458|466494140|FG004|Main Study: Through Week 30|Other|0|||
129600358|NCT00094458|466494141|FG005|Main Study: Through Week 30|Other|0|||
129600359|NCT00094458|466494136|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
129600360|NCT00094458|466494137|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
129885909|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
129885910|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
129600361|NCT00094458|466494138|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
129600362|NCT00094458|466494139|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129600363|NCT00094458|466494140|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129600364|NCT00094458|466494141|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
129600365|NCT00094458|466494136|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
129697628|NCT03460704|466851876|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
129697629|NCT03460704|466851875|FG000|Overall Study|Other|2|||
129697630|NCT03460704|466851876|FG001|Overall Study|Other|1|||
129697631|NCT02913326|466851881|FG000|Overall Study|Reason not listed|0|||
129697632|NCT02913326|466851882|FG001|Overall Study|Reason not listed|1|||
129697633|NCT02913326|466851881|FG000|Overall Study|Lost to Follow-up|0|||
129697634|NCT02913326|466851882|FG001|Overall Study|Lost to Follow-up|1|||
129697635|NCT02913326|466851881|FG000|Overall Study|Adverse Event|1|||
129697636|NCT02913326|466851882|FG001|Overall Study|Adverse Event|0|||
129697637|NCT01767857|466851883|FG000|Overall Study|Adverse Event|27|||
129697638|NCT01767857|466851884|FG001|Overall Study|Adverse Event|7|||
129697639|NCT01767857|466851883|FG000|Overall Study|Death|28|||
129697640|NCT01767857|466851884|FG001|Overall Study|Death|13|||
129697641|NCT01767857|466851883|FG000|Overall Study|Lack of Efficacy|299|||
129697642|NCT01767857|466851884|FG001|Overall Study|Lack of Efficacy|151|||
129697643|NCT01767857|466851883|FG000|Overall Study|Lost to Follow-up|1|||
129697644|NCT01767857|466851884|FG001|Overall Study|Lost to Follow-up|1|||
129697645|NCT01767857|466851883|FG000|Overall Study|Withdrawal by Subject|38|||
129697646|NCT01767857|466851884|FG001|Overall Study|Withdrawal by Subject|18|||
129697647|NCT01767857|466851883|FG000|Overall Study|Physician Decision|17|||
129697648|NCT01767857|466851884|FG001|Overall Study|Physician Decision|10|||
129697649|NCT01767857|466851883|FG000|Overall Study|Protocol Terminated|1|||
129697650|NCT01767857|466851884|FG001|Overall Study|Protocol Terminated|0|||
129697651|NCT01767857|466851883|FG000|Overall Study|Randomized But Never Treated|19|||
129697652|NCT01767857|466851884|FG001|Overall Study|Randomized But Never Treated|13|||
129697653|NCT00420056|466851903|FG000|Overall Study|Objective progression or relapse|17|||
129697654|NCT01390584|466851909|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
129697655|NCT01390584|466851910|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
129697656|NCT01390584|466851911|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
129697657|NCT01720602|466851912|FG000|Overall Study|Adverse Event|3|||
129697658|NCT01720602|466851912|FG000|Overall Study|Progressive disease on therapy|2|||
129697659|NCT00452400|466851913|FG000|Overall Study|Adverse Event|1|||
129697660|NCT00452400|466851914|FG001|Overall Study|Adverse Event|1|||
129697661|NCT00452400|466851915|FG002|Overall Study|Adverse Event|5|||
129697662|NCT00452400|466851916|FG003|Overall Study|Adverse Event|0|||
129697663|NCT00452400|466851917|FG004|Overall Study|Adverse Event|2|||
129697664|NCT00452400|466851913|FG000|Overall Study|Protocol Violation|0|||
129697665|NCT00452400|466851914|FG001|Overall Study|Protocol Violation|0|||
129697666|NCT00452400|466851915|FG002|Overall Study|Protocol Violation|1|||
129697667|NCT00452400|466851916|FG003|Overall Study|Protocol Violation|0|||
129697668|NCT00452400|466851917|FG004|Overall Study|Protocol Violation|0|||
129697669|NCT00452400|466851913|FG000|Overall Study|Lost to Follow-up|1|||
129697670|NCT00452400|466851914|FG001|Overall Study|Lost to Follow-up|0|||
129697671|NCT00452400|466851915|FG002|Overall Study|Lost to Follow-up|0|||
129697672|NCT00452400|466851916|FG003|Overall Study|Lost to Follow-up|0|||
129697673|NCT00452400|466851917|FG004|Overall Study|Lost to Follow-up|0|||
129697674|NCT00452400|466851913|FG000|Overall Study|Withdrawal by Subject|1|||
129697675|NCT00452400|466851914|FG001|Overall Study|Withdrawal by Subject|0|||
129697676|NCT00452400|466851915|FG002|Overall Study|Withdrawal by Subject|1|||
129697677|NCT00452400|466851916|FG003|Overall Study|Withdrawal by Subject|0|||
129697678|NCT00452400|466851917|FG004|Overall Study|Withdrawal by Subject|0|||
129697679|NCT00452400|466851913|FG000|Overall Study|Lack of Efficacy|2|||
129697680|NCT00452400|466851914|FG001|Overall Study|Lack of Efficacy|0|||
129697681|NCT00452400|466851915|FG002|Overall Study|Lack of Efficacy|0|||
129697682|NCT00452400|466851916|FG003|Overall Study|Lack of Efficacy|0|||
129697683|NCT00452400|466851917|FG004|Overall Study|Lack of Efficacy|0|||
129697684|NCT00452400|466851913|FG000|Overall Study|Other reasons not listed above|0|||
129697685|NCT00452400|466851914|FG001|Overall Study|Other reasons not listed above|0|||
129697686|NCT00452400|466851915|FG002|Overall Study|Other reasons not listed above|0|||
129697687|NCT00452400|466851916|FG003|Overall Study|Other reasons not listed above|1|||
129600366|NCT00094458|466494137|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129600367|NCT00094458|466494138|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
129600368|NCT00094458|466494139|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129600369|NCT00094458|466494140|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129600370|NCT00094458|466494141|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
129600371|NCT00094458|466494136|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
129600372|NCT00094458|466494137|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
129600373|NCT00094458|466494138|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
129600374|NCT00094458|466494139|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
129600375|NCT00094458|466494140|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
129600376|NCT00094458|466494141|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
129600377|NCT00094458|466494136|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
129600378|NCT00094458|466494137|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
129600379|NCT00094458|466494138|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
129600380|NCT00094458|466494139|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
129600381|NCT00094458|466494140|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
129600382|NCT00094458|466494141|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
129600383|NCT00094458|466494136|FG000|OLE: Open-Label Extension|Adverse Event|0|||
129600384|NCT00094458|466494137|FG001|OLE: Open-Label Extension|Adverse Event|0|||
129600385|NCT00094458|466494138|FG002|OLE: Open-Label Extension|Adverse Event|0|||
129600386|NCT00094458|466494139|FG003|OLE: Open-Label Extension|Adverse Event|0|||
129600387|NCT00094458|466494140|FG004|OLE: Open-Label Extension|Adverse Event|3|||
129600388|NCT00094458|466494141|FG005|OLE: Open-Label Extension|Adverse Event|4|||
129600389|NCT00094458|466494136|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129600390|NCT00094458|466494137|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129600391|NCT00094458|466494138|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129600392|NCT00094458|466494139|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
129600393|NCT00094458|466494140|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
129600394|NCT00094458|466494141|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
129600395|NCT00094458|466494136|FG000|OLE: Open-Label Extension|Patient decision|0|||
129600396|NCT00094458|466494137|FG001|OLE: Open-Label Extension|Patient decision|0|||
129600397|NCT00094458|466494138|FG002|OLE: Open-Label Extension|Patient decision|0|||
129600398|NCT00094458|466494139|FG003|OLE: Open-Label Extension|Patient decision|0|||
129600399|NCT00094458|466494140|FG004|OLE: Open-Label Extension|Patient decision|1|||
129600400|NCT00094458|466494141|FG005|OLE: Open-Label Extension|Patient decision|0|||
129600401|NCT03265288|466494142|FG000|Overall Study|Adverse Event|0|||
129600402|NCT03265288|466494143|FG001|Overall Study|Adverse Event|1|||
129600403|NCT03265288|466494142|FG000|Overall Study|Withdrawal by Subject|13|||
129600404|NCT03265288|466494143|FG001|Overall Study|Withdrawal by Subject|5|||
129600405|NCT03265288|466494142|FG000|Overall Study|Drug Withdrawn|3|||
129600406|NCT03265288|466494143|FG001|Overall Study|Drug Withdrawn|3|||
129600407|NCT03265288|466494142|FG000|Overall Study|Any Other Reason|7|||
129600408|NCT03265288|466494143|FG001|Overall Study|Any Other Reason|3|||
129600409|NCT03197558|466494144|FG000|Overall Study|Tubes not placed|1|||
129600410|NCT03578237|466494145|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
129600411|NCT03578237|466494146|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
129600412|NCT00973765|466494147|FG000|Overall Study|Lost to Follow-up|8|||
129600413|NCT00973765|466494148|FG001|Overall Study|Lost to Follow-up|14|||
129600414|NCT02011113|466494149|FG000|Overall Study|Adverse Event|4|||
129600415|NCT02011113|466494149|FG000|Overall Study|Disease Progression (DP)|16|||
129600416|NCT02011113|466494149|FG000|Overall Study|Death|1|||
129600417|NCT02011113|466494149|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
129600418|NCT02011113|466494149|FG000|Overall Study|Investigator's judgement- DP|3|||
129600419|NCT02011113|466494149|FG000|Overall Study|Study terminated by sponsor|11|||
129600420|NCT01892657|466494152|FG000|Overall Study|Withdrawal by Subject|6|||
129600421|NCT01892657|466494152|FG000|Overall Study|Protocol Violation|12|||
129600422|NCT00468728|466494155|FG000|Treatment|criteria for mITT population|4|||
129600423|NCT00468728|466494156|FG001|Treatment|criteria for mITT population|11|||
129600424|NCT00468728|466494155|FG000|Follow-up|mITT failure|34|||
129600425|NCT00468728|466494156|FG001|Follow-up|mITT failure|31|||
129600426|NCT02712333|466494158|FG000|First Period|Withdrawal by Subject|3|||
129600427|NCT02712333|466494159|FG001|First Period|Withdrawal by Subject|2|||
129600428|NCT03463993|466494160|FG000|Overall Study|Lost to Follow-up|7|||
129600429|NCT03463993|466494161|FG001|Overall Study|Lost to Follow-up|8|||
129647481|NCT03729570|466665337|FG001|Overall Study|Lost to Follow-up|20|||
129647482|NCT03729570|466665336|FG000|Overall Study|Seroconversion|5|||
129647483|NCT03729570|466665337|FG001|Overall Study|Seroconversion|0|||
129647484|NCT03729570|466665336|FG000|Overall Study|Moved out of the city|1|||
129647485|NCT03729570|466665337|FG001|Overall Study|Moved out of the city|0|||
129647486|NCT03729570|466665336|FG000|Overall Study|Time Conflict|1|||
129647487|NCT03729570|466665337|FG001|Overall Study|Time Conflict|0|||
129600430|NCT03463993|466494160|FG000|Overall Study|Withdrawal by Subject|2|||
129600431|NCT03463993|466494161|FG001|Overall Study|Withdrawal by Subject|0|||
129600432|NCT03463993|466494160|FG000|Overall Study|Protocol Violation|4|||
129600433|NCT03463993|466494161|FG001|Overall Study|Protocol Violation|1|||
129600434|NCT03463993|466494160|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
129600435|NCT03463993|466494161|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
129600436|NCT03463993|466494160|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
129600437|NCT03463993|466494161|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
129600438|NCT01478828|466494162|FG000|Overall Study|Adverse Event|1|||
129600439|NCT02278718|466494163|FG000|Overall Study|Adverse Event|1|||
129600440|NCT02278718|466494164|FG001|Overall Study|Adverse Event|0|||
129600441|NCT02278718|466494163|FG000|Overall Study|Lost to Follow-up|2|||
129600442|NCT02278718|466494164|FG001|Overall Study|Lost to Follow-up|4|||
129600443|NCT02278718|466494163|FG000|Overall Study|Withdrawal by Subject|1|||
129600444|NCT02278718|466494164|FG001|Overall Study|Withdrawal by Subject|4|||
129600445|NCT02278718|466494163|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
129600446|NCT02278718|466494164|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
129600447|NCT02278718|466494163|FG000|Overall Study|Missing|0|||
129600448|NCT02278718|466494164|FG001|Overall Study|Missing|1|||
129600449|NCT04440449|466494165|FG000|Overall Study|Lost to Follow-up|2|||
129600450|NCT04440449|466494166|FG001|Overall Study|Lost to Follow-up|0|||
129600451|NCT01763918|466494167|FG000|Overall Study|Withdrawal by Subject|2|||
129600452|NCT01763918|466494168|FG001|Overall Study|Withdrawal by Subject|1|||
129600453|NCT01763918|466494169|FG002|Overall Study|Withdrawal by Subject|1|||
129600454|NCT01763918|466494170|FG003|Overall Study|Withdrawal by Subject|2|||
129600455|NCT01763918|466494167|FG000|Overall Study|Sponsor Decision|4|||
129600456|NCT01763918|466494168|FG001|Overall Study|Sponsor Decision|0|||
129600457|NCT01763918|466494169|FG002|Overall Study|Sponsor Decision|9|||
129600458|NCT01763918|466494170|FG003|Overall Study|Sponsor Decision|0|||
129600459|NCT00897949|466494171|FG000|Overall Study|Adverse Event|1|||
129600460|NCT00897949|466494172|FG001|Overall Study|Adverse Event|1|||
129600461|NCT00897949|466494173|FG002|Overall Study|Adverse Event|0|||
129600462|NCT00897949|466494171|FG000|Overall Study|Lost to Follow-up|0|||
129600463|NCT00897949|466494172|FG001|Overall Study|Lost to Follow-up|2|||
129600464|NCT00897949|466494173|FG002|Overall Study|Lost to Follow-up|1|||
129600465|NCT00897949|466494171|FG000|Overall Study|Protocol Violation|6|||
129600466|NCT00897949|466494172|FG001|Overall Study|Protocol Violation|3|||
129600467|NCT00897949|466494173|FG002|Overall Study|Protocol Violation|1|||
129600468|NCT00897949|466494171|FG000|Overall Study|Withdrawal by Subject|1|||
129600469|NCT00897949|466494172|FG001|Overall Study|Withdrawal by Subject|2|||
129600470|NCT00897949|466494173|FG002|Overall Study|Withdrawal by Subject|0|||
129600471|NCT00897949|466494171|FG000|Overall Study|Patient Uncoorperative|0|||
129600472|NCT00897949|466494172|FG001|Overall Study|Patient Uncoorperative|2|||
129600473|NCT00897949|466494173|FG002|Overall Study|Patient Uncoorperative|1|||
129600474|NCT00897949|466494171|FG000|Overall Study|Lost to Follow-up|30|||
129600475|NCT00897949|466494172|FG001|Overall Study|Lost to Follow-up|23|||
129600476|NCT00897949|466494173|FG002|Overall Study|Lost to Follow-up|17|||
129600477|NCT00897949|466494171|FG000|Overall Study|Withdrawal by Subject|24|||
129600478|NCT00897949|466494172|FG001|Overall Study|Withdrawal by Subject|31|||
129600479|NCT00897949|466494173|FG002|Overall Study|Withdrawal by Subject|17|||
129600480|NCT00897949|466494171|FG000|Overall Study|Abnormal Prestudy Labs|2|||
129600481|NCT00897949|466494172|FG001|Overall Study|Abnormal Prestudy Labs|3|||
129600482|NCT00897949|466494173|FG002|Overall Study|Abnormal Prestudy Labs|4|||
129600483|NCT00897949|466494171|FG000|Overall Study|Abnormal Baseline ECG|2|||
129600484|NCT00897949|466494172|FG001|Overall Study|Abnormal Baseline ECG|2|||
129600485|NCT00897949|466494173|FG002|Overall Study|Abnormal Baseline ECG|4|||
129600486|NCT00897949|466494171|FG000|Overall Study|Need for Concom. Med.|0|||
129600487|NCT00897949|466494172|FG001|Overall Study|Need for Concom. Med.|1|||
129600488|NCT00897949|466494173|FG002|Overall Study|Need for Concom. Med.|1|||
129600489|NCT00897949|466494171|FG000|Overall Study|Lack of Migraine Attack|29|||
129600490|NCT00897949|466494172|FG001|Overall Study|Lack of Migraine Attack|30|||
129600491|NCT00897949|466494173|FG002|Overall Study|Lack of Migraine Attack|19|||
129600492|NCT00897949|466494171|FG000|Overall Study|Did not take study drug|9|||
129600493|NCT00897949|466494172|FG001|Overall Study|Did not take study drug|3|||
129600494|NCT00897949|466494173|FG002|Overall Study|Did not take study drug|4|||
129600495|NCT01553747|466494174|FG000|Overall Study|Protocol Violation|0|||
129600496|NCT01553747|466494175|FG001|Overall Study|Protocol Violation|2|||
129600497|NCT01553747|466494176|FG002|Overall Study|Protocol Violation|0|||
129697688|NCT00452400|466851917|FG004|Overall Study|Other reasons not listed above|1|||
129600498|NCT01553747|466494174|FG000|Overall Study|Voluntarily withdrew|70|||
129600499|NCT01553747|466494175|FG001|Overall Study|Voluntarily withdrew|66|||
129600500|NCT01553747|466494176|FG002|Overall Study|Voluntarily withdrew|74|||
129600501|NCT01553747|466494174|FG000|Overall Study|Adverse event or SAE|32|||
129600502|NCT01553747|466494175|FG001|Overall Study|Adverse event or SAE|28|||
129600503|NCT01553747|466494176|FG002|Overall Study|Adverse event or SAE|19|||
129788408|NCT00065429|467191719|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
129788409|NCT00065429|467191720|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
129788410|NCT00065429|467191721|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
129788411|NCT00065429|467191722|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
129788412|NCT00065429|467191723|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
129788413|NCT00065429|467191724|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
129788414|NCT00065429|467191718|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
129788415|NCT00065429|467191719|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
129788416|NCT00065429|467191720|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
129788417|NCT00065429|467191721|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
129788418|NCT00065429|467191722|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
129788419|NCT00065429|467191723|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
129885911|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885912|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
129600504|NCT01553747|466494174|FG000|Overall Study|Physician decision: other|10|||
129600505|NCT01553747|466494175|FG001|Overall Study|Physician decision: other|8|||
129600506|NCT01553747|466494176|FG002|Overall Study|Physician decision: other|7|||
129600507|NCT01553747|466494174|FG000|Overall Study|Lost to Follow-up|11|||
129600508|NCT01553747|466494175|FG001|Overall Study|Lost to Follow-up|5|||
129600509|NCT01553747|466494176|FG002|Overall Study|Lost to Follow-up|6|||
129600510|NCT01553747|466494174|FG000|Overall Study|Sponsor decision, specify|7|||
129600511|NCT01553747|466494175|FG001|Overall Study|Sponsor decision, specify|5|||
129600512|NCT01553747|466494176|FG002|Overall Study|Sponsor decision, specify|0|||
129600513|NCT01553747|466494174|FG000|Overall Study|Physician decision: lack of efficacy|1|||
129600514|NCT01553747|466494175|FG001|Overall Study|Physician decision: lack of efficacy|5|||
129600515|NCT01553747|466494176|FG002|Overall Study|Physician decision: lack of efficacy|3|||
129600516|NCT01875471|466494186|FG000|Overall Study|Adverse Event|0|||
129600517|NCT01875471|466494187|FG001|Overall Study|Adverse Event|1|||
129600518|NCT01875471|466494186|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
129600519|NCT01875471|466494187|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
129600520|NCT03407118|466494188|FG000|Period 2|Withdrawal by Subject|1|||
129600521|NCT03407118|466494189|FG001|Period 2|Withdrawal by Subject|0|||
129600522|NCT02972502|466494193|FG000|Overall Study|Lost to Follow-up|3|||
129600523|NCT02972502|466494194|FG001|Overall Study|Lost to Follow-up|1|||
129600524|NCT02972502|466494193|FG000|Overall Study|Withdrawal by Subject|1|||
129600525|NCT02972502|466494194|FG001|Overall Study|Withdrawal by Subject|1|||
129600526|NCT03832738|466494197|FG000|Overall Study|Withdrawal by Subject|6|||
129600527|NCT03832738|466494198|FG001|Overall Study|Withdrawal by Subject|7|||
129600528|NCT03832738|466494199|FG002|Overall Study|Withdrawal by Subject|16|||
129600529|NCT03832738|466494197|FG000|Overall Study|Physician Decision|0|||
129600530|NCT03832738|466494198|FG001|Overall Study|Physician Decision|1|||
129600531|NCT03832738|466494199|FG002|Overall Study|Physician Decision|2|||
129600532|NCT03832738|466494197|FG000|Overall Study|Adverse Event|2|||
129600533|NCT03832738|466494198|FG001|Overall Study|Adverse Event|3|||
129600534|NCT03832738|466494199|FG002|Overall Study|Adverse Event|1|||
129600535|NCT03832738|466494197|FG000|Overall Study|Pregnancy|0|||
129600536|NCT03832738|466494198|FG001|Overall Study|Pregnancy|1|||
129600537|NCT03832738|466494199|FG002|Overall Study|Pregnancy|0|||
129600538|NCT01347866|466494200|FG000|Overall Study|Death|0|||
129600539|NCT01347866|466494201|FG001|Overall Study|Death|0|||
129600540|NCT01347866|466494202|FG002|Overall Study|Death|0|||
129600541|NCT01347866|466494203|FG003|Overall Study|Death|1|||
129600542|NCT01347866|466494204|FG004|Overall Study|Death|2|||
129600543|NCT01347866|466494205|FG005|Overall Study|Death|2|||
129600544|NCT01347866|466494206|FG006|Overall Study|Death|1|||
129600545|NCT01347866|466494207|FG007|Overall Study|Death|0|||
129600546|NCT01347866|466494208|FG008|Overall Study|Death|4|||
129600547|NCT01347866|466494209|FG009|Overall Study|Death|1|||
129600548|NCT01347866|466494210|FG010|Overall Study|Death|3|||
129600549|NCT01347866|466494211|FG011|Overall Study|Death|1|||
129600550|NCT01347866|466494212|FG012|Overall Study|Death|2|||
129600551|NCT01347866|466494213|FG013|Overall Study|Death|0|||
129600552|NCT01347866|466494214|FG014|Overall Study|Death|0|||
129600553|NCT01347866|466494215|FG015|Overall Study|Death|1|||
129600554|NCT01347866|466494216|FG016|Overall Study|Death|0|||
129788420|NCT00065429|467191724|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
129788421|NCT00065429|467191718|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
129600555|NCT01347866|466494200|FG000|Overall Study|Lost to Follow-up|0|||
129600556|NCT01347866|466494201|FG001|Overall Study|Lost to Follow-up|0|||
129600557|NCT01347866|466494202|FG002|Overall Study|Lost to Follow-up|0|||
129600558|NCT01347866|466494203|FG003|Overall Study|Lost to Follow-up|0|||
129600559|NCT01347866|466494204|FG004|Overall Study|Lost to Follow-up|0|||
129600560|NCT01347866|466494205|FG005|Overall Study|Lost to Follow-up|0|||
129600561|NCT01347866|466494206|FG006|Overall Study|Lost to Follow-up|0|||
129600562|NCT01347866|466494207|FG007|Overall Study|Lost to Follow-up|1|||
129600563|NCT01347866|466494208|FG008|Overall Study|Lost to Follow-up|1|||
129600564|NCT01347866|466494209|FG009|Overall Study|Lost to Follow-up|0|||
129788422|NCT00065429|467191719|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
129788423|NCT00065429|467191720|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
129788424|NCT00065429|467191721|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
129788425|NCT00065429|467191722|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
129788426|NCT00065429|467191723|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
129788427|NCT00065429|467191724|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
129788428|NCT00065429|467191718|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
129788429|NCT00065429|467191719|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
129788430|NCT00065429|467191720|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
129788431|NCT00065429|467191721|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
129788432|NCT00065429|467191722|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
129788433|NCT00065429|467191723|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
129788434|NCT00065429|467191724|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
129788435|NCT00065429|467191718|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
129788436|NCT00065429|467191719|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
129788437|NCT00065429|467191720|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
129788438|NCT00065429|467191721|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
129788439|NCT00065429|467191722|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
129788440|NCT00065429|467191723|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
129788441|NCT00065429|467191724|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
129788442|NCT00065429|467191718|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
129788443|NCT00065429|467191719|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
129788444|NCT00065429|467191720|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
129788445|NCT00065429|467191721|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
129788446|NCT00065429|467191722|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
129788447|NCT00065429|467191723|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
129788448|NCT00065429|467191724|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
129788449|NCT00065429|467191718|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129788450|NCT00065429|467191719|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129788451|NCT00065429|467191720|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129788452|NCT00065429|467191721|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129788453|NCT00065429|467191722|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
129788454|NCT00065429|467191723|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129788455|NCT00065429|467191724|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
129788456|NCT00781885|467191726|FG000|Overall Study|Physician Decision|1|||
129788457|NCT01755026|467191727|FG000|Overall Study|Adverse Event|1|||
129788458|NCT01755026|467191728|FG001|Overall Study|Adverse Event|0|||
129788459|NCT01755026|467191727|FG000|Overall Study|Withdrawal by Subject|1|||
129788460|NCT01755026|467191728|FG001|Overall Study|Withdrawal by Subject|1|||
129788461|NCT01806662|467191735|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
129788462|NCT01806662|467191736|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
129788463|NCT01806662|467191735|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
129788464|NCT01806662|467191736|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
129885913|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885914|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
129885915|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
129600565|NCT01347866|466494210|FG010|Overall Study|Lost to Follow-up|0|||
129600566|NCT01347866|466494211|FG011|Overall Study|Lost to Follow-up|0|||
129600567|NCT01347866|466494212|FG012|Overall Study|Lost to Follow-up|0|||
129600568|NCT01347866|466494213|FG013|Overall Study|Lost to Follow-up|0|||
129600569|NCT01347866|466494214|FG014|Overall Study|Lost to Follow-up|0|||
129600570|NCT01347866|466494215|FG015|Overall Study|Lost to Follow-up|0|||
129600571|NCT01347866|466494216|FG016|Overall Study|Lost to Follow-up|0|||
129600572|NCT01347866|466494200|FG000|Overall Study|Other|3|||
129600573|NCT01347866|466494201|FG001|Overall Study|Other|1|||
129600574|NCT01347866|466494202|FG002|Overall Study|Other|1|||
129600575|NCT01347866|466494203|FG003|Overall Study|Other|4|||
129600576|NCT01347866|466494204|FG004|Overall Study|Other|5|||
129600577|NCT01347866|466494205|FG005|Overall Study|Other|0|||
129600578|NCT01347866|466494206|FG006|Overall Study|Other|5|||
129600579|NCT01347866|466494207|FG007|Overall Study|Other|3|||
129600580|NCT01347866|466494208|FG008|Overall Study|Other|22|||
129600581|NCT01347866|466494209|FG009|Overall Study|Other|5|||
129600582|NCT01347866|466494210|FG010|Overall Study|Other|0|||
129788465|NCT01806662|467191735|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
129788466|NCT01806662|467191736|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
129600583|NCT01347866|466494211|FG011|Overall Study|Other|3|||
129600584|NCT01347866|466494212|FG012|Overall Study|Other|4|||
129600585|NCT01347866|466494213|FG013|Overall Study|Other|4|||
129600586|NCT01347866|466494214|FG014|Overall Study|Other|2|||
129600587|NCT01347866|466494215|FG015|Overall Study|Other|3|||
129600588|NCT01347866|466494216|FG016|Overall Study|Other|0|||
129600589|NCT01347866|466494200|FG000|Overall Study|Subject refused further follow-up|2|||
129600590|NCT01347866|466494201|FG001|Overall Study|Subject refused further follow-up|0|||
129600591|NCT01347866|466494202|FG002|Overall Study|Subject refused further follow-up|0|||
129600592|NCT01347866|466494203|FG003|Overall Study|Subject refused further follow-up|2|||
129600593|NCT01347866|466494204|FG004|Overall Study|Subject refused further follow-up|0|||
129600594|NCT01347866|466494205|FG005|Overall Study|Subject refused further follow-up|1|||
129600595|NCT01347866|466494206|FG006|Overall Study|Subject refused further follow-up|0|||
129600596|NCT01347866|466494207|FG007|Overall Study|Subject refused further follow-up|0|||
129600597|NCT01347866|466494208|FG008|Overall Study|Subject refused further follow-up|4|||
129600598|NCT01347866|466494209|FG009|Overall Study|Subject refused further follow-up|1|||
129600599|NCT01347866|466494210|FG010|Overall Study|Subject refused further follow-up|0|||
129600600|NCT01347866|466494211|FG011|Overall Study|Subject refused further follow-up|0|||
129600601|NCT01347866|466494212|FG012|Overall Study|Subject refused further follow-up|1|||
129600602|NCT01347866|466494213|FG013|Overall Study|Subject refused further follow-up|3|||
129600603|NCT01347866|466494214|FG014|Overall Study|Subject refused further follow-up|1|||
129600604|NCT01347866|466494215|FG015|Overall Study|Subject refused further follow-up|0|||
129788467|NCT01806662|467191735|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
129788468|NCT01806662|467191736|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
129788469|NCT01917656|467191744|FG000|Overall Study|Adverse Event|11|||
129788470|NCT01917656|467191745|FG001|Overall Study|Adverse Event|0|||
129788471|NCT01917656|467191744|FG000|Overall Study|Withdrawal criteria|8|||
129788472|NCT01917656|467191745|FG001|Overall Study|Withdrawal criteria|14|||
129788473|NCT01917656|467191744|FG000|Overall Study|Unclassified|0|||
129788474|NCT01917656|467191745|FG001|Overall Study|Unclassified|3|||
129788475|NCT01917656|467191744|FG000|Overall Study|Withdrawal by Subject|4|||
129788476|NCT01917656|467191745|FG001|Overall Study|Withdrawal by Subject|3|||
129788477|NCT01917656|467191744|FG000|Overall Study|Lost to Follow-up|3|||
129788478|NCT01917656|467191745|FG001|Overall Study|Lost to Follow-up|4|||
129788479|NCT02081859|467191746|FG000|Overall Study|No fertilization|2|||
129788480|NCT02081859|467191747|FG001|Overall Study|No fertilization|2|||
129788481|NCT02081859|467191746|FG000|Overall Study|No sperm|1|||
129788482|NCT02081859|467191747|FG001|Overall Study|No sperm|0|||
129788483|NCT02081859|467191746|FG000|Overall Study|Unanticipated freeze all cycle|2|||
129788484|NCT02081859|467191747|FG001|Overall Study|Unanticipated freeze all cycle|6|||
129788485|NCT02081859|467191746|FG000|Overall Study|< 4 embryos|27|||
129788486|NCT02081859|467191747|FG001|Overall Study|< 4 embryos|23|||
129788487|NCT02081859|467191746|FG000|Overall Study|Other reasons|2|||
129788488|NCT02081859|467191747|FG001|Overall Study|Other reasons|0|||
129788489|NCT02285062|467191748|FG000|Pre-Treatment Period|Protocol Violation|0|||
129788490|NCT02285062|467191749|FG001|Pre-Treatment Period|Protocol Violation|2|||
129788491|NCT02285062|467191748|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
129788492|NCT02285062|467191749|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129788493|NCT02015221|467191750|FG000|Overall Study|Withdrawal by Subject|8|||
129788494|NCT02015221|467191751|FG001|Overall Study|Withdrawal by Subject|6|||
129788495|NCT02015221|467191750|FG000|Overall Study|Lost to Follow-up|1|||
129788496|NCT02015221|467191751|FG001|Overall Study|Lost to Follow-up|0|||
129788497|NCT01870076|467191752|FG000|Overall Study|Withdrawal by Subject|1|||
129788498|NCT01870076|467191753|FG001|Overall Study|Withdrawal by Subject|0|||
129788499|NCT01870076|467191754|FG002|Overall Study|Withdrawal by Subject|1|||
129788500|NCT01870076|467191755|FG003|Overall Study|Withdrawal by Subject|0|||
129788501|NCT00492063|467191762|FG000|Overall Study|Death|0|||
129788502|NCT00492063|467191763|FG001|Overall Study|Death|0|||
129885916|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
129885917|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
129600605|NCT01347866|466494216|FG016|Overall Study|Subject refused further follow-up|2|||
129600606|NCT00430950|466494217|FG000|Overall Study|Adverse Event|7|||
129600607|NCT00430950|466494218|FG001|Overall Study|Adverse Event|6|||
129600608|NCT00430950|466494217|FG000|Overall Study|Withdrawal by Subject|1|||
129600609|NCT00430950|466494218|FG001|Overall Study|Withdrawal by Subject|0|||
129600610|NCT00430950|466494217|FG000|Overall Study|concomitant medication,etc.|5|||
129600611|NCT00430950|466494218|FG001|Overall Study|concomitant medication,etc.|7|||
129600612|NCT02429934|466494219|FG000|Overall Study|Withdrawal by Subject|0|||
129788503|NCT00492063|467191764|FG002|Overall Study|Death|1|||
129788504|NCT00492063|467191765|FG003|Overall Study|Death|2|||
129788505|NCT00492063|467191762|FG000|Overall Study|Withdrawal by Subject|4|||
129788506|NCT00492063|467191763|FG001|Overall Study|Withdrawal by Subject|3|||
129788507|NCT00492063|467191764|FG002|Overall Study|Withdrawal by Subject|5|||
129788508|NCT00492063|467191765|FG003|Overall Study|Withdrawal by Subject|4|||
129788509|NCT00492063|467191762|FG000|Overall Study|Lost to Follow-up|6|||
129788510|NCT00492063|467191763|FG001|Overall Study|Lost to Follow-up|11|||
129788511|NCT00492063|467191764|FG002|Overall Study|Lost to Follow-up|5|||
129788512|NCT00492063|467191765|FG003|Overall Study|Lost to Follow-up|3|||
129788513|NCT00492063|467191762|FG000|Overall Study|Protocol Violation|0|||
129788514|NCT00492063|467191763|FG001|Overall Study|Protocol Violation|0|||
129788515|NCT00492063|467191764|FG002|Overall Study|Protocol Violation|0|||
129788516|NCT00492063|467191765|FG003|Overall Study|Protocol Violation|1|||
129788517|NCT03041129|467191768|FG000|Overall Study|Withdrawal by Subject|2|||
129788518|NCT03041129|467191769|FG001|Overall Study|Withdrawal by Subject|0|||
129788519|NCT03041129|467191770|FG002|Overall Study|Withdrawal by Subject|0|||
129788520|NCT03041129|467191771|FG003|Overall Study|Withdrawal by Subject|0|||
129788521|NCT00510653|467191772|FG000|Overall Study|Withdrawal by Subject|8|||
129788522|NCT00510653|467191772|FG000|Overall Study|Monetary|3|||
129788523|NCT01947855|467191773|FG000|Overall Study|Withdrawal by Subject|1|||
129788524|NCT01947855|467191774|FG001|Overall Study|Withdrawal by Subject|0|||
129788525|NCT01947855|467191775|FG002|Overall Study|Withdrawal by Subject|0|||
129788526|NCT00821509|467191776|FG000|Overall Study|Withdrawal by Subject|12|||
129788527|NCT00821509|467191777|FG001|Overall Study|Withdrawal by Subject|11|||
129788528|NCT00821509|467191778|FG002|Overall Study|Withdrawal by Subject|34|||
129788529|NCT01246466|467193378|FG000|Overall Study|Death|1|||
129788530|NCT01246466|467193378|FG000|Overall Study|Withdrawal by Subject|1|||
129788531|NCT00877773|467193379|FG000|Overall Study|Disease Progression|44|||
129788532|NCT01012219|467193382|FG000|Period 1|Withdrawal by Subject|1|||
129788533|NCT01012219|467193382|FG000|Period 2|Withdrawal by Subject|1|||
129788534|NCT00003590|467193385|FG000|Overall Study|Ineligible Patient|1|||
129788535|NCT00003590|467193385|FG000|Overall Study|Adverse Event|7|||
129788536|NCT00003590|467193385|FG000|Overall Study|Withdrawal by Subject|1|||
129788537|NCT00003590|467193385|FG000|Overall Study|Lack of Efficacy|11|||
129788538|NCT00003590|467193385|FG000|Overall Study|Death|1|||
129788539|NCT00003590|467193385|FG000|Overall Study|Physician Decision|1|||
129788540|NCT00883688|467193386|FG000|Overall Study|Ineligible|2|||
129788541|NCT01350544|467193390|FG000|Overall Study|Administrative Withdrawal|0|||
129788542|NCT01350544|467193391|FG001|Overall Study|Administrative Withdrawal|1|||
129788543|NCT01350544|467193390|FG000|Overall Study|Death|1|||
129788544|NCT01350544|467193391|FG001|Overall Study|Death|2|||
129788545|NCT01350544|467193390|FG000|Overall Study|Moved out of LA County|2|||
129788546|NCT01350544|467193391|FG001|Overall Study|Moved out of LA County|2|||
129788547|NCT01350544|467193390|FG000|Overall Study|Medical Issues|1|||
129788548|NCT01350544|467193391|FG001|Overall Study|Medical Issues|1|||
129788549|NCT01350544|467193390|FG000|Overall Study|Withdrawal by Subject|0|||
129788550|NCT01350544|467193391|FG001|Overall Study|Withdrawal by Subject|1|||
129788551|NCT01350544|467193390|FG000|Overall Study|Incarceration|1|||
129788552|NCT01350544|467193391|FG001|Overall Study|Incarceration|0|||
129788553|NCT01350544|467193390|FG000|Overall Study|Lost to Follow-up|18|||
129788554|NCT01350544|467193391|FG001|Overall Study|Lost to Follow-up|15|||
129788555|NCT01444092|467193392|FG000|Overall Study|Adverse Event|8|||
129788556|NCT01444092|467193392|FG000|Overall Study|Protocol Violation|1|||
129788557|NCT01444092|467193392|FG000|Overall Study|Withdrawal by Subject|1|||
129788558|NCT01444092|467193392|FG000|Overall Study|Other Eligibility criteria|7|||
129788559|NCT03085914|467193397|FG000|Overall Study|Death|6|||
129788560|NCT03085914|467193398|FG001|Overall Study|Death|6|||
129788561|NCT03085914|467193399|FG002|Overall Study|Death|4|||
129788562|NCT03085914|467193400|FG003|Overall Study|Death|1|||
129788563|NCT03085914|467193401|FG004|Overall Study|Death|5|||
129788564|NCT03085914|467193402|FG005|Overall Study|Death|2|||
129788565|NCT03085914|467193403|FG006|Overall Study|Death|2|||
129788566|NCT03085914|467193397|FG000|Overall Study|Withdrawal by Subject|1|||
129600613|NCT02429934|466494220|FG001|Overall Study|Withdrawal by Subject|2|||
129600614|NCT02429934|466494219|FG000|Overall Study|Adverse Event|2|||
129600615|NCT02429934|466494220|FG001|Overall Study|Adverse Event|0|||
129600616|NCT02429934|466494219|FG000|Overall Study|Lost to Follow-up|1|||
129600617|NCT02429934|466494220|FG001|Overall Study|Lost to Follow-up|1|||
129600618|NCT02429934|466494219|FG000|Overall Study|Physician Decision|1|||
129600619|NCT02429934|466494220|FG001|Overall Study|Physician Decision|0|||
129600620|NCT01564459|466494221|FG000|Run-In|Adverse Event|7|||
129600621|NCT01564459|466494222|FG001|Run-In|Adverse Event|0|||
129600622|NCT01564459|466494223|FG002|Run-In|Adverse Event|0|||
129788567|NCT03085914|467193398|FG001|Overall Study|Withdrawal by Subject|1|||
129788568|NCT03085914|467193399|FG002|Overall Study|Withdrawal by Subject|2|||
129788569|NCT03085914|467193400|FG003|Overall Study|Withdrawal by Subject|2|||
129788570|NCT03085914|467193401|FG004|Overall Study|Withdrawal by Subject|2|||
129788571|NCT03085914|467193402|FG005|Overall Study|Withdrawal by Subject|0|||
129788572|NCT03085914|467193403|FG006|Overall Study|Withdrawal by Subject|1|||
129788573|NCT03085914|467193397|FG000|Overall Study|Lost to Follow-up|0|||
129788574|NCT03085914|467193398|FG001|Overall Study|Lost to Follow-up|0|||
129788575|NCT03085914|467193399|FG002|Overall Study|Lost to Follow-up|1|||
129788576|NCT03085914|467193400|FG003|Overall Study|Lost to Follow-up|0|||
129788577|NCT03085914|467193401|FG004|Overall Study|Lost to Follow-up|0|||
129788578|NCT03085914|467193402|FG005|Overall Study|Lost to Follow-up|1|||
129788579|NCT03085914|467193403|FG006|Overall Study|Lost to Follow-up|1|||
129788580|NCT03085914|467193397|FG000|Overall Study|Reason was not specified,|2|||
129788581|NCT03085914|467193398|FG001|Overall Study|Reason was not specified,|2|||
129788582|NCT03085914|467193399|FG002|Overall Study|Reason was not specified,|2|||
129788583|NCT03085914|467193400|FG003|Overall Study|Reason was not specified,|3|||
129788584|NCT03085914|467193401|FG004|Overall Study|Reason was not specified,|3|||
129788585|NCT03085914|467193402|FG005|Overall Study|Reason was not specified,|3|||
129788586|NCT03085914|467193403|FG006|Overall Study|Reason was not specified,|6|||
129788587|NCT03085914|467193397|FG000|Overall Study|Progressive Disease|0|||
129788588|NCT03085914|467193398|FG001|Overall Study|Progressive Disease|0|||
129788589|NCT03085914|467193399|FG002|Overall Study|Progressive Disease|2|||
129788590|NCT03085914|467193400|FG003|Overall Study|Progressive Disease|2|||
129788591|NCT03085914|467193401|FG004|Overall Study|Progressive Disease|1|||
129788592|NCT03085914|467193402|FG005|Overall Study|Progressive Disease|1|||
129788593|NCT03085914|467193403|FG006|Overall Study|Progressive Disease|1|||
129788594|NCT03085914|467193397|FG000|Overall Study|Study Terminated by the Sponsor|0|||
129788595|NCT03085914|467193398|FG001|Overall Study|Study Terminated by the Sponsor|0|||
129788596|NCT03085914|467193399|FG002|Overall Study|Study Terminated by the Sponsor|0|||
129788597|NCT03085914|467193400|FG003|Overall Study|Study Terminated by the Sponsor|1|||
129788598|NCT03085914|467193401|FG004|Overall Study|Study Terminated by the Sponsor|2|||
129788599|NCT03085914|467193402|FG005|Overall Study|Study Terminated by the Sponsor|1|||
129788600|NCT03085914|467193403|FG006|Overall Study|Study Terminated by the Sponsor|0|||
129788601|NCT01242813|467193404|FG000|Overall Study|Lost to Follow-up|2|||
129788602|NCT01252667|467193406|FG000|Overall Study|Transplant aborted post-conditioning|0|||
129788603|NCT01252667|467193407|FG001|Overall Study|Transplant aborted post-conditioning|0|||
129788604|NCT01252667|467193408|FG002|Overall Study|Transplant aborted post-conditioning|0|||
129788605|NCT01252667|467193409|FG003|Overall Study|Transplant aborted post-conditioning|0|||
129788606|NCT01252667|467193410|FG004|Overall Study|Transplant aborted post-conditioning|0|||
129788607|NCT01252667|467193411|FG005|Overall Study|Transplant aborted post-conditioning|1|||
129788608|NCT04644315|467193412|FG000|Overall Study|Subject withdrawal of consent|1|||
129788609|NCT01836276|467193413|FG000|Overall Study|Lost to Follow-up|28|||
129788610|NCT01836276|467193414|FG001|Overall Study|Lost to Follow-up|51|||
129788611|NCT00331552|467193417|FG000|Period 3: Phase II|Neurological Symptoms|1|||
129788612|NCT00331552|467193418|FG001|Period 3: Phase II|Neurological Symptoms|0|||
129788613|NCT00331552|467193417|FG000|Period 3: Phase II|Severe Nausea|1|||
129788614|NCT00331552|467193418|FG001|Period 3: Phase II|Severe Nausea|0|||
129788615|NCT01445548|467193419|FG000|Overall Study|Adverse Event|1|||
129788616|NCT02122783|467193426|FG000|Overall Study|Adverse Event|0|||
129788617|NCT02122783|467193427|FG001|Overall Study|Adverse Event|1|||
129788618|NCT01579812|467193429|FG000|Overall Study|Ineligible after treatment start|40|||
129788619|NCT01579812|467193429|FG000|Overall Study|Patient choice|3|||
129788620|NCT01579812|467193429|FG000|Overall Study|Noncompliance|3|||
129788621|NCT01579812|467193429|FG000|Overall Study|Withdrawal by Subject|6|||
129788622|NCT01038869|467193434|FG000|Overall Study|Withdrawal by Subject|1|||
129788623|NCT01038869|467193434|FG000|Overall Study|Lost to Follow-up|6|||
129788624|NCT02353143|467193435|FG000|Overall Study|Withdrawal by Subject|1|||
129788625|NCT02353143|467193436|FG001|Overall Study|Withdrawal by Subject|0|||
129788626|NCT02353143|467193437|FG002|Overall Study|Withdrawal by Subject|0|||
129788627|NCT02353143|467193438|FG003|Overall Study|Withdrawal by Subject|0|||
129788628|NCT02353143|467193439|FG004|Overall Study|Withdrawal by Subject|1|||
129788629|NCT02353143|467193440|FG005|Overall Study|Withdrawal by Subject|0|||
129788630|NCT02353143|467193441|FG006|Overall Study|Withdrawal by Subject|0|||
129788631|NCT02353143|467193442|FG007|Overall Study|Withdrawal by Subject|1|||
129788632|NCT02353143|467193443|FG008|Overall Study|Withdrawal by Subject|1|||
129788633|NCT02353143|467193435|FG000|Overall Study|Lack of Efficacy|2|||
129788634|NCT02353143|467193436|FG001|Overall Study|Lack of Efficacy|1|||
129788635|NCT02353143|467193437|FG002|Overall Study|Lack of Efficacy|2|||
129788636|NCT02353143|467193438|FG003|Overall Study|Lack of Efficacy|4|||
129788637|NCT02353143|467193439|FG004|Overall Study|Lack of Efficacy|13|||
129788638|NCT02353143|467193440|FG005|Overall Study|Lack of Efficacy|2|||
129788639|NCT02353143|467193441|FG006|Overall Study|Lack of Efficacy|2|||
129788640|NCT02353143|467193442|FG007|Overall Study|Lack of Efficacy|2|||
129885918|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
129885919|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
129885920|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
129885921|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
129788641|NCT02353143|467193443|FG008|Overall Study|Lack of Efficacy|1|||
129788642|NCT02353143|467193435|FG000|Overall Study|reason not specified|1|||
129788643|NCT02353143|467193436|FG001|Overall Study|reason not specified|2|||
129788644|NCT02353143|467193437|FG002|Overall Study|reason not specified|0|||
129788645|NCT02353143|467193438|FG003|Overall Study|reason not specified|0|||
129788646|NCT02353143|467193439|FG004|Overall Study|reason not specified|6|||
129788647|NCT02353143|467193440|FG005|Overall Study|reason not specified|1|||
129788648|NCT02353143|467193441|FG006|Overall Study|reason not specified|0|||
129788649|NCT02353143|467193442|FG007|Overall Study|reason not specified|3|||
129788650|NCT02353143|467193443|FG008|Overall Study|reason not specified|1|||
129788651|NCT02353143|467193435|FG000|Overall Study|Physician Decision|0|||
129788652|NCT02353143|467193436|FG001|Overall Study|Physician Decision|4|||
129788653|NCT02353143|467193437|FG002|Overall Study|Physician Decision|2|||
129788654|NCT02353143|467193438|FG003|Overall Study|Physician Decision|3|||
129788655|NCT02353143|467193439|FG004|Overall Study|Physician Decision|4|||
129788656|NCT02353143|467193440|FG005|Overall Study|Physician Decision|0|||
129788657|NCT02353143|467193441|FG006|Overall Study|Physician Decision|1|||
129788658|NCT02353143|467193442|FG007|Overall Study|Physician Decision|2|||
129788659|NCT02353143|467193443|FG008|Overall Study|Physician Decision|0|||
129788660|NCT02353143|467193435|FG000|Overall Study|Adverse Event|0|||
129788661|NCT02353143|467193436|FG001|Overall Study|Adverse Event|0|||
129788662|NCT02353143|467193437|FG002|Overall Study|Adverse Event|1|||
129788663|NCT02353143|467193438|FG003|Overall Study|Adverse Event|0|||
129788664|NCT02353143|467193439|FG004|Overall Study|Adverse Event|1|||
129788665|NCT02353143|467193440|FG005|Overall Study|Adverse Event|1|||
129788666|NCT02353143|467193441|FG006|Overall Study|Adverse Event|0|||
129788667|NCT02353143|467193442|FG007|Overall Study|Adverse Event|0|||
129788668|NCT02353143|467193443|FG008|Overall Study|Adverse Event|0|||
129788669|NCT02353143|467193435|FG000|Overall Study|patient receiving other treatment for AML|0|||
129788670|NCT02353143|467193436|FG001|Overall Study|patient receiving other treatment for AML|0|||
129788671|NCT02353143|467193437|FG002|Overall Study|patient receiving other treatment for AML|1|||
129788672|NCT02353143|467193438|FG003|Overall Study|patient receiving other treatment for AML|0|||
129788673|NCT02353143|467193439|FG004|Overall Study|patient receiving other treatment for AML|0|||
129788674|NCT02353143|467193440|FG005|Overall Study|patient receiving other treatment for AML|0|||
129600623|NCT01564459|466494221|FG000|Run-In|Lost to Follow-up|1|||
129600624|NCT01564459|466494222|FG001|Run-In|Lost to Follow-up|0|||
129600625|NCT01564459|466494223|FG002|Run-In|Lost to Follow-up|0|||
129788675|NCT02353143|467193441|FG006|Overall Study|patient receiving other treatment for AML|0|||
129788676|NCT02353143|467193442|FG007|Overall Study|patient receiving other treatment for AML|0|||
129788677|NCT02353143|467193443|FG008|Overall Study|patient receiving other treatment for AML|0|||
129788678|NCT02353143|467193435|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
129788679|NCT02353143|467193436|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
129788680|NCT02353143|467193437|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
129600626|NCT01564459|466494221|FG000|Run-In|Non-compliance with study drug|2|||
129600627|NCT01564459|466494222|FG001|Run-In|Non-compliance with study drug|0|||
129600628|NCT01564459|466494223|FG002|Run-In|Non-compliance with study drug|0|||
129788681|NCT02353143|467193438|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
129788682|NCT02353143|467193439|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
129788683|NCT02353143|467193440|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
129788684|NCT02353143|467193441|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
129788685|NCT02353143|467193442|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
129788686|NCT02353143|467193443|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
129788687|NCT02946931|467193452|FG000|Overall Study|Did not require collection of CRFs|588|||
129788688|NCT02946931|467193452|FG000|Overall Study|Other than listed|37|||
129788689|NCT02946931|467193452|FG000|Overall Study|Discharge from hospital|118|||
129788690|NCT02946931|467193452|FG000|Overall Study|Adverse Event|81|||
129788691|NCT02946931|467193452|FG000|Overall Study|CRFs not valid|1|||
129788692|NCT02946931|467193452|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
129788693|NCT03339297|467193453|FG000|Overall Study|Relapse of Hematologic Disease|1|||
129788694|NCT03339297|467193454|FG001|Overall Study|Relapse of Hematologic Disease|0|||
129788695|NCT03339297|467193453|FG000|Overall Study|Death|10|||
129788696|NCT03339297|467193454|FG001|Overall Study|Death|7|||
129788697|NCT03339297|467193453|FG000|Overall Study|Hepatic Candidosis|1|||
129788698|NCT03339297|467193454|FG001|Overall Study|Hepatic Candidosis|0|||
129788699|NCT03339297|467193453|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
129788700|NCT03339297|467193454|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
129788701|NCT03339297|467193453|FG000|Overall Study|Consent Withdrawn by Participant|3|||
129600629|NCT01564459|466494221|FG000|Run-In|Protocol Violation|1|||
129600630|NCT01564459|466494222|FG001|Run-In|Protocol Violation|0|||
129788702|NCT03339297|467193454|FG001|Overall Study|Consent Withdrawn by Participant|3|||
129600631|NCT01564459|466494223|FG002|Run-In|Protocol Violation|0|||
129600632|NCT01564459|466494221|FG000|Run-In|Withdrawal by Subject|1|||
129788703|NCT03339297|467193453|FG000|Overall Study|Disease Relapse|2|||
129788704|NCT03339297|467193454|FG001|Overall Study|Disease Relapse|0|||
129788705|NCT03339297|467193453|FG000|Overall Study|Physician Decision|1|||
129788706|NCT03339297|467193454|FG001|Overall Study|Physician Decision|1|||
129788707|NCT03339297|467193453|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
129788708|NCT03339297|467193454|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
129788709|NCT03339297|467193453|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
129788710|NCT03339297|467193454|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
129600633|NCT01564459|466494222|FG001|Run-In|Withdrawal by Subject|0|||
129600634|NCT01564459|466494223|FG002|Run-In|Withdrawal by Subject|0|||
129600635|NCT01564459|466494221|FG000|Double-blind Treatment|Adverse Event|0|||
129788711|NCT03339297|467193453|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
129788712|NCT03339297|467193454|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
129788713|NCT03339297|467193453|FG000|Overall Study|Adverse Event, Non-fatal|1|||
129788714|NCT03339297|467193454|FG001|Overall Study|Adverse Event, Non-fatal|0|||
129788715|NCT03339297|467193453|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
129600636|NCT01564459|466494222|FG001|Double-blind Treatment|Adverse Event|0|||
129600637|NCT01564459|466494223|FG002|Double-blind Treatment|Adverse Event|1|||
129788716|NCT03339297|467193454|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
129788717|NCT03339297|467193453|FG000|Overall Study|Patient Was Not Eligible|1|||
129788718|NCT03339297|467193454|FG001|Overall Study|Patient Was Not Eligible|0|||
129788719|NCT02213133|467193455|FG000|Overall Study|Participant discontinued study therapy|2|||
129788720|NCT02213133|467193456|FG001|Overall Study|Participant discontinued study therapy|0|||
129788721|NCT02213133|467193457|FG002|Overall Study|Participant discontinued study therapy|0|||
129788722|NCT02213133|467193455|FG000|Overall Study|Participant withdrew informed consent|2|||
129788723|NCT02213133|467193456|FG001|Overall Study|Participant withdrew informed consent|1|||
129788724|NCT02213133|467193457|FG002|Overall Study|Participant withdrew informed consent|2|||
129788725|NCT02213133|467193455|FG000|Overall Study|Disease progression|11|||
129788726|NCT02213133|467193456|FG001|Overall Study|Disease progression|2|||
129788727|NCT02213133|467193457|FG002|Overall Study|Disease progression|0|||
129788728|NCT02213133|467193455|FG000|Overall Study|Adverse Event (AE)|1|||
129788729|NCT02213133|467193456|FG001|Overall Study|Adverse Event (AE)|0|||
129788730|NCT02213133|467193457|FG002|Overall Study|Adverse Event (AE)|0|||
129788731|NCT02213133|467193455|FG000|Overall Study|Death|16|||
129788732|NCT02213133|467193456|FG001|Overall Study|Death|2|||
129788733|NCT02213133|467193457|FG002|Overall Study|Death|1|||
129788734|NCT02213133|467193455|FG000|Overall Study|Other|5|||
129788735|NCT02213133|467193456|FG001|Overall Study|Other|0|||
129788736|NCT02213133|467193457|FG002|Overall Study|Other|0|||
129788737|NCT04740905|467193466|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
129788738|NCT04740905|467193467|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
129788739|NCT04740905|467193466|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
129788740|NCT04740905|467193467|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
129788741|NCT04740905|467193466|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
129788742|NCT04740905|467193467|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
129788743|NCT04740905|467193466|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
129788744|NCT04740905|467193467|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
129788745|NCT04740905|467193466|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
129788746|NCT04740905|467193467|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
129788747|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
129788748|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
129788749|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
129788750|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
129788751|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
129788752|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
129788753|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
129788754|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
129788755|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
129788756|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
129788757|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
129788758|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
129788759|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
129788760|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
129788761|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
129788762|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
129885922|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
129885923|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
129600638|NCT01138111|466494229|FG000|Overall Study|Withdrawal by Subject|5|||
129600639|NCT01138111|466494229|FG000|Overall Study|Adverse Event|1|||
129600640|NCT01138111|466494229|FG000|Overall Study|Death|1|||
129600641|NCT01138111|466494229|FG000|Overall Study|Lost to Follow-up|2|||
129600642|NCT01491035|466494230|FG000|Overall Study|Lost to Follow-up|0|||
129788763|NCT04740905|467193466|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
129788764|NCT04740905|467193467|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
129788765|NCT03051620|467193468|FG000|Overall Study|Lost to Follow-up|6|||
129788766|NCT03051620|467193468|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
129788767|NCT00393510|467193470|FG000|Overall Study|Physician Decision|3|||
129788768|NCT00393510|467193471|FG001|Overall Study|Physician Decision|9|||
129788769|NCT02412488|467193474|FG000|Overall Study|Lost to Follow-up|10|||
129788770|NCT02412488|467193474|FG000|Overall Study|Withdrawal by Subject|5|||
129788771|NCT02412488|467193474|FG000|Overall Study|Physician Decision|1|||
129885924|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
129600643|NCT01491035|466494231|FG001|Overall Study|Lost to Follow-up|0|||
129600644|NCT01491035|466494232|FG002|Overall Study|Lost to Follow-up|0|||
129788772|NCT02412488|467193474|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
129788773|NCT02412488|467193474|FG000|Overall Study|Reveal LINQ explant|1|||
129788774|NCT00313781|467193475|FG000|Before Crossover|Death|22|||
129788775|NCT00313781|467193476|FG001|Before Crossover|Death|8|||
129788776|NCT00313781|467193477|FG002|Before Crossover|Death|0|||
129788777|NCT00313781|467193475|FG000|Before Crossover|Lost to Follow-up|0|||
129788778|NCT00313781|467193476|FG001|Before Crossover|Lost to Follow-up|3|||
129788779|NCT00313781|467193477|FG002|Before Crossover|Lost to Follow-up|0|||
129788780|NCT00313781|467193475|FG000|Before Crossover|Withdrawal by Subject|3|||
129788781|NCT00313781|467193476|FG001|Before Crossover|Withdrawal by Subject|1|||
129788782|NCT00313781|467193477|FG002|Before Crossover|Withdrawal by Subject|0|||
129788783|NCT00313781|467193475|FG000|Before Crossover|Other|45|||
129788784|NCT00313781|467193476|FG001|Before Crossover|Other|30|||
129788785|NCT00313781|467193477|FG002|Before Crossover|Other|0|||
129788786|NCT00313781|467193475|FG000|Before Crossover|Crossover|0|||
129788787|NCT00313781|467193476|FG001|Before Crossover|Crossover|37|||
129788788|NCT00313781|467193477|FG002|Before Crossover|Crossover|0|||
129788789|NCT00313781|467193475|FG000|Before Crossover|Randomized, not treated|5|||
129788790|NCT00313781|467193476|FG001|Before Crossover|Randomized, not treated|0|||
129788791|NCT00313781|467193477|FG002|Before Crossover|Randomized, not treated|0|||
129788792|NCT00313781|467193475|FG000|After Crossover|Death|0|||
129788793|NCT00313781|467193476|FG001|After Crossover|Death|0|||
129788794|NCT00313781|467193477|FG002|After Crossover|Death|6|||
129788795|NCT00313781|467193475|FG000|After Crossover|Withdrawal by Subject|0|||
129788796|NCT00313781|467193476|FG001|After Crossover|Withdrawal by Subject|0|||
129788797|NCT00313781|467193477|FG002|After Crossover|Withdrawal by Subject|3|||
129788798|NCT00313781|467193475|FG000|After Crossover|Other|0|||
129788799|NCT00313781|467193476|FG001|After Crossover|Other|0|||
129788800|NCT00313781|467193477|FG002|After Crossover|Other|18|||
129788801|NCT03567343|467193478|FG000|Overall Study|Lost to Follow-up|2|||
129788802|NCT03567343|467193479|FG001|Overall Study|Lost to Follow-up|1|||
129788803|NCT03567343|467193478|FG000|Overall Study|No longer eligible|2|||
129788804|NCT03567343|467193479|FG001|Overall Study|No longer eligible|1|||
129788805|NCT03567343|467193478|FG000|Overall Study|Adverse Event|1|||
129788806|NCT03567343|467193479|FG001|Overall Study|Adverse Event|0|||
129788807|NCT03567343|467193478|FG000|Overall Study|Protocol Violation|1|||
129788808|NCT03567343|467193479|FG001|Overall Study|Protocol Violation|1|||
129788809|NCT00834080|467193480|FG000|Overall Study|Adverse Event|7|||
129600645|NCT01491035|466494233|FG003|Overall Study|Lost to Follow-up|0|||
129600646|NCT01491035|466494234|FG004|Overall Study|Lost to Follow-up|1|||
129600647|NCT01491035|466494235|FG005|Overall Study|Lost to Follow-up|0|||
129885925|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
129885926|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
129885927|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
129885928|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
129885929|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
129600648|NCT01491035|466494236|FG006|Overall Study|Lost to Follow-up|0|||
129600649|NCT01491035|466494237|FG007|Overall Study|Lost to Follow-up|0|||
129600650|NCT03351231|466494259|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
129600651|NCT03351231|466494259|FG000|Combination Therapy Period|Disease progression|2|||
129600652|NCT03351231|466494259|FG000|Combination Therapy Period|Study drug toxicity|1|||
129788810|NCT00834080|467193480|FG000|Overall Study|Lost to Follow-up|7|||
129788811|NCT00834080|467193480|FG000|Overall Study|Withdrawal by Subject|5|||
129788812|NCT00834080|467193480|FG000|Overall Study|Other - Pregnancy|1|||
129788813|NCT00834080|467193480|FG000|Overall Study|Other - False positive tests of the UDS|1|||
129885930|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
129885931|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Physician Decision|0|||
129600653|NCT03351231|466494259|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
129788814|NCT00834080|467193480|FG000|Overall Study|Physician Decision|1|||
129788815|NCT00834080|467193480|FG000|Overall Study|Subject Relocated|1|||
129788816|NCT00392379|467193483|FG000|Overall Study|Withdrawal by Subject|17|||
129788817|NCT00392379|467193484|FG001|Overall Study|Withdrawal by Subject|28|||
129788818|NCT00392379|467193483|FG000|Overall Study|Lost to Follow-up|4|||
129788819|NCT00392379|467193484|FG001|Overall Study|Lost to Follow-up|9|||
129788820|NCT00392379|467193483|FG000|Overall Study|Adverse Event|1|||
129788821|NCT00392379|467193484|FG001|Overall Study|Adverse Event|1|||
129885932|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Physician Decision|2|||
129600654|NCT03351231|466494259|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
129788822|NCT02365233|467193485|FG000|Overall Study|IRB withheld the data|1|||
129788823|NCT02365233|467193486|FG001|Overall Study|IRB withheld the data|2|||
129788824|NCT02365233|467193487|FG002|Overall Study|IRB withheld the data|2|||
129788825|NCT00827931|467193491|FG000|Overall Study|Death|3|||
129885933|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Physician Decision|0|||
129600655|NCT03351231|466494259|FG000|Safety Follow-Up Period|Other reason|2|||
129600656|NCT02340221|466494260|FG000|Overall Study|Death|100|||
129600657|NCT02340221|466494261|FG001|Overall Study|Death|197|||
129600658|NCT02340221|466494260|FG000|Overall Study|Withdrawal by Participant|24|||
129600659|NCT02340221|466494261|FG001|Overall Study|Withdrawal by Participant|37|||
129600660|NCT02340221|466494260|FG000|Overall Study|Lost to Follow-up|4|||
129600661|NCT02340221|466494261|FG001|Overall Study|Lost to Follow-up|15|||
129600662|NCT02340221|466494260|FG000|Overall Study|Reason Not Specified|85|||
129600663|NCT02340221|466494261|FG001|Overall Study|Reason Not Specified|165|||
129600664|NCT02340221|466494260|FG000|Overall Study|Study Terminated by Sponsor|1|||
129600665|NCT02340221|466494261|FG001|Overall Study|Study Terminated by Sponsor|3|||
129600666|NCT00588640|466494262|FG000|Overall Study|Physician Decision|1|||
129600667|NCT00588640|466494262|FG000|Overall Study|Ineligible Patient|1|||
129600668|NCT00003138|466496119|FG000|Step 1|Reasons off treatment not documented|60|||
129600669|NCT00003138|466496120|FG001|Step 1|Reasons off treatment not documented|57|||
129600670|NCT00003138|466496119|FG000|Step 1|Never started treatment|1|||
129600671|NCT00003138|466496120|FG001|Step 1|Never started treatment|0|||
129600672|NCT00003138|466496119|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
129697689|NCT01943825|466851918|FG000|Overall Study|Lost to Follow-up|9|||
129697690|NCT01943825|466851919|FG001|Overall Study|Lost to Follow-up|3|||
129697691|NCT01943825|466851920|FG002|Overall Study|Lost to Follow-up|12|||
129697692|NCT01943825|466851921|FG003|Overall Study|Lost to Follow-up|8|||
129697693|NCT01943825|466851918|FG000|Overall Study|Withdrawal by Subject|1|||
129697694|NCT01943825|466851919|FG001|Overall Study|Withdrawal by Subject|0|||
129697695|NCT01943825|466851920|FG002|Overall Study|Withdrawal by Subject|3|||
129697696|NCT01943825|466851921|FG003|Overall Study|Withdrawal by Subject|2|||
129697697|NCT01943825|466851918|FG000|Overall Study|Other than specified above|0|||
129697698|NCT01943825|466851919|FG001|Overall Study|Other than specified above|1|||
129697699|NCT01943825|466851920|FG002|Overall Study|Other than specified above|0|||
129697700|NCT01943825|466851921|FG003|Overall Study|Other than specified above|1|||
129697701|NCT01835431|466851922|FG000|Overall Study|Adverse Event|1|||
129697702|NCT01835431|466851923|FG001|Overall Study|Adverse Event|0|||
129697703|NCT01835431|466851922|FG000|Overall Study|other|0|||
129697704|NCT01835431|466851923|FG001|Overall Study|other|2|||
129697705|NCT01835431|466851922|FG000|Overall Study|Withdrawal by Subject|6|||
129697706|NCT01835431|466851923|FG001|Overall Study|Withdrawal by Subject|10|||
129697707|NCT01835431|466851922|FG000|Overall Study|Protocol Violation|1|||
129697708|NCT01835431|466851923|FG001|Overall Study|Protocol Violation|0|||
129697709|NCT00562861|466851926|FG000|Overall Study|Adverse Event|1|||
129697710|NCT00562861|466851927|FG001|Overall Study|Adverse Event|1|||
129697711|NCT00562861|466851926|FG000|Overall Study|Lack of Efficacy|5|||
129697712|NCT00562861|466851927|FG001|Overall Study|Lack of Efficacy|5|||
129697713|NCT00562861|466851926|FG000|Overall Study|noncompliance, moved|7|||
129697714|NCT00562861|466851927|FG001|Overall Study|noncompliance, moved|2|||
129697715|NCT00562861|466851926|FG000|Overall Study|Lost to Follow-up|7|||
129697716|NCT00562861|466851927|FG001|Overall Study|Lost to Follow-up|3|||
129697717|NCT00655356|466851928|FG000|Overall Study|Withdrawal by Subject|3|||
129697718|NCT00655356|466851929|FG001|Overall Study|Withdrawal by Subject|4|||
129697719|NCT00655356|466851928|FG000|Overall Study|Sponsor Request|10|||
129697720|NCT00655356|466851929|FG001|Overall Study|Sponsor Request|4|||
129697721|NCT00655356|466851928|FG000|Overall Study|Adverse Event|1|||
129697722|NCT00655356|466851929|FG001|Overall Study|Adverse Event|1|||
129697723|NCT00655356|466851928|FG000|Overall Study|Protocol Violation|2|||
129697724|NCT00655356|466851929|FG001|Overall Study|Protocol Violation|1|||
129697725|NCT00655356|466851928|FG000|Overall Study|Other Reason|1|||
129697726|NCT00655356|466851929|FG001|Overall Study|Other Reason|0|||
129697727|NCT04349098|466851930|FG000|Overall Study|Death|16|||
129697728|NCT04349098|466851931|FG001|Overall Study|Death|8|||
129697729|NCT04349098|466851930|FG000|Overall Study|Lost to Follow-up|11|||
129697730|NCT04349098|466851931|FG001|Overall Study|Lost to Follow-up|8|||
129697731|NCT04349098|466851930|FG000|Overall Study|Withdrawal by Subject|8|||
129697732|NCT04349098|466851931|FG001|Overall Study|Withdrawal by Subject|5|||
129697733|NCT04349098|466851930|FG000|Overall Study|Other|3|||
129697734|NCT04349098|466851931|FG001|Overall Study|Other|5|||
129697735|NCT01703221|466851932|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
129697736|NCT01703221|466851933|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
129600673|NCT00003138|466496120|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
129600674|NCT00003138|466496119|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
129600675|NCT00003138|466496120|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
129697737|NCT01703221|466851934|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129697738|NCT01703221|466851932|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
129697739|NCT01703221|466851933|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
129788826|NCT00827931|467193492|FG001|Overall Study|Death|5|||
129788827|NCT00827931|467193491|FG000|Overall Study|Adverse Event|1|||
129788828|NCT00827931|467193492|FG001|Overall Study|Adverse Event|0|||
129788829|NCT00827931|467193491|FG000|Overall Study|Lost to Follow-up|1|||
129788830|NCT00827931|467193492|FG001|Overall Study|Lost to Follow-up|0|||
129788831|NCT00827931|467193491|FG000|Overall Study|Withdrawal by Subject|0|||
129788832|NCT00827931|467193492|FG001|Overall Study|Withdrawal by Subject|1|||
129788833|NCT00827931|467193491|FG000|Overall Study|Other|1|||
129600676|NCT00003138|466496119|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
129600677|NCT00003138|466496120|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
129600678|NCT00003138|466496119|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
129600679|NCT00003138|466496120|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
129788834|NCT00827931|467193492|FG001|Overall Study|Other|0|||
129788835|NCT00995566|467193493|FG000|Overall Study|Adverse Event|2|||
129788836|NCT00995566|467193493|FG000|Overall Study|Early study termination|52|||
129788837|NCT00608569|467193494|FG000|Overall Study|Death|4|||
129788838|NCT00608569|467193495|FG001|Overall Study|Death|3|||
129788839|NCT00608569|467193494|FG000|Overall Study|Lost to Follow-up|4|||
129600680|NCT05142566|466496122|FG000|Overall Study|Protocol Violation|1|||
129600681|NCT03247517|466496131|FG000|Overall Study|Adverse Event|0|||
129600682|NCT03247517|466496132|FG001|Overall Study|Adverse Event|4|||
129600683|NCT03247517|466496133|FG002|Overall Study|Adverse Event|2|||
129600684|NCT03247517|466496131|FG000|Overall Study|Lost to Follow-up|2|||
129600685|NCT03247517|466496132|FG001|Overall Study|Lost to Follow-up|6|||
129600686|NCT03247517|466496133|FG002|Overall Study|Lost to Follow-up|4|||
129600687|NCT03247517|466496131|FG000|Overall Study|Consent withdrawn by caregiver|1|||
129600688|NCT03247517|466496132|FG001|Overall Study|Consent withdrawn by caregiver|4|||
129600689|NCT03247517|466496133|FG002|Overall Study|Consent withdrawn by caregiver|7|||
129600690|NCT03247517|466496131|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
129600691|NCT03247517|466496132|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
129600692|NCT03247517|466496133|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
129600693|NCT03247517|466496131|FG000|Overall Study|Protocol Violation|0|||
129600694|NCT03247517|466496132|FG001|Overall Study|Protocol Violation|2|||
129600695|NCT03247517|466496133|FG002|Overall Study|Protocol Violation|0|||
129600696|NCT03247517|466496131|FG000|Overall Study|Multiple reasons|3|||
129600697|NCT03247517|466496132|FG001|Overall Study|Multiple reasons|1|||
129600698|NCT03247517|466496133|FG002|Overall Study|Multiple reasons|0|||
129600699|NCT02072148|466496144|FG000|Overall Study|withdrew prior to surgery|23|||
129600700|NCT02072148|466496145|FG001|Overall Study|withdrew prior to surgery|0|||
129600701|NCT02072148|466496146|FG002|Overall Study|withdrew prior to surgery|0|||
129600702|NCT02072148|466496144|FG000|Overall Study|Death|0|||
129600703|NCT02072148|466496145|FG001|Overall Study|Death|0|||
129600704|NCT02072148|466496146|FG002|Overall Study|Death|1|||
129600705|NCT02072148|466496144|FG000|Overall Study|Withdrawal by Subject|0|||
129600706|NCT02072148|466496145|FG001|Overall Study|Withdrawal by Subject|13|||
129600707|NCT02072148|466496146|FG002|Overall Study|Withdrawal by Subject|12|||
129600708|NCT01939496|466496148|FG000|Overall Study|Adverse Event|2|||
129600709|NCT01939496|466496149|FG001|Overall Study|Adverse Event|0|||
129600710|NCT01939496|466496150|FG002|Overall Study|Adverse Event|0|||
129600711|NCT01939496|466496148|FG000|Overall Study|Lost to Follow-up|1|||
129600712|NCT01939496|466496149|FG001|Overall Study|Lost to Follow-up|1|||
129600713|NCT01939496|466496150|FG002|Overall Study|Lost to Follow-up|0|||
129600714|NCT01939496|466496148|FG000|Overall Study|Physician Decision|1|||
129600715|NCT01939496|466496149|FG001|Overall Study|Physician Decision|0|||
129600716|NCT01939496|466496150|FG002|Overall Study|Physician Decision|0|||
129600717|NCT01939496|466496148|FG000|Overall Study|Protocol Violation|3|||
129600718|NCT01939496|466496149|FG001|Overall Study|Protocol Violation|0|||
129600719|NCT01939496|466496150|FG002|Overall Study|Protocol Violation|0|||
129600720|NCT01939496|466496148|FG000|Overall Study|Withdrawal by Subject|0|||
129600721|NCT01939496|466496149|FG001|Overall Study|Withdrawal by Subject|1|||
129600722|NCT01939496|466496150|FG002|Overall Study|Withdrawal by Subject|1|||
129600723|NCT01939496|466496148|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
129600724|NCT01939496|466496149|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
129600725|NCT01939496|466496150|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
129600726|NCT01939496|466496148|FG000|Overall Study|Other|2|||
129600727|NCT01939496|466496149|FG001|Overall Study|Other|0|||
129600728|NCT01939496|466496150|FG002|Overall Study|Other|1|||
129600729|NCT03052322|466496151|FG000|Overall Study|Other un-specified|1|||
129600730|NCT03052322|466496152|FG001|Overall Study|Other un-specified|2|||
129600731|NCT03052322|466496151|FG000|Overall Study|Withdrawal by Subject|10|||
129600732|NCT03052322|466496152|FG001|Overall Study|Withdrawal by Subject|9|||
129600733|NCT03052322|466496151|FG000|Overall Study|Death|0|||
129600734|NCT03052322|466496152|FG001|Overall Study|Death|2|||
129600735|NCT03052322|466496151|FG000|Overall Study|Lack of Efficacy|1|||
129600736|NCT03052322|466496152|FG001|Overall Study|Lack of Efficacy|2|||
129600737|NCT03052322|466496151|FG000|Overall Study|Protocol Violation|1|||
129600738|NCT03052322|466496152|FG001|Overall Study|Protocol Violation|0|||
129600739|NCT03052322|466496151|FG000|Overall Study|Lost to Follow-up|2|||
129600740|NCT03052322|466496152|FG001|Overall Study|Lost to Follow-up|4|||
129600741|NCT03052322|466496151|FG000|Overall Study|Adverse Event|6|||
129600742|NCT03052322|466496152|FG001|Overall Study|Adverse Event|13|||
129600743|NCT04920916|466496153|FG000|Phase IIa 60 Day Study|Death|2|||
129600744|NCT04920916|466496154|FG001|Phase IIa 60 Day Study|Death|5|||
129600745|NCT04920916|466496153|FG000|1 Year Follow up (Phone Call)|Death|1|||
129600746|NCT04920916|466496154|FG001|1 Year Follow up (Phone Call)|Death|3|||
129697740|NCT01703221|466851934|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
129697741|NCT01703221|466851932|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
129600747|NCT04920916|466496153|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
129600748|NCT04920916|466496154|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
129697742|NCT01703221|466851933|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129600749|NCT03251963|466496163|FG000|Overall Study|inappropriate Xa level timing|6|||
129600750|NCT03251963|466496164|FG001|Overall Study|inappropriate Xa level timing|3|||
129600751|NCT03251963|466496163|FG000|Overall Study|no peak Xa level drawn|2|||
129600752|NCT03251963|466496164|FG001|Overall Study|no peak Xa level drawn|0|||
129600753|NCT03251963|466496163|FG000|Overall Study|bled prior to Xa level|1|||
129788840|NCT00608569|467193495|FG001|Overall Study|Lost to Follow-up|5|||
129788841|NCT00608569|467193494|FG000|Overall Study|Withdrawal by Subject|1|||
129600754|NCT03251963|466496164|FG001|Overall Study|bled prior to Xa level|2|||
129600755|NCT00136318|466496167|FG000|Overall Study|Adverse Event|5|||
129788842|NCT00608569|467193495|FG001|Overall Study|Withdrawal by Subject|0|||
129788843|NCT00608569|467193494|FG000|Overall Study|Adverse Event|1|||
129788844|NCT00608569|467193495|FG001|Overall Study|Adverse Event|0|||
129788845|NCT00608569|467193494|FG000|Overall Study|Unable to adhere with study requirements|0|||
129788846|NCT00608569|467193495|FG001|Overall Study|Unable to adhere with study requirements|1|||
129788847|NCT02282293|467193496|FG000|Overall Study|Lost to Follow-up|2|||
129788848|NCT02282293|467193497|FG001|Overall Study|Lost to Follow-up|2|||
129788849|NCT02282293|467193496|FG000|Overall Study|Unable to comply with study procedures|1|||
129788850|NCT02282293|467193497|FG001|Overall Study|Unable to comply with study procedures|0|||
129788851|NCT02282293|467193496|FG000|Overall Study|Moved out of study area|0|||
129788852|NCT02282293|467193497|FG001|Overall Study|Moved out of study area|1|||
129788853|NCT03011892|467193498|FG000|Double Blind (DB) Period|Adverse Event|0|||
129788854|NCT03011892|467193499|FG001|Double Blind (DB) Period|Adverse Event|1|||
129788855|NCT03011892|467193500|FG002|Double Blind (DB) Period|Adverse Event|1|||
129788856|NCT03011892|467193501|FG003|Double Blind (DB) Period|Adverse Event|0|||
129600756|NCT00136318|466496168|FG001|Overall Study|Adverse Event|5|||
129600757|NCT00136318|466496167|FG000|Overall Study|Withdrawal by Subject|2|||
129600758|NCT00136318|466496168|FG001|Overall Study|Withdrawal by Subject|2|||
129600759|NCT01546649|466496171|FG000|Overall Study|Adverse Event|4|||
129600760|NCT01546649|466496172|FG001|Overall Study|Adverse Event|5|||
129600761|NCT01546649|466496171|FG000|Overall Study|Protocol Violation|1|||
129600762|NCT01546649|466496172|FG001|Overall Study|Protocol Violation|0|||
129600763|NCT01546649|466496171|FG000|Overall Study|Lack of Efficacy|1|||
129600764|NCT01546649|466496172|FG001|Overall Study|Lack of Efficacy|0|||
129600765|NCT01546649|466496171|FG000|Overall Study|Recurrence|1|||
129600766|NCT01546649|466496172|FG001|Overall Study|Recurrence|1|||
129600767|NCT01546649|466496171|FG000|Overall Study|Discovery of secondary cancer|0|||
129600768|NCT01546649|466496172|FG001|Overall Study|Discovery of secondary cancer|1|||
129600769|NCT01546649|466496171|FG000|Overall Study|Withdrawal by Subject|1|||
129600770|NCT01546649|466496172|FG001|Overall Study|Withdrawal by Subject|2|||
129600771|NCT01134627|466496177|FG000|Overall Study|Adverse Event|47|||
129600772|NCT01134627|466496178|FG001|Overall Study|Adverse Event|31|||
129600773|NCT01134627|466496177|FG000|Overall Study|Lost to Follow-up|1|||
129600774|NCT01134627|466496178|FG001|Overall Study|Lost to Follow-up|2|||
129600775|NCT01134627|466496177|FG000|Overall Study|Protocol Violation|3|||
129600776|NCT01134627|466496178|FG001|Overall Study|Protocol Violation|5|||
129600777|NCT01134627|466496177|FG000|Overall Study|Lack of Efficacy|2|||
129600778|NCT01134627|466496178|FG001|Overall Study|Lack of Efficacy|12|||
129600779|NCT01134627|466496177|FG000|Overall Study|Withdrawal by Subject|4|||
129600780|NCT01134627|466496178|FG001|Overall Study|Withdrawal by Subject|3|||
129600781|NCT01134627|466496177|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
129600782|NCT01134627|466496178|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
129600783|NCT01134627|466496177|FG000|Overall Study|Other|11|||
129600784|NCT01134627|466496178|FG001|Overall Study|Other|14|||
129600785|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
129788857|NCT03011892|467193502|FG004|Double Blind (DB) Period|Adverse Event|0|||
129788858|NCT03011892|467193503|FG005|Double Blind (DB) Period|Adverse Event|0|||
129788859|NCT03011892|467193504|FG006|Double Blind (DB) Period|Adverse Event|0|||
129788860|NCT03011892|467193505|FG007|Double Blind (DB) Period|Adverse Event|0|||
129788861|NCT03011892|467193506|FG008|Double Blind (DB) Period|Adverse Event|0|||
129788862|NCT03011892|467193507|FG009|Double Blind (DB) Period|Adverse Event|0|||
129788863|NCT03011892|467193508|FG010|Double Blind (DB) Period|Adverse Event|0|||
129788864|NCT03011892|467193509|FG011|Double Blind (DB) Period|Adverse Event|0|||
129788865|NCT03011892|467193498|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
129788866|NCT03011892|467193499|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
129788867|NCT03011892|467193500|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
129788868|NCT03011892|467193501|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
129788869|NCT03011892|467193502|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
129788870|NCT03011892|467193503|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
129788871|NCT03011892|467193504|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
129788872|NCT03011892|467193505|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
129788873|NCT03011892|467193506|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
129600786|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
129600787|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
129600788|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
129600789|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
129600790|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
129600791|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
129600792|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
129600793|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
129600794|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
129600795|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Subject decision|1|||
129885934|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Physician Decision|0|||
129885935|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Physician Decision|3|||
129885936|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Physician Decision|0|||
129885937|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Physician Decision|0|||
129885938|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Physician Decision|0|||
129885939|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Physician Decision|0|||
129885940|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Physician Decision|0|||
129885941|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Physician Decision|1|||
129885942|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Physician Decision|3|||
129885943|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Physician Decision|0|||
129885944|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Not Treated|0|||
129885945|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Not Treated|0|||
129885946|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Not Treated|2|||
129885947|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Not Treated|0|||
129885948|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Not Treated|0|||
129885949|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Not Treated|0|||
129885950|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Not Treated|0|||
129885951|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Not Treated|0|||
129885952|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Not Treated|0|||
129885953|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Not Treated|0|||
129885954|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Not Treated|0|||
129885955|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Not Treated|0|||
129885956|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Not Treated|0|||
129885957|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885958|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
129885959|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885960|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885961|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885962|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885963|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885964|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885965|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885966|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885967|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885968|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129885969|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
129788874|NCT03011892|467193507|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
129788875|NCT03011892|467193508|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
129600796|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Subject decision|1|||
129600797|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
129600798|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
129600799|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
129600800|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
129600801|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
129600802|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
129600803|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
129600804|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
129600805|NCT00518882|466496184|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
129600806|NCT00518882|466496185|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
129600807|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
129600808|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
129600809|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
129600810|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
129600811|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
129600812|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
129600813|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
129600814|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
129600815|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
129600816|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
129600817|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
129600818|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
129600819|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
129600820|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
129600821|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
129600822|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
129600823|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
129600824|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
129600825|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
129600826|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
129600827|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
129600828|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
129600829|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
129600830|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
129600831|NCT00518882|466496184|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
129788876|NCT03011892|467193509|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
129788877|NCT03011892|467193498|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
129788878|NCT03011892|467193499|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
129788879|NCT03011892|467193500|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
129788880|NCT03011892|467193501|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
129788881|NCT03011892|467193502|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
129788882|NCT03011892|467193503|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
129788883|NCT03011892|467193504|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
129788884|NCT03011892|467193505|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
129788885|NCT03011892|467193506|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
129885970|NCT02291289|467542793|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
129600832|NCT00518882|466496185|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
129600833|NCT03395639|466496186|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
129600834|NCT03395639|466496187|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
129600835|NCT03395639|466496188|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
129600836|NCT03395639|466496186|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
129600837|NCT03395639|466496187|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
129600838|NCT03395639|466496188|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
129788886|NCT03011892|467193507|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
129600839|NCT03395639|466496186|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
129600840|NCT03395639|466496187|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
129600841|NCT03395639|466496188|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
129600842|NCT03395639|466496186|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
129600843|NCT03395639|466496187|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
129600844|NCT03395639|466496188|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
129600845|NCT03395639|466496186|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
129600846|NCT03395639|466496187|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
129600847|NCT03395639|466496188|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
129600848|NCT00942331|466496189|FG000|Overall Study|Did not start treatment|15|||
129600849|NCT00942331|466496190|FG001|Overall Study|Did not start treatment|22|||
129600850|NCT00567476|466496195|FG000|Overall Study|Adverse Event|2|||
129600851|NCT00567476|466496196|FG001|Overall Study|Adverse Event|0|||
129600852|NCT00567476|466496195|FG000|Overall Study|Pregnancy|1|||
129600853|NCT00567476|466496196|FG001|Overall Study|Pregnancy|0|||
129600854|NCT00567476|466496195|FG000|Overall Study|Protocol Violation|4|||
129600855|NCT00567476|466496196|FG001|Overall Study|Protocol Violation|1|||
129600856|NCT00567476|466496195|FG000|Overall Study|Lost to Follow-up|0|||
129600857|NCT00567476|466496196|FG001|Overall Study|Lost to Follow-up|1|||
129600858|NCT00567476|466496195|FG000|Overall Study|Administrative issues|1|||
129600859|NCT00567476|466496196|FG001|Overall Study|Administrative issues|0|||
129436578|NCT01222507|465897140|FG000|Overall Study|Physician Decision|1|||
129436579|NCT01222507|465897140|FG000|Overall Study|Withdrawal by Subject|1|||
129436580|NCT02647320|465897141|FG000|Overall Study|Adverse Event|0|||
129436581|NCT02647320|465897142|FG001|Overall Study|Adverse Event|1|||
129436582|NCT02647320|465897143|FG002|Overall Study|Adverse Event|3|||
129436583|NCT02647320|465897144|FG003|Overall Study|Adverse Event|2|||
129436584|NCT02647320|465897145|FG004|Overall Study|Adverse Event|1|||
129436585|NCT02647320|465897141|FG000|Overall Study|Protocol Violation|0|||
129436586|NCT02647320|465897142|FG001|Overall Study|Protocol Violation|0|||
129788887|NCT03011892|467193508|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
129436587|NCT02647320|465897143|FG002|Overall Study|Protocol Violation|3|||
129436588|NCT02647320|465897144|FG003|Overall Study|Protocol Violation|0|||
129436589|NCT02647320|465897145|FG004|Overall Study|Protocol Violation|0|||
129600860|NCT00567476|466496195|FG000|Overall Study|Medical Decision|0|||
129600861|NCT00567476|466496196|FG001|Overall Study|Medical Decision|1|||
129600862|NCT00567476|466496195|FG000|Overall Study|Non-adherence to protocol|0|||
129600863|NCT00567476|466496196|FG001|Overall Study|Non-adherence to protocol|1|||
129600864|NCT02696031|466496198|FG000|Up to Week 24|Adverse Event|2|||
129788888|NCT03011892|467193509|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
129788889|NCT03011892|467193498|FG000|Double Blind (DB) Period|Other|1|||
129788890|NCT03011892|467193499|FG001|Double Blind (DB) Period|Other|1|||
129788891|NCT03011892|467193500|FG002|Double Blind (DB) Period|Other|1|||
129788892|NCT03011892|467193501|FG003|Double Blind (DB) Period|Other|0|||
129788893|NCT03011892|467193502|FG004|Double Blind (DB) Period|Other|1|||
129788894|NCT03011892|467193503|FG005|Double Blind (DB) Period|Other|0|||
129788895|NCT03011892|467193504|FG006|Double Blind (DB) Period|Other|0|||
129788896|NCT03011892|467193505|FG007|Double Blind (DB) Period|Other|0|||
129788897|NCT03011892|467193506|FG008|Double Blind (DB) Period|Other|0|||
129788898|NCT03011892|467193507|FG009|Double Blind (DB) Period|Other|0|||
129788899|NCT03011892|467193508|FG010|Double Blind (DB) Period|Other|0|||
129788900|NCT03011892|467193509|FG011|Double Blind (DB) Period|Other|0|||
129788901|NCT03011892|467193498|FG000|Double Blind (DB) Period|Physician Decision|1|||
129788902|NCT03011892|467193499|FG001|Double Blind (DB) Period|Physician Decision|0|||
129788903|NCT03011892|467193500|FG002|Double Blind (DB) Period|Physician Decision|1|||
129788904|NCT03011892|467193501|FG003|Double Blind (DB) Period|Physician Decision|0|||
129788905|NCT03011892|467193502|FG004|Double Blind (DB) Period|Physician Decision|0|||
129788906|NCT03011892|467193503|FG005|Double Blind (DB) Period|Physician Decision|0|||
129600865|NCT02696031|466496199|FG001|Up to Week 24|Adverse Event|4|||
129600866|NCT02696031|466496200|FG002|Up to Week 24|Adverse Event|2|||
129600867|NCT02696031|466496201|FG003|Up to Week 24|Adverse Event|0|||
129600868|NCT02696031|466496202|FG004|Up to Week 24|Adverse Event|0|||
129600869|NCT02696031|466496203|FG005|Up to Week 24|Adverse Event|0|||
129600870|NCT02696031|466496198|FG000|Up to Week 24|Lack of Efficacy|2|||
129600871|NCT02696031|466496199|FG001|Up to Week 24|Lack of Efficacy|1|||
129600872|NCT02696031|466496200|FG002|Up to Week 24|Lack of Efficacy|2|||
129600873|NCT02696031|466496201|FG003|Up to Week 24|Lack of Efficacy|0|||
129600874|NCT02696031|466496202|FG004|Up to Week 24|Lack of Efficacy|0|||
129600875|NCT02696031|466496203|FG005|Up to Week 24|Lack of Efficacy|0|||
129600876|NCT02696031|466496198|FG000|Up to Week 24|Lost to Follow-up|0|||
129600877|NCT02696031|466496199|FG001|Up to Week 24|Lost to Follow-up|1|||
129600878|NCT02696031|466496200|FG002|Up to Week 24|Lost to Follow-up|1|||
129600879|NCT02696031|466496201|FG003|Up to Week 24|Lost to Follow-up|0|||
129600880|NCT02696031|466496202|FG004|Up to Week 24|Lost to Follow-up|0|||
129600881|NCT02696031|466496203|FG005|Up to Week 24|Lost to Follow-up|0|||
129600882|NCT02696031|466496198|FG000|Up to Week 24|Physician Decision|1|||
129600883|NCT02696031|466496199|FG001|Up to Week 24|Physician Decision|0|||
129600884|NCT02696031|466496200|FG002|Up to Week 24|Physician Decision|1|||
129600885|NCT02696031|466496201|FG003|Up to Week 24|Physician Decision|0|||
129600886|NCT02696031|466496202|FG004|Up to Week 24|Physician Decision|0|||
129600887|NCT02696031|466496203|FG005|Up to Week 24|Physician Decision|0|||
129600888|NCT02696031|466496198|FG000|Up to Week 24|Protocol Violation|1|||
129600889|NCT02696031|466496199|FG001|Up to Week 24|Protocol Violation|0|||
129600890|NCT02696031|466496200|FG002|Up to Week 24|Protocol Violation|0|||
129600891|NCT02696031|466496201|FG003|Up to Week 24|Protocol Violation|0|||
129600892|NCT02696031|466496202|FG004|Up to Week 24|Protocol Violation|0|||
129600893|NCT02696031|466496203|FG005|Up to Week 24|Protocol Violation|0|||
129600894|NCT02696031|466496198|FG000|Up to Week 24|Withdrawal by Subject|4|||
129600895|NCT02696031|466496199|FG001|Up to Week 24|Withdrawal by Subject|1|||
129600896|NCT02696031|466496200|FG002|Up to Week 24|Withdrawal by Subject|5|||
129600897|NCT02696031|466496201|FG003|Up to Week 24|Withdrawal by Subject|0|||
129600898|NCT02696031|466496202|FG004|Up to Week 24|Withdrawal by Subject|0|||
129600899|NCT02696031|466496203|FG005|Up to Week 24|Withdrawal by Subject|0|||
129600900|NCT02696031|466496198|FG000|Up to Week 52|Adverse Event|4|||
129600901|NCT02696031|466496199|FG001|Up to Week 52|Adverse Event|5|||
129600902|NCT02696031|466496200|FG002|Up to Week 52|Adverse Event|3|||
129600903|NCT02696031|466496201|FG003|Up to Week 52|Adverse Event|0|||
129600904|NCT02696031|466496202|FG004|Up to Week 52|Adverse Event|0|||
129788907|NCT03011892|467193504|FG006|Double Blind (DB) Period|Physician Decision|0|||
129600905|NCT02696031|466496203|FG005|Up to Week 52|Adverse Event|0|||
129788908|NCT03011892|467193505|FG007|Double Blind (DB) Period|Physician Decision|0|||
129788909|NCT03011892|467193506|FG008|Double Blind (DB) Period|Physician Decision|0|||
129600906|NCT02696031|466496198|FG000|Up to Week 52|Lack of Efficacy|10|||
129600907|NCT02696031|466496199|FG001|Up to Week 52|Lack of Efficacy|7|||
129600908|NCT02696031|466496200|FG002|Up to Week 52|Lack of Efficacy|11|||
129788910|NCT03011892|467193507|FG009|Double Blind (DB) Period|Physician Decision|0|||
129788911|NCT03011892|467193508|FG010|Double Blind (DB) Period|Physician Decision|0|||
129788912|NCT03011892|467193509|FG011|Double Blind (DB) Period|Physician Decision|0|||
129600909|NCT02696031|466496201|FG003|Up to Week 52|Lack of Efficacy|0|||
129600910|NCT02696031|466496202|FG004|Up to Week 52|Lack of Efficacy|0|||
129600911|NCT02696031|466496203|FG005|Up to Week 52|Lack of Efficacy|0|||
129600912|NCT02696031|466496198|FG000|Up to Week 52|Lost to Follow-up|1|||
129600913|NCT02696031|466496199|FG001|Up to Week 52|Lost to Follow-up|1|||
129600914|NCT02696031|466496200|FG002|Up to Week 52|Lost to Follow-up|1|||
129600915|NCT02696031|466496201|FG003|Up to Week 52|Lost to Follow-up|0|||
129600916|NCT02696031|466496202|FG004|Up to Week 52|Lost to Follow-up|0|||
129600917|NCT02696031|466496203|FG005|Up to Week 52|Lost to Follow-up|0|||
129788913|NCT03011892|467193498|FG000|Double Blind (DB) Period|Pregnancy|0|||
129788914|NCT03011892|467193499|FG001|Double Blind (DB) Period|Pregnancy|0|||
129788915|NCT03011892|467193500|FG002|Double Blind (DB) Period|Pregnancy|0|||
129788916|NCT03011892|467193501|FG003|Double Blind (DB) Period|Pregnancy|0|||
129788917|NCT03011892|467193502|FG004|Double Blind (DB) Period|Pregnancy|1|||
129788918|NCT03011892|467193503|FG005|Double Blind (DB) Period|Pregnancy|0|||
129788919|NCT03011892|467193504|FG006|Double Blind (DB) Period|Pregnancy|0|||
129788920|NCT03011892|467193505|FG007|Double Blind (DB) Period|Pregnancy|0|||
129788921|NCT03011892|467193506|FG008|Double Blind (DB) Period|Pregnancy|0|||
129788922|NCT03011892|467193507|FG009|Double Blind (DB) Period|Pregnancy|0|||
129788923|NCT03011892|467193508|FG010|Double Blind (DB) Period|Pregnancy|0|||
129788924|NCT03011892|467193509|FG011|Double Blind (DB) Period|Pregnancy|0|||
129788925|NCT03011892|467193498|FG000|Double Blind (DB) Period|Protocol Violation|1|||
129788926|NCT03011892|467193499|FG001|Double Blind (DB) Period|Protocol Violation|0|||
129788927|NCT03011892|467193500|FG002|Double Blind (DB) Period|Protocol Violation|0|||
129788928|NCT03011892|467193501|FG003|Double Blind (DB) Period|Protocol Violation|0|||
129788929|NCT03011892|467193502|FG004|Double Blind (DB) Period|Protocol Violation|0|||
129788930|NCT03011892|467193503|FG005|Double Blind (DB) Period|Protocol Violation|0|||
129788931|NCT03011892|467193504|FG006|Double Blind (DB) Period|Protocol Violation|0|||
129788932|NCT03011892|467193505|FG007|Double Blind (DB) Period|Protocol Violation|0|||
129885971|NCT02291289|467542794|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
129885972|NCT02291289|467542795|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
129885973|NCT02291289|467542796|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
129885974|NCT02291289|467542797|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
129885975|NCT02291289|467542798|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
129885976|NCT02291289|467542799|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
129885977|NCT02291289|467542800|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
129885978|NCT02291289|467542801|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
129885979|NCT02291289|467542802|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
129600918|NCT02696031|466496198|FG000|Up to Week 52|Physician Decision|1|||
129600919|NCT02696031|466496199|FG001|Up to Week 52|Physician Decision|1|||
129600920|NCT02696031|466496200|FG002|Up to Week 52|Physician Decision|2|||
129600921|NCT02696031|466496201|FG003|Up to Week 52|Physician Decision|0|||
129600922|NCT02696031|466496202|FG004|Up to Week 52|Physician Decision|0|||
129600923|NCT02696031|466496203|FG005|Up to Week 52|Physician Decision|0|||
129600924|NCT02696031|466496198|FG000|Up to Week 52|Pregnancy|0|||
129600925|NCT02696031|466496199|FG001|Up to Week 52|Pregnancy|2|||
129600926|NCT02696031|466496200|FG002|Up to Week 52|Pregnancy|0|||
129600927|NCT02696031|466496201|FG003|Up to Week 52|Pregnancy|0|||
129600928|NCT02696031|466496202|FG004|Up to Week 52|Pregnancy|0|||
129600929|NCT02696031|466496203|FG005|Up to Week 52|Pregnancy|0|||
129600930|NCT02696031|466496198|FG000|Up to Week 52|Protocol Violation|1|||
129600931|NCT02696031|466496199|FG001|Up to Week 52|Protocol Violation|0|||
129600932|NCT02696031|466496200|FG002|Up to Week 52|Protocol Violation|0|||
129600933|NCT02696031|466496201|FG003|Up to Week 52|Protocol Violation|0|||
129600934|NCT02696031|466496202|FG004|Up to Week 52|Protocol Violation|0|||
129600935|NCT02696031|466496203|FG005|Up to Week 52|Protocol Violation|0|||
129600936|NCT02696031|466496198|FG000|Up to Week 52|Withdrawal by Subject|12|||
129600937|NCT02696031|466496199|FG001|Up to Week 52|Withdrawal by Subject|3|||
129600938|NCT02696031|466496200|FG002|Up to Week 52|Withdrawal by Subject|9|||
129600939|NCT02696031|466496201|FG003|Up to Week 52|Withdrawal by Subject|0|||
129885980|NCT02291289|467542803|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
129600940|NCT02696031|466496202|FG004|Up to Week 52|Withdrawal by Subject|0|||
129600941|NCT02696031|466496203|FG005|Up to Week 52|Withdrawal by Subject|0|||
129788933|NCT03011892|467193506|FG008|Double Blind (DB) Period|Protocol Violation|0|||
129885981|NCT02291289|467542804|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
129600942|NCT02696031|466496198|FG000|Up to Week 104|Pregnancy|0|||
129600943|NCT02696031|466496199|FG001|Up to Week 104|Pregnancy|2|||
129600944|NCT02696031|466496200|FG002|Up to Week 104|Pregnancy|1|||
129600945|NCT02696031|466496201|FG003|Up to Week 104|Pregnancy|0|||
129600946|NCT02696031|466496202|FG004|Up to Week 104|Pregnancy|0|||
129600947|NCT02696031|466496203|FG005|Up to Week 104|Pregnancy|0|||
129600948|NCT02696031|466496198|FG000|Up to Week 104|Withdrawal by Subject|15|||
129600949|NCT02696031|466496199|FG001|Up to Week 104|Withdrawal by Subject|10|||
129600950|NCT02696031|466496200|FG002|Up to Week 104|Withdrawal by Subject|16|||
129600951|NCT02696031|466496201|FG003|Up to Week 104|Withdrawal by Subject|0|||
129788934|NCT03011892|467193507|FG009|Double Blind (DB) Period|Protocol Violation|0|||
129788935|NCT03011892|467193508|FG010|Double Blind (DB) Period|Protocol Violation|0|||
129600952|NCT02696031|466496202|FG004|Up to Week 104|Withdrawal by Subject|0|||
129600953|NCT02696031|466496203|FG005|Up to Week 104|Withdrawal by Subject|0|||
129600954|NCT02696031|466496198|FG000|Up to Week 104|Protocol Violation|1|||
129600955|NCT02696031|466496199|FG001|Up to Week 104|Protocol Violation|0|||
129600956|NCT02696031|466496200|FG002|Up to Week 104|Protocol Violation|0|||
129600957|NCT02696031|466496201|FG003|Up to Week 104|Protocol Violation|0|||
129600958|NCT02696031|466496202|FG004|Up to Week 104|Protocol Violation|0|||
129600959|NCT02696031|466496203|FG005|Up to Week 104|Protocol Violation|0|||
129600960|NCT02696031|466496198|FG000|Up to Week 104|Physician Decision|1|||
129600961|NCT02696031|466496199|FG001|Up to Week 104|Physician Decision|2|||
129788936|NCT03011892|467193509|FG011|Double Blind (DB) Period|Protocol Violation|0|||
129788937|NCT03011892|467193498|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
129600962|NCT02696031|466496200|FG002|Up to Week 104|Physician Decision|3|||
129600963|NCT02696031|466496201|FG003|Up to Week 104|Physician Decision|0|||
129600964|NCT02696031|466496202|FG004|Up to Week 104|Physician Decision|0|||
129600965|NCT02696031|466496203|FG005|Up to Week 104|Physician Decision|0|||
129600966|NCT02696031|466496198|FG000|Up to Week 104|Lost to Follow-up|2|||
129600967|NCT02696031|466496199|FG001|Up to Week 104|Lost to Follow-up|3|||
129600968|NCT02696031|466496200|FG002|Up to Week 104|Lost to Follow-up|1|||
129600969|NCT02696031|466496201|FG003|Up to Week 104|Lost to Follow-up|0|||
129788938|NCT03011892|467193499|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
129788939|NCT03011892|467193500|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
129788940|NCT03011892|467193501|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
129788941|NCT03011892|467193502|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
129600970|NCT02696031|466496202|FG004|Up to Week 104|Lost to Follow-up|0|||
129600971|NCT02696031|466496203|FG005|Up to Week 104|Lost to Follow-up|0|||
129600972|NCT02696031|466496198|FG000|Up to Week 104|Lack of Efficacy|13|||
129600973|NCT02696031|466496199|FG001|Up to Week 104|Lack of Efficacy|12|||
129600974|NCT02696031|466496200|FG002|Up to Week 104|Lack of Efficacy|11|||
129600975|NCT02696031|466496201|FG003|Up to Week 104|Lack of Efficacy|0|||
129600976|NCT02696031|466496202|FG004|Up to Week 104|Lack of Efficacy|0|||
129600977|NCT02696031|466496203|FG005|Up to Week 104|Lack of Efficacy|0|||
129600978|NCT02696031|466496198|FG000|Up to Week 104|Adverse Event|7|||
129600979|NCT02696031|466496199|FG001|Up to Week 104|Adverse Event|11|||
129600980|NCT02696031|466496200|FG002|Up to Week 104|Adverse Event|5|||
129600981|NCT02696031|466496201|FG003|Up to Week 104|Adverse Event|0|||
129600982|NCT02696031|466496202|FG004|Up to Week 104|Adverse Event|0|||
129600983|NCT02696031|466496203|FG005|Up to Week 104|Adverse Event|0|||
129600984|NCT02696031|466496198|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129600985|NCT02696031|466496199|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
129600986|NCT02696031|466496200|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129600987|NCT02696031|466496201|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129600988|NCT02696031|466496202|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129600989|NCT02696031|466496203|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
129600990|NCT02696031|466496198|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
129600991|NCT02696031|466496199|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
129600992|NCT02696031|466496200|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
129600993|NCT02696031|466496201|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
129600994|NCT02696031|466496202|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
129600995|NCT02696031|466496203|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
129600996|NCT02696031|466496198|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129600997|NCT02696031|466496199|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129600998|NCT02696031|466496200|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129600999|NCT02696031|466496201|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
129601000|NCT02696031|466496202|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
129601001|NCT02696031|466496203|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
129601002|NCT02696031|466496198|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129601003|NCT02696031|466496199|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129601004|NCT02696031|466496200|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129601005|NCT02696031|466496201|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
129601006|NCT02696031|466496202|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129601007|NCT02696031|466496203|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
129601008|NCT02696031|466496198|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129601009|NCT02696031|466496199|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129601010|NCT02696031|466496200|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129601011|NCT02696031|466496201|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129601012|NCT02696031|466496202|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
129601013|NCT02696031|466496203|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
129601014|NCT02696031|466496198|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
129601015|NCT02696031|466496199|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
129601016|NCT02696031|466496200|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
129601017|NCT02696031|466496201|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
129601018|NCT02696031|466496202|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
129601019|NCT02696031|466496203|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
129601020|NCT02696031|466496198|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
129601021|NCT02696031|466496199|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
129601022|NCT02696031|466496200|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
129601023|NCT02696031|466496201|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
129601024|NCT02696031|466496202|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
129601025|NCT02696031|466496203|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
129601026|NCT00597116|466496204|FG000|Overall Study|Adverse Event|2|||
129601027|NCT00597116|466496205|FG001|Overall Study|Adverse Event|1|||
129601028|NCT00597116|466496204|FG000|Overall Study|Withdrawal by Subject|0|||
129601029|NCT00597116|466496205|FG001|Overall Study|Withdrawal by Subject|2|||
129601030|NCT00597116|466496204|FG000|Overall Study|Physician Decision|0|||
129601031|NCT00597116|466496205|FG001|Overall Study|Physician Decision|1|||
129601032|NCT00597116|466496204|FG000|Overall Study|Death|0|||
129601033|NCT00597116|466496205|FG001|Overall Study|Death|1|||
129601034|NCT00597116|466496204|FG000|Overall Study|Lost to Follow-up|1|||
129601035|NCT00597116|466496205|FG001|Overall Study|Lost to Follow-up|0|||
129601036|NCT00597116|466496204|FG000|Overall Study|Progressive disease|11|||
129601037|NCT00597116|466496205|FG001|Overall Study|Progressive disease|6|||
129601038|NCT01901874|466496208|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
129601039|NCT01901874|466496208|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
129601040|NCT01901874|466496208|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
129601041|NCT01901874|466496208|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
129601042|NCT01901874|466496208|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
129601043|NCT01901874|466496208|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
129601044|NCT03978091|466496209|FG000|Overall Study|Lost to Follow-up|0|||
129601045|NCT03978091|466496210|FG001|Overall Study|Lost to Follow-up|0|||
129601046|NCT03978091|466496211|FG002|Overall Study|Lost to Follow-up|1|||
129601047|NCT03978091|466496212|FG003|Overall Study|Lost to Follow-up|0|||
129601048|NCT03978091|466496213|FG004|Overall Study|Lost to Follow-up|0|||
129601049|NCT03978091|466496214|FG005|Overall Study|Lost to Follow-up|0|||
129601050|NCT03978091|466496209|FG000|Overall Study|Withdrawal by Subject|0|||
129601051|NCT03978091|466496210|FG001|Overall Study|Withdrawal by Subject|0|||
129601052|NCT03978091|466496211|FG002|Overall Study|Withdrawal by Subject|0|||
129601053|NCT03978091|466496212|FG003|Overall Study|Withdrawal by Subject|1|||
129601054|NCT03978091|466496213|FG004|Overall Study|Withdrawal by Subject|1|||
129601055|NCT03978091|466496214|FG005|Overall Study|Withdrawal by Subject|0|||
129601056|NCT02595008|466496219|FG000|Overall Study|Enrolled In Error|1|||
129601057|NCT02595008|466496220|FG001|Overall Study|Enrolled In Error|0|||
129601058|NCT03078582|466496227|FG000|Overall Study|Adverse Event|0|||
129601059|NCT03078582|466496228|FG001|Overall Study|Adverse Event|8|||
129601060|NCT01843348|466496231|FG000|Overall Study|Withdrawal by Subject|4|||
129601061|NCT01843348|466496232|FG001|Overall Study|Withdrawal by Subject|16|||
129601062|NCT01843348|466496233|FG002|Overall Study|Withdrawal by Subject|18|||
129601063|NCT01843348|466496231|FG000|Overall Study|Lost to Follow-up|5|||
129601064|NCT01843348|466496232|FG001|Overall Study|Lost to Follow-up|4|||
129601065|NCT01843348|466496233|FG002|Overall Study|Lost to Follow-up|2|||
129601066|NCT01843348|466496231|FG000|Overall Study|Death|5|||
129601067|NCT01843348|466496232|FG001|Overall Study|Death|3|||
129601068|NCT01843348|466496233|FG002|Overall Study|Death|4|||
129601069|NCT01843348|466496231|FG000|Overall Study|Graft loss/retransplantation|5|||
129601070|NCT01843348|466496232|FG001|Overall Study|Graft loss/retransplantation|8|||
129601071|NCT01843348|466496233|FG002|Overall Study|Graft loss/retransplantation|11|||
129601072|NCT01843348|466496231|FG000|Overall Study|Various reasons|4|||
129601073|NCT01843348|466496232|FG001|Overall Study|Various reasons|9|||
129601074|NCT01843348|466496233|FG002|Overall Study|Various reasons|6|||
129601075|NCT02039414|466496242|FG000|Overall Study|Delivered|1|||
129601076|NCT02039414|466496243|FG001|Overall Study|Delivered|1|||
129601077|NCT02039414|466496242|FG000|Overall Study|Lost to Follow-up|2|||
129601078|NCT02039414|466496243|FG001|Overall Study|Lost to Follow-up|0|||
129601079|NCT02039414|466496242|FG000|Overall Study|Protocol Violation|3|||
129601080|NCT02039414|466496243|FG001|Overall Study|Protocol Violation|1|||
129601081|NCT03977701|466496244|FG000|Overall Study|COVID-19 pandemic|0|||
129601082|NCT03977701|466496245|FG001|Overall Study|COVID-19 pandemic|0|||
129601083|NCT03977701|466496246|FG002|Overall Study|COVID-19 pandemic|0|||
129601084|NCT03977701|466496247|FG003|Overall Study|COVID-19 pandemic|0|||
129601085|NCT03977701|466496248|FG004|Overall Study|COVID-19 pandemic|0|||
129601086|NCT03977701|466496249|FG005|Overall Study|COVID-19 pandemic|1|||
129601087|NCT03977701|466496250|FG006|Overall Study|COVID-19 pandemic|0|||
129601088|NCT03977701|466496251|FG007|Overall Study|COVID-19 pandemic|1|||
129601089|NCT03977701|466496252|FG008|Overall Study|COVID-19 pandemic|0|||
129601090|NCT03977701|466496253|FG009|Overall Study|COVID-19 pandemic|0|||
129601091|NCT00869024|466496254|FG000|Overall Study|Death|2|||
129601092|NCT00869024|466496255|FG001|Overall Study|Death|3|||
129601093|NCT00869024|466496254|FG000|Overall Study|Lost to Follow-up|0|||
129601094|NCT00869024|466496255|FG001|Overall Study|Lost to Follow-up|1|||
129601095|NCT00869024|466496254|FG000|Overall Study|Protocol Violation|0|||
129601096|NCT00869024|466496255|FG001|Overall Study|Protocol Violation|1|||
129601097|NCT00831623|466496259|FG000|Overall Study|Withdrawal by Subject|9|||
129601098|NCT00831623|466496259|FG000|Overall Study|Lost to Follow-up|1|||
129601099|NCT00831623|466496259|FG000|Overall Study|Not 2 years post-treatment|12|||
129601100|NCT00653991|466496263|FG000|3 Month Follow-up|Participant would not respond|150|||
129601101|NCT00653991|466496264|FG001|3 Month Follow-up|Participant would not respond|157|||
129601102|NCT00653991|466496263|FG000|6 Month Follow-up|Participant would not respond|133|||
129601103|NCT00653991|466496264|FG001|6 Month Follow-up|Participant would not respond|141|||
129601104|NCT02939014|466496267|FG000|Overall Study|Lost to Follow-up|1|||
129601105|NCT02939014|466496268|FG001|Overall Study|Lost to Follow-up|0|||
129601106|NCT02939014|466496267|FG000|Overall Study|Death|4|||
129601107|NCT02939014|466496268|FG001|Overall Study|Death|3|||
129601108|NCT03864042|466496269|FG000|DDI Phase|Adverse Event|2|||
129601109|NCT03864042|466496270|FG001|DDI Phase|Adverse Event|0|||
129601110|NCT03864042|466496271|FG002|DDI Phase|Adverse Event|0|||
129601111|NCT03864042|466496269|FG000|DDI Phase|Physician Decision|1|||
129601112|NCT03864042|466496270|FG001|DDI Phase|Physician Decision|0|||
129601113|NCT03864042|466496271|FG002|DDI Phase|Physician Decision|0|||
129601114|NCT03864042|466496269|FG000|DDI Phase|Progressive Disease|1|||
129601115|NCT03864042|466496270|FG001|DDI Phase|Progressive Disease|0|||
129601116|NCT03864042|466496271|FG002|DDI Phase|Progressive Disease|0|||
129601117|NCT03864042|466496269|FG000|Post-DDI Phase|Adverse Event|5|||
129601118|NCT03864042|466496270|FG001|Post-DDI Phase|Adverse Event|3|||
129601119|NCT03864042|466496271|FG002|Post-DDI Phase|Adverse Event|2|||
129601120|NCT03864042|466496269|FG000|Post-DDI Phase|Progressive Disease|11|||
129601121|NCT03864042|466496270|FG001|Post-DDI Phase|Progressive Disease|6|||
129601122|NCT03864042|466496271|FG002|Post-DDI Phase|Progressive Disease|13|||
129601123|NCT03864042|466496269|FG000|Post-DDI Phase|Discretion of investigator|1|||
129601124|NCT03864042|466496270|FG001|Post-DDI Phase|Discretion of investigator|1|||
129601125|NCT03864042|466496271|FG002|Post-DDI Phase|Discretion of investigator|0|||
129601126|NCT03864042|466496269|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
129601127|NCT03864042|466496270|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
129601128|NCT03864042|466496271|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
129601129|NCT03864042|466496269|FG000|Post-DDI Phase|Withdrawal of consent|1|||
129601130|NCT03864042|466496270|FG001|Post-DDI Phase|Withdrawal of consent|2|||
129601131|NCT03864042|466496271|FG002|Post-DDI Phase|Withdrawal of consent|0|||
129601132|NCT02220725|466496272|FG000|Overall Study|Lost to Follow-up|0|||
129601133|NCT02220725|466496273|FG001|Overall Study|Lost to Follow-up|0|||
129601134|NCT02220725|466496274|FG002|Overall Study|Lost to Follow-up|0|||
129601135|NCT02220725|466496275|FG003|Overall Study|Lost to Follow-up|1|||
129885982|NCT02291289|467542805|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
129885983|NCT02291289|467542793|FG000|Early Disease Progression|Death|0|||
129885984|NCT02291289|467542794|FG001|Early Disease Progression|Death|0|||
129885985|NCT02291289|467542795|FG002|Early Disease Progression|Death|0|||
129885986|NCT02291289|467542796|FG003|Early Disease Progression|Death|0|||
129885987|NCT02291289|467542797|FG004|Early Disease Progression|Death|0|||
129885988|NCT02291289|467542798|FG005|Early Disease Progression|Death|0|||
129885989|NCT02291289|467542799|FG006|Early Disease Progression|Death|0|||
129885990|NCT02291289|467542800|FG007|Early Disease Progression|Death|0|||
129601136|NCT02220725|466496272|FG000|Overall Study|Withdrawal by Subject|0|||
129601137|NCT02220725|466496273|FG001|Overall Study|Withdrawal by Subject|0|||
129601138|NCT02220725|466496274|FG002|Overall Study|Withdrawal by Subject|0|||
129601139|NCT02220725|466496275|FG003|Overall Study|Withdrawal by Subject|1|||
129601140|NCT03487848|466496276|FG000|Overall Study|Lost to Follow-up|1|||
129601141|NCT00731549|466496277|FG000|Overall Study|Lost to Follow-up|19|||
129601142|NCT00731549|466496277|FG000|Overall Study|Met withdrawal criteria|24|||
129601143|NCT00731549|466496277|FG000|Overall Study|Physician Decision|16|||
129601144|NCT00731549|466496277|FG000|Overall Study|Withdrawal by Subject|89|||
129601145|NCT00731549|466496277|FG000|Overall Study|Protocol deviation|1|||
129601146|NCT00731549|466496277|FG000|Overall Study|Adverse Event|31|||
129601147|NCT00731549|466496277|FG000|Overall Study|Lack of efficacy with AE|37|||
129601148|NCT00731549|466496277|FG000|Overall Study|Lack of efficacy without AE|6|||
129601149|NCT00103402|466496278|FG000|Overall Study|Adverse Event|3|||
129601150|NCT00103402|466496279|FG001|Overall Study|Adverse Event|4|||
129601151|NCT00103402|466496278|FG000|Overall Study|Lost to Follow-up|8|||
129601152|NCT00103402|466496279|FG001|Overall Study|Lost to Follow-up|7|||
129601153|NCT00103402|466496278|FG000|Overall Study|Dissatisfied/No longer interested|6|||
129885991|NCT02291289|467542801|FG008|Early Disease Progression|Death|0|||
129885992|NCT02291289|467542802|FG009|Early Disease Progression|Death|0|||
129601154|NCT00103402|466496279|FG001|Overall Study|Dissatisfied/No longer interested|6|||
129601155|NCT00103402|466496278|FG000|Overall Study|Personal constraints/Other|5|||
129601156|NCT00103402|466496279|FG001|Overall Study|Personal constraints/Other|0|||
129601157|NCT01393730|466496280|FG000|Overall Study|Withdrawal by Subject|3|||
129601158|NCT01393730|466496280|FG000|Overall Study|Other|2|||
129601159|NCT01393730|466496280|FG000|Overall Study|Adverse Event|1|||
129601160|NCT02333487|466496281|FG000|Overall Study|Adverse Event|0|||
129601161|NCT02333487|466496282|FG001|Overall Study|Adverse Event|2|||
129601162|NCT02333487|466496283|FG002|Overall Study|Adverse Event|0|||
129601163|NCT01297322|466496284|FG000|Overall Study|Lost to Follow-up|1|||
129601164|NCT01297322|466496285|FG001|Overall Study|Lost to Follow-up|0|||
129601165|NCT01297322|466496284|FG000|Overall Study|Withdrawal by Subject|0|||
129601166|NCT01297322|466496285|FG001|Overall Study|Withdrawal by Subject|1|||
129601167|NCT01297322|466496284|FG000|Overall Study|Protocol Violation|0|||
129601168|NCT01297322|466496285|FG001|Overall Study|Protocol Violation|3|||
129601169|NCT01111019|466496286|FG000|Overall Study|Withdrew Prematurely|2|||
129601170|NCT01111019|466496286|FG000|Overall Study|Other|1|||
129601171|NCT01583218|466496290|FG000|Overall Study|Withdrawal by Subject|43|||
129601172|NCT01583218|466496291|FG001|Overall Study|Withdrawal by Subject|29|||
129601173|NCT01583218|466496290|FG000|Overall Study|Death|206|||
129601174|NCT01583218|466496291|FG001|Overall Study|Death|211|||
129601175|NCT01583218|466496290|FG000|Overall Study|Lost to Follow-up|11|||
129601176|NCT01583218|466496291|FG001|Overall Study|Lost to Follow-up|17|||
129601177|NCT01583218|466496290|FG000|Overall Study|Adverse event or serious adverse event|3|||
129601178|NCT01583218|466496291|FG001|Overall Study|Adverse event or serious adverse event|3|||
129601179|NCT01583218|466496290|FG000|Overall Study|Patient /Family decision|3|||
129601180|NCT01583218|466496291|FG001|Overall Study|Patient /Family decision|0|||
129601181|NCT01583218|466496290|FG000|Overall Study|Cannot contact patient directly|1|||
129601182|NCT01583218|466496291|FG001|Overall Study|Cannot contact patient directly|2|||
129601183|NCT01583218|466496290|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
129601184|NCT01583218|466496291|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
129601185|NCT01583218|466496290|FG000|Overall Study|Patient did not wish to attend visits|0|||
129601186|NCT01583218|466496291|FG001|Overall Study|Patient did not wish to attend visits|1|||
129601187|NCT01583218|466496290|FG000|Overall Study|Patient randomized but not dosed|17|||
129601188|NCT01583218|466496291|FG001|Overall Study|Patient randomized but not dosed|16|||
129601189|NCT01583218|466496290|FG000|Overall Study|Patient was assessed via phone in person|1|||
129601190|NCT01583218|466496291|FG001|Overall Study|Patient was assessed via phone in person|0|||
129601191|NCT01583218|466496290|FG000|Overall Study|Patient deemed ineligible after random|2|||
129601192|NCT01583218|466496291|FG001|Overall Study|Patient deemed ineligible after random|0|||
129601193|NCT01583218|466496290|FG000|Overall Study|Patient was early terminated from study|0|||
129601194|NCT01583218|466496291|FG001|Overall Study|Patient was early terminated from study|1|||
129601195|NCT01583218|466496290|FG000|Overall Study|Patient was randomized due to mistake|1|||
129601196|NCT01583218|466496291|FG001|Overall Study|Patient was randomized due to mistake|0|||
129601197|NCT01583218|466496290|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
129601198|NCT01583218|466496291|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
129601199|NCT01583218|466496290|FG000|Overall Study|Withdraw of consent on day of random|1|||
129601200|NCT01583218|466496291|FG001|Overall Study|Withdraw of consent on day of random|0|||
129601201|NCT03334721|466496294|FG000|Overall Study|Withdrawal by Subject|1|||
129601202|NCT03334721|466496295|FG001|Overall Study|Withdrawal by Subject|0|||
129601203|NCT03334721|466496294|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
129601204|NCT03334721|466496295|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
129601205|NCT04718194|466497875|FG000|Overall Study|Withdrawal by Subject|3|||
129601206|NCT04718194|466497876|FG001|Overall Study|Withdrawal by Subject|0|||
129601207|NCT04718194|466497875|FG000|Overall Study|Lost to Follow-up|3|||
129601208|NCT04718194|466497876|FG001|Overall Study|Lost to Follow-up|0|||
129601209|NCT02091141|466497878|FG000|Overall Study|Death|280|||
129601210|NCT02091141|466497879|FG001|Overall Study|Death|118|||
129601211|NCT02091141|466497880|FG002|Overall Study|Death|46|||
129601212|NCT02091141|466497881|FG003|Overall Study|Death|13|||
129601213|NCT02091141|466497882|FG004|Overall Study|Death|31|||
129601214|NCT02091141|466497883|FG005|Overall Study|Death|16|||
129601215|NCT02091141|466497884|FG006|Overall Study|Death|12|||
129601216|NCT02091141|466497878|FG000|Overall Study|Withdrawal by Subject|21|||
129885993|NCT02291289|467542803|FG010|Early Disease Progression|Death|0|||
129601217|NCT02091141|466497879|FG001|Overall Study|Withdrawal by Subject|13|||
129601218|NCT02091141|466497880|FG002|Overall Study|Withdrawal by Subject|3|||
129601219|NCT02091141|466497881|FG003|Overall Study|Withdrawal by Subject|2|||
129885994|NCT02291289|467542804|FG011|Early Disease Progression|Death|0|||
129885995|NCT02291289|467542805|FG012|Early Disease Progression|Death|10|||
129601220|NCT02091141|466497882|FG004|Overall Study|Withdrawal by Subject|2|||
129601221|NCT02091141|466497883|FG005|Overall Study|Withdrawal by Subject|3|||
129885996|NCT02291289|467542793|FG000|Early Disease Progression|Lost to Follow-up|0|||
129601222|NCT02091141|466497884|FG006|Overall Study|Withdrawal by Subject|0|||
129601223|NCT02091141|466497878|FG000|Overall Study|Lost to Follow-up|21|||
129601224|NCT02091141|466497879|FG001|Overall Study|Lost to Follow-up|5|||
129601225|NCT02091141|466497880|FG002|Overall Study|Lost to Follow-up|1|||
129601226|NCT02091141|466497881|FG003|Overall Study|Lost to Follow-up|0|||
129601227|NCT02091141|466497882|FG004|Overall Study|Lost to Follow-up|1|||
129601228|NCT02091141|466497883|FG005|Overall Study|Lost to Follow-up|2|||
129601229|NCT02091141|466497884|FG006|Overall Study|Lost to Follow-up|0|||
129601230|NCT02091141|466497878|FG000|Overall Study|Reason Not Specified|6|||
129601231|NCT02091141|466497879|FG001|Overall Study|Reason Not Specified|5|||
129601232|NCT02091141|466497880|FG002|Overall Study|Reason Not Specified|2|||
129601233|NCT02091141|466497881|FG003|Overall Study|Reason Not Specified|0|||
129601234|NCT02091141|466497882|FG004|Overall Study|Reason Not Specified|0|||
129601235|NCT02091141|466497883|FG005|Overall Study|Reason Not Specified|0|||
129601236|NCT02091141|466497884|FG006|Overall Study|Reason Not Specified|1|||
129601237|NCT02091141|466497878|FG000|Overall Study|Study Ended by Sponsor|1|||
129601238|NCT02091141|466497879|FG001|Overall Study|Study Ended by Sponsor|9|||
129601239|NCT02091141|466497880|FG002|Overall Study|Study Ended by Sponsor|0|||
129601240|NCT02091141|466497881|FG003|Overall Study|Study Ended by Sponsor|0|||
129601241|NCT02091141|466497882|FG004|Overall Study|Study Ended by Sponsor|0|||
129601242|NCT02091141|466497883|FG005|Overall Study|Study Ended by Sponsor|0|||
129601243|NCT02091141|466497884|FG006|Overall Study|Study Ended by Sponsor|0|||
129601244|NCT02091141|466497878|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
129601245|NCT02091141|466497879|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
129601246|NCT02091141|466497880|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
129601247|NCT02091141|466497881|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
129601248|NCT02091141|466497882|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
129601249|NCT02091141|466497883|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
129601250|NCT02091141|466497884|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
129601251|NCT02246439|466497885|FG000|Overall Study|Adverse Event|3|||
129601252|NCT02246439|466497886|FG001|Overall Study|Adverse Event|0|||
129601253|NCT02246439|466497885|FG000|Overall Study|Lost to Follow-up|7|||
129601254|NCT02246439|466497886|FG001|Overall Study|Lost to Follow-up|5|||
129601255|NCT02246439|466497885|FG000|Overall Study|Protocol Violation|0|||
129788942|NCT03011892|467193503|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
129788943|NCT03011892|467193504|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
129788944|NCT03011892|467193505|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
129601256|NCT02246439|466497886|FG001|Overall Study|Protocol Violation|2|||
129601257|NCT02246439|466497885|FG000|Overall Study|Physician Decision|0|||
129601258|NCT02246439|466497886|FG001|Overall Study|Physician Decision|1|||
129601259|NCT02246439|466497885|FG000|Overall Study|Unkonwn|1|||
129601260|NCT02246439|466497886|FG001|Overall Study|Unkonwn|3|||
129601261|NCT02246439|466497885|FG000|Overall Study|Withdrawal by Subject|1|||
129601262|NCT02246439|466497886|FG001|Overall Study|Withdrawal by Subject|0|||
129601263|NCT03439852|466497887|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
129601264|NCT03439852|466497888|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
129601265|NCT03439852|466497887|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
129601266|NCT03439852|466497888|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
129601267|NCT03439852|466497887|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
129601268|NCT03439852|466497888|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
129601269|NCT01215513|466497889|FG000|Overall Study|Not completed CS42|9|||
129601270|NCT01215513|466497889|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
129601271|NCT01215513|466497889|FG000|Overall Study|Adverse event (CS42A)|2|||
129601272|NCT01215513|466497889|FG000|Overall Study|Physician decision (CS42A)|6|||
129601273|NCT01215513|466497889|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
129601274|NCT01215513|466497889|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
129788945|NCT03011892|467193506|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
129788946|NCT03011892|467193507|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
129788947|NCT03011892|467193508|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
129788948|NCT03011892|467193509|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
129788949|NCT03011892|467193498|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
129788950|NCT03011892|467193499|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
129788951|NCT03011892|467193500|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
129788952|NCT03011892|467193501|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
129788953|NCT03011892|467193502|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
129788954|NCT03011892|467193503|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
129788955|NCT03011892|467193504|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
129788956|NCT03011892|467193505|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
129788957|NCT03011892|467193506|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
129601275|NCT01553279|466497890|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
129601276|NCT01553279|466497891|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
129601277|NCT01553279|466497890|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
129601278|NCT01553279|466497891|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
129601279|NCT01553279|466497890|FG000|Interim Period|Withdrawal by Subject|2|||
129601280|NCT01553279|466497891|FG001|Interim Period|Withdrawal by Subject|2|||
129601281|NCT01553279|466497890|FG000|Interim Period|Lost to Follow-up|1|||
129601282|NCT01553279|466497891|FG001|Interim Period|Lost to Follow-up|0|||
129601283|NCT01553279|466497890|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
129601284|NCT01553279|466497891|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
129601285|NCT01553279|466497890|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
129601286|NCT01553279|466497891|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
129601287|NCT03955471|466497892|FG000|Overall Study|Death|22|||
129601288|NCT03955471|466497892|FG000|Overall Study|Lost to Follow-up|1|||
129601289|NCT03955471|466497892|FG000|Overall Study|Withdrawal by Subject|6|||
129601290|NCT03955471|466497892|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
129601291|NCT01996332|466497903|FG000|Overall Study|Adverse Event|117|||
129601292|NCT01996332|466497903|FG000|Overall Study|Lack of Efficacy|1245|||
129601293|NCT01996332|466497903|FG000|Overall Study|Death|264|||
129601294|NCT01996332|466497903|FG000|Overall Study|Protocol Violation|9|||
129601295|NCT01996332|466497903|FG000|Overall Study|Withdrawal by Subject|71|||
129601296|NCT01996332|466497903|FG000|Overall Study|Other|20|||
129601297|NCT01996332|466497903|FG000|Overall Study|Clinical Deterioration|28|||
129601298|NCT01996332|466497903|FG000|Overall Study|Physician Decision|17|||
129601299|NCT01996332|466497903|FG000|Overall Study|Lost to Follow-up|34|||
129601300|NCT02113189|466497904|FG000|Overall Study|Lost to follow up|2|||
129601301|NCT02113189|466497905|FG001|Overall Study|Lost to follow up|1|||
129601302|NCT02113189|466497906|FG002|Overall Study|Lost to follow up|3|||
129601303|NCT00931268|466497907|FG000|Overall Study|Lost to Follow-up|6|||
129601304|NCT01388166|466497908|FG000|Overall Study|Adverse Event|16|||
129601305|NCT01388166|466497908|FG000|Overall Study|Lost to Follow-up|30|||
129601306|NCT01388166|466497908|FG000|Overall Study|Others than specified above|13|||
129601307|NCT00430495|466497909|FG000|Overall Study|Adverse Event|2|||
129788958|NCT03011892|467193507|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
129788959|NCT03011892|467193508|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
129788960|NCT03011892|467193509|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
129788961|NCT03011892|467193498|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
129601308|NCT00430495|466497910|FG001|Overall Study|Adverse Event|3|||
129601309|NCT00430495|466497911|FG002|Overall Study|Adverse Event|2|||
129601310|NCT00430495|466497912|FG003|Overall Study|Adverse Event|0|||
129601311|NCT00430495|466497909|FG000|Overall Study|Death|0|||
129601312|NCT00430495|466497910|FG001|Overall Study|Death|0|||
129601313|NCT00430495|466497911|FG002|Overall Study|Death|1|||
129601314|NCT00430495|466497912|FG003|Overall Study|Death|0|||
129601315|NCT00430495|466497909|FG000|Overall Study|Lost to Follow-up|0|||
129601316|NCT00430495|466497910|FG001|Overall Study|Lost to Follow-up|1|||
129601317|NCT00430495|466497911|FG002|Overall Study|Lost to Follow-up|4|||
129788962|NCT03011892|467193499|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
129788963|NCT03011892|467193500|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
129788964|NCT03011892|467193501|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
129788965|NCT03011892|467193502|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
129788966|NCT03011892|467193503|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
129788967|NCT03011892|467193504|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
129788968|NCT03011892|467193505|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
129788969|NCT03011892|467193506|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
129788970|NCT03011892|467193507|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
129788971|NCT03011892|467193508|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
129601318|NCT00430495|466497912|FG003|Overall Study|Lost to Follow-up|0|||
129601319|NCT00430495|466497909|FG000|Overall Study|Protocol Violation|1|||
129601320|NCT00430495|466497910|FG001|Overall Study|Protocol Violation|0|||
129601321|NCT00430495|466497911|FG002|Overall Study|Protocol Violation|1|||
129601322|NCT00430495|466497912|FG003|Overall Study|Protocol Violation|0|||
129601323|NCT00430495|466497909|FG000|Overall Study|Disease Progression|1|||
129601324|NCT00430495|466497910|FG001|Overall Study|Disease Progression|1|||
129601325|NCT00430495|466497911|FG002|Overall Study|Disease Progression|0|||
129601326|NCT00430495|466497912|FG003|Overall Study|Disease Progression|0|||
129601327|NCT00430495|466497909|FG000|Overall Study|Other|8|||
129601328|NCT00430495|466497910|FG001|Overall Study|Other|2|||
129601329|NCT00430495|466497911|FG002|Overall Study|Other|5|||
129601330|NCT00430495|466497912|FG003|Overall Study|Other|4|||
129601331|NCT00430495|466497909|FG000|Overall Study|Randomized but not Treated|2|||
129601332|NCT00430495|466497910|FG001|Overall Study|Randomized but not Treated|0|||
129601333|NCT00430495|466497911|FG002|Overall Study|Randomized but not Treated|0|||
129601334|NCT00430495|466497912|FG003|Overall Study|Randomized but not Treated|0|||
129601335|NCT00158756|466497917|FG000|Overall Study|Withdrawal by Subject|5|||
129601336|NCT00158756|466497918|FG001|Overall Study|Withdrawal by Subject|0|||
129601337|NCT00158756|466497919|FG002|Overall Study|Withdrawal by Subject|6|||
129601338|NCT00158756|466497920|FG003|Overall Study|Withdrawal by Subject|1|||
129601339|NCT00158756|466497921|FG004|Overall Study|Withdrawal by Subject|3|||
129601340|NCT00158756|466497917|FG000|Overall Study|Adverse Event|0|||
129788972|NCT03011892|467193509|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
129788973|NCT03011892|467193498|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
129788974|NCT03011892|467193499|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
129788975|NCT03011892|467193500|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
129788976|NCT03011892|467193501|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
129788977|NCT03011892|467193502|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
129788978|NCT03011892|467193503|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
129788979|NCT03011892|467193504|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
129788980|NCT03011892|467193505|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
129788981|NCT03011892|467193506|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
129788982|NCT03011892|467193507|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
129788983|NCT03011892|467193508|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
129788984|NCT03011892|467193509|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
129788985|NCT03011892|467193498|FG000|Open Label (OL) Period|Reason not specified|0|||
129788986|NCT03011892|467193499|FG001|Open Label (OL) Period|Reason not specified|0|||
129788987|NCT03011892|467193500|FG002|Open Label (OL) Period|Reason not specified|0|||
129788988|NCT03011892|467193501|FG003|Open Label (OL) Period|Reason not specified|0|||
129601341|NCT00158756|466497918|FG001|Overall Study|Adverse Event|0|||
129788989|NCT03011892|467193502|FG004|Open Label (OL) Period|Reason not specified|0|||
129788990|NCT03011892|467193503|FG005|Open Label (OL) Period|Reason not specified|0|||
129601342|NCT00158756|466497919|FG002|Overall Study|Adverse Event|1|||
129601343|NCT00158756|466497920|FG003|Overall Study|Adverse Event|0|||
129601344|NCT00158756|466497921|FG004|Overall Study|Adverse Event|0|||
129601345|NCT00158756|466497917|FG000|Overall Study|Serious adverse event|0|||
129601346|NCT00158756|466497918|FG001|Overall Study|Serious adverse event|0|||
129601347|NCT00158756|466497919|FG002|Overall Study|Serious adverse event|1|||
129601348|NCT00158756|466497920|FG003|Overall Study|Serious adverse event|0|||
129601349|NCT00158756|466497921|FG004|Overall Study|Serious adverse event|0|||
129601350|NCT02145026|466497922|FG000|Overall Study|Adverse Event|2|||
129601351|NCT02145026|466497922|FG000|Overall Study|Death|4|||
129601352|NCT02145026|466497922|FG000|Overall Study|Withdrawal by Subject|2|||
129601353|NCT02145026|466497922|FG000|Overall Study|Physician Decision|4|||
129601354|NCT01429051|466497925|FG000|Titration Phase|Death|1|||
129601355|NCT01429051|466497925|FG000|Titration Phase|Withdrawal by Subject|7|||
129601356|NCT01429051|466497925|FG000|Titration Phase|Physician Decision|1|||
129601357|NCT01429051|466497925|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
129601358|NCT01429051|466497925|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
129601359|NCT01429051|466497925|FG000|Efficacy Phase|Adverse Event|1|||
129601360|NCT01429051|466497925|FG000|Efficacy Phase|Death|1|||
129601361|NCT01429051|466497925|FG000|Tolerability Phase|Death|5|||
129601362|NCT01429051|466497925|FG000|Tolerability Phase|Adverse Event|2|||
129601363|NCT01429051|466497925|FG000|Tolerability Phase|Withdrawal by Subject|5|||
129601364|NCT01429051|466497925|FG000|Tolerability Phase|Physician Decision|1|||
129601365|NCT01429051|466497925|FG000|Tolerability Phase|Other|2|||
129601366|NCT04132336|466497927|FG000|Overall Study|Investigator Decision|0|||
129601367|NCT04132336|466497928|FG001|Overall Study|Investigator Decision|1|||
129601368|NCT04132336|466497929|FG002|Overall Study|Investigator Decision|0|||
129601369|NCT04132336|466497930|FG003|Overall Study|Investigator Decision|0|||
129601370|NCT04132336|466497931|FG004|Overall Study|Investigator Decision|0|||
129601371|NCT04132336|466497932|FG005|Overall Study|Investigator Decision|0|||
129601372|NCT04132336|466497933|FG006|Overall Study|Investigator Decision|0|||
129601373|NCT03656874|466497934|FG000|Overall Study|Lost to Follow-up|3|||
129601374|NCT03656874|466497935|FG001|Overall Study|Lost to Follow-up|17|||
129601375|NCT00857792|466497936|FG000|Overall Study|inadequate image quality for analysis|12|||
129601376|NCT00584844|466497937|FG000|Overall Study|Withdrawal by Subject|59|||
129601377|NCT00584844|466497937|FG000|Overall Study|Screen Failure|20|||
129601378|NCT01797835|466497938|FG000|Overall Study|Lost to Follow-up|31|||
129601379|NCT01797835|466497939|FG001|Overall Study|Lost to Follow-up|27|||
129601380|NCT02528123|466497941|FG000|Overall Study|Lost to Follow-up|1|||
129601381|NCT04421586|466497949|FG000|Overall Study|Death|0|||
129601382|NCT04421586|466497950|FG001|Overall Study|Death|1|||
129601383|NCT04421586|466497949|FG000|Overall Study|Lost to Follow-up|2|||
129601384|NCT04421586|466497950|FG001|Overall Study|Lost to Follow-up|2|||
129601385|NCT04421586|466497949|FG000|Overall Study|Withdrawn by PI|1|||
129601386|NCT04421586|466497950|FG001|Overall Study|Withdrawn by PI|0|||
129601387|NCT04421586|466497949|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
129601388|NCT04421586|466497950|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
129601389|NCT04505293|466497951|FG000|Overall Study|Lost to Follow-up|2|||
129601390|NCT04505293|466497951|FG000|Overall Study|Withdrawal by Subject|6|||
129601391|NCT04505293|466497951|FG000|Overall Study|CT scan unreadable|277|||
129601392|NCT04295135|466497952|FG000|Overall Study|Withdrawal by Subject|2|||
129601393|NCT04295135|466497953|FG001|Overall Study|Withdrawal by Subject|1|||
129601394|NCT04295135|466497952|FG000|Overall Study|Subject left organization|8|||
129601395|NCT04295135|466497953|FG001|Overall Study|Subject left organization|4|||
129601396|NCT03484117|466497955|FG000|Overall Study|Lost to Follow-up|1|||
129601397|NCT03484117|466497956|FG001|Overall Study|Lost to Follow-up|3|||
129601398|NCT03484117|466497955|FG000|Overall Study|Declined participation in exit assess|1|||
129601399|NCT03484117|466497956|FG001|Overall Study|Declined participation in exit assess|1|||
129601400|NCT00289874|466497957|FG000|Overall Study|Adverse Event|1|||
129601401|NCT00289874|466497958|FG001|Overall Study|Adverse Event|5|||
129601402|NCT00289874|466497957|FG000|Overall Study|Lost to Follow-up|1|||
129601403|NCT00289874|466497958|FG001|Overall Study|Lost to Follow-up|1|||
129601404|NCT00289874|466497957|FG000|Overall Study|Protocol Violation|3|||
129601405|NCT00289874|466497958|FG001|Overall Study|Protocol Violation|2|||
129601406|NCT00289874|466497957|FG000|Overall Study|Did not meet eligibility|1|||
129601407|NCT00289874|466497958|FG001|Overall Study|Did not meet eligibility|0|||
129601408|NCT03835325|466497959|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
129601409|NCT03835325|466497959|FG000|Overall Study|Selection failure|1|||
129601410|NCT00775606|466497960|FG000|Overall Study|Study sponsor terminated funding|3|||
129601411|NCT00775606|466497961|FG001|Overall Study|Study sponsor terminated funding|0|||
129601412|NCT03212794|466497962|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
129601413|NCT03212794|466497963|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
129601414|NCT03212794|466497962|FG000|Overall Study|Lost to Follow-up|5|||
129601415|NCT03212794|466497963|FG001|Overall Study|Lost to Follow-up|6|||
129601416|NCT03212794|466497962|FG000|Overall Study|Incarcerated; unable to participate|2|||
129601417|NCT03212794|466497963|FG001|Overall Study|Incarcerated; unable to participate|0|||
129601418|NCT03212794|466497962|FG000|Overall Study|Withdrawal by Subject|1|||
129601419|NCT03212794|466497963|FG001|Overall Study|Withdrawal by Subject|0|||
129601420|NCT03212794|466497962|FG000|Overall Study|Death|0|||
129601421|NCT03212794|466497963|FG001|Overall Study|Death|1|||
129601422|NCT03212794|466497962|FG000|Overall Study|Found to be ineligible after allocation|0|||
129601423|NCT03212794|466497963|FG001|Overall Study|Found to be ineligible after allocation|1|||
129601424|NCT03212794|466497962|FG000|Overall Study|Relocated out of area|2|||
129601425|NCT03212794|466497963|FG001|Overall Study|Relocated out of area|0|||
129436590|NCT02647320|465897141|FG000|Overall Study|Withdrawal by Subject|7|||
129436591|NCT02647320|465897142|FG001|Overall Study|Withdrawal by Subject|4|||
129436592|NCT02647320|465897143|FG002|Overall Study|Withdrawal by Subject|2|||
129436593|NCT02647320|465897144|FG003|Overall Study|Withdrawal by Subject|2|||
129436594|NCT02647320|465897145|FG004|Overall Study|Withdrawal by Subject|7|||
129436595|NCT02647320|465897141|FG000|Overall Study|Persistent hyperglycemia|0|||
129436596|NCT02647320|465897142|FG001|Overall Study|Persistent hyperglycemia|1|||
129436597|NCT02647320|465897143|FG002|Overall Study|Persistent hyperglycemia|1|||
129436598|NCT02647320|465897144|FG003|Overall Study|Persistent hyperglycemia|1|||
129436599|NCT02647320|465897145|FG004|Overall Study|Persistent hyperglycemia|1|||
129436600|NCT02647320|465897141|FG000|Overall Study|Study terminated by sponsor|1|||
129436601|NCT02647320|465897142|FG001|Overall Study|Study terminated by sponsor|1|||
129436602|NCT02647320|465897143|FG002|Overall Study|Study terminated by sponsor|1|||
129436603|NCT02647320|465897144|FG003|Overall Study|Study terminated by sponsor|1|||
129436604|NCT02647320|465897145|FG004|Overall Study|Study terminated by sponsor|2|||
129436605|NCT02647320|465897141|FG000|Overall Study|Reason not provided|0|||
129436606|NCT02647320|465897142|FG001|Overall Study|Reason not provided|0|||
129436607|NCT02647320|465897143|FG002|Overall Study|Reason not provided|1|||
129436608|NCT02647320|465897144|FG003|Overall Study|Reason not provided|0|||
129436609|NCT02647320|465897145|FG004|Overall Study|Reason not provided|2|||
129436610|NCT02647320|465897141|FG000|Overall Study|Lost to Follow-up|1|||
129436611|NCT02647320|465897142|FG001|Overall Study|Lost to Follow-up|1|||
129436612|NCT02647320|465897143|FG002|Overall Study|Lost to Follow-up|0|||
129601426|NCT00257920|466497965|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
129601427|NCT00257920|466497966|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
129601428|NCT00257920|466497965|FG000|Period: Second Intervention|Other|2|||
129601429|NCT00257920|466497966|FG001|Period: Second Intervention|Other|1|||
129601430|NCT00770692|466497969|FG000|Overall Study|Withdrawal by Subject|7|||
129601431|NCT00770692|466497970|FG001|Overall Study|Withdrawal by Subject|9|||
129601432|NCT00770692|466497971|FG002|Overall Study|Withdrawal by Subject|9|||
129436613|NCT02647320|465897144|FG003|Overall Study|Lost to Follow-up|0|||
129436614|NCT02647320|465897145|FG004|Overall Study|Lost to Follow-up|0|||
129601433|NCT00770692|466497972|FG003|Overall Study|Withdrawal by Subject|6|||
129601434|NCT00770692|466497969|FG000|Overall Study|Adverse Event|3|||
129601435|NCT00770692|466497970|FG001|Overall Study|Adverse Event|0|||
129601436|NCT00770692|466497971|FG002|Overall Study|Adverse Event|4|||
129601437|NCT00770692|466497972|FG003|Overall Study|Adverse Event|4|||
129601438|NCT00770692|466497969|FG000|Overall Study|Investigator judgment|2|||
129601439|NCT00770692|466497970|FG001|Overall Study|Investigator judgment|0|||
129601440|NCT00770692|466497971|FG002|Overall Study|Investigator judgment|1|||
129601441|NCT00770692|466497972|FG003|Overall Study|Investigator judgment|1|||
129601442|NCT00560937|466497974|FG000|Overall Study|Withdrawal by Subject|0|||
129601443|NCT00560937|466497975|FG001|Overall Study|Withdrawal by Subject|1|||
129601444|NCT00560937|466497974|FG000|Overall Study|Physician Decision|1|||
129601445|NCT00560937|466497975|FG001|Overall Study|Physician Decision|1|||
129601446|NCT03629028|466497978|FG000|Overall Study|Lost to Follow-up|26|||
129601447|NCT03629028|466497979|FG001|Overall Study|Lost to Follow-up|23|||
129601448|NCT03629028|466497978|FG000|Overall Study|Pregnancy|4|||
129601449|NCT03629028|466497979|FG001|Overall Study|Pregnancy|2|||
129601450|NCT03629028|466497978|FG000|Overall Study|intolerance to examination|2|||
129601451|NCT03629028|466497979|FG001|Overall Study|intolerance to examination|0|||
129601452|NCT02025751|466497982|FG000|Overall Study|Lost to Follow-up|1|||
129601453|NCT02025751|466497983|FG001|Overall Study|Lost to Follow-up|0|||
129601454|NCT02025751|466497982|FG000|Overall Study|Adverse Event|0|||
129601455|NCT02025751|466497983|FG001|Overall Study|Adverse Event|1|||
129601456|NCT02025751|466497982|FG000|Overall Study|Physician Decision|0|||
129601457|NCT02025751|466497983|FG001|Overall Study|Physician Decision|1|||
129601458|NCT02025751|466497982|FG000|Overall Study|Withdrawal by Subject|0|||
129601459|NCT02025751|466497983|FG001|Overall Study|Withdrawal by Subject|1|||
129601460|NCT01846273|466497984|FG000|Overall Study|Adverse Event|9|||
129601461|NCT01846273|466497985|FG001|Overall Study|Adverse Event|7|||
129601462|NCT01846273|466497986|FG002|Overall Study|Adverse Event|0|||
129601463|NCT01846273|466497984|FG000|Overall Study|Subject withdrew consent|5|||
129601464|NCT01846273|466497985|FG001|Overall Study|Subject withdrew consent|8|||
129601465|NCT01846273|466497986|FG002|Overall Study|Subject withdrew consent|0|||
129601466|NCT01846273|466497984|FG000|Overall Study|Lost to Follow-up|2|||
129601467|NCT01846273|466497985|FG001|Overall Study|Lost to Follow-up|1|||
129601468|NCT01846273|466497986|FG002|Overall Study|Lost to Follow-up|0|||
129601469|NCT01846273|466497984|FG000|Overall Study|Administrative problems|1|||
129601470|NCT01846273|466497985|FG001|Overall Study|Administrative problems|0|||
129601471|NCT01846273|466497986|FG002|Overall Study|Administrative problems|0|||
129601472|NCT01846273|466497984|FG000|Overall Study|Death|2|||
129601473|NCT01846273|466497985|FG001|Overall Study|Death|1|||
129601474|NCT01846273|466497986|FG002|Overall Study|Death|0|||
129601475|NCT01846273|466497984|FG000|Overall Study|Disease Progression|0|||
129601476|NCT01846273|466497985|FG001|Overall Study|Disease Progression|4|||
129601477|NCT01846273|466497986|FG002|Overall Study|Disease Progression|0|||
129601478|NCT01846273|466497984|FG000|Overall Study|Protocol Deviation|2|||
129601479|NCT01846273|466497985|FG001|Overall Study|Protocol Deviation|3|||
129601480|NCT01846273|466497986|FG002|Overall Study|Protocol Deviation|0|||
129601481|NCT01846273|466497984|FG000|Overall Study|Physician Decision|1|||
129601482|NCT01846273|466497985|FG001|Overall Study|Physician Decision|2|||
129601483|NCT01846273|466497986|FG002|Overall Study|Physician Decision|0|||
129601484|NCT00891839|466497987|FG000|Overall Study|Adverse Event|2|||
129601485|NCT00891839|466497987|FG000|Overall Study|Withdrawal by Subject|2|||
129601486|NCT00891839|466497987|FG000|Overall Study|Disease progression|3|||
129601487|NCT05069155|466497988|FG000|Overall Study|Withdrawal by Subject|1|||
129601488|NCT05069155|466497989|FG001|Overall Study|Withdrawal by Subject|3|||
129601489|NCT00712985|466497990|FG000|Overall Study|1 withdrew prior to start of drug|1|||
129601490|NCT00712985|466497990|FG000|Overall Study|1 patient moved out of state|1|||
129788991|NCT03011892|467193504|FG006|Open Label (OL) Period|Reason not specified|0|||
129788992|NCT03011892|467193505|FG007|Open Label (OL) Period|Reason not specified|1|||
129788993|NCT03011892|467193506|FG008|Open Label (OL) Period|Reason not specified|0|||
129436615|NCT02647320|465897141|FG000|Overall Study|Develop anemia|1|||
129601491|NCT00712985|466497990|FG000|Overall Study|Lack of Efficacy|3|||
129601492|NCT02674061|466497991|FG000|Overall Study|Death|229|||
129601493|NCT02674061|466497992|FG001|Overall Study|Death|77|||
129601494|NCT02674061|466497991|FG000|Overall Study|Lost to Follow-up|3|||
129601495|NCT02674061|466497992|FG001|Overall Study|Lost to Follow-up|3|||
129601496|NCT02674061|466497991|FG000|Overall Study|Withdrawal by Subject|9|||
129601497|NCT02674061|466497992|FG001|Overall Study|Withdrawal by Subject|1|||
129601498|NCT02674061|466497991|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
129601499|NCT02674061|466497992|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
129601500|NCT01299805|466497995|FG000|Overall Study|Adverse Event|2|||
129601501|NCT01299805|466497996|FG001|Overall Study|Adverse Event|0|||
129601502|NCT00123955|466498000|FG000|Overall Study|Adverse Event|1|||
129601503|NCT00123955|466498001|FG001|Overall Study|Adverse Event|0|||
129601504|NCT00123955|466498000|FG000|Overall Study|Withdrawal by Subject|4|||
129601505|NCT00123955|466498001|FG001|Overall Study|Withdrawal by Subject|3|||
129601506|NCT00123955|466498000|FG000|Overall Study|Death|0|||
129601507|NCT00123955|466498001|FG001|Overall Study|Death|1|||
129601508|NCT04969861|466498003|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
129601509|NCT04969861|466498004|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
129601510|NCT04556552|466499497|FG000|Overall Study|Lost to Follow-up|1|||
129601511|NCT04556552|466499498|FG001|Overall Study|Lost to Follow-up|0|||
129601512|NCT04556552|466499497|FG000|Overall Study|Claustrophobia|0|||
129601513|NCT04556552|466499498|FG001|Overall Study|Claustrophobia|1|||
129601514|NCT04556552|466499497|FG000|Overall Study|Inability to continue|0|||
129601515|NCT04556552|466499498|FG001|Overall Study|Inability to continue|1|||
129601516|NCT00605865|466499499|FG000|Overall Study|Protocol Violation|115|||
129601517|NCT00793780|466499502|FG000|Overall Study|Withdrawal by Subject|2|||
129601518|NCT00793780|466499503|FG001|Overall Study|Withdrawal by Subject|1|||
129601519|NCT02858492|466499504|FG000|Overall Study|Withdrawal by Subject|0|||
129788994|NCT03011892|467193507|FG009|Open Label (OL) Period|Reason not specified|0|||
129788995|NCT03011892|467193508|FG010|Open Label (OL) Period|Reason not specified|0|||
129788996|NCT03011892|467193509|FG011|Open Label (OL) Period|Reason not specified|0|||
129788997|NCT02312687|467193511|FG000|Overall Study|Other, Not Specified|1|||
129788998|NCT00384111|467193512|FG000|Overall Study|Disease Progression|3|||
129788999|NCT00384111|467193512|FG000|Overall Study|Adverse Event|1|||
129789000|NCT00384111|467193512|FG000|Overall Study|Investigator Decision|3|||
129789001|NCT00384111|467193512|FG000|Overall Study|Study Terminated by the Sponsor|19|||
129789002|NCT03612856|467193513|FG000|Pre-dose Period|Physician Decision|0|||
129789003|NCT03612856|467193514|FG001|Pre-dose Period|Physician Decision|1|||
129789004|NCT03612856|467193515|FG002|Pre-dose Period|Physician Decision|1|||
129601520|NCT02858492|466499505|FG001|Overall Study|Withdrawal by Subject|1|||
129601521|NCT02858492|466499506|FG002|Overall Study|Withdrawal by Subject|0|||
129601522|NCT02858492|466499507|FG003|Overall Study|Withdrawal by Subject|1|||
129601523|NCT02858492|466499504|FG000|Overall Study|Adverse Event|0|||
129601524|NCT02858492|466499505|FG001|Overall Study|Adverse Event|0|||
129601525|NCT02858492|466499506|FG002|Overall Study|Adverse Event|0|||
129601526|NCT02858492|466499507|FG003|Overall Study|Adverse Event|3|||
129601527|NCT02858492|466499504|FG000|Overall Study|Lack of Efficacy|0|||
129601528|NCT02858492|466499505|FG001|Overall Study|Lack of Efficacy|0|||
129601529|NCT02858492|466499506|FG002|Overall Study|Lack of Efficacy|0|||
129601530|NCT02858492|466499507|FG003|Overall Study|Lack of Efficacy|1|||
129601531|NCT02858492|466499504|FG000|Overall Study|Protocol defined stopping criteria|0|||
129601532|NCT02858492|466499505|FG001|Overall Study|Protocol defined stopping criteria|0|||
129601533|NCT02858492|466499506|FG002|Overall Study|Protocol defined stopping criteria|0|||
129601534|NCT02858492|466499507|FG003|Overall Study|Protocol defined stopping criteria|1|||
129601535|NCT02119286|466499512|FG000|Overall Study|Adverse Event|9|||
129601536|NCT02119286|466499513|FG001|Overall Study|Adverse Event|7|||
129601537|NCT02119286|466499514|FG002|Overall Study|Adverse Event|2|||
129789005|NCT03612856|467193513|FG000|Pre-dose Period|Withdrawal by Subject|0|||
129789006|NCT03612856|467193514|FG001|Pre-dose Period|Withdrawal by Subject|1|||
129789007|NCT03612856|467193515|FG002|Pre-dose Period|Withdrawal by Subject|0|||
129789008|NCT03720652|467193518|FG000|Overall Study|Withdrawal by Subject|2|||
129436616|NCT02647320|465897142|FG001|Overall Study|Develop anemia|0|||
129601538|NCT02119286|466499512|FG000|Overall Study|Lack of Efficacy|11|||
129601539|NCT02119286|466499513|FG001|Overall Study|Lack of Efficacy|3|||
129601540|NCT02119286|466499514|FG002|Overall Study|Lack of Efficacy|4|||
129601541|NCT02119286|466499512|FG000|Overall Study|Lost to Follow-up|2|||
129601542|NCT02119286|466499513|FG001|Overall Study|Lost to Follow-up|0|||
129601543|NCT02119286|466499514|FG002|Overall Study|Lost to Follow-up|1|||
129601544|NCT02119286|466499512|FG000|Overall Study|Withdrawal by Subject|4|||
129885997|NCT02291289|467542794|FG001|Early Disease Progression|Lost to Follow-up|0|||
129601545|NCT02119286|466499513|FG001|Overall Study|Withdrawal by Subject|1|||
129789009|NCT03720652|467193519|FG001|Overall Study|Withdrawal by Subject|7|||
129789010|NCT03720652|467193518|FG000|Overall Study|Lost to Follow-up|0|||
129789011|NCT03720652|467193519|FG001|Overall Study|Lost to Follow-up|4|||
129789012|NCT01454778|467193524|FG000|Overall Study|Lost to Follow-up|2|||
129601546|NCT02119286|466499514|FG002|Overall Study|Withdrawal by Subject|0|||
129601547|NCT03310411|466499515|FG000|Period 1|Adverse Event|0|||
129601548|NCT03310411|466499516|FG001|Period 1|Adverse Event|0|||
129601549|NCT03310411|466499517|FG002|Period 1|Adverse Event|0|||
129601550|NCT03310411|466499518|FG003|Period 1|Adverse Event|1|||
129601551|NCT00619112|466499519|FG000|Overall Study|Adverse Event|1|||
129601552|NCT00619112|466499520|FG001|Overall Study|Adverse Event|2|||
129601553|NCT03623386|466499523|FG000|Overall Study|Protocol Violation|3|||
129601554|NCT03623386|466499524|FG001|Overall Study|Protocol Violation|2|||
129601555|NCT03623386|466499525|FG002|Overall Study|Protocol Violation|0|||
129601556|NCT03623386|466499523|FG000|Overall Study|Physician Decision|1|||
129601557|NCT03623386|466499524|FG001|Overall Study|Physician Decision|1|||
129601558|NCT03623386|466499525|FG002|Overall Study|Physician Decision|0|||
129601559|NCT03623386|466499523|FG000|Overall Study|Lost to Follow-up|0|||
129601560|NCT03623386|466499524|FG001|Overall Study|Lost to Follow-up|2|||
129601561|NCT03623386|466499525|FG002|Overall Study|Lost to Follow-up|0|||
129601562|NCT03623386|466499523|FG000|Overall Study|COVID-19|0|||
129601563|NCT03623386|466499524|FG001|Overall Study|COVID-19|1|||
129601564|NCT03623386|466499525|FG002|Overall Study|COVID-19|0|||
129601565|NCT04271735|466499530|FG000|Overall Study|Physician Decision|2|||
129601566|NCT04271735|466499531|FG001|Overall Study|Physician Decision|0|||
129601567|NCT00515541|466499532|FG000|Overall Study|Physician Decision|0|||
129601568|NCT00515541|466499533|FG001|Overall Study|Physician Decision|2|||
129601569|NCT00515541|466499534|FG002|Overall Study|Physician Decision|0|||
129601570|NCT00515541|466499535|FG003|Overall Study|Physician Decision|1|||
129601571|NCT00515541|466499532|FG000|Overall Study|No show for appointments|0|||
129601572|NCT00515541|466499533|FG001|Overall Study|No show for appointments|1|||
129601573|NCT00515541|466499534|FG002|Overall Study|No show for appointments|0|||
129601574|NCT00515541|466499535|FG003|Overall Study|No show for appointments|2|||
129601575|NCT00515541|466499532|FG000|Overall Study|Withdrawal by Subject|0|||
129601576|NCT00515541|466499533|FG001|Overall Study|Withdrawal by Subject|2|||
129601577|NCT00515541|466499534|FG002|Overall Study|Withdrawal by Subject|0|||
129601578|NCT00515541|466499535|FG003|Overall Study|Withdrawal by Subject|2|||
129601579|NCT02040779|466499537|FG000|Overall Study|Adverse Event|1|||
129601580|NCT02040779|466499538|FG001|Overall Study|Adverse Event|0|||
129601581|NCT02040779|466499539|FG002|Overall Study|Adverse Event|0|||
129601582|NCT02040779|466499537|FG000|Overall Study|Withdrawal by Subject|4|||
129601583|NCT02040779|466499538|FG001|Overall Study|Withdrawal by Subject|1|||
129601584|NCT02040779|466499539|FG002|Overall Study|Withdrawal by Subject|3|||
129601585|NCT02040779|466499537|FG000|Overall Study|Non-compliance|0|||
129601586|NCT02040779|466499538|FG001|Overall Study|Non-compliance|1|||
129601587|NCT02040779|466499539|FG002|Overall Study|Non-compliance|0|||
129789013|NCT01454778|467193524|FG000|Overall Study|Death|1|||
129789014|NCT00348881|467193525|FG000|Overall Study|Lost to Follow-up|12|||
129789015|NCT00348881|467193526|FG001|Overall Study|Lost to Follow-up|6|||
129789016|NCT00348881|467193525|FG000|Overall Study|Withdrawal by Subject|3|||
129789017|NCT00348881|467193526|FG001|Overall Study|Withdrawal by Subject|4|||
129789018|NCT00348881|467193525|FG000|Overall Study|Adverse Event|2|||
129789019|NCT00348881|467193526|FG001|Overall Study|Adverse Event|0|||
129789020|NCT00348881|467193525|FG000|Overall Study|Serious Adverse Event|0|||
129789021|NCT00348881|467193526|FG001|Overall Study|Serious Adverse Event|2|||
129789022|NCT03658876|467195516|FG000|Overall Study|Protocol Violation|3|||
129789023|NCT03658876|467195517|FG001|Overall Study|Protocol Violation|2|||
129789024|NCT03658876|467195516|FG000|Overall Study|Withdrawal by Subject|2|||
129789025|NCT03658876|467195517|FG001|Overall Study|Withdrawal by Subject|0|||
129789026|NCT03658876|467195516|FG000|Overall Study|Death|0|||
129789027|NCT03658876|467195517|FG001|Overall Study|Death|1|||
129436617|NCT02647320|465897143|FG002|Overall Study|Develop anemia|0|||
129436618|NCT02647320|465897144|FG003|Overall Study|Develop anemia|0|||
129436619|NCT02647320|465897145|FG004|Overall Study|Develop anemia|0|||
129601588|NCT02040779|466499537|FG000|Overall Study|Protocol Violation|2|||
129601589|NCT02040779|466499538|FG001|Overall Study|Protocol Violation|1|||
129601590|NCT02040779|466499539|FG002|Overall Study|Protocol Violation|0|||
129601591|NCT02040779|466499537|FG000|Overall Study|Lost to Follow-up|1|||
129601592|NCT02040779|466499538|FG001|Overall Study|Lost to Follow-up|2|||
129601593|NCT02040779|466499539|FG002|Overall Study|Lost to Follow-up|1|||
129601594|NCT02040779|466499537|FG000|Overall Study|Lack of Efficacy|4|||
129601595|NCT02040779|466499538|FG001|Overall Study|Lack of Efficacy|2|||
129601596|NCT02040779|466499539|FG002|Overall Study|Lack of Efficacy|0|||
129789028|NCT03658876|467195516|FG000|Overall Study|Intercurrent illness|6|||
129789029|NCT03658876|467195517|FG001|Overall Study|Intercurrent illness|4|||
129789030|NCT03658876|467195516|FG000|Overall Study|Transplantation/other operation|1|||
129789031|NCT03658876|467195517|FG001|Overall Study|Transplantation/other operation|5|||
129789032|NCT01330017|467195518|FG000|Overall Study|Adverse Event|0|||
129601597|NCT02132637|466499540|FG000|Study Period 1|Withdrawal by Subject|0|||
129601598|NCT02132637|466499541|FG001|Study Period 1|Withdrawal by Subject|4|||
129789033|NCT01330017|467195519|FG001|Overall Study|Adverse Event|1|||
129601599|NCT02132637|466499540|FG000|Study Period 1|Physician Decision|1|||
129601600|NCT02132637|466499541|FG001|Study Period 1|Physician Decision|0|||
129789034|NCT01330017|467195520|FG002|Overall Study|Adverse Event|1|||
129789035|NCT01330017|467195521|FG003|Overall Study|Adverse Event|4|||
129789036|NCT01330017|467195522|FG004|Overall Study|Adverse Event|0|||
129789037|NCT01330017|467195518|FG000|Overall Study|Withdrawal by Subject|0|||
129789038|NCT01330017|467195519|FG001|Overall Study|Withdrawal by Subject|0|||
129789039|NCT01330017|467195520|FG002|Overall Study|Withdrawal by Subject|1|||
129789040|NCT01330017|467195521|FG003|Overall Study|Withdrawal by Subject|0|||
129789041|NCT01330017|467195522|FG004|Overall Study|Withdrawal by Subject|1|||
129789042|NCT01330017|467195518|FG000|Overall Study|Lost to Follow-up|0|||
129789043|NCT01330017|467195519|FG001|Overall Study|Lost to Follow-up|0|||
129789044|NCT01330017|467195520|FG002|Overall Study|Lost to Follow-up|1|||
129789045|NCT01330017|467195521|FG003|Overall Study|Lost to Follow-up|0|||
129789046|NCT01330017|467195522|FG004|Overall Study|Lost to Follow-up|0|||
129789047|NCT01330017|467195518|FG000|Overall Study|Protocol Violation|0|||
129789048|NCT01330017|467195519|FG001|Overall Study|Protocol Violation|0|||
129789049|NCT01330017|467195520|FG002|Overall Study|Protocol Violation|0|||
129789050|NCT01330017|467195521|FG003|Overall Study|Protocol Violation|1|||
129789051|NCT01330017|467195522|FG004|Overall Study|Protocol Violation|0|||
129789052|NCT01330017|467195518|FG000|Overall Study|Unknown Reason|5|||
129789053|NCT01330017|467195519|FG001|Overall Study|Unknown Reason|3|||
129789054|NCT01330017|467195520|FG002|Overall Study|Unknown Reason|5|||
129789055|NCT01330017|467195521|FG003|Overall Study|Unknown Reason|7|||
129789056|NCT01330017|467195522|FG004|Overall Study|Unknown Reason|2|||
129789057|NCT02616146|467195524|FG000|Overall Study|Adverse Event|64|||
129789058|NCT02616146|467195525|FG001|Overall Study|Adverse Event|24|||
129789059|NCT02616146|467195524|FG000|Overall Study|Lost to Follow-up|23|||
129789060|NCT02616146|467195525|FG001|Overall Study|Lost to Follow-up|13|||
129789061|NCT02616146|467195524|FG000|Overall Study|Non-compliance with study protocol|2|||
129601601|NCT02132637|466499540|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
129601602|NCT02132637|466499541|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
129601603|NCT02132637|466499540|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
129601604|NCT02132637|466499541|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
129601605|NCT00922272|466499544|FG000|Open-label Phase|Adverse Event|5|||
129601606|NCT00922272|466499545|FG001|Open-label Phase|Adverse Event|0|||
129601607|NCT00922272|466499544|FG000|Open-label Phase|Protocol Violation|1|||
129601608|NCT00922272|466499545|FG001|Open-label Phase|Protocol Violation|0|||
129601609|NCT00922272|466499544|FG000|Open-label Phase|Withdrawal by Subject|11|||
129601610|NCT00922272|466499545|FG001|Open-label Phase|Withdrawal by Subject|0|||
129601611|NCT00922272|466499544|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
129601612|NCT00922272|466499545|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
129601613|NCT00922272|466499544|FG000|Open-label Phase|Withdrawal criteria met|5|||
129601614|NCT00922272|466499545|FG001|Open-label Phase|Withdrawal criteria met|0|||
129601615|NCT00922272|466499544|FG000|Double-blind Phase|Adverse Event|1|||
129601616|NCT00922272|466499545|FG001|Double-blind Phase|Adverse Event|1|||
129601617|NCT00922272|466499544|FG000|Double-blind Phase|Withdrawal by Subject|1|||
129601618|NCT00922272|466499545|FG001|Double-blind Phase|Withdrawal by Subject|1|||
129601619|NCT00922272|466499544|FG000|Double-blind Phase|Lost to Follow-up|2|||
129601620|NCT00922272|466499545|FG001|Double-blind Phase|Lost to Follow-up|1|||
129601621|NCT00922272|466499544|FG000|Double-blind Phase|Withdrawal criteria met|1|||
129601622|NCT00922272|466499545|FG001|Double-blind Phase|Withdrawal criteria met|1|||
129601623|NCT00922272|466499544|FG000|Double-blind Phase|Noncompliance|1|||
129601624|NCT00922272|466499545|FG001|Double-blind Phase|Noncompliance|1|||
129601625|NCT00922272|466499544|FG000|Double-blind Phase|Positive urine drug screen|1|||
129601626|NCT00922272|466499545|FG001|Double-blind Phase|Positive urine drug screen|1|||
129601627|NCT02588950|466499546|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
129601628|NCT02588950|466499547|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
129601629|NCT02588950|466499548|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
129601630|NCT02588950|466499549|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
129601631|NCT02588950|466499546|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
129601632|NCT02588950|466499547|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
129601633|NCT02588950|466499548|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
129601634|NCT02588950|466499549|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
129601635|NCT00652028|466499552|FG000|Overall Study|Adverse Event|1|||
129601636|NCT00652028|466499553|FG001|Overall Study|Adverse Event|0|||
129601637|NCT00652028|466499554|FG002|Overall Study|Adverse Event|0|||
129789062|NCT02616146|467195525|FG001|Overall Study|Non-compliance with study protocol|0|||
129789063|NCT02616146|467195524|FG000|Overall Study|Non-compliance with study drug|4|||
129789064|NCT02616146|467195525|FG001|Overall Study|Non-compliance with study drug|2|||
129789065|NCT02616146|467195524|FG000|Overall Study|Pregnancy|2|||
129789066|NCT02616146|467195525|FG001|Overall Study|Pregnancy|2|||
129789067|NCT02616146|467195524|FG000|Overall Study|Pregnancy wish|3|||
129436620|NCT02647320|465897141|FG000|Overall Study|Lack of Efficacy|0|||
129436621|NCT02647320|465897142|FG001|Overall Study|Lack of Efficacy|0|||
129436622|NCT02647320|465897143|FG002|Overall Study|Lack of Efficacy|0|||
129436623|NCT02647320|465897144|FG003|Overall Study|Lack of Efficacy|1|||
129436624|NCT02647320|465897145|FG004|Overall Study|Lack of Efficacy|0|||
129436625|NCT02647320|465897141|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
129436626|NCT02647320|465897142|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
129436627|NCT02647320|465897143|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
129436628|NCT02647320|465897144|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
129436629|NCT02647320|465897145|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
129436630|NCT00596427|465897146|FG000|Overall Study|Withdrawal by Subject|2|||
129436631|NCT00596427|465897147|FG001|Overall Study|Withdrawal by Subject|2|||
129436632|NCT00596427|465897146|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
129436633|NCT00596427|465897147|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
129436634|NCT00596427|465897146|FG000|Overall Study|Protocol Violation|1|||
129436635|NCT00596427|465897147|FG001|Overall Study|Protocol Violation|0|||
129436636|NCT00320541|465897148|FG000|Overall Study|Adverse Event|21|||
129697743|NCT01703221|466851934|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129697744|NCT01703221|466851932|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
129697745|NCT01703221|466851933|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129697746|NCT01703221|466851934|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129697747|NCT01703221|466851932|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129697748|NCT01703221|466851933|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129697749|NCT01703221|466851934|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
129697750|NCT01703221|466851932|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
129697751|NCT01703221|466851933|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
129697752|NCT01703221|466851934|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
129697753|NCT01703221|466851932|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
129697754|NCT01703221|466851933|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
129697755|NCT01703221|466851934|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
129697756|NCT01703221|466851932|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
129697757|NCT01703221|466851933|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
129697758|NCT01703221|466851934|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
129697759|NCT03927846|466851936|FG000|Overall Study|Lost to Follow-up|10|||
129697760|NCT03927846|466851937|FG001|Overall Study|Lost to Follow-up|11|||
129697761|NCT03878069|466851938|FG000|Overall Study|Death|0|||
129697762|NCT03878069|466851939|FG001|Overall Study|Death|1|||
129697763|NCT03878069|466851940|FG002|Overall Study|Death|0|||
129697764|NCT00834587|466851941|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
129697765|NCT00834587|466851942|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
129697766|NCT00530257|466853337|FG000|Overall Study|Lost to Follow-up|1|||
129697767|NCT05520333|466853341|FG000|Overall Study|Lost to Follow-up|3|||
129697768|NCT05520333|466853342|FG001|Overall Study|Lost to Follow-up|6|||
129697769|NCT01897896|466853343|FG000|Overall Study|Death|1|||
129697770|NCT01897896|466853344|FG001|Overall Study|Death|0|||
129697771|NCT01897896|466853343|FG000|Overall Study|Adverse Event|11|||
129697772|NCT01897896|466853344|FG001|Overall Study|Adverse Event|1|||
129697773|NCT01897896|466853343|FG000|Overall Study|Lost to Follow-up|1|||
129697774|NCT01897896|466853344|FG001|Overall Study|Lost to Follow-up|0|||
129697775|NCT01897896|466853343|FG000|Overall Study|Non-compliance with study drug dosing|1|||
129436637|NCT00320541|465897149|FG001|Overall Study|Adverse Event|19|||
129436638|NCT00320541|465897148|FG000|Overall Study|Protocol Violation|0|||
129436639|NCT00320541|465897149|FG001|Overall Study|Protocol Violation|1|||
129697776|NCT01897896|466853344|FG001|Overall Study|Non-compliance with study drug dosing|1|||
129697777|NCT01897896|466853343|FG000|Overall Study|Withdrawal by Subject|7|||
129697778|NCT01897896|466853344|FG001|Overall Study|Withdrawal by Subject|1|||
129697779|NCT01897896|466853343|FG000|Overall Study|Require drug that interfere with study|1|||
129697780|NCT01897896|466853344|FG001|Overall Study|Require drug that interfere with study|4|||
129697781|NCT01897896|466853343|FG000|Overall Study|Protocol Violation|1|||
129697782|NCT01897896|466853344|FG001|Overall Study|Protocol Violation|1|||
129697783|NCT01897896|466853343|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
129697784|NCT01897896|466853344|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
129697785|NCT01897896|466853343|FG000|Overall Study|Caregiver can no longer participate|0|||
129697786|NCT01897896|466853344|FG001|Overall Study|Caregiver can no longer participate|2|||
129697787|NCT01897896|466853343|FG000|Overall Study|Other than specified|2|||
129697788|NCT01897896|466853344|FG001|Overall Study|Other than specified|1|||
129697789|NCT05069415|466853345|FG000|Overall Study|Withdrawal by Subject|2|||
129697790|NCT05069415|466853346|FG001|Overall Study|Withdrawal by Subject|0|||
129697791|NCT05069415|466853345|FG000|Overall Study|Adverse Event|2|||
129697792|NCT05069415|466853346|FG001|Overall Study|Adverse Event|0|||
129697793|NCT00203242|466853347|FG000|Overall Study|Lost to Follow-up|1|||
129697794|NCT00866775|466853348|FG000|Overall Study|Adverse Event|5|||
129697795|NCT00866775|466853349|FG001|Overall Study|Adverse Event|19|||
129697796|NCT00866775|466853348|FG000|Overall Study|Death|1|||
129697797|NCT00866775|466853349|FG001|Overall Study|Death|0|||
129697798|NCT00866775|466853348|FG000|Overall Study|Lost to Follow-up|0|||
129697799|NCT00866775|466853349|FG001|Overall Study|Lost to Follow-up|4|||
129697800|NCT00866775|466853348|FG000|Overall Study|Physician Decision|0|||
129697801|NCT00866775|466853349|FG001|Overall Study|Physician Decision|3|||
129789068|NCT02616146|467195525|FG001|Overall Study|Pregnancy wish|0|||
129789069|NCT02616146|467195524|FG000|Overall Study|Protocol Violation|6|||
129697802|NCT00866775|466853348|FG000|Overall Study|Protocol Violation|3|||
129697803|NCT00866775|466853349|FG001|Overall Study|Protocol Violation|4|||
129697804|NCT00866775|466853348|FG000|Overall Study|Withdrawal by Subject|4|||
129697805|NCT00866775|466853349|FG001|Overall Study|Withdrawal by Subject|4|||
129697806|NCT00866775|466853348|FG000|Overall Study|met exit criteria|23|||
129697807|NCT00866775|466853349|FG001|Overall Study|met exit criteria|17|||
129697808|NCT00866775|466853348|FG000|Overall Study|discontinued due to communication error|0|||
129697809|NCT00866775|466853349|FG001|Overall Study|discontinued due to communication error|1|||
129697810|NCT01500135|466853350|FG000|Overall Study|Withdrawal of Consent|4|||
129789070|NCT02616146|467195525|FG001|Overall Study|Protocol Violation|3|||
129789071|NCT02616146|467195524|FG000|Overall Study|Study terminated by sponsor|1372|||
129789072|NCT02616146|467195525|FG001|Overall Study|Study terminated by sponsor|432|||
129789073|NCT02616146|467195524|FG000|Overall Study|Participant moved|4|||
129789074|NCT02616146|467195525|FG001|Overall Study|Participant moved|3|||
129789075|NCT02616146|467195524|FG000|Overall Study|Withdrawal by Subject|30|||
129789076|NCT02616146|467195525|FG001|Overall Study|Withdrawal by Subject|24|||
129789077|NCT02616146|467195524|FG000|Overall Study|Physician Decision|2|||
129789078|NCT02616146|467195525|FG001|Overall Study|Physician Decision|1|||
129789079|NCT01221272|467195526|FG000|Period 1|Adverse Event|2|||
129789080|NCT01221272|467195527|FG001|Period 1|Adverse Event|0|||
129789081|NCT01221272|467195526|FG000|Period 1|Consent Withdrawal|0|||
129789082|NCT01221272|467195527|FG001|Period 1|Consent Withdrawal|1|||
129789083|NCT01221272|467195526|FG000|Period 1|Significant Dosing Noncompliance|0|||
129789084|NCT01221272|467195527|FG001|Period 1|Significant Dosing Noncompliance|1|||
129789085|NCT01221272|467195526|FG000|Period 2|Adverse Event|0|||
129789086|NCT01221272|467195527|FG001|Period 2|Adverse Event|2|||
129789087|NCT01106092|467195530|FG000|Overall Study|Withdrawal by Subject|0|||
129789088|NCT01106092|467195531|FG001|Overall Study|Withdrawal by Subject|0|||
129789089|NCT01106092|467195532|FG002|Overall Study|Withdrawal by Subject|0|||
129789090|NCT01106092|467195533|FG003|Overall Study|Withdrawal by Subject|1|||
129789091|NCT04839562|467195540|FG000|Overall Study|Withdrawal by Subject|0|||
129789092|NCT04839562|467195541|FG001|Overall Study|Withdrawal by Subject|1|||
129697811|NCT01500135|466853351|FG001|Overall Study|Withdrawal of Consent|0|||
129697812|NCT01500135|466853350|FG000|Overall Study|Lost to Follow-up|6|||
129697813|NCT01500135|466853351|FG001|Overall Study|Lost to Follow-up|4|||
129697814|NCT01500135|466853350|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
129697815|NCT01500135|466853351|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
129436640|NCT00320541|465897148|FG000|Overall Study|Withdrawal by Subject|12|||
129789093|NCT04839562|467195540|FG000|Overall Study|Physician Decision|0|||
129789094|NCT04839562|467195541|FG001|Overall Study|Physician Decision|1|||
129789095|NCT00730028|467195542|FG000|Overall Study|Adverse Event|23|||
129789096|NCT00730028|467195543|FG001|Overall Study|Adverse Event|26|||
129789097|NCT00730028|467195544|FG002|Overall Study|Adverse Event|16|||
129697816|NCT01500135|466853350|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
129697817|NCT01500135|466853351|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
129697818|NCT01500135|466853350|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
129697819|NCT01500135|466853351|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
129697820|NCT01500135|466853350|FG000|Overall Study|Participant was a Safety Concern|1|||
129697821|NCT01500135|466853351|FG001|Overall Study|Participant was a Safety Concern|0|||
129697822|NCT01500135|466853350|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
129789098|NCT00730028|467195545|FG003|Overall Study|Adverse Event|20|||
129789099|NCT00730028|467195546|FG004|Overall Study|Adverse Event|43|||
129789100|NCT00730028|467195542|FG000|Overall Study|Lost to Follow-up|13|||
129601638|NCT00652028|466499555|FG003|Overall Study|Adverse Event|0|||
129601639|NCT00652028|466499552|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
129601640|NCT00652028|466499553|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
129601641|NCT00652028|466499554|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
129601642|NCT00652028|466499555|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
129601643|NCT00652028|466499552|FG000|Overall Study|Physician Decision|0|||
129601644|NCT00652028|466499553|FG001|Overall Study|Physician Decision|0|||
129885998|NCT02291289|467542795|FG002|Early Disease Progression|Lost to Follow-up|0|||
129885999|NCT02291289|467542796|FG003|Early Disease Progression|Lost to Follow-up|0|||
129601645|NCT00652028|466499554|FG002|Overall Study|Physician Decision|1|||
129601646|NCT00652028|466499555|FG003|Overall Study|Physician Decision|0|||
129601647|NCT02751359|466499559|FG000|Overall Study|Lost to Follow-up|1|||
129601648|NCT00912093|466499560|FG000|The Controlled Phase|Death|0|||
129601649|NCT00912093|466499561|FG001|The Controlled Phase|Death|1|||
129601650|NCT00912093|466499562|FG002|The Controlled Phase|Death|0|||
129601651|NCT00912093|466499563|FG003|The Controlled Phase|Death|0|||
129601652|NCT00912093|466499564|FG004|The Controlled Phase|Death|0|||
129601653|NCT00912093|466499560|FG000|The Controlled Phase|Medical Condition|0|||
129601654|NCT00912093|466499561|FG001|The Controlled Phase|Medical Condition|1|||
129601655|NCT00912093|466499562|FG002|The Controlled Phase|Medical Condition|0|||
129601656|NCT00912093|466499563|FG003|The Controlled Phase|Medical Condition|0|||
129601657|NCT00912093|466499564|FG004|The Controlled Phase|Medical Condition|0|||
129601658|NCT00912093|466499560|FG000|The Controlled Phase|Lost to Follow-up|0|||
129601659|NCT00912093|466499561|FG001|The Controlled Phase|Lost to Follow-up|0|||
129601660|NCT00912093|466499562|FG002|The Controlled Phase|Lost to Follow-up|0|||
129601661|NCT00912093|466499563|FG003|The Controlled Phase|Lost to Follow-up|0|||
129601662|NCT00912093|466499564|FG004|The Controlled Phase|Lost to Follow-up|1|||
129601663|NCT02400671|466499565|FG000|Overall Study|Death|5|||
129601664|NCT02400671|466499566|FG001|Overall Study|Death|3|||
129601665|NCT02400671|466499567|FG002|Overall Study|Death|4|||
129601666|NCT02400671|466499565|FG000|Overall Study|Lost to Follow-up|20|||
129601667|NCT02400671|466499566|FG001|Overall Study|Lost to Follow-up|27|||
129601668|NCT02400671|466499567|FG002|Overall Study|Lost to Follow-up|24|||
129601669|NCT02400671|466499565|FG000|Overall Study|Withdrawal by Subject|2|||
129601670|NCT02400671|466499566|FG001|Overall Study|Withdrawal by Subject|2|||
129601671|NCT02400671|466499567|FG002|Overall Study|Withdrawal by Subject|0|||
129601672|NCT04397445|466499573|FG000|Overall Study|Withdrawal by Subject|1|||
129601673|NCT04397445|466499574|FG001|Overall Study|Withdrawal by Subject|0|||
129601674|NCT04397445|466499575|FG002|Overall Study|Withdrawal by Subject|0|||
129601675|NCT04397445|466499576|FG003|Overall Study|Withdrawal by Subject|0|||
129601676|NCT03001219|466499581|FG000|Proof of Concept|Study Termination by Sponsor|0|||
129601677|NCT03001219|466499582|FG001|Proof of Concept|Study Termination by Sponsor|1|||
129601678|NCT03001219|466499581|FG000|Proof of Concept|Withdrawal by Subject|0|||
129601679|NCT03001219|466499582|FG001|Proof of Concept|Withdrawal by Subject|4|||
129601680|NCT03001219|466499581|FG000|Proof of Concept|Protocol Deviation|0|||
129601681|NCT03001219|466499582|FG001|Proof of Concept|Protocol Deviation|1|||
129601682|NCT03001219|466499581|FG000|Proof of Concept|Adverse Event|1|||
129601683|NCT03001219|466499582|FG001|Proof of Concept|Adverse Event|1|||
129601684|NCT03001219|466499581|FG000|Proof of Concept|Physician Decision|1|||
129601685|NCT03001219|466499582|FG001|Proof of Concept|Physician Decision|0|||
129601686|NCT03001219|466499581|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
129601687|NCT03001219|466499582|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
129601688|NCT03001219|466499581|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
129601689|NCT03001219|466499582|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
129601690|NCT03001219|466499581|FG000|Extension Period Analysis|Physician Decision|0|||
129601691|NCT03001219|466499582|FG001|Extension Period Analysis|Physician Decision|1|||
129601692|NCT03001219|466499581|FG000|Extension Period Analysis|Adverse Event|1|||
129601693|NCT03001219|466499582|FG001|Extension Period Analysis|Adverse Event|1|||
129601694|NCT03001219|466499581|FG000|Extension Period Analysis|Protocol Deviation|0|||
129601695|NCT03001219|466499582|FG001|Extension Period Analysis|Protocol Deviation|1|||
129601696|NCT03001219|466499581|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
129601697|NCT03001219|466499582|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
129601698|NCT01195103|466499583|FG000|Overall Study|Withdrawal by Subject|1|||
129601699|NCT01195103|466499584|FG001|Overall Study|Withdrawal by Subject|0|||
129601700|NCT01195103|466499585|FG002|Overall Study|Withdrawal by Subject|0|||
129601701|NCT03760250|466499586|FG000|Overall Study|Withdrawal by Subject|1|||
129886000|NCT02291289|467542797|FG004|Early Disease Progression|Lost to Follow-up|0|||
129601702|NCT03760250|466499586|FG000|Overall Study|Physician Decision|1|||
129601703|NCT03733210|466499587|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
129601704|NCT03733210|466499588|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
129601705|NCT02963441|466499589|FG000|Overall Study|Protocol violation or withdrawn|8|||
129601706|NCT02963441|466499589|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
129601707|NCT02963441|466499589|FG000|Overall Study|IDx-DR insufficient quality|33|||
129601708|NCT02669940|466499592|FG000|Overall Study|Failure to return|0|||
129601709|NCT02669940|466499593|FG001|Overall Study|Failure to return|3|||
129601710|NCT02669940|466499592|FG000|Overall Study|Insufficient follow-up data|1|||
129601711|NCT02669940|466499593|FG001|Overall Study|Insufficient follow-up data|0|||
129601712|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Adverse Event|9|||
129601713|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Adverse Event|4|||
129601714|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Adverse Event|5|||
129601715|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Adverse Event|9|||
129601716|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Adverse Event|8|||
129601717|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Adverse Event|0|||
129601718|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Adverse Event|0|||
129601719|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
129601720|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
129601721|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
129601722|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
129601723|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
129601724|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
129601725|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
129601726|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Death|1|||
129601727|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Death|1|||
129601728|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Death|1|||
129601729|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Death|1|||
129601730|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Death|0|||
129601731|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Death|0|||
129601732|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Death|0|||
129601733|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
129601734|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
129601735|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
129601736|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
129601737|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
129601738|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
129601739|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
129601740|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129601741|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129601742|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
129601743|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129601744|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129601745|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129601746|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
129601747|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
129601748|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
129601749|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
129601750|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
129601751|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
129601752|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
129601753|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
129601754|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Other|2|||
129601755|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Other|9|||
129601756|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Other|9|||
129601757|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Other|3|||
129601758|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Other|2|||
129601759|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Other|0|||
129601760|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Other|0|||
129601761|NCT00361335|466499595|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
129601762|NCT00361335|466499596|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
129601763|NCT00361335|466499597|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
129601764|NCT00361335|466499598|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
129601765|NCT00361335|466499599|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
129601766|NCT00361335|466499600|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
129601767|NCT00361335|466499601|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
129601768|NCT00361335|466499595|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
129601769|NCT00361335|466499596|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
129601770|NCT00361335|466499597|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
129601771|NCT00361335|466499598|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
129601772|NCT00361335|466499599|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
129601773|NCT00361335|466499600|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
129601774|NCT00361335|466499601|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
129601775|NCT00361335|466499595|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
129601776|NCT00361335|466499596|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129601777|NCT00361335|466499597|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
129601778|NCT00361335|466499598|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129601779|NCT00361335|466499599|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129601780|NCT00361335|466499600|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
129601781|NCT00361335|466499601|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
129789101|NCT00730028|467195543|FG001|Overall Study|Lost to Follow-up|26|||
129789102|NCT00730028|467195544|FG002|Overall Study|Lost to Follow-up|22|||
129789103|NCT00730028|467195545|FG003|Overall Study|Lost to Follow-up|26|||
129789104|NCT00730028|467195546|FG004|Overall Study|Lost to Follow-up|25|||
129789105|NCT00730028|467195542|FG000|Overall Study|Protocol Violation|6|||
129789106|NCT00730028|467195543|FG001|Overall Study|Protocol Violation|1|||
129789107|NCT00730028|467195544|FG002|Overall Study|Protocol Violation|1|||
129789108|NCT00730028|467195545|FG003|Overall Study|Protocol Violation|2|||
129789109|NCT00730028|467195546|FG004|Overall Study|Protocol Violation|0|||
129789110|NCT00730028|467195542|FG000|Overall Study|Withdrawal by Subject|9|||
129601782|NCT00361335|466499595|FG000|SC Period: Week E0 to Week E24|Death|0|||
129601783|NCT00361335|466499596|FG001|SC Period: Week E0 to Week E24|Death|0|||
129601784|NCT00361335|466499597|FG002|SC Period: Week E0 to Week E24|Death|0|||
129601785|NCT00361335|466499598|FG003|SC Period: Week E0 to Week E24|Death|0|||
129601786|NCT00361335|466499599|FG004|SC Period: Week E0 to Week E24|Death|0|||
129601787|NCT00361335|466499600|FG005|SC Period: Week E0 to Week E24|Death|0|||
129789111|NCT00730028|467195543|FG001|Overall Study|Withdrawal by Subject|5|||
129789112|NCT00730028|467195544|FG002|Overall Study|Withdrawal by Subject|4|||
129789113|NCT00730028|467195545|FG003|Overall Study|Withdrawal by Subject|5|||
129789114|NCT00730028|467195546|FG004|Overall Study|Withdrawal by Subject|9|||
129789115|NCT00730028|467195542|FG000|Overall Study|Physician Decision|3|||
129789116|NCT00730028|467195543|FG001|Overall Study|Physician Decision|3|||
129789117|NCT00730028|467195544|FG002|Overall Study|Physician Decision|2|||
129789118|NCT00730028|467195545|FG003|Overall Study|Physician Decision|3|||
129789119|NCT00730028|467195546|FG004|Overall Study|Physician Decision|2|||
129789120|NCT00730028|467195542|FG000|Overall Study|Treatment Failure|5|||
129789121|NCT00730028|467195543|FG001|Overall Study|Treatment Failure|5|||
129789122|NCT00730028|467195544|FG002|Overall Study|Treatment Failure|0|||
129789123|NCT00730028|467195545|FG003|Overall Study|Treatment Failure|0|||
129789124|NCT00730028|467195546|FG004|Overall Study|Treatment Failure|1|||
129789125|NCT00730028|467195542|FG000|Overall Study|Randomization Error|1|||
129789126|NCT00730028|467195543|FG001|Overall Study|Randomization Error|0|||
129789127|NCT00730028|467195544|FG002|Overall Study|Randomization Error|0|||
129789128|NCT00730028|467195545|FG003|Overall Study|Randomization Error|0|||
129789129|NCT00730028|467195546|FG004|Overall Study|Randomization Error|2|||
129789130|NCT00003472|467195547|FG000|Overall Study|Not evaluable|3|||
129789131|NCT00528970|467195548|FG000|Overall Study|Adverse Event|6|||
129789132|NCT00528970|467195549|FG001|Overall Study|Adverse Event|8|||
129789133|NCT00528970|467195550|FG002|Overall Study|Adverse Event|5|||
129789134|NCT00528970|467195548|FG000|Overall Study|Lost to Follow-up|0|||
129789135|NCT00528970|467195549|FG001|Overall Study|Lost to Follow-up|0|||
129789136|NCT00528970|467195550|FG002|Overall Study|Lost to Follow-up|1|||
129789137|NCT00528970|467195548|FG000|Overall Study|Other than specified|2|||
129789138|NCT00528970|467195549|FG001|Overall Study|Other than specified|3|||
129789139|NCT00528970|467195550|FG002|Overall Study|Other than specified|3|||
129789140|NCT00528970|467195548|FG000|Overall Study|Protocol Violation|2|||
129789141|NCT00528970|467195549|FG001|Overall Study|Protocol Violation|1|||
129789142|NCT00528970|467195550|FG002|Overall Study|Protocol Violation|4|||
129789143|NCT00528970|467195548|FG000|Overall Study|Lack of Efficacy|0|||
129789144|NCT00528970|467195549|FG001|Overall Study|Lack of Efficacy|0|||
129789145|NCT00528970|467195550|FG002|Overall Study|Lack of Efficacy|1|||
129601788|NCT00361335|466499601|FG006|SC Period: Week E0 to Week E24|Death|1|||
129789146|NCT00528970|467195548|FG000|Overall Study|Withdrawal by Subject|4|||
129789147|NCT00528970|467195549|FG001|Overall Study|Withdrawal by Subject|3|||
129789148|NCT00528970|467195550|FG002|Overall Study|Withdrawal by Subject|5|||
129601789|NCT00361335|466499595|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129601790|NCT00361335|466499596|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
129601791|NCT00361335|466499597|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
129601792|NCT00361335|466499598|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
129601793|NCT00361335|466499599|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129601794|NCT00361335|466499600|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129601795|NCT00361335|466499601|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
129601796|NCT00361335|466499595|FG000|SC Period: Week E0 to Week E24|Other|1|||
129601797|NCT00361335|466499596|FG001|SC Period: Week E0 to Week E24|Other|0|||
129601798|NCT00361335|466499597|FG002|SC Period: Week E0 to Week E24|Other|0|||
129601799|NCT00361335|466499598|FG003|SC Period: Week E0 to Week E24|Other|1|||
129601800|NCT00361335|466499599|FG004|SC Period: Week E0 to Week E24|Other|0|||
129601801|NCT00361335|466499600|FG005|SC Period: Week E0 to Week E24|Other|1|||
129601802|NCT00361335|466499601|FG006|SC Period: Week E0 to Week E24|Other|2|||
129601803|NCT00361335|466499595|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129601804|NCT00361335|466499596|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129601805|NCT00361335|466499597|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
129601806|NCT00361335|466499598|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129601807|NCT00361335|466499599|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129601808|NCT00361335|466499600|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
129601809|NCT00361335|466499601|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
129601810|NCT05065983|466499602|FG000|Overall Study|Lost to Follow-up|2|||
129601811|NCT01765582|466499603|FG000|Overall Study|Other|3|||
129601812|NCT01765582|466499604|FG001|Overall Study|Other|6|||
129601813|NCT01765582|466499605|FG002|Overall Study|Other|9|||
129601814|NCT01765582|466499603|FG000|Overall Study|Lost to Follow-up|2|||
129601815|NCT01765582|466499604|FG001|Overall Study|Lost to Follow-up|2|||
129601816|NCT01765582|466499605|FG002|Overall Study|Lost to Follow-up|1|||
129601817|NCT01765582|466499603|FG000|Overall Study|Death|31|||
129601818|NCT01765582|466499604|FG001|Overall Study|Death|36|||
129601819|NCT01765582|466499605|FG002|Overall Study|Death|33|||
129601820|NCT01765582|466499603|FG000|Overall Study|Sponsor Decision|46|||
129601821|NCT01765582|466499604|FG001|Overall Study|Sponsor Decision|42|||
129601822|NCT01765582|466499605|FG002|Overall Study|Sponsor Decision|42|||
129601823|NCT01765582|466499603|FG000|Overall Study|Withdrawal of Consent|11|||
129601824|NCT01765582|466499604|FG001|Overall Study|Withdrawal of Consent|6|||
129601825|NCT01765582|466499605|FG002|Overall Study|Withdrawal of Consent|10|||
129601826|NCT00986180|466499606|FG000|Overall Study|Adverse Event|21|||
129601827|NCT00986180|466499607|FG001|Overall Study|Adverse Event|23|||
129601828|NCT00986180|466499606|FG000|Overall Study|Lack of Efficacy|4|||
129601829|NCT00986180|466499607|FG001|Overall Study|Lack of Efficacy|3|||
129601830|NCT00986180|466499606|FG000|Overall Study|Lost to Follow-up|5|||
129601831|NCT00986180|466499607|FG001|Overall Study|Lost to Follow-up|7|||
129601832|NCT00986180|466499606|FG000|Overall Study|Physician Decision|1|||
129601833|NCT00986180|466499607|FG001|Overall Study|Physician Decision|3|||
129601834|NCT00986180|466499606|FG000|Overall Study|Protocol Violation|2|||
129789149|NCT00528970|467195548|FG000|Overall Study|Randomized but not treated|0|||
129601835|NCT00986180|466499607|FG001|Overall Study|Protocol Violation|0|||
129601836|NCT00986180|466499606|FG000|Overall Study|Withdrawal by Subject|1|||
129601837|NCT00986180|466499607|FG001|Overall Study|Withdrawal by Subject|9|||
129601838|NCT00986180|466499606|FG000|Overall Study|Miscellanies|10|||
129601839|NCT00986180|466499607|FG001|Overall Study|Miscellanies|11|||
129601840|NCT01691820|466499608|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
129601841|NCT01691820|466499609|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
129789150|NCT00528970|467195549|FG001|Overall Study|Randomized but not treated|0|||
129601842|NCT01691820|466499608|FG000|Overall Study|Migrated/moved from study area|7|||
129601843|NCT01691820|466499609|FG001|Overall Study|Migrated/moved from study area|4|||
129601844|NCT01691820|466499608|FG000|Overall Study|Lost to Follow-up|6|||
129601845|NCT01691820|466499609|FG001|Overall Study|Lost to Follow-up|17|||
129601846|NCT01691820|466499608|FG000|Overall Study|Other (unspecified)|4|||
129601847|NCT01691820|466499609|FG001|Overall Study|Other (unspecified)|1|||
129601848|NCT00076804|466499614|FG000|Overall Study|Death|9|||
129601849|NCT00076804|466499615|FG001|Overall Study|Death|20|||
129601850|NCT00076804|466499614|FG000|Overall Study|Lost to Follow-up|9|||
129601851|NCT00076804|466499615|FG001|Overall Study|Lost to Follow-up|9|||
129601852|NCT00076804|466499614|FG000|Overall Study|Withdrawal by Subject|10|||
129601853|NCT00076804|466499615|FG001|Overall Study|Withdrawal by Subject|8|||
129601854|NCT00076804|466499614|FG000|Overall Study|Early study Closure|32|||
129601855|NCT00076804|466499615|FG001|Overall Study|Early study Closure|32|||
129601856|NCT02408068|466499617|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
129601857|NCT02408068|466499618|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
129601858|NCT02408068|466499619|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
129601859|NCT02408068|466499620|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
129601860|NCT02408068|466499621|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
129601861|NCT02408068|466499622|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
129601862|NCT02303041|466499623|FG000|Overall Study|Adverse Event|1|||
129601863|NCT02303041|466499624|FG001|Overall Study|Adverse Event|2|||
129601864|NCT02458092|466499630|FG000|Overall Study|Withdrawal by Subject|1|||
129601865|NCT02458092|466499631|FG001|Overall Study|Withdrawal by Subject|0|||
129601866|NCT03852459|466499634|FG000|Overall Study|Adverse Event|2|||
129601867|NCT03852459|466499635|FG001|Overall Study|Adverse Event|2|||
129601868|NCT03852459|466499634|FG000|Overall Study|Withdrawal by Subject|1|||
129601869|NCT03852459|466499635|FG001|Overall Study|Withdrawal by Subject|1|||
129601870|NCT00456495|466499636|FG000|Overall Study|Physician Decision|2|||
129601871|NCT01663727|466499639|FG000|Overall Study|Death|161|||
129601872|NCT01663727|466499640|FG001|Overall Study|Death|155|||
129601873|NCT01663727|466499639|FG000|Overall Study|Lost to Follow-up|10|||
129601874|NCT01663727|466499640|FG001|Overall Study|Lost to Follow-up|8|||
129601875|NCT01663727|466499639|FG000|Overall Study|Withdrawal by Subject|18|||
129601876|NCT01663727|466499640|FG001|Overall Study|Withdrawal by Subject|25|||
129601877|NCT01663727|466499639|FG000|Overall Study|Study Terminated|51|||
129601878|NCT01663727|466499640|FG001|Overall Study|Study Terminated|50|||
129601879|NCT01663727|466499639|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
129601880|NCT01663727|466499640|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
129601881|NCT01663727|466499639|FG000|Overall Study|Withdrawal prior to dosing.|1|||
129601882|NCT01663727|466499640|FG001|Overall Study|Withdrawal prior to dosing.|0|||
129601883|NCT01902628|466499641|FG000|Overall Study|Withdrawal of participant's consent|7|||
129601884|NCT01902628|466499641|FG000|Overall Study|Adverse Event|41|||
129601885|NCT01902628|466499641|FG000|Overall Study|Lost to Follow-up|35|||
129601886|NCT02932228|466499646|FG000|Overall Study|Death|8|||
129601887|NCT02932228|466499647|FG001|Overall Study|Death|23|||
129601888|NCT02932228|466499646|FG000|Overall Study|not eligible upon chart review|2|||
129601889|NCT02932228|466499647|FG001|Overall Study|not eligible upon chart review|5|||
129601890|NCT03340064|466501211|FG000|First Period|Adverse Event, non-fatal|2|||
129601891|NCT03340064|466501212|FG001|First Period|Adverse Event, non-fatal|0|||
129601892|NCT03340064|466501211|FG000|First Period|Lack of Efficacy|3|||
129601893|NCT03340064|466501212|FG001|First Period|Lack of Efficacy|0|||
129601894|NCT03340064|466501211|FG000|Second Period|Adverse Event, non-fatal|1|||
129601895|NCT03340064|466501212|FG001|Second Period|Adverse Event, non-fatal|1|||
129601896|NCT03340064|466501211|FG000|Second Period|Lack of Efficacy|11|||
129601897|NCT03340064|466501212|FG001|Second Period|Lack of Efficacy|0|||
129601898|NCT03340064|466501211|FG000|Second Period|Physician Decision|3|||
129601899|NCT03340064|466501212|FG001|Second Period|Physician Decision|0|||
129601900|NCT03340064|466501211|FG000|Second Period|Withdrawal by Subject|2|||
129601901|NCT03340064|466501212|FG001|Second Period|Withdrawal by Subject|1|||
129601902|NCT03340064|466501211|FG000|Second Period|Approved Drug Available For Indication|1|||
129601903|NCT03340064|466501212|FG001|Second Period|Approved Drug Available For Indication|0|||
129601904|NCT03340064|466501211|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
129601905|NCT03340064|466501212|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
129601906|NCT02522403|466501213|FG000|Overall Study|Lost to Follow-up|2|||
129601907|NCT02522403|466501214|FG001|Overall Study|Lost to Follow-up|2|||
129601908|NCT02522403|466501213|FG000|Overall Study|Withdrawal by Subject|2|||
129601909|NCT02522403|466501214|FG001|Overall Study|Withdrawal by Subject|4|||
129601910|NCT00856973|466501217|FG000|Overall Study|Adverse Event|5|||
129601911|NCT00856973|466501218|FG001|Overall Study|Adverse Event|5|||
129601912|NCT00856973|466501219|FG002|Overall Study|Adverse Event|3|||
129601913|NCT00856973|466501217|FG000|Overall Study|Lost to Follow-up|6|||
129601914|NCT00856973|466501218|FG001|Overall Study|Lost to Follow-up|3|||
129601915|NCT00856973|466501219|FG002|Overall Study|Lost to Follow-up|5|||
129601916|NCT00856973|466501217|FG000|Overall Study|Physician Decision|0|||
129601917|NCT00856973|466501218|FG001|Overall Study|Physician Decision|3|||
129601918|NCT00856973|466501219|FG002|Overall Study|Physician Decision|1|||
129601919|NCT00856973|466501217|FG000|Overall Study|Protocol Violation|1|||
129601920|NCT00856973|466501218|FG001|Overall Study|Protocol Violation|2|||
129601921|NCT00856973|466501219|FG002|Overall Study|Protocol Violation|1|||
129601922|NCT00856973|466501217|FG000|Overall Study|Withdrawal by Subject|13|||
129601923|NCT00856973|466501218|FG001|Overall Study|Withdrawal by Subject|16|||
129601924|NCT00856973|466501219|FG002|Overall Study|Withdrawal by Subject|15|||
129601925|NCT00856973|466501217|FG000|Overall Study|Other|11|||
129601926|NCT00856973|466501218|FG001|Overall Study|Other|12|||
129601927|NCT00856973|466501219|FG002|Overall Study|Other|13|||
129601928|NCT02667288|466501223|FG000|Overall Study|Protocol Violation|5|||
129601929|NCT02667288|466501223|FG000|Overall Study|Lost to Follow-up|3|||
129601930|NCT02667288|466501223|FG000|Overall Study|Withdrawal by Subject|5|||
129601931|NCT03921151|466501224|FG000|Overall Study|Withdrawal by Subject|11|||
129601932|NCT03921151|466501225|FG001|Overall Study|Withdrawal by Subject|16|||
129601933|NCT00616941|466501226|FG000|Overall Study|Progressive Disease|1|||
129601934|NCT00616941|466501227|FG001|Overall Study|Progressive Disease|2|||
129601935|NCT00616941|466501228|FG002|Overall Study|Progressive Disease|1|||
129601936|NCT00616941|466501226|FG000|Overall Study|Adverse Event|0|||
129601937|NCT00616941|466501227|FG001|Overall Study|Adverse Event|1|||
129601938|NCT00616941|466501228|FG002|Overall Study|Adverse Event|1|||
129601939|NCT00616941|466501226|FG000|Overall Study|Subject Non-compliance|0|||
129601940|NCT00616941|466501227|FG001|Overall Study|Subject Non-compliance|0|||
129601941|NCT00616941|466501228|FG002|Overall Study|Subject Non-compliance|1|||
129601942|NCT00616941|466501226|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
129601943|NCT00616941|466501227|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
129601944|NCT00616941|466501228|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
129601945|NCT00616941|466501226|FG000|Overall Study|Vaccination Suspended|0|||
129601946|NCT00616941|466501227|FG001|Overall Study|Vaccination Suspended|0|||
129601947|NCT00616941|466501228|FG002|Overall Study|Vaccination Suspended|3|||
129601948|NCT01370213|466501236|FG000|Overall Study|Early Death|1|||
129601949|NCT01370213|466501237|FG001|Overall Study|Early Death|0|||
129601950|NCT01370213|466501238|FG002|Overall Study|Early Death|0|||
129601951|NCT01370213|466501236|FG000|Overall Study|Not evaluable|0|||
129601952|NCT01370213|466501237|FG001|Overall Study|Not evaluable|2|||
129601953|NCT01370213|466501238|FG002|Overall Study|Not evaluable|0|||
129601954|NCT00160641|466501239|FG000|Overall Study|Adverse Event|102|||
129601955|NCT00160641|466501239|FG000|Overall Study|Withdrawal by Subject|87|||
129601956|NCT00160641|466501239|FG000|Overall Study|Lost to Follow-up|8|||
129601957|NCT00160641|466501239|FG000|Overall Study|Lack of Efficacy|12|||
129601958|NCT00160641|466501239|FG000|Overall Study|Protocol Violation|3|||
129601959|NCT00160641|466501239|FG000|Overall Study|Other|9|||
129601960|NCT01782482|466501242|FG000|Overall Study|Adverse Event|2|||
129601961|NCT01782482|466501243|FG001|Overall Study|Adverse Event|1|||
129601962|NCT01782482|466501242|FG000|Overall Study|Lost to Follow-up|2|||
129601963|NCT01782482|466501243|FG001|Overall Study|Lost to Follow-up|3|||
129601964|NCT01782482|466501242|FG000|Overall Study|Physician Decision|1|||
129601965|NCT01782482|466501243|FG001|Overall Study|Physician Decision|0|||
129789151|NCT00528970|467195550|FG002|Overall Study|Randomized but not treated|1|||
129789152|NCT01119937|467195556|FG000|Overall Study|Adverse Event|11|||
129789153|NCT01119937|467195557|FG001|Overall Study|Adverse Event|5|||
129789154|NCT01119937|467195556|FG000|Overall Study|Protocol deviation|3|||
129789155|NCT01119937|467195557|FG001|Overall Study|Protocol deviation|1|||
129789156|NCT01119937|467195556|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129789157|NCT01119937|467195557|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129789158|NCT01119937|467195556|FG000|Overall Study|Withdrawal by Subject|2|||
129789159|NCT01119937|467195557|FG001|Overall Study|Withdrawal by Subject|1|||
129789160|NCT03316911|467195558|FG000|Overall Study|Lost to Follow-up|33|||
129789161|NCT03316911|467195559|FG001|Overall Study|Lost to Follow-up|29|||
129789162|NCT02536404|467195561|FG000|Overall Study|Adverse Event|5|||
129789163|NCT02536404|467195562|FG001|Overall Study|Adverse Event|0|||
129789164|NCT02536404|467195561|FG000|Overall Study|Withdrawal by Subject|4|||
129789165|NCT02536404|467195562|FG001|Overall Study|Withdrawal by Subject|1|||
129601966|NCT01782482|466501242|FG000|Overall Study|Protocol Violation|1|||
129789166|NCT02536404|467195561|FG000|Overall Study|Physician Decision|10|||
129789167|NCT02536404|467195562|FG001|Overall Study|Physician Decision|0|||
129601967|NCT01782482|466501243|FG001|Overall Study|Protocol Violation|0|||
129601968|NCT01782482|466501242|FG000|Overall Study|Withdrawal by Subject|2|||
129601969|NCT01782482|466501243|FG001|Overall Study|Withdrawal by Subject|3|||
129601970|NCT01782482|466501242|FG000|Overall Study|Randomized in Error|2|||
129601971|NCT01782482|466501243|FG001|Overall Study|Randomized in Error|2|||
129601972|NCT01782482|466501242|FG000|Overall Study|Habitually wearing toric lens OS|0|||
129601973|NCT01782482|466501243|FG001|Overall Study|Habitually wearing toric lens OS|1|||
129601974|NCT01640873|466501244|FG000|Overall Study|Protocol Violation|2|||
129601975|NCT01640873|466501245|FG001|Overall Study|Protocol Violation|1|||
129601976|NCT01321008|466501246|FG000|Overall Study|Early Study Termination|1|||
129601977|NCT02749292|466501249|FG000|Overall Study|Physician Decision|1|||
129601978|NCT02749292|466501250|FG001|Overall Study|Physician Decision|0|||
129789168|NCT02536404|467195561|FG000|Overall Study|Sponsor decision|1|||
129789169|NCT02536404|467195562|FG001|Overall Study|Sponsor decision|0|||
129789170|NCT00770146|467195563|FG000|Treatment Period|Withdrawal by Subject|6|||
129601979|NCT02749292|466501249|FG000|Overall Study|Withdrawal by Subject|5|||
129601980|NCT02749292|466501250|FG001|Overall Study|Withdrawal by Subject|7|||
129436641|NCT00320541|465897149|FG001|Overall Study|Withdrawal by Subject|16|||
129436642|NCT00320541|465897148|FG000|Overall Study|Physician Decision|9|||
129436643|NCT00320541|465897149|FG001|Overall Study|Physician Decision|13|||
129436644|NCT00320541|465897148|FG000|Overall Study|Other|3|||
129436645|NCT00320541|465897149|FG001|Overall Study|Other|4|||
129436646|NCT00320541|465897148|FG000|Overall Study|Sponsor Decision|2|||
129436647|NCT00320541|465897149|FG001|Overall Study|Sponsor Decision|1|||
129436648|NCT00320541|465897148|FG000|Overall Study|Death due to Study Disease|1|||
129436649|NCT00320541|465897149|FG001|Overall Study|Death due to Study Disease|3|||
129436650|NCT00320541|465897148|FG000|Overall Study|Death due to Adverse Event(s)|1|||
129436651|NCT00320541|465897149|FG001|Overall Study|Death due to Adverse Event(s)|0|||
129436652|NCT00320541|465897148|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
129436653|NCT00320541|465897149|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
129436654|NCT03057977|465897150|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
129436655|NCT03057977|465897151|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
129436656|NCT03057977|465897150|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
129436657|NCT03057977|465897151|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
129436658|NCT03057977|465897150|FG000|Discontinuation From Treatment|Protocol Violation|6|||
129436659|NCT03057977|465897151|FG001|Discontinuation From Treatment|Protocol Violation|5|||
129436660|NCT03057977|465897150|FG000|Discontinuation From Treatment|Not treated|4|||
129436661|NCT03057977|465897151|FG001|Discontinuation From Treatment|Not treated|0|||
129436662|NCT03057977|465897150|FG000|Discontinuation From Treatment|Adverse Event|343|||
129601981|NCT02749292|466501249|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
129601982|NCT02749292|466501250|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
129601983|NCT02749292|466501249|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
129601984|NCT02749292|466501250|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
129601985|NCT02749292|466501249|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
129601986|NCT02749292|466501250|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
129601987|NCT02749292|466501249|FG000|Overall Study|Adverse Event|4|||
129601988|NCT02749292|466501250|FG001|Overall Study|Adverse Event|1|||
129601989|NCT02749292|466501249|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
129601990|NCT02749292|466501250|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
129601991|NCT02749292|466501249|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
129601992|NCT02749292|466501250|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
129601993|NCT02749292|466501249|FG000|Overall Study|Requiring glucocorticoids|0|||
129601994|NCT02749292|466501250|FG001|Overall Study|Requiring glucocorticoids|3|||
129601995|NCT02749292|466501249|FG000|Overall Study|Cancer|1|||
129601996|NCT02749292|466501250|FG001|Overall Study|Cancer|0|||
129601997|NCT00251641|466501251|FG000|Overall Study|Adverse Event|80|||
129601998|NCT00251641|466501252|FG001|Overall Study|Adverse Event|8|||
129601999|NCT00251641|466501251|FG000|Overall Study|Lack of Efficacy|2|||
129602000|NCT00251641|466501252|FG001|Overall Study|Lack of Efficacy|1|||
129602001|NCT00251641|466501251|FG000|Overall Study|Progression of Disease|0|||
129602002|NCT00251641|466501252|FG001|Overall Study|Progression of Disease|2|||
129602003|NCT00251641|466501251|FG000|Overall Study|Lost to Follow-up|3|||
129602004|NCT00251641|466501252|FG001|Overall Study|Lost to Follow-up|3|||
129602005|NCT00251641|466501251|FG000|Overall Study|Withdrawal by Subject|6|||
129602006|NCT00251641|466501252|FG001|Overall Study|Withdrawal by Subject|8|||
129602007|NCT00251641|466501251|FG000|Overall Study|Protocol Violation|10|||
129602008|NCT00251641|466501252|FG001|Overall Study|Protocol Violation|2|||
129602009|NCT00251641|466501251|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
129602010|NCT00251641|466501252|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
129602011|NCT00251641|466501251|FG000|Overall Study|Switched Treatment|9|||
129602012|NCT00251641|466501252|FG001|Overall Study|Switched Treatment|63|||
129602013|NCT02093221|466501255|FG000|Overall Study|Adverse Event|1|||
129602014|NCT02093221|466501256|FG001|Overall Study|Adverse Event|0|||
129789171|NCT00770146|467195564|FG001|Treatment Period|Withdrawal by Subject|13|||
129789172|NCT00770146|467195563|FG000|Treatment Period|Adverse Event|2|||
129789173|NCT00770146|467195564|FG001|Treatment Period|Adverse Event|26|||
129789174|NCT00770146|467195563|FG000|Treatment Period|Other|1|||
129789175|NCT00770146|467195564|FG001|Treatment Period|Other|5|||
129789176|NCT00770146|467195563|FG000|Treatment Period|Protocol non-compliance|0|||
129789177|NCT00770146|467195564|FG001|Treatment Period|Protocol non-compliance|1|||
129436663|NCT03057977|465897151|FG001|Discontinuation From Treatment|Adverse Event|337|||
129602015|NCT02093221|466501257|FG002|Overall Study|Adverse Event|0|||
129602016|NCT02093221|466501258|FG003|Overall Study|Adverse Event|0|||
129602017|NCT02093221|466501259|FG004|Overall Study|Adverse Event|0|||
129602018|NCT02093221|466501255|FG000|Overall Study|Withdrawal by Subject|1|||
129602019|NCT02093221|466501256|FG001|Overall Study|Withdrawal by Subject|1|||
129602020|NCT02093221|466501257|FG002|Overall Study|Withdrawal by Subject|4|||
129789178|NCT00770146|467195563|FG000|Follow-up Period|Withdrawal by Subject|7|||
129436664|NCT03057977|465897150|FG000|Discontinuation From Treatment|Reason Unknown|0|||
129436665|NCT03057977|465897151|FG001|Discontinuation From Treatment|Reason Unknown|1|||
129436666|NCT03057977|465897150|FG000|Discontinuation From Treatment|Personal Reasons|1|||
129697823|NCT01500135|466853351|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
129436667|NCT03057977|465897151|FG001|Discontinuation From Treatment|Personal Reasons|1|||
129697824|NCT02003898|466853356|FG000|Overall Study|Death|3|||
129697825|NCT02003898|466853356|FG000|Overall Study|Lost to Follow-up|12|||
129886001|NCT02291289|467542798|FG005|Early Disease Progression|Lost to Follow-up|0|||
129602021|NCT02093221|466501258|FG003|Overall Study|Withdrawal by Subject|1|||
129602022|NCT02093221|466501259|FG004|Overall Study|Withdrawal by Subject|1|||
129602023|NCT02093221|466501255|FG000|Overall Study|Lost to Follow-up|2|||
129602024|NCT02093221|466501256|FG001|Overall Study|Lost to Follow-up|0|||
129602025|NCT02093221|466501257|FG002|Overall Study|Lost to Follow-up|1|||
129602026|NCT02093221|466501258|FG003|Overall Study|Lost to Follow-up|1|||
129602027|NCT02093221|466501259|FG004|Overall Study|Lost to Follow-up|0|||
129602028|NCT02093221|466501255|FG000|Overall Study|Death|0|||
129697826|NCT02003898|466853356|FG000|Overall Study|Withdrawal by Subject|52|||
129602029|NCT02093221|466501256|FG001|Overall Study|Death|1|||
129602030|NCT02093221|466501257|FG002|Overall Study|Death|0|||
129602031|NCT02093221|466501258|FG003|Overall Study|Death|0|||
129602032|NCT02093221|466501259|FG004|Overall Study|Death|0|||
129602033|NCT02093221|466501255|FG000|Overall Study|Protocol Violation|0|||
129602034|NCT02093221|466501256|FG001|Overall Study|Protocol Violation|1|||
129602035|NCT02093221|466501257|FG002|Overall Study|Protocol Violation|0|||
129602036|NCT02093221|466501258|FG003|Overall Study|Protocol Violation|0|||
129602037|NCT02093221|466501259|FG004|Overall Study|Protocol Violation|0|||
129602038|NCT02093221|466501255|FG000|Overall Study|Study termination|6|||
129602039|NCT02093221|466501256|FG001|Overall Study|Study termination|5|||
129602040|NCT02093221|466501257|FG002|Overall Study|Study termination|4|||
129602041|NCT02093221|466501258|FG003|Overall Study|Study termination|6|||
129602042|NCT02093221|466501259|FG004|Overall Study|Study termination|7|||
129602043|NCT03097588|466501276|FG000|Overall Study|Adverse Event|1|||
129602044|NCT02687360|466501277|FG000|Overall Study|Withdrawal by Subject|3|||
129602045|NCT02687360|466501278|FG001|Overall Study|Withdrawal by Subject|0|||
129602046|NCT03456960|466501279|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129602047|NCT03456960|466501280|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129602048|NCT03456960|466501281|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
129602049|NCT03456960|466501282|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
129602050|NCT03456960|466501283|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129602051|NCT03456960|466501284|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129602052|NCT03456960|466501279|FG000|Period 2 (1 Day)|Adverse Event|1|||
129602053|NCT03456960|466501280|FG001|Period 2 (1 Day)|Adverse Event|0|||
129602054|NCT03456960|466501281|FG002|Period 2 (1 Day)|Adverse Event|0|||
129602055|NCT03456960|466501282|FG003|Period 2 (1 Day)|Adverse Event|1|||
129602056|NCT03456960|466501283|FG004|Period 2 (1 Day)|Adverse Event|0|||
129602057|NCT03456960|466501284|FG005|Period 2 (1 Day)|Adverse Event|0|||
129602058|NCT02989168|466501285|FG000|Overall Study|Withdrawal by Subject|2|||
129602059|NCT02989168|466501286|FG001|Overall Study|Withdrawal by Subject|0|||
129602060|NCT02989168|466501285|FG000|Overall Study|Physician Decision|0|||
129602061|NCT02989168|466501286|FG001|Overall Study|Physician Decision|1|||
129602062|NCT02989168|466501285|FG000|Overall Study|Adverse Event|1|||
129602063|NCT02989168|466501286|FG001|Overall Study|Adverse Event|2|||
129602064|NCT02989168|466501285|FG000|Overall Study|Sponsor stopped study.|1|||
129602065|NCT02989168|466501286|FG001|Overall Study|Sponsor stopped study.|0|||
129602066|NCT03828448|466501287|FG000|Overall Study|Sponsor's Discretion|34|||
129602067|NCT02037165|466501288|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129602068|NCT02037165|466501289|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129602069|NCT02037165|466501290|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129602070|NCT02037165|466501291|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
129602071|NCT02037165|466501292|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
129602072|NCT00532935|466501293|FG000|Overall Study|Adverse Event|11|||
129602073|NCT00532935|466501294|FG001|Overall Study|Adverse Event|12|||
129602074|NCT00532935|466501293|FG000|Overall Study|Lack of Efficacy|0|||
129602075|NCT00532935|466501294|FG001|Overall Study|Lack of Efficacy|3|||
129602076|NCT00532935|466501293|FG000|Overall Study|Lost to Follow-up|10|||
129697827|NCT05345405|466853359|FG000|Overall Study|Withdrawal by Subject|2|||
129697828|NCT05345405|466853360|FG001|Overall Study|Withdrawal by Subject|0|||
129697829|NCT05345405|466853361|FG002|Overall Study|Withdrawal by Subject|0|||
129697830|NCT05345405|466853359|FG000|Overall Study|Did not meet eligibility criteria|0|||
129697831|NCT05345405|466853360|FG001|Overall Study|Did not meet eligibility criteria|2|||
129697832|NCT05345405|466853361|FG002|Overall Study|Did not meet eligibility criteria|0|||
129697833|NCT05345405|466853359|FG000|Overall Study|Lost to Follow-up|0|||
129697834|NCT05345405|466853360|FG001|Overall Study|Lost to Follow-up|0|||
129697835|NCT05345405|466853361|FG002|Overall Study|Lost to Follow-up|1|||
129697836|NCT03766906|466853363|FG000|Overall Study|Withdrawal by Subject|6|||
129886002|NCT02291289|467542799|FG006|Early Disease Progression|Lost to Follow-up|0|||
129602077|NCT00532935|466501294|FG001|Overall Study|Lost to Follow-up|6|||
129697837|NCT03268499|466853368|FG000|Overall Study|Withdrawal by Subject|2|||
129697838|NCT03268499|466853369|FG001|Overall Study|Withdrawal by Subject|1|||
129602078|NCT00532935|466501293|FG000|Overall Study|Physician Decision|4|||
129602079|NCT00532935|466501294|FG001|Overall Study|Physician Decision|5|||
129602080|NCT00532935|466501293|FG000|Overall Study|Pregnancy|1|||
129602081|NCT00532935|466501294|FG001|Overall Study|Pregnancy|0|||
129602082|NCT00532935|466501293|FG000|Overall Study|Protocol Violation|4|||
129602083|NCT00532935|466501294|FG001|Overall Study|Protocol Violation|2|||
129602084|NCT00532935|466501293|FG000|Overall Study|Withdrawal by Subject|10|||
129602085|NCT00532935|466501294|FG001|Overall Study|Withdrawal by Subject|9|||
129602086|NCT00532935|466501293|FG000|Overall Study|Protocol Specific Criteria|11|||
129602087|NCT00532935|466501294|FG001|Overall Study|Protocol Specific Criteria|15|||
129602088|NCT02192164|466501295|FG000|Overall Study|Other|8|||
129602089|NCT02192164|466501295|FG000|Overall Study|Withdrawal by Subject|1|||
129602090|NCT02192164|466501295|FG000|Overall Study|Physician Decision|4|||
129602091|NCT02192164|466501295|FG000|Overall Study|Did not meet the exclusion criteria|1|||
129602092|NCT01300923|466501296|FG000|Overall Study|Physician Decision|0|||
129602093|NCT01300923|466501297|FG001|Overall Study|Physician Decision|2|||
129602094|NCT01568866|466501298|FG000|Overall Study|Disease Progression|208|||
129602095|NCT01568866|466501299|FG001|Overall Study|Disease Progression|183|||
129602096|NCT01568866|466501298|FG000|Overall Study|Adverse Event|94|||
129602097|NCT01568866|466501299|FG001|Overall Study|Adverse Event|96|||
129602098|NCT01568866|466501298|FG000|Overall Study|Patient Request|55|||
129602099|NCT01568866|466501299|FG001|Overall Study|Patient Request|71|||
129602100|NCT01568866|466501298|FG000|Overall Study|Physician Decision|40|||
129602101|NCT01568866|466501299|FG001|Overall Study|Physician Decision|32|||
129602102|NCT01568866|466501298|FG000|Overall Study|Withdrawal by Subject|19|||
129602103|NCT01568866|466501299|FG001|Overall Study|Withdrawal by Subject|11|||
129602104|NCT01568866|466501298|FG000|Overall Study|Death|10|||
129602105|NCT01568866|466501299|FG001|Overall Study|Death|18|||
129602106|NCT01568866|466501298|FG000|Overall Study|Protocol Non-compliance|2|||
129602107|NCT01568866|466501299|FG001|Overall Study|Protocol Non-compliance|4|||
129602108|NCT01568866|466501298|FG000|Overall Study|Lost to Follow-up|1|||
129602109|NCT01568866|466501299|FG001|Overall Study|Lost to Follow-up|0|||
129602110|NCT01568866|466501298|FG000|Overall Study|Randomized but Not Dosed|9|||
129602111|NCT01568866|466501299|FG001|Overall Study|Randomized but Not Dosed|1|||
129602112|NCT01698775|466501302|FG000|Phase A|Adverse Event|2|||
129602113|NCT01698775|466501303|FG001|Phase A|Adverse Event|1|||
129602114|NCT01698775|466501302|FG000|Phase A|Death|1|||
129602115|NCT01698775|466501303|FG001|Phase A|Death|1|||
129602116|NCT01698775|466501302|FG000|Phase A|Lack of Efficacy|1|||
129602117|NCT01698775|466501303|FG001|Phase A|Lack of Efficacy|0|||
129602118|NCT01698775|466501302|FG000|Phase A|Lost to Follow-up|1|||
129602119|NCT01698775|466501303|FG001|Phase A|Lost to Follow-up|2|||
129602120|NCT01698775|466501302|FG000|Phase A|Protocol Violation|1|||
129602121|NCT01698775|466501303|FG001|Phase A|Protocol Violation|0|||
129602122|NCT01698775|466501302|FG000|Phase A|Withdrawal by Subject|3|||
129602123|NCT01698775|466501303|FG001|Phase A|Withdrawal by Subject|4|||
129602124|NCT01698775|466501302|FG000|Phase A|Kidney [transplant]|0|||
129602125|NCT01698775|466501303|FG001|Phase A|Kidney [transplant]|1|||
129602126|NCT01698775|466501302|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
129602127|NCT01698775|466501303|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
129602128|NCT01698775|466501302|FG000|Phase B|Adverse Event|6|||
129602129|NCT01698775|466501303|FG001|Phase B|Adverse Event|3|||
129602130|NCT01698775|466501302|FG000|Phase B|Death|0|||
129602131|NCT01698775|466501303|FG001|Phase B|Death|1|||
129602132|NCT01698775|466501302|FG000|Phase B|Lack of Efficacy|0|||
129602133|NCT01698775|466501303|FG001|Phase B|Lack of Efficacy|1|||
129602134|NCT01698775|466501302|FG000|Phase B|Lost to Follow-up|0|||
129602135|NCT01698775|466501303|FG001|Phase B|Lost to Follow-up|1|||
129602136|NCT01698775|466501302|FG000|Phase B|Physician Decision|1|||
129602137|NCT01698775|466501303|FG001|Phase B|Physician Decision|1|||
129602138|NCT01698775|466501302|FG000|Phase B|Protocol Violation|1|||
129602139|NCT01698775|466501303|FG001|Phase B|Protocol Violation|1|||
129602140|NCT01698775|466501302|FG000|Phase B|Withdrawal by Subject|6|||
129602141|NCT01698775|466501303|FG001|Phase B|Withdrawal by Subject|2|||
129697839|NCT03533491|466853370|FG000|Overall Study|Lost to Follow-up|2|||
129602142|NCT00359788|466501304|FG000|Overall Study|Adverse Event|11|||
129602143|NCT00359788|466501305|FG001|Overall Study|Adverse Event|10|||
129602144|NCT00359788|466501304|FG000|Overall Study|Lack of Efficacy|1|||
129602145|NCT00359788|466501305|FG001|Overall Study|Lack of Efficacy|2|||
129602146|NCT00359788|466501304|FG000|Overall Study|Lost to Follow-up|3|||
129602147|NCT00359788|466501305|FG001|Overall Study|Lost to Follow-up|2|||
129602148|NCT00359788|466501304|FG000|Overall Study|Withdrawal by Subject|4|||
129602149|NCT00359788|466501305|FG001|Overall Study|Withdrawal by Subject|1|||
129602150|NCT00359788|466501304|FG000|Overall Study|Protocol Violation|4|||
129602151|NCT00359788|466501305|FG001|Overall Study|Protocol Violation|2|||
129602152|NCT02143583|466501306|FG000|Overall Study|Withdrawal by Subject|1|||
129602153|NCT02143583|466501307|FG001|Overall Study|Withdrawal by Subject|0|||
129602154|NCT02143583|466501308|FG002|Overall Study|Withdrawal by Subject|1|||
129602155|NCT02143583|466501306|FG000|Overall Study|husband illness|0|||
129602156|NCT02143583|466501307|FG001|Overall Study|husband illness|0|||
129602157|NCT02143583|466501308|FG002|Overall Study|husband illness|1|||
129602158|NCT01244061|466501309|FG000|Overall Study|Death|1|||
129602159|NCT01244061|466501310|FG001|Overall Study|Death|0|||
129602160|NCT01244061|466501309|FG000|Overall Study|Did not meet entrance criteria|1|||
129602161|NCT01244061|466501310|FG001|Overall Study|Did not meet entrance criteria|0|||
129602162|NCT01244061|466501309|FG000|Overall Study|Lack of Efficacy|1|||
129602163|NCT01244061|466501310|FG001|Overall Study|Lack of Efficacy|3|||
129602164|NCT01244061|466501309|FG000|Overall Study|Lost to Follow-up|34|||
129602165|NCT01244061|466501310|FG001|Overall Study|Lost to Follow-up|30|||
129602166|NCT01244061|466501309|FG000|Overall Study|Withdrawal by Subject|29|||
129602167|NCT01244061|466501310|FG001|Overall Study|Withdrawal by Subject|46|||
129602168|NCT01244061|466501309|FG000|Overall Study|Other|8|||
129602169|NCT01244061|466501310|FG001|Overall Study|Other|19|||
129602170|NCT01244061|466501309|FG000|Overall Study|Protocol Violation|1|||
129602171|NCT01244061|466501310|FG001|Overall Study|Protocol Violation|1|||
129602172|NCT01244061|466501309|FG000|Overall Study|Adverse Event|5|||
129602173|NCT01244061|466501310|FG001|Overall Study|Adverse Event|2|||
129602174|NCT01244061|466501309|FG000|Overall Study|Randomized but not treated|2|||
129602175|NCT01244061|466501310|FG001|Overall Study|Randomized but not treated|2|||
129602176|NCT00673933|466501311|FG000|Overall Study|Withdrawal by Subject|2|||
129602177|NCT00673933|466501311|FG000|Overall Study|Lost to Follow-up|1|||
129602178|NCT04932941|466501314|FG000|Overall Study|Lost to Follow-up|3|||
129602179|NCT04932941|466501315|FG001|Overall Study|Lost to Follow-up|1|||
129602180|NCT04932941|466501314|FG000|Overall Study|Withdrawal by Subject|7|||
129602181|NCT04932941|466501315|FG001|Overall Study|Withdrawal by Subject|4|||
129602182|NCT04932941|466501314|FG000|Overall Study|Other|4|||
129602183|NCT04932941|466501315|FG001|Overall Study|Other|2|||
129602184|NCT01929031|466501318|FG000|Overall Study|Adverse Event|3|||
129602185|NCT01929031|466501319|FG001|Overall Study|Adverse Event|1|||
129602186|NCT01929031|466501320|FG002|Overall Study|Adverse Event|1|||
129602187|NCT01929031|466501321|FG003|Overall Study|Adverse Event|0|||
129602188|NCT01929031|466501322|FG004|Overall Study|Adverse Event|0|||
129602189|NCT01929031|466501323|FG005|Overall Study|Adverse Event|0|||
129602190|NCT01929031|466501318|FG000|Overall Study|Protocol Violation|1|||
129602191|NCT01929031|466501319|FG001|Overall Study|Protocol Violation|0|||
129602192|NCT01929031|466501320|FG002|Overall Study|Protocol Violation|0|||
129602193|NCT01929031|466501321|FG003|Overall Study|Protocol Violation|0|||
129602194|NCT01929031|466501322|FG004|Overall Study|Protocol Violation|0|||
129602195|NCT01929031|466501323|FG005|Overall Study|Protocol Violation|1|||
129602196|NCT01929031|466501318|FG000|Overall Study|Reason other than specified above|0|||
129602197|NCT01929031|466501319|FG001|Overall Study|Reason other than specified above|1|||
129602198|NCT01929031|466501320|FG002|Overall Study|Reason other than specified above|0|||
129602199|NCT01929031|466501321|FG003|Overall Study|Reason other than specified above|0|||
129602200|NCT01929031|466501322|FG004|Overall Study|Reason other than specified above|1|||
129602201|NCT01929031|466501323|FG005|Overall Study|Reason other than specified above|0|||
129602202|NCT05816200|466501324|FG000|Overall Study|Lost to Follow-up|2|||
129602203|NCT05816200|466501325|FG001|Overall Study|Lost to Follow-up|1|||
129602204|NCT01366443|466501326|FG000|Overall Study|Lost to Follow-up|2|||
129602205|NCT01366443|466501326|FG000|Overall Study|Under 18 yo|1|||
129602206|NCT00369382|466501332|FG000|Overall Study|Death|0|||
129602207|NCT00369382|466501333|FG001|Overall Study|Death|2|||
129602208|NCT00369382|466501332|FG000|Overall Study|Physician Decision|2|||
129602209|NCT00369382|466501333|FG001|Overall Study|Physician Decision|1|||
129602210|NCT00369382|466501332|FG000|Overall Study|Withdrawal by Subject|5|||
129602211|NCT00369382|466501333|FG001|Overall Study|Withdrawal by Subject|0|||
129602212|NCT00369382|466501332|FG000|Overall Study|Randomized, not treated|2|||
129602213|NCT00369382|466501333|FG001|Overall Study|Randomized, not treated|0|||
129602214|NCT00369382|466501332|FG000|Overall Study|Other|1|||
129436668|NCT03057977|465897150|FG000|Discontinuation From Treatment|Unblinded medication|1|||
129436669|NCT03057977|465897151|FG001|Discontinuation From Treatment|Unblinded medication|0|||
129602215|NCT00369382|466501333|FG001|Overall Study|Other|0|||
129602216|NCT02394730|466501334|FG000|Overall Study|Lost to Follow-up|1|||
129602217|NCT02394730|466501335|FG001|Overall Study|Lost to Follow-up|0|||
129602218|NCT02394730|466501334|FG000|Overall Study|Withdrawal by Subject|0|||
129602219|NCT02394730|466501335|FG001|Overall Study|Withdrawal by Subject|1|||
129602220|NCT02384850|466501339|FG000|Overall Study|Withdrawal by Subject|2|||
129602221|NCT02384850|466501340|FG001|Overall Study|Withdrawal by Subject|2|||
129697840|NCT01725282|466853373|FG000|Overall Study|Adverse Event|1|||
129602222|NCT01673698|466501341|FG000|Overall Study|Lost to Follow-up|51|||
129602223|NCT01673698|466501342|FG001|Overall Study|Lost to Follow-up|13|||
129602224|NCT00507546|466501343|FG000|Overall Study|Withdrawal by Subject|1|||
129602225|NCT00507546|466501344|FG001|Overall Study|Withdrawal by Subject|0|||
129602226|NCT00507546|466501343|FG000|Overall Study|Protocol Violation|1|||
129602227|NCT00507546|466501344|FG001|Overall Study|Protocol Violation|0|||
129602228|NCT00507546|466501343|FG000|Overall Study|Physician Decision|0|||
129602229|NCT00507546|466501344|FG001|Overall Study|Physician Decision|1|||
129602230|NCT00448136|466501345|FG000|Overall Study|Death|3|||
129697841|NCT01725282|466853374|FG001|Overall Study|Adverse Event|3|||
129697842|NCT01725282|466853375|FG002|Overall Study|Adverse Event|6|||
129602231|NCT00448136|466501346|FG001|Overall Study|Death|8|||
129602232|NCT00448136|466501345|FG000|Overall Study|Investigator's decision (progression)|1|||
129602233|NCT00448136|466501346|FG001|Overall Study|Investigator's decision (progression)|0|||
129602234|NCT02013375|466501347|FG000|Overall Study|Did not engraft|1|||
129602235|NCT02013375|466501347|FG000|Overall Study|Did not engraft|1|||
129602236|NCT03510182|466501350|FG000|Overall Study|Withdrawal by Subject|2|||
129602237|NCT01334710|466501357|FG000|Overall Study|Trial was terminated|3|||
129602238|NCT01558297|466501358|FG000|Overall Study|Withdrawal by Subject|2|||
129602239|NCT01558297|466501359|FG001|Overall Study|Withdrawal by Subject|2|||
129602240|NCT01558297|466501360|FG002|Overall Study|Withdrawal by Subject|1|||
129602241|NCT00375492|466501361|FG000|Overall Study|Adverse Event|4|||
129602242|NCT00375492|466501362|FG001|Overall Study|Adverse Event|5|||
129602243|NCT00375492|466501361|FG000|Overall Study|Entry Criteria Not Met|0|||
129602244|NCT00375492|466501362|FG001|Overall Study|Entry Criteria Not Met|1|||
129602245|NCT00375492|466501361|FG000|Overall Study|Loss of Glucose Control|0|||
129602246|NCT00375492|466501362|FG001|Overall Study|Loss of Glucose Control|1|||
129602247|NCT00375492|466501361|FG000|Overall Study|Lost to Follow-up|10|||
129602248|NCT00375492|466501362|FG001|Overall Study|Lost to Follow-up|5|||
129602249|NCT00375492|466501361|FG000|Overall Study|Physician Decision|0|||
129602250|NCT00375492|466501362|FG001|Overall Study|Physician Decision|4|||
129602251|NCT00375492|466501361|FG000|Overall Study|Protocol Violation|6|||
129602252|NCT00375492|466501362|FG001|Overall Study|Protocol Violation|3|||
129602253|NCT00375492|466501361|FG000|Overall Study|Sponsor Decision|0|||
129602254|NCT00375492|466501362|FG001|Overall Study|Sponsor Decision|1|||
129602255|NCT00375492|466501361|FG000|Overall Study|Withdrawal by Subject|6|||
129602256|NCT00375492|466501362|FG001|Overall Study|Withdrawal by Subject|6|||
129602257|NCT01232491|466501363|FG000|Overall Study|Adverse Event|13|||
129602258|NCT01232491|466501364|FG001|Overall Study|Adverse Event|8|||
129602259|NCT01232491|466501363|FG000|Overall Study|Lack of Efficacy|1|||
129602260|NCT01232491|466501364|FG001|Overall Study|Lack of Efficacy|5|||
129602261|NCT01232491|466501363|FG000|Overall Study|Protocol Violation|13|||
129602262|NCT01232491|466501364|FG001|Overall Study|Protocol Violation|11|||
129602263|NCT01232491|466501363|FG000|Overall Study|Withdrawal Criteria|12|||
129602264|NCT01232491|466501364|FG001|Overall Study|Withdrawal Criteria|21|||
129602265|NCT01232491|466501363|FG000|Overall Study|Other|21|||
129602266|NCT01232491|466501364|FG001|Overall Study|Other|18|||
129602267|NCT04905290|466502800|FG000|Overall Study|Adverse Event|4|||
129602268|NCT04905290|466502800|FG000|Overall Study|Death|2|||
129602269|NCT04905290|466502800|FG000|Overall Study|Withdrawal by Subject|4|||
129602270|NCT04905290|466502800|FG000|Overall Study|Physician Decision|2|||
129602271|NCT04905290|466502800|FG000|Overall Study|Lost to Follow-up|2|||
129602272|NCT04905290|466502800|FG000|Overall Study|Screen Failure|2|||
129602273|NCT04905290|466502800|FG000|Overall Study|Unsuccessful Procedure|2|||
129602274|NCT00821873|466502801|FG000|Overall Study|Lost to Follow-up|4|||
129602275|NCT01995266|466502803|FG000|Overall Study|Death|1|||
129602276|NCT01995266|466502803|FG000|Overall Study|Lack of Efficacy|6|||
129602277|NCT01995266|466502803|FG000|Overall Study|Adverse Event|2|||
129602278|NCT03596151|466502804|FG000|Overall Study|Withdrawal by Subject|1|||
129602279|NCT00729248|466502810|FG000|Overall Study|Physician Decision|2|||
129602280|NCT03222583|466502811|FG000|Overall Study|Withdrawal by Subject|3|||
129602281|NCT03222583|466502812|FG001|Overall Study|Withdrawal by Subject|3|||
129602282|NCT03222583|466502811|FG000|Overall Study|Lost to Follow-up|1|||
129602283|NCT03222583|466502812|FG001|Overall Study|Lost to Follow-up|0|||
129602284|NCT03222583|466502811|FG000|Overall Study|Other|1|||
129602285|NCT03222583|466502812|FG001|Overall Study|Other|3|||
129602286|NCT04280705|466502813|FG000|Overall Study|Enrolled but not treated|4|||
129602287|NCT04280705|466502814|FG001|Overall Study|Enrolled but not treated|10|||
129602288|NCT04280705|466502813|FG000|Overall Study|Physician Decision|1|||
129602289|NCT04280705|466502814|FG001|Overall Study|Physician Decision|0|||
129602290|NCT04280705|466502813|FG000|Overall Study|Withdrawal by Subject|7|||
129602291|NCT04280705|466502814|FG001|Overall Study|Withdrawal by Subject|9|||
129789179|NCT00770146|467195564|FG001|Follow-up Period|Withdrawal by Subject|13|||
129602292|NCT04280705|466502813|FG000|Overall Study|Adverse Event|0|||
129602293|NCT04280705|466502814|FG001|Overall Study|Adverse Event|4|||
129602294|NCT04280705|466502813|FG000|Overall Study|Transferred to another hospital|1|||
129602295|NCT04280705|466502814|FG001|Overall Study|Transferred to another hospital|1|||
129602296|NCT03573505|466502815|FG000|Overall Study|Adverse Event|1|||
129602297|NCT03573505|466502816|FG001|Overall Study|Adverse Event|1|||
129602298|NCT03573505|466502815|FG000|Overall Study|Consent withdrawn|0|||
129602299|NCT03573505|466502816|FG001|Overall Study|Consent withdrawn|1|||
129602300|NCT03573505|466502815|FG000|Overall Study|Disease progression|0|||
129602301|NCT03573505|466502816|FG001|Overall Study|Disease progression|1|||
129789180|NCT00770146|467195563|FG000|Follow-up Period|Adverse Event|0|||
129789181|NCT00770146|467195564|FG001|Follow-up Period|Adverse Event|2|||
129602302|NCT03573505|466502815|FG000|Overall Study|Site Terminated by Sponsor|1|||
129602303|NCT03573505|466502816|FG001|Overall Study|Site Terminated by Sponsor|1|||
129602304|NCT03573505|466502815|FG000|Overall Study|Study terminated by sponsor|50|||
129602305|NCT03573505|466502816|FG001|Overall Study|Study terminated by sponsor|45|||
129602306|NCT03573505|466502815|FG000|Overall Study|Reason not specified|0|||
129602307|NCT03573505|466502816|FG001|Overall Study|Reason not specified|1|||
129602308|NCT03573505|466502815|FG000|Overall Study|Death|0|||
129602309|NCT03573505|466502816|FG001|Overall Study|Death|4|||
129602310|NCT04268316|466502819|FG000|Overall Study|Withdrawal by Subject|2|||
129602311|NCT04268316|466502820|FG001|Overall Study|Withdrawal by Subject|1|||
129602312|NCT04268316|466502821|FG002|Overall Study|Withdrawal by Subject|0|||
129602313|NCT03188718|466502828|FG000|Overall Study|Participant noncompliance|4|||
129436670|NCT03057977|465897150|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
129436671|NCT03057977|465897151|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
129436672|NCT03057977|465897150|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
129436673|NCT03057977|465897151|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
129436674|NCT03057977|465897150|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
129436675|NCT03057977|465897151|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
129436676|NCT03057977|465897150|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
129436677|NCT03057977|465897151|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
129436678|NCT03057977|465897150|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
129436679|NCT03057977|465897151|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
129436680|NCT03057977|465897150|FG000|Discontinuation From Treatment|Not attending study visit|3|||
129436681|NCT03057977|465897151|FG001|Discontinuation From Treatment|Not attending study visit|10|||
129602314|NCT03188718|466502828|FG000|Overall Study|Withdrawal by Subject|1|||
129602315|NCT03188718|466502828|FG000|Overall Study|Device failure|3|||
129602316|NCT04032158|466502829|FG000|Overall Study|Study Termination|2|||
129602317|NCT04032158|466502830|FG001|Overall Study|Study Termination|1|||
129602318|NCT02072824|466502831|FG000|Overall Study|Insufficient clinical response|1|||
129602319|NCT02072824|466502832|FG001|Overall Study|Insufficient clinical response|0|||
129602320|NCT02072824|466502833|FG002|Overall Study|Insufficient clinical response|1|||
129602321|NCT02072824|466502831|FG000|Overall Study|No longer willing to participate|1|||
129602322|NCT02072824|466502832|FG001|Overall Study|No longer willing to participate|0|||
129602323|NCT02072824|466502833|FG002|Overall Study|No longer willing to participate|1|||
129602324|NCT02072824|466502831|FG000|Overall Study|Medication error|0|||
129602325|NCT02072824|466502832|FG001|Overall Study|Medication error|1|||
129602326|NCT02072824|466502833|FG002|Overall Study|Medication error|0|||
129602327|NCT02072824|466502831|FG000|Overall Study|Adverse Event|0|||
129602328|NCT02072824|466502832|FG001|Overall Study|Adverse Event|0|||
129602329|NCT02072824|466502833|FG002|Overall Study|Adverse Event|1|||
129602330|NCT03084367|466502834|FG000|Overall Study|Lost to Follow-up|32|||
129602331|NCT03084367|466502834|FG000|Overall Study|Withdrawal by Subject|4|||
129602332|NCT03084367|466502834|FG000|Overall Study|Other|1|||
129697843|NCT01725282|466853376|FG003|Overall Study|Adverse Event|4|||
129697844|NCT01725282|466853373|FG000|Overall Study|Exacerbation of Target Disease|1|||
129697845|NCT01725282|466853374|FG001|Overall Study|Exacerbation of Target Disease|0|||
129697846|NCT01725282|466853375|FG002|Overall Study|Exacerbation of Target Disease|0|||
129697847|NCT01725282|466853376|FG003|Overall Study|Exacerbation of Target Disease|1|||
129697848|NCT01725282|466853373|FG000|Overall Study|Met Exclusion Criteria|0|||
129697849|NCT01725282|466853374|FG001|Overall Study|Met Exclusion Criteria|0|||
129602333|NCT00841906|466502835|FG000|Overall Study|Withdrawal by Subject|2|||
129602334|NCT00841906|466502836|FG001|Overall Study|Withdrawal by Subject|0|||
129697850|NCT01725282|466853375|FG002|Overall Study|Met Exclusion Criteria|1|||
129697851|NCT01725282|466853376|FG003|Overall Study|Met Exclusion Criteria|0|||
129697852|NCT01725282|466853373|FG000|Overall Study|Study Site Withdrawal|0|||
129697853|NCT01725282|466853374|FG001|Overall Study|Study Site Withdrawal|1|||
129697854|NCT01725282|466853375|FG002|Overall Study|Study Site Withdrawal|0|||
129697855|NCT01725282|466853376|FG003|Overall Study|Study Site Withdrawal|0|||
129697856|NCT01725282|466853373|FG000|Overall Study|Withdrawal by Subject|0|||
129602335|NCT01196078|466502839|FG000|Overall Study|Withdrawal by Subject|3|||
129602336|NCT01196078|466502840|FG001|Overall Study|Withdrawal by Subject|5|||
129602337|NCT01196078|466502839|FG000|Overall Study|Adverse Event|4|||
129697857|NCT01725282|466853374|FG001|Overall Study|Withdrawal by Subject|0|||
129697858|NCT01725282|466853375|FG002|Overall Study|Withdrawal by Subject|1|||
129697859|NCT01725282|466853376|FG003|Overall Study|Withdrawal by Subject|1|||
129789182|NCT00770146|467195563|FG000|Follow-up Period|Other|4|||
129789183|NCT00770146|467195564|FG001|Follow-up Period|Other|5|||
129436682|NCT03057977|465897150|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
129436683|NCT03057977|465897151|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
129436684|NCT03057977|465897150|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
129436685|NCT03057977|465897151|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
129436686|NCT03057977|465897150|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
129602338|NCT01196078|466502840|FG001|Overall Study|Adverse Event|4|||
129602339|NCT01196078|466502839|FG000|Overall Study|Protocol Violation|2|||
129602340|NCT01196078|466502840|FG001|Overall Study|Protocol Violation|1|||
129602341|NCT01196078|466502839|FG000|Overall Study|Lack of Efficacy|17|||
129602342|NCT01196078|466502840|FG001|Overall Study|Lack of Efficacy|23|||
129602343|NCT01196078|466502839|FG000|Overall Study|Lost to Follow-up|1|||
129602344|NCT01196078|466502840|FG001|Overall Study|Lost to Follow-up|0|||
129602345|NCT01196078|466502839|FG000|Overall Study|Death|6|||
129602346|NCT01196078|466502840|FG001|Overall Study|Death|4|||
129602347|NCT00127036|466502841|FG000|Overall Study|Insufficient Data for Analysis|6|||
129602348|NCT00127036|466502842|FG001|Overall Study|Insufficient Data for Analysis|11|||
129602349|NCT00127036|466502841|FG000|Overall Study|Screen Failure|2|||
129602350|NCT00127036|466502842|FG001|Overall Study|Screen Failure|0|||
129602351|NCT00270257|466502849|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
129602352|NCT00270257|466502850|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
129602353|NCT01403064|466502851|FG000|Overall Study|Death|0|||
129602354|NCT01403064|466502852|FG001|Overall Study|Death|0|||
129602355|NCT01403064|466502853|FG002|Overall Study|Death|1|||
129436687|NCT03057977|465897151|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
129436688|NCT03057977|465897150|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
129436689|NCT03057977|465897151|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
129602356|NCT01403064|466502854|FG003|Overall Study|Death|1|||
129602357|NCT01403064|466502851|FG000|Overall Study|Withdrawal by Subject|0|||
129602358|NCT01403064|466502852|FG001|Overall Study|Withdrawal by Subject|0|||
129602359|NCT01403064|466502853|FG002|Overall Study|Withdrawal by Subject|1|||
129602360|NCT01403064|466502854|FG003|Overall Study|Withdrawal by Subject|1|||
129602361|NCT01403064|466502851|FG000|Overall Study|Other|1|||
129602362|NCT01403064|466502852|FG001|Overall Study|Other|0|||
129602363|NCT01403064|466502853|FG002|Overall Study|Other|2|||
129602364|NCT01403064|466502854|FG003|Overall Study|Other|1|||
129602365|NCT02621034|466502855|FG000|Overall Study|Lost to Follow-up|3|||
129602366|NCT02621034|466502856|FG001|Overall Study|Lost to Follow-up|2|||
129602367|NCT02621034|466502857|FG002|Overall Study|Lost to Follow-up|5|||
129602368|NCT04688931|466502863|FG000|Overall Study|Adverse Event|4|||
129436690|NCT03057977|465897150|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
129436691|NCT03057977|465897151|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
129436692|NCT01650246|465897152|FG000|Overall Study|Adverse Event|23|||
129436693|NCT01650246|465897152|FG000|Overall Study|Protocol Violation|5|||
129436694|NCT01650246|465897152|FG000|Overall Study|Sponsor terminated study|53|||
129436695|NCT01650246|465897152|FG000|Overall Study|Lost to Follow-up|5|||
129436696|NCT01650246|465897152|FG000|Overall Study|Withdrawal by Subject|26|||
129436697|NCT01650246|465897152|FG000|Overall Study|Death|1|||
129436698|NCT01650246|465897152|FG000|Overall Study|Lack of Efficacy|30|||
129436699|NCT00953407|465897153|FG000|Overall Study|Failed inclusion criteria|1|||
129436700|NCT00953407|465897154|FG001|Overall Study|Failed inclusion criteria|1|||
129436701|NCT00953407|465897155|FG002|Overall Study|Failed inclusion criteria|1|||
129436702|NCT00953407|465897156|FG003|Overall Study|Failed inclusion criteria|1|||
129436703|NCT00953407|465897157|FG004|Overall Study|Failed inclusion criteria|1|||
129436704|NCT00953407|465897153|FG000|Overall Study|Lost to Follow-up|0|||
129436705|NCT00953407|465897154|FG001|Overall Study|Lost to Follow-up|0|||
129436706|NCT00953407|465897155|FG002|Overall Study|Lost to Follow-up|0|||
129436707|NCT00953407|465897156|FG003|Overall Study|Lost to Follow-up|1|||
129436708|NCT00953407|465897157|FG004|Overall Study|Lost to Follow-up|0|||
129436709|NCT03435497|465897159|FG000|Overall Study|Lost to Follow-up|1|||
129436710|NCT03435497|465897160|FG001|Overall Study|Lost to Follow-up|0|||
129602369|NCT04688931|466502864|FG001|Overall Study|Adverse Event|1|||
129602370|NCT04688931|466502863|FG000|Overall Study|Withdrawal by Subject|5|||
129602371|NCT04688931|466502864|FG001|Overall Study|Withdrawal by Subject|16|||
129697860|NCT01725282|466853373|FG000|Overall Study|Lack of Efficacy|0|||
129436711|NCT03435497|465897159|FG000|Overall Study|Death|1|||
129436712|NCT03435497|465897160|FG001|Overall Study|Death|0|||
129436713|NCT03435497|465897159|FG000|Overall Study|Withdrawal by Subject|0|||
129602372|NCT04688931|466502863|FG000|Overall Study|Physician Decision|3|||
129602373|NCT04688931|466502864|FG001|Overall Study|Physician Decision|5|||
129602374|NCT04688931|466502863|FG000|Overall Study|Noncompliance|0|||
129602375|NCT04688931|466502864|FG001|Overall Study|Noncompliance|1|||
129602376|NCT04688931|466502863|FG000|Overall Study|Lost to Follow-up|1|||
129602377|NCT04688931|466502864|FG001|Overall Study|Lost to Follow-up|3|||
129602378|NCT04688931|466502863|FG000|Overall Study|Randomization Error|3|||
129602379|NCT04688931|466502864|FG001|Overall Study|Randomization Error|0|||
129602380|NCT04688931|466502863|FG000|Overall Study|Not Eligible|1|||
129697861|NCT01725282|466853374|FG001|Overall Study|Lack of Efficacy|1|||
129602381|NCT04688931|466502864|FG001|Overall Study|Not Eligible|3|||
129602382|NCT04688931|466502863|FG000|Overall Study|Disease Progression|0|||
129602383|NCT04688931|466502864|FG001|Overall Study|Disease Progression|2|||
129602384|NCT04688931|466502863|FG000|Overall Study|Sponsor Requirement|1|||
129602385|NCT04688931|466502864|FG001|Overall Study|Sponsor Requirement|1|||
129602386|NCT04688931|466502863|FG000|Overall Study|Other Reason|1|||
129602387|NCT04688931|466502864|FG001|Overall Study|Other Reason|2|||
129602388|NCT00450619|466502865|FG000|Overall Study|refused treatment after randomization|2|||
129602389|NCT00450619|466502866|FG001|Overall Study|refused treatment after randomization|0|||
129602390|NCT00450619|466502865|FG000|Overall Study|did not progress; refused further trmt|1|||
129602391|NCT00450619|466502866|FG001|Overall Study|did not progress; refused further trmt|1|||
129602392|NCT00450619|466502865|FG000|Overall Study|Adverse Event|1|||
129602393|NCT00450619|466502866|FG001|Overall Study|Adverse Event|0|||
129602394|NCT00714493|466502878|FG000|Overall Study|Adverse Event|11|||
129602395|NCT00714493|466502878|FG000|Overall Study|Death|3|||
129602396|NCT00714493|466502878|FG000|Overall Study|Lack of Efficacy|10|||
129602397|NCT00714493|466502878|FG000|Overall Study|Lost to Follow-up|3|||
129602398|NCT00714493|466502878|FG000|Overall Study|Protocol Violation|12|||
129602399|NCT00714493|466502878|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
129602400|NCT00714493|466502878|FG000|Overall Study|OTHER|2|||
129602401|NCT02372071|466502879|FG000|Overall Study|Protocol Violation|18|||
129602402|NCT00506129|466502880|FG000|Overall Study|Disease Progression/Relapse|15|||
129602403|NCT00506129|466502880|FG000|Overall Study|Death|7|||
129602404|NCT01968694|466502881|FG000|Washout (1 Month)|Lost to Follow-up|0|||
129602405|NCT01968694|466502882|FG001|Washout (1 Month)|Lost to Follow-up|1|||
129602406|NCT00354341|466502883|FG000|Overall Study|Adverse Event|1|||
129602407|NCT00354341|466502884|FG001|Overall Study|Adverse Event|0|||
129602408|NCT00354341|466502883|FG000|Overall Study|Death|0|||
129602409|NCT00354341|466502884|FG001|Overall Study|Death|2|||
129602410|NCT00354341|466502883|FG000|Overall Study|Refused treatment|1|||
129602411|NCT00354341|466502884|FG001|Overall Study|Refused treatment|2|||
129602412|NCT00354341|466502883|FG000|Overall Study|Failure to return|0|||
129602413|NCT00354341|466502884|FG001|Overall Study|Failure to return|1|||
129602414|NCT00354341|466502883|FG000|Overall Study|Other|1|||
129602415|NCT00354341|466502884|FG001|Overall Study|Other|2|||
129602416|NCT00251719|466502885|FG000|Overall Study|Adverse Event|14|||
129602417|NCT00251719|466502886|FG001|Overall Study|Adverse Event|8|||
129602418|NCT00251719|466502887|FG002|Overall Study|Adverse Event|7|||
129602419|NCT00251719|466502885|FG000|Overall Study|Protocol Violation|1|||
129602420|NCT00251719|466502886|FG001|Overall Study|Protocol Violation|1|||
129602421|NCT00251719|466502887|FG002|Overall Study|Protocol Violation|1|||
129602422|NCT00251719|466502885|FG000|Overall Study|Lost to Follow-up|5|||
129602423|NCT00251719|466502886|FG001|Overall Study|Lost to Follow-up|11|||
129602424|NCT00251719|466502887|FG002|Overall Study|Lost to Follow-up|8|||
129602425|NCT00251719|466502885|FG000|Overall Study|Withdrawal by Subject|14|||
129602426|NCT00251719|466502886|FG001|Overall Study|Withdrawal by Subject|12|||
129602427|NCT00251719|466502887|FG002|Overall Study|Withdrawal by Subject|11|||
129602428|NCT00251719|466502885|FG000|Overall Study|Lack of Efficacy|2|||
129602429|NCT00251719|466502886|FG001|Overall Study|Lack of Efficacy|1|||
129602430|NCT00251719|466502887|FG002|Overall Study|Lack of Efficacy|0|||
129602431|NCT00251719|466502885|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
129602432|NCT00251719|466502886|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
129602433|NCT00251719|466502887|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
129602434|NCT00251719|466502885|FG000|Overall Study|Investigator decision|1|||
129602435|NCT00251719|466502886|FG001|Overall Study|Investigator decision|1|||
129602436|NCT00251719|466502887|FG002|Overall Study|Investigator decision|0|||
129602437|NCT00251719|466502885|FG000|Overall Study|Noncompliance|2|||
129602438|NCT00251719|466502886|FG001|Overall Study|Noncompliance|3|||
129602439|NCT00251719|466502887|FG002|Overall Study|Noncompliance|1|||
129602440|NCT00251719|466502885|FG000|Overall Study|Barrett's esophagus|2|||
129602441|NCT00251719|466502886|FG001|Overall Study|Barrett's esophagus|2|||
129602442|NCT00251719|466502887|FG002|Overall Study|Barrett's esophagus|0|||
129602443|NCT01732874|466502890|FG000|Overall Study|Withdrawal by Subject|5|||
129602444|NCT01732874|466502891|FG001|Overall Study|Withdrawal by Subject|1|||
129602445|NCT01732874|466502890|FG000|Overall Study|Death of Infant|3|||
129602446|NCT01732874|466502891|FG001|Overall Study|Death of Infant|2|||
129602447|NCT00688376|466502894|FG000|Double-Blind Phase|Adverse Event|4|||
129602448|NCT00688376|466502895|FG001|Double-Blind Phase|Adverse Event|4|||
129602449|NCT00688376|466502894|FG000|Double-Blind Phase|Protocol Violation|1|||
129602450|NCT00688376|466502895|FG001|Double-Blind Phase|Protocol Violation|2|||
129602451|NCT00688376|466502894|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
129602452|NCT00688376|466502895|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
129602453|NCT00688376|466502894|FG000|Double-Blind Phase|Not treated|0|||
129602454|NCT00688376|466502895|FG001|Double-Blind Phase|Not treated|1|||
129602455|NCT00688376|466502894|FG000|Blinded Extension Phase|Adverse Event|3|||
129602456|NCT00688376|466502895|FG001|Blinded Extension Phase|Adverse Event|4|||
129602457|NCT00688376|466502894|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
129602458|NCT00688376|466502895|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
129602459|NCT00688376|466502894|FG000|Blinded Extension Phase|Physician Decision|1|||
129602460|NCT00688376|466502895|FG001|Blinded Extension Phase|Physician Decision|0|||
129602461|NCT00688376|466502894|FG000|Blinded Extension Phase|Other|1|||
129602462|NCT00688376|466502895|FG001|Blinded Extension Phase|Other|0|||
129602463|NCT00557076|466502896|FG000|Overall Study|Unblinding|0|||
129602464|NCT00557076|466502897|FG001|Overall Study|Unblinding|1|||
129602465|NCT04392583|466502898|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
129602466|NCT01070771|466502902|FG000|Overall Study|Adverse Event|2|||
129602467|NCT01070771|466502902|FG000|Overall Study|Protocol Violation|1|||
129602468|NCT00857259|466502905|FG000|Overall Study|Protocol Violation|1|||
129602469|NCT00857259|466502906|FG001|Overall Study|Protocol Violation|0|||
129602470|NCT00857259|466502907|FG002|Overall Study|Protocol Violation|1|||
129602471|NCT02701413|466502908|FG000|Overall Study|Withdrawal by Subject|7|||
129602472|NCT02701413|466502909|FG001|Overall Study|Withdrawal by Subject|11|||
129602473|NCT01621191|466502912|FG000|Overall Study|Adverse Event|9|||
129602474|NCT01621191|466502912|FG000|Overall Study|Withdrawal by Subject|8|||
129602475|NCT01621191|466502912|FG000|Overall Study|Lack of Efficacy|6|||
129602476|NCT01621191|466502912|FG000|Overall Study|Lost to Follow-up|1|||
129602477|NCT01621191|466502912|FG000|Overall Study|Site Removed From Study|1|||
129602478|NCT00706381|466502913|FG000|Overall Study|Lost to Follow-up|0|||
129602479|NCT00706381|466502914|FG001|Overall Study|Lost to Follow-up|1|||
129602480|NCT00706381|466502915|FG002|Overall Study|Lost to Follow-up|1|||
129602481|NCT00706381|466502916|FG003|Overall Study|Lost to Follow-up|0|||
129602482|NCT00038649|466502923|FG000|Overall Study|Adverse Event|9|||
129602483|NCT00995085|466502924|FG000|Overall Study|Withdrawal by Subject|5|||
129602484|NCT03096847|466502930|FG000|Overall Study|Other|2|||
129602485|NCT03096847|466502931|FG001|Overall Study|Other|1|||
129602486|NCT03096847|466502932|FG002|Overall Study|Other|2|||
129602487|NCT03096847|466502930|FG000|Overall Study|Lost to Follow-up|1|||
129602488|NCT03096847|466502931|FG001|Overall Study|Lost to Follow-up|0|||
129602489|NCT03096847|466502932|FG002|Overall Study|Lost to Follow-up|1|||
129602490|NCT03096847|466502930|FG000|Overall Study|Death|6|||
129602491|NCT03096847|466502931|FG001|Overall Study|Death|0|||
129602492|NCT03096847|466502932|FG002|Overall Study|Death|2|||
129602493|NCT03096847|466502930|FG000|Overall Study|Protocol Violation|3|||
129602494|NCT03096847|466502931|FG001|Overall Study|Protocol Violation|0|||
129602495|NCT03096847|466502932|FG002|Overall Study|Protocol Violation|6|||
129602496|NCT03096847|466502930|FG000|Overall Study|Physician Decision|12|||
129602497|NCT03096847|466502931|FG001|Overall Study|Physician Decision|2|||
129602498|NCT03096847|466502932|FG002|Overall Study|Physician Decision|8|||
129602499|NCT03096847|466502930|FG000|Overall Study|Withdrawal by Subject|24|||
129602500|NCT03096847|466502931|FG001|Overall Study|Withdrawal by Subject|1|||
129602501|NCT03096847|466502932|FG002|Overall Study|Withdrawal by Subject|12|||
129602502|NCT03096847|466502930|FG000|Overall Study|Adverse Event|72|||
129602503|NCT03096847|466502931|FG001|Overall Study|Adverse Event|6|||
129602504|NCT03096847|466502932|FG002|Overall Study|Adverse Event|28|||
129602505|NCT03096847|466502930|FG000|Overall Study|Progressive disease|97|||
129602506|NCT03096847|466502931|FG001|Overall Study|Progressive disease|10|||
129602507|NCT03096847|466502932|FG002|Overall Study|Progressive disease|78|||
129602508|NCT03096847|466502930|FG000|Overall Study|Non-compliance with study medication|1|||
129602509|NCT03096847|466502931|FG001|Overall Study|Non-compliance with study medication|0|||
129602510|NCT03096847|466502932|FG002|Overall Study|Non-compliance with study medication|0|||
129602511|NCT03096847|466502930|FG000|Overall Study|New therapy for study indication|1|||
129602512|NCT03096847|466502931|FG001|Overall Study|New therapy for study indication|0|||
129602513|NCT03096847|466502932|FG002|Overall Study|New therapy for study indication|1|||
129602514|NCT00062751|466502933|FG000|Overall Study|Disease progression|24|||
129602515|NCT00062751|466502934|FG001|Overall Study|Disease progression|17|||
129789184|NCT00816023|467195568|FG000|Overall Study|Lost to Follow-up|1|||
129789185|NCT00816023|467195569|FG001|Overall Study|Lost to Follow-up|1|||
129789186|NCT00816023|467195570|FG002|Overall Study|Lost to Follow-up|0|||
129789187|NCT00816023|467195571|FG003|Overall Study|Lost to Follow-up|0|||
129789188|NCT00816023|467195568|FG000|Overall Study|Withdrawal by Subject|1|||
129789189|NCT00816023|467195569|FG001|Overall Study|Withdrawal by Subject|0|||
129602516|NCT00062751|466502935|FG002|Overall Study|Disease progression|24|||
129602517|NCT00062751|466502936|FG003|Overall Study|Disease progression|2|||
129602518|NCT00062751|466502937|FG004|Overall Study|Disease progression|2|||
129789190|NCT00816023|467195570|FG002|Overall Study|Withdrawal by Subject|0|||
129602519|NCT00062751|466502933|FG000|Overall Study|Adverse Event|4|||
129602520|NCT00062751|466502934|FG001|Overall Study|Adverse Event|7|||
129602521|NCT00062751|466502935|FG002|Overall Study|Adverse Event|2|||
129602522|NCT00062751|466502936|FG003|Overall Study|Adverse Event|2|||
129602523|NCT00062751|466502937|FG004|Overall Study|Adverse Event|2|||
129602524|NCT00062751|466502933|FG000|Overall Study|Other|2|||
129602525|NCT00062751|466502934|FG001|Overall Study|Other|3|||
129602526|NCT00062751|466502935|FG002|Overall Study|Other|1|||
129602527|NCT00062751|466502936|FG003|Overall Study|Other|0|||
129789191|NCT00816023|467195571|FG003|Overall Study|Withdrawal by Subject|0|||
129789192|NCT00816023|467195568|FG000|Overall Study|Physician Decision|0|||
129436714|NCT03435497|465897160|FG001|Overall Study|Withdrawal by Subject|4|||
129436715|NCT03435497|465897159|FG000|Overall Study|Wrong survey administered|0|||
129436716|NCT03435497|465897160|FG001|Overall Study|Wrong survey administered|2|||
129436717|NCT02795429|465897161|FG000|Overall Study|Adverse Event|1|||
129436718|NCT02795429|465897162|FG001|Overall Study|Adverse Event|2|||
129436719|NCT02795429|465897163|FG002|Overall Study|Adverse Event|1|||
129436720|NCT02795429|465897164|FG003|Overall Study|Adverse Event|2|||
129436721|NCT02795429|465897165|FG004|Overall Study|Adverse Event|1|||
129436722|NCT02795429|465897161|FG000|Overall Study|Death|1|||
129436723|NCT02795429|465897162|FG001|Overall Study|Death|0|||
129436724|NCT02795429|465897163|FG002|Overall Study|Death|1|||
129436725|NCT02795429|465897164|FG003|Overall Study|Death|2|||
129436726|NCT02795429|465897165|FG004|Overall Study|Death|1|||
129436727|NCT02795429|465897161|FG000|Overall Study|Physician Decision|0|||
129436728|NCT02795429|465897162|FG001|Overall Study|Physician Decision|0|||
129436729|NCT02795429|465897163|FG002|Overall Study|Physician Decision|2|||
129436730|NCT02795429|465897164|FG003|Overall Study|Physician Decision|1|||
129436731|NCT02795429|465897165|FG004|Overall Study|Physician Decision|5|||
129436732|NCT02795429|465897161|FG000|Overall Study|Progressive disease|3|||
129436733|NCT02795429|465897162|FG001|Overall Study|Progressive disease|7|||
129436734|NCT02795429|465897163|FG002|Overall Study|Progressive disease|6|||
129436735|NCT02795429|465897164|FG003|Overall Study|Progressive disease|26|||
129436736|NCT02795429|465897165|FG004|Overall Study|Progressive disease|20|||
129436737|NCT02795429|465897161|FG000|Overall Study|Subject/guardian decision|1|||
129436738|NCT02795429|465897162|FG001|Overall Study|Subject/guardian decision|1|||
129436739|NCT02795429|465897163|FG002|Overall Study|Subject/guardian decision|1|||
129436740|NCT02795429|465897164|FG003|Overall Study|Subject/guardian decision|1|||
129436741|NCT02795429|465897165|FG004|Overall Study|Subject/guardian decision|3|||
129436742|NCT00701779|465897166|FG000|Overall Study|Adverse Event|6|||
129436743|NCT00701779|465897166|FG000|Overall Study|Lost to Follow-up|1|||
129436744|NCT00701779|465897166|FG000|Overall Study|Withdrawal by Subject|2|||
129436745|NCT01640054|465897169|FG000|Overall Study|Study-specific disc criteria|1|||
129436746|NCT01640054|465897169|FG000|Overall Study|Lack of Efficacy|3|||
129436747|NCT01640054|465897169|FG000|Overall Study|Adverse Event|2|||
129436748|NCT05220254|465897171|FG000|Overall Study|Withdrawal by Subject|4|||
129436749|NCT05220254|465897171|FG000|Overall Study|Removed due to ineligibility|1|||
129436750|NCT05220254|465897171|FG000|Overall Study|Lost to Follow-up|7|||
129436751|NCT03645057|465897172|FG000|Randomization to Baseline|Lost to Follow-up|1|||
129436752|NCT03645057|465897173|FG001|Randomization to Baseline|Lost to Follow-up|0|||
129436753|NCT03645057|465897174|FG002|Randomization to Baseline|Lost to Follow-up|1|||
129436754|NCT03645057|465897175|FG003|Randomization to Baseline|Lost to Follow-up|0|||
129436755|NCT03645057|465897172|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
129436756|NCT03645057|465897173|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
129602528|NCT00062751|466502937|FG004|Overall Study|Other|1|||
129602529|NCT00062751|466502933|FG000|Overall Study|Withdrawal by Subject|1|||
129602530|NCT00062751|466502934|FG001|Overall Study|Withdrawal by Subject|2|||
129602531|NCT00062751|466502935|FG002|Overall Study|Withdrawal by Subject|2|||
129602532|NCT00062751|466502936|FG003|Overall Study|Withdrawal by Subject|1|||
129602533|NCT00062751|466502937|FG004|Overall Study|Withdrawal by Subject|0|||
129602534|NCT00062751|466502933|FG000|Overall Study|Symptomatic deterioration|1|||
129436757|NCT03645057|465897174|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
129436758|NCT03645057|465897175|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
129436759|NCT03645057|465897172|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
129602535|NCT00062751|466502934|FG001|Overall Study|Symptomatic deterioration|1|||
129602536|NCT00062751|466502935|FG002|Overall Study|Symptomatic deterioration|0|||
129602537|NCT00062751|466502936|FG003|Overall Study|Symptomatic deterioration|0|||
129602538|NCT00062751|466502937|FG004|Overall Study|Symptomatic deterioration|1|||
129602539|NCT00062751|466502933|FG000|Overall Study|Death|1|||
129602540|NCT00062751|466502934|FG001|Overall Study|Death|0|||
129602541|NCT00062751|466502935|FG002|Overall Study|Death|1|||
129602542|NCT00062751|466502936|FG003|Overall Study|Death|0|||
129602543|NCT00062751|466502937|FG004|Overall Study|Death|0|||
129602544|NCT00851643|466502944|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
129602545|NCT00851643|466502945|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129602546|NCT00851643|466502946|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129602547|NCT00851643|466502947|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129602548|NCT00851643|466502948|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129436760|NCT03645057|465897173|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
129436761|NCT03645057|465897174|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
129436762|NCT03645057|465897175|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
129436763|NCT03645057|465897172|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
129602549|NCT00851643|466502949|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
129602550|NCT00851643|466502944|FG000|Base Study (Up to 12 Months)|Other|0|||
129602551|NCT00851643|466502945|FG001|Base Study (Up to 12 Months)|Other|0|||
129602552|NCT00851643|466502946|FG002|Base Study (Up to 12 Months)|Other|0|||
129602553|NCT00851643|466502947|FG003|Base Study (Up to 12 Months)|Other|0|||
129602554|NCT00851643|466502948|FG004|Base Study (Up to 12 Months)|Other|0|||
129886003|NCT02291289|467542800|FG007|Early Disease Progression|Lost to Follow-up|0|||
129602555|NCT00851643|466502949|FG005|Base Study (Up to 12 Months)|Other|1|||
129602556|NCT00851643|466502944|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
129602557|NCT00851643|466502945|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
129602558|NCT00851643|466502946|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
129602559|NCT00851643|466502947|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
129602560|NCT00851643|466502948|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
129602561|NCT00851643|466502949|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
129602562|NCT00851643|466502944|FG000|Extension Study (Up to 36 Months)|Moved|0|||
129602563|NCT00851643|466502945|FG001|Extension Study (Up to 36 Months)|Moved|2|||
129602564|NCT00851643|466502946|FG002|Extension Study (Up to 36 Months)|Moved|1|||
129602565|NCT00851643|466502947|FG003|Extension Study (Up to 36 Months)|Moved|1|||
129602566|NCT00851643|466502948|FG004|Extension Study (Up to 36 Months)|Moved|0|||
129602567|NCT00851643|466502949|FG005|Extension Study (Up to 36 Months)|Moved|1|||
129602568|NCT01641133|466502952|FG000|Overall Study|Protocol Violation|0|||
129602569|NCT01641133|466502953|FG001|Overall Study|Protocol Violation|1|||
129602570|NCT01641133|466502954|FG002|Overall Study|Protocol Violation|1|||
129602571|NCT01641133|466502952|FG000|Overall Study|Migrated/moved from study area|5|||
129602572|NCT01641133|466502953|FG001|Overall Study|Migrated/moved from study area|3|||
129602573|NCT01641133|466502954|FG002|Overall Study|Migrated/moved from study area|1|||
129602574|NCT01641133|466502952|FG000|Overall Study|Adverse Event|0|||
129602575|NCT01641133|466502953|FG001|Overall Study|Adverse Event|0|||
129602576|NCT01641133|466502954|FG002|Overall Study|Adverse Event|1|||
129602577|NCT01641133|466502952|FG000|Overall Study|Withdrawal by Subject|5|||
129602578|NCT01641133|466502953|FG001|Overall Study|Withdrawal by Subject|3|||
129602579|NCT01641133|466502954|FG002|Overall Study|Withdrawal by Subject|3|||
129602580|NCT01641133|466502952|FG000|Overall Study|Lost to Follow-up|0|||
129602581|NCT01641133|466502953|FG001|Overall Study|Lost to Follow-up|2|||
129602582|NCT01641133|466502954|FG002|Overall Study|Lost to Follow-up|2|||
129602583|NCT00609466|466502955|FG000|Overall Study|Withdrawal by Subject|0|||
129602584|NCT00609466|466502956|FG001|Overall Study|Withdrawal by Subject|1|||
129602585|NCT00609466|466502957|FG002|Overall Study|Withdrawal by Subject|1|||
129602586|NCT00609466|466502955|FG000|Overall Study|Adverse Event|2|||
129602587|NCT00609466|466502956|FG001|Overall Study|Adverse Event|3|||
129602588|NCT00609466|466502957|FG002|Overall Study|Adverse Event|1|||
129602589|NCT00609466|466502955|FG000|Overall Study|Lack of Efficacy|0|||
129602590|NCT00609466|466502956|FG001|Overall Study|Lack of Efficacy|2|||
129602591|NCT00609466|466502957|FG002|Overall Study|Lack of Efficacy|2|||
129602592|NCT03512262|466502958|FG000|Overall Study|Adverse Event|8|||
129602593|NCT03512262|466502959|FG001|Overall Study|Adverse Event|3|||
129602594|NCT03512262|466502958|FG000|Overall Study|Death (non-treatment emergent)|1|||
129602595|NCT03512262|466502959|FG001|Overall Study|Death (non-treatment emergent)|0|||
129602596|NCT03512262|466502958|FG000|Overall Study|Withdrawal by Subject|17|||
129602597|NCT03512262|466502959|FG001|Overall Study|Withdrawal by Subject|9|||
129602598|NCT03512262|466502958|FG000|Overall Study|Lost to Follow-up|7|||
129602599|NCT03512262|466502959|FG001|Overall Study|Lost to Follow-up|1|||
129602600|NCT03512262|466502958|FG000|Overall Study|Other than Specified|2|||
129602601|NCT03512262|466502959|FG001|Overall Study|Other than Specified|2|||
129602602|NCT03407430|466502960|FG000|Washout|Protocol Violation|1|||
129602603|NCT03407430|466502961|FG001|Washout|Protocol Violation|0|||
129602604|NCT01195272|466502962|FG000|Overall Study|Adverse Event|1|||
129602605|NCT01195272|466502962|FG000|Overall Study|Lack of Efficacy|3|||
129602606|NCT03295318|466504380|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
129602607|NCT03295318|466504381|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
129602608|NCT03295318|466504382|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
129602609|NCT03295318|466504380|FG000|Overall Study|Death|1|||
129602610|NCT03295318|466504381|FG001|Overall Study|Death|1|||
129602611|NCT03295318|466504382|FG002|Overall Study|Death|1|||
129602612|NCT03295318|466504380|FG000|Overall Study|Protocol Violation|4|||
129602613|NCT03295318|466504381|FG001|Overall Study|Protocol Violation|3|||
129602614|NCT03295318|466504382|FG002|Overall Study|Protocol Violation|3|||
129602615|NCT03295318|466504380|FG000|Overall Study|Withdrawal by Subject|0|||
129602616|NCT03295318|466504381|FG001|Overall Study|Withdrawal by Subject|0|||
129602617|NCT03295318|466504382|FG002|Overall Study|Withdrawal by Subject|1|||
129602618|NCT03295318|466504380|FG000|Overall Study|Subject discontinued due to travel|0|||
129602619|NCT03295318|466504381|FG001|Overall Study|Subject discontinued due to travel|1|||
129602620|NCT03295318|466504382|FG002|Overall Study|Subject discontinued due to travel|0|||
129602621|NCT04319718|466504383|FG000|Overall Study|Adverse Event|0|||
129602622|NCT04319718|466504384|FG001|Overall Study|Adverse Event|2|||
129602623|NCT04319718|466504383|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
129602624|NCT04319718|466504384|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
129602625|NCT01288053|466504385|FG000|Overall Study|Death|1|||
129697862|NCT01725282|466853375|FG002|Overall Study|Lack of Efficacy|0|||
129697863|NCT01725282|466853376|FG003|Overall Study|Lack of Efficacy|1|||
129697864|NCT04064567|466853377|FG000|Overall Study|Lost to Follow-up|23|||
129697865|NCT04064567|466853378|FG001|Overall Study|Lost to Follow-up|22|||
129697866|NCT04064567|466853377|FG000|Overall Study|Withdrawal by Subject|0|||
129697867|NCT04064567|466853378|FG001|Overall Study|Withdrawal by Subject|1|||
129697868|NCT04064567|466853377|FG000|Overall Study|Reincarcerated|7|||
129697869|NCT04064567|466853378|FG001|Overall Study|Reincarcerated|10|||
129697870|NCT04064567|466853377|FG000|Overall Study|Moved out of U.S.|0|||
129697871|NCT04064567|466853378|FG001|Overall Study|Moved out of U.S.|1|||
129697872|NCT04576481|466853380|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
129697873|NCT04576481|466853381|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
129697874|NCT04576481|466853382|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
129697875|NCT04576481|466853383|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
129697876|NCT01682720|466853384|FG000|Overall Study|Randomized but Not Treated|0|||
129697877|NCT01682720|466853385|FG001|Overall Study|Randomized but Not Treated|1|||
129602626|NCT00144781|466504386|FG000|Overall Study|Adverse Event|0|||
129602627|NCT00144781|466504387|FG001|Overall Study|Adverse Event|1|||
129602628|NCT00144781|466504388|FG002|Overall Study|Adverse Event|0|||
129602629|NCT00144781|466504389|FG003|Overall Study|Adverse Event|0|||
129602630|NCT00144781|466504386|FG000|Overall Study|Non-compliant|0|||
129602631|NCT00144781|466504387|FG001|Overall Study|Non-compliant|1|||
129602632|NCT00144781|466504388|FG002|Overall Study|Non-compliant|0|||
129602633|NCT00144781|466504389|FG003|Overall Study|Non-compliant|0|||
129602634|NCT02068092|466504390|FG000|Overall Study|Physician Decision|2|||
129602635|NCT02068092|466504390|FG000|Overall Study|Adverse Event|2|||
129602636|NCT02068092|466504390|FG000|Overall Study|Lost to Follow-up|4|||
129602637|NCT02068092|466504390|FG000|Overall Study|Withdrawal by Subject|2|||
129602638|NCT06204887|466504391|FG000|Overall Study|Lost to Follow-up|3|||
129602639|NCT06204887|466504392|FG001|Overall Study|Lost to Follow-up|4|||
129602640|NCT06204887|466504393|FG002|Overall Study|Lost to Follow-up|1|||
129602641|NCT06204887|466504394|FG003|Overall Study|Lost to Follow-up|6|||
129602642|NCT01045421|466504395|FG000|Phase 1|Progressive Disease|0|||
129602643|NCT01045421|466504396|FG001|Phase 1|Progressive Disease|0|||
129602644|NCT01045421|466504397|FG002|Phase 1|Progressive Disease|0|||
129602645|NCT01045421|466504398|FG003|Phase 1|Progressive Disease|0|||
129602646|NCT01045421|466504399|FG004|Phase 1|Progressive Disease|1|||
129602647|NCT01045421|466504400|FG005|Phase 1|Progressive Disease|0|||
129602648|NCT01045421|466504401|FG006|Phase 1|Progressive Disease|0|||
129602649|NCT01045421|466504402|FG007|Phase 1|Progressive Disease|0|||
129602650|NCT01045421|466504403|FG008|Phase 1|Progressive Disease|0|||
129602651|NCT01045421|466504404|FG009|Phase 1|Progressive Disease|0|||
129602652|NCT01045421|466504405|FG010|Phase 1|Progressive Disease|0|||
129602653|NCT01045421|466504395|FG000|Phase 1|Withdrawal by Subject|0|||
129602654|NCT01045421|466504396|FG001|Phase 1|Withdrawal by Subject|0|||
129602655|NCT01045421|466504397|FG002|Phase 1|Withdrawal by Subject|0|||
129602656|NCT01045421|466504398|FG003|Phase 1|Withdrawal by Subject|1|||
129602657|NCT01045421|466504399|FG004|Phase 1|Withdrawal by Subject|0|||
129602658|NCT01045421|466504400|FG005|Phase 1|Withdrawal by Subject|0|||
129602659|NCT01045421|466504401|FG006|Phase 1|Withdrawal by Subject|0|||
129602660|NCT01045421|466504402|FG007|Phase 1|Withdrawal by Subject|0|||
129602661|NCT01045421|466504403|FG008|Phase 1|Withdrawal by Subject|0|||
129602662|NCT01045421|466504404|FG009|Phase 1|Withdrawal by Subject|0|||
129602663|NCT01045421|466504405|FG010|Phase 1|Withdrawal by Subject|0|||
129602664|NCT01045421|466504395|FG000|Phase 2|Progressive Disease|0|||
129602665|NCT01045421|466504396|FG001|Phase 2|Progressive Disease|0|||
129602666|NCT01045421|466504397|FG002|Phase 2|Progressive Disease|0|||
129602667|NCT01045421|466504398|FG003|Phase 2|Progressive Disease|0|||
129602668|NCT01045421|466504399|FG004|Phase 2|Progressive Disease|0|||
129602669|NCT01045421|466504400|FG005|Phase 2|Progressive Disease|0|||
129602670|NCT01045421|466504401|FG006|Phase 2|Progressive Disease|0|||
129602671|NCT01045421|466504402|FG007|Phase 2|Progressive Disease|1|||
129697878|NCT01682720|466853386|FG002|Overall Study|Randomized but Not Treated|1|||
129697879|NCT01682720|466853387|FG003|Overall Study|Randomized but Not Treated|0|||
129697880|NCT01682720|466853384|FG000|Overall Study|Terminated by Sponsor|83|||
129602672|NCT01045421|466504403|FG008|Phase 2|Progressive Disease|1|||
129602673|NCT01045421|466504404|FG009|Phase 2|Progressive Disease|1|||
129602674|NCT01045421|466504405|FG010|Phase 2|Progressive Disease|1|||
129602675|NCT01045421|466504395|FG000|Phase 2|Death|0|||
129602676|NCT01045421|466504396|FG001|Phase 2|Death|0|||
129602677|NCT01045421|466504397|FG002|Phase 2|Death|0|||
129602678|NCT01045421|466504398|FG003|Phase 2|Death|0|||
129602679|NCT01045421|466504399|FG004|Phase 2|Death|0|||
129602680|NCT01045421|466504400|FG005|Phase 2|Death|0|||
129697881|NCT01682720|466853385|FG001|Overall Study|Terminated by Sponsor|0|||
129697882|NCT01682720|466853386|FG002|Overall Study|Terminated by Sponsor|0|||
129602681|NCT01045421|466504401|FG006|Phase 2|Death|0|||
129602682|NCT01045421|466504402|FG007|Phase 2|Death|1|||
129602683|NCT01045421|466504403|FG008|Phase 2|Death|1|||
129602684|NCT01045421|466504404|FG009|Phase 2|Death|2|||
129602685|NCT01045421|466504405|FG010|Phase 2|Death|0|||
129602686|NCT01045421|466504395|FG000|Phase 2|Other|0|||
129602687|NCT01045421|466504396|FG001|Phase 2|Other|0|||
129602688|NCT01045421|466504397|FG002|Phase 2|Other|0|||
129602689|NCT01045421|466504398|FG003|Phase 2|Other|0|||
129602690|NCT01045421|466504399|FG004|Phase 2|Other|0|||
129697883|NCT01682720|466853387|FG003|Overall Study|Terminated by Sponsor|0|||
129602691|NCT01045421|466504400|FG005|Phase 2|Other|0|||
129602692|NCT01045421|466504401|FG006|Phase 2|Other|0|||
129602693|NCT01045421|466504402|FG007|Phase 2|Other|3|||
129602694|NCT01045421|466504403|FG008|Phase 2|Other|0|||
129602695|NCT01045421|466504404|FG009|Phase 2|Other|0|||
129602696|NCT01045421|466504405|FG010|Phase 2|Other|1|||
129789193|NCT00816023|467195569|FG001|Overall Study|Physician Decision|0|||
129789194|NCT00816023|467195570|FG002|Overall Study|Physician Decision|1|||
129789195|NCT00816023|467195571|FG003|Overall Study|Physician Decision|0|||
129789196|NCT00816023|467195568|FG000|Overall Study|assessments complete prior to window|1|||
129789197|NCT00816023|467195569|FG001|Overall Study|assessments complete prior to window|1|||
129789198|NCT00816023|467195570|FG002|Overall Study|assessments complete prior to window|2|||
129789199|NCT00816023|467195571|FG003|Overall Study|assessments complete prior to window|1|||
129789200|NCT00816023|467195568|FG000|Overall Study|Randomized Not Treated|6|||
129789201|NCT00816023|467195569|FG001|Overall Study|Randomized Not Treated|4|||
129602697|NCT04551911|466504406|FG000|Overall Study|Lost to Follow-up|2|||
129602698|NCT04551911|466504407|FG001|Overall Study|Lost to Follow-up|1|||
129602699|NCT04551911|466504406|FG000|Overall Study|Withdrawal by Subject|10|||
129602700|NCT04551911|466504407|FG001|Overall Study|Withdrawal by Subject|10|||
129602701|NCT04551911|466504406|FG000|Overall Study|Did not receive the study drug|3|||
129602702|NCT04551911|466504407|FG001|Overall Study|Did not receive the study drug|4|||
129602703|NCT01030341|466504408|FG000|Overall Study|Withdrawal by Subject|1|||
129602704|NCT01030341|466504408|FG000|Overall Study|Lost to Follow-up|2|||
129602705|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Death|89|||
129602706|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Death|193|||
129602707|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Death|198|||
129602708|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
129602709|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
129602710|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
129602711|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
129602712|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
129697884|NCT01682720|466853384|FG000|Overall Study|Efficacy Failure|0|||
129697885|NCT01682720|466853385|FG001|Overall Study|Efficacy Failure|3|||
129697886|NCT01682720|466853386|FG002|Overall Study|Efficacy Failure|3|||
129697887|NCT01682720|466853387|FG003|Overall Study|Efficacy Failure|30|||
129697888|NCT01682720|466853384|FG000|Overall Study|Lost to Follow-up|1|||
129697889|NCT01682720|466853385|FG001|Overall Study|Lost to Follow-up|1|||
129697890|NCT01682720|466853386|FG002|Overall Study|Lost to Follow-up|0|||
129697891|NCT01682720|466853387|FG003|Overall Study|Lost to Follow-up|6|||
129697892|NCT01682720|466853384|FG000|Overall Study|Subject Withdrew Consent|0|||
129697893|NCT01682720|466853385|FG001|Overall Study|Subject Withdrew Consent|0|||
129697894|NCT01682720|466853386|FG002|Overall Study|Subject Withdrew Consent|2|||
129697895|NCT01682720|466853387|FG003|Overall Study|Subject Withdrew Consent|2|||
129697896|NCT01682720|466853384|FG000|Overall Study|Adverse Event|1|||
129697897|NCT01682720|466853385|FG001|Overall Study|Adverse Event|0|||
129697898|NCT01682720|466853386|FG002|Overall Study|Adverse Event|1|||
129697899|NCT01682720|466853387|FG003|Overall Study|Adverse Event|1|||
129697900|NCT00069953|466853388|FG000|Overall Study|Protocol Violation|2|||
129697901|NCT02034565|466853389|FG000|Overall Study|Adverse Event|1|||
129697902|NCT02034565|466853390|FG001|Overall Study|Adverse Event|0|||
129697903|NCT00113373|466853391|FG000|Overall Study|Ineligible: wrong primary|1|||
129697904|NCT00113373|466853391|FG000|Overall Study|Ineligible: second primary|1|||
129697905|NCT00113373|466853391|FG000|Overall Study|Never Treated|1|||
129697906|NCT04525183|466853395|FG000|Overall Study|Withdrawal by Subject|0|||
129697907|NCT04525183|466853396|FG001|Overall Study|Withdrawal by Subject|0|||
129697908|NCT04525183|466853397|FG002|Overall Study|Withdrawal by Subject|3|||
129697909|NCT04525183|466853395|FG000|Overall Study|Study non-compliance|0|||
129697910|NCT04525183|466853396|FG001|Overall Study|Study non-compliance|0|||
129697911|NCT04525183|466853397|FG002|Overall Study|Study non-compliance|1|||
129697912|NCT04525183|466853395|FG000|Overall Study|Recurrent disease before starting on study|0|||
129697913|NCT04525183|466853396|FG001|Overall Study|Recurrent disease before starting on study|0|||
129789202|NCT00816023|467195570|FG002|Overall Study|Randomized Not Treated|6|||
129789203|NCT00816023|467195571|FG003|Overall Study|Randomized Not Treated|11|||
129602713|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
129602714|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
129697914|NCT04525183|466853397|FG002|Overall Study|Recurrent disease before starting on study|1|||
129697915|NCT00979407|466853398|FG000|Overall Study|Withdrawal by Subject|3|||
129697916|NCT00979407|466853399|FG001|Overall Study|Withdrawal by Subject|4|||
129697917|NCT00979407|466853398|FG000|Overall Study|Lost to Follow-up|3|||
129697918|NCT00979407|466853399|FG001|Overall Study|Lost to Follow-up|3|||
129697919|NCT01166646|466853400|FG000|Overall Study|Protocol Violation|0|||
129697920|NCT01166646|466853401|FG001|Overall Study|Protocol Violation|1|||
129602715|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
129602716|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
129697921|NCT01166646|466853400|FG000|Overall Study|Adverse Event|1|||
129789204|NCT01525901|467195572|FG000|Period 2: 12 Weeks|Adverse Event|0|||
129602717|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
129602718|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
129602719|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
129602720|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
129602721|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
129602722|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
129602723|NCT02031458|466504410|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
129602724|NCT02031458|466504411|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
129602725|NCT02031458|466504412|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
129602726|NCT02031458|466504410|FG000|Baseline to May 8, 2015|Death|36|||
129602727|NCT02031458|466504411|FG001|Baseline to May 8, 2015|Death|87|||
129602728|NCT02031458|466504412|FG002|Baseline to May 8, 2015|Death|100|||
129602729|NCT02031458|466504410|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
129602730|NCT02031458|466504411|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
129602731|NCT02031458|466504412|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
129602732|NCT02031458|466504410|FG000|Baseline to May 8, 2015|Physician Decision|0|||
129602733|NCT02031458|466504411|FG001|Baseline to May 8, 2015|Physician Decision|1|||
129602734|NCT02031458|466504412|FG002|Baseline to May 8, 2015|Physician Decision|0|||
129602735|NCT02031458|466504410|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
129602736|NCT02031458|466504411|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
129602737|NCT02031458|466504412|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
129602738|NCT02031458|466504410|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
129602739|NCT02031458|466504411|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
129602740|NCT02031458|466504412|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
129602741|NCT02031458|466504410|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
129602742|NCT02031458|466504411|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
129602743|NCT02031458|466504412|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
129602744|NCT02031458|466504410|FG000|Baseline to May 8, 2015|On Treatment|43|||
129602745|NCT02031458|466504411|FG001|Baseline to May 8, 2015|On Treatment|81|||
129602746|NCT02031458|466504412|FG002|Baseline to May 8, 2015|On Treatment|73|||
129602747|NCT02031458|466504410|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
129602748|NCT02031458|466504411|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
129602749|NCT02031458|466504412|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
129602750|NCT01959035|466504416|FG000|Overall Study|Adverse Event|5|||
129602751|NCT01959035|466504416|FG000|Overall Study|Withdrawal by Subject|4|||
129602752|NCT01959035|466504416|FG000|Overall Study|Lost to Follow-up|1|||
129602753|NCT01959035|466504416|FG000|Overall Study|Other (no primary reason given)|1|||
129602754|NCT02034058|466504417|FG000|Overall Study|Death|3|||
129602755|NCT02963311|466504418|FG000|Overall Study|Withdrawal by Subject|1|||
129602756|NCT02963311|466504418|FG000|Overall Study|Screen Failure|4|||
129602757|NCT01400919|466504420|FG000|Overall Study|Withdrawal by Subject|4|||
129602758|NCT01400919|466504420|FG000|Overall Study|Lost to Follow-up|2|||
129602759|NCT01400919|466504420|FG000|Overall Study|Missed visit|2|||
129789205|NCT01525901|467195573|FG001|Period 2: 12 Weeks|Adverse Event|1|||
129789206|NCT01525901|467195574|FG002|Period 2: 12 Weeks|Adverse Event|0|||
129789207|NCT01525901|467195575|FG003|Period 2: 12 Weeks|Adverse Event|0|||
129789208|NCT05027971|467195580|FG000|Overall Study|Physician Decision|7|||
129789209|NCT05027971|467195581|FG001|Overall Study|Physician Decision|3|||
129789210|NCT05027971|467195580|FG000|Overall Study|Lost to Follow-up|1|||
129789211|NCT05027971|467195581|FG001|Overall Study|Lost to Follow-up|1|||
129789212|NCT05027971|467195580|FG000|Overall Study|Withdrawal by Subject|0|||
129789213|NCT05027971|467195581|FG001|Overall Study|Withdrawal by Subject|2|||
129789214|NCT05027971|467195580|FG000|Overall Study|Non-study fiber used.|0|||
129789215|NCT05027971|467195581|FG001|Overall Study|Non-study fiber used.|1|||
129602760|NCT02923674|466504421|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
129602761|NCT02923674|466504422|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
129602762|NCT02923674|466504423|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
129602763|NCT02923674|466504421|FG000|Overall Study|Lost to Follow-up|7|||
129602764|NCT02923674|466504422|FG001|Overall Study|Lost to Follow-up|12|||
129602765|NCT02923674|466504423|FG002|Overall Study|Lost to Follow-up|7|||
129602766|NCT02923674|466504421|FG000|Overall Study|Problem with intervention|2|||
129602767|NCT02923674|466504422|FG001|Overall Study|Problem with intervention|2|||
129602768|NCT02923674|466504423|FG002|Overall Study|Problem with intervention|1|||
129602769|NCT02923674|466504421|FG000|Overall Study|Adverse Event|3|||
129602770|NCT02923674|466504422|FG001|Overall Study|Adverse Event|1|||
129602771|NCT02923674|466504423|FG002|Overall Study|Adverse Event|1|||
129602772|NCT02923674|466504421|FG000|Overall Study|Withdrawal by Subject|2|||
129602773|NCT02923674|466504422|FG001|Overall Study|Withdrawal by Subject|2|||
129602774|NCT02923674|466504423|FG002|Overall Study|Withdrawal by Subject|2|||
129602775|NCT00158600|466504426|FG000|Overall Study|unable to commit time to study|0|||
129602776|NCT00158600|466504427|FG001|Overall Study|unable to commit time to study|1|||
129602777|NCT00158600|466504426|FG000|Overall Study|Adverse Event|2|||
129602778|NCT00158600|466504427|FG001|Overall Study|Adverse Event|1|||
129602779|NCT00158600|466504426|FG000|Overall Study|Death|1|||
129602780|NCT00158600|466504427|FG001|Overall Study|Death|0|||
129602781|NCT00158600|466504426|FG000|Overall Study|Withdrawal by Subject|2|||
129602782|NCT00158600|466504427|FG001|Overall Study|Withdrawal by Subject|2|||
129602783|NCT00846521|466504436|FG000|Overall Study|Withdrawal by Subject|5|||
129602784|NCT00846521|466504436|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
129602785|NCT00846521|466504436|FG000|Overall Study|Protocol Violation|1|||
129602786|NCT02618408|466504437|FG000|Overall Study|Withdrawal by Subject|1|||
129602787|NCT02618408|466504438|FG001|Overall Study|Withdrawal by Subject|0|||
129602788|NCT02618408|466504439|FG002|Overall Study|Withdrawal by Subject|4|||
129602789|NCT02618408|466504437|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
129602790|NCT02618408|466504438|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
129602791|NCT02618408|466504439|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
129602792|NCT02618408|466504437|FG000|Overall Study|Lost to Follow-up|4|||
129602793|NCT02618408|466504438|FG001|Overall Study|Lost to Follow-up|2|||
129602794|NCT02618408|466504439|FG002|Overall Study|Lost to Follow-up|6|||
129602795|NCT02618408|466504437|FG000|Overall Study|Adverse Event|4|||
129602796|NCT02618408|466504438|FG001|Overall Study|Adverse Event|0|||
129602797|NCT02618408|466504439|FG002|Overall Study|Adverse Event|10|||
129602798|NCT02618408|466504437|FG000|Overall Study|Physician Decision|1|||
129602799|NCT02618408|466504438|FG001|Overall Study|Physician Decision|1|||
129602800|NCT02618408|466504439|FG002|Overall Study|Physician Decision|2|||
129602801|NCT02618408|466504437|FG000|Overall Study|Protocol Violation|1|||
129602802|NCT02618408|466504438|FG001|Overall Study|Protocol Violation|1|||
129602803|NCT02618408|466504439|FG002|Overall Study|Protocol Violation|2|||
129602804|NCT02618408|466504437|FG000|Overall Study|Other, Multiple Categories|0|||
129602805|NCT02618408|466504438|FG001|Overall Study|Other, Multiple Categories|0|||
129602806|NCT02618408|466504439|FG002|Overall Study|Other, Multiple Categories|4|||
129602807|NCT01246011|466504441|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
129602808|NCT01246011|466504442|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
129602809|NCT01246011|466504443|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
129602810|NCT01246011|466504441|FG000|Overall Study|Withdrawal by Subject|0|||
129602811|NCT01246011|466504442|FG001|Overall Study|Withdrawal by Subject|0|||
129602812|NCT01246011|466504443|FG002|Overall Study|Withdrawal by Subject|1|||
129789216|NCT05027971|467195580|FG000|Overall Study|Protocol Violation|0|||
129602813|NCT04492020|466504444|FG000|Overall Study|Adverse Event|1|||
129789217|NCT05027971|467195581|FG001|Overall Study|Protocol Violation|2|||
129789218|NCT02486627|467195583|FG000|Overall Study|Death|1|||
129789219|NCT02486627|467195584|FG001|Overall Study|Death|0|||
129602814|NCT04492020|466504445|FG001|Overall Study|Adverse Event|3|||
129602815|NCT04492020|466504444|FG000|Overall Study|Withdrawal by Subject|4|||
129602816|NCT04492020|466504445|FG001|Overall Study|Withdrawal by Subject|3|||
129602817|NCT04492020|466504444|FG000|Overall Study|Lost to Follow-up|4|||
129602818|NCT04492020|466504445|FG001|Overall Study|Lost to Follow-up|3|||
129789220|NCT02486627|467195583|FG000|Overall Study|Other Unspecified|0|||
129789221|NCT02486627|467195584|FG001|Overall Study|Other Unspecified|2|||
129697922|NCT01166646|466853401|FG001|Overall Study|Adverse Event|0|||
129697923|NCT01335685|466853405|FG000|Overall Study|Study Terminated by Sponsor|2|||
129697924|NCT01335685|466853406|FG001|Overall Study|Study Terminated by Sponsor|1|||
129697925|NCT01335685|466853407|FG002|Overall Study|Study Terminated by Sponsor|1|||
129697926|NCT01335685|466853408|FG003|Overall Study|Study Terminated by Sponsor|10|||
129697927|NCT01335685|466853409|FG004|Overall Study|Study Terminated by Sponsor|0|||
129886004|NCT02291289|467542801|FG008|Early Disease Progression|Lost to Follow-up|0|||
129886005|NCT02291289|467542802|FG009|Early Disease Progression|Lost to Follow-up|0|||
129886006|NCT02291289|467542803|FG010|Early Disease Progression|Lost to Follow-up|0|||
129886007|NCT02291289|467542804|FG011|Early Disease Progression|Lost to Follow-up|0|||
129886008|NCT02291289|467542805|FG012|Early Disease Progression|Lost to Follow-up|1|||
129886009|NCT00962585|467542819|FG000|Overall Study|Adverse Event|0|||
129886010|NCT00962585|467542820|FG001|Overall Study|Adverse Event|2|||
129886011|NCT00962585|467542821|FG002|Overall Study|Adverse Event|1|||
129886012|NCT00962585|467542822|FG003|Overall Study|Adverse Event|0|||
129886013|NCT00962585|467542819|FG000|Overall Study|Lost to Follow-up|3|||
129886014|NCT00962585|467542820|FG001|Overall Study|Lost to Follow-up|0|||
129886015|NCT00962585|467542821|FG002|Overall Study|Lost to Follow-up|1|||
129886016|NCT00962585|467542822|FG003|Overall Study|Lost to Follow-up|0|||
129886017|NCT00962585|467542819|FG000|Overall Study|Protocol Violation|0|||
129886018|NCT00962585|467542820|FG001|Overall Study|Protocol Violation|0|||
129886019|NCT00962585|467542821|FG002|Overall Study|Protocol Violation|1|||
129789222|NCT02486627|467195583|FG000|Overall Study|Consent Withdrawn by Participant|4|||
129789223|NCT02486627|467195584|FG001|Overall Study|Consent Withdrawn by Participant|3|||
129789224|NCT02486627|467195583|FG000|Overall Study|Significant Participant Noncompliance|1|||
129789225|NCT02486627|467195584|FG001|Overall Study|Significant Participant Noncompliance|1|||
129789226|NCT02486627|467195583|FG000|Overall Study|Lost to Follow-up|1|||
129789227|NCT02486627|467195584|FG001|Overall Study|Lost to Follow-up|3|||
129886020|NCT00962585|467542822|FG003|Overall Study|Protocol Violation|0|||
129602819|NCT04492020|466504444|FG000|Overall Study|Protocol Violation|5|||
129602820|NCT04492020|466504445|FG001|Overall Study|Protocol Violation|2|||
129602821|NCT04492020|466504444|FG000|Overall Study|Lack of Qualifying Event|25|||
129602822|NCT04492020|466504445|FG001|Overall Study|Lack of Qualifying Event|27|||
129602823|NCT04492020|466504444|FG000|Overall Study|Non-compliance with Study Drug|2|||
129602824|NCT04492020|466504445|FG001|Overall Study|Non-compliance with Study Drug|1|||
129602825|NCT02792959|466504447|FG000|Overall Study|Protocol Violation|1|||
129602826|NCT00003875|466504459|FG000|Overall Study|Screen Failed|1|||
129602827|NCT01780987|466504460|FG000|Overall Study|Adverse Event|0|||
129602828|NCT01780987|466504461|FG001|Overall Study|Adverse Event|4|||
129602829|NCT01780987|466504460|FG000|Overall Study|Withdrawal by Subject|2|||
129602830|NCT01780987|466504461|FG001|Overall Study|Withdrawal by Subject|0|||
129602831|NCT01780987|466504460|FG000|Overall Study|Request of Changing Hospital|0|||
129602832|NCT01780987|466504461|FG001|Overall Study|Request of Changing Hospital|1|||
129602833|NCT01780987|466504460|FG000|Overall Study|Changing Residence|1|||
129602834|NCT01780987|466504461|FG001|Overall Study|Changing Residence|0|||
129602835|NCT01780987|466504460|FG000|Overall Study|Not Receiving any Study Medication|0|||
129602836|NCT01780987|466504461|FG001|Overall Study|Not Receiving any Study Medication|1|||
129602837|NCT04168190|466504462|FG000|Overall Study|Lost to Follow-up|0|||
129602838|NCT04168190|466504463|FG001|Overall Study|Lost to Follow-up|1|||
129602839|NCT04168190|466504464|FG002|Overall Study|Lost to Follow-up|0|||
129602840|NCT04168190|466504465|FG003|Overall Study|Lost to Follow-up|7|||
129602841|NCT04168190|466504466|FG004|Overall Study|Lost to Follow-up|5|||
129602842|NCT04168190|466504462|FG000|Overall Study|Withdrawal by Subject|1|||
129602843|NCT04168190|466504463|FG001|Overall Study|Withdrawal by Subject|0|||
129602844|NCT04168190|466504464|FG002|Overall Study|Withdrawal by Subject|0|||
129602845|NCT04168190|466504465|FG003|Overall Study|Withdrawal by Subject|2|||
129602846|NCT04168190|466504466|FG004|Overall Study|Withdrawal by Subject|4|||
129602847|NCT04168190|466504462|FG000|Overall Study|Death|0|||
129602848|NCT04168190|466504463|FG001|Overall Study|Death|0|||
129602849|NCT04168190|466504464|FG002|Overall Study|Death|0|||
129602850|NCT04168190|466504465|FG003|Overall Study|Death|1|||
129602851|NCT04168190|466504466|FG004|Overall Study|Death|0|||
129602852|NCT00629265|466504467|FG000|Overall Study|Lost to Follow-up|4|||
129602853|NCT00629265|466504468|FG001|Overall Study|Lost to Follow-up|5|||
129602854|NCT00629265|466504467|FG000|Overall Study|Withdrawal by Subject|11|||
129602855|NCT00629265|466504468|FG001|Overall Study|Withdrawal by Subject|8|||
129602856|NCT00629265|466504467|FG000|Overall Study|Death|1|||
129602857|NCT00629265|466504468|FG001|Overall Study|Death|0|||
129602858|NCT00629265|466504467|FG000|Overall Study|Adverse Event|2|||
129602859|NCT00629265|466504468|FG001|Overall Study|Adverse Event|0|||
129602860|NCT00629265|466504467|FG000|Overall Study|HNC Recurrence|4|||
129602861|NCT00629265|466504468|FG001|Overall Study|HNC Recurrence|0|||
129886021|NCT00962585|467542819|FG000|Overall Study|Withdrawal by Subject|1|||
129602862|NCT00629265|466504467|FG000|Overall Study|Other CA Requiring Treatment|1|||
129602863|NCT00629265|466504468|FG001|Overall Study|Other CA Requiring Treatment|3|||
129602864|NCT00629265|466504467|FG000|Overall Study|Needed Esophageal Dilation|4|||
129602865|NCT00629265|466504468|FG001|Overall Study|Needed Esophageal Dilation|1|||
129789228|NCT01073462|467195585|FG000|Overall Study|Death|14|||
129789229|NCT01073462|467195585|FG000|Overall Study|Kidney transplant|10|||
129789230|NCT01073462|467195585|FG000|Overall Study|Low parathyroid hormone levels|8|||
129886022|NCT00962585|467542820|FG001|Overall Study|Withdrawal by Subject|0|||
129886023|NCT00962585|467542821|FG002|Overall Study|Withdrawal by Subject|0|||
129886024|NCT00962585|467542822|FG003|Overall Study|Withdrawal by Subject|0|||
129602866|NCT00629265|466504467|FG000|Overall Study|Unrelated Medical Complications|3|||
129602867|NCT00629265|466504468|FG001|Overall Study|Unrelated Medical Complications|1|||
129602868|NCT00629265|466504467|FG000|Overall Study|Unknown Reason|2|||
129602869|NCT00629265|466504468|FG001|Overall Study|Unknown Reason|2|||
129602870|NCT04465630|466504469|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
129602871|NCT04465630|466504469|FG000|Overall Study|Screen failure|8|||
129602872|NCT04465630|466504469|FG000|Overall Study|Baseline failure|16|||
129602873|NCT02032706|466504472|FG000|Overall Study|Did not qualify|5|||
129602874|NCT02032706|466504472|FG000|Overall Study|Protocol Violation|1|||
129602875|NCT00895947|466504473|FG000|Overall Study|Adverse Event|3|||
129602876|NCT00895947|466504474|FG001|Overall Study|Adverse Event|4|||
129602877|NCT00895947|466504473|FG000|Overall Study|Lost to Follow-up|3|||
129602878|NCT00895947|466504474|FG001|Overall Study|Lost to Follow-up|4|||
129602879|NCT00895947|466504473|FG000|Overall Study|Protocol Violation|4|||
129602880|NCT00895947|466504474|FG001|Overall Study|Protocol Violation|2|||
129602881|NCT00895947|466504473|FG000|Overall Study|Withdrawal by Subject|2|||
129602882|NCT00895947|466504474|FG001|Overall Study|Withdrawal by Subject|0|||
129602883|NCT04620135|466504477|FG000|Study Completion|Adverse Event|2|||
129602884|NCT04620135|466504478|FG001|Study Completion|Adverse Event|3|||
129602885|NCT04620135|466504477|FG000|Study Completion|Withdrawal by Subject|2|||
129602886|NCT04620135|466504478|FG001|Study Completion|Withdrawal by Subject|0|||
129602887|NCT01615263|466504482|FG000|Overall Study|Post-randomization exclusion|0|||
129602888|NCT01615263|466504483|FG001|Overall Study|Post-randomization exclusion|2|||
129602889|NCT02138136|466504484|FG000|Overall Study|Protocol Violation|4|||
129602890|NCT02138136|466504484|FG000|Overall Study|Physician Decision|7|||
129602891|NCT02138136|466504484|FG000|Overall Study|Lack of Efficacy|35|||
129602892|NCT02138136|466504484|FG000|Overall Study|Pregnancy|2|||
129602893|NCT02138136|466504484|FG000|Overall Study|Adverse Event|18|||
129602894|NCT02138136|466504484|FG000|Overall Study|Withdrawal by Subject|36|||
129602895|NCT02138136|466504484|FG000|Overall Study|Lost to Follow-up|32|||
129602896|NCT02138136|466504484|FG000|Overall Study|Withdrawn by Sponsor|5|||
129602897|NCT03979820|466504487|FG000|Overall Study|Protocol Violation|1|||
129602898|NCT03979820|466504488|FG001|Overall Study|Protocol Violation|0|||
129602899|NCT03979820|466504489|FG002|Overall Study|Protocol Violation|0|||
129602900|NCT03979820|466504490|FG003|Overall Study|Protocol Violation|0|||
129602901|NCT03979820|466504487|FG000|Overall Study|Withdrawal by Subject|0|||
129602902|NCT03979820|466504488|FG001|Overall Study|Withdrawal by Subject|0|||
129602903|NCT03979820|466504489|FG002|Overall Study|Withdrawal by Subject|1|||
129602904|NCT03979820|466504490|FG003|Overall Study|Withdrawal by Subject|0|||
129602905|NCT03979820|466504487|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
129602906|NCT03979820|466504488|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
129602907|NCT03979820|466504489|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
129602908|NCT03979820|466504490|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
129602909|NCT04355663|466504491|FG000|Overall Study|Physician Decision|2|||
129602910|NCT04355663|466504492|FG001|Overall Study|Physician Decision|7|||
129602911|NCT04355663|466504493|FG002|Overall Study|Physician Decision|0|||
129602912|NCT04355663|466504491|FG000|Overall Study|Adverse Event|0|||
129602913|NCT04355663|466504492|FG001|Overall Study|Adverse Event|0|||
129602914|NCT04355663|466504493|FG002|Overall Study|Adverse Event|1|||
129602915|NCT04355663|466504491|FG000|Overall Study|Withdrawal by Subject|0|||
129602916|NCT04355663|466504492|FG001|Overall Study|Withdrawal by Subject|8|||
129602917|NCT04355663|466504493|FG002|Overall Study|Withdrawal by Subject|3|||
129602918|NCT00876018|466504496|FG000|Overall Study|Lost to Follow-up|0|||
129602919|NCT00876018|466504497|FG001|Overall Study|Lost to Follow-up|1|||
129602920|NCT00876018|466504498|FG002|Overall Study|Lost to Follow-up|1|||
129602921|NCT00876018|466504496|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
129602922|NCT00876018|466504497|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
129602923|NCT00876018|466504498|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
129886025|NCT00962585|467542819|FG000|Overall Study|Withdrew Consent|2|||
129886026|NCT00962585|467542820|FG001|Overall Study|Withdrew Consent|0|||
129886027|NCT00962585|467542821|FG002|Overall Study|Withdrew Consent|0|||
129886028|NCT00962585|467542822|FG003|Overall Study|Withdrew Consent|0|||
129602924|NCT01230892|466504499|FG000|Overall Study|Withdrawal by Subject|1|||
129602925|NCT01230892|466504500|FG001|Overall Study|Withdrawal by Subject|1|||
129602926|NCT01230892|466504499|FG000|Overall Study|Lost to Follow-up|2|||
129602927|NCT01230892|466504500|FG001|Overall Study|Lost to Follow-up|0|||
129602928|NCT00679913|466504501|FG000|Overall Study|Protocol Violation|18|||
129602929|NCT00679913|466504502|FG001|Overall Study|Protocol Violation|13|||
129602930|NCT00725621|466504503|FG000|Overall Study|Adverse Event|25|||
129602931|NCT00725621|466504503|FG000|Overall Study|Lack of Efficacy|46|||
129602932|NCT00725621|466504503|FG000|Overall Study|Withdrawal by Subject|57|||
129602933|NCT00725621|466504503|FG000|Overall Study|Physician Decision|19|||
129602934|NCT00725621|466504503|FG000|Overall Study|Lost to Follow-up|52|||
129602935|NCT00725621|466504503|FG000|Overall Study|Non-compliance|8|||
129602936|NCT00725621|466504503|FG000|Overall Study|Continued treatment by other physician|6|||
129602937|NCT00725621|466504503|FG000|Overall Study|Switched to other study|1|||
129602938|NCT00725621|466504503|FG000|Overall Study|Switched to other drug|1|||
129602939|NCT00725621|466504503|FG000|Overall Study|Prepared for elective surgery|1|||
129602940|NCT00725621|466504503|FG000|Overall Study|Reason not specified|55|||
129602941|NCT01189500|466504504|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
129602942|NCT01189500|466504504|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
129602943|NCT01144364|466504508|FG000|Induction Phase|Disease progression|14|||
129602944|NCT01144364|466504509|FG001|Induction Phase|Disease progression|0|||
129602945|NCT01144364|466504510|FG002|Induction Phase|Disease progression|0|||
129602946|NCT01144364|466504508|FG000|Induction Phase|Adverse Event|9|||
129602947|NCT01144364|466504509|FG001|Induction Phase|Adverse Event|0|||
129602948|NCT01144364|466504510|FG002|Induction Phase|Adverse Event|0|||
129602949|NCT01144364|466504508|FG000|Induction Phase|Death|1|||
129602950|NCT01144364|466504509|FG001|Induction Phase|Death|0|||
129602951|NCT01144364|466504510|FG002|Induction Phase|Death|0|||
129602952|NCT01144364|466504508|FG000|Induction Phase|Withdrawal by Subject|1|||
129602953|NCT01144364|466504509|FG001|Induction Phase|Withdrawal by Subject|0|||
129602954|NCT01144364|466504510|FG002|Induction Phase|Withdrawal by Subject|0|||
129602955|NCT01144364|466504508|FG000|Induction Phase|Lost to Follow-up|2|||
129602956|NCT01144364|466504509|FG001|Induction Phase|Lost to Follow-up|0|||
129602957|NCT01144364|466504510|FG002|Induction Phase|Lost to Follow-up|0|||
129602958|NCT01144364|466504508|FG000|Induction Phase|Physician Decision|1|||
129602959|NCT01144364|466504509|FG001|Induction Phase|Physician Decision|0|||
129602960|NCT01144364|466504510|FG002|Induction Phase|Physician Decision|0|||
129602961|NCT01144364|466504508|FG000|Induction Phase|Stable disease|2|||
129602962|NCT01144364|466504509|FG001|Induction Phase|Stable disease|0|||
129789231|NCT01073462|467195585|FG000|Overall Study|Serious adverse event|2|||
129789232|NCT01073462|467195585|FG000|Overall Study|Lost to Follow-up|7|||
129789233|NCT01238588|467195586|FG000|Overall Study|Withdrawal by Subject|1|||
129789234|NCT01238588|467195586|FG000|Overall Study|Physician Decision|2|||
129789235|NCT05395091|467195589|FG000|Baseline to Month 12|Adverse Event|7|||
129789236|NCT05395091|467195590|FG001|Baseline to Month 12|Adverse Event|2|||
129602963|NCT01144364|466504510|FG002|Induction Phase|Stable disease|0|||
129602964|NCT01144364|466504508|FG000|Induction Phase|Secondary neoplasia|1|||
129602965|NCT01144364|466504509|FG001|Induction Phase|Secondary neoplasia|0|||
129602966|NCT01144364|466504510|FG002|Induction Phase|Secondary neoplasia|0|||
129602967|NCT01144364|466504508|FG000|Induction Phase|Protocol Violation|1|||
129602968|NCT01144364|466504509|FG001|Induction Phase|Protocol Violation|0|||
129602969|NCT01144364|466504510|FG002|Induction Phase|Protocol Violation|0|||
129602970|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
129602971|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
129602972|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
129602973|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
129602974|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
129602975|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
129602976|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Death|0|||
129602977|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Death|2|||
129602978|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Death|0|||
129602979|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
129602980|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
129602981|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
129602982|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
129602983|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
129602984|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
129602985|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
129602986|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
129602987|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
129602988|NCT01144364|466504508|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
129602989|NCT01144364|466504509|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
129602990|NCT01144364|466504510|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
129602991|NCT01301508|466504513|FG000|Overall Study|Withdrawal by Subject|1|||
129602992|NCT01301508|466504514|FG001|Overall Study|Withdrawal by Subject|2|||
129602993|NCT01301508|466504513|FG000|Overall Study|Lost to Follow-up|0|||
129602994|NCT01301508|466504514|FG001|Overall Study|Lost to Follow-up|1|||
129602995|NCT01940497|466504515|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
129602996|NCT01940497|466504516|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
129602997|NCT01940497|466504515|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
129789237|NCT05395091|467195591|FG002|Baseline to Month 12|Adverse Event|0|||
129789238|NCT05395091|467195589|FG000|Baseline to Month 12|Death|3|||
129602998|NCT01940497|466504516|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
129602999|NCT01940497|466504515|FG000|Overall Study|Violation of Entry Criteria|1|||
129603000|NCT01940497|466504516|FG001|Overall Study|Violation of Entry Criteria|1|||
129603001|NCT01940497|466504515|FG000|Overall Study|Refused Treatment|1|||
129603002|NCT01940497|466504516|FG001|Overall Study|Refused Treatment|3|||
129789239|NCT05395091|467195590|FG001|Baseline to Month 12|Death|1|||
129789240|NCT05395091|467195591|FG002|Baseline to Month 12|Death|0|||
129789241|NCT05395091|467195589|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
129603003|NCT01940497|466504515|FG000|Overall Study|Withdrew Consent|6|||
129603004|NCT01940497|466504516|FG001|Overall Study|Withdrew Consent|2|||
129603005|NCT01940497|466504515|FG000|Overall Study|Administrative/Other|1|||
129603006|NCT01940497|466504516|FG001|Overall Study|Administrative/Other|1|||
129603007|NCT02707861|466504517|FG000|Overall Study|Went onto commercial drug|30|||
129603008|NCT02707861|466504518|FG001|Overall Study|Went onto commercial drug|23|||
129603009|NCT02707861|466504517|FG000|Overall Study|Adverse Event|2|||
129603010|NCT02707861|466504518|FG001|Overall Study|Adverse Event|3|||
129603011|NCT02707861|466504517|FG000|Overall Study|Death|5|||
129603012|NCT02707861|466504518|FG001|Overall Study|Death|2|||
129603013|NCT02707861|466504517|FG000|Overall Study|Lack of Efficacy|0|||
129603014|NCT02707861|466504518|FG001|Overall Study|Lack of Efficacy|2|||
129603015|NCT02707861|466504517|FG000|Overall Study|Physician Decision|1|||
129603016|NCT02707861|466504518|FG001|Overall Study|Physician Decision|4|||
129603017|NCT02707861|466504517|FG000|Overall Study|Withdrawal by Subject|2|||
129603018|NCT02707861|466504518|FG001|Overall Study|Withdrawal by Subject|1|||
129603019|NCT02707861|466504517|FG000|Overall Study|Lost to Follow-up|1|||
129603020|NCT02707861|466504518|FG001|Overall Study|Lost to Follow-up|3|||
129603021|NCT03123861|466504519|FG000|Overall Study|Protocol Violation|1|||
129603022|NCT03123861|466504520|FG001|Overall Study|Protocol Violation|1|||
129603023|NCT03123861|466504519|FG000|Overall Study|Withdrawal by Subject|2|||
129603024|NCT03123861|466504520|FG001|Overall Study|Withdrawal by Subject|2|||
129603025|NCT02206620|466504521|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129603026|NCT02206620|466504522|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129603027|NCT02206620|466504521|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
129603028|NCT02206620|466504522|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
129603029|NCT03188666|466505864|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
129603030|NCT03188666|466505865|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
129603031|NCT03188666|466505866|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
129603032|NCT03188666|466505867|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
129603033|NCT03188666|466505864|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
129603034|NCT03188666|466505865|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
129603035|NCT03188666|466505866|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
129603036|NCT03188666|466505867|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
129603037|NCT03188666|466505864|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
129603038|NCT03188666|466505865|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
129603039|NCT03188666|466505866|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
129603040|NCT03188666|466505867|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
129603041|NCT03188666|466505864|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
129603042|NCT03188666|466505865|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
129603043|NCT03188666|466505866|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
129603044|NCT03188666|466505867|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
129603045|NCT03696953|466505868|FG000|Overall Study|Withdrawal by Subject|6|||
129603046|NCT03696953|466505869|FG001|Overall Study|Withdrawal by Subject|1|||
129603047|NCT03696953|466505868|FG000|Overall Study|missed GBS swabs|2|||
129603048|NCT03696953|466505869|FG001|Overall Study|missed GBS swabs|2|||
129603049|NCT03696953|466505868|FG000|Overall Study|lost study bottle containing capsules|2|||
129603050|NCT03696953|466505869|FG001|Overall Study|lost study bottle containing capsules|0|||
129603051|NCT03696953|466505868|FG000|Overall Study|Premature birth|1|||
129603052|NCT03696953|466505869|FG001|Overall Study|Premature birth|4|||
129603053|NCT03696953|466505868|FG000|Overall Study|Gestational hypertension|1|||
129603054|NCT03696953|466505869|FG001|Overall Study|Gestational hypertension|1|||
129603055|NCT03696953|466505868|FG000|Overall Study|Gestational diabetes|2|||
129603056|NCT03696953|466505869|FG001|Overall Study|Gestational diabetes|1|||
129603057|NCT03696953|466505868|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
129603058|NCT03696953|466505869|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
129603059|NCT03696953|466505868|FG000|Overall Study|Changed prenatal provider|1|||
129603060|NCT03696953|466505869|FG001|Overall Study|Changed prenatal provider|1|||
129603061|NCT03502707|466505870|FG000|Overall Study|Adverse Event|0|||
129603062|NCT03502707|466505871|FG001|Overall Study|Adverse Event|0|||
129603063|NCT03502707|466505872|FG002|Overall Study|Adverse Event|0|||
129603064|NCT03502707|466505873|FG003|Overall Study|Adverse Event|0|||
129603065|NCT03502707|466505874|FG004|Overall Study|Adverse Event|0|||
129603066|NCT03502707|466505875|FG005|Overall Study|Adverse Event|0|||
129603067|NCT03502707|466505876|FG006|Overall Study|Adverse Event|0|||
129436764|NCT03645057|465897173|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
129436765|NCT03645057|465897174|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
129603068|NCT03502707|466505877|FG007|Overall Study|Adverse Event|0|||
129603069|NCT03502707|466505878|FG008|Overall Study|Adverse Event|0|||
129603070|NCT03502707|466505879|FG009|Overall Study|Adverse Event|0|||
129603071|NCT03502707|466505880|FG010|Overall Study|Adverse Event|0|||
129603072|NCT03502707|466505881|FG011|Overall Study|Adverse Event|0|||
129603073|NCT03502707|466505882|FG012|Overall Study|Adverse Event|0|||
129603074|NCT03502707|466505883|FG013|Overall Study|Adverse Event|0|||
129603075|NCT03502707|466505884|FG014|Overall Study|Adverse Event|0|||
129603076|NCT03502707|466505885|FG015|Overall Study|Adverse Event|1|||
129886029|NCT02254421|467542825|FG000|Overall Study|Randomized but Not Treated|1|||
129886030|NCT02254421|467542826|FG001|Overall Study|Randomized but Not Treated|0|||
129436766|NCT03645057|465897175|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
129436767|NCT01873495|465897176|FG000|Overall Study|Withdrawal by Subject|1|||
129436768|NCT01873495|465897176|FG000|Overall Study|Physician Decision|3|||
129436769|NCT01873495|465897176|FG000|Overall Study|Adverse Event|1|||
129436770|NCT01873495|465897176|FG000|Overall Study|Removed for Transplantation|1|||
129436771|NCT01873495|465897176|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
129436772|NCT01206777|465897177|FG000|Overall Study|Death|1|||
129436773|NCT01206777|465897177|FG000|Overall Study|Adverse Event|1|||
129436774|NCT02080221|465897178|FG000|Overall Study|Withdrawal by Subject|1|||
129436775|NCT02080221|465897178|FG000|Overall Study|Clinical Progression of Disease|1|||
129436776|NCT01386788|465897181|FG000|Overall Study|Lost to Follow-up|2|||
129436777|NCT02986334|465897182|FG000|Overall Study|Withdrawal by Subject|0|||
129436778|NCT02986334|465897183|FG001|Overall Study|Withdrawal by Subject|1|||
129436779|NCT02986334|465897184|FG002|Overall Study|Withdrawal by Subject|2|||
129436780|NCT02986334|465897182|FG000|Overall Study|Lost to Follow-up|1|||
129436781|NCT02986334|465897183|FG001|Overall Study|Lost to Follow-up|2|||
129436782|NCT02986334|465897184|FG002|Overall Study|Lost to Follow-up|1|||
129436783|NCT02986334|465897182|FG000|Overall Study|Adverse Event|0|||
129436784|NCT02986334|465897183|FG001|Overall Study|Adverse Event|2|||
129436785|NCT02986334|465897184|FG002|Overall Study|Adverse Event|1|||
129436786|NCT02986334|465897182|FG000|Overall Study|non compliance in phone ratings|2|||
129436787|NCT02986334|465897183|FG001|Overall Study|non compliance in phone ratings|1|||
129436788|NCT02986334|465897184|FG002|Overall Study|non compliance in phone ratings|2|||
129436789|NCT02986334|465897182|FG000|Overall Study|undisclosed comorbidities|0|||
129436790|NCT02986334|465897183|FG001|Overall Study|undisclosed comorbidities|1|||
129436791|NCT02986334|465897184|FG002|Overall Study|undisclosed comorbidities|1|||
129697928|NCT01335685|466853410|FG005|Overall Study|Study Terminated by Sponsor|4|||
129697929|NCT01335685|466853411|FG006|Overall Study|Study Terminated by Sponsor|2|||
129436792|NCT00120406|465897185|FG000|Overall Study|Death|9|||
129436793|NCT00120406|465897186|FG001|Overall Study|Death|4|||
129436794|NCT00120406|465897185|FG000|Overall Study|Withdrawal by Subject|5|||
129697930|NCT01335685|466853412|FG007|Overall Study|Study Terminated by Sponsor|3|||
129697931|NCT01335685|466853405|FG000|Overall Study|Withdrawal by Subject|1|||
129697932|NCT01335685|466853406|FG001|Overall Study|Withdrawal by Subject|0|||
129697933|NCT01335685|466853407|FG002|Overall Study|Withdrawal by Subject|0|||
129697934|NCT01335685|466853408|FG003|Overall Study|Withdrawal by Subject|1|||
129697935|NCT01335685|466853409|FG004|Overall Study|Withdrawal by Subject|0|||
129697936|NCT01335685|466853410|FG005|Overall Study|Withdrawal by Subject|0|||
129697937|NCT01335685|466853411|FG006|Overall Study|Withdrawal by Subject|0|||
129697938|NCT01335685|466853412|FG007|Overall Study|Withdrawal by Subject|0|||
129697939|NCT01335685|466853405|FG000|Overall Study|Reason not Specified|0|||
129697940|NCT01335685|466853406|FG001|Overall Study|Reason not Specified|0|||
129697941|NCT01335685|466853407|FG002|Overall Study|Reason not Specified|1|||
129697942|NCT01335685|466853408|FG003|Overall Study|Reason not Specified|0|||
129697943|NCT01335685|466853409|FG004|Overall Study|Reason not Specified|0|||
129789242|NCT05395091|467195590|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
129789243|NCT05395091|467195591|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
129789244|NCT05395091|467195589|FG000|Baseline to Month 12|Protocol Violation|2|||
129789245|NCT05395091|467195590|FG001|Baseline to Month 12|Protocol Violation|3|||
129436795|NCT00120406|465897186|FG001|Overall Study|Withdrawal by Subject|7|||
129436796|NCT00120406|465897185|FG000|Overall Study|Lost to Follow-up|5|||
129436797|NCT00120406|465897186|FG001|Overall Study|Lost to Follow-up|2|||
129436798|NCT00120406|465897185|FG000|Overall Study|received non-study stent|0|||
129436799|NCT00120406|465897186|FG001|Overall Study|received non-study stent|2|||
129436800|NCT00120406|465897185|FG000|Overall Study|patient moved but has not withdrawn|0|||
129697944|NCT01335685|466853410|FG005|Overall Study|Reason not Specified|1|||
129789246|NCT05395091|467195591|FG002|Baseline to Month 12|Protocol Violation|0|||
129789247|NCT05395091|467195589|FG000|Baseline to Month 12|Physician Decision|1|||
129789248|NCT05395091|467195590|FG001|Baseline to Month 12|Physician Decision|0|||
129789249|NCT05395091|467195591|FG002|Baseline to Month 12|Physician Decision|0|||
129789250|NCT05395091|467195589|FG000|Month 12 to Month 18|Death|1|||
129789251|NCT05395091|467195590|FG001|Month 12 to Month 18|Death|0|||
129886031|NCT02254421|467542825|FG000|Overall Study|Death|0|||
129886032|NCT02254421|467542826|FG001|Overall Study|Death|2|||
129789252|NCT05395091|467195591|FG002|Month 12 to Month 18|Death|0|||
129789253|NCT05395091|467195589|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
129789254|NCT05395091|467195590|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
129436801|NCT00120406|465897186|FG001|Overall Study|patient moved but has not withdrawn|1|||
129436802|NCT01295034|465897187|FG000|Overall Study|Lost to Follow-up|5|||
129436803|NCT01295034|465897188|FG001|Overall Study|Lost to Follow-up|5|||
129436804|NCT01313637|465897189|FG000|Overall Study|Adverse Event|17|||
129436805|NCT01313637|465897190|FG001|Overall Study|Adverse Event|24|||
129436806|NCT01313637|465897191|FG002|Overall Study|Adverse Event|25|||
129436807|NCT01313637|465897192|FG003|Overall Study|Adverse Event|18|||
129697945|NCT01335685|466853411|FG006|Overall Study|Reason not Specified|0|||
129603077|NCT03502707|466505886|FG016|Overall Study|Adverse Event|5|||
129603078|NCT03502707|466505887|FG017|Overall Study|Adverse Event|0|||
129603079|NCT03502707|466505870|FG000|Overall Study|Death|0|||
129603080|NCT03502707|466505871|FG001|Overall Study|Death|0|||
129603081|NCT03502707|466505872|FG002|Overall Study|Death|0|||
129603082|NCT03502707|466505873|FG003|Overall Study|Death|1|||
129603083|NCT03502707|466505874|FG004|Overall Study|Death|0|||
129603084|NCT03502707|466505875|FG005|Overall Study|Death|0|||
129603085|NCT03502707|466505876|FG006|Overall Study|Death|0|||
129603086|NCT03502707|466505877|FG007|Overall Study|Death|0|||
129603087|NCT03502707|466505878|FG008|Overall Study|Death|1|||
129603088|NCT03502707|466505879|FG009|Overall Study|Death|1|||
129603089|NCT03502707|466505880|FG010|Overall Study|Death|0|||
129603090|NCT03502707|466505881|FG011|Overall Study|Death|0|||
129603091|NCT03502707|466505882|FG012|Overall Study|Death|1|||
129603092|NCT03502707|466505883|FG013|Overall Study|Death|0|||
129603093|NCT03502707|466505884|FG014|Overall Study|Death|0|||
129603094|NCT03502707|466505885|FG015|Overall Study|Death|1|||
129603095|NCT03502707|466505886|FG016|Overall Study|Death|0|||
129603096|NCT03502707|466505887|FG017|Overall Study|Death|0|||
129603097|NCT03502707|466505870|FG000|Overall Study|Lost to Follow-up|0|||
129603098|NCT03502707|466505871|FG001|Overall Study|Lost to Follow-up|0|||
129603099|NCT03502707|466505872|FG002|Overall Study|Lost to Follow-up|0|||
129603100|NCT03502707|466505873|FG003|Overall Study|Lost to Follow-up|0|||
129603101|NCT03502707|466505874|FG004|Overall Study|Lost to Follow-up|0|||
129603102|NCT03502707|466505875|FG005|Overall Study|Lost to Follow-up|0|||
129603103|NCT03502707|466505876|FG006|Overall Study|Lost to Follow-up|0|||
129603104|NCT03502707|466505877|FG007|Overall Study|Lost to Follow-up|5|||
129603105|NCT03502707|466505878|FG008|Overall Study|Lost to Follow-up|0|||
129603106|NCT03502707|466505879|FG009|Overall Study|Lost to Follow-up|2|||
129603107|NCT03502707|466505880|FG010|Overall Study|Lost to Follow-up|1|||
129603108|NCT03502707|466505881|FG011|Overall Study|Lost to Follow-up|2|||
129603109|NCT03502707|466505882|FG012|Overall Study|Lost to Follow-up|1|||
129603110|NCT03502707|466505883|FG013|Overall Study|Lost to Follow-up|1|||
129603111|NCT03502707|466505884|FG014|Overall Study|Lost to Follow-up|0|||
129603112|NCT03502707|466505885|FG015|Overall Study|Lost to Follow-up|4|||
129603113|NCT03502707|466505886|FG016|Overall Study|Lost to Follow-up|9|||
129603114|NCT03502707|466505887|FG017|Overall Study|Lost to Follow-up|2|||
129603115|NCT03502707|466505870|FG000|Overall Study|Physician Decision|0|||
129603116|NCT03502707|466505871|FG001|Overall Study|Physician Decision|0|||
129603117|NCT03502707|466505872|FG002|Overall Study|Physician Decision|0|||
129603118|NCT03502707|466505873|FG003|Overall Study|Physician Decision|0|||
129603119|NCT03502707|466505874|FG004|Overall Study|Physician Decision|0|||
129603120|NCT03502707|466505875|FG005|Overall Study|Physician Decision|0|||
129603121|NCT03502707|466505876|FG006|Overall Study|Physician Decision|0|||
129603122|NCT03502707|466505877|FG007|Overall Study|Physician Decision|0|||
129603123|NCT03502707|466505878|FG008|Overall Study|Physician Decision|2|||
129697946|NCT01335685|466853412|FG007|Overall Study|Reason not Specified|0|||
129697947|NCT03777020|466853417|FG000|Overall Study|Withdrawal by Subject|4|||
129697948|NCT03777020|466853418|FG001|Overall Study|Withdrawal by Subject|4|||
129697949|NCT03777020|466853417|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
129697950|NCT03777020|466853418|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
129697951|NCT00489476|466853419|FG000|Overall Study|Lost to Follow-up|0|||
129697952|NCT00489476|466853420|FG001|Overall Study|Lost to Follow-up|1|||
129886033|NCT02254421|467542825|FG000|Overall Study|Withdrew Consent|1|||
129603124|NCT03502707|466505879|FG009|Overall Study|Physician Decision|1|||
129603125|NCT03502707|466505880|FG010|Overall Study|Physician Decision|0|||
129603126|NCT03502707|466505881|FG011|Overall Study|Physician Decision|0|||
129603127|NCT03502707|466505882|FG012|Overall Study|Physician Decision|0|||
129603128|NCT03502707|466505883|FG013|Overall Study|Physician Decision|0|||
129603129|NCT03502707|466505884|FG014|Overall Study|Physician Decision|1|||
129603130|NCT03502707|466505885|FG015|Overall Study|Physician Decision|3|||
129603131|NCT03502707|466505886|FG016|Overall Study|Physician Decision|0|||
129603132|NCT03502707|466505887|FG017|Overall Study|Physician Decision|0|||
129603133|NCT03502707|466505870|FG000|Overall Study|Protocol Violation|0|||
129603134|NCT03502707|466505871|FG001|Overall Study|Protocol Violation|0|||
129603135|NCT03502707|466505872|FG002|Overall Study|Protocol Violation|0|||
129603136|NCT03502707|466505873|FG003|Overall Study|Protocol Violation|0|||
129603137|NCT03502707|466505874|FG004|Overall Study|Protocol Violation|0|||
129603138|NCT03502707|466505875|FG005|Overall Study|Protocol Violation|0|||
129603139|NCT03502707|466505876|FG006|Overall Study|Protocol Violation|0|||
129603140|NCT03502707|466505877|FG007|Overall Study|Protocol Violation|0|||
129603141|NCT03502707|466505878|FG008|Overall Study|Protocol Violation|0|||
129603142|NCT03502707|466505879|FG009|Overall Study|Protocol Violation|0|||
129603143|NCT03502707|466505880|FG010|Overall Study|Protocol Violation|0|||
129603144|NCT03502707|466505881|FG011|Overall Study|Protocol Violation|0|||
129603145|NCT03502707|466505882|FG012|Overall Study|Protocol Violation|0|||
129603146|NCT03502707|466505883|FG013|Overall Study|Protocol Violation|0|||
129603147|NCT03502707|466505884|FG014|Overall Study|Protocol Violation|0|||
129603148|NCT03502707|466505885|FG015|Overall Study|Protocol Violation|1|||
129603149|NCT03502707|466505886|FG016|Overall Study|Protocol Violation|0|||
129603150|NCT03502707|466505887|FG017|Overall Study|Protocol Violation|0|||
129436808|NCT01313637|465897189|FG000|Overall Study|Lack of Efficacy|44|||
129436809|NCT01313637|465897190|FG001|Overall Study|Lack of Efficacy|38|||
129436810|NCT01313637|465897191|FG002|Overall Study|Lack of Efficacy|37|||
129436811|NCT01313637|465897192|FG003|Overall Study|Lack of Efficacy|24|||
129436812|NCT01313637|465897189|FG000|Overall Study|Protocol Violation|4|||
129436813|NCT01313637|465897190|FG001|Overall Study|Protocol Violation|3|||
129436814|NCT01313637|465897191|FG002|Overall Study|Protocol Violation|11|||
129436815|NCT01313637|465897192|FG003|Overall Study|Protocol Violation|5|||
129436816|NCT01313637|465897189|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
129603151|NCT03502707|466505870|FG000|Overall Study|Withdrawal by Subject|1|||
129436817|NCT01313637|465897190|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
129603152|NCT03502707|466505871|FG001|Overall Study|Withdrawal by Subject|1|||
129603153|NCT03502707|466505872|FG002|Overall Study|Withdrawal by Subject|0|||
129603154|NCT03502707|466505873|FG003|Overall Study|Withdrawal by Subject|0|||
129603155|NCT03502707|466505874|FG004|Overall Study|Withdrawal by Subject|0|||
129603156|NCT03502707|466505875|FG005|Overall Study|Withdrawal by Subject|2|||
129603157|NCT03502707|466505876|FG006|Overall Study|Withdrawal by Subject|0|||
129436818|NCT01313637|465897191|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
129436819|NCT01313637|465897192|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
129436820|NCT01313637|465897189|FG000|Overall Study|Lost to Follow-up|0|||
129436821|NCT01313637|465897190|FG001|Overall Study|Lost to Follow-up|2|||
129603158|NCT03502707|466505877|FG007|Overall Study|Withdrawal by Subject|3|||
129603159|NCT03502707|466505878|FG008|Overall Study|Withdrawal by Subject|1|||
129436822|NCT01313637|465897191|FG002|Overall Study|Lost to Follow-up|1|||
129436823|NCT01313637|465897192|FG003|Overall Study|Lost to Follow-up|3|||
129603160|NCT03502707|466505879|FG009|Overall Study|Withdrawal by Subject|2|||
129603161|NCT03502707|466505880|FG010|Overall Study|Withdrawal by Subject|12|||
129603162|NCT03502707|466505881|FG011|Overall Study|Withdrawal by Subject|23|||
129603163|NCT03502707|466505882|FG012|Overall Study|Withdrawal by Subject|5|||
129603164|NCT03502707|466505883|FG013|Overall Study|Withdrawal by Subject|3|||
129603165|NCT03502707|466505884|FG014|Overall Study|Withdrawal by Subject|3|||
129603166|NCT03502707|466505885|FG015|Overall Study|Withdrawal by Subject|43|||
129603167|NCT03502707|466505886|FG016|Overall Study|Withdrawal by Subject|44|||
129603168|NCT03502707|466505887|FG017|Overall Study|Withdrawal by Subject|18|||
129603169|NCT03502707|466505870|FG000|Overall Study|Sponsor's Decision|1|||
129603170|NCT03502707|466505871|FG001|Overall Study|Sponsor's Decision|0|||
129603171|NCT03502707|466505872|FG002|Overall Study|Sponsor's Decision|0|||
129603172|NCT03502707|466505873|FG003|Overall Study|Sponsor's Decision|0|||
129603173|NCT03502707|466505874|FG004|Overall Study|Sponsor's Decision|0|||
129603174|NCT03502707|466505875|FG005|Overall Study|Sponsor's Decision|0|||
129603175|NCT03502707|466505876|FG006|Overall Study|Sponsor's Decision|0|||
129603176|NCT03502707|466505877|FG007|Overall Study|Sponsor's Decision|0|||
129603177|NCT03502707|466505878|FG008|Overall Study|Sponsor's Decision|0|||
129603178|NCT03502707|466505879|FG009|Overall Study|Sponsor's Decision|1|||
129603179|NCT03502707|466505880|FG010|Overall Study|Sponsor's Decision|0|||
129603180|NCT03502707|466505881|FG011|Overall Study|Sponsor's Decision|0|||
129603181|NCT03502707|466505882|FG012|Overall Study|Sponsor's Decision|0|||
129603182|NCT03502707|466505883|FG013|Overall Study|Sponsor's Decision|0|||
129603183|NCT03502707|466505884|FG014|Overall Study|Sponsor's Decision|0|||
129603184|NCT03502707|466505885|FG015|Overall Study|Sponsor's Decision|2|||
129603185|NCT03502707|466505886|FG016|Overall Study|Sponsor's Decision|1|||
129603186|NCT03502707|466505887|FG017|Overall Study|Sponsor's Decision|0|||
129603187|NCT03502707|466505870|FG000|Overall Study|Initiated Prohibited Medication|0|||
129603188|NCT03502707|466505871|FG001|Overall Study|Initiated Prohibited Medication|0|||
129603189|NCT03502707|466505872|FG002|Overall Study|Initiated Prohibited Medication|0|||
129603190|NCT03502707|466505873|FG003|Overall Study|Initiated Prohibited Medication|0|||
129603191|NCT03502707|466505874|FG004|Overall Study|Initiated Prohibited Medication|0|||
129603192|NCT03502707|466505875|FG005|Overall Study|Initiated Prohibited Medication|0|||
129603193|NCT03502707|466505876|FG006|Overall Study|Initiated Prohibited Medication|0|||
129603194|NCT03502707|466505877|FG007|Overall Study|Initiated Prohibited Medication|0|||
129603195|NCT03502707|466505878|FG008|Overall Study|Initiated Prohibited Medication|0|||
129603196|NCT03502707|466505879|FG009|Overall Study|Initiated Prohibited Medication|0|||
129603197|NCT03502707|466505880|FG010|Overall Study|Initiated Prohibited Medication|0|||
129603198|NCT03502707|466505881|FG011|Overall Study|Initiated Prohibited Medication|0|||
129603199|NCT03502707|466505882|FG012|Overall Study|Initiated Prohibited Medication|0|||
129603200|NCT03502707|466505883|FG013|Overall Study|Initiated Prohibited Medication|0|||
129436824|NCT01313637|465897189|FG000|Overall Study|Withdrawal by Subject|11|||
129436825|NCT01313637|465897190|FG001|Overall Study|Withdrawal by Subject|13|||
129436826|NCT01313637|465897191|FG002|Overall Study|Withdrawal by Subject|18|||
129436827|NCT01313637|465897192|FG003|Overall Study|Withdrawal by Subject|15|||
129603201|NCT03502707|466505884|FG014|Overall Study|Initiated Prohibited Medication|0|||
129603202|NCT03502707|466505885|FG015|Overall Study|Initiated Prohibited Medication|0|||
129603203|NCT03502707|466505886|FG016|Overall Study|Initiated Prohibited Medication|1|||
129603204|NCT03502707|466505887|FG017|Overall Study|Initiated Prohibited Medication|0|||
129603205|NCT03502707|466505870|FG000|Overall Study|Other|0|||
129603206|NCT03502707|466505871|FG001|Overall Study|Other|0|||
129603207|NCT03502707|466505872|FG002|Overall Study|Other|0|||
129603208|NCT03502707|466505873|FG003|Overall Study|Other|0|||
129603209|NCT03502707|466505874|FG004|Overall Study|Other|0|||
129603210|NCT03502707|466505875|FG005|Overall Study|Other|0|||
129603211|NCT03502707|466505876|FG006|Overall Study|Other|0|||
129603212|NCT03502707|466505877|FG007|Overall Study|Other|0|||
129603213|NCT03502707|466505878|FG008|Overall Study|Other|1|||
129603214|NCT03502707|466505879|FG009|Overall Study|Other|1|||
129603215|NCT03502707|466505880|FG010|Overall Study|Other|2|||
129436828|NCT04218084|465897194|FG000|Overall Study|Adverse Event|7|||
129603216|NCT03502707|466505881|FG011|Overall Study|Other|0|||
129603217|NCT03502707|466505882|FG012|Overall Study|Other|0|||
129603218|NCT03502707|466505883|FG013|Overall Study|Other|0|||
129603219|NCT03502707|466505884|FG014|Overall Study|Other|0|||
129603220|NCT03502707|466505885|FG015|Overall Study|Other|4|||
129603221|NCT03502707|466505886|FG016|Overall Study|Other|1|||
129603222|NCT03502707|466505887|FG017|Overall Study|Other|0|||
129603223|NCT03502707|466505870|FG000|Overall Study|Randomized but not vaccinated|0|||
129603224|NCT03502707|466505871|FG001|Overall Study|Randomized but not vaccinated|0|||
129603225|NCT03502707|466505872|FG002|Overall Study|Randomized but not vaccinated|0|||
129603226|NCT03502707|466505873|FG003|Overall Study|Randomized but not vaccinated|0|||
129603227|NCT03502707|466505874|FG004|Overall Study|Randomized but not vaccinated|0|||
129436829|NCT04218084|465897195|FG001|Overall Study|Adverse Event|2|||
129603228|NCT03502707|466505875|FG005|Overall Study|Randomized but not vaccinated|0|||
129603229|NCT03502707|466505876|FG006|Overall Study|Randomized but not vaccinated|0|||
129789255|NCT05395091|467195591|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
129789256|NCT05395091|467195589|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
129789257|NCT05395091|467195590|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
129789258|NCT05395091|467195591|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
129789259|NCT05395091|467195589|FG000|Month 12 to Month 18|Other reasons|0|||
129789260|NCT05395091|467195590|FG001|Month 12 to Month 18|Other reasons|0|||
129789261|NCT05395091|467195591|FG002|Month 12 to Month 18|Other reasons|1|||
129789262|NCT03554486|467195592|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
129789263|NCT03554486|467195593|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
129789264|NCT03554486|467195594|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
129789265|NCT03554486|467195592|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
129789266|NCT03554486|467195593|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
129789267|NCT03554486|467195594|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
129789268|NCT03554486|467195592|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
129789269|NCT03554486|467195593|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
129789270|NCT03554486|467195594|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
129789271|NCT01509053|467195595|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
129789272|NCT01509053|467195595|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
129789273|NCT01509053|467195595|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
129789274|NCT01509053|467195595|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
129789275|NCT01509053|467195595|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
129789276|NCT01509053|467195595|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
129789277|NCT01915303|467195596|FG000|Core Phase|Adverse Event|7|||
129789278|NCT01915303|467195596|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
129789279|NCT01915303|467195596|FG000|Core Phase|Death|2|||
129789280|NCT01915303|467195596|FG000|Core Phase|Protocol Violation|2|||
129789281|NCT01915303|467195596|FG000|Core Phase|Abnormal lab value|1|||
129789282|NCT01915303|467195596|FG000|Core Phase|Withdrawal by Subject|1|||
129789283|NCT01915303|467195596|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
129789284|NCT01915303|467195596|FG000|Extension Phase|Withdrawal by Subject|4|||
129789285|NCT01915303|467195596|FG000|Extension Phase|Adverse Event|3|||
129603230|NCT03502707|466505877|FG007|Overall Study|Randomized but not vaccinated|0|||
129789286|NCT01915303|467195596|FG000|Extension Phase|Death|1|||
129886034|NCT02254421|467542826|FG001|Overall Study|Withdrew Consent|1|||
129886035|NCT03354637|467542829|FG000|Double-blind Period|Protocol Violation|2|||
129886036|NCT03354637|467542830|FG001|Double-blind Period|Protocol Violation|0|||
129886037|NCT03354637|467542831|FG002|Double-blind Period|Protocol Violation|0|||
129886038|NCT03354637|467542829|FG000|Double-blind Period|Adverse Event|1|||
129886039|NCT03354637|467542830|FG001|Double-blind Period|Adverse Event|2|||
129886040|NCT03354637|467542831|FG002|Double-blind Period|Adverse Event|0|||
129886041|NCT03354637|467542829|FG000|Double-blind Period|Lost to Follow-up|3|||
129886042|NCT03354637|467542830|FG001|Double-blind Period|Lost to Follow-up|4|||
129886043|NCT03354637|467542831|FG002|Double-blind Period|Lost to Follow-up|3|||
129886044|NCT03354637|467542829|FG000|Double-blind Period|Withdrawal by Subject|10|||
129886045|NCT03354637|467542830|FG001|Double-blind Period|Withdrawal by Subject|6|||
129886046|NCT03354637|467542831|FG002|Double-blind Period|Withdrawal by Subject|4|||
129886047|NCT03354637|467542829|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
129886048|NCT03354637|467542830|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
129886049|NCT03354637|467542831|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
129886050|NCT03354637|467542829|FG000|Open Label Extension|Adverse Event|0|||
129886051|NCT03354637|467542830|FG001|Open Label Extension|Adverse Event|0|||
129886052|NCT03354637|467542831|FG002|Open Label Extension|Adverse Event|1|||
129886053|NCT03354637|467542829|FG000|Open Label Extension|Lost to Follow-up|0|||
129886054|NCT03354637|467542830|FG001|Open Label Extension|Lost to Follow-up|0|||
129886055|NCT03354637|467542831|FG002|Open Label Extension|Lost to Follow-up|2|||
129886056|NCT03354637|467542829|FG000|Open Label Extension|Withdrawal by Subject|0|||
129886057|NCT03354637|467542830|FG001|Open Label Extension|Withdrawal by Subject|0|||
129886058|NCT03354637|467542831|FG002|Open Label Extension|Withdrawal by Subject|5|||
129886059|NCT03354637|467542829|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
129886060|NCT03354637|467542830|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
129886061|NCT03354637|467542831|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
129886062|NCT03354637|467542829|FG000|Open Label Extension|Subject Noncompliance|0|||
129886063|NCT03354637|467542830|FG001|Open Label Extension|Subject Noncompliance|0|||
129886064|NCT03354637|467542831|FG002|Open Label Extension|Subject Noncompliance|1|||
129886065|NCT03354637|467542829|FG000|Open Label Extension|Lack of Efficacy|0|||
129886066|NCT03354637|467542830|FG001|Open Label Extension|Lack of Efficacy|0|||
129886067|NCT03354637|467542831|FG002|Open Label Extension|Lack of Efficacy|1|||
129886068|NCT03354637|467542829|FG000|Open Label Extension|Physician Decision|0|||
129886069|NCT03354637|467542830|FG001|Open Label Extension|Physician Decision|0|||
129886070|NCT03354637|467542831|FG002|Open Label Extension|Physician Decision|1|||
129436830|NCT04218084|465897194|FG000|Overall Study|Withdrawal of Consent|4|||
129436831|NCT04218084|465897195|FG001|Overall Study|Withdrawal of Consent|5|||
129436832|NCT04218084|465897194|FG000|Overall Study|Physician Decision|1|||
129436833|NCT04218084|465897195|FG001|Overall Study|Physician Decision|1|||
129436834|NCT04218084|465897194|FG000|Overall Study|Lost to Follow-up|1|||
129436835|NCT04218084|465897195|FG001|Overall Study|Lost to Follow-up|1|||
129436836|NCT04218084|465897194|FG000|Overall Study|Non-compliance with study drug|1|||
129436837|NCT04218084|465897195|FG001|Overall Study|Non-compliance with study drug|1|||
129436838|NCT04218084|465897194|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
129603231|NCT03502707|466505878|FG008|Overall Study|Randomized but not vaccinated|0|||
129603232|NCT03502707|466505879|FG009|Overall Study|Randomized but not vaccinated|0|||
129603233|NCT03502707|466505880|FG010|Overall Study|Randomized but not vaccinated|0|||
129603234|NCT03502707|466505881|FG011|Overall Study|Randomized but not vaccinated|1|||
129603235|NCT03502707|466505882|FG012|Overall Study|Randomized but not vaccinated|0|||
129603236|NCT03502707|466505883|FG013|Overall Study|Randomized but not vaccinated|0|||
129603237|NCT03502707|466505884|FG014|Overall Study|Randomized but not vaccinated|0|||
129603238|NCT03502707|466505885|FG015|Overall Study|Randomized but not vaccinated|0|||
129603239|NCT03502707|466505886|FG016|Overall Study|Randomized but not vaccinated|0|||
129603240|NCT03502707|466505887|FG017|Overall Study|Randomized but not vaccinated|1|||
129603241|NCT04908683|466505888|FG000|Overall Study|Failure to meet continuation criteria|34|||
129603242|NCT04908683|466505889|FG001|Overall Study|Failure to meet continuation criteria|22|||
129603243|NCT04908683|466505888|FG000|Overall Study|Initiated prohibited medication|3|||
129603244|NCT04908683|466505889|FG001|Overall Study|Initiated prohibited medication|0|||
129603245|NCT04908683|466505888|FG000|Overall Study|Randomized by mistake|1|||
129603246|NCT04908683|466505889|FG001|Overall Study|Randomized by mistake|0|||
129603247|NCT04908683|466505888|FG000|Overall Study|Lost to Follow-up|679|||
129603248|NCT04908683|466505889|FG001|Overall Study|Lost to Follow-up|341|||
129886071|NCT02726399|467542832|FG000|Overall Study|Participant Non-Compliance|1|||
129603249|NCT04908683|466505888|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
129886072|NCT02726399|467542832|FG000|Overall Study|Adverse Event|2|||
129886073|NCT02726399|467542832|FG000|Overall Study|Progression of disease|4|||
129603250|NCT04908683|466505889|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
129886074|NCT02564055|467542847|FG000|Overall Study|Adverse Event|1|||
129603251|NCT04908683|466505888|FG000|Overall Study|Physician Decision|44|||
129436839|NCT04218084|465897195|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
129603252|NCT04908683|466505889|FG001|Overall Study|Physician Decision|35|||
129603253|NCT04908683|466505888|FG000|Overall Study|Technical problems|12|||
129603254|NCT04908683|466505889|FG001|Overall Study|Technical problems|9|||
129603255|NCT04908683|466505888|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
129603256|NCT04908683|466505889|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
129603257|NCT04908683|466505888|FG000|Overall Study|Protocol Violation|2|||
129603258|NCT04908683|466505889|FG001|Overall Study|Protocol Violation|0|||
129603259|NCT04908683|466505888|FG000|Overall Study|Withdrawal by Subject|1188|||
129603260|NCT04908683|466505889|FG001|Overall Study|Withdrawal by Subject|570|||
129603261|NCT04908683|466505888|FG000|Overall Study|Site Closure by Sponsor|6|||
129603262|NCT04908683|466505889|FG001|Overall Study|Site Closure by Sponsor|3|||
129603263|NCT04908683|466505888|FG000|Overall Study|Adverse Event|21|||
129603264|NCT04908683|466505889|FG001|Overall Study|Adverse Event|11|||
129603265|NCT04908683|466505888|FG000|Overall Study|Death|101|||
129603266|NCT04908683|466505889|FG001|Overall Study|Death|61|||
129603267|NCT04908683|466505888|FG000|Overall Study|Sponsor's decision|14398|||
129603268|NCT04908683|466505889|FG001|Overall Study|Sponsor's decision|7205|||
129603269|NCT04908683|466505888|FG000|Overall Study|Other|92|||
129603270|NCT04908683|466505889|FG001|Overall Study|Other|50|||
129603271|NCT04908683|466505888|FG000|Overall Study|Randomized not vaccinated|108|||
129603272|NCT04908683|466505889|FG001|Overall Study|Randomized not vaccinated|52|||
129603273|NCT02221037|466505891|FG000|Overall Study|Physician Decision|0|||
129603274|NCT02221037|466505892|FG001|Overall Study|Physician Decision|0|||
129603275|NCT02221037|466505893|FG002|Overall Study|Physician Decision|1|||
129603276|NCT02221037|466505894|FG003|Overall Study|Physician Decision|0|||
129603277|NCT01884311|466505895|FG000|Overall Study|Withdrawal by Subject|3|||
129603278|NCT01884311|466505895|FG000|Overall Study|withdrew consent due to AEs|1|||
129603279|NCT01884311|466505895|FG000|Overall Study|Precautionary measure|1|||
129603280|NCT02307266|466505896|FG000|Overall Study|Adverse Event|3|||
129603281|NCT02307266|466505897|FG001|Overall Study|Adverse Event|1|||
129603282|NCT02307266|466505898|FG002|Overall Study|Adverse Event|5|||
129603283|NCT02307266|466505896|FG000|Overall Study|Withdrawal by Subject|2|||
129603284|NCT02307266|466505897|FG001|Overall Study|Withdrawal by Subject|0|||
129603285|NCT02307266|466505898|FG002|Overall Study|Withdrawal by Subject|1|||
129603286|NCT02307266|466505896|FG000|Overall Study|Lost to Follow-up|3|||
129603287|NCT02307266|466505897|FG001|Overall Study|Lost to Follow-up|0|||
129603288|NCT02307266|466505898|FG002|Overall Study|Lost to Follow-up|0|||
129603289|NCT01293539|466505910|FG000|Overall Study|Physician Decision|1|||
129603290|NCT00866658|466505911|FG000|Overall Study|Adverse Event|5|||
129603291|NCT00866658|466505912|FG001|Overall Study|Adverse Event|14|||
129603292|NCT00866658|466505911|FG000|Overall Study|Lack of Efficacy|2|||
129603293|NCT00866658|466505912|FG001|Overall Study|Lack of Efficacy|1|||
129603294|NCT00866658|466505911|FG000|Overall Study|Withdrawal by Subject|1|||
129603295|NCT00866658|466505912|FG001|Overall Study|Withdrawal by Subject|0|||
129603296|NCT00866658|466505911|FG000|Overall Study|Protocol Violation|1|||
129603297|NCT00866658|466505912|FG001|Overall Study|Protocol Violation|1|||
129603298|NCT00866658|466505911|FG000|Overall Study|Familial and Personal Reasons|4|||
129603299|NCT00866658|466505912|FG001|Overall Study|Familial and Personal Reasons|5|||
129603300|NCT00609518|466505913|FG000|Overall Study|Death from Study Disease|32|||
129603301|NCT00609518|466505914|FG001|Overall Study|Death from Study Disease|32|||
129603302|NCT00609518|466505913|FG000|Overall Study|Withdrawal by Subject|5|||
129603303|NCT00609518|466505914|FG001|Overall Study|Withdrawal by Subject|3|||
129603304|NCT00609518|466505913|FG000|Overall Study|Lost to Follow-up|3|||
129603305|NCT00609518|466505914|FG001|Overall Study|Lost to Follow-up|0|||
129603306|NCT00609518|466505913|FG000|Overall Study|Physician Decision|1|||
129603307|NCT00609518|466505914|FG001|Overall Study|Physician Decision|3|||
129603308|NCT00609518|466505913|FG000|Overall Study|Death from Adverse Event|2|||
129603309|NCT00609518|466505914|FG001|Overall Study|Death from Adverse Event|2|||
129603310|NCT01687478|466505915|FG000|Overall Study|Adverse Event|3|||
129603311|NCT01687478|466505916|FG001|Overall Study|Adverse Event|10|||
129603312|NCT01687478|466505915|FG000|Overall Study|Lost to Follow-up|1|||
129603313|NCT01687478|466505916|FG001|Overall Study|Lost to Follow-up|3|||
129603314|NCT01687478|466505915|FG000|Overall Study|Protocol Violation|0|||
129603315|NCT01687478|466505916|FG001|Overall Study|Protocol Violation|2|||
129603316|NCT01687478|466505915|FG000|Overall Study|Withdrawal by Subject|21|||
129603317|NCT01687478|466505916|FG001|Overall Study|Withdrawal by Subject|19|||
129603318|NCT01687478|466505915|FG000|Overall Study|Physician Decision|1|||
129603319|NCT01687478|466505916|FG001|Overall Study|Physician Decision|3|||
129603320|NCT01687478|466505915|FG000|Overall Study|Entry Criteria Not Met|6|||
129603321|NCT01687478|466505916|FG001|Overall Study|Entry Criteria Not Met|2|||
129603322|NCT05855616|466505920|FG000|Overall Study|Lost to Follow-up|1|||
129603323|NCT05855616|466505921|FG001|Overall Study|Lost to Follow-up|2|||
129603324|NCT00059787|466505922|FG000|Overall Study|Adverse Event|13|||
129436840|NCT04218084|465897194|FG000|Overall Study|Other|0|||
129436841|NCT04218084|465897195|FG001|Overall Study|Other|1|||
129436842|NCT04218084|465897194|FG000|Overall Study|Ongoing at data cut-off date|62|||
129436843|NCT04218084|465897195|FG001|Overall Study|Ongoing at data cut-off date|58|||
129436844|NCT05580588|465897196|FG000|Overall Study|Lack of Efficacy|12|||
129436845|NCT00211185|465897199|FG000|Overall Study|Death|2|||
129436846|NCT00211185|465897199|FG000|Overall Study|Disease progression|7|||
129886075|NCT02564055|467542848|FG001|Overall Study|Adverse Event|0|||
129886076|NCT02564055|467542849|FG002|Overall Study|Adverse Event|4|||
129886077|NCT02564055|467542850|FG003|Overall Study|Adverse Event|1|||
129886078|NCT02564055|467542851|FG004|Overall Study|Adverse Event|4|||
129886079|NCT02564055|467542852|FG005|Overall Study|Adverse Event|1|||
129886080|NCT02564055|467542847|FG000|Overall Study|Protocol Violation|1|||
129886081|NCT02564055|467542848|FG001|Overall Study|Protocol Violation|0|||
129886082|NCT02564055|467542849|FG002|Overall Study|Protocol Violation|0|||
129603325|NCT00059787|466505922|FG000|Overall Study|disease progression|2|||
129603326|NCT00059787|466505922|FG000|Overall Study|ineligible|1|||
129603327|NCT00059787|466505922|FG000|Overall Study|Other|4|||
129603328|NCT00292188|466505923|FG000|Single-Blind|Adverse Event|14|||
129603329|NCT00292188|466505924|FG001|Single-Blind|Adverse Event|0|||
129603330|NCT00292188|466505925|FG002|Single-Blind|Adverse Event|0|||
129603331|NCT00292188|466505923|FG000|Single-Blind|Lack of Efficacy|2|||
129603332|NCT00292188|466505924|FG001|Single-Blind|Lack of Efficacy|0|||
129603333|NCT00292188|466505925|FG002|Single-Blind|Lack of Efficacy|0|||
129603334|NCT00292188|466505923|FG000|Single-Blind|Laboratory Abnormality|5|||
129603335|NCT00292188|466505924|FG001|Single-Blind|Laboratory Abnormality|0|||
129603336|NCT00292188|466505925|FG002|Single-Blind|Laboratory Abnormality|0|||
129603337|NCT00292188|466505923|FG000|Single-Blind|Lost to Follow-up|3|||
129603338|NCT00292188|466505924|FG001|Single-Blind|Lost to Follow-up|0|||
129603339|NCT00292188|466505925|FG002|Single-Blind|Lost to Follow-up|0|||
129603340|NCT00292188|466505923|FG000|Single-Blind|Other|77|||
129603341|NCT00292188|466505924|FG001|Single-Blind|Other|0|||
129603342|NCT00292188|466505925|FG002|Single-Blind|Other|0|||
129886083|NCT02564055|467542850|FG003|Overall Study|Protocol Violation|0|||
129886084|NCT02564055|467542851|FG004|Overall Study|Protocol Violation|0|||
129603343|NCT00292188|466505923|FG000|Single-Blind|Withdrawal by Subject|12|||
129603344|NCT00292188|466505924|FG001|Single-Blind|Withdrawal by Subject|0|||
129603345|NCT00292188|466505925|FG002|Single-Blind|Withdrawal by Subject|0|||
129603346|NCT00292188|466505923|FG000|Single-Blind|Did not receive treatment|1|||
129603347|NCT00292188|466505924|FG001|Single-Blind|Did not receive treatment|0|||
129603348|NCT00292188|466505925|FG002|Single-Blind|Did not receive treatment|0|||
129603349|NCT00292188|466505923|FG000|Double-Blind|Adverse Event|0|||
129603350|NCT00292188|466505924|FG001|Double-Blind|Adverse Event|25|||
129603351|NCT00292188|466505925|FG002|Double-Blind|Adverse Event|9|||
129603352|NCT00292188|466505923|FG000|Double-Blind|Lack of Efficacy|0|||
129603353|NCT00292188|466505924|FG001|Double-Blind|Lack of Efficacy|2|||
129603354|NCT00292188|466505925|FG002|Double-Blind|Lack of Efficacy|12|||
129603355|NCT00292188|466505923|FG000|Double-Blind|Lost to Follow-up|0|||
129603356|NCT00292188|466505924|FG001|Double-Blind|Lost to Follow-up|1|||
129603357|NCT00292188|466505925|FG002|Double-Blind|Lost to Follow-up|0|||
129603358|NCT00292188|466505923|FG000|Double-Blind|Other|0|||
129603359|NCT00292188|466505924|FG001|Double-Blind|Other|3|||
129603360|NCT00292188|466505925|FG002|Double-Blind|Other|4|||
129603361|NCT00292188|466505923|FG000|Double-Blind|Withdrawal by Subject|0|||
129603362|NCT00292188|466505924|FG001|Double-Blind|Withdrawal by Subject|0|||
129603363|NCT00292188|466505925|FG002|Double-Blind|Withdrawal by Subject|3|||
129603364|NCT00292188|466505923|FG000|Double-Blind|Laboratory Abnormality|0|||
129603365|NCT00292188|466505924|FG001|Double-Blind|Laboratory Abnormality|0|||
129603366|NCT00292188|466505925|FG002|Double-Blind|Laboratory Abnormality|1|||
129603367|NCT00824616|466505926|FG000|Overall Study|Adverse Event|2|||
129603368|NCT00824616|466505927|FG001|Overall Study|Adverse Event|1|||
129603369|NCT00824616|466505926|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
129603370|NCT00824616|466505927|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
129603371|NCT00824616|466505926|FG000|Overall Study|Hyperglycemia|1|||
129603372|NCT00824616|466505927|FG001|Overall Study|Hyperglycemia|1|||
129603373|NCT00824616|466505926|FG000|Overall Study|Lack of Efficacy|2|||
129603374|NCT00824616|466505927|FG001|Overall Study|Lack of Efficacy|1|||
129603375|NCT00824616|466505926|FG000|Overall Study|Lost to Follow-up|0|||
129603376|NCT00824616|466505927|FG001|Overall Study|Lost to Follow-up|1|||
129603377|NCT00824616|466505926|FG000|Overall Study|Withdrawal by Subject|1|||
129603378|NCT00824616|466505927|FG001|Overall Study|Withdrawal by Subject|1|||
129603379|NCT04322149|466505928|FG000|Overall Study|Adverse Event|1|||
129603380|NCT04322149|466505929|FG001|Overall Study|Adverse Event|1|||
129603381|NCT04322149|466505930|FG002|Overall Study|Adverse Event|0|||
129603382|NCT04322149|466505931|FG003|Overall Study|Adverse Event|0|||
129603383|NCT04322149|466505928|FG000|Overall Study|Withdrawal by Subject|0|||
129603384|NCT04322149|466505929|FG001|Overall Study|Withdrawal by Subject|0|||
129603385|NCT04322149|466505930|FG002|Overall Study|Withdrawal by Subject|0|||
129603386|NCT04322149|466505931|FG003|Overall Study|Withdrawal by Subject|2|||
129603387|NCT04322149|466505928|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
129603388|NCT04322149|466505929|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
129603389|NCT04322149|466505930|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
129603390|NCT04322149|466505931|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
129603391|NCT00103311|466505940|FG000|Overall Study|Lost to Follow-up|1|||
129603392|NCT00103311|466505941|FG001|Overall Study|Lost to Follow-up|0|||
129603393|NCT00103311|466505940|FG000|Overall Study|Withdrawal by Subject|2|||
129603394|NCT00103311|466505941|FG001|Overall Study|Withdrawal by Subject|1|||
129603395|NCT00103311|466505940|FG000|Overall Study|Adverse Event|1|||
129603396|NCT00103311|466505941|FG001|Overall Study|Adverse Event|0|||
129436847|NCT00211185|465897199|FG000|Overall Study|Withdrawal by Subject|6|||
129436848|NCT00211185|465897199|FG000|Overall Study|Physician Decision|5|||
129603397|NCT00974974|466505946|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
129603398|NCT00974974|466505947|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
129603399|NCT00974974|466505946|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
129603400|NCT00974974|466505947|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
129603401|NCT00974974|466505946|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
129603402|NCT00974974|466505947|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
129603403|NCT00974974|466505946|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
129603404|NCT00974974|466505947|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
129603405|NCT00974974|466505946|FG000|IR CD-LD Dose Adjustment|Various|0|||
129789287|NCT01915303|467195596|FG000|Extension Phase|Protocol Violation|1|||
129789288|NCT02925338|467195597|FG000|Overall Study|Death|0|||
129789289|NCT02925338|467195598|FG001|Overall Study|Death|2|||
129789290|NCT02925338|467195599|FG002|Overall Study|Death|1|||
129789291|NCT02925338|467195600|FG003|Overall Study|Death|0|||
129789292|NCT02925338|467195601|FG004|Overall Study|Death|0|||
129789293|NCT02925338|467195597|FG000|Overall Study|Lost to Follow-up|30|||
129789294|NCT02925338|467195598|FG001|Overall Study|Lost to Follow-up|10|||
129789295|NCT02925338|467195599|FG002|Overall Study|Lost to Follow-up|1|||
129789296|NCT02925338|467195600|FG003|Overall Study|Lost to Follow-up|16|||
129789297|NCT02925338|467195601|FG004|Overall Study|Lost to Follow-up|3|||
129789298|NCT02925338|467195597|FG000|Overall Study|Withdrawal by Subject|3|||
129789299|NCT02925338|467195598|FG001|Overall Study|Withdrawal by Subject|0|||
129789300|NCT02925338|467195599|FG002|Overall Study|Withdrawal by Subject|3|||
129789301|NCT02925338|467195600|FG003|Overall Study|Withdrawal by Subject|2|||
129789302|NCT02925338|467195601|FG004|Overall Study|Withdrawal by Subject|2|||
129789303|NCT02925338|467195597|FG000|Overall Study|Missing|38|||
129436849|NCT00712673|465897200|FG000|Overall Study|Adverse Event|3|||
129436850|NCT00712673|465897201|FG001|Overall Study|Adverse Event|3|||
129603406|NCT00974974|466505947|FG001|IR CD-LD Dose Adjustment|Various|9|||
129603407|NCT00974974|466505946|FG000|IPX066 Dose Conversion|Adverse Event|23|||
129603408|NCT00974974|466505947|FG001|IPX066 Dose Conversion|Adverse Event|0|||
129603409|NCT00974974|466505946|FG000|IPX066 Dose Conversion|Death|2|||
129603410|NCT00974974|466505947|FG001|IPX066 Dose Conversion|Death|0|||
129603411|NCT00974974|466505946|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
129603412|NCT00974974|466505947|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
129603413|NCT00974974|466505946|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
129603414|NCT00974974|466505947|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
129603415|NCT00974974|466505946|FG000|IPX066 Dose Conversion|Various|3|||
129603416|NCT00974974|466505947|FG001|IPX066 Dose Conversion|Various|0|||
129603417|NCT00974974|466505946|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
129603418|NCT00974974|466505947|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
129603419|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
129603420|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
129603421|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
129603422|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
129603423|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
129603424|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
129603425|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
129603426|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
129603427|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
129603428|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
129603429|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
129603430|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
129603431|NCT00974974|466505946|FG000|Maintenance - Double Blind Treatment|Various|4|||
129603432|NCT00974974|466505947|FG001|Maintenance - Double Blind Treatment|Various|0|||
129789304|NCT02925338|467195598|FG001|Overall Study|Missing|27|||
129603433|NCT03254602|466505948|FG000|Overall Study|Lost to Follow-up|4|||
129603434|NCT02836496|466505955|FG000|Overall Study|Adverse Event|2|||
129789305|NCT02925338|467195599|FG002|Overall Study|Missing|0|||
129789306|NCT02925338|467195600|FG003|Overall Study|Missing|3|||
129789307|NCT02925338|467195601|FG004|Overall Study|Missing|2|||
129603435|NCT02836496|466505956|FG001|Overall Study|Adverse Event|1|||
129603436|NCT02836496|466505955|FG000|Overall Study|Withdrawal by Subject|0|||
129789308|NCT02925338|467195597|FG000|Overall Study|Participant's Decision|11|||
129789309|NCT02925338|467195598|FG001|Overall Study|Participant's Decision|7|||
129436851|NCT00712673|465897202|FG002|Overall Study|Adverse Event|21|||
129789310|NCT02925338|467195599|FG002|Overall Study|Participant's Decision|3|||
129603437|NCT02836496|466505956|FG001|Overall Study|Withdrawal by Subject|1|||
129603438|NCT03822832|466505957|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
129603439|NCT03822832|466505958|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
129603440|NCT03822832|466505957|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
129603441|NCT03822832|466505958|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
129603442|NCT03822832|466505957|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
129603443|NCT03822832|466505958|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
129603444|NCT03822832|466505957|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
129603445|NCT03822832|466505958|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
129603446|NCT03822832|466505957|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
129603447|NCT03822832|466505958|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
129603448|NCT03822832|466505957|FG000|Re-allocation|Not re-allocated to open label period|2|||
129603449|NCT03822832|466505958|FG001|Re-allocation|Not re-allocated to open label period|6|||
129603450|NCT03822832|466505957|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
129603451|NCT03822832|466505958|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
129603452|NCT03822832|466505957|FG000|Period 2 - Open Label Period|Adverse Event|0|||
129603453|NCT03822832|466505958|FG001|Period 2 - Open Label Period|Adverse Event|3|||
129603454|NCT03914950|466505963|FG000|Overall Study|Physician Decision|54|||
129603455|NCT02575911|466505964|FG000|Overall Study|Lost to Follow-up|1|||
129603456|NCT01249365|466505965|FG000|Overall Study|Lost to Follow-up|1|||
129603457|NCT01460901|466505966|FG000|Overall Study|Withdrawal by Subject|2|||
129603458|NCT02566993|466505967|FG000|Overall Study|Randomized but not treated|5|||
129603459|NCT02566993|466505968|FG001|Overall Study|Randomized but not treated|16|||
129603460|NCT02566993|466505967|FG000|Overall Study|Progressive disease|213|||
129603461|NCT02566993|466505968|FG001|Overall Study|Progressive disease|152|||
129603462|NCT02566993|466505967|FG000|Overall Study|Withdrawal by Subject|12|||
129603463|NCT02566993|466505968|FG001|Overall Study|Withdrawal by Subject|28|||
129603464|NCT02566993|466505967|FG000|Overall Study|Death|17|||
129603465|NCT02566993|466505968|FG001|Overall Study|Death|23|||
129603466|NCT02566993|466505967|FG000|Overall Study|Physician Decision|10|||
129603467|NCT02566993|466505968|FG001|Overall Study|Physician Decision|17|||
129603468|NCT02566993|466505967|FG000|Overall Study|Study drug-related adverse event|20|||
129603469|NCT02566993|466505968|FG001|Overall Study|Study drug-related adverse event|41|||
129603470|NCT02566993|466505967|FG000|Overall Study|Non study drug-related adverse event|9|||
129603471|NCT02566993|466505968|FG001|Overall Study|Non study drug-related adverse event|9|||
129603472|NCT02566993|466505967|FG000|Overall Study|Symptomatic deterioration|9|||
129603473|NCT02566993|466505968|FG001|Overall Study|Symptomatic deterioration|16|||
129603474|NCT02566993|466505967|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
129603475|NCT02566993|466505968|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
129603476|NCT02566993|466505967|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
129603477|NCT02566993|466505968|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
129603478|NCT02566993|466505967|FG000|Overall Study|Screening failure|2|||
129603479|NCT02566993|466505968|FG001|Overall Study|Screening failure|0|||
129603480|NCT02566993|466505967|FG000|Overall Study|Lost to Follow-up|0|||
129603481|NCT02566993|466505968|FG001|Overall Study|Lost to Follow-up|1|||
129603482|NCT02566993|466505967|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
129603483|NCT02566993|466505968|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
129603484|NCT01169532|466505973|FG000|Overall Study|Withdrawal by Subject|1|||
129603485|NCT03127644|466505981|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129603486|NCT03127644|466505982|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129603487|NCT03127644|466505983|FG002|Overall Study|Study-specific withdrawal criteria|2|||
129603488|NCT02005887|466505984|FG000|Overall Study|Protocol Violation|0|||
129603489|NCT02005887|466505985|FG001|Overall Study|Protocol Violation|2|||
129603490|NCT01550744|466505986|FG000|Open-Label|Lost to Follow-up|7|||
129603491|NCT01550744|466505987|FG001|Open-Label|Lost to Follow-up|0|||
129603492|NCT01550744|466505988|FG002|Open-Label|Lost to Follow-up|0|||
129603493|NCT01550744|466505986|FG000|Open-Label|Withdrawal by Subject|13|||
129603494|NCT01550744|466505987|FG001|Open-Label|Withdrawal by Subject|0|||
129603495|NCT01550744|466505988|FG002|Open-Label|Withdrawal by Subject|0|||
129603496|NCT01550744|466505986|FG000|Open-Label|Adverse Event|11|||
129603497|NCT01550744|466505987|FG001|Open-Label|Adverse Event|0|||
129603498|NCT01550744|466505988|FG002|Open-Label|Adverse Event|0|||
129603499|NCT01550744|466505986|FG000|Open-Label|Lack of Efficacy|4|||
129697953|NCT00489476|466853421|FG002|Overall Study|Lost to Follow-up|0|||
129697954|NCT00489476|466853422|FG003|Overall Study|Lost to Follow-up|0|||
129697955|NCT00803049|466853423|FG000|Overall Study|Adverse Event|21|||
129697956|NCT00803049|466853424|FG001|Overall Study|Adverse Event|33|||
129697957|NCT00803049|466853425|FG002|Overall Study|Adverse Event|13|||
129697958|NCT00803049|466853426|FG003|Overall Study|Adverse Event|27|||
129697959|NCT00803049|466853423|FG000|Overall Study|Lack of Efficacy|10|||
129697960|NCT00803049|466853424|FG001|Overall Study|Lack of Efficacy|19|||
129697961|NCT00803049|466853425|FG002|Overall Study|Lack of Efficacy|6|||
129436852|NCT00712673|465897203|FG003|Overall Study|Adverse Event|26|||
129436853|NCT00712673|465897200|FG000|Overall Study|Lack of Efficacy|2|||
129436854|NCT00712673|465897201|FG001|Overall Study|Lack of Efficacy|8|||
129436855|NCT00712673|465897202|FG002|Overall Study|Lack of Efficacy|8|||
129436856|NCT00712673|465897203|FG003|Overall Study|Lack of Efficacy|6|||
129436857|NCT00712673|465897200|FG000|Overall Study|Poor Compliance to Protocol|3|||
129436858|NCT00712673|465897201|FG001|Overall Study|Poor Compliance to Protocol|3|||
129436859|NCT00712673|465897202|FG002|Overall Study|Poor Compliance to Protocol|4|||
129436860|NCT00712673|465897203|FG003|Overall Study|Poor Compliance to Protocol|16|||
129436861|NCT00712673|465897200|FG000|Overall Study|Lost to Follow-up|1|||
129436862|NCT00712673|465897201|FG001|Overall Study|Lost to Follow-up|0|||
129436863|NCT00712673|465897202|FG002|Overall Study|Lost to Follow-up|2|||
129436864|NCT00712673|465897203|FG003|Overall Study|Lost to Follow-up|0|||
129436865|NCT00712673|465897200|FG000|Overall Study|Withdrawal by Subject|6|||
129436866|NCT00712673|465897201|FG001|Overall Study|Withdrawal by Subject|7|||
129436867|NCT00712673|465897202|FG002|Overall Study|Withdrawal by Subject|15|||
129436868|NCT00712673|465897203|FG003|Overall Study|Withdrawal by Subject|20|||
129436869|NCT00712673|465897200|FG000|Overall Study|Familial and Personal Reasons|5|||
129436870|NCT00712673|465897201|FG001|Overall Study|Familial and Personal Reasons|0|||
129436871|NCT00712673|465897202|FG002|Overall Study|Familial and Personal Reasons|5|||
129436872|NCT00712673|465897203|FG003|Overall Study|Familial and Personal Reasons|2|||
129436873|NCT00712673|465897200|FG000|Overall Study|Investigator's Decision|1|||
129436874|NCT00712673|465897201|FG001|Overall Study|Investigator's Decision|0|||
129436875|NCT00712673|465897202|FG002|Overall Study|Investigator's Decision|0|||
129436876|NCT00712673|465897203|FG003|Overall Study|Investigator's Decision|0|||
129436877|NCT00712673|465897200|FG000|Overall Study|Protocol Violation|0|||
129436878|NCT00712673|465897201|FG001|Overall Study|Protocol Violation|0|||
129436879|NCT00712673|465897202|FG002|Overall Study|Protocol Violation|2|||
129436880|NCT00712673|465897203|FG003|Overall Study|Protocol Violation|0|||
129436881|NCT03603028|465897204|FG000|Overall Study|Withdrawal by Subject|1|||
129789311|NCT02925338|467195600|FG003|Overall Study|Participant's Decision|8|||
129789312|NCT02925338|467195601|FG004|Overall Study|Participant's Decision|1|||
129789313|NCT02925338|467195597|FG000|Overall Study|Treatment Discontinuation|144|||
129789314|NCT02925338|467195598|FG001|Overall Study|Treatment Discontinuation|65|||
129789315|NCT02925338|467195599|FG002|Overall Study|Treatment Discontinuation|56|||
129789316|NCT02925338|467195600|FG003|Overall Study|Treatment Discontinuation|131|||
129789317|NCT02925338|467195601|FG004|Overall Study|Treatment Discontinuation|22|||
129789318|NCT00636363|467195604|FG000|Overall Study|Conjunctivitis|0|||
129789319|NCT00636363|467195605|FG001|Overall Study|Conjunctivitis|0|||
129789320|NCT00636363|467195606|FG002|Overall Study|Conjunctivitis|1|||
129789321|NCT00636363|467195604|FG000|Overall Study|Adverse Event|0|||
129789322|NCT00636363|467195605|FG001|Overall Study|Adverse Event|0|||
129436882|NCT00842985|465897209|FG000|Screening|Did not meet entrance requirements|27|||
129789323|NCT00636363|467195606|FG002|Overall Study|Adverse Event|1|||
129436883|NCT00842985|465897209|FG000|First Intervention|Withdrawal by Subject|3|||
129436884|NCT00842985|465897209|FG000|First Intervention|Protocol Violation|3|||
129436885|NCT00842985|465897209|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
129436886|NCT00842985|465897209|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
129603500|NCT01550744|466505987|FG001|Open-Label|Lack of Efficacy|0|||
129603501|NCT01550744|466505988|FG002|Open-Label|Lack of Efficacy|0|||
129603502|NCT01550744|466505986|FG000|Open-Label|Protocol Violation|4|||
129603503|NCT01550744|466505987|FG001|Open-Label|Protocol Violation|0|||
129603504|NCT01550744|466505988|FG002|Open-Label|Protocol Violation|0|||
129603505|NCT01550744|466505986|FG000|Open-Label|Not all 3 study drug injections received|2|||
129603506|NCT01550744|466505987|FG001|Open-Label|Not all 3 study drug injections received|0|||
129603507|NCT01550744|466505988|FG002|Open-Label|Not all 3 study drug injections received|0|||
129603508|NCT01550744|466505986|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
129603509|NCT01550744|466505987|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
129603510|NCT01550744|466505988|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
129603511|NCT01550744|466505986|FG000|Open-Label|Other|1|||
129603512|NCT01550744|466505987|FG001|Open-Label|Other|0|||
129603513|NCT01550744|466505988|FG002|Open-Label|Other|0|||
129603514|NCT01550744|466505986|FG000|Double-Blind|Lost to Follow-up|0|||
129603515|NCT01550744|466505987|FG001|Double-Blind|Lost to Follow-up|6|||
129603516|NCT01550744|466505988|FG002|Double-Blind|Lost to Follow-up|12|||
129603517|NCT01550744|466505986|FG000|Double-Blind|Withdrawal by Subject|0|||
129603518|NCT01550744|466505987|FG001|Double-Blind|Withdrawal by Subject|2|||
129603519|NCT01550744|466505988|FG002|Double-Blind|Withdrawal by Subject|15|||
129603520|NCT01550744|466505986|FG000|Double-Blind|Adverse Event|0|||
129603521|NCT01550744|466505987|FG001|Double-Blind|Adverse Event|4|||
129603522|NCT01550744|466505988|FG002|Double-Blind|Adverse Event|15|||
129603523|NCT01550744|466505986|FG000|Double-Blind|Death|0|||
129603524|NCT01550744|466505987|FG001|Double-Blind|Death|1|||
129603525|NCT01550744|466505988|FG002|Double-Blind|Death|0|||
129603526|NCT01550744|466505986|FG000|Double-Blind|Lack of Efficacy|0|||
129603527|NCT01550744|466505987|FG001|Double-Blind|Lack of Efficacy|2|||
129603528|NCT01550744|466505988|FG002|Double-Blind|Lack of Efficacy|8|||
129603529|NCT01550744|466505986|FG000|Double-Blind|Protocol Violation|0|||
129603530|NCT01550744|466505987|FG001|Double-Blind|Protocol Violation|0|||
129603531|NCT01550744|466505988|FG002|Double-Blind|Protocol Violation|4|||
129603532|NCT01550744|466505986|FG000|Double-Blind|Pregnancy|0|||
129603533|NCT01550744|466505987|FG001|Double-Blind|Pregnancy|0|||
129603534|NCT01550744|466505988|FG002|Double-Blind|Pregnancy|3|||
129603535|NCT01550744|466505986|FG000|Double-Blind|Other|0|||
129603536|NCT01550744|466505987|FG001|Double-Blind|Other|2|||
129603537|NCT01550744|466505988|FG002|Double-Blind|Other|10|||
129603538|NCT01660334|466505989|FG000|Overall Study|Lost to Follow-up|1|||
129603539|NCT00311311|466505991|FG000|Overall Study|Adverse Event|3|||
129603540|NCT00311311|466505992|FG001|Overall Study|Adverse Event|2|||
129603541|NCT00311311|466505991|FG000|Overall Study|Withdrawal by Subject|1|||
129603542|NCT00311311|466505992|FG001|Overall Study|Withdrawal by Subject|1|||
129603543|NCT00311311|466505991|FG000|Overall Study|Noncompliance|0|||
129603544|NCT00311311|466505992|FG001|Overall Study|Noncompliance|1|||
129603545|NCT00311311|466505991|FG000|Overall Study|Study Termination by Sponsor|3|||
129603546|NCT00311311|466505992|FG001|Overall Study|Study Termination by Sponsor|4|||
129603547|NCT00311311|466505991|FG000|Overall Study|Death|1|||
129603548|NCT00311311|466505992|FG001|Overall Study|Death|0|||
129603549|NCT00311311|466505991|FG000|Overall Study|Lack of ancillary assistance|0|||
129603550|NCT00311311|466505992|FG001|Overall Study|Lack of ancillary assistance|1|||
129603551|NCT00988065|466505994|FG000|Overall Study|Adverse Event|4|||
129603552|NCT00988065|466505995|FG001|Overall Study|Adverse Event|10|||
129603553|NCT00988065|466505996|FG002|Overall Study|Adverse Event|2|||
129603554|NCT00988065|466505994|FG000|Overall Study|Lost to Follow-up|1|||
129603555|NCT00988065|466505995|FG001|Overall Study|Lost to Follow-up|2|||
129603556|NCT00988065|466505996|FG002|Overall Study|Lost to Follow-up|2|||
129697962|NCT00803049|466853426|FG003|Overall Study|Lack of Efficacy|13|||
129603557|NCT00988065|466505994|FG000|Overall Study|Subject withdrew consent|3|||
129697963|NCT00803049|466853423|FG000|Overall Study|Lost to Follow-up|0|||
129697964|NCT00803049|466853424|FG001|Overall Study|Lost to Follow-up|2|||
129697965|NCT00803049|466853425|FG002|Overall Study|Lost to Follow-up|0|||
129697966|NCT00803049|466853426|FG003|Overall Study|Lost to Follow-up|3|||
129603558|NCT00988065|466505995|FG001|Overall Study|Subject withdrew consent|5|||
129603559|NCT00988065|466505996|FG002|Overall Study|Subject withdrew consent|2|||
129603560|NCT00988065|466505994|FG000|Overall Study|Noncompliance with protocol|5|||
129603561|NCT00988065|466505995|FG001|Overall Study|Noncompliance with protocol|6|||
129603562|NCT00988065|466505996|FG002|Overall Study|Noncompliance with protocol|9|||
129603563|NCT01229735|466505997|FG000|Overall Study|Lack of Efficacy|8|||
129603564|NCT01229735|466505998|FG001|Overall Study|Lack of Efficacy|8|||
129603565|NCT01229735|466505997|FG000|Overall Study|Protocol Violation|13|||
129603566|NCT01229735|466505998|FG001|Overall Study|Protocol Violation|8|||
129603567|NCT01229735|466505997|FG000|Overall Study|Lost to Follow-up|0|||
129603568|NCT01229735|466505998|FG001|Overall Study|Lost to Follow-up|2|||
129603569|NCT01229735|466505997|FG000|Overall Study|Withdrawal by Subject|18|||
129603570|NCT01229735|466505998|FG001|Overall Study|Withdrawal by Subject|17|||
129603571|NCT01229735|466505997|FG000|Overall Study|Other Reason|13|||
129603572|NCT01229735|466505998|FG001|Overall Study|Other Reason|10|||
129697967|NCT00803049|466853423|FG000|Overall Study|Death|2|||
129697968|NCT00803049|466853424|FG001|Overall Study|Death|1|||
129436887|NCT01000636|465897210|FG000|Overall Study|Withdrawal by Subject|1|||
129436888|NCT01000636|465897210|FG000|Overall Study|Adverse Event|1|||
129436889|NCT03305731|465897211|FG000|Overall Study|Protocol Violation|1|||
129436890|NCT04964414|465897214|FG000|Overall Study|Lost to Follow-up|10|||
129436891|NCT04964414|465897215|FG001|Overall Study|Lost to Follow-up|8|||
129436892|NCT04964414|465897214|FG000|Overall Study|Withdrawal by Subject|1|||
129436893|NCT04964414|465897215|FG001|Overall Study|Withdrawal by Subject|1|||
129436894|NCT01718353|465897216|FG000|Overall Study|Lost to Follow-up|0|||
129436895|NCT01718353|465897217|FG001|Overall Study|Lost to Follow-up|1|||
129436896|NCT01718353|465897216|FG000|Overall Study|Principal Investigator's Decision|10|||
129436897|NCT01718353|465897217|FG001|Overall Study|Principal Investigator's Decision|4|||
129697969|NCT00803049|466853425|FG002|Overall Study|Death|0|||
129697970|NCT00803049|466853426|FG003|Overall Study|Death|2|||
129697971|NCT00803049|466853423|FG000|Overall Study|Progressive Disease|6|||
129697972|NCT00803049|466853424|FG001|Overall Study|Progressive Disease|10|||
129697973|NCT00803049|466853425|FG002|Overall Study|Progressive Disease|6|||
129697974|NCT00803049|466853426|FG003|Overall Study|Progressive Disease|6|||
129697975|NCT00803049|466853423|FG000|Overall Study|Withdrawal by Subject|19|||
129697976|NCT00803049|466853424|FG001|Overall Study|Withdrawal by Subject|43|||
129697977|NCT00803049|466853425|FG002|Overall Study|Withdrawal by Subject|16|||
129789324|NCT00636363|467195604|FG000|Overall Study|Positive slit lamp finding|0|||
129789325|NCT00636363|467195605|FG001|Overall Study|Positive slit lamp finding|2|||
129789326|NCT00636363|467195606|FG002|Overall Study|Positive slit lamp finding|1|||
129789327|NCT00636363|467195604|FG000|Overall Study|Study related symptoms/complaints|8|||
129789328|NCT00636363|467195605|FG001|Overall Study|Study related symptoms/complaints|7|||
129789329|NCT00636363|467195606|FG002|Overall Study|Study related symptoms/complaints|4|||
129789330|NCT00636363|467195604|FG000|Overall Study|Met ineligibility criteria|0|||
129789331|NCT00636363|467195605|FG001|Overall Study|Met ineligibility criteria|0|||
129789332|NCT00636363|467195606|FG002|Overall Study|Met ineligibility criteria|3|||
129789333|NCT00636363|467195604|FG000|Overall Study|Missed > 1 visit|0|||
129789334|NCT00636363|467195605|FG001|Overall Study|Missed > 1 visit|1|||
129789335|NCT00636363|467195606|FG002|Overall Study|Missed > 1 visit|3|||
129789336|NCT00636363|467195604|FG000|Overall Study|Lack of motivation|1|||
129789337|NCT00636363|467195605|FG001|Overall Study|Lack of motivation|0|||
129789338|NCT00636363|467195606|FG002|Overall Study|Lack of motivation|1|||
129789339|NCT00636363|467195604|FG000|Overall Study|Protocol Violation|0|||
129789340|NCT00636363|467195605|FG001|Overall Study|Protocol Violation|3|||
129789341|NCT00636363|467195606|FG002|Overall Study|Protocol Violation|0|||
129789342|NCT00636363|467195604|FG000|Overall Study|Lost to Follow-up|3|||
129789343|NCT00636363|467195605|FG001|Overall Study|Lost to Follow-up|4|||
129789344|NCT00636363|467195606|FG002|Overall Study|Lost to Follow-up|2|||
129789345|NCT00636363|467195604|FG000|Overall Study|Withdrawal by Subject|1|||
129789346|NCT00636363|467195605|FG001|Overall Study|Withdrawal by Subject|3|||
129789347|NCT00636363|467195606|FG002|Overall Study|Withdrawal by Subject|2|||
129436898|NCT01718353|465897216|FG000|Overall Study|Randomized but not treated|2|||
129436899|NCT01718353|465897217|FG001|Overall Study|Randomized but not treated|0|||
129436900|NCT00455325|465897218|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
129697978|NCT00803049|466853426|FG003|Overall Study|Withdrawal by Subject|44|||
129697979|NCT00803049|466853423|FG000|Overall Study|Protocol Violation|0|||
129789348|NCT00796991|467195607|FG000|Overall Study|Adverse Event|0|||
129789349|NCT00796991|467195608|FG001|Overall Study|Adverse Event|0|||
129789350|NCT00796991|467195609|FG002|Overall Study|Adverse Event|1|||
129789351|NCT00796991|467195607|FG000|Overall Study|Death|2|||
129789352|NCT00796991|467195608|FG001|Overall Study|Death|0|||
129789353|NCT00796991|467195609|FG002|Overall Study|Death|0|||
129789354|NCT00796991|467195607|FG000|Overall Study|Disease Progression|10|||
129436901|NCT00455325|465897219|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
129436902|NCT00455325|465897220|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
129436903|NCT00455325|465897221|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
129436904|NCT00455325|465897218|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
129436905|NCT00455325|465897219|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
129436906|NCT00455325|465897220|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
129436907|NCT00455325|465897221|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
129436908|NCT00455325|465897218|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
129436909|NCT00455325|465897219|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
129436910|NCT00455325|465897220|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
129436911|NCT00455325|465897221|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
129436912|NCT00455325|465897218|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
129436913|NCT00455325|465897219|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
129436914|NCT00455325|465897220|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
129436915|NCT00455325|465897221|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
129436916|NCT00455325|465897218|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
129436917|NCT00455325|465897219|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
129436918|NCT00455325|465897220|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
129436919|NCT00455325|465897221|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
129436920|NCT00455325|465897218|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
129436921|NCT00455325|465897219|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
129603573|NCT01229735|466505997|FG000|Overall Study|SAE, non-fatal|0|||
129603574|NCT01229735|466505998|FG001|Overall Study|SAE, non-fatal|4|||
129603575|NCT01229735|466505997|FG000|Overall Study|AE, non-serious non-fatal|13|||
129603576|NCT01229735|466505998|FG001|Overall Study|AE, non-serious non-fatal|17|||
129603577|NCT01229735|466505997|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129603578|NCT01229735|466505998|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129603579|NCT02685202|466505999|FG000|Overall Study|Lost to Follow-up|9|||
129603580|NCT02787408|466506000|FG000|Overall Study|Death|16|||
129603581|NCT02787408|466506000|FG000|Overall Study|Withdrawal by Subject|1|||
129603582|NCT02787408|466506000|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
129603583|NCT00985712|466506001|FG000|Overall Study|Adverse Event|0|||
129603584|NCT00985712|466506002|FG001|Overall Study|Adverse Event|1|||
129789355|NCT00796991|467195608|FG001|Overall Study|Disease Progression|9|||
129789356|NCT00796991|467195609|FG002|Overall Study|Disease Progression|7|||
129789357|NCT00796991|467195607|FG000|Overall Study|Study Drug Toxicity|3|||
129789358|NCT00796991|467195608|FG001|Overall Study|Study Drug Toxicity|3|||
129789359|NCT00796991|467195609|FG002|Overall Study|Study Drug Toxicity|5|||
129789360|NCT00796991|467195607|FG000|Overall Study|Withdrawal by Subject|0|||
129789361|NCT00796991|467195608|FG001|Overall Study|Withdrawal by Subject|0|||
129789362|NCT00796991|467195609|FG002|Overall Study|Withdrawal by Subject|1|||
129789363|NCT00280748|467195611|FG000|Overall Study|Decline in performance|3|||
129789364|NCT00280748|467195611|FG000|Overall Study|Extra-cranial disease progression|1|||
129789365|NCT00029146|467195612|FG000|Overall Study|Lost to Follow-up|2|||
129789366|NCT00029146|467195613|FG001|Overall Study|Lost to Follow-up|1|||
129789367|NCT01433250|467195615|FG000|Overall Study|Protocol Violation|0|||
129789368|NCT01433250|467195616|FG001|Overall Study|Protocol Violation|1|||
129789369|NCT01433250|467195615|FG000|Overall Study|Withdrawal by Subject|3|||
129789370|NCT01433250|467195616|FG001|Overall Study|Withdrawal by Subject|2|||
129789371|NCT00321646|467195620|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
129789372|NCT00321646|467195620|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
129789373|NCT00321646|467195620|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
129789374|NCT02730793|467195621|FG000|Overall Study|Physician Decision|0|||
129789375|NCT02730793|467195622|FG001|Overall Study|Physician Decision|1|||
129789376|NCT02730793|467195621|FG000|Overall Study|Withdrawal by Subject|0|||
129789377|NCT02730793|467195622|FG001|Overall Study|Withdrawal by Subject|1|||
129789378|NCT00534313|467195623|FG000|Short-term Period|Adverse Event|1|||
129789379|NCT00534313|467195624|FG001|Short-term Period|Adverse Event|2|||
129789380|NCT00534313|467195625|FG002|Short-term Period|Adverse Event|1|||
129789381|NCT00534313|467195626|FG003|Short-term Period|Adverse Event|3|||
129789382|NCT00534313|467195623|FG000|Short-term Period|Lack of Efficacy|3|||
129789383|NCT00534313|467195624|FG001|Short-term Period|Lack of Efficacy|4|||
129603585|NCT00985712|466506001|FG000|Overall Study|Lost to Follow-up|2|||
129603586|NCT00985712|466506002|FG001|Overall Study|Lost to Follow-up|2|||
129603587|NCT00985712|466506001|FG000|Overall Study|Protocol Violation|0|||
129789384|NCT00534313|467195625|FG002|Short-term Period|Lack of Efficacy|0|||
129603588|NCT00985712|466506002|FG001|Overall Study|Protocol Violation|1|||
129603589|NCT00985712|466506001|FG000|Overall Study|Withdrawal by Subject|4|||
129789385|NCT00534313|467195626|FG003|Short-term Period|Lack of Efficacy|3|||
129789386|NCT00534313|467195623|FG000|Short-term Period|Participant not meeting study criteria|0|||
129789387|NCT00534313|467195624|FG001|Short-term Period|Participant not meeting study criteria|0|||
129789388|NCT00534313|467195625|FG002|Short-term Period|Participant not meeting study criteria|0|||
129789389|NCT00534313|467195626|FG003|Short-term Period|Participant not meeting study criteria|1|||
129789390|NCT00534313|467195623|FG000|Short-term Period|Participant withdrew consent|2|||
129436922|NCT00455325|465897220|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
129436923|NCT00455325|465897221|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
129436924|NCT00455325|465897218|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
129436925|NCT00455325|465897219|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
129436926|NCT00455325|465897220|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
129603590|NCT00985712|466506002|FG001|Overall Study|Withdrawal by Subject|1|||
129603591|NCT00985712|466506001|FG000|Overall Study|Sponsor decision|0|||
129603592|NCT00985712|466506002|FG001|Overall Study|Sponsor decision|2|||
129603593|NCT01346774|466506003|FG000|Overall Study|Did not take a single dose|6|||
129603594|NCT01346774|466506004|FG001|Overall Study|Did not take a single dose|4|||
129603595|NCT01346774|466506003|FG000|Overall Study|Lost to Follow-up|3|||
129603596|NCT01346774|466506004|FG001|Overall Study|Lost to Follow-up|4|||
129603597|NCT01346774|466506003|FG000|Overall Study|Withdrawal by Subject|1|||
129603598|NCT01346774|466506004|FG001|Overall Study|Withdrawal by Subject|4|||
129603599|NCT01346774|466506003|FG000|Overall Study|Protocol Violation|2|||
129603600|NCT01346774|466506004|FG001|Overall Study|Protocol Violation|3|||
129603601|NCT01346774|466506003|FG000|Overall Study|Adverse Event|1|||
129603602|NCT01346774|466506004|FG001|Overall Study|Adverse Event|2|||
129603603|NCT00321737|466506007|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
129603604|NCT00321737|466506008|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
129603605|NCT00321737|466506009|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
129603606|NCT00321737|466506007|FG000|Overall Study|Adverse Event|11|||
129603607|NCT00321737|466506008|FG001|Overall Study|Adverse Event|3|||
129603608|NCT00321737|466506009|FG002|Overall Study|Adverse Event|6|||
129603609|NCT00321737|466506007|FG000|Overall Study|Lost to Follow-up|5|||
129603610|NCT00321737|466506008|FG001|Overall Study|Lost to Follow-up|5|||
129603611|NCT00321737|466506009|FG002|Overall Study|Lost to Follow-up|6|||
129603612|NCT00321737|466506007|FG000|Overall Study|Withdrawal by Subject|19|||
129603613|NCT00321737|466506008|FG001|Overall Study|Withdrawal by Subject|12|||
129697980|NCT00803049|466853424|FG001|Overall Study|Protocol Violation|1|||
129697981|NCT00803049|466853425|FG002|Overall Study|Protocol Violation|1|||
129697982|NCT00803049|466853426|FG003|Overall Study|Protocol Violation|0|||
129697983|NCT00803049|466853423|FG000|Overall Study|Randomized and Not Treated|0|||
129697984|NCT00803049|466853424|FG001|Overall Study|Randomized and Not Treated|0|||
129697985|NCT00803049|466853425|FG002|Overall Study|Randomized and Not Treated|0|||
129697986|NCT00803049|466853426|FG003|Overall Study|Randomized and Not Treated|2|||
129697987|NCT00803049|466853423|FG000|Overall Study|Other than Specified Above|3|||
129697988|NCT00803049|466853424|FG001|Overall Study|Other than Specified Above|9|||
129697989|NCT00803049|466853425|FG002|Overall Study|Other than Specified Above|2|||
129697990|NCT00803049|466853426|FG003|Overall Study|Other than Specified Above|5|||
129697991|NCT04126174|466853427|FG000|Overall Study|Lost to Follow-up|3|||
129697992|NCT04126174|466853428|FG001|Overall Study|Lost to Follow-up|3|||
129697993|NCT01514422|466853429|FG000|Overall Study|Lost to Follow-up|1|||
129697994|NCT04003142|466853440|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
129697995|NCT04003142|466853441|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
129697996|NCT04003142|466853442|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
129697997|NCT04003142|466853443|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
129697998|NCT04003142|466853444|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
129697999|NCT04003142|466853440|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
129698000|NCT04003142|466853441|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
129698001|NCT04003142|466853442|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
129698002|NCT04003142|466853443|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
129698003|NCT04003142|466853444|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
129698004|NCT04003142|466853440|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
129698005|NCT04003142|466853441|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
129698006|NCT04003142|466853442|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
129698007|NCT04003142|466853443|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
129698008|NCT04003142|466853444|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
129698009|NCT04003142|466853440|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
129698010|NCT04003142|466853441|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
129698011|NCT04003142|466853442|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
129698012|NCT04003142|466853443|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
129698013|NCT04003142|466853444|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
129789391|NCT00534313|467195624|FG001|Short-term Period|Participant withdrew consent|0|||
129789392|NCT00534313|467195625|FG002|Short-term Period|Participant withdrew consent|0|||
129789393|NCT00534313|467195626|FG003|Short-term Period|Participant withdrew consent|2|||
129789394|NCT00534313|467195623|FG000|Short-term Period|Pregnancy|0|||
129789395|NCT00534313|467195624|FG001|Short-term Period|Pregnancy|0|||
129603614|NCT00321737|466506009|FG002|Overall Study|Withdrawal by Subject|17|||
129603615|NCT00321737|466506007|FG000|Overall Study|Protocol Violation|0|||
129603616|NCT00321737|466506008|FG001|Overall Study|Protocol Violation|0|||
129698014|NCT04003142|466853440|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
129698015|NCT04003142|466853441|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
129789396|NCT00534313|467195625|FG002|Short-term Period|Pregnancy|1|||
129886085|NCT02564055|467542852|FG005|Overall Study|Protocol Violation|0|||
129603617|NCT00321737|466506009|FG002|Overall Study|Protocol Violation|1|||
129603618|NCT00321737|466506007|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
129603619|NCT00321737|466506008|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129603620|NCT00321737|466506009|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129603621|NCT00321737|466506007|FG000|Overall Study|Possible Barrett's Esophagus|2|||
129603622|NCT00321737|466506008|FG001|Overall Study|Possible Barrett's Esophagus|1|||
129603623|NCT00321737|466506009|FG002|Overall Study|Possible Barrett's Esophagus|1|||
129603624|NCT00321737|466506007|FG000|Overall Study|Therapeutic Failure|6|||
129603625|NCT00321737|466506008|FG001|Overall Study|Therapeutic Failure|0|||
129603626|NCT00321737|466506009|FG002|Overall Study|Therapeutic Failure|2|||
129603627|NCT00321737|466506007|FG000|Overall Study|Pregnancy|0|||
129603628|NCT00321737|466506008|FG001|Overall Study|Pregnancy|2|||
129603629|NCT00321737|466506009|FG002|Overall Study|Pregnancy|0|||
129603630|NCT00321737|466506007|FG000|Overall Study|Noncompliance|2|||
129603631|NCT00321737|466506008|FG001|Overall Study|Noncompliance|0|||
129603632|NCT00321737|466506009|FG002|Overall Study|Noncompliance|0|||
129603633|NCT00321737|466506007|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
129603634|NCT00321737|466506008|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
129603635|NCT00321737|466506009|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
129603636|NCT01769339|466506010|FG000|Overall Study|Lost to Follow-up|42|||
129603637|NCT01769339|466506010|FG000|Overall Study|Adverse Event|1|||
129603638|NCT00290251|466506011|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129603639|NCT00290251|466506012|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129603640|NCT00290251|466506013|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129603641|NCT00290251|466506014|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129603642|NCT00290251|466506015|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
129603643|NCT00290251|466506016|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
129603644|NCT00290251|466506011|FG000|Treatment 1 (Months 2-4)|headache|0|||
129603645|NCT00290251|466506012|FG001|Treatment 1 (Months 2-4)|headache|0|||
129603646|NCT00290251|466506013|FG002|Treatment 1 (Months 2-4)|headache|0|||
129603647|NCT00290251|466506014|FG003|Treatment 1 (Months 2-4)|headache|0|||
129603648|NCT00290251|466506015|FG004|Treatment 1 (Months 2-4)|headache|1|||
129603649|NCT00290251|466506016|FG005|Treatment 1 (Months 2-4)|headache|0|||
129603650|NCT00290251|466506011|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
129603651|NCT00290251|466506012|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
129603652|NCT00290251|466506013|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
129603653|NCT00290251|466506014|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
129603654|NCT00290251|466506015|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
129603655|NCT00290251|466506016|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
129603656|NCT04062448|466508436|FG000|Overall Study|Lost to Follow-up|1|||
129603657|NCT04062448|466508436|FG000|Overall Study|Withdrawal by Subject|2|||
129603658|NCT05101486|466508437|FG000|Overall Study|Death|1|||
129603659|NCT05101486|466508438|FG001|Overall Study|Death|0|||
129698016|NCT04003142|466853442|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
129698017|NCT04003142|466853443|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
129698018|NCT04003142|466853444|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
129698019|NCT04003142|466853440|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
129698020|NCT04003142|466853441|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
129698021|NCT04003142|466853442|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
129698022|NCT04003142|466853443|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
129698023|NCT04003142|466853444|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
129698024|NCT04003142|466853440|FG000|Extension Period (40 Weeks)|Death|0|||
129698025|NCT04003142|466853441|FG001|Extension Period (40 Weeks)|Death|0|||
129698026|NCT04003142|466853442|FG002|Extension Period (40 Weeks)|Death|0|||
129698027|NCT04003142|466853443|FG003|Extension Period (40 Weeks)|Death|0|||
129698028|NCT04003142|466853444|FG004|Extension Period (40 Weeks)|Death|1|||
129886086|NCT02564055|467542847|FG000|Overall Study|Reached stopping criteria|0|||
129603660|NCT05101486|466508439|FG002|Overall Study|Death|1|||
129603661|NCT05101486|466508437|FG000|Overall Study|Lost to Follow-up|12|||
129603662|NCT05101486|466508438|FG001|Overall Study|Lost to Follow-up|8|||
129603663|NCT05101486|466508439|FG002|Overall Study|Lost to Follow-up|17|||
129603664|NCT05101486|466508437|FG000|Overall Study|Physician Decision|1|||
129698029|NCT04003142|466853440|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
129603665|NCT05101486|466508438|FG001|Overall Study|Physician Decision|0|||
129603666|NCT05101486|466508439|FG002|Overall Study|Physician Decision|0|||
129603667|NCT05101486|466508437|FG000|Overall Study|Protocol Violation|0|||
129603668|NCT05101486|466508438|FG001|Overall Study|Protocol Violation|0|||
129603669|NCT05101486|466508439|FG002|Overall Study|Protocol Violation|1|||
129603670|NCT05101486|466508437|FG000|Overall Study|Withdrawal by Subject|5|||
129603671|NCT05101486|466508438|FG001|Overall Study|Withdrawal by Subject|2|||
129603672|NCT05101486|466508439|FG002|Overall Study|Withdrawal by Subject|4|||
129603673|NCT05101486|466508437|FG000|Overall Study|Randomized but not vaccinated|1|||
129603674|NCT05101486|466508438|FG001|Overall Study|Randomized but not vaccinated|1|||
129603675|NCT05101486|466508439|FG002|Overall Study|Randomized but not vaccinated|1|||
129603676|NCT02788045|466508440|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
129603677|NCT02788045|466508441|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
129603678|NCT02788045|466508442|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
129603679|NCT02788045|466508440|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
129603680|NCT02788045|466508441|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
129603681|NCT02788045|466508442|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
129603682|NCT02788045|466508440|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
129603683|NCT02788045|466508441|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
129603684|NCT02788045|466508442|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
129603685|NCT02788045|466508440|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
129603686|NCT02788045|466508441|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
129603687|NCT02788045|466508442|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
129603688|NCT02788045|466508440|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
129603689|NCT02788045|466508441|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
129603690|NCT02788045|466508442|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
129603691|NCT02788045|466508440|FG000|Main Study (Up to Week 72)|Other|3|||
129603692|NCT02788045|466508441|FG001|Main Study (Up to Week 72)|Other|0|||
129603693|NCT02788045|466508442|FG002|Main Study (Up to Week 72)|Other|0|||
129603694|NCT02788045|466508440|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
129603695|NCT02788045|466508441|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
129603696|NCT02788045|466508442|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
129603697|NCT02788045|466508440|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
129603698|NCT02788045|466508441|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
129603699|NCT02788045|466508442|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
129603700|NCT02788045|466508440|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
129603701|NCT02788045|466508441|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
129603702|NCT02788045|466508442|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
129603703|NCT01183221|466508443|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
129603704|NCT01183221|466508444|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
129603705|NCT00858143|466508450|FG000|Overall Study|Adverse Event|16|||
129603706|NCT00858143|466508450|FG000|Overall Study|Lack of Efficacy|4|||
129603707|NCT00858143|466508450|FG000|Overall Study|Death|7|||
129603708|NCT00858143|466508450|FG000|Overall Study|Other|23|||
129603709|NCT00852969|466508451|FG000|Overall Study|Adverse Event|0|||
129603710|NCT00852969|466508452|FG001|Overall Study|Adverse Event|1|||
129603711|NCT00852969|466508451|FG000|Overall Study|Lost to Follow-up|0|||
129603712|NCT00852969|466508452|FG001|Overall Study|Lost to Follow-up|1|||
129603713|NCT03853148|466508453|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
129603714|NCT03853148|466508454|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
129603715|NCT03853148|466508455|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
129603716|NCT03853148|466508456|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
129603717|NCT00658658|466508459|FG000|Overall Study|Withdrawal by Subject|0|||
129603718|NCT00658658|466508460|FG001|Overall Study|Withdrawal by Subject|1|||
129603719|NCT00658658|466508461|FG002|Overall Study|Withdrawal by Subject|0|||
129603720|NCT00658658|466508462|FG003|Overall Study|Withdrawal by Subject|0|||
129603721|NCT00658658|466508463|FG004|Overall Study|Withdrawal by Subject|0|||
129603722|NCT00658658|466508459|FG000|Overall Study|Death|4|||
129603723|NCT00658658|466508460|FG001|Overall Study|Death|0|||
129603724|NCT00658658|466508461|FG002|Overall Study|Death|0|||
129603725|NCT00658658|466508462|FG003|Overall Study|Death|1|||
129603726|NCT00658658|466508463|FG004|Overall Study|Death|1|||
129603727|NCT00658658|466508459|FG000|Overall Study|Disease Progression|0|||
129603728|NCT00658658|466508460|FG001|Overall Study|Disease Progression|1|||
129603729|NCT00658658|466508461|FG002|Overall Study|Disease Progression|0|||
129603730|NCT00658658|466508462|FG003|Overall Study|Disease Progression|1|||
129603731|NCT00658658|466508463|FG004|Overall Study|Disease Progression|3|||
129603732|NCT00658658|466508459|FG000|Overall Study|Protocol-specified Criteria|1|||
129603733|NCT00658658|466508460|FG001|Overall Study|Protocol-specified Criteria|0|||
129603734|NCT00658658|466508461|FG002|Overall Study|Protocol-specified Criteria|0|||
129603735|NCT00658658|466508462|FG003|Overall Study|Protocol-specified Criteria|0|||
129603736|NCT00658658|466508463|FG004|Overall Study|Protocol-specified Criteria|0|||
129603737|NCT00658658|466508459|FG000|Overall Study|Other|0|||
129603738|NCT00658658|466508460|FG001|Overall Study|Other|0|||
129603739|NCT00658658|466508461|FG002|Overall Study|Other|0|||
129603740|NCT00658658|466508462|FG003|Overall Study|Other|0|||
129603741|NCT00658658|466508463|FG004|Overall Study|Other|1|||
129603742|NCT00678041|466508464|FG000|Overall Study|Physician Decision|5|||
129603743|NCT00678041|466508465|FG001|Overall Study|Physician Decision|5|||
129603744|NCT02358343|466508466|FG000|Screening Intervention|Death|0|||
129603745|NCT02358343|466508467|FG001|Screening Intervention|Death|2|||
129603746|NCT02358343|466508468|FG002|Screening Intervention|Death|0|||
129603747|NCT02358343|466508469|FG003|Screening Intervention|Death|0|||
129603748|NCT02358343|466508470|FG004|Screening Intervention|Death|0|||
129603749|NCT02358343|466508466|FG000|Screening Intervention|Withdrawal by Subject|1|||
129603750|NCT02358343|466508467|FG001|Screening Intervention|Withdrawal by Subject|0|||
129603751|NCT02358343|466508468|FG002|Screening Intervention|Withdrawal by Subject|0|||
129603752|NCT02358343|466508469|FG003|Screening Intervention|Withdrawal by Subject|0|||
129603753|NCT02358343|466508470|FG004|Screening Intervention|Withdrawal by Subject|0|||
129603754|NCT02358343|466508466|FG000|Screening Intervention|Determined Ineligible|5|||
129603755|NCT02358343|466508467|FG001|Screening Intervention|Determined Ineligible|6|||
129603756|NCT02358343|466508468|FG002|Screening Intervention|Determined Ineligible|0|||
129603757|NCT02358343|466508469|FG003|Screening Intervention|Determined Ineligible|0|||
129603758|NCT02358343|466508470|FG004|Screening Intervention|Determined Ineligible|0|||
129603759|NCT02358343|466508466|FG000|Comparative Efficacy Trial / Observation|Death|0|||
129603760|NCT02358343|466508467|FG001|Comparative Efficacy Trial / Observation|Death|0|||
129603761|NCT02358343|466508468|FG002|Comparative Efficacy Trial / Observation|Death|2|||
129603762|NCT02358343|466508469|FG003|Comparative Efficacy Trial / Observation|Death|0|||
129603763|NCT02358343|466508470|FG004|Comparative Efficacy Trial / Observation|Death|0|||
129603764|NCT02358343|466508466|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
129603765|NCT02358343|466508467|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
129603766|NCT02358343|466508468|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
129603767|NCT02358343|466508469|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
129603768|NCT02358343|466508470|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
129603769|NCT02358343|466508466|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129603770|NCT02358343|466508467|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129603771|NCT02358343|466508468|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
129603772|NCT02358343|466508469|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129603773|NCT02358343|466508470|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
129603774|NCT00090610|466508473|FG000|Overall Study|Withdrawal by Subject|1|||
129603775|NCT00090610|466508474|FG001|Overall Study|Withdrawal by Subject|1|||
129603776|NCT00807248|466508475|FG000|Overall Study|Adverse Event|1|||
129603777|NCT00807248|466508476|FG001|Overall Study|Adverse Event|2|||
129603778|NCT00807248|466508477|FG002|Overall Study|Adverse Event|2|||
129603779|NCT00807248|466508478|FG003|Overall Study|Adverse Event|6|||
129603780|NCT00807248|466508475|FG000|Overall Study|Lack of Efficacy|14|||
129603781|NCT00807248|466508476|FG001|Overall Study|Lack of Efficacy|4|||
129603782|NCT00807248|466508477|FG002|Overall Study|Lack of Efficacy|8|||
129603783|NCT00807248|466508478|FG003|Overall Study|Lack of Efficacy|3|||
129603784|NCT00807248|466508475|FG000|Overall Study|Protocol Violation|0|||
129603785|NCT00807248|466508476|FG001|Overall Study|Protocol Violation|1|||
129603786|NCT00807248|466508477|FG002|Overall Study|Protocol Violation|1|||
129603787|NCT00807248|466508478|FG003|Overall Study|Protocol Violation|0|||
129603788|NCT00807248|466508475|FG000|Overall Study|Withdrawal of Consent|5|||
129603789|NCT00807248|466508476|FG001|Overall Study|Withdrawal of Consent|5|||
129603790|NCT00807248|466508477|FG002|Overall Study|Withdrawal of Consent|5|||
129603791|NCT00807248|466508478|FG003|Overall Study|Withdrawal of Consent|5|||
129603792|NCT00807248|466508475|FG000|Overall Study|Lost to Follow-up|1|||
129603793|NCT00807248|466508476|FG001|Overall Study|Lost to Follow-up|0|||
129603794|NCT00807248|466508477|FG002|Overall Study|Lost to Follow-up|0|||
129603795|NCT00807248|466508478|FG003|Overall Study|Lost to Follow-up|0|||
129603796|NCT00807248|466508475|FG000|Overall Study|Other Reason|0|||
129603797|NCT00807248|466508476|FG001|Overall Study|Other Reason|0|||
129603798|NCT00807248|466508477|FG002|Overall Study|Other Reason|2|||
129789397|NCT00534313|467195626|FG003|Short-term Period|Pregnancy|0|||
129789398|NCT00534313|467195623|FG000|Long-term Period|Adverse Event|2|||
129789399|NCT00534313|467195624|FG001|Long-term Period|Adverse Event|1|||
129789400|NCT00534313|467195625|FG002|Long-term Period|Adverse Event|0|||
129603799|NCT00807248|466508478|FG003|Overall Study|Other Reason|0|||
129603800|NCT02504671|466508479|FG000|Overall Study|Withdrawal by Subject|1|||
129603801|NCT02504671|466508480|FG001|Overall Study|Withdrawal by Subject|5|||
129603802|NCT02504671|466508481|FG002|Overall Study|Withdrawal by Subject|4|||
129603803|NCT02504671|466508482|FG003|Overall Study|Withdrawal by Subject|4|||
129603804|NCT02504671|466508483|FG004|Overall Study|Withdrawal by Subject|5|||
129789401|NCT00534313|467195626|FG003|Long-term Period|Adverse Event|1|||
129603805|NCT02504671|466508484|FG005|Overall Study|Withdrawal by Subject|3|||
129603806|NCT02504671|466508479|FG000|Overall Study|Lack of Efficacy|1|||
129603807|NCT02504671|466508480|FG001|Overall Study|Lack of Efficacy|3|||
129603808|NCT02504671|466508481|FG002|Overall Study|Lack of Efficacy|1|||
129603809|NCT02504671|466508482|FG003|Overall Study|Lack of Efficacy|0|||
129603810|NCT02504671|466508483|FG004|Overall Study|Lack of Efficacy|4|||
129603811|NCT02504671|466508484|FG005|Overall Study|Lack of Efficacy|4|||
129603812|NCT02504671|466508479|FG000|Overall Study|Adverse Event|1|||
129603813|NCT02504671|466508480|FG001|Overall Study|Adverse Event|1|||
129603814|NCT02504671|466508481|FG002|Overall Study|Adverse Event|0|||
129603815|NCT02504671|466508482|FG003|Overall Study|Adverse Event|1|||
129603816|NCT02504671|466508483|FG004|Overall Study|Adverse Event|0|||
129603817|NCT02504671|466508484|FG005|Overall Study|Adverse Event|2|||
129603818|NCT02504671|466508479|FG000|Overall Study|Protocol Violation|2|||
129603819|NCT02504671|466508480|FG001|Overall Study|Protocol Violation|1|||
129603820|NCT02504671|466508481|FG002|Overall Study|Protocol Violation|0|||
129603821|NCT02504671|466508482|FG003|Overall Study|Protocol Violation|0|||
129603822|NCT02504671|466508483|FG004|Overall Study|Protocol Violation|0|||
129603823|NCT02504671|466508484|FG005|Overall Study|Protocol Violation|1|||
129603824|NCT02504671|466508479|FG000|Overall Study|Lost to Follow-up|0|||
129603825|NCT02504671|466508480|FG001|Overall Study|Lost to Follow-up|0|||
129603826|NCT02504671|466508481|FG002|Overall Study|Lost to Follow-up|2|||
129603827|NCT02504671|466508482|FG003|Overall Study|Lost to Follow-up|0|||
129603828|NCT02504671|466508483|FG004|Overall Study|Lost to Follow-up|0|||
129603829|NCT02504671|466508484|FG005|Overall Study|Lost to Follow-up|1|||
129603830|NCT02504671|466508479|FG000|Overall Study|Protocol defined stopping criteria|7|||
129603831|NCT02504671|466508480|FG001|Overall Study|Protocol defined stopping criteria|4|||
129603832|NCT02504671|466508481|FG002|Overall Study|Protocol defined stopping criteria|3|||
129603833|NCT02504671|466508482|FG003|Overall Study|Protocol defined stopping criteria|5|||
129603834|NCT02504671|466508483|FG004|Overall Study|Protocol defined stopping criteria|3|||
129603835|NCT02504671|466508484|FG005|Overall Study|Protocol defined stopping criteria|3|||
129603836|NCT00210249|466508485|FG000|Overall Study|Lost to Follow-up|5|||
129603837|NCT00210249|466508485|FG000|Overall Study|Protocol Violation|11|||
129603838|NCT02518919|466508486|FG000|Overall Study|Protocol Violation|1|||
129603839|NCT02518919|466508487|FG001|Overall Study|Protocol Violation|1|||
129603840|NCT02518919|466508488|FG002|Overall Study|Protocol Violation|2|||
129603841|NCT01700049|466508492|FG000|Overall Study|Withdrawal by Subject|1|||
129603842|NCT01248013|466508493|FG000|Overall Study|Withdrawal by Subject|14|||
129603843|NCT01859130|466508494|FG000|Overall Study|Death|4|||
129603844|NCT01859130|466508494|FG000|Overall Study|Lost to Follow-up|16|||
129603845|NCT01859130|466508494|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
129603846|NCT01859130|466508494|FG000|Overall Study|Physician Decision|6|||
129603847|NCT01859130|466508494|FG000|Overall Study|Withdrawal by Subject|17|||
129603848|NCT01859130|466508494|FG000|Overall Study|Adverse Event|11|||
129603849|NCT00307034|466508495|FG000|Overall Study|Adverse Event|1|||
129603850|NCT00307034|466508496|FG001|Overall Study|Adverse Event|2|||
129603851|NCT00307034|466508495|FG000|Overall Study|Withdrawal by Subject|1|||
129603852|NCT00307034|466508496|FG001|Overall Study|Withdrawal by Subject|2|||
129603853|NCT00307034|466508495|FG000|Overall Study|Lost to Follow-up|0|||
129603854|NCT00307034|466508496|FG001|Overall Study|Lost to Follow-up|3|||
129603855|NCT04442490|466508501|FG000|Overall Study|Withdrawal by Subject|18|||
129603856|NCT04442490|466508502|FG001|Overall Study|Withdrawal by Subject|10|||
129603857|NCT04442490|466508501|FG000|Overall Study|Lost to Follow-up|7|||
129603858|NCT04442490|466508502|FG001|Overall Study|Lost to Follow-up|7|||
129603859|NCT04442490|466508501|FG000|Overall Study|Adverse Event|2|||
129603860|NCT04442490|466508502|FG001|Overall Study|Adverse Event|6|||
129603861|NCT04442490|466508501|FG000|Overall Study|Noncompliance|3|||
129789402|NCT00534313|467195623|FG000|Long-term Period|Lack of Efficacy|14|||
129789403|NCT00534313|467195624|FG001|Long-term Period|Lack of Efficacy|10|||
129789404|NCT00534313|467195625|FG002|Long-term Period|Lack of Efficacy|14|||
129789405|NCT00534313|467195626|FG003|Long-term Period|Lack of Efficacy|12|||
129436927|NCT00455325|465897221|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
129436928|NCT02745392|465897230|FG000|Overall Study|Lost to Follow-up|0|||
129603862|NCT04442490|466508502|FG001|Overall Study|Noncompliance|1|||
129603863|NCT04442490|466508501|FG000|Overall Study|Physician Decision|2|||
129603864|NCT04442490|466508502|FG001|Overall Study|Physician Decision|1|||
129603865|NCT04442490|466508501|FG000|Overall Study|Reason not Specified|2|||
129603866|NCT04442490|466508502|FG001|Overall Study|Reason not Specified|1|||
129603867|NCT04442490|466508501|FG000|Overall Study|Randomized but not Treated|3|||
129603868|NCT04442490|466508502|FG001|Overall Study|Randomized but not Treated|3|||
129603869|NCT02227147|466508503|FG000|Controlled Treatment Period|Adverse Event|4|||
129603870|NCT02227147|466508504|FG001|Controlled Treatment Period|Adverse Event|3|||
129603871|NCT02227147|466508503|FG000|Controlled Treatment Period|Other|2|||
129603872|NCT02227147|466508504|FG001|Controlled Treatment Period|Other|0|||
129603873|NCT02227147|466508503|FG000|Follow-up Period|Other|3|||
129603874|NCT02227147|466508504|FG001|Follow-up Period|Other|5|||
129603875|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
129647488|NCT03729570|466665336|FG000|Overall Study|Time Commitment|2|||
129789406|NCT00534313|467195623|FG000|Long-term Period|Lost to Follow-up|1|||
129789407|NCT00534313|467195624|FG001|Long-term Period|Lost to Follow-up|2|||
129789408|NCT00534313|467195625|FG002|Long-term Period|Lost to Follow-up|0|||
129603876|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
129603877|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
129603878|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
129603879|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
129603880|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
129603881|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
129603882|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
129603883|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
129603884|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
129603885|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
129603886|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
129603887|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
129603888|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
129603889|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
129603890|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
129603891|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
129603892|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
129603893|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
129603894|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
129603895|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
129603896|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
129603897|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
129603898|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
129603899|NCT03514641|466508505|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
129603900|NCT03514641|466508506|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
129603901|NCT03514641|466508507|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
129603902|NCT03514641|466508508|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
129603903|NCT03514641|466508505|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
129603904|NCT03514641|466508506|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
129603905|NCT03514641|466508507|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
129603906|NCT03514641|466508508|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
129603907|NCT03514641|466508505|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
129603908|NCT03514641|466508506|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
129603909|NCT03514641|466508507|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
129603910|NCT03514641|466508508|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
129603911|NCT03514641|466508505|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
129603912|NCT03514641|466508506|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
129603913|NCT03514641|466508507|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
129603914|NCT03514641|466508508|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
129603915|NCT03514641|466508505|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
129603916|NCT03514641|466508506|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
129603917|NCT03514641|466508507|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
129603918|NCT03514641|466508508|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
129603919|NCT03514641|466508505|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
129603920|NCT03514641|466508506|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
129603921|NCT03514641|466508507|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
129603922|NCT03514641|466508508|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
129603923|NCT01449279|466508509|FG000|Overall Study|Lack of Efficacy|5|||
129603924|NCT01449279|466508509|FG000|Overall Study|Toxicity|2|||
129603925|NCT04234984|466508510|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
129603926|NCT04234984|466508510|FG000|Follow-up at the Second Time Point|Death|1|||
129603927|NCT04234984|466508510|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
129603928|NCT01055132|466508511|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
129603929|NCT01055132|466508512|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
129603930|NCT01055132|466508511|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
129603931|NCT01055132|466508512|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
129603932|NCT02038907|466508513|FG000|Overall Study|Protocol Violation|0|||
129603933|NCT02038907|466508514|FG001|Overall Study|Protocol Violation|0|||
129789409|NCT00534313|467195626|FG003|Long-term Period|Lost to Follow-up|0|||
129789410|NCT00534313|467195623|FG000|Long-term Period|Withdrawal by Subject|2|||
129436929|NCT02745392|465897231|FG001|Overall Study|Lost to Follow-up|1|||
129603934|NCT02038907|466508515|FG002|Overall Study|Protocol Violation|0|||
129603935|NCT02038907|466508516|FG003|Overall Study|Protocol Violation|0|||
129603936|NCT02038907|466508517|FG004|Overall Study|Protocol Violation|0|||
129603937|NCT02038907|466508518|FG005|Overall Study|Protocol Violation|0|||
129603938|NCT02038907|466508519|FG006|Overall Study|Protocol Violation|0|||
129436930|NCT02745392|465897232|FG002|Overall Study|Lost to Follow-up|0|||
129603939|NCT02038907|466508520|FG007|Overall Study|Protocol Violation|0|||
129603940|NCT02038907|466508521|FG008|Overall Study|Protocol Violation|0|||
129603941|NCT02038907|466508522|FG009|Overall Study|Protocol Violation|0|||
129603942|NCT02038907|466508523|FG010|Overall Study|Protocol Violation|1|||
129603943|NCT02038907|466508524|FG011|Overall Study|Protocol Violation|0|||
129603944|NCT02038907|466508525|FG012|Overall Study|Protocol Violation|0|||
129603945|NCT02038907|466508526|FG013|Overall Study|Protocol Violation|0|||
129603946|NCT02038907|466508513|FG000|Overall Study|Withdrawal by Subject|0|||
129603947|NCT02038907|466508514|FG001|Overall Study|Withdrawal by Subject|0|||
129603948|NCT02038907|466508515|FG002|Overall Study|Withdrawal by Subject|0|||
129603949|NCT02038907|466508516|FG003|Overall Study|Withdrawal by Subject|0|||
129603950|NCT02038907|466508517|FG004|Overall Study|Withdrawal by Subject|0|||
129603951|NCT02038907|466508518|FG005|Overall Study|Withdrawal by Subject|0|||
129603952|NCT02038907|466508519|FG006|Overall Study|Withdrawal by Subject|0|||
129603953|NCT02038907|466508520|FG007|Overall Study|Withdrawal by Subject|0|||
129603954|NCT02038907|466508521|FG008|Overall Study|Withdrawal by Subject|0|||
129603955|NCT02038907|466508522|FG009|Overall Study|Withdrawal by Subject|0|||
129603956|NCT02038907|466508523|FG010|Overall Study|Withdrawal by Subject|1|||
129603957|NCT02038907|466508524|FG011|Overall Study|Withdrawal by Subject|0|||
129603958|NCT02038907|466508525|FG012|Overall Study|Withdrawal by Subject|0|||
129603959|NCT02038907|466508526|FG013|Overall Study|Withdrawal by Subject|0|||
129603960|NCT01156142|466508530|FG000|Overall Study|Withdrawal by Subject|8|||
129603961|NCT01156142|466508531|FG001|Overall Study|Withdrawal by Subject|6|||
129603962|NCT01156142|466508530|FG000|Overall Study|Ineligible|0|||
129603963|NCT01156142|466508531|FG001|Overall Study|Ineligible|1|||
129603964|NCT00893737|466508532|FG000|Overall Study|Adverse Event|4|||
129603965|NCT00893737|466508532|FG000|Overall Study|Withdrawal by Subject|2|||
129603966|NCT00893737|466508532|FG000|Overall Study|Lost to Follow-up|6|||
129603967|NCT02140411|466508533|FG000|Overall Study|Adverse Event|1|||
129603968|NCT03981419|466508536|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
129603969|NCT03981419|466508537|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
129603970|NCT01330459|466508538|FG000|Overall Study|Physician Decision|0|||
129603971|NCT01330459|466508539|FG001|Overall Study|Physician Decision|2|||
129603972|NCT01359644|466508553|FG000|Treatment Period|Lack of Efficacy|0|||
129603973|NCT01359644|466508554|FG001|Treatment Period|Lack of Efficacy|1|||
129603974|NCT01359644|466508555|FG002|Treatment Period|Lack of Efficacy|0|||
129603975|NCT01359644|466508556|FG003|Treatment Period|Lack of Efficacy|0|||
129603976|NCT01359644|466508557|FG004|Treatment Period|Lack of Efficacy|0|||
129603977|NCT01359644|466508558|FG005|Treatment Period|Lack of Efficacy|0|||
129603978|NCT01359644|466508559|FG006|Treatment Period|Lack of Efficacy|0|||
129603979|NCT01359644|466508560|FG007|Treatment Period|Lack of Efficacy|0|||
129603980|NCT01359644|466508561|FG008|Treatment Period|Lack of Efficacy|0|||
129603981|NCT01359644|466508562|FG009|Treatment Period|Lack of Efficacy|0|||
129603982|NCT01359644|466508553|FG000|Treatment Period|Adverse Event|0|||
129603983|NCT01359644|466508554|FG001|Treatment Period|Adverse Event|0|||
129603984|NCT01359644|466508555|FG002|Treatment Period|Adverse Event|1|||
129603985|NCT01359644|466508556|FG003|Treatment Period|Adverse Event|0|||
129603986|NCT01359644|466508557|FG004|Treatment Period|Adverse Event|0|||
129603987|NCT01359644|466508558|FG005|Treatment Period|Adverse Event|1|||
129603988|NCT01359644|466508559|FG006|Treatment Period|Adverse Event|0|||
129603989|NCT01359644|466508560|FG007|Treatment Period|Adverse Event|0|||
129603990|NCT01359644|466508561|FG008|Treatment Period|Adverse Event|0|||
129603991|NCT01359644|466508562|FG009|Treatment Period|Adverse Event|0|||
129603992|NCT01359644|466508553|FG000|Treatment Period|Lost to Follow-up|0|||
129603993|NCT01359644|466508554|FG001|Treatment Period|Lost to Follow-up|0|||
129603994|NCT01359644|466508555|FG002|Treatment Period|Lost to Follow-up|0|||
129603995|NCT01359644|466508556|FG003|Treatment Period|Lost to Follow-up|0|||
129603996|NCT01359644|466508557|FG004|Treatment Period|Lost to Follow-up|0|||
129603997|NCT01359644|466508558|FG005|Treatment Period|Lost to Follow-up|1|||
129603998|NCT01359644|466508559|FG006|Treatment Period|Lost to Follow-up|0|||
129603999|NCT01359644|466508560|FG007|Treatment Period|Lost to Follow-up|0|||
129604000|NCT01359644|466508561|FG008|Treatment Period|Lost to Follow-up|0|||
129604001|NCT01359644|466508562|FG009|Treatment Period|Lost to Follow-up|0|||
129604002|NCT01359644|466508553|FG000|Follow-up Period|Withdrawal by Subject|0|||
129604003|NCT01359644|466508554|FG001|Follow-up Period|Withdrawal by Subject|0|||
129604004|NCT01359644|466508555|FG002|Follow-up Period|Withdrawal by Subject|0|||
129604005|NCT01359644|466508556|FG003|Follow-up Period|Withdrawal by Subject|0|||
129604006|NCT01359644|466508557|FG004|Follow-up Period|Withdrawal by Subject|0|||
129604007|NCT01359644|466508558|FG005|Follow-up Period|Withdrawal by Subject|1|||
129604008|NCT01359644|466508559|FG006|Follow-up Period|Withdrawal by Subject|0|||
129436931|NCT02745392|465897233|FG003|Overall Study|Lost to Follow-up|0|||
129604009|NCT01359644|466508560|FG007|Follow-up Period|Withdrawal by Subject|0|||
129604010|NCT01359644|466508561|FG008|Follow-up Period|Withdrawal by Subject|0|||
129604011|NCT01359644|466508562|FG009|Follow-up Period|Withdrawal by Subject|0|||
129604012|NCT01359644|466508553|FG000|Follow-up Period|Lost to Follow-up|0|||
129604013|NCT01359644|466508554|FG001|Follow-up Period|Lost to Follow-up|0|||
129604014|NCT01359644|466508555|FG002|Follow-up Period|Lost to Follow-up|0|||
129604015|NCT01359644|466508556|FG003|Follow-up Period|Lost to Follow-up|0|||
129604016|NCT01359644|466508557|FG004|Follow-up Period|Lost to Follow-up|0|||
129604017|NCT01359644|466508558|FG005|Follow-up Period|Lost to Follow-up|0|||
129604018|NCT01359644|466508559|FG006|Follow-up Period|Lost to Follow-up|1|||
129604019|NCT01359644|466508560|FG007|Follow-up Period|Lost to Follow-up|2|||
129604020|NCT01359644|466508561|FG008|Follow-up Period|Lost to Follow-up|0|||
129604021|NCT01359644|466508562|FG009|Follow-up Period|Lost to Follow-up|0|||
129604022|NCT02130882|466508563|FG000|Overall Study|Withdrawal by Subject|0|||
129604023|NCT02130882|466508564|FG001|Overall Study|Withdrawal by Subject|1|||
129604024|NCT01355159|466508575|FG000|Overall Study|Withdrew consent|39|||
129604025|NCT01355159|466508576|FG001|Overall Study|Withdrew consent|47|||
129604026|NCT01355159|466508575|FG000|Overall Study|No primary outcome data|17|||
129604027|NCT01355159|466508576|FG001|Overall Study|No primary outcome data|11|||
129604028|NCT01355159|466508575|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
129604029|NCT01355159|466508576|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
129604030|NCT01355159|466508575|FG000|Overall Study|Early intrauterine fetal death|6|||
129604031|NCT01355159|466508576|FG001|Overall Study|Early intrauterine fetal death|6|||
129604032|NCT01194973|466508577|FG000|Screening Period|Screen Failure|3|||
129604033|NCT01194973|466508577|FG000|26 Week Treatment Period|Adverse Event|1|||
129604034|NCT01194973|466508577|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
129604035|NCT01194973|466508577|FG000|26 Week Treatment Period|Pregnancy|1|||
129604036|NCT00359632|466508580|FG000|Overall Study|Death|2|||
129604037|NCT00359632|466508581|FG001|Overall Study|Death|0|||
129604038|NCT00359632|466508580|FG000|Overall Study|Adverse Event|1|||
129604039|NCT00359632|466508581|FG001|Overall Study|Adverse Event|0|||
129604040|NCT00359632|466508580|FG000|Overall Study|Non-compliance with visit schedule|1|||
129604041|NCT00359632|466508581|FG001|Overall Study|Non-compliance with visit schedule|0|||
129604042|NCT04700280|466508582|FG000|Overall Study|Adverse Event|4|||
129604043|NCT04700280|466508583|FG001|Overall Study|Adverse Event|0|||
129604044|NCT04700280|466508582|FG000|Overall Study|Lack of Efficacy|1|||
129604045|NCT04700280|466508583|FG001|Overall Study|Lack of Efficacy|0|||
129604046|NCT04700280|466508582|FG000|Overall Study|Study terminated by sponsor|5|||
129604047|NCT04700280|466508583|FG001|Overall Study|Study terminated by sponsor|3|||
129604048|NCT04700280|466508582|FG000|Overall Study|Other than specified|1|||
129604049|NCT04700280|466508583|FG001|Overall Study|Other than specified|0|||
129604050|NCT02615171|466508584|FG000|Overall Study|Lost to Follow-up|2|||
129604051|NCT02615171|466508585|FG001|Overall Study|Lost to Follow-up|1|||
129604052|NCT01000493|466508593|FG000|Overall Study|Adverse Event|3|||
129604053|NCT01000493|466508594|FG001|Overall Study|Adverse Event|6|||
129604054|NCT01000493|466508593|FG000|Overall Study|Lack of Efficacy|1|||
129604055|NCT01000493|466508594|FG001|Overall Study|Lack of Efficacy|1|||
129604056|NCT01000493|466508593|FG000|Overall Study|Protocol Violation|1|||
129604057|NCT01000493|466508594|FG001|Overall Study|Protocol Violation|8|||
129604058|NCT01000493|466508593|FG000|Overall Study|Study closed/terminated|25|||
129604059|NCT01000493|466508594|FG001|Overall Study|Study closed/terminated|23|||
129604060|NCT01000493|466508593|FG000|Overall Study|Lost to Follow-up|5|||
129604061|NCT01000493|466508594|FG001|Overall Study|Lost to Follow-up|9|||
129604062|NCT01000493|466508593|FG000|Overall Study|Physician Decision|1|||
129604063|NCT01000493|466508594|FG001|Overall Study|Physician Decision|1|||
129604064|NCT01000493|466508593|FG000|Overall Study|Withdrawal by Subject|3|||
129604065|NCT01000493|466508594|FG001|Overall Study|Withdrawal by Subject|7|||
129604066|NCT00502801|466508595|FG000|Treatment Period|Withdrawal by Subject|3|||
129604067|NCT00502801|466508595|FG000|Treatment Period|Adverse Event|7|||
129604068|NCT00502801|466508595|FG000|Treatment Period|Death|14|||
129604069|NCT00502801|466508595|FG000|Treatment Period|OTHER|30|||
129604070|NCT00502801|466508595|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
129604071|NCT00502801|466508595|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
129604072|NCT00502801|466508595|FG000|End of Therapy to Test of Cure|Death|3|||
129604073|NCT00502801|466508595|FG000|End of Therapy to Test of Cure|OTHER|2|||
129604074|NCT00444457|466508601|FG000|Infant Series|Other|0|||
129604075|NCT00444457|466508602|FG001|Infant Series|Other|1|||
129604076|NCT00444457|466508603|FG002|Infant Series|Other|0|||
129604077|NCT00444457|466508604|FG003|Infant Series|Other|0|||
129604078|NCT00444457|466508601|FG000|Infant Series|Parent or legal guardian request|18|||
129604079|NCT00444457|466508602|FG001|Infant Series|Parent or legal guardian request|29|||
129604080|NCT00444457|466508603|FG002|Infant Series|Parent or legal guardian request|34|||
129698030|NCT04003142|466853441|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
129698031|NCT04003142|466853442|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
129698032|NCT04003142|466853443|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
129698033|NCT04003142|466853444|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
129698034|NCT04003142|466853440|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
129698035|NCT04003142|466853441|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
129698036|NCT04003142|466853442|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
129436932|NCT01691768|465897234|FG000|Overall Study|Death|0|||
129604081|NCT00444457|466508604|FG003|Infant Series|Parent or legal guardian request|14|||
129604082|NCT00444457|466508601|FG000|Infant Series|Lost to Follow-up|10|||
129604083|NCT00444457|466508602|FG001|Infant Series|Lost to Follow-up|11|||
129604084|NCT00444457|466508603|FG002|Infant Series|Lost to Follow-up|7|||
129604085|NCT00444457|466508604|FG003|Infant Series|Lost to Follow-up|6|||
129604086|NCT00444457|466508601|FG000|Infant Series|Protocol Violation|16|||
129604087|NCT00444457|466508602|FG001|Infant Series|Protocol Violation|8|||
129604088|NCT00444457|466508603|FG002|Infant Series|Protocol Violation|6|||
129604089|NCT00444457|466508604|FG003|Infant Series|Protocol Violation|3|||
129604090|NCT00444457|466508601|FG000|Infant Series|Failed to return|5|||
129604091|NCT00444457|466508602|FG001|Infant Series|Failed to return|4|||
129604092|NCT00444457|466508603|FG002|Infant Series|Failed to return|4|||
129604093|NCT00444457|466508604|FG003|Infant Series|Failed to return|2|||
129604094|NCT00444457|466508601|FG000|Infant Series|Investigator request|4|||
129604095|NCT00444457|466508602|FG001|Infant Series|Investigator request|3|||
129604096|NCT00444457|466508603|FG002|Infant Series|Investigator request|3|||
129604097|NCT00444457|466508604|FG003|Infant Series|Investigator request|2|||
129604098|NCT00444457|466508601|FG000|Infant Series|Other|0|||
129604099|NCT00444457|466508602|FG001|Infant Series|Other|2|||
129604100|NCT00444457|466508603|FG002|Infant Series|Other|4|||
129604101|NCT00444457|466508604|FG003|Infant Series|Other|0|||
129604102|NCT00444457|466508601|FG000|Infant Series|Adverse Event|1|||
129604103|NCT00444457|466508602|FG001|Infant Series|Adverse Event|2|||
129604104|NCT00444457|466508603|FG002|Infant Series|Adverse Event|2|||
129604105|NCT00444457|466508604|FG003|Infant Series|Adverse Event|0|||
129604106|NCT00444457|466508601|FG000|Infant Series|Death|0|||
129604107|NCT00444457|466508602|FG001|Infant Series|Death|1|||
129604108|NCT00444457|466508603|FG002|Infant Series|Death|1|||
129604109|NCT00444457|466508604|FG003|Infant Series|Death|1|||
129604110|NCT00444457|466508601|FG000|After Infant Series|Other|0|||
129604111|NCT00444457|466508602|FG001|After Infant Series|Other|1|||
129604112|NCT00444457|466508603|FG002|After Infant Series|Other|1|||
129604113|NCT00444457|466508604|FG003|After Infant Series|Other|1|||
129604114|NCT00444457|466508601|FG000|After Infant Series|Parent or legal guardian request|4|||
129604115|NCT00444457|466508602|FG001|After Infant Series|Parent or legal guardian request|11|||
129604116|NCT00444457|466508603|FG002|After Infant Series|Parent or legal guardian request|6|||
129604117|NCT00444457|466508604|FG003|After Infant Series|Parent or legal guardian request|3|||
129604118|NCT00444457|466508601|FG000|After Infant Series|Failed to return|7|||
129604119|NCT00444457|466508602|FG001|After Infant Series|Failed to return|6|||
129604120|NCT00444457|466508603|FG002|After Infant Series|Failed to return|5|||
129604121|NCT00444457|466508604|FG003|After Infant Series|Failed to return|1|||
129604122|NCT00444457|466508601|FG000|After Infant Series|Lost to Follow-up|5|||
129604123|NCT00444457|466508602|FG001|After Infant Series|Lost to Follow-up|5|||
129604124|NCT00444457|466508603|FG002|After Infant Series|Lost to Follow-up|5|||
129604125|NCT00444457|466508604|FG003|After Infant Series|Lost to Follow-up|2|||
129604126|NCT00444457|466508601|FG000|After Infant Series|Protocol Violation|2|||
129604127|NCT00444457|466508602|FG001|After Infant Series|Protocol Violation|4|||
129604128|NCT00444457|466508603|FG002|After Infant Series|Protocol Violation|2|||
129604129|NCT00444457|466508604|FG003|After Infant Series|Protocol Violation|2|||
129604130|NCT00444457|466508601|FG000|After Infant Series|Adverse Event|2|||
129604131|NCT00444457|466508602|FG001|After Infant Series|Adverse Event|2|||
129604132|NCT00444457|466508603|FG002|After Infant Series|Adverse Event|0|||
129604133|NCT00444457|466508604|FG003|After Infant Series|Adverse Event|0|||
129604134|NCT00444457|466508601|FG000|After Infant Series|Investigator request|0|||
129604135|NCT00444457|466508602|FG001|After Infant Series|Investigator request|0|||
129604136|NCT00444457|466508603|FG002|After Infant Series|Investigator request|0|||
129604137|NCT00444457|466508604|FG003|After Infant Series|Investigator request|1|||
129604138|NCT00444457|466508601|FG000|After Infant Series|Other|0|||
129604139|NCT00444457|466508602|FG001|After Infant Series|Other|1|||
129604140|NCT00444457|466508603|FG002|After Infant Series|Other|0|||
129604141|NCT00444457|466508604|FG003|After Infant Series|Other|0|||
129604142|NCT00444457|466508601|FG000|Toddler Dose|Lost to Follow-up|4|||
129604143|NCT00444457|466508602|FG001|Toddler Dose|Lost to Follow-up|1|||
129604144|NCT00444457|466508603|FG002|Toddler Dose|Lost to Follow-up|1|||
129604145|NCT00444457|466508604|FG003|Toddler Dose|Lost to Follow-up|3|||
129604146|NCT00444457|466508601|FG000|Toddler Dose|Failed to return|2|||
129604147|NCT00444457|466508602|FG001|Toddler Dose|Failed to return|2|||
129604148|NCT00444457|466508603|FG002|Toddler Dose|Failed to return|1|||
129604149|NCT00444457|466508604|FG003|Toddler Dose|Failed to return|3|||
129604150|NCT00444457|466508601|FG000|Toddler Dose|Parent or legal guardian request|0|||
129604151|NCT00444457|466508602|FG001|Toddler Dose|Parent or legal guardian request|3|||
129604152|NCT00444457|466508603|FG002|Toddler Dose|Parent or legal guardian request|2|||
129604153|NCT00444457|466508604|FG003|Toddler Dose|Parent or legal guardian request|1|||
129698037|NCT04003142|466853443|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
129604154|NCT00444457|466508601|FG000|Toddler Dose|Protocol Violation|1|||
129604155|NCT00444457|466508602|FG001|Toddler Dose|Protocol Violation|0|||
129604156|NCT00444457|466508603|FG002|Toddler Dose|Protocol Violation|0|||
129604157|NCT00444457|466508604|FG003|Toddler Dose|Protocol Violation|1|||
129604158|NCT01121666|466508607|FG000|Overall Study|Protocol Violation|29|||
129604159|NCT01121666|466508608|FG001|Overall Study|Protocol Violation|10|||
129604160|NCT03176459|466508611|FG000|Overall Study|Lost to Follow-up|5|||
129604161|NCT03176459|466508612|FG001|Overall Study|Lost to Follow-up|7|||
129604162|NCT01602965|466508613|FG000|Overall Study|Lost to Follow-up|4|||
129604163|NCT01602965|466508614|FG001|Overall Study|Lost to Follow-up|2|||
129604164|NCT02283294|466508615|FG000|Overall Study|Lost to Follow-up|1|||
129604165|NCT02283294|466508616|FG001|Overall Study|Lost to Follow-up|1|||
129604166|NCT02283294|466508615|FG000|Overall Study|Withdrawal by Subject|1|||
129604167|NCT02283294|466508616|FG001|Overall Study|Withdrawal by Subject|6|||
129604168|NCT02283294|466508615|FG000|Overall Study|Protocol Violation|1|||
129604169|NCT02283294|466508616|FG001|Overall Study|Protocol Violation|0|||
129604170|NCT02283294|466508615|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
129604171|NCT02283294|466508616|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
129604172|NCT03047473|466511230|FG000|Overall Study|Lost to Follow-up|2|||
129604173|NCT02935686|466511231|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
129604174|NCT02935686|466511232|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129604175|NCT02935686|466511233|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129604176|NCT02935686|466511234|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129604177|NCT02935686|466511235|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
129604178|NCT02935686|466511231|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
129604179|NCT02935686|466511232|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
129604180|NCT02935686|466511233|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
129604181|NCT02935686|466511234|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
129604182|NCT02935686|466511235|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
129604183|NCT02935686|466511231|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129604184|NCT02935686|466511232|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
129604185|NCT02935686|466511233|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129604186|NCT02935686|466511234|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129604187|NCT02935686|466511235|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
129604188|NCT02935686|466511231|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
129604189|NCT02935686|466511232|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
129604190|NCT02935686|466511233|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
129604191|NCT02935686|466511234|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
129604192|NCT02935686|466511235|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
129604193|NCT02935686|466511231|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
129604194|NCT02935686|466511232|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
129604195|NCT02935686|466511233|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
129604196|NCT02935686|466511234|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
129604197|NCT02935686|466511235|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
129604198|NCT02935686|466511231|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129604199|NCT02935686|466511232|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
129604200|NCT02935686|466511233|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129604201|NCT02935686|466511234|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129604202|NCT02935686|466511235|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
129604203|NCT02935686|466511231|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
129604204|NCT02935686|466511232|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
129604205|NCT02935686|466511233|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129604206|NCT02935686|466511234|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129604207|NCT02935686|466511235|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
129604208|NCT02935686|466511231|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129604209|NCT02935686|466511232|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
129604210|NCT02935686|466511233|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129604211|NCT02935686|466511234|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129604212|NCT02935686|466511235|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
129604213|NCT02935686|466511231|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129604214|NCT02935686|466511232|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
129604215|NCT02935686|466511233|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129604216|NCT02935686|466511234|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129604217|NCT02935686|466511235|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
129604218|NCT02935686|466511231|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129604219|NCT02935686|466511232|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129604220|NCT02935686|466511233|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129604221|NCT02935686|466511234|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
129604222|NCT02935686|466511235|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
129604223|NCT02935686|466511231|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
129604224|NCT02935686|466511232|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
129604225|NCT02935686|466511233|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
129604226|NCT02935686|466511234|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
129604227|NCT02935686|466511235|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
129604228|NCT00541970|466511241|FG000|Month 7|Protocol Violation|9|||
129436933|NCT01691768|465897235|FG001|Overall Study|Death|2|||
129604229|NCT00541970|466511242|FG001|Month 7|Protocol Violation|13|||
129604230|NCT00541970|466511243|FG002|Month 7|Protocol Violation|11|||
129698038|NCT04003142|466853444|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
129698039|NCT04003142|466853440|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
129698040|NCT04003142|466853441|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
129698041|NCT04003142|466853442|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
129698042|NCT04003142|466853443|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
129698043|NCT04003142|466853444|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
129698044|NCT04003142|466853440|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
129698045|NCT04003142|466853441|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
129698046|NCT04003142|466853442|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
129698047|NCT04003142|466853443|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
129698048|NCT04003142|466853444|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
129698049|NCT04042311|466853445|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
129698050|NCT04042311|466853445|FG000|Overall Study|Unable to tolerate|4|||
129698051|NCT04042311|466853445|FG000|Overall Study|Concurrent illness|2|||
129698052|NCT04042311|466853445|FG000|Overall Study|Adverse Event|2|||
129698053|NCT04042311|466853445|FG000|Overall Study|No longer meeting inclusion criteria|2|||
129698054|NCT04042311|466853445|FG000|Overall Study|No reason given|1|||
129698055|NCT04042311|466853445|FG000|Overall Study|Withdrawal by Subject|4|||
129698056|NCT03382873|466853446|FG000|Overall Study|Lost to Follow-up|9|||
129698057|NCT03382873|466853447|FG001|Overall Study|Lost to Follow-up|10|||
129698058|NCT03382873|466853446|FG000|Overall Study|Withdrawal by Subject|6|||
129698059|NCT03382873|466853447|FG001|Overall Study|Withdrawal by Subject|11|||
129698060|NCT03382873|466853446|FG000|Overall Study|Visit not completed due to pandemic|16|||
129698061|NCT03382873|466853447|FG001|Overall Study|Visit not completed due to pandemic|41|||
129698062|NCT01044459|466853458|FG000|Overall Study|Withdrawal by Subject|21|||
129698063|NCT01044459|466853459|FG001|Overall Study|Withdrawal by Subject|28|||
129698064|NCT01044459|466853458|FG000|Overall Study|Terminated by Sponsor|22|||
129698065|NCT01044459|466853459|FG001|Overall Study|Terminated by Sponsor|21|||
129698066|NCT01044459|466853458|FG000|Overall Study|Adverse Event|22|||
129698067|NCT01044459|466853459|FG001|Overall Study|Adverse Event|20|||
129698068|NCT01044459|466853458|FG000|Overall Study|Lack of Efficacy|23|||
129698069|NCT01044459|466853459|FG001|Overall Study|Lack of Efficacy|12|||
129698070|NCT01044459|466853458|FG000|Overall Study|Protocol Violation|11|||
129698071|NCT01044459|466853459|FG001|Overall Study|Protocol Violation|16|||
129698072|NCT01044459|466853458|FG000|Overall Study|Other Reason|7|||
129698073|NCT01044459|466853459|FG001|Overall Study|Other Reason|14|||
129698074|NCT01044459|466853458|FG000|Overall Study|COPD exacerbation|9|||
129698075|NCT01044459|466853459|FG001|Overall Study|COPD exacerbation|8|||
129698076|NCT01044459|466853458|FG000|Overall Study|Lost to Follow-up|18|||
129698077|NCT01044459|466853459|FG001|Overall Study|Lost to Follow-up|12|||
129698078|NCT04105725|466853460|FG000|Primary Intervention|Lost to Follow-up|0|||
129698079|NCT04105725|466853461|FG001|Primary Intervention|Lost to Follow-up|2|||
129698080|NCT04105725|466853460|FG000|Primary Intervention|Withdrawal by Subject|0|||
129698081|NCT04105725|466853461|FG001|Primary Intervention|Withdrawal by Subject|1|||
129698082|NCT05346640|466853462|FG000|Overall Study|Lack of Efficacy|2|||
129698083|NCT05346640|466853462|FG000|Overall Study|Lost to Follow-up|14|||
129698084|NCT05346640|466853462|FG000|Overall Study|Protocol Violation|4|||
129698085|NCT05346640|466853462|FG000|Overall Study|Withdrawal by Subject|2|||
129698086|NCT05346640|466853462|FG000|Overall Study|Physiological Complications|3|||
129698087|NCT05346640|466853462|FG000|Overall Study|Other Reason|3|||
129698088|NCT00480025|466853463|FG000|Overall Study|Protocol Violation|12|||
129698089|NCT00480025|466853464|FG001|Overall Study|Protocol Violation|7|||
129698090|NCT00480025|466853463|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
129698091|NCT00480025|466853464|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
129698092|NCT00480025|466853463|FG000|Overall Study|Disease Progression / Recurrence|449|||
129698093|NCT00480025|466853464|FG001|Overall Study|Disease Progression / Recurrence|224|||
129698094|NCT00480025|466853463|FG000|Overall Study|Adverse Event|44|||
129698095|NCT00480025|466853464|FG001|Overall Study|Adverse Event|12|||
129698096|NCT00480025|466853463|FG000|Overall Study|Other|70|||
129698097|NCT00480025|466853464|FG001|Overall Study|Other|29|||
129698098|NCT00480025|466853463|FG000|Overall Study|SAE including intercurrent illness|76|||
129789411|NCT00534313|467195624|FG001|Long-term Period|Withdrawal by Subject|2|||
129789412|NCT00534313|467195625|FG002|Long-term Period|Withdrawal by Subject|0|||
129789413|NCT00534313|467195626|FG003|Long-term Period|Withdrawal by Subject|0|||
129789414|NCT00534313|467195623|FG000|Long-term Period|No longer meets study criteria|0|||
129698099|NCT00480025|466853464|FG001|Overall Study|SAE including intercurrent illness|42|||
129698100|NCT04634331|466853469|FG000|Overall Study|Withdrawal by Subject|2|||
129698101|NCT04634331|466853470|FG001|Overall Study|Withdrawal by Subject|2|||
129698102|NCT03726879|466853471|FG000|Overall Study|Death|11|||
129698103|NCT03726879|466853472|FG001|Overall Study|Death|13|||
129789415|NCT00534313|467195624|FG001|Long-term Period|No longer meets study criteria|1|||
129789416|NCT00534313|467195625|FG002|Long-term Period|No longer meets study criteria|0|||
129789417|NCT00534313|467195626|FG003|Long-term Period|No longer meets study criteria|0|||
129789418|NCT00534313|467195623|FG000|Long-term Period|Poor compliance/noncompliance|0|||
129789419|NCT00534313|467195624|FG001|Long-term Period|Poor compliance/noncompliance|1|||
129789420|NCT00534313|467195625|FG002|Long-term Period|Poor compliance/noncompliance|1|||
129789421|NCT00534313|467195626|FG003|Long-term Period|Poor compliance/noncompliance|0|||
129604231|NCT00541970|466511244|FG003|Month 7|Protocol Violation|5|||
129604232|NCT00541970|466511241|FG000|Month 12|Adverse Event|0|||
129604233|NCT00541970|466511242|FG001|Month 12|Adverse Event|1|||
129604234|NCT00541970|466511243|FG002|Month 12|Adverse Event|1|||
129604235|NCT00541970|466511244|FG003|Month 12|Adverse Event|1|||
129604236|NCT00541970|466511241|FG000|Month 12|Protocol Violation|12|||
129604237|NCT00541970|466511242|FG001|Month 12|Protocol Violation|21|||
129604238|NCT00541970|466511243|FG002|Month 12|Protocol Violation|20|||
129604239|NCT00541970|466511244|FG003|Month 12|Protocol Violation|15|||
129604240|NCT00541970|466511241|FG000|Month 18|Adverse Event|0|||
129604241|NCT00541970|466511242|FG001|Month 18|Adverse Event|1|||
129604242|NCT00541970|466511243|FG002|Month 18|Adverse Event|1|||
129604243|NCT00541970|466511244|FG003|Month 18|Adverse Event|1|||
129604244|NCT00541970|466511241|FG000|Month 18|Protocol Violation|14|||
129604245|NCT00541970|466511242|FG001|Month 18|Protocol Violation|23|||
129604246|NCT00541970|466511243|FG002|Month 18|Protocol Violation|24|||
129604247|NCT00541970|466511244|FG003|Month 18|Protocol Violation|16|||
129604248|NCT00541970|466511241|FG000|Month 24|Adverse Event|0|||
129604249|NCT00541970|466511242|FG001|Month 24|Adverse Event|1|||
129604250|NCT00541970|466511243|FG002|Month 24|Adverse Event|1|||
129604251|NCT00541970|466511244|FG003|Month 24|Adverse Event|1|||
129604252|NCT00541970|466511241|FG000|Month 24|Protocol Violation|29|||
129604253|NCT00541970|466511242|FG001|Month 24|Protocol Violation|31|||
129604254|NCT00541970|466511243|FG002|Month 24|Protocol Violation|31|||
129604255|NCT00541970|466511244|FG003|Month 24|Protocol Violation|21|||
129604256|NCT00541970|466511241|FG000|Month 36|Protocol Violation|61|||
129604257|NCT00541970|466511242|FG001|Month 36|Protocol Violation|66|||
129604258|NCT00541970|466511243|FG002|Month 36|Protocol Violation|66|||
129604259|NCT00541970|466511244|FG003|Month 36|Protocol Violation|60|||
129604260|NCT00541970|466511241|FG000|Month 48|Withdrawal by Subject|2|||
129604261|NCT00541970|466511242|FG001|Month 48|Withdrawal by Subject|4|||
129604262|NCT00541970|466511243|FG002|Month 48|Withdrawal by Subject|4|||
129604263|NCT00541970|466511244|FG003|Month 48|Withdrawal by Subject|2|||
129604264|NCT00541970|466511241|FG000|Month 48|Other|3|||
129604265|NCT00541970|466511242|FG001|Month 48|Other|1|||
129604266|NCT00541970|466511243|FG002|Month 48|Other|1|||
129604267|NCT00541970|466511244|FG003|Month 48|Other|0|||
129604268|NCT00541970|466511241|FG000|Month 48|Lost to Follow-up|66|||
129604269|NCT00541970|466511242|FG001|Month 48|Lost to Follow-up|68|||
129604270|NCT00541970|466511243|FG002|Month 48|Lost to Follow-up|68|||
129604271|NCT00541970|466511244|FG003|Month 48|Lost to Follow-up|73|||
129604272|NCT00541970|466511241|FG000|Month 60|Protocol Violation|78|||
129604273|NCT00541970|466511242|FG001|Month 60|Protocol Violation|77|||
129604274|NCT00541970|466511243|FG002|Month 60|Protocol Violation|82|||
129604275|NCT00541970|466511244|FG003|Month 60|Protocol Violation|72|||
129604276|NCT00321828|466511245|FG000|Overall Study|Ineligible|3|||
129604277|NCT00321828|466511245|FG000|Overall Study|No follow up data|1|||
129604278|NCT00062010|466511248|FG000|Overall Study|Ineligible|3|||
129604279|NCT02856880|466511249|FG000|Overall Study|Withdrawal of consent|1|||
129604280|NCT00573157|466511250|FG000|Overall Study|Adverse Event|3|||
129604281|NCT00573157|466511251|FG001|Overall Study|Adverse Event|1|||
129604282|NCT00573157|466511250|FG000|Overall Study|Other|1|||
129604283|NCT00573157|466511251|FG001|Overall Study|Other|1|||
129604284|NCT02944383|466511252|FG000|Overall Study|Lost to Follow-up|0|||
129604285|NCT02944383|466511253|FG001|Overall Study|Lost to Follow-up|0|||
129604286|NCT02944383|466511254|FG002|Overall Study|Lost to Follow-up|1|||
129604287|NCT02944383|466511252|FG000|Overall Study|Withdrawal by Subject|1|||
129604288|NCT02944383|466511253|FG001|Overall Study|Withdrawal by Subject|0|||
129604289|NCT02944383|466511254|FG002|Overall Study|Withdrawal by Subject|0|||
129604290|NCT02444793|466511257|FG000|Overall Study|Lost to Follow-up|2|||
129604291|NCT02444793|466511258|FG001|Overall Study|Lost to Follow-up|2|||
129604292|NCT02444793|466511259|FG002|Overall Study|Lost to Follow-up|0|||
129604293|NCT02444793|466511260|FG003|Overall Study|Lost to Follow-up|0|||
129789422|NCT00534313|467195623|FG000|Long-term Period|Administrative reason by sponsor|17|||
129604294|NCT02444793|466511257|FG000|Overall Study|Death|0|||
129604295|NCT02444793|466511258|FG001|Overall Study|Death|3|||
129604296|NCT02444793|466511259|FG002|Overall Study|Death|0|||
129604297|NCT02444793|466511260|FG003|Overall Study|Death|0|||
129604298|NCT02444793|466511257|FG000|Overall Study|Other|0|||
129604299|NCT02444793|466511258|FG001|Overall Study|Other|0|||
129604300|NCT02444793|466511259|FG002|Overall Study|Other|2|||
129604301|NCT02444793|466511260|FG003|Overall Study|Other|0|||
129604302|NCT02444793|466511257|FG000|Overall Study|Objective progression or relapse|9|||
129604303|NCT02444793|466511258|FG001|Overall Study|Objective progression or relapse|1|||
129647489|NCT03729570|466665337|FG001|Overall Study|Time Commitment|0|||
129698104|NCT03726879|466853471|FG000|Overall Study|Physician Decision|0|||
129698105|NCT03726879|466853472|FG001|Overall Study|Physician Decision|2|||
129698106|NCT03726879|466853471|FG000|Overall Study|Protocol Violation|0|||
129698107|NCT03726879|466853472|FG001|Overall Study|Protocol Violation|1|||
129698108|NCT03726879|466853471|FG000|Overall Study|Withdrawal by Subject|5|||
129698109|NCT03726879|466853472|FG001|Overall Study|Withdrawal by Subject|6|||
129698110|NCT03726879|466853471|FG000|Overall Study|TSH result is unstable|0|||
129698111|NCT03726879|466853472|FG001|Overall Study|TSH result is unstable|1|||
129698112|NCT03726879|466853471|FG000|Overall Study|Disease relapse|1|||
129698113|NCT03726879|466853472|FG001|Overall Study|Disease relapse|0|||
129698114|NCT03726879|466853471|FG000|Overall Study|Lost to Follow-up|3|||
129698115|NCT03726879|466853472|FG001|Overall Study|Lost to Follow-up|0|||
129698116|NCT02766478|466853473|FG000|Overall Study|Withdrawal by Subject|1|||
129698117|NCT02766478|466853474|FG001|Overall Study|Withdrawal by Subject|1|||
129604304|NCT02444793|466511259|FG002|Overall Study|Objective progression or relapse|2|||
129604305|NCT02444793|466511260|FG003|Overall Study|Objective progression or relapse|3|||
129604306|NCT00599521|466511262|FG000|Overall Study|Lack of Efficacy|4|||
129604307|NCT00599521|466511263|FG001|Overall Study|Lack of Efficacy|8|||
129604308|NCT00599521|466511262|FG000|Overall Study|Adverse Event|4|||
129604309|NCT00599521|466511263|FG001|Overall Study|Adverse Event|1|||
129604310|NCT00599521|466511262|FG000|Overall Study|Withdrawal by Subject|28|||
129604311|NCT00599521|466511263|FG001|Overall Study|Withdrawal by Subject|34|||
129604312|NCT00599521|466511262|FG000|Overall Study|Protocol Violation|1|||
129604313|NCT00599521|466511263|FG001|Overall Study|Protocol Violation|1|||
129604314|NCT00599521|466511262|FG000|Overall Study|Lost to Follow-up|23|||
129604315|NCT00599521|466511263|FG001|Overall Study|Lost to Follow-up|23|||
129604316|NCT00599521|466511262|FG000|Overall Study|Pregnancy|0|||
129604317|NCT00599521|466511263|FG001|Overall Study|Pregnancy|2|||
129604318|NCT04498403|466511264|FG000|Overall Study|Adverse Event|1|||
129604319|NCT04498403|466511265|FG001|Overall Study|Adverse Event|0|||
129604320|NCT04498403|466511264|FG000|Overall Study|Study Terminated By Sponsor|29|||
129604321|NCT04498403|466511265|FG001|Overall Study|Study Terminated By Sponsor|10|||
129604322|NCT01951885|466511267|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
129604323|NCT01951885|466511268|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
129604324|NCT01951885|466511267|FG000|Overall Study|Adverse Event|1|||
129604325|NCT01951885|466511268|FG001|Overall Study|Adverse Event|0|||
129604326|NCT01951885|466511267|FG000|Overall Study|Withdrawal by Subject|0|||
129604327|NCT01951885|466511268|FG001|Overall Study|Withdrawal by Subject|1|||
129604328|NCT01951885|466511267|FG000|Overall Study|ineligible due to a change in donor|0|||
129604329|NCT01951885|466511268|FG001|Overall Study|ineligible due to a change in donor|1|||
129604330|NCT01951885|466511267|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
129604331|NCT01951885|466511268|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
129604332|NCT01206101|466511269|FG000|Overall Study|Adverse Event|1|||
129604333|NCT01206101|466511270|FG001|Overall Study|Adverse Event|0|||
129604334|NCT01206101|466511269|FG000|Overall Study|Physician Decision|0|||
129604335|NCT01206101|466511270|FG001|Overall Study|Physician Decision|1|||
129604336|NCT01206101|466511269|FG000|Overall Study|Unclassified|1|||
129604337|NCT01206101|466511270|FG001|Overall Study|Unclassified|0|||
129604338|NCT02746471|466511274|FG000|Overall Study|Death|43|||
129604339|NCT02746471|466511274|FG000|Overall Study|Exited before 36 months|1119|||
129698118|NCT01093573|466853475|FG000|Overall Study|Physician Decision|0|||
129698119|NCT01093573|466853476|FG001|Overall Study|Physician Decision|0|||
129698120|NCT01093573|466853477|FG002|Overall Study|Physician Decision|1|||
129789423|NCT00534313|467195624|FG001|Long-term Period|Administrative reason by sponsor|15|||
129789424|NCT00534313|467195625|FG002|Long-term Period|Administrative reason by sponsor|26|||
129789425|NCT00534313|467195626|FG003|Long-term Period|Administrative reason by sponsor|18|||
129789426|NCT00534313|467195623|FG000|Long-term Period|Other|1|||
129604340|NCT04594707|466511278|FG000|Overall Study|Adverse Event|0|||
129604341|NCT04594707|466511279|FG001|Overall Study|Adverse Event|0|||
129604342|NCT04594707|466511280|FG002|Overall Study|Adverse Event|1|||
129604343|NCT04594707|466511278|FG000|Overall Study|Death|0|||
129604344|NCT04594707|466511279|FG001|Overall Study|Death|2|||
129604345|NCT04594707|466511280|FG002|Overall Study|Death|2|||
129604346|NCT04594707|466511278|FG000|Overall Study|Lung Transplant|0|||
129604347|NCT04594707|466511279|FG001|Overall Study|Lung Transplant|0|||
129604348|NCT04594707|466511280|FG002|Overall Study|Lung Transplant|1|||
129604349|NCT04594707|466511278|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
129604350|NCT04594707|466511279|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
129604351|NCT04594707|466511280|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
129604352|NCT04594707|466511278|FG000|Overall Study|Study Terminated By Sponsor|19|||
129604353|NCT04594707|466511279|FG001|Overall Study|Study Terminated By Sponsor|47|||
129604354|NCT04594707|466511280|FG002|Overall Study|Study Terminated By Sponsor|41|||
129604355|NCT04594707|466511278|FG000|Overall Study|Withdrawal by Subject|1|||
129698121|NCT01093573|466853475|FG000|Overall Study|Insurance Denied|0|||
129698122|NCT01093573|466853476|FG001|Overall Study|Insurance Denied|0|||
129698123|NCT01093573|466853477|FG002|Overall Study|Insurance Denied|1|||
129698124|NCT05626686|466853478|FG000|Overall Study|Protocol Violation|3|||
129698125|NCT05626686|466853478|FG000|Overall Study|Withdrawal by Subject|3|||
129698126|NCT01197300|466854915|FG000|Overall Study|Lost to Follow-up|0|||
129698127|NCT01197300|466854916|FG001|Overall Study|Lost to Follow-up|1|||
129698128|NCT01197300|466854915|FG000|Overall Study|Protocol Violation|0|||
129698129|NCT01197300|466854916|FG001|Overall Study|Protocol Violation|1|||
129698130|NCT02113878|466854917|FG000|Overall Study|Adverse Event|1|||
129698131|NCT02113878|466854918|FG001|Overall Study|Adverse Event|0|||
129698132|NCT02113878|466854917|FG000|Overall Study|Withdrawal by Subject|1|||
129698133|NCT02113878|466854918|FG001|Overall Study|Withdrawal by Subject|0|||
129698134|NCT02113878|466854917|FG000|Overall Study|patient non-compliance|1|||
129698135|NCT02113878|466854918|FG001|Overall Study|patient non-compliance|0|||
129698136|NCT00581100|466854919|FG000|Overall Study|Death|1|||
129698137|NCT00581100|466854920|FG001|Overall Study|Death|0|||
129698138|NCT00581100|466854919|FG000|Overall Study|Adverse Event|2|||
129698139|NCT00581100|466854920|FG001|Overall Study|Adverse Event|1|||
129698140|NCT00581100|466854919|FG000|Overall Study|Withdrawal by Subject|1|||
129698141|NCT00581100|466854920|FG001|Overall Study|Withdrawal by Subject|4|||
129698142|NCT00581100|466854919|FG000|Overall Study|Other|3|||
129698143|NCT00581100|466854920|FG001|Overall Study|Other|0|||
129698144|NCT03058952|466854923|FG000|Overall Study|Adverse Event|1|||
129698145|NCT03058952|466854924|FG001|Overall Study|Adverse Event|0|||
129698146|NCT03058952|466854923|FG000|Overall Study|Lost to Follow-up|15|||
129698147|NCT03058952|466854924|FG001|Overall Study|Lost to Follow-up|15|||
129604356|NCT04594707|466511279|FG001|Overall Study|Withdrawal by Subject|0|||
129604357|NCT04594707|466511280|FG002|Overall Study|Withdrawal by Subject|2|||
129604358|NCT01593696|466511281|FG000|Dose Escalation|Progressive Disease|2|||
129604359|NCT01593696|466511282|FG001|Dose Escalation|Progressive Disease|0|||
129604360|NCT01593696|466511283|FG002|Dose Escalation|Progressive Disease|0|||
129604361|NCT01593696|466511284|FG003|Dose Escalation|Progressive Disease|0|||
129604362|NCT01593696|466511281|FG000|Dose Expansion|Fungal infection|0|||
129604363|NCT01593696|466511282|FG001|Dose Expansion|Fungal infection|0|||
129604364|NCT01593696|466511283|FG002|Dose Expansion|Fungal infection|1|||
129604365|NCT01593696|466511284|FG003|Dose Expansion|Fungal infection|0|||
129604366|NCT01936623|466511285|FG000|Overall Study|Lost to Follow-up|0|||
129604367|NCT01936623|466511286|FG001|Overall Study|Lost to Follow-up|5|||
129604368|NCT01340768|466511287|FG000|Overall Study|Lost to Follow-up|10|||
129604369|NCT01340768|466511288|FG001|Overall Study|Lost to Follow-up|4|||
129604370|NCT01340768|466511287|FG000|Overall Study|Withdrawal by Subject|5|||
129604371|NCT01340768|466511288|FG001|Overall Study|Withdrawal by Subject|1|||
129604372|NCT01340768|466511287|FG000|Overall Study|Other|2|||
129604373|NCT01340768|466511288|FG001|Overall Study|Other|0|||
129604374|NCT03052959|466511293|FG000|Overall Study|Lost to Follow-up|4|||
129604375|NCT03052959|466511294|FG001|Overall Study|Lost to Follow-up|5|||
129604376|NCT00950963|466511295|FG000|Overall Study|Lost to Follow-up|29|||
129604377|NCT00950963|466511296|FG001|Overall Study|Lost to Follow-up|24|||
129604378|NCT00655876|466511297|FG000|Overall Study|Protocol Violation|9|||
129604379|NCT00655876|466511298|FG001|Overall Study|Protocol Violation|7|||
129604380|NCT01831765|466511299|FG000|Overall Study|Lack of Efficacy|1|||
129604381|NCT01831765|466511300|FG001|Overall Study|Lack of Efficacy|0|||
129604382|NCT01831765|466511301|FG002|Overall Study|Lack of Efficacy|0|||
129604383|NCT01831765|466511299|FG000|Overall Study|Other, sponsor withdrew subject|0|||
129604384|NCT01831765|466511300|FG001|Overall Study|Other, sponsor withdrew subject|1|||
129604385|NCT01831765|466511301|FG002|Overall Study|Other, sponsor withdrew subject|0|||
129604386|NCT01831765|466511299|FG000|Overall Study|Pregnancy|1|||
129604387|NCT01831765|466511300|FG001|Overall Study|Pregnancy|1|||
129604388|NCT01831765|466511301|FG002|Overall Study|Pregnancy|2|||
129604389|NCT01831765|466511299|FG000|Overall Study|Death|0|||
129604390|NCT01831765|466511300|FG001|Overall Study|Death|1|||
129604391|NCT01831765|466511301|FG002|Overall Study|Death|1|||
129789427|NCT00534313|467195624|FG001|Long-term Period|Other|2|||
129789428|NCT00534313|467195625|FG002|Long-term Period|Other|2|||
129789429|NCT00534313|467195626|FG003|Long-term Period|Other|2|||
129789430|NCT03007888|467195628|FG000|First Intervention (14 Days)|Adverse Event|1|||
129789431|NCT03007888|467195629|FG001|First Intervention (14 Days)|Adverse Event|0|||
129789432|NCT00927940|467195630|FG000|Overall Study|Death|1|||
129789433|NCT00043550|467195634|FG000|Overall Study|Withdrawal by Subject|22|||
129604392|NCT01831765|466511299|FG000|Overall Study|Other, site closed|1|||
129604393|NCT01831765|466511300|FG001|Overall Study|Other, site closed|1|||
129604394|NCT01831765|466511301|FG002|Overall Study|Other, site closed|0|||
129789434|NCT00043550|467195635|FG001|Overall Study|Withdrawal by Subject|12|||
129604395|NCT01831765|466511299|FG000|Overall Study|Adverse Event|5|||
129604396|NCT01831765|466511300|FG001|Overall Study|Adverse Event|3|||
129604397|NCT01831765|466511301|FG002|Overall Study|Adverse Event|3|||
129604398|NCT01831765|466511299|FG000|Overall Study|Withdrawal by Subject|22|||
129604399|NCT01831765|466511300|FG001|Overall Study|Withdrawal by Subject|7|||
129698148|NCT03058952|466854923|FG000|Overall Study|Withdrawal by Subject|7|||
129698149|NCT03058952|466854924|FG001|Overall Study|Withdrawal by Subject|11|||
129698150|NCT04744831|466854925|FG000|Overall Study|Progressive Disease|31|||
129698151|NCT04744831|466854926|FG001|Overall Study|Progressive Disease|27|||
129698152|NCT04744831|466854927|FG002|Overall Study|Progressive Disease|25|||
129604400|NCT01831765|466511301|FG002|Overall Study|Withdrawal by Subject|17|||
129604401|NCT01831765|466511299|FG000|Overall Study|Withdrawal criteria|12|||
129604402|NCT01831765|466511300|FG001|Overall Study|Withdrawal criteria|10|||
129604403|NCT01831765|466511301|FG002|Overall Study|Withdrawal criteria|16|||
129604404|NCT01831765|466511299|FG000|Overall Study|Lost to Follow-up|2|||
129604405|NCT01831765|466511300|FG001|Overall Study|Lost to Follow-up|3|||
129604406|NCT01831765|466511301|FG002|Overall Study|Lost to Follow-up|3|||
129604407|NCT00859586|466511302|FG000|Overall Study|Donors|4|||
129604408|NCT00080938|466511303|FG000|Overall Study|Adverse Event|3|||
129604409|NCT00080938|466511303|FG000|Overall Study|Withdrawal by Subject|6|||
129604410|NCT00080938|466511303|FG000|Overall Study|Death|2|||
129604411|NCT00080938|466511303|FG000|Overall Study|Lack of Efficacy|7|||
129604412|NCT00080938|466511303|FG000|Overall Study|other disease|1|||
129604413|NCT00080938|466511303|FG000|Overall Study|Not started protocol therapy|1|||
129604414|NCT00080938|466511303|FG000|Overall Study|Ineligible|4|||
129604415|NCT00706511|466511306|FG000|Overall Study|Withdrawal by Subject|1|||
129604416|NCT00706511|466511307|FG001|Overall Study|Withdrawal by Subject|0|||
129604417|NCT00706511|466511308|FG002|Overall Study|Withdrawal by Subject|0|||
129604418|NCT00706511|466511309|FG003|Overall Study|Withdrawal by Subject|0|||
129604419|NCT05297578|466511313|FG000|Overall Study|Lost to Follow-up|1|||
129604420|NCT05297578|466511314|FG001|Overall Study|Lost to Follow-up|1|||
129604421|NCT05297578|466511315|FG002|Overall Study|Lost to Follow-up|2|||
129604422|NCT05297578|466511316|FG003|Overall Study|Lost to Follow-up|1|||
129604423|NCT05297578|466511313|FG000|Overall Study|Death|0|||
129604424|NCT05297578|466511314|FG001|Overall Study|Death|1|||
129604425|NCT05297578|466511315|FG002|Overall Study|Death|0|||
129604426|NCT05297578|466511316|FG003|Overall Study|Death|0|||
129604427|NCT05297578|466511313|FG000|Overall Study|Withdrawal by Subject|0|||
129604428|NCT05297578|466511314|FG001|Overall Study|Withdrawal by Subject|0|||
129604429|NCT05297578|466511315|FG002|Overall Study|Withdrawal by Subject|1|||
129604430|NCT05297578|466511316|FG003|Overall Study|Withdrawal by Subject|0|||
129604431|NCT01732484|466511317|FG000|Overall Study|Death|7|||
129604432|NCT01732484|466511317|FG000|Overall Study|Lost to Follow-up|14|||
129604433|NCT01732484|466511317|FG000|Overall Study|chronical illness|5|||
129604434|NCT01087489|466511318|FG000|Overall Study|enrolled in another VA study|0|||
129604435|NCT01087489|466511319|FG001|Overall Study|enrolled in another VA study|1|||
129604436|NCT01087489|466511318|FG000|Overall Study|Death|0|||
129604437|NCT01087489|466511319|FG001|Overall Study|Death|1|||
129604438|NCT01087489|466511318|FG000|Overall Study|unable to survey by telephone|0|||
129604439|NCT01087489|466511319|FG001|Overall Study|unable to survey by telephone|1|||
129604440|NCT00928707|466511320|FG000|Overall Study|Protocol Violation|1|||
129604441|NCT00928707|466511321|FG001|Overall Study|Protocol Violation|0|||
129604442|NCT00132028|466511322|FG000|Overall Study|Adverse Event|7|||
129604443|NCT00132028|466511322|FG000|Overall Study|Death|2|||
129604444|NCT00132028|466511322|FG000|Overall Study|Lack of Efficacy|11|||
129604445|NCT00132028|466511322|FG000|Overall Study|Withdrawal by Subject|2|||
129604446|NCT00132028|466511322|FG000|Overall Study|not eligible|2|||
129604447|NCT00132028|466511322|FG000|Overall Study|Physician Decision|3|||
129604448|NCT02731326|466511323|FG000|Overall Study|Withdrawal by Subject|4|||
129604449|NCT02731326|466511324|FG001|Overall Study|Withdrawal by Subject|1|||
129604450|NCT02731326|466511323|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
129604451|NCT02731326|466511324|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
129789435|NCT00043550|467195636|FG002|Overall Study|Withdrawal by Subject|20|||
129789436|NCT00436501|467195639|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
129789437|NCT00436501|467195640|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
129789438|NCT00436501|467195639|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
129789439|NCT00436501|467195640|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
129789440|NCT00217464|467195644|FG000|Overall Study|Progression|15|||
129789441|NCT00217464|467195644|FG000|Overall Study|Other|2|||
129604452|NCT02731326|466511323|FG000|Overall Study|Discharged without AliveCor|10|||
129604453|NCT02731326|466511324|FG001|Overall Study|Discharged without AliveCor|0|||
129789442|NCT01089361|467195645|FG000|Overall Study|Death|1|||
129604454|NCT02731326|466511323|FG000|Overall Study|Duplicate Participant|1|||
129604455|NCT02731326|466511324|FG001|Overall Study|Duplicate Participant|1|||
129604456|NCT02272634|466511325|FG000|Overall Study|Adverse Event|1|||
129604457|NCT02272634|466511326|FG001|Overall Study|Adverse Event|0|||
129604458|NCT02272634|466511327|FG002|Overall Study|Adverse Event|0|||
129604459|NCT02272634|466511325|FG000|Overall Study|Protocol Violation|0|||
129604460|NCT02272634|466511326|FG001|Overall Study|Protocol Violation|0|||
129604461|NCT02272634|466511327|FG002|Overall Study|Protocol Violation|1|||
129604462|NCT02272634|466511325|FG000|Overall Study|Withdrawal by Subject|0|||
129604463|NCT02272634|466511326|FG001|Overall Study|Withdrawal by Subject|1|||
129604464|NCT02272634|466511327|FG002|Overall Study|Withdrawal by Subject|0|||
129604465|NCT04647721|466511329|FG000|Overall Study|Withdrawal by Subject|0|||
129604466|NCT04647721|466511330|FG001|Overall Study|Withdrawal by Subject|2|||
129436934|NCT01691768|465897234|FG000|Overall Study|Lost to Follow-up|4|||
129604467|NCT04647721|466511329|FG000|Overall Study|Lost to Follow-up|2|||
129604468|NCT04647721|466511330|FG001|Overall Study|Lost to Follow-up|0|||
129604469|NCT05070546|466511331|FG000|Overall Study|Death|0|||
129604470|NCT05070546|466511332|FG001|Overall Study|Death|0|||
129604471|NCT05070546|466511333|FG002|Overall Study|Death|0|||
129604472|NCT05070546|466511334|FG003|Overall Study|Death|0|||
129604473|NCT05070546|466511335|FG004|Overall Study|Death|0|||
129604474|NCT05070546|466511336|FG005|Overall Study|Death|1|||
129604475|NCT05070546|466511331|FG000|Overall Study|Lost to Follow-up|8|||
129604476|NCT05070546|466511332|FG001|Overall Study|Lost to Follow-up|2|||
129604477|NCT05070546|466511333|FG002|Overall Study|Lost to Follow-up|7|||
129604478|NCT05070546|466511334|FG003|Overall Study|Lost to Follow-up|1|||
129604479|NCT05070546|466511335|FG004|Overall Study|Lost to Follow-up|2|||
129604480|NCT05070546|466511336|FG005|Overall Study|Lost to Follow-up|0|||
129604481|NCT05070546|466511331|FG000|Overall Study|Withdrawal by Subject|1|||
129604482|NCT05070546|466511332|FG001|Overall Study|Withdrawal by Subject|1|||
129604483|NCT05070546|466511333|FG002|Overall Study|Withdrawal by Subject|3|||
129604484|NCT05070546|466511334|FG003|Overall Study|Withdrawal by Subject|0|||
129604485|NCT05070546|466511335|FG004|Overall Study|Withdrawal by Subject|0|||
129604486|NCT05070546|466511336|FG005|Overall Study|Withdrawal by Subject|0|||
129604487|NCT05070546|466511331|FG000|Overall Study|Other|0|||
129604488|NCT05070546|466511332|FG001|Overall Study|Other|0|||
129604489|NCT05070546|466511333|FG002|Overall Study|Other|0|||
129604490|NCT05070546|466511334|FG003|Overall Study|Other|0|||
129604491|NCT05070546|466511335|FG004|Overall Study|Other|3|||
129604492|NCT05070546|466511336|FG005|Overall Study|Other|0|||
129604493|NCT05070546|466511331|FG000|Overall Study|Randomized but not vaccinated|1|||
129604494|NCT05070546|466511332|FG001|Overall Study|Randomized but not vaccinated|0|||
129604495|NCT05070546|466511333|FG002|Overall Study|Randomized but not vaccinated|1|||
129604496|NCT05070546|466511334|FG003|Overall Study|Randomized but not vaccinated|1|||
129604497|NCT05070546|466511335|FG004|Overall Study|Randomized but not vaccinated|3|||
129604498|NCT05070546|466511336|FG005|Overall Study|Randomized but not vaccinated|0|||
129604499|NCT00302081|466511337|FG000|Overall Study|Adverse Event|6|||
129604500|NCT00302081|466511338|FG001|Overall Study|Adverse Event|5|||
129604501|NCT00302081|466511339|FG002|Overall Study|Adverse Event|4|||
129604502|NCT00302081|466511337|FG000|Overall Study|Lost to Follow-up|21|||
129604503|NCT00302081|466511338|FG001|Overall Study|Lost to Follow-up|18|||
129604504|NCT00302081|466511339|FG002|Overall Study|Lost to Follow-up|28|||
129604505|NCT00302081|466511337|FG000|Overall Study|Withdrawal by Subject|8|||
129604506|NCT00302081|466511338|FG001|Overall Study|Withdrawal by Subject|12|||
129604507|NCT00302081|466511339|FG002|Overall Study|Withdrawal by Subject|8|||
129604508|NCT00302081|466511337|FG000|Overall Study|Protocol Violation|5|||
129604509|NCT00302081|466511338|FG001|Overall Study|Protocol Violation|1|||
129604510|NCT00302081|466511339|FG002|Overall Study|Protocol Violation|2|||
129604511|NCT00302081|466511337|FG000|Overall Study|Lack of Efficacy|1|||
129604512|NCT00302081|466511338|FG001|Overall Study|Lack of Efficacy|0|||
129604513|NCT00302081|466511339|FG002|Overall Study|Lack of Efficacy|5|||
129604514|NCT00302081|466511337|FG000|Overall Study|Death|2|||
129604515|NCT00302081|466511338|FG001|Overall Study|Death|1|||
129604516|NCT00302081|466511339|FG002|Overall Study|Death|0|||
129604517|NCT00302081|466511337|FG000|Overall Study|Other|13|||
129604518|NCT00302081|466511338|FG001|Overall Study|Other|6|||
129604519|NCT00302081|466511339|FG002|Overall Study|Other|5|||
129604520|NCT04771403|466511340|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
129604521|NCT04771403|466511341|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
129604522|NCT04771403|466511340|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
129604523|NCT04771403|466511341|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
129604524|NCT04771403|466511340|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
129604525|NCT04771403|466511341|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
129604526|NCT04771403|466511340|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
129604527|NCT04771403|466511341|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
129604528|NCT04771403|466511340|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
129604529|NCT04771403|466511341|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
129604530|NCT04771403|466511340|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
129604531|NCT04771403|466511341|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
129604532|NCT04771403|466511340|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
129647490|NCT03729570|466665336|FG000|Overall Study|Bad Experience|0|||
129789443|NCT01089361|467195646|FG001|Overall Study|Death|0|||
129789444|NCT01576159|467195647|FG000|Overall Study|Withdrawal by Subject|0|||
129604533|NCT04771403|466511341|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
129604534|NCT04771403|466511340|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
129604535|NCT04771403|466511341|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
129604536|NCT00816361|466511346|FG000|Overall Study|Withdrawal by Subject|0|||
129604537|NCT00816361|466511347|FG001|Overall Study|Withdrawal by Subject|0|||
129604538|NCT00816361|466511348|FG002|Overall Study|Withdrawal by Subject|0|||
129604539|NCT00816361|466511349|FG003|Overall Study|Withdrawal by Subject|0|||
129604540|NCT00816361|466511350|FG004|Overall Study|Withdrawal by Subject|1|||
129604541|NCT00816361|466511351|FG005|Overall Study|Withdrawal by Subject|2|||
129604542|NCT00816361|466511352|FG006|Overall Study|Withdrawal by Subject|0|||
129604543|NCT00816361|466511353|FG007|Overall Study|Withdrawal by Subject|2|||
129604544|NCT00816361|466511354|FG008|Overall Study|Withdrawal by Subject|1|||
129604545|NCT00816361|466511346|FG000|Overall Study|Death|4|||
129604546|NCT00816361|466511347|FG001|Overall Study|Death|3|||
129604547|NCT00816361|466511348|FG002|Overall Study|Death|3|||
129604548|NCT00816361|466511349|FG003|Overall Study|Death|3|||
129604549|NCT00816361|466511350|FG004|Overall Study|Death|1|||
129604550|NCT00816361|466511351|FG005|Overall Study|Death|1|||
129604551|NCT00816361|466511352|FG006|Overall Study|Death|3|||
129604552|NCT00816361|466511353|FG007|Overall Study|Death|7|||
129604553|NCT00816361|466511354|FG008|Overall Study|Death|8|||
129604554|NCT00816361|466511346|FG000|Overall Study|Other|0|||
129604555|NCT00816361|466511347|FG001|Overall Study|Other|0|||
129604556|NCT00816361|466511348|FG002|Overall Study|Other|0|||
129604557|NCT00816361|466511349|FG003|Overall Study|Other|0|||
129604558|NCT00816361|466511350|FG004|Overall Study|Other|0|||
129604559|NCT00816361|466511351|FG005|Overall Study|Other|0|||
129604560|NCT00816361|466511352|FG006|Overall Study|Other|0|||
129604561|NCT00816361|466511353|FG007|Overall Study|Other|0|||
129604562|NCT00816361|466511354|FG008|Overall Study|Other|1|||
129604563|NCT00546572|466511355|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
129604564|NCT00546572|466511356|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
129604565|NCT00546572|466511355|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
129604566|NCT00546572|466511356|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
129604567|NCT00546572|466511355|FG000|Vax 1 / Year 0|Protocol Violation|3|||
129604568|NCT00546572|466511356|FG001|Vax 1 / Year 0|Protocol Violation|4|||
129604569|NCT00546572|466511355|FG000|Vax 1 / Year 0|Death|2|||
129604570|NCT00546572|466511356|FG001|Vax 1 / Year 0|Death|2|||
129604571|NCT00546572|466511355|FG000|Vax 1 / Year 0|Adverse Event|0|||
129604572|NCT00546572|466511356|FG001|Vax 1 / Year 0|Adverse Event|1|||
129604573|NCT00546572|466511355|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
129604574|NCT00546572|466511356|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
129604575|NCT00546572|466511355|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
129604576|NCT00546572|466511356|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
129604577|NCT00546572|466511355|FG000|Vax 2 / Year 1|Other|1|||
129604578|NCT00546572|466511356|FG001|Vax 2 / Year 1|Other|1|||
129604579|NCT00546572|466511355|FG000|Vax 2 / Year 1|Adverse Event|1|||
129604580|NCT00546572|466511356|FG001|Vax 2 / Year 1|Adverse Event|0|||
129604581|NCT00546572|466511355|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
129604582|NCT00546572|466511356|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
129604583|NCT00741936|466511362|FG000|Overall Study|Lost to Follow-up|1|||
129604584|NCT00741936|466511363|FG001|Overall Study|Lost to Follow-up|1|||
129604585|NCT00741936|466511362|FG000|Overall Study|Adverse Event|3|||
129604586|NCT00741936|466511363|FG001|Overall Study|Adverse Event|4|||
129604587|NCT00741936|466511362|FG000|Overall Study|Pregnancy|0|||
129604588|NCT00741936|466511363|FG001|Overall Study|Pregnancy|1|||
129604589|NCT00741936|466511362|FG000|Overall Study|Protocol Violation|2|||
129604590|NCT00741936|466511363|FG001|Overall Study|Protocol Violation|0|||
129604591|NCT00741936|466511362|FG000|Overall Study|Lack of Efficacy|0|||
129604592|NCT00741936|466511363|FG001|Overall Study|Lack of Efficacy|2|||
129604593|NCT00741936|466511362|FG000|Overall Study|Low compliance|3|||
129604594|NCT00741936|466511363|FG001|Overall Study|Low compliance|0|||
129604595|NCT01408628|466511364|FG000|Consented|Withdrawal by Subject|12|||
129604596|NCT01408628|466511364|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
129604597|NCT01408628|466511364|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
129604598|NCT01408628|466511364|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
129604599|NCT01941940|466511365|FG000|Overall Study|Adverse Event|11|||
129604600|NCT01941940|466511365|FG000|Overall Study|Lost to Follow-up|2|||
129698153|NCT04744831|466854925|FG000|Overall Study|Adverse Event|3|||
129698154|NCT04744831|466854926|FG001|Overall Study|Adverse Event|3|||
129698155|NCT04744831|466854927|FG002|Overall Study|Adverse Event|3|||
129698156|NCT04744831|466854925|FG000|Overall Study|Clinical Progression|3|||
129698157|NCT04744831|466854926|FG001|Overall Study|Clinical Progression|2|||
129698158|NCT04744831|466854927|FG002|Overall Study|Clinical Progression|5|||
129604601|NCT01941940|466511365|FG000|Overall Study|Physician Decision|2|||
129604602|NCT01941940|466511365|FG000|Overall Study|Withdrawal by Subject|15|||
129698159|NCT04744831|466854925|FG000|Overall Study|Other|0|||
129698160|NCT04744831|466854926|FG001|Overall Study|Other|2|||
129604603|NCT01941940|466511365|FG000|Overall Study|Death|1|||
129604604|NCT01941940|466511365|FG000|Overall Study|Other|1|||
129604605|NCT01941940|466511365|FG000|Overall Study|Other|1|||
129604606|NCT00750308|466511366|FG000|First Treatment|Adverse Event|0|||
129604607|NCT00750308|466511367|FG001|First Treatment|Adverse Event|1|||
129604608|NCT00750308|466511368|FG002|First Treatment|Adverse Event|0|||
129604609|NCT00750308|466511369|FG003|First Treatment|Adverse Event|0|||
129604610|NCT00750308|466511370|FG004|First Treatment|Adverse Event|0|||
129604611|NCT00750308|466511371|FG005|First Treatment|Adverse Event|0|||
129604612|NCT00750308|466511372|FG006|First Treatment|Adverse Event|0|||
129604613|NCT00750308|466511373|FG007|First Treatment|Adverse Event|0|||
129604614|NCT00750308|466511374|FG008|First Treatment|Adverse Event|0|||
129604615|NCT00750308|466511375|FG009|First Treatment|Adverse Event|0|||
129604616|NCT00750308|466511376|FG010|First Treatment|Adverse Event|1|||
129604617|NCT00750308|466511377|FG011|First Treatment|Adverse Event|1|||
129604618|NCT00750308|466511366|FG000|First Treatment|Withdrawal by Subject|0|||
129604619|NCT00750308|466511367|FG001|First Treatment|Withdrawal by Subject|0|||
129604620|NCT00750308|466511368|FG002|First Treatment|Withdrawal by Subject|0|||
129604621|NCT00750308|466511369|FG003|First Treatment|Withdrawal by Subject|1|||
129604622|NCT00750308|466511370|FG004|First Treatment|Withdrawal by Subject|0|||
129604623|NCT00750308|466511371|FG005|First Treatment|Withdrawal by Subject|0|||
129604624|NCT00750308|466511372|FG006|First Treatment|Withdrawal by Subject|0|||
129604625|NCT00750308|466511373|FG007|First Treatment|Withdrawal by Subject|1|||
129604626|NCT00750308|466511374|FG008|First Treatment|Withdrawal by Subject|0|||
129604627|NCT00750308|466511375|FG009|First Treatment|Withdrawal by Subject|0|||
129604628|NCT00750308|466511376|FG010|First Treatment|Withdrawal by Subject|0|||
129604629|NCT00750308|466511377|FG011|First Treatment|Withdrawal by Subject|0|||
129604630|NCT00750308|466511366|FG000|Second Treatment|Adverse Event|0|||
129604631|NCT00750308|466511367|FG001|Second Treatment|Adverse Event|0|||
129604632|NCT00750308|466511368|FG002|Second Treatment|Adverse Event|0|||
129604633|NCT00750308|466511369|FG003|Second Treatment|Adverse Event|0|||
129604634|NCT00750308|466511370|FG004|Second Treatment|Adverse Event|0|||
129604635|NCT00750308|466511371|FG005|Second Treatment|Adverse Event|1|||
129604636|NCT00750308|466511372|FG006|Second Treatment|Adverse Event|0|||
129604637|NCT00750308|466511373|FG007|Second Treatment|Adverse Event|0|||
129604638|NCT00750308|466511374|FG008|Second Treatment|Adverse Event|1|||
129604639|NCT00750308|466511375|FG009|Second Treatment|Adverse Event|0|||
129604640|NCT00750308|466511376|FG010|Second Treatment|Adverse Event|0|||
129604641|NCT00750308|466511377|FG011|Second Treatment|Adverse Event|0|||
129604642|NCT00750308|466511366|FG000|Second Treatment|Withdrawal by Subject|0|||
129604643|NCT00750308|466511367|FG001|Second Treatment|Withdrawal by Subject|0|||
129604644|NCT00750308|466511368|FG002|Second Treatment|Withdrawal by Subject|0|||
129604645|NCT00750308|466511369|FG003|Second Treatment|Withdrawal by Subject|0|||
129604646|NCT00750308|466511370|FG004|Second Treatment|Withdrawal by Subject|1|||
129604647|NCT00750308|466511371|FG005|Second Treatment|Withdrawal by Subject|0|||
129604648|NCT00750308|466511372|FG006|Second Treatment|Withdrawal by Subject|0|||
129604649|NCT00750308|466511373|FG007|Second Treatment|Withdrawal by Subject|0|||
129604650|NCT00750308|466511374|FG008|Second Treatment|Withdrawal by Subject|0|||
129604651|NCT00750308|466511375|FG009|Second Treatment|Withdrawal by Subject|0|||
129604652|NCT00750308|466511376|FG010|Second Treatment|Withdrawal by Subject|0|||
129604653|NCT00750308|466511377|FG011|Second Treatment|Withdrawal by Subject|0|||
129604654|NCT00750308|466511366|FG000|Third Treatment|Withdrawal by Subject|0|||
129604655|NCT00750308|466511367|FG001|Third Treatment|Withdrawal by Subject|1|||
129604656|NCT00750308|466511368|FG002|Third Treatment|Withdrawal by Subject|0|||
129604657|NCT00750308|466511369|FG003|Third Treatment|Withdrawal by Subject|0|||
129604658|NCT00750308|466511370|FG004|Third Treatment|Withdrawal by Subject|0|||
129604659|NCT00750308|466511371|FG005|Third Treatment|Withdrawal by Subject|0|||
129604660|NCT00750308|466511372|FG006|Third Treatment|Withdrawal by Subject|0|||
129604661|NCT00750308|466511373|FG007|Third Treatment|Withdrawal by Subject|0|||
129604662|NCT00750308|466511374|FG008|Third Treatment|Withdrawal by Subject|0|||
129604663|NCT00750308|466511375|FG009|Third Treatment|Withdrawal by Subject|0|||
129604664|NCT00750308|466511376|FG010|Third Treatment|Withdrawal by Subject|0|||
129604665|NCT00750308|466511377|FG011|Third Treatment|Withdrawal by Subject|0|||
129604666|NCT00513682|466511378|FG000|Washout Phase|Adverse Event|2|||
129604667|NCT02450526|466511379|FG000|DB Period (Cycle 1)|Adverse Event|0|||
129604668|NCT02450526|466511380|FG001|DB Period (Cycle 1)|Adverse Event|0|||
129604669|NCT02450526|466511381|FG002|DB Period (Cycle 1)|Adverse Event|2|||
129604670|NCT02450526|466511382|FG003|DB Period (Cycle 1)|Adverse Event|0|||
129604671|NCT02450526|466511383|FG004|DB Period (Cycle 1)|Adverse Event|0|||
129604672|NCT02450526|466511379|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
129604673|NCT02450526|466511380|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
129604674|NCT02450526|466511381|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
129604675|NCT02450526|466511382|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
129604676|NCT02450526|466511383|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
129604677|NCT02450526|466511379|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
129604678|NCT02450526|466511380|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
129604679|NCT02450526|466511381|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
129604680|NCT02450526|466511382|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
129604681|NCT02450526|466511383|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
129604682|NCT02450526|466511379|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
129604683|NCT02450526|466511380|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
129604684|NCT02450526|466511381|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
129604685|NCT02450526|466511382|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
129604686|NCT02450526|466511383|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
129604687|NCT02450526|466511379|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
129604688|NCT02450526|466511380|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
129604689|NCT02450526|466511381|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
129604690|NCT02450526|466511382|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
129604691|NCT02450526|466511383|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
129604692|NCT02450526|466511379|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129604693|NCT02450526|466511380|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129604694|NCT02450526|466511381|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129604695|NCT02450526|466511382|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
129604696|NCT02450526|466511383|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
129604697|NCT02450526|466511379|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129604698|NCT02450526|466511380|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129604699|NCT02450526|466511381|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129604700|NCT02450526|466511382|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
129604701|NCT02450526|466511383|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
129604702|NCT02450526|466511379|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
129604703|NCT02450526|466511380|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
129604704|NCT02450526|466511381|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
129604705|NCT02450526|466511382|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
129604706|NCT02450526|466511383|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
129604707|NCT03212521|466511384|FG000|Overall Study|Adverse Event|1|||
129604708|NCT03212521|466511384|FG000|Overall Study|Lost to Follow-up|4|||
129604709|NCT03212521|466511384|FG000|Overall Study|Withdrawal by Subject|1|||
129604710|NCT03212521|466511384|FG000|Overall Study|Other|1|||
129604711|NCT02435836|466511385|FG000|Overall Study|Lost to Follow-up|21|||
129604712|NCT02435836|466511385|FG000|Overall Study|Lack of Efficacy|1|||
129604713|NCT02435836|466511385|FG000|Overall Study|Withdrawal by Subject|236|||
129604714|NCT02435836|466511385|FG000|Overall Study|Insufficient Clinical Response|26|||
129604715|NCT02435836|466511385|FG000|Overall Study|Adverse Event|44|||
129604716|NCT02435836|466511385|FG000|Overall Study|Sponsor discontinued trial|167|||
129604717|NCT02435836|466511385|FG000|Overall Study|Noncompliance|27|||
129604718|NCT02435836|466511385|FG000|Overall Study|Protocol Violation|6|||
129604719|NCT02435836|466511385|FG000|Overall Study|Met Withdrawal Criteria|7|||
129604720|NCT02435836|466511385|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
129604721|NCT01970865|466511386|FG000|Overall Study|Death|3|||
129604722|NCT01970865|466511387|FG001|Overall Study|Death|2|||
129604723|NCT01970865|466511388|FG002|Overall Study|Death|3|||
129604724|NCT01970865|466511389|FG003|Overall Study|Death|6|||
129604725|NCT01970865|466511390|FG004|Overall Study|Death|9|||
129604726|NCT01970865|466511391|FG005|Overall Study|Death|3|||
129604727|NCT01970865|466511392|FG006|Overall Study|Death|2|||
129604728|NCT01970865|466511393|FG007|Overall Study|Death|3|||
129604729|NCT01970865|466511394|FG008|Overall Study|Death|2|||
129604730|NCT01970865|466511395|FG009|Overall Study|Death|2|||
129604731|NCT01970865|466511396|FG010|Overall Study|Death|8|||
129604732|NCT01970865|466511397|FG011|Overall Study|Death|13|||
129604733|NCT01970865|466511398|FG012|Overall Study|Death|25|||
129604734|NCT01970865|466511399|FG013|Overall Study|Death|46|||
129604735|NCT01970865|466511400|FG014|Overall Study|Death|37|||
129604736|NCT01970865|466511401|FG015|Overall Study|Death|22|||
129604737|NCT01970865|466511402|FG016|Overall Study|Death|1|||
129604738|NCT01970865|466511403|FG017|Overall Study|Death|17|||
129604739|NCT01970865|466511386|FG000|Overall Study|Lost to Follow-up|0|||
129604740|NCT01970865|466511387|FG001|Overall Study|Lost to Follow-up|0|||
129604741|NCT01970865|466511388|FG002|Overall Study|Lost to Follow-up|0|||
129604742|NCT01970865|466511389|FG003|Overall Study|Lost to Follow-up|1|||
129604743|NCT01970865|466511390|FG004|Overall Study|Lost to Follow-up|1|||
129604744|NCT01970865|466511391|FG005|Overall Study|Lost to Follow-up|0|||
129604745|NCT01970865|466511392|FG006|Overall Study|Lost to Follow-up|0|||
129604746|NCT01970865|466511393|FG007|Overall Study|Lost to Follow-up|0|||
129604747|NCT01970865|466511394|FG008|Overall Study|Lost to Follow-up|0|||
129604748|NCT01970865|466511395|FG009|Overall Study|Lost to Follow-up|0|||
129604749|NCT01970865|466511396|FG010|Overall Study|Lost to Follow-up|1|||
129604750|NCT01970865|466511397|FG011|Overall Study|Lost to Follow-up|0|||
129604751|NCT01970865|466511398|FG012|Overall Study|Lost to Follow-up|2|||
129604752|NCT01970865|466511399|FG013|Overall Study|Lost to Follow-up|0|||
129604753|NCT01970865|466511400|FG014|Overall Study|Lost to Follow-up|1|||
129604754|NCT01970865|466511401|FG015|Overall Study|Lost to Follow-up|4|||
129604755|NCT01970865|466511402|FG016|Overall Study|Lost to Follow-up|0|||
129604756|NCT01970865|466511403|FG017|Overall Study|Lost to Follow-up|1|||
129604757|NCT01970865|466511386|FG000|Overall Study|Other|0|||
129604758|NCT01970865|466511387|FG001|Overall Study|Other|1|||
129604759|NCT01970865|466511388|FG002|Overall Study|Other|0|||
129604760|NCT01970865|466511389|FG003|Overall Study|Other|1|||
129604761|NCT01970865|466511390|FG004|Overall Study|Other|1|||
129604762|NCT01970865|466511391|FG005|Overall Study|Other|0|||
129604763|NCT01970865|466511392|FG006|Overall Study|Other|1|||
129604764|NCT01970865|466511393|FG007|Overall Study|Other|0|||
129604765|NCT01970865|466511394|FG008|Overall Study|Other|0|||
129604766|NCT01970865|466511395|FG009|Overall Study|Other|0|||
129604767|NCT01970865|466511396|FG010|Overall Study|Other|2|||
129604768|NCT01970865|466511397|FG011|Overall Study|Other|3|||
129604769|NCT01970865|466511398|FG012|Overall Study|Other|8|||
129604770|NCT01970865|466511399|FG013|Overall Study|Other|3|||
129604771|NCT01970865|466511400|FG014|Overall Study|Other|2|||
129604772|NCT01970865|466511401|FG015|Overall Study|Other|3|||
129604773|NCT01970865|466511402|FG016|Overall Study|Other|0|||
129604774|NCT01970865|466511403|FG017|Overall Study|Other|2|||
129604775|NCT01970865|466511386|FG000|Overall Study|Participant refused further follow-up|0|||
129604776|NCT01970865|466511387|FG001|Overall Study|Participant refused further follow-up|0|||
129604777|NCT01970865|466511388|FG002|Overall Study|Participant refused further follow-up|0|||
129604778|NCT01970865|466511389|FG003|Overall Study|Participant refused further follow-up|2|||
129604779|NCT01970865|466511390|FG004|Overall Study|Participant refused further follow-up|3|||
129604780|NCT01970865|466511391|FG005|Overall Study|Participant refused further follow-up|0|||
129604781|NCT01970865|466511392|FG006|Overall Study|Participant refused further follow-up|0|||
129604782|NCT01970865|466511393|FG007|Overall Study|Participant refused further follow-up|0|||
129604783|NCT01970865|466511394|FG008|Overall Study|Participant refused further follow-up|0|||
129604784|NCT01970865|466511395|FG009|Overall Study|Participant refused further follow-up|0|||
129604785|NCT01970865|466511396|FG010|Overall Study|Participant refused further follow-up|1|||
129604786|NCT01970865|466511397|FG011|Overall Study|Participant refused further follow-up|4|||
129604787|NCT01970865|466511398|FG012|Overall Study|Participant refused further follow-up|7|||
129604788|NCT01970865|466511399|FG013|Overall Study|Participant refused further follow-up|8|||
129604789|NCT01970865|466511400|FG014|Overall Study|Participant refused further follow-up|3|||
129604790|NCT01970865|466511401|FG015|Overall Study|Participant refused further follow-up|11|||
129604791|NCT01970865|466511402|FG016|Overall Study|Participant refused further follow-up|0|||
129604792|NCT01970865|466511403|FG017|Overall Study|Participant refused further follow-up|6|||
129604793|NCT02041091|466511406|FG000|Treatment|Adverse Event|3|||
129604794|NCT02041091|466511407|FG001|Treatment|Adverse Event|3|||
129604795|NCT02041091|466511406|FG000|Treatment|Withdrawal by Subject|2|||
129604796|NCT02041091|466511407|FG001|Treatment|Withdrawal by Subject|4|||
129604797|NCT02041091|466511406|FG000|Treatment|Physician Decision|1|||
129604798|NCT02041091|466511407|FG001|Treatment|Physician Decision|0|||
129604799|NCT02041091|466511406|FG000|Treatment|Sponsor Decision|15|||
129604800|NCT02041091|466511407|FG001|Treatment|Sponsor Decision|16|||
129604801|NCT02041091|466511406|FG000|Treatment|Lost to Follow-up|1|||
129604802|NCT02041091|466511407|FG001|Treatment|Lost to Follow-up|0|||
129604803|NCT02041091|466511406|FG000|Optional Safety Extension Period|Adverse Event|4|||
129604804|NCT02041091|466511407|FG001|Optional Safety Extension Period|Adverse Event|2|||
129604805|NCT02041091|466511406|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
129604806|NCT02041091|466511407|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
129604807|NCT02041091|466511406|FG000|Optional Safety Extension Period|Protocol Violation|2|||
129604808|NCT02041091|466511407|FG001|Optional Safety Extension Period|Protocol Violation|0|||
129604809|NCT02041091|466511406|FG000|Optional Safety Extension Period|Physician Decision|2|||
129604810|NCT02041091|466511407|FG001|Optional Safety Extension Period|Physician Decision|1|||
129604811|NCT02041091|466511406|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
129604812|NCT02041091|466511407|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
129604813|NCT02041091|466511406|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
129604814|NCT02041091|466511407|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
129604815|NCT01855074|466511408|FG000|Overall Study|Adverse Event|1|||
129604816|NCT01855074|466511408|FG000|Overall Study|Lost to Follow-up|4|||
129604817|NCT01855074|466511408|FG000|Overall Study|Withdrawal by Subject|8|||
129604818|NCT01855074|466511408|FG000|Overall Study|Started but not treated|1|||
129604819|NCT01150890|466511409|FG000|Overall Study|Other|0|||
129604820|NCT01150890|466511410|FG001|Overall Study|Other|1|||
129604821|NCT01150890|466511411|FG002|Overall Study|Other|0|||
129604822|NCT01150890|466511412|FG003|Overall Study|Other|2|||
129604823|NCT01150890|466511409|FG000|Overall Study|Pregnancy|0|||
129604824|NCT01150890|466511410|FG001|Overall Study|Pregnancy|0|||
129604825|NCT01150890|466511411|FG002|Overall Study|Pregnancy|0|||
129604826|NCT01150890|466511412|FG003|Overall Study|Pregnancy|1|||
129604827|NCT01150890|466511409|FG000|Overall Study|Administrative Decision|4|||
129604828|NCT01150890|466511410|FG001|Overall Study|Administrative Decision|4|||
129604829|NCT01150890|466511411|FG002|Overall Study|Administrative Decision|5|||
129604830|NCT01150890|466511412|FG003|Overall Study|Administrative Decision|6|||
129604831|NCT01150890|466511409|FG000|Overall Study|Ineligibility determined|0|||
129604832|NCT01150890|466511410|FG001|Overall Study|Ineligibility determined|1|||
129604833|NCT01150890|466511411|FG002|Overall Study|Ineligibility determined|0|||
129604834|NCT01150890|466511412|FG003|Overall Study|Ineligibility determined|0|||
129604835|NCT01150890|466511409|FG000|Overall Study|Adverse Event|0|||
129604836|NCT01150890|466511410|FG001|Overall Study|Adverse Event|0|||
129604837|NCT01150890|466511411|FG002|Overall Study|Adverse Event|2|||
129604838|NCT01150890|466511412|FG003|Overall Study|Adverse Event|0|||
129604839|NCT01150890|466511409|FG000|Overall Study|Withdrawal by Subject|0|||
129604840|NCT01150890|466511410|FG001|Overall Study|Withdrawal by Subject|0|||
129604841|NCT01150890|466511411|FG002|Overall Study|Withdrawal by Subject|2|||
129604842|NCT01150890|466511412|FG003|Overall Study|Withdrawal by Subject|1|||
129604843|NCT01150890|466511409|FG000|Overall Study|Disease progression|0|||
129604844|NCT01150890|466511410|FG001|Overall Study|Disease progression|7|||
129604845|NCT01150890|466511411|FG002|Overall Study|Disease progression|3|||
129604846|NCT01150890|466511412|FG003|Overall Study|Disease progression|7|||
129604847|NCT00922987|466511413|FG000|Overall Study|Insufficient clinical response|1|||
129604848|NCT00922987|466511413|FG000|Overall Study|Protocol Violation|2|||
129604849|NCT00922987|466511413|FG000|Overall Study|Adverse Event|1|||
129604850|NCT00446199|466511414|FG000|Overall Study|Adverse Event|7|||
129604851|NCT00446199|466511415|FG001|Overall Study|Adverse Event|4|||
129604852|NCT00446199|466511416|FG002|Overall Study|Adverse Event|6|||
129604853|NCT00446199|466511417|FG003|Overall Study|Adverse Event|4|||
129604854|NCT00446199|466511414|FG000|Overall Study|Lost to Follow-up|4|||
129604855|NCT00446199|466511415|FG001|Overall Study|Lost to Follow-up|5|||
129604856|NCT00446199|466511416|FG002|Overall Study|Lost to Follow-up|2|||
129604857|NCT00446199|466511417|FG003|Overall Study|Lost to Follow-up|6|||
129604858|NCT00446199|466511414|FG000|Overall Study|Protocol Violation|1|||
129604859|NCT00446199|466511415|FG001|Overall Study|Protocol Violation|2|||
129604860|NCT00446199|466511416|FG002|Overall Study|Protocol Violation|1|||
129604861|NCT00446199|466511417|FG003|Overall Study|Protocol Violation|3|||
129604862|NCT00446199|466511414|FG000|Overall Study|Withdrawal by Subject|2|||
129604863|NCT00446199|466511415|FG001|Overall Study|Withdrawal by Subject|5|||
129604864|NCT00446199|466511416|FG002|Overall Study|Withdrawal by Subject|9|||
129604865|NCT00446199|466511417|FG003|Overall Study|Withdrawal by Subject|10|||
129604866|NCT00446199|466511414|FG000|Overall Study|Site termination|2|||
129604867|NCT00446199|466511415|FG001|Overall Study|Site termination|0|||
129604868|NCT00446199|466511416|FG002|Overall Study|Site termination|0|||
129604869|NCT00446199|466511417|FG003|Overall Study|Site termination|1|||
129604870|NCT00446199|466511414|FG000|Overall Study|Randomization in Error|2|||
129604871|NCT00446199|466511415|FG001|Overall Study|Randomization in Error|0|||
129604872|NCT00446199|466511416|FG002|Overall Study|Randomization in Error|1|||
129604873|NCT00446199|466511417|FG003|Overall Study|Randomization in Error|1|||
129604874|NCT00446199|466511414|FG000|Overall Study|Lack of Efficacy|1|||
129604875|NCT00446199|466511415|FG001|Overall Study|Lack of Efficacy|0|||
129604876|NCT00446199|466511416|FG002|Overall Study|Lack of Efficacy|0|||
129604877|NCT00446199|466511417|FG003|Overall Study|Lack of Efficacy|1|||
129604878|NCT00446199|466511414|FG000|Overall Study|Non-compliant with study drug|1|||
129604879|NCT00446199|466511415|FG001|Overall Study|Non-compliant with study drug|0|||
129604880|NCT00446199|466511416|FG002|Overall Study|Non-compliant with study drug|5|||
129604881|NCT00446199|466511417|FG003|Overall Study|Non-compliant with study drug|0|||
129604882|NCT00446199|466511414|FG000|Overall Study|Non-compliant with visit schedule|1|||
129604883|NCT00446199|466511415|FG001|Overall Study|Non-compliant with visit schedule|1|||
129604884|NCT00446199|466511416|FG002|Overall Study|Non-compliant with visit schedule|1|||
129604885|NCT00446199|466511417|FG003|Overall Study|Non-compliant with visit schedule|2|||
129604886|NCT00446199|466511414|FG000|Overall Study|Hormone fear|0|||
129604887|NCT00446199|466511415|FG001|Overall Study|Hormone fear|0|||
129604888|NCT00446199|466511416|FG002|Overall Study|Hormone fear|0|||
129604889|NCT00446199|466511417|FG003|Overall Study|Hormone fear|1|||
129604890|NCT00446199|466511414|FG000|Overall Study|Lost interest in study participation|0|||
129604891|NCT00446199|466511415|FG001|Overall Study|Lost interest in study participation|1|||
129604892|NCT00446199|466511416|FG002|Overall Study|Lost interest in study participation|0|||
129604893|NCT00446199|466511417|FG003|Overall Study|Lost interest in study participation|0|||
129789445|NCT01576159|467195648|FG001|Overall Study|Withdrawal by Subject|1|||
129789446|NCT01576159|467195649|FG002|Overall Study|Withdrawal by Subject|0|||
129789447|NCT01576159|467195650|FG003|Overall Study|Withdrawal by Subject|0|||
129789448|NCT01576159|467195647|FG000|Overall Study|Physician Decision|0|||
129436935|NCT01691768|465897235|FG001|Overall Study|Lost to Follow-up|3|||
129604894|NCT00446199|466511414|FG000|Overall Study|In-/Exclusion criterion violated|2|||
129604895|NCT00446199|466511415|FG001|Overall Study|In-/Exclusion criterion violated|1|||
129604896|NCT00446199|466511416|FG002|Overall Study|In-/Exclusion criterion violated|2|||
129604897|NCT00446199|466511417|FG003|Overall Study|In-/Exclusion criterion violated|1|||
129604898|NCT00446199|466511414|FG000|Overall Study|Move|0|||
129604899|NCT00446199|466511415|FG001|Overall Study|Move|1|||
129604900|NCT00446199|466511416|FG002|Overall Study|Move|0|||
129789449|NCT01576159|467195648|FG001|Overall Study|Physician Decision|0|||
129436936|NCT01691768|465897234|FG000|Overall Study|Withdrawal by Subject|10|||
129436937|NCT01691768|465897235|FG001|Overall Study|Withdrawal by Subject|9|||
129604901|NCT00446199|466511417|FG003|Overall Study|Move|0|||
129604902|NCT03071094|466511421|FG000|Overall Study|Death|1|||
129604903|NCT03071094|466511422|FG001|Overall Study|Death|1|||
129604904|NCT03071094|466511421|FG000|Overall Study|Adverse Event|1|||
129604905|NCT03071094|466511422|FG001|Overall Study|Adverse Event|0|||
129604906|NCT02312063|466511423|FG000|Overall Study|Withdrawal by Subject|0|||
129604907|NCT02312063|466511424|FG001|Overall Study|Withdrawal by Subject|1|||
129604908|NCT01079832|466511425|FG000|Overall Study|Withdrawal by Subject|1|||
129604909|NCT00577395|466513287|FG000|Overall Study|Study was terminated early by Sponsor|7|||
129604910|NCT00577395|466513288|FG001|Overall Study|Study was terminated early by Sponsor|6|||
129604911|NCT04709835|466513293|FG000|Overall Study|Withdrawal by Subject|0|||
129604912|NCT04709835|466513294|FG001|Overall Study|Withdrawal by Subject|1|||
129604913|NCT04709835|466513295|FG002|Overall Study|Withdrawal by Subject|0|||
129604914|NCT04325204|466513296|FG000|Overall Study|Death|0|||
129604915|NCT04325204|466513297|FG001|Overall Study|Death|1|||
129604916|NCT04325204|466513296|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
129604917|NCT04325204|466513297|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
129604918|NCT04325204|466513296|FG000|Overall Study|Lost to Follow-up|8|||
129604919|NCT04325204|466513297|FG001|Overall Study|Lost to Follow-up|8|||
129604920|NCT04325204|466513296|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
129604921|NCT04325204|466513297|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
129604922|NCT04711902|466513299|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
129604923|NCT04711902|466513300|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
129604924|NCT04711902|466513301|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
129604925|NCT04711902|466513302|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
129604926|NCT04711902|466513303|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
129604927|NCT04711902|466513304|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
129604928|NCT04710979|466513305|FG000|Overall Study|Lost to Follow-up|2|||
129604929|NCT04710979|466513306|FG001|Overall Study|Lost to Follow-up|4|||
129604930|NCT04710979|466513305|FG000|Overall Study|Withdrawal by Subject|1|||
129604931|NCT04710979|466513306|FG001|Overall Study|Withdrawal by Subject|0|||
129604932|NCT01462318|466513309|FG000|Main Study / TP-DI Study|Other|2|||
129604933|NCT01462318|466513310|FG001|Main Study / TP-DI Study|Other|0|||
129604934|NCT01462318|466513311|FG002|Main Study / TP-DI Study|Other|0|||
129604935|NCT01462318|466513309|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
129604936|NCT01462318|466513310|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
129604937|NCT01462318|466513311|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
129604938|NCT01462318|466513309|FG000|Main Study / TP-DI Study|Adverse Event|4|||
129604939|NCT01462318|466513310|FG001|Main Study / TP-DI Study|Adverse Event|0|||
129604940|NCT01462318|466513311|FG002|Main Study / TP-DI Study|Adverse Event|0|||
129604941|NCT01462318|466513309|FG000|Extension Phase|Lost to Follow-up|0|||
129604942|NCT01462318|466513310|FG001|Extension Phase|Lost to Follow-up|0|||
129604943|NCT01462318|466513311|FG002|Extension Phase|Lost to Follow-up|1|||
129604944|NCT01462318|466513309|FG000|Extension Phase|Other|0|||
129604945|NCT01462318|466513310|FG001|Extension Phase|Other|0|||
129604946|NCT01462318|466513311|FG002|Extension Phase|Other|1|||
129604947|NCT01462318|466513309|FG000|Extension Phase|Disease Progression|0|||
129604948|NCT01462318|466513310|FG001|Extension Phase|Disease Progression|0|||
129604949|NCT01462318|466513311|FG002|Extension Phase|Disease Progression|1|||
129604950|NCT01462318|466513309|FG000|Extension Phase|Withdrawal by Subject|0|||
129604951|NCT01462318|466513310|FG001|Extension Phase|Withdrawal by Subject|0|||
129604952|NCT01462318|466513311|FG002|Extension Phase|Withdrawal by Subject|15|||
129604953|NCT01462318|466513309|FG000|Extension Phase|Investigator Decision|0|||
129604954|NCT01462318|466513310|FG001|Extension Phase|Investigator Decision|0|||
129604955|NCT01462318|466513311|FG002|Extension Phase|Investigator Decision|5|||
129604956|NCT01462318|466513309|FG000|Extension Phase|Adverse Event|0|||
129604957|NCT01462318|466513310|FG001|Extension Phase|Adverse Event|0|||
129604958|NCT01462318|466513311|FG002|Extension Phase|Adverse Event|22|||
129604959|NCT03827564|466513312|FG000|Overall Study|Discontinued due to Study Termination|1|||
129604960|NCT03827564|466513313|FG001|Overall Study|Discontinued due to Study Termination|0|||
129604961|NCT00891371|466513314|FG000|Pre-assignment|Inclusion/exclusion|5|||
129604962|NCT00891371|466513314|FG000|Pre-assignment|Consent withdrawal|1|||
129604963|NCT00891371|466513314|FG000|Treatment|Lack of Efficacy|5|||
129604964|NCT00891371|466513314|FG000|Treatment|Adverse Event|2|||
129604965|NCT00891371|466513314|FG000|Treatment|Death|1|||
129604966|NCT00891371|466513314|FG000|Treatment|Lost to Follow-up|1|||
129604967|NCT02238626|466513315|FG000|Overall Study|Adverse Event|3|||
129604968|NCT02238626|466513316|FG001|Overall Study|Adverse Event|5|||
129436938|NCT01691768|465897234|FG000|Overall Study|Relocated|0|||
129436939|NCT01691768|465897235|FG001|Overall Study|Relocated|1|||
129604969|NCT02238626|466513317|FG002|Overall Study|Adverse Event|0|||
129604970|NCT02238626|466513318|FG003|Overall Study|Adverse Event|3|||
129604971|NCT02238626|466513315|FG000|Overall Study|Lost to Follow-up|2|||
129604972|NCT02238626|466513316|FG001|Overall Study|Lost to Follow-up|4|||
129604973|NCT02238626|466513317|FG002|Overall Study|Lost to Follow-up|2|||
129604974|NCT02238626|466513318|FG003|Overall Study|Lost to Follow-up|2|||
129604975|NCT02238626|466513315|FG000|Overall Study|Withdrawal by Subject|0|||
129604976|NCT02238626|466513316|FG001|Overall Study|Withdrawal by Subject|3|||
129604977|NCT02238626|466513317|FG002|Overall Study|Withdrawal by Subject|0|||
129604978|NCT02238626|466513318|FG003|Overall Study|Withdrawal by Subject|1|||
129604979|NCT02238626|466513315|FG000|Overall Study|Death|0|||
129604980|NCT02238626|466513316|FG001|Overall Study|Death|0|||
129604981|NCT02238626|466513317|FG002|Overall Study|Death|1|||
129604982|NCT02238626|466513318|FG003|Overall Study|Death|1|||
129604983|NCT02238626|466513315|FG000|Overall Study|Other|0|||
129604984|NCT02238626|466513316|FG001|Overall Study|Other|2|||
129604985|NCT02238626|466513317|FG002|Overall Study|Other|0|||
129604986|NCT02238626|466513318|FG003|Overall Study|Other|0|||
129604987|NCT02622113|466513321|FG000|Overall Study|Adverse Event|4|||
129604988|NCT02622113|466513322|FG001|Overall Study|Adverse Event|4|||
129604989|NCT02622113|466513321|FG000|Overall Study|Physician Decision|0|||
129604990|NCT02622113|466513322|FG001|Overall Study|Physician Decision|1|||
129604991|NCT02622113|466513321|FG000|Overall Study|Withdrawal by Subject|0|||
129604992|NCT02622113|466513322|FG001|Overall Study|Withdrawal by Subject|2|||
129604993|NCT02622113|466513321|FG000|Overall Study|Stopping Criteria|1|||
129604994|NCT02622113|466513322|FG001|Overall Study|Stopping Criteria|3|||
129604995|NCT00667810|466513323|FG000|Overall Study|Adverse Event|13|||
129698161|NCT04744831|466854927|FG002|Overall Study|Other|1|||
129698162|NCT04744831|466854925|FG000|Overall Study|Death|0|||
129698163|NCT04744831|466854926|FG001|Overall Study|Death|2|||
129698164|NCT04744831|466854927|FG002|Overall Study|Death|1|||
129436940|NCT01691768|465897234|FG000|Overall Study|Investigator decision|1|||
129436941|NCT01691768|465897235|FG001|Overall Study|Investigator decision|1|||
129436942|NCT01959334|465897236|FG000|Second Dose|Adverse Event|1|||
129436943|NCT01959334|465897237|FG001|Second Dose|Adverse Event|0|||
129436944|NCT01959334|465897236|FG000|Third Dose|Adverse Event|0|||
129436945|NCT01959334|465897237|FG001|Third Dose|Adverse Event|1|||
129436946|NCT04781387|465897238|FG000|Overall Study|Withdrawal by Subject|1|||
129604996|NCT00667810|466513324|FG001|Overall Study|Adverse Event|14|||
129604997|NCT00667810|466513325|FG002|Overall Study|Adverse Event|19|||
129698165|NCT03837509|466854928|FG000|Phase 1|Death|5|||
129436947|NCT04781387|465897239|FG001|Overall Study|Withdrawal by Subject|0|||
129436948|NCT04781387|465897240|FG002|Overall Study|Withdrawal by Subject|1|||
129436949|NCT04781387|465897238|FG000|Overall Study|Lost to Follow-up|1|||
129604998|NCT00667810|466513326|FG003|Overall Study|Adverse Event|1|||
129604999|NCT00667810|466513323|FG000|Overall Study|Death|1|||
129605000|NCT00667810|466513324|FG001|Overall Study|Death|1|||
129605001|NCT00667810|466513325|FG002|Overall Study|Death|3|||
129698166|NCT03837509|466854929|FG001|Phase 1|Death|2|||
129698167|NCT03837509|466854930|FG002|Phase 1|Death|0|||
129698168|NCT03837509|466854931|FG003|Phase 1|Death|0|||
129698169|NCT03837509|466854932|FG004|Phase 1|Death|0|||
129605002|NCT00667810|466513326|FG003|Overall Study|Death|0|||
129605003|NCT00667810|466513323|FG000|Overall Study|Lack of Efficacy|1|||
129605004|NCT00667810|466513324|FG001|Overall Study|Lack of Efficacy|0|||
129605005|NCT00667810|466513325|FG002|Overall Study|Lack of Efficacy|2|||
129605006|NCT00667810|466513326|FG003|Overall Study|Lack of Efficacy|0|||
129886087|NCT02564055|467542848|FG001|Overall Study|Reached stopping criteria|0|||
129886088|NCT02564055|467542849|FG002|Overall Study|Reached stopping criteria|0|||
129886089|NCT02564055|467542850|FG003|Overall Study|Reached stopping criteria|0|||
129886090|NCT02564055|467542851|FG004|Overall Study|Reached stopping criteria|0|||
129886091|NCT02564055|467542852|FG005|Overall Study|Reached stopping criteria|1|||
129886092|NCT02564055|467542847|FG000|Overall Study|Lost to Follow-up|0|||
129886093|NCT02564055|467542848|FG001|Overall Study|Lost to Follow-up|1|||
129886094|NCT02564055|467542849|FG002|Overall Study|Lost to Follow-up|4|||
129886095|NCT02564055|467542850|FG003|Overall Study|Lost to Follow-up|2|||
129886096|NCT02564055|467542851|FG004|Overall Study|Lost to Follow-up|1|||
129886097|NCT02564055|467542852|FG005|Overall Study|Lost to Follow-up|0|||
129886098|NCT02564055|467542847|FG000|Overall Study|Physician Decision|0|||
129886099|NCT02564055|467542848|FG001|Overall Study|Physician Decision|0|||
129886100|NCT02564055|467542849|FG002|Overall Study|Physician Decision|1|||
129886101|NCT02564055|467542850|FG003|Overall Study|Physician Decision|0|||
129886102|NCT02564055|467542851|FG004|Overall Study|Physician Decision|0|||
129886103|NCT02564055|467542852|FG005|Overall Study|Physician Decision|0|||
129886104|NCT02564055|467542847|FG000|Overall Study|Withdrawal by Subject|4|||
129886105|NCT02564055|467542848|FG001|Overall Study|Withdrawal by Subject|4|||
129886106|NCT02564055|467542849|FG002|Overall Study|Withdrawal by Subject|3|||
129605007|NCT00667810|466513323|FG000|Overall Study|Lost to Follow-up|1|||
129605008|NCT00667810|466513324|FG001|Overall Study|Lost to Follow-up|4|||
129605009|NCT00667810|466513325|FG002|Overall Study|Lost to Follow-up|2|||
129605010|NCT00667810|466513326|FG003|Overall Study|Lost to Follow-up|0|||
129605011|NCT00667810|466513323|FG000|Overall Study|Physician Decision|1|||
129886107|NCT02564055|467542850|FG003|Overall Study|Withdrawal by Subject|3|||
129886108|NCT02564055|467542851|FG004|Overall Study|Withdrawal by Subject|10|||
129886109|NCT02564055|467542852|FG005|Overall Study|Withdrawal by Subject|10|||
129886110|NCT00531011|467542853|FG000|Overall Study|Withdrawal by Subject|2|||
129789450|NCT01576159|467195649|FG002|Overall Study|Physician Decision|1|||
129789451|NCT01576159|467195650|FG003|Overall Study|Physician Decision|0|||
129789452|NCT01576159|467195647|FG000|Overall Study|Lost to Follow-up|0|||
129789453|NCT01576159|467195648|FG001|Overall Study|Lost to Follow-up|0|||
129789454|NCT01576159|467195649|FG002|Overall Study|Lost to Follow-up|0|||
129789455|NCT01576159|467195650|FG003|Overall Study|Lost to Follow-up|1|||
129789456|NCT01576159|467195647|FG000|Overall Study|Protocol Violation|1|||
129789457|NCT01576159|467195648|FG001|Overall Study|Protocol Violation|0|||
129789458|NCT01576159|467195649|FG002|Overall Study|Protocol Violation|0|||
129789459|NCT01576159|467195650|FG003|Overall Study|Protocol Violation|0|||
129789460|NCT00169442|467195651|FG000|Overall Study|Withdrawal by Subject|0|||
129789461|NCT00169442|467195652|FG001|Overall Study|Withdrawal by Subject|0|||
129789462|NCT00169442|467195653|FG002|Overall Study|Withdrawal by Subject|1|||
129789463|NCT00169442|467195654|FG003|Overall Study|Withdrawal by Subject|0|||
129789464|NCT00169442|467195655|FG004|Overall Study|Withdrawal by Subject|0|||
129789465|NCT00169442|467195656|FG005|Overall Study|Withdrawal by Subject|0|||
129789466|NCT00169442|467195651|FG000|Overall Study|Migrated/moved from study area|0|||
129789467|NCT00169442|467195652|FG001|Overall Study|Migrated/moved from study area|0|||
129789468|NCT00169442|467195653|FG002|Overall Study|Migrated/moved from study area|0|||
129789469|NCT00169442|467195654|FG003|Overall Study|Migrated/moved from study area|0|||
129789470|NCT00169442|467195655|FG004|Overall Study|Migrated/moved from study area|0|||
129789471|NCT00169442|467195656|FG005|Overall Study|Migrated/moved from study area|2|||
129789472|NCT00169442|467195651|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
129789473|NCT00169442|467195652|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
129789474|NCT00169442|467195653|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
129789475|NCT00169442|467195654|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
129789476|NCT00169442|467195655|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
129789477|NCT00169442|467195656|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
129789478|NCT00169442|467195651|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
129789479|NCT00169442|467195652|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
129789480|NCT00169442|467195653|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
129789481|NCT00169442|467195654|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
129789482|NCT00169442|467195655|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
129789483|NCT00169442|467195656|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
129789484|NCT01426789|467195657|FG000|Part 1|Protocol deviation|0|||
129789485|NCT01426789|467195658|FG001|Part 1|Protocol deviation|1|||
129789486|NCT01426789|467195659|FG002|Part 1|Protocol deviation|0|||
129789487|NCT01426789|467195660|FG003|Part 1|Protocol deviation|0|||
129789488|NCT01426789|467195661|FG004|Part 1|Protocol deviation|0|||
129789489|NCT01426789|467195662|FG005|Part 1|Protocol deviation|0|||
129789490|NCT01426789|467195657|FG000|Part 1|Lost to Follow-up|1|||
129789491|NCT01426789|467195658|FG001|Part 1|Lost to Follow-up|2|||
129789492|NCT01426789|467195659|FG002|Part 1|Lost to Follow-up|0|||
129789493|NCT01426789|467195660|FG003|Part 1|Lost to Follow-up|0|||
129789494|NCT01426789|467195661|FG004|Part 1|Lost to Follow-up|0|||
129789495|NCT01426789|467195662|FG005|Part 1|Lost to Follow-up|0|||
129789496|NCT01426789|467195657|FG000|Part 1|Lack of Efficacy|2|||
129789497|NCT01426789|467195658|FG001|Part 1|Lack of Efficacy|1|||
129789498|NCT01426789|467195659|FG002|Part 1|Lack of Efficacy|0|||
129886111|NCT00531011|467542854|FG001|Overall Study|Withdrawal by Subject|4|||
129886112|NCT00531011|467542853|FG000|Overall Study|Death|1|||
129886113|NCT00531011|467542854|FG001|Overall Study|Death|0|||
129605012|NCT00667810|466513324|FG001|Overall Study|Physician Decision|1|||
129605013|NCT00667810|466513325|FG002|Overall Study|Physician Decision|2|||
129605014|NCT00667810|466513326|FG003|Overall Study|Physician Decision|0|||
129789499|NCT01426789|467195660|FG003|Part 1|Lack of Efficacy|0|||
129789500|NCT01426789|467195661|FG004|Part 1|Lack of Efficacy|0|||
129789501|NCT01426789|467195662|FG005|Part 1|Lack of Efficacy|0|||
129789502|NCT01426789|467195657|FG000|Part 1|Adverse Event|3|||
129789503|NCT01426789|467195658|FG001|Part 1|Adverse Event|0|||
129789504|NCT01426789|467195659|FG002|Part 1|Adverse Event|0|||
129789505|NCT01426789|467195660|FG003|Part 1|Adverse Event|0|||
129789506|NCT01426789|467195661|FG004|Part 1|Adverse Event|0|||
129789507|NCT01426789|467195662|FG005|Part 1|Adverse Event|0|||
129789508|NCT01426789|467195657|FG000|Part 2|Protocol deviation|0|||
129605015|NCT00667810|466513323|FG000|Overall Study|Protocol Violation|0|||
129789509|NCT01426789|467195658|FG001|Part 2|Protocol deviation|0|||
129886114|NCT00531011|467542853|FG000|Overall Study|Lost to Follow-up|1|||
129698170|NCT03837509|466854928|FG000|Phase 2|Death|0|||
129698171|NCT03837509|466854929|FG001|Phase 2|Death|0|||
129698172|NCT03837509|466854930|FG002|Phase 2|Death|0|||
129698173|NCT03837509|466854931|FG003|Phase 2|Death|1|||
129698174|NCT03837509|466854932|FG004|Phase 2|Death|1|||
129698175|NCT03682367|466854942|FG000|Overall Study|Protocol Violation|2|||
129698176|NCT03682367|466854943|FG001|Overall Study|Protocol Violation|1|||
129698177|NCT03682367|466854942|FG000|Overall Study|Closed Study Early|0|||
129698178|NCT03682367|466854943|FG001|Overall Study|Closed Study Early|3|||
129698179|NCT00129974|466854944|FG000|Overall Study|Other|1|||
129698180|NCT00414609|466854945|FG000|Core Study|Adverse Event|9|||
129698181|NCT00414609|466854946|FG001|Core Study|Adverse Event|11|||
129698182|NCT00414609|466854947|FG002|Core Study|Adverse Event|0|||
129698183|NCT00414609|466854945|FG000|Core Study|Abnormal laboratory values|0|||
129698184|NCT00414609|466854946|FG001|Core Study|Abnormal laboratory values|1|||
129698185|NCT00414609|466854947|FG002|Core Study|Abnormal laboratory values|0|||
129698186|NCT00414609|466854945|FG000|Core Study|Abnormal test procedure results|1|||
129698187|NCT00414609|466854946|FG001|Core Study|Abnormal test procedure results|1|||
129698188|NCT00414609|466854947|FG002|Core Study|Abnormal test procedure results|0|||
129698189|NCT00414609|466854945|FG000|Core Study|Protocol deviation|0|||
129698190|NCT00414609|466854946|FG001|Core Study|Protocol deviation|1|||
129698191|NCT00414609|466854947|FG002|Core Study|Protocol deviation|0|||
129698192|NCT00414609|466854945|FG000|Core Study|Patient withdrew consent|10|||
129698193|NCT00414609|466854946|FG001|Core Study|Patient withdrew consent|11|||
129698194|NCT00414609|466854947|FG002|Core Study|Patient withdrew consent|0|||
129698195|NCT00414609|466854945|FG000|Core Study|Lost to Follow-up|7|||
129698196|NCT00414609|466854946|FG001|Core Study|Lost to Follow-up|4|||
129698197|NCT00414609|466854947|FG002|Core Study|Lost to Follow-up|0|||
129698198|NCT00414609|466854945|FG000|Core Study|Administrative problems|0|||
129436950|NCT04781387|465897239|FG001|Overall Study|Lost to Follow-up|0|||
129436951|NCT04781387|465897240|FG002|Overall Study|Lost to Follow-up|0|||
129436952|NCT01275131|465897248|FG000|Period 1|Withdrawal by Subject|1|||
129436953|NCT01275131|465897249|FG001|Period 1|Withdrawal by Subject|0|||
129436954|NCT01275131|465897250|FG002|Period 1|Withdrawal by Subject|3|||
129436955|NCT01275131|465897251|FG003|Period 1|Withdrawal by Subject|2|||
129436956|NCT01275131|465897248|FG000|Period 1|Physician Decision|1|||
129436957|NCT01275131|465897249|FG001|Period 1|Physician Decision|0|||
129436958|NCT01275131|465897250|FG002|Period 1|Physician Decision|0|||
129436959|NCT01275131|465897251|FG003|Period 1|Physician Decision|0|||
129698199|NCT00414609|466854946|FG001|Core Study|Administrative problems|2|||
129436960|NCT01275131|465897248|FG000|Period 2 (Crossover)|Adverse Event|0|||
129436961|NCT01275131|465897249|FG001|Period 2 (Crossover)|Adverse Event|1|||
129436962|NCT01275131|465897250|FG002|Period 2 (Crossover)|Adverse Event|0|||
129436963|NCT01275131|465897251|FG003|Period 2 (Crossover)|Adverse Event|0|||
129436964|NCT01275131|465897248|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
129698200|NCT00414609|466854947|FG002|Core Study|Administrative problems|0|||
129698201|NCT00414609|466854945|FG000|Core Study|Death|7|||
129698202|NCT00414609|466854946|FG001|Core Study|Death|14|||
129698203|NCT00414609|466854947|FG002|Core Study|Death|0|||
129698204|NCT00414609|466854945|FG000|Extension Study|Adverse Event|0|||
129698205|NCT00414609|466854946|FG001|Extension Study|Adverse Event|0|||
129698206|NCT00414609|466854947|FG002|Extension Study|Adverse Event|14|||
129698207|NCT00414609|466854945|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
129789510|NCT01426789|467195659|FG002|Part 2|Protocol deviation|1|||
129789511|NCT01426789|467195660|FG003|Part 2|Protocol deviation|0|||
129789512|NCT01426789|467195661|FG004|Part 2|Protocol deviation|0|||
129789513|NCT01426789|467195662|FG005|Part 2|Protocol deviation|0|||
129789514|NCT01426789|467195657|FG000|Part 2|Death|0|||
129789515|NCT01426789|467195658|FG001|Part 2|Death|0|||
129789516|NCT01426789|467195659|FG002|Part 2|Death|1|||
129789517|NCT01426789|467195660|FG003|Part 2|Death|0|||
129789518|NCT01426789|467195661|FG004|Part 2|Death|1|||
129789519|NCT01426789|467195662|FG005|Part 2|Death|0|||
129789520|NCT01426789|467195657|FG000|Part 2|Administrative problems|0|||
129789521|NCT01426789|467195658|FG001|Part 2|Administrative problems|0|||
129789522|NCT01426789|467195659|FG002|Part 2|Administrative problems|2|||
129789523|NCT01426789|467195660|FG003|Part 2|Administrative problems|0|||
129789524|NCT01426789|467195661|FG004|Part 2|Administrative problems|1|||
129789525|NCT01426789|467195662|FG005|Part 2|Administrative problems|0|||
129789526|NCT01426789|467195657|FG000|Part 2|Lost to Follow-up|0|||
129789527|NCT01426789|467195658|FG001|Part 2|Lost to Follow-up|0|||
129789528|NCT01426789|467195659|FG002|Part 2|Lost to Follow-up|4|||
129789529|NCT01426789|467195660|FG003|Part 2|Lost to Follow-up|0|||
129789530|NCT01426789|467195661|FG004|Part 2|Lost to Follow-up|1|||
129789531|NCT01426789|467195662|FG005|Part 2|Lost to Follow-up|0|||
129789532|NCT01426789|467195657|FG000|Part 2|Withdrawal by Subject|0|||
129789533|NCT01426789|467195658|FG001|Part 2|Withdrawal by Subject|0|||
129789534|NCT01426789|467195659|FG002|Part 2|Withdrawal by Subject|0|||
129789535|NCT01426789|467195660|FG003|Part 2|Withdrawal by Subject|1|||
129789536|NCT01426789|467195661|FG004|Part 2|Withdrawal by Subject|2|||
129789537|NCT01426789|467195662|FG005|Part 2|Withdrawal by Subject|0|||
129789538|NCT01426789|467195657|FG000|Part 2|Lack of Efficacy|0|||
129789539|NCT01426789|467195658|FG001|Part 2|Lack of Efficacy|0|||
129789540|NCT01426789|467195659|FG002|Part 2|Lack of Efficacy|5|||
129789541|NCT01426789|467195660|FG003|Part 2|Lack of Efficacy|0|||
129789542|NCT01426789|467195661|FG004|Part 2|Lack of Efficacy|2|||
129789543|NCT01426789|467195662|FG005|Part 2|Lack of Efficacy|0|||
129789544|NCT01426789|467195657|FG000|Part 2|Adverse Event|0|||
129789545|NCT01426789|467195658|FG001|Part 2|Adverse Event|0|||
129789546|NCT01426789|467195659|FG002|Part 2|Adverse Event|2|||
129789547|NCT01426789|467195660|FG003|Part 2|Adverse Event|0|||
129698208|NCT00414609|466854946|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
129698209|NCT00414609|466854947|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
129698210|NCT00414609|466854945|FG000|Extension Study|Withdrawal by Subject|0|||
129698211|NCT00414609|466854946|FG001|Extension Study|Withdrawal by Subject|0|||
129698212|NCT00414609|466854947|FG002|Extension Study|Withdrawal by Subject|13|||
129698213|NCT00414609|466854945|FG000|Extension Study|Lost to Follow-up|0|||
129698214|NCT00414609|466854946|FG001|Extension Study|Lost to Follow-up|0|||
129436965|NCT01275131|465897249|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
129698215|NCT00414609|466854947|FG002|Extension Study|Lost to Follow-up|10|||
129698216|NCT00414609|466854945|FG000|Extension Study|Administrative problems|0|||
129886115|NCT00531011|467542854|FG001|Overall Study|Lost to Follow-up|0|||
129789548|NCT01426789|467195661|FG004|Part 2|Adverse Event|1|||
129789549|NCT01426789|467195662|FG005|Part 2|Adverse Event|0|||
129789550|NCT01181986|467195663|FG000|Phase 1|Lost to Follow-up|0|||
129436966|NCT01275131|465897250|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
129436967|NCT01275131|465897251|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
129436968|NCT00529958|465897252|FG000|2-Year Follow-up|Lost to Follow-up|1|||
129436969|NCT00529958|465897253|FG001|2-Year Follow-up|Lost to Follow-up|2|||
129436970|NCT00529958|465897254|FG002|2-Year Follow-up|Lost to Follow-up|2|||
129436971|NCT00529958|465897252|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
129436972|NCT00529958|465897253|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
129436973|NCT00529958|465897254|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
129436974|NCT00529958|465897252|FG000|5-Year Follow-up|Lost to Follow-up|2|||
129436975|NCT00529958|465897253|FG001|5-Year Follow-up|Lost to Follow-up|3|||
129436976|NCT00529958|465897254|FG002|5-Year Follow-up|Lost to Follow-up|1|||
129436977|NCT00529958|465897252|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
129436978|NCT00529958|465897253|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
129436979|NCT00529958|465897254|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
129436980|NCT03316300|465897255|FG000|Overall Study|Withdrawal by Subject|3|||
129436981|NCT03316300|465897256|FG001|Overall Study|Withdrawal by Subject|2|||
129436982|NCT03316300|465897255|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
129436983|NCT03316300|465897256|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
129436984|NCT03316300|465897255|FG000|Overall Study|Adverse Event|1|||
129436985|NCT03316300|465897256|FG001|Overall Study|Adverse Event|0|||
129436986|NCT03316300|465897255|FG000|Overall Study|COVID-19|0|||
129436987|NCT03316300|465897256|FG001|Overall Study|COVID-19|1|||
129436988|NCT01315353|465897257|FG000|Overall Study|Death|2|||
129436989|NCT01315353|465897258|FG001|Overall Study|Death|1|||
129436990|NCT01315353|465897259|FG002|Overall Study|Death|0|||
129436991|NCT01315353|465897257|FG000|Overall Study|Withdrawal by Subject|2|||
129436992|NCT01315353|465897258|FG001|Overall Study|Withdrawal by Subject|6|||
129436993|NCT01315353|465897259|FG002|Overall Study|Withdrawal by Subject|1|||
129436994|NCT01315353|465897257|FG000|Overall Study|Lost to Follow-up|13|||
129436995|NCT01315353|465897258|FG001|Overall Study|Lost to Follow-up|6|||
129436996|NCT01315353|465897259|FG002|Overall Study|Lost to Follow-up|6|||
129436997|NCT01315353|465897257|FG000|Overall Study|Unwilling to adhere to requirements|5|||
129436998|NCT01315353|465897258|FG001|Overall Study|Unwilling to adhere to requirements|5|||
129436999|NCT01315353|465897259|FG002|Overall Study|Unwilling to adhere to requirements|4|||
129437000|NCT01315353|465897257|FG000|Overall Study|Site closing|7|||
129437001|NCT01315353|465897258|FG001|Overall Study|Site closing|4|||
129437002|NCT01315353|465897259|FG002|Overall Study|Site closing|0|||
129437003|NCT01315353|465897257|FG000|Overall Study|Taken off study by site in error|0|||
129437004|NCT01315353|465897258|FG001|Overall Study|Taken off study by site in error|1|||
129437005|NCT01315353|465897259|FG002|Overall Study|Taken off study by site in error|0|||
129437006|NCT01315353|465897257|FG000|Overall Study|Inadvertent randomization/assignment|0|||
129437007|NCT01315353|465897258|FG001|Overall Study|Inadvertent randomization/assignment|0|||
129437008|NCT01315353|465897259|FG002|Overall Study|Inadvertent randomization/assignment|2|||
129437009|NCT03567434|465897260|FG000|Overall Study|Lost to Follow-up|1|||
129437010|NCT03567434|465897261|FG001|Overall Study|Lost to Follow-up|3|||
129437011|NCT01050790|465897263|FG000|Overall Study|Adverse Event|1|||
129437012|NCT03705832|465897264|FG000|Overall Study|Physician Decision|0|||
129437013|NCT03705832|465897265|FG001|Overall Study|Physician Decision|1|||
129437014|NCT03705832|465897264|FG000|Overall Study|Withdrawal by Subject|1|||
129437015|NCT03705832|465897265|FG001|Overall Study|Withdrawal by Subject|0|||
129437016|NCT01880528|465897266|FG000|Overall Study|Other|1|||
129437017|NCT01880528|465897267|FG001|Overall Study|Other|1|||
129437018|NCT01439360|465897268|FG000|Overall Study|Adverse Event|4|||
129437019|NCT01439360|465897269|FG001|Overall Study|Adverse Event|16|||
129437020|NCT01439360|465897268|FG000|Overall Study|Lost to Follow-up|43|||
129437021|NCT01439360|465897269|FG001|Overall Study|Lost to Follow-up|58|||
129437022|NCT01439360|465897268|FG000|Overall Study|Others|10|||
129437023|NCT01439360|465897269|FG001|Overall Study|Others|5|||
129437024|NCT01439360|465897268|FG000|Overall Study|Protocol Violation|1|||
129437025|NCT01439360|465897269|FG001|Overall Study|Protocol Violation|0|||
129437026|NCT01439360|465897268|FG000|Overall Study|Withdrawal by Subject|140|||
129437027|NCT01439360|465897269|FG001|Overall Study|Withdrawal by Subject|129|||
129437028|NCT03440320|465898603|FG000|Overall Study|Withdrawal by Subject|0|||
129437029|NCT03440320|465898604|FG001|Overall Study|Withdrawal by Subject|1|||
129437030|NCT01912456|465898605|FG000|Period 1|Physician Decision|0|||
129437031|NCT01912456|465898606|FG001|Period 1|Physician Decision|0|||
129437032|NCT01912456|465898607|FG002|Period 1|Physician Decision|1|||
129437033|NCT01912456|465898608|FG003|Period 1|Physician Decision|0|||
129437034|NCT01912456|465898605|FG000|Period 1|non-compliance|1|||
129437035|NCT01912456|465898606|FG001|Period 1|non-compliance|0|||
129437036|NCT01912456|465898607|FG002|Period 1|non-compliance|0|||
129437037|NCT01912456|465898608|FG003|Period 1|non-compliance|1|||
129437038|NCT01912456|465898605|FG000|Period 1|Adverse Event|1|||
129437039|NCT01912456|465898606|FG001|Period 1|Adverse Event|0|||
129437040|NCT01912456|465898607|FG002|Period 1|Adverse Event|0|||
129437041|NCT01912456|465898608|FG003|Period 1|Adverse Event|1|||
129437042|NCT01912456|465898605|FG000|Period 1|Withdrawal by Subject|0|||
129437043|NCT01912456|465898606|FG001|Period 1|Withdrawal by Subject|1|||
129789551|NCT01181986|467195664|FG001|Phase 1|Lost to Follow-up|1|||
129789552|NCT01181986|467195665|FG002|Phase 1|Lost to Follow-up|1|||
129789553|NCT01181986|467195663|FG000|Phase 1|Adverse Event|0|||
129789554|NCT01181986|467195664|FG001|Phase 1|Adverse Event|0|||
129789555|NCT01181986|467195665|FG002|Phase 1|Adverse Event|1|||
129789556|NCT01181986|467195663|FG000|Phase 1|Protocol Violation|1|||
129789557|NCT01181986|467195664|FG001|Phase 1|Protocol Violation|0|||
129789558|NCT01181986|467195665|FG002|Phase 1|Protocol Violation|0|||
129789559|NCT01181986|467195663|FG000|Phase 2|Adverse Event|0|||
129789560|NCT01181986|467195664|FG001|Phase 2|Adverse Event|3|||
129789561|NCT01181986|467195665|FG002|Phase 2|Adverse Event|0|||
129789562|NCT01181986|467195663|FG000|Phase 2|Medical condition|0|||
129789563|NCT01181986|467195664|FG001|Phase 2|Medical condition|1|||
129789564|NCT01181986|467195665|FG002|Phase 2|Medical condition|0|||
129789565|NCT00311584|467195668|FG000|Overall Study|Death|1|||
129789566|NCT00311584|467195669|FG001|Overall Study|Death|0|||
129789567|NCT00311584|467195668|FG000|Overall Study|Lack of Efficacy|12|||
129789568|NCT00311584|467195669|FG001|Overall Study|Lack of Efficacy|15|||
129789569|NCT00311584|467195668|FG000|Overall Study|Physician Decision|4|||
129789570|NCT00311584|467195669|FG001|Overall Study|Physician Decision|5|||
129789571|NCT00311584|467195668|FG000|Overall Study|Withdrawal by Subject|1|||
129789572|NCT00311584|467195669|FG001|Overall Study|Withdrawal by Subject|1|||
129789573|NCT00311584|467195668|FG000|Overall Study|ineligible|2|||
129789574|NCT00311584|467195669|FG001|Overall Study|ineligible|2|||
129789575|NCT03073733|467195670|FG000|Overall Study|Lost to Follow-up|1|||
129789576|NCT03073733|467195671|FG001|Overall Study|Lost to Follow-up|0|||
129789577|NCT03073733|467195672|FG002|Overall Study|Lost to Follow-up|0|||
129789578|NCT03073733|467195670|FG000|Overall Study|Physician Decision|0|||
129789579|NCT03073733|467195671|FG001|Overall Study|Physician Decision|1|||
129789580|NCT03073733|467195672|FG002|Overall Study|Physician Decision|0|||
129789581|NCT03073733|467195670|FG000|Overall Study|Withdrawal by Subject|0|||
129789582|NCT03073733|467195671|FG001|Overall Study|Withdrawal by Subject|0|||
129789583|NCT03073733|467195672|FG002|Overall Study|Withdrawal by Subject|1|||
129789584|NCT00835731|467195673|FG000|Overall Study|Withdrawal by Subject|1|||
129789585|NCT00835731|467195674|FG001|Overall Study|Withdrawal by Subject|0|||
129437044|NCT01912456|465898607|FG002|Period 1|Withdrawal by Subject|1|||
129789586|NCT00835731|467195673|FG000|Overall Study|Physician Decision|1|||
129789587|NCT00835731|467195674|FG001|Overall Study|Physician Decision|1|||
129789588|NCT01155167|467195675|FG000|Overall Study|Insufficient ultrasound data|2|||
129789589|NCT01155167|467195676|FG001|Overall Study|Insufficient ultrasound data|0|||
129789590|NCT01155167|467195675|FG000|Overall Study|Access site changed to femoral artery|1|||
129789591|NCT01155167|467195676|FG001|Overall Study|Access site changed to femoral artery|0|||
129789592|NCT00167778|467195677|FG000|Overall Study|Withdrawal by Subject|1|||
129789593|NCT02654717|467195678|FG000|Overall Study|Adverse Event|2|||
129789594|NCT02654717|467195679|FG001|Overall Study|Adverse Event|2|||
129789595|NCT02654717|467195678|FG000|Overall Study|Protocol Violation|1|||
129789596|NCT02654717|467195679|FG001|Overall Study|Protocol Violation|2|||
129789597|NCT02654717|467195678|FG000|Overall Study|Withdrawal by Subject|0|||
129789598|NCT02654717|467195679|FG001|Overall Study|Withdrawal by Subject|1|||
129789599|NCT02654717|467195678|FG000|Overall Study|Non-permitted medication|3|||
129698217|NCT00414609|466854946|FG001|Extension Study|Administrative problems|0|||
129437045|NCT01912456|465898608|FG003|Period 1|Withdrawal by Subject|1|||
129698218|NCT00414609|466854947|FG002|Extension Study|Administrative problems|1|||
129886116|NCT00531011|467542853|FG000|Overall Study|Physician Decision|0|||
129886117|NCT00531011|467542854|FG001|Overall Study|Physician Decision|3|||
129605016|NCT00667810|466513324|FG001|Overall Study|Protocol Violation|2|||
129605017|NCT00667810|466513325|FG002|Overall Study|Protocol Violation|0|||
129605018|NCT00667810|466513326|FG003|Overall Study|Protocol Violation|0|||
129605019|NCT00667810|466513323|FG000|Overall Study|Withdrawal by Subject|14|||
129605020|NCT00667810|466513324|FG001|Overall Study|Withdrawal by Subject|20|||
129605021|NCT00667810|466513325|FG002|Overall Study|Withdrawal by Subject|29|||
129605022|NCT00667810|466513326|FG003|Overall Study|Withdrawal by Subject|1|||
129605023|NCT00667810|466513323|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
129605024|NCT00667810|466513324|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
129605025|NCT00667810|466513325|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
129605026|NCT00667810|466513326|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129605027|NCT00667810|466513323|FG000|Overall Study|Failed to Return|0|||
129605028|NCT00667810|466513324|FG001|Overall Study|Failed to Return|0|||
129605029|NCT00667810|466513325|FG002|Overall Study|Failed to Return|2|||
129605030|NCT00667810|466513326|FG003|Overall Study|Failed to Return|0|||
129789600|NCT02654717|467195679|FG001|Overall Study|Non-permitted medication|0|||
129789601|NCT02880956|467195681|FG000|Overall Study|Adverse Event|3|||
129789602|NCT02880956|467195682|FG001|Overall Study|Adverse Event|6|||
129789603|NCT02880956|467195683|FG002|Overall Study|Adverse Event|5|||
129789604|NCT02880956|467195684|FG003|Overall Study|Adverse Event|4|||
129789605|NCT02880956|467195681|FG000|Overall Study|Withdrawal by Subject|9|||
129789606|NCT02880956|467195682|FG001|Overall Study|Withdrawal by Subject|4|||
129789607|NCT02880956|467195683|FG002|Overall Study|Withdrawal by Subject|6|||
129789608|NCT02880956|467195684|FG003|Overall Study|Withdrawal by Subject|11|||
129789609|NCT02880956|467195681|FG000|Overall Study|Lost to Follow-up|0|||
129789610|NCT02880956|467195682|FG001|Overall Study|Lost to Follow-up|1|||
129789611|NCT02880956|467195683|FG002|Overall Study|Lost to Follow-up|0|||
129789612|NCT02880956|467195684|FG003|Overall Study|Lost to Follow-up|0|||
129789613|NCT02880956|467195681|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129789614|NCT02880956|467195682|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
129789615|NCT02880956|467195683|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
129886118|NCT02206152|467542877|FG000|Pre-Randomization|Withdrawal by Subject|2|||
129886119|NCT00478608|467542878|FG000|Overall Study|Adverse Event|1|||
129886120|NCT00478608|467542878|FG000|Overall Study|Serious Adverse Event|14|||
129886121|NCT00478608|467542878|FG000|Overall Study|Withdrawal by Subject|2|||
129886122|NCT00478608|467542878|FG000|Overall Study|Protocol Violation|3|||
129886123|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
129886124|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
129886125|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
129886126|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
129886127|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129886128|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
129886129|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129886130|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
129886131|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
129886132|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
129886133|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129886134|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
129886135|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
129886136|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
129886137|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129886138|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
129886139|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
129886140|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
129886141|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
129886142|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
129886143|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
129886144|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
129886145|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
129886146|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
129886147|NCT03230864|467542885|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
129886148|NCT03230864|467542886|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
129886149|NCT03230864|467542887|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
129886150|NCT03230864|467542888|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
129886151|NCT03230864|467542885|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
129886152|NCT03230864|467542886|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
129886153|NCT03230864|467542887|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
129886154|NCT03230864|467542888|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
129886155|NCT03230864|467542885|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129886156|NCT03230864|467542886|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129886157|NCT03230864|467542887|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
129886158|NCT03230864|467542888|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
129886159|NCT03230864|467542885|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
129886160|NCT03230864|467542886|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
129886161|NCT03230864|467542887|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
129886162|NCT03230864|467542888|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
129886163|NCT01744496|467542893|FG000|Titration Period|Adverse Event|2|||
129886164|NCT01744496|467542894|FG001|Titration Period|Adverse Event|1|||
129886165|NCT01744496|467542893|FG000|Titration Period|Personal reasons|0|||
129886166|NCT01744496|467542894|FG001|Titration Period|Personal reasons|1|||
129886167|NCT01744496|467542893|FG000|Maintenance Period|Adverse Event|1|||
129886168|NCT01744496|467542894|FG001|Maintenance Period|Adverse Event|3|||
129886169|NCT01744496|467542893|FG000|Maintenance Period|Protocol Violation|1|||
129886170|NCT01744496|467542894|FG001|Maintenance Period|Protocol Violation|0|||
129886171|NCT01744496|467542893|FG000|Maintenance Period|Withdrawal by Subject|1|||
129886172|NCT01744496|467542894|FG001|Maintenance Period|Withdrawal by Subject|1|||
129437046|NCT01912456|465898605|FG000|Period 2|Lack of Efficacy|0|||
129437047|NCT01912456|465898606|FG001|Period 2|Lack of Efficacy|2|||
129886173|NCT01744496|467542893|FG000|Maintenance Period|Subject left town|1|||
129886174|NCT01744496|467542894|FG001|Maintenance Period|Subject left town|0|||
129886175|NCT02374593|467542900|FG000|Overall Study|non-compliant|2|||
129886176|NCT02374593|467542901|FG001|Overall Study|non-compliant|0|||
129886177|NCT00579982|467542902|FG000|Overall Study|Adverse Event|4|||
129886178|NCT00579982|467542902|FG000|Overall Study|Protocol Violation|4|||
129886179|NCT04827134|467542903|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
129886180|NCT04827134|467542904|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
129886181|NCT04827134|467542905|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
129886182|NCT04827134|467542906|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
129886183|NCT00287469|467542910|FG000|Overall Study|serious adverse event|1|||
129886184|NCT00287469|467542911|FG001|Overall Study|serious adverse event|6|||
129437048|NCT01912456|465898607|FG002|Period 2|Lack of Efficacy|0|||
129789616|NCT02880956|467195684|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
129789617|NCT02880956|467195681|FG000|Overall Study|Other, Not Specified|4|||
129789618|NCT02880956|467195682|FG001|Overall Study|Other, Not Specified|2|||
129789619|NCT02880956|467195683|FG002|Overall Study|Other, Not Specified|0|||
129789620|NCT02880956|467195684|FG003|Overall Study|Other, Not Specified|3|||
129800249|NCT05597020|467236279|FG001|Treatment Period II|Advice from primary care physician|0|||
129800250|NCT05597020|467236278|FG000|Treatment Period II|Subject lost investigational product|1|||
129800251|NCT05597020|467236279|FG001|Treatment Period II|Subject lost investigational product|0|||
129800252|NCT05597020|467236278|FG000|Treatment Period II|Private reasons|0|||
129800253|NCT05597020|467236279|FG001|Treatment Period II|Private reasons|1|||
129800254|NCT02445391|467236290|FG000|Overall Study|No active protocol treatment|3|||
129800255|NCT02445391|467236291|FG001|Overall Study|No active protocol treatment|0|||
129800256|NCT02445391|467236292|FG002|Overall Study|No active protocol treatment|0|||
129800257|NCT02445391|467236290|FG000|Overall Study|Adverse Event|0|||
129437049|NCT01912456|465898608|FG003|Period 2|Lack of Efficacy|0|||
129437050|NCT01912456|465898605|FG000|Period 2|Adverse Event|0|||
129789621|NCT00576420|467197707|FG000|Overall Study|Death|0|||
129789622|NCT00576420|467197708|FG001|Overall Study|Death|0|||
129789623|NCT00576420|467197709|FG002|Overall Study|Death|1|||
129789624|NCT01340872|467197711|FG000|Double-blind Phase|Adverse Event|6|||
129789625|NCT01340872|467197712|FG001|Double-blind Phase|Adverse Event|4|||
129437051|NCT01912456|465898606|FG001|Period 2|Adverse Event|0|||
129437052|NCT01912456|465898607|FG002|Period 2|Adverse Event|0|||
129437053|NCT01912456|465898608|FG003|Period 2|Adverse Event|1|||
129789626|NCT01340872|467197713|FG002|Double-blind Phase|Adverse Event|0|||
129789627|NCT01340872|467197714|FG003|Double-blind Phase|Adverse Event|0|||
129789628|NCT01340872|467197711|FG000|Double-blind Phase|Withdrawal by Subject|3|||
129789629|NCT01340872|467197712|FG001|Double-blind Phase|Withdrawal by Subject|5|||
129789630|NCT01340872|467197713|FG002|Double-blind Phase|Withdrawal by Subject|0|||
129789631|NCT01340872|467197714|FG003|Double-blind Phase|Withdrawal by Subject|0|||
129789632|NCT01340872|467197711|FG000|Double-blind Phase|Lost to Follow-up|0|||
129789633|NCT01340872|467197712|FG001|Double-blind Phase|Lost to Follow-up|1|||
129789634|NCT01340872|467197713|FG002|Double-blind Phase|Lost to Follow-up|0|||
129789635|NCT01340872|467197714|FG003|Double-blind Phase|Lost to Follow-up|0|||
129789636|NCT01340872|467197711|FG000|Double-blind Phase|Protocol Violation|0|||
129789637|NCT01340872|467197712|FG001|Double-blind Phase|Protocol Violation|1|||
129789638|NCT01340872|467197713|FG002|Double-blind Phase|Protocol Violation|0|||
129789639|NCT01340872|467197714|FG003|Double-blind Phase|Protocol Violation|0|||
129789640|NCT01340872|467197711|FG000|Open-label Phase|Physician Decision|0|||
129789641|NCT01340872|467197712|FG001|Open-label Phase|Physician Decision|0|||
129789642|NCT01340872|467197713|FG002|Open-label Phase|Physician Decision|2|||
129789643|NCT01340872|467197714|FG003|Open-label Phase|Physician Decision|1|||
129789644|NCT01340872|467197711|FG000|Open-label Phase|Pregnancy|0|||
129789645|NCT01340872|467197712|FG001|Open-label Phase|Pregnancy|0|||
129789646|NCT01340872|467197713|FG002|Open-label Phase|Pregnancy|1|||
129789647|NCT01340872|467197714|FG003|Open-label Phase|Pregnancy|0|||
129886185|NCT00287469|467542910|FG000|Overall Study|Adverse Event|1|||
129886186|NCT00287469|467542911|FG001|Overall Study|Adverse Event|1|||
129886187|NCT00287469|467542910|FG000|Overall Study|moved from area|144|||
129886188|NCT00287469|467542911|FG001|Overall Study|moved from area|138|||
129886189|NCT00287469|467542910|FG000|Overall Study|Lost to Follow-up|74|||
129886190|NCT00287469|467542911|FG001|Overall Study|Lost to Follow-up|69|||
129886191|NCT00507026|467542917|FG000|Overall Study|Lack of Efficacy|6|||
129886192|NCT00507026|467542918|FG001|Overall Study|Lack of Efficacy|4|||
129886193|NCT00507026|467542919|FG002|Overall Study|Lack of Efficacy|21|||
129886194|NCT00507026|467542917|FG000|Overall Study|Withdrawal by Subject|2|||
129789648|NCT01340872|467197711|FG000|Open-label Phase|Adverse Event|0|||
129789649|NCT01340872|467197712|FG001|Open-label Phase|Adverse Event|0|||
129789650|NCT01340872|467197713|FG002|Open-label Phase|Adverse Event|8|||
129789651|NCT01340872|467197714|FG003|Open-label Phase|Adverse Event|4|||
129789652|NCT01340872|467197711|FG000|Open-label Phase|Withdrawal by Subject|0|||
129789653|NCT01340872|467197712|FG001|Open-label Phase|Withdrawal by Subject|0|||
129789654|NCT01340872|467197713|FG002|Open-label Phase|Withdrawal by Subject|1|||
129789655|NCT01340872|467197714|FG003|Open-label Phase|Withdrawal by Subject|6|||
129789656|NCT01340872|467197711|FG000|Open-label Phase|Worsening of IBD|0|||
129789657|NCT01340872|467197712|FG001|Open-label Phase|Worsening of IBD|0|||
129789658|NCT01340872|467197713|FG002|Open-label Phase|Worsening of IBD|1|||
129437054|NCT01201343|465898609|FG000|Overall Study|Adverse Event|6|||
129437055|NCT01201343|465898609|FG000|Overall Study|Withdrawal by Subject|5|||
129789659|NCT01340872|467197714|FG003|Open-label Phase|Worsening of IBD|0|||
129789660|NCT01771809|467197717|FG000|Overall Study|Adverse Event|4|||
129886195|NCT00507026|467542918|FG001|Overall Study|Withdrawal by Subject|0|||
129789661|NCT01771809|467197718|FG001|Overall Study|Adverse Event|12|||
129789662|NCT01771809|467197717|FG000|Overall Study|Protocol Violation|0|||
129789663|NCT01771809|467197718|FG001|Overall Study|Protocol Violation|1|||
129886196|NCT00507026|467542919|FG002|Overall Study|Withdrawal by Subject|0|||
129886197|NCT00507026|467542917|FG000|Overall Study|Investigator Decision|1|||
129886198|NCT00507026|467542918|FG001|Overall Study|Investigator Decision|0|||
129886199|NCT00507026|467542919|FG002|Overall Study|Investigator Decision|0|||
129886200|NCT00507026|467542917|FG000|Overall Study|Adverse Event|2|||
129886201|NCT00507026|467542918|FG001|Overall Study|Adverse Event|0|||
129886202|NCT00507026|467542919|FG002|Overall Study|Adverse Event|0|||
129886203|NCT00507026|467542917|FG000|Overall Study|Protocol Violation|1|||
129886204|NCT00507026|467542918|FG001|Overall Study|Protocol Violation|0|||
129886205|NCT00507026|467542919|FG002|Overall Study|Protocol Violation|0|||
129886206|NCT00507026|467542917|FG000|Overall Study|Other|1|||
129886207|NCT00507026|467542918|FG001|Overall Study|Other|0|||
129886208|NCT00507026|467542919|FG002|Overall Study|Other|0|||
129886209|NCT02372058|467542920|FG000|Overall Study|Withdrawal by Subject|3|||
129886210|NCT00972179|467542924|FG000|Overall Study|Noncompliance|1|||
129886211|NCT00972179|467542925|FG001|Overall Study|Noncompliance|0|||
129886212|NCT00972179|467542926|FG002|Overall Study|Noncompliance|0|||
129886213|NCT00972179|467542927|FG003|Overall Study|Noncompliance|0|||
129886214|NCT00972179|467542928|FG004|Overall Study|Noncompliance|1|||
129886215|NCT00972179|467542929|FG005|Overall Study|Noncompliance|0|||
129886216|NCT00972179|467542930|FG006|Overall Study|Noncompliance|1|||
129886217|NCT00972179|467542924|FG000|Overall Study|Withdrawal by Subject|0|||
129886218|NCT00972179|467542925|FG001|Overall Study|Withdrawal by Subject|3|||
129886219|NCT00972179|467542926|FG002|Overall Study|Withdrawal by Subject|0|||
129886220|NCT00972179|467542927|FG003|Overall Study|Withdrawal by Subject|1|||
129886221|NCT00972179|467542928|FG004|Overall Study|Withdrawal by Subject|0|||
129886222|NCT00972179|467542929|FG005|Overall Study|Withdrawal by Subject|0|||
129886223|NCT00972179|467542930|FG006|Overall Study|Withdrawal by Subject|2|||
129886224|NCT00972179|467542924|FG000|Overall Study|Administrative Decision|0|||
129886225|NCT00972179|467542925|FG001|Overall Study|Administrative Decision|0|||
129886226|NCT00972179|467542926|FG002|Overall Study|Administrative Decision|0|||
129886227|NCT00972179|467542927|FG003|Overall Study|Administrative Decision|0|||
129886228|NCT00972179|467542928|FG004|Overall Study|Administrative Decision|1|||
129886229|NCT00972179|467542929|FG005|Overall Study|Administrative Decision|0|||
129886230|NCT00972179|467542930|FG006|Overall Study|Administrative Decision|0|||
129886231|NCT00972179|467542924|FG000|Overall Study|Lost to Follow-up|0|||
129789664|NCT01771809|467197717|FG000|Overall Study|Withdrawal by Subject|34|||
129789665|NCT01771809|467197718|FG001|Overall Study|Withdrawal by Subject|42|||
129789666|NCT01771809|467197717|FG000|Overall Study|Lost to Follow-up|1|||
129789667|NCT01771809|467197718|FG001|Overall Study|Lost to Follow-up|3|||
129789668|NCT01771809|467197717|FG000|Overall Study|Other (Insufficient clinical response)|22|||
129789669|NCT01771809|467197718|FG001|Overall Study|Other (Insufficient clinical response)|20|||
129789670|NCT01771809|467197717|FG000|Overall Study|Death|1|||
129789671|NCT01771809|467197718|FG001|Overall Study|Death|0|||
129789672|NCT01771809|467197717|FG000|Overall Study|Other (other)|9|||
129789673|NCT01771809|467197718|FG001|Overall Study|Other (other)|5|||
129789674|NCT01142089|467197730|FG000|Overall Study|Physician Decision|1|||
129789675|NCT01142089|467197731|FG001|Overall Study|Physician Decision|0|||
129789676|NCT01142089|467197730|FG000|Overall Study|Withdrawal by Subject|1|||
129789677|NCT01142089|467197731|FG001|Overall Study|Withdrawal by Subject|2|||
129789678|NCT01142089|467197730|FG000|Overall Study|Use of prohibited medications|0|||
129789679|NCT01142089|467197731|FG001|Overall Study|Use of prohibited medications|1|||
129789680|NCT01142089|467197730|FG000|Overall Study|Noncompliance with study procedures|2|||
129789681|NCT01142089|467197731|FG001|Overall Study|Noncompliance with study procedures|1|||
129789682|NCT01142089|467197730|FG000|Overall Study|Patient required rescue medication|8|||
129886232|NCT00972179|467542925|FG001|Overall Study|Lost to Follow-up|0|||
129886233|NCT00972179|467542926|FG002|Overall Study|Lost to Follow-up|1|||
129789683|NCT01142089|467197731|FG001|Overall Study|Patient required rescue medication|17|||
129789684|NCT02907892|467197736|FG000|Overall Study|Lost to Follow-up|27|||
129789685|NCT02907892|467197737|FG001|Overall Study|Lost to Follow-up|40|||
129789686|NCT01974765|467197738|FG000|Overall Study|Withdrawal by Subject|1|||
129886234|NCT00972179|467542927|FG003|Overall Study|Lost to Follow-up|0|||
129886235|NCT00972179|467542928|FG004|Overall Study|Lost to Follow-up|0|||
129886236|NCT00972179|467542929|FG005|Overall Study|Lost to Follow-up|3|||
129886237|NCT00972179|467542930|FG006|Overall Study|Lost to Follow-up|1|||
129886238|NCT02061761|467542931|FG000|Overall Study|Disease progression|2|||
129886239|NCT02061761|467542932|FG001|Overall Study|Disease progression|8|||
129789687|NCT01974765|467197738|FG000|Overall Study|Death|1|||
129886240|NCT02061761|467542933|FG002|Overall Study|Disease progression|4|||
129789688|NCT01974765|467197738|FG000|Overall Study|Adverse Event|2|||
129789689|NCT03860935|467197742|FG000|Overall Study|Withdrawal of Consent|15|||
129789690|NCT03860935|467197743|FG001|Overall Study|Withdrawal of Consent|6|||
129789691|NCT03860935|467197742|FG000|Overall Study|Death|75|||
129789692|NCT03860935|467197743|FG001|Overall Study|Death|51|||
129789693|NCT03086967|467197744|FG000|Overall Study|Screen Failure|2|||
129789694|NCT03086967|467197745|FG001|Overall Study|Screen Failure|2|||
129789695|NCT01430754|467197748|FG000|Run-In Phase|Circadian Period Ineligible|24|||
129789696|NCT01430754|467197749|FG001|Run-In Phase|Circadian Period Ineligible|0|||
129789697|NCT01430754|467197748|FG000|Run-In Phase|Protocol Violation|6|||
129789698|NCT01430754|467197749|FG001|Run-In Phase|Protocol Violation|0|||
129789699|NCT01430754|467197748|FG000|Run-In Phase|Adverse Event|2|||
129789700|NCT01430754|467197749|FG001|Run-In Phase|Adverse Event|0|||
129789701|NCT01430754|467197748|FG000|Run-In Phase|Other|2|||
129789702|NCT01430754|467197749|FG001|Run-In Phase|Other|0|||
129789703|NCT01430754|467197748|FG000|Run-In Phase|Withdrawal by Subject|2|||
129789704|NCT01430754|467197749|FG001|Run-In Phase|Withdrawal by Subject|0|||
129789705|NCT01430754|467197748|FG000|Run-In Phase|Lost to Follow-up|1|||
129789706|NCT01430754|467197749|FG001|Run-In Phase|Lost to Follow-up|0|||
129789707|NCT02230527|467197751|FG000|Overall Study|Withdrawal by Subject|1|||
129789708|NCT02230527|467197752|FG001|Overall Study|Withdrawal by Subject|1|||
129789709|NCT02230527|467197751|FG000|Overall Study|Death|1|||
129789710|NCT02230527|467197752|FG001|Overall Study|Death|0|||
129789711|NCT02230527|467197751|FG000|Overall Study|Lost to Follow-up|2|||
129789712|NCT02230527|467197752|FG001|Overall Study|Lost to Follow-up|1|||
129789713|NCT02230527|467197751|FG000|Overall Study|Other|1|||
129789714|NCT02230527|467197752|FG001|Overall Study|Other|0|||
129789715|NCT04461600|467197753|FG000|Overall Study|Death|6|||
129789716|NCT04461600|467197754|FG001|Overall Study|Death|5|||
129789717|NCT04461600|467197753|FG000|Overall Study|Withdrawal by Subject|0|||
129789718|NCT04461600|467197754|FG001|Overall Study|Withdrawal by Subject|1|||
129789719|NCT00704522|467197760|FG000|Overall Study|Lack of Efficacy|65|||
129789720|NCT00704522|467197761|FG001|Overall Study|Lack of Efficacy|17|||
129789721|NCT00704522|467197760|FG000|Overall Study|Failure to appear again at hospital|56|||
129789722|NCT00704522|467197761|FG001|Overall Study|Failure to appear again at hospital|10|||
129789723|NCT00704522|467197760|FG000|Overall Study|Withdrawal by Subject|17|||
129789724|NCT00704522|467197761|FG001|Overall Study|Withdrawal by Subject|8|||
129789725|NCT00704522|467197760|FG000|Overall Study|Adverse Event|9|||
129789726|NCT00704522|467197761|FG001|Overall Study|Adverse Event|1|||
129789727|NCT00704522|467197760|FG000|Overall Study|Undefined causes|9|||
129789728|NCT00704522|467197761|FG001|Overall Study|Undefined causes|7|||
129789729|NCT00704522|467197760|FG000|Overall Study|No information on therapy end|27|||
129789730|NCT00704522|467197761|FG001|Overall Study|No information on therapy end|2|||
129789731|NCT00775203|467197762|FG000|Overall Study|Adverse Event|25|||
129789732|NCT00775203|467197763|FG001|Overall Study|Adverse Event|6|||
129789733|NCT00775203|467197762|FG000|Overall Study|Lack of Efficacy|8|||
129789734|NCT00775203|467197763|FG001|Overall Study|Lack of Efficacy|9|||
129789735|NCT00775203|467197762|FG000|Overall Study|Withdrawal by Subject|11|||
129789736|NCT00775203|467197763|FG001|Overall Study|Withdrawal by Subject|9|||
129789737|NCT00775203|467197762|FG000|Overall Study|Lost to Follow-up|11|||
129789738|NCT00775203|467197763|FG001|Overall Study|Lost to Follow-up|15|||
129789739|NCT00775203|467197762|FG000|Overall Study|Administrative reason|2|||
129789740|NCT00775203|467197763|FG001|Overall Study|Administrative reason|0|||
129789741|NCT00775203|467197762|FG000|Overall Study|Noncompliance|4|||
129789742|NCT00775203|467197763|FG001|Overall Study|Noncompliance|2|||
129789743|NCT00775203|467197762|FG000|Overall Study|Protocol Violation|0|||
129789744|NCT00775203|467197763|FG001|Overall Study|Protocol Violation|1|||
129789745|NCT00775203|467197762|FG000|Overall Study|Entered other study|1|||
129789746|NCT00775203|467197763|FG001|Overall Study|Entered other study|0|||
129789747|NCT00775203|467197762|FG000|Overall Study|Physician Decision|0|||
129789748|NCT00775203|467197763|FG001|Overall Study|Physician Decision|1|||
129789749|NCT00701662|467197764|FG000|Overall Study|Lack of Efficacy|1|||
129789750|NCT00635024|467197765|FG000|Overall Study|Adverse Event|1|||
129789751|NCT01105065|467197766|FG000|Overall Study|Adverse Event|5|||
129789752|NCT01105065|467197766|FG000|Overall Study|Technical Problems|1|||
129789753|NCT02984943|467197767|FG000|Overall Study|Withdrawal by Subject|3|||
129789754|NCT02984943|467197767|FG000|Overall Study|Physician Decision|1|||
129789755|NCT04575597|467197770|FG000|Overall Study|Death|0|||
129789756|NCT04575597|467197771|FG001|Overall Study|Death|0|||
129789757|NCT04575597|467197772|FG002|Overall Study|Death|0|||
129789758|NCT04575597|467197773|FG003|Overall Study|Death|1|||
129789759|NCT04575597|467197774|FG004|Overall Study|Death|3|||
129789760|NCT04575597|467197775|FG005|Overall Study|Death|14|||
129789761|NCT04575597|467197770|FG000|Overall Study|Lost to Follow-up|2|||
129789762|NCT04575597|467197771|FG001|Overall Study|Lost to Follow-up|1|||
129789763|NCT04575597|467197772|FG002|Overall Study|Lost to Follow-up|1|||
129789764|NCT04575597|467197773|FG003|Overall Study|Lost to Follow-up|2|||
129789765|NCT04575597|467197774|FG004|Overall Study|Lost to Follow-up|10|||
129789766|NCT04575597|467197775|FG005|Overall Study|Lost to Follow-up|8|||
129789767|NCT04575597|467197770|FG000|Overall Study|Withdrawal by Subject|2|||
129789768|NCT04575597|467197771|FG001|Overall Study|Withdrawal by Subject|2|||
129789769|NCT04575597|467197772|FG002|Overall Study|Withdrawal by Subject|4|||
129789770|NCT04575597|467197773|FG003|Overall Study|Withdrawal by Subject|2|||
129789771|NCT04575597|467197774|FG004|Overall Study|Withdrawal by Subject|25|||
129789772|NCT04575597|467197775|FG005|Overall Study|Withdrawal by Subject|28|||
129789773|NCT04575597|467197770|FG000|Overall Study|Not Recorded|0|||
129789774|NCT04575597|467197771|FG001|Overall Study|Not Recorded|0|||
129789775|NCT04575597|467197772|FG002|Overall Study|Not Recorded|0|||
129789776|NCT04575597|467197773|FG003|Overall Study|Not Recorded|0|||
129789777|NCT04575597|467197774|FG004|Overall Study|Not Recorded|0|||
129789778|NCT04575597|467197775|FG005|Overall Study|Not Recorded|2|||
129789779|NCT04575597|467197770|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129789780|NCT04575597|467197771|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129789781|NCT04575597|467197772|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129789782|NCT04575597|467197773|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129789783|NCT04575597|467197774|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
129789784|NCT04575597|467197775|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
129789785|NCT01587898|467197784|FG000|Overall Study|Adverse Event|1|||
129789786|NCT01587898|467197785|FG001|Overall Study|Adverse Event|1|||
129789787|NCT01587898|467197786|FG002|Overall Study|Adverse Event|0|||
129789788|NCT01587898|467197787|FG003|Overall Study|Adverse Event|0|||
129789789|NCT01587898|467197784|FG000|Overall Study|Protocol Violation|0|||
129789790|NCT01587898|467197785|FG001|Overall Study|Protocol Violation|2|||
129789791|NCT01587898|467197786|FG002|Overall Study|Protocol Violation|1|||
129789792|NCT01587898|467197787|FG003|Overall Study|Protocol Violation|1|||
129789793|NCT01587898|467197784|FG000|Overall Study|Lost to Follow-up|0|||
129789794|NCT01587898|467197785|FG001|Overall Study|Lost to Follow-up|0|||
129789795|NCT01587898|467197786|FG002|Overall Study|Lost to Follow-up|0|||
129789796|NCT01587898|467197787|FG003|Overall Study|Lost to Follow-up|1|||
129789797|NCT01587898|467197784|FG000|Overall Study|Withdrawal by Subject|2|||
129789798|NCT01587898|467197785|FG001|Overall Study|Withdrawal by Subject|1|||
129789799|NCT01587898|467197786|FG002|Overall Study|Withdrawal by Subject|0|||
129789800|NCT01587898|467197787|FG003|Overall Study|Withdrawal by Subject|0|||
129789801|NCT01587898|467197784|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
129789802|NCT01587898|467197785|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
129789803|NCT01587898|467197786|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
129789804|NCT01587898|467197787|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
129789805|NCT01738477|467197788|FG000|Overall Study|Lost to Follow-up|1|||
129789806|NCT01738477|467197789|FG001|Overall Study|Lost to Follow-up|4|||
129789807|NCT02437110|467197790|FG000|Screening|Lost to Follow-up|3|||
129789808|NCT02437110|467197790|FG000|Screening|Physician Decision|1|||
129789809|NCT02437110|467197790|FG000|ART|Adverse Event|3|||
129789810|NCT02437110|467197790|FG000|ART|Protocol Violation|3|||
129789811|NCT02437110|467197790|FG000|ART|Withdrawal by Subject|4|||
129789812|NCT02437110|467197790|FG000|ART|Lost to follow-up prior to start of intervention|1|||
129789813|NCT02437110|467197790|FG000|ART|Physician decision prior to start of intervention|2|||
129789814|NCT02437110|467197790|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
129789815|NCT02437110|467197790|FG000|Post-ART|Lost to Follow-up|3|||
129789816|NCT02437110|467197790|FG000|Post-ART|Protocol Violation|4|||
129789817|NCT02437110|467197790|FG000|Post-ART|Withdrawal by Subject|3|||
129789818|NCT02576145|467197794|FG000|Overall Study|Adverse Event|1|||
129789819|NCT02576145|467197795|FG001|Overall Study|Adverse Event|0|||
129789820|NCT02576145|467197794|FG000|Overall Study|Withdrawal by Subject|1|||
129789821|NCT02576145|467197795|FG001|Overall Study|Withdrawal by Subject|0|||
129789822|NCT02576145|467197794|FG000|Overall Study|Acute rejection|1|||
129789823|NCT02576145|467197795|FG001|Overall Study|Acute rejection|0|||
129789824|NCT02576145|467197794|FG000|Overall Study|Tetanus Titers Decreased|0|||
129789825|NCT02576145|467197795|FG001|Overall Study|Tetanus Titers Decreased|1|||
129789826|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
129789827|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
129789828|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
129789829|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
129789830|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
129789831|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
129789832|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
129789833|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
129789834|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
129789835|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
129789836|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
129789837|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
129789838|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
129789839|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
129789840|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
129789841|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
129789842|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
129789843|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
129789844|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
129789845|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
129789846|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
129789847|NCT01227824|467197796|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
129789848|NCT01227824|467197797|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
129789849|NCT01227824|467197798|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
129789850|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
129789851|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
129789852|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
129789853|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
129886241|NCT02061761|467542934|FG003|Overall Study|Disease progression|5|||
129789854|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
129789855|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
129789856|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
129789857|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
129789858|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
129437056|NCT01201343|465898609|FG000|Overall Study|Lost to Follow-up|2|||
129437057|NCT01201343|465898609|FG000|Overall Study|Lack of Efficacy|2|||
129698219|NCT00414609|466854945|FG000|Extension Study|Death|0|||
129437058|NCT01201343|465898609|FG000|Overall Study|Participant wrongly included in trial|1|||
129698220|NCT00414609|466854946|FG001|Extension Study|Death|0|||
129698221|NCT00414609|466854947|FG002|Extension Study|Death|17|||
129437059|NCT01201343|465898609|FG000|Overall Study|Randomized, not treated|3|||
129437060|NCT01440374|465898612|FG000|Part 1: Open-label Phase|Adverse Event|5|||
129437061|NCT01440374|465898613|FG001|Part 1: Open-label Phase|Adverse Event|0|||
129437062|NCT01440374|465898614|FG002|Part 1: Open-label Phase|Adverse Event|0|||
129437063|NCT01440374|465898615|FG003|Part 1: Open-label Phase|Adverse Event|0|||
129437064|NCT01440374|465898612|FG000|Part 1: Open-label Phase|Physician Decision|1|||
129437065|NCT01440374|465898613|FG001|Part 1: Open-label Phase|Physician Decision|0|||
129437066|NCT01440374|465898614|FG002|Part 1: Open-label Phase|Physician Decision|0|||
129437067|NCT01440374|465898615|FG003|Part 1: Open-label Phase|Physician Decision|0|||
129437068|NCT01440374|465898612|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
129437069|NCT01440374|465898613|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
129437070|NCT01440374|465898614|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
129437071|NCT01440374|465898615|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
129437072|NCT01440374|465898612|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
129437073|NCT01440374|465898613|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
129437074|NCT01440374|465898614|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
129437075|NCT01440374|465898615|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
129437076|NCT01440374|465898612|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
129437077|NCT01440374|465898613|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
129437078|NCT01440374|465898614|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
129437079|NCT01440374|465898615|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
129437080|NCT01440374|465898612|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
129437081|NCT01440374|465898613|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
129437082|NCT01440374|465898614|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
129437083|NCT01440374|465898615|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
129437084|NCT01440374|465898612|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
129437085|NCT01440374|465898613|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
129437086|NCT01440374|465898614|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
129437087|NCT01440374|465898615|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
129437088|NCT01440374|465898612|FG000|Part 2; Double-blind Phase|Not treated|0|||
129437089|NCT01440374|465898613|FG001|Part 2; Double-blind Phase|Not treated|0|||
129437090|NCT01440374|465898614|FG002|Part 2; Double-blind Phase|Not treated|1|||
129437091|NCT01440374|465898615|FG003|Part 2; Double-blind Phase|Not treated|0|||
129437092|NCT01440374|465898612|FG000|Part 3: Extension|Withdrawal by Subject|0|||
129437093|NCT01440374|465898613|FG001|Part 3: Extension|Withdrawal by Subject|0|||
129437094|NCT01440374|465898614|FG002|Part 3: Extension|Withdrawal by Subject|0|||
129437095|NCT01440374|465898615|FG003|Part 3: Extension|Withdrawal by Subject|5|||
129437096|NCT01440374|465898612|FG000|Part 3: Extension|Adverse Event|0|||
129437097|NCT01440374|465898613|FG001|Part 3: Extension|Adverse Event|0|||
129437098|NCT01440374|465898614|FG002|Part 3: Extension|Adverse Event|0|||
129437099|NCT01440374|465898615|FG003|Part 3: Extension|Adverse Event|13|||
129437100|NCT01440374|465898612|FG000|Part 3: Extension|Physician Decision|0|||
129437101|NCT01440374|465898613|FG001|Part 3: Extension|Physician Decision|0|||
129437102|NCT01440374|465898614|FG002|Part 3: Extension|Physician Decision|0|||
129437103|NCT01440374|465898615|FG003|Part 3: Extension|Physician Decision|14|||
129437104|NCT01177722|465898621|FG000|Overall Study|Serious Adverse Event|0|||
129437105|NCT01177722|465898622|FG001|Overall Study|Serious Adverse Event|0|||
129437106|NCT01177722|465898623|FG002|Overall Study|Serious Adverse Event|1|||
129437107|NCT01177722|465898624|FG003|Overall Study|Serious Adverse Event|0|||
129437108|NCT01177722|465898621|FG000|Overall Study|Protocol Violation|0|||
129437109|NCT01177722|465898622|FG001|Overall Study|Protocol Violation|0|||
129437110|NCT01177722|465898623|FG002|Overall Study|Protocol Violation|1|||
129437111|NCT01177722|465898624|FG003|Overall Study|Protocol Violation|0|||
129437112|NCT01177722|465898621|FG000|Overall Study|Lost to Follow-up|3|||
129437113|NCT01177722|465898622|FG001|Overall Study|Lost to Follow-up|4|||
129437114|NCT01177722|465898623|FG002|Overall Study|Lost to Follow-up|3|||
129437115|NCT01177722|465898624|FG003|Overall Study|Lost to Follow-up|1|||
129437116|NCT01177722|465898621|FG000|Overall Study|Withdrawal by Subject|10|||
129437117|NCT01177722|465898622|FG001|Overall Study|Withdrawal by Subject|6|||
129437118|NCT01177722|465898623|FG002|Overall Study|Withdrawal by Subject|4|||
129437119|NCT01177722|465898624|FG003|Overall Study|Withdrawal by Subject|6|||
129437120|NCT04281004|465898637|FG000|Overall Study|Physician Decision|1|||
129437121|NCT04281004|465898638|FG001|Overall Study|Physician Decision|0|||
129437122|NCT03628898|465898639|FG000|Overall Study|Device deficiency|1|||
129437123|NCT03864146|465898640|FG000|Overall Study|Lost to Follow-up|14|||
129437124|NCT03864146|465898641|FG001|Overall Study|Lost to Follow-up|23|||
129437125|NCT03864146|465898640|FG000|Overall Study|Withdrawal by Subject|3|||
129437126|NCT03864146|465898641|FG001|Overall Study|Withdrawal by Subject|2|||
129698222|NCT01853280|466854952|FG000|Overall Study|Lack of Efficacy|2|||
129698223|NCT01853280|466854953|FG001|Overall Study|Lack of Efficacy|2|||
129698224|NCT01853280|466854952|FG000|Overall Study|Lost to Follow-up|0|||
129437127|NCT00690820|465898645|FG000|Period 1|Withdrawal by Subject|0|||
129437128|NCT00690820|465898646|FG001|Period 1|Withdrawal by Subject|1|||
129437129|NCT01768117|465898648|FG000|Overall Study|Lost to Follow-up|1|||
129698225|NCT01853280|466854953|FG001|Overall Study|Lost to Follow-up|1|||
129886242|NCT02061761|467542935|FG004|Overall Study|Disease progression|9|||
129886243|NCT02061761|467542936|FG005|Overall Study|Disease progression|3|||
129886244|NCT02061761|467542937|FG006|Overall Study|Disease progression|1|||
129886245|NCT02061761|467542938|FG007|Overall Study|Disease progression|2|||
129886246|NCT02061761|467542939|FG008|Overall Study|Disease progression|28|||
129886247|NCT02061761|467542931|FG000|Overall Study|Study Drug toxicity|0|||
129886248|NCT02061761|467542932|FG001|Overall Study|Study Drug toxicity|0|||
129886249|NCT02061761|467542933|FG002|Overall Study|Study Drug toxicity|0|||
129698226|NCT01853280|466854952|FG000|Overall Study|Physician Decision|0|||
129886250|NCT02061761|467542934|FG003|Overall Study|Study Drug toxicity|0|||
129437130|NCT01768117|465898648|FG000|Overall Study|Withdrawal by Subject|2|||
129886251|NCT02061761|467542935|FG004|Overall Study|Study Drug toxicity|0|||
129886252|NCT02061761|467542936|FG005|Overall Study|Study Drug toxicity|1|||
129886253|NCT02061761|467542937|FG006|Overall Study|Study Drug toxicity|0|||
129698227|NCT01853280|466854953|FG001|Overall Study|Physician Decision|1|||
129886254|NCT02061761|467542938|FG007|Overall Study|Study Drug toxicity|2|||
129886255|NCT02061761|467542939|FG008|Overall Study|Study Drug toxicity|6|||
129886256|NCT02061761|467542931|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
129886257|NCT02061761|467542932|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
129886258|NCT02061761|467542933|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
129886259|NCT02061761|467542934|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
129886260|NCT02061761|467542935|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
129886261|NCT02061761|467542936|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
129886262|NCT02061761|467542937|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
129886263|NCT02061761|467542938|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
129886264|NCT02061761|467542939|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
129886265|NCT02061761|467542931|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129886266|NCT02061761|467542932|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129886267|NCT02061761|467542933|FG002|Overall Study|Participant request to discontinue study treatment|2|||
129886268|NCT02061761|467542934|FG003|Overall Study|Participant request to discontinue study treatment|2|||
129886269|NCT02061761|467542935|FG004|Overall Study|Participant request to discontinue study treatment|0|||
129886270|NCT02061761|467542936|FG005|Overall Study|Participant request to discontinue study treatment|1|||
129886271|NCT02061761|467542937|FG006|Overall Study|Participant request to discontinue study treatment|0|||
129886272|NCT02061761|467542938|FG007|Overall Study|Participant request to discontinue study treatment|0|||
129886273|NCT02061761|467542939|FG008|Overall Study|Participant request to discontinue study treatment|2|||
129886274|NCT02061761|467542931|FG000|Overall Study|Withdrawal by Subject|0|||
129437131|NCT01768117|465898648|FG000|Overall Study|Protocol Violation|3|||
129437132|NCT03451162|465898651|FG000|Overall Study|Lost to Follow-up|1|||
129437133|NCT03451162|465898652|FG001|Overall Study|Lost to Follow-up|0|||
129605031|NCT00667810|466513323|FG000|Overall Study|Loss of Caregiver|0|||
129605032|NCT00667810|466513324|FG001|Overall Study|Loss of Caregiver|1|||
129605033|NCT00667810|466513325|FG002|Overall Study|Loss of Caregiver|3|||
129605034|NCT00667810|466513326|FG003|Overall Study|Loss of Caregiver|0|||
129605035|NCT00667810|466513323|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
129605036|NCT00667810|466513324|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
129605037|NCT00667810|466513325|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
129605038|NCT00667810|466513326|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
129605039|NCT00667810|466513323|FG000|Overall Study|Other|6|||
129605040|NCT00667810|466513324|FG001|Overall Study|Other|6|||
129605041|NCT00667810|466513325|FG002|Overall Study|Other|5|||
129605042|NCT00667810|466513326|FG003|Overall Study|Other|0|||
129605043|NCT00505375|466513329|FG000|Overall Study|Death|1|||
129605044|NCT00505375|466513330|FG001|Overall Study|Death|0|||
129605045|NCT00505375|466513329|FG000|Overall Study|Withdrawal by Subject|2|||
129605046|NCT00505375|466513330|FG001|Overall Study|Withdrawal by Subject|2|||
129605047|NCT00505375|466513329|FG000|Overall Study|Lost to Follow-up|0|||
129605048|NCT00505375|466513330|FG001|Overall Study|Lost to Follow-up|2|||
129605049|NCT00505375|466513329|FG000|Overall Study|Pregnancy|1|||
129605050|NCT00505375|466513330|FG001|Overall Study|Pregnancy|0|||
129605051|NCT00505375|466513329|FG000|Overall Study|Travel issues|0|||
129605052|NCT00505375|466513330|FG001|Overall Study|Travel issues|1|||
129605053|NCT01561430|466513333|FG000|Overall Study|Adverse Event|0|||
129605054|NCT01561430|466513334|FG001|Overall Study|Adverse Event|0|||
129605055|NCT01561430|466513335|FG002|Overall Study|Adverse Event|3|||
129605056|NCT01561430|466513336|FG003|Overall Study|Adverse Event|1|||
129605057|NCT01561430|466513333|FG000|Overall Study|Withdrawal by Subject|0|||
129605058|NCT01561430|466513334|FG001|Overall Study|Withdrawal by Subject|0|||
129605059|NCT01561430|466513335|FG002|Overall Study|Withdrawal by Subject|1|||
129605060|NCT01561430|466513336|FG003|Overall Study|Withdrawal by Subject|0|||
129698228|NCT01853280|466854952|FG000|Overall Study|Withdrawal by Subject|0|||
129698229|NCT01853280|466854953|FG001|Overall Study|Withdrawal by Subject|1|||
129698230|NCT01853280|466854952|FG000|Overall Study|Ineligible|0|||
129698231|NCT01853280|466854953|FG001|Overall Study|Ineligible|1|||
129698232|NCT03032484|466854954|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
129698233|NCT03032484|466854955|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
129698234|NCT03032484|466854954|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
129698235|NCT03032484|466854955|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
129698236|NCT01229111|466854956|FG000|Overall Study|Death|1|||
129437134|NCT03451162|465898653|FG002|Overall Study|Lost to Follow-up|0|||
129437135|NCT03451162|465898654|FG003|Overall Study|Lost to Follow-up|0|||
129437136|NCT03451162|465898655|FG004|Overall Study|Lost to Follow-up|0|||
129437137|NCT03451162|465898651|FG000|Overall Study|Physician Decision|0|||
129437138|NCT03451162|465898652|FG001|Overall Study|Physician Decision|1|||
129437139|NCT03451162|465898653|FG002|Overall Study|Physician Decision|0|||
129437140|NCT03451162|465898654|FG003|Overall Study|Physician Decision|0|||
129437141|NCT03451162|465898655|FG004|Overall Study|Physician Decision|0|||
129437142|NCT03451162|465898651|FG000|Overall Study|Withdrawal by Subject|1|||
129437143|NCT03451162|465898652|FG001|Overall Study|Withdrawal by Subject|1|||
129437144|NCT03451162|465898653|FG002|Overall Study|Withdrawal by Subject|0|||
129437145|NCT03451162|465898654|FG003|Overall Study|Withdrawal by Subject|0|||
129437146|NCT03451162|465898655|FG004|Overall Study|Withdrawal by Subject|0|||
129437147|NCT03658668|465898656|FG000|Overall Study|Time Commitment|1|||
129437148|NCT03658668|465898657|FG001|Overall Study|Time Commitment|1|||
129437149|NCT01127139|465898658|FG000|Overall Study|Adverse Event|40|||
129437150|NCT01127139|465898658|FG000|Overall Study|Incompliance|12|||
129437151|NCT01127139|465898658|FG000|Overall Study|Lack of Efficacy|4|||
129437152|NCT01127139|465898658|FG000|Overall Study|Reason not specified|1|||
129437153|NCT01580969|465898660|FG000|Overall Study|Physician Decision|3|||
129437154|NCT01580969|465898661|FG001|Overall Study|Physician Decision|0|||
129437155|NCT01580969|465898662|FG002|Overall Study|Physician Decision|0|||
129437156|NCT01079741|465898668|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129437157|NCT01079741|465898669|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
129437158|NCT01079741|465898670|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129437159|NCT01079741|465898671|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129437160|NCT01079741|465898672|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
129437161|NCT01079741|465898668|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129437162|NCT01079741|465898669|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129437163|NCT01079741|465898670|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129437164|NCT01079741|465898671|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
129437165|NCT01079741|465898672|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
129437166|NCT00446992|465898673|FG000|Overall Study|Adverse Event|11|||
129437167|NCT00446992|465898673|FG000|Overall Study|Lost to Follow-up|5|||
129437168|NCT02076178|465898674|FG000|Oral Phase|Adverse Event|0|||
129437169|NCT02076178|465898675|FG001|Oral Phase|Adverse Event|7|||
129437170|NCT02076178|465898674|FG000|Oral Phase|Withdrawal by Subject|0|||
129437171|NCT02076178|465898675|FG001|Oral Phase|Withdrawal by Subject|4|||
129437172|NCT02076178|465898674|FG000|Oral Phase|Physician Decision|0|||
129437173|NCT02076178|465898675|FG001|Oral Phase|Physician Decision|1|||
129437174|NCT02076178|465898674|FG000|Injection Phase|Protocol defined stopping criteria|1|||
129437175|NCT02076178|465898675|FG001|Injection Phase|Protocol defined stopping criteria|0|||
129437176|NCT02076178|465898674|FG000|Injection Phase|Withdrawal by Subject|0|||
129437177|NCT02076178|465898675|FG001|Injection Phase|Withdrawal by Subject|3|||
129437178|NCT02076178|465898674|FG000|Injection Phase|Physician Decision|0|||
129437179|NCT02076178|465898675|FG001|Injection Phase|Physician Decision|3|||
129437180|NCT02076178|465898674|FG000|Injection Phase|Lost to Follow-up|0|||
129437181|NCT02076178|465898675|FG001|Injection Phase|Lost to Follow-up|1|||
129437182|NCT02434939|465898683|FG000|Overall Study|Lack of Efficacy|34|||
129437183|NCT02434939|465898684|FG001|Overall Study|Lack of Efficacy|48|||
129437184|NCT02434939|465898683|FG000|Overall Study|Withdrawal by Subject|3|||
129437185|NCT02434939|465898684|FG001|Overall Study|Withdrawal by Subject|0|||
129437186|NCT02434939|465898683|FG000|Overall Study|Adverse Event|0|||
129437187|NCT02434939|465898684|FG001|Overall Study|Adverse Event|1|||
129437188|NCT03021954|465898687|FG000|Overall Study|Lost to Follow-up|10|||
129437189|NCT03021954|465898688|FG001|Overall Study|Lost to Follow-up|43|||
129437190|NCT03021954|465898687|FG000|Overall Study|Subjects had avulsion trauma|4|||
129437191|NCT03021954|465898688|FG001|Overall Study|Subjects had avulsion trauma|1|||
129437192|NCT00069238|465898689|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
129437193|NCT00069238|465898690|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
129437194|NCT00069238|465898691|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
129437195|NCT00069238|465898689|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
129437196|NCT00069238|465898690|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
129789859|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
129789860|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
129789861|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
129789862|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
129789863|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
129789864|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
129437197|NCT00069238|465898691|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
129437198|NCT00069238|465898689|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
129437199|NCT00069238|465898690|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
129437200|NCT00069238|465898691|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
129437201|NCT01001832|465898694|FG000|Short-term Period|Adverse Event|2|||
129437202|NCT01001832|465898695|FG001|Short-term Period|Adverse Event|3|||
129437203|NCT01001832|465898694|FG000|Long-term Period|Adverse Event|2|||
129437204|NCT01001832|465898695|FG001|Long-term Period|Adverse Event|1|||
129437205|NCT01001832|465898694|FG000|Long-term Period|Withdrawal by Subject|1|||
129437206|NCT01001832|465898695|FG001|Long-term Period|Withdrawal by Subject|0|||
129437207|NCT01001832|465898694|FG000|Long-term Period|Lack of Efficacy|0|||
129437208|NCT01001832|465898695|FG001|Long-term Period|Lack of Efficacy|2|||
129437209|NCT01001832|465898694|FG000|Long-term Period|Other|1|||
129437210|NCT01001832|465898695|FG001|Long-term Period|Other|2|||
129437211|NCT01001832|465898694|FG000|Follow-up Period|Withdrawal by Subject|1|||
129437212|NCT01001832|465898695|FG001|Follow-up Period|Withdrawal by Subject|0|||
129437213|NCT01001832|465898694|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
129437214|NCT01001832|465898695|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
129605061|NCT01561430|466513333|FG000|Overall Study|Physician Decision|0|||
129437215|NCT01001832|465898694|FG000|Follow-up Period|Other|2|||
129437216|NCT01001832|465898695|FG001|Follow-up Period|Other|1|||
129605062|NCT01561430|466513334|FG001|Overall Study|Physician Decision|1|||
129605063|NCT01561430|466513335|FG002|Overall Study|Physician Decision|0|||
129605064|NCT01561430|466513336|FG003|Overall Study|Physician Decision|0|||
129605065|NCT01561430|466513333|FG000|Overall Study|Sponsor Decision|1|||
129605066|NCT01561430|466513334|FG001|Overall Study|Sponsor Decision|14|||
129605067|NCT01561430|466513335|FG002|Overall Study|Sponsor Decision|13|||
129605068|NCT01561430|466513336|FG003|Overall Study|Sponsor Decision|12|||
129605069|NCT03709823|466513337|FG000|Overall Study|Adverse Event|0|||
129605070|NCT03709823|466513338|FG001|Overall Study|Adverse Event|0|||
129605071|NCT03709823|466513339|FG002|Overall Study|Adverse Event|1|||
129605072|NCT03709823|466513340|FG003|Overall Study|Adverse Event|0|||
129605073|NCT03709823|466513341|FG004|Overall Study|Adverse Event|0|||
129605074|NCT03709823|466513342|FG005|Overall Study|Adverse Event|0|||
129605075|NCT03709823|466513337|FG000|Overall Study|Lost to Follow-up|2|||
129605076|NCT03709823|466513338|FG001|Overall Study|Lost to Follow-up|2|||
129605077|NCT03709823|466513339|FG002|Overall Study|Lost to Follow-up|2|||
129605078|NCT03709823|466513340|FG003|Overall Study|Lost to Follow-up|1|||
129605079|NCT03709823|466513341|FG004|Overall Study|Lost to Follow-up|1|||
129605080|NCT03709823|466513342|FG005|Overall Study|Lost to Follow-up|0|||
129605081|NCT03709823|466513337|FG000|Overall Study|Withdrawal by Subject|1|||
129605082|NCT03709823|466513338|FG001|Overall Study|Withdrawal by Subject|3|||
129605083|NCT03709823|466513339|FG002|Overall Study|Withdrawal by Subject|0|||
129605084|NCT03709823|466513340|FG003|Overall Study|Withdrawal by Subject|0|||
129605085|NCT03709823|466513341|FG004|Overall Study|Withdrawal by Subject|0|||
129605086|NCT03709823|466513342|FG005|Overall Study|Withdrawal by Subject|0|||
129605087|NCT03709823|466513337|FG000|Overall Study|Other, Not Specified|0|||
129605088|NCT03709823|466513338|FG001|Overall Study|Other, Not Specified|0|||
129605089|NCT03709823|466513339|FG002|Overall Study|Other, Not Specified|0|||
129605090|NCT03709823|466513340|FG003|Overall Study|Other, Not Specified|1|||
129605091|NCT03709823|466513341|FG004|Overall Study|Other, Not Specified|0|||
129605092|NCT03709823|466513342|FG005|Overall Study|Other, Not Specified|0|||
129605093|NCT03201250|466513345|FG000|Overall Study|screen failures|3|||
129605094|NCT03201250|466513346|FG001|Overall Study|screen failures|0|||
129605095|NCT03201250|466513347|FG002|Overall Study|screen failures|0|||
129605096|NCT03167723|466513348|FG000|Overall Study|Protocol Violation|4|||
129605097|NCT03167723|466513349|FG001|Overall Study|Protocol Violation|6|||
129605098|NCT01175811|466513350|FG000|Overall Study|Adverse Event|1|||
129605099|NCT01175811|466513351|FG001|Overall Study|Adverse Event|1|||
129605100|NCT01175811|466513350|FG000|Overall Study|Entry criteria not met|3|||
129605101|NCT01175811|466513351|FG001|Overall Study|Entry criteria not met|1|||
129605102|NCT01175811|466513350|FG000|Overall Study|Lack of Efficacy|1|||
129605103|NCT01175811|466513351|FG001|Overall Study|Lack of Efficacy|0|||
129605104|NCT01175811|466513350|FG000|Overall Study|Lost to Follow-up|3|||
129605105|NCT01175811|466513351|FG001|Overall Study|Lost to Follow-up|2|||
129605106|NCT01175811|466513350|FG000|Overall Study|Physician Decision|1|||
129605107|NCT01175811|466513351|FG001|Overall Study|Physician Decision|1|||
129605108|NCT01175811|466513350|FG000|Overall Study|Protocol Violation|1|||
129605109|NCT01175811|466513351|FG001|Overall Study|Protocol Violation|2|||
129605110|NCT01175811|466513350|FG000|Overall Study|Withdrawal by Subject|6|||
129605111|NCT01175811|466513351|FG001|Overall Study|Withdrawal by Subject|7|||
129605112|NCT03579966|466513352|FG000|Overall Study|Adverse Event|6|||
129605113|NCT03579966|466513352|FG000|Overall Study|Lost to Follow-up|4|||
129605114|NCT03579966|466513352|FG000|Overall Study|Physician Decision|10|||
129605115|NCT03579966|466513352|FG000|Overall Study|Pregnancy|1|||
129605116|NCT03579966|466513352|FG000|Overall Study|Withdrawal by Subject|16|||
129605117|NCT03579966|466513352|FG000|Overall Study|Study terminated by Sponsor|22|||
129789865|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
129437217|NCT00710021|465898704|FG000|Overall Study|Lost to Follow-up|1|||
129437218|NCT00710021|465898705|FG001|Overall Study|Lost to Follow-up|0|||
129605118|NCT03579966|466513352|FG000|Overall Study|Protocol Violation|1|||
129605119|NCT00415194|466513353|FG000|Overall Study|Adverse Event|37|||
129605120|NCT00415194|466513354|FG001|Overall Study|Adverse Event|32|||
129605121|NCT00415194|466513353|FG000|Overall Study|Entry Criteria Not Met|4|||
129605122|NCT00415194|466513354|FG001|Overall Study|Entry Criteria Not Met|8|||
129605123|NCT00415194|466513353|FG000|Overall Study|Lost to Follow-up|1|||
129605124|NCT00415194|466513354|FG001|Overall Study|Lost to Follow-up|0|||
129605125|NCT00415194|466513353|FG000|Overall Study|Physician Decision|10|||
129605126|NCT00415194|466513354|FG001|Overall Study|Physician Decision|16|||
129605127|NCT00415194|466513353|FG000|Overall Study|Progressive Disease|180|||
129605128|NCT00415194|466513354|FG001|Overall Study|Progressive Disease|217|||
129605129|NCT00415194|466513353|FG000|Overall Study|Protocol Violation|4|||
129605130|NCT00415194|466513354|FG001|Overall Study|Protocol Violation|2|||
129605131|NCT00415194|466513353|FG000|Overall Study|Withdrawal by Subject|28|||
129605132|NCT00415194|466513354|FG001|Overall Study|Withdrawal by Subject|21|||
129605133|NCT00415194|466513353|FG000|Overall Study|Death Due to Study Disease|26|||
129605134|NCT00415194|466513354|FG001|Overall Study|Death Due to Study Disease|29|||
129605135|NCT00415194|466513353|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
129605136|NCT00415194|466513354|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
129605137|NCT00415194|466513353|FG000|Overall Study|Death Due to Procedural Related AE|0|||
129605138|NCT00415194|466513354|FG001|Overall Study|Death Due to Procedural Related AE|1|||
129605139|NCT00415194|466513353|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
129605140|NCT00415194|466513354|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
129605141|NCT01297465|466513355|FG000|Overall Study|Lack of Ovarian Response|1|||
129605142|NCT01297465|466513356|FG001|Overall Study|Lack of Ovarian Response|1|||
129605143|NCT01297465|466513355|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129605144|NCT01297465|466513356|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129605145|NCT01297465|466513355|FG000|Overall Study|No Oocytes Retrieved|1|||
129605146|NCT01297465|466513356|FG001|Overall Study|No Oocytes Retrieved|1|||
129605147|NCT01297465|466513355|FG000|Overall Study|Poor oocyte quality|0|||
129605148|NCT01297465|466513356|FG001|Overall Study|Poor oocyte quality|1|||
129605149|NCT01297465|466513355|FG000|Overall Study|No Fertilization|6|||
129605150|NCT01297465|466513356|FG001|Overall Study|No Fertilization|4|||
129605151|NCT01297465|466513355|FG000|Overall Study|All Embryos Discarded|0|||
129605152|NCT01297465|466513356|FG001|Overall Study|All Embryos Discarded|1|||
129605153|NCT01297465|466513355|FG000|Overall Study|Intention to Freeze all Embryos|0|||
129605154|NCT01297465|466513356|FG001|Overall Study|Intention to Freeze all Embryos|1|||
129605155|NCT00369655|466513357|FG000|Overall Study|Refusal of further treatment|2|||
129605156|NCT04049617|466513358|FG000|Overall Study|Adverse Event|0|||
129605157|NCT04049617|466513359|FG001|Overall Study|Adverse Event|0|||
129605158|NCT04049617|466513360|FG002|Overall Study|Adverse Event|0|||
129605159|NCT04049617|466513361|FG003|Overall Study|Adverse Event|1|||
129605160|NCT04049617|466513362|FG004|Overall Study|Adverse Event|0|||
129605161|NCT04049617|466513363|FG005|Overall Study|Adverse Event|0|||
129605162|NCT04049617|466513358|FG000|Overall Study|Death|0|||
129605163|NCT04049617|466513359|FG001|Overall Study|Death|0|||
129605164|NCT04049617|466513360|FG002|Overall Study|Death|0|||
129605165|NCT04049617|466513361|FG003|Overall Study|Death|0|||
129605166|NCT04049617|466513362|FG004|Overall Study|Death|0|||
129605167|NCT04049617|466513363|FG005|Overall Study|Death|1|||
129605168|NCT04049617|466513358|FG000|Overall Study|Lost to Follow-up|0|||
129605169|NCT04049617|466513359|FG001|Overall Study|Lost to Follow-up|0|||
129605170|NCT04049617|466513360|FG002|Overall Study|Lost to Follow-up|0|||
129605171|NCT04049617|466513361|FG003|Overall Study|Lost to Follow-up|1|||
129605172|NCT04049617|466513362|FG004|Overall Study|Lost to Follow-up|0|||
129605173|NCT04049617|466513363|FG005|Overall Study|Lost to Follow-up|0|||
129605174|NCT04049617|466513358|FG000|Overall Study|Withdrew consent|0|||
129605175|NCT04049617|466513359|FG001|Overall Study|Withdrew consent|0|||
129605176|NCT04049617|466513360|FG002|Overall Study|Withdrew consent|1|||
129789866|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
129789867|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
129789868|NCT01227824|467197796|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
129789869|NCT01227824|467197797|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
129789870|NCT01227824|467197798|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
129789871|NCT02660138|467197800|FG000|Overall Study|Adverse Event|0|||
129605177|NCT04049617|466513361|FG003|Overall Study|Withdrew consent|0|||
129605178|NCT04049617|466513362|FG004|Overall Study|Withdrew consent|0|||
129605179|NCT04049617|466513363|FG005|Overall Study|Withdrew consent|0|||
129605180|NCT03551496|466513364|FG000|Overall Study|Death|11|||
129605181|NCT03551496|466513365|FG001|Overall Study|Death|7|||
129605182|NCT03551496|466513364|FG000|Overall Study|Withdrawal by Subject|4|||
129605183|NCT03551496|466513365|FG001|Overall Study|Withdrawal by Subject|3|||
129789872|NCT02660138|467197801|FG001|Overall Study|Adverse Event|3|||
129605184|NCT03551496|466513364|FG000|Overall Study|Other Reasons|1|||
129605185|NCT03551496|466513365|FG001|Overall Study|Other Reasons|0|||
129605186|NCT00140426|466513366|FG000|Overall Study|Withdrawal by Subject|0|||
129605187|NCT00140426|466513367|FG001|Overall Study|Withdrawal by Subject|3|||
129605188|NCT02149108|466513368|FG000|Overall Study|Not treated|1|||
129605189|NCT02149108|466513369|FG001|Overall Study|Not treated|2|||
129605190|NCT02149108|466513368|FG000|Overall Study|Progressive Disease (PD)|324|||
129605191|NCT02149108|466513369|FG001|Overall Study|Progressive Disease (PD)|318|||
129605192|NCT02149108|466513368|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
129605193|NCT02149108|466513369|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
129605194|NCT02149108|466513368|FG000|Overall Study|Other Adverse Event (AE)|8|||
129605195|NCT02149108|466513369|FG001|Overall Study|Other Adverse Event (AE)|18|||
129605196|NCT02149108|466513368|FG000|Overall Study|Other not defined above|0|||
129605197|NCT02149108|466513369|FG001|Overall Study|Other not defined above|2|||
129605198|NCT02149108|466513368|FG000|Overall Study|Refusal to continue trial medication|15|||
129605199|NCT02149108|466513369|FG001|Overall Study|Refusal to continue trial medication|11|||
129605200|NCT02149108|466513368|FG000|Overall Study|Lost to Follow-up|1|||
129605201|NCT02149108|466513369|FG001|Overall Study|Lost to Follow-up|0|||
129605202|NCT04765384|466513370|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
129605203|NCT04765384|466513371|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
129605204|NCT04765384|466513372|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
129605205|NCT04765384|466513373|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
129605206|NCT04765384|466513374|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
129605207|NCT04765384|466513375|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
129605208|NCT04765384|466513370|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
129605209|NCT04765384|466513371|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
129605210|NCT04765384|466513372|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
129605211|NCT04765384|466513373|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
129605212|NCT04765384|466513374|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
129605213|NCT04765384|466513375|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
129605214|NCT04765384|466513370|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129605215|NCT04765384|466513371|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129605216|NCT04765384|466513372|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129605217|NCT04765384|466513373|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129605218|NCT04765384|466513374|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
129605219|NCT04765384|466513375|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
129605220|NCT04765384|466513370|FG000|Post-natal: Neonates and Infants|Death|0|||
129605221|NCT04765384|466513371|FG001|Post-natal: Neonates and Infants|Death|0|||
129605222|NCT04765384|466513372|FG002|Post-natal: Neonates and Infants|Death|0|||
129605223|NCT04765384|466513373|FG003|Post-natal: Neonates and Infants|Death|1|||
129605224|NCT04765384|466513374|FG004|Post-natal: Neonates and Infants|Death|0|||
129605225|NCT04765384|466513375|FG005|Post-natal: Neonates and Infants|Death|0|||
129605226|NCT04765384|466513370|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129605227|NCT04765384|466513371|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129605228|NCT04765384|466513372|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129605229|NCT04765384|466513373|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129605230|NCT04765384|466513374|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
129605231|NCT04765384|466513375|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
129605232|NCT01971970|466513376|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
129605233|NCT01971970|466513377|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
129605234|NCT01971970|466513376|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
129605235|NCT01971970|466513377|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
129605236|NCT01971970|466513376|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
129605237|NCT01971970|466513377|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
129605238|NCT01971970|466513376|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
129605239|NCT01971970|466513377|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
129605240|NCT01971970|466513376|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
129605241|NCT01971970|466513377|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
129605242|NCT01971970|466513376|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
129605243|NCT01971970|466513377|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
129605244|NCT01971970|466513376|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
129605245|NCT01971970|466513377|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
129605246|NCT00848107|466513378|FG000|Overall Study|Lost to Follow-up|2|||
129605247|NCT00848107|466513378|FG000|Overall Study|Withdrawal by Subject|8|||
129605248|NCT00848107|466513378|FG000|Overall Study|Adverse Event|9|||
129605249|NCT00848107|466513378|FG000|Overall Study|Death|1|||
129605250|NCT00848107|466513378|FG000|Overall Study|Pregnancy|1|||
129605251|NCT02335983|466513379|FG000|Overall Study|Sponsor Decision|0|||
129605252|NCT02335983|466513380|FG001|Overall Study|Sponsor Decision|0|||
129605253|NCT02335983|466513381|FG002|Overall Study|Sponsor Decision|1|||
129605254|NCT02335983|466513382|FG003|Overall Study|Sponsor Decision|1|||
129605255|NCT02335983|466513383|FG004|Overall Study|Sponsor Decision|0|||
129605256|NCT02335983|466513384|FG005|Overall Study|Sponsor Decision|1|||
129605257|NCT02335983|466513379|FG000|Overall Study|Withdrawal by Subject|3|||
129605258|NCT02335983|466513380|FG001|Overall Study|Withdrawal by Subject|2|||
129605259|NCT02335983|466513381|FG002|Overall Study|Withdrawal by Subject|2|||
129605260|NCT02335983|466513382|FG003|Overall Study|Withdrawal by Subject|1|||
129605261|NCT02335983|466513383|FG004|Overall Study|Withdrawal by Subject|3|||
129605262|NCT02335983|466513384|FG005|Overall Study|Withdrawal by Subject|9|||
129605263|NCT02335983|466513379|FG000|Overall Study|Death|0|||
129605264|NCT02335983|466513380|FG001|Overall Study|Death|0|||
129605265|NCT02335983|466513381|FG002|Overall Study|Death|2|||
129605266|NCT02335983|466513382|FG003|Overall Study|Death|0|||
129605267|NCT02335983|466513383|FG004|Overall Study|Death|0|||
129605268|NCT02335983|466513384|FG005|Overall Study|Death|0|||
129605269|NCT02335983|466513379|FG000|Overall Study|Lost to Follow-up|0|||
129605270|NCT02335983|466513380|FG001|Overall Study|Lost to Follow-up|0|||
129605271|NCT02335983|466513381|FG002|Overall Study|Lost to Follow-up|0|||
129605272|NCT02335983|466513382|FG003|Overall Study|Lost to Follow-up|0|||
129605273|NCT02335983|466513383|FG004|Overall Study|Lost to Follow-up|0|||
129605274|NCT02335983|466513384|FG005|Overall Study|Lost to Follow-up|1|||
129605275|NCT02335983|466513379|FG000|Overall Study|Protocol Specified Criteria|5|||
129605276|NCT02335983|466513380|FG001|Overall Study|Protocol Specified Criteria|7|||
129605277|NCT02335983|466513381|FG002|Overall Study|Protocol Specified Criteria|27|||
129605278|NCT02335983|466513382|FG003|Overall Study|Protocol Specified Criteria|7|||
129437219|NCT00710021|465898706|FG002|Overall Study|Lost to Follow-up|0|||
129437220|NCT00710021|465898704|FG000|Overall Study|Subject's Decision|0|||
129437221|NCT00710021|465898705|FG001|Overall Study|Subject's Decision|1|||
129437222|NCT00710021|465898706|FG002|Overall Study|Subject's Decision|0|||
129437223|NCT00710021|465898704|FG000|Overall Study|Subject misrandomized|0|||
129437224|NCT00710021|465898705|FG001|Overall Study|Subject misrandomized|1|||
129437225|NCT00710021|465898706|FG002|Overall Study|Subject misrandomized|1|||
129437226|NCT00710021|465898704|FG000|Overall Study|Physician Decision|0|||
129437227|NCT00710021|465898705|FG001|Overall Study|Physician Decision|1|||
129437228|NCT00710021|465898706|FG002|Overall Study|Physician Decision|0|||
129437229|NCT01536015|465898707|FG000|Overall Study|Adverse Event|1|||
129437230|NCT01536015|465898708|FG001|Overall Study|Adverse Event|4|||
129437231|NCT01536015|465898707|FG000|Overall Study|Lost to Follow-up|0|||
129437232|NCT01536015|465898708|FG001|Overall Study|Lost to Follow-up|1|||
129437233|NCT01536015|465898707|FG000|Overall Study|Inclusion Criterion not met|2|||
129437234|NCT01536015|465898708|FG001|Overall Study|Inclusion Criterion not met|0|||
129437235|NCT01536015|465898707|FG000|Overall Study|Study closure|5|||
129437236|NCT01536015|465898708|FG001|Overall Study|Study closure|5|||
129437237|NCT03581825|465898710|FG000|Period 1|Lens Discomfort|1|||
129437238|NCT03581825|465898711|FG001|Period 1|Lens Discomfort|0|||
129437239|NCT03581825|465898710|FG000|Period 2|Unsatisfactory Vision to Test|0|||
129437240|NCT03581825|465898711|FG001|Period 2|Unsatisfactory Vision to Test|1|||
129437241|NCT01668667|465898712|FG000|Overall Study|Adverse Event|3|||
129437242|NCT01668667|465898713|FG001|Overall Study|Adverse Event|6|||
129437243|NCT01668667|465898714|FG002|Overall Study|Adverse Event|4|||
129437244|NCT01668667|465898715|FG003|Overall Study|Adverse Event|4|||
129437245|NCT01668667|465898712|FG000|Overall Study|Lack of Efficacy|3|||
129437246|NCT01668667|465898713|FG001|Overall Study|Lack of Efficacy|2|||
129437247|NCT01668667|465898714|FG002|Overall Study|Lack of Efficacy|2|||
129437248|NCT01668667|465898715|FG003|Overall Study|Lack of Efficacy|3|||
129437249|NCT01668667|465898712|FG000|Overall Study|Protocol Violation|6|||
129437250|NCT01668667|465898713|FG001|Overall Study|Protocol Violation|10|||
129437251|NCT01668667|465898714|FG002|Overall Study|Protocol Violation|12|||
129437252|NCT01668667|465898715|FG003|Overall Study|Protocol Violation|5|||
129437253|NCT01668667|465898712|FG000|Overall Study|Lost to Follow-up|9|||
129605279|NCT02335983|466513383|FG004|Overall Study|Protocol Specified Criteria|5|||
129605280|NCT02335983|466513384|FG005|Overall Study|Protocol Specified Criteria|21|||
129605281|NCT00987389|466513385|FG000|Overall Study|Ineligible|0|||
129605282|NCT00987389|466513386|FG001|Overall Study|Ineligible|3|||
129605283|NCT00987389|466513387|FG002|Overall Study|Ineligible|0|||
129605284|NCT00987389|466513388|FG003|Overall Study|Ineligible|0|||
129605285|NCT00987389|466513385|FG000|Overall Study|Lost to Follow-up|4|||
129605286|NCT00987389|466513386|FG001|Overall Study|Lost to Follow-up|1|||
129605287|NCT00987389|466513387|FG002|Overall Study|Lost to Follow-up|3|||
129605288|NCT00987389|466513388|FG003|Overall Study|Lost to Follow-up|1|||
129698237|NCT04893811|466854957|FG000|Vaccination Phase|Death|1|||
129698238|NCT04893811|466854958|FG001|Vaccination Phase|Death|0|||
129698239|NCT04893811|466854957|FG000|Vaccination Phase|Lost to Follow-up|1|||
129698240|NCT04893811|466854958|FG001|Vaccination Phase|Lost to Follow-up|1|||
129698241|NCT04893811|466854957|FG000|Vaccination Phase|Protocol Violation|2|||
129698242|NCT04893811|466854958|FG001|Vaccination Phase|Protocol Violation|0|||
129698243|NCT04893811|466854957|FG000|Vaccination Phase|Withdrawal by Subject|2|||
129437254|NCT01668667|465898713|FG001|Overall Study|Lost to Follow-up|4|||
129605289|NCT00987389|466513385|FG000|Overall Study|Withdrawal by Subject|4|||
129437255|NCT01668667|465898714|FG002|Overall Study|Lost to Follow-up|7|||
129605290|NCT00987389|466513386|FG001|Overall Study|Withdrawal by Subject|3|||
129437256|NCT01668667|465898715|FG003|Overall Study|Lost to Follow-up|6|||
129437257|NCT01668667|465898712|FG000|Overall Study|Physician Decision|3|||
129437258|NCT01668667|465898713|FG001|Overall Study|Physician Decision|0|||
129437259|NCT01668667|465898714|FG002|Overall Study|Physician Decision|1|||
129605291|NCT00987389|466513387|FG002|Overall Study|Withdrawal by Subject|2|||
129605292|NCT00987389|466513388|FG003|Overall Study|Withdrawal by Subject|1|||
129698244|NCT04893811|466854958|FG001|Vaccination Phase|Withdrawal by Subject|1|||
129605293|NCT00987389|466513385|FG000|Overall Study|Withdrawn from Treatment|0|||
129605294|NCT00987389|466513386|FG001|Overall Study|Withdrawn from Treatment|1|||
129605295|NCT00987389|466513387|FG002|Overall Study|Withdrawn from Treatment|0|||
129605296|NCT00987389|466513388|FG003|Overall Study|Withdrawn from Treatment|0|||
129605297|NCT00987389|466513385|FG000|Overall Study|Multiple different reasons|1|||
129605298|NCT00987389|466513386|FG001|Overall Study|Multiple different reasons|0|||
129605299|NCT00987389|466513387|FG002|Overall Study|Multiple different reasons|3|||
129605300|NCT00987389|466513388|FG003|Overall Study|Multiple different reasons|1|||
129605301|NCT00326963|466513389|FG000|Overall Study|Adverse Event|2|||
129605302|NCT00326963|466513389|FG000|Overall Study|Injection site reaction|1|||
129605303|NCT00326963|466513389|FG000|Overall Study|Death|1|||
129605304|NCT00326963|466513389|FG000|Overall Study|Failure to return|10|||
129605305|NCT00326963|466513389|FG000|Overall Study|Withdrawal by Subject|10|||
129605306|NCT00326963|466513389|FG000|Overall Study|Refused treatment / did not cooperate|5|||
129605307|NCT00326963|466513389|FG000|Overall Study|Violation of selection criteria at entry|2|||
129605308|NCT00326963|466513389|FG000|Overall Study|Other protocol violation|1|||
129605309|NCT00326963|466513389|FG000|Overall Study|Administrative / other|1|||
129605310|NCT00507130|466513390|FG000|Overall Study|Lost to Follow-up|0|||
129605311|NCT00507130|466513391|FG001|Overall Study|Lost to Follow-up|0|||
129605312|NCT00507130|466513392|FG002|Overall Study|Lost to Follow-up|1|||
129605313|NCT00507130|466513393|FG003|Overall Study|Lost to Follow-up|1|||
129605314|NCT00507130|466513390|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
129605315|NCT00507130|466513391|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
129605316|NCT00507130|466513392|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
129605317|NCT00507130|466513393|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
129605318|NCT02524730|466513394|FG000|Overall Study|Lost to Follow-up|5|||
129605319|NCT02524730|466513394|FG000|Overall Study|Withdrawal by Subject|18|||
129605320|NCT02524730|466513394|FG000|Overall Study|Death|10|||
129605321|NCT02524730|466513394|FG000|Overall Study|Adverse Event|8|||
129605322|NCT02524730|466513394|FG000|Overall Study|Protocol Violation|1|||
129605323|NCT02524730|466513394|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
129605324|NCT00977379|466513399|FG000|Overall Study|Withdrawal by Subject|1|||
129605325|NCT00977379|466513400|FG001|Overall Study|Withdrawal by Subject|1|||
129605326|NCT00977379|466513399|FG000|Overall Study|Death|7|||
129605327|NCT00977379|466513400|FG001|Overall Study|Death|9|||
129605328|NCT00977379|466513399|FG000|Overall Study|Premature Study Termination|4|||
129605329|NCT00977379|466513400|FG001|Overall Study|Premature Study Termination|0|||
129605330|NCT00977379|466513399|FG000|Overall Study|Participant Moving House|0|||
129605331|NCT00977379|466513400|FG001|Overall Study|Participant Moving House|1|||
129605332|NCT00977379|466513399|FG000|Overall Study|Randomization Error|0|||
129605333|NCT00977379|466513400|FG001|Overall Study|Randomization Error|1|||
129605334|NCT02992418|466513406|FG000|Overall Study|Withdrawal by Subject|11|||
129605335|NCT02992418|466513407|FG001|Overall Study|Withdrawal by Subject|12|||
129605336|NCT02992418|466513406|FG000|Overall Study|Non-compliance with the protocol|308|||
129605337|NCT02992418|466513407|FG001|Overall Study|Non-compliance with the protocol|308|||
129605338|NCT02992418|466513406|FG000|Overall Study|Lost to Follow-up|27|||
129605339|NCT02992418|466513407|FG001|Overall Study|Lost to Follow-up|22|||
129789873|NCT02660138|467197802|FG002|Overall Study|Adverse Event|2|||
129789874|NCT02660138|467197800|FG000|Overall Study|Lack of Efficacy|1|||
129789875|NCT02660138|467197801|FG001|Overall Study|Lack of Efficacy|2|||
129789876|NCT02660138|467197802|FG002|Overall Study|Lack of Efficacy|1|||
129789877|NCT02660138|467197800|FG000|Overall Study|Withdrawal by Subject|7|||
129789878|NCT02660138|467197801|FG001|Overall Study|Withdrawal by Subject|6|||
129789879|NCT02660138|467197802|FG002|Overall Study|Withdrawal by Subject|6|||
129789880|NCT02660138|467197800|FG000|Overall Study|Lost to Follow-up|4|||
129789881|NCT02660138|467197801|FG001|Overall Study|Lost to Follow-up|4|||
129789882|NCT02660138|467197802|FG002|Overall Study|Lost to Follow-up|1|||
129789883|NCT02660138|467197800|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
129789884|NCT02660138|467197801|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
129789885|NCT02660138|467197802|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
129789886|NCT02660138|467197800|FG000|Overall Study|Other|1|||
129789887|NCT02660138|467197801|FG001|Overall Study|Other|1|||
129789888|NCT02660138|467197802|FG002|Overall Study|Other|0|||
129789889|NCT02660138|467197800|FG000|Overall Study|Not treated|0|||
129789890|NCT02660138|467197801|FG001|Overall Study|Not treated|1|||
129789891|NCT02660138|467197802|FG002|Overall Study|Not treated|0|||
129789892|NCT00308581|467197806|FG000|Induction Phase|Adverse Event|0|||
129789893|NCT00308581|467197807|FG001|Induction Phase|Adverse Event|0|||
129789894|NCT00308581|467197808|FG002|Induction Phase|Adverse Event|37|||
129789895|NCT00308581|467197806|FG000|Induction Phase|Lack of Efficacy|0|||
129789896|NCT00308581|467197807|FG001|Induction Phase|Lack of Efficacy|0|||
129789897|NCT00308581|467197808|FG002|Induction Phase|Lack of Efficacy|121|||
129789898|NCT00308581|467197806|FG000|Induction Phase|Withdrawal by Subject|0|||
129789899|NCT00308581|467197807|FG001|Induction Phase|Withdrawal by Subject|0|||
129605340|NCT03246126|466513412|FG000|Overall Study|Withdrawal by Subject|0|||
129605341|NCT03246126|466513413|FG001|Overall Study|Withdrawal by Subject|1|||
129605342|NCT01006135|466513422|FG000|Overall Study|Adverse Event|22|||
129605343|NCT01006135|466513422|FG000|Overall Study|Protocol Violation|14|||
129605344|NCT01006135|466513422|FG000|Overall Study|Lost to Follow-up|32|||
129605345|NCT01006135|466513422|FG000|Overall Study|Other|72|||
129605346|NCT02266134|466513423|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
129605347|NCT02266134|466513424|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
129605348|NCT02266134|466513425|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
129605349|NCT02266134|466513426|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
129605350|NCT02266134|466513423|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
129605351|NCT02266134|466513424|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
129605352|NCT02266134|466513425|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
129605353|NCT02266134|466513426|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
129605354|NCT02266134|466513423|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
129605355|NCT02266134|466513424|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
129605356|NCT02266134|466513425|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
129605357|NCT02266134|466513426|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
129605358|NCT02266134|466513423|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
129605359|NCT02266134|466513424|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
129605360|NCT02266134|466513425|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
129605361|NCT02266134|466513426|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
129605362|NCT02266134|466513423|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
129605363|NCT02266134|466513424|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
129605364|NCT02266134|466513425|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
129605365|NCT02266134|466513426|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
129605366|NCT02266134|466513423|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
129605367|NCT02266134|466513424|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
129605368|NCT02266134|466513425|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
129605369|NCT02266134|466513426|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
129605370|NCT01437943|466513431|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
129789900|NCT00308581|467197808|FG002|Induction Phase|Withdrawal by Subject|5|||
129789901|NCT00308581|467197806|FG000|Induction Phase|Unknown reason|0|||
129789902|NCT00308581|467197807|FG001|Induction Phase|Unknown reason|0|||
129789903|NCT00308581|467197808|FG002|Induction Phase|Unknown reason|3|||
129789904|NCT00308581|467197806|FG000|Randomized Maintenance Phase|Adverse Event|10|||
129789905|NCT00308581|467197807|FG001|Randomized Maintenance Phase|Adverse Event|17|||
129789906|NCT00308581|467197808|FG002|Randomized Maintenance Phase|Adverse Event|0|||
129789907|NCT00308581|467197806|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
129789908|NCT00308581|467197807|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
129789909|NCT00308581|467197808|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
129789910|NCT00308581|467197806|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
129789911|NCT00308581|467197807|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
129789912|NCT00308581|467197808|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
129789913|NCT00308581|467197806|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
129789914|NCT00308581|467197807|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
129789915|NCT00308581|467197808|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
129789916|NCT00308581|467197806|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
129789917|NCT00308581|467197807|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
129789918|NCT00308581|467197808|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
129789919|NCT00308581|467197806|FG000|Randomized Maintenance Phase|Unknown reason|3|||
129789920|NCT00308581|467197807|FG001|Randomized Maintenance Phase|Unknown reason|0|||
129789921|NCT00308581|467197808|FG002|Randomized Maintenance Phase|Unknown reason|0|||
129789922|NCT00899353|467197811|FG000|Overall Study|Adverse Event|2|||
129789923|NCT00899353|467197811|FG000|Overall Study|Lost to Follow-up|1|||
129789924|NCT00899353|467197811|FG000|Overall Study|Withdrawal by Subject|2|||
129789925|NCT01284491|467197813|FG000|Overall Study|Study termination|13|||
129789926|NCT02694757|467197816|FG000|Overall Study|Lack of Efficacy|3|||
129789927|NCT02650921|467197817|FG000|Overall Study|Withdrawal by Subject|4|||
129789928|NCT02650921|467197817|FG000|Overall Study|Lost to Follow-up|2|||
129789929|NCT02650921|467197817|FG000|Overall Study|Adverse Event|1|||
129789930|NCT02650921|467197817|FG000|Overall Study|Due to Medical Condition|1|||
129789931|NCT00783302|467197818|FG000|Overall Study|Lost to Follow-up|17|||
129789932|NCT00783302|467197818|FG000|Overall Study|Technical Problems|11|||
129789933|NCT00783302|467197818|FG000|Overall Study|Protocol Violation|3|||
129789934|NCT00783302|467197818|FG000|Overall Study|Physician Decision|1|||
129789935|NCT00783302|467197818|FG000|Overall Study|Withdrawal by Subject|3|||
129789936|NCT03400956|467197819|FG000|Treatment Period 1|Adverse Event|0|||
129789937|NCT03400956|467197820|FG001|Treatment Period 1|Adverse Event|1|||
129789938|NCT03400956|467197821|FG002|Treatment Period 1|Adverse Event|0|||
129789939|NCT03400956|467197819|FG000|Treatment Period 1|Lost to Follow-up|0|||
129605371|NCT01437943|466513432|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
129605372|NCT01437943|466513431|FG000|Overall Study|Subject expressed pregnancy plans|1|||
129605373|NCT01437943|466513432|FG001|Overall Study|Subject expressed pregnancy plans|0|||
129605374|NCT01437943|466513431|FG000|Overall Study|Adverse Event|2|||
129605375|NCT01437943|466513432|FG001|Overall Study|Adverse Event|0|||
129605376|NCT05442866|466513433|FG000|Overall Study|Death|1|||
129605377|NCT05442866|466513433|FG000|Overall Study|Lost to Follow-up|9|||
129605378|NCT05442866|466513433|FG000|Overall Study|Protocol Violation|1|||
129605379|NCT03819049|466513434|FG000|Overall Study|Lost to Follow-up|1|||
129698245|NCT04893811|466854957|FG000|Vaccination Phase|Other|0|||
129698246|NCT04893811|466854958|FG001|Vaccination Phase|Other|1|||
129698247|NCT04893811|466854957|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
129698248|NCT04893811|466854958|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
129698249|NCT04893811|466854957|FG000|Follow-up Phase|Lost to Follow-up|0|||
129698250|NCT04893811|466854958|FG001|Follow-up Phase|Lost to Follow-up|1|||
129698251|NCT05463952|466854967|FG000|Treatment|Progressive disease|4|||
129698252|NCT05463952|466854967|FG000|Treatment|Ongoing|2|||
129698253|NCT01946880|466854968|FG000|Overall Study|Lost to Follow-up|1|||
129698254|NCT01946880|466854969|FG001|Overall Study|Lost to Follow-up|0|||
129698255|NCT01946880|466854968|FG000|Overall Study|Physician Decision|1|||
129698256|NCT01946880|466854969|FG001|Overall Study|Physician Decision|1|||
129698257|NCT01946880|466854968|FG000|Overall Study|Withdrawal by Subject|3|||
129698258|NCT01946880|466854969|FG001|Overall Study|Withdrawal by Subject|2|||
129698259|NCT01946880|466854968|FG000|Overall Study|Met Primary Endpoint|1|||
129698260|NCT01946880|466854969|FG001|Overall Study|Met Primary Endpoint|0|||
129698261|NCT01946880|466854968|FG000|Overall Study|Personal and Family Issues|1|||
129698262|NCT01946880|466854969|FG001|Overall Study|Personal and Family Issues|0|||
129698263|NCT02758626|466854971|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
129698264|NCT02758626|466854972|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
129698265|NCT02758626|466854971|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
129698266|NCT02758626|466854972|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
129698267|NCT02758626|466854971|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
129698268|NCT02758626|466854972|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
129698269|NCT02758626|466854971|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
129698270|NCT02758626|466854972|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
129698271|NCT04204902|466854975|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
129698272|NCT04204902|466854976|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
129698273|NCT00456365|466854979|FG000|Overall Study|Lost to Follow-up|1|||
129698274|NCT00456365|466854980|FG001|Overall Study|Lost to Follow-up|3|||
129698275|NCT00456365|466854979|FG000|Overall Study|Withdrawal by Subject|4|||
129698276|NCT00456365|466854980|FG001|Overall Study|Withdrawal by Subject|7|||
129698277|NCT00456365|466854979|FG000|Overall Study|Pregnancy|1|||
129698278|NCT00456365|466854980|FG001|Overall Study|Pregnancy|1|||
129698279|NCT00456365|466854979|FG000|Overall Study|oncologic diagnosis|1|||
129698280|NCT00456365|466854980|FG001|Overall Study|oncologic diagnosis|1|||
129698281|NCT05451329|466854981|FG000|Overall Study|Adverse Event|1|||
129698282|NCT05451329|466854982|FG001|Overall Study|Adverse Event|1|||
129698283|NCT05451329|466854983|FG002|Overall Study|Adverse Event|0|||
129698284|NCT05451329|466854981|FG000|Overall Study|Withdrawal by Subject|1|||
129698285|NCT05451329|466854982|FG001|Overall Study|Withdrawal by Subject|0|||
129698286|NCT05451329|466854983|FG002|Overall Study|Withdrawal by Subject|0|||
129698287|NCT05451329|466854981|FG000|Overall Study|Investigational Product Lot exchange|1|||
129698288|NCT05451329|466854982|FG001|Overall Study|Investigational Product Lot exchange|1|||
129698289|NCT05451329|466854983|FG002|Overall Study|Investigational Product Lot exchange|0|||
129698290|NCT02202577|466854984|FG000|Overall Study|Lost to Follow-up|6|||
129698291|NCT02202577|466854985|FG001|Overall Study|Lost to Follow-up|16|||
129698292|NCT02202577|466854984|FG000|Overall Study|Protocol Violation|7|||
129698293|NCT02202577|466854985|FG001|Overall Study|Protocol Violation|3|||
129698294|NCT00829868|466854986|FG000|Washout|Physician Decision|1|||
129789940|NCT03400956|467197820|FG001|Treatment Period 1|Lost to Follow-up|0|||
129789941|NCT03400956|467197821|FG002|Treatment Period 1|Lost to Follow-up|1|||
129789942|NCT03400956|467197819|FG000|Treatment Period 1|Protocol Violation|0|||
129789943|NCT03400956|467197820|FG001|Treatment Period 1|Protocol Violation|2|||
129789944|NCT03400956|467197821|FG002|Treatment Period 1|Protocol Violation|0|||
129789945|NCT03400956|467197819|FG000|Treatment Period 1|Study terminated by sponsor|3|||
129789946|NCT03400956|467197820|FG001|Treatment Period 1|Study terminated by sponsor|1|||
129698295|NCT00829868|466854987|FG001|Washout|Physician Decision|0|||
129605380|NCT03819049|466513435|FG001|Overall Study|Lost to Follow-up|2|||
129605381|NCT03819049|466513436|FG002|Overall Study|Lost to Follow-up|9|||
129605382|NCT03819049|466513437|FG003|Overall Study|Lost to Follow-up|0|||
129605383|NCT03819049|466513438|FG004|Overall Study|Lost to Follow-up|3|||
129605384|NCT03819049|466513439|FG005|Overall Study|Lost to Follow-up|1|||
129605385|NCT03819049|466513440|FG006|Overall Study|Lost to Follow-up|0|||
129605386|NCT03819049|466513434|FG000|Overall Study|Withdrawal by Subject|0|||
129605387|NCT03819049|466513435|FG001|Overall Study|Withdrawal by Subject|0|||
129605388|NCT03819049|466513436|FG002|Overall Study|Withdrawal by Subject|18|||
129605389|NCT03819049|466513437|FG003|Overall Study|Withdrawal by Subject|0|||
129605390|NCT03819049|466513438|FG004|Overall Study|Withdrawal by Subject|10|||
129605391|NCT03819049|466513439|FG005|Overall Study|Withdrawal by Subject|9|||
129605392|NCT03819049|466513440|FG006|Overall Study|Withdrawal by Subject|1|||
129605393|NCT03819049|466513434|FG000|Overall Study|Ongoing|0|||
129605394|NCT03819049|466513435|FG001|Overall Study|Ongoing|0|||
129605395|NCT03819049|466513436|FG002|Overall Study|Ongoing|75|||
129605396|NCT03819049|466513437|FG003|Overall Study|Ongoing|0|||
129605397|NCT03819049|466513438|FG004|Overall Study|Ongoing|41|||
129605398|NCT03819049|466513439|FG005|Overall Study|Ongoing|0|||
129605399|NCT03819049|466513440|FG006|Overall Study|Ongoing|0|||
129605400|NCT03819049|466513434|FG000|Overall Study|Other|0|||
129605401|NCT03819049|466513435|FG001|Overall Study|Other|0|||
129605402|NCT03819049|466513436|FG002|Overall Study|Other|2|||
129605403|NCT03819049|466513437|FG003|Overall Study|Other|0|||
129605404|NCT03819049|466513438|FG004|Overall Study|Other|0|||
129605405|NCT03819049|466513439|FG005|Overall Study|Other|0|||
129605406|NCT03819049|466513440|FG006|Overall Study|Other|0|||
129605407|NCT03819049|466513434|FG000|Overall Study|Randomized but not vaccinated|0|||
129605408|NCT03819049|466513435|FG001|Overall Study|Randomized but not vaccinated|0|||
129605409|NCT03819049|466513436|FG002|Overall Study|Randomized but not vaccinated|0|||
129605410|NCT03819049|466513437|FG003|Overall Study|Randomized but not vaccinated|1|||
129605411|NCT03819049|466513438|FG004|Overall Study|Randomized but not vaccinated|0|||
129605412|NCT03819049|466513439|FG005|Overall Study|Randomized but not vaccinated|2|||
129605413|NCT03819049|466513440|FG006|Overall Study|Randomized but not vaccinated|1|||
129605414|NCT03819049|466513434|FG000|Overall Study|Physician Decision|0|||
129605415|NCT03819049|466513435|FG001|Overall Study|Physician Decision|0|||
129605416|NCT03819049|466513436|FG002|Overall Study|Physician Decision|0|||
129605417|NCT03819049|466513437|FG003|Overall Study|Physician Decision|0|||
129605418|NCT03819049|466513438|FG004|Overall Study|Physician Decision|0|||
129605419|NCT03819049|466513439|FG005|Overall Study|Physician Decision|0|||
129605420|NCT03819049|466513440|FG006|Overall Study|Physician Decision|1|||
129605421|NCT01986010|466513441|FG000|Overall Study|Adverse Event|0|||
129605422|NCT01986010|466513442|FG001|Overall Study|Adverse Event|1|||
129789947|NCT03400956|467197821|FG002|Treatment Period 1|Study terminated by sponsor|1|||
129789948|NCT03400956|467197819|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129789949|NCT03400956|467197820|FG001|Treatment Period 1|Withdrawal by Subject|2|||
129789950|NCT03400956|467197821|FG002|Treatment Period 1|Withdrawal by Subject|4|||
129789951|NCT03400956|467197819|FG000|Treatment Period 1|Other|1|||
129789952|NCT03400956|467197820|FG001|Treatment Period 1|Other|2|||
129789953|NCT03400956|467197821|FG002|Treatment Period 1|Other|3|||
129789954|NCT03400956|467197819|FG000|Post-treatment Period 1|Adverse Event|0|||
129789955|NCT03400956|467197820|FG001|Post-treatment Period 1|Adverse Event|0|||
129789956|NCT03400956|467197821|FG002|Post-treatment Period 1|Adverse Event|1|||
129789957|NCT03400956|467197819|FG000|Post-treatment Period 1|Physician Decision|2|||
129789958|NCT03400956|467197820|FG001|Post-treatment Period 1|Physician Decision|3|||
129789959|NCT03400956|467197821|FG002|Post-treatment Period 1|Physician Decision|0|||
129789960|NCT03400956|467197819|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
129789961|NCT03400956|467197820|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
129605423|NCT01986010|466513443|FG002|Overall Study|Adverse Event|0|||
129605424|NCT01986010|466513444|FG003|Overall Study|Adverse Event|0|||
129605425|NCT01986010|466513445|FG004|Overall Study|Adverse Event|0|||
129605426|NCT01986010|466513446|FG005|Overall Study|Adverse Event|0|||
129605427|NCT01986010|466513447|FG006|Overall Study|Adverse Event|0|||
129605428|NCT01986010|466513448|FG007|Overall Study|Adverse Event|0|||
129605429|NCT01986010|466513449|FG008|Overall Study|Adverse Event|0|||
129789962|NCT03400956|467197821|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
129789963|NCT03400956|467197819|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
129605430|NCT01986010|466513450|FG009|Overall Study|Adverse Event|0|||
129605431|NCT01986010|466513451|FG010|Overall Study|Adverse Event|0|||
129789964|NCT03400956|467197820|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
129789965|NCT03400956|467197821|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
129605432|NCT01986010|466513452|FG011|Overall Study|Adverse Event|0|||
129605433|NCT01986010|466513453|FG012|Overall Study|Adverse Event|0|||
129605434|NCT01986010|466513454|FG013|Overall Study|Adverse Event|0|||
129605435|NCT01986010|466513455|FG014|Overall Study|Adverse Event|0|||
129605436|NCT01986010|466513456|FG015|Overall Study|Adverse Event|1|||
129605437|NCT01986010|466513457|FG016|Overall Study|Adverse Event|0|||
129605438|NCT01986010|466513441|FG000|Overall Study|Lost to Follow-up|2|||
129605439|NCT01986010|466513442|FG001|Overall Study|Lost to Follow-up|1|||
129605440|NCT01986010|466513443|FG002|Overall Study|Lost to Follow-up|2|||
129605441|NCT01986010|466513444|FG003|Overall Study|Lost to Follow-up|2|||
129605442|NCT01986010|466513445|FG004|Overall Study|Lost to Follow-up|2|||
129605443|NCT01986010|466513446|FG005|Overall Study|Lost to Follow-up|2|||
129605444|NCT01986010|466513447|FG006|Overall Study|Lost to Follow-up|0|||
129605445|NCT01986010|466513448|FG007|Overall Study|Lost to Follow-up|0|||
129605446|NCT01986010|466513449|FG008|Overall Study|Lost to Follow-up|4|||
129605447|NCT01986010|466513450|FG009|Overall Study|Lost to Follow-up|2|||
129605448|NCT01986010|466513451|FG010|Overall Study|Lost to Follow-up|0|||
129605449|NCT01986010|466513452|FG011|Overall Study|Lost to Follow-up|1|||
129605450|NCT01986010|466513453|FG012|Overall Study|Lost to Follow-up|1|||
129605451|NCT01986010|466513454|FG013|Overall Study|Lost to Follow-up|1|||
129605452|NCT01986010|466513455|FG014|Overall Study|Lost to Follow-up|2|||
129605453|NCT01986010|466513456|FG015|Overall Study|Lost to Follow-up|0|||
129605454|NCT01986010|466513457|FG016|Overall Study|Lost to Follow-up|0|||
129605455|NCT01986010|466513441|FG000|Overall Study|Physician Decision|0|||
129605456|NCT01986010|466513442|FG001|Overall Study|Physician Decision|0|||
129605457|NCT01986010|466513443|FG002|Overall Study|Physician Decision|0|||
129605458|NCT01986010|466513444|FG003|Overall Study|Physician Decision|0|||
129605459|NCT01986010|466513445|FG004|Overall Study|Physician Decision|0|||
129605460|NCT01986010|466513446|FG005|Overall Study|Physician Decision|0|||
129605461|NCT01986010|466513447|FG006|Overall Study|Physician Decision|0|||
129605462|NCT01986010|466513448|FG007|Overall Study|Physician Decision|0|||
129605463|NCT01986010|466513449|FG008|Overall Study|Physician Decision|0|||
129605464|NCT01986010|466513450|FG009|Overall Study|Physician Decision|0|||
129605465|NCT01986010|466513451|FG010|Overall Study|Physician Decision|0|||
129605466|NCT01986010|466513452|FG011|Overall Study|Physician Decision|0|||
129605467|NCT01986010|466513453|FG012|Overall Study|Physician Decision|0|||
129605468|NCT01986010|466513454|FG013|Overall Study|Physician Decision|0|||
129605469|NCT01986010|466513455|FG014|Overall Study|Physician Decision|1|||
129605470|NCT01986010|466513456|FG015|Overall Study|Physician Decision|0|||
129605471|NCT01986010|466513457|FG016|Overall Study|Physician Decision|0|||
129605472|NCT01986010|466513441|FG000|Overall Study|Withdrawal by Subject|2|||
129605473|NCT01986010|466513442|FG001|Overall Study|Withdrawal by Subject|2|||
129605474|NCT01986010|466513443|FG002|Overall Study|Withdrawal by Subject|3|||
129605475|NCT01986010|466513444|FG003|Overall Study|Withdrawal by Subject|0|||
129605476|NCT01986010|466513445|FG004|Overall Study|Withdrawal by Subject|2|||
129605477|NCT01986010|466513446|FG005|Overall Study|Withdrawal by Subject|4|||
129605478|NCT01986010|466513447|FG006|Overall Study|Withdrawal by Subject|0|||
129605479|NCT01986010|466513448|FG007|Overall Study|Withdrawal by Subject|0|||
129605480|NCT01986010|466513449|FG008|Overall Study|Withdrawal by Subject|0|||
129605481|NCT01986010|466513450|FG009|Overall Study|Withdrawal by Subject|0|||
129605482|NCT01986010|466513451|FG010|Overall Study|Withdrawal by Subject|0|||
129605483|NCT01986010|466513452|FG011|Overall Study|Withdrawal by Subject|2|||
129605484|NCT01986010|466513453|FG012|Overall Study|Withdrawal by Subject|0|||
129605485|NCT01986010|466513454|FG013|Overall Study|Withdrawal by Subject|1|||
129605486|NCT01986010|466513455|FG014|Overall Study|Withdrawal by Subject|2|||
129605487|NCT01986010|466513456|FG015|Overall Study|Withdrawal by Subject|0|||
129605488|NCT01986010|466513457|FG016|Overall Study|Withdrawal by Subject|0|||
129605489|NCT01986010|466513441|FG000|Overall Study|Status Not Recorded|2|||
129605490|NCT01986010|466513442|FG001|Overall Study|Status Not Recorded|4|||
129605491|NCT01986010|466513443|FG002|Overall Study|Status Not Recorded|2|||
129789966|NCT03400956|467197819|FG000|Post-treatment Period 1|Other|4|||
129437260|NCT01668667|465898715|FG003|Overall Study|Physician Decision|0|||
129437261|NCT01668667|465898712|FG000|Overall Study|Withdrawal by Subject|7|||
129437262|NCT01668667|465898713|FG001|Overall Study|Withdrawal by Subject|4|||
129605492|NCT01986010|466513444|FG003|Overall Study|Status Not Recorded|0|||
129605493|NCT01986010|466513445|FG004|Overall Study|Status Not Recorded|1|||
129605494|NCT01986010|466513446|FG005|Overall Study|Status Not Recorded|2|||
129605495|NCT01986010|466513447|FG006|Overall Study|Status Not Recorded|0|||
129605496|NCT01986010|466513448|FG007|Overall Study|Status Not Recorded|0|||
129605497|NCT01986010|466513449|FG008|Overall Study|Status Not Recorded|2|||
129605498|NCT01986010|466513450|FG009|Overall Study|Status Not Recorded|1|||
129605499|NCT01986010|466513451|FG010|Overall Study|Status Not Recorded|7|||
129789967|NCT03400956|467197820|FG001|Post-treatment Period 1|Other|3|||
129789968|NCT03400956|467197821|FG002|Post-treatment Period 1|Other|4|||
129437263|NCT01668667|465898714|FG002|Overall Study|Withdrawal by Subject|5|||
129605500|NCT01986010|466513452|FG011|Overall Study|Status Not Recorded|7|||
129605501|NCT01986010|466513453|FG012|Overall Study|Status Not Recorded|9|||
129605502|NCT01986010|466513454|FG013|Overall Study|Status Not Recorded|9|||
129605503|NCT01986010|466513455|FG014|Overall Study|Status Not Recorded|5|||
129605504|NCT01986010|466513456|FG015|Overall Study|Status Not Recorded|10|||
129605505|NCT01986010|466513457|FG016|Overall Study|Status Not Recorded|4|||
129605506|NCT01335997|466513458|FG000|Period I and II|Adverse Event|63|||
129605507|NCT01335997|466513459|FG001|Period I and II|Adverse Event|43|||
129605508|NCT01335997|466513458|FG000|Period I and II|Noncompliance with Study Drug|1|||
129605509|NCT01335997|466513459|FG001|Period I and II|Noncompliance with Study Drug|1|||
129605510|NCT01335997|466513458|FG000|Period I and II|Lost to Follow-up|3|||
129605511|NCT01335997|466513459|FG001|Period I and II|Lost to Follow-up|5|||
129605512|NCT01335997|466513458|FG000|Period I and II|Withdrawal by Subject|9|||
129605513|NCT01335997|466513459|FG001|Period I and II|Withdrawal by Subject|4|||
129605514|NCT01335997|466513458|FG000|Period I and II|Study Terminated by Sponsor|406|||
129605515|NCT01335997|466513459|FG001|Period I and II|Study Terminated by Sponsor|415|||
129605516|NCT01335997|466513458|FG000|Period I and II|Protocol Violation|9|||
129605517|NCT01335997|466513459|FG001|Period I and II|Protocol Violation|10|||
129605518|NCT01335997|466513458|FG000|Period I and II|Physician Decision|2|||
129605519|NCT01335997|466513459|FG001|Period I and II|Physician Decision|1|||
129605520|NCT01335997|466513458|FG000|Period III|Adverse Event|0|||
129605521|NCT01335997|466513459|FG001|Period III|Adverse Event|2|||
129605522|NCT01335997|466513458|FG000|Period III|Study Terminated by Sponsor|77|||
129605523|NCT01335997|466513459|FG001|Period III|Study Terminated by Sponsor|76|||
129605524|NCT01335997|466513458|FG000|Period III|Protocol Violation|0|||
129437264|NCT01668667|465898715|FG003|Overall Study|Withdrawal by Subject|5|||
129437265|NCT00511901|465898716|FG000|Overall Study|Withdrawal by Subject|1|||
129437266|NCT00511901|465898717|FG001|Overall Study|Withdrawal by Subject|3|||
129437267|NCT02447172|465898718|FG000|Overall Study|Adverse Event|11|||
129437268|NCT02447172|465898719|FG001|Overall Study|Adverse Event|8|||
129437269|NCT02447172|465898720|FG002|Overall Study|Adverse Event|7|||
129605525|NCT01335997|466513459|FG001|Period III|Protocol Violation|1|||
129605526|NCT01335997|466513458|FG000|Period III|Lost to Follow-up|1|||
129605527|NCT01335997|466513459|FG001|Period III|Lost to Follow-up|0|||
129605528|NCT04740814|466513460|FG000|Overall Study|Adverse Event|3|||
129605529|NCT04740814|466513460|FG000|Overall Study|Protocol Violation|2|||
129605530|NCT04740814|466513460|FG000|Overall Study|Lost to Follow-up|2|||
129605531|NCT04740814|466513460|FG000|Overall Study|Withdrawal by Subject|3|||
129605532|NCT02500641|466513463|FG000|Overall Study|Adverse Event|0|||
129605533|NCT02500641|466513464|FG001|Overall Study|Adverse Event|2|||
129605534|NCT02500641|466513463|FG000|Overall Study|Withdrawal by Subject|4|||
129605535|NCT02500641|466513464|FG001|Overall Study|Withdrawal by Subject|5|||
129605536|NCT02500641|466513463|FG000|Overall Study|Unable to follow study procedures|3|||
129605537|NCT02500641|466513464|FG001|Overall Study|Unable to follow study procedures|2|||
129605538|NCT02500641|466513463|FG000|Overall Study|Protocol Violation|1|||
129605539|NCT02500641|466513464|FG001|Overall Study|Protocol Violation|2|||
129605540|NCT02500641|466513463|FG000|Overall Study|Lost to Follow-up|1|||
129605541|NCT02500641|466513464|FG001|Overall Study|Lost to Follow-up|0|||
129605542|NCT02500641|466513463|FG000|Overall Study|Sponsor decision|1|||
129605543|NCT02500641|466513464|FG001|Overall Study|Sponsor decision|0|||
129605544|NCT02500641|466513463|FG000|Overall Study|Non compliance to study drug|0|||
129605545|NCT02500641|466513464|FG001|Overall Study|Non compliance to study drug|1|||
129605546|NCT01763684|466513466|FG000|Overall Study|Study terminated early due to low enrollment|126|||
129605547|NCT01763684|466513467|FG001|Overall Study|Study terminated early due to low enrollment|127|||
129605548|NCT01763684|466513466|FG000|Overall Study|Study surgery not performed|7|||
129605549|NCT01763684|466513467|FG001|Overall Study|Study surgery not performed|6|||
129605550|NCT00643565|466513468|FG000|Overall Study|Death|12|||
129605551|NCT00643565|466513469|FG001|Overall Study|Death|11|||
129605552|NCT00643565|466513468|FG000|Overall Study|Withdrawal by Subject|4|||
129605553|NCT00643565|466513469|FG001|Overall Study|Withdrawal by Subject|1|||
129605554|NCT00643565|466513468|FG000|Overall Study|Lost to Follow-up|0|||
129605555|NCT00643565|466513469|FG001|Overall Study|Lost to Follow-up|6|||
129605556|NCT00643565|466513468|FG000|Overall Study|Other|7|||
129605557|NCT00643565|466513469|FG001|Overall Study|Other|8|||
129605558|NCT00643565|466513468|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
129605559|NCT00643565|466513469|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
129605560|NCT00643565|466513468|FG000|Overall Study|Recurrence of Disease|2|||
129605561|NCT00643565|466513469|FG001|Overall Study|Recurrence of Disease|1|||
129605562|NCT00643565|466513468|FG000|Overall Study|Progression of Disease|18|||
129605563|NCT00643565|466513469|FG001|Overall Study|Progression of Disease|14|||
129605564|NCT00643565|466513468|FG000|Overall Study|Protocol Violation|3|||
129605565|NCT00643565|466513469|FG001|Overall Study|Protocol Violation|0|||
129605566|NCT00643565|466513468|FG000|Overall Study|Did Not Cooperate|0|||
129605567|NCT00643565|466513469|FG001|Overall Study|Did Not Cooperate|1|||
129605568|NCT00643565|466513468|FG000|Overall Study|Administrative|22|||
129605569|NCT00643565|466513469|FG001|Overall Study|Administrative|16|||
129437270|NCT02447172|465898718|FG000|Overall Study|Death|3|||
129437271|NCT02447172|465898719|FG001|Overall Study|Death|1|||
129437272|NCT02447172|465898720|FG002|Overall Study|Death|0|||
129605570|NCT00643565|466513468|FG000|Overall Study|Adverse Event|5|||
129605571|NCT00643565|466513469|FG001|Overall Study|Adverse Event|8|||
129605572|NCT02317614|466513470|FG000|Overall Study|Lost to Follow-up|1|||
129605573|NCT02317614|466513471|FG001|Overall Study|Lost to Follow-up|1|||
129605574|NCT02317614|466513470|FG000|Overall Study|Withdrawal by Subject|1|||
129605575|NCT02317614|466513471|FG001|Overall Study|Withdrawal by Subject|0|||
129605576|NCT02317614|466513470|FG000|Overall Study|Death|1|||
129605577|NCT02317614|466513471|FG001|Overall Study|Death|1|||
129605578|NCT00669071|466513476|FG000|Overall Study|Lost to Follow-up|3|||
129605579|NCT00669071|466513476|FG000|Overall Study|Final visit 40 days out of window|1|||
129605580|NCT02980874|466513484|FG000|Overall Study|Adverse Event|2|||
129605581|NCT02980874|466513485|FG001|Overall Study|Adverse Event|7|||
129605582|NCT02980874|466513484|FG000|Overall Study|Withdrawal by Subject|7|||
129605583|NCT02980874|466513485|FG001|Overall Study|Withdrawal by Subject|2|||
129605584|NCT02980874|466513484|FG000|Overall Study|Lost to Follow-up|5|||
129605585|NCT02980874|466513485|FG001|Overall Study|Lost to Follow-up|5|||
129605586|NCT02980874|466513484|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
129605587|NCT02980874|466513485|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
129605588|NCT02980874|466513484|FG000|Overall Study|Unknown study completion status|1|||
129605589|NCT02980874|466513485|FG001|Overall Study|Unknown study completion status|0|||
129605590|NCT06077487|466515412|FG000|Overall Study|Withdrawal by Subject|0|||
129605591|NCT06077487|466515413|FG001|Overall Study|Withdrawal by Subject|1|||
129605592|NCT00759902|466515415|FG000|Overall Study|Adverse Event|0|||
129605593|NCT00759902|466515416|FG001|Overall Study|Adverse Event|1|||
129605594|NCT02128217|466515419|FG000|Overall Study|Lost to Follow-up|0|||
129605595|NCT02128217|466515420|FG001|Overall Study|Lost to Follow-up|1|||
129605596|NCT05071313|466515421|FG000|Overall Study|Lost to Follow-up|17|||
129605597|NCT05071313|466515422|FG001|Overall Study|Lost to Follow-up|10|||
129605598|NCT05071313|466515421|FG000|Overall Study|Physician Decision|1|||
129605599|NCT05071313|466515422|FG001|Overall Study|Physician Decision|6|||
129605600|NCT05071313|466515421|FG000|Overall Study|Death|1|||
129605601|NCT05071313|466515422|FG001|Overall Study|Death|0|||
129605602|NCT05071313|466515421|FG000|Overall Study|Withdrawal by Subject|10|||
129605603|NCT05071313|466515422|FG001|Overall Study|Withdrawal by Subject|15|||
129605604|NCT05071313|466515421|FG000|Overall Study|Other|1|||
129605605|NCT05071313|466515422|FG001|Overall Study|Other|0|||
129605606|NCT05071313|466515421|FG000|Overall Study|Randomized but not vaccinated|4|||
129605607|NCT05071313|466515422|FG001|Overall Study|Randomized but not vaccinated|2|||
129605608|NCT03107026|466515423|FG000|Overall Study|Adverse Event|2|||
129605609|NCT03107026|466515424|FG001|Overall Study|Adverse Event|14|||
129605610|NCT03107026|466515425|FG002|Overall Study|Adverse Event|23|||
129605611|NCT03107026|466515423|FG000|Overall Study|Lost to Follow-up|12|||
129605612|NCT03107026|466515424|FG001|Overall Study|Lost to Follow-up|12|||
129605613|NCT03107026|466515425|FG002|Overall Study|Lost to Follow-up|13|||
129605614|NCT03107026|466515423|FG000|Overall Study|Protocol Violation|1|||
129605615|NCT03107026|466515424|FG001|Overall Study|Protocol Violation|2|||
129605616|NCT03107026|466515425|FG002|Overall Study|Protocol Violation|0|||
129605617|NCT03107026|466515423|FG000|Overall Study|Pregnancy|1|||
129605618|NCT03107026|466515424|FG001|Overall Study|Pregnancy|0|||
129605619|NCT03107026|466515425|FG002|Overall Study|Pregnancy|0|||
129605620|NCT03107026|466515423|FG000|Overall Study|Withdrawal by Subject|13|||
129605621|NCT03107026|466515424|FG001|Overall Study|Withdrawal by Subject|5|||
129605622|NCT03107026|466515425|FG002|Overall Study|Withdrawal by Subject|17|||
129605623|NCT03107026|466515423|FG000|Overall Study|non compliance with study visits|1|||
129605624|NCT03107026|466515424|FG001|Overall Study|non compliance with study visits|2|||
129605625|NCT03107026|466515425|FG002|Overall Study|non compliance with study visits|0|||
129605626|NCT03107026|466515423|FG000|Overall Study|non-compliance with study drug|2|||
129605627|NCT03107026|466515424|FG001|Overall Study|non-compliance with study drug|2|||
129605628|NCT03107026|466515425|FG002|Overall Study|non-compliance with study drug|3|||
129605629|NCT03107026|466515423|FG000|Overall Study|Physician Decision|0|||
129605630|NCT03107026|466515424|FG001|Overall Study|Physician Decision|1|||
129605631|NCT03107026|466515425|FG002|Overall Study|Physician Decision|0|||
129605632|NCT02049450|466515426|FG000|Overall Study|Adverse Event|2|||
129605633|NCT02049450|466515426|FG000|Overall Study|Withdrawal by Subject|1|||
129605634|NCT02049450|466515426|FG000|Overall Study|Patients/guardian decision|1|||
129605635|NCT03347422|466515430|FG000|Part A (26 Weeks)|Adverse Event|3|||
129605636|NCT03347422|466515431|FG001|Part A (26 Weeks)|Adverse Event|0|||
129605637|NCT03347422|466515430|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
129605638|NCT03347422|466515431|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
129605639|NCT03347422|466515430|FG000|Part B (149 Weeks)|Adverse Event|0|||
129605640|NCT03347422|466515431|FG001|Part B (149 Weeks)|Adverse Event|1|||
129605641|NCT03347422|466515430|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
129605642|NCT03347422|466515431|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
129605643|NCT03347422|466515430|FG000|Part B (149 Weeks)|Other|1|||
129605644|NCT03347422|466515431|FG001|Part B (149 Weeks)|Other|0|||
129605645|NCT05183217|466515432|FG000|Overall Study|Withdrawal by Subject|1|||
129605646|NCT05183217|466515433|FG001|Overall Study|Withdrawal by Subject|1|||
129605647|NCT00969540|466515436|FG000|Overall Study|Lost to Follow-up|1|||
129605648|NCT00969540|466515437|FG001|Overall Study|Lost to Follow-up|1|||
129605649|NCT02397408|466515438|FG000|Overall Study|Physician Decision|4|||
129605650|NCT02397408|466515438|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
129605651|NCT01646138|466515439|FG000|Overall Study|Lost to Follow-up|0|||
129605652|NCT01646138|466515440|FG001|Overall Study|Lost to Follow-up|0|||
129605653|NCT01646138|466515441|FG002|Overall Study|Lost to Follow-up|0|||
129605654|NCT01646138|466515442|FG003|Overall Study|Lost to Follow-up|0|||
129605655|NCT01646138|466515443|FG004|Overall Study|Lost to Follow-up|2|||
129605656|NCT01683838|466515444|FG000|Overall Study|Adverse Event|12|||
129605657|NCT01683838|466515445|FG001|Overall Study|Adverse Event|2|||
129605658|NCT01683838|466515444|FG000|Overall Study|Protocol Violation|3|||
129605659|NCT01683838|466515445|FG001|Overall Study|Protocol Violation|1|||
129605660|NCT01683838|466515444|FG000|Overall Study|Withdrawal by Subject|6|||
129605661|NCT01683838|466515445|FG001|Overall Study|Withdrawal by Subject|5|||
129605662|NCT01683838|466515444|FG000|Overall Study|Lost to Follow-up|1|||
129605663|NCT01683838|466515445|FG001|Overall Study|Lost to Follow-up|1|||
129605664|NCT01683838|466515444|FG000|Overall Study|Other|4|||
129605665|NCT01683838|466515445|FG001|Overall Study|Other|3|||
129605666|NCT01524679|466515446|FG000|Overall Study|Lost to Follow-up|1|||
129605667|NCT01524679|466515447|FG001|Overall Study|Lost to Follow-up|4|||
129605668|NCT01524679|466515446|FG000|Overall Study|Withdrawal by Subject|4|||
129605669|NCT01524679|466515447|FG001|Overall Study|Withdrawal by Subject|4|||
129605670|NCT01524679|466515446|FG000|Overall Study|Adverse Event|9|||
129605671|NCT01524679|466515447|FG001|Overall Study|Adverse Event|0|||
129605672|NCT01524679|466515446|FG000|Overall Study|Protocol Violation|1|||
129605673|NCT01524679|466515447|FG001|Overall Study|Protocol Violation|0|||
129605674|NCT01524679|466515446|FG000|Overall Study|Lack of Efficacy|2|||
129605675|NCT01524679|466515447|FG001|Overall Study|Lack of Efficacy|0|||
129605676|NCT01524679|466515446|FG000|Overall Study|e.g.wish for children, relocation|6|||
129605677|NCT01524679|466515447|FG001|Overall Study|e.g.wish for children, relocation|1|||
129605678|NCT00801099|466515448|FG000|Overall Study|Lost to Follow-up|101|||
129605679|NCT03321630|466515456|FG000|Overall Study|Adverse Event|1|||
129605680|NCT03321630|466515456|FG000|Overall Study|Investigator Discretion|2|||
129605681|NCT03321630|466515456|FG000|Overall Study|Withdrawal by Subject|1|||
129605682|NCT02455050|466515457|FG000|Treatment Period 1|Lost to Follow-up|1|||
129605683|NCT02455050|466515458|FG001|Treatment Period 1|Lost to Follow-up|1|||
129605684|NCT02455050|466515459|FG002|Treatment Period 1|Lost to Follow-up|1|||
129605685|NCT02455050|466515460|FG003|Treatment Period 1|Lost to Follow-up|2|||
129605686|NCT02455050|466515457|FG000|Treatment Period 2|Lost to Follow-up|1|||
129605687|NCT02455050|466515458|FG001|Treatment Period 2|Lost to Follow-up|0|||
129605688|NCT02455050|466515459|FG002|Treatment Period 2|Lost to Follow-up|2|||
129605689|NCT02455050|466515460|FG003|Treatment Period 2|Lost to Follow-up|1|||
129605690|NCT02981303|466515461|FG000|Overall Study|Progressive Disease|17|||
129605691|NCT02981303|466515462|FG001|Overall Study|Progressive Disease|37|||
129605692|NCT02981303|466515461|FG000|Overall Study|Adverse Event|1|||
129605693|NCT02981303|466515462|FG001|Overall Study|Adverse Event|4|||
129605694|NCT02981303|466515461|FG000|Overall Study|Withdrawal by Subject|0|||
129605695|NCT02981303|466515462|FG001|Overall Study|Withdrawal by Subject|1|||
129605696|NCT02325518|466515463|FG000|Overall Study|Adverse Event|4|||
129605697|NCT02325518|466515464|FG001|Overall Study|Adverse Event|1|||
129605698|NCT02325518|466515463|FG000|Overall Study|Physician Decision|0|||
129605699|NCT02325518|466515464|FG001|Overall Study|Physician Decision|1|||
129605700|NCT02325518|466515463|FG000|Overall Study|Withdrawal by Subject|0|||
129605701|NCT02325518|466515464|FG001|Overall Study|Withdrawal by Subject|1|||
129605702|NCT03393806|466515467|FG000|Overall Study|Physician Decision|1|||
129605703|NCT03393806|466515468|FG001|Overall Study|Physician Decision|0|||
129605704|NCT00886288|466515469|FG000|Overall Study|no respect of the 12 weeks period|657|||
129698296|NCT02799043|466854988|FG000|Overall Study|Adverse Event|0|||
129698297|NCT02799043|466854989|FG001|Overall Study|Adverse Event|1|||
129605705|NCT00886288|466515470|FG001|Overall Study|no respect of the 12 weeks period|227|||
129605706|NCT00886288|466515469|FG000|Overall Study|Lost to Follow-up|86|||
129605707|NCT00886288|466515470|FG001|Overall Study|Lost to Follow-up|0|||
129605708|NCT01259115|466515471|FG000|Period 1|Adverse Event|1|||
129605709|NCT01259115|466515472|FG001|Period 1|Adverse Event|0|||
129605710|NCT01259115|466515471|FG000|Period 1|Protocol Violation|2|||
129605711|NCT01259115|466515472|FG001|Period 1|Protocol Violation|0|||
129605712|NCT01259115|466515471|FG000|Period 1|Lost to Follow-up|0|||
129605713|NCT01259115|466515472|FG001|Period 1|Lost to Follow-up|1|||
129605714|NCT01259115|466515471|FG000|Period 2|Adverse Event|1|||
129698298|NCT02799043|466854988|FG000|Overall Study|Death|1|||
129605715|NCT01259115|466515472|FG001|Period 2|Adverse Event|0|||
129605716|NCT01675661|466515473|FG000|Overall Study|Lost to Follow-up|22|||
129605717|NCT01675661|466515474|FG001|Overall Study|Lost to Follow-up|23|||
129605718|NCT01675661|466515473|FG000|Overall Study|Practical problems|9|||
129605719|NCT01675661|466515474|FG001|Overall Study|Practical problems|5|||
129698299|NCT02799043|466854989|FG001|Overall Study|Death|1|||
129437273|NCT02447172|465898718|FG000|Overall Study|Protocol Violation|2|||
129437274|NCT02447172|465898719|FG001|Overall Study|Protocol Violation|1|||
129437275|NCT02447172|465898720|FG002|Overall Study|Protocol Violation|2|||
129437276|NCT02447172|465898718|FG000|Overall Study|Lost to Follow-up|7|||
129437277|NCT02447172|465898719|FG001|Overall Study|Lost to Follow-up|4|||
129437278|NCT02447172|465898720|FG002|Overall Study|Lost to Follow-up|4|||
129437279|NCT02447172|465898718|FG000|Overall Study|Withdrawal by Subject|5|||
129437280|NCT02447172|465898719|FG001|Overall Study|Withdrawal by Subject|1|||
129437281|NCT02447172|465898720|FG002|Overall Study|Withdrawal by Subject|3|||
129437282|NCT02447172|465898718|FG000|Overall Study|protocol specific treatment unrelated|3|||
129437283|NCT02447172|465898719|FG001|Overall Study|protocol specific treatment unrelated|0|||
129437284|NCT02447172|465898720|FG002|Overall Study|protocol specific treatment unrelated|2|||
129437285|NCT03343301|465898721|FG000|Overall Study|Withdrawal by Subject|1|||
129437286|NCT03343301|465898722|FG001|Overall Study|Withdrawal by Subject|1|||
129437287|NCT03343301|465898721|FG000|Overall Study|Death|0|||
129437288|NCT03343301|465898722|FG001|Overall Study|Death|2|||
129437289|NCT03343301|465898721|FG000|Overall Study|Other|0|||
129437290|NCT03343301|465898722|FG001|Overall Study|Other|6|||
129437291|NCT03343301|465898721|FG000|Overall Study|Missing|2|||
129437292|NCT03343301|465898722|FG001|Overall Study|Missing|0|||
129437293|NCT02881957|465898735|FG000|Overall Study|Comfort care|0|||
129437294|NCT02881957|465898736|FG001|Overall Study|Comfort care|1|||
129437295|NCT02881957|465898735|FG000|Overall Study|Concurrent trial enrollment|0|||
129437296|NCT02881957|465898736|FG001|Overall Study|Concurrent trial enrollment|1|||
129437297|NCT02881957|465898735|FG000|Overall Study|Discharged within 48 hours|0|||
129437298|NCT02881957|465898736|FG001|Overall Study|Discharged within 48 hours|1|||
129437299|NCT02881957|465898735|FG000|Overall Study|Withdrawal by Subject|2|||
129437300|NCT02881957|465898736|FG001|Overall Study|Withdrawal by Subject|1|||
129437301|NCT02881957|465898735|FG000|Overall Study|Protocol Violation|1|||
129437302|NCT02881957|465898736|FG001|Overall Study|Protocol Violation|0|||
129437303|NCT00345293|465898737|FG000|Overall Study|Unable to access line for sample|1|||
129437304|NCT00345293|465898738|FG001|Overall Study|Unable to access line for sample|0|||
129437305|NCT00345293|465898737|FG000|Overall Study|Withdrawal by Subject|1|||
129437306|NCT00345293|465898738|FG001|Overall Study|Withdrawal by Subject|0|||
129437307|NCT02390245|465898739|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
129437308|NCT02390245|465898740|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
129789969|NCT03400956|467197819|FG000|Treatment Period 2|Adverse Event|2|||
129789970|NCT03400956|467197820|FG001|Treatment Period 2|Adverse Event|1|||
129789971|NCT03400956|467197821|FG002|Treatment Period 2|Adverse Event|1|||
129789972|NCT03400956|467197819|FG000|Treatment Period 2|Lost to Follow-up|1|||
129789973|NCT03400956|467197820|FG001|Treatment Period 2|Lost to Follow-up|1|||
129789974|NCT03400956|467197821|FG002|Treatment Period 2|Lost to Follow-up|0|||
129437309|NCT02390245|465898741|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
129437310|NCT02390245|465898739|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
129437311|NCT02390245|465898740|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
129437312|NCT02390245|465898741|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
129437313|NCT01328717|465900343|FG000|Overall Study|Adverse Event|1|||
129437314|NCT00001962|465900344|FG000|Overall Study|Lack of Efficacy|18|||
129437315|NCT00001962|465900344|FG000|Overall Study|Lack of Accrual|6|||
129437316|NCT00001962|465900344|FG000|Overall Study|Death|1|||
129605720|NCT01675661|466515473|FG000|Overall Study|Moved away|5|||
129605721|NCT01675661|466515474|FG001|Overall Study|Moved away|6|||
129605722|NCT01675661|466515473|FG000|Overall Study|Withdrawal by Subject|3|||
129789975|NCT03400956|467197819|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129605723|NCT01675661|466515474|FG001|Overall Study|Withdrawal by Subject|7|||
129605724|NCT01675661|466515473|FG000|Overall Study|Physician Decision|0|||
129605725|NCT01675661|466515474|FG001|Overall Study|Physician Decision|2|||
129605726|NCT01675661|466515473|FG000|Overall Study|Death|0|||
129605727|NCT01675661|466515474|FG001|Overall Study|Death|1|||
129605728|NCT01675661|466515473|FG000|Overall Study|Other reason|1|||
129605729|NCT01675661|466515474|FG001|Overall Study|Other reason|2|||
129605730|NCT02393248|466515475|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605731|NCT02393248|466515476|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
129605732|NCT02393248|466515477|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129789976|NCT03400956|467197820|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129800258|NCT02445391|467236291|FG001|Overall Study|Adverse Event|21|||
129437317|NCT00001962|465900344|FG000|Overall Study|Lost to Follow-up|2|||
129437318|NCT00001962|465900344|FG000|Overall Study|Adverse Event|1|||
129437319|NCT03442985|465900348|FG000|Overall Study|Sponsor Request|55|||
129437320|NCT03442985|465900349|FG001|Overall Study|Sponsor Request|60|||
129437321|NCT03442985|465900350|FG002|Overall Study|Sponsor Request|54|||
129437322|NCT03442985|465900348|FG000|Overall Study|Lost to Follow-up|5|||
129437323|NCT03442985|465900349|FG001|Overall Study|Lost to Follow-up|2|||
129437324|NCT03442985|465900350|FG002|Overall Study|Lost to Follow-up|7|||
129605733|NCT02393248|466515478|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605734|NCT02393248|466515479|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605735|NCT02393248|466515480|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
129698300|NCT02799043|466854988|FG000|Overall Study|Lost to Follow-up|3|||
129698301|NCT02799043|466854989|FG001|Overall Study|Lost to Follow-up|6|||
129698302|NCT02799043|466854988|FG000|Overall Study|Withdrawal by Subject|4|||
129698303|NCT02799043|466854989|FG001|Overall Study|Withdrawal by Subject|4|||
129698304|NCT02799043|466854988|FG000|Overall Study|Moved to different country|0|||
129698305|NCT02799043|466854989|FG001|Overall Study|Moved to different country|1|||
129698306|NCT02799043|466854988|FG000|Overall Study|Trial Screen Failure|1|||
129698307|NCT02799043|466854989|FG001|Overall Study|Trial Screen Failure|0|||
129698308|NCT02799043|466854988|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
129698309|NCT02799043|466854989|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
129698310|NCT06091956|466854990|FG000|Overall Study|Withdrawal by Subject|1|||
129698311|NCT06091956|466854990|FG000|Overall Study|Complicating Disease|1|||
129698312|NCT01421459|466854999|FG000|Overall Study|Adverse Event|6|||
129698313|NCT01421459|466855000|FG001|Overall Study|Adverse Event|10|||
129698314|NCT01421459|466854999|FG000|Overall Study|Death|1|||
129698315|NCT01421459|466855000|FG001|Overall Study|Death|1|||
129698316|NCT01421459|466854999|FG000|Overall Study|Lack of Efficacy|1|||
129698317|NCT01421459|466855000|FG001|Overall Study|Lack of Efficacy|2|||
129698318|NCT01421459|466854999|FG000|Overall Study|Lost to Follow-up|8|||
129698319|NCT01421459|466855000|FG001|Overall Study|Lost to Follow-up|9|||
129698320|NCT01421459|466854999|FG000|Overall Study|Physician Decision|9|||
129698321|NCT01421459|466855000|FG001|Overall Study|Physician Decision|9|||
129698322|NCT01421459|466854999|FG000|Overall Study|Protocol Violation|8|||
129698323|NCT01421459|466855000|FG001|Overall Study|Protocol Violation|5|||
129698324|NCT01421459|466854999|FG000|Overall Study|Withdrawal by Subject|12|||
129698325|NCT01421459|466855000|FG001|Overall Study|Withdrawal by Subject|16|||
129698326|NCT04439903|466855003|FG000|Overall Study|Withdrawal by Subject|2|||
129698327|NCT04439903|466855003|FG000|Overall Study|Screen Failure|1|||
129698328|NCT02899754|466855004|FG000|Overall Study|Lost to Follow-up|7|||
129698329|NCT02899754|466855005|FG001|Overall Study|Lost to Follow-up|9|||
129698330|NCT03996395|466855012|FG000|Overall Study|Lost to Follow-up|4|||
129698331|NCT03996395|466855012|FG000|Overall Study|Withdrawal by Subject|1|||
129698332|NCT03996395|466855012|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
129698333|NCT02544763|466855013|FG000|Overall Study|Adverse Event|8|||
129698334|NCT02544763|466855014|FG001|Overall Study|Adverse Event|8|||
129698335|NCT02544763|466855015|FG002|Overall Study|Adverse Event|0|||
129698336|NCT02544763|466855013|FG000|Overall Study|Withdrawn by parent/guardian|1|||
129698337|NCT02544763|466855014|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129698338|NCT02544763|466855015|FG002|Overall Study|Withdrawn by parent/guardian|1|||
129698339|NCT02544763|466855013|FG000|Overall Study|Met withdrawal criteria|0|||
129698340|NCT02544763|466855014|FG001|Overall Study|Met withdrawal criteria|2|||
129698341|NCT02544763|466855015|FG002|Overall Study|Met withdrawal criteria|0|||
129698342|NCT02544763|466855013|FG000|Overall Study|Physician Decision|0|||
129886275|NCT02061761|467542932|FG001|Overall Study|Withdrawal by Subject|0|||
129886276|NCT02061761|467542933|FG002|Overall Study|Withdrawal by Subject|0|||
129437325|NCT03442985|465900348|FG000|Overall Study|Withdrawal by Subject|2|||
129437326|NCT03442985|465900349|FG001|Overall Study|Withdrawal by Subject|3|||
129437327|NCT03442985|465900350|FG002|Overall Study|Withdrawal by Subject|4|||
129605736|NCT02393248|466515481|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
129605737|NCT02393248|466515482|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605738|NCT02393248|466515483|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605739|NCT02393248|466515484|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605740|NCT02393248|466515485|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605741|NCT02393248|466515486|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605742|NCT02393248|466515487|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605743|NCT02393248|466515488|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605744|NCT02393248|466515489|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605745|NCT02393248|466515490|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605746|NCT02393248|466515491|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605747|NCT02393248|466515492|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605748|NCT02393248|466515493|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605749|NCT02393248|466515494|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605750|NCT02393248|466515495|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605751|NCT02393248|466515496|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605752|NCT02393248|466515497|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605753|NCT02393248|466515498|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605754|NCT02393248|466515499|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
129605755|NCT02393248|466515475|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605756|NCT02393248|466515476|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
129605757|NCT02393248|466515477|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605758|NCT02393248|466515478|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605759|NCT02393248|466515479|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605760|NCT02393248|466515480|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605761|NCT02393248|466515481|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605762|NCT02393248|466515482|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605763|NCT02393248|466515483|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605764|NCT02393248|466515484|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605765|NCT02393248|466515485|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605766|NCT02393248|466515486|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605767|NCT02393248|466515487|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605768|NCT02393248|466515488|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605769|NCT02393248|466515489|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605770|NCT02393248|466515490|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605771|NCT02393248|466515491|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605772|NCT02393248|466515492|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605773|NCT02393248|466515493|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605774|NCT02393248|466515494|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605775|NCT02393248|466515495|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605776|NCT02393248|466515496|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605777|NCT02393248|466515497|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605778|NCT02393248|466515498|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605779|NCT02393248|466515499|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
129605780|NCT02393248|466515475|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
129605781|NCT02393248|466515476|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
129605782|NCT02393248|466515477|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
129698343|NCT02544763|466855014|FG001|Overall Study|Physician Decision|1|||
129437328|NCT03442985|465900348|FG000|Overall Study|Adverse Event|0|||
129437329|NCT03442985|465900349|FG001|Overall Study|Adverse Event|1|||
129437330|NCT03442985|465900350|FG002|Overall Study|Adverse Event|0|||
129437331|NCT01217957|465900351|FG000|Phase 1|Withdrawal by Patient|1|||
129605783|NCT02393248|466515478|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
129605784|NCT02393248|466515479|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
129605785|NCT02393248|466515480|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
129605786|NCT02393248|466515481|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
129605787|NCT02393248|466515482|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
129698344|NCT02544763|466855015|FG002|Overall Study|Physician Decision|0|||
129698345|NCT02544763|466855013|FG000|Overall Study|Difficulties taking IMP|1|||
129605788|NCT02393248|466515483|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
129605789|NCT02393248|466515484|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
129698346|NCT02544763|466855014|FG001|Overall Study|Difficulties taking IMP|0|||
129886277|NCT02061761|467542934|FG003|Overall Study|Withdrawal by Subject|0|||
129605790|NCT02393248|466515485|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
129605791|NCT02393248|466515486|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
129605792|NCT02393248|466515487|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
129605793|NCT02393248|466515488|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
129605794|NCT02393248|466515489|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
129605795|NCT02393248|466515490|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
129605796|NCT02393248|466515491|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
129605797|NCT02393248|466515492|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
129605798|NCT02393248|466515493|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
129605799|NCT02393248|466515494|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
129605800|NCT02393248|466515495|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
129605801|NCT02393248|466515496|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
129605802|NCT02393248|466515497|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
129605803|NCT02393248|466515498|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
129605804|NCT02393248|466515499|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
129605805|NCT02393248|466515475|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
129605806|NCT02393248|466515476|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605807|NCT02393248|466515477|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605808|NCT02393248|466515478|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605809|NCT02393248|466515479|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605810|NCT02393248|466515480|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605811|NCT02393248|466515481|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605812|NCT02393248|466515482|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605813|NCT02393248|466515483|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605814|NCT02393248|466515484|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605815|NCT02393248|466515485|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605816|NCT02393248|466515486|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605817|NCT02393248|466515487|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605818|NCT02393248|466515488|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129698347|NCT02544763|466855015|FG002|Overall Study|Difficulties taking IMP|0|||
129886278|NCT02061761|467542935|FG004|Overall Study|Withdrawal by Subject|0|||
129437332|NCT01217957|465900352|FG001|Phase 1|Withdrawal by Patient|0|||
129886279|NCT02061761|467542936|FG005|Overall Study|Withdrawal by Subject|0|||
129886280|NCT02061761|467542937|FG006|Overall Study|Withdrawal by Subject|0|||
129437333|NCT01217957|465900353|FG002|Phase 1|Withdrawal by Patient|1|||
129437334|NCT01217957|465900354|FG003|Phase 1|Withdrawal by Patient|1|||
129605819|NCT02393248|466515489|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605820|NCT02393248|466515490|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605821|NCT02393248|466515491|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605822|NCT02393248|466515492|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605823|NCT02393248|466515493|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605824|NCT02393248|466515494|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605825|NCT02393248|466515495|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605826|NCT02393248|466515496|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605827|NCT02393248|466515497|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605828|NCT02393248|466515498|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605829|NCT02393248|466515499|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
129605830|NCT02393248|466515475|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605831|NCT02393248|466515476|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605832|NCT02393248|466515477|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605833|NCT02393248|466515478|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605834|NCT02393248|466515479|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605835|NCT02393248|466515480|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
129605836|NCT02393248|466515481|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
129605837|NCT02393248|466515482|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605838|NCT02393248|466515483|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605839|NCT02393248|466515484|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
129605840|NCT02393248|466515485|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605841|NCT02393248|466515486|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605842|NCT02393248|466515487|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605843|NCT02393248|466515488|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605844|NCT02393248|466515489|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605845|NCT02393248|466515490|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605846|NCT02393248|466515491|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605847|NCT02393248|466515492|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605848|NCT02393248|466515493|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605849|NCT02393248|466515494|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605850|NCT02393248|466515495|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129437335|NCT01217957|465900355|FG004|Phase 1|Withdrawal by Patient|0|||
129437336|NCT01217957|465900351|FG000|Phase 2|Withdrawal by Patient|0|||
129437337|NCT01217957|465900352|FG001|Phase 2|Withdrawal by Patient|0|||
129647491|NCT03729570|466665337|FG001|Overall Study|Bad Experience|1|||
129647492|NCT03729570|466665336|FG000|Overall Study|No reason provided|2|||
129647493|NCT03729570|466665337|FG001|Overall Study|No reason provided|1|||
129647494|NCT03729570|466665336|FG000|Overall Study|Family Conflict|0|||
129647495|NCT03729570|466665337|FG001|Overall Study|Family Conflict|1|||
129647496|NCT03729570|466665336|FG000|Overall Study|Did not want to continue taking medications|0|||
129647497|NCT03729570|466665337|FG001|Overall Study|Did not want to continue taking medications|1|||
129647498|NCT03729570|466665336|FG000|Overall Study|Found another PrEP provider|1|||
129647499|NCT03729570|466665337|FG001|Overall Study|Found another PrEP provider|0|||
129647500|NCT03729570|466665336|FG000|Overall Study|Did not enjoy being in the control group|0|||
129647501|NCT03729570|466665337|FG001|Overall Study|Did not enjoy being in the control group|1|||
129647502|NCT01701193|466665340|FG000|Overall Study|Withdrawal by Subject|2|||
129647503|NCT01701193|466665341|FG001|Overall Study|Withdrawal by Subject|2|||
129647504|NCT01701193|466665342|FG002|Overall Study|Withdrawal by Subject|1|||
129647505|NCT01701193|466665343|FG003|Overall Study|Withdrawal by Subject|2|||
129647506|NCT01701193|466665340|FG000|Overall Study|Adverse Event|1|||
129647507|NCT01701193|466665341|FG001|Overall Study|Adverse Event|0|||
129698348|NCT02097225|466855016|FG000|Dose Level 4|Adverse Event|0|||
129698349|NCT02097225|466855017|FG001|Dose Level 4|Adverse Event|0|||
129698350|NCT02097225|466855018|FG002|Dose Level 4|Adverse Event|0|||
129698351|NCT02097225|466855019|FG003|Dose Level 4|Adverse Event|0|||
129698352|NCT02097225|466855020|FG004|Dose Level 4|Adverse Event|1|||
129698353|NCT01027351|466855022|FG000|Overall Study|Withdrawal by Subject|1|||
129698354|NCT01027351|466855023|FG001|Overall Study|Withdrawal by Subject|0|||
129605851|NCT02393248|466515496|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605852|NCT02393248|466515497|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605853|NCT02393248|466515498|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605854|NCT02393248|466515499|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
129605855|NCT02393248|466515475|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605856|NCT02393248|466515476|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605857|NCT02393248|466515477|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605858|NCT02393248|466515478|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605859|NCT02393248|466515479|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605860|NCT02393248|466515480|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605861|NCT02393248|466515481|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
129437338|NCT01217957|465900353|FG002|Phase 2|Withdrawal by Patient|0|||
129437339|NCT01217957|465900354|FG003|Phase 2|Withdrawal by Patient|0|||
129437340|NCT01217957|465900355|FG004|Phase 2|Withdrawal by Patient|1|||
129698355|NCT01027351|466855024|FG002|Overall Study|Withdrawal by Subject|1|||
129698356|NCT01027351|466855025|FG003|Overall Study|Withdrawal by Subject|0|||
129698357|NCT01027351|466855026|FG004|Overall Study|Withdrawal by Subject|3|||
129698358|NCT01027351|466855027|FG005|Overall Study|Withdrawal by Subject|5|||
129698359|NCT01027351|466855022|FG000|Overall Study|Lost to Follow-up|1|||
129698360|NCT01027351|466855023|FG001|Overall Study|Lost to Follow-up|1|||
129698361|NCT01027351|466855024|FG002|Overall Study|Lost to Follow-up|0|||
129698362|NCT01027351|466855025|FG003|Overall Study|Lost to Follow-up|1|||
129698363|NCT01027351|466855026|FG004|Overall Study|Lost to Follow-up|6|||
129698364|NCT01027351|466855027|FG005|Overall Study|Lost to Follow-up|0|||
129698365|NCT01027351|466855022|FG000|Overall Study|Inappropriate enrollment|0|||
129698366|NCT01027351|466855023|FG001|Overall Study|Inappropriate enrollment|0|||
129698367|NCT01027351|466855024|FG002|Overall Study|Inappropriate enrollment|0|||
129698368|NCT01027351|466855025|FG003|Overall Study|Inappropriate enrollment|0|||
129698369|NCT01027351|466855026|FG004|Overall Study|Inappropriate enrollment|1|||
129698370|NCT01027351|466855027|FG005|Overall Study|Inappropriate enrollment|0|||
129698371|NCT01027351|466855022|FG000|Overall Study|Protocol Violation|1|||
129698372|NCT01027351|466855023|FG001|Overall Study|Protocol Violation|0|||
129886281|NCT02061761|467542938|FG007|Overall Study|Withdrawal by Subject|0|||
129886282|NCT02061761|467542939|FG008|Overall Study|Withdrawal by Subject|2|||
129886283|NCT02061761|467542931|FG000|Overall Study|Maximum clinical benefit|0|||
129886284|NCT02061761|467542932|FG001|Overall Study|Maximum clinical benefit|0|||
129886285|NCT02061761|467542933|FG002|Overall Study|Maximum clinical benefit|0|||
129886286|NCT02061761|467542934|FG003|Overall Study|Maximum clinical benefit|1|||
129886287|NCT02061761|467542935|FG004|Overall Study|Maximum clinical benefit|0|||
129886288|NCT02061761|467542936|FG005|Overall Study|Maximum clinical benefit|0|||
129886289|NCT02061761|467542937|FG006|Overall Study|Maximum clinical benefit|0|||
129886290|NCT02061761|467542938|FG007|Overall Study|Maximum clinical benefit|0|||
129886291|NCT02061761|467542939|FG008|Overall Study|Maximum clinical benefit|6|||
129886292|NCT02061761|467542931|FG000|Overall Study|Participant no longer meets study criteria|0|||
129886293|NCT02061761|467542932|FG001|Overall Study|Participant no longer meets study criteria|0|||
129886294|NCT02061761|467542933|FG002|Overall Study|Participant no longer meets study criteria|0|||
129886295|NCT02061761|467542934|FG003|Overall Study|Participant no longer meets study criteria|0|||
129886296|NCT02061761|467542935|FG004|Overall Study|Participant no longer meets study criteria|0|||
129886297|NCT02061761|467542936|FG005|Overall Study|Participant no longer meets study criteria|0|||
129886298|NCT02061761|467542937|FG006|Overall Study|Participant no longer meets study criteria|0|||
129886299|NCT02061761|467542938|FG007|Overall Study|Participant no longer meets study criteria|0|||
129886300|NCT02061761|467542939|FG008|Overall Study|Participant no longer meets study criteria|1|||
129886301|NCT02061761|467542931|FG000|Overall Study|Other reasons|0|||
129886302|NCT02061761|467542932|FG001|Overall Study|Other reasons|0|||
129886303|NCT02061761|467542933|FG002|Overall Study|Other reasons|0|||
129886304|NCT02061761|467542934|FG003|Overall Study|Other reasons|0|||
129698373|NCT01027351|466855024|FG002|Overall Study|Protocol Violation|0|||
129698374|NCT01027351|466855025|FG003|Overall Study|Protocol Violation|1|||
129698375|NCT01027351|466855026|FG004|Overall Study|Protocol Violation|1|||
129698376|NCT01027351|466855027|FG005|Overall Study|Protocol Violation|0|||
129698377|NCT02971137|466855028|FG000|Overall Study|Lost to Follow-up|44|||
129698378|NCT02971137|466855029|FG001|Overall Study|Lost to Follow-up|56|||
129698379|NCT02757963|466855030|FG000|Overall Study|Adverse Event|3|||
129698380|NCT02757963|466855030|FG000|Overall Study|Reached Stopping Criteria|1054|||
129698381|NCT02757963|466855030|FG000|Overall Study|Lost to Follow-up|5|||
129698382|NCT02757963|466855030|FG000|Overall Study|Physician Decision|1|||
129698383|NCT02757963|466855030|FG000|Overall Study|Withdrawal by Subject|34|||
129698384|NCT04755231|466855031|FG000|Overall Study|Lost to Follow-up|5|||
129886305|NCT02061761|467542935|FG004|Overall Study|Other reasons|2|||
129886306|NCT02061761|467542936|FG005|Overall Study|Other reasons|0|||
129886307|NCT02061761|467542937|FG006|Overall Study|Other reasons|0|||
129886308|NCT02061761|467542938|FG007|Overall Study|Other reasons|0|||
129437341|NCT01716117|465900361|FG000|Overall Study|Death|5|||
129437342|NCT01716117|465900362|FG001|Overall Study|Death|2|||
129437343|NCT01716117|465900361|FG000|Overall Study|Withdrawal by Subject|2|||
129698385|NCT04755231|466855031|FG000|Overall Study|Withdrawal by Subject|5|||
129886309|NCT02061761|467542939|FG008|Overall Study|Other reasons|6|||
129437344|NCT01716117|465900362|FG001|Overall Study|Withdrawal by Subject|0|||
129437345|NCT00762970|465900366|FG000|Overall Study|Withdrawal by Subject|7|||
129437346|NCT00762970|465900367|FG001|Overall Study|Withdrawal by Subject|4|||
129698386|NCT00911157|466855032|FG000|Overall Study|Adverse Event|4|||
129698387|NCT00911157|466855033|FG001|Overall Study|Adverse Event|1|||
129698388|NCT00911157|466855032|FG000|Overall Study|Withdrawal by Subject|1|||
129698389|NCT00911157|466855033|FG001|Overall Study|Withdrawal by Subject|1|||
129698390|NCT00911157|466855032|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
129698391|NCT00911157|466855033|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
129698392|NCT00911157|466855032|FG000|Overall Study|Need to treat for lung cancer|1|||
129605862|NCT02393248|466515482|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605863|NCT02393248|466515483|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605864|NCT02393248|466515484|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605865|NCT02393248|466515485|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605866|NCT02393248|466515486|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605867|NCT02393248|466515487|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605868|NCT02393248|466515488|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129789977|NCT03400956|467197821|FG002|Treatment Period 2|Withdrawal by Subject|3|||
129789978|NCT03400956|467197819|FG000|Treatment Period 2|Other|1|||
129647508|NCT01701193|466665342|FG002|Overall Study|Adverse Event|0|||
129647509|NCT01701193|466665343|FG003|Overall Study|Adverse Event|0|||
129647510|NCT00278148|466665344|FG000|Phase II - Expansion Phase|Disease progression|0|||
129647511|NCT00278148|466665345|FG001|Phase II - Expansion Phase|Disease progression|0|||
129789979|NCT03400956|467197820|FG001|Treatment Period 2|Other|1|||
129789980|NCT03400956|467197821|FG002|Treatment Period 2|Other|0|||
129789981|NCT03400956|467197819|FG000|Follow-up Period|Withdrawal by Subject|0|||
129789982|NCT03400956|467197820|FG001|Follow-up Period|Withdrawal by Subject|0|||
129647512|NCT00278148|466665346|FG002|Phase II - Expansion Phase|Disease progression|4|||
129647513|NCT00278148|466665344|FG000|Phase II - Expansion Phase|Adverse Event|0|||
129647514|NCT00278148|466665345|FG001|Phase II - Expansion Phase|Adverse Event|0|||
129647515|NCT00278148|466665346|FG002|Phase II - Expansion Phase|Adverse Event|2|||
129647516|NCT02407457|466665347|FG000|1 Month|Death|3|||
129647517|NCT02407457|466665348|FG001|1 Month|Death|0|||
129647518|NCT02407457|466665347|FG000|1 Month|Lost to Follow-up|1|||
129647519|NCT02407457|466665348|FG001|1 Month|Lost to Follow-up|1|||
129647520|NCT02407457|466665347|FG000|1 Month|missed visit|2|||
129647521|NCT02407457|466665348|FG001|1 Month|missed visit|5|||
129647522|NCT02407457|466665347|FG000|6-Month|Death|2|||
129647523|NCT02407457|466665348|FG001|6-Month|Death|8|||
129647524|NCT02407457|466665347|FG000|6-Month|Lost to Follow-up|2|||
129647525|NCT02407457|466665348|FG001|6-Month|Lost to Follow-up|2|||
129647526|NCT02407457|466665347|FG000|6-Month|missed visit|16|||
129647527|NCT02407457|466665348|FG001|6-Month|missed visit|14|||
129647528|NCT02407457|466665347|FG000|6-Month|Open Repair|0|||
129647529|NCT02407457|466665348|FG001|6-Month|Open Repair|1|||
129647530|NCT02407457|466665347|FG000|1 Year|Death|6|||
129647531|NCT02407457|466665348|FG001|1 Year|Death|11|||
129605869|NCT02393248|466515489|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129789983|NCT03400956|467197821|FG002|Follow-up Period|Withdrawal by Subject|1|||
129789984|NCT03400956|467197819|FG000|Follow-up Period|Other|0|||
129789985|NCT03400956|467197820|FG001|Follow-up Period|Other|0|||
129605870|NCT02393248|466515490|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605871|NCT02393248|466515491|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129789986|NCT03400956|467197821|FG002|Follow-up Period|Other|1|||
129886310|NCT00903786|467542946|FG000|Overall Study|Physician Decision|6|||
129886311|NCT00903786|467542946|FG000|Overall Study|Lack of Efficacy|5|||
129886312|NCT00903786|467542946|FG000|Overall Study|Reason other than lack of efficacy|4|||
129886313|NCT01163747|467542951|FG000|Overall Study|Adverse Event|0|||
129886314|NCT01163747|467542952|FG001|Overall Study|Adverse Event|5|||
129886315|NCT01163747|467542951|FG000|Overall Study|Insufficient Therapeutic Response|0|||
129886316|NCT01163747|467542952|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129886317|NCT01163747|467542951|FG000|Overall Study|Protocol Violation|0|||
129886318|NCT01163747|467542952|FG001|Overall Study|Protocol Violation|1|||
129886319|NCT01163747|467542951|FG000|Overall Study|Refused Treatment|6|||
129886320|NCT01163747|467542952|FG001|Overall Study|Refused Treatment|4|||
129605872|NCT02393248|466515492|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605873|NCT02393248|466515493|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605874|NCT02393248|466515494|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605875|NCT02393248|466515495|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605876|NCT02393248|466515496|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605877|NCT02393248|466515497|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605878|NCT02393248|466515498|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605879|NCT02393248|466515499|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
129605880|NCT02393248|466515475|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605881|NCT02393248|466515476|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605882|NCT02393248|466515477|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605883|NCT02393248|466515478|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605884|NCT02393248|466515479|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129698393|NCT00911157|466855033|FG001|Overall Study|Need to treat for lung cancer|0|||
129886321|NCT03363659|467542953|FG000|Overall Study|Adverse Event|1|||
129886322|NCT03363659|467542953|FG000|Overall Study|Screen fail|1|||
129886323|NCT03363659|467542953|FG000|Overall Study|Withdrawal by Subject|1|||
129698394|NCT04650893|466855034|FG000|Overall Study|Lost to Follow-up|11|||
129698395|NCT04650893|466855035|FG001|Overall Study|Lost to Follow-up|10|||
129698396|NCT04650893|466855036|FG002|Overall Study|Lost to Follow-up|11|||
129698397|NCT00176254|466855049|FG000|Overall Study|Lost to Follow-up|1|||
129698398|NCT00590317|466856720|FG000|Overall Study|Lack of Efficacy|1|||
129886324|NCT03872388|467542954|FG000|Overall Study|Disease Progression|0|||
129886325|NCT03872388|467542955|FG001|Overall Study|Disease Progression|0|||
129886326|NCT03872388|467542956|FG002|Overall Study|Disease Progression|0|||
129886327|NCT03872388|467542957|FG003|Overall Study|Disease Progression|0|||
129886328|NCT03872388|467542958|FG004|Overall Study|Disease Progression|0|||
129886329|NCT03872388|467542959|FG005|Overall Study|Disease Progression|0|||
129886330|NCT03872388|467542960|FG006|Overall Study|Disease Progression|1|||
129886331|NCT03872388|467542961|FG007|Overall Study|Disease Progression|1|||
129886332|NCT03681639|467545554|FG000|Overall Study|Death|4|||
129886333|NCT03681639|467545554|FG000|Overall Study|Lost to Follow-up|2|||
129698399|NCT00590317|466856721|FG001|Overall Study|Lack of Efficacy|5|||
129886334|NCT03681639|467545554|FG000|Overall Study|Withdrawal by Subject|1|||
129886335|NCT03681639|467545554|FG000|Overall Study|Adverse Event|2|||
129886336|NCT00654940|467545555|FG000|Period 1|Adverse Event|0|||
129605885|NCT02393248|466515480|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605886|NCT02393248|466515481|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605887|NCT02393248|466515482|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605888|NCT02393248|466515483|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605889|NCT02393248|466515484|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605890|NCT02393248|466515485|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605891|NCT02393248|466515486|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
129605892|NCT02393248|466515487|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
129605893|NCT02393248|466515488|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
129605894|NCT02393248|466515489|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
129605895|NCT02393248|466515490|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605896|NCT02393248|466515491|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605897|NCT02393248|466515492|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605898|NCT02393248|466515493|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605899|NCT02393248|466515494|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605900|NCT02393248|466515495|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605901|NCT02393248|466515496|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605902|NCT02393248|466515497|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605903|NCT02393248|466515498|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605904|NCT02393248|466515499|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
129605905|NCT02393248|466515475|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605906|NCT02393248|466515476|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605907|NCT02393248|466515477|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605908|NCT02393248|466515478|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605909|NCT02393248|466515479|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605910|NCT02393248|466515480|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605911|NCT02393248|466515481|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605912|NCT02393248|466515482|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605913|NCT02393248|466515483|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605914|NCT02393248|466515484|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605915|NCT02393248|466515485|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
129605916|NCT02393248|466515486|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
129605917|NCT02393248|466515487|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605918|NCT02393248|466515488|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605919|NCT02393248|466515489|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605920|NCT02393248|466515490|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605921|NCT02393248|466515491|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605922|NCT02393248|466515492|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605923|NCT02393248|466515493|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605924|NCT02393248|466515494|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605925|NCT02393248|466515495|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129789987|NCT00160667|467197822|FG000|Overall Study|Adverse Event|3|||
129789988|NCT00160667|467197823|FG001|Overall Study|Adverse Event|1|||
129789989|NCT00160667|467197824|FG002|Overall Study|Adverse Event|4|||
129789990|NCT00160667|467197822|FG000|Overall Study|Withdrawal by Subject|2|||
129789991|NCT00160667|467197823|FG001|Overall Study|Withdrawal by Subject|0|||
129789992|NCT00160667|467197824|FG002|Overall Study|Withdrawal by Subject|1|||
129789993|NCT00160667|467197822|FG000|Overall Study|Lack of Efficacy|0|||
129789994|NCT00160667|467197823|FG001|Overall Study|Lack of Efficacy|1|||
129605926|NCT02393248|466515496|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129789995|NCT00160667|467197824|FG002|Overall Study|Lack of Efficacy|0|||
129698400|NCT01251965|466856722|FG000|Overall Study|Participant/physician decision|1|||
129698401|NCT01251965|466856723|FG001|Overall Study|Participant/physician decision|2|||
129698402|NCT01251965|466856724|FG002|Overall Study|Participant/physician decision|0|||
129698403|NCT01251965|466856722|FG000|Overall Study|Death|0|||
129698404|NCT01251965|466856723|FG001|Overall Study|Death|0|||
129698405|NCT01251965|466856724|FG002|Overall Study|Death|11|||
129698406|NCT04616196|466856725|FG000|Overall Study|Progressive Disease|3|||
129698407|NCT04616196|466856726|FG001|Overall Study|Progressive Disease|0|||
129698408|NCT04616196|466856727|FG002|Overall Study|Progressive Disease|4|||
129789996|NCT00160667|467197822|FG000|Overall Study|Protocol Violation|0|||
129789997|NCT00160667|467197823|FG001|Overall Study|Protocol Violation|1|||
129789998|NCT00160667|467197824|FG002|Overall Study|Protocol Violation|0|||
129437347|NCT00762970|465900368|FG002|Overall Study|Withdrawal by Subject|0|||
129437348|NCT00762970|465900366|FG000|Overall Study|Protocol Violation|3|||
129437349|NCT00762970|465900367|FG001|Overall Study|Protocol Violation|1|||
129437350|NCT00762970|465900368|FG002|Overall Study|Protocol Violation|1|||
129437351|NCT00762970|465900366|FG000|Overall Study|Lost to Follow-up|1|||
129437352|NCT00762970|465900367|FG001|Overall Study|Lost to Follow-up|2|||
129437353|NCT00762970|465900368|FG002|Overall Study|Lost to Follow-up|0|||
129437354|NCT00762970|465900366|FG000|Overall Study|Difficulty of handling lens|1|||
129437355|NCT00762970|465900367|FG001|Overall Study|Difficulty of handling lens|2|||
129437356|NCT00762970|465900368|FG002|Overall Study|Difficulty of handling lens|0|||
129437357|NCT00846391|465900371|FG000|Overall Study|Physician Decision|0|||
129437358|NCT00846391|465900372|FG001|Overall Study|Physician Decision|0|||
129437359|NCT00846391|465900373|FG002|Overall Study|Physician Decision|1|||
129437360|NCT00846391|465900371|FG000|Overall Study|Study Terminated by Sponsor|1|||
129437361|NCT00846391|465900372|FG001|Overall Study|Study Terminated by Sponsor|2|||
129437362|NCT00846391|465900373|FG002|Overall Study|Study Terminated by Sponsor|2|||
129437363|NCT04634825|465900375|FG000|Overall Study|Death|10|||
129437364|NCT04634825|465900376|FG001|Overall Study|Death|3|||
129437365|NCT04634825|465900375|FG000|Overall Study|Lost to Follow-up|1|||
129437366|NCT04634825|465900376|FG001|Overall Study|Lost to Follow-up|0|||
129437367|NCT04634825|465900375|FG000|Overall Study|Study terminated by sponsor|35|||
129437368|NCT04634825|465900376|FG001|Overall Study|Study terminated by sponsor|11|||
129437369|NCT04634825|465900375|FG000|Overall Study|Withdrawal by Subject|2|||
129437370|NCT04634825|465900376|FG001|Overall Study|Withdrawal by Subject|0|||
129437371|NCT01337115|465900383|FG000|Overall Study|Protocol Violation|2|||
129437372|NCT01337115|465900384|FG001|Overall Study|Protocol Violation|0|||
129437373|NCT00551460|465900390|FG000|Overall Study|Adverse Event|1|||
129437374|NCT00551460|465900390|FG000|Overall Study|Withdrawal by Subject|1|||
129437375|NCT00551460|465900390|FG000|Overall Study|Physician Decision|1|||
129437376|NCT00551460|465900390|FG000|Overall Study|Death|7|||
129437377|NCT00551460|465900390|FG000|Overall Study|Ineligible|4|||
129437378|NCT00551460|465900390|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
129437379|NCT01745848|465900391|FG000|Overall Study|Adverse Event|6|||
129437380|NCT00679627|465900392|FG000|Overall Study|Death|41|||
129437381|NCT00679627|465900393|FG001|Overall Study|Death|29|||
129437382|NCT00679627|465900392|FG000|Overall Study|Adverse Event|43|||
129437383|NCT00679627|465900393|FG001|Overall Study|Adverse Event|53|||
129437384|NCT00679627|465900392|FG000|Overall Study|Withdrawal by Subject|168|||
129437385|NCT00679627|465900393|FG001|Overall Study|Withdrawal by Subject|172|||
129437386|NCT00679627|465900392|FG000|Overall Study|Lost to Follow-up|22|||
129437387|NCT00679627|465900393|FG001|Overall Study|Lost to Follow-up|26|||
129437388|NCT00679627|465900392|FG000|Overall Study|Early Study Closure|425|||
129437389|NCT00679627|465900393|FG001|Overall Study|Early Study Closure|405|||
129789999|NCT00160667|467197822|FG000|Overall Study|Patient decision|0|||
129790000|NCT00160667|467197823|FG001|Overall Study|Patient decision|0|||
129790001|NCT00160667|467197824|FG002|Overall Study|Patient decision|1|||
129790002|NCT01306929|467197830|FG000|Overall Study|Withdrawal by Subject|23|||
129790003|NCT01306929|467197830|FG000|Overall Study|Adverse Event|21|||
129790004|NCT01306929|467197830|FG000|Overall Study|Physician Decision|13|||
129437390|NCT00448123|465900394|FG000|Overall Study|Lost to Follow-up|9|||
129437391|NCT00448123|465900395|FG001|Overall Study|Lost to Follow-up|6|||
129437392|NCT00448123|465900394|FG000|Overall Study|Physician Decision|6|||
129698409|NCT04616196|466856728|FG003|Overall Study|Progressive Disease|1|||
129698410|NCT04616196|466856725|FG000|Overall Study|Death|2|||
129698411|NCT04616196|466856726|FG001|Overall Study|Death|4|||
129790005|NCT01306929|467197830|FG000|Overall Study|Death|8|||
129437393|NCT00448123|465900395|FG001|Overall Study|Physician Decision|6|||
129437394|NCT02027623|465900397|FG000|Overall Study|Lost to Follow-up|3|||
129437395|NCT02027623|465900398|FG001|Overall Study|Lost to Follow-up|3|||
129437396|NCT02027623|465900397|FG000|Overall Study|Withdrawal by Subject|6|||
129437397|NCT02027623|465900398|FG001|Overall Study|Withdrawal by Subject|9|||
129790006|NCT01306929|467197830|FG000|Overall Study|Withdrawal by parent/guardian|5|||
129437398|NCT01886378|465900399|FG000|Overall Study|Adverse Event|1|||
129437399|NCT01886378|465900399|FG000|Overall Study|Withdrawal by Subject|4|||
129437400|NCT00406653|465900404|FG000|Induction Period|Adverse Event|1|||
129698412|NCT04616196|466856727|FG002|Overall Study|Death|1|||
129698413|NCT04616196|466856728|FG003|Overall Study|Death|0|||
129790007|NCT01306929|467197830|FG000|Overall Study|Protocol Violation|3|||
129605927|NCT02393248|466515497|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605928|NCT02393248|466515498|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605929|NCT02393248|466515499|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
129605930|NCT02393248|466515475|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
129605931|NCT02393248|466515476|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
129605932|NCT02393248|466515477|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
129605933|NCT02393248|466515478|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
129605934|NCT02393248|466515479|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
129605935|NCT02393248|466515480|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
129605936|NCT02393248|466515481|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
129605937|NCT02393248|466515482|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
129605938|NCT02393248|466515483|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
129605939|NCT02393248|466515484|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
129605940|NCT02393248|466515485|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
129605941|NCT02393248|466515486|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
129605942|NCT02393248|466515487|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
129605943|NCT02393248|466515488|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
129605944|NCT02393248|466515489|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
129605945|NCT02393248|466515490|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
129605946|NCT02393248|466515491|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
129605947|NCT02393248|466515492|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
129605948|NCT02393248|466515493|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
129605949|NCT02393248|466515494|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
129605950|NCT02393248|466515495|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
129605951|NCT02393248|466515496|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
129605952|NCT02393248|466515497|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
129605953|NCT02393248|466515498|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
129605954|NCT02393248|466515499|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
129605955|NCT02393248|466515475|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605956|NCT02393248|466515476|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605957|NCT02393248|466515477|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605958|NCT02393248|466515478|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605959|NCT02393248|466515479|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605960|NCT02393248|466515480|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605961|NCT02393248|466515481|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605962|NCT02393248|466515482|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605963|NCT02393248|466515483|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605964|NCT02393248|466515484|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605965|NCT02393248|466515485|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605966|NCT02393248|466515486|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
129605967|NCT02393248|466515487|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605968|NCT02393248|466515488|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
129605969|NCT02393248|466515489|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605970|NCT02393248|466515490|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129698414|NCT04616196|466856725|FG000|Overall Study|Withdrawal by Subject|0|||
129698415|NCT04616196|466856726|FG001|Overall Study|Withdrawal by Subject|2|||
129698416|NCT04616196|466856727|FG002|Overall Study|Withdrawal by Subject|0|||
129698417|NCT04616196|466856728|FG003|Overall Study|Withdrawal by Subject|0|||
129698418|NCT04616196|466856725|FG000|Overall Study|Lost to Follow-up|1|||
129698419|NCT04616196|466856726|FG001|Overall Study|Lost to Follow-up|0|||
129698420|NCT04616196|466856727|FG002|Overall Study|Lost to Follow-up|0|||
129698421|NCT04616196|466856728|FG003|Overall Study|Lost to Follow-up|0|||
129698422|NCT04616196|466856725|FG000|Overall Study|Sponsor request|2|||
129698423|NCT04616196|466856726|FG001|Overall Study|Sponsor request|1|||
129698424|NCT04616196|466856727|FG002|Overall Study|Sponsor request|1|||
129698425|NCT04616196|466856728|FG003|Overall Study|Sponsor request|2|||
129698426|NCT05401409|466856729|FG000|Overall Study|Lost to Follow-up|1|||
129698427|NCT05401409|466856730|FG001|Overall Study|Lost to Follow-up|0|||
129698428|NCT02371889|466856731|FG000|Overall Study|Adverse medication effect|11|||
129698429|NCT02371889|466856732|FG001|Overall Study|Adverse medication effect|2|||
129698430|NCT02371889|466856731|FG000|Overall Study|Lost to Follow-up|6|||
129698431|NCT02371889|466856732|FG001|Overall Study|Lost to Follow-up|5|||
129698432|NCT02371889|466856731|FG000|Overall Study|Personal time constraints|2|||
129698433|NCT02371889|466856732|FG001|Overall Study|Personal time constraints|4|||
129698434|NCT02371889|466856731|FG000|Overall Study|Lack of Efficacy|0|||
129698435|NCT02371889|466856732|FG001|Overall Study|Lack of Efficacy|2|||
129698436|NCT02371889|466856731|FG000|Overall Study|Relapse|0|||
129698437|NCT02371889|466856732|FG001|Overall Study|Relapse|1|||
129698438|NCT02579759|466856733|FG000|Overall Study|Protocol Violation|2|||
129698439|NCT02579759|466856734|FG001|Overall Study|Protocol Violation|0|||
129698440|NCT02579759|466856735|FG002|Overall Study|Protocol Violation|0|||
129698441|NCT02579759|466856733|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
129605971|NCT02393248|466515491|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605972|NCT02393248|466515492|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605973|NCT02393248|466515493|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605974|NCT02393248|466515494|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605975|NCT02393248|466515495|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605976|NCT02393248|466515496|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605977|NCT02393248|466515497|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605978|NCT02393248|466515498|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605979|NCT02393248|466515499|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
129605980|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605981|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605982|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605983|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605984|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605985|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605986|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605987|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605988|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605989|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605990|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605991|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129790008|NCT01306929|467197830|FG000|Overall Study|Non-compliance with study drug|2|||
129790009|NCT01306929|467197830|FG000|Overall Study|Lost to Follow-up|2|||
129790010|NCT01306929|467197830|FG000|Overall Study|Various|17|||
129790011|NCT03709576|467197831|FG000|Overall Study|progression prior to enrollment|1|||
129790012|NCT00890045|467197837|FG000|Overall Study|Death|0|||
129790013|NCT00890045|467197838|FG001|Overall Study|Death|1|||
129698442|NCT02579759|466856734|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
129698443|NCT02579759|466856735|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
129698444|NCT02579759|466856733|FG000|Overall Study|BfArM hold|13|||
129698445|NCT02579759|466856734|FG001|Overall Study|BfArM hold|12|||
129698446|NCT02579759|466856735|FG002|Overall Study|BfArM hold|12|||
129698447|NCT02579759|466856733|FG000|Overall Study|Sponsor stopped Dose 2|0|||
129698448|NCT02579759|466856734|FG001|Overall Study|Sponsor stopped Dose 2|41|||
129698449|NCT02579759|466856735|FG002|Overall Study|Sponsor stopped Dose 2|0|||
129698450|NCT02579759|466856733|FG000|Overall Study|Non compliance|0|||
129790014|NCT00890045|467197837|FG000|Overall Study|Did not receive HeRO Graft|0|||
129790015|NCT00890045|467197838|FG001|Overall Study|Did not receive HeRO Graft|2|||
129790016|NCT00890045|467197837|FG000|Overall Study|Lost to Follow-up|5|||
129698451|NCT02579759|466856734|FG001|Overall Study|Non compliance|1|||
129698452|NCT02579759|466856735|FG002|Overall Study|Non compliance|0|||
129698453|NCT02579759|466856733|FG000|Overall Study|Pregnancy|0|||
129698454|NCT02579759|466856734|FG001|Overall Study|Pregnancy|1|||
129437401|NCT00406653|465900405|FG001|Induction Period|Adverse Event|10|||
129437402|NCT00406653|465900406|FG002|Induction Period|Adverse Event|4|||
129437403|NCT00406653|465900407|FG003|Induction Period|Adverse Event|11|||
129437404|NCT00406653|465900408|FG004|Induction Period|Adverse Event|0|||
129437405|NCT00406653|465900409|FG005|Induction Period|Adverse Event|0|||
129437406|NCT00406653|465900410|FG006|Induction Period|Adverse Event|0|||
129437407|NCT00406653|465900404|FG000|Induction Period|Lack of Efficacy|11|||
129437408|NCT00406653|465900405|FG001|Induction Period|Lack of Efficacy|14|||
129437409|NCT00406653|465900406|FG002|Induction Period|Lack of Efficacy|8|||
129437410|NCT00406653|465900407|FG003|Induction Period|Lack of Efficacy|10|||
129437411|NCT00406653|465900408|FG004|Induction Period|Lack of Efficacy|0|||
129437412|NCT00406653|465900409|FG005|Induction Period|Lack of Efficacy|0|||
129437413|NCT00406653|465900410|FG006|Induction Period|Lack of Efficacy|0|||
129437414|NCT00406653|465900404|FG000|Induction Period|Lost to Follow-up|0|||
129437415|NCT00406653|465900405|FG001|Induction Period|Lost to Follow-up|2|||
129437416|NCT00406653|465900406|FG002|Induction Period|Lost to Follow-up|0|||
129437417|NCT00406653|465900407|FG003|Induction Period|Lost to Follow-up|0|||
129437418|NCT00406653|465900408|FG004|Induction Period|Lost to Follow-up|0|||
129437419|NCT00406653|465900409|FG005|Induction Period|Lost to Follow-up|0|||
129437420|NCT00406653|465900410|FG006|Induction Period|Lost to Follow-up|0|||
129437421|NCT00406653|465900404|FG000|Induction Period|Withdrawal of Consent|2|||
129437422|NCT00406653|465900405|FG001|Induction Period|Withdrawal of Consent|5|||
129437423|NCT00406653|465900406|FG002|Induction Period|Withdrawal of Consent|1|||
129437424|NCT00406653|465900407|FG003|Induction Period|Withdrawal of Consent|2|||
129437425|NCT00406653|465900408|FG004|Induction Period|Withdrawal of Consent|0|||
129437426|NCT00406653|465900409|FG005|Induction Period|Withdrawal of Consent|0|||
129437427|NCT00406653|465900410|FG006|Induction Period|Withdrawal of Consent|0|||
129437428|NCT00406653|465900404|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
129437429|NCT00406653|465900405|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
129437430|NCT00406653|465900406|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
129437431|NCT00406653|465900407|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
129437432|NCT00406653|465900408|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
129437433|NCT00406653|465900409|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
129437434|NCT00406653|465900410|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
129437435|NCT00406653|465900404|FG000|Induction Period|Pregnancy|1|||
129437436|NCT00406653|465900405|FG001|Induction Period|Pregnancy|0|||
129437437|NCT00406653|465900406|FG002|Induction Period|Pregnancy|0|||
129437438|NCT00406653|465900407|FG003|Induction Period|Pregnancy|0|||
129437439|NCT00406653|465900408|FG004|Induction Period|Pregnancy|0|||
129437440|NCT00406653|465900409|FG005|Induction Period|Pregnancy|0|||
129437441|NCT00406653|465900410|FG006|Induction Period|Pregnancy|0|||
129437442|NCT00406653|465900404|FG000|Induction Period|Declined participation but followup done|0|||
129437443|NCT00406653|465900405|FG001|Induction Period|Declined participation but followup done|2|||
129437444|NCT00406653|465900406|FG002|Induction Period|Declined participation but followup done|1|||
129437445|NCT00406653|465900407|FG003|Induction Period|Declined participation but followup done|1|||
129437446|NCT00406653|465900408|FG004|Induction Period|Declined participation but followup done|0|||
129437447|NCT00406653|465900409|FG005|Induction Period|Declined participation but followup done|0|||
129437448|NCT00406653|465900410|FG006|Induction Period|Declined participation but followup done|0|||
129437449|NCT00406653|465900404|FG000|Induction Period|Given prohibited drug|0|||
129437450|NCT00406653|465900405|FG001|Induction Period|Given prohibited drug|1|||
129437451|NCT00406653|465900406|FG002|Induction Period|Given prohibited drug|2|||
129437452|NCT00406653|465900407|FG003|Induction Period|Given prohibited drug|0|||
129437453|NCT00406653|465900408|FG004|Induction Period|Given prohibited drug|0|||
129437454|NCT00406653|465900409|FG005|Induction Period|Given prohibited drug|0|||
129437455|NCT00406653|465900410|FG006|Induction Period|Given prohibited drug|0|||
129437456|NCT00406653|465900404|FG000|Induction Period|Incarcerated|0|||
129437457|NCT00406653|465900405|FG001|Induction Period|Incarcerated|0|||
129437458|NCT00406653|465900406|FG002|Induction Period|Incarcerated|1|||
129437459|NCT00406653|465900407|FG003|Induction Period|Incarcerated|0|||
129437460|NCT00406653|465900408|FG004|Induction Period|Incarcerated|0|||
129437461|NCT00406653|465900409|FG005|Induction Period|Incarcerated|0|||
129437462|NCT00406653|465900410|FG006|Induction Period|Incarcerated|0|||
129437463|NCT00406653|465900404|FG000|Induction Period|Patient relocated|0|||
129437464|NCT00406653|465900405|FG001|Induction Period|Patient relocated|0|||
129437465|NCT00406653|465900406|FG002|Induction Period|Patient relocated|1|||
129886337|NCT00654940|467545556|FG001|Period 1|Adverse Event|1|||
129437466|NCT00406653|465900407|FG003|Induction Period|Patient relocated|0|||
129437467|NCT00406653|465900408|FG004|Induction Period|Patient relocated|0|||
129437468|NCT00406653|465900409|FG005|Induction Period|Patient relocated|0|||
129437469|NCT00406653|465900410|FG006|Induction Period|Patient relocated|0|||
129437470|NCT00406653|465900404|FG000|Maintenance Period|Adverse Event|0|||
129437471|NCT00406653|465900405|FG001|Maintenance Period|Adverse Event|0|||
129437472|NCT00406653|465900406|FG002|Maintenance Period|Adverse Event|0|||
129437473|NCT00406653|465900407|FG003|Maintenance Period|Adverse Event|0|||
129605992|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129886338|NCT00654940|467545555|FG000|Period 1|Intolerable Pain Level|1|||
129437474|NCT00406653|465900408|FG004|Maintenance Period|Adverse Event|1|||
129437475|NCT00406653|465900409|FG005|Maintenance Period|Adverse Event|1|||
129437476|NCT00406653|465900410|FG006|Maintenance Period|Adverse Event|0|||
129437477|NCT00406653|465900404|FG000|Maintenance Period|Lack of Efficacy|0|||
129437478|NCT00406653|465900405|FG001|Maintenance Period|Lack of Efficacy|0|||
129605993|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605994|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605995|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605996|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605997|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129605998|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
129605999|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129606000|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
129606001|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
129606002|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129606003|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
129606004|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
129606005|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Death|0|||
129606006|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Death|0|||
129606007|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Death|0|||
129606008|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Death|0|||
129606009|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Death|0|||
129606010|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Death|0|||
129606011|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Death|0|||
129606012|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Death|0|||
129606013|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Death|0|||
129606014|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Death|0|||
129606015|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Death|0|||
129606016|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Death|0|||
129606017|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Death|0|||
129606018|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Death|0|||
129606019|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Death|0|||
129606020|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Death|1|||
129606021|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Death|7|||
129606022|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Death|5|||
129606023|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Death|5|||
129606024|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Death|3|||
129606025|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Death|7|||
129606026|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Death|5|||
129606027|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Death|6|||
129606028|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Death|3|||
129606029|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Death|0|||
129606030|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606031|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606032|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606033|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606034|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606035|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606036|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606037|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606038|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606039|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606040|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606041|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606042|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606043|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606044|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606045|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606046|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606047|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129606048|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129606049|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
129606050|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129606051|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129606052|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129606053|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
129606054|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
129606055|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Disease Progression|0|||
129606056|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Disease Progression|0|||
129606057|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Disease Progression|0|||
129790017|NCT00890045|467197838|FG001|Overall Study|Lost to Follow-up|7|||
129790018|NCT00483756|467197843|FG000|Overall Study|Death|2|||
129437479|NCT00406653|465900406|FG002|Maintenance Period|Lack of Efficacy|0|||
129698455|NCT02579759|466856735|FG002|Overall Study|Pregnancy|0|||
129698456|NCT02579759|466856733|FG000|Overall Study|Inclusion/exclusion criteria|0|||
129698457|NCT02579759|466856734|FG001|Overall Study|Inclusion/exclusion criteria|0|||
129698458|NCT02579759|466856735|FG002|Overall Study|Inclusion/exclusion criteria|1|||
129698459|NCT02579759|466856733|FG000|Overall Study|Adverse Event|4|||
129698460|NCT02579759|466856734|FG001|Overall Study|Adverse Event|3|||
129698461|NCT02579759|466856735|FG002|Overall Study|Adverse Event|1|||
129698462|NCT02579759|466856733|FG000|Overall Study|Withdrawal by Subject|3|||
129698463|NCT02579759|466856734|FG001|Overall Study|Withdrawal by Subject|3|||
129698464|NCT02579759|466856735|FG002|Overall Study|Withdrawal by Subject|5|||
129698465|NCT02579759|466856733|FG000|Overall Study|Lost to Follow-up|2|||
129698466|NCT02579759|466856734|FG001|Overall Study|Lost to Follow-up|2|||
129698467|NCT02579759|466856735|FG002|Overall Study|Lost to Follow-up|2|||
129698468|NCT02410200|466856738|FG000|Overall Study|Adverse Event|2|||
129698469|NCT01050218|466856743|FG000|Overall Study|Adverse Event|37|||
129698470|NCT01050218|466856743|FG000|Overall Study|Lack of Efficacy|8|||
129698471|NCT01050218|466856743|FG000|Overall Study|Protocol Violation|3|||
129698472|NCT01050218|466856743|FG000|Overall Study|Withdrawal by Subject|18|||
129698473|NCT01050218|466856743|FG000|Overall Study|Discontinued by sponsor|18|||
129698474|NCT01050218|466856743|FG000|Overall Study|Compliance|2|||
129698475|NCT01050218|466856743|FG000|Overall Study|Failed to return|7|||
129698476|NCT01050218|466856743|FG000|Overall Study|Serious Adverse Event|1|||
129698477|NCT01050218|466856743|FG000|Overall Study|Family emergency|1|||
129698478|NCT01149460|466856744|FG000|Overall Study|Withdrawal by Subject|0|||
129698479|NCT01149460|466856745|FG001|Overall Study|Withdrawal by Subject|2|||
129698480|NCT02801578|466856752|FG000|Overall Study|Adverse Event|2|||
129698481|NCT00668642|466856753|FG000|First Off-cycle|Cancer progression|1|||
129698482|NCT00668642|466856754|FG001|First Off-cycle|Cancer progression|0|||
129698483|NCT00668642|466856753|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
129698484|NCT00668642|466856754|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
129698485|NCT03412591|466856755|FG000|Overall Study|Withdrawal by Subject|1|||
129698486|NCT03412591|466856756|FG001|Overall Study|Withdrawal by Subject|8|||
129698487|NCT03412591|466856755|FG000|Overall Study|Adverse Event|0|||
129698488|NCT03412591|466856756|FG001|Overall Study|Adverse Event|1|||
129698489|NCT02272985|466856757|FG000|Overall Study|Withdrawal by Subject|1|||
129698490|NCT02272985|466856757|FG000|Overall Study|hip fracture|1|||
129698491|NCT02272985|466856757|FG000|Overall Study|kidney transplantation|1|||
129698492|NCT00770679|466856758|FG000|Overall Study|Lost to Follow-up|3|||
129698493|NCT00770679|466856758|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
129698494|NCT00266032|466856764|FG000|Treatment|Adverse Event|42|||
129698495|NCT00266032|466856765|FG001|Treatment|Adverse Event|26|||
129698496|NCT00266032|466856766|FG002|Treatment|Adverse Event|10|||
129698497|NCT00266032|466856764|FG000|Treatment|Lost to Follow-up|19|||
129698498|NCT00266032|466856765|FG001|Treatment|Lost to Follow-up|4|||
129790019|NCT00483756|467197844|FG001|Overall Study|Death|0|||
129437480|NCT00406653|465900407|FG003|Maintenance Period|Lack of Efficacy|0|||
129437481|NCT00406653|465900408|FG004|Maintenance Period|Lack of Efficacy|20|||
129437482|NCT00406653|465900409|FG005|Maintenance Period|Lack of Efficacy|26|||
129437483|NCT00406653|465900410|FG006|Maintenance Period|Lack of Efficacy|0|||
129437484|NCT00406653|465900404|FG000|Maintenance Period|Lost to Follow-up|0|||
129437485|NCT00406653|465900405|FG001|Maintenance Period|Lost to Follow-up|0|||
129437486|NCT00406653|465900406|FG002|Maintenance Period|Lost to Follow-up|0|||
129437487|NCT00406653|465900407|FG003|Maintenance Period|Lost to Follow-up|0|||
129437488|NCT00406653|465900408|FG004|Maintenance Period|Lost to Follow-up|2|||
129437489|NCT00406653|465900409|FG005|Maintenance Period|Lost to Follow-up|1|||
129437490|NCT00406653|465900410|FG006|Maintenance Period|Lost to Follow-up|0|||
129437491|NCT00406653|465900404|FG000|Maintenance Period|Withdrawal of Consent|0|||
129437492|NCT00406653|465900405|FG001|Maintenance Period|Withdrawal of Consent|0|||
129437493|NCT00406653|465900406|FG002|Maintenance Period|Withdrawal of Consent|0|||
129437494|NCT00406653|465900407|FG003|Maintenance Period|Withdrawal of Consent|0|||
129437495|NCT00406653|465900408|FG004|Maintenance Period|Withdrawal of Consent|2|||
129437496|NCT00406653|465900409|FG005|Maintenance Period|Withdrawal of Consent|0|||
129437497|NCT00406653|465900410|FG006|Maintenance Period|Withdrawal of Consent|0|||
129437498|NCT00406653|465900404|FG000|Maintenance Period|Pregnancy|0|||
129437499|NCT00406653|465900405|FG001|Maintenance Period|Pregnancy|0|||
129437500|NCT00406653|465900406|FG002|Maintenance Period|Pregnancy|0|||
129437501|NCT00406653|465900407|FG003|Maintenance Period|Pregnancy|0|||
129437502|NCT00406653|465900408|FG004|Maintenance Period|Pregnancy|0|||
129437503|NCT00406653|465900409|FG005|Maintenance Period|Pregnancy|1|||
129437504|NCT00406653|465900410|FG006|Maintenance Period|Pregnancy|0|||
129437505|NCT00406653|465900404|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
129437506|NCT00406653|465900405|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
129437507|NCT00406653|465900406|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
129437508|NCT00406653|465900407|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
129437509|NCT00406653|465900408|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
129437510|NCT00406653|465900409|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
129437511|NCT00406653|465900410|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
129437512|NCT00406653|465900404|FG000|Maintenance Period|Error in disease score evaluation|0|||
129437513|NCT00406653|465900405|FG001|Maintenance Period|Error in disease score evaluation|0|||
129437514|NCT00406653|465900406|FG002|Maintenance Period|Error in disease score evaluation|0|||
129437515|NCT00406653|465900407|FG003|Maintenance Period|Error in disease score evaluation|0|||
129437516|NCT00406653|465900408|FG004|Maintenance Period|Error in disease score evaluation|1|||
129437517|NCT00406653|465900409|FG005|Maintenance Period|Error in disease score evaluation|0|||
129437518|NCT00406653|465900410|FG006|Maintenance Period|Error in disease score evaluation|0|||
129437519|NCT00406653|465900404|FG000|Open-Label Period|Death|0|||
129437520|NCT00406653|465900405|FG001|Open-Label Period|Death|0|||
129437521|NCT00406653|465900406|FG002|Open-Label Period|Death|0|||
129437522|NCT00406653|465900407|FG003|Open-Label Period|Death|0|||
129437523|NCT00406653|465900408|FG004|Open-Label Period|Death|0|||
129437524|NCT00406653|465900409|FG005|Open-Label Period|Death|0|||
129437525|NCT00406653|465900410|FG006|Open-Label Period|Death|1|||
129437526|NCT00406653|465900404|FG000|Open-Label Period|Adverse Event|0|||
129437527|NCT00406653|465900405|FG001|Open-Label Period|Adverse Event|0|||
129437528|NCT00406653|465900406|FG002|Open-Label Period|Adverse Event|0|||
129437529|NCT00406653|465900407|FG003|Open-Label Period|Adverse Event|0|||
129437530|NCT00406653|465900408|FG004|Open-Label Period|Adverse Event|0|||
129437531|NCT00406653|465900409|FG005|Open-Label Period|Adverse Event|0|||
129437532|NCT00406653|465900410|FG006|Open-Label Period|Adverse Event|18|||
129437533|NCT00406653|465900404|FG000|Open-Label Period|Lack of Efficacy|0|||
129437534|NCT00406653|465900405|FG001|Open-Label Period|Lack of Efficacy|0|||
129437535|NCT00406653|465900406|FG002|Open-Label Period|Lack of Efficacy|0|||
129606058|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Disease Progression|0|||
129606059|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Disease Progression|0|||
129606060|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Disease Progression|0|||
129606061|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Disease Progression|0|||
129606062|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Disease Progression|0|||
129606063|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Disease Progression|0|||
129606064|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Disease Progression|0|||
129606065|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Disease Progression|0|||
129606066|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Disease Progression|0|||
129606067|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Disease Progression|0|||
129790020|NCT00483756|467197845|FG002|Overall Study|Death|1|||
129437536|NCT00406653|465900407|FG003|Open-Label Period|Lack of Efficacy|0|||
129437537|NCT00406653|465900408|FG004|Open-Label Period|Lack of Efficacy|0|||
129437538|NCT00406653|465900409|FG005|Open-Label Period|Lack of Efficacy|0|||
129437539|NCT00406653|465900410|FG006|Open-Label Period|Lack of Efficacy|160|||
129437540|NCT00406653|465900404|FG000|Open-Label Period|Lost to Follow-up|0|||
129437541|NCT00406653|465900405|FG001|Open-Label Period|Lost to Follow-up|0|||
129606068|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Disease Progression|0|||
129790021|NCT00483756|467197843|FG000|Overall Study|Adverse Event|19|||
129647532|NCT02407457|466665347|FG000|1 Year|Lost to Follow-up|3|||
129790022|NCT00483756|467197844|FG001|Overall Study|Adverse Event|38|||
129437542|NCT00406653|465900406|FG002|Open-Label Period|Lost to Follow-up|0|||
129437543|NCT00406653|465900407|FG003|Open-Label Period|Lost to Follow-up|0|||
129437544|NCT00406653|465900408|FG004|Open-Label Period|Lost to Follow-up|0|||
129437545|NCT00406653|465900409|FG005|Open-Label Period|Lost to Follow-up|0|||
129437546|NCT00406653|465900410|FG006|Open-Label Period|Lost to Follow-up|6|||
129437547|NCT00406653|465900404|FG000|Open-Label Period|Withdrawal of Consent|0|||
129437548|NCT00406653|465900405|FG001|Open-Label Period|Withdrawal of Consent|0|||
129437549|NCT00406653|465900406|FG002|Open-Label Period|Withdrawal of Consent|0|||
129437550|NCT00406653|465900407|FG003|Open-Label Period|Withdrawal of Consent|0|||
129437551|NCT00406653|465900408|FG004|Open-Label Period|Withdrawal of Consent|0|||
129437552|NCT00406653|465900409|FG005|Open-Label Period|Withdrawal of Consent|0|||
129437553|NCT00406653|465900410|FG006|Open-Label Period|Withdrawal of Consent|11|||
129437554|NCT00406653|465900404|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129437555|NCT00406653|465900405|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129437556|NCT00406653|465900406|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129437557|NCT00406653|465900407|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129437558|NCT00406653|465900408|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129437559|NCT00406653|465900409|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
129437560|NCT00406653|465900410|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
129437561|NCT00406653|465900404|FG000|Open-Label Period|Pregnancy|0|||
129437562|NCT00406653|465900405|FG001|Open-Label Period|Pregnancy|0|||
129437563|NCT00406653|465900406|FG002|Open-Label Period|Pregnancy|0|||
129437564|NCT00406653|465900407|FG003|Open-Label Period|Pregnancy|0|||
129437565|NCT00406653|465900408|FG004|Open-Label Period|Pregnancy|0|||
129437566|NCT00406653|465900409|FG005|Open-Label Period|Pregnancy|0|||
129437567|NCT00406653|465900410|FG006|Open-Label Period|Pregnancy|2|||
129437568|NCT00406653|465900404|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
129437569|NCT00406653|465900405|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
129437570|NCT00406653|465900406|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
129437571|NCT00406653|465900407|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
129437572|NCT00406653|465900408|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
129437573|NCT00406653|465900409|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
129437574|NCT00406653|465900410|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
129437575|NCT00406653|465900404|FG000|Open-Label Period|Declined participation but followup done|0|||
129437576|NCT00406653|465900405|FG001|Open-Label Period|Declined participation but followup done|0|||
129437577|NCT00406653|465900406|FG002|Open-Label Period|Declined participation but followup done|0|||
129437578|NCT00406653|465900407|FG003|Open-Label Period|Declined participation but followup done|0|||
129437579|NCT00406653|465900408|FG004|Open-Label Period|Declined participation but followup done|0|||
129437580|NCT00406653|465900409|FG005|Open-Label Period|Declined participation but followup done|0|||
129437581|NCT00406653|465900410|FG006|Open-Label Period|Declined participation but followup done|8|||
129437582|NCT00406653|465900404|FG000|Open-Label Period|Discontinued by Sponsor|0|||
129437583|NCT00406653|465900405|FG001|Open-Label Period|Discontinued by Sponsor|0|||
129698499|NCT00266032|466856766|FG002|Treatment|Lost to Follow-up|2|||
129698500|NCT00266032|466856764|FG000|Treatment|Pregnancy|3|||
129698501|NCT00266032|466856765|FG001|Treatment|Pregnancy|2|||
129698502|NCT00266032|466856766|FG002|Treatment|Pregnancy|2|||
129698503|NCT00266032|466856764|FG000|Treatment|Protocol Violation|6|||
129698504|NCT00266032|466856765|FG001|Treatment|Protocol Violation|14|||
129698505|NCT00266032|466856766|FG002|Treatment|Protocol Violation|13|||
129698506|NCT00266032|466856764|FG000|Treatment|Withdrawal by Subject|28|||
129698507|NCT00266032|466856765|FG001|Treatment|Withdrawal by Subject|13|||
129698508|NCT00266032|466856766|FG002|Treatment|Withdrawal by Subject|12|||
129698509|NCT00266032|466856764|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
129698510|NCT00266032|466856765|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
129698511|NCT00266032|466856766|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
129698512|NCT00266032|466856764|FG000|Open-label Safety Extension|Adverse Event|5|||
129698513|NCT00266032|466856765|FG001|Open-label Safety Extension|Adverse Event|0|||
129698514|NCT00266032|466856766|FG002|Open-label Safety Extension|Adverse Event|4|||
129698515|NCT00266032|466856764|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
129606069|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Disease Progression|0|||
129647533|NCT02407457|466665348|FG001|1 Year|Lost to Follow-up|2|||
129790023|NCT00483756|467197845|FG002|Overall Study|Adverse Event|40|||
129790024|NCT00483756|467197843|FG000|Overall Study|Lack of Efficacy|1|||
129790025|NCT00483756|467197844|FG001|Overall Study|Lack of Efficacy|0|||
129790026|NCT00483756|467197845|FG002|Overall Study|Lack of Efficacy|0|||
129790027|NCT00483756|467197843|FG000|Overall Study|Lost to Follow-up|3|||
129790028|NCT00483756|467197844|FG001|Overall Study|Lost to Follow-up|1|||
129790029|NCT00483756|467197845|FG002|Overall Study|Lost to Follow-up|0|||
129790030|NCT00483756|467197843|FG000|Overall Study|Withdrawal by Subject|5|||
129790031|NCT00483756|467197844|FG001|Overall Study|Withdrawal by Subject|3|||
129790032|NCT00483756|467197845|FG002|Overall Study|Withdrawal by Subject|4|||
129790033|NCT00483756|467197843|FG000|Overall Study|Other|2|||
129790034|NCT00483756|467197844|FG001|Overall Study|Other|4|||
129790035|NCT00483756|467197845|FG002|Overall Study|Other|3|||
129790036|NCT00483756|467197843|FG000|Overall Study|Randomized, Not Treated|1|||
129790037|NCT00483756|467197844|FG001|Overall Study|Randomized, Not Treated|4|||
129790038|NCT00483756|467197845|FG002|Overall Study|Randomized, Not Treated|4|||
129790039|NCT04463069|467197846|FG000|Overall Study|Withdrawal by Subject|2|||
129790040|NCT04463069|467197847|FG001|Overall Study|Withdrawal by Subject|10|||
129790041|NCT04463069|467197846|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
129800259|NCT02445391|467236292|FG002|Overall Study|Adverse Event|12|||
129790042|NCT04463069|467197847|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
129790043|NCT03603509|467199669|FG000|Overall Study|Lost to Follow-up|3|||
129790044|NCT03603509|467199670|FG001|Overall Study|Lost to Follow-up|4|||
129790045|NCT02656680|467199673|FG000|Overall Study|Lost to Follow-up|0|||
129790046|NCT02656680|467199674|FG001|Overall Study|Lost to Follow-up|1|||
129790047|NCT02656680|467199675|FG002|Overall Study|Lost to Follow-up|7|||
129790048|NCT04966910|467199676|FG000|Baseline|Participant did not complete measure|0|||
129790049|NCT04966910|467199677|FG001|Baseline|Participant did not complete measure|0|||
129790050|NCT04966910|467199678|FG002|Baseline|Participant did not complete measure|1|||
129790051|NCT04966910|467199679|FG003|Baseline|Participant did not complete measure|0|||
129790052|NCT04966910|467199676|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
129790053|NCT04966910|467199677|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
129790054|NCT04966910|467199678|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
129790055|NCT04966910|467199679|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
129790056|NCT04966910|467199676|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
129790057|NCT04966910|467199677|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
129790058|NCT04966910|467199678|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
129790059|NCT04966910|467199679|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
129790060|NCT04966910|467199676|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
129790061|NCT04966910|467199677|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
129790062|NCT04966910|467199678|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
129790063|NCT04966910|467199679|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
129790064|NCT04531462|467199683|FG000|Overall Study|Withdrawal by Subject|3|||
129790065|NCT04531462|467199684|FG001|Overall Study|Withdrawal by Subject|1|||
129790066|NCT04531462|467199683|FG000|Overall Study|Adverse Event|3|||
129790067|NCT04531462|467199684|FG001|Overall Study|Adverse Event|3|||
129790068|NCT00504582|467199685|FG000|Overall Study|Lost to Follow-up|1|||
129790069|NCT00504582|467199686|FG001|Overall Study|Lost to Follow-up|0|||
129698516|NCT00266032|466856765|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
129698517|NCT00266032|466856766|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
129698518|NCT00266032|466856764|FG000|Open-label Safety Extension|Pregnancy|4|||
129698519|NCT00266032|466856765|FG001|Open-label Safety Extension|Pregnancy|1|||
129698520|NCT00266032|466856766|FG002|Open-label Safety Extension|Pregnancy|2|||
129698521|NCT00266032|466856764|FG000|Open-label Safety Extension|Protocol Violation|1|||
129698522|NCT00266032|466856765|FG001|Open-label Safety Extension|Protocol Violation|3|||
129698523|NCT00266032|466856766|FG002|Open-label Safety Extension|Protocol Violation|2|||
129698524|NCT00266032|466856764|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
129698525|NCT00266032|466856765|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
129698526|NCT00266032|466856766|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
129698527|NCT00266032|466856764|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
129698528|NCT00266032|466856765|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
129698529|NCT00266032|466856766|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
129698530|NCT00814983|466856769|FG000|Overall Study|Screen failure|1|||
129698531|NCT00814983|466856770|FG001|Overall Study|Screen failure|0|||
129698532|NCT00814983|466856769|FG000|Overall Study|Withdrawal by Subject|1|||
129698533|NCT00814983|466856770|FG001|Overall Study|Withdrawal by Subject|0|||
129698534|NCT00814983|466856769|FG000|Overall Study|Graft failure|1|||
129698535|NCT00814983|466856770|FG001|Overall Study|Graft failure|0|||
129698536|NCT03627468|466856771|FG000|Overall Study|Adverse Event|5|||
129698537|NCT03627468|466856772|FG001|Overall Study|Adverse Event|33|||
129698538|NCT03627468|466856771|FG000|Overall Study|Withdrawal by Subject|13|||
129698539|NCT03627468|466856772|FG001|Overall Study|Withdrawal by Subject|23|||
129886339|NCT00654940|467545556|FG001|Period 1|Intolerable Pain Level|0|||
129886340|NCT01642186|467545557|FG000|Overall Study|Death|0|||
129437584|NCT00406653|465900406|FG002|Open-Label Period|Discontinued by Sponsor|0|||
129437585|NCT00406653|465900407|FG003|Open-Label Period|Discontinued by Sponsor|0|||
129437586|NCT00406653|465900408|FG004|Open-Label Period|Discontinued by Sponsor|0|||
129437587|NCT00406653|465900409|FG005|Open-Label Period|Discontinued by Sponsor|0|||
129437588|NCT00406653|465900410|FG006|Open-Label Period|Discontinued by Sponsor|1|||
129437589|NCT00406653|465900404|FG000|Open-Label Period|Refused followup|0|||
129437590|NCT00406653|465900405|FG001|Open-Label Period|Refused followup|0|||
129437591|NCT00406653|465900406|FG002|Open-Label Period|Refused followup|0|||
129437592|NCT00406653|465900407|FG003|Open-Label Period|Refused followup|0|||
129437593|NCT00406653|465900408|FG004|Open-Label Period|Refused followup|0|||
129437594|NCT00406653|465900409|FG005|Open-Label Period|Refused followup|0|||
129437595|NCT00406653|465900410|FG006|Open-Label Period|Refused followup|1|||
129437596|NCT00818649|465900411|FG000|Overall Study|Declining performance status|2|||
129437597|NCT00818649|465900411|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
129437598|NCT00818649|465900411|FG000|Overall Study|Adverse Event|1|||
129437599|NCT03513588|465900412|FG000|Overall Study|Lost to Follow-up|0|||
129437600|NCT03513588|465900413|FG001|Overall Study|Lost to Follow-up|1|||
129437601|NCT03513588|465900414|FG002|Overall Study|Lost to Follow-up|1|||
129437602|NCT03513588|465900412|FG000|Overall Study|Study dosing paused by sponsor|1|||
129437603|NCT03513588|465900413|FG001|Overall Study|Study dosing paused by sponsor|1|||
129437604|NCT03513588|465900414|FG002|Overall Study|Study dosing paused by sponsor|0|||
129437605|NCT03513588|465900412|FG000|Overall Study|Death|0|||
129437606|NCT03513588|465900413|FG001|Overall Study|Death|0|||
129437607|NCT03513588|465900414|FG002|Overall Study|Death|1|||
129437608|NCT00940108|465900415|FG000|Overall Study|Adverse Event|2|||
129437609|NCT00940108|465900416|FG001|Overall Study|Adverse Event|4|||
129437610|NCT00940108|465900417|FG002|Overall Study|Adverse Event|0|||
129437611|NCT00940108|465900418|FG003|Overall Study|Adverse Event|2|||
129437612|NCT00940108|465900415|FG000|Overall Study|Withdrew Consent|2|||
129437613|NCT00940108|465900416|FG001|Overall Study|Withdrew Consent|1|||
129437614|NCT00940108|465900417|FG002|Overall Study|Withdrew Consent|0|||
129437615|NCT00940108|465900418|FG003|Overall Study|Withdrew Consent|1|||
129437616|NCT00940108|465900415|FG000|Overall Study|Dose 2 contraindicated|1|||
129437617|NCT00940108|465900416|FG001|Overall Study|Dose 2 contraindicated|1|||
129437618|NCT00940108|465900417|FG002|Overall Study|Dose 2 contraindicated|0|||
129437619|NCT00940108|465900418|FG003|Overall Study|Dose 2 contraindicated|1|||
129437620|NCT00940108|465900415|FG000|Overall Study|Declined further vaccination|0|||
129437621|NCT00940108|465900416|FG001|Overall Study|Declined further vaccination|1|||
129437622|NCT00940108|465900417|FG002|Overall Study|Declined further vaccination|3|||
129437623|NCT00940108|465900418|FG003|Overall Study|Declined further vaccination|0|||
129437624|NCT00940108|465900415|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
129437625|NCT00940108|465900416|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
129437626|NCT00940108|465900417|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
129437627|NCT00940108|465900418|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
129437628|NCT00940108|465900415|FG000|Overall Study|Viral illness after Dose 1|0|||
129437629|NCT00940108|465900416|FG001|Overall Study|Viral illness after Dose 1|1|||
129437630|NCT00940108|465900417|FG002|Overall Study|Viral illness after Dose 1|0|||
129437631|NCT00940108|465900418|FG003|Overall Study|Viral illness after Dose 1|0|||
129437632|NCT00940108|465900415|FG000|Overall Study|Diagnosed with H1N1|0|||
129437633|NCT00940108|465900416|FG001|Overall Study|Diagnosed with H1N1|0|||
129886341|NCT01642186|467545558|FG001|Overall Study|Death|2|||
129437634|NCT00940108|465900417|FG002|Overall Study|Diagnosed with H1N1|0|||
129437635|NCT00940108|465900418|FG003|Overall Study|Diagnosed with H1N1|1|||
129698540|NCT03627468|466856771|FG000|Overall Study|Physician Decision|1|||
129698541|NCT03627468|466856772|FG001|Overall Study|Physician Decision|0|||
129698542|NCT03627468|466856771|FG000|Overall Study|Protocol Violation|0|||
129698543|NCT03627468|466856772|FG001|Overall Study|Protocol Violation|2|||
129698544|NCT03627468|466856771|FG000|Overall Study|Lost to Follow-up|10|||
129698545|NCT03627468|466856772|FG001|Overall Study|Lost to Follow-up|16|||
129698546|NCT03627468|466856771|FG000|Overall Study|Death|1|||
129698547|NCT03627468|466856772|FG001|Overall Study|Death|0|||
129698548|NCT03627468|466856771|FG000|Overall Study|Pregnancy|1|||
129698549|NCT03627468|466856772|FG001|Overall Study|Pregnancy|1|||
129698550|NCT03627468|466856771|FG000|Overall Study|Lack of Efficacy|0|||
129698551|NCT03627468|466856772|FG001|Overall Study|Lack of Efficacy|2|||
129886342|NCT01642186|467545559|FG002|Overall Study|Death|2|||
129698552|NCT03627468|466856771|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
129437636|NCT02075541|465900422|FG000|Overall Study|Serious Adverse Event|1|||
129437637|NCT02075541|465900423|FG001|Overall Study|Serious Adverse Event|4|||
129437638|NCT02075541|465900422|FG000|Overall Study|Protocol Violation|1|||
129437639|NCT02075541|465900423|FG001|Overall Study|Protocol Violation|0|||
129437640|NCT02075541|465900422|FG000|Overall Study|Withdrawal by Subject|1|||
129437641|NCT02075541|465900423|FG001|Overall Study|Withdrawal by Subject|3|||
129437642|NCT02075541|465900422|FG000|Overall Study|Sponsor study termination|0|||
129437643|NCT02075541|465900423|FG001|Overall Study|Sponsor study termination|1|||
129698553|NCT03627468|466856772|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
129606070|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Disease Progression|0|||
129606071|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Disease Progression|0|||
129606072|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Disease Progression|0|||
129606073|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Disease Progression|0|||
129606074|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Disease Progression|0|||
129606075|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Disease Progression|2|||
129606076|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Disease Progression|1|||
129606077|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Disease Progression|0|||
129606078|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Disease Progression|0|||
129790070|NCT00504582|467199687|FG002|Overall Study|Lost to Follow-up|0|||
129790071|NCT00348933|467199690|FG000|Overall Study|Withdrawal by Subject|10|||
129790072|NCT00348933|467199690|FG000|Overall Study|Lost to Follow-up|6|||
129790073|NCT00348933|467199690|FG000|Overall Study|Protocol Violation|2|||
129790074|NCT00348933|467199690|FG000|Overall Study|Adverse Event|7|||
129790075|NCT01489111|467199691|FG000|Overall Study|Withdrawal criterion|1|||
129790076|NCT00711516|467199695|FG000|Overall Study|Adverse Event|1|||
129790077|NCT00711516|467199696|FG001|Overall Study|Adverse Event|1|||
129790078|NCT00711516|467199695|FG000|Overall Study|Withdrawal by Subject|0|||
129790079|NCT00711516|467199696|FG001|Overall Study|Withdrawal by Subject|1|||
129790080|NCT00711516|467199695|FG000|Overall Study|Protocol Violation|0|||
129790081|NCT00711516|467199696|FG001|Overall Study|Protocol Violation|1|||
129886343|NCT01642186|467545557|FG000|Overall Study|Lost to Follow-up|0|||
129886344|NCT01642186|467545558|FG001|Overall Study|Lost to Follow-up|0|||
129790082|NCT01029405|467199700|FG000|Overall Study|Withdrawal by Subject|0|||
129437644|NCT02075541|465900422|FG000|Overall Study|Other- unable to perform study procedure|1|||
129790083|NCT01029405|467199701|FG001|Overall Study|Withdrawal by Subject|1|||
129437645|NCT02075541|465900423|FG001|Overall Study|Other- unable to perform study procedure|0|||
129437646|NCT01142596|465900425|FG000|Overall Study|Withdrawal by Subject|9|||
129437647|NCT01142596|465900426|FG001|Overall Study|Withdrawal by Subject|35|||
129437648|NCT01142596|465900425|FG000|Overall Study|Adverse Event|8|||
129437649|NCT01142596|465900426|FG001|Overall Study|Adverse Event|35|||
129437650|NCT01142596|465900425|FG000|Overall Study|Lack of Efficacy|5|||
129437651|NCT01142596|465900426|FG001|Overall Study|Lack of Efficacy|9|||
129606079|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Disease Progression|0|||
129606080|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606081|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606082|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606083|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606084|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606085|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606086|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606087|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606088|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606089|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606090|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606091|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606092|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606093|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606094|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606095|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606096|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606097|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606098|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606099|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606100|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
129606101|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
129606102|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606103|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606104|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
129606105|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129698554|NCT04157738|466856773|FG000|Overall Study|Moved out of state|0|||
129698555|NCT04157738|466856774|FG001|Overall Study|Moved out of state|2|||
129698556|NCT04157738|466856773|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
129698557|NCT04157738|466856774|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
129698558|NCT00160563|466856775|FG000|Overall Study|Adverse Event|1|||
129698559|NCT00160563|466856776|FG001|Overall Study|Adverse Event|1|||
129698560|NCT00160563|466856777|FG002|Overall Study|Adverse Event|1|||
129698561|NCT00160563|466856775|FG000|Overall Study|Lost to Follow-up|1|||
129698562|NCT00160563|466856776|FG001|Overall Study|Lost to Follow-up|1|||
129698563|NCT00160563|466856777|FG002|Overall Study|Lost to Follow-up|2|||
129698564|NCT00160563|466856775|FG000|Overall Study|Protocol Violation|0|||
129698565|NCT00160563|466856776|FG001|Overall Study|Protocol Violation|0|||
129698566|NCT00160563|466856777|FG002|Overall Study|Protocol Violation|3|||
129698567|NCT00160563|466856775|FG000|Overall Study|Withdrawal by Subject|1|||
129698568|NCT00160563|466856776|FG001|Overall Study|Withdrawal by Subject|2|||
129698569|NCT00160563|466856777|FG002|Overall Study|Withdrawal by Subject|3|||
129698570|NCT00160563|466856775|FG000|Overall Study|Other (listed in the study report)|48|||
129698571|NCT00160563|466856776|FG001|Overall Study|Other (listed in the study report)|40|||
129698572|NCT00160563|466856777|FG002|Overall Study|Other (listed in the study report)|81|||
129698573|NCT00160563|466856775|FG000|Overall Study|Missing reason|0|||
129437652|NCT01142596|465900425|FG000|Overall Study|Lost to Follow-up|2|||
129698574|NCT00160563|466856776|FG001|Overall Study|Missing reason|1|||
129437653|NCT01142596|465900426|FG001|Overall Study|Lost to Follow-up|3|||
129437654|NCT01142596|465900425|FG000|Overall Study|Other reason (not specified)|5|||
129437655|NCT01142596|465900426|FG001|Overall Study|Other reason (not specified)|4|||
129437656|NCT01013597|465900427|FG000|Overall Study|Withdrawal by Subject|1|||
129437657|NCT00427895|465900428|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437658|NCT00427895|465900429|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437659|NCT00427895|465900430|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437660|NCT00427895|465900431|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
129437661|NCT00427895|465900432|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437662|NCT00427895|465900433|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437663|NCT00427895|465900434|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437664|NCT00427895|465900435|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
129437665|NCT00427895|465900428|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437666|NCT00427895|465900429|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437667|NCT00427895|465900430|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437668|NCT00427895|465900431|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437669|NCT00427895|465900432|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437670|NCT00427895|465900433|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437671|NCT00427895|465900434|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
129437672|NCT00427895|465900435|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
129437673|NCT00427895|465900428|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437674|NCT00427895|465900429|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437675|NCT00427895|465900430|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437676|NCT00427895|465900431|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437677|NCT00427895|465900432|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437678|NCT00427895|465900433|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437679|NCT00427895|465900434|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
129437680|NCT00427895|465900435|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
129437681|NCT00427895|465900428|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
129437682|NCT00427895|465900429|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
129437683|NCT00427895|465900430|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
129437684|NCT00427895|465900431|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
129437685|NCT00427895|465900432|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
129437686|NCT00427895|465900433|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
129437687|NCT00427895|465900434|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
129437688|NCT00427895|465900435|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
129437689|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129437690|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
129790084|NCT01029405|467199702|FG002|Overall Study|Withdrawal by Subject|2|||
129437691|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
129790085|NCT01029405|467199703|FG003|Overall Study|Withdrawal by Subject|0|||
129790086|NCT01029405|467199700|FG000|Overall Study|Protocol Violation|0|||
129790087|NCT01029405|467199701|FG001|Overall Study|Protocol Violation|0|||
129790088|NCT01029405|467199702|FG002|Overall Study|Protocol Violation|0|||
129790089|NCT01029405|467199703|FG003|Overall Study|Protocol Violation|1|||
129790090|NCT01029405|467199700|FG000|Overall Study|Adverse Event|0|||
129790091|NCT01029405|467199701|FG001|Overall Study|Adverse Event|0|||
129790092|NCT01029405|467199702|FG002|Overall Study|Adverse Event|1|||
129790093|NCT01029405|467199703|FG003|Overall Study|Adverse Event|1|||
129790094|NCT01029405|467199700|FG000|Overall Study|Lost to Follow-up|2|||
129790095|NCT01029405|467199701|FG001|Overall Study|Lost to Follow-up|1|||
129886345|NCT01642186|467545559|FG002|Overall Study|Lost to Follow-up|1|||
129886346|NCT00506285|467545561|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
129886347|NCT00506285|467545562|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
129437692|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
129437693|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129437694|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129437695|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129437696|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
129437697|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
129437698|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129437699|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
129437700|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
129437701|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129437702|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129886348|NCT00506285|467545561|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
129886349|NCT00506285|467545562|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
129437703|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129790096|NCT01029405|467199702|FG002|Overall Study|Lost to Follow-up|1|||
129790097|NCT01029405|467199703|FG003|Overall Study|Lost to Follow-up|2|||
129790098|NCT01029405|467199700|FG000|Overall Study|Other|0|||
129437704|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
129437705|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
129437706|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
129437707|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129437708|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129437709|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129437710|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129437711|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129437712|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
129437713|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
129437714|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
129437715|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
129437716|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
129606106|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606107|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129647534|NCT02407457|466665347|FG000|1 Year|Missed Visit|24|||
129790099|NCT01029405|467199701|FG001|Overall Study|Other|1|||
129437717|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129437718|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129437719|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129606108|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606109|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606110|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606111|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606112|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606113|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606114|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606115|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606116|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606117|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606118|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606119|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606120|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606121|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606122|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606123|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606124|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606125|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
129606126|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606127|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606128|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606129|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
129606130|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Adverse Event|0|||
129606131|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Adverse Event|0|||
129606132|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Adverse Event|0|||
129606133|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Adverse Event|0|||
129606134|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Adverse Event|0|||
129606135|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Adverse Event|0|||
129606136|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Adverse Event|0|||
129606137|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Adverse Event|0|||
129606138|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Adverse Event|0|||
129606139|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Adverse Event|0|||
129606140|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Adverse Event|0|||
129606141|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Adverse Event|0|||
129606142|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Adverse Event|0|||
129606143|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Adverse Event|0|||
129606144|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Adverse Event|0|||
129606145|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Adverse Event|0|||
129606146|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Adverse Event|0|||
129606147|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Adverse Event|0|||
129606148|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Adverse Event|0|||
129606149|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Adverse Event|0|||
129606150|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Adverse Event|0|||
129606151|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Adverse Event|0|||
129606152|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Adverse Event|0|||
129606153|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Adverse Event|1|||
129606154|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Adverse Event|0|||
129606155|NCT02393248|466515475|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606156|NCT02393248|466515476|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606157|NCT02393248|466515477|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606158|NCT02393248|466515478|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606159|NCT02393248|466515479|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606160|NCT02393248|466515480|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606161|NCT02393248|466515481|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606162|NCT02393248|466515482|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606163|NCT02393248|466515483|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606164|NCT02393248|466515484|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606165|NCT02393248|466515485|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606166|NCT02393248|466515486|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606167|NCT02393248|466515487|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606168|NCT02393248|466515488|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606169|NCT02393248|466515489|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606170|NCT02393248|466515490|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129437720|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
129606171|NCT02393248|466515491|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606172|NCT02393248|466515492|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606173|NCT02393248|466515493|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606174|NCT02393248|466515494|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129437721|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437722|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437723|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437724|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
129437725|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437726|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437727|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437728|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
129437729|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
129437730|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
129437731|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
129437732|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
129437733|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129437734|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129437735|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129437736|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
129437737|NCT00427895|465900428|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129437738|NCT00427895|465900429|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129437739|NCT00427895|465900430|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
129437740|NCT00427895|465900431|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
129606175|NCT02393248|466515495|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606176|NCT02393248|466515496|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129437741|NCT00427895|465900432|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129437742|NCT00427895|465900433|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129437743|NCT00427895|465900434|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129437744|NCT00427895|465900435|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
129437745|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129437746|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
129437747|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
129437748|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
129437749|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129437750|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129437751|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129437752|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
129437753|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
129437754|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
129437755|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129437756|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
129606177|NCT02393248|466515497|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606178|NCT02393248|466515498|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
129606179|NCT02393248|466515499|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
129606180|NCT00117325|466515500|FG000|Overall Study|Adverse Event|3|||
129606181|NCT00117325|466515501|FG001|Overall Study|Adverse Event|3|||
129606182|NCT00117325|466515500|FG000|Overall Study|Lost to Follow-up|1|||
129606183|NCT00117325|466515501|FG001|Overall Study|Lost to Follow-up|1|||
129437757|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129698575|NCT00160563|466856777|FG002|Overall Study|Missing reason|0|||
129698576|NCT01514357|466856781|FG000|Overall Study|Screen failure|2|||
129698577|NCT01514357|466856782|FG001|Overall Study|Screen failure|0|||
129698578|NCT01514357|466856781|FG000|Overall Study|Withdrawal by Subject|2|||
129698579|NCT01514357|466856782|FG001|Overall Study|Withdrawal by Subject|0|||
129698580|NCT00752219|466856783|FG000|Overall Study|Clinical failure|0|||
129698581|NCT00752219|466856784|FG001|Overall Study|Clinical failure|1|||
129698582|NCT00752219|466856783|FG000|Overall Study|Adverse Event|5|||
129698583|NCT00752219|466856784|FG001|Overall Study|Adverse Event|3|||
129698584|NCT00752219|466856783|FG000|Overall Study|Protocol deviation|1|||
129698585|NCT00752219|466856784|FG001|Overall Study|Protocol deviation|0|||
129698586|NCT00752219|466856783|FG000|Overall Study|Lost to Follow-up|1|||
129698587|NCT00752219|466856784|FG001|Overall Study|Lost to Follow-up|2|||
129698588|NCT00752219|466856783|FG000|Overall Study|Randomized but not treated|1|||
129698589|NCT00752219|466856784|FG001|Overall Study|Randomized but not treated|0|||
129437758|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129437759|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129698590|NCT00752219|466856783|FG000|Overall Study|Other|3|||
129606184|NCT00117325|466515500|FG000|Overall Study|Protocol Violation|2|||
129606185|NCT00117325|466515501|FG001|Overall Study|Protocol Violation|3|||
129606186|NCT00117325|466515500|FG000|Overall Study|Withdrawal by Subject|3|||
129606187|NCT00117325|466515501|FG001|Overall Study|Withdrawal by Subject|2|||
129606188|NCT00117325|466515500|FG000|Overall Study|Lack of Efficacy|1|||
129606189|NCT00117325|466515501|FG001|Overall Study|Lack of Efficacy|0|||
129606190|NCT00117325|466515500|FG000|Overall Study|Use of prohibited medicine|1|||
129606191|NCT00117325|466515501|FG001|Overall Study|Use of prohibited medicine|2|||
129606192|NCT00117325|466515500|FG000|Overall Study|Early termination|1|||
129606193|NCT00117325|466515501|FG001|Overall Study|Early termination|1|||
129606194|NCT00117325|466515500|FG000|Overall Study|Admisnitrative|1|||
129606195|NCT00117325|466515501|FG001|Overall Study|Admisnitrative|0|||
129606196|NCT00338455|466515509|FG000|Overall Study|Death|2|||
129606197|NCT00338455|466515510|FG001|Overall Study|Death|1|||
129606198|NCT00338455|466515509|FG000|Overall Study|Physician Decision|1|||
129606199|NCT00338455|466515510|FG001|Overall Study|Physician Decision|0|||
129606200|NCT05084963|466515511|FG000|Overall Study|Withdrawal by Subject|0|||
129606201|NCT05084963|466515512|FG001|Overall Study|Withdrawal by Subject|0|||
129606202|NCT05084963|466515513|FG002|Overall Study|Withdrawal by Subject|1|||
129606203|NCT01568320|466515514|FG000|Overall Study|Death|20|||
129886350|NCT00506285|467545561|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
129606204|NCT01568320|466515514|FG000|Overall Study|Lost to Follow-up|9|||
129606205|NCT01568320|466515514|FG000|Overall Study|Withdrawal by Subject|10|||
129606206|NCT01568320|466515514|FG000|Overall Study|Conversion to open repair|1|||
129647535|NCT02407457|466665348|FG001|1 Year|Missed Visit|14|||
129437760|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
129437761|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
129437762|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
129437763|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
129437764|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
129437765|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129437766|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129437767|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129437768|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
129437769|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437770|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
129437771|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437772|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437773|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437774|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437775|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437776|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
129437777|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Death|1|||
129437778|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Death|0|||
129437779|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Death|0|||
129437780|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Death|0|||
129437781|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Death|0|||
129437782|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Death|0|||
129437783|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Death|0|||
129437784|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Death|0|||
129437785|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129437786|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129437787|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
129437788|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
129437789|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129437790|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129437791|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129437792|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
129437793|NCT00427895|465900428|FG000|Vax 1/Year 1 Follow-up|Other|0|||
129437794|NCT00427895|465900429|FG001|Vax 1/Year 1 Follow-up|Other|0|||
129437795|NCT00427895|465900430|FG002|Vax 1/Year 1 Follow-up|Other|0|||
129437796|NCT00427895|465900431|FG003|Vax 1/Year 1 Follow-up|Other|2|||
129437797|NCT00427895|465900432|FG004|Vax 1/Year 1 Follow-up|Other|0|||
129437798|NCT00427895|465900433|FG005|Vax 1/Year 1 Follow-up|Other|0|||
129437799|NCT00427895|465900434|FG006|Vax 1/Year 1 Follow-up|Other|0|||
129437800|NCT00427895|465900435|FG007|Vax 1/Year 1 Follow-up|Other|0|||
129437801|NCT00427895|465900428|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
129437802|NCT00427895|465900429|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
129437803|NCT00427895|465900430|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
129437804|NCT00427895|465900431|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
129437805|NCT00427895|465900432|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129437806|NCT00427895|465900433|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129437807|NCT00427895|465900434|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129437808|NCT00427895|465900435|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
129437809|NCT00585195|465900438|FG000|Overall Study|Adverse Event|0|||
129437810|NCT00585195|465900439|FG001|Overall Study|Adverse Event|0|||
129437811|NCT00585195|465900440|FG002|Overall Study|Adverse Event|0|||
129790100|NCT01029405|467199702|FG002|Overall Study|Other|0|||
129790101|NCT01029405|467199703|FG003|Overall Study|Other|1|||
129437812|NCT00585195|465900441|FG003|Overall Study|Adverse Event|0|||
129437813|NCT00585195|465900442|FG004|Overall Study|Adverse Event|2|||
129437814|NCT00585195|465900443|FG005|Overall Study|Adverse Event|1|||
129437815|NCT00585195|465900444|FG006|Overall Study|Adverse Event|0|||
129790102|NCT01534182|467199706|FG000|Overall Study|Administrative problems|1|||
129790103|NCT01534182|467199707|FG001|Overall Study|Administrative problems|0|||
129790104|NCT01534182|467199706|FG000|Overall Study|Withdrawal by Subject|4|||
129790105|NCT01534182|467199707|FG001|Overall Study|Withdrawal by Subject|7|||
129790106|NCT01534182|467199706|FG000|Overall Study|Adverse Event|7|||
129790107|NCT01534182|467199707|FG001|Overall Study|Adverse Event|3|||
129790108|NCT00924170|467199713|FG000|Overall Study|Refused further treatment|0|||
129790109|NCT00924170|467199714|FG001|Overall Study|Refused further treatment|1|||
129790110|NCT00924170|467199713|FG000|Overall Study|Physician Decision|0|||
129790111|NCT00924170|467199714|FG001|Overall Study|Physician Decision|1|||
129790112|NCT00924170|467199713|FG000|Overall Study|Progressive disease|3|||
129790113|NCT00924170|467199714|FG001|Overall Study|Progressive disease|6|||
129790114|NCT00924170|467199713|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
129606207|NCT01568320|466515514|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
129790115|NCT00924170|467199714|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
129790116|NCT00924170|467199713|FG000|Overall Study|Death|1|||
129790117|NCT00924170|467199714|FG001|Overall Study|Death|0|||
129790118|NCT04449029|467199718|FG000|Overall Study|Adverse Event|0|||
129790119|NCT04449029|467199719|FG001|Overall Study|Adverse Event|1|||
129790120|NCT04449029|467199720|FG002|Overall Study|Adverse Event|1|||
129790121|NCT04449029|467199721|FG003|Overall Study|Adverse Event|0|||
129790122|NCT04449029|467199722|FG004|Overall Study|Adverse Event|1|||
129790123|NCT04449029|467199723|FG005|Overall Study|Adverse Event|0|||
129790124|NCT04449029|467199724|FG006|Overall Study|Adverse Event|1|||
129790125|NCT04449029|467199725|FG007|Overall Study|Adverse Event|0|||
129790126|NCT04449029|467199718|FG000|Overall Study|Lost to Follow-up|0|||
129790127|NCT04449029|467199719|FG001|Overall Study|Lost to Follow-up|1|||
129790128|NCT04449029|467199720|FG002|Overall Study|Lost to Follow-up|0|||
129790129|NCT04449029|467199721|FG003|Overall Study|Lost to Follow-up|0|||
129790130|NCT04449029|467199722|FG004|Overall Study|Lost to Follow-up|0|||
129790131|NCT04449029|467199723|FG005|Overall Study|Lost to Follow-up|0|||
129790132|NCT04449029|467199724|FG006|Overall Study|Lost to Follow-up|0|||
129790133|NCT04449029|467199725|FG007|Overall Study|Lost to Follow-up|0|||
129790134|NCT04449029|467199718|FG000|Overall Study|Protocol Violation|0|||
129790135|NCT04449029|467199719|FG001|Overall Study|Protocol Violation|1|||
129790136|NCT04449029|467199720|FG002|Overall Study|Protocol Violation|0|||
129790137|NCT04449029|467199721|FG003|Overall Study|Protocol Violation|0|||
129790138|NCT04449029|467199722|FG004|Overall Study|Protocol Violation|0|||
129790139|NCT04449029|467199723|FG005|Overall Study|Protocol Violation|0|||
129790140|NCT04449029|467199724|FG006|Overall Study|Protocol Violation|0|||
129790141|NCT04449029|467199725|FG007|Overall Study|Protocol Violation|0|||
129437816|NCT00585195|465900445|FG007|Overall Study|Adverse Event|1|||
129437817|NCT00585195|465900446|FG008|Overall Study|Adverse Event|0|||
129437818|NCT00585195|465900447|FG009|Overall Study|Adverse Event|0|||
129606208|NCT01616953|466515515|FG000|Overall Study|Lost to Follow-up|1|||
129606209|NCT01616953|466515516|FG001|Overall Study|Lost to Follow-up|0|||
129606210|NCT01616953|466515515|FG000|Overall Study|lack of bone and soft tissue|1|||
129606211|NCT01616953|466515516|FG001|Overall Study|lack of bone and soft tissue|0|||
129606212|NCT01394952|466515517|FG000|Overall Study|Lost to Follow-up|0|||
129606213|NCT01394952|466515518|FG001|Overall Study|Lost to Follow-up|5|||
129606214|NCT01394952|466515517|FG000|Overall Study|Withdrawal by Subject|10|||
129606215|NCT01394952|466515518|FG001|Overall Study|Withdrawal by Subject|5|||
129606216|NCT01394952|466515517|FG000|Overall Study|Physician Decision|2|||
129606217|NCT01394952|466515518|FG001|Overall Study|Physician Decision|0|||
129606218|NCT01394952|466515517|FG000|Overall Study|Sponsor Decision|5|||
129698591|NCT00752219|466856784|FG001|Overall Study|Other|0|||
129698592|NCT01047540|466856790|FG000|Overall Study|Protocol Violation|1|||
129698593|NCT01047540|466856791|FG001|Overall Study|Protocol Violation|0|||
129698594|NCT01047540|466856792|FG002|Overall Study|Protocol Violation|0|||
129698595|NCT01047540|466856793|FG003|Overall Study|Protocol Violation|0|||
129698596|NCT01047540|466856794|FG004|Overall Study|Protocol Violation|0|||
129698597|NCT01047540|466856790|FG000|Overall Study|Lost to Follow-up|1|||
129698598|NCT01047540|466856791|FG001|Overall Study|Lost to Follow-up|0|||
129698599|NCT01047540|466856792|FG002|Overall Study|Lost to Follow-up|0|||
129790142|NCT04449029|467199718|FG000|Overall Study|Physician Decision|0|||
129790143|NCT04449029|467199719|FG001|Overall Study|Physician Decision|0|||
129790144|NCT04449029|467199720|FG002|Overall Study|Physician Decision|0|||
129790145|NCT04449029|467199721|FG003|Overall Study|Physician Decision|0|||
129437819|NCT00585195|465900448|FG010|Overall Study|Adverse Event|3|||
129437820|NCT00585195|465900449|FG011|Overall Study|Adverse Event|0|||
129437821|NCT00585195|465900450|FG012|Overall Study|Adverse Event|8|||
129437822|NCT00585195|465900451|FG013|Overall Study|Adverse Event|6|||
129437823|NCT00585195|465900452|FG014|Overall Study|Adverse Event|4|||
129437824|NCT00585195|465900453|FG015|Overall Study|Adverse Event|1|||
129437825|NCT00585195|465900454|FG016|Overall Study|Adverse Event|14|||
129437826|NCT00585195|465900455|FG017|Overall Study|Adverse Event|9|||
129437827|NCT00585195|465900456|FG018|Overall Study|Adverse Event|2|||
129437828|NCT00585195|465900457|FG019|Overall Study|Adverse Event|3|||
129437829|NCT00585195|465900458|FG020|Overall Study|Adverse Event|1|||
129437830|NCT00585195|465900438|FG000|Overall Study|Progressive Disease|2|||
129437831|NCT00585195|465900439|FG001|Overall Study|Progressive Disease|2|||
129437832|NCT00585195|465900440|FG002|Overall Study|Progressive Disease|5|||
129437833|NCT00585195|465900441|FG003|Overall Study|Progressive Disease|4|||
129437834|NCT00585195|465900442|FG004|Overall Study|Progressive Disease|6|||
129437835|NCT00585195|465900443|FG005|Overall Study|Progressive Disease|4|||
129437836|NCT00585195|465900444|FG006|Overall Study|Progressive Disease|6|||
129437837|NCT00585195|465900445|FG007|Overall Study|Progressive Disease|3|||
129698600|NCT01047540|466856793|FG003|Overall Study|Lost to Follow-up|0|||
129698601|NCT01047540|466856794|FG004|Overall Study|Lost to Follow-up|0|||
129698602|NCT01047540|466856790|FG000|Overall Study|Withdrawal by Subject|1|||
129698603|NCT01047540|466856791|FG001|Overall Study|Withdrawal by Subject|0|||
129790146|NCT04449029|467199722|FG004|Overall Study|Physician Decision|0|||
129790147|NCT04449029|467199723|FG005|Overall Study|Physician Decision|1|||
129790148|NCT04449029|467199724|FG006|Overall Study|Physician Decision|0|||
129790149|NCT04449029|467199725|FG007|Overall Study|Physician Decision|0|||
129790150|NCT04449029|467199718|FG000|Overall Study|Withdrawal by Subject|3|||
129790151|NCT04449029|467199719|FG001|Overall Study|Withdrawal by Subject|0|||
129790152|NCT04449029|467199720|FG002|Overall Study|Withdrawal by Subject|1|||
129790153|NCT04449029|467199721|FG003|Overall Study|Withdrawal by Subject|1|||
129790154|NCT04449029|467199722|FG004|Overall Study|Withdrawal by Subject|5|||
129790155|NCT04449029|467199723|FG005|Overall Study|Withdrawal by Subject|1|||
129437838|NCT00585195|465900446|FG008|Overall Study|Progressive Disease|0|||
129437839|NCT00585195|465900447|FG009|Overall Study|Progressive Disease|5|||
129698604|NCT01047540|466856792|FG002|Overall Study|Withdrawal by Subject|3|||
129698605|NCT01047540|466856793|FG003|Overall Study|Withdrawal by Subject|0|||
129698606|NCT01047540|466856794|FG004|Overall Study|Withdrawal by Subject|1|||
129698607|NCT01047540|466856790|FG000|Overall Study|Pregnancy|1|||
129698608|NCT01047540|466856791|FG001|Overall Study|Pregnancy|0|||
129698609|NCT01047540|466856792|FG002|Overall Study|Pregnancy|0|||
129698610|NCT01047540|466856793|FG003|Overall Study|Pregnancy|0|||
129698611|NCT01047540|466856794|FG004|Overall Study|Pregnancy|0|||
129698612|NCT01047540|466856790|FG000|Overall Study|Adverse Event|1|||
129698613|NCT01047540|466856791|FG001|Overall Study|Adverse Event|0|||
129698614|NCT01047540|466856792|FG002|Overall Study|Adverse Event|0|||
129698615|NCT01047540|466856793|FG003|Overall Study|Adverse Event|0|||
129698616|NCT01047540|466856794|FG004|Overall Study|Adverse Event|0|||
129698617|NCT01437189|466856798|FG000|Overall Study|Adverse Event|3|||
129698618|NCT01437189|466856798|FG000|Overall Study|Lack of Efficacy|4|||
129698619|NCT01437189|466856798|FG000|Overall Study|Withdrawal by Subject|8|||
129698620|NCT00347269|466856799|FG000|Overall Study|Lost to Follow-up|74|||
129698621|NCT00347269|466856800|FG001|Overall Study|Lost to Follow-up|65|||
129790156|NCT04449029|467199724|FG006|Overall Study|Withdrawal by Subject|4|||
129790157|NCT04449029|467199725|FG007|Overall Study|Withdrawal by Subject|0|||
129437840|NCT00585195|465900448|FG010|Overall Study|Progressive Disease|2|||
129698622|NCT00347269|466856799|FG000|Overall Study|Withdrawal by Subject|18|||
129698623|NCT00347269|466856800|FG001|Overall Study|Withdrawal by Subject|38|||
129698624|NCT00347269|466856799|FG000|Overall Study|Death|2|||
129698625|NCT00347269|466856800|FG001|Overall Study|Death|3|||
129437841|NCT00585195|465900449|FG011|Overall Study|Progressive Disease|25|||
129437842|NCT00585195|465900450|FG012|Overall Study|Progressive Disease|29|||
129437843|NCT00585195|465900451|FG013|Overall Study|Progressive Disease|26|||
129437844|NCT00585195|465900452|FG014|Overall Study|Progressive Disease|21|||
129437845|NCT00585195|465900453|FG015|Overall Study|Progressive Disease|12|||
129790158|NCT02025556|467199726|FG000|Overall Study|Adverse Event|0|||
129606219|NCT01394952|466515518|FG001|Overall Study|Sponsor Decision|7|||
129606220|NCT01103466|466515521|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
129606221|NCT01103466|466515522|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
129606222|NCT01103466|466515523|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
129606223|NCT01103466|466515521|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
129606224|NCT01103466|466515522|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
129606225|NCT01103466|466515523|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
129606226|NCT01103466|466515521|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
129606227|NCT01103466|466515522|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
129606228|NCT01103466|466515523|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
129790159|NCT02025556|467199727|FG001|Overall Study|Adverse Event|4|||
129606229|NCT01103466|466515521|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
129606230|NCT01103466|466515522|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
129790160|NCT02025556|467199728|FG002|Overall Study|Adverse Event|2|||
129698626|NCT03654326|466856801|FG000|Overall Study|Withdrawal by Subject|5|||
129698627|NCT03654326|466856802|FG001|Overall Study|Withdrawal by Subject|3|||
129886351|NCT00506285|467545562|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
129886352|NCT00506285|467545561|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
129886353|NCT00506285|467545562|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
129886354|NCT00506285|467545561|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
129886355|NCT00506285|467545562|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
129886356|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
129886357|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
129886358|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886359|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886360|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886361|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
129886362|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
129886363|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
129886364|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886365|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886366|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886367|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
129886368|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
129886369|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
129886370|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886371|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886372|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886373|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
129886374|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886375|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
129886376|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886377|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886378|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886379|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
129886380|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
129886381|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886382|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886383|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886384|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886385|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
129886386|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
129886387|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
129886388|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129437846|NCT00585195|465900454|FG016|Overall Study|Progressive Disease|94|||
129437847|NCT00585195|465900455|FG017|Overall Study|Progressive Disease|42|||
129437848|NCT00585195|465900456|FG018|Overall Study|Progressive Disease|4|||
129437849|NCT00585195|465900457|FG019|Overall Study|Progressive Disease|9|||
129437850|NCT00585195|465900458|FG020|Overall Study|Progressive Disease|8|||
129437851|NCT00585195|465900438|FG000|Overall Study|Withdrawal by Subject|1|||
129437852|NCT00585195|465900439|FG001|Overall Study|Withdrawal by Subject|1|||
129437853|NCT00585195|465900440|FG002|Overall Study|Withdrawal by Subject|2|||
129437854|NCT00585195|465900441|FG003|Overall Study|Withdrawal by Subject|2|||
129437855|NCT00585195|465900442|FG004|Overall Study|Withdrawal by Subject|0|||
129437856|NCT00585195|465900443|FG005|Overall Study|Withdrawal by Subject|0|||
129437857|NCT00585195|465900444|FG006|Overall Study|Withdrawal by Subject|0|||
129437858|NCT00585195|465900445|FG007|Overall Study|Withdrawal by Subject|1|||
129437859|NCT00585195|465900446|FG008|Overall Study|Withdrawal by Subject|0|||
129437860|NCT00585195|465900447|FG009|Overall Study|Withdrawal by Subject|0|||
129437861|NCT00585195|465900448|FG010|Overall Study|Withdrawal by Subject|3|||
129437862|NCT00585195|465900449|FG011|Overall Study|Withdrawal by Subject|8|||
129437863|NCT00585195|465900450|FG012|Overall Study|Withdrawal by Subject|15|||
129437864|NCT00585195|465900451|FG013|Overall Study|Withdrawal by Subject|0|||
129437865|NCT00585195|465900452|FG014|Overall Study|Withdrawal by Subject|3|||
129437866|NCT00585195|465900453|FG015|Overall Study|Withdrawal by Subject|0|||
129437867|NCT00585195|465900454|FG016|Overall Study|Withdrawal by Subject|7|||
129437868|NCT00585195|465900455|FG017|Overall Study|Withdrawal by Subject|1|||
129437869|NCT00585195|465900456|FG018|Overall Study|Withdrawal by Subject|2|||
129437870|NCT00585195|465900457|FG019|Overall Study|Withdrawal by Subject|2|||
129437871|NCT00585195|465900458|FG020|Overall Study|Withdrawal by Subject|0|||
129437872|NCT00585195|465900438|FG000|Overall Study|Other|0|||
129437873|NCT00585195|465900439|FG001|Overall Study|Other|1|||
129437874|NCT00585195|465900440|FG002|Overall Study|Other|1|||
129437875|NCT00585195|465900441|FG003|Overall Study|Other|1|||
129437876|NCT00585195|465900442|FG004|Overall Study|Other|0|||
129437877|NCT00585195|465900443|FG005|Overall Study|Other|1|||
129437878|NCT00585195|465900444|FG006|Overall Study|Other|0|||
129437879|NCT00585195|465900445|FG007|Overall Study|Other|0|||
129437880|NCT00585195|465900446|FG008|Overall Study|Other|2|||
129437881|NCT00585195|465900447|FG009|Overall Study|Other|1|||
129437882|NCT00585195|465900448|FG010|Overall Study|Other|0|||
129437883|NCT00585195|465900449|FG011|Overall Study|Other|19|||
129437884|NCT00585195|465900450|FG012|Overall Study|Other|24|||
129437885|NCT00585195|465900451|FG013|Overall Study|Other|7|||
129437886|NCT00585195|465900452|FG014|Overall Study|Other|11|||
129437887|NCT00585195|465900453|FG015|Overall Study|Other|3|||
129437888|NCT00585195|465900454|FG016|Overall Study|Other|28|||
129437889|NCT00585195|465900455|FG017|Overall Study|Other|12|||
129437890|NCT00585195|465900456|FG018|Overall Study|Other|10|||
129437891|NCT00585195|465900457|FG019|Overall Study|Other|4|||
129437892|NCT00585195|465900458|FG020|Overall Study|Other|2|||
129437893|NCT00585195|465900438|FG000|Overall Study|Randomized not treated|0|||
129437894|NCT00585195|465900439|FG001|Overall Study|Randomized not treated|0|||
129437895|NCT00585195|465900440|FG002|Overall Study|Randomized not treated|1|||
129606231|NCT01103466|466515523|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
129606232|NCT01103466|466515521|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
129606233|NCT01103466|466515522|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
129606234|NCT01103466|466515523|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
129606235|NCT01103466|466515521|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
129606236|NCT01103466|466515522|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
129606237|NCT01103466|466515523|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
129606238|NCT02331368|466515528|FG000|Overall Study|Withdrawal by Subject|3|||
129606239|NCT02283983|466515533|FG000|Overall Study|Inclusion criteria not met|0|||
129437896|NCT00585195|465900441|FG003|Overall Study|Randomized not treated|0|||
129606240|NCT02283983|466515534|FG001|Overall Study|Inclusion criteria not met|1|||
129437897|NCT00585195|465900442|FG004|Overall Study|Randomized not treated|1|||
129437898|NCT00585195|465900443|FG005|Overall Study|Randomized not treated|0|||
129437899|NCT00585195|465900444|FG006|Overall Study|Randomized not treated|1|||
129437900|NCT00585195|465900445|FG007|Overall Study|Randomized not treated|0|||
129437901|NCT00585195|465900446|FG008|Overall Study|Randomized not treated|0|||
129437902|NCT00585195|465900447|FG009|Overall Study|Randomized not treated|0|||
129606241|NCT02283983|466515533|FG000|Overall Study|Withdrawal by Subject|4|||
129606242|NCT02283983|466515534|FG001|Overall Study|Withdrawal by Subject|2|||
129606243|NCT02283983|466515533|FG000|Overall Study|Protocol Violation|0|||
129606244|NCT02283983|466515534|FG001|Overall Study|Protocol Violation|4|||
129790161|NCT02025556|467199726|FG000|Overall Study|Lack of Efficacy|2|||
129606245|NCT02283983|466515533|FG000|Overall Study|Physician Decision|2|||
129606246|NCT02283983|466515534|FG001|Overall Study|Physician Decision|4|||
129437903|NCT00585195|465900448|FG010|Overall Study|Randomized not treated|2|||
129437904|NCT00585195|465900449|FG011|Overall Study|Randomized not treated|0|||
129437905|NCT00585195|465900450|FG012|Overall Study|Randomized not treated|0|||
129437906|NCT00585195|465900451|FG013|Overall Study|Randomized not treated|0|||
129606247|NCT02283983|466515533|FG000|Overall Study|Death|1|||
129606248|NCT02283983|466515534|FG001|Overall Study|Death|0|||
129606249|NCT02283983|466515533|FG000|Overall Study|Adverse Event|1|||
129606250|NCT02283983|466515534|FG001|Overall Study|Adverse Event|0|||
129606251|NCT02283983|466515533|FG000|Overall Study|Lost to Follow-up|9|||
129606252|NCT02283983|466515534|FG001|Overall Study|Lost to Follow-up|8|||
129606253|NCT02283983|466515533|FG000|Overall Study|Relapse|1|||
129606254|NCT02283983|466515534|FG001|Overall Study|Relapse|0|||
129606255|NCT04453202|466515540|FG000|Overall Study|Adverse Event|0|||
129606256|NCT04453202|466515541|FG001|Overall Study|Adverse Event|0|||
129606257|NCT04453202|466515542|FG002|Overall Study|Adverse Event|0|||
129606258|NCT04453202|466515543|FG003|Overall Study|Adverse Event|0|||
129606259|NCT04453202|466515544|FG004|Overall Study|Adverse Event|0|||
129606260|NCT04453202|466515545|FG005|Overall Study|Adverse Event|0|||
129606261|NCT04453202|466515546|FG006|Overall Study|Adverse Event|1|||
129606262|NCT04453202|466515547|FG007|Overall Study|Adverse Event|0|||
129606263|NCT04453202|466515548|FG008|Overall Study|Adverse Event|0|||
129606264|NCT04453202|466515549|FG009|Overall Study|Adverse Event|0|||
129606265|NCT04453202|466515550|FG010|Overall Study|Adverse Event|0|||
129606266|NCT04453202|466515540|FG000|Overall Study|Death|0|||
129606267|NCT04453202|466515541|FG001|Overall Study|Death|0|||
129606268|NCT04453202|466515542|FG002|Overall Study|Death|0|||
129886389|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129886390|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129886391|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
129886392|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
129886393|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
129886394|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886395|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886396|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886397|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
129886398|NCT01089556|467545563|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
129886399|NCT01089556|467545564|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
129886400|NCT01089556|467545565|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886401|NCT01089556|467545566|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886402|NCT01089556|467545567|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886403|NCT01089556|467545568|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
129886404|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
129886405|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
129886406|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
129886407|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
129886408|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
129886409|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
129886410|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
129886411|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
129886412|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886413|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886414|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886415|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
129886416|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886417|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886418|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886419|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
129886420|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
129886421|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
129886422|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886423|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886424|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
129886425|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886426|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886427|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
129886428|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129886429|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129886430|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
129886431|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
129606269|NCT04453202|466515543|FG003|Overall Study|Death|0|||
129606270|NCT04453202|466515544|FG004|Overall Study|Death|0|||
129606271|NCT04453202|466515545|FG005|Overall Study|Death|0|||
129606272|NCT04453202|466515546|FG006|Overall Study|Death|0|||
129606273|NCT04453202|466515547|FG007|Overall Study|Death|0|||
129606274|NCT04453202|466515548|FG008|Overall Study|Death|0|||
129606275|NCT04453202|466515549|FG009|Overall Study|Death|1|||
129606276|NCT04453202|466515550|FG010|Overall Study|Death|0|||
129606277|NCT04453202|466515540|FG000|Overall Study|Lost to Follow-up|0|||
129790162|NCT02025556|467199727|FG001|Overall Study|Lack of Efficacy|1|||
129790163|NCT02025556|467199728|FG002|Overall Study|Lack of Efficacy|0|||
129790164|NCT02025556|467199726|FG000|Overall Study|Protocol Violation|2|||
129790165|NCT02025556|467199727|FG001|Overall Study|Protocol Violation|1|||
129790166|NCT02025556|467199728|FG002|Overall Study|Protocol Violation|0|||
129790167|NCT02025556|467199726|FG000|Overall Study|Withdrawal by Subject|0|||
129790168|NCT02025556|467199727|FG001|Overall Study|Withdrawal by Subject|3|||
129790169|NCT02025556|467199728|FG002|Overall Study|Withdrawal by Subject|6|||
129790170|NCT02025556|467199726|FG000|Overall Study|Lost to Follow-up|2|||
129790171|NCT02025556|467199727|FG001|Overall Study|Lost to Follow-up|4|||
129790172|NCT02025556|467199728|FG002|Overall Study|Lost to Follow-up|0|||
129790173|NCT02025556|467199726|FG000|Overall Study|Reason not reported|0|||
129886432|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
129437907|NCT00585195|465900452|FG014|Overall Study|Randomized not treated|0|||
129437908|NCT00585195|465900453|FG015|Overall Study|Randomized not treated|1|||
129606278|NCT04453202|466515541|FG001|Overall Study|Lost to Follow-up|1|||
129606279|NCT04453202|466515542|FG002|Overall Study|Lost to Follow-up|0|||
129606280|NCT04453202|466515543|FG003|Overall Study|Lost to Follow-up|1|||
129606281|NCT04453202|466515544|FG004|Overall Study|Lost to Follow-up|0|||
129606282|NCT04453202|466515545|FG005|Overall Study|Lost to Follow-up|0|||
129606283|NCT04453202|466515546|FG006|Overall Study|Lost to Follow-up|0|||
129606284|NCT04453202|466515547|FG007|Overall Study|Lost to Follow-up|0|||
129606285|NCT04453202|466515548|FG008|Overall Study|Lost to Follow-up|0|||
129606286|NCT04453202|466515549|FG009|Overall Study|Lost to Follow-up|1|||
129606287|NCT04453202|466515550|FG010|Overall Study|Lost to Follow-up|1|||
129606288|NCT04453202|466515540|FG000|Overall Study|Withdrawal by Subject|1|||
129606289|NCT04453202|466515541|FG001|Overall Study|Withdrawal by Subject|2|||
129606290|NCT04453202|466515542|FG002|Overall Study|Withdrawal by Subject|1|||
129606291|NCT04453202|466515543|FG003|Overall Study|Withdrawal by Subject|2|||
129606292|NCT04453202|466515544|FG004|Overall Study|Withdrawal by Subject|1|||
129606293|NCT04453202|466515545|FG005|Overall Study|Withdrawal by Subject|1|||
129606294|NCT04453202|466515546|FG006|Overall Study|Withdrawal by Subject|0|||
129606295|NCT04453202|466515547|FG007|Overall Study|Withdrawal by Subject|0|||
129606296|NCT04453202|466515548|FG008|Overall Study|Withdrawal by Subject|0|||
129606297|NCT04453202|466515549|FG009|Overall Study|Withdrawal by Subject|1|||
129606298|NCT04453202|466515550|FG010|Overall Study|Withdrawal by Subject|0|||
129606299|NCT04453202|466515540|FG000|Overall Study|Adverse Event|0|||
129606300|NCT04453202|466515541|FG001|Overall Study|Adverse Event|0|||
129606301|NCT04453202|466515542|FG002|Overall Study|Adverse Event|0|||
129606302|NCT04453202|466515543|FG003|Overall Study|Adverse Event|0|||
129606303|NCT04453202|466515544|FG004|Overall Study|Adverse Event|0|||
129606304|NCT04453202|466515545|FG005|Overall Study|Adverse Event|1|||
129606305|NCT04453202|466515546|FG006|Overall Study|Adverse Event|0|||
129606306|NCT04453202|466515547|FG007|Overall Study|Adverse Event|0|||
129606307|NCT04453202|466515548|FG008|Overall Study|Adverse Event|0|||
129606308|NCT04453202|466515549|FG009|Overall Study|Adverse Event|0|||
129886433|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
129886434|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
129886435|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
129886436|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
129886437|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
129886438|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
129886439|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
129886440|NCT01089556|467545563|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
129886441|NCT01089556|467545564|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
129886442|NCT01089556|467545565|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
129886443|NCT01089556|467545566|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
129886444|NCT01089556|467545567|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
129886445|NCT01089556|467545568|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
129886446|NCT01238575|467545569|FG000|Overall Study|Lack of Efficacy|2|||
129886447|NCT01238575|467545570|FG001|Overall Study|Lack of Efficacy|4|||
129437909|NCT00585195|465900454|FG016|Overall Study|Randomized not treated|0|||
129437910|NCT00585195|465900455|FG017|Overall Study|Randomized not treated|1|||
129606309|NCT04453202|466515550|FG010|Overall Study|Adverse Event|0|||
129606310|NCT01157897|466515551|FG000|Overall Study|Lost to Follow-up|2|||
129606311|NCT01157897|466515552|FG001|Overall Study|Lost to Follow-up|0|||
129606312|NCT01157897|466515553|FG002|Overall Study|Lost to Follow-up|0|||
129606313|NCT01157897|466515554|FG003|Overall Study|Lost to Follow-up|1|||
129606314|NCT01157897|466515551|FG000|Overall Study|Relocated|0|||
129606315|NCT01157897|466515552|FG001|Overall Study|Relocated|2|||
129606316|NCT01157897|466515553|FG002|Overall Study|Relocated|0|||
129606317|NCT01157897|466515554|FG003|Overall Study|Relocated|0|||
129790174|NCT02025556|467199727|FG001|Overall Study|Reason not reported|0|||
129790175|NCT02025556|467199728|FG002|Overall Study|Reason not reported|1|||
129790176|NCT00627445|467199729|FG000|Overall Study|Adverse Event|3|||
129790177|NCT00627445|467199730|FG001|Overall Study|Adverse Event|3|||
129886448|NCT01238575|467545569|FG000|Overall Study|Adverse Event|2|||
129886449|NCT01238575|467545570|FG001|Overall Study|Adverse Event|0|||
129886450|NCT01950273|467545573|FG000|Overall Study|Protocol Violation|1|||
129886451|NCT01950273|467545574|FG001|Overall Study|Protocol Violation|0|||
129886452|NCT01950273|467545573|FG000|Overall Study|Withdrawal by Subject|2|||
129886453|NCT01950273|467545574|FG001|Overall Study|Withdrawal by Subject|0|||
129886454|NCT01950273|467545573|FG000|Overall Study|Other not defined above|1|||
129886455|NCT01950273|467545574|FG001|Overall Study|Other not defined above|0|||
129886456|NCT01591460|467545579|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
129886457|NCT01591460|467545579|FG000|Overall Study|Futility Rule (Week 12)|7|||
129886458|NCT01591460|467545579|FG000|Overall Study|Futility Rule (Week 24)|3|||
129886459|NCT01591460|467545579|FG000|Overall Study|Rebound or Breakthrough|3|||
129886460|NCT01591460|467545579|FG000|Overall Study|Treatment Discontinued by Error|1|||
129886461|NCT01591460|467545579|FG000|Overall Study|Lost to Follow-up|1|||
129886462|NCT01591460|467545579|FG000|Overall Study|Noncompliance|1|||
129886463|NCT01591460|467545579|FG000|Overall Study|Participant Refusal|3|||
129886464|NCT01591460|467545579|FG000|Overall Study|Withdrawal by Subject|1|||
129886465|NCT01591460|467545579|FG000|Overall Study|Protocol Violation|1|||
129886466|NCT00432679|467545582|FG000|Overall Study|Adverse Event|2|||
129886467|NCT00432679|467545583|FG001|Overall Study|Adverse Event|1|||
129886468|NCT00432679|467545582|FG000|Overall Study|Withdrawal by Subject|3|||
129886469|NCT00432679|467545583|FG001|Overall Study|Withdrawal by Subject|2|||
129886470|NCT01567163|467545584|FG000|Overall Study|Progressive Disease|2|||
129886471|NCT01567163|467545584|FG000|Overall Study|Lost to Follow-up|2|||
129886472|NCT03405662|467545585|FG000|Overall Study|COVID-19 restriction|1|||
129886473|NCT03405662|467545586|FG001|Overall Study|COVID-19 restriction|0|||
129886474|NCT03405662|467545585|FG000|Overall Study|unblinding|0|||
129886475|NCT03405662|467545586|FG001|Overall Study|unblinding|1|||
129886476|NCT03405662|467545585|FG000|Overall Study|placement in memory care facility|0|||
129886477|NCT03405662|467545586|FG001|Overall Study|placement in memory care facility|2|||
129886478|NCT01177813|467545587|FG000|Overall Study|Adverse Event|8|||
129886479|NCT01177813|467545588|FG001|Overall Study|Adverse Event|2|||
129886480|NCT01177813|467545589|FG002|Overall Study|Adverse Event|4|||
129886481|NCT01177813|467545590|FG003|Overall Study|Adverse Event|6|||
129886482|NCT01177813|467545591|FG004|Overall Study|Adverse Event|3|||
129886483|NCT01177813|467545587|FG000|Overall Study|Lack of Efficacy|1|||
129886484|NCT01177813|467545588|FG001|Overall Study|Lack of Efficacy|0|||
129886485|NCT01177813|467545589|FG002|Overall Study|Lack of Efficacy|0|||
129886486|NCT01177813|467545590|FG003|Overall Study|Lack of Efficacy|0|||
129886487|NCT01177813|467545591|FG004|Overall Study|Lack of Efficacy|0|||
129886488|NCT01177813|467545587|FG000|Overall Study|Protocol Violation|3|||
129886489|NCT01177813|467545588|FG001|Overall Study|Protocol Violation|2|||
129886490|NCT01177813|467545589|FG002|Overall Study|Protocol Violation|2|||
129886491|NCT01177813|467545590|FG003|Overall Study|Protocol Violation|0|||
129886492|NCT01177813|467545591|FG004|Overall Study|Protocol Violation|1|||
129886493|NCT01177813|467545587|FG000|Overall Study|Lost to Follow-up|12|||
129886494|NCT01177813|467545588|FG001|Overall Study|Lost to Follow-up|5|||
129886495|NCT01177813|467545589|FG002|Overall Study|Lost to Follow-up|6|||
129886496|NCT01177813|467545590|FG003|Overall Study|Lost to Follow-up|3|||
129886497|NCT01177813|467545591|FG004|Overall Study|Lost to Follow-up|0|||
129886498|NCT01177813|467545587|FG000|Overall Study|Withdrawal by Subject|12|||
129886499|NCT01177813|467545588|FG001|Overall Study|Withdrawal by Subject|7|||
129886500|NCT01177813|467545589|FG002|Overall Study|Withdrawal by Subject|6|||
129606318|NCT03276221|466515555|FG000|Overall Study|Lost to Follow-up|6|||
129606319|NCT03276221|466515556|FG001|Overall Study|Lost to Follow-up|2|||
129606320|NCT03276221|466515557|FG002|Overall Study|Lost to Follow-up|0|||
129606321|NCT03276221|466515555|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
129606322|NCT03276221|466515556|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
129606323|NCT03276221|466515557|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
129606324|NCT00424775|466515558|FG000|Overall Study|Adverse Event|2|||
129606325|NCT00424775|466515559|FG001|Overall Study|Adverse Event|0|||
129606326|NCT00424775|466515558|FG000|Overall Study|Lack of Efficacy|1|||
129606327|NCT00424775|466515559|FG001|Overall Study|Lack of Efficacy|0|||
129886501|NCT01177813|467545590|FG003|Overall Study|Withdrawal by Subject|5|||
129886502|NCT01177813|467545591|FG004|Overall Study|Withdrawal by Subject|3|||
129886503|NCT01177813|467545587|FG000|Overall Study|Other reason not defined above|5|||
129886504|NCT01177813|467545588|FG001|Overall Study|Other reason not defined above|2|||
129606328|NCT02912650|466515560|FG000|Overall Study|Withdrawal by Subject|1|||
129606329|NCT02912650|466515561|FG001|Overall Study|Withdrawal by Subject|0|||
129886505|NCT01177813|467545589|FG002|Overall Study|Other reason not defined above|2|||
129886506|NCT01177813|467545590|FG003|Overall Study|Other reason not defined above|3|||
129886507|NCT01177813|467545591|FG004|Overall Study|Other reason not defined above|2|||
129886508|NCT00109928|467545594|FG000|Overall Study|Adverse Event|2|||
129606330|NCT02912650|466515562|FG002|Overall Study|Withdrawal by Subject|1|||
129886509|NCT00109928|467545594|FG000|Overall Study|Progression|6|||
129886510|NCT00109928|467545594|FG000|Overall Study|Death|2|||
129886511|NCT00109928|467545594|FG000|Overall Study|not protocol specified|2|||
129886512|NCT00109928|467545594|FG000|Overall Study|not eligible|1|||
129886513|NCT01196104|467545595|FG000|Overall Study|Lost to Follow-up|1|||
129606331|NCT02912650|466515563|FG003|Overall Study|Withdrawal by Subject|5|||
129886514|NCT01196104|467545596|FG001|Overall Study|Lost to Follow-up|0|||
129606332|NCT02912650|466515560|FG000|Overall Study|Adverse Event|0|||
129606333|NCT02912650|466515561|FG001|Overall Study|Adverse Event|0|||
129606334|NCT02912650|466515562|FG002|Overall Study|Adverse Event|1|||
129606335|NCT02912650|466515563|FG003|Overall Study|Adverse Event|0|||
129606336|NCT02562482|466515565|FG000|Overall Study|Enrolled, but did not receive product|4|||
129606337|NCT02562482|466515566|FG001|Overall Study|Enrolled, but did not receive product|0|||
129606338|NCT02562482|466515565|FG000|Overall Study|Lost to Follow-up|9|||
129606339|NCT02562482|466515566|FG001|Overall Study|Lost to Follow-up|6|||
129606340|NCT02562482|466515565|FG000|Overall Study|Moved from area|2|||
129606341|NCT02562482|466515566|FG001|Overall Study|Moved from area|3|||
129606342|NCT02562482|466515565|FG000|Overall Study|Withdrawal by Subject|5|||
129606343|NCT02562482|466515566|FG001|Overall Study|Withdrawal by Subject|3|||
129606344|NCT02562482|466515565|FG000|Overall Study|Physician Decision|1|||
129606345|NCT02562482|466515566|FG001|Overall Study|Physician Decision|3|||
129606346|NCT02562482|466515565|FG000|Overall Study|Illness/Injury unrelated to product|0|||
129606347|NCT02562482|466515566|FG001|Overall Study|Illness/Injury unrelated to product|1|||
129606348|NCT00975286|466515567|FG000|Overall Study|Adverse Event|9|||
129606349|NCT00975286|466515568|FG001|Overall Study|Adverse Event|19|||
129606350|NCT00975286|466515567|FG000|Overall Study|Protocol Violation|1|||
129606351|NCT00975286|466515568|FG001|Overall Study|Protocol Violation|2|||
129606352|NCT00975286|466515567|FG000|Overall Study|Withdrawal by Subject|0|||
129606353|NCT00975286|466515568|FG001|Overall Study|Withdrawal by Subject|2|||
129606354|NCT00975286|466515567|FG000|Overall Study|Familial and Personal Reasons|2|||
129606355|NCT00975286|466515568|FG001|Overall Study|Familial and Personal Reasons|2|||
129606356|NCT00975286|466515567|FG000|Overall Study|Poor Compliance to Protocol|0|||
129606357|NCT00975286|466515568|FG001|Overall Study|Poor Compliance to Protocol|2|||
129606358|NCT00975286|466515567|FG000|Overall Study|Sponsor Decision|0|||
129606359|NCT00975286|466515568|FG001|Overall Study|Sponsor Decision|2|||
129606360|NCT01674647|466515569|FG000|Treatment Period|Death|4|||
129606361|NCT01674647|466515570|FG001|Treatment Period|Death|1|||
129606362|NCT01674647|466515569|FG000|Treatment Period|Efficacy outcome reached|0|||
129606363|NCT01674647|466515570|FG001|Treatment Period|Efficacy outcome reached|1|||
129606364|NCT01674647|466515569|FG000|Treatment Period|Physician Decision|3|||
129606365|NCT01674647|466515570|FG001|Treatment Period|Physician Decision|1|||
129606366|NCT01674647|466515569|FG000|Treatment Period|Adverse Event|60|||
129606367|NCT01674647|466515570|FG001|Treatment Period|Adverse Event|22|||
129606368|NCT01674647|466515569|FG000|Treatment Period|Non-compliance with study drug|3|||
129606369|NCT01674647|466515570|FG001|Treatment Period|Non-compliance with study drug|0|||
129606370|NCT01674647|466515569|FG000|Treatment Period|Lost to Follow-up|1|||
129606371|NCT01674647|466515570|FG001|Treatment Period|Lost to Follow-up|1|||
129606372|NCT01674647|466515569|FG000|Treatment Period|Withdrawal by Subject|19|||
129606373|NCT01674647|466515570|FG001|Treatment Period|Withdrawal by Subject|16|||
129606374|NCT01674647|466515569|FG000|Treatment Period|Switching to other therapy|5|||
129606375|NCT01674647|466515570|FG001|Treatment Period|Switching to other therapy|2|||
129606376|NCT01674647|466515569|FG000|Treatment Period|Logistical difficulties|5|||
129606377|NCT01674647|466515570|FG001|Treatment Period|Logistical difficulties|8|||
129606378|NCT01674647|466515569|FG000|Treatment Period|Treatment failure|0|||
129606379|NCT01674647|466515570|FG001|Treatment Period|Treatment failure|14|||
129606380|NCT01674647|466515569|FG000|Treatment Period|Protocol Violation|56|||
129606381|NCT01674647|466515570|FG001|Treatment Period|Protocol Violation|36|||
129606382|NCT01674647|466515569|FG000|30-day Safety Follow-up Period|Death|3|||
129606383|NCT01674647|466515570|FG001|30-day Safety Follow-up Period|Death|2|||
129606384|NCT01674647|466515569|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
129886515|NCT01196104|467545595|FG000|Overall Study|Physician Decision|0|||
129886516|NCT01196104|467545596|FG001|Overall Study|Physician Decision|1|||
129886517|NCT01196104|467545595|FG000|Overall Study|Withdrawal by Subject|3|||
129886518|NCT01196104|467545596|FG001|Overall Study|Withdrawal by Subject|3|||
129886519|NCT01196104|467545595|FG000|Overall Study|Various|0|||
129886520|NCT01196104|467545596|FG001|Overall Study|Various|1|||
129886521|NCT00610675|467545597|FG000|Overall Study|Untreated|4|||
129606385|NCT01674647|466515570|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
129606386|NCT01674647|466515569|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
129606387|NCT01674647|466515570|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
129606388|NCT01674647|466515569|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
129886522|NCT00610675|467545597|FG000|Overall Study|Adverse Event|67|||
129886523|NCT00610675|467545597|FG000|Overall Study|Insufficient Effect|31|||
129606389|NCT01674647|466515570|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
129606390|NCT01674647|466515569|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
129606391|NCT01674647|466515570|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
129606392|NCT01674647|466515569|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
129606393|NCT01674647|466515570|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
129886524|NCT00610675|467545597|FG000|Overall Study|Withdrawal by Subject|28|||
129698628|NCT03654326|466856801|FG000|Overall Study|Physician Decision|0|||
129698629|NCT03654326|466856802|FG001|Overall Study|Physician Decision|1|||
129698630|NCT03654326|466856801|FG000|Overall Study|Unable to adhere to study schedule|0|||
129886525|NCT00610675|467545597|FG000|Overall Study|Reasons unrelated to trial|27|||
129437911|NCT00585195|465900456|FG018|Overall Study|Randomized not treated|3|||
129437912|NCT00585195|465900457|FG019|Overall Study|Randomized not treated|0|||
129437913|NCT00585195|465900458|FG020|Overall Study|Randomized not treated|2|||
129437914|NCT00585195|465900438|FG000|Overall Study|Death|0|||
129437915|NCT00585195|465900439|FG001|Overall Study|Death|0|||
129437916|NCT00585195|465900440|FG002|Overall Study|Death|0|||
129437917|NCT00585195|465900441|FG003|Overall Study|Death|0|||
129437918|NCT00585195|465900442|FG004|Overall Study|Death|0|||
129437919|NCT00585195|465900443|FG005|Overall Study|Death|0|||
129437920|NCT00585195|465900444|FG006|Overall Study|Death|0|||
129437921|NCT00585195|465900445|FG007|Overall Study|Death|0|||
129437922|NCT00585195|465900446|FG008|Overall Study|Death|1|||
129437923|NCT00585195|465900447|FG009|Overall Study|Death|0|||
129437924|NCT00585195|465900448|FG010|Overall Study|Death|1|||
129437925|NCT00585195|465900449|FG011|Overall Study|Death|1|||
129437926|NCT00585195|465900450|FG012|Overall Study|Death|7|||
129437927|NCT00585195|465900451|FG013|Overall Study|Death|2|||
129437928|NCT00585195|465900452|FG014|Overall Study|Death|8|||
129437929|NCT00585195|465900453|FG015|Overall Study|Death|2|||
129437930|NCT00585195|465900454|FG016|Overall Study|Death|11|||
129437931|NCT00585195|465900455|FG017|Overall Study|Death|0|||
129437932|NCT00585195|465900456|FG018|Overall Study|Death|0|||
129437933|NCT00585195|465900457|FG019|Overall Study|Death|0|||
129437934|NCT00585195|465900458|FG020|Overall Study|Death|1|||
129437935|NCT00585195|465900438|FG000|Overall Study|Lost to Follow-up|0|||
129437936|NCT00585195|465900439|FG001|Overall Study|Lost to Follow-up|0|||
129437937|NCT00585195|465900440|FG002|Overall Study|Lost to Follow-up|0|||
129437938|NCT00585195|465900441|FG003|Overall Study|Lost to Follow-up|0|||
129437939|NCT00585195|465900442|FG004|Overall Study|Lost to Follow-up|0|||
129437940|NCT00585195|465900443|FG005|Overall Study|Lost to Follow-up|0|||
129437941|NCT00585195|465900444|FG006|Overall Study|Lost to Follow-up|0|||
129437942|NCT00585195|465900445|FG007|Overall Study|Lost to Follow-up|0|||
129437943|NCT00585195|465900446|FG008|Overall Study|Lost to Follow-up|0|||
129437944|NCT00585195|465900447|FG009|Overall Study|Lost to Follow-up|0|||
129437945|NCT00585195|465900448|FG010|Overall Study|Lost to Follow-up|0|||
129437946|NCT00585195|465900449|FG011|Overall Study|Lost to Follow-up|0|||
129437947|NCT00585195|465900450|FG012|Overall Study|Lost to Follow-up|1|||
129437948|NCT00585195|465900451|FG013|Overall Study|Lost to Follow-up|0|||
129437949|NCT00585195|465900452|FG014|Overall Study|Lost to Follow-up|0|||
129437950|NCT00585195|465900453|FG015|Overall Study|Lost to Follow-up|0|||
129437951|NCT00585195|465900454|FG016|Overall Study|Lost to Follow-up|0|||
129437952|NCT00585195|465900455|FG017|Overall Study|Lost to Follow-up|2|||
129437953|NCT00585195|465900456|FG018|Overall Study|Lost to Follow-up|0|||
129437954|NCT00585195|465900457|FG019|Overall Study|Lost to Follow-up|0|||
129698631|NCT03654326|466856802|FG001|Overall Study|Unable to adhere to study schedule|1|||
129698632|NCT03654326|466856801|FG000|Overall Study|Lost to Follow-up|1|||
129698633|NCT03654326|466856802|FG001|Overall Study|Lost to Follow-up|1|||
129698634|NCT04102514|466856803|FG000|Overall Study|Death|3|||
129698635|NCT04102514|466856804|FG001|Overall Study|Death|0|||
129698636|NCT04102514|466856805|FG002|Overall Study|Death|0|||
129698637|NCT04102514|466856806|FG003|Overall Study|Death|0|||
129698638|NCT04102514|466856803|FG000|Overall Study|Lost to Follow-up|0|||
129698639|NCT04102514|466856804|FG001|Overall Study|Lost to Follow-up|0|||
129886526|NCT00610675|467545597|FG000|Overall Study|Lack of Compliance|7|||
129886527|NCT00610675|467545597|FG000|Overall Study|Lost to Follow-up|31|||
129886528|NCT00610675|467545597|FG000|Overall Study|Other reason (not specified)|25|||
129886529|NCT01316692|467545600|FG000|Overall Study|Adverse Event|5|||
129886530|NCT01316692|467545600|FG000|Overall Study|Disease Progression|7|||
129886531|NCT00983619|467545601|FG000|Overall Study|Lost to Follow-up|0|||
129886532|NCT00983619|467545602|FG001|Overall Study|Lost to Follow-up|1|||
129886533|NCT00983619|467545603|FG002|Overall Study|Lost to Follow-up|0|||
129886534|NCT00983619|467545604|FG003|Overall Study|Lost to Follow-up|0|||
129886535|NCT00983619|467545605|FG004|Overall Study|Lost to Follow-up|0|||
129437955|NCT00585195|465900458|FG020|Overall Study|Lost to Follow-up|0|||
129437956|NCT00585195|465900438|FG000|Overall Study|Site Terminated by Sponsor|0|||
129437957|NCT00585195|465900439|FG001|Overall Study|Site Terminated by Sponsor|0|||
129437958|NCT00585195|465900440|FG002|Overall Study|Site Terminated by Sponsor|0|||
129437959|NCT00585195|465900441|FG003|Overall Study|Site Terminated by Sponsor|0|||
129437960|NCT00585195|465900442|FG004|Overall Study|Site Terminated by Sponsor|0|||
129437961|NCT00585195|465900443|FG005|Overall Study|Site Terminated by Sponsor|0|||
129437962|NCT00585195|465900444|FG006|Overall Study|Site Terminated by Sponsor|0|||
129437963|NCT00585195|465900445|FG007|Overall Study|Site Terminated by Sponsor|0|||
129437964|NCT00585195|465900446|FG008|Overall Study|Site Terminated by Sponsor|0|||
129437965|NCT00585195|465900447|FG009|Overall Study|Site Terminated by Sponsor|0|||
129437966|NCT00585195|465900448|FG010|Overall Study|Site Terminated by Sponsor|0|||
129437967|NCT00585195|465900449|FG011|Overall Study|Site Terminated by Sponsor|0|||
129698640|NCT04102514|466856805|FG002|Overall Study|Lost to Follow-up|3|||
129606394|NCT01490866|466515571|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
129606395|NCT01490866|466515571|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
129606396|NCT01490866|466515571|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
129606397|NCT01490866|466515571|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
129606398|NCT01490866|466515571|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
129606399|NCT01490866|466515571|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
129606400|NCT01490866|466515571|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
129606401|NCT01490866|466515571|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
129606402|NCT01490866|466515571|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
129606403|NCT01490866|466515571|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
129606404|NCT01490866|466515571|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
129606405|NCT02722148|466515572|FG000|Overall Study|Lost to Follow-up|2|||
129606406|NCT02722148|466515572|FG000|Overall Study|Non compliant with treatment regimen|3|||
129606407|NCT00914459|466515574|FG000|Overall Study|Protocol Violation|0|||
129606408|NCT00914459|466515575|FG001|Overall Study|Protocol Violation|1|||
129606409|NCT00914459|466515574|FG000|Overall Study|Parent/Legal guardian request|1|||
129606410|NCT00914459|466515575|FG001|Overall Study|Parent/Legal guardian request|0|||
129606411|NCT01661179|466515579|FG000|Overall Study|Death|1|||
129606412|NCT01661179|466515579|FG000|Overall Study|Withdrawal by Subject|1|||
129886536|NCT00983619|467545606|FG005|Overall Study|Lost to Follow-up|2|||
129886537|NCT00983619|467545607|FG006|Overall Study|Lost to Follow-up|0|||
129886538|NCT00983619|467545608|FG007|Overall Study|Lost to Follow-up|0|||
129886539|NCT00983619|467545609|FG008|Overall Study|Lost to Follow-up|0|||
129886540|NCT00983619|467545610|FG009|Overall Study|Lost to Follow-up|0|||
129886541|NCT00983619|467545611|FG010|Overall Study|Lost to Follow-up|0|||
129886542|NCT00983619|467545612|FG011|Overall Study|Lost to Follow-up|2|||
129886543|NCT00983619|467545601|FG000|Overall Study|Withdrawal by Subject|2|||
129886544|NCT00983619|467545602|FG001|Overall Study|Withdrawal by Subject|1|||
129886545|NCT00983619|467545603|FG002|Overall Study|Withdrawal by Subject|1|||
129886546|NCT00983619|467545604|FG003|Overall Study|Withdrawal by Subject|3|||
129886547|NCT00983619|467545605|FG004|Overall Study|Withdrawal by Subject|1|||
129886548|NCT00983619|467545606|FG005|Overall Study|Withdrawal by Subject|23|||
129886549|NCT00983619|467545607|FG006|Overall Study|Withdrawal by Subject|0|||
129886550|NCT00983619|467545608|FG007|Overall Study|Withdrawal by Subject|0|||
129886551|NCT00983619|467545609|FG008|Overall Study|Withdrawal by Subject|0|||
129886552|NCT00983619|467545610|FG009|Overall Study|Withdrawal by Subject|0|||
129886553|NCT00983619|467545611|FG010|Overall Study|Withdrawal by Subject|1|||
129886554|NCT00983619|467545612|FG011|Overall Study|Withdrawal by Subject|1|||
129886555|NCT00983619|467545601|FG000|Overall Study|Death|0|||
129886556|NCT00983619|467545602|FG001|Overall Study|Death|2|||
129886557|NCT00983619|467545603|FG002|Overall Study|Death|2|||
129886558|NCT00983619|467545604|FG003|Overall Study|Death|1|||
129886559|NCT00983619|467545605|FG004|Overall Study|Death|2|||
129886560|NCT00983619|467545606|FG005|Overall Study|Death|30|||
129886561|NCT00983619|467545607|FG006|Overall Study|Death|1|||
129886562|NCT00983619|467545608|FG007|Overall Study|Death|0|||
129886563|NCT00983619|467545609|FG008|Overall Study|Death|1|||
129886564|NCT00983619|467545610|FG009|Overall Study|Death|2|||
129886565|NCT00983619|467545611|FG010|Overall Study|Death|9|||
129886566|NCT00983619|467545612|FG011|Overall Study|Death|8|||
129886567|NCT00983619|467545601|FG000|Overall Study|Other|1|||
129886568|NCT00983619|467545602|FG001|Overall Study|Other|0|||
129886569|NCT00983619|467545603|FG002|Overall Study|Other|0|||
129886570|NCT00983619|467545604|FG003|Overall Study|Other|1|||
129886571|NCT00983619|467545605|FG004|Overall Study|Other|0|||
129886572|NCT00983619|467545606|FG005|Overall Study|Other|12|||
129886573|NCT00983619|467545607|FG006|Overall Study|Other|2|||
129886574|NCT00983619|467545608|FG007|Overall Study|Other|2|||
129886575|NCT00983619|467545609|FG008|Overall Study|Other|0|||
129886576|NCT00983619|467545610|FG009|Overall Study|Other|1|||
129886577|NCT00983619|467545611|FG010|Overall Study|Other|1|||
129886578|NCT00983619|467545612|FG011|Overall Study|Other|0|||
129886579|NCT03772314|467545619|FG000|Overall Study|Adverse Event|7|||
129886580|NCT03772314|467545620|FG001|Overall Study|Adverse Event|2|||
129886581|NCT01536145|467545621|FG000|Overall Study|Progressive disease|3|||
129886582|NCT01536145|467545622|FG001|Overall Study|Progressive disease|4|||
129886583|NCT01536145|467545623|FG002|Overall Study|Progressive disease|1|||
129606413|NCT01661179|466515579|FG000|Overall Study|Other Eligibility criteria|4|||
129606414|NCT01946191|466515580|FG000|Allocation|Did not complete orientation|1|||
129886584|NCT01536145|467545624|FG003|Overall Study|Progressive disease|2|||
129886585|NCT01536145|467545625|FG004|Overall Study|Progressive disease|1|||
129886586|NCT01536145|467545626|FG005|Overall Study|Progressive disease|2|||
129886587|NCT01536145|467545627|FG006|Overall Study|Progressive disease|1|||
129886588|NCT01536145|467545628|FG007|Overall Study|Progressive disease|2|||
129886589|NCT01536145|467545629|FG008|Overall Study|Progressive disease|1|||
129886590|NCT01536145|467545630|FG009|Overall Study|Progressive disease|3|||
129886591|NCT01536145|467545631|FG010|Overall Study|Progressive disease|3|||
129886592|NCT01536145|467545621|FG000|Overall Study|Withdrawal by Subject|0|||
129886593|NCT01536145|467545622|FG001|Overall Study|Withdrawal by Subject|0|||
129437968|NCT00585195|465900450|FG012|Overall Study|Site Terminated by Sponsor|1|||
129437969|NCT00585195|465900451|FG013|Overall Study|Site Terminated by Sponsor|0|||
129437970|NCT00585195|465900452|FG014|Overall Study|Site Terminated by Sponsor|0|||
129437971|NCT00585195|465900453|FG015|Overall Study|Site Terminated by Sponsor|0|||
129437972|NCT00585195|465900454|FG016|Overall Study|Site Terminated by Sponsor|0|||
129437973|NCT00585195|465900455|FG017|Overall Study|Site Terminated by Sponsor|0|||
129437974|NCT00585195|465900456|FG018|Overall Study|Site Terminated by Sponsor|0|||
129437975|NCT00585195|465900457|FG019|Overall Study|Site Terminated by Sponsor|0|||
129437976|NCT00585195|465900458|FG020|Overall Study|Site Terminated by Sponsor|0|||
129437977|NCT00585195|465900438|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
129437978|NCT00585195|465900439|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
129437979|NCT00585195|465900440|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
129437980|NCT00585195|465900441|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
129437981|NCT00585195|465900442|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
129437982|NCT00585195|465900443|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
129437983|NCT00585195|465900444|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
129437984|NCT00585195|465900445|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
129437985|NCT00585195|465900446|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
129437986|NCT00585195|465900447|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
129437987|NCT00585195|465900448|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
129437988|NCT00585195|465900449|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
129437989|NCT00585195|465900450|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
129437990|NCT00585195|465900451|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
129437991|NCT00585195|465900452|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
129790178|NCT00627445|467199729|FG000|Overall Study|Lack of Efficacy|0|||
129790179|NCT00627445|467199730|FG001|Overall Study|Lack of Efficacy|1|||
129790180|NCT00627445|467199729|FG000|Overall Study|Other|6|||
129790181|NCT00627445|467199730|FG001|Overall Study|Other|8|||
129790182|NCT04098224|467199731|FG000|Overall Study|Adverse Event|1|||
129790183|NCT04098224|467199732|FG001|Overall Study|Adverse Event|0|||
129790184|NCT04098224|467199731|FG000|Overall Study|Physician Decision|1|||
129790185|NCT04098224|467199732|FG001|Overall Study|Physician Decision|0|||
129790186|NCT04098224|467199731|FG000|Overall Study|Patient not required enteral feeding|1|||
129790187|NCT04098224|467199732|FG001|Overall Study|Patient not required enteral feeding|0|||
129790188|NCT04098224|467199731|FG000|Overall Study|Patient failure nasogastric tube|1|||
129790189|NCT04098224|467199732|FG001|Overall Study|Patient failure nasogastric tube|0|||
129790190|NCT04098224|467199731|FG000|Overall Study|Patient early extubation|1|||
129790191|NCT04098224|467199732|FG001|Overall Study|Patient early extubation|3|||
129790192|NCT01203852|467199736|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
129790193|NCT01203852|467199736|FG000|Washout 2 Weeks|Physician Decision|46|||
129790194|NCT00247611|467199742|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
129790195|NCT00247611|467199743|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
129790196|NCT00247611|467199742|FG000|Baselined|Completed baseline only|9|||
129790197|NCT00247611|467199743|FG001|Baselined|Completed baseline only|8|||
129790198|NCT02395302|467199753|FG000|Overall Study|Screen Failure|3|||
129790199|NCT02395302|467199753|FG000|Overall Study|Run In Failure|7|||
129790200|NCT02395302|467199753|FG000|Overall Study|Withdrawal by Subject|2|||
129790201|NCT02395302|467199753|FG000|Overall Study|Physician Decision|2|||
129790202|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
129790203|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
129790204|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
129790205|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
129790206|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
129790207|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
129790208|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
129790209|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
129790210|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
129790211|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
129790212|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
129790213|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
129790214|NCT01087788|467199754|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
129790215|NCT01087788|467199755|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
129790216|NCT01087788|467199756|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
129790217|NCT01087788|467199754|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
129790218|NCT01087788|467199755|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
129437992|NCT00585195|465900453|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
129437993|NCT00585195|465900454|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
129437994|NCT00585195|465900455|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
129437995|NCT00585195|465900456|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
129437996|NCT00585195|465900457|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
129437997|NCT00585195|465900458|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
129437998|NCT02796560|465900459|FG000|Overall Study|Adverse Event|2|||
129437999|NCT02796560|465900460|FG001|Overall Study|Adverse Event|0|||
129647536|NCT02407457|466665347|FG000|1 Year|Open Repair|0|||
129438000|NCT02796560|465900459|FG000|Overall Study|Withdrawal by Subject|2|||
129438001|NCT02796560|465900460|FG001|Overall Study|Withdrawal by Subject|2|||
129438002|NCT02533570|465900462|FG000|Overall Study|Adverse Event|0|||
129438003|NCT02533570|465900463|FG001|Overall Study|Adverse Event|1|||
129438004|NCT02533570|465900464|FG002|Overall Study|Adverse Event|1|||
129438005|NCT00423930|465900465|FG000|Overall Study|Withdrawal by Subject|2|||
129438006|NCT04002401|465900466|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
129438007|NCT04002401|465900466|FG000|Overall Study|Death|10|||
129438008|NCT04002401|465900466|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
129438009|NCT04002401|465900466|FG000|Overall Study|Enrolled but Never Treated|1|||
129438010|NCT04002401|465900466|FG000|Overall Study|Lost to Follow-up|1|||
129438011|NCT02656823|465900467|FG000|Overall Study|Adverse Event|3|||
129438012|NCT02656823|465900467|FG000|Overall Study|Lost to Follow-up|2|||
129606415|NCT01946191|466515581|FG001|Allocation|Did not complete orientation|1|||
129606416|NCT01946191|466515580|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
129606417|NCT01946191|466515581|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
129606418|NCT01946191|466515580|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
129606419|NCT01946191|466515581|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
129606420|NCT01946191|466515580|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
129606421|NCT01946191|466515581|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
129606422|NCT04188301|466515582|FG000|Month 3|Lost to Follow-up|0|||
129606423|NCT04188301|466515583|FG001|Month 3|Lost to Follow-up|0|||
129606424|NCT04188301|466515584|FG002|Month 3|Lost to Follow-up|1|||
129606425|NCT04188301|466515582|FG000|Month 12|Lost to Follow-up|0|||
129606426|NCT04188301|466515583|FG001|Month 12|Lost to Follow-up|0|||
129606427|NCT04188301|466515584|FG002|Month 12|Lost to Follow-up|2|||
129606428|NCT04188301|466515582|FG000|Month 12|Death|1|||
129606429|NCT04188301|466515583|FG001|Month 12|Death|1|||
129606430|NCT04188301|466515584|FG002|Month 12|Death|0|||
129606431|NCT04188301|466515582|FG000|Month 18|Lost to Follow-up|6|||
129606432|NCT04188301|466515583|FG001|Month 18|Lost to Follow-up|0|||
129606433|NCT04188301|466515584|FG002|Month 18|Lost to Follow-up|0|||
129606434|NCT01104779|466515587|FG000|Overall Study|Protocol Violation|1|||
129606435|NCT01104779|466515588|FG001|Overall Study|Protocol Violation|2|||
129606436|NCT01104779|466515589|FG002|Overall Study|Protocol Violation|2|||
129606437|NCT01104779|466515587|FG000|Overall Study|Lack of Efficacy|26|||
129606438|NCT01104779|466515588|FG001|Overall Study|Lack of Efficacy|12|||
129606439|NCT01104779|466515589|FG002|Overall Study|Lack of Efficacy|13|||
129606440|NCT01104779|466515587|FG000|Overall Study|Adverse Event|13|||
129606441|NCT01104779|466515588|FG001|Overall Study|Adverse Event|14|||
129606442|NCT01104779|466515589|FG002|Overall Study|Adverse Event|13|||
129606443|NCT01104779|466515587|FG000|Overall Study|Did not meet inc/exc criteria|1|||
129606444|NCT01104779|466515588|FG001|Overall Study|Did not meet inc/exc criteria|1|||
129606445|NCT01104779|466515589|FG002|Overall Study|Did not meet inc/exc criteria|1|||
129606446|NCT01104779|466515587|FG000|Overall Study|Other reasons|0|||
129606447|NCT01104779|466515588|FG001|Overall Study|Other reasons|1|||
129606448|NCT01104779|466515589|FG002|Overall Study|Other reasons|0|||
129606449|NCT01104779|466515587|FG000|Overall Study|Lost to Follow-up|2|||
129606450|NCT01104779|466515588|FG001|Overall Study|Lost to Follow-up|0|||
129606451|NCT01104779|466515589|FG002|Overall Study|Lost to Follow-up|1|||
129606452|NCT01104779|466515587|FG000|Overall Study|Withdrawal by Subject|16|||
129606453|NCT01104779|466515588|FG001|Overall Study|Withdrawal by Subject|25|||
129606454|NCT01104779|466515589|FG002|Overall Study|Withdrawal by Subject|32|||
129606455|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
129606456|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
129606457|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606458|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606459|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606460|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606461|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606462|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606463|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606464|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606465|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606466|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129438013|NCT01009580|465900472|FG000|Overall Study|Adverse Event|4|||
129438014|NCT01009580|465900473|FG001|Overall Study|Adverse Event|4|||
129438015|NCT01009580|465900472|FG000|Overall Study|Lack of Efficacy|0|||
129606467|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606468|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
129606469|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
129606470|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
129698641|NCT04102514|466856806|FG003|Overall Study|Lost to Follow-up|0|||
129438016|NCT01009580|465900473|FG001|Overall Study|Lack of Efficacy|1|||
129438017|NCT01009580|465900472|FG000|Overall Study|Protocol Violation|2|||
129438018|NCT01009580|465900473|FG001|Overall Study|Protocol Violation|3|||
129438019|NCT01009580|465900472|FG000|Overall Study|Withdrawal Criteria|4|||
129438020|NCT01009580|465900473|FG001|Overall Study|Withdrawal Criteria|6|||
129438021|NCT01009580|465900472|FG000|Overall Study|Unclassified|17|||
129438022|NCT01009580|465900473|FG001|Overall Study|Unclassified|21|||
129438023|NCT05269355|465900477|FG000|Overall Study|Progressive Disease|104|||
129438024|NCT05269355|465900478|FG001|Overall Study|Progressive Disease|68|||
129438025|NCT05269355|465900477|FG000|Overall Study|Study Terminated by Sponsor|87|||
129438026|NCT05269355|465900478|FG001|Overall Study|Study Terminated by Sponsor|29|||
129438027|NCT05269355|465900477|FG000|Overall Study|Adverse Event|15|||
129438028|NCT05269355|465900478|FG001|Overall Study|Adverse Event|8|||
129438029|NCT05269355|465900477|FG000|Overall Study|Withdrawal by Subject|18|||
129438030|NCT05269355|465900478|FG001|Overall Study|Withdrawal by Subject|5|||
129438031|NCT05269355|465900477|FG000|Overall Study|Physician Decision|6|||
129438032|NCT05269355|465900478|FG001|Overall Study|Physician Decision|4|||
129438033|NCT05269355|465900477|FG000|Overall Study|Death|3|||
129438034|NCT05269355|465900478|FG001|Overall Study|Death|5|||
129438035|NCT05269355|465900477|FG000|Overall Study|Other Than Specified|5|||
129438036|NCT05269355|465900478|FG001|Overall Study|Other Than Specified|1|||
129438037|NCT05269355|465900477|FG000|Overall Study|Randomized But Not Treated|1|||
129886594|NCT01536145|467545623|FG002|Overall Study|Withdrawal by Subject|1|||
129886595|NCT01536145|467545624|FG003|Overall Study|Withdrawal by Subject|0|||
129886596|NCT01536145|467545625|FG004|Overall Study|Withdrawal by Subject|0|||
129438038|NCT05269355|465900478|FG001|Overall Study|Randomized But Not Treated|0|||
129438039|NCT00081497|465900479|FG000|Overall Study|Adverse Event|2|||
129438040|NCT00081497|465900480|FG001|Overall Study|Adverse Event|0|||
129438041|NCT00081497|465900479|FG000|Overall Study|Death|0|||
129438042|NCT00081497|465900480|FG001|Overall Study|Death|1|||
129438043|NCT00081497|465900479|FG000|Overall Study|Withdrawal by Subject|1|||
129438044|NCT00081497|465900480|FG001|Overall Study|Withdrawal by Subject|0|||
129438045|NCT00081497|465900479|FG000|Overall Study|Non-compliance|0|||
129438046|NCT00081497|465900480|FG001|Overall Study|Non-compliance|1|||
129438047|NCT00959647|465900482|FG000|Overall Study|Adverse Event|2|||
129438048|NCT00959647|465900482|FG000|Overall Study|Progressive disease|6|||
129438049|NCT00959647|465900482|FG000|Overall Study|Study terminated by sponsor|4|||
129438050|NCT00959647|465900482|FG000|Overall Study|Withdrawal by Subject|7|||
129438051|NCT01786174|465902313|FG000|Overall Study|Discontinued Study Drug|2|||
129438052|NCT01786174|465902314|FG001|Overall Study|Discontinued Study Drug|0|||
129438053|NCT01620255|465902315|FG000|Overall Study|Withdrawal by Subject|4|||
129606471|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606472|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606473|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606474|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606475|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606476|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606477|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606478|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606479|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606480|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606481|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606482|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
129606483|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
129606484|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
129606485|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606486|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606487|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606488|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606489|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606490|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606491|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606492|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606493|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606494|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606495|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606496|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
129606497|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
129606498|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
129606499|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129886597|NCT01536145|467545626|FG005|Overall Study|Withdrawal by Subject|1|||
129438054|NCT01620255|465902316|FG001|Overall Study|Withdrawal by Subject|1|||
129438055|NCT01620255|465902317|FG002|Overall Study|Withdrawal by Subject|1|||
129438056|NCT01620255|465902318|FG003|Overall Study|Withdrawal by Subject|2|||
129438057|NCT01620255|465902319|FG004|Overall Study|Withdrawal by Subject|4|||
129438058|NCT01620255|465902315|FG000|Overall Study|Participant underwent fecal transplant|0|||
129438059|NCT01620255|465902316|FG001|Overall Study|Participant underwent fecal transplant|0|||
129438060|NCT01620255|465902317|FG002|Overall Study|Participant underwent fecal transplant|1|||
129438061|NCT01620255|465902318|FG003|Overall Study|Participant underwent fecal transplant|0|||
129438062|NCT01620255|465902319|FG004|Overall Study|Participant underwent fecal transplant|0|||
129438063|NCT01620255|465902315|FG000|Overall Study|Non-compliance|0|||
129438064|NCT01620255|465902316|FG001|Overall Study|Non-compliance|1|||
129438065|NCT01620255|465902317|FG002|Overall Study|Non-compliance|0|||
129438066|NCT01620255|465902318|FG003|Overall Study|Non-compliance|0|||
129438067|NCT01620255|465902319|FG004|Overall Study|Non-compliance|0|||
129438068|NCT01620255|465902315|FG000|Overall Study|Adverse Event|0|||
129438069|NCT01620255|465902316|FG001|Overall Study|Adverse Event|4|||
129438070|NCT01620255|465902317|FG002|Overall Study|Adverse Event|0|||
129438071|NCT01620255|465902318|FG003|Overall Study|Adverse Event|1|||
129438072|NCT01620255|465902319|FG004|Overall Study|Adverse Event|1|||
129438073|NCT01620255|465902315|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
129438074|NCT01620255|465902316|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
129438075|NCT01620255|465902317|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
129438076|NCT01620255|465902318|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
129438077|NCT01620255|465902319|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
129438078|NCT01155375|465902328|FG000|Overall Study|Adverse Event|1|||
129438079|NCT01155375|465902329|FG001|Overall Study|Adverse Event|0|||
129438080|NCT01480674|465902333|FG000|Overall Study|Death|23|||
129438081|NCT01480674|465902333|FG000|Overall Study|Lost to Follow-up|2|||
129438082|NCT01480674|465902333|FG000|Overall Study|visit not done|10|||
129438083|NCT03818204|465902334|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438084|NCT03818204|465902335|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438085|NCT03818204|465902336|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438086|NCT03818204|465902337|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438087|NCT03818204|465902338|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
129438088|NCT03818204|465902339|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438089|NCT03818204|465902340|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438090|NCT03818204|465902341|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438091|NCT03818204|465902342|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438092|NCT03818204|465902343|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438093|NCT03818204|465902344|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438094|NCT03818204|465902345|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438095|NCT03818204|465902346|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438096|NCT03818204|465902347|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
129438097|NCT03818204|465902348|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438098|NCT03818204|465902349|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438099|NCT03818204|465902350|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438100|NCT03818204|465902351|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438101|NCT03818204|465902352|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
129438102|NCT03818204|465902334|FG000|Overall Study|Physician Decision|0|||
129438103|NCT03818204|465902335|FG001|Overall Study|Physician Decision|0|||
129438104|NCT03818204|465902336|FG002|Overall Study|Physician Decision|0|||
129438105|NCT03818204|465902337|FG003|Overall Study|Physician Decision|0|||
129438106|NCT03818204|465902338|FG004|Overall Study|Physician Decision|0|||
129438107|NCT03818204|465902339|FG005|Overall Study|Physician Decision|0|||
129438108|NCT03818204|465902340|FG006|Overall Study|Physician Decision|0|||
129438109|NCT03818204|465902341|FG007|Overall Study|Physician Decision|0|||
129606500|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606501|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606502|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606503|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606504|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606505|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606506|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606507|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606508|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606509|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606510|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
129606511|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
129606512|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
129438110|NCT03818204|465902342|FG008|Overall Study|Physician Decision|0|||
129438111|NCT03818204|465902343|FG009|Overall Study|Physician Decision|0|||
129606513|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606514|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129438112|NCT03818204|465902344|FG010|Overall Study|Physician Decision|0|||
129606515|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606516|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606517|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606518|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606519|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606520|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606521|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606522|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606523|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606524|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
129606525|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
129606526|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
129606527|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606528|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606529|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606530|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606531|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606532|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606533|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606534|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606535|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606536|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606537|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606538|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
129606539|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
129606540|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
129606541|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606542|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606543|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606544|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606545|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606546|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606547|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606548|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606549|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606550|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606551|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606552|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
129606553|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
129606554|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
129606555|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606556|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129438113|NCT03818204|465902345|FG011|Overall Study|Physician Decision|0|||
129438114|NCT03818204|465902346|FG012|Overall Study|Physician Decision|0|||
129438115|NCT03818204|465902347|FG013|Overall Study|Physician Decision|0|||
129438116|NCT03818204|465902348|FG014|Overall Study|Physician Decision|1|||
129438117|NCT03818204|465902349|FG015|Overall Study|Physician Decision|0|||
129438118|NCT03818204|465902350|FG016|Overall Study|Physician Decision|0|||
129438119|NCT03818204|465902351|FG017|Overall Study|Physician Decision|0|||
129438120|NCT03818204|465902352|FG018|Overall Study|Physician Decision|0|||
129438121|NCT00887250|465902353|FG000|Overall Study|Adverse Event|3|||
129438122|NCT00887250|465902354|FG001|Overall Study|Adverse Event|0|||
129438123|NCT00887250|465902355|FG002|Overall Study|Adverse Event|7|||
129438124|NCT00887250|465902353|FG000|Overall Study|Lack of Efficacy|9|||
129438125|NCT00887250|465902354|FG001|Overall Study|Lack of Efficacy|6|||
129438126|NCT00887250|465902355|FG002|Overall Study|Lack of Efficacy|1|||
129438127|NCT00887250|465902353|FG000|Overall Study|Lost to Follow-up|2|||
129438128|NCT00887250|465902354|FG001|Overall Study|Lost to Follow-up|3|||
129438129|NCT00887250|465902355|FG002|Overall Study|Lost to Follow-up|1|||
129438130|NCT00887250|465902353|FG000|Overall Study|Protocol Violation|2|||
129606557|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606558|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606559|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606560|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129698642|NCT04102514|466856803|FG000|Overall Study|Physician Decision|0|||
129698643|NCT04102514|466856804|FG001|Overall Study|Physician Decision|0|||
129438131|NCT00887250|465902354|FG001|Overall Study|Protocol Violation|2|||
129438132|NCT00887250|465902355|FG002|Overall Study|Protocol Violation|1|||
129438133|NCT00887250|465902353|FG000|Overall Study|Withdrawal by Subject|2|||
129438134|NCT00887250|465902354|FG001|Overall Study|Withdrawal by Subject|1|||
129606561|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606562|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606563|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606564|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606565|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606566|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
129606567|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
129606568|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
129606569|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129438135|NCT00887250|465902355|FG002|Overall Study|Withdrawal by Subject|2|||
129438136|NCT00887250|465902353|FG000|Overall Study|Patient uncooperative|0|||
129438137|NCT00887250|465902354|FG001|Overall Study|Patient uncooperative|0|||
129438138|NCT00887250|465902355|FG002|Overall Study|Patient uncooperative|1|||
129438139|NCT01933113|465902356|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
129438140|NCT00879762|465902357|FG000|Overall Study|Lost to Follow-up|3|||
129438141|NCT00879762|465902358|FG001|Overall Study|Lost to Follow-up|1|||
129438142|NCT04981366|465902359|FG000|Overall Study|Withdrawal by Subject|5|||
129438143|NCT04981366|465902360|FG001|Overall Study|Withdrawal by Subject|4|||
129438144|NCT04981366|465902361|FG002|Overall Study|Withdrawal by Subject|8|||
129438145|NCT04981366|465902359|FG000|Overall Study|Health issues unrelated to the trial|1|||
129438146|NCT04981366|465902360|FG001|Overall Study|Health issues unrelated to the trial|2|||
129438147|NCT04981366|465902361|FG002|Overall Study|Health issues unrelated to the trial|0|||
129438148|NCT00881608|465902362|FG000|Overall Study|Study prematurely terminated|11|||
129438149|NCT03214094|465902363|FG000|Overall Study|Case Report Forms Uncollected|14|||
129438150|NCT03214094|465902363|FG000|Overall Study|Protocol Deviation|46|||
129438151|NCT00795951|465902369|FG000|Overall Study|Lost to Follow-up|1|||
129606570|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606571|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606572|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606573|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606574|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606575|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606576|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606577|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606578|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606579|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606580|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
129606581|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
129606582|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
129606583|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606584|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129438152|NCT00795951|465902369|FG000|Overall Study|Withdrawal by Subject|1|||
129438153|NCT00655486|465902375|FG000|Overall Study|Adverse Event|10|||
129438154|NCT00655486|465902375|FG000|Overall Study|Lack of Efficacy|8|||
129438155|NCT00655486|465902375|FG000|Overall Study|Withdrawal by Subject|4|||
129438156|NCT00655486|465902375|FG000|Overall Study|Protocol Violation|1|||
129438157|NCT00655486|465902375|FG000|Overall Study|Unsatisfactory compliance|2|||
129438158|NCT00655486|465902375|FG000|Overall Study|Other: Pregnancy|1|||
129438159|NCT00655486|465902375|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
129438160|NCT00655486|465902375|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
129438161|NCT02768870|465902386|FG000|Overall Study|Death|1|||
129438162|NCT02768870|465902386|FG000|Overall Study|Reoperation|6|||
129438163|NCT02768870|465902386|FG000|Overall Study|Lost to Follow-up|1|||
129438164|NCT02768870|465902386|FG000|Overall Study|Exit|4|||
129438165|NCT03401229|465902387|FG000|Overall Study|Lost to Follow-up|2|||
129438166|NCT03401229|465902388|FG001|Overall Study|Lost to Follow-up|1|||
129438167|NCT03401229|465902387|FG000|Overall Study|Other|1|||
129438168|NCT03401229|465902388|FG001|Overall Study|Other|3|||
129438169|NCT03401229|465902387|FG000|Overall Study|Adverse Event|8|||
129438170|NCT03401229|465902388|FG001|Overall Study|Adverse Event|6|||
129438171|NCT03401229|465902387|FG000|Overall Study|Withdrawal by Subject|29|||
129438172|NCT03401229|465902388|FG001|Overall Study|Withdrawal by Subject|26|||
129438173|NCT03401229|465902387|FG000|Overall Study|COVID-19|0|||
129438174|NCT03401229|465902388|FG001|Overall Study|COVID-19|1|||
129438175|NCT01122862|465902389|FG000|Period 1|Protocol Violation|0|||
129438176|NCT01122862|465902390|FG001|Period 1|Protocol Violation|1|||
129698644|NCT04102514|466856805|FG002|Overall Study|Physician Decision|1|||
129698645|NCT04102514|466856806|FG003|Overall Study|Physician Decision|0|||
129438177|NCT01122862|465902391|FG002|Period 1|Protocol Violation|0|||
129438178|NCT01122862|465902389|FG000|Period 2|Adverse Event|0|||
129438179|NCT01122862|465902390|FG001|Period 2|Adverse Event|0|||
129438180|NCT01122862|465902391|FG002|Period 2|Adverse Event|1|||
129606585|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606586|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129698646|NCT04102514|466856803|FG000|Overall Study|Withdrawal by Subject|7|||
129698647|NCT04102514|466856804|FG001|Overall Study|Withdrawal by Subject|13|||
129698648|NCT04102514|466856805|FG002|Overall Study|Withdrawal by Subject|7|||
129698649|NCT04102514|466856806|FG003|Overall Study|Withdrawal by Subject|14|||
129698650|NCT04102514|466856803|FG000|Overall Study|Moved to longterm care facility|6|||
129698651|NCT04102514|466856804|FG001|Overall Study|Moved to longterm care facility|0|||
129698652|NCT04102514|466856805|FG002|Overall Study|Moved to longterm care facility|4|||
129606587|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606588|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606589|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606590|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606591|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606592|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606593|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606594|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
129606595|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
129606596|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
129606597|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606598|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606599|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606600|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606601|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606602|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606603|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606604|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606605|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129698653|NCT04102514|466856806|FG003|Overall Study|Moved to longterm care facility|0|||
129698654|NCT01689649|466856807|FG000|Overall Study|Lack of Efficacy|3|||
129698655|NCT01689649|466856807|FG000|Overall Study|Non-compliance|11|||
129698656|NCT01689649|466856807|FG000|Overall Study|Protocol Violation|3|||
129698657|NCT01689649|466856807|FG000|Overall Study|Lost to Follow-up|5|||
129698658|NCT00835549|466856808|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
129698659|NCT00835549|466856809|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129698660|NCT00835042|466856810|FG000|First Intervention|Withdrawal by Subject|3|||
129698661|NCT00835042|466856811|FG001|First Intervention|Withdrawal by Subject|0|||
129886598|NCT01536145|467545627|FG006|Overall Study|Withdrawal by Subject|0|||
129886599|NCT01536145|467545628|FG007|Overall Study|Withdrawal by Subject|0|||
129886600|NCT01536145|467545629|FG008|Overall Study|Withdrawal by Subject|2|||
129886601|NCT01536145|467545630|FG009|Overall Study|Withdrawal by Subject|0|||
129886602|NCT01536145|467545631|FG010|Overall Study|Withdrawal by Subject|2|||
129886603|NCT01536145|467545621|FG000|Overall Study|Other|0|||
129886604|NCT01536145|467545622|FG001|Overall Study|Other|0|||
129886605|NCT01536145|467545623|FG002|Overall Study|Other|0|||
129886606|NCT01536145|467545624|FG003|Overall Study|Other|0|||
129886607|NCT01536145|467545625|FG004|Overall Study|Other|1|||
129886608|NCT01536145|467545626|FG005|Overall Study|Other|0|||
129886609|NCT01536145|467545627|FG006|Overall Study|Other|0|||
129886610|NCT01536145|467545628|FG007|Overall Study|Other|0|||
129886611|NCT01536145|467545629|FG008|Overall Study|Other|0|||
129886612|NCT01536145|467545630|FG009|Overall Study|Other|3|||
129886613|NCT01536145|467545631|FG010|Overall Study|Other|2|||
129886614|NCT01536145|467545621|FG000|Overall Study|Death|0|||
129886615|NCT01536145|467545622|FG001|Overall Study|Death|0|||
129886616|NCT01536145|467545623|FG002|Overall Study|Death|0|||
129886617|NCT01536145|467545624|FG003|Overall Study|Death|0|||
129886618|NCT01536145|467545625|FG004|Overall Study|Death|0|||
129886619|NCT01536145|467545626|FG005|Overall Study|Death|0|||
129886620|NCT01536145|467545627|FG006|Overall Study|Death|1|||
129886621|NCT01536145|467545628|FG007|Overall Study|Death|0|||
129606606|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606607|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129606608|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
129698662|NCT00835042|466856810|FG000|First Intervention|Adverse Event|1|||
129886622|NCT01536145|467545629|FG008|Overall Study|Death|0|||
129886623|NCT01536145|467545630|FG009|Overall Study|Death|0|||
129886624|NCT01536145|467545631|FG010|Overall Study|Death|0|||
129886625|NCT01536145|467545621|FG000|Overall Study|Adverse Event|0|||
129698663|NCT00835042|466856811|FG001|First Intervention|Adverse Event|2|||
129698664|NCT00835042|466856810|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
129698665|NCT00835042|466856811|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
129886626|NCT01536145|467545622|FG001|Overall Study|Adverse Event|0|||
129886627|NCT01536145|467545623|FG002|Overall Study|Adverse Event|0|||
129886628|NCT01536145|467545624|FG003|Overall Study|Adverse Event|0|||
129886629|NCT01536145|467545625|FG004|Overall Study|Adverse Event|0|||
129886630|NCT01536145|467545626|FG005|Overall Study|Adverse Event|0|||
129438181|NCT02699983|465902392|FG000|Overall Study|Withdrawal by Subject|1|||
129438182|NCT02699983|465902393|FG001|Overall Study|Withdrawal by Subject|0|||
129438183|NCT01259726|465902394|FG000|Overall Study|Death|1|||
129438184|NCT01259726|465902395|FG001|Overall Study|Death|0|||
129438185|NCT01259726|465902396|FG002|Overall Study|Death|0|||
129606609|NCT03982199|466515590|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
129606610|NCT03982199|466515591|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
129606611|NCT03982199|466515592|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606612|NCT03982199|466515593|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606613|NCT03982199|466515594|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606614|NCT03982199|466515595|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606615|NCT03982199|466515596|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606616|NCT03982199|466515597|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606617|NCT03982199|466515598|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606618|NCT03982199|466515599|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606619|NCT03982199|466515600|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606620|NCT03982199|466515601|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606621|NCT03982199|466515602|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606622|NCT03982199|466515603|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
129606623|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606624|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606625|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606626|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
129606627|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606628|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606629|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606630|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606631|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606632|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606633|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606634|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606635|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606636|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
129606637|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606638|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606639|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
129606640|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606641|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606642|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606643|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606644|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606645|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606646|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606647|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606648|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606649|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606650|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
129606651|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606652|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606653|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
129606654|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606655|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606656|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606657|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606658|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606659|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606660|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606661|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606662|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606663|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129438186|NCT01259726|465902397|FG003|Overall Study|Death|0|||
129438187|NCT01259726|465902394|FG000|Overall Study|Physician Decision|2|||
129438188|NCT01259726|465902395|FG001|Overall Study|Physician Decision|0|||
129438189|NCT01259726|465902396|FG002|Overall Study|Physician Decision|1|||
129438190|NCT01259726|465902397|FG003|Overall Study|Physician Decision|1|||
129606664|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
129606665|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606666|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606667|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
129606668|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
129647537|NCT02407457|466665348|FG001|1 Year|Open Repair|1|||
129886631|NCT01536145|467545627|FG006|Overall Study|Adverse Event|0|||
129886632|NCT01536145|467545628|FG007|Overall Study|Adverse Event|2|||
129886633|NCT01536145|467545629|FG008|Overall Study|Adverse Event|0|||
129886634|NCT01536145|467545630|FG009|Overall Study|Adverse Event|0|||
129886635|NCT01536145|467545631|FG010|Overall Study|Adverse Event|3|||
129886636|NCT01284140|467545634|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
129886637|NCT01284140|467545635|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
129886638|NCT01284140|467545634|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
129886639|NCT01284140|467545635|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
129886640|NCT00088205|467545636|FG000|Overall Study|Adverse Event|4|||
129886641|NCT00088205|467545636|FG000|Overall Study|Progressive Disease|51|||
129886642|NCT00088205|467545636|FG000|Overall Study|Physician Decision|1|||
129886643|NCT00088205|467545636|FG000|Overall Study|Death Due to Study Disease|4|||
129886644|NCT03192215|467545637|FG000|Overall Study|Death|28|||
129886645|NCT03192215|467545638|FG001|Overall Study|Death|23|||
129886646|NCT03192215|467545637|FG000|Overall Study|Lost to Follow-up|10|||
129886647|NCT03192215|467545638|FG001|Overall Study|Lost to Follow-up|15|||
129886648|NCT03192215|467545637|FG000|Overall Study|Withdrawal by Subject|49|||
129886649|NCT03192215|467545638|FG001|Overall Study|Withdrawal by Subject|48|||
129886650|NCT03192215|467545637|FG000|Overall Study|Other as reported in analysis|4|||
129886651|NCT03192215|467545638|FG001|Overall Study|Other as reported in analysis|1|||
129886652|NCT05199233|467545641|FG000|Overall Study|Lack of Efficacy|1|||
129886653|NCT02443103|467545648|FG000|Overall Study|Adverse Event|2|||
129886654|NCT02443103|467545648|FG000|Overall Study|Noncompliance|1|||
129886655|NCT01630590|467545649|FG000|Overall Study|Adverse Event|9|||
129886656|NCT01630590|467545649|FG000|Overall Study|Lack of Efficacy|37|||
129886657|NCT01630590|467545649|FG000|Overall Study|Withdrawal by Subject|4|||
129886658|NCT01630590|467545649|FG000|Overall Study|2nd primary tumor|2|||
129886659|NCT01630590|467545649|FG000|Overall Study|Automobile accident|1|||
129886660|NCT01630590|467545649|FG000|Overall Study|Maximum benefit|4|||
129886661|NCT02366936|467545650|FG000|Overall Study|Withdrawal by Subject|2|||
129886662|NCT02366936|467545650|FG000|Overall Study|Lost to Follow-up|4|||
129886663|NCT02366936|467545650|FG000|Overall Study|Physician Decision|2|||
129886664|NCT03358329|467545653|FG000|Overall Study|Lost to Follow-up|2|||
129886665|NCT03358329|467545653|FG000|Overall Study|Withdrawal by Subject|2|||
129886666|NCT02982720|467545654|FG000|Overall Study|Adverse Event|3|||
129886667|NCT02982720|467545654|FG000|Overall Study|Death|1|||
129886668|NCT00750893|467545657|FG000|Overall Study|Adverse Event|5|||
129886669|NCT00750893|467545657|FG000|Overall Study|Withdrawal by Subject|10|||
129886670|NCT00750893|467545657|FG000|Overall Study|Lost to Follow-up|510|||
129886671|NCT00750893|467545657|FG000|Overall Study|Other|17|||
129886672|NCT02420327|467545658|FG000|Overall Study|Adverse Event|7|||
129886673|NCT02420327|467545658|FG000|Overall Study|Pregnancy|1|||
129886674|NCT02420327|467545658|FG000|Overall Study|Withdrawal by Subject|6|||
129886675|NCT02420327|467545658|FG000|Overall Study|Lost to Follow-up|1|||
129886676|NCT02420327|467545658|FG000|Overall Study|Protocol Violation|1|||
129886677|NCT02589392|467545660|FG000|Overall Study|Adverse Event|1|||
129886678|NCT02589392|467545661|FG001|Overall Study|Adverse Event|1|||
129886679|NCT02589392|467545660|FG000|Overall Study|Withdrawal by Subject|1|||
129886680|NCT02589392|467545661|FG001|Overall Study|Withdrawal by Subject|2|||
129886681|NCT02589392|467545660|FG000|Overall Study|Protocol Violation|1|||
129886682|NCT02589392|467545661|FG001|Overall Study|Protocol Violation|1|||
129886683|NCT02589392|467545660|FG000|Overall Study|Lost to Follow-up|2|||
129886684|NCT02589392|467545661|FG001|Overall Study|Lost to Follow-up|2|||
129886685|NCT02589392|467545660|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
129886686|NCT02589392|467545661|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
129886687|NCT00393094|467545666|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
129886688|NCT00393094|467545666|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
129886689|NCT04230980|467545667|FG000|Overall Study|Lost to Follow-up|1|||
129886690|NCT04230980|467545668|FG001|Overall Study|Lost to Follow-up|2|||
129886691|NCT04230980|467545667|FG000|Overall Study|Adverse Event|0|||
129886692|NCT04230980|467545668|FG001|Overall Study|Adverse Event|1|||
129886693|NCT03523871|467545669|FG000|Overall Study|Death|1|||
129886694|NCT01994720|467545670|FG000|Overall Study|Withdrawal by Subject|46|||
129886695|NCT01994720|467545671|FG001|Overall Study|Withdrawal by Subject|56|||
129886696|NCT04285229|467545675|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129886697|NCT04285229|467545676|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129886698|NCT04285229|467545677|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129886699|NCT04285229|467545678|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129698666|NCT00619918|466856812|FG000|Overall Study|Withdrawal by Subject|4|||
129438191|NCT01259726|465902394|FG000|Overall Study|Withdrawal by Subject|1|||
129438192|NCT01259726|465902395|FG001|Overall Study|Withdrawal by Subject|3|||
129438193|NCT01259726|465902396|FG002|Overall Study|Withdrawal by Subject|2|||
129438194|NCT01259726|465902397|FG003|Overall Study|Withdrawal by Subject|1|||
129438195|NCT01259726|465902394|FG000|Overall Study|Lost to Follow-up|1|||
129438196|NCT01259726|465902395|FG001|Overall Study|Lost to Follow-up|1|||
129438197|NCT01259726|465902396|FG002|Overall Study|Lost to Follow-up|1|||
129438198|NCT01259726|465902397|FG003|Overall Study|Lost to Follow-up|3|||
129438199|NCT01790126|465902403|FG000|Overall Study|PSA Progression|12|||
129438200|NCT01790126|465902404|FG001|Overall Study|PSA Progression|16|||
129438201|NCT01790126|465902405|FG002|Overall Study|PSA Progression|16|||
129438202|NCT01790126|465902403|FG000|Overall Study|Other|5|||
129438203|NCT01790126|465902404|FG001|Overall Study|Other|4|||
129438204|NCT01790126|465902405|FG002|Overall Study|Other|8|||
129438205|NCT01790126|465902403|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
129438206|NCT01790126|465902404|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
129438207|NCT01790126|465902405|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
129438208|NCT01790126|465902403|FG000|Overall Study|Withdrawal by Physician|1|||
129438209|NCT01790126|465902404|FG001|Overall Study|Withdrawal by Physician|1|||
129438210|NCT01790126|465902405|FG002|Overall Study|Withdrawal by Physician|2|||
129438211|NCT01790126|465902403|FG000|Overall Study|Withdrawal by Subject|3|||
129438212|NCT01790126|465902404|FG001|Overall Study|Withdrawal by Subject|1|||
129438213|NCT01790126|465902405|FG002|Overall Study|Withdrawal by Subject|2|||
129438214|NCT01790126|465902403|FG000|Overall Study|Lost to Follow-up|1|||
129438215|NCT01790126|465902404|FG001|Overall Study|Lost to Follow-up|0|||
129438216|NCT01790126|465902405|FG002|Overall Study|Lost to Follow-up|1|||
129438217|NCT01790126|465902403|FG000|Overall Study|Adverse Event|0|||
129438218|NCT01790126|465902404|FG001|Overall Study|Adverse Event|2|||
129438219|NCT01790126|465902405|FG002|Overall Study|Adverse Event|0|||
129438220|NCT01790126|465902403|FG000|Overall Study|Death|2|||
129438221|NCT01790126|465902404|FG001|Overall Study|Death|0|||
129438222|NCT01790126|465902405|FG002|Overall Study|Death|0|||
129438223|NCT01790126|465902403|FG000|Overall Study|Radiographic Progression|3|||
129438224|NCT01790126|465902404|FG001|Overall Study|Radiographic Progression|1|||
129698667|NCT00619918|466856813|FG001|Overall Study|Withdrawal by Subject|3|||
129698668|NCT00619918|466856812|FG000|Overall Study|Physician Decision|2|||
129698669|NCT00619918|466856813|FG001|Overall Study|Physician Decision|4|||
129698670|NCT00619918|466856812|FG000|Overall Study|Transfer to outside facility|3|||
129698671|NCT00619918|466856813|FG001|Overall Study|Transfer to outside facility|3|||
129698672|NCT00619918|466856812|FG000|Overall Study|Left before receiving first dose|7|||
129698673|NCT00619918|466856813|FG001|Overall Study|Left before receiving first dose|6|||
129698674|NCT00619918|466856812|FG000|Overall Study|ICU admission|4|||
129698675|NCT00619918|466856813|FG001|Overall Study|ICU admission|6|||
129698676|NCT05524948|466856841|FG000|Overall Study|Withdrawal by Subject|1|||
129438225|NCT01790126|465902405|FG002|Overall Study|Radiographic Progression|0|||
129438226|NCT01128738|465902406|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
129438227|NCT01128738|465902407|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
129438228|NCT01128738|465902406|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
129438229|NCT01128738|465902407|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
129438230|NCT01128738|465902406|FG000|Second TP|Lost to Follow-up|0|||
129438231|NCT01128738|465902407|FG001|Second TP|Lost to Follow-up|1|||
129438232|NCT01128738|465902406|FG000|Second TP|Withdrawal by Subject|0|||
129438233|NCT01128738|465902407|FG001|Second TP|Withdrawal by Subject|2|||
129438234|NCT01178671|465902408|FG000|Overall Study|Adverse Event|4|||
129438235|NCT01178671|465902409|FG001|Overall Study|Adverse Event|6|||
129438236|NCT01178671|465902408|FG000|Overall Study|Protocol Violation|1|||
129438237|NCT01178671|465902409|FG001|Overall Study|Protocol Violation|1|||
129438238|NCT01178671|465902408|FG000|Overall Study|Lack of Efficacy|0|||
129438239|NCT01178671|465902409|FG001|Overall Study|Lack of Efficacy|1|||
129438240|NCT01178671|465902408|FG000|Overall Study|Lost to Follow-up|3|||
129438241|NCT01178671|465902409|FG001|Overall Study|Lost to Follow-up|1|||
129438242|NCT01178671|465902408|FG000|Overall Study|Physician Decision|4|||
129438243|NCT01178671|465902409|FG001|Overall Study|Physician Decision|6|||
129438244|NCT02435966|465902410|FG000|Overall Study|Withdrawal by Subject|0|||
129438245|NCT02435966|465902411|FG001|Overall Study|Withdrawal by Subject|1|||
129698677|NCT05524948|466856842|FG001|Overall Study|Withdrawal by Subject|0|||
129698678|NCT05524948|466856841|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
129698679|NCT05524948|466856842|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
129438246|NCT02435966|465902412|FG002|Overall Study|Withdrawal by Subject|0|||
129438247|NCT01211197|465902415|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129438248|NCT01211197|465902416|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129438249|NCT01211197|465902417|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129438250|NCT01211197|465902418|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129438251|NCT01211197|465902419|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129438252|NCT01211197|465902420|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129606669|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606670|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606671|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129698680|NCT00595075|466856845|FG000|Overall Study|Withdrawal by Subject|1|||
129698681|NCT00595075|466856846|FG001|Overall Study|Withdrawal by Subject|0|||
129886700|NCT04285229|467545679|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129886701|NCT04285229|467545680|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129606672|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606673|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606674|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606675|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606676|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606677|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606678|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
129606679|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606680|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606681|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606682|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
129606683|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606684|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606685|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606686|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606687|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606688|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606689|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606690|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606691|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606692|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
129606693|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606694|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606695|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
129606696|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
129606697|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606698|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606699|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606700|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606701|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606702|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606703|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606704|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606705|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606706|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
129606707|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606708|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606709|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606710|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606711|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606712|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606713|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129886702|NCT04285229|467545675|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
129886703|NCT04285229|467545676|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
129886704|NCT04285229|467545677|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
129886705|NCT04285229|467545678|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
129886706|NCT04285229|467545679|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
129886707|NCT04285229|467545680|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
129886708|NCT04285229|467545675|FG000|Extended Treatment Period|Adverse Event|0|||
129886709|NCT04285229|467545676|FG001|Extended Treatment Period|Adverse Event|0|||
129886710|NCT04285229|467545677|FG002|Extended Treatment Period|Adverse Event|0|||
129886711|NCT04285229|467545678|FG003|Extended Treatment Period|Adverse Event|1|||
129886712|NCT04285229|467545679|FG004|Extended Treatment Period|Adverse Event|0|||
129886713|NCT04285229|467545680|FG005|Extended Treatment Period|Adverse Event|0|||
129886714|NCT04285229|467545675|FG000|Extended Treatment Period|Physician Decision|0|||
129886715|NCT04285229|467545676|FG001|Extended Treatment Period|Physician Decision|0|||
129886716|NCT04285229|467545677|FG002|Extended Treatment Period|Physician Decision|1|||
129886717|NCT04285229|467545678|FG003|Extended Treatment Period|Physician Decision|0|||
129886718|NCT04285229|467545679|FG004|Extended Treatment Period|Physician Decision|0|||
129438253|NCT01211197|465902415|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
129438254|NCT01211197|465902416|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
129438255|NCT01211197|465902417|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
129438256|NCT01211197|465902418|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
129438257|NCT01211197|465902419|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
129438258|NCT01211197|465902420|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
129438259|NCT01054846|465902421|FG000|Overall Study|Lost to Follow-up|76|||
129438260|NCT01054846|465902422|FG001|Overall Study|Lost to Follow-up|17|||
129438261|NCT02446886|465902423|FG000|Overall Study|Adverse Event|1|||
129438262|NCT02446886|465902424|FG001|Overall Study|Adverse Event|3|||
129438263|NCT02446886|465902423|FG000|Overall Study|Withdrawal by Subject|1|||
129438264|NCT02446886|465902424|FG001|Overall Study|Withdrawal by Subject|1|||
129438265|NCT00928447|465902425|FG000|Overall Study|Withdrawal by Subject|1|||
129438266|NCT00928447|465902425|FG000|Overall Study|Investigator's decision|1|||
129438267|NCT01259284|465902426|FG000|Overall Study|Study Termination|2|||
129438268|NCT01259284|465902427|FG001|Overall Study|Study Termination|0|||
129438269|NCT01259284|465902428|FG002|Overall Study|Study Termination|0|||
129438270|NCT01971203|465902429|FG000|Overall Study|Protocol Violation|3|||
129438271|NCT01971203|465902430|FG001|Overall Study|Protocol Violation|2|||
129438272|NCT01971203|465902429|FG000|Overall Study|Withdrawal by Subject|5|||
129438273|NCT01971203|465902430|FG001|Overall Study|Withdrawal by Subject|6|||
129438274|NCT01971203|465902429|FG000|Overall Study|Adverse Event|1|||
129438275|NCT01971203|465902430|FG001|Overall Study|Adverse Event|0|||
129438276|NCT00807235|465902431|FG000|Overall Study|Adverse Event|1|||
129438277|NCT00807235|465902432|FG001|Overall Study|Adverse Event|0|||
129438278|NCT01765179|465902433|FG000|Overall Study|Adverse Event|3|||
129438279|NCT01765179|465902433|FG000|Overall Study|Lost to Follow-up|5|||
129438280|NCT01765179|465902433|FG000|Overall Study|Non-compliance with study drug|2|||
129438281|NCT01765179|465902433|FG000|Overall Study|Protocol Violation|1|||
129438282|NCT01765179|465902433|FG000|Overall Study|Withdrawal by Subject|8|||
129438283|NCT01765179|465902433|FG000|Overall Study|Hematocrit >54%|3|||
129438284|NCT01765179|465902433|FG000|Overall Study|prohibited med|1|||
129438285|NCT01765179|465902433|FG000|Overall Study|Out of country unable to finish study|1|||
129438286|NCT01765179|465902433|FG000|Overall Study|lack of venous access|1|||
129438287|NCT01765179|465902433|FG000|Overall Study|work conflict|1|||
129438288|NCT01765179|465902433|FG000|Overall Study|Ca elevated 10.6|1|||
129438289|NCT02988622|465902434|FG000|Overall Study|Lost to Follow-up|17|||
129438290|NCT00178126|465902435|FG000|Overall Study|Lost to Follow-up|21|||
129438291|NCT00178126|465902436|FG001|Overall Study|Lost to Follow-up|21|||
129438292|NCT00178126|465902435|FG000|Overall Study|did not receive intervention|4|||
129438293|NCT00178126|465902436|FG001|Overall Study|did not receive intervention|6|||
129438294|NCT03562247|465902440|FG000|Overall Study|Lost to Follow-up|3|||
129606714|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606715|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
129606716|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606717|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606718|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606719|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606720|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
129606721|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606722|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606723|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606724|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606725|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606726|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606727|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606728|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606729|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
129606730|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606731|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606732|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606733|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129606734|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
129438295|NCT03562247|465902441|FG001|Overall Study|Lost to Follow-up|1|||
129438296|NCT03562247|465902442|FG002|Overall Study|Lost to Follow-up|1|||
129438297|NCT01204398|465902443|FG000|Overall Study|Adverse Event|1|||
129438298|NCT00983931|465902444|FG000|14 Day Washout Period|Physician Decision|1|||
129438299|NCT01281969|465902447|FG000|Overall Study|not randomized didn't meet criteria|0|||
129438300|NCT01281969|465902448|FG001|Overall Study|not randomized didn't meet criteria|0|||
129438301|NCT01281969|465902449|FG002|Overall Study|not randomized didn't meet criteria|7|||
129438302|NCT01281969|465902447|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
129438303|NCT01281969|465902448|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
129606735|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606736|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606737|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606738|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606739|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606740|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129886719|NCT04285229|467545680|FG005|Extended Treatment Period|Physician Decision|0|||
129886720|NCT04285229|467545675|FG000|Follow-up Period|Adverse Event|0|||
129886721|NCT04285229|467545676|FG001|Follow-up Period|Adverse Event|0|||
129886722|NCT04285229|467545677|FG002|Follow-up Period|Adverse Event|0|||
129886723|NCT04285229|467545678|FG003|Follow-up Period|Adverse Event|0|||
129886724|NCT04285229|467545679|FG004|Follow-up Period|Adverse Event|1|||
129886725|NCT04285229|467545680|FG005|Follow-up Period|Adverse Event|4|||
129886726|NCT04285229|467545675|FG000|Follow-up Period|Withdrawal by Subject|0|||
129886727|NCT04285229|467545676|FG001|Follow-up Period|Withdrawal by Subject|0|||
129886728|NCT04285229|467545677|FG002|Follow-up Period|Withdrawal by Subject|0|||
129886729|NCT04285229|467545678|FG003|Follow-up Period|Withdrawal by Subject|0|||
129886730|NCT04285229|467545679|FG004|Follow-up Period|Withdrawal by Subject|0|||
129886731|NCT04285229|467545680|FG005|Follow-up Period|Withdrawal by Subject|5|||
129886732|NCT04285229|467545675|FG000|Follow-up Period|Covid-19|0|||
129886733|NCT04285229|467545676|FG001|Follow-up Period|Covid-19|0|||
129886734|NCT04285229|467545677|FG002|Follow-up Period|Covid-19|0|||
129886735|NCT04285229|467545678|FG003|Follow-up Period|Covid-19|0|||
129886736|NCT04285229|467545679|FG004|Follow-up Period|Covid-19|0|||
129886737|NCT04285229|467545680|FG005|Follow-up Period|Covid-19|2|||
129886738|NCT04285229|467545675|FG000|Follow-up Period|Physician Decision|0|||
129886739|NCT04285229|467545676|FG001|Follow-up Period|Physician Decision|0|||
129886740|NCT04285229|467545677|FG002|Follow-up Period|Physician Decision|0|||
129886741|NCT04285229|467545678|FG003|Follow-up Period|Physician Decision|0|||
129886742|NCT04285229|467545679|FG004|Follow-up Period|Physician Decision|0|||
129886743|NCT04285229|467545680|FG005|Follow-up Period|Physician Decision|1|||
129886744|NCT03257995|467545681|FG000|Overall Study|Adverse Event|0|||
129886745|NCT03257995|467545682|FG001|Overall Study|Adverse Event|1|||
129886746|NCT03257995|467545683|FG002|Overall Study|Adverse Event|0|||
129886747|NCT03257995|467545684|FG003|Overall Study|Adverse Event|0|||
129886748|NCT03257995|467545685|FG004|Overall Study|Adverse Event|0|||
129886749|NCT03257995|467545686|FG005|Overall Study|Adverse Event|0|||
129886750|NCT03257995|467545681|FG000|Overall Study|Protocol deviation|0|||
129886751|NCT03257995|467545682|FG001|Overall Study|Protocol deviation|0|||
129886752|NCT03257995|467545683|FG002|Overall Study|Protocol deviation|0|||
129886753|NCT03257995|467545684|FG003|Overall Study|Protocol deviation|0|||
129886754|NCT03257995|467545685|FG004|Overall Study|Protocol deviation|0|||
129886755|NCT03257995|467545686|FG005|Overall Study|Protocol deviation|2|||
129886756|NCT01556763|467545690|FG000|Overall Study|Withdrawal by Subject|0|||
129886757|NCT01556763|467545691|FG001|Overall Study|Withdrawal by Subject|1|||
129886758|NCT01556763|467545692|FG002|Overall Study|Withdrawal by Subject|0|||
129886759|NCT02258464|467545693|FG000|Overall Study|Progressive disease (PD)|9|||
129886760|NCT02258464|467545694|FG001|Overall Study|Progressive disease (PD)|17|||
129886761|NCT02258464|467545693|FG000|Overall Study|Study drug never administered|1|||
129886762|NCT02258464|467545694|FG001|Overall Study|Study drug never administered|1|||
129886763|NCT02258464|467545693|FG000|Overall Study|AE not related to clinical PD|1|||
129886764|NCT02258464|467545694|FG001|Overall Study|AE not related to clinical PD|3|||
129886765|NCT02258464|467545693|FG000|Overall Study|Withdrawal by Subject|5|||
129886766|NCT02258464|467545694|FG001|Overall Study|Withdrawal by Subject|4|||
129886767|NCT02258464|467545693|FG000|Overall Study|AE related to clinical PD|1|||
129886768|NCT02258464|467545694|FG001|Overall Study|AE related to clinical PD|0|||
129886769|NCT02138747|467545695|FG000|Treatment Period 1|Adverse Event|10|||
129886770|NCT02138747|467545696|FG001|Treatment Period 1|Adverse Event|14|||
129886771|NCT02138747|467545697|FG002|Treatment Period 1|Adverse Event|2|||
129886772|NCT02138747|467545698|FG003|Treatment Period 1|Adverse Event|1|||
129886773|NCT02138747|467545695|FG000|Treatment Period 1|Lost to Follow-up|0|||
129886774|NCT02138747|467545696|FG001|Treatment Period 1|Lost to Follow-up|1|||
129886775|NCT02138747|467545697|FG002|Treatment Period 1|Lost to Follow-up|1|||
129886776|NCT02138747|467545698|FG003|Treatment Period 1|Lost to Follow-up|0|||
129886777|NCT02138747|467545695|FG000|Treatment Period 1|Protocol Violation|0|||
129886778|NCT02138747|467545696|FG001|Treatment Period 1|Protocol Violation|2|||
129886779|NCT02138747|467545697|FG002|Treatment Period 1|Protocol Violation|0|||
129886780|NCT02138747|467545698|FG003|Treatment Period 1|Protocol Violation|0|||
129886781|NCT02138747|467545695|FG000|Treatment Period 1|Withdrawal by Subject|8|||
129886782|NCT02138747|467545696|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129886783|NCT02138747|467545697|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129886784|NCT02138747|467545698|FG003|Treatment Period 1|Withdrawal by Subject|3|||
129886785|NCT02138747|467545695|FG000|Treatment Period 1|Other - Miscellaneous|2|||
129886786|NCT02138747|467545696|FG001|Treatment Period 1|Other - Miscellaneous|4|||
129886787|NCT02138747|467545697|FG002|Treatment Period 1|Other - Miscellaneous|0|||
129886788|NCT02138747|467545698|FG003|Treatment Period 1|Other - Miscellaneous|0|||
129438304|NCT01281969|465902449|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
129438305|NCT01281969|465902447|FG000|Overall Study|not randomized, child consent not given|0|||
129438306|NCT01281969|465902448|FG001|Overall Study|not randomized, child consent not given|0|||
129438307|NCT01281969|465902449|FG002|Overall Study|not randomized, child consent not given|2|||
129438308|NCT01201265|465902454|FG000|Overall Study|Death|14|||
129438309|NCT01201265|465902454|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129438310|NCT01201265|465902454|FG000|Overall Study|Lost to Follow-up|10|||
129438311|NCT01201265|465902454|FG000|Overall Study|Withdrawal by Subject|7|||
129438312|NCT01201265|465902454|FG000|Overall Study|Disease Progression|4|||
129438313|NCT04640077|465902455|FG000|Period 1|Withdrawal by Subject|4|||
129438314|NCT04640077|465902456|FG001|Period 1|Withdrawal by Subject|5|||
129438315|NCT04640077|465902457|FG002|Period 1|Withdrawal by Subject|0|||
129438316|NCT04640077|465902455|FG000|Period 1|Adverse Event|1|||
129438317|NCT04640077|465902456|FG001|Period 1|Adverse Event|1|||
129438318|NCT04640077|465902457|FG002|Period 1|Adverse Event|0|||
129438319|NCT04640077|465902455|FG000|Period 1|Screen Failure|2|||
129438320|NCT04640077|465902456|FG001|Period 1|Screen Failure|0|||
129438321|NCT04640077|465902457|FG002|Period 1|Screen Failure|0|||
129438322|NCT04640077|465902455|FG000|Period 2|Withdrawal by Subject|0|||
129438323|NCT04640077|465902456|FG001|Period 2|Withdrawal by Subject|0|||
129438324|NCT04640077|465902457|FG002|Period 2|Withdrawal by Subject|18|||
129438325|NCT04640077|465902455|FG000|Period 2|Adverse Event|0|||
129438326|NCT04640077|465902456|FG001|Period 2|Adverse Event|0|||
129438327|NCT04640077|465902457|FG002|Period 2|Adverse Event|6|||
129438328|NCT04640077|465902455|FG000|Period 2|Lost to Follow-up|0|||
129438329|NCT04640077|465902456|FG001|Period 2|Lost to Follow-up|0|||
129438330|NCT04640077|465902457|FG002|Period 2|Lost to Follow-up|2|||
129438331|NCT04640077|465902455|FG000|Period 2|Death|0|||
129438332|NCT04640077|465902456|FG001|Period 2|Death|0|||
129438333|NCT04640077|465902457|FG002|Period 2|Death|2|||
129438334|NCT04640077|465902455|FG000|Period 2|Progressive Disease|0|||
129438335|NCT04640077|465902456|FG001|Period 2|Progressive Disease|0|||
129438336|NCT04640077|465902457|FG002|Period 2|Progressive Disease|1|||
129438337|NCT04640077|465902455|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
129438338|NCT04640077|465902456|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
129438339|NCT04640077|465902457|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
129438340|NCT01257425|465902458|FG000|Overall Study|Lack of Efficacy|3|||
129438341|NCT01257425|465902459|FG001|Overall Study|Lack of Efficacy|3|||
129438342|NCT01257425|465902458|FG000|Overall Study|Adverse Event|1|||
129438343|NCT01257425|465902459|FG001|Overall Study|Adverse Event|1|||
129438344|NCT01257425|465902458|FG000|Overall Study|Protocol Violation|1|||
129438345|NCT01257425|465902459|FG001|Overall Study|Protocol Violation|1|||
129438346|NCT01257425|465902458|FG000|Overall Study|Withdrawal by Subject|0|||
129438347|NCT01257425|465902459|FG001|Overall Study|Withdrawal by Subject|1|||
129438348|NCT01257425|465902458|FG000|Overall Study|Death|1|||
129438349|NCT01257425|465902459|FG001|Overall Study|Death|0|||
129438350|NCT01182194|465902460|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
129438351|NCT01182194|465902461|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
129438352|NCT00368992|465902463|FG000|Overall Study|Ineligible|5|||
129438353|NCT00368992|465902463|FG000|Overall Study|Refused treatment|3|||
129438354|NCT00368992|465902463|FG000|Overall Study|Lack of Efficacy|63|||
129438355|NCT00368992|465902463|FG000|Overall Study|Adverse Event|26|||
129438356|NCT00368992|465902463|FG000|Overall Study|Death|4|||
129438357|NCT00368992|465902463|FG000|Overall Study|Other|9|||
129438358|NCT02668185|465902464|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
129438359|NCT02668185|465902465|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
129438360|NCT02668185|465902464|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
129606741|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606742|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606743|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
129606744|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606745|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606746|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606747|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129606748|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
129438361|NCT02668185|465902465|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
129438362|NCT02668185|465902464|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
129438363|NCT02668185|465902465|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
129438364|NCT02668185|465902464|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
129438365|NCT02668185|465902465|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
129438366|NCT00723021|465902470|FG000|Intervention Period 4|Adverse Event|0|||
129438367|NCT00723021|465902471|FG001|Intervention Period 4|Adverse Event|0|||
129438368|NCT00723021|465902472|FG002|Intervention Period 4|Adverse Event|0|||
129606749|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129438369|NCT00723021|465902473|FG003|Intervention Period 4|Adverse Event|0|||
129438370|NCT00723021|465902474|FG004|Intervention Period 4|Adverse Event|1|||
129790219|NCT01087788|467199756|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
129790220|NCT01087788|467199754|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
129790221|NCT01087788|467199755|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
129790222|NCT01087788|467199756|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
129606750|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606751|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606752|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606753|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606754|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606755|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606756|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606757|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
129790223|NCT01087788|467199754|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
129606758|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606759|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606760|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606761|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606762|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
129606763|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606764|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129790224|NCT01087788|467199755|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
129790225|NCT01087788|467199756|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
129790226|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
129790227|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
129790228|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
129790229|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
129790230|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
129790231|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
129790232|NCT01087788|467199754|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
129790233|NCT01087788|467199755|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
129790234|NCT01087788|467199756|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
129790235|NCT01087788|467199754|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
129790236|NCT01087788|467199755|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
129790237|NCT01087788|467199756|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
129790238|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
129790239|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
129790240|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
129790241|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
129790242|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
129790243|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
129790244|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
129790245|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
129790246|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
129790247|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
129790248|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
129790249|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
129790250|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
129790251|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
129790252|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
129790253|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
129790254|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
129790255|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
129790256|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
129790257|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
129790258|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
129790259|NCT01087788|467199754|FG000|24-weeks Dose-blind Period|Patient moved|0|||
129790260|NCT01087788|467199755|FG001|24-weeks Dose-blind Period|Patient moved|0|||
129790261|NCT01087788|467199756|FG002|24-weeks Dose-blind Period|Patient moved|1|||
129790262|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
129790263|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
129790264|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
129790265|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
129790266|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
129790267|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
129790268|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
129790269|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
129790270|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
129606765|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606766|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606767|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606768|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606769|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606770|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606771|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
129606772|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606773|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606774|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606775|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606776|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
129606777|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606778|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606779|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606780|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606781|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606782|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
129606783|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606784|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
129606785|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
129606786|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606787|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606788|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606789|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606790|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
129606791|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606792|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606793|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606794|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606795|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606796|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129886789|NCT02138747|467545695|FG000|Treatment Period 2|Adverse Event|6|||
129886790|NCT02138747|467545696|FG001|Treatment Period 2|Adverse Event|3|||
129886791|NCT02138747|467545697|FG002|Treatment Period 2|Adverse Event|1|||
129886792|NCT02138747|467545698|FG003|Treatment Period 2|Adverse Event|1|||
129886793|NCT02138747|467545695|FG000|Treatment Period 2|Lost to Follow-up|2|||
129886794|NCT02138747|467545696|FG001|Treatment Period 2|Lost to Follow-up|0|||
129886795|NCT02138747|467545697|FG002|Treatment Period 2|Lost to Follow-up|0|||
129886796|NCT02138747|467545698|FG003|Treatment Period 2|Lost to Follow-up|0|||
129886797|NCT02138747|467545695|FG000|Treatment Period 2|Protocol Violation|1|||
129886798|NCT02138747|467545696|FG001|Treatment Period 2|Protocol Violation|0|||
129886799|NCT02138747|467545697|FG002|Treatment Period 2|Protocol Violation|0|||
129606797|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606798|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606799|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
129606800|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606801|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606802|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129606803|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129886800|NCT02138747|467545698|FG003|Treatment Period 2|Protocol Violation|0|||
129886801|NCT02138747|467545695|FG000|Treatment Period 2|Withdrawal by Subject|5|||
129886802|NCT02138747|467545696|FG001|Treatment Period 2|Withdrawal by Subject|4|||
129886803|NCT02138747|467545697|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129886804|NCT02138747|467545698|FG003|Treatment Period 2|Withdrawal by Subject|2|||
129886805|NCT02138747|467545695|FG000|Treatment Period 2|Other - Miscellaneous|3|||
129886806|NCT02138747|467545696|FG001|Treatment Period 2|Other - Miscellaneous|0|||
129606804|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
129698682|NCT03715829|466856849|FG000|Dose Ranging Period|Adverse Event|2|||
129698683|NCT03715829|466856850|FG001|Dose Ranging Period|Adverse Event|4|||
129698684|NCT03715829|466856851|FG002|Dose Ranging Period|Adverse Event|5|||
129698685|NCT03715829|466856852|FG003|Dose Ranging Period|Adverse Event|2|||
129886807|NCT02138747|467545697|FG002|Treatment Period 2|Other - Miscellaneous|0|||
129886808|NCT02138747|467545698|FG003|Treatment Period 2|Other - Miscellaneous|0|||
129886809|NCT00932646|467545699|FG000|Overall Study|Adverse Event|2|||
129886810|NCT00932646|467545700|FG001|Overall Study|Adverse Event|1|||
129886811|NCT00932646|467545701|FG002|Overall Study|Adverse Event|1|||
129886812|NCT00932646|467545702|FG003|Overall Study|Adverse Event|1|||
129606805|NCT03982199|466515590|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606806|NCT03982199|466515591|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606807|NCT03982199|466515592|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606808|NCT03982199|466515593|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606809|NCT03982199|466515594|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606810|NCT03982199|466515595|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
129606811|NCT03982199|466515596|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606812|NCT03982199|466515597|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
129606813|NCT03982199|466515598|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
129606814|NCT03982199|466515599|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129438371|NCT00770341|465902476|FG000|Overall Study|Did not meet eligibility criteria|1|||
129438372|NCT00770341|465902477|FG001|Overall Study|Did not meet eligibility criteria|0|||
129438373|NCT00770341|465902478|FG002|Overall Study|Did not meet eligibility criteria|0|||
129438374|NCT00770341|465902476|FG000|Overall Study|Withdrawal by Subject|0|||
129438375|NCT00770341|465902477|FG001|Overall Study|Withdrawal by Subject|1|||
129438376|NCT00770341|465902478|FG002|Overall Study|Withdrawal by Subject|0|||
129438377|NCT00770341|465902476|FG000|Overall Study|Clinical Adverse Event|3|||
129438378|NCT00770341|465902477|FG001|Overall Study|Clinical Adverse Event|1|||
129438379|NCT00770341|465902478|FG002|Overall Study|Clinical Adverse Event|2|||
129438380|NCT00770341|465902476|FG000|Overall Study|Laboratory adverse event|3|||
129438381|NCT00770341|465902477|FG001|Overall Study|Laboratory adverse event|3|||
129438382|NCT00770341|465902478|FG002|Overall Study|Laboratory adverse event|0|||
129438383|NCT00770341|465902476|FG000|Overall Study|Lack of Efficacy|3|||
129438384|NCT00770341|465902477|FG001|Overall Study|Lack of Efficacy|0|||
129438385|NCT00770341|465902478|FG002|Overall Study|Lack of Efficacy|1|||
129438386|NCT00770341|465902476|FG000|Overall Study|Other|1|||
129438387|NCT00770341|465902477|FG001|Overall Study|Other|0|||
129438388|NCT00770341|465902478|FG002|Overall Study|Other|0|||
129438389|NCT00770341|465902476|FG000|Overall Study|Not treated|1|||
129438390|NCT00770341|465902477|FG001|Overall Study|Not treated|0|||
129438391|NCT00770341|465902478|FG002|Overall Study|Not treated|0|||
129438392|NCT00960531|465902484|FG000|Overall Study|Lack of Efficacy|1|||
129438393|NCT00960531|465902485|FG001|Overall Study|Lack of Efficacy|0|||
129438394|NCT00960531|465902486|FG002|Overall Study|Lack of Efficacy|0|||
129438395|NCT00960531|465902487|FG003|Overall Study|Lack of Efficacy|0|||
129438396|NCT00960531|465902488|FG004|Overall Study|Lack of Efficacy|0|||
129438397|NCT00960531|465902489|FG005|Overall Study|Lack of Efficacy|0|||
129438398|NCT00960531|465902490|FG006|Overall Study|Lack of Efficacy|0|||
129438399|NCT00960531|465902491|FG007|Overall Study|Lack of Efficacy|0|||
129438400|NCT00960531|465902492|FG008|Overall Study|Lack of Efficacy|0|||
129438401|NCT00960531|465902493|FG009|Overall Study|Lack of Efficacy|0|||
129438402|NCT00960531|465902484|FG000|Overall Study|Withdrawal by Subject|1|||
129438403|NCT00960531|465902485|FG001|Overall Study|Withdrawal by Subject|0|||
129438404|NCT00960531|465902486|FG002|Overall Study|Withdrawal by Subject|5|||
129606815|NCT03982199|466515600|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606816|NCT03982199|466515601|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606817|NCT03982199|466515602|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606818|NCT03982199|466515603|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
129606819|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606820|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606821|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606822|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129438405|NCT00960531|465902487|FG003|Overall Study|Withdrawal by Subject|2|||
129438406|NCT00960531|465902488|FG004|Overall Study|Withdrawal by Subject|0|||
129438407|NCT00960531|465902489|FG005|Overall Study|Withdrawal by Subject|0|||
129438408|NCT00960531|465902490|FG006|Overall Study|Withdrawal by Subject|2|||
129438409|NCT00960531|465902491|FG007|Overall Study|Withdrawal by Subject|0|||
129438410|NCT00960531|465902492|FG008|Overall Study|Withdrawal by Subject|1|||
129438411|NCT00960531|465902493|FG009|Overall Study|Withdrawal by Subject|0|||
129438412|NCT00960531|465902484|FG000|Overall Study|Caregiver Request|2|||
129606823|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606824|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129438413|NCT00960531|465902485|FG001|Overall Study|Caregiver Request|0|||
129438414|NCT00960531|465902486|FG002|Overall Study|Caregiver Request|6|||
129438415|NCT00960531|465902487|FG003|Overall Study|Caregiver Request|5|||
129438416|NCT00960531|465902488|FG004|Overall Study|Caregiver Request|0|||
129438417|NCT00960531|465902489|FG005|Overall Study|Caregiver Request|2|||
129438418|NCT00960531|465902490|FG006|Overall Study|Caregiver Request|3|||
129438419|NCT00960531|465902491|FG007|Overall Study|Caregiver Request|1|||
129438420|NCT00960531|465902492|FG008|Overall Study|Caregiver Request|3|||
129438421|NCT00960531|465902493|FG009|Overall Study|Caregiver Request|0|||
129438422|NCT00960531|465902484|FG000|Overall Study|Investigator Request|0|||
129438423|NCT00960531|465902485|FG001|Overall Study|Investigator Request|0|||
129438424|NCT00960531|465902486|FG002|Overall Study|Investigator Request|1|||
129438425|NCT00960531|465902487|FG003|Overall Study|Investigator Request|0|||
129438426|NCT00960531|465902488|FG004|Overall Study|Investigator Request|0|||
129438427|NCT00960531|465902489|FG005|Overall Study|Investigator Request|0|||
129438428|NCT00960531|465902490|FG006|Overall Study|Investigator Request|0|||
129438429|NCT00960531|465902491|FG007|Overall Study|Investigator Request|0|||
129438430|NCT00960531|465902492|FG008|Overall Study|Investigator Request|0|||
129438431|NCT00960531|465902493|FG009|Overall Study|Investigator Request|0|||
129438432|NCT00960531|465902484|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
129438433|NCT00960531|465902485|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129438434|NCT00960531|465902486|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
129438435|NCT00960531|465902487|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129438436|NCT00960531|465902488|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
129438437|NCT00960531|465902489|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
129438438|NCT00960531|465902490|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
129606825|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606826|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606827|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
129606828|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
129606829|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
129606830|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
129606831|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
129606832|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
129606833|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606834|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606835|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606836|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606837|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606838|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606839|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606840|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606841|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606842|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
129606843|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606844|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606845|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606846|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
129606847|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606848|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606849|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606850|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606851|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606852|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606853|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606854|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606855|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129790271|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
129790272|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
129790273|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
129606856|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606857|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606858|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606859|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
129606860|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
129606861|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606862|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606863|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606864|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606865|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129790274|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
129606866|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129438439|NCT00960531|465902491|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
129438440|NCT00960531|465902492|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
129438441|NCT00960531|465902493|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
129606867|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606868|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606869|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606870|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606871|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
129606872|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
129606873|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
129698686|NCT03715829|466856853|FG004|Dose Ranging Period|Adverse Event|3|||
129698687|NCT03715829|466856854|FG005|Dose Ranging Period|Adverse Event|3|||
129698688|NCT03715829|466856855|FG006|Dose Ranging Period|Adverse Event|0|||
129698689|NCT03715829|466856856|FG007|Dose Ranging Period|Adverse Event|0|||
129698690|NCT03715829|466856857|FG008|Dose Ranging Period|Adverse Event|0|||
129698691|NCT03715829|466856858|FG009|Dose Ranging Period|Adverse Event|0|||
129698692|NCT03715829|466856859|FG010|Dose Ranging Period|Adverse Event|0|||
129698693|NCT03715829|466856849|FG000|Dose Ranging Period|Lack of Efficacy|0|||
129698694|NCT03715829|466856850|FG001|Dose Ranging Period|Lack of Efficacy|1|||
129698695|NCT03715829|466856851|FG002|Dose Ranging Period|Lack of Efficacy|0|||
129698696|NCT03715829|466856852|FG003|Dose Ranging Period|Lack of Efficacy|1|||
129698697|NCT03715829|466856853|FG004|Dose Ranging Period|Lack of Efficacy|0|||
129698698|NCT03715829|466856854|FG005|Dose Ranging Period|Lack of Efficacy|0|||
129698699|NCT03715829|466856855|FG006|Dose Ranging Period|Lack of Efficacy|0|||
129698700|NCT03715829|466856856|FG007|Dose Ranging Period|Lack of Efficacy|0|||
129698701|NCT03715829|466856857|FG008|Dose Ranging Period|Lack of Efficacy|0|||
129698702|NCT03715829|466856858|FG009|Dose Ranging Period|Lack of Efficacy|0|||
129698703|NCT03715829|466856859|FG010|Dose Ranging Period|Lack of Efficacy|0|||
129698704|NCT03715829|466856849|FG000|Dose Ranging Period|Lost to Follow-up|2|||
129698705|NCT03715829|466856850|FG001|Dose Ranging Period|Lost to Follow-up|0|||
129698706|NCT03715829|466856851|FG002|Dose Ranging Period|Lost to Follow-up|1|||
129698707|NCT03715829|466856852|FG003|Dose Ranging Period|Lost to Follow-up|1|||
129698708|NCT03715829|466856853|FG004|Dose Ranging Period|Lost to Follow-up|1|||
129698709|NCT03715829|466856854|FG005|Dose Ranging Period|Lost to Follow-up|2|||
129698710|NCT03715829|466856855|FG006|Dose Ranging Period|Lost to Follow-up|0|||
129698711|NCT03715829|466856856|FG007|Dose Ranging Period|Lost to Follow-up|0|||
129698712|NCT03715829|466856857|FG008|Dose Ranging Period|Lost to Follow-up|0|||
129698713|NCT03715829|466856858|FG009|Dose Ranging Period|Lost to Follow-up|0|||
129698714|NCT03715829|466856859|FG010|Dose Ranging Period|Lost to Follow-up|0|||
129698715|NCT03715829|466856849|FG000|Dose Ranging Period|Protocol Violation|0|||
129698716|NCT03715829|466856850|FG001|Dose Ranging Period|Protocol Violation|0|||
129698717|NCT03715829|466856851|FG002|Dose Ranging Period|Protocol Violation|0|||
129698718|NCT03715829|466856852|FG003|Dose Ranging Period|Protocol Violation|1|||
129698719|NCT03715829|466856853|FG004|Dose Ranging Period|Protocol Violation|0|||
129698720|NCT03715829|466856854|FG005|Dose Ranging Period|Protocol Violation|0|||
129698721|NCT03715829|466856855|FG006|Dose Ranging Period|Protocol Violation|0|||
129698722|NCT03715829|466856856|FG007|Dose Ranging Period|Protocol Violation|0|||
129698723|NCT03715829|466856857|FG008|Dose Ranging Period|Protocol Violation|0|||
129698724|NCT03715829|466856858|FG009|Dose Ranging Period|Protocol Violation|0|||
129698725|NCT03715829|466856859|FG010|Dose Ranging Period|Protocol Violation|0|||
129698726|NCT03715829|466856849|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
129698727|NCT03715829|466856850|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
129698728|NCT03715829|466856851|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
129698729|NCT03715829|466856852|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
129698730|NCT03715829|466856853|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
129698731|NCT03715829|466856854|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
129698732|NCT03715829|466856855|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
129698733|NCT03715829|466856856|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
129698734|NCT03715829|466856857|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
129698735|NCT03715829|466856858|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
129698736|NCT03715829|466856859|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
129698737|NCT03715829|466856849|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698738|NCT03715829|466856850|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698739|NCT03715829|466856851|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
129698740|NCT03715829|466856852|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698741|NCT03715829|466856853|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698742|NCT03715829|466856854|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698743|NCT03715829|466856855|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698744|NCT03715829|466856856|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698745|NCT03715829|466856857|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698746|NCT03715829|466856858|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129698747|NCT03715829|466856859|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
129790275|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
129790276|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
129886813|NCT00932646|467545699|FG000|Overall Study|Lost to Follow-up|2|||
129886814|NCT00932646|467545700|FG001|Overall Study|Lost to Follow-up|1|||
129886815|NCT00932646|467545701|FG002|Overall Study|Lost to Follow-up|0|||
129886816|NCT00932646|467545702|FG003|Overall Study|Lost to Follow-up|0|||
129886817|NCT00932646|467545699|FG000|Overall Study|Withdrawal by Subject|1|||
129886818|NCT00932646|467545700|FG001|Overall Study|Withdrawal by Subject|1|||
129886819|NCT00932646|467545701|FG002|Overall Study|Withdrawal by Subject|3|||
129886820|NCT00932646|467545702|FG003|Overall Study|Withdrawal by Subject|0|||
129886821|NCT04170296|467545703|FG000|Overall Study|Adverse Event|1|||
129886822|NCT04170296|467545704|FG001|Overall Study|Adverse Event|0|||
129886823|NCT04170296|467545703|FG000|Overall Study|Withdrawal by Subject|3|||
129886824|NCT04170296|467545704|FG001|Overall Study|Withdrawal by Subject|2|||
129886825|NCT04170296|467545703|FG000|Overall Study|Lost to Follow-up|4|||
129886826|NCT04170296|467545704|FG001|Overall Study|Lost to Follow-up|2|||
129886827|NCT00653263|467545705|FG000|Overall Study|Withdrawal by Subject|1|||
129886828|NCT00653263|467545705|FG000|Overall Study|Physician Decision|1|||
129886829|NCT00776100|467545716|FG000|Overall Study|Disease Progression|1|||
129886830|NCT00776100|467545717|FG001|Overall Study|Disease Progression|0|||
129886831|NCT03567993|467545718|FG000|Overall Study|Lost to Follow-up|4|||
129886832|NCT03567993|467545719|FG001|Overall Study|Lost to Follow-up|2|||
129886833|NCT03567993|467545718|FG000|Overall Study|Death|1|||
129886834|NCT03567993|467545719|FG001|Overall Study|Death|1|||
129886835|NCT03567993|467545718|FG000|Overall Study|Withdrawal by Subject|1|||
129886836|NCT03567993|467545719|FG001|Overall Study|Withdrawal by Subject|0|||
129886837|NCT04793464|467545720|FG000|Overall Study|Lost to Follow-up|458|||
129886838|NCT04793464|467545721|FG001|Overall Study|Lost to Follow-up|168|||
129886839|NCT04793464|467545722|FG002|Overall Study|Lost to Follow-up|5|||
129886840|NCT04793464|467545720|FG000|Overall Study|Withdrawal by Subject|43|||
129886841|NCT04793464|467545721|FG001|Overall Study|Withdrawal by Subject|15|||
129886842|NCT04793464|467545722|FG002|Overall Study|Withdrawal by Subject|0|||
129886843|NCT02285595|467545723|FG000|Overall Study|Lost to Follow-up|14|||
129886844|NCT02285595|467545723|FG000|Overall Study|Withdrawal by Subject|1|||
129886845|NCT00195715|467545724|FG000|Overall Study|Adverse Event|122|||
129886846|NCT00195715|467545724|FG000|Overall Study|Withdrawal by Subject|58|||
129886847|NCT00195715|467545724|FG000|Overall Study|Lost to Follow-up|27|||
129886848|NCT00195715|467545724|FG000|Overall Study|Protocol Violation|13|||
129886849|NCT00195715|467545724|FG000|Overall Study|Lack of Efficacy|93|||
129886850|NCT00195715|467545724|FG000|Overall Study|Pregnancy|14|||
129886851|NCT00195715|467545724|FG000|Overall Study|Investigative site closure|8|||
129886852|NCT00195715|467545724|FG000|Overall Study|Subject moved/relocated|7|||
129886853|NCT00195715|467545724|FG000|Overall Study|Subject non-compliance|6|||
129886854|NCT00195715|467545724|FG000|Overall Study|Subject started commercial Humira|5|||
129886855|NCT00195715|467545724|FG000|Overall Study|Subject choice|3|||
129886856|NCT00195715|467545724|FG000|Overall Study|Loss of response/no improvement|3|||
129886857|NCT00195715|467545724|FG000|Overall Study|Sponsor stopped study|1|||
129886858|NCT00195715|467545724|FG000|Overall Study|Administrative reasons|2|||
129886859|NCT00195715|467545724|FG000|Overall Study|Investigator's decision|2|||
129886860|NCT00195715|467545724|FG000|Overall Study|Subject wants to get pregnant|4|||
129886861|NCT00195715|467545724|FG000|Overall Study|Use of prohibited medication|2|||
129886862|NCT00195715|467545724|FG000|Overall Study|Planned surgery|2|||
129886863|NCT00195715|467545724|FG000|Overall Study|Increased infection rate|1|||
129886864|NCT00195715|467545724|FG000|Overall Study|Ineligible|1|||
129886865|NCT00195715|467545724|FG000|Overall Study|Colonic stricture|1|||
129886866|NCT00195715|467545724|FG000|Overall Study|Sponsor discontinued trial|1|||
129886867|NCT00195715|467545724|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
129886868|NCT00845871|467545729|FG000|Assessment Period|Adverse Event|2|||
129886869|NCT00845871|467545729|FG000|Assessment Period|Abnormal laboratory values|1|||
129886870|NCT00845871|467545729|FG000|Assessment Period|Abnormal test procedure results|1|||
129886871|NCT00845871|467545729|FG000|Assessment Period|Patient withdrew consent|3|||
129886872|NCT00064025|467545739|FG000|Overall Study|Ineligible|4|||
129886873|NCT00064025|467545739|FG000|Overall Study|Inevaluable|3|||
129886874|NCT02468934|467545742|FG000|Overall Study|Withdrawal by Subject|4|||
129886875|NCT02468934|467545742|FG000|Overall Study|Screen Failure|3|||
129886876|NCT01370603|467545743|FG000|Period 1|Adverse Event|5|||
129606874|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
129606875|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129886877|NCT01370603|467545744|FG001|Period 1|Adverse Event|3|||
129886878|NCT01370603|467545743|FG000|Period 1|Lost to Follow-up|2|||
129886879|NCT01370603|467545744|FG001|Period 1|Lost to Follow-up|0|||
129886880|NCT01370603|467545743|FG000|Period 1|Protocol Violation|2|||
129886881|NCT01370603|467545744|FG001|Period 1|Protocol Violation|2|||
129886882|NCT01370603|467545743|FG000|Period 1|Withdrawal by Subject|5|||
129886883|NCT01370603|467545744|FG001|Period 1|Withdrawal by Subject|5|||
129647538|NCT02407457|466665347|FG000|2-year|Death|14|||
129886884|NCT01370603|467545743|FG000|Crossover Washout|Adverse Event|2|||
129886885|NCT01370603|467545744|FG001|Crossover Washout|Adverse Event|1|||
129886886|NCT01370603|467545743|FG000|Crossover Washout|Lost to Follow-up|2|||
129886887|NCT01370603|467545744|FG001|Crossover Washout|Lost to Follow-up|0|||
129606876|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606877|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606878|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129438442|NCT00960531|465902484|FG000|Overall Study|Lost to Follow-up|0|||
129438443|NCT00960531|465902485|FG001|Overall Study|Lost to Follow-up|0|||
129438444|NCT00960531|465902486|FG002|Overall Study|Lost to Follow-up|1|||
129438445|NCT00960531|465902487|FG003|Overall Study|Lost to Follow-up|0|||
129438446|NCT00960531|465902488|FG004|Overall Study|Lost to Follow-up|0|||
129438447|NCT00960531|465902489|FG005|Overall Study|Lost to Follow-up|0|||
129438448|NCT00960531|465902490|FG006|Overall Study|Lost to Follow-up|1|||
129438449|NCT00960531|465902491|FG007|Overall Study|Lost to Follow-up|0|||
129438450|NCT00960531|465902492|FG008|Overall Study|Lost to Follow-up|0|||
129438451|NCT00960531|465902493|FG009|Overall Study|Lost to Follow-up|0|||
129438452|NCT00960531|465902484|FG000|Overall Study|Failed to Return|2|||
129438453|NCT00960531|465902485|FG001|Overall Study|Failed to Return|0|||
129606879|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606880|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606881|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606882|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606883|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129438454|NCT00960531|465902486|FG002|Overall Study|Failed to Return|0|||
129438455|NCT00960531|465902487|FG003|Overall Study|Failed to Return|0|||
129438456|NCT00960531|465902488|FG004|Overall Study|Failed to Return|0|||
129438457|NCT00960531|465902489|FG005|Overall Study|Failed to Return|0|||
129438458|NCT00960531|465902490|FG006|Overall Study|Failed to Return|0|||
129438459|NCT00960531|465902491|FG007|Overall Study|Failed to Return|2|||
129438460|NCT00960531|465902492|FG008|Overall Study|Failed to Return|0|||
129438461|NCT00960531|465902493|FG009|Overall Study|Failed to Return|0|||
129438462|NCT00960531|465902484|FG000|Overall Study|Adverse Event (AE)|2|||
129438463|NCT00960531|465902485|FG001|Overall Study|Adverse Event (AE)|0|||
129438464|NCT00960531|465902486|FG002|Overall Study|Adverse Event (AE)|0|||
129438465|NCT00960531|465902487|FG003|Overall Study|Adverse Event (AE)|0|||
129438466|NCT00960531|465902488|FG004|Overall Study|Adverse Event (AE)|0|||
129438467|NCT00960531|465902489|FG005|Overall Study|Adverse Event (AE)|1|||
129438468|NCT00960531|465902490|FG006|Overall Study|Adverse Event (AE)|2|||
129438469|NCT00960531|465902491|FG007|Overall Study|Adverse Event (AE)|0|||
129438470|NCT00960531|465902492|FG008|Overall Study|Adverse Event (AE)|2|||
129438471|NCT00960531|465902493|FG009|Overall Study|Adverse Event (AE)|0|||
129438472|NCT00960531|465902484|FG000|Overall Study|Reason not Specified|2|||
129438473|NCT00960531|465902485|FG001|Overall Study|Reason not Specified|1|||
129438474|NCT00960531|465902486|FG002|Overall Study|Reason not Specified|13|||
129438475|NCT00960531|465902487|FG003|Overall Study|Reason not Specified|1|||
129438476|NCT00960531|465902488|FG004|Overall Study|Reason not Specified|2|||
129438477|NCT00960531|465902489|FG005|Overall Study|Reason not Specified|0|||
129438478|NCT00960531|465902490|FG006|Overall Study|Reason not Specified|16|||
129438479|NCT00960531|465902491|FG007|Overall Study|Reason not Specified|0|||
129438480|NCT00960531|465902492|FG008|Overall Study|Reason not Specified|8|||
129438481|NCT00960531|465902493|FG009|Overall Study|Reason not Specified|1|||
129438482|NCT01163916|465902496|FG000|Overall Study|Withdrawal by Subject|2|||
129438483|NCT01163916|465902497|FG001|Overall Study|Withdrawal by Subject|0|||
129606884|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606885|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606886|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129606887|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
129698748|NCT03715829|466856849|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698749|NCT03715829|466856850|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698750|NCT03715829|466856851|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
129698751|NCT03715829|466856852|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698752|NCT03715829|466856853|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
129438484|NCT01163916|465902498|FG002|Overall Study|Withdrawal by Subject|2|||
129438485|NCT01163916|465902496|FG000|Overall Study|Adverse Event|2|||
129438486|NCT01163916|465902497|FG001|Overall Study|Adverse Event|0|||
129698753|NCT03715829|466856854|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698754|NCT03715829|466856855|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698755|NCT03715829|466856856|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698756|NCT03715829|466856857|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698757|NCT03715829|466856858|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698758|NCT03715829|466856859|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
129698759|NCT03715829|466856849|FG000|Dose Ranging Period|Other|0|||
129800260|NCT02445391|467236290|FG000|Overall Study|Alternative therapy|0|||
129438487|NCT01163916|465902498|FG002|Overall Study|Adverse Event|1|||
129438488|NCT01163916|465902496|FG000|Overall Study|Lack of Efficacy|2|||
129438489|NCT01163916|465902497|FG001|Overall Study|Lack of Efficacy|0|||
129438490|NCT01163916|465902498|FG002|Overall Study|Lack of Efficacy|1|||
129438491|NCT01163916|465902496|FG000|Overall Study|Other|24|||
129438492|NCT01163916|465902497|FG001|Overall Study|Other|4|||
129438493|NCT01163916|465902498|FG002|Overall Study|Other|16|||
129438494|NCT00883051|465902499|FG000|Overall Study|Lost to Follow-up|0|||
129438495|NCT00883051|465902500|FG001|Overall Study|Lost to Follow-up|0|||
129438496|NCT00883051|465902501|FG002|Overall Study|Lost to Follow-up|0|||
129438497|NCT00883051|465902502|FG003|Overall Study|Lost to Follow-up|0|||
129438498|NCT00883051|465902503|FG004|Overall Study|Lost to Follow-up|1|||
129438499|NCT00883051|465902499|FG000|Overall Study|Did not use study medication|24|||
129438500|NCT00883051|465902500|FG001|Overall Study|Did not use study medication|22|||
129438501|NCT00883051|465902501|FG002|Overall Study|Did not use study medication|29|||
129438502|NCT00883051|465902502|FG003|Overall Study|Did not use study medication|29|||
129438503|NCT00883051|465902503|FG004|Overall Study|Did not use study medication|17|||
129438504|NCT02337751|465902504|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
129438505|NCT02337751|465902505|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
129438506|NCT02337751|465902504|FG000|Overall Study|Voluntary Withdrawal|6|||
129438507|NCT02337751|465902505|FG001|Overall Study|Voluntary Withdrawal|8|||
129438508|NCT02337751|465902504|FG000|Overall Study|Lack of Efficacy|2|||
129438509|NCT02337751|465902505|FG001|Overall Study|Lack of Efficacy|5|||
129438510|NCT02337751|465902504|FG000|Overall Study|Investigator's Judgement|1|||
129438511|NCT02337751|465902505|FG001|Overall Study|Investigator's Judgement|0|||
129438512|NCT01910181|465902512|FG000|Overall Study|Death|37|||
129438513|NCT01910181|465902512|FG000|Overall Study|Lost to Follow-up|3|||
129438514|NCT01910181|465902512|FG000|Overall Study|Study Terminated by Sponsor|6|||
129438515|NCT02963610|465904415|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
129438516|NCT01774110|465904416|FG000|Overall Study|Lost to Follow-up|7|||
129438517|NCT00640016|465904417|FG000|Overall Study|Withdrawal by Subject|0|||
129438518|NCT00640016|465904418|FG001|Overall Study|Withdrawal by Subject|1|||
129438519|NCT00640016|465904419|FG002|Overall Study|Withdrawal by Subject|0|||
129438520|NCT00640016|465904420|FG003|Overall Study|Withdrawal by Subject|0|||
129438521|NCT00640016|465904417|FG000|Overall Study|Study termination|2|||
129438522|NCT00640016|465904418|FG001|Overall Study|Study termination|1|||
129438523|NCT00640016|465904419|FG002|Overall Study|Study termination|3|||
129438524|NCT00640016|465904420|FG003|Overall Study|Study termination|2|||
129438525|NCT00640016|465904417|FG000|Overall Study|Adverse Event|0|||
129438526|NCT00640016|465904418|FG001|Overall Study|Adverse Event|0|||
129438527|NCT00640016|465904419|FG002|Overall Study|Adverse Event|0|||
129438528|NCT00640016|465904420|FG003|Overall Study|Adverse Event|1|||
129438529|NCT03575143|465904423|FG000|Overall Study|Lost to Follow-up|0|||
129438530|NCT03575143|465904424|FG001|Overall Study|Lost to Follow-up|0|||
129438531|NCT03575143|465904425|FG002|Overall Study|Lost to Follow-up|4|||
129438532|NCT03575143|465904423|FG000|Overall Study|Withdrawal by Subject|0|||
129438533|NCT03575143|465904424|FG001|Overall Study|Withdrawal by Subject|0|||
129438534|NCT03575143|465904425|FG002|Overall Study|Withdrawal by Subject|5|||
129438535|NCT03575143|465904423|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
129438536|NCT03575143|465904424|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
129438537|NCT03575143|465904425|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
129438538|NCT01287065|465904428|FG000|Treatment Period 1|Adverse Event|0|||
129438539|NCT01287065|465904429|FG001|Treatment Period 1|Adverse Event|0|||
129438540|NCT01287065|465904430|FG002|Treatment Period 1|Adverse Event|0|||
129438541|NCT01287065|465904431|FG003|Treatment Period 1|Adverse Event|0|||
129438542|NCT01287065|465904432|FG004|Treatment Period 1|Adverse Event|1|||
129438543|NCT01287065|465904433|FG005|Treatment Period 1|Adverse Event|0|||
129438544|NCT01287065|465904428|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129438545|NCT01287065|465904429|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129438546|NCT01287065|465904430|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129438547|NCT01287065|465904431|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129438548|NCT01287065|465904432|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129438549|NCT01287065|465904433|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129438550|NCT02875977|465904434|FG000|Overall Study|Lost to Follow-up|42|||
129438551|NCT02875977|465904435|FG001|Overall Study|Lost to Follow-up|29|||
129438552|NCT03421431|465904438|FG000|Overall Study|Adverse Event|2|||
129438553|NCT03421431|465904439|FG001|Overall Study|Adverse Event|1|||
129438554|NCT03421431|465904440|FG002|Overall Study|Adverse Event|12|||
129438555|NCT03421431|465904438|FG000|Overall Study|Lost to Follow-up|1|||
129438556|NCT03421431|465904439|FG001|Overall Study|Lost to Follow-up|1|||
129438557|NCT03421431|465904440|FG002|Overall Study|Lost to Follow-up|1|||
129698760|NCT03715829|466856850|FG001|Dose Ranging Period|Other|0|||
129698761|NCT03715829|466856851|FG002|Dose Ranging Period|Other|2|||
129698762|NCT03715829|466856852|FG003|Dose Ranging Period|Other|0|||
129698763|NCT03715829|466856853|FG004|Dose Ranging Period|Other|0|||
129698764|NCT03715829|466856854|FG005|Dose Ranging Period|Other|3|||
129438558|NCT03421431|465904438|FG000|Overall Study|Withdrawal by Subject|3|||
129438559|NCT03421431|465904439|FG001|Overall Study|Withdrawal by Subject|2|||
129698765|NCT03715829|466856855|FG006|Dose Ranging Period|Other|0|||
129698766|NCT03715829|466856856|FG007|Dose Ranging Period|Other|0|||
129698767|NCT03715829|466856857|FG008|Dose Ranging Period|Other|0|||
129606888|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
129606889|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606890|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606891|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606892|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606893|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606894|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606895|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606896|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606897|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606898|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606899|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129647539|NCT02407457|466665348|FG001|2-year|Death|8|||
129790277|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
129790278|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
129438560|NCT03421431|465904440|FG002|Overall Study|Withdrawal by Subject|1|||
129438561|NCT03421431|465904438|FG000|Overall Study|Protocol Violation|0|||
129790279|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
129790280|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
129790281|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
129790282|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
129790283|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
129790284|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
129790285|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
129790286|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
129790287|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
129790288|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
129790289|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
129790290|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
129790291|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
129790292|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
129790293|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
129790294|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
129790295|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
129790296|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
129790297|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
129790298|NCT01087788|467199754|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
129790299|NCT01087788|467199755|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
129790300|NCT01087788|467199756|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
129790301|NCT04604132|467199757|FG000|Overall Study|Adverse Event|2|||
129790302|NCT04604132|467199758|FG001|Overall Study|Adverse Event|0|||
129790303|NCT04604132|467199759|FG002|Overall Study|Adverse Event|0|||
129790304|NCT04604132|467199760|FG003|Overall Study|Adverse Event|1|||
129790305|NCT04604132|467199761|FG004|Overall Study|Adverse Event|2|||
129790306|NCT04604132|467199757|FG000|Overall Study|Study terminated by sponsor|0|||
129790307|NCT04604132|467199758|FG001|Overall Study|Study terminated by sponsor|0|||
129790308|NCT04604132|467199759|FG002|Overall Study|Study terminated by sponsor|0|||
129790309|NCT04604132|467199760|FG003|Overall Study|Study terminated by sponsor|0|||
129790310|NCT04604132|467199761|FG004|Overall Study|Study terminated by sponsor|1|||
129790311|NCT04604132|467199757|FG000|Overall Study|Progressive disease: Clinical progression|0|||
129790312|NCT04604132|467199758|FG001|Overall Study|Progressive disease: Clinical progression|0|||
129790313|NCT04604132|467199759|FG002|Overall Study|Progressive disease: Clinical progression|1|||
129790314|NCT04604132|467199760|FG003|Overall Study|Progressive disease: Clinical progression|0|||
129790315|NCT04604132|467199761|FG004|Overall Study|Progressive disease: Clinical progression|0|||
129790316|NCT04604132|467199757|FG000|Overall Study|Progressive disease: Radiological progression|8|||
129790317|NCT04604132|467199758|FG001|Overall Study|Progressive disease: Radiological progression|7|||
129790318|NCT04604132|467199759|FG002|Overall Study|Progressive disease: Radiological progression|10|||
129790319|NCT04604132|467199760|FG003|Overall Study|Progressive disease: Radiological progression|4|||
129790320|NCT04604132|467199761|FG004|Overall Study|Progressive disease: Radiological progression|3|||
129790321|NCT04604132|467199757|FG000|Overall Study|Death|3|||
129790322|NCT04604132|467199758|FG001|Overall Study|Death|1|||
129790323|NCT04604132|467199759|FG002|Overall Study|Death|2|||
129790324|NCT04604132|467199760|FG003|Overall Study|Death|1|||
129790325|NCT04604132|467199761|FG004|Overall Study|Death|0|||
129790326|NCT00952380|467199762|FG000|Overall Study|Other|0|||
129790327|NCT00952380|467199763|FG001|Overall Study|Other|0|||
129790328|NCT00952380|467199764|FG002|Overall Study|Other|0|||
129790329|NCT00952380|467199765|FG003|Overall Study|Other|0|||
129790330|NCT00952380|467199766|FG004|Overall Study|Other|1|||
129790331|NCT00952380|467199762|FG000|Overall Study|Withdrawal by Subject|0|||
129790332|NCT00952380|467199763|FG001|Overall Study|Withdrawal by Subject|0|||
129790333|NCT00952380|467199764|FG002|Overall Study|Withdrawal by Subject|1|||
129790334|NCT00952380|467199765|FG003|Overall Study|Withdrawal by Subject|0|||
129438562|NCT03421431|465904439|FG001|Overall Study|Protocol Violation|1|||
129438563|NCT03421431|465904440|FG002|Overall Study|Protocol Violation|0|||
129438564|NCT03421431|465904438|FG000|Overall Study|Participant met Stopping Rules|0|||
129438565|NCT03421431|465904439|FG001|Overall Study|Participant met Stopping Rules|1|||
129438566|NCT03421431|465904440|FG002|Overall Study|Participant met Stopping Rules|0|||
129438567|NCT00141726|465904444|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
129438568|NCT00235326|465904449|FG000|Overall Study|Lost to Follow-up|746|||
129438569|NCT00235326|465904450|FG001|Overall Study|Lost to Follow-up|1400|||
129438570|NCT02349451|465904452|FG000|Overall Study|Withdrawal by Subject|0|||
129438571|NCT02349451|465904453|FG001|Overall Study|Withdrawal by Subject|1|||
129438572|NCT02349451|465904454|FG002|Overall Study|Withdrawal by Subject|2|||
129438573|NCT02349451|465904455|FG003|Overall Study|Withdrawal by Subject|1|||
129438574|NCT05116046|465904458|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129438575|NCT05116046|465904459|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129438576|NCT05116046|465904460|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129438577|NCT05116046|465904458|FG000|Overall Study|Study terminated by sponsor|14|||
129438578|NCT05116046|465904459|FG001|Overall Study|Study terminated by sponsor|16|||
129438579|NCT05116046|465904460|FG002|Overall Study|Study terminated by sponsor|1|||
129438580|NCT02683941|465904461|FG000|Double-blind Phase|Adverse Event|0|||
129438581|NCT02683941|465904462|FG001|Double-blind Phase|Adverse Event|1|||
129438582|NCT02683941|465904461|FG000|Double-blind Phase|Withdrawal by Subject|4|||
129438583|NCT02683941|465904462|FG001|Double-blind Phase|Withdrawal by Subject|2|||
129438584|NCT02683941|465904461|FG000|Double-blind Phase|Lost to Follow-up|1|||
129438585|NCT02683941|465904462|FG001|Double-blind Phase|Lost to Follow-up|0|||
129438586|NCT02683941|465904461|FG000|Double-blind Phase|Disease Progression|5|||
129438587|NCT02683941|465904462|FG001|Double-blind Phase|Disease Progression|2|||
129438588|NCT02683941|465904461|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
129438589|NCT02683941|465904462|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
129438590|NCT02683941|465904461|FG000|Open-label Treatment Phase|Disease Progression|1|||
129438591|NCT02683941|465904462|FG001|Open-label Treatment Phase|Disease Progression|2|||
129438592|NCT02683941|465904461|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
129438593|NCT02683941|465904462|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
129438594|NCT02683941|465904461|FG000|Open-label Treatment Phase|Other|1|||
129438595|NCT02683941|465904462|FG001|Open-label Treatment Phase|Other|0|||
129438596|NCT02683941|465904461|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
129438597|NCT02683941|465904462|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
129438598|NCT02683941|465904461|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
129438599|NCT02683941|465904462|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
129438600|NCT02683941|465904461|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
129438601|NCT02683941|465904462|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
129438602|NCT02683941|465904461|FG000|Open-label Follow-up Phase|Other|8|||
129438603|NCT02683941|465904462|FG001|Open-label Follow-up Phase|Other|1|||
129438604|NCT00261846|465904463|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
129438605|NCT00261846|465904464|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
129438606|NCT00261846|465904465|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
129438607|NCT00261846|465904466|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438608|NCT00261846|465904467|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438609|NCT00261846|465904468|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438610|NCT00261846|465904469|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438611|NCT00261846|465904470|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438612|NCT00261846|465904471|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438613|NCT00261846|465904472|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129438614|NCT00261846|465904473|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129606900|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
129606901|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
129606902|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
129790335|NCT00952380|467199766|FG004|Overall Study|Withdrawal by Subject|2|||
129790336|NCT00952380|467199762|FG000|Overall Study|Adverse Event|0|||
129438615|NCT00261846|465904474|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
129606903|NCT03982199|466515590|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129438616|NCT00261846|465904463|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438617|NCT00261846|465904464|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438618|NCT00261846|465904465|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438619|NCT00261846|465904466|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
129438620|NCT00261846|465904467|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438621|NCT00261846|465904468|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438622|NCT00261846|465904469|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438623|NCT00261846|465904470|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129606904|NCT03982199|466515591|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606905|NCT03982199|466515592|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606906|NCT03982199|466515593|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606907|NCT03982199|466515594|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606908|NCT03982199|466515595|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606909|NCT03982199|466515596|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606910|NCT03982199|466515597|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606911|NCT03982199|466515598|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606912|NCT03982199|466515599|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606913|NCT03982199|466515600|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606914|NCT03982199|466515601|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606915|NCT03982199|466515602|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
129606916|NCT03982199|466515603|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
129606917|NCT00594646|466515604|FG000|Overall Study|Withdrawal by Subject|1|||
129606918|NCT00594646|466515604|FG000|Overall Study|Lost to Follow-up|15|||
129606919|NCT03907462|466515607|FG000|Overall Study|Physician Decision|1|||
129606920|NCT03907462|466515608|FG001|Overall Study|Physician Decision|3|||
129606921|NCT03907462|466515609|FG002|Overall Study|Physician Decision|1|||
129606922|NCT03907462|466515607|FG000|Overall Study|Withdrawal by Subject|6|||
129606923|NCT03907462|466515608|FG001|Overall Study|Withdrawal by Subject|3|||
129606924|NCT03907462|466515609|FG002|Overall Study|Withdrawal by Subject|3|||
129606925|NCT03907462|466515607|FG000|Overall Study|Pregnancy|4|||
129790337|NCT00952380|467199763|FG001|Overall Study|Adverse Event|1|||
129790338|NCT00952380|467199764|FG002|Overall Study|Adverse Event|0|||
129790339|NCT00952380|467199765|FG003|Overall Study|Adverse Event|0|||
129790340|NCT00952380|467199766|FG004|Overall Study|Adverse Event|3|||
129790341|NCT00952380|467199762|FG000|Overall Study|Physician Decision|0|||
129790342|NCT00952380|467199763|FG001|Overall Study|Physician Decision|0|||
129790343|NCT00952380|467199764|FG002|Overall Study|Physician Decision|1|||
129790344|NCT00952380|467199765|FG003|Overall Study|Physician Decision|2|||
129790345|NCT00952380|467199766|FG004|Overall Study|Physician Decision|0|||
129790346|NCT00952380|467199762|FG000|Overall Study|Non-compliant to protocol|0|||
129886888|NCT01370603|467545743|FG000|Crossover Washout|Protocol Violation|1|||
129606926|NCT03907462|466515608|FG001|Overall Study|Pregnancy|2|||
129606927|NCT03907462|466515609|FG002|Overall Study|Pregnancy|6|||
129606928|NCT03907462|466515607|FG000|Overall Study|Lost to Follow-up|16|||
129606929|NCT03907462|466515608|FG001|Overall Study|Lost to Follow-up|18|||
129606930|NCT03907462|466515609|FG002|Overall Study|Lost to Follow-up|22|||
129606931|NCT03548064|466517755|FG000|Overall Study|Withdrawal by Subject|0|||
129606932|NCT03548064|466517756|FG001|Overall Study|Withdrawal by Subject|0|||
129606933|NCT03548064|466517757|FG002|Overall Study|Withdrawal by Subject|0|||
129790347|NCT00952380|467199763|FG001|Overall Study|Non-compliant to protocol|0|||
129790348|NCT00952380|467199764|FG002|Overall Study|Non-compliant to protocol|0|||
129886889|NCT01370603|467545744|FG001|Crossover Washout|Protocol Violation|0|||
129886890|NCT01370603|467545743|FG000|Crossover Washout|Withdrawal by Subject|4|||
129886891|NCT01370603|467545744|FG001|Crossover Washout|Withdrawal by Subject|1|||
129886892|NCT01370603|467545743|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
129886893|NCT01370603|467545744|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
129886894|NCT01370603|467545743|FG000|Period 2|Adverse Event|1|||
129886895|NCT01370603|467545744|FG001|Period 2|Adverse Event|4|||
129886896|NCT01370603|467545743|FG000|Period 2|Lost to Follow-up|1|||
129886897|NCT01370603|467545744|FG001|Period 2|Lost to Follow-up|0|||
129886898|NCT01370603|467545743|FG000|Period 2|Withdrawal by Subject|1|||
129886899|NCT01370603|467545744|FG001|Period 2|Withdrawal by Subject|0|||
129886900|NCT00641186|467545749|FG000|Overall Study|Adverse Event|3|||
129886901|NCT02218489|467545752|FG000|Overall Study|Withdrawal by Subject|4|||
129886902|NCT02218489|467545753|FG001|Overall Study|Withdrawal by Subject|3|||
129886903|NCT02218489|467545752|FG000|Overall Study|Lost to Follow-up|1|||
129886904|NCT02218489|467545753|FG001|Overall Study|Lost to Follow-up|0|||
129438624|NCT00261846|465904471|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
129438625|NCT00261846|465904472|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438626|NCT00261846|465904473|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129606934|NCT03548064|466517758|FG003|Overall Study|Withdrawal by Subject|1|||
129606935|NCT03548064|466517759|FG004|Overall Study|Withdrawal by Subject|0|||
129790349|NCT00952380|467199765|FG003|Overall Study|Non-compliant to protocol|1|||
129606936|NCT03548064|466517760|FG005|Overall Study|Withdrawal by Subject|0|||
129790350|NCT00952380|467199766|FG004|Overall Study|Non-compliant to protocol|0|||
129790351|NCT03044574|467199774|FG000|Overall Study|Lost to Follow-up|37|||
129606937|NCT03548064|466517761|FG006|Overall Study|Withdrawal by Subject|0|||
129606938|NCT03548064|466517762|FG007|Overall Study|Withdrawal by Subject|0|||
129790352|NCT03044574|467199775|FG001|Overall Study|Lost to Follow-up|45|||
129886905|NCT05221749|467545754|FG000|Overall Study|Lost to Follow-up|2|||
129886906|NCT05221749|467545755|FG001|Overall Study|Lost to Follow-up|3|||
129886907|NCT02404493|467545756|FG000|Overall Study|Adverse Event|1|||
129886908|NCT02404493|467545757|FG001|Overall Study|Adverse Event|1|||
129790353|NCT00710762|467199776|FG000|Overall Study|Progressive disease|27|||
129790354|NCT00710762|467199777|FG001|Overall Study|Progressive disease|30|||
129886909|NCT04714216|467547193|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
129886910|NCT04714216|467547193|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
129886911|NCT01818141|467547194|FG000|Overall Study|Withdrawal by Subject|2|||
129886912|NCT01818141|467547195|FG001|Overall Study|Withdrawal by Subject|0|||
129886913|NCT01818141|467547194|FG000|Overall Study|No baseline C.diff colonies|1|||
129886914|NCT01818141|467547195|FG001|Overall Study|No baseline C.diff colonies|1|||
129886915|NCT01818141|467547194|FG000|Overall Study|Lost to Follow-up|0|||
129886916|NCT01818141|467547195|FG001|Overall Study|Lost to Follow-up|2|||
129886917|NCT02169830|467547201|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
129886918|NCT02169830|467547202|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
129886919|NCT02169830|467547203|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
129886920|NCT02169830|467547201|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
129886921|NCT02169830|467547202|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129886922|NCT02169830|467547203|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129886923|NCT02169830|467547201|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
129886924|NCT02169830|467547202|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
129886925|NCT02169830|467547203|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129886926|NCT02169830|467547201|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
129886927|NCT02169830|467547202|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
129886928|NCT02169830|467547203|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
129886929|NCT02169830|467547201|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
129886930|NCT02169830|467547202|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
129886931|NCT02169830|467547203|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
129886932|NCT03204695|467547204|FG000|Overall Study|Death|1|||
129886933|NCT03204695|467547204|FG000|Overall Study|Participant was treated with another device|1|||
129886934|NCT03204695|467547204|FG000|Overall Study|Physician Decision|2|||
129886935|NCT04834362|467547205|FG000|Overall Study|Death|1|||
129886936|NCT04834362|467547206|FG001|Overall Study|Death|2|||
129886937|NCT01349829|467547209|FG000|Overall Study|Lost to Follow-up|4|||
129886938|NCT01349829|467547210|FG001|Overall Study|Lost to Follow-up|8|||
129886939|NCT01349829|467547209|FG000|Overall Study|Consent withdrawal|3|||
129886940|NCT01349829|467547210|FG001|Overall Study|Consent withdrawal|8|||
129790355|NCT00710762|467199776|FG000|Overall Study|Adverse Event other disease worsening|2|||
129790356|NCT00710762|467199777|FG001|Overall Study|Adverse Event other disease worsening|1|||
129790357|NCT00710762|467199776|FG000|Overall Study|Other Adverse Event|7|||
129790358|NCT00710762|467199777|FG001|Overall Study|Other Adverse Event|7|||
129790359|NCT00710762|467199776|FG000|Overall Study|Lost to Follow-up|1|||
129790360|NCT00710762|467199777|FG001|Overall Study|Lost to Follow-up|0|||
129790361|NCT00710762|467199776|FG000|Overall Study|Reason other than listed above|2|||
129790362|NCT00710762|467199777|FG001|Overall Study|Reason other than listed above|2|||
129790363|NCT00495040|467199779|FG000|Overall Study|Withdrawal by Subject|3|||
129790364|NCT01700439|467199783|FG000|Overall Study|Lost to Follow-up|47|||
129790365|NCT01700439|467199783|FG000|Overall Study|Withdrawal by Subject|183|||
129790366|NCT01700439|467199783|FG000|Overall Study|Death|186|||
129790367|NCT00592774|467199784|FG000|Overall Study|Adverse Event|5|||
129790368|NCT00592774|467199785|FG001|Overall Study|Adverse Event|19|||
129790369|NCT00592774|467199786|FG002|Overall Study|Adverse Event|2|||
129790370|NCT00592774|467199787|FG003|Overall Study|Adverse Event|14|||
129790371|NCT00592774|467199788|FG004|Overall Study|Adverse Event|8|||
129790372|NCT00592774|467199784|FG000|Overall Study|Protocol Violation|0|||
129790373|NCT00592774|467199785|FG001|Overall Study|Protocol Violation|1|||
129790374|NCT00592774|467199786|FG002|Overall Study|Protocol Violation|0|||
129790375|NCT00592774|467199787|FG003|Overall Study|Protocol Violation|0|||
129790376|NCT00592774|467199788|FG004|Overall Study|Protocol Violation|1|||
129790377|NCT00592774|467199784|FG000|Overall Study|Withdrawal by Subject|3|||
129790378|NCT00592774|467199785|FG001|Overall Study|Withdrawal by Subject|7|||
129790379|NCT00592774|467199786|FG002|Overall Study|Withdrawal by Subject|0|||
129790380|NCT00592774|467199787|FG003|Overall Study|Withdrawal by Subject|0|||
129790381|NCT00592774|467199788|FG004|Overall Study|Withdrawal by Subject|0|||
129790382|NCT00592774|467199784|FG000|Overall Study|Lack of Efficacy|3|||
129790383|NCT00592774|467199785|FG001|Overall Study|Lack of Efficacy|3|||
129790384|NCT00592774|467199786|FG002|Overall Study|Lack of Efficacy|0|||
129790385|NCT00592774|467199787|FG003|Overall Study|Lack of Efficacy|0|||
129790386|NCT00592774|467199788|FG004|Overall Study|Lack of Efficacy|2|||
129790387|NCT00592774|467199784|FG000|Overall Study|Physician Decision|0|||
129790388|NCT00592774|467199785|FG001|Overall Study|Physician Decision|1|||
129790389|NCT00592774|467199786|FG002|Overall Study|Physician Decision|1|||
129790390|NCT00592774|467199787|FG003|Overall Study|Physician Decision|0|||
129790391|NCT00592774|467199788|FG004|Overall Study|Physician Decision|1|||
129790392|NCT00592774|467199784|FG000|Overall Study|Other|0|||
129790393|NCT00592774|467199785|FG001|Overall Study|Other|1|||
129886941|NCT01349829|467547209|FG000|Overall Study|Migrated/moved|2|||
129886942|NCT01349829|467547210|FG001|Overall Study|Migrated/moved|7|||
129886943|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
129790394|NCT00592774|467199786|FG002|Overall Study|Other|1|||
129790395|NCT00592774|467199787|FG003|Overall Study|Other|0|||
129790396|NCT00592774|467199788|FG004|Overall Study|Other|2|||
129790397|NCT01892384|467199789|FG000|Overall Study|Withdrawal by Subject|1|||
129790398|NCT01892384|467199790|FG001|Overall Study|Withdrawal by Subject|1|||
129790399|NCT01892384|467199791|FG002|Overall Study|Withdrawal by Subject|0|||
129790400|NCT01892384|467199792|FG003|Overall Study|Withdrawal by Subject|0|||
129790401|NCT00621621|467199801|FG000|Overall Study|Subjects were exited at EP study|30|||
129790402|NCT00621621|467199802|FG001|Overall Study|Subjects were exited at EP study|0|||
129790403|NCT01829243|467199807|FG000|First Intervention|Screen Failure|4|||
129790404|NCT01829243|467199808|FG001|First Intervention|Screen Failure|2|||
129790405|NCT00053898|467199824|FG000|Overall Study|No follow-up data from any source|9|||
129790406|NCT00053898|467199825|FG001|Overall Study|No follow-up data from any source|12|||
129790407|NCT00053898|467199824|FG000|Overall Study|Follow-up from telephone contact only|5|||
129790408|NCT00053898|467199825|FG001|Overall Study|Follow-up from telephone contact only|1|||
129790409|NCT01077375|467199830|FG000|Overall Study|Adverse Event|2|||
129790410|NCT01077375|467199831|FG001|Overall Study|Adverse Event|15|||
129790411|NCT01077375|467199830|FG000|Overall Study|Lack of Efficacy|6|||
129790412|NCT01077375|467199831|FG001|Overall Study|Lack of Efficacy|8|||
129790413|NCT01077375|467199830|FG000|Overall Study|Withdrawal by Subject|0|||
129790414|NCT01077375|467199831|FG001|Overall Study|Withdrawal by Subject|6|||
129790415|NCT01077375|467199830|FG000|Overall Study|Lost to Follow-up|2|||
129790416|NCT01077375|467199831|FG001|Overall Study|Lost to Follow-up|5|||
129790417|NCT01077375|467199830|FG000|Overall Study|Other Reason|0|||
129790418|NCT01077375|467199831|FG001|Overall Study|Other Reason|1|||
129790419|NCT01924429|467199834|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
129790420|NCT01924429|467199835|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
129790421|NCT00906971|467199836|FG000|Overall Study|Withdrawal by Subject|8|||
129790422|NCT00906971|467199837|FG001|Overall Study|Withdrawal by Subject|2|||
129790423|NCT00906971|467199836|FG000|Overall Study|Lost to Follow-up|0|||
129790424|NCT00906971|467199837|FG001|Overall Study|Lost to Follow-up|1|||
129790425|NCT00545129|467199838|FG000|Overall Study|Lack of Efficacy|2|||
129790426|NCT00545129|467199839|FG001|Overall Study|Lack of Efficacy|5|||
129790427|NCT00545129|467199838|FG000|Overall Study|Death|2|||
129790428|NCT00545129|467199839|FG001|Overall Study|Death|1|||
129790429|NCT00545129|467199838|FG000|Overall Study|Adverse Event|1|||
129790430|NCT00545129|467199839|FG001|Overall Study|Adverse Event|1|||
129790431|NCT00545129|467199838|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
129790432|NCT00545129|467199839|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
129790433|NCT00545129|467199838|FG000|Overall Study|Other|3|||
129790434|NCT00545129|467199839|FG001|Overall Study|Other|3|||
129886944|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886945|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886946|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886947|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
129886948|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
129886949|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129886950|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129886951|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129886952|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
129790435|NCT01894568|467199840|FG000|Overall Study|Adverse Event|2|||
129790436|NCT01894568|467199841|FG001|Overall Study|Adverse Event|3|||
129790437|NCT01894568|467199840|FG000|Overall Study|Protocol required discontinuation|2|||
129790438|NCT01894568|467199841|FG001|Overall Study|Protocol required discontinuation|1|||
129790439|NCT01894568|467199840|FG000|Overall Study|Withdrawal by Subject|5|||
129790440|NCT01894568|467199841|FG001|Overall Study|Withdrawal by Subject|5|||
129790441|NCT01894568|467199840|FG000|Overall Study|Physician Decision|1|||
129790442|NCT01894568|467199841|FG001|Overall Study|Physician Decision|0|||
129790443|NCT01894568|467199840|FG000|Overall Study|Lost to Follow-up|0|||
129790444|NCT01894568|467199841|FG001|Overall Study|Lost to Follow-up|1|||
129698768|NCT03715829|466856858|FG009|Dose Ranging Period|Other|0|||
129698769|NCT03715829|466856859|FG010|Dose Ranging Period|Other|0|||
129698770|NCT03715829|466856849|FG000|Extension Period|Adverse Event|0|||
129698771|NCT03715829|466856850|FG001|Extension Period|Adverse Event|0|||
129698772|NCT03715829|466856851|FG002|Extension Period|Adverse Event|0|||
129698773|NCT03715829|466856852|FG003|Extension Period|Adverse Event|0|||
129698774|NCT03715829|466856853|FG004|Extension Period|Adverse Event|0|||
129698775|NCT03715829|466856854|FG005|Extension Period|Adverse Event|0|||
129698776|NCT03715829|466856855|FG006|Extension Period|Adverse Event|3|||
129790445|NCT00807573|467199842|FG000|Overall Study|Withdrawal by Subject|1|||
129790446|NCT00807573|467199842|FG000|Overall Study|Adverse Event|1|||
129698777|NCT03715829|466856856|FG007|Extension Period|Adverse Event|1|||
129698778|NCT03715829|466856857|FG008|Extension Period|Adverse Event|6|||
129698779|NCT03715829|466856858|FG009|Extension Period|Adverse Event|0|||
129698780|NCT03715829|466856859|FG010|Extension Period|Adverse Event|0|||
129698781|NCT03715829|466856849|FG000|Extension Period|Lack of Efficacy|0|||
129698782|NCT03715829|466856850|FG001|Extension Period|Lack of Efficacy|0|||
129698783|NCT03715829|466856851|FG002|Extension Period|Lack of Efficacy|0|||
129790447|NCT01514370|467199845|FG000|Overall Study|Protocol Violation|2|||
129438627|NCT00261846|465904474|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
129438628|NCT00261846|465904463|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129438629|NCT00261846|465904464|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129438630|NCT00261846|465904465|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129438631|NCT00261846|465904466|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
129438632|NCT00261846|465904467|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
129438633|NCT00261846|465904468|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
129438634|NCT00261846|465904469|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
129438635|NCT00261846|465904470|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
129438636|NCT00261846|465904471|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129438637|NCT00261846|465904472|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
129438638|NCT00261846|465904473|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129438639|NCT00261846|465904474|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
129438640|NCT00261846|465904463|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129438641|NCT00261846|465904464|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129438642|NCT00261846|465904465|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129438643|NCT00261846|465904466|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
129438644|NCT00261846|465904467|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129438645|NCT00261846|465904468|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129886953|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
129886954|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886955|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886956|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886957|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
129886958|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
129886959|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
129886960|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
129438646|NCT00261846|465904469|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129438647|NCT00261846|465904470|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129438648|NCT00261846|465904471|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
129438649|NCT00261846|465904472|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129438650|NCT00261846|465904473|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
129438651|NCT00261846|465904474|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
129438652|NCT00261846|465904463|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
129438653|NCT00261846|465904464|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
129438654|NCT00261846|465904465|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
129438655|NCT00261846|465904466|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
129438656|NCT00261846|465904467|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
129438657|NCT00261846|465904468|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
129438658|NCT00261846|465904469|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
129438659|NCT00261846|465904470|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
129438660|NCT00261846|465904471|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
129438661|NCT00261846|465904472|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
129438662|NCT00261846|465904473|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
129438663|NCT00261846|465904474|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
129438664|NCT00261846|465904463|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
129438665|NCT00261846|465904464|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
129438666|NCT00261846|465904465|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
129606939|NCT03548064|466517755|FG000|Overall Study|Lost to Follow-up|0|||
129438667|NCT00261846|465904466|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
129438668|NCT00261846|465904467|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
129438669|NCT00261846|465904468|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
129438670|NCT00261846|465904469|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
129438671|NCT00261846|465904470|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
129438672|NCT00261846|465904471|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
129886961|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
129438673|NCT00261846|465904472|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
129438674|NCT00261846|465904473|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
129606940|NCT03548064|466517756|FG001|Overall Study|Lost to Follow-up|0|||
129606941|NCT03548064|466517757|FG002|Overall Study|Lost to Follow-up|0|||
129606942|NCT03548064|466517758|FG003|Overall Study|Lost to Follow-up|0|||
129606943|NCT03548064|466517759|FG004|Overall Study|Lost to Follow-up|2|||
129606944|NCT03548064|466517760|FG005|Overall Study|Lost to Follow-up|0|||
129606945|NCT03548064|466517761|FG006|Overall Study|Lost to Follow-up|0|||
129606946|NCT03548064|466517762|FG007|Overall Study|Lost to Follow-up|0|||
129606947|NCT03548064|466517755|FG000|Overall Study|Covid-19 Pandemic|0|||
129606948|NCT03548064|466517756|FG001|Overall Study|Covid-19 Pandemic|0|||
129606949|NCT03548064|466517757|FG002|Overall Study|Covid-19 Pandemic|0|||
129606950|NCT03548064|466517758|FG003|Overall Study|Covid-19 Pandemic|0|||
129606951|NCT03548064|466517759|FG004|Overall Study|Covid-19 Pandemic|10|||
129606952|NCT03548064|466517760|FG005|Overall Study|Covid-19 Pandemic|3|||
129606953|NCT03548064|466517761|FG006|Overall Study|Covid-19 Pandemic|0|||
129606954|NCT03548064|466517762|FG007|Overall Study|Covid-19 Pandemic|0|||
129438675|NCT00261846|465904474|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
129438676|NCT00261846|465904463|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
129606955|NCT05011123|466517763|FG000|Overall Study|Withdrawal by Subject|4|||
129606956|NCT05011123|466517764|FG001|Overall Study|Withdrawal by Subject|2|||
129606957|NCT05011123|466517763|FG000|Overall Study|Lost to Follow-up|7|||
129606958|NCT05011123|466517764|FG001|Overall Study|Lost to Follow-up|6|||
129606959|NCT05011123|466517763|FG000|Overall Study|Ongoing at the time of DBL date|36|||
129606960|NCT05011123|466517764|FG001|Overall Study|Ongoing at the time of DBL date|10|||
129606961|NCT05011123|466517763|FG000|Overall Study|Randomized but did not receive vaccination|1|||
129606962|NCT05011123|466517764|FG001|Overall Study|Randomized but did not receive vaccination|0|||
129606963|NCT04221789|466517765|FG000|Overall Study|deviation from protoco|22|||
129606964|NCT04221789|466517766|FG001|Overall Study|deviation from protoco|8|||
129606965|NCT04732221|466517767|FG000|Base Period|Death|2|||
129606966|NCT04732221|466517768|FG001|Base Period|Death|0|||
129606967|NCT04732221|466517769|FG002|Base Period|Death|0|||
129606968|NCT04732221|466517770|FG003|Base Period|Death|0|||
129606969|NCT04732221|466517771|FG004|Base Period|Death|0|||
129606970|NCT04732221|466517772|FG005|Base Period|Death|0|||
129606971|NCT04732221|466517773|FG006|Base Period|Death|0|||
129606972|NCT04732221|466517767|FG000|Base Period|Withdrawal by Subject|0|||
129606973|NCT04732221|466517768|FG001|Base Period|Withdrawal by Subject|1|||
129606974|NCT04732221|466517769|FG002|Base Period|Withdrawal by Subject|1|||
129606975|NCT04732221|466517770|FG003|Base Period|Withdrawal by Subject|0|||
129606976|NCT04732221|466517771|FG004|Base Period|Withdrawal by Subject|0|||
129606977|NCT04732221|466517772|FG005|Base Period|Withdrawal by Subject|0|||
129606978|NCT04732221|466517773|FG006|Base Period|Withdrawal by Subject|0|||
129606979|NCT04732221|466517767|FG000|Extension Period|Adverse Event|0|||
129606980|NCT04732221|466517768|FG001|Extension Period|Adverse Event|0|||
129606981|NCT04732221|466517769|FG002|Extension Period|Adverse Event|0|||
129606982|NCT04732221|466517770|FG003|Extension Period|Adverse Event|0|||
129606983|NCT04732221|466517771|FG004|Extension Period|Adverse Event|0|||
129606984|NCT04732221|466517772|FG005|Extension Period|Adverse Event|1|||
129606985|NCT04732221|466517773|FG006|Extension Period|Adverse Event|0|||
129606986|NCT04732221|466517767|FG000|Extension Period|Death|0|||
129606987|NCT04732221|466517768|FG001|Extension Period|Death|0|||
129606988|NCT04732221|466517769|FG002|Extension Period|Death|0|||
129606989|NCT04732221|466517770|FG003|Extension Period|Death|0|||
129606990|NCT04732221|466517771|FG004|Extension Period|Death|1|||
129606991|NCT04732221|466517772|FG005|Extension Period|Death|0|||
129606992|NCT04732221|466517773|FG006|Extension Period|Death|2|||
129606993|NCT04732221|466517767|FG000|Extension Period|Pregnancy|0|||
129606994|NCT04732221|466517768|FG001|Extension Period|Pregnancy|0|||
129606995|NCT04732221|466517769|FG002|Extension Period|Pregnancy|0|||
129606996|NCT04732221|466517770|FG003|Extension Period|Pregnancy|0|||
129606997|NCT04732221|466517771|FG004|Extension Period|Pregnancy|1|||
129606998|NCT04732221|466517772|FG005|Extension Period|Pregnancy|0|||
129606999|NCT04732221|466517773|FG006|Extension Period|Pregnancy|0|||
129607000|NCT04732221|466517767|FG000|Extension Period|Sponsors Decision|0|||
129607001|NCT04732221|466517768|FG001|Extension Period|Sponsors Decision|0|||
129607002|NCT04732221|466517769|FG002|Extension Period|Sponsors Decision|0|||
129607003|NCT04732221|466517770|FG003|Extension Period|Sponsors Decision|0|||
129607004|NCT04732221|466517771|FG004|Extension Period|Sponsors Decision|41|||
129607005|NCT04732221|466517772|FG005|Extension Period|Sponsors Decision|40|||
129607006|NCT04732221|466517773|FG006|Extension Period|Sponsors Decision|40|||
129607007|NCT04732221|466517767|FG000|Extension Period|Withdrawal by Subject|0|||
129607008|NCT04732221|466517768|FG001|Extension Period|Withdrawal by Subject|0|||
129607009|NCT04732221|466517769|FG002|Extension Period|Withdrawal by Subject|0|||
129607010|NCT04732221|466517770|FG003|Extension Period|Withdrawal by Subject|0|||
129607011|NCT04732221|466517771|FG004|Extension Period|Withdrawal by Subject|1|||
129607012|NCT04732221|466517772|FG005|Extension Period|Withdrawal by Subject|5|||
129607013|NCT04732221|466517773|FG006|Extension Period|Withdrawal by Subject|2|||
129607014|NCT03303625|466517774|FG000|Overall Study|Withdrawal by Subject|2|||
129607015|NCT03303625|466517775|FG001|Overall Study|Withdrawal by Subject|0|||
129607016|NCT03303625|466517776|FG002|Overall Study|Withdrawal by Subject|0|||
129607017|NCT03303625|466517777|FG003|Overall Study|Withdrawal by Subject|0|||
129607018|NCT05327816|466517778|FG000|Overall Study|Lost to Follow-up|1|||
129607019|NCT05327816|466517779|FG001|Overall Study|Lost to Follow-up|0|||
129607020|NCT05327816|466517780|FG002|Overall Study|Lost to Follow-up|0|||
129607021|NCT05327816|466517781|FG003|Overall Study|Lost to Follow-up|0|||
129607022|NCT05327816|466517782|FG004|Overall Study|Lost to Follow-up|0|||
129607023|NCT05327816|466517783|FG005|Overall Study|Lost to Follow-up|0|||
129607024|NCT05327816|466517784|FG006|Overall Study|Lost to Follow-up|0|||
129790448|NCT01514370|467199846|FG001|Overall Study|Protocol Violation|3|||
129607025|NCT05327816|466517785|FG007|Overall Study|Lost to Follow-up|0|||
129607026|NCT05327816|466517786|FG008|Overall Study|Lost to Follow-up|0|||
129607027|NCT05327816|466517787|FG009|Overall Study|Lost to Follow-up|1|||
129607028|NCT05327816|466517788|FG010|Overall Study|Lost to Follow-up|0|||
129790449|NCT01514370|467199845|FG000|Overall Study|Lost to Follow-up|0|||
129607029|NCT05327816|466517778|FG000|Overall Study|Withdrawal by Subject|0|||
129607030|NCT05327816|466517779|FG001|Overall Study|Withdrawal by Subject|0|||
129607031|NCT05327816|466517780|FG002|Overall Study|Withdrawal by Subject|0|||
129607032|NCT05327816|466517781|FG003|Overall Study|Withdrawal by Subject|0|||
129607033|NCT05327816|466517782|FG004|Overall Study|Withdrawal by Subject|1|||
129607034|NCT05327816|466517783|FG005|Overall Study|Withdrawal by Subject|1|||
129607035|NCT05327816|466517784|FG006|Overall Study|Withdrawal by Subject|0|||
129607036|NCT05327816|466517785|FG007|Overall Study|Withdrawal by Subject|0|||
129607037|NCT05327816|466517786|FG008|Overall Study|Withdrawal by Subject|0|||
129607038|NCT05327816|466517787|FG009|Overall Study|Withdrawal by Subject|0|||
129607039|NCT05327816|466517788|FG010|Overall Study|Withdrawal by Subject|0|||
129607040|NCT05327816|466517778|FG000|Overall Study|Study Terminated by Sponsor|11|||
129607041|NCT05327816|466517779|FG001|Overall Study|Study Terminated by Sponsor|12|||
129607042|NCT05327816|466517780|FG002|Overall Study|Study Terminated by Sponsor|12|||
129607043|NCT05327816|466517781|FG003|Overall Study|Study Terminated by Sponsor|12|||
129607044|NCT05327816|466517782|FG004|Overall Study|Study Terminated by Sponsor|11|||
129607045|NCT05327816|466517783|FG005|Overall Study|Study Terminated by Sponsor|11|||
129607046|NCT05327816|466517784|FG006|Overall Study|Study Terminated by Sponsor|11|||
129607047|NCT05327816|466517785|FG007|Overall Study|Study Terminated by Sponsor|11|||
129607048|NCT05327816|466517786|FG008|Overall Study|Study Terminated by Sponsor|11|||
129607049|NCT05327816|466517787|FG009|Overall Study|Study Terminated by Sponsor|11|||
129607050|NCT05327816|466517788|FG010|Overall Study|Study Terminated by Sponsor|12|||
129607051|NCT05327816|466517778|FG000|Overall Study|Randomized but not treated|0|||
129607052|NCT05327816|466517779|FG001|Overall Study|Randomized but not treated|0|||
129607053|NCT05327816|466517780|FG002|Overall Study|Randomized but not treated|0|||
129607054|NCT05327816|466517781|FG003|Overall Study|Randomized but not treated|0|||
129607055|NCT05327816|466517782|FG004|Overall Study|Randomized but not treated|0|||
129607056|NCT05327816|466517783|FG005|Overall Study|Randomized but not treated|0|||
129607057|NCT05327816|466517784|FG006|Overall Study|Randomized but not treated|1|||
129607058|NCT05327816|466517785|FG007|Overall Study|Randomized but not treated|1|||
129607059|NCT05327816|466517786|FG008|Overall Study|Randomized but not treated|1|||
129607060|NCT05327816|466517787|FG009|Overall Study|Randomized but not treated|0|||
129607061|NCT05327816|466517788|FG010|Overall Study|Randomized but not treated|0|||
129607062|NCT04305587|466517789|FG000|Overall Study|Withdrawal by Subject|0|||
129607063|NCT04305587|466517790|FG001|Overall Study|Withdrawal by Subject|0|||
129607064|NCT04305587|466517791|FG002|Overall Study|Withdrawal by Subject|0|||
129607065|NCT04305587|466517792|FG003|Overall Study|Withdrawal by Subject|1|||
129607066|NCT04305587|466517793|FG004|Overall Study|Withdrawal by Subject|0|||
129607067|NCT04305587|466517794|FG005|Overall Study|Withdrawal by Subject|0|||
129607068|NCT04305587|466517795|FG006|Overall Study|Withdrawal by Subject|0|||
129607069|NCT04305587|466517796|FG007|Overall Study|Withdrawal by Subject|0|||
129607070|NCT04305587|466517797|FG008|Overall Study|Withdrawal by Subject|0|||
129607071|NCT01367665|466517798|FG000|Overall Study|Death|102|||
129607072|NCT01367665|466517799|FG001|Overall Study|Death|19|||
129607073|NCT01367665|466517798|FG000|Overall Study|Lost to Follow-up|222|||
129607074|NCT01367665|466517799|FG001|Overall Study|Lost to Follow-up|22|||
129607075|NCT01367665|466517798|FG000|Overall Study|Not Done|118|||
129607076|NCT01367665|466517799|FG001|Overall Study|Not Done|14|||
129607077|NCT02752906|466517800|FG000|Overall Study|Protocol Violation|2|||
129607078|NCT02752906|466517801|FG001|Overall Study|Protocol Violation|1|||
129607079|NCT02752906|466517800|FG000|Overall Study|Withdrawal by Subject|2|||
129607080|NCT02752906|466517801|FG001|Overall Study|Withdrawal by Subject|2|||
129607081|NCT02752906|466517800|FG000|Overall Study|Lost to Follow-up|3|||
129607082|NCT02752906|466517801|FG001|Overall Study|Lost to Follow-up|2|||
129607083|NCT02771795|466517803|FG000|Overall Study|Withdrawal by Subject|47|||
129607084|NCT02771795|466517804|FG001|Overall Study|Withdrawal by Subject|37|||
129607085|NCT02771795|466517803|FG000|Overall Study|Termination by premature discontinuation of study|168|||
129607086|NCT02771795|466517804|FG001|Overall Study|Termination by premature discontinuation of study|185|||
129607087|NCT04112173|466517805|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
129607088|NCT02906930|466517806|FG000|Overall Study|Withdrawal by Subject|0|||
129607089|NCT02906930|466517807|FG001|Overall Study|Withdrawal by Subject|5|||
129607090|NCT02906930|466517808|FG002|Overall Study|Withdrawal by Subject|5|||
129607091|NCT02906930|466517809|FG003|Overall Study|Withdrawal by Subject|4|||
129607092|NCT02906930|466517806|FG000|Overall Study|Lost to Follow-up|5|||
129607093|NCT02906930|466517807|FG001|Overall Study|Lost to Follow-up|7|||
129607094|NCT02906930|466517808|FG002|Overall Study|Lost to Follow-up|5|||
129607095|NCT02906930|466517809|FG003|Overall Study|Lost to Follow-up|2|||
129607096|NCT02906930|466517806|FG000|Overall Study|Death|0|||
129607097|NCT02906930|466517807|FG001|Overall Study|Death|0|||
129607098|NCT02906930|466517808|FG002|Overall Study|Death|1|||
129607099|NCT02906930|466517809|FG003|Overall Study|Death|0|||
129607100|NCT02906930|466517806|FG000|Overall Study|Other|1|||
129607101|NCT02906930|466517807|FG001|Overall Study|Other|2|||
129607102|NCT02906930|466517808|FG002|Overall Study|Other|1|||
129607103|NCT02906930|466517809|FG003|Overall Study|Other|2|||
129647540|NCT02407457|466665347|FG000|2-year|Lost to Follow-up|7|||
129607104|NCT02570113|466517812|FG000|Overall Study|Withdrawal by Subject|3|||
129607105|NCT02564211|466517813|FG000|Overall Study|Adverse Event|4|||
129607106|NCT00910091|466517814|FG000|Pre-assignment|Withdrawal by Subject|0|||
129607107|NCT00910091|466517815|FG001|Pre-assignment|Withdrawal by Subject|2|||
129607108|NCT00910091|466517814|FG000|Treatment and Survival|Withdrawal by Subject|3|||
129607109|NCT00910091|466517815|FG001|Treatment and Survival|Withdrawal by Subject|4|||
129607110|NCT00910091|466517814|FG000|Treatment and Survival|Adverse Event|1|||
129607111|NCT00910091|466517815|FG001|Treatment and Survival|Adverse Event|0|||
129607112|NCT00622466|466517816|FG000|Overall Study|Death|1|||
129607113|NCT00622466|466517816|FG000|Overall Study|Adverse Event|1|||
129607114|NCT00622466|466517816|FG000|Overall Study|Withdrawal by Subject|2|||
129607115|NCT01908816|466517817|FG000|Overall Study|Subject's no longer requires study drug|0|||
129607116|NCT01908816|466517818|FG001|Overall Study|Subject's no longer requires study drug|0|||
129607117|NCT01908816|466517819|FG002|Overall Study|Subject's no longer requires study drug|0|||
129607118|NCT01908816|466517820|FG003|Overall Study|Subject's no longer requires study drug|1|||
129607119|NCT01908816|466517817|FG000|Overall Study|Protocol deviation|1|||
129607120|NCT01908816|466517818|FG001|Overall Study|Protocol deviation|2|||
129607121|NCT01908816|466517819|FG002|Overall Study|Protocol deviation|1|||
129607122|NCT01908816|466517820|FG003|Overall Study|Protocol deviation|1|||
129607123|NCT01908816|466517817|FG000|Overall Study|Withdrawal by Subject|0|||
129607124|NCT01908816|466517818|FG001|Overall Study|Withdrawal by Subject|4|||
129607125|NCT01908816|466517819|FG002|Overall Study|Withdrawal by Subject|2|||
129607126|NCT01908816|466517820|FG003|Overall Study|Withdrawal by Subject|2|||
129607127|NCT01908816|466517817|FG000|Overall Study|Lost to Follow-up|3|||
129607128|NCT01908816|466517818|FG001|Overall Study|Lost to Follow-up|5|||
129607129|NCT01908816|466517819|FG002|Overall Study|Lost to Follow-up|4|||
129607130|NCT01908816|466517820|FG003|Overall Study|Lost to Follow-up|2|||
129607131|NCT01908816|466517817|FG000|Overall Study|Death|1|||
129607132|NCT01908816|466517818|FG001|Overall Study|Death|0|||
129607133|NCT01908816|466517819|FG002|Overall Study|Death|7|||
129607134|NCT01908816|466517820|FG003|Overall Study|Death|1|||
129607135|NCT01908816|466517817|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129607136|NCT01908816|466517818|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
129607137|NCT01908816|466517819|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
129607138|NCT01908816|466517820|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129607139|NCT01908816|466517817|FG000|Overall Study|Early termination|87|||
129607140|NCT01908816|466517818|FG001|Overall Study|Early termination|60|||
129607141|NCT01908816|466517819|FG002|Overall Study|Early termination|43|||
129607142|NCT01908816|466517820|FG003|Overall Study|Early termination|28|||
129607143|NCT01155024|466517821|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
129607144|NCT01155024|466517822|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
129607145|NCT01155024|466517821|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
129607146|NCT01155024|466517822|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
129607147|NCT01155024|466517821|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
129607148|NCT01155024|466517822|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
129607149|NCT04585789|466517823|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
129438677|NCT00261846|465904464|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
129438678|NCT00261846|465904465|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
129438679|NCT00261846|465904466|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
129438680|NCT00261846|465904467|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
129438681|NCT00261846|465904468|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
129438682|NCT00261846|465904469|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
129438683|NCT00261846|465904470|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
129607150|NCT04585789|466517824|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
129438684|NCT00261846|465904471|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
129438685|NCT00261846|465904472|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
129438686|NCT00261846|465904473|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
129607151|NCT04585789|466517825|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
129607152|NCT04585789|466517823|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
129607153|NCT04585789|466517824|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
129607154|NCT04585789|466517825|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
129607155|NCT01154816|466517828|FG000|Overall Study|Withdrawal by Subject|1|||
129607156|NCT01154816|466517829|FG001|Overall Study|Withdrawal by Subject|0|||
129607157|NCT01154816|466517830|FG002|Overall Study|Withdrawal by Subject|0|||
129607158|NCT01154816|466517831|FG003|Overall Study|Withdrawal by Subject|1|||
129607159|NCT01154816|466517832|FG004|Overall Study|Withdrawal by Subject|0|||
129607160|NCT01154816|466517833|FG005|Overall Study|Withdrawal by Subject|0|||
129607161|NCT01154816|466517834|FG006|Overall Study|Withdrawal by Subject|0|||
129607162|NCT01154816|466517835|FG007|Overall Study|Withdrawal by Subject|0|||
129607163|NCT01154816|466517836|FG008|Overall Study|Withdrawal by Subject|1|||
129607164|NCT01154816|466517837|FG009|Overall Study|Withdrawal by Subject|3|||
129607165|NCT01154816|466517838|FG010|Overall Study|Withdrawal by Subject|0|||
129607166|NCT01154816|466517839|FG011|Overall Study|Withdrawal by Subject|0|||
129607167|NCT01154816|466517828|FG000|Overall Study|Progressive Disease|13|||
129607168|NCT01154816|466517829|FG001|Overall Study|Progressive Disease|8|||
129607169|NCT01154816|466517830|FG002|Overall Study|Progressive Disease|9|||
129607170|NCT01154816|466517831|FG003|Overall Study|Progressive Disease|9|||
129607171|NCT01154816|466517832|FG004|Overall Study|Progressive Disease|8|||
129607172|NCT01154816|466517833|FG005|Overall Study|Progressive Disease|8|||
129607173|NCT01154816|466517834|FG006|Overall Study|Progressive Disease|5|||
129607174|NCT01154816|466517835|FG007|Overall Study|Progressive Disease|6|||
129607175|NCT01154816|466517836|FG008|Overall Study|Progressive Disease|8|||
129607176|NCT01154816|466517837|FG009|Overall Study|Progressive Disease|6|||
129607177|NCT01154816|466517838|FG010|Overall Study|Progressive Disease|10|||
129607178|NCT01154816|466517839|FG011|Overall Study|Progressive Disease|3|||
129607179|NCT01154816|466517828|FG000|Overall Study|Physician Decision|1|||
129607180|NCT01154816|466517829|FG001|Overall Study|Physician Decision|0|||
129607181|NCT01154816|466517830|FG002|Overall Study|Physician Decision|1|||
129607182|NCT01154816|466517831|FG003|Overall Study|Physician Decision|0|||
129607183|NCT01154816|466517832|FG004|Overall Study|Physician Decision|2|||
129607184|NCT01154816|466517833|FG005|Overall Study|Physician Decision|0|||
129607185|NCT01154816|466517834|FG006|Overall Study|Physician Decision|0|||
129607186|NCT01154816|466517835|FG007|Overall Study|Physician Decision|0|||
129607187|NCT01154816|466517836|FG008|Overall Study|Physician Decision|0|||
129607188|NCT01154816|466517837|FG009|Overall Study|Physician Decision|1|||
129607189|NCT01154816|466517838|FG010|Overall Study|Physician Decision|1|||
129607190|NCT01154816|466517839|FG011|Overall Study|Physician Decision|1|||
129607191|NCT01154816|466517828|FG000|Overall Study|Adverse Event|5|||
129607192|NCT01154816|466517829|FG001|Overall Study|Adverse Event|2|||
129607193|NCT01154816|466517830|FG002|Overall Study|Adverse Event|0|||
129607194|NCT01154816|466517831|FG003|Overall Study|Adverse Event|0|||
129790450|NCT01514370|467199846|FG001|Overall Study|Lost to Follow-up|2|||
129607195|NCT01154816|466517832|FG004|Overall Study|Adverse Event|0|||
129607196|NCT01154816|466517833|FG005|Overall Study|Adverse Event|0|||
129607197|NCT01154816|466517834|FG006|Overall Study|Adverse Event|1|||
129607198|NCT01154816|466517835|FG007|Overall Study|Adverse Event|1|||
129607199|NCT01154816|466517836|FG008|Overall Study|Adverse Event|0|||
129607200|NCT01154816|466517837|FG009|Overall Study|Adverse Event|0|||
129607201|NCT01154816|466517838|FG010|Overall Study|Adverse Event|0|||
129607202|NCT01154816|466517839|FG011|Overall Study|Adverse Event|0|||
129607203|NCT03397771|466517840|FG000|Overall Study|2 erroneously randomized, never treated|3|||
129607204|NCT03397771|466517841|FG001|Overall Study|2 erroneously randomized, never treated|1|||
129607205|NCT03397771|466517840|FG000|Overall Study|Withdrawal by Subject|1|||
129607206|NCT03397771|466517841|FG001|Overall Study|Withdrawal by Subject|3|||
129607207|NCT03397771|466517840|FG000|Overall Study|Protocol Violation|2|||
129607208|NCT03397771|466517841|FG001|Overall Study|Protocol Violation|2|||
129607209|NCT03397771|466517840|FG000|Overall Study|Adverse Event|2|||
129607210|NCT03397771|466517841|FG001|Overall Study|Adverse Event|1|||
129607211|NCT04078126|466517842|FG000|Washout|Study put on hold due to COVID-19|0|||
129607212|NCT04078126|466517843|FG001|Washout|Study put on hold due to COVID-19|2|||
129607213|NCT04078126|466517842|FG000|Period 2|Study put on hold due to COVID-19|1|||
129607214|NCT04078126|466517843|FG001|Period 2|Study put on hold due to COVID-19|1|||
129607215|NCT02669758|466517846|FG000|Overall Study|Withdrawal by Subject|43|||
129607216|NCT02669758|466517846|FG000|Overall Study|Lost to Follow-up|19|||
129607217|NCT02669758|466517846|FG000|Overall Study|Adverse Event|16|||
129607218|NCT02669758|466517846|FG000|Overall Study|Non-Compliance with Study Drug|8|||
129607219|NCT02669758|466517846|FG000|Overall Study|Lack of Efficacy|5|||
129607220|NCT02669758|466517846|FG000|Overall Study|Pregnancy|1|||
129607221|NCT02669758|466517846|FG000|Overall Study|Study noncompliance|1|||
129607222|NCT02669758|466517846|FG000|Overall Study|Protocol Violation|1|||
129607223|NCT02605993|466517849|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
129607224|NCT02605993|466517850|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
129607225|NCT02605993|466517851|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
129607226|NCT02605993|466517852|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
129607227|NCT02603393|466517853|FG000|Overall Study|Patient/guardian decision|32|||
129607228|NCT02603393|466517854|FG001|Overall Study|Patient/guardian decision|18|||
129607229|NCT02603393|466517853|FG000|Overall Study|Adverse Event|17|||
129607230|NCT02603393|466517854|FG001|Overall Study|Adverse Event|15|||
129607231|NCT02603393|466517853|FG000|Overall Study|Technical problems|4|||
129607232|NCT02603393|466517854|FG001|Overall Study|Technical problems|7|||
129607233|NCT02603393|466517853|FG000|Overall Study|Lack of Efficacy|7|||
129607234|NCT02603393|466517854|FG001|Overall Study|Lack of Efficacy|2|||
129607235|NCT02603393|466517853|FG000|Overall Study|Death|3|||
129607236|NCT02603393|466517854|FG001|Overall Study|Death|4|||
129607237|NCT02603393|466517853|FG000|Overall Study|Physician Decision|3|||
129607238|NCT02603393|466517854|FG001|Overall Study|Physician Decision|3|||
129607239|NCT02603393|466517853|FG000|Overall Study|Protocol deviation|2|||
129607240|NCT02603393|466517854|FG001|Overall Study|Protocol deviation|3|||
129607241|NCT02603393|466517853|FG000|Overall Study|Lost to Follow-up|1|||
129607242|NCT02603393|466517854|FG001|Overall Study|Lost to Follow-up|2|||
129607243|NCT02603393|466517853|FG000|Overall Study|Non-compliance with study treatment|1|||
129607244|NCT02603393|466517854|FG001|Overall Study|Non-compliance with study treatment|0|||
129607245|NCT02603393|466517853|FG000|Overall Study|Sponsor decision|1|||
129607246|NCT02603393|466517854|FG001|Overall Study|Sponsor decision|0|||
129607247|NCT01868893|466517857|FG000|Overall Study|Adverse Event|2|||
129607248|NCT01868893|466517857|FG000|Overall Study|Commercial availability of study drug|17|||
129607249|NCT01868893|466517857|FG000|Overall Study|Neutropenia|1|||
129607250|NCT01783548|466517858|FG000|Overall Study|Adverse Event|8|||
129607251|NCT01783548|466517859|FG001|Overall Study|Adverse Event|4|||
129607252|NCT01783548|466517858|FG000|Overall Study|Withdrawal by Subject|11|||
129607253|NCT01783548|466517859|FG001|Overall Study|Withdrawal by Subject|8|||
129607254|NCT01783548|466517858|FG000|Overall Study|Non-compliance|4|||
129607255|NCT01783548|466517859|FG001|Overall Study|Non-compliance|0|||
129607256|NCT01783548|466517858|FG000|Overall Study|Protocol Violation|2|||
129607257|NCT01783548|466517859|FG001|Overall Study|Protocol Violation|2|||
129607258|NCT01783548|466517858|FG000|Overall Study|Lost to Follow-up|8|||
129607259|NCT01783548|466517859|FG001|Overall Study|Lost to Follow-up|3|||
129607260|NCT01783548|466517858|FG000|Overall Study|Lack of Efficacy|1|||
129607261|NCT01783548|466517859|FG001|Overall Study|Lack of Efficacy|1|||
129607262|NCT00988442|466517860|FG000|Overall Study|Death|1|||
129607263|NCT00988442|466517861|FG001|Overall Study|Death|2|||
129607264|NCT00988442|466517860|FG000|Overall Study|Lost to Follow-up|0|||
129607265|NCT00988442|466517861|FG001|Overall Study|Lost to Follow-up|1|||
129607266|NCT00988442|466517860|FG000|Overall Study|Early Study Closure|29|||
129790451|NCT01514370|467199845|FG000|Overall Study|Withdrawal by Subject|2|||
129607267|NCT00988442|466517861|FG001|Overall Study|Early Study Closure|25|||
129607268|NCT01212588|466517865|FG000|Overall Study|Physician Decision|0|||
129607269|NCT01212588|466517866|FG001|Overall Study|Physician Decision|1|||
129607270|NCT01212588|466517865|FG000|Overall Study|Protocol Violation|1|||
129607271|NCT01212588|466517866|FG001|Overall Study|Protocol Violation|1|||
129607272|NCT01735955|466517867|FG000|Overall Study|Administrative problems|1|||
129607273|NCT01735955|466517867|FG000|Overall Study|Patient/guardian decision|1|||
129790452|NCT01514370|467199846|FG001|Overall Study|Withdrawal by Subject|1|||
129790453|NCT01514370|467199845|FG000|Overall Study|Adverse Event|1|||
129790454|NCT01514370|467199846|FG001|Overall Study|Adverse Event|3|||
129790455|NCT01514370|467199845|FG000|Overall Study|Other|6|||
129790456|NCT01514370|467199846|FG001|Overall Study|Other|7|||
129790457|NCT01551420|467199847|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
129607274|NCT01735955|466517867|FG000|Overall Study|Patient withdrew consent|2|||
129607275|NCT01735955|466517867|FG000|Overall Study|Physician Decision|4|||
129607276|NCT01735955|466517867|FG000|Overall Study|Disease progression|24|||
129607277|NCT01735955|466517867|FG000|Overall Study|Adverse Event|5|||
129607278|NCT03317834|466517870|FG000|Overall Study|Death|2|||
129607279|NCT03317834|466517870|FG000|Overall Study|Device Revision|5|||
129607280|NCT03317834|466517870|FG000|Overall Study|Withdrawal by Subject|13|||
129607281|NCT03317834|466517870|FG000|Overall Study|Lost to Follow-up|13|||
129607282|NCT00123474|466517876|FG000|Randomized to Treatment|Randomized, never treated|1|||
129607283|NCT00123474|466517877|FG001|Randomized to Treatment|Randomized, never treated|4|||
129607284|NCT00123474|466517878|FG002|Randomized to Treatment|Randomized, never treated|2|||
129607285|NCT00123474|466517879|FG003|Randomized to Treatment|Randomized, never treated|1|||
129607286|NCT00123474|466517876|FG000|As Treated at Study Closure|not reported when site closed|1|||
129607287|NCT00123474|466517877|FG001|As Treated at Study Closure|not reported when site closed|0|||
129607288|NCT00123474|466517878|FG002|As Treated at Study Closure|not reported when site closed|1|||
129607289|NCT00123474|466517879|FG003|As Treated at Study Closure|not reported when site closed|0|||
129607290|NCT00123474|466517876|FG000|As Treated at Study Closure|Adverse Event|10|||
129607291|NCT00123474|466517877|FG001|As Treated at Study Closure|Adverse Event|4|||
129607292|NCT00123474|466517878|FG002|As Treated at Study Closure|Adverse Event|10|||
129607293|NCT00123474|466517879|FG003|As Treated at Study Closure|Adverse Event|8|||
129607294|NCT00123474|466517876|FG000|As Treated at Study Closure|Disease Progression|35|||
129607295|NCT00123474|466517877|FG001|As Treated at Study Closure|Disease Progression|42|||
129607296|NCT00123474|466517878|FG002|As Treated at Study Closure|Disease Progression|29|||
129607297|NCT00123474|466517879|FG003|As Treated at Study Closure|Disease Progression|27|||
129607298|NCT00123474|466517876|FG000|As Treated at Study Closure|Investigator Request|12|||
129607299|NCT00123474|466517877|FG001|As Treated at Study Closure|Investigator Request|6|||
129607300|NCT00123474|466517878|FG002|As Treated at Study Closure|Investigator Request|7|||
129607301|NCT00123474|466517879|FG003|As Treated at Study Closure|Investigator Request|5|||
129607302|NCT00123474|466517876|FG000|As Treated at Study Closure|non-specified|54|||
129607303|NCT00123474|466517877|FG001|As Treated at Study Closure|non-specified|47|||
129607304|NCT00123474|466517878|FG002|As Treated at Study Closure|non-specified|57|||
129607305|NCT00123474|466517879|FG003|As Treated at Study Closure|non-specified|60|||
129607306|NCT00123474|466517876|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
129607307|NCT00123474|466517877|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
129607308|NCT00123474|466517878|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
129607309|NCT00123474|466517879|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
129607310|NCT00123474|466517876|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
129607311|NCT00123474|466517877|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
129607312|NCT00123474|466517878|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
129607313|NCT00123474|466517879|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
129607314|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
129607315|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
129607316|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
129607317|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
129607318|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
129607319|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
129607320|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
129607321|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
129607322|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
129607323|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607324|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
129607325|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607326|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607327|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607328|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607329|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607330|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607331|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
129607332|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607333|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
129607334|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129647541|NCT02407457|466665348|FG001|2-year|Lost to Follow-up|10|||
129790458|NCT01551420|467199848|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
129790459|NCT01551420|467199847|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
129790460|NCT01551420|467199848|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
129607335|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
129607336|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607337|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607338|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607339|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607340|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607341|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607342|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
129607343|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607344|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
129607345|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607346|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607347|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607348|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607349|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
129607350|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
129607351|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
129607352|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
129607353|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607354|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
129607355|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607356|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607357|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607358|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607359|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607360|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
129607361|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607362|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607363|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607364|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607365|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607366|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607367|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
129607368|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607369|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607370|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607371|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
129607372|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607373|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607374|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607375|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607376|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607377|NCT03893565|466517884|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129607378|NCT03893565|466517885|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
129607379|NCT03893565|466517886|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
129607380|NCT03893565|466517887|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
129607381|NCT03893565|466517888|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129607382|NCT03893565|466517889|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129607383|NCT03893565|466517890|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129607384|NCT03893565|466517891|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129607385|NCT03893565|466517892|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
129607386|NCT03893565|466517884|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
129647542|NCT02407457|466665347|FG000|2-year|Missed Visit|13|||
129790461|NCT01551420|467199847|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
129790462|NCT01551420|467199848|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
129790463|NCT01551420|467199847|FG000|Screened for Part B Eligibility|Declined participation|8|||
129790464|NCT01551420|467199848|FG001|Screened for Part B Eligibility|Declined participation|1|||
129790465|NCT01551420|467199847|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
129790466|NCT01551420|467199848|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
129607387|NCT03893565|466517885|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
129607388|NCT03893565|466517886|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
129607389|NCT03893565|466517887|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
129607390|NCT03893565|466517888|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
129607391|NCT03893565|466517889|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
129607392|NCT03893565|466517890|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
129607393|NCT03893565|466517891|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
129607394|NCT03893565|466517892|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
129607395|NCT03893565|466517884|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607396|NCT03893565|466517885|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607397|NCT03893565|466517886|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607398|NCT03893565|466517887|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607399|NCT03893565|466517888|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607400|NCT03893565|466517889|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607401|NCT03893565|466517890|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
129607402|NCT03893565|466517891|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607403|NCT03893565|466517892|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
129607404|NCT03893565|466517884|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607405|NCT03893565|466517885|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607406|NCT03893565|466517886|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607407|NCT03893565|466517887|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607408|NCT03893565|466517888|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607409|NCT03893565|466517889|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
129607410|NCT03893565|466517890|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
129607411|NCT03893565|466517891|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607412|NCT03893565|466517892|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
129607413|NCT03893565|466517884|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
129607414|NCT03893565|466517885|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
129607415|NCT03893565|466517886|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
129607416|NCT03893565|466517887|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
129607417|NCT03893565|466517888|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
129607418|NCT03893565|466517889|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
129607419|NCT03893565|466517890|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
129607420|NCT03893565|466517891|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
129607421|NCT03893565|466517892|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
129607422|NCT03893565|466517884|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607423|NCT03893565|466517885|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607424|NCT03893565|466517886|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607425|NCT03893565|466517887|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607426|NCT03893565|466517888|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607427|NCT03893565|466517889|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607428|NCT03893565|466517890|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607429|NCT03893565|466517891|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
129607430|NCT03893565|466517892|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
129607431|NCT03893565|466517884|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607432|NCT03893565|466517885|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607433|NCT03893565|466517886|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607434|NCT03893565|466517887|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607435|NCT03893565|466517888|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607436|NCT03893565|466517889|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607437|NCT03893565|466517890|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607438|NCT03893565|466517891|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
129607439|NCT03893565|466517892|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
129607440|NCT03893565|466517884|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129698784|NCT03715829|466856852|FG003|Extension Period|Lack of Efficacy|0|||
129698785|NCT03715829|466856853|FG004|Extension Period|Lack of Efficacy|0|||
129698786|NCT03715829|466856854|FG005|Extension Period|Lack of Efficacy|0|||
129698787|NCT03715829|466856855|FG006|Extension Period|Lack of Efficacy|1|||
129698788|NCT03715829|466856856|FG007|Extension Period|Lack of Efficacy|9|||
129698789|NCT03715829|466856857|FG008|Extension Period|Lack of Efficacy|2|||
129698790|NCT03715829|466856858|FG009|Extension Period|Lack of Efficacy|0|||
129698791|NCT03715829|466856859|FG010|Extension Period|Lack of Efficacy|0|||
129698792|NCT03715829|466856849|FG000|Extension Period|Lost to Follow-up|0|||
129698793|NCT03715829|466856850|FG001|Extension Period|Lost to Follow-up|0|||
129698794|NCT03715829|466856851|FG002|Extension Period|Lost to Follow-up|0|||
129698795|NCT03715829|466856852|FG003|Extension Period|Lost to Follow-up|0|||
129790467|NCT01551420|467199847|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
129790468|NCT01551420|467199848|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
129790469|NCT01551420|467199847|FG000|Home Use (Part B)|Withdrawal by staff|0|||
129790470|NCT01551420|467199848|FG001|Home Use (Part B)|Withdrawal by staff|1|||
129790471|NCT04054947|467199849|FG000|Overall Study|Withdrawal by Subject|1|||
129607441|NCT03893565|466517885|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607442|NCT03893565|466517886|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607443|NCT03893565|466517887|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129790472|NCT04054947|467199850|FG001|Overall Study|Withdrawal by Subject|0|||
129790473|NCT04054947|467199849|FG000|Overall Study|Lost to Follow-up|2|||
129790474|NCT04054947|467199850|FG001|Overall Study|Lost to Follow-up|5|||
129790475|NCT00853970|467199855|FG000|Overall Study|Withdrawal by Subject|2|||
129790476|NCT00853970|467199856|FG001|Overall Study|Withdrawal by Subject|1|||
129790477|NCT00853970|467199855|FG000|Overall Study|Cancelled surgery|4|||
129790478|NCT00853970|467199856|FG001|Overall Study|Cancelled surgery|2|||
129790479|NCT02055365|467201343|FG000|Overall Study|Prematurely Withdrawn|1|||
129790480|NCT01258998|467201344|FG000|Overall Study|Ineligible|1|||
129790481|NCT01143389|467201345|FG000|Overall Study|Lost to Follow-up|26|||
129607444|NCT03893565|466517888|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607445|NCT03893565|466517889|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607446|NCT03893565|466517890|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607447|NCT03893565|466517891|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
129607448|NCT03893565|466517892|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
129607449|NCT03893565|466517884|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607450|NCT03893565|466517885|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607451|NCT03893565|466517886|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607452|NCT03893565|466517887|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607453|NCT03893565|466517888|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607454|NCT03893565|466517889|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607455|NCT03893565|466517890|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607456|NCT03893565|466517891|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
129607457|NCT03893565|466517892|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
129607458|NCT02387983|466517896|FG000|Overall Study|Adverse Event|4|||
129607459|NCT02387983|466517896|FG000|Overall Study|Protocol Violation|1|||
129607460|NCT02387983|466517896|FG000|Overall Study|Withdrawal by Subject|2|||
129607461|NCT02440568|466517897|FG000|Overall Study|Death|1|||
129607462|NCT02440568|466517898|FG001|Overall Study|Death|3|||
129607463|NCT02440568|466517899|FG002|Overall Study|Death|4|||
129607464|NCT02440568|466517900|FG003|Overall Study|Death|2|||
129607465|NCT02440568|466517897|FG000|Overall Study|Lack of Efficacy|2|||
129607466|NCT02440568|466517898|FG001|Overall Study|Lack of Efficacy|0|||
129607467|NCT02440568|466517899|FG002|Overall Study|Lack of Efficacy|1|||
129607468|NCT02440568|466517900|FG003|Overall Study|Lack of Efficacy|0|||
129607469|NCT02440568|466517897|FG000|Overall Study|Lost to Follow-up|1|||
129607470|NCT02440568|466517898|FG001|Overall Study|Lost to Follow-up|0|||
129607471|NCT02440568|466517899|FG002|Overall Study|Lost to Follow-up|0|||
129607472|NCT02440568|466517900|FG003|Overall Study|Lost to Follow-up|0|||
129607473|NCT02302859|466517910|FG000|Overall Study|Lost Phone|1|||
129607474|NCT02302859|466517911|FG001|Overall Study|Lost Phone|1|||
129607475|NCT02302859|466517910|FG000|Overall Study|Withdrawal by Subject|0|||
129607476|NCT02302859|466517911|FG001|Overall Study|Withdrawal by Subject|1|||
129607477|NCT03285308|466517915|FG000|Overall Study|Adverse Event|3|||
129607478|NCT03285308|466517916|FG001|Overall Study|Adverse Event|7|||
129607479|NCT03285308|466517915|FG000|Overall Study|Withdrawal by Subject|8|||
129607480|NCT03285308|466517916|FG001|Overall Study|Withdrawal by Subject|9|||
129607481|NCT03285308|466517915|FG000|Overall Study|Lost to Follow-up|3|||
129607482|NCT03285308|466517916|FG001|Overall Study|Lost to Follow-up|1|||
129607483|NCT03285308|466517915|FG000|Overall Study|Protocol Deviation|6|||
129607484|NCT03285308|466517916|FG001|Overall Study|Protocol Deviation|5|||
129607485|NCT03285308|466517915|FG000|Overall Study|Reason not Specified|0|||
129790482|NCT01143389|467201346|FG001|Overall Study|Lost to Follow-up|25|||
129790483|NCT02276027|467201349|FG000|Overall Study|Death|1|||
129790484|NCT02276027|467201350|FG001|Overall Study|Death|0|||
129790485|NCT02276027|467201351|FG002|Overall Study|Death|0|||
129790486|NCT02276027|467201352|FG003|Overall Study|Death|2|||
129790487|NCT02276027|467201349|FG000|Overall Study|Physician Decision|0|||
129790488|NCT02276027|467201350|FG001|Overall Study|Physician Decision|0|||
129607486|NCT03285308|466517916|FG001|Overall Study|Reason not Specified|1|||
129607487|NCT03734666|466517920|FG000|Overall Study|Other|7|||
129607488|NCT03734666|466517921|FG001|Overall Study|Other|4|||
129607489|NCT03734666|466517920|FG000|Overall Study|Lost to Follow-up|12|||
129607490|NCT03734666|466517921|FG001|Overall Study|Lost to Follow-up|12|||
129790489|NCT02276027|467201351|FG002|Overall Study|Physician Decision|0|||
129790490|NCT02276027|467201352|FG003|Overall Study|Physician Decision|1|||
129790491|NCT02276027|467201349|FG000|Overall Study|Progressive disease|1|||
129607491|NCT00681590|466517922|FG000|Overall Study|Withdrawal by Subject|2|||
129607492|NCT00681590|466517923|FG001|Overall Study|Withdrawal by Subject|12|||
129607493|NCT01791153|466517924|FG000|Part 1: Blinded Period|Adverse Event|7|||
129607494|NCT01791153|466517925|FG001|Part 1: Blinded Period|Adverse Event|3|||
129607495|NCT01791153|466517926|FG002|Part 1: Blinded Period|Adverse Event|2|||
129607496|NCT01791153|466517927|FG003|Part 1: Blinded Period|Adverse Event|0|||
129607497|NCT01791153|466517928|FG004|Part 1: Blinded Period|Adverse Event|0|||
129607498|NCT01791153|466517929|FG005|Part 1: Blinded Period|Adverse Event|0|||
129607499|NCT01791153|466517930|FG006|Part 1: Blinded Period|Adverse Event|0|||
129607500|NCT01791153|466517931|FG007|Part 1: Blinded Period|Adverse Event|0|||
129607501|NCT01791153|466517924|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
129607502|NCT01791153|466517925|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
129607503|NCT01791153|466517926|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
129607504|NCT01791153|466517927|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
129607505|NCT01791153|466517928|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
129607506|NCT01791153|466517929|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
129607507|NCT01791153|466517930|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
129607508|NCT01791153|466517931|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
129607509|NCT01791153|466517924|FG000|Part 1: Blinded Period|Non-Compliance|1|||
129607510|NCT01791153|466517925|FG001|Part 1: Blinded Period|Non-Compliance|0|||
129607511|NCT01791153|466517926|FG002|Part 1: Blinded Period|Non-Compliance|0|||
129607512|NCT01791153|466517927|FG003|Part 1: Blinded Period|Non-Compliance|0|||
129607513|NCT01791153|466517928|FG004|Part 1: Blinded Period|Non-Compliance|0|||
129607514|NCT01791153|466517929|FG005|Part 1: Blinded Period|Non-Compliance|0|||
129607515|NCT01791153|466517930|FG006|Part 1: Blinded Period|Non-Compliance|0|||
129607516|NCT01791153|466517931|FG007|Part 1: Blinded Period|Non-Compliance|0|||
129607517|NCT01791153|466517924|FG000|Part 1: Blinded Period|Physician Decision|0|||
129607518|NCT01791153|466517925|FG001|Part 1: Blinded Period|Physician Decision|0|||
129607519|NCT01791153|466517926|FG002|Part 1: Blinded Period|Physician Decision|0|||
129607520|NCT01791153|466517927|FG003|Part 1: Blinded Period|Physician Decision|1|||
129607521|NCT01791153|466517928|FG004|Part 1: Blinded Period|Physician Decision|0|||
129607522|NCT01791153|466517929|FG005|Part 1: Blinded Period|Physician Decision|0|||
129607523|NCT01791153|466517930|FG006|Part 1: Blinded Period|Physician Decision|0|||
129607524|NCT01791153|466517931|FG007|Part 1: Blinded Period|Physician Decision|0|||
129607525|NCT01791153|466517924|FG000|Part 1: Blinded Period|Protocol Violation|0|||
129607526|NCT01791153|466517925|FG001|Part 1: Blinded Period|Protocol Violation|0|||
129607527|NCT01791153|466517926|FG002|Part 1: Blinded Period|Protocol Violation|0|||
129607528|NCT01791153|466517927|FG003|Part 1: Blinded Period|Protocol Violation|1|||
129607529|NCT01791153|466517928|FG004|Part 1: Blinded Period|Protocol Violation|0|||
129607530|NCT01791153|466517929|FG005|Part 1: Blinded Period|Protocol Violation|0|||
129607531|NCT01791153|466517930|FG006|Part 1: Blinded Period|Protocol Violation|0|||
129607532|NCT01791153|466517931|FG007|Part 1: Blinded Period|Protocol Violation|0|||
129607533|NCT01791153|466517924|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
129607534|NCT01791153|466517925|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
129607535|NCT01791153|466517926|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
129607536|NCT01791153|466517927|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
129607537|NCT01791153|466517928|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
129607538|NCT01791153|466517929|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
129607539|NCT01791153|466517930|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
129607540|NCT01791153|466517931|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
129607541|NCT01791153|466517924|FG000|Part 2: Open-label Period|Adverse Event|0|||
129607542|NCT01791153|466517925|FG001|Part 2: Open-label Period|Adverse Event|0|||
129607543|NCT01791153|466517926|FG002|Part 2: Open-label Period|Adverse Event|0|||
129607544|NCT01791153|466517927|FG003|Part 2: Open-label Period|Adverse Event|0|||
129607545|NCT01791153|466517928|FG004|Part 2: Open-label Period|Adverse Event|0|||
129607546|NCT01791153|466517929|FG005|Part 2: Open-label Period|Adverse Event|1|||
129607547|NCT01791153|466517930|FG006|Part 2: Open-label Period|Adverse Event|1|||
129607548|NCT01791153|466517931|FG007|Part 2: Open-label Period|Adverse Event|2|||
129607549|NCT01791153|466517924|FG000|Part 2: Open-label Period|Death|0|||
129607550|NCT01791153|466517925|FG001|Part 2: Open-label Period|Death|0|||
129607551|NCT01791153|466517926|FG002|Part 2: Open-label Period|Death|0|||
129607552|NCT01791153|466517927|FG003|Part 2: Open-label Period|Death|0|||
129607553|NCT01791153|466517928|FG004|Part 2: Open-label Period|Death|0|||
129607554|NCT01791153|466517929|FG005|Part 2: Open-label Period|Death|1|||
129607555|NCT01791153|466517930|FG006|Part 2: Open-label Period|Death|1|||
129607556|NCT01791153|466517931|FG007|Part 2: Open-label Period|Death|1|||
129607557|NCT01791153|466517924|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
129607558|NCT01791153|466517925|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
129607559|NCT01791153|466517926|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
129607560|NCT01791153|466517927|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
129607561|NCT01791153|466517928|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
129607562|NCT01791153|466517929|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
129607563|NCT01791153|466517930|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
129607564|NCT01791153|466517931|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
129647543|NCT02407457|466665348|FG001|2-year|Missed Visit|15|||
129607565|NCT01791153|466517924|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
129607566|NCT01791153|466517925|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
129607567|NCT01791153|466517926|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
129607568|NCT01791153|466517927|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
129607569|NCT01791153|466517928|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
129607570|NCT01791153|466517929|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
129607571|NCT01791153|466517930|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
129607572|NCT01791153|466517931|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
129607573|NCT01791153|466517924|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
129607574|NCT01791153|466517925|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
129607575|NCT01791153|466517926|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
129607576|NCT01791153|466517927|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
129607577|NCT01791153|466517928|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
129607578|NCT01791153|466517929|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
129647544|NCT02407457|466665347|FG000|2-year|Open Repair|0|||
129790492|NCT02276027|467201350|FG001|Overall Study|Progressive disease|13|||
129790493|NCT02276027|467201351|FG002|Overall Study|Progressive disease|12|||
129790494|NCT02276027|467201352|FG003|Overall Study|Progressive disease|14|||
129790495|NCT02276027|467201349|FG000|Overall Study|Subject/guardian decision|0|||
129790496|NCT02276027|467201350|FG001|Overall Study|Subject/guardian decision|1|||
129790497|NCT02276027|467201351|FG002|Overall Study|Subject/guardian decision|0|||
129790498|NCT02276027|467201352|FG003|Overall Study|Subject/guardian decision|3|||
129790499|NCT02276027|467201349|FG000|Overall Study|Adverse Event|0|||
129790500|NCT02276027|467201350|FG001|Overall Study|Adverse Event|2|||
129790501|NCT02276027|467201351|FG002|Overall Study|Adverse Event|8|||
129790502|NCT02276027|467201352|FG003|Overall Study|Adverse Event|2|||
129790503|NCT03224598|467201353|FG000|Overall Study|Lost to Follow-up|0|||
129790504|NCT03224598|467201354|FG001|Overall Study|Lost to Follow-up|2|||
129790505|NCT03224598|467201355|FG002|Overall Study|Lost to Follow-up|0|||
129790506|NCT03224598|467201353|FG000|Overall Study|Other|0|||
129790507|NCT03224598|467201354|FG001|Overall Study|Other|1|||
129790508|NCT03224598|467201355|FG002|Overall Study|Other|0|||
129790509|NCT01527357|467201357|FG000|Overall Study|Death|8|||
129790510|NCT01527357|467201358|FG001|Overall Study|Death|2|||
129790511|NCT01527357|467201357|FG000|Overall Study|Lost to Follow-up|6|||
129790512|NCT01527357|467201358|FG001|Overall Study|Lost to Follow-up|4|||
129790513|NCT01527357|467201357|FG000|Overall Study|Withdrew Consent|1|||
129790514|NCT01527357|467201358|FG001|Overall Study|Withdrew Consent|1|||
129790515|NCT01527357|467201357|FG000|Overall Study|Non-compliance|0|||
129790516|NCT01527357|467201358|FG001|Overall Study|Non-compliance|1|||
129790517|NCT01527357|467201357|FG000|Overall Study|No Day 29 Visit|0|||
129790518|NCT01527357|467201358|FG001|Overall Study|No Day 29 Visit|1|||
129790519|NCT01527357|467201357|FG000|Overall Study|Did Not Receive Treatment|2|||
129790520|NCT01527357|467201358|FG001|Overall Study|Did Not Receive Treatment|0|||
129790521|NCT02446171|467201359|FG000|Overall Study|Withdrawal by Subject|0|||
129790522|NCT02446171|467201360|FG001|Overall Study|Withdrawal by Subject|0|||
129790523|NCT02446171|467201361|FG002|Overall Study|Withdrawal by Subject|2|||
129790524|NCT02446171|467201362|FG003|Overall Study|Withdrawal by Subject|0|||
129790525|NCT03811093|467201364|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
129790526|NCT03811093|467201365|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
129790527|NCT03811093|467201364|FG000|Overall Study|Unable to measure body fat percentage|2|||
129790528|NCT03811093|467201365|FG001|Overall Study|Unable to measure body fat percentage|0|||
129790529|NCT00464490|467201366|FG000|Overall Study|Physician Decision|11|||
129790530|NCT00464490|467201367|FG001|Overall Study|Physician Decision|11|||
129790531|NCT03188042|467201368|FG000|Overall Study|Withdrawal by Subject|1|||
129790532|NCT03188042|467201369|FG001|Overall Study|Withdrawal by Subject|1|||
129790533|NCT00603590|467201370|FG000|Overall Study|Did not attend study clinic|39|||
129790534|NCT00603590|467201371|FG001|Overall Study|Did not attend study clinic|30|||
129790535|NCT00603590|467201370|FG000|Overall Study|Refused blood test|5|||
129790536|NCT00603590|467201371|FG001|Overall Study|Refused blood test|1|||
129790537|NCT00603590|467201370|FG000|Overall Study|Patient discontinued study drug|22|||
129790538|NCT00603590|467201371|FG001|Overall Study|Patient discontinued study drug|15|||
129790539|NCT00603590|467201370|FG000|Overall Study|Adverse Event|2|||
129790540|NCT00603590|467201371|FG001|Overall Study|Adverse Event|0|||
129790541|NCT00603590|467201370|FG000|Overall Study|Lost to Follow-up|8|||
129790542|NCT00603590|467201371|FG001|Overall Study|Lost to Follow-up|4|||
129790543|NCT00603590|467201370|FG000|Overall Study|Cardiovascular event|0|||
129790544|NCT00603590|467201371|FG001|Overall Study|Cardiovascular event|1|||
129790545|NCT01475071|467201375|FG000|Overall Study|Physician Decision|1|||
129790546|NCT01475071|467201375|FG000|Overall Study|Withdrawal by Subject|6|||
129790547|NCT01475071|467201375|FG000|Overall Study|Lost to Follow-up|1|||
129790548|NCT01343823|467201376|FG000|Overall Study|Study Terminated|1|||
129790549|NCT01343823|467201377|FG001|Overall Study|Study Terminated|0|||
129790550|NCT01343823|467201378|FG002|Overall Study|Study Terminated|0|||
129790551|NCT01343823|467201379|FG003|Overall Study|Study Terminated|1|||
129790552|NCT01343823|467201376|FG000|Overall Study|Withdrawal by Subject|1|||
129438687|NCT00261846|465904474|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
129438688|NCT00325039|465904475|FG000|Overall Study|Lost to Follow-up|18|||
129438689|NCT00325039|465904476|FG001|Overall Study|Lost to Follow-up|14|||
129438690|NCT01009203|465904477|FG000|Overall Study|Withdrawal by Subject|1|||
129438691|NCT01009203|465904477|FG000|Overall Study|Adverse Event|5|||
129438692|NCT01009203|465904477|FG000|Overall Study|Treatment-unrelated death|1|||
129438693|NCT00892723|465904478|FG000|Overall Study|Lost to Follow-up|1|||
129438694|NCT00892723|465904479|FG001|Overall Study|Lost to Follow-up|3|||
129438695|NCT00892723|465904480|FG002|Overall Study|Lost to Follow-up|1|||
129438696|NCT00892723|465904478|FG000|Overall Study|Withdrawal by Subject|1|||
129438697|NCT00892723|465904479|FG001|Overall Study|Withdrawal by Subject|1|||
129438698|NCT00892723|465904480|FG002|Overall Study|Withdrawal by Subject|1|||
129438699|NCT02974088|465904481|FG000|Overall Study|Lost to Follow-up|0|||
129438700|NCT02974088|465904482|FG001|Overall Study|Lost to Follow-up|2|||
129438701|NCT02974088|465904481|FG000|Overall Study|Adverse Event|0|||
129438702|NCT02974088|465904482|FG001|Overall Study|Adverse Event|1|||
129438703|NCT00150969|465904483|FG000|24 Month Main Study|Adverse Event|3|||
129790553|NCT01343823|467201377|FG001|Overall Study|Withdrawal by Subject|0|||
129790554|NCT01343823|467201378|FG002|Overall Study|Withdrawal by Subject|0|||
129790555|NCT01343823|467201379|FG003|Overall Study|Withdrawal by Subject|0|||
129790556|NCT00923364|467201380|FG000|Overall Study|Death|3|||
129790557|NCT00923364|467201381|FG001|Overall Study|Death|0|||
129790558|NCT00923364|467201380|FG000|Overall Study|Did not go to transplant|1|||
129790559|NCT00923364|467201381|FG001|Overall Study|Did not go to transplant|0|||
129790560|NCT01011478|467201382|FG000|Overall Study|No follow up data|12|||
129790561|NCT01011478|467201383|FG001|Overall Study|No follow up data|7|||
129790562|NCT04352127|467201385|FG000|Overall Study|Unable to obtain readings|4|||
129790563|NCT04352127|467201386|FG001|Overall Study|Unable to obtain readings|1|||
129790564|NCT05338671|467201387|FG000|Overall Study|Lost to Follow-up|2|||
129790565|NCT05338671|467201388|FG001|Overall Study|Lost to Follow-up|2|||
129790566|NCT05338671|467201387|FG000|Overall Study|Root canal completed in a single visit|1|||
129790567|NCT05338671|467201388|FG001|Overall Study|Root canal completed in a single visit|0|||
129790568|NCT04456673|467201389|FG000|Overall Study|Adverse Event|7|||
129790569|NCT04456673|467201390|FG001|Overall Study|Adverse Event|14|||
129790570|NCT04456673|467201389|FG000|Overall Study|Poor compliance to protocol|1|||
129790571|NCT04456673|467201390|FG001|Overall Study|Poor compliance to protocol|0|||
129790572|NCT04456673|467201389|FG000|Overall Study|Withdrawal by Subject|31|||
129790573|NCT04456673|467201390|FG001|Overall Study|Withdrawal by Subject|23|||
129790574|NCT04456673|467201389|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
129607579|NCT01791153|466517930|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
129607580|NCT01791153|466517931|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
129607581|NCT01791153|466517924|FG000|Part 2: Open-label Period|Physician Decision|0|||
129607582|NCT01791153|466517925|FG001|Part 2: Open-label Period|Physician Decision|0|||
129607583|NCT01791153|466517926|FG002|Part 2: Open-label Period|Physician Decision|0|||
129607584|NCT01791153|466517927|FG003|Part 2: Open-label Period|Physician Decision|0|||
129607585|NCT01791153|466517928|FG004|Part 2: Open-label Period|Physician Decision|1|||
129607586|NCT01791153|466517929|FG005|Part 2: Open-label Period|Physician Decision|1|||
129607587|NCT01791153|466517930|FG006|Part 2: Open-label Period|Physician Decision|0|||
129607588|NCT01791153|466517931|FG007|Part 2: Open-label Period|Physician Decision|0|||
129607589|NCT02357342|466517932|FG000|First 6 Months|Death|2|||
129607590|NCT02357342|466517933|FG001|First 6 Months|Death|0|||
129607591|NCT04156620|466517935|FG000|Overall Study|Adverse event - TP 1|5|||
129607592|NCT04156620|466517936|FG001|Overall Study|Adverse event - TP 1|2|||
129607593|NCT04156620|466517935|FG000|Overall Study|Lost to follow-up TP 1|1|||
129607594|NCT04156620|466517936|FG001|Overall Study|Lost to follow-up TP 1|1|||
129607595|NCT04156620|466517935|FG000|Overall Study|Progressive disease - TP 1|0|||
129607596|NCT04156620|466517936|FG001|Overall Study|Progressive disease - TP 1|1|||
129607597|NCT04156620|466517935|FG000|Overall Study|Subject decision - TP 1|3|||
129790575|NCT04456673|467201390|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
129607598|NCT04156620|466517936|FG001|Overall Study|Subject decision - TP 1|5|||
129790576|NCT04391049|467201391|FG000|Overall Study|Protocol Violation|1|||
129886962|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
129886963|NCT02555371|467547211|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
129438704|NCT00150969|465904484|FG001|24 Month Main Study|Adverse Event|4|||
129438705|NCT00150969|465904483|FG000|24 Month Main Study|Death|1|||
129607599|NCT04156620|466517935|FG000|Overall Study|Adverse event - TP 2|5|||
129607600|NCT04156620|466517936|FG001|Overall Study|Adverse event - TP 2|6|||
129607601|NCT04156620|466517935|FG000|Overall Study|Death - TP 2|1|||
129607602|NCT04156620|466517936|FG001|Overall Study|Death - TP 2|0|||
129790577|NCT03874429|467201392|FG000|Overall Study|Adverse Event|2|||
129790578|NCT03874429|467201393|FG001|Overall Study|Adverse Event|2|||
129790579|NCT03874429|467201392|FG000|Overall Study|Lack of Efficacy|0|||
129790580|NCT03874429|467201393|FG001|Overall Study|Lack of Efficacy|1|||
129790581|NCT03874429|467201392|FG000|Overall Study|Covid-19 pandemic|4|||
129438706|NCT00150969|465904484|FG001|24 Month Main Study|Death|1|||
129647545|NCT02407457|466665348|FG001|2-year|Open Repair|2|||
129698796|NCT03715829|466856853|FG004|Extension Period|Lost to Follow-up|0|||
129698797|NCT03715829|466856854|FG005|Extension Period|Lost to Follow-up|0|||
129698798|NCT03715829|466856855|FG006|Extension Period|Lost to Follow-up|0|||
129698799|NCT03715829|466856856|FG007|Extension Period|Lost to Follow-up|0|||
129698800|NCT03715829|466856857|FG008|Extension Period|Lost to Follow-up|2|||
129698801|NCT03715829|466856858|FG009|Extension Period|Lost to Follow-up|0|||
129698802|NCT03715829|466856859|FG010|Extension Period|Lost to Follow-up|0|||
129698803|NCT03715829|466856849|FG000|Extension Period|Protocol Violation|0|||
129698804|NCT03715829|466856850|FG001|Extension Period|Protocol Violation|0|||
129698805|NCT03715829|466856851|FG002|Extension Period|Protocol Violation|0|||
129698806|NCT03715829|466856852|FG003|Extension Period|Protocol Violation|0|||
129698807|NCT03715829|466856853|FG004|Extension Period|Protocol Violation|0|||
129790582|NCT03874429|467201393|FG001|Overall Study|Covid-19 pandemic|2|||
129790583|NCT00992589|467201397|FG000|Open-Label Phase|Adverse Event|4|||
129790584|NCT00992589|467201398|FG001|Open-Label Phase|Adverse Event|0|||
129790585|NCT00992589|467201399|FG002|Open-Label Phase|Adverse Event|0|||
129790586|NCT00992589|467201400|FG003|Open-Label Phase|Adverse Event|0|||
129790587|NCT00992589|467201397|FG000|Open-Label Phase|Withdrawal by Subject|20|||
129790588|NCT00992589|467201398|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129790589|NCT00992589|467201399|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129886964|NCT02555371|467547212|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
129886965|NCT02555371|467547213|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
129698808|NCT03715829|466856854|FG005|Extension Period|Protocol Violation|0|||
129698809|NCT03715829|466856855|FG006|Extension Period|Protocol Violation|0|||
129698810|NCT03715829|466856856|FG007|Extension Period|Protocol Violation|0|||
129698811|NCT03715829|466856857|FG008|Extension Period|Protocol Violation|1|||
129698812|NCT03715829|466856858|FG009|Extension Period|Protocol Violation|0|||
129607603|NCT04156620|466517935|FG000|Overall Study|Lost to follow-up - TP 2|5|||
129607604|NCT04156620|466517936|FG001|Overall Study|Lost to follow-up - TP 2|2|||
129607605|NCT04156620|466517935|FG000|Overall Study|Physician decision - TP 2|4|||
129607606|NCT04156620|466517936|FG001|Overall Study|Physician decision - TP 2|2|||
129607607|NCT04156620|466517935|FG000|Overall Study|Pregnancy - TP 2|1|||
129607608|NCT04156620|466517936|FG001|Overall Study|Pregnancy - TP 2|1|||
129607609|NCT04156620|466517935|FG000|Overall Study|Subject decision - TP 2|11|||
129607610|NCT04156620|466517936|FG001|Overall Study|Subject decision - TP 2|9|||
129607611|NCT04156620|466517935|FG000|Overall Study|New therapy for study indication - TP 2|1|||
129607612|NCT04156620|466517936|FG001|Overall Study|New therapy for study indication - TP 2|0|||
129607613|NCT01753336|466517937|FG000|Overall Study|Patient decision|12|||
129607614|NCT01753336|466517937|FG000|Overall Study|Lost to Follow-up|3|||
129607615|NCT01753336|466517937|FG000|Overall Study|Physician Decision|2|||
129607616|NCT01753336|466517937|FG000|Overall Study|Sponsor's decision|2|||
129607617|NCT01753336|466517937|FG000|Overall Study|Withdrawal by Subject|1|||
129607618|NCT01629966|466517938|FG000|Overall Study|Pregnancy|0|||
129607619|NCT01629966|466517939|FG001|Overall Study|Pregnancy|1|||
129607620|NCT01629966|466517940|FG002|Overall Study|Pregnancy|0|||
129607621|NCT01629966|466517938|FG000|Overall Study|Lost to Follow-up|10|||
129607622|NCT01629966|466517939|FG001|Overall Study|Lost to Follow-up|13|||
129607623|NCT01629966|466517940|FG002|Overall Study|Lost to Follow-up|9|||
129607624|NCT01629966|466517938|FG000|Overall Study|Withdrawal by Subject|8|||
129607625|NCT01629966|466517939|FG001|Overall Study|Withdrawal by Subject|9|||
129607626|NCT01629966|466517940|FG002|Overall Study|Withdrawal by Subject|16|||
129607627|NCT01629966|466517938|FG000|Overall Study|Protocol Violation|7|||
129607628|NCT01629966|466517939|FG001|Overall Study|Protocol Violation|9|||
129607629|NCT01629966|466517940|FG002|Overall Study|Protocol Violation|7|||
129607630|NCT01629966|466517938|FG000|Overall Study|Lack of Efficacy|5|||
129607631|NCT01629966|466517939|FG001|Overall Study|Lack of Efficacy|2|||
129607632|NCT01629966|466517940|FG002|Overall Study|Lack of Efficacy|4|||
129607633|NCT01629966|466517938|FG000|Overall Study|Adverse Event|11|||
129607634|NCT01629966|466517939|FG001|Overall Study|Adverse Event|18|||
129607635|NCT01629966|466517940|FG002|Overall Study|Adverse Event|30|||
129607636|NCT04568031|466517941|FG000|Overall Study|Lost to Follow-up|1|||
129607637|NCT04568031|466517942|FG001|Overall Study|Lost to Follow-up|0|||
129607638|NCT04568031|466517943|FG002|Overall Study|Lost to Follow-up|0|||
129607639|NCT04568031|466517944|FG003|Overall Study|Lost to Follow-up|0|||
129607640|NCT04568031|466517941|FG000|Overall Study|Physician Decision|1|||
129607641|NCT04568031|466517942|FG001|Overall Study|Physician Decision|0|||
129607642|NCT04568031|466517943|FG002|Overall Study|Physician Decision|1|||
129607643|NCT04568031|466517944|FG003|Overall Study|Physician Decision|0|||
129607644|NCT04568031|466517941|FG000|Overall Study|Withdrawal by Subject|1|||
129607645|NCT04568031|466517942|FG001|Overall Study|Withdrawal by Subject|0|||
129607646|NCT04568031|466517943|FG002|Overall Study|Withdrawal by Subject|4|||
129607647|NCT04568031|466517944|FG003|Overall Study|Withdrawal by Subject|1|||
129607648|NCT03753763|466517961|FG000|Overall Study|Adverse Event|2|||
129607649|NCT03753763|466517962|FG001|Overall Study|Adverse Event|0|||
129607650|NCT03753763|466517961|FG000|Overall Study|Withdrawal by Subject|3|||
129607651|NCT03753763|466517962|FG001|Overall Study|Withdrawal by Subject|1|||
129607652|NCT03753763|466517961|FG000|Overall Study|clinical deterioration|1|||
129607653|NCT03753763|466517962|FG001|Overall Study|clinical deterioration|0|||
129607654|NCT00389831|466517963|FG000|Overall Study|Lack of Efficacy|0|||
129607655|NCT00389831|466517964|FG001|Overall Study|Lack of Efficacy|2|||
129607656|NCT00389831|466517963|FG000|Overall Study|Did not receive treatment.|0|||
129607657|NCT00389831|466517964|FG001|Overall Study|Did not receive treatment.|2|||
129607658|NCT00389831|466517963|FG000|Overall Study|Other reasons|0|||
129607659|NCT00389831|466517964|FG001|Overall Study|Other reasons|2|||
129790590|NCT00992589|467201400|FG003|Open-Label Phase|Withdrawal by Subject|0|||
129790591|NCT00992589|467201397|FG000|Open-Label Phase|Lost to Follow-up|1|||
129607660|NCT00389831|466517963|FG000|Overall Study|Lost to Follow-up|0|||
129607661|NCT00389831|466517964|FG001|Overall Study|Lost to Follow-up|1|||
129607662|NCT00006721|466520206|FG000|Overall Study|Adverse Event|0|||
129607663|NCT00006721|466520207|FG001|Overall Study|Adverse Event|4|||
129607664|NCT00006721|466520208|FG002|Overall Study|Adverse Event|4|||
129607665|NCT00006721|466520206|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129607666|NCT00006721|466520207|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
129607667|NCT00006721|466520208|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
129607668|NCT00006721|466520206|FG000|Overall Study|Progression/Relapse|0|||
129607669|NCT00006721|466520207|FG001|Overall Study|Progression/Relapse|1|||
129607670|NCT00006721|466520208|FG002|Overall Study|Progression/Relapse|2|||
129607671|NCT00006721|466520206|FG000|Overall Study|Death|0|||
129607672|NCT00006721|466520207|FG001|Overall Study|Death|1|||
129607673|NCT00006721|466520208|FG002|Overall Study|Death|2|||
129607674|NCT00006721|466520206|FG000|Overall Study|Other - Not Protocol Specified|0|||
129607675|NCT00006721|466520207|FG001|Overall Study|Other - Not Protocol Specified|7|||
129607676|NCT00006721|466520208|FG002|Overall Study|Other - Not Protocol Specified|7|||
129607677|NCT00006721|466520206|FG000|Overall Study|Ineligible|2|||
129790592|NCT00992589|467201398|FG001|Open-Label Phase|Lost to Follow-up|0|||
129607678|NCT00006721|466520207|FG001|Overall Study|Ineligible|12|||
129607679|NCT00006721|466520208|FG002|Overall Study|Ineligible|10|||
129607680|NCT00006721|466520206|FG000|Overall Study|Eligible but no Treatment Received|1|||
129607681|NCT00006721|466520207|FG001|Overall Study|Eligible but no Treatment Received|0|||
129607682|NCT00006721|466520208|FG002|Overall Study|Eligible but no Treatment Received|0|||
129607683|NCT05091307|466520209|FG000|Overall Study|Death|0|||
129607684|NCT05091307|466520210|FG001|Overall Study|Death|0|||
129607685|NCT05091307|466520211|FG002|Overall Study|Death|1|||
129607686|NCT05091307|466520212|FG003|Overall Study|Death|0|||
129607687|NCT05091307|466520209|FG000|Overall Study|Lost to Follow-up|33|||
129607688|NCT05091307|466520210|FG001|Overall Study|Lost to Follow-up|33|||
129607689|NCT05091307|466520211|FG002|Overall Study|Lost to Follow-up|2|||
129607690|NCT05091307|466520212|FG003|Overall Study|Lost to Follow-up|0|||
129607691|NCT05091307|466520209|FG000|Overall Study|Physician Decision|1|||
129607692|NCT05091307|466520210|FG001|Overall Study|Physician Decision|0|||
129607693|NCT05091307|466520211|FG002|Overall Study|Physician Decision|0|||
129607694|NCT05091307|466520212|FG003|Overall Study|Physician Decision|0|||
129607695|NCT05091307|466520209|FG000|Overall Study|Protocol Violation|1|||
129607696|NCT05091307|466520210|FG001|Overall Study|Protocol Violation|0|||
129607697|NCT05091307|466520211|FG002|Overall Study|Protocol Violation|0|||
129607698|NCT05091307|466520212|FG003|Overall Study|Protocol Violation|0|||
129607699|NCT05091307|466520209|FG000|Overall Study|Withdrawal by Subject|16|||
129607700|NCT05091307|466520210|FG001|Overall Study|Withdrawal by Subject|16|||
129607701|NCT05091307|466520211|FG002|Overall Study|Withdrawal by Subject|0|||
129607702|NCT05091307|466520212|FG003|Overall Study|Withdrawal by Subject|1|||
129607703|NCT05091307|466520209|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
129607704|NCT05091307|466520210|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
129607705|NCT05091307|466520211|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
129607706|NCT05091307|466520212|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
129607707|NCT05091307|466520209|FG000|Overall Study|Initiated Prohibited Medication|1|||
129607708|NCT05091307|466520210|FG001|Overall Study|Initiated Prohibited Medication|0|||
129607709|NCT05091307|466520211|FG002|Overall Study|Initiated Prohibited Medication|0|||
129607710|NCT05091307|466520212|FG003|Overall Study|Initiated Prohibited Medication|0|||
129607711|NCT05091307|466520209|FG000|Overall Study|Other|4|||
129607712|NCT05091307|466520210|FG001|Overall Study|Other|4|||
129607713|NCT05091307|466520211|FG002|Overall Study|Other|0|||
129607714|NCT05091307|466520212|FG003|Overall Study|Other|0|||
129607715|NCT05091307|466520209|FG000|Overall Study|Randomized but not vaccinated|0|||
129607716|NCT05091307|466520210|FG001|Overall Study|Randomized but not vaccinated|2|||
129607717|NCT05091307|466520211|FG002|Overall Study|Randomized but not vaccinated|0|||
129607718|NCT05091307|466520212|FG003|Overall Study|Randomized but not vaccinated|0|||
129607719|NCT03747601|466520213|FG000|Overall Study|COVID halt to visits|4|||
129607720|NCT04347122|466520214|FG000|Overall Study|Physician Decision|0|||
129607721|NCT04347122|466520215|FG001|Overall Study|Physician Decision|3|||
129607722|NCT04347122|466520216|FG002|Overall Study|Physician Decision|3|||
129607723|NCT04347122|466520217|FG003|Overall Study|Physician Decision|6|||
129607724|NCT00112866|466520218|FG000|Overall Study|Protocol Violation|1|||
129607725|NCT00112866|466520219|FG001|Overall Study|Protocol Violation|0|||
129607726|NCT00112866|466520218|FG000|Overall Study|did not start treatment post-op|1|||
129607727|NCT00112866|466520219|FG001|Overall Study|did not start treatment post-op|2|||
129607728|NCT01167257|466520221|FG000|Overall Study|Lost to Follow-up|2|||
129607729|NCT01167257|466520222|FG001|Overall Study|Lost to Follow-up|2|||
129607730|NCT01167257|466520221|FG000|Overall Study|Withdrew consent|1|||
129607731|NCT01167257|466520222|FG001|Overall Study|Withdrew consent|1|||
129607732|NCT02492880|466520223|FG000|Overall Study|Lost to Follow-up|1|||
129607733|NCT02492880|466520223|FG000|Overall Study|Protocol Violation|1|||
129607734|NCT00554190|466520224|FG000|Overall Study|Termination forms not completed|10|||
129607735|NCT04241315|466520231|FG000|Overall Study|Withdrawal by Subject|0|||
129607736|NCT04241315|466520232|FG001|Overall Study|Withdrawal by Subject|1|||
129607737|NCT00699283|466520233|FG000|Overall Study|Lack of Efficacy|15|||
129607738|NCT00699283|466520234|FG001|Overall Study|Lack of Efficacy|5|||
129790593|NCT00992589|467201399|FG002|Open-Label Phase|Lost to Follow-up|0|||
129607739|NCT00699283|466520233|FG000|Overall Study|Lost to Follow-up|2|||
129607740|NCT00699283|466520234|FG001|Overall Study|Lost to Follow-up|0|||
129607741|NCT00699283|466520233|FG000|Overall Study|Withdrawal by Subject|1|||
129607742|NCT00699283|466520234|FG001|Overall Study|Withdrawal by Subject|0|||
129607743|NCT00699283|466520233|FG000|Overall Study|Other Reason|5|||
129607744|NCT00699283|466520234|FG001|Overall Study|Other Reason|1|||
129607745|NCT00699283|466520233|FG000|Overall Study|SAE, non-fatal|1|||
129607746|NCT00699283|466520234|FG001|Overall Study|SAE, non-fatal|1|||
129607747|NCT00699283|466520233|FG000|Overall Study|AE, non-serious non-fatal|8|||
129607748|NCT00699283|466520234|FG001|Overall Study|AE, non-serious non-fatal|1|||
129607749|NCT00699283|466520233|FG000|Overall Study|AE of unknown type|1|||
129790594|NCT00992589|467201400|FG003|Open-Label Phase|Lost to Follow-up|0|||
129607750|NCT00699283|466520234|FG001|Overall Study|AE of unknown type|0|||
129607751|NCT00394524|466520235|FG000|Overall Study|Protocol Violation|2|||
129790595|NCT00992589|467201397|FG000|Open-Label Phase|Protocol Violation|3|||
129607752|NCT00394524|466520236|FG001|Overall Study|Protocol Violation|3|||
129607753|NCT00394524|466520235|FG000|Overall Study|Death|1|||
129607754|NCT00394524|466520236|FG001|Overall Study|Death|0|||
129607755|NCT00394524|466520235|FG000|Overall Study|Withdrawal by Subject|0|||
129607756|NCT00394524|466520236|FG001|Overall Study|Withdrawal by Subject|1|||
129607757|NCT01398514|466520237|FG000|Overall Study|Adverse Event|1|||
129607758|NCT01398514|466520238|FG001|Overall Study|Adverse Event|0|||
129607759|NCT01398514|466520237|FG000|Overall Study|Non-compliance with study procedures|2|||
129607760|NCT01398514|466520238|FG001|Overall Study|Non-compliance with study procedures|0|||
129607761|NCT01398514|466520237|FG000|Overall Study|Physiologic non-responsiveness|1|||
129607762|NCT01398514|466520238|FG001|Overall Study|Physiologic non-responsiveness|3|||
129607763|NCT01398514|466520237|FG000|Overall Study|Failure to show a conditioned response|4|||
129607764|NCT01398514|466520238|FG001|Overall Study|Failure to show a conditioned response|3|||
129607765|NCT01345175|466520243|FG000|Overall Study|Physician Decision|0|||
129607766|NCT01345175|466520244|FG001|Overall Study|Physician Decision|1|||
129607767|NCT01345175|466520243|FG000|Overall Study|Withdrawal by Subject|1|||
129607768|NCT01345175|466520244|FG001|Overall Study|Withdrawal by Subject|1|||
129607769|NCT01345175|466520243|FG000|Overall Study|Failed to complete BFI|3|||
129607770|NCT01345175|466520244|FG001|Overall Study|Failed to complete BFI|2|||
129607771|NCT01345175|466520243|FG000|Overall Study|Stopped taking medication|2|||
129607772|NCT01345175|466520244|FG001|Overall Study|Stopped taking medication|2|||
129607773|NCT03537599|466520255|FG000|Overall Study|Disease Progression|2|||
129607774|NCT03537599|466520256|FG001|Overall Study|Disease Progression|1|||
129607775|NCT03537599|466520255|FG000|Overall Study|Death|0|||
129607776|NCT03537599|466520256|FG001|Overall Study|Death|1|||
129607777|NCT01007942|466520259|FG000|Overall Study|Adverse Event|29|||
129607778|NCT01007942|466520260|FG001|Overall Study|Adverse Event|14|||
129607779|NCT01007942|466520259|FG000|Overall Study|Abnormal test procedure|0|||
129607780|NCT01007942|466520260|FG001|Overall Study|Abnormal test procedure|1|||
129607781|NCT01007942|466520259|FG000|Overall Study|Disease progression|217|||
129607782|NCT01007942|466520260|FG001|Overall Study|Disease progression|242|||
129607783|NCT01007942|466520259|FG000|Overall Study|New cancer therapy|5|||
129607784|NCT01007942|466520260|FG001|Overall Study|New cancer therapy|1|||
129607785|NCT01007942|466520259|FG000|Overall Study|Protocol Violation|1|||
129607786|NCT01007942|466520260|FG001|Overall Study|Protocol Violation|1|||
129607787|NCT01007942|466520259|FG000|Overall Study|Withdrawal by Subject|19|||
129607788|NCT01007942|466520260|FG001|Overall Study|Withdrawal by Subject|14|||
129607789|NCT01007942|466520259|FG000|Overall Study|Lost to Follow-up|1|||
129607790|NCT01007942|466520260|FG001|Overall Study|Lost to Follow-up|0|||
129607791|NCT01007942|466520259|FG000|Overall Study|Administrative problems|2|||
129607792|NCT01007942|466520260|FG001|Overall Study|Administrative problems|0|||
129607793|NCT01007942|466520259|FG000|Overall Study|Death|3|||
129607794|NCT01007942|466520260|FG001|Overall Study|Death|2|||
129607795|NCT01007942|466520259|FG000|Overall Study|Patients untreated|4|||
129607796|NCT01007942|466520260|FG001|Overall Study|Patients untreated|3|||
129607797|NCT05083585|466520265|FG000|Overall Study|Death|1|||
129607798|NCT05083585|466520266|FG001|Overall Study|Death|1|||
129607799|NCT05083585|466520265|FG000|Overall Study|Lost to Follow-up|1|||
129607800|NCT05083585|466520266|FG001|Overall Study|Lost to Follow-up|1|||
129607801|NCT05083585|466520265|FG000|Overall Study|Withdrawal by Subject|2|||
129607802|NCT05083585|466520266|FG001|Overall Study|Withdrawal by Subject|0|||
129607803|NCT05083585|466520265|FG000|Overall Study|Randomized but not vaccinated|2|||
129607804|NCT05083585|466520266|FG001|Overall Study|Randomized but not vaccinated|0|||
129607805|NCT01383135|466520267|FG000|Overall Study|Not Scanned / Imaged|1|||
129607806|NCT01383135|466520268|FG001|Overall Study|Not Scanned / Imaged|0|||
129607807|NCT01383135|466520269|FG002|Overall Study|Not Scanned / Imaged|1|||
129790596|NCT00992589|467201398|FG001|Open-Label Phase|Protocol Violation|0|||
129790597|NCT00992589|467201399|FG002|Open-Label Phase|Protocol Violation|0|||
129790598|NCT00992589|467201400|FG003|Open-Label Phase|Protocol Violation|0|||
129790599|NCT00992589|467201397|FG000|Open-Label Phase|Physician Decision|4|||
129790600|NCT00992589|467201398|FG001|Open-Label Phase|Physician Decision|0|||
129607808|NCT01383135|466520270|FG003|Overall Study|Not Scanned / Imaged|0|||
129607809|NCT00114166|466520272|FG000|Overall Study|Wrong primary|0|||
129607810|NCT00114166|466520273|FG001|Overall Study|Wrong primary|1|||
129607811|NCT03469336|466520274|FG000|Overall Study|Adverse Event|1|||
129607812|NCT02628743|466520276|FG000|Overall Study|Other|3|||
129607813|NCT02628743|466520276|FG000|Overall Study|Withdrawal by Subject|50|||
129607814|NCT02628743|466520276|FG000|Overall Study|Study Terminated by Sponsor|76|||
129607815|NCT02628743|466520276|FG000|Overall Study|Physician Decision|2|||
129607816|NCT02534844|466520277|FG000|Part B|Withdrawal by Subject|0|||
129607817|NCT02534844|466520278|FG001|Part B|Withdrawal by Subject|0|||
129607818|NCT02534844|466520279|FG002|Part B|Withdrawal by Subject|0|||
129607819|NCT02534844|466520280|FG003|Part B|Withdrawal by Subject|0|||
129607820|NCT02534844|466520281|FG004|Part B|Withdrawal by Subject|2|||
129607821|NCT02534844|466520282|FG005|Part B|Withdrawal by Subject|1|||
129607822|NCT03560986|466520283|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
129607823|NCT03560986|466520284|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
129607824|NCT03560986|466520283|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
129607825|NCT03560986|466520284|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
129607826|NCT03560986|466520283|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
129607827|NCT03560986|466520284|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
129607828|NCT03560986|466520283|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
129607829|NCT03560986|466520284|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
129607830|NCT03560986|466520283|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
129607831|NCT03560986|466520284|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
129607832|NCT03560986|466520283|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
129607833|NCT03560986|466520284|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
129607834|NCT03560986|466520283|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
129438707|NCT00150969|465904483|FG000|24 Month Main Study|Lack of Efficacy|1|||
129438708|NCT00150969|465904484|FG001|24 Month Main Study|Lack of Efficacy|8|||
129438709|NCT00150969|465904483|FG000|24 Month Main Study|Lost to Follow-up|3|||
129607835|NCT03560986|466520284|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
129607836|NCT00593736|466520296|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
129607837|NCT00593736|466520297|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
129607838|NCT00593736|466520298|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
129607839|NCT00593736|466520299|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
129607840|NCT00593736|466520296|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
129607841|NCT00593736|466520297|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
129607842|NCT00593736|466520298|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
129607843|NCT00593736|466520299|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
129607844|NCT00593736|466520296|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
129607845|NCT00593736|466520297|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
129607846|NCT00593736|466520298|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
129607847|NCT00593736|466520299|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
129607848|NCT00593736|466520296|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
129607849|NCT00593736|466520297|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
129607850|NCT00593736|466520298|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
129607851|NCT00593736|466520299|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
129607852|NCT00593736|466520296|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
129607853|NCT00593736|466520297|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
129607854|NCT00593736|466520298|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
129607855|NCT00593736|466520299|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
129607856|NCT00593736|466520296|FG000|Screening Period and Placebo Run-in|Various|0|||
129607857|NCT00593736|466520297|FG001|Screening Period and Placebo Run-in|Various|0|||
129607858|NCT00593736|466520298|FG002|Screening Period and Placebo Run-in|Various|0|||
129607859|NCT00593736|466520299|FG003|Screening Period and Placebo Run-in|Various|25|||
129607860|NCT00593736|466520296|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
129607861|NCT00593736|466520297|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
129607862|NCT00593736|466520298|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
129607863|NCT00593736|466520299|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
129607864|NCT00593736|466520296|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
129607865|NCT00593736|466520297|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
129607866|NCT00593736|466520298|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
129607867|NCT00593736|466520299|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
129607868|NCT00593736|466520296|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
129607869|NCT00593736|466520297|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
129607870|NCT00593736|466520298|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
129607871|NCT00593736|466520299|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
129607872|NCT00593736|466520296|FG000|Treatment Period and Placebo Run-out|Various|1|||
129607873|NCT00593736|466520297|FG001|Treatment Period and Placebo Run-out|Various|1|||
129607874|NCT00593736|466520298|FG002|Treatment Period and Placebo Run-out|Various|1|||
129607875|NCT00593736|466520299|FG003|Treatment Period and Placebo Run-out|Various|0|||
129607876|NCT01857271|466520300|FG000|Overall Study|Lost to Follow-up|1|||
129607877|NCT03493386|466520301|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129607878|NCT03493386|466520302|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129607879|NCT03493386|466520303|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129607880|NCT03493386|466520304|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129607881|NCT04645966|466520305|FG000|Vaccination Phase|Adverse Event|1|||
129698813|NCT03715829|466856859|FG010|Extension Period|Protocol Violation|0|||
129438710|NCT00150969|465904484|FG001|24 Month Main Study|Lost to Follow-up|2|||
129607882|NCT04645966|466520306|FG001|Vaccination Phase|Adverse Event|0|||
129698814|NCT03715829|466856849|FG000|Extension Period|Withdrawal by Subject|0|||
129698815|NCT03715829|466856850|FG001|Extension Period|Withdrawal by Subject|0|||
129607883|NCT04645966|466520307|FG002|Vaccination Phase|Adverse Event|0|||
129607884|NCT04645966|466520308|FG003|Vaccination Phase|Adverse Event|0|||
129607885|NCT04645966|466520309|FG004|Vaccination Phase|Adverse Event|0|||
129607886|NCT04645966|466520310|FG005|Vaccination Phase|Adverse Event|0|||
129607887|NCT04645966|466520311|FG006|Vaccination Phase|Adverse Event|1|||
129607888|NCT04645966|466520312|FG007|Vaccination Phase|Adverse Event|0|||
129607889|NCT04645966|466520313|FG008|Vaccination Phase|Adverse Event|0|||
129607890|NCT04645966|466520305|FG000|Vaccination Phase|Death|0|||
129607891|NCT04645966|466520306|FG001|Vaccination Phase|Death|0|||
129607892|NCT04645966|466520307|FG002|Vaccination Phase|Death|0|||
129607893|NCT04645966|466520308|FG003|Vaccination Phase|Death|0|||
129607894|NCT04645966|466520309|FG004|Vaccination Phase|Death|0|||
129607895|NCT04645966|466520310|FG005|Vaccination Phase|Death|1|||
129607896|NCT04645966|466520311|FG006|Vaccination Phase|Death|0|||
129607897|NCT04645966|466520312|FG007|Vaccination Phase|Death|0|||
129607898|NCT04645966|466520313|FG008|Vaccination Phase|Death|0|||
129607899|NCT04645966|466520305|FG000|Vaccination Phase|Protocol Violation|0|||
129607900|NCT04645966|466520306|FG001|Vaccination Phase|Protocol Violation|0|||
129607901|NCT04645966|466520307|FG002|Vaccination Phase|Protocol Violation|0|||
129607902|NCT04645966|466520308|FG003|Vaccination Phase|Protocol Violation|0|||
129607903|NCT04645966|466520309|FG004|Vaccination Phase|Protocol Violation|1|||
129607904|NCT04645966|466520310|FG005|Vaccination Phase|Protocol Violation|0|||
129607905|NCT04645966|466520311|FG006|Vaccination Phase|Protocol Violation|0|||
129607906|NCT04645966|466520312|FG007|Vaccination Phase|Protocol Violation|0|||
129607907|NCT04645966|466520313|FG008|Vaccination Phase|Protocol Violation|0|||
129607908|NCT04645966|466520305|FG000|Vaccination Phase|Study terminated by sponsor|0|||
129607909|NCT04645966|466520306|FG001|Vaccination Phase|Study terminated by sponsor|0|||
129607910|NCT04645966|466520307|FG002|Vaccination Phase|Study terminated by sponsor|14|||
129607911|NCT04645966|466520308|FG003|Vaccination Phase|Study terminated by sponsor|15|||
129607912|NCT04645966|466520309|FG004|Vaccination Phase|Study terminated by sponsor|47|||
129607913|NCT04645966|466520310|FG005|Vaccination Phase|Study terminated by sponsor|43|||
129607914|NCT04645966|466520311|FG006|Vaccination Phase|Study terminated by sponsor|29|||
129607915|NCT04645966|466520312|FG007|Vaccination Phase|Study terminated by sponsor|29|||
129607916|NCT04645966|466520313|FG008|Vaccination Phase|Study terminated by sponsor|12|||
129607917|NCT04645966|466520305|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
129607918|NCT04645966|466520306|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
129607919|NCT04645966|466520307|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
129607920|NCT04645966|466520308|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
129607921|NCT04645966|466520309|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
129607922|NCT04645966|466520310|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
129607923|NCT04645966|466520311|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
129607924|NCT04645966|466520312|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
129607925|NCT04645966|466520313|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
129607926|NCT04645966|466520305|FG000|Vaccination Phase|Other|0|||
129607927|NCT04645966|466520306|FG001|Vaccination Phase|Other|0|||
129607928|NCT04645966|466520307|FG002|Vaccination Phase|Other|0|||
129607929|NCT04645966|466520308|FG003|Vaccination Phase|Other|0|||
129607930|NCT04645966|466520309|FG004|Vaccination Phase|Other|0|||
129607931|NCT04645966|466520310|FG005|Vaccination Phase|Other|2|||
129607932|NCT04645966|466520311|FG006|Vaccination Phase|Other|0|||
129607933|NCT04645966|466520312|FG007|Vaccination Phase|Other|0|||
129607934|NCT04645966|466520313|FG008|Vaccination Phase|Other|0|||
129607935|NCT04645966|466520305|FG000|Vaccination Phase|Lost to Follow-up|0|||
129607936|NCT04645966|466520306|FG001|Vaccination Phase|Lost to Follow-up|0|||
129607937|NCT04645966|466520307|FG002|Vaccination Phase|Lost to Follow-up|0|||
129607938|NCT04645966|466520308|FG003|Vaccination Phase|Lost to Follow-up|0|||
129607939|NCT04645966|466520309|FG004|Vaccination Phase|Lost to Follow-up|0|||
129607940|NCT04645966|466520310|FG005|Vaccination Phase|Lost to Follow-up|0|||
129607941|NCT04645966|466520311|FG006|Vaccination Phase|Lost to Follow-up|0|||
129607942|NCT04645966|466520312|FG007|Vaccination Phase|Lost to Follow-up|1|||
129607943|NCT04645966|466520313|FG008|Vaccination Phase|Lost to Follow-up|0|||
129607944|NCT04645966|466520305|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
129607945|NCT04645966|466520306|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
129607946|NCT04645966|466520307|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
129607947|NCT04645966|466520308|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
129607948|NCT04645966|466520309|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
129607949|NCT04645966|466520310|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
129607950|NCT04645966|466520311|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
129607951|NCT04645966|466520312|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
129607952|NCT04645966|466520313|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
129607953|NCT04645966|466520305|FG000|Follow-up Phase|Lost to Follow-up|0|||
129607954|NCT04645966|466520306|FG001|Follow-up Phase|Lost to Follow-up|0|||
129790601|NCT00992589|467201399|FG002|Open-Label Phase|Physician Decision|0|||
129607955|NCT04645966|466520307|FG002|Follow-up Phase|Lost to Follow-up|0|||
129607956|NCT04645966|466520308|FG003|Follow-up Phase|Lost to Follow-up|0|||
129607957|NCT04645966|466520309|FG004|Follow-up Phase|Lost to Follow-up|0|||
129698816|NCT03715829|466856851|FG002|Extension Period|Withdrawal by Subject|0|||
129698817|NCT03715829|466856852|FG003|Extension Period|Withdrawal by Subject|0|||
129698818|NCT03715829|466856853|FG004|Extension Period|Withdrawal by Subject|0|||
129698819|NCT03715829|466856854|FG005|Extension Period|Withdrawal by Subject|0|||
129698820|NCT03715829|466856855|FG006|Extension Period|Withdrawal by Subject|3|||
129698821|NCT03715829|466856856|FG007|Extension Period|Withdrawal by Subject|3|||
129698822|NCT03715829|466856857|FG008|Extension Period|Withdrawal by Subject|12|||
129698823|NCT03715829|466856858|FG009|Extension Period|Withdrawal by Subject|3|||
129698824|NCT03715829|466856859|FG010|Extension Period|Withdrawal by Subject|0|||
129698825|NCT03715829|466856849|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698826|NCT03715829|466856850|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698827|NCT03715829|466856851|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698828|NCT03715829|466856852|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698829|NCT03715829|466856853|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698830|NCT03715829|466856854|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698831|NCT03715829|466856855|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698832|NCT03715829|466856856|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
129607958|NCT04645966|466520310|FG005|Follow-up Phase|Lost to Follow-up|0|||
129607959|NCT04645966|466520311|FG006|Follow-up Phase|Lost to Follow-up|0|||
129607960|NCT04645966|466520312|FG007|Follow-up Phase|Lost to Follow-up|1|||
129607961|NCT04645966|466520313|FG008|Follow-up Phase|Lost to Follow-up|0|||
129607962|NCT02116608|466520315|FG000|Overall Study|Lost to Follow-up|0|||
129607963|NCT02116608|466520316|FG001|Overall Study|Lost to Follow-up|0|||
129607964|NCT02116608|466520317|FG002|Overall Study|Lost to Follow-up|1|||
129607965|NCT02116608|466520315|FG000|Overall Study|Physician Decision|0|||
129607966|NCT02116608|466520316|FG001|Overall Study|Physician Decision|1|||
129607967|NCT02116608|466520317|FG002|Overall Study|Physician Decision|0|||
129607968|NCT02116608|466520315|FG000|Overall Study|Death|0|||
129607969|NCT02116608|466520316|FG001|Overall Study|Death|1|||
129607970|NCT02116608|466520317|FG002|Overall Study|Death|0|||
129607971|NCT01468818|466520321|FG000|Overall Study|Death during treatment|2|||
129607972|NCT02338193|466520323|FG000|Overall Study|Withdrawal by Subject|0|||
129607973|NCT02338193|466520324|FG001|Overall Study|Withdrawal by Subject|0|||
129607974|NCT02338193|466520325|FG002|Overall Study|Withdrawal by Subject|2|||
129607975|NCT02338193|466520323|FG000|Overall Study|Pregnancy|0|||
129607976|NCT02338193|466520324|FG001|Overall Study|Pregnancy|1|||
129607977|NCT02338193|466520325|FG002|Overall Study|Pregnancy|1|||
129607978|NCT02338193|466520323|FG000|Overall Study|Noncompliant with visits|2|||
129607979|NCT02338193|466520324|FG001|Overall Study|Noncompliant with visits|2|||
129607980|NCT02338193|466520325|FG002|Overall Study|Noncompliant with visits|7|||
129607981|NCT02338193|466520323|FG000|Overall Study|moved out of state|0|||
129607982|NCT02338193|466520324|FG001|Overall Study|moved out of state|1|||
129607983|NCT02338193|466520325|FG002|Overall Study|moved out of state|0|||
129607984|NCT02338193|466520323|FG000|Overall Study|intolerant of side effects|1|||
129607985|NCT02338193|466520324|FG001|Overall Study|intolerant of side effects|0|||
129607986|NCT02338193|466520325|FG002|Overall Study|intolerant of side effects|0|||
129607987|NCT01059344|466520326|FG000|Overall Study|Adverse Event|12|||
129607988|NCT01059344|466520327|FG001|Overall Study|Adverse Event|30|||
129607989|NCT01059344|466520326|FG000|Overall Study|Withdrawal by Subject|6|||
129607990|NCT01059344|466520327|FG001|Overall Study|Withdrawal by Subject|9|||
129607991|NCT01059344|466520326|FG000|Overall Study|Lost to Follow-up|1|||
129607992|NCT01059344|466520327|FG001|Overall Study|Lost to Follow-up|1|||
129607993|NCT01059344|466520326|FG000|Overall Study|Other|3|||
129607994|NCT01059344|466520327|FG001|Overall Study|Other|6|||
129607995|NCT01739348|466520328|FG000|Part I (Base Study)|Adverse Event|41|||
129607996|NCT01739348|466520329|FG001|Part I (Base Study)|Adverse Event|52|||
129607997|NCT01739348|466520330|FG002|Part I (Base Study)|Adverse Event|8|||
129607998|NCT01739348|466520331|FG003|Part I (Base Study)|Adverse Event|33|||
129607999|NCT01739348|466520328|FG000|Part I (Base Study)|Death|10|||
129698833|NCT03715829|466856857|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
129698834|NCT03715829|466856858|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
129698835|NCT03715829|466856859|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
129608000|NCT01739348|466520329|FG001|Part I (Base Study)|Death|7|||
129698836|NCT03715829|466856849|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
129608001|NCT01739348|466520330|FG002|Part I (Base Study)|Death|2|||
129698837|NCT03715829|466856850|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
129608002|NCT01739348|466520331|FG003|Part I (Base Study)|Death|8|||
129608003|NCT01739348|466520328|FG000|Part I (Base Study)|Lack of Efficacy|3|||
129608004|NCT01739348|466520329|FG001|Part I (Base Study)|Lack of Efficacy|8|||
129608005|NCT01739348|466520330|FG002|Part I (Base Study)|Lack of Efficacy|0|||
129608006|NCT01739348|466520331|FG003|Part I (Base Study)|Lack of Efficacy|7|||
129608007|NCT01739348|466520328|FG000|Part I (Base Study)|Lost to Follow-up|4|||
129608008|NCT01739348|466520329|FG001|Part I (Base Study)|Lost to Follow-up|2|||
129608009|NCT01739348|466520330|FG002|Part I (Base Study)|Lost to Follow-up|4|||
129698838|NCT03715829|466856851|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
129608010|NCT01739348|466520331|FG003|Part I (Base Study)|Lost to Follow-up|4|||
129608011|NCT01739348|466520328|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
129608012|NCT01739348|466520329|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
129608013|NCT01739348|466520330|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
129608014|NCT01739348|466520331|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
129608015|NCT01739348|466520328|FG000|Part I (Base Study)|Physician Decision|10|||
129608016|NCT01739348|466520329|FG001|Part I (Base Study)|Physician Decision|7|||
129608017|NCT01739348|466520330|FG002|Part I (Base Study)|Physician Decision|1|||
129608018|NCT01739348|466520331|FG003|Part I (Base Study)|Physician Decision|4|||
129608019|NCT01739348|466520328|FG000|Part I (Base Study)|Protocol Violation|2|||
129608020|NCT01739348|466520329|FG001|Part I (Base Study)|Protocol Violation|0|||
129608021|NCT01739348|466520330|FG002|Part I (Base Study)|Protocol Violation|1|||
129608022|NCT01739348|466520331|FG003|Part I (Base Study)|Protocol Violation|2|||
129608023|NCT01739348|466520328|FG000|Part I (Base Study)|Screen Failure|2|||
129608024|NCT01739348|466520329|FG001|Part I (Base Study)|Screen Failure|0|||
129608025|NCT01739348|466520330|FG002|Part I (Base Study)|Screen Failure|0|||
129608026|NCT01739348|466520331|FG003|Part I (Base Study)|Screen Failure|0|||
129608027|NCT01739348|466520328|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
129608028|NCT01739348|466520329|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
129608029|NCT01739348|466520330|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
129608030|NCT01739348|466520331|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
129608031|NCT01739348|466520328|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
129608032|NCT01739348|466520329|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
129608033|NCT01739348|466520330|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
129608034|NCT01739348|466520331|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
129608035|NCT01739348|466520328|FG000|Part I (Base Study)|Participant Moved|4|||
129608036|NCT01739348|466520329|FG001|Part I (Base Study)|Participant Moved|3|||
129608037|NCT01739348|466520330|FG002|Part I (Base Study)|Participant Moved|1|||
129608038|NCT01739348|466520331|FG003|Part I (Base Study)|Participant Moved|7|||
129608039|NCT01739348|466520328|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
129608040|NCT01739348|466520329|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
129608041|NCT01739348|466520330|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
129608042|NCT01739348|466520331|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
129608043|NCT01739348|466520328|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
129608044|NCT01739348|466520329|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
129608045|NCT01739348|466520330|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
129608046|NCT01739348|466520331|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
129608047|NCT01739348|466520328|FG000|Part II (Extension Study)|Adverse Event|10|||
129608048|NCT01739348|466520329|FG001|Part II (Extension Study)|Adverse Event|11|||
129608049|NCT01739348|466520330|FG002|Part II (Extension Study)|Adverse Event|7|||
129608050|NCT01739348|466520331|FG003|Part II (Extension Study)|Adverse Event|26|||
129608051|NCT01739348|466520328|FG000|Part II (Extension Study)|Death|3|||
129608052|NCT01739348|466520329|FG001|Part II (Extension Study)|Death|3|||
129608053|NCT01739348|466520330|FG002|Part II (Extension Study)|Death|2|||
129608054|NCT01739348|466520331|FG003|Part II (Extension Study)|Death|6|||
129608055|NCT01739348|466520328|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
129608056|NCT01739348|466520329|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
129608057|NCT01739348|466520330|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
129647546|NCT02407457|466665347|FG000|3-year|Death|11|||
129647547|NCT02407457|466665348|FG001|3-year|Death|10|||
129647548|NCT02407457|466665347|FG000|3-year|Lost to Follow-up|9|||
129647549|NCT02407457|466665348|FG001|3-year|Lost to Follow-up|10|||
129647550|NCT02407457|466665347|FG000|3-year|Missed Visit|19|||
129647551|NCT02407457|466665348|FG001|3-year|Missed Visit|16|||
129647552|NCT02407457|466665347|FG000|4-year|Death|18|||
129647553|NCT02407457|466665348|FG001|4-year|Death|10|||
129647554|NCT02407457|466665347|FG000|4-year|Lost to Follow-up|10|||
129647555|NCT02407457|466665348|FG001|4-year|Lost to Follow-up|12|||
129647556|NCT02407457|466665347|FG000|4-year|Missed Visit|18|||
129647557|NCT02407457|466665348|FG001|4-year|Missed Visit|16|||
129647558|NCT02407457|466665347|FG000|5-year|Death|10|||
129647559|NCT02407457|466665348|FG001|5-year|Death|3|||
129647560|NCT02407457|466665347|FG000|5-year|Lost to Follow-up|22|||
129647561|NCT02407457|466665348|FG001|5-year|Lost to Follow-up|13|||
129647562|NCT02407457|466665347|FG000|5-year|Missed Visit|9|||
129647563|NCT02407457|466665348|FG001|5-year|Missed Visit|1|||
129647564|NCT02083185|466665349|FG000|Overall Study|Lost to Follow-up|0|||
129647565|NCT02083185|466665350|FG001|Overall Study|Lost to Follow-up|3|||
129647566|NCT02083185|466665351|FG002|Overall Study|Lost to Follow-up|0|||
129647567|NCT02083185|466665349|FG000|Overall Study|Withdrawal by Subject|9|||
129647568|NCT02083185|466665350|FG001|Overall Study|Withdrawal by Subject|15|||
129647569|NCT02083185|466665351|FG002|Overall Study|Withdrawal by Subject|1|||
129647570|NCT02083185|466665349|FG000|Overall Study|Death|2|||
129647571|NCT02083185|466665350|FG001|Overall Study|Death|2|||
129647572|NCT02083185|466665351|FG002|Overall Study|Death|1|||
129647573|NCT02083185|466665349|FG000|Overall Study|Reason not Specified|9|||
129608058|NCT01739348|466520331|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
129608059|NCT01739348|466520328|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
129608060|NCT01739348|466520329|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
129608061|NCT01739348|466520330|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
129608062|NCT01739348|466520331|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
129608063|NCT01739348|466520328|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
129608064|NCT01739348|466520329|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
129608065|NCT01739348|466520330|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
129608066|NCT01739348|466520331|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
129608067|NCT01739348|466520328|FG000|Part II (Extension Study)|Physician Decision|7|||
129608068|NCT01739348|466520329|FG001|Part II (Extension Study)|Physician Decision|11|||
129608069|NCT01739348|466520330|FG002|Part II (Extension Study)|Physician Decision|6|||
129608070|NCT01739348|466520331|FG003|Part II (Extension Study)|Physician Decision|12|||
129608071|NCT01739348|466520328|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
129608072|NCT01739348|466520329|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
129608073|NCT01739348|466520330|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
129608074|NCT01739348|466520331|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
129608075|NCT01739348|466520328|FG000|Part II (Extension Study)|Participant Moved|3|||
129608076|NCT01739348|466520329|FG001|Part II (Extension Study)|Participant Moved|3|||
129608077|NCT01739348|466520330|FG002|Part II (Extension Study)|Participant Moved|0|||
129608078|NCT01739348|466520331|FG003|Part II (Extension Study)|Participant Moved|3|||
129608079|NCT01739348|466520328|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
129608080|NCT01739348|466520329|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
129608081|NCT01739348|466520330|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
129608082|NCT01739348|466520331|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
129608083|NCT01739348|466520328|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
129608084|NCT01739348|466520329|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
129608085|NCT01739348|466520330|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
129698839|NCT03715829|466856852|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698840|NCT03715829|466856853|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698841|NCT03715829|466856854|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698842|NCT03715829|466856855|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698843|NCT03715829|466856856|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698844|NCT03715829|466856857|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
129698845|NCT03715829|466856858|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698846|NCT03715829|466856859|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
129698847|NCT03715829|466856849|FG000|Extension Period|Other|0|||
129698848|NCT03715829|466856850|FG001|Extension Period|Other|0|||
129698849|NCT03715829|466856851|FG002|Extension Period|Other|0|||
129698850|NCT03715829|466856852|FG003|Extension Period|Other|0|||
129698851|NCT03715829|466856853|FG004|Extension Period|Other|0|||
129698852|NCT03715829|466856854|FG005|Extension Period|Other|0|||
129698853|NCT03715829|466856855|FG006|Extension Period|Other|1|||
129698854|NCT03715829|466856856|FG007|Extension Period|Other|2|||
129698855|NCT03715829|466856857|FG008|Extension Period|Other|4|||
129698856|NCT03715829|466856858|FG009|Extension Period|Other|0|||
129698857|NCT03715829|466856859|FG010|Extension Period|Other|0|||
129698858|NCT03579719|466856860|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
129698859|NCT00855166|466856861|FG000|Overall Study|Adverse Event|0|||
129698860|NCT00855166|466856862|FG001|Overall Study|Adverse Event|2|||
129698861|NCT00855166|466856861|FG000|Overall Study|Death|0|||
129698862|NCT00855166|466856862|FG001|Overall Study|Death|1|||
129698863|NCT00855166|466856861|FG000|Overall Study|Withdrawal by Subject|1|||
129698864|NCT00855166|466856862|FG001|Overall Study|Withdrawal by Subject|4|||
129698865|NCT00855166|466856861|FG000|Overall Study|Poor/non-compliance|2|||
129698866|NCT00855166|466856862|FG001|Overall Study|Poor/non-compliance|0|||
129698867|NCT00855166|466856861|FG000|Overall Study|Administrative reasons by sponsor|1|||
129698868|NCT00855166|466856862|FG001|Overall Study|Administrative reasons by sponsor|0|||
129698869|NCT00855166|466856861|FG000|Overall Study|Subject no longer meets study criteria|1|||
129698870|NCT00855166|466856862|FG001|Overall Study|Subject no longer meets study criteria|1|||
129698871|NCT04818229|466856865|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
129698872|NCT04818229|466856866|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
129698873|NCT04818229|466856867|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
129698874|NCT04818229|466856865|FG000|Overall Study|Adverse Event|3|||
129698875|NCT04818229|466856866|FG001|Overall Study|Adverse Event|1|||
129698876|NCT04818229|466856867|FG002|Overall Study|Adverse Event|1|||
129698877|NCT04818229|466856865|FG000|Overall Study|Withdrawal by Subject|0|||
129698878|NCT04818229|466856866|FG001|Overall Study|Withdrawal by Subject|0|||
129698879|NCT04818229|466856867|FG002|Overall Study|Withdrawal by Subject|2|||
129698880|NCT04818229|466856865|FG000|Overall Study|Lost to Follow-up|0|||
129698881|NCT04818229|466856866|FG001|Overall Study|Lost to Follow-up|0|||
129698882|NCT04818229|466856867|FG002|Overall Study|Lost to Follow-up|1|||
129698883|NCT04082364|466856868|FG000|Overall Study|Death|23|||
129698884|NCT04082364|466856869|FG001|Overall Study|Death|1|||
129698885|NCT04082364|466856870|FG002|Overall Study|Death|1|||
129698886|NCT04082364|466856871|FG003|Overall Study|Death|2|||
129698887|NCT04082364|466856872|FG004|Overall Study|Death|1|||
129698888|NCT04082364|466856868|FG000|Overall Study|Lost to Follow-up|1|||
129698889|NCT04082364|466856869|FG001|Overall Study|Lost to Follow-up|0|||
129698890|NCT04082364|466856870|FG002|Overall Study|Lost to Follow-up|0|||
129698891|NCT04082364|466856871|FG003|Overall Study|Lost to Follow-up|0|||
129698892|NCT04082364|466856872|FG004|Overall Study|Lost to Follow-up|1|||
129698893|NCT04082364|466856868|FG000|Overall Study|Physician Decision|1|||
129698894|NCT04082364|466856869|FG001|Overall Study|Physician Decision|1|||
129698895|NCT04082364|466856870|FG002|Overall Study|Physician Decision|0|||
129698896|NCT04082364|466856871|FG003|Overall Study|Physician Decision|2|||
129698897|NCT04082364|466856872|FG004|Overall Study|Physician Decision|1|||
129698898|NCT04082364|466856868|FG000|Overall Study|Withdrawal by Subject|1|||
129698899|NCT04082364|466856869|FG001|Overall Study|Withdrawal by Subject|1|||
129608086|NCT01739348|466520331|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
129608087|NCT01447420|466520335|FG000|Overall Study|Adverse Event|2|||
129608088|NCT01447420|466520336|FG001|Overall Study|Adverse Event|4|||
129608089|NCT01447420|466520337|FG002|Overall Study|Adverse Event|2|||
129608090|NCT01447420|466520335|FG000|Overall Study|Protocol Violation|3|||
129608091|NCT01447420|466520336|FG001|Overall Study|Protocol Violation|3|||
129608092|NCT01447420|466520337|FG002|Overall Study|Protocol Violation|0|||
129608093|NCT01447420|466520335|FG000|Overall Study|Withdrawal by Subject|4|||
129608094|NCT01447420|466520336|FG001|Overall Study|Withdrawal by Subject|1|||
129608095|NCT01447420|466520337|FG002|Overall Study|Withdrawal by Subject|0|||
129608096|NCT01447420|466520335|FG000|Overall Study|Lack of Efficacy|1|||
129608097|NCT01447420|466520336|FG001|Overall Study|Lack of Efficacy|19|||
129608098|NCT01447420|466520337|FG002|Overall Study|Lack of Efficacy|8|||
129608099|NCT05788289|466520344|FG000|Overall Study|Death|3|||
129608100|NCT01974440|466520345|FG000|Overall Study|Lost to Follow-up|7|||
129608101|NCT01974440|466520346|FG001|Overall Study|Lost to Follow-up|7|||
129608102|NCT01974440|466520345|FG000|Overall Study|Withdrawal by Subject|24|||
129608103|NCT01974440|466520346|FG001|Overall Study|Withdrawal by Subject|20|||
129608104|NCT01974440|466520345|FG000|Overall Study|Sponsor decision|109|||
129608105|NCT01974440|466520346|FG001|Overall Study|Sponsor decision|110|||
129608106|NCT00762437|466520347|FG000|Overall Study|Lost to Follow-up|7|||
129608107|NCT00762437|466520347|FG000|Overall Study|Missed final study visit|11|||
129608108|NCT00762437|466520347|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
129608109|NCT03569228|466520348|FG000|Overall Study|Withdrawal by PI|0|||
129608110|NCT03569228|466520349|FG001|Overall Study|Withdrawal by PI|0|||
129608111|NCT03569228|466520350|FG002|Overall Study|Withdrawal by PI|2|||
129608112|NCT03569228|466520351|FG003|Overall Study|Withdrawal by PI|2|||
129608113|NCT03569228|466520352|FG004|Overall Study|Withdrawal by PI|1|||
129608114|NCT03569228|466520353|FG005|Overall Study|Withdrawal by PI|0|||
129608115|NCT03569228|466520354|FG006|Overall Study|Withdrawal by PI|0|||
129608116|NCT03569228|466520355|FG007|Overall Study|Withdrawal by PI|0|||
129608117|NCT03569228|466520356|FG008|Overall Study|Withdrawal by PI|0|||
129608118|NCT03569228|466520348|FG000|Overall Study|Lost to Follow-up|0|||
129608119|NCT03569228|466520349|FG001|Overall Study|Lost to Follow-up|0|||
129608120|NCT03569228|466520350|FG002|Overall Study|Lost to Follow-up|0|||
129608121|NCT03569228|466520351|FG003|Overall Study|Lost to Follow-up|0|||
129608122|NCT03569228|466520352|FG004|Overall Study|Lost to Follow-up|0|||
129698900|NCT04082364|466856870|FG002|Overall Study|Withdrawal by Subject|0|||
129698901|NCT04082364|466856871|FG003|Overall Study|Withdrawal by Subject|0|||
129698902|NCT04082364|466856872|FG004|Overall Study|Withdrawal by Subject|1|||
129698903|NCT04082364|466856868|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
129698904|NCT04082364|466856869|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
129698905|NCT04082364|466856870|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
129698906|NCT04082364|466856871|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
129698907|NCT04082364|466856872|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
129698908|NCT04082364|466856868|FG000|Overall Study|Disease progression|0|||
129790602|NCT00992589|467201400|FG003|Open-Label Phase|Physician Decision|0|||
129608123|NCT03569228|466520353|FG005|Overall Study|Lost to Follow-up|0|||
129608124|NCT03569228|466520354|FG006|Overall Study|Lost to Follow-up|0|||
129608125|NCT03569228|466520355|FG007|Overall Study|Lost to Follow-up|0|||
129608126|NCT03569228|466520356|FG008|Overall Study|Lost to Follow-up|1|||
129608127|NCT03569228|466520348|FG000|Overall Study|Screen Fail|2|||
129608128|NCT03569228|466520349|FG001|Overall Study|Screen Fail|2|||
129608129|NCT03569228|466520350|FG002|Overall Study|Screen Fail|1|||
129608130|NCT03569228|466520351|FG003|Overall Study|Screen Fail|1|||
129698909|NCT04082364|466856869|FG001|Overall Study|Disease progression|0|||
129698910|NCT04082364|466856870|FG002|Overall Study|Disease progression|0|||
129698911|NCT04082364|466856871|FG003|Overall Study|Disease progression|1|||
129608131|NCT03569228|466520352|FG004|Overall Study|Screen Fail|1|||
129608132|NCT03569228|466520353|FG005|Overall Study|Screen Fail|3|||
129608133|NCT03569228|466520354|FG006|Overall Study|Screen Fail|1|||
129608134|NCT03569228|466520355|FG007|Overall Study|Screen Fail|5|||
129608135|NCT03569228|466520356|FG008|Overall Study|Screen Fail|2|||
129608136|NCT06354998|466520357|FG000|Overall Study|Withdrawal by Subject|3|||
129608137|NCT06354998|466520358|FG001|Overall Study|Withdrawal by Subject|0|||
129608138|NCT00085423|466520363|FG000|Overall Study|Withdrawal by Subject|1|||
129608139|NCT00085423|466520363|FG000|Overall Study|screen failure|1|||
129608140|NCT00536263|466520371|FG000|Overall Study|Adverse Event|5|||
129608141|NCT00536263|466520372|FG001|Overall Study|Adverse Event|5|||
129608142|NCT00536263|466520373|FG002|Overall Study|Adverse Event|7|||
129608143|NCT00536263|466520371|FG000|Overall Study|Lost to Follow-up|3|||
129608144|NCT00536263|466520372|FG001|Overall Study|Lost to Follow-up|4|||
129608145|NCT00536263|466520373|FG002|Overall Study|Lost to Follow-up|4|||
129608146|NCT00536263|466520371|FG000|Overall Study|Subject withdrew - not treatment related|2|||
129608147|NCT00536263|466520372|FG001|Overall Study|Subject withdrew - not treatment related|0|||
129608148|NCT00536263|466520373|FG002|Overall Study|Subject withdrew - not treatment related|5|||
129608149|NCT00536263|466520371|FG000|Overall Study|Subject withdrew - treatment related|0|||
129608150|NCT00536263|466520372|FG001|Overall Study|Subject withdrew - treatment related|3|||
129608151|NCT00536263|466520373|FG002|Overall Study|Subject withdrew - treatment related|2|||
129608152|NCT00536263|466520371|FG000|Overall Study|Noncompliance with protocol|0|||
129608153|NCT00536263|466520372|FG001|Overall Study|Noncompliance with protocol|0|||
129608154|NCT00536263|466520373|FG002|Overall Study|Noncompliance with protocol|1|||
129608155|NCT00536263|466520371|FG000|Overall Study|Did not meet protocol eligibility|1|||
129608156|NCT00536263|466520372|FG001|Overall Study|Did not meet protocol eligibility|2|||
129790603|NCT00992589|467201397|FG000|Open-Label Phase|Other|45|||
129790604|NCT00992589|467201398|FG001|Open-Label Phase|Other|0|||
129790605|NCT00992589|467201399|FG002|Open-Label Phase|Other|0|||
129790606|NCT00992589|467201400|FG003|Open-Label Phase|Other|0|||
129790607|NCT00992589|467201397|FG000|Double-Blind Phase|Adverse Event|0|||
129790608|NCT00992589|467201398|FG001|Double-Blind Phase|Adverse Event|6|||
129790609|NCT00992589|467201399|FG002|Double-Blind Phase|Adverse Event|2|||
129790610|NCT00992589|467201400|FG003|Double-Blind Phase|Adverse Event|3|||
129790611|NCT00992589|467201397|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129608157|NCT00536263|466520373|FG002|Overall Study|Did not meet protocol eligibility|2|||
129608158|NCT01181271|466520376|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
129608159|NCT01181271|466520376|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
129608160|NCT01181271|466520376|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
129608161|NCT01181271|466520376|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
129608162|NCT03201211|466520377|FG000|Overall Study|Adverse Event|1|||
129608163|NCT03201211|466520378|FG001|Overall Study|Adverse Event|0|||
129608164|NCT03201211|466520379|FG002|Overall Study|Adverse Event|0|||
129608165|NCT03201211|466520377|FG000|Overall Study|Protocol Violation|1|||
129608166|NCT03201211|466520378|FG001|Overall Study|Protocol Violation|0|||
129608167|NCT03201211|466520379|FG002|Overall Study|Protocol Violation|0|||
129608168|NCT03201211|466520377|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129608169|NCT03201211|466520378|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129608170|NCT03201211|466520379|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
129608171|NCT03201211|466520377|FG000|Overall Study|OTHER unknown reasons|0|||
129608172|NCT03201211|466520378|FG001|Overall Study|OTHER unknown reasons|1|||
129608173|NCT03201211|466520379|FG002|Overall Study|OTHER unknown reasons|0|||
129608174|NCT01083810|466520380|FG000|Overall Study|Lost to Follow-up|23|||
129608175|NCT01083810|466520381|FG001|Overall Study|Lost to Follow-up|11|||
129608176|NCT01083810|466520382|FG002|Overall Study|Lost to Follow-up|4|||
129608177|NCT01083810|466520380|FG000|Overall Study|Adverse Event|15|||
129608178|NCT01083810|466520381|FG001|Overall Study|Adverse Event|11|||
129608179|NCT01083810|466520382|FG002|Overall Study|Adverse Event|4|||
129608180|NCT01083810|466520380|FG000|Overall Study|Withdrawal by Subject|7|||
129608181|NCT01083810|466520381|FG001|Overall Study|Withdrawal by Subject|2|||
129608182|NCT01083810|466520382|FG002|Overall Study|Withdrawal by Subject|4|||
129608183|NCT01083810|466520380|FG000|Overall Study|Reason not reported|6|||
129608184|NCT01083810|466520381|FG001|Overall Study|Reason not reported|1|||
129608185|NCT01083810|466520382|FG002|Overall Study|Reason not reported|1|||
129608186|NCT01083810|466520380|FG000|Overall Study|Non-compliance|4|||
129608187|NCT01083810|466520381|FG001|Overall Study|Non-compliance|7|||
129608188|NCT01083810|466520382|FG002|Overall Study|Non-compliance|2|||
129608189|NCT01083810|466520380|FG000|Overall Study|Simplification|4|||
129608190|NCT01083810|466520381|FG001|Overall Study|Simplification|1|||
129608191|NCT01083810|466520382|FG002|Overall Study|Simplification|0|||
129608192|NCT01083810|466520380|FG000|Overall Study|Death|2|||
129608193|NCT01083810|466520381|FG001|Overall Study|Death|2|||
129608194|NCT01083810|466520382|FG002|Overall Study|Death|3|||
129438711|NCT00150969|465904483|FG000|24 Month Main Study|Protocol Violation|4|||
129608195|NCT01083810|466520380|FG000|Overall Study|Co-morbidities|1|||
129790612|NCT00992589|467201398|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
129608196|NCT01083810|466520381|FG001|Overall Study|Co-morbidities|0|||
129608197|NCT01083810|466520382|FG002|Overall Study|Co-morbidities|0|||
129608198|NCT01083810|466520380|FG000|Overall Study|Participation in study|1|||
129608199|NCT01083810|466520381|FG001|Overall Study|Participation in study|0|||
129790613|NCT00992589|467201399|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
129698912|NCT04082364|466856872|FG004|Overall Study|Disease progression|0|||
129698913|NCT03186378|466856873|FG000|Overall Study|Lost to Follow-up|1|||
129698914|NCT03186378|466856874|FG001|Overall Study|Lost to Follow-up|0|||
129698915|NCT02514746|466856875|FG000|Overall Study|Chronically Ill|1|||
129698916|NCT02514746|466856876|FG001|Overall Study|Chronically Ill|2|||
129608200|NCT01083810|466520382|FG002|Overall Study|Participation in study|0|||
129608201|NCT01083810|466520380|FG000|Overall Study|Therapy break|1|||
129608202|NCT01083810|466520381|FG001|Overall Study|Therapy break|2|||
129608203|NCT01083810|466520382|FG002|Overall Study|Therapy break|2|||
129608204|NCT01083810|466520380|FG000|Overall Study|Virologic failure|1|||
129608205|NCT01083810|466520381|FG001|Overall Study|Virologic failure|8|||
129608206|NCT01083810|466520382|FG002|Overall Study|Virologic failure|0|||
129608207|NCT03118570|466520385|FG000|Overall Study|Adverse Event|2|||
129608208|NCT03118570|466520386|FG001|Overall Study|Adverse Event|0|||
129608209|NCT03118570|466520387|FG002|Overall Study|Adverse Event|0|||
129608210|NCT03118570|466520388|FG003|Overall Study|Adverse Event|0|||
129608211|NCT03118570|466520389|FG004|Overall Study|Adverse Event|3|||
129608212|NCT03118570|466520385|FG000|Overall Study|Withdrawal by Subject|0|||
129608213|NCT03118570|466520386|FG001|Overall Study|Withdrawal by Subject|1|||
129608214|NCT03118570|466520387|FG002|Overall Study|Withdrawal by Subject|4|||
129608215|NCT03118570|466520388|FG003|Overall Study|Withdrawal by Subject|0|||
129608216|NCT03118570|466520389|FG004|Overall Study|Withdrawal by Subject|1|||
129608217|NCT03118570|466520385|FG000|Overall Study|Lost to Follow-up|2|||
129608218|NCT03118570|466520386|FG001|Overall Study|Lost to Follow-up|3|||
129608219|NCT03118570|466520387|FG002|Overall Study|Lost to Follow-up|1|||
129608220|NCT03118570|466520388|FG003|Overall Study|Lost to Follow-up|0|||
129608221|NCT03118570|466520389|FG004|Overall Study|Lost to Follow-up|1|||
129608222|NCT03118570|466520385|FG000|Overall Study|Other, Not Specified|1|||
129608223|NCT03118570|466520386|FG001|Overall Study|Other, Not Specified|3|||
129608224|NCT03118570|466520387|FG002|Overall Study|Other, Not Specified|0|||
129608225|NCT03118570|466520388|FG003|Overall Study|Other, Not Specified|0|||
129608226|NCT03118570|466520389|FG004|Overall Study|Other, Not Specified|0|||
129608227|NCT00477295|466520392|FG000|Overall Study|Adverse Event|31|||
129608228|NCT00477295|466520393|FG001|Overall Study|Adverse Event|35|||
129608229|NCT00477295|466520392|FG000|Overall Study|Withdrawal by Subject|35|||
129608230|NCT00477295|466520393|FG001|Overall Study|Withdrawal by Subject|24|||
129608231|NCT00477295|466520392|FG000|Overall Study|Lack of Efficacy|23|||
129608232|NCT00477295|466520393|FG001|Overall Study|Lack of Efficacy|23|||
129608233|NCT00477295|466520392|FG000|Overall Study|Protocol Violation|3|||
129608234|NCT00477295|466520393|FG001|Overall Study|Protocol Violation|8|||
129608235|NCT00477295|466520392|FG000|Overall Study|Physician Decision|4|||
129608236|NCT00477295|466520393|FG001|Overall Study|Physician Decision|5|||
129608237|NCT00477295|466520392|FG000|Overall Study|Lost to Follow-up|21|||
129608238|NCT00477295|466520393|FG001|Overall Study|Lost to Follow-up|11|||
129608239|NCT00477295|466520392|FG000|Overall Study|Other|4|||
129608240|NCT00477295|466520393|FG001|Overall Study|Other|3|||
129608241|NCT00228423|466520396|FG000|Overall Study|Adverse Event|2|||
129608242|NCT00228423|466520397|FG001|Overall Study|Adverse Event|5|||
129608243|NCT00228423|466520396|FG000|Overall Study|Withdrawal by Subject|7|||
129608244|NCT00228423|466520397|FG001|Overall Study|Withdrawal by Subject|3|||
129608245|NCT00228423|466520396|FG000|Overall Study|Protocol Violation|1|||
129608246|NCT00228423|466520397|FG001|Overall Study|Protocol Violation|3|||
129608247|NCT00228423|466520396|FG000|Overall Study|Physician Decision|0|||
129608248|NCT00228423|466520397|FG001|Overall Study|Physician Decision|1|||
129608249|NCT01709838|466520411|FG000|Overall Study|Withdrawal by Subject|21|||
129608250|NCT01709838|466520411|FG000|Overall Study|Lost to Follow-up|16|||
129608251|NCT01709838|466520411|FG000|Overall Study|Pregnancy|10|||
129608252|NCT01709838|466520411|FG000|Overall Study|Subject/guardian decision|8|||
129608253|NCT01709838|466520411|FG000|Overall Study|Adverse Event|4|||
129608254|NCT01709838|466520411|FG000|Overall Study|Physician Decision|4|||
129608255|NCT01709838|466520411|FG000|Overall Study|Death|3|||
129608256|NCT01709838|466520411|FG000|Overall Study|Protocol Violation|1|||
129608257|NCT03433755|466520416|FG000|Overall Study|Lost to Follow-up|1|||
129698917|NCT02514746|466856875|FG000|Overall Study|Physician Decision|4|||
129698918|NCT02514746|466856876|FG001|Overall Study|Physician Decision|2|||
129698919|NCT02514746|466856875|FG000|Overall Study|Withdrawal by Subject|12|||
129698920|NCT02514746|466856876|FG001|Overall Study|Withdrawal by Subject|10|||
129698921|NCT02514746|466856875|FG000|Overall Study|Other|5|||
129698922|NCT02514746|466856876|FG001|Overall Study|Other|1|||
129698923|NCT02181413|466856877|FG000|Overall Study|Withdrawal by Subject|45|||
129698924|NCT02181413|466856878|FG001|Overall Study|Withdrawal by Subject|61|||
129608258|NCT03433755|466520417|FG001|Overall Study|Lost to Follow-up|0|||
129608259|NCT03433755|466520418|FG002|Overall Study|Lost to Follow-up|0|||
129608260|NCT03433755|466520419|FG003|Overall Study|Lost to Follow-up|0|||
129698925|NCT02181413|466856877|FG000|Overall Study|Reason Not Specified|2|||
129698926|NCT02181413|466856878|FG001|Overall Study|Reason Not Specified|5|||
129698927|NCT02181413|466856877|FG000|Overall Study|Lost to Follow-up|8|||
129608261|NCT03433755|466520416|FG000|Overall Study|Decision by Sponsor|1|||
129698928|NCT02181413|466856878|FG001|Overall Study|Lost to Follow-up|7|||
129608262|NCT03433755|466520417|FG001|Overall Study|Decision by Sponsor|0|||
129438712|NCT00150969|465904484|FG001|24 Month Main Study|Protocol Violation|2|||
129438713|NCT00150969|465904483|FG000|24 Month Main Study|Withdrawal by Subject|7|||
129438714|NCT00150969|465904484|FG001|24 Month Main Study|Withdrawal by Subject|4|||
129438715|NCT00150969|465904483|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
129438716|NCT00150969|465904484|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
129438717|NCT00150969|465904483|FG000|24-48 Month Extension|Lack of Efficacy|0|||
129438718|NCT00150969|465904484|FG001|24-48 Month Extension|Lack of Efficacy|1|||
129438719|NCT00150969|465904483|FG000|24-48 Month Extension|Adverse Event|1|||
129438720|NCT00150969|465904484|FG001|24-48 Month Extension|Adverse Event|3|||
129438721|NCT00150969|465904483|FG000|24-48 Month Extension|Other Reason|81|||
129438722|NCT00150969|465904484|FG001|24-48 Month Extension|Other Reason|91|||
129438723|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
129438724|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
129438725|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
129438726|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
129438727|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
129438728|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
129438729|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
129438730|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
129438731|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
129438732|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
129608263|NCT03433755|466520418|FG002|Overall Study|Decision by Sponsor|0|||
129608264|NCT03433755|466520419|FG003|Overall Study|Decision by Sponsor|0|||
129608265|NCT03190330|466523783|FG000|Overall Study|Adverse Event|2|||
129608266|NCT03190330|466523783|FG000|Overall Study|Death|10|||
129608267|NCT03190330|466523783|FG000|Overall Study|Lost to Follow-up|1|||
129608268|NCT03190330|466523783|FG000|Overall Study|Withdrawal by Subject|6|||
129608269|NCT03190330|466523783|FG000|Overall Study|Progressive Disease|1|||
129608270|NCT03845296|466523792|FG000|Overall Study|On Treatment|2|||
129608271|NCT03845296|466523793|FG001|Overall Study|On Treatment|1|||
129608272|NCT03845296|466523792|FG000|Overall Study|Adverse Event|4|||
129608273|NCT03845296|466523793|FG001|Overall Study|Adverse Event|11|||
129608274|NCT03845296|466523792|FG000|Overall Study|Refusal unrelated to adverse event|0|||
129608275|NCT03845296|466523793|FG001|Overall Study|Refusal unrelated to adverse event|1|||
129608276|NCT03845296|466523792|FG000|Overall Study|Progression/relapse|14|||
129608277|NCT03845296|466523793|FG001|Overall Study|Progression/relapse|18|||
129608278|NCT03845296|466523792|FG000|Overall Study|Death|4|||
129608279|NCT03845296|466523793|FG001|Overall Study|Death|0|||
129608280|NCT03845296|466523792|FG000|Overall Study|Other - not protocol specified|1|||
129608281|NCT03845296|466523793|FG001|Overall Study|Other - not protocol specified|3|||
129608282|NCT03611543|466523796|FG000|Overall Study|Withdrawal by Subject|4|||
129608283|NCT03611543|466523797|FG001|Overall Study|Withdrawal by Subject|4|||
129608284|NCT03611543|466523796|FG000|Overall Study|Physician Decision|1|||
129608285|NCT03611543|466523797|FG001|Overall Study|Physician Decision|1|||
129608286|NCT03611543|466523796|FG000|Overall Study|Protocol Violation|2|||
129608287|NCT03611543|466523797|FG001|Overall Study|Protocol Violation|2|||
129608288|NCT03611543|466523796|FG000|Overall Study|Device failure|2|||
129608289|NCT03611543|466523797|FG001|Overall Study|Device failure|2|||
129608290|NCT03611543|466523796|FG000|Overall Study|Missing information|5|||
129608291|NCT03611543|466523797|FG001|Overall Study|Missing information|5|||
129608292|NCT02081209|466523798|FG000|Overall Study|Withdrawal by Subject|1|||
129608293|NCT02799095|466523806|FG000|Part A|Adverse Event|1|||
129608294|NCT02799095|466523807|FG001|Part A|Adverse Event|0|||
129608295|NCT02799095|466523808|FG002|Part A|Adverse Event|1|||
129608296|NCT02799095|466523809|FG003|Part A|Adverse Event|4|||
129608297|NCT02799095|466523810|FG004|Part A|Adverse Event|1|||
129608298|NCT02799095|466523811|FG005|Part A|Adverse Event|0|||
129608299|NCT02799095|466523812|FG006|Part A|Adverse Event|0|||
129608300|NCT02799095|466523813|FG007|Part A|Adverse Event|0|||
129698929|NCT03973489|466856886|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
129698930|NCT03973489|466856887|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129698931|NCT03973489|466856888|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129698932|NCT03973489|466856889|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129698933|NCT03973489|466856890|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
129438733|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
129438734|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
129438735|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
129608301|NCT02799095|466523814|FG008|Part A|Adverse Event|0|||
129608302|NCT02799095|466523815|FG009|Part A|Adverse Event|0|||
129608303|NCT02799095|466523816|FG010|Part A|Adverse Event|0|||
129608304|NCT02799095|466523817|FG011|Part A|Adverse Event|0|||
129608305|NCT02799095|466523818|FG012|Part A|Adverse Event|0|||
129608306|NCT02799095|466523819|FG013|Part A|Adverse Event|0|||
129608307|NCT02799095|466523820|FG014|Part A|Adverse Event|0|||
129608308|NCT02799095|466523821|FG015|Part A|Adverse Event|0|||
129608309|NCT02799095|466523822|FG016|Part A|Adverse Event|0|||
129608310|NCT02799095|466523806|FG000|Part A|Death|0|||
129790614|NCT00992589|467201400|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
129608311|NCT02799095|466523807|FG001|Part A|Death|0|||
129608312|NCT02799095|466523808|FG002|Part A|Death|0|||
129608313|NCT02799095|466523809|FG003|Part A|Death|0|||
129608314|NCT02799095|466523810|FG004|Part A|Death|0|||
129608315|NCT02799095|466523811|FG005|Part A|Death|0|||
129608316|NCT02799095|466523812|FG006|Part A|Death|3|||
129608317|NCT02799095|466523813|FG007|Part A|Death|0|||
129608318|NCT02799095|466523814|FG008|Part A|Death|0|||
129608319|NCT02799095|466523815|FG009|Part A|Death|0|||
129608320|NCT02799095|466523816|FG010|Part A|Death|0|||
129608321|NCT02799095|466523817|FG011|Part A|Death|0|||
129608322|NCT02799095|466523818|FG012|Part A|Death|0|||
129608323|NCT02799095|466523819|FG013|Part A|Death|0|||
129608324|NCT02799095|466523820|FG014|Part A|Death|0|||
129608325|NCT02799095|466523821|FG015|Part A|Death|0|||
129608326|NCT02799095|466523822|FG016|Part A|Death|0|||
129608327|NCT02799095|466523806|FG000|Part A|Lost to Follow-up|0|||
129608328|NCT02799095|466523807|FG001|Part A|Lost to Follow-up|1|||
129608329|NCT02799095|466523808|FG002|Part A|Lost to Follow-up|0|||
129608330|NCT02799095|466523809|FG003|Part A|Lost to Follow-up|0|||
129608331|NCT02799095|466523810|FG004|Part A|Lost to Follow-up|0|||
129608332|NCT02799095|466523811|FG005|Part A|Lost to Follow-up|0|||
129608333|NCT02799095|466523812|FG006|Part A|Lost to Follow-up|1|||
129608334|NCT02799095|466523813|FG007|Part A|Lost to Follow-up|0|||
129608335|NCT02799095|466523814|FG008|Part A|Lost to Follow-up|0|||
129608336|NCT02799095|466523815|FG009|Part A|Lost to Follow-up|0|||
129608337|NCT02799095|466523816|FG010|Part A|Lost to Follow-up|0|||
129608338|NCT02799095|466523817|FG011|Part A|Lost to Follow-up|0|||
129608339|NCT02799095|466523818|FG012|Part A|Lost to Follow-up|0|||
129608340|NCT02799095|466523819|FG013|Part A|Lost to Follow-up|0|||
129608341|NCT02799095|466523820|FG014|Part A|Lost to Follow-up|0|||
129608342|NCT02799095|466523821|FG015|Part A|Lost to Follow-up|0|||
129608343|NCT02799095|466523822|FG016|Part A|Lost to Follow-up|0|||
129608344|NCT02799095|466523806|FG000|Part A|Progressive Disease|3|||
129608345|NCT02799095|466523807|FG001|Part A|Progressive Disease|3|||
129608346|NCT02799095|466523808|FG002|Part A|Progressive Disease|3|||
129608347|NCT02799095|466523809|FG003|Part A|Progressive Disease|2|||
129608348|NCT02799095|466523810|FG004|Part A|Progressive Disease|2|||
129608349|NCT02799095|466523811|FG005|Part A|Progressive Disease|0|||
129608350|NCT02799095|466523812|FG006|Part A|Progressive Disease|0|||
129608351|NCT02799095|466523813|FG007|Part A|Progressive Disease|0|||
129608352|NCT02799095|466523814|FG008|Part A|Progressive Disease|0|||
129608353|NCT02799095|466523815|FG009|Part A|Progressive Disease|0|||
129608354|NCT02799095|466523816|FG010|Part A|Progressive Disease|0|||
129608355|NCT02799095|466523817|FG011|Part A|Progressive Disease|0|||
129608356|NCT02799095|466523818|FG012|Part A|Progressive Disease|0|||
129608357|NCT02799095|466523819|FG013|Part A|Progressive Disease|0|||
129608358|NCT02799095|466523820|FG014|Part A|Progressive Disease|0|||
129608359|NCT02799095|466523821|FG015|Part A|Progressive Disease|0|||
129608360|NCT02799095|466523822|FG016|Part A|Progressive Disease|0|||
129608361|NCT02799095|466523806|FG000|Part A|Clinical Progression|1|||
129608362|NCT02799095|466523807|FG001|Part A|Clinical Progression|0|||
129608363|NCT02799095|466523808|FG002|Part A|Clinical Progression|2|||
129608364|NCT02799095|466523809|FG003|Part A|Clinical Progression|1|||
129608365|NCT02799095|466523810|FG004|Part A|Clinical Progression|5|||
129608366|NCT02799095|466523811|FG005|Part A|Clinical Progression|0|||
129608367|NCT02799095|466523812|FG006|Part A|Clinical Progression|0|||
129608368|NCT02799095|466523813|FG007|Part A|Clinical Progression|0|||
129608369|NCT02799095|466523814|FG008|Part A|Clinical Progression|0|||
129608370|NCT02799095|466523815|FG009|Part A|Clinical Progression|0|||
129608371|NCT02799095|466523816|FG010|Part A|Clinical Progression|0|||
129608372|NCT02799095|466523817|FG011|Part A|Clinical Progression|0|||
129608373|NCT02799095|466523818|FG012|Part A|Clinical Progression|0|||
129608374|NCT02799095|466523819|FG013|Part A|Clinical Progression|0|||
129608375|NCT02799095|466523820|FG014|Part A|Clinical Progression|0|||
129608376|NCT02799095|466523821|FG015|Part A|Clinical Progression|0|||
129608377|NCT02799095|466523822|FG016|Part A|Clinical Progression|0|||
129608378|NCT02799095|466523806|FG000|Part A|Protocol Deviation|0|||
129608379|NCT02799095|466523807|FG001|Part A|Protocol Deviation|0|||
129608380|NCT02799095|466523808|FG002|Part A|Protocol Deviation|1|||
129608381|NCT02799095|466523809|FG003|Part A|Protocol Deviation|0|||
129608382|NCT02799095|466523810|FG004|Part A|Protocol Deviation|0|||
129608383|NCT02799095|466523811|FG005|Part A|Protocol Deviation|0|||
129790615|NCT00992589|467201397|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129608384|NCT02799095|466523812|FG006|Part A|Protocol Deviation|0|||
129608385|NCT02799095|466523813|FG007|Part A|Protocol Deviation|0|||
129608386|NCT02799095|466523814|FG008|Part A|Protocol Deviation|0|||
129608387|NCT02799095|466523815|FG009|Part A|Protocol Deviation|0|||
129608388|NCT02799095|466523816|FG010|Part A|Protocol Deviation|0|||
129608389|NCT02799095|466523817|FG011|Part A|Protocol Deviation|0|||
129608390|NCT02799095|466523818|FG012|Part A|Protocol Deviation|0|||
129608391|NCT02799095|466523819|FG013|Part A|Protocol Deviation|0|||
129608392|NCT02799095|466523820|FG014|Part A|Protocol Deviation|0|||
129608393|NCT02799095|466523821|FG015|Part A|Protocol Deviation|0|||
129608394|NCT02799095|466523822|FG016|Part A|Protocol Deviation|0|||
129608395|NCT02799095|466523806|FG000|Part A|Withdrawal by Subject|0|||
129608396|NCT02799095|466523807|FG001|Part A|Withdrawal by Subject|0|||
129608397|NCT02799095|466523808|FG002|Part A|Withdrawal by Subject|0|||
129608398|NCT02799095|466523809|FG003|Part A|Withdrawal by Subject|1|||
129608399|NCT02799095|466523810|FG004|Part A|Withdrawal by Subject|3|||
129608400|NCT02799095|466523811|FG005|Part A|Withdrawal by Subject|1|||
129608401|NCT02799095|466523812|FG006|Part A|Withdrawal by Subject|1|||
129608402|NCT02799095|466523813|FG007|Part A|Withdrawal by Subject|0|||
129608403|NCT02799095|466523814|FG008|Part A|Withdrawal by Subject|0|||
129608404|NCT02799095|466523815|FG009|Part A|Withdrawal by Subject|0|||
129608405|NCT02799095|466523816|FG010|Part A|Withdrawal by Subject|0|||
129608406|NCT02799095|466523817|FG011|Part A|Withdrawal by Subject|0|||
129608407|NCT02799095|466523818|FG012|Part A|Withdrawal by Subject|0|||
129608408|NCT02799095|466523819|FG013|Part A|Withdrawal by Subject|0|||
129608409|NCT02799095|466523820|FG014|Part A|Withdrawal by Subject|0|||
129608410|NCT02799095|466523821|FG015|Part A|Withdrawal by Subject|0|||
129608411|NCT02799095|466523822|FG016|Part A|Withdrawal by Subject|0|||
129790616|NCT00992589|467201398|FG001|Double-Blind Phase|Lost to Follow-up|0|||
129790617|NCT00992589|467201399|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129790618|NCT00992589|467201400|FG003|Double-Blind Phase|Lost to Follow-up|2|||
129608412|NCT02799095|466523806|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
129608413|NCT02799095|466523807|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
129608414|NCT02799095|466523808|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
129608415|NCT02799095|466523809|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
129608416|NCT02799095|466523810|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
129608417|NCT02799095|466523811|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
129608418|NCT02799095|466523812|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
129608419|NCT02799095|466523813|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
129608420|NCT02799095|466523814|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
129608421|NCT02799095|466523815|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
129608422|NCT02799095|466523816|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
129608423|NCT02799095|466523817|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
129608424|NCT02799095|466523818|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
129608425|NCT02799095|466523819|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
129608426|NCT02799095|466523820|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
129608427|NCT02799095|466523821|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
129608428|NCT02799095|466523822|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
129608429|NCT02799095|466523806|FG000|Part B|Death|0|||
129608430|NCT02799095|466523807|FG001|Part B|Death|0|||
129608431|NCT02799095|466523808|FG002|Part B|Death|0|||
129608432|NCT02799095|466523809|FG003|Part B|Death|0|||
129608433|NCT02799095|466523810|FG004|Part B|Death|0|||
129608434|NCT02799095|466523811|FG005|Part B|Death|0|||
129608435|NCT02799095|466523812|FG006|Part B|Death|0|||
129608436|NCT02799095|466523813|FG007|Part B|Death|7|||
129608437|NCT02799095|466523814|FG008|Part B|Death|7|||
129608438|NCT02799095|466523815|FG009|Part B|Death|0|||
129608439|NCT02799095|466523816|FG010|Part B|Death|0|||
129608440|NCT02799095|466523817|FG011|Part B|Death|0|||
129608441|NCT02799095|466523818|FG012|Part B|Death|0|||
129608442|NCT02799095|466523819|FG013|Part B|Death|0|||
129608443|NCT02799095|466523820|FG014|Part B|Death|0|||
129608444|NCT02799095|466523821|FG015|Part B|Death|0|||
129608445|NCT02799095|466523822|FG016|Part B|Death|0|||
129608446|NCT02799095|466523806|FG000|Part B|Progressive Disease|0|||
129608447|NCT02799095|466523807|FG001|Part B|Progressive Disease|0|||
129608448|NCT02799095|466523808|FG002|Part B|Progressive Disease|0|||
129608449|NCT02799095|466523809|FG003|Part B|Progressive Disease|0|||
129608450|NCT02799095|466523810|FG004|Part B|Progressive Disease|0|||
129608451|NCT02799095|466523811|FG005|Part B|Progressive Disease|0|||
129608452|NCT02799095|466523812|FG006|Part B|Progressive Disease|0|||
129608453|NCT02799095|466523813|FG007|Part B|Progressive Disease|1|||
129608454|NCT02799095|466523814|FG008|Part B|Progressive Disease|0|||
129608455|NCT02799095|466523815|FG009|Part B|Progressive Disease|0|||
129608456|NCT02799095|466523816|FG010|Part B|Progressive Disease|0|||
129608457|NCT02799095|466523817|FG011|Part B|Progressive Disease|0|||
129608458|NCT02799095|466523818|FG012|Part B|Progressive Disease|0|||
129608459|NCT02799095|466523819|FG013|Part B|Progressive Disease|0|||
129608460|NCT02799095|466523820|FG014|Part B|Progressive Disease|0|||
129608461|NCT02799095|466523821|FG015|Part B|Progressive Disease|0|||
129608462|NCT02799095|466523822|FG016|Part B|Progressive Disease|0|||
129608463|NCT02799095|466523806|FG000|Part B|Withdrawal by Subject|0|||
129608464|NCT02799095|466523807|FG001|Part B|Withdrawal by Subject|0|||
129608465|NCT02799095|466523808|FG002|Part B|Withdrawal by Subject|0|||
129608466|NCT02799095|466523809|FG003|Part B|Withdrawal by Subject|0|||
129608467|NCT02799095|466523810|FG004|Part B|Withdrawal by Subject|0|||
129608468|NCT02799095|466523811|FG005|Part B|Withdrawal by Subject|0|||
129608469|NCT02799095|466523812|FG006|Part B|Withdrawal by Subject|0|||
129608470|NCT02799095|466523813|FG007|Part B|Withdrawal by Subject|10|||
129790619|NCT00992589|467201397|FG000|Double-Blind Phase|Other|0|||
129790620|NCT00992589|467201398|FG001|Double-Blind Phase|Other|1|||
129790621|NCT00992589|467201399|FG002|Double-Blind Phase|Other|6|||
129608471|NCT02799095|466523814|FG008|Part B|Withdrawal by Subject|7|||
129608472|NCT02799095|466523815|FG009|Part B|Withdrawal by Subject|0|||
129608473|NCT02799095|466523816|FG010|Part B|Withdrawal by Subject|0|||
129608474|NCT02799095|466523817|FG011|Part B|Withdrawal by Subject|0|||
129608475|NCT02799095|466523818|FG012|Part B|Withdrawal by Subject|0|||
129608476|NCT02799095|466523819|FG013|Part B|Withdrawal by Subject|0|||
129608477|NCT02799095|466523820|FG014|Part B|Withdrawal by Subject|0|||
129608478|NCT02799095|466523821|FG015|Part B|Withdrawal by Subject|0|||
129608479|NCT02799095|466523822|FG016|Part B|Withdrawal by Subject|0|||
129608480|NCT02799095|466523806|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
129608481|NCT02799095|466523807|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
129608482|NCT02799095|466523808|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
129608483|NCT02799095|466523809|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
129608484|NCT02799095|466523810|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
129608485|NCT02799095|466523811|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
129608486|NCT02799095|466523812|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
129608487|NCT02799095|466523813|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
129608488|NCT02799095|466523814|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
129608489|NCT02799095|466523815|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
129608490|NCT02799095|466523816|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
129608491|NCT02799095|466523817|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
129608492|NCT02799095|466523818|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
129608493|NCT02799095|466523819|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
129608494|NCT02799095|466523820|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
129608495|NCT02799095|466523821|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
129608496|NCT02799095|466523822|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
129608497|NCT02799095|466523806|FG000|Part C|Adverse Event|0|||
129608498|NCT02799095|466523807|FG001|Part C|Adverse Event|0|||
129608499|NCT02799095|466523808|FG002|Part C|Adverse Event|0|||
129608500|NCT02799095|466523809|FG003|Part C|Adverse Event|0|||
129608501|NCT02799095|466523810|FG004|Part C|Adverse Event|0|||
129608502|NCT02799095|466523811|FG005|Part C|Adverse Event|0|||
129608503|NCT02799095|466523812|FG006|Part C|Adverse Event|0|||
129608504|NCT02799095|466523813|FG007|Part C|Adverse Event|0|||
129608505|NCT02799095|466523814|FG008|Part C|Adverse Event|0|||
129608506|NCT02799095|466523815|FG009|Part C|Adverse Event|0|||
129608507|NCT02799095|466523816|FG010|Part C|Adverse Event|3|||
129608508|NCT02799095|466523817|FG011|Part C|Adverse Event|1|||
129608509|NCT02799095|466523818|FG012|Part C|Adverse Event|0|||
129608510|NCT02799095|466523819|FG013|Part C|Adverse Event|1|||
129608511|NCT02799095|466523820|FG014|Part C|Adverse Event|0|||
129608512|NCT02799095|466523821|FG015|Part C|Adverse Event|0|||
129608513|NCT02799095|466523822|FG016|Part C|Adverse Event|0|||
129608514|NCT02799095|466523806|FG000|Part C|Death|0|||
129608515|NCT02799095|466523807|FG001|Part C|Death|0|||
129608516|NCT02799095|466523808|FG002|Part C|Death|0|||
129608517|NCT02799095|466523809|FG003|Part C|Death|0|||
129608518|NCT02799095|466523810|FG004|Part C|Death|0|||
129608519|NCT02799095|466523811|FG005|Part C|Death|0|||
129608520|NCT02799095|466523812|FG006|Part C|Death|0|||
129608521|NCT02799095|466523813|FG007|Part C|Death|0|||
129608522|NCT02799095|466523814|FG008|Part C|Death|0|||
129608523|NCT02799095|466523815|FG009|Part C|Death|0|||
129608524|NCT02799095|466523816|FG010|Part C|Death|7|||
129608525|NCT02799095|466523817|FG011|Part C|Death|5|||
129608526|NCT02799095|466523818|FG012|Part C|Death|6|||
129608527|NCT02799095|466523819|FG013|Part C|Death|8|||
129608528|NCT02799095|466523820|FG014|Part C|Death|1|||
129608529|NCT02799095|466523821|FG015|Part C|Death|8|||
129608530|NCT02799095|466523822|FG016|Part C|Death|1|||
129608531|NCT02799095|466523806|FG000|Part C|Lost to Follow-up|0|||
129608532|NCT02799095|466523807|FG001|Part C|Lost to Follow-up|0|||
129608533|NCT02799095|466523808|FG002|Part C|Lost to Follow-up|0|||
129608534|NCT02799095|466523809|FG003|Part C|Lost to Follow-up|0|||
129608535|NCT02799095|466523810|FG004|Part C|Lost to Follow-up|0|||
129608536|NCT02799095|466523811|FG005|Part C|Lost to Follow-up|0|||
129608537|NCT02799095|466523812|FG006|Part C|Lost to Follow-up|0|||
129608538|NCT02799095|466523813|FG007|Part C|Lost to Follow-up|0|||
129608539|NCT02799095|466523814|FG008|Part C|Lost to Follow-up|0|||
129608540|NCT02799095|466523815|FG009|Part C|Lost to Follow-up|0|||
129608541|NCT02799095|466523816|FG010|Part C|Lost to Follow-up|1|||
129608542|NCT02799095|466523817|FG011|Part C|Lost to Follow-up|1|||
129608543|NCT02799095|466523818|FG012|Part C|Lost to Follow-up|1|||
129608544|NCT02799095|466523819|FG013|Part C|Lost to Follow-up|3|||
129608545|NCT02799095|466523820|FG014|Part C|Lost to Follow-up|0|||
129608546|NCT02799095|466523821|FG015|Part C|Lost to Follow-up|0|||
129608547|NCT02799095|466523822|FG016|Part C|Lost to Follow-up|0|||
129608548|NCT02799095|466523806|FG000|Part C|Progressive Disease|0|||
129608549|NCT02799095|466523807|FG001|Part C|Progressive Disease|0|||
129608550|NCT02799095|466523808|FG002|Part C|Progressive Disease|0|||
129608551|NCT02799095|466523809|FG003|Part C|Progressive Disease|0|||
129608552|NCT02799095|466523810|FG004|Part C|Progressive Disease|0|||
129608553|NCT02799095|466523811|FG005|Part C|Progressive Disease|0|||
129608554|NCT02799095|466523812|FG006|Part C|Progressive Disease|0|||
129608555|NCT02799095|466523813|FG007|Part C|Progressive Disease|0|||
129608556|NCT02799095|466523814|FG008|Part C|Progressive Disease|0|||
129608557|NCT02799095|466523815|FG009|Part C|Progressive Disease|2|||
129608558|NCT02799095|466523816|FG010|Part C|Progressive Disease|13|||
129608559|NCT02799095|466523817|FG011|Part C|Progressive Disease|2|||
129608560|NCT02799095|466523818|FG012|Part C|Progressive Disease|0|||
129608561|NCT02799095|466523819|FG013|Part C|Progressive Disease|1|||
129608562|NCT02799095|466523820|FG014|Part C|Progressive Disease|0|||
129608563|NCT02799095|466523821|FG015|Part C|Progressive Disease|0|||
129608564|NCT02799095|466523822|FG016|Part C|Progressive Disease|0|||
129608565|NCT02799095|466523806|FG000|Part C|Clinical Progression|0|||
129608566|NCT02799095|466523807|FG001|Part C|Clinical Progression|0|||
129608567|NCT02799095|466523808|FG002|Part C|Clinical Progression|0|||
129886966|NCT02555371|467547214|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
129886967|NCT02555371|467547215|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
129438736|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
129438737|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
129608568|NCT02799095|466523809|FG003|Part C|Clinical Progression|0|||
129608569|NCT02799095|466523810|FG004|Part C|Clinical Progression|0|||
129608570|NCT02799095|466523811|FG005|Part C|Clinical Progression|0|||
129608571|NCT02799095|466523812|FG006|Part C|Clinical Progression|0|||
129608572|NCT02799095|466523813|FG007|Part C|Clinical Progression|0|||
129608573|NCT02799095|466523814|FG008|Part C|Clinical Progression|0|||
129608574|NCT02799095|466523815|FG009|Part C|Clinical Progression|1|||
129608575|NCT02799095|466523816|FG010|Part C|Clinical Progression|3|||
129608576|NCT02799095|466523817|FG011|Part C|Clinical Progression|0|||
129608577|NCT02799095|466523818|FG012|Part C|Clinical Progression|0|||
129608578|NCT02799095|466523819|FG013|Part C|Clinical Progression|1|||
129608579|NCT02799095|466523820|FG014|Part C|Clinical Progression|0|||
129608580|NCT02799095|466523821|FG015|Part C|Clinical Progression|0|||
129608581|NCT02799095|466523822|FG016|Part C|Clinical Progression|0|||
129608582|NCT02799095|466523806|FG000|Part C|Withdrawal by Subject|0|||
129608583|NCT02799095|466523807|FG001|Part C|Withdrawal by Subject|0|||
129608584|NCT02799095|466523808|FG002|Part C|Withdrawal by Subject|0|||
129608585|NCT02799095|466523809|FG003|Part C|Withdrawal by Subject|0|||
129608586|NCT02799095|466523810|FG004|Part C|Withdrawal by Subject|0|||
129608587|NCT02799095|466523811|FG005|Part C|Withdrawal by Subject|0|||
129608588|NCT02799095|466523812|FG006|Part C|Withdrawal by Subject|0|||
129608589|NCT02799095|466523813|FG007|Part C|Withdrawal by Subject|0|||
129608590|NCT02799095|466523814|FG008|Part C|Withdrawal by Subject|0|||
129608591|NCT02799095|466523815|FG009|Part C|Withdrawal by Subject|0|||
129608592|NCT02799095|466523816|FG010|Part C|Withdrawal by Subject|13|||
129608593|NCT02799095|466523817|FG011|Part C|Withdrawal by Subject|15|||
129608594|NCT02799095|466523818|FG012|Part C|Withdrawal by Subject|13|||
129608595|NCT02799095|466523819|FG013|Part C|Withdrawal by Subject|21|||
129608596|NCT02799095|466523820|FG014|Part C|Withdrawal by Subject|0|||
129608597|NCT02799095|466523821|FG015|Part C|Withdrawal by Subject|12|||
129608598|NCT02799095|466523822|FG016|Part C|Withdrawal by Subject|1|||
129608599|NCT02799095|466523806|FG000|Part C|Physician Decision|0|||
129608600|NCT02799095|466523807|FG001|Part C|Physician Decision|0|||
129608601|NCT02799095|466523808|FG002|Part C|Physician Decision|0|||
129608602|NCT02799095|466523809|FG003|Part C|Physician Decision|0|||
129608603|NCT02799095|466523810|FG004|Part C|Physician Decision|0|||
129438738|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
129438739|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
129438740|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
129438741|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
129438742|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
129438743|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
129608604|NCT02799095|466523811|FG005|Part C|Physician Decision|0|||
129608605|NCT02799095|466523812|FG006|Part C|Physician Decision|0|||
129608606|NCT02799095|466523813|FG007|Part C|Physician Decision|0|||
129608607|NCT02799095|466523814|FG008|Part C|Physician Decision|0|||
129608608|NCT02799095|466523815|FG009|Part C|Physician Decision|0|||
129608609|NCT02799095|466523816|FG010|Part C|Physician Decision|1|||
129698934|NCT03973489|466856891|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129608610|NCT02799095|466523817|FG011|Part C|Physician Decision|0|||
129608611|NCT02799095|466523818|FG012|Part C|Physician Decision|0|||
129608612|NCT02799095|466523819|FG013|Part C|Physician Decision|0|||
129608613|NCT02799095|466523820|FG014|Part C|Physician Decision|0|||
129608614|NCT02799095|466523821|FG015|Part C|Physician Decision|0|||
129608615|NCT02799095|466523822|FG016|Part C|Physician Decision|0|||
129608616|NCT02799095|466523806|FG000|Part C|Other|0|||
129608617|NCT02799095|466523807|FG001|Part C|Other|0|||
129608618|NCT02799095|466523808|FG002|Part C|Other|0|||
129608619|NCT02799095|466523809|FG003|Part C|Other|0|||
129790622|NCT00992589|467201400|FG003|Double-Blind Phase|Other|3|||
129790623|NCT01215916|467201401|FG000|Overall Study|Progressive Disease|0|||
129790624|NCT01215916|467201402|FG001|Overall Study|Progressive Disease|2|||
129790625|NCT01215916|467201403|FG002|Overall Study|Progressive Disease|1|||
129790626|NCT01215916|467201404|FG003|Overall Study|Progressive Disease|2|||
129790627|NCT01215916|467201405|FG004|Overall Study|Progressive Disease|5|||
129790628|NCT01215916|467201406|FG005|Overall Study|Progressive Disease|4|||
129790629|NCT01215916|467201407|FG006|Overall Study|Progressive Disease|5|||
129790630|NCT01215916|467201408|FG007|Overall Study|Progressive Disease|3|||
129608620|NCT02799095|466523810|FG004|Part C|Other|0|||
129608621|NCT02799095|466523811|FG005|Part C|Other|0|||
129608622|NCT02799095|466523812|FG006|Part C|Other|0|||
129608623|NCT02799095|466523813|FG007|Part C|Other|0|||
129608624|NCT02799095|466523814|FG008|Part C|Other|0|||
129608625|NCT02799095|466523815|FG009|Part C|Other|0|||
129608626|NCT02799095|466523816|FG010|Part C|Other|0|||
129608627|NCT02799095|466523817|FG011|Part C|Other|2|||
129608628|NCT02799095|466523818|FG012|Part C|Other|2|||
129608629|NCT02799095|466523819|FG013|Part C|Other|0|||
129608630|NCT02799095|466523820|FG014|Part C|Other|0|||
129608631|NCT02799095|466523821|FG015|Part C|Other|0|||
129608632|NCT02799095|466523822|FG016|Part C|Other|0|||
129608633|NCT04994483|466523826|FG000|Overall Study|Adverse Event|26|||
129608634|NCT04994483|466523827|FG001|Overall Study|Adverse Event|17|||
129608635|NCT04994483|466523826|FG000|Overall Study|Lost to Follow-up|6|||
129608636|NCT04994483|466523827|FG001|Overall Study|Lost to Follow-up|10|||
129608637|NCT04994483|466523826|FG000|Overall Study|Noncompliance with study drug|8|||
129608638|NCT04994483|466523827|FG001|Overall Study|Noncompliance with study drug|5|||
129608639|NCT04994483|466523826|FG000|Overall Study|Physician Decision|5|||
129608640|NCT04994483|466523827|FG001|Overall Study|Physician Decision|0|||
129608641|NCT04994483|466523826|FG000|Overall Study|Withdrawal by Subject|41|||
129608642|NCT04994483|466523827|FG001|Overall Study|Withdrawal by Subject|38|||
129608643|NCT04994483|466523826|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
129608644|NCT04994483|466523827|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
129608645|NCT04994483|466523826|FG000|Overall Study|Met stopping criteria|1|||
129608646|NCT04994483|466523827|FG001|Overall Study|Met stopping criteria|0|||
129608647|NCT04994483|466523826|FG000|Overall Study|Randomized in error, not treated|4|||
129608648|NCT04994483|466523827|FG001|Overall Study|Randomized in error, not treated|3|||
129608649|NCT04994483|466523826|FG000|Overall Study|Lack of a reliable study partner|0|||
129698935|NCT03973489|466856892|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129698936|NCT03973489|466856893|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
129698937|NCT03973489|466856886|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129698938|NCT03973489|466856887|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129698939|NCT03973489|466856888|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129698940|NCT03973489|466856889|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
129698941|NCT03973489|466856890|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
129698942|NCT03973489|466856891|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129698943|NCT03973489|466856892|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129698944|NCT03973489|466856893|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
129698945|NCT03973489|466856886|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
129698946|NCT03973489|466856887|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
129698947|NCT03973489|466856888|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
129698948|NCT03973489|466856889|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
129698949|NCT03973489|466856890|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
129698950|NCT03973489|466856891|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
129698951|NCT03973489|466856892|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
129698952|NCT03973489|466856893|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
129698953|NCT03973489|466856886|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
129698954|NCT03973489|466856887|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129698955|NCT03973489|466856888|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129698956|NCT03973489|466856889|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
129698957|NCT03973489|466856890|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129698958|NCT03973489|466856891|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129790631|NCT01215916|467201409|FG008|Overall Study|Progressive Disease|1|||
129790632|NCT01215916|467201401|FG000|Overall Study|Adverse Event|1|||
129608650|NCT04994483|466523827|FG001|Overall Study|Lack of a reliable study partner|1|||
129790633|NCT01215916|467201402|FG001|Overall Study|Adverse Event|1|||
129790634|NCT01215916|467201403|FG002|Overall Study|Adverse Event|0|||
129698959|NCT03973489|466856892|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129698960|NCT03973489|466856893|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
129698961|NCT03973489|466856886|FG000|Second Intervention (1 Day)|Adverse Event|0|||
129698962|NCT03973489|466856887|FG001|Second Intervention (1 Day)|Adverse Event|0|||
129698963|NCT03973489|466856888|FG002|Second Intervention (1 Day)|Adverse Event|0|||
129698964|NCT03973489|466856889|FG003|Second Intervention (1 Day)|Adverse Event|1|||
129698965|NCT03973489|466856890|FG004|Second Intervention (1 Day)|Adverse Event|0|||
129698966|NCT03973489|466856891|FG005|Second Intervention (1 Day)|Adverse Event|0|||
129698967|NCT03973489|466856892|FG006|Second Intervention (1 Day)|Adverse Event|0|||
129698968|NCT03973489|466856893|FG007|Second Intervention (1 Day)|Adverse Event|0|||
129698969|NCT03301415|466856894|FG000|Overall Study|Lost to Follow-up|2|||
129698970|NCT03301415|466856894|FG000|Overall Study|Unable to comply with visit schedule|2|||
129698971|NCT03247673|466856895|FG000|Overall Study|Withdrawal by Subject|1|||
129698972|NCT03247673|466856896|FG001|Overall Study|Withdrawal by Subject|0|||
129698973|NCT03247673|466856897|FG002|Overall Study|Withdrawal by Subject|3|||
129698974|NCT03247673|466856895|FG000|Overall Study|Lost to Follow-up|0|||
129698975|NCT03247673|466856896|FG001|Overall Study|Lost to Follow-up|0|||
129698976|NCT03247673|466856897|FG002|Overall Study|Lost to Follow-up|1|||
129698977|NCT00392288|466856898|FG000|Overall Study|Adverse Event|17|||
129698978|NCT00392288|466856899|FG001|Overall Study|Adverse Event|7|||
129698979|NCT00392288|466856900|FG002|Overall Study|Adverse Event|8|||
129698980|NCT00392288|466856898|FG000|Overall Study|Lack of Efficacy|8|||
129698981|NCT00392288|466856899|FG001|Overall Study|Lack of Efficacy|5|||
129698982|NCT00392288|466856900|FG002|Overall Study|Lack of Efficacy|3|||
129698983|NCT00392288|466856898|FG000|Overall Study|Protocol Violation|1|||
129698984|NCT00392288|466856899|FG001|Overall Study|Protocol Violation|3|||
129698985|NCT00392288|466856900|FG002|Overall Study|Protocol Violation|1|||
129698986|NCT00392288|466856898|FG000|Overall Study|Lost to Follow-up|1|||
129698987|NCT00392288|466856899|FG001|Overall Study|Lost to Follow-up|1|||
129698988|NCT00392288|466856900|FG002|Overall Study|Lost to Follow-up|1|||
129698989|NCT00392288|466856898|FG000|Overall Study|Withdrawal by Subject|1|||
129698990|NCT00392288|466856899|FG001|Overall Study|Withdrawal by Subject|0|||
129698991|NCT00392288|466856900|FG002|Overall Study|Withdrawal by Subject|2|||
129698992|NCT00392288|466856898|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
129698993|NCT00392288|466856899|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
129698994|NCT00392288|466856900|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
129698995|NCT00392288|466856898|FG000|Overall Study|Other|3|||
129698996|NCT00392288|466856899|FG001|Overall Study|Other|4|||
129698997|NCT00392288|466856900|FG002|Overall Study|Other|1|||
129698998|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
129698999|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129699000|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129699001|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129699002|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129699003|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
129699004|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129699005|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129699006|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129699007|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129699008|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
129699009|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129699010|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129699011|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129699012|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129699013|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
129699014|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129699015|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129699016|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129699017|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
129699018|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
129699019|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129699020|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129699021|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129699022|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
129699023|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
129699024|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129699025|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129699026|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129699027|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
129699028|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
129699029|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129699030|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129699031|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129699032|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129699033|NCT01111552|466856901|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
129699034|NCT01111552|466856902|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129699035|NCT01111552|466856903|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129699036|NCT01111552|466856904|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129608651|NCT04994483|466523826|FG000|Overall Study|Met MRI exclusion criteria|0|||
129608652|NCT04994483|466523827|FG001|Overall Study|Met MRI exclusion criteria|1|||
129608653|NCT03589768|466523832|FG000|Overall Study|Death|1|||
129608654|NCT03589768|466523833|FG001|Overall Study|Death|0|||
129608655|NCT03589768|466523834|FG002|Overall Study|Death|8|||
129608656|NCT03589768|466523835|FG003|Overall Study|Death|3|||
129608657|NCT03589768|466523832|FG000|Overall Study|Withdrawal by Subject|2|||
129608658|NCT03589768|466523833|FG001|Overall Study|Withdrawal by Subject|0|||
129608659|NCT03589768|466523834|FG002|Overall Study|Withdrawal by Subject|0|||
129608660|NCT03589768|466523835|FG003|Overall Study|Withdrawal by Subject|0|||
129608661|NCT03589768|466523832|FG000|Overall Study|Protocol Violation|1|||
129608662|NCT03589768|466523833|FG001|Overall Study|Protocol Violation|0|||
129608663|NCT03589768|466523834|FG002|Overall Study|Protocol Violation|0|||
129608664|NCT03589768|466523835|FG003|Overall Study|Protocol Violation|0|||
129608665|NCT01200992|466523838|FG000|Overall Study|Study terminated early|35|||
129608666|NCT01200992|466523839|FG001|Overall Study|Study terminated early|41|||
129608667|NCT01200992|466523838|FG000|Overall Study|Randomized but not treated|2|||
129608668|NCT01200992|466523839|FG001|Overall Study|Randomized but not treated|0|||
129608669|NCT02213510|466523848|FG000|Overall Study|Death|0|||
129608670|NCT02213510|466523849|FG001|Overall Study|Death|1|||
129608671|NCT02213510|466523848|FG000|Overall Study|Lost to Follow-up|1|||
129608672|NCT02213510|466523849|FG001|Overall Study|Lost to Follow-up|0|||
129699037|NCT01111552|466856905|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
129699038|NCT01111552|466856901|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129699039|NCT01111552|466856902|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129699040|NCT01111552|466856903|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129699041|NCT01111552|466856904|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
129699042|NCT01111552|466856905|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129790635|NCT01215916|467201404|FG003|Overall Study|Adverse Event|1|||
129790636|NCT01215916|467201405|FG004|Overall Study|Adverse Event|0|||
129790637|NCT01215916|467201406|FG005|Overall Study|Adverse Event|0|||
129790638|NCT01215916|467201407|FG006|Overall Study|Adverse Event|3|||
129699043|NCT01111552|466856901|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
129699044|NCT01111552|466856902|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
129699045|NCT01111552|466856903|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
129699046|NCT01111552|466856904|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
129699047|NCT01111552|466856905|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
129699048|NCT01111552|466856901|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129699049|NCT01111552|466856902|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
129699050|NCT01111552|466856903|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129699051|NCT01111552|466856904|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129699052|NCT01111552|466856905|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
129699053|NCT01111552|466856901|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129699054|NCT01111552|466856902|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
129790639|NCT01215916|467201408|FG007|Overall Study|Adverse Event|0|||
129790640|NCT01215916|467201409|FG008|Overall Study|Adverse Event|0|||
129790641|NCT01215916|467201401|FG000|Overall Study|Withdrawal by Subject|0|||
129790642|NCT01215916|467201402|FG001|Overall Study|Withdrawal by Subject|1|||
129790643|NCT01215916|467201403|FG002|Overall Study|Withdrawal by Subject|1|||
129438744|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
129438745|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
129438746|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
129438747|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
129608673|NCT01502410|466523853|FG000|Overall Study|Adverse Event|1|||
129699055|NCT01111552|466856903|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129699056|NCT01111552|466856904|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129699057|NCT01111552|466856905|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
129699058|NCT01111552|466856901|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129608674|NCT01502410|466523854|FG001|Overall Study|Adverse Event|2|||
129608675|NCT01502410|466523855|FG002|Overall Study|Adverse Event|0|||
129608676|NCT01502410|466523856|FG003|Overall Study|Adverse Event|0|||
129608677|NCT01502410|466523853|FG000|Overall Study|Lack of Efficacy|7|||
129608678|NCT01502410|466523854|FG001|Overall Study|Lack of Efficacy|7|||
129608679|NCT01502410|466523855|FG002|Overall Study|Lack of Efficacy|0|||
129608680|NCT01502410|466523856|FG003|Overall Study|Lack of Efficacy|0|||
129608681|NCT01502410|466523853|FG000|Overall Study|Physician Decision|0|||
129608682|NCT01502410|466523854|FG001|Overall Study|Physician Decision|1|||
129608683|NCT01502410|466523855|FG002|Overall Study|Physician Decision|0|||
129608684|NCT01502410|466523856|FG003|Overall Study|Physician Decision|0|||
129608685|NCT01502410|466523853|FG000|Overall Study|Withdrawal by Subject|2|||
129608686|NCT01502410|466523854|FG001|Overall Study|Withdrawal by Subject|0|||
129608687|NCT01502410|466523855|FG002|Overall Study|Withdrawal by Subject|0|||
129608688|NCT01502410|466523856|FG003|Overall Study|Withdrawal by Subject|0|||
129608689|NCT02903030|466523857|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129608690|NCT02903030|466523858|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129608691|NCT03786718|466523862|FG000|Overall Study|Lost to Follow-up|3|||
129608692|NCT03786718|466523862|FG000|Overall Study|Withdrawal by Subject|1|||
129608693|NCT03786718|466523862|FG000|Overall Study|Did not use the intervention|2|||
129608694|NCT03786718|466523862|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
129608695|NCT00754650|466523876|FG000|Overall Study|Disease Progression|2|||
129608696|NCT00805675|466523877|FG000|Overall Study|Adverse Event|0|||
129608697|NCT00805675|466523878|FG001|Overall Study|Adverse Event|0|||
129608698|NCT00805675|466523879|FG002|Overall Study|Adverse Event|1|||
129608699|NCT03929757|466523880|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
129608700|NCT03929757|466523881|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
129608701|NCT03929757|466523882|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
129608702|NCT03929757|466523880|FG000|Main Study: Up to Day 365|Other|1|||
129608703|NCT03929757|466523881|FG001|Main Study: Up to Day 365|Other|0|||
129608704|NCT03929757|466523882|FG002|Main Study: Up to Day 365|Other|0|||
129608705|NCT03929757|466523880|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
129608706|NCT03929757|466523881|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
129608707|NCT03929757|466523882|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
129608708|NCT00806286|466523883|FG000|Overall Study|Adverse Event|5|||
129608709|NCT00806286|466523884|FG001|Overall Study|Adverse Event|2|||
129608710|NCT00806286|466523885|FG002|Overall Study|Adverse Event|0|||
129608711|NCT00806286|466523883|FG000|Overall Study|Disease progression|31|||
129608712|NCT00806286|466523884|FG001|Overall Study|Disease progression|38|||
129608713|NCT00806286|466523885|FG002|Overall Study|Disease progression|1|||
129608714|NCT00806286|466523883|FG000|Overall Study|Death|1|||
129608715|NCT00806286|466523884|FG001|Overall Study|Death|6|||
129608716|NCT00806286|466523885|FG002|Overall Study|Death|0|||
129608717|NCT00806286|466523883|FG000|Overall Study|Lost to Follow-up|0|||
129608718|NCT00806286|466523884|FG001|Overall Study|Lost to Follow-up|1|||
129608719|NCT00806286|466523885|FG002|Overall Study|Lost to Follow-up|0|||
129608720|NCT00806286|466523883|FG000|Overall Study|Withdrawal by Subject|8|||
129608721|NCT00806286|466523884|FG001|Overall Study|Withdrawal by Subject|3|||
129608722|NCT00806286|466523885|FG002|Overall Study|Withdrawal by Subject|1|||
129608723|NCT00806286|466523883|FG000|Overall Study|Physician Decision|2|||
129608724|NCT00806286|466523884|FG001|Overall Study|Physician Decision|2|||
129608725|NCT00806286|466523885|FG002|Overall Study|Physician Decision|0|||
129886968|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
129608726|NCT00806286|466523883|FG000|Overall Study|Due to a variety of reasons|7|||
129608727|NCT00806286|466523884|FG001|Overall Study|Due to a variety of reasons|2|||
129608728|NCT00806286|466523885|FG002|Overall Study|Due to a variety of reasons|1|||
129608729|NCT03402750|466523886|FG000|Overall Study|Lost to Follow-up|2|||
129608730|NCT03402750|466523887|FG001|Overall Study|Lost to Follow-up|1|||
129608731|NCT03825341|466523888|FG000|Overall Study|Withdrawal by Subject|0|||
129608732|NCT03825341|466523889|FG001|Overall Study|Withdrawal by Subject|1|||
129608733|NCT00289536|466523891|FG000|Period 3|Lost to Follow-up|0|||
129608734|NCT00289536|466523892|FG001|Period 3|Lost to Follow-up|0|||
129608735|NCT00289536|466523893|FG002|Period 3|Lost to Follow-up|1|||
129608736|NCT04283500|466523894|FG000|Overall Study|Lost to Follow-up|8|||
129647574|NCT02083185|466665350|FG001|Overall Study|Reason not Specified|6|||
129647575|NCT02083185|466665351|FG002|Overall Study|Reason not Specified|5|||
129647576|NCT02083185|466665349|FG000|Overall Study|Study Terminated by Sponsor|0|||
129647577|NCT02083185|466665350|FG001|Overall Study|Study Terminated by Sponsor|1|||
129647578|NCT02083185|466665351|FG002|Overall Study|Study Terminated by Sponsor|0|||
129647579|NCT02083185|466665349|FG000|Overall Study|Did not Receive Study Drug|0|||
129647580|NCT02083185|466665350|FG001|Overall Study|Did not Receive Study Drug|2|||
129647581|NCT02083185|466665351|FG002|Overall Study|Did not Receive Study Drug|0|||
129647582|NCT03054064|466665352|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
129647583|NCT03054064|466665352|FG000|Overall Study|Investigator Decision|2|||
129647584|NCT03054064|466665352|FG000|Overall Study|Bladder Issue|1|||
129647585|NCT03054064|466665352|FG000|Overall Study|High Blood Pressure|1|||
129438748|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
129608737|NCT04283500|466523894|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
129608738|NCT02006693|466523897|FG000|Overall Study|No Reason Specified|6|||
129608739|NCT02006693|466523898|FG001|Overall Study|No Reason Specified|8|||
129608740|NCT02006693|466523897|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
129608741|NCT02006693|466523898|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
129608742|NCT02006693|466523897|FG000|Overall Study|XEN Implant Explantation|0|||
129608743|NCT02006693|466523898|FG001|Overall Study|XEN Implant Explantation|1|||
129608744|NCT02006693|466523897|FG000|Overall Study|Death|2|||
129608745|NCT02006693|466523898|FG001|Overall Study|Death|2|||
129608746|NCT02006693|466523897|FG000|Overall Study|Lost to Follow-up|4|||
129608747|NCT02006693|466523898|FG001|Overall Study|Lost to Follow-up|1|||
129608748|NCT02006693|466523897|FG000|Overall Study|Patient Decision|4|||
129699059|NCT01111552|466856902|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
129699060|NCT01111552|466856903|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129699061|NCT01111552|466856904|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129699062|NCT01111552|466856905|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
129699063|NCT01111552|466856901|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129699064|NCT01111552|466856902|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129699065|NCT01111552|466856903|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
129699066|NCT01111552|466856904|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129699067|NCT01111552|466856905|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129699068|NCT04129398|466858489|FG000|Overall Study|Physician Decision|2|||
129699069|NCT02363283|466858494|FG000|Overall Study|Withdrawal by Subject|1|||
129699070|NCT02363283|466858494|FG000|Overall Study|Not eligible due to transaminitis|1|||
129699071|NCT00003907|466858504|FG000|Overall Study|Adverse Event|2|||
129699072|NCT00003907|466858505|FG001|Overall Study|Adverse Event|11|||
129699073|NCT00003907|466858504|FG000|Overall Study|Death|2|||
129699074|NCT00003907|466858505|FG001|Overall Study|Death|0|||
129699075|NCT00003907|466858504|FG000|Overall Study|Withdrawal by Subject|1|||
129699076|NCT00003907|466858505|FG001|Overall Study|Withdrawal by Subject|3|||
129699077|NCT00003907|466858504|FG000|Overall Study|Progressive disease|4|||
129699078|NCT00003907|466858505|FG001|Overall Study|Progressive disease|4|||
129699079|NCT00003907|466858504|FG000|Overall Study|Complicating disease|1|||
129699080|NCT00003907|466858505|FG001|Overall Study|Complicating disease|0|||
129699081|NCT00003907|466858504|FG000|Overall Study|Other|1|||
129699082|NCT00003907|466858505|FG001|Overall Study|Other|3|||
129699083|NCT00003907|466858504|FG000|Overall Study|ineligible or not treated|2|||
129699084|NCT00003907|466858505|FG001|Overall Study|ineligible or not treated|2|||
129699085|NCT01517178|466858506|FG000|Period 1|Adverse Event|1|||
129699086|NCT01517178|466858507|FG001|Period 1|Adverse Event|2|||
129699087|NCT01517178|466858506|FG000|Period 1|Lack of Efficacy|0|||
129699088|NCT01517178|466858507|FG001|Period 1|Lack of Efficacy|1|||
129699089|NCT01517178|466858506|FG000|Period 1|E.g. study termination|3|||
129699090|NCT01517178|466858507|FG001|Period 1|E.g. study termination|1|||
129699091|NCT01517178|466858506|FG000|Period 1|Withdrawal by Subject|0|||
129699092|NCT01517178|466858507|FG001|Period 1|Withdrawal by Subject|1|||
129699093|NCT01517178|466858506|FG000|Period 2|Adverse Event|1|||
129699094|NCT01517178|466858507|FG001|Period 2|Adverse Event|0|||
129699095|NCT01517178|466858506|FG000|Period 2|Withdrawal by Subject|3|||
129699096|NCT01517178|466858507|FG001|Period 2|Withdrawal by Subject|0|||
129699097|NCT01517178|466858506|FG000|Period 2|E.g. study termination|2|||
129699098|NCT01517178|466858507|FG001|Period 2|E.g. study termination|2|||
129699099|NCT01557569|466858510|FG000|Overall Study|Adverse Event|2|||
129699100|NCT01557569|466858511|FG001|Overall Study|Adverse Event|0|||
129699101|NCT01557569|466858510|FG000|Overall Study|high blood pressure|0|||
129699102|NCT01557569|466858511|FG001|Overall Study|high blood pressure|1|||
129699103|NCT01557569|466858510|FG000|Overall Study|Withdrawal by Subject|3|||
129699104|NCT01557569|466858511|FG001|Overall Study|Withdrawal by Subject|5|||
129699105|NCT01557569|466858510|FG000|Overall Study|noncompliance with rules of residential|0|||
129699106|NCT01557569|466858511|FG001|Overall Study|noncompliance with rules of residential|1|||
129699107|NCT04691115|466858517|FG000|Overall Study|Withdrawal by Subject|0|||
129699108|NCT04691115|466858518|FG001|Overall Study|Withdrawal by Subject|0|||
129699109|NCT04691115|466858519|FG002|Overall Study|Withdrawal by Subject|0|||
129699110|NCT04691115|466858520|FG003|Overall Study|Withdrawal by Subject|0|||
129699111|NCT04691115|466858521|FG004|Overall Study|Withdrawal by Subject|0|||
129699112|NCT04691115|466858522|FG005|Overall Study|Withdrawal by Subject|1|||
129699113|NCT04691115|466858523|FG006|Overall Study|Withdrawal by Subject|0|||
129438749|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
129608749|NCT02006693|466523898|FG001|Overall Study|Patient Decision|0|||
129608750|NCT01119508|466523901|FG000|Overall Study|Adverse Event|56|||
129608751|NCT01119508|466523901|FG000|Overall Study|Withdrawal by Subject|2|||
129608752|NCT01119508|466523901|FG000|Overall Study|Died before tumor response evaluation|1|||
129699114|NCT04691115|466858524|FG007|Overall Study|Withdrawal by Subject|0|||
129699115|NCT04691115|466858525|FG008|Overall Study|Withdrawal by Subject|0|||
129699116|NCT04691115|466858526|FG009|Overall Study|Withdrawal by Subject|0|||
129608753|NCT00265395|466523902|FG000|Overall Study|Adverse Event|3|||
129608754|NCT00265395|466523903|FG001|Overall Study|Adverse Event|6|||
129608755|NCT00265395|466523902|FG000|Overall Study|Lost to Follow-up|2|||
129608756|NCT00265395|466523903|FG001|Overall Study|Lost to Follow-up|1|||
129608757|NCT00265395|466523902|FG000|Overall Study|Withdrawal by Subject|1|||
129608758|NCT00265395|466523903|FG001|Overall Study|Withdrawal by Subject|6|||
129608759|NCT00265395|466523902|FG000|Overall Study|Protocol Violation|2|||
129608760|NCT00265395|466523903|FG001|Overall Study|Protocol Violation|2|||
129608761|NCT00265395|466523902|FG000|Overall Study|Lack of Efficacy|0|||
129608762|NCT00265395|466523903|FG001|Overall Study|Lack of Efficacy|1|||
129608763|NCT00265395|466523902|FG000|Overall Study|Administrative|0|||
129608764|NCT00265395|466523903|FG001|Overall Study|Administrative|1|||
129608765|NCT04053465|466523907|FG000|Overall Study|Withdrawal by Subject|4|||
129608766|NCT04053465|466523908|FG001|Overall Study|Withdrawal by Subject|4|||
129608767|NCT00742924|466523909|FG000|Overall Study|Adverse Event|0|||
129608768|NCT00742924|466523910|FG001|Overall Study|Adverse Event|0|||
129608769|NCT00742924|466523911|FG002|Overall Study|Adverse Event|1|||
129608770|NCT00742924|466523912|FG003|Overall Study|Adverse Event|1|||
129608771|NCT00742924|466523909|FG000|Overall Study|Lack of Efficacy|5|||
129608772|NCT00742924|466523910|FG001|Overall Study|Lack of Efficacy|1|||
129608773|NCT00742924|466523911|FG002|Overall Study|Lack of Efficacy|2|||
129608774|NCT00742924|466523912|FG003|Overall Study|Lack of Efficacy|4|||
129608775|NCT00742924|466523909|FG000|Overall Study|Physician Decision|0|||
129608776|NCT00742924|466523910|FG001|Overall Study|Physician Decision|0|||
129608777|NCT00742924|466523911|FG002|Overall Study|Physician Decision|0|||
129608778|NCT00742924|466523912|FG003|Overall Study|Physician Decision|1|||
129608779|NCT00742924|466523909|FG000|Overall Study|Withdrawal by Subject|0|||
129608780|NCT00742924|466523910|FG001|Overall Study|Withdrawal by Subject|1|||
129608781|NCT00742924|466523911|FG002|Overall Study|Withdrawal by Subject|1|||
129608782|NCT00742924|466523912|FG003|Overall Study|Withdrawal by Subject|0|||
129608783|NCT00660400|466523913|FG000|Overall Study|Lack of insurance approval|1|||
129608784|NCT00660400|466523913|FG000|Overall Study|Suboptimal organ function|1|||
129608785|NCT00660400|466523913|FG000|Overall Study|Intracranial hemorrhage|1|||
129608786|NCT00660400|466523913|FG000|Overall Study|Withdrawal by Subject|1|||
129608787|NCT02643355|466523914|FG000|Overall Study|Withdrawal by Subject|1|||
129608788|NCT02643355|466523915|FG001|Overall Study|Withdrawal by Subject|3|||
129608789|NCT02643355|466523914|FG000|Overall Study|Protocol Violation|0|||
129608790|NCT02643355|466523915|FG001|Overall Study|Protocol Violation|2|||
129608791|NCT04524364|466523916|FG000|Overall Study|Physician Decision|3|||
129608792|NCT04524364|466523917|FG001|Overall Study|Physician Decision|6|||
129608793|NCT04524364|466523916|FG000|Overall Study|Adverse Event|0|||
129608794|NCT04524364|466523917|FG001|Overall Study|Adverse Event|1|||
129608795|NCT04524364|466523916|FG000|Overall Study|Investigational device deficiency|0|||
129608796|NCT04524364|466523917|FG001|Overall Study|Investigational device deficiency|1|||
129608797|NCT04524364|466523916|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
129608798|NCT04524364|466523917|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
129608799|NCT04524364|466523916|FG000|Overall Study|Device unavailability|0|||
129608800|NCT04524364|466523917|FG001|Overall Study|Device unavailability|2|||
129608801|NCT04524364|466523916|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
129608802|NCT04524364|466523917|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
129608803|NCT04524364|466523916|FG000|Overall Study|Low International normalized ratio (INR)|1|||
129608804|NCT04524364|466523917|FG001|Overall Study|Low International normalized ratio (INR)|0|||
129608805|NCT00826449|466523918|FG000|Overall Study|Disease Progression|4|||
129608806|NCT00826449|466523918|FG000|Overall Study|Withdrawal by Subject|1|||
129699117|NCT04691115|466858527|FG010|Overall Study|Withdrawal by Subject|0|||
129699118|NCT04691115|466858528|FG011|Overall Study|Withdrawal by Subject|0|||
129699119|NCT04691115|466858529|FG012|Overall Study|Withdrawal by Subject|0|||
129699120|NCT04691115|466858530|FG013|Overall Study|Withdrawal by Subject|0|||
129699121|NCT04661839|466858535|FG000|Overall Study|Not Treated|0|||
129699122|NCT04661839|466858536|FG001|Overall Study|Not Treated|0|||
129699123|NCT04661839|466858537|FG002|Overall Study|Not Treated|1|||
129699124|NCT04661839|466858538|FG003|Overall Study|Not Treated|0|||
129699125|NCT04661839|466858535|FG000|Overall Study|Lost to Follow-up|1|||
129608807|NCT03233230|466523919|FG000|Overall Study|Adverse Event|6|||
129608808|NCT03233230|466523920|FG001|Overall Study|Adverse Event|3|||
129608809|NCT03233230|466523921|FG002|Overall Study|Adverse Event|6|||
129608810|NCT03233230|466523922|FG003|Overall Study|Adverse Event|3|||
129608811|NCT03233230|466523919|FG000|Overall Study|Protocol Violation|1|||
129699126|NCT04661839|466858536|FG001|Overall Study|Lost to Follow-up|0|||
129790644|NCT01215916|467201404|FG003|Overall Study|Withdrawal by Subject|2|||
129608812|NCT03233230|466523920|FG001|Overall Study|Protocol Violation|2|||
129608813|NCT03233230|466523921|FG002|Overall Study|Protocol Violation|1|||
129608814|NCT03233230|466523922|FG003|Overall Study|Protocol Violation|1|||
129608815|NCT03233230|466523919|FG000|Overall Study|Lack of Efficacy|1|||
129608816|NCT03233230|466523920|FG001|Overall Study|Lack of Efficacy|0|||
129608817|NCT03233230|466523921|FG002|Overall Study|Lack of Efficacy|0|||
129699127|NCT04661839|466858537|FG002|Overall Study|Lost to Follow-up|0|||
129608818|NCT03233230|466523922|FG003|Overall Study|Lack of Efficacy|0|||
129608819|NCT03233230|466523919|FG000|Overall Study|Other|5|||
129608820|NCT03233230|466523920|FG001|Overall Study|Other|5|||
129608821|NCT03233230|466523921|FG002|Overall Study|Other|5|||
129608822|NCT03233230|466523922|FG003|Overall Study|Other|3|||
129608823|NCT03233230|466523919|FG000|Overall Study|Withdrawal by Subject|2|||
129608824|NCT03233230|466523920|FG001|Overall Study|Withdrawal by Subject|2|||
129608825|NCT03233230|466523921|FG002|Overall Study|Withdrawal by Subject|0|||
129608826|NCT03233230|466523922|FG003|Overall Study|Withdrawal by Subject|1|||
129608827|NCT03233230|466523919|FG000|Overall Study|Lost to Follow-up|0|||
129608828|NCT03233230|466523920|FG001|Overall Study|Lost to Follow-up|3|||
129608829|NCT03233230|466523921|FG002|Overall Study|Lost to Follow-up|0|||
129608830|NCT03233230|466523922|FG003|Overall Study|Lost to Follow-up|0|||
129608831|NCT02994940|466523923|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
129608832|NCT02994940|466523924|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
129608833|NCT02994940|466523923|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
129608834|NCT02994940|466523924|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
129608835|NCT02994940|466523923|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
129608836|NCT02994940|466523924|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
129608837|NCT02987959|466523925|FG000|Overall Study|Grantor stopped supply of drugs|6|||
129608838|NCT02853370|466523926|FG000|Overall Study|Physician Decision|1|||
129608839|NCT02853370|466523926|FG000|Overall Study|Lack of Efficacy|2|||
129608840|NCT02853370|466523926|FG000|Overall Study|Death|1|||
129608841|NCT02853370|466523926|FG000|Overall Study|Adverse Event|4|||
129608842|NCT02853370|466523926|FG000|Overall Study|Withdrawal by Subject|3|||
129608843|NCT01898650|466523931|FG000|Overall Study|the subject would not lie still for imaging|1|||
129608844|NCT04135196|466523933|FG000|Overall Study|Lost to Follow-up|8|||
129608845|NCT04135196|466523934|FG001|Overall Study|Lost to Follow-up|7|||
129608846|NCT04135196|466523935|FG002|Overall Study|Lost to Follow-up|8|||
129608847|NCT04135196|466523936|FG003|Overall Study|Lost to Follow-up|9|||
129608848|NCT04135196|466523937|FG004|Overall Study|Lost to Follow-up|1|||
129608849|NCT04135196|466523933|FG000|Overall Study|Pregnancy|0|||
129608850|NCT04135196|466523934|FG001|Overall Study|Pregnancy|0|||
129608851|NCT04135196|466523935|FG002|Overall Study|Pregnancy|1|||
129608852|NCT04135196|466523936|FG003|Overall Study|Pregnancy|0|||
129608853|NCT04135196|466523937|FG004|Overall Study|Pregnancy|0|||
129608854|NCT04135196|466523933|FG000|Overall Study|Withdrawal by Subject|0|||
129608855|NCT04135196|466523934|FG001|Overall Study|Withdrawal by Subject|0|||
129608856|NCT04135196|466523935|FG002|Overall Study|Withdrawal by Subject|0|||
129608857|NCT04135196|466523936|FG003|Overall Study|Withdrawal by Subject|0|||
129608858|NCT04135196|466523937|FG004|Overall Study|Withdrawal by Subject|1|||
129608859|NCT00911807|466523938|FG000|Overall Study|Adverse Event|2|||
129608860|NCT00911807|466523939|FG001|Overall Study|Adverse Event|1|||
129608861|NCT00911807|466523940|FG002|Overall Study|Adverse Event|5|||
129608862|NCT00911807|466523938|FG000|Overall Study|Death|0|||
129608863|NCT00911807|466523939|FG001|Overall Study|Death|0|||
129608864|NCT00911807|466523940|FG002|Overall Study|Death|1|||
129608865|NCT00911807|466523938|FG000|Overall Study|Protocol Violation|6|||
129608866|NCT00911807|466523939|FG001|Overall Study|Protocol Violation|4|||
129608867|NCT00911807|466523940|FG002|Overall Study|Protocol Violation|9|||
129608868|NCT00911807|466523938|FG000|Overall Study|Withdrawal by Subject|8|||
129608869|NCT00911807|466523939|FG001|Overall Study|Withdrawal by Subject|10|||
129608870|NCT00911807|466523940|FG002|Overall Study|Withdrawal by Subject|7|||
129608871|NCT00911807|466523938|FG000|Overall Study|Organizational reasons|1|||
129608872|NCT00911807|466523939|FG001|Overall Study|Organizational reasons|3|||
129608873|NCT00911807|466523940|FG002|Overall Study|Organizational reasons|1|||
129608874|NCT00809159|466523941|FG000|Part 1|Adverse Event|1|||
129608875|NCT00809159|466523942|FG001|Part 1|Adverse Event|1|||
129608876|NCT00809159|466523943|FG002|Part 1|Adverse Event|0|||
129608877|NCT00809159|466523944|FG003|Part 1|Adverse Event|0|||
129608878|NCT00809159|466523945|FG004|Part 1|Adverse Event|0|||
129608879|NCT00809159|466523946|FG005|Part 1|Adverse Event|0|||
129608880|NCT00809159|466523941|FG000|Part 1|Lost to Follow-up|1|||
129608881|NCT00809159|466523942|FG001|Part 1|Lost to Follow-up|0|||
129608882|NCT00809159|466523943|FG002|Part 1|Lost to Follow-up|0|||
129608883|NCT00809159|466523944|FG003|Part 1|Lost to Follow-up|0|||
129608884|NCT00809159|466523945|FG004|Part 1|Lost to Follow-up|0|||
129608885|NCT00809159|466523946|FG005|Part 1|Lost to Follow-up|0|||
129608886|NCT00809159|466523941|FG000|Part 1|Withdrawal by Subject|3|||
129608887|NCT00809159|466523942|FG001|Part 1|Withdrawal by Subject|1|||
129608888|NCT00809159|466523943|FG002|Part 1|Withdrawal by Subject|0|||
129608889|NCT00809159|466523944|FG003|Part 1|Withdrawal by Subject|0|||
129608890|NCT00809159|466523945|FG004|Part 1|Withdrawal by Subject|0|||
129608891|NCT00809159|466523946|FG005|Part 1|Withdrawal by Subject|0|||
129608892|NCT00809159|466523941|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
129608893|NCT00809159|466523942|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
129608894|NCT00809159|466523943|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
129608895|NCT00809159|466523944|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
129608896|NCT00809159|466523945|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
129608897|NCT00809159|466523946|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
129608898|NCT00809159|466523941|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
129608899|NCT00809159|466523942|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
129608900|NCT00809159|466523943|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
129608901|NCT00809159|466523944|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
129438750|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
129438751|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
129438752|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
129438753|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Other|10|||
129438754|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Other|7|||
129438755|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Other|8|||
129438756|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Other|8|||
129438757|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Other|0|||
129438758|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
129438759|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
129438760|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
129438761|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
129438762|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
129438763|NCT00615836|465904485|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
129438764|NCT00615836|465904486|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129438765|NCT00615836|465904487|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129438766|NCT00615836|465904488|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129438767|NCT00615836|465904489|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
129438768|NCT01313689|465904490|FG000|24-Week Randomization 1|Adverse Event|10|||
129438769|NCT01313689|465904491|FG001|24-Week Randomization 1|Adverse Event|5|||
129438770|NCT01313689|465904492|FG002|24-Week Randomization 1|Adverse Event|0|||
129699128|NCT04661839|466858538|FG003|Overall Study|Lost to Follow-up|1|||
129699129|NCT02096354|466858539|FG000|Overall Study|Physician Decision|4|||
129699130|NCT02096354|466858540|FG001|Overall Study|Physician Decision|5|||
129699131|NCT02096354|466858541|FG002|Overall Study|Physician Decision|0|||
129699132|NCT02096354|466858539|FG000|Overall Study|Withdrawal by Subject|3|||
129699133|NCT02096354|466858540|FG001|Overall Study|Withdrawal by Subject|1|||
129699134|NCT02096354|466858541|FG002|Overall Study|Withdrawal by Subject|0|||
129699135|NCT02096354|466858539|FG000|Overall Study|Adverse Event|7|||
129790645|NCT01215916|467201405|FG004|Overall Study|Withdrawal by Subject|0|||
129790646|NCT01215916|467201406|FG005|Overall Study|Withdrawal by Subject|0|||
129790647|NCT01215916|467201407|FG006|Overall Study|Withdrawal by Subject|1|||
129790648|NCT01215916|467201408|FG007|Overall Study|Withdrawal by Subject|0|||
129790649|NCT01215916|467201409|FG008|Overall Study|Withdrawal by Subject|0|||
129790650|NCT01215916|467201401|FG000|Overall Study|Death|0|||
129790651|NCT01215916|467201402|FG001|Overall Study|Death|1|||
129438771|NCT01313689|465904493|FG003|24-Week Randomization 1|Adverse Event|0|||
129438772|NCT01313689|465904494|FG004|24-Week Randomization 1|Adverse Event|0|||
129438773|NCT01313689|465904490|FG000|24-Week Randomization 1|Physician Decision|4|||
129438774|NCT01313689|465904491|FG001|24-Week Randomization 1|Physician Decision|5|||
129438775|NCT01313689|465904492|FG002|24-Week Randomization 1|Physician Decision|0|||
129438776|NCT01313689|465904493|FG003|24-Week Randomization 1|Physician Decision|0|||
129438777|NCT01313689|465904494|FG004|24-Week Randomization 1|Physician Decision|0|||
129608902|NCT00809159|466523945|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
129608903|NCT00809159|466523946|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
129608904|NCT00809159|466523941|FG000|Part 1 and 2|Administrative problems|0|||
129608905|NCT00809159|466523942|FG001|Part 1 and 2|Administrative problems|0|||
129608906|NCT00809159|466523943|FG002|Part 1 and 2|Administrative problems|0|||
129608907|NCT00809159|466523944|FG003|Part 1 and 2|Administrative problems|1|||
129608908|NCT00809159|466523945|FG004|Part 1 and 2|Administrative problems|0|||
129608909|NCT00809159|466523946|FG005|Part 1 and 2|Administrative problems|0|||
129608910|NCT00809159|466523941|FG000|Part 1 and 2|Adverse Event|0|||
129608911|NCT00809159|466523942|FG001|Part 1 and 2|Adverse Event|0|||
129608912|NCT00809159|466523943|FG002|Part 1 and 2|Adverse Event|1|||
129608913|NCT00809159|466523944|FG003|Part 1 and 2|Adverse Event|0|||
129608914|NCT00809159|466523945|FG004|Part 1 and 2|Adverse Event|1|||
129608915|NCT00809159|466523946|FG005|Part 1 and 2|Adverse Event|1|||
129608916|NCT00809159|466523941|FG000|Part 1 and 2|Lost to Follow-up|0|||
129608917|NCT00809159|466523942|FG001|Part 1 and 2|Lost to Follow-up|0|||
129608918|NCT00809159|466523943|FG002|Part 1 and 2|Lost to Follow-up|1|||
129608919|NCT00809159|466523944|FG003|Part 1 and 2|Lost to Follow-up|1|||
129608920|NCT00809159|466523945|FG004|Part 1 and 2|Lost to Follow-up|0|||
129608921|NCT00809159|466523946|FG005|Part 1 and 2|Lost to Follow-up|0|||
129608922|NCT00809159|466523941|FG000|Part 1 and 2|Withdrawal by Subject|0|||
129608923|NCT00809159|466523942|FG001|Part 1 and 2|Withdrawal by Subject|0|||
129608924|NCT00809159|466523943|FG002|Part 1 and 2|Withdrawal by Subject|4|||
129699136|NCT02096354|466858540|FG001|Overall Study|Adverse Event|4|||
129699137|NCT02096354|466858541|FG002|Overall Study|Adverse Event|0|||
129438778|NCT01313689|465904490|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
129438779|NCT01313689|465904491|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
129438780|NCT01313689|465904492|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
129438781|NCT01313689|465904493|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
129438782|NCT01313689|465904494|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
129438783|NCT01313689|465904490|FG000|24-Week Randomization 2|Adverse Event|0|||
129438784|NCT01313689|465904491|FG001|24-Week Randomization 2|Adverse Event|0|||
129438785|NCT01313689|465904492|FG002|24-Week Randomization 2|Adverse Event|2|||
129438786|NCT01313689|465904493|FG003|24-Week Randomization 2|Adverse Event|0|||
129438787|NCT01313689|465904494|FG004|24-Week Randomization 2|Adverse Event|8|||
129438788|NCT01313689|465904490|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
129438789|NCT01313689|465904491|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
129438790|NCT01313689|465904492|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
129438791|NCT01313689|465904493|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
129438792|NCT01313689|465904494|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
129438793|NCT01313689|465904490|FG000|24-Week Randomization 2|Physician Decision|0|||
129438794|NCT01313689|465904491|FG001|24-Week Randomization 2|Physician Decision|0|||
129438795|NCT01313689|465904492|FG002|24-Week Randomization 2|Physician Decision|0|||
129438796|NCT01313689|465904493|FG003|24-Week Randomization 2|Physician Decision|0|||
129438797|NCT01313689|465904494|FG004|24-Week Randomization 2|Physician Decision|4|||
129438798|NCT00687973|465904495|FG000|Overall Study|Adverse Event|18|||
129608925|NCT00809159|466523944|FG003|Part 1 and 2|Withdrawal by Subject|0|||
129608926|NCT00809159|466523945|FG004|Part 1 and 2|Withdrawal by Subject|0|||
129438799|NCT00687973|465904496|FG001|Overall Study|Adverse Event|28|||
129438800|NCT00687973|465904495|FG000|Overall Study|Lack of Efficacy|2|||
129438801|NCT00687973|465904496|FG001|Overall Study|Lack of Efficacy|3|||
129438802|NCT00687973|465904495|FG000|Overall Study|Protocol Violation|1|||
129438803|NCT00687973|465904496|FG001|Overall Study|Protocol Violation|2|||
129438804|NCT00687973|465904495|FG000|Overall Study|Administrative Reasons|0|||
129438805|NCT00687973|465904496|FG001|Overall Study|Administrative Reasons|2|||
129438806|NCT00687973|465904495|FG000|Overall Study|Withdrawal by Subject|3|||
129438807|NCT00687973|465904496|FG001|Overall Study|Withdrawal by Subject|3|||
129438808|NCT01007448|465904497|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
129438809|NCT01007448|465904498|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
129438810|NCT01007448|465904497|FG000|Overall Study|Staph Skin Infection Flare|1|||
129438811|NCT01007448|465904498|FG001|Overall Study|Staph Skin Infection Flare|0|||
129438812|NCT01007448|465904497|FG000|Overall Study|Participant Leaving the Country|1|||
129438813|NCT01007448|465904498|FG001|Overall Study|Participant Leaving the Country|0|||
129438814|NCT01007448|465904497|FG000|Overall Study|Participant Given Prohibited Medication|1|||
129608927|NCT00809159|466523946|FG005|Part 1 and 2|Withdrawal by Subject|1|||
129608928|NCT02991430|466523947|FG000|Treatment Period 1|Adverse Event|1|||
129608929|NCT02991430|466523948|FG001|Treatment Period 1|Adverse Event|0|||
129608930|NCT02991430|466523949|FG002|Treatment Period 1|Adverse Event|2|||
129608931|NCT02991430|466523947|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129608932|NCT02991430|466523948|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129608933|NCT02991430|466523949|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129608934|NCT02991430|466523947|FG000|Treatment Period 2|Study Termination|6|||
129608935|NCT02991430|466523948|FG001|Treatment Period 2|Study Termination|3|||
129608936|NCT02991430|466523949|FG002|Treatment Period 2|Study Termination|3|||
129608937|NCT02991430|466523947|FG000|Treatment Period 2|Lost to Follow-up|0|||
129608938|NCT02991430|466523948|FG001|Treatment Period 2|Lost to Follow-up|0|||
129608939|NCT02991430|466523949|FG002|Treatment Period 2|Lost to Follow-up|1|||
129608940|NCT02991430|466523947|FG000|Post-treatment Observation Period|Study Termination|3|||
129608941|NCT02991430|466523948|FG001|Post-treatment Observation Period|Study Termination|6|||
129608942|NCT02991430|466523949|FG002|Post-treatment Observation Period|Study Termination|5|||
129608943|NCT03970837|466523950|FG000|Overall Study|Adverse Event|23|||
129608944|NCT03970837|466523951|FG001|Overall Study|Adverse Event|20|||
129608945|NCT03970837|466523952|FG002|Overall Study|Adverse Event|16|||
129608946|NCT03970837|466523953|FG003|Overall Study|Adverse Event|6|||
129608947|NCT03970837|466523954|FG004|Overall Study|Adverse Event|4|||
129608948|NCT03970837|466523955|FG005|Overall Study|Adverse Event|5|||
129608949|NCT03970837|466523956|FG006|Overall Study|Adverse Event|1|||
129608950|NCT03970837|466523957|FG007|Overall Study|Adverse Event|5|||
129608951|NCT03970837|466523958|FG008|Overall Study|Adverse Event|0|||
129608952|NCT03970837|466523959|FG009|Overall Study|Adverse Event|0|||
129608953|NCT03970837|466523960|FG010|Overall Study|Adverse Event|1|||
129608954|NCT03970837|466523961|FG011|Overall Study|Adverse Event|1|||
129608955|NCT03970837|466523950|FG000|Overall Study|Lack of Efficacy|14|||
129608956|NCT03970837|466523951|FG001|Overall Study|Lack of Efficacy|12|||
129608957|NCT03970837|466523952|FG002|Overall Study|Lack of Efficacy|1|||
129608958|NCT03970837|466523953|FG003|Overall Study|Lack of Efficacy|2|||
129608959|NCT03970837|466523954|FG004|Overall Study|Lack of Efficacy|3|||
129608960|NCT03970837|466523955|FG005|Overall Study|Lack of Efficacy|4|||
129608961|NCT03970837|466523956|FG006|Overall Study|Lack of Efficacy|6|||
129608962|NCT03970837|466523957|FG007|Overall Study|Lack of Efficacy|1|||
129608963|NCT03970837|466523958|FG008|Overall Study|Lack of Efficacy|1|||
129608964|NCT03970837|466523959|FG009|Overall Study|Lack of Efficacy|0|||
129608965|NCT03970837|466523960|FG010|Overall Study|Lack of Efficacy|0|||
129608966|NCT03970837|466523961|FG011|Overall Study|Lack of Efficacy|0|||
129608967|NCT03970837|466523950|FG000|Overall Study|Lost to Follow-up|6|||
129608968|NCT03970837|466523951|FG001|Overall Study|Lost to Follow-up|5|||
129608969|NCT03970837|466523952|FG002|Overall Study|Lost to Follow-up|5|||
129608970|NCT03970837|466523953|FG003|Overall Study|Lost to Follow-up|1|||
129608971|NCT03970837|466523954|FG004|Overall Study|Lost to Follow-up|0|||
129608972|NCT03970837|466523955|FG005|Overall Study|Lost to Follow-up|2|||
129608973|NCT03970837|466523956|FG006|Overall Study|Lost to Follow-up|0|||
129608974|NCT03970837|466523957|FG007|Overall Study|Lost to Follow-up|0|||
129608975|NCT03970837|466523958|FG008|Overall Study|Lost to Follow-up|0|||
129608976|NCT03970837|466523959|FG009|Overall Study|Lost to Follow-up|0|||
129608977|NCT03970837|466523960|FG010|Overall Study|Lost to Follow-up|0|||
129790652|NCT01215916|467201403|FG002|Overall Study|Death|0|||
129608978|NCT03970837|466523961|FG011|Overall Study|Lost to Follow-up|0|||
129608979|NCT03970837|466523950|FG000|Overall Study|Protocol Violation|1|||
129608980|NCT03970837|466523951|FG001|Overall Study|Protocol Violation|0|||
129608981|NCT03970837|466523952|FG002|Overall Study|Protocol Violation|0|||
129608982|NCT03970837|466523953|FG003|Overall Study|Protocol Violation|0|||
129608983|NCT03970837|466523954|FG004|Overall Study|Protocol Violation|0|||
129608984|NCT03970837|466523955|FG005|Overall Study|Protocol Violation|0|||
129608985|NCT03970837|466523956|FG006|Overall Study|Protocol Violation|0|||
129608986|NCT03970837|466523957|FG007|Overall Study|Protocol Violation|0|||
129608987|NCT03970837|466523958|FG008|Overall Study|Protocol Violation|0|||
129608988|NCT03970837|466523959|FG009|Overall Study|Protocol Violation|0|||
129608989|NCT03970837|466523960|FG010|Overall Study|Protocol Violation|0|||
129608990|NCT03970837|466523961|FG011|Overall Study|Protocol Violation|0|||
129608991|NCT03970837|466523950|FG000|Overall Study|Physician Decision|5|||
129608992|NCT03970837|466523951|FG001|Overall Study|Physician Decision|8|||
129608993|NCT03970837|466523952|FG002|Overall Study|Physician Decision|4|||
129608994|NCT03970837|466523953|FG003|Overall Study|Physician Decision|1|||
129608995|NCT03970837|466523954|FG004|Overall Study|Physician Decision|5|||
129608996|NCT03970837|466523955|FG005|Overall Study|Physician Decision|2|||
129608997|NCT03970837|466523956|FG006|Overall Study|Physician Decision|4|||
129608998|NCT03970837|466523957|FG007|Overall Study|Physician Decision|5|||
129608999|NCT03970837|466523958|FG008|Overall Study|Physician Decision|0|||
129609000|NCT03970837|466523959|FG009|Overall Study|Physician Decision|1|||
129609001|NCT03970837|466523960|FG010|Overall Study|Physician Decision|0|||
129609002|NCT03970837|466523961|FG011|Overall Study|Physician Decision|0|||
129609003|NCT03970837|466523950|FG000|Overall Study|Withdrawal by Subject|32|||
129609004|NCT03970837|466523951|FG001|Overall Study|Withdrawal by Subject|35|||
129609005|NCT03970837|466523952|FG002|Overall Study|Withdrawal by Subject|12|||
129609006|NCT03970837|466523953|FG003|Overall Study|Withdrawal by Subject|8|||
129609007|NCT03970837|466523954|FG004|Overall Study|Withdrawal by Subject|6|||
129609008|NCT03970837|466523955|FG005|Overall Study|Withdrawal by Subject|8|||
129609009|NCT03970837|466523956|FG006|Overall Study|Withdrawal by Subject|2|||
129609010|NCT03970837|466523957|FG007|Overall Study|Withdrawal by Subject|3|||
129609011|NCT03970837|466523958|FG008|Overall Study|Withdrawal by Subject|0|||
129609012|NCT03970837|466523959|FG009|Overall Study|Withdrawal by Subject|0|||
129609013|NCT03970837|466523960|FG010|Overall Study|Withdrawal by Subject|0|||
129609014|NCT03970837|466523961|FG011|Overall Study|Withdrawal by Subject|1|||
129609015|NCT03970837|466523950|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
129609016|NCT03970837|466523951|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
129609017|NCT03970837|466523952|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
129609018|NCT03970837|466523953|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129609019|NCT03970837|466523954|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
129609020|NCT03970837|466523955|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129609021|NCT03970837|466523956|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129609022|NCT03970837|466523957|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129609023|NCT03970837|466523958|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
129609024|NCT03970837|466523959|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129609025|NCT03970837|466523960|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129699138|NCT02096354|466858539|FG000|Overall Study|Ineligible|0|||
129699139|NCT02096354|466858540|FG001|Overall Study|Ineligible|0|||
129699140|NCT02096354|466858541|FG002|Overall Study|Ineligible|11|||
129699141|NCT03253627|466858544|FG000|Overall Study|Lost to Follow-up|1|||
129699142|NCT03253627|466858545|FG001|Overall Study|Lost to Follow-up|2|||
129438815|NCT01007448|465904498|FG001|Overall Study|Participant Given Prohibited Medication|0|||
129438816|NCT01007448|465904497|FG000|Overall Study|Progressive Disease|1|||
129438817|NCT01007448|465904498|FG001|Overall Study|Progressive Disease|2|||
129438818|NCT01007448|465904497|FG000|Overall Study|Lack of Efficacy|2|||
129438819|NCT01007448|465904498|FG001|Overall Study|Lack of Efficacy|0|||
129438820|NCT01007448|465904497|FG000|Overall Study|Withdrawal by Subject|2|||
129438821|NCT01007448|465904498|FG001|Overall Study|Withdrawal by Subject|3|||
129438822|NCT01007448|465904497|FG000|Overall Study|Adverse Event|1|||
129438823|NCT01007448|465904498|FG001|Overall Study|Adverse Event|4|||
129438824|NCT02121834|465904500|FG000|Overall Study|Protocol Violation|0|||
129438825|NCT02121834|465904501|FG001|Overall Study|Protocol Violation|1|||
129438826|NCT02121834|465904502|FG002|Overall Study|Protocol Violation|0|||
129438827|NCT02121834|465904503|FG003|Overall Study|Protocol Violation|0|||
129438828|NCT02121834|465904504|FG004|Overall Study|Protocol Violation|0|||
129438829|NCT02121834|465904505|FG005|Overall Study|Protocol Violation|0|||
129438830|NCT02121834|465904506|FG006|Overall Study|Protocol Violation|0|||
129438831|NCT02121834|465904500|FG000|Overall Study|Withdrawal by Subject|0|||
129438832|NCT02121834|465904501|FG001|Overall Study|Withdrawal by Subject|1|||
129438833|NCT02121834|465904502|FG002|Overall Study|Withdrawal by Subject|1|||
129438834|NCT02121834|465904503|FG003|Overall Study|Withdrawal by Subject|0|||
129609026|NCT03970837|466523961|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
129609027|NCT03970837|466523950|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129609028|NCT03970837|466523951|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129609029|NCT03970837|466523952|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129609030|NCT03970837|466523953|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129609031|NCT03970837|466523954|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129609032|NCT03970837|466523955|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129609033|NCT03970837|466523956|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
129609034|NCT03970837|466523957|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
129609035|NCT03970837|466523958|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
129609036|NCT03970837|466523959|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
129609037|NCT03970837|466523960|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
129609038|NCT03970837|466523961|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
129609039|NCT02132754|466523962|FG000|Overall Study|Adverse Event|0|||
129609040|NCT02132754|466523963|FG001|Overall Study|Adverse Event|0|||
129609041|NCT02132754|466523964|FG002|Overall Study|Adverse Event|0|||
129609042|NCT02132754|466523965|FG003|Overall Study|Adverse Event|0|||
129609043|NCT02132754|466523966|FG004|Overall Study|Adverse Event|0|||
129609044|NCT02132754|466523967|FG005|Overall Study|Adverse Event|0|||
129609045|NCT02132754|466523968|FG006|Overall Study|Adverse Event|0|||
129609046|NCT02132754|466523969|FG007|Overall Study|Adverse Event|0|||
129609047|NCT02132754|466523970|FG008|Overall Study|Adverse Event|0|||
129609048|NCT02132754|466523971|FG009|Overall Study|Adverse Event|0|||
129609049|NCT02132754|466523972|FG010|Overall Study|Adverse Event|0|||
129609050|NCT02132754|466523973|FG011|Overall Study|Adverse Event|0|||
129609051|NCT02132754|466523974|FG012|Overall Study|Adverse Event|0|||
129609052|NCT02132754|466523975|FG013|Overall Study|Adverse Event|0|||
129609053|NCT02132754|466523976|FG014|Overall Study|Adverse Event|0|||
129609054|NCT02132754|466523977|FG015|Overall Study|Adverse Event|0|||
129609055|NCT02132754|466523978|FG016|Overall Study|Adverse Event|0|||
129609056|NCT02132754|466523979|FG017|Overall Study|Adverse Event|1|||
129609057|NCT02132754|466523980|FG018|Overall Study|Adverse Event|0|||
129609058|NCT02132754|466523981|FG019|Overall Study|Adverse Event|0|||
129609059|NCT02132754|466523982|FG020|Overall Study|Adverse Event|0|||
129609060|NCT02132754|466523983|FG021|Overall Study|Adverse Event|0|||
129609061|NCT02132754|466523984|FG022|Overall Study|Adverse Event|0|||
129609062|NCT02132754|466523985|FG023|Overall Study|Adverse Event|0|||
129609063|NCT02132754|466523986|FG024|Overall Study|Adverse Event|0|||
129609064|NCT02132754|466523987|FG025|Overall Study|Adverse Event|1|||
129609065|NCT02132754|466523988|FG026|Overall Study|Adverse Event|1|||
129609066|NCT02132754|466523989|FG027|Overall Study|Adverse Event|0|||
129609067|NCT02132754|466523990|FG028|Overall Study|Adverse Event|0|||
129609068|NCT02132754|466523991|FG029|Overall Study|Adverse Event|0|||
129609069|NCT02132754|466523992|FG030|Overall Study|Adverse Event|1|||
129609070|NCT02132754|466523993|FG031|Overall Study|Adverse Event|0|||
129609071|NCT02132754|466523994|FG032|Overall Study|Adverse Event|1|||
129609072|NCT02132754|466523995|FG033|Overall Study|Adverse Event|1|||
129609073|NCT02132754|466523962|FG000|Overall Study|Clinical Progression|0|||
129609074|NCT02132754|466523963|FG001|Overall Study|Clinical Progression|0|||
129609075|NCT02132754|466523964|FG002|Overall Study|Clinical Progression|0|||
129609076|NCT02132754|466523965|FG003|Overall Study|Clinical Progression|0|||
129609077|NCT02132754|466523966|FG004|Overall Study|Clinical Progression|0|||
129609078|NCT02132754|466523967|FG005|Overall Study|Clinical Progression|0|||
129609079|NCT02132754|466523968|FG006|Overall Study|Clinical Progression|0|||
129609080|NCT02132754|466523969|FG007|Overall Study|Clinical Progression|0|||
129609081|NCT02132754|466523970|FG008|Overall Study|Clinical Progression|0|||
129438835|NCT02121834|465904504|FG004|Overall Study|Withdrawal by Subject|0|||
129609082|NCT02132754|466523971|FG009|Overall Study|Clinical Progression|1|||
129790653|NCT01215916|467201404|FG003|Overall Study|Death|0|||
129790654|NCT01215916|467201405|FG004|Overall Study|Death|1|||
129790655|NCT01215916|467201406|FG005|Overall Study|Death|0|||
129790656|NCT01215916|467201407|FG006|Overall Study|Death|0|||
129790657|NCT01215916|467201408|FG007|Overall Study|Death|0|||
129790658|NCT01215916|467201409|FG008|Overall Study|Death|1|||
129790659|NCT01215916|467201401|FG000|Overall Study|Physician Decision|0|||
129790660|NCT01215916|467201402|FG001|Overall Study|Physician Decision|0|||
129790661|NCT01215916|467201403|FG002|Overall Study|Physician Decision|1|||
129790662|NCT01215916|467201404|FG003|Overall Study|Physician Decision|1|||
129790663|NCT01215916|467201405|FG004|Overall Study|Physician Decision|0|||
129790664|NCT01215916|467201406|FG005|Overall Study|Physician Decision|0|||
129790665|NCT01215916|467201407|FG006|Overall Study|Physician Decision|0|||
129790666|NCT01215916|467201408|FG007|Overall Study|Physician Decision|0|||
129790667|NCT01215916|467201409|FG008|Overall Study|Physician Decision|0|||
129790668|NCT00045942|467201410|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
129790669|NCT00045942|467201411|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790670|NCT00045942|467201412|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790671|NCT00045942|467201413|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790672|NCT00045942|467201414|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790673|NCT00045942|467201415|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790674|NCT00045942|467201416|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790675|NCT00045942|467201417|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790676|NCT00045942|467201418|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
129790677|NCT00045942|467201410|FG000|PKC412A2104 (Core)|Adverse Event|5|||
129790678|NCT00045942|467201411|FG001|PKC412A2104 (Core)|Adverse Event|0|||
129790679|NCT00045942|467201412|FG002|PKC412A2104 (Core)|Adverse Event|0|||
129790680|NCT00045942|467201413|FG003|PKC412A2104 (Core)|Adverse Event|0|||
129790681|NCT00045942|467201414|FG004|PKC412A2104 (Core)|Adverse Event|0|||
129790682|NCT00045942|467201415|FG005|PKC412A2104 (Core)|Adverse Event|0|||
129790683|NCT00045942|467201416|FG006|PKC412A2104 (Core)|Adverse Event|0|||
129790684|NCT00045942|467201417|FG007|PKC412A2104 (Core)|Adverse Event|0|||
129790685|NCT00045942|467201418|FG008|PKC412A2104 (Core)|Adverse Event|0|||
129790686|NCT00045942|467201410|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
129790687|NCT00045942|467201411|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790688|NCT00045942|467201412|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790689|NCT00045942|467201413|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790690|NCT00045942|467201414|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790691|NCT00045942|467201415|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790692|NCT00045942|467201416|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790693|NCT00045942|467201417|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
129609083|NCT02132754|466523972|FG010|Overall Study|Clinical Progression|0|||
129609084|NCT02132754|466523973|FG011|Overall Study|Clinical Progression|0|||
129609085|NCT02132754|466523974|FG012|Overall Study|Clinical Progression|0|||
129609086|NCT02132754|466523975|FG013|Overall Study|Clinical Progression|0|||
129609087|NCT02132754|466523976|FG014|Overall Study|Clinical Progression|0|||
129609088|NCT02132754|466523977|FG015|Overall Study|Clinical Progression|0|||
129609089|NCT02132754|466523978|FG016|Overall Study|Clinical Progression|1|||
129609090|NCT02132754|466523979|FG017|Overall Study|Clinical Progression|1|||
129609091|NCT02132754|466523980|FG018|Overall Study|Clinical Progression|0|||
129609092|NCT02132754|466523981|FG019|Overall Study|Clinical Progression|1|||
129609093|NCT02132754|466523982|FG020|Overall Study|Clinical Progression|0|||
129609094|NCT02132754|466523983|FG021|Overall Study|Clinical Progression|0|||
129609095|NCT02132754|466523984|FG022|Overall Study|Clinical Progression|1|||
129609096|NCT02132754|466523985|FG023|Overall Study|Clinical Progression|0|||
129609097|NCT02132754|466523986|FG024|Overall Study|Clinical Progression|1|||
129609098|NCT02132754|466523987|FG025|Overall Study|Clinical Progression|1|||
129609099|NCT02132754|466523988|FG026|Overall Study|Clinical Progression|0|||
129609100|NCT02132754|466523989|FG027|Overall Study|Clinical Progression|1|||
129609101|NCT02132754|466523990|FG028|Overall Study|Clinical Progression|1|||
129609102|NCT02132754|466523991|FG029|Overall Study|Clinical Progression|0|||
129609103|NCT02132754|466523992|FG030|Overall Study|Clinical Progression|1|||
129609104|NCT02132754|466523993|FG031|Overall Study|Clinical Progression|0|||
129609105|NCT02132754|466523994|FG032|Overall Study|Clinical Progression|0|||
129609106|NCT02132754|466523995|FG033|Overall Study|Clinical Progression|2|||
129609107|NCT02132754|466523962|FG000|Overall Study|Death|0|||
129609108|NCT02132754|466523963|FG001|Overall Study|Death|0|||
129790694|NCT00045942|467201418|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
129790695|NCT00045942|467201410|FG000|PKC412A2104 (Core)|Death|1|||
129790696|NCT00045942|467201411|FG001|PKC412A2104 (Core)|Death|0|||
129790697|NCT00045942|467201412|FG002|PKC412A2104 (Core)|Death|0|||
129790698|NCT00045942|467201413|FG003|PKC412A2104 (Core)|Death|0|||
129609109|NCT02132754|466523964|FG002|Overall Study|Death|0|||
129790699|NCT00045942|467201414|FG004|PKC412A2104 (Core)|Death|0|||
129790700|NCT00045942|467201415|FG005|PKC412A2104 (Core)|Death|0|||
129790701|NCT00045942|467201416|FG006|PKC412A2104 (Core)|Death|0|||
129790702|NCT00045942|467201417|FG007|PKC412A2104 (Core)|Death|0|||
129790703|NCT00045942|467201418|FG008|PKC412A2104 (Core)|Death|0|||
129609110|NCT02132754|466523965|FG003|Overall Study|Death|0|||
129609111|NCT02132754|466523966|FG004|Overall Study|Death|0|||
129609112|NCT02132754|466523967|FG005|Overall Study|Death|0|||
129609113|NCT02132754|466523968|FG006|Overall Study|Death|0|||
129609114|NCT02132754|466523969|FG007|Overall Study|Death|0|||
129609115|NCT02132754|466523970|FG008|Overall Study|Death|0|||
129609116|NCT02132754|466523971|FG009|Overall Study|Death|0|||
129609117|NCT02132754|466523972|FG010|Overall Study|Death|0|||
129609118|NCT02132754|466523973|FG011|Overall Study|Death|0|||
129609119|NCT02132754|466523974|FG012|Overall Study|Death|0|||
129609120|NCT02132754|466523975|FG013|Overall Study|Death|0|||
129609121|NCT02132754|466523976|FG014|Overall Study|Death|0|||
129609122|NCT02132754|466523977|FG015|Overall Study|Death|1|||
129609123|NCT02132754|466523978|FG016|Overall Study|Death|0|||
129609124|NCT02132754|466523979|FG017|Overall Study|Death|0|||
129609125|NCT02132754|466523980|FG018|Overall Study|Death|0|||
129609126|NCT02132754|466523981|FG019|Overall Study|Death|1|||
129609127|NCT02132754|466523982|FG020|Overall Study|Death|0|||
129609128|NCT02132754|466523983|FG021|Overall Study|Death|1|||
129609129|NCT02132754|466523984|FG022|Overall Study|Death|0|||
129609130|NCT02132754|466523985|FG023|Overall Study|Death|0|||
129609131|NCT02132754|466523986|FG024|Overall Study|Death|0|||
129609132|NCT02132754|466523987|FG025|Overall Study|Death|0|||
129609133|NCT02132754|466523988|FG026|Overall Study|Death|1|||
129609134|NCT02132754|466523989|FG027|Overall Study|Death|0|||
129609135|NCT02132754|466523990|FG028|Overall Study|Death|0|||
129609136|NCT02132754|466523991|FG029|Overall Study|Death|0|||
129609137|NCT02132754|466523992|FG030|Overall Study|Death|0|||
129609138|NCT02132754|466523993|FG031|Overall Study|Death|0|||
129609139|NCT02132754|466523994|FG032|Overall Study|Death|0|||
129609140|NCT02132754|466523995|FG033|Overall Study|Death|2|||
129609141|NCT02132754|466523962|FG000|Overall Study|Excluded Medication|0|||
129609142|NCT02132754|466523963|FG001|Overall Study|Excluded Medication|0|||
129609143|NCT02132754|466523964|FG002|Overall Study|Excluded Medication|0|||
129609144|NCT02132754|466523965|FG003|Overall Study|Excluded Medication|0|||
129438836|NCT02121834|465904505|FG005|Overall Study|Withdrawal by Subject|0|||
129438837|NCT02121834|465904506|FG006|Overall Study|Withdrawal by Subject|0|||
129609145|NCT02132754|466523966|FG004|Overall Study|Excluded Medication|0|||
129609146|NCT02132754|466523967|FG005|Overall Study|Excluded Medication|0|||
129609147|NCT02132754|466523968|FG006|Overall Study|Excluded Medication|0|||
129609148|NCT02132754|466523969|FG007|Overall Study|Excluded Medication|0|||
129609149|NCT02132754|466523970|FG008|Overall Study|Excluded Medication|0|||
129609150|NCT02132754|466523971|FG009|Overall Study|Excluded Medication|0|||
129609151|NCT02132754|466523972|FG010|Overall Study|Excluded Medication|0|||
129609152|NCT02132754|466523973|FG011|Overall Study|Excluded Medication|0|||
129609153|NCT02132754|466523974|FG012|Overall Study|Excluded Medication|0|||
129609154|NCT02132754|466523975|FG013|Overall Study|Excluded Medication|0|||
129609155|NCT02132754|466523976|FG014|Overall Study|Excluded Medication|0|||
129609156|NCT02132754|466523977|FG015|Overall Study|Excluded Medication|0|||
129609157|NCT02132754|466523978|FG016|Overall Study|Excluded Medication|0|||
129609158|NCT02132754|466523979|FG017|Overall Study|Excluded Medication|0|||
129609159|NCT02132754|466523980|FG018|Overall Study|Excluded Medication|0|||
129609160|NCT02132754|466523981|FG019|Overall Study|Excluded Medication|0|||
129609161|NCT02132754|466523982|FG020|Overall Study|Excluded Medication|1|||
129609162|NCT02132754|466523983|FG021|Overall Study|Excluded Medication|0|||
129609163|NCT02132754|466523984|FG022|Overall Study|Excluded Medication|0|||
129609164|NCT02132754|466523985|FG023|Overall Study|Excluded Medication|0|||
129609165|NCT02132754|466523986|FG024|Overall Study|Excluded Medication|0|||
129609166|NCT02132754|466523987|FG025|Overall Study|Excluded Medication|0|||
129609167|NCT02132754|466523988|FG026|Overall Study|Excluded Medication|0|||
129609168|NCT02132754|466523989|FG027|Overall Study|Excluded Medication|0|||
129790704|NCT00045942|467201410|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
129609169|NCT02132754|466523990|FG028|Overall Study|Excluded Medication|0|||
129609170|NCT02132754|466523991|FG029|Overall Study|Excluded Medication|0|||
129609171|NCT02132754|466523992|FG030|Overall Study|Excluded Medication|0|||
129609172|NCT02132754|466523993|FG031|Overall Study|Excluded Medication|0|||
129609173|NCT02132754|466523994|FG032|Overall Study|Excluded Medication|0|||
129609174|NCT02132754|466523995|FG033|Overall Study|Excluded Medication|1|||
129609175|NCT02132754|466523962|FG000|Overall Study|Physician Decision|0|||
129609176|NCT02132754|466523963|FG001|Overall Study|Physician Decision|0|||
129609177|NCT02132754|466523964|FG002|Overall Study|Physician Decision|0|||
129609178|NCT02132754|466523965|FG003|Overall Study|Physician Decision|0|||
129609179|NCT02132754|466523966|FG004|Overall Study|Physician Decision|0|||
129609180|NCT02132754|466523967|FG005|Overall Study|Physician Decision|0|||
129609181|NCT02132754|466523968|FG006|Overall Study|Physician Decision|0|||
129609182|NCT02132754|466523969|FG007|Overall Study|Physician Decision|0|||
129609183|NCT02132754|466523970|FG008|Overall Study|Physician Decision|0|||
129609184|NCT02132754|466523971|FG009|Overall Study|Physician Decision|1|||
129609185|NCT02132754|466523972|FG010|Overall Study|Physician Decision|0|||
129609186|NCT02132754|466523973|FG011|Overall Study|Physician Decision|1|||
129609187|NCT02132754|466523974|FG012|Overall Study|Physician Decision|1|||
129609188|NCT02132754|466523975|FG013|Overall Study|Physician Decision|0|||
129609189|NCT02132754|466523976|FG014|Overall Study|Physician Decision|0|||
129609190|NCT02132754|466523977|FG015|Overall Study|Physician Decision|1|||
129609191|NCT02132754|466523978|FG016|Overall Study|Physician Decision|0|||
129609192|NCT02132754|466523979|FG017|Overall Study|Physician Decision|0|||
129609193|NCT02132754|466523980|FG018|Overall Study|Physician Decision|0|||
129609194|NCT02132754|466523981|FG019|Overall Study|Physician Decision|0|||
129609195|NCT02132754|466523982|FG020|Overall Study|Physician Decision|0|||
129609196|NCT02132754|466523983|FG021|Overall Study|Physician Decision|0|||
129609197|NCT02132754|466523984|FG022|Overall Study|Physician Decision|0|||
129609198|NCT02132754|466523985|FG023|Overall Study|Physician Decision|0|||
129609199|NCT02132754|466523986|FG024|Overall Study|Physician Decision|1|||
129609200|NCT02132754|466523987|FG025|Overall Study|Physician Decision|0|||
129609201|NCT02132754|466523988|FG026|Overall Study|Physician Decision|0|||
129609202|NCT02132754|466523989|FG027|Overall Study|Physician Decision|0|||
129609203|NCT02132754|466523990|FG028|Overall Study|Physician Decision|0|||
129609204|NCT02132754|466523991|FG029|Overall Study|Physician Decision|0|||
129438838|NCT02121834|465904500|FG000|Overall Study|Lost to Follow-up|0|||
129438839|NCT02121834|465904501|FG001|Overall Study|Lost to Follow-up|0|||
129438840|NCT02121834|465904502|FG002|Overall Study|Lost to Follow-up|1|||
129438841|NCT02121834|465904503|FG003|Overall Study|Lost to Follow-up|0|||
129438842|NCT02121834|465904504|FG004|Overall Study|Lost to Follow-up|0|||
129438843|NCT02121834|465904505|FG005|Overall Study|Lost to Follow-up|0|||
129438844|NCT02121834|465904506|FG006|Overall Study|Lost to Follow-up|0|||
129438845|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
129438846|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
129438847|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Death|0|||
129438848|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Death|2|||
129438849|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129438850|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
129438851|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
129438852|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
129438853|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
129609205|NCT02132754|466523992|FG030|Overall Study|Physician Decision|0|||
129609206|NCT02132754|466523993|FG031|Overall Study|Physician Decision|1|||
129609207|NCT02132754|466523994|FG032|Overall Study|Physician Decision|0|||
129609208|NCT02132754|466523995|FG033|Overall Study|Physician Decision|3|||
129609209|NCT02132754|466523962|FG000|Overall Study|Progressive Disease|1|||
129609210|NCT02132754|466523963|FG001|Overall Study|Progressive Disease|1|||
129609211|NCT02132754|466523964|FG002|Overall Study|Progressive Disease|1|||
129609212|NCT02132754|466523965|FG003|Overall Study|Progressive Disease|1|||
129609213|NCT02132754|466523966|FG004|Overall Study|Progressive Disease|1|||
129609214|NCT02132754|466523967|FG005|Overall Study|Progressive Disease|1|||
129609215|NCT02132754|466523968|FG006|Overall Study|Progressive Disease|1|||
129609216|NCT02132754|466523969|FG007|Overall Study|Progressive Disease|1|||
129609217|NCT02132754|466523970|FG008|Overall Study|Progressive Disease|1|||
129790705|NCT00045942|467201411|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
129790706|NCT00045942|467201412|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
129790707|NCT00045942|467201413|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
129790708|NCT00045942|467201414|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
129609218|NCT02132754|466523971|FG009|Overall Study|Progressive Disease|3|||
129609219|NCT02132754|466523972|FG010|Overall Study|Progressive Disease|3|||
129609220|NCT02132754|466523973|FG011|Overall Study|Progressive Disease|2|||
129609221|NCT02132754|466523974|FG012|Overall Study|Progressive Disease|2|||
129609222|NCT02132754|466523975|FG013|Overall Study|Progressive Disease|3|||
129609223|NCT02132754|466523976|FG014|Overall Study|Progressive Disease|2|||
129609224|NCT02132754|466523977|FG015|Overall Study|Progressive Disease|1|||
129790709|NCT00045942|467201415|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
129609225|NCT02132754|466523978|FG016|Overall Study|Progressive Disease|2|||
129609226|NCT02132754|466523979|FG017|Overall Study|Progressive Disease|1|||
129609227|NCT02132754|466523980|FG018|Overall Study|Progressive Disease|3|||
129609228|NCT02132754|466523981|FG019|Overall Study|Progressive Disease|1|||
129790710|NCT00045942|467201416|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
129609229|NCT02132754|466523982|FG020|Overall Study|Progressive Disease|1|||
129609230|NCT02132754|466523983|FG021|Overall Study|Progressive Disease|3|||
129609231|NCT02132754|466523984|FG022|Overall Study|Progressive Disease|2|||
129609232|NCT02132754|466523985|FG023|Overall Study|Progressive Disease|3|||
129609233|NCT02132754|466523986|FG024|Overall Study|Progressive Disease|0|||
129609234|NCT02132754|466523987|FG025|Overall Study|Progressive Disease|1|||
129609235|NCT02132754|466523988|FG026|Overall Study|Progressive Disease|2|||
129609236|NCT02132754|466523989|FG027|Overall Study|Progressive Disease|1|||
129609237|NCT02132754|466523990|FG028|Overall Study|Progressive Disease|2|||
129609238|NCT02132754|466523991|FG029|Overall Study|Progressive Disease|3|||
129609239|NCT02132754|466523992|FG030|Overall Study|Progressive Disease|1|||
129609240|NCT02132754|466523993|FG031|Overall Study|Progressive Disease|1|||
129609241|NCT02132754|466523994|FG032|Overall Study|Progressive Disease|3|||
129609242|NCT02132754|466523995|FG033|Overall Study|Progressive Disease|6|||
129609243|NCT02132754|466523962|FG000|Overall Study|Screen Failure|0|||
129609244|NCT02132754|466523963|FG001|Overall Study|Screen Failure|0|||
129609245|NCT02132754|466523964|FG002|Overall Study|Screen Failure|0|||
129609246|NCT02132754|466523965|FG003|Overall Study|Screen Failure|0|||
129609247|NCT02132754|466523966|FG004|Overall Study|Screen Failure|0|||
129609248|NCT02132754|466523967|FG005|Overall Study|Screen Failure|0|||
129609249|NCT02132754|466523968|FG006|Overall Study|Screen Failure|0|||
129609250|NCT02132754|466523969|FG007|Overall Study|Screen Failure|0|||
129609251|NCT02132754|466523970|FG008|Overall Study|Screen Failure|0|||
129609252|NCT02132754|466523971|FG009|Overall Study|Screen Failure|0|||
129609253|NCT02132754|466523972|FG010|Overall Study|Screen Failure|0|||
129609254|NCT02132754|466523973|FG011|Overall Study|Screen Failure|0|||
129609255|NCT02132754|466523974|FG012|Overall Study|Screen Failure|0|||
129609256|NCT02132754|466523975|FG013|Overall Study|Screen Failure|0|||
129609257|NCT02132754|466523976|FG014|Overall Study|Screen Failure|0|||
129609258|NCT02132754|466523977|FG015|Overall Study|Screen Failure|0|||
129609259|NCT02132754|466523978|FG016|Overall Study|Screen Failure|0|||
129609260|NCT02132754|466523979|FG017|Overall Study|Screen Failure|0|||
129609261|NCT02132754|466523980|FG018|Overall Study|Screen Failure|0|||
129609262|NCT02132754|466523981|FG019|Overall Study|Screen Failure|1|||
129609263|NCT02132754|466523982|FG020|Overall Study|Screen Failure|0|||
129609264|NCT02132754|466523983|FG021|Overall Study|Screen Failure|1|||
129609265|NCT02132754|466523984|FG022|Overall Study|Screen Failure|0|||
129609266|NCT02132754|466523985|FG023|Overall Study|Screen Failure|0|||
129609267|NCT02132754|466523986|FG024|Overall Study|Screen Failure|0|||
129609268|NCT02132754|466523987|FG025|Overall Study|Screen Failure|0|||
129609269|NCT02132754|466523988|FG026|Overall Study|Screen Failure|0|||
129609270|NCT02132754|466523989|FG027|Overall Study|Screen Failure|0|||
129609271|NCT02132754|466523990|FG028|Overall Study|Screen Failure|0|||
129609272|NCT02132754|466523991|FG029|Overall Study|Screen Failure|0|||
129609273|NCT02132754|466523992|FG030|Overall Study|Screen Failure|0|||
129609274|NCT02132754|466523993|FG031|Overall Study|Screen Failure|0|||
129609275|NCT02132754|466523994|FG032|Overall Study|Screen Failure|0|||
129609276|NCT02132754|466523995|FG033|Overall Study|Screen Failure|0|||
129609277|NCT02132754|466523962|FG000|Overall Study|Transferred to Extension Study|0|||
129609278|NCT02132754|466523963|FG001|Overall Study|Transferred to Extension Study|0|||
129609279|NCT02132754|466523964|FG002|Overall Study|Transferred to Extension Study|0|||
129609280|NCT02132754|466523965|FG003|Overall Study|Transferred to Extension Study|0|||
129609281|NCT02132754|466523966|FG004|Overall Study|Transferred to Extension Study|0|||
129609282|NCT02132754|466523967|FG005|Overall Study|Transferred to Extension Study|0|||
129699143|NCT03253627|466858544|FG000|Overall Study|Withdrawal by Subject|0|||
129699144|NCT03253627|466858545|FG001|Overall Study|Withdrawal by Subject|2|||
129699145|NCT03253627|466858544|FG000|Overall Study|Inability to complete MRI|1|||
129699146|NCT03253627|466858545|FG001|Overall Study|Inability to complete MRI|0|||
129699147|NCT03829683|466858548|FG000|Overall Study|Lost to Follow-up|1|||
129699148|NCT03829683|466858549|FG001|Overall Study|Lost to Follow-up|0|||
129699149|NCT03829683|466858548|FG000|Overall Study|Physician Decision|3|||
129699150|NCT03829683|466858549|FG001|Overall Study|Physician Decision|1|||
129699151|NCT03829683|466858548|FG000|Overall Study|Withdrawal by Subject|0|||
129609283|NCT02132754|466523968|FG006|Overall Study|Transferred to Extension Study|0|||
129609284|NCT02132754|466523969|FG007|Overall Study|Transferred to Extension Study|0|||
129609285|NCT02132754|466523970|FG008|Overall Study|Transferred to Extension Study|0|||
129609286|NCT02132754|466523971|FG009|Overall Study|Transferred to Extension Study|0|||
129609287|NCT02132754|466523972|FG010|Overall Study|Transferred to Extension Study|0|||
129699152|NCT03829683|466858549|FG001|Overall Study|Withdrawal by Subject|1|||
129609288|NCT02132754|466523973|FG011|Overall Study|Transferred to Extension Study|0|||
129609289|NCT02132754|466523974|FG012|Overall Study|Transferred to Extension Study|0|||
129609290|NCT02132754|466523975|FG013|Overall Study|Transferred to Extension Study|0|||
129609291|NCT02132754|466523976|FG014|Overall Study|Transferred to Extension Study|0|||
129609292|NCT02132754|466523977|FG015|Overall Study|Transferred to Extension Study|0|||
129609293|NCT02132754|466523978|FG016|Overall Study|Transferred to Extension Study|0|||
129609294|NCT02132754|466523979|FG017|Overall Study|Transferred to Extension Study|0|||
129609295|NCT02132754|466523980|FG018|Overall Study|Transferred to Extension Study|0|||
129609296|NCT02132754|466523981|FG019|Overall Study|Transferred to Extension Study|0|||
129609297|NCT02132754|466523982|FG020|Overall Study|Transferred to Extension Study|0|||
129609298|NCT02132754|466523983|FG021|Overall Study|Transferred to Extension Study|0|||
129609299|NCT02132754|466523984|FG022|Overall Study|Transferred to Extension Study|0|||
129609300|NCT02132754|466523985|FG023|Overall Study|Transferred to Extension Study|0|||
129609301|NCT02132754|466523986|FG024|Overall Study|Transferred to Extension Study|0|||
129609302|NCT02132754|466523987|FG025|Overall Study|Transferred to Extension Study|0|||
129609303|NCT02132754|466523988|FG026|Overall Study|Transferred to Extension Study|0|||
129609304|NCT02132754|466523989|FG027|Overall Study|Transferred to Extension Study|0|||
129609305|NCT02132754|466523990|FG028|Overall Study|Transferred to Extension Study|0|||
129790711|NCT00045942|467201417|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
129790712|NCT00045942|467201418|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
129790713|NCT00045942|467201410|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
129790714|NCT00045942|467201411|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
129790715|NCT00045942|467201412|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
129790716|NCT00045942|467201413|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
129790717|NCT00045942|467201414|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
129790718|NCT00045942|467201415|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
129790719|NCT00045942|467201416|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
129790720|NCT00045942|467201417|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
129790721|NCT00045942|467201418|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
129790722|NCT00045942|467201410|FG000|PKC412A2104E1|Lack of Efficacy|0|||
129790723|NCT00045942|467201411|FG001|PKC412A2104E1|Lack of Efficacy|11|||
129790724|NCT00045942|467201412|FG002|PKC412A2104E1|Lack of Efficacy|11|||
129609306|NCT02132754|466523991|FG029|Overall Study|Transferred to Extension Study|0|||
129609307|NCT02132754|466523992|FG030|Overall Study|Transferred to Extension Study|0|||
129609308|NCT02132754|466523993|FG031|Overall Study|Transferred to Extension Study|0|||
129609309|NCT02132754|466523994|FG032|Overall Study|Transferred to Extension Study|0|||
129609310|NCT02132754|466523995|FG033|Overall Study|Transferred to Extension Study|6|||
129609311|NCT02132754|466523962|FG000|Overall Study|Withdrawal by Subject|0|||
129609312|NCT02132754|466523963|FG001|Overall Study|Withdrawal by Subject|0|||
129609313|NCT02132754|466523964|FG002|Overall Study|Withdrawal by Subject|0|||
129609314|NCT02132754|466523965|FG003|Overall Study|Withdrawal by Subject|0|||
129609315|NCT02132754|466523966|FG004|Overall Study|Withdrawal by Subject|0|||
129609316|NCT02132754|466523967|FG005|Overall Study|Withdrawal by Subject|0|||
129609317|NCT02132754|466523968|FG006|Overall Study|Withdrawal by Subject|0|||
129609318|NCT02132754|466523969|FG007|Overall Study|Withdrawal by Subject|0|||
129609319|NCT02132754|466523970|FG008|Overall Study|Withdrawal by Subject|0|||
129609320|NCT02132754|466523971|FG009|Overall Study|Withdrawal by Subject|1|||
129609321|NCT02132754|466523972|FG010|Overall Study|Withdrawal by Subject|0|||
129609322|NCT02132754|466523973|FG011|Overall Study|Withdrawal by Subject|0|||
129609323|NCT02132754|466523974|FG012|Overall Study|Withdrawal by Subject|1|||
129609324|NCT02132754|466523975|FG013|Overall Study|Withdrawal by Subject|0|||
129609325|NCT02132754|466523976|FG014|Overall Study|Withdrawal by Subject|1|||
129609326|NCT02132754|466523977|FG015|Overall Study|Withdrawal by Subject|2|||
129609327|NCT02132754|466523978|FG016|Overall Study|Withdrawal by Subject|1|||
129609328|NCT02132754|466523979|FG017|Overall Study|Withdrawal by Subject|0|||
129609329|NCT02132754|466523980|FG018|Overall Study|Withdrawal by Subject|0|||
129609330|NCT02132754|466523981|FG019|Overall Study|Withdrawal by Subject|0|||
129609331|NCT02132754|466523982|FG020|Overall Study|Withdrawal by Subject|1|||
129609332|NCT02132754|466523983|FG021|Overall Study|Withdrawal by Subject|0|||
129609333|NCT02132754|466523984|FG022|Overall Study|Withdrawal by Subject|0|||
129609334|NCT02132754|466523985|FG023|Overall Study|Withdrawal by Subject|0|||
129609335|NCT02132754|466523986|FG024|Overall Study|Withdrawal by Subject|1|||
129609336|NCT02132754|466523987|FG025|Overall Study|Withdrawal by Subject|0|||
129609337|NCT02132754|466523988|FG026|Overall Study|Withdrawal by Subject|0|||
129609338|NCT02132754|466523989|FG027|Overall Study|Withdrawal by Subject|1|||
129609339|NCT02132754|466523990|FG028|Overall Study|Withdrawal by Subject|0|||
129609340|NCT02132754|466523991|FG029|Overall Study|Withdrawal by Subject|0|||
129609341|NCT02132754|466523992|FG030|Overall Study|Withdrawal by Subject|0|||
129609342|NCT02132754|466523993|FG031|Overall Study|Withdrawal by Subject|1|||
129790725|NCT00045942|467201413|FG003|PKC412A2104E1|Lack of Efficacy|23|||
129609343|NCT02132754|466523994|FG032|Overall Study|Withdrawal by Subject|0|||
129609344|NCT02132754|466523995|FG033|Overall Study|Withdrawal by Subject|2|||
129438854|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
129438855|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
129438856|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
129438857|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
129438858|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
129438859|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
129438860|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
129438861|NCT00343252|465904507|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
129438862|NCT00343252|465904508|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
129438863|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
129438864|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
129438865|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Death|3|||
129438866|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Death|3|||
129438867|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129438868|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129438869|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
129438870|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
129438871|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
129438872|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
129438873|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
129438874|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
129609345|NCT04430855|466524000|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
129609346|NCT04430855|466524001|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
129609347|NCT04430855|466524000|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
129609348|NCT04430855|466524001|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
129609349|NCT04430855|466524000|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
129609350|NCT04430855|466524001|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
129609351|NCT04430855|466524000|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
129609352|NCT04430855|466524001|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
129609353|NCT04430855|466524000|FG000|Period 1 (Weeks 1-12)|Other|0|||
129609354|NCT04430855|466524001|FG001|Period 1 (Weeks 1-12)|Other|1|||
129609355|NCT04430855|466524000|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
129609356|NCT04430855|466524001|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
129609357|NCT04430855|466524000|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
129609358|NCT04430855|466524001|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
129609359|NCT04430855|466524000|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
129609360|NCT04430855|466524001|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
129609361|NCT01425723|466524002|FG000|Overall Study|Lack of Efficacy|0|||
129609362|NCT01425723|466524003|FG001|Overall Study|Lack of Efficacy|1|||
129609363|NCT01425723|466524002|FG000|Overall Study|Withdrawal by Subject|1|||
129609364|NCT01425723|466524003|FG001|Overall Study|Withdrawal by Subject|4|||
129609365|NCT01425723|466524002|FG000|Overall Study|Lost to Follow-up|0|||
129609366|NCT01425723|466524003|FG001|Overall Study|Lost to Follow-up|3|||
129609367|NCT01425723|466524002|FG000|Overall Study|Physician Decision|2|||
129609368|NCT01425723|466524003|FG001|Overall Study|Physician Decision|0|||
129609369|NCT01425723|466524002|FG000|Overall Study|Other|1|||
129609370|NCT01425723|466524003|FG001|Overall Study|Other|10|||
129609371|NCT00186043|466524004|FG000|Overall Study|Lack of Efficacy|1|||
129609372|NCT00186043|466524005|FG001|Overall Study|Lack of Efficacy|3|||
129609373|NCT00186043|466524004|FG000|Overall Study|Lost to Follow-up|4|||
129886969|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
129438875|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
129438876|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
129438877|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
129438878|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
129438879|NCT00343252|465904507|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
129438880|NCT00343252|465904508|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
129438881|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
129438882|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
129438883|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Death|4|||
129438884|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Death|5|||
129438885|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
129609374|NCT00186043|466524005|FG001|Overall Study|Lost to Follow-up|6|||
129609375|NCT00186043|466524004|FG000|Overall Study|Withdrawal by Subject|1|||
129609376|NCT00186043|466524005|FG001|Overall Study|Withdrawal by Subject|0|||
129609377|NCT00186043|466524004|FG000|Overall Study|Adverse Event|7|||
129609378|NCT00186043|466524005|FG001|Overall Study|Adverse Event|3|||
129609379|NCT00186043|466524004|FG000|Overall Study|Protocol Violation|2|||
129609380|NCT00186043|466524005|FG001|Overall Study|Protocol Violation|1|||
129609381|NCT04874636|466524006|FG000|Overall Study|Adverse Event|17|||
129609382|NCT04874636|466524007|FG001|Overall Study|Adverse Event|7|||
129699153|NCT03829683|466858548|FG000|Overall Study|Discharge from hospital|1|||
129699154|NCT03829683|466858549|FG001|Overall Study|Discharge from hospital|0|||
129699155|NCT01922895|466858553|FG000|Overall Study|Death|0|||
129699156|NCT01922895|466858554|FG001|Overall Study|Death|1|||
129699157|NCT01922895|466858553|FG000|Overall Study|Withdrawal by Subject|1|||
129699158|NCT01922895|466858554|FG001|Overall Study|Withdrawal by Subject|2|||
129699159|NCT01922895|466858553|FG000|Overall Study|Lost to Follow-up|5|||
129699160|NCT01922895|466858554|FG001|Overall Study|Lost to Follow-up|11|||
129699161|NCT01916226|466858555|FG000|Overall Study|Adverse Event|1|||
129699162|NCT01916226|466858556|FG001|Overall Study|Adverse Event|0|||
129699163|NCT01916226|466858557|FG002|Overall Study|Adverse Event|1|||
129699164|NCT01916226|466858558|FG003|Overall Study|Adverse Event|1|||
129699165|NCT01916226|466858555|FG000|Overall Study|Lack of Efficacy|0|||
129699166|NCT01916226|466858556|FG001|Overall Study|Lack of Efficacy|0|||
129699167|NCT01916226|466858557|FG002|Overall Study|Lack of Efficacy|2|||
129699168|NCT01916226|466858558|FG003|Overall Study|Lack of Efficacy|1|||
129790726|NCT00045942|467201414|FG004|PKC412A2104E1|Lack of Efficacy|17|||
129790727|NCT00045942|467201415|FG005|PKC412A2104E1|Lack of Efficacy|0|||
129790728|NCT00045942|467201416|FG006|PKC412A2104E1|Lack of Efficacy|0|||
129790729|NCT00045942|467201417|FG007|PKC412A2104E1|Lack of Efficacy|0|||
129790730|NCT00045942|467201418|FG008|PKC412A2104E1|Lack of Efficacy|0|||
129790731|NCT00045942|467201410|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
129790732|NCT00045942|467201411|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
129790733|NCT00045942|467201412|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
129790734|NCT00045942|467201413|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
129790735|NCT00045942|467201414|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
129790736|NCT00045942|467201415|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
129790737|NCT00045942|467201416|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
129790738|NCT00045942|467201417|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
129790739|NCT00045942|467201418|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
129790740|NCT00045942|467201410|FG000|PKC412A2104E1|Adverse Event|0|||
129790741|NCT00045942|467201411|FG001|PKC412A2104E1|Adverse Event|1|||
129790742|NCT00045942|467201412|FG002|PKC412A2104E1|Adverse Event|1|||
129790743|NCT00045942|467201413|FG003|PKC412A2104E1|Adverse Event|3|||
129790744|NCT00045942|467201414|FG004|PKC412A2104E1|Adverse Event|6|||
129790745|NCT00045942|467201415|FG005|PKC412A2104E1|Adverse Event|0|||
129790746|NCT00045942|467201416|FG006|PKC412A2104E1|Adverse Event|0|||
129790747|NCT00045942|467201417|FG007|PKC412A2104E1|Adverse Event|0|||
129790748|NCT00045942|467201418|FG008|PKC412A2104E1|Adverse Event|0|||
129790749|NCT00045942|467201410|FG000|PKC412A2104E1|Death|0|||
129790750|NCT00045942|467201411|FG001|PKC412A2104E1|Death|4|||
129790751|NCT00045942|467201412|FG002|PKC412A2104E1|Death|1|||
129790752|NCT00045942|467201413|FG003|PKC412A2104E1|Death|1|||
129790753|NCT00045942|467201414|FG004|PKC412A2104E1|Death|1|||
129790754|NCT00045942|467201415|FG005|PKC412A2104E1|Death|0|||
129790755|NCT00045942|467201416|FG006|PKC412A2104E1|Death|0|||
129790756|NCT00045942|467201417|FG007|PKC412A2104E1|Death|0|||
129790757|NCT00045942|467201418|FG008|PKC412A2104E1|Death|0|||
129790758|NCT00045942|467201410|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129790759|NCT00045942|467201411|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129790760|NCT00045942|467201412|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
129790761|NCT00045942|467201413|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
129699169|NCT01916226|466858555|FG000|Overall Study|Protocol Violation|0|||
129699170|NCT01916226|466858556|FG001|Overall Study|Protocol Violation|1|||
129699171|NCT01916226|466858557|FG002|Overall Study|Protocol Violation|0|||
129699172|NCT01916226|466858558|FG003|Overall Study|Protocol Violation|1|||
129790762|NCT00045942|467201414|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129699173|NCT01916226|466858555|FG000|Overall Study|Physician Decision|0|||
129790763|NCT00045942|467201415|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129790764|NCT00045942|467201416|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129790765|NCT00045942|467201417|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129699174|NCT01916226|466858556|FG001|Overall Study|Physician Decision|0|||
129699175|NCT01916226|466858557|FG002|Overall Study|Physician Decision|0|||
129790766|NCT00045942|467201418|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
129438886|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
129438887|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
129438888|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
129438889|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
129438890|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
129438891|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
129438892|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
129438893|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
129438894|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
129438895|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
129438896|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
129438897|NCT00343252|465904507|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
129438898|NCT00343252|465904508|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
129438899|NCT01740323|465904509|FG000|Overall Study|Adverse Event|1|||
129438900|NCT01740323|465904510|FG001|Overall Study|Adverse Event|0|||
129438901|NCT01740323|465904509|FG000|Overall Study|Randomized but did not take study drug|1|||
129438902|NCT01740323|465904510|FG001|Overall Study|Randomized but did not take study drug|0|||
129438903|NCT03353350|465904521|FG000|30-week Core Treatment Period|Protocol Violation|1|||
129438904|NCT03353350|465904522|FG001|30-week Core Treatment Period|Protocol Violation|1|||
129438905|NCT03353350|465904523|FG002|30-week Core Treatment Period|Protocol Violation|1|||
129438906|NCT03353350|465904524|FG003|30-week Core Treatment Period|Protocol Violation|0|||
129438907|NCT03353350|465904521|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
129438908|NCT03353350|465904522|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
129438909|NCT03353350|465904523|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
129438910|NCT03353350|465904524|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
129438911|NCT03353350|465904521|FG000|30-week Core Treatment Period|Adverse Event|0|||
129438912|NCT03353350|465904522|FG001|30-week Core Treatment Period|Adverse Event|4|||
129438913|NCT03353350|465904523|FG002|30-week Core Treatment Period|Adverse Event|2|||
129438914|NCT03353350|465904524|FG003|30-week Core Treatment Period|Adverse Event|3|||
129438915|NCT03353350|465904521|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
129438916|NCT03353350|465904522|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
129438917|NCT03353350|465904523|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
129438918|NCT03353350|465904524|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
129438919|NCT03353350|465904521|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
129438920|NCT03353350|465904522|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
129438921|NCT03353350|465904523|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
129438922|NCT03353350|465904524|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
129438923|NCT03353350|465904521|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
129438924|NCT03353350|465904522|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
129438925|NCT03353350|465904523|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
129438926|NCT03353350|465904524|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
129438927|NCT03353350|465904521|FG000|26-week Treatment Extension Period|Adverse Event|1|||
129438928|NCT03353350|465904522|FG001|26-week Treatment Extension Period|Adverse Event|0|||
129438929|NCT03353350|465904523|FG002|26-week Treatment Extension Period|Adverse Event|0|||
129438930|NCT03353350|465904524|FG003|26-week Treatment Extension Period|Adverse Event|1|||
129438931|NCT03353350|465904521|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
129438932|NCT03353350|465904522|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
129438933|NCT03353350|465904523|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
129438934|NCT03353350|465904524|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
129438935|NCT01423253|465904528|FG000|Overall Study|Adverse Event|2|||
129438936|NCT01423253|465904528|FG000|Overall Study|Lack of Efficacy|2|||
129438937|NCT01423253|465904528|FG000|Overall Study|Lost to Follow-up|1|||
129438938|NCT01423253|465904528|FG000|Overall Study|Protocol Violation|2|||
129438939|NCT01423253|465904528|FG000|Overall Study|Withdrawal by Subject|2|||
129438940|NCT00307125|465904531|FG000|Screening Phase|Adverse Event|1|||
129438941|NCT00307125|465904532|FG001|Screening Phase|Adverse Event|0|||
129438942|NCT00307125|465904533|FG002|Screening Phase|Adverse Event|0|||
129438943|NCT00307125|465904531|FG000|Screening Phase|Protocol Violation|27|||
129438944|NCT00307125|465904532|FG001|Screening Phase|Protocol Violation|0|||
129438945|NCT00307125|465904533|FG002|Screening Phase|Protocol Violation|0|||
129438946|NCT00307125|465904531|FG000|Screening Phase|Lost to Follow-up|87|||
129438947|NCT00307125|465904532|FG001|Screening Phase|Lost to Follow-up|0|||
129438948|NCT00307125|465904533|FG002|Screening Phase|Lost to Follow-up|0|||
129438949|NCT00307125|465904531|FG000|Screening Phase|Death|10|||
129609383|NCT04874636|466524006|FG000|Overall Study|Lost to Follow-up|1|||
129609384|NCT04874636|466524007|FG001|Overall Study|Lost to Follow-up|0|||
129609385|NCT04874636|466524006|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129609386|NCT04874636|466524007|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129609387|NCT04874636|466524006|FG000|Overall Study|Physician Decision|1|||
129609388|NCT04874636|466524007|FG001|Overall Study|Physician Decision|0|||
129609389|NCT04874636|466524006|FG000|Overall Study|Withdrawal by Subject|6|||
129609390|NCT04874636|466524007|FG001|Overall Study|Withdrawal by Subject|5|||
129609391|NCT01770392|466524008|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
129609392|NCT04639713|466524009|FG000|Overall Study|Protocol Noncompliance|2|||
129609393|NCT04639713|466524009|FG000|Overall Study|Withdrawal by Subject|1|||
129609394|NCT00390221|466524012|FG000|Overall Study|Lost to Follow-up|0|||
129609395|NCT00390221|466524013|FG001|Overall Study|Lost to Follow-up|3|||
129609396|NCT00390221|466524014|FG002|Overall Study|Lost to Follow-up|0|||
129609397|NCT00390221|466524012|FG000|Overall Study|Adverse Event|1|||
129609398|NCT00390221|466524013|FG001|Overall Study|Adverse Event|4|||
129609399|NCT00390221|466524014|FG002|Overall Study|Adverse Event|3|||
129609400|NCT00390221|466524012|FG000|Overall Study|Investigator Decision|0|||
129609401|NCT00390221|466524013|FG001|Overall Study|Investigator Decision|0|||
129609402|NCT00390221|466524014|FG002|Overall Study|Investigator Decision|1|||
129609403|NCT00390221|466524012|FG000|Overall Study|Withdrawal by Subject|13|||
129699176|NCT01916226|466858558|FG003|Overall Study|Physician Decision|1|||
129699177|NCT03163667|466858559|FG000|Overall Study|Death|15|||
129699178|NCT03163667|466858560|FG001|Overall Study|Death|27|||
129438950|NCT00307125|465904532|FG001|Screening Phase|Death|0|||
129438951|NCT00307125|465904533|FG002|Screening Phase|Death|0|||
129438952|NCT00307125|465904531|FG000|Screening Phase|Withdrawal by Subject|77|||
129438953|NCT00307125|465904532|FG001|Screening Phase|Withdrawal by Subject|0|||
129438954|NCT00307125|465904533|FG002|Screening Phase|Withdrawal by Subject|0|||
129438955|NCT00307125|465904531|FG000|Screening Phase|Physician Decision|26|||
129438956|NCT00307125|465904532|FG001|Screening Phase|Physician Decision|0|||
129438957|NCT00307125|465904533|FG002|Screening Phase|Physician Decision|0|||
129438958|NCT00307125|465904531|FG000|Screening Phase|Sponsor Decision|4|||
129699179|NCT03163667|466858559|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
129438959|NCT00307125|465904532|FG001|Screening Phase|Sponsor Decision|0|||
129438960|NCT00307125|465904533|FG002|Screening Phase|Sponsor Decision|0|||
129699180|NCT03163667|466858560|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
129438961|NCT00307125|465904531|FG000|Screening Phase|Study Terminated|17|||
129438962|NCT00307125|465904532|FG001|Screening Phase|Study Terminated|0|||
129438963|NCT00307125|465904533|FG002|Screening Phase|Study Terminated|0|||
129438964|NCT00307125|465904531|FG000|Screening Phase|Graft Loss|3|||
129438965|NCT00307125|465904532|FG001|Screening Phase|Graft Loss|0|||
129438966|NCT00307125|465904533|FG002|Screening Phase|Graft Loss|0|||
129438967|NCT00307125|465904531|FG000|Screening Phase|Graft Failure|8|||
129438968|NCT00307125|465904532|FG001|Screening Phase|Graft Failure|0|||
129438969|NCT00307125|465904533|FG002|Screening Phase|Graft Failure|0|||
129699181|NCT05430919|466858561|FG000|Overall Study|Protocol Violation|0|||
129699182|NCT05430919|466858562|FG001|Overall Study|Protocol Violation|0|||
129699183|NCT05430919|466858563|FG002|Overall Study|Protocol Violation|1|||
129438970|NCT00307125|465904531|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
129438971|NCT00307125|465904532|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
129438972|NCT00307125|465904533|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
129438973|NCT00307125|465904531|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
129438974|NCT00307125|465904532|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
129438975|NCT00307125|465904533|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
129438976|NCT00307125|465904531|FG000|Screening Phase|Moved or transferred facilities|34|||
129438977|NCT00307125|465904532|FG001|Screening Phase|Moved or transferred facilities|0|||
129438978|NCT00307125|465904533|FG002|Screening Phase|Moved or transferred facilities|0|||
129438979|NCT00307125|465904531|FG000|Screening Phase|Received Pancreas Transplant|8|||
129438980|NCT00307125|465904532|FG001|Screening Phase|Received Pancreas Transplant|0|||
129438981|NCT00307125|465904533|FG002|Screening Phase|Received Pancreas Transplant|0|||
129438982|NCT00307125|465904531|FG000|Screening Phase|Ineligible for pilot|4|||
129438983|NCT00307125|465904532|FG001|Screening Phase|Ineligible for pilot|0|||
129438984|NCT00307125|465904533|FG002|Screening Phase|Ineligible for pilot|0|||
129438985|NCT00307125|465904531|FG000|Screening Phase|Try to get pregnant|1|||
129609404|NCT00390221|466524013|FG001|Overall Study|Withdrawal by Subject|9|||
129609405|NCT00390221|466524014|FG002|Overall Study|Withdrawal by Subject|7|||
129609406|NCT00390221|466524012|FG000|Overall Study|Subject Non-compliance|1|||
129609407|NCT00390221|466524013|FG001|Overall Study|Subject Non-compliance|0|||
129609408|NCT00390221|466524014|FG002|Overall Study|Subject Non-compliance|2|||
129699184|NCT05430919|466858564|FG003|Overall Study|Protocol Violation|0|||
129699185|NCT05430919|466858561|FG000|Overall Study|Lost to Follow-up|0|||
129699186|NCT05430919|466858562|FG001|Overall Study|Lost to Follow-up|1|||
129699187|NCT05430919|466858563|FG002|Overall Study|Lost to Follow-up|0|||
129699188|NCT05430919|466858564|FG003|Overall Study|Lost to Follow-up|0|||
129699189|NCT05430919|466858561|FG000|Overall Study|Withdrawal by Subject|3|||
129699190|NCT05430919|466858562|FG001|Overall Study|Withdrawal by Subject|0|||
129699191|NCT05430919|466858563|FG002|Overall Study|Withdrawal by Subject|0|||
129699192|NCT05430919|466858564|FG003|Overall Study|Withdrawal by Subject|1|||
129699193|NCT01848457|466858567|FG000|Overall Study|Death|1|||
129699194|NCT01848457|466858568|FG001|Overall Study|Death|0|||
129699195|NCT01848457|466858569|FG002|Overall Study|Death|0|||
129699196|NCT01848457|466858570|FG003|Overall Study|Death|0|||
129699197|NCT02940223|466858573|FG000|Overall Study|Failed Requirement|2|||
129699198|NCT02940223|466858574|FG001|Overall Study|Failed Requirement|0|||
129699199|NCT01422382|466858577|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
129699200|NCT01813357|466858578|FG000|Overall Study|Lost to Follow-up|5|||
129699201|NCT01813357|466858579|FG001|Overall Study|Lost to Follow-up|6|||
129699202|NCT03773562|466858580|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
129699203|NCT03773562|466858580|FG000|Overall Study|Lost to Follow-up|10|||
129699204|NCT03773562|466858580|FG000|Overall Study|Withdrawal by Subject|1|||
129699205|NCT01272219|466858581|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
129699206|NCT01272219|466858582|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
129699207|NCT01272219|466858583|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
129699208|NCT01272219|466858584|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
129699209|NCT01272219|466858585|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
129699210|NCT01272219|466858586|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
129699211|NCT01272219|466858581|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
129699212|NCT01272219|466858582|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
129699213|NCT01272219|466858583|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
129699214|NCT01272219|466858584|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
129699215|NCT01272219|466858585|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
129699216|NCT01272219|466858586|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
129699217|NCT01272219|466858581|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
129699218|NCT01272219|466858582|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
129699219|NCT01272219|466858583|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
129699220|NCT01272219|466858584|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
129699221|NCT01272219|466858585|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
129699222|NCT01272219|466858586|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
129699223|NCT01272219|466858581|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
129699224|NCT01272219|466858582|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
129699225|NCT01272219|466858583|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
129699226|NCT01272219|466858584|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
129699227|NCT01272219|466858585|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
129699228|NCT01272219|466858586|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
129699229|NCT01272219|466858581|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
129699230|NCT01272219|466858582|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
129699231|NCT01272219|466858583|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
129699232|NCT01272219|466858584|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
129699233|NCT01272219|466858585|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
129699234|NCT01272219|466858586|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
129699235|NCT01272219|466858581|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
129699236|NCT01272219|466858582|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
129699237|NCT01272219|466858583|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
129699238|NCT01272219|466858584|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
129699239|NCT01272219|466858585|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
129699240|NCT01272219|466858586|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
129699241|NCT01272219|466858581|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129699242|NCT01272219|466858582|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129699243|NCT01272219|466858583|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129699244|NCT01272219|466858584|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
129699245|NCT01272219|466858585|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129699246|NCT01272219|466858586|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
129699247|NCT01272219|466858581|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129699248|NCT01272219|466858582|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
129699249|NCT01272219|466858583|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129699250|NCT01272219|466858584|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
129699251|NCT01272219|466858585|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129699252|NCT01272219|466858586|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
129790767|NCT00045942|467201410|FG000|PKC412A2104E2|Lost to Follow-up|0|||
129438986|NCT00307125|465904532|FG001|Screening Phase|Try to get pregnant|0|||
129438987|NCT00307125|465904533|FG002|Screening Phase|Try to get pregnant|0|||
129438988|NCT00307125|465904531|FG000|Screening Phase|Developed acute leukemia|1|||
129438989|NCT00307125|465904532|FG001|Screening Phase|Developed acute leukemia|0|||
129438990|NCT00307125|465904533|FG002|Screening Phase|Developed acute leukemia|0|||
129438991|NCT00307125|465904531|FG000|Screening Phase|Metastatic colon cancer|1|||
129438992|NCT00307125|465904532|FG001|Screening Phase|Metastatic colon cancer|0|||
129438993|NCT00307125|465904533|FG002|Screening Phase|Metastatic colon cancer|0|||
129438994|NCT00307125|465904531|FG000|Screening Phase|Malignancy|1|||
129438995|NCT00307125|465904532|FG001|Screening Phase|Malignancy|0|||
129438996|NCT00307125|465904533|FG002|Screening Phase|Malignancy|0|||
129438997|NCT00307125|465904531|FG000|Screening Phase|PAK|1|||
129438998|NCT00307125|465904532|FG001|Screening Phase|PAK|0|||
129438999|NCT00307125|465904533|FG002|Screening Phase|PAK|0|||
129439000|NCT00307125|465904531|FG000|Screening Phase|Ineligible|1|||
129439001|NCT00307125|465904532|FG001|Screening Phase|Ineligible|0|||
129439002|NCT00307125|465904533|FG002|Screening Phase|Ineligible|0|||
129439003|NCT00307125|465904531|FG000|Screening Phase|Screen Error|1|||
129439004|NCT00307125|465904532|FG001|Screening Phase|Screen Error|0|||
129439005|NCT00307125|465904533|FG002|Screening Phase|Screen Error|0|||
129439006|NCT00307125|465904531|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
129439007|NCT00307125|465904532|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
129439008|NCT00307125|465904533|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
129439009|NCT00307125|465904531|FG000|Screening Phase|AMR and treated with rituximab|1|||
129439010|NCT00307125|465904532|FG001|Screening Phase|AMR and treated with rituximab|0|||
129439011|NCT00307125|465904533|FG002|Screening Phase|AMR and treated with rituximab|0|||
129439012|NCT00307125|465904531|FG000|Screening Phase|Coronary artery bypass|1|||
129439013|NCT00307125|465904532|FG001|Screening Phase|Coronary artery bypass|0|||
129439014|NCT00307125|465904533|FG002|Screening Phase|Coronary artery bypass|0|||
129439015|NCT00307125|465904531|FG000|Pilot Phase|Lost to Follow-up|0|||
129439016|NCT00307125|465904532|FG001|Pilot Phase|Lost to Follow-up|1|||
129439017|NCT00307125|465904533|FG002|Pilot Phase|Lost to Follow-up|0|||
129439018|NCT00307125|465904531|FG000|Pilot Phase|Withdrawal by Subject|0|||
129439019|NCT00307125|465904532|FG001|Pilot Phase|Withdrawal by Subject|1|||
129439020|NCT00307125|465904533|FG002|Pilot Phase|Withdrawal by Subject|1|||
129699253|NCT01272219|466858581|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
129699254|NCT01272219|466858582|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
129699255|NCT01272219|466858583|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
129699256|NCT01272219|466858584|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
129439021|NCT00051363|465904534|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
129439022|NCT00051363|465904535|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
129439023|NCT00051363|465904534|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
129439024|NCT00051363|465904535|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
129439025|NCT00051363|465904534|FG000|Overall Study|Death|2|||
129699257|NCT01272219|466858585|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
129699258|NCT01272219|466858586|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
129699259|NCT01272219|466858581|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
129699260|NCT01272219|466858582|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
129699261|NCT01272219|466858583|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
129699262|NCT01272219|466858584|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
129699263|NCT01272219|466858585|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
129699264|NCT01272219|466858586|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
129699265|NCT01272219|466858581|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
129699266|NCT01272219|466858582|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
129699267|NCT01272219|466858583|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
129699268|NCT01272219|466858584|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
129699269|NCT01272219|466858585|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
129699270|NCT01272219|466858586|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
129699271|NCT01272219|466858581|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129699272|NCT01272219|466858582|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129699273|NCT01272219|466858583|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129699274|NCT01272219|466858584|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
129699275|NCT01272219|466858585|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
129699276|NCT01272219|466858586|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
129699277|NCT01272219|466858581|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129699278|NCT01272219|466858582|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129699279|NCT01272219|466858583|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129699280|NCT01272219|466858584|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
129699281|NCT01272219|466858585|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
129699282|NCT01272219|466858586|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
129699283|NCT01272219|466858581|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129699284|NCT01272219|466858582|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129699285|NCT01272219|466858583|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129699286|NCT01272219|466858584|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
129699287|NCT01272219|466858585|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
129699288|NCT01272219|466858586|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
129699289|NCT01272219|466858581|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
129699290|NCT01272219|466858582|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
129699291|NCT01272219|466858583|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
129699292|NCT01272219|466858584|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
129699293|NCT01272219|466858585|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
129699294|NCT01272219|466858586|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
129699295|NCT01272219|466858581|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
129699296|NCT01272219|466858582|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
129699297|NCT01272219|466858583|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
129699298|NCT01272219|466858584|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
129699299|NCT01272219|466858585|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
129699300|NCT01272219|466858586|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
129699301|NCT03131479|466858587|FG000|Overall Study|Adverse Event|0|||
129699302|NCT03131479|466858588|FG001|Overall Study|Adverse Event|0|||
129699303|NCT03131479|466858589|FG002|Overall Study|Adverse Event|1|||
129699304|NCT03131479|466858590|FG003|Overall Study|Adverse Event|1|||
129699305|NCT03131479|466858591|FG004|Overall Study|Adverse Event|0|||
129699306|NCT03131479|466858587|FG000|Overall Study|Subject/Guardian Decision|0|||
129699307|NCT03131479|466858588|FG001|Overall Study|Subject/Guardian Decision|0|||
129699308|NCT03131479|466858589|FG002|Overall Study|Subject/Guardian Decision|0|||
129699309|NCT03131479|466858590|FG003|Overall Study|Subject/Guardian Decision|1|||
129699310|NCT03131479|466858591|FG004|Overall Study|Subject/Guardian Decision|0|||
129699311|NCT00050011|466858593|FG000|Overall Study|Adverse Event|41|||
129699312|NCT00050011|466858594|FG001|Overall Study|Adverse Event|46|||
129699313|NCT00050011|466858593|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129699314|NCT00050011|466858594|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129699315|NCT00050011|466858593|FG000|Overall Study|Abnormal test procedure results|0|||
129699316|NCT00050011|466858594|FG001|Overall Study|Abnormal test procedure results|1|||
129699317|NCT00050011|466858593|FG000|Overall Study|Lack of Efficacy|16|||
129439026|NCT00051363|465904535|FG001|Overall Study|Death|2|||
129439027|NCT00051363|465904534|FG000|Overall Study|Excluded Pre-Randomization|2|||
129439028|NCT00051363|465904535|FG001|Overall Study|Excluded Pre-Randomization|5|||
129439029|NCT00147823|465904538|FG000|Overall Study|Lost to Follow-up|6|||
129439030|NCT00147823|465904539|FG001|Overall Study|Lost to Follow-up|12|||
129439031|NCT00147823|465904538|FG000|Overall Study|Physician Decision|1|||
129439032|NCT00147823|465904539|FG001|Overall Study|Physician Decision|0|||
129439033|NCT00147823|465904538|FG000|Overall Study|Withdrawal by Subject|0|||
129439034|NCT00147823|465904539|FG001|Overall Study|Withdrawal by Subject|1|||
129439035|NCT00147823|465904538|FG000|Overall Study|Did not receive vitoss due to infection|6|||
129439036|NCT00147823|465904539|FG001|Overall Study|Did not receive vitoss due to infection|2|||
129439037|NCT01032382|465904540|FG000|Overall Study|Disease dissemination|1|||
129439038|NCT01032382|465904541|FG001|Overall Study|Disease dissemination|1|||
129439039|NCT01032382|465904540|FG000|Overall Study|Treatment failure|3|||
129439040|NCT01032382|465904541|FG001|Overall Study|Treatment failure|1|||
129439041|NCT01032382|465904540|FG000|Overall Study|Index lesion relapse|1|||
129439042|NCT01032382|465904541|FG001|Overall Study|Index lesion relapse|3|||
129439043|NCT00412971|465904542|FG000|Overall Study|Lost to Follow-up|17|||
129439044|NCT00412971|465904543|FG001|Overall Study|Lost to Follow-up|9|||
129439045|NCT00412971|465904542|FG000|Overall Study|Protocol Violation|13|||
129439046|NCT00412971|465904543|FG001|Overall Study|Protocol Violation|1|||
129439047|NCT01012713|465904544|FG000|Overall Study|Lack of Efficacy|3|||
129439048|NCT02571049|465904545|FG000|Screening|Did not meet entry criteria|2|||
129439049|NCT02571049|465904546|FG001|Screening|Did not meet entry criteria|2|||
129439050|NCT02571049|465904545|FG000|Randomization|No migraine attack|0|||
129439051|NCT02571049|465904546|FG001|Randomization|No migraine attack|1|||
129439052|NCT02571049|465904545|FG000|Randomization|Adverse Event|0|||
129439053|NCT02571049|465904546|FG001|Randomization|Adverse Event|1|||
129439054|NCT00985153|465904547|FG000|Overall Study|Lost to Follow-up|16|||
129439055|NCT00985153|465904548|FG001|Overall Study|Lost to Follow-up|19|||
129439056|NCT00985153|465904549|FG002|Overall Study|Lost to Follow-up|17|||
129439057|NCT00985153|465904550|FG003|Overall Study|Lost to Follow-up|20|||
129439058|NCT00985153|465904547|FG000|Overall Study|Protocol Violation|3|||
129439059|NCT00985153|465904548|FG001|Overall Study|Protocol Violation|2|||
129439060|NCT00985153|465904549|FG002|Overall Study|Protocol Violation|4|||
129439061|NCT00985153|465904550|FG003|Overall Study|Protocol Violation|3|||
129439062|NCT00985153|465904547|FG000|Overall Study|Withdrawal by Subject|6|||
129439063|NCT00985153|465904548|FG001|Overall Study|Withdrawal by Subject|11|||
129439064|NCT00985153|465904549|FG002|Overall Study|Withdrawal by Subject|11|||
129439065|NCT00985153|465904550|FG003|Overall Study|Withdrawal by Subject|10|||
129439066|NCT00985153|465904547|FG000|Overall Study|Missed One or More Bleeds|7|||
129439067|NCT00985153|465904548|FG001|Overall Study|Missed One or More Bleeds|7|||
129439068|NCT00985153|465904549|FG002|Overall Study|Missed One or More Bleeds|8|||
129439069|NCT00985153|465904550|FG003|Overall Study|Missed One or More Bleeds|10|||
129439070|NCT00985153|465904547|FG000|Overall Study|Incomplete Safety Follow-up|3|||
129439071|NCT00985153|465904548|FG001|Overall Study|Incomplete Safety Follow-up|5|||
129439072|NCT00985153|465904549|FG002|Overall Study|Incomplete Safety Follow-up|4|||
129439073|NCT00985153|465904550|FG003|Overall Study|Incomplete Safety Follow-up|4|||
129439074|NCT01055262|465904551|FG000|Overall Study|Adverse Event|5|||
129439075|NCT01055262|465904551|FG000|Overall Study|Protocol Violation|3|||
129439076|NCT01055262|465904551|FG000|Overall Study|Uncooperativeness|1|||
129439077|NCT03370471|465904552|FG000|Overall Study|Withdrawal by Subject|6|||
129439078|NCT03370471|465904553|FG001|Overall Study|Withdrawal by Subject|1|||
129439079|NCT03370471|465904552|FG000|Overall Study|Unable to access veins for blood draw|0|||
129439080|NCT03370471|465904553|FG001|Overall Study|Unable to access veins for blood draw|1|||
129439081|NCT03370471|465904552|FG000|Overall Study|Screen fail|1|||
129439082|NCT03370471|465904553|FG001|Overall Study|Screen fail|0|||
129439083|NCT00561951|465904555|FG000|Overall Study|Adverse Event|11|||
129439084|NCT00561951|465904556|FG001|Overall Study|Adverse Event|14|||
129439085|NCT00561951|465904557|FG002|Overall Study|Adverse Event|14|||
129439086|NCT00561951|465904555|FG000|Overall Study|Lack of Efficacy|5|||
129699318|NCT00050011|466858594|FG001|Overall Study|Lack of Efficacy|21|||
129699319|NCT00050011|466858593|FG000|Overall Study|Participant condition no longer required|1|||
129439087|NCT00561951|465904556|FG001|Overall Study|Lack of Efficacy|3|||
129439088|NCT00561951|465904557|FG002|Overall Study|Lack of Efficacy|2|||
129439089|NCT00561951|465904555|FG000|Overall Study|Lost to Follow-up|1|||
129439090|NCT00561951|465904556|FG001|Overall Study|Lost to Follow-up|1|||
129439091|NCT00561951|465904557|FG002|Overall Study|Lost to Follow-up|0|||
129439092|NCT00561951|465904555|FG000|Overall Study|Withdrawal by Subject|10|||
129439093|NCT00561951|465904556|FG001|Overall Study|Withdrawal by Subject|9|||
129439094|NCT00561951|465904557|FG002|Overall Study|Withdrawal by Subject|10|||
129439095|NCT00561951|465904555|FG000|Overall Study|Protocol Violation|4|||
129439096|NCT00561951|465904556|FG001|Overall Study|Protocol Violation|3|||
129439097|NCT00561951|465904557|FG002|Overall Study|Protocol Violation|4|||
129439098|NCT00561951|465904555|FG000|Overall Study|Physician Decision|1|||
129439099|NCT00561951|465904556|FG001|Overall Study|Physician Decision|0|||
129439100|NCT00561951|465904557|FG002|Overall Study|Physician Decision|0|||
129699320|NCT00050011|466858594|FG001|Overall Study|Participant condition no longer required|0|||
129609409|NCT00390221|466524012|FG000|Overall Study|Other|3|||
129609410|NCT00390221|466524013|FG001|Overall Study|Other|4|||
129609411|NCT00390221|466524014|FG002|Overall Study|Other|2|||
129609412|NCT02533375|466524015|FG000|Overall Study|Lack of Efficacy|3|||
129609413|NCT02533375|466524015|FG000|Overall Study|Adverse Event|2|||
129609414|NCT03870477|466524024|FG000|Overall Study|Early Study Termination|1|||
129609415|NCT03258853|466524025|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
129609416|NCT03258853|466524026|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
129609417|NCT00871741|466524029|FG000|Overall Study|Premature study termination|9|||
129609418|NCT00871741|466524030|FG001|Overall Study|Premature study termination|7|||
129609419|NCT01565850|466524035|FG000|Overall Study|Adverse Event|0|||
129609420|NCT01565850|466524036|FG001|Overall Study|Adverse Event|1|||
129609421|NCT01565850|466524035|FG000|Overall Study|Lost to Follow-up|12|||
129609422|NCT01565850|466524036|FG001|Overall Study|Lost to Follow-up|4|||
129609423|NCT01565850|466524035|FG000|Overall Study|Investigator's Discretion|2|||
129609424|NCT01565850|466524036|FG001|Overall Study|Investigator's Discretion|1|||
129609425|NCT01565850|466524035|FG000|Overall Study|Participant noncompliance|2|||
129609426|NCT01565850|466524036|FG001|Overall Study|Participant noncompliance|0|||
129609427|NCT01565850|466524035|FG000|Overall Study|Withdrew Consent|4|||
129609428|NCT01565850|466524036|FG001|Overall Study|Withdrew Consent|2|||
129609429|NCT04941729|466525850|FG000|Overall Study|Death|0|||
129609430|NCT04941729|466525851|FG001|Overall Study|Death|1|||
129886970|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
129886971|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
129609431|NCT04941729|466525850|FG000|Overall Study|Study terminated by sponsor|11|||
129609432|NCT04941729|466525851|FG001|Overall Study|Study terminated by sponsor|10|||
129609433|NCT00191113|466525852|FG000|Core Study|Withdrawal by Subject|25|||
129609434|NCT00191113|466525853|FG001|Core Study|Withdrawal by Subject|9|||
129609435|NCT00191113|466525852|FG000|Core Study|Protocol Violation|6|||
129609436|NCT00191113|466525853|FG001|Core Study|Protocol Violation|2|||
129609437|NCT00191113|466525852|FG000|Core Study|Lost to Follow-up|3|||
129609438|NCT00191113|466525853|FG001|Core Study|Lost to Follow-up|0|||
129609439|NCT00191113|466525852|FG000|Core Study|Adverse Event|0|||
129609440|NCT00191113|466525853|FG001|Core Study|Adverse Event|2|||
129609441|NCT00191113|466525852|FG000|Core Study|Lack of Efficacy|0|||
129609442|NCT00191113|466525853|FG001|Core Study|Lack of Efficacy|2|||
129609443|NCT00191113|466525852|FG000|Core Study|Death|1|||
129609444|NCT00191113|466525853|FG001|Core Study|Death|0|||
129609445|NCT00368979|466525858|FG000|Overall Study|Adverse Event|9|||
129609446|NCT00368979|466525859|FG001|Overall Study|Adverse Event|16|||
129609447|NCT00368979|466525858|FG000|Overall Study|Lack of Efficacy|5|||
129609448|NCT00368979|466525859|FG001|Overall Study|Lack of Efficacy|3|||
129609449|NCT00368979|466525858|FG000|Overall Study|Other|3|||
129609450|NCT00368979|466525859|FG001|Overall Study|Other|1|||
129609451|NCT00368979|466525858|FG000|Overall Study|Lost to Follow-up|1|||
129609452|NCT00368979|466525859|FG001|Overall Study|Lost to Follow-up|0|||
129609453|NCT00368979|466525858|FG000|Overall Study|Protocol Violation|2|||
129609454|NCT00368979|466525859|FG001|Overall Study|Protocol Violation|1|||
129790768|NCT00045942|467201411|FG001|PKC412A2104E2|Lost to Follow-up|0|||
129790769|NCT00045942|467201412|FG002|PKC412A2104E2|Lost to Follow-up|0|||
129790770|NCT00045942|467201413|FG003|PKC412A2104E2|Lost to Follow-up|0|||
129790771|NCT00045942|467201414|FG004|PKC412A2104E2|Lost to Follow-up|0|||
129790772|NCT00045942|467201415|FG005|PKC412A2104E2|Lost to Follow-up|0|||
129790773|NCT00045942|467201416|FG006|PKC412A2104E2|Lost to Follow-up|0|||
129790774|NCT00045942|467201417|FG007|PKC412A2104E2|Lost to Follow-up|3|||
129609455|NCT00368979|466525858|FG000|Overall Study|Withdrawal by Subject|5|||
129609456|NCT00368979|466525859|FG001|Overall Study|Withdrawal by Subject|9|||
129609457|NCT00631657|466525862|FG000|6-Month Treatment Period|Adverse Event|47|||
129609458|NCT00631657|466525863|FG001|6-Month Treatment Period|Adverse Event|0|||
129609459|NCT00631657|466525864|FG002|6-Month Treatment Period|Adverse Event|7|||
129609460|NCT00631657|466525862|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
129609461|NCT00631657|466525863|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
129609462|NCT00631657|466525864|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
129609463|NCT00631657|466525862|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
129609464|NCT00631657|466525863|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
129609465|NCT00631657|466525864|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
129609466|NCT00631657|466525862|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
129609467|NCT00631657|466525863|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
129609468|NCT00631657|466525864|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
129609469|NCT00631657|466525862|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
129609470|NCT00631657|466525863|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
129609471|NCT00631657|466525864|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
129609472|NCT00631657|466525862|FG000|6-Month Treatment Period|Other|16|||
129609473|NCT00631657|466525863|FG001|6-Month Treatment Period|Other|0|||
129609474|NCT00631657|466525864|FG002|6-Month Treatment Period|Other|4|||
129609475|NCT00631657|466525862|FG000|6-Month Treatment Period|Not Treated|2|||
129609476|NCT00631657|466525863|FG001|6-Month Treatment Period|Not Treated|0|||
129609477|NCT00631657|466525864|FG002|6-Month Treatment Period|Not Treated|1|||
129609478|NCT00631657|466525862|FG000|7-Day Discontinuation Period|Not Treated|1|||
129609479|NCT00631657|466525863|FG001|7-Day Discontinuation Period|Not Treated|1|||
129609480|NCT00631657|466525864|FG002|7-Day Discontinuation Period|Not Treated|1|||
129609481|NCT00631657|466525862|FG000|7-Day Discontinuation Period|Other|1|||
129609482|NCT00631657|466525863|FG001|7-Day Discontinuation Period|Other|0|||
129609483|NCT00631657|466525864|FG002|7-Day Discontinuation Period|Other|0|||
129609484|NCT00325195|466525865|FG000|Randomized|Not dosed|5|||
129609485|NCT00325195|466525866|FG001|Randomized|Not dosed|5|||
129609486|NCT00325195|466525867|FG002|Randomized|Not dosed|3|||
129609487|NCT00325195|466525865|FG000|Received Intervention: ITT Population|Adverse Event|15|||
129609488|NCT00325195|466525866|FG001|Received Intervention: ITT Population|Adverse Event|17|||
129609489|NCT00325195|466525867|FG002|Received Intervention: ITT Population|Adverse Event|1|||
129609490|NCT00325195|466525865|FG000|Received Intervention: ITT Population|Death|3|||
129609491|NCT00325195|466525866|FG001|Received Intervention: ITT Population|Death|1|||
129609492|NCT00325195|466525867|FG002|Received Intervention: ITT Population|Death|0|||
129609493|NCT00325195|466525865|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
129609494|NCT00325195|466525866|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
129609495|NCT00325195|466525867|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
129609496|NCT00325195|466525865|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
129609497|NCT00325195|466525866|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
129609498|NCT00325195|466525867|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
129609499|NCT00325195|466525865|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
129609500|NCT00325195|466525866|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
129609501|NCT00325195|466525867|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
129609502|NCT00552578|466525873|FG000|Overall Study|Lost to Follow-up|1|||
129609503|NCT00552578|466525874|FG001|Overall Study|Lost to Follow-up|1|||
129609504|NCT01716715|466525875|FG000|Overall Study|Never Treated|2|||
129609505|NCT01716715|466525876|FG001|Overall Study|Never Treated|4|||
129609506|NCT00626392|466525877|FG000|Run-in Period|Adverse Event|0|||
129609507|NCT00626392|466525878|FG001|Run-in Period|Adverse Event|0|||
129609508|NCT00626392|466525879|FG002|Run-in Period|Adverse Event|1|||
129609509|NCT00626392|466525880|FG003|Run-in Period|Adverse Event|0|||
129609510|NCT00626392|466525881|FG004|Run-in Period|Adverse Event|1|||
129609511|NCT00626392|466525882|FG005|Run-in Period|Adverse Event|0|||
129609512|NCT00626392|466525877|FG000|Run-in Period|Withdrawal by Subject|0|||
129609513|NCT00626392|466525878|FG001|Run-in Period|Withdrawal by Subject|1|||
129609514|NCT00626392|466525879|FG002|Run-in Period|Withdrawal by Subject|1|||
129699321|NCT00050011|466858593|FG000|Overall Study|Protocol Violation|4|||
129609515|NCT00626392|466525880|FG003|Run-in Period|Withdrawal by Subject|1|||
129609516|NCT00626392|466525881|FG004|Run-in Period|Withdrawal by Subject|3|||
129609517|NCT00626392|466525882|FG005|Run-in Period|Withdrawal by Subject|1|||
129609518|NCT00626392|466525877|FG000|Run-in Period|Noncompliance|1|||
129609519|NCT00626392|466525878|FG001|Run-in Period|Noncompliance|0|||
129609520|NCT00626392|466525879|FG002|Run-in Period|Noncompliance|1|||
129609521|NCT00626392|466525880|FG003|Run-in Period|Noncompliance|0|||
129609522|NCT00626392|466525881|FG004|Run-in Period|Noncompliance|0|||
129609523|NCT00626392|466525882|FG005|Run-in Period|Noncompliance|0|||
129609524|NCT00626392|466525877|FG000|Coadministration Period|Adverse Event|3|||
129699322|NCT00050011|466858594|FG001|Overall Study|Protocol Violation|10|||
129699323|NCT00050011|466858593|FG000|Overall Study|Withdrawal by Subject|34|||
129609525|NCT00626392|466525878|FG001|Coadministration Period|Adverse Event|1|||
129609526|NCT00626392|466525879|FG002|Coadministration Period|Adverse Event|7|||
129609527|NCT00626392|466525880|FG003|Coadministration Period|Adverse Event|4|||
129609528|NCT00626392|466525881|FG004|Coadministration Period|Adverse Event|3|||
129609529|NCT00626392|466525882|FG005|Coadministration Period|Adverse Event|4|||
129609530|NCT00626392|466525877|FG000|Coadministration Period|Withdrawal by Subject|1|||
129609531|NCT00626392|466525878|FG001|Coadministration Period|Withdrawal by Subject|1|||
129609532|NCT00626392|466525879|FG002|Coadministration Period|Withdrawal by Subject|0|||
129609533|NCT00626392|466525880|FG003|Coadministration Period|Withdrawal by Subject|1|||
129609534|NCT00626392|466525881|FG004|Coadministration Period|Withdrawal by Subject|0|||
129609535|NCT00626392|466525882|FG005|Coadministration Period|Withdrawal by Subject|1|||
129609536|NCT00626392|466525877|FG000|Coadministration Period|Protocol Violation|0|||
129609537|NCT00626392|466525878|FG001|Coadministration Period|Protocol Violation|1|||
129609538|NCT00626392|466525879|FG002|Coadministration Period|Protocol Violation|0|||
129609539|NCT00626392|466525880|FG003|Coadministration Period|Protocol Violation|1|||
129609540|NCT00626392|466525881|FG004|Coadministration Period|Protocol Violation|1|||
129609541|NCT00626392|466525882|FG005|Coadministration Period|Protocol Violation|0|||
129609542|NCT00626392|466525877|FG000|Coadministration Period|Other|0|||
129609543|NCT00626392|466525878|FG001|Coadministration Period|Other|2|||
129609544|NCT00626392|466525879|FG002|Coadministration Period|Other|3|||
129609545|NCT00626392|466525880|FG003|Coadministration Period|Other|1|||
129609546|NCT00626392|466525881|FG004|Coadministration Period|Other|1|||
129609547|NCT00626392|466525882|FG005|Coadministration Period|Other|1|||
129609548|NCT03327792|466525883|FG000|Overall Study|Adverse Event|4|||
129609549|NCT03327792|466525884|FG001|Overall Study|Adverse Event|0|||
129609550|NCT03327792|466525883|FG000|Overall Study|Family/Personal issues|3|||
129609551|NCT03327792|466525884|FG001|Overall Study|Family/Personal issues|2|||
129609552|NCT03327792|466525883|FG000|Overall Study|Lost to Follow-up|0|||
129609553|NCT03327792|466525884|FG001|Overall Study|Lost to Follow-up|1|||
129609554|NCT01085734|466525889|FG000|Overall Study|Adverse Event|0|||
129609555|NCT01085734|466525890|FG001|Overall Study|Adverse Event|2|||
129609556|NCT01085734|466525889|FG000|Overall Study|Death|1|||
129609557|NCT01085734|466525890|FG001|Overall Study|Death|0|||
129609558|NCT01085734|466525889|FG000|Overall Study|Lost to Follow-up|0|||
129609559|NCT01085734|466525890|FG001|Overall Study|Lost to Follow-up|1|||
129609560|NCT01085734|466525889|FG000|Overall Study|Withdrawal by Subject|0|||
129609561|NCT01085734|466525890|FG001|Overall Study|Withdrawal by Subject|1|||
129609562|NCT01715571|466525891|FG000|Overall Study|Lost to Follow-up|8|||
129609563|NCT04480710|466525898|FG000|Overall Study|Adverse Event|0|||
129609564|NCT04480710|466525899|FG001|Overall Study|Adverse Event|2|||
129609565|NCT04480710|466525900|FG002|Overall Study|Adverse Event|0|||
129609566|NCT04480710|466525901|FG003|Overall Study|Adverse Event|0|||
129609567|NCT04480710|466525898|FG000|Overall Study|Withdrawal by Subject|0|||
129609568|NCT04480710|466525899|FG001|Overall Study|Withdrawal by Subject|1|||
129609569|NCT04480710|466525900|FG002|Overall Study|Withdrawal by Subject|0|||
129609570|NCT04480710|466525901|FG003|Overall Study|Withdrawal by Subject|0|||
129609571|NCT04480710|466525898|FG000|Overall Study|Physician Decision|0|||
129609572|NCT04480710|466525899|FG001|Overall Study|Physician Decision|0|||
129609573|NCT04480710|466525900|FG002|Overall Study|Physician Decision|1|||
129609574|NCT04480710|466525901|FG003|Overall Study|Physician Decision|0|||
129609575|NCT04126213|466525903|FG000|Overall Study|Lost to Follow-up|9|||
129609576|NCT04126213|466525904|FG001|Overall Study|Lost to Follow-up|1|||
129609577|NCT04126213|466525905|FG002|Overall Study|Lost to Follow-up|5|||
129609578|NCT04126213|466525906|FG003|Overall Study|Lost to Follow-up|10|||
129609579|NCT04126213|466525907|FG004|Overall Study|Lost to Follow-up|4|||
129609580|NCT04126213|466525908|FG005|Overall Study|Lost to Follow-up|7|||
129609581|NCT04126213|466525903|FG000|Overall Study|Withdrawal by Subject|3|||
129609582|NCT04126213|466525904|FG001|Overall Study|Withdrawal by Subject|2|||
129609583|NCT04126213|466525905|FG002|Overall Study|Withdrawal by Subject|1|||
129609584|NCT04126213|466525906|FG003|Overall Study|Withdrawal by Subject|1|||
129609585|NCT04126213|466525907|FG004|Overall Study|Withdrawal by Subject|1|||
129609586|NCT04126213|466525908|FG005|Overall Study|Withdrawal by Subject|1|||
129609587|NCT04126213|466525903|FG000|Overall Study|Other|0|||
129609588|NCT04126213|466525904|FG001|Overall Study|Other|0|||
129609589|NCT04126213|466525905|FG002|Overall Study|Other|2|||
129609590|NCT04126213|466525906|FG003|Overall Study|Other|2|||
129609591|NCT04126213|466525907|FG004|Overall Study|Other|0|||
129609592|NCT04126213|466525908|FG005|Overall Study|Other|1|||
129609593|NCT04126213|466525903|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129609594|NCT04126213|466525904|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129609595|NCT04126213|466525905|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129609596|NCT04126213|466525906|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129609597|NCT04126213|466525907|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129609598|NCT04126213|466525908|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129609599|NCT02196701|466525911|FG000|Overall Study|Adverse Event|1|||
129609600|NCT02196701|466525911|FG000|Overall Study|Lost to Follow-up|1|||
129609601|NCT02196701|466525911|FG000|Overall Study|Non-adherence to Protocol|1|||
129609602|NCT03275064|466525912|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129609603|NCT03275064|466525913|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129609604|NCT03275064|466525914|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129609605|NCT03275064|466525915|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
129609606|NCT03275064|466525916|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
129609607|NCT03275064|466525912|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
129609608|NCT03275064|466525913|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129609609|NCT03275064|466525914|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129609610|NCT03275064|466525915|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129609611|NCT03275064|466525916|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
129609612|NCT03275064|466525912|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
129609613|NCT03275064|466525913|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
129609614|NCT03275064|466525914|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
129609615|NCT03275064|466525915|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
129609616|NCT03275064|466525916|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
129609617|NCT03275064|466525912|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129609618|NCT03275064|466525913|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129609619|NCT03275064|466525914|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129609620|NCT03275064|466525915|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
129609621|NCT03275064|466525916|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
129609622|NCT03275064|466525912|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
129609623|NCT03275064|466525913|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
129609624|NCT03275064|466525914|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
129609625|NCT03275064|466525915|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
129609626|NCT03275064|466525916|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
129609627|NCT04159935|466525917|FG000|Overall Study|Study terminated due to COVID-19|1|||
129609628|NCT04159935|466525918|FG001|Overall Study|Study terminated due to COVID-19|3|||
129609629|NCT01341782|466525919|FG000|Overall Study|Adverse Event|1|||
129609630|NCT01341782|466525920|FG001|Overall Study|Adverse Event|1|||
129609631|NCT01341782|466525919|FG000|Overall Study|Withdrawal by Subject|6|||
129609632|NCT01341782|466525920|FG001|Overall Study|Withdrawal by Subject|5|||
129609633|NCT01341782|466525919|FG000|Overall Study|Missed 3 consecutive doses|0|||
129609634|NCT01341782|466525920|FG001|Overall Study|Missed 3 consecutive doses|4|||
129609635|NCT01341782|466525919|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
129609636|NCT01341782|466525920|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
129609637|NCT01341782|466525919|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
129609638|NCT01341782|466525920|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
129609639|NCT01341782|466525919|FG000|Overall Study|Other|5|||
129609640|NCT01341782|466525920|FG001|Overall Study|Other|0|||
129609641|NCT00620555|466525921|FG000|Overall Study|Adverse Event|4|||
129699324|NCT00050011|466858594|FG001|Overall Study|Withdrawal by Subject|26|||
129699325|NCT00050011|466858593|FG000|Overall Study|Lost to Follow-up|7|||
129699326|NCT00050011|466858594|FG001|Overall Study|Lost to Follow-up|9|||
129699327|NCT00050011|466858593|FG000|Overall Study|Administrative problems|10|||
129699328|NCT00050011|466858594|FG001|Overall Study|Administrative problems|6|||
129699329|NCT00050011|466858593|FG000|Overall Study|Death|7|||
129699330|NCT00050011|466858594|FG001|Overall Study|Death|4|||
129699331|NCT00050011|466858593|FG000|Overall Study|Unknown - Reason is missing|0|||
129439101|NCT00561951|465904555|FG000|Overall Study|Pregnancy|0|||
129609642|NCT00620555|466525921|FG000|Overall Study|Protocol Violation|2|||
129609643|NCT00620555|466525921|FG000|Overall Study|Lack of Efficacy|12|||
129609644|NCT00620555|466525921|FG000|Overall Study|Withdrawal by Subject|1|||
129699332|NCT00050011|466858594|FG001|Overall Study|Unknown - Reason is missing|2|||
129699333|NCT04806373|466858596|FG000|Overall Study|Withdrawal by Subject|1|||
129699334|NCT04806373|466858597|FG001|Overall Study|Withdrawal by Subject|1|||
129699335|NCT05810597|466858598|FG000|Period 1|Adverse Event|2|||
129699336|NCT05810597|466858599|FG001|Period 1|Adverse Event|0|||
129439102|NCT00561951|465904556|FG001|Overall Study|Pregnancy|1|||
129439103|NCT00561951|465904557|FG002|Overall Study|Pregnancy|0|||
129609645|NCT00620555|466525921|FG000|Overall Study|Choice of other treatment|1|||
129609646|NCT00620555|466525921|FG000|Overall Study|Visit failure against planned|1|||
129609647|NCT01140503|466525922|FG000|Overall Study|Withdrawal by Subject|1|||
129609648|NCT00724048|466525923|FG000|Overall Study|Adverse Event|1|||
129609649|NCT00724048|466525924|FG001|Overall Study|Adverse Event|1|||
129609650|NCT00724048|466525925|FG002|Overall Study|Adverse Event|1|||
129609651|NCT00724048|466525926|FG003|Overall Study|Adverse Event|0|||
129609652|NCT00724048|466525923|FG000|Overall Study|Lost to Follow-up|0|||
129609653|NCT00724048|466525924|FG001|Overall Study|Lost to Follow-up|1|||
129609654|NCT00724048|466525925|FG002|Overall Study|Lost to Follow-up|0|||
129609655|NCT00724048|466525926|FG003|Overall Study|Lost to Follow-up|0|||
129609656|NCT00724048|466525923|FG000|Overall Study|Withdrawal by Subject|1|||
129609657|NCT00724048|466525924|FG001|Overall Study|Withdrawal by Subject|2|||
129609658|NCT00724048|466525925|FG002|Overall Study|Withdrawal by Subject|1|||
129609659|NCT00724048|466525926|FG003|Overall Study|Withdrawal by Subject|2|||
129609660|NCT00724048|466525923|FG000|Overall Study|Investigator decision|0|||
129609661|NCT00724048|466525924|FG001|Overall Study|Investigator decision|0|||
129609662|NCT00724048|466525925|FG002|Overall Study|Investigator decision|1|||
129609663|NCT00724048|466525926|FG003|Overall Study|Investigator decision|0|||
129609664|NCT00724048|466525923|FG000|Overall Study|Did not tolerate study drug|0|||
129609665|NCT00724048|466525924|FG001|Overall Study|Did not tolerate study drug|0|||
129609666|NCT00724048|466525925|FG002|Overall Study|Did not tolerate study drug|0|||
129609667|NCT00724048|466525926|FG003|Overall Study|Did not tolerate study drug|1|||
129609668|NCT00724048|466525923|FG000|Overall Study|Other than specified|1|||
129609669|NCT00724048|466525924|FG001|Overall Study|Other than specified|1|||
129609670|NCT00724048|466525925|FG002|Overall Study|Other than specified|0|||
129609671|NCT00724048|466525926|FG003|Overall Study|Other than specified|0|||
129609672|NCT03923530|466525927|FG000|Overall Study|Withdrawal by Subject|1|||
129609673|NCT03923530|466525927|FG000|Overall Study|screen failure|3|||
129609674|NCT00407758|466525928|FG000|Overall Study|ineligible -improper prior treatment|1|||
129609675|NCT01822275|466525936|FG000|Overall Study|Withdrawal by Subject|3|||
129609676|NCT01822275|466525936|FG000|Overall Study|Adverse Event|3|||
129609677|NCT01822275|466525936|FG000|Overall Study|Progression|14|||
129609678|NCT01822275|466525936|FG000|Overall Study|Physician Decision|2|||
129609679|NCT00073021|466525938|FG000|Overall Study|Protocol Violation|2|||
129609680|NCT00073021|466525939|FG001|Overall Study|Protocol Violation|1|||
129609681|NCT00073021|466525938|FG000|Overall Study|Adverse Event|4|||
129609682|NCT00073021|466525939|FG001|Overall Study|Adverse Event|4|||
129609683|NCT00073021|466525938|FG000|Overall Study|Withdrawal by Subject|6|||
129609684|NCT00073021|466525939|FG001|Overall Study|Withdrawal by Subject|5|||
129609685|NCT00073021|466525938|FG000|Overall Study|Physician Decision|3|||
129609686|NCT00073021|466525939|FG001|Overall Study|Physician Decision|1|||
129609687|NCT00073021|466525938|FG000|Overall Study|Lack of Efficacy|11|||
129609688|NCT00073021|466525939|FG001|Overall Study|Lack of Efficacy|5|||
129609689|NCT01458106|466525940|FG000|Overall Study|Withdrawal by Subject|2|||
129609690|NCT01458106|466525941|FG001|Overall Study|Withdrawal by Subject|0|||
129609691|NCT01458106|466525940|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
129609692|NCT01458106|466525941|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
129609693|NCT01458106|466525940|FG000|Overall Study|Withdrawn Per Protocol|0|||
129609694|NCT01458106|466525941|FG001|Overall Study|Withdrawn Per Protocol|1|||
129609695|NCT00855803|466525942|FG000|Overall Study|Death|2|||
129609696|NCT00855803|466525942|FG000|Overall Study|Lost to Follow-up|2|||
129609697|NCT00855803|466525942|FG000|Overall Study|Technical inability to undergo procedure|2|||
129609698|NCT00855803|466525942|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
129609699|NCT00855803|466525942|FG000|Overall Study|Withdrawal by Subject|3|||
129609700|NCT00855803|466525942|FG000|Overall Study|Physician Decision|3|||
129609701|NCT01672970|466525946|FG000|Overall Study|Lack of Efficacy|12|||
129609702|NCT01672970|466525946|FG000|Overall Study|Adverse Event|18|||
129699337|NCT05810597|466858598|FG000|Period 1|Physician Decision|1|||
129699338|NCT05810597|466858599|FG001|Period 1|Physician Decision|0|||
129699339|NCT05021224|466858602|FG000|Overall Study|Did not complete all survey items|4|||
129699340|NCT05021224|466858603|FG001|Overall Study|Did not complete all survey items|1|||
129699341|NCT05021224|466858604|FG002|Overall Study|Did not complete all survey items|0|||
129699342|NCT05021224|466858605|FG003|Overall Study|Did not complete all survey items|2|||
129699343|NCT02061085|466858608|FG000|Overall Study|Adverse Event|8|||
129699344|NCT04903093|466858613|FG000|Overall Study|Withdrawal by Subject|0|||
129699345|NCT04903093|466858614|FG001|Overall Study|Withdrawal by Subject|0|||
129609703|NCT01672970|466525946|FG000|Overall Study|Withdrawal by Subject|2|||
129609704|NCT01672970|466525946|FG000|Overall Study|Lost to Follow-up|5|||
129609705|NCT01672970|466525946|FG000|Overall Study|Other|9|||
129609706|NCT01672970|466525946|FG000|Overall Study|Enrolled but not treated|1|||
129609707|NCT03276780|466525949|FG000|Overall Study|Withdrawal by Subject|5|||
129609708|NCT03276780|466525950|FG001|Overall Study|Withdrawal by Subject|3|||
129609709|NCT03276780|466525949|FG000|Overall Study|Lost to Follow-up|3|||
129609710|NCT03276780|466525950|FG001|Overall Study|Lost to Follow-up|5|||
129609711|NCT03276780|466525949|FG000|Overall Study|Moved out of state|1|||
129699346|NCT04903093|466858615|FG002|Overall Study|Withdrawal by Subject|0|||
129609712|NCT03276780|466525950|FG001|Overall Study|Moved out of state|1|||
129609713|NCT03276780|466525949|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
129609714|NCT03276780|466525950|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
129609715|NCT03276780|466525949|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
129609716|NCT03276780|466525950|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
129609717|NCT03050060|466525951|FG000|Overall Study|Adverse Event|7|||
129609718|NCT03050060|466525951|FG000|Overall Study|Withdrawal by Subject|1|||
129609719|NCT03050060|466525951|FG000|Overall Study|Progression|7|||
129609720|NCT03835221|466525952|FG000|Methafilcon A|Withdrawal by Subject|1|||
129609721|NCT02582866|466525959|FG000|Overall Study|Death|1|||
129609722|NCT02582866|466525959|FG000|Overall Study|Lack of Efficacy|2|||
129609723|NCT02582866|466525959|FG000|Overall Study|Lost to Follow-up|2|||
129609724|NCT02582866|466525959|FG000|Overall Study|Withdrawal by Subject|7|||
129609725|NCT02582866|466525959|FG000|Overall Study|Investigator decision|5|||
129609726|NCT02582866|466525959|FG000|Overall Study|Participant wants to get pregnant|1|||
129609727|NCT02582866|466525959|FG000|Overall Study|Pregnancy|2|||
129609728|NCT02582866|466525959|FG000|Overall Study|Sponsor decision|1|||
129609729|NCT02582866|466525959|FG000|Overall Study|Withdrawal due to personal reasons|1|||
129609730|NCT02823652|466525960|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
129609731|NCT02823652|466525961|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
129609732|NCT02823652|466525962|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
129609733|NCT02823652|466525960|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
129609734|NCT02823652|466525961|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
129609735|NCT02823652|466525962|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
129609736|NCT02823652|466525960|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
129609737|NCT02823652|466525961|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
129609738|NCT02823652|466525962|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
129609739|NCT02823652|466525960|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
129609740|NCT02823652|466525961|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
129609741|NCT02823652|466525962|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
129609742|NCT03567382|466525965|FG000|Overall Study|Lost to Follow-up|1|||
129609743|NCT03567382|466525966|FG001|Overall Study|Lost to Follow-up|21|||
129609744|NCT03567382|466525967|FG002|Overall Study|Lost to Follow-up|1|||
129609745|NCT03567382|466525968|FG003|Overall Study|Lost to Follow-up|21|||
129609746|NCT03567382|466525965|FG000|Overall Study|Withdrawal by Subject|2|||
129609747|NCT03567382|466525966|FG001|Overall Study|Withdrawal by Subject|14|||
129609748|NCT03567382|466525967|FG002|Overall Study|Withdrawal by Subject|1|||
129609749|NCT03567382|466525968|FG003|Overall Study|Withdrawal by Subject|12|||
129609750|NCT00620659|466525969|FG000|Treatment Period 1|Adverse Event|1|||
129609751|NCT00620659|466525970|FG001|Treatment Period 1|Adverse Event|0|||
129609752|NCT00620659|466525971|FG002|Treatment Period 1|Adverse Event|0|||
129609753|NCT00620659|466525972|FG003|Treatment Period 1|Adverse Event|3|||
129609754|NCT00620659|466525973|FG004|Treatment Period 1|Adverse Event|0|||
129609755|NCT00620659|466525974|FG005|Treatment Period 1|Adverse Event|0|||
129609756|NCT00620659|466525969|FG000|Treatment Period 1|Protocol Violation|1|||
129609757|NCT00620659|466525970|FG001|Treatment Period 1|Protocol Violation|0|||
129609758|NCT00620659|466525971|FG002|Treatment Period 1|Protocol Violation|0|||
129609759|NCT00620659|466525972|FG003|Treatment Period 1|Protocol Violation|0|||
129609760|NCT00620659|466525973|FG004|Treatment Period 1|Protocol Violation|0|||
129609761|NCT00620659|466525974|FG005|Treatment Period 1|Protocol Violation|0|||
129609762|NCT00620659|466525969|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129609763|NCT00620659|466525970|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129609764|NCT00620659|466525971|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129609765|NCT00620659|466525972|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129609766|NCT00620659|466525973|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129609767|NCT00620659|466525974|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129609768|NCT00620659|466525969|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
129609769|NCT00620659|466525970|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
129609770|NCT00620659|466525971|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
129609771|NCT00620659|466525972|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
129699347|NCT04903093|466858616|FG003|Overall Study|Withdrawal by Subject|1|||
129699348|NCT04903093|466858617|FG004|Overall Study|Withdrawal by Subject|0|||
129699349|NCT04903093|466858618|FG005|Overall Study|Withdrawal by Subject|0|||
129699350|NCT02412436|466858619|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
129609772|NCT00620659|466525973|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
129609773|NCT00620659|466525974|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
129609774|NCT00620659|466525969|FG000|Treatment Period 2|Adverse Event|0|||
129609775|NCT00620659|466525970|FG001|Treatment Period 2|Adverse Event|3|||
129609776|NCT00620659|466525971|FG002|Treatment Period 2|Adverse Event|0|||
129609777|NCT00620659|466525972|FG003|Treatment Period 2|Adverse Event|0|||
129609778|NCT00620659|466525973|FG004|Treatment Period 2|Adverse Event|2|||
129609779|NCT00620659|466525974|FG005|Treatment Period 2|Adverse Event|0|||
129609780|NCT00620659|466525969|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129609781|NCT00620659|466525970|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129609782|NCT00620659|466525971|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129609783|NCT00620659|466525972|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129609784|NCT00620659|466525973|FG004|Treatment Period 2|Withdrawal by Subject|3|||
129609785|NCT00620659|466525974|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129609786|NCT00620659|466525969|FG000|Placebo Washout Period 2|Adverse Event|2|||
129609787|NCT00620659|466525970|FG001|Placebo Washout Period 2|Adverse Event|0|||
129609788|NCT00620659|466525971|FG002|Placebo Washout Period 2|Adverse Event|0|||
129609789|NCT00620659|466525972|FG003|Placebo Washout Period 2|Adverse Event|0|||
129609790|NCT00620659|466525973|FG004|Placebo Washout Period 2|Adverse Event|0|||
129609791|NCT00620659|466525974|FG005|Placebo Washout Period 2|Adverse Event|0|||
129609792|NCT00620659|466525969|FG000|Treatment Period 3|Adverse Event|0|||
129609793|NCT00620659|466525970|FG001|Treatment Period 3|Adverse Event|2|||
129609794|NCT00620659|466525971|FG002|Treatment Period 3|Adverse Event|0|||
129609795|NCT00620659|466525972|FG003|Treatment Period 3|Adverse Event|0|||
129609796|NCT00620659|466525973|FG004|Treatment Period 3|Adverse Event|0|||
129609797|NCT00620659|466525974|FG005|Treatment Period 3|Adverse Event|0|||
129609798|NCT00620659|466525969|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129609799|NCT00620659|466525970|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129609800|NCT00620659|466525971|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129609801|NCT00620659|466525972|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129439104|NCT00561951|465904555|FG000|Overall Study|Meet Withdrawal Criterion|0|||
129439105|NCT00561951|465904556|FG001|Overall Study|Meet Withdrawal Criterion|1|||
129439106|NCT00561951|465904557|FG002|Overall Study|Meet Withdrawal Criterion|1|||
129439107|NCT00561951|465904555|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
129439108|NCT00561951|465904556|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
129439109|NCT00561951|465904557|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
129439110|NCT00392327|465904569|FG000|Overall Study|Death|1|||
129439111|NCT00392327|465904570|FG001|Overall Study|Death|0|||
129439112|NCT00392327|465904571|FG002|Overall Study|Death|1|||
129609802|NCT00620659|466525973|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129609803|NCT00620659|466525974|FG005|Treatment Period 3|Withdrawal by Subject|0|||
129609804|NCT01193127|466525977|FG000|Randomized|Surgery Cancelled|0|||
129609805|NCT01193127|466525978|FG001|Randomized|Surgery Cancelled|0|||
129609806|NCT01193127|466525979|FG002|Randomized|Surgery Cancelled|0|||
129609807|NCT01193127|466525980|FG003|Randomized|Surgery Cancelled|1|||
129609808|NCT01193127|466525977|FG000|Treated|Withdrawal by Subject|0|||
129609809|NCT01193127|466525978|FG001|Treated|Withdrawal by Subject|0|||
129609810|NCT01193127|466525979|FG002|Treated|Withdrawal by Subject|0|||
129609811|NCT01193127|466525980|FG003|Treated|Withdrawal by Subject|1|||
129609812|NCT03246646|466525981|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
129609813|NCT03246646|466525982|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
129609814|NCT03246646|466525981|FG000|Overall Study|Withdrawal by Subject|3|||
129609815|NCT03246646|466525982|FG001|Overall Study|Withdrawal by Subject|0|||
129609816|NCT03246646|466525981|FG000|Overall Study|Lost to Follow-up|7|||
129609817|NCT03246646|466525982|FG001|Overall Study|Lost to Follow-up|0|||
129609818|NCT02352779|466525983|FG000|Overall Study|Personal Issues|1|||
129609819|NCT02352779|466525984|FG001|Overall Study|Personal Issues|1|||
129609820|NCT02352779|466525985|FG002|Overall Study|Personal Issues|0|||
129609821|NCT02352779|466525983|FG000|Overall Study|Too Many Forms|2|||
129609822|NCT02352779|466525984|FG001|Overall Study|Too Many Forms|0|||
129609823|NCT02352779|466525985|FG002|Overall Study|Too Many Forms|0|||
129609824|NCT02352779|466525983|FG000|Overall Study|Feeling Overwhelmed|1|||
129609825|NCT02352779|466525984|FG001|Overall Study|Feeling Overwhelmed|0|||
129790775|NCT00045942|467201418|FG008|PKC412A2104E2|Lost to Follow-up|0|||
129790776|NCT00045942|467201410|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
129609826|NCT02352779|466525985|FG002|Overall Study|Feeling Overwhelmed|0|||
129609827|NCT02352779|466525983|FG000|Overall Study|Disliked Intervention|1|||
129790777|NCT00045942|467201411|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
129790778|NCT00045942|467201412|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
129790779|NCT00045942|467201413|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
129439113|NCT00392327|465904572|FG003|Overall Study|Death|0|||
129439114|NCT00392327|465904573|FG004|Overall Study|Death|0|||
129439115|NCT00392327|465904574|FG005|Overall Study|Death|0|||
129609828|NCT02352779|466525984|FG001|Overall Study|Disliked Intervention|0|||
129609829|NCT02352779|466525985|FG002|Overall Study|Disliked Intervention|0|||
129609830|NCT02352779|466525983|FG000|Overall Study|Changed Mind|1|||
129609831|NCT02352779|466525984|FG001|Overall Study|Changed Mind|0|||
129609832|NCT02352779|466525985|FG002|Overall Study|Changed Mind|0|||
129609833|NCT02352779|466525983|FG000|Overall Study|Study Related Symptoms|1|||
129609834|NCT02352779|466525984|FG001|Overall Study|Study Related Symptoms|0|||
129609835|NCT02352779|466525985|FG002|Overall Study|Study Related Symptoms|0|||
129699351|NCT02412436|466858619|FG000|Overall Study|Lost to Follow-up|6|||
129699352|NCT02412436|466858619|FG000|Overall Study|Unable to get to clinic|3|||
129699353|NCT02412436|466858619|FG000|Overall Study|Death|1|||
129699354|NCT02412436|466858619|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
129699355|NCT04090749|466858625|FG000|Open Label Pilot|Lost to Follow-up|1|||
129699356|NCT04090749|466858626|FG001|Open Label Pilot|Lost to Follow-up|0|||
129699357|NCT04090749|466858627|FG002|Open Label Pilot|Lost to Follow-up|0|||
129699358|NCT04090749|466858625|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
129699359|NCT04090749|466858626|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
129699360|NCT04090749|466858627|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
129699361|NCT04090749|466858625|FG000|Pilot Trial|Lost to Follow-up|0|||
129699362|NCT04090749|466858626|FG001|Pilot Trial|Lost to Follow-up|1|||
129699363|NCT04090749|466858627|FG002|Pilot Trial|Lost to Follow-up|1|||
129699364|NCT02184442|466858628|FG000|Overall Study|Death|61|||
129699365|NCT02184442|466858629|FG001|Overall Study|Death|65|||
129699366|NCT02184442|466858628|FG000|Overall Study|Withdrawal by Subject|3|||
129699367|NCT02184442|466858629|FG001|Overall Study|Withdrawal by Subject|11|||
129699368|NCT01852214|466858630|FG000|Period 1|Adverse Event|1|||
129699369|NCT01852214|466858631|FG001|Period 1|Adverse Event|2|||
129699370|NCT01852214|466858630|FG000|Period 1|Withdrawal by Subject|0|||
129699371|NCT01852214|466858631|FG001|Period 1|Withdrawal by Subject|1|||
129699372|NCT01852214|466858630|FG000|Washout Period|Withdrawal by Subject|0|||
129699373|NCT01852214|466858631|FG001|Washout Period|Withdrawal by Subject|1|||
129699374|NCT04091438|466858632|FG000|Treatment Period 1 (1 Day)|Other|1|||
129699375|NCT04091438|466858633|FG001|Treatment Period 1 (1 Day)|Other|0|||
129699376|NCT04091438|466858632|FG000|Washout Period (1 Day)|Protocol deviation|0|||
129699377|NCT04091438|466858633|FG001|Washout Period (1 Day)|Protocol deviation|1|||
129699378|NCT04091438|466858632|FG000|Washout Period (1 Day)|Other|0|||
129699379|NCT04091438|466858633|FG001|Washout Period (1 Day)|Other|1|||
129699380|NCT00421408|466858634|FG000|Overall Study|Lost to Follow-up|30|||
129699381|NCT00421408|466858635|FG001|Overall Study|Lost to Follow-up|20|||
129699382|NCT00421408|466858634|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
129699383|NCT00421408|466858635|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
129699384|NCT02691494|466858638|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
129699385|NCT02691494|466858639|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
129699386|NCT02691494|466858640|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
129699387|NCT02691494|466858638|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129699388|NCT02691494|466858639|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129699389|NCT02691494|466858640|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
129699390|NCT02691494|466858638|FG000|Post-Treatment Follow-Up Period|Other|2|||
129699391|NCT02691494|466858639|FG001|Post-Treatment Follow-Up Period|Other|1|||
129699392|NCT02691494|466858640|FG002|Post-Treatment Follow-Up Period|Other|1|||
129699393|NCT02691494|466858638|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
129699394|NCT02691494|466858639|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
129699395|NCT02691494|466858640|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
129699396|NCT02691494|466858638|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129699397|NCT02691494|466858639|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
129699398|NCT02691494|466858640|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
129699399|NCT03249558|466858645|FG000|Overall Study|Lost to Follow-up|2|||
129699400|NCT03249558|466858646|FG001|Overall Study|Lost to Follow-up|1|||
129699401|NCT03249558|466858647|FG002|Overall Study|Lost to Follow-up|4|||
129699402|NCT03249558|466858645|FG000|Overall Study|Physician Decision|1|||
129699403|NCT03249558|466858646|FG001|Overall Study|Physician Decision|0|||
129699404|NCT03249558|466858647|FG002|Overall Study|Physician Decision|0|||
129699405|NCT03249558|466858645|FG000|Overall Study|Withdrawal by Subject|6|||
129699406|NCT03249558|466858646|FG001|Overall Study|Withdrawal by Subject|5|||
129699407|NCT03249558|466858647|FG002|Overall Study|Withdrawal by Subject|7|||
129699408|NCT03249558|466858645|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
129699409|NCT03249558|466858646|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
129699410|NCT03249558|466858647|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
129699411|NCT03249558|466858645|FG000|Overall Study|Protocol Violation|1|||
129699412|NCT03249558|466858646|FG001|Overall Study|Protocol Violation|1|||
129699413|NCT03249558|466858647|FG002|Overall Study|Protocol Violation|2|||
129699414|NCT02613507|466858649|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
129699415|NCT02613507|466858650|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
129699416|NCT02613507|466858649|FG000|Pre-Treamtent|Participant withdrew consent|0|||
129699417|NCT02613507|466858650|FG001|Pre-Treamtent|Participant withdrew consent|4|||
129699418|NCT02613507|466858649|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
129699419|NCT02613507|466858650|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
129699420|NCT02613507|466858649|FG000|Treatment|Not reported|3|||
129699421|NCT02613507|466858650|FG001|Treatment|Not reported|0|||
129609836|NCT02352779|466525983|FG000|Overall Study|Absence of Symptoms|1|||
129609837|NCT02352779|466525984|FG001|Overall Study|Absence of Symptoms|0|||
129609838|NCT02352779|466525985|FG002|Overall Study|Absence of Symptoms|0|||
129609839|NCT02352779|466525983|FG000|Overall Study|Other Medical Reason|0|||
129609840|NCT02352779|466525984|FG001|Overall Study|Other Medical Reason|0|||
129609841|NCT02352779|466525985|FG002|Overall Study|Other Medical Reason|1|||
129609842|NCT02352779|466525983|FG000|Overall Study|No Reason|0|||
129609843|NCT02352779|466525984|FG001|Overall Study|No Reason|0|||
129609844|NCT02352779|466525985|FG002|Overall Study|No Reason|1|||
129609845|NCT04555720|466525988|FG000|Overall Study|Lost to Follow-up|2|||
129609846|NCT04555720|466525989|FG001|Overall Study|Lost to Follow-up|0|||
129609847|NCT04555720|466525990|FG002|Overall Study|Lost to Follow-up|0|||
129609848|NCT04555720|466525991|FG003|Overall Study|Lost to Follow-up|0|||
129609849|NCT04555720|466525988|FG000|Overall Study|Withdrawal by Subject|4|||
129609850|NCT04555720|466525989|FG001|Overall Study|Withdrawal by Subject|6|||
129609851|NCT04555720|466525990|FG002|Overall Study|Withdrawal by Subject|0|||
129609852|NCT04555720|466525991|FG003|Overall Study|Withdrawal by Subject|0|||
129609853|NCT00968799|466525992|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
129609854|NCT00719849|466525993|FG000|Overall Study|Death|0|||
129609855|NCT00719849|466525994|FG001|Overall Study|Death|1|||
129609856|NCT01372774|466525997|FG000|Overall Study|Withdrawal prior to treatment|4|||
129609857|NCT01372774|466525998|FG001|Overall Study|Withdrawal prior to treatment|5|||
129609858|NCT02201290|466525999|FG000|Overall Study|Withdrawal by Subject|2|||
129609859|NCT02201290|466525999|FG000|Overall Study|Lack of Efficacy|2|||
129609860|NCT02201290|466525999|FG000|Overall Study|Adverse Event|1|||
129609861|NCT00461253|466528582|FG000|Overall Study|Death|985|||
129609862|NCT00461253|466528583|FG001|Overall Study|Death|0|||
129609863|NCT00461253|466528582|FG000|Overall Study|Protocol Violation|613|||
129609864|NCT00461253|466528583|FG001|Overall Study|Protocol Violation|236|||
129609865|NCT00461253|466528582|FG000|Overall Study|no response|2609|||
129609866|NCT00461253|466528583|FG001|Overall Study|no response|11789|||
129609867|NCT00461253|466528582|FG000|Overall Study|administrative|773|||
129609868|NCT00461253|466528583|FG001|Overall Study|administrative|7773|||
129609869|NCT04240392|466528584|FG000|Overall Study|Withdrawal by Subject|13|||
129609870|NCT04240392|466528585|FG001|Overall Study|Withdrawal by Subject|4|||
129609871|NCT04240392|466528584|FG000|Overall Study|Lost to Follow-up|11|||
129609872|NCT04240392|466528585|FG001|Overall Study|Lost to Follow-up|12|||
129609873|NCT03283319|466528586|FG000|Overall Study|Lost to Follow-up|5|||
129609874|NCT03283319|466528587|FG001|Overall Study|Lost to Follow-up|4|||
129609875|NCT03283319|466528588|FG002|Overall Study|Lost to Follow-up|5|||
129609876|NCT03283319|466528589|FG003|Overall Study|Lost to Follow-up|5|||
129609877|NCT03283319|466528590|FG004|Overall Study|Lost to Follow-up|4|||
129609878|NCT03283319|466528591|FG005|Overall Study|Lost to Follow-up|3|||
129609879|NCT03283319|466528586|FG000|Overall Study|Withdrawal by Subject|2|||
129609880|NCT03283319|466528587|FG001|Overall Study|Withdrawal by Subject|2|||
129609881|NCT03283319|466528588|FG002|Overall Study|Withdrawal by Subject|2|||
129609882|NCT03283319|466528589|FG003|Overall Study|Withdrawal by Subject|1|||
129609883|NCT03283319|466528590|FG004|Overall Study|Withdrawal by Subject|0|||
129609884|NCT03283319|466528591|FG005|Overall Study|Withdrawal by Subject|1|||
129609885|NCT03283319|466528586|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
129609886|NCT03283319|466528587|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
129609887|NCT03283319|466528588|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
129609888|NCT03283319|466528589|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
129609889|NCT03283319|466528590|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
129609890|NCT03283319|466528591|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
129609891|NCT00721630|466528592|FG000|Overall Study|Participant found to be ineligible|1|||
129609892|NCT03186781|466528593|FG000|Overall Study|Lost to Follow-up|0|||
129609893|NCT03186781|466528594|FG001|Overall Study|Lost to Follow-up|0|||
129609894|NCT03186781|466528595|FG002|Overall Study|Lost to Follow-up|1|||
129699422|NCT02613507|466858649|FG000|Treatment|Other reasons|8|||
129699423|NCT02613507|466858650|FG001|Treatment|Other reasons|0|||
129699424|NCT02613507|466858649|FG000|Treatment|Participant no longer meets criteria|3|||
129699425|NCT02613507|466858650|FG001|Treatment|Participant no longer meets criteria|0|||
129609895|NCT03186781|466528596|FG003|Overall Study|Lost to Follow-up|0|||
129609896|NCT03186781|466528597|FG004|Overall Study|Lost to Follow-up|1|||
129609897|NCT03186781|466528598|FG005|Overall Study|Lost to Follow-up|0|||
129609898|NCT03186781|466528593|FG000|Overall Study|Moved from Area|0|||
129609899|NCT03186781|466528594|FG001|Overall Study|Moved from Area|0|||
129699426|NCT02613507|466858649|FG000|Treatment|Maximum clinical benefit|5|||
129609900|NCT03186781|466528595|FG002|Overall Study|Moved from Area|0|||
129609901|NCT03186781|466528596|FG003|Overall Study|Moved from Area|0|||
129609902|NCT03186781|466528597|FG004|Overall Study|Moved from Area|1|||
129609903|NCT03186781|466528598|FG005|Overall Study|Moved from Area|0|||
129699427|NCT02613507|466858650|FG001|Treatment|Maximum clinical benefit|10|||
129609904|NCT03186781|466528593|FG000|Overall Study|Withdrawal by Subject|0|||
129609905|NCT03186781|466528594|FG001|Overall Study|Withdrawal by Subject|0|||
129609906|NCT03186781|466528595|FG002|Overall Study|Withdrawal by Subject|0|||
129699428|NCT02613507|466858649|FG000|Treatment|Lost to Follow-up|1|||
129699429|NCT02613507|466858650|FG001|Treatment|Lost to Follow-up|0|||
129699430|NCT02613507|466858649|FG000|Treatment|Participant withdrew consent|0|||
129699431|NCT02613507|466858650|FG001|Treatment|Participant withdrew consent|2|||
129699432|NCT02613507|466858649|FG000|Treatment|Participant request to discontinue study treatment|13|||
129699433|NCT02613507|466858650|FG001|Treatment|Participant request to discontinue study treatment|17|||
129699434|NCT02613507|466858649|FG000|Treatment|Adverse event unrelated to study drug|20|||
129699435|NCT02613507|466858650|FG001|Treatment|Adverse event unrelated to study drug|3|||
129699436|NCT02613507|466858649|FG000|Treatment|Death|2|||
129699437|NCT02613507|466858650|FG001|Treatment|Death|0|||
129699438|NCT02613507|466858649|FG000|Treatment|Study drug toxicity|19|||
129699439|NCT02613507|466858650|FG001|Treatment|Study drug toxicity|14|||
129699440|NCT02613507|466858649|FG000|Treatment|Disease progression|263|||
129699441|NCT02613507|466858650|FG001|Treatment|Disease progression|110|||
129699442|NCT03941093|466858651|FG000|Overall Study|Protocol Violation|0|||
129699443|NCT03941093|466858652|FG001|Overall Study|Protocol Violation|1|||
129699444|NCT03941093|466858651|FG000|Overall Study|Withdrawal by Subject|9|||
129699445|NCT03941093|466858652|FG001|Overall Study|Withdrawal by Subject|6|||
129699446|NCT00561821|466858654|FG000|Overall Study|Not treated|0|||
129699447|NCT00561821|466858655|FG001|Overall Study|Not treated|0|||
129699448|NCT00561821|466858656|FG002|Overall Study|Not treated|1|||
129699449|NCT00561821|466858657|FG003|Overall Study|Not treated|0|||
129699450|NCT00561821|466858654|FG000|Overall Study|Withdrawal by Subject|0|||
129699451|NCT00561821|466858655|FG001|Overall Study|Withdrawal by Subject|1|||
129699452|NCT00561821|466858656|FG002|Overall Study|Withdrawal by Subject|0|||
129699453|NCT00561821|466858657|FG003|Overall Study|Withdrawal by Subject|2|||
129699454|NCT00561821|466858654|FG000|Overall Study|Reasons not related to trial|2|||
129699455|NCT00561821|466858655|FG001|Overall Study|Reasons not related to trial|1|||
129699456|NCT00561821|466858656|FG002|Overall Study|Reasons not related to trial|0|||
129699457|NCT00561821|466858657|FG003|Overall Study|Reasons not related to trial|0|||
129699458|NCT00561821|466858654|FG000|Overall Study|Other (reason not specified)|1|||
129699459|NCT00561821|466858655|FG001|Overall Study|Other (reason not specified)|1|||
129699460|NCT00561821|466858656|FG002|Overall Study|Other (reason not specified)|0|||
129699461|NCT00561821|466858657|FG003|Overall Study|Other (reason not specified)|0|||
129699462|NCT00561821|466858654|FG000|Overall Study|Adverse Event|2|||
129699463|NCT00561821|466858655|FG001|Overall Study|Adverse Event|3|||
129699464|NCT00561821|466858656|FG002|Overall Study|Adverse Event|1|||
129699465|NCT00561821|466858657|FG003|Overall Study|Adverse Event|1|||
129699466|NCT03379870|466859777|FG000|Overall Study|Lost to Follow-up|1|||
129699467|NCT03379870|466859778|FG001|Overall Study|Lost to Follow-up|0|||
129699468|NCT03379870|466859777|FG000|Overall Study|Protocol Violation|1|||
129699469|NCT03379870|466859778|FG001|Overall Study|Protocol Violation|1|||
129699470|NCT01394185|466859779|FG000|Overall Study|Withdrawal by Subject|2|||
129699471|NCT01394185|466859780|FG001|Overall Study|Withdrawal by Subject|0|||
129699472|NCT01394185|466859781|FG002|Overall Study|Withdrawal by Subject|0|||
129699473|NCT01394185|466859782|FG003|Overall Study|Withdrawal by Subject|0|||
129699474|NCT01394185|466859783|FG004|Overall Study|Withdrawal by Subject|1|||
129699475|NCT01394185|466859784|FG005|Overall Study|Withdrawal by Subject|0|||
129699476|NCT01394185|466859779|FG000|Overall Study|Change in protocol|3|||
129699477|NCT01394185|466859780|FG001|Overall Study|Change in protocol|0|||
129699478|NCT01394185|466859781|FG002|Overall Study|Change in protocol|0|||
129699479|NCT01394185|466859782|FG003|Overall Study|Change in protocol|0|||
129699480|NCT01394185|466859783|FG004|Overall Study|Change in protocol|3|||
129699481|NCT01394185|466859784|FG005|Overall Study|Change in protocol|0|||
129699482|NCT01394185|466859779|FG000|Overall Study|Protocol Violation|1|||
129699483|NCT01394185|466859780|FG001|Overall Study|Protocol Violation|0|||
129699484|NCT01394185|466859781|FG002|Overall Study|Protocol Violation|0|||
129699485|NCT01394185|466859782|FG003|Overall Study|Protocol Violation|1|||
129699486|NCT01394185|466859783|FG004|Overall Study|Protocol Violation|0|||
129699487|NCT01394185|466859784|FG005|Overall Study|Protocol Violation|1|||
129699488|NCT00267488|466859788|FG000|Overall Study|Sponsor Terminated Study|9|||
129699489|NCT00267488|466859788|FG000|Overall Study|Protocol Violation|1|||
129699490|NCT00267488|466859788|FG000|Overall Study|Other (Disease Progression)|1|||
129699491|NCT00831389|466859789|FG000|Overall Study|Withdrawal by Subject|0|||
129699492|NCT00831389|466859790|FG001|Overall Study|Withdrawal by Subject|1|||
129699493|NCT00278161|466859792|FG000|Overall Study|Death|11|||
129699494|NCT01592747|466859793|FG000|Overall Study|Loss of Therapeutic Response|107|||
129699495|NCT01592747|466859794|FG001|Overall Study|Loss of Therapeutic Response|108|||
129699496|NCT01592747|466859795|FG002|Overall Study|Loss of Therapeutic Response|100|||
129699497|NCT01592747|466859793|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129699498|NCT01592747|466859794|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
129609907|NCT03186781|466528596|FG003|Overall Study|Withdrawal by Subject|0|||
129609908|NCT03186781|466528597|FG004|Overall Study|Withdrawal by Subject|1|||
129609909|NCT03186781|466528598|FG005|Overall Study|Withdrawal by Subject|0|||
129609910|NCT00792935|466528599|FG000|Overall Study|Adverse Event|2|||
129609911|NCT00792935|466528600|FG001|Overall Study|Adverse Event|1|||
129609912|NCT00792935|466528599|FG000|Overall Study|Lost to Follow-up|0|||
129609913|NCT00792935|466528600|FG001|Overall Study|Lost to Follow-up|1|||
129609914|NCT00792935|466528599|FG000|Overall Study|Protocol Violation|2|||
129609915|NCT00792935|466528600|FG001|Overall Study|Protocol Violation|0|||
129609916|NCT00792935|466528599|FG000|Overall Study|Withdrawal by Subject|0|||
129609917|NCT00792935|466528600|FG001|Overall Study|Withdrawal by Subject|1|||
129609918|NCT04663295|466528601|FG000|Run-in Period|Withdrawal by Subject|3|||
129609919|NCT04663295|466528601|FG000|Overall Study Period|Pregnancy|1|||
129609920|NCT04663295|466528601|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
129609921|NCT03665441|466528602|FG000|Overall Study|survival follow up ongoing|23|||
129609922|NCT03665441|466528603|FG001|Overall Study|survival follow up ongoing|0|||
129609923|NCT03665441|466528602|FG000|Overall Study|Patients ongoing on treatment|9|||
129609924|NCT03665441|466528603|FG001|Overall Study|Patients ongoing on treatment|6|||
129609925|NCT03665441|466528602|FG000|Overall Study|Randomized but not treated|7|||
129609926|NCT03665441|466528603|FG001|Overall Study|Randomized but not treated|11|||
129609927|NCT03954834|466528604|FG000|Overall Study|Adverse Event|1|||
129609928|NCT03954834|466528605|FG001|Overall Study|Adverse Event|3|||
129609929|NCT03954834|466528606|FG002|Overall Study|Adverse Event|1|||
129609930|NCT03954834|466528607|FG003|Overall Study|Adverse Event|1|||
129609931|NCT03954834|466528604|FG000|Overall Study|Death|0|||
129609932|NCT03954834|466528605|FG001|Overall Study|Death|0|||
129609933|NCT03954834|466528606|FG002|Overall Study|Death|0|||
129609934|NCT03954834|466528607|FG003|Overall Study|Death|1|||
129609935|NCT03954834|466528604|FG000|Overall Study|Physician Decision|0|||
129609936|NCT03954834|466528605|FG001|Overall Study|Physician Decision|1|||
129609937|NCT03954834|466528606|FG002|Overall Study|Physician Decision|0|||
129609938|NCT03954834|466528607|FG003|Overall Study|Physician Decision|2|||
129609939|NCT03954834|466528604|FG000|Overall Study|Protocol Violation|1|||
129609940|NCT03954834|466528605|FG001|Overall Study|Protocol Violation|0|||
129609941|NCT03954834|466528606|FG002|Overall Study|Protocol Violation|0|||
129609942|NCT03954834|466528607|FG003|Overall Study|Protocol Violation|1|||
129609943|NCT03954834|466528604|FG000|Overall Study|Withdrawal by Subject|2|||
129609944|NCT03954834|466528605|FG001|Overall Study|Withdrawal by Subject|3|||
129609945|NCT03954834|466528606|FG002|Overall Study|Withdrawal by Subject|13|||
129609946|NCT03954834|466528607|FG003|Overall Study|Withdrawal by Subject|6|||
129609947|NCT03954834|466528604|FG000|Overall Study|Participant left the country|0|||
129609948|NCT03954834|466528605|FG001|Overall Study|Participant left the country|0|||
129609949|NCT03954834|466528606|FG002|Overall Study|Participant left the country|1|||
129609950|NCT03954834|466528607|FG003|Overall Study|Participant left the country|0|||
129609951|NCT03954834|466528604|FG000|Overall Study|Lost to Follow-up|3|||
129609952|NCT03954834|466528605|FG001|Overall Study|Lost to Follow-up|2|||
129609953|NCT03954834|466528606|FG002|Overall Study|Lost to Follow-up|3|||
129609954|NCT03954834|466528607|FG003|Overall Study|Lost to Follow-up|5|||
129609955|NCT03047330|466528608|FG000|Sleep Block 1|Withdrawal by Subject|3|||
129609956|NCT00663026|466528612|FG000|Overall Study|Lost to Follow-up|1|||
129609957|NCT00663026|466528613|FG001|Overall Study|Lost to Follow-up|0|||
129699499|NCT01592747|466859795|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
129699500|NCT01592747|466859793|FG000|Overall Study|Adverse Event|1|||
129699501|NCT01592747|466859794|FG001|Overall Study|Adverse Event|0|||
129699502|NCT01592747|466859795|FG002|Overall Study|Adverse Event|0|||
129699503|NCT01592747|466859793|FG000|Overall Study|Protocol Violation|4|||
129699504|NCT01592747|466859794|FG001|Overall Study|Protocol Violation|0|||
129699505|NCT01592747|466859795|FG002|Overall Study|Protocol Violation|4|||
129699506|NCT01592747|466859793|FG000|Overall Study|Lack of Efficacy|0|||
129699507|NCT01592747|466859794|FG001|Overall Study|Lack of Efficacy|1|||
129699508|NCT01592747|466859795|FG002|Overall Study|Lack of Efficacy|0|||
129699509|NCT01592747|466859793|FG000|Overall Study|Withdrawal by Subject|2|||
129699510|NCT01592747|466859794|FG001|Overall Study|Withdrawal by Subject|0|||
129699511|NCT01592747|466859795|FG002|Overall Study|Withdrawal by Subject|2|||
129699512|NCT01592747|466859793|FG000|Overall Study|Lost to Follow-up|1|||
129699513|NCT01592747|466859794|FG001|Overall Study|Lost to Follow-up|0|||
129699514|NCT01592747|466859795|FG002|Overall Study|Lost to Follow-up|1|||
129699515|NCT01592747|466859793|FG000|Overall Study|Other Reasons|1|||
129699516|NCT01592747|466859794|FG001|Overall Study|Other Reasons|1|||
129699517|NCT01592747|466859795|FG002|Overall Study|Other Reasons|0|||
129609958|NCT00663026|466528614|FG002|Overall Study|Lost to Follow-up|0|||
129609959|NCT00663026|466528612|FG000|Overall Study|Other|1|||
129609960|NCT00663026|466528613|FG001|Overall Study|Other|2|||
129609961|NCT00663026|466528614|FG002|Overall Study|Other|0|||
129609962|NCT00663026|466528612|FG000|Overall Study|Adverse Event|0|||
129609963|NCT00663026|466528613|FG001|Overall Study|Adverse Event|2|||
129609964|NCT00663026|466528614|FG002|Overall Study|Adverse Event|3|||
129699518|NCT00124657|466859796|FG000|Overall Study|Toxicity|0|||
129699519|NCT00124657|466859797|FG001|Overall Study|Toxicity|0|||
129609965|NCT00663026|466528612|FG000|Overall Study|Caregiver Request|0|||
129609966|NCT00663026|466528613|FG001|Overall Study|Caregiver Request|2|||
129609967|NCT00663026|466528614|FG002|Overall Study|Caregiver Request|0|||
129609968|NCT00663026|466528612|FG000|Overall Study|Withdrawal by Subject|0|||
129609969|NCT00663026|466528613|FG001|Overall Study|Withdrawal by Subject|0|||
129609970|NCT00663026|466528614|FG002|Overall Study|Withdrawal by Subject|1|||
129609971|NCT01570686|466528615|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129609972|NCT01570686|466528616|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129609973|NCT01570686|466528615|FG000|Overall Study|Administrative problems|0|||
129609974|NCT01570686|466528616|FG001|Overall Study|Administrative problems|1|||
129609975|NCT01570686|466528615|FG000|Overall Study|Adverse Event|8|||
129609976|NCT01570686|466528616|FG001|Overall Study|Adverse Event|6|||
129609977|NCT01570686|466528615|FG000|Overall Study|Lost to Follow-up|4|||
129609978|NCT01570686|466528616|FG001|Overall Study|Lost to Follow-up|3|||
129609979|NCT01570686|466528615|FG000|Overall Study|Protocol Deviation|3|||
129609980|NCT01570686|466528616|FG001|Overall Study|Protocol Deviation|0|||
129609981|NCT01570686|466528615|FG000|Overall Study|Withdrawal by Subject|4|||
129609982|NCT01570686|466528616|FG001|Overall Study|Withdrawal by Subject|4|||
129609983|NCT01570686|466528615|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129609984|NCT01570686|466528616|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129609985|NCT00686075|466528618|FG000|Overall Study|Withdrawal by Subject|4|||
129609986|NCT00686075|466528619|FG001|Overall Study|Withdrawal by Subject|3|||
129609987|NCT00686075|466528620|FG002|Overall Study|Withdrawal by Subject|3|||
129609988|NCT00686075|466528621|FG003|Overall Study|Withdrawal by Subject|7|||
129609989|NCT00686075|466528622|FG004|Overall Study|Withdrawal by Subject|1|||
129609990|NCT00686075|466528623|FG005|Overall Study|Withdrawal by Subject|0|||
129609991|NCT00686075|466528624|FG006|Overall Study|Withdrawal by Subject|0|||
129609992|NCT00686075|466528625|FG007|Overall Study|Withdrawal by Subject|2|||
129609993|NCT00686075|466528626|FG008|Overall Study|Withdrawal by Subject|4|||
129609994|NCT00686075|466528627|FG009|Overall Study|Withdrawal by Subject|6|||
129609995|NCT00686075|466528618|FG000|Overall Study|Lost to Follow-up|3|||
129609996|NCT00686075|466528619|FG001|Overall Study|Lost to Follow-up|6|||
129609997|NCT00686075|466528620|FG002|Overall Study|Lost to Follow-up|3|||
129609998|NCT00686075|466528621|FG003|Overall Study|Lost to Follow-up|2|||
129609999|NCT00686075|466528622|FG004|Overall Study|Lost to Follow-up|3|||
129610000|NCT00686075|466528623|FG005|Overall Study|Lost to Follow-up|3|||
129610001|NCT00686075|466528624|FG006|Overall Study|Lost to Follow-up|0|||
129610002|NCT00686075|466528625|FG007|Overall Study|Lost to Follow-up|0|||
129610003|NCT00686075|466528626|FG008|Overall Study|Lost to Follow-up|2|||
129610004|NCT00686075|466528627|FG009|Overall Study|Lost to Follow-up|3|||
129610005|NCT00686075|466528618|FG000|Overall Study|Other|1|||
129610006|NCT00686075|466528619|FG001|Overall Study|Other|1|||
129610007|NCT00686075|466528620|FG002|Overall Study|Other|0|||
129610008|NCT00686075|466528621|FG003|Overall Study|Other|0|||
129610009|NCT00686075|466528622|FG004|Overall Study|Other|0|||
129610010|NCT00686075|466528623|FG005|Overall Study|Other|0|||
129610011|NCT00686075|466528624|FG006|Overall Study|Other|0|||
129610012|NCT00686075|466528625|FG007|Overall Study|Other|0|||
129610013|NCT00686075|466528626|FG008|Overall Study|Other|0|||
129610014|NCT00686075|466528627|FG009|Overall Study|Other|1|||
129610015|NCT04715932|466528628|FG000|Overall Study|Lost to Follow-up|1|||
129610016|NCT04715932|466528629|FG001|Overall Study|Lost to Follow-up|0|||
129610017|NCT02740699|466528641|FG000|Overall Study|Lost to Follow-up|5|||
129610018|NCT02740699|466528641|FG000|Overall Study|Withdrawal by Subject|14|||
129610019|NCT02740699|466528641|FG000|Overall Study|Physician Decision|5|||
129610020|NCT03783039|466528643|FG000|Overall Study|Death|2|||
129610021|NCT03783039|466528644|FG001|Overall Study|Death|1|||
129610022|NCT01682863|466528645|FG000|Overall Study|Subject/guardian decision|19|||
129610023|NCT01682863|466528646|FG001|Overall Study|Subject/guardian decision|12|||
129610024|NCT01682863|466528647|FG002|Overall Study|Subject/guardian decision|10|||
129699520|NCT00124657|466859798|FG002|Overall Study|Toxicity|1|||
129699521|NCT00124657|466859796|FG000|Overall Study|Non-compliance|1|||
129699522|NCT00124657|466859797|FG001|Overall Study|Non-compliance|0|||
129699523|NCT00124657|466859798|FG002|Overall Study|Non-compliance|4|||
129699524|NCT00124657|466859796|FG000|Overall Study|Progressive disease|14|||
129610025|NCT01682863|466528645|FG000|Overall Study|Lost to Follow-up|5|||
129610026|NCT01682863|466528646|FG001|Overall Study|Lost to Follow-up|1|||
129610027|NCT01682863|466528647|FG002|Overall Study|Lost to Follow-up|6|||
129610028|NCT01682863|466528645|FG000|Overall Study|Death|1|||
129610029|NCT01682863|466528646|FG001|Overall Study|Death|3|||
129610030|NCT01682863|466528647|FG002|Overall Study|Death|4|||
129610031|NCT01682863|466528645|FG000|Overall Study|Protocol deviation|1|||
129610032|NCT01682863|466528646|FG001|Overall Study|Protocol deviation|0|||
129610033|NCT01682863|466528647|FG002|Overall Study|Protocol deviation|1|||
129610034|NCT01682863|466528645|FG000|Overall Study|Technical problems|1|||
129610035|NCT01682863|466528646|FG001|Overall Study|Technical problems|0|||
129610036|NCT01682863|466528647|FG002|Overall Study|Technical problems|0|||
129610037|NCT01682863|466528645|FG000|Overall Study|Adverse Event|0|||
129610038|NCT01682863|466528646|FG001|Overall Study|Adverse Event|1|||
129610039|NCT01682863|466528647|FG002|Overall Study|Adverse Event|2|||
129610040|NCT01682863|466528645|FG000|Overall Study|Physician Decision|0|||
129610041|NCT01682863|466528646|FG001|Overall Study|Physician Decision|0|||
129610042|NCT01682863|466528647|FG002|Overall Study|Physician Decision|1|||
129610043|NCT00918138|466528649|FG000|Overall Study|Subject withdrew consent|1|||
129610044|NCT00918138|466528650|FG001|Overall Study|Subject withdrew consent|1|||
129610045|NCT00918138|466528649|FG000|Overall Study|Death|1|||
129610046|NCT00918138|466528650|FG001|Overall Study|Death|0|||
129610047|NCT00699374|466528651|FG000|Overall Study|Death|93|||
129610048|NCT00699374|466528652|FG001|Overall Study|Death|83|||
129610049|NCT00699374|466528651|FG000|Overall Study|Adverse Event|70|||
129610050|NCT00699374|466528652|FG001|Overall Study|Adverse Event|67|||
129610051|NCT00699374|466528651|FG000|Overall Study|Global deterioration of health status|7|||
129610052|NCT00699374|466528652|FG001|Overall Study|Global deterioration of health status|8|||
129886972|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
129610053|NCT00699374|466528651|FG000|Overall Study|Lost to Follow-up|3|||
129610054|NCT00699374|466528652|FG001|Overall Study|Lost to Follow-up|5|||
129610055|NCT00699374|466528651|FG000|Overall Study|Withdrawal by Subject|34|||
129610056|NCT00699374|466528652|FG001|Overall Study|Withdrawal by Subject|44|||
129886973|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129886974|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
129886975|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
129886976|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129886977|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
129886978|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886979|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
129886980|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886981|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886982|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
129886983|NCT02555371|467547211|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
129886984|NCT02555371|467547212|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
129886985|NCT02555371|467547213|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
129886986|NCT02555371|467547214|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
129886987|NCT02555371|467547215|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
129886988|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886989|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886990|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886991|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
129886992|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
129886993|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886994|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886995|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886996|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
129886997|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
129886998|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129886999|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129887000|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129887001|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
129887002|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
129887003|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
129887004|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
129610057|NCT00699374|466528651|FG000|Overall Study|Objective progression or relapse|281|||
129610058|NCT00699374|466528652|FG001|Overall Study|Objective progression or relapse|277|||
129610059|NCT00699374|466528651|FG000|Overall Study|Other|18|||
129610060|NCT00699374|466528652|FG001|Overall Study|Other|15|||
129610061|NCT00699374|466528651|FG000|Overall Study|Protocol Violation|2|||
129610062|NCT00699374|466528652|FG001|Overall Study|Protocol Violation|6|||
129610063|NCT00699374|466528651|FG000|Overall Study|Study terminated by sponsor|13|||
129610064|NCT00699374|466528652|FG001|Overall Study|Study terminated by sponsor|28|||
129610065|NCT00699374|466528651|FG000|Overall Study|Randomized but not treated|4|||
129610066|NCT00699374|466528652|FG001|Overall Study|Randomized but not treated|2|||
129887005|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
129887006|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
129610067|NCT00699374|466528651|FG000|Overall Study|Died 28 days after last dose|5|||
129610068|NCT00699374|466528652|FG001|Overall Study|Died 28 days after last dose|9|||
129610069|NCT01136967|466528656|FG000|Overall Study|Adverse Event|9|||
129610070|NCT01136967|466528657|FG001|Overall Study|Adverse Event|12|||
129610071|NCT01136967|466528656|FG000|Overall Study|Participant Choice|8|||
129610072|NCT01136967|466528657|FG001|Overall Study|Participant Choice|3|||
129699525|NCT00124657|466859797|FG001|Overall Study|Progressive disease|5|||
129610073|NCT01136967|466528656|FG000|Overall Study|Lost to Follow-up|0|||
129610074|NCT01136967|466528657|FG001|Overall Study|Lost to Follow-up|1|||
129699526|NCT00124657|466859798|FG002|Overall Study|Progressive disease|27|||
129699527|NCT00124657|466859796|FG000|Overall Study|Intercurrent illness|1|||
129699528|NCT00124657|466859797|FG001|Overall Study|Intercurrent illness|0|||
129699529|NCT00124657|466859798|FG002|Overall Study|Intercurrent illness|0|||
129699530|NCT01935947|466859799|FG000|Overall Study|Adverse Event|0|||
129699531|NCT01935947|466859800|FG001|Overall Study|Adverse Event|2|||
129699532|NCT01935947|466859801|FG002|Overall Study|Adverse Event|0|||
129699533|NCT01935947|466859799|FG000|Overall Study|Diease Progression|2|||
129699534|NCT01935947|466859800|FG001|Overall Study|Diease Progression|2|||
129699535|NCT01935947|466859801|FG002|Overall Study|Diease Progression|2|||
129699536|NCT01935947|466859799|FG000|Overall Study|Death|1|||
129790780|NCT00045942|467201414|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
129790781|NCT00045942|467201415|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
129790782|NCT00045942|467201416|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
129790783|NCT00045942|467201417|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
129790784|NCT00045942|467201418|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
129610075|NCT01136967|466528656|FG000|Overall Study|Withdrawal by Subject|1|||
129610076|NCT01136967|466528657|FG001|Overall Study|Withdrawal by Subject|2|||
129610077|NCT01136967|466528656|FG000|Overall Study|Clinical Progression|3|||
129610078|NCT01136967|466528657|FG001|Overall Study|Clinical Progression|5|||
129610079|NCT01136967|466528656|FG000|Overall Study|Radiation|1|||
129610080|NCT01136967|466528657|FG001|Overall Study|Radiation|0|||
129610081|NCT01136967|466528656|FG000|Overall Study|Non-compliance|1|||
129610082|NCT01136967|466528657|FG001|Overall Study|Non-compliance|0|||
129610083|NCT01136967|466528656|FG000|Overall Study|Investigator's Choice|1|||
129610084|NCT01136967|466528657|FG001|Overall Study|Investigator's Choice|1|||
129610085|NCT01136967|466528656|FG000|Overall Study|Increase in Lesion Size|0|||
129610086|NCT01136967|466528657|FG001|Overall Study|Increase in Lesion Size|2|||
129610087|NCT01136967|466528656|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
129610088|NCT01136967|466528657|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
129610089|NCT02885181|466528658|FG000|Overall Study|Investigator's Discretion|0|||
129610090|NCT02885181|466528659|FG001|Overall Study|Investigator's Discretion|1|||
129610091|NCT02885181|466528660|FG002|Overall Study|Investigator's Discretion|0|||
129610092|NCT02885181|466528661|FG003|Overall Study|Investigator's Discretion|1|||
129610093|NCT02885181|466528658|FG000|Overall Study|Adverse Event|0|||
129610094|NCT02885181|466528659|FG001|Overall Study|Adverse Event|0|||
129610095|NCT02885181|466528660|FG002|Overall Study|Adverse Event|0|||
129610096|NCT02885181|466528661|FG003|Overall Study|Adverse Event|1|||
129610097|NCT02885181|466528658|FG000|Overall Study|Withdrawal by Subject|0|||
129610098|NCT02885181|466528659|FG001|Overall Study|Withdrawal by Subject|0|||
129610099|NCT02885181|466528660|FG002|Overall Study|Withdrawal by Subject|0|||
129610100|NCT02885181|466528661|FG003|Overall Study|Withdrawal by Subject|1|||
129610101|NCT03839823|466528662|FG000|Overall Study|Adverse Event|8|||
129610102|NCT03839823|466528663|FG001|Overall Study|Adverse Event|4|||
129610103|NCT03839823|466528662|FG000|Overall Study|Death|1|||
129610104|NCT03839823|466528663|FG001|Overall Study|Death|0|||
129610105|NCT03839823|466528662|FG000|Overall Study|Physician Decision|1|||
129610106|NCT03839823|466528663|FG001|Overall Study|Physician Decision|5|||
129610107|NCT03839823|466528662|FG000|Overall Study|Progressive Disease (PD)|65|||
129610108|NCT03839823|466528663|FG001|Overall Study|Progressive Disease (PD)|65|||
129610109|NCT03839823|466528662|FG000|Overall Study|Subject Decision|2|||
129610110|NCT03839823|466528663|FG001|Overall Study|Subject Decision|9|||
129610111|NCT03839823|466528662|FG000|Overall Study|Not Treated|0|||
129610112|NCT03839823|466528663|FG001|Overall Study|Not Treated|10|||
129610113|NCT04228783|466528664|FG000|Overall Study|Adverse Event|1|||
129610114|NCT04228783|466528665|FG001|Overall Study|Adverse Event|0|||
129610115|NCT04228783|466528666|FG002|Overall Study|Adverse Event|2|||
129610116|NCT04228783|466528667|FG003|Overall Study|Adverse Event|0|||
129610117|NCT04228783|466528668|FG004|Overall Study|Adverse Event|0|||
129610118|NCT04228783|466528669|FG005|Overall Study|Adverse Event|1|||
129610119|NCT04228783|466528664|FG000|Overall Study|Death|0|||
129699537|NCT01935947|466859800|FG001|Overall Study|Death|0|||
129790785|NCT00045942|467201410|FG000|PKC412A2104E2|Lack of Efficacy|0|||
129790786|NCT00045942|467201411|FG001|PKC412A2104E2|Lack of Efficacy|0|||
129610120|NCT04228783|466528665|FG001|Overall Study|Death|0|||
129790787|NCT00045942|467201412|FG002|PKC412A2104E2|Lack of Efficacy|0|||
129699538|NCT01935947|466859801|FG002|Overall Study|Death|0|||
129699539|NCT01148771|466859802|FG000|Washout Period|Withdrawal by Subject|0|||
129790788|NCT00045942|467201413|FG003|PKC412A2104E2|Lack of Efficacy|0|||
129790789|NCT00045942|467201414|FG004|PKC412A2104E2|Lack of Efficacy|0|||
129610121|NCT04228783|466528666|FG002|Overall Study|Death|0|||
129610122|NCT04228783|466528667|FG003|Overall Study|Death|0|||
129610123|NCT04228783|466528668|FG004|Overall Study|Death|1|||
129610124|NCT04228783|466528669|FG005|Overall Study|Death|0|||
129610125|NCT04228783|466528664|FG000|Overall Study|Lost to Follow-up|36|||
129610126|NCT04228783|466528665|FG001|Overall Study|Lost to Follow-up|36|||
129610127|NCT04228783|466528666|FG002|Overall Study|Lost to Follow-up|28|||
129610128|NCT04228783|466528667|FG003|Overall Study|Lost to Follow-up|6|||
129610129|NCT04228783|466528668|FG004|Overall Study|Lost to Follow-up|14|||
129699540|NCT01148771|466859803|FG001|Washout Period|Withdrawal by Subject|1|||
129610130|NCT04228783|466528669|FG005|Overall Study|Lost to Follow-up|3|||
129610131|NCT04228783|466528664|FG000|Overall Study|Physician Decision|1|||
129610132|NCT04228783|466528665|FG001|Overall Study|Physician Decision|2|||
129610133|NCT04228783|466528666|FG002|Overall Study|Physician Decision|0|||
129610134|NCT04228783|466528667|FG003|Overall Study|Physician Decision|0|||
129610135|NCT04228783|466528668|FG004|Overall Study|Physician Decision|0|||
129610136|NCT04228783|466528669|FG005|Overall Study|Physician Decision|0|||
129610137|NCT04228783|466528664|FG000|Overall Study|Protocol Violation|0|||
129610138|NCT04228783|466528665|FG001|Overall Study|Protocol Violation|0|||
129610139|NCT04228783|466528666|FG002|Overall Study|Protocol Violation|0|||
129610140|NCT04228783|466528667|FG003|Overall Study|Protocol Violation|1|||
129610141|NCT04228783|466528668|FG004|Overall Study|Protocol Violation|0|||
129610142|NCT04228783|466528669|FG005|Overall Study|Protocol Violation|0|||
129610143|NCT04228783|466528664|FG000|Overall Study|Withdrawal by Subject|6|||
129610144|NCT04228783|466528665|FG001|Overall Study|Withdrawal by Subject|10|||
129610145|NCT04228783|466528666|FG002|Overall Study|Withdrawal by Subject|19|||
129610146|NCT04228783|466528667|FG003|Overall Study|Withdrawal by Subject|1|||
129610147|NCT04228783|466528668|FG004|Overall Study|Withdrawal by Subject|2|||
129610148|NCT04228783|466528669|FG005|Overall Study|Withdrawal by Subject|0|||
129610149|NCT04228783|466528664|FG000|Overall Study|Other|4|||
129610150|NCT04228783|466528665|FG001|Overall Study|Other|3|||
129610151|NCT04228783|466528666|FG002|Overall Study|Other|2|||
129610152|NCT04228783|466528667|FG003|Overall Study|Other|1|||
129610153|NCT04228783|466528668|FG004|Overall Study|Other|0|||
129610154|NCT04228783|466528669|FG005|Overall Study|Other|0|||
129610155|NCT03151811|466528674|FG000|Overall Study|Randomized But Not Treated|18|||
129610156|NCT03151811|466528675|FG001|Overall Study|Randomized But Not Treated|3|||
129610157|NCT03151811|466528674|FG000|Overall Study|Progressive Disease|130|||
129610158|NCT03151811|466528675|FG001|Overall Study|Progressive Disease|170|||
129610159|NCT03151811|466528674|FG000|Overall Study|Adverse Event|49|||
129610160|NCT03151811|466528675|FG001|Overall Study|Adverse Event|40|||
129610161|NCT03151811|466528674|FG000|Overall Study|Lack of Efficacy|6|||
129610162|NCT03151811|466528675|FG001|Overall Study|Lack of Efficacy|8|||
129610163|NCT03151811|466528674|FG000|Overall Study|Physician Decision|21|||
129610164|NCT03151811|466528675|FG001|Overall Study|Physician Decision|9|||
129610165|NCT03151811|466528674|FG000|Overall Study|Withdrawal by Subject|17|||
129610166|NCT03151811|466528675|FG001|Overall Study|Withdrawal by Subject|7|||
129610167|NCT03151811|466528674|FG000|Overall Study|Lost to Follow-up|0|||
129610168|NCT03151811|466528675|FG001|Overall Study|Lost to Follow-up|1|||
129610169|NCT03151811|466528674|FG000|Overall Study|Study Terminated by Sponsor|5|||
129610170|NCT03151811|466528675|FG001|Overall Study|Study Terminated by Sponsor|11|||
129610171|NCT01517373|466528676|FG000|Run-in Period|Death|1|||
129790790|NCT00045942|467201415|FG005|PKC412A2104E2|Lack of Efficacy|3|||
129790791|NCT00045942|467201416|FG006|PKC412A2104E2|Lack of Efficacy|2|||
129790792|NCT00045942|467201417|FG007|PKC412A2104E2|Lack of Efficacy|2|||
129790793|NCT00045942|467201418|FG008|PKC412A2104E2|Lack of Efficacy|6|||
129790794|NCT00045942|467201410|FG000|PKC412A2104E2|Adverse Event|0|||
129790795|NCT00045942|467201411|FG001|PKC412A2104E2|Adverse Event|0|||
129790796|NCT00045942|467201412|FG002|PKC412A2104E2|Adverse Event|0|||
129790797|NCT00045942|467201413|FG003|PKC412A2104E2|Adverse Event|0|||
129790798|NCT00045942|467201414|FG004|PKC412A2104E2|Adverse Event|0|||
129790799|NCT00045942|467201415|FG005|PKC412A2104E2|Adverse Event|4|||
129790800|NCT00045942|467201416|FG006|PKC412A2104E2|Adverse Event|3|||
129790801|NCT00045942|467201417|FG007|PKC412A2104E2|Adverse Event|1|||
129790802|NCT00045942|467201418|FG008|PKC412A2104E2|Adverse Event|0|||
129790803|NCT00045942|467201410|FG000|PKC412A2104E2|Death|0|||
129790804|NCT00045942|467201411|FG001|PKC412A2104E2|Death|0|||
129790805|NCT00045942|467201412|FG002|PKC412A2104E2|Death|0|||
129790806|NCT00045942|467201413|FG003|PKC412A2104E2|Death|0|||
129790807|NCT00045942|467201414|FG004|PKC412A2104E2|Death|0|||
129790808|NCT00045942|467201415|FG005|PKC412A2104E2|Death|1|||
129610172|NCT01517373|466528677|FG001|Run-in Period|Death|0|||
129610173|NCT01517373|466528678|FG002|Run-in Period|Death|0|||
129610174|NCT01517373|466528679|FG003|Run-in Period|Death|0|||
129610175|NCT01517373|466528680|FG004|Run-in Period|Death|0|||
129610176|NCT01517373|466528681|FG005|Run-in Period|Death|0|||
129610177|NCT01517373|466528676|FG000|Run-in Period|Adverse Event|5|||
129610178|NCT01517373|466528677|FG001|Run-in Period|Adverse Event|0|||
129790809|NCT00045942|467201416|FG006|PKC412A2104E2|Death|2|||
129610179|NCT01517373|466528678|FG002|Run-in Period|Adverse Event|0|||
129790810|NCT00045942|467201417|FG007|PKC412A2104E2|Death|0|||
129790811|NCT00045942|467201418|FG008|PKC412A2104E2|Death|0|||
129790812|NCT02142387|467201419|FG000|Overall Study|<19 years old|49|||
129790813|NCT02142387|467201420|FG001|Overall Study|<19 years old|326|||
129610180|NCT01517373|466528679|FG003|Run-in Period|Adverse Event|0|||
129610181|NCT01517373|466528680|FG004|Run-in Period|Adverse Event|0|||
129610182|NCT01517373|466528681|FG005|Run-in Period|Adverse Event|0|||
129610183|NCT01517373|466528676|FG000|Run-in Period|Did not meet eligibility criteria|34|||
129610184|NCT01517373|466528677|FG001|Run-in Period|Did not meet eligibility criteria|0|||
129610185|NCT01517373|466528678|FG002|Run-in Period|Did not meet eligibility criteria|0|||
129790814|NCT02142387|467201419|FG000|Overall Study|non-cardiac etiology|504|||
129610186|NCT01517373|466528679|FG003|Run-in Period|Did not meet eligibility criteria|0|||
129610187|NCT01517373|466528680|FG004|Run-in Period|Did not meet eligibility criteria|0|||
129610188|NCT01517373|466528681|FG005|Run-in Period|Did not meet eligibility criteria|0|||
129610189|NCT01517373|466528676|FG000|Run-in Period|Lost to Follow-up|1|||
129610190|NCT01517373|466528677|FG001|Run-in Period|Lost to Follow-up|0|||
129610191|NCT01517373|466528678|FG002|Run-in Period|Lost to Follow-up|0|||
129610192|NCT01517373|466528679|FG003|Run-in Period|Lost to Follow-up|0|||
129610193|NCT01517373|466528680|FG004|Run-in Period|Lost to Follow-up|0|||
129610194|NCT01517373|466528681|FG005|Run-in Period|Lost to Follow-up|0|||
129610195|NCT01517373|466528676|FG000|Run-in Period|Withdrawal by Subject|12|||
129610196|NCT01517373|466528677|FG001|Run-in Period|Withdrawal by Subject|0|||
129610197|NCT01517373|466528678|FG002|Run-in Period|Withdrawal by Subject|0|||
129610198|NCT01517373|466528679|FG003|Run-in Period|Withdrawal by Subject|0|||
129610199|NCT01517373|466528680|FG004|Run-in Period|Withdrawal by Subject|0|||
129610200|NCT01517373|466528681|FG005|Run-in Period|Withdrawal by Subject|0|||
129610201|NCT01517373|466528676|FG000|Run-in Period|Sponsor Decision|3|||
129610202|NCT01517373|466528677|FG001|Run-in Period|Sponsor Decision|0|||
129610203|NCT01517373|466528678|FG002|Run-in Period|Sponsor Decision|0|||
129610204|NCT01517373|466528679|FG003|Run-in Period|Sponsor Decision|0|||
129610205|NCT01517373|466528680|FG004|Run-in Period|Sponsor Decision|0|||
129610206|NCT01517373|466528681|FG005|Run-in Period|Sponsor Decision|0|||
129610207|NCT01517373|466528676|FG000|Run-in Period|Other|1|||
129610208|NCT01517373|466528677|FG001|Run-in Period|Other|0|||
129610209|NCT01517373|466528678|FG002|Run-in Period|Other|0|||
129610210|NCT01517373|466528679|FG003|Run-in Period|Other|0|||
129610211|NCT01517373|466528680|FG004|Run-in Period|Other|0|||
129610212|NCT01517373|466528681|FG005|Run-in Period|Other|0|||
129610213|NCT01517373|466528676|FG000|Treatment Period|Adverse Event|0|||
129610214|NCT01517373|466528677|FG001|Treatment Period|Adverse Event|0|||
129610215|NCT01517373|466528678|FG002|Treatment Period|Adverse Event|0|||
129610216|NCT01517373|466528679|FG003|Treatment Period|Adverse Event|0|||
129610217|NCT01517373|466528680|FG004|Treatment Period|Adverse Event|0|||
129610218|NCT01517373|466528681|FG005|Treatment Period|Adverse Event|2|||
129610219|NCT01517373|466528676|FG000|Treatment Period|Lost to Follow-up|0|||
129610220|NCT01517373|466528677|FG001|Treatment Period|Lost to Follow-up|0|||
129610221|NCT01517373|466528678|FG002|Treatment Period|Lost to Follow-up|1|||
129610222|NCT01517373|466528679|FG003|Treatment Period|Lost to Follow-up|1|||
129610223|NCT01517373|466528680|FG004|Treatment Period|Lost to Follow-up|0|||
129610224|NCT01517373|466528681|FG005|Treatment Period|Lost to Follow-up|0|||
129610225|NCT01517373|466528676|FG000|Treatment Period|Withdrawal by Subject|0|||
129610226|NCT01517373|466528677|FG001|Treatment Period|Withdrawal by Subject|3|||
129610227|NCT01517373|466528678|FG002|Treatment Period|Withdrawal by Subject|2|||
129610228|NCT01517373|466528679|FG003|Treatment Period|Withdrawal by Subject|2|||
129610229|NCT01517373|466528680|FG004|Treatment Period|Withdrawal by Subject|2|||
129610230|NCT01517373|466528681|FG005|Treatment Period|Withdrawal by Subject|3|||
129610231|NCT01517373|466528676|FG000|Treatment Period|Other|0|||
129610232|NCT01517373|466528677|FG001|Treatment Period|Other|0|||
129610233|NCT01517373|466528678|FG002|Treatment Period|Other|0|||
129610234|NCT01517373|466528679|FG003|Treatment Period|Other|0|||
129610235|NCT01517373|466528680|FG004|Treatment Period|Other|1|||
129610236|NCT01517373|466528681|FG005|Treatment Period|Other|0|||
129610237|NCT01517373|466528676|FG000|Treatment Period|Protocol Violation|0|||
129610238|NCT01517373|466528677|FG001|Treatment Period|Protocol Violation|0|||
129610239|NCT01517373|466528678|FG002|Treatment Period|Protocol Violation|0|||
129610240|NCT01517373|466528679|FG003|Treatment Period|Protocol Violation|0|||
129610241|NCT01517373|466528680|FG004|Treatment Period|Protocol Violation|1|||
129610242|NCT01517373|466528681|FG005|Treatment Period|Protocol Violation|0|||
129610243|NCT01517373|466528676|FG000|Treatment Period|Lack of Efficacy|0|||
129610244|NCT01517373|466528677|FG001|Treatment Period|Lack of Efficacy|1|||
129610245|NCT01517373|466528678|FG002|Treatment Period|Lack of Efficacy|1|||
129610246|NCT01517373|466528679|FG003|Treatment Period|Lack of Efficacy|3|||
129610247|NCT01517373|466528680|FG004|Treatment Period|Lack of Efficacy|2|||
129610248|NCT01517373|466528681|FG005|Treatment Period|Lack of Efficacy|0|||
129610249|NCT01517373|466528676|FG000|Treatment Period|Medication error without AEs|0|||
129610250|NCT01517373|466528677|FG001|Treatment Period|Medication error without AEs|0|||
129610251|NCT01517373|466528678|FG002|Treatment Period|Medication error without AEs|2|||
129610252|NCT01517373|466528679|FG003|Treatment Period|Medication error without AEs|1|||
129610253|NCT01517373|466528680|FG004|Treatment Period|Medication error without AEs|0|||
129610254|NCT01517373|466528681|FG005|Treatment Period|Medication error without AEs|2|||
129610255|NCT04562155|466528685|FG000|Overall Study|COVID-19 pandemic|0|||
129699541|NCT02951819|466859808|FG000|Overall Study|Death|9|||
129699542|NCT02951819|466859809|FG001|Overall Study|Death|7|||
129610256|NCT04562155|466528686|FG001|Overall Study|COVID-19 pandemic|0|||
129610257|NCT04562155|466528687|FG002|Overall Study|COVID-19 pandemic|0|||
129610258|NCT04562155|466528688|FG003|Overall Study|COVID-19 pandemic|1|||
129610259|NCT04562155|466528685|FG000|Overall Study|Adverse Event|7|||
129610260|NCT04562155|466528686|FG001|Overall Study|Adverse Event|3|||
129610261|NCT04562155|466528687|FG002|Overall Study|Adverse Event|8|||
129610262|NCT04562155|466528688|FG003|Overall Study|Adverse Event|1|||
129699543|NCT02951819|466859808|FG000|Overall Study|Withdrawal by Subject|3|||
129699544|NCT02951819|466859809|FG001|Overall Study|Withdrawal by Subject|0|||
129699545|NCT02951819|466859808|FG000|Overall Study|Adverse Event|1|||
129699546|NCT02951819|466859809|FG001|Overall Study|Adverse Event|0|||
129699547|NCT02951819|466859808|FG000|Overall Study|Lack of Efficacy|4|||
129699548|NCT02951819|466859809|FG001|Overall Study|Lack of Efficacy|0|||
129699549|NCT02951819|466859808|FG000|Overall Study|Lost to Follow-up|1|||
129699550|NCT02951819|466859809|FG001|Overall Study|Lost to Follow-up|0|||
129699551|NCT02951819|466859808|FG000|Overall Study|Progressive Disease|1|||
129699552|NCT02951819|466859809|FG001|Overall Study|Progressive Disease|0|||
129699553|NCT02951819|466859808|FG000|Overall Study|Other|9|||
129699554|NCT02951819|466859809|FG001|Overall Study|Other|0|||
129699555|NCT03647137|466859811|FG000|Overall Study|Scan Limitation|2|||
129699556|NCT03647137|466859812|FG001|Overall Study|Scan Limitation|1|||
129699557|NCT03647137|466859813|FG002|Overall Study|Scan Limitation|1|||
129699558|NCT03647137|466859814|FG003|Overall Study|Scan Limitation|2|||
129699559|NCT01443026|466859816|FG000|Overall Study|Physician Decision|1|||
129610263|NCT04562155|466528685|FG000|Overall Study|Withdrawal by Subject|3|||
129610264|NCT04562155|466528686|FG001|Overall Study|Withdrawal by Subject|6|||
129610265|NCT04562155|466528687|FG002|Overall Study|Withdrawal by Subject|3|||
129610266|NCT04562155|466528688|FG003|Overall Study|Withdrawal by Subject|3|||
129610267|NCT04562155|466528685|FG000|Overall Study|Participant personal reason|1|||
129610268|NCT04562155|466528686|FG001|Overall Study|Participant personal reason|0|||
129610269|NCT04562155|466528687|FG002|Overall Study|Participant personal reason|2|||
129610270|NCT04562155|466528688|FG003|Overall Study|Participant personal reason|1|||
129610271|NCT01085201|466528691|FG000|Overall Study|Scheduling conflict|1|||
129610272|NCT01085201|466528692|FG001|Overall Study|Scheduling conflict|0|||
129610273|NCT01085201|466528693|FG002|Overall Study|Scheduling conflict|1|||
129610274|NCT01085201|466528694|FG003|Overall Study|Scheduling conflict|0|||
129610275|NCT01085201|466528695|FG004|Overall Study|Scheduling conflict|0|||
129610276|NCT01085201|466528691|FG000|Overall Study|Unknown- no study drug|2|||
129610277|NCT01085201|466528692|FG001|Overall Study|Unknown- no study drug|0|||
129610278|NCT01085201|466528693|FG002|Overall Study|Unknown- no study drug|0|||
129610279|NCT01085201|466528694|FG003|Overall Study|Unknown- no study drug|0|||
129610280|NCT01085201|466528695|FG004|Overall Study|Unknown- no study drug|0|||
129610281|NCT01085201|466528691|FG000|Overall Study|Fond ineligible after consent|0|||
129610282|NCT01085201|466528692|FG001|Overall Study|Fond ineligible after consent|1|||
129610283|NCT01085201|466528693|FG002|Overall Study|Fond ineligible after consent|1|||
129610284|NCT01085201|466528694|FG003|Overall Study|Fond ineligible after consent|0|||
129610285|NCT01085201|466528695|FG004|Overall Study|Fond ineligible after consent|0|||
129610286|NCT04516759|466528698|FG000|Overall Study|Withdrawal by Subject|1|||
129610287|NCT04516759|466528699|FG001|Overall Study|Withdrawal by Subject|1|||
129610288|NCT04516759|466528698|FG000|Overall Study|Other|0|||
129610289|NCT04516759|466528699|FG001|Overall Study|Other|1|||
129610290|NCT00528411|466528700|FG000|Overall Study|Adverse Event|4|||
129610291|NCT00528411|466528701|FG001|Overall Study|Adverse Event|0|||
129610292|NCT00528411|466528702|FG002|Overall Study|Adverse Event|1|||
129610293|NCT00528411|466528700|FG000|Overall Study|Incorrect Enrolment|1|||
129610294|NCT00528411|466528701|FG001|Overall Study|Incorrect Enrolment|1|||
129610295|NCT00528411|466528702|FG002|Overall Study|Incorrect Enrolment|0|||
129610296|NCT00528411|466528700|FG000|Overall Study|Severe non-compliance to protocol|0|||
129610297|NCT00528411|466528701|FG001|Overall Study|Severe non-compliance to protocol|1|||
129610298|NCT00528411|466528702|FG002|Overall Study|Severe non-compliance to protocol|0|||
129610299|NCT00528411|466528700|FG000|Overall Study|Prior commitment medication|0|||
129610300|NCT00528411|466528701|FG001|Overall Study|Prior commitment medication|1|||
129610301|NCT00528411|466528702|FG002|Overall Study|Prior commitment medication|0|||
129610302|NCT01221363|466528706|FG000|Overall Study|Pregnancy|1|||
129610303|NCT01221363|466528707|FG001|Overall Study|Pregnancy|0|||
129610304|NCT01221363|466528706|FG000|Overall Study|Withdrawal by Subject|11|||
129610305|NCT01221363|466528707|FG001|Overall Study|Withdrawal by Subject|5|||
129610306|NCT02695537|466528712|FG000|Overall Study|Adverse Event|3|||
129610307|NCT02695537|466528712|FG000|Overall Study|Lack of Efficacy|28|||
129699560|NCT01443026|466859817|FG001|Overall Study|Physician Decision|0|||
129699561|NCT01443026|466859816|FG000|Overall Study|Death|0|||
129699562|NCT01443026|466859817|FG001|Overall Study|Death|1|||
129699563|NCT01443026|466859816|FG000|Overall Study|Withdrawal by Subject|0|||
129610308|NCT02695537|466528712|FG000|Overall Study|Withdrawal by Subject|4|||
129610309|NCT02695537|466528712|FG000|Overall Study|Protocol Violation|3|||
129610310|NCT03597529|466528713|FG000|Overall Study|Lost to Follow-up|10|||
129610311|NCT03597529|466528714|FG001|Overall Study|Lost to Follow-up|12|||
129610312|NCT03597529|466528713|FG000|Overall Study|Physician Decision|3|||
129610313|NCT03597529|466528714|FG001|Overall Study|Physician Decision|1|||
129610314|NCT03597529|466528713|FG000|Overall Study|Withdrawal by Subject|6|||
129439116|NCT00392327|465904575|FG006|Overall Study|Death|0|||
129439117|NCT00392327|465904576|FG007|Overall Study|Death|0|||
129610315|NCT03597529|466528714|FG001|Overall Study|Withdrawal by Subject|3|||
129610316|NCT03597529|466528713|FG000|Overall Study|Non-compliant with study activities|1|||
129610317|NCT03597529|466528714|FG001|Overall Study|Non-compliant with study activities|2|||
129610318|NCT00998309|466528721|FG000|Overall Study|Protocol Violation|4|||
129610319|NCT02865460|466528722|FG000|Overall Study|Adverse Event|1|||
129610320|NCT02865460|466528723|FG001|Overall Study|Adverse Event|0|||
129610321|NCT02865460|466528722|FG000|Overall Study|Withdrawal by Subject|1|||
129610322|NCT02865460|466528723|FG001|Overall Study|Withdrawal by Subject|1|||
129610323|NCT02865460|466528722|FG000|Overall Study|Lost to Follow-up|7|||
129610324|NCT02865460|466528723|FG001|Overall Study|Lost to Follow-up|4|||
129610325|NCT02865460|466528722|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
129610326|NCT02865460|466528723|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
129610327|NCT02238795|466528730|FG000|Overall Study|Patient without purpura fulminans|1|||
129610328|NCT01292226|466528734|FG000|Overall Study|Adverse Event|5|||
129610329|NCT01292226|466528734|FG000|Overall Study|Death|1|||
129610330|NCT01292226|466528734|FG000|Overall Study|Graft loss|1|||
129610331|NCT01292226|466528734|FG000|Overall Study|Protocol Violation|3|||
129610332|NCT01292226|466528734|FG000|Overall Study|Withdrawal by Subject|1|||
129610333|NCT01292226|466528734|FG000|Overall Study|Other|2|||
129610334|NCT00311402|466528735|FG000|Overall Study|Adverse Event|118|||
129610335|NCT00311402|466528736|FG001|Overall Study|Adverse Event|105|||
129610336|NCT00311402|466528735|FG000|Overall Study|Lost to Follow-up|0|||
129610337|NCT00311402|466528736|FG001|Overall Study|Lost to Follow-up|3|||
129610338|NCT00311402|466528735|FG000|Overall Study|Withdrawal by Subject|17|||
129610339|NCT00311402|466528736|FG001|Overall Study|Withdrawal by Subject|18|||
129610340|NCT00311402|466528735|FG000|Overall Study|Lack of Efficacy|58|||
129610341|NCT00311402|466528736|FG001|Overall Study|Lack of Efficacy|42|||
129610342|NCT00311402|466528735|FG000|Overall Study|Protocol Violation|7|||
129610343|NCT00311402|466528736|FG001|Overall Study|Protocol Violation|6|||
129610344|NCT00311402|466528735|FG000|Overall Study|IRB's rejection etc.|10|||
129610345|NCT00311402|466528736|FG001|Overall Study|IRB's rejection etc.|3|||
129610346|NCT02640053|466528737|FG000|Overall Study|Withdrawal by Subject|2|||
129610347|NCT02640053|466528738|FG001|Overall Study|Withdrawal by Subject|1|||
129610348|NCT02640053|466528737|FG000|Overall Study|Adverse Event|1|||
129610349|NCT02640053|466528738|FG001|Overall Study|Adverse Event|1|||
129610350|NCT02640053|466528737|FG000|Overall Study|Alternative Therapy|1|||
129610351|NCT02640053|466528738|FG001|Overall Study|Alternative Therapy|1|||
129610352|NCT02640053|466528737|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
129610353|NCT02640053|466528738|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
129610354|NCT03283761|466528739|FG000|Study Treatment|Patient Non-Compliance|1|||
129610355|NCT03283761|466528739|FG000|Study Treatment|Alternative Cancer Therapy|7|||
129610356|NCT03283761|466528739|FG000|Study Treatment|Disease progression|21|||
129610357|NCT03283761|466528739|FG000|Study Treatment|Adverse Event|3|||
129610358|NCT03283761|466528739|FG000|Study Treatment|Withdrawal by Subject|4|||
129610359|NCT03283761|466528739|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
129610360|NCT03283761|466528739|FG000|Study Treatment|Symptomatic Deterioration|1|||
129610361|NCT03283761|466528739|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
129610362|NCT03283761|466528739|FG000|Follow up|Lost to Follow-up|1|||
129610363|NCT03283761|466528739|FG000|Follow up|Symptomatic Deterioration|1|||
129610364|NCT03283761|466528739|FG000|Follow up|Death|29|||
129610365|NCT03283761|466528739|FG000|Follow up|study terminated|4|||
129610366|NCT03283761|466528739|FG000|Follow up|Primary Investigator Withdrawal|1|||
129610367|NCT03283761|466528739|FG000|Follow up|Switched to alternative therapy|1|||
129610368|NCT03283761|466528739|FG000|Follow up|Subject is now in Hospice|1|||
129610369|NCT02288182|466528740|FG000|Overall Study|Adverse Event|0|||
129610370|NCT02288182|466528741|FG001|Overall Study|Adverse Event|1|||
129610371|NCT02288182|466528740|FG000|Overall Study|Lost to Follow-up|0|||
129610372|NCT02288182|466528741|FG001|Overall Study|Lost to Follow-up|1|||
129610373|NCT01214915|466528745|FG000|Overall Study|Adverse Event|8|||
129610374|NCT01214915|466528745|FG000|Overall Study|Lack of Efficacy|3|||
129610375|NCT02056392|466528746|FG000|Overall Study|Lost to Follow-up|0|||
129439118|NCT00392327|465904569|FG000|Overall Study|Lack of Efficacy|8|||
129439119|NCT00392327|465904570|FG001|Overall Study|Lack of Efficacy|8|||
129610376|NCT02056392|466528747|FG001|Overall Study|Lost to Follow-up|1|||
129610377|NCT02056392|466528748|FG002|Overall Study|Lost to Follow-up|2|||
129610378|NCT02056392|466528749|FG003|Overall Study|Lost to Follow-up|0|||
129610379|NCT02056392|466528750|FG004|Overall Study|Lost to Follow-up|0|||
129610380|NCT02056392|466528751|FG005|Overall Study|Lost to Follow-up|0|||
129610381|NCT02056392|466528746|FG000|Overall Study|Protocol Violation|1|||
129610382|NCT02056392|466528747|FG001|Overall Study|Protocol Violation|0|||
129610383|NCT02056392|466528748|FG002|Overall Study|Protocol Violation|1|||
129610384|NCT02056392|466528749|FG003|Overall Study|Protocol Violation|0|||
129610385|NCT02056392|466528750|FG004|Overall Study|Protocol Violation|0|||
129610386|NCT02056392|466528751|FG005|Overall Study|Protocol Violation|0|||
129610387|NCT02056392|466528746|FG000|Overall Study|Withdrawal by Subject|1|||
129699564|NCT01443026|466859817|FG001|Overall Study|Withdrawal by Subject|3|||
129699565|NCT01443026|466859816|FG000|Overall Study|Lost to Follow-up|2|||
129699566|NCT01443026|466859817|FG001|Overall Study|Lost to Follow-up|1|||
129699567|NCT00581919|466859818|FG000|Overall Study|Adverse Event|8|||
129699568|NCT00581919|466859818|FG000|Overall Study|Death|1|||
129699569|NCT00581919|466859818|FG000|Overall Study|Disease Progression|10|||
129699570|NCT00581919|466859818|FG000|Overall Study|Physician Decision|1|||
129699571|NCT00581919|466859818|FG000|Overall Study|Other Complicating Disease|1|||
129699572|NCT00581919|466859818|FG000|Overall Study|Started Non-Protocol Therapy|2|||
129699573|NCT00581919|466859818|FG000|Overall Study|Withdrawal by Subject|1|||
129699574|NCT02655601|466859819|FG000|Overall Study|Adverse Event|0|||
129699575|NCT02655601|466859820|FG001|Overall Study|Adverse Event|0|||
129699576|NCT02655601|466859821|FG002|Overall Study|Adverse Event|0|||
129699577|NCT02655601|466859822|FG003|Overall Study|Adverse Event|1|||
129699578|NCT02655601|466859823|FG004|Overall Study|Adverse Event|1|||
129699579|NCT02655601|466859824|FG005|Overall Study|Adverse Event|0|||
129790815|NCT02142387|467201420|FG001|Overall Study|non-cardiac etiology|3431|||
129790816|NCT02142387|467201419|FG000|Overall Study|CPR not performed|74|||
129790817|NCT02142387|467201420|FG001|Overall Study|CPR not performed|473|||
129790818|NCT02142387|467201419|FG000|Overall Study|witnessed by paramedic|139|||
129610388|NCT02056392|466528747|FG001|Overall Study|Withdrawal by Subject|0|||
129610389|NCT02056392|466528748|FG002|Overall Study|Withdrawal by Subject|0|||
129610390|NCT02056392|466528749|FG003|Overall Study|Withdrawal by Subject|0|||
129610391|NCT02056392|466528750|FG004|Overall Study|Withdrawal by Subject|1|||
129610392|NCT02056392|466528751|FG005|Overall Study|Withdrawal by Subject|0|||
129610393|NCT00633243|466530712|FG000|Overall Study|Withdrawal by Subject|0|||
129610394|NCT00633243|466530713|FG001|Overall Study|Withdrawal by Subject|1|||
129610395|NCT00633243|466530712|FG000|Overall Study|incarceration|0|||
129610396|NCT00633243|466530713|FG001|Overall Study|incarceration|2|||
129610397|NCT00633243|466530712|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
129610398|NCT00633243|466530713|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
129610399|NCT00633243|466530712|FG000|Overall Study|Not comfortable with self-injecting|0|||
129610400|NCT00633243|466530713|FG001|Overall Study|Not comfortable with self-injecting|1|||
129610401|NCT00633243|466530712|FG000|Overall Study|Mental Health--Depression|0|||
129610402|NCT00633243|466530713|FG001|Overall Study|Mental Health--Depression|1|||
129610403|NCT00633243|466530712|FG000|Overall Study|Couldn't tolerate side-effects|1|||
129610404|NCT00633243|466530713|FG001|Overall Study|Couldn't tolerate side-effects|1|||
129610405|NCT02022748|466530714|FG000|Overall Study|Adverse Event|1|||
129610406|NCT02022748|466530715|FG001|Overall Study|Adverse Event|1|||
129610407|NCT02022748|466530716|FG002|Overall Study|Adverse Event|0|||
129610408|NCT02022748|466530714|FG000|Overall Study|Withdrawal by Subject|0|||
129610409|NCT02022748|466530715|FG001|Overall Study|Withdrawal by Subject|1|||
129610410|NCT02022748|466530716|FG002|Overall Study|Withdrawal by Subject|0|||
129610411|NCT01523457|466530717|FG000|Overall Study|Withdrawal by Subject|7|||
129610412|NCT01523457|466530718|FG001|Overall Study|Withdrawal by Subject|2|||
129610413|NCT03700385|466530721|FG000|Overall Study|Lost to Follow-up|1|||
129610414|NCT01555671|466530725|FG000|Overall Study|Physician Decision|20|||
129610415|NCT01555671|466530726|FG001|Overall Study|Physician Decision|25|||
129610416|NCT00372411|466530727|FG000|Overall Study|Withdrawal by Subject|3|||
129610417|NCT00372411|466530728|FG001|Overall Study|Withdrawal by Subject|4|||
129610418|NCT00372411|466530729|FG002|Overall Study|Withdrawal by Subject|1|||
129610419|NCT00372411|466530727|FG000|Overall Study|Death|0|||
129610420|NCT00372411|466530728|FG001|Overall Study|Death|2|||
129610421|NCT00372411|466530729|FG002|Overall Study|Death|1|||
129610422|NCT00372411|466530727|FG000|Overall Study|Lost to Follow-up|1|||
129610423|NCT00372411|466530728|FG001|Overall Study|Lost to Follow-up|1|||
129610424|NCT00372411|466530729|FG002|Overall Study|Lost to Follow-up|1|||
129610425|NCT00372411|466530727|FG000|Overall Study|Adverse Event|1|||
129610426|NCT00372411|466530728|FG001|Overall Study|Adverse Event|1|||
129610427|NCT00372411|466530729|FG002|Overall Study|Adverse Event|0|||
129610428|NCT04590040|466530730|FG000|Treatment Period|Lost to Follow-up|2|||
129790819|NCT02142387|467201420|FG001|Overall Study|witnessed by paramedic|917|||
129790820|NCT02142387|467201419|FG000|Overall Study|incomplete data|1|||
129699580|NCT02655601|466859819|FG000|Overall Study|Physician Decision|0|||
129790821|NCT02142387|467201420|FG001|Overall Study|incomplete data|9|||
129610429|NCT04590040|466530731|FG001|Treatment Period|Lost to Follow-up|5|||
129699581|NCT02655601|466859820|FG001|Overall Study|Physician Decision|0|||
129699582|NCT02655601|466859821|FG002|Overall Study|Physician Decision|0|||
129610430|NCT04590040|466530732|FG002|Treatment Period|Lost to Follow-up|0|||
129610431|NCT04590040|466530730|FG000|Treatment Period|Physician Decision|0|||
129610432|NCT04590040|466530731|FG001|Treatment Period|Physician Decision|0|||
129610433|NCT04590040|466530732|FG002|Treatment Period|Physician Decision|2|||
129790822|NCT02142387|467201419|FG000|Overall Study|occurred not at home|298|||
129887007|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
129610434|NCT01284361|466530735|FG000|Overall Study|Withdrawal by Subject|1|||
129699583|NCT02655601|466859822|FG003|Overall Study|Physician Decision|0|||
129699584|NCT02655601|466859823|FG004|Overall Study|Physician Decision|1|||
129699585|NCT02655601|466859824|FG005|Overall Study|Physician Decision|1|||
129610435|NCT01284361|466530735|FG000|Overall Study|Protocol Violation|5|||
129610436|NCT01284361|466530735|FG000|Overall Study|Adverse Event|1|||
129610437|NCT01284361|466530735|FG000|Overall Study|Lost to Follow-up|2|||
129610438|NCT04003896|466530736|FG000|Overall Study|Withdrawal by Subject|3|||
129610439|NCT04003896|466530736|FG000|Overall Study|Physician Decision|1|||
129610440|NCT01957397|466530739|FG000|Test Period 1|sudden leakage/small bag|1|||
129610441|NCT01957397|466530740|FG001|Test Period 1|sudden leakage/small bag|1|||
129610442|NCT01957397|466530739|FG000|Test Period 1|Withdrawal by Subject|1|||
129610443|NCT01957397|466530740|FG001|Test Period 1|Withdrawal by Subject|0|||
129610444|NCT01957397|466530739|FG000|Test Period 2|Adverse Event|0|||
129610445|NCT01957397|466530740|FG001|Test Period 2|Adverse Event|1|||
129610446|NCT01957397|466530739|FG000|Test Period 3|Adverse Event|1|||
129610447|NCT01957397|466530740|FG001|Test Period 3|Adverse Event|2|||
129610448|NCT01957397|466530739|FG000|Test Period 3|the adhesive did not work|1|||
129610449|NCT01957397|466530740|FG001|Test Period 3|the adhesive did not work|0|||
129610450|NCT00324649|466530741|FG000|Overall Study|Adverse Event|1|||
129610451|NCT00324649|466530742|FG001|Overall Study|Adverse Event|4|||
129610452|NCT00324649|466530741|FG000|Overall Study|Withdrawal by Subject|0|||
129610453|NCT00324649|466530742|FG001|Overall Study|Withdrawal by Subject|1|||
129610454|NCT00324649|466530741|FG000|Overall Study|Noncompliance|1|||
129610455|NCT00324649|466530742|FG001|Overall Study|Noncompliance|0|||
129610456|NCT00540293|466530743|FG000|Overall Study|Adverse event related to study drug|10|||
129610457|NCT00540293|466530743|FG000|Overall Study|Adverse event not related to study drug|7|||
129610458|NCT00540293|466530743|FG000|Overall Study|Withdrawal by Subject|6|||
129610459|NCT00540293|466530743|FG000|Overall Study|Protocol violation, & subject schedule|12|||
129610460|NCT04713553|466530746|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
129610461|NCT04713553|466530747|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
129610462|NCT04713553|466530748|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
129610463|NCT04713553|466530749|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
129610464|NCT04713553|466530750|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
129610465|NCT04713553|466530751|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
129610466|NCT04713553|466530752|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
129610467|NCT04713553|466530746|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129610468|NCT04713553|466530747|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129610469|NCT04713553|466530748|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129610470|NCT04713553|466530749|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
129610471|NCT04713553|466530750|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129610472|NCT04713553|466530751|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129610473|NCT04713553|466530752|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
129610474|NCT04713553|466530746|FG000|Primary Study (2 Months)|Other|1|||
129610475|NCT04713553|466530747|FG001|Primary Study (2 Months)|Other|2|||
129610476|NCT04713553|466530748|FG002|Primary Study (2 Months)|Other|0|||
129610477|NCT04713553|466530749|FG003|Primary Study (2 Months)|Other|0|||
129610478|NCT04713553|466530750|FG004|Primary Study (2 Months)|Other|1|||
129610479|NCT04713553|466530751|FG005|Primary Study (2 Months)|Other|0|||
129610480|NCT04713553|466530752|FG006|Primary Study (2 Months)|Other|0|||
129610481|NCT04713553|466530746|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
129610482|NCT04713553|466530747|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
129610483|NCT04713553|466530748|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
129610484|NCT04713553|466530749|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
129610485|NCT04713553|466530750|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
129610486|NCT04713553|466530751|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
129610487|NCT04713553|466530752|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
129610488|NCT04713553|466530746|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
129610489|NCT04713553|466530747|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
129610490|NCT04713553|466530748|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
129610491|NCT04713553|466530749|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
129610492|NCT04713553|466530750|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
129610493|NCT04713553|466530751|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
129699586|NCT02655601|466859819|FG000|Overall Study|Withdrawal by Subject|0|||
129610494|NCT04713553|466530752|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
129610495|NCT02315196|466530759|FG000|Overall Study|Withdrew consent|9|||
129610496|NCT04729309|466530760|FG000|Period 1|Subject unable to return for Period 2|3|||
129610497|NCT04729309|466530761|FG001|Period 1|Subject unable to return for Period 2|0|||
129610498|NCT04729309|466530760|FG000|Period 1|Lost to Follow-up|1|||
129610499|NCT04729309|466530761|FG001|Period 1|Lost to Follow-up|0|||
129610500|NCT00537303|466530762|FG000|Overall Study|Adverse Event|1|||
129699587|NCT02655601|466859820|FG001|Overall Study|Withdrawal by Subject|0|||
129699588|NCT02655601|466859821|FG002|Overall Study|Withdrawal by Subject|0|||
129610501|NCT00537303|466530763|FG001|Overall Study|Adverse Event|4|||
129610502|NCT00537303|466530762|FG000|Overall Study|Lack of Efficacy|6|||
129610503|NCT00537303|466530763|FG001|Overall Study|Lack of Efficacy|7|||
129610504|NCT00537303|466530762|FG000|Overall Study|Protocol Violation|8|||
129610505|NCT00537303|466530763|FG001|Overall Study|Protocol Violation|4|||
129610506|NCT00537303|466530762|FG000|Overall Study|Withdrawal criteria|3|||
129610507|NCT00537303|466530763|FG001|Overall Study|Withdrawal criteria|3|||
129610508|NCT00537303|466530762|FG000|Overall Study|Unclassified|8|||
129610509|NCT00537303|466530763|FG001|Overall Study|Unclassified|7|||
129610510|NCT02085135|466530764|FG000|Overall Study|Adverse Event|4|||
129610511|NCT02085135|466530765|FG001|Overall Study|Adverse Event|7|||
129610512|NCT02085135|466530764|FG000|Overall Study|Lost to Follow-up|2|||
129610513|NCT02085135|466530765|FG001|Overall Study|Lost to Follow-up|2|||
129610514|NCT02085135|466530764|FG000|Overall Study|Withdrawal by Subject|3|||
129610515|NCT02085135|466530765|FG001|Overall Study|Withdrawal by Subject|0|||
129610516|NCT02085135|466530764|FG000|Overall Study|Lack of Efficacy|2|||
129610517|NCT02085135|466530765|FG001|Overall Study|Lack of Efficacy|0|||
129610518|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
129610519|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
129610520|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
129610521|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
129610522|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
129610523|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
129610524|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
129610525|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
129610526|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
129610527|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
129610528|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Death|1|||
129610529|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Death|0|||
129610530|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Death|0|||
129610531|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Death|0|||
129610532|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Death|0|||
129610533|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129610534|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
129610535|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
129610536|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
129610537|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
129610538|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
129610539|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
129610540|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
129610541|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
129610542|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
129610543|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
129610544|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
129610545|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
129610546|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
129610547|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
129610548|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
129610549|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
129610550|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
129610551|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
129610552|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129610553|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
129610554|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129610555|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129610556|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129610557|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129610558|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Other|4|||
129610559|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Other|4|||
129610560|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Other|3|||
129610561|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Other|1|||
129610562|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Other|0|||
129610563|NCT01081834|466530772|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
129610564|NCT01081834|466530773|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
129610565|NCT01081834|466530774|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129610566|NCT01081834|466530775|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129610567|NCT01081834|466530776|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
129610568|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129610569|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129610570|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129610571|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129610572|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
129610573|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Death|1|||
129610574|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Death|0|||
129610575|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Death|0|||
129610576|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Death|0|||
129610577|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Death|0|||
129610578|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
129610579|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
129610580|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129610581|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129610582|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129610583|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129610584|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129610585|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129610586|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129610587|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129610588|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129610589|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
129610590|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129610591|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129610592|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
129610593|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129610594|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129610595|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129610596|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129610597|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129610598|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
129610599|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
129610600|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129610601|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129610602|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
129610603|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Other|4|||
129610604|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Other|5|||
129610605|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Other|4|||
129610606|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Other|0|||
129610607|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Other|0|||
129610608|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
129610609|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
129610610|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
129610611|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
129610612|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
129610613|NCT01081834|466530772|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129610614|NCT01081834|466530773|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
129610615|NCT01081834|466530774|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129610616|NCT01081834|466530775|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129610617|NCT01081834|466530776|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129610618|NCT01475097|466530783|FG000|Overall Study|Protocol Violation|1|||
129610619|NCT01475097|466530784|FG001|Overall Study|Protocol Violation|1|||
129610620|NCT00851318|466530795|FG000|Overall Study|Withdrawal by Subject|7|||
129610621|NCT00851318|466530796|FG001|Overall Study|Withdrawal by Subject|1|||
129610622|NCT00851318|466530797|FG002|Overall Study|Withdrawal by Subject|5|||
129610623|NCT00851318|466530798|FG003|Overall Study|Withdrawal by Subject|3|||
129610624|NCT00851318|466530795|FG000|Overall Study|Adverse Event|13|||
129610625|NCT00851318|466530796|FG001|Overall Study|Adverse Event|2|||
129610626|NCT00851318|466530797|FG002|Overall Study|Adverse Event|9|||
129610627|NCT00851318|466530798|FG003|Overall Study|Adverse Event|12|||
129610628|NCT00851318|466530795|FG000|Overall Study|Pregnancy|0|||
129610629|NCT00851318|466530796|FG001|Overall Study|Pregnancy|0|||
129610630|NCT00851318|466530797|FG002|Overall Study|Pregnancy|1|||
129610631|NCT00851318|466530798|FG003|Overall Study|Pregnancy|1|||
129610632|NCT00851318|466530795|FG000|Overall Study|Lack of Efficacy|8|||
129610633|NCT00851318|466530796|FG001|Overall Study|Lack of Efficacy|2|||
129610634|NCT00851318|466530797|FG002|Overall Study|Lack of Efficacy|4|||
129610635|NCT00851318|466530798|FG003|Overall Study|Lack of Efficacy|2|||
129610636|NCT00851318|466530795|FG000|Overall Study|Non-compliance with Study Procedures|2|||
129610637|NCT00851318|466530796|FG001|Overall Study|Non-compliance with Study Procedures|0|||
129610638|NCT00851318|466530797|FG002|Overall Study|Non-compliance with Study Procedures|1|||
129610639|NCT00851318|466530798|FG003|Overall Study|Non-compliance with Study Procedures|0|||
129610640|NCT00851318|466530795|FG000|Overall Study|Physician Decision|0|||
129610641|NCT00851318|466530796|FG001|Overall Study|Physician Decision|0|||
129610642|NCT00851318|466530797|FG002|Overall Study|Physician Decision|1|||
129610643|NCT00851318|466530798|FG003|Overall Study|Physician Decision|1|||
129610644|NCT01844856|466530805|FG000|Overall Study|Lost to Follow-up|15|||
129610645|NCT01844856|466530806|FG001|Overall Study|Lost to Follow-up|3|||
129610646|NCT01844856|466530805|FG000|Overall Study|Adverse Event|3|||
129610647|NCT01844856|466530806|FG001|Overall Study|Adverse Event|6|||
129610648|NCT01844856|466530805|FG000|Overall Study|Withdrawal by Subject|3|||
129610649|NCT01844856|466530806|FG001|Overall Study|Withdrawal by Subject|2|||
129610650|NCT01844856|466530805|FG000|Overall Study|Noncompliance|2|||
129610651|NCT01844856|466530806|FG001|Overall Study|Noncompliance|3|||
129610652|NCT01844856|466530805|FG000|Overall Study|Enterococcus Resistant|0|||
129610653|NCT01844856|466530806|FG001|Overall Study|Enterococcus Resistant|1|||
129610654|NCT01844856|466530805|FG000|Overall Study|Inadvertently Not Scheduled|1|||
129610655|NCT01844856|466530806|FG001|Overall Study|Inadvertently Not Scheduled|0|||
129610656|NCT01844856|466530805|FG000|Overall Study|Randomized but was a Screen Failure|0|||
129610657|NCT01844856|466530806|FG001|Overall Study|Randomized but was a Screen Failure|1|||
129610658|NCT01001988|466530807|FG000|Overall Study|Protocol Violation|84|||
129610659|NCT01001988|466530807|FG000|Overall Study|Withdrawal by Subject|18|||
129610660|NCT01001988|466530807|FG000|Overall Study|Lost to Follow-up|15|||
129610661|NCT01442688|466530808|FG000|First Intervention|Withdrawal by Subject|1|||
129610662|NCT01442688|466530809|FG001|First Intervention|Withdrawal by Subject|0|||
129610663|NCT01442688|466530808|FG000|First Intervention|subject incarcerated|1|||
129610664|NCT01442688|466530809|FG001|First Intervention|subject incarcerated|0|||
129610665|NCT01442688|466530808|FG000|Second Intervention|Adverse Event|1|||
129610666|NCT01442688|466530809|FG001|Second Intervention|Adverse Event|0|||
129610667|NCT00927394|466530812|FG000|Overall Study|Adverse Event|14|||
129610668|NCT00927394|466530813|FG001|Overall Study|Adverse Event|9|||
129610669|NCT00927394|466530812|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
129610670|NCT00927394|466530813|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
129610671|NCT00927394|466530812|FG000|Overall Study|Withdrawal by Subject|20|||
129610672|NCT00927394|466530813|FG001|Overall Study|Withdrawal by Subject|24|||
129610673|NCT00927394|466530812|FG000|Overall Study|Lost to Follow-up|8|||
129610674|NCT00927394|466530813|FG001|Overall Study|Lost to Follow-up|14|||
129610675|NCT00927394|466530812|FG000|Overall Study|Administrative Problem|1|||
129610676|NCT00927394|466530813|FG001|Overall Study|Administrative Problem|0|||
129610677|NCT00927394|466530812|FG000|Overall Study|Death|1|||
129610678|NCT00927394|466530813|FG001|Overall Study|Death|1|||
129610679|NCT00927394|466530812|FG000|Overall Study|Protocol deviation|16|||
129610680|NCT00927394|466530813|FG001|Overall Study|Protocol deviation|13|||
129610681|NCT00927394|466530812|FG000|Overall Study|Randomized in error|0|||
129610682|NCT00927394|466530813|FG001|Overall Study|Randomized in error|1|||
129610683|NCT01329549|466530816|FG000|Overall Study|Withdrawal by Subject|1|||
129610684|NCT01329549|466530816|FG000|Overall Study|Adverse Event|1|||
129610685|NCT02792699|466530826|FG000|Overall Study|Adverse Event|1|||
129610686|NCT02792699|466530827|FG001|Overall Study|Adverse Event|2|||
129610687|NCT02792699|466530828|FG002|Overall Study|Adverse Event|4|||
129610688|NCT02792699|466530826|FG000|Overall Study|Withdrawal by Subject|4|||
129610689|NCT02792699|466530827|FG001|Overall Study|Withdrawal by Subject|4|||
129610690|NCT02792699|466530828|FG002|Overall Study|Withdrawal by Subject|3|||
129610691|NCT02792699|466530826|FG000|Overall Study|Lost to Follow-up|0|||
129610692|NCT02792699|466530827|FG001|Overall Study|Lost to Follow-up|1|||
129610693|NCT02792699|466530828|FG002|Overall Study|Lost to Follow-up|2|||
129610694|NCT02792699|466530826|FG000|Overall Study|Physician Decision|2|||
129610695|NCT02792699|466530827|FG001|Overall Study|Physician Decision|0|||
129610696|NCT02792699|466530828|FG002|Overall Study|Physician Decision|0|||
129610697|NCT02792699|466530826|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
129610698|NCT02792699|466530827|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
129610699|NCT02792699|466530828|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
129610700|NCT02792699|466530826|FG000|Overall Study|Other|1|||
129610701|NCT02792699|466530827|FG001|Overall Study|Other|0|||
129610702|NCT02792699|466530828|FG002|Overall Study|Other|0|||
129610703|NCT01755767|466530829|FG000|Overall Study|Progressive Disease|8|||
129610704|NCT01755767|466530830|FG001|Overall Study|Progressive Disease|7|||
129610705|NCT01755767|466530831|FG002|Overall Study|Progressive Disease|91|||
129800261|NCT02445391|467236291|FG001|Overall Study|Alternative therapy|0|||
129610706|NCT01755767|466530832|FG003|Overall Study|Progressive Disease|43|||
129610707|NCT01755767|466530829|FG000|Overall Study|Clinical Disease Progression|4|||
129610708|NCT01755767|466530830|FG001|Overall Study|Clinical Disease Progression|2|||
129610709|NCT01755767|466530831|FG002|Overall Study|Clinical Disease Progression|29|||
129610710|NCT01755767|466530832|FG003|Overall Study|Clinical Disease Progression|20|||
129800262|NCT02445391|467236292|FG002|Overall Study|Alternative therapy|1|||
129800263|NCT02445391|467236290|FG000|Overall Study|Disease progression|0|||
129800264|NCT02445391|467236291|FG001|Overall Study|Disease progression|7|||
129800265|NCT02445391|467236292|FG002|Overall Study|Disease progression|22|||
129800266|NCT02445391|467236290|FG000|Overall Study|Complicating disease|0|||
129699589|NCT02655601|466859822|FG003|Overall Study|Withdrawal by Subject|0|||
129699590|NCT02655601|466859823|FG004|Overall Study|Withdrawal by Subject|4|||
129699591|NCT02655601|466859824|FG005|Overall Study|Withdrawal by Subject|8|||
129699592|NCT02655601|466859819|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
129699593|NCT02655601|466859820|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129699594|NCT02655601|466859821|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129699595|NCT02655601|466859822|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129699596|NCT02655601|466859823|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129699597|NCT02655601|466859824|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
129699598|NCT02528305|466859828|FG000|Overall Study|Withdrawal by Subject|1|||
129699599|NCT02528305|466859828|FG000|Overall Study|Adverse Event|1|||
129699600|NCT02528305|466859828|FG000|Overall Study|Physician Decision|1|||
129699601|NCT00787800|466859829|FG000|Overall Study|Withdrawal by Subject|3|||
129699602|NCT00787800|466859830|FG001|Overall Study|Withdrawal by Subject|5|||
129699603|NCT00787800|466859829|FG000|Overall Study|Death|0|||
129699604|NCT00787800|466859830|FG001|Overall Study|Death|2|||
129699605|NCT04309500|466859834|FG000|Overall Study|Lost to Follow-up|1|||
129699606|NCT04309500|466859835|FG001|Overall Study|Lost to Follow-up|0|||
129699607|NCT04309500|466859836|FG002|Overall Study|Lost to Follow-up|0|||
129699608|NCT04309500|466859837|FG003|Overall Study|Lost to Follow-up|0|||
129699609|NCT00913835|466859838|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
129699610|NCT00913835|466859839|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
129699611|NCT00913835|466859838|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
129699612|NCT00913835|466859839|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
129699613|NCT00913835|466859838|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
129699614|NCT00913835|466859839|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
129699615|NCT00913835|466859838|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
129699616|NCT00913835|466859839|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
129699617|NCT00913835|466859838|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
129699618|NCT00913835|466859839|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
129699619|NCT00637156|466859840|FG000|Overall Study|Withdrawal by Subject|0|||
129699620|NCT00637156|466859841|FG001|Overall Study|Withdrawal by Subject|7|||
129699621|NCT00637156|466859840|FG000|Overall Study|Death|0|||
129699622|NCT00637156|466859841|FG001|Overall Study|Death|1|||
129699623|NCT00637156|466859840|FG000|Overall Study|Lost to Follow-up|10|||
129699624|NCT00637156|466859841|FG001|Overall Study|Lost to Follow-up|16|||
129699625|NCT00461812|466859842|FG000|Overall Study|study terminated|10|||
129699626|NCT01308788|466859843|FG000|2-year Treatment|medication change by treating physician|4|||
129699627|NCT01308788|466859844|FG001|2-year Treatment|medication change by treating physician|11|||
129699628|NCT03193437|466859845|FG000|Overall Study|Adverse Event|4|||
129699629|NCT03193437|466859845|FG000|Overall Study|Withdrawal by Subject|2|||
129699630|NCT03193437|466859845|FG000|Overall Study|Disease Progression|2|||
129699631|NCT05487378|466859846|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
129699632|NCT05487378|466859847|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
129699633|NCT05487378|466859846|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
129699634|NCT05487378|466859847|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
129699635|NCT02414841|466859848|FG000|Overall Study|Withdrawal by Subject|7|||
129699636|NCT02414841|466859849|FG001|Overall Study|Withdrawal by Subject|5|||
129699637|NCT02414841|466859848|FG000|Overall Study|Lost to Follow-up|13|||
129699638|NCT02414841|466859849|FG001|Overall Study|Lost to Follow-up|6|||
129699639|NCT02414841|466859848|FG000|Overall Study|Death|17|||
129610711|NCT01755767|466530829|FG000|Overall Study|Radiographic Disease Progression|9|||
129610712|NCT01755767|466530830|FG001|Overall Study|Radiographic Disease Progression|4|||
129610713|NCT01755767|466530831|FG002|Overall Study|Radiographic Disease Progression|44|||
129610714|NCT01755767|466530832|FG003|Overall Study|Radiographic Disease Progression|27|||
129610715|NCT01755767|466530829|FG000|Overall Study|Adverse Event|6|||
129610716|NCT01755767|466530830|FG001|Overall Study|Adverse Event|0|||
129610717|NCT01755767|466530831|FG002|Overall Study|Adverse Event|28|||
129610718|NCT01755767|466530832|FG003|Overall Study|Adverse Event|11|||
129610719|NCT01755767|466530829|FG000|Overall Study|Death|1|||
129699640|NCT02414841|466859849|FG001|Overall Study|Death|14|||
129699641|NCT02414841|466859848|FG000|Overall Study|Received a Kidney Transplant|13|||
129699642|NCT02414841|466859849|FG001|Overall Study|Received a Kidney Transplant|4|||
129699643|NCT02414841|466859848|FG000|Overall Study|Randomized But Not Treated|6|||
129699644|NCT02414841|466859849|FG001|Overall Study|Randomized But Not Treated|4|||
129699645|NCT00964678|466859867|FG000|Overall Study|Physician Decision|4|||
129699646|NCT03359395|466859870|FG000|First Intervention A / B|Withdrawal by Subject|1|||
129699647|NCT03359395|466859871|FG001|First Intervention A / B|Withdrawal by Subject|0|||
129610720|NCT01755767|466530830|FG001|Overall Study|Death|2|||
129610721|NCT01755767|466530831|FG002|Overall Study|Death|15|||
129610722|NCT01755767|466530832|FG003|Overall Study|Death|4|||
129610723|NCT01755767|466530829|FG000|Overall Study|Subject Decision|0|||
129610724|NCT01755767|466530830|FG001|Overall Study|Subject Decision|0|||
129610725|NCT01755767|466530831|FG002|Overall Study|Subject Decision|10|||
129610726|NCT01755767|466530832|FG003|Overall Study|Subject Decision|3|||
129610727|NCT01755767|466530829|FG000|Overall Study|Withdrawal by Subject|0|||
129610728|NCT01755767|466530830|FG001|Overall Study|Withdrawal by Subject|0|||
129610729|NCT01755767|466530831|FG002|Overall Study|Withdrawal by Subject|2|||
129610730|NCT01755767|466530832|FG003|Overall Study|Withdrawal by Subject|1|||
129610731|NCT01755767|466530829|FG000|Overall Study|Other|0|||
129610732|NCT01755767|466530830|FG001|Overall Study|Other|0|||
129610733|NCT01755767|466530831|FG002|Overall Study|Other|2|||
129610734|NCT01755767|466530832|FG003|Overall Study|Other|3|||
129610735|NCT01755767|466530829|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
129610736|NCT01755767|466530830|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
129610737|NCT01755767|466530831|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
129610738|NCT01755767|466530832|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
129610739|NCT03464630|466530833|FG000|Overall Study|Lost to Follow-up|62|||
129610740|NCT03464630|466530834|FG001|Overall Study|Lost to Follow-up|52|||
129610741|NCT03464630|466530833|FG000|Overall Study|Withdrawal by Subject|16|||
129610742|NCT03464630|466530834|FG001|Overall Study|Withdrawal by Subject|10|||
129610743|NCT03464630|466530833|FG000|Overall Study|Passive Disengagement|8|||
129610744|NCT03464630|466530834|FG001|Overall Study|Passive Disengagement|4|||
129610745|NCT00191165|466530835|FG000|Overall Study|Adverse Event|2|||
129610746|NCT00191165|466530836|FG001|Overall Study|Adverse Event|0|||
129610747|NCT00191165|466530835|FG000|Overall Study|Protocol Violation|0|||
129610748|NCT00191165|466530836|FG001|Overall Study|Protocol Violation|1|||
129610749|NCT00191165|466530835|FG000|Overall Study|Participant Moved Away|0|||
129610750|NCT00191165|466530836|FG001|Overall Study|Participant Moved Away|1|||
129610751|NCT03196635|466530837|FG000|Overall Study|Withdrawal by Subject|1|||
129610752|NCT00380744|466530842|FG000|Overall Study|Death|0|||
129610753|NCT00380744|466530843|FG001|Overall Study|Death|0|||
129610754|NCT00380744|466530844|FG002|Overall Study|Death|0|||
129610755|NCT00380744|466530845|FG003|Overall Study|Death|0|||
129610756|NCT00380744|466530846|FG004|Overall Study|Death|0|||
129610757|NCT00380744|466530847|FG005|Overall Study|Death|0|||
129610758|NCT00380744|466530848|FG006|Overall Study|Death|1|||
129610759|NCT00380744|466530842|FG000|Overall Study|Withdrawal by Subject|1|||
129610760|NCT00380744|466530843|FG001|Overall Study|Withdrawal by Subject|0|||
129610761|NCT00380744|466530844|FG002|Overall Study|Withdrawal by Subject|0|||
129610762|NCT00380744|466530845|FG003|Overall Study|Withdrawal by Subject|0|||
129610763|NCT00380744|466530846|FG004|Overall Study|Withdrawal by Subject|0|||
129610764|NCT00380744|466530847|FG005|Overall Study|Withdrawal by Subject|0|||
129610765|NCT00380744|466530848|FG006|Overall Study|Withdrawal by Subject|0|||
129610766|NCT01338870|466530849|FG000|Overall Study|Lost to Follow-up|0|||
129610767|NCT01338870|466530850|FG001|Overall Study|Lost to Follow-up|0|||
129610768|NCT01338870|466530851|FG002|Overall Study|Lost to Follow-up|1|||
129610769|NCT01338870|466530852|FG003|Overall Study|Lost to Follow-up|0|||
129610770|NCT01338870|466530853|FG004|Overall Study|Lost to Follow-up|1|||
129610771|NCT01338870|466530854|FG005|Overall Study|Lost to Follow-up|0|||
129610772|NCT01338870|466530849|FG000|Overall Study|Withdrawal by Subject|2|||
129610773|NCT01338870|466530850|FG001|Overall Study|Withdrawal by Subject|3|||
129610774|NCT01338870|466530851|FG002|Overall Study|Withdrawal by Subject|4|||
129610775|NCT01338870|466530852|FG003|Overall Study|Withdrawal by Subject|0|||
129610776|NCT01338870|466530853|FG004|Overall Study|Withdrawal by Subject|0|||
129610777|NCT01338870|466530854|FG005|Overall Study|Withdrawal by Subject|2|||
129610778|NCT01338870|466530849|FG000|Overall Study|Other|3|||
129610779|NCT01338870|466530850|FG001|Overall Study|Other|3|||
129610780|NCT01338870|466530851|FG002|Overall Study|Other|3|||
129610781|NCT01338870|466530852|FG003|Overall Study|Other|2|||
129610782|NCT01338870|466530853|FG004|Overall Study|Other|0|||
129610783|NCT01338870|466530854|FG005|Overall Study|Other|2|||
129610784|NCT01338870|466530849|FG000|Overall Study|Protocol Violation|0|||
129610785|NCT01338870|466530850|FG001|Overall Study|Protocol Violation|2|||
129610786|NCT01338870|466530851|FG002|Overall Study|Protocol Violation|2|||
129610787|NCT01338870|466530852|FG003|Overall Study|Protocol Violation|2|||
129610788|NCT01338870|466530853|FG004|Overall Study|Protocol Violation|1|||
129610789|NCT01338870|466530854|FG005|Overall Study|Protocol Violation|1|||
129610790|NCT01338870|466530849|FG000|Overall Study|Adverse Event|4|||
129610791|NCT01338870|466530850|FG001|Overall Study|Adverse Event|4|||
129610792|NCT01338870|466530851|FG002|Overall Study|Adverse Event|1|||
129610793|NCT01338870|466530852|FG003|Overall Study|Adverse Event|5|||
129610794|NCT01338870|466530853|FG004|Overall Study|Adverse Event|4|||
129610795|NCT01338870|466530854|FG005|Overall Study|Adverse Event|1|||
129610796|NCT04480021|466530859|FG000|Overall Study|Lost to Follow-up|3|||
129610797|NCT04480021|466530860|FG001|Overall Study|Lost to Follow-up|4|||
129610798|NCT01844505|466530863|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
129610799|NCT01844505|466530864|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
129610800|NCT01844505|466530865|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
129610801|NCT01844505|466530863|FG000|Treatment Period|Other Reasons|120|||
129610802|NCT01844505|466530864|FG001|Treatment Period|Other Reasons|136|||
129610803|NCT01844505|466530865|FG002|Treatment Period|Other Reasons|58|||
129610804|NCT01844505|466530863|FG000|Treatment Period|Lost to Follow-up|9|||
129610805|NCT01844505|466530864|FG001|Treatment Period|Lost to Follow-up|11|||
129610806|NCT01844505|466530865|FG002|Treatment Period|Lost to Follow-up|6|||
129610807|NCT01844505|466530863|FG000|Treatment Period|Death|175|||
129610808|NCT01844505|466530864|FG001|Treatment Period|Death|154|||
129610809|NCT01844505|466530865|FG002|Treatment Period|Death|228|||
129610810|NCT03384654|466530866|FG000|Overall Study|Withdrawal by Subject|0|||
129610811|NCT03384654|466530867|FG001|Overall Study|Withdrawal by Subject|0|||
129610812|NCT03384654|466530868|FG002|Overall Study|Withdrawal by Subject|1|||
129610813|NCT03384654|466530869|FG003|Overall Study|Withdrawal by Subject|0|||
129610814|NCT00423319|466530870|FG000|Overall Study|Death|2|||
129610815|NCT00423319|466530871|FG001|Overall Study|Death|0|||
129610816|NCT00423319|466530870|FG000|Overall Study|Adverse Event|93|||
129610817|NCT00423319|466530871|FG001|Overall Study|Adverse Event|112|||
129610818|NCT00423319|466530870|FG000|Overall Study|Withdrawal by Subject|86|||
129610819|NCT00423319|466530871|FG001|Overall Study|Withdrawal by Subject|99|||
129610820|NCT00423319|466530870|FG000|Overall Study|Lost to Follow-up|4|||
129610821|NCT00423319|466530871|FG001|Overall Study|Lost to Follow-up|3|||
129610822|NCT00423319|466530870|FG000|Overall Study|Poor compliance or noncompliance|1|||
129610823|NCT00423319|466530871|FG001|Overall Study|Poor compliance or noncompliance|1|||
129610824|NCT00423319|466530870|FG000|Overall Study|No longer meets study criteria|15|||
129610825|NCT00423319|466530871|FG001|Overall Study|No longer meets study criteria|15|||
129610826|NCT00423319|466530870|FG000|Overall Study|Other|23|||
129610827|NCT00423319|466530871|FG001|Overall Study|Other|22|||
129610828|NCT01584843|466530872|FG000|First Treatment Period|Adverse Event|0|||
129610829|NCT01584843|466530873|FG001|First Treatment Period|Adverse Event|0|||
129610830|NCT01584843|466530874|FG002|First Treatment Period|Adverse Event|1|||
129610831|NCT01584843|466530875|FG003|First Treatment Period|Adverse Event|0|||
129610832|NCT01584843|466530876|FG004|First Treatment Period|Adverse Event|0|||
129610833|NCT01584843|466530877|FG005|First Treatment Period|Adverse Event|0|||
129610834|NCT01584843|466530872|FG000|First Treatment Period|Protocol Violation|0|||
129610835|NCT01584843|466530873|FG001|First Treatment Period|Protocol Violation|0|||
129610836|NCT01584843|466530874|FG002|First Treatment Period|Protocol Violation|0|||
129610837|NCT01584843|466530875|FG003|First Treatment Period|Protocol Violation|0|||
129610838|NCT01584843|466530876|FG004|First Treatment Period|Protocol Violation|0|||
129610839|NCT01584843|466530877|FG005|First Treatment Period|Protocol Violation|1|||
129610840|NCT01584843|466530872|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129610841|NCT01584843|466530873|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129610842|NCT01584843|466530874|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129610843|NCT01584843|466530875|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129610844|NCT01584843|466530876|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
129610845|NCT01584843|466530877|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
129610846|NCT01584843|466530872|FG000|Second Treatment Period|Withdrawal by Subject|0|||
129610847|NCT01584843|466530873|FG001|Second Treatment Period|Withdrawal by Subject|0|||
129610848|NCT01584843|466530874|FG002|Second Treatment Period|Withdrawal by Subject|0|||
129610849|NCT01584843|466530875|FG003|Second Treatment Period|Withdrawal by Subject|0|||
129610850|NCT01584843|466530876|FG004|Second Treatment Period|Withdrawal by Subject|0|||
129610851|NCT01584843|466530877|FG005|Second Treatment Period|Withdrawal by Subject|1|||
129610852|NCT02036775|466530878|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129610853|NCT02036775|466530879|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129610854|NCT02036775|466530880|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129610855|NCT02036775|466530881|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129610856|NCT02036775|466530882|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
129610857|NCT02036775|466530883|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
129610858|NCT01268501|466530884|FG000|Overall Study|Lost to Follow-up|1|||
129610859|NCT01268501|466530884|FG000|Overall Study|Withdrawal by Subject|3|||
129610860|NCT01268501|466530884|FG000|Overall Study|Unacceptable Subjective Vision|3|||
129610861|NCT01268501|466530884|FG000|Overall Study|Handling Difficulties|2|||
129610862|NCT00678886|466530885|FG000|Overall Study|Withdrawal by Subject|0|||
129610863|NCT00678886|466530886|FG001|Overall Study|Withdrawal by Subject|0|||
129610864|NCT00678886|466530887|FG002|Overall Study|Withdrawal by Subject|4|||
129610865|NCT00678886|466530888|FG003|Overall Study|Withdrawal by Subject|6|||
129610866|NCT00678886|466530885|FG000|Overall Study|Physician Decision|0|||
129610867|NCT00678886|466530886|FG001|Overall Study|Physician Decision|0|||
129610868|NCT00678886|466530887|FG002|Overall Study|Physician Decision|1|||
129699648|NCT03359395|466859870|FG000|First Intervention A / B|Lost to Follow-up|2|||
129699649|NCT03359395|466859871|FG001|First Intervention A / B|Lost to Follow-up|3|||
129610869|NCT00678886|466530888|FG003|Overall Study|Physician Decision|1|||
129610870|NCT00678886|466530885|FG000|Overall Study|Lost to Follow-up|0|||
129610871|NCT00678886|466530886|FG001|Overall Study|Lost to Follow-up|0|||
129610872|NCT00678886|466530887|FG002|Overall Study|Lost to Follow-up|3|||
129610873|NCT00678886|466530888|FG003|Overall Study|Lost to Follow-up|2|||
129610874|NCT00678886|466530885|FG000|Overall Study|Other|0|||
129610875|NCT00678886|466530886|FG001|Overall Study|Other|0|||
129610876|NCT00678886|466530887|FG002|Overall Study|Other|1|||
129610877|NCT00678886|466530888|FG003|Overall Study|Other|0|||
129610878|NCT00206323|466530889|FG000|Overall Study|Lack of Efficacy|4|||
129610879|NCT00206323|466530890|FG001|Overall Study|Lack of Efficacy|1|||
129610880|NCT00206323|466530889|FG000|Overall Study|Adverse Event|1|||
129610881|NCT00206323|466530890|FG001|Overall Study|Adverse Event|1|||
129610882|NCT00206323|466530889|FG000|Overall Study|Lost to Follow-up|1|||
129610883|NCT00206323|466530890|FG001|Overall Study|Lost to Follow-up|1|||
129610884|NCT00827632|466530893|FG000|Overall Study|Lost to Follow-up|8|||
129610885|NCT00827632|466530894|FG001|Overall Study|Lost to Follow-up|12|||
129610886|NCT00827632|466530893|FG000|Overall Study|Early withdrawal|14|||
129610887|NCT00827632|466530894|FG001|Overall Study|Early withdrawal|11|||
129610888|NCT01910389|466530897|FG000|Overall Study|Withdrawal by Subject|2|||
129610889|NCT01910389|466530898|FG001|Overall Study|Withdrawal by Subject|0|||
129610890|NCT01910389|466530897|FG000|Overall Study|Study Closed|13|||
129610891|NCT01910389|466530898|FG001|Overall Study|Study Closed|8|||
129610892|NCT04669691|466530902|FG000|Overall Study|Death|0|||
129610893|NCT04669691|466530903|FG001|Overall Study|Death|1|||
129610894|NCT04669691|466530904|FG002|Overall Study|Death|0|||
129610895|NCT04669691|466530905|FG003|Overall Study|Death|0|||
129610896|NCT04669691|466530906|FG004|Overall Study|Death|0|||
129610897|NCT04669691|466530907|FG005|Overall Study|Death|0|||
129610898|NCT02304458|466530908|FG000|Overall Study|Adverse Event|0|||
129610899|NCT02304458|466530909|FG001|Overall Study|Adverse Event|0|||
129610900|NCT02304458|466530910|FG002|Overall Study|Adverse Event|7|||
129610901|NCT02304458|466530911|FG003|Overall Study|Adverse Event|0|||
129610902|NCT02304458|466530912|FG004|Overall Study|Adverse Event|0|||
129610903|NCT02304458|466530913|FG005|Overall Study|Adverse Event|0|||
129610904|NCT02304458|466530914|FG006|Overall Study|Adverse Event|3|||
129610905|NCT02304458|466530915|FG007|Overall Study|Adverse Event|4|||
129610906|NCT02304458|466530908|FG000|Overall Study|Death|0|||
129610907|NCT02304458|466530909|FG001|Overall Study|Death|0|||
129610908|NCT02304458|466530910|FG002|Overall Study|Death|2|||
129610909|NCT02304458|466530911|FG003|Overall Study|Death|0|||
129610910|NCT02304458|466530912|FG004|Overall Study|Death|0|||
129610911|NCT02304458|466530913|FG005|Overall Study|Death|0|||
129610912|NCT02304458|466530914|FG006|Overall Study|Death|1|||
129610913|NCT02304458|466530915|FG007|Overall Study|Death|0|||
129610914|NCT02304458|466530908|FG000|Overall Study|Lack of Efficacy|4|||
129610915|NCT02304458|466530909|FG001|Overall Study|Lack of Efficacy|6|||
129610916|NCT02304458|466530910|FG002|Overall Study|Lack of Efficacy|38|||
129610917|NCT02304458|466530911|FG003|Overall Study|Lack of Efficacy|5|||
129610918|NCT02304458|466530912|FG004|Overall Study|Lack of Efficacy|6|||
129610919|NCT02304458|466530913|FG005|Overall Study|Lack of Efficacy|6|||
129610920|NCT02304458|466530914|FG006|Overall Study|Lack of Efficacy|21|||
129610921|NCT02304458|466530915|FG007|Overall Study|Lack of Efficacy|4|||
129610922|NCT02304458|466530908|FG000|Overall Study|Physician Decision|2|||
129610923|NCT02304458|466530909|FG001|Overall Study|Physician Decision|0|||
129610924|NCT02304458|466530910|FG002|Overall Study|Physician Decision|16|||
129610925|NCT02304458|466530911|FG003|Overall Study|Physician Decision|1|||
129610926|NCT02304458|466530912|FG004|Overall Study|Physician Decision|0|||
129610927|NCT02304458|466530913|FG005|Overall Study|Physician Decision|0|||
129610928|NCT02304458|466530914|FG006|Overall Study|Physician Decision|3|||
129610929|NCT02304458|466530915|FG007|Overall Study|Physician Decision|0|||
129610930|NCT02304458|466530908|FG000|Overall Study|Protocol Violation|0|||
129699650|NCT03359395|466859870|FG000|Second Intervention B/A|Exclusion criteria|0|||
129610931|NCT02304458|466530909|FG001|Overall Study|Protocol Violation|0|||
129610932|NCT02304458|466530910|FG002|Overall Study|Protocol Violation|1|||
129610933|NCT02304458|466530911|FG003|Overall Study|Protocol Violation|0|||
129610934|NCT02304458|466530912|FG004|Overall Study|Protocol Violation|0|||
129610935|NCT02304458|466530913|FG005|Overall Study|Protocol Violation|0|||
129610936|NCT02304458|466530914|FG006|Overall Study|Protocol Violation|0|||
129610937|NCT02304458|466530915|FG007|Overall Study|Protocol Violation|0|||
129610938|NCT02304458|466530908|FG000|Overall Study|Withdrawal by Subject|1|||
129610939|NCT02304458|466530909|FG001|Overall Study|Withdrawal by Subject|0|||
129610940|NCT02304458|466530910|FG002|Overall Study|Withdrawal by Subject|7|||
129610941|NCT02304458|466530911|FG003|Overall Study|Withdrawal by Subject|0|||
129610942|NCT02304458|466530912|FG004|Overall Study|Withdrawal by Subject|0|||
129610943|NCT02304458|466530913|FG005|Overall Study|Withdrawal by Subject|0|||
129610944|NCT02304458|466530914|FG006|Overall Study|Withdrawal by Subject|1|||
129610945|NCT02304458|466530915|FG007|Overall Study|Withdrawal by Subject|0|||
129610946|NCT03401450|466530916|FG000|Overall Study|Lost to Follow-up|4|||
129610947|NCT03401450|466530917|FG001|Overall Study|Lost to Follow-up|6|||
129610948|NCT03401450|466530916|FG000|Overall Study|Anesthesia plan changed|2|||
129610949|NCT03401450|466530917|FG001|Overall Study|Anesthesia plan changed|2|||
129699651|NCT03359395|466859871|FG001|Second Intervention B/A|Exclusion criteria|1|||
129699652|NCT03359395|466859870|FG000|Second Intervention B/A|Lost to Follow-up|3|||
129699653|NCT03359395|466859871|FG001|Second Intervention B/A|Lost to Follow-up|2|||
129699654|NCT03164356|466859872|FG000|Overall Study|Lost to Follow-up|1|||
129699655|NCT03164356|466859873|FG001|Overall Study|Lost to Follow-up|1|||
129699656|NCT03164356|466859874|FG002|Overall Study|Lost to Follow-up|2|||
129699657|NCT03164356|466859875|FG003|Overall Study|Lost to Follow-up|1|||
129699658|NCT03164356|466859872|FG000|Overall Study|Physician Decision|0|||
129699659|NCT03164356|466859873|FG001|Overall Study|Physician Decision|0|||
129699660|NCT03164356|466859874|FG002|Overall Study|Physician Decision|3|||
129699661|NCT03164356|466859875|FG003|Overall Study|Physician Decision|0|||
129699662|NCT03164356|466859872|FG000|Overall Study|Protocol Violation|2|||
129699663|NCT03164356|466859873|FG001|Overall Study|Protocol Violation|1|||
129699664|NCT03164356|466859874|FG002|Overall Study|Protocol Violation|0|||
129699665|NCT03164356|466859875|FG003|Overall Study|Protocol Violation|0|||
129699666|NCT03164356|466859872|FG000|Overall Study|Withdrawal by Subject|1|||
129699667|NCT03164356|466859873|FG001|Overall Study|Withdrawal by Subject|0|||
129699668|NCT03164356|466859874|FG002|Overall Study|Withdrawal by Subject|0|||
129699669|NCT03164356|466859875|FG003|Overall Study|Withdrawal by Subject|0|||
129699670|NCT03164356|466859872|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
129699671|NCT03164356|466859873|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
129699672|NCT03164356|466859874|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
129699673|NCT03164356|466859875|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
129699674|NCT03164356|466859872|FG000|Overall Study|Subject Incarcerated|0|||
129699675|NCT03164356|466859873|FG001|Overall Study|Subject Incarcerated|1|||
129699676|NCT03164356|466859874|FG002|Overall Study|Subject Incarcerated|0|||
129699677|NCT03164356|466859875|FG003|Overall Study|Subject Incarcerated|0|||
129699678|NCT03164356|466859872|FG000|Overall Study|Prosthetist unable to participate|0|||
129699679|NCT03164356|466859873|FG001|Overall Study|Prosthetist unable to participate|2|||
129699680|NCT03164356|466859874|FG002|Overall Study|Prosthetist unable to participate|1|||
129699681|NCT03164356|466859875|FG003|Overall Study|Prosthetist unable to participate|0|||
129699682|NCT05943990|466859878|FG000|Overall Study|Study Terminated by Sponsor|0|||
129699683|NCT05943990|466859879|FG001|Overall Study|Study Terminated by Sponsor|0|||
129610950|NCT03401450|466530916|FG000|Overall Study|Did not complete medication diary|4|||
129610951|NCT03401450|466530917|FG001|Overall Study|Did not complete medication diary|2|||
129610952|NCT03401450|466530916|FG000|Overall Study|post surgery medication change|2|||
129610953|NCT03401450|466530917|FG001|Overall Study|post surgery medication change|1|||
129610954|NCT03401450|466530916|FG000|Overall Study|Cancelled surgery|0|||
129610955|NCT03401450|466530917|FG001|Overall Study|Cancelled surgery|2|||
129610956|NCT03155945|466530918|FG000|Overall Study|Lost to Follow-up|0|||
129610957|NCT03155945|466530919|FG001|Overall Study|Lost to Follow-up|1|||
129610958|NCT03155945|466530918|FG000|Overall Study|Withdrawal by Subject|0|||
129610959|NCT03155945|466530919|FG001|Overall Study|Withdrawal by Subject|1|||
129610960|NCT03155945|466530918|FG000|Overall Study|Other Reason|0|||
129610961|NCT03155945|466530919|FG001|Overall Study|Other Reason|1|||
129610962|NCT03395405|466532452|FG000|Overall Study|Death|0|||
129610963|NCT03395405|466532453|FG001|Overall Study|Death|2|||
129699684|NCT05943990|466859880|FG002|Overall Study|Study Terminated by Sponsor|1|||
129699685|NCT02657356|466860715|FG000|Overall Study|Death|1|||
129699686|NCT02657356|466860716|FG001|Overall Study|Death|0|||
129699687|NCT02657356|466860715|FG000|Overall Study|Withdrawal by Subject|5|||
129699688|NCT02657356|466860716|FG001|Overall Study|Withdrawal by Subject|6|||
129699689|NCT02657356|466860715|FG000|Overall Study|Terminated by Sponsor|8|||
129699690|NCT02657356|466860716|FG001|Overall Study|Terminated by Sponsor|5|||
129699691|NCT02657356|466860715|FG000|Overall Study|Rolled over to EAP study|6|||
129699692|NCT02657356|466860716|FG001|Overall Study|Rolled over to EAP study|4|||
129699693|NCT03443401|466860723|FG000|Overall Study|Lost to Follow-up|13|||
129699694|NCT03443401|466860723|FG000|Overall Study|Influential outlier|1|||
129699695|NCT00980044|466860724|FG000|Overall Study|Withdrawal by Subject|5|||
129699696|NCT00980044|466860725|FG001|Overall Study|Withdrawal by Subject|7|||
129699697|NCT00980044|466860726|FG002|Overall Study|Withdrawal by Subject|3|||
129699698|NCT00980044|466860724|FG000|Overall Study|Protocol Violation|0|||
129699699|NCT00980044|466860725|FG001|Overall Study|Protocol Violation|0|||
129699700|NCT00980044|466860726|FG002|Overall Study|Protocol Violation|2|||
129699701|NCT02904265|466860727|FG000|Overall Study|Physician Decision|1|||
129699702|NCT02904265|466860728|FG001|Overall Study|Physician Decision|2|||
129699703|NCT00833703|466860730|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
129699704|NCT00833703|466860731|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
129610964|NCT03395405|466532452|FG000|Overall Study|Lost to Follow-up|0|||
129610965|NCT03395405|466532453|FG001|Overall Study|Lost to Follow-up|1|||
129610966|NCT03395405|466532452|FG000|Overall Study|Protocol Violation|0|||
129610967|NCT03395405|466532453|FG001|Overall Study|Protocol Violation|1|||
129699705|NCT05538728|466860732|FG000|Overall Study|Withdrawal by Subject|1|||
129610968|NCT03395405|466532452|FG000|Overall Study|Withdrawal by Subject|3|||
129610969|NCT03395405|466532453|FG001|Overall Study|Withdrawal by Subject|1|||
129610970|NCT03395405|466532452|FG000|Overall Study|COVID-19 Pandemic|1|||
129610971|NCT03395405|466532453|FG001|Overall Study|COVID-19 Pandemic|0|||
129610972|NCT04345601|466532454|FG000|Overall Study|Death|0|||
129610973|NCT04345601|466532455|FG001|Overall Study|Death|3|||
129610974|NCT04345601|466532456|FG002|Overall Study|Death|2|||
129610975|NCT04345601|466532454|FG000|Overall Study|Lost to Follow-up|0|||
129610976|NCT04345601|466532455|FG001|Overall Study|Lost to Follow-up|0|||
129610977|NCT04345601|466532456|FG002|Overall Study|Lost to Follow-up|2|||
129610978|NCT00000378|466532457|FG000|Overall Study|Lack of Efficacy|16|||
129610979|NCT00000378|466532458|FG001|Overall Study|Lack of Efficacy|14|||
129610980|NCT02585934|466532463|FG000|Overall Study|Lost to Follow-up|2|||
129610981|NCT02585934|466532464|FG001|Overall Study|Lost to Follow-up|2|||
129610982|NCT02585934|466532463|FG000|Overall Study|Protocol Violation|14|||
129610983|NCT02585934|466532464|FG001|Overall Study|Protocol Violation|11|||
129610984|NCT02585934|466532463|FG000|Overall Study|Adverse Event|21|||
129610985|NCT02585934|466532464|FG001|Overall Study|Adverse Event|22|||
129610986|NCT02585934|466532463|FG000|Overall Study|Physician Decision|3|||
129610987|NCT02585934|466532464|FG001|Overall Study|Physician Decision|2|||
129610988|NCT02585934|466532463|FG000|Overall Study|Withdrawal by Subject|7|||
129610989|NCT02585934|466532464|FG001|Overall Study|Withdrawal by Subject|21|||
129610990|NCT02585934|466532463|FG000|Overall Study|Lack of Efficacy|2|||
129610991|NCT02585934|466532464|FG001|Overall Study|Lack of Efficacy|1|||
129610992|NCT02585934|466532463|FG000|Overall Study|Death|2|||
129610993|NCT02585934|466532464|FG001|Overall Study|Death|0|||
129610994|NCT02585934|466532463|FG000|Overall Study|Caregiver Withdrew Consent|7|||
129610995|NCT02585934|466532464|FG001|Overall Study|Caregiver Withdrew Consent|7|||
129610996|NCT02585934|466532463|FG000|Overall Study|Sponsor Termination|1|||
129610997|NCT02585934|466532464|FG001|Overall Study|Sponsor Termination|2|||
129610998|NCT02585934|466532463|FG000|Overall Study|Another Reason|10|||
129610999|NCT02585934|466532464|FG001|Overall Study|Another Reason|5|||
129611000|NCT02448706|466532465|FG000|Overall Study|Withdrawal by Subject|4|||
129611001|NCT02448706|466532466|FG001|Overall Study|Withdrawal by Subject|3|||
129611002|NCT02448706|466532465|FG000|Overall Study|Protocol Violation|1|||
129611003|NCT02448706|466532466|FG001|Overall Study|Protocol Violation|1|||
129611004|NCT01359969|466532467|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
129611005|NCT00470067|466532475|FG000|Overall Study|Death|1|||
129611006|NCT00470067|466532475|FG000|Overall Study|Disease Progression|6|||
129611007|NCT03400943|466532476|FG000|Treatment Period 1|Adverse Event|0|||
129611008|NCT03400943|466532477|FG001|Treatment Period 1|Adverse Event|0|||
129611009|NCT03400943|466532478|FG002|Treatment Period 1|Adverse Event|0|||
129611010|NCT03400943|466532479|FG003|Treatment Period 1|Adverse Event|1|||
129611011|NCT03400943|466532476|FG000|Treatment Period 1|Lost to Follow-up|1|||
129611012|NCT03400943|466532477|FG001|Treatment Period 1|Lost to Follow-up|0|||
129611013|NCT03400943|466532478|FG002|Treatment Period 1|Lost to Follow-up|0|||
129611014|NCT03400943|466532479|FG003|Treatment Period 1|Lost to Follow-up|0|||
129611015|NCT03400943|466532476|FG000|Treatment Period 1|Protocol Violation|0|||
129611016|NCT03400943|466532477|FG001|Treatment Period 1|Protocol Violation|1|||
129611017|NCT03400943|466532478|FG002|Treatment Period 1|Protocol Violation|1|||
129611018|NCT03400943|466532479|FG003|Treatment Period 1|Protocol Violation|0|||
129611019|NCT03400943|466532476|FG000|Treatment Period 1|Study terminated by sponsor|2|||
129611020|NCT03400943|466532477|FG001|Treatment Period 1|Study terminated by sponsor|0|||
129611021|NCT03400943|466532478|FG002|Treatment Period 1|Study terminated by sponsor|0|||
129611022|NCT03400943|466532479|FG003|Treatment Period 1|Study terminated by sponsor|1|||
129611023|NCT03400943|466532476|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129611024|NCT03400943|466532477|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129611025|NCT03400943|466532478|FG002|Treatment Period 1|Withdrawal by Subject|3|||
129611026|NCT03400943|466532479|FG003|Treatment Period 1|Withdrawal by Subject|1|||
129611027|NCT03400943|466532476|FG000|Treatment Period 1|Other|2|||
129611028|NCT03400943|466532477|FG001|Treatment Period 1|Other|1|||
129611029|NCT03400943|466532478|FG002|Treatment Period 1|Other|2|||
129611030|NCT03400943|466532479|FG003|Treatment Period 1|Other|2|||
129611031|NCT03400943|466532476|FG000|Post-treatment Period 1|Adverse Event|2|||
129611032|NCT03400943|466532477|FG001|Post-treatment Period 1|Adverse Event|0|||
129611033|NCT03400943|466532478|FG002|Post-treatment Period 1|Adverse Event|0|||
129611034|NCT03400943|466532479|FG003|Post-treatment Period 1|Adverse Event|0|||
129611035|NCT03400943|466532476|FG000|Post-treatment Period 1|Protocol Violation|1|||
129611036|NCT03400943|466532477|FG001|Post-treatment Period 1|Protocol Violation|0|||
129611037|NCT03400943|466532478|FG002|Post-treatment Period 1|Protocol Violation|0|||
129611038|NCT03400943|466532479|FG003|Post-treatment Period 1|Protocol Violation|0|||
129611039|NCT03400943|466532476|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
129611040|NCT03400943|466532477|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
129611041|NCT03400943|466532478|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
129611042|NCT03400943|466532479|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
129611043|NCT03400943|466532476|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
129611044|NCT03400943|466532477|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
129611045|NCT03400943|466532478|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
129611046|NCT03400943|466532479|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
129611047|NCT03400943|466532476|FG000|Post-treatment Period 1|Other|2|||
129611048|NCT03400943|466532477|FG001|Post-treatment Period 1|Other|0|||
129611049|NCT03400943|466532478|FG002|Post-treatment Period 1|Other|4|||
129611050|NCT03400943|466532479|FG003|Post-treatment Period 1|Other|5|||
129611051|NCT03400943|466532476|FG000|Treatment Period 2|Study terminated by sponsor|0|||
129611052|NCT03400943|466532477|FG001|Treatment Period 2|Study terminated by sponsor|1|||
129611053|NCT03400943|466532478|FG002|Treatment Period 2|Study terminated by sponsor|0|||
129611054|NCT03400943|466532479|FG003|Treatment Period 2|Study terminated by sponsor|0|||
129611055|NCT03400943|466532476|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129611056|NCT03400943|466532477|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129611057|NCT03400943|466532478|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129611058|NCT03400943|466532479|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129611059|NCT03400943|466532476|FG000|Treatment Period 2|Other|1|||
129611060|NCT03400943|466532477|FG001|Treatment Period 2|Other|6|||
129611061|NCT03400943|466532478|FG002|Treatment Period 2|Other|0|||
129611062|NCT03400943|466532479|FG003|Treatment Period 2|Other|0|||
129611063|NCT03400943|466532476|FG000|Follow-up Period|Withdrawal by Subject|1|||
129611064|NCT03400943|466532477|FG001|Follow-up Period|Withdrawal by Subject|0|||
129611065|NCT03400943|466532478|FG002|Follow-up Period|Withdrawal by Subject|0|||
129611066|NCT03400943|466532479|FG003|Follow-up Period|Withdrawal by Subject|0|||
129611067|NCT02563106|466532480|FG000|Overall Study|Withdrawal by Subject|7|||
129611068|NCT02563106|466532481|FG001|Overall Study|Withdrawal by Subject|8|||
129611069|NCT02563106|466532480|FG000|Overall Study|Adverse Event|17|||
129611070|NCT02563106|466532481|FG001|Overall Study|Adverse Event|15|||
129611071|NCT02563106|466532480|FG000|Overall Study|Protocol Violation|1|||
129611072|NCT02563106|466532481|FG001|Overall Study|Protocol Violation|0|||
129611073|NCT02563106|466532480|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
129611074|NCT02563106|466532481|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
129611075|NCT02563106|466532480|FG000|Overall Study|Lost to Follow-up|3|||
129611076|NCT02563106|466532481|FG001|Overall Study|Lost to Follow-up|2|||
129611077|NCT02563106|466532480|FG000|Overall Study|Physician Decision|3|||
129611078|NCT02563106|466532481|FG001|Overall Study|Physician Decision|1|||
129611079|NCT02563106|466532480|FG000|Overall Study|Other reason - not specified|2|||
129611080|NCT02563106|466532481|FG001|Overall Study|Other reason - not specified|1|||
129611081|NCT01059539|466532482|FG000|Overall Study|Adverse Event|66|||
129611082|NCT01059539|466532482|FG000|Overall Study|Insufficient Therapeutic Response|26|||
129611083|NCT01059539|466532482|FG000|Overall Study|Protocol Violation|55|||
129611084|NCT01059539|466532482|FG000|Overall Study|Withdrawal of Consent|80|||
129611085|NCT01059539|466532482|FG000|Overall Study|Lost to Follow-up|42|||
129611086|NCT01059539|466532482|FG000|Overall Study|Reason Not Specified|2|||
129611087|NCT04091659|466532483|FG000|Overall Study|Protocol Violation|3|||
129611088|NCT04091659|466532484|FG001|Overall Study|Protocol Violation|0|||
129611089|NCT04091659|466532483|FG000|Overall Study|Lost to Follow-up|0|||
129611090|NCT04091659|466532484|FG001|Overall Study|Lost to Follow-up|1|||
129611091|NCT03678285|466532489|FG000|Overall Study|Adverse Event|2|||
129611092|NCT03678285|466532489|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
129611093|NCT03678285|466532489|FG000|Overall Study|Dehydrated prior to start of workout|1|||
129611094|NCT00616629|466532490|FG000|Overall Study|Protocol Violation|1|||
129611095|NCT00616629|466532491|FG001|Overall Study|Protocol Violation|2|||
129611096|NCT00616629|466532492|FG002|Overall Study|Protocol Violation|1|||
129611097|NCT00616629|466532493|FG003|Overall Study|Protocol Violation|0|||
129611098|NCT00616629|466532494|FG004|Overall Study|Protocol Violation|0|||
129611099|NCT00616629|466532490|FG000|Overall Study|AV-block|1|||
129611100|NCT00616629|466532491|FG001|Overall Study|AV-block|0|||
129611101|NCT00616629|466532492|FG002|Overall Study|AV-block|0|||
129611102|NCT00616629|466532493|FG003|Overall Study|AV-block|0|||
129611103|NCT00616629|466532494|FG004|Overall Study|AV-block|0|||
129611104|NCT01777620|466532495|FG000|Overall Study|Subject Withdrawal|1|||
129611105|NCT01777620|466532496|FG001|Overall Study|Subject Withdrawal|0|||
129611106|NCT04005352|466532498|FG000|Overall Study|Adverse Event|4|||
129611107|NCT04005352|466532499|FG001|Overall Study|Adverse Event|5|||
129611108|NCT04005352|466532498|FG000|Overall Study|Death|4|||
129611109|NCT04005352|466532499|FG001|Overall Study|Death|2|||
129611110|NCT04005352|466532498|FG000|Overall Study|Lost to Follow-up|6|||
129611111|NCT04005352|466532499|FG001|Overall Study|Lost to Follow-up|2|||
129611112|NCT04005352|466532498|FG000|Overall Study|Physician Decision|7|||
129790823|NCT02142387|467201420|FG001|Overall Study|occurred not at home|2474|||
129790824|NCT05028361|467201421|FG000|Overall Study|Withdrawal by Subject|1|||
129611113|NCT04005352|466532499|FG001|Overall Study|Physician Decision|13|||
129611114|NCT04005352|466532498|FG000|Overall Study|Protocol Violation|0|||
129611115|NCT04005352|466532499|FG001|Overall Study|Protocol Violation|1|||
129611116|NCT04005352|466532498|FG000|Overall Study|Withdrawal by Subject|28|||
129611117|NCT04005352|466532499|FG001|Overall Study|Withdrawal by Subject|38|||
129611118|NCT00936897|466532502|FG000|Overall Study|Withdrawal by Subject|9|||
129611119|NCT00936897|466532503|FG001|Overall Study|Withdrawal by Subject|19|||
129611120|NCT00936897|466532502|FG000|Overall Study|Adverse Event|4|||
129611121|NCT00936897|466532503|FG001|Overall Study|Adverse Event|13|||
129611122|NCT00936897|466532502|FG000|Overall Study|Other|3|||
129699706|NCT05538728|466860733|FG001|Overall Study|Withdrawal by Subject|1|||
129699707|NCT02254460|466860734|FG000|Overall Study|Adverse Event|1|||
129699708|NCT02254460|466860735|FG001|Overall Study|Adverse Event|0|||
129699709|NCT01904279|466860738|FG000|Overall Study|Lack of Efficacy|2|||
129699710|NCT01904279|466860739|FG001|Overall Study|Lack of Efficacy|3|||
129699711|NCT01904279|466860738|FG000|Overall Study|Withdrawal by Subject|1|||
129699712|NCT01904279|466860739|FG001|Overall Study|Withdrawal by Subject|0|||
129699713|NCT01356940|466860742|FG000|First Intervention (28 Days)|Adverse Event|1|||
129699714|NCT01356940|466860743|FG001|First Intervention (28 Days)|Adverse Event|0|||
129699715|NCT01356940|466860742|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
129699716|NCT01356940|466860743|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
129699717|NCT00095576|466860746|FG000|Overall Study|Adverse Event|5|||
129699718|NCT00095576|466860747|FG001|Overall Study|Adverse Event|3|||
129699719|NCT00095576|466860746|FG000|Overall Study|Lost to Follow-up|233|||
129699720|NCT00095576|466860747|FG001|Overall Study|Lost to Follow-up|229|||
129699721|NCT00095576|466860746|FG000|Overall Study|Protocol Violation|1|||
129699722|NCT00095576|466860747|FG001|Overall Study|Protocol Violation|0|||
129699723|NCT00095576|466860746|FG000|Overall Study|Withdrawal by Subject|34|||
129699724|NCT00095576|466860747|FG001|Overall Study|Withdrawal by Subject|47|||
129699725|NCT00095576|466860746|FG000|Overall Study|Option to switch to a rollover study|1097|||
129699726|NCT00095576|466860747|FG001|Overall Study|Option to switch to a rollover study|1099|||
129699727|NCT00095576|466860746|FG000|Overall Study|Site terminated|75|||
129699728|NCT00095576|466860747|FG001|Overall Study|Site terminated|67|||
129699729|NCT00095576|466860746|FG000|Overall Study|Subject moved|30|||
129699730|NCT00095576|466860747|FG001|Overall Study|Subject moved|36|||
129699731|NCT01344356|466860748|FG000|Overall Study|Physician Decision|0|||
129699732|NCT01344356|466860749|FG001|Overall Study|Physician Decision|3|||
129699733|NCT01344356|466860748|FG000|Overall Study|Lost to Follow-up|0|||
129699734|NCT01344356|466860749|FG001|Overall Study|Lost to Follow-up|6|||
129699735|NCT00505687|466860750|FG000|Overall Study|Important protocol violation|2|||
129699736|NCT00505687|466860750|FG000|Overall Study|Lack of Efficacy|15|||
129699737|NCT00505687|466860750|FG000|Overall Study|Adverse Event|48|||
129699738|NCT00505687|466860750|FG000|Overall Study|Subject withdrew consent|15|||
129699739|NCT00505687|466860750|FG000|Overall Study|Lost to Follow-up|1|||
129699740|NCT00505687|466860750|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
129699741|NCT00505687|466860750|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
129699742|NCT00505687|466860750|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
129699743|NCT00505687|466860750|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
129699744|NCT00505687|466860750|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
129699745|NCT00505687|466860750|FG000|Overall Study|Other: Disease Progression|1|||
129699746|NCT00505687|466860750|FG000|Overall Study|Other: As Per Sponsor|8|||
129699747|NCT00480532|466860751|FG000|Overall Study|Withdrawal by Subject|2|||
129699748|NCT00480532|466860752|FG001|Overall Study|Withdrawal by Subject|4|||
129699749|NCT00480532|466860753|FG002|Overall Study|Withdrawal by Subject|3|||
129699750|NCT00480532|466860754|FG003|Overall Study|Withdrawal by Subject|1|||
129699751|NCT00480532|466860751|FG000|Overall Study|Protocol Violation|0|||
129699752|NCT00480532|466860752|FG001|Overall Study|Protocol Violation|0|||
129699753|NCT00480532|466860753|FG002|Overall Study|Protocol Violation|1|||
129699754|NCT00480532|466860754|FG003|Overall Study|Protocol Violation|0|||
129699755|NCT01817777|466860755|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
129699756|NCT01817777|466860756|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
129699757|NCT01817777|466860757|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
129699758|NCT01817777|466860755|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
129699759|NCT01817777|466860756|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
129699760|NCT01817777|466860757|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
129699761|NCT01817777|466860755|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
129699762|NCT01817777|466860756|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
129699763|NCT01817777|466860757|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
129699764|NCT01817777|466860755|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
129699765|NCT01817777|466860756|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
129699766|NCT01817777|466860757|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
129699767|NCT01817777|466860755|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
129699768|NCT01817777|466860756|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
129699769|NCT01817777|466860757|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
129699770|NCT00443456|466860758|FG000|Overall Study|Adverse Event|16|||
129699771|NCT00443456|466860758|FG000|Overall Study|Move|1|||
129699772|NCT00443456|466860758|FG000|Overall Study|Withdrawal by Subject|1|||
129699773|NCT00557440|466860759|FG000|Treatment Period 1|Adverse Event|0|||
129699774|NCT00557440|466860760|FG001|Treatment Period 1|Adverse Event|0|||
129699775|NCT00557440|466860761|FG002|Treatment Period 1|Adverse Event|1|||
129699776|NCT03524157|466860762|FG000|Overall Study|cytology not readable|0|||
129699777|NCT03524157|466860763|FG001|Overall Study|cytology not readable|0|||
129699778|NCT03524157|466860764|FG002|Overall Study|cytology not readable|1|||
129699779|NCT02157610|466860765|FG000|Overall Study|Death|4|||
129699780|NCT02157610|466860766|FG001|Overall Study|Death|4|||
129699781|NCT01378195|466860767|FG000|Overall Study|Lost to Follow-up|29|||
129699782|NCT01378195|466860768|FG001|Overall Study|Lost to Follow-up|18|||
129699783|NCT00425555|466860769|FG000|Overall Study|Withdrawal by Subject|11|||
129699784|NCT00425555|466860770|FG001|Overall Study|Withdrawal by Subject|8|||
129699785|NCT00425555|466860769|FG000|Overall Study|Lost to Follow-up|0|||
129699786|NCT00425555|466860770|FG001|Overall Study|Lost to Follow-up|1|||
129699787|NCT00425555|466860769|FG000|Overall Study|Administrative problems|3|||
129699788|NCT00425555|466860770|FG001|Overall Study|Administrative problems|0|||
129699789|NCT00425555|466860769|FG000|Overall Study|Death|1|||
129699790|NCT00425555|466860770|FG001|Overall Study|Death|2|||
129699791|NCT00425555|466860769|FG000|Overall Study|New cancer therapy|2|||
129699792|NCT00425555|466860770|FG001|Overall Study|New cancer therapy|1|||
129699793|NCT00425555|466860769|FG000|Overall Study|Disease progression|36|||
129699794|NCT00425555|466860770|FG001|Overall Study|Disease progression|33|||
129699795|NCT00425555|466860769|FG000|Overall Study|Adverse Event|25|||
129699796|NCT00425555|466860770|FG001|Overall Study|Adverse Event|15|||
129699797|NCT00425555|466860769|FG000|Overall Study|Protocol Violation|1|||
129699798|NCT00425555|466860770|FG001|Overall Study|Protocol Violation|0|||
129699799|NCT05418426|466860771|FG000|Overall Study|Adverse Event|0|||
129699800|NCT05418426|466860772|FG001|Overall Study|Adverse Event|1|||
129699801|NCT05418426|466860773|FG002|Overall Study|Adverse Event|0|||
129699802|NCT05418426|466860771|FG000|Overall Study|Withdrawal by Subject|0|||
129699803|NCT05418426|466860772|FG001|Overall Study|Withdrawal by Subject|1|||
129699804|NCT05418426|466860773|FG002|Overall Study|Withdrawal by Subject|0|||
129699805|NCT05418426|466860771|FG000|Overall Study|Protocol Violation|0|||
129699806|NCT05418426|466860772|FG001|Overall Study|Protocol Violation|0|||
129699807|NCT05418426|466860773|FG002|Overall Study|Protocol Violation|1|||
129699808|NCT01674062|466860774|FG000|Overall Study|Insufficient Therapeutic Response|56|||
129699809|NCT01674062|466860775|FG001|Overall Study|Insufficient Therapeutic Response|26|||
129699810|NCT01674062|466860774|FG000|Overall Study|Other|8|||
129699811|NCT01674062|466860775|FG001|Overall Study|Other|1|||
129699812|NCT01674062|466860774|FG000|Overall Study|Adverse Event|1|||
129699813|NCT01674062|466860775|FG001|Overall Study|Adverse Event|1|||
129699814|NCT01674062|466860774|FG000|Overall Study|Death|0|||
129699815|NCT01674062|466860775|FG001|Overall Study|Death|1|||
129699816|NCT01674062|466860774|FG000|Overall Study|Programming Error|1|||
129699817|NCT01674062|466860775|FG001|Overall Study|Programming Error|0|||
129699818|NCT04620668|466860776|FG000|Overall Study|Withdrawal by Subject|2|||
129699819|NCT04620668|466860777|FG001|Overall Study|Withdrawal by Subject|0|||
129699820|NCT04620668|466860776|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
129699821|NCT04620668|466860777|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
129699822|NCT04620668|466860776|FG000|Overall Study|Removed before analysis: missing data|2|||
129699823|NCT04620668|466860777|FG001|Overall Study|Removed before analysis: missing data|0|||
129699824|NCT04620668|466860776|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
129699825|NCT04620668|466860777|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
129699826|NCT04620668|466860776|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
129699827|NCT04620668|466860777|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
129699828|NCT02796651|466860785|FG000|Overall Study|Adverse Event|6|||
129699829|NCT02796651|466860785|FG000|Overall Study|Lost to Follow-up|1|||
129699830|NCT02796651|466860785|FG000|Overall Study|Withdrawal by Subject|4|||
129699831|NCT02796651|466860785|FG000|Overall Study|Protocol Violation|4|||
129699832|NCT02796651|466860785|FG000|Overall Study|Lack of Efficacy|1|||
129699833|NCT02796651|466860785|FG000|Overall Study|Other|10|||
129699834|NCT05014919|466860786|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
129699835|NCT05014919|466860787|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
129790825|NCT05028361|467201422|FG001|Overall Study|Withdrawal by Subject|0|||
129790826|NCT00779259|467201425|FG000|Quinine Alone|Adverse Event|2|||
129790827|NCT02047318|467201429|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
129790828|NCT02047318|467201429|FG000|Core Study Period|Adverse Event|1|||
129699836|NCT05014919|466860788|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
129699837|NCT05014919|466860786|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
129699838|NCT05014919|466860787|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
129699839|NCT05014919|466860788|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
129699840|NCT05014919|466860786|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
129699841|NCT05014919|466860787|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
129790829|NCT02047318|467201429|FG000|Core Study Period|Withdrawal by caregiver|3|||
129790830|NCT02047318|467201429|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
129790831|NCT02095132|467201430|FG000|Overall Study|Adverse Event|0|||
129790832|NCT02095132|467201431|FG001|Overall Study|Adverse Event|0|||
129699842|NCT05014919|466860788|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
129699843|NCT05014919|466860786|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
129699844|NCT05014919|466860787|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
129699845|NCT05014919|466860788|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
129790833|NCT02095132|467201432|FG002|Overall Study|Adverse Event|0|||
129790834|NCT02095132|467201433|FG003|Overall Study|Adverse Event|0|||
129611123|NCT00936897|466532503|FG001|Overall Study|Other|9|||
129611124|NCT00936897|466532502|FG000|Overall Study|Lost to Follow-up|1|||
129611125|NCT00936897|466532503|FG001|Overall Study|Lost to Follow-up|10|||
129611126|NCT00936897|466532502|FG000|Overall Study|Administrative Decision|1|||
129611127|NCT00936897|466532503|FG001|Overall Study|Administrative Decision|2|||
129611128|NCT00936897|466532502|FG000|Overall Study|Protocol Violation|1|||
129611129|NCT00936897|466532503|FG001|Overall Study|Protocol Violation|1|||
129611130|NCT00936897|466532502|FG000|Overall Study|Ineligibility Determined|0|||
129611131|NCT00936897|466532503|FG001|Overall Study|Ineligibility Determined|3|||
129611132|NCT00936897|466532502|FG000|Overall Study|Noncompliance|0|||
129611133|NCT00936897|466532503|FG001|Overall Study|Noncompliance|2|||
129611134|NCT00936897|466532502|FG000|Overall Study|Death|0|||
129611135|NCT00936897|466532503|FG001|Overall Study|Death|1|||
129611136|NCT04058067|466532504|FG000|Overall Study|Adverse Event|2|||
129611137|NCT04058067|466532505|FG001|Overall Study|Adverse Event|0|||
129611138|NCT04058067|466532504|FG000|Overall Study|Death|0|||
129611139|NCT04058067|466532505|FG001|Overall Study|Death|1|||
129611140|NCT04058067|466532504|FG000|Overall Study|Physician Decision|3|||
129611141|NCT04058067|466532505|FG001|Overall Study|Physician Decision|1|||
129611142|NCT04058067|466532504|FG000|Overall Study|Protocol Violation|0|||
129611143|NCT04058067|466532505|FG001|Overall Study|Protocol Violation|1|||
129611144|NCT04058067|466532504|FG000|Overall Study|Withdrawal by Subject|7|||
129611145|NCT04058067|466532505|FG001|Overall Study|Withdrawal by Subject|8|||
129611146|NCT00417170|466532506|FG000|Overall Study|Adverse Event|1|||
129611147|NCT00417170|466532507|FG001|Overall Study|Adverse Event|1|||
129611148|NCT00417170|466532506|FG000|Overall Study|Withdrawal by Subject|1|||
129611149|NCT00417170|466532507|FG001|Overall Study|Withdrawal by Subject|1|||
129611150|NCT00417170|466532506|FG000|Overall Study|Lost to Follow-up|0|||
129611151|NCT00417170|466532507|FG001|Overall Study|Lost to Follow-up|1|||
129611152|NCT05005312|466532508|FG000|Overall Study|Enrolled, but not treated|0|||
129611153|NCT05005312|466532509|FG001|Overall Study|Enrolled, but not treated|1|||
129611154|NCT01283035|466532511|FG000|Overall Study|Subject later found ineligible|1|||
129611155|NCT00867503|466532512|FG000|Overall Study|Withdrawal by Subject|1|||
129611156|NCT02704403|466532513|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
129611157|NCT02704403|466532514|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
129611158|NCT02704403|466532513|FG000|Overall Study|Administrative reasons by sponsor|1251|||
129611159|NCT02704403|466532514|FG001|Overall Study|Administrative reasons by sponsor|616|||
129611160|NCT02704403|466532513|FG000|Overall Study|Death|4|||
129611161|NCT02704403|466532514|FG001|Overall Study|Death|3|||
129611162|NCT02704403|466532513|FG000|Overall Study|Endpoint event|52|||
129611163|NCT02704403|466532514|FG001|Overall Study|Endpoint event|24|||
129611164|NCT02704403|466532513|FG000|Overall Study|Lost to Follow-up|22|||
129611165|NCT02704403|466532514|FG001|Overall Study|Lost to Follow-up|11|||
129611166|NCT02704403|466532513|FG000|Overall Study|Protocol Violation|15|||
129611167|NCT02704403|466532514|FG001|Overall Study|Protocol Violation|15|||
129611168|NCT02704403|466532513|FG000|Overall Study|Adverse Event|2|||
129611169|NCT02704403|466532514|FG001|Overall Study|Adverse Event|0|||
129611170|NCT02704403|466532513|FG000|Overall Study|Withdrawal by Subject|85|||
129611171|NCT02704403|466532514|FG001|Overall Study|Withdrawal by Subject|45|||
129611172|NCT02704403|466532513|FG000|Overall Study|Investigator decision|1|||
129611173|NCT02704403|466532514|FG001|Overall Study|Investigator decision|1|||
129611174|NCT02704403|466532513|FG000|Overall Study|Follow-up not possible|1|||
129611175|NCT02704403|466532514|FG001|Overall Study|Follow-up not possible|2|||
129611176|NCT00077857|466532515|FG000|Overall Study|Adverse Event|30|||
129611177|NCT00077857|466532516|FG001|Overall Study|Adverse Event|32|||
129611178|NCT00077857|466532515|FG000|Overall Study|Death|7|||
129611179|NCT00077857|466532516|FG001|Overall Study|Death|3|||
129611180|NCT00077857|466532515|FG000|Overall Study|Insufficient therapeutic response|112|||
129611181|NCT00077857|466532516|FG001|Overall Study|Insufficient therapeutic response|128|||
129611182|NCT00077857|466532515|FG000|Overall Study|Violation of selection criteria at entry|3|||
129611183|NCT00077857|466532516|FG001|Overall Study|Violation of selection criteria at entry|1|||
129611184|NCT00077857|466532515|FG000|Overall Study|Other protocol violation|0|||
129611185|NCT00077857|466532516|FG001|Overall Study|Other protocol violation|1|||
129611186|NCT00077857|466532515|FG000|Overall Study|Refused treatment|29|||
129699846|NCT05014919|466860786|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
129611187|NCT00077857|466532516|FG001|Overall Study|Refused treatment|21|||
129699847|NCT05014919|466860787|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
129611188|NCT00077857|466532515|FG000|Overall Study|Failure to return|5|||
129611189|NCT00077857|466532516|FG001|Overall Study|Failure to return|5|||
129611190|NCT00077857|466532515|FG000|Overall Study|Other|15|||
129611191|NCT00077857|466532516|FG001|Overall Study|Other|13|||
129611192|NCT02348723|466532518|FG000|Overall Study|No ablation|21|||
129611193|NCT02348723|466532519|FG001|Overall Study|No ablation|20|||
129611194|NCT02348723|466532518|FG000|Overall Study|Non-compliant with Protocol|1|||
129611195|NCT02348723|466532519|FG001|Overall Study|Non-compliant with Protocol|0|||
129611196|NCT02348723|466532518|FG000|Overall Study|Lost to Follow-up|1|||
129611197|NCT02348723|466532519|FG001|Overall Study|Lost to Follow-up|1|||
129611198|NCT02348723|466532518|FG000|Overall Study|Consent withdrawn|1|||
129611199|NCT02348723|466532519|FG001|Overall Study|Consent withdrawn|3|||
129611200|NCT02348723|466532518|FG000|Overall Study|Reason other than specified|1|||
129611201|NCT02348723|466532519|FG001|Overall Study|Reason other than specified|1|||
129611202|NCT02348723|466532518|FG000|Overall Study|Adverse Event|3|||
129611203|NCT02348723|466532519|FG001|Overall Study|Adverse Event|1|||
129611204|NCT04874155|466532523|FG000|Overall Study|Lost to Follow-up|1|||
129611205|NCT04874155|466532524|FG001|Overall Study|Lost to Follow-up|1|||
129611206|NCT04874155|466532523|FG000|Overall Study|Withdrawal by Subject|2|||
129611207|NCT04874155|466532524|FG001|Overall Study|Withdrawal by Subject|2|||
129611208|NCT02329847|466532525|FG000|Overall Study|Death|4|||
129611209|NCT02329847|466532526|FG001|Overall Study|Death|4|||
129611210|NCT02329847|466532527|FG002|Overall Study|Death|22|||
129611211|NCT02329847|466532528|FG003|Overall Study|Death|12|||
129611212|NCT02329847|466532529|FG004|Overall Study|Death|20|||
129611213|NCT02329847|466532530|FG005|Overall Study|Death|13|||
129611214|NCT02329847|466532525|FG000|Overall Study|Lost to Follow-up|0|||
129611215|NCT02329847|466532526|FG001|Overall Study|Lost to Follow-up|0|||
129611216|NCT02329847|466532527|FG002|Overall Study|Lost to Follow-up|2|||
129611217|NCT02329847|466532528|FG003|Overall Study|Lost to Follow-up|3|||
129611218|NCT02329847|466532529|FG004|Overall Study|Lost to Follow-up|0|||
129611219|NCT02329847|466532530|FG005|Overall Study|Lost to Follow-up|1|||
129611220|NCT02329847|466532525|FG000|Overall Study|Physician Decision|0|||
129611221|NCT02329847|466532526|FG001|Overall Study|Physician Decision|0|||
129611222|NCT02329847|466532527|FG002|Overall Study|Physician Decision|0|||
129611223|NCT02329847|466532528|FG003|Overall Study|Physician Decision|0|||
129611224|NCT02329847|466532529|FG004|Overall Study|Physician Decision|1|||
129611225|NCT02329847|466532530|FG005|Overall Study|Physician Decision|0|||
129611226|NCT02329847|466532525|FG000|Overall Study|Withdrawal by Subject|2|||
129611227|NCT02329847|466532526|FG001|Overall Study|Withdrawal by Subject|1|||
129611228|NCT02329847|466532527|FG002|Overall Study|Withdrawal by Subject|5|||
129611229|NCT02329847|466532528|FG003|Overall Study|Withdrawal by Subject|7|||
129611230|NCT02329847|466532529|FG004|Overall Study|Withdrawal by Subject|8|||
129611231|NCT02329847|466532530|FG005|Overall Study|Withdrawal by Subject|3|||
129611232|NCT02329847|466532525|FG000|Overall Study|Other|1|||
129611233|NCT02329847|466532526|FG001|Overall Study|Other|2|||
129611234|NCT02329847|466532527|FG002|Overall Study|Other|6|||
129611235|NCT02329847|466532528|FG003|Overall Study|Other|13|||
129611236|NCT02329847|466532529|FG004|Overall Study|Other|10|||
129611237|NCT02329847|466532530|FG005|Overall Study|Other|3|||
129611238|NCT05293639|466532531|FG000|Overall Study|Withdrawal by Subject|1|||
129611239|NCT05293639|466532532|FG001|Overall Study|Withdrawal by Subject|1|||
129611240|NCT05293639|466532533|FG002|Overall Study|Withdrawal by Subject|2|||
129611241|NCT05293639|466532531|FG000|Overall Study|Death|0|||
129611242|NCT05293639|466532532|FG001|Overall Study|Death|1|||
129611243|NCT05293639|466532533|FG002|Overall Study|Death|0|||
129611244|NCT05293639|466532531|FG000|Overall Study|Lost to Follow-up|0|||
129611245|NCT05293639|466532532|FG001|Overall Study|Lost to Follow-up|0|||
129611246|NCT05293639|466532533|FG002|Overall Study|Lost to Follow-up|5|||
129611247|NCT05293639|466532531|FG000|Overall Study|Other|0|||
129611248|NCT05293639|466532532|FG001|Overall Study|Other|0|||
129611249|NCT05293639|466532533|FG002|Overall Study|Other|1|||
129611250|NCT03918109|466532544|FG000|Overall Study|Withdrawal by Subject|0|||
129611251|NCT03918109|466532545|FG001|Overall Study|Withdrawal by Subject|0|||
129611252|NCT03918109|466532546|FG002|Overall Study|Withdrawal by Subject|2|||
129611253|NCT03918109|466532547|FG003|Overall Study|Withdrawal by Subject|1|||
129611254|NCT03918109|466532544|FG000|Overall Study|Lost to Follow-up|0|||
129611255|NCT03918109|466532545|FG001|Overall Study|Lost to Follow-up|0|||
129611256|NCT03918109|466532546|FG002|Overall Study|Lost to Follow-up|0|||
129611257|NCT03918109|466532547|FG003|Overall Study|Lost to Follow-up|1|||
129611258|NCT00758680|466532548|FG000|Overall Study|Adverse Event|0|||
129611259|NCT00758680|466532549|FG001|Overall Study|Adverse Event|0|||
129611260|NCT00758680|466532550|FG002|Overall Study|Adverse Event|0|||
129611261|NCT00758680|466532551|FG003|Overall Study|Adverse Event|0|||
129611262|NCT00758680|466532552|FG004|Overall Study|Adverse Event|0|||
129611263|NCT00758680|466532553|FG005|Overall Study|Adverse Event|0|||
129611264|NCT00758680|466532554|FG006|Overall Study|Adverse Event|0|||
129611265|NCT00758680|466532555|FG007|Overall Study|Adverse Event|1|||
129611266|NCT00758680|466532556|FG008|Overall Study|Adverse Event|0|||
129611267|NCT00758680|466532557|FG009|Overall Study|Adverse Event|1|||
129611268|NCT00758680|466532548|FG000|Overall Study|Laboratory Adverse Event|0|||
129611269|NCT00758680|466532549|FG001|Overall Study|Laboratory Adverse Event|0|||
129611270|NCT00758680|466532550|FG002|Overall Study|Laboratory Adverse Event|0|||
129611271|NCT00758680|466532551|FG003|Overall Study|Laboratory Adverse Event|0|||
129611272|NCT00758680|466532552|FG004|Overall Study|Laboratory Adverse Event|0|||
129611273|NCT00758680|466532553|FG005|Overall Study|Laboratory Adverse Event|0|||
129611274|NCT00758680|466532554|FG006|Overall Study|Laboratory Adverse Event|0|||
129611275|NCT00758680|466532555|FG007|Overall Study|Laboratory Adverse Event|0|||
129611276|NCT00758680|466532556|FG008|Overall Study|Laboratory Adverse Event|1|||
129611277|NCT00758680|466532557|FG009|Overall Study|Laboratory Adverse Event|0|||
129611278|NCT00758680|466532548|FG000|Overall Study|Withdrawal by Subject|0|||
129611279|NCT00758680|466532549|FG001|Overall Study|Withdrawal by Subject|0|||
129611280|NCT00758680|466532550|FG002|Overall Study|Withdrawal by Subject|0|||
129611281|NCT00758680|466532551|FG003|Overall Study|Withdrawal by Subject|0|||
129611282|NCT00758680|466532552|FG004|Overall Study|Withdrawal by Subject|0|||
129611283|NCT00758680|466532553|FG005|Overall Study|Withdrawal by Subject|0|||
129611284|NCT00758680|466532554|FG006|Overall Study|Withdrawal by Subject|1|||
129611285|NCT00758680|466532555|FG007|Overall Study|Withdrawal by Subject|0|||
129611286|NCT00758680|466532556|FG008|Overall Study|Withdrawal by Subject|1|||
129611287|NCT00758680|466532557|FG009|Overall Study|Withdrawal by Subject|0|||
129611288|NCT00761865|466532558|FG000|Overall Study|Lost to Follow-up|8|||
129611289|NCT00761865|466532559|FG001|Overall Study|Lost to Follow-up|7|||
129611290|NCT00319982|466532562|FG000|Overall Study|Withdrawal by Subject|1|||
129611291|NCT00319982|466532563|FG001|Overall Study|Withdrawal by Subject|0|||
129611292|NCT01094886|466532564|FG000|Overall Study|Adverse Event|2|||
129611293|NCT01094886|466532564|FG000|Overall Study|Withdrawal by Subject|5|||
129611294|NCT03866902|466532566|FG000|Overall Study|Lost to Follow-up|98|||
129611295|NCT03866902|466532567|FG001|Overall Study|Lost to Follow-up|82|||
129611296|NCT03866902|466532566|FG000|Overall Study|Pregnancy|18|||
129611297|NCT03866902|466532567|FG001|Overall Study|Pregnancy|24|||
129611298|NCT04730349|466532570|FG000|Overall Study|Participant withdrew consent|1|||
129611299|NCT04730349|466532571|FG001|Overall Study|Participant withdrew consent|0|||
129611300|NCT04730349|466532570|FG000|Overall Study|Disease progression|6|||
129611301|NCT04730349|466532571|FG001|Overall Study|Disease progression|4|||
129611302|NCT04730349|466532570|FG000|Overall Study|Study drug toxicity|0|||
129611303|NCT04730349|466532571|FG001|Overall Study|Study drug toxicity|1|||
129611304|NCT00638027|466532572|FG000|Overall Study|Adverse Event|0|||
129611305|NCT00638027|466532573|FG001|Overall Study|Adverse Event|2|||
129611306|NCT00371397|466532575|FG000|Session 1|Withdrawal by Subject|1|||
129611307|NCT00371397|466532576|FG001|Session 1|Withdrawal by Subject|0|||
129611308|NCT00371397|466532577|FG002|Session 1|Withdrawal by Subject|0|||
129611309|NCT00371397|466532578|FG003|Session 1|Withdrawal by Subject|0|||
129611310|NCT00371397|466532579|FG004|Session 1|Withdrawal by Subject|0|||
129611311|NCT00371397|466532580|FG005|Session 1|Withdrawal by Subject|0|||
129611312|NCT00371397|466532581|FG006|Session 1|Withdrawal by Subject|0|||
129611313|NCT00371397|466532582|FG007|Session 1|Withdrawal by Subject|1|||
129611314|NCT00371397|466532583|FG008|Session 1|Withdrawal by Subject|0|||
129611315|NCT00371397|466532584|FG009|Session 1|Withdrawal by Subject|0|||
129611316|NCT00371397|466532585|FG010|Session 1|Withdrawal by Subject|0|||
129611317|NCT00371397|466532586|FG011|Session 1|Withdrawal by Subject|0|||
129611318|NCT03014180|466532587|FG000|Overall Study|Protocol Violation|2|||
129611319|NCT01284621|466532588|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129611320|NCT01284621|466532589|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129611321|NCT01284621|466532590|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129611322|NCT01284621|466532591|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129611323|NCT01284621|466532592|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
129611324|NCT01284621|466532593|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
129611325|NCT02802631|466532596|FG000|Overall Study|Withdrawal by Subject|1|||
129611326|NCT02802631|466532597|FG001|Overall Study|Withdrawal by Subject|0|||
129611327|NCT02802631|466532598|FG002|Overall Study|Withdrawal by Subject|0|||
129611328|NCT02802631|466532599|FG003|Overall Study|Withdrawal by Subject|0|||
129611329|NCT02802631|466532600|FG004|Overall Study|Withdrawal by Subject|0|||
129611330|NCT02802631|466532601|FG005|Overall Study|Withdrawal by Subject|0|||
129611331|NCT02802631|466532602|FG006|Overall Study|Withdrawal by Subject|0|||
129611332|NCT02802631|466532603|FG007|Overall Study|Withdrawal by Subject|0|||
129611333|NCT02802631|466532596|FG000|Overall Study|Physician Decision|1|||
129611334|NCT02802631|466532597|FG001|Overall Study|Physician Decision|0|||
129611335|NCT02802631|466532598|FG002|Overall Study|Physician Decision|0|||
129611336|NCT02802631|466532599|FG003|Overall Study|Physician Decision|0|||
129611337|NCT02802631|466532600|FG004|Overall Study|Physician Decision|0|||
129611338|NCT02802631|466532601|FG005|Overall Study|Physician Decision|0|||
129611339|NCT02802631|466532602|FG006|Overall Study|Physician Decision|1|||
129611340|NCT02802631|466532603|FG007|Overall Study|Physician Decision|0|||
129611341|NCT02802631|466532596|FG000|Overall Study|Adverse Event|0|||
129611342|NCT02802631|466532597|FG001|Overall Study|Adverse Event|2|||
129611343|NCT02802631|466532598|FG002|Overall Study|Adverse Event|0|||
129611344|NCT02802631|466532599|FG003|Overall Study|Adverse Event|1|||
129611345|NCT02802631|466532600|FG004|Overall Study|Adverse Event|6|||
129611346|NCT02802631|466532601|FG005|Overall Study|Adverse Event|1|||
129611347|NCT02802631|466532602|FG006|Overall Study|Adverse Event|4|||
129611348|NCT02802631|466532603|FG007|Overall Study|Adverse Event|0|||
129611349|NCT02802631|466532596|FG000|Overall Study|Sponsor Decision|0|||
129611350|NCT02802631|466532597|FG001|Overall Study|Sponsor Decision|0|||
129611351|NCT02802631|466532598|FG002|Overall Study|Sponsor Decision|6|||
129611352|NCT02802631|466532599|FG003|Overall Study|Sponsor Decision|0|||
129611353|NCT02802631|466532600|FG004|Overall Study|Sponsor Decision|2|||
129611354|NCT02802631|466532601|FG005|Overall Study|Sponsor Decision|0|||
129611355|NCT02802631|466532602|FG006|Overall Study|Sponsor Decision|0|||
129611356|NCT02802631|466532603|FG007|Overall Study|Sponsor Decision|4|||
129611357|NCT02377427|466532604|FG000|Part A (Up to Week 20)|Physician Decision|1|||
129611358|NCT02377427|466532605|FG001|Part A (Up to Week 20)|Physician Decision|0|||
129611359|NCT02377427|466532606|FG002|Part A (Up to Week 20)|Physician Decision|0|||
129611360|NCT02377427|466532607|FG003|Part A (Up to Week 20)|Physician Decision|0|||
129611361|NCT02377427|466532608|FG004|Part A (Up to Week 20)|Physician Decision|0|||
129611362|NCT02377427|466532604|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
129611363|NCT02377427|466532605|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129611364|NCT02377427|466532606|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129611365|NCT02377427|466532607|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129611366|NCT02377427|466532608|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
129611367|NCT02377427|466532604|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
129611368|NCT02377427|466532605|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129611369|NCT02377427|466532606|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129611370|NCT02377427|466532607|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129611371|NCT02377427|466532608|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
129611372|NCT02377427|466532604|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129611373|NCT02377427|466532605|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129611374|NCT02377427|466532606|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
129611375|NCT02377427|466532607|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129611376|NCT02377427|466532608|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
129611377|NCT02342639|466532609|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
129611378|NCT02342639|466532610|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
129611379|NCT02342639|466532609|FG000|Overall Study|Protocol Violation|0|||
129611380|NCT02342639|466532610|FG001|Overall Study|Protocol Violation|2|||
129611381|NCT02212379|466532611|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
129611382|NCT02212379|466532611|FG000|From Baseline to Week 48|Adverse Event|7|||
129611383|NCT02212379|466532611|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
129611384|NCT02212379|466532611|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
129611385|NCT02212379|466532611|FG000|From Week 48 to Week 96|Adverse Event|1|||
129611386|NCT02212379|466532611|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
129611387|NCT02105974|466532612|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
129611388|NCT02105974|466532613|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
129611389|NCT02105974|466532614|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
129611390|NCT02105974|466532612|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
129611391|NCT02105974|466532613|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
129611392|NCT02105974|466532614|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
129611393|NCT02105974|466532612|FG000|2 Week Run-in Period|Adverse Event|6|||
129611394|NCT02105974|466532613|FG001|2 Week Run-in Period|Adverse Event|0|||
129611395|NCT02105974|466532614|FG002|2 Week Run-in Period|Adverse Event|0|||
129611396|NCT02105974|466532612|FG000|2 Week Run-in Period|Study closed/terminated|1|||
129611397|NCT02105974|466532613|FG001|2 Week Run-in Period|Study closed/terminated|0|||
129611398|NCT02105974|466532614|FG002|2 Week Run-in Period|Study closed/terminated|0|||
129439120|NCT00392327|465904571|FG002|Overall Study|Lack of Efficacy|9|||
129611399|NCT02105974|466532612|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
129611400|NCT02105974|466532613|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
129611401|NCT02105974|466532614|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
129611402|NCT02105974|466532612|FG000|2 Week Run-in Period|Withdrew consent|23|||
129611403|NCT02105974|466532613|FG001|2 Week Run-in Period|Withdrew consent|0|||
129611404|NCT02105974|466532614|FG002|2 Week Run-in Period|Withdrew consent|0|||
129611405|NCT02105974|466532612|FG000|2 Week Run-in Period|Investigator discretion|8|||
129611406|NCT02105974|466532613|FG001|2 Week Run-in Period|Investigator discretion|0|||
129611407|NCT02105974|466532614|FG002|2 Week Run-in Period|Investigator discretion|0|||
129611408|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
129611409|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
129611410|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
129611411|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
129611412|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
129611413|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
129611414|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
129611415|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
129611416|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
129611417|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
129611418|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
129611419|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
129611420|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
129611421|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
129611422|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
129611423|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
129611424|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
129611425|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
129611426|NCT02105974|466532612|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
129611427|NCT02105974|466532613|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
129611428|NCT02105974|466532614|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
129611429|NCT01177059|466532616|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
129611430|NCT01177059|466532616|FG000|Overall Study|Withdrew consent|2|||
129611431|NCT01177059|466532616|FG000|Overall Study|Lost to Follow-up|18|||
129611432|NCT02886624|466533995|FG000|12-week Post Treatment Follow-up|Death|1|||
129611433|NCT02886624|466533995|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
129611434|NCT03972163|466533996|FG000|Overall Study|Death|0|||
129611435|NCT03972163|466533997|FG001|Overall Study|Death|1|||
129611436|NCT01161407|466534000|FG000|Overall Study|Protocol Violation|3|||
129611437|NCT01161407|466534001|FG001|Overall Study|Protocol Violation|1|||
129611438|NCT00849186|466534008|FG000|Overall Study|Adverse Event|2|||
129611439|NCT00849186|466534008|FG000|Overall Study|Withdrawal by Subject|1|||
129611440|NCT00849186|466534008|FG000|Overall Study|not treated|6|||
129611441|NCT00849186|466534008|FG000|Overall Study|Other|1|||
129611442|NCT00492024|466534011|FG000|Treatment|Adverse Event|3|||
129611443|NCT00492024|466534012|FG001|Treatment|Adverse Event|1|||
129611444|NCT00492024|466534011|FG000|Treatment|Lack of Efficacy|21|||
129611445|NCT00492024|466534012|FG001|Treatment|Lack of Efficacy|20|||
129611446|NCT00492024|466534011|FG000|Treatment|Lost to Follow-up|3|||
129611447|NCT00492024|466534012|FG001|Treatment|Lost to Follow-up|1|||
129611448|NCT00492024|466534011|FG000|Treatment|Withdrawal by Subject|2|||
129611449|NCT00492024|466534012|FG001|Treatment|Withdrawal by Subject|0|||
129611450|NCT00492024|466534011|FG000|Follow up|Lack of Efficacy|0|||
129611451|NCT00492024|466534012|FG001|Follow up|Lack of Efficacy|1|||
129611452|NCT00492024|466534011|FG000|Follow up|Lost to Follow-up|1|||
129611453|NCT00492024|466534012|FG001|Follow up|Lost to Follow-up|1|||
129611454|NCT03247816|466534015|FG000|Overall Study|Adverse Event|12|||
129611455|NCT03247816|466534015|FG000|Overall Study|Physician Decision|3|||
129611456|NCT03247816|466534015|FG000|Overall Study|Lack of Efficacy|1|||
129611457|NCT03247816|466534015|FG000|Overall Study|Lost to Follow-up|10|||
129611458|NCT03247816|466534015|FG000|Overall Study|Missing Feraccru stop date|3|||
129611459|NCT03257865|466534016|FG000|Overall Study|Adverse Event|4|||
129611460|NCT03257865|466534017|FG001|Overall Study|Adverse Event|8|||
129611461|NCT03257865|466534016|FG000|Overall Study|Lack of Efficacy|1|||
129611462|NCT03257865|466534017|FG001|Overall Study|Lack of Efficacy|2|||
129611463|NCT03257865|466534016|FG000|Overall Study|Non-compliance with Study Drug|0|||
129611464|NCT03257865|466534017|FG001|Overall Study|Non-compliance with Study Drug|2|||
129611465|NCT03257865|466534016|FG000|Overall Study|Withdrawal by Subject|23|||
129611466|NCT03257865|466534017|FG001|Overall Study|Withdrawal by Subject|17|||
129611467|NCT03257865|466534016|FG000|Overall Study|Physician Decision|3|||
129611468|NCT03257865|466534017|FG001|Overall Study|Physician Decision|1|||
129611469|NCT03257865|466534016|FG000|Overall Study|Other|0|||
129611470|NCT03257865|466534017|FG001|Overall Study|Other|1|||
129611471|NCT03257865|466534016|FG000|Overall Study|Lost to Follow-up|4|||
129611472|NCT03257865|466534017|FG001|Overall Study|Lost to Follow-up|4|||
129611473|NCT04015908|466534018|FG000|Overall Study|Lost to Follow-up|0|||
129611474|NCT04015908|466534019|FG001|Overall Study|Lost to Follow-up|1|||
129611475|NCT04623086|466534020|FG000|Overall Study|Withdrawal by Subject|0|||
129611476|NCT04623086|466534021|FG001|Overall Study|Withdrawal by Subject|0|||
129611477|NCT04623086|466534022|FG002|Overall Study|Withdrawal by Subject|10|||
129611478|NCT02538965|466534023|FG000|Treatment Period|Other = Death due to disease progression|1|||
129611479|NCT02538965|466534023|FG000|Treatment Period|Adverse Event|2|||
129611480|NCT02538965|466534023|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
129611481|NCT02538965|466534023|FG000|Treatment Period|Treatment Failure|9|||
129611482|NCT02538965|466534023|FG000|Treatment Period|Disease Progression|1|||
129611483|NCT02538965|466534023|FG000|Treatment Period|Physician Decision|2|||
129611484|NCT02538965|466534023|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
129611485|NCT02538965|466534023|FG000|Follow-Up Period|Withdrawal by Parent|4|||
129611486|NCT04546724|466534024|FG000|Overall Study|Withdrawal by Subject|145|||
129611487|NCT04546724|466534025|FG001|Overall Study|Withdrawal by Subject|41|||
129611488|NCT04546724|466534024|FG000|Overall Study|Adverse Event|1|||
129611489|NCT04546724|466534025|FG001|Overall Study|Adverse Event|1|||
129611490|NCT04546724|466534024|FG000|Overall Study|Lost to Follow-up|186|||
129611491|NCT04546724|466534025|FG001|Overall Study|Lost to Follow-up|63|||
129611492|NCT04546724|466534024|FG000|Overall Study|Physician Decision|8|||
129611493|NCT04546724|466534025|FG001|Overall Study|Physician Decision|2|||
129611494|NCT04546724|466534024|FG000|Overall Study|Death|2|||
129611495|NCT04546724|466534025|FG001|Overall Study|Death|1|||
129611496|NCT04546724|466534024|FG000|Overall Study|subject has been out of town|1|||
129611497|NCT04546724|466534025|FG001|Overall Study|subject has been out of town|0|||
129611498|NCT04546724|466534024|FG000|Overall Study|subject is incarcerated|2|||
129611499|NCT04546724|466534025|FG001|Overall Study|subject is incarcerated|0|||
129611500|NCT04546724|466534024|FG000|Overall Study|subject is relocating|12|||
129611501|NCT04546724|466534025|FG001|Overall Study|subject is relocating|4|||
129611502|NCT04546724|466534024|FG000|Overall Study|Subject in another study|1|||
129611503|NCT04546724|466534025|FG001|Overall Study|Subject in another study|1|||
129611504|NCT01147107|466534031|FG000|Overall Study|Lack of Efficacy|5|||
129611505|NCT01147107|466534032|FG001|Overall Study|Lack of Efficacy|0|||
129611506|NCT01147107|466534031|FG000|Overall Study|Withdrawal by Subject|1|||
129611507|NCT01147107|466534032|FG001|Overall Study|Withdrawal by Subject|1|||
129611508|NCT03201965|466534035|FG000|Overall Study|Death|5|||
129611509|NCT03201965|466534036|FG001|Overall Study|Death|27|||
129611510|NCT03201965|466534037|FG002|Overall Study|Death|27|||
129611511|NCT03201965|466534035|FG000|Overall Study|Lost to Follow-up|0|||
129611512|NCT03201965|466534036|FG001|Overall Study|Lost to Follow-up|1|||
129611513|NCT03201965|466534037|FG002|Overall Study|Lost to Follow-up|0|||
129611514|NCT03201965|466534035|FG000|Overall Study|Withdrawal by Subject|3|||
129611515|NCT03201965|466534036|FG001|Overall Study|Withdrawal by Subject|13|||
129611516|NCT03201965|466534037|FG002|Overall Study|Withdrawal by Subject|4|||
129611517|NCT03201965|466534035|FG000|Overall Study|Ongoing|20|||
129611518|NCT03201965|466534036|FG001|Overall Study|Ongoing|152|||
129611519|NCT03201965|466534037|FG002|Overall Study|Ongoing|164|||
129611520|NCT02365558|466534041|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
129611521|NCT02365558|466534042|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
129611522|NCT02365558|466534041|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
129611523|NCT02365558|466534042|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
129611524|NCT00369317|466534043|FG000|Overall Study|Adverse Event|3|||
129611525|NCT00369317|466534043|FG000|Overall Study|Death|1|||
129611526|NCT00369317|466534043|FG000|Overall Study|Lack of Efficacy|5|||
129611527|NCT00369317|466534043|FG000|Overall Study|Physician Decision|2|||
129611528|NCT00369317|466534043|FG000|Overall Study|Withdrawal by Subject|8|||
129611529|NCT00369317|466534043|FG000|Overall Study|Ineligible|1|||
129611530|NCT02828241|466534052|FG000|Overall Study|Adverse Event|7|||
129611531|NCT02828241|466534053|FG001|Overall Study|Adverse Event|2|||
129611532|NCT02828241|466534052|FG000|Overall Study|Protocol Violation|1|||
129611533|NCT02828241|466534053|FG001|Overall Study|Protocol Violation|0|||
129611534|NCT03185013|466534058|FG000|Overall Study|Withdrawal by Subject|5|||
129611535|NCT03185013|466534059|FG001|Overall Study|Withdrawal by Subject|3|||
129611536|NCT03185013|466534058|FG000|Overall Study|Adverse Event|1|||
129611537|NCT03185013|466534059|FG001|Overall Study|Adverse Event|0|||
129611538|NCT03185013|466534058|FG000|Overall Study|Progressive Disease|1|||
129611539|NCT03185013|466534059|FG001|Overall Study|Progressive Disease|0|||
129611540|NCT03185013|466534058|FG000|Overall Study|Lost to Follow-up|8|||
129611541|NCT03185013|466534059|FG001|Overall Study|Lost to Follow-up|2|||
129611542|NCT03185013|466534058|FG000|Overall Study|Physician Decision|1|||
129790835|NCT02095132|467201434|FG004|Overall Study|Adverse Event|1|||
129611543|NCT03185013|466534059|FG001|Overall Study|Physician Decision|0|||
129611544|NCT03185013|466534058|FG000|Overall Study|Protocol Deviation|2|||
129611545|NCT03185013|466534059|FG001|Overall Study|Protocol Deviation|0|||
129611546|NCT03185013|466534058|FG000|Overall Study|Reason not Specified|3|||
129611547|NCT03185013|466534059|FG001|Overall Study|Reason not Specified|2|||
129611548|NCT03185013|466534058|FG000|Overall Study|Death|1|||
129611549|NCT03185013|466534059|FG001|Overall Study|Death|0|||
129611550|NCT00510289|466534063|FG000|Overall Study|Withdrawal by Subject|7|||
129611551|NCT00510289|466534063|FG000|Overall Study|Refused bone marrow biopsy|2|||
129611552|NCT00510289|466534063|FG000|Overall Study|Lost to Follow-up|1|||
129611553|NCT00510289|466534063|FG000|Overall Study|Progressed prior to starting drug|2|||
129611554|NCT00673387|466534066|FG000|Overall Study|Withdrawal by Subject|15|||
129611555|NCT00673387|466534067|FG001|Overall Study|Withdrawal by Subject|16|||
129611556|NCT00673387|466534068|FG002|Overall Study|Withdrawal by Subject|20|||
129611557|NCT00673387|466534069|FG003|Overall Study|Withdrawal by Subject|16|||
129611558|NCT00673387|466534070|FG004|Overall Study|Withdrawal by Subject|18|||
129611559|NCT00673387|466534071|FG005|Overall Study|Withdrawal by Subject|21|||
129611560|NCT00673387|466534072|FG006|Overall Study|Withdrawal by Subject|15|||
129611561|NCT00673387|466534073|FG007|Overall Study|Withdrawal by Subject|21|||
129611562|NCT00673387|466534066|FG000|Overall Study|Adverse Event|3|||
129611563|NCT00673387|466534067|FG001|Overall Study|Adverse Event|1|||
129611564|NCT00673387|466534068|FG002|Overall Study|Adverse Event|5|||
129611565|NCT00673387|466534069|FG003|Overall Study|Adverse Event|2|||
129611566|NCT00673387|466534070|FG004|Overall Study|Adverse Event|6|||
129611567|NCT00673387|466534071|FG005|Overall Study|Adverse Event|2|||
129611568|NCT00673387|466534072|FG006|Overall Study|Adverse Event|5|||
129611569|NCT00673387|466534073|FG007|Overall Study|Adverse Event|5|||
129611570|NCT00673387|466534066|FG000|Overall Study|Physician Decision|0|||
129611571|NCT00673387|466534067|FG001|Overall Study|Physician Decision|0|||
129611572|NCT00673387|466534068|FG002|Overall Study|Physician Decision|0|||
129611573|NCT00673387|466534069|FG003|Overall Study|Physician Decision|0|||
129611574|NCT00673387|466534070|FG004|Overall Study|Physician Decision|0|||
129611575|NCT00673387|466534071|FG005|Overall Study|Physician Decision|5|||
129611576|NCT00673387|466534072|FG006|Overall Study|Physician Decision|1|||
129611577|NCT00673387|466534073|FG007|Overall Study|Physician Decision|1|||
129611578|NCT00673387|466534066|FG000|Overall Study|Protocol Violation|3|||
129611579|NCT00673387|466534067|FG001|Overall Study|Protocol Violation|0|||
129611580|NCT00673387|466534068|FG002|Overall Study|Protocol Violation|1|||
129611581|NCT00673387|466534069|FG003|Overall Study|Protocol Violation|2|||
129611582|NCT00673387|466534070|FG004|Overall Study|Protocol Violation|0|||
129611583|NCT00673387|466534071|FG005|Overall Study|Protocol Violation|1|||
129611584|NCT00673387|466534072|FG006|Overall Study|Protocol Violation|1|||
129611585|NCT00673387|466534073|FG007|Overall Study|Protocol Violation|3|||
129611586|NCT00673387|466534066|FG000|Overall Study|Lost to Follow-up|8|||
129611587|NCT00673387|466534067|FG001|Overall Study|Lost to Follow-up|6|||
129611588|NCT00673387|466534068|FG002|Overall Study|Lost to Follow-up|5|||
129611589|NCT00673387|466534069|FG003|Overall Study|Lost to Follow-up|6|||
129611590|NCT00673387|466534070|FG004|Overall Study|Lost to Follow-up|6|||
129611591|NCT00673387|466534071|FG005|Overall Study|Lost to Follow-up|5|||
129611592|NCT00673387|466534072|FG006|Overall Study|Lost to Follow-up|8|||
129611593|NCT00673387|466534073|FG007|Overall Study|Lost to Follow-up|5|||
129611594|NCT00960115|466534076|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
129611595|NCT00960115|466534077|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
129611596|NCT00861198|466534078|FG000|Overall Study|SpyGlass Failed|5|||
129611597|NCT02011386|466534079|FG000|Overall Study|Non-compliance|2|||
129611598|NCT02011386|466534079|FG000|Overall Study|Lack of Efficacy|3|||
129611599|NCT01197755|466534080|FG000|Overall Study|Adverse Event|8|||
129611600|NCT01197755|466534081|FG001|Overall Study|Adverse Event|10|||
129611601|NCT01197755|466534082|FG002|Overall Study|Adverse Event|10|||
129611602|NCT01197755|466534080|FG000|Overall Study|Study-specific discontinuation criteria|2|||
129611603|NCT01197755|466534081|FG001|Overall Study|Study-specific discontinuation criteria|1|||
129611604|NCT01197755|466534082|FG002|Overall Study|Study-specific discontinuation criteria|0|||
129611605|NCT01197755|466534080|FG000|Overall Study|Entered the long-term extension study|18|||
129611606|NCT01197755|466534081|FG001|Overall Study|Entered the long-term extension study|21|||
129611607|NCT01197755|466534082|FG002|Overall Study|Entered the long-term extension study|35|||
129611608|NCT01197755|466534080|FG000|Overall Study|Lack of therapeutic response|0|||
129611609|NCT01197755|466534081|FG001|Overall Study|Lack of therapeutic response|7|||
129611610|NCT01197755|466534082|FG002|Overall Study|Lack of therapeutic response|4|||
129611611|NCT01197755|466534080|FG000|Overall Study|Severe non-compliance to the protocol|2|||
129611612|NCT01197755|466534081|FG001|Overall Study|Severe non-compliance to the protocol|1|||
129611613|NCT01197755|466534082|FG002|Overall Study|Severe non-compliance to the protocol|2|||
129699848|NCT05014919|466860788|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
129611614|NCT01197755|466534080|FG000|Overall Study|Withdrawal by Subject|1|||
129611615|NCT01197755|466534081|FG001|Overall Study|Withdrawal by Subject|0|||
129611616|NCT01197755|466534082|FG002|Overall Study|Withdrawal by Subject|0|||
129611617|NCT01197755|466534080|FG000|Overall Study|Lost to Follow-up|0|||
129611618|NCT01197755|466534081|FG001|Overall Study|Lost to Follow-up|0|||
129611619|NCT01197755|466534082|FG002|Overall Study|Lost to Follow-up|1|||
129611620|NCT01197755|466534080|FG000|Overall Study|eg, change in circumstances|7|||
129611621|NCT01197755|466534081|FG001|Overall Study|eg, change in circumstances|3|||
129611622|NCT01197755|466534082|FG002|Overall Study|eg, change in circumstances|2|||
129611623|NCT03255655|466534083|FG000|Overall Study|Lost to Follow-up|7|||
129611624|NCT03255655|466534084|FG001|Overall Study|Lost to Follow-up|4|||
129611625|NCT04428333|466534087|FG000|Overall Study|Physician Decision|5|||
129611626|NCT04428333|466534088|FG001|Overall Study|Physician Decision|6|||
129611627|NCT04428333|466534087|FG000|Overall Study|Withdrawal by Subject|1|||
129611628|NCT04428333|466534088|FG001|Overall Study|Withdrawal by Subject|3|||
129611629|NCT04428333|466534087|FG000|Overall Study|Study Terminated By Sponsor|14|||
129611630|NCT04428333|466534088|FG001|Overall Study|Study Terminated By Sponsor|16|||
129611631|NCT04853992|466534089|FG000|Treatment Period A|Adverse Event|0|||
129611632|NCT04853992|466534090|FG001|Treatment Period A|Adverse Event|1|||
129611633|NCT04853992|466534089|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
129611634|NCT04853992|466534090|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
129611635|NCT03582826|466534091|FG000|Overall Study|Lost to Follow-up|39|||
129611636|NCT03582826|466534092|FG001|Overall Study|Lost to Follow-up|0|||
129611637|NCT03582826|466534091|FG000|Overall Study|Withdrawal by Subject|2|||
129611638|NCT03582826|466534092|FG001|Overall Study|Withdrawal by Subject|0|||
129611639|NCT00499174|466534093|FG000|Overall Study|Physician Decision|78|||
129611640|NCT00499174|466534094|FG001|Overall Study|Physician Decision|9|||
129611641|NCT02269163|466534095|FG000|Overall Study|Lost to Follow-up|1|||
129611642|NCT02269163|466534096|FG001|Overall Study|Lost to Follow-up|0|||
129611643|NCT02269163|466534095|FG000|Overall Study|Major protocol violation|0|||
129611644|NCT02269163|466534096|FG001|Overall Study|Major protocol violation|1|||
129611645|NCT02269163|466534095|FG000|Overall Study|Other|2|||
129611646|NCT02269163|466534096|FG001|Overall Study|Other|2|||
129611647|NCT02269163|466534095|FG000|Overall Study|Withdrawal by Subject|0|||
129611648|NCT02269163|466534096|FG001|Overall Study|Withdrawal by Subject|3|||
129611649|NCT02269163|466534095|FG000|Overall Study|Physician Decision|0|||
129611650|NCT02269163|466534096|FG001|Overall Study|Physician Decision|1|||
129611651|NCT02351960|466534099|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
129611652|NCT02351960|466534100|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
129611653|NCT02351960|466534099|FG000|Overall Study|Voluntary Withdrawal|5|||
129611654|NCT02351960|466534100|FG001|Overall Study|Voluntary Withdrawal|4|||
129611655|NCT02351960|466534099|FG000|Overall Study|Significant Protocol Deviation|0|||
129611656|NCT02351960|466534100|FG001|Overall Study|Significant Protocol Deviation|5|||
129611657|NCT02968849|466534106|FG000|Overall Study|Death|8|||
129611658|NCT02968849|466534107|FG001|Overall Study|Death|10|||
129611659|NCT02968849|466534106|FG000|Overall Study|Lost to Follow-up|31|||
129611660|NCT02968849|466534107|FG001|Overall Study|Lost to Follow-up|29|||
129611661|NCT02968849|466534106|FG000|Overall Study|Withdrawal by Subject|73|||
129611662|NCT02968849|466534107|FG001|Overall Study|Withdrawal by Subject|64|||
129611663|NCT02968849|466534106|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
129611664|NCT02968849|466534107|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
129611665|NCT02968849|466534106|FG000|Overall Study|Physician Decision|6|||
129611666|NCT02968849|466534107|FG001|Overall Study|Physician Decision|9|||
129611667|NCT02968849|466534106|FG000|Overall Study|Other|16|||
129611668|NCT02968849|466534107|FG001|Overall Study|Other|10|||
129611669|NCT02013674|466534110|FG000|Overall Study|Death|0|||
129611670|NCT02013674|466534111|FG001|Overall Study|Death|1|||
129611671|NCT02013674|466534110|FG000|Overall Study|Lost to Follow-up|1|||
129611672|NCT02013674|466534111|FG001|Overall Study|Lost to Follow-up|0|||
129611673|NCT00416884|466534112|FG000|Overall Study|Study terminated due to low accrual|1|||
129611674|NCT02203331|466534113|FG000|Overall Study|Pregnancy|1|||
129611675|NCT02203331|466534114|FG001|Overall Study|Pregnancy|0|||
129699849|NCT05014919|466860786|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
129699850|NCT05014919|466860787|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
129699851|NCT05014919|466860788|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
129699852|NCT05014919|466860786|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
129699853|NCT05014919|466860787|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
129699854|NCT05014919|466860788|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
129699855|NCT05014919|466860786|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
129699856|NCT05014919|466860787|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
129699857|NCT05014919|466860788|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
129699858|NCT00680914|466860789|FG000|Overall Study|Consent withdrawal|6|||
129699859|NCT00680914|466860790|FG001|Overall Study|Consent withdrawal|3|||
129699860|NCT00680914|466860789|FG000|Overall Study|Lost to Follow-up|4|||
129699861|NCT00680914|466860790|FG001|Overall Study|Lost to Follow-up|0|||
129699862|NCT00680914|466860789|FG000|Overall Study|serious adverse event (SAE)|0|||
129699863|NCT00680914|466860790|FG001|Overall Study|serious adverse event (SAE)|1|||
129699864|NCT02971163|466860791|FG000|Overall Study|Lost to Follow-up|4|||
129699865|NCT02971163|466860792|FG001|Overall Study|Lost to Follow-up|2|||
129699866|NCT00539500|466860793|FG000|Overall Study|Disease Progression|1|||
129699867|NCT00539500|466860793|FG000|Overall Study|Lost to Follow-up|2|||
129611676|NCT02203331|466534115|FG002|Overall Study|Pregnancy|0|||
129611677|NCT02203331|466534116|FG003|Overall Study|Pregnancy|0|||
129611678|NCT02203331|466534117|FG004|Overall Study|Pregnancy|2|||
129611679|NCT02203331|466534118|FG005|Overall Study|Pregnancy|0|||
129611680|NCT02203331|466534113|FG000|Overall Study|Withdrawal by Subject|1|||
129611681|NCT02203331|466534114|FG001|Overall Study|Withdrawal by Subject|0|||
129611682|NCT02203331|466534115|FG002|Overall Study|Withdrawal by Subject|1|||
129611683|NCT02203331|466534116|FG003|Overall Study|Withdrawal by Subject|0|||
129611684|NCT02203331|466534117|FG004|Overall Study|Withdrawal by Subject|0|||
129611685|NCT02203331|466534118|FG005|Overall Study|Withdrawal by Subject|3|||
129611686|NCT02203331|466534113|FG000|Overall Study|Adverse Event|4|||
129611687|NCT02203331|466534114|FG001|Overall Study|Adverse Event|8|||
129611688|NCT02203331|466534115|FG002|Overall Study|Adverse Event|3|||
129611689|NCT02203331|466534116|FG003|Overall Study|Adverse Event|4|||
129611690|NCT02203331|466534117|FG004|Overall Study|Adverse Event|3|||
129611691|NCT02203331|466534118|FG005|Overall Study|Adverse Event|3|||
129611692|NCT02203331|466534113|FG000|Overall Study|Other Reasons|1|||
129611693|NCT02203331|466534114|FG001|Overall Study|Other Reasons|2|||
129611694|NCT02203331|466534115|FG002|Overall Study|Other Reasons|0|||
129611695|NCT02203331|466534116|FG003|Overall Study|Other Reasons|2|||
129611696|NCT02203331|466534117|FG004|Overall Study|Other Reasons|0|||
129611697|NCT02203331|466534118|FG005|Overall Study|Other Reasons|0|||
129611698|NCT02203331|466534113|FG000|Overall Study|Lack of Efficacy|0|||
129611699|NCT02203331|466534114|FG001|Overall Study|Lack of Efficacy|2|||
129611700|NCT02203331|466534115|FG002|Overall Study|Lack of Efficacy|1|||
129611701|NCT02203331|466534116|FG003|Overall Study|Lack of Efficacy|0|||
129611702|NCT02203331|466534117|FG004|Overall Study|Lack of Efficacy|0|||
129611703|NCT02203331|466534118|FG005|Overall Study|Lack of Efficacy|1|||
129611704|NCT02203331|466534113|FG000|Overall Study|Protocol Violation|0|||
129611705|NCT02203331|466534114|FG001|Overall Study|Protocol Violation|2|||
129611706|NCT02203331|466534115|FG002|Overall Study|Protocol Violation|0|||
129611707|NCT02203331|466534116|FG003|Overall Study|Protocol Violation|1|||
129699868|NCT01491919|466860796|FG000|Overall Study|Insufficient PK sampling|1|||
129611708|NCT02203331|466534117|FG004|Overall Study|Protocol Violation|1|||
129611709|NCT02203331|466534118|FG005|Overall Study|Protocol Violation|0|||
129611710|NCT02203331|466534113|FG000|Overall Study|Lost to Follow-up|0|||
129699869|NCT01491919|466860797|FG001|Overall Study|Insufficient PK sampling|2|||
129611711|NCT02203331|466534114|FG001|Overall Study|Lost to Follow-up|0|||
129611712|NCT02203331|466534115|FG002|Overall Study|Lost to Follow-up|0|||
129611713|NCT02203331|466534116|FG003|Overall Study|Lost to Follow-up|0|||
129611714|NCT02203331|466534117|FG004|Overall Study|Lost to Follow-up|1|||
129611715|NCT02203331|466534118|FG005|Overall Study|Lost to Follow-up|0|||
129611716|NCT00704730|466534125|FG000|Overall Study|Adverse Event|35|||
129611717|NCT00704730|466534126|FG001|Overall Study|Adverse Event|9|||
129611718|NCT00704730|466534125|FG000|Overall Study|Death|11|||
129611719|NCT00704730|466534126|FG001|Overall Study|Death|5|||
129611720|NCT00704730|466534125|FG000|Overall Study|Physician Decision|2|||
129611721|NCT00704730|466534126|FG001|Overall Study|Physician Decision|0|||
129611722|NCT00704730|466534125|FG000|Overall Study|Did not receive drug|5|||
129611723|NCT00704730|466534126|FG001|Overall Study|Did not receive drug|2|||
129611724|NCT00704730|466534125|FG000|Overall Study|Disease progression per PI|58|||
129611725|NCT00704730|466534126|FG001|Overall Study|Disease progression per PI|67|||
129611726|NCT00704730|466534125|FG000|Overall Study|data unavailable|1|||
129611727|NCT00704730|466534126|FG001|Overall Study|data unavailable|0|||
129611728|NCT00704730|466534125|FG000|Overall Study|Withdrawal by Subject|9|||
129611729|NCT00704730|466534126|FG001|Overall Study|Withdrawal by Subject|13|||
129611730|NCT05065567|466534128|FG000|Overall Study|Lost to Follow-up|10|||
129611731|NCT05065567|466534129|FG001|Overall Study|Lost to Follow-up|9|||
129611732|NCT05065567|466534130|FG002|Overall Study|Lost to Follow-up|6|||
129611733|NCT02551666|466534131|FG000|Overall Study|Withdrawal by Subject|1|||
129611734|NCT02551666|466534132|FG001|Overall Study|Withdrawal by Subject|3|||
129611735|NCT04051619|466534133|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
129611736|NCT04051619|466534134|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
129611737|NCT04051619|466534133|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
129611738|NCT04051619|466534134|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
129611739|NCT03510598|466535551|FG000|Overall Study|Withdrawal by Subject|1|||
129611740|NCT05307510|466535555|FG000|Overall Study|Lost to Follow-up|3|||
129611741|NCT05307510|466535556|FG001|Overall Study|Lost to Follow-up|6|||
129611742|NCT05307510|466535555|FG000|Overall Study|Withdrawal by Subject|0|||
129611743|NCT05307510|466535556|FG001|Overall Study|Withdrawal by Subject|1|||
129611744|NCT03610516|466535559|FG000|Treatment Epoch|Adverse Event|3|||
129611745|NCT03610516|466535560|FG001|Treatment Epoch|Adverse Event|1|||
129611746|NCT03610516|466535559|FG000|Treatment Epoch|Death|1|||
129611747|NCT03610516|466535560|FG001|Treatment Epoch|Death|0|||
129439121|NCT00392327|465904572|FG003|Overall Study|Lack of Efficacy|6|||
129439122|NCT00392327|465904573|FG004|Overall Study|Lack of Efficacy|3|||
129439123|NCT00392327|465904574|FG005|Overall Study|Lack of Efficacy|3|||
129439124|NCT00392327|465904575|FG006|Overall Study|Lack of Efficacy|3|||
129611748|NCT03610516|466535559|FG000|Treatment Epoch|Lack of Efficacy|0|||
129611749|NCT03610516|466535560|FG001|Treatment Epoch|Lack of Efficacy|1|||
129611750|NCT03610516|466535559|FG000|Treatment Epoch|No longer requires treatment|1|||
129611751|NCT03610516|466535560|FG001|Treatment Epoch|No longer requires treatment|0|||
129611752|NCT03610516|466535559|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
129611753|NCT03610516|466535560|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
129611754|NCT03610516|466535559|FG000|Treatment Epoch|Physician Decision|8|||
129699870|NCT01491919|466860798|FG002|Overall Study|Insufficient PK sampling|1|||
129439125|NCT00392327|465904576|FG007|Overall Study|Lack of Efficacy|3|||
129611755|NCT03610516|466535560|FG001|Treatment Epoch|Physician Decision|5|||
129611756|NCT03610516|466535559|FG000|Treatment Epoch|Protocol Deviation|1|||
129611757|NCT03610516|466535560|FG001|Treatment Epoch|Protocol Deviation|0|||
129611758|NCT03610516|466535559|FG000|Treatment Epoch|Withdrawal by Subject|3|||
129439126|NCT00392327|465904569|FG000|Overall Study|Physician Decision|3|||
129611759|NCT03610516|466535560|FG001|Treatment Epoch|Withdrawal by Subject|1|||
129611760|NCT03610516|466535559|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
129611761|NCT03610516|466535560|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
129611762|NCT03610516|466535559|FG000|Post-Treatment Follow-up|Death|1|||
129611763|NCT03610516|466535560|FG001|Post-Treatment Follow-up|Death|0|||
129611764|NCT01664130|466535565|FG000|Overall Study|competing secondary disease|2|||
129439127|NCT00392327|465904570|FG001|Overall Study|Physician Decision|5|||
129439128|NCT00392327|465904571|FG002|Overall Study|Physician Decision|2|||
129439129|NCT00392327|465904572|FG003|Overall Study|Physician Decision|2|||
129611765|NCT00554606|466535566|FG000|Overall Study|Adverse Event|3|||
129611766|NCT00554606|466535566|FG000|Overall Study|Abnormal laboratory values|1|||
129611767|NCT00554606|466535566|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
129611768|NCT00554606|466535566|FG000|Overall Study|Subject withdrew consent|2|||
129611769|NCT00554606|466535566|FG000|Overall Study|Lost to Follow-up|2|||
129611770|NCT00554606|466535566|FG000|Overall Study|Administrative problems|60|||
129611771|NCT00554606|466535566|FG000|Overall Study|Death|1|||
129611772|NCT00554606|466535566|FG000|Overall Study|Protocol deviation|2|||
129611773|NCT03323437|466535567|FG000|Overall Study|Withdrawal by Subject|0|||
129611774|NCT03323437|466535568|FG001|Overall Study|Withdrawal by Subject|4|||
129611775|NCT01305044|466535570|FG000|Overall Study|Withdrawal by Subject|3|||
129611776|NCT01305044|466535571|FG001|Overall Study|Withdrawal by Subject|6|||
129611777|NCT02677714|466535578|FG000|Overall Study|Withdrawal by Subject|2|||
129611778|NCT02677714|466535579|FG001|Overall Study|Withdrawal by Subject|0|||
129611779|NCT04628793|466535580|FG000|Overall Study|Study terminated by sponsor|0|||
129611780|NCT04628793|466535581|FG001|Overall Study|Study terminated by sponsor|0|||
129611781|NCT04628793|466535582|FG002|Overall Study|Study terminated by sponsor|8|||
129611782|NCT04628793|466535580|FG000|Overall Study|Withdrawal by Subject|2|||
129611783|NCT04628793|466535581|FG001|Overall Study|Withdrawal by Subject|3|||
129611784|NCT04628793|466535582|FG002|Overall Study|Withdrawal by Subject|0|||
129611785|NCT04628793|466535580|FG000|Overall Study|Lost to Follow-up|0|||
129611786|NCT04628793|466535581|FG001|Overall Study|Lost to Follow-up|1|||
129611787|NCT04628793|466535582|FG002|Overall Study|Lost to Follow-up|0|||
129611788|NCT01422187|466535585|FG000|Overall Study|Personal reason|1|||
129611789|NCT01422187|466535586|FG001|Overall Study|Personal reason|0|||
129611790|NCT01422187|466535587|FG002|Overall Study|Personal reason|0|||
129611791|NCT01422187|466535585|FG000|Overall Study|Lost to Follow-up|0|||
129611792|NCT01422187|466535586|FG001|Overall Study|Lost to Follow-up|1|||
129611793|NCT01422187|466535587|FG002|Overall Study|Lost to Follow-up|0|||
129611794|NCT02227446|466535588|FG000|Overall Study|not eligible post randomization|18|||
129611795|NCT02227446|466535589|FG001|Overall Study|not eligible post randomization|29|||
129611796|NCT02227446|466535588|FG000|Overall Study|Withdrawal by Subject|4|||
129611797|NCT02227446|466535589|FG001|Overall Study|Withdrawal by Subject|5|||
129611798|NCT00875797|466535590|FG000|Overall Study|Protocol Violation|6|||
129611799|NCT00875797|466535591|FG001|Overall Study|Protocol Violation|3|||
129611800|NCT00715624|466535592|FG000|Overall Study|Adverse Event|12|||
129611801|NCT00715624|466535593|FG001|Overall Study|Adverse Event|37|||
129611802|NCT00715624|466535592|FG000|Overall Study|Lack of Efficacy|11|||
129611803|NCT00715624|466535593|FG001|Overall Study|Lack of Efficacy|11|||
129611804|NCT00715624|466535592|FG000|Overall Study|Lost to Follow-up|1|||
129611805|NCT00715624|466535593|FG001|Overall Study|Lost to Follow-up|2|||
129611806|NCT00715624|466535592|FG000|Overall Study|Protocol Violation|1|||
129611807|NCT00715624|466535593|FG001|Overall Study|Protocol Violation|0|||
129611808|NCT00715624|466535592|FG000|Overall Study|Withdrawal by Subject|11|||
129611809|NCT00715624|466535593|FG001|Overall Study|Withdrawal by Subject|25|||
129611810|NCT00715624|466535592|FG000|Overall Study|Familial and personal reasons|10|||
129611811|NCT00715624|466535593|FG001|Overall Study|Familial and personal reasons|22|||
129611812|NCT00715624|466535592|FG000|Overall Study|Poor compliance|6|||
129611813|NCT00715624|466535593|FG001|Overall Study|Poor compliance|13|||
129611814|NCT00715624|466535592|FG000|Overall Study|Sponsor decision|0|||
129611815|NCT00715624|466535593|FG001|Overall Study|Sponsor decision|4|||
129647586|NCT03054064|466665352|FG000|Overall Study|Change in Status|1|||
129611816|NCT00715624|466535592|FG000|Overall Study|Incorrect randomization (not treated)|0|||
129611817|NCT00715624|466535593|FG001|Overall Study|Incorrect randomization (not treated)|1|||
129611818|NCT00715624|466535592|FG000|Overall Study|Other|0|||
129611819|NCT00715624|466535593|FG001|Overall Study|Other|1|||
129611820|NCT03200912|466535594|FG000|Overall Study|Adverse Event|3|||
129611821|NCT03200912|466535595|FG001|Overall Study|Adverse Event|0|||
129611822|NCT03200912|466535596|FG002|Overall Study|Adverse Event|0|||
129611823|NCT03200912|466535594|FG000|Overall Study|Withdrawal by Subject|1|||
129611824|NCT03200912|466535595|FG001|Overall Study|Withdrawal by Subject|2|||
129611825|NCT03200912|466535596|FG002|Overall Study|Withdrawal by Subject|4|||
129699871|NCT02871219|466860799|FG000|Overall Study|Adverse Event|15|||
129611826|NCT03200912|466535594|FG000|Overall Study|Non-compliance with study drug|0|||
129611827|NCT03200912|466535595|FG001|Overall Study|Non-compliance with study drug|1|||
129611828|NCT03200912|466535596|FG002|Overall Study|Non-compliance with study drug|0|||
129611829|NCT02309138|466535597|FG000|Overall Study|Withdrawal by Subject|44|||
129611830|NCT02309138|466535598|FG001|Overall Study|Withdrawal by Subject|15|||
129611831|NCT02309138|466535597|FG000|Overall Study|Protocol Violation|4|||
129611832|NCT02309138|466535598|FG001|Overall Study|Protocol Violation|2|||
129611833|NCT02309138|466535597|FG000|Overall Study|delivered before visit 2|0|||
129611834|NCT02309138|466535598|FG001|Overall Study|delivered before visit 2|1|||
129611835|NCT03421730|466535607|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611836|NCT03421730|466535608|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
129611837|NCT03421730|466535609|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611838|NCT03421730|466535610|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611839|NCT03421730|466535611|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129699872|NCT02871219|466860799|FG000|Overall Study|Death|3|||
129699873|NCT02871219|466860799|FG000|Overall Study|Progression|3|||
129699874|NCT02871219|466860799|FG000|Overall Study|Infections|7|||
129699875|NCT02871219|466860799|FG000|Overall Study|Infusion Related|4|||
129699876|NCT05375929|466860807|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
129699877|NCT05375929|466860808|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
129699878|NCT05375929|466860809|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
129699879|NCT05375929|466860810|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
129699880|NCT05375929|466860807|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129699881|NCT05375929|466860808|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129699882|NCT05375929|466860809|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129699883|NCT05375929|466860810|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129699884|NCT05375929|466860807|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
129611840|NCT03421730|466535612|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611841|NCT03421730|466535613|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611842|NCT03421730|466535614|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611843|NCT03421730|466535615|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611844|NCT03421730|466535616|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611845|NCT03421730|466535617|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611846|NCT03421730|466535618|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
129611847|NCT03421730|466535607|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611848|NCT03421730|466535608|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611849|NCT03421730|466535609|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611850|NCT03421730|466535610|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611851|NCT03421730|466535611|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
129611852|NCT03421730|466535612|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611853|NCT03421730|466535613|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611854|NCT03421730|466535614|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611855|NCT03421730|466535615|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611856|NCT03421730|466535616|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611857|NCT03421730|466535617|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611858|NCT03421730|466535618|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
129611859|NCT02901548|466535623|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
129611860|NCT01955083|466535624|FG000|Overall Study|Lost to Follow-up|1|||
129611861|NCT01955083|466535625|FG001|Overall Study|Lost to Follow-up|1|||
129611862|NCT02871492|466535634|FG000|Overall Study|Lost to Follow-up|6|||
129611863|NCT02871492|466535635|FG001|Overall Study|Lost to Follow-up|3|||
129611864|NCT02871492|466535636|FG002|Overall Study|Lost to Follow-up|5|||
129611865|NCT02871492|466535634|FG000|Overall Study|Withdrawal by Subject|0|||
129611866|NCT02871492|466535635|FG001|Overall Study|Withdrawal by Subject|0|||
129611867|NCT02871492|466535636|FG002|Overall Study|Withdrawal by Subject|1|||
129611868|NCT02256436|466535637|FG000|Overall Study|Adverse Event|9|||
129611869|NCT02256436|466535638|FG001|Overall Study|Adverse Event|14|||
129611870|NCT02256436|466535637|FG000|Overall Study|Death|216|||
129611871|NCT02256436|466535638|FG001|Overall Study|Death|208|||
129611872|NCT02256436|466535637|FG000|Overall Study|Lost to Follow-up|1|||
129611873|NCT02256436|466535638|FG001|Overall Study|Lost to Follow-up|2|||
129611874|NCT02256436|466535637|FG000|Overall Study|Physician Decision|1|||
129611875|NCT02256436|466535638|FG001|Overall Study|Physician Decision|0|||
129611876|NCT02256436|466535637|FG000|Overall Study|Protocol Violation|0|||
129611877|NCT02256436|466535638|FG001|Overall Study|Protocol Violation|1|||
129611878|NCT02256436|466535637|FG000|Overall Study|Withdrawal by Subject|26|||
129611879|NCT02256436|466535638|FG001|Overall Study|Withdrawal by Subject|10|||
129611880|NCT02256436|466535637|FG000|Overall Study|Transferred to Extension Study|11|||
129699885|NCT05375929|466860808|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
129611881|NCT02256436|466535638|FG001|Overall Study|Transferred to Extension Study|23|||
129611882|NCT02256436|466535637|FG000|Overall Study|Did Not Continue on Extension Study|8|||
129611883|NCT02256436|466535638|FG001|Overall Study|Did Not Continue on Extension Study|12|||
129611884|NCT03583086|466535639|FG000|Overall Study|Death|2|||
129611885|NCT03583086|466535640|FG001|Overall Study|Death|6|||
129611886|NCT03583086|466535641|FG002|Overall Study|Death|12|||
129611887|NCT03583086|466535642|FG003|Overall Study|Death|10|||
129611888|NCT03583086|466535643|FG004|Overall Study|Death|14|||
129611889|NCT03583086|466535644|FG005|Overall Study|Death|14|||
129611890|NCT03583086|466535645|FG006|Overall Study|Death|4|||
129611891|NCT03583086|466535639|FG000|Overall Study|Withdrawal by Subject|0|||
129611892|NCT03583086|466535640|FG001|Overall Study|Withdrawal by Subject|0|||
129611893|NCT03583086|466535641|FG002|Overall Study|Withdrawal by Subject|1|||
129611894|NCT03583086|466535642|FG003|Overall Study|Withdrawal by Subject|0|||
129611895|NCT03583086|466535643|FG004|Overall Study|Withdrawal by Subject|0|||
129611896|NCT03583086|466535644|FG005|Overall Study|Withdrawal by Subject|0|||
129611897|NCT03583086|466535645|FG006|Overall Study|Withdrawal by Subject|1|||
129611898|NCT03583086|466535639|FG000|Overall Study|Refused follow-up|0|||
129611899|NCT03583086|466535640|FG001|Overall Study|Refused follow-up|0|||
129611900|NCT03583086|466535641|FG002|Overall Study|Refused follow-up|1|||
129611901|NCT03583086|466535642|FG003|Overall Study|Refused follow-up|0|||
129611902|NCT03583086|466535643|FG004|Overall Study|Refused follow-up|1|||
129611903|NCT03583086|466535644|FG005|Overall Study|Refused follow-up|0|||
129611904|NCT03583086|466535645|FG006|Overall Study|Refused follow-up|0|||
129611905|NCT03583086|466535639|FG000|Overall Study|Declining Performance Status|0|||
129611906|NCT03583086|466535640|FG001|Overall Study|Declining Performance Status|0|||
129611907|NCT03583086|466535641|FG002|Overall Study|Declining Performance Status|1|||
129611908|NCT03583086|466535642|FG003|Overall Study|Declining Performance Status|0|||
129611909|NCT03583086|466535643|FG004|Overall Study|Declining Performance Status|0|||
129611910|NCT03583086|466535644|FG005|Overall Study|Declining Performance Status|0|||
129611911|NCT03583086|466535645|FG006|Overall Study|Declining Performance Status|0|||
129611912|NCT03583086|466535639|FG000|Overall Study|Still on study|0|||
129611913|NCT03583086|466535640|FG001|Overall Study|Still on study|0|||
129611914|NCT03583086|466535641|FG002|Overall Study|Still on study|0|||
129611915|NCT03583086|466535642|FG003|Overall Study|Still on study|1|||
129611916|NCT03583086|466535643|FG004|Overall Study|Still on study|0|||
129611917|NCT03583086|466535644|FG005|Overall Study|Still on study|0|||
129611918|NCT03583086|466535645|FG006|Overall Study|Still on study|1|||
129611919|NCT03583086|466535639|FG000|Overall Study|Disease progression|0|||
129611920|NCT03583086|466535640|FG001|Overall Study|Disease progression|0|||
129611921|NCT03583086|466535641|FG002|Overall Study|Disease progression|0|||
129611922|NCT03583086|466535642|FG003|Overall Study|Disease progression|0|||
129611923|NCT03583086|466535643|FG004|Overall Study|Disease progression|0|||
129611924|NCT03583086|466535644|FG005|Overall Study|Disease progression|0|||
129611925|NCT03583086|466535645|FG006|Overall Study|Disease progression|1|||
129611926|NCT03583086|466535639|FG000|Overall Study|Undergoing radiation therapy|0|||
129611927|NCT03583086|466535640|FG001|Overall Study|Undergoing radiation therapy|0|||
129611928|NCT03583086|466535641|FG002|Overall Study|Undergoing radiation therapy|0|||
129611929|NCT03583086|466535642|FG003|Overall Study|Undergoing radiation therapy|0|||
129611930|NCT03583086|466535643|FG004|Overall Study|Undergoing radiation therapy|0|||
129611931|NCT03583086|466535644|FG005|Overall Study|Undergoing radiation therapy|0|||
129611932|NCT03583086|466535645|FG006|Overall Study|Undergoing radiation therapy|1|||
129611933|NCT03583086|466535639|FG000|Overall Study|Lost to Follow-up|0|||
129611934|NCT03583086|466535640|FG001|Overall Study|Lost to Follow-up|0|||
129611935|NCT03583086|466535641|FG002|Overall Study|Lost to Follow-up|0|||
129611936|NCT03583086|466535642|FG003|Overall Study|Lost to Follow-up|0|||
129611937|NCT03583086|466535643|FG004|Overall Study|Lost to Follow-up|0|||
129611938|NCT03583086|466535644|FG005|Overall Study|Lost to Follow-up|1|||
129611939|NCT03583086|466535645|FG006|Overall Study|Lost to Follow-up|0|||
129611940|NCT03583086|466535639|FG000|Overall Study|Adverse Event|0|||
129611941|NCT03583086|466535640|FG001|Overall Study|Adverse Event|0|||
129611942|NCT03583086|466535641|FG002|Overall Study|Adverse Event|0|||
129611943|NCT03583086|466535642|FG003|Overall Study|Adverse Event|0|||
129611944|NCT03583086|466535643|FG004|Overall Study|Adverse Event|0|||
129611945|NCT03583086|466535644|FG005|Overall Study|Adverse Event|1|||
129611946|NCT03583086|466535645|FG006|Overall Study|Adverse Event|0|||
129611947|NCT01696279|466535646|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
129611948|NCT01696279|466535647|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
129611949|NCT01696279|466535648|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
129611950|NCT01696279|466535649|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
129611951|NCT01696279|466535646|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
129611952|NCT01696279|466535647|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
129611953|NCT01696279|466535648|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
129611954|NCT01696279|466535649|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
129611955|NCT01696279|466535646|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
129611956|NCT01696279|466535647|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
129611957|NCT01696279|466535648|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
129611958|NCT01696279|466535649|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
129611959|NCT01696279|466535646|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
129611960|NCT01696279|466535647|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
129611961|NCT01696279|466535648|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
129611962|NCT01696279|466535649|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
129611963|NCT01696279|466535646|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129611964|NCT01696279|466535647|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
129611965|NCT01696279|466535648|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129611966|NCT01696279|466535649|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
129611967|NCT01696279|466535646|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
129611968|NCT01696279|466535647|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
129611969|NCT01696279|466535648|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
129611970|NCT01696279|466535649|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
129611971|NCT01696279|466535646|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
129611972|NCT01696279|466535647|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
129611973|NCT01696279|466535648|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
129611974|NCT01696279|466535649|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
129611975|NCT01696279|466535646|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
129611976|NCT01696279|466535647|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
129611977|NCT01696279|466535648|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
129611978|NCT01696279|466535649|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
129611979|NCT01696279|466535646|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
129611980|NCT01696279|466535647|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
129611981|NCT01696279|466535648|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
129611982|NCT01696279|466535649|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
129611983|NCT01696279|466535646|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
129611984|NCT01696279|466535647|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
129611985|NCT01696279|466535648|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
129611986|NCT01696279|466535649|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
129611987|NCT01696279|466535646|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
129611988|NCT01696279|466535647|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
129611989|NCT01696279|466535648|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
129611990|NCT01696279|466535649|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
129611991|NCT01441947|466535652|FG000|Overall Study|Withdrawal by Subject|3|||
129611992|NCT01441947|466535653|FG001|Overall Study|Withdrawal by Subject|0|||
129611993|NCT04106661|466535657|FG000|Overall Study|Protocol Violation|3|||
129611994|NCT04106661|466535658|FG001|Overall Study|Protocol Violation|0|||
129611995|NCT04106661|466535657|FG000|Overall Study|Scheduling difficulties|1|||
129611996|NCT04106661|466535658|FG001|Overall Study|Scheduling difficulties|1|||
129611997|NCT00468650|466535660|FG000|Overall Study|Lost to Follow-up|4|||
129611998|NCT00468650|466535660|FG000|Overall Study|Withdrawal by Subject|2|||
129611999|NCT00468650|466535660|FG000|Overall Study|Protocol Violation|1|||
129612000|NCT02639052|466535661|FG000|Overall Study|Lost to Follow-up|1|||
129612001|NCT02730351|466535663|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
129612002|NCT02730351|466535664|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
129612003|NCT02730351|466535663|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
129612004|NCT02730351|466535664|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
129612005|NCT02730351|466535663|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
129612006|NCT02730351|466535664|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
129612007|NCT02730351|466535663|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
129612008|NCT02730351|466535664|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
129612009|NCT02730351|466535663|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
129612010|NCT02730351|466535664|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
129612011|NCT00128830|466535665|FG000|Overall Study|Adverse Event|10|||
129612012|NCT00128830|466535665|FG000|Overall Study|Withdrawal by Subject|14|||
129612013|NCT00128830|466535665|FG000|Overall Study|Lost to Follow-up|4|||
129612014|NCT00128830|466535665|FG000|Overall Study|Reached a virologic endpoint|29|||
129439130|NCT00392327|465904573|FG004|Overall Study|Physician Decision|0|||
129612015|NCT00128830|466535665|FG000|Overall Study|Non-compliant|4|||
129612016|NCT00128830|466535665|FG000|Overall Study|Discontinued or ineligible for study|2|||
129612017|NCT00128830|466535665|FG000|Overall Study|Other|9|||
129612018|NCT00838435|466535666|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
129612019|NCT00838435|466535666|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
129612020|NCT00838435|466535666|FG000|Part 2 (7 Years)|Adverse Event|2|||
129612021|NCT00838435|466535666|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
129612022|NCT00838435|466535666|FG000|Part 2 (7 Years)|Physician Decision|1|||
129612023|NCT00838435|466535666|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
129612024|NCT00838435|466535666|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
129612025|NCT03796039|466535668|FG000|Overall Study|Death|2|||
129612026|NCT03796039|466535669|FG001|Overall Study|Death|1|||
129612027|NCT03796039|466535668|FG000|Overall Study|Withdrawal by Subject|7|||
129612028|NCT03796039|466535669|FG001|Overall Study|Withdrawal by Subject|4|||
129612029|NCT02927366|466535670|FG000|Overall Study|Adverse Event|1|||
129612030|NCT02927366|466535671|FG001|Overall Study|Adverse Event|0|||
129612031|NCT02927366|466535670|FG000|Overall Study|Patient schedule|1|||
129612032|NCT02927366|466535671|FG001|Overall Study|Patient schedule|0|||
129612033|NCT00587990|466535676|FG000|Overall Study|Death|0|||
129612034|NCT00587990|466535677|FG001|Overall Study|Death|0|||
129612035|NCT00587990|466535678|FG002|Overall Study|Death|1|||
129612036|NCT02754856|466535679|FG000|Overall Study|Withdrawal by Subject|1|||
129612037|NCT00530218|466535680|FG000|Overall Study|CMV Not Detected|13|||
129612038|NCT00530218|466535680|FG000|Overall Study|Death|12|||
129612039|NCT03477903|466535681|FG000|Overall Study|Study Terminated by Sponsor|1|||
129612040|NCT00426361|466535682|FG000|Overall Study|Lost to Follow-up|3|||
129612041|NCT00426361|466535683|FG001|Overall Study|Lost to Follow-up|2|||
129612042|NCT00426361|466535684|FG002|Overall Study|Lost to Follow-up|5|||
129612043|NCT00426361|466535682|FG000|Overall Study|Withdrawal by Subject|1|||
129612044|NCT00426361|466535683|FG001|Overall Study|Withdrawal by Subject|3|||
129612045|NCT00426361|466535684|FG002|Overall Study|Withdrawal by Subject|0|||
129612046|NCT02478320|466535685|FG000|Overall Study|Adverse Event|2|||
129612047|NCT02478320|466535686|FG001|Overall Study|Adverse Event|0|||
129612048|NCT02478320|466535685|FG000|Overall Study|Death|1|||
129612049|NCT02478320|466535686|FG001|Overall Study|Death|0|||
129612050|NCT02478320|466535685|FG000|Overall Study|Lack of Efficacy|4|||
129612051|NCT02478320|466535686|FG001|Overall Study|Lack of Efficacy|0|||
129612052|NCT02478320|466535685|FG000|Overall Study|Withdrawal by Subject|2|||
129612053|NCT02478320|466535686|FG001|Overall Study|Withdrawal by Subject|0|||
129612054|NCT02478320|466535685|FG000|Overall Study|Screen Failure|3|||
129612055|NCT02478320|466535686|FG001|Overall Study|Screen Failure|0|||
129612056|NCT03365011|466535687|FG000|Overall Study|Withdrawal by Subject|1|||
129439131|NCT00392327|465904574|FG005|Overall Study|Physician Decision|1|||
129439132|NCT00392327|465904575|FG006|Overall Study|Physician Decision|5|||
129439133|NCT00392327|465904576|FG007|Overall Study|Physician Decision|3|||
129439134|NCT00392327|465904569|FG000|Overall Study|Protocol Violation|0|||
129439135|NCT00392327|465904570|FG001|Overall Study|Protocol Violation|0|||
129439136|NCT00392327|465904571|FG002|Overall Study|Protocol Violation|1|||
129612057|NCT03365011|466535688|FG001|Overall Study|Withdrawal by Subject|2|||
129612058|NCT03480386|466535689|FG000|Overall Study|Did not complete measures at 3-months|17|||
129612059|NCT03480386|466535690|FG001|Overall Study|Did not complete measures at 3-months|14|||
129612060|NCT03480386|466535689|FG000|Overall Study|No baseline measures|11|||
129612061|NCT03480386|466535690|FG001|Overall Study|No baseline measures|14|||
129612062|NCT03480386|466535689|FG000|Overall Study|Death|0|||
129612063|NCT03480386|466535690|FG001|Overall Study|Death|5|||
129612064|NCT03480386|466535689|FG000|Overall Study|Withdrawal by Subject|12|||
129612065|NCT03480386|466535690|FG001|Overall Study|Withdrawal by Subject|8|||
129612066|NCT03480386|466535689|FG000|Overall Study|Lost to Follow-up|2|||
129612067|NCT03480386|466535690|FG001|Overall Study|Lost to Follow-up|1|||
129612068|NCT03480386|466535689|FG000|Overall Study|Complicating disease|0|||
129612069|NCT03480386|466535690|FG001|Overall Study|Complicating disease|1|||
129612070|NCT03480386|466535689|FG000|Overall Study|Disease progression|3|||
129612071|NCT03480386|466535690|FG001|Overall Study|Disease progression|0|||
129612072|NCT03480386|466535689|FG000|Overall Study|Became ineligible|0|||
129612073|NCT03480386|466535690|FG001|Overall Study|Became ineligible|2|||
129612074|NCT00574912|466535691|FG000|Overall Study|Could not place IV lines.|3|||
129612075|NCT00574912|466535691|FG000|Overall Study|scheduling conflicts|3|||
129612076|NCT00574912|466535691|FG000|Overall Study|Physician Decision|2|||
129612077|NCT02099682|466535694|FG000|Overall Study|Data Not Available|51|||
129612078|NCT02099682|466535694|FG000|Overall Study|Lost to Follow-up|31|||
129612079|NCT02099682|466535694|FG000|Overall Study|Other|29|||
129612080|NCT00805467|466537911|FG000|Overall Study|Lack of Efficacy|0|||
129612081|NCT00805467|466537912|FG001|Overall Study|Lack of Efficacy|8|||
129612082|NCT00805467|466537913|FG002|Overall Study|Lack of Efficacy|13|||
129612083|NCT00805467|466537914|FG003|Overall Study|Lack of Efficacy|86|||
129612084|NCT00805467|466537911|FG000|Overall Study|Lost to Follow-up|0|||
129612085|NCT00805467|466537912|FG001|Overall Study|Lost to Follow-up|1|||
129612086|NCT00805467|466537913|FG002|Overall Study|Lost to Follow-up|7|||
129612087|NCT00805467|466537914|FG003|Overall Study|Lost to Follow-up|21|||
129612088|NCT00805467|466537911|FG000|Overall Study|Withdrawal by Subject|0|||
129612089|NCT00805467|466537912|FG001|Overall Study|Withdrawal by Subject|6|||
129612090|NCT00805467|466537913|FG002|Overall Study|Withdrawal by Subject|45|||
129612091|NCT00805467|466537914|FG003|Overall Study|Withdrawal by Subject|50|||
129612092|NCT00805467|466537911|FG000|Overall Study|Protocol Violation|0|||
129612093|NCT00805467|466537912|FG001|Overall Study|Protocol Violation|3|||
129612094|NCT00805467|466537913|FG002|Overall Study|Protocol Violation|0|||
129612095|NCT00805467|466537914|FG003|Overall Study|Protocol Violation|5|||
129612096|NCT00805467|466537911|FG000|Overall Study|Adverse Event|0|||
129612097|NCT00805467|466537912|FG001|Overall Study|Adverse Event|13|||
129612098|NCT00805467|466537913|FG002|Overall Study|Adverse Event|26|||
129612099|NCT00805467|466537914|FG003|Overall Study|Adverse Event|57|||
129612100|NCT00805467|466537911|FG000|Overall Study|Death|0|||
129612101|NCT00805467|466537912|FG001|Overall Study|Death|2|||
129612102|NCT00805467|466537913|FG002|Overall Study|Death|7|||
129612103|NCT00805467|466537914|FG003|Overall Study|Death|5|||
129612104|NCT00805467|466537911|FG000|Overall Study|Physician Decision|0|||
129612105|NCT00805467|466537912|FG001|Overall Study|Physician Decision|1|||
129612106|NCT00805467|466537913|FG002|Overall Study|Physician Decision|2|||
129612107|NCT00805467|466537914|FG003|Overall Study|Physician Decision|6|||
129612108|NCT00805467|466537911|FG000|Overall Study|Not reported|0|||
129612109|NCT00805467|466537912|FG001|Overall Study|Not reported|0|||
129612110|NCT00805467|466537913|FG002|Overall Study|Not reported|3|||
129612111|NCT00805467|466537914|FG003|Overall Study|Not reported|7|||
129612112|NCT00213135|466537915|FG000|Overall Study|Adverse Event|9|||
129612113|NCT00213135|466537916|FG001|Overall Study|Adverse Event|5|||
129612114|NCT00213135|466537917|FG002|Overall Study|Adverse Event|5|||
129612115|NCT00213135|466537915|FG000|Overall Study|Lost to Follow-up|11|||
129612116|NCT00213135|466537916|FG001|Overall Study|Lost to Follow-up|8|||
129612117|NCT00213135|466537917|FG002|Overall Study|Lost to Follow-up|4|||
129612118|NCT00213135|466537915|FG000|Overall Study|Protocol Violation|4|||
129612119|NCT00213135|466537916|FG001|Overall Study|Protocol Violation|4|||
129612120|NCT00213135|466537917|FG002|Overall Study|Protocol Violation|10|||
129612121|NCT00213135|466537915|FG000|Overall Study|Death|1|||
129612122|NCT00213135|466537916|FG001|Overall Study|Death|1|||
129612123|NCT00213135|466537917|FG002|Overall Study|Death|2|||
129612124|NCT00213135|466537915|FG000|Overall Study|Disease progression|4|||
129612125|NCT00213135|466537916|FG001|Overall Study|Disease progression|5|||
129612126|NCT00213135|466537917|FG002|Overall Study|Disease progression|21|||
129612127|NCT00213135|466537915|FG000|Overall Study|Other|21|||
129612128|NCT00213135|466537916|FG001|Overall Study|Other|12|||
129612129|NCT00213135|466537917|FG002|Overall Study|Other|15|||
129699886|NCT05375929|466860809|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
129699887|NCT05375929|466860810|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
129439137|NCT00392327|465904572|FG003|Overall Study|Protocol Violation|0|||
129612130|NCT00660907|466537921|FG000|Overall Study|Incorrect Enrollment|1|||
129612131|NCT00660907|466537922|FG001|Overall Study|Incorrect Enrollment|1|||
129612132|NCT00660907|466537921|FG000|Overall Study|Adverse Event|33|||
129612133|NCT00660907|466537922|FG001|Overall Study|Adverse Event|19|||
129612134|NCT00660907|466537921|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
129612135|NCT00660907|466537922|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
129612136|NCT00660907|466537921|FG000|Overall Study|Withdrawal by Subject|23|||
129612137|NCT00660907|466537922|FG001|Overall Study|Withdrawal by Subject|32|||
129612138|NCT00660907|466537921|FG000|Overall Study|Lost to Follow-up|3|||
129612139|NCT00660907|466537922|FG001|Overall Study|Lost to Follow-up|3|||
129612140|NCT00660907|466537921|FG000|Overall Study|Poor/Non-Compliance|5|||
129612141|NCT00660907|466537922|FG001|Overall Study|Poor/Non-Compliance|1|||
129612142|NCT00660907|466537921|FG000|Overall Study|Safety|1|||
129612143|NCT00660907|466537922|FG001|Overall Study|Safety|0|||
129612144|NCT00660907|466537921|FG000|Overall Study|Death|1|||
129612145|NCT00660907|466537922|FG001|Overall Study|Death|3|||
129612146|NCT00660907|466537921|FG000|Overall Study|Various|11|||
129612147|NCT00660907|466537922|FG001|Overall Study|Various|8|||
129612148|NCT04975191|466537925|FG000|Overall Study|Protocol Violation|1|||
129612149|NCT04975191|466537926|FG001|Overall Study|Protocol Violation|2|||
129612150|NCT04975191|466537927|FG002|Overall Study|Protocol Violation|2|||
129612151|NCT04975191|466537928|FG003|Overall Study|Protocol Violation|2|||
129612152|NCT04975191|466537925|FG000|Overall Study|Lost to Follow-up|13|||
129612153|NCT04975191|466537926|FG001|Overall Study|Lost to Follow-up|3|||
129612154|NCT04975191|466537927|FG002|Overall Study|Lost to Follow-up|8|||
129612155|NCT04975191|466537928|FG003|Overall Study|Lost to Follow-up|8|||
129612156|NCT01056289|466537947|FG000|Open-label Phase|Adverse Event|29|||
129612157|NCT01056289|466537948|FG001|Open-label Phase|Adverse Event|0|||
129612158|NCT01056289|466537949|FG002|Open-label Phase|Adverse Event|0|||
129612159|NCT01056289|466537950|FG003|Open-label Phase|Adverse Event|0|||
129612160|NCT01056289|466537947|FG000|Open-label Phase|Lost to Follow-up|30|||
129612161|NCT01056289|466537948|FG001|Open-label Phase|Lost to Follow-up|0|||
129612162|NCT01056289|466537949|FG002|Open-label Phase|Lost to Follow-up|0|||
129612163|NCT01056289|466537950|FG003|Open-label Phase|Lost to Follow-up|0|||
129612164|NCT01056289|466537947|FG000|Open-label Phase|Other|9|||
129612165|NCT01056289|466537948|FG001|Open-label Phase|Other|0|||
129612166|NCT01056289|466537949|FG002|Open-label Phase|Other|0|||
129612167|NCT01056289|466537950|FG003|Open-label Phase|Other|0|||
129612168|NCT01056289|466537947|FG000|Open-label Phase|Protocol Violation|6|||
129612169|NCT01056289|466537948|FG001|Open-label Phase|Protocol Violation|0|||
129612170|NCT01056289|466537949|FG002|Open-label Phase|Protocol Violation|0|||
129612171|NCT01056289|466537950|FG003|Open-label Phase|Protocol Violation|0|||
129612172|NCT01056289|466537947|FG000|Open-label Phase|Withdrawal by Subject|26|||
129612173|NCT01056289|466537948|FG001|Open-label Phase|Withdrawal by Subject|0|||
129612174|NCT01056289|466537949|FG002|Open-label Phase|Withdrawal by Subject|0|||
129612175|NCT01056289|466537950|FG003|Open-label Phase|Withdrawal by Subject|0|||
129612176|NCT01056289|466537947|FG000|Open-label Phase|Lack of Efficacy|18|||
129612177|NCT01056289|466537948|FG001|Open-label Phase|Lack of Efficacy|0|||
129612178|NCT01056289|466537949|FG002|Open-label Phase|Lack of Efficacy|0|||
129612179|NCT01056289|466537950|FG003|Open-label Phase|Lack of Efficacy|0|||
129612180|NCT01056289|466537947|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
129612181|NCT01056289|466537948|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
129612182|NCT01056289|466537949|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
129612183|NCT01056289|466537950|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
129612184|NCT01056289|466537947|FG000|Double-blind Phase|Adverse Event|0|||
129612185|NCT01056289|466537948|FG001|Double-blind Phase|Adverse Event|1|||
129612186|NCT01056289|466537949|FG002|Double-blind Phase|Adverse Event|2|||
129612187|NCT01056289|466537950|FG003|Double-blind Phase|Adverse Event|1|||
129612188|NCT01056289|466537947|FG000|Double-blind Phase|Lost to Follow-up|0|||
129612189|NCT01056289|466537948|FG001|Double-blind Phase|Lost to Follow-up|2|||
129612190|NCT01056289|466537949|FG002|Double-blind Phase|Lost to Follow-up|2|||
129612191|NCT01056289|466537950|FG003|Double-blind Phase|Lost to Follow-up|2|||
129612192|NCT01056289|466537947|FG000|Double-blind Phase|Other|0|||
129612193|NCT01056289|466537948|FG001|Double-blind Phase|Other|0|||
129612194|NCT01056289|466537949|FG002|Double-blind Phase|Other|1|||
129612195|NCT01056289|466537950|FG003|Double-blind Phase|Other|2|||
129612196|NCT01056289|466537947|FG000|Double-blind Phase|Protocol Violation|0|||
129612197|NCT01056289|466537948|FG001|Double-blind Phase|Protocol Violation|0|||
129612198|NCT01056289|466537949|FG002|Double-blind Phase|Protocol Violation|1|||
129612199|NCT01056289|466537950|FG003|Double-blind Phase|Protocol Violation|1|||
129612200|NCT01056289|466537947|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129612201|NCT01056289|466537948|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129612202|NCT01056289|466537949|FG002|Double-blind Phase|Withdrawal by Subject|4|||
129612203|NCT01056289|466537950|FG003|Double-blind Phase|Withdrawal by Subject|2|||
129612204|NCT01056289|466537947|FG000|Double-blind Phase|Discontinuation symptom|0|||
129612205|NCT01056289|466537948|FG001|Double-blind Phase|Discontinuation symptom|1|||
129612206|NCT01056289|466537949|FG002|Double-blind Phase|Discontinuation symptom|2|||
129612207|NCT01056289|466537950|FG003|Double-blind Phase|Discontinuation symptom|2|||
129612208|NCT01056289|466537947|FG000|Double-blind Phase|Physician Decision|0|||
129612209|NCT01056289|466537948|FG001|Double-blind Phase|Physician Decision|0|||
129612210|NCT01056289|466537949|FG002|Double-blind Phase|Physician Decision|1|||
129612211|NCT01056289|466537950|FG003|Double-blind Phase|Physician Decision|0|||
129612212|NCT05776862|466537953|FG000|Overall Study|Adverse Event|0|||
129612213|NCT05776862|466537954|FG001|Overall Study|Adverse Event|1|||
129612214|NCT05776862|466537953|FG000|Overall Study|non-compliance|1|||
129612215|NCT05776862|466537954|FG001|Overall Study|non-compliance|0|||
129612216|NCT01199471|466537955|FG000|Overall Study|Protocol Violation|4|||
129612217|NCT01199471|466537955|FG000|Overall Study|Withdrawal by Subject|1|||
129612218|NCT01199471|466537955|FG000|Overall Study|Physician Decision|1|||
129612219|NCT02065700|466537956|FG000|Overall Study|Adverse Event|165|||
129612220|NCT02065700|466537957|FG001|Overall Study|Adverse Event|101|||
129612221|NCT02065700|466537956|FG000|Overall Study|Withdrawal by Subject|90|||
129612222|NCT02065700|466537957|FG001|Overall Study|Withdrawal by Subject|29|||
129612223|NCT02065700|466537956|FG000|Overall Study|Lost to Follow-up|12|||
129612224|NCT02065700|466537957|FG001|Overall Study|Lost to Follow-up|9|||
129612225|NCT02065700|466537956|FG000|Overall Study|Physician Decision|2|||
129612226|NCT02065700|466537957|FG001|Overall Study|Physician Decision|0|||
129612227|NCT02065700|466537956|FG000|Overall Study|Sponsor Request|38|||
129612228|NCT02065700|466537957|FG001|Overall Study|Sponsor Request|15|||
129612229|NCT02065700|466537956|FG000|Overall Study|Treatment Failure|3|||
129612230|NCT02065700|466537957|FG001|Overall Study|Treatment Failure|2|||
129612231|NCT02065700|466537956|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
129612232|NCT02065700|466537957|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
129612233|NCT02065700|466537956|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
129612234|NCT02065700|466537957|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
129612235|NCT02065700|466537956|FG000|Overall Study|Non-compliance with Study Procedures|2|||
129612236|NCT02065700|466537957|FG001|Overall Study|Non-compliance with Study Procedures|0|||
129612237|NCT02065700|466537956|FG000|Overall Study|Not Defined|21|||
129612238|NCT02065700|466537957|FG001|Overall Study|Not Defined|3|||
129612239|NCT03511326|466537965|FG000|Overall Study|Withdrawal by Subject|1|||
129612240|NCT04746794|466537966|FG000|Overall Study|Did not complete any study assessment|50303|||
129612241|NCT04746794|466537967|FG001|Overall Study|Did not complete any study assessment|44997|||
129612242|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
129612243|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
129612244|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
129612245|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
129612246|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
129612247|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
129612248|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
129612249|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
129612250|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
129612251|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
129612252|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
129612253|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
129612254|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
129612255|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
129612256|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
129612257|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
129612258|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
129612259|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
129612260|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
129699888|NCT05375929|466860807|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
129699889|NCT05375929|466860808|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
129612261|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
129699890|NCT05375929|466860809|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
129699891|NCT05375929|466860810|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
129699892|NCT05375929|466860807|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
129699893|NCT05375929|466860808|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
129699894|NCT05375929|466860809|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
129699895|NCT05375929|466860810|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
129699896|NCT05375929|466860807|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
129699897|NCT05375929|466860808|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
129699898|NCT05375929|466860809|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
129699899|NCT05375929|466860810|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
129699900|NCT05375929|466860807|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
129699901|NCT05375929|466860808|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
129699902|NCT05375929|466860809|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
129699903|NCT05375929|466860810|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
129699904|NCT05375929|466860807|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
129699905|NCT05375929|466860808|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
129699906|NCT05375929|466860809|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
129699907|NCT05375929|466860810|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
129612262|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
129699908|NCT05375929|466860807|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
129790836|NCT02095132|467201435|FG005|Overall Study|Adverse Event|0|||
129699909|NCT05375929|466860808|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
129699910|NCT05375929|466860809|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
129699911|NCT05375929|466860810|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
129699912|NCT05375929|466860807|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
129699913|NCT05375929|466860808|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
129699914|NCT05375929|466860809|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
129790837|NCT02095132|467201436|FG006|Overall Study|Adverse Event|1|||
129790838|NCT02095132|467201437|FG007|Overall Study|Adverse Event|0|||
129790839|NCT02095132|467201438|FG008|Overall Study|Adverse Event|0|||
129790840|NCT02095132|467201430|FG000|Overall Study|Death|0|||
129790841|NCT02095132|467201431|FG001|Overall Study|Death|0|||
129790842|NCT02095132|467201432|FG002|Overall Study|Death|0|||
129790843|NCT02095132|467201433|FG003|Overall Study|Death|0|||
129790844|NCT02095132|467201434|FG004|Overall Study|Death|0|||
129790845|NCT02095132|467201435|FG005|Overall Study|Death|0|||
129790846|NCT02095132|467201436|FG006|Overall Study|Death|1|||
129790847|NCT02095132|467201437|FG007|Overall Study|Death|0|||
129790848|NCT02095132|467201438|FG008|Overall Study|Death|0|||
129790849|NCT02095132|467201430|FG000|Overall Study|Lack of Efficacy|3|||
129790850|NCT02095132|467201431|FG001|Overall Study|Lack of Efficacy|5|||
129790851|NCT02095132|467201432|FG002|Overall Study|Lack of Efficacy|2|||
129790852|NCT02095132|467201433|FG003|Overall Study|Lack of Efficacy|8|||
129790853|NCT02095132|467201434|FG004|Overall Study|Lack of Efficacy|3|||
129790854|NCT02095132|467201435|FG005|Overall Study|Lack of Efficacy|6|||
129790855|NCT02095132|467201436|FG006|Overall Study|Lack of Efficacy|10|||
129790856|NCT02095132|467201437|FG007|Overall Study|Lack of Efficacy|9|||
129790857|NCT02095132|467201438|FG008|Overall Study|Lack of Efficacy|8|||
129790858|NCT02095132|467201430|FG000|Overall Study|Physician Decision|1|||
129790859|NCT02095132|467201431|FG001|Overall Study|Physician Decision|0|||
129699915|NCT05375929|466860810|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
129699916|NCT00773461|466860815|FG000|Overall Study|Adverse Event|1|||
129699917|NCT00773461|466860816|FG001|Overall Study|Adverse Event|3|||
129699918|NCT00773461|466860815|FG000|Overall Study|Withdrawal by Subject|4|||
129699919|NCT00773461|466860816|FG001|Overall Study|Withdrawal by Subject|1|||
129699920|NCT00322218|466860819|FG000|Overall Study|Death|3|||
129699921|NCT00322218|466860820|FG001|Overall Study|Death|6|||
129699922|NCT00908141|466860822|FG000|Overall Study|Withdrawal by Subject|0|||
129699923|NCT00908141|466860823|FG001|Overall Study|Withdrawal by Subject|1|||
129699924|NCT02520154|466860824|FG000|Overall Study|Death|1|||
129699925|NCT02520154|466860824|FG000|Overall Study|Withdrawal by Subject|2|||
129699926|NCT02520154|466860824|FG000|Overall Study|Physician Decision|2|||
129699927|NCT02254291|466862427|FG000|Overall Study|Withdrawal by Subject|0|||
129699928|NCT02254291|466862428|FG001|Overall Study|Withdrawal by Subject|3|||
129699929|NCT02254291|466862429|FG002|Overall Study|Withdrawal by Subject|1|||
129699930|NCT02254291|466862427|FG000|Overall Study|Missing follow-up information|0|||
129699931|NCT02254291|466862428|FG001|Overall Study|Missing follow-up information|0|||
129699932|NCT02254291|466862429|FG002|Overall Study|Missing follow-up information|1|||
129699933|NCT00488293|466862434|FG000|Overall Study|Lost to Follow-up|28|||
129699934|NCT00488293|466862435|FG001|Overall Study|Lost to Follow-up|25|||
129699935|NCT00488293|466862434|FG000|Overall Study|Withdrawal by Subject|5|||
129699936|NCT00488293|466862435|FG001|Overall Study|Withdrawal by Subject|3|||
129699937|NCT00488293|466862434|FG000|Overall Study|Death|2|||
129699938|NCT00488293|466862435|FG001|Overall Study|Death|1|||
129699939|NCT00488293|466862434|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
129699940|NCT00488293|466862435|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
129699941|NCT00500331|466862436|FG000|Overall Study|Adverse Event|0|||
129699942|NCT00500331|466862437|FG001|Overall Study|Adverse Event|2|||
129699943|NCT00500331|466862438|FG002|Overall Study|Adverse Event|0|||
129699944|NCT00500331|466862439|FG003|Overall Study|Adverse Event|1|||
129699945|NCT00500331|466862440|FG004|Overall Study|Adverse Event|2|||
129699946|NCT00500331|466862441|FG005|Overall Study|Adverse Event|2|||
129699947|NCT00500331|466862442|FG006|Overall Study|Adverse Event|0|||
129699948|NCT00500331|466862436|FG000|Overall Study|Lost to Follow-up|1|||
129699949|NCT00500331|466862437|FG001|Overall Study|Lost to Follow-up|1|||
129699950|NCT00500331|466862438|FG002|Overall Study|Lost to Follow-up|1|||
129699951|NCT00500331|466862439|FG003|Overall Study|Lost to Follow-up|2|||
129699952|NCT00500331|466862440|FG004|Overall Study|Lost to Follow-up|1|||
129699953|NCT00500331|466862441|FG005|Overall Study|Lost to Follow-up|0|||
129699954|NCT00500331|466862442|FG006|Overall Study|Lost to Follow-up|0|||
129790860|NCT02095132|467201432|FG002|Overall Study|Physician Decision|0|||
129790861|NCT02095132|467201433|FG003|Overall Study|Physician Decision|0|||
129790862|NCT02095132|467201434|FG004|Overall Study|Physician Decision|0|||
129790863|NCT02095132|467201435|FG005|Overall Study|Physician Decision|0|||
129790864|NCT02095132|467201436|FG006|Overall Study|Physician Decision|1|||
129439138|NCT00392327|465904573|FG004|Overall Study|Protocol Violation|0|||
129439139|NCT00392327|465904574|FG005|Overall Study|Protocol Violation|0|||
129612263|NCT04040192|466537968|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
129790865|NCT02095132|467201437|FG007|Overall Study|Physician Decision|0|||
129790866|NCT02095132|467201438|FG008|Overall Study|Physician Decision|2|||
129612264|NCT04040192|466537969|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
129612265|NCT04040192|466537970|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
129612266|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
129612267|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
129612268|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
129612269|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
129612270|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
129612271|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
129612272|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
129612273|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
129612274|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
129612275|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
129612276|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
129612277|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
129612278|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129612279|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
129612280|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
129612281|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
129612282|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
129612283|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
129612284|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
129612285|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
129612286|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
129612287|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
129612288|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
129612289|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
129612290|NCT04040192|466537968|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
129612291|NCT04040192|466537969|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
129612292|NCT04040192|466537970|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
129612293|NCT03207243|466537971|FG000|Overall Study|Adverse Event|2|||
129612294|NCT03207243|466537972|FG001|Overall Study|Adverse Event|2|||
129612295|NCT03207243|466537971|FG000|Overall Study|Loss of Asthma Control|47|||
129612296|NCT03207243|466537972|FG001|Overall Study|Loss of Asthma Control|31|||
129612297|NCT03207243|466537971|FG000|Overall Study|Withdrawal by Subject|2|||
129612298|NCT03207243|466537972|FG001|Overall Study|Withdrawal by Subject|4|||
129699955|NCT00500331|466862436|FG000|Overall Study|Protocol Violation|3|||
129699956|NCT00500331|466862437|FG001|Overall Study|Protocol Violation|1|||
129699957|NCT00500331|466862438|FG002|Overall Study|Protocol Violation|1|||
129699958|NCT00500331|466862439|FG003|Overall Study|Protocol Violation|0|||
129699959|NCT00500331|466862440|FG004|Overall Study|Protocol Violation|1|||
129699960|NCT00500331|466862441|FG005|Overall Study|Protocol Violation|1|||
129612299|NCT03207243|466537971|FG000|Overall Study|Physician Decision|1|||
129612300|NCT03207243|466537972|FG001|Overall Study|Physician Decision|1|||
129612301|NCT03207243|466537971|FG000|Overall Study|Lost to Follow-up|0|||
129612302|NCT03207243|466537972|FG001|Overall Study|Lost to Follow-up|1|||
129612303|NCT03207243|466537971|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
129612304|NCT03207243|466537972|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
129612305|NCT03207243|466537971|FG000|Overall Study|Protocol Violation|0|||
129612306|NCT03207243|466537972|FG001|Overall Study|Protocol Violation|3|||
129612307|NCT00229723|466537973|FG000|Concomitant Phase|Adverse Event|4|||
129612308|NCT00229723|466537974|FG001|Concomitant Phase|Adverse Event|2|||
129612309|NCT00229723|466537975|FG002|Concomitant Phase|Adverse Event|5|||
129612310|NCT00229723|466537976|FG003|Concomitant Phase|Adverse Event|2|||
129612311|NCT00229723|466537977|FG004|Concomitant Phase|Adverse Event|0|||
129612312|NCT00229723|466537978|FG005|Concomitant Phase|Adverse Event|1|||
129612313|NCT00229723|466537979|FG006|Concomitant Phase|Adverse Event|2|||
129612314|NCT00229723|466537973|FG000|Concomitant Phase|Objective disease progression|0|||
129612315|NCT00229723|466537974|FG001|Concomitant Phase|Objective disease progression|0|||
129612316|NCT00229723|466537975|FG002|Concomitant Phase|Objective disease progression|0|||
129612317|NCT00229723|466537976|FG003|Concomitant Phase|Objective disease progression|0|||
129612318|NCT00229723|466537977|FG004|Concomitant Phase|Objective disease progression|0|||
129612319|NCT00229723|466537978|FG005|Concomitant Phase|Objective disease progression|0|||
129612320|NCT00229723|466537979|FG006|Concomitant Phase|Objective disease progression|0|||
129612321|NCT00229723|466537973|FG000|Concomitant Phase|Clinical progression|0|||
129699961|NCT00500331|466862442|FG006|Overall Study|Protocol Violation|1|||
129699962|NCT00500331|466862436|FG000|Overall Study|Withdrawal by Subject|4|||
129612322|NCT00229723|466537974|FG001|Concomitant Phase|Clinical progression|0|||
129612323|NCT00229723|466537975|FG002|Concomitant Phase|Clinical progression|0|||
129612324|NCT00229723|466537976|FG003|Concomitant Phase|Clinical progression|0|||
129612325|NCT00229723|466537977|FG004|Concomitant Phase|Clinical progression|0|||
129699963|NCT00500331|466862437|FG001|Overall Study|Withdrawal by Subject|0|||
129699964|NCT00500331|466862438|FG002|Overall Study|Withdrawal by Subject|1|||
129439140|NCT00392327|465904575|FG006|Overall Study|Protocol Violation|0|||
129439141|NCT00392327|465904576|FG007|Overall Study|Protocol Violation|0|||
129612326|NCT00229723|466537978|FG005|Concomitant Phase|Clinical progression|0|||
129612327|NCT00229723|466537979|FG006|Concomitant Phase|Clinical progression|1|||
129612328|NCT00229723|466537973|FG000|Concomitant Phase|Lost to Follow-up|0|||
129612329|NCT00229723|466537974|FG001|Concomitant Phase|Lost to Follow-up|0|||
129612330|NCT00229723|466537975|FG002|Concomitant Phase|Lost to Follow-up|0|||
129612331|NCT00229723|466537976|FG003|Concomitant Phase|Lost to Follow-up|0|||
129612332|NCT00229723|466537977|FG004|Concomitant Phase|Lost to Follow-up|1|||
129612333|NCT00229723|466537978|FG005|Concomitant Phase|Lost to Follow-up|0|||
129612334|NCT00229723|466537979|FG006|Concomitant Phase|Lost to Follow-up|0|||
129612335|NCT00229723|466537973|FG000|Concomitant Phase|Informed consent withdrawn|3|||
129612336|NCT00229723|466537974|FG001|Concomitant Phase|Informed consent withdrawn|2|||
129612337|NCT00229723|466537975|FG002|Concomitant Phase|Informed consent withdrawn|0|||
129612338|NCT00229723|466537976|FG003|Concomitant Phase|Informed consent withdrawn|2|||
129612339|NCT00229723|466537977|FG004|Concomitant Phase|Informed consent withdrawn|0|||
129612340|NCT00229723|466537978|FG005|Concomitant Phase|Informed consent withdrawn|0|||
129612341|NCT00229723|466537979|FG006|Concomitant Phase|Informed consent withdrawn|0|||
129612342|NCT00229723|466537973|FG000|Concomitant Phase|Severe non-compliance|0|||
129612343|NCT00229723|466537974|FG001|Concomitant Phase|Severe non-compliance|1|||
129612344|NCT00229723|466537975|FG002|Concomitant Phase|Severe non-compliance|0|||
129612345|NCT00229723|466537976|FG003|Concomitant Phase|Severe non-compliance|0|||
129612346|NCT00229723|466537977|FG004|Concomitant Phase|Severe non-compliance|1|||
129612347|NCT00229723|466537978|FG005|Concomitant Phase|Severe non-compliance|0|||
129612348|NCT00229723|466537979|FG006|Concomitant Phase|Severe non-compliance|0|||
129612349|NCT00229723|466537973|FG000|Concomitant Phase|Other|3|||
129612350|NCT00229723|466537974|FG001|Concomitant Phase|Other|0|||
129612351|NCT00229723|466537975|FG002|Concomitant Phase|Other|1|||
129612352|NCT00229723|466537976|FG003|Concomitant Phase|Other|1|||
129612353|NCT00229723|466537977|FG004|Concomitant Phase|Other|0|||
129612354|NCT00229723|466537978|FG005|Concomitant Phase|Other|2|||
129612355|NCT00229723|466537979|FG006|Concomitant Phase|Other|0|||
129612356|NCT00229723|466537973|FG000|Maintenance Phase|Adverse Event|7|||
129612357|NCT00229723|466537974|FG001|Maintenance Phase|Adverse Event|2|||
129612358|NCT00229723|466537975|FG002|Maintenance Phase|Adverse Event|1|||
129612359|NCT00229723|466537976|FG003|Maintenance Phase|Adverse Event|4|||
129612360|NCT00229723|466537977|FG004|Maintenance Phase|Adverse Event|7|||
129612361|NCT00229723|466537978|FG005|Maintenance Phase|Adverse Event|5|||
129612362|NCT00229723|466537979|FG006|Maintenance Phase|Adverse Event|2|||
129612363|NCT00229723|466537973|FG000|Maintenance Phase|Objective disease progression|5|||
129612364|NCT00229723|466537974|FG001|Maintenance Phase|Objective disease progression|5|||
129439142|NCT00392327|465904569|FG000|Overall Study|Withdrawal by Subject|3|||
129439143|NCT00392327|465904570|FG001|Overall Study|Withdrawal by Subject|2|||
129612365|NCT00229723|466537975|FG002|Maintenance Phase|Objective disease progression|3|||
129612366|NCT00229723|466537976|FG003|Maintenance Phase|Objective disease progression|6|||
129612367|NCT00229723|466537977|FG004|Maintenance Phase|Objective disease progression|2|||
129612368|NCT00229723|466537978|FG005|Maintenance Phase|Objective disease progression|9|||
129699965|NCT00500331|466862439|FG003|Overall Study|Withdrawal by Subject|5|||
129612369|NCT00229723|466537979|FG006|Maintenance Phase|Objective disease progression|5|||
129612370|NCT00229723|466537973|FG000|Maintenance Phase|Clinical progression|4|||
129612371|NCT00229723|466537974|FG001|Maintenance Phase|Clinical progression|1|||
129612372|NCT00229723|466537975|FG002|Maintenance Phase|Clinical progression|2|||
129612373|NCT00229723|466537976|FG003|Maintenance Phase|Clinical progression|2|||
129612374|NCT00229723|466537977|FG004|Maintenance Phase|Clinical progression|1|||
129612375|NCT00229723|466537978|FG005|Maintenance Phase|Clinical progression|1|||
129612376|NCT00229723|466537979|FG006|Maintenance Phase|Clinical progression|1|||
129612377|NCT00229723|466537973|FG000|Maintenance Phase|Lost to Follow-up|0|||
129612378|NCT00229723|466537974|FG001|Maintenance Phase|Lost to Follow-up|1|||
129612379|NCT00229723|466537975|FG002|Maintenance Phase|Lost to Follow-up|2|||
129612380|NCT00229723|466537976|FG003|Maintenance Phase|Lost to Follow-up|2|||
129612381|NCT00229723|466537977|FG004|Maintenance Phase|Lost to Follow-up|0|||
129612382|NCT00229723|466537978|FG005|Maintenance Phase|Lost to Follow-up|0|||
129612383|NCT00229723|466537979|FG006|Maintenance Phase|Lost to Follow-up|1|||
129612384|NCT00229723|466537973|FG000|Maintenance Phase|Informed consent withdrawn|1|||
129612385|NCT00229723|466537974|FG001|Maintenance Phase|Informed consent withdrawn|0|||
129612386|NCT00229723|466537975|FG002|Maintenance Phase|Informed consent withdrawn|0|||
129612387|NCT00229723|466537976|FG003|Maintenance Phase|Informed consent withdrawn|1|||
129612388|NCT00229723|466537977|FG004|Maintenance Phase|Informed consent withdrawn|1|||
129612389|NCT00229723|466537978|FG005|Maintenance Phase|Informed consent withdrawn|1|||
129612390|NCT00229723|466537979|FG006|Maintenance Phase|Informed consent withdrawn|0|||
129612391|NCT00229723|466537973|FG000|Maintenance Phase|Severe non-compliance|3|||
129612392|NCT00229723|466537974|FG001|Maintenance Phase|Severe non-compliance|1|||
129612393|NCT00229723|466537975|FG002|Maintenance Phase|Severe non-compliance|0|||
129612394|NCT00229723|466537976|FG003|Maintenance Phase|Severe non-compliance|0|||
129699966|NCT00500331|466862440|FG004|Overall Study|Withdrawal by Subject|0|||
129699967|NCT00500331|466862441|FG005|Overall Study|Withdrawal by Subject|1|||
129699968|NCT00500331|466862442|FG006|Overall Study|Withdrawal by Subject|1|||
129612395|NCT00229723|466537977|FG004|Maintenance Phase|Severe non-compliance|1|||
129612396|NCT00229723|466537978|FG005|Maintenance Phase|Severe non-compliance|0|||
129612397|NCT00229723|466537979|FG006|Maintenance Phase|Severe non-compliance|0|||
129612398|NCT00229723|466537973|FG000|Maintenance Phase|Other|5|||
129612399|NCT00229723|466537974|FG001|Maintenance Phase|Other|4|||
129612400|NCT00229723|466537975|FG002|Maintenance Phase|Other|1|||
129612401|NCT00229723|466537976|FG003|Maintenance Phase|Other|2|||
129612402|NCT00229723|466537977|FG004|Maintenance Phase|Other|3|||
129612403|NCT00229723|466537978|FG005|Maintenance Phase|Other|3|||
129612404|NCT00229723|466537979|FG006|Maintenance Phase|Other|1|||
129612405|NCT00735397|466537982|FG000|Overall Study|Adverse Event|194|||
129612406|NCT00735397|466537982|FG000|Overall Study|Lost to Follow-up|33|||
129790867|NCT02095132|467201430|FG000|Overall Study|Withdrawal by Subject|0|||
129612407|NCT00735397|466537982|FG000|Overall Study|Participant choice|252|||
129612408|NCT00735397|466537982|FG000|Overall Study|Inadequate therapeutic effect|202|||
129612409|NCT00735397|466537982|FG000|Overall Study|Administrative/Other|502|||
129612410|NCT03016975|466537987|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
129612411|NCT03016975|466537988|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
129612412|NCT03016975|466537989|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
129612413|NCT03016975|466537987|FG000|At 6 Months Follow-up|Death|2|||
129612414|NCT03016975|466537988|FG001|At 6 Months Follow-up|Death|0|||
129612415|NCT03016975|466537989|FG002|At 6 Months Follow-up|Death|0|||
129612416|NCT03016975|466537987|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
129612417|NCT03016975|466537988|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
129612418|NCT03016975|466537989|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
129612419|NCT03016975|466537987|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
129612420|NCT03016975|466537988|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
129612421|NCT03016975|466537989|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
129612422|NCT03016975|466537987|FG000|At 6 Months Follow-up|Aborted implant|1|||
129612423|NCT03016975|466537988|FG001|At 6 Months Follow-up|Aborted implant|0|||
129612424|NCT03016975|466537989|FG002|At 6 Months Follow-up|Aborted implant|0|||
129612425|NCT03016975|466537987|FG000|At 2 Year Follow-up|Death|1|||
129612426|NCT03016975|466537988|FG001|At 2 Year Follow-up|Death|0|||
129612427|NCT03016975|466537989|FG002|At 2 Year Follow-up|Death|0|||
129612428|NCT03016975|466537987|FG000|At 3 Year Follow-up|Death|1|||
129612429|NCT03016975|466537988|FG001|At 3 Year Follow-up|Death|0|||
129612430|NCT03016975|466537989|FG002|At 3 Year Follow-up|Death|0|||
129612431|NCT03016975|466537987|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
129612432|NCT03016975|466537988|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
129612433|NCT03016975|466537989|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
129612434|NCT03016975|466537987|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
129612435|NCT03016975|466537988|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
129612436|NCT03016975|466537989|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
129612437|NCT01590797|466537992|FG000|Overall Study|Adverse Event|4|||
129612438|NCT01590797|466537993|FG001|Overall Study|Adverse Event|3|||
129612439|NCT01590797|466537992|FG000|Overall Study|Lack of Efficacy|0|||
129612440|NCT01590797|466537993|FG001|Overall Study|Lack of Efficacy|2|||
129612441|NCT01590797|466537992|FG000|Overall Study|Lost to Follow-up|0|||
129612442|NCT01590797|466537993|FG001|Overall Study|Lost to Follow-up|1|||
129612443|NCT01590797|466537992|FG000|Overall Study|Protocol Violation|4|||
129612444|NCT01590797|466537993|FG001|Overall Study|Protocol Violation|1|||
129612445|NCT01590797|466537992|FG000|Overall Study|Withdrawal by Subject|7|||
129790868|NCT02095132|467201431|FG001|Overall Study|Withdrawal by Subject|0|||
129790869|NCT02095132|467201432|FG002|Overall Study|Withdrawal by Subject|2|||
129790870|NCT02095132|467201433|FG003|Overall Study|Withdrawal by Subject|2|||
129790871|NCT02095132|467201434|FG004|Overall Study|Withdrawal by Subject|3|||
129790872|NCT02095132|467201435|FG005|Overall Study|Withdrawal by Subject|0|||
129790873|NCT02095132|467201436|FG006|Overall Study|Withdrawal by Subject|5|||
129790874|NCT02095132|467201437|FG007|Overall Study|Withdrawal by Subject|0|||
129790875|NCT02095132|467201438|FG008|Overall Study|Withdrawal by Subject|0|||
129790876|NCT00409175|467201439|FG000|Overall Study|Adverse Event|4|||
129612446|NCT01590797|466537993|FG001|Overall Study|Withdrawal by Subject|5|||
129612447|NCT01590797|466537992|FG000|Overall Study|Other Protocol Specified Criteria|2|||
129790877|NCT00409175|467201440|FG001|Overall Study|Adverse Event|3|||
129790878|NCT00409175|467201439|FG000|Overall Study|Withdrawal by Subject|1|||
129790879|NCT00409175|467201440|FG001|Overall Study|Withdrawal by Subject|2|||
129790880|NCT00409175|467201439|FG000|Overall Study|Negative genotype|0|||
129790881|NCT00409175|467201440|FG001|Overall Study|Negative genotype|1|||
129790882|NCT00409175|467201439|FG000|Overall Study|Liver transplantation|13|||
129790883|NCT00409175|467201440|FG001|Overall Study|Liver transplantation|13|||
129790884|NCT02108262|467201443|FG000|Overall Study|Non-compliance|0|||
129790885|NCT02108262|467201444|FG001|Overall Study|Non-compliance|2|||
129790886|NCT02108262|467201445|FG002|Overall Study|Non-compliance|1|||
129887008|NCT02555371|467547211|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
129887009|NCT02555371|467547212|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
129612448|NCT01590797|466537993|FG001|Overall Study|Other Protocol Specified Criteria|4|||
129612449|NCT00901576|466537999|FG000|Second Intervention|Withdrawal by Subject|0|||
129612450|NCT00901576|466538000|FG001|Second Intervention|Withdrawal by Subject|0|||
129612451|NCT00901576|466538001|FG002|Second Intervention|Withdrawal by Subject|0|||
129612452|NCT00901576|466538002|FG003|Second Intervention|Withdrawal by Subject|1|||
129612453|NCT00901576|466538003|FG004|Second Intervention|Withdrawal by Subject|0|||
129612454|NCT00901576|466538004|FG005|Second Intervention|Withdrawal by Subject|1|||
129612455|NCT00901576|466537999|FG000|Second Intervention|Physician Decision|1|||
129612456|NCT00901576|466538000|FG001|Second Intervention|Physician Decision|0|||
129612457|NCT00901576|466538001|FG002|Second Intervention|Physician Decision|0|||
129612458|NCT00901576|466538002|FG003|Second Intervention|Physician Decision|0|||
129612459|NCT00901576|466538003|FG004|Second Intervention|Physician Decision|0|||
129612460|NCT00901576|466538004|FG005|Second Intervention|Physician Decision|0|||
129612461|NCT01559389|466538005|FG000|Overall Study|Withdrawal by Subject|20|||
129612462|NCT01559389|466538006|FG001|Overall Study|Withdrawal by Subject|20|||
129612463|NCT03201445|466538007|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
129612464|NCT03201445|466538008|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
129612465|NCT03201445|466538007|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
129612466|NCT03201445|466538008|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
129612467|NCT03201445|466538007|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
129612468|NCT03201445|466538008|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
129612469|NCT03201445|466538007|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
129612470|NCT03201445|466538008|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
129612471|NCT03201445|466538007|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
129612472|NCT03201445|466538008|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
129612473|NCT03201445|466538007|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
129612474|NCT03201445|466538008|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
129612475|NCT03201445|466538007|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
129612476|NCT03201445|466538008|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
129612477|NCT03201445|466538007|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
129612478|NCT03201445|466538008|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
129612479|NCT03201445|466538007|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
129612480|NCT03201445|466538008|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
129612481|NCT03201445|466538007|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
129612482|NCT03201445|466538008|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
129612483|NCT03201445|466538007|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
129612484|NCT03201445|466538008|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
129612485|NCT03201445|466538007|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
129612486|NCT03201445|466538008|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
129612487|NCT03201445|466538007|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
129612488|NCT03201445|466538008|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
129612489|NCT03201445|466538007|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
129612490|NCT03201445|466538008|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
129612491|NCT03201445|466538007|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
129612492|NCT03201445|466538008|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
129612493|NCT03201445|466538007|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
129612494|NCT03201445|466538008|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
129612495|NCT03201445|466538007|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
129612496|NCT03201445|466538008|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
129612497|NCT03201445|466538007|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
129612498|NCT03201445|466538008|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
129612499|NCT03201445|466538007|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
129612500|NCT03201445|466538008|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
129612501|NCT03201445|466538007|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
129612502|NCT03201445|466538008|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
129612503|NCT03201445|466538007|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
129612504|NCT03201445|466538008|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
129612505|NCT01228019|466538009|FG000|Overall Study|Dose Violation|70|||
129612506|NCT01228019|466538009|FG000|Overall Study|Duplicate enrollment|1|||
129612507|NCT01228019|466538009|FG000|Overall Study|Missing pre-treatment data|72|||
129612508|NCT01228019|466538009|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
129612509|NCT01228019|466538009|FG000|Overall Study|Violation of Entry Criterion|9|||
129612510|NCT01346293|466538012|FG000|Overall Study|Protocol Violation|30|||
129699969|NCT00500331|466862436|FG000|Overall Study|Lack of Efficacy|3|||
129699970|NCT00500331|466862437|FG001|Overall Study|Lack of Efficacy|1|||
129699971|NCT00500331|466862438|FG002|Overall Study|Lack of Efficacy|0|||
129699972|NCT00500331|466862439|FG003|Overall Study|Lack of Efficacy|0|||
129699973|NCT00500331|466862440|FG004|Overall Study|Lack of Efficacy|0|||
129699974|NCT00500331|466862441|FG005|Overall Study|Lack of Efficacy|0|||
129699975|NCT00500331|466862442|FG006|Overall Study|Lack of Efficacy|0|||
129699976|NCT00500331|466862436|FG000|Overall Study|Liver function test abnormality|0|||
129699977|NCT00500331|466862437|FG001|Overall Study|Liver function test abnormality|0|||
129699978|NCT00500331|466862438|FG002|Overall Study|Liver function test abnormality|1|||
129699979|NCT00500331|466862439|FG003|Overall Study|Liver function test abnormality|0|||
129699980|NCT00500331|466862440|FG004|Overall Study|Liver function test abnormality|0|||
129699981|NCT00500331|466862441|FG005|Overall Study|Liver function test abnormality|0|||
129699982|NCT00500331|466862442|FG006|Overall Study|Liver function test abnormality|0|||
129699983|NCT00500331|466862436|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
129699984|NCT00500331|466862437|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
129699985|NCT00500331|466862438|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
129699986|NCT00500331|466862439|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
129699987|NCT00500331|466862440|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
129699988|NCT00500331|466862441|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
129699989|NCT00500331|466862442|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
129699990|NCT00500331|466862436|FG000|Overall Study|Didn't return for continuation of study|1|||
129699991|NCT00500331|466862437|FG001|Overall Study|Didn't return for continuation of study|0|||
129699992|NCT00500331|466862438|FG002|Overall Study|Didn't return for continuation of study|0|||
129699993|NCT00500331|466862439|FG003|Overall Study|Didn't return for continuation of study|0|||
129699994|NCT00500331|466862440|FG004|Overall Study|Didn't return for continuation of study|0|||
129699995|NCT00500331|466862441|FG005|Overall Study|Didn't return for continuation of study|0|||
129699996|NCT00500331|466862442|FG006|Overall Study|Didn't return for continuation of study|0|||
129699997|NCT00500331|466862436|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
129699998|NCT00500331|466862437|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
129699999|NCT00500331|466862438|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
129700000|NCT00500331|466862439|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
129700001|NCT00500331|466862440|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
129700002|NCT00500331|466862441|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
129700003|NCT00500331|466862442|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
129700004|NCT00500331|466862436|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
129700005|NCT00500331|466862437|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
129700006|NCT00500331|466862438|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
129700007|NCT00500331|466862439|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
129700008|NCT00500331|466862440|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
129700009|NCT00500331|466862441|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
129700010|NCT00500331|466862442|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
129700011|NCT00500331|466862436|FG000|Overall Study|Participant was randomized by mistake|1|||
129700012|NCT00500331|466862437|FG001|Overall Study|Participant was randomized by mistake|0|||
129700013|NCT00500331|466862438|FG002|Overall Study|Participant was randomized by mistake|0|||
129700014|NCT00500331|466862439|FG003|Overall Study|Participant was randomized by mistake|0|||
129700015|NCT00500331|466862440|FG004|Overall Study|Participant was randomized by mistake|0|||
129700016|NCT00500331|466862441|FG005|Overall Study|Participant was randomized by mistake|0|||
129700017|NCT00500331|466862442|FG006|Overall Study|Participant was randomized by mistake|0|||
129700018|NCT00500331|466862436|FG000|Overall Study|Diabetologist nurse in the study|0|||
129700019|NCT00500331|466862437|FG001|Overall Study|Diabetologist nurse in the study|0|||
129700020|NCT00500331|466862438|FG002|Overall Study|Diabetologist nurse in the study|1|||
129700021|NCT00500331|466862439|FG003|Overall Study|Diabetologist nurse in the study|0|||
129700022|NCT00500331|466862440|FG004|Overall Study|Diabetologist nurse in the study|0|||
129700023|NCT00500331|466862441|FG005|Overall Study|Diabetologist nurse in the study|0|||
129700024|NCT00500331|466862442|FG006|Overall Study|Diabetologist nurse in the study|0|||
129700025|NCT00500331|466862436|FG000|Overall Study|State ban of biological samples export|0|||
129700026|NCT00500331|466862437|FG001|Overall Study|State ban of biological samples export|0|||
129700027|NCT00500331|466862438|FG002|Overall Study|State ban of biological samples export|0|||
129700028|NCT00500331|466862439|FG003|Overall Study|State ban of biological samples export|1|||
129700029|NCT00500331|466862440|FG004|Overall Study|State ban of biological samples export|0|||
129700030|NCT00500331|466862441|FG005|Overall Study|State ban of biological samples export|0|||
129700031|NCT00500331|466862442|FG006|Overall Study|State ban of biological samples export|0|||
129700032|NCT00500331|466862436|FG000|Overall Study|Protocol violated|0|||
129700033|NCT00500331|466862437|FG001|Overall Study|Protocol violated|0|||
129700034|NCT00500331|466862438|FG002|Overall Study|Protocol violated|0|||
129700035|NCT00500331|466862439|FG003|Overall Study|Protocol violated|1|||
129700036|NCT00500331|466862440|FG004|Overall Study|Protocol violated|0|||
129700037|NCT00500331|466862441|FG005|Overall Study|Protocol violated|0|||
129700038|NCT00500331|466862442|FG006|Overall Study|Protocol violated|0|||
129700039|NCT03436732|466862443|FG000|Overall Study|Not treated-enrolled in different study|1|||
129700040|NCT03436732|466862444|FG001|Overall Study|Not treated-enrolled in different study|0|||
129700041|NCT03436732|466862443|FG000|Overall Study|Off study after cycle 1|1|||
129700042|NCT03436732|466862444|FG001|Overall Study|Off study after cycle 1|0|||
129700043|NCT03436732|466862443|FG000|Overall Study|Adverse Event|2|||
129700044|NCT03436732|466862444|FG001|Overall Study|Adverse Event|0|||
129700045|NCT03436732|466862443|FG000|Overall Study|Death|0|||
129700046|NCT03436732|466862444|FG001|Overall Study|Death|1|||
129700047|NCT03345550|466862445|FG000|Overall Study|Withdrawal by Subject|1|||
129700048|NCT03345550|466862446|FG001|Overall Study|Withdrawal by Subject|0|||
129700049|NCT03345550|466862445|FG000|Overall Study|Lost to Follow-up|4|||
129700050|NCT03345550|466862446|FG001|Overall Study|Lost to Follow-up|5|||
129700051|NCT00959049|466862447|FG000|Overall Study|Adverse Event|1|||
129700052|NCT00959049|466862448|FG001|Overall Study|Adverse Event|0|||
129700053|NCT00959049|466862449|FG002|Overall Study|Adverse Event|0|||
129700054|NCT00959049|466862450|FG003|Overall Study|Adverse Event|0|||
129700055|NCT00959049|466862451|FG004|Overall Study|Adverse Event|0|||
129700056|NCT00959049|466862452|FG005|Overall Study|Adverse Event|0|||
129700057|NCT00959049|466862447|FG000|Overall Study|Lost to Follow-up|17|||
129700058|NCT00959049|466862448|FG001|Overall Study|Lost to Follow-up|5|||
129612511|NCT01346293|466538013|FG001|Overall Study|Protocol Violation|9|||
129612512|NCT01346293|466538012|FG000|Overall Study|Lost to Follow-up|21|||
129612513|NCT01346293|466538013|FG001|Overall Study|Lost to Follow-up|8|||
129612514|NCT01346293|466538012|FG000|Overall Study|Withdrawal by Subject|15|||
129612515|NCT01346293|466538013|FG001|Overall Study|Withdrawal by Subject|4|||
129612516|NCT01346293|466538012|FG000|Overall Study|Other|1|||
129612517|NCT01346293|466538013|FG001|Overall Study|Other|0|||
129612518|NCT03503864|466538014|FG000|Overall Study|Protocol Violation|6|||
129612519|NCT03503864|466538014|FG000|Overall Study|Withdrawal by Subject|7|||
129612520|NCT02910063|466538015|FG000|Phase 2|Withdrawal by Subject|3|||
129612521|NCT02910063|466538016|FG001|Phase 2|Withdrawal by Subject|0|||
129612522|NCT02910063|466538017|FG002|Phase 2|Withdrawal by Subject|0|||
129612523|NCT02910063|466538015|FG000|Phase 2|Lost to Follow-up|1|||
129612524|NCT02910063|466538016|FG001|Phase 2|Lost to Follow-up|0|||
129612525|NCT02910063|466538017|FG002|Phase 2|Lost to Follow-up|0|||
129612526|NCT02910063|466538015|FG000|Phase 2|Death|24|||
129612527|NCT02910063|466538016|FG001|Phase 2|Death|0|||
129612528|NCT02910063|466538017|FG002|Phase 2|Death|0|||
129612529|NCT04693416|466538018|FG000|Overall Study|Lost to Follow-up|13|||
129612530|NCT04693416|466538019|FG001|Overall Study|Lost to Follow-up|0|||
129612531|NCT00474266|466538020|FG000|Overall Study|Withdrawal by Subject|7|||
129612532|NCT00474266|466538021|FG001|Overall Study|Withdrawal by Subject|20|||
129612533|NCT00474266|466538022|FG002|Overall Study|Withdrawal by Subject|4|||
129612534|NCT00474266|466538023|FG003|Overall Study|Withdrawal by Subject|7|||
129612535|NCT02774642|466538024|FG000|Overall Study|Lost to Follow-up|9|||
129612536|NCT02774642|466538025|FG001|Overall Study|Lost to Follow-up|7|||
129612537|NCT04642365|466538035|FG000|Overall Study|Death|3|||
129612538|NCT04642365|466538036|FG001|Overall Study|Death|2|||
129612539|NCT04642365|466538037|FG002|Overall Study|Death|4|||
129612540|NCT04642365|466538038|FG003|Overall Study|Death|5|||
129612541|NCT04642365|466538039|FG004|Overall Study|Death|5|||
129612542|NCT04642365|466538040|FG005|Overall Study|Death|3|||
129612543|NCT04642365|466538041|FG006|Overall Study|Death|2|||
129612544|NCT04642365|466538042|FG007|Overall Study|Death|1|||
129612545|NCT04642365|466538035|FG000|Overall Study|Physician Decision|1|||
129612546|NCT04642365|466538036|FG001|Overall Study|Physician Decision|0|||
129700059|NCT00959049|466862449|FG002|Overall Study|Lost to Follow-up|1|||
129700060|NCT00959049|466862450|FG003|Overall Study|Lost to Follow-up|10|||
129700061|NCT00959049|466862451|FG004|Overall Study|Lost to Follow-up|9|||
129700062|NCT00959049|466862452|FG005|Overall Study|Lost to Follow-up|1|||
129700063|NCT00959049|466862447|FG000|Overall Study|Contraindicated medication|0|||
129700064|NCT00959049|466862448|FG001|Overall Study|Contraindicated medication|0|||
129700065|NCT00959049|466862449|FG002|Overall Study|Contraindicated medication|0|||
129612547|NCT04642365|466538037|FG002|Overall Study|Physician Decision|0|||
129612548|NCT04642365|466538038|FG003|Overall Study|Physician Decision|0|||
129612549|NCT04642365|466538039|FG004|Overall Study|Physician Decision|0|||
129612550|NCT04642365|466538040|FG005|Overall Study|Physician Decision|0|||
129700066|NCT00959049|466862450|FG003|Overall Study|Contraindicated medication|1|||
129700067|NCT00959049|466862451|FG004|Overall Study|Contraindicated medication|0|||
129612551|NCT04642365|466538041|FG006|Overall Study|Physician Decision|0|||
129612552|NCT04642365|466538042|FG007|Overall Study|Physician Decision|0|||
129612553|NCT04642365|466538035|FG000|Overall Study|Progressive Disease|1|||
129612554|NCT04642365|466538036|FG001|Overall Study|Progressive Disease|1|||
129612555|NCT04642365|466538037|FG002|Overall Study|Progressive Disease|1|||
129612556|NCT04642365|466538038|FG003|Overall Study|Progressive Disease|0|||
129612557|NCT04642365|466538039|FG004|Overall Study|Progressive Disease|0|||
129700068|NCT00959049|466862452|FG005|Overall Study|Contraindicated medication|0|||
129439144|NCT00392327|465904571|FG002|Overall Study|Withdrawal by Subject|4|||
129439145|NCT00392327|465904572|FG003|Overall Study|Withdrawal by Subject|6|||
129439146|NCT00392327|465904573|FG004|Overall Study|Withdrawal by Subject|0|||
129439147|NCT00392327|465904574|FG005|Overall Study|Withdrawal by Subject|1|||
129439148|NCT00392327|465904575|FG006|Overall Study|Withdrawal by Subject|1|||
129439149|NCT00392327|465904576|FG007|Overall Study|Withdrawal by Subject|5|||
129439150|NCT00392327|465904569|FG000|Overall Study|Ineligible|0|||
129439151|NCT00392327|465904570|FG001|Overall Study|Ineligible|4|||
129612558|NCT04642365|466538040|FG005|Overall Study|Progressive Disease|0|||
129612559|NCT04642365|466538041|FG006|Overall Study|Progressive Disease|1|||
129612560|NCT04642365|466538042|FG007|Overall Study|Progressive Disease|0|||
129612561|NCT04642365|466538035|FG000|Overall Study|Study Terminated By Sponsor|0|||
129612562|NCT04642365|466538036|FG001|Overall Study|Study Terminated By Sponsor|2|||
129612563|NCT04642365|466538037|FG002|Overall Study|Study Terminated By Sponsor|1|||
129612564|NCT04642365|466538038|FG003|Overall Study|Study Terminated By Sponsor|1|||
129612565|NCT04642365|466538039|FG004|Overall Study|Study Terminated By Sponsor|1|||
129612566|NCT04642365|466538040|FG005|Overall Study|Study Terminated By Sponsor|2|||
129612567|NCT04642365|466538041|FG006|Overall Study|Study Terminated By Sponsor|2|||
129612568|NCT04642365|466538042|FG007|Overall Study|Study Terminated By Sponsor|1|||
129612569|NCT04642365|466538035|FG000|Overall Study|Symptomatic Deterioration|1|||
129612570|NCT04642365|466538036|FG001|Overall Study|Symptomatic Deterioration|1|||
129612571|NCT04642365|466538037|FG002|Overall Study|Symptomatic Deterioration|0|||
129612572|NCT04642365|466538038|FG003|Overall Study|Symptomatic Deterioration|0|||
129612573|NCT04642365|466538039|FG004|Overall Study|Symptomatic Deterioration|0|||
129612574|NCT04642365|466538040|FG005|Overall Study|Symptomatic Deterioration|1|||
129612575|NCT04642365|466538041|FG006|Overall Study|Symptomatic Deterioration|0|||
129612576|NCT04642365|466538042|FG007|Overall Study|Symptomatic Deterioration|0|||
129612577|NCT04642365|466538035|FG000|Overall Study|Withdrawal by Subject|0|||
129612578|NCT04642365|466538036|FG001|Overall Study|Withdrawal by Subject|0|||
129612579|NCT04642365|466538037|FG002|Overall Study|Withdrawal by Subject|1|||
129612580|NCT04642365|466538038|FG003|Overall Study|Withdrawal by Subject|1|||
129612581|NCT04642365|466538039|FG004|Overall Study|Withdrawal by Subject|0|||
129612582|NCT04642365|466538040|FG005|Overall Study|Withdrawal by Subject|0|||
129612583|NCT04642365|466538041|FG006|Overall Study|Withdrawal by Subject|2|||
129612584|NCT04642365|466538042|FG007|Overall Study|Withdrawal by Subject|0|||
129612585|NCT04642365|466538035|FG000|Overall Study|Adverse Event|0|||
129612586|NCT04642365|466538036|FG001|Overall Study|Adverse Event|0|||
129612587|NCT04642365|466538037|FG002|Overall Study|Adverse Event|0|||
129612588|NCT04642365|466538038|FG003|Overall Study|Adverse Event|0|||
129612589|NCT04642365|466538039|FG004|Overall Study|Adverse Event|0|||
129612590|NCT04642365|466538040|FG005|Overall Study|Adverse Event|0|||
129612591|NCT04642365|466538041|FG006|Overall Study|Adverse Event|0|||
129612592|NCT04642365|466538042|FG007|Overall Study|Adverse Event|1|||
129612593|NCT01144715|466538043|FG000|Overall Study|Lost to Follow-up|2|||
129612594|NCT01144715|466538044|FG001|Overall Study|Lost to Follow-up|1|||
129612595|NCT01144715|466538043|FG000|Overall Study|Withdrawal by Subject|2|||
129612596|NCT01144715|466538044|FG001|Overall Study|Withdrawal by Subject|1|||
129612597|NCT01144715|466538043|FG000|Overall Study|Adverse Event|0|||
129612598|NCT01144715|466538044|FG001|Overall Study|Adverse Event|1|||
129612599|NCT06281171|466538045|FG000|Timepoint 2|Lost to Follow-up|6|||
129612600|NCT06281171|466538046|FG001|Timepoint 2|Lost to Follow-up|4|||
129612601|NCT06281171|466538045|FG000|Timepoint 3|Lost to Follow-up|0|||
129612602|NCT06281171|466538046|FG001|Timepoint 3|Lost to Follow-up|5|||
129612603|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
129612604|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
129612605|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
129612606|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
129612607|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
129790887|NCT02108262|467201446|FG003|Overall Study|Non-compliance|1|||
129612608|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
129612609|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
129612610|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
129612611|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
129612612|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
129612613|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
129612614|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
129612615|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
129612616|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
129439152|NCT00392327|465904571|FG002|Overall Study|Ineligible|3|||
129439153|NCT00392327|465904572|FG003|Overall Study|Ineligible|2|||
129439154|NCT00392327|465904573|FG004|Overall Study|Ineligible|0|||
129439155|NCT00392327|465904574|FG005|Overall Study|Ineligible|0|||
129612617|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
129612618|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
129647587|NCT03787303|466665353|FG000|Overall Study|Death|1|||
129700069|NCT00959049|466862447|FG000|Overall Study|Withdrawal by Subject|0|||
129700070|NCT00959049|466862448|FG001|Overall Study|Withdrawal by Subject|2|||
129700071|NCT00959049|466862449|FG002|Overall Study|Withdrawal by Subject|0|||
129700072|NCT00959049|466862450|FG003|Overall Study|Withdrawal by Subject|0|||
129700073|NCT00959049|466862451|FG004|Overall Study|Withdrawal by Subject|0|||
129700074|NCT00959049|466862452|FG005|Overall Study|Withdrawal by Subject|0|||
129700075|NCT00137449|466862453|FG000|Overall Study|Disease Progression|8|||
129700076|NCT00137449|466862454|FG001|Overall Study|Disease Progression|13|||
129700077|NCT00137449|466862453|FG000|Overall Study|Death|4|||
129700078|NCT00137449|466862454|FG001|Overall Study|Death|3|||
129700079|NCT00137449|466862453|FG000|Overall Study|Adverse Event|3|||
129700080|NCT00137449|466862454|FG001|Overall Study|Adverse Event|1|||
129700081|NCT00137449|466862453|FG000|Overall Study|Withdrawal by Subject|1|||
129700082|NCT00137449|466862454|FG001|Overall Study|Withdrawal by Subject|1|||
129700083|NCT02489279|466862455|FG000|Overall Study|Lost to Follow-up|12|||
129700084|NCT02489279|466862456|FG001|Overall Study|Lost to Follow-up|10|||
129700085|NCT02263547|466862457|FG000|Overall Study|Adverse Event|1|||
129700086|NCT02263547|466862457|FG000|Overall Study|Lost to Follow-up|2|||
129700087|NCT00586157|466862458|FG000|First Intervention|Worsening behavior|1|||
129700088|NCT00586157|466862459|FG001|First Intervention|Worsening behavior|0|||
129700089|NCT00586157|466862458|FG000|Second Intervention|Withdrawal by Subject|1|||
129700090|NCT00586157|466862459|FG001|Second Intervention|Withdrawal by Subject|0|||
129700091|NCT00586157|466862458|FG000|Second Intervention|Worsening behavior|1|||
129700092|NCT00586157|466862459|FG001|Second Intervention|Worsening behavior|0|||
129700093|NCT00586157|466862458|FG000|Second Intervention|Adverse Event|0|||
129700094|NCT00586157|466862459|FG001|Second Intervention|Adverse Event|1|||
129700095|NCT02378480|466862461|FG000|Overall Study|Physician Decision|1|||
129700096|NCT02378480|466862462|FG001|Overall Study|Physician Decision|1|||
129700097|NCT02378480|466862461|FG000|Overall Study|Death|1|||
129700098|NCT02378480|466862462|FG001|Overall Study|Death|2|||
129700099|NCT02378480|466862461|FG000|Overall Study|Randomized, but Not Treated|6|||
129700100|NCT02378480|466862462|FG001|Overall Study|Randomized, but Not Treated|4|||
129700101|NCT02378480|466862461|FG000|Overall Study|Adverse Event|0|||
129700102|NCT02378480|466862462|FG001|Overall Study|Adverse Event|1|||
129700103|NCT02378480|466862461|FG000|Overall Study|Missed EOT/PTE Visit|1|||
129700104|NCT02378480|466862462|FG001|Overall Study|Missed EOT/PTE Visit|2|||
129700105|NCT02378480|466862461|FG000|Overall Study|Withdrawal by Subject|9|||
129700106|NCT02378480|466862462|FG001|Overall Study|Withdrawal by Subject|4|||
129700107|NCT02378480|466862461|FG000|Overall Study|Lost to Follow-up|10|||
129700108|NCT02378480|466862462|FG001|Overall Study|Lost to Follow-up|18|||
129700109|NCT02014467|466862468|FG000|Overall Study|Adverse Event|4|||
129700110|NCT02014467|466862469|FG001|Overall Study|Adverse Event|0|||
129700111|NCT02014467|466862468|FG000|Overall Study|Protocol Violation|3|||
129700112|NCT02014467|466862469|FG001|Overall Study|Protocol Violation|0|||
129700113|NCT02014467|466862468|FG000|Overall Study|Physician Decision|2|||
129700114|NCT02014467|466862469|FG001|Overall Study|Physician Decision|3|||
129700115|NCT02014467|466862468|FG000|Overall Study|Withdrawal by Subject|16|||
129700116|NCT02014467|466862469|FG001|Overall Study|Withdrawal by Subject|4|||
129700117|NCT01230060|466862470|FG000|Overall Study|Withdrawal by Subject|1|||
129700118|NCT01217892|466862472|FG000|Overall Study|Adverse Event|1|||
129700119|NCT01217892|466862473|FG001|Overall Study|Adverse Event|1|||
129700120|NCT01217892|466862474|FG002|Overall Study|Adverse Event|1|||
129700121|NCT01217892|466862475|FG003|Overall Study|Adverse Event|0|||
129700122|NCT01217892|466862472|FG000|Overall Study|Withdrawal by Subject|0|||
129700123|NCT01217892|466862473|FG001|Overall Study|Withdrawal by Subject|2|||
129700124|NCT01217892|466862474|FG002|Overall Study|Withdrawal by Subject|1|||
129700125|NCT01217892|466862475|FG003|Overall Study|Withdrawal by Subject|0|||
129700126|NCT01217892|466862472|FG000|Overall Study|Lab value|1|||
129700127|NCT01217892|466862473|FG001|Overall Study|Lab value|0|||
129700128|NCT01217892|466862474|FG002|Overall Study|Lab value|1|||
129700129|NCT01217892|466862475|FG003|Overall Study|Lab value|0|||
129700130|NCT01217892|466862472|FG000|Overall Study|Subject no longer meets study criteria|5|||
129700131|NCT01217892|466862473|FG001|Overall Study|Subject no longer meets study criteria|2|||
129700132|NCT01217892|466862474|FG002|Overall Study|Subject no longer meets study criteria|4|||
129700133|NCT01217892|466862475|FG003|Overall Study|Subject no longer meets study criteria|8|||
129700134|NCT01217892|466862472|FG000|Overall Study|Incorrect enrollment|0|||
129700135|NCT01217892|466862473|FG001|Overall Study|Incorrect enrollment|1|||
129700136|NCT01217892|466862474|FG002|Overall Study|Incorrect enrollment|1|||
129700137|NCT01217892|466862475|FG003|Overall Study|Incorrect enrollment|0|||
129700138|NCT01217892|466862472|FG000|Overall Study|Poor/Non-Compliance|0|||
129700139|NCT01217892|466862473|FG001|Overall Study|Poor/Non-Compliance|0|||
129700140|NCT01217892|466862474|FG002|Overall Study|Poor/Non-Compliance|1|||
129700141|NCT01217892|466862475|FG003|Overall Study|Poor/Non-Compliance|0|||
129700142|NCT01052779|466862476|FG000|Overall Study|Adverse Event|1|||
129700143|NCT01052779|466862477|FG001|Overall Study|Adverse Event|4|||
129612619|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
129612620|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
129612621|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
129612622|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
129612623|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
129612624|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
129612625|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
129612626|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
129612627|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
129612628|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
129612629|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
129612630|NCT02552212|466538047|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
129612631|NCT02552212|466538048|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
129612632|NCT02552212|466538049|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
129612633|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
129612634|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
129612635|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
129612636|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
129612637|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
129612638|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
129612639|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
129612640|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
129612641|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
129612642|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
129612643|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
129612644|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
129612645|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
129612646|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
129612647|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
129612648|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
129612649|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
129612650|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
129612651|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
129612652|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
129612653|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
129612654|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
129612655|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
129612656|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
129612657|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
129612658|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
129612659|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
129612660|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
129612661|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
129612662|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
129612663|NCT02552212|466538047|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
129612664|NCT02552212|466538048|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
129612665|NCT02552212|466538049|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
129612666|NCT00205803|466538056|FG000|Infant Series|Lost to Follow-up|10|||
129612667|NCT00205803|466538057|FG001|Infant Series|Lost to Follow-up|4|||
129612668|NCT00205803|466538056|FG000|Infant Series|Withdrawal by Subject|2|||
129612669|NCT00205803|466538057|FG001|Infant Series|Withdrawal by Subject|5|||
129612670|NCT00205803|466538056|FG000|Infant Series|Physician Decision|3|||
129612671|NCT00205803|466538057|FG001|Infant Series|Physician Decision|1|||
129612672|NCT00205803|466538056|FG000|Infant Series|Protocol Violation|1|||
129612673|NCT00205803|466538057|FG001|Infant Series|Protocol Violation|0|||
129612674|NCT00205803|466538056|FG000|Infant Series|Lost Kaiser coverage|0|||
129612675|NCT00205803|466538057|FG001|Infant Series|Lost Kaiser coverage|1|||
129612676|NCT00205803|466538056|FG000|Infant Series|Non-compliant|1|||
129612677|NCT00205803|466538057|FG001|Infant Series|Non-compliant|0|||
129612678|NCT00205803|466538056|FG000|Infant Series|Sponsor request|1|||
129612679|NCT00205803|466538057|FG001|Infant Series|Sponsor request|0|||
129612680|NCT00205803|466538056|FG000|After Infant Series|Adverse Event|1|||
129612681|NCT00205803|466538057|FG001|After Infant Series|Adverse Event|1|||
129612682|NCT00205803|466538056|FG000|After Infant Series|Protocol Violation|1|||
129612683|NCT00205803|466538057|FG001|After Infant Series|Protocol Violation|1|||
129612684|NCT00205803|466538056|FG000|After Infant Series|Lost to Follow-up|2|||
129612685|NCT00205803|466538057|FG001|After Infant Series|Lost to Follow-up|1|||
129612686|NCT00205803|466538056|FG000|After Infant Series|Physician Decision|3|||
129612687|NCT00205803|466538057|FG001|After Infant Series|Physician Decision|2|||
129612688|NCT00205803|466538056|FG000|After Infant Series|Withdrawal by Subject|1|||
129612689|NCT00205803|466538057|FG001|After Infant Series|Withdrawal by Subject|4|||
129612690|NCT00205803|466538056|FG000|After Infant Series|Other|10|||
129612691|NCT00205803|466538057|FG001|After Infant Series|Other|4|||
129612692|NCT00205803|466538056|FG000|Toddler Dose|Lost to Follow-up|2|||
129612693|NCT00205803|466538057|FG001|Toddler Dose|Lost to Follow-up|3|||
129612694|NCT02369458|466538059|FG000|Overall Study|Determined to be not eligible|1|||
129612695|NCT02369458|466538060|FG001|Overall Study|Determined to be not eligible|0|||
129612696|NCT04572893|466538061|FG000|Part A|Adverse Event|1|||
129612697|NCT04572893|466538062|FG001|Part A|Adverse Event|0|||
129612698|NCT04572893|466538063|FG002|Part A|Adverse Event|0|||
129612699|NCT04572893|466538064|FG003|Part A|Adverse Event|0|||
129612700|NCT04572893|466538065|FG004|Part A|Adverse Event|0|||
129612701|NCT04572893|466538066|FG005|Part A|Adverse Event|0|||
129612702|NCT04572893|466538067|FG006|Part A|Adverse Event|0|||
129612703|NCT04572893|466538061|FG000|Part B|Withdrawal by Subject|0|||
129612704|NCT04572893|466538062|FG001|Part B|Withdrawal by Subject|0|||
129612705|NCT04572893|466538063|FG002|Part B|Withdrawal by Subject|0|||
129612706|NCT04572893|466538064|FG003|Part B|Withdrawal by Subject|0|||
129612707|NCT04572893|466538065|FG004|Part B|Withdrawal by Subject|0|||
129612708|NCT04572893|466538066|FG005|Part B|Withdrawal by Subject|1|||
129612709|NCT04572893|466538067|FG006|Part B|Withdrawal by Subject|0|||
129612710|NCT04572893|466538061|FG000|Part B|Study terminated by sponsor|0|||
129612711|NCT04572893|466538062|FG001|Part B|Study terminated by sponsor|0|||
129612712|NCT04572893|466538063|FG002|Part B|Study terminated by sponsor|0|||
129612713|NCT04572893|466538064|FG003|Part B|Study terminated by sponsor|0|||
129612714|NCT04572893|466538065|FG004|Part B|Study terminated by sponsor|7|||
129612715|NCT04572893|466538066|FG005|Part B|Study terminated by sponsor|5|||
129612716|NCT04572893|466538067|FG006|Part B|Study terminated by sponsor|3|||
129612717|NCT04572893|466538061|FG000|Part B|Lost to Follow-up|0|||
129612718|NCT04572893|466538062|FG001|Part B|Lost to Follow-up|0|||
129612719|NCT04572893|466538063|FG002|Part B|Lost to Follow-up|0|||
129612720|NCT04572893|466538064|FG003|Part B|Lost to Follow-up|0|||
129612721|NCT04572893|466538065|FG004|Part B|Lost to Follow-up|0|||
129612722|NCT04572893|466538066|FG005|Part B|Lost to Follow-up|0|||
129612723|NCT04572893|466538067|FG006|Part B|Lost to Follow-up|1|||
129612724|NCT04572893|466538061|FG000|Part B|Adverse Event|0|||
129612725|NCT04572893|466538062|FG001|Part B|Adverse Event|0|||
129612726|NCT04572893|466538063|FG002|Part B|Adverse Event|0|||
129612727|NCT04572893|466538064|FG003|Part B|Adverse Event|0|||
129612728|NCT04572893|466538065|FG004|Part B|Adverse Event|1|||
129612729|NCT04572893|466538066|FG005|Part B|Adverse Event|1|||
129612730|NCT04572893|466538067|FG006|Part B|Adverse Event|0|||
129612731|NCT00121134|466538068|FG000|Overall Study|Progression of Disease|5|||
129612732|NCT00121134|466538069|FG001|Overall Study|Progression of Disease|3|||
129612733|NCT00121134|466538070|FG002|Overall Study|Progression of Disease|4|||
129612734|NCT00121134|466538071|FG003|Overall Study|Progression of Disease|2|||
129612735|NCT00121134|466538068|FG000|Overall Study|Toxicity|4|||
129612736|NCT00121134|466538069|FG001|Overall Study|Toxicity|7|||
129612737|NCT00121134|466538070|FG002|Overall Study|Toxicity|13|||
129612738|NCT00121134|466538071|FG003|Overall Study|Toxicity|5|||
129612739|NCT00121134|466538068|FG000|Overall Study|Physician Decision|6|||
129612740|NCT00121134|466538069|FG001|Overall Study|Physician Decision|4|||
129612741|NCT00121134|466538070|FG002|Overall Study|Physician Decision|4|||
129612742|NCT00121134|466538071|FG003|Overall Study|Physician Decision|1|||
129612743|NCT00121134|466538068|FG000|Overall Study|Treatment Delay|1|||
129612744|NCT00121134|466538069|FG001|Overall Study|Treatment Delay|0|||
129612745|NCT00121134|466538070|FG002|Overall Study|Treatment Delay|0|||
129612746|NCT00121134|466538071|FG003|Overall Study|Treatment Delay|0|||
129612747|NCT00121134|466538068|FG000|Overall Study|Intercurrent Illness|0|||
129612748|NCT00121134|466538069|FG001|Overall Study|Intercurrent Illness|0|||
129612749|NCT00121134|466538070|FG002|Overall Study|Intercurrent Illness|0|||
129612750|NCT00121134|466538071|FG003|Overall Study|Intercurrent Illness|1|||
129612751|NCT00121134|466538068|FG000|Overall Study|Patient Personal Reasons|0|||
129612752|NCT00121134|466538069|FG001|Overall Study|Patient Personal Reasons|1|||
129612753|NCT00121134|466538070|FG002|Overall Study|Patient Personal Reasons|0|||
129612754|NCT00121134|466538071|FG003|Overall Study|Patient Personal Reasons|0|||
129612755|NCT01102374|466538085|FG000|Overall Study|Death|9|||
129612756|NCT01102374|466538086|FG001|Overall Study|Death|13|||
129612757|NCT01102374|466538085|FG000|Overall Study|Lost to Follow-up|7|||
129612758|NCT01102374|466538086|FG001|Overall Study|Lost to Follow-up|6|||
129612759|NCT00418821|466538087|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
129612760|NCT02071849|466538088|FG000|6-month Primary Endpoint|Did not receive device|4|||
129612761|NCT02071849|466538088|FG000|6-month Primary Endpoint|Adverse Event|1|||
129612762|NCT02071849|466538088|FG000|2-year Extended Follow-up|Adverse Event|1|||
129612763|NCT04619992|466538089|FG000|Overall Study|Withdrawal by Subject|1|||
129612764|NCT04619992|466538090|FG001|Overall Study|Withdrawal by Subject|0|||
129612765|NCT02618759|466539649|FG000|Overall Study|Lost to Follow-up|0|||
129612766|NCT02618759|466539650|FG001|Overall Study|Lost to Follow-up|1|||
129612767|NCT02618759|466539649|FG000|Overall Study|Withdrawal by Subject|1|||
129612768|NCT02618759|466539650|FG001|Overall Study|Withdrawal by Subject|0|||
129612769|NCT02618759|466539649|FG000|Overall Study|Other Reasons|1|||
129612770|NCT02618759|466539650|FG001|Overall Study|Other Reasons|4|||
129612771|NCT02856555|466539653|FG000|Overall Study|Adverse Event|1|||
129612772|NCT02856555|466539654|FG001|Overall Study|Adverse Event|0|||
129612773|NCT02856555|466539655|FG002|Overall Study|Adverse Event|0|||
129612774|NCT02856555|466539653|FG000|Overall Study|Lost to Follow-up|1|||
129612775|NCT02856555|466539654|FG001|Overall Study|Lost to Follow-up|3|||
129612776|NCT02856555|466539655|FG002|Overall Study|Lost to Follow-up|0|||
129612777|NCT02856555|466539653|FG000|Overall Study|Withdrawal by Subject|3|||
129612778|NCT02856555|466539654|FG001|Overall Study|Withdrawal by Subject|0|||
129612779|NCT02856555|466539655|FG002|Overall Study|Withdrawal by Subject|0|||
129612780|NCT02856555|466539653|FG000|Overall Study|Randomized but Never Treated|0|||
129612781|NCT02856555|466539654|FG001|Overall Study|Randomized but Never Treated|1|||
129612782|NCT02856555|466539655|FG002|Overall Study|Randomized but Never Treated|0|||
129612783|NCT03333941|466539656|FG000|Overall Study|Lost to Follow-up|10|||
129612784|NCT03333941|466539656|FG000|Overall Study|Death|2|||
129612785|NCT03333941|466539656|FG000|Overall Study|Adverse Event|1|||
129612786|NCT02932306|466539657|FG000|Overall Study|Withdrawal by Subject|16|||
129612787|NCT02932306|466539658|FG001|Overall Study|Withdrawal by Subject|25|||
129612788|NCT02932306|466539657|FG000|Overall Study|Adverse Event|3|||
129612789|NCT02932306|466539658|FG001|Overall Study|Adverse Event|0|||
129612790|NCT02932306|466539657|FG000|Overall Study|Pregnancy|2|||
129612791|NCT02932306|466539658|FG001|Overall Study|Pregnancy|0|||
129612792|NCT02932306|466539657|FG000|Overall Study|Protocol Violation|1|||
129612793|NCT02932306|466539658|FG001|Overall Study|Protocol Violation|1|||
129612794|NCT02932306|466539657|FG000|Overall Study|Noncompliance with Study Drug|1|||
129612795|NCT02932306|466539658|FG001|Overall Study|Noncompliance with Study Drug|1|||
129612796|NCT02932306|466539657|FG000|Overall Study|Lost to Follow-up|36|||
129612797|NCT02932306|466539658|FG001|Overall Study|Lost to Follow-up|40|||
129612798|NCT02932306|466539657|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
129612799|NCT02932306|466539658|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
129612800|NCT02932306|466539657|FG000|Overall Study|Lack of Efficacy|0|||
129612801|NCT02932306|466539658|FG001|Overall Study|Lack of Efficacy|2|||
129612802|NCT02932306|466539657|FG000|Overall Study|Worsening condition|2|||
129612803|NCT02932306|466539658|FG001|Overall Study|Worsening condition|0|||
129612804|NCT02932306|466539657|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
129612805|NCT02932306|466539658|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
129612806|NCT00605540|466539663|FG000|Overall Study|Death|15|||
129612807|NCT00605540|466539663|FG000|Overall Study|Lost to Follow-up|23|||
129612808|NCT01544179|466539666|FG000|Overall Study|Death|50|||
129612809|NCT01544179|466539667|FG001|Overall Study|Death|37|||
129612810|NCT01544179|466539666|FG000|Overall Study|Lost to Follow-up|0|||
129612811|NCT01544179|466539667|FG001|Overall Study|Lost to Follow-up|1|||
129612812|NCT01544179|466539666|FG000|Overall Study|Adverse Event|0|||
129612813|NCT01544179|466539667|FG001|Overall Study|Adverse Event|1|||
129612814|NCT01544179|466539666|FG000|Overall Study|Withdrawal by Subject|12|||
129612815|NCT01544179|466539667|FG001|Overall Study|Withdrawal by Subject|7|||
129612816|NCT01544179|466539666|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
129612817|NCT01544179|466539667|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129612818|NCT00049530|466539668|FG000|Overall Study|Lack of Efficacy|25|||
129612819|NCT00049530|466539668|FG000|Overall Study|Adverse Event|2|||
129612820|NCT00049530|466539668|FG000|Overall Study|Death|1|||
129612821|NCT00049530|466539668|FG000|Overall Study|symptomatic deterioration|1|||
129700144|NCT01052779|466862476|FG000|Overall Study|Withdrawal by Subject|1|||
129612822|NCT00049530|466539668|FG000|Overall Study|ineligible|3|||
129612823|NCT01635283|466539669|FG000|Overall Study|Tumor Progression|3|||
129612824|NCT01635283|466539669|FG000|Overall Study|Lost to Follow-up|1|||
129612825|NCT01438996|466539670|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
129612826|NCT01438996|466539671|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
129700145|NCT01052779|466862477|FG001|Overall Study|Withdrawal by Subject|2|||
129612827|NCT01438996|466539672|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
129612828|NCT01433549|466539673|FG000|Phase 2: Second Study Product|Adverse Event|0|||
129612829|NCT01433549|466539674|FG001|Phase 2: Second Study Product|Adverse Event|1|||
129612830|NCT01696058|466539678|FG000|Overall Study|Adverse Event|21|||
129700146|NCT01052779|466862476|FG000|Overall Study|Other-Protocol Violation|1|||
129612831|NCT01696058|466539679|FG001|Overall Study|Adverse Event|11|||
129612832|NCT01696058|466539678|FG000|Overall Study|Lack of Efficacy|2|||
129612833|NCT01696058|466539679|FG001|Overall Study|Lack of Efficacy|3|||
129612834|NCT01696058|466539678|FG000|Overall Study|Protocol Violation|9|||
129612835|NCT01696058|466539679|FG001|Overall Study|Protocol Violation|3|||
129612836|NCT01696058|466539678|FG000|Overall Study|Lost to Follow-up|2|||
129612837|NCT01696058|466539679|FG001|Overall Study|Lost to Follow-up|5|||
129612838|NCT01696058|466539678|FG000|Overall Study|Withdrawal by Subject|4|||
129612839|NCT01696058|466539679|FG001|Overall Study|Withdrawal by Subject|6|||
129612840|NCT01696058|466539678|FG000|Overall Study|Other reason prematurely discontinued|5|||
129612841|NCT01696058|466539679|FG001|Overall Study|Other reason prematurely discontinued|3|||
129612842|NCT02278055|466539680|FG000|Overall Study|Adverse Event|1|||
129612843|NCT02278055|466539680|FG000|Overall Study|Lost to Follow-up|1|||
129612844|NCT02278055|466539680|FG000|Overall Study|Withdrawal by Subject|2|||
129612845|NCT02278055|466539680|FG000|Overall Study|Progressive Disease|4|||
129612846|NCT01934335|466539681|FG000|Overall Study|Withdrawal by Subject|1|||
129612847|NCT01934335|466539682|FG001|Overall Study|Withdrawal by Subject|1|||
129612848|NCT01421511|466539683|FG000|Overall Study|Lost to Follow-up|11|||
129612849|NCT01421511|466539684|FG001|Overall Study|Lost to Follow-up|14|||
129612850|NCT01421511|466539683|FG000|Overall Study|Randomized but didn't receive study drug|1|||
129612851|NCT01421511|466539684|FG001|Overall Study|Randomized but didn't receive study drug|7|||
129612852|NCT01421511|466539683|FG000|Overall Study|Physician Decision|0|||
129612853|NCT01421511|466539684|FG001|Overall Study|Physician Decision|1|||
129612854|NCT01421511|466539683|FG000|Overall Study|Withdrawal by Subject|6|||
129612855|NCT01421511|466539684|FG001|Overall Study|Withdrawal by Subject|5|||
129612856|NCT01421511|466539683|FG000|Overall Study|Death|1|||
129612857|NCT01421511|466539684|FG001|Overall Study|Death|1|||
129612858|NCT05384171|466539685|FG000|Overall Study|Lost to Follow-up|9|||
129612859|NCT05384171|466539686|FG001|Overall Study|Lost to Follow-up|9|||
129612860|NCT05384171|466539685|FG000|Overall Study|Withdrawal by Subject|3|||
129612861|NCT05384171|466539686|FG001|Overall Study|Withdrawal by Subject|0|||
129612862|NCT00749892|466539687|FG000|Overall Study|Withdrawal by Subject|3|||
129612863|NCT00106964|466539690|FG000|Overall Study|Lost to Follow-up|8|||
129612864|NCT00106964|466539691|FG001|Overall Study|Lost to Follow-up|6|||
129612865|NCT00106964|466539692|FG002|Overall Study|Lost to Follow-up|2|||
129612866|NCT00106964|466539690|FG000|Overall Study|Pregnancy|2|||
129612867|NCT00106964|466539691|FG001|Overall Study|Pregnancy|3|||
129612868|NCT00106964|466539692|FG002|Overall Study|Pregnancy|2|||
129612869|NCT00106964|466539690|FG000|Overall Study|Death|1|||
129612870|NCT00106964|466539691|FG001|Overall Study|Death|1|||
129612871|NCT00106964|466539692|FG002|Overall Study|Death|0|||
129612872|NCT00106964|466539690|FG000|Overall Study|Incarceration|0|||
129612873|NCT00106964|466539691|FG001|Overall Study|Incarceration|1|||
129612874|NCT00106964|466539692|FG002|Overall Study|Incarceration|0|||
129612875|NCT00106964|466539690|FG000|Overall Study|Site Funding Terminated|0|||
129612876|NCT00106964|466539691|FG001|Overall Study|Site Funding Terminated|1|||
129612877|NCT00106964|466539692|FG002|Overall Study|Site Funding Terminated|1|||
129612878|NCT00106964|466539690|FG000|Overall Study|Failure to adhere|2|||
129612879|NCT00106964|466539691|FG001|Overall Study|Failure to adhere|0|||
129612880|NCT00106964|466539692|FG002|Overall Study|Failure to adhere|0|||
129612881|NCT00106964|466539690|FG000|Overall Study|Did not meet eligibility criteria|0|||
129612882|NCT00106964|466539691|FG001|Overall Study|Did not meet eligibility criteria|2|||
129612883|NCT00106964|466539692|FG002|Overall Study|Did not meet eligibility criteria|2|||
129612884|NCT00106964|466539690|FG000|Overall Study|Required disallowed medication|0|||
129612885|NCT00106964|466539691|FG001|Overall Study|Required disallowed medication|1|||
129790888|NCT02108262|467201443|FG000|Overall Study|Randomized by error/screen failure|0|||
129790889|NCT02108262|467201444|FG001|Overall Study|Randomized by error/screen failure|0|||
129790890|NCT02108262|467201445|FG002|Overall Study|Randomized by error/screen failure|1|||
129790891|NCT02108262|467201446|FG003|Overall Study|Randomized by error/screen failure|0|||
129790892|NCT02108262|467201443|FG000|Overall Study|Distance to center|0|||
129790893|NCT02108262|467201444|FG001|Overall Study|Distance to center|1|||
129790894|NCT02108262|467201445|FG002|Overall Study|Distance to center|1|||
129790895|NCT02108262|467201446|FG003|Overall Study|Distance to center|0|||
129790896|NCT02108262|467201443|FG000|Overall Study|Adverse Event|0|||
129790897|NCT02108262|467201444|FG001|Overall Study|Adverse Event|11|||
129612886|NCT00106964|466539692|FG002|Overall Study|Required disallowed medication|0|||
129612887|NCT01756079|466539693|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
129612888|NCT01756079|466539693|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
129612889|NCT01756079|466539693|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
129612890|NCT01756079|466539693|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
129612891|NCT01756079|466539693|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
129612892|NCT00168818|466539700|FG000|Overall Study|Adverse Event|23|||
129612893|NCT00168818|466539701|FG001|Overall Study|Adverse Event|29|||
129612894|NCT00168818|466539702|FG002|Overall Study|Adverse Event|31|||
129612895|NCT00168818|466539700|FG000|Overall Study|Protocol Violation|16|||
129612896|NCT00168818|466539701|FG001|Overall Study|Protocol Violation|11|||
129612897|NCT00168818|466539702|FG002|Overall Study|Protocol Violation|11|||
129612898|NCT00168818|466539700|FG000|Overall Study|Lost to Follow-up|13|||
129612899|NCT00168818|466539701|FG001|Overall Study|Lost to Follow-up|4|||
129612900|NCT00168818|466539702|FG002|Overall Study|Lost to Follow-up|15|||
129612901|NCT00168818|466539700|FG000|Overall Study|Withdrawal by Subject|43|||
129612902|NCT00168818|466539701|FG001|Overall Study|Withdrawal by Subject|41|||
129612903|NCT00168818|466539702|FG002|Overall Study|Withdrawal by Subject|37|||
129612904|NCT00168818|466539700|FG000|Overall Study|Other|22|||
129612905|NCT00168818|466539701|FG001|Overall Study|Other|24|||
129612906|NCT00168818|466539702|FG002|Overall Study|Other|30|||
129612907|NCT00168818|466539700|FG000|Treatment|Adverse Event|77|||
129612908|NCT00168818|466539701|FG001|Treatment|Adverse Event|89|||
129612909|NCT00168818|466539702|FG002|Treatment|Adverse Event|68|||
129612910|NCT00168818|466539700|FG000|Treatment|Protocol Violation|8|||
129612911|NCT00168818|466539701|FG001|Treatment|Protocol Violation|11|||
129612912|NCT00168818|466539702|FG002|Treatment|Protocol Violation|11|||
129612913|NCT00168818|466539700|FG000|Treatment|Lost to Follow-up|0|||
129612914|NCT00168818|466539701|FG001|Treatment|Lost to Follow-up|2|||
129612915|NCT00168818|466539702|FG002|Treatment|Lost to Follow-up|1|||
129612916|NCT00168818|466539700|FG000|Treatment|Withdrawal by Subject|25|||
129612917|NCT00168818|466539701|FG001|Treatment|Withdrawal by Subject|20|||
129612918|NCT00168818|466539702|FG002|Treatment|Withdrawal by Subject|22|||
129612919|NCT00168818|466539700|FG000|Treatment|Other|23|||
129612920|NCT00168818|466539701|FG001|Treatment|Other|29|||
129612921|NCT00168818|466539702|FG002|Treatment|Other|31|||
129612922|NCT00469144|466539705|FG000|Overall Study|Death|0|||
129612923|NCT00469144|466539706|FG001|Overall Study|Death|1|||
129612924|NCT00469144|466539705|FG000|Overall Study|No Response|5|||
129612925|NCT00469144|466539706|FG001|Overall Study|No Response|5|||
129612926|NCT00469144|466539705|FG000|Overall Study|Progressive Disease|1|||
129612927|NCT00469144|466539706|FG001|Overall Study|Progressive Disease|0|||
129612928|NCT04602546|466539707|FG000|Overall Study|Training|2|||
129612929|NCT04602546|466539708|FG001|Overall Study|Training|2|||
129612930|NCT04602546|466539709|FG002|Overall Study|Training|1|||
129612931|NCT04602546|466539710|FG003|Overall Study|Training|2|||
129612932|NCT04602546|466539711|FG004|Overall Study|Training|0|||
129612933|NCT04602546|466539707|FG000|Overall Study|Randomized with disqualified data|2|||
129612934|NCT04602546|466539708|FG001|Overall Study|Randomized with disqualified data|0|||
129612935|NCT04602546|466539709|FG002|Overall Study|Randomized with disqualified data|2|||
129612936|NCT04602546|466539710|FG003|Overall Study|Randomized with disqualified data|5|||
129612937|NCT04602546|466539711|FG004|Overall Study|Randomized with disqualified data|3|||
129612938|NCT02794246|466539712|FG000|Overall Study|Withdrawal by Subject|2|||
129612939|NCT02794246|466539712|FG000|Overall Study|Physician Decision|4|||
129612940|NCT01994291|466539713|FG000|Overall Study|Adverse Event|4|||
129612941|NCT01994291|466539714|FG001|Overall Study|Adverse Event|1|||
129612942|NCT01994291|466539715|FG002|Overall Study|Adverse Event|3|||
129612943|NCT01994291|466539713|FG000|Overall Study|Lost to Follow-up|1|||
129612944|NCT01994291|466539714|FG001|Overall Study|Lost to Follow-up|1|||
129612945|NCT01994291|466539715|FG002|Overall Study|Lost to Follow-up|0|||
129612946|NCT01994291|466539713|FG000|Overall Study|Does not meet entrance criteria|1|||
129612947|NCT01994291|466539714|FG001|Overall Study|Does not meet entrance criteria|0|||
129612948|NCT01994291|466539715|FG002|Overall Study|Does not meet entrance criteria|0|||
129612949|NCT01994291|466539713|FG000|Overall Study|Medication error without associated AE|1|||
129612950|NCT01994291|466539714|FG001|Overall Study|Medication error without associated AE|0|||
129612951|NCT01994291|466539715|FG002|Overall Study|Medication error without associated AE|1|||
129612952|NCT01994291|466539713|FG000|Overall Study|Protocol Violation|1|||
129612953|NCT01994291|466539714|FG001|Overall Study|Protocol Violation|0|||
129612954|NCT01994291|466539715|FG002|Overall Study|Protocol Violation|0|||
129612955|NCT01994291|466539713|FG000|Overall Study|Withdrawal by Subject|6|||
129612956|NCT01994291|466539714|FG001|Overall Study|Withdrawal by Subject|3|||
129612957|NCT01994291|466539715|FG002|Overall Study|Withdrawal by Subject|5|||
129612958|NCT01994291|466539713|FG000|Overall Study|Other|1|||
129612959|NCT01994291|466539714|FG001|Overall Study|Other|2|||
129612960|NCT01994291|466539715|FG002|Overall Study|Other|0|||
129612961|NCT01775189|466539716|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129612962|NCT01775189|466539717|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
129700147|NCT01052779|466862477|FG001|Overall Study|Other-Protocol Violation|1|||
129700148|NCT01052779|466862476|FG000|Overall Study|Other-Surgery|0|||
129700149|NCT01052779|466862477|FG001|Overall Study|Other-Surgery|2|||
129700150|NCT01052779|466862476|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
129700151|NCT01052779|466862477|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
129612963|NCT01775189|466539718|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129612964|NCT01775189|466539719|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129612965|NCT01775189|466539720|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129700152|NCT03802916|466862478|FG000|Overall Study|Adverse Event|0|||
129612966|NCT01775189|466539721|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129612967|NCT01775189|466539722|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
129612968|NCT01775189|466539716|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129612969|NCT01775189|466539717|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
129612970|NCT01775189|466539718|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129612971|NCT01775189|466539719|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129612972|NCT01775189|466539720|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129700153|NCT03802916|466862479|FG001|Overall Study|Adverse Event|1|||
129612973|NCT01775189|466539721|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129612974|NCT01775189|466539722|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
129612975|NCT01775189|466539716|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129612976|NCT01775189|466539717|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
129612977|NCT01775189|466539718|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
129612978|NCT01775189|466539719|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129612979|NCT01775189|466539720|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129612980|NCT01775189|466539721|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129612981|NCT01775189|466539722|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
129612982|NCT01775189|466539716|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129612983|NCT01775189|466539717|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129612984|NCT01775189|466539718|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129612985|NCT01775189|466539719|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129612986|NCT01775189|466539720|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129612987|NCT01775189|466539721|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
129612988|NCT01775189|466539722|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
129612989|NCT01775189|466539716|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129612990|NCT01775189|466539717|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129612991|NCT01775189|466539718|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129612992|NCT01775189|466539719|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
129612993|NCT01775189|466539720|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129612994|NCT01775189|466539721|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129612995|NCT01775189|466539722|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
129612996|NCT01775189|466539716|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129612997|NCT01775189|466539717|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129612998|NCT01775189|466539718|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129612999|NCT01775189|466539719|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
129613000|NCT01775189|466539720|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129613001|NCT01775189|466539721|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
129613002|NCT01775189|466539722|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
129613003|NCT00856375|466539723|FG000|Overall Study|Other|0|||
129613004|NCT00856375|466539724|FG001|Overall Study|Other|1|||
129613005|NCT00856375|466539723|FG000|Overall Study|Death|32|||
129613006|NCT00856375|466539724|FG001|Overall Study|Death|30|||
129613007|NCT00856375|466539723|FG000|Overall Study|Sponsor Terminated Study|7|||
129613008|NCT00856375|466539724|FG001|Overall Study|Sponsor Terminated Study|7|||
129613009|NCT00856375|466539723|FG000|Overall Study|Withdrawal by Subject|2|||
129613010|NCT00856375|466539724|FG001|Overall Study|Withdrawal by Subject|1|||
129613011|NCT00856375|466539723|FG000|Overall Study|Lost to Follow-up|1|||
129613012|NCT00856375|466539724|FG001|Overall Study|Lost to Follow-up|2|||
129613013|NCT02121392|466539727|FG000|Prior to Intervention|Protocol Violation|40|||
129613014|NCT02121392|466539728|FG001|Prior to Intervention|Protocol Violation|35|||
129613015|NCT02121392|466539727|FG000|Prior to Intervention|Withdrawal by Subject|8|||
129613016|NCT02121392|466539728|FG001|Prior to Intervention|Withdrawal by Subject|6|||
129613017|NCT02121392|466539727|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
129613018|NCT02121392|466539728|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
129613019|NCT02121392|466539727|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
129613020|NCT02121392|466539728|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
129613021|NCT01352416|466539729|FG000|Overall Study|Physician Decision|1|||
129613022|NCT01352416|466539730|FG001|Overall Study|Physician Decision|2|||
129613023|NCT01352416|466539731|FG002|Overall Study|Physician Decision|2|||
129613024|NCT01352416|466539732|FG003|Overall Study|Physician Decision|1|||
129613025|NCT00811928|466539743|FG000|Overall Study|AEs and SAEs Including Death|7|||
129613026|NCT00811928|466539744|FG001|Overall Study|AEs and SAEs Including Death|11|||
129613027|NCT00811928|466539743|FG000|Overall Study|Withdrawal by Subject|18|||
129613028|NCT00811928|466539744|FG001|Overall Study|Withdrawal by Subject|12|||
129613029|NCT00811928|466539743|FG000|Overall Study|Did Not Take Study Drug|3|||
129613030|NCT00811928|466539744|FG001|Overall Study|Did Not Take Study Drug|0|||
129613031|NCT00811928|466539743|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
129613032|NCT00811928|466539744|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
129613033|NCT00811928|466539743|FG000|Overall Study|Investigator Decision|2|||
129613034|NCT00811928|466539744|FG001|Overall Study|Investigator Decision|1|||
129613035|NCT00811928|466539743|FG000|Overall Study|Poor Compliance|2|||
129613036|NCT00811928|466539744|FG001|Overall Study|Poor Compliance|5|||
129613037|NCT00171951|466539745|FG000|Overall Study|Adverse Event|1|||
129613038|NCT00171951|466539745|FG000|Overall Study|Abnormal Laboratory Values|2|||
129613039|NCT00171951|466539745|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129790898|NCT02108262|467201445|FG002|Overall Study|Adverse Event|6|||
129613040|NCT00171951|466539745|FG000|Overall Study|Participants Withdrew Consent|3|||
129613041|NCT00171951|466539745|FG000|Overall Study|New Cancer Therapy|5|||
129613042|NCT00171951|466539745|FG000|Overall Study|Reason not Specified|2|||
129613043|NCT00396812|466539746|FG000|Overall Study|Physician Decision|1|||
129613044|NCT00843635|466539751|FG000|Overall Study|Adverse Event|2|||
129613045|NCT00843635|466539752|FG001|Overall Study|Adverse Event|2|||
129613046|NCT00843635|466539753|FG002|Overall Study|Adverse Event|0|||
129613047|NCT03496610|466539754|FG000|Overall Study|Lost to Follow-up|3|||
129613048|NCT03496610|466539755|FG001|Overall Study|Lost to Follow-up|2|||
129613049|NCT03496610|466539754|FG000|Overall Study|Physician Decision|1|||
129613050|NCT03496610|466539755|FG001|Overall Study|Physician Decision|0|||
129613051|NCT03496610|466539754|FG000|Overall Study|Withdrawal by Subject|1|||
129613052|NCT03496610|466539755|FG001|Overall Study|Withdrawal by Subject|0|||
129613053|NCT04435184|466539756|FG000|Overall Study|follow-up blood draws missing|3|||
129613054|NCT04435184|466539757|FG001|Overall Study|follow-up blood draws missing|5|||
129613055|NCT02714426|466539761|FG000|Overall Study|Withdrawal by Subject|2|||
129613056|NCT02714426|466539762|FG001|Overall Study|Withdrawal by Subject|2|||
129613057|NCT00813800|466539766|FG000|Overall Study|Screen Failure after Consent|2|||
129613058|NCT00813800|466539766|FG000|Overall Study|Adverse Event|1|||
129613059|NCT00813800|466539766|FG000|Overall Study|Worsening of depression|2|||
129613060|NCT00813800|466539766|FG000|Overall Study|Physician Decision|1|||
129613061|NCT03456453|466539767|FG000|Overall Study|Withdrawal by Subject|2|||
129613062|NCT03456453|466539768|FG001|Overall Study|Withdrawal by Subject|0|||
129613063|NCT03456453|466539767|FG000|Overall Study|Not released to community|1|||
129613064|NCT03456453|466539768|FG001|Overall Study|Not released to community|5|||
129613065|NCT03456453|466539767|FG000|Overall Study|Lost to Follow-up|0|||
129613066|NCT03456453|466539768|FG001|Overall Study|Lost to Follow-up|2|||
129613067|NCT01860677|466539769|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
129613068|NCT01860677|466539770|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
129613069|NCT04762277|466539771|FG000|Overall Study|Withdrawal by Subject|0|||
129613070|NCT04762277|466539772|FG001|Overall Study|Withdrawal by Subject|2|||
129613071|NCT04762277|466539771|FG000|Overall Study|Protocol Violation|0|||
129613072|NCT04762277|466539772|FG001|Overall Study|Protocol Violation|1|||
129613073|NCT04762277|466539771|FG000|Overall Study|Adverse Event|1|||
129613074|NCT04762277|466539772|FG001|Overall Study|Adverse Event|0|||
129613075|NCT00896480|466539773|FG000|Overall Study|Disease progression/recurrence|21|||
129613076|NCT00642278|466539774|FG000|Overall Study|Adverse Event|2|||
129613077|NCT00642278|466539775|FG001|Overall Study|Adverse Event|1|||
129613078|NCT00642278|466539776|FG002|Overall Study|Adverse Event|3|||
129613079|NCT00642278|466539777|FG003|Overall Study|Adverse Event|1|||
129613080|NCT00642278|466539778|FG004|Overall Study|Adverse Event|2|||
129613081|NCT00642278|466539779|FG005|Overall Study|Adverse Event|2|||
129613082|NCT00642278|466539780|FG006|Overall Study|Adverse Event|0|||
129613083|NCT00642278|466539774|FG000|Overall Study|Lack of Efficacy|0|||
129613084|NCT00642278|466539775|FG001|Overall Study|Lack of Efficacy|1|||
129613085|NCT00642278|466539776|FG002|Overall Study|Lack of Efficacy|0|||
129613086|NCT00642278|466539777|FG003|Overall Study|Lack of Efficacy|0|||
129613087|NCT00642278|466539778|FG004|Overall Study|Lack of Efficacy|0|||
129613088|NCT00642278|466539779|FG005|Overall Study|Lack of Efficacy|0|||
129613089|NCT00642278|466539780|FG006|Overall Study|Lack of Efficacy|0|||
129613090|NCT00642278|466539774|FG000|Overall Study|Lost to Follow-up|5|||
129613091|NCT00642278|466539775|FG001|Overall Study|Lost to Follow-up|1|||
129613092|NCT00642278|466539776|FG002|Overall Study|Lost to Follow-up|0|||
129613093|NCT00642278|466539777|FG003|Overall Study|Lost to Follow-up|1|||
129613094|NCT00642278|466539778|FG004|Overall Study|Lost to Follow-up|0|||
129613095|NCT00642278|466539779|FG005|Overall Study|Lost to Follow-up|1|||
129613096|NCT00642278|466539780|FG006|Overall Study|Lost to Follow-up|1|||
129613097|NCT00642278|466539774|FG000|Overall Study|Physician Decision|0|||
129613098|NCT00642278|466539775|FG001|Overall Study|Physician Decision|0|||
129613099|NCT00642278|466539776|FG002|Overall Study|Physician Decision|0|||
129700154|NCT03802916|466862478|FG000|Overall Study|Withdrawal by Subject|0|||
129700155|NCT03802916|466862479|FG001|Overall Study|Withdrawal by Subject|1|||
129700156|NCT03663582|466862480|FG000|Overall Study|Physician Decision|1|||
129613100|NCT00642278|466539777|FG003|Overall Study|Physician Decision|1|||
129613101|NCT00642278|466539778|FG004|Overall Study|Physician Decision|0|||
129613102|NCT00642278|466539779|FG005|Overall Study|Physician Decision|0|||
129700157|NCT03242434|466862483|FG000|Overall Study|Death|0|||
129613103|NCT00642278|466539780|FG006|Overall Study|Physician Decision|0|||
129613104|NCT00642278|466539774|FG000|Overall Study|Protocol Violation|0|||
129700158|NCT03242434|466862484|FG001|Overall Study|Death|2|||
129700159|NCT04507763|466862485|FG000|Overall Study|Participants did not meet entrance criteria|201|||
129700160|NCT03427619|466862486|FG000|Overall Study|Physician Decision|3|||
129700161|NCT03427619|466862486|FG000|Overall Study|Withdrawal by Subject|4|||
129700162|NCT03427619|466862486|FG000|Overall Study|Lost to Follow-up|5|||
129700163|NCT03427619|466862486|FG000|Overall Study|Administrative|4|||
129700164|NCT03427619|466862486|FG000|Overall Study|Other|2|||
129700165|NCT03427619|466862486|FG000|Overall Study|Unknown or Missing Completion Status|48|||
129700166|NCT05763381|466862487|FG000|Overall Study|Lost to Follow-up|2|||
129700167|NCT05763381|466862488|FG001|Overall Study|Lost to Follow-up|3|||
129700168|NCT05763381|466862487|FG000|Overall Study|Withdrawal by Subject|1|||
129700169|NCT05763381|466862488|FG001|Overall Study|Withdrawal by Subject|2|||
129700170|NCT02853136|466862489|FG000|Wash-out|Adverse Event|0|||
129700171|NCT02853136|466862490|FG001|Wash-out|Adverse Event|0|||
129700172|NCT02853136|466862491|FG002|Wash-out|Adverse Event|0|||
129700173|NCT02853136|466862492|FG003|Wash-out|Adverse Event|1|||
129700174|NCT00841815|466862493|FG000|Washout|Withdrawal by Subject|0|||
129700175|NCT00841815|466862494|FG001|Washout|Withdrawal by Subject|1|||
129700176|NCT00867334|466862496|FG000|Overall Study|Withdrawal by Subject|0|||
129700177|NCT00867334|466862497|FG001|Overall Study|Withdrawal by Subject|1|||
129700178|NCT00867334|466862496|FG000|Overall Study|Withdrawal by Subject|1|||
129700179|NCT00867334|466862497|FG001|Overall Study|Withdrawal by Subject|0|||
129700180|NCT00867334|466862496|FG000|Overall Study|Withdrawal by Subject|1|||
129700181|NCT00867334|466862497|FG001|Overall Study|Withdrawal by Subject|0|||
129700182|NCT03787615|466862498|FG000|Overall Study|Withdrawal by Subject|2|||
129700183|NCT03787615|466862498|FG000|Overall Study|Lost to Follow-up|2|||
129700184|NCT02697448|466862499|FG000|Overall Study|Protocol Violation|2|||
129700185|NCT02697448|466862500|FG001|Overall Study|Protocol Violation|4|||
129700186|NCT02697448|466862499|FG000|Overall Study|Clinical concerns during ablation|1|||
129700187|NCT02697448|466862500|FG001|Overall Study|Clinical concerns during ablation|1|||
129700188|NCT02697448|466862499|FG000|Overall Study|No data collected|2|||
129700189|NCT02697448|466862500|FG001|Overall Study|No data collected|0|||
129700190|NCT03464461|466862501|FG000|Overall Study|exclusionary medication given ,|1|||
129700191|NCT03464461|466862502|FG001|Overall Study|exclusionary medication given ,|2|||
129700192|NCT03464461|466862503|FG002|Overall Study|exclusionary medication given ,|0|||
129700193|NCT03464461|466862501|FG000|Overall Study|Physician Decision|0|||
129700194|NCT03464461|466862502|FG001|Overall Study|Physician Decision|1|||
129700195|NCT03464461|466862503|FG002|Overall Study|Physician Decision|0|||
129700196|NCT03685149|466862505|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
129700197|NCT03685149|466862506|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
129700198|NCT03685149|466862505|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129700199|NCT03685149|466862506|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129700200|NCT03685149|466862505|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
129700201|NCT03685149|466862506|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
129700202|NCT04876391|466862507|FG000|Overall Study|Withdrawal by Subject|1|||
129700203|NCT04876391|466862508|FG001|Overall Study|Withdrawal by Subject|10|||
129700204|NCT04876391|466862507|FG000|Overall Study|Lost to Follow-up|2|||
129700205|NCT04876391|466862508|FG001|Overall Study|Lost to Follow-up|4|||
129700206|NCT04876391|466862507|FG000|Overall Study|Lack of Efficacy|0|||
129700207|NCT04876391|466862508|FG001|Overall Study|Lack of Efficacy|2|||
129700208|NCT04876391|466862507|FG000|Overall Study|Adverse Event|3|||
129700209|NCT04876391|466862508|FG001|Overall Study|Adverse Event|1|||
129700210|NCT04876391|466862507|FG000|Overall Study|Patient non-compliance|0|||
129700211|NCT04876391|466862508|FG001|Overall Study|Patient non-compliance|1|||
129700212|NCT04876391|466862507|FG000|Overall Study|Personal reasons|0|||
129700213|NCT04876391|466862508|FG001|Overall Study|Personal reasons|1|||
129700214|NCT04876391|466862507|FG000|Overall Study|Withdrawn as per protocol|2|||
129790899|NCT02108262|467201446|FG003|Overall Study|Adverse Event|12|||
129790900|NCT02108262|467201443|FG000|Overall Study|Death|0|||
129790901|NCT02108262|467201444|FG001|Overall Study|Death|2|||
129790902|NCT02108262|467201445|FG002|Overall Study|Death|2|||
129790903|NCT02108262|467201446|FG003|Overall Study|Death|1|||
129700215|NCT04876391|466862508|FG001|Overall Study|Withdrawn as per protocol|2|||
129700216|NCT00209131|466862513|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
129700217|NCT00209131|466862514|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
129700218|NCT05360784|466862515|FG000|Overall Study|Discontinued|25|||
129700219|NCT05360784|466862516|FG001|Overall Study|Discontinued|11|||
129700220|NCT05142306|466862520|FG000|Overall Study|Withdrawal by Subject|0|||
129700221|NCT05142306|466862521|FG001|Overall Study|Withdrawal by Subject|0|||
129700222|NCT05142306|466862522|FG002|Overall Study|Withdrawal by Subject|1|||
129700223|NCT02251041|466862523|FG000|Overall Study|Did not receive intervention|15|||
129700224|NCT02251041|466862524|FG001|Overall Study|Did not receive intervention|4|||
129700225|NCT04079920|466862525|FG000|Overall Study|Adverse event, not related to study drug|2|||
129700226|NCT04079920|466862525|FG000|Overall Study|Adverse event related to study drug|10|||
129700227|NCT04079920|466862525|FG000|Overall Study|Death|2|||
129790904|NCT02108262|467201443|FG000|Overall Study|Lost to Follow-up|0|||
129700228|NCT04079920|466862525|FG000|Overall Study|Lost to Follow-up|22|||
129700229|NCT04079920|466862525|FG000|Overall Study|Physician Decision|1|||
129613105|NCT00642278|466539775|FG001|Overall Study|Protocol Violation|0|||
129613106|NCT00642278|466539776|FG002|Overall Study|Protocol Violation|1|||
129613107|NCT00642278|466539777|FG003|Overall Study|Protocol Violation|1|||
129613108|NCT00642278|466539778|FG004|Overall Study|Protocol Violation|0|||
129613109|NCT00642278|466539779|FG005|Overall Study|Protocol Violation|1|||
129613110|NCT00642278|466539780|FG006|Overall Study|Protocol Violation|2|||
129613111|NCT00642278|466539774|FG000|Overall Study|Withdrawal by Subject|1|||
129613112|NCT00642278|466539775|FG001|Overall Study|Withdrawal by Subject|1|||
129613113|NCT00642278|466539776|FG002|Overall Study|Withdrawal by Subject|1|||
129613114|NCT00642278|466539777|FG003|Overall Study|Withdrawal by Subject|3|||
129613115|NCT00642278|466539778|FG004|Overall Study|Withdrawal by Subject|6|||
129613116|NCT00642278|466539779|FG005|Overall Study|Withdrawal by Subject|2|||
129613117|NCT00642278|466539780|FG006|Overall Study|Withdrawal by Subject|2|||
129613118|NCT00642278|466539774|FG000|Overall Study|Noncompliance with study drug regimen|0|||
129613119|NCT00642278|466539775|FG001|Overall Study|Noncompliance with study drug regimen|0|||
129613120|NCT00642278|466539776|FG002|Overall Study|Noncompliance with study drug regimen|0|||
129613121|NCT00642278|466539777|FG003|Overall Study|Noncompliance with study drug regimen|1|||
129613122|NCT00642278|466539778|FG004|Overall Study|Noncompliance with study drug regimen|0|||
129613123|NCT00642278|466539779|FG005|Overall Study|Noncompliance with study drug regimen|0|||
129613124|NCT00642278|466539780|FG006|Overall Study|Noncompliance with study drug regimen|0|||
129613125|NCT00642278|466539774|FG000|Overall Study|Other|2|||
129613126|NCT00642278|466539775|FG001|Overall Study|Other|1|||
129790905|NCT02108262|467201444|FG001|Overall Study|Lost to Follow-up|0|||
129790906|NCT02108262|467201445|FG002|Overall Study|Lost to Follow-up|1|||
129790907|NCT02108262|467201446|FG003|Overall Study|Lost to Follow-up|0|||
129790908|NCT02108262|467201443|FG000|Overall Study|Physician Decision|0|||
129790909|NCT02108262|467201444|FG001|Overall Study|Physician Decision|0|||
129790910|NCT02108262|467201445|FG002|Overall Study|Physician Decision|2|||
129790911|NCT02108262|467201446|FG003|Overall Study|Physician Decision|0|||
129790912|NCT02108262|467201443|FG000|Overall Study|Withdrawal by Subject|0|||
129790913|NCT02108262|467201444|FG001|Overall Study|Withdrawal by Subject|7|||
129790914|NCT02108262|467201445|FG002|Overall Study|Withdrawal by Subject|3|||
129790915|NCT02108262|467201446|FG003|Overall Study|Withdrawal by Subject|4|||
129790916|NCT02108262|467201443|FG000|Overall Study|Due to key hepatic values|0|||
129790917|NCT02108262|467201444|FG001|Overall Study|Due to key hepatic values|1|||
129790918|NCT02108262|467201445|FG002|Overall Study|Due to key hepatic values|0|||
129790919|NCT02108262|467201446|FG003|Overall Study|Due to key hepatic values|0|||
129790920|NCT02108262|467201443|FG000|Overall Study|Unable to contact patient|0|||
129790921|NCT02108262|467201444|FG001|Overall Study|Unable to contact patient|3|||
129790922|NCT02108262|467201445|FG002|Overall Study|Unable to contact patient|1|||
129790923|NCT02108262|467201446|FG003|Overall Study|Unable to contact patient|2|||
129790924|NCT02108262|467201443|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
129790925|NCT02108262|467201444|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
129790926|NCT02108262|467201445|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
129790927|NCT02108262|467201446|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
129790928|NCT02108262|467201443|FG000|Overall Study|Patient did not want another infusion|0|||
129790929|NCT02108262|467201444|FG001|Overall Study|Patient did not want another infusion|3|||
129790930|NCT02108262|467201445|FG002|Overall Study|Patient did not want another infusion|3|||
129790931|NCT02108262|467201446|FG003|Overall Study|Patient did not want another infusion|2|||
129613127|NCT00642278|466539776|FG002|Overall Study|Other|0|||
129613128|NCT00642278|466539777|FG003|Overall Study|Other|1|||
129613129|NCT00642278|466539778|FG004|Overall Study|Other|0|||
129613130|NCT00642278|466539779|FG005|Overall Study|Other|1|||
129613131|NCT00642278|466539780|FG006|Overall Study|Other|0|||
129613132|NCT00090363|466539781|FG000|Overall Study|Lost to Follow-up|1|||
129613133|NCT00090363|466539782|FG001|Overall Study|Lost to Follow-up|2|||
129613134|NCT00090363|466539783|FG002|Overall Study|Lost to Follow-up|1|||
129613135|NCT00090363|466539781|FG000|Overall Study|Withdrawal by Subject|7|||
129613136|NCT00090363|466539782|FG001|Overall Study|Withdrawal by Subject|7|||
129613137|NCT00090363|466539783|FG002|Overall Study|Withdrawal by Subject|6|||
129613138|NCT00090363|466539781|FG000|Overall Study|Study-specific discontinuation criteria|75|||
129613139|NCT00090363|466539782|FG001|Overall Study|Study-specific discontinuation criteria|74|||
129613140|NCT00090363|466539783|FG002|Overall Study|Study-specific discontinuation criteria|62|||
129613141|NCT00090363|466539781|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129613142|NCT00090363|466539782|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129613143|NCT00090363|466539783|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129613144|NCT00090363|466539781|FG000|Overall Study|Consent expired|7|||
129613145|NCT00090363|466539782|FG001|Overall Study|Consent expired|10|||
129613146|NCT00090363|466539783|FG002|Overall Study|Consent expired|9|||
129613147|NCT00090363|466539781|FG000|Overall Study|Reasons not specified|2|||
129613148|NCT00090363|466539782|FG001|Overall Study|Reasons not specified|1|||
129613149|NCT00090363|466539783|FG002|Overall Study|Reasons not specified|1|||
129613150|NCT00090363|466539781|FG000|Overall Study|Continuing on study off treatment|14|||
129613151|NCT00090363|466539782|FG001|Overall Study|Continuing on study off treatment|13|||
129613152|NCT00090363|466539783|FG002|Overall Study|Continuing on study off treatment|16|||
129613153|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
129613154|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129613155|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
129613156|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129613157|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129613158|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
129613159|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129613160|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129613161|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129613162|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129613163|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
129790932|NCT02108262|467201443|FG000|Overall Study|Vacation|0|||
129790933|NCT02108262|467201444|FG001|Overall Study|Vacation|1|||
129790934|NCT02108262|467201445|FG002|Overall Study|Vacation|0|||
129790935|NCT02108262|467201446|FG003|Overall Study|Vacation|0|||
129790936|NCT02108262|467201443|FG000|Overall Study|Patient decision|0|||
129613164|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
129613165|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
129613166|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
129613167|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
129613168|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
129613169|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129613170|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129613171|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129613172|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129613173|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
129613174|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
129613175|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
129613176|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129613177|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129613178|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129613179|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129613180|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
129613181|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129613182|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
129613183|NCT03713619|466539784|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
129613184|NCT03713619|466539785|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
129613185|NCT03713619|466539786|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
129613186|NCT03713619|466539787|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
129613187|NCT03713619|466539788|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
129613188|NCT03713619|466539784|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
129613189|NCT03713619|466539785|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
129613190|NCT03713619|466539786|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
129613191|NCT03713619|466539787|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
129613192|NCT03713619|466539788|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
129613193|NCT03713619|466539784|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
129613194|NCT03713619|466539785|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129613195|NCT03713619|466539786|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129613196|NCT03713619|466539787|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
129613197|NCT03713619|466539788|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129613198|NCT03713619|466539784|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
129613199|NCT03713619|466539785|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
129613200|NCT03713619|466539786|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
129613201|NCT03713619|466539787|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
129613202|NCT03713619|466539788|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
129613203|NCT03713619|466539784|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
129613204|NCT03713619|466539785|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
129613205|NCT03713619|466539786|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
129613206|NCT03713619|466539787|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
129613207|NCT03713619|466539788|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
129613208|NCT03713619|466539784|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
129613209|NCT03713619|466539785|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
129613210|NCT03713619|466539786|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
129613211|NCT03713619|466539787|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
129613212|NCT03713619|466539788|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
129613213|NCT03713619|466539784|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129613214|NCT03713619|466539785|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
129613215|NCT03713619|466539786|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129613216|NCT03713619|466539787|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
129613217|NCT03713619|466539788|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
129613218|NCT00197496|466539794|FG000|Baseline to Discharge|not interested|1|||
129613219|NCT00197496|466539795|FG001|Baseline to Discharge|not interested|0|||
129613220|NCT00197496|466539794|FG000|Baseline to Discharge|MRSA|1|||
129613221|NCT00197496|466539795|FG001|Baseline to Discharge|MRSA|0|||
129613222|NCT00197496|466539794|FG000|Baseline to Discharge|Physician Decision|0|||
129613223|NCT00197496|466539795|FG001|Baseline to Discharge|Physician Decision|1|||
129613224|NCT00197496|466539794|FG000|Baseline to Discharge|Protocol Violation|0|||
129613225|NCT00197496|466539795|FG001|Baseline to Discharge|Protocol Violation|1|||
129613226|NCT00197496|466539794|FG000|Follow-up|Lost to Follow-up|2|||
129613227|NCT00197496|466539795|FG001|Follow-up|Lost to Follow-up|1|||
129700230|NCT04079920|466862525|FG000|Overall Study|Withdrawal by Subject|11|||
129700231|NCT04918771|466862526|FG000|Overall Study|Withdrawal by Subject|4|||
129700232|NCT04918771|466862527|FG001|Overall Study|Withdrawal by Subject|5|||
129700233|NCT04918771|466862526|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
129700234|NCT04918771|466862527|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
129700235|NCT01299961|466862536|FG000|Overall Study|Adverse Event|3|||
129613228|NCT00857584|466539796|FG000|Overall Study|Lack of Efficacy|1|||
129613229|NCT00857584|466539797|FG001|Overall Study|Lack of Efficacy|2|||
129613230|NCT00857584|466539796|FG000|Overall Study|Adverse Event|2|||
129613231|NCT00857584|466539797|FG001|Overall Study|Adverse Event|2|||
129613232|NCT00857584|466539796|FG000|Overall Study|Physician Decision|1|||
129613233|NCT00857584|466539797|FG001|Overall Study|Physician Decision|1|||
129613234|NCT00259272|466539798|FG000|Overall Study|Adverse Event|2|||
129613235|NCT00259272|466539799|FG001|Overall Study|Adverse Event|1|||
129613236|NCT00259272|466539800|FG002|Overall Study|Adverse Event|0|||
129613237|NCT00259272|466539801|FG003|Overall Study|Adverse Event|3|||
129613238|NCT00259272|466539798|FG000|Overall Study|Lack of Efficacy|5|||
129613239|NCT00259272|466539799|FG001|Overall Study|Lack of Efficacy|1|||
129613240|NCT00259272|466539800|FG002|Overall Study|Lack of Efficacy|2|||
129613241|NCT00259272|466539801|FG003|Overall Study|Lack of Efficacy|6|||
129613242|NCT00259272|466539798|FG000|Overall Study|Physician Decision|1|||
129613243|NCT00259272|466539799|FG001|Overall Study|Physician Decision|2|||
129613244|NCT00259272|466539800|FG002|Overall Study|Physician Decision|1|||
129613245|NCT00259272|466539801|FG003|Overall Study|Physician Decision|3|||
129613246|NCT00259272|466539798|FG000|Overall Study|Protocol Violation|2|||
129613247|NCT00259272|466539799|FG001|Overall Study|Protocol Violation|0|||
129613248|NCT00259272|466539800|FG002|Overall Study|Protocol Violation|0|||
129613249|NCT00259272|466539801|FG003|Overall Study|Protocol Violation|1|||
129613250|NCT00259272|466539798|FG000|Overall Study|Sponsor Decision|0|||
129613251|NCT00259272|466539799|FG001|Overall Study|Sponsor Decision|1|||
129613252|NCT00259272|466539800|FG002|Overall Study|Sponsor Decision|0|||
129613253|NCT00259272|466539801|FG003|Overall Study|Sponsor Decision|0|||
129613254|NCT00259272|466539798|FG000|Overall Study|Withdrawal by Subject|4|||
129613255|NCT00259272|466539799|FG001|Overall Study|Withdrawal by Subject|2|||
129613256|NCT00259272|466539800|FG002|Overall Study|Withdrawal by Subject|2|||
129613257|NCT00259272|466539801|FG003|Overall Study|Withdrawal by Subject|7|||
129613258|NCT00259272|466539798|FG000|Overall Study|Lost to Follow-up|1|||
129613259|NCT00259272|466539799|FG001|Overall Study|Lost to Follow-up|0|||
129613260|NCT00259272|466539800|FG002|Overall Study|Lost to Follow-up|0|||
129613261|NCT00259272|466539801|FG003|Overall Study|Lost to Follow-up|1|||
129613262|NCT01908907|466541221|FG000|Overall Study|Physician Decision|1|||
129613263|NCT01908907|466541222|FG001|Overall Study|Physician Decision|0|||
129613264|NCT01908907|466541221|FG000|Overall Study|Protocol Violation|1|||
129613265|NCT01908907|466541222|FG001|Overall Study|Protocol Violation|0|||
129613266|NCT00761657|466541223|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
129613267|NCT00761657|466541224|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
129613268|NCT00761657|466541225|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
129613269|NCT00761657|466541226|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
129613270|NCT00761657|466541227|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
129613271|NCT00761657|466541228|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
129613272|NCT00761657|466541229|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
129613273|NCT00761657|466541230|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
129613274|NCT00761657|466541231|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
129613275|NCT00761657|466541223|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613276|NCT00761657|466541224|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613277|NCT00761657|466541225|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
129613278|NCT00761657|466541226|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
129613279|NCT00761657|466541227|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613280|NCT00761657|466541228|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613281|NCT00761657|466541229|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613282|NCT00761657|466541230|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613283|NCT00761657|466541231|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
129613284|NCT00761657|466541223|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
129613285|NCT00761657|466541224|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
129790937|NCT02108262|467201444|FG001|Overall Study|Patient decision|7|||
129613286|NCT00761657|466541225|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
129613287|NCT00761657|466541226|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
129613288|NCT00761657|466541227|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
129613289|NCT00761657|466541228|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
129613290|NCT00761657|466541229|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
129613291|NCT00761657|466541230|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
129613292|NCT00761657|466541231|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
129613293|NCT00761657|466541223|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
129790938|NCT02108262|467201445|FG002|Overall Study|Patient decision|9|||
129790939|NCT02108262|467201446|FG003|Overall Study|Patient decision|14|||
129613294|NCT00761657|466541224|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
129613295|NCT00761657|466541225|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
129613296|NCT00761657|466541226|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
129790940|NCT02108262|467201443|FG000|Overall Study|Missed IV due to pharmacy error|0|||
129790941|NCT02108262|467201444|FG001|Overall Study|Missed IV due to pharmacy error|0|||
129700236|NCT01299961|466862536|FG000|Overall Study|Lack of Efficacy|2|||
129700237|NCT01299961|466862536|FG000|Overall Study|Lost to Follow-up|1|||
129700238|NCT02904096|466862537|FG000|Overall Study|Adverse Event|1|||
129700239|NCT02904096|466862538|FG001|Overall Study|Adverse Event|0|||
129700240|NCT02904096|466862537|FG000|Overall Study|Withdrawal by Subject|4|||
129700241|NCT02904096|466862538|FG001|Overall Study|Withdrawal by Subject|3|||
129700242|NCT02904096|466862537|FG000|Overall Study|Lost to Follow-up|10|||
129700243|NCT02904096|466862538|FG001|Overall Study|Lost to Follow-up|17|||
129700244|NCT02904096|466862537|FG000|Overall Study|Non-compliant|3|||
129700245|NCT02904096|466862538|FG001|Overall Study|Non-compliant|1|||
129700246|NCT02904096|466862537|FG000|Overall Study|Sponsor instructed|1|||
129700247|NCT02904096|466862538|FG001|Overall Study|Sponsor instructed|0|||
129700248|NCT05305651|466862539|FG000|Overall Study|Death|1|||
129700249|NCT05305651|466862539|FG000|Overall Study|Withdrawal by Subject|4|||
129700250|NCT05305651|466862539|FG000|Overall Study|Lost to Follow-up|4|||
129700251|NCT00526799|466862540|FG000|Overall Study|Withdrawal by Subject|1|||
129700252|NCT00526799|466862541|FG001|Overall Study|Withdrawal by Subject|0|||
129700253|NCT00526799|466862540|FG000|Overall Study|Intercurrent Complicating Disease|0|||
129700254|NCT00526799|466862541|FG001|Overall Study|Intercurrent Complicating Disease|1|||
129700255|NCT04003389|466862542|FG000|Overall Study|Adverse Event|27|||
129700256|NCT04003389|466862543|FG001|Overall Study|Adverse Event|34|||
129700257|NCT04003389|466862544|FG002|Overall Study|Adverse Event|28|||
129700258|NCT04003389|466862542|FG000|Overall Study|Lost to Follow-up|39|||
129700259|NCT04003389|466862543|FG001|Overall Study|Lost to Follow-up|30|||
129700260|NCT04003389|466862544|FG002|Overall Study|Lost to Follow-up|33|||
129700261|NCT04003389|466862542|FG000|Overall Study|Protocol Violation|1|||
129700262|NCT04003389|466862543|FG001|Overall Study|Protocol Violation|6|||
129700263|NCT04003389|466862544|FG002|Overall Study|Protocol Violation|5|||
129700264|NCT04003389|466862542|FG000|Overall Study|Withdrawal by Subject|119|||
129700265|NCT04003389|466862543|FG001|Overall Study|Withdrawal by Subject|79|||
129700266|NCT04003389|466862544|FG002|Overall Study|Withdrawal by Subject|85|||
129700267|NCT04003389|466862542|FG000|Overall Study|Miscellaneous|14|||
129700268|NCT04003389|466862543|FG001|Overall Study|Miscellaneous|11|||
129700269|NCT04003389|466862544|FG002|Overall Study|Miscellaneous|14|||
129700270|NCT04003389|466862542|FG000|Overall Study|Participant did not receive study drug|1|||
129700271|NCT04003389|466862543|FG001|Overall Study|Participant did not receive study drug|0|||
129700272|NCT04003389|466862544|FG002|Overall Study|Participant did not receive study drug|0|||
129700273|NCT02298946|466862545|FG000|Overall Study|Did not receive treatment|2|||
129700274|NCT02298946|466862546|FG001|Overall Study|Did not receive treatment|0|||
129700275|NCT02298946|466862545|FG000|Overall Study|Unevaluable|2|||
129700276|NCT02298946|466862546|FG001|Overall Study|Unevaluable|1|||
129700277|NCT03648372|466862552|FG000|Overall Study|Withdrawal by Subject|2|||
129700278|NCT03648372|466862553|FG001|Overall Study|Withdrawal by Subject|0|||
129700279|NCT03648372|466862554|FG002|Overall Study|Withdrawal by Subject|0|||
129700280|NCT03648372|466862555|FG003|Overall Study|Withdrawal by Subject|0|||
129700281|NCT03648372|466862556|FG004|Overall Study|Withdrawal by Subject|0|||
129700282|NCT03648372|466862557|FG005|Overall Study|Withdrawal by Subject|1|||
129700283|NCT03648372|466862558|FG006|Overall Study|Withdrawal by Subject|2|||
129700284|NCT03648372|466862559|FG007|Overall Study|Withdrawal by Subject|0|||
129700285|NCT03648372|466862560|FG008|Overall Study|Withdrawal by Subject|0|||
129700286|NCT03648372|466862561|FG009|Overall Study|Withdrawal by Subject|0|||
129700287|NCT03648372|466862562|FG010|Overall Study|Withdrawal by Subject|2|||
129700288|NCT03648372|466862563|FG011|Overall Study|Withdrawal by Subject|0|||
129700289|NCT03648372|466862564|FG012|Overall Study|Withdrawal by Subject|2|||
129700290|NCT03648372|466862565|FG013|Overall Study|Withdrawal by Subject|0|||
129700291|NCT03648372|466862566|FG014|Overall Study|Withdrawal by Subject|0|||
129700292|NCT03648372|466862567|FG015|Overall Study|Withdrawal by Subject|0|||
129700293|NCT03648372|466862568|FG016|Overall Study|Withdrawal by Subject|1|||
129700294|NCT03648372|466862569|FG017|Overall Study|Withdrawal by Subject|0|||
129700295|NCT03648372|466862570|FG018|Overall Study|Withdrawal by Subject|0|||
129700296|NCT03648372|466862571|FG019|Overall Study|Withdrawal by Subject|0|||
129700297|NCT03648372|466862572|FG020|Overall Study|Withdrawal by Subject|0|||
129700298|NCT03648372|466862552|FG000|Overall Study|Progressive Disease|2|||
129700299|NCT03648372|466862553|FG001|Overall Study|Progressive Disease|3|||
129700300|NCT03648372|466862554|FG002|Overall Study|Progressive Disease|4|||
129700301|NCT03648372|466862555|FG003|Overall Study|Progressive Disease|3|||
129700302|NCT03648372|466862556|FG004|Overall Study|Progressive Disease|2|||
129700303|NCT03648372|466862557|FG005|Overall Study|Progressive Disease|2|||
129700304|NCT03648372|466862558|FG006|Overall Study|Progressive Disease|3|||
129700305|NCT03648372|466862559|FG007|Overall Study|Progressive Disease|3|||
129700306|NCT03648372|466862560|FG008|Overall Study|Progressive Disease|5|||
129700307|NCT03648372|466862561|FG009|Overall Study|Progressive Disease|5|||
129700308|NCT03648372|466862562|FG010|Overall Study|Progressive Disease|2|||
129700309|NCT03648372|466862563|FG011|Overall Study|Progressive Disease|3|||
129700310|NCT03648372|466862564|FG012|Overall Study|Progressive Disease|3|||
129700311|NCT03648372|466862565|FG013|Overall Study|Progressive Disease|3|||
129700312|NCT03648372|466862566|FG014|Overall Study|Progressive Disease|6|||
129700313|NCT03648372|466862567|FG015|Overall Study|Progressive Disease|0|||
129700314|NCT03648372|466862568|FG016|Overall Study|Progressive Disease|0|||
129700315|NCT03648372|466862569|FG017|Overall Study|Progressive Disease|0|||
129700316|NCT03648372|466862570|FG018|Overall Study|Progressive Disease|0|||
129700317|NCT03648372|466862571|FG019|Overall Study|Progressive Disease|0|||
129700318|NCT03648372|466862572|FG020|Overall Study|Progressive Disease|0|||
129700319|NCT03648372|466862552|FG000|Overall Study|Other|0|||
129700320|NCT03648372|466862553|FG001|Overall Study|Other|0|||
129700321|NCT03648372|466862554|FG002|Overall Study|Other|0|||
129700322|NCT03648372|466862555|FG003|Overall Study|Other|0|||
129700323|NCT03648372|466862556|FG004|Overall Study|Other|1|||
129700324|NCT03648372|466862557|FG005|Overall Study|Other|0|||
129700325|NCT03648372|466862558|FG006|Overall Study|Other|0|||
129700326|NCT03648372|466862559|FG007|Overall Study|Other|0|||
129700327|NCT03648372|466862560|FG008|Overall Study|Other|0|||
129700328|NCT03648372|466862561|FG009|Overall Study|Other|0|||
129700329|NCT03648372|466862562|FG010|Overall Study|Other|1|||
129700330|NCT03648372|466862563|FG011|Overall Study|Other|2|||
129700331|NCT03648372|466862564|FG012|Overall Study|Other|1|||
129700332|NCT03648372|466862565|FG013|Overall Study|Other|3|||
129700333|NCT03648372|466862566|FG014|Overall Study|Other|0|||
129700334|NCT03648372|466862567|FG015|Overall Study|Other|5|||
129700335|NCT03648372|466862568|FG016|Overall Study|Other|1|||
129700336|NCT03648372|466862569|FG017|Overall Study|Other|5|||
129700337|NCT03648372|466862570|FG018|Overall Study|Other|0|||
129700338|NCT03648372|466862571|FG019|Overall Study|Other|1|||
129700339|NCT03648372|466862572|FG020|Overall Study|Other|0|||
129700340|NCT03648372|466862552|FG000|Overall Study|Lost to Follow-up|0|||
129700341|NCT03648372|466862553|FG001|Overall Study|Lost to Follow-up|0|||
129439156|NCT00392327|465904575|FG006|Overall Study|Ineligible|0|||
129439157|NCT00392327|465904576|FG007|Overall Study|Ineligible|0|||
129439158|NCT04508023|465904577|FG000|Overall Study|Withdrawal by Subject|1|||
129700342|NCT03648372|466862554|FG002|Overall Study|Lost to Follow-up|0|||
129700343|NCT03648372|466862555|FG003|Overall Study|Lost to Follow-up|0|||
129439159|NCT04508023|465904578|FG001|Overall Study|Withdrawal by Subject|2|||
129700344|NCT03648372|466862556|FG004|Overall Study|Lost to Follow-up|0|||
129700345|NCT03648372|466862557|FG005|Overall Study|Lost to Follow-up|0|||
129700346|NCT03648372|466862558|FG006|Overall Study|Lost to Follow-up|0|||
129700347|NCT03648372|466862559|FG007|Overall Study|Lost to Follow-up|0|||
129439160|NCT03261700|465904583|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
129700348|NCT03648372|466862560|FG008|Overall Study|Lost to Follow-up|0|||
129700349|NCT03648372|466862561|FG009|Overall Study|Lost to Follow-up|0|||
129700350|NCT03648372|466862562|FG010|Overall Study|Lost to Follow-up|0|||
129439161|NCT03261700|465904584|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
129700351|NCT03648372|466862563|FG011|Overall Study|Lost to Follow-up|0|||
129700352|NCT03648372|466862564|FG012|Overall Study|Lost to Follow-up|0|||
129700353|NCT03648372|466862565|FG013|Overall Study|Lost to Follow-up|1|||
129700354|NCT03648372|466862566|FG014|Overall Study|Lost to Follow-up|0|||
129700355|NCT03648372|466862567|FG015|Overall Study|Lost to Follow-up|1|||
129700356|NCT03648372|466862568|FG016|Overall Study|Lost to Follow-up|0|||
129700357|NCT03648372|466862569|FG017|Overall Study|Lost to Follow-up|1|||
129700358|NCT03648372|466862570|FG018|Overall Study|Lost to Follow-up|0|||
129700359|NCT03648372|466862571|FG019|Overall Study|Lost to Follow-up|0|||
129700360|NCT03648372|466862572|FG020|Overall Study|Lost to Follow-up|0|||
129700361|NCT03648372|466862552|FG000|Overall Study|Start of a New Systemic Treatment|0|||
129700362|NCT03648372|466862553|FG001|Overall Study|Start of a New Systemic Treatment|0|||
129613297|NCT00761657|466541227|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
129613298|NCT00761657|466541228|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
129613299|NCT00761657|466541229|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
129613300|NCT00761657|466541230|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
129613301|NCT00761657|466541231|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
129613302|NCT00359801|466541232|FG000|Overall Study|Lost to Follow-up|72|||
129613303|NCT00359801|466541233|FG001|Overall Study|Lost to Follow-up|58|||
129613304|NCT00359801|466541232|FG000|Overall Study|Withdrawal by Subject|143|||
129613305|NCT00359801|466541233|FG001|Overall Study|Withdrawal by Subject|96|||
129613306|NCT00359801|466541232|FG000|Overall Study|Other|66|||
129613307|NCT00359801|466541233|FG001|Overall Study|Other|46|||
129613308|NCT00359801|466541232|FG000|Overall Study|Final Status Unknown: missing data|7|||
129613309|NCT00359801|466541233|FG001|Overall Study|Final Status Unknown: missing data|4|||
129613310|NCT00359801|466541232|FG000|Overall Study|Sponsor Decision|17|||
129613311|NCT00359801|466541233|FG001|Overall Study|Sponsor Decision|16|||
129613312|NCT02500043|466541238|FG000|Overall Study|Randomized, but not Treated|2|||
129613313|NCT02500043|466541239|FG001|Overall Study|Randomized, but not Treated|2|||
129613314|NCT02500043|466541238|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
129613315|NCT02500043|466541239|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
129613316|NCT02500043|466541238|FG000|Overall Study|Adverse Event|33|||
129613317|NCT02500043|466541239|FG001|Overall Study|Adverse Event|11|||
129613318|NCT02500043|466541238|FG000|Overall Study|Clinical Progression|54|||
129613319|NCT02500043|466541239|FG001|Overall Study|Clinical Progression|35|||
129613320|NCT02500043|466541238|FG000|Overall Study|Radiological Progression|192|||
129613321|NCT02500043|466541239|FG001|Overall Study|Radiological Progression|110|||
129613322|NCT02500043|466541238|FG000|Overall Study|Physician's Decision|11|||
129613323|NCT02500043|466541239|FG001|Overall Study|Physician's Decision|3|||
129613324|NCT02500043|466541238|FG000|Overall Study|Withdrawal by Subject|14|||
129613325|NCT02500043|466541239|FG001|Overall Study|Withdrawal by Subject|4|||
129613326|NCT02500043|466541238|FG000|Overall Study|Death|11|||
129613327|NCT02500043|466541239|FG001|Overall Study|Death|2|||
129613328|NCT02500043|466541238|FG000|Overall Study|Protocol Deviation|1|||
129613329|NCT02500043|466541239|FG001|Overall Study|Protocol Deviation|0|||
129613330|NCT03151408|466541240|FG000|Overall Study|Adverse Event|24|||
129613331|NCT03151408|466541241|FG001|Overall Study|Adverse Event|23|||
129613332|NCT03151408|466541240|FG000|Overall Study|Death|46|||
129613333|NCT03151408|466541241|FG001|Overall Study|Death|26|||
129613334|NCT03151408|466541240|FG000|Overall Study|Physician Decision|13|||
129613335|NCT03151408|466541241|FG001|Overall Study|Physician Decision|19|||
129613336|NCT03151408|466541240|FG000|Overall Study|Withdrawal by Subject|16|||
129613337|NCT03151408|466541241|FG001|Overall Study|Withdrawal by Subject|20|||
129613338|NCT03151408|466541240|FG000|Overall Study|Progressive disease|45|||
129613339|NCT03151408|466541241|FG001|Overall Study|Progressive disease|61|||
129613340|NCT03151408|466541240|FG000|Overall Study|non-compliance by patient|1|||
129613341|NCT03151408|466541241|FG001|Overall Study|non-compliance by patient|0|||
129613342|NCT03151408|466541240|FG000|Overall Study|other reasons|56|||
129613343|NCT03151408|466541241|FG001|Overall Study|other reasons|52|||
129613344|NCT03151408|466541240|FG000|Overall Study|randomized and not treated|2|||
129613345|NCT03151408|466541241|FG001|Overall Study|randomized and not treated|2|||
129613346|NCT01473524|466541244|FG000|DB Phase|Adverse Event|4|||
129613347|NCT01473524|466541245|FG001|DB Phase|Adverse Event|8|||
129613348|NCT01473524|466541246|FG002|DB Phase|Adverse Event|2|||
129613349|NCT01473524|466541247|FG003|DB Phase|Adverse Event|0|||
129613350|NCT01473524|466541248|FG004|DB Phase|Adverse Event|0|||
129700363|NCT03648372|466862554|FG002|Overall Study|Start of a New Systemic Treatment|0|||
129700364|NCT03648372|466862555|FG003|Overall Study|Start of a New Systemic Treatment|0|||
129700365|NCT03648372|466862556|FG004|Overall Study|Start of a New Systemic Treatment|0|||
129700366|NCT03648372|466862557|FG005|Overall Study|Start of a New Systemic Treatment|0|||
129700367|NCT03648372|466862558|FG006|Overall Study|Start of a New Systemic Treatment|0|||
129613351|NCT01473524|466541249|FG005|DB Phase|Adverse Event|0|||
129613352|NCT01473524|466541244|FG000|DB Phase|Death|1|||
129613353|NCT01473524|466541245|FG001|DB Phase|Death|0|||
129700368|NCT03648372|466862559|FG007|Overall Study|Start of a New Systemic Treatment|2|||
129613354|NCT01473524|466541246|FG002|DB Phase|Death|0|||
129613355|NCT01473524|466541247|FG003|DB Phase|Death|0|||
129613356|NCT01473524|466541248|FG004|DB Phase|Death|0|||
129613357|NCT01473524|466541249|FG005|DB Phase|Death|0|||
129613358|NCT01473524|466541244|FG000|DB Phase|Withdrawal by Subject|2|||
129613359|NCT01473524|466541245|FG001|DB Phase|Withdrawal by Subject|1|||
129700369|NCT03648372|466862560|FG008|Overall Study|Start of a New Systemic Treatment|0|||
129700370|NCT03648372|466862561|FG009|Overall Study|Start of a New Systemic Treatment|0|||
129700371|NCT03648372|466862562|FG010|Overall Study|Start of a New Systemic Treatment|1|||
129700372|NCT03648372|466862563|FG011|Overall Study|Start of a New Systemic Treatment|0|||
129700373|NCT03648372|466862564|FG012|Overall Study|Start of a New Systemic Treatment|0|||
129700374|NCT03648372|466862565|FG013|Overall Study|Start of a New Systemic Treatment|0|||
129700375|NCT03648372|466862566|FG014|Overall Study|Start of a New Systemic Treatment|0|||
129700376|NCT03648372|466862567|FG015|Overall Study|Start of a New Systemic Treatment|0|||
129700377|NCT03648372|466862568|FG016|Overall Study|Start of a New Systemic Treatment|0|||
129700378|NCT03648372|466862569|FG017|Overall Study|Start of a New Systemic Treatment|0|||
129700379|NCT03648372|466862570|FG018|Overall Study|Start of a New Systemic Treatment|0|||
129700380|NCT03648372|466862571|FG019|Overall Study|Start of a New Systemic Treatment|0|||
129700381|NCT03648372|466862572|FG020|Overall Study|Start of a New Systemic Treatment|0|||
129700382|NCT04280783|466863911|FG000|Overall Study|Family issues unrelated to the study.|1|||
129700383|NCT04280783|466863912|FG001|Overall Study|Family issues unrelated to the study.|0|||
129700384|NCT04280783|466863911|FG000|Overall Study|Withdrawal by Subject|0|||
129700385|NCT04280783|466863912|FG001|Overall Study|Withdrawal by Subject|1|||
129700386|NCT05654181|466863913|FG000|Overall Study|Adverse Event|1|||
129700387|NCT05654181|466863914|FG001|Overall Study|Adverse Event|0|||
129700388|NCT05654181|466863915|FG002|Overall Study|Adverse Event|0|||
129700389|NCT05654181|466863916|FG003|Overall Study|Adverse Event|0|||
129700390|NCT05654181|466863917|FG004|Overall Study|Adverse Event|0|||
129700391|NCT05654181|466863918|FG005|Overall Study|Adverse Event|0|||
129700392|NCT05654181|466863919|FG006|Overall Study|Adverse Event|0|||
129700393|NCT05654181|466863920|FG007|Overall Study|Adverse Event|1|||
129700394|NCT05654181|466863921|FG008|Overall Study|Adverse Event|0|||
129700395|NCT05654181|466863922|FG009|Overall Study|Adverse Event|0|||
129700396|NCT05654181|466863913|FG000|Overall Study|Withdrawal by Subject|0|||
129700397|NCT05654181|466863914|FG001|Overall Study|Withdrawal by Subject|0|||
129700398|NCT05654181|466863915|FG002|Overall Study|Withdrawal by Subject|0|||
129700399|NCT05654181|466863916|FG003|Overall Study|Withdrawal by Subject|0|||
129700400|NCT05654181|466863917|FG004|Overall Study|Withdrawal by Subject|0|||
129700401|NCT05654181|466863918|FG005|Overall Study|Withdrawal by Subject|0|||
129700402|NCT05654181|466863919|FG006|Overall Study|Withdrawal by Subject|0|||
129700403|NCT05654181|466863920|FG007|Overall Study|Withdrawal by Subject|1|||
129700404|NCT05654181|466863921|FG008|Overall Study|Withdrawal by Subject|0|||
129700405|NCT05654181|466863922|FG009|Overall Study|Withdrawal by Subject|0|||
129700406|NCT05654181|466863913|FG000|Overall Study|Other|0|||
129700407|NCT05654181|466863914|FG001|Overall Study|Other|0|||
129613360|NCT01473524|466541246|FG002|DB Phase|Withdrawal by Subject|1|||
129613361|NCT01473524|466541247|FG003|DB Phase|Withdrawal by Subject|0|||
129613362|NCT01473524|466541248|FG004|DB Phase|Withdrawal by Subject|0|||
129613363|NCT01473524|466541249|FG005|DB Phase|Withdrawal by Subject|0|||
129613364|NCT01473524|466541244|FG000|LTSE Phase|Withdrawal by Subject|0|||
129613365|NCT01473524|466541245|FG001|LTSE Phase|Withdrawal by Subject|0|||
129613366|NCT01473524|466541246|FG002|LTSE Phase|Withdrawal by Subject|0|||
129613367|NCT01473524|466541247|FG003|LTSE Phase|Withdrawal by Subject|3|||
129613368|NCT01473524|466541248|FG004|LTSE Phase|Withdrawal by Subject|3|||
129613369|NCT01473524|466541249|FG005|LTSE Phase|Withdrawal by Subject|6|||
129613370|NCT01473524|466541244|FG000|LTSE Phase|Death|0|||
129613371|NCT01473524|466541245|FG001|LTSE Phase|Death|0|||
129613372|NCT01473524|466541246|FG002|LTSE Phase|Death|0|||
129613373|NCT01473524|466541247|FG003|LTSE Phase|Death|0|||
129700408|NCT05654181|466863915|FG002|Overall Study|Other|0|||
129700409|NCT05654181|466863916|FG003|Overall Study|Other|0|||
129700410|NCT05654181|466863917|FG004|Overall Study|Other|1|||
129700411|NCT05654181|466863918|FG005|Overall Study|Other|1|||
129700412|NCT05654181|466863919|FG006|Overall Study|Other|0|||
129700413|NCT05654181|466863920|FG007|Overall Study|Other|0|||
129613374|NCT01473524|466541248|FG004|LTSE Phase|Death|1|||
129613375|NCT01473524|466541249|FG005|LTSE Phase|Death|0|||
129613376|NCT01473524|466541244|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
129700414|NCT05654181|466863921|FG008|Overall Study|Other|0|||
129700415|NCT05654181|466863922|FG009|Overall Study|Other|0|||
129790942|NCT02108262|467201445|FG002|Overall Study|Missed IV due to pharmacy error|1|||
129790943|NCT02108262|467201446|FG003|Overall Study|Missed IV due to pharmacy error|0|||
129700416|NCT04101331|466863923|FG000|Overall Study|Adverse Event|9|||
129700417|NCT04101331|466863923|FG000|Overall Study|Disease progression|82|||
129700418|NCT04101331|466863923|FG000|Overall Study|Withdrawal by Subject|1|||
129700419|NCT04101331|466863923|FG000|Overall Study|Investigator decision|6|||
129700420|NCT04101331|466863923|FG000|Overall Study|Death|6|||
129700421|NCT04101331|466863923|FG000|Overall Study|Allogenic transplant|1|||
129790944|NCT01895361|467201447|FG000|Overall Study|Adverse Event|1|||
129790945|NCT01895361|467201448|FG001|Overall Study|Adverse Event|1|||
129613377|NCT01473524|466541245|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
129613378|NCT01473524|466541246|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
129613379|NCT01473524|466541247|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
129613380|NCT01473524|466541248|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
129613381|NCT01473524|466541249|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
129613382|NCT01473524|466541244|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
129613383|NCT01473524|466541245|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
129613384|NCT01473524|466541246|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
129613385|NCT01473524|466541247|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
129613386|NCT01473524|466541248|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
129613387|NCT01473524|466541249|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
129613388|NCT01473524|466541244|FG000|LTSE Phase|Lost to Follow-up|0|||
129613389|NCT01473524|466541245|FG001|LTSE Phase|Lost to Follow-up|0|||
129613390|NCT01473524|466541246|FG002|LTSE Phase|Lost to Follow-up|0|||
129613391|NCT01473524|466541247|FG003|LTSE Phase|Lost to Follow-up|1|||
129613392|NCT01473524|466541248|FG004|LTSE Phase|Lost to Follow-up|3|||
129613393|NCT01473524|466541249|FG005|LTSE Phase|Lost to Follow-up|2|||
129613394|NCT01473524|466541244|FG000|LTSE Phase|Principal Investigator Decision|0|||
129613395|NCT01473524|466541245|FG001|LTSE Phase|Principal Investigator Decision|0|||
129613396|NCT01473524|466541246|FG002|LTSE Phase|Principal Investigator Decision|0|||
129613397|NCT01473524|466541247|FG003|LTSE Phase|Principal Investigator Decision|1|||
129613398|NCT01473524|466541248|FG004|LTSE Phase|Principal Investigator Decision|1|||
129613399|NCT01473524|466541249|FG005|LTSE Phase|Principal Investigator Decision|3|||
129613400|NCT01473524|466541244|FG000|LTSE Phase|Liver Transplantation|0|||
129613401|NCT01473524|466541245|FG001|LTSE Phase|Liver Transplantation|0|||
129613402|NCT01473524|466541246|FG002|LTSE Phase|Liver Transplantation|0|||
129613403|NCT01473524|466541247|FG003|LTSE Phase|Liver Transplantation|0|||
129613404|NCT01473524|466541248|FG004|LTSE Phase|Liver Transplantation|0|||
129613405|NCT01473524|466541249|FG005|LTSE Phase|Liver Transplantation|1|||
129613406|NCT01473524|466541244|FG000|LTSE Phase|Pregnancy|0|||
129613407|NCT01473524|466541245|FG001|LTSE Phase|Pregnancy|0|||
129613408|NCT01473524|466541246|FG002|LTSE Phase|Pregnancy|0|||
129613409|NCT01473524|466541247|FG003|LTSE Phase|Pregnancy|1|||
129613410|NCT01473524|466541248|FG004|LTSE Phase|Pregnancy|0|||
129613411|NCT01473524|466541249|FG005|LTSE Phase|Pregnancy|0|||
129613412|NCT01473524|466541244|FG000|LTSE Phase|Protocol Violation|0|||
129613413|NCT01473524|466541245|FG001|LTSE Phase|Protocol Violation|0|||
129613414|NCT01473524|466541246|FG002|LTSE Phase|Protocol Violation|0|||
129613415|NCT01473524|466541247|FG003|LTSE Phase|Protocol Violation|0|||
129613416|NCT01473524|466541248|FG004|LTSE Phase|Protocol Violation|0|||
129613417|NCT01473524|466541249|FG005|LTSE Phase|Protocol Violation|1|||
129613418|NCT02383810|466541250|FG000|Overall Study|Physician Decision|1|||
129613419|NCT02383810|466541251|FG001|Overall Study|Physician Decision|1|||
129613420|NCT02383810|466541252|FG002|Overall Study|Physician Decision|0|||
129613421|NCT02383810|466541253|FG003|Overall Study|Physician Decision|0|||
129613422|NCT02383810|466541254|FG004|Overall Study|Physician Decision|0|||
129613423|NCT02383810|466541255|FG005|Overall Study|Physician Decision|0|||
129613424|NCT02383810|466541256|FG006|Overall Study|Physician Decision|0|||
129613425|NCT02383810|466541257|FG007|Overall Study|Physician Decision|0|||
129613426|NCT02383810|466541250|FG000|Overall Study|Withdrawal by Subject|2|||
129613427|NCT02383810|466541251|FG001|Overall Study|Withdrawal by Subject|3|||
129613428|NCT02383810|466541252|FG002|Overall Study|Withdrawal by Subject|3|||
129613429|NCT02383810|466541253|FG003|Overall Study|Withdrawal by Subject|3|||
129613430|NCT02383810|466541254|FG004|Overall Study|Withdrawal by Subject|0|||
129613431|NCT02383810|466541255|FG005|Overall Study|Withdrawal by Subject|0|||
129613432|NCT02383810|466541256|FG006|Overall Study|Withdrawal by Subject|0|||
129613433|NCT02383810|466541257|FG007|Overall Study|Withdrawal by Subject|0|||
129613434|NCT02383810|466541250|FG000|Overall Study|Adverse Event|0|||
129613435|NCT02383810|466541251|FG001|Overall Study|Adverse Event|2|||
129790946|NCT01895361|467201449|FG002|Overall Study|Adverse Event|3|||
129613436|NCT02383810|466541252|FG002|Overall Study|Adverse Event|4|||
129613437|NCT02383810|466541253|FG003|Overall Study|Adverse Event|5|||
129613438|NCT02383810|466541254|FG004|Overall Study|Adverse Event|0|||
129613439|NCT02383810|466541255|FG005|Overall Study|Adverse Event|1|||
129613440|NCT02383810|466541256|FG006|Overall Study|Adverse Event|1|||
129790947|NCT01895361|467201447|FG000|Overall Study|Death|2|||
129790948|NCT01895361|467201448|FG001|Overall Study|Death|1|||
129613441|NCT02383810|466541257|FG007|Overall Study|Adverse Event|0|||
129613442|NCT02383810|466541250|FG000|Overall Study|Lost to Follow-up|0|||
129613443|NCT02383810|466541251|FG001|Overall Study|Lost to Follow-up|1|||
129613444|NCT02383810|466541252|FG002|Overall Study|Lost to Follow-up|0|||
129613445|NCT02383810|466541253|FG003|Overall Study|Lost to Follow-up|1|||
129613446|NCT02383810|466541254|FG004|Overall Study|Lost to Follow-up|0|||
129613447|NCT02383810|466541255|FG005|Overall Study|Lost to Follow-up|0|||
129613448|NCT02383810|466541256|FG006|Overall Study|Lost to Follow-up|0|||
129790949|NCT01895361|467201449|FG002|Overall Study|Death|2|||
129613449|NCT02383810|466541257|FG007|Overall Study|Lost to Follow-up|0|||
129613450|NCT02383810|466541250|FG000|Overall Study|other|0|||
129613451|NCT02383810|466541251|FG001|Overall Study|other|0|||
129613452|NCT02383810|466541252|FG002|Overall Study|other|0|||
129613453|NCT02383810|466541253|FG003|Overall Study|other|2|||
129613454|NCT02383810|466541254|FG004|Overall Study|other|0|||
129613455|NCT02383810|466541255|FG005|Overall Study|other|0|||
129613456|NCT02383810|466541256|FG006|Overall Study|other|0|||
129613457|NCT02383810|466541257|FG007|Overall Study|other|0|||
129613458|NCT02383810|466541250|FG000|Overall Study|subject did not receive study treatment|0|||
129613459|NCT02383810|466541251|FG001|Overall Study|subject did not receive study treatment|1|||
129613460|NCT02383810|466541252|FG002|Overall Study|subject did not receive study treatment|0|||
129613461|NCT02383810|466541253|FG003|Overall Study|subject did not receive study treatment|0|||
129613462|NCT02383810|466541254|FG004|Overall Study|subject did not receive study treatment|0|||
129613463|NCT02383810|466541255|FG005|Overall Study|subject did not receive study treatment|0|||
129613464|NCT02383810|466541256|FG006|Overall Study|subject did not receive study treatment|0|||
129613465|NCT02383810|466541257|FG007|Overall Study|subject did not receive study treatment|0|||
129613466|NCT00282919|466541258|FG000|Overall Study|Lack of Efficacy|4|||
129613467|NCT00282919|466541258|FG000|Overall Study|Withdrawal by Subject|1|||
129613468|NCT00282919|466541258|FG000|Overall Study|Asymptomatic Parasitemia|2|||
129613469|NCT02540850|466541261|FG000|Overall Study|Lost to Follow-up|69|||
129613470|NCT02540850|466541262|FG001|Overall Study|Lost to Follow-up|66|||
129613471|NCT02540850|466541263|FG002|Overall Study|Lost to Follow-up|34|||
129613472|NCT02861014|466541264|FG000|Primary Analysis|Adverse Event|7|||
129613473|NCT02861014|466541264|FG000|Primary Analysis|Death|1|||
129613474|NCT02861014|466541264|FG000|Primary Analysis|Lack of Efficacy|3|||
129613475|NCT02861014|466541264|FG000|Primary Analysis|Physician Decision|2|||
129613476|NCT02861014|466541264|FG000|Primary Analysis|Pregnancy|4|||
129613477|NCT02861014|466541264|FG000|Primary Analysis|Protocol Violation|2|||
129613478|NCT02861014|466541264|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
129613479|NCT02861014|466541264|FG000|Primary Analysis|Withdrawal by Subject|14|||
129613480|NCT02861014|466541264|FG000|Primary Analysis|Commercial ocrelizumab|3|||
129613481|NCT02861014|466541264|FG000|Safety Follow-up|Adverse Event|1|||
129613482|NCT02861014|466541264|FG000|Safety Follow-up|Pregnancy|1|||
129613483|NCT02861014|466541264|FG000|Safety Follow-up|Withdrawal by Subject|9|||
129613484|NCT02861014|466541264|FG000|Safety Follow-up|Study terminated by sponsor|1|||
129613485|NCT02861014|466541264|FG000|Safety Follow-up|Physician Decision|1|||
129613486|NCT02861014|466541264|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
129613487|NCT02861014|466541264|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
129613488|NCT00926783|466541265|FG000|Overall Study|Incomplete CFAE Procedures|3|||
129613489|NCT00926783|466541266|FG001|Overall Study|Incomplete CFAE Procedures|3|||
129613490|NCT02549027|466541268|FG000|Washout After Period 4|Withdrawal by Subject|0|||
129613491|NCT02549027|466541269|FG001|Washout After Period 4|Withdrawal by Subject|1|||
129613492|NCT02549027|466541270|FG002|Washout After Period 4|Withdrawal by Subject|1|||
129613493|NCT02549027|466541271|FG003|Washout After Period 4|Withdrawal by Subject|1|||
129613494|NCT02549027|466541272|FG004|Washout After Period 4|Withdrawal by Subject|0|||
129613495|NCT02549027|466541273|FG005|Washout After Period 4|Withdrawal by Subject|0|||
129613496|NCT02549027|466541268|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129613497|NCT02549027|466541269|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129613498|NCT02549027|466541270|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129887010|NCT02555371|467547213|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
129613499|NCT02549027|466541271|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129613500|NCT02549027|466541272|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
129613501|NCT02549027|466541273|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
129613502|NCT02186834|466541274|FG000|Dose Escalation|Death|0|||
129613503|NCT02186834|466541275|FG001|Dose Escalation|Death|0|||
129613504|NCT02186834|466541276|FG002|Dose Escalation|Death|0|||
129613505|NCT02186834|466541277|FG003|Dose Escalation|Death|1|||
129613506|NCT02186834|466541278|FG004|Dose Escalation|Death|0|||
129613507|NCT02186834|466541279|FG005|Dose Escalation|Death|0|||
129613508|NCT02186834|466541274|FG000|Treatment at RP2D|Died prior to treatment|0|||
129613509|NCT02186834|466541275|FG001|Treatment at RP2D|Died prior to treatment|0|||
129887011|NCT02555371|467547214|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
129887012|NCT02555371|467547215|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
129613510|NCT02186834|466541276|FG002|Treatment at RP2D|Died prior to treatment|0|||
129613511|NCT02186834|466541277|FG003|Treatment at RP2D|Died prior to treatment|0|||
129613512|NCT02186834|466541278|FG004|Treatment at RP2D|Died prior to treatment|0|||
129613513|NCT02186834|466541279|FG005|Treatment at RP2D|Died prior to treatment|1|||
129439162|NCT04223856|465904587|FG000|Overall Study|Progressive disease|153|||
129439163|NCT04223856|465904588|FG001|Overall Study|Progressive disease|73|||
129613514|NCT04581369|466541285|FG000|Overall Study|Death|7|||
129613515|NCT04581369|466541286|FG001|Overall Study|Death|6|||
129613516|NCT04581369|466541287|FG002|Overall Study|Death|0|||
129613517|NCT04581369|466541285|FG000|Overall Study|Lost to Follow-up|7|||
129613518|NCT04581369|466541286|FG001|Overall Study|Lost to Follow-up|3|||
129613519|NCT04581369|466541287|FG002|Overall Study|Lost to Follow-up|0|||
129613520|NCT04581369|466541285|FG000|Overall Study|liver transplant|2|||
129613521|NCT04581369|466541286|FG001|Overall Study|liver transplant|2|||
129613522|NCT04581369|466541287|FG002|Overall Study|liver transplant|0|||
129613523|NCT04581369|466541285|FG000|Overall Study|transitioned to hospice care|0|||
129613524|NCT04581369|466541286|FG001|Overall Study|transitioned to hospice care|5|||
129613525|NCT04581369|466541287|FG002|Overall Study|transitioned to hospice care|0|||
129613526|NCT00780910|466541288|FG000|Overall Study|Adverse Event|2|||
129613527|NCT01111825|466541289|FG000|Overall Study|Withdrawal by Subject|0|||
129613528|NCT01111825|466541290|FG001|Overall Study|Withdrawal by Subject|0|||
129613529|NCT01111825|466541291|FG002|Overall Study|Withdrawal by Subject|1|||
129613530|NCT01111825|466541292|FG003|Overall Study|Withdrawal by Subject|0|||
129613531|NCT01111825|466541289|FG000|Overall Study|Lost to Follow-up|0|||
129613532|NCT01111825|466541290|FG001|Overall Study|Lost to Follow-up|0|||
129613533|NCT01111825|466541291|FG002|Overall Study|Lost to Follow-up|3|||
129613534|NCT01111825|466541292|FG003|Overall Study|Lost to Follow-up|1|||
129613535|NCT01111825|466541289|FG000|Overall Study|Adverse Event|2|||
129613536|NCT01111825|466541290|FG001|Overall Study|Adverse Event|1|||
129613537|NCT01111825|466541291|FG002|Overall Study|Adverse Event|4|||
129613538|NCT01111825|466541292|FG003|Overall Study|Adverse Event|0|||
129613539|NCT01111825|466541289|FG000|Overall Study|Disease Progression|1|||
129613540|NCT01111825|466541290|FG001|Overall Study|Disease Progression|0|||
129613541|NCT01111825|466541291|FG002|Overall Study|Disease Progression|0|||
129613542|NCT01111825|466541292|FG003|Overall Study|Disease Progression|0|||
129613543|NCT01111825|466541289|FG000|Overall Study|Discontinuation by Sponsor|0|||
129613544|NCT01111825|466541290|FG001|Overall Study|Discontinuation by Sponsor|0|||
129613545|NCT01111825|466541291|FG002|Overall Study|Discontinuation by Sponsor|0|||
129613546|NCT01111825|466541292|FG003|Overall Study|Discontinuation by Sponsor|20|||
129613547|NCT00741286|466541299|FG000|Overall Study|Lost to Follow-up|15|||
129613548|NCT00741286|466541300|FG001|Overall Study|Lost to Follow-up|10|||
129613549|NCT00741286|466541299|FG000|Overall Study|Adverse Event|1|||
129613550|NCT00741286|466541300|FG001|Overall Study|Adverse Event|6|||
129613551|NCT00741286|466541299|FG000|Overall Study|Protocol Violation|3|||
129613552|NCT00741286|466541300|FG001|Overall Study|Protocol Violation|2|||
129613553|NCT00741286|466541299|FG000|Overall Study|Primary Outcome|1|||
129613554|NCT00741286|466541300|FG001|Overall Study|Primary Outcome|1|||
129613555|NCT01831258|466541301|FG000|Overall Study|Withdrawal by Subject|2|||
129613556|NCT01831258|466541302|FG001|Overall Study|Withdrawal by Subject|1|||
129613557|NCT01831258|466541301|FG000|Overall Study|Lost to Follow-up|3|||
129613558|NCT01831258|466541302|FG001|Overall Study|Lost to Follow-up|2|||
129613559|NCT02564887|466541303|FG000|Overall Study|Lost to Follow-up|6|||
129613560|NCT02564887|466541304|FG001|Overall Study|Lost to Follow-up|0|||
129613561|NCT01851330|466541305|FG000|Overall Study|Lack of Efficacy|10|||
129613562|NCT01851330|466541306|FG001|Overall Study|Lack of Efficacy|9|||
129613563|NCT01851330|466541307|FG002|Overall Study|Lack of Efficacy|2|||
129790950|NCT01895361|467201447|FG000|Overall Study|Lost to Follow-up|4|||
129790951|NCT01895361|467201448|FG001|Overall Study|Lost to Follow-up|4|||
129790952|NCT01895361|467201449|FG002|Overall Study|Lost to Follow-up|6|||
129790953|NCT01895361|467201447|FG000|Overall Study|Non-compliance with study|1|||
129613564|NCT01851330|466541305|FG000|Overall Study|Lost to Follow-up|1|||
129613565|NCT01851330|466541306|FG001|Overall Study|Lost to Follow-up|6|||
129613566|NCT01851330|466541307|FG002|Overall Study|Lost to Follow-up|9|||
129613567|NCT01851330|466541305|FG000|Overall Study|Withdrew Consent|2|||
129613568|NCT01851330|466541306|FG001|Overall Study|Withdrew Consent|1|||
129613569|NCT01851330|466541307|FG002|Overall Study|Withdrew Consent|0|||
129613570|NCT01851330|466541305|FG000|Overall Study|Investigator's Discretion|0|||
129613571|NCT01851330|466541306|FG001|Overall Study|Investigator's Discretion|0|||
129613572|NCT01851330|466541307|FG002|Overall Study|Investigator's Discretion|1|||
129613573|NCT00314951|466541310|FG000|Treatment|Didn't meet criteria for mITT population|16|||
129613574|NCT00314951|466541311|FG001|Treatment|Didn't meet criteria for mITT population|11|||
129790954|NCT01895361|467201448|FG001|Overall Study|Non-compliance with study|3|||
129613575|NCT00314951|466541310|FG000|Follow-up|mITT failure|44|||
129613576|NCT00314951|466541311|FG001|Follow-up|mITT failure|34|||
129613577|NCT00233402|466541312|FG000|Overall Study|No pathology data|12|||
129613578|NCT00233402|466541313|FG001|Overall Study|No pathology data|9|||
129613579|NCT00233402|466541312|FG000|Overall Study|No Ta/T1|89|||
129613580|NCT00233402|466541313|FG001|Overall Study|No Ta/T1|94|||
129613581|NCT00233402|466541312|FG000|Overall Study|Lost to follow up etc|3|||
129439164|NCT04223856|465904587|FG000|Overall Study|Adverse Event|97|||
129439165|NCT04223856|465904588|FG001|Overall Study|Adverse Event|62|||
129613582|NCT00233402|466541313|FG001|Overall Study|Lost to follow up etc|21|||
129613583|NCT02087189|466541316|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
129613584|NCT01189487|466541321|FG000|Overall Study|Lack of Efficacy|2|||
129613585|NCT01189487|466541321|FG000|Overall Study|Adverse Event|1|||
129613586|NCT04630158|466541322|FG000|Overall Study|Adverse Event|1|||
129613587|NCT04630158|466541323|FG001|Overall Study|Adverse Event|1|||
129613588|NCT04630158|466541324|FG002|Overall Study|Adverse Event|1|||
129613589|NCT04630158|466541322|FG000|Overall Study|Physician Decision|0|||
129613590|NCT04630158|466541323|FG001|Overall Study|Physician Decision|2|||
129613591|NCT04630158|466541324|FG002|Overall Study|Physician Decision|0|||
129613592|NCT04630158|466541322|FG000|Overall Study|Protocol Violation|1|||
129613593|NCT04630158|466541323|FG001|Overall Study|Protocol Violation|0|||
129613594|NCT04630158|466541324|FG002|Overall Study|Protocol Violation|1|||
129613595|NCT04630158|466541322|FG000|Overall Study|Withdrawal by Subject|2|||
129613596|NCT04630158|466541323|FG001|Overall Study|Withdrawal by Subject|1|||
129613597|NCT04630158|466541324|FG002|Overall Study|Withdrawal by Subject|2|||
129613598|NCT03136965|466541330|FG000|Overall Study|Lost to Follow-up|0|||
129613599|NCT03136965|466541331|FG001|Overall Study|Lost to Follow-up|1|||
129613600|NCT03136965|466541332|FG002|Overall Study|Lost to Follow-up|0|||
129613601|NCT04868968|466541333|FG000|Overall Study|Lost to Follow-up|1|||
129613602|NCT03553576|466541336|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
129613603|NCT03553576|466541337|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
129613604|NCT03553576|466541336|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
129613605|NCT03553576|466541337|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
129613606|NCT03553576|466541336|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
129613607|NCT03553576|466541337|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
129613608|NCT03553576|466541336|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
129613609|NCT03553576|466541337|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
129613610|NCT03553576|466541336|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
129613611|NCT03553576|466541337|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
129613612|NCT03553576|466541336|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
129613613|NCT03553576|466541337|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
129613614|NCT03553576|466541336|FG000|Overall Study|Physician Decision|2|||
129613615|NCT03553576|466541337|FG001|Overall Study|Physician Decision|5|||
129613616|NCT05038800|466541339|FG000|Overall Study|Death|1|||
129613617|NCT05038800|466541340|FG001|Overall Study|Death|1|||
129613618|NCT05038800|466541341|FG002|Overall Study|Death|5|||
129613619|NCT05038800|466541342|FG003|Overall Study|Death|3|||
129613620|NCT05038800|466541343|FG004|Overall Study|Death|1|||
129613621|NCT05038800|466541339|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129613622|NCT05038800|466541340|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129613623|NCT05038800|466541341|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129613624|NCT05038800|466541342|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129613625|NCT05038800|466541343|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129613626|NCT05038800|466541339|FG000|Overall Study|Lack of Efficacy|0|||
129613627|NCT05038800|466541340|FG001|Overall Study|Lack of Efficacy|0|||
129613628|NCT05038800|466541341|FG002|Overall Study|Lack of Efficacy|0|||
129613629|NCT05038800|466541342|FG003|Overall Study|Lack of Efficacy|0|||
129613630|NCT05038800|466541343|FG004|Overall Study|Lack of Efficacy|1|||
129613631|NCT01104792|466541344|FG000|Overall Study|Adverse Event|77|||
129613632|NCT01104792|466541344|FG000|Overall Study|Insufficient Therapeutic Response|22|||
129613633|NCT01104792|466541344|FG000|Overall Study|Protocol Violation|45|||
129613634|NCT01104792|466541344|FG000|Overall Study|Withdrawal of Consent|179|||
129613635|NCT01104792|466541344|FG000|Overall Study|Lost to Follow-up|43|||
129613636|NCT01104792|466541344|FG000|Overall Study|Reasons Not Specified|27|||
129613637|NCT01104792|466541344|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
129613638|NCT00658021|466541347|FG000|28-Week Treatment Period|Adverse Event|3|||
129613639|NCT00658021|466541348|FG001|28-Week Treatment Period|Adverse Event|1|||
129613640|NCT00658021|466541349|FG002|28-Week Treatment Period|Adverse Event|0|||
129613641|NCT00658021|466541347|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
129700422|NCT04110145|466863924|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129700423|NCT04110145|466863925|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129700424|NCT04110145|466863926|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129613642|NCT00658021|466541348|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
129613643|NCT00658021|466541349|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
129613644|NCT00658021|466541347|FG000|28-Week Treatment Period|Protocol Violation|0|||
129613645|NCT00658021|466541348|FG001|28-Week Treatment Period|Protocol Violation|2|||
129613646|NCT00658021|466541349|FG002|28-Week Treatment Period|Protocol Violation|1|||
129613647|NCT00658021|466541347|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
129613648|NCT00658021|466541348|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
129613649|NCT00658021|466541349|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
129613650|NCT00658021|466541347|FG000|28-Week Treatment Period|Physician Decision|1|||
129613651|NCT00658021|466541348|FG001|28-Week Treatment Period|Physician Decision|2|||
129613652|NCT00658021|466541349|FG002|28-Week Treatment Period|Physician Decision|1|||
129613653|NCT00658021|466541347|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
129613654|NCT00658021|466541348|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
129613655|NCT00658021|466541349|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
129613656|NCT00658021|466541347|FG000|28-Week Treatment Period|Loss of glucose control|1|||
129613657|NCT00658021|466541348|FG001|28-Week Treatment Period|Loss of glucose control|1|||
129613658|NCT00658021|466541349|FG002|28-Week Treatment Period|Loss of glucose control|10|||
129613659|NCT00658021|466541347|FG000|28-Week Treatment Period|Other|2|||
129613660|NCT00658021|466541348|FG001|28-Week Treatment Period|Other|3|||
129613661|NCT00658021|466541349|FG002|28-Week Treatment Period|Other|1|||
129613662|NCT00658021|466541347|FG000|28-Week Treatment Period|Did not receive treatment|2|||
129613663|NCT00658021|466541348|FG001|28-Week Treatment Period|Did not receive treatment|0|||
129613664|NCT00658021|466541349|FG002|28-Week Treatment Period|Did not receive treatment|0|||
129613665|NCT00658021|466541347|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
129613666|NCT00658021|466541348|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
129613667|NCT00658021|466541349|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
129613668|NCT00658021|466541347|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
129613669|NCT00658021|466541348|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
129613670|NCT00658021|466541349|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
129613671|NCT02952898|466541355|FG000|Overall Study|Withdrawal by Subject|10|||
129613672|NCT02952898|466541356|FG001|Overall Study|Withdrawal by Subject|8|||
129613673|NCT02952898|466541357|FG002|Overall Study|Withdrawal by Subject|8|||
129613674|NCT02952898|466541355|FG000|Overall Study|Adverse Event|8|||
129613675|NCT02952898|466541356|FG001|Overall Study|Adverse Event|8|||
129613676|NCT02952898|466541357|FG002|Overall Study|Adverse Event|3|||
129613677|NCT02952898|466541355|FG000|Overall Study|Lost to Follow-up|3|||
129613678|NCT02952898|466541356|FG001|Overall Study|Lost to Follow-up|2|||
129613679|NCT02952898|466541357|FG002|Overall Study|Lost to Follow-up|2|||
129613680|NCT02952898|466541355|FG000|Overall Study|Non-compliance with study drug|1|||
129613681|NCT02952898|466541356|FG001|Overall Study|Non-compliance with study drug|1|||
129613682|NCT02952898|466541357|FG002|Overall Study|Non-compliance with study drug|2|||
129613683|NCT04123561|466541368|FG000|Overall Study|Lost to Follow-up|20|||
129613684|NCT04123561|466541369|FG001|Overall Study|Lost to Follow-up|12|||
129613685|NCT04123561|466541370|FG002|Overall Study|Lost to Follow-up|5|||
129613686|NCT04123561|466541368|FG000|Overall Study|Withdrawal by Subject|9|||
129613687|NCT04123561|466541369|FG001|Overall Study|Withdrawal by Subject|7|||
129613688|NCT04123561|466541370|FG002|Overall Study|Withdrawal by Subject|9|||
129613689|NCT04123561|466541368|FG000|Overall Study|Lack of Efficacy|7|||
129613690|NCT04123561|466541369|FG001|Overall Study|Lack of Efficacy|8|||
129613691|NCT04123561|466541370|FG002|Overall Study|Lack of Efficacy|6|||
129613692|NCT04123561|466541368|FG000|Overall Study|Adverse Event|5|||
129613693|NCT04123561|466541369|FG001|Overall Study|Adverse Event|2|||
129613694|NCT04123561|466541370|FG002|Overall Study|Adverse Event|3|||
129613695|NCT04123561|466541368|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
129613696|NCT04123561|466541369|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
129613697|NCT04123561|466541370|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
129613698|NCT04123561|466541368|FG000|Overall Study|Death|0|||
129613699|NCT04123561|466541369|FG001|Overall Study|Death|0|||
129613700|NCT04123561|466541370|FG002|Overall Study|Death|1|||
129613701|NCT04123561|466541368|FG000|Overall Study|Protocol Violation|0|||
129613702|NCT04123561|466541369|FG001|Overall Study|Protocol Violation|1|||
129613703|NCT04123561|466541370|FG002|Overall Study|Protocol Violation|0|||
129613704|NCT00278889|466541381|FG000|Overall Study|Withdrawal by Subject|0|||
129613705|NCT00278889|466541382|FG001|Overall Study|Withdrawal by Subject|5|||
129613706|NCT00278889|466541383|FG002|Overall Study|Withdrawal by Subject|3|||
129613707|NCT00278889|466541381|FG000|Overall Study|Lost to Follow-up|1|||
129613708|NCT00278889|466541382|FG001|Overall Study|Lost to Follow-up|1|||
129613709|NCT00278889|466541383|FG002|Overall Study|Lost to Follow-up|0|||
129613710|NCT00278889|466541381|FG000|Overall Study|Death|24|||
129613711|NCT00278889|466541382|FG001|Overall Study|Death|21|||
129613712|NCT00278889|466541383|FG002|Overall Study|Death|17|||
129613713|NCT03462459|466541384|FG000|Overall Study|Death|1|||
129613714|NCT03462459|466541385|FG001|Overall Study|Death|0|||
129613715|NCT03462459|466541384|FG000|Overall Study|Lack of Efficacy|2|||
129613716|NCT03462459|466541385|FG001|Overall Study|Lack of Efficacy|4|||
129613717|NCT03462459|466541384|FG000|Overall Study|Lost to Follow-up|1|||
129613718|NCT03462459|466541385|FG001|Overall Study|Lost to Follow-up|3|||
129613719|NCT03462459|466541384|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
129613720|NCT03462459|466541385|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
129613721|NCT03462459|466541384|FG000|Overall Study|Withdrawal by Subject|3|||
129613722|NCT03462459|466541385|FG001|Overall Study|Withdrawal by Subject|2|||
129613723|NCT03462459|466541384|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
129790955|NCT01895361|467201449|FG002|Overall Study|Non-compliance with study|1|||
129790956|NCT01895361|467201447|FG000|Overall Study|Physician Decision|2|||
129613724|NCT03462459|466541385|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
129790957|NCT01895361|467201448|FG001|Overall Study|Physician Decision|2|||
129790958|NCT01895361|467201449|FG002|Overall Study|Physician Decision|2|||
129790959|NCT01895361|467201447|FG000|Overall Study|Withdrawal by Subject|7|||
129790960|NCT01895361|467201448|FG001|Overall Study|Withdrawal by Subject|6|||
129790961|NCT01895361|467201449|FG002|Overall Study|Withdrawal by Subject|6|||
129790962|NCT01895361|467201447|FG000|Overall Study|Lack of Efficacy|0|||
129790963|NCT01895361|467201448|FG001|Overall Study|Lack of Efficacy|1|||
129790964|NCT01895361|467201449|FG002|Overall Study|Lack of Efficacy|0|||
129790965|NCT01895361|467201447|FG000|Overall Study|Reasons different from categories above|7|||
129887013|NCT03095599|467547216|FG000|Overall Study|Withdrawal by Subject|1|||
129613725|NCT04042376|466541387|FG000|Overall Study|Withdrawal by Subject|1|||
129613726|NCT04042376|466541387|FG000|Overall Study|Death|3|||
129613727|NCT03132155|466543413|FG000|Overall Study|Lack of Efficacy|6|||
129613728|NCT03132155|466543413|FG000|Overall Study|Lost to Follow-up|1|||
129613729|NCT03132155|466543413|FG000|Overall Study|Withdrawal by Subject|1|||
129613730|NCT00270855|466543417|FG000|Overall Study|Withdrawal by Subject|8|||
129613731|NCT00270855|466543418|FG001|Overall Study|Withdrawal by Subject|8|||
129613732|NCT01396512|466543421|FG000|Overall Study|Withdrawal by Subject|0|||
129613733|NCT01396512|466543422|FG001|Overall Study|Withdrawal by Subject|1|||
129613734|NCT02755649|466543423|FG000|Overall Study|Transitioned into OLE study|99|||
129613735|NCT02755649|466543424|FG001|Overall Study|Transitioned into OLE study|98|||
129613736|NCT02755649|466543425|FG002|Overall Study|Transitioned into OLE study|100|||
129613737|NCT02755649|466543423|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
129613738|NCT02755649|466543424|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
129613739|NCT02755649|466543425|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
129613740|NCT02755649|466543423|FG000|Overall Study|Physician Decision|0|||
129613741|NCT02755649|466543424|FG001|Overall Study|Physician Decision|0|||
129613742|NCT02755649|466543425|FG002|Overall Study|Physician Decision|2|||
129613743|NCT02755649|466543423|FG000|Overall Study|Withdrawal by Subject|0|||
129613744|NCT02755649|466543424|FG001|Overall Study|Withdrawal by Subject|1|||
129613745|NCT02755649|466543425|FG002|Overall Study|Withdrawal by Subject|0|||
129613746|NCT02755649|466543423|FG000|Overall Study|Undecided|1|||
129613747|NCT02755649|466543424|FG001|Overall Study|Undecided|0|||
129613748|NCT02755649|466543425|FG002|Overall Study|Undecided|0|||
129613749|NCT02152605|466543426|FG000|Overall Study|Adverse Event|6|||
129613750|NCT02152605|466543427|FG001|Overall Study|Adverse Event|8|||
129613751|NCT02152605|466543426|FG000|Overall Study|Lack of Efficacy|7|||
129613752|NCT02152605|466543427|FG001|Overall Study|Lack of Efficacy|4|||
129613753|NCT02152605|466543426|FG000|Overall Study|Protocol deviation|1|||
129613754|NCT02152605|466543427|FG001|Overall Study|Protocol deviation|4|||
129790966|NCT01895361|467201448|FG001|Overall Study|Reasons different from categories above|3|||
129613755|NCT02152605|466543426|FG000|Overall Study|Lost to Follow-up|1|||
129613756|NCT02152605|466543427|FG001|Overall Study|Lost to Follow-up|0|||
129613757|NCT02152605|466543426|FG000|Overall Study|Withdrew consent|4|||
129613758|NCT02152605|466543427|FG001|Overall Study|Withdrew consent|2|||
129613759|NCT03301649|466543428|FG000|Overall Study|Need alternate therapy due to live lice|17|||
129613760|NCT03301649|466543429|FG001|Overall Study|Need alternate therapy due to live lice|25|||
129613761|NCT03301649|466543430|FG002|Overall Study|Need alternate therapy due to live lice|81|||
129613762|NCT03301649|466543428|FG000|Overall Study|Lost to Follow-up|11|||
129613763|NCT03301649|466543429|FG001|Overall Study|Lost to Follow-up|11|||
129613764|NCT03301649|466543430|FG002|Overall Study|Lost to Follow-up|3|||
129613765|NCT03301649|466543428|FG000|Overall Study|Protocol Violation|0|||
129613766|NCT03301649|466543429|FG001|Overall Study|Protocol Violation|1|||
129613767|NCT03301649|466543430|FG002|Overall Study|Protocol Violation|1|||
129613768|NCT03301649|466543428|FG000|Overall Study|Withdrawal by Subject|10|||
129613769|NCT03301649|466543429|FG001|Overall Study|Withdrawal by Subject|4|||
129613770|NCT03301649|466543430|FG002|Overall Study|Withdrawal by Subject|0|||
129613771|NCT03301649|466543428|FG000|Overall Study|Other than specified|5|||
129613772|NCT03301649|466543429|FG001|Overall Study|Other than specified|3|||
129613773|NCT03301649|466543430|FG002|Overall Study|Other than specified|0|||
129613774|NCT01564537|466543431|FG000|Overall Study|Site Terminated by Sponsor|1|||
129613775|NCT01564537|466543432|FG001|Overall Study|Site Terminated by Sponsor|0|||
129613776|NCT01564537|466543431|FG000|Overall Study|Withdrawal by Subject|12|||
129613777|NCT01564537|466543432|FG001|Overall Study|Withdrawal by Subject|14|||
129613778|NCT01564537|466543431|FG000|Overall Study|Lost to Follow-up|7|||
129613779|NCT01564537|466543432|FG001|Overall Study|Lost to Follow-up|3|||
129613780|NCT01564537|466543431|FG000|Overall Study|Reason not specified|81|||
129613781|NCT01564537|466543432|FG001|Overall Study|Reason not specified|82|||
129613782|NCT00837473|466543433|FG000|Overall Study|Lost to Follow-up|1|||
129613783|NCT00837473|466543433|FG000|Overall Study|Withdrawal by Subject|2|||
129613784|NCT01635218|466543434|FG000|Overall Study|Lost to Follow-up|3|||
129613785|NCT01635218|466543435|FG001|Overall Study|Lost to Follow-up|7|||
129613786|NCT01635218|466543436|FG002|Overall Study|Lost to Follow-up|6|||
129613787|NCT03559400|466543437|FG000|Overall Study|Lost to Follow-up|9|||
129613788|NCT03559400|466543438|FG001|Overall Study|Lost to Follow-up|7|||
129613789|NCT03559400|466543437|FG000|Overall Study|Death|0|||
129613790|NCT03559400|466543438|FG001|Overall Study|Death|2|||
129613791|NCT03262038|466543439|FG000|Overall Study|Withdrawal by Subject|0|||
129613792|NCT03262038|466543440|FG001|Overall Study|Withdrawal by Subject|1|||
129613793|NCT04933968|466543441|FG000|Overall Study|Adverse Event|0|||
129613794|NCT04933968|466543442|FG001|Overall Study|Adverse Event|0|||
129613795|NCT04933968|466543443|FG002|Overall Study|Adverse Event|1|||
129613796|NCT04933968|466543444|FG003|Overall Study|Adverse Event|1|||
129613797|NCT04933968|466543445|FG004|Overall Study|Adverse Event|0|||
129613798|NCT04933968|466543446|FG005|Overall Study|Adverse Event|0|||
129613799|NCT04933968|466543441|FG000|Overall Study|Lost to Follow-up|1|||
129613800|NCT04933968|466543442|FG001|Overall Study|Lost to Follow-up|0|||
129613801|NCT04933968|466543443|FG002|Overall Study|Lost to Follow-up|1|||
129613802|NCT04933968|466543444|FG003|Overall Study|Lost to Follow-up|0|||
129613803|NCT04933968|466543445|FG004|Overall Study|Lost to Follow-up|0|||
129613804|NCT04933968|466543446|FG005|Overall Study|Lost to Follow-up|0|||
129613805|NCT04933968|466543441|FG000|Overall Study|Randomized not treated|1|||
129613806|NCT04933968|466543442|FG001|Overall Study|Randomized not treated|0|||
129613807|NCT04933968|466543443|FG002|Overall Study|Randomized not treated|0|||
129613808|NCT04933968|466543444|FG003|Overall Study|Randomized not treated|0|||
129613809|NCT04933968|466543445|FG004|Overall Study|Randomized not treated|0|||
129613810|NCT04933968|466543446|FG005|Overall Study|Randomized not treated|0|||
129613811|NCT04933968|466543441|FG000|Overall Study|Sponsor terminated study|0|||
129613812|NCT04933968|466543442|FG001|Overall Study|Sponsor terminated study|0|||
129613813|NCT04933968|466543443|FG002|Overall Study|Sponsor terminated study|0|||
129613814|NCT04933968|466543444|FG003|Overall Study|Sponsor terminated study|1|||
129613815|NCT04933968|466543445|FG004|Overall Study|Sponsor terminated study|2|||
129613816|NCT04933968|466543446|FG005|Overall Study|Sponsor terminated study|0|||
129613817|NCT04933968|466543441|FG000|Overall Study|Other|0|||
129887014|NCT03095599|467547217|FG001|Overall Study|Withdrawal by Subject|0|||
129613818|NCT04933968|466543442|FG001|Overall Study|Other|0|||
129613819|NCT04933968|466543443|FG002|Overall Study|Other|0|||
129613820|NCT04933968|466543444|FG003|Overall Study|Other|1|||
129613821|NCT04933968|466543445|FG004|Overall Study|Other|0|||
129613822|NCT04933968|466543446|FG005|Overall Study|Other|0|||
129613823|NCT04933968|466543441|FG000|Overall Study|Missing|1|||
129613824|NCT04933968|466543442|FG001|Overall Study|Missing|3|||
129613825|NCT04933968|466543443|FG002|Overall Study|Missing|2|||
129613826|NCT04933968|466543444|FG003|Overall Study|Missing|1|||
129613827|NCT04933968|466543445|FG004|Overall Study|Missing|1|||
129613828|NCT04933968|466543446|FG005|Overall Study|Missing|0|||
129613829|NCT01724489|466543447|FG000|Overall Study|Adverse Event|8|||
129887015|NCT03095599|467547216|FG000|Overall Study|Lost to Follow-up|1|||
129613830|NCT01724489|466543448|FG001|Overall Study|Adverse Event|3|||
129613831|NCT01724489|466543447|FG000|Overall Study|Surgery, medication|1|||
129613832|NCT01724489|466543448|FG001|Overall Study|Surgery, medication|1|||
129613833|NCT01724489|466543447|FG000|Overall Study|Lost to Follow-up|1|||
129613834|NCT01724489|466543448|FG001|Overall Study|Lost to Follow-up|2|||
129613835|NCT01724489|466543447|FG000|Overall Study|Withdrawal by Subject|6|||
129613836|NCT01724489|466543448|FG001|Overall Study|Withdrawal by Subject|6|||
129613837|NCT04576923|466543449|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
129613838|NCT02679235|466543452|FG000|Overall Study|Withdrawal by Subject|3|||
129613839|NCT02679235|466543452|FG000|Overall Study|Adverse Event|1|||
129613840|NCT00923273|466543453|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129613841|NCT00923273|466543454|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129613842|NCT00923273|466543455|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129613843|NCT00923273|466543456|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
129613844|NCT00923273|466543457|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
129613845|NCT00923273|466543453|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129613846|NCT00923273|466543454|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129613847|NCT00923273|466543455|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129613848|NCT00923273|466543456|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
129613849|NCT00923273|466543457|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
129613850|NCT00094861|466543458|FG000|Overall Study|Adverse Event|5|||
129613851|NCT00094861|466543459|FG001|Overall Study|Adverse Event|2|||
129613852|NCT00094861|466543458|FG000|Overall Study|Withdrawal by Subject|5|||
129613853|NCT00094861|466543459|FG001|Overall Study|Withdrawal by Subject|3|||
129613854|NCT00094861|466543458|FG000|Overall Study|Physician Decision|1|||
129613855|NCT00094861|466543459|FG001|Overall Study|Physician Decision|1|||
129613856|NCT00094861|466543458|FG000|Overall Study|Lost to Follow-up|0|||
129613857|NCT00094861|466543459|FG001|Overall Study|Lost to Follow-up|1|||
129613858|NCT00094861|466543458|FG000|Overall Study|Death|4|||
129613859|NCT00094861|466543459|FG001|Overall Study|Death|2|||
129613860|NCT00094861|466543458|FG000|Overall Study|Other|3|||
129613861|NCT00094861|466543459|FG001|Overall Study|Other|0|||
129613862|NCT00509366|466543460|FG000|Overall Study|Not Treated (Screen Failure)|1|||
129613863|NCT00509366|466543461|FG001|Overall Study|Not Treated (Screen Failure)|1|||
129613864|NCT00509366|466543462|FG002|Overall Study|Not Treated (Screen Failure)|1|||
129613865|NCT00509366|466543463|FG003|Overall Study|Not Treated (Screen Failure)|0|||
129613866|NCT00509366|466543464|FG004|Overall Study|Not Treated (Screen Failure)|0|||
129613867|NCT02552303|466543473|FG000|Allocation|Withdrawal by Subject|2|||
129613868|NCT02552303|466543474|FG001|Allocation|Withdrawal by Subject|1|||
129613869|NCT02552303|466543475|FG002|Allocation|Withdrawal by Subject|1|||
129613870|NCT02552303|466543476|FG003|Allocation|Withdrawal by Subject|1|||
129613871|NCT02552303|466543473|FG000|Allocation|ineligible|1|||
129613872|NCT02552303|466543474|FG001|Allocation|ineligible|1|||
129613873|NCT02552303|466543475|FG002|Allocation|ineligible|0|||
129613874|NCT02552303|466543476|FG003|Allocation|ineligible|0|||
129613875|NCT02552303|466543473|FG000|Follow-Up|Lost to Follow-up|0|||
129613876|NCT02552303|466543474|FG001|Follow-Up|Lost to Follow-up|0|||
129613877|NCT02552303|466543475|FG002|Follow-Up|Lost to Follow-up|1|||
129613878|NCT02552303|466543476|FG003|Follow-Up|Lost to Follow-up|0|||
129613879|NCT02552303|466543473|FG000|Follow-Up|ineligible|0|||
129613880|NCT02552303|466543474|FG001|Follow-Up|ineligible|2|||
129613881|NCT02552303|466543475|FG002|Follow-Up|ineligible|0|||
129613882|NCT02552303|466543476|FG003|Follow-Up|ineligible|0|||
129613883|NCT01377987|466543477|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
129613884|NCT01377987|466543478|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
129613885|NCT00253448|466543485|FG000|Overall Study|Withdrawal by Subject|1|||
129613886|NCT01199016|466543486|FG000|Overall Study|No longer meets eligibility criteria|4|||
129613887|NCT01199016|466543486|FG000|Overall Study|Entrance criteria|5|||
129613888|NCT01199016|466543486|FG000|Overall Study|Protocol Violation|9|||
129613889|NCT01199016|466543486|FG000|Overall Study|Other|13|||
129613890|NCT01199016|466543486|FG000|Overall Study|Withdrawal by Subject|21|||
129439166|NCT04223856|465904587|FG000|Overall Study|Physician Decision|9|||
129613891|NCT01199016|466543486|FG000|Overall Study|Lost to Follow-up|25|||
129613892|NCT02368314|466543497|FG000|Overall Study|Withdrawal by Subject|2|||
129613893|NCT02368314|466543498|FG001|Overall Study|Withdrawal by Subject|1|||
129613894|NCT02368314|466543497|FG000|Overall Study|Adverse Event|1|||
129613895|NCT02368314|466543498|FG001|Overall Study|Adverse Event|2|||
129613896|NCT02842073|466543503|FG000|Overall Study|Withdrawal by Subject|1|||
129613897|NCT00195338|466543504|FG000|Overall Study|Lost to Follow-up|2|||
129613898|NCT00195338|466543504|FG000|Overall Study|Adverse Event|5|||
129613899|NCT00195338|466543504|FG000|Overall Study|Lack of Efficacy|1|||
129613900|NCT00195338|466543504|FG000|Overall Study|Early closure of the site|4|||
129613901|NCT05320887|466543513|FG000|Overall Study|Lost to Follow-up|0|||
129613902|NCT05320887|466543514|FG001|Overall Study|Lost to Follow-up|3|||
129613903|NCT05320887|466543515|FG002|Overall Study|Lost to Follow-up|0|||
129613904|NCT05320887|466543516|FG003|Overall Study|Lost to Follow-up|0|||
129613905|NCT02289456|466543517|FG000|Induction Period|Death|2|||
129613906|NCT02289456|466543517|FG000|Induction Period|Adverse Event|11|||
129613907|NCT02289456|466543517|FG000|Induction Period|Progressive Disease (PD)|4|||
129613908|NCT02289456|466543517|FG000|Induction Period|Symptomatic Deterioration|4|||
129613909|NCT02289456|466543517|FG000|Induction Period|Withdrawal by Subject|2|||
129613910|NCT02289456|466543517|FG000|Induction Period|Miscellaneous|1|||
129613911|NCT02289456|466543517|FG000|Monotherapy Period|Death|1|||
129613912|NCT02289456|466543517|FG000|Monotherapy Period|Adverse Event|1|||
129613913|NCT02289456|466543517|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
129613914|NCT02289456|466543517|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
129613915|NCT02289456|466543517|FG000|Monotherapy Period|Withdrawal by Subject|2|||
129613916|NCT02289456|466543517|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
129613917|NCT02289456|466543517|FG000|Monotherapy Period|Miscellaneous|1|||
129613918|NCT01661062|466543520|FG000|Overall Study|Completed Treatment Off Study|3|||
129613919|NCT01661062|466543520|FG000|Overall Study|Withdrawal by Subject|2|||
129613920|NCT02015065|466543523|FG000|Overall Study|Death on study|1|||
129613921|NCT02015065|466543524|FG001|Overall Study|Death on study|2|||
129613922|NCT02015065|466543525|FG002|Overall Study|Death on study|1|||
129613923|NCT03485365|466543558|FG000|Overall Study|Protocol Violation|0|||
129613924|NCT03485365|466543559|FG001|Overall Study|Protocol Violation|0|||
129613925|NCT03485365|466543560|FG002|Overall Study|Protocol Violation|0|||
129613926|NCT03485365|466543561|FG003|Overall Study|Protocol Violation|1|||
129613927|NCT03485365|466543562|FG004|Overall Study|Protocol Violation|0|||
129613928|NCT03485365|466543563|FG005|Overall Study|Protocol Violation|0|||
129613929|NCT03485365|466543564|FG006|Overall Study|Protocol Violation|1|||
129613930|NCT03485365|466543565|FG007|Overall Study|Protocol Violation|0|||
129613931|NCT03485365|466543566|FG008|Overall Study|Protocol Violation|0|||
129613932|NCT01547130|466543569|FG000|Overall Study|Lost to Follow-up|9|||
129613933|NCT01547130|466543570|FG001|Overall Study|Lost to Follow-up|5|||
129613934|NCT00103610|466543573|FG000|Overall Study|Entered Rescue Procedure|10|||
129613935|NCT00103610|466543574|FG001|Overall Study|Entered Rescue Procedure|52|||
129613936|NCT00103610|466543573|FG000|Overall Study|Death|16|||
129613937|NCT00103610|466543574|FG001|Overall Study|Death|12|||
129613938|NCT00103610|466543573|FG000|Overall Study|Elective Withdrawal|4|||
129613939|NCT00103610|466543574|FG001|Overall Study|Elective Withdrawal|0|||
129613940|NCT00103610|466543573|FG000|Overall Study|Lost to Follow-up|3|||
129613941|NCT00103610|466543574|FG001|Overall Study|Lost to Follow-up|1|||
129613942|NCT00103610|466543573|FG000|Overall Study|Adverse Event|2|||
129613943|NCT00103610|466543574|FG001|Overall Study|Adverse Event|2|||
129613944|NCT00103610|466543573|FG000|Overall Study|Other|2|||
129700425|NCT04110145|466863927|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
129700426|NCT04110145|466863928|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
129700427|NCT00567502|466863936|FG000|Overall Study|Lost to Follow-up|91|||
129700428|NCT00567502|466863937|FG001|Overall Study|Lost to Follow-up|14|||
129700429|NCT00567502|466863938|FG002|Overall Study|Lost to Follow-up|351|||
129700430|NCT00567502|466863939|FG003|Overall Study|Lost to Follow-up|2|||
129700431|NCT00567502|466863936|FG000|Overall Study|Death|65|||
129700432|NCT00567502|466863937|FG001|Overall Study|Death|16|||
129700433|NCT00567502|466863938|FG002|Overall Study|Death|360|||
129700434|NCT00567502|466863939|FG003|Overall Study|Death|5|||
129700435|NCT00567502|466863936|FG000|Overall Study|Other|64|||
129700436|NCT00567502|466863937|FG001|Overall Study|Other|2|||
129700437|NCT00567502|466863938|FG002|Overall Study|Other|134|||
129700438|NCT00567502|466863939|FG003|Overall Study|Other|6|||
129613945|NCT00103610|466543574|FG001|Overall Study|Other|7|||
129700439|NCT00567502|466863936|FG000|Overall Study|Participant request|12|||
129700440|NCT00567502|466863937|FG001|Overall Study|Participant request|1|||
129700441|NCT00567502|466863938|FG002|Overall Study|Participant request|33|||
129700442|NCT00567502|466863939|FG003|Overall Study|Participant request|1|||
129700443|NCT00567502|466863936|FG000|Overall Study|Sponsor request|9|||
129887016|NCT03095599|467547217|FG001|Overall Study|Lost to Follow-up|0|||
129613946|NCT00103610|466543573|FG000|Overall Study|Failed mobilization|1|||
129613947|NCT00103610|466543574|FG001|Overall Study|Failed mobilization|5|||
129613948|NCT00103610|466543573|FG000|Overall Study|Noncompliance|0|||
129613949|NCT00103610|466543574|FG001|Overall Study|Noncompliance|1|||
129613950|NCT03301623|466543575|FG000|Overall Study|Death|3|||
129613951|NCT03301623|466543576|FG001|Overall Study|Death|1|||
129613952|NCT03301623|466543575|FG000|Overall Study|Withdrawal by Subject|11|||
129700444|NCT00567502|466863937|FG001|Overall Study|Sponsor request|0|||
129700445|NCT00567502|466863938|FG002|Overall Study|Sponsor request|30|||
129700446|NCT00567502|466863939|FG003|Overall Study|Sponsor request|1|||
129700447|NCT00567502|466863936|FG000|Overall Study|Never Initiated Treatment|0|||
129700448|NCT00567502|466863937|FG001|Overall Study|Never Initiated Treatment|0|||
129700449|NCT00567502|466863938|FG002|Overall Study|Never Initiated Treatment|0|||
129700450|NCT00567502|466863939|FG003|Overall Study|Never Initiated Treatment|72|||
129700451|NCT00337168|466863940|FG000|Overall Study|Death|5|||
129700452|NCT00337168|466863940|FG000|Overall Study|Not protocol specified|2|||
129700453|NCT00337168|466863940|FG000|Overall Study|Did not start therapy|1|||
129700454|NCT03283241|466863941|FG000|Overall Study|Adverse Event|4|||
129700455|NCT03283241|466863942|FG001|Overall Study|Adverse Event|1|||
129700456|NCT03283241|466863941|FG000|Overall Study|Withdrawal by Subject|0|||
129700457|NCT03283241|466863942|FG001|Overall Study|Withdrawal by Subject|1|||
129700458|NCT03283241|466863941|FG000|Overall Study|Subject relocated to Finland|0|||
129700459|NCT03283241|466863942|FG001|Overall Study|Subject relocated to Finland|1|||
129700460|NCT00666263|466863945|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
129700461|NCT00666263|466863946|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
129700462|NCT00666263|466863945|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
129700463|NCT00666263|466863946|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
129700464|NCT00666263|466863945|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
129700465|NCT00666263|466863946|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
129700466|NCT01225952|466863947|FG000|Overall Study|Lost to Follow-up|1|||
129700467|NCT01225952|466863948|FG001|Overall Study|Lost to Follow-up|0|||
129700468|NCT01225952|466863949|FG002|Overall Study|Lost to Follow-up|0|||
129700469|NCT01225952|466863947|FG000|Overall Study|Study Eye Explanted|0|||
129700470|NCT01225952|466863948|FG001|Overall Study|Study Eye Explanted|0|||
129700471|NCT01225952|466863949|FG002|Overall Study|Study Eye Explanted|1|||
129700472|NCT01225952|466863947|FG000|Overall Study|Withdrawal by Subject|4|||
129700473|NCT01225952|466863948|FG001|Overall Study|Withdrawal by Subject|4|||
129700474|NCT01225952|466863949|FG002|Overall Study|Withdrawal by Subject|5|||
129700475|NCT01225952|466863947|FG000|Overall Study|Surgical complications|1|||
129700476|NCT01225952|466863948|FG001|Overall Study|Surgical complications|0|||
129700477|NCT01225952|466863949|FG002|Overall Study|Surgical complications|0|||
129700478|NCT01285102|466863951|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
129700479|NCT03729609|466863967|FG000|Overall Study|Protocol Violation|1|||
129700480|NCT00605189|466863973|FG000|Overall Study|Adverse Event|1|||
129700481|NCT00605189|466863974|FG001|Overall Study|Adverse Event|0|||
129700482|NCT00605189|466863975|FG002|Overall Study|Adverse Event|0|||
129700483|NCT00605189|466863973|FG000|Overall Study|Other|2|||
129700484|NCT00605189|466863974|FG001|Overall Study|Other|2|||
129700485|NCT00605189|466863975|FG002|Overall Study|Other|0|||
129700486|NCT02919618|466863976|FG000|Overall Study|Death|1|||
129700487|NCT02592863|466863977|FG000|Overall Study|Withdrawal by Subject|2|||
129700488|NCT02592863|466863978|FG001|Overall Study|Withdrawal by Subject|2|||
129700489|NCT02592863|466863977|FG000|Overall Study|Lost to Follow-up|1|||
129700490|NCT02592863|466863978|FG001|Overall Study|Lost to Follow-up|1|||
129700491|NCT02743221|466863979|FG000|Overall Study|Progressive disease|29|||
129700492|NCT02743221|466863980|FG001|Overall Study|Progressive disease|38|||
129700493|NCT02743221|466863979|FG000|Overall Study|Adverse Event|17|||
129700494|NCT02743221|466863980|FG001|Overall Study|Adverse Event|14|||
129700495|NCT02743221|466863979|FG000|Overall Study|non medical reason|8|||
129700496|NCT02743221|466863980|FG001|Overall Study|non medical reason|2|||
129700497|NCT02743221|466863979|FG000|Overall Study|Physician Decision|2|||
129700498|NCT02743221|466863980|FG001|Overall Study|Physician Decision|5|||
129700499|NCT02743221|466863979|FG000|Overall Study|Patient not eligible, not treated|0|||
129700500|NCT02743221|466863980|FG001|Overall Study|Patient not eligible, not treated|1|||
129700501|NCT03411044|466863982|FG000|Overall Study|Death|30|||
129700502|NCT03411044|466863982|FG000|Overall Study|Withdrawal by Subject|48|||
129700503|NCT03411044|466863982|FG000|Overall Study|Lost to Follow-up|78|||
129700504|NCT03411044|466863982|FG000|Overall Study|Adverse Event|30|||
129790967|NCT01895361|467201449|FG002|Overall Study|Reasons different from categories above|4|||
129790968|NCT02586506|467201450|FG000|Overall Study|Protocol Violation|6|||
129790969|NCT02586506|467201450|FG000|Overall Study|Lost to Follow-up|1|||
129700505|NCT03411044|466863982|FG000|Overall Study|Missing status|4|||
129700506|NCT02609503|466863983|FG000|Overall Study|Adverse Event|1|||
129790970|NCT02586506|467201450|FG000|Overall Study|Other Reason|2|||
129700507|NCT02609503|466863983|FG000|Overall Study|Death|1|||
129700508|NCT02609503|466863983|FG000|Overall Study|Withdrawal by Subject|1|||
129700509|NCT02609503|466863983|FG000|Overall Study|Disease progression|1|||
129700510|NCT01969409|466863986|FG000|Overall Study|Death|2|||
129700511|NCT01969409|466863987|FG001|Overall Study|Death|2|||
129700512|NCT01969409|466863986|FG000|Overall Study|Transplant|1|||
129700513|NCT01969409|466863987|FG001|Overall Study|Transplant|1|||
129700514|NCT01969409|466863986|FG000|Overall Study|Withdrawal by Subject|0|||
129700515|NCT01969409|466863987|FG001|Overall Study|Withdrawal by Subject|1|||
129700516|NCT02226653|466863991|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
129700517|NCT02226653|466863992|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
129700518|NCT02226653|466863991|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
129700519|NCT02226653|466863992|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
129700520|NCT03078868|466863994|FG000|Overall Study|Physician Decision|3|||
129700521|NCT04629196|466864000|FG000|Overall Study|Subject discontinued study drug|1|||
129700522|NCT04629196|466864001|FG001|Overall Study|Subject discontinued study drug|0|||
129700523|NCT04629196|466864000|FG000|Overall Study|Subject study drug dosing increased|1|||
129700524|NCT04629196|466864001|FG001|Overall Study|Subject study drug dosing increased|1|||
129700525|NCT04629196|466864000|FG000|Overall Study|Withdrawal by Subject|1|||
129700526|NCT04629196|466864001|FG001|Overall Study|Withdrawal by Subject|2|||
129700527|NCT01450631|466864005|FG000|Overall Study|Lost to Follow-up|2|||
129700528|NCT01450631|466864006|FG001|Overall Study|Lost to Follow-up|4|||
129700529|NCT01450631|466864005|FG000|Overall Study|Withdrawal by Subject|1|||
129700530|NCT01450631|466864006|FG001|Overall Study|Withdrawal by Subject|0|||
129700531|NCT00835354|466864007|FG000|First Intervention|Adverse Event|0|||
129700532|NCT00835354|466864008|FG001|First Intervention|Adverse Event|1|||
129700533|NCT03204812|466864009|FG000|Overall Study|Adverse Event|3|||
129700534|NCT01385995|466864011|FG000|Period 1, 2 Months|Physician Decision|1|||
129700535|NCT01385995|466864012|FG001|Period 1, 2 Months|Physician Decision|0|||
129700536|NCT00112385|466864013|FG000|Overall Study|Lost to Follow-up|1|||
129700537|NCT00112385|466864014|FG001|Overall Study|Lost to Follow-up|0|||
129700538|NCT00112385|466864013|FG000|Overall Study|Withdrawal by Subject|0|||
129700539|NCT00112385|466864014|FG001|Overall Study|Withdrawal by Subject|1|||
129700540|NCT04191135|466864037|FG000|Induction Treatment|Not Treated|2|||
129700541|NCT04191135|466864038|FG001|Induction Treatment|Not Treated|0|||
129700542|NCT04191135|466864039|FG002|Induction Treatment|Not Treated|0|||
129700543|NCT04191135|466864037|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
129700544|NCT04191135|466864038|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
129700545|NCT04191135|466864039|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
129700546|NCT04191135|466864037|FG000|Induction Treatment|Adverse Event|25|||
129700547|NCT04191135|466864038|FG001|Induction Treatment|Adverse Event|0|||
129700548|NCT04191135|466864039|FG002|Induction Treatment|Adverse Event|0|||
129613953|NCT03301623|466543576|FG001|Overall Study|Withdrawal by Subject|13|||
129613954|NCT03301623|466543575|FG000|Overall Study|Lost to Follow-up|3|||
129613955|NCT03301623|466543576|FG001|Overall Study|Lost to Follow-up|1|||
129613956|NCT02092467|466543577|FG000|Overall Study|Death|49|||
129613957|NCT02092467|466543578|FG001|Overall Study|Death|66|||
129613958|NCT02092467|466543579|FG002|Overall Study|Death|38|||
129613959|NCT02092467|466543577|FG000|Overall Study|Lost to Follow-up|38|||
129613960|NCT02092467|466543578|FG001|Overall Study|Lost to Follow-up|35|||
129613961|NCT02092467|466543579|FG002|Overall Study|Lost to Follow-up|40|||
129613962|NCT02092467|466543577|FG000|Overall Study|Global Deterioration of Health Status|1|||
129613963|NCT02092467|466543578|FG001|Overall Study|Global Deterioration of Health Status|0|||
129613964|NCT02092467|466543579|FG002|Overall Study|Global Deterioration of Health Status|0|||
129613965|NCT02092467|466543577|FG000|Overall Study|Other|32|||
129613966|NCT02092467|466543578|FG001|Overall Study|Other|30|||
129613967|NCT02092467|466543579|FG002|Overall Study|Other|24|||
129613968|NCT02092467|466543577|FG000|Overall Study|Withdrawal by Subject|282|||
129613969|NCT02092467|466543578|FG001|Overall Study|Withdrawal by Subject|327|||
129613970|NCT02092467|466543579|FG002|Overall Study|Withdrawal by Subject|289|||
129613971|NCT02092467|466543577|FG000|Overall Study|Randomized but not treated|2|||
129613972|NCT02092467|466543578|FG001|Overall Study|Randomized but not treated|1|||
129613973|NCT02092467|466543579|FG002|Overall Study|Randomized but not treated|7|||
129613974|NCT04844762|466543584|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613975|NCT04844762|466543585|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613976|NCT04844762|466543586|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
129613977|NCT04844762|466543587|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613978|NCT04844762|466543588|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129700549|NCT04191135|466864037|FG000|Induction Treatment|Clinical Progression|8|||
129700550|NCT04191135|466864038|FG001|Induction Treatment|Clinical Progression|0|||
129700551|NCT04191135|466864039|FG002|Induction Treatment|Clinical Progression|0|||
129790971|NCT00674154|467201451|FG000|Overall Study|Withdrawal by Subject|3|||
129790972|NCT00674154|467201452|FG001|Overall Study|Withdrawal by Subject|1|||
129613979|NCT04844762|466543589|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613980|NCT04844762|466543584|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
129700552|NCT04191135|466864037|FG000|Induction Treatment|Excluded Medication|1|||
129700553|NCT04191135|466864038|FG001|Induction Treatment|Excluded Medication|0|||
129700554|NCT04191135|466864039|FG002|Induction Treatment|Excluded Medication|0|||
129700555|NCT04191135|466864037|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
129790973|NCT00674154|467201451|FG000|Overall Study|Did not want parathyroidectomy|0|||
129613981|NCT04844762|466543585|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
129613982|NCT04844762|466543586|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
129613983|NCT04844762|466543587|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
129613984|NCT04844762|466543588|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
129613985|NCT04844762|466543589|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
129613986|NCT04844762|466543584|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129613987|NCT04844762|466543585|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129613988|NCT04844762|466543586|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129613989|NCT04844762|466543587|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
129613990|NCT04844762|466543588|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129613991|NCT04844762|466543589|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129613992|NCT04844762|466543584|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613993|NCT04844762|466543585|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613994|NCT04844762|466543586|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
129613995|NCT04844762|466543587|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
129613996|NCT04844762|466543588|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
129613997|NCT04844762|466543589|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129613998|NCT04844762|466543584|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
129613999|NCT04844762|466543585|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
129614000|NCT04844762|466543586|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614001|NCT04844762|466543587|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614002|NCT04844762|466543588|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614003|NCT04844762|466543589|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614004|NCT04844762|466543584|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129614005|NCT04844762|466543585|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614006|NCT04844762|466543586|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614007|NCT04844762|466543587|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614008|NCT04844762|466543588|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614009|NCT04844762|466543589|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614010|NCT04844762|466543584|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129614011|NCT04844762|466543585|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129614012|NCT04844762|466543586|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129614013|NCT04844762|466543587|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129614014|NCT04844762|466543588|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
129614015|NCT04844762|466543589|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
129614016|NCT04844762|466543584|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
129614017|NCT04844762|466543585|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614018|NCT04844762|466543586|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614019|NCT04844762|466543587|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614020|NCT04844762|466543588|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614021|NCT04844762|466543589|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
129614022|NCT04844762|466543584|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129614023|NCT04844762|466543585|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614024|NCT04844762|466543586|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614025|NCT04844762|466543587|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614026|NCT04844762|466543588|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
129614027|NCT04844762|466543589|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
129614028|NCT04844762|466543584|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129614029|NCT04844762|466543585|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
129614030|NCT04844762|466543586|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129614031|NCT04844762|466543587|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129614032|NCT04844762|466543588|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129614033|NCT04844762|466543589|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
129614034|NCT04844762|466543584|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129614035|NCT04844762|466543585|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129614036|NCT04844762|466543586|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129614037|NCT04844762|466543587|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
129614038|NCT04844762|466543588|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129614039|NCT04844762|466543589|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
129614040|NCT04400682|466543590|FG000|Period 1|Withdrawal by Subject|1|||
129614041|NCT04400682|466543591|FG001|Period 1|Withdrawal by Subject|4|||
129614042|NCT02293863|466543592|FG000|Overall Study|Death|4|||
129614043|NCT02293863|466543593|FG001|Overall Study|Death|6|||
129614044|NCT02293863|466543594|FG002|Overall Study|Death|4|||
129614045|NCT02293863|466543592|FG000|Overall Study|Lost to Follow-up|2|||
129614046|NCT02293863|466543593|FG001|Overall Study|Lost to Follow-up|2|||
129614047|NCT02293863|466543594|FG002|Overall Study|Lost to Follow-up|2|||
129614048|NCT02293863|466543592|FG000|Overall Study|Withdrawal by Subject|3|||
129614049|NCT02293863|466543593|FG001|Overall Study|Withdrawal by Subject|3|||
129614050|NCT02293863|466543594|FG002|Overall Study|Withdrawal by Subject|1|||
129614051|NCT02293863|466543592|FG000|Overall Study|Reason Not Specified|0|||
129614052|NCT02293863|466543593|FG001|Overall Study|Reason Not Specified|2|||
129614053|NCT02293863|466543594|FG002|Overall Study|Reason Not Specified|2|||
129614054|NCT00477633|466543595|FG000|Overall Study|Did not receive treatment|23|||
129614055|NCT00477633|466543595|FG000|Overall Study|Adverse Event|143|||
129614056|NCT00477633|466543595|FG000|Overall Study|Pregnancy|23|||
129614057|NCT00477633|466543595|FG000|Overall Study|Lost to Follow-up|271|||
129614058|NCT00477633|466543595|FG000|Overall Study|Withdrawal by Subject|149|||
129614059|NCT00477633|466543595|FG000|Overall Study|Protocol Violation|25|||
129614060|NCT00477633|466543595|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
129614061|NCT01374269|466543601|FG000|Overall Study|Withdrawal by Subject|4|||
129614062|NCT01374269|466543602|FG001|Overall Study|Withdrawal by Subject|0|||
129614063|NCT01374269|466543601|FG000|Overall Study|Lost to Follow-up|1|||
129614064|NCT01374269|466543602|FG001|Overall Study|Lost to Follow-up|3|||
129614065|NCT01374269|466543601|FG000|Overall Study|closed research|1|||
129614066|NCT01374269|466543602|FG001|Overall Study|closed research|2|||
129614067|NCT00996892|466543603|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
129614068|NCT00996892|466543604|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
129614069|NCT00996892|466543605|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
129614070|NCT00996892|466543606|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
129614071|NCT00996892|466543607|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
129614072|NCT00996892|466543608|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
129790974|NCT00674154|467201452|FG001|Overall Study|Did not want parathyroidectomy|2|||
129790975|NCT05093790|467201453|FG000|Overall Study|Failure to meet continuation criteria|0|||
129790976|NCT05093790|467201454|FG001|Overall Study|Failure to meet continuation criteria|0|||
129790977|NCT05093790|467201455|FG002|Overall Study|Failure to meet continuation criteria|1|||
129790978|NCT05093790|467201456|FG003|Overall Study|Failure to meet continuation criteria|0|||
129790979|NCT05093790|467201453|FG000|Overall Study|Adverse Event|1|||
129790980|NCT05093790|467201454|FG001|Overall Study|Adverse Event|0|||
129790981|NCT05093790|467201455|FG002|Overall Study|Adverse Event|0|||
129790982|NCT05093790|467201456|FG003|Overall Study|Adverse Event|0|||
129790983|NCT01903252|467201458|FG000|Double-Blind Induction|Adverse Event|20|||
129790984|NCT01903252|467201459|FG001|Double-Blind Induction|Adverse Event|18|||
129790985|NCT01903252|467201460|FG002|Double-Blind Induction|Adverse Event|0|||
129790986|NCT01903252|467201461|FG003|Double-Blind Induction|Adverse Event|0|||
129790987|NCT01903252|467201462|FG004|Double-Blind Induction|Adverse Event|0|||
129790988|NCT01903252|467201463|FG005|Double-Blind Induction|Adverse Event|0|||
129790989|NCT01903252|467201458|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
129790990|NCT01903252|467201459|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
129790991|NCT01903252|467201460|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
129790992|NCT01903252|467201461|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
129790993|NCT01903252|467201462|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
129790994|NCT01903252|467201463|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
129790995|NCT01903252|467201458|FG000|Double-Blind Induction|Physician Decision|2|||
129614073|NCT00996892|466543609|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
129614074|NCT00996892|466543610|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
129614075|NCT00996892|466543611|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
129790996|NCT01903252|467201459|FG001|Double-Blind Induction|Physician Decision|3|||
129790997|NCT01903252|467201460|FG002|Double-Blind Induction|Physician Decision|0|||
129790998|NCT01903252|467201461|FG003|Double-Blind Induction|Physician Decision|0|||
129790999|NCT01903252|467201462|FG004|Double-Blind Induction|Physician Decision|0|||
129791000|NCT01903252|467201463|FG005|Double-Blind Induction|Physician Decision|0|||
129791001|NCT01903252|467201458|FG000|Double-Blind Induction|non-compliance,|7|||
129791002|NCT01903252|467201459|FG001|Double-Blind Induction|non-compliance,|7|||
129614076|NCT00996892|466543612|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
129614077|NCT00996892|466543613|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
129791003|NCT01903252|467201460|FG002|Double-Blind Induction|non-compliance,|0|||
129791004|NCT01903252|467201461|FG003|Double-Blind Induction|non-compliance,|0|||
129791005|NCT01903252|467201462|FG004|Double-Blind Induction|non-compliance,|0|||
129791006|NCT01903252|467201463|FG005|Double-Blind Induction|non-compliance,|0|||
129791007|NCT01903252|467201458|FG000|Extended Induction, Open-Label|Adverse Event|0|||
129614078|NCT00996892|466543614|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
129614079|NCT00996892|466543615|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
129614080|NCT00996892|466543616|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
129614081|NCT00996892|466543617|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
129614082|NCT00996892|466543618|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
129614083|NCT00996892|466543619|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
129614084|NCT00996892|466543620|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
129614085|NCT00996892|466543621|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
129614086|NCT00996892|466543622|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
129614087|NCT00996892|466543603|FG000|Dose-Escalation Stage 1|Death|1|||
129614088|NCT00996892|466543604|FG001|Dose-Escalation Stage 1|Death|0|||
129614089|NCT00996892|466543605|FG002|Dose-Escalation Stage 1|Death|0|||
129614090|NCT00996892|466543606|FG003|Dose-Escalation Stage 1|Death|0|||
129614091|NCT00996892|466543607|FG004|Dose-Escalation Stage 1|Death|0|||
129614092|NCT00996892|466543608|FG005|Dose-Escalation Stage 1|Death|1|||
129614093|NCT00996892|466543609|FG006|Dose-Escalation Stage 1|Death|0|||
129614094|NCT00996892|466543610|FG007|Dose-Escalation Stage 1|Death|0|||
129614095|NCT00996892|466543611|FG008|Dose-Escalation Stage 1|Death|0|||
129614096|NCT00996892|466543612|FG009|Dose-Escalation Stage 1|Death|0|||
129614097|NCT00996892|466543613|FG010|Dose-Escalation Stage 1|Death|0|||
129614098|NCT00996892|466543614|FG011|Dose-Escalation Stage 1|Death|0|||
129614099|NCT00996892|466543615|FG012|Dose-Escalation Stage 1|Death|0|||
129614100|NCT00996892|466543616|FG013|Dose-Escalation Stage 1|Death|0|||
129614101|NCT00996892|466543617|FG014|Dose-Escalation Stage 1|Death|0|||
129614102|NCT00996892|466543618|FG015|Dose-Escalation Stage 1|Death|0|||
129614103|NCT00996892|466543619|FG016|Dose-Escalation Stage 1|Death|0|||
129614104|NCT00996892|466543620|FG017|Dose-Escalation Stage 1|Death|0|||
129614105|NCT00996892|466543621|FG018|Dose-Escalation Stage 1|Death|0|||
129614106|NCT00996892|466543622|FG019|Dose-Escalation Stage 1|Death|0|||
129614107|NCT00996892|466543603|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
129614108|NCT00996892|466543604|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
129614109|NCT00996892|466543605|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
129614110|NCT00996892|466543606|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
129614111|NCT00996892|466543607|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
129614112|NCT00996892|466543608|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
129614113|NCT00996892|466543609|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
129614114|NCT00996892|466543610|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
129614115|NCT00996892|466543611|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
129614116|NCT00996892|466543612|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
129614117|NCT00996892|466543613|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
129614118|NCT00996892|466543614|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
129614119|NCT00996892|466543615|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
129614120|NCT00996892|466543616|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
129614121|NCT00996892|466543617|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
129614122|NCT00996892|466543618|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
129614123|NCT00996892|466543619|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
129614124|NCT00996892|466543620|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
129614125|NCT00996892|466543621|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
129614126|NCT00996892|466543622|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
129614127|NCT00996892|466543603|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614128|NCT00996892|466543604|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129614129|NCT00996892|466543605|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614130|NCT00996892|466543606|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
129614131|NCT00996892|466543607|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129614132|NCT00996892|466543608|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129614133|NCT00996892|466543609|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
129614134|NCT00996892|466543610|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614135|NCT00996892|466543611|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614136|NCT00996892|466543612|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614137|NCT00996892|466543613|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614138|NCT00996892|466543614|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614139|NCT00996892|466543615|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614140|NCT00996892|466543616|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614141|NCT00996892|466543617|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614142|NCT00996892|466543618|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614143|NCT00996892|466543619|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614144|NCT00996892|466543620|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614145|NCT00996892|466543621|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614146|NCT00996892|466543622|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
129614147|NCT00996892|466543603|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
129614148|NCT00996892|466543604|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
129614149|NCT00996892|466543605|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
129614150|NCT00996892|466543606|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
129614151|NCT00996892|466543607|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
129614152|NCT00996892|466543608|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
129614153|NCT00996892|466543609|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
129614154|NCT00996892|466543610|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
129614155|NCT00996892|466543611|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
129614156|NCT00996892|466543612|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
129614157|NCT00996892|466543613|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
129614158|NCT00996892|466543614|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
129614159|NCT00996892|466543615|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
129614160|NCT00996892|466543616|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
129614161|NCT00996892|466543617|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
129614162|NCT00996892|466543618|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
129614163|NCT00996892|466543619|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
129614164|NCT00996892|466543620|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
129614165|NCT00996892|466543621|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
129614166|NCT00996892|466543622|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
129614167|NCT00996892|466543603|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
129614168|NCT00996892|466543604|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
129614169|NCT00996892|466543605|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
129614170|NCT00996892|466543606|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
129614171|NCT00996892|466543607|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
129614172|NCT00996892|466543608|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
129614173|NCT00996892|466543609|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
129614174|NCT00996892|466543610|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
129614175|NCT00996892|466543611|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
129614176|NCT00996892|466543612|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
129614177|NCT00996892|466543613|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
129614178|NCT00996892|466543614|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
129614179|NCT00996892|466543615|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
129614180|NCT00996892|466543616|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
129614181|NCT00996892|466543617|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
129614182|NCT00996892|466543618|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
129614183|NCT00996892|466543619|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
129614184|NCT00996892|466543620|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
129614185|NCT00996892|466543621|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
129614186|NCT00996892|466543622|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
129614187|NCT00996892|466543603|FG000|Dose-Escalation Stage 1A|Death|0|||
129614188|NCT00996892|466543604|FG001|Dose-Escalation Stage 1A|Death|0|||
129614189|NCT00996892|466543605|FG002|Dose-Escalation Stage 1A|Death|0|||
129614190|NCT00996892|466543606|FG003|Dose-Escalation Stage 1A|Death|0|||
129614191|NCT00996892|466543607|FG004|Dose-Escalation Stage 1A|Death|0|||
129614192|NCT00996892|466543608|FG005|Dose-Escalation Stage 1A|Death|0|||
129614193|NCT00996892|466543609|FG006|Dose-Escalation Stage 1A|Death|0|||
129614194|NCT00996892|466543610|FG007|Dose-Escalation Stage 1A|Death|0|||
129614195|NCT00996892|466543611|FG008|Dose-Escalation Stage 1A|Death|0|||
129614196|NCT00996892|466543612|FG009|Dose-Escalation Stage 1A|Death|2|||
129614197|NCT00996892|466543613|FG010|Dose-Escalation Stage 1A|Death|0|||
129614198|NCT00996892|466543614|FG011|Dose-Escalation Stage 1A|Death|1|||
129614199|NCT00996892|466543615|FG012|Dose-Escalation Stage 1A|Death|1|||
129614200|NCT00996892|466543616|FG013|Dose-Escalation Stage 1A|Death|0|||
129614201|NCT00996892|466543617|FG014|Dose-Escalation Stage 1A|Death|0|||
129614202|NCT00996892|466543618|FG015|Dose-Escalation Stage 1A|Death|0|||
129614203|NCT00996892|466543619|FG016|Dose-Escalation Stage 1A|Death|0|||
129614204|NCT00996892|466543620|FG017|Dose-Escalation Stage 1A|Death|0|||
129614205|NCT00996892|466543621|FG018|Dose-Escalation Stage 1A|Death|0|||
129614206|NCT00996892|466543622|FG019|Dose-Escalation Stage 1A|Death|0|||
129614207|NCT00996892|466543603|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
129614208|NCT00996892|466543604|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
129614209|NCT00996892|466543605|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
129614210|NCT00996892|466543606|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
129614211|NCT00996892|466543607|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
129614212|NCT00996892|466543608|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
129614213|NCT00996892|466543609|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
129614214|NCT00996892|466543610|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
129614215|NCT00996892|466543611|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
129614216|NCT00996892|466543612|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
129614217|NCT00996892|466543613|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
129614218|NCT00996892|466543614|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
129614219|NCT00996892|466543615|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
129614220|NCT00996892|466543616|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
129614221|NCT00996892|466543617|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
129614222|NCT00996892|466543618|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
129614223|NCT00996892|466543619|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
129614224|NCT00996892|466543620|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
129614225|NCT00996892|466543621|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
129614226|NCT00996892|466543622|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
129700556|NCT04191135|466864038|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
129700557|NCT04191135|466864039|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
129700558|NCT04191135|466864037|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
129700559|NCT04191135|466864038|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
129700560|NCT04191135|466864039|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
129700561|NCT04191135|466864037|FG000|Induction Treatment|Physician Decision|2|||
129700562|NCT04191135|466864038|FG001|Induction Treatment|Physician Decision|0|||
129700563|NCT04191135|466864039|FG002|Induction Treatment|Physician Decision|0|||
129700564|NCT04191135|466864037|FG000|Induction Treatment|Progressive Disease|135|||
129700565|NCT04191135|466864038|FG001|Induction Treatment|Progressive Disease|0|||
129700566|NCT04191135|466864039|FG002|Induction Treatment|Progressive Disease|0|||
129700567|NCT04191135|466864037|FG000|Induction Treatment|Protocol Violation|10|||
129700568|NCT04191135|466864038|FG001|Induction Treatment|Protocol Violation|0|||
129700569|NCT04191135|466864039|FG002|Induction Treatment|Protocol Violation|0|||
129700570|NCT04191135|466864037|FG000|Induction Treatment|Withdrawal by Subject|4|||
129700571|NCT04191135|466864038|FG001|Induction Treatment|Withdrawal by Subject|0|||
129700572|NCT04191135|466864039|FG002|Induction Treatment|Withdrawal by Subject|0|||
129700573|NCT04191135|466864037|FG000|Randomized Treatment|Death|0|||
129700574|NCT04191135|466864038|FG001|Randomized Treatment|Death|50|||
129700575|NCT04191135|466864039|FG002|Randomized Treatment|Death|54|||
129700576|NCT04191135|466864037|FG000|Randomized Treatment|Lost to Follow-up|0|||
129700577|NCT04191135|466864038|FG001|Randomized Treatment|Lost to Follow-up|0|||
129700578|NCT04191135|466864039|FG002|Randomized Treatment|Lost to Follow-up|1|||
129700579|NCT04191135|466864037|FG000|Randomized Treatment|Withdrawal by Subject|0|||
129887017|NCT03095599|467547216|FG000|Overall Study|Withdrawal prior to vaccination|1|||
129614227|NCT00996892|466543603|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614228|NCT00996892|466543604|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614229|NCT00996892|466543605|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614230|NCT00996892|466543606|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614231|NCT00996892|466543607|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614232|NCT00996892|466543608|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614233|NCT00996892|466543609|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614234|NCT00996892|466543610|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614235|NCT00996892|466543611|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614236|NCT00996892|466543612|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129614237|NCT00996892|466543613|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129614238|NCT00996892|466543614|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129614239|NCT00996892|466543615|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
129614240|NCT00996892|466543616|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614241|NCT00996892|466543617|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614242|NCT00996892|466543618|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614243|NCT00996892|466543619|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614244|NCT00996892|466543620|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614245|NCT00996892|466543621|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614246|NCT00996892|466543622|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
129614247|NCT00996892|466543603|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
129614248|NCT00996892|466543604|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
129614249|NCT00996892|466543605|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
129614250|NCT00996892|466543606|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
129614251|NCT00996892|466543607|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
129614252|NCT00996892|466543608|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
129614253|NCT00996892|466543609|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
129614254|NCT00996892|466543610|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
129614255|NCT00996892|466543611|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
129614256|NCT00996892|466543612|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
129614257|NCT00996892|466543613|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
129614258|NCT00996892|466543614|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
129614259|NCT00996892|466543615|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
129614260|NCT00996892|466543616|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
129614261|NCT00996892|466543617|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
129614262|NCT00996892|466543618|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
129614263|NCT00996892|466543619|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
129614264|NCT00996892|466543620|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
129614265|NCT00996892|466543621|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
129614266|NCT00996892|466543622|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
129614267|NCT00996892|466543603|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
129614268|NCT00996892|466543604|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
129614269|NCT00996892|466543605|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
129614270|NCT00996892|466543606|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
129614271|NCT00996892|466543607|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
129614272|NCT00996892|466543608|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
129614273|NCT00996892|466543609|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
129614274|NCT00996892|466543610|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
129614275|NCT00996892|466543611|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
129614276|NCT00996892|466543612|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
129614277|NCT00996892|466543613|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
129614278|NCT00996892|466543614|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
129614279|NCT00996892|466543615|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
129614280|NCT00996892|466543616|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
129614281|NCT00996892|466543617|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
129614282|NCT00996892|466543618|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
129614283|NCT00996892|466543619|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
129614284|NCT00996892|466543620|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
129614285|NCT00996892|466543621|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
129614286|NCT00996892|466543622|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
129614287|NCT00996892|466543603|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
129614288|NCT00996892|466543604|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
129614289|NCT00996892|466543605|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
129614290|NCT00996892|466543606|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
129614291|NCT00996892|466543607|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
129614292|NCT00996892|466543608|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
129614293|NCT00996892|466543609|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
129614294|NCT00996892|466543610|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
129614295|NCT00996892|466543611|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
129614296|NCT00996892|466543612|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
129614297|NCT00996892|466543613|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
129614298|NCT00996892|466543614|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
129614299|NCT00996892|466543615|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
129614300|NCT00996892|466543616|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
129614301|NCT00996892|466543617|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
129614302|NCT00996892|466543618|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
129614303|NCT00996892|466543619|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
129614304|NCT00996892|466543620|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
129614305|NCT00996892|466543621|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
129614306|NCT00996892|466543622|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
129614307|NCT00996892|466543603|FG000|Expansion Stage 2|Adverse Event|0|||
129614308|NCT00996892|466543604|FG001|Expansion Stage 2|Adverse Event|0|||
129614309|NCT00996892|466543605|FG002|Expansion Stage 2|Adverse Event|0|||
129614310|NCT00996892|466543606|FG003|Expansion Stage 2|Adverse Event|0|||
129614311|NCT00996892|466543607|FG004|Expansion Stage 2|Adverse Event|0|||
129614312|NCT00996892|466543608|FG005|Expansion Stage 2|Adverse Event|0|||
129614313|NCT00996892|466543609|FG006|Expansion Stage 2|Adverse Event|0|||
129614314|NCT00996892|466543610|FG007|Expansion Stage 2|Adverse Event|0|||
129614315|NCT00996892|466543611|FG008|Expansion Stage 2|Adverse Event|0|||
129614316|NCT00996892|466543612|FG009|Expansion Stage 2|Adverse Event|0|||
129614317|NCT00996892|466543613|FG010|Expansion Stage 2|Adverse Event|0|||
129614318|NCT00996892|466543614|FG011|Expansion Stage 2|Adverse Event|0|||
129614319|NCT00996892|466543615|FG012|Expansion Stage 2|Adverse Event|0|||
129614320|NCT00996892|466543616|FG013|Expansion Stage 2|Adverse Event|0|||
129614321|NCT00996892|466543617|FG014|Expansion Stage 2|Adverse Event|0|||
129614322|NCT00996892|466543618|FG015|Expansion Stage 2|Adverse Event|0|||
129614323|NCT00996892|466543619|FG016|Expansion Stage 2|Adverse Event|0|||
129614324|NCT00996892|466543620|FG017|Expansion Stage 2|Adverse Event|0|||
129614325|NCT00996892|466543621|FG018|Expansion Stage 2|Adverse Event|3|||
129614326|NCT00996892|466543622|FG019|Expansion Stage 2|Adverse Event|0|||
129614327|NCT00996892|466543603|FG000|Expansion Stage 2|Death|0|||
129614328|NCT00996892|466543604|FG001|Expansion Stage 2|Death|0|||
129791008|NCT01903252|467201459|FG001|Extended Induction, Open-Label|Adverse Event|0|||
129791009|NCT01903252|467201460|FG002|Extended Induction, Open-Label|Adverse Event|17|||
129614329|NCT00996892|466543605|FG002|Expansion Stage 2|Death|0|||
129614330|NCT00996892|466543606|FG003|Expansion Stage 2|Death|0|||
129791010|NCT01903252|467201461|FG003|Extended Induction, Open-Label|Adverse Event|0|||
129791011|NCT01903252|467201462|FG004|Extended Induction, Open-Label|Adverse Event|0|||
129614331|NCT00996892|466543607|FG004|Expansion Stage 2|Death|0|||
129614332|NCT00996892|466543608|FG005|Expansion Stage 2|Death|0|||
129614333|NCT00996892|466543609|FG006|Expansion Stage 2|Death|0|||
129614334|NCT00996892|466543610|FG007|Expansion Stage 2|Death|0|||
129614335|NCT00996892|466543611|FG008|Expansion Stage 2|Death|0|||
129614336|NCT00996892|466543612|FG009|Expansion Stage 2|Death|0|||
129614337|NCT00996892|466543613|FG010|Expansion Stage 2|Death|0|||
129614338|NCT00996892|466543614|FG011|Expansion Stage 2|Death|0|||
129614339|NCT00996892|466543615|FG012|Expansion Stage 2|Death|0|||
129614340|NCT00996892|466543616|FG013|Expansion Stage 2|Death|0|||
129614341|NCT00996892|466543617|FG014|Expansion Stage 2|Death|0|||
129614342|NCT00996892|466543618|FG015|Expansion Stage 2|Death|0|||
129614343|NCT00996892|466543619|FG016|Expansion Stage 2|Death|0|||
129791012|NCT01903252|467201463|FG005|Extended Induction, Open-Label|Adverse Event|0|||
129614344|NCT00996892|466543620|FG017|Expansion Stage 2|Death|0|||
129614345|NCT00996892|466543621|FG018|Expansion Stage 2|Death|2|||
129614346|NCT00996892|466543622|FG019|Expansion Stage 2|Death|0|||
129614347|NCT00996892|466543603|FG000|Expansion Stage 2|Physician Decision|0|||
129614348|NCT00996892|466543604|FG001|Expansion Stage 2|Physician Decision|0|||
129614349|NCT00996892|466543605|FG002|Expansion Stage 2|Physician Decision|0|||
129614350|NCT00996892|466543606|FG003|Expansion Stage 2|Physician Decision|0|||
129614351|NCT00996892|466543607|FG004|Expansion Stage 2|Physician Decision|0|||
129614352|NCT00996892|466543608|FG005|Expansion Stage 2|Physician Decision|0|||
129614353|NCT00996892|466543609|FG006|Expansion Stage 2|Physician Decision|0|||
129614354|NCT00996892|466543610|FG007|Expansion Stage 2|Physician Decision|0|||
129614355|NCT00996892|466543611|FG008|Expansion Stage 2|Physician Decision|0|||
129614356|NCT00996892|466543612|FG009|Expansion Stage 2|Physician Decision|0|||
129614357|NCT00996892|466543613|FG010|Expansion Stage 2|Physician Decision|0|||
129614358|NCT00996892|466543614|FG011|Expansion Stage 2|Physician Decision|0|||
129614359|NCT00996892|466543615|FG012|Expansion Stage 2|Physician Decision|0|||
129614360|NCT00996892|466543616|FG013|Expansion Stage 2|Physician Decision|0|||
129614361|NCT00996892|466543617|FG014|Expansion Stage 2|Physician Decision|0|||
129614362|NCT00996892|466543618|FG015|Expansion Stage 2|Physician Decision|0|||
129614363|NCT00996892|466543619|FG016|Expansion Stage 2|Physician Decision|0|||
129614364|NCT00996892|466543620|FG017|Expansion Stage 2|Physician Decision|0|||
129614365|NCT00996892|466543621|FG018|Expansion Stage 2|Physician Decision|1|||
129614366|NCT00996892|466543622|FG019|Expansion Stage 2|Physician Decision|0|||
129614367|NCT00996892|466543603|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
129614368|NCT00996892|466543604|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
129614369|NCT00996892|466543605|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
129614370|NCT00996892|466543606|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
129614371|NCT00996892|466543607|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
129614372|NCT00996892|466543608|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
129614373|NCT00996892|466543609|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
129614374|NCT00996892|466543610|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
129614375|NCT00996892|466543611|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
129614376|NCT00996892|466543612|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
129614377|NCT00996892|466543613|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
129614378|NCT00996892|466543614|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
129614379|NCT00996892|466543615|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
129614380|NCT00996892|466543616|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
129614381|NCT00996892|466543617|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
129614382|NCT00996892|466543618|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
129614383|NCT00996892|466543619|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
129614384|NCT00996892|466543620|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
129614385|NCT00996892|466543621|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
129614386|NCT00996892|466543622|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
129614387|NCT00996892|466543603|FG000|Expansion Stage 2|Disease Progression|0|||
129614388|NCT00996892|466543604|FG001|Expansion Stage 2|Disease Progression|0|||
129614389|NCT00996892|466543605|FG002|Expansion Stage 2|Disease Progression|0|||
129614390|NCT00996892|466543606|FG003|Expansion Stage 2|Disease Progression|0|||
129614391|NCT00996892|466543607|FG004|Expansion Stage 2|Disease Progression|0|||
129614392|NCT00996892|466543608|FG005|Expansion Stage 2|Disease Progression|0|||
129614393|NCT00996892|466543609|FG006|Expansion Stage 2|Disease Progression|0|||
129614394|NCT00996892|466543610|FG007|Expansion Stage 2|Disease Progression|0|||
129614395|NCT00996892|466543611|FG008|Expansion Stage 2|Disease Progression|0|||
129614396|NCT00996892|466543612|FG009|Expansion Stage 2|Disease Progression|0|||
129614397|NCT00996892|466543613|FG010|Expansion Stage 2|Disease Progression|0|||
129614398|NCT00996892|466543614|FG011|Expansion Stage 2|Disease Progression|0|||
129614399|NCT00996892|466543615|FG012|Expansion Stage 2|Disease Progression|0|||
129614400|NCT00996892|466543616|FG013|Expansion Stage 2|Disease Progression|0|||
129614401|NCT00996892|466543617|FG014|Expansion Stage 2|Disease Progression|0|||
129614402|NCT00996892|466543618|FG015|Expansion Stage 2|Disease Progression|0|||
129614403|NCT00996892|466543619|FG016|Expansion Stage 2|Disease Progression|0|||
129614404|NCT00996892|466543620|FG017|Expansion Stage 2|Disease Progression|0|||
129614405|NCT00996892|466543621|FG018|Expansion Stage 2|Disease Progression|28|||
129614406|NCT00996892|466543622|FG019|Expansion Stage 2|Disease Progression|0|||
129791013|NCT01903252|467201458|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
129791014|NCT01903252|467201459|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
129791015|NCT01903252|467201460|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
129614407|NCT00996892|466543603|FG000|Expansion Stage 2A|Adverse Event|0|||
129614408|NCT00996892|466543604|FG001|Expansion Stage 2A|Adverse Event|0|||
129614409|NCT00996892|466543605|FG002|Expansion Stage 2A|Adverse Event|0|||
129614410|NCT00996892|466543606|FG003|Expansion Stage 2A|Adverse Event|0|||
129614411|NCT00996892|466543607|FG004|Expansion Stage 2A|Adverse Event|0|||
129791016|NCT01903252|467201461|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
129614412|NCT00996892|466543608|FG005|Expansion Stage 2A|Adverse Event|0|||
129614413|NCT00996892|466543609|FG006|Expansion Stage 2A|Adverse Event|0|||
129614414|NCT00996892|466543610|FG007|Expansion Stage 2A|Adverse Event|0|||
129614415|NCT00996892|466543611|FG008|Expansion Stage 2A|Adverse Event|0|||
129614416|NCT00996892|466543612|FG009|Expansion Stage 2A|Adverse Event|0|||
129614417|NCT00996892|466543613|FG010|Expansion Stage 2A|Adverse Event|0|||
129614418|NCT00996892|466543614|FG011|Expansion Stage 2A|Adverse Event|0|||
129614419|NCT00996892|466543615|FG012|Expansion Stage 2A|Adverse Event|0|||
129614420|NCT00996892|466543616|FG013|Expansion Stage 2A|Adverse Event|0|||
129614421|NCT00996892|466543617|FG014|Expansion Stage 2A|Adverse Event|0|||
129614422|NCT00996892|466543618|FG015|Expansion Stage 2A|Adverse Event|0|||
129614423|NCT00996892|466543619|FG016|Expansion Stage 2A|Adverse Event|0|||
129614424|NCT00996892|466543620|FG017|Expansion Stage 2A|Adverse Event|0|||
129614425|NCT00996892|466543621|FG018|Expansion Stage 2A|Adverse Event|0|||
129614426|NCT00996892|466543622|FG019|Expansion Stage 2A|Adverse Event|8|||
129614427|NCT00996892|466543603|FG000|Expansion Stage 2A|Physician Decision|0|||
129614428|NCT00996892|466543604|FG001|Expansion Stage 2A|Physician Decision|0|||
129614429|NCT00996892|466543605|FG002|Expansion Stage 2A|Physician Decision|0|||
129614430|NCT00996892|466543606|FG003|Expansion Stage 2A|Physician Decision|0|||
129614431|NCT00996892|466543607|FG004|Expansion Stage 2A|Physician Decision|0|||
129614432|NCT00996892|466543608|FG005|Expansion Stage 2A|Physician Decision|0|||
129614433|NCT00996892|466543609|FG006|Expansion Stage 2A|Physician Decision|0|||
129614434|NCT00996892|466543610|FG007|Expansion Stage 2A|Physician Decision|0|||
129614435|NCT00996892|466543611|FG008|Expansion Stage 2A|Physician Decision|0|||
129614436|NCT00996892|466543612|FG009|Expansion Stage 2A|Physician Decision|0|||
129614437|NCT00996892|466543613|FG010|Expansion Stage 2A|Physician Decision|0|||
129614438|NCT00996892|466543614|FG011|Expansion Stage 2A|Physician Decision|0|||
129614439|NCT00996892|466543615|FG012|Expansion Stage 2A|Physician Decision|0|||
129614440|NCT00996892|466543616|FG013|Expansion Stage 2A|Physician Decision|0|||
129614441|NCT00996892|466543617|FG014|Expansion Stage 2A|Physician Decision|0|||
129614442|NCT00996892|466543618|FG015|Expansion Stage 2A|Physician Decision|0|||
129614443|NCT00996892|466543619|FG016|Expansion Stage 2A|Physician Decision|0|||
129614444|NCT00996892|466543620|FG017|Expansion Stage 2A|Physician Decision|0|||
129614445|NCT00996892|466543621|FG018|Expansion Stage 2A|Physician Decision|0|||
129614446|NCT00996892|466543622|FG019|Expansion Stage 2A|Physician Decision|2|||
129614447|NCT00996892|466543603|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
129614448|NCT00996892|466543604|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
129614449|NCT00996892|466543605|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
129614450|NCT00996892|466543606|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
129614451|NCT00996892|466543607|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
129614452|NCT00996892|466543608|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
129614453|NCT00996892|466543609|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
129614454|NCT00996892|466543610|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
129614455|NCT00996892|466543611|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
129614456|NCT00996892|466543612|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
129614457|NCT00996892|466543613|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
129614458|NCT00996892|466543614|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
129614459|NCT00996892|466543615|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
129614460|NCT00996892|466543616|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
129614461|NCT00996892|466543617|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
129614462|NCT00996892|466543618|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
129614463|NCT00996892|466543619|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
129614464|NCT00996892|466543620|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
129614465|NCT00996892|466543621|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
129614466|NCT00996892|466543622|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
129614467|NCT00996892|466543603|FG000|Expansion Stage 2A|Disease Progression|0|||
129614468|NCT00996892|466543604|FG001|Expansion Stage 2A|Disease Progression|0|||
129614469|NCT00996892|466543605|FG002|Expansion Stage 2A|Disease Progression|0|||
129614470|NCT00996892|466543606|FG003|Expansion Stage 2A|Disease Progression|0|||
129614471|NCT00996892|466543607|FG004|Expansion Stage 2A|Disease Progression|0|||
129614472|NCT00996892|466543608|FG005|Expansion Stage 2A|Disease Progression|0|||
129614473|NCT00996892|466543609|FG006|Expansion Stage 2A|Disease Progression|0|||
129614474|NCT00996892|466543610|FG007|Expansion Stage 2A|Disease Progression|0|||
129614475|NCT00996892|466543611|FG008|Expansion Stage 2A|Disease Progression|0|||
129614476|NCT00996892|466543612|FG009|Expansion Stage 2A|Disease Progression|0|||
129614477|NCT00996892|466543613|FG010|Expansion Stage 2A|Disease Progression|0|||
129614478|NCT00996892|466543614|FG011|Expansion Stage 2A|Disease Progression|0|||
129614479|NCT00996892|466543615|FG012|Expansion Stage 2A|Disease Progression|0|||
129614480|NCT00996892|466543616|FG013|Expansion Stage 2A|Disease Progression|0|||
129614481|NCT00996892|466543617|FG014|Expansion Stage 2A|Disease Progression|0|||
129614482|NCT00996892|466543618|FG015|Expansion Stage 2A|Disease Progression|0|||
129614483|NCT00996892|466543619|FG016|Expansion Stage 2A|Disease Progression|0|||
129614484|NCT00996892|466543620|FG017|Expansion Stage 2A|Disease Progression|0|||
129614485|NCT00996892|466543621|FG018|Expansion Stage 2A|Disease Progression|0|||
129614486|NCT00996892|466543622|FG019|Expansion Stage 2A|Disease Progression|31|||
129614487|NCT01987479|466543623|FG000|Overall Study|Protocol Violation|1|||
129439167|NCT04223856|465904588|FG001|Overall Study|Physician Decision|28|||
129439168|NCT04223856|465904587|FG000|Overall Study|Withdrawal by Subject|22|||
129439169|NCT04223856|465904588|FG001|Overall Study|Withdrawal by Subject|24|||
129614488|NCT01987479|466543623|FG000|Overall Study|Physician Decision|2|||
129614489|NCT01987479|466543623|FG000|Overall Study|Participant/legal guardian decision|1|||
129614490|NCT01987479|466543623|FG000|Overall Study|Other|5|||
129614491|NCT01987479|466543623|FG000|Overall Study|Lost to Follow-up|1|||
129614492|NCT01987479|466543623|FG000|Overall Study|Adverse Event|7|||
129614493|NCT00602641|466545487|FG000|Overall Study|Never started protocol therapy|6|||
129614494|NCT00602641|466545488|FG001|Overall Study|Never started protocol therapy|2|||
129614495|NCT00602641|466545487|FG000|Overall Study|Still on treatment at time of analysis|8|||
129614496|NCT00602641|466545488|FG001|Overall Study|Still on treatment at time of analysis|15|||
129614497|NCT00602641|466545487|FG000|Overall Study|Adverse Event|62|||
129614498|NCT00602641|466545488|FG001|Overall Study|Adverse Event|53|||
129614499|NCT00602641|466545487|FG000|Overall Study|Disease progression|38|||
129614500|NCT00602641|466545488|FG001|Overall Study|Disease progression|55|||
129614501|NCT00602641|466545487|FG000|Overall Study|Death|6|||
129614502|NCT00602641|466545488|FG001|Overall Study|Death|5|||
129614503|NCT00602641|466545487|FG000|Overall Study|Withdrawal by Subject|15|||
129614504|NCT00602641|466545488|FG001|Overall Study|Withdrawal by Subject|12|||
129614505|NCT00602641|466545487|FG000|Overall Study|Alternative therapy|5|||
129614506|NCT00602641|466545488|FG001|Overall Study|Alternative therapy|2|||
129614507|NCT00602641|466545487|FG000|Overall Study|Other Complicating Disease|5|||
129614508|NCT00602641|466545488|FG001|Overall Study|Other Complicating Disease|2|||
129614509|NCT00602641|466545487|FG000|Overall Study|Physician Decision|5|||
129614510|NCT00602641|466545488|FG001|Overall Study|Physician Decision|4|||
129614511|NCT00602641|466545487|FG000|Overall Study|Administrative Closure|1|||
129614512|NCT00602641|466545488|FG001|Overall Study|Administrative Closure|1|||
129614513|NCT00602641|466545487|FG000|Overall Study|Other|3|||
129614514|NCT00602641|466545488|FG001|Overall Study|Other|1|||
129614515|NCT00478244|466545491|FG000|Overall Study|Did not receive transplant|1|||
129614516|NCT02929056|466545494|FG000|Overall Study|Lost to Follow-up|0|||
129614517|NCT02929056|466545495|FG001|Overall Study|Lost to Follow-up|1|||
129614518|NCT02925403|466545501|FG000|Overall Study|Lost to Follow-up|0|||
129614519|NCT02925403|466545502|FG001|Overall Study|Lost to Follow-up|1|||
129614520|NCT00459043|466545503|FG000|Overall Study|Withdrawal by Subject|1|||
129614521|NCT00459043|466545504|FG001|Overall Study|Withdrawal by Subject|0|||
129614522|NCT02899195|466545507|FG000|Concurrent Durvalumab|Adverse Event|4|||
129614523|NCT02899195|466545507|FG000|Concurrent Durvalumab|Physician Decision|1|||
129614524|NCT02899195|466545507|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
129614525|NCT02899195|466545507|FG000|Concurrent Durvalumab|Progressive Disease|5|||
129614526|NCT02899195|466545507|FG000|Maintenance Durvalumab|Adverse Event|1|||
129614527|NCT02899195|466545507|FG000|Maintenance Durvalumab|Physician Decision|1|||
129614528|NCT02899195|466545507|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
129614529|NCT02899195|466545507|FG000|Maintenance Durvalumab|Progressive Disease|31|||
129614530|NCT03156504|466545509|FG000|Overall Study|Withdrawal by Subject|1|||
129614531|NCT00450801|466545510|FG000|Overall Study|Death|1|||
129614532|NCT03452137|466545511|FG000|Overall Study|Death|67|||
129614533|NCT03452137|466545512|FG001|Overall Study|Death|70|||
129614534|NCT03452137|466545511|FG000|Overall Study|Lost to Follow-up|4|||
129439170|NCT04223856|465904587|FG000|Overall Study|Other|7|||
129439171|NCT04223856|465904588|FG001|Overall Study|Other|2|||
129439172|NCT04223856|465904587|FG000|Overall Study|Randomized but not treated|2|||
129439173|NCT04223856|465904588|FG001|Overall Study|Randomized but not treated|11|||
129439174|NCT04223856|465904587|FG000|Overall Study|On-treatment|144|||
129439175|NCT04223856|465904588|FG001|Overall Study|On-treatment|0|||
129439176|NCT03226275|465904589|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129439177|NCT03226275|465904590|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129439178|NCT03226275|465904591|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
129614535|NCT03452137|466545512|FG001|Overall Study|Lost to Follow-up|2|||
129439179|NCT03226275|465904592|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
129439180|NCT03226275|465904589|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
129614536|NCT03452137|466545511|FG000|Overall Study|Physician Decision|0|||
129614537|NCT03452137|466545512|FG001|Overall Study|Physician Decision|1|||
129614538|NCT03452137|466545511|FG000|Overall Study|Study Terminated by Sponsor|120|||
129614539|NCT03452137|466545512|FG001|Overall Study|Study Terminated by Sponsor|121|||
129614540|NCT03452137|466545511|FG000|Overall Study|Withdrawal by Subject|12|||
129614541|NCT03452137|466545512|FG001|Overall Study|Withdrawal by Subject|9|||
129614542|NCT00587860|466545513|FG000|Overall Study|Lost to Follow-up|2|||
129614543|NCT00587860|466545514|FG001|Overall Study|Lost to Follow-up|2|||
129439181|NCT03226275|465904590|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
129614544|NCT00587860|466545513|FG000|Overall Study|Withdrawal by Subject|3|||
129614545|NCT00587860|466545514|FG001|Overall Study|Withdrawal by Subject|3|||
129614546|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
129614547|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
129614548|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
129614549|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
129614550|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
129614551|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
129614552|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
129614553|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
129614554|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
129614555|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
129614556|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
129614557|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
129614558|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
129614559|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
129614560|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
129614561|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
129614562|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
129614563|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
129614564|NCT00261443|466545515|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
129614565|NCT00261443|466545516|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
129614566|NCT00261443|466545517|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
129614567|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
129614568|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
129614569|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
129614570|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
129614571|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
129614572|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
129614573|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
129614574|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
129614575|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
129614576|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
129614577|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
129614578|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
129614579|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
129614580|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
129614581|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
129614582|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
129614583|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
129614584|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
129614585|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
129614586|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
129614587|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
129614588|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
129614589|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
129614590|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
129614591|NCT00261443|466545515|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
129614592|NCT00261443|466545516|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
129614593|NCT00261443|466545517|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
129614594|NCT00261443|466545515|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
129614595|NCT00261443|466545516|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
129614596|NCT00261443|466545517|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
129614597|NCT00261443|466545515|FG000|3: Assessment of Relapse|Adverse Event|0|||
129614598|NCT00261443|466545516|FG001|3: Assessment of Relapse|Adverse Event|15|||
129614599|NCT00261443|466545517|FG002|3: Assessment of Relapse|Adverse Event|19|||
129614600|NCT00261443|466545515|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
129614601|NCT00261443|466545516|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
129614602|NCT00261443|466545517|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
129614603|NCT00261443|466545515|FG000|3: Assessment of Relapse|Death|0|||
129614604|NCT00261443|466545516|FG001|3: Assessment of Relapse|Death|0|||
129614605|NCT00261443|466545517|FG002|3: Assessment of Relapse|Death|1|||
129614606|NCT00261443|466545515|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
129614607|NCT00261443|466545516|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
129614608|NCT00261443|466545517|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
129614609|NCT00261443|466545515|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
129614610|NCT00261443|466545516|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
129614611|NCT00261443|466545517|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
129614612|NCT00261443|466545515|FG000|3: Assessment of Relapse|Pregnancy|0|||
129614613|NCT00261443|466545516|FG001|3: Assessment of Relapse|Pregnancy|2|||
129614614|NCT00261443|466545517|FG002|3: Assessment of Relapse|Pregnancy|1|||
129614615|NCT00261443|466545515|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
129614616|NCT00261443|466545516|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
129614617|NCT00261443|466545517|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
129614618|NCT00261443|466545515|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
129614619|NCT00261443|466545516|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
129614620|NCT00261443|466545517|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
129614621|NCT00261443|466545515|FG000|3: Assessment of Relapse|Other Reasons|0|||
129614622|NCT00261443|466545516|FG001|3: Assessment of Relapse|Other Reasons|4|||
129614623|NCT00261443|466545517|FG002|3: Assessment of Relapse|Other Reasons|3|||
129614624|NCT00261443|466545515|FG000|4: Extension Phase|Adverse Event|0|||
129614625|NCT00261443|466545516|FG001|4: Extension Phase|Adverse Event|1|||
129614626|NCT00261443|466545517|FG002|4: Extension Phase|Adverse Event|0|||
129614627|NCT00261443|466545515|FG000|4: Extension Phase|Withdrawal by Subject|0|||
129614628|NCT00261443|466545516|FG001|4: Extension Phase|Withdrawal by Subject|1|||
129614629|NCT00261443|466545517|FG002|4: Extension Phase|Withdrawal by Subject|2|||
129614630|NCT00261443|466545515|FG000|4: Extension Phase|Lost to Follow-up|0|||
129614631|NCT00261443|466545516|FG001|4: Extension Phase|Lost to Follow-up|1|||
129614632|NCT00261443|466545517|FG002|4: Extension Phase|Lost to Follow-up|0|||
129614633|NCT01286753|466545520|FG000|Overall Study|Adverse Event|7|||
129614634|NCT01286753|466545521|FG001|Overall Study|Adverse Event|6|||
129614635|NCT01286753|466545520|FG000|Overall Study|Progression|11|||
129614636|NCT01286753|466545521|FG001|Overall Study|Progression|13|||
129614637|NCT01286753|466545520|FG000|Overall Study|Refused Treatment|1|||
129614638|NCT01286753|466545521|FG001|Overall Study|Refused Treatment|0|||
129614639|NCT01286753|466545520|FG000|Overall Study|Withdrawal of Consent|0|||
129614640|NCT01286753|466545521|FG001|Overall Study|Withdrawal of Consent|2|||
129614641|NCT01286753|466545520|FG000|Overall Study|Discontinued to Join Extension Study|6|||
129614642|NCT01286753|466545521|FG001|Overall Study|Discontinued to Join Extension Study|4|||
129614643|NCT01286753|466545520|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
129614644|NCT01286753|466545521|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
129614645|NCT02094417|466545529|FG000|Overall Study|Adverse Event|0|||
129614646|NCT02094417|466545530|FG001|Overall Study|Adverse Event|0|||
129614647|NCT02094417|466545531|FG002|Overall Study|Adverse Event|0|||
129614648|NCT02094417|466545532|FG003|Overall Study|Adverse Event|1|||
129614649|NCT02094417|466545529|FG000|Overall Study|Eligibility criteria|0|||
129614650|NCT02094417|466545530|FG001|Overall Study|Eligibility criteria|1|||
129614651|NCT02094417|466545531|FG002|Overall Study|Eligibility criteria|0|||
129614652|NCT02094417|466545532|FG003|Overall Study|Eligibility criteria|0|||
129614653|NCT02094417|466545529|FG000|Overall Study|No responder|4|||
129614654|NCT02094417|466545530|FG001|Overall Study|No responder|4|||
129614655|NCT02094417|466545531|FG002|Overall Study|No responder|4|||
129614656|NCT02094417|466545532|FG003|Overall Study|No responder|3|||
129614657|NCT02094417|466545529|FG000|Overall Study|Unable to conduct observations or assess|0|||
129614658|NCT02094417|466545530|FG001|Overall Study|Unable to conduct observations or assess|1|||
129614659|NCT02094417|466545531|FG002|Overall Study|Unable to conduct observations or assess|0|||
129614660|NCT02094417|466545532|FG003|Overall Study|Unable to conduct observations or assess|0|||
129614661|NCT02094417|466545529|FG000|Overall Study|Withdrawal by Subject|1|||
129614662|NCT02094417|466545530|FG001|Overall Study|Withdrawal by Subject|2|||
129614663|NCT02094417|466545531|FG002|Overall Study|Withdrawal by Subject|1|||
129614664|NCT02094417|466545532|FG003|Overall Study|Withdrawal by Subject|3|||
129614665|NCT02119819|466545535|FG000|Overall Study|Adverse Event|3|||
129614666|NCT02119819|466545536|FG001|Overall Study|Adverse Event|1|||
129614667|NCT02119819|466545537|FG002|Overall Study|Adverse Event|2|||
129614668|NCT02119819|466545538|FG003|Overall Study|Adverse Event|3|||
129614669|NCT02119819|466545539|FG004|Overall Study|Adverse Event|0|||
129614670|NCT02119819|466545540|FG005|Overall Study|Adverse Event|1|||
129614671|NCT02119819|466545535|FG000|Overall Study|Lack of Efficacy|0|||
129614672|NCT02119819|466545536|FG001|Overall Study|Lack of Efficacy|0|||
129614673|NCT02119819|466545537|FG002|Overall Study|Lack of Efficacy|0|||
129614674|NCT02119819|466545538|FG003|Overall Study|Lack of Efficacy|0|||
129614675|NCT02119819|466545539|FG004|Overall Study|Lack of Efficacy|0|||
129614676|NCT02119819|466545540|FG005|Overall Study|Lack of Efficacy|1|||
129614677|NCT02119819|466545535|FG000|Overall Study|Lost to Follow-up|0|||
129614678|NCT02119819|466545536|FG001|Overall Study|Lost to Follow-up|0|||
129614679|NCT02119819|466545537|FG002|Overall Study|Lost to Follow-up|1|||
129614680|NCT02119819|466545538|FG003|Overall Study|Lost to Follow-up|2|||
129439182|NCT03226275|465904591|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
129614681|NCT02119819|466545539|FG004|Overall Study|Lost to Follow-up|1|||
129614682|NCT02119819|466545540|FG005|Overall Study|Lost to Follow-up|2|||
129614683|NCT02119819|466545535|FG000|Overall Study|Physician Decision|1|||
129614684|NCT02119819|466545536|FG001|Overall Study|Physician Decision|1|||
129614685|NCT02119819|466545537|FG002|Overall Study|Physician Decision|0|||
129614686|NCT02119819|466545538|FG003|Overall Study|Physician Decision|0|||
129614687|NCT02119819|466545539|FG004|Overall Study|Physician Decision|0|||
129614688|NCT02119819|466545540|FG005|Overall Study|Physician Decision|1|||
129614689|NCT02119819|466545535|FG000|Overall Study|Withdrawal by Subject|5|||
129614690|NCT02119819|466545536|FG001|Overall Study|Withdrawal by Subject|3|||
129614691|NCT02119819|466545537|FG002|Overall Study|Withdrawal by Subject|0|||
129614692|NCT02119819|466545538|FG003|Overall Study|Withdrawal by Subject|0|||
129614693|NCT02119819|466545539|FG004|Overall Study|Withdrawal by Subject|6|||
129614694|NCT02119819|466545540|FG005|Overall Study|Withdrawal by Subject|10|||
129614695|NCT02119819|466545535|FG000|Overall Study|Jury Duty|0|||
129614696|NCT02119819|466545536|FG001|Overall Study|Jury Duty|0|||
129614697|NCT02119819|466545537|FG002|Overall Study|Jury Duty|1|||
129614698|NCT02119819|466545538|FG003|Overall Study|Jury Duty|0|||
129614699|NCT02119819|466545539|FG004|Overall Study|Jury Duty|0|||
129614700|NCT02119819|466545540|FG005|Overall Study|Jury Duty|0|||
129614701|NCT02119819|466545535|FG000|Overall Study|Protocol Violation|0|||
129614702|NCT02119819|466545536|FG001|Overall Study|Protocol Violation|0|||
129614703|NCT02119819|466545537|FG002|Overall Study|Protocol Violation|0|||
129614704|NCT02119819|466545538|FG003|Overall Study|Protocol Violation|1|||
129614705|NCT02119819|466545539|FG004|Overall Study|Protocol Violation|0|||
129614706|NCT02119819|466545540|FG005|Overall Study|Protocol Violation|0|||
129614707|NCT02119819|466545535|FG000|Overall Study|Left the city to get a job|0|||
129614708|NCT02119819|466545536|FG001|Overall Study|Left the city to get a job|0|||
129614709|NCT02119819|466545537|FG002|Overall Study|Left the city to get a job|0|||
129614710|NCT02119819|466545538|FG003|Overall Study|Left the city to get a job|1|||
129614711|NCT02119819|466545539|FG004|Overall Study|Left the city to get a job|0|||
129614712|NCT02119819|466545540|FG005|Overall Study|Left the city to get a job|0|||
129614713|NCT02699684|466545541|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
129614714|NCT02699684|466545542|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
129614715|NCT00264550|466545543|FG000|Overall Study|Death|0|||
129614716|NCT00264550|466545544|FG001|Overall Study|Death|3|||
129614717|NCT00264550|466545545|FG002|Overall Study|Death|0|||
129614718|NCT00264550|466545546|FG003|Overall Study|Death|0|||
129614719|NCT00264550|466545543|FG000|Overall Study|Lost to Follow-up|3|||
129614720|NCT00264550|466545544|FG001|Overall Study|Lost to Follow-up|1|||
129614721|NCT00264550|466545545|FG002|Overall Study|Lost to Follow-up|1|||
129614722|NCT00264550|466545546|FG003|Overall Study|Lost to Follow-up|1|||
129614723|NCT00264550|466545543|FG000|Overall Study|Adverse Event|23|||
129614724|NCT00264550|466545544|FG001|Overall Study|Adverse Event|18|||
129614725|NCT00264550|466545545|FG002|Overall Study|Adverse Event|9|||
129614726|NCT00264550|466545546|FG003|Overall Study|Adverse Event|14|||
129614727|NCT00264550|466545543|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129614728|NCT00264550|466545544|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
129614729|NCT00264550|466545545|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
129614730|NCT00264550|466545546|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
129614731|NCT00264550|466545543|FG000|Overall Study|Discontinued oral study agent|0|||
129614732|NCT00264550|466545544|FG001|Overall Study|Discontinued oral study agent|1|||
129614733|NCT00264550|466545545|FG002|Overall Study|Discontinued oral study agent|0|||
129614734|NCT00264550|466545546|FG003|Overall Study|Discontinued oral study agent|0|||
129614735|NCT00264550|466545543|FG000|Overall Study|Other|13|||
129614736|NCT00264550|466545544|FG001|Overall Study|Other|7|||
129614737|NCT00264550|466545545|FG002|Overall Study|Other|3|||
129614738|NCT00264550|466545546|FG003|Overall Study|Other|9|||
129614739|NCT01439009|466545549|FG000|Overall Study|Physician Decision|5|||
129614740|NCT01439009|466545550|FG001|Overall Study|Physician Decision|3|||
129614741|NCT01439009|466545549|FG000|Overall Study|Protocol Violation|2|||
129614742|NCT01439009|466545550|FG001|Overall Study|Protocol Violation|0|||
129614743|NCT01439009|466545549|FG000|Overall Study|Deviation of exclusion criteria|1|||
129614744|NCT01439009|466545550|FG001|Overall Study|Deviation of exclusion criteria|0|||
129614745|NCT00696787|466545551|FG000|Overall Study|Adverse Event|1|||
129614746|NCT00696787|466545552|FG001|Overall Study|Adverse Event|0|||
129614747|NCT00696787|466545553|FG002|Overall Study|Adverse Event|6|||
129614748|NCT00696787|466545551|FG000|Overall Study|Discontinuation by Sponsor|9|||
129614749|NCT00696787|466545552|FG001|Overall Study|Discontinuation by Sponsor|13|||
129614750|NCT00696787|466545553|FG002|Overall Study|Discontinuation by Sponsor|14|||
129614751|NCT00696787|466545551|FG000|Overall Study|Lack of Efficacy|0|||
129614752|NCT00696787|466545552|FG001|Overall Study|Lack of Efficacy|1|||
129614753|NCT00696787|466545553|FG002|Overall Study|Lack of Efficacy|0|||
129614754|NCT00696787|466545551|FG000|Overall Study|Lost to Follow-up|4|||
129614755|NCT00696787|466545552|FG001|Overall Study|Lost to Follow-up|0|||
129614756|NCT00696787|466545553|FG002|Overall Study|Lost to Follow-up|3|||
129614757|NCT00696787|466545551|FG000|Overall Study|Withdrawal by Subject|0|||
129614758|NCT00696787|466545552|FG001|Overall Study|Withdrawal by Subject|3|||
129614759|NCT00696787|466545553|FG002|Overall Study|Withdrawal by Subject|2|||
129614760|NCT00696787|466545551|FG000|Overall Study|Failed to return|1|||
129614761|NCT00696787|466545552|FG001|Overall Study|Failed to return|3|||
129614762|NCT00696787|466545553|FG002|Overall Study|Failed to return|1|||
129614763|NCT01191944|466545558|FG000|Overall Study|Adverse Event|11|||
129614764|NCT01191944|466545559|FG001|Overall Study|Adverse Event|12|||
129614765|NCT01191944|466545558|FG000|Overall Study|Protocol Violation|1|||
129614766|NCT01191944|466545559|FG001|Overall Study|Protocol Violation|2|||
129614767|NCT01191944|466545558|FG000|Overall Study|Withdrawal by Subject|4|||
129614768|NCT01191944|466545559|FG001|Overall Study|Withdrawal by Subject|2|||
129614769|NCT01191944|466545558|FG000|Overall Study|Other|1|||
129614770|NCT01191944|466545559|FG001|Overall Study|Other|3|||
129614771|NCT00603837|466545560|FG000|Overall Study|Physician Decision|3|||
129614772|NCT00603837|466545561|FG001|Overall Study|Physician Decision|0|||
129614773|NCT04611529|466545562|FG000|2-day Follow up|Lost to Follow-up|5|||
129614774|NCT04611529|466545563|FG001|2-day Follow up|Lost to Follow-up|6|||
129614775|NCT04611529|466545564|FG002|2-day Follow up|Lost to Follow-up|3|||
129614776|NCT02052011|466545565|FG000|Overall Study|Lost to Follow-up|3|||
129614777|NCT02052011|466545566|FG001|Overall Study|Lost to Follow-up|0|||
129614778|NCT02052011|466545565|FG000|Overall Study|Withdrawal by Subject|1|||
129614779|NCT02052011|466545566|FG001|Overall Study|Withdrawal by Subject|2|||
129614780|NCT00000620|466545567|FG000|Overall Study|Death|86|||
129614781|NCT00000620|466545568|FG001|Overall Study|Death|67|||
129614782|NCT00000620|466545569|FG002|Overall Study|Death|112|||
129614783|NCT00000620|466545570|FG003|Overall Study|Death|126|||
129614784|NCT00000620|466545571|FG004|Overall Study|Death|64|||
129614785|NCT00000620|466545572|FG005|Overall Study|Death|77|||
129614786|NCT00000620|466545573|FG006|Overall Study|Death|91|||
129614787|NCT00000620|466545574|FG007|Overall Study|Death|95|||
129614788|NCT00000620|466545567|FG000|Overall Study|Lost to Follow-up|14|||
129614789|NCT00000620|466545568|FG001|Overall Study|Lost to Follow-up|14|||
129614790|NCT00000620|466545569|FG002|Overall Study|Lost to Follow-up|14|||
129614791|NCT00000620|466545570|FG003|Overall Study|Lost to Follow-up|14|||
129614792|NCT00000620|466545571|FG004|Overall Study|Lost to Follow-up|15|||
129614793|NCT00000620|466545572|FG005|Overall Study|Lost to Follow-up|15|||
129614794|NCT00000620|466545573|FG006|Overall Study|Lost to Follow-up|13|||
129614795|NCT00000620|466545574|FG007|Overall Study|Lost to Follow-up|14|||
129614796|NCT00000620|466545567|FG000|Overall Study|Withdrawal by Subject|40|||
129614797|NCT00000620|466545568|FG001|Overall Study|Withdrawal by Subject|27|||
129614798|NCT00000620|466545569|FG002|Overall Study|Withdrawal by Subject|28|||
129614799|NCT00000620|466545570|FG003|Overall Study|Withdrawal by Subject|27|||
129614800|NCT00000620|466545571|FG004|Overall Study|Withdrawal by Subject|30|||
129614801|NCT00000620|466545572|FG005|Overall Study|Withdrawal by Subject|32|||
129614802|NCT00000620|466545573|FG006|Overall Study|Withdrawal by Subject|32|||
129614803|NCT00000620|466545574|FG007|Overall Study|Withdrawal by Subject|21|||
129614804|NCT00000620|466545567|FG000|Overall Study|missed closeout visit|22|||
129614805|NCT00000620|466545568|FG001|Overall Study|missed closeout visit|28|||
129614806|NCT00000620|466545569|FG002|Overall Study|missed closeout visit|16|||
129614807|NCT00000620|466545570|FG003|Overall Study|missed closeout visit|11|||
129614808|NCT00000620|466545571|FG004|Overall Study|missed closeout visit|26|||
129614809|NCT00000620|466545572|FG005|Overall Study|missed closeout visit|28|||
129614810|NCT00000620|466545573|FG006|Overall Study|missed closeout visit|13|||
129614811|NCT00000620|466545574|FG007|Overall Study|missed closeout visit|16|||
129614812|NCT02648932|466545575|FG000|Overall Study|No transplant|3|||
129614813|NCT02648932|466545576|FG001|Overall Study|No transplant|1|||
129614814|NCT02960490|466545577|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
129614815|NCT02960490|466545578|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
129614816|NCT02960490|466545579|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614817|NCT02960490|466545580|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614818|NCT02960490|466545581|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614819|NCT02960490|466545582|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614820|NCT02960490|466545583|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614821|NCT02960490|466545584|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614822|NCT02960490|466545585|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614823|NCT02960490|466545586|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
129614824|NCT02960490|466545577|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614825|NCT02960490|466545578|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
129614826|NCT02960490|466545579|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614827|NCT02960490|466545580|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614828|NCT02960490|466545581|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614829|NCT02960490|466545582|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614830|NCT02960490|466545583|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614831|NCT02960490|466545584|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614832|NCT02960490|466545585|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614833|NCT02960490|466545586|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
129614834|NCT02960490|466545577|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
129614835|NCT02960490|466545578|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
129614836|NCT02960490|466545579|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614837|NCT02960490|466545580|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614838|NCT02960490|466545581|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614839|NCT02960490|466545582|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614840|NCT02960490|466545583|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614841|NCT02960490|466545584|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614842|NCT02960490|466545585|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614843|NCT02960490|466545586|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
129614844|NCT02960490|466545577|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
129614845|NCT02960490|466545578|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
129614846|NCT02960490|466545579|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614847|NCT02960490|466545580|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129700580|NCT04191135|466864038|FG001|Randomized Treatment|Withdrawal by Subject|2|||
129439183|NCT03226275|465904592|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
129614848|NCT02960490|466545581|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614849|NCT02960490|466545582|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614850|NCT02960490|466545583|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614851|NCT02960490|466545584|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614852|NCT02960490|466545585|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614853|NCT02960490|466545586|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
129614854|NCT02960490|466545577|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614855|NCT02960490|466545578|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614856|NCT02960490|466545579|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
129614857|NCT02960490|466545580|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
129614858|NCT02960490|466545581|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614859|NCT02960490|466545582|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
129614860|NCT02960490|466545583|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614861|NCT02960490|466545584|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614862|NCT02960490|466545585|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614863|NCT02960490|466545586|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
129614864|NCT02960490|466545577|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614865|NCT02960490|466545578|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614866|NCT02960490|466545579|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
129614867|NCT02960490|466545580|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614868|NCT02960490|466545581|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
129614869|NCT02960490|466545582|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614870|NCT02960490|466545583|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614871|NCT02960490|466545584|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614872|NCT02960490|466545585|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614873|NCT02960490|466545586|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
129614874|NCT02960490|466545577|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
129614875|NCT02960490|466545578|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
129614876|NCT02960490|466545579|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
129614877|NCT02960490|466545580|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
129614878|NCT02960490|466545581|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
129614879|NCT02960490|466545582|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
129614880|NCT02960490|466545583|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
129614881|NCT02960490|466545584|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
129614882|NCT02960490|466545585|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
129614883|NCT02960490|466545586|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
129614884|NCT02960490|466545577|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614885|NCT02960490|466545578|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614886|NCT02960490|466545579|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614887|NCT02960490|466545580|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614888|NCT02960490|466545581|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614889|NCT02960490|466545582|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614890|NCT02960490|466545583|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
129614891|NCT02960490|466545584|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
129614892|NCT02960490|466545585|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
129614893|NCT02960490|466545586|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
129614894|NCT02960490|466545577|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614895|NCT02960490|466545578|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614896|NCT02960490|466545579|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614897|NCT02960490|466545580|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614898|NCT02960490|466545581|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614899|NCT02960490|466545582|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614900|NCT02960490|466545583|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614901|NCT02960490|466545584|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
129614902|NCT02960490|466545585|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614903|NCT02960490|466545586|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
129614904|NCT02960490|466545577|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129614905|NCT02960490|466545578|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129791017|NCT01903252|467201462|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
129439184|NCT01340196|465906376|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
129614906|NCT02960490|466545579|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129614907|NCT02960490|466545580|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129614908|NCT02960490|466545581|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129614909|NCT02960490|466545582|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
129614910|NCT02960490|466545583|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
129614911|NCT02960490|466545584|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
129614912|NCT02960490|466545585|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
129614913|NCT02960490|466545586|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
129614914|NCT02960490|466545577|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614915|NCT02960490|466545578|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129791018|NCT01903252|467201463|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
129791019|NCT01903252|467201458|FG000|Extended Induction, Open-Label|Physician Decision|0|||
129791020|NCT01903252|467201459|FG001|Extended Induction, Open-Label|Physician Decision|0|||
129791021|NCT01903252|467201460|FG002|Extended Induction, Open-Label|Physician Decision|1|||
129791022|NCT01903252|467201461|FG003|Extended Induction, Open-Label|Physician Decision|0|||
129791023|NCT01903252|467201462|FG004|Extended Induction, Open-Label|Physician Decision|0|||
129791024|NCT01903252|467201463|FG005|Extended Induction, Open-Label|Physician Decision|0|||
129791025|NCT01903252|467201458|FG000|Maintenance, Open-Label|Adverse Event|0|||
129791026|NCT01903252|467201459|FG001|Maintenance, Open-Label|Adverse Event|0|||
129791027|NCT01903252|467201460|FG002|Maintenance, Open-Label|Adverse Event|0|||
129791028|NCT01903252|467201461|FG003|Maintenance, Open-Label|Adverse Event|3|||
129791029|NCT01903252|467201462|FG004|Maintenance, Open-Label|Adverse Event|9|||
129791030|NCT01903252|467201463|FG005|Maintenance, Open-Label|Adverse Event|14|||
129791031|NCT01903252|467201458|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
129791032|NCT01903252|467201459|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
129791033|NCT01903252|467201460|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
129791034|NCT01903252|467201461|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
129791035|NCT01903252|467201462|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
129791036|NCT01903252|467201463|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
129791037|NCT01903252|467201458|FG000|Maintenance, Open-Label|Other|0|||
129791038|NCT01903252|467201459|FG001|Maintenance, Open-Label|Other|0|||
129791039|NCT01903252|467201460|FG002|Maintenance, Open-Label|Other|0|||
129791040|NCT01903252|467201461|FG003|Maintenance, Open-Label|Other|2|||
129791041|NCT01903252|467201462|FG004|Maintenance, Open-Label|Other|6|||
129791042|NCT01903252|467201463|FG005|Maintenance, Open-Label|Other|2|||
129791043|NCT01381562|467201464|FG000|Overall Study|Adverse Event|0|||
129791044|NCT01381562|467201465|FG001|Overall Study|Adverse Event|1|||
129791045|NCT01381562|467201466|FG002|Overall Study|Adverse Event|0|||
129791046|NCT01642732|467201467|FG000|Overall Study|Withdrawal by Subject|1|||
129791047|NCT01606878|467201472|FG000|Overall Study|Adverse Event|1|||
129791048|NCT01606878|467201473|FG001|Overall Study|Adverse Event|1|||
129791049|NCT01606878|467201474|FG002|Overall Study|Adverse Event|0|||
129791050|NCT01606878|467201475|FG003|Overall Study|Adverse Event|0|||
129791051|NCT01606878|467201476|FG004|Overall Study|Adverse Event|0|||
129791052|NCT01606878|467201477|FG005|Overall Study|Adverse Event|0|||
129791053|NCT01606878|467201478|FG006|Overall Study|Adverse Event|1|||
129791054|NCT01606878|467201479|FG007|Overall Study|Adverse Event|0|||
129791055|NCT01606878|467201480|FG008|Overall Study|Adverse Event|1|||
129791056|NCT01606878|467201481|FG009|Overall Study|Adverse Event|3|||
129791057|NCT01606878|467201482|FG010|Overall Study|Adverse Event|0|||
129791058|NCT01606878|467201472|FG000|Overall Study|Lack of Efficacy|1|||
129791059|NCT01606878|467201473|FG001|Overall Study|Lack of Efficacy|1|||
129791060|NCT01606878|467201474|FG002|Overall Study|Lack of Efficacy|1|||
129791061|NCT01606878|467201475|FG003|Overall Study|Lack of Efficacy|2|||
129791062|NCT01606878|467201476|FG004|Overall Study|Lack of Efficacy|1|||
129791063|NCT01606878|467201477|FG005|Overall Study|Lack of Efficacy|2|||
129791064|NCT01606878|467201478|FG006|Overall Study|Lack of Efficacy|1|||
129791065|NCT01606878|467201479|FG007|Overall Study|Lack of Efficacy|2|||
129791066|NCT01606878|467201480|FG008|Overall Study|Lack of Efficacy|2|||
129791067|NCT01606878|467201481|FG009|Overall Study|Lack of Efficacy|0|||
129791068|NCT01606878|467201482|FG010|Overall Study|Lack of Efficacy|1|||
129791069|NCT01606878|467201472|FG000|Overall Study|Physician Decision|1|||
129791070|NCT01606878|467201473|FG001|Overall Study|Physician Decision|0|||
129791071|NCT01606878|467201474|FG002|Overall Study|Physician Decision|2|||
129791072|NCT01606878|467201475|FG003|Overall Study|Physician Decision|1|||
129791073|NCT01606878|467201476|FG004|Overall Study|Physician Decision|1|||
129791074|NCT01606878|467201477|FG005|Overall Study|Physician Decision|1|||
129791075|NCT01606878|467201478|FG006|Overall Study|Physician Decision|2|||
129791076|NCT01606878|467201479|FG007|Overall Study|Physician Decision|0|||
129791077|NCT01606878|467201480|FG008|Overall Study|Physician Decision|1|||
129791078|NCT01606878|467201481|FG009|Overall Study|Physician Decision|0|||
129791079|NCT01606878|467201482|FG010|Overall Study|Physician Decision|0|||
129791080|NCT01606878|467201472|FG000|Overall Study|Withdrawal by Subject|3|||
129791081|NCT01606878|467201473|FG001|Overall Study|Withdrawal by Subject|2|||
129791082|NCT01606878|467201474|FG002|Overall Study|Withdrawal by Subject|2|||
129791083|NCT01606878|467201475|FG003|Overall Study|Withdrawal by Subject|0|||
129614916|NCT02960490|466545579|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129791084|NCT01606878|467201476|FG004|Overall Study|Withdrawal by Subject|1|||
129791085|NCT01606878|467201477|FG005|Overall Study|Withdrawal by Subject|1|||
129439185|NCT00171704|465906379|FG000|Overall Study|Adverse Event|24|||
129439186|NCT00171704|465906380|FG001|Overall Study|Adverse Event|33|||
129439187|NCT00171704|465906379|FG000|Overall Study|Disease Progression|14|||
129439188|NCT00171704|465906380|FG001|Overall Study|Disease Progression|9|||
129439189|NCT00171704|465906379|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
129439190|NCT00171704|465906380|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
129439191|NCT00171704|465906379|FG000|Overall Study|Administrative Problems|2|||
129439192|NCT00171704|465906380|FG001|Overall Study|Administrative Problems|1|||
129439193|NCT00171704|465906379|FG000|Overall Study|Death|2|||
129439194|NCT00171704|465906380|FG001|Overall Study|Death|2|||
129439195|NCT00171704|465906379|FG000|Overall Study|Withdrawal by Subject|1|||
129439196|NCT00171704|465906380|FG001|Overall Study|Withdrawal by Subject|3|||
129439197|NCT00171704|465906379|FG000|Overall Study|Protocol Violation|0|||
129439198|NCT00171704|465906380|FG001|Overall Study|Protocol Violation|1|||
129439199|NCT02141984|465906381|FG000|Overall Study|Lack of Efficacy|2|||
129614917|NCT02960490|466545580|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614918|NCT02960490|466545581|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614919|NCT02960490|466545582|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614920|NCT02960490|466545583|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
129614921|NCT02960490|466545584|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614922|NCT02960490|466545585|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614923|NCT02960490|466545586|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
129614924|NCT02960490|466545577|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614925|NCT02960490|466545578|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614926|NCT02960490|466545579|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614927|NCT02960490|466545580|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614928|NCT02960490|466545581|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614929|NCT02960490|466545582|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614930|NCT02960490|466545583|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614931|NCT02960490|466545584|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
129614932|NCT02960490|466545585|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614933|NCT02960490|466545586|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
129614934|NCT01307111|466545589|FG000|IUD Insertion|Lost to Follow-up|2|||
129614935|NCT01307111|466545590|FG001|IUD Insertion|Lost to Follow-up|0|||
129614936|NCT01307111|466545589|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
129614937|NCT01307111|466545590|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
129614938|NCT01333397|466545591|FG000|Overall Study|Lost to Follow-up|1|||
129614939|NCT01333397|466545592|FG001|Overall Study|Lost to Follow-up|0|||
129614940|NCT01333397|466545593|FG002|Overall Study|Lost to Follow-up|0|||
129614941|NCT01333397|466545594|FG003|Overall Study|Lost to Follow-up|1|||
129614942|NCT01333397|466545595|FG004|Overall Study|Lost to Follow-up|0|||
129614943|NCT01085357|466545596|FG000|Overall Study|Adverse Event|1|||
129614944|NCT01085357|466545597|FG001|Overall Study|Adverse Event|1|||
129614945|NCT01085357|466545596|FG000|Overall Study|Subject Decision|4|||
129614946|NCT01085357|466545597|FG001|Overall Study|Subject Decision|3|||
129614947|NCT01085357|466545596|FG000|Overall Study|Investigator Decision|1|||
129614948|NCT01085357|466545597|FG001|Overall Study|Investigator Decision|1|||
129614949|NCT01085357|466545596|FG000|Overall Study|Death|11|||
129614950|NCT01085357|466545597|FG001|Overall Study|Death|1|||
129614951|NCT01085357|466545596|FG000|Overall Study|Lost to Follow-up|2|||
129614952|NCT01085357|466545597|FG001|Overall Study|Lost to Follow-up|0|||
129614953|NCT00920790|466545600|FG000|Overall Study|aggravation of general condition|14|||
129614954|NCT02892149|466545603|FG000|Overall Study|Death|262|||
129614955|NCT02892149|466545604|FG001|Overall Study|Death|278|||
129614956|NCT02892149|466545603|FG000|Overall Study|Withdrawal by Subject|53|||
129614957|NCT02892149|466545604|FG001|Overall Study|Withdrawal by Subject|47|||
129614958|NCT02892149|466545603|FG000|Overall Study|Lost to Follow-up|37|||
129614959|NCT02892149|466545604|FG001|Overall Study|Lost to Follow-up|31|||
129614960|NCT00895414|466545609|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
129614961|NCT00895414|466545610|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
129614962|NCT00895414|466545609|FG000|First Intervention (14 Days)|Physician Decision|0|||
129614963|NCT00895414|466545610|FG001|First Intervention (14 Days)|Physician Decision|1|||
129614964|NCT00252239|466545611|FG000|Overall Study|Withdrawal by Subject|1|||
129614965|NCT00252239|466545612|FG001|Overall Study|Withdrawal by Subject|0|||
129614966|NCT00252239|466545613|FG002|Overall Study|Withdrawal by Subject|0|||
129614967|NCT00252239|466545614|FG003|Overall Study|Withdrawal by Subject|1|||
129439200|NCT00816400|465906385|FG000|Overall Study|Death|2|||
129439201|NCT00816400|465906386|FG001|Overall Study|Death|3|||
129614968|NCT00252239|466545611|FG000|Overall Study|Lost to Follow-up|0|||
129614969|NCT00252239|466545612|FG001|Overall Study|Lost to Follow-up|0|||
129614970|NCT00252239|466545613|FG002|Overall Study|Lost to Follow-up|2|||
129614971|NCT00252239|466545614|FG003|Overall Study|Lost to Follow-up|0|||
129614972|NCT00478426|466545615|FG000|Overall Study|Withdrawal by Subject|1|||
129614973|NCT02752087|466545620|FG000|Washout|Physician Decision|1|||
129614974|NCT02752087|466545621|FG001|Washout|Physician Decision|0|||
129614975|NCT00863772|466545622|FG000|Overall Study|Adverse Event|1|||
129614976|NCT00863772|466545623|FG001|Overall Study|Adverse Event|4|||
129614977|NCT00863772|466545624|FG002|Overall Study|Adverse Event|0|||
129614978|NCT00863772|466545622|FG000|Overall Study|Lack of Efficacy|4|||
129614979|NCT00863772|466545623|FG001|Overall Study|Lack of Efficacy|2|||
129614980|NCT00863772|466545624|FG002|Overall Study|Lack of Efficacy|4|||
129614981|NCT00863772|466545622|FG000|Overall Study|Lost to Follow-up|5|||
129614982|NCT00863772|466545623|FG001|Overall Study|Lost to Follow-up|1|||
129614983|NCT00863772|466545624|FG002|Overall Study|Lost to Follow-up|1|||
129614984|NCT00863772|466545622|FG000|Overall Study|Protocol Violation|2|||
129614985|NCT00863772|466545623|FG001|Overall Study|Protocol Violation|0|||
129614986|NCT00863772|466545624|FG002|Overall Study|Protocol Violation|2|||
129614987|NCT00863772|466545622|FG000|Overall Study|Withdrawal by Subject|4|||
129614988|NCT00863772|466545623|FG001|Overall Study|Withdrawal by Subject|7|||
129614989|NCT00863772|466545624|FG002|Overall Study|Withdrawal by Subject|5|||
129614990|NCT00863772|466545622|FG000|Overall Study|Study terminated by sponsor|44|||
129614991|NCT00863772|466545623|FG001|Overall Study|Study terminated by sponsor|45|||
129614992|NCT00863772|466545624|FG002|Overall Study|Study terminated by sponsor|36|||
129614993|NCT00863772|466545622|FG000|Overall Study|Entered extension study|6|||
129614994|NCT00863772|466545623|FG001|Overall Study|Entered extension study|4|||
129614995|NCT00863772|466545624|FG002|Overall Study|Entered extension study|9|||
129614996|NCT00863772|466545622|FG000|Overall Study|Other|1|||
129614997|NCT00863772|466545623|FG001|Overall Study|Other|2|||
129614998|NCT00863772|466545624|FG002|Overall Study|Other|4|||
129614999|NCT00863772|466545622|FG000|Overall Study|Randomized but not Treated|1|||
129615000|NCT00863772|466545623|FG001|Overall Study|Randomized but not Treated|0|||
129615001|NCT00863772|466545624|FG002|Overall Study|Randomized but not Treated|0|||
129615002|NCT02785952|466545625|FG000|Overall Study|Adverse Event|31|||
129615003|NCT02785952|466545626|FG001|Overall Study|Adverse Event|19|||
129615004|NCT02785952|466545625|FG000|Overall Study|Refusal unrelated to adverse events|10|||
129615005|NCT02785952|466545626|FG001|Overall Study|Refusal unrelated to adverse events|5|||
129615006|NCT02785952|466545625|FG000|Overall Study|Disease progression/relapse|61|||
129615007|NCT02785952|466545626|FG001|Overall Study|Disease progression/relapse|89|||
129615008|NCT02785952|466545625|FG000|Overall Study|Death|11|||
129615009|NCT02785952|466545626|FG001|Overall Study|Death|7|||
129615010|NCT02785952|466545625|FG000|Overall Study|Other- not protocol specified|6|||
129615011|NCT02785952|466545626|FG001|Overall Study|Other- not protocol specified|4|||
129615012|NCT02785952|466545625|FG000|Overall Study|On protocol treatment|6|||
129615013|NCT02785952|466545626|FG001|Overall Study|On protocol treatment|3|||
129615014|NCT02728843|466545627|FG000|Overall Study|Adverse Event|0|||
129615015|NCT02728843|466545628|FG001|Overall Study|Adverse Event|2|||
129615016|NCT02728843|466545629|FG002|Overall Study|Adverse Event|3|||
129615017|NCT02728843|466545630|FG003|Overall Study|Adverse Event|1|||
129615018|NCT02728843|466545631|FG004|Overall Study|Adverse Event|2|||
129615019|NCT02728843|466545627|FG000|Overall Study|Lack of Efficacy|0|||
129615020|NCT02728843|466545628|FG001|Overall Study|Lack of Efficacy|1|||
129615021|NCT02728843|466545629|FG002|Overall Study|Lack of Efficacy|1|||
129615022|NCT02728843|466545630|FG003|Overall Study|Lack of Efficacy|0|||
129615023|NCT02728843|466545631|FG004|Overall Study|Lack of Efficacy|0|||
129615024|NCT02728843|466545627|FG000|Overall Study|Protocol Violation|2|||
129615025|NCT02728843|466545628|FG001|Overall Study|Protocol Violation|0|||
129615026|NCT02728843|466545629|FG002|Overall Study|Protocol Violation|4|||
129615027|NCT02728843|466545630|FG003|Overall Study|Protocol Violation|2|||
129615028|NCT02728843|466545631|FG004|Overall Study|Protocol Violation|2|||
129615029|NCT02728843|466545627|FG000|Overall Study|Withdrawal by Subject|1|||
129615030|NCT02728843|466545628|FG001|Overall Study|Withdrawal by Subject|0|||
129700581|NCT04191135|466864039|FG002|Randomized Treatment|Withdrawal by Subject|0|||
129700582|NCT04191135|466864037|FG000|Randomized Treatment|Ongoing in Trial|0|||
129615031|NCT02728843|466545629|FG002|Overall Study|Withdrawal by Subject|0|||
129615032|NCT02728843|466545630|FG003|Overall Study|Withdrawal by Subject|1|||
129615033|NCT02728843|466545631|FG004|Overall Study|Withdrawal by Subject|0|||
129615034|NCT02728843|466545627|FG000|Overall Study|Use of rescue medication|0|||
129615035|NCT02728843|466545628|FG001|Overall Study|Use of rescue medication|2|||
129615036|NCT02728843|466545629|FG002|Overall Study|Use of rescue medication|0|||
129615037|NCT02728843|466545630|FG003|Overall Study|Use of rescue medication|2|||
129615038|NCT02728843|466545631|FG004|Overall Study|Use of rescue medication|1|||
129615039|NCT01671332|466545632|FG000|Overall Study|Withdrawal by Subject|1|||
129615040|NCT01671332|466545633|FG001|Overall Study|Withdrawal by Subject|1|||
129615041|NCT00351533|466545634|FG000|Overall Study|Extubated before first BAL|1|||
129615042|NCT00351533|466545635|FG001|Overall Study|Extubated before first BAL|0|||
129615043|NCT00351533|466545634|FG000|Overall Study|Lost to Follow-up|1|||
129615044|NCT00351533|466545635|FG001|Overall Study|Lost to Follow-up|3|||
129615045|NCT00351533|466545634|FG000|Overall Study|Physician Decision|0|||
129615046|NCT00351533|466545635|FG001|Overall Study|Physician Decision|1|||
129615047|NCT00351533|466545634|FG000|Overall Study|Withdrawal by Subject|0|||
129615048|NCT00351533|466545635|FG001|Overall Study|Withdrawal by Subject|1|||
129615049|NCT01806506|466545636|FG000|Overall Study|Lost to Follow-up|2|||
129615050|NCT01806506|466545637|FG001|Overall Study|Lost to Follow-up|1|||
129615051|NCT01653912|466545643|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129615052|NCT01653912|466545644|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
129615053|NCT01653912|466545645|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129615054|NCT01653912|466545646|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129615055|NCT01653912|466545647|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129615056|NCT01653912|466545648|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
129615057|NCT01653912|466545643|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129615058|NCT01653912|466545644|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129615059|NCT01653912|466545645|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
129615060|NCT01653912|466545646|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129615061|NCT01653912|466545647|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129615062|NCT01653912|466545648|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
129615063|NCT01653912|466545643|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129615064|NCT01653912|466545644|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129615065|NCT01653912|466545645|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129615066|NCT01653912|466545646|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
129615067|NCT01653912|466545647|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129615068|NCT01653912|466545648|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
129615069|NCT01653912|466545643|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615070|NCT01653912|466545644|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615071|NCT01653912|466545645|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615072|NCT01653912|466545646|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
129615073|NCT01653912|466545647|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615074|NCT01653912|466545648|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615075|NCT01653912|466545643|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129615076|NCT01653912|466545644|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129615077|NCT01653912|466545645|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129615078|NCT01653912|466545646|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129615079|NCT01653912|466545647|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
129615080|NCT01653912|466545648|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
129615081|NCT01653912|466545643|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129615082|NCT01653912|466545644|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129615083|NCT01653912|466545645|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129615084|NCT01653912|466545646|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129615085|NCT01653912|466545647|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
129615086|NCT01653912|466545648|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
129615087|NCT01653912|466545643|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615088|NCT01653912|466545644|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615089|NCT01653912|466545645|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615090|NCT01653912|466545646|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615091|NCT01653912|466545647|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
129615092|NCT01653912|466545648|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
129615093|NCT02245412|466547332|FG000|Treatment Period|Death|1|||
129615094|NCT02245412|466547333|FG001|Treatment Period|Death|1|||
129615095|NCT02245412|466547334|FG002|Treatment Period|Death|0|||
129615096|NCT02245412|466547332|FG000|Treatment Period|Physician Decision|1|||
129791086|NCT01606878|467201478|FG006|Overall Study|Withdrawal by Subject|2|||
129791087|NCT01606878|467201479|FG007|Overall Study|Withdrawal by Subject|1|||
129791088|NCT01606878|467201480|FG008|Overall Study|Withdrawal by Subject|2|||
129439202|NCT00816400|465906387|FG002|Overall Study|Death|3|||
129615097|NCT02245412|466547333|FG001|Treatment Period|Physician Decision|1|||
129615098|NCT02245412|466547334|FG002|Treatment Period|Physician Decision|0|||
129615099|NCT02245412|466547332|FG000|Treatment Period|Withdrawal by Subject|2|||
129615100|NCT02245412|466547333|FG001|Treatment Period|Withdrawal by Subject|1|||
129615101|NCT02245412|466547334|FG002|Treatment Period|Withdrawal by Subject|0|||
129615102|NCT02245412|466547332|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
129615103|NCT02245412|466547333|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
129615104|NCT02245412|466547334|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
129615105|NCT02245412|466547332|FG000|Follow-Up Period|Death|4|||
129615106|NCT02245412|466547333|FG001|Follow-Up Period|Death|2|||
129615107|NCT02245412|466547334|FG002|Follow-Up Period|Death|1|||
129615108|NCT02245412|466547332|FG000|Follow-Up Period|Physician Decision|1|||
129615109|NCT02245412|466547333|FG001|Follow-Up Period|Physician Decision|0|||
129615110|NCT02245412|466547334|FG002|Follow-Up Period|Physician Decision|0|||
129615111|NCT02245412|466547332|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
129615112|NCT02245412|466547333|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
129615113|NCT02245412|466547334|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
129615114|NCT01371747|466547335|FG000|Overall Study|Adverse Event|4|||
129615115|NCT01371747|466547336|FG001|Overall Study|Adverse Event|2|||
129615116|NCT01371747|466547337|FG002|Overall Study|Adverse Event|7|||
129615117|NCT01371747|466547338|FG003|Overall Study|Adverse Event|2|||
129615118|NCT01371747|466547339|FG004|Overall Study|Adverse Event|2|||
129615119|NCT01371747|466547340|FG005|Overall Study|Adverse Event|2|||
129615120|NCT01371747|466547335|FG000|Overall Study|Death|1|||
129615121|NCT01371747|466547336|FG001|Overall Study|Death|0|||
129615122|NCT01371747|466547337|FG002|Overall Study|Death|4|||
129615123|NCT01371747|466547338|FG003|Overall Study|Death|1|||
129615124|NCT01371747|466547339|FG004|Overall Study|Death|2|||
129615125|NCT01371747|466547340|FG005|Overall Study|Death|0|||
129615126|NCT01371747|466547335|FG000|Overall Study|Abnormal Renal Function|0|||
129615127|NCT01371747|466547336|FG001|Overall Study|Abnormal Renal Function|2|||
129615128|NCT01371747|466547337|FG002|Overall Study|Abnormal Renal Function|0|||
129615129|NCT01371747|466547338|FG003|Overall Study|Abnormal Renal Function|1|||
129615130|NCT01371747|466547339|FG004|Overall Study|Abnormal Renal Function|0|||
129615131|NCT01371747|466547340|FG005|Overall Study|Abnormal Renal Function|1|||
129615132|NCT01371747|466547335|FG000|Overall Study|High Serum Potassium Results|1|||
129615133|NCT01371747|466547336|FG001|Overall Study|High Serum Potassium Results|1|||
129615134|NCT01371747|466547337|FG002|Overall Study|High Serum Potassium Results|1|||
129615135|NCT01371747|466547338|FG003|Overall Study|High Serum Potassium Results|2|||
129615136|NCT01371747|466547339|FG004|Overall Study|High Serum Potassium Results|0|||
129615137|NCT01371747|466547340|FG005|Overall Study|High Serum Potassium Results|2|||
129615138|NCT01371747|466547335|FG000|Overall Study|Low Serum Potassium Results|1|||
129615139|NCT01371747|466547336|FG001|Overall Study|Low Serum Potassium Results|1|||
129615140|NCT01371747|466547337|FG002|Overall Study|Low Serum Potassium Results|1|||
129615141|NCT01371747|466547338|FG003|Overall Study|Low Serum Potassium Results|1|||
129615142|NCT01371747|466547339|FG004|Overall Study|Low Serum Potassium Results|0|||
129615143|NCT01371747|466547340|FG005|Overall Study|Low Serum Potassium Results|3|||
129615144|NCT01371747|466547335|FG000|Overall Study|Protocol Violation|0|||
129615145|NCT01371747|466547336|FG001|Overall Study|Protocol Violation|0|||
129615146|NCT01371747|466547337|FG002|Overall Study|Protocol Violation|1|||
129615147|NCT01371747|466547338|FG003|Overall Study|Protocol Violation|0|||
129615148|NCT01371747|466547339|FG004|Overall Study|Protocol Violation|0|||
129615149|NCT01371747|466547340|FG005|Overall Study|Protocol Violation|0|||
129615150|NCT01371747|466547335|FG000|Overall Study|Non-Compliance|3|||
129615151|NCT01371747|466547336|FG001|Overall Study|Non-Compliance|4|||
129615152|NCT01371747|466547337|FG002|Overall Study|Non-Compliance|3|||
129615153|NCT01371747|466547338|FG003|Overall Study|Non-Compliance|0|||
129615154|NCT01371747|466547339|FG004|Overall Study|Non-Compliance|0|||
129615155|NCT01371747|466547340|FG005|Overall Study|Non-Compliance|1|||
129615156|NCT01371747|466547335|FG000|Overall Study|Physician Decision|0|||
129615157|NCT01371747|466547336|FG001|Overall Study|Physician Decision|0|||
129615158|NCT01371747|466547337|FG002|Overall Study|Physician Decision|0|||
129615159|NCT01371747|466547338|FG003|Overall Study|Physician Decision|0|||
129615160|NCT01371747|466547339|FG004|Overall Study|Physician Decision|1|||
129615161|NCT01371747|466547340|FG005|Overall Study|Physician Decision|0|||
129615162|NCT01371747|466547335|FG000|Overall Study|Withdrawal by Subject|6|||
129615163|NCT01371747|466547336|FG001|Overall Study|Withdrawal by Subject|12|||
129615164|NCT01371747|466547337|FG002|Overall Study|Withdrawal by Subject|5|||
129615165|NCT01371747|466547338|FG003|Overall Study|Withdrawal by Subject|2|||
129615166|NCT01371747|466547339|FG004|Overall Study|Withdrawal by Subject|2|||
129615167|NCT01371747|466547340|FG005|Overall Study|Withdrawal by Subject|4|||
129615168|NCT01371747|466547335|FG000|Overall Study|Other Reasons|2|||
129615169|NCT01371747|466547336|FG001|Overall Study|Other Reasons|1|||
129615170|NCT01371747|466547337|FG002|Overall Study|Other Reasons|2|||
129615171|NCT01371747|466547338|FG003|Overall Study|Other Reasons|0|||
129615172|NCT01371747|466547339|FG004|Overall Study|Other Reasons|0|||
129615173|NCT01371747|466547340|FG005|Overall Study|Other Reasons|1|||
129615174|NCT00580788|466547344|FG000|Overall Study|Adverse Event|0|||
129615175|NCT00580788|466547345|FG001|Overall Study|Adverse Event|0|||
129615176|NCT00580788|466547346|FG002|Overall Study|Adverse Event|0|||
129615177|NCT00580788|466547347|FG003|Overall Study|Adverse Event|1|||
129615178|NCT01443728|466547348|FG000|Overall Study|Lost to Follow-up|2|||
129615179|NCT01443728|466547349|FG001|Overall Study|Lost to Follow-up|0|||
129615180|NCT01443728|466547348|FG000|Overall Study|Withdrawal by Subject|1|||
129615181|NCT01443728|466547349|FG001|Overall Study|Withdrawal by Subject|1|||
129615182|NCT01443728|466547348|FG000|Overall Study|Adverse Event|0|||
129615183|NCT01443728|466547349|FG001|Overall Study|Adverse Event|2|||
129615184|NCT04971187|466547350|FG000|Overall Study|Screen failures|2|||
129615185|NCT01403051|466547351|FG000|Overall Study|Protocol Violation|2|||
129615186|NCT01403051|466547352|FG001|Overall Study|Protocol Violation|0|||
129615187|NCT01403051|466547351|FG000|Overall Study|Death|1|||
129615188|NCT01403051|466547352|FG001|Overall Study|Death|0|||
129615189|NCT01403051|466547351|FG000|Overall Study|Withdrawal by Subject|2|||
129615190|NCT01403051|466547352|FG001|Overall Study|Withdrawal by Subject|1|||
129615191|NCT01403051|466547351|FG000|Overall Study|Lost to Follow-up|5|||
129615192|NCT01403051|466547352|FG001|Overall Study|Lost to Follow-up|5|||
129615193|NCT02135614|466547358|FG000|Overall Study|Randomized but Not Treated|2|||
129615194|NCT02135614|466547359|FG001|Overall Study|Randomized but Not Treated|1|||
129615195|NCT02135614|466547358|FG000|Overall Study|Adverse Event|0|||
129615196|NCT02135614|466547359|FG001|Overall Study|Adverse Event|1|||
129615197|NCT02135614|466547358|FG000|Overall Study|Death|1|||
129615198|NCT02135614|466547359|FG001|Overall Study|Death|0|||
129615199|NCT02135614|466547358|FG000|Overall Study|Investigator's Discretion|0|||
129615200|NCT02135614|466547359|FG001|Overall Study|Investigator's Discretion|1|||
129887018|NCT03095599|467547217|FG001|Overall Study|Withdrawal prior to vaccination|0|||
129615201|NCT02135614|466547358|FG000|Overall Study|Withdrew Consent|2|||
129615202|NCT02135614|466547359|FG001|Overall Study|Withdrew Consent|2|||
129615203|NCT02135614|466547358|FG000|Overall Study|Lost to Follow-up|3|||
129887019|NCT00513019|467547219|FG000|Overall Study|Adverse Event|1|||
129439203|NCT00816400|465906388|FG003|Overall Study|Death|3|||
129615204|NCT02135614|466547359|FG001|Overall Study|Lost to Follow-up|0|||
129615205|NCT02906358|466547363|FG000|Overall Study|Withdrawal by Subject|10|||
129615206|NCT02906358|466547364|FG001|Overall Study|Withdrawal by Subject|7|||
129615207|NCT02906358|466547363|FG000|Overall Study|Lost to Follow-up|12|||
129615208|NCT02906358|466547364|FG001|Overall Study|Lost to Follow-up|15|||
129700583|NCT04191135|466864038|FG001|Randomized Treatment|Ongoing in Trial|83|||
129700584|NCT04191135|466864039|FG002|Randomized Treatment|Ongoing in Trial|81|||
129700585|NCT03514134|466865895|FG000|Overall Study|Lost to Follow-up|0|||
129700586|NCT03514134|466865896|FG001|Overall Study|Lost to Follow-up|1|||
129700587|NCT02471144|466865897|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
129700588|NCT02471144|466865898|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
129700589|NCT02471144|466865899|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
129700590|NCT02471144|466865900|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
129700591|NCT02471144|466865901|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
129700592|NCT02471144|466865902|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
129700593|NCT02471144|466865903|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
129700594|NCT02471144|466865904|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
129700595|NCT02471144|466865905|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
129700596|NCT02471144|466865906|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
129700597|NCT02471144|466865907|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
129700598|NCT02471144|466865897|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700599|NCT02471144|466865898|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700600|NCT02471144|466865899|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700601|NCT02471144|466865900|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
129700602|NCT02471144|466865901|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700603|NCT02471144|466865902|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700604|NCT02471144|466865903|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700605|NCT02471144|466865904|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700606|NCT02471144|466865905|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700607|NCT02471144|466865906|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700608|NCT02471144|466865907|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
129700609|NCT02471144|466865897|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129887020|NCT00513019|467547220|FG001|Overall Study|Adverse Event|0|||
129615209|NCT01145508|466547366|FG000|Overall Study|Adverse Event|1|||
129615210|NCT01145508|466547367|FG001|Overall Study|Adverse Event|0|||
129615211|NCT01145508|466547366|FG000|Overall Study|Death|1|||
129615212|NCT01145508|466547367|FG001|Overall Study|Death|0|||
129615213|NCT01145508|466547366|FG000|Overall Study|Physician Decision|2|||
129615214|NCT01145508|466547367|FG001|Overall Study|Physician Decision|1|||
129615215|NCT01145508|466547366|FG000|Overall Study|Never started treatment|1|||
129615216|NCT01145508|466547367|FG001|Overall Study|Never started treatment|1|||
129615217|NCT02045147|466547368|FG000|Overall Study|Withdrawal by Subject|2|||
129615218|NCT02045147|466547369|FG001|Overall Study|Withdrawal by Subject|0|||
129615219|NCT02045147|466547370|FG002|Overall Study|Withdrawal by Subject|0|||
129615220|NCT02045147|466547371|FG003|Overall Study|Withdrawal by Subject|0|||
129615221|NCT02045147|466547372|FG004|Overall Study|Withdrawal by Subject|0|||
129615222|NCT02045147|466547373|FG005|Overall Study|Withdrawal by Subject|0|||
129615223|NCT02045147|466547374|FG006|Overall Study|Withdrawal by Subject|0|||
129615224|NCT02045147|466547375|FG007|Overall Study|Withdrawal by Subject|1|||
129615225|NCT02045147|466547368|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
129615226|NCT02045147|466547369|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
129615227|NCT02045147|466547370|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
129615228|NCT02045147|466547371|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
129615229|NCT02045147|466547372|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
129615230|NCT02045147|466547373|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
129615231|NCT02045147|466547374|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
129615232|NCT02045147|466547375|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
129615233|NCT04839692|466547376|FG000|Overall Study|Withdrawal by Subject|0|||
129615234|NCT04839692|466547377|FG001|Overall Study|Withdrawal by Subject|3|||
129615235|NCT04839692|466547376|FG000|Overall Study|Physician Decision|1|||
129615236|NCT04839692|466547377|FG001|Overall Study|Physician Decision|0|||
129615237|NCT03146962|466547378|FG000|Overall Study|Lost to Follow-up|1|||
129615238|NCT03146962|466547379|FG001|Overall Study|Lost to Follow-up|1|||
129615239|NCT03146962|466547380|FG002|Overall Study|Lost to Follow-up|0|||
129615240|NCT03146962|466547381|FG003|Overall Study|Lost to Follow-up|0|||
129615241|NCT03146962|466547382|FG004|Overall Study|Lost to Follow-up|0|||
129615242|NCT03146962|466547383|FG005|Overall Study|Lost to Follow-up|0|||
129615243|NCT03146962|466547384|FG006|Overall Study|Lost to Follow-up|0|||
129615244|NCT03146962|466547385|FG007|Overall Study|Lost to Follow-up|0|||
129615245|NCT03146962|466547386|FG008|Overall Study|Lost to Follow-up|0|||
129615246|NCT03146962|466547387|FG009|Overall Study|Lost to Follow-up|0|||
129615247|NCT03146962|466547378|FG000|Overall Study|Adverse Event|0|||
129615248|NCT03146962|466547379|FG001|Overall Study|Adverse Event|3|||
129615249|NCT03146962|466547380|FG002|Overall Study|Adverse Event|0|||
129615250|NCT03146962|466547381|FG003|Overall Study|Adverse Event|0|||
129615251|NCT03146962|466547382|FG004|Overall Study|Adverse Event|0|||
129615252|NCT03146962|466547383|FG005|Overall Study|Adverse Event|0|||
129615253|NCT03146962|466547384|FG006|Overall Study|Adverse Event|0|||
129615254|NCT03146962|466547385|FG007|Overall Study|Adverse Event|1|||
129615255|NCT03146962|466547386|FG008|Overall Study|Adverse Event|0|||
129615256|NCT03146962|466547387|FG009|Overall Study|Adverse Event|0|||
129615257|NCT03146962|466547378|FG000|Overall Study|Withdrawal by Subject|0|||
129615258|NCT03146962|466547379|FG001|Overall Study|Withdrawal by Subject|0|||
129615259|NCT03146962|466547380|FG002|Overall Study|Withdrawal by Subject|0|||
129615260|NCT03146962|466547381|FG003|Overall Study|Withdrawal by Subject|0|||
129615261|NCT03146962|466547382|FG004|Overall Study|Withdrawal by Subject|1|||
129615262|NCT03146962|466547383|FG005|Overall Study|Withdrawal by Subject|0|||
129615263|NCT03146962|466547384|FG006|Overall Study|Withdrawal by Subject|0|||
129615264|NCT03146962|466547385|FG007|Overall Study|Withdrawal by Subject|0|||
129615265|NCT03146962|466547386|FG008|Overall Study|Withdrawal by Subject|0|||
129615266|NCT03146962|466547387|FG009|Overall Study|Withdrawal by Subject|0|||
129615267|NCT03146962|466547378|FG000|Overall Study|Death|0|||
129615268|NCT03146962|466547379|FG001|Overall Study|Death|1|||
129615269|NCT03146962|466547380|FG002|Overall Study|Death|0|||
129615270|NCT03146962|466547381|FG003|Overall Study|Death|0|||
129615271|NCT03146962|466547382|FG004|Overall Study|Death|0|||
129615272|NCT03146962|466547383|FG005|Overall Study|Death|0|||
129615273|NCT03146962|466547384|FG006|Overall Study|Death|0|||
129615274|NCT03146962|466547385|FG007|Overall Study|Death|0|||
129615275|NCT03146962|466547386|FG008|Overall Study|Death|0|||
129615276|NCT03146962|466547387|FG009|Overall Study|Death|0|||
129615277|NCT03146962|466547378|FG000|Overall Study|COVID Precautions|1|||
129615278|NCT03146962|466547379|FG001|Overall Study|COVID Precautions|0|||
129615279|NCT03146962|466547380|FG002|Overall Study|COVID Precautions|0|||
129615280|NCT03146962|466547381|FG003|Overall Study|COVID Precautions|0|||
129615281|NCT03146962|466547382|FG004|Overall Study|COVID Precautions|0|||
129615282|NCT03146962|466547383|FG005|Overall Study|COVID Precautions|0|||
129615283|NCT03146962|466547384|FG006|Overall Study|COVID Precautions|0|||
129615284|NCT03146962|466547385|FG007|Overall Study|COVID Precautions|0|||
129615285|NCT03146962|466547386|FG008|Overall Study|COVID Precautions|0|||
129615286|NCT03146962|466547387|FG009|Overall Study|COVID Precautions|0|||
129615287|NCT03146962|466547378|FG000|Overall Study|Physician Decision|0|||
129615288|NCT03146962|466547379|FG001|Overall Study|Physician Decision|0|||
129615289|NCT03146962|466547380|FG002|Overall Study|Physician Decision|0|||
129615290|NCT03146962|466547381|FG003|Overall Study|Physician Decision|0|||
129615291|NCT03146962|466547382|FG004|Overall Study|Physician Decision|0|||
129615292|NCT03146962|466547383|FG005|Overall Study|Physician Decision|0|||
129615293|NCT03146962|466547384|FG006|Overall Study|Physician Decision|0|||
129615294|NCT03146962|466547385|FG007|Overall Study|Physician Decision|0|||
129615295|NCT03146962|466547386|FG008|Overall Study|Physician Decision|0|||
129615296|NCT03146962|466547387|FG009|Overall Study|Physician Decision|1|||
129615297|NCT03146962|466547378|FG000|Overall Study|Started New Treatment|0|||
129615298|NCT03146962|466547379|FG001|Overall Study|Started New Treatment|1|||
129615299|NCT03146962|466547380|FG002|Overall Study|Started New Treatment|0|||
129615300|NCT03146962|466547381|FG003|Overall Study|Started New Treatment|0|||
129615301|NCT03146962|466547382|FG004|Overall Study|Started New Treatment|0|||
129615302|NCT03146962|466547383|FG005|Overall Study|Started New Treatment|0|||
129615303|NCT03146962|466547384|FG006|Overall Study|Started New Treatment|0|||
129615304|NCT03146962|466547385|FG007|Overall Study|Started New Treatment|0|||
129615305|NCT03146962|466547386|FG008|Overall Study|Started New Treatment|0|||
129615306|NCT03146962|466547387|FG009|Overall Study|Started New Treatment|0|||
129615307|NCT04497948|466547390|FG000|Overall Study|Death|2|||
129615308|NCT02246114|466547391|FG000|Overall Study|miscarriage|1|||
129615309|NCT02246114|466547392|FG001|Overall Study|miscarriage|0|||
129615310|NCT00129389|466547397|FG000|Overall Study|Adverse Event|19|||
129615311|NCT00129389|466547398|FG001|Overall Study|Adverse Event|87|||
129615312|NCT00129389|466547397|FG000|Overall Study|Death|0|||
129615313|NCT00129389|466547398|FG001|Overall Study|Death|1|||
129615314|NCT00129389|466547397|FG000|Overall Study|Lost to Follow-up|2|||
129615315|NCT00129389|466547398|FG001|Overall Study|Lost to Follow-up|1|||
129615316|NCT00129389|466547397|FG000|Overall Study|Physician Decision|0|||
129615317|NCT00129389|466547398|FG001|Overall Study|Physician Decision|4|||
129615318|NCT00129389|466547397|FG000|Overall Study|Protocol Violation|0|||
129615319|NCT00129389|466547398|FG001|Overall Study|Protocol Violation|6|||
129615320|NCT00129389|466547397|FG000|Overall Study|Withdrawal by Subject|9|||
129615321|NCT00129389|466547398|FG001|Overall Study|Withdrawal by Subject|23|||
129615322|NCT00129389|466547397|FG000|Overall Study|Relapse|1|||
129615323|NCT00129389|466547398|FG001|Overall Study|Relapse|0|||
129615324|NCT00129389|466547397|FG000|Overall Study|Not eligible|1|||
129615325|NCT00129389|466547398|FG001|Overall Study|Not eligible|2|||
129615326|NCT00129389|466547397|FG000|Overall Study|Crossed to the other arm|1|||
129615327|NCT00129389|466547398|FG001|Overall Study|Crossed to the other arm|16|||
129615328|NCT03760185|466547399|FG000|Overall Study|Lost to Follow-up|1|||
129615329|NCT03760185|466547400|FG001|Overall Study|Lost to Follow-up|1|||
129615330|NCT00425373|466547466|FG000|Overall Study|Adverse Event|2|||
129615331|NCT00425373|466547467|FG001|Overall Study|Adverse Event|2|||
129615332|NCT00425373|466547468|FG002|Overall Study|Adverse Event|0|||
129615333|NCT00425373|466547469|FG003|Overall Study|Adverse Event|1|||
129615334|NCT00425373|466547470|FG004|Overall Study|Adverse Event|4|||
129615335|NCT00425373|466547471|FG005|Overall Study|Adverse Event|6|||
129615336|NCT00425373|466547472|FG006|Overall Study|Adverse Event|2|||
129615337|NCT00425373|466547473|FG007|Overall Study|Adverse Event|3|||
129615338|NCT00425373|466547474|FG008|Overall Study|Adverse Event|8|||
129615339|NCT00425373|466547466|FG000|Overall Study|Lost to Follow-up|0|||
129615340|NCT00425373|466547467|FG001|Overall Study|Lost to Follow-up|1|||
129615341|NCT00425373|466547468|FG002|Overall Study|Lost to Follow-up|0|||
129615342|NCT00425373|466547469|FG003|Overall Study|Lost to Follow-up|0|||
129615343|NCT00425373|466547470|FG004|Overall Study|Lost to Follow-up|1|||
129615344|NCT00425373|466547471|FG005|Overall Study|Lost to Follow-up|0|||
129615345|NCT00425373|466547472|FG006|Overall Study|Lost to Follow-up|0|||
129615346|NCT00425373|466547473|FG007|Overall Study|Lost to Follow-up|0|||
129615347|NCT00425373|466547474|FG008|Overall Study|Lost to Follow-up|0|||
129615348|NCT00425373|466547466|FG000|Overall Study|Protocol Violation|1|||
129615349|NCT00425373|466547467|FG001|Overall Study|Protocol Violation|0|||
129615350|NCT00425373|466547468|FG002|Overall Study|Protocol Violation|1|||
129615351|NCT00425373|466547469|FG003|Overall Study|Protocol Violation|0|||
129615352|NCT00425373|466547470|FG004|Overall Study|Protocol Violation|0|||
129615353|NCT00425373|466547471|FG005|Overall Study|Protocol Violation|0|||
129615354|NCT00425373|466547472|FG006|Overall Study|Protocol Violation|0|||
129615355|NCT00425373|466547473|FG007|Overall Study|Protocol Violation|5|||
129615356|NCT00425373|466547474|FG008|Overall Study|Protocol Violation|3|||
129615357|NCT00425373|466547466|FG000|Overall Study|Withdrawal by Subject|2|||
129700610|NCT02471144|466865898|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700611|NCT02471144|466865899|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
129700612|NCT02471144|466865900|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700613|NCT02471144|466865901|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700614|NCT02471144|466865902|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700615|NCT02471144|466865903|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700616|NCT02471144|466865904|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700617|NCT02471144|466865905|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700618|NCT02471144|466865906|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700619|NCT02471144|466865907|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
129700620|NCT02471144|466865897|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
129700621|NCT02471144|466865898|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
129700622|NCT02471144|466865899|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700623|NCT02471144|466865900|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700624|NCT02471144|466865901|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700625|NCT02471144|466865902|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700626|NCT02471144|466865903|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700627|NCT02471144|466865904|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700628|NCT02471144|466865905|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700629|NCT02471144|466865906|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700630|NCT02471144|466865907|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
129700631|NCT02471144|466865897|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700632|NCT02471144|466865898|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700633|NCT02471144|466865899|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700634|NCT02471144|466865900|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700635|NCT02471144|466865901|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
129700636|NCT02471144|466865902|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700637|NCT02471144|466865903|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
129700638|NCT02471144|466865904|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700639|NCT02471144|466865905|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
129700640|NCT02471144|466865906|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700641|NCT02471144|466865907|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
129700642|NCT02471144|466865897|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700643|NCT02471144|466865898|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700644|NCT02471144|466865899|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700645|NCT02471144|466865900|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700646|NCT02471144|466865901|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700647|NCT02471144|466865902|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
129887021|NCT00513019|467547219|FG000|Overall Study|Withdrawal by Subject|4|||
129887022|NCT00513019|467547220|FG001|Overall Study|Withdrawal by Subject|5|||
129887023|NCT00742885|467547223|FG000|Overall Study|Lost to Follow-up|1|||
129887024|NCT00742885|467547224|FG001|Overall Study|Lost to Follow-up|0|||
129887025|NCT04781647|467547225|FG000|Overall Study|Study terminated by Sponsor|11|||
129887026|NCT04781647|467547226|FG001|Overall Study|Study terminated by Sponsor|9|||
129887027|NCT04781647|467547227|FG002|Overall Study|Study terminated by Sponsor|9|||
129700648|NCT02471144|466865903|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700649|NCT02471144|466865904|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700650|NCT02471144|466865905|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
129700651|NCT02471144|466865906|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700652|NCT02471144|466865907|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
129700653|NCT02471144|466865897|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700654|NCT02471144|466865898|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700655|NCT02471144|466865899|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700656|NCT02471144|466865900|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700657|NCT02471144|466865901|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700658|NCT02471144|466865902|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700659|NCT02471144|466865903|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700660|NCT02471144|466865904|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700661|NCT02471144|466865905|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
129700662|NCT02471144|466865906|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700663|NCT02471144|466865907|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
129700664|NCT02471144|466865897|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700665|NCT02471144|466865898|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700666|NCT02471144|466865899|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129887028|NCT04781647|467547225|FG000|Overall Study|Withdrawal by Subject|1|||
129887029|NCT04781647|467547226|FG001|Overall Study|Withdrawal by Subject|2|||
129887030|NCT04781647|467547227|FG002|Overall Study|Withdrawal by Subject|0|||
129615358|NCT00425373|466547467|FG001|Overall Study|Withdrawal by Subject|0|||
129615359|NCT00425373|466547468|FG002|Overall Study|Withdrawal by Subject|2|||
129615360|NCT00425373|466547469|FG003|Overall Study|Withdrawal by Subject|1|||
129615361|NCT00425373|466547470|FG004|Overall Study|Withdrawal by Subject|4|||
129615362|NCT00425373|466547471|FG005|Overall Study|Withdrawal by Subject|0|||
129615363|NCT00425373|466547472|FG006|Overall Study|Withdrawal by Subject|2|||
129615364|NCT00425373|466547473|FG007|Overall Study|Withdrawal by Subject|2|||
129615365|NCT00425373|466547474|FG008|Overall Study|Withdrawal by Subject|2|||
129615366|NCT00425373|466547466|FG000|Overall Study|Lack of Efficacy|0|||
129887031|NCT04781647|467547225|FG000|Overall Study|Adverse Event|0|||
129887032|NCT04781647|467547226|FG001|Overall Study|Adverse Event|1|||
129887033|NCT04781647|467547227|FG002|Overall Study|Adverse Event|1|||
129887034|NCT04781647|467547225|FG000|Overall Study|Protocol Violation|1|||
129615367|NCT00425373|466547467|FG001|Overall Study|Lack of Efficacy|0|||
129615368|NCT00425373|466547468|FG002|Overall Study|Lack of Efficacy|0|||
129887035|NCT04781647|467547226|FG001|Overall Study|Protocol Violation|0|||
129887036|NCT04781647|467547227|FG002|Overall Study|Protocol Violation|0|||
129887037|NCT04781647|467547225|FG000|Overall Study|Pregnancy|0|||
129887038|NCT04781647|467547226|FG001|Overall Study|Pregnancy|0|||
129887039|NCT04781647|467547227|FG002|Overall Study|Pregnancy|1|||
129887040|NCT04781647|467547225|FG000|Overall Study|Virology rebounded|1|||
129887041|NCT04781647|467547226|FG001|Overall Study|Virology rebounded|0|||
129887042|NCT04781647|467547227|FG002|Overall Study|Virology rebounded|0|||
129887043|NCT01755689|467547228|FG000|Overall Study|Withdrawal by Subject|1|||
129887044|NCT01755689|467547229|FG001|Overall Study|Withdrawal by Subject|3|||
129887045|NCT01755689|467547230|FG002|Overall Study|Withdrawal by Subject|2|||
129887046|NCT01755689|467547231|FG003|Overall Study|Withdrawal by Subject|1|||
129615369|NCT00425373|466547469|FG003|Overall Study|Lack of Efficacy|0|||
129615370|NCT00425373|466547470|FG004|Overall Study|Lack of Efficacy|1|||
129615371|NCT00425373|466547471|FG005|Overall Study|Lack of Efficacy|3|||
129615372|NCT00425373|466547472|FG006|Overall Study|Lack of Efficacy|3|||
129615373|NCT00425373|466547473|FG007|Overall Study|Lack of Efficacy|0|||
129615374|NCT00425373|466547474|FG008|Overall Study|Lack of Efficacy|5|||
129615375|NCT01275729|466547482|FG000|Overall Study|Death|3|||
129615376|NCT01275729|466547482|FG000|Overall Study|Withdrawal by Subject|1|||
129615377|NCT02252406|466547483|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
129615378|NCT02252406|466547484|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
129615379|NCT02252406|466547483|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
129615380|NCT02252406|466547484|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
129615381|NCT02252406|466547483|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
129615382|NCT02252406|466547484|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
129615383|NCT02252406|466547483|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
129615384|NCT02252406|466547484|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
129615385|NCT02252406|466547483|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
129615386|NCT02252406|466547484|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
129615387|NCT02952586|466547492|FG000|Lead-In Phase (7 Days)|Death|0|||
129615388|NCT02952586|466547493|FG001|Lead-In Phase (7 Days)|Death|1|||
129615389|NCT02952586|466547492|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
129615390|NCT02952586|466547493|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
129615391|NCT02952586|466547492|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
129615392|NCT02952586|466547493|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
129615393|NCT02952586|466547492|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
129615394|NCT02952586|466547493|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
129615395|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
129615396|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
129615397|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
129615398|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
129615399|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
129615400|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
129615401|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
129700667|NCT02471144|466865900|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700668|NCT02471144|466865901|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129887047|NCT01755689|467547232|FG004|Overall Study|Withdrawal by Subject|1|||
129887048|NCT01755689|467547228|FG000|Overall Study|Migrated/moved from study area|0|||
129887049|NCT01755689|467547229|FG001|Overall Study|Migrated/moved from study area|1|||
129887050|NCT01755689|467547230|FG002|Overall Study|Migrated/moved from study area|1|||
129887051|NCT01755689|467547231|FG003|Overall Study|Migrated/moved from study area|1|||
129615402|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
129615403|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
129615404|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
129887052|NCT01755689|467547232|FG004|Overall Study|Migrated/moved from study area|1|||
129887053|NCT01755689|467547228|FG000|Overall Study|Lost to Follow-up|1|||
129887054|NCT01755689|467547229|FG001|Overall Study|Lost to Follow-up|0|||
129615405|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
129615406|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
129615407|NCT02952586|466547492|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
129615408|NCT02952586|466547493|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
129615409|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Death|3|||
129615410|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Death|8|||
129615411|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
129615412|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
129615413|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
129615414|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
129615415|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
129615416|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
129615417|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
129615418|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
129615419|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
129615420|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
129615421|NCT02952586|466547492|FG000|CRT for Cisplatin (63 Days)|Other|1|||
129615422|NCT02952586|466547493|FG001|CRT for Cisplatin (63 Days)|Other|1|||
129615423|NCT02952586|466547492|FG000|CRT for IMRT (63 Days)|Death|5|||
129615424|NCT02952586|466547493|FG001|CRT for IMRT (63 Days)|Death|8|||
129615425|NCT02952586|466547492|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
129615426|NCT02952586|466547493|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
129615427|NCT02952586|466547492|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
129615428|NCT02952586|466547493|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
129615429|NCT02952586|466547492|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
129615430|NCT02952586|466547493|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
129615431|NCT02952586|466547492|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
129615432|NCT02952586|466547493|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
129615433|NCT02952586|466547492|FG000|CRT for IMRT (63 Days)|Other|1|||
129615434|NCT02952586|466547493|FG001|CRT for IMRT (63 Days)|Other|0|||
129615435|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Death|17|||
129615436|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Death|11|||
129791089|NCT01606878|467201481|FG009|Overall Study|Withdrawal by Subject|0|||
129791090|NCT01606878|467201482|FG010|Overall Study|Withdrawal by Subject|2|||
129791091|NCT00002931|467202724|FG000|Overall Study|rapidly progressing disease during|2|||
129791092|NCT01879579|467202725|FG000|Overall Study|Phone incompatible with texting platform|3|||
129791093|NCT01879579|467202726|FG001|Overall Study|Phone incompatible with texting platform|0|||
129791094|NCT01879579|467202725|FG000|Overall Study|Did not enroll in texting platform|1|||
129791095|NCT01879579|467202726|FG001|Overall Study|Did not enroll in texting platform|0|||
129791096|NCT01879579|467202725|FG000|Overall Study|Did not initiate insulin treatment|1|||
129791097|NCT01879579|467202726|FG001|Overall Study|Did not initiate insulin treatment|0|||
129791098|NCT01879579|467202725|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
129791099|NCT01879579|467202726|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
129791100|NCT01879579|467202725|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
129791101|NCT01879579|467202726|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
129791102|NCT02292784|467202727|FG000|Overall Study|Lost to Follow-up|1|||
129791103|NCT02292784|467202728|FG001|Overall Study|Lost to Follow-up|17|||
129791104|NCT02292784|467202729|FG002|Overall Study|Lost to Follow-up|18|||
129791105|NCT02292784|467202727|FG000|Overall Study|Withdrawal by Subject|0|||
129791106|NCT02292784|467202728|FG001|Overall Study|Withdrawal by Subject|3|||
129791107|NCT02292784|467202729|FG002|Overall Study|Withdrawal by Subject|3|||
129791108|NCT01264081|467202730|FG000|Participants Screened|Screening failures|30|||
129791109|NCT01264081|467202730|FG000|Started Treatment|Withdrawal by Subject|1|||
129791110|NCT01264081|467202730|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
129791111|NCT00134784|467202731|FG000|Overall Study|Withdrawal by Subject|2|||
129791112|NCT00134784|467202732|FG001|Overall Study|Withdrawal by Subject|2|||
129791113|NCT00134784|467202733|FG002|Overall Study|Withdrawal by Subject|2|||
129791114|NCT00134784|467202734|FG003|Overall Study|Withdrawal by Subject|1|||
129791115|NCT02716896|467202735|FG000|Overall Study|Physician Decision|0|||
129791116|NCT02716896|467202736|FG001|Overall Study|Physician Decision|1|||
129439204|NCT00816400|465906389|FG004|Overall Study|Death|2|||
129615437|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
129615438|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
129615439|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
129615440|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
129615441|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
129615442|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
129791117|NCT03565367|467202740|FG000|Overall Study|No scan due to technical issues|4|||
129791118|NCT03565367|467202741|FG001|Overall Study|No scan due to technical issues|0|||
129791119|NCT03699475|467202747|FG000|Overall Study|Death|1|||
129615443|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
129615444|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
129791120|NCT00137839|467202748|FG000|Overall Study|Adverse Event|7|||
129615445|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
129615446|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
129615447|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
129615448|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
129615449|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
129615450|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
129615451|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Other|2|||
129615452|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Other|1|||
129615453|NCT02952586|466547492|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
129615454|NCT02952586|466547493|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
129615455|NCT02952586|466547492|FG000|Follow-Up Phase (90 Days)|Death|12|||
129615456|NCT02952586|466547493|FG001|Follow-Up Phase (90 Days)|Death|10|||
129615457|NCT02952586|466547492|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
129615458|NCT02952586|466547493|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
129615459|NCT02952586|466547492|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
129615460|NCT02952586|466547493|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
129615461|NCT02952586|466547492|FG000|Follow-Up Phase (90 Days)|Other|7|||
129615462|NCT02952586|466547493|FG001|Follow-Up Phase (90 Days)|Other|5|||
129615463|NCT02952586|466547492|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
129615464|NCT02952586|466547493|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
129615465|NCT02952586|466547492|FG000|LT Follow-up (up to 45 Months)|Death|51|||
129615466|NCT02952586|466547493|FG001|LT Follow-up (up to 45 Months)|Death|31|||
129615467|NCT02952586|466547492|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
129615468|NCT02952586|466547493|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
129615469|NCT02952586|466547492|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
129615470|NCT02952586|466547493|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
129615471|NCT02952586|466547492|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
129615472|NCT02952586|466547493|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
129615473|NCT03717012|466547494|FG000|Overall Study|Due to trial termination|1|||
129615474|NCT03717012|466547495|FG001|Overall Study|Due to trial termination|2|||
129615475|NCT03717012|466547494|FG000|Overall Study|Protocol Violation|0|||
129615476|NCT03717012|466547495|FG001|Overall Study|Protocol Violation|2|||
129791121|NCT00137839|467202748|FG000|Overall Study|Physician Decision|7|||
129791122|NCT00137839|467202748|FG000|Overall Study|Death|8|||
129791123|NCT00137839|467202748|FG000|Overall Study|Disease Progression|60|||
129791124|NCT00137839|467202748|FG000|Overall Study|Not Start Treatment|1|||
129791125|NCT00137839|467202748|FG000|Overall Study|Prolonged Treatment Delay|1|||
129791126|NCT02882152|467202753|FG000|Overall Study|Lost to Follow-up|1|||
129791127|NCT02882152|467202754|FG001|Overall Study|Lost to Follow-up|0|||
129791128|NCT01752036|467202757|FG000|Overall Study|Death|2|||
129791129|NCT03468543|467202758|FG000|Overall Study|Protocol stopping rules met|3|||
129791130|NCT01437995|467202759|FG000|Overall Study|Lost to Follow-up|11|||
129791131|NCT01437995|467202760|FG001|Overall Study|Lost to Follow-up|18|||
129791132|NCT01437995|467202761|FG002|Overall Study|Lost to Follow-up|20|||
129791133|NCT00159822|467202762|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
129791134|NCT00159822|467202762|FG000|Voriconazole Treatment Period|Adverse Event|9|||
129791135|NCT00159822|467202762|FG000|Voriconazole Treatment Period|Death|4|||
129791136|NCT00159822|467202762|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
129791137|NCT00159822|467202762|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
129791138|NCT00159822|467202762|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
129791139|NCT00159822|467202762|FG000|Post-treatment Follow-up Period|Death|1|||
129791140|NCT00159822|467202762|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
129791141|NCT00159822|467202762|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
129791142|NCT00275821|467202764|FG000|Overall Study|Adverse Event|4|||
129791143|NCT00275821|467202765|FG001|Overall Study|Adverse Event|12|||
129791144|NCT00275821|467202766|FG002|Overall Study|Adverse Event|5|||
129791145|NCT00275821|467202764|FG000|Overall Study|Administrative problems|3|||
129791146|NCT00275821|467202765|FG001|Overall Study|Administrative problems|4|||
129791147|NCT00275821|467202766|FG002|Overall Study|Administrative problems|4|||
129791148|NCT00275821|467202764|FG000|Overall Study|Withdrawal by Subject|0|||
129791149|NCT00275821|467202765|FG001|Overall Study|Withdrawal by Subject|2|||
129615477|NCT03717012|466547494|FG000|Overall Study|Adverse Event|0|||
129791150|NCT00275821|467202766|FG002|Overall Study|Withdrawal by Subject|1|||
129791151|NCT00275821|467202764|FG000|Overall Study|Lost to Follow-up|0|||
129887055|NCT01755689|467547230|FG002|Overall Study|Lost to Follow-up|1|||
129887056|NCT01755689|467547231|FG003|Overall Study|Lost to Follow-up|0|||
129887057|NCT01755689|467547232|FG004|Overall Study|Lost to Follow-up|2|||
129615478|NCT03717012|466547495|FG001|Overall Study|Adverse Event|1|||
129615479|NCT03717012|466547494|FG000|Overall Study|Lung transplant|0|||
129791152|NCT00275821|467202765|FG001|Overall Study|Lost to Follow-up|1|||
129791153|NCT00275821|467202766|FG002|Overall Study|Lost to Follow-up|1|||
129791154|NCT00275821|467202764|FG000|Overall Study|Death|0|||
129791155|NCT00275821|467202765|FG001|Overall Study|Death|2|||
129615480|NCT03717012|466547495|FG001|Overall Study|Lung transplant|1|||
129615481|NCT00789035|466547496|FG000|Overall Study|Adverse Event|0|||
129615482|NCT00789035|466547497|FG001|Overall Study|Adverse Event|2|||
129615483|NCT00789035|466547498|FG002|Overall Study|Adverse Event|0|||
129615484|NCT00789035|466547499|FG003|Overall Study|Adverse Event|1|||
129615485|NCT00789035|466547500|FG004|Overall Study|Adverse Event|3|||
129615486|NCT00789035|466547496|FG000|Overall Study|Lack of Efficacy|3|||
129615487|NCT00789035|466547497|FG001|Overall Study|Lack of Efficacy|0|||
129615488|NCT00789035|466547498|FG002|Overall Study|Lack of Efficacy|0|||
129615489|NCT00789035|466547499|FG003|Overall Study|Lack of Efficacy|0|||
129791156|NCT00275821|467202766|FG002|Overall Study|Death|1|||
129791157|NCT00275821|467202764|FG000|Overall Study|Lack of Efficacy|2|||
129791158|NCT00275821|467202765|FG001|Overall Study|Lack of Efficacy|1|||
129791159|NCT00275821|467202766|FG002|Overall Study|Lack of Efficacy|0|||
129791160|NCT00275821|467202764|FG000|Overall Study|Protocol Violation|5|||
129791161|NCT00275821|467202765|FG001|Overall Study|Protocol Violation|1|||
129791162|NCT00275821|467202766|FG002|Overall Study|Protocol Violation|0|||
129791163|NCT00329901|467202767|FG000|Overall Study|Withdrawal by Subject|4|||
129791164|NCT00329901|467202768|FG001|Overall Study|Withdrawal by Subject|3|||
129791165|NCT00329901|467202769|FG002|Overall Study|Withdrawal by Subject|2|||
129791166|NCT00329901|467202767|FG000|Overall Study|Lost to Follow-up|2|||
129791167|NCT00329901|467202768|FG001|Overall Study|Lost to Follow-up|0|||
129791168|NCT00329901|467202769|FG002|Overall Study|Lost to Follow-up|1|||
129791169|NCT00329901|467202767|FG000|Overall Study|Protocol Violation|1|||
129791170|NCT00329901|467202768|FG001|Overall Study|Protocol Violation|0|||
129791171|NCT00329901|467202769|FG002|Overall Study|Protocol Violation|1|||
129791172|NCT00329901|467202767|FG000|Overall Study|Unable to classify|2|||
129791173|NCT00329901|467202768|FG001|Overall Study|Unable to classify|2|||
129791174|NCT00329901|467202769|FG002|Overall Study|Unable to classify|0|||
129791175|NCT02296138|467202770|FG000|Overall Study|Adverse Event|348|||
129791176|NCT02296138|467202771|FG001|Overall Study|Adverse Event|259|||
129791177|NCT02296138|467202770|FG000|Overall Study|Lack of Efficacy|59|||
129791178|NCT02296138|467202771|FG001|Overall Study|Lack of Efficacy|37|||
129791179|NCT02296138|467202770|FG000|Overall Study|Protocol Violation|35|||
129791180|NCT02296138|467202771|FG001|Overall Study|Protocol Violation|36|||
129791181|NCT02296138|467202770|FG000|Overall Study|Lost to Follow-up|9|||
129791182|NCT02296138|467202771|FG001|Overall Study|Lost to Follow-up|12|||
129791183|NCT02296138|467202770|FG000|Overall Study|Withdrawal by Subject|184|||
129791184|NCT02296138|467202771|FG001|Overall Study|Withdrawal by Subject|131|||
129791185|NCT02296138|467202770|FG000|Overall Study|Not Treated|1|||
129791186|NCT02296138|467202771|FG001|Overall Study|Not Treated|1|||
129791187|NCT02296138|467202770|FG000|Overall Study|Patients with data irregularities|10|||
129791188|NCT02296138|467202771|FG001|Overall Study|Patients with data irregularities|11|||
129791189|NCT02296138|467202770|FG000|Overall Study|Other than specified|15|||
129791190|NCT02296138|467202771|FG001|Overall Study|Other than specified|13|||
129791191|NCT01268579|467202778|FG000|Overall Study|Adverse Event|1|||
129791192|NCT01268579|467202778|FG000|Overall Study|Withdrawal by Subject|2|||
129791193|NCT01209832|467202779|FG000|Period 1|Sponsor Decision and was not dosed|1|||
129791194|NCT01209832|467202779|FG000|Period 2|Sponsor Decision|1|||
129791195|NCT00761150|467202780|FG000|Open-label Period|Adverse Event|36|||
129791196|NCT00761150|467202781|FG001|Open-label Period|Adverse Event|0|||
129791197|NCT00761150|467202782|FG002|Open-label Period|Adverse Event|0|||
129791198|NCT00761150|467202780|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
129791199|NCT00761150|467202781|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
129791200|NCT00761150|467202782|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
129791201|NCT00761150|467202780|FG000|Open-label Period|Lost to Follow-up|7|||
129791202|NCT00761150|467202781|FG001|Open-label Period|Lost to Follow-up|0|||
129791203|NCT00761150|467202782|FG002|Open-label Period|Lost to Follow-up|0|||
129791204|NCT00761150|467202780|FG000|Open-label Period|Lack of Efficacy|4|||
129791205|NCT00761150|467202781|FG001|Open-label Period|Lack of Efficacy|0|||
129791206|NCT00761150|467202782|FG002|Open-label Period|Lack of Efficacy|0|||
129439205|NCT00816400|465906390|FG005|Overall Study|Death|3|||
129615490|NCT00789035|466547500|FG004|Overall Study|Lack of Efficacy|2|||
129615491|NCT00789035|466547496|FG000|Overall Study|Protocol Violation|1|||
129615492|NCT00789035|466547497|FG001|Overall Study|Protocol Violation|0|||
129615493|NCT00789035|466547498|FG002|Overall Study|Protocol Violation|0|||
129615494|NCT00789035|466547499|FG003|Overall Study|Protocol Violation|0|||
129791207|NCT00761150|467202780|FG000|Open-label Period|Withdrawal by Subject|5|||
129791208|NCT00761150|467202781|FG001|Open-label Period|Withdrawal by Subject|0|||
129791209|NCT00761150|467202782|FG002|Open-label Period|Withdrawal by Subject|0|||
129791210|NCT00761150|467202780|FG000|Open-label Period|Noncompliance|2|||
129615495|NCT00789035|466547500|FG004|Overall Study|Protocol Violation|0|||
129615496|NCT00789035|466547496|FG000|Overall Study|Withdrawal by Subject|0|||
129615497|NCT00789035|466547497|FG001|Overall Study|Withdrawal by Subject|2|||
129791211|NCT00761150|467202781|FG001|Open-label Period|Noncompliance|0|||
129791212|NCT00761150|467202782|FG002|Open-label Period|Noncompliance|0|||
129791213|NCT00761150|467202780|FG000|Open-label Period|Other|5|||
129791214|NCT00761150|467202781|FG001|Open-label Period|Other|0|||
129791215|NCT00761150|467202782|FG002|Open-label Period|Other|0|||
129887058|NCT01755689|467547228|FG000|Overall Study|Pregnancy|1|||
129887059|NCT01755689|467547229|FG001|Overall Study|Pregnancy|1|||
129887060|NCT01755689|467547230|FG002|Overall Study|Pregnancy|2|||
129887061|NCT01755689|467547231|FG003|Overall Study|Pregnancy|4|||
129887062|NCT01755689|467547232|FG004|Overall Study|Pregnancy|2|||
129887063|NCT01995357|467547233|FG000|Period 5|Lack of Efficacy|1|||
129887064|NCT01995357|467547234|FG001|Period 5|Lack of Efficacy|0|||
129887065|NCT01995357|467547235|FG002|Period 5|Lack of Efficacy|0|||
129887066|NCT01995357|467547236|FG003|Period 5|Lack of Efficacy|0|||
129887067|NCT01995357|467547237|FG004|Period 5|Lack of Efficacy|0|||
129887068|NCT01995357|467547238|FG005|Period 5|Lack of Efficacy|0|||
129887069|NCT01995357|467547233|FG000|Period 5|Adverse Event|1|||
129887070|NCT01995357|467547234|FG001|Period 5|Adverse Event|0|||
129887071|NCT01995357|467547235|FG002|Period 5|Adverse Event|1|||
129887072|NCT01995357|467547236|FG003|Period 5|Adverse Event|0|||
129887073|NCT01995357|467547237|FG004|Period 5|Adverse Event|0|||
129615498|NCT00789035|466547498|FG002|Overall Study|Withdrawal by Subject|0|||
129887074|NCT01995357|467547238|FG005|Period 5|Adverse Event|0|||
129887075|NCT03615482|467547239|FG000|Overall Study|Death|1|||
129887076|NCT03615482|467547240|FG001|Overall Study|Death|0|||
129887077|NCT03615482|467547239|FG000|Overall Study|Lost to Follow-up|7|||
129887078|NCT03615482|467547240|FG001|Overall Study|Lost to Follow-up|7|||
129887079|NCT03615482|467547239|FG000|Overall Study|Physician Decision|2|||
129615499|NCT00789035|466547499|FG003|Overall Study|Withdrawal by Subject|0|||
129615500|NCT00789035|466547500|FG004|Overall Study|Withdrawal by Subject|0|||
129615501|NCT00789035|466547496|FG000|Overall Study|Other reason not defined above|2|||
129615502|NCT00789035|466547497|FG001|Overall Study|Other reason not defined above|3|||
129615503|NCT00789035|466547498|FG002|Overall Study|Other reason not defined above|1|||
129615504|NCT00789035|466547499|FG003|Overall Study|Other reason not defined above|0|||
129615505|NCT00789035|466547500|FG004|Overall Study|Other reason not defined above|1|||
129615506|NCT02640690|466547501|FG000|Overall Study|Lost to Follow-up|7|||
129615507|NCT02640690|466547502|FG001|Overall Study|Lost to Follow-up|7|||
129615508|NCT02640690|466547501|FG000|Overall Study|Withdrawal by Subject|16|||
129615509|NCT02640690|466547502|FG001|Overall Study|Withdrawal by Subject|20|||
129615510|NCT02640690|466547501|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
129615511|NCT02640690|466547502|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
129615512|NCT01118975|466547503|FG000|Overall Study|Adverse Event|0|||
129615513|NCT01118975|466547504|FG001|Overall Study|Adverse Event|1|||
129615514|NCT01520870|466547505|FG000|Overall Study|Withdrawal by Subject|2|||
129615515|NCT02463357|466547506|FG000|Overall Study|Withdrawal by Subject|1|||
129615516|NCT02463357|466547507|FG001|Overall Study|Withdrawal by Subject|0|||
129615517|NCT02463357|466547508|FG002|Overall Study|Withdrawal by Subject|0|||
129615518|NCT02463357|466547509|FG003|Overall Study|Withdrawal by Subject|0|||
129615519|NCT02463357|466547510|FG004|Overall Study|Withdrawal by Subject|0|||
129615520|NCT02463357|466547506|FG000|Overall Study|Withdrawal by Subject|0|||
129615521|NCT02463357|466547507|FG001|Overall Study|Withdrawal by Subject|0|||
129615522|NCT02463357|466547508|FG002|Overall Study|Withdrawal by Subject|0|||
129615523|NCT02463357|466547509|FG003|Overall Study|Withdrawal by Subject|0|||
129887080|NCT03615482|467547240|FG001|Overall Study|Physician Decision|3|||
129887081|NCT03615482|467547239|FG000|Overall Study|Withdrawal by Subject|7|||
129887082|NCT03615482|467547240|FG001|Overall Study|Withdrawal by Subject|7|||
129615524|NCT02463357|466547510|FG004|Overall Study|Withdrawal by Subject|1|||
129615525|NCT01399658|466547511|FG000|Overall Study|Ineligible|1|||
129700669|NCT02471144|466865902|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700670|NCT02471144|466865903|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700671|NCT02471144|466865904|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
129700672|NCT02471144|466865905|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
129700673|NCT02471144|466865906|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700674|NCT02471144|466865907|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
129700675|NCT02471144|466865897|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700676|NCT02471144|466865898|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700677|NCT02471144|466865899|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700678|NCT02471144|466865900|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700679|NCT02471144|466865901|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700680|NCT02471144|466865902|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700681|NCT02471144|466865903|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700682|NCT02471144|466865904|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700683|NCT02471144|466865905|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
129700684|NCT02471144|466865906|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
129887083|NCT01500226|467547243|FG000|Overall Study|Adverse Event|31|||
129887084|NCT01500226|467547244|FG001|Overall Study|Adverse Event|38|||
129615526|NCT01399658|466547511|FG000|Overall Study|Machine Technical Issue|3|||
129700685|NCT02471144|466865907|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
129887085|NCT01500226|467547243|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
129887086|NCT01500226|467547244|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
129791216|NCT00761150|467202780|FG000|Double-blind Period|Lack of Efficacy|0|||
129791217|NCT00761150|467202781|FG001|Double-blind Period|Lack of Efficacy|2|||
129791218|NCT00761150|467202782|FG002|Double-blind Period|Lack of Efficacy|19|||
129791219|NCT00761150|467202780|FG000|Double-blind Period|Adverse Event|0|||
129791220|NCT00761150|467202781|FG001|Double-blind Period|Adverse Event|3|||
129791221|NCT00761150|467202782|FG002|Double-blind Period|Adverse Event|3|||
129791222|NCT00761150|467202780|FG000|Double-blind Period|Withdrawal by Subject|0|||
129615527|NCT01399658|466547511|FG000|Overall Study|Alternative therapy|1|||
129615528|NCT01399658|466547511|FG000|Overall Study|No reason given|1|||
129615529|NCT02460679|466547512|FG000|Overall Study|Investigator Decision|1|||
129615530|NCT02460679|466547512|FG000|Overall Study|Withdrawal by Subject|4|||
129791223|NCT00761150|467202781|FG001|Double-blind Period|Withdrawal by Subject|3|||
129791224|NCT00761150|467202782|FG002|Double-blind Period|Withdrawal by Subject|2|||
129791225|NCT00761150|467202780|FG000|Double-blind Period|Lost to Follow-up|0|||
129791226|NCT00761150|467202781|FG001|Double-blind Period|Lost to Follow-up|2|||
129791227|NCT00761150|467202782|FG002|Double-blind Period|Lost to Follow-up|1|||
129791228|NCT00761150|467202780|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
129791229|NCT00761150|467202781|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
129791230|NCT00761150|467202782|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
129791231|NCT00761150|467202780|FG000|Double-blind Period|Noncompliance|0|||
129791232|NCT00761150|467202781|FG001|Double-blind Period|Noncompliance|1|||
129791233|NCT00761150|467202782|FG002|Double-blind Period|Noncompliance|0|||
129791234|NCT00761150|467202780|FG000|Double-blind Period|Other|0|||
129791235|NCT00761150|467202781|FG001|Double-blind Period|Other|3|||
129791236|NCT00761150|467202782|FG002|Double-blind Period|Other|3|||
129791237|NCT02692651|467202783|FG000|Study Treatment|Death|7|||
129791238|NCT02692651|467202784|FG001|Study Treatment|Death|3|||
129615531|NCT02620579|466547518|FG000|Overall Study|Physician Decision|0|||
129615532|NCT02620579|466547519|FG001|Overall Study|Physician Decision|0|||
129615533|NCT02620579|466547520|FG002|Overall Study|Physician Decision|0|||
129615534|NCT02620579|466547521|FG003|Overall Study|Physician Decision|1|||
129791239|NCT02692651|467202783|FG000|Study Treatment|comfort care|1|||
129791240|NCT02692651|467202784|FG001|Study Treatment|comfort care|1|||
129791241|NCT02692651|467202783|FG000|Study Treatment|Protocol violation per treating team preference|8|||
129615535|NCT02620579|466547518|FG000|Overall Study|Withdrawal by Subject|0|||
129615536|NCT02620579|466547519|FG001|Overall Study|Withdrawal by Subject|1|||
129615537|NCT02620579|466547520|FG002|Overall Study|Withdrawal by Subject|1|||
129615538|NCT02620579|466547521|FG003|Overall Study|Withdrawal by Subject|0|||
129615539|NCT00796107|466547522|FG000|Overall Study|Lack of Efficacy|1|||
129615540|NCT00796107|466547522|FG000|Overall Study|Progressive Disease|5|||
129615541|NCT04411914|466547523|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
129615542|NCT04411914|466547524|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
129615543|NCT01721317|466547526|FG000|Overall Study|Study Closed / Terminated|2|||
129615544|NCT01721317|466547527|FG001|Overall Study|Study Closed / Terminated|2|||
129615545|NCT01721317|466547526|FG000|Overall Study|Physician Decision|0|||
129615546|NCT01721317|466547527|FG001|Overall Study|Physician Decision|1|||
129615547|NCT01721317|466547526|FG000|Overall Study|Withdrawal by Subject|0|||
129615548|NCT01721317|466547527|FG001|Overall Study|Withdrawal by Subject|1|||
129615549|NCT02806024|466547546|FG000|Overall Study|Night Delivery|1|||
129615550|NCT02806024|466547547|FG001|Overall Study|Night Delivery|1|||
129615551|NCT02806024|466547546|FG000|Overall Study|DVT during antepartum admission|0|||
129615552|NCT02806024|466547547|FG001|Overall Study|DVT during antepartum admission|1|||
129615553|NCT01994850|466547548|FG000|Overall Study|Physician Decision|1|||
129615554|NCT01994850|466547548|FG000|Overall Study|Withdrawal by Subject|1|||
129615555|NCT00789737|466547551|FG000|Overall Study|Withdrawal by Subject|13|||
129615556|NCT00789737|466547552|FG001|Overall Study|Withdrawal by Subject|22|||
129615557|NCT00789737|466547551|FG000|Overall Study|Lost to Follow-up|10|||
129615558|NCT00789737|466547552|FG001|Overall Study|Lost to Follow-up|14|||
129615559|NCT00789737|466547551|FG000|Overall Study|Adverse Event|8|||
129615560|NCT00789737|466547552|FG001|Overall Study|Adverse Event|8|||
129615561|NCT00789737|466547551|FG000|Overall Study|Protocol Violation|3|||
129615562|NCT00789737|466547552|FG001|Overall Study|Protocol Violation|0|||
129615563|NCT00789737|466547551|FG000|Overall Study|Lack of Efficacy|3|||
129615564|NCT00789737|466547552|FG001|Overall Study|Lack of Efficacy|0|||
129615565|NCT00789737|466547551|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
129615566|NCT00789737|466547552|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
129615567|NCT00789737|466547551|FG000|Overall Study|Other|11|||
129615568|NCT00789737|466547552|FG001|Overall Study|Other|7|||
129615569|NCT03489109|466547555|FG000|Overall Study|Lost to Follow-up|1|||
129615570|NCT03489109|466547556|FG001|Overall Study|Lost to Follow-up|2|||
129615571|NCT00384930|466547557|FG000|Overall Study|Adverse Event|5|||
129615572|NCT00384930|466547558|FG001|Overall Study|Adverse Event|4|||
129615573|NCT00384930|466547559|FG002|Overall Study|Adverse Event|12|||
129615574|NCT00384930|466547560|FG003|Overall Study|Adverse Event|11|||
129615575|NCT00384930|466547561|FG004|Overall Study|Adverse Event|14|||
129615576|NCT00384930|466547557|FG000|Overall Study|Entry Criteria Not Met|2|||
129615577|NCT00384930|466547558|FG001|Overall Study|Entry Criteria Not Met|6|||
129615578|NCT00384930|466547559|FG002|Overall Study|Entry Criteria Not Met|7|||
129615579|NCT00384930|466547560|FG003|Overall Study|Entry Criteria Not Met|8|||
129615580|NCT00384930|466547561|FG004|Overall Study|Entry Criteria Not Met|4|||
129615581|NCT00384930|466547557|FG000|Overall Study|Lack of Efficacy|1|||
129615582|NCT00384930|466547558|FG001|Overall Study|Lack of Efficacy|1|||
129615583|NCT00384930|466547559|FG002|Overall Study|Lack of Efficacy|2|||
129615584|NCT00384930|466547560|FG003|Overall Study|Lack of Efficacy|1|||
129615585|NCT00384930|466547561|FG004|Overall Study|Lack of Efficacy|2|||
129615586|NCT00384930|466547557|FG000|Overall Study|Lost to Follow-up|5|||
129615587|NCT00384930|466547558|FG001|Overall Study|Lost to Follow-up|3|||
129615588|NCT00384930|466547559|FG002|Overall Study|Lost to Follow-up|0|||
129615589|NCT00384930|466547560|FG003|Overall Study|Lost to Follow-up|4|||
129615590|NCT00384930|466547561|FG004|Overall Study|Lost to Follow-up|6|||
129615591|NCT00384930|466547557|FG000|Overall Study|Physician Decision|0|||
129615592|NCT00384930|466547558|FG001|Overall Study|Physician Decision|1|||
129615593|NCT00384930|466547559|FG002|Overall Study|Physician Decision|1|||
129615594|NCT00384930|466547560|FG003|Overall Study|Physician Decision|0|||
129615595|NCT00384930|466547561|FG004|Overall Study|Physician Decision|1|||
129615596|NCT00384930|466547557|FG000|Overall Study|Protocol Violation|1|||
129615597|NCT00384930|466547558|FG001|Overall Study|Protocol Violation|0|||
129615598|NCT00384930|466547559|FG002|Overall Study|Protocol Violation|1|||
129615599|NCT00384930|466547560|FG003|Overall Study|Protocol Violation|6|||
129615600|NCT00384930|466547561|FG004|Overall Study|Protocol Violation|4|||
129700686|NCT02471144|466865897|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700687|NCT02471144|466865898|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700688|NCT02471144|466865899|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700689|NCT02471144|466865900|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700690|NCT02471144|466865901|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700691|NCT02471144|466865902|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129615601|NCT00384930|466547557|FG000|Overall Study|Sponsor Decision|3|||
129615602|NCT00384930|466547558|FG001|Overall Study|Sponsor Decision|4|||
129615603|NCT00384930|466547559|FG002|Overall Study|Sponsor Decision|0|||
129700692|NCT02471144|466865903|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700693|NCT02471144|466865904|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129887087|NCT01500226|467547243|FG000|Overall Study|Withdrawal by Subject|93|||
129887088|NCT01500226|467547244|FG001|Overall Study|Withdrawal by Subject|96|||
129887089|NCT01500226|467547243|FG000|Overall Study|Death|12|||
129887090|NCT01500226|467547244|FG001|Overall Study|Death|4|||
129439206|NCT00816400|465906391|FG006|Overall Study|Death|2|||
129439207|NCT00816400|465906392|FG007|Overall Study|Death|5|||
129439208|NCT00816400|465906393|FG008|Overall Study|Death|6|||
129439209|NCT00816400|465906385|FG000|Overall Study|In hospice care at the end of the study|0|||
129439210|NCT00816400|465906386|FG001|Overall Study|In hospice care at the end of the study|0|||
129439211|NCT00816400|465906387|FG002|Overall Study|In hospice care at the end of the study|2|||
129439212|NCT00816400|465906388|FG003|Overall Study|In hospice care at the end of the study|0|||
129439213|NCT00816400|465906389|FG004|Overall Study|In hospice care at the end of the study|0|||
129439214|NCT00816400|465906390|FG005|Overall Study|In hospice care at the end of the study|0|||
129439215|NCT00816400|465906391|FG006|Overall Study|In hospice care at the end of the study|0|||
129439216|NCT00816400|465906392|FG007|Overall Study|In hospice care at the end of the study|0|||
129439217|NCT00816400|465906393|FG008|Overall Study|In hospice care at the end of the study|0|||
129615604|NCT00384930|466547560|FG003|Overall Study|Sponsor Decision|5|||
129615605|NCT00384930|466547561|FG004|Overall Study|Sponsor Decision|0|||
129615606|NCT00384930|466547557|FG000|Overall Study|Withdrawal by Subject|9|||
129615607|NCT00384930|466547558|FG001|Overall Study|Withdrawal by Subject|7|||
129615608|NCT00384930|466547559|FG002|Overall Study|Withdrawal by Subject|7|||
129615609|NCT00384930|466547560|FG003|Overall Study|Withdrawal by Subject|6|||
129791242|NCT02692651|467202784|FG001|Study Treatment|Protocol violation per treating team preference|6|||
129791243|NCT02692651|467202783|FG000|Post Study Treatment Follow-up|Death|4|||
129791244|NCT02692651|467202784|FG001|Post Study Treatment Follow-up|Death|4|||
129791245|NCT02480712|467202785|FG000|Overall Study|Enrolled but Never Treated|1|||
129791246|NCT02480712|467202785|FG000|Overall Study|Lost to Follow-up|5|||
129791247|NCT02480712|467202785|FG000|Overall Study|Withdrew Consent|3|||
129791248|NCT02480712|467202785|FG000|Overall Study|Death|1|||
129791249|NCT02480712|467202785|FG000|Overall Study|Lack of Efficacy|1|||
129791250|NCT00475423|467202786|FG000|Overall Study|Protocol Violation|5|||
129791251|NCT00475423|467202786|FG000|Overall Study|Adverse Event|4|||
129791252|NCT00475423|467202786|FG000|Overall Study|Withdrawal by Subject|6|||
129791253|NCT00475423|467202786|FG000|Overall Study|Lack of Efficacy|8|||
129887091|NCT01500226|467547243|FG000|Overall Study|Disease Progression|16|||
129887092|NCT01500226|467547244|FG001|Overall Study|Disease Progression|14|||
129439218|NCT00081770|465906394|FG000|Overall Study|Adverse Event|130|||
129439219|NCT00081770|465906395|FG001|Overall Study|Adverse Event|98|||
129439220|NCT00081770|465906396|FG002|Overall Study|Adverse Event|136|||
129615610|NCT00384930|466547561|FG004|Overall Study|Withdrawal by Subject|16|||
129791254|NCT00475423|467202786|FG000|Overall Study|Death|1|||
129791255|NCT00475423|467202786|FG000|Overall Study|Reason not specified|1|||
129791256|NCT00475423|467202786|FG000|Overall Study|Lost to Follow-up|7|||
129700694|NCT02471144|466865905|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700695|NCT02471144|466865906|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
129700696|NCT02471144|466865907|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
129700697|NCT02471144|466865897|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700698|NCT02471144|466865898|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700699|NCT02471144|466865899|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700700|NCT02471144|466865900|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700701|NCT02471144|466865901|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700702|NCT02471144|466865902|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700703|NCT02471144|466865903|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700704|NCT02471144|466865904|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700705|NCT02471144|466865905|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700706|NCT02471144|466865906|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
129700707|NCT02471144|466865907|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
129700708|NCT02471144|466865897|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129700709|NCT02471144|466865898|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129700710|NCT02471144|466865899|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129887093|NCT01500226|467547243|FG000|Overall Study|Protocol Violation|53|||
129887094|NCT01500226|467547244|FG001|Overall Study|Protocol Violation|39|||
129887095|NCT01500226|467547243|FG000|Overall Study|Physician Decision|17|||
129887096|NCT01500226|467547244|FG001|Overall Study|Physician Decision|15|||
129887097|NCT01500226|467547243|FG000|Overall Study|Lack of Efficacy|14|||
129887098|NCT01500226|467547244|FG001|Overall Study|Lack of Efficacy|30|||
129887099|NCT01500226|467547243|FG000|Overall Study|Lost to Follow-up|9|||
129887100|NCT01500226|467547244|FG001|Overall Study|Lost to Follow-up|5|||
129887101|NCT01500226|467547243|FG000|Overall Study|Other Reasons|19|||
129887102|NCT01500226|467547244|FG001|Overall Study|Other Reasons|16|||
129887103|NCT02955277|467547245|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
129887104|NCT02955277|467547246|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
129887105|NCT02955277|467547245|FG000|Post to Follow-up|Lost to Follow-up|8|||
129887106|NCT02955277|467547246|FG001|Post to Follow-up|Lost to Follow-up|11|||
129887107|NCT01668147|467547257|FG000|Overall Study|Withdrawal by Subject|6|||
129887108|NCT01809210|467547258|FG000|Overall Study|Withdrawal by Subject|0|||
129887109|NCT01809210|467547259|FG001|Overall Study|Withdrawal by Subject|0|||
129887110|NCT01809210|467547260|FG002|Overall Study|Withdrawal by Subject|1|||
129887111|NCT01809210|467547261|FG003|Overall Study|Withdrawal by Subject|1|||
129887112|NCT01809210|467547262|FG004|Overall Study|Withdrawal by Subject|1|||
129887113|NCT01809210|467547263|FG005|Overall Study|Withdrawal by Subject|0|||
129887114|NCT01809210|467547264|FG006|Overall Study|Withdrawal by Subject|4|||
129887115|NCT01809210|467547258|FG000|Overall Study|Death|1|||
129887116|NCT01809210|467547259|FG001|Overall Study|Death|1|||
129887117|NCT01809210|467547260|FG002|Overall Study|Death|2|||
129615611|NCT00384930|466547557|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
129615612|NCT00384930|466547558|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
129615613|NCT00384930|466547559|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
129615614|NCT00384930|466547560|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
129615615|NCT00384930|466547561|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
129615616|NCT02181790|466547562|FG000|Overall Study|study terminated|2|||
129615617|NCT02181790|466547563|FG001|Overall Study|study terminated|0|||
129615618|NCT02458287|466547564|FG000|Overall Study|Adverse Event|0|||
129615619|NCT02458287|466547565|FG001|Overall Study|Adverse Event|0|||
129615620|NCT02458287|466547566|FG002|Overall Study|Adverse Event|0|||
129615621|NCT02458287|466547567|FG003|Overall Study|Adverse Event|1|||
129615622|NCT02458287|466547564|FG000|Overall Study|Lost to Follow-up|0|||
129615623|NCT02458287|466547565|FG001|Overall Study|Lost to Follow-up|1|||
129615624|NCT02458287|466547566|FG002|Overall Study|Lost to Follow-up|1|||
129615625|NCT02458287|466547567|FG003|Overall Study|Lost to Follow-up|0|||
129615626|NCT02458287|466547564|FG000|Overall Study|Protocol Violation|0|||
129615627|NCT02458287|466547565|FG001|Overall Study|Protocol Violation|1|||
129615628|NCT02458287|466547566|FG002|Overall Study|Protocol Violation|0|||
129615629|NCT02458287|466547567|FG003|Overall Study|Protocol Violation|0|||
129615630|NCT02458287|466547564|FG000|Overall Study|Withdrawal by Subject|0|||
129615631|NCT02458287|466547565|FG001|Overall Study|Withdrawal by Subject|2|||
129615632|NCT02458287|466547566|FG002|Overall Study|Withdrawal by Subject|2|||
129700711|NCT02471144|466865900|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129887118|NCT01809210|467547261|FG003|Overall Study|Death|0|||
129887119|NCT01809210|467547262|FG004|Overall Study|Death|1|||
129615633|NCT02458287|466547567|FG003|Overall Study|Withdrawal by Subject|1|||
129615634|NCT02458287|466547564|FG000|Overall Study|Relocated Out of State|0|||
129700712|NCT02471144|466865901|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129700713|NCT02471144|466865902|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129887120|NCT01809210|467547263|FG005|Overall Study|Death|3|||
129887121|NCT01809210|467547264|FG006|Overall Study|Death|1|||
129887122|NCT00590980|467547265|FG000|Overall Study|Did not meet all inclusion criteria|10|||
129887123|NCT03699124|467547269|FG000|Overall Study|Adverse Event|6|||
129887124|NCT03699124|467547270|FG001|Overall Study|Adverse Event|5|||
129887125|NCT03699124|467547271|FG002|Overall Study|Adverse Event|2|||
129887126|NCT03699124|467547269|FG000|Overall Study|Death|0|||
129887127|NCT03699124|467547270|FG001|Overall Study|Death|2|||
129887128|NCT03699124|467547271|FG002|Overall Study|Death|0|||
129887129|NCT03699124|467547269|FG000|Overall Study|Lost to Follow-up|20|||
129887130|NCT03699124|467547270|FG001|Overall Study|Lost to Follow-up|16|||
129887131|NCT03699124|467547271|FG002|Overall Study|Lost to Follow-up|15|||
129887132|NCT03699124|467547269|FG000|Overall Study|Protocol Violation|1|||
129887133|NCT03699124|467547270|FG001|Overall Study|Protocol Violation|0|||
129887134|NCT03699124|467547271|FG002|Overall Study|Protocol Violation|0|||
129887135|NCT03699124|467547269|FG000|Overall Study|Withdrawal by Subject|13|||
129887136|NCT03699124|467547270|FG001|Overall Study|Withdrawal by Subject|14|||
129887137|NCT03699124|467547271|FG002|Overall Study|Withdrawal by Subject|13|||
129887138|NCT03699124|467547269|FG000|Overall Study|Other reasons|5|||
129887139|NCT03699124|467547270|FG001|Overall Study|Other reasons|3|||
129887140|NCT03699124|467547271|FG002|Overall Study|Other reasons|10|||
129887141|NCT01474512|467547272|FG000|Induction Period|Adverse Event|6|||
129887142|NCT01474512|467547273|FG001|Induction Period|Adverse Event|10|||
129887143|NCT01474512|467547274|FG002|Induction Period|Adverse Event|10|||
129887144|NCT01474512|467547275|FG003|Induction Period|Adverse Event|0|||
129887145|NCT01474512|467547276|FG004|Induction Period|Adverse Event|0|||
129887146|NCT01474512|467547277|FG005|Induction Period|Adverse Event|0|||
129887147|NCT01474512|467547278|FG006|Induction Period|Adverse Event|0|||
129887148|NCT01474512|467547279|FG007|Induction Period|Adverse Event|0|||
129887149|NCT01474512|467547280|FG008|Induction Period|Adverse Event|0|||
129887150|NCT01474512|467547281|FG009|Induction Period|Adverse Event|0|||
129887151|NCT01474512|467547282|FG010|Induction Period|Adverse Event|0|||
129439221|NCT00081770|465906394|FG000|Overall Study|Lack of Efficacy|262|||
129439222|NCT00081770|465906395|FG001|Overall Study|Lack of Efficacy|357|||
129439223|NCT00081770|465906396|FG002|Overall Study|Lack of Efficacy|211|||
129615635|NCT02458287|466547565|FG001|Overall Study|Relocated Out of State|0|||
129615636|NCT02458287|466547566|FG002|Overall Study|Relocated Out of State|0|||
129615637|NCT02458287|466547567|FG003|Overall Study|Relocated Out of State|1|||
129615638|NCT02613182|466547568|FG000|Overall Study|Death|6|||
129615639|NCT02613182|466547568|FG000|Overall Study|Physician Decision|1|||
129615640|NCT02613182|466547568|FG000|Overall Study|Study Terminated by Sponsor|21|||
129615641|NCT02613182|466547568|FG000|Overall Study|Withdrawal by Subject|6|||
129615642|NCT03968978|466547569|FG000|Overall Study|Adverse Event|1|||
129615643|NCT03968978|466547570|FG001|Overall Study|Adverse Event|0|||
129615644|NCT00908310|466547574|FG000|Overall Study|Death|37|||
129615645|NCT00908310|466547574|FG000|Overall Study|Withdrawal by Subject|7|||
129615646|NCT00908310|466547574|FG000|Overall Study|Lost to Follow-up|7|||
129615647|NCT00908310|466547574|FG000|Overall Study|Screening failure|5|||
129615648|NCT00908310|466547574|FG000|Overall Study|Other reasons|4|||
129615649|NCT04614246|466547577|FG000|Overall Study|Adverse Event|0|||
129615650|NCT04614246|466547578|FG001|Overall Study|Adverse Event|1|||
129615651|NCT04614246|466547579|FG002|Overall Study|Adverse Event|1|||
129615652|NCT04614246|466547580|FG003|Overall Study|Adverse Event|2|||
129615653|NCT04614246|466547581|FG004|Overall Study|Adverse Event|1|||
129615654|NCT04614246|466547577|FG000|Overall Study|Lost to Follow-up|0|||
129615655|NCT04614246|466547578|FG001|Overall Study|Lost to Follow-up|1|||
129615656|NCT04614246|466547579|FG002|Overall Study|Lost to Follow-up|0|||
129700714|NCT02471144|466865903|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129700715|NCT02471144|466865904|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129700716|NCT02471144|466865905|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
129700717|NCT02471144|466865906|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
129700718|NCT02471144|466865907|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
129700719|NCT02471144|466865897|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700720|NCT02471144|466865898|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700721|NCT02471144|466865899|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700722|NCT02471144|466865900|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700723|NCT02471144|466865901|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700724|NCT02471144|466865902|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700725|NCT02471144|466865903|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129887152|NCT01474512|467547283|FG011|Induction Period|Adverse Event|0|||
129887153|NCT01474512|467547284|FG012|Induction Period|Adverse Event|0|||
129615657|NCT04614246|466547580|FG003|Overall Study|Lost to Follow-up|1|||
129887154|NCT01474512|467547285|FG013|Induction Period|Adverse Event|0|||
129887155|NCT01474512|467547286|FG014|Induction Period|Adverse Event|0|||
129887156|NCT01474512|467547287|FG015|Induction Period|Adverse Event|0|||
129615658|NCT04614246|466547581|FG004|Overall Study|Lost to Follow-up|3|||
129887157|NCT01474512|467547288|FG016|Induction Period|Adverse Event|0|||
129615659|NCT04614246|466547577|FG000|Overall Study|Other reason|0|||
129615660|NCT04614246|466547578|FG001|Overall Study|Other reason|1|||
129615661|NCT04614246|466547579|FG002|Overall Study|Other reason|2|||
129887158|NCT01474512|467547289|FG017|Induction Period|Adverse Event|0|||
129791257|NCT05463198|467202787|FG000|Overall Study|Withdrawal by Subject|19|||
129791258|NCT05463198|467202787|FG000|Overall Study|Procedure Notes Missing|18|||
129791259|NCT01860846|467202788|FG000|Overall Study|Lost to Follow-up|33|||
129791260|NCT02239120|467202791|FG000|Overall Study|Death|56|||
129791261|NCT02239120|467202792|FG001|Overall Study|Death|58|||
129791262|NCT02239120|467202791|FG000|Overall Study|Lost to Follow-up|19|||
129791263|NCT02239120|467202792|FG001|Overall Study|Lost to Follow-up|14|||
129791264|NCT00466687|467202793|FG000|Overall Study|Adverse Event|1|||
129791265|NCT00466687|467202793|FG000|Overall Study|Other complicating illness|3|||
129791266|NCT00466687|467202793|FG000|Overall Study|Withdrawal by Subject|1|||
129791267|NCT00466687|467202793|FG000|Overall Study|Disease progression|29|||
129791268|NCT01925989|467202794|FG000|Period 1|Sponsor Decision|1|||
129791269|NCT01925989|467202795|FG001|Period 1|Sponsor Decision|1|||
129791270|NCT01925989|467202796|FG002|Period 1|Sponsor Decision|0|||
129791271|NCT01925989|467202794|FG000|Period 1|Withdrawal by Subject|0|||
129791272|NCT01925989|467202795|FG001|Period 1|Withdrawal by Subject|1|||
129791273|NCT01925989|467202796|FG002|Period 1|Withdrawal by Subject|0|||
129791274|NCT00868517|467202801|FG000|Overall Study|Withdrawal by Subject|3|||
129791275|NCT00868517|467202802|FG001|Overall Study|Withdrawal by Subject|3|||
129791276|NCT00868517|467202803|FG002|Overall Study|Withdrawal by Subject|2|||
129791277|NCT00868517|467202801|FG000|Overall Study|Protocol Violation|1|||
129791278|NCT00868517|467202802|FG001|Overall Study|Protocol Violation|1|||
129791279|NCT00868517|467202803|FG002|Overall Study|Protocol Violation|0|||
129791280|NCT00420641|467202807|FG000|Overall Study|Adverse Event|3|||
129791281|NCT00420641|467202808|FG001|Overall Study|Adverse Event|25|||
129791282|NCT00420641|467202809|FG002|Overall Study|Adverse Event|10|||
129615662|NCT04614246|466547580|FG003|Overall Study|Other reason|0|||
129615663|NCT04614246|466547581|FG004|Overall Study|Other reason|0|||
129615664|NCT04614246|466547577|FG000|Overall Study|Withdrawal by Subject|4|||
129615665|NCT04614246|466547578|FG001|Overall Study|Withdrawal by Subject|2|||
129615666|NCT04614246|466547579|FG002|Overall Study|Withdrawal by Subject|4|||
129615667|NCT04614246|466547580|FG003|Overall Study|Withdrawal by Subject|3|||
129615668|NCT04614246|466547581|FG004|Overall Study|Withdrawal by Subject|4|||
129615669|NCT04614246|466547577|FG000|Overall Study|Physician Decision|0|||
129615670|NCT04614246|466547578|FG001|Overall Study|Physician Decision|2|||
129615671|NCT04614246|466547579|FG002|Overall Study|Physician Decision|1|||
129615672|NCT04614246|466547580|FG003|Overall Study|Physician Decision|0|||
129615673|NCT04614246|466547581|FG004|Overall Study|Physician Decision|0|||
129615674|NCT04614246|466547577|FG000|Overall Study|Study terminated by sponsor|10|||
129615675|NCT04614246|466547578|FG001|Overall Study|Study terminated by sponsor|15|||
129615676|NCT04614246|466547579|FG002|Overall Study|Study terminated by sponsor|12|||
129615677|NCT04614246|466547580|FG003|Overall Study|Study terminated by sponsor|13|||
129615678|NCT04614246|466547581|FG004|Overall Study|Study terminated by sponsor|9|||
129615679|NCT04614246|466547577|FG000|Overall Study|Pregnancy|2|||
129615680|NCT04614246|466547578|FG001|Overall Study|Pregnancy|0|||
129615681|NCT04614246|466547579|FG002|Overall Study|Pregnancy|1|||
129615682|NCT04614246|466547580|FG003|Overall Study|Pregnancy|0|||
129615683|NCT04614246|466547581|FG004|Overall Study|Pregnancy|0|||
129615684|NCT01680497|466547582|FG000|Overall Study|Lost to Follow-up|2|||
129615685|NCT00725205|466547583|FG000|Overall Study|Adverse Event|22|||
129615686|NCT00725205|466547583|FG000|Overall Study|Investigator Discontinued|1|||
129615687|NCT00725205|466547583|FG000|Overall Study|Non-compliance With Protocol|14|||
129615688|NCT00725205|466547583|FG000|Overall Study|Other|8|||
129615689|NCT00725205|466547583|FG000|Overall Study|Protocol Defined Clinical Event|1|||
129615690|NCT00725205|466547583|FG000|Overall Study|Treatment Failure|41|||
129615691|NCT01200069|466549620|FG000|Overall Study|Withdrawal by Subject|0|||
129615692|NCT01200069|466549621|FG001|Overall Study|Withdrawal by Subject|1|||
129615693|NCT03408639|466549622|FG000|Overall Study|Death|5|||
129615694|NCT03408639|466549623|FG001|Overall Study|Death|5|||
129615695|NCT03408639|466549622|FG000|Overall Study|Lost to Follow-up|1|||
129615696|NCT03408639|466549623|FG001|Overall Study|Lost to Follow-up|4|||
129615697|NCT03408639|466549622|FG000|Overall Study|Withdrawal by Subject|2|||
129615698|NCT03408639|466549623|FG001|Overall Study|Withdrawal by Subject|7|||
129615699|NCT03408639|466549622|FG000|Overall Study|Physician Decision|3|||
129615700|NCT03408639|466549623|FG001|Overall Study|Physician Decision|6|||
129615701|NCT04998851|466549624|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
129615702|NCT04998851|466549625|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
129615703|NCT04998851|466549624|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
129615704|NCT04998851|466549625|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
129615705|NCT00070499|466549626|FG000|Overall Study|Adverse Event|6|||
129615706|NCT00070499|466549627|FG001|Overall Study|Adverse Event|6|||
129791283|NCT00420641|467202807|FG000|Overall Study|Lost to Follow-up|2|||
129791284|NCT00420641|467202808|FG001|Overall Study|Lost to Follow-up|4|||
129791285|NCT00420641|467202809|FG002|Overall Study|Lost to Follow-up|2|||
129791286|NCT00420641|467202807|FG000|Overall Study|Protocol Violation|8|||
129791287|NCT00420641|467202808|FG001|Overall Study|Protocol Violation|8|||
129791288|NCT00420641|467202809|FG002|Overall Study|Protocol Violation|7|||
129791289|NCT00420641|467202807|FG000|Overall Study|Withdrawal by Subject|15|||
129791290|NCT00420641|467202808|FG001|Overall Study|Withdrawal by Subject|21|||
129615707|NCT00070499|466549628|FG002|Overall Study|Adverse Event|19|||
129615708|NCT00070499|466549629|FG003|Overall Study|Adverse Event|15|||
129615709|NCT00070499|466549626|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
129615710|NCT00070499|466549627|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
129615711|NCT00070499|466549628|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
129615712|NCT00070499|466549629|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
129615713|NCT00070499|466549626|FG000|Overall Study|Progression/relapse|4|||
129615714|NCT00070499|466549627|FG001|Overall Study|Progression/relapse|2|||
129615715|NCT00070499|466549628|FG002|Overall Study|Progression/relapse|1|||
129615716|NCT00070499|466549629|FG003|Overall Study|Progression/relapse|4|||
129615717|NCT00070499|466549626|FG000|Overall Study|Death|1|||
129615718|NCT00070499|466549627|FG001|Overall Study|Death|1|||
129615719|NCT00070499|466549628|FG002|Overall Study|Death|1|||
129615720|NCT00070499|466549629|FG003|Overall Study|Death|2|||
129615721|NCT00070499|466549626|FG000|Overall Study|Other - not protocol specified|7|||
129615722|NCT00070499|466549627|FG001|Overall Study|Other - not protocol specified|3|||
129615723|NCT00070499|466549628|FG002|Overall Study|Other - not protocol specified|12|||
129615724|NCT00070499|466549629|FG003|Overall Study|Other - not protocol specified|20|||
129615725|NCT00070499|466549626|FG000|Overall Study|Still on protocol treatment|10|||
129615726|NCT00070499|466549627|FG001|Overall Study|Still on protocol treatment|4|||
129615727|NCT00070499|466549628|FG002|Overall Study|Still on protocol treatment|79|||
129615728|NCT00070499|466549629|FG003|Overall Study|Still on protocol treatment|57|||
129615729|NCT00070499|466549626|FG000|Overall Study|Did not start treatment|1|||
129615730|NCT00070499|466549627|FG001|Overall Study|Did not start treatment|0|||
129615731|NCT00070499|466549628|FG002|Overall Study|Did not start treatment|0|||
129615732|NCT00070499|466549629|FG003|Overall Study|Did not start treatment|2|||
129615733|NCT00070499|466549626|FG000|Overall Study|Not eligible|2|||
129615734|NCT00070499|466549627|FG001|Overall Study|Not eligible|5|||
129615735|NCT00070499|466549628|FG002|Overall Study|Not eligible|3|||
129615736|NCT00070499|466549629|FG003|Overall Study|Not eligible|2|||
129615737|NCT02883049|466549630|FG000|Induction|Adverse Event|52|||
129615738|NCT02883049|466549631|FG001|Induction|Adverse Event|2|||
129615739|NCT02883049|466549632|FG002|Induction|Adverse Event|0|||
129615740|NCT02883049|466549633|FG003|Induction|Adverse Event|0|||
129615741|NCT02883049|466549634|FG004|Induction|Adverse Event|0|||
129615742|NCT02883049|466549635|FG005|Induction|Adverse Event|0|||
129615743|NCT02883049|466549636|FG006|Induction|Adverse Event|0|||
129615744|NCT02883049|466549637|FG007|Induction|Adverse Event|0|||
129615745|NCT02883049|466549638|FG008|Induction|Adverse Event|0|||
129615746|NCT02883049|466549639|FG009|Induction|Adverse Event|0|||
129615747|NCT02883049|466549640|FG010|Induction|Adverse Event|0|||
129615748|NCT02883049|466549641|FG011|Induction|Adverse Event|0|||
129615749|NCT02883049|466549642|FG012|Induction|Adverse Event|0|||
129615750|NCT02883049|466549643|FG013|Induction|Adverse Event|0|||
129615751|NCT02883049|466549644|FG014|Induction|Adverse Event|0|||
129615752|NCT02883049|466549645|FG015|Induction|Adverse Event|0|||
129615753|NCT02883049|466549630|FG000|Induction|Death|76|||
129615754|NCT02883049|466549631|FG001|Induction|Death|8|||
129615755|NCT02883049|466549632|FG002|Induction|Death|0|||
129615756|NCT02883049|466549633|FG003|Induction|Death|0|||
129615757|NCT02883049|466549634|FG004|Induction|Death|0|||
129615758|NCT02883049|466549635|FG005|Induction|Death|0|||
129615759|NCT02883049|466549636|FG006|Induction|Death|0|||
129615760|NCT02883049|466549637|FG007|Induction|Death|0|||
129615761|NCT02883049|466549638|FG008|Induction|Death|0|||
129615762|NCT02883049|466549639|FG009|Induction|Death|0|||
129615763|NCT02883049|466549640|FG010|Induction|Death|0|||
129615764|NCT02883049|466549641|FG011|Induction|Death|0|||
129615765|NCT02883049|466549642|FG012|Induction|Death|0|||
129615766|NCT02883049|466549643|FG013|Induction|Death|0|||
129615767|NCT02883049|466549644|FG014|Induction|Death|0|||
129615768|NCT02883049|466549645|FG015|Induction|Death|0|||
129615769|NCT02883049|466549630|FG000|Induction|Lost to Follow-up|2|||
129615770|NCT02883049|466549631|FG001|Induction|Lost to Follow-up|0|||
129615771|NCT02883049|466549632|FG002|Induction|Lost to Follow-up|0|||
129615772|NCT02883049|466549633|FG003|Induction|Lost to Follow-up|0|||
129615773|NCT02883049|466549634|FG004|Induction|Lost to Follow-up|0|||
129615774|NCT02883049|466549635|FG005|Induction|Lost to Follow-up|0|||
129615775|NCT02883049|466549636|FG006|Induction|Lost to Follow-up|0|||
129615776|NCT02883049|466549637|FG007|Induction|Lost to Follow-up|0|||
129615777|NCT02883049|466549638|FG008|Induction|Lost to Follow-up|0|||
129615778|NCT02883049|466549639|FG009|Induction|Lost to Follow-up|0|||
129615779|NCT02883049|466549640|FG010|Induction|Lost to Follow-up|0|||
129615780|NCT02883049|466549641|FG011|Induction|Lost to Follow-up|0|||
129615781|NCT02883049|466549642|FG012|Induction|Lost to Follow-up|0|||
129615782|NCT02883049|466549643|FG013|Induction|Lost to Follow-up|0|||
129615783|NCT02883049|466549644|FG014|Induction|Lost to Follow-up|0|||
129615784|NCT02883049|466549645|FG015|Induction|Lost to Follow-up|0|||
129615785|NCT02883049|466549630|FG000|Induction|Physician Decision|1407|||
129615786|NCT02883049|466549631|FG001|Induction|Physician Decision|8|||
129615787|NCT02883049|466549632|FG002|Induction|Physician Decision|0|||
129615788|NCT02883049|466549633|FG003|Induction|Physician Decision|0|||
129615789|NCT02883049|466549634|FG004|Induction|Physician Decision|0|||
129887159|NCT01474512|467547272|FG000|Induction Period|Lack of Efficacy|7|||
129887160|NCT01474512|467547273|FG001|Induction Period|Lack of Efficacy|1|||
129887161|NCT01474512|467547274|FG002|Induction Period|Lack of Efficacy|0|||
129887162|NCT01474512|467547275|FG003|Induction Period|Lack of Efficacy|0|||
129887163|NCT01474512|467547276|FG004|Induction Period|Lack of Efficacy|0|||
129887164|NCT01474512|467547277|FG005|Induction Period|Lack of Efficacy|0|||
129887165|NCT01474512|467547278|FG006|Induction Period|Lack of Efficacy|0|||
129887166|NCT01474512|467547279|FG007|Induction Period|Lack of Efficacy|0|||
129887167|NCT01474512|467547280|FG008|Induction Period|Lack of Efficacy|0|||
129887168|NCT01474512|467547281|FG009|Induction Period|Lack of Efficacy|0|||
129887169|NCT01474512|467547282|FG010|Induction Period|Lack of Efficacy|0|||
129887170|NCT01474512|467547283|FG011|Induction Period|Lack of Efficacy|0|||
129887171|NCT01474512|467547284|FG012|Induction Period|Lack of Efficacy|0|||
129887172|NCT01474512|467547285|FG013|Induction Period|Lack of Efficacy|0|||
129887173|NCT01474512|467547286|FG014|Induction Period|Lack of Efficacy|0|||
129887174|NCT01474512|467547287|FG015|Induction Period|Lack of Efficacy|0|||
129887175|NCT01474512|467547288|FG016|Induction Period|Lack of Efficacy|0|||
129887176|NCT01474512|467547289|FG017|Induction Period|Lack of Efficacy|0|||
129887177|NCT01474512|467547272|FG000|Induction Period|Withdrawal by Subject|6|||
129887178|NCT01474512|467547273|FG001|Induction Period|Withdrawal by Subject|6|||
129887179|NCT01474512|467547274|FG002|Induction Period|Withdrawal by Subject|5|||
129887180|NCT01474512|467547275|FG003|Induction Period|Withdrawal by Subject|0|||
129887181|NCT01474512|467547276|FG004|Induction Period|Withdrawal by Subject|0|||
129887182|NCT01474512|467547277|FG005|Induction Period|Withdrawal by Subject|0|||
129887183|NCT01474512|467547278|FG006|Induction Period|Withdrawal by Subject|0|||
129887184|NCT01474512|467547279|FG007|Induction Period|Withdrawal by Subject|0|||
129887185|NCT01474512|467547280|FG008|Induction Period|Withdrawal by Subject|0|||
129615790|NCT02883049|466549635|FG005|Induction|Physician Decision|0|||
129615791|NCT02883049|466549636|FG006|Induction|Physician Decision|0|||
129615792|NCT02883049|466549637|FG007|Induction|Physician Decision|0|||
129615793|NCT02883049|466549638|FG008|Induction|Physician Decision|0|||
129615794|NCT02883049|466549639|FG009|Induction|Physician Decision|0|||
129615795|NCT02883049|466549640|FG010|Induction|Physician Decision|0|||
129615796|NCT02883049|466549641|FG011|Induction|Physician Decision|0|||
129615797|NCT02883049|466549642|FG012|Induction|Physician Decision|0|||
129615798|NCT02883049|466549643|FG013|Induction|Physician Decision|0|||
129615799|NCT02883049|466549644|FG014|Induction|Physician Decision|0|||
129615800|NCT02883049|466549645|FG015|Induction|Physician Decision|0|||
129615801|NCT02883049|466549630|FG000|Induction|Protocol Violation|6|||
129615802|NCT02883049|466549631|FG001|Induction|Protocol Violation|0|||
129615803|NCT02883049|466549632|FG002|Induction|Protocol Violation|0|||
129615804|NCT02883049|466549633|FG003|Induction|Protocol Violation|0|||
129615805|NCT02883049|466549634|FG004|Induction|Protocol Violation|0|||
129615806|NCT02883049|466549635|FG005|Induction|Protocol Violation|0|||
129615807|NCT02883049|466549636|FG006|Induction|Protocol Violation|0|||
129615808|NCT02883049|466549637|FG007|Induction|Protocol Violation|0|||
129615809|NCT02883049|466549638|FG008|Induction|Protocol Violation|0|||
129615810|NCT02883049|466549639|FG009|Induction|Protocol Violation|0|||
129615811|NCT02883049|466549640|FG010|Induction|Protocol Violation|0|||
129615812|NCT02883049|466549641|FG011|Induction|Protocol Violation|0|||
129615813|NCT02883049|466549642|FG012|Induction|Protocol Violation|0|||
129615814|NCT02883049|466549643|FG013|Induction|Protocol Violation|0|||
129615815|NCT02883049|466549644|FG014|Induction|Protocol Violation|0|||
129615816|NCT02883049|466549645|FG015|Induction|Protocol Violation|0|||
129615817|NCT02883049|466549630|FG000|Induction|Withdrawal by Subject|6|||
129615818|NCT02883049|466549631|FG001|Induction|Withdrawal by Subject|0|||
129615819|NCT02883049|466549632|FG002|Induction|Withdrawal by Subject|0|||
129615820|NCT02883049|466549633|FG003|Induction|Withdrawal by Subject|0|||
129887186|NCT01474512|467547281|FG009|Induction Period|Withdrawal by Subject|0|||
129887187|NCT01474512|467547282|FG010|Induction Period|Withdrawal by Subject|0|||
129887188|NCT01474512|467547283|FG011|Induction Period|Withdrawal by Subject|0|||
129887189|NCT01474512|467547284|FG012|Induction Period|Withdrawal by Subject|0|||
129887190|NCT01474512|467547285|FG013|Induction Period|Withdrawal by Subject|0|||
129887191|NCT01474512|467547286|FG014|Induction Period|Withdrawal by Subject|0|||
129615821|NCT02883049|466549634|FG004|Induction|Withdrawal by Subject|0|||
129887192|NCT01474512|467547287|FG015|Induction Period|Withdrawal by Subject|0|||
129887193|NCT01474512|467547288|FG016|Induction Period|Withdrawal by Subject|0|||
129887194|NCT01474512|467547289|FG017|Induction Period|Withdrawal by Subject|0|||
129887195|NCT01474512|467547272|FG000|Induction Period|Protocol Violation|3|||
129615822|NCT02883049|466549635|FG005|Induction|Withdrawal by Subject|0|||
129615823|NCT02883049|466549636|FG006|Induction|Withdrawal by Subject|0|||
129615824|NCT02883049|466549637|FG007|Induction|Withdrawal by Subject|0|||
129615825|NCT02883049|466549638|FG008|Induction|Withdrawal by Subject|0|||
129615826|NCT02883049|466549639|FG009|Induction|Withdrawal by Subject|0|||
129615827|NCT02883049|466549640|FG010|Induction|Withdrawal by Subject|0|||
129615828|NCT02883049|466549641|FG011|Induction|Withdrawal by Subject|0|||
129887196|NCT01474512|467547273|FG001|Induction Period|Protocol Violation|6|||
129887197|NCT01474512|467547274|FG002|Induction Period|Protocol Violation|0|||
129887198|NCT01474512|467547275|FG003|Induction Period|Protocol Violation|0|||
129791291|NCT00420641|467202809|FG002|Overall Study|Withdrawal by Subject|14|||
129791292|NCT00420641|467202807|FG000|Overall Study|Lack of Efficacy|6|||
129791293|NCT00420641|467202808|FG001|Overall Study|Lack of Efficacy|5|||
129791294|NCT00420641|467202809|FG002|Overall Study|Lack of Efficacy|4|||
129791295|NCT00420641|467202807|FG000|Overall Study|Non-compliance|7|||
129791296|NCT00420641|467202808|FG001|Overall Study|Non-compliance|5|||
129791297|NCT00420641|467202809|FG002|Overall Study|Non-compliance|4|||
129791298|NCT00420641|467202807|FG000|Overall Study|Other|4|||
129615829|NCT02883049|466549642|FG012|Induction|Withdrawal by Subject|0|||
129615830|NCT02883049|466549643|FG013|Induction|Withdrawal by Subject|0|||
129615831|NCT02883049|466549644|FG014|Induction|Withdrawal by Subject|0|||
129615832|NCT02883049|466549645|FG015|Induction|Withdrawal by Subject|0|||
129615833|NCT02883049|466549630|FG000|Induction|Ineligible|35|||
129615834|NCT02883049|466549631|FG001|Induction|Ineligible|1|||
129615835|NCT02883049|466549632|FG002|Induction|Ineligible|0|||
129615836|NCT02883049|466549633|FG003|Induction|Ineligible|0|||
129615837|NCT02883049|466549634|FG004|Induction|Ineligible|0|||
129615838|NCT02883049|466549635|FG005|Induction|Ineligible|0|||
129615839|NCT02883049|466549636|FG006|Induction|Ineligible|0|||
129615840|NCT02883049|466549637|FG007|Induction|Ineligible|0|||
129615841|NCT02883049|466549638|FG008|Induction|Ineligible|0|||
129615842|NCT02883049|466549639|FG009|Induction|Ineligible|0|||
129615843|NCT02883049|466549640|FG010|Induction|Ineligible|0|||
129615844|NCT02883049|466549641|FG011|Induction|Ineligible|0|||
129615845|NCT02883049|466549642|FG012|Induction|Ineligible|0|||
129615846|NCT02883049|466549643|FG013|Induction|Ineligible|0|||
129615847|NCT02883049|466549644|FG014|Induction|Ineligible|0|||
129615848|NCT02883049|466549645|FG015|Induction|Ineligible|0|||
129615849|NCT02883049|466549630|FG000|Induction|Refusal of further protocol therapy|466|||
129615850|NCT02883049|466549631|FG001|Induction|Refusal of further protocol therapy|2|||
129615851|NCT02883049|466549632|FG002|Induction|Refusal of further protocol therapy|0|||
129615852|NCT02883049|466549633|FG003|Induction|Refusal of further protocol therapy|0|||
129615853|NCT02883049|466549634|FG004|Induction|Refusal of further protocol therapy|0|||
129615854|NCT02883049|466549635|FG005|Induction|Refusal of further protocol therapy|0|||
129615855|NCT02883049|466549636|FG006|Induction|Refusal of further protocol therapy|0|||
129615856|NCT02883049|466549637|FG007|Induction|Refusal of further protocol therapy|0|||
129615857|NCT02883049|466549638|FG008|Induction|Refusal of further protocol therapy|0|||
129615858|NCT02883049|466549639|FG009|Induction|Refusal of further protocol therapy|0|||
129615859|NCT02883049|466549640|FG010|Induction|Refusal of further protocol therapy|0|||
129615860|NCT02883049|466549641|FG011|Induction|Refusal of further protocol therapy|0|||
129615861|NCT02883049|466549642|FG012|Induction|Refusal of further protocol therapy|0|||
129615862|NCT02883049|466549643|FG013|Induction|Refusal of further protocol therapy|0|||
129615863|NCT02883049|466549644|FG014|Induction|Refusal of further protocol therapy|0|||
129615864|NCT02883049|466549645|FG015|Induction|Refusal of further protocol therapy|0|||
129615865|NCT02883049|466549630|FG000|Induction|Identified as Ph+ patients|279|||
129615866|NCT02883049|466549631|FG001|Induction|Identified as Ph+ patients|1|||
129615867|NCT02883049|466549632|FG002|Induction|Identified as Ph+ patients|0|||
129615868|NCT02883049|466549633|FG003|Induction|Identified as Ph+ patients|0|||
129615869|NCT02883049|466549634|FG004|Induction|Identified as Ph+ patients|0|||
129615870|NCT02883049|466549635|FG005|Induction|Identified as Ph+ patients|0|||
129615871|NCT02883049|466549636|FG006|Induction|Identified as Ph+ patients|0|||
129615872|NCT02883049|466549637|FG007|Induction|Identified as Ph+ patients|0|||
129615873|NCT02883049|466549638|FG008|Induction|Identified as Ph+ patients|0|||
129615874|NCT02883049|466549639|FG009|Induction|Identified as Ph+ patients|0|||
129615875|NCT02883049|466549640|FG010|Induction|Identified as Ph+ patients|0|||
129615876|NCT02883049|466549641|FG011|Induction|Identified as Ph+ patients|0|||
129791299|NCT00420641|467202808|FG001|Overall Study|Other|4|||
129791300|NCT00420641|467202809|FG002|Overall Study|Other|3|||
129791301|NCT03459690|467202811|FG000|Overall Study|Lost to Follow-up|0|||
129615877|NCT02883049|466549642|FG012|Induction|Identified as Ph+ patients|0|||
129615878|NCT02883049|466549643|FG013|Induction|Identified as Ph+ patients|0|||
129791302|NCT03459690|467202812|FG001|Overall Study|Lost to Follow-up|1|||
129791303|NCT03459690|467202811|FG000|Overall Study|Withdrawal by Subject|1|||
129615879|NCT02883049|466549644|FG014|Induction|Identified as Ph+ patients|0|||
129615880|NCT02883049|466549645|FG015|Induction|Identified as Ph+ patients|0|||
129615881|NCT02883049|466549630|FG000|Induction|M3 Marrow at Day29|8|||
129615882|NCT02883049|466549631|FG001|Induction|M3 Marrow at Day29|1|||
129615883|NCT02883049|466549632|FG002|Induction|M3 Marrow at Day29|0|||
129615884|NCT02883049|466549633|FG003|Induction|M3 Marrow at Day29|0|||
129615885|NCT02883049|466549634|FG004|Induction|M3 Marrow at Day29|0|||
129615886|NCT02883049|466549635|FG005|Induction|M3 Marrow at Day29|0|||
129615887|NCT02883049|466549636|FG006|Induction|M3 Marrow at Day29|0|||
129615888|NCT02883049|466549637|FG007|Induction|M3 Marrow at Day29|0|||
129615889|NCT02883049|466549638|FG008|Induction|M3 Marrow at Day29|0|||
129615890|NCT02883049|466549639|FG009|Induction|M3 Marrow at Day29|0|||
129615891|NCT02883049|466549640|FG010|Induction|M3 Marrow at Day29|0|||
129615892|NCT02883049|466549641|FG011|Induction|M3 Marrow at Day29|0|||
129615893|NCT02883049|466549642|FG012|Induction|M3 Marrow at Day29|0|||
129615894|NCT02883049|466549643|FG013|Induction|M3 Marrow at Day29|0|||
129615895|NCT02883049|466549644|FG014|Induction|M3 Marrow at Day29|0|||
129615896|NCT02883049|466549645|FG015|Induction|M3 Marrow at Day29|0|||
129615897|NCT02883049|466549630|FG000|Induction|Inevaluable|33|||
129615898|NCT02883049|466549631|FG001|Induction|Inevaluable|1|||
129615899|NCT02883049|466549632|FG002|Induction|Inevaluable|0|||
129615900|NCT02883049|466549633|FG003|Induction|Inevaluable|0|||
129615901|NCT02883049|466549634|FG004|Induction|Inevaluable|0|||
129615902|NCT02883049|466549635|FG005|Induction|Inevaluable|0|||
129615903|NCT02883049|466549636|FG006|Induction|Inevaluable|0|||
129615904|NCT02883049|466549637|FG007|Induction|Inevaluable|0|||
129615905|NCT02883049|466549638|FG008|Induction|Inevaluable|0|||
129615906|NCT02883049|466549639|FG009|Induction|Inevaluable|0|||
129615907|NCT02883049|466549640|FG010|Induction|Inevaluable|0|||
129615908|NCT02883049|466549641|FG011|Induction|Inevaluable|0|||
129615909|NCT02883049|466549642|FG012|Induction|Inevaluable|0|||
129791304|NCT03459690|467202812|FG001|Overall Study|Withdrawal by Subject|1|||
129791305|NCT02815280|467202813|FG000|Double-Blind Phase|Adverse Event|1|||
129791306|NCT02815280|467202814|FG001|Double-Blind Phase|Adverse Event|1|||
129791307|NCT02815280|467202813|FG000|Double-Blind Phase|Lost to Follow-up|10|||
129791308|NCT02815280|467202814|FG001|Double-Blind Phase|Lost to Follow-up|9|||
129791309|NCT02815280|467202813|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
129791310|NCT02815280|467202814|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
129791311|NCT02815280|467202813|FG000|Double-Blind Phase|Protocol Violation|2|||
129791312|NCT02815280|467202814|FG001|Double-Blind Phase|Protocol Violation|2|||
129791313|NCT02815280|467202813|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
129791314|NCT02815280|467202814|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
129791315|NCT02815280|467202813|FG000|Open-Label Phase|Adverse Event|2|||
129791316|NCT02815280|467202814|FG001|Open-Label Phase|Adverse Event|3|||
129791317|NCT02815280|467202813|FG000|Open-Label Phase|Lost to Follow-up|18|||
129791318|NCT02815280|467202814|FG001|Open-Label Phase|Lost to Follow-up|9|||
129791319|NCT02815280|467202813|FG000|Open-Label Phase|Withdrawal by Subject|33|||
129791320|NCT02815280|467202814|FG001|Open-Label Phase|Withdrawal by Subject|18|||
129791321|NCT02815280|467202813|FG000|Open-Label Phase|Protocol Violation|3|||
129791322|NCT02815280|467202814|FG001|Open-Label Phase|Protocol Violation|0|||
129791323|NCT02815280|467202813|FG000|Open-Label Phase|Administrative|26|||
129791324|NCT02815280|467202814|FG001|Open-Label Phase|Administrative|12|||
129791325|NCT02815280|467202813|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
129791326|NCT02815280|467202814|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
129791327|NCT02514473|467202829|FG000|Overall Study|Adverse Event|0|||
129791328|NCT02514473|467202830|FG001|Overall Study|Adverse Event|2|||
129791329|NCT02514473|467202829|FG000|Overall Study|Withdrawal by Subject|2|||
129791330|NCT02514473|467202830|FG001|Overall Study|Withdrawal by Subject|1|||
129791331|NCT02514473|467202829|FG000|Overall Study|Lost to Follow-up|0|||
129791332|NCT02514473|467202830|FG001|Overall Study|Lost to Follow-up|1|||
129791333|NCT02514473|467202829|FG000|Overall Study|Other|1|||
129791334|NCT02514473|467202830|FG001|Overall Study|Other|1|||
129791335|NCT02158364|467202831|FG000|Overall Study|Case report forms uncollected|10|||
129791336|NCT02158364|467202831|FG000|Overall Study|Protocol Deviation|50|||
129615910|NCT02883049|466549643|FG013|Induction|Inevaluable|0|||
129615911|NCT02883049|466549644|FG014|Induction|Inevaluable|0|||
129615912|NCT02883049|466549645|FG015|Induction|Inevaluable|0|||
129791337|NCT01944839|467202832|FG000|Overall Study|Physician Decision|2|||
129791338|NCT01944839|467202833|FG001|Overall Study|Physician Decision|2|||
129791339|NCT01944839|467202832|FG000|Overall Study|Protocol Violation|0|||
129615913|NCT02883049|466549630|FG000|Induction|Identified as VHR at end of Induction|244|||
129615914|NCT02883049|466549631|FG001|Induction|Identified as VHR at end of Induction|0|||
129615915|NCT02883049|466549632|FG002|Induction|Identified as VHR at end of Induction|0|||
129615916|NCT02883049|466549633|FG003|Induction|Identified as VHR at end of Induction|0|||
129615917|NCT02883049|466549634|FG004|Induction|Identified as VHR at end of Induction|0|||
129615918|NCT02883049|466549635|FG005|Induction|Identified as VHR at end of Induction|0|||
129615919|NCT02883049|466549636|FG006|Induction|Identified as VHR at end of Induction|0|||
129615920|NCT02883049|466549637|FG007|Induction|Identified as VHR at end of Induction|0|||
129615921|NCT02883049|466549638|FG008|Induction|Identified as VHR at end of Induction|0|||
129615922|NCT02883049|466549639|FG009|Induction|Identified as VHR at end of Induction|0|||
129615923|NCT02883049|466549640|FG010|Induction|Identified as VHR at end of Induction|0|||
129615924|NCT02883049|466549641|FG011|Induction|Identified as VHR at end of Induction|0|||
129615925|NCT02883049|466549642|FG012|Induction|Identified as VHR at end of Induction|0|||
129615926|NCT02883049|466549643|FG013|Induction|Identified as VHR at end of Induction|0|||
129615927|NCT02883049|466549644|FG014|Induction|Identified as VHR at end of Induction|0|||
129615928|NCT02883049|466549645|FG015|Induction|Identified as VHR at end of Induction|0|||
129615929|NCT02883049|466549630|FG000|Induction|Moved to another non-COG institution|3|||
129615930|NCT02883049|466549631|FG001|Induction|Moved to another non-COG institution|0|||
129615931|NCT02883049|466549632|FG002|Induction|Moved to another non-COG institution|0|||
129615932|NCT02883049|466549633|FG003|Induction|Moved to another non-COG institution|0|||
129615933|NCT02883049|466549634|FG004|Induction|Moved to another non-COG institution|0|||
129615934|NCT02883049|466549635|FG005|Induction|Moved to another non-COG institution|0|||
129615935|NCT02883049|466549636|FG006|Induction|Moved to another non-COG institution|0|||
129615936|NCT02883049|466549637|FG007|Induction|Moved to another non-COG institution|0|||
129615937|NCT02883049|466549638|FG008|Induction|Moved to another non-COG institution|0|||
129615938|NCT02883049|466549639|FG009|Induction|Moved to another non-COG institution|0|||
129615939|NCT02883049|466549640|FG010|Induction|Moved to another non-COG institution|0|||
129615940|NCT02883049|466549641|FG011|Induction|Moved to another non-COG institution|0|||
129615941|NCT02883049|466549642|FG012|Induction|Moved to another non-COG institution|0|||
129615942|NCT02883049|466549643|FG013|Induction|Moved to another non-COG institution|0|||
129615943|NCT02883049|466549644|FG014|Induction|Moved to another non-COG institution|0|||
129615944|NCT02883049|466549645|FG015|Induction|Moved to another non-COG institution|0|||
129615945|NCT02883049|466549630|FG000|Induction|Randomization closed|41|||
129615946|NCT02883049|466549631|FG001|Induction|Randomization closed|0|||
129615947|NCT02883049|466549632|FG002|Induction|Randomization closed|0|||
129615948|NCT02883049|466549633|FG003|Induction|Randomization closed|0|||
129615949|NCT02883049|466549634|FG004|Induction|Randomization closed|0|||
129615950|NCT02883049|466549635|FG005|Induction|Randomization closed|0|||
129791340|NCT01944839|467202833|FG001|Overall Study|Protocol Violation|1|||
129439224|NCT00081770|465906394|FG000|Overall Study|Lost to Follow-up|45|||
129615951|NCT02883049|466549636|FG006|Induction|Randomization closed|0|||
129615952|NCT02883049|466549637|FG007|Induction|Randomization closed|0|||
129615953|NCT02883049|466549638|FG008|Induction|Randomization closed|0|||
129791341|NCT01944839|467202832|FG000|Overall Study|Adverse Event|10|||
129791342|NCT01944839|467202833|FG001|Overall Study|Adverse Event|5|||
129791343|NCT01944839|467202832|FG000|Overall Study|Withdrawal by Subject|9|||
129791344|NCT01944839|467202833|FG001|Overall Study|Withdrawal by Subject|17|||
129791345|NCT01944839|467202832|FG000|Overall Study|Lost to Follow-up|1|||
129791346|NCT01944839|467202833|FG001|Overall Study|Lost to Follow-up|0|||
129791347|NCT01944839|467202832|FG000|Overall Study|Subject non-compliance|0|||
129791348|NCT01944839|467202833|FG001|Overall Study|Subject non-compliance|3|||
129791349|NCT02217527|467202834|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
129791350|NCT02217527|467202835|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
129791351|NCT02217527|467202834|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
129791352|NCT02217527|467202835|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
129791353|NCT01878149|467202836|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
129791354|NCT01878149|467202837|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
129791355|NCT00502203|467202845|FG000|Overall Study|Inevaluable|1|||
129791356|NCT02241889|467202848|FG000|Overall Study|device issues|0|||
129791357|NCT02241889|467202849|FG001|Overall Study|device issues|0|||
129791358|NCT02241889|467202850|FG002|Overall Study|device issues|1|||
129791359|NCT02241889|467202851|FG003|Overall Study|device issues|0|||
129791360|NCT02241889|467202852|FG004|Overall Study|device issues|0|||
129791361|NCT02241889|467202853|FG005|Overall Study|device issues|0|||
129791362|NCT02241889|467202848|FG000|Overall Study|Withdrawal by Subject|0|||
129791363|NCT02241889|467202849|FG001|Overall Study|Withdrawal by Subject|0|||
129791364|NCT02241889|467202850|FG002|Overall Study|Withdrawal by Subject|0|||
129791365|NCT02241889|467202851|FG003|Overall Study|Withdrawal by Subject|0|||
129791366|NCT02241889|467202852|FG004|Overall Study|Withdrawal by Subject|0|||
129791367|NCT02241889|467202853|FG005|Overall Study|Withdrawal by Subject|1|||
129791368|NCT03836001|467202854|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
129791369|NCT03836001|467202855|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
129791370|NCT03836001|467202856|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
129791371|NCT03836001|467202854|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
129791372|NCT03836001|467202855|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
129791373|NCT03836001|467202856|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
129791374|NCT03836001|467202854|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
129791375|NCT03836001|467202855|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
129791376|NCT03836001|467202856|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
129887199|NCT01474512|467547276|FG004|Induction Period|Protocol Violation|0|||
129887200|NCT01474512|467547277|FG005|Induction Period|Protocol Violation|0|||
129887201|NCT01474512|467547278|FG006|Induction Period|Protocol Violation|0|||
129887202|NCT01474512|467547279|FG007|Induction Period|Protocol Violation|0|||
129887203|NCT01474512|467547280|FG008|Induction Period|Protocol Violation|0|||
129887204|NCT01474512|467547281|FG009|Induction Period|Protocol Violation|0|||
129887205|NCT01474512|467547282|FG010|Induction Period|Protocol Violation|0|||
129887206|NCT01474512|467547283|FG011|Induction Period|Protocol Violation|0|||
129887207|NCT01474512|467547284|FG012|Induction Period|Protocol Violation|0|||
129887208|NCT01474512|467547285|FG013|Induction Period|Protocol Violation|0|||
129615954|NCT02883049|466549639|FG009|Induction|Randomization closed|0|||
129615955|NCT02883049|466549640|FG010|Induction|Randomization closed|0|||
129615956|NCT02883049|466549641|FG011|Induction|Randomization closed|0|||
129615957|NCT02883049|466549642|FG012|Induction|Randomization closed|0|||
129615958|NCT02883049|466549643|FG013|Induction|Randomization closed|0|||
129615959|NCT02883049|466549644|FG014|Induction|Randomization closed|0|||
129615960|NCT02883049|466549645|FG015|Induction|Randomization closed|0|||
129615961|NCT02883049|466549630|FG000|Induction|MRD negative|36|||
129615962|NCT02883049|466549631|FG001|Induction|MRD negative|0|||
129615963|NCT02883049|466549632|FG002|Induction|MRD negative|0|||
129615964|NCT02883049|466549633|FG003|Induction|MRD negative|0|||
129615965|NCT02883049|466549634|FG004|Induction|MRD negative|0|||
129615966|NCT02883049|466549635|FG005|Induction|MRD negative|0|||
129615967|NCT02883049|466549636|FG006|Induction|MRD negative|0|||
129615968|NCT02883049|466549637|FG007|Induction|MRD negative|0|||
129615969|NCT02883049|466549638|FG008|Induction|MRD negative|0|||
129615970|NCT02883049|466549639|FG009|Induction|MRD negative|0|||
129615971|NCT02883049|466549640|FG010|Induction|MRD negative|0|||
129615972|NCT02883049|466549641|FG011|Induction|MRD negative|0|||
129615973|NCT02883049|466549642|FG012|Induction|MRD negative|0|||
129615974|NCT02883049|466549643|FG013|Induction|MRD negative|0|||
129615975|NCT02883049|466549644|FG014|Induction|MRD negative|0|||
129615976|NCT02883049|466549645|FG015|Induction|MRD negative|0|||
129615977|NCT02883049|466549630|FG000|Induction|Identified as HR patients|165|||
129615978|NCT02883049|466549631|FG001|Induction|Identified as HR patients|0|||
129615979|NCT02883049|466549632|FG002|Induction|Identified as HR patients|0|||
129615980|NCT02883049|466549633|FG003|Induction|Identified as HR patients|0|||
129615981|NCT02883049|466549634|FG004|Induction|Identified as HR patients|0|||
129615982|NCT02883049|466549635|FG005|Induction|Identified as HR patients|0|||
129615983|NCT02883049|466549636|FG006|Induction|Identified as HR patients|0|||
129615984|NCT02883049|466549637|FG007|Induction|Identified as HR patients|0|||
129615985|NCT02883049|466549638|FG008|Induction|Identified as HR patients|0|||
129615986|NCT02883049|466549639|FG009|Induction|Identified as HR patients|0|||
129615987|NCT02883049|466549640|FG010|Induction|Identified as HR patients|0|||
129615988|NCT02883049|466549641|FG011|Induction|Identified as HR patients|0|||
129615989|NCT02883049|466549642|FG012|Induction|Identified as HR patients|0|||
129615990|NCT02883049|466549643|FG013|Induction|Identified as HR patients|0|||
129615991|NCT02883049|466549644|FG014|Induction|Identified as HR patients|0|||
129615992|NCT02883049|466549645|FG015|Induction|Identified as HR patients|0|||
129615993|NCT02883049|466549630|FG000|Induction|Developed SMN|0|||
129615994|NCT02883049|466549631|FG001|Induction|Developed SMN|1|||
129615995|NCT02883049|466549632|FG002|Induction|Developed SMN|0|||
129615996|NCT02883049|466549633|FG003|Induction|Developed SMN|0|||
129615997|NCT02883049|466549634|FG004|Induction|Developed SMN|0|||
129615998|NCT02883049|466549635|FG005|Induction|Developed SMN|0|||
129615999|NCT02883049|466549636|FG006|Induction|Developed SMN|0|||
129616000|NCT02883049|466549637|FG007|Induction|Developed SMN|0|||
129616001|NCT02883049|466549638|FG008|Induction|Developed SMN|0|||
129616002|NCT02883049|466549639|FG009|Induction|Developed SMN|0|||
129616003|NCT02883049|466549640|FG010|Induction|Developed SMN|0|||
129616004|NCT02883049|466549641|FG011|Induction|Developed SMN|0|||
129616005|NCT02883049|466549642|FG012|Induction|Developed SMN|0|||
129616006|NCT02883049|466549643|FG013|Induction|Developed SMN|0|||
129616007|NCT02883049|466549644|FG014|Induction|Developed SMN|0|||
129616008|NCT02883049|466549645|FG015|Induction|Developed SMN|0|||
129616009|NCT02883049|466549630|FG000|Induction|Enrolled onto another COG study|72|||
129616010|NCT02883049|466549631|FG001|Induction|Enrolled onto another COG study|0|||
129616011|NCT02883049|466549632|FG002|Induction|Enrolled onto another COG study|0|||
129616012|NCT02883049|466549633|FG003|Induction|Enrolled onto another COG study|0|||
129616013|NCT02883049|466549634|FG004|Induction|Enrolled onto another COG study|0|||
129616014|NCT02883049|466549635|FG005|Induction|Enrolled onto another COG study|0|||
129616015|NCT02883049|466549636|FG006|Induction|Enrolled onto another COG study|0|||
129887209|NCT01474512|467547286|FG014|Induction Period|Protocol Violation|0|||
129887210|NCT01474512|467547287|FG015|Induction Period|Protocol Violation|0|||
129700726|NCT02471144|466865904|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700727|NCT02471144|466865905|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129887211|NCT01474512|467547288|FG016|Induction Period|Protocol Violation|0|||
129700728|NCT02471144|466865906|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
129700729|NCT02471144|466865907|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
129700730|NCT02471144|466865897|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700731|NCT02471144|466865898|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700732|NCT02471144|466865899|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700733|NCT02471144|466865900|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700734|NCT02471144|466865901|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129439225|NCT00081770|465906395|FG001|Overall Study|Lost to Follow-up|34|||
129439226|NCT00081770|465906396|FG002|Overall Study|Lost to Follow-up|45|||
129439227|NCT00081770|465906394|FG000|Overall Study|Protocol Violation|15|||
129439228|NCT00081770|465906395|FG001|Overall Study|Protocol Violation|10|||
129439229|NCT00081770|465906396|FG002|Overall Study|Protocol Violation|10|||
129439230|NCT00081770|465906394|FG000|Overall Study|Withdrawal by Subject|45|||
129439231|NCT00081770|465906395|FG001|Overall Study|Withdrawal by Subject|40|||
129439232|NCT00081770|465906396|FG002|Overall Study|Withdrawal by Subject|42|||
129439233|NCT00081770|465906394|FG000|Overall Study|Did not meet protocol eligibility|2|||
129700735|NCT02471144|466865902|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700736|NCT02471144|466865903|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700737|NCT02471144|466865904|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700738|NCT02471144|466865905|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
129700739|NCT02471144|466865906|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
129700740|NCT02471144|466865907|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
129700741|NCT00003645|466865908|FG000|Overall Study|Death|4|||
129700742|NCT00003645|466865909|FG001|Overall Study|Death|1|||
129700743|NCT00003645|466865908|FG000|Overall Study|Lost to Follow-up|7|||
129700744|NCT00003645|466865909|FG001|Overall Study|Lost to Follow-up|8|||
129700745|NCT00003645|466865908|FG000|Overall Study|Withdrawal by Subject|1|||
129700746|NCT00003645|466865909|FG001|Overall Study|Withdrawal by Subject|3|||
129700747|NCT03768336|466865912|FG000|Overall Study|Lost to Follow-up|3|||
129700748|NCT03768336|466865913|FG001|Overall Study|Lost to Follow-up|2|||
129700749|NCT03768336|466865912|FG000|Overall Study|Became Ineligible|2|||
129700750|NCT03768336|466865913|FG001|Overall Study|Became Ineligible|0|||
129700751|NCT03768336|466865912|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
129700752|NCT03768336|466865913|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
129700753|NCT03768336|466865912|FG000|Overall Study|Missed final survey (post-treatment|0|||
129700754|NCT03768336|466865913|FG001|Overall Study|Missed final survey (post-treatment|1|||
129700755|NCT03977155|466865914|FG000|Overall Study|Adverse Event|3|||
129700756|NCT03977155|466865915|FG001|Overall Study|Adverse Event|0|||
129887212|NCT01474512|467547289|FG017|Induction Period|Protocol Violation|0|||
129887213|NCT01474512|467547272|FG000|Induction Period|Sponsor Decision|1|||
129887214|NCT01474512|467547273|FG001|Induction Period|Sponsor Decision|1|||
129887215|NCT01474512|467547274|FG002|Induction Period|Sponsor Decision|1|||
129887216|NCT01474512|467547275|FG003|Induction Period|Sponsor Decision|0|||
129887217|NCT01474512|467547276|FG004|Induction Period|Sponsor Decision|0|||
129887218|NCT01474512|467547277|FG005|Induction Period|Sponsor Decision|0|||
129887219|NCT01474512|467547278|FG006|Induction Period|Sponsor Decision|0|||
129887220|NCT01474512|467547279|FG007|Induction Period|Sponsor Decision|0|||
129887221|NCT01474512|467547280|FG008|Induction Period|Sponsor Decision|0|||
129887222|NCT01474512|467547281|FG009|Induction Period|Sponsor Decision|0|||
129887223|NCT01474512|467547282|FG010|Induction Period|Sponsor Decision|0|||
129887224|NCT01474512|467547283|FG011|Induction Period|Sponsor Decision|0|||
129887225|NCT01474512|467547284|FG012|Induction Period|Sponsor Decision|0|||
129887226|NCT01474512|467547285|FG013|Induction Period|Sponsor Decision|0|||
129887227|NCT01474512|467547286|FG014|Induction Period|Sponsor Decision|0|||
129700757|NCT03977155|466865916|FG002|Overall Study|Adverse Event|0|||
129887228|NCT01474512|467547287|FG015|Induction Period|Sponsor Decision|0|||
129887229|NCT01474512|467547288|FG016|Induction Period|Sponsor Decision|0|||
129887230|NCT01474512|467547289|FG017|Induction Period|Sponsor Decision|0|||
129887231|NCT01474512|467547272|FG000|Induction Period|Lost to Follow-up|1|||
129887232|NCT01474512|467547273|FG001|Induction Period|Lost to Follow-up|0|||
129887233|NCT01474512|467547274|FG002|Induction Period|Lost to Follow-up|2|||
129887234|NCT01474512|467547275|FG003|Induction Period|Lost to Follow-up|0|||
129887235|NCT01474512|467547276|FG004|Induction Period|Lost to Follow-up|0|||
129439234|NCT00081770|465906395|FG001|Overall Study|Did not meet protocol eligibility|0|||
129439235|NCT00081770|465906396|FG002|Overall Study|Did not meet protocol eligibility|3|||
129700758|NCT03977155|466865914|FG000|Overall Study|Lost to Follow-up|0|||
129700759|NCT03977155|466865915|FG001|Overall Study|Lost to Follow-up|1|||
129700760|NCT03977155|466865916|FG002|Overall Study|Lost to Follow-up|0|||
129887236|NCT01474512|467547277|FG005|Induction Period|Lost to Follow-up|0|||
129887237|NCT01474512|467547278|FG006|Induction Period|Lost to Follow-up|0|||
129887238|NCT01474512|467547279|FG007|Induction Period|Lost to Follow-up|0|||
129616016|NCT02883049|466549637|FG007|Induction|Enrolled onto another COG study|0|||
129616017|NCT02883049|466549638|FG008|Induction|Enrolled onto another COG study|0|||
129616018|NCT02883049|466549639|FG009|Induction|Enrolled onto another COG study|0|||
129616019|NCT02883049|466549640|FG010|Induction|Enrolled onto another COG study|0|||
129616020|NCT02883049|466549641|FG011|Induction|Enrolled onto another COG study|0|||
129616021|NCT02883049|466549642|FG012|Induction|Enrolled onto another COG study|0|||
129616022|NCT02883049|466549643|FG013|Induction|Enrolled onto another COG study|0|||
129616023|NCT02883049|466549644|FG014|Induction|Enrolled onto another COG study|0|||
129616024|NCT02883049|466549645|FG015|Induction|Enrolled onto another COG study|0|||
129616025|NCT02883049|466549630|FG000|Induction|Incomplete induction data|17|||
129616026|NCT02883049|466549631|FG001|Induction|Incomplete induction data|0|||
129616027|NCT02883049|466549632|FG002|Induction|Incomplete induction data|0|||
129616028|NCT02883049|466549633|FG003|Induction|Incomplete induction data|0|||
129616029|NCT02883049|466549634|FG004|Induction|Incomplete induction data|0|||
129616030|NCT02883049|466549635|FG005|Induction|Incomplete induction data|0|||
129616031|NCT02883049|466549636|FG006|Induction|Incomplete induction data|0|||
129616032|NCT02883049|466549637|FG007|Induction|Incomplete induction data|0|||
129616033|NCT02883049|466549638|FG008|Induction|Incomplete induction data|0|||
129616034|NCT02883049|466549639|FG009|Induction|Incomplete induction data|0|||
129700761|NCT03977155|466865914|FG000|Overall Study|Withdrawal by Subject|1|||
129700762|NCT03977155|466865915|FG001|Overall Study|Withdrawal by Subject|1|||
129700763|NCT03977155|466865916|FG002|Overall Study|Withdrawal by Subject|2|||
129700764|NCT03977155|466865914|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
129700765|NCT03977155|466865915|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
129700766|NCT03977155|466865916|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
129700767|NCT03502681|466865919|FG000|Overall Study|Adverse Event|1|||
129700768|NCT03502681|466865920|FG001|Overall Study|Adverse Event|1|||
129700769|NCT03502681|466865919|FG000|Overall Study|Disease Progression|2|||
129700770|NCT03502681|466865920|FG001|Overall Study|Disease Progression|1|||
129700771|NCT01444781|466865921|FG000|Overall Study|Lost to Follow-up|0|||
129700772|NCT01444781|466865922|FG001|Overall Study|Lost to Follow-up|3|||
129700773|NCT01444781|466865923|FG002|Overall Study|Lost to Follow-up|1|||
129700774|NCT01444781|466865921|FG000|Overall Study|Withdrawal by Subject|3|||
129700775|NCT01444781|466865922|FG001|Overall Study|Withdrawal by Subject|1|||
129700776|NCT01444781|466865923|FG002|Overall Study|Withdrawal by Subject|2|||
129700777|NCT06790303|466865924|FG000|Overall Study|Study Terminated by sponsor|4|||
129700778|NCT06790303|466865924|FG000|Overall Study|Death|4|||
129700779|NCT00321932|466865930|FG000|Overall Study|Death|3|||
129700780|NCT00321932|466865931|FG001|Overall Study|Death|6|||
129700781|NCT00321932|466865930|FG000|Overall Study|Withdrawal by Subject|3|||
129700782|NCT00321932|466865931|FG001|Overall Study|Withdrawal by Subject|6|||
129700783|NCT00321932|466865930|FG000|Overall Study|Early relapse|2|||
129700784|NCT00321932|466865931|FG001|Overall Study|Early relapse|8|||
129700785|NCT00321932|466865930|FG000|Overall Study|Missing data|2|||
129700786|NCT00321932|466865931|FG001|Overall Study|Missing data|1|||
129700787|NCT03360344|466865934|FG000|Overall Study|Withdrawal by Subject|0|||
129700788|NCT03360344|466865935|FG001|Overall Study|Withdrawal by Subject|1|||
129700789|NCT03360344|466865936|FG002|Overall Study|Withdrawal by Subject|1|||
129700790|NCT03257657|466865941|FG000|Overall Study|Lost to Follow-up|0|||
129700791|NCT03257657|466865942|FG001|Overall Study|Lost to Follow-up|3|||
129700792|NCT03257657|466865941|FG000|Overall Study|Withdrawn|0|||
129700793|NCT03257657|466865942|FG001|Overall Study|Withdrawn|1|||
129700794|NCT03257657|466865941|FG000|Overall Study|Noted not eligible right after enrolled|0|||
129700795|NCT03257657|466865942|FG001|Overall Study|Noted not eligible right after enrolled|1|||
129700796|NCT01905540|466865957|FG000|Period 3|Other|1|||
129700797|NCT01905540|466865958|FG001|Period 3|Other|0|||
129700798|NCT01905540|466865959|FG002|Period 3|Other|1|||
129700799|NCT01905540|466865960|FG003|Period 3|Other|1|||
129700800|NCT02367885|466865961|FG000|Overall Study|Lost to Follow-up|1|||
129700801|NCT02367885|466865962|FG001|Overall Study|Lost to Follow-up|0|||
129700802|NCT02367885|466865963|FG002|Overall Study|Lost to Follow-up|0|||
129700803|NCT02367885|466865961|FG000|Overall Study|Withdrawal by Subject|1|||
129700804|NCT02367885|466865962|FG001|Overall Study|Withdrawal by Subject|0|||
129700805|NCT02367885|466865963|FG002|Overall Study|Withdrawal by Subject|0|||
129700806|NCT01602484|466865964|FG000|Overall Study|Airway issues unrelated to study|0|||
129700807|NCT01602484|466865965|FG001|Overall Study|Airway issues unrelated to study|1|||
129700808|NCT02743962|466865968|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
129616035|NCT02883049|466549640|FG010|Induction|Incomplete induction data|0|||
129616036|NCT02883049|466549641|FG011|Induction|Incomplete induction data|0|||
129616037|NCT02883049|466549642|FG012|Induction|Incomplete induction data|0|||
129616038|NCT02883049|466549643|FG013|Induction|Incomplete induction data|0|||
129700809|NCT02743962|466865969|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
129700810|NCT02327169|466865971|FG000|Overall Study|Progressive Disease|1|||
129700811|NCT02327169|466865972|FG001|Overall Study|Progressive Disease|3|||
129700812|NCT02327169|466865973|FG002|Overall Study|Progressive Disease|4|||
129700813|NCT02327169|466865974|FG003|Overall Study|Progressive Disease|3|||
129700814|NCT02327169|466865975|FG004|Overall Study|Progressive Disease|4|||
129616039|NCT02883049|466549644|FG014|Induction|Incomplete induction data|0|||
129616040|NCT02883049|466549645|FG015|Induction|Incomplete induction data|0|||
129616041|NCT02883049|466549630|FG000|Post Induction|Adverse Event|0|||
129616042|NCT02883049|466549631|FG001|Post Induction|Adverse Event|0|||
129616043|NCT02883049|466549632|FG002|Post Induction|Adverse Event|0|||
129616044|NCT02883049|466549633|FG003|Post Induction|Adverse Event|7|||
129616045|NCT02883049|466549634|FG004|Post Induction|Adverse Event|8|||
129616046|NCT02883049|466549635|FG005|Post Induction|Adverse Event|3|||
129616047|NCT02883049|466549636|FG006|Post Induction|Adverse Event|4|||
129616048|NCT02883049|466549637|FG007|Post Induction|Adverse Event|5|||
129616049|NCT02883049|466549638|FG008|Post Induction|Adverse Event|6|||
129616050|NCT02883049|466549639|FG009|Post Induction|Adverse Event|7|||
129616051|NCT02883049|466549640|FG010|Post Induction|Adverse Event|2|||
129616052|NCT02883049|466549641|FG011|Post Induction|Adverse Event|2|||
129616053|NCT02883049|466549642|FG012|Post Induction|Adverse Event|0|||
129616054|NCT02883049|466549643|FG013|Post Induction|Adverse Event|0|||
129616055|NCT02883049|466549644|FG014|Post Induction|Adverse Event|5|||
129616056|NCT02883049|466549645|FG015|Post Induction|Adverse Event|2|||
129616057|NCT02883049|466549630|FG000|Post Induction|Death|0|||
129616058|NCT02883049|466549631|FG001|Post Induction|Death|0|||
129616059|NCT02883049|466549632|FG002|Post Induction|Death|0|||
129616060|NCT02883049|466549633|FG003|Post Induction|Death|9|||
129616061|NCT02883049|466549634|FG004|Post Induction|Death|9|||
129616062|NCT02883049|466549635|FG005|Post Induction|Death|0|||
129616063|NCT02883049|466549636|FG006|Post Induction|Death|1|||
129616064|NCT02883049|466549637|FG007|Post Induction|Death|6|||
129616065|NCT02883049|466549638|FG008|Post Induction|Death|5|||
129616066|NCT02883049|466549639|FG009|Post Induction|Death|3|||
129616067|NCT02883049|466549640|FG010|Post Induction|Death|1|||
129616068|NCT02883049|466549641|FG011|Post Induction|Death|0|||
129616069|NCT02883049|466549642|FG012|Post Induction|Death|1|||
129616070|NCT02883049|466549643|FG013|Post Induction|Death|1|||
129616071|NCT02883049|466549644|FG014|Post Induction|Death|10|||
129616072|NCT02883049|466549645|FG015|Post Induction|Death|2|||
129616073|NCT02883049|466549630|FG000|Post Induction|Lost to Follow-up|0|||
129616074|NCT02883049|466549631|FG001|Post Induction|Lost to Follow-up|0|||
129616075|NCT02883049|466549632|FG002|Post Induction|Lost to Follow-up|0|||
129616076|NCT02883049|466549633|FG003|Post Induction|Lost to Follow-up|0|||
129616077|NCT02883049|466549634|FG004|Post Induction|Lost to Follow-up|1|||
129616078|NCT02883049|466549635|FG005|Post Induction|Lost to Follow-up|1|||
129616079|NCT02883049|466549636|FG006|Post Induction|Lost to Follow-up|0|||
129616080|NCT02883049|466549637|FG007|Post Induction|Lost to Follow-up|0|||
129616081|NCT02883049|466549638|FG008|Post Induction|Lost to Follow-up|3|||
129700815|NCT02327169|466865976|FG005|Overall Study|Progressive Disease|3|||
129791377|NCT03836001|467202854|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
129791378|NCT03836001|467202855|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
129791379|NCT03836001|467202856|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
129791380|NCT03353740|467202868|FG000|Overall Study|Images for these participants not viable|52|||
129791381|NCT01395784|467202869|FG000|Overall Study|Lost to Follow-up|7|||
129791382|NCT01395784|467202869|FG000|Overall Study|Withdrawal by Subject|3|||
129791383|NCT01395784|467202869|FG000|Overall Study|Physician Decision|5|||
129791384|NCT04268823|467202870|FG000|Overall Study|Adverse Event|1|||
129887239|NCT01474512|467547280|FG008|Induction Period|Lost to Follow-up|0|||
129887240|NCT01474512|467547281|FG009|Induction Period|Lost to Follow-up|0|||
129887241|NCT01474512|467547282|FG010|Induction Period|Lost to Follow-up|0|||
129616082|NCT02883049|466549639|FG009|Post Induction|Lost to Follow-up|0|||
129700816|NCT02327169|466865977|FG006|Overall Study|Progressive Disease|3|||
129700817|NCT02327169|466865978|FG007|Overall Study|Progressive Disease|3|||
129700818|NCT02327169|466865979|FG008|Overall Study|Progressive Disease|4|||
129700819|NCT02327169|466865980|FG009|Overall Study|Progressive Disease|4|||
129700820|NCT02327169|466865981|FG010|Overall Study|Progressive Disease|4|||
129700821|NCT02327169|466865982|FG011|Overall Study|Progressive Disease|3|||
129700822|NCT02327169|466865983|FG012|Overall Study|Progressive Disease|1|||
129616083|NCT02883049|466549640|FG010|Post Induction|Lost to Follow-up|1|||
129616084|NCT02883049|466549641|FG011|Post Induction|Lost to Follow-up|0|||
129616085|NCT02883049|466549642|FG012|Post Induction|Lost to Follow-up|0|||
129616086|NCT02883049|466549643|FG013|Post Induction|Lost to Follow-up|0|||
129616087|NCT02883049|466549644|FG014|Post Induction|Lost to Follow-up|0|||
129616088|NCT02883049|466549645|FG015|Post Induction|Lost to Follow-up|0|||
129616089|NCT02883049|466549630|FG000|Post Induction|Physician Decision|0|||
129616090|NCT02883049|466549631|FG001|Post Induction|Physician Decision|0|||
129616091|NCT02883049|466549632|FG002|Post Induction|Physician Decision|0|||
129616092|NCT02883049|466549633|FG003|Post Induction|Physician Decision|27|||
129616093|NCT02883049|466549634|FG004|Post Induction|Physician Decision|27|||
129616094|NCT02883049|466549635|FG005|Post Induction|Physician Decision|23|||
129700823|NCT02327169|466865984|FG013|Overall Study|Progressive Disease|3|||
129700824|NCT02327169|466865985|FG014|Overall Study|Progressive Disease|3|||
129616095|NCT02883049|466549636|FG006|Post Induction|Physician Decision|30|||
129700825|NCT02327169|466865971|FG000|Overall Study|Adverse Event|2|||
129700826|NCT02327169|466865972|FG001|Overall Study|Adverse Event|0|||
129700827|NCT02327169|466865973|FG002|Overall Study|Adverse Event|1|||
129700828|NCT02327169|466865974|FG003|Overall Study|Adverse Event|0|||
129700829|NCT02327169|466865975|FG004|Overall Study|Adverse Event|1|||
129700830|NCT02327169|466865976|FG005|Overall Study|Adverse Event|0|||
129700831|NCT02327169|466865977|FG006|Overall Study|Adverse Event|0|||
129700832|NCT02327169|466865978|FG007|Overall Study|Adverse Event|0|||
129700833|NCT02327169|466865979|FG008|Overall Study|Adverse Event|0|||
129700834|NCT02327169|466865980|FG009|Overall Study|Adverse Event|2|||
129700835|NCT02327169|466865981|FG010|Overall Study|Adverse Event|0|||
129700836|NCT02327169|466865982|FG011|Overall Study|Adverse Event|3|||
129700837|NCT02327169|466865983|FG012|Overall Study|Adverse Event|0|||
129700838|NCT02327169|466865984|FG013|Overall Study|Adverse Event|2|||
129700839|NCT02327169|466865985|FG014|Overall Study|Adverse Event|1|||
129700840|NCT02327169|466865971|FG000|Overall Study|Symptomatic Deterioration|0|||
129700841|NCT02327169|466865972|FG001|Overall Study|Symptomatic Deterioration|0|||
129700842|NCT02327169|466865973|FG002|Overall Study|Symptomatic Deterioration|1|||
129700843|NCT02327169|466865974|FG003|Overall Study|Symptomatic Deterioration|0|||
129700844|NCT02327169|466865975|FG004|Overall Study|Symptomatic Deterioration|1|||
129700845|NCT02327169|466865976|FG005|Overall Study|Symptomatic Deterioration|1|||
129700846|NCT02327169|466865977|FG006|Overall Study|Symptomatic Deterioration|0|||
129700847|NCT02327169|466865978|FG007|Overall Study|Symptomatic Deterioration|0|||
129700848|NCT02327169|466865979|FG008|Overall Study|Symptomatic Deterioration|2|||
129700849|NCT02327169|466865980|FG009|Overall Study|Symptomatic Deterioration|1|||
129700850|NCT02327169|466865981|FG010|Overall Study|Symptomatic Deterioration|0|||
129700851|NCT02327169|466865982|FG011|Overall Study|Symptomatic Deterioration|0|||
129700852|NCT02327169|466865983|FG012|Overall Study|Symptomatic Deterioration|0|||
129700853|NCT02327169|466865984|FG013|Overall Study|Symptomatic Deterioration|2|||
129700854|NCT02327169|466865985|FG014|Overall Study|Symptomatic Deterioration|1|||
129700855|NCT02327169|466865971|FG000|Overall Study|Reason Not Specified|0|||
129700856|NCT02327169|466865972|FG001|Overall Study|Reason Not Specified|0|||
129700857|NCT02327169|466865973|FG002|Overall Study|Reason Not Specified|1|||
129700858|NCT02327169|466865974|FG003|Overall Study|Reason Not Specified|0|||
129700859|NCT02327169|466865975|FG004|Overall Study|Reason Not Specified|0|||
129700860|NCT02327169|466865976|FG005|Overall Study|Reason Not Specified|0|||
129700861|NCT02327169|466865977|FG006|Overall Study|Reason Not Specified|0|||
129700862|NCT02327169|466865978|FG007|Overall Study|Reason Not Specified|0|||
129887242|NCT01474512|467547283|FG011|Induction Period|Lost to Follow-up|0|||
129887243|NCT01474512|467547284|FG012|Induction Period|Lost to Follow-up|0|||
129887244|NCT01474512|467547285|FG013|Induction Period|Lost to Follow-up|0|||
129887245|NCT01474512|467547286|FG014|Induction Period|Lost to Follow-up|0|||
129700863|NCT02327169|466865979|FG008|Overall Study|Reason Not Specified|0|||
129700864|NCT02327169|466865980|FG009|Overall Study|Reason Not Specified|1|||
129700865|NCT02327169|466865981|FG010|Overall Study|Reason Not Specified|2|||
129700866|NCT02327169|466865982|FG011|Overall Study|Reason Not Specified|1|||
129700867|NCT02327169|466865983|FG012|Overall Study|Reason Not Specified|0|||
129700868|NCT02327169|466865984|FG013|Overall Study|Reason Not Specified|0|||
129700869|NCT02327169|466865985|FG014|Overall Study|Reason Not Specified|2|||
129700870|NCT02327169|466865971|FG000|Overall Study|Withdrawal by Subject|1|||
129700871|NCT02327169|466865972|FG001|Overall Study|Withdrawal by Subject|0|||
129700872|NCT02327169|466865973|FG002|Overall Study|Withdrawal by Subject|0|||
129700873|NCT02327169|466865974|FG003|Overall Study|Withdrawal by Subject|0|||
129700874|NCT02327169|466865975|FG004|Overall Study|Withdrawal by Subject|1|||
129700875|NCT02327169|466865976|FG005|Overall Study|Withdrawal by Subject|0|||
129700876|NCT02327169|466865977|FG006|Overall Study|Withdrawal by Subject|0|||
129700877|NCT02327169|466865978|FG007|Overall Study|Withdrawal by Subject|1|||
129700878|NCT02327169|466865979|FG008|Overall Study|Withdrawal by Subject|0|||
129700879|NCT02327169|466865980|FG009|Overall Study|Withdrawal by Subject|0|||
129700880|NCT02327169|466865981|FG010|Overall Study|Withdrawal by Subject|0|||
129700881|NCT02327169|466865982|FG011|Overall Study|Withdrawal by Subject|0|||
129700882|NCT02327169|466865983|FG012|Overall Study|Withdrawal by Subject|0|||
129616096|NCT02883049|466549637|FG007|Post Induction|Physician Decision|56|||
129616097|NCT02883049|466549638|FG008|Post Induction|Physician Decision|85|||
129616098|NCT02883049|466549639|FG009|Post Induction|Physician Decision|12|||
129616099|NCT02883049|466549640|FG010|Post Induction|Physician Decision|5|||
129616100|NCT02883049|466549641|FG011|Post Induction|Physician Decision|14|||
129616101|NCT02883049|466549642|FG012|Post Induction|Physician Decision|1|||
129616102|NCT02883049|466549643|FG013|Post Induction|Physician Decision|11|||
129616103|NCT02883049|466549644|FG014|Post Induction|Physician Decision|19|||
129616104|NCT02883049|466549645|FG015|Post Induction|Physician Decision|5|||
129616105|NCT02883049|466549630|FG000|Post Induction|Protocol Violation|0|||
129616106|NCT02883049|466549631|FG001|Post Induction|Protocol Violation|0|||
129616107|NCT02883049|466549632|FG002|Post Induction|Protocol Violation|0|||
129616108|NCT02883049|466549633|FG003|Post Induction|Protocol Violation|0|||
129616109|NCT02883049|466549634|FG004|Post Induction|Protocol Violation|0|||
129616110|NCT02883049|466549635|FG005|Post Induction|Protocol Violation|0|||
129616111|NCT02883049|466549636|FG006|Post Induction|Protocol Violation|0|||
129616112|NCT02883049|466549637|FG007|Post Induction|Protocol Violation|1|||
129616113|NCT02883049|466549638|FG008|Post Induction|Protocol Violation|0|||
129616114|NCT02883049|466549639|FG009|Post Induction|Protocol Violation|0|||
129616115|NCT02883049|466549640|FG010|Post Induction|Protocol Violation|0|||
129616116|NCT02883049|466549641|FG011|Post Induction|Protocol Violation|0|||
129616117|NCT02883049|466549642|FG012|Post Induction|Protocol Violation|0|||
129616118|NCT02883049|466549643|FG013|Post Induction|Protocol Violation|0|||
129616119|NCT02883049|466549644|FG014|Post Induction|Protocol Violation|0|||
129616120|NCT02883049|466549645|FG015|Post Induction|Protocol Violation|0|||
129616121|NCT02883049|466549630|FG000|Post Induction|Withdrawal by Subject|0|||
129616122|NCT02883049|466549631|FG001|Post Induction|Withdrawal by Subject|0|||
129616123|NCT02883049|466549632|FG002|Post Induction|Withdrawal by Subject|0|||
129616124|NCT02883049|466549633|FG003|Post Induction|Withdrawal by Subject|5|||
129616125|NCT02883049|466549634|FG004|Post Induction|Withdrawal by Subject|2|||
129616126|NCT02883049|466549635|FG005|Post Induction|Withdrawal by Subject|1|||
129616127|NCT02883049|466549636|FG006|Post Induction|Withdrawal by Subject|0|||
129616128|NCT02883049|466549637|FG007|Post Induction|Withdrawal by Subject|0|||
129616129|NCT02883049|466549638|FG008|Post Induction|Withdrawal by Subject|2|||
129616130|NCT02883049|466549639|FG009|Post Induction|Withdrawal by Subject|0|||
129616131|NCT02883049|466549640|FG010|Post Induction|Withdrawal by Subject|1|||
129439236|NCT00081770|465906394|FG000|Overall Study|Administrative|1|||
129616132|NCT02883049|466549641|FG011|Post Induction|Withdrawal by Subject|1|||
129616133|NCT02883049|466549642|FG012|Post Induction|Withdrawal by Subject|0|||
129616134|NCT02883049|466549643|FG013|Post Induction|Withdrawal by Subject|0|||
129616135|NCT02883049|466549644|FG014|Post Induction|Withdrawal by Subject|1|||
129616136|NCT02883049|466549645|FG015|Post Induction|Withdrawal by Subject|0|||
129616137|NCT02883049|466549630|FG000|Post Induction|Ineligible|0|||
129616138|NCT02883049|466549631|FG001|Post Induction|Ineligible|0|||
129616139|NCT02883049|466549632|FG002|Post Induction|Ineligible|2|||
129616140|NCT02883049|466549633|FG003|Post Induction|Ineligible|0|||
129616141|NCT02883049|466549634|FG004|Post Induction|Ineligible|0|||
129616142|NCT02883049|466549635|FG005|Post Induction|Ineligible|0|||
129616143|NCT02883049|466549636|FG006|Post Induction|Ineligible|1|||
129616144|NCT02883049|466549637|FG007|Post Induction|Ineligible|0|||
129616145|NCT02883049|466549638|FG008|Post Induction|Ineligible|0|||
129616146|NCT02883049|466549639|FG009|Post Induction|Ineligible|0|||
129616147|NCT02883049|466549640|FG010|Post Induction|Ineligible|1|||
129616148|NCT02883049|466549641|FG011|Post Induction|Ineligible|0|||
129616149|NCT02883049|466549642|FG012|Post Induction|Ineligible|0|||
129616150|NCT02883049|466549643|FG013|Post Induction|Ineligible|0|||
129616151|NCT02883049|466549644|FG014|Post Induction|Ineligible|0|||
129616152|NCT02883049|466549645|FG015|Post Induction|Ineligible|1|||
129616153|NCT02883049|466549630|FG000|Post Induction|Refusal of further protocol therapy|0|||
129616154|NCT02883049|466549631|FG001|Post Induction|Refusal of further protocol therapy|0|||
129616155|NCT02883049|466549632|FG002|Post Induction|Refusal of further protocol therapy|0|||
129616156|NCT02883049|466549633|FG003|Post Induction|Refusal of further protocol therapy|11|||
129616157|NCT02883049|466549634|FG004|Post Induction|Refusal of further protocol therapy|15|||
129616158|NCT02883049|466549635|FG005|Post Induction|Refusal of further protocol therapy|9|||
129616159|NCT02883049|466549636|FG006|Post Induction|Refusal of further protocol therapy|13|||
129616160|NCT02883049|466549637|FG007|Post Induction|Refusal of further protocol therapy|5|||
129616161|NCT02883049|466549638|FG008|Post Induction|Refusal of further protocol therapy|21|||
129616162|NCT02883049|466549639|FG009|Post Induction|Refusal of further protocol therapy|7|||
129616163|NCT02883049|466549640|FG010|Post Induction|Refusal of further protocol therapy|0|||
129616164|NCT02883049|466549641|FG011|Post Induction|Refusal of further protocol therapy|7|||
129616165|NCT02883049|466549642|FG012|Post Induction|Refusal of further protocol therapy|3|||
129616166|NCT02883049|466549643|FG013|Post Induction|Refusal of further protocol therapy|0|||
129616167|NCT02883049|466549644|FG014|Post Induction|Refusal of further protocol therapy|4|||
129616168|NCT02883049|466549645|FG015|Post Induction|Refusal of further protocol therapy|1|||
129616169|NCT02883049|466549630|FG000|Post Induction|Inevaluable|0|||
129616170|NCT02883049|466549631|FG001|Post Induction|Inevaluable|0|||
129616171|NCT02883049|466549632|FG002|Post Induction|Inevaluable|0|||
129616172|NCT02883049|466549633|FG003|Post Induction|Inevaluable|1|||
129616173|NCT02883049|466549634|FG004|Post Induction|Inevaluable|1|||
129616174|NCT02883049|466549635|FG005|Post Induction|Inevaluable|2|||
129616175|NCT02883049|466549636|FG006|Post Induction|Inevaluable|7|||
129616176|NCT02883049|466549637|FG007|Post Induction|Inevaluable|6|||
129616177|NCT02883049|466549638|FG008|Post Induction|Inevaluable|4|||
129616178|NCT02883049|466549639|FG009|Post Induction|Inevaluable|4|||
129616179|NCT02883049|466549640|FG010|Post Induction|Inevaluable|1|||
129616180|NCT02883049|466549641|FG011|Post Induction|Inevaluable|1|||
129616181|NCT02883049|466549642|FG012|Post Induction|Inevaluable|2|||
129616182|NCT02883049|466549643|FG013|Post Induction|Inevaluable|0|||
129616183|NCT02883049|466549644|FG014|Post Induction|Inevaluable|0|||
129616184|NCT02883049|466549645|FG015|Post Induction|Inevaluable|1|||
129616185|NCT02883049|466549630|FG000|Post Induction|Moved to another non-COG institution|0|||
129700883|NCT02327169|466865984|FG013|Overall Study|Withdrawal by Subject|0|||
129700884|NCT02327169|466865985|FG014|Overall Study|Withdrawal by Subject|3|||
129700885|NCT02327169|466865971|FG000|Overall Study|Lost to Follow-up|0|||
129700886|NCT02327169|466865972|FG001|Overall Study|Lost to Follow-up|0|||
129700887|NCT02327169|466865973|FG002|Overall Study|Lost to Follow-up|0|||
129700888|NCT02327169|466865974|FG003|Overall Study|Lost to Follow-up|0|||
129700889|NCT02327169|466865975|FG004|Overall Study|Lost to Follow-up|1|||
129700890|NCT02327169|466865976|FG005|Overall Study|Lost to Follow-up|0|||
129700891|NCT02327169|466865977|FG006|Overall Study|Lost to Follow-up|0|||
129700892|NCT02327169|466865978|FG007|Overall Study|Lost to Follow-up|0|||
129700893|NCT02327169|466865979|FG008|Overall Study|Lost to Follow-up|0|||
129700894|NCT02327169|466865980|FG009|Overall Study|Lost to Follow-up|0|||
129700895|NCT02327169|466865981|FG010|Overall Study|Lost to Follow-up|0|||
129700896|NCT02327169|466865982|FG011|Overall Study|Lost to Follow-up|0|||
129700897|NCT02327169|466865983|FG012|Overall Study|Lost to Follow-up|0|||
129700898|NCT02327169|466865984|FG013|Overall Study|Lost to Follow-up|0|||
129700899|NCT02327169|466865985|FG014|Overall Study|Lost to Follow-up|0|||
129700900|NCT05473715|466865988|FG000|Overall Study|Trial terminate|2|||
129700901|NCT05473715|466865989|FG001|Overall Study|Trial terminate|1|||
129700902|NCT00427700|466865993|FG000|Overall Study|Lost to Follow-up|2|||
129700903|NCT00427700|466865994|FG001|Overall Study|Lost to Follow-up|5|||
129700904|NCT00427700|466865993|FG000|Overall Study|no induction of menses|1|||
129700905|NCT00427700|466865994|FG001|Overall Study|no induction of menses|4|||
129700906|NCT00427700|466865993|FG000|Overall Study|Pregnancy|0|||
129700907|NCT00427700|466865994|FG001|Overall Study|Pregnancy|2|||
129700908|NCT02014376|466865995|FG000|Overall Study|Adverse Event|1|||
129700909|NCT02014376|466865996|FG001|Overall Study|Adverse Event|1|||
129700910|NCT02014376|466865997|FG002|Overall Study|Adverse Event|0|||
129700911|NCT02014376|466865995|FG000|Overall Study|Lost to Follow-up|2|||
129700912|NCT02014376|466865996|FG001|Overall Study|Lost to Follow-up|0|||
129700913|NCT02014376|466865997|FG002|Overall Study|Lost to Follow-up|0|||
129700914|NCT01051661|466866000|FG000|Overall Study|Adverse Event|1|||
129700915|NCT01051661|466866001|FG001|Overall Study|Adverse Event|1|||
129700916|NCT01051661|466866002|FG002|Overall Study|Adverse Event|1|||
129700917|NCT01051661|466866003|FG003|Overall Study|Adverse Event|1|||
129700918|NCT01051661|466866004|FG004|Overall Study|Adverse Event|0|||
129700919|NCT01051661|466866005|FG005|Overall Study|Adverse Event|0|||
129700920|NCT01051661|466866000|FG000|Overall Study|Lost to Follow-up|13|||
129616186|NCT02883049|466549631|FG001|Post Induction|Moved to another non-COG institution|0|||
129616187|NCT02883049|466549632|FG002|Post Induction|Moved to another non-COG institution|0|||
129616188|NCT02883049|466549633|FG003|Post Induction|Moved to another non-COG institution|0|||
129616189|NCT02883049|466549634|FG004|Post Induction|Moved to another non-COG institution|0|||
129616190|NCT02883049|466549635|FG005|Post Induction|Moved to another non-COG institution|0|||
129616191|NCT02883049|466549636|FG006|Post Induction|Moved to another non-COG institution|0|||
129616192|NCT02883049|466549637|FG007|Post Induction|Moved to another non-COG institution|2|||
129616193|NCT02883049|466549638|FG008|Post Induction|Moved to another non-COG institution|2|||
129616194|NCT02883049|466549639|FG009|Post Induction|Moved to another non-COG institution|0|||
129616195|NCT02883049|466549640|FG010|Post Induction|Moved to another non-COG institution|0|||
129616196|NCT02883049|466549641|FG011|Post Induction|Moved to another non-COG institution|1|||
129616197|NCT02883049|466549642|FG012|Post Induction|Moved to another non-COG institution|0|||
129616198|NCT02883049|466549643|FG013|Post Induction|Moved to another non-COG institution|0|||
129616199|NCT02883049|466549644|FG014|Post Induction|Moved to another non-COG institution|0|||
129616200|NCT02883049|466549645|FG015|Post Induction|Moved to another non-COG institution|0|||
129616201|NCT02883049|466549630|FG000|Post Induction|Randomization closed|0|||
129616202|NCT02883049|466549631|FG001|Post Induction|Randomization closed|0|||
129616203|NCT02883049|466549632|FG002|Post Induction|Randomization closed|0|||
129616204|NCT02883049|466549633|FG003|Post Induction|Randomization closed|0|||
129616205|NCT02883049|466549634|FG004|Post Induction|Randomization closed|0|||
129616206|NCT02883049|466549635|FG005|Post Induction|Randomization closed|0|||
129616207|NCT02883049|466549636|FG006|Post Induction|Randomization closed|0|||
129616208|NCT02883049|466549637|FG007|Post Induction|Randomization closed|20|||
129616209|NCT02883049|466549638|FG008|Post Induction|Randomization closed|0|||
129616210|NCT02883049|466549639|FG009|Post Induction|Randomization closed|0|||
129616211|NCT02883049|466549640|FG010|Post Induction|Randomization closed|0|||
129616212|NCT02883049|466549641|FG011|Post Induction|Randomization closed|0|||
129616213|NCT02883049|466549642|FG012|Post Induction|Randomization closed|0|||
129616214|NCT02883049|466549643|FG013|Post Induction|Randomization closed|0|||
129616215|NCT02883049|466549644|FG014|Post Induction|Randomization closed|0|||
129616216|NCT02883049|466549645|FG015|Post Induction|Randomization closed|0|||
129616217|NCT02883049|466549630|FG000|Post Induction|MRD negative|0|||
129616218|NCT02883049|466549631|FG001|Post Induction|MRD negative|0|||
129616219|NCT02883049|466549632|FG002|Post Induction|MRD negative|0|||
129616220|NCT02883049|466549633|FG003|Post Induction|MRD negative|0|||
129616221|NCT02883049|466549634|FG004|Post Induction|MRD negative|0|||
129616222|NCT02883049|466549635|FG005|Post Induction|MRD negative|0|||
129616223|NCT02883049|466549636|FG006|Post Induction|MRD negative|0|||
129616224|NCT02883049|466549637|FG007|Post Induction|MRD negative|11|||
129616225|NCT02883049|466549638|FG008|Post Induction|MRD negative|0|||
129616226|NCT02883049|466549639|FG009|Post Induction|MRD negative|0|||
129616227|NCT02883049|466549640|FG010|Post Induction|MRD negative|0|||
129616228|NCT02883049|466549641|FG011|Post Induction|MRD negative|0|||
129616229|NCT02883049|466549642|FG012|Post Induction|MRD negative|0|||
129616230|NCT02883049|466549643|FG013|Post Induction|MRD negative|0|||
129616231|NCT02883049|466549644|FG014|Post Induction|MRD negative|0|||
129616232|NCT02883049|466549645|FG015|Post Induction|MRD negative|0|||
129791385|NCT04268823|467202871|FG001|Overall Study|Adverse Event|0|||
129791386|NCT04268823|467202870|FG000|Overall Study|Participant Decision|1|||
129791387|NCT04268823|467202871|FG001|Overall Study|Participant Decision|0|||
129791388|NCT03039621|467204386|FG000|Overall Study|Violation of inclusion criteria|3|||
129791389|NCT03039621|467204387|FG001|Overall Study|Violation of inclusion criteria|2|||
129791390|NCT03039621|467204386|FG000|Overall Study|Non-compliance with protocol requirement|4|||
129791391|NCT03039621|467204387|FG001|Overall Study|Non-compliance with protocol requirement|5|||
129791392|NCT03039621|467204386|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
129791393|NCT03039621|467204387|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
129791394|NCT03039621|467204386|FG000|Overall Study|Violation of non-inclusion criteria|1|||
129791395|NCT03039621|467204387|FG001|Overall Study|Violation of non-inclusion criteria|2|||
129791396|NCT02519855|467204391|FG000|Overall Study|Adverse Event|0|||
129791397|NCT02519855|467204392|FG001|Overall Study|Adverse Event|1|||
129791398|NCT02519855|467204391|FG000|Overall Study|Lost to Follow-up|3|||
129791399|NCT02519855|467204392|FG001|Overall Study|Lost to Follow-up|3|||
129791400|NCT00003830|467204406|FG000|Overall Study|No follow up data|3|||
129791401|NCT00003830|467204407|FG001|Overall Study|No follow up data|0|||
129791402|NCT00003830|467204406|FG000|Overall Study|Sentinel node positive patients|829|||
129791403|NCT00003830|467204407|FG001|Overall Study|Sentinel node positive patients|793|||
129791404|NCT03739242|467204411|FG000|Overall Study|Withdrawal by Subject|1|||
129791405|NCT03739242|467204412|FG001|Overall Study|Withdrawal by Subject|1|||
129791406|NCT03739242|467204411|FG000|Overall Study|Protocol Violation|0|||
129887246|NCT01474512|467547287|FG015|Induction Period|Lost to Follow-up|0|||
129439237|NCT00081770|465906395|FG001|Overall Study|Administrative|0|||
129791407|NCT03739242|467204412|FG001|Overall Study|Protocol Violation|1|||
129616233|NCT02883049|466549630|FG000|Post Induction|Developed SMN|0|||
129616234|NCT02883049|466549631|FG001|Post Induction|Developed SMN|0|||
129616235|NCT02883049|466549632|FG002|Post Induction|Developed SMN|0|||
129616236|NCT02883049|466549633|FG003|Post Induction|Developed SMN|0|||
129616237|NCT02883049|466549634|FG004|Post Induction|Developed SMN|1|||
129616238|NCT02883049|466549635|FG005|Post Induction|Developed SMN|0|||
129616239|NCT02883049|466549636|FG006|Post Induction|Developed SMN|1|||
129616240|NCT02883049|466549637|FG007|Post Induction|Developed SMN|0|||
129616241|NCT02883049|466549638|FG008|Post Induction|Developed SMN|0|||
129616242|NCT02883049|466549639|FG009|Post Induction|Developed SMN|0|||
129616243|NCT02883049|466549640|FG010|Post Induction|Developed SMN|1|||
129616244|NCT02883049|466549641|FG011|Post Induction|Developed SMN|1|||
129616245|NCT02883049|466549642|FG012|Post Induction|Developed SMN|0|||
129616246|NCT02883049|466549643|FG013|Post Induction|Developed SMN|0|||
129616247|NCT02883049|466549644|FG014|Post Induction|Developed SMN|1|||
129616248|NCT02883049|466549645|FG015|Post Induction|Developed SMN|0|||
129616249|NCT02883049|466549630|FG000|Post Induction|Enrolled onto another COG study|0|||
129616250|NCT02883049|466549631|FG001|Post Induction|Enrolled onto another COG study|0|||
129616251|NCT02883049|466549632|FG002|Post Induction|Enrolled onto another COG study|0|||
129616252|NCT02883049|466549633|FG003|Post Induction|Enrolled onto another COG study|1|||
129616253|NCT02883049|466549634|FG004|Post Induction|Enrolled onto another COG study|1|||
129616254|NCT02883049|466549635|FG005|Post Induction|Enrolled onto another COG study|0|||
129616255|NCT02883049|466549636|FG006|Post Induction|Enrolled onto another COG study|0|||
129616256|NCT02883049|466549637|FG007|Post Induction|Enrolled onto another COG study|4|||
129616257|NCT02883049|466549638|FG008|Post Induction|Enrolled onto another COG study|0|||
129616258|NCT02883049|466549639|FG009|Post Induction|Enrolled onto another COG study|0|||
129616259|NCT02883049|466549640|FG010|Post Induction|Enrolled onto another COG study|0|||
129616260|NCT02883049|466549641|FG011|Post Induction|Enrolled onto another COG study|2|||
129616261|NCT02883049|466549642|FG012|Post Induction|Enrolled onto another COG study|0|||
129616262|NCT02883049|466549643|FG013|Post Induction|Enrolled onto another COG study|1|||
129616263|NCT02883049|466549644|FG014|Post Induction|Enrolled onto another COG study|0|||
129616264|NCT02883049|466549645|FG015|Post Induction|Enrolled onto another COG study|0|||
129791408|NCT01992159|467204413|FG000|Overall Study|Withdrawal by Subject|4|||
129791409|NCT01992159|467204414|FG001|Overall Study|Withdrawal by Subject|7|||
129791410|NCT01992159|467204415|FG002|Overall Study|Withdrawal by Subject|0|||
129791411|NCT01992159|467204416|FG003|Overall Study|Withdrawal by Subject|3|||
129616265|NCT02883049|466549630|FG000|Post Induction|Recurrent leukemia|0|||
129616266|NCT02883049|466549631|FG001|Post Induction|Recurrent leukemia|0|||
129616267|NCT02883049|466549632|FG002|Post Induction|Recurrent leukemia|0|||
129616268|NCT02883049|466549633|FG003|Post Induction|Recurrent leukemia|17|||
129700921|NCT01051661|466866001|FG001|Overall Study|Lost to Follow-up|22|||
129700922|NCT01051661|466866002|FG002|Overall Study|Lost to Follow-up|15|||
129700923|NCT01051661|466866003|FG003|Overall Study|Lost to Follow-up|17|||
129700924|NCT01051661|466866004|FG004|Overall Study|Lost to Follow-up|10|||
129700925|NCT01051661|466866005|FG005|Overall Study|Lost to Follow-up|24|||
129700926|NCT01051661|466866000|FG000|Overall Study|Migrated/moved from study area|1|||
129700927|NCT01051661|466866001|FG001|Overall Study|Migrated/moved from study area|6|||
129700928|NCT01051661|466866002|FG002|Overall Study|Migrated/moved from study area|6|||
129700929|NCT01051661|466866003|FG003|Overall Study|Migrated/moved from study area|8|||
129700930|NCT01051661|466866004|FG004|Overall Study|Migrated/moved from study area|7|||
129700931|NCT01051661|466866005|FG005|Overall Study|Migrated/moved from study area|3|||
129700932|NCT01051661|466866000|FG000|Overall Study|Refused blood sampling|0|||
129700933|NCT01051661|466866001|FG001|Overall Study|Refused blood sampling|0|||
129700934|NCT01051661|466866002|FG002|Overall Study|Refused blood sampling|0|||
129616269|NCT02883049|466549634|FG004|Post Induction|Recurrent leukemia|12|||
129616270|NCT02883049|466549635|FG005|Post Induction|Recurrent leukemia|4|||
129616271|NCT02883049|466549636|FG006|Post Induction|Recurrent leukemia|1|||
129616272|NCT02883049|466549637|FG007|Post Induction|Recurrent leukemia|13|||
129616273|NCT02883049|466549638|FG008|Post Induction|Recurrent leukemia|27|||
129616274|NCT02883049|466549639|FG009|Post Induction|Recurrent leukemia|5|||
129616275|NCT02883049|466549640|FG010|Post Induction|Recurrent leukemia|3|||
129616276|NCT02883049|466549641|FG011|Post Induction|Recurrent leukemia|12|||
129616277|NCT02883049|466549642|FG012|Post Induction|Recurrent leukemia|1|||
129616278|NCT02883049|466549643|FG013|Post Induction|Recurrent leukemia|1|||
129616279|NCT02883049|466549644|FG014|Post Induction|Recurrent leukemia|9|||
129616280|NCT02883049|466549645|FG015|Post Induction|Recurrent leukemia|3|||
129616281|NCT02883049|466549630|FG000|Post Induction|Induction Failure|0|||
129616282|NCT02883049|466549631|FG001|Post Induction|Induction Failure|0|||
129616283|NCT02883049|466549632|FG002|Post Induction|Induction Failure|0|||
129616284|NCT02883049|466549633|FG003|Post Induction|Induction Failure|0|||
129616285|NCT02883049|466549634|FG004|Post Induction|Induction Failure|0|||
129616286|NCT02883049|466549635|FG005|Post Induction|Induction Failure|0|||
129616287|NCT02883049|466549636|FG006|Post Induction|Induction Failure|0|||
129616288|NCT02883049|466549637|FG007|Post Induction|Induction Failure|2|||
129616289|NCT02883049|466549638|FG008|Post Induction|Induction Failure|2|||
129616290|NCT02883049|466549639|FG009|Post Induction|Induction Failure|0|||
129616291|NCT02883049|466549640|FG010|Post Induction|Induction Failure|0|||
129616292|NCT02883049|466549641|FG011|Post Induction|Induction Failure|0|||
129616293|NCT02883049|466549642|FG012|Post Induction|Induction Failure|0|||
129616294|NCT02883049|466549643|FG013|Post Induction|Induction Failure|2|||
129616295|NCT02883049|466549644|FG014|Post Induction|Induction Failure|0|||
129616296|NCT02883049|466549645|FG015|Post Induction|Induction Failure|0|||
129616297|NCT01924754|466549649|FG000|Overall Study|Lost to Follow-up|1|||
129616298|NCT01924754|466549650|FG001|Overall Study|Lost to Follow-up|2|||
129616299|NCT01924754|466549651|FG002|Overall Study|Lost to Follow-up|1|||
129616300|NCT01924754|466549649|FG000|Overall Study|Pregnancy|0|||
129616301|NCT01924754|466549650|FG001|Overall Study|Pregnancy|1|||
129616302|NCT01924754|466549651|FG002|Overall Study|Pregnancy|2|||
129700935|NCT01051661|466866003|FG003|Overall Study|Refused blood sampling|0|||
129700936|NCT01051661|466866004|FG004|Overall Study|Refused blood sampling|0|||
129700937|NCT01051661|466866005|FG005|Overall Study|Refused blood sampling|1|||
129700938|NCT01051661|466866000|FG000|Overall Study|Data not reliable|1|||
129700939|NCT01051661|466866001|FG001|Overall Study|Data not reliable|0|||
129700940|NCT01051661|466866002|FG002|Overall Study|Data not reliable|0|||
129700941|NCT01051661|466866003|FG003|Overall Study|Data not reliable|0|||
129700942|NCT01051661|466866004|FG004|Overall Study|Data not reliable|0|||
129700943|NCT01051661|466866005|FG005|Overall Study|Data not reliable|1|||
129700944|NCT01051661|466866000|FG000|Overall Study|Unable to attend visit(s)|2|||
129700945|NCT01051661|466866001|FG001|Overall Study|Unable to attend visit(s)|4|||
129700946|NCT01051661|466866002|FG002|Overall Study|Unable to attend visit(s)|2|||
129700947|NCT01051661|466866003|FG003|Overall Study|Unable to attend visit(s)|1|||
129700948|NCT01051661|466866004|FG004|Overall Study|Unable to attend visit(s)|3|||
129700949|NCT01051661|466866005|FG005|Overall Study|Unable to attend visit(s)|2|||
129700950|NCT01051661|466866000|FG000|Overall Study|Consent not received from both parents|0|||
129700951|NCT01051661|466866001|FG001|Overall Study|Consent not received from both parents|0|||
129700952|NCT01051661|466866002|FG002|Overall Study|Consent not received from both parents|0|||
129700953|NCT01051661|466866003|FG003|Overall Study|Consent not received from both parents|0|||
129700954|NCT01051661|466866004|FG004|Overall Study|Consent not received from both parents|0|||
129700955|NCT01051661|466866005|FG005|Overall Study|Consent not received from both parents|1|||
129700956|NCT01051661|466866000|FG000|Overall Study|Failure to comply with protocol|0|||
129700957|NCT01051661|466866001|FG001|Overall Study|Failure to comply with protocol|0|||
129616303|NCT00369486|466549652|FG000|4-Week Visit|Missed visit|2|||
129616304|NCT00369486|466549653|FG001|4-Week Visit|Missed visit|2|||
129616305|NCT00369486|466549654|FG002|4-Week Visit|Missed visit|0|||
129616306|NCT00369486|466549655|FG003|4-Week Visit|Missed visit|2|||
129616307|NCT00369486|466549656|FG004|4-Week Visit|Missed visit|1|||
129616308|NCT00369486|466549652|FG000|4-Week Visit|Dropped|0|||
129616309|NCT00369486|466549653|FG001|4-Week Visit|Dropped|0|||
129791412|NCT01992159|467204413|FG000|Overall Study|Adverse Event|0|||
129791413|NCT01992159|467204414|FG001|Overall Study|Adverse Event|1|||
129791414|NCT01992159|467204415|FG002|Overall Study|Adverse Event|0|||
129791415|NCT01992159|467204416|FG003|Overall Study|Adverse Event|1|||
129791416|NCT01992159|467204413|FG000|Overall Study|Death|0|||
129791417|NCT01992159|467204414|FG001|Overall Study|Death|0|||
129791418|NCT01992159|467204415|FG002|Overall Study|Death|1|||
129791419|NCT01992159|467204416|FG003|Overall Study|Death|0|||
129791420|NCT01205581|467204417|FG000|Overall Study|Withdrawal by Subject|1|||
129791421|NCT01205581|467204418|FG001|Overall Study|Withdrawal by Subject|0|||
129439238|NCT00081770|465906396|FG002|Overall Study|Administrative|1|||
129439239|NCT00081770|465906394|FG000|Overall Study|Other|2|||
129439240|NCT00081770|465906395|FG001|Overall Study|Other|7|||
129616310|NCT00369486|466549654|FG002|4-Week Visit|Dropped|1|||
129616311|NCT00369486|466549655|FG003|4-Week Visit|Dropped|0|||
129616312|NCT00369486|466549656|FG004|4-Week Visit|Dropped|0|||
129616313|NCT00369486|466549652|FG000|8-Week Visit|Missed visit|0|||
129616314|NCT00369486|466549653|FG001|8-Week Visit|Missed visit|1|||
129616315|NCT00369486|466549654|FG002|8-Week Visit|Missed visit|0|||
129616316|NCT00369486|466549655|FG003|8-Week Visit|Missed visit|0|||
129616317|NCT00369486|466549656|FG004|8-Week Visit|Missed visit|1|||
129616318|NCT00369486|466549652|FG000|8-Week Visit|Dropped|0|||
129616319|NCT00369486|466549653|FG001|8-Week Visit|Dropped|0|||
129616320|NCT00369486|466549654|FG002|8-Week Visit|Dropped|0|||
129616321|NCT00369486|466549655|FG003|8-Week Visit|Dropped|1|||
129616322|NCT00369486|466549656|FG004|8-Week Visit|Dropped|0|||
129616323|NCT00369486|466549652|FG000|17-Week Visit|Missed visit|0|||
129616324|NCT00369486|466549653|FG001|17-Week Visit|Missed visit|0|||
129616325|NCT00369486|466549654|FG002|17-Week Visit|Missed visit|1|||
129616326|NCT00369486|466549655|FG003|17-Week Visit|Missed visit|1|||
129616327|NCT00369486|466549656|FG004|17-Week Visit|Missed visit|1|||
129616328|NCT00369486|466549652|FG000|34-Week Visit|Dropped|0|||
129616329|NCT00369486|466549653|FG001|34-Week Visit|Dropped|1|||
129616330|NCT00369486|466549654|FG002|34-Week Visit|Dropped|1|||
129616331|NCT00369486|466549655|FG003|34-Week Visit|Dropped|3|||
129616332|NCT00369486|466549656|FG004|34-Week Visit|Dropped|3|||
129616333|NCT01392963|466549657|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
129616334|NCT01392963|466549658|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
129616335|NCT01392963|466549657|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
129616336|NCT01392963|466549658|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
129616337|NCT01392963|466549657|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
129616338|NCT01392963|466549658|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
129616339|NCT00402116|466549659|FG000|Overall Study|Jaw infection after surgery-other|1|||
129616340|NCT00402116|466549660|FG001|Overall Study|Jaw infection after surgery-other|0|||
129616341|NCT00402116|466549661|FG002|Overall Study|Jaw infection after surgery-other|0|||
129616342|NCT00402116|466549659|FG000|Overall Study|Withdrawal by Subject|1|||
129616343|NCT00402116|466549660|FG001|Overall Study|Withdrawal by Subject|0|||
129616344|NCT00402116|466549661|FG002|Overall Study|Withdrawal by Subject|5|||
129616345|NCT00402116|466549659|FG000|Overall Study|Treatment completed per protocol|1|||
129616346|NCT00402116|466549660|FG001|Overall Study|Treatment completed per protocol|1|||
129616347|NCT00402116|466549661|FG002|Overall Study|Treatment completed per protocol|2|||
129616348|NCT00402116|466549659|FG000|Overall Study|other complicating disease|0|||
129616349|NCT00402116|466549660|FG001|Overall Study|other complicating disease|0|||
129616350|NCT00402116|466549661|FG002|Overall Study|other complicating disease|2|||
129616351|NCT00402116|466549659|FG000|Overall Study|Disease Progression|0|||
129616352|NCT00402116|466549660|FG001|Overall Study|Disease Progression|4|||
129616353|NCT00402116|466549661|FG002|Overall Study|Disease Progression|38|||
129616354|NCT00402116|466549659|FG000|Overall Study|mistaken thrombocytopenia|0|||
129616355|NCT00402116|466549660|FG001|Overall Study|mistaken thrombocytopenia|0|||
129616356|NCT00402116|466549661|FG002|Overall Study|mistaken thrombocytopenia|1|||
129616357|NCT00402116|466549659|FG000|Overall Study|decline related hyponatremia/tumor|0|||
129616358|NCT00402116|466549660|FG001|Overall Study|decline related hyponatremia/tumor|0|||
129616359|NCT00402116|466549661|FG002|Overall Study|decline related hyponatremia/tumor|1|||
129616360|NCT00402116|466549659|FG000|Overall Study|Adverse Event|0|||
129616361|NCT00402116|466549660|FG001|Overall Study|Adverse Event|1|||
129791422|NCT01205581|467204419|FG002|Overall Study|Withdrawal by Subject|0|||
129791423|NCT01205581|467204420|FG003|Overall Study|Withdrawal by Subject|0|||
129791424|NCT01205581|467204421|FG004|Overall Study|Withdrawal by Subject|0|||
129791425|NCT01205581|467204422|FG005|Overall Study|Withdrawal by Subject|0|||
129791426|NCT02278471|467204423|FG000|Overall Study|Lost to Follow-up|6|||
129616362|NCT00402116|466549661|FG002|Overall Study|Adverse Event|6|||
129616363|NCT04778904|466549662|FG000|Overall Study|Protocol Violation|1|||
129616364|NCT04778904|466549663|FG001|Overall Study|Protocol Violation|0|||
129616365|NCT04778904|466549664|FG002|Overall Study|Protocol Violation|0|||
129616366|NCT04778904|466549665|FG003|Overall Study|Protocol Violation|0|||
129616367|NCT04778904|466549662|FG000|Overall Study|Withdrawal by Subject|0|||
129616368|NCT04778904|466549663|FG001|Overall Study|Withdrawal by Subject|0|||
129616369|NCT04778904|466549664|FG002|Overall Study|Withdrawal by Subject|1|||
129791427|NCT02278471|467204424|FG001|Overall Study|Lost to Follow-up|15|||
129791428|NCT02278471|467204423|FG000|Overall Study|Death|2|||
129616370|NCT04778904|466549665|FG003|Overall Study|Withdrawal by Subject|0|||
129616371|NCT05048329|466549672|FG000|Overall Study|Withdrawal by Subject|1|||
129616372|NCT05048329|466549672|FG000|Overall Study|Screenfail|1|||
129616373|NCT02856802|466549673|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
129616374|NCT02856802|466549674|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
129616375|NCT02856802|466549673|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
129616376|NCT02856802|466549674|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
129616377|NCT02856802|466549673|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
129616378|NCT02856802|466549674|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
129616379|NCT02856802|466549673|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
129616380|NCT02856802|466549674|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
129616381|NCT02856802|466549673|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
129616382|NCT02856802|466549674|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
129616383|NCT02856802|466549673|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
129616384|NCT02856802|466549674|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
129616385|NCT03772717|466549675|FG000|Overall Study|Withdrawal by Subject|2|||
129616386|NCT04138043|466549676|FG000|Overall Study|Withdrawal by Subject|0|||
129616387|NCT04138043|466549677|FG001|Overall Study|Withdrawal by Subject|1|||
129616388|NCT03092219|466549678|FG000|Overall Study|Protocol Violation|7|||
129616389|NCT03092219|466549679|FG001|Overall Study|Protocol Violation|4|||
129616390|NCT00459355|466549688|FG000|Overall Study|Subject no longer met inc criteria|20|||
129616391|NCT00459355|466549689|FG001|Overall Study|Subject no longer met inc criteria|18|||
129616392|NCT00287586|466549690|FG000|Overall Study|Withdrew Consent|19|||
129616393|NCT00287586|466549691|FG001|Overall Study|Withdrew Consent|30|||
129616394|NCT00287586|466549690|FG000|Overall Study|Lost to Follow-up|5|||
129616395|NCT00287586|466549691|FG001|Overall Study|Lost to Follow-up|4|||
129616396|NCT00287586|466549690|FG000|Overall Study|Death|2|||
129616397|NCT00287586|466549691|FG001|Overall Study|Death|3|||
129616398|NCT00287586|466549690|FG000|Overall Study|Elevated Hematocrit|3|||
129616399|NCT00287586|466549691|FG001|Overall Study|Elevated Hematocrit|0|||
129616400|NCT00287586|466549690|FG000|Overall Study|Rash|3|||
129616401|NCT00287586|466549691|FG001|Overall Study|Rash|0|||
129616402|NCT00287586|466549690|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
129616403|NCT00287586|466549691|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
129616404|NCT00287586|466549690|FG000|Overall Study|Stroke|2|||
129616405|NCT00287586|466549691|FG001|Overall Study|Stroke|0|||
129616406|NCT00287586|466549690|FG000|Overall Study|Myocardial Infarction|1|||
129616407|NCT00287586|466549691|FG001|Overall Study|Myocardial Infarction|0|||
129887247|NCT01474512|467547288|FG016|Induction Period|Lost to Follow-up|0|||
129887248|NCT01474512|467547289|FG017|Induction Period|Lost to Follow-up|0|||
129616408|NCT00287586|466549690|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
129616409|NCT00287586|466549691|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
129616410|NCT00287586|466549690|FG000|Overall Study|Cognitive Impairment|1|||
129616411|NCT00287586|466549691|FG001|Overall Study|Cognitive Impairment|0|||
129616412|NCT00287586|466549690|FG000|Overall Study|Pancreatic Cancer|1|||
129616413|NCT00287586|466549691|FG001|Overall Study|Pancreatic Cancer|3|||
129616414|NCT00287586|466549690|FG000|Overall Study|Sleep Apnea|1|||
129616415|NCT00287586|466549691|FG001|Overall Study|Sleep Apnea|0|||
129616416|NCT00287586|466549690|FG000|Overall Study|Shoulder Pain|1|||
129616417|NCT00287586|466549691|FG001|Overall Study|Shoulder Pain|0|||
129616418|NCT00287586|466549690|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
129616419|NCT00287586|466549691|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
129616420|NCT00287586|466549690|FG000|Overall Study|Nonadherence|1|||
129616421|NCT00287586|466549691|FG001|Overall Study|Nonadherence|1|||
129616422|NCT00287586|466549690|FG000|Overall Study|Enrolled in Another Study|1|||
129616423|NCT00287586|466549691|FG001|Overall Study|Enrolled in Another Study|0|||
129616424|NCT00287586|466549690|FG000|Overall Study|Major Depression|0|||
129616425|NCT00287586|466549691|FG001|Overall Study|Major Depression|2|||
129616426|NCT00287586|466549690|FG000|Overall Study|Lung Cancer|0|||
129616427|NCT00287586|466549691|FG001|Overall Study|Lung Cancer|2|||
129616428|NCT00287586|466549690|FG000|Overall Study|Elevated IPSS Score|0|||
129616429|NCT00287586|466549691|FG001|Overall Study|Elevated IPSS Score|1|||
129616430|NCT00287586|466549690|FG000|Overall Study|Retroperitoneal Cancer|0|||
129616431|NCT00287586|466549691|FG001|Overall Study|Retroperitoneal Cancer|1|||
129616432|NCT00287586|466549690|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
129616433|NCT00287586|466549691|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
129616434|NCT00287586|466549690|FG000|Overall Study|Mood Swings and Irritability|0|||
129616435|NCT00287586|466549691|FG001|Overall Study|Mood Swings and Irritability|1|||
129616436|NCT00287586|466549690|FG000|Overall Study|Bradycardia|0|||
129616437|NCT00287586|466549691|FG001|Overall Study|Bradycardia|1|||
129616438|NCT00287586|466549690|FG000|Overall Study|Itchy Swollen Eyes|0|||
129616439|NCT00287586|466549691|FG001|Overall Study|Itchy Swollen Eyes|1|||
129616440|NCT00287586|466549690|FG000|Overall Study|Recurrent Melanoma|0|||
129616441|NCT00287586|466549691|FG001|Overall Study|Recurrent Melanoma|1|||
129616442|NCT03743415|466549693|FG000|Overall Study|Death|5|||
129616443|NCT03743415|466549694|FG001|Overall Study|Death|3|||
129616444|NCT03743415|466549695|FG002|Overall Study|Death|1|||
129616445|NCT03743415|466549696|FG003|Overall Study|Death|4|||
129616446|NCT03743415|466549697|FG004|Overall Study|Death|0|||
129616447|NCT03743415|466549698|FG005|Overall Study|Death|0|||
129616448|NCT03743415|466549699|FG006|Overall Study|Death|0|||
129616449|NCT03743415|466549700|FG007|Overall Study|Death|0|||
129616450|NCT03743415|466549701|FG008|Overall Study|Death|1|||
129616451|NCT03743415|466549702|FG009|Overall Study|Death|0|||
129616452|NCT03743415|466549693|FG000|Overall Study|Withdrawal by Subject|1|||
129616453|NCT03743415|466549694|FG001|Overall Study|Withdrawal by Subject|0|||
129616454|NCT03743415|466549695|FG002|Overall Study|Withdrawal by Subject|4|||
129616455|NCT03743415|466549696|FG003|Overall Study|Withdrawal by Subject|5|||
129616456|NCT03743415|466549697|FG004|Overall Study|Withdrawal by Subject|5|||
129616457|NCT03743415|466549698|FG005|Overall Study|Withdrawal by Subject|2|||
129616458|NCT03743415|466549699|FG006|Overall Study|Withdrawal by Subject|2|||
129616459|NCT03743415|466549700|FG007|Overall Study|Withdrawal by Subject|5|||
129616460|NCT03743415|466549701|FG008|Overall Study|Withdrawal by Subject|9|||
129616461|NCT03743415|466549702|FG009|Overall Study|Withdrawal by Subject|10|||
129616462|NCT03743415|466549693|FG000|Overall Study|Lost to Follow-up|2|||
129616463|NCT03743415|466549694|FG001|Overall Study|Lost to Follow-up|0|||
129616464|NCT03743415|466549695|FG002|Overall Study|Lost to Follow-up|2|||
129616465|NCT03743415|466549696|FG003|Overall Study|Lost to Follow-up|1|||
129616466|NCT03743415|466549697|FG004|Overall Study|Lost to Follow-up|1|||
129616467|NCT03743415|466549698|FG005|Overall Study|Lost to Follow-up|0|||
129616468|NCT03743415|466549699|FG006|Overall Study|Lost to Follow-up|1|||
129616469|NCT03743415|466549700|FG007|Overall Study|Lost to Follow-up|4|||
129616470|NCT03743415|466549701|FG008|Overall Study|Lost to Follow-up|13|||
129616471|NCT03743415|466549702|FG009|Overall Study|Lost to Follow-up|13|||
129616472|NCT02242045|466549703|FG000|Overall Study|Investigator's Discretion|1|||
129616473|NCT02242045|466549703|FG000|Overall Study|Progressive Disease|2|||
129616474|NCT02242045|466549703|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
129616475|NCT02242045|466549703|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
129616476|NCT02473523|466549704|FG000|Overall Study|Death|1|||
129616477|NCT02473523|466549704|FG000|Overall Study|Lost to Follow-up|1|||
129616478|NCT00976911|466549710|FG000|Overall Study|Withdrawal by Subject|4|||
129616479|NCT00976911|466549711|FG001|Overall Study|Withdrawal by Subject|6|||
129616480|NCT00976911|466549710|FG000|Overall Study|Death|138|||
129616481|NCT00976911|466549711|FG001|Overall Study|Death|126|||
129616482|NCT00976911|466549710|FG000|Overall Study|Adverse Event|0|||
129616483|NCT00976911|466549711|FG001|Overall Study|Adverse Event|1|||
129616484|NCT00976911|466549710|FG000|Overall Study|Protocol Violation|2|||
129616485|NCT00976911|466549711|FG001|Overall Study|Protocol Violation|0|||
129616486|NCT00976911|466549710|FG000|Overall Study|Other|8|||
129616487|NCT00976911|466549711|FG001|Overall Study|Other|9|||
129616488|NCT00976911|466549710|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
129616489|NCT00976911|466549711|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
129616490|NCT02954991|466549712|FG000|Overall Study|Death|92|||
129616491|NCT02954991|466549713|FG001|Overall Study|Death|11|||
129616492|NCT02954991|466549714|FG002|Overall Study|Death|2|||
129616493|NCT02954991|466549712|FG000|Overall Study|Lost to Follow-up|3|||
129616494|NCT02954991|466549713|FG001|Overall Study|Lost to Follow-up|2|||
129616495|NCT02954991|466549714|FG002|Overall Study|Lost to Follow-up|0|||
129616496|NCT02954991|466549712|FG000|Overall Study|Withdrawal by Subject|9|||
129616497|NCT02954991|466549713|FG001|Overall Study|Withdrawal by Subject|8|||
129616498|NCT02954991|466549714|FG002|Overall Study|Withdrawal by Subject|1|||
129616499|NCT02954991|466549712|FG000|Overall Study|Study Terminated by Sponsor|18|||
129616500|NCT02954991|466549713|FG001|Overall Study|Study Terminated by Sponsor|10|||
129439241|NCT00081770|465906396|FG002|Overall Study|Other|8|||
129616501|NCT02954991|466549714|FG002|Overall Study|Study Terminated by Sponsor|1|||
129616502|NCT02954991|466549712|FG000|Overall Study|Miscellaneous|2|||
129616503|NCT02954991|466549713|FG001|Overall Study|Miscellaneous|1|||
129616504|NCT02954991|466549714|FG002|Overall Study|Miscellaneous|1|||
129616505|NCT00576316|466549715|FG000|Overall Study|Adverse Event|9|||
129616506|NCT00576316|466549715|FG000|Overall Study|Withdrawal by Subject|2|||
129616507|NCT00576316|466549715|FG000|Overall Study|Protocol Violation|9|||
129616508|NCT01266031|466549717|FG000|Overall Study|Not treated|0|||
129616509|NCT01266031|466549718|FG001|Overall Study|Not treated|3|||
129616510|NCT01266031|466549719|FG002|Overall Study|Not treated|2|||
129616511|NCT01434810|466549720|FG000|Overall Study|Did not receive treatment|11|||
129791429|NCT02278471|467204424|FG001|Overall Study|Death|2|||
129791430|NCT02278471|467204423|FG000|Overall Study|Withdrawal by Subject|0|||
129791431|NCT02278471|467204424|FG001|Overall Study|Withdrawal by Subject|3|||
129791432|NCT00640835|467204425|FG000|Overall Study|Adverse Event|5|||
129791433|NCT00640835|467204426|FG001|Overall Study|Adverse Event|3|||
129791434|NCT00640835|467204425|FG000|Overall Study|Withdrawal by Subject|12|||
129791435|NCT00640835|467204426|FG001|Overall Study|Withdrawal by Subject|14|||
129791436|NCT00640835|467204425|FG000|Overall Study|Physician Decision|10|||
129791437|NCT00640835|467204426|FG001|Overall Study|Physician Decision|14|||
129791438|NCT00640835|467204425|FG000|Overall Study|Sponsor's Decision|11|||
129791439|NCT00640835|467204426|FG001|Overall Study|Sponsor's Decision|7|||
129791440|NCT00640835|467204425|FG000|Overall Study|Protocol Violation|2|||
129791441|NCT00640835|467204426|FG001|Overall Study|Protocol Violation|2|||
129791442|NCT00640835|467204425|FG000|Overall Study|Lost to Follow-up|17|||
129791443|NCT00640835|467204426|FG001|Overall Study|Lost to Follow-up|13|||
129791444|NCT00640835|467204425|FG000|Overall Study|Other Reason|19|||
129791445|NCT00640835|467204426|FG001|Overall Study|Other Reason|4|||
129791446|NCT04535167|467204429|FG000|Treatment|Adverse Event|0|||
129791447|NCT04535167|467204430|FG001|Treatment|Adverse Event|0|||
129791448|NCT04535167|467204431|FG002|Treatment|Adverse Event|0|||
129791449|NCT04535167|467204432|FG003|Treatment|Adverse Event|0|||
129791450|NCT04535167|467204433|FG004|Treatment|Adverse Event|0|||
129791451|NCT04535167|467204434|FG005|Treatment|Adverse Event|0|||
129791452|NCT04535167|467204435|FG006|Treatment|Adverse Event|1|||
129791453|NCT04535167|467204429|FG000|Follow-Up|Death|0|||
129791454|NCT04535167|467204430|FG001|Follow-Up|Death|0|||
129791455|NCT04535167|467204431|FG002|Follow-Up|Death|0|||
129791456|NCT04535167|467204432|FG003|Follow-Up|Death|0|||
129791457|NCT04535167|467204433|FG004|Follow-Up|Death|0|||
129791458|NCT04535167|467204434|FG005|Follow-Up|Death|0|||
129791459|NCT04535167|467204435|FG006|Follow-Up|Death|1|||
129791460|NCT04535167|467204429|FG000|Follow-Up|Lost to Follow-up|0|||
129791461|NCT04535167|467204430|FG001|Follow-Up|Lost to Follow-up|0|||
129791462|NCT04535167|467204431|FG002|Follow-Up|Lost to Follow-up|0|||
129791463|NCT04535167|467204432|FG003|Follow-Up|Lost to Follow-up|1|||
129791464|NCT04535167|467204433|FG004|Follow-Up|Lost to Follow-up|0|||
129791465|NCT04535167|467204434|FG005|Follow-Up|Lost to Follow-up|0|||
129791466|NCT04535167|467204435|FG006|Follow-Up|Lost to Follow-up|0|||
129791467|NCT00978432|467204436|FG000|Overall Study|Withdrawal by Subject|0|||
129791468|NCT00978432|467204437|FG001|Overall Study|Withdrawal by Subject|0|||
129616512|NCT01434810|466549721|FG001|Overall Study|Did not receive treatment|3|||
129616513|NCT01434810|466549720|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
129616514|NCT01434810|466549721|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
129616515|NCT04893018|466549723|FG000|Overall Study|Lost to Follow-up|1|||
129616516|NCT04893018|466549724|FG001|Overall Study|Lost to Follow-up|0|||
129616517|NCT04893018|466549723|FG000|Overall Study|Withdrawal by Subject|2|||
129616518|NCT04893018|466549724|FG001|Overall Study|Withdrawal by Subject|0|||
129616519|NCT04893018|466549723|FG000|Overall Study|Study Terminated|1|||
129616520|NCT04893018|466549724|FG001|Overall Study|Study Terminated|2|||
129616521|NCT00447876|466549727|FG000|Overall Study|Withdrawal by Subject|1|||
129616522|NCT00447876|466549728|FG001|Overall Study|Withdrawal by Subject|4|||
129616523|NCT00447876|466549727|FG000|Overall Study|Lost to Follow-up|1|||
129616524|NCT00447876|466549728|FG001|Overall Study|Lost to Follow-up|0|||
129616525|NCT00447876|466549727|FG000|Overall Study|Deterioration of symptomology|1|||
129616526|NCT00447876|466549728|FG001|Overall Study|Deterioration of symptomology|0|||
129791469|NCT00978432|467204438|FG002|Overall Study|Withdrawal by Subject|1|||
129791470|NCT00978432|467204436|FG000|Overall Study|Lack of Efficacy|1|||
129791471|NCT00978432|467204437|FG001|Overall Study|Lack of Efficacy|1|||
129791472|NCT00978432|467204438|FG002|Overall Study|Lack of Efficacy|3|||
129791473|NCT00978432|467204436|FG000|Overall Study|Adverse Event|2|||
129791474|NCT00978432|467204437|FG001|Overall Study|Adverse Event|0|||
129791475|NCT00978432|467204438|FG002|Overall Study|Adverse Event|1|||
129791476|NCT04618770|467204439|FG000|Overall Study|Censored from Analysis|12|||
129791477|NCT04618770|467204439|FG000|Overall Study|Early Termination|25|||
129791478|NCT04972630|467204442|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
129791479|NCT04972630|467204443|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
129616527|NCT02533180|466549729|FG000|Overall Study|Death|0|||
129616528|NCT02533180|466549730|FG001|Overall Study|Death|2|||
129616529|NCT02533180|466549729|FG000|Overall Study|Lost to Follow-up|0|||
129791480|NCT04972630|467204444|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
129791481|NCT00075270|467204447|FG000|Overall Study|Withdrawal by Subject|28|||
129616530|NCT02533180|466549730|FG001|Overall Study|Lost to Follow-up|1|||
129616531|NCT02533180|466549729|FG000|Overall Study|Physician Decision|0|||
129616532|NCT02533180|466549730|FG001|Overall Study|Physician Decision|1|||
129616533|NCT02533180|466549729|FG000|Overall Study|Withdrawal by Subject|2|||
129616534|NCT02533180|466549730|FG001|Overall Study|Withdrawal by Subject|5|||
129616535|NCT02533180|466549729|FG000|Overall Study|Screen Failure|37|||
129616536|NCT02533180|466549730|FG001|Overall Study|Screen Failure|0|||
129616537|NCT02533180|466549729|FG000|Overall Study|Protocol Deviation|0|||
129616538|NCT02533180|466549730|FG001|Overall Study|Protocol Deviation|1|||
129616539|NCT02533180|466549729|FG000|Overall Study|Non-compliance|0|||
129616540|NCT02533180|466549730|FG001|Overall Study|Non-compliance|1|||
129616541|NCT00005957|466549733|FG000|Overall Study|No treated|3|||
129616542|NCT00005957|466549734|FG001|Overall Study|No treated|9|||
129616543|NCT00005957|466549733|FG000|Overall Study|Crossover to the other arm|5|||
129616544|NCT00005957|466549734|FG001|Overall Study|Crossover to the other arm|19|||
129616545|NCT01609023|466549735|FG000|Overall Study|Lack of Efficacy|3|||
129616546|NCT01609023|466549735|FG000|Overall Study|Withdrawal by Subject|4|||
129616547|NCT01609023|466549735|FG000|Overall Study|Lost to Follow-up|8|||
129616548|NCT01609023|466549735|FG000|Overall Study|Toxicity|3|||
129616549|NCT01609023|466549735|FG000|Overall Study|Disease progression|10|||
129616550|NCT01609023|466549735|FG000|Overall Study|Physician Decision|2|||
129616551|NCT01609023|466549735|FG000|Overall Study|Death|2|||
129616552|NCT01609023|466549735|FG000|Overall Study|Personal reasons|1|||
129616553|NCT02047734|466549737|FG000|Overall Study|Adverse Event|18|||
129616554|NCT02047734|466549738|FG001|Overall Study|Adverse Event|13|||
129616555|NCT02047734|466549739|FG002|Overall Study|Adverse Event|13|||
129616556|NCT02047734|466549737|FG000|Overall Study|Lack of Efficacy|4|||
129616557|NCT02047734|466549738|FG001|Overall Study|Lack of Efficacy|5|||
129616558|NCT02047734|466549739|FG002|Overall Study|Lack of Efficacy|1|||
129616559|NCT02047734|466549737|FG000|Overall Study|Protocol Violation|3|||
129616560|NCT02047734|466549738|FG001|Overall Study|Protocol Violation|1|||
129616561|NCT02047734|466549739|FG002|Overall Study|Protocol Violation|1|||
129616562|NCT02047734|466549737|FG000|Overall Study|Lost to Follow-up|1|||
129616563|NCT02047734|466549738|FG001|Overall Study|Lost to Follow-up|4|||
129616564|NCT02047734|466549739|FG002|Overall Study|Lost to Follow-up|0|||
129616565|NCT02047734|466549737|FG000|Overall Study|Death|0|||
129616566|NCT02047734|466549738|FG001|Overall Study|Death|1|||
129616567|NCT02047734|466549739|FG002|Overall Study|Death|0|||
129616568|NCT02047734|466549737|FG000|Overall Study|Withdrawal by Subject|30|||
129616569|NCT02047734|466549738|FG001|Overall Study|Withdrawal by Subject|31|||
129616570|NCT02047734|466549739|FG002|Overall Study|Withdrawal by Subject|19|||
129616571|NCT02047734|466549737|FG000|Overall Study|Physician Decision|7|||
129616572|NCT02047734|466549738|FG001|Overall Study|Physician Decision|6|||
129616573|NCT02047734|466549739|FG002|Overall Study|Physician Decision|5|||
129616574|NCT02047734|466549737|FG000|Overall Study|Miscellaneous|2|||
129616575|NCT02047734|466549738|FG001|Overall Study|Miscellaneous|4|||
129616576|NCT02047734|466549739|FG002|Overall Study|Miscellaneous|6|||
129616577|NCT02047734|466549737|FG000|Overall Study|Did Not Receive Study Drug|2|||
129616578|NCT02047734|466549738|FG001|Overall Study|Did Not Receive Study Drug|4|||
129616579|NCT02047734|466549739|FG002|Overall Study|Did Not Receive Study Drug|1|||
129616580|NCT00799825|466549742|FG000|Overall Study|Adverse Event|1|||
129616581|NCT00799825|466549742|FG000|Overall Study|Withdrawal by Subject|6|||
129616582|NCT00799825|466549742|FG000|Overall Study|Lost to Follow-up|38|||
129616583|NCT00799825|466549742|FG000|Overall Study|Pregnancy|3|||
129616584|NCT02439970|466549743|FG000|Overall Study|Study Terminated|2|||
129616585|NCT02439970|466549744|FG001|Overall Study|Study Terminated|3|||
129700958|NCT01051661|466866002|FG002|Overall Study|Failure to comply with protocol|2|||
129616586|NCT00492778|466549745|FG000|Overall Study|Ineligible by Pathology Review|8|||
129616587|NCT00492778|466549746|FG001|Overall Study|Ineligible by Pathology Review|1|||
129616588|NCT02910011|466549749|FG000|Overall Study|Physician Decision|2|||
129616589|NCT03280381|466549750|FG000|Overall Study|Physician Decision|0|||
129616590|NCT03280381|466549751|FG001|Overall Study|Physician Decision|2|||
129616591|NCT01822366|466549752|FG000|Overall Study|Lost to Follow-up|5|||
129616592|NCT01822366|466549753|FG001|Overall Study|Lost to Follow-up|1|||
129616593|NCT01822366|466549754|FG002|Overall Study|Lost to Follow-up|5|||
129616594|NCT01822366|466549755|FG003|Overall Study|Lost to Follow-up|1|||
129616595|NCT01822366|466549752|FG000|Overall Study|Withdrawal by Subject|0|||
129616596|NCT01822366|466549753|FG001|Overall Study|Withdrawal by Subject|6|||
129616597|NCT01822366|466549754|FG002|Overall Study|Withdrawal by Subject|0|||
129616598|NCT01822366|466549755|FG003|Overall Study|Withdrawal by Subject|6|||
129616599|NCT01822366|466549752|FG000|Overall Study|Partial Intervention Completion|0|||
129616600|NCT01822366|466549753|FG001|Overall Study|Partial Intervention Completion|15|||
129791482|NCT00075270|467204448|FG001|Overall Study|Withdrawal by Subject|21|||
129791483|NCT00075270|467204447|FG000|Overall Study|Lost to Follow-up|25|||
129791484|NCT00075270|467204448|FG001|Overall Study|Lost to Follow-up|28|||
129616601|NCT01822366|466549754|FG002|Overall Study|Partial Intervention Completion|0|||
129616602|NCT01822366|466549755|FG003|Overall Study|Partial Intervention Completion|15|||
129616603|NCT00025259|466549756|FG000|Overall Study|Death|1|||
129616604|NCT00025259|466549757|FG001|Overall Study|Death|3|||
129616605|NCT00025259|466549758|FG002|Overall Study|Death|0|||
129616606|NCT00025259|466549759|FG003|Overall Study|Death|3|||
129616607|NCT00025259|466549760|FG004|Overall Study|Death|0|||
129616608|NCT00025259|466549761|FG005|Overall Study|Death|1|||
129616609|NCT00025259|466549762|FG006|Overall Study|Death|2|||
129616610|NCT00025259|466549756|FG000|Overall Study|Lack of Efficacy|2|||
129616611|NCT00025259|466549757|FG001|Overall Study|Lack of Efficacy|46|||
129791485|NCT00075270|467204447|FG000|Overall Study|Protocol Violation|0|||
129791486|NCT00075270|467204448|FG001|Overall Study|Protocol Violation|2|||
129791487|NCT00075270|467204447|FG000|Overall Study|Death|198|||
129791488|NCT00075270|467204448|FG001|Overall Study|Death|215|||
129791489|NCT00075270|467204447|FG000|Overall Study|Other/Unknown|9|||
129791490|NCT00075270|467204448|FG001|Overall Study|Other/Unknown|5|||
129791491|NCT00075270|467204447|FG000|Overall Study|Missing|26|||
129791492|NCT00075270|467204448|FG001|Overall Study|Missing|13|||
129791493|NCT02160002|467204449|FG000|Overall Study|Withdrawal by Subject|2|||
129791494|NCT02160002|467204450|FG001|Overall Study|Withdrawal by Subject|1|||
129791495|NCT04896229|467204451|FG000|Overall Study|Lost to Follow-up|113|||
129791496|NCT04896229|467204452|FG001|Overall Study|Lost to Follow-up|113|||
129791497|NCT04418661|467204453|FG000|Overall Study|Adverse Event|0|||
129791498|NCT04418661|467204454|FG001|Overall Study|Adverse Event|1|||
129791499|NCT04418661|467204455|FG002|Overall Study|Adverse Event|5|||
129791500|NCT04418661|467204456|FG003|Overall Study|Adverse Event|3|||
129791501|NCT04418661|467204457|FG004|Overall Study|Adverse Event|0|||
129791502|NCT04418661|467204458|FG005|Overall Study|Adverse Event|2|||
129791503|NCT04418661|467204453|FG000|Overall Study|Progressive disease|4|||
129791504|NCT04418661|467204454|FG001|Overall Study|Progressive disease|11|||
129791505|NCT04418661|467204455|FG002|Overall Study|Progressive disease|6|||
129791506|NCT04418661|467204456|FG003|Overall Study|Progressive disease|11|||
129791507|NCT04418661|467204457|FG004|Overall Study|Progressive disease|1|||
129791508|NCT04418661|467204458|FG005|Overall Study|Progressive disease|12|||
129791509|NCT04418661|467204453|FG000|Overall Study|Withdrawal by Subject|0|||
129791510|NCT04418661|467204454|FG001|Overall Study|Withdrawal by Subject|1|||
129791511|NCT04418661|467204455|FG002|Overall Study|Withdrawal by Subject|0|||
129791512|NCT04418661|467204456|FG003|Overall Study|Withdrawal by Subject|1|||
129791513|NCT04418661|467204457|FG004|Overall Study|Withdrawal by Subject|0|||
129791514|NCT04418661|467204458|FG005|Overall Study|Withdrawal by Subject|0|||
129791515|NCT04418661|467204453|FG000|Overall Study|Other|0|||
129791516|NCT04418661|467204454|FG001|Overall Study|Other|0|||
129791517|NCT04418661|467204455|FG002|Overall Study|Other|1|||
129791518|NCT04418661|467204456|FG003|Overall Study|Other|3|||
129791519|NCT04418661|467204457|FG004|Overall Study|Other|0|||
129791520|NCT04418661|467204458|FG005|Overall Study|Other|1|||
129791521|NCT00046891|467204461|FG000|Overall Study|Cancels|5|||
129791522|NCT00046891|467204462|FG001|Overall Study|Cancels|9|||
129791523|NCT00046891|467204461|FG000|Overall Study|Ineligible|1|||
129791524|NCT00046891|467204462|FG001|Overall Study|Ineligible|1|||
129791525|NCT00046891|467204461|FG000|Overall Study|Withdrawal by Subject|18|||
129791526|NCT00046891|467204462|FG001|Overall Study|Withdrawal by Subject|15|||
129791527|NCT00046891|467204461|FG000|Overall Study|Adverse Event|5|||
129791528|NCT00046891|467204462|FG001|Overall Study|Adverse Event|5|||
129791529|NCT02496676|467204463|FG000|Phase 1 - Period 1|Adverse Event|0|||
129791530|NCT02496676|467204464|FG001|Phase 1 - Period 1|Adverse Event|1|||
129616612|NCT00025259|466549758|FG002|Overall Study|Lack of Efficacy|60|||
129616613|NCT00025259|466549759|FG003|Overall Study|Lack of Efficacy|78|||
129616614|NCT00025259|466549760|FG004|Overall Study|Lack of Efficacy|11|||
129616615|NCT00025259|466549761|FG005|Overall Study|Lack of Efficacy|30|||
129616616|NCT00025259|466549762|FG006|Overall Study|Lack of Efficacy|38|||
129791531|NCT02496676|467204463|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
129791532|NCT02496676|467204464|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
129791533|NCT04381988|467204475|FG000|Overall Study|The study was terminated|4|||
129616617|NCT00025259|466549756|FG000|Overall Study|Lost to Follow-up|2|||
129616618|NCT00025259|466549757|FG001|Overall Study|Lost to Follow-up|9|||
129616619|NCT00025259|466549758|FG002|Overall Study|Lost to Follow-up|13|||
129616620|NCT00025259|466549759|FG003|Overall Study|Lost to Follow-up|13|||
129791534|NCT04381988|467204476|FG001|Overall Study|The study was terminated|0|||
129791535|NCT01107379|467204477|FG000|Overall Study|Withdrawal by Subject|18|||
129791536|NCT01107379|467204477|FG000|Overall Study|Lost to Follow-up|3|||
129791537|NCT00609362|467204478|FG000|Overall Study|Withdrawal by Subject|2|||
129616621|NCT00025259|466549760|FG004|Overall Study|Lost to Follow-up|1|||
129791538|NCT00609362|467204479|FG001|Overall Study|Withdrawal by Subject|1|||
129791539|NCT00609362|467204478|FG000|Overall Study|Adverse Event|1|||
129791540|NCT00609362|467204479|FG001|Overall Study|Adverse Event|0|||
129791541|NCT04559529|467204480|FG000|First Intervention (1 Day)|Adverse Event|0|||
129439242|NCT00601419|465906397|FG000|Overall Study|Lost to Follow-up|3|||
129616622|NCT00025259|466549761|FG005|Overall Study|Lost to Follow-up|3|||
129616623|NCT00025259|466549762|FG006|Overall Study|Lost to Follow-up|1|||
129616624|NCT00025259|466549756|FG000|Overall Study|Physician Decision|12|||
129616625|NCT00025259|466549757|FG001|Overall Study|Physician Decision|1|||
129616626|NCT00025259|466549758|FG002|Overall Study|Physician Decision|0|||
129616627|NCT00025259|466549759|FG003|Overall Study|Physician Decision|5|||
129616628|NCT00025259|466549760|FG004|Overall Study|Physician Decision|4|||
129616629|NCT00025259|466549761|FG005|Overall Study|Physician Decision|2|||
129616630|NCT00025259|466549762|FG006|Overall Study|Physician Decision|1|||
129616631|NCT00025259|466549756|FG000|Overall Study|Protocol Violation|3|||
129616632|NCT00025259|466549757|FG001|Overall Study|Protocol Violation|2|||
129791542|NCT04559529|467204481|FG001|First Intervention (1 Day)|Adverse Event|0|||
129791543|NCT04559529|467204482|FG002|First Intervention (1 Day)|Adverse Event|0|||
129791544|NCT04559529|467204483|FG003|First Intervention (1 Day)|Adverse Event|1|||
129791545|NCT04559529|467204480|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
129791546|NCT04559529|467204481|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
129791547|NCT04559529|467204482|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
129791548|NCT04559529|467204483|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
129791549|NCT04559529|467204480|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
129791550|NCT04559529|467204481|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
129791551|NCT04559529|467204482|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
129791552|NCT04559529|467204483|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
129791553|NCT01009281|467204484|FG000|Overall Study|Administrative problems|7|||
129791554|NCT00548405|467204485|FG000|Overall Study|Adverse Event|6|||
129791555|NCT00548405|467204486|FG001|Overall Study|Adverse Event|2|||
129791556|NCT00548405|467204487|FG002|Overall Study|Adverse Event|0|||
129791557|NCT00548405|467204485|FG000|Overall Study|Lack of Efficacy|6|||
129791558|NCT00548405|467204486|FG001|Overall Study|Lack of Efficacy|0|||
129791559|NCT00548405|467204487|FG002|Overall Study|Lack of Efficacy|0|||
129791560|NCT00548405|467204485|FG000|Overall Study|Physician Decision|3|||
129791561|NCT00548405|467204486|FG001|Overall Study|Physician Decision|4|||
129791562|NCT00548405|467204487|FG002|Overall Study|Physician Decision|1|||
129791563|NCT00548405|467204485|FG000|Overall Study|Pregnancy|1|||
129791564|NCT00548405|467204486|FG001|Overall Study|Pregnancy|0|||
129439243|NCT00601419|465906397|FG000|Overall Study|Missed Visits|1|||
129439244|NCT01614197|465906398|FG000|Overall Study|Withdrawal by Subject|0|||
129439245|NCT01614197|465906399|FG001|Overall Study|Withdrawal by Subject|1|||
129616633|NCT00025259|466549758|FG002|Overall Study|Protocol Violation|2|||
129791565|NCT00548405|467204487|FG002|Overall Study|Pregnancy|0|||
129791566|NCT00548405|467204485|FG000|Overall Study|Protocol Violation|1|||
129616634|NCT00025259|466549759|FG003|Overall Study|Protocol Violation|1|||
129616635|NCT00025259|466549760|FG004|Overall Study|Protocol Violation|2|||
129791567|NCT00548405|467204486|FG001|Overall Study|Protocol Violation|0|||
129791568|NCT00548405|467204487|FG002|Overall Study|Protocol Violation|0|||
129616636|NCT00025259|466549761|FG005|Overall Study|Protocol Violation|1|||
129887249|NCT01474512|467547272|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887250|NCT01474512|467547273|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887251|NCT01474512|467547274|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887252|NCT01474512|467547275|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
129887253|NCT01474512|467547276|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
129887254|NCT01474512|467547277|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
129887255|NCT01474512|467547278|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
129887256|NCT01474512|467547279|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887257|NCT01474512|467547280|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887258|NCT01474512|467547281|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887259|NCT01474512|467547282|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887260|NCT01474512|467547283|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887261|NCT01474512|467547284|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887262|NCT01474512|467547285|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887263|NCT01474512|467547286|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887264|NCT01474512|467547287|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887265|NCT01474512|467547288|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887266|NCT01474512|467547289|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
129887267|NCT01474512|467547272|FG000|Maintenance Period|Adverse Event|0|||
129887268|NCT01474512|467547273|FG001|Maintenance Period|Adverse Event|0|||
129887269|NCT01474512|467547274|FG002|Maintenance Period|Adverse Event|0|||
129887270|NCT01474512|467547275|FG003|Maintenance Period|Adverse Event|4|||
129887271|NCT01474512|467547276|FG004|Maintenance Period|Adverse Event|2|||
129887272|NCT01474512|467547277|FG005|Maintenance Period|Adverse Event|7|||
129887273|NCT01474512|467547278|FG006|Maintenance Period|Adverse Event|0|||
129887274|NCT01474512|467547279|FG007|Maintenance Period|Adverse Event|19|||
129887275|NCT01474512|467547280|FG008|Maintenance Period|Adverse Event|1|||
129887276|NCT01474512|467547281|FG009|Maintenance Period|Adverse Event|3|||
129887277|NCT01474512|467547282|FG010|Maintenance Period|Adverse Event|0|||
129887278|NCT01474512|467547283|FG011|Maintenance Period|Adverse Event|0|||
129887279|NCT01474512|467547284|FG012|Maintenance Period|Adverse Event|0|||
129887280|NCT01474512|467547285|FG013|Maintenance Period|Adverse Event|0|||
129887281|NCT01474512|467547286|FG014|Maintenance Period|Adverse Event|0|||
129887282|NCT01474512|467547287|FG015|Maintenance Period|Adverse Event|0|||
129887283|NCT01474512|467547288|FG016|Maintenance Period|Adverse Event|0|||
129887284|NCT01474512|467547289|FG017|Maintenance Period|Adverse Event|0|||
129887285|NCT01474512|467547272|FG000|Maintenance Period|Withdrawal by Subject|0|||
129887286|NCT01474512|467547273|FG001|Maintenance Period|Withdrawal by Subject|0|||
129887287|NCT01474512|467547274|FG002|Maintenance Period|Withdrawal by Subject|0|||
129887288|NCT01474512|467547275|FG003|Maintenance Period|Withdrawal by Subject|6|||
129887289|NCT01474512|467547276|FG004|Maintenance Period|Withdrawal by Subject|2|||
129887290|NCT01474512|467547277|FG005|Maintenance Period|Withdrawal by Subject|3|||
129887291|NCT01474512|467547278|FG006|Maintenance Period|Withdrawal by Subject|1|||
129887292|NCT01474512|467547279|FG007|Maintenance Period|Withdrawal by Subject|6|||
129887293|NCT01474512|467547280|FG008|Maintenance Period|Withdrawal by Subject|3|||
129887294|NCT01474512|467547281|FG009|Maintenance Period|Withdrawal by Subject|1|||
129887295|NCT01474512|467547282|FG010|Maintenance Period|Withdrawal by Subject|0|||
129887296|NCT01474512|467547283|FG011|Maintenance Period|Withdrawal by Subject|0|||
129887297|NCT01474512|467547284|FG012|Maintenance Period|Withdrawal by Subject|0|||
129887298|NCT01474512|467547285|FG013|Maintenance Period|Withdrawal by Subject|0|||
129887299|NCT01474512|467547286|FG014|Maintenance Period|Withdrawal by Subject|0|||
129887300|NCT01474512|467547287|FG015|Maintenance Period|Withdrawal by Subject|0|||
129791569|NCT00548405|467204485|FG000|Overall Study|Withdrawal by Subject|36|||
129791570|NCT00548405|467204486|FG001|Overall Study|Withdrawal by Subject|12|||
129791571|NCT00548405|467204487|FG002|Overall Study|Withdrawal by Subject|5|||
129791572|NCT00548405|467204485|FG000|Overall Study|Lost to Follow-up|1|||
129791573|NCT00548405|467204486|FG001|Overall Study|Lost to Follow-up|1|||
129791574|NCT00548405|467204487|FG002|Overall Study|Lost to Follow-up|2|||
129791575|NCT00548405|467204485|FG000|Overall Study|Death|0|||
129791576|NCT00548405|467204486|FG001|Overall Study|Death|1|||
129791577|NCT00548405|467204487|FG002|Overall Study|Death|1|||
129791578|NCT00548405|467204485|FG000|Overall Study|Sponsor decision|1|||
129887301|NCT01474512|467547288|FG016|Maintenance Period|Withdrawal by Subject|0|||
129887302|NCT01474512|467547289|FG017|Maintenance Period|Withdrawal by Subject|0|||
129887303|NCT01474512|467547272|FG000|Maintenance Period|Lost to Follow-up|0|||
129887304|NCT01474512|467547273|FG001|Maintenance Period|Lost to Follow-up|0|||
129887305|NCT01474512|467547274|FG002|Maintenance Period|Lost to Follow-up|0|||
129887306|NCT01474512|467547275|FG003|Maintenance Period|Lost to Follow-up|3|||
129791579|NCT00548405|467204486|FG001|Overall Study|Sponsor decision|0|||
129791580|NCT00548405|467204487|FG002|Overall Study|Sponsor decision|0|||
129887307|NCT01474512|467547276|FG004|Maintenance Period|Lost to Follow-up|3|||
129887308|NCT01474512|467547277|FG005|Maintenance Period|Lost to Follow-up|0|||
129887309|NCT01474512|467547278|FG006|Maintenance Period|Lost to Follow-up|0|||
129887310|NCT01474512|467547279|FG007|Maintenance Period|Lost to Follow-up|2|||
129616637|NCT00025259|466549762|FG006|Overall Study|Protocol Violation|3|||
129616638|NCT00025259|466549756|FG000|Overall Study|Withdrawal by Subject|9|||
129616639|NCT00025259|466549757|FG001|Overall Study|Withdrawal by Subject|27|||
129616640|NCT00025259|466549758|FG002|Overall Study|Withdrawal by Subject|6|||
129616641|NCT00025259|466549759|FG003|Overall Study|Withdrawal by Subject|14|||
129616642|NCT00025259|466549760|FG004|Overall Study|Withdrawal by Subject|11|||
129616643|NCT00025259|466549761|FG005|Overall Study|Withdrawal by Subject|8|||
129616644|NCT00025259|466549762|FG006|Overall Study|Withdrawal by Subject|3|||
129887311|NCT01474512|467547280|FG008|Maintenance Period|Lost to Follow-up|1|||
129887312|NCT01474512|467547281|FG009|Maintenance Period|Lost to Follow-up|1|||
129887313|NCT01474512|467547282|FG010|Maintenance Period|Lost to Follow-up|0|||
129887314|NCT01474512|467547283|FG011|Maintenance Period|Lost to Follow-up|0|||
129887315|NCT01474512|467547284|FG012|Maintenance Period|Lost to Follow-up|0|||
129887316|NCT01474512|467547285|FG013|Maintenance Period|Lost to Follow-up|0|||
129887317|NCT01474512|467547286|FG014|Maintenance Period|Lost to Follow-up|0|||
129887318|NCT01474512|467547287|FG015|Maintenance Period|Lost to Follow-up|0|||
129887319|NCT01474512|467547288|FG016|Maintenance Period|Lost to Follow-up|0|||
129887320|NCT01474512|467547289|FG017|Maintenance Period|Lost to Follow-up|0|||
129887321|NCT01474512|467547272|FG000|Maintenance Period|Death|0|||
129887322|NCT01474512|467547273|FG001|Maintenance Period|Death|0|||
129887323|NCT01474512|467547274|FG002|Maintenance Period|Death|0|||
129887324|NCT01474512|467547275|FG003|Maintenance Period|Death|0|||
129887325|NCT01474512|467547276|FG004|Maintenance Period|Death|0|||
129887326|NCT01474512|467547277|FG005|Maintenance Period|Death|2|||
129887327|NCT01474512|467547278|FG006|Maintenance Period|Death|0|||
129887328|NCT01474512|467547279|FG007|Maintenance Period|Death|0|||
129887329|NCT01474512|467547280|FG008|Maintenance Period|Death|0|||
129887330|NCT01474512|467547281|FG009|Maintenance Period|Death|0|||
129887331|NCT01474512|467547282|FG010|Maintenance Period|Death|0|||
129887332|NCT01474512|467547283|FG011|Maintenance Period|Death|0|||
129887333|NCT01474512|467547284|FG012|Maintenance Period|Death|0|||
129887334|NCT01474512|467547285|FG013|Maintenance Period|Death|0|||
129887335|NCT01474512|467547286|FG014|Maintenance Period|Death|0|||
129887336|NCT01474512|467547287|FG015|Maintenance Period|Death|0|||
129887337|NCT01474512|467547288|FG016|Maintenance Period|Death|0|||
129887338|NCT01474512|467547289|FG017|Maintenance Period|Death|0|||
129887339|NCT01474512|467547272|FG000|Maintenance Period|Physician Decision|0|||
129616645|NCT00025259|466549756|FG000|Overall Study|Ineligible|14|||
129616646|NCT00025259|466549757|FG001|Overall Study|Ineligible|1|||
129616647|NCT00025259|466549758|FG002|Overall Study|Ineligible|0|||
129616648|NCT00025259|466549759|FG003|Overall Study|Ineligible|0|||
129616649|NCT00025259|466549760|FG004|Overall Study|Ineligible|6|||
129616650|NCT00025259|466549761|FG005|Overall Study|Ineligible|0|||
129616651|NCT00025259|466549762|FG006|Overall Study|Ineligible|1|||
129616652|NCT00025259|466549756|FG000|Overall Study|Randomization error|1|||
129616653|NCT00025259|466549757|FG001|Overall Study|Randomization error|0|||
129616654|NCT00025259|466549758|FG002|Overall Study|Randomization error|0|||
129616655|NCT00025259|466549759|FG003|Overall Study|Randomization error|0|||
129616656|NCT00025259|466549760|FG004|Overall Study|Randomization error|1|||
129616657|NCT00025259|466549761|FG005|Overall Study|Randomization error|7|||
129616658|NCT00025259|466549762|FG006|Overall Study|Randomization error|2|||
129616659|NCT00025259|466549756|FG000|Overall Study|Adverse Event|1|||
129616660|NCT00025259|466549757|FG001|Overall Study|Adverse Event|0|||
129616661|NCT00025259|466549758|FG002|Overall Study|Adverse Event|0|||
129616662|NCT00025259|466549759|FG003|Overall Study|Adverse Event|0|||
129616663|NCT00025259|466549760|FG004|Overall Study|Adverse Event|0|||
129616664|NCT00025259|466549761|FG005|Overall Study|Adverse Event|0|||
129616665|NCT00025259|466549762|FG006|Overall Study|Adverse Event|0|||
129791581|NCT00548405|467204485|FG000|Overall Study|Randomized but not treated|1|||
129791582|NCT00548405|467204486|FG001|Overall Study|Randomized but not treated|0|||
129791583|NCT00548405|467204487|FG002|Overall Study|Randomized but not treated|0|||
129791584|NCT02582684|467204489|FG000|Overall Study|Unable to contact subject/parent|4|||
129791585|NCT02582684|467204489|FG000|Overall Study|Subject not able to get to clinic|10|||
129791586|NCT02582684|467204489|FG000|Overall Study|Subject withdrew consent|1|||
129791587|NCT02582684|467204489|FG000|Overall Study|Found to be ineligible after enrollment|2|||
129791588|NCT03025035|467204490|FG000|Overall Study|Death|2|||
129887340|NCT01474512|467547273|FG001|Maintenance Period|Physician Decision|0|||
129887341|NCT01474512|467547274|FG002|Maintenance Period|Physician Decision|0|||
129887342|NCT01474512|467547275|FG003|Maintenance Period|Physician Decision|0|||
129887343|NCT01474512|467547276|FG004|Maintenance Period|Physician Decision|0|||
129887344|NCT01474512|467547277|FG005|Maintenance Period|Physician Decision|1|||
129887345|NCT01474512|467547278|FG006|Maintenance Period|Physician Decision|0|||
129616666|NCT01449370|466549763|FG000|Overall Study|Disease Progression|5|||
129616667|NCT01449370|466549764|FG001|Overall Study|Disease Progression|4|||
129616668|NCT01449370|466549765|FG002|Overall Study|Disease Progression|8|||
129616669|NCT01449370|466549766|FG003|Overall Study|Disease Progression|3|||
129616670|NCT01449370|466549767|FG004|Overall Study|Disease Progression|3|||
129616671|NCT01449370|466549768|FG005|Overall Study|Disease Progression|3|||
129616672|NCT01449370|466549769|FG006|Overall Study|Disease Progression|3|||
129616673|NCT01449370|466549770|FG007|Overall Study|Disease Progression|2|||
129616674|NCT01449370|466549771|FG008|Overall Study|Disease Progression|9|||
129616675|NCT01449370|466549772|FG009|Overall Study|Disease Progression|1|||
129616676|NCT01449370|466549773|FG010|Overall Study|Disease Progression|3|||
129616677|NCT01449370|466549774|FG011|Overall Study|Disease Progression|3|||
129616678|NCT01449370|466549775|FG012|Overall Study|Disease Progression|2|||
129616679|NCT01449370|466549776|FG013|Overall Study|Disease Progression|8|||
129616680|NCT01449370|466549777|FG014|Overall Study|Disease Progression|3|||
129616681|NCT01449370|466549778|FG015|Overall Study|Disease Progression|1|||
129616682|NCT01449370|466549779|FG016|Overall Study|Disease Progression|4|||
129616683|NCT01449370|466549780|FG017|Overall Study|Disease Progression|3|||
129616684|NCT01449370|466549781|FG018|Overall Study|Disease Progression|1|||
129616685|NCT01449370|466549782|FG019|Overall Study|Disease Progression|2|||
129616686|NCT01449370|466549783|FG020|Overall Study|Disease Progression|5|||
129616687|NCT01449370|466549784|FG021|Overall Study|Disease Progression|2|||
129616688|NCT01449370|466549785|FG022|Overall Study|Disease Progression|3|||
129616689|NCT01449370|466549786|FG023|Overall Study|Disease Progression|7|||
129616690|NCT01449370|466549787|FG024|Overall Study|Disease Progression|3|||
129616691|NCT01449370|466549763|FG000|Overall Study|Adverse Event|1|||
129616692|NCT01449370|466549764|FG001|Overall Study|Adverse Event|2|||
129616693|NCT01449370|466549765|FG002|Overall Study|Adverse Event|0|||
129616694|NCT01449370|466549766|FG003|Overall Study|Adverse Event|1|||
129616695|NCT01449370|466549767|FG004|Overall Study|Adverse Event|0|||
129616696|NCT01449370|466549768|FG005|Overall Study|Adverse Event|0|||
129616697|NCT01449370|466549769|FG006|Overall Study|Adverse Event|0|||
129616698|NCT01449370|466549770|FG007|Overall Study|Adverse Event|0|||
129616699|NCT01449370|466549771|FG008|Overall Study|Adverse Event|1|||
129616700|NCT01449370|466549772|FG009|Overall Study|Adverse Event|1|||
129616701|NCT01449370|466549773|FG010|Overall Study|Adverse Event|0|||
129616702|NCT01449370|466549774|FG011|Overall Study|Adverse Event|0|||
129616703|NCT01449370|466549775|FG012|Overall Study|Adverse Event|0|||
129616704|NCT01449370|466549776|FG013|Overall Study|Adverse Event|2|||
129616705|NCT01449370|466549777|FG014|Overall Study|Adverse Event|0|||
129616706|NCT01449370|466549778|FG015|Overall Study|Adverse Event|1|||
129616707|NCT01449370|466549779|FG016|Overall Study|Adverse Event|0|||
129616708|NCT01449370|466549780|FG017|Overall Study|Adverse Event|0|||
129616709|NCT01449370|466549781|FG018|Overall Study|Adverse Event|1|||
129616710|NCT01449370|466549782|FG019|Overall Study|Adverse Event|1|||
129616711|NCT01449370|466549783|FG020|Overall Study|Adverse Event|0|||
129616712|NCT01449370|466549784|FG021|Overall Study|Adverse Event|1|||
129616713|NCT01449370|466549785|FG022|Overall Study|Adverse Event|0|||
129616714|NCT01449370|466549786|FG023|Overall Study|Adverse Event|1|||
129616715|NCT01449370|466549787|FG024|Overall Study|Adverse Event|3|||
129616716|NCT01449370|466549763|FG000|Overall Study|Participant Decision|0|||
129616717|NCT01449370|466549764|FG001|Overall Study|Participant Decision|0|||
129616718|NCT01449370|466549765|FG002|Overall Study|Participant Decision|0|||
129616719|NCT01449370|466549766|FG003|Overall Study|Participant Decision|0|||
129616720|NCT01449370|466549767|FG004|Overall Study|Participant Decision|0|||
129439246|NCT01614197|465906400|FG002|Overall Study|Withdrawal by Subject|0|||
129439247|NCT01614197|465906401|FG003|Overall Study|Withdrawal by Subject|0|||
129616721|NCT01449370|466549768|FG005|Overall Study|Participant Decision|0|||
129616722|NCT01449370|466549769|FG006|Overall Study|Participant Decision|0|||
129616723|NCT01449370|466549770|FG007|Overall Study|Participant Decision|1|||
129616724|NCT01449370|466549771|FG008|Overall Study|Participant Decision|1|||
129616725|NCT01449370|466549772|FG009|Overall Study|Participant Decision|0|||
129616726|NCT01449370|466549773|FG010|Overall Study|Participant Decision|0|||
129616727|NCT01449370|466549774|FG011|Overall Study|Participant Decision|0|||
129616728|NCT01449370|466549775|FG012|Overall Study|Participant Decision|1|||
129616729|NCT01449370|466549776|FG013|Overall Study|Participant Decision|1|||
129616730|NCT01449370|466549777|FG014|Overall Study|Participant Decision|0|||
129616731|NCT01449370|466549778|FG015|Overall Study|Participant Decision|1|||
129616732|NCT01449370|466549779|FG016|Overall Study|Participant Decision|3|||
129616733|NCT01449370|466549780|FG017|Overall Study|Participant Decision|0|||
129616734|NCT01449370|466549781|FG018|Overall Study|Participant Decision|1|||
129616735|NCT01449370|466549782|FG019|Overall Study|Participant Decision|0|||
129616736|NCT01449370|466549783|FG020|Overall Study|Participant Decision|0|||
129616737|NCT01449370|466549784|FG021|Overall Study|Participant Decision|1|||
129616738|NCT01449370|466549785|FG022|Overall Study|Participant Decision|0|||
129616739|NCT01449370|466549786|FG023|Overall Study|Participant Decision|0|||
129616740|NCT01449370|466549787|FG024|Overall Study|Participant Decision|1|||
129616741|NCT01449370|466549763|FG000|Overall Study|Lost to Follow-up|0|||
129616742|NCT01449370|466549764|FG001|Overall Study|Lost to Follow-up|0|||
129616743|NCT01449370|466549765|FG002|Overall Study|Lost to Follow-up|0|||
129616744|NCT01449370|466549766|FG003|Overall Study|Lost to Follow-up|0|||
129616745|NCT01449370|466549767|FG004|Overall Study|Lost to Follow-up|0|||
129616746|NCT01449370|466549768|FG005|Overall Study|Lost to Follow-up|0|||
129616747|NCT01449370|466549769|FG006|Overall Study|Lost to Follow-up|0|||
129616748|NCT01449370|466549770|FG007|Overall Study|Lost to Follow-up|0|||
129616749|NCT01449370|466549771|FG008|Overall Study|Lost to Follow-up|0|||
129616750|NCT01449370|466549772|FG009|Overall Study|Lost to Follow-up|0|||
129616751|NCT01449370|466549773|FG010|Overall Study|Lost to Follow-up|0|||
129616752|NCT01449370|466549774|FG011|Overall Study|Lost to Follow-up|0|||
129616753|NCT01449370|466549775|FG012|Overall Study|Lost to Follow-up|0|||
129616754|NCT01449370|466549776|FG013|Overall Study|Lost to Follow-up|0|||
129616755|NCT01449370|466549777|FG014|Overall Study|Lost to Follow-up|0|||
129616756|NCT01449370|466549778|FG015|Overall Study|Lost to Follow-up|0|||
129616757|NCT01449370|466549779|FG016|Overall Study|Lost to Follow-up|0|||
129616758|NCT01449370|466549780|FG017|Overall Study|Lost to Follow-up|0|||
129616759|NCT01449370|466549781|FG018|Overall Study|Lost to Follow-up|0|||
129700959|NCT01051661|466866003|FG003|Overall Study|Failure to comply with protocol|0|||
129700960|NCT01051661|466866004|FG004|Overall Study|Failure to comply with protocol|0|||
129700961|NCT01051661|466866005|FG005|Overall Study|Failure to comply with protocol|0|||
129700962|NCT01051661|466866000|FG000|Overall Study|Subject lost legal representation|0|||
129700963|NCT01051661|466866001|FG001|Overall Study|Subject lost legal representation|0|||
129700964|NCT01051661|466866002|FG002|Overall Study|Subject lost legal representation|0|||
129700965|NCT01051661|466866003|FG003|Overall Study|Subject lost legal representation|0|||
129700966|NCT01051661|466866004|FG004|Overall Study|Subject lost legal representation|1|||
129700967|NCT01051661|466866005|FG005|Overall Study|Subject lost legal representation|0|||
129616760|NCT01449370|466549782|FG019|Overall Study|Lost to Follow-up|0|||
129616761|NCT01449370|466549783|FG020|Overall Study|Lost to Follow-up|1|||
129616762|NCT01449370|466549784|FG021|Overall Study|Lost to Follow-up|0|||
129616763|NCT01449370|466549785|FG022|Overall Study|Lost to Follow-up|0|||
129616764|NCT01449370|466549786|FG023|Overall Study|Lost to Follow-up|0|||
129616765|NCT01449370|466549787|FG024|Overall Study|Lost to Follow-up|0|||
129616766|NCT01449370|466549763|FG000|Overall Study|Other|0|||
129616767|NCT01449370|466549764|FG001|Overall Study|Other|0|||
129616768|NCT01449370|466549765|FG002|Overall Study|Other|0|||
129616769|NCT01449370|466549766|FG003|Overall Study|Other|0|||
129616770|NCT01449370|466549767|FG004|Overall Study|Other|0|||
129616771|NCT01449370|466549768|FG005|Overall Study|Other|0|||
129616772|NCT01449370|466549769|FG006|Overall Study|Other|0|||
129616773|NCT01449370|466549770|FG007|Overall Study|Other|0|||
129616774|NCT01449370|466549771|FG008|Overall Study|Other|1|||
129616775|NCT01449370|466549772|FG009|Overall Study|Other|1|||
129616776|NCT01449370|466549773|FG010|Overall Study|Other|0|||
129616777|NCT01449370|466549774|FG011|Overall Study|Other|0|||
129616778|NCT01449370|466549775|FG012|Overall Study|Other|0|||
129616779|NCT01449370|466549776|FG013|Overall Study|Other|0|||
129616780|NCT01449370|466549777|FG014|Overall Study|Other|0|||
129616781|NCT01449370|466549778|FG015|Overall Study|Other|0|||
129616782|NCT01449370|466549779|FG016|Overall Study|Other|0|||
129616783|NCT01449370|466549780|FG017|Overall Study|Other|0|||
129616784|NCT01449370|466549781|FG018|Overall Study|Other|0|||
129616785|NCT01449370|466549782|FG019|Overall Study|Other|0|||
129616786|NCT01449370|466549783|FG020|Overall Study|Other|0|||
129616787|NCT01449370|466549784|FG021|Overall Study|Other|0|||
129616788|NCT01449370|466549785|FG022|Overall Study|Other|1|||
129616789|NCT01449370|466549786|FG023|Overall Study|Other|1|||
129616790|NCT01449370|466549787|FG024|Overall Study|Other|0|||
129616791|NCT01449370|466549763|FG000|Overall Study|Medication Prohibited by Protocol|0|||
129616792|NCT01449370|466549764|FG001|Overall Study|Medication Prohibited by Protocol|0|||
129616793|NCT01449370|466549765|FG002|Overall Study|Medication Prohibited by Protocol|0|||
129616794|NCT01449370|466549766|FG003|Overall Study|Medication Prohibited by Protocol|0|||
129616795|NCT01449370|466549767|FG004|Overall Study|Medication Prohibited by Protocol|0|||
129791589|NCT03025035|467204490|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
129791590|NCT02048241|467204491|FG000|Overall Study|Withdrawal by Subject|0|||
129791591|NCT02048241|467204492|FG001|Overall Study|Withdrawal by Subject|1|||
129791592|NCT00402233|467204493|FG000|Overall Study|Adverse Event|1|||
129791593|NCT00402233|467204494|FG001|Overall Study|Adverse Event|7|||
129791594|NCT00402233|467204495|FG002|Overall Study|Adverse Event|9|||
129791595|NCT00402233|467204496|FG003|Overall Study|Adverse Event|9|||
129791596|NCT00402233|467204493|FG000|Overall Study|Protocol Violation|0|||
129791597|NCT00402233|467204494|FG001|Overall Study|Protocol Violation|1|||
129791598|NCT00402233|467204495|FG002|Overall Study|Protocol Violation|0|||
129791599|NCT00402233|467204496|FG003|Overall Study|Protocol Violation|0|||
129791600|NCT00402233|467204493|FG000|Overall Study|Withdrawal by Subject|2|||
129791601|NCT00402233|467204494|FG001|Overall Study|Withdrawal by Subject|1|||
129791602|NCT00402233|467204495|FG002|Overall Study|Withdrawal by Subject|2|||
129791603|NCT00402233|467204496|FG003|Overall Study|Withdrawal by Subject|2|||
129791604|NCT00402233|467204493|FG000|Overall Study|Worsening of disease under study|2|||
129791605|NCT00402233|467204494|FG001|Overall Study|Worsening of disease under study|0|||
129791606|NCT00402233|467204495|FG002|Overall Study|Worsening of disease under study|0|||
129791607|NCT00402233|467204496|FG003|Overall Study|Worsening of disease under study|0|||
129791608|NCT00402233|467204493|FG000|Overall Study|Worsening of other pre-existing disease|0|||
129791609|NCT00402233|467204494|FG001|Overall Study|Worsening of other pre-existing disease|1|||
129791610|NCT00402233|467204495|FG002|Overall Study|Worsening of other pre-existing disease|0|||
129791611|NCT00402233|467204496|FG003|Overall Study|Worsening of other pre-existing disease|0|||
129791612|NCT04658940|467204497|FG000|Overall Study|Withdrawal by Subject|1|||
129791613|NCT03579602|467204498|FG000|Overall Study|Subject unable to receive study drug|0|||
129616796|NCT01449370|466549768|FG005|Overall Study|Medication Prohibited by Protocol|0|||
129616797|NCT01449370|466549769|FG006|Overall Study|Medication Prohibited by Protocol|0|||
129616798|NCT01449370|466549770|FG007|Overall Study|Medication Prohibited by Protocol|0|||
129616799|NCT01449370|466549771|FG008|Overall Study|Medication Prohibited by Protocol|0|||
129616800|NCT01449370|466549772|FG009|Overall Study|Medication Prohibited by Protocol|0|||
129616801|NCT01449370|466549773|FG010|Overall Study|Medication Prohibited by Protocol|0|||
129616802|NCT01449370|466549774|FG011|Overall Study|Medication Prohibited by Protocol|0|||
129616803|NCT01449370|466549775|FG012|Overall Study|Medication Prohibited by Protocol|0|||
129616804|NCT01449370|466549776|FG013|Overall Study|Medication Prohibited by Protocol|0|||
129616805|NCT01449370|466549777|FG014|Overall Study|Medication Prohibited by Protocol|0|||
129616806|NCT01449370|466549778|FG015|Overall Study|Medication Prohibited by Protocol|0|||
129616807|NCT01449370|466549779|FG016|Overall Study|Medication Prohibited by Protocol|0|||
129616808|NCT01449370|466549780|FG017|Overall Study|Medication Prohibited by Protocol|0|||
129616809|NCT01449370|466549781|FG018|Overall Study|Medication Prohibited by Protocol|0|||
129616810|NCT01449370|466549782|FG019|Overall Study|Medication Prohibited by Protocol|0|||
129616811|NCT01449370|466549783|FG020|Overall Study|Medication Prohibited by Protocol|0|||
129616812|NCT01449370|466549784|FG021|Overall Study|Medication Prohibited by Protocol|0|||
129616813|NCT01449370|466549785|FG022|Overall Study|Medication Prohibited by Protocol|0|||
129616814|NCT01449370|466549786|FG023|Overall Study|Medication Prohibited by Protocol|1|||
129616815|NCT01449370|466549787|FG024|Overall Study|Medication Prohibited by Protocol|0|||
129616816|NCT01449370|466549763|FG000|Overall Study|Death|0|||
129616817|NCT01449370|466549764|FG001|Overall Study|Death|0|||
129616818|NCT01449370|466549765|FG002|Overall Study|Death|0|||
129616819|NCT01449370|466549766|FG003|Overall Study|Death|0|||
129616820|NCT01449370|466549767|FG004|Overall Study|Death|0|||
129616821|NCT01449370|466549768|FG005|Overall Study|Death|0|||
129616822|NCT01449370|466549769|FG006|Overall Study|Death|0|||
129616823|NCT01449370|466549770|FG007|Overall Study|Death|0|||
129616824|NCT01449370|466549771|FG008|Overall Study|Death|0|||
129616825|NCT01449370|466549772|FG009|Overall Study|Death|0|||
129616826|NCT01449370|466549773|FG010|Overall Study|Death|0|||
129616827|NCT01449370|466549774|FG011|Overall Study|Death|0|||
129616828|NCT01449370|466549775|FG012|Overall Study|Death|0|||
129616829|NCT01449370|466549776|FG013|Overall Study|Death|0|||
129616830|NCT01449370|466549777|FG014|Overall Study|Death|0|||
129616831|NCT01449370|466549778|FG015|Overall Study|Death|0|||
129616832|NCT01449370|466549779|FG016|Overall Study|Death|0|||
129616833|NCT01449370|466549780|FG017|Overall Study|Death|0|||
129616834|NCT01449370|466549781|FG018|Overall Study|Death|0|||
129616835|NCT01449370|466549782|FG019|Overall Study|Death|0|||
129616836|NCT01449370|466549783|FG020|Overall Study|Death|0|||
129616837|NCT01449370|466549784|FG021|Overall Study|Death|0|||
129616838|NCT01449370|466549785|FG022|Overall Study|Death|0|||
129616839|NCT01449370|466549786|FG023|Overall Study|Death|0|||
129887346|NCT01474512|467547279|FG007|Maintenance Period|Physician Decision|2|||
129887347|NCT01474512|467547280|FG008|Maintenance Period|Physician Decision|0|||
129616840|NCT01449370|466549787|FG024|Overall Study|Death|1|||
129616841|NCT00534404|466549788|FG000|Overall Study|Death|0|||
129616842|NCT00534404|466549789|FG001|Overall Study|Death|0|||
129616843|NCT00534404|466549790|FG002|Overall Study|Death|2|||
129616844|NCT00534404|466549788|FG000|Overall Study|Withdrawal by Subject|8|||
129616845|NCT00534404|466549789|FG001|Overall Study|Withdrawal by Subject|2|||
129616846|NCT00534404|466549790|FG002|Overall Study|Withdrawal by Subject|38|||
129616847|NCT00534404|466549788|FG000|Overall Study|Removed by study staff|2|||
129700968|NCT01051661|466866000|FG000|Overall Study|Protocol Violation|0|||
129700969|NCT01051661|466866001|FG001|Overall Study|Protocol Violation|0|||
129700970|NCT01051661|466866002|FG002|Overall Study|Protocol Violation|0|||
129700971|NCT01051661|466866003|FG003|Overall Study|Protocol Violation|1|||
129700972|NCT01051661|466866004|FG004|Overall Study|Protocol Violation|2|||
129700973|NCT01051661|466866005|FG005|Overall Study|Protocol Violation|1|||
129700974|NCT01051661|466866000|FG000|Overall Study|Withdrawal by Subject|16|||
129700975|NCT01051661|466866001|FG001|Overall Study|Withdrawal by Subject|30|||
129700976|NCT01051661|466866002|FG002|Overall Study|Withdrawal by Subject|13|||
129700977|NCT01051661|466866003|FG003|Overall Study|Withdrawal by Subject|28|||
129700978|NCT01051661|466866004|FG004|Overall Study|Withdrawal by Subject|12|||
129700979|NCT01051661|466866005|FG005|Overall Study|Withdrawal by Subject|34|||
129700980|NCT04642079|466866006|FG000|Overall Study|Lost to Follow-up|2|||
129700981|NCT04642079|466866007|FG001|Overall Study|Lost to Follow-up|5|||
129700982|NCT04642079|466866008|FG002|Overall Study|Lost to Follow-up|2|||
129700983|NCT04642079|466866009|FG003|Overall Study|Lost to Follow-up|0|||
129700984|NCT04642079|466866006|FG000|Overall Study|Withdrawal by Subject|0|||
129700985|NCT04642079|466866007|FG001|Overall Study|Withdrawal by Subject|4|||
129700986|NCT04642079|466866008|FG002|Overall Study|Withdrawal by Subject|1|||
129700987|NCT04642079|466866009|FG003|Overall Study|Withdrawal by Subject|2|||
129700988|NCT04642079|466866006|FG000|Overall Study|Other|0|||
129700989|NCT04642079|466866007|FG001|Overall Study|Other|0|||
129700990|NCT04642079|466866008|FG002|Overall Study|Other|0|||
129700991|NCT04642079|466866009|FG003|Overall Study|Other|1|||
129700992|NCT04642079|466866006|FG000|Overall Study|No longer met eligibility criteria|1|||
129700993|NCT04642079|466866007|FG001|Overall Study|No longer met eligibility criteria|0|||
129700994|NCT04642079|466866008|FG002|Overall Study|No longer met eligibility criteria|1|||
129700995|NCT04642079|466866009|FG003|Overall Study|No longer met eligibility criteria|1|||
129700996|NCT00635050|466866014|FG000|Overall Study|Withdrawal by Subject|1|||
129700997|NCT03038620|466866015|FG000|Overall Study|Lost to Follow-up|18|||
129700998|NCT03038620|466866016|FG001|Overall Study|Lost to Follow-up|23|||
129616848|NCT00534404|466549789|FG001|Overall Study|Removed by study staff|3|||
129616849|NCT00534404|466549790|FG002|Overall Study|Removed by study staff|1|||
129616850|NCT00534404|466549788|FG000|Overall Study|Lost to Follow-up|170|||
129616851|NCT00534404|466549789|FG001|Overall Study|Lost to Follow-up|138|||
129616852|NCT00534404|466549790|FG002|Overall Study|Lost to Follow-up|201|||
129616853|NCT03371459|466549795|FG000|Washout|Lost to Follow-up|0|||
129616854|NCT03371459|466549796|FG001|Washout|Lost to Follow-up|1|||
129616855|NCT00315731|466549798|FG000|Overall Study|Lost to Follow-up|1|||
129616856|NCT00315731|466549798|FG000|Overall Study|Death|5|||
129616857|NCT02185053|466549799|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
129616858|NCT02185053|466549800|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
129791614|NCT03579602|467204499|FG001|Overall Study|Subject unable to receive study drug|2|||
129791615|NCT03579602|467204498|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
129791616|NCT03579602|467204499|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
129791617|NCT02518464|467204500|FG000|Overall Study|Adverse Event|2|||
129791618|NCT01120067|467204501|FG000|Overall Study|Lost to Follow-up|3|||
129791619|NCT01120067|467204502|FG001|Overall Study|Lost to Follow-up|1|||
129791620|NCT01120067|467204501|FG000|Overall Study|fail to engage >3 sessions|2|||
129791621|NCT01120067|467204502|FG001|Overall Study|fail to engage >3 sessions|0|||
129791622|NCT00266877|467204503|FG000|Overall Study|Death|1|||
129791623|NCT00266877|467204504|FG001|Overall Study|Death|1|||
129791624|NCT00266877|467204505|FG002|Overall Study|Death|1|||
129791625|NCT00266877|467204503|FG000|Overall Study|Adverse Event|6|||
129791626|NCT00266877|467204504|FG001|Overall Study|Adverse Event|4|||
129791627|NCT00266877|467204505|FG002|Overall Study|Adverse Event|1|||
129791628|NCT00266877|467204503|FG000|Overall Study|Physician Decision|2|||
129791629|NCT00266877|467204504|FG001|Overall Study|Physician Decision|1|||
129791630|NCT00266877|467204505|FG002|Overall Study|Physician Decision|1|||
129791631|NCT00266877|467204503|FG000|Overall Study|Withdrawal by Subject|3|||
129791632|NCT00266877|467204504|FG001|Overall Study|Withdrawal by Subject|1|||
129791633|NCT00266877|467204505|FG002|Overall Study|Withdrawal by Subject|1|||
129791634|NCT00266877|467204503|FG000|Overall Study|Disease Progression|72|||
129791635|NCT00266877|467204504|FG001|Overall Study|Disease Progression|37|||
129791636|NCT00266877|467204505|FG002|Overall Study|Disease Progression|23|||
129791637|NCT00266877|467204503|FG000|Overall Study|Symptomatic Deterioration|6|||
129791638|NCT00266877|467204504|FG001|Overall Study|Symptomatic Deterioration|3|||
129791639|NCT00266877|467204505|FG002|Overall Study|Symptomatic Deterioration|1|||
129791640|NCT00266877|467204503|FG000|Overall Study|Hospitalization|1|||
129791641|NCT00266877|467204504|FG001|Overall Study|Hospitalization|0|||
129791642|NCT00266877|467204505|FG002|Overall Study|Hospitalization|0|||
129791643|NCT00266877|467204503|FG000|Overall Study|Concomitant Radiotherapy|0|||
129791644|NCT00266877|467204504|FG001|Overall Study|Concomitant Radiotherapy|1|||
129791645|NCT00266877|467204505|FG002|Overall Study|Concomitant Radiotherapy|0|||
129791646|NCT03985878|467204507|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
129791647|NCT03985878|467204507|FG000|Overall Study|Study Terminated by Sponsor|12|||
129791648|NCT03985878|467204507|FG000|Overall Study|Withdrawal by Subject|1|||
129791649|NCT00278915|467204510|FG000|Overall Study|Disease progression|1|||
129616859|NCT02185053|466549801|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
129791650|NCT02520089|467204511|FG000|Overall Study|Lost to Follow-up|3|||
129791651|NCT02520089|467204512|FG001|Overall Study|Lost to Follow-up|4|||
129791652|NCT03473548|467204515|FG000|Overall Study|Did not attempt HST testing|3|||
129791653|NCT03473548|467204516|FG001|Overall Study|Did not attempt HST testing|0|||
129791654|NCT00129311|467204518|FG000|Overall Study|Withdrawal by Subject|12|||
129791655|NCT00129311|467204519|FG001|Overall Study|Withdrawal by Subject|19|||
129791656|NCT02232880|467204520|FG000|Overall Study|study stopped prior to randomization|1|||
129791657|NCT02545543|467204521|FG000|Overall Study|Lost to Follow-up|67|||
129887348|NCT01474512|467547281|FG009|Maintenance Period|Physician Decision|0|||
129887349|NCT01474512|467547282|FG010|Maintenance Period|Physician Decision|0|||
129887350|NCT01474512|467547283|FG011|Maintenance Period|Physician Decision|0|||
129791658|NCT02545543|467204522|FG001|Overall Study|Lost to Follow-up|25|||
129791659|NCT02545543|467204521|FG000|Overall Study|Physician Decision|3|||
129791660|NCT02545543|467204522|FG001|Overall Study|Physician Decision|0|||
129791661|NCT02545543|467204521|FG000|Overall Study|Withdrawal by Subject|9|||
129791662|NCT02545543|467204522|FG001|Overall Study|Withdrawal by Subject|8|||
129791663|NCT02545543|467204521|FG000|Overall Study|Noncomplaince|1|||
129791664|NCT02545543|467204522|FG001|Overall Study|Noncomplaince|0|||
129791665|NCT02545543|467204521|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
129791666|NCT02545543|467204522|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
129791667|NCT02829944|467204526|FG000|Overall Study|Physician Decision|0|||
129791668|NCT02829944|467204527|FG001|Overall Study|Physician Decision|1|||
129791669|NCT02829944|467204526|FG000|Overall Study|Screen Failure|2|||
129791670|NCT02829944|467204527|FG001|Overall Study|Screen Failure|2|||
129791671|NCT02829944|467204526|FG000|Overall Study|Inadequate Neuraxial Block|1|||
129791672|NCT02829944|467204527|FG001|Overall Study|Inadequate Neuraxial Block|1|||
129791673|NCT02829944|467204526|FG000|Overall Study|Withdrawal by Subject|2|||
129791674|NCT02829944|467204527|FG001|Overall Study|Withdrawal by Subject|1|||
129791675|NCT02829944|467204526|FG000|Overall Study|Catheter Displacement|1|||
129791676|NCT02829944|467204527|FG001|Overall Study|Catheter Displacement|0|||
129791677|NCT02829944|467204526|FG000|Overall Study|Catheter broke|0|||
129791678|NCT02829944|467204527|FG001|Overall Study|Catheter broke|1|||
129791679|NCT02829944|467204526|FG000|Overall Study|Staff unavailable|0|||
129791680|NCT02829944|467204527|FG001|Overall Study|Staff unavailable|1|||
129647588|NCT03787303|466665353|FG000|Overall Study|Premature Termination of Study|1|||
129791681|NCT00336583|467206127|FG000|Overall Study|Lost to Follow-up|1|||
129791682|NCT00336583|467206127|FG000|Overall Study|Death|1|||
129791683|NCT00910247|467206128|FG000|Overall Study|Adverse Event|15|||
129791684|NCT00910247|467206128|FG000|Overall Study|Death|2|||
129791685|NCT00910247|467206128|FG000|Overall Study|Lost to Follow-up|10|||
129791686|NCT00910247|467206128|FG000|Overall Study|Physician Decision|3|||
129791687|NCT00910247|467206128|FG000|Overall Study|Protocol Violation|10|||
129791688|NCT00910247|467206128|FG000|Overall Study|Withdrawal by Subject|25|||
129887351|NCT01474512|467547284|FG012|Maintenance Period|Physician Decision|0|||
129791689|NCT00910247|467206128|FG000|Overall Study|Not collected|4|||
129791690|NCT02927067|467206129|FG000|Overall Study|Withdrawn Consent|20|||
129791691|NCT02927067|467206130|FG001|Overall Study|Withdrawn Consent|12|||
129791692|NCT02927067|467206129|FG000|Overall Study|Death|18|||
129791693|NCT02927067|467206130|FG001|Overall Study|Death|31|||
129616860|NCT02185053|466549799|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
129616861|NCT02185053|466549800|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129616862|NCT02185053|466549801|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129616863|NCT02185053|466549799|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
129616864|NCT02185053|466549800|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
129616865|NCT02185053|466549801|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
129616866|NCT02185053|466549799|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
129616867|NCT02185053|466549800|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
129616868|NCT02185053|466549801|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
129616869|NCT02185053|466549799|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129616870|NCT02185053|466549800|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
129616871|NCT02185053|466549801|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
129616872|NCT02185053|466549799|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
129616873|NCT02185053|466549800|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
129616874|NCT02185053|466549801|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
129616875|NCT02185053|466549799|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
129616876|NCT02185053|466549800|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
129616877|NCT02185053|466549801|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
129616878|NCT02185053|466549799|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
129616879|NCT02185053|466549800|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
129616880|NCT02185053|466549801|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
129616881|NCT03597464|466549804|FG000|Overall Study|Withdrawal by Subject|4|||
129616882|NCT03597464|466549805|FG001|Overall Study|Withdrawal by Subject|5|||
129616883|NCT03597464|466549804|FG000|Overall Study|Lost to Follow-up|3|||
129616884|NCT03597464|466549805|FG001|Overall Study|Lost to Follow-up|1|||
129616885|NCT03597464|466549804|FG000|Overall Study|Pregnancy|3|||
129616886|NCT03597464|466549805|FG001|Overall Study|Pregnancy|1|||
129616887|NCT03597464|466549804|FG000|Overall Study|Lack of Efficacy|2|||
129616888|NCT03597464|466549805|FG001|Overall Study|Lack of Efficacy|0|||
129616889|NCT03597464|466549804|FG000|Overall Study|Physician Decision|2|||
129616890|NCT03597464|466549805|FG001|Overall Study|Physician Decision|2|||
129616891|NCT03597464|466549804|FG000|Overall Study|Protocol Violation|1|||
129616892|NCT03597464|466549805|FG001|Overall Study|Protocol Violation|1|||
129616893|NCT03597464|466549804|FG000|Overall Study|Adverse Event|0|||
129616894|NCT03597464|466549805|FG001|Overall Study|Adverse Event|2|||
129616895|NCT03597464|466549804|FG000|Overall Study|Death|0|||
129616896|NCT03597464|466549805|FG001|Overall Study|Death|3|||
129616897|NCT02542605|466549808|FG000|Part B: Challenge Phase|Sponsor decision|1|||
129616898|NCT02542605|466549809|FG001|Part B: Challenge Phase|Sponsor decision|0|||
129616899|NCT02542605|466549810|FG002|Part B: Challenge Phase|Sponsor decision|0|||
129616900|NCT02542605|466549808|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
129616901|NCT02542605|466549809|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
129616902|NCT02542605|466549810|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
129616903|NCT02682927|466549811|FG000|Overall Study|Adverse Event|0|||
129616904|NCT02682927|466549812|FG001|Overall Study|Adverse Event|0|||
129616905|NCT02682927|466549813|FG002|Overall Study|Adverse Event|5|||
129616906|NCT02682927|466549814|FG003|Overall Study|Adverse Event|1|||
129616907|NCT02682927|466549815|FG004|Overall Study|Adverse Event|0|||
129616908|NCT02682927|466549816|FG005|Overall Study|Adverse Event|2|||
129616909|NCT02682927|466549811|FG000|Overall Study|Death|0|||
129616910|NCT02682927|466549812|FG001|Overall Study|Death|0|||
129616911|NCT02682927|466549813|FG002|Overall Study|Death|0|||
129616912|NCT02682927|466549814|FG003|Overall Study|Death|1|||
129791694|NCT02927067|467206129|FG000|Overall Study|Adverse Event|13|||
129791695|NCT02927067|467206130|FG001|Overall Study|Adverse Event|10|||
129791696|NCT02927067|467206129|FG000|Overall Study|Noncompliance|5|||
129791697|NCT02927067|467206130|FG001|Overall Study|Noncompliance|2|||
129791698|NCT02927067|467206129|FG000|Overall Study|Reason not Specified|4|||
129791699|NCT02927067|467206130|FG001|Overall Study|Reason not Specified|6|||
129791700|NCT01727700|467206133|FG000|Overall Study|Adverse Event|0|||
129791701|NCT01727700|467206134|FG001|Overall Study|Adverse Event|7|||
129791702|NCT01727700|467206135|FG002|Overall Study|Adverse Event|1|||
129791703|NCT01727700|467206133|FG000|Overall Study|Particpant withdrew consent|0|||
129791704|NCT01727700|467206134|FG001|Overall Study|Particpant withdrew consent|3|||
129616913|NCT02682927|466549815|FG004|Overall Study|Death|0|||
129616914|NCT02682927|466549816|FG005|Overall Study|Death|0|||
129616915|NCT02682927|466549811|FG000|Overall Study|Lack of Efficacy|1|||
129791705|NCT01727700|467206135|FG002|Overall Study|Particpant withdrew consent|1|||
129791706|NCT01727700|467206133|FG000|Overall Study|Protocol Violation|2|||
129616916|NCT02682927|466549812|FG001|Overall Study|Lack of Efficacy|0|||
129616917|NCT02682927|466549813|FG002|Overall Study|Lack of Efficacy|0|||
129616918|NCT02682927|466549814|FG003|Overall Study|Lack of Efficacy|1|||
129616919|NCT02682927|466549815|FG004|Overall Study|Lack of Efficacy|0|||
129616920|NCT02682927|466549816|FG005|Overall Study|Lack of Efficacy|0|||
129616921|NCT02682927|466549811|FG000|Overall Study|Other|0|||
129616922|NCT02682927|466549812|FG001|Overall Study|Other|0|||
129616923|NCT02682927|466549813|FG002|Overall Study|Other|0|||
129616924|NCT02682927|466549814|FG003|Overall Study|Other|2|||
129616925|NCT02682927|466549815|FG004|Overall Study|Other|0|||
129616926|NCT02682927|466549816|FG005|Overall Study|Other|0|||
129616927|NCT02682927|466549811|FG000|Overall Study|Withdrawal by Subject|2|||
129616928|NCT02682927|466549812|FG001|Overall Study|Withdrawal by Subject|0|||
129616929|NCT02682927|466549813|FG002|Overall Study|Withdrawal by Subject|1|||
129616930|NCT02682927|466549814|FG003|Overall Study|Withdrawal by Subject|0|||
129616931|NCT02682927|466549815|FG004|Overall Study|Withdrawal by Subject|1|||
129616932|NCT02682927|466549816|FG005|Overall Study|Withdrawal by Subject|1|||
129616933|NCT05314816|466549818|FG000|Overall Study|Lost to Follow-up|5|||
129616934|NCT05314816|466549819|FG001|Overall Study|Lost to Follow-up|0|||
129616935|NCT05314816|466549820|FG002|Overall Study|Lost to Follow-up|1|||
129616936|NCT05314816|466549818|FG000|Overall Study|Protocol Violation|13|||
129616937|NCT05314816|466549819|FG001|Overall Study|Protocol Violation|8|||
129616938|NCT05314816|466549820|FG002|Overall Study|Protocol Violation|0|||
129616939|NCT01810302|466551766|FG000|Overall Study|Death|1|||
129616940|NCT01810302|466551767|FG001|Overall Study|Death|0|||
129616941|NCT01810302|466551766|FG000|Overall Study|Physician Decision|0|||
129616942|NCT01810302|466551767|FG001|Overall Study|Physician Decision|1|||
129791707|NCT01727700|467206134|FG001|Overall Study|Protocol Violation|0|||
129791708|NCT01727700|467206135|FG002|Overall Study|Protocol Violation|0|||
129791709|NCT01757691|467206139|FG000|Overall Study|Administrative problems|2|||
129791710|NCT01757691|467206140|FG001|Overall Study|Administrative problems|0|||
129791711|NCT02054481|467206143|FG000|Overall Study|Adverse Event|1|||
129791712|NCT02054481|467206144|FG001|Overall Study|Adverse Event|1|||
129791713|NCT02054481|467206145|FG002|Overall Study|Adverse Event|0|||
129791714|NCT02054481|467206146|FG003|Overall Study|Adverse Event|1|||
129791715|NCT02054481|467206143|FG000|Overall Study|Lost to Follow-up|1|||
129791716|NCT02054481|467206144|FG001|Overall Study|Lost to Follow-up|0|||
129791717|NCT02054481|467206145|FG002|Overall Study|Lost to Follow-up|0|||
129791718|NCT02054481|467206146|FG003|Overall Study|Lost to Follow-up|0|||
129791719|NCT02054481|467206143|FG000|Overall Study|Other reason|2|||
129791720|NCT02054481|467206144|FG001|Overall Study|Other reason|1|||
129791721|NCT02054481|467206145|FG002|Overall Study|Other reason|2|||
129791722|NCT02054481|467206146|FG003|Overall Study|Other reason|0|||
129791723|NCT02320903|467206147|FG000|Overall Study|Withdrawal by Subject|0|||
129791724|NCT02320903|467206148|FG001|Overall Study|Withdrawal by Subject|9|||
129791725|NCT02320903|467206149|FG002|Overall Study|Withdrawal by Subject|9|||
129791726|NCT02320903|467206147|FG000|Overall Study|Exited therapy; no longer eligible|8|||
129791727|NCT02320903|467206148|FG001|Overall Study|Exited therapy; no longer eligible|2|||
129791728|NCT02320903|467206149|FG002|Overall Study|Exited therapy; no longer eligible|2|||
129791729|NCT02320903|467206147|FG000|Overall Study|Lost to Follow-up|0|||
129791730|NCT02320903|467206148|FG001|Overall Study|Lost to Follow-up|5|||
129791731|NCT02320903|467206149|FG002|Overall Study|Lost to Follow-up|5|||
129791732|NCT01095094|467206153|FG000|Overall Study|Withdrawal by Subject|1|||
129791733|NCT01095094|467206153|FG000|Overall Study|Death|1|||
129791734|NCT01095094|467206153|FG000|Overall Study|Physician Decision|1|||
129791735|NCT05347147|467206154|FG000|Overall Study|Lost to Follow-up|0|||
129791736|NCT05347147|467206155|FG001|Overall Study|Lost to Follow-up|1|||
129791737|NCT05347147|467206154|FG000|Overall Study|Sponsor request|3|||
129791738|NCT05347147|467206155|FG001|Overall Study|Sponsor request|3|||
129791739|NCT05347147|467206154|FG000|Overall Study|Study termination|2|||
129616943|NCT04981717|466551771|FG000|Overall Study|Protocol Violation|0|||
129616944|NCT04981717|466551772|FG001|Overall Study|Protocol Violation|3|||
129616945|NCT04981717|466551771|FG000|Overall Study|Adverse Event|1|||
129616946|NCT04981717|466551772|FG001|Overall Study|Adverse Event|3|||
129616947|NCT04981717|466551771|FG000|Overall Study|Pregnancy|1|||
129616948|NCT04981717|466551772|FG001|Overall Study|Pregnancy|0|||
129791740|NCT05347147|467206155|FG001|Overall Study|Study termination|1|||
129791741|NCT01122394|467206160|FG000|Overall Study|Withdrawal by Subject|1|||
129791742|NCT01122394|467206161|FG001|Overall Study|Withdrawal by Subject|1|||
129791743|NCT01122394|467206160|FG000|Overall Study|Lost to Follow-up|2|||
129887352|NCT01474512|467547285|FG013|Maintenance Period|Physician Decision|0|||
129791744|NCT01122394|467206161|FG001|Overall Study|Lost to Follow-up|2|||
129791745|NCT01122394|467206160|FG000|Overall Study|Adverse Event|0|||
129616949|NCT04981717|466551771|FG000|Overall Study|Physician Decision|1|||
129791746|NCT01122394|467206161|FG001|Overall Study|Adverse Event|1|||
129791747|NCT02446743|467206162|FG000|Overall Study|Withdrawal by Subject|1|||
129791748|NCT02446743|467206163|FG001|Overall Study|Withdrawal by Subject|1|||
129791749|NCT02446743|467206162|FG000|Overall Study|Lost to Follow-up|1|||
129791750|NCT02446743|467206163|FG001|Overall Study|Lost to Follow-up|0|||
129791751|NCT02446743|467206162|FG000|Overall Study|Adverse Event|1|||
129791752|NCT02446743|467206163|FG001|Overall Study|Adverse Event|1|||
129791753|NCT02446743|467206162|FG000|Overall Study|Other|2|||
129791754|NCT02446743|467206163|FG001|Overall Study|Other|3|||
129791755|NCT03361176|467206164|FG000|Overall Study|Lost to Follow-up|1|||
129791756|NCT03361176|467206165|FG001|Overall Study|Lost to Follow-up|2|||
129791757|NCT03361176|467206164|FG000|Overall Study|Adverse Event|0|||
129791758|NCT03361176|467206165|FG001|Overall Study|Adverse Event|2|||
129791759|NCT03361176|467206164|FG000|Overall Study|Withdrawal by Subject|0|||
129791760|NCT03361176|467206165|FG001|Overall Study|Withdrawal by Subject|1|||
129791761|NCT03718299|467206166|FG000|Overall Study|Adverse Event|1|||
129791762|NCT03718299|467206166|FG000|Overall Study|Withdrawal by Subject|6|||
129791763|NCT03718299|467206166|FG000|Overall Study|Physician Decision|2|||
129791764|NCT03718299|467206166|FG000|Overall Study|Lost to Follow-up|1|||
129791765|NCT04389970|467206167|FG000|Overall Study|Lost to Follow-up|1|||
129791766|NCT01931670|467206169|FG000|Treatment Period|Exclusionary Medication Received|1|||
129616950|NCT04981717|466551772|FG001|Overall Study|Physician Decision|0|||
129616951|NCT04981717|466551771|FG000|Overall Study|Sponsor Request|157|||
129616952|NCT04981717|466551772|FG001|Overall Study|Sponsor Request|172|||
129616953|NCT04981717|466551771|FG000|Overall Study|Lost to Follow-up|4|||
129616954|NCT04981717|466551772|FG001|Overall Study|Lost to Follow-up|5|||
129616955|NCT04981717|466551771|FG000|Overall Study|Withdrawal by Subject|50|||
129616956|NCT04981717|466551772|FG001|Overall Study|Withdrawal by Subject|37|||
129616957|NCT02207634|466551773|FG000|Overall Study|Withdrawal by Subject|21|||
129616958|NCT02207634|466551774|FG001|Overall Study|Withdrawal by Subject|31|||
129616959|NCT02207634|466551773|FG000|Overall Study|Lost to Follow-up|1|||
129616960|NCT02207634|466551774|FG001|Overall Study|Lost to Follow-up|0|||
129616961|NCT00887289|466551775|FG000|Overall Study|Lack of Efficacy|14|||
129616962|NCT00887289|466551775|FG000|Overall Study|Adverse Event|27|||
129616963|NCT00887289|466551775|FG000|Overall Study|Withdrawal by Subject|26|||
129616964|NCT00887289|466551775|FG000|Overall Study|Lost to Follow-up|8|||
129616965|NCT00887289|466551775|FG000|Overall Study|Other|20|||
129616966|NCT00591773|466551776|FG000|Overall Study|Adverse Event|9|||
129616967|NCT00591773|466551777|FG001|Overall Study|Adverse Event|9|||
129616968|NCT00591773|466551778|FG002|Overall Study|Adverse Event|6|||
129616969|NCT00591773|466551776|FG000|Overall Study|Protocol Violation|2|||
129616970|NCT00591773|466551777|FG001|Overall Study|Protocol Violation|3|||
129616971|NCT00591773|466551778|FG002|Overall Study|Protocol Violation|0|||
129616972|NCT00591773|466551776|FG000|Overall Study|Lost to Follow-up|1|||
129616973|NCT00591773|466551777|FG001|Overall Study|Lost to Follow-up|4|||
129616974|NCT00591773|466551778|FG002|Overall Study|Lost to Follow-up|1|||
129616975|NCT00591773|466551776|FG000|Overall Study|Withdrawal by Subject|2|||
129616976|NCT00591773|466551777|FG001|Overall Study|Withdrawal by Subject|5|||
129616977|NCT00591773|466551778|FG002|Overall Study|Withdrawal by Subject|3|||
129616978|NCT00591773|466551776|FG000|Overall Study|Lack of Efficacy|1|||
129616979|NCT00591773|466551777|FG001|Overall Study|Lack of Efficacy|2|||
129616980|NCT00591773|466551778|FG002|Overall Study|Lack of Efficacy|2|||
129616981|NCT00591773|466551776|FG000|Overall Study|Other|1|||
129616982|NCT00591773|466551777|FG001|Overall Study|Other|1|||
129616983|NCT00591773|466551778|FG002|Overall Study|Other|4|||
129616984|NCT01371539|466551779|FG000|Period One: One Week|Lost to Follow-up|0|||
129616985|NCT01371539|466551780|FG001|Period One: One Week|Lost to Follow-up|1|||
129616986|NCT01371539|466551779|FG000|Period Two: One Week|Lost to Follow-up|0|||
129791767|NCT01931670|467206170|FG001|Treatment Period|Exclusionary Medication Received|1|||
129791768|NCT01931670|467206171|FG002|Treatment Period|Exclusionary Medication Received|1|||
129791769|NCT01931670|467206169|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
129791770|NCT01931670|467206170|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
129791771|NCT01931670|467206171|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
129791772|NCT01931670|467206169|FG000|Treatment Period|Subject Noncompliant|4|||
129791773|NCT01931670|467206170|FG001|Treatment Period|Subject Noncompliant|9|||
129791774|NCT01931670|467206171|FG002|Treatment Period|Subject Noncompliant|5|||
129791775|NCT01931670|467206169|FG000|Treatment Period|Adverse Event|19|||
129616987|NCT01371539|466551780|FG001|Period Two: One Week|Lost to Follow-up|1|||
129616988|NCT01371539|466551779|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
129616989|NCT01371539|466551780|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
129616990|NCT01371539|466551779|FG000|Period Two: One Week|Time/job conflict|0|||
129616991|NCT01371539|466551780|FG001|Period Two: One Week|Time/job conflict|1|||
129616992|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
129616993|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
129616994|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
129791776|NCT01931670|467206170|FG001|Treatment Period|Adverse Event|8|||
129791777|NCT01931670|467206171|FG002|Treatment Period|Adverse Event|21|||
129616995|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129616996|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
129616997|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
129616998|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
129616999|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
129617000|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129617001|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
129617002|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129617003|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129617004|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
129617005|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129617006|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
129617007|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
129617008|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
129617009|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
129617010|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
129617011|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
129617012|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
129617013|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129617014|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
129617015|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129617016|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
129617017|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129617018|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129617019|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
129617020|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129617021|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
129617022|NCT03713632|466551781|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
129617023|NCT03713632|466551782|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129617024|NCT03713632|466551783|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129617025|NCT03713632|466551784|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129617026|NCT03713632|466551785|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
129617027|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
129617028|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
129617029|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
129617030|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
129617031|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
129700999|NCT03038620|466866015|FG000|Overall Study|Withdrawal by Subject|0|||
129701000|NCT03038620|466866016|FG001|Overall Study|Withdrawal by Subject|15|||
129701001|NCT03038620|466866015|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
129701002|NCT03038620|466866016|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
129701003|NCT00759395|466866022|FG000|Overall Study|Adverse Event|1|||
129701004|NCT00759395|466866023|FG001|Overall Study|Adverse Event|0|||
129701005|NCT00759395|466866022|FG000|Overall Study|Withdrawal by Subject|1|||
129701006|NCT00759395|466866023|FG001|Overall Study|Withdrawal by Subject|0|||
129701007|NCT00759395|466866022|FG000|Overall Study|Lack of Efficacy|0|||
129701008|NCT00759395|466866023|FG001|Overall Study|Lack of Efficacy|2|||
129701009|NCT01435356|466866024|FG000|Overall Study|Adverse Event|2|||
129701010|NCT01435356|466866025|FG001|Overall Study|Adverse Event|0|||
129701011|NCT01435356|466866024|FG000|Overall Study|Disease progression/recurrence|17|||
129701012|NCT01435356|466866025|FG001|Overall Study|Disease progression/recurrence|10|||
129701013|NCT01435356|466866024|FG000|Overall Study|Protocol Violation|0|||
129701014|NCT01435356|466866025|FG001|Overall Study|Protocol Violation|1|||
129701015|NCT01435356|466866024|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
129701016|NCT01435356|466866025|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
129701017|NCT01435356|466866024|FG000|Overall Study|Withdrawal by Subject|1|||
129701018|NCT01435356|466866025|FG001|Overall Study|Withdrawal by Subject|1|||
129701019|NCT01435356|466866024|FG000|Overall Study|Facial palsy|1|||
129701020|NCT01435356|466866025|FG001|Overall Study|Facial palsy|0|||
129701021|NCT01435356|466866024|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
129701022|NCT01435356|466866025|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
129701023|NCT01435356|466866024|FG000|Overall Study|Physician Decision|1|||
129617032|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
129617033|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
129701024|NCT01435356|466866025|FG001|Overall Study|Physician Decision|0|||
129701025|NCT01435356|466866024|FG000|Overall Study|Patient decision|3|||
129791778|NCT01931670|467206169|FG000|Treatment Period|Lack of Efficacy|11|||
129617034|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
129617035|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
129617036|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
129617037|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
129617038|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
129617039|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
129617040|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
129617041|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
129617042|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
129617043|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
129617044|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
129617045|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
129617046|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
129617047|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
129617048|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
129617049|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129617050|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
129617051|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
129617052|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
129617053|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129617054|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129617055|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129617056|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
129617057|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Death|0|||
129617058|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Death|1|||
129617059|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Death|0|||
129617060|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Death|0|||
129617061|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Death|0|||
129617062|NCT03713632|466551781|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129617063|NCT03713632|466551782|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
129617064|NCT03713632|466551783|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129617065|NCT03713632|466551784|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129617066|NCT03713632|466551785|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
129617067|NCT01098474|466551786|FG000|Active Phase|Other|0|||
129617068|NCT01098474|466551787|FG001|Active Phase|Other|0|||
129617069|NCT01098474|466551788|FG002|Active Phase|Other|3|||
129617070|NCT01098474|466551789|FG003|Active Phase|Other|0|||
129617071|NCT01098474|466551790|FG004|Active Phase|Other|0|||
129617072|NCT01098474|466551791|FG005|Active Phase|Other|0|||
129617073|NCT01098474|466551786|FG000|Active Phase|Withdrawal by Subject|1|||
129617074|NCT01098474|466551787|FG001|Active Phase|Withdrawal by Subject|1|||
129617075|NCT01098474|466551788|FG002|Active Phase|Withdrawal by Subject|2|||
129617076|NCT01098474|466551789|FG003|Active Phase|Withdrawal by Subject|0|||
129617077|NCT01098474|466551790|FG004|Active Phase|Withdrawal by Subject|0|||
129617078|NCT01098474|466551791|FG005|Active Phase|Withdrawal by Subject|0|||
129791779|NCT01931670|467206170|FG001|Treatment Period|Lack of Efficacy|2|||
129791780|NCT01931670|467206171|FG002|Treatment Period|Lack of Efficacy|2|||
129791781|NCT01931670|467206169|FG000|Treatment Period|Pregnancy|7|||
129791782|NCT01931670|467206170|FG001|Treatment Period|Pregnancy|2|||
129791783|NCT01931670|467206171|FG002|Treatment Period|Pregnancy|0|||
129791784|NCT01931670|467206169|FG000|Treatment Period|Other|8|||
129791785|NCT01931670|467206170|FG001|Treatment Period|Other|7|||
129791786|NCT01931670|467206171|FG002|Treatment Period|Other|2|||
129791787|NCT01931670|467206169|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
129791788|NCT01931670|467206170|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
129617079|NCT01098474|466551786|FG000|Active Phase|Lost to Follow-up|1|||
129617080|NCT01098474|466551787|FG001|Active Phase|Lost to Follow-up|0|||
129791789|NCT01931670|467206171|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
129791790|NCT01931670|467206169|FG000|Treatment Period|Lost to Follow-up|19|||
129791791|NCT01931670|467206170|FG001|Treatment Period|Lost to Follow-up|5|||
129617081|NCT01098474|466551788|FG002|Active Phase|Lost to Follow-up|0|||
129617082|NCT01098474|466551789|FG003|Active Phase|Lost to Follow-up|0|||
129791792|NCT01931670|467206171|FG002|Treatment Period|Lost to Follow-up|7|||
129617083|NCT01098474|466551790|FG004|Active Phase|Lost to Follow-up|0|||
129791793|NCT01931670|467206169|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
129791794|NCT01931670|467206170|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
129617084|NCT01098474|466551791|FG005|Active Phase|Lost to Follow-up|0|||
129617085|NCT01098474|466551786|FG000|Follow Up Phase|Travelled out of study area|0|||
129617086|NCT01098474|466551787|FG001|Follow Up Phase|Travelled out of study area|0|||
129617087|NCT01098474|466551788|FG002|Follow Up Phase|Travelled out of study area|0|||
129617088|NCT01098474|466551789|FG003|Follow Up Phase|Travelled out of study area|0|||
129617089|NCT01098474|466551790|FG004|Follow Up Phase|Travelled out of study area|1|||
129617090|NCT01098474|466551791|FG005|Follow Up Phase|Travelled out of study area|0|||
129617091|NCT01098474|466551786|FG000|Follow Up Phase|Other|0|||
129617092|NCT01098474|466551787|FG001|Follow Up Phase|Other|0|||
129617093|NCT01098474|466551788|FG002|Follow Up Phase|Other|0|||
129617094|NCT01098474|466551789|FG003|Follow Up Phase|Other|0|||
129617095|NCT01098474|466551790|FG004|Follow Up Phase|Other|0|||
129617096|NCT01098474|466551791|FG005|Follow Up Phase|Other|4|||
129617097|NCT01098474|466551786|FG000|Follow Up Phase|Withdrawal by Subject|0|||
129617098|NCT01098474|466551787|FG001|Follow Up Phase|Withdrawal by Subject|0|||
129617099|NCT01098474|466551788|FG002|Follow Up Phase|Withdrawal by Subject|0|||
129617100|NCT01098474|466551789|FG003|Follow Up Phase|Withdrawal by Subject|2|||
129617101|NCT01098474|466551790|FG004|Follow Up Phase|Withdrawal by Subject|0|||
129617102|NCT01098474|466551791|FG005|Follow Up Phase|Withdrawal by Subject|1|||
129617103|NCT01098474|466551786|FG000|Follow Up Phase|Lost to Follow-up|0|||
129617104|NCT01098474|466551787|FG001|Follow Up Phase|Lost to Follow-up|0|||
129617105|NCT01098474|466551788|FG002|Follow Up Phase|Lost to Follow-up|0|||
129617106|NCT01098474|466551789|FG003|Follow Up Phase|Lost to Follow-up|0|||
129617107|NCT01098474|466551790|FG004|Follow Up Phase|Lost to Follow-up|1|||
129617108|NCT01098474|466551791|FG005|Follow Up Phase|Lost to Follow-up|0|||
129617109|NCT02165735|466551794|FG000|Overall Study|Lost to Follow-up|12|||
129617110|NCT02165735|466551795|FG001|Overall Study|Lost to Follow-up|10|||
129617111|NCT02165735|466551794|FG000|Overall Study|Withdrawal by Subject|3|||
129617112|NCT02165735|466551795|FG001|Overall Study|Withdrawal by Subject|0|||
129701026|NCT01435356|466866025|FG001|Overall Study|Patient decision|0|||
129887353|NCT01474512|467547286|FG014|Maintenance Period|Physician Decision|0|||
129887354|NCT01474512|467547287|FG015|Maintenance Period|Physician Decision|0|||
129887355|NCT01474512|467547288|FG016|Maintenance Period|Physician Decision|0|||
129887356|NCT01474512|467547289|FG017|Maintenance Period|Physician Decision|0|||
129887357|NCT01474512|467547272|FG000|Maintenance Period|Clinical Relapse|0|||
129887358|NCT01474512|467547273|FG001|Maintenance Period|Clinical Relapse|0|||
129887359|NCT01474512|467547274|FG002|Maintenance Period|Clinical Relapse|0|||
129887360|NCT01474512|467547275|FG003|Maintenance Period|Clinical Relapse|1|||
129887361|NCT01474512|467547276|FG004|Maintenance Period|Clinical Relapse|0|||
129887362|NCT01474512|467547277|FG005|Maintenance Period|Clinical Relapse|0|||
129887363|NCT01474512|467547278|FG006|Maintenance Period|Clinical Relapse|0|||
129887364|NCT01474512|467547279|FG007|Maintenance Period|Clinical Relapse|0|||
129887365|NCT01474512|467547280|FG008|Maintenance Period|Clinical Relapse|0|||
129887366|NCT01474512|467547281|FG009|Maintenance Period|Clinical Relapse|0|||
129887367|NCT01474512|467547282|FG010|Maintenance Period|Clinical Relapse|0|||
129887368|NCT01474512|467547283|FG011|Maintenance Period|Clinical Relapse|0|||
129887369|NCT01474512|467547284|FG012|Maintenance Period|Clinical Relapse|0|||
129887370|NCT01474512|467547285|FG013|Maintenance Period|Clinical Relapse|0|||
129887371|NCT01474512|467547286|FG014|Maintenance Period|Clinical Relapse|0|||
129887372|NCT01474512|467547287|FG015|Maintenance Period|Clinical Relapse|0|||
129887373|NCT01474512|467547288|FG016|Maintenance Period|Clinical Relapse|0|||
129887374|NCT01474512|467547289|FG017|Maintenance Period|Clinical Relapse|0|||
129887375|NCT01474512|467547272|FG000|Maintenance Period|Lack of Efficacy|0|||
129887376|NCT01474512|467547273|FG001|Maintenance Period|Lack of Efficacy|0|||
129887377|NCT01474512|467547274|FG002|Maintenance Period|Lack of Efficacy|0|||
129887378|NCT01474512|467547275|FG003|Maintenance Period|Lack of Efficacy|1|||
129887379|NCT01474512|467547276|FG004|Maintenance Period|Lack of Efficacy|0|||
129887380|NCT01474512|467547277|FG005|Maintenance Period|Lack of Efficacy|0|||
129887381|NCT01474512|467547278|FG006|Maintenance Period|Lack of Efficacy|0|||
129617113|NCT02165735|466551794|FG000|Overall Study|Participant indicated lack of time|1|||
129617114|NCT02165735|466551795|FG001|Overall Study|Participant indicated lack of time|3|||
129887382|NCT01474512|467547279|FG007|Maintenance Period|Lack of Efficacy|11|||
129887383|NCT01474512|467547280|FG008|Maintenance Period|Lack of Efficacy|11|||
129887384|NCT01474512|467547281|FG009|Maintenance Period|Lack of Efficacy|12|||
129887385|NCT01474512|467547282|FG010|Maintenance Period|Lack of Efficacy|0|||
129887386|NCT01474512|467547283|FG011|Maintenance Period|Lack of Efficacy|0|||
129887387|NCT01474512|467547284|FG012|Maintenance Period|Lack of Efficacy|0|||
129617115|NCT02165735|466551794|FG000|Overall Study|Protocol Violation|0|||
129617116|NCT02165735|466551795|FG001|Overall Study|Protocol Violation|1|||
129617117|NCT02784795|466551796|FG000|Overall Study|Progressive Disease|2|||
129617118|NCT02784795|466551797|FG001|Overall Study|Progressive Disease|1|||
129887388|NCT01474512|467547285|FG013|Maintenance Period|Lack of Efficacy|0|||
129617119|NCT02784795|466551798|FG002|Overall Study|Progressive Disease|1|||
129887389|NCT01474512|467547286|FG014|Maintenance Period|Lack of Efficacy|0|||
129617120|NCT02784795|466551799|FG003|Overall Study|Progressive Disease|0|||
129617121|NCT02784795|466551800|FG004|Overall Study|Progressive Disease|2|||
129617122|NCT02784795|466551801|FG005|Overall Study|Progressive Disease|0|||
129617123|NCT02784795|466551802|FG006|Overall Study|Progressive Disease|2|||
129617124|NCT02784795|466551803|FG007|Overall Study|Progressive Disease|0|||
129617125|NCT02784795|466551804|FG008|Overall Study|Progressive Disease|0|||
129617126|NCT02784795|466551805|FG009|Overall Study|Progressive Disease|0|||
129617127|NCT02784795|466551806|FG010|Overall Study|Progressive Disease|1|||
129617128|NCT02784795|466551807|FG011|Overall Study|Progressive Disease|0|||
129617129|NCT02784795|466551796|FG000|Overall Study|Adverse Event|1|||
129617130|NCT02784795|466551797|FG001|Overall Study|Adverse Event|0|||
129617131|NCT02784795|466551798|FG002|Overall Study|Adverse Event|0|||
129617132|NCT02784795|466551799|FG003|Overall Study|Adverse Event|1|||
129617133|NCT02784795|466551800|FG004|Overall Study|Adverse Event|0|||
129617134|NCT02784795|466551801|FG005|Overall Study|Adverse Event|0|||
129617135|NCT02784795|466551802|FG006|Overall Study|Adverse Event|1|||
129617136|NCT02784795|466551803|FG007|Overall Study|Adverse Event|0|||
129617137|NCT02784795|466551804|FG008|Overall Study|Adverse Event|0|||
129617138|NCT02784795|466551805|FG009|Overall Study|Adverse Event|0|||
129617139|NCT02784795|466551806|FG010|Overall Study|Adverse Event|0|||
129617140|NCT02784795|466551807|FG011|Overall Study|Adverse Event|2|||
129617141|NCT02784795|466551796|FG000|Overall Study|Withdrawal by Subject|1|||
129617142|NCT02784795|466551797|FG001|Overall Study|Withdrawal by Subject|0|||
129617143|NCT02784795|466551798|FG002|Overall Study|Withdrawal by Subject|2|||
129617144|NCT02784795|466551799|FG003|Overall Study|Withdrawal by Subject|1|||
129617145|NCT02784795|466551800|FG004|Overall Study|Withdrawal by Subject|3|||
129617146|NCT02784795|466551801|FG005|Overall Study|Withdrawal by Subject|0|||
129617147|NCT02784795|466551802|FG006|Overall Study|Withdrawal by Subject|0|||
129617148|NCT02784795|466551803|FG007|Overall Study|Withdrawal by Subject|1|||
129617149|NCT02784795|466551804|FG008|Overall Study|Withdrawal by Subject|0|||
129617150|NCT02784795|466551805|FG009|Overall Study|Withdrawal by Subject|0|||
129617151|NCT02784795|466551806|FG010|Overall Study|Withdrawal by Subject|0|||
129617152|NCT02784795|466551807|FG011|Overall Study|Withdrawal by Subject|2|||
129617153|NCT02784795|466551796|FG000|Overall Study|Death|0|||
129617154|NCT02784795|466551797|FG001|Overall Study|Death|0|||
129617155|NCT02784795|466551798|FG002|Overall Study|Death|0|||
129617156|NCT02784795|466551799|FG003|Overall Study|Death|0|||
129617157|NCT02784795|466551800|FG004|Overall Study|Death|1|||
129617158|NCT02784795|466551801|FG005|Overall Study|Death|0|||
129617159|NCT02784795|466551802|FG006|Overall Study|Death|0|||
129617160|NCT02784795|466551803|FG007|Overall Study|Death|0|||
129617161|NCT02784795|466551804|FG008|Overall Study|Death|0|||
129617162|NCT02784795|466551805|FG009|Overall Study|Death|0|||
129617163|NCT02784795|466551806|FG010|Overall Study|Death|0|||
129617164|NCT02784795|466551807|FG011|Overall Study|Death|0|||
129617165|NCT02784795|466551796|FG000|Overall Study|Physician Decision|0|||
129617166|NCT02784795|466551797|FG001|Overall Study|Physician Decision|0|||
129617167|NCT02784795|466551798|FG002|Overall Study|Physician Decision|0|||
129617168|NCT02784795|466551799|FG003|Overall Study|Physician Decision|0|||
129617169|NCT02784795|466551800|FG004|Overall Study|Physician Decision|0|||
129617170|NCT02784795|466551801|FG005|Overall Study|Physician Decision|0|||
129617171|NCT02784795|466551802|FG006|Overall Study|Physician Decision|1|||
129617172|NCT02784795|466551803|FG007|Overall Study|Physician Decision|0|||
129617173|NCT02784795|466551804|FG008|Overall Study|Physician Decision|0|||
129617174|NCT02784795|466551805|FG009|Overall Study|Physician Decision|0|||
129617175|NCT02784795|466551806|FG010|Overall Study|Physician Decision|0|||
129617176|NCT02784795|466551807|FG011|Overall Study|Physician Decision|0|||
129617177|NCT00595309|466551808|FG000|Overall Study|Lost to Follow-up|1|||
129617178|NCT00595309|466551808|FG000|Overall Study|planned vaccination against yellow fever|1|||
129617179|NCT00595309|466551808|FG000|Overall Study|acute infection after V0|1|||
129617180|NCT00595309|466551808|FG000|Overall Study|personal reason|1|||
129617181|NCT00626561|466551811|FG000|Overall Study|Withdrawal by Subject|2|||
129617182|NCT00626561|466551811|FG000|Overall Study|Disease Progression|2|||
129617183|NCT00101283|466551812|FG000|Overall Study|Withdrawal by Subject|0|||
129617184|NCT00101283|466551813|FG001|Overall Study|Withdrawal by Subject|1|||
129617185|NCT00101283|466551812|FG000|Overall Study|Insurance Refusal|0|||
129617186|NCT00101283|466551813|FG001|Overall Study|Insurance Refusal|1|||
129617187|NCT00101283|466551812|FG000|Overall Study|Prostate Cancer Recurrence|0|||
129617188|NCT00101283|466551813|FG001|Overall Study|Prostate Cancer Recurrence|1|||
129617189|NCT00398866|466551820|FG000|Overall Study|Adverse Event|1|||
129617190|NCT00398866|466551821|FG001|Overall Study|Adverse Event|0|||
129617191|NCT00398866|466551822|FG002|Overall Study|Adverse Event|0|||
129617192|NCT00398866|466551820|FG000|Overall Study|Lack of Efficacy|0|||
129617193|NCT00398866|466551821|FG001|Overall Study|Lack of Efficacy|0|||
129617194|NCT00398866|466551822|FG002|Overall Study|Lack of Efficacy|1|||
129617195|NCT00398866|466551820|FG000|Overall Study|Lost to Follow-up|7|||
129617196|NCT00398866|466551821|FG001|Overall Study|Lost to Follow-up|6|||
129617197|NCT00398866|466551822|FG002|Overall Study|Lost to Follow-up|4|||
129617198|NCT00398866|466551820|FG000|Overall Study|Withdrawal by Subject|5|||
129617199|NCT00398866|466551821|FG001|Overall Study|Withdrawal by Subject|1|||
129617200|NCT00398866|466551822|FG002|Overall Study|Withdrawal by Subject|2|||
129617201|NCT00398866|466551820|FG000|Overall Study|Unable to complete requirements of study|1|||
129617202|NCT00398866|466551821|FG001|Overall Study|Unable to complete requirements of study|1|||
129617203|NCT00398866|466551822|FG002|Overall Study|Unable to complete requirements of study|1|||
129617204|NCT00442962|466551826|FG000|Overall Study|Pregnancy|1|||
129617205|NCT00442962|466551826|FG000|Overall Study|Lost to Follow-up|7|||
129617206|NCT03633825|466551827|FG000|Enrollment|Did not post on network|5066|||
129617207|NCT03633825|466551828|FG001|Enrollment|Did not post on network|5080|||
129617208|NCT03633825|466551827|FG000|Enrollment|Post not classified as crisis|13967|||
129617209|NCT03633825|466551828|FG001|Enrollment|Post not classified as crisis|13757|||
129617210|NCT03633825|466551827|FG000|Follow up|Lost to Follow-up|478|||
129617211|NCT03633825|466551828|FG001|Follow up|Lost to Follow-up|450|||
129617212|NCT04841577|466551830|FG000|Overall Study|Adverse Event|5|||
129617213|NCT04841577|466551831|FG001|Overall Study|Adverse Event|10|||
129617214|NCT04841577|466551830|FG000|Overall Study|Lost to Follow-up|8|||
129617215|NCT04841577|466551831|FG001|Overall Study|Lost to Follow-up|7|||
129617216|NCT04841577|466551830|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
129617217|NCT04841577|466551831|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
129617218|NCT04841577|466551830|FG000|Overall Study|Other|0|||
129617219|NCT04841577|466551831|FG001|Overall Study|Other|1|||
129617220|NCT00182325|466551832|FG000|Overall Study|Lost to Follow-up|7|||
129617221|NCT00182325|466551833|FG001|Overall Study|Lost to Follow-up|7|||
129617222|NCT00182325|466551832|FG000|Overall Study|Miscarriage|5|||
129617223|NCT00182325|466551833|FG001|Overall Study|Miscarriage|3|||
129617224|NCT00182325|466551832|FG000|Overall Study|Did not complete survey|22|||
129617225|NCT00182325|466551833|FG001|Overall Study|Did not complete survey|43|||
129617226|NCT01420965|466551838|FG000|Overall Study|Withdrawal by Subject|1|||
129617227|NCT01420965|466551839|FG001|Overall Study|Withdrawal by Subject|0|||
129617228|NCT01420965|466551840|FG002|Overall Study|Withdrawal by Subject|0|||
129617229|NCT01420965|466551838|FG000|Overall Study|Adverse Event|0|||
129617230|NCT01420965|466551839|FG001|Overall Study|Adverse Event|1|||
129791795|NCT01931670|467206171|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
129791796|NCT01931670|467206169|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
129791797|NCT01931670|467206170|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
129791798|NCT01931670|467206171|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
129791799|NCT01931670|467206169|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
129791800|NCT01931670|467206170|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
129791801|NCT01931670|467206171|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
129791802|NCT01931670|467206169|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
129791803|NCT01931670|467206170|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
129791804|NCT01931670|467206171|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
129791805|NCT01931670|467206169|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
129791806|NCT01931670|467206170|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
129791807|NCT01931670|467206171|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
129791808|NCT01931670|467206169|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
129887390|NCT01474512|467547287|FG015|Maintenance Period|Lack of Efficacy|0|||
129887391|NCT01474512|467547288|FG016|Maintenance Period|Lack of Efficacy|0|||
129887392|NCT01474512|467547289|FG017|Maintenance Period|Lack of Efficacy|0|||
129439248|NCT02245672|465906402|FG000|Overall Study|Adverse Event|4|||
129617231|NCT01420965|466551840|FG002|Overall Study|Adverse Event|0|||
129617232|NCT00339144|466551845|FG000|Overall Study|Disease progression|5|||
129617233|NCT00339144|466551846|FG001|Overall Study|Disease progression|2|||
129617234|NCT00339144|466551847|FG002|Overall Study|Disease progression|2|||
129617235|NCT00339144|466551845|FG000|Overall Study|Study drug toxicity|3|||
129617236|NCT00339144|466551846|FG001|Overall Study|Study drug toxicity|1|||
129617237|NCT00339144|466551847|FG002|Overall Study|Study drug toxicity|1|||
129617238|NCT00339144|466551845|FG000|Overall Study|Participant's request to discontinuation|1|||
129617239|NCT00339144|466551846|FG001|Overall Study|Participant's request to discontinuation|0|||
129617240|NCT00339144|466551847|FG002|Overall Study|Participant's request to discontinuation|1|||
129617241|NCT01890434|466551848|FG000|Overall Study|Adverse Event|8|||
129617242|NCT01890434|466551848|FG000|Overall Study|PCI at external hospital|1|||
129617243|NCT01890434|466551848|FG000|Overall Study|Assessment discrepancy|1|||
129617244|NCT01890434|466551848|FG000|Overall Study|CRC didn't contact participant for FU|1|||
129617245|NCT01890434|466551848|FG000|Overall Study|Could not get whole set of images|1|||
129617246|NCT01890434|466551848|FG000|Overall Study|Decline to return for GSPECT|1|||
129617247|NCT01890434|466551848|FG000|Overall Study|GSPECT at rest was not done|1|||
129617248|NCT01890434|466551848|FG000|Overall Study|Participant didn't complete MRI|1|||
129617249|NCT01890434|466551848|FG000|Overall Study|Uncontactable by phone|1|||
129617250|NCT01890434|466551848|FG000|Overall Study|Moved out of position|1|||
129617251|NCT01890434|466551848|FG000|Overall Study|Unable to contact|1|||
129617252|NCT01890434|466551848|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
129617253|NCT01141205|466551849|FG000|Overall Study|Physician Decision|1|||
129617254|NCT01141205|466551850|FG001|Overall Study|Physician Decision|1|||
129617255|NCT01141205|466551849|FG000|Overall Study|Lost to Follow-up|1|||
129617256|NCT01141205|466551850|FG001|Overall Study|Lost to Follow-up|0|||
129617257|NCT01141205|466551849|FG000|Overall Study|Withdrawal by Subject|1|||
129617258|NCT01141205|466551850|FG001|Overall Study|Withdrawal by Subject|1|||
129617259|NCT02257385|466551852|FG000|Overall Study|Adverse Event|12|||
129617260|NCT02257385|466551853|FG001|Overall Study|Adverse Event|8|||
129617261|NCT02257385|466551852|FG000|Overall Study|Lack of Efficacy|1|||
129617262|NCT02257385|466551853|FG001|Overall Study|Lack of Efficacy|2|||
129617263|NCT02257385|466551852|FG000|Overall Study|Protocol Violation|5|||
129617264|NCT02257385|466551853|FG001|Overall Study|Protocol Violation|7|||
129617265|NCT02257385|466551852|FG000|Overall Study|Lost to Follow-up|0|||
129617266|NCT02257385|466551853|FG001|Overall Study|Lost to Follow-up|1|||
129617267|NCT02257385|466551852|FG000|Overall Study|Withdrawal by Subject|4|||
129617268|NCT02257385|466551853|FG001|Overall Study|Withdrawal by Subject|4|||
129617269|NCT05199090|466551854|FG000|Overall Study|Adverse Event|1|||
129617270|NCT05199090|466551855|FG001|Overall Study|Adverse Event|4|||
129617271|NCT05199090|466551856|FG002|Overall Study|Adverse Event|0|||
129617272|NCT05199090|466551857|FG003|Overall Study|Adverse Event|0|||
129617273|NCT05199090|466551858|FG004|Overall Study|Adverse Event|0|||
129617274|NCT05199090|466551859|FG005|Overall Study|Adverse Event|0|||
129617275|NCT05199090|466551854|FG000|Overall Study|Lost to Follow-up|1|||
129617276|NCT05199090|466551855|FG001|Overall Study|Lost to Follow-up|0|||
129617277|NCT05199090|466551856|FG002|Overall Study|Lost to Follow-up|1|||
129617278|NCT05199090|466551857|FG003|Overall Study|Lost to Follow-up|4|||
129617279|NCT05199090|466551858|FG004|Overall Study|Lost to Follow-up|0|||
129617280|NCT05199090|466551859|FG005|Overall Study|Lost to Follow-up|5|||
129617281|NCT05199090|466551854|FG000|Overall Study|Physician Decision|0|||
129617282|NCT05199090|466551855|FG001|Overall Study|Physician Decision|0|||
129617283|NCT05199090|466551856|FG002|Overall Study|Physician Decision|0|||
129617284|NCT05199090|466551857|FG003|Overall Study|Physician Decision|0|||
129617285|NCT05199090|466551858|FG004|Overall Study|Physician Decision|0|||
129617286|NCT05199090|466551859|FG005|Overall Study|Physician Decision|1|||
129617287|NCT05199090|466551854|FG000|Overall Study|Study terminated by sponsor|0|||
129617288|NCT05199090|466551855|FG001|Overall Study|Study terminated by sponsor|6|||
129617289|NCT05199090|466551856|FG002|Overall Study|Study terminated by sponsor|0|||
129617290|NCT05199090|466551857|FG003|Overall Study|Study terminated by sponsor|0|||
129617291|NCT05199090|466551858|FG004|Overall Study|Study terminated by sponsor|0|||
129617292|NCT05199090|466551859|FG005|Overall Study|Study terminated by sponsor|5|||
129791809|NCT01931670|467206170|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
129791810|NCT01931670|467206171|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
129791811|NCT00976508|467206172|FG000|Overall Study|Death|7|||
129791812|NCT00976508|467206173|FG001|Overall Study|Death|1|||
129791813|NCT00976508|467206172|FG000|Overall Study|Lost to Follow-up|1|||
129791814|NCT00976508|467206173|FG001|Overall Study|Lost to Follow-up|0|||
129617293|NCT05199090|466551854|FG000|Overall Study|Subject decision|0|||
129617294|NCT05199090|466551855|FG001|Overall Study|Subject decision|4|||
129617295|NCT05199090|466551856|FG002|Overall Study|Subject decision|0|||
129791815|NCT00976508|467206172|FG000|Overall Study|Withdrawal by Subject|1|||
129617296|NCT05199090|466551857|FG003|Overall Study|Subject decision|2|||
129617297|NCT05199090|466551858|FG004|Overall Study|Subject decision|5|||
129791816|NCT00976508|467206173|FG001|Overall Study|Withdrawal by Subject|0|||
129791817|NCT00976508|467206172|FG000|Overall Study|Disease Progression|4|||
129791818|NCT00976508|467206173|FG001|Overall Study|Disease Progression|4|||
129617298|NCT05199090|466551859|FG005|Overall Study|Subject decision|2|||
129791819|NCT00976508|467206172|FG000|Overall Study|Subject Enrolled in Hospice|1|||
129617299|NCT03276078|466551861|FG000|Overall Study|Adverse Event|1|||
129617300|NCT02552732|466551862|FG000|Overall Study|Lost to Follow-up|2|||
129617301|NCT02552732|466551862|FG000|Overall Study|Physician Decision|1|||
129791820|NCT00976508|467206173|FG001|Overall Study|Subject Enrolled in Hospice|0|||
129617302|NCT02552732|466551862|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
129617303|NCT02552732|466551862|FG000|Overall Study|Withdrawal by Subject|6|||
129617304|NCT04988087|466551865|FG000|Overall Study|Adverse Event|4|||
129617305|NCT04988087|466551866|FG001|Overall Study|Adverse Event|0|||
129617306|NCT04988087|466551867|FG002|Overall Study|Adverse Event|0|||
129617307|NCT04988087|466551868|FG003|Overall Study|Adverse Event|0|||
129617308|NCT04988087|466551865|FG000|Overall Study|Withdrawal by Subject|1|||
129617309|NCT04988087|466551866|FG001|Overall Study|Withdrawal by Subject|1|||
129617310|NCT04988087|466551867|FG002|Overall Study|Withdrawal by Subject|0|||
129617311|NCT04988087|466551868|FG003|Overall Study|Withdrawal by Subject|0|||
129617312|NCT04988087|466551865|FG000|Overall Study|Technical problems|7|||
129617313|NCT04988087|466551866|FG001|Overall Study|Technical problems|9|||
129617314|NCT04988087|466551867|FG002|Overall Study|Technical problems|1|||
129617315|NCT04988087|466551868|FG003|Overall Study|Technical problems|2|||
129617316|NCT02290223|466551869|FG000|6 Months|Lost to Follow-up|9|||
129617317|NCT02290223|466551870|FG001|6 Months|Lost to Follow-up|6|||
129617318|NCT02290223|466551869|FG000|6 Months|Withdrawal by Subject|5|||
129617319|NCT02290223|466551870|FG001|6 Months|Withdrawal by Subject|0|||
129617320|NCT02290223|466551869|FG000|6 Months|deceased (not related to study)|2|||
129617321|NCT02290223|466551870|FG001|6 Months|deceased (not related to study)|0|||
129617322|NCT02290223|466551869|FG000|12 Months|Lost to Follow-up|16|||
129617323|NCT02290223|466551870|FG001|12 Months|Lost to Follow-up|10|||
129617324|NCT02290223|466551869|FG000|12 Months|Refusal|0|||
129617325|NCT02290223|466551870|FG001|12 Months|Refusal|1|||
129617326|NCT02800642|466551874|FG000|Overall Study|Death|3|||
129617327|NCT02800642|466551874|FG000|Overall Study|Other|10|||
129617328|NCT02800642|466551874|FG000|Overall Study|Physician Decision|2|||
129617329|NCT02800642|466551874|FG000|Overall Study|Adverse Event|6|||
129617330|NCT02800642|466551874|FG000|Overall Study|Withdrawal by Subject|3|||
129617331|NCT02800642|466551874|FG000|Overall Study|Lost to Follow-up|1|||
129617332|NCT01004003|466551875|FG000|Overall Study|Progressive disease|2|||
129617333|NCT01004003|466551876|FG001|Overall Study|Progressive disease|1|||
129617334|NCT01004003|466551877|FG002|Overall Study|Progressive disease|1|||
129617335|NCT01004003|466551878|FG003|Overall Study|Progressive disease|0|||
129617336|NCT01004003|466551879|FG004|Overall Study|Progressive disease|2|||
129617337|NCT01004003|466551880|FG005|Overall Study|Progressive disease|1|||
129617338|NCT01004003|466551881|FG006|Overall Study|Progressive disease|1|||
129617339|NCT01004003|466551882|FG007|Overall Study|Progressive disease|39|||
129791821|NCT00976508|467206172|FG000|Overall Study|Terminated by the Sponsor|0|||
129791822|NCT00976508|467206173|FG001|Overall Study|Terminated by the Sponsor|1|||
129791823|NCT03023046|467206177|FG000|Overall Study|Withdrawal by Subject|1|||
129791824|NCT00246571|467206180|FG000|Overall Study|Adverse Event|7|||
129791825|NCT00246571|467206181|FG001|Overall Study|Adverse Event|0|||
129791826|NCT00246571|467206180|FG000|Overall Study|Protocol Violation|0|||
129791827|NCT00246571|467206181|FG001|Overall Study|Protocol Violation|1|||
129791828|NCT00246571|467206180|FG000|Overall Study|Withdrawal by Subject|2|||
129791829|NCT00246571|467206181|FG001|Overall Study|Withdrawal by Subject|3|||
129791830|NCT00246571|467206180|FG000|Overall Study|Lack of Efficacy|84|||
129791831|NCT00246571|467206181|FG001|Overall Study|Lack of Efficacy|21|||
129791832|NCT00246571|467206180|FG000|Overall Study|Death|17|||
129791833|NCT00246571|467206181|FG001|Overall Study|Death|3|||
129791834|NCT00246571|467206180|FG000|Overall Study|Sponsor|0|||
129791835|NCT00246571|467206181|FG001|Overall Study|Sponsor|1|||
129791836|NCT00246571|467206180|FG000|Overall Study|Did not meet entrance criteria|2|||
129791837|NCT00246571|467206181|FG001|Overall Study|Did not meet entrance criteria|1|||
129791838|NCT00246571|467206180|FG000|Overall Study|Laboratory abnormalities|1|||
129791839|NCT00246571|467206181|FG001|Overall Study|Laboratory abnormalities|0|||
129791840|NCT00246571|467206180|FG000|Overall Study|Crossover participants|0|||
129791841|NCT00246571|467206181|FG001|Overall Study|Crossover participants|74|||
129617340|NCT01004003|466551883|FG008|Overall Study|Progressive disease|22|||
129617341|NCT01004003|466551875|FG000|Overall Study|Adverse Event|4|||
129617342|NCT01004003|466551876|FG001|Overall Study|Adverse Event|2|||
129617343|NCT01004003|466551877|FG002|Overall Study|Adverse Event|3|||
129617344|NCT01004003|466551878|FG003|Overall Study|Adverse Event|3|||
129617345|NCT01004003|466551879|FG004|Overall Study|Adverse Event|2|||
129617346|NCT01004003|466551880|FG005|Overall Study|Adverse Event|2|||
129791842|NCT00713310|467206188|FG000|Overall Study|Adverse Event|5|||
129791843|NCT00713310|467206189|FG001|Overall Study|Adverse Event|2|||
129791844|NCT00713310|467206188|FG000|Overall Study|Lack of Efficacy|0|||
129791845|NCT00713310|467206189|FG001|Overall Study|Lack of Efficacy|2|||
129791846|NCT00713310|467206188|FG000|Overall Study|Withdrawal by Subject|0|||
129617347|NCT01004003|466551881|FG006|Overall Study|Adverse Event|7|||
129617348|NCT01004003|466551882|FG007|Overall Study|Adverse Event|21|||
129617349|NCT01004003|466551883|FG008|Overall Study|Adverse Event|6|||
129617350|NCT01004003|466551875|FG000|Overall Study|Refused to continue taking trial med.|0|||
129617351|NCT01004003|466551876|FG001|Overall Study|Refused to continue taking trial med.|0|||
129617352|NCT01004003|466551877|FG002|Overall Study|Refused to continue taking trial med.|0|||
129617353|NCT01004003|466551878|FG003|Overall Study|Refused to continue taking trial med.|0|||
129617354|NCT01004003|466551879|FG004|Overall Study|Refused to continue taking trial med.|0|||
129617355|NCT01004003|466551880|FG005|Overall Study|Refused to continue taking trial med.|0|||
129617356|NCT01004003|466551881|FG006|Overall Study|Refused to continue taking trial med.|0|||
129617357|NCT01004003|466551882|FG007|Overall Study|Refused to continue taking trial med.|0|||
129617358|NCT01004003|466551883|FG008|Overall Study|Refused to continue taking trial med.|2|||
129617359|NCT01004003|466551875|FG000|Overall Study|Other|0|||
129617360|NCT01004003|466551876|FG001|Overall Study|Other|0|||
129791847|NCT00713310|467206189|FG001|Overall Study|Withdrawal by Subject|2|||
129617361|NCT01004003|466551877|FG002|Overall Study|Other|0|||
129617362|NCT01004003|466551878|FG003|Overall Study|Other|0|||
129617363|NCT01004003|466551879|FG004|Overall Study|Other|0|||
129617364|NCT01004003|466551880|FG005|Overall Study|Other|1|||
129617365|NCT01004003|466551881|FG006|Overall Study|Other|0|||
129617366|NCT01004003|466551882|FG007|Overall Study|Other|0|||
129617367|NCT01004003|466551883|FG008|Overall Study|Other|0|||
129617368|NCT01130597|466551890|FG000|Overall Study|Protocol-specified (High K+)|1|||
129617369|NCT01130597|466551890|FG000|Overall Study|Adverse Event|4|||
129617370|NCT01130597|466551890|FG000|Overall Study|Death|1|||
129617371|NCT01130597|466551890|FG000|Overall Study|Protocol Violation|1|||
129617372|NCT05794503|466551891|FG000|Overall Study|Operation Cancelled|2|||
129617373|NCT05794503|466551892|FG001|Overall Study|Operation Cancelled|0|||
129617374|NCT05794503|466551891|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
129617375|NCT05794503|466551892|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
129617376|NCT05794503|466551891|FG000|Overall Study|Protocol Violation|1|||
129617377|NCT05794503|466551892|FG001|Overall Study|Protocol Violation|0|||
129617378|NCT01589497|466551893|FG000|Overall Study|Withdrawal by Subject|0|||
129617379|NCT01589497|466551894|FG001|Overall Study|Withdrawal by Subject|1|||
129617380|NCT01589497|466551895|FG002|Overall Study|Withdrawal by Subject|0|||
129617381|NCT01589497|466551896|FG003|Overall Study|Withdrawal by Subject|1|||
129617382|NCT01589497|466551893|FG000|Overall Study|Death|1|||
129617383|NCT01589497|466551894|FG001|Overall Study|Death|0|||
129617384|NCT01589497|466551895|FG002|Overall Study|Death|0|||
129617385|NCT01589497|466551896|FG003|Overall Study|Death|0|||
129617386|NCT01589497|466551893|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
129617387|NCT01589497|466551894|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
129617388|NCT01589497|466551895|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
129617389|NCT01589497|466551896|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
129617390|NCT05819203|466551903|FG000|Overall Study|Protocol Violation|1|||
129617391|NCT05819203|466551904|FG001|Overall Study|Protocol Violation|2|||
129617392|NCT05819203|466551903|FG000|Overall Study|Withdrawal by Subject|1|||
129617393|NCT05819203|466551904|FG001|Overall Study|Withdrawal by Subject|0|||
129617394|NCT04784533|466551905|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
129617395|NCT04784533|466551906|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
129617396|NCT04784533|466551907|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617397|NCT04784533|466551908|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129791848|NCT00686634|467206194|FG000|Overall Study|Protocol Violation|6|||
129791849|NCT02361580|467206197|FG000|Overall Study|Lost to Follow-up|6|||
129791850|NCT02361580|467206198|FG001|Overall Study|Lost to Follow-up|3|||
129791851|NCT00924781|467206199|FG000|Overall Study|Study terminated by sponsor|12|||
129617398|NCT04784533|466551909|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617399|NCT04784533|466551910|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617400|NCT04784533|466551911|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617401|NCT04784533|466551912|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617402|NCT04784533|466551913|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617403|NCT04784533|466551914|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
129617404|NCT04784533|466551905|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
129617405|NCT04784533|466551906|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
129617406|NCT04784533|466551907|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617407|NCT04784533|466551908|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617408|NCT04784533|466551909|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617409|NCT04784533|466551910|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617410|NCT04784533|466551911|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617411|NCT04784533|466551912|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617412|NCT04784533|466551913|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617413|NCT04784533|466551914|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
129617414|NCT04784533|466551905|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617415|NCT04784533|466551906|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
129617416|NCT04784533|466551907|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617417|NCT04784533|466551908|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617418|NCT04784533|466551909|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617419|NCT04784533|466551910|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617420|NCT04784533|466551911|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617421|NCT04784533|466551912|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617422|NCT04784533|466551913|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617423|NCT04784533|466551914|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
129617424|NCT04784533|466551905|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
129617425|NCT04784533|466551906|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617426|NCT04784533|466551907|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617427|NCT04784533|466551908|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617428|NCT04784533|466551909|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617429|NCT04784533|466551910|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617430|NCT04784533|466551911|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617431|NCT04784533|466551912|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617432|NCT04784533|466551913|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617433|NCT04784533|466551914|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
129617434|NCT04784533|466551905|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
129617435|NCT04784533|466551906|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
129617436|NCT04784533|466551907|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617437|NCT04784533|466551908|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617438|NCT04784533|466551909|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617439|NCT04784533|466551910|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617440|NCT04784533|466551911|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617441|NCT04784533|466551912|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617442|NCT04784533|466551913|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617443|NCT04784533|466551914|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
129617444|NCT04784533|466551905|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
129617445|NCT04784533|466551906|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
129617446|NCT04784533|466551907|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617447|NCT04784533|466551908|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617448|NCT04784533|466551909|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617449|NCT04784533|466551910|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617450|NCT04784533|466551911|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617451|NCT04784533|466551912|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617452|NCT04784533|466551913|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617453|NCT04784533|466551914|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
129617454|NCT04784533|466551905|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617455|NCT04784533|466551906|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617456|NCT04784533|466551907|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
129617457|NCT04784533|466551908|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617458|NCT04784533|466551909|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617459|NCT04784533|466551910|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617460|NCT04784533|466551911|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617461|NCT04784533|466551912|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617462|NCT04784533|466551913|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617463|NCT04784533|466551914|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
129617464|NCT04784533|466551905|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129701027|NCT01435356|466866024|FG000|Overall Study|Patient moved to another city|1|||
129701028|NCT01435356|466866025|FG001|Overall Study|Patient moved to another city|1|||
129617465|NCT04784533|466551906|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617466|NCT04784533|466551907|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617467|NCT04784533|466551908|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617468|NCT04784533|466551909|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617469|NCT04784533|466551910|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617470|NCT04784533|466551911|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617471|NCT04784533|466551912|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617472|NCT04784533|466551913|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
129617473|NCT04784533|466551914|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
129617474|NCT04784533|466551905|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617475|NCT04784533|466551906|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617476|NCT04784533|466551907|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617477|NCT04784533|466551908|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617478|NCT04784533|466551909|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617479|NCT04784533|466551910|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617480|NCT04784533|466551911|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617481|NCT04784533|466551912|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
129617482|NCT04784533|466551913|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
129617483|NCT04784533|466551914|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
129617484|NCT02521376|466551915|FG000|Overall Study|Enrolled, But Not Treated|1|||
129617485|NCT02521376|466551916|FG001|Overall Study|Enrolled, But Not Treated|0|||
129617486|NCT02521376|466551917|FG002|Overall Study|Enrolled, But Not Treated|0|||
129617487|NCT02521376|466551918|FG003|Overall Study|Enrolled, But Not Treated|0|||
129617488|NCT00340678|466551928|FG000|Overall Study|Lost to Follow-up|1|||
129617489|NCT00340678|466551929|FG001|Overall Study|Lost to Follow-up|0|||
129617490|NCT00340678|466551930|FG002|Overall Study|Lost to Follow-up|0|||
129617491|NCT00340678|466551931|FG003|Overall Study|Lost to Follow-up|0|||
129617492|NCT00708227|466551935|FG000|Overall Study|Physician Decision|0|||
129617493|NCT00708227|466551936|FG001|Overall Study|Physician Decision|3|||
129617494|NCT00708227|466551937|FG002|Overall Study|Physician Decision|1|||
129617495|NCT00708227|466551938|FG003|Overall Study|Physician Decision|2|||
129617496|NCT00708227|466551935|FG000|Overall Study|Withdrawal by Subject|1|||
129617497|NCT00708227|466551936|FG001|Overall Study|Withdrawal by Subject|2|||
129617498|NCT00708227|466551937|FG002|Overall Study|Withdrawal by Subject|0|||
129791852|NCT00924781|467206200|FG001|Overall Study|Study terminated by sponsor|10|||
129791853|NCT00708201|467206201|FG000|Overall Study|Adverse Event|4|||
129791854|NCT00708201|467206202|FG001|Overall Study|Adverse Event|4|||
129791855|NCT00708201|467206201|FG000|Overall Study|Withdrawal by Subject|1|||
129791856|NCT00708201|467206202|FG001|Overall Study|Withdrawal by Subject|1|||
129791857|NCT00708201|467206201|FG000|Overall Study|Lost to Follow-up|2|||
129791858|NCT00708201|467206202|FG001|Overall Study|Lost to Follow-up|0|||
129791859|NCT00708201|467206201|FG000|Overall Study|Protocol Violation|0|||
129791860|NCT00708201|467206202|FG001|Overall Study|Protocol Violation|1|||
129791861|NCT01653132|467206203|FG000|First Intervention|Protocol Violation|1|||
129791862|NCT01653132|467206204|FG001|First Intervention|Protocol Violation|0|||
129791863|NCT00761748|467206205|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
129791864|NCT00761748|467206206|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
129791865|NCT00761748|467206205|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
129791866|NCT00761748|467206206|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
129791867|NCT03312751|467206207|FG000|Overall Study|Death|7|||
129791868|NCT03312751|467206208|FG001|Overall Study|Death|9|||
129791869|NCT03312751|467206207|FG000|Overall Study|Study discontinuation due to other reason|0|||
129791870|NCT03312751|467206208|FG001|Overall Study|Study discontinuation due to other reason|1|||
129617499|NCT00708227|466551938|FG003|Overall Study|Withdrawal by Subject|1|||
129617500|NCT04007991|466551939|FG000|Overall Study|Withdrawal by Subject|1|||
129617501|NCT04007991|466551940|FG001|Overall Study|Withdrawal by Subject|1|||
129617502|NCT04007991|466551939|FG000|Overall Study|Physician Decision|1|||
129617503|NCT04007991|466551940|FG001|Overall Study|Physician Decision|1|||
129617504|NCT04007991|466551939|FG000|Overall Study|Non-compliance with Study Drug|0|||
129617505|NCT04007991|466551940|FG001|Overall Study|Non-compliance with Study Drug|1|||
129617506|NCT04007991|466551939|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
129791871|NCT03490981|467206209|FG000|Overall Study|Lost to Follow-up|1|||
129617507|NCT04007991|466551940|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
129617508|NCT04007991|466551939|FG000|Overall Study|Adverse event, non-fatal|5|||
129791872|NCT03490981|467206210|FG001|Overall Study|Lost to Follow-up|2|||
129791873|NCT00282464|467206217|FG000|Overall Study|Adverse Event|26|||
129791874|NCT00282464|467206218|FG001|Overall Study|Adverse Event|20|||
129791875|NCT00282464|467206217|FG000|Overall Study|Lack of Efficacy|8|||
129791876|NCT00282464|467206218|FG001|Overall Study|Lack of Efficacy|8|||
129791877|NCT00282464|467206217|FG000|Overall Study|Lost to Follow-up|10|||
129791878|NCT00282464|467206218|FG001|Overall Study|Lost to Follow-up|10|||
129791879|NCT00282464|467206217|FG000|Overall Study|Withdrawal by Subject|24|||
129791880|NCT00282464|467206218|FG001|Overall Study|Withdrawal by Subject|10|||
129791881|NCT00282464|467206217|FG000|Overall Study|laboratory abnormality|1|||
129791882|NCT00282464|467206218|FG001|Overall Study|laboratory abnormality|2|||
129617509|NCT04007991|466551940|FG001|Overall Study|Adverse event, non-fatal|0|||
129617510|NCT04007991|466551939|FG000|Overall Study|Lost to Follow-up|2|||
129617511|NCT04007991|466551940|FG001|Overall Study|Lost to Follow-up|1|||
129791883|NCT00282464|467206217|FG000|Overall Study|Protocol Violation|0|||
129791884|NCT00282464|467206218|FG001|Overall Study|Protocol Violation|7|||
129791885|NCT00282464|467206217|FG000|Overall Study|Patient moved|1|||
129791886|NCT00282464|467206218|FG001|Overall Study|Patient moved|0|||
129791887|NCT00282464|467206217|FG000|Overall Study|patient non-compliant|3|||
129791888|NCT00282464|467206218|FG001|Overall Study|patient non-compliant|0|||
129791889|NCT00282464|467206217|FG000|Overall Study|patient no show|0|||
129791890|NCT00282464|467206218|FG001|Overall Study|patient no show|1|||
129791891|NCT00282464|467206217|FG000|Overall Study|patient incarcerated|0|||
129617512|NCT02126826|466552877|FG000|Overall Study|Withdrawal by Subject|0|||
129617513|NCT02126826|466552878|FG001|Overall Study|Withdrawal by Subject|0|||
129617514|NCT02126826|466552879|FG002|Overall Study|Withdrawal by Subject|0|||
129617515|NCT02126826|466552880|FG003|Overall Study|Withdrawal by Subject|1|||
129617516|NCT02126826|466552881|FG004|Overall Study|Withdrawal by Subject|0|||
129617517|NCT02126826|466552882|FG005|Overall Study|Withdrawal by Subject|0|||
129617518|NCT02126826|466552883|FG006|Overall Study|Withdrawal by Subject|0|||
129617519|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #1|24|||
129617520|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #1|0|||
129617521|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
129617522|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
129617523|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617524|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617525|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
129617526|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
129617527|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
129617528|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
129617529|NCT03888066|466552884|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617530|NCT03888066|466552885|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617531|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617532|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617533|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
129617534|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
129617535|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617536|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617537|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
129617538|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617539|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #2|5|||
129617540|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #2|0|||
129617541|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
129617542|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
129617543|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
129791892|NCT00282464|467206218|FG001|Overall Study|patient incarcerated|1|||
129791893|NCT00282464|467206217|FG000|Overall Study|family crisis|0|||
129791894|NCT00282464|467206218|FG001|Overall Study|family crisis|1|||
129617544|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
129617545|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
129791895|NCT00282464|467206217|FG000|Overall Study|dispensed wrong kit|0|||
129791896|NCT00282464|467206218|FG001|Overall Study|dispensed wrong kit|1|||
129791897|NCT00282464|467206217|FG000|Overall Study|dropped due to missed visits|0|||
129617546|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
129617547|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #3|11|||
129791898|NCT00282464|467206218|FG001|Overall Study|dropped due to missed visits|1|||
129617548|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #3|0|||
129617549|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
129617550|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
129791899|NCT01624870|467206219|FG000|Overall Study|Death|19|||
129791900|NCT01624870|467206219|FG000|Overall Study|Withdrawal by Subject|1|||
129791901|NCT01624870|467206219|FG000|Overall Study|CoreValve not implanted|6|||
129791902|NCT01624870|467206219|FG000|Overall Study|Lost to follow up|1|||
129791903|NCT04672252|467206223|FG000|Overall Study|Protocol Violation|1|||
129791904|NCT04672252|467206224|FG001|Overall Study|Protocol Violation|0|||
129791905|NCT04391569|467206225|FG000|Overall Study|Death|15|||
129617551|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
129617552|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129617553|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617554|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617555|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #4|3|||
129617556|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #4|0|||
129617557|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
129617558|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
129617559|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
129617560|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
129617561|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
129617562|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129617563|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
129617564|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
129617565|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
129617566|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617567|NCT03888066|466552884|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
129617568|NCT03888066|466552885|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129617569|NCT03888066|466552884|FG000|Run-in Phase|AE (Adverse Event)|17|||
129617570|NCT03888066|466552885|FG001|Run-in Phase|AE (Adverse Event)|0|||
129617571|NCT03888066|466552884|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
129617572|NCT03888066|466552885|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
129617573|NCT03888066|466552884|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617574|NCT03888066|466552885|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617575|NCT03888066|466552884|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
129617576|NCT03888066|466552885|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617577|NCT03888066|466552884|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
129617578|NCT03888066|466552885|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129617579|NCT03888066|466552884|FG000|Run-in Phase|Withdrawal by Subject|43|||
129617580|NCT03888066|466552885|FG001|Run-in Phase|Withdrawal by Subject|0|||
129617581|NCT03888066|466552884|FG000|Run-in Phase|AE; Physician Decision|1|||
129617582|NCT03888066|466552885|FG001|Run-in Phase|AE; Physician Decision|0|||
129617583|NCT03888066|466552884|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
129617584|NCT03888066|466552885|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
129617585|NCT03888066|466552884|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
129617586|NCT03888066|466552885|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
129617587|NCT03888066|466552884|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
129617588|NCT03888066|466552885|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
129617589|NCT03888066|466552884|FG000|Run-in Phase|Death|1|||
129617590|NCT03888066|466552885|FG001|Run-in Phase|Death|0|||
129617591|NCT03888066|466552884|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
129617592|NCT03888066|466552885|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
129617593|NCT03888066|466552884|FG000|Run-in Phase|Physician Decision|1|||
129617594|NCT03888066|466552885|FG001|Run-in Phase|Physician Decision|0|||
129617595|NCT03888066|466552884|FG000|Run-in Phase|Protocol Violation|13|||
129617596|NCT03888066|466552885|FG001|Run-in Phase|Protocol Violation|0|||
129617597|NCT03888066|466552884|FG000|Run-in Phase|Sponsor Request|34|||
129617598|NCT03888066|466552885|FG001|Run-in Phase|Sponsor Request|0|||
129617599|NCT03888066|466552884|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
129617600|NCT03888066|466552885|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
129617601|NCT03888066|466552884|FG000|Run-in Phase|Withdrawal Of Consent|1|||
129617602|NCT03888066|466552885|FG001|Run-in Phase|Withdrawal Of Consent|0|||
129617603|NCT03888066|466552884|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
129791906|NCT04391569|467206226|FG001|Overall Study|Death|10|||
129791907|NCT04391569|467206225|FG000|Overall Study|Withdrawal by Subject|1|||
129791908|NCT04391569|467206226|FG001|Overall Study|Withdrawal by Subject|0|||
129791909|NCT04391569|467206225|FG000|Overall Study|Lost to Follow-up|3|||
129791910|NCT04391569|467206226|FG001|Overall Study|Lost to Follow-up|2|||
129791911|NCT04391569|467206225|FG000|Overall Study|Lack of Efficacy|0|||
129791912|NCT04391569|467206226|FG001|Overall Study|Lack of Efficacy|1|||
129887393|NCT01474512|467547272|FG000|Maintenance Period|Protocol Violation|0|||
129617604|NCT03888066|466552885|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
129617605|NCT03888066|466552884|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
129617606|NCT03888066|466552885|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
129617607|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
129617608|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
129617609|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
129617610|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
129617611|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
129617612|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
129617613|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
129617614|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
129617615|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
129617616|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
129617617|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
129617618|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
129617619|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
129617620|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
129617621|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
129617622|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
129617623|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
129617624|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
129617625|NCT03888066|466552884|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
129617626|NCT03888066|466552885|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
129617627|NCT03278626|466552886|FG000|Overall Study|Death|2|||
129617628|NCT03278626|466552886|FG000|Overall Study|Toxicity|1|||
129617629|NCT03278626|466552886|FG000|Overall Study|Disease Progression|2|||
129617630|NCT05013008|466552888|FG000|Overall Study|Exclusion from mBFAS|5|||
129617631|NCT05013008|466552889|FG001|Overall Study|Exclusion from mBFAS|25|||
129617632|NCT02111603|466552899|FG000|Overall Study|Withdrawal by Subject|1|||
129617633|NCT03106987|466552900|FG000|Overall Study|Death|37|||
129617634|NCT03106987|466552901|FG001|Overall Study|Death|22|||
129617635|NCT03106987|466552902|FG002|Overall Study|Death|12|||
129617636|NCT03106987|466552903|FG003|Overall Study|Death|8|||
129617637|NCT03106987|466552900|FG000|Overall Study|Lost to Follow-up|2|||
129617638|NCT03106987|466552901|FG001|Overall Study|Lost to Follow-up|0|||
129617639|NCT03106987|466552902|FG002|Overall Study|Lost to Follow-up|2|||
129617640|NCT03106987|466552903|FG003|Overall Study|Lost to Follow-up|2|||
129617641|NCT03106987|466552900|FG000|Overall Study|Withdrawal by Subject|5|||
129617642|NCT03106987|466552901|FG001|Overall Study|Withdrawal by Subject|1|||
129617643|NCT03106987|466552902|FG002|Overall Study|Withdrawal by Subject|4|||
129617644|NCT03106987|466552903|FG003|Overall Study|Withdrawal by Subject|1|||
129617645|NCT02114385|466552905|FG000|Overall Study|Withdrawal by Subject|3|||
129617646|NCT02114385|466552906|FG001|Overall Study|Withdrawal by Subject|2|||
129617647|NCT02114385|466552905|FG000|Overall Study|Lost to Follow-up|0|||
129617648|NCT02114385|466552906|FG001|Overall Study|Lost to Follow-up|6|||
129617649|NCT01174043|466552910|FG000|Overall Study|Disease progression|5|||
129617650|NCT01174043|466552910|FG000|Overall Study|Adverse Event|3|||
129617651|NCT01174043|466552910|FG000|Overall Study|Death|1|||
129617652|NCT01174043|466552910|FG000|Overall Study|Withdrawal by Subject|2|||
129617653|NCT00582010|466552915|FG000|Overall Study|Death|0|||
129617654|NCT00582010|466552916|FG001|Overall Study|Death|1|||
129617655|NCT02681510|466552924|FG000|Overall Study|Withdrawal by Subject|1|||
129791913|NCT04391569|467206225|FG000|Overall Study|Participant discharged to hospice facility|0|||
129617656|NCT02681510|466552924|FG000|Overall Study|Lost to Follow-up|9|||
129617657|NCT00741338|466552928|FG000|Overall Study|Adverse Event|0|||
129617658|NCT00741338|466552929|FG001|Overall Study|Adverse Event|1|||
129617659|NCT03066258|466552932|FG000|Overall Study|Death|1|||
129617660|NCT03066258|466552933|FG001|Overall Study|Death|0|||
129617661|NCT03066258|466552934|FG002|Overall Study|Death|0|||
129617662|NCT03066258|466552935|FG003|Overall Study|Death|0|||
129617663|NCT03066258|466552936|FG004|Overall Study|Death|1|||
129617664|NCT00704132|466552941|FG000|Overall Study|Clinical Adverse Experience|1|||
129617665|NCT00704132|466552942|FG001|Overall Study|Clinical Adverse Experience|0|||
129617666|NCT00704132|466552941|FG000|Overall Study|Lack of Efficacy|0|||
129617667|NCT00704132|466552942|FG001|Overall Study|Lack of Efficacy|1|||
129617668|NCT00704132|466552941|FG000|Overall Study|Withdrawal by Subject|0|||
129617669|NCT00704132|466552942|FG001|Overall Study|Withdrawal by Subject|1|||
129617670|NCT00214383|466552943|FG000|Overall Study|Lost to Follow-up|16|||
129617671|NCT00214383|466552944|FG001|Overall Study|Lost to Follow-up|26|||
129617672|NCT00879411|466552945|FG000|Overall Study|lost to follow-up (non-AE)|162|||
129617673|NCT01267994|466552948|FG000|Overall Study|Adverse Event|2|||
129617674|NCT02655666|466552949|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
129617675|NCT03837743|466552950|FG000|Overall Study|Adverse Event|1|||
129617676|NCT03837743|466552950|FG000|Overall Study|Withdrawal by Subject|2|||
129701029|NCT00437073|466866026|FG000|Overall Study|Sponsor Terminated Study|1|||
129439249|NCT02245672|465906403|FG001|Overall Study|Adverse Event|4|||
129617677|NCT01210612|466552954|FG000|Overall Study|Withdrawal by Subject|0|||
129617678|NCT01210612|466552955|FG001|Overall Study|Withdrawal by Subject|2|||
129617679|NCT00086281|466552958|FG000|Phase 1|Adverse Event|0|||
129617680|NCT00086281|466552959|FG001|Phase 1|Adverse Event|0|||
129617681|NCT00086281|466552960|FG002|Phase 1|Adverse Event|0|||
129617682|NCT00086281|466552961|FG003|Phase 1|Adverse Event|0|||
129617683|NCT00086281|466552962|FG004|Phase 1|Adverse Event|0|||
129617684|NCT00086281|466552963|FG005|Phase 1|Adverse Event|0|||
129617685|NCT00086281|466552964|FG006|Phase 1|Adverse Event|0|||
129617686|NCT00086281|466552965|FG007|Phase 1|Adverse Event|0|||
129617687|NCT00086281|466552966|FG008|Phase 1|Adverse Event|0|||
129617688|NCT00086281|466552967|FG009|Phase 1|Adverse Event|1|||
129617689|NCT00086281|466552968|FG010|Phase 1|Adverse Event|2|||
129617690|NCT00086281|466552969|FG011|Phase 1|Adverse Event|1|||
129617691|NCT00086281|466552970|FG012|Phase 1|Adverse Event|1|||
129617692|NCT00086281|466552971|FG013|Phase 1|Adverse Event|1|||
129617693|NCT00086281|466552972|FG014|Phase 1|Adverse Event|2|||
129617694|NCT00086281|466552958|FG000|Phase 1|Protocol Violation|0|||
129617695|NCT00086281|466552959|FG001|Phase 1|Protocol Violation|0|||
129617696|NCT00086281|466552960|FG002|Phase 1|Protocol Violation|0|||
129617697|NCT00086281|466552961|FG003|Phase 1|Protocol Violation|0|||
129617698|NCT00086281|466552962|FG004|Phase 1|Protocol Violation|0|||
129617699|NCT00086281|466552963|FG005|Phase 1|Protocol Violation|0|||
129617700|NCT00086281|466552964|FG006|Phase 1|Protocol Violation|0|||
129617701|NCT00086281|466552965|FG007|Phase 1|Protocol Violation|0|||
129617702|NCT00086281|466552966|FG008|Phase 1|Protocol Violation|0|||
129617703|NCT00086281|466552967|FG009|Phase 1|Protocol Violation|0|||
129617704|NCT00086281|466552968|FG010|Phase 1|Protocol Violation|1|||
129617705|NCT00086281|466552969|FG011|Phase 1|Protocol Violation|0|||
129617706|NCT00086281|466552970|FG012|Phase 1|Protocol Violation|0|||
129617707|NCT00086281|466552971|FG013|Phase 1|Protocol Violation|0|||
129617708|NCT00086281|466552972|FG014|Phase 1|Protocol Violation|0|||
129617709|NCT00086281|466552958|FG000|Phase 1|Serious Adverse Event|0|||
129617710|NCT00086281|466552959|FG001|Phase 1|Serious Adverse Event|0|||
129617711|NCT00086281|466552960|FG002|Phase 1|Serious Adverse Event|0|||
129617712|NCT00086281|466552961|FG003|Phase 1|Serious Adverse Event|0|||
129617713|NCT00086281|466552962|FG004|Phase 1|Serious Adverse Event|0|||
129617714|NCT00086281|466552963|FG005|Phase 1|Serious Adverse Event|0|||
129617715|NCT00086281|466552964|FG006|Phase 1|Serious Adverse Event|0|||
129617716|NCT00086281|466552965|FG007|Phase 1|Serious Adverse Event|0|||
129617717|NCT00086281|466552966|FG008|Phase 1|Serious Adverse Event|0|||
129617718|NCT00086281|466552967|FG009|Phase 1|Serious Adverse Event|0|||
129701030|NCT00437073|466866027|FG001|Overall Study|Sponsor Terminated Study|0|||
129701031|NCT00437073|466866026|FG000|Overall Study|Physician Decision|0|||
129701032|NCT00437073|466866027|FG001|Overall Study|Physician Decision|1|||
129701033|NCT04875533|466866028|FG000|Overall Study|Adverse Event|6|||
129701034|NCT04875533|466866029|FG001|Overall Study|Adverse Event|4|||
129701035|NCT04875533|466866028|FG000|Overall Study|Protocol Violation|4|||
129701036|NCT04875533|466866029|FG001|Overall Study|Protocol Violation|0|||
129701037|NCT04875533|466866028|FG000|Overall Study|Withdrawal by Subject|8|||
129701038|NCT04875533|466866029|FG001|Overall Study|Withdrawal by Subject|5|||
129701039|NCT04875533|466866028|FG000|Overall Study|No longer meets eligibility criteria|1|||
129701040|NCT04875533|466866029|FG001|Overall Study|No longer meets eligibility criteria|0|||
129701041|NCT04875533|466866028|FG000|Overall Study|Other|0|||
129791914|NCT04391569|467206226|FG001|Overall Study|Participant discharged to hospice facility|1|||
129791915|NCT04391569|467206225|FG000|Overall Study|Participant family decision|1|||
129791916|NCT04391569|467206226|FG001|Overall Study|Participant family decision|0|||
129791917|NCT04391569|467206225|FG000|Overall Study|Participant discharged prematurely|1|||
129791918|NCT04391569|467206226|FG001|Overall Study|Participant discharged prematurely|0|||
129791919|NCT00899392|467206227|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
129791920|NCT00899392|467206228|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
129791921|NCT01431638|467206235|FG000|Overall Study|Adverse Event|1|||
129791922|NCT01431638|467206236|FG001|Overall Study|Adverse Event|3|||
129791923|NCT01431638|467206237|FG002|Overall Study|Adverse Event|1|||
129791924|NCT01431638|467206235|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129791925|NCT01431638|467206236|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129791926|NCT01431638|467206237|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
129791927|NCT01431638|467206235|FG000|Overall Study|Participants condition no longer requires study drug|0|||
129617719|NCT00086281|466552968|FG010|Phase 1|Serious Adverse Event|0|||
129701042|NCT04875533|466866029|FG001|Overall Study|Other|2|||
129701043|NCT02657343|466866032|FG000|Overall Study|Death|0|||
129617720|NCT00086281|466552969|FG011|Phase 1|Serious Adverse Event|0|||
129617721|NCT00086281|466552970|FG012|Phase 1|Serious Adverse Event|0|||
129617722|NCT00086281|466552971|FG013|Phase 1|Serious Adverse Event|0|||
129617723|NCT00086281|466552972|FG014|Phase 1|Serious Adverse Event|1|||
129617724|NCT00086281|466552958|FG000|Phase 2|Adverse Event|0|||
129617725|NCT00086281|466552959|FG001|Phase 2|Adverse Event|0|||
129617726|NCT00086281|466552960|FG002|Phase 2|Adverse Event|0|||
129617727|NCT00086281|466552961|FG003|Phase 2|Adverse Event|0|||
129617728|NCT00086281|466552962|FG004|Phase 2|Adverse Event|0|||
129617729|NCT00086281|466552963|FG005|Phase 2|Adverse Event|0|||
129617730|NCT00086281|466552964|FG006|Phase 2|Adverse Event|0|||
129617731|NCT00086281|466552965|FG007|Phase 2|Adverse Event|0|||
129617732|NCT00086281|466552966|FG008|Phase 2|Adverse Event|0|||
129617733|NCT00086281|466552967|FG009|Phase 2|Adverse Event|0|||
129617734|NCT00086281|466552968|FG010|Phase 2|Adverse Event|0|||
129617735|NCT00086281|466552969|FG011|Phase 2|Adverse Event|0|||
129617736|NCT00086281|466552970|FG012|Phase 2|Adverse Event|1|||
129617737|NCT00086281|466552971|FG013|Phase 2|Adverse Event|1|||
129617738|NCT00086281|466552972|FG014|Phase 2|Adverse Event|0|||
129617739|NCT04759768|466552973|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
129617740|NCT04759768|466552974|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
129617741|NCT04759768|466552973|FG000|Washout (7 Days)|Physician Decision|0|||
129617742|NCT04759768|466552974|FG001|Washout (7 Days)|Physician Decision|1|||
129617743|NCT02996487|466552975|FG000|Overall Study|Lost to Follow-up|1|||
129617744|NCT02996487|466552976|FG001|Overall Study|Lost to Follow-up|1|||
129617745|NCT02996487|466552977|FG002|Overall Study|Lost to Follow-up|0|||
129617746|NCT02996487|466552975|FG000|Overall Study|Death|0|||
129617747|NCT02996487|466552976|FG001|Overall Study|Death|1|||
129617748|NCT02996487|466552977|FG002|Overall Study|Death|0|||
129617749|NCT02996487|466552975|FG000|Overall Study|Withdrawal by Subject|2|||
129617750|NCT02996487|466552976|FG001|Overall Study|Withdrawal by Subject|3|||
129617751|NCT02996487|466552977|FG002|Overall Study|Withdrawal by Subject|0|||
129617752|NCT02027428|466552978|FG000|Induction|Never treated|7|||
129617753|NCT02027428|466552979|FG001|Induction|Never treated|0|||
129617754|NCT02027428|466552980|FG002|Induction|Never treated|0|||
129617755|NCT02027428|466552978|FG000|Induction|Progressive disease|77|||
129617756|NCT02027428|466552979|FG001|Induction|Progressive disease|0|||
129617757|NCT02027428|466552980|FG002|Induction|Progressive disease|0|||
129617758|NCT02027428|466552978|FG000|Induction|Adverse Event|51|||
129617759|NCT02027428|466552979|FG001|Induction|Adverse Event|0|||
129617760|NCT02027428|466552980|FG002|Induction|Adverse Event|0|||
129617761|NCT02027428|466552978|FG000|Induction|Withdrawal by Subject|22|||
129617762|NCT02027428|466552979|FG001|Induction|Withdrawal by Subject|0|||
129617763|NCT02027428|466552980|FG002|Induction|Withdrawal by Subject|0|||
129617764|NCT02027428|466552978|FG000|Induction|Death|21|||
129617765|NCT02027428|466552979|FG001|Induction|Death|0|||
129617766|NCT02027428|466552980|FG002|Induction|Death|0|||
129617767|NCT02027428|466552978|FG000|Induction|Symptomatic deterioration|16|||
129617768|NCT02027428|466552979|FG001|Induction|Symptomatic deterioration|0|||
129617769|NCT02027428|466552980|FG002|Induction|Symptomatic deterioration|0|||
129617770|NCT02027428|466552978|FG000|Induction|Study terminated by sponsor|12|||
129617771|NCT02027428|466552979|FG001|Induction|Study terminated by sponsor|0|||
129617772|NCT02027428|466552980|FG002|Induction|Study terminated by sponsor|0|||
129617773|NCT02027428|466552978|FG000|Induction|Protocol Violation|1|||
129617774|NCT02027428|466552979|FG001|Induction|Protocol Violation|0|||
129617775|NCT02027428|466552980|FG002|Induction|Protocol Violation|0|||
129617776|NCT02027428|466552978|FG000|Induction|Miscellaneous|14|||
129617777|NCT02027428|466552979|FG001|Induction|Miscellaneous|0|||
129617778|NCT02027428|466552980|FG002|Induction|Miscellaneous|0|||
129617779|NCT02027428|466552978|FG000|Induction|Induction Treatment Ongoing|4|||
129617780|NCT02027428|466552979|FG001|Induction|Induction Treatment Ongoing|0|||
129617781|NCT02027428|466552980|FG002|Induction|Induction Treatment Ongoing|0|||
129617782|NCT02027428|466552978|FG000|Maintenance|Death|0|||
129617783|NCT02027428|466552979|FG001|Maintenance|Death|3|||
129617784|NCT02027428|466552980|FG002|Maintenance|Death|2|||
129617785|NCT02027428|466552978|FG000|Maintenance|Adverse Event|0|||
129701044|NCT02657343|466866033|FG001|Overall Study|Death|2|||
129701045|NCT02657343|466866034|FG002|Overall Study|Death|0|||
129701046|NCT02657343|466866035|FG003|Overall Study|Death|0|||
129701047|NCT02657343|466866036|FG004|Overall Study|Death|0|||
129701048|NCT02657343|466866037|FG005|Overall Study|Death|0|||
129701049|NCT02657343|466866032|FG000|Overall Study|Patient went to hospice|1|||
129701050|NCT02657343|466866033|FG001|Overall Study|Patient went to hospice|0|||
129701051|NCT02657343|466866034|FG002|Overall Study|Patient went to hospice|0|||
129701052|NCT02657343|466866035|FG003|Overall Study|Patient went to hospice|0|||
129701053|NCT02657343|466866036|FG004|Overall Study|Patient went to hospice|0|||
129701054|NCT02657343|466866037|FG005|Overall Study|Patient went to hospice|0|||
129617786|NCT02027428|466552979|FG001|Maintenance|Adverse Event|21|||
129617787|NCT02027428|466552980|FG002|Maintenance|Adverse Event|1|||
129617788|NCT02027428|466552978|FG000|Maintenance|Progressive disease|0|||
129617789|NCT02027428|466552979|FG001|Maintenance|Progressive disease|84|||
129617790|NCT02027428|466552980|FG002|Maintenance|Progressive disease|47|||
129617791|NCT02027428|466552978|FG000|Maintenance|Symptomatic deterioration|0|||
129617792|NCT02027428|466552979|FG001|Maintenance|Symptomatic deterioration|4|||
129617793|NCT02027428|466552980|FG002|Maintenance|Symptomatic deterioration|1|||
129617794|NCT02027428|466552978|FG000|Maintenance|Withdrawal by Subject|0|||
129617795|NCT02027428|466552979|FG001|Maintenance|Withdrawal by Subject|6|||
129617796|NCT02027428|466552980|FG002|Maintenance|Withdrawal by Subject|5|||
129617797|NCT02027428|466552978|FG000|Maintenance|Protocol Violation|0|||
129617798|NCT02027428|466552979|FG001|Maintenance|Protocol Violation|0|||
129617799|NCT02027428|466552980|FG002|Maintenance|Protocol Violation|1|||
129617800|NCT02027428|466552978|FG000|Maintenance|Other|0|||
129617801|NCT02027428|466552979|FG001|Maintenance|Other|6|||
129617802|NCT02027428|466552980|FG002|Maintenance|Other|3|||
129617803|NCT02027428|466552978|FG000|Survival Follow-up|Death|0|||
129617804|NCT02027428|466552979|FG001|Survival Follow-up|Death|78|||
129617805|NCT02027428|466552980|FG002|Survival Follow-up|Death|45|||
129617806|NCT02027428|466552978|FG000|Survival Follow-up|Lost to Follow-up|0|||
129617807|NCT02027428|466552979|FG001|Survival Follow-up|Lost to Follow-up|1|||
129617808|NCT02027428|466552980|FG002|Survival Follow-up|Lost to Follow-up|1|||
129617809|NCT04873934|466552981|FG000|Overall Study|Adverse Event|0|||
129617810|NCT04873934|466552982|FG001|Overall Study|Adverse Event|1|||
129617811|NCT04873934|466552981|FG000|Overall Study|Death|0|||
129617812|NCT04873934|466552982|FG001|Overall Study|Death|2|||
129617813|NCT04873934|466552981|FG000|Overall Study|Lost to Follow-up|13|||
129617814|NCT04873934|466552982|FG001|Overall Study|Lost to Follow-up|9|||
129617815|NCT04873934|466552981|FG000|Overall Study|Physician Decision|1|||
129617816|NCT04873934|466552982|FG001|Overall Study|Physician Decision|1|||
129617817|NCT04873934|466552981|FG000|Overall Study|Protocol deviation|2|||
129617818|NCT04873934|466552982|FG001|Overall Study|Protocol deviation|1|||
129617819|NCT04873934|466552981|FG000|Overall Study|Subject decision|1|||
129617820|NCT04873934|466552982|FG001|Overall Study|Subject decision|8|||
129617821|NCT04873934|466552981|FG000|Overall Study|Withdrew consent|0|||
129617822|NCT04873934|466552982|FG001|Overall Study|Withdrew consent|4|||
129617823|NCT04873934|466552981|FG000|Overall Study|Missing|1|||
129617824|NCT04873934|466552982|FG001|Overall Study|Missing|0|||
129617825|NCT00307437|466552985|FG000|Controlled Period|Adverse Event|7|||
129617826|NCT00307437|466552986|FG001|Controlled Period|Adverse Event|2|||
129617827|NCT00307437|466552987|FG002|Controlled Period|Adverse Event|5|||
129617828|NCT00307437|466552988|FG003|Controlled Period|Adverse Event|0|||
129617829|NCT00307437|466552989|FG004|Controlled Period|Adverse Event|0|||
129617830|NCT00307437|466552990|FG005|Controlled Period|Adverse Event|0|||
129617831|NCT00307437|466552991|FG006|Controlled Period|Adverse Event|0|||
129617832|NCT00307437|466552985|FG000|Controlled Period|Death|0|||
129617833|NCT00307437|466552986|FG001|Controlled Period|Death|0|||
129617834|NCT00307437|466552987|FG002|Controlled Period|Death|1|||
129617835|NCT00307437|466552988|FG003|Controlled Period|Death|0|||
129439250|NCT02245672|465906404|FG002|Overall Study|Adverse Event|4|||
129617836|NCT00307437|466552989|FG004|Controlled Period|Death|0|||
129617837|NCT00307437|466552990|FG005|Controlled Period|Death|0|||
129617838|NCT00307437|466552991|FG006|Controlled Period|Death|0|||
129617839|NCT00307437|466552985|FG000|Controlled Period|Lack of Efficacy|2|||
129617840|NCT00307437|466552986|FG001|Controlled Period|Lack of Efficacy|0|||
129617841|NCT00307437|466552987|FG002|Controlled Period|Lack of Efficacy|0|||
129701055|NCT02657343|466866032|FG000|Overall Study|Withdrawal by Subject|0|||
129701056|NCT02657343|466866033|FG001|Overall Study|Withdrawal by Subject|0|||
129701057|NCT02657343|466866034|FG002|Overall Study|Withdrawal by Subject|0|||
129701058|NCT02657343|466866035|FG003|Overall Study|Withdrawal by Subject|0|||
129701059|NCT02657343|466866036|FG004|Overall Study|Withdrawal by Subject|1|||
129701060|NCT02657343|466866037|FG005|Overall Study|Withdrawal by Subject|0|||
129701061|NCT02011542|466866039|FG000|Overall Study|Physician Decision|1|||
129701062|NCT00982280|466866043|FG000|Observation Period|Not eligible to be dosed|19|||
129701063|NCT00982280|466866043|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
129701064|NCT00982280|466866043|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
129701065|NCT00982280|466866043|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
129701066|NCT00982280|466866043|FG000|Maintenance Period|Adverse Event|1|||
129701067|NCT01979185|466866044|FG000|Period 2|Other|0|||
129701068|NCT01979185|466866045|FG001|Period 2|Other|1|||
129701069|NCT00980798|466866046|FG000|Overall Study|Adverse Event|7|||
129701070|NCT00980798|466866047|FG001|Overall Study|Adverse Event|36|||
129701071|NCT00980798|466866046|FG000|Overall Study|Lack of Efficacy|16|||
129701072|NCT00980798|466866047|FG001|Overall Study|Lack of Efficacy|5|||
129701073|NCT00980798|466866046|FG000|Overall Study|Lost to Follow-up|0|||
129701074|NCT00980798|466866047|FG001|Overall Study|Lost to Follow-up|1|||
129701075|NCT00980798|466866046|FG000|Overall Study|Physician Decision|2|||
129791928|NCT01431638|467206236|FG001|Overall Study|Participants condition no longer requires study drug|1|||
129617842|NCT00307437|466552988|FG003|Controlled Period|Lack of Efficacy|0|||
129701076|NCT00980798|466866047|FG001|Overall Study|Physician Decision|1|||
129791929|NCT01431638|467206237|FG002|Overall Study|Participants condition no longer requires study drug|0|||
129791930|NCT01431638|467206235|FG000|Overall Study|Participant withdrew consent|14|||
129791931|NCT01431638|467206236|FG001|Overall Study|Participant withdrew consent|5|||
129617843|NCT00307437|466552989|FG004|Controlled Period|Lack of Efficacy|0|||
129617844|NCT00307437|466552990|FG005|Controlled Period|Lack of Efficacy|0|||
129617845|NCT00307437|466552991|FG006|Controlled Period|Lack of Efficacy|0|||
129617846|NCT00307437|466552985|FG000|Controlled Period|Lost to Follow-up|2|||
129617847|NCT00307437|466552986|FG001|Controlled Period|Lost to Follow-up|3|||
129701077|NCT00980798|466866046|FG000|Overall Study|Withdrawal by Subject|8|||
129701078|NCT00980798|466866047|FG001|Overall Study|Withdrawal by Subject|11|||
129701079|NCT00980798|466866046|FG000|Overall Study|Other|0|||
129701080|NCT00980798|466866047|FG001|Overall Study|Other|1|||
129701081|NCT04221438|466866048|FG000|Overall Study|Adverse Event|1|||
129701082|NCT04221438|466866048|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
129701083|NCT04724837|466866051|FG000|Overall Study|Other|4|||
129701084|NCT04724837|466866052|FG001|Overall Study|Other|16|||
129701085|NCT04724837|466866053|FG002|Overall Study|Other|0|||
129701086|NCT04724837|466866051|FG000|Overall Study|Withdrawal by Subject|2|||
129701087|NCT04724837|466866052|FG001|Overall Study|Withdrawal by Subject|9|||
129701088|NCT04724837|466866053|FG002|Overall Study|Withdrawal by Subject|9|||
129701089|NCT04724837|466866051|FG000|Overall Study|Adverse Event|2|||
129791932|NCT01431638|467206237|FG002|Overall Study|Participant withdrew consent|8|||
129791933|NCT01431638|467206235|FG000|Overall Study|Lost to Follow-up|7|||
129791934|NCT01431638|467206236|FG001|Overall Study|Lost to Follow-up|9|||
129791935|NCT01431638|467206237|FG002|Overall Study|Lost to Follow-up|7|||
129791936|NCT01431638|467206235|FG000|Overall Study|Administrative problems|1|||
129791937|NCT01431638|467206236|FG001|Overall Study|Administrative problems|4|||
129791938|NCT01431638|467206237|FG002|Overall Study|Administrative problems|6|||
129791939|NCT01431638|467206235|FG000|Overall Study|Death|1|||
129791940|NCT01431638|467206236|FG001|Overall Study|Death|0|||
129791941|NCT01431638|467206237|FG002|Overall Study|Death|0|||
129791942|NCT01431638|467206235|FG000|Overall Study|Protocol deviation|1|||
129791943|NCT01431638|467206236|FG001|Overall Study|Protocol deviation|1|||
129791944|NCT01431638|467206237|FG002|Overall Study|Protocol deviation|4|||
129791945|NCT01431638|467206235|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
129791946|NCT01431638|467206236|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
129791947|NCT01431638|467206237|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
129791948|NCT01239732|467206238|FG000|Overall Study|Termination of study per protocol|667|||
129791949|NCT01239732|467206238|FG000|Overall Study|Death|226|||
129791950|NCT01239732|467206238|FG000|Overall Study|Withdrawal by Subject|87|||
129791951|NCT01239732|467206238|FG000|Overall Study|Adverse Event|6|||
129791952|NCT01239732|467206238|FG000|Overall Study|Protocol Violation|3|||
129791953|NCT01239732|467206238|FG000|Overall Study|Participant non compliance|5|||
129791954|NCT01239732|467206238|FG000|Overall Study|Study termination by sponsor|2|||
129791955|NCT01239732|467206238|FG000|Overall Study|Investigator's decision|4|||
129791956|NCT01239732|467206238|FG000|Overall Study|Treatment failure|2|||
129791957|NCT01239732|467206238|FG000|Overall Study|Other|19|||
129791958|NCT02216812|467206256|FG000|Overall Study|Lost to Follow-up|10|||
129791959|NCT02216812|467206257|FG001|Overall Study|Lost to Follow-up|5|||
129791960|NCT00527488|467206262|FG000|Overall Study|Withdrawn prior to dosing|0|||
129791961|NCT00527488|467206263|FG001|Overall Study|Withdrawn prior to dosing|1|||
129791962|NCT00527488|467206264|FG002|Overall Study|Withdrawn prior to dosing|1|||
129791963|NCT00527488|467206265|FG003|Overall Study|Withdrawn prior to dosing|0|||
129791964|NCT01958827|467206266|FG000|Overall Study|Adverse Event|3|||
129791965|NCT01958827|467206266|FG000|Overall Study|Lack of Efficacy|6|||
129791966|NCT01958827|467206266|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
129791967|NCT00604214|467206271|FG000|Baseline to Day 28|Death|223|||
129791968|NCT00604214|467206272|FG001|Baseline to Day 28|Death|202|||
129791969|NCT00604214|467206271|FG000|Baseline to Day 28|Lost to Follow-up|2|||
129791970|NCT00604214|467206272|FG001|Baseline to Day 28|Lost to Follow-up|4|||
129791971|NCT00604214|467206271|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
129791972|NCT00604214|467206272|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
129791973|NCT00604214|467206271|FG000|Day 29 to Day 90|Death|64|||
129791974|NCT00604214|467206272|FG001|Day 29 to Day 90|Death|67|||
129791975|NCT00604214|467206271|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
129791976|NCT00604214|467206272|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
129791977|NCT00604214|467206271|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
129791978|NCT00604214|467206272|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
129701090|NCT04724837|466866052|FG001|Overall Study|Adverse Event|7|||
129701091|NCT04724837|466866053|FG002|Overall Study|Adverse Event|4|||
129701092|NCT04724837|466866051|FG000|Overall Study|Lost to Follow-up|0|||
129791979|NCT00604214|467206271|FG000|Day 91 to Day 180|Death|19|||
129791980|NCT00604214|467206272|FG001|Day 91 to Day 180|Death|23|||
129791981|NCT00604214|467206271|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
129791982|NCT00604214|467206272|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
129791983|NCT00604214|467206271|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
129791984|NCT00604214|467206272|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
129791985|NCT00130442|467207381|FG000|Overall Study|Withdrawal by Subject|0|||
129791986|NCT00130442|467207382|FG001|Overall Study|Withdrawal by Subject|1|||
129701093|NCT04724837|466866052|FG001|Overall Study|Lost to Follow-up|1|||
129701094|NCT04724837|466866053|FG002|Overall Study|Lost to Follow-up|3|||
129701095|NCT04724837|466866051|FG000|Overall Study|Physician Decision|1|||
129701096|NCT04724837|466866052|FG001|Overall Study|Physician Decision|2|||
129791987|NCT00130442|467207381|FG000|Overall Study|did not meet criteria|1|||
129791988|NCT00130442|467207382|FG001|Overall Study|did not meet criteria|1|||
129791989|NCT00814333|467207383|FG000|Enrollment|Lost to Follow-up|1|||
129617848|NCT00307437|466552987|FG002|Controlled Period|Lost to Follow-up|0|||
129617849|NCT00307437|466552988|FG003|Controlled Period|Lost to Follow-up|0|||
129617850|NCT00307437|466552989|FG004|Controlled Period|Lost to Follow-up|0|||
129617851|NCT00307437|466552990|FG005|Controlled Period|Lost to Follow-up|0|||
129617852|NCT00307437|466552991|FG006|Controlled Period|Lost to Follow-up|0|||
129617853|NCT00307437|466552985|FG000|Controlled Period|Other|5|||
129617854|NCT00307437|466552986|FG001|Controlled Period|Other|1|||
129617855|NCT00307437|466552987|FG002|Controlled Period|Other|3|||
129617856|NCT00307437|466552988|FG003|Controlled Period|Other|0|||
129617857|NCT00307437|466552989|FG004|Controlled Period|Other|0|||
129617858|NCT00307437|466552990|FG005|Controlled Period|Other|0|||
129617859|NCT00307437|466552991|FG006|Controlled Period|Other|0|||
129617860|NCT00307437|466552985|FG000|After Controlled Period|Adverse Event|0|||
129617861|NCT00307437|466552986|FG001|After Controlled Period|Adverse Event|0|||
129617862|NCT00307437|466552987|FG002|After Controlled Period|Adverse Event|0|||
129617863|NCT00307437|466552988|FG003|After Controlled Period|Adverse Event|18|||
129617864|NCT00307437|466552989|FG004|After Controlled Period|Adverse Event|16|||
129617865|NCT00307437|466552990|FG005|After Controlled Period|Adverse Event|31|||
129617866|NCT00307437|466552991|FG006|After Controlled Period|Adverse Event|40|||
129617867|NCT00307437|466552985|FG000|After Controlled Period|Death|0|||
129617868|NCT00307437|466552986|FG001|After Controlled Period|Death|0|||
129617869|NCT00307437|466552987|FG002|After Controlled Period|Death|0|||
129617870|NCT00307437|466552988|FG003|After Controlled Period|Death|3|||
129617871|NCT00307437|466552989|FG004|After Controlled Period|Death|1|||
129617872|NCT00307437|466552990|FG005|After Controlled Period|Death|1|||
129617873|NCT00307437|466552991|FG006|After Controlled Period|Death|3|||
129617874|NCT00307437|466552985|FG000|After Controlled Period|Lack of Efficacy|0|||
129617875|NCT00307437|466552986|FG001|After Controlled Period|Lack of Efficacy|0|||
129617876|NCT00307437|466552987|FG002|After Controlled Period|Lack of Efficacy|0|||
129617877|NCT00307437|466552988|FG003|After Controlled Period|Lack of Efficacy|15|||
129617878|NCT00307437|466552989|FG004|After Controlled Period|Lack of Efficacy|17|||
129617879|NCT00307437|466552990|FG005|After Controlled Period|Lack of Efficacy|37|||
129617880|NCT00307437|466552991|FG006|After Controlled Period|Lack of Efficacy|24|||
129617881|NCT00307437|466552985|FG000|After Controlled Period|Lost to Follow-up|0|||
129617882|NCT00307437|466552986|FG001|After Controlled Period|Lost to Follow-up|0|||
129617883|NCT00307437|466552987|FG002|After Controlled Period|Lost to Follow-up|0|||
129617884|NCT00307437|466552988|FG003|After Controlled Period|Lost to Follow-up|7|||
129617885|NCT00307437|466552989|FG004|After Controlled Period|Lost to Follow-up|12|||
129617886|NCT00307437|466552990|FG005|After Controlled Period|Lost to Follow-up|13|||
129617887|NCT00307437|466552991|FG006|After Controlled Period|Lost to Follow-up|18|||
129617888|NCT00307437|466552985|FG000|After Controlled Period|Other|0|||
129617889|NCT00307437|466552986|FG001|After Controlled Period|Other|0|||
129617890|NCT00307437|466552987|FG002|After Controlled Period|Other|0|||
129617891|NCT00307437|466552988|FG003|After Controlled Period|Other|15|||
129617892|NCT00307437|466552989|FG004|After Controlled Period|Other|9|||
129617893|NCT00307437|466552990|FG005|After Controlled Period|Other|40|||
129617894|NCT00307437|466552991|FG006|After Controlled Period|Other|28|||
129617895|NCT00338728|466552998|FG000|Overall Study|Screen Failure|14|||
129617896|NCT00143247|466553002|FG000|Overall Study|Death|8|||
129617897|NCT00143247|466553002|FG000|Overall Study|Adverse Event|19|||
129617898|NCT00143247|466553002|FG000|Overall Study|Lack of Efficacy|3|||
129617899|NCT00143247|466553002|FG000|Overall Study|Withdrawal by Subject|55|||
129617900|NCT00143247|466553002|FG000|Overall Study|Study terminated by sponsor|31|||
129617901|NCT00143247|466553002|FG000|Overall Study|Protocol Violation|15|||
129617902|NCT00143247|466553002|FG000|Overall Study|Lost to Follow-up|12|||
129791990|NCT00814333|467207384|FG001|Enrollment|Lost to Follow-up|0|||
129791991|NCT02233946|467207385|FG000|Baseline|Withdrawal by Subject|2|||
129791992|NCT02233946|467207386|FG001|Baseline|Withdrawal by Subject|0|||
129791993|NCT02233946|467207385|FG000|3-months Follow-up|Lost to Follow-up|53|||
129617903|NCT00143247|466553002|FG000|Overall Study|following inaccurate lab adverse event|1|||
129617904|NCT00143247|466553002|FG000|Overall Study|Other|12|||
129617905|NCT02766283|466553003|FG000|Overall Study|Lost to Follow-up|27|||
129617906|NCT04803305|466553004|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
129617907|NCT04803305|466553005|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
129617908|NCT04803305|466553004|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
129617909|NCT04803305|466553005|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
129617910|NCT04803305|466553004|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
129617911|NCT04803305|466553005|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
129617912|NCT04803305|466553004|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
129791994|NCT02233946|467207386|FG001|3-months Follow-up|Lost to Follow-up|29|||
129617913|NCT04803305|466553005|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
129617914|NCT04803305|466553004|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
129617915|NCT04803305|466553005|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
129617916|NCT04803305|466553004|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
129617917|NCT04803305|466553005|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
129791995|NCT02233946|467207385|FG000|6-months Follow-up|Lost to Follow-up|21|||
129791996|NCT02233946|467207386|FG001|6-months Follow-up|Lost to Follow-up|2|||
129617918|NCT04803305|466553004|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
129617919|NCT04803305|466553005|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
129617920|NCT04803305|466553004|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
129617921|NCT04803305|466553005|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
129617922|NCT03316547|466553006|FG000|Overall Study|Death|3|||
129617923|NCT03316547|466553007|FG001|Overall Study|Death|1|||
129617924|NCT03316547|466553006|FG000|Overall Study|Lost to Follow-up|6|||
129617925|NCT03316547|466553007|FG001|Overall Study|Lost to Follow-up|6|||
129617926|NCT03316547|466553006|FG000|Overall Study|Withdrawal by Subject|3|||
129617927|NCT03316547|466553007|FG001|Overall Study|Withdrawal by Subject|2|||
129617928|NCT03316547|466553006|FG000|Overall Study|Transfer to another hospital|6|||
129617929|NCT03316547|466553007|FG001|Overall Study|Transfer to another hospital|4|||
129617930|NCT00721227|466553008|FG000|Overall Study|Lost to Follow-up|3|||
129617931|NCT00721227|466553009|FG001|Overall Study|Lost to Follow-up|0|||
129617932|NCT00721227|466553008|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
129617933|NCT00721227|466553009|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
129617934|NCT03654599|466553015|FG000|Overall Study|Lost to Follow-up|14|||
129617935|NCT03654599|466553016|FG001|Overall Study|Lost to Follow-up|12|||
129617936|NCT03654599|466553015|FG000|Overall Study|Death|8|||
129617937|NCT03654599|466553016|FG001|Overall Study|Death|6|||
129617938|NCT03654599|466553015|FG000|Overall Study|Withdrawal by Subject|6|||
129617939|NCT03654599|466553016|FG001|Overall Study|Withdrawal by Subject|4|||
129701097|NCT04724837|466866053|FG002|Overall Study|Physician Decision|0|||
129701098|NCT04724837|466866051|FG000|Overall Study|Death|0|||
129701099|NCT04724837|466866052|FG001|Overall Study|Death|0|||
129701100|NCT04724837|466866053|FG002|Overall Study|Death|1|||
129701101|NCT04724837|466866051|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129701102|NCT04724837|466866052|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
129701103|NCT04724837|466866053|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
129701104|NCT04724837|466866051|FG000|Overall Study|Study Terminated by Sponsor|0|||
129701105|NCT04724837|466866052|FG001|Overall Study|Study Terminated by Sponsor|1|||
129701106|NCT04724837|466866053|FG002|Overall Study|Study Terminated by Sponsor|0|||
129701107|NCT00522379|466866054|FG000|Overall Study|Adverse Event|12|||
129701108|NCT00522379|466866055|FG001|Overall Study|Adverse Event|15|||
129701109|NCT00522379|466866056|FG002|Overall Study|Adverse Event|12|||
129617940|NCT01243775|466553017|FG000|Overall Study|Withdrawal by Subject|2|||
129617941|NCT06390826|466555161|FG000|Overall Study|Never Start Protocol Therapy|1|||
129617942|NCT06390826|466555161|FG000|Overall Study|Adverse Event|1|||
129617943|NCT06390826|466555161|FG000|Overall Study|Disease Progression|8|||
129617944|NCT01659125|466555162|FG000|Overall Study|Withdrawal by Subject|2|||
129617945|NCT01659125|466555162|FG000|Overall Study|Lost to Follow-up|7|||
129617946|NCT01659125|466555162|FG000|Overall Study|Technical Problem|1|||
129617947|NCT01659125|466555162|FG000|Overall Study|Time Constraints|2|||
129617948|NCT01659125|466555162|FG000|Overall Study|Failed to Start Treatment|2|||
129617949|NCT01762800|466555165|FG000|Overall Study|Adverse Event|8|||
129617950|NCT01762800|466555166|FG001|Overall Study|Adverse Event|13|||
129617951|NCT01762800|466555165|FG000|Overall Study|Lack of Efficacy|3|||
129617952|NCT01762800|466555166|FG001|Overall Study|Lack of Efficacy|2|||
129617953|NCT01762800|466555165|FG000|Overall Study|Study Closed/Terminated|0|||
129617954|NCT01762800|466555166|FG001|Overall Study|Study Closed/Terminated|1|||
129617955|NCT01762800|466555165|FG000|Overall Study|Physician Decision|1|||
129617956|NCT01762800|466555166|FG001|Overall Study|Physician Decision|1|||
129617957|NCT01762800|466555165|FG000|Overall Study|Withdrawal by Subject|7|||
129617958|NCT01762800|466555166|FG001|Overall Study|Withdrawal by Subject|4|||
129617959|NCT02640482|466555167|FG000|Overall Study|Lost to Follow-up|3|||
129617960|NCT02640482|466555168|FG001|Overall Study|Lost to Follow-up|0|||
129617961|NCT00113763|466555170|FG000|Overall Study|Adverse Event|5|||
129617962|NCT00113763|466555171|FG001|Overall Study|Adverse Event|2|||
129617963|NCT00113763|466555170|FG000|Overall Study|Disease Progression|28|||
129617964|NCT00113763|466555171|FG001|Overall Study|Disease Progression|14|||
129617965|NCT00113763|466555170|FG000|Overall Study|Lost to Follow-up|10|||
129617966|NCT00113763|466555171|FG001|Overall Study|Lost to Follow-up|0|||
129617967|NCT00113763|466555170|FG000|Overall Study|Withdrawal by Subject|1|||
129617968|NCT00113763|466555171|FG001|Overall Study|Withdrawal by Subject|4|||
129617969|NCT00113763|466555170|FG000|Overall Study|Other|27|||
129617970|NCT00113763|466555171|FG001|Overall Study|Other|6|||
129617971|NCT00113763|466555170|FG000|Overall Study|Non-compliance|1|||
129617972|NCT00113763|466555171|FG001|Overall Study|Non-compliance|0|||
129617973|NCT00113763|466555170|FG000|Overall Study|Ongoing|1|||
129617974|NCT00113763|466555171|FG001|Overall Study|Ongoing|0|||
129617975|NCT00517881|466555172|FG000|Overall Study|Protocol Violation|2|||
129617976|NCT00517881|466555172|FG000|Overall Study|Adverse Event|1|||
129617977|NCT00517881|466555172|FG000|Overall Study|Renal transplantation|2|||
129617978|NCT01383707|466555175|FG000|Overall Study|Consent withdrawal|6|||
129617979|NCT01383707|466555175|FG000|Overall Study|Death|19|||
129617980|NCT01383707|466555175|FG000|Overall Study|Other|8|||
129617981|NCT01383707|466555175|FG000|Overall Study|Sponsor's decision|2|||
129617982|NCT01383707|466555175|FG000|Overall Study|Adverse Event|14|||
129617983|NCT01383707|466555175|FG000|Overall Study|Progressive disease|23|||
129617984|NCT02013817|466555180|FG000|Overall Study|Adverse Event|12|||
129617985|NCT02013817|466555180|FG000|Overall Study|Withdrawal by Subject|4|||
129617986|NCT02013817|466555180|FG000|Overall Study|Death|2|||
129617987|NCT02013817|466555180|FG000|Overall Study|Other|9|||
129617988|NCT03336528|466555189|FG000|Overall Study|Protocol Violation|1|||
129617989|NCT03336528|466555190|FG001|Overall Study|Protocol Violation|1|||
129617990|NCT03336528|466555189|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
129617991|NCT03336528|466555190|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
129617992|NCT03336528|466555189|FG000|Overall Study|Did not receive study medication|1|||
129617993|NCT03336528|466555190|FG001|Overall Study|Did not receive study medication|2|||
129617994|NCT01753297|466555195|FG000|Overall Study|Lost to Follow-up|7|||
129617995|NCT01753297|466555196|FG001|Overall Study|Lost to Follow-up|2|||
129617996|NCT01753297|466555195|FG000|Overall Study|Withdrawal by Subject|26|||
129617997|NCT01753297|466555196|FG001|Overall Study|Withdrawal by Subject|23|||
129617998|NCT01753297|466555195|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
129617999|NCT01753297|466555196|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
129618000|NCT01753297|466555195|FG000|Overall Study|Death|0|||
129618001|NCT01753297|466555196|FG001|Overall Study|Death|2|||
129618002|NCT01753297|466555195|FG000|Overall Study|Did not attend end of study visit|7|||
129618003|NCT01753297|466555196|FG001|Overall Study|Did not attend end of study visit|8|||
129618004|NCT00230178|466555197|FG000|Overall Study|Adverse Event|1|||
129618005|NCT00230178|466555198|FG001|Overall Study|Adverse Event|5|||
129618006|NCT00230178|466555199|FG002|Overall Study|Adverse Event|2|||
129618007|NCT00230178|466555197|FG000|Overall Study|Withdrawal by Subject|0|||
129618008|NCT00230178|466555198|FG001|Overall Study|Withdrawal by Subject|0|||
129618009|NCT00230178|466555199|FG002|Overall Study|Withdrawal by Subject|1|||
129618010|NCT00230178|466555197|FG000|Overall Study|Various other reasons|3|||
129618011|NCT00230178|466555198|FG001|Overall Study|Various other reasons|2|||
129618012|NCT00230178|466555199|FG002|Overall Study|Various other reasons|4|||
129618013|NCT04974749|466555206|FG000|Overall Study|Withdrawal by Subject|2|||
129618014|NCT04974749|466555206|FG000|Overall Study|Gestation|1|||
129618015|NCT01645787|466555207|FG000|Washout (2 Weeks)|Adverse Event|1|||
129618016|NCT01645787|466555208|FG001|Washout (2 Weeks)|Adverse Event|0|||
129618017|NCT04315506|466555210|FG000|Overall Study|Lost to Follow-up|74|||
129618018|NCT04315506|466555211|FG001|Overall Study|Lost to Follow-up|82|||
129618019|NCT04315506|466555210|FG000|Overall Study|Withdrawal by Subject|8|||
129618020|NCT04315506|466555211|FG001|Overall Study|Withdrawal by Subject|8|||
129618021|NCT04315506|466555210|FG000|Overall Study|Physician Decision|0|||
129618022|NCT04315506|466555211|FG001|Overall Study|Physician Decision|1|||
129618023|NCT00958893|466555218|FG000|Overall Study|Study prematurely terminated|4|||
129618024|NCT03593395|466555225|FG000|Overall Study|Lost to Follow-up|48|||
129618025|NCT03593395|466555226|FG001|Overall Study|Lost to Follow-up|3|||
129618026|NCT03593395|466555225|FG000|Overall Study|Withdrawal by Subject|5|||
129618027|NCT03593395|466555226|FG001|Overall Study|Withdrawal by Subject|24|||
129618028|NCT03593395|466555225|FG000|Overall Study|Death|2|||
129618029|NCT03593395|466555226|FG001|Overall Study|Death|3|||
129618030|NCT03593395|466555225|FG000|Overall Study|Physician Decision|0|||
129618031|NCT03593395|466555226|FG001|Overall Study|Physician Decision|6|||
129618032|NCT03593395|466555225|FG000|Overall Study|Participant Relocated|19|||
129618033|NCT03593395|466555226|FG001|Overall Study|Participant Relocated|3|||
129618034|NCT03593395|466555225|FG000|Overall Study|No Information|1|||
129618035|NCT03593395|466555226|FG001|Overall Study|No Information|7|||
129618036|NCT01524978|466555227|FG000|Overall Study|Other|16|||
129618037|NCT01524978|466555228|FG001|Overall Study|Other|2|||
129618038|NCT01524978|466555229|FG002|Overall Study|Other|1|||
129618039|NCT01524978|466555230|FG003|Overall Study|Other|2|||
129618040|NCT01524978|466555231|FG004|Overall Study|Other|1|||
129618041|NCT01524978|466555232|FG005|Overall Study|Other|3|||
129618042|NCT01524978|466555233|FG006|Overall Study|Other|17|||
129618043|NCT01524978|466555234|FG007|Overall Study|Other|1|||
129618044|NCT01524978|466555235|FG008|Overall Study|Other|2|||
129618045|NCT01524978|466555236|FG009|Overall Study|Other|2|||
129618046|NCT01524978|466555237|FG010|Overall Study|Other|5|||
129618047|NCT01524978|466555227|FG000|Overall Study|Withdrawal by Subject|12|||
129618048|NCT01524978|466555228|FG001|Overall Study|Withdrawal by Subject|0|||
129618049|NCT01524978|466555229|FG002|Overall Study|Withdrawal by Subject|1|||
129618050|NCT01524978|466555230|FG003|Overall Study|Withdrawal by Subject|1|||
129618051|NCT01524978|466555231|FG004|Overall Study|Withdrawal by Subject|3|||
129618052|NCT01524978|466555232|FG005|Overall Study|Withdrawal by Subject|1|||
129618053|NCT01524978|466555233|FG006|Overall Study|Withdrawal by Subject|6|||
129618054|NCT01524978|466555234|FG007|Overall Study|Withdrawal by Subject|2|||
129618055|NCT01524978|466555235|FG008|Overall Study|Withdrawal by Subject|4|||
129618056|NCT01524978|466555236|FG009|Overall Study|Withdrawal by Subject|0|||
129618057|NCT01524978|466555237|FG010|Overall Study|Withdrawal by Subject|5|||
129618058|NCT01524978|466555227|FG000|Overall Study|Lost to Follow-up|0|||
129618059|NCT01524978|466555228|FG001|Overall Study|Lost to Follow-up|0|||
129618060|NCT01524978|466555229|FG002|Overall Study|Lost to Follow-up|3|||
129618061|NCT01524978|466555230|FG003|Overall Study|Lost to Follow-up|0|||
129618062|NCT01524978|466555231|FG004|Overall Study|Lost to Follow-up|1|||
129618063|NCT01524978|466555232|FG005|Overall Study|Lost to Follow-up|1|||
129618064|NCT01524978|466555233|FG006|Overall Study|Lost to Follow-up|2|||
129791997|NCT02233946|467207385|FG000|9-month Follow-up|Lost to Follow-up|20|||
129791998|NCT02233946|467207386|FG001|9-month Follow-up|Lost to Follow-up|11|||
129791999|NCT02233946|467207385|FG000|12-month Follow-up|Lost to Follow-up|28|||
129792000|NCT02233946|467207386|FG001|12-month Follow-up|Lost to Follow-up|11|||
129792001|NCT00773383|467207387|FG000|Overall Study|Adverse Event|4|||
129792002|NCT00773383|467207387|FG000|Overall Study|Death|1|||
129792003|NCT00773383|467207387|FG000|Overall Study|Progression of Disease|23|||
129792004|NCT00773383|467207387|FG000|Overall Study|Other|2|||
129792005|NCT00773383|467207387|FG000|Overall Study|No study dose received|1|||
129792006|NCT03384693|467207388|FG000|Overall Study|Adverse Event|3|||
129792007|NCT02919969|467207391|FG000|Overall Study|Lack of Efficacy|22|||
129792008|NCT02919969|467207391|FG000|Overall Study|Death|4|||
129792009|NCT02919969|467207391|FG000|Overall Study|Physician Decision|3|||
129887394|NCT01474512|467547273|FG001|Maintenance Period|Protocol Violation|0|||
129887395|NCT01474512|467547274|FG002|Maintenance Period|Protocol Violation|0|||
129887396|NCT01474512|467547275|FG003|Maintenance Period|Protocol Violation|1|||
129887397|NCT01474512|467547276|FG004|Maintenance Period|Protocol Violation|0|||
129618065|NCT01524978|466555234|FG007|Overall Study|Lost to Follow-up|0|||
129618066|NCT01524978|466555235|FG008|Overall Study|Lost to Follow-up|1|||
129887398|NCT01474512|467547277|FG005|Maintenance Period|Protocol Violation|0|||
129887399|NCT01474512|467547278|FG006|Maintenance Period|Protocol Violation|0|||
129618067|NCT01524978|466555236|FG009|Overall Study|Lost to Follow-up|1|||
129618068|NCT01524978|466555237|FG010|Overall Study|Lost to Follow-up|1|||
129618069|NCT01524978|466555227|FG000|Overall Study|Death|34|||
129618070|NCT01524978|466555228|FG001|Overall Study|Death|2|||
129618071|NCT01524978|466555229|FG002|Overall Study|Death|5|||
129618072|NCT01524978|466555230|FG003|Overall Study|Death|24|||
129618073|NCT01524978|466555231|FG004|Overall Study|Death|4|||
129618074|NCT01524978|466555232|FG005|Overall Study|Death|4|||
129618075|NCT01524978|466555233|FG006|Overall Study|Death|1|||
129618076|NCT01524978|466555234|FG007|Overall Study|Death|9|||
129618077|NCT01524978|466555235|FG008|Overall Study|Death|5|||
129792010|NCT02919969|467207391|FG000|Overall Study|Withdrawal by Subject|2|||
129792011|NCT01842633|467207392|FG000|Overall Study|Screen Failure|1|||
129792012|NCT01842633|467207393|FG001|Overall Study|Screen Failure|0|||
129618078|NCT01524978|466555236|FG009|Overall Study|Death|6|||
129618079|NCT01524978|466555237|FG010|Overall Study|Death|17|||
129618080|NCT00606632|466555240|FG000|Overall Study|Withdrawal by Subject|13|||
129618081|NCT00606632|466555240|FG000|Overall Study|Miscellaneous reasons|9|||
129618082|NCT02481869|466555241|FG000|Overall Study|Lost to Follow-up|3|||
129618083|NCT02481869|466555242|FG001|Overall Study|Lost to Follow-up|4|||
129618084|NCT02481869|466555241|FG000|Overall Study|Withdrawal by Subject|2|||
129618085|NCT02481869|466555242|FG001|Overall Study|Withdrawal by Subject|0|||
129618086|NCT00711880|466555243|FG000|Overall Study|Adverse Event|11|||
129618087|NCT00711880|466555244|FG001|Overall Study|Adverse Event|2|||
129618088|NCT00711880|466555243|FG000|Overall Study|Patient non-compliance|1|||
129618089|NCT00711880|466555244|FG001|Overall Study|Patient non-compliance|0|||
129618090|NCT00711880|466555243|FG000|Overall Study|Lack of Efficacy|1|||
129618091|NCT00711880|466555244|FG001|Overall Study|Lack of Efficacy|5|||
129618092|NCT04238650|466555247|FG000|Overall Study|Withdrawal by Subject|0|||
129618093|NCT04238650|466555248|FG001|Overall Study|Withdrawal by Subject|1|||
129618094|NCT02756208|466555252|FG000|Overall Study|Withdrawal by Subject|1|||
129618095|NCT02756208|466555253|FG001|Overall Study|Withdrawal by Subject|0|||
129618096|NCT02756208|466555254|FG002|Overall Study|Withdrawal by Subject|1|||
129618097|NCT02756208|466555255|FG003|Overall Study|Withdrawal by Subject|3|||
129618098|NCT02756208|466555252|FG000|Overall Study|Lost to Follow-up|3|||
129618099|NCT02756208|466555253|FG001|Overall Study|Lost to Follow-up|1|||
129618100|NCT02756208|466555254|FG002|Overall Study|Lost to Follow-up|1|||
129618101|NCT02756208|466555255|FG003|Overall Study|Lost to Follow-up|1|||
129618102|NCT02756208|466555252|FG000|Overall Study|Physician Decision|1|||
129618103|NCT02756208|466555253|FG001|Overall Study|Physician Decision|0|||
129618104|NCT02756208|466555254|FG002|Overall Study|Physician Decision|0|||
129618105|NCT02756208|466555255|FG003|Overall Study|Physician Decision|0|||
129618106|NCT02756208|466555252|FG000|Overall Study|Protocol Violation|0|||
129618107|NCT02756208|466555253|FG001|Overall Study|Protocol Violation|1|||
129618108|NCT02756208|466555254|FG002|Overall Study|Protocol Violation|0|||
129618109|NCT02756208|466555255|FG003|Overall Study|Protocol Violation|0|||
129618110|NCT02370238|466555256|FG000|Overall Study|Death|42|||
129618111|NCT02370238|466555257|FG001|Overall Study|Death|35|||
129618112|NCT02370238|466555256|FG000|Overall Study|Lost to Follow-up|1|||
129618113|NCT02370238|466555257|FG001|Overall Study|Lost to Follow-up|3|||
129618114|NCT02370238|466555256|FG000|Overall Study|Withdrawal by Subject|2|||
129618115|NCT02370238|466555257|FG001|Overall Study|Withdrawal by Subject|6|||
129618116|NCT02370238|466555256|FG000|Overall Study|Other|2|||
129701110|NCT00522379|466866057|FG003|Overall Study|Adverse Event|5|||
129701111|NCT00522379|466866058|FG004|Overall Study|Adverse Event|17|||
129701112|NCT00522379|466866054|FG000|Overall Study|Lack of Efficacy|3|||
129701113|NCT00522379|466866055|FG001|Overall Study|Lack of Efficacy|0|||
129701114|NCT00522379|466866056|FG002|Overall Study|Lack of Efficacy|2|||
129701115|NCT00522379|466866057|FG003|Overall Study|Lack of Efficacy|2|||
129701116|NCT00522379|466866058|FG004|Overall Study|Lack of Efficacy|7|||
129701117|NCT00522379|466866054|FG000|Overall Study|Withdrawal by Subject|2|||
129701118|NCT00522379|466866055|FG001|Overall Study|Withdrawal by Subject|3|||
129701119|NCT00522379|466866056|FG002|Overall Study|Withdrawal by Subject|1|||
129701120|NCT00522379|466866057|FG003|Overall Study|Withdrawal by Subject|2|||
129701121|NCT00522379|466866058|FG004|Overall Study|Withdrawal by Subject|0|||
129701122|NCT00522379|466866054|FG000|Overall Study|Protocol Violation|1|||
129701123|NCT00522379|466866055|FG001|Overall Study|Protocol Violation|1|||
129701124|NCT00522379|466866056|FG002|Overall Study|Protocol Violation|2|||
129701125|NCT00522379|466866057|FG003|Overall Study|Protocol Violation|0|||
129701126|NCT00522379|466866058|FG004|Overall Study|Protocol Violation|0|||
129701127|NCT00522379|466866054|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
129701128|NCT00522379|466866055|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
129701129|NCT00522379|466866056|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
129701130|NCT00522379|466866057|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
129701131|NCT00522379|466866058|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
129701132|NCT00522379|466866054|FG000|Overall Study|Lost to Follow-up|1|||
129701133|NCT00522379|466866055|FG001|Overall Study|Lost to Follow-up|0|||
129792013|NCT01842633|467207394|FG002|Overall Study|Screen Failure|0|||
129792014|NCT01842633|467207392|FG000|Overall Study|Adverse Event|1|||
129792015|NCT01842633|467207393|FG001|Overall Study|Adverse Event|1|||
129792016|NCT01842633|467207394|FG002|Overall Study|Adverse Event|0|||
129792017|NCT01842633|467207392|FG000|Overall Study|Withdrawal by Subject|0|||
129618117|NCT02370238|466555257|FG001|Overall Study|Other|1|||
129618118|NCT01295320|466555262|FG000|Overall Study|Adverse Event|2|||
129618119|NCT01295320|466555262|FG000|Overall Study|Lost to Follow-up|4|||
129618120|NCT01295320|466555262|FG000|Overall Study|Withdrawal by Subject|2|||
129618121|NCT01295320|466555262|FG000|Overall Study|Subject was bedridden|1|||
129618122|NCT01295320|466555262|FG000|Overall Study|Unable to travel|1|||
129701134|NCT00522379|466866056|FG002|Overall Study|Lost to Follow-up|4|||
129701135|NCT00522379|466866057|FG003|Overall Study|Lost to Follow-up|2|||
129701136|NCT00522379|466866058|FG004|Overall Study|Lost to Follow-up|2|||
129701137|NCT00522379|466866054|FG000|Overall Study|Randomization error|0|||
129792018|NCT01842633|467207393|FG001|Overall Study|Withdrawal by Subject|1|||
129439251|NCT02245672|465906402|FG000|Overall Study|Lost to Follow-up|3|||
129618123|NCT00652340|466555263|FG000|Overall Study|Had not progressed.|4|||
129618124|NCT00652340|466555264|FG001|Overall Study|Had not progressed.|3|||
129618125|NCT03682107|466555265|FG000|Overall Study|Withdrawal by Subject|0|||
129618126|NCT03682107|466555266|FG001|Overall Study|Withdrawal by Subject|1|||
129618127|NCT03682107|466555267|FG002|Overall Study|Withdrawal by Subject|0|||
129618128|NCT03682107|466555268|FG003|Overall Study|Withdrawal by Subject|0|||
129618129|NCT03682107|466555269|FG004|Overall Study|Withdrawal by Subject|0|||
129618130|NCT04342819|466555270|FG000|Overall Study|Declined|4|||
129618131|NCT04342819|466555270|FG000|Overall Study|Not meeeting selection criteria|1|||
129618132|NCT01569295|466555271|FG000|Overall Study|Progressive Disease|75|||
129618133|NCT01569295|466555272|FG001|Overall Study|Progressive Disease|139|||
129439252|NCT02245672|465906403|FG001|Overall Study|Lost to Follow-up|5|||
129618134|NCT01569295|466555271|FG000|Overall Study|Adverse Event|39|||
129439253|NCT02245672|465906404|FG002|Overall Study|Lost to Follow-up|1|||
129618135|NCT01569295|466555272|FG001|Overall Study|Adverse Event|14|||
129792019|NCT01842633|467207394|FG002|Overall Study|Withdrawal by Subject|0|||
129792020|NCT01842633|467207392|FG000|Overall Study|Technical issues|1|||
129618136|NCT01569295|466555271|FG000|Overall Study|Withdrawal by Subject|25|||
129618137|NCT01569295|466555272|FG001|Overall Study|Withdrawal by Subject|12|||
129618138|NCT01569295|466555271|FG000|Overall Study|Death|19|||
129618139|NCT01569295|466555272|FG001|Overall Study|Death|15|||
129618140|NCT01569295|466555271|FG000|Overall Study|Physician Decision|13|||
129618141|NCT01569295|466555272|FG001|Overall Study|Physician Decision|18|||
129618142|NCT01569295|466555271|FG000|Overall Study|Study Terminated by Sponsor|24|||
129618143|NCT01569295|466555272|FG001|Overall Study|Study Terminated by Sponsor|2|||
129618144|NCT01569295|466555271|FG000|Overall Study|Other Reason not Specified|3|||
129618145|NCT01569295|466555272|FG001|Overall Study|Other Reason not Specified|5|||
129618146|NCT01569295|466555271|FG000|Overall Study|Non-Compliance with Study Drug|6|||
129618147|NCT01569295|466555272|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129618148|NCT01569295|466555271|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
129618149|NCT01569295|466555272|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
129618150|NCT01569295|466555271|FG000|Overall Study|Lost to Follow-up|1|||
129701138|NCT00522379|466866055|FG001|Overall Study|Randomization error|0|||
129618151|NCT01569295|466555272|FG001|Overall Study|Lost to Follow-up|1|||
129618152|NCT03607487|466555273|FG000|Overall Study|Withdrawal by Subject|2|||
129618153|NCT03607487|466555274|FG001|Overall Study|Withdrawal by Subject|0|||
129701139|NCT00522379|466866056|FG002|Overall Study|Randomization error|0|||
129701140|NCT00522379|466866057|FG003|Overall Study|Randomization error|0|||
129701141|NCT00522379|466866058|FG004|Overall Study|Randomization error|1|||
129701142|NCT00522379|466866054|FG000|Overall Study|Dispensing error|1|||
129701143|NCT00522379|466866055|FG001|Overall Study|Dispensing error|0|||
129701144|NCT00522379|466866056|FG002|Overall Study|Dispensing error|0|||
129701145|NCT00522379|466866057|FG003|Overall Study|Dispensing error|1|||
129701146|NCT00522379|466866058|FG004|Overall Study|Dispensing error|0|||
129701147|NCT00522379|466866054|FG000|Overall Study|Subject Moved|1|||
129701148|NCT00522379|466866055|FG001|Overall Study|Subject Moved|1|||
129701149|NCT00522379|466866056|FG002|Overall Study|Subject Moved|0|||
129701150|NCT00522379|466866057|FG003|Overall Study|Subject Moved|0|||
129701151|NCT00522379|466866058|FG004|Overall Study|Subject Moved|0|||
129701152|NCT00522379|466866054|FG000|Overall Study|Sponsor Request|0|||
129701153|NCT00522379|466866055|FG001|Overall Study|Sponsor Request|1|||
129701154|NCT00522379|466866056|FG002|Overall Study|Sponsor Request|0|||
129701155|NCT00522379|466866057|FG003|Overall Study|Sponsor Request|0|||
129701156|NCT00522379|466866058|FG004|Overall Study|Sponsor Request|0|||
129701157|NCT00522379|466866054|FG000|Overall Study|Family Problem|0|||
129701158|NCT00522379|466866055|FG001|Overall Study|Family Problem|0|||
129701159|NCT00522379|466866056|FG002|Overall Study|Family Problem|1|||
129701160|NCT00522379|466866057|FG003|Overall Study|Family Problem|0|||
129701161|NCT00522379|466866058|FG004|Overall Study|Family Problem|0|||
129701162|NCT00522379|466866054|FG000|Overall Study|Site Closed|0|||
129701163|NCT00522379|466866055|FG001|Overall Study|Site Closed|0|||
129701164|NCT00522379|466866056|FG002|Overall Study|Site Closed|0|||
129701165|NCT00522379|466866057|FG003|Overall Study|Site Closed|1|||
129701166|NCT00522379|466866058|FG004|Overall Study|Site Closed|0|||
129701167|NCT00522379|466866054|FG000|Overall Study|Subject Withdrawal|0|||
129701168|NCT00522379|466866055|FG001|Overall Study|Subject Withdrawal|0|||
129701169|NCT00522379|466866056|FG002|Overall Study|Subject Withdrawal|0|||
129701170|NCT00522379|466866057|FG003|Overall Study|Subject Withdrawal|1|||
129701171|NCT00522379|466866058|FG004|Overall Study|Subject Withdrawal|0|||
129701172|NCT00967499|466866063|FG000|Overall Study|Adverse Event|0|||
129701173|NCT00967499|466866064|FG001|Overall Study|Adverse Event|1|||
129792021|NCT01842633|467207393|FG001|Overall Study|Technical issues|0|||
129618154|NCT03607487|466555275|FG002|Overall Study|Withdrawal by Subject|0|||
129618155|NCT03607487|466555276|FG003|Overall Study|Withdrawal by Subject|1|||
129701174|NCT00967499|466866063|FG000|Overall Study|Protocol Violation|1|||
129701175|NCT00967499|466866064|FG001|Overall Study|Protocol Violation|0|||
129701176|NCT00967499|466866063|FG000|Overall Study|Sponsor Decision|1|||
129701177|NCT00967499|466866064|FG001|Overall Study|Sponsor Decision|0|||
129701178|NCT00967499|466866063|FG000|Overall Study|Randomized but not treated|63|||
129701179|NCT00967499|466866064|FG001|Overall Study|Randomized but not treated|59|||
129701180|NCT03034044|466866066|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
129701181|NCT05535972|466866067|FG000|Overall Study|Withdrawal by Subject|31|||
129701182|NCT05535972|466866067|FG000|Overall Study|Lost to Follow-up|5|||
129701183|NCT05535972|466866067|FG000|Overall Study|Adverse Event|6|||
129701184|NCT05535972|466866067|FG000|Overall Study|Protocol Deviation|2|||
129618156|NCT01884337|466555277|FG000|Treatment|Adverse Event|2|||
129618157|NCT01884337|466555278|FG001|Treatment|Adverse Event|2|||
129618158|NCT01884337|466555277|FG000|Treatment|Subj. request to discont. treatment|2|||
129618159|NCT01884337|466555278|FG001|Treatment|Subj. request to discont. treatment|0|||
129618160|NCT01884337|466555277|FG000|Follow-up Period|Lost to Follow-up|1|||
129618161|NCT01884337|466555278|FG001|Follow-up Period|Lost to Follow-up|1|||
129792022|NCT01842633|467207394|FG002|Overall Study|Technical issues|0|||
129792023|NCT02093351|467207395|FG000|Part A|Adverse Event|0|||
129792024|NCT02093351|467207396|FG001|Part A|Adverse Event|1|||
129792025|NCT02093351|467207397|FG002|Part A|Adverse Event|1|||
129792026|NCT02093351|467207398|FG003|Part A|Adverse Event|0|||
129792027|NCT02093351|467207395|FG000|Part A|Condition under investigation worsened|2|||
129792028|NCT02093351|467207396|FG001|Part A|Condition under investigation worsened|0|||
129792029|NCT02093351|467207397|FG002|Part A|Condition under investigation worsened|2|||
129792030|NCT02093351|467207398|FG003|Part A|Condition under investigation worsened|0|||
129792031|NCT02093351|467207395|FG000|Part A|Death|0|||
129792032|NCT02093351|467207396|FG001|Part A|Death|1|||
129792033|NCT02093351|467207397|FG002|Part A|Death|0|||
129792034|NCT02093351|467207398|FG003|Part A|Death|0|||
129792035|NCT02093351|467207395|FG000|Part B|Patient decision|0|||
129792036|NCT02093351|467207396|FG001|Part B|Patient decision|0|||
129792037|NCT02093351|467207397|FG002|Part B|Patient decision|0|||
129792038|NCT02093351|467207398|FG003|Part B|Patient decision|3|||
129792039|NCT02093351|467207395|FG000|Part B|Disease progression|0|||
129792040|NCT02093351|467207396|FG001|Part B|Disease progression|0|||
129792041|NCT02093351|467207397|FG002|Part B|Disease progression|0|||
129792042|NCT02093351|467207398|FG003|Part B|Disease progression|4|||
129792043|NCT02093351|467207395|FG000|Part B|Complete response|0|||
129792044|NCT02093351|467207396|FG001|Part B|Complete response|0|||
129792045|NCT02093351|467207397|FG002|Part B|Complete response|0|||
129792046|NCT02093351|467207398|FG003|Part B|Complete response|1|||
129792047|NCT02093351|467207395|FG000|Part B|Adverse event + disease progression|0|||
129792048|NCT02093351|467207396|FG001|Part B|Adverse event + disease progression|0|||
129792049|NCT02093351|467207397|FG002|Part B|Adverse event + disease progression|0|||
129792050|NCT02093351|467207398|FG003|Part B|Adverse event + disease progression|1|||
129792051|NCT02093351|467207395|FG000|Part B|Lack of therapeutic response|0|||
129792052|NCT02093351|467207396|FG001|Part B|Lack of therapeutic response|0|||
129792053|NCT02093351|467207397|FG002|Part B|Lack of therapeutic response|0|||
129792054|NCT02093351|467207398|FG003|Part B|Lack of therapeutic response|12|||
129792055|NCT02093351|467207395|FG000|Part B|Condition under investigation worsened|0|||
129792056|NCT02093351|467207396|FG001|Part B|Condition under investigation worsened|0|||
129792057|NCT02093351|467207397|FG002|Part B|Condition under investigation worsened|0|||
129792058|NCT02093351|467207398|FG003|Part B|Condition under investigation worsened|39|||
129792059|NCT02093351|467207395|FG000|Part B|Adverse Event|0|||
129792060|NCT02093351|467207396|FG001|Part B|Adverse Event|0|||
129792061|NCT02093351|467207397|FG002|Part B|Adverse Event|0|||
129792062|NCT02093351|467207398|FG003|Part B|Adverse Event|2|||
129792063|NCT02093351|467207395|FG000|Part B|Death|0|||
129792064|NCT02093351|467207396|FG001|Part B|Death|0|||
129792065|NCT02093351|467207397|FG002|Part B|Death|0|||
129792066|NCT02093351|467207398|FG003|Part B|Death|1|||
129792067|NCT01099709|467207399|FG000|Period 1|Withdrawal by Subject|0|||
129792068|NCT01099709|467207400|FG001|Period 1|Withdrawal by Subject|1|||
129792069|NCT01099709|467207399|FG000|Period 1|Positive cotinine test|0|||
129792070|NCT01099709|467207400|FG001|Period 1|Positive cotinine test|1|||
129792071|NCT01099709|467207399|FG000|Period 1|Adverse Event|1|||
129792072|NCT01099709|467207400|FG001|Period 1|Adverse Event|0|||
129792073|NCT00718081|467207404|FG000|Overall Study|Adverse Event|0|||
129792074|NCT00718081|467207405|FG001|Overall Study|Adverse Event|1|||
129792075|NCT00718081|467207406|FG002|Overall Study|Adverse Event|0|||
129792076|NCT00718081|467207404|FG000|Overall Study|Lack of Efficacy|7|||
129792077|NCT00718081|467207405|FG001|Overall Study|Lack of Efficacy|3|||
129792078|NCT00718081|467207406|FG002|Overall Study|Lack of Efficacy|21|||
129792079|NCT01397825|467207409|FG000|Overall Study|Progressive Disease|10|||
129792080|NCT01397825|467207410|FG001|Overall Study|Progressive Disease|3|||
129792081|NCT01397825|467207411|FG002|Overall Study|Progressive Disease|11|||
129618162|NCT02455518|466555279|FG000|Overall Study|Protocol Violation|0|||
129618163|NCT02455518|466555280|FG001|Overall Study|Protocol Violation|1|||
129792082|NCT01397825|467207412|FG003|Overall Study|Progressive Disease|1|||
129792083|NCT01397825|467207413|FG004|Overall Study|Progressive Disease|0|||
129792084|NCT01397825|467207409|FG000|Overall Study|Symptomatic Deterioration|2|||
129792085|NCT01397825|467207410|FG001|Overall Study|Symptomatic Deterioration|0|||
129792086|NCT01397825|467207411|FG002|Overall Study|Symptomatic Deterioration|4|||
129792087|NCT01397825|467207412|FG003|Overall Study|Symptomatic Deterioration|0|||
129792088|NCT01397825|467207413|FG004|Overall Study|Symptomatic Deterioration|0|||
129792089|NCT01397825|467207409|FG000|Overall Study|Adverse Event|0|||
129618164|NCT02455518|466555281|FG002|Overall Study|Protocol Violation|1|||
129618165|NCT02455518|466555282|FG003|Overall Study|Protocol Violation|3|||
129792090|NCT01397825|467207410|FG001|Overall Study|Adverse Event|1|||
129792091|NCT01397825|467207411|FG002|Overall Study|Adverse Event|5|||
129792092|NCT01397825|467207412|FG003|Overall Study|Adverse Event|1|||
129887400|NCT01474512|467547279|FG007|Maintenance Period|Protocol Violation|1|||
129887401|NCT01474512|467547280|FG008|Maintenance Period|Protocol Violation|0|||
129887402|NCT01474512|467547281|FG009|Maintenance Period|Protocol Violation|1|||
129887403|NCT01474512|467547282|FG010|Maintenance Period|Protocol Violation|0|||
129887404|NCT01474512|467547283|FG011|Maintenance Period|Protocol Violation|0|||
129887405|NCT01474512|467547284|FG012|Maintenance Period|Protocol Violation|0|||
129887406|NCT01474512|467547285|FG013|Maintenance Period|Protocol Violation|0|||
129887407|NCT01474512|467547286|FG014|Maintenance Period|Protocol Violation|0|||
129887408|NCT01474512|467547287|FG015|Maintenance Period|Protocol Violation|0|||
129887409|NCT01474512|467547288|FG016|Maintenance Period|Protocol Violation|0|||
129887410|NCT01474512|467547289|FG017|Maintenance Period|Protocol Violation|0|||
129887411|NCT01474512|467547272|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
129887412|NCT01474512|467547273|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
129887413|NCT01474512|467547274|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
129887414|NCT01474512|467547275|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
129887415|NCT01474512|467547276|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
129887416|NCT01474512|467547277|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
129887417|NCT01474512|467547278|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
129887418|NCT01474512|467547279|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
129887419|NCT01474512|467547280|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
129887420|NCT01474512|467547281|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
129887421|NCT01474512|467547282|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
129887422|NCT01474512|467547283|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
129887423|NCT01474512|467547284|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
129887424|NCT01474512|467547285|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
129887425|NCT01474512|467547286|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
129887426|NCT01474512|467547287|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
129887427|NCT01474512|467547288|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
129887428|NCT01474512|467547289|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
129887429|NCT01474512|467547272|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
129887430|NCT01474512|467547273|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
129887431|NCT01474512|467547274|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
129887432|NCT01474512|467547275|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
129887433|NCT01474512|467547276|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
129887434|NCT01474512|467547277|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
129887435|NCT01474512|467547278|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
129887436|NCT01474512|467547279|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
129887437|NCT01474512|467547280|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
129887438|NCT01474512|467547281|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
129887439|NCT01474512|467547282|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
129887440|NCT01474512|467547283|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
129887441|NCT01474512|467547284|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
129887442|NCT01474512|467547285|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
129887443|NCT01474512|467547286|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
129887444|NCT01474512|467547287|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
129887445|NCT01474512|467547288|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
129887446|NCT01474512|467547289|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
129887447|NCT01474512|467547272|FG000|Long-Term Extension Period|Adverse Event|0|||
129887448|NCT01474512|467547273|FG001|Long-Term Extension Period|Adverse Event|0|||
129887449|NCT01474512|467547274|FG002|Long-Term Extension Period|Adverse Event|0|||
129887450|NCT01474512|467547275|FG003|Long-Term Extension Period|Adverse Event|0|||
129887451|NCT01474512|467547276|FG004|Long-Term Extension Period|Adverse Event|0|||
129887452|NCT01474512|467547277|FG005|Long-Term Extension Period|Adverse Event|0|||
129887453|NCT01474512|467547278|FG006|Long-Term Extension Period|Adverse Event|0|||
129887454|NCT01474512|467547279|FG007|Long-Term Extension Period|Adverse Event|0|||
129887455|NCT01474512|467547280|FG008|Long-Term Extension Period|Adverse Event|0|||
129887456|NCT01474512|467547281|FG009|Long-Term Extension Period|Adverse Event|0|||
129887457|NCT01474512|467547282|FG010|Long-Term Extension Period|Adverse Event|0|||
129887458|NCT01474512|467547283|FG011|Long-Term Extension Period|Adverse Event|1|||
129887459|NCT01474512|467547284|FG012|Long-Term Extension Period|Adverse Event|57|||
129887460|NCT01474512|467547285|FG013|Long-Term Extension Period|Adverse Event|58|||
129887461|NCT01474512|467547286|FG014|Long-Term Extension Period|Adverse Event|0|||
129618166|NCT01038297|466555285|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
129618167|NCT01038297|466555286|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
129887462|NCT01474512|467547287|FG015|Long-Term Extension Period|Adverse Event|0|||
129887463|NCT01474512|467547288|FG016|Long-Term Extension Period|Adverse Event|0|||
129887464|NCT01474512|467547289|FG017|Long-Term Extension Period|Adverse Event|0|||
129618168|NCT01038297|466555287|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
129887465|NCT01474512|467547272|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
129439254|NCT02245672|465906402|FG000|Overall Study|Withdrawal by Subject|6|||
129887466|NCT01474512|467547273|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
129887467|NCT01474512|467547274|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
129887468|NCT01474512|467547275|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
129887469|NCT01474512|467547276|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
129887470|NCT01474512|467547277|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
129887471|NCT01474512|467547278|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
129887472|NCT01474512|467547279|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
129887473|NCT01474512|467547280|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
129887474|NCT01474512|467547281|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
129618169|NCT02508935|466555289|FG000|Overall Study|Withdrawal by Subject|1|||
129618170|NCT02508935|466555289|FG000|Overall Study|Withdrawal by Caregiver|8|||
129618171|NCT02508935|466555289|FG000|Overall Study|Pain Score <4|1|||
129618172|NCT02508935|466555289|FG000|Overall Study|Emesis|3|||
129618173|NCT02508935|466555289|FG000|Overall Study|Adverse Event|3|||
129887475|NCT01474512|467547282|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
129887476|NCT01474512|467547283|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
129439255|NCT02245672|465906403|FG001|Overall Study|Withdrawal by Subject|3|||
129618174|NCT02508935|466555289|FG000|Overall Study|Protocol Violation|1|||
129618175|NCT02508935|466555289|FG000|Overall Study|Physician Decision|1|||
129618176|NCT02508935|466555289|FG000|Overall Study|Trial terminated by sponsor|5|||
129618177|NCT01973595|466555290|FG000|Washout|Withdrawal by Subject|1|||
129618178|NCT01973595|466555291|FG001|Washout|Withdrawal by Subject|0|||
129618179|NCT01973595|466555292|FG002|Washout|Withdrawal by Subject|1|||
129618180|NCT01973595|466555293|FG003|Washout|Withdrawal by Subject|0|||
129618181|NCT01275430|466555298|FG000|Overall Study|Adverse Event|1|||
129618182|NCT01275430|466555298|FG000|Overall Study|No Contrast Injection|6|||
129618183|NCT01275430|466555298|FG000|Overall Study|Device Malfunction|1|||
129618184|NCT01275430|466555298|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
129618185|NCT04036110|466555299|FG000|Overall Study|Lost to Follow-up|3|||
129618186|NCT04036110|466555300|FG001|Overall Study|Lost to Follow-up|2|||
129618187|NCT04036110|466555301|FG002|Overall Study|Lost to Follow-up|1|||
129618188|NCT04036110|466555299|FG000|Overall Study|Study Suspended|4|||
129618189|NCT04036110|466555300|FG001|Overall Study|Study Suspended|5|||
129618190|NCT04036110|466555301|FG002|Overall Study|Study Suspended|1|||
129618191|NCT00396565|466555306|FG000|Overall Study|Physician Decision|3|||
129618192|NCT00396565|466555307|FG001|Overall Study|Physician Decision|1|||
129618193|NCT00396565|466555308|FG002|Overall Study|Physician Decision|2|||
129792093|NCT01397825|467207413|FG004|Overall Study|Adverse Event|0|||
129792094|NCT01397825|467207409|FG000|Overall Study|Withdrawal by Subject|1|||
129792095|NCT01397825|467207410|FG001|Overall Study|Withdrawal by Subject|0|||
129792096|NCT01397825|467207411|FG002|Overall Study|Withdrawal by Subject|5|||
129792097|NCT01397825|467207412|FG003|Overall Study|Withdrawal by Subject|1|||
129792098|NCT01397825|467207413|FG004|Overall Study|Withdrawal by Subject|0|||
129792099|NCT00815516|467207414|FG000|Overall Study|Death|3|||
129792100|NCT00815516|467207415|FG001|Overall Study|Death|1|||
129792101|NCT00815516|467207414|FG000|Overall Study|Physician Decision|1|||
129792102|NCT00815516|467207415|FG001|Overall Study|Physician Decision|0|||
129792103|NCT01741012|467207421|FG000|Overall Study|Lost to Follow-up|1|||
129792104|NCT01741012|467207421|FG000|Overall Study|Withdrawal by Subject|2|||
129792105|NCT00470158|467207422|FG000|Overall Study|Death|0|||
129792106|NCT00470158|467207423|FG001|Overall Study|Death|0|||
129792107|NCT00470158|467207424|FG002|Overall Study|Death|0|||
129792108|NCT00470158|467207425|FG003|Overall Study|Death|0|||
129792109|NCT00470158|467207426|FG004|Overall Study|Death|2|||
129792110|NCT00470158|467207422|FG000|Overall Study|Lost to Follow-up|7|||
129792111|NCT00470158|467207423|FG001|Overall Study|Lost to Follow-up|8|||
129792112|NCT00470158|467207424|FG002|Overall Study|Lost to Follow-up|8|||
129792113|NCT00470158|467207425|FG003|Overall Study|Lost to Follow-up|5|||
129792114|NCT00470158|467207426|FG004|Overall Study|Lost to Follow-up|4|||
129792115|NCT00470158|467207422|FG000|Overall Study|Protocol Violation|1|||
129792116|NCT00470158|467207423|FG001|Overall Study|Protocol Violation|0|||
129792117|NCT00470158|467207424|FG002|Overall Study|Protocol Violation|0|||
129792118|NCT00470158|467207425|FG003|Overall Study|Protocol Violation|0|||
129792119|NCT00470158|467207426|FG004|Overall Study|Protocol Violation|0|||
129792120|NCT01236118|467207427|FG000|Overall Study|Adverse Event|2|||
129792121|NCT01236118|467207428|FG001|Overall Study|Adverse Event|0|||
129792122|NCT01236118|467207429|FG002|Overall Study|Adverse Event|2|||
129792123|NCT01236118|467207427|FG000|Overall Study|Physician Decision|0|||
129792124|NCT01236118|467207428|FG001|Overall Study|Physician Decision|1|||
129792125|NCT01236118|467207429|FG002|Overall Study|Physician Decision|0|||
129792126|NCT01236118|467207427|FG000|Overall Study|Withdrawal by Subject|0|||
129792127|NCT01236118|467207428|FG001|Overall Study|Withdrawal by Subject|0|||
129792128|NCT01236118|467207429|FG002|Overall Study|Withdrawal by Subject|1|||
129792129|NCT01129024|467207434|FG000|Overall Study|Physician Decision|5|||
129792130|NCT01129024|467207434|FG000|Overall Study|Study Terminated by Sponsor|8|||
129792131|NCT01129024|467207434|FG000|Overall Study|Withdrawal by Subject|2|||
129792132|NCT01129024|467207434|FG000|Overall Study|Lack of Efficacy|3|||
129792133|NCT01129024|467207434|FG000|Overall Study|Needed a Platelet Transfusion|1|||
129792134|NCT01993836|467207435|FG000|Overall Study|Surgery Cancelled|3|||
129792135|NCT01993836|467207436|FG001|Overall Study|Surgery Cancelled|0|||
129618194|NCT00396565|466555306|FG000|Overall Study|Adverse Event|5|||
129618195|NCT00396565|466555307|FG001|Overall Study|Adverse Event|13|||
129792136|NCT01993836|467207437|FG002|Overall Study|Surgery Cancelled|0|||
129792137|NCT01993836|467207435|FG000|Overall Study|Physician Decision|2|||
129792138|NCT01993836|467207436|FG001|Overall Study|Physician Decision|1|||
129792139|NCT01993836|467207437|FG002|Overall Study|Physician Decision|0|||
129792140|NCT01993836|467207435|FG000|Overall Study|Death|0|||
129792141|NCT01993836|467207436|FG001|Overall Study|Death|2|||
129792142|NCT01993836|467207437|FG002|Overall Study|Death|0|||
129792143|NCT01993836|467207435|FG000|Overall Study|Withdrawal by Subject|12|||
129618196|NCT00396565|466555308|FG002|Overall Study|Adverse Event|3|||
129618197|NCT00396565|466555306|FG000|Overall Study|Withdrawal by Subject|8|||
129618198|NCT00396565|466555307|FG001|Overall Study|Withdrawal by Subject|13|||
129792144|NCT01993836|467207436|FG001|Overall Study|Withdrawal by Subject|10|||
129792145|NCT01993836|467207437|FG002|Overall Study|Withdrawal by Subject|5|||
129792146|NCT02195687|467207439|FG000|Overall Study|Personal Reasons|1|||
129792147|NCT02195687|467207440|FG001|Overall Study|Personal Reasons|1|||
129701185|NCT02402647|466866070|FG000|Overall Study|Lost to Follow-up|13|||
129701186|NCT02402647|466866071|FG001|Overall Study|Lost to Follow-up|7|||
129701187|NCT02402647|466866070|FG000|Overall Study|Protocol Violation|1|||
129701188|NCT02402647|466866071|FG001|Overall Study|Protocol Violation|1|||
129701189|NCT02402647|466866070|FG000|Overall Study|scheduled and timed out|2|||
129701190|NCT02402647|466866071|FG001|Overall Study|scheduled and timed out|1|||
129701191|NCT02402647|466866070|FG000|Overall Study|medical illness|2|||
129701192|NCT02402647|466866071|FG001|Overall Study|medical illness|4|||
129701193|NCT02402647|466866070|FG000|Overall Study|Moved|2|||
129701194|NCT02402647|466866071|FG001|Overall Study|Moved|0|||
129701195|NCT02402647|466866070|FG000|Overall Study|loved one illness|1|||
129701196|NCT02402647|466866071|FG001|Overall Study|loved one illness|0|||
129701197|NCT02402647|466866070|FG000|Overall Study|deceased preexisting condition|2|||
129701198|NCT02402647|466866071|FG001|Overall Study|deceased preexisting condition|0|||
129701199|NCT02402647|466866070|FG000|Overall Study|Other|2|||
129701200|NCT02402647|466866071|FG001|Overall Study|Other|1|||
129701201|NCT04197583|466866072|FG000|Overall Study|Study Stent Replacement|34|||
129701202|NCT04197583|466866073|FG001|Overall Study|Study Stent Replacement|8|||
129701203|NCT04197583|466866072|FG000|Overall Study|Lost to Follow-up|14|||
129701204|NCT04197583|466866073|FG001|Overall Study|Lost to Follow-up|3|||
129701205|NCT04197583|466866072|FG000|Overall Study|Death|3|||
129701206|NCT04197583|466866073|FG001|Overall Study|Death|0|||
129701207|NCT04197583|466866072|FG000|Overall Study|Physician Decision|1|||
129701208|NCT04197583|466866073|FG001|Overall Study|Physician Decision|0|||
129701209|NCT04197583|466866072|FG000|Overall Study|Withdrawal by Subject|1|||
129701210|NCT04197583|466866073|FG001|Overall Study|Withdrawal by Subject|1|||
129701211|NCT04197583|466866072|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
129701212|NCT04197583|466866073|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
129701213|NCT04197583|466866072|FG000|Overall Study|Screen Failure|0|||
129701214|NCT04197583|466866073|FG001|Overall Study|Screen Failure|20|||
129701215|NCT00323622|466866075|FG000|Overall Study|Other|30|||
129701216|NCT00323622|466866076|FG001|Overall Study|Other|91|||
129701217|NCT00323622|466866077|FG002|Overall Study|Other|4|||
129701218|NCT00323622|466866078|FG003|Overall Study|Other|12|||
129701219|NCT00323622|466866079|FG004|Overall Study|Other|32|||
129701220|NCT00323622|466866080|FG005|Overall Study|Other|74|||
129701221|NCT00323622|466866081|FG006|Overall Study|Other|5|||
129701222|NCT00323622|466866082|FG007|Overall Study|Other|13|||
129701223|NCT00323622|466866075|FG000|Overall Study|Death|1|||
129701224|NCT00323622|466866076|FG001|Overall Study|Death|1|||
129701225|NCT00323622|466866077|FG002|Overall Study|Death|0|||
129701226|NCT00323622|466866078|FG003|Overall Study|Death|0|||
129701227|NCT00323622|466866079|FG004|Overall Study|Death|7|||
129701228|NCT00323622|466866080|FG005|Overall Study|Death|0|||
129701229|NCT00323622|466866081|FG006|Overall Study|Death|0|||
129701230|NCT00323622|466866082|FG007|Overall Study|Death|2|||
129701231|NCT03033784|466867434|FG000|Overall Study|Anxiety related to MRI scanner|0|||
129701232|NCT03033784|466867435|FG001|Overall Study|Anxiety related to MRI scanner|1|||
129701233|NCT03033784|466867436|FG002|Overall Study|Anxiety related to MRI scanner|0|||
129701234|NCT03033784|466867437|FG003|Overall Study|Anxiety related to MRI scanner|0|||
129701235|NCT03033784|466867438|FG004|Overall Study|Anxiety related to MRI scanner|0|||
129701236|NCT03033784|466867439|FG005|Overall Study|Anxiety related to MRI scanner|0|||
129701237|NCT03033784|466867440|FG006|Overall Study|Anxiety related to MRI scanner|0|||
129701238|NCT03033784|466867441|FG007|Overall Study|Anxiety related to MRI scanner|0|||
129701239|NCT03033784|466867442|FG008|Overall Study|Anxiety related to MRI scanner|0|||
129701240|NCT03033784|466867443|FG009|Overall Study|Anxiety related to MRI scanner|0|||
129701241|NCT03033784|466867444|FG010|Overall Study|Anxiety related to MRI scanner|0|||
129701242|NCT03033784|466867445|FG011|Overall Study|Anxiety related to MRI scanner|0|||
129792148|NCT02195687|467207439|FG000|Overall Study|Lost to Follow-up|4|||
129701243|NCT03033784|466867446|FG012|Overall Study|Anxiety related to MRI scanner|0|||
129701244|NCT03033784|466867434|FG000|Overall Study|Withdrawal by Subject|0|||
129701245|NCT03033784|466867435|FG001|Overall Study|Withdrawal by Subject|0|||
129701246|NCT03033784|466867436|FG002|Overall Study|Withdrawal by Subject|0|||
129701247|NCT03033784|466867437|FG003|Overall Study|Withdrawal by Subject|0|||
129701248|NCT03033784|466867438|FG004|Overall Study|Withdrawal by Subject|0|||
129701249|NCT03033784|466867439|FG005|Overall Study|Withdrawal by Subject|0|||
129701250|NCT03033784|466867440|FG006|Overall Study|Withdrawal by Subject|0|||
129701251|NCT03033784|466867441|FG007|Overall Study|Withdrawal by Subject|0|||
129701252|NCT03033784|466867442|FG008|Overall Study|Withdrawal by Subject|0|||
129701253|NCT03033784|466867443|FG009|Overall Study|Withdrawal by Subject|0|||
129701254|NCT03033784|466867444|FG010|Overall Study|Withdrawal by Subject|0|||
129701255|NCT03033784|466867445|FG011|Overall Study|Withdrawal by Subject|0|||
129701256|NCT03033784|466867446|FG012|Overall Study|Withdrawal by Subject|2|||
129701257|NCT03332056|466867448|FG000|Overall Study|Incomplete questionnaires|8|||
129701258|NCT03332056|466867449|FG001|Overall Study|Incomplete questionnaires|9|||
129701259|NCT03332056|466867448|FG000|Overall Study|Passed stone prior to surgery date|1|||
129701260|NCT03332056|466867449|FG001|Overall Study|Passed stone prior to surgery date|0|||
129701261|NCT03332056|466867448|FG000|Overall Study|Did not require a ureteral stent|0|||
129701262|NCT03332056|466867449|FG001|Overall Study|Did not require a ureteral stent|1|||
129887477|NCT01474512|467547284|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
129887478|NCT01474512|467547285|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
129887479|NCT01474512|467547286|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
129887480|NCT01474512|467547287|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
129887481|NCT01474512|467547288|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
129887482|NCT01474512|467547289|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
129887483|NCT01474512|467547272|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
129887484|NCT01474512|467547273|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
129887485|NCT01474512|467547274|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
129887486|NCT01474512|467547275|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
129887487|NCT01474512|467547276|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
129887488|NCT01474512|467547277|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
129887489|NCT01474512|467547278|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
129887490|NCT01474512|467547279|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
129887491|NCT01474512|467547280|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
129887492|NCT01474512|467547281|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
129887493|NCT01474512|467547282|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
129887494|NCT01474512|467547283|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
129887495|NCT01474512|467547284|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
129887496|NCT01474512|467547285|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
129887497|NCT01474512|467547286|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
129887498|NCT01474512|467547287|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
129887499|NCT01474512|467547288|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
129887500|NCT01474512|467547289|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
129887501|NCT01474512|467547272|FG000|Long-Term Extension Period|Physician Decision|0|||
129887502|NCT01474512|467547273|FG001|Long-Term Extension Period|Physician Decision|0|||
129887503|NCT01474512|467547274|FG002|Long-Term Extension Period|Physician Decision|0|||
129887504|NCT01474512|467547275|FG003|Long-Term Extension Period|Physician Decision|0|||
129887505|NCT01474512|467547276|FG004|Long-Term Extension Period|Physician Decision|0|||
129887506|NCT01474512|467547277|FG005|Long-Term Extension Period|Physician Decision|0|||
129887507|NCT01474512|467547278|FG006|Long-Term Extension Period|Physician Decision|0|||
129887508|NCT01474512|467547279|FG007|Long-Term Extension Period|Physician Decision|0|||
129887509|NCT01474512|467547280|FG008|Long-Term Extension Period|Physician Decision|0|||
129887510|NCT01474512|467547281|FG009|Long-Term Extension Period|Physician Decision|0|||
129887511|NCT01474512|467547282|FG010|Long-Term Extension Period|Physician Decision|0|||
129887512|NCT01474512|467547283|FG011|Long-Term Extension Period|Physician Decision|0|||
129887513|NCT01474512|467547284|FG012|Long-Term Extension Period|Physician Decision|21|||
129887514|NCT01474512|467547285|FG013|Long-Term Extension Period|Physician Decision|21|||
129887515|NCT01474512|467547286|FG014|Long-Term Extension Period|Physician Decision|0|||
129887516|NCT01474512|467547287|FG015|Long-Term Extension Period|Physician Decision|0|||
129887517|NCT01474512|467547288|FG016|Long-Term Extension Period|Physician Decision|0|||
129887518|NCT01474512|467547289|FG017|Long-Term Extension Period|Physician Decision|0|||
129887519|NCT01474512|467547272|FG000|Long-Term Extension Period|Clinical Relapse|0|||
129701263|NCT02374255|466867450|FG000|Overall Study|Withdrawal by Subject|2|||
129701264|NCT02374255|466867451|FG001|Overall Study|Withdrawal by Subject|0|||
129701265|NCT02374255|466867452|FG002|Overall Study|Withdrawal by Subject|0|||
129701266|NCT02374255|466867453|FG003|Overall Study|Withdrawal by Subject|0|||
129701267|NCT02093520|466867454|FG000|Overall Study|Not treated|6|||
129701268|NCT02093520|466867455|FG001|Overall Study|Not treated|22|||
129701269|NCT03014089|466867456|FG000|Overall Study|Withdrawal by Subject|0|||
129701270|NCT03014089|466867457|FG001|Overall Study|Withdrawal by Subject|1|||
129701271|NCT03014089|466867458|FG002|Overall Study|Withdrawal by Subject|1|||
129701272|NCT03014089|466867459|FG003|Overall Study|Withdrawal by Subject|1|||
129701273|NCT03014089|466867456|FG000|Overall Study|Lost to Follow-up|1|||
129701274|NCT03014089|466867457|FG001|Overall Study|Lost to Follow-up|0|||
129701275|NCT03014089|466867458|FG002|Overall Study|Lost to Follow-up|0|||
129701276|NCT03014089|466867459|FG003|Overall Study|Lost to Follow-up|0|||
129701277|NCT03014089|466867456|FG000|Overall Study|Adverse Event|1|||
129887520|NCT01474512|467547273|FG001|Long-Term Extension Period|Clinical Relapse|0|||
129887521|NCT01474512|467547274|FG002|Long-Term Extension Period|Clinical Relapse|0|||
129887522|NCT01474512|467547275|FG003|Long-Term Extension Period|Clinical Relapse|0|||
129887523|NCT01474512|467547276|FG004|Long-Term Extension Period|Clinical Relapse|0|||
129701278|NCT03014089|466867457|FG001|Overall Study|Adverse Event|0|||
129618199|NCT00396565|466555308|FG002|Overall Study|Withdrawal by Subject|1|||
129618200|NCT00396565|466555306|FG000|Overall Study|Lack of Efficacy|32|||
129618201|NCT00396565|466555307|FG001|Overall Study|Lack of Efficacy|64|||
129618202|NCT00396565|466555308|FG002|Overall Study|Lack of Efficacy|11|||
129618203|NCT04324021|466555311|FG000|Overall Study|Adverse Event|1|||
129618204|NCT04324021|466555312|FG001|Overall Study|Adverse Event|0|||
129618205|NCT04324021|466555313|FG002|Overall Study|Adverse Event|0|||
129887524|NCT01474512|467547277|FG005|Long-Term Extension Period|Clinical Relapse|0|||
129618206|NCT04324021|466555311|FG000|Overall Study|Lack of Efficacy|0|||
129618207|NCT04324021|466555312|FG001|Overall Study|Lack of Efficacy|0|||
129618208|NCT04324021|466555313|FG002|Overall Study|Lack of Efficacy|1|||
129618209|NCT04324021|466555311|FG000|Overall Study|Death|1|||
129618210|NCT04324021|466555312|FG001|Overall Study|Death|1|||
129618211|NCT04324021|466555313|FG002|Overall Study|Death|0|||
129618212|NCT03097991|466555314|FG000|Overall Study|Didn't meet study criteria|8|||
129618213|NCT03097991|466555315|FG001|Overall Study|Didn't meet study criteria|0|||
129618214|NCT03097991|466555314|FG000|Overall Study|Withdrawal by Subject|12|||
129618215|NCT03097991|466555315|FG001|Overall Study|Withdrawal by Subject|6|||
129618216|NCT03097991|466555314|FG000|Overall Study|Death of Baby|3|||
129618217|NCT03097991|466555315|FG001|Overall Study|Death of Baby|1|||
129618218|NCT03097991|466555314|FG000|Overall Study|Lost to Follow-up|24|||
129618219|NCT03097991|466555315|FG001|Overall Study|Lost to Follow-up|38|||
129618220|NCT03097991|466555314|FG000|Overall Study|Adverse Event|3|||
129618221|NCT03097991|466555315|FG001|Overall Study|Adverse Event|5|||
129618222|NCT00246324|466555316|FG000|Overall Study|Withdrawal by Subject|1|||
129701279|NCT03014089|466867458|FG002|Overall Study|Adverse Event|1|||
129618223|NCT02006732|466555317|FG000|Overall Study|Adverse Event|10|||
129618224|NCT02006732|466555318|FG001|Overall Study|Adverse Event|7|||
129618225|NCT02006732|466555319|FG002|Overall Study|Adverse Event|4|||
129701280|NCT03014089|466867459|FG003|Overall Study|Adverse Event|0|||
129701281|NCT01992757|466867468|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
129701282|NCT00688740|466867469|FG000|Overall Study|Adverse Event|45|||
129701283|NCT00688740|466867470|FG001|Overall Study|Adverse Event|8|||
129701284|NCT00688740|466867469|FG000|Overall Study|Death|2|||
129701285|NCT00688740|466867470|FG001|Overall Study|Death|2|||
129701286|NCT00688740|466867469|FG000|Overall Study|Lost to Follow-up|0|||
129701287|NCT00688740|466867470|FG001|Overall Study|Lost to Follow-up|1|||
129701288|NCT00688740|466867469|FG000|Overall Study|Consent Withdrawn|17|||
129701289|NCT00688740|466867470|FG001|Overall Study|Consent Withdrawn|17|||
129701290|NCT00688740|466867469|FG000|Overall Study|Breast Cancer Relapse|1|||
129701291|NCT00688740|466867470|FG001|Overall Study|Breast Cancer Relapse|4|||
129701292|NCT00688740|466867469|FG000|Overall Study|Violation of Inclusion Criteria|1|||
129701293|NCT00688740|466867470|FG001|Overall Study|Violation of Inclusion Criteria|3|||
129701294|NCT00856557|466867471|FG000|Overall Study|No patients with contextual flags|12|||
129701295|NCT00856557|466867472|FG001|Overall Study|No patients with contextual flags|16|||
129701296|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
129701297|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
129701298|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
129701299|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
129701300|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
129701301|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
129701302|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
129701303|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
129701304|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
129701305|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
129701306|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
129701307|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
129701308|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
129701309|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
129701310|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
129701311|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
129701312|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
129701313|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
129701314|NCT01432444|466867473|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
129701315|NCT01432444|466867474|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
129701316|NCT01432444|466867475|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
129701317|NCT01432444|466867473|FG000|Treatment Phase|Lost to Follow-up|0|||
129701318|NCT01432444|466867474|FG001|Treatment Phase|Lost to Follow-up|33|||
129701319|NCT01432444|466867475|FG002|Treatment Phase|Lost to Follow-up|0|||
129701320|NCT01432444|466867473|FG000|Treatment Phase|Adverse Event|0|||
129701321|NCT01432444|466867474|FG001|Treatment Phase|Adverse Event|37|||
129701322|NCT01432444|466867475|FG002|Treatment Phase|Adverse Event|0|||
129701323|NCT01432444|466867473|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
129701324|NCT01432444|466867474|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
129701325|NCT01432444|466867475|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
129701326|NCT01432444|466867473|FG000|Treatment Phase|Physician Decision|0|||
129701327|NCT01432444|466867474|FG001|Treatment Phase|Physician Decision|5|||
129701328|NCT01432444|466867475|FG002|Treatment Phase|Physician Decision|0|||
129701329|NCT01432444|466867473|FG000|Treatment Phase|Withdrawal by Subject|0|||
129701330|NCT01432444|466867474|FG001|Treatment Phase|Withdrawal by Subject|41|||
129701331|NCT01432444|466867475|FG002|Treatment Phase|Withdrawal by Subject|0|||
129618226|NCT02006732|466555320|FG003|Overall Study|Adverse Event|2|||
129618227|NCT02006732|466555317|FG000|Overall Study|Lack of Efficacy|6|||
129618228|NCT02006732|466555318|FG001|Overall Study|Lack of Efficacy|3|||
129618229|NCT02006732|466555319|FG002|Overall Study|Lack of Efficacy|1|||
129618230|NCT02006732|466555320|FG003|Overall Study|Lack of Efficacy|1|||
129618231|NCT02006732|466555317|FG000|Overall Study|Protocol Violation|1|||
129618232|NCT02006732|466555318|FG001|Overall Study|Protocol Violation|1|||
129618233|NCT02006732|466555319|FG002|Overall Study|Protocol Violation|0|||
129618234|NCT02006732|466555320|FG003|Overall Study|Protocol Violation|0|||
129618235|NCT02006732|466555317|FG000|Overall Study|Lost to Follow-up|0|||
129618236|NCT02006732|466555318|FG001|Overall Study|Lost to Follow-up|1|||
129618237|NCT02006732|466555319|FG002|Overall Study|Lost to Follow-up|0|||
129618238|NCT02006732|466555320|FG003|Overall Study|Lost to Follow-up|0|||
129618239|NCT02006732|466555317|FG000|Overall Study|Withdrawal by Subject|3|||
129618240|NCT02006732|466555318|FG001|Overall Study|Withdrawal by Subject|0|||
129618241|NCT02006732|466555319|FG002|Overall Study|Withdrawal by Subject|4|||
129618242|NCT02006732|466555320|FG003|Overall Study|Withdrawal by Subject|1|||
129618243|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
129618244|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
129618245|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
129618246|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Death|1|||
129618247|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Death|3|||
129618248|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Death|1|||
129618249|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
129618250|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
129618251|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
129618252|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
129792149|NCT02195687|467207440|FG001|Overall Study|Lost to Follow-up|1|||
129792150|NCT04369924|467207443|FG000|Overall Study|Lost to Follow-up|302|||
129792151|NCT04369924|467207444|FG001|Overall Study|Lost to Follow-up|339|||
129792152|NCT02677324|467207445|FG000|Overall Study|Disease Progression|6|||
129792153|NCT02677324|467207445|FG000|Overall Study|Inability to Swallow pills|1|||
129792154|NCT02677324|467207445|FG000|Overall Study|Non-compliance|1|||
129792155|NCT02677324|467207445|FG000|Overall Study|Lack of Efficacy|1|||
129792156|NCT02677324|467207445|FG000|Overall Study|Medical insurance coverage|1|||
129792157|NCT02677324|467207445|FG000|Overall Study|Adverse Event|1|||
129792158|NCT02677324|467207445|FG000|Overall Study|IgM Myeloma diagnosis|1|||
129792159|NCT02106923|467207450|FG000|Overall Study|Protocol Violation|0|||
129792160|NCT02106923|467207451|FG001|Overall Study|Protocol Violation|0|||
129792161|NCT02106923|467207452|FG002|Overall Study|Protocol Violation|0|||
129792162|NCT02106923|467207453|FG003|Overall Study|Protocol Violation|0|||
129792163|NCT02106923|467207454|FG004|Overall Study|Protocol Violation|0|||
129792164|NCT02106923|467207455|FG005|Overall Study|Protocol Violation|1|||
129792165|NCT03485495|467207456|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
129792166|NCT03485495|467207457|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
129792167|NCT01056380|467207460|FG000|Overall Study|Lost to Follow-up|2|||
129792168|NCT01056380|467207461|FG001|Overall Study|Lost to Follow-up|3|||
129792169|NCT03901456|467207462|FG000|Overall Study|Withdrawal by Subject|0|||
129792170|NCT03901456|467207463|FG001|Overall Study|Withdrawal by Subject|0|||
129792171|NCT03901456|467207464|FG002|Overall Study|Withdrawal by Subject|1|||
129792172|NCT03901456|467207462|FG000|Overall Study|Lost to Follow-up|0|||
129792173|NCT03901456|467207463|FG001|Overall Study|Lost to Follow-up|1|||
129792174|NCT03901456|467207464|FG002|Overall Study|Lost to Follow-up|0|||
129792175|NCT01261780|467207466|FG000|Overall Study|Withdrawal by Subject|1|||
129792176|NCT01261780|467207467|FG001|Overall Study|Withdrawal by Subject|0|||
129792177|NCT01261780|467207466|FG000|Overall Study|Event not related to subject|1|||
129792178|NCT01261780|467207467|FG001|Overall Study|Event not related to subject|2|||
129792179|NCT00732940|467207468|FG000|Overall Study|Withdrawal by Subject|1|||
129792180|NCT00732940|467207469|FG001|Overall Study|Withdrawal by Subject|2|||
129792181|NCT00732940|467207468|FG000|Overall Study|Adverse Event|0|||
129792182|NCT00732940|467207469|FG001|Overall Study|Adverse Event|1|||
129792183|NCT00732940|467207468|FG000|Overall Study|Lost to Follow-up|1|||
129792184|NCT00732940|467207469|FG001|Overall Study|Lost to Follow-up|0|||
129792185|NCT00773838|467207470|FG000|Overall Study|Adverse Event|29|||
129792186|NCT00773838|467207470|FG000|Overall Study|Lost to Follow-up|1|||
129792187|NCT00773838|467207470|FG000|Overall Study|Physician Decision|8|||
129792188|NCT00773838|467207470|FG000|Overall Study|Progressive Disease|82|||
129618253|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
129618254|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
129618255|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
129618256|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
129792189|NCT00773838|467207470|FG000|Overall Study|Protocol Violation|2|||
129792190|NCT00773838|467207470|FG000|Overall Study|Withdrawal by Subject|21|||
129792191|NCT03562767|467207476|FG000|Overall Study|Physician Decision|2|||
129792192|NCT03562767|467207477|FG001|Overall Study|Physician Decision|0|||
129792193|NCT03562767|467207478|FG002|Overall Study|Physician Decision|0|||
129792194|NCT03562767|467207476|FG000|Overall Study|Logistic Reason|1|||
129792195|NCT03562767|467207477|FG001|Overall Study|Logistic Reason|3|||
129792196|NCT03562767|467207478|FG002|Overall Study|Logistic Reason|0|||
129887525|NCT01474512|467547278|FG006|Long-Term Extension Period|Clinical Relapse|0|||
129618257|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
129618258|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
129618259|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
129618260|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
129618261|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
129618262|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
129618263|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
129618264|NCT00299130|466555321|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
129618265|NCT00299130|466555322|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
129618266|NCT00299130|466555323|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
129618267|NCT00299130|466555321|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
129618268|NCT00299130|466555322|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
129618269|NCT00299130|466555323|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
129618270|NCT00299130|466555321|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
129618271|NCT00299130|466555322|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
129618272|NCT00299130|466555323|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
129618273|NCT00299130|466555321|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
129618274|NCT00299130|466555322|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
129618275|NCT00299130|466555323|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
129618276|NCT00299130|466555321|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
129618277|NCT00299130|466555322|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
129618278|NCT00299130|466555323|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
129618279|NCT00299130|466555321|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
129618280|NCT00299130|466555322|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
129618281|NCT00299130|466555323|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
129618282|NCT00299130|466555321|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
129618283|NCT00299130|466555322|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
129618284|NCT00299130|466555323|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
129618285|NCT00299130|466555321|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
129618286|NCT00299130|466555322|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
129618287|NCT00299130|466555323|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
129887526|NCT01474512|467547279|FG007|Long-Term Extension Period|Clinical Relapse|0|||
129887527|NCT01474512|467547280|FG008|Long-Term Extension Period|Clinical Relapse|0|||
129887528|NCT01474512|467547281|FG009|Long-Term Extension Period|Clinical Relapse|0|||
129887529|NCT01474512|467547282|FG010|Long-Term Extension Period|Clinical Relapse|0|||
129887530|NCT01474512|467547283|FG011|Long-Term Extension Period|Clinical Relapse|0|||
129887531|NCT01474512|467547284|FG012|Long-Term Extension Period|Clinical Relapse|9|||
129618288|NCT00299130|466555321|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
129618289|NCT00299130|466555322|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
129618290|NCT00299130|466555323|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
129618291|NCT00299130|466555321|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
129618292|NCT00299130|466555322|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
129887532|NCT01474512|467547285|FG013|Long-Term Extension Period|Clinical Relapse|9|||
129887533|NCT01474512|467547286|FG014|Long-Term Extension Period|Clinical Relapse|0|||
129887534|NCT01474512|467547287|FG015|Long-Term Extension Period|Clinical Relapse|0|||
129887535|NCT01474512|467547288|FG016|Long-Term Extension Period|Clinical Relapse|0|||
129887536|NCT01474512|467547289|FG017|Long-Term Extension Period|Clinical Relapse|0|||
129887537|NCT01474512|467547272|FG000|Long-Term Extension Period|Death|0|||
129887538|NCT01474512|467547273|FG001|Long-Term Extension Period|Death|0|||
129887539|NCT01474512|467547274|FG002|Long-Term Extension Period|Death|0|||
129618293|NCT00299130|466555323|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
129618294|NCT02516553|466555324|FG000|Overall Study|Progressive disease|2|||
129618295|NCT02516553|466555325|FG001|Overall Study|Progressive disease|2|||
129618296|NCT02516553|466555326|FG002|Overall Study|Progressive disease|3|||
129618297|NCT02516553|466555327|FG003|Overall Study|Progressive disease|5|||
129618298|NCT02516553|466555328|FG004|Overall Study|Progressive disease|3|||
129618299|NCT02516553|466555329|FG005|Overall Study|Progressive disease|0|||
129618300|NCT02516553|466555330|FG006|Overall Study|Progressive disease|5|||
129618301|NCT02516553|466555331|FG007|Overall Study|Progressive disease|5|||
129618302|NCT02516553|466555332|FG008|Overall Study|Progressive disease|11|||
129439256|NCT02245672|465906404|FG002|Overall Study|Withdrawal by Subject|0|||
129618303|NCT02516553|466555333|FG009|Overall Study|Progressive disease|3|||
129618304|NCT02516553|466555334|FG010|Overall Study|Progressive disease|10|||
129618305|NCT02516553|466555335|FG011|Overall Study|Progressive disease|8|||
129618306|NCT02516553|466555336|FG012|Overall Study|Progressive disease|8|||
129618307|NCT02516553|466555337|FG013|Overall Study|Progressive disease|2|||
129887540|NCT01474512|467547275|FG003|Long-Term Extension Period|Death|0|||
129887541|NCT01474512|467547276|FG004|Long-Term Extension Period|Death|0|||
129887542|NCT01474512|467547277|FG005|Long-Term Extension Period|Death|0|||
129887543|NCT01474512|467547278|FG006|Long-Term Extension Period|Death|0|||
129887544|NCT01474512|467547279|FG007|Long-Term Extension Period|Death|0|||
129887545|NCT01474512|467547280|FG008|Long-Term Extension Period|Death|0|||
129887546|NCT01474512|467547281|FG009|Long-Term Extension Period|Death|0|||
129887547|NCT01474512|467547282|FG010|Long-Term Extension Period|Death|0|||
129887548|NCT01474512|467547283|FG011|Long-Term Extension Period|Death|0|||
129887549|NCT01474512|467547284|FG012|Long-Term Extension Period|Death|9|||
129887550|NCT01474512|467547285|FG013|Long-Term Extension Period|Death|9|||
129887551|NCT01474512|467547286|FG014|Long-Term Extension Period|Death|0|||
129887552|NCT01474512|467547287|FG015|Long-Term Extension Period|Death|0|||
129887553|NCT01474512|467547288|FG016|Long-Term Extension Period|Death|0|||
129887554|NCT01474512|467547289|FG017|Long-Term Extension Period|Death|0|||
129887555|NCT01474512|467547272|FG000|Long-Term Extension Period|Sponsor Decision|0|||
129887556|NCT01474512|467547273|FG001|Long-Term Extension Period|Sponsor Decision|0|||
129887557|NCT01474512|467547274|FG002|Long-Term Extension Period|Sponsor Decision|0|||
129887558|NCT01474512|467547275|FG003|Long-Term Extension Period|Sponsor Decision|0|||
129887559|NCT01474512|467547276|FG004|Long-Term Extension Period|Sponsor Decision|0|||
129887560|NCT01474512|467547277|FG005|Long-Term Extension Period|Sponsor Decision|0|||
129887561|NCT01474512|467547278|FG006|Long-Term Extension Period|Sponsor Decision|0|||
129887562|NCT01474512|467547279|FG007|Long-Term Extension Period|Sponsor Decision|0|||
129887563|NCT01474512|467547280|FG008|Long-Term Extension Period|Sponsor Decision|0|||
129887564|NCT01474512|467547281|FG009|Long-Term Extension Period|Sponsor Decision|0|||
129887565|NCT01474512|467547282|FG010|Long-Term Extension Period|Sponsor Decision|0|||
129887566|NCT01474512|467547283|FG011|Long-Term Extension Period|Sponsor Decision|0|||
129887567|NCT01474512|467547284|FG012|Long-Term Extension Period|Sponsor Decision|6|||
129887568|NCT01474512|467547285|FG013|Long-Term Extension Period|Sponsor Decision|6|||
129887569|NCT01474512|467547286|FG014|Long-Term Extension Period|Sponsor Decision|0|||
129887570|NCT01474512|467547287|FG015|Long-Term Extension Period|Sponsor Decision|0|||
129887571|NCT01474512|467547288|FG016|Long-Term Extension Period|Sponsor Decision|0|||
129887572|NCT01474512|467547289|FG017|Long-Term Extension Period|Sponsor Decision|0|||
129887573|NCT01474512|467547272|FG000|Long-Term Extension Period|Protocol Violation|0|||
129887574|NCT01474512|467547273|FG001|Long-Term Extension Period|Protocol Violation|0|||
129887575|NCT01474512|467547274|FG002|Long-Term Extension Period|Protocol Violation|0|||
129887576|NCT01474512|467547275|FG003|Long-Term Extension Period|Protocol Violation|0|||
129887577|NCT01474512|467547276|FG004|Long-Term Extension Period|Protocol Violation|0|||
129887578|NCT01474512|467547277|FG005|Long-Term Extension Period|Protocol Violation|0|||
129887579|NCT01474512|467547278|FG006|Long-Term Extension Period|Protocol Violation|0|||
129887580|NCT01474512|467547279|FG007|Long-Term Extension Period|Protocol Violation|0|||
129887581|NCT01474512|467547280|FG008|Long-Term Extension Period|Protocol Violation|0|||
129887582|NCT01474512|467547281|FG009|Long-Term Extension Period|Protocol Violation|0|||
129887583|NCT01474512|467547282|FG010|Long-Term Extension Period|Protocol Violation|0|||
129887584|NCT01474512|467547283|FG011|Long-Term Extension Period|Protocol Violation|0|||
129887585|NCT01474512|467547284|FG012|Long-Term Extension Period|Protocol Violation|5|||
129887586|NCT01474512|467547285|FG013|Long-Term Extension Period|Protocol Violation|5|||
129887587|NCT01474512|467547286|FG014|Long-Term Extension Period|Protocol Violation|0|||
129887588|NCT01474512|467547287|FG015|Long-Term Extension Period|Protocol Violation|0|||
129887589|NCT01474512|467547288|FG016|Long-Term Extension Period|Protocol Violation|0|||
129887590|NCT01474512|467547289|FG017|Long-Term Extension Period|Protocol Violation|0|||
129887591|NCT01474512|467547272|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887592|NCT01474512|467547273|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887593|NCT01474512|467547274|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887594|NCT01474512|467547275|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887595|NCT01474512|467547276|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887596|NCT01474512|467547277|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887597|NCT01474512|467547278|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887598|NCT01474512|467547279|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887599|NCT01474512|467547280|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887600|NCT01474512|467547281|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887601|NCT01474512|467547282|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887602|NCT01474512|467547283|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887603|NCT01474512|467547284|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
129887604|NCT01474512|467547285|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
129887605|NCT01474512|467547286|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887606|NCT01474512|467547287|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887607|NCT01474512|467547288|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887608|NCT01474512|467547289|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
129887609|NCT01474512|467547272|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887610|NCT01474512|467547273|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887611|NCT01474512|467547274|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129618308|NCT02516553|466555338|FG014|Overall Study|Progressive disease|2|||
129618309|NCT02516553|466555339|FG015|Overall Study|Progressive disease|2|||
129618310|NCT02516553|466555340|FG016|Overall Study|Progressive disease|1|||
129618311|NCT02516553|466555341|FG017|Overall Study|Progressive disease|9|||
129618312|NCT02516553|466555342|FG018|Overall Study|Progressive disease|12|||
129618313|NCT02516553|466555343|FG019|Overall Study|Progressive disease|7|||
129618314|NCT02516553|466555344|FG020|Overall Study|Progressive disease|16|||
129618315|NCT02516553|466555345|FG021|Overall Study|Progressive disease|18|||
129618316|NCT02516553|466555324|FG000|Overall Study|Dose limiting toxicity|0|||
129618317|NCT02516553|466555325|FG001|Overall Study|Dose limiting toxicity|0|||
129618318|NCT02516553|466555326|FG002|Overall Study|Dose limiting toxicity|0|||
129439257|NCT02245672|465906402|FG000|Overall Study|Randomized in error (not treated)|0|||
129701332|NCT01432444|466867473|FG000|Treatment Phase|Protocol Deviation|0|||
129701333|NCT01432444|466867474|FG001|Treatment Phase|Protocol Deviation|3|||
129618319|NCT02516553|466555327|FG003|Overall Study|Dose limiting toxicity|0|||
129792197|NCT00509262|467207479|FG000|Overall Study|Adverse Event|16|||
129792198|NCT00509262|467207480|FG001|Overall Study|Adverse Event|18|||
129792199|NCT00509262|467207479|FG000|Overall Study|Other|2|||
129792200|NCT00509262|467207480|FG001|Overall Study|Other|2|||
129792201|NCT00509262|467207479|FG000|Overall Study|Lack of Efficacy|1|||
129792202|NCT00509262|467207480|FG001|Overall Study|Lack of Efficacy|0|||
129792203|NCT00509262|467207479|FG000|Overall Study|Lost to Follow-up|1|||
129792204|NCT00509262|467207480|FG001|Overall Study|Lost to Follow-up|6|||
129792205|NCT00509262|467207479|FG000|Overall Study|Physician Decision|1|||
129792206|NCT00509262|467207480|FG001|Overall Study|Physician Decision|3|||
129792207|NCT00509262|467207479|FG000|Overall Study|Protocol Violation|2|||
129792208|NCT00509262|467207480|FG001|Overall Study|Protocol Violation|2|||
129792209|NCT00509262|467207479|FG000|Overall Study|Withdrawal by Subject|24|||
129792210|NCT00509262|467207480|FG001|Overall Study|Withdrawal by Subject|11|||
129792211|NCT01589770|467207481|FG000|Overall Study|EGFR <60ml/min|6|||
129792212|NCT01589770|467207482|FG001|Overall Study|EGFR <60ml/min|4|||
129792213|NCT01589770|467207481|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
129792214|NCT01589770|467207482|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
129792215|NCT01658813|467207487|FG000|Overall Study|Disease progression|3|||
129792216|NCT00938886|467207488|FG000|Overall Study|Death|0|||
129792217|NCT00938886|467207489|FG001|Overall Study|Death|1|||
129792218|NCT00938886|467207488|FG000|Overall Study|Withdrawal by Subject|4|||
129792219|NCT00938886|467207489|FG001|Overall Study|Withdrawal by Subject|7|||
129792220|NCT00938886|467207488|FG000|Overall Study|Lost to Follow-up|3|||
129792221|NCT00938886|467207489|FG001|Overall Study|Lost to Follow-up|2|||
129792222|NCT02674854|467207494|FG000|Overall Study|Adverse Event|17|||
129792223|NCT02674854|467207495|FG001|Overall Study|Adverse Event|15|||
129792224|NCT02674854|467207496|FG002|Overall Study|Adverse Event|5|||
129792225|NCT02674854|467207494|FG000|Overall Study|Withdrawal by Subject|1|||
129792226|NCT02674854|467207495|FG001|Overall Study|Withdrawal by Subject|5|||
129792227|NCT02674854|467207496|FG002|Overall Study|Withdrawal by Subject|4|||
129792228|NCT02674854|467207494|FG000|Overall Study|No-compliant subject|1|||
129792229|NCT02674854|467207495|FG001|Overall Study|No-compliant subject|0|||
129792230|NCT02674854|467207496|FG002|Overall Study|No-compliant subject|1|||
129792231|NCT02674854|467207494|FG000|Overall Study|Lost to Follow-up|1|||
129792232|NCT02674854|467207495|FG001|Overall Study|Lost to Follow-up|0|||
129792233|NCT02674854|467207496|FG002|Overall Study|Lost to Follow-up|2|||
129792234|NCT02674854|467207494|FG000|Overall Study|Lack of Efficacy|0|||
129792235|NCT02674854|467207495|FG001|Overall Study|Lack of Efficacy|3|||
129792236|NCT02674854|467207496|FG002|Overall Study|Lack of Efficacy|0|||
129792237|NCT02674854|467207494|FG000|Overall Study|Disallowed Concurrent Medication|2|||
129792238|NCT02674854|467207495|FG001|Overall Study|Disallowed Concurrent Medication|2|||
129792239|NCT02674854|467207496|FG002|Overall Study|Disallowed Concurrent Medication|0|||
129792240|NCT02674854|467207494|FG000|Overall Study|Protocol Violation|1|||
129792241|NCT02674854|467207495|FG001|Overall Study|Protocol Violation|1|||
129792242|NCT02674854|467207496|FG002|Overall Study|Protocol Violation|2|||
129792243|NCT02674854|467207494|FG000|Overall Study|Death|0|||
129792244|NCT02674854|467207495|FG001|Overall Study|Death|1|||
129792245|NCT02674854|467207496|FG002|Overall Study|Death|0|||
129792246|NCT02674854|467207494|FG000|Overall Study|Subject missed V6.2|1|||
129792247|NCT02674854|467207495|FG001|Overall Study|Subject missed V6.2|0|||
129792248|NCT02674854|467207496|FG002|Overall Study|Subject missed V6.2|0|||
129792249|NCT00913692|467207497|FG000|Screening (4 Months)|Physician Decision|3|||
129792250|NCT00913692|467207497|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
129792251|NCT00913692|467207497|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
129792252|NCT04738318|467207498|FG000|Overall Study|Protocol Violation|1|||
129792253|NCT04738318|467207499|FG001|Overall Study|Protocol Violation|0|||
129792254|NCT04231981|467207500|FG000|Overall Study|Adverse Event|1|||
129792255|NCT04231981|467207500|FG000|Overall Study|Death|16|||
129792256|NCT04231981|467207500|FG000|Overall Study|Lost to Follow-up|1|||
129792257|NCT02889562|467207501|FG000|Overall Study|Physician Decision|0|||
129701334|NCT01432444|466867475|FG002|Treatment Phase|Protocol Deviation|0|||
129701335|NCT01432444|466867473|FG000|Treatment Phase|Lack of Efficacy|0|||
129701336|NCT01432444|466867474|FG001|Treatment Phase|Lack of Efficacy|10|||
129701337|NCT01432444|466867475|FG002|Treatment Phase|Lack of Efficacy|0|||
129701338|NCT01432444|466867473|FG000|Extension Phase|Lost to Follow-up|0|||
129701339|NCT01432444|466867474|FG001|Extension Phase|Lost to Follow-up|0|||
129792258|NCT02889562|467207502|FG001|Overall Study|Physician Decision|1|||
129792259|NCT02889562|467207501|FG000|Overall Study|Withdrawal by Subject|0|||
129792260|NCT02889562|467207502|FG001|Overall Study|Withdrawal by Subject|1|||
129792261|NCT01470989|467207505|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
129792262|NCT01470989|467207506|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
129792263|NCT01470989|467207505|FG000|Overall Study|Adverse Event|2|||
129792264|NCT01470989|467207506|FG001|Overall Study|Adverse Event|5|||
129792265|NCT01470989|467207505|FG000|Overall Study|Abnormal laboratory value|1|||
129792266|NCT01470989|467207506|FG001|Overall Study|Abnormal laboratory value|1|||
129792267|NCT01470989|467207505|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129792268|NCT01470989|467207506|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129792269|NCT01470989|467207505|FG000|Overall Study|Withdrawal by Subject|19|||
129792270|NCT01470989|467207506|FG001|Overall Study|Withdrawal by Subject|17|||
129792271|NCT01470989|467207505|FG000|Overall Study|Lost to Follow-up|18|||
129792272|NCT01470989|467207506|FG001|Overall Study|Lost to Follow-up|13|||
129792273|NCT01470989|467207505|FG000|Overall Study|Administrative problems|2|||
129792274|NCT01470989|467207506|FG001|Overall Study|Administrative problems|4|||
129792275|NCT01470989|467207505|FG000|Overall Study|Death|2|||
129792276|NCT01470989|467207506|FG001|Overall Study|Death|2|||
129792277|NCT01470989|467207505|FG000|Overall Study|Protocol deviation|1|||
129792278|NCT01470989|467207506|FG001|Overall Study|Protocol deviation|2|||
129792279|NCT00969280|467207507|FG000|Overall Study|Protocol Violation|2|||
129792280|NCT00969280|467207508|FG001|Overall Study|Protocol Violation|1|||
129792281|NCT00969280|467207507|FG000|Overall Study|Withdrawal by Subject|0|||
129792282|NCT00969280|467207508|FG001|Overall Study|Withdrawal by Subject|1|||
129792283|NCT00969280|467207507|FG000|Overall Study|infection of influenza A(H1N1)|0|||
129792284|NCT00969280|467207508|FG001|Overall Study|infection of influenza A(H1N1)|1|||
129792285|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792286|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792287|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792288|NCT05985980|467207509|FG000|Overall Study|Withdrawal by Subject|1|||
129792289|NCT04085367|467209060|FG000|Overall Study|Adverse Event|1|||
129792290|NCT04085367|467209061|FG001|Overall Study|Adverse Event|1|||
129792291|NCT04085367|467209060|FG000|Overall Study|Withdrawal by Subject|13|||
129792292|NCT04085367|467209061|FG001|Overall Study|Withdrawal by Subject|4|||
129792293|NCT04085367|467209060|FG000|Overall Study|Lost to Follow-up|3|||
129792294|NCT04085367|467209061|FG001|Overall Study|Lost to Follow-up|1|||
129792295|NCT04085367|467209060|FG000|Overall Study|Other unspecified|2|||
129792296|NCT04085367|467209061|FG001|Overall Study|Other unspecified|1|||
129792297|NCT04085367|467209060|FG000|Overall Study|Status Unknown|1|||
129439258|NCT02245672|465906403|FG001|Overall Study|Randomized in error (not treated)|1|||
129439259|NCT02245672|465906404|FG002|Overall Study|Randomized in error (not treated)|0|||
129439260|NCT00971932|465906405|FG000|Overall Study|Withdrawal by Subject|1|||
129439261|NCT00971932|465906405|FG000|Overall Study|Investigator's decision|2|||
129439262|NCT00971932|465906405|FG000|Overall Study|Ongoing|4|||
129439263|NCT01765192|465906408|FG000|Treatment Period 1|Adverse Event|0|||
129701340|NCT01432444|466867475|FG002|Extension Phase|Lost to Follow-up|17|||
129701341|NCT01432444|466867473|FG000|Extension Phase|Adverse Event|0|||
129701342|NCT01432444|466867474|FG001|Extension Phase|Adverse Event|0|||
129701343|NCT01432444|466867475|FG002|Extension Phase|Adverse Event|10|||
129701344|NCT01432444|466867473|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
129701345|NCT01432444|466867474|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
129701346|NCT01432444|466867475|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
129701347|NCT01432444|466867473|FG000|Extension Phase|Met Withdrawal Criteria|0|||
129701348|NCT01432444|466867474|FG001|Extension Phase|Met Withdrawal Criteria|0|||
129701349|NCT01432444|466867475|FG002|Extension Phase|Met Withdrawal Criteria|144|||
129701350|NCT01432444|466867473|FG000|Extension Phase|Physician Decision|0|||
129701351|NCT01432444|466867474|FG001|Extension Phase|Physician Decision|0|||
129701352|NCT01432444|466867475|FG002|Extension Phase|Physician Decision|1|||
129701353|NCT01432444|466867473|FG000|Extension Phase|Withdrawal by Subject|0|||
129792298|NCT04085367|467209061|FG001|Overall Study|Status Unknown|1|||
129792299|NCT03621475|467209064|FG000|Overall Study|No longer required restraints at initiation|0|||
129701354|NCT01432444|466867474|FG001|Extension Phase|Withdrawal by Subject|0|||
129701355|NCT01432444|466867475|FG002|Extension Phase|Withdrawal by Subject|13|||
129701356|NCT03673176|466867476|FG000|Overall Study|Death prior to intervention|1|||
129792300|NCT03621475|467209065|FG001|Overall Study|No longer required restraints at initiation|1|||
129792301|NCT00706849|467209072|FG000|Treatment Period|Adverse Event|0|||
129792302|NCT00706849|467209073|FG001|Treatment Period|Adverse Event|9|||
129792303|NCT00706849|467209072|FG000|Treatment Period|Other|0|||
129701357|NCT03673176|466867476|FG000|Overall Study|Death following intervention|3|||
129701358|NCT03673176|466867476|FG000|Overall Study|Withdrawal by Subject|1|||
129701359|NCT02301897|466867477|FG000|Treatment Course 1|Non-Compliance|0|||
129701360|NCT02301897|466867478|FG001|Treatment Course 1|Non-Compliance|0|||
129701361|NCT02301897|466867479|FG002|Treatment Course 1|Non-Compliance|1|||
129701362|NCT02301897|466867477|FG000|Treatment Course 1|Adverse Event|1|||
129701363|NCT02301897|466867478|FG001|Treatment Course 1|Adverse Event|1|||
129701364|NCT02301897|466867479|FG002|Treatment Course 1|Adverse Event|0|||
129701365|NCT02301897|466867477|FG000|Treatment Course 1|Lost to Follow-up|1|||
129701366|NCT02301897|466867478|FG001|Treatment Course 1|Lost to Follow-up|2|||
129701367|NCT02301897|466867479|FG002|Treatment Course 1|Lost to Follow-up|1|||
129701368|NCT02301897|466867477|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
129701369|NCT02301897|466867478|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
129701370|NCT02301897|466867479|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
129701371|NCT02301897|466867477|FG000|Treatment Course 1|Withdrawal by Subject|0|||
129701372|NCT02301897|466867478|FG001|Treatment Course 1|Withdrawal by Subject|0|||
129701373|NCT02301897|466867479|FG002|Treatment Course 1|Withdrawal by Subject|2|||
129701374|NCT02301897|466867477|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
129701375|NCT02301897|466867478|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
129701376|NCT02301897|466867479|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
129701377|NCT02301897|466867477|FG000|Treatment Course 2|Lost to Follow-up|0|||
129701378|NCT02301897|466867478|FG001|Treatment Course 2|Lost to Follow-up|2|||
129701379|NCT02301897|466867479|FG002|Treatment Course 2|Lost to Follow-up|0|||
129701380|NCT02301897|466867477|FG000|Treatment Course 2|Pregnancy|0|||
129701381|NCT02301897|466867478|FG001|Treatment Course 2|Pregnancy|1|||
129701382|NCT02301897|466867479|FG002|Treatment Course 2|Pregnancy|1|||
129701383|NCT02301897|466867477|FG000|Treatment Course 2|Withdrawal by Subject|0|||
129701384|NCT02301897|466867478|FG001|Treatment Course 2|Withdrawal by Subject|2|||
129701385|NCT02301897|466867479|FG002|Treatment Course 2|Withdrawal by Subject|0|||
129701386|NCT02301897|466867477|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
129701387|NCT02301897|466867478|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
129701388|NCT02301897|466867479|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
129701389|NCT02439957|466867480|FG000|Overall Study|Study Terminated|3|||
129701390|NCT02439957|466867481|FG001|Overall Study|Study Terminated|3|||
129701391|NCT00478257|466867486|FG000|Overall Study|Withdrawal by Subject|8|||
129701392|NCT00478257|466867487|FG001|Overall Study|Withdrawal by Subject|3|||
129701393|NCT03931330|466867488|FG000|Overall Study|Physician Decision|1|||
129701394|NCT03412929|466867489|FG000|Overall Study|Protocol Violation|3|||
129701395|NCT01381679|466867494|FG000|Overall Study|Adverse Event|3|||
129701396|NCT01381679|466867494|FG000|Overall Study|Lost to Follow-up|885|||
129701397|NCT04023487|466867495|FG000|Overall Study|Lost to Follow-up|5|||
129701398|NCT04023487|466867496|FG001|Overall Study|Lost to Follow-up|4|||
129701399|NCT04023487|466867495|FG000|Overall Study|Pregnancy|1|||
129701400|NCT04023487|466867496|FG001|Overall Study|Pregnancy|2|||
129701401|NCT04023487|466867495|FG000|Overall Study|Withdrawal by Subject|4|||
129701402|NCT04023487|466867496|FG001|Overall Study|Withdrawal by Subject|5|||
129701403|NCT04023487|466867495|FG000|Overall Study|Partially completed testing|8|||
129701404|NCT04023487|466867496|FG001|Overall Study|Partially completed testing|4|||
129701405|NCT04770285|466867499|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
129701406|NCT04770285|466867500|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
129701407|NCT04770285|466867499|FG000|Overall Study|Lack of Efficacy|0|||
129701408|NCT04770285|466867500|FG001|Overall Study|Lack of Efficacy|1|||
129701409|NCT04770285|466867499|FG000|Overall Study|Lost to Follow-up|11|||
129701410|NCT04770285|466867500|FG001|Overall Study|Lost to Follow-up|8|||
129701411|NCT04770285|466867499|FG000|Overall Study|Protocol Deviation|6|||
129701412|NCT04770285|466867500|FG001|Overall Study|Protocol Deviation|6|||
129701413|NCT04770285|466867499|FG000|Overall Study|Technical Problem|0|||
129701414|NCT04770285|466867500|FG001|Overall Study|Technical Problem|1|||
129701415|NCT04770285|466867499|FG000|Overall Study|Withdrawal by Subject|9|||
129701416|NCT04770285|466867500|FG001|Overall Study|Withdrawal by Subject|8|||
129701417|NCT04770285|466867499|FG000|Overall Study|Reason Not Specified|0|||
129701418|NCT04770285|466867500|FG001|Overall Study|Reason Not Specified|1|||
129701419|NCT03766399|466867501|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701420|NCT03766399|466867502|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701421|NCT03766399|466867503|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701422|NCT03766399|466867504|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701423|NCT03766399|466867505|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701424|NCT03766399|466867506|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701425|NCT03766399|466867507|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701426|NCT03766399|466867508|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701427|NCT03766399|466867509|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701428|NCT03766399|466867510|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129792304|NCT00706849|467209073|FG001|Treatment Period|Other|1|||
129618320|NCT02516553|466555328|FG004|Overall Study|Dose limiting toxicity|3|||
129618321|NCT02516553|466555329|FG005|Overall Study|Dose limiting toxicity|1|||
129618322|NCT02516553|466555330|FG006|Overall Study|Dose limiting toxicity|1|||
129618323|NCT02516553|466555331|FG007|Overall Study|Dose limiting toxicity|0|||
129618324|NCT02516553|466555332|FG008|Overall Study|Dose limiting toxicity|1|||
129618325|NCT02516553|466555333|FG009|Overall Study|Dose limiting toxicity|0|||
129618326|NCT02516553|466555334|FG010|Overall Study|Dose limiting toxicity|0|||
129618327|NCT02516553|466555335|FG011|Overall Study|Dose limiting toxicity|1|||
129618328|NCT02516553|466555336|FG012|Overall Study|Dose limiting toxicity|0|||
129618329|NCT02516553|466555337|FG013|Overall Study|Dose limiting toxicity|1|||
129618330|NCT02516553|466555338|FG014|Overall Study|Dose limiting toxicity|0|||
129618331|NCT02516553|466555339|FG015|Overall Study|Dose limiting toxicity|0|||
129618332|NCT02516553|466555340|FG016|Overall Study|Dose limiting toxicity|1|||
129618333|NCT02516553|466555341|FG017|Overall Study|Dose limiting toxicity|1|||
129618334|NCT02516553|466555342|FG018|Overall Study|Dose limiting toxicity|0|||
129792305|NCT00706849|467209072|FG000|Follow-up Period|Withdrawal by Subject|0|||
129618335|NCT02516553|466555343|FG019|Overall Study|Dose limiting toxicity|2|||
129618336|NCT02516553|466555344|FG020|Overall Study|Dose limiting toxicity|0|||
129618337|NCT02516553|466555345|FG021|Overall Study|Dose limiting toxicity|0|||
129618338|NCT02516553|466555324|FG000|Overall Study|Other Adverse Events|0|||
129618339|NCT02516553|466555325|FG001|Overall Study|Other Adverse Events|0|||
129618340|NCT02516553|466555326|FG002|Overall Study|Other Adverse Events|0|||
129618341|NCT02516553|466555327|FG003|Overall Study|Other Adverse Events|1|||
129618342|NCT02516553|466555328|FG004|Overall Study|Other Adverse Events|0|||
129618343|NCT02516553|466555329|FG005|Overall Study|Other Adverse Events|1|||
129618344|NCT02516553|466555330|FG006|Overall Study|Other Adverse Events|0|||
129618345|NCT02516553|466555331|FG007|Overall Study|Other Adverse Events|0|||
129618346|NCT02516553|466555332|FG008|Overall Study|Other Adverse Events|0|||
129618347|NCT02516553|466555333|FG009|Overall Study|Other Adverse Events|1|||
129618348|NCT02516553|466555334|FG010|Overall Study|Other Adverse Events|3|||
129618349|NCT02516553|466555335|FG011|Overall Study|Other Adverse Events|2|||
129618350|NCT02516553|466555336|FG012|Overall Study|Other Adverse Events|0|||
129618351|NCT02516553|466555337|FG013|Overall Study|Other Adverse Events|1|||
129618352|NCT02516553|466555338|FG014|Overall Study|Other Adverse Events|0|||
129618353|NCT02516553|466555339|FG015|Overall Study|Other Adverse Events|0|||
129618354|NCT02516553|466555340|FG016|Overall Study|Other Adverse Events|0|||
129618355|NCT02516553|466555341|FG017|Overall Study|Other Adverse Events|2|||
129618356|NCT02516553|466555342|FG018|Overall Study|Other Adverse Events|1|||
129618357|NCT02516553|466555343|FG019|Overall Study|Other Adverse Events|2|||
129618358|NCT02516553|466555344|FG020|Overall Study|Other Adverse Events|2|||
129618359|NCT02516553|466555345|FG021|Overall Study|Other Adverse Events|1|||
129618360|NCT02516553|466555324|FG000|Overall Study|Refused to continue trial medication|0|||
129618361|NCT02516553|466555325|FG001|Overall Study|Refused to continue trial medication|0|||
129618362|NCT02516553|466555326|FG002|Overall Study|Refused to continue trial medication|0|||
129618363|NCT02516553|466555327|FG003|Overall Study|Refused to continue trial medication|0|||
129618364|NCT02516553|466555328|FG004|Overall Study|Refused to continue trial medication|0|||
129792306|NCT00706849|467209073|FG001|Follow-up Period|Withdrawal by Subject|2|||
129792307|NCT00706849|467209072|FG000|Follow-up Period|Protocol non-compliance|0|||
129792308|NCT00706849|467209073|FG001|Follow-up Period|Protocol non-compliance|1|||
129792309|NCT01611454|467209074|FG000|Overall Study|Lack of Efficacy|18|||
129792310|NCT01611454|467209075|FG001|Overall Study|Lack of Efficacy|10|||
129792311|NCT03269552|467209077|FG000|Overall Study|Adverse Event|2|||
129792312|NCT00920907|467209078|FG000|Induction Period|Adverse Event|0|||
129792313|NCT00920907|467209079|FG001|Induction Period|Adverse Event|2|||
129792314|NCT00920907|467209078|FG000|Induction Period|Death|1|||
129792315|NCT00920907|467209079|FG001|Induction Period|Death|1|||
129792316|NCT00920907|467209078|FG000|Induction Period|Disease Progression|12|||
129792317|NCT00920907|467209079|FG001|Induction Period|Disease Progression|11|||
129792318|NCT00920907|467209078|FG000|Induction Period|Study Drug Toxicity|8|||
129792319|NCT00920907|467209079|FG001|Induction Period|Study Drug Toxicity|6|||
129792320|NCT00920907|467209078|FG000|Induction Period|No longer meets study criteria|0|||
129792321|NCT00920907|467209079|FG001|Induction Period|No longer meets study criteria|1|||
129792322|NCT00920907|467209078|FG000|Induction Period|Withdrawal by Subject|1|||
129792323|NCT00920907|467209079|FG001|Induction Period|Withdrawal by Subject|1|||
129792324|NCT00920907|467209078|FG000|Maintenance Period|Disease Progression|3|||
129792325|NCT00920907|467209079|FG001|Maintenance Period|Disease Progression|7|||
129792326|NCT00920907|467209078|FG000|Maintenance Period|Administrative (study closure)|7|||
129792327|NCT00920907|467209079|FG001|Maintenance Period|Administrative (study closure)|2|||
129792328|NCT00920907|467209078|FG000|Maintenance Period|Study Drug Toxicity|0|||
129792329|NCT00920907|467209079|FG001|Maintenance Period|Study Drug Toxicity|2|||
129792330|NCT00920907|467209078|FG000|Maintenance Period|Death|1|||
129792331|NCT00920907|467209079|FG001|Maintenance Period|Death|1|||
129792332|NCT00920907|467209078|FG000|Maintenance Period|Withdrawal by Subject|1|||
129792333|NCT00920907|467209079|FG001|Maintenance Period|Withdrawal by Subject|0|||
129792334|NCT00920907|467209078|FG000|Maintenance Period|Adverse Event|0|||
129792335|NCT00920907|467209079|FG001|Maintenance Period|Adverse Event|1|||
129792336|NCT02616601|467209080|FG000|Overall Study|Withdrawal by Subject|4|||
129792337|NCT02616601|467209081|FG001|Overall Study|Withdrawal by Subject|4|||
129792338|NCT02616601|467209082|FG002|Overall Study|Withdrawal by Subject|3|||
129792339|NCT02616601|467209080|FG000|Overall Study|Adverse Event|2|||
129792340|NCT02616601|467209081|FG001|Overall Study|Adverse Event|0|||
129792341|NCT02616601|467209082|FG002|Overall Study|Adverse Event|2|||
129792342|NCT02616601|467209080|FG000|Overall Study|Death|1|||
129792343|NCT02616601|467209081|FG001|Overall Study|Death|0|||
129792344|NCT02616601|467209082|FG002|Overall Study|Death|0|||
129792345|NCT02616601|467209080|FG000|Overall Study|Lost to Follow-up|1|||
129792346|NCT02616601|467209081|FG001|Overall Study|Lost to Follow-up|0|||
129792347|NCT02616601|467209082|FG002|Overall Study|Lost to Follow-up|1|||
129792348|NCT02616601|467209080|FG000|Overall Study|Non-Compliance with Test Article|1|||
129792349|NCT02616601|467209081|FG001|Overall Study|Non-Compliance with Test Article|0|||
129792350|NCT02616601|467209082|FG002|Overall Study|Non-Compliance with Test Article|1|||
129792351|NCT00039871|467209083|FG000|Overall Study|Adverse Event|165|||
129792352|NCT00039871|467209083|FG000|Overall Study|Lost to Follow-up|18|||
129792353|NCT00039871|467209083|FG000|Overall Study|Protocol Violation|24|||
129792354|NCT00039871|467209083|FG000|Overall Study|Withdrawal by Subject|97|||
129792355|NCT00039871|467209083|FG000|Overall Study|Did not meet eligibility criteria|11|||
129792356|NCT00039871|467209083|FG000|Overall Study|Administrative|1|||
129792357|NCT00039871|467209083|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
129792358|NCT00039871|467209083|FG000|Overall Study|Never entered follow-up|7|||
129887612|NCT01474512|467547275|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887613|NCT01474512|467547276|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887614|NCT01474512|467547277|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129792359|NCT02186301|467209084|FG000|Overall Study|Progressive Disease|7|||
129792360|NCT02186301|467209085|FG001|Overall Study|Progressive Disease|22|||
129792361|NCT02186301|467209086|FG002|Overall Study|Progressive Disease|27|||
129792362|NCT02186301|467209084|FG000|Overall Study|Adverse Event|5|||
129792363|NCT02186301|467209085|FG001|Overall Study|Adverse Event|5|||
129887615|NCT01474512|467547278|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887616|NCT01474512|467547279|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887617|NCT01474512|467547280|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887618|NCT01474512|467547281|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129439264|NCT01765192|465906409|FG001|Treatment Period 1|Adverse Event|1|||
129887619|NCT01474512|467547282|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887620|NCT01474512|467547283|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
129887621|NCT01474512|467547284|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887622|NCT01474512|467547285|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887623|NCT01474512|467547286|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887624|NCT01474512|467547287|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887625|NCT01474512|467547288|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887626|NCT01474512|467547289|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
129887627|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
129887628|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
129887629|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
129887630|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
129887631|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
129887632|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
129887633|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
129887634|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
129887635|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
129887636|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
129887637|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
129887638|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
129887639|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
129887640|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
129887641|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
129887642|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
129887643|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
129887644|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
129439265|NCT01765192|465906408|FG000|Washout Period|Voluntary Withdrawal|1|||
129887645|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129439266|NCT01765192|465906409|FG001|Washout Period|Voluntary Withdrawal|1|||
129887646|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887647|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887648|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887649|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129439267|NCT01765192|465906408|FG000|Washout Period|Reason not specified|1|||
129792364|NCT02186301|467209086|FG002|Overall Study|Adverse Event|5|||
129792365|NCT02186301|467209084|FG000|Overall Study|Death|1|||
129792366|NCT02186301|467209085|FG001|Overall Study|Death|0|||
129792367|NCT02186301|467209086|FG002|Overall Study|Death|0|||
129792368|NCT02186301|467209084|FG000|Overall Study|Withdrawal by Subject|5|||
129792369|NCT02186301|467209085|FG001|Overall Study|Withdrawal by Subject|1|||
129792370|NCT02186301|467209086|FG002|Overall Study|Withdrawal by Subject|3|||
129792371|NCT02186301|467209084|FG000|Overall Study|Physician Decision|1|||
129792372|NCT02186301|467209085|FG001|Overall Study|Physician Decision|0|||
129792373|NCT02186301|467209086|FG002|Overall Study|Physician Decision|1|||
129792374|NCT02186301|467209084|FG000|Overall Study|Study Terminated by Sponsor|1|||
129792375|NCT02186301|467209085|FG001|Overall Study|Study Terminated by Sponsor|0|||
129792376|NCT02186301|467209086|FG002|Overall Study|Study Terminated by Sponsor|11|||
129792377|NCT02186301|467209084|FG000|Overall Study|Protocol Deviation|0|||
129792378|NCT02186301|467209085|FG001|Overall Study|Protocol Deviation|2|||
129792379|NCT02186301|467209086|FG002|Overall Study|Protocol Deviation|0|||
129792380|NCT02186301|467209084|FG000|Overall Study|Missing|0|||
129792381|NCT02186301|467209085|FG001|Overall Study|Missing|0|||
129792382|NCT02186301|467209086|FG002|Overall Study|Missing|2|||
129792383|NCT02186301|467209084|FG000|Overall Study|Other|0|||
129792384|NCT02186301|467209085|FG001|Overall Study|Other|0|||
129792385|NCT02186301|467209086|FG002|Overall Study|Other|1|||
129792386|NCT01275339|467209088|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
129792387|NCT01275339|467209089|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
129792388|NCT01275339|467209090|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
129792389|NCT01275339|467209091|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
129792390|NCT01275339|467209088|FG000|Overall Study|Withdrawal by Subject|0|||
129792391|NCT01275339|467209089|FG001|Overall Study|Withdrawal by Subject|0|||
129792392|NCT01275339|467209090|FG002|Overall Study|Withdrawal by Subject|1|||
129792393|NCT01275339|467209091|FG003|Overall Study|Withdrawal by Subject|0|||
129792394|NCT03560739|467209092|FG000|Overall Study|Adverse Event|0|||
129792395|NCT03560739|467209093|FG001|Overall Study|Adverse Event|1|||
129792396|NCT03560739|467209094|FG002|Overall Study|Adverse Event|0|||
129792397|NCT03560739|467209095|FG003|Overall Study|Adverse Event|0|||
129792398|NCT02478398|467209096|FG000|Overall Study|Adverse Event|20|||
129792399|NCT02478398|467209097|FG001|Overall Study|Adverse Event|5|||
129792400|NCT02478398|467209096|FG000|Overall Study|Lost to Follow-up|5|||
129792401|NCT02478398|467209097|FG001|Overall Study|Lost to Follow-up|4|||
129792402|NCT02478398|467209096|FG000|Overall Study|Non-Compliance With Study Drug|5|||
129618365|NCT02516553|466555329|FG005|Overall Study|Refused to continue trial medication|0|||
129618366|NCT02516553|466555330|FG006|Overall Study|Refused to continue trial medication|0|||
129618367|NCT02516553|466555331|FG007|Overall Study|Refused to continue trial medication|0|||
129618368|NCT02516553|466555332|FG008|Overall Study|Refused to continue trial medication|0|||
129618369|NCT02516553|466555333|FG009|Overall Study|Refused to continue trial medication|0|||
129618370|NCT02516553|466555334|FG010|Overall Study|Refused to continue trial medication|1|||
129618371|NCT02516553|466555335|FG011|Overall Study|Refused to continue trial medication|0|||
129618372|NCT02516553|466555336|FG012|Overall Study|Refused to continue trial medication|0|||
129618373|NCT02516553|466555337|FG013|Overall Study|Refused to continue trial medication|0|||
129618374|NCT02516553|466555338|FG014|Overall Study|Refused to continue trial medication|0|||
129618375|NCT02516553|466555339|FG015|Overall Study|Refused to continue trial medication|0|||
129618376|NCT02516553|466555340|FG016|Overall Study|Refused to continue trial medication|0|||
129618377|NCT02516553|466555341|FG017|Overall Study|Refused to continue trial medication|0|||
129618378|NCT02516553|466555342|FG018|Overall Study|Refused to continue trial medication|1|||
129618379|NCT02516553|466555343|FG019|Overall Study|Refused to continue trial medication|0|||
129792403|NCT02478398|467209097|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129792404|NCT02478398|467209096|FG000|Overall Study|Protocol Violation|3|||
129792405|NCT02478398|467209097|FG001|Overall Study|Protocol Violation|1|||
129792406|NCT02478398|467209096|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
129792407|NCT02478398|467209097|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129792408|NCT02478398|467209096|FG000|Overall Study|Withdrawal By Participant|10|||
129792409|NCT02478398|467209097|FG001|Overall Study|Withdrawal By Participant|4|||
129792410|NCT03123185|467209098|FG000|Overall Study|Withdrawal by Subject|0|||
129792411|NCT03123185|467209099|FG001|Overall Study|Withdrawal by Subject|0|||
129792412|NCT03123185|467209100|FG002|Overall Study|Withdrawal by Subject|0|||
129792413|NCT03123185|467209101|FG003|Overall Study|Withdrawal by Subject|0|||
129792414|NCT03123185|467209102|FG004|Overall Study|Withdrawal by Subject|0|||
129792415|NCT03123185|467209103|FG005|Overall Study|Withdrawal by Subject|0|||
129792416|NCT03123185|467209104|FG006|Overall Study|Withdrawal by Subject|0|||
129792417|NCT03123185|467209105|FG007|Overall Study|Withdrawal by Subject|0|||
129792418|NCT03123185|467209106|FG008|Overall Study|Withdrawal by Subject|0|||
129792419|NCT03123185|467209107|FG009|Overall Study|Withdrawal by Subject|0|||
129792420|NCT03123185|467209108|FG010|Overall Study|Withdrawal by Subject|0|||
129792421|NCT03123185|467209109|FG011|Overall Study|Withdrawal by Subject|0|||
129792422|NCT03123185|467209110|FG012|Overall Study|Withdrawal by Subject|1|||
129792423|NCT03123185|467209111|FG013|Overall Study|Withdrawal by Subject|0|||
129792424|NCT00880685|467209115|FG000|Memantine 10mg|Lost to Follow-up|2|||
129792425|NCT00880685|467209115|FG000|Memantine 20mg|Withdrawal by Subject|1|||
129792426|NCT01249118|467209116|FG000|First Washout Period|Physician Decision|0|||
129887650|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129618380|NCT02516553|466555344|FG020|Overall Study|Refused to continue trial medication|0|||
129618381|NCT02516553|466555345|FG021|Overall Study|Refused to continue trial medication|1|||
129792427|NCT01249118|467209117|FG001|First Washout Period|Physician Decision|1|||
129792428|NCT01249118|467209118|FG002|First Washout Period|Physician Decision|0|||
129618382|NCT02516553|466555324|FG000|Overall Study|other reasons than listed|0|||
129618383|NCT02516553|466555325|FG001|Overall Study|other reasons than listed|0|||
129618384|NCT02516553|466555326|FG002|Overall Study|other reasons than listed|0|||
129618385|NCT02516553|466555327|FG003|Overall Study|other reasons than listed|0|||
129618386|NCT02516553|466555328|FG004|Overall Study|other reasons than listed|0|||
129618387|NCT02516553|466555329|FG005|Overall Study|other reasons than listed|0|||
129618388|NCT02516553|466555330|FG006|Overall Study|other reasons than listed|0|||
129618389|NCT02516553|466555331|FG007|Overall Study|other reasons than listed|1|||
129618390|NCT02516553|466555332|FG008|Overall Study|other reasons than listed|1|||
129618391|NCT02516553|466555333|FG009|Overall Study|other reasons than listed|0|||
129618392|NCT02516553|466555334|FG010|Overall Study|other reasons than listed|1|||
129618393|NCT02516553|466555335|FG011|Overall Study|other reasons than listed|1|||
129618394|NCT02516553|466555336|FG012|Overall Study|other reasons than listed|0|||
129618395|NCT02516553|466555337|FG013|Overall Study|other reasons than listed|0|||
129618396|NCT02516553|466555338|FG014|Overall Study|other reasons than listed|0|||
129618397|NCT02516553|466555339|FG015|Overall Study|other reasons than listed|0|||
129618398|NCT02516553|466555340|FG016|Overall Study|other reasons than listed|0|||
129618399|NCT02516553|466555341|FG017|Overall Study|other reasons than listed|0|||
129618400|NCT02516553|466555342|FG018|Overall Study|other reasons than listed|0|||
129618401|NCT02516553|466555343|FG019|Overall Study|other reasons than listed|0|||
129618402|NCT02516553|466555344|FG020|Overall Study|other reasons than listed|2|||
129618403|NCT02516553|466555345|FG021|Overall Study|other reasons than listed|2|||
129618404|NCT03052127|466555346|FG000|Overall Study|Withdrawal by Subject|0|||
129618405|NCT03052127|466555347|FG001|Overall Study|Withdrawal by Subject|0|||
129618406|NCT03052127|466555348|FG002|Overall Study|Withdrawal by Subject|0|||
129618407|NCT03052127|466555349|FG003|Overall Study|Withdrawal by Subject|0|||
129618408|NCT03052127|466555350|FG004|Overall Study|Withdrawal by Subject|0|||
129618409|NCT03052127|466555351|FG005|Overall Study|Withdrawal by Subject|0|||
129618410|NCT03052127|466555352|FG006|Overall Study|Withdrawal by Subject|0|||
129618411|NCT03052127|466555353|FG007|Overall Study|Withdrawal by Subject|1|||
129618412|NCT03052127|466555354|FG008|Overall Study|Withdrawal by Subject|1|||
129618413|NCT03052127|466555355|FG009|Overall Study|Withdrawal by Subject|1|||
129618414|NCT03052127|466555356|FG010|Overall Study|Withdrawal by Subject|0|||
129618415|NCT03052127|466555357|FG011|Overall Study|Withdrawal by Subject|0|||
129618416|NCT03052127|466555346|FG000|Overall Study|Discontinuation by Sponsor|0|||
129618417|NCT03052127|466555347|FG001|Overall Study|Discontinuation by Sponsor|0|||
129701429|NCT03766399|466867511|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701430|NCT03766399|466867512|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701431|NCT03766399|466867513|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701432|NCT03766399|466867514|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
129701433|NCT03766399|466867515|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701434|NCT03766399|466867516|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701435|NCT03766399|466867517|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701436|NCT03766399|466867518|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
129701437|NCT03895372|466867521|FG000|Investigational Treatment Period|Adverse Event|1|||
129701438|NCT03895372|466867522|FG001|Investigational Treatment Period|Adverse Event|0|||
129701439|NCT03895372|466867523|FG002|Investigational Treatment Period|Adverse Event|0|||
129701440|NCT03895372|466867524|FG003|Investigational Treatment Period|Adverse Event|0|||
129701441|NCT03895372|466867525|FG004|Investigational Treatment Period|Adverse Event|0|||
129701442|NCT03895372|466867526|FG005|Investigational Treatment Period|Adverse Event|0|||
129701443|NCT03895372|466867527|FG006|Investigational Treatment Period|Adverse Event|4|||
129701444|NCT03895372|466867528|FG007|Investigational Treatment Period|Adverse Event|3|||
129701445|NCT03895372|466867521|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
129701446|NCT03895372|466867522|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
129701447|NCT03895372|466867523|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
129701448|NCT03895372|466867524|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
129701449|NCT03895372|466867525|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
129701450|NCT03895372|466867526|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
129701451|NCT03895372|466867527|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
129701452|NCT03895372|466867528|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
129701453|NCT03895372|466867521|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
129701454|NCT03895372|466867522|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
129701455|NCT03895372|466867523|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
129701456|NCT03895372|466867524|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
129701457|NCT03895372|466867525|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
129701458|NCT03895372|466867526|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
129701459|NCT03895372|466867527|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
129701460|NCT03895372|466867528|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
129701461|NCT03895372|466867521|FG000|Investigational Treatment Period|Other|0|||
129701462|NCT03895372|466867522|FG001|Investigational Treatment Period|Other|0|||
129701463|NCT03895372|466867523|FG002|Investigational Treatment Period|Other|0|||
129701464|NCT03895372|466867524|FG003|Investigational Treatment Period|Other|0|||
129701465|NCT03895372|466867525|FG004|Investigational Treatment Period|Other|0|||
129701466|NCT03895372|466867526|FG005|Investigational Treatment Period|Other|1|||
129701467|NCT03895372|466867527|FG006|Investigational Treatment Period|Other|0|||
129701468|NCT03895372|466867528|FG007|Investigational Treatment Period|Other|2|||
129701469|NCT03895372|466867521|FG000|Investigational Treatment Period|Protocol Violation|0|||
129701470|NCT03895372|466867522|FG001|Investigational Treatment Period|Protocol Violation|0|||
129701471|NCT03895372|466867523|FG002|Investigational Treatment Period|Protocol Violation|0|||
129701472|NCT03895372|466867524|FG003|Investigational Treatment Period|Protocol Violation|1|||
129701473|NCT03895372|466867525|FG004|Investigational Treatment Period|Protocol Violation|0|||
129701474|NCT03895372|466867526|FG005|Investigational Treatment Period|Protocol Violation|0|||
129701475|NCT03895372|466867527|FG006|Investigational Treatment Period|Protocol Violation|0|||
129701476|NCT03895372|466867528|FG007|Investigational Treatment Period|Protocol Violation|0|||
129701477|NCT03895372|466867521|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
129701478|NCT03895372|466867522|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
129701479|NCT03895372|466867523|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
129701480|NCT03895372|466867524|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
129701481|NCT03895372|466867525|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
129701482|NCT03895372|466867526|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
129701483|NCT03895372|466867527|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
129701484|NCT03895372|466867528|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
129701485|NCT03895372|466867521|FG000|Extension Treatment Period|Adverse Event|0|||
129701486|NCT03895372|466867522|FG001|Extension Treatment Period|Adverse Event|1|||
129701487|NCT03895372|466867523|FG002|Extension Treatment Period|Adverse Event|0|||
129701488|NCT03895372|466867524|FG003|Extension Treatment Period|Adverse Event|1|||
129701489|NCT03895372|466867525|FG004|Extension Treatment Period|Adverse Event|0|||
129701490|NCT03895372|466867526|FG005|Extension Treatment Period|Adverse Event|0|||
129701491|NCT03895372|466867527|FG006|Extension Treatment Period|Adverse Event|3|||
129701492|NCT03895372|466867528|FG007|Extension Treatment Period|Adverse Event|3|||
129701493|NCT03895372|466867521|FG000|Extension Treatment Period|Other|1|||
129701494|NCT03895372|466867522|FG001|Extension Treatment Period|Other|3|||
129701495|NCT03895372|466867523|FG002|Extension Treatment Period|Other|0|||
129792429|NCT04179890|467209119|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
129792430|NCT04179890|467209120|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
129792431|NCT04179890|467209119|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
129792432|NCT04179890|467209120|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
129792433|NCT04179890|467209119|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
129792434|NCT04179890|467209120|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
129792435|NCT04179890|467209119|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
129792436|NCT04179890|467209120|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
129618418|NCT03052127|466555348|FG002|Overall Study|Discontinuation by Sponsor|0|||
129618419|NCT03052127|466555349|FG003|Overall Study|Discontinuation by Sponsor|0|||
129618420|NCT03052127|466555350|FG004|Overall Study|Discontinuation by Sponsor|0|||
129618421|NCT03052127|466555351|FG005|Overall Study|Discontinuation by Sponsor|0|||
129618422|NCT03052127|466555352|FG006|Overall Study|Discontinuation by Sponsor|0|||
129618423|NCT03052127|466555353|FG007|Overall Study|Discontinuation by Sponsor|0|||
129618424|NCT03052127|466555354|FG008|Overall Study|Discontinuation by Sponsor|4|||
129618425|NCT03052127|466555355|FG009|Overall Study|Discontinuation by Sponsor|2|||
129439268|NCT01765192|465906409|FG001|Washout Period|Reason not specified|0|||
129439269|NCT01765192|465906408|FG000|Treatment Period 2|Reason not specified|0|||
129618426|NCT03052127|466555356|FG010|Overall Study|Discontinuation by Sponsor|5|||
129618427|NCT03052127|466555357|FG011|Overall Study|Discontinuation by Sponsor|13|||
129701496|NCT03895372|466867524|FG003|Extension Treatment Period|Other|0|||
129701497|NCT03895372|466867525|FG004|Extension Treatment Period|Other|1|||
129701498|NCT03895372|466867526|FG005|Extension Treatment Period|Other|0|||
129701499|NCT03895372|466867527|FG006|Extension Treatment Period|Other|0|||
129701500|NCT03895372|466867528|FG007|Extension Treatment Period|Other|2|||
129701501|NCT03895372|466867521|FG000|Extension Treatment Period|Pregnancy|0|||
129701502|NCT03895372|466867522|FG001|Extension Treatment Period|Pregnancy|0|||
129701503|NCT03895372|466867523|FG002|Extension Treatment Period|Pregnancy|0|||
129618428|NCT03052127|466555346|FG000|Overall Study|Inability to comply with trial requirements|0|||
129618429|NCT03052127|466555347|FG001|Overall Study|Inability to comply with trial requirements|0|||
129618430|NCT03052127|466555348|FG002|Overall Study|Inability to comply with trial requirements|1|||
129618431|NCT03052127|466555349|FG003|Overall Study|Inability to comply with trial requirements|0|||
129618432|NCT03052127|466555350|FG004|Overall Study|Inability to comply with trial requirements|0|||
129618433|NCT03052127|466555351|FG005|Overall Study|Inability to comply with trial requirements|0|||
129618434|NCT03052127|466555352|FG006|Overall Study|Inability to comply with trial requirements|0|||
129618435|NCT03052127|466555353|FG007|Overall Study|Inability to comply with trial requirements|0|||
129618436|NCT03052127|466555354|FG008|Overall Study|Inability to comply with trial requirements|0|||
129618437|NCT03052127|466555355|FG009|Overall Study|Inability to comply with trial requirements|0|||
129618438|NCT03052127|466555356|FG010|Overall Study|Inability to comply with trial requirements|0|||
129618439|NCT03052127|466555357|FG011|Overall Study|Inability to comply with trial requirements|0|||
129618440|NCT03052127|466555346|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129618441|NCT03052127|466555347|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618442|NCT03052127|466555348|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618443|NCT03052127|466555349|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618444|NCT03052127|466555350|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129618445|NCT03052127|466555351|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129618446|NCT03052127|466555352|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
129618447|NCT03052127|466555353|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618448|NCT03052127|466555354|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618449|NCT03052127|466555355|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618450|NCT03052127|466555356|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129618451|NCT03052127|466555357|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
129701504|NCT03895372|466867524|FG003|Extension Treatment Period|Pregnancy|0|||
129701505|NCT03895372|466867525|FG004|Extension Treatment Period|Pregnancy|1|||
129701506|NCT03895372|466867526|FG005|Extension Treatment Period|Pregnancy|0|||
129701507|NCT03895372|466867527|FG006|Extension Treatment Period|Pregnancy|0|||
129701508|NCT03895372|466867528|FG007|Extension Treatment Period|Pregnancy|0|||
129701509|NCT03895372|466867521|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
129701510|NCT03895372|466867522|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
129701511|NCT03895372|466867523|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129701512|NCT03895372|466867524|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
129701513|NCT03895372|466867525|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
129701514|NCT03895372|466867526|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
129701515|NCT03895372|466867527|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
129701516|NCT03895372|466867528|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
129701517|NCT01472185|466867533|FG000|Overall Study|Randomized but Not Treated|0|||
129701518|NCT01472185|466867534|FG001|Overall Study|Randomized but Not Treated|1|||
129701519|NCT01472185|466867533|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
129701520|NCT01472185|466867534|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
129701521|NCT01472185|466867533|FG000|Overall Study|Hyperglycemia|5|||
129701522|NCT01472185|466867534|FG001|Overall Study|Hyperglycemia|2|||
129701523|NCT01472185|466867533|FG000|Overall Study|Investigator's Discretion|3|||
129701524|NCT01472185|466867534|FG001|Overall Study|Investigator's Discretion|1|||
129701525|NCT01472185|466867533|FG000|Overall Study|Lost to Follow-up|4|||
129701526|NCT01472185|466867534|FG001|Overall Study|Lost to Follow-up|1|||
129701527|NCT01472185|466867533|FG000|Overall Study|Protocol Violation|5|||
129701528|NCT01472185|466867534|FG001|Overall Study|Protocol Violation|1|||
129701529|NCT01472185|466867533|FG000|Overall Study|Subject Noncompliance|8|||
129701530|NCT01472185|466867534|FG001|Overall Study|Subject Noncompliance|15|||
129701531|NCT01472185|466867533|FG000|Overall Study|Subject Withdrew Consent|6|||
129701532|NCT01472185|466867534|FG001|Overall Study|Subject Withdrew Consent|3|||
129701533|NCT05889468|466867535|FG000|Overall Study|Lost to Follow-up|9|||
129701534|NCT05889468|466867536|FG001|Overall Study|Lost to Follow-up|2|||
129701535|NCT05889468|466867535|FG000|Overall Study|Withdrawal by Subject|2|||
129701536|NCT05889468|466867536|FG001|Overall Study|Withdrawal by Subject|2|||
129701537|NCT01309230|466867537|FG000|Overall Study|Withdrawal by Subject|0|||
129701538|NCT01309230|466867538|FG001|Overall Study|Withdrawal by Subject|2|||
129701539|NCT01309230|466867537|FG000|Overall Study|Observation arm closed|0|||
129701540|NCT01309230|466867538|FG001|Overall Study|Observation arm closed|2|||
129701541|NCT00049543|466867547|FG000|Overall Study|still on treatment|2|||
129618452|NCT03694327|466555358|FG000|Overall Study|Lost to Follow-up|13|||
129618453|NCT03694327|466555359|FG001|Overall Study|Lost to Follow-up|23|||
129618454|NCT01464931|466555360|FG000|Overall Study|Withdrawal by Subject|1|||
129618455|NCT01464931|466555361|FG001|Overall Study|Withdrawal by Subject|0|||
129618456|NCT01982812|466555364|FG000|Overall Study|Death|1|||
129618457|NCT01982812|466555365|FG001|Overall Study|Death|5|||
129618458|NCT01982812|466555364|FG000|Overall Study|Adverse Event|0|||
129618459|NCT01982812|466555365|FG001|Overall Study|Adverse Event|5|||
129618460|NCT02933255|466555368|FG000|Overall Study|Discontinued due to study closure.|1|||
129618461|NCT02933255|466555369|FG001|Overall Study|Discontinued due to study closure.|0|||
129618462|NCT05833139|466557944|FG000|Study Period 2|Adverse Event|1|||
129618463|NCT03922529|466557945|FG000|Overall Study|Withdrawal by Subject|13|||
129887651|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887652|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887653|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887654|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887655|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887656|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887657|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887658|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
129887659|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
129887660|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
129887661|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
129887662|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
129887663|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887664|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887665|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887666|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887667|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887668|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887669|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887670|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887671|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887672|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887673|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887674|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887675|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887676|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
129887677|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
129887678|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
129887679|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
129887680|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
129887681|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887682|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887683|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887684|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887685|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887686|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887687|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129618464|NCT03922529|466557946|FG001|Overall Study|Withdrawal by Subject|12|||
129618465|NCT03922529|466557945|FG000|Overall Study|Death|7|||
129618466|NCT03922529|466557946|FG001|Overall Study|Death|12|||
129618467|NCT03922529|466557945|FG000|Overall Study|Lost to Follow-up|12|||
129618468|NCT03922529|466557946|FG001|Overall Study|Lost to Follow-up|19|||
129701542|NCT00049543|466867548|FG001|Overall Study|still on treatment|9|||
129439270|NCT01765192|465906409|FG001|Treatment Period 2|Reason not specified|2|||
129439271|NCT01765192|465906408|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
129439272|NCT01765192|465906409|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
129618469|NCT03922529|466557945|FG000|Overall Study|Adverse Event|1|||
129618470|NCT03922529|466557946|FG001|Overall Study|Adverse Event|0|||
129701543|NCT04562090|466867549|FG000|Overall Study|Withdrawal by Subject|3|||
129887688|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887689|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129618471|NCT03922529|466557945|FG000|Overall Study|Death after withdrawal|1|||
129887690|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887691|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887692|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887693|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129439273|NCT00876694|465906414|FG000|Overall Study|Adverse Event|10|||
129439274|NCT00876694|465906415|FG001|Overall Study|Adverse Event|7|||
129439275|NCT00876694|465906414|FG000|Overall Study|Subject withdrew consent|6|||
129439276|NCT00876694|465906415|FG001|Overall Study|Subject withdrew consent|4|||
129618472|NCT03922529|466557946|FG001|Overall Study|Death after withdrawal|0|||
129618473|NCT03922529|466557945|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
129618474|NCT03922529|466557946|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
129618475|NCT03922529|466557945|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
129618476|NCT03922529|466557946|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
129618477|NCT02506153|466557947|FG000|Overall Study|Adverse Event|359|||
129618478|NCT02506153|466557948|FG001|Overall Study|Adverse Event|114|||
129618479|NCT02506153|466557947|FG000|Overall Study|Refused unrelated to adverse event|127|||
129618480|NCT02506153|466557948|FG001|Overall Study|Refused unrelated to adverse event|18|||
129618481|NCT02506153|466557947|FG000|Overall Study|Progression/relapse|91|||
129618482|NCT02506153|466557948|FG001|Overall Study|Progression/relapse|136|||
129618483|NCT02506153|466557947|FG000|Overall Study|Death|2|||
129618484|NCT02506153|466557948|FG001|Overall Study|Death|1|||
129618485|NCT02506153|466557947|FG000|Overall Study|Other - not protocol specified|23|||
129618486|NCT02506153|466557948|FG001|Overall Study|Other - not protocol specified|12|||
129618487|NCT02017015|466557949|FG000|Overall Study|Adverse Event|9|||
129618488|NCT02017015|466557949|FG000|Overall Study|Withdrawal by Subject|21|||
129618489|NCT02017015|466557949|FG000|Overall Study|Death|4|||
129618490|NCT02017015|466557949|FG000|Overall Study|Progressive Disease|31|||
129618491|NCT02017015|466557949|FG000|Overall Study|Non-compliance with study drug|2|||
129618492|NCT02017015|466557949|FG000|Overall Study|Physician Decision|2|||
129618493|NCT04158245|466557950|FG000|Overall Study|Lost to Follow-up|1|||
129618494|NCT02567435|466557953|FG000|Overall Study|Death|1|||
129618495|NCT02567435|466557954|FG001|Overall Study|Death|1|||
129618496|NCT02567435|466557955|FG002|Overall Study|Death|0|||
129618497|NCT02567435|466557956|FG003|Overall Study|Death|0|||
129618498|NCT02567435|466557953|FG000|Overall Study|Ineligible|1|||
129618499|NCT02567435|466557954|FG001|Overall Study|Ineligible|3|||
129618500|NCT02567435|466557955|FG002|Overall Study|Ineligible|0|||
129618501|NCT02567435|466557956|FG003|Overall Study|Ineligible|0|||
129618502|NCT02567435|466557953|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
129618503|NCT02567435|466557954|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
129618504|NCT02567435|466557955|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
129618505|NCT02567435|466557956|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
129618506|NCT03765788|466557957|FG000|Overall Study|Subject decision|2|||
129618507|NCT03765788|466557958|FG001|Overall Study|Subject decision|3|||
129618508|NCT03765788|466557957|FG000|Overall Study|Physician Decision|2|||
129618509|NCT03765788|466557958|FG001|Overall Study|Physician Decision|4|||
129618510|NCT03765788|466557957|FG000|Overall Study|Death|0|||
129618511|NCT03765788|466557958|FG001|Overall Study|Death|1|||
129618512|NCT03765788|466557957|FG000|Overall Study|Lost to Follow-up|1|||
129618513|NCT03765788|466557958|FG001|Overall Study|Lost to Follow-up|0|||
129618514|NCT04856930|466557959|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
129618515|NCT04856930|466557960|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
129618516|NCT04856930|466557961|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
129618517|NCT04856930|466557959|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
129618518|NCT04856930|466557960|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
129618519|NCT04856930|466557961|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
129618520|NCT04856930|466557959|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
129618521|NCT04856930|466557960|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
129618522|NCT04856930|466557961|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
129618523|NCT04856930|466557959|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
129887694|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129792437|NCT04179890|467209119|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
129792438|NCT04179890|467209120|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
129792439|NCT04179890|467209119|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
129792440|NCT04179890|467209120|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
129792441|NCT04179890|467209119|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
129792442|NCT04179890|467209120|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
129887695|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887696|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
129887697|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
129887698|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
129887699|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
129887700|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
129887701|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
129887702|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
129887703|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
129887704|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
129887705|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
129887706|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
129887707|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
129887708|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
129887709|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
129887710|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
129887711|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
129887712|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
129887713|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
129887714|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
129887715|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
129887716|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
129887717|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887718|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887719|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887720|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887721|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887722|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887723|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887724|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887725|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887726|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887727|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887728|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887729|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887730|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887731|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887732|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
129887733|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
129887734|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
129887735|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
129887736|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
129701544|NCT04562090|466867550|FG001|Overall Study|Withdrawal by Subject|4|||
129887737|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
129887738|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
129887739|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
129887740|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
129887741|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
129887742|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
129887743|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
129887744|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
129887745|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
129887746|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
129887747|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
129887748|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
129701545|NCT04562090|466867549|FG000|Overall Study|Protocol Violation|2|||
129701546|NCT04562090|466867550|FG001|Overall Study|Protocol Violation|0|||
129701547|NCT04562090|466867549|FG000|Overall Study|Lack of Efficacy|0|||
129701548|NCT04562090|466867550|FG001|Overall Study|Lack of Efficacy|1|||
129701549|NCT04562090|466867549|FG000|Overall Study|Adverse Event|1|||
129701550|NCT04562090|466867550|FG001|Overall Study|Adverse Event|4|||
129701551|NCT04562090|466867549|FG000|Overall Study|Miscellaneous|0|||
129701552|NCT04562090|466867550|FG001|Overall Study|Miscellaneous|3|||
129701553|NCT03633058|466867551|FG000|Overall Study|Adverse Event|0|||
129701554|NCT03633058|466867552|FG001|Overall Study|Adverse Event|0|||
129701555|NCT03633058|466867553|FG002|Overall Study|Adverse Event|1|||
129701556|NCT03633058|466867554|FG003|Overall Study|Adverse Event|0|||
129701557|NCT03312543|466867555|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
129887749|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
129887750|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
129887751|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
129701558|NCT03312543|466867556|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
129701559|NCT03312543|466867555|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
129618524|NCT04856930|466557960|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
129618525|NCT04856930|466557961|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
129618526|NCT04856930|466557959|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
129618527|NCT04856930|466557960|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
129618528|NCT04856930|466557961|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
129618529|NCT04856930|466557959|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129618530|NCT04856930|466557960|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
129618531|NCT04856930|466557961|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129618532|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
129618533|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
129618534|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
129618535|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
129618536|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
129618537|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
129618538|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
129618539|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
129618540|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
129618541|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
129618542|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
129618543|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
129618544|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
129618545|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129618546|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
129618547|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
129618548|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
129887752|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
129887753|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887754|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887755|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887756|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887757|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887758|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887759|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887760|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887761|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887762|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887763|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887764|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887765|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887766|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887767|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
129887768|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
129887769|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
129887770|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
129618549|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
129618550|NCT04856930|466557959|FG000|Extension Period (16 Weeks)|Other than specified|0|||
129618551|NCT04856930|466557960|FG001|Extension Period (16 Weeks)|Other than specified|0|||
129618552|NCT04856930|466557961|FG002|Extension Period (16 Weeks)|Other than specified|1|||
129618553|NCT04856930|466557959|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
129618554|NCT04856930|466557960|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
129618555|NCT04856930|466557961|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
129618556|NCT04856930|466557959|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
129618557|NCT04856930|466557960|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
129618558|NCT04856930|466557961|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
129618559|NCT04856930|466557959|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
129618560|NCT04856930|466557960|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
129701560|NCT03312543|466867556|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
129701561|NCT03312543|466867555|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
129887771|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129618561|NCT04856930|466557961|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
129887772|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887773|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887774|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129701562|NCT03312543|466867556|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
129701563|NCT03312543|466867555|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
129701564|NCT03312543|466867556|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
129701565|NCT03312543|466867555|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
129701566|NCT03312543|466867556|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
129701567|NCT03312543|466867555|FG000|Regression (Week 12 to Week 24)|Death|0|||
129701568|NCT03312543|466867556|FG001|Regression (Week 12 to Week 24)|Death|1|||
129701569|NCT04134936|466867557|FG000|Overall Study|Adverse Event|3|||
129701570|NCT04134936|466867558|FG001|Overall Study|Adverse Event|2|||
129701571|NCT04134936|466867557|FG000|Overall Study|Withdrawal by Subject|2|||
129701572|NCT04134936|466867558|FG001|Overall Study|Withdrawal by Subject|3|||
129701573|NCT04134936|466867557|FG000|Overall Study|Physician Decision|0|||
129701574|NCT04134936|466867558|FG001|Overall Study|Physician Decision|1|||
129701575|NCT04134936|466867557|FG000|Overall Study|Progressive disease, joined another trial|1|||
129701576|NCT04134936|466867558|FG001|Overall Study|Progressive disease, joined another trial|0|||
129701577|NCT04134936|466867557|FG000|Overall Study|Progressive disease|1|||
129701578|NCT04134936|466867558|FG001|Overall Study|Progressive disease|0|||
129701579|NCT02420717|466867561|FG000|Overall Study|Did not receive all study medication|2|||
129701580|NCT02420717|466867562|FG001|Overall Study|Did not receive all study medication|0|||
129701581|NCT02420717|466867563|FG002|Overall Study|Did not receive all study medication|0|||
129701582|NCT04144517|466867566|FG000|Overall Study|Physician Decision|0|||
129701583|NCT04144517|466867567|FG001|Overall Study|Physician Decision|1|||
129701584|NCT04144517|466867566|FG000|Overall Study|Other|2|||
129701585|NCT04144517|466867567|FG001|Overall Study|Other|2|||
129701586|NCT04144517|466867566|FG000|Overall Study|Death|6|||
129701587|NCT04144517|466867567|FG001|Overall Study|Death|3|||
129701588|NCT00835367|466867573|FG000|Washout|Adverse Event|2|||
129701589|NCT00835367|466867574|FG001|Washout|Adverse Event|0|||
129701590|NCT00835367|466867573|FG000|Washout|Withdrawal by Subject|1|||
129701591|NCT00835367|466867574|FG001|Washout|Withdrawal by Subject|0|||
129701592|NCT00835367|466867573|FG000|Second Intervention|Adverse Event|1|||
129701593|NCT00835367|466867574|FG001|Second Intervention|Adverse Event|1|||
129701594|NCT00936936|466869360|FG000|Overall Study|Adverse Event|7|||
129701595|NCT00936936|466869361|FG001|Overall Study|Adverse Event|1|||
129701596|NCT00936936|466869360|FG000|Overall Study|Disease Progression|2|||
129701597|NCT00936936|466869361|FG001|Overall Study|Disease Progression|2|||
129701598|NCT00936936|466869360|FG000|Overall Study|Unrelated|3|||
129701599|NCT00936936|466869361|FG001|Overall Study|Unrelated|1|||
129701600|NCT01373281|466869362|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
129701601|NCT01373281|466869363|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
129701602|NCT01373281|466869362|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
129701603|NCT01373281|466869363|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
129701604|NCT01373281|466869362|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
129701605|NCT01373281|466869363|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
129701606|NCT01373281|466869362|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
129701607|NCT01373281|466869363|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
129701608|NCT01373281|466869362|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
129792443|NCT04179890|467209119|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
129792444|NCT04179890|467209120|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
129792445|NCT04179890|467209119|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
129792446|NCT04179890|467209120|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
129792447|NCT00095238|467209121|FG000|Overall Study|Lack of Efficacy|9|||
129792448|NCT00095238|467209122|FG001|Overall Study|Lack of Efficacy|9|||
129792449|NCT00095238|467209121|FG000|Overall Study|Adverse Event|331|||
129792450|NCT00095238|467209122|FG001|Overall Study|Adverse Event|287|||
129792451|NCT00095238|467209121|FG000|Overall Study|Subject Withdrew Consent|208|||
129792452|NCT00095238|467209122|FG001|Overall Study|Subject Withdrew Consent|223|||
129792453|NCT00095238|467209121|FG000|Overall Study|Death|154|||
129792454|NCT00095238|467209122|FG001|Overall Study|Death|170|||
129792455|NCT00095238|467209121|FG000|Overall Study|Lost to Follow-up|19|||
129792456|NCT00095238|467209122|FG001|Overall Study|Lost to Follow-up|24|||
129792457|NCT00095238|467209121|FG000|Overall Study|Noncompliance|44|||
129792458|NCT00095238|467209122|FG001|Overall Study|Noncompliance|45|||
129792459|NCT00095238|467209121|FG000|Overall Study|No longer met study criteria|4|||
129792460|NCT00095238|467209122|FG001|Overall Study|No longer met study criteria|5|||
129792461|NCT00095238|467209121|FG000|Overall Study|Study terminated by sponsor|0|||
129792462|NCT00095238|467209122|FG001|Overall Study|Study terminated by sponsor|1|||
129792463|NCT00095238|467209121|FG000|Overall Study|Missing|1|||
129792464|NCT00095238|467209122|FG001|Overall Study|Missing|0|||
129792465|NCT00095238|467209121|FG000|Overall Study|Other Reasons|87|||
129792466|NCT00095238|467209122|FG001|Overall Study|Other Reasons|88|||
129792467|NCT04393298|467209125|FG000|Overall Study|Adverse Event|0|||
129792468|NCT04393298|467209126|FG001|Overall Study|Adverse Event|0|||
129792469|NCT04393298|467209127|FG002|Overall Study|Adverse Event|0|||
129792470|NCT04393298|467209128|FG003|Overall Study|Adverse Event|0|||
129792471|NCT04393298|467209129|FG004|Overall Study|Adverse Event|1|||
129792472|NCT04393298|467209130|FG005|Overall Study|Adverse Event|0|||
129792473|NCT04393298|467209131|FG006|Overall Study|Adverse Event|0|||
129792474|NCT04393298|467209132|FG007|Overall Study|Adverse Event|0|||
129792475|NCT04393298|467209133|FG008|Overall Study|Adverse Event|2|||
129792476|NCT04393298|467209134|FG009|Overall Study|Adverse Event|0|||
129792477|NCT04393298|467209135|FG010|Overall Study|Adverse Event|0|||
129792478|NCT04393298|467209136|FG011|Overall Study|Adverse Event|0|||
129792479|NCT04393298|467209137|FG012|Overall Study|Adverse Event|1|||
129792480|NCT04393298|467209138|FG013|Overall Study|Adverse Event|1|||
129792481|NCT04393298|467209139|FG014|Overall Study|Adverse Event|0|||
129792482|NCT04393298|467209125|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792483|NCT04393298|467209126|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129887775|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129792484|NCT04393298|467209127|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
129792485|NCT04393298|467209128|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792486|NCT04393298|467209129|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792487|NCT04393298|467209130|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792488|NCT04393298|467209131|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792489|NCT04393298|467209132|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792490|NCT04393298|467209133|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792491|NCT04393298|467209134|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792492|NCT04393298|467209135|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792493|NCT04393298|467209136|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792494|NCT04393298|467209137|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129618562|NCT04856930|466557959|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
129618563|NCT04856930|466557960|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
129618564|NCT04856930|466557961|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
129618565|NCT00678210|466557962|FG000|Overall Study|Adverse Event|1|||
129618566|NCT00678210|466557963|FG001|Overall Study|Adverse Event|2|||
129618567|NCT00678210|466557964|FG002|Overall Study|Adverse Event|3|||
129618568|NCT00678210|466557965|FG003|Overall Study|Adverse Event|3|||
129618569|NCT00678210|466557962|FG000|Overall Study|Lack of Efficacy|2|||
129618570|NCT00678210|466557963|FG001|Overall Study|Lack of Efficacy|3|||
129887776|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887777|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887778|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887779|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887780|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887781|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887782|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887783|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887784|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887785|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
129887786|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887787|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
129887788|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
129887789|NCT01474512|467547272|FG000|Post-Treatment Follow-Up|Death|0|||
129887790|NCT01474512|467547273|FG001|Post-Treatment Follow-Up|Death|0|||
129887791|NCT01474512|467547274|FG002|Post-Treatment Follow-Up|Death|0|||
129887792|NCT01474512|467547275|FG003|Post-Treatment Follow-Up|Death|0|||
129887793|NCT01474512|467547276|FG004|Post-Treatment Follow-Up|Death|0|||
129887794|NCT01474512|467547277|FG005|Post-Treatment Follow-Up|Death|0|||
129887795|NCT01474512|467547278|FG006|Post-Treatment Follow-Up|Death|0|||
129887796|NCT01474512|467547279|FG007|Post-Treatment Follow-Up|Death|0|||
129887797|NCT01474512|467547280|FG008|Post-Treatment Follow-Up|Death|0|||
129887798|NCT01474512|467547281|FG009|Post-Treatment Follow-Up|Death|0|||
129887799|NCT01474512|467547282|FG010|Post-Treatment Follow-Up|Death|0|||
129887800|NCT01474512|467547283|FG011|Post-Treatment Follow-Up|Death|0|||
129887801|NCT01474512|467547284|FG012|Post-Treatment Follow-Up|Death|0|||
129887802|NCT01474512|467547285|FG013|Post-Treatment Follow-Up|Death|0|||
129887803|NCT01474512|467547286|FG014|Post-Treatment Follow-Up|Death|0|||
129887804|NCT01474512|467547287|FG015|Post-Treatment Follow-Up|Death|0|||
129887805|NCT01474512|467547288|FG016|Post-Treatment Follow-Up|Death|1|||
129887806|NCT01474512|467547289|FG017|Post-Treatment Follow-Up|Death|0|||
129887807|NCT01118962|467547292|FG000|Overall Study|Adverse Event|2|||
129887808|NCT01118962|467547292|FG000|Overall Study|Lack of Efficacy|1|||
129887809|NCT01118962|467547292|FG000|Overall Study|Protocol Violation|1|||
129887810|NCT01118962|467547292|FG000|Overall Study|Withdrawal by Subject|4|||
129887811|NCT01118962|467547292|FG000|Overall Study|Pregnancy|1|||
129887812|NCT01118962|467547292|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
129887813|NCT01023308|467547295|FG000|Overall Study|Abnormal test proceedure results|3|||
129887814|NCT01023308|467547296|FG001|Overall Study|Abnormal test proceedure results|8|||
129887815|NCT01023308|467547295|FG000|Overall Study|Administrative problems|2|||
129887816|NCT01023308|467547296|FG001|Overall Study|Administrative problems|1|||
129887817|NCT01023308|467547295|FG000|Overall Study|Adverse Event|130|||
129887818|NCT01023308|467547296|FG001|Overall Study|Adverse Event|66|||
129887819|NCT01023308|467547295|FG000|Overall Study|Death|21|||
129887820|NCT01023308|467547296|FG001|Overall Study|Death|17|||
129887821|NCT01023308|467547295|FG000|Overall Study|Disease progression|82|||
129887822|NCT01023308|467547296|FG001|Overall Study|Disease progression|153|||
129887823|NCT01023308|467547295|FG000|Overall Study|New Cancer therapy|4|||
129887824|NCT01023308|467547296|FG001|Overall Study|New Cancer therapy|7|||
129887825|NCT01023308|467547295|FG000|Overall Study|Protocol Violation|3|||
129887826|NCT01023308|467547296|FG001|Overall Study|Protocol Violation|4|||
129887827|NCT01023308|467547295|FG000|Overall Study|Untreated|5|||
129887828|NCT01023308|467547296|FG001|Overall Study|Untreated|5|||
129887829|NCT01023308|467547295|FG000|Overall Study|Lost to Follow-up|1|||
129887830|NCT01023308|467547296|FG001|Overall Study|Lost to Follow-up|0|||
129887831|NCT01023308|467547295|FG000|Overall Study|Withdrawal by Subject|34|||
129887832|NCT01023308|467547296|FG001|Overall Study|Withdrawal by Subject|18|||
129887833|NCT00262743|467547299|FG000|Overall Study|Adverse Event|0|||
129887834|NCT00262743|467547300|FG001|Overall Study|Adverse Event|9|||
129887835|NCT00262743|467547299|FG000|Overall Study|Disease progression|0|||
129887836|NCT00262743|467547300|FG001|Overall Study|Disease progression|3|||
129887837|NCT04430335|467547307|FG000|Overall Study|Withdrawal by Subject|1|||
129887838|NCT03249376|467547308|FG000|Overall Study|Adverse Event|11|||
129887839|NCT03249376|467547309|FG001|Overall Study|Adverse Event|5|||
129887840|NCT03249376|467547308|FG000|Overall Study|Lack of Efficacy|2|||
129887841|NCT03249376|467547309|FG001|Overall Study|Lack of Efficacy|4|||
129887842|NCT03249376|467547308|FG000|Overall Study|Protocol Violation|3|||
129887843|NCT03249376|467547309|FG001|Overall Study|Protocol Violation|2|||
129887844|NCT03249376|467547308|FG000|Overall Study|Physician Decision|0|||
129887845|NCT03249376|467547309|FG001|Overall Study|Physician Decision|2|||
129887846|NCT03249376|467547308|FG000|Overall Study|Withdrawal by Subject|3|||
129887847|NCT03249376|467547309|FG001|Overall Study|Withdrawal by Subject|9|||
129887848|NCT03249376|467547308|FG000|Overall Study|LTFU|2|||
129792495|NCT04393298|467209138|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
129792496|NCT04393298|467209139|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
129792497|NCT04393298|467209125|FG000|Overall Study|Lack of Efficacy|0|||
129792498|NCT04393298|467209126|FG001|Overall Study|Lack of Efficacy|0|||
129792499|NCT04393298|467209127|FG002|Overall Study|Lack of Efficacy|0|||
129792500|NCT04393298|467209128|FG003|Overall Study|Lack of Efficacy|0|||
129792501|NCT04393298|467209129|FG004|Overall Study|Lack of Efficacy|0|||
129792502|NCT04393298|467209130|FG005|Overall Study|Lack of Efficacy|0|||
129792503|NCT04393298|467209131|FG006|Overall Study|Lack of Efficacy|0|||
129792504|NCT04393298|467209132|FG007|Overall Study|Lack of Efficacy|0|||
129792505|NCT04393298|467209133|FG008|Overall Study|Lack of Efficacy|0|||
129792506|NCT04393298|467209134|FG009|Overall Study|Lack of Efficacy|0|||
129792507|NCT04393298|467209135|FG010|Overall Study|Lack of Efficacy|0|||
129792508|NCT04393298|467209136|FG011|Overall Study|Lack of Efficacy|0|||
129792509|NCT04393298|467209137|FG012|Overall Study|Lack of Efficacy|0|||
129792510|NCT04393298|467209138|FG013|Overall Study|Lack of Efficacy|0|||
129792511|NCT04393298|467209139|FG014|Overall Study|Lack of Efficacy|1|||
129792512|NCT04393298|467209125|FG000|Overall Study|Progression|1|||
129792513|NCT04393298|467209126|FG001|Overall Study|Progression|0|||
129792514|NCT04393298|467209127|FG002|Overall Study|Progression|0|||
129792515|NCT04393298|467209128|FG003|Overall Study|Progression|0|||
129792516|NCT04393298|467209129|FG004|Overall Study|Progression|0|||
129792517|NCT04393298|467209130|FG005|Overall Study|Progression|0|||
129792518|NCT04393298|467209131|FG006|Overall Study|Progression|0|||
129792519|NCT04393298|467209132|FG007|Overall Study|Progression|0|||
129792520|NCT04393298|467209133|FG008|Overall Study|Progression|0|||
129792521|NCT04393298|467209134|FG009|Overall Study|Progression|0|||
129792522|NCT04393298|467209135|FG010|Overall Study|Progression|1|||
129792523|NCT04393298|467209136|FG011|Overall Study|Progression|1|||
129792524|NCT04393298|467209137|FG012|Overall Study|Progression|0|||
129792525|NCT04393298|467209138|FG013|Overall Study|Progression|0|||
129792526|NCT04393298|467209139|FG014|Overall Study|Progression|0|||
129792527|NCT04393298|467209125|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
129792528|NCT04393298|467209126|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792529|NCT04393298|467209127|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792530|NCT04393298|467209128|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792531|NCT04393298|467209129|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792532|NCT04393298|467209130|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792533|NCT04393298|467209131|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792534|NCT04393298|467209132|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792535|NCT04393298|467209133|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792536|NCT04393298|467209134|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792537|NCT04393298|467209135|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792538|NCT04393298|467209136|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792539|NCT04393298|467209137|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792540|NCT04393298|467209138|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792541|NCT04393298|467209139|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
129792542|NCT04393298|467209125|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792543|NCT04393298|467209126|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
129792544|NCT04393298|467209127|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792545|NCT04393298|467209128|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792546|NCT04393298|467209129|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792547|NCT04393298|467209130|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792548|NCT04393298|467209131|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792549|NCT04393298|467209132|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792550|NCT04393298|467209133|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792551|NCT04393298|467209134|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792552|NCT04393298|467209135|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792553|NCT04393298|467209136|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792554|NCT04393298|467209137|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792555|NCT04393298|467209138|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792556|NCT04393298|467209139|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
129792557|NCT04393298|467209125|FG000|Overall Study|Clinical Progression|0|||
129792558|NCT04393298|467209126|FG001|Overall Study|Clinical Progression|2|||
129792559|NCT04393298|467209127|FG002|Overall Study|Clinical Progression|0|||
129792560|NCT04393298|467209128|FG003|Overall Study|Clinical Progression|0|||
129792561|NCT04393298|467209129|FG004|Overall Study|Clinical Progression|0|||
129792562|NCT04393298|467209130|FG005|Overall Study|Clinical Progression|0|||
129792563|NCT04393298|467209131|FG006|Overall Study|Clinical Progression|0|||
129792564|NCT04393298|467209132|FG007|Overall Study|Clinical Progression|0|||
129792565|NCT04393298|467209133|FG008|Overall Study|Clinical Progression|0|||
129792566|NCT04393298|467209134|FG009|Overall Study|Clinical Progression|0|||
129792567|NCT04393298|467209135|FG010|Overall Study|Clinical Progression|0|||
129792568|NCT04393298|467209136|FG011|Overall Study|Clinical Progression|0|||
129792569|NCT04393298|467209137|FG012|Overall Study|Clinical Progression|0|||
129792570|NCT04393298|467209138|FG013|Overall Study|Clinical Progression|0|||
129792571|NCT04393298|467209139|FG014|Overall Study|Clinical Progression|0|||
129792572|NCT04393298|467209125|FG000|Overall Study|Disease Progression|0|||
129792573|NCT04393298|467209126|FG001|Overall Study|Disease Progression|1|||
129792574|NCT04393298|467209127|FG002|Overall Study|Disease Progression|0|||
129792575|NCT04393298|467209128|FG003|Overall Study|Disease Progression|0|||
129792576|NCT04393298|467209129|FG004|Overall Study|Disease Progression|0|||
129792577|NCT04393298|467209130|FG005|Overall Study|Disease Progression|3|||
129792578|NCT04393298|467209131|FG006|Overall Study|Disease Progression|2|||
129792579|NCT04393298|467209132|FG007|Overall Study|Disease Progression|1|||
129792580|NCT04393298|467209133|FG008|Overall Study|Disease Progression|2|||
129792581|NCT04393298|467209134|FG009|Overall Study|Disease Progression|1|||
129792582|NCT04393298|467209135|FG010|Overall Study|Disease Progression|0|||
129792583|NCT04393298|467209136|FG011|Overall Study|Disease Progression|3|||
129792584|NCT04393298|467209137|FG012|Overall Study|Disease Progression|0|||
129792585|NCT04393298|467209138|FG013|Overall Study|Disease Progression|0|||
129792586|NCT04393298|467209139|FG014|Overall Study|Disease Progression|1|||
129792587|NCT04393298|467209125|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792588|NCT04393298|467209126|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792589|NCT04393298|467209127|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
129792590|NCT04393298|467209128|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792591|NCT04393298|467209129|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792592|NCT04393298|467209130|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792593|NCT04393298|467209131|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792594|NCT04393298|467209132|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792595|NCT04393298|467209133|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792596|NCT04393298|467209134|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792597|NCT04393298|467209135|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792598|NCT04393298|467209136|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792599|NCT04393298|467209137|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792600|NCT04393298|467209138|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792601|NCT04393298|467209139|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
129792602|NCT04393298|467209125|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792603|NCT04393298|467209126|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792604|NCT04393298|467209127|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
129792605|NCT04393298|467209128|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792606|NCT04393298|467209129|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
129618571|NCT00678210|466557964|FG002|Overall Study|Lack of Efficacy|1|||
129618572|NCT00678210|466557965|FG003|Overall Study|Lack of Efficacy|9|||
129618573|NCT00678210|466557962|FG000|Overall Study|Lost to Follow-up|4|||
129618574|NCT00678210|466557963|FG001|Overall Study|Lost to Follow-up|2|||
129618575|NCT00678210|466557964|FG002|Overall Study|Lost to Follow-up|0|||
129618576|NCT00678210|466557965|FG003|Overall Study|Lost to Follow-up|1|||
129618577|NCT00678210|466557962|FG000|Overall Study|Withdrawal by Subject|3|||
129618578|NCT00678210|466557963|FG001|Overall Study|Withdrawal by Subject|4|||
129618579|NCT00678210|466557964|FG002|Overall Study|Withdrawal by Subject|1|||
129618580|NCT00678210|466557965|FG003|Overall Study|Withdrawal by Subject|7|||
129618581|NCT00678210|466557962|FG000|Overall Study|Other|1|||
129618582|NCT00678210|466557963|FG001|Overall Study|Other|0|||
129618583|NCT00678210|466557964|FG002|Overall Study|Other|1|||
129618584|NCT00678210|466557965|FG003|Overall Study|Other|0|||
129618585|NCT04825912|466557966|FG000|Overall Study|Death|3|||
129618586|NCT04825912|466557966|FG000|Overall Study|Withdrawal by Subject|1|||
129618587|NCT02077140|466557967|FG000|Overall Study|Lost to Follow-up|4|||
129618588|NCT02077140|466557968|FG001|Overall Study|Lost to Follow-up|1|||
129618589|NCT02077140|466557969|FG002|Overall Study|Lost to Follow-up|2|||
129618590|NCT02077140|466557970|FG003|Overall Study|Lost to Follow-up|2|||
129618591|NCT02077140|466557971|FG004|Overall Study|Lost to Follow-up|3|||
129618592|NCT02077140|466557967|FG000|Overall Study|Withdrawal by Subject|0|||
129618593|NCT02077140|466557968|FG001|Overall Study|Withdrawal by Subject|1|||
129618594|NCT02077140|466557969|FG002|Overall Study|Withdrawal by Subject|0|||
129618595|NCT02077140|466557970|FG003|Overall Study|Withdrawal by Subject|2|||
129618596|NCT02077140|466557971|FG004|Overall Study|Withdrawal by Subject|2|||
129618597|NCT00974922|466557972|FG000|Overall Study|study terminated|24|||
129618598|NCT03965689|466557973|FG000|Overall Study|Too sick to get study intervention|2|||
129618599|NCT03022084|466557974|FG000|Overall Study|Lost to Follow-up|2|||
129618600|NCT03022084|466557975|FG001|Overall Study|Lost to Follow-up|3|||
129618601|NCT01173120|466557976|FG000|Overall Study|Lack of Efficacy|2|||
129618602|NCT01173120|466557976|FG000|Overall Study|Lost to Follow-up|1|||
129618603|NCT01173120|466557976|FG000|Overall Study|Participant Decision|2|||
129618604|NCT01173120|466557976|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
129701609|NCT01373281|466869363|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
129701610|NCT01373281|466869362|FG000|Surveillance Expansion Period|Protocol Violation|9|||
129701611|NCT01373281|466869363|FG001|Surveillance Expansion Period|Protocol Violation|1|||
129701612|NCT01373281|466869362|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
129701613|NCT01373281|466869363|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
129701614|NCT01373281|466869362|FG000|Surveillance Expansion Period|Serious adverse event|3|||
129701615|NCT01373281|466869363|FG001|Surveillance Expansion Period|Serious adverse event|4|||
129701616|NCT00851084|466869364|FG000|Overall Study|Randomized but not treated|1|||
129701617|NCT00851084|466869365|FG001|Overall Study|Randomized but not treated|0|||
129701618|NCT00851084|466869364|FG000|Overall Study|Adverse Event|26|||
129701619|NCT00851084|466869365|FG001|Overall Study|Adverse Event|36|||
129701620|NCT00851084|466869364|FG000|Overall Study|Disease progression|52|||
129701621|NCT00851084|466869365|FG001|Overall Study|Disease progression|47|||
129701622|NCT00851084|466869364|FG000|Overall Study|Poor compliance to protocol|1|||
129701623|NCT00851084|466869365|FG001|Overall Study|Poor compliance to protocol|1|||
129701624|NCT00851084|466869364|FG000|Overall Study|Physician Decision|13|||
129701625|NCT00851084|466869365|FG001|Overall Study|Physician Decision|14|||
129701626|NCT00851084|466869364|FG000|Overall Study|Consent withdrawn|0|||
129701627|NCT00851084|466869365|FG001|Overall Study|Consent withdrawn|2|||
129701628|NCT00851084|466869364|FG000|Overall Study|Withdrawal by Subject|11|||
129792607|NCT04393298|467209130|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792608|NCT04393298|467209131|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792609|NCT04393298|467209132|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792610|NCT04393298|467209133|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792611|NCT04393298|467209134|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792612|NCT04393298|467209135|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792613|NCT04393298|467209136|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792614|NCT04393298|467209137|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792615|NCT04393298|467209138|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792616|NCT04393298|467209139|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
129792617|NCT04393298|467209125|FG000|Overall Study|Progressive Disease (PD)|0|||
129792618|NCT04393298|467209126|FG001|Overall Study|Progressive Disease (PD)|0|||
129792619|NCT04393298|467209127|FG002|Overall Study|Progressive Disease (PD)|0|||
129792620|NCT04393298|467209128|FG003|Overall Study|Progressive Disease (PD)|3|||
129792621|NCT04393298|467209129|FG004|Overall Study|Progressive Disease (PD)|0|||
129792622|NCT04393298|467209130|FG005|Overall Study|Progressive Disease (PD)|0|||
129792623|NCT04393298|467209131|FG006|Overall Study|Progressive Disease (PD)|0|||
129792624|NCT04393298|467209132|FG007|Overall Study|Progressive Disease (PD)|0|||
129792625|NCT04393298|467209133|FG008|Overall Study|Progressive Disease (PD)|0|||
129792626|NCT04393298|467209134|FG009|Overall Study|Progressive Disease (PD)|0|||
129792627|NCT04393298|467209135|FG010|Overall Study|Progressive Disease (PD)|0|||
129792628|NCT04393298|467209136|FG011|Overall Study|Progressive Disease (PD)|0|||
129792629|NCT04393298|467209137|FG012|Overall Study|Progressive Disease (PD)|0|||
129792630|NCT04393298|467209138|FG013|Overall Study|Progressive Disease (PD)|0|||
129792631|NCT04393298|467209139|FG014|Overall Study|Progressive Disease (PD)|0|||
129792632|NCT04393298|467209125|FG000|Overall Study|Started a New Cancer Treatment|0|||
129792633|NCT04393298|467209126|FG001|Overall Study|Started a New Cancer Treatment|0|||
129792634|NCT04393298|467209127|FG002|Overall Study|Started a New Cancer Treatment|0|||
129792635|NCT04393298|467209128|FG003|Overall Study|Started a New Cancer Treatment|0|||
129792636|NCT04393298|467209129|FG004|Overall Study|Started a New Cancer Treatment|1|||
129792637|NCT04393298|467209130|FG005|Overall Study|Started a New Cancer Treatment|0|||
129792638|NCT04393298|467209131|FG006|Overall Study|Started a New Cancer Treatment|0|||
129792639|NCT04393298|467209132|FG007|Overall Study|Started a New Cancer Treatment|0|||
129792640|NCT04393298|467209133|FG008|Overall Study|Started a New Cancer Treatment|0|||
129792641|NCT04393298|467209134|FG009|Overall Study|Started a New Cancer Treatment|0|||
129792642|NCT04393298|467209135|FG010|Overall Study|Started a New Cancer Treatment|0|||
129792643|NCT04393298|467209136|FG011|Overall Study|Started a New Cancer Treatment|0|||
129792644|NCT04393298|467209137|FG012|Overall Study|Started a New Cancer Treatment|0|||
129792645|NCT04393298|467209138|FG013|Overall Study|Started a New Cancer Treatment|0|||
129792646|NCT04393298|467209139|FG014|Overall Study|Started a New Cancer Treatment|0|||
129792647|NCT04393298|467209125|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792648|NCT04393298|467209126|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792649|NCT04393298|467209127|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129701629|NCT00851084|466869365|FG001|Overall Study|Withdrawal by Subject|12|||
129701630|NCT00851084|466869364|FG000|Overall Study|Metastatic surgery|6|||
129701631|NCT00851084|466869365|FG001|Overall Study|Metastatic surgery|6|||
129701632|NCT00851084|466869364|FG000|Overall Study|Other|7|||
129701633|NCT00851084|466869365|FG001|Overall Study|Other|1|||
129701634|NCT00734032|466869366|FG000|Overall Study|Adverse Event|0|||
129701635|NCT00734032|466869367|FG001|Overall Study|Adverse Event|1|||
129792650|NCT04393298|467209128|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792651|NCT04393298|467209129|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
129887849|NCT03249376|467547309|FG001|Overall Study|LTFU|1|||
129887850|NCT01154036|467547310|FG000|Phase I|Physician Decision|0|||
129887851|NCT01154036|467547311|FG001|Phase I|Physician Decision|1|||
129887852|NCT01154036|467547312|FG002|Phase I|Physician Decision|0|||
129887853|NCT01154036|467547313|FG003|Phase I|Physician Decision|0|||
129887854|NCT01154036|467547314|FG004|Phase I|Physician Decision|0|||
129887855|NCT01154036|467547315|FG005|Phase I|Physician Decision|0|||
129887856|NCT01154036|467547316|FG006|Phase I|Physician Decision|0|||
129887857|NCT01154036|467547317|FG007|Phase I|Physician Decision|0|||
129887858|NCT01154036|467547310|FG000|Phase I|Lost to Follow-up|0|||
129887859|NCT01154036|467547311|FG001|Phase I|Lost to Follow-up|3|||
129887860|NCT01154036|467547312|FG002|Phase I|Lost to Follow-up|6|||
129887861|NCT01154036|467547313|FG003|Phase I|Lost to Follow-up|0|||
129887862|NCT01154036|467547314|FG004|Phase I|Lost to Follow-up|0|||
129887863|NCT01154036|467547315|FG005|Phase I|Lost to Follow-up|0|||
129887864|NCT01154036|467547316|FG006|Phase I|Lost to Follow-up|0|||
129887865|NCT01154036|467547317|FG007|Phase I|Lost to Follow-up|0|||
129887866|NCT01154036|467547310|FG000|Phase I|Protocol Violation|0|||
129887867|NCT01154036|467547311|FG001|Phase I|Protocol Violation|3|||
129887868|NCT01154036|467547312|FG002|Phase I|Protocol Violation|9|||
129887869|NCT01154036|467547313|FG003|Phase I|Protocol Violation|0|||
129887870|NCT01154036|467547314|FG004|Phase I|Protocol Violation|0|||
129887871|NCT01154036|467547315|FG005|Phase I|Protocol Violation|0|||
129887872|NCT01154036|467547316|FG006|Phase I|Protocol Violation|0|||
129887873|NCT01154036|467547317|FG007|Phase I|Protocol Violation|0|||
129887874|NCT01154036|467547310|FG000|Phase I|Withdrawal by Subject|2|||
129887875|NCT01154036|467547311|FG001|Phase I|Withdrawal by Subject|10|||
129887876|NCT01154036|467547312|FG002|Phase I|Withdrawal by Subject|29|||
129887877|NCT01154036|467547313|FG003|Phase I|Withdrawal by Subject|0|||
129887878|NCT01154036|467547314|FG004|Phase I|Withdrawal by Subject|0|||
129887879|NCT01154036|467547315|FG005|Phase I|Withdrawal by Subject|0|||
129887880|NCT01154036|467547316|FG006|Phase I|Withdrawal by Subject|0|||
129887881|NCT01154036|467547317|FG007|Phase I|Withdrawal by Subject|0|||
129887882|NCT01154036|467547310|FG000|Phase I|Adverse Event|1|||
129887883|NCT01154036|467547311|FG001|Phase I|Adverse Event|11|||
129887884|NCT01154036|467547312|FG002|Phase I|Adverse Event|12|||
129887885|NCT01154036|467547313|FG003|Phase I|Adverse Event|0|||
129887886|NCT01154036|467547314|FG004|Phase I|Adverse Event|0|||
129887887|NCT01154036|467547315|FG005|Phase I|Adverse Event|0|||
129887888|NCT01154036|467547316|FG006|Phase I|Adverse Event|0|||
129887889|NCT01154036|467547317|FG007|Phase I|Adverse Event|0|||
129887890|NCT01154036|467547310|FG000|Phase II|Adverse Event|0|||
129887891|NCT01154036|467547311|FG001|Phase II|Adverse Event|0|||
129887892|NCT01154036|467547312|FG002|Phase II|Adverse Event|0|||
129887893|NCT01154036|467547313|FG003|Phase II|Adverse Event|0|||
129887894|NCT01154036|467547314|FG004|Phase II|Adverse Event|1|||
129887895|NCT01154036|467547315|FG005|Phase II|Adverse Event|1|||
129887896|NCT01154036|467547316|FG006|Phase II|Adverse Event|1|||
129887897|NCT01154036|467547317|FG007|Phase II|Adverse Event|1|||
129887898|NCT01154036|467547310|FG000|Phase II|Physician Decision|0|||
129887899|NCT01154036|467547311|FG001|Phase II|Physician Decision|0|||
129887900|NCT01154036|467547312|FG002|Phase II|Physician Decision|0|||
129887901|NCT01154036|467547313|FG003|Phase II|Physician Decision|0|||
129887902|NCT01154036|467547314|FG004|Phase II|Physician Decision|0|||
129887903|NCT01154036|467547315|FG005|Phase II|Physician Decision|0|||
129887904|NCT01154036|467547316|FG006|Phase II|Physician Decision|1|||
129887905|NCT01154036|467547317|FG007|Phase II|Physician Decision|0|||
129618605|NCT01173120|466557976|FG000|Overall Study|Switch-Participant Decision|12|||
129618606|NCT01173120|466557976|FG000|Overall Study|Switch-Difficulty With Device|12|||
129618607|NCT01207583|466557977|FG000|Overall Study|Withdrawal by Subject|0|||
129618608|NCT01207583|466557978|FG001|Overall Study|Withdrawal by Subject|3|||
129618609|NCT01207583|466557979|FG002|Overall Study|Withdrawal by Subject|1|||
129618610|NCT01207583|466557977|FG000|Overall Study|Participant failed to return|1|||
129618611|NCT01207583|466557978|FG001|Overall Study|Participant failed to return|0|||
129887906|NCT01154036|467547310|FG000|Phase II|Lost to Follow-up|0|||
129887907|NCT01154036|467547311|FG001|Phase II|Lost to Follow-up|0|||
129618612|NCT01207583|466557979|FG002|Overall Study|Participant failed to return|0|||
129887908|NCT01154036|467547312|FG002|Phase II|Lost to Follow-up|0|||
129887909|NCT01154036|467547313|FG003|Phase II|Lost to Follow-up|1|||
129887910|NCT01154036|467547314|FG004|Phase II|Lost to Follow-up|2|||
129887911|NCT01154036|467547315|FG005|Phase II|Lost to Follow-up|0|||
129887912|NCT01154036|467547316|FG006|Phase II|Lost to Follow-up|2|||
129887913|NCT01154036|467547317|FG007|Phase II|Lost to Follow-up|1|||
129887914|NCT01154036|467547310|FG000|Phase II|Protocol Violation|0|||
129887915|NCT01154036|467547311|FG001|Phase II|Protocol Violation|0|||
129887916|NCT01154036|467547312|FG002|Phase II|Protocol Violation|0|||
129887917|NCT01154036|467547313|FG003|Phase II|Protocol Violation|0|||
129618613|NCT01207583|466557977|FG000|Overall Study|Lost to Follow-up|0|||
129618614|NCT01207583|466557978|FG001|Overall Study|Lost to Follow-up|2|||
129618615|NCT01207583|466557979|FG002|Overall Study|Lost to Follow-up|0|||
129618616|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
129618617|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
129618618|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
129618619|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
129701636|NCT00734032|466869368|FG002|Overall Study|Adverse Event|0|||
129701637|NCT00734032|466869369|FG003|Overall Study|Adverse Event|0|||
129701638|NCT00133705|466869372|FG000|Overall Study|Withdrawal by Subject|2|||
129701639|NCT00133705|466869373|FG001|Overall Study|Withdrawal by Subject|3|||
129701640|NCT03440411|466869375|FG000|Overall Study|Adverse Event|0|||
129701641|NCT03440411|466869376|FG001|Overall Study|Adverse Event|0|||
129701642|NCT03440411|466869377|FG002|Overall Study|Adverse Event|1|||
129701643|NCT03440411|466869378|FG003|Overall Study|Adverse Event|0|||
129701644|NCT03440411|466869375|FG000|Overall Study|PD|2|||
129701645|NCT03440411|466869376|FG001|Overall Study|PD|1|||
129701646|NCT03440411|466869377|FG002|Overall Study|PD|1|||
129701647|NCT03440411|466869378|FG003|Overall Study|PD|1|||
129701648|NCT03440411|466869375|FG000|Overall Study|Withdrawal by Subject|1|||
129701649|NCT03440411|466869376|FG001|Overall Study|Withdrawal by Subject|0|||
129618620|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
129618621|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
129618622|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
129701650|NCT03440411|466869377|FG002|Overall Study|Withdrawal by Subject|0|||
129701651|NCT03440411|466869378|FG003|Overall Study|Withdrawal by Subject|0|||
129701652|NCT03440411|466869375|FG000|Overall Study|Closed study by sponsor|0|||
129618623|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
129618624|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
129618625|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
129618626|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
129618627|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
129618628|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
129618629|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
129618630|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
129618631|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129618632|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129618633|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129618634|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129618635|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
129618636|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
129618637|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
129618638|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
129618639|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
129618640|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
129618641|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129618642|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129792652|NCT04393298|467209130|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792653|NCT04393298|467209131|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792654|NCT04393298|467209132|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792655|NCT04393298|467209133|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792656|NCT04393298|467209134|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792657|NCT04393298|467209135|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792658|NCT04393298|467209136|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792659|NCT04393298|467209137|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792660|NCT04393298|467209138|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792661|NCT04393298|467209139|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
129792662|NCT04393298|467209125|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792663|NCT04393298|467209126|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792664|NCT04393298|467209127|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792665|NCT04393298|467209128|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792666|NCT04393298|467209129|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792667|NCT04393298|467209130|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
129792668|NCT04393298|467209131|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792669|NCT04393298|467209132|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792670|NCT04393298|467209133|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792671|NCT04393298|467209134|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792672|NCT04393298|467209135|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792673|NCT04393298|467209136|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792674|NCT04393298|467209137|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792675|NCT04393298|467209138|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792676|NCT04393298|467209139|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
129792677|NCT04393298|467209125|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792678|NCT04393298|467209126|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792679|NCT04393298|467209127|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129887918|NCT01154036|467547314|FG004|Phase II|Protocol Violation|1|||
129887919|NCT01154036|467547315|FG005|Phase II|Protocol Violation|2|||
129618643|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129618644|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129792680|NCT04393298|467209128|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792681|NCT04393298|467209129|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792682|NCT04393298|467209130|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
129618645|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
129618646|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
129618647|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
129618648|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
129618649|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
129618650|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
129618651|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129618652|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129618653|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129618654|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129618655|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
129618656|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618657|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618658|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618659|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
129618660|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618661|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618662|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618663|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618664|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618665|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
129618666|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
129618667|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
129618668|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
129618669|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
129618670|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
129618671|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
129618672|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
129618673|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
129618674|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
129618675|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
129618676|NCT03104400|466557980|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618677|NCT03104400|466557981|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618678|NCT03104400|466557982|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618679|NCT03104400|466557983|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
129618680|NCT03104400|466557984|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618681|NCT03104400|466557985|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618682|NCT03104400|466557986|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618683|NCT03104400|466557987|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618684|NCT03104400|466557988|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618685|NCT03104400|466557989|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
129618686|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
129618687|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
129618688|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
129618689|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
129618690|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
129618691|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
129618692|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
129618693|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
129618694|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
129618695|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
129618696|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129618697|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129618698|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129618699|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129618700|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
129618701|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
129618702|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
129618703|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
129618704|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
129618705|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
129618706|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129618707|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129618708|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129701653|NCT03440411|466869376|FG001|Overall Study|Closed study by sponsor|0|||
129701654|NCT03440411|466869377|FG002|Overall Study|Closed study by sponsor|0|||
129701655|NCT03440411|466869378|FG003|Overall Study|Closed study by sponsor|1|||
129701656|NCT04992273|466869379|FG000|Overall Study|Lost to Follow-up|0|||
129701657|NCT04992273|466869380|FG001|Overall Study|Lost to Follow-up|1|||
129701658|NCT00863304|466869383|FG000|Overall Study|Adverse Event|10|||
129701659|NCT00863304|466869384|FG001|Overall Study|Adverse Event|4|||
129701660|NCT00863304|466869385|FG002|Overall Study|Adverse Event|14|||
129701661|NCT00863304|466869386|FG003|Overall Study|Adverse Event|16|||
129701662|NCT00863304|466869383|FG000|Overall Study|Lost to Follow-up|1|||
129701663|NCT00863304|466869384|FG001|Overall Study|Lost to Follow-up|5|||
129701664|NCT00863304|466869385|FG002|Overall Study|Lost to Follow-up|4|||
129701665|NCT00863304|466869386|FG003|Overall Study|Lost to Follow-up|2|||
129701666|NCT00863304|466869383|FG000|Overall Study|Lack of Efficacy|57|||
129701667|NCT00863304|466869384|FG001|Overall Study|Lack of Efficacy|26|||
129701668|NCT00863304|466869385|FG002|Overall Study|Lack of Efficacy|30|||
129701669|NCT00863304|466869386|FG003|Overall Study|Lack of Efficacy|28|||
129701670|NCT00863304|466869383|FG000|Overall Study|Withdrawal by Subject|19|||
129701671|NCT00863304|466869384|FG001|Overall Study|Withdrawal by Subject|14|||
129701672|NCT00863304|466869385|FG002|Overall Study|Withdrawal by Subject|20|||
129701673|NCT00863304|466869386|FG003|Overall Study|Withdrawal by Subject|18|||
129701674|NCT00863304|466869383|FG000|Overall Study|Other|1|||
129701675|NCT00863304|466869384|FG001|Overall Study|Other|0|||
129701676|NCT00863304|466869385|FG002|Overall Study|Other|0|||
129701677|NCT00863304|466869386|FG003|Overall Study|Other|1|||
129701678|NCT00863304|466869383|FG000|Overall Study|Protocol Violation|2|||
129701679|NCT00863304|466869384|FG001|Overall Study|Protocol Violation|6|||
129701680|NCT00863304|466869385|FG002|Overall Study|Protocol Violation|2|||
129701681|NCT00863304|466869386|FG003|Overall Study|Protocol Violation|0|||
129701682|NCT00863304|466869383|FG000|Overall Study|Randomized, but not Treated|3|||
129701683|NCT00863304|466869384|FG001|Overall Study|Randomized, but not Treated|1|||
129701684|NCT00863304|466869385|FG002|Overall Study|Randomized, but not Treated|4|||
129701685|NCT00863304|466869386|FG003|Overall Study|Randomized, but not Treated|1|||
129701686|NCT00863304|466869383|FG000|Overall Study|Entered extension study|101|||
129701687|NCT00863304|466869384|FG001|Overall Study|Entered extension study|129|||
129701688|NCT00863304|466869385|FG002|Overall Study|Entered extension study|113|||
129701689|NCT00863304|466869386|FG003|Overall Study|Entered extension study|125|||
129701690|NCT03528902|466869389|FG000|Overall Study|Adverse Event|1|||
129618709|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129618710|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
129618711|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
129618712|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
129618713|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
129618714|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
129618715|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
129618716|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129618717|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129618718|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129618719|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129618720|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
129618721|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
129618722|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
129618723|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
129618724|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
129618725|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
129618726|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129618727|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129701691|NCT03528902|466869390|FG001|Overall Study|Adverse Event|0|||
129701692|NCT05030766|466869391|FG000|Phase 1 Participants|Lost to Follow-up|12|||
129701693|NCT05030766|466869392|FG001|Phase 1 Participants|Lost to Follow-up|22|||
129701694|NCT05030766|466869393|FG002|Phase 1 Participants|Lost to Follow-up|0|||
129701695|NCT05030766|466869394|FG003|Phase 1 Participants|Lost to Follow-up|0|||
129792683|NCT04393298|467209131|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129701696|NCT05030766|466869391|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
129701697|NCT05030766|466869392|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
129701698|NCT05030766|466869393|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
129701699|NCT05030766|466869394|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
129618728|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129618729|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129618730|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129618731|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129618732|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
129618733|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
129618734|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
129618735|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
129618736|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618737|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618738|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618739|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618740|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618741|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618742|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618743|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
129618744|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
129618745|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
129618746|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
129618747|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
129618748|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
129618749|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
129618750|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
129618751|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
129618752|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
129618753|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
129618754|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
129618755|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
129618756|NCT03104400|466557980|FG000|Period 2 Week 56 - 260)|Other|0|||
129618757|NCT03104400|466557981|FG001|Period 2 Week 56 - 260)|Other|0|||
129618758|NCT03104400|466557982|FG002|Period 2 Week 56 - 260)|Other|0|||
129618759|NCT03104400|466557983|FG003|Period 2 Week 56 - 260)|Other|0|||
129618760|NCT03104400|466557984|FG004|Period 2 Week 56 - 260)|Other|0|||
129618761|NCT03104400|466557985|FG005|Period 2 Week 56 - 260)|Other|0|||
129618762|NCT03104400|466557986|FG006|Period 2 Week 56 - 260)|Other|0|||
129618763|NCT03104400|466557987|FG007|Period 2 Week 56 - 260)|Other|0|||
129618764|NCT03104400|466557988|FG008|Period 2 Week 56 - 260)|Other|1|||
129618765|NCT03104400|466557989|FG009|Period 2 Week 56 - 260)|Other|1|||
129618766|NCT04948333|466557990|FG000|Overall Study|Adverse Event|6|||
129618767|NCT04948333|466557991|FG001|Overall Study|Adverse Event|4|||
129618768|NCT04948333|466557992|FG002|Overall Study|Adverse Event|0|||
129618769|NCT04948333|466557993|FG003|Overall Study|Adverse Event|2|||
129618770|NCT04948333|466557990|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
129618771|NCT04948333|466557991|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129618772|NCT04948333|466557992|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129887920|NCT01154036|467547316|FG006|Phase II|Protocol Violation|0|||
129618773|NCT04948333|466557993|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129618774|NCT04948333|466557990|FG000|Overall Study|Progressive Disease|1|||
129618775|NCT04948333|466557991|FG001|Overall Study|Progressive Disease|5|||
129618776|NCT04948333|466557992|FG002|Overall Study|Progressive Disease|0|||
129618777|NCT04948333|466557993|FG003|Overall Study|Progressive Disease|0|||
129618778|NCT04948333|466557990|FG000|Overall Study|Physician Decision|2|||
129618779|NCT04948333|466557991|FG001|Overall Study|Physician Decision|2|||
129618780|NCT04948333|466557992|FG002|Overall Study|Physician Decision|0|||
129618781|NCT04948333|466557993|FG003|Overall Study|Physician Decision|0|||
129618782|NCT04948333|466557990|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
129618783|NCT04948333|466557991|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
129618784|NCT04948333|466557992|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
129618785|NCT04948333|466557993|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
129618786|NCT04948333|466557990|FG000|Overall Study|Withdrawal by Subject|2|||
129618787|NCT04948333|466557991|FG001|Overall Study|Withdrawal by Subject|0|||
129618788|NCT04948333|466557992|FG002|Overall Study|Withdrawal by Subject|0|||
129618789|NCT04948333|466557993|FG003|Overall Study|Withdrawal by Subject|1|||
129618790|NCT04948333|466557990|FG000|Overall Study|Protocol Violation|0|||
129618791|NCT04948333|466557991|FG001|Overall Study|Protocol Violation|1|||
129618792|NCT04948333|466557992|FG002|Overall Study|Protocol Violation|0|||
129618793|NCT04948333|466557993|FG003|Overall Study|Protocol Violation|0|||
129701700|NCT05030766|466869391|FG000|Phase 2 Participants|Lost to Follow-up|0|||
129701701|NCT05030766|466869392|FG001|Phase 2 Participants|Lost to Follow-up|0|||
129701702|NCT05030766|466869393|FG002|Phase 2 Participants|Lost to Follow-up|6|||
129701703|NCT05030766|466869394|FG003|Phase 2 Participants|Lost to Follow-up|2|||
129701704|NCT00645658|466869395|FG000|Overall Study|Withdrawal by Subject|1|||
129701705|NCT00645658|466869396|FG001|Overall Study|Withdrawal by Subject|0|||
129701706|NCT00645658|466869395|FG000|Overall Study|Did not complete all assesments|0|||
129701707|NCT00645658|466869396|FG001|Overall Study|Did not complete all assesments|2|||
129701708|NCT00023595|466869397|FG000|5 Year Follow up|Lost to Follow-up|2|||
129701709|NCT00023595|466869398|FG001|5 Year Follow up|Lost to Follow-up|2|||
129701710|NCT00023595|466869399|FG002|5 Year Follow up|Lost to Follow-up|1|||
129701711|NCT00023595|466869400|FG003|5 Year Follow up|Lost to Follow-up|7|||
129701712|NCT00023595|466869401|FG004|5 Year Follow up|Lost to Follow-up|3|||
129792684|NCT04393298|467209132|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792685|NCT04393298|467209133|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792686|NCT04393298|467209134|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792687|NCT04393298|467209135|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792688|NCT04393298|467209136|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792689|NCT04393298|467209137|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129618794|NCT04948333|466557990|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
129618795|NCT04948333|466557991|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
129618796|NCT04948333|466557992|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
129618797|NCT04948333|466557993|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
129618798|NCT02129608|466557994|FG000|Overall Study|Lost to Follow-up|0|||
129618799|NCT02129608|466557995|FG001|Overall Study|Lost to Follow-up|1|||
129618800|NCT02129608|466557996|FG002|Overall Study|Lost to Follow-up|1|||
129618801|NCT02129608|466557994|FG000|Overall Study|Withdrawal by Subject|0|||
129618802|NCT02129608|466557995|FG001|Overall Study|Withdrawal by Subject|0|||
129618803|NCT02129608|466557996|FG002|Overall Study|Withdrawal by Subject|2|||
129618804|NCT03055624|466557997|FG000|Overall Study|Study closed|9|||
129618805|NCT02794870|466558001|FG000|Overall Study|Withdrawal by Subject|2|||
129618806|NCT02794870|466558002|FG001|Overall Study|Withdrawal by Subject|0|||
129618807|NCT02437903|466558003|FG000|Overall Study|Adverse Event|1|||
129618808|NCT02437903|466558003|FG000|Overall Study|Withdrawal by Subject|1|||
129618809|NCT02437903|466558003|FG000|Overall Study|Lost to Follow-up|3|||
129618810|NCT04414618|466558007|FG000|Overall Study|Death|3|||
129618811|NCT04414618|466558008|FG001|Overall Study|Death|3|||
129618812|NCT04414618|466558007|FG000|Overall Study|Withdrawal by Subject|2|||
129618813|NCT04414618|466558008|FG001|Overall Study|Withdrawal by Subject|1|||
129618814|NCT04414618|466558007|FG000|Overall Study|Lost to Follow-up|2|||
129792690|NCT04393298|467209138|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
129792691|NCT04393298|467209139|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
129792692|NCT04393298|467209125|FG000|Overall Study|Death|0|||
129792693|NCT04393298|467209126|FG001|Overall Study|Death|0|||
129792694|NCT04393298|467209127|FG002|Overall Study|Death|0|||
129792695|NCT04393298|467209128|FG003|Overall Study|Death|0|||
129792696|NCT04393298|467209129|FG004|Overall Study|Death|0|||
129792697|NCT04393298|467209130|FG005|Overall Study|Death|1|||
129792698|NCT04393298|467209131|FG006|Overall Study|Death|1|||
129792699|NCT04393298|467209132|FG007|Overall Study|Death|0|||
129439277|NCT00876694|465906414|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129439278|NCT00876694|465906415|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129618815|NCT04414618|466558008|FG001|Overall Study|Lost to Follow-up|3|||
129618816|NCT04414618|466558007|FG000|Overall Study|Physician Decision|1|||
129618817|NCT04414618|466558008|FG001|Overall Study|Physician Decision|0|||
129618818|NCT00658879|466558009|FG000|Overall Study|Protocol Violation|1|||
129618819|NCT00616421|466558010|FG000|Overall Study|Withdrawal by Subject|9|||
129618820|NCT00616421|466558011|FG001|Overall Study|Withdrawal by Subject|11|||
129618821|NCT00616421|466558012|FG002|Overall Study|Withdrawal by Subject|8|||
129618822|NCT00616421|466558010|FG000|Overall Study|Lost to Follow-up|12|||
129618823|NCT00616421|466558011|FG001|Overall Study|Lost to Follow-up|26|||
129618824|NCT00616421|466558012|FG002|Overall Study|Lost to Follow-up|30|||
129618825|NCT00616421|466558010|FG000|Overall Study|Inappropriate enrollment|3|||
129618826|NCT00616421|466558011|FG001|Overall Study|Inappropriate enrollment|0|||
129618827|NCT00616421|466558012|FG002|Overall Study|Inappropriate enrollment|1|||
129618828|NCT00616421|466558010|FG000|Overall Study|Administrative reason|1|||
129618829|NCT00616421|466558011|FG001|Overall Study|Administrative reason|0|||
129618830|NCT00616421|466558012|FG002|Overall Study|Administrative reason|0|||
129618831|NCT00616421|466558010|FG000|Overall Study|Protocol Violation|0|||
129618832|NCT00616421|466558011|FG001|Overall Study|Protocol Violation|1|||
129618833|NCT00616421|466558012|FG002|Overall Study|Protocol Violation|2|||
129618834|NCT00616421|466558010|FG000|Overall Study|Unable to classify|1|||
129618835|NCT00616421|466558011|FG001|Overall Study|Unable to classify|0|||
129618836|NCT00616421|466558012|FG002|Overall Study|Unable to classify|0|||
129618837|NCT02661217|466558013|FG000|Overall Study|Physician Decision|12|||
129618838|NCT02661217|466558014|FG001|Overall Study|Physician Decision|15|||
129618839|NCT02661217|466558013|FG000|Overall Study|Lost to Follow-up|1|||
129618840|NCT02661217|466558014|FG001|Overall Study|Lost to Follow-up|4|||
129618841|NCT02661217|466558013|FG000|Overall Study|Protocol Deviation|0|||
129618842|NCT02661217|466558014|FG001|Overall Study|Protocol Deviation|4|||
129618843|NCT02661217|466558013|FG000|Overall Study|Non-compliance with study treatment|5|||
129618844|NCT02661217|466558014|FG001|Overall Study|Non-compliance with study treatment|5|||
129618845|NCT02661217|466558013|FG000|Overall Study|Death|21|||
129618846|NCT02661217|466558014|FG001|Overall Study|Death|15|||
129618847|NCT02661217|466558013|FG000|Overall Study|Adverse Event|10|||
129618848|NCT02661217|466558014|FG001|Overall Study|Adverse Event|8|||
129618849|NCT02661217|466558013|FG000|Overall Study|Withdrawal by Subject|15|||
129618850|NCT02661217|466558014|FG001|Overall Study|Withdrawal by Subject|19|||
129618851|NCT02661217|466558013|FG000|Overall Study|Did not enter follow-up epoch|7|||
129792700|NCT04393298|467209133|FG008|Overall Study|Death|1|||
129792701|NCT04393298|467209134|FG009|Overall Study|Death|1|||
129792702|NCT04393298|467209135|FG010|Overall Study|Death|0|||
129792703|NCT04393298|467209136|FG011|Overall Study|Death|1|||
129792704|NCT04393298|467209137|FG012|Overall Study|Death|1|||
129792705|NCT04393298|467209138|FG013|Overall Study|Death|0|||
129792706|NCT04393298|467209139|FG014|Overall Study|Death|1|||
129792707|NCT04393298|467209125|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129618852|NCT02661217|466558014|FG001|Overall Study|Did not enter follow-up epoch|10|||
129618853|NCT02661217|466558013|FG000|Overall Study|Death - no study drug received|1|||
129618854|NCT02661217|466558014|FG001|Overall Study|Death - no study drug received|2|||
129618855|NCT02661217|466558013|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
129618856|NCT02661217|466558014|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
129618857|NCT02604407|466558017|FG000|Overall Study|Adverse Event|0|||
129439279|NCT00876694|465906414|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129439280|NCT00876694|465906415|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129439281|NCT00876694|465906414|FG000|Overall Study|Administrative problems|1|||
129439282|NCT00876694|465906415|FG001|Overall Study|Administrative problems|1|||
129439283|NCT00876694|465906414|FG000|Overall Study|Death|1|||
129439284|NCT00876694|465906415|FG001|Overall Study|Death|0|||
129439285|NCT00288509|465906416|FG000|Treatment Cycle 1|Adverse Event|1|||
129439286|NCT00288509|465906416|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
129439287|NCT00288509|465906416|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
129439288|NCT00288509|465906416|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
129439289|NCT00288509|465906416|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
129439290|NCT00288509|465906416|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
129439291|NCT00288509|465906416|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
129439292|NCT00288509|465906416|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
129439293|NCT00288509|465906416|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
129439294|NCT00288509|465906416|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
129439295|NCT00288509|465906416|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
129439296|NCT00288509|465906416|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
129439297|NCT00288509|465906416|FG000|Treatment Cycle 4|Physician Decision|4|||
129439298|NCT00288509|465906416|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
129439299|NCT01215422|465906421|FG000|Overall Study|Relocation|1|||
129439300|NCT01215422|465906422|FG001|Overall Study|Relocation|0|||
129618858|NCT02604407|466558018|FG001|Overall Study|Adverse Event|7|||
129439301|NCT01215422|465906423|FG002|Overall Study|Relocation|0|||
129439302|NCT01215422|465906424|FG003|Overall Study|Relocation|0|||
129618859|NCT02604407|466558019|FG002|Overall Study|Adverse Event|5|||
129618860|NCT02604407|466558017|FG000|Overall Study|Protocol Violation|2|||
129792708|NCT04393298|467209126|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129439303|NCT01215422|465906421|FG000|Overall Study|Failed intubations|0|||
129439304|NCT01215422|465906422|FG001|Overall Study|Failed intubations|0|||
129439305|NCT01215422|465906423|FG002|Overall Study|Failed intubations|3|||
129439306|NCT01215422|465906424|FG003|Overall Study|Failed intubations|8|||
129439307|NCT01215422|465906421|FG000|Overall Study|Did not complete all intubations|7|||
129439308|NCT01215422|465906422|FG001|Overall Study|Did not complete all intubations|0|||
129439309|NCT01215422|465906423|FG002|Overall Study|Did not complete all intubations|0|||
129439310|NCT01215422|465906424|FG003|Overall Study|Did not complete all intubations|0|||
129439311|NCT00294554|465906427|FG000|Overall Study|Lack of Efficacy|0|||
129439312|NCT00294554|465906428|FG001|Overall Study|Lack of Efficacy|1|||
129439313|NCT00294554|465906427|FG000|Overall Study|Physician Decision|0|||
129439314|NCT00294554|465906428|FG001|Overall Study|Physician Decision|1|||
129439315|NCT00462865|465906429|FG000|Overall Study|Adverse Event|1|||
129439316|NCT02864381|465906430|FG000|Overall Study|Death|58|||
129439317|NCT02864381|465906431|FG001|Overall Study|Death|61|||
129439318|NCT02864381|465906430|FG000|Overall Study|Withdrew Consent|5|||
129439319|NCT02864381|465906431|FG001|Overall Study|Withdrew Consent|6|||
129439320|NCT02864381|465906430|FG000|Overall Study|Reason Unknown|7|||
129439321|NCT02864381|465906431|FG001|Overall Study|Reason Unknown|3|||
129439322|NCT02864381|465906430|FG000|Overall Study|Lost to Follow-up|1|||
129439323|NCT02864381|465906431|FG001|Overall Study|Lost to Follow-up|1|||
129439324|NCT02864381|465906430|FG000|Overall Study|Investigator's Discretion|1|||
129439325|NCT02864381|465906431|FG001|Overall Study|Investigator's Discretion|0|||
129439326|NCT02864381|465906430|FG000|Overall Study|Protocol Violation|0|||
129439327|NCT02864381|465906431|FG001|Overall Study|Protocol Violation|1|||
129439328|NCT04142450|465906432|FG000|Overall Study|Screen Failure|1|||
129439329|NCT04142450|465906432|FG000|Overall Study|Lost to Follow-up|1|||
129439330|NCT01146054|465906435|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
129439331|NCT01146054|465906435|FG000|Overall Study|Rapid tumor progression|2|||
129439332|NCT01146054|465906435|FG000|Overall Study|Other illness precluded treatment|2|||
129439333|NCT01146054|465906435|FG000|Overall Study|Lost to Follow-up|1|||
129439334|NCT04335812|465906436|FG000|Overall Study|Withdrawal by Subject|1|||
129439335|NCT04335812|465906437|FG001|Overall Study|Withdrawal by Subject|3|||
129439336|NCT04335812|465906436|FG000|Overall Study|Lost to Follow-up|12|||
129618861|NCT02604407|466558018|FG001|Overall Study|Protocol Violation|0|||
129618862|NCT02604407|466558019|FG002|Overall Study|Protocol Violation|0|||
129618863|NCT02604407|466558017|FG000|Overall Study|Withdrawal by Subject|3|||
129618864|NCT02604407|466558018|FG001|Overall Study|Withdrawal by Subject|3|||
129618865|NCT02604407|466558019|FG002|Overall Study|Withdrawal by Subject|5|||
129618866|NCT02604407|466558017|FG000|Overall Study|Lost to Follow-up|2|||
129618867|NCT02604407|466558018|FG001|Overall Study|Lost to Follow-up|1|||
129618868|NCT02604407|466558019|FG002|Overall Study|Lost to Follow-up|2|||
129439337|NCT04335812|465906437|FG001|Overall Study|Lost to Follow-up|12|||
129439338|NCT04335812|465906436|FG000|Overall Study|Did not engage in the intervention|22|||
129439339|NCT04335812|465906437|FG001|Overall Study|Did not engage in the intervention|18|||
129618869|NCT02604407|466558017|FG000|Overall Study|Lack of Efficacy|1|||
129618870|NCT02604407|466558018|FG001|Overall Study|Lack of Efficacy|0|||
129618871|NCT02604407|466558019|FG002|Overall Study|Lack of Efficacy|0|||
129618872|NCT02604407|466558017|FG000|Overall Study|Other|3|||
129618873|NCT02604407|466558018|FG001|Overall Study|Other|1|||
129618874|NCT02604407|466558019|FG002|Overall Study|Other|4|||
129618875|NCT00185588|466558020|FG000|Overall Study|Adverse Event|3|||
129618876|NCT00185588|466558021|FG001|Overall Study|Adverse Event|1|||
129618877|NCT00185588|466558022|FG002|Overall Study|Adverse Event|4|||
129618878|NCT00185588|466558023|FG003|Overall Study|Adverse Event|2|||
129618879|NCT00185588|466558020|FG000|Overall Study|Lost to Follow-up|0|||
129618880|NCT00185588|466558021|FG001|Overall Study|Lost to Follow-up|0|||
129618881|NCT00185588|466558022|FG002|Overall Study|Lost to Follow-up|1|||
129618882|NCT00185588|466558023|FG003|Overall Study|Lost to Follow-up|2|||
129618883|NCT00185588|466558020|FG000|Overall Study|Withdrawal by Subject|0|||
129618884|NCT00185588|466558021|FG001|Overall Study|Withdrawal by Subject|1|||
129618885|NCT00185588|466558022|FG002|Overall Study|Withdrawal by Subject|0|||
129618886|NCT00185588|466558023|FG003|Overall Study|Withdrawal by Subject|0|||
129618887|NCT00185588|466558020|FG000|Overall Study|Physician Decision|0|||
129618888|NCT00185588|466558021|FG001|Overall Study|Physician Decision|0|||
129618889|NCT00185588|466558022|FG002|Overall Study|Physician Decision|1|||
129618890|NCT00185588|466558023|FG003|Overall Study|Physician Decision|0|||
129618891|NCT03908437|466558024|FG000|Overall Study|Death|0|||
129618892|NCT03908437|466558025|FG001|Overall Study|Death|1|||
129618893|NCT03908437|466558024|FG000|Overall Study|Lost to Follow-up|31|||
129618894|NCT03908437|466558025|FG001|Overall Study|Lost to Follow-up|24|||
129618895|NCT05445492|466558026|FG000|Overall Study|Physician Decision|1|||
129618896|NCT00191191|466558027|FG000|Overall Study|Entry Criteria Exclusion|2|||
129618897|NCT00191191|466558028|FG001|Overall Study|Entry Criteria Exclusion|0|||
129618898|NCT00191191|466558027|FG000|Overall Study|Treated with Another Systemic Agent|1|||
129618899|NCT00191191|466558028|FG001|Overall Study|Treated with Another Systemic Agent|1|||
129618900|NCT00191191|466558027|FG000|Overall Study|Adverse Event|11|||
129618901|NCT00191191|466558028|FG001|Overall Study|Adverse Event|21|||
129792709|NCT04393298|467209127|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792710|NCT04393298|467209128|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792711|NCT04393298|467209129|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792712|NCT04393298|467209130|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
129792713|NCT04393298|467209131|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792714|NCT04393298|467209132|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792715|NCT04393298|467209133|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792716|NCT04393298|467209134|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792717|NCT04393298|467209135|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792718|NCT04393298|467209136|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792719|NCT04393298|467209137|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792720|NCT04393298|467209138|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792721|NCT04393298|467209139|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
129792722|NCT04393298|467209125|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
129792723|NCT04393298|467209126|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
129792724|NCT04393298|467209127|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
129792725|NCT04393298|467209128|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
129792726|NCT04393298|467209129|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
129792727|NCT04393298|467209130|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
129792728|NCT04393298|467209131|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
129792729|NCT04393298|467209132|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
129792730|NCT04393298|467209133|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
129792731|NCT04393298|467209134|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
129792732|NCT04393298|467209135|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
129792733|NCT04393298|467209136|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
129792734|NCT04393298|467209137|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
129618902|NCT00191191|466558027|FG000|Overall Study|Progressive Disease|84|||
129618903|NCT00191191|466558028|FG001|Overall Study|Progressive Disease|72|||
129618904|NCT00191191|466558027|FG000|Overall Study|Toxicity After Dose Reduction|7|||
129618905|NCT00191191|466558028|FG001|Overall Study|Toxicity After Dose Reduction|8|||
129618906|NCT00191191|466558027|FG000|Overall Study|Family/Caregiver Decision|5|||
129618907|NCT00191191|466558028|FG001|Overall Study|Family/Caregiver Decision|7|||
129792735|NCT04393298|467209138|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
129792736|NCT04393298|467209139|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
129792737|NCT04393298|467209125|FG000|Overall Study|Patient Passed Away|0|||
129792738|NCT04393298|467209126|FG001|Overall Study|Patient Passed Away|0|||
129792739|NCT04393298|467209127|FG002|Overall Study|Patient Passed Away|0|||
129792740|NCT04393298|467209128|FG003|Overall Study|Patient Passed Away|0|||
129792741|NCT04393298|467209129|FG004|Overall Study|Patient Passed Away|0|||
129792742|NCT04393298|467209130|FG005|Overall Study|Patient Passed Away|0|||
129618908|NCT00191191|466558027|FG000|Overall Study|Lost to Follow-up|1|||
129618909|NCT00191191|466558028|FG001|Overall Study|Lost to Follow-up|0|||
129618910|NCT00191191|466558027|FG000|Overall Study|Physician Decision|3|||
129618911|NCT00191191|466558028|FG001|Overall Study|Physician Decision|2|||
129618912|NCT00191191|466558027|FG000|Overall Study|Good Clinical Practice Violation|0|||
129618913|NCT00191191|466558028|FG001|Overall Study|Good Clinical Practice Violation|1|||
129618914|NCT04289363|466558029|FG000|Overall Study|Lost to Follow-up|14|||
129618915|NCT04289363|466558030|FG001|Overall Study|Lost to Follow-up|0|||
129439340|NCT03840486|465906453|FG000|Overall Study|Withdrawal by Subject|0|||
129439341|NCT03840486|465906454|FG001|Overall Study|Withdrawal by Subject|1|||
129439342|NCT03840486|465906455|FG002|Overall Study|Withdrawal by Subject|0|||
129439343|NCT03840486|465906456|FG003|Overall Study|Withdrawal by Subject|0|||
129439344|NCT03840486|465906457|FG004|Overall Study|Withdrawal by Subject|0|||
129439345|NCT03840486|465906458|FG005|Overall Study|Withdrawal by Subject|0|||
129439346|NCT03840486|465906459|FG006|Overall Study|Withdrawal by Subject|0|||
129439347|NCT03840486|465906460|FG007|Overall Study|Withdrawal by Subject|0|||
129439348|NCT03840486|465906461|FG008|Overall Study|Withdrawal by Subject|0|||
129439349|NCT03840486|465906462|FG009|Overall Study|Withdrawal by Subject|0|||
129439350|NCT03840486|465906463|FG010|Overall Study|Withdrawal by Subject|0|||
129439351|NCT03840486|465906464|FG011|Overall Study|Withdrawal by Subject|0|||
129439352|NCT01139021|465906465|FG000|Overall Study|Adverse Event|0|||
129439353|NCT01139021|465906466|FG001|Overall Study|Adverse Event|0|||
129439354|NCT01139021|465906467|FG002|Overall Study|Adverse Event|0|||
129439355|NCT01139021|465906468|FG003|Overall Study|Adverse Event|0|||
129439356|NCT01139021|465906469|FG004|Overall Study|Adverse Event|1|||
129439357|NCT01139021|465906470|FG005|Overall Study|Adverse Event|0|||
129439358|NCT01139021|465906465|FG000|Overall Study|Lost to Follow-up|0|||
129439359|NCT01139021|465906466|FG001|Overall Study|Lost to Follow-up|0|||
129439360|NCT01139021|465906467|FG002|Overall Study|Lost to Follow-up|0|||
129439361|NCT01139021|465906468|FG003|Overall Study|Lost to Follow-up|0|||
129439362|NCT01139021|465906469|FG004|Overall Study|Lost to Follow-up|2|||
129618916|NCT03348163|466558031|FG000|Overall Study|Withdrawal by Subject|2|||
129618917|NCT03348163|466558032|FG001|Overall Study|Withdrawal by Subject|0|||
129618918|NCT02585778|466558033|FG000|Overall Study|Adverse Event|17|||
129618919|NCT02585778|466558034|FG001|Overall Study|Adverse Event|4|||
129618920|NCT02585778|466558033|FG000|Overall Study|Participant did not wish to continue|9|||
129618921|NCT02585778|466558034|FG001|Overall Study|Participant did not wish to continue|4|||
129618922|NCT02585778|466558033|FG000|Overall Study|Poor compliance to study protocol|0|||
129618923|NCT02585778|466558034|FG001|Overall Study|Poor compliance to study protocol|2|||
129618924|NCT02585778|466558033|FG000|Overall Study|Death|0|||
129618925|NCT02585778|466558034|FG001|Overall Study|Death|1|||
129618926|NCT02585778|466558033|FG000|Overall Study|Randomized but not treated|1|||
129618927|NCT02585778|466558034|FG001|Overall Study|Randomized but not treated|2|||
129618928|NCT02585778|466558033|FG000|Overall Study|Other than specified above|6|||
129618929|NCT02585778|466558034|FG001|Overall Study|Other than specified above|2|||
129618930|NCT02789137|466558036|FG000|Overall Study|Dropped out/Died|58|||
129618931|NCT01482312|466558039|FG000|Period 1, 90 Minutes of Wear|Other|1|||
129618932|NCT01482312|466558040|FG001|Period 1, 90 Minutes of Wear|Other|0|||
129618933|NCT01482312|466558041|FG002|Period 1, 90 Minutes of Wear|Other|0|||
129618934|NCT01482312|466558039|FG000|Period 2, 90 Minutes of Wear|Other|1|||
129618935|NCT01482312|466558040|FG001|Period 2, 90 Minutes of Wear|Other|0|||
129618936|NCT01482312|466558041|FG002|Period 2, 90 Minutes of Wear|Other|0|||
129618937|NCT03597295|466558043|FG000|Overall Study|Death|70|||
129618938|NCT03597295|466558043|FG000|Overall Study|Lost to Follow-up|7|||
129618939|NCT00428116|466558044|FG000|Overall Study|Death|1|||
129618940|NCT00428116|466558045|FG001|Overall Study|Death|0|||
129618941|NCT00428116|466558044|FG000|Overall Study|Withdrawal by Subject|1|||
129618942|NCT00428116|466558045|FG001|Overall Study|Withdrawal by Subject|0|||
129618943|NCT00428116|466558044|FG000|Overall Study|Lost to Follow-up|1|||
129618944|NCT00428116|466558045|FG001|Overall Study|Lost to Follow-up|0|||
129618945|NCT02125877|466558046|FG000|Overall Study|Physician Decision|1|||
129618946|NCT02125877|466558047|FG001|Overall Study|Physician Decision|0|||
129618947|NCT02125877|466558046|FG000|Overall Study|Death|0|||
129618948|NCT02125877|466558047|FG001|Overall Study|Death|1|||
129618949|NCT02125877|466558046|FG000|Overall Study|Administrative problems|0|||
129618950|NCT02125877|466558047|FG001|Overall Study|Administrative problems|1|||
129618951|NCT02125877|466558046|FG000|Overall Study|Participant/guardian decision|0|||
129439363|NCT01139021|465906470|FG005|Overall Study|Lost to Follow-up|0|||
129439364|NCT01139021|465906465|FG000|Overall Study|Protocol Violation|1|||
129439365|NCT01139021|465906466|FG001|Overall Study|Protocol Violation|0|||
129618952|NCT02125877|466558047|FG001|Overall Study|Participant/guardian decision|2|||
129792743|NCT04393298|467209131|FG006|Overall Study|Patient Passed Away|0|||
129439366|NCT01139021|465906467|FG002|Overall Study|Protocol Violation|0|||
129618953|NCT02125877|466558046|FG000|Overall Study|Withdrawal by Subject|2|||
129618954|NCT02125877|466558047|FG001|Overall Study|Withdrawal by Subject|1|||
129618955|NCT02125877|466558046|FG000|Overall Study|Protocol deviation|4|||
129792744|NCT04393298|467209132|FG007|Overall Study|Patient Passed Away|1|||
129792745|NCT04393298|467209133|FG008|Overall Study|Patient Passed Away|0|||
129701713|NCT00023595|466869397|FG000|10 Year Follow up|Lost to Follow-up|12|||
129701714|NCT00023595|466869398|FG001|10 Year Follow up|Lost to Follow-up|10|||
129701715|NCT00023595|466869399|FG002|10 Year Follow up|Lost to Follow-up|3|||
129701716|NCT00023595|466869400|FG003|10 Year Follow up|Lost to Follow-up|0|||
129701717|NCT00023595|466869401|FG004|10 Year Follow up|Lost to Follow-up|0|||
129887921|NCT01154036|467547317|FG007|Phase II|Protocol Violation|0|||
129887922|NCT01154036|467547310|FG000|Phase II|Withdrawal by Subject|0|||
129887923|NCT01154036|467547311|FG001|Phase II|Withdrawal by Subject|0|||
129887924|NCT01154036|467547312|FG002|Phase II|Withdrawal by Subject|0|||
129887925|NCT01154036|467547313|FG003|Phase II|Withdrawal by Subject|0|||
129887926|NCT01154036|467547314|FG004|Phase II|Withdrawal by Subject|4|||
129887927|NCT01154036|467547315|FG005|Phase II|Withdrawal by Subject|2|||
129887928|NCT01154036|467547316|FG006|Phase II|Withdrawal by Subject|5|||
129887929|NCT01154036|467547317|FG007|Phase II|Withdrawal by Subject|4|||
129887930|NCT01555021|467547323|FG000|Overall Study|Lost to Follow-up|1|||
129887931|NCT01555021|467547324|FG001|Overall Study|Lost to Follow-up|2|||
129887932|NCT00322374|467547325|FG000|Starting Dose|Physician Decision|2|||
129887933|NCT00322374|467547326|FG001|Starting Dose|Physician Decision|0|||
129887934|NCT00322374|467547327|FG002|Starting Dose|Physician Decision|0|||
129887935|NCT00322374|467547328|FG003|Starting Dose|Physician Decision|0|||
129887936|NCT00322374|467547325|FG000|Starting Dose|Study Drug Toxicity|4|||
129887937|NCT00322374|467547326|FG001|Starting Dose|Study Drug Toxicity|0|||
129887938|NCT00322374|467547327|FG002|Starting Dose|Study Drug Toxicity|0|||
129618956|NCT02125877|466558047|FG001|Overall Study|Protocol deviation|1|||
129618957|NCT02125877|466558046|FG000|Overall Study|Adverse Event|6|||
129618958|NCT02125877|466558047|FG001|Overall Study|Adverse Event|4|||
129618959|NCT00710866|466558048|FG000|Overall Study|Protocol Violation|5|||
129618960|NCT00710866|466558049|FG001|Overall Study|Protocol Violation|4|||
129618961|NCT00710866|466558048|FG000|Overall Study|Withdrawal by Subject|2|||
129618962|NCT00710866|466558049|FG001|Overall Study|Withdrawal by Subject|1|||
129618963|NCT00710866|466558048|FG000|Overall Study|Lost to Follow-up|1|||
129618964|NCT00710866|466558049|FG001|Overall Study|Lost to Follow-up|0|||
129701718|NCT03900650|466869402|FG000|Overall Study|Withdrawal by Subject|1|||
129701719|NCT03900650|466869403|FG001|Overall Study|Withdrawal by Subject|1|||
129618965|NCT00710866|466558048|FG000|Overall Study|Failed to meet eligibility|1|||
129618966|NCT00710866|466558049|FG001|Overall Study|Failed to meet eligibility|1|||
129618967|NCT01128543|466558050|FG000|Overall Study|Withdrawal by Subject|3|||
129618968|NCT01128543|466558050|FG000|Overall Study|Protocol Violation|1|||
129618969|NCT01198132|466558054|FG000|Overall Study|Withdrawal by Subject|4|||
129618970|NCT01198132|466558055|FG001|Overall Study|Withdrawal by Subject|5|||
129618971|NCT01198132|466558054|FG000|Overall Study|Physician Decision|5|||
129618972|NCT01198132|466558055|FG001|Overall Study|Physician Decision|4|||
129618973|NCT01198132|466558054|FG000|Overall Study|Other Unspecified|3|||
129618974|NCT01198132|466558055|FG001|Overall Study|Other Unspecified|6|||
129618975|NCT01198132|466558054|FG000|Overall Study|Lack of Efficacy|2|||
129618976|NCT01198132|466558055|FG001|Overall Study|Lack of Efficacy|3|||
129618977|NCT01198132|466558054|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
129618978|NCT01198132|466558055|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
129618979|NCT01198132|466558054|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
129618980|NCT01198132|466558055|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
129618981|NCT01198132|466558054|FG000|Overall Study|Adverse Event|0|||
129618982|NCT01198132|466558055|FG001|Overall Study|Adverse Event|1|||
129618983|NCT01198132|466558054|FG000|Overall Study|Protocol Violation|1|||
129618984|NCT01198132|466558055|FG001|Overall Study|Protocol Violation|0|||
129618985|NCT03516513|466558056|FG000|Overall Study|Withdrawal by Subject|2|||
129618986|NCT03516513|466558057|FG001|Overall Study|Withdrawal by Subject|2|||
129618987|NCT03516513|466558058|FG002|Overall Study|Withdrawal by Subject|0|||
129618988|NCT03516513|466558059|FG003|Overall Study|Withdrawal by Subject|0|||
129618989|NCT01098487|466558061|FG000|Overall Study|Adverse Event|22|||
129701720|NCT03900650|466869404|FG002|Overall Study|Withdrawal by Subject|0|||
129701721|NCT03900650|466869405|FG003|Overall Study|Withdrawal by Subject|0|||
129887939|NCT00322374|467547328|FG003|Starting Dose|Study Drug Toxicity|0|||
129701722|NCT03900650|466869402|FG000|Overall Study|Withdrawn by staff|1|||
129701723|NCT03900650|466869403|FG001|Overall Study|Withdrawn by staff|0|||
129701724|NCT03900650|466869404|FG002|Overall Study|Withdrawn by staff|0|||
129701725|NCT03900650|466869405|FG003|Overall Study|Withdrawn by staff|0|||
129701726|NCT02082977|466869406|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
129701727|NCT02082977|466869407|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
129701728|NCT02082977|466869408|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
129701729|NCT02082977|466869409|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
129701730|NCT02082977|466869410|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
129701731|NCT02082977|466869411|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
129701732|NCT02082977|466869412|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
129701733|NCT02082977|466869413|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
129701734|NCT02082977|466869414|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
129701735|NCT02082977|466869415|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
129701736|NCT02082977|466869406|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129701737|NCT02082977|466869407|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129439367|NCT01139021|465906468|FG003|Overall Study|Protocol Violation|0|||
129618990|NCT01098487|466558061|FG000|Overall Study|Lack of Efficacy|11|||
129618991|NCT01098487|466558061|FG000|Overall Study|Withdrawal by Subject|7|||
129618992|NCT01098487|466558061|FG000|Overall Study|Lost to Follow-up|3|||
129618993|NCT01098487|466558061|FG000|Overall Study|Physician Decision|1|||
129618994|NCT00345631|466558062|FG000|Overall Study|Withdrawal by Subject|1|||
129618995|NCT00345631|466558063|FG001|Overall Study|Withdrawal by Subject|0|||
129618996|NCT00345631|466558064|FG002|Overall Study|Withdrawal by Subject|1|||
129618997|NCT00345631|466558062|FG000|Overall Study|Adverse Event|0|||
129618998|NCT00345631|466558063|FG001|Overall Study|Adverse Event|1|||
129618999|NCT00345631|466558064|FG002|Overall Study|Adverse Event|0|||
129619000|NCT00345631|466558062|FG000|Overall Study|Lost to Follow-up|3|||
129619001|NCT00345631|466558063|FG001|Overall Study|Lost to Follow-up|7|||
129619002|NCT00345631|466558064|FG002|Overall Study|Lost to Follow-up|4|||
129619003|NCT00345631|466558062|FG000|Overall Study|Other reasons|0|||
129619004|NCT00345631|466558063|FG001|Overall Study|Other reasons|0|||
129619005|NCT00345631|466558064|FG002|Overall Study|Other reasons|1|||
129619006|NCT01301729|466558065|FG000|Overall Study|Withdrawal by Subject|2|||
129619007|NCT01301729|466558065|FG000|Overall Study|Participant did not Return for Treatment|1|||
129619008|NCT01301729|466558065|FG000|Overall Study|Violated Selection Criteria|1|||
129619009|NCT03071276|466558066|FG000|Overall Study|Adverse Event|1|||
129619010|NCT03071276|466558066|FG000|Overall Study|Lack of Efficacy|14|||
129619011|NCT01885195|466558067|FG000|Overall Study|Adverse Event|29|||
129619012|NCT01885195|466558067|FG000|Overall Study|Death|1|||
129619013|NCT01885195|466558067|FG000|Overall Study|Disease Progression|67|||
129619014|NCT01885195|466558067|FG000|Overall Study|Protocol Deviation|2|||
129701738|NCT02082977|466869408|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129619015|NCT01885195|466558067|FG000|Overall Study|Physician Decision|3|||
129619016|NCT01885195|466558067|FG000|Overall Study|Patient/guardian decision|8|||
129619017|NCT03390426|466558068|FG000|Overall Study|Protocol Violation|0|||
129619018|NCT03390426|466558069|FG001|Overall Study|Protocol Violation|1|||
129619019|NCT00548093|466558074|FG000|Overall Study|Death|33|||
129439368|NCT01139021|465906469|FG004|Overall Study|Protocol Violation|2|||
129439369|NCT01139021|465906470|FG005|Overall Study|Protocol Violation|0|||
129619020|NCT00548093|466558075|FG001|Overall Study|Death|13|||
129619021|NCT00548093|466558074|FG000|Overall Study|Lost to Follow-up|3|||
129619022|NCT00548093|466558075|FG001|Overall Study|Lost to Follow-up|1|||
129887940|NCT00322374|467547325|FG000|First Escalation|Documented Disease Progression|0|||
129887941|NCT00322374|467547326|FG001|First Escalation|Documented Disease Progression|6|||
129887942|NCT00322374|467547327|FG002|First Escalation|Documented Disease Progression|0|||
129887943|NCT00322374|467547328|FG003|First Escalation|Documented Disease Progression|0|||
129887944|NCT00322374|467547325|FG000|First Escalation|Physician Decision|0|||
129887945|NCT00322374|467547326|FG001|First Escalation|Physician Decision|12|||
129887946|NCT00322374|467547327|FG002|First Escalation|Physician Decision|0|||
129887947|NCT00322374|467547328|FG003|First Escalation|Physician Decision|0|||
129887948|NCT00322374|467547325|FG000|First Escalation|Study Drug Toxicity|0|||
129887949|NCT00322374|467547326|FG001|First Escalation|Study Drug Toxicity|11|||
129887950|NCT00322374|467547327|FG002|First Escalation|Study Drug Toxicity|0|||
129887951|NCT00322374|467547328|FG003|First Escalation|Study Drug Toxicity|0|||
129887952|NCT00322374|467547325|FG000|First Escalation|Participant Request|0|||
129887953|NCT00322374|467547326|FG001|First Escalation|Participant Request|1|||
129887954|NCT00322374|467547327|FG002|First Escalation|Participant Request|0|||
129887955|NCT00322374|467547328|FG003|First Escalation|Participant Request|0|||
129887956|NCT00322374|467547325|FG000|Second Escalation|Physician Decision|0|||
129887957|NCT00322374|467547326|FG001|Second Escalation|Physician Decision|0|||
129887958|NCT00322374|467547327|FG002|Second Escalation|Physician Decision|5|||
129887959|NCT00322374|467547328|FG003|Second Escalation|Physician Decision|0|||
129887960|NCT00322374|467547325|FG000|Second Escalation|Study Drug Toxicity|0|||
129887961|NCT00322374|467547326|FG001|Second Escalation|Study Drug Toxicity|0|||
129887962|NCT00322374|467547327|FG002|Second Escalation|Study Drug Toxicity|1|||
129887963|NCT00322374|467547328|FG003|Second Escalation|Study Drug Toxicity|0|||
129887964|NCT03653416|467547329|FG000|Overall Study|Protocol Violation|6|||
129887965|NCT03653416|467547330|FG001|Overall Study|Protocol Violation|1|||
129887966|NCT02388074|467547331|FG000|Overall Study|Lost in Transit|2|||
129887967|NCT02388074|467547331|FG000|Overall Study|Sample Not Returned|1|||
129887968|NCT00003458|467547334|FG000|Overall Study|Not evaluable|4|||
129887969|NCT02133924|467547335|FG000|Overall Study|Death|38|||
129887970|NCT02133924|467547335|FG000|Overall Study|Physician Decision|1|||
129887971|NCT02133924|467547335|FG000|Overall Study|Withdrawal by Subject|3|||
129887972|NCT01254890|467547336|FG000|Overall Study|Ineligible|0|||
129887973|NCT01254890|467547337|FG001|Overall Study|Ineligible|3|||
129887974|NCT01254890|467547336|FG000|Overall Study|Withdrawal by Subject|1|||
129887975|NCT01254890|467547337|FG001|Overall Study|Withdrawal by Subject|2|||
129887976|NCT01254890|467547336|FG000|Overall Study|Disease Progression|0|||
129887977|NCT01254890|467547337|FG001|Overall Study|Disease Progression|5|||
129887978|NCT04039503|467547342|FG000|Overall Study|Adverse Event|3|||
129887979|NCT04039503|467547343|FG001|Overall Study|Adverse Event|0|||
129887980|NCT04039503|467547344|FG002|Overall Study|Adverse Event|2|||
129887981|NCT04039503|467547345|FG003|Overall Study|Adverse Event|0|||
129887982|NCT04039503|467547342|FG000|Overall Study|Lost to Follow-up|0|||
129887983|NCT04039503|467547343|FG001|Overall Study|Lost to Follow-up|0|||
129887984|NCT04039503|467547344|FG002|Overall Study|Lost to Follow-up|1|||
129887985|NCT04039503|467547345|FG003|Overall Study|Lost to Follow-up|0|||
129887986|NCT04039503|467547342|FG000|Overall Study|Protocol Violation|0|||
129887987|NCT04039503|467547343|FG001|Overall Study|Protocol Violation|1|||
129887988|NCT04039503|467547344|FG002|Overall Study|Protocol Violation|2|||
129887989|NCT04039503|467547345|FG003|Overall Study|Protocol Violation|1|||
129887990|NCT04039503|467547342|FG000|Overall Study|Withdrawal by Subject|4|||
129887991|NCT04039503|467547343|FG001|Overall Study|Withdrawal by Subject|3|||
129887992|NCT04039503|467547344|FG002|Overall Study|Withdrawal by Subject|5|||
129887993|NCT04039503|467547345|FG003|Overall Study|Withdrawal by Subject|2|||
129887994|NCT04157686|467547347|FG000|Overall Study|Adverse Event|1|||
129887995|NCT04157686|467547348|FG001|Overall Study|Adverse Event|0|||
129887996|NCT04157686|467547349|FG002|Overall Study|Adverse Event|1|||
129887997|NCT04157686|467547350|FG003|Overall Study|Adverse Event|0|||
129887998|NCT04157686|467547351|FG004|Overall Study|Adverse Event|1|||
129887999|NCT04157686|467547352|FG005|Overall Study|Adverse Event|0|||
129888000|NCT04157686|467547353|FG006|Overall Study|Adverse Event|0|||
129888001|NCT04157686|467547354|FG007|Overall Study|Adverse Event|0|||
129888002|NCT04157686|467547347|FG000|Overall Study|Pregnancy|0|||
129888003|NCT04157686|467547348|FG001|Overall Study|Pregnancy|1|||
129888004|NCT04157686|467547349|FG002|Overall Study|Pregnancy|3|||
129888005|NCT04157686|467547350|FG003|Overall Study|Pregnancy|0|||
129619023|NCT00548093|466558074|FG000|Overall Study|Objective progression or relapse|1|||
129888006|NCT04157686|467547351|FG004|Overall Study|Pregnancy|0|||
129888007|NCT04157686|467547352|FG005|Overall Study|Pregnancy|0|||
129888008|NCT04157686|467547353|FG006|Overall Study|Pregnancy|3|||
129888009|NCT04157686|467547354|FG007|Overall Study|Pregnancy|0|||
129888010|NCT04157686|467547347|FG000|Overall Study|Lost to Follow-up|1|||
129888011|NCT04157686|467547348|FG001|Overall Study|Lost to Follow-up|2|||
129888012|NCT04157686|467547349|FG002|Overall Study|Lost to Follow-up|8|||
129888013|NCT04157686|467547350|FG003|Overall Study|Lost to Follow-up|6|||
129888014|NCT04157686|467547351|FG004|Overall Study|Lost to Follow-up|6|||
129888015|NCT04157686|467547352|FG005|Overall Study|Lost to Follow-up|3|||
129888016|NCT04157686|467547353|FG006|Overall Study|Lost to Follow-up|7|||
129888017|NCT04157686|467547354|FG007|Overall Study|Lost to Follow-up|9|||
129619024|NCT00548093|466558075|FG001|Overall Study|Objective progression or relapse|1|||
129619025|NCT00548093|466558074|FG000|Overall Study|Other|11|||
129619026|NCT00548093|466558075|FG001|Overall Study|Other|1|||
129619027|NCT00548093|466558074|FG000|Overall Study|Withdrawal by Subject|1|||
129619028|NCT00548093|466558075|FG001|Overall Study|Withdrawal by Subject|0|||
129619029|NCT00548093|466558074|FG000|Overall Study|Completed post-treatment follow-up|1|||
129619030|NCT00548093|466558075|FG001|Overall Study|Completed post-treatment follow-up|0|||
129619031|NCT02924727|466558076|FG000|Overall Study|Withdrawal by Subject|2|||
129619032|NCT02924727|466558077|FG001|Overall Study|Withdrawal by Subject|4|||
129619033|NCT02924727|466558076|FG000|Overall Study|Lost to Follow-up|2|||
129619034|NCT02924727|466558077|FG001|Overall Study|Lost to Follow-up|5|||
129619035|NCT02924727|466558076|FG000|Overall Study|Death|221|||
129619036|NCT02924727|466558077|FG001|Overall Study|Death|247|||
129619037|NCT02924727|466558076|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
129619038|NCT02924727|466558077|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
129619039|NCT00509795|466558084|FG000|Overall Study|Adverse Event|4|||
129619040|NCT00509795|466558085|FG001|Overall Study|Adverse Event|3|||
129619041|NCT00509795|466558086|FG002|Overall Study|Adverse Event|5|||
129619042|NCT00509795|466558087|FG003|Overall Study|Adverse Event|4|||
129619043|NCT00509795|466558084|FG000|Overall Study|Death|3|||
129619044|NCT00509795|466558085|FG001|Overall Study|Death|1|||
129619045|NCT00509795|466558086|FG002|Overall Study|Death|2|||
129619046|NCT00509795|466558087|FG003|Overall Study|Death|7|||
129619047|NCT00509795|466558084|FG000|Overall Study|Lack of Efficacy|0|||
129888018|NCT04157686|467547347|FG000|Overall Study|Lack of Efficacy|0|||
129888019|NCT04157686|467547348|FG001|Overall Study|Lack of Efficacy|0|||
129888020|NCT04157686|467547349|FG002|Overall Study|Lack of Efficacy|0|||
129888021|NCT04157686|467547350|FG003|Overall Study|Lack of Efficacy|0|||
129888022|NCT04157686|467547351|FG004|Overall Study|Lack of Efficacy|0|||
129888023|NCT04157686|467547352|FG005|Overall Study|Lack of Efficacy|2|||
129888024|NCT04157686|467547353|FG006|Overall Study|Lack of Efficacy|0|||
129888025|NCT04157686|467547354|FG007|Overall Study|Lack of Efficacy|1|||
129888026|NCT04157686|467547347|FG000|Overall Study|Withdrawal by Subject|10|||
129888027|NCT04157686|467547348|FG001|Overall Study|Withdrawal by Subject|10|||
129888028|NCT04157686|467547349|FG002|Overall Study|Withdrawal by Subject|12|||
129888029|NCT04157686|467547350|FG003|Overall Study|Withdrawal by Subject|20|||
129888030|NCT04157686|467547351|FG004|Overall Study|Withdrawal by Subject|12|||
129888031|NCT04157686|467547352|FG005|Overall Study|Withdrawal by Subject|11|||
129888032|NCT04157686|467547353|FG006|Overall Study|Withdrawal by Subject|18|||
129619048|NCT00509795|466558085|FG001|Overall Study|Lack of Efficacy|0|||
129888033|NCT04157686|467547354|FG007|Overall Study|Withdrawal by Subject|24|||
129619049|NCT00509795|466558086|FG002|Overall Study|Lack of Efficacy|2|||
129619050|NCT00509795|466558087|FG003|Overall Study|Lack of Efficacy|2|||
129619051|NCT00509795|466558084|FG000|Overall Study|Lost to Follow-up|1|||
129619052|NCT00509795|466558085|FG001|Overall Study|Lost to Follow-up|2|||
129619053|NCT00509795|466558086|FG002|Overall Study|Lost to Follow-up|4|||
129619054|NCT00509795|466558087|FG003|Overall Study|Lost to Follow-up|4|||
129619055|NCT00509795|466558084|FG000|Overall Study|OTHER|1|||
129619056|NCT00509795|466558085|FG001|Overall Study|OTHER|0|||
129619057|NCT00509795|466558086|FG002|Overall Study|OTHER|4|||
129619058|NCT00509795|466558087|FG003|Overall Study|OTHER|1|||
129619059|NCT00509795|466558084|FG000|Overall Study|Protocol Violation|3|||
129619060|NCT00509795|466558085|FG001|Overall Study|Protocol Violation|0|||
129619061|NCT00509795|466558086|FG002|Overall Study|Protocol Violation|3|||
129619062|NCT00509795|466558087|FG003|Overall Study|Protocol Violation|1|||
129619063|NCT00509795|466558084|FG000|Overall Study|Withdrawal by Subject|10|||
129619064|NCT00509795|466558085|FG001|Overall Study|Withdrawal by Subject|5|||
129619065|NCT00509795|466558086|FG002|Overall Study|Withdrawal by Subject|7|||
129619066|NCT00509795|466558087|FG003|Overall Study|Withdrawal by Subject|8|||
129619067|NCT04386616|466558093|FG000|Overall Study|Death|22|||
129888034|NCT04157686|467547347|FG000|Overall Study|Physician Decision|0|||
129888035|NCT04157686|467547348|FG001|Overall Study|Physician Decision|0|||
129888036|NCT04157686|467547349|FG002|Overall Study|Physician Decision|1|||
129888037|NCT04157686|467547350|FG003|Overall Study|Physician Decision|0|||
129888038|NCT04157686|467547351|FG004|Overall Study|Physician Decision|1|||
129619068|NCT04386616|466558094|FG001|Overall Study|Death|22|||
129619069|NCT04386616|466558095|FG002|Overall Study|Death|21|||
129619070|NCT04386616|466558093|FG000|Overall Study|Lost to Follow-up|5|||
129619071|NCT04386616|466558094|FG001|Overall Study|Lost to Follow-up|8|||
129619072|NCT04386616|466558095|FG002|Overall Study|Lost to Follow-up|6|||
129619073|NCT04386616|466558093|FG000|Overall Study|Withdrawal by Subject|2|||
129619074|NCT04386616|466558094|FG001|Overall Study|Withdrawal by Subject|4|||
129619075|NCT04386616|466558095|FG002|Overall Study|Withdrawal by Subject|1|||
129619076|NCT04386616|466558093|FG000|Overall Study|Adverse Event|1|||
129619077|NCT04386616|466558094|FG001|Overall Study|Adverse Event|1|||
129619078|NCT04386616|466558095|FG002|Overall Study|Adverse Event|0|||
129619079|NCT02759692|466558096|FG000|Period 1|Test article no longer available|1|||
129619080|NCT02759692|466558097|FG001|Period 1|Test article no longer available|1|||
129619081|NCT02759692|466558096|FG000|Period 1|No longer meets eligibility criteria.|1|||
129619082|NCT02759692|466558097|FG001|Period 1|No longer meets eligibility criteria.|0|||
129619083|NCT02759692|466558096|FG000|Period 1|Miss-Randomized|1|||
129619084|NCT02759692|466558097|FG001|Period 1|Miss-Randomized|1|||
129619085|NCT02759692|466558096|FG000|Period 2|Lost to Follow-up|1|||
129619086|NCT02759692|466558097|FG001|Period 2|Lost to Follow-up|0|||
129619087|NCT02759692|466558096|FG000|Period 2|Test article no longer available|0|||
129619088|NCT02759692|466558097|FG001|Period 2|Test article no longer available|1|||
129619089|NCT00451178|466558098|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
129619090|NCT00451178|466558099|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
129619091|NCT00451178|466558098|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
129619092|NCT00451178|466558099|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
129619093|NCT00451178|466558098|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
129619094|NCT00451178|466558099|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
129619095|NCT00451178|466558098|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
129619096|NCT00451178|466558099|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
129619097|NCT00451178|466558098|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
129619098|NCT00451178|466558099|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
129619099|NCT00451178|466558098|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
129619100|NCT00451178|466558099|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
129619101|NCT00451178|466558098|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
129619102|NCT00451178|466558099|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
129619103|NCT00451178|466558098|FG000|Prior to Maintenance Therapy|PD|2|||
129619104|NCT00451178|466558099|FG001|Prior to Maintenance Therapy|PD|0|||
129619105|NCT00451178|466558098|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
129619106|NCT00451178|466558099|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
129619107|NCT00451178|466558098|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
129619108|NCT00451178|466558099|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
129619109|NCT00451178|466558098|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
129619110|NCT00451178|466558099|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
129619111|NCT00451178|466558098|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
129619112|NCT00451178|466558099|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
129619113|NCT00451178|466558098|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
129619114|NCT00451178|466558099|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
129619115|NCT00451178|466558098|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
129619116|NCT00451178|466558099|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
129619117|NCT00451178|466558098|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
129619118|NCT00451178|466558099|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
129619119|NCT03207867|466558102|FG000|Overall Study|Adverse Event|1|||
129619120|NCT03207867|466558103|FG001|Overall Study|Adverse Event|0|||
129619121|NCT03207867|466558104|FG002|Overall Study|Adverse Event|1|||
129619122|NCT03207867|466558105|FG003|Overall Study|Adverse Event|0|||
129619123|NCT03207867|466558106|FG004|Overall Study|Adverse Event|0|||
129619124|NCT03207867|466558107|FG005|Overall Study|Adverse Event|2|||
129619125|NCT03207867|466558108|FG006|Overall Study|Adverse Event|1|||
129619126|NCT03207867|466558109|FG007|Overall Study|Adverse Event|1|||
129619127|NCT03207867|466558110|FG008|Overall Study|Adverse Event|2|||
129619128|NCT03207867|466558111|FG009|Overall Study|Adverse Event|2|||
129619129|NCT03207867|466558112|FG010|Overall Study|Adverse Event|0|||
129619130|NCT03207867|466558113|FG011|Overall Study|Adverse Event|0|||
129619131|NCT03207867|466558114|FG012|Overall Study|Adverse Event|0|||
129619132|NCT03207867|466558115|FG013|Overall Study|Adverse Event|0|||
129619133|NCT03207867|466558116|FG014|Overall Study|Adverse Event|0|||
129619134|NCT03207867|466558117|FG015|Overall Study|Adverse Event|0|||
129619135|NCT03207867|466558118|FG016|Overall Study|Adverse Event|3|||
129619136|NCT03207867|466558119|FG017|Overall Study|Adverse Event|1|||
129619137|NCT03207867|466558120|FG018|Overall Study|Adverse Event|2|||
129619138|NCT03207867|466558121|FG019|Overall Study|Adverse Event|1|||
129619139|NCT03207867|466558122|FG020|Overall Study|Adverse Event|0|||
129619140|NCT03207867|466558123|FG021|Overall Study|Adverse Event|0|||
129619141|NCT03207867|466558124|FG022|Overall Study|Adverse Event|0|||
129619142|NCT03207867|466558125|FG023|Overall Study|Adverse Event|0|||
129619143|NCT03207867|466558102|FG000|Overall Study|Death|0|||
129619144|NCT03207867|466558103|FG001|Overall Study|Death|0|||
129619145|NCT03207867|466558104|FG002|Overall Study|Death|0|||
129619146|NCT03207867|466558105|FG003|Overall Study|Death|0|||
129619147|NCT03207867|466558106|FG004|Overall Study|Death|0|||
129701739|NCT02082977|466869409|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129701740|NCT02082977|466869410|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129888039|NCT04157686|467547352|FG005|Overall Study|Physician Decision|0|||
129619148|NCT03207867|466558107|FG005|Overall Study|Death|1|||
129619149|NCT03207867|466558108|FG006|Overall Study|Death|0|||
129619150|NCT03207867|466558109|FG007|Overall Study|Death|3|||
129619151|NCT03207867|466558110|FG008|Overall Study|Death|1|||
129619152|NCT03207867|466558111|FG009|Overall Study|Death|2|||
129619153|NCT03207867|466558112|FG010|Overall Study|Death|0|||
129888040|NCT04157686|467547353|FG006|Overall Study|Physician Decision|3|||
129619154|NCT03207867|466558113|FG011|Overall Study|Death|1|||
129619155|NCT03207867|466558114|FG012|Overall Study|Death|0|||
129619156|NCT03207867|466558115|FG013|Overall Study|Death|1|||
129619157|NCT03207867|466558116|FG014|Overall Study|Death|0|||
129619158|NCT03207867|466558117|FG015|Overall Study|Death|0|||
129619159|NCT03207867|466558118|FG016|Overall Study|Death|0|||
129619160|NCT03207867|466558119|FG017|Overall Study|Death|2|||
129619161|NCT03207867|466558120|FG018|Overall Study|Death|0|||
129619162|NCT03207867|466558121|FG019|Overall Study|Death|1|||
129619163|NCT03207867|466558122|FG020|Overall Study|Death|0|||
129619164|NCT03207867|466558123|FG021|Overall Study|Death|0|||
129619165|NCT03207867|466558124|FG022|Overall Study|Death|0|||
129619166|NCT03207867|466558125|FG023|Overall Study|Death|0|||
129619167|NCT03207867|466558102|FG000|Overall Study|Physician Decision|3|||
129619168|NCT03207867|466558103|FG001|Overall Study|Physician Decision|5|||
129619169|NCT03207867|466558104|FG002|Overall Study|Physician Decision|0|||
129619170|NCT03207867|466558105|FG003|Overall Study|Physician Decision|3|||
129619171|NCT03207867|466558106|FG004|Overall Study|Physician Decision|2|||
129619172|NCT03207867|466558107|FG005|Overall Study|Physician Decision|0|||
129619173|NCT03207867|466558108|FG006|Overall Study|Physician Decision|0|||
129619174|NCT03207867|466558109|FG007|Overall Study|Physician Decision|0|||
129619175|NCT03207867|466558110|FG008|Overall Study|Physician Decision|4|||
129619176|NCT03207867|466558111|FG009|Overall Study|Physician Decision|2|||
129619177|NCT03207867|466558112|FG010|Overall Study|Physician Decision|0|||
129619178|NCT03207867|466558113|FG011|Overall Study|Physician Decision|4|||
129619179|NCT03207867|466558114|FG012|Overall Study|Physician Decision|0|||
129619180|NCT03207867|466558115|FG013|Overall Study|Physician Decision|0|||
129619181|NCT03207867|466558116|FG014|Overall Study|Physician Decision|2|||
129619182|NCT03207867|466558117|FG015|Overall Study|Physician Decision|1|||
129619183|NCT03207867|466558118|FG016|Overall Study|Physician Decision|1|||
129619184|NCT03207867|466558119|FG017|Overall Study|Physician Decision|2|||
129619185|NCT03207867|466558120|FG018|Overall Study|Physician Decision|1|||
129619186|NCT03207867|466558121|FG019|Overall Study|Physician Decision|3|||
129619187|NCT03207867|466558122|FG020|Overall Study|Physician Decision|0|||
129619188|NCT03207867|466558123|FG021|Overall Study|Physician Decision|0|||
129619189|NCT03207867|466558124|FG022|Overall Study|Physician Decision|0|||
129619190|NCT03207867|466558125|FG023|Overall Study|Physician Decision|0|||
129619191|NCT03207867|466558102|FG000|Overall Study|Progressive Disease|7|||
129619192|NCT03207867|466558103|FG001|Overall Study|Progressive Disease|7|||
129619193|NCT03207867|466558104|FG002|Overall Study|Progressive Disease|9|||
129619194|NCT03207867|466558105|FG003|Overall Study|Progressive Disease|10|||
129619195|NCT03207867|466558106|FG004|Overall Study|Progressive Disease|11|||
129619196|NCT03207867|466558107|FG005|Overall Study|Progressive Disease|10|||
129619197|NCT03207867|466558108|FG006|Overall Study|Progressive Disease|9|||
129619198|NCT03207867|466558109|FG007|Overall Study|Progressive Disease|8|||
129619199|NCT03207867|466558110|FG008|Overall Study|Progressive Disease|19|||
129619200|NCT03207867|466558111|FG009|Overall Study|Progressive Disease|23|||
129619201|NCT03207867|466558112|FG010|Overall Study|Progressive Disease|2|||
129619202|NCT03207867|466558113|FG011|Overall Study|Progressive Disease|24|||
129619203|NCT03207867|466558114|FG012|Overall Study|Progressive Disease|3|||
129619204|NCT03207867|466558115|FG013|Overall Study|Progressive Disease|11|||
129888041|NCT04157686|467547354|FG007|Overall Study|Physician Decision|0|||
129619205|NCT03207867|466558116|FG014|Overall Study|Progressive Disease|9|||
129619206|NCT03207867|466558117|FG015|Overall Study|Progressive Disease|5|||
129619207|NCT03207867|466558118|FG016|Overall Study|Progressive Disease|10|||
129619208|NCT03207867|466558119|FG017|Overall Study|Progressive Disease|14|||
129619209|NCT03207867|466558120|FG018|Overall Study|Progressive Disease|13|||
129619210|NCT03207867|466558121|FG019|Overall Study|Progressive Disease|14|||
129619211|NCT03207867|466558122|FG020|Overall Study|Progressive Disease|6|||
129619212|NCT03207867|466558123|FG021|Overall Study|Progressive Disease|3|||
129619213|NCT03207867|466558124|FG022|Overall Study|Progressive Disease|3|||
129439370|NCT01139021|465906465|FG000|Overall Study|Withdrawal by Subject|0|||
129619214|NCT03207867|466558125|FG023|Overall Study|Progressive Disease|3|||
129619215|NCT03207867|466558102|FG000|Overall Study|Patient/guardian Decision|0|||
129619216|NCT03207867|466558103|FG001|Overall Study|Patient/guardian Decision|0|||
129619217|NCT03207867|466558104|FG002|Overall Study|Patient/guardian Decision|1|||
129619218|NCT03207867|466558105|FG003|Overall Study|Patient/guardian Decision|1|||
129619219|NCT03207867|466558106|FG004|Overall Study|Patient/guardian Decision|1|||
129619220|NCT03207867|466558107|FG005|Overall Study|Patient/guardian Decision|2|||
129619221|NCT03207867|466558108|FG006|Overall Study|Patient/guardian Decision|1|||
129619222|NCT03207867|466558109|FG007|Overall Study|Patient/guardian Decision|0|||
129439371|NCT01139021|465906466|FG001|Overall Study|Withdrawal by Subject|0|||
129439372|NCT01139021|465906467|FG002|Overall Study|Withdrawal by Subject|0|||
129619223|NCT03207867|466558110|FG008|Overall Study|Patient/guardian Decision|1|||
129619224|NCT03207867|466558111|FG009|Overall Study|Patient/guardian Decision|0|||
129619225|NCT03207867|466558112|FG010|Overall Study|Patient/guardian Decision|0|||
129619226|NCT03207867|466558113|FG011|Overall Study|Patient/guardian Decision|1|||
129619227|NCT03207867|466558114|FG012|Overall Study|Patient/guardian Decision|0|||
129619228|NCT03207867|466558115|FG013|Overall Study|Patient/guardian Decision|1|||
129439373|NCT01139021|465906468|FG003|Overall Study|Withdrawal by Subject|1|||
129439374|NCT01139021|465906469|FG004|Overall Study|Withdrawal by Subject|4|||
129439375|NCT01139021|465906470|FG005|Overall Study|Withdrawal by Subject|0|||
129619229|NCT03207867|466558116|FG014|Overall Study|Patient/guardian Decision|2|||
129619230|NCT03207867|466558117|FG015|Overall Study|Patient/guardian Decision|0|||
129619231|NCT03207867|466558118|FG016|Overall Study|Patient/guardian Decision|1|||
129619232|NCT03207867|466558119|FG017|Overall Study|Patient/guardian Decision|3|||
129619233|NCT03207867|466558120|FG018|Overall Study|Patient/guardian Decision|4|||
129439376|NCT01978262|465906471|FG000|Overall Study|Withdrawal by Subject|9|||
129439377|NCT01978262|465906471|FG000|Overall Study|Lost to Follow-up|2|||
129439378|NCT02168842|465906473|FG000|Overall Study|Withdrawal by Subject|5|||
129439379|NCT02168842|465906474|FG001|Overall Study|Withdrawal by Subject|3|||
129439380|NCT02168842|465906473|FG000|Overall Study|Lost to Follow-up|0|||
129439381|NCT02168842|465906474|FG001|Overall Study|Lost to Follow-up|2|||
129439382|NCT02168842|465906473|FG000|Overall Study|Death|2|||
129439383|NCT02168842|465906474|FG001|Overall Study|Death|1|||
129439384|NCT02168842|465906473|FG000|Overall Study|Physician Decision|1|||
129439385|NCT02168842|465906474|FG001|Overall Study|Physician Decision|2|||
129439386|NCT02019927|465906479|FG000|Overall Study|Lost to Follow-up|2|||
129439387|NCT02019927|465906480|FG001|Overall Study|Lost to Follow-up|4|||
129439388|NCT02019927|465906481|FG002|Overall Study|Lost to Follow-up|1|||
129439389|NCT02019927|465906482|FG003|Overall Study|Lost to Follow-up|2|||
129439390|NCT02019927|465906483|FG004|Overall Study|Lost to Follow-up|3|||
129439391|NCT02019927|465906484|FG005|Overall Study|Lost to Follow-up|1|||
129619234|NCT03207867|466558121|FG019|Overall Study|Patient/guardian Decision|1|||
129792746|NCT04393298|467209134|FG009|Overall Study|Patient Passed Away|0|||
129439392|NCT03945825|465906487|FG000|Overall Study|Enrolled but treatment not administered|0|||
129439393|NCT03945825|465906488|FG001|Overall Study|Enrolled but treatment not administered|0|||
129439394|NCT03945825|465906489|FG002|Overall Study|Enrolled but treatment not administered|0|||
129792747|NCT04393298|467209135|FG010|Overall Study|Patient Passed Away|0|||
129439395|NCT03945825|465906490|FG003|Overall Study|Enrolled but treatment not administered|0|||
129439396|NCT03945825|465906491|FG004|Overall Study|Enrolled but treatment not administered|1|||
129439397|NCT03945825|465906492|FG005|Overall Study|Enrolled but treatment not administered|0|||
129439398|NCT03945825|465906487|FG000|Overall Study|Lost to Follow-up|1|||
129619235|NCT03207867|466558122|FG020|Overall Study|Patient/guardian Decision|0|||
129619236|NCT03207867|466558123|FG021|Overall Study|Patient/guardian Decision|0|||
129619237|NCT03207867|466558124|FG022|Overall Study|Patient/guardian Decision|0|||
129792748|NCT04393298|467209136|FG011|Overall Study|Patient Passed Away|0|||
129619238|NCT03207867|466558125|FG023|Overall Study|Patient/guardian Decision|0|||
129619239|NCT00912912|466558126|FG000|Overall Study|Withdrawal by Subject|1|||
129619240|NCT00912912|466558126|FG000|Overall Study|Disease Progression|3|||
129619241|NCT02447744|466558127|FG000|Overall Study|Withdrawal by Subject|3|||
129619242|NCT02447744|466558128|FG001|Overall Study|Withdrawal by Subject|1|||
129619243|NCT02447744|466558127|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
129619244|NCT02447744|466558128|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
129619245|NCT00306995|466558129|FG000|Study Part I|Withdrawal by Subject|0|||
129619246|NCT00306995|466558130|FG001|Study Part I|Withdrawal by Subject|0|||
129619247|NCT00306995|466558131|FG002|Study Part I|Withdrawal by Subject|0|||
129619248|NCT00306995|466558132|FG003|Study Part I|Withdrawal by Subject|0|||
129619249|NCT00306995|466558133|FG004|Study Part I|Withdrawal by Subject|0|||
129619250|NCT00306995|466558134|FG005|Study Part I|Withdrawal by Subject|0|||
129619251|NCT00306995|466558135|FG006|Study Part I|Withdrawal by Subject|1|||
129619252|NCT00306995|466558129|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
129619253|NCT00306995|466558130|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
129619254|NCT00306995|466558131|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
129619255|NCT00306995|466558132|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
129619256|NCT00306995|466558133|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
129619257|NCT00306995|466558134|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
129619258|NCT00306995|466558135|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
129619259|NCT05422625|466558136|FG000|Overall Study|Withdrawal by Subject|1|||
129619260|NCT05422625|466558137|FG001|Overall Study|Withdrawal by Subject|0|||
129619261|NCT04324073|466559886|FG000|Overall Study|withdrew consent|0|||
129619262|NCT04324073|466559887|FG001|Overall Study|withdrew consent|4|||
129619263|NCT04324073|466559888|FG002|Overall Study|withdrew consent|2|||
129619264|NCT04324073|466559889|FG003|Overall Study|withdrew consent|8|||
129619265|NCT06400238|466559894|FG000|Overall Study|Started Protocol Therapy|2|||
129619266|NCT06400238|466559894|FG000|Overall Study|Adverse Event|1|||
129619267|NCT06400238|466559894|FG000|Overall Study|Death|1|||
129619268|NCT06400238|466559894|FG000|Overall Study|Disease Progression|27|||
129619269|NCT06400238|466559894|FG000|Overall Study|Withdrawal by Subject|2|||
129619270|NCT06400238|466559894|FG000|Overall Study|Physician Decision|2|||
129619271|NCT01277601|466559897|FG000|Overall Study|Adverse Event|5|||
129619272|NCT01277601|466559898|FG001|Overall Study|Adverse Event|3|||
129619273|NCT01277601|466559899|FG002|Overall Study|Adverse Event|0|||
129619274|NCT01277601|466559900|FG003|Overall Study|Adverse Event|7|||
129619275|NCT01277601|466559897|FG000|Overall Study|Withdrawal by Subject|18|||
129619276|NCT01277601|466559898|FG001|Overall Study|Withdrawal by Subject|21|||
129619277|NCT01277601|466559899|FG002|Overall Study|Withdrawal by Subject|8|||
129619278|NCT01277601|466559900|FG003|Overall Study|Withdrawal by Subject|17|||
129619279|NCT01277601|466559897|FG000|Overall Study|Lost to Follow-up|7|||
129619280|NCT01277601|466559898|FG001|Overall Study|Lost to Follow-up|9|||
129619281|NCT01277601|466559899|FG002|Overall Study|Lost to Follow-up|4|||
129619282|NCT01277601|466559900|FG003|Overall Study|Lost to Follow-up|2|||
129619283|NCT01277601|466559897|FG000|Overall Study|Physician Decision|3|||
129619284|NCT01277601|466559898|FG001|Overall Study|Physician Decision|5|||
129619285|NCT01277601|466559899|FG002|Overall Study|Physician Decision|1|||
129619286|NCT01277601|466559900|FG003|Overall Study|Physician Decision|6|||
129619287|NCT01277601|466559897|FG000|Overall Study|Pregnancy|2|||
129619288|NCT01277601|466559898|FG001|Overall Study|Pregnancy|2|||
129619289|NCT01277601|466559899|FG002|Overall Study|Pregnancy|4|||
129619290|NCT01277601|466559900|FG003|Overall Study|Pregnancy|1|||
129619291|NCT01277601|466559897|FG000|Overall Study|Noncompliance with Study Drug|1|||
129619292|NCT01277601|466559898|FG001|Overall Study|Noncompliance with Study Drug|3|||
129619293|NCT01277601|466559899|FG002|Overall Study|Noncompliance with Study Drug|2|||
129619294|NCT01277601|466559900|FG003|Overall Study|Noncompliance with Study Drug|0|||
129619295|NCT01277601|466559897|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
129701741|NCT02082977|466869411|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129701742|NCT02082977|466869412|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129701743|NCT02082977|466869413|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
129439399|NCT03945825|465906488|FG001|Overall Study|Lost to Follow-up|5|||
129619296|NCT01277601|466559898|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
129619297|NCT01277601|466559899|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
129619298|NCT01277601|466559900|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
129619299|NCT01277601|466559897|FG000|Overall Study|Protocol Violation|0|||
129701744|NCT02082977|466869414|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129619300|NCT01277601|466559898|FG001|Overall Study|Protocol Violation|2|||
129619301|NCT01277601|466559899|FG002|Overall Study|Protocol Violation|5|||
129619302|NCT01277601|466559900|FG003|Overall Study|Protocol Violation|0|||
129701745|NCT02082977|466869415|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
129619303|NCT01277601|466559897|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
129619304|NCT01277601|466559898|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
129619305|NCT01277601|466559899|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
129701746|NCT02082977|466869406|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129792749|NCT04393298|467209137|FG012|Overall Study|Patient Passed Away|0|||
129619306|NCT01277601|466559900|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
129888042|NCT04157686|467547347|FG000|Overall Study|Death|0|||
129888043|NCT04157686|467547348|FG001|Overall Study|Death|0|||
129888044|NCT04157686|467547349|FG002|Overall Study|Death|0|||
129888045|NCT04157686|467547350|FG003|Overall Study|Death|2|||
129888046|NCT04157686|467547351|FG004|Overall Study|Death|0|||
129888047|NCT04157686|467547352|FG005|Overall Study|Death|0|||
129888048|NCT04157686|467547353|FG006|Overall Study|Death|0|||
129888049|NCT04157686|467547354|FG007|Overall Study|Death|0|||
129888050|NCT04157686|467547347|FG000|Overall Study|Protocol Violation|0|||
129888051|NCT04157686|467547348|FG001|Overall Study|Protocol Violation|0|||
129888052|NCT04157686|467547349|FG002|Overall Study|Protocol Violation|0|||
129888053|NCT04157686|467547350|FG003|Overall Study|Protocol Violation|0|||
129888054|NCT04157686|467547351|FG004|Overall Study|Protocol Violation|1|||
129888055|NCT04157686|467547352|FG005|Overall Study|Protocol Violation|0|||
129888056|NCT04157686|467547353|FG006|Overall Study|Protocol Violation|0|||
129888057|NCT04157686|467547354|FG007|Overall Study|Protocol Violation|0|||
129619307|NCT04034927|466559901|FG000|Overall Study|Adverse Event|4|||
129619308|NCT04034927|466559902|FG001|Overall Study|Adverse Event|9|||
129619309|NCT04034927|466559901|FG000|Overall Study|Death|0|||
129619310|NCT04034927|466559902|FG001|Overall Study|Death|1|||
129619311|NCT04034927|466559901|FG000|Overall Study|Withdrawal by Subject|0|||
129619312|NCT04034927|466559902|FG001|Overall Study|Withdrawal by Subject|3|||
129619313|NCT04034927|466559901|FG000|Overall Study|Still on Treatment|2|||
129619314|NCT04034927|466559902|FG001|Overall Study|Still on Treatment|1|||
129619315|NCT04034927|466559901|FG000|Overall Study|Other|1|||
129619316|NCT04034927|466559902|FG001|Overall Study|Other|1|||
129619317|NCT03996447|466559903|FG000|First MRI Examination|Adverse Event|2|||
129619318|NCT03996447|466559904|FG001|First MRI Examination|Adverse Event|0|||
129619319|NCT03996447|466559903|FG000|First MRI Examination|Withdrawal by Subject|1|||
129619320|NCT03996447|466559904|FG001|First MRI Examination|Withdrawal by Subject|2|||
129619321|NCT03996447|466559903|FG000|First MRI Examination|Protocol Violation|0|||
129619322|NCT03996447|466559904|FG001|First MRI Examination|Protocol Violation|1|||
129888058|NCT04157686|467547347|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
129888059|NCT04157686|467547348|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
129888060|NCT04157686|467547349|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
129619323|NCT03996447|466559903|FG000|Washout|Adverse Event|2|||
129619324|NCT03996447|466559904|FG001|Washout|Adverse Event|0|||
129888061|NCT04157686|467547350|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
129888062|NCT04157686|467547351|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
129619325|NCT03996447|466559903|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
129619326|NCT03996447|466559904|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
129701747|NCT02082977|466869407|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129439400|NCT03945825|465906489|FG002|Overall Study|Lost to Follow-up|0|||
129439401|NCT03945825|465906490|FG003|Overall Study|Lost to Follow-up|1|||
129619327|NCT03996447|466559903|FG000|Washout|Withdrawal by Subject|0|||
129619328|NCT03996447|466559904|FG001|Washout|Withdrawal by Subject|1|||
129619329|NCT03996447|466559903|FG000|Washout|Other reason|1|||
129619330|NCT03996447|466559904|FG001|Washout|Other reason|1|||
129619331|NCT03842228|466559905|FG000|Overall Study|Adverse Event|1|||
129619332|NCT03842228|466559906|FG001|Overall Study|Adverse Event|1|||
129619333|NCT03842228|466559907|FG002|Overall Study|Adverse Event|1|||
129619334|NCT03842228|466559908|FG003|Overall Study|Adverse Event|0|||
129619335|NCT03842228|466559909|FG004|Overall Study|Adverse Event|0|||
129619336|NCT03842228|466559910|FG005|Overall Study|Adverse Event|0|||
129619337|NCT03842228|466559911|FG006|Overall Study|Adverse Event|0|||
129619338|NCT03842228|466559905|FG000|Overall Study|Death|0|||
129619339|NCT03842228|466559906|FG001|Overall Study|Death|1|||
129619340|NCT03842228|466559907|FG002|Overall Study|Death|0|||
129619341|NCT03842228|466559908|FG003|Overall Study|Death|0|||
129619342|NCT03842228|466559909|FG004|Overall Study|Death|0|||
129619343|NCT03842228|466559910|FG005|Overall Study|Death|0|||
129619344|NCT03842228|466559911|FG006|Overall Study|Death|0|||
129619345|NCT03842228|466559905|FG000|Overall Study|Withdrawal by Subject|0|||
129619346|NCT03842228|466559906|FG001|Overall Study|Withdrawal by Subject|0|||
129619347|NCT03842228|466559907|FG002|Overall Study|Withdrawal by Subject|2|||
129619348|NCT03842228|466559908|FG003|Overall Study|Withdrawal by Subject|1|||
129619349|NCT03842228|466559909|FG004|Overall Study|Withdrawal by Subject|0|||
129619350|NCT03842228|466559910|FG005|Overall Study|Withdrawal by Subject|0|||
129619351|NCT03842228|466559911|FG006|Overall Study|Withdrawal by Subject|2|||
129619352|NCT03842228|466559905|FG000|Overall Study|Progression|8|||
129619353|NCT03842228|466559906|FG001|Overall Study|Progression|1|||
129619354|NCT03842228|466559907|FG002|Overall Study|Progression|7|||
129619355|NCT03842228|466559908|FG003|Overall Study|Progression|5|||
129619356|NCT03842228|466559909|FG004|Overall Study|Progression|4|||
129619357|NCT03842228|466559910|FG005|Overall Study|Progression|2|||
129619358|NCT03842228|466559911|FG006|Overall Study|Progression|3|||
129619359|NCT02291510|466559912|FG000|Overall Study|Adverse Event|0|||
129619360|NCT02291510|466559913|FG001|Overall Study|Adverse Event|0|||
129619361|NCT02291510|466559914|FG002|Overall Study|Adverse Event|0|||
129619362|NCT02291510|466559915|FG003|Overall Study|Adverse Event|1|||
129619363|NCT06390839|466559917|FG000|Overall Study|Ineligible|2|||
129619364|NCT06390839|466559917|FG000|Overall Study|Never start protocol therapy|3|||
129619365|NCT06390839|466559917|FG000|Overall Study|Adverse Event|1|||
129619366|NCT06390839|466559917|FG000|Overall Study|Alternative therapy|2|||
129619367|NCT06390839|466559917|FG000|Overall Study|Death|3|||
129619368|NCT06390839|466559917|FG000|Overall Study|Disease progression|28|||
129619369|NCT06390839|466559917|FG000|Overall Study|Withdrawal by Subject|2|||
129619370|NCT06390839|466559917|FG000|Overall Study|Complicating disease|1|||
129619371|NCT06390839|466559917|FG000|Overall Study|Noncompliance|1|||
129619372|NCT04458922|466559918|FG000|Overall Study|Withdrawal by Subject|1|||
129619373|NCT04458922|466559919|FG001|Overall Study|Withdrawal by Subject|0|||
129619374|NCT04458922|466559920|FG002|Overall Study|Withdrawal by Subject|2|||
129619375|NCT04458922|466559918|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
129619376|NCT04458922|466559919|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
129619377|NCT04458922|466559920|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
129619378|NCT04458922|466559918|FG000|Overall Study|Adverse Event|1|||
129619379|NCT04458922|466559919|FG001|Overall Study|Adverse Event|0|||
129619380|NCT04458922|466559920|FG002|Overall Study|Adverse Event|0|||
129619381|NCT04458922|466559918|FG000|Overall Study|Started new study|0|||
129619382|NCT04458922|466559919|FG001|Overall Study|Started new study|0|||
129619383|NCT04458922|466559920|FG002|Overall Study|Started new study|1|||
129619384|NCT04458922|466559918|FG000|Overall Study|Progressive disease|6|||
129619385|NCT04458922|466559919|FG001|Overall Study|Progressive disease|8|||
129619386|NCT04458922|466559920|FG002|Overall Study|Progressive disease|2|||
129619387|NCT04458922|466559918|FG000|Overall Study|Death|1|||
129619388|NCT04458922|466559919|FG001|Overall Study|Death|0|||
129619389|NCT04458922|466559920|FG002|Overall Study|Death|2|||
129792750|NCT04393298|467209138|FG013|Overall Study|Patient Passed Away|0|||
129619390|NCT04458922|466559918|FG000|Overall Study|Participant started chemotherapy|0|||
129619391|NCT04458922|466559919|FG001|Overall Study|Participant started chemotherapy|1|||
129619392|NCT04458922|466559920|FG002|Overall Study|Participant started chemotherapy|0|||
129619393|NCT06351371|466559922|FG000|Overall Study|Mutation Status Not Confirmed|9|||
129619394|NCT06351371|466559922|FG000|Overall Study|Ineligible|1|||
129619395|NCT06351371|466559922|FG000|Overall Study|Adverse Event|4|||
129619396|NCT06351371|466559922|FG000|Overall Study|Death|1|||
129619397|NCT06351371|466559922|FG000|Overall Study|Disease progression|14|||
129619398|NCT06351371|466559922|FG000|Overall Study|Withdrawal by Subject|3|||
129619399|NCT06351371|466559922|FG000|Overall Study|Physician Decision|3|||
129792751|NCT04393298|467209139|FG014|Overall Study|Patient Passed Away|0|||
129792752|NCT04393298|467209125|FG000|Overall Study|Patient Deceased|0|||
129792753|NCT04393298|467209126|FG001|Overall Study|Patient Deceased|0|||
129792754|NCT04393298|467209127|FG002|Overall Study|Patient Deceased|0|||
129792755|NCT04393298|467209128|FG003|Overall Study|Patient Deceased|0|||
129792756|NCT04393298|467209129|FG004|Overall Study|Patient Deceased|0|||
129619400|NCT03203850|466559924|FG000|Overall Study|Subject/guardian decision|4|||
129619401|NCT03203850|466559925|FG001|Overall Study|Subject/guardian decision|3|||
129619402|NCT03203850|466559924|FG000|Overall Study|Adverse Event|3|||
129619403|NCT03203850|466559925|FG001|Overall Study|Adverse Event|0|||
129619404|NCT03203850|466559924|FG000|Overall Study|Death|1|||
129619405|NCT03203850|466559925|FG001|Overall Study|Death|0|||
129619406|NCT01272037|466559926|FG000|Overall Study|Death|25|||
129619407|NCT01272037|466559927|FG001|Overall Study|Death|28|||
129619408|NCT01272037|466559926|FG000|Overall Study|Adverse Event|12|||
129619409|NCT01272037|466559927|FG001|Overall Study|Adverse Event|7|||
129619410|NCT01272037|466559926|FG000|Overall Study|Withdrawal by Subject|175|||
129619411|NCT01272037|466559927|FG001|Overall Study|Withdrawal by Subject|93|||
129619412|NCT01272037|466559926|FG000|Overall Study|Disease progression|70|||
129619413|NCT01272037|466559927|FG001|Overall Study|Disease progression|111|||
129619414|NCT01272037|466559926|FG000|Overall Study|Other reason|42|||
129619415|NCT01272037|466559927|FG001|Overall Study|Other reason|41|||
129619416|NCT01272037|466559926|FG000|Overall Study|Delinquent data|24|||
129619417|NCT01272037|466559927|FG001|Overall Study|Delinquent data|19|||
129619418|NCT01272037|466559926|FG000|Overall Study|Reason under review|33|||
129619419|NCT01272037|466559927|FG001|Overall Study|Reason under review|29|||
129619420|NCT01272037|466559926|FG000|Overall Study|On treatment|626|||
129619421|NCT01272037|466559927|FG001|Overall Study|On treatment|632|||
129619422|NCT01009814|466559929|FG000|Overall Study|No longer met study criteria|1|||
129619423|NCT01009814|466559930|FG001|Overall Study|No longer met study criteria|1|||
129619424|NCT01009814|466559931|FG002|Overall Study|No longer met study criteria|0|||
129619425|NCT01009814|466559932|FG003|Overall Study|No longer met study criteria|0|||
129619426|NCT01009814|466559933|FG004|Overall Study|No longer met study criteria|0|||
129619427|NCT00618371|466559934|FG000|Overall Study|Withdrawal by Subject|2|||
129619428|NCT03348631|466559937|FG000|Overall Study|Not Eligible, No treatment|0|||
129619429|NCT03348631|466559938|FG001|Overall Study|Not Eligible, No treatment|1|||
129619430|NCT03348631|466559937|FG000|Overall Study|Not Eligible, Treated|2|||
129619431|NCT03348631|466559938|FG001|Overall Study|Not Eligible, Treated|0|||
129619432|NCT03348631|466559937|FG000|Overall Study|Eligible, No Treatment|1|||
129619433|NCT03348631|466559938|FG001|Overall Study|Eligible, No Treatment|0|||
129619434|NCT00451204|466559939|FG000|Overall Study|Adverse Event|4|||
129619435|NCT00451204|466559940|FG001|Overall Study|Adverse Event|6|||
129619436|NCT00451204|466559939|FG000|Overall Study|Lack of Efficacy|4|||
129619437|NCT00451204|466559940|FG001|Overall Study|Lack of Efficacy|4|||
129619438|NCT00451204|466559939|FG000|Overall Study|Lost to Follow-up|4|||
129619439|NCT00451204|466559940|FG001|Overall Study|Lost to Follow-up|4|||
129619440|NCT00451204|466559939|FG000|Overall Study|Protocol Violation|1|||
129619441|NCT00451204|466559940|FG001|Overall Study|Protocol Violation|0|||
129619442|NCT00451204|466559939|FG000|Overall Study|Patient refusal|8|||
129619443|NCT00451204|466559940|FG001|Overall Study|Patient refusal|4|||
129619444|NCT00451204|466559939|FG000|Overall Study|Other|1|||
129619445|NCT00451204|466559940|FG001|Overall Study|Other|2|||
129619446|NCT01582152|466559941|FG000|Overall Study|Disease Progression|4|||
129619447|NCT01582152|466559942|FG001|Overall Study|Disease Progression|5|||
129619448|NCT01582152|466559941|FG000|Overall Study|Adverse Event|2|||
129619449|NCT01582152|466559942|FG001|Overall Study|Adverse Event|1|||
129619450|NCT04172597|466559945|FG000|Overall Study|Disease Progression|0|||
129619451|NCT04172597|466559946|FG001|Overall Study|Disease Progression|0|||
129619452|NCT04172597|466559947|FG002|Overall Study|Disease Progression|0|||
129619453|NCT04172597|466559948|FG003|Overall Study|Disease Progression|0|||
129619454|NCT04172597|466559949|FG004|Overall Study|Disease Progression|1|||
129619455|NCT00794339|466559950|FG000|Overall Study|Withdrawal by Subject|3|||
129619456|NCT00794339|466559950|FG000|Overall Study|Ineligible|4|||
129619457|NCT00794339|466559950|FG000|Overall Study|Tx prior to ATSM|3|||
129619458|NCT00794339|466559950|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
129701748|NCT02082977|466869408|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129619459|NCT00794339|466559950|FG000|Overall Study|Tx not per protocol|1|||
129619460|NCT01611857|466559951|FG000|Overall Study|Withdrawal by Subject|0|||
129619461|NCT01611857|466559952|FG001|Overall Study|Withdrawal by Subject|2|||
129619462|NCT00362336|466559969|FG000|Overall Study|Serious Adverse Event|1|||
129619463|NCT00362336|466559970|FG001|Overall Study|Serious Adverse Event|0|||
129619464|NCT00362336|466559971|FG002|Overall Study|Serious Adverse Event|1|||
129619465|NCT00362336|466559969|FG000|Overall Study|Protocol Violation|0|||
129619466|NCT00362336|466559970|FG001|Overall Study|Protocol Violation|0|||
129619467|NCT00362336|466559971|FG002|Overall Study|Protocol Violation|1|||
129619468|NCT00362336|466559969|FG000|Overall Study|Lost to Follow-up|6|||
129619469|NCT00362336|466559970|FG001|Overall Study|Lost to Follow-up|4|||
129619470|NCT00362336|466559971|FG002|Overall Study|Lost to Follow-up|0|||
129701749|NCT02082977|466869409|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129619471|NCT00362336|466559969|FG000|Overall Study|Withdrawal by Subject|3|||
129619472|NCT00362336|466559970|FG001|Overall Study|Withdrawal by Subject|3|||
129619473|NCT00362336|466559971|FG002|Overall Study|Withdrawal by Subject|1|||
129619474|NCT01121562|466559974|FG000|Overall Study|Objective progression or relapse|8|||
129619475|NCT01121562|466559974|FG000|Overall Study|Withdrawal by Subject|1|||
129619476|NCT01121562|466559974|FG000|Overall Study|Adverse Event|1|||
129619477|NCT01121562|466559974|FG000|Overall Study|Sponsor Decision|1|||
129619478|NCT01121562|466559974|FG000|Overall Study|Met study discontinuation criteria|1|||
129619479|NCT01495702|466559975|FG000|Randomized Phase|Randomized But Not Treated|1|||
129619480|NCT01495702|466559976|FG001|Randomized Phase|Randomized But Not Treated|4|||
129619481|NCT01495702|466559975|FG000|Randomized Phase|Adverse Event|2|||
129619482|NCT01495702|466559976|FG001|Randomized Phase|Adverse Event|2|||
129619483|NCT01495702|466559975|FG000|Randomized Phase|Death|1|||
129619484|NCT01495702|466559976|FG001|Randomized Phase|Death|0|||
129888063|NCT04157686|467547352|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
129888064|NCT04157686|467547353|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
129888065|NCT04157686|467547354|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
129888066|NCT01216293|467547355|FG000|Main Study|Adverse Event|1|||
129888067|NCT01216293|467547356|FG001|Main Study|Adverse Event|4|||
129888068|NCT01216293|467547357|FG002|Main Study|Adverse Event|2|||
129888069|NCT01216293|467547355|FG000|Main Study|Major Protocol Deviation|1|||
129888070|NCT01216293|467547356|FG001|Main Study|Major Protocol Deviation|0|||
129888071|NCT01216293|467547357|FG002|Main Study|Major Protocol Deviation|1|||
129888072|NCT01216293|467547355|FG000|Main Study|Lost to Follow-up|3|||
129888073|NCT01216293|467547356|FG001|Main Study|Lost to Follow-up|1|||
129888074|NCT01216293|467547357|FG002|Main Study|Lost to Follow-up|0|||
129888075|NCT01216293|467547355|FG000|Main Study|Voluntary Withdrawal|2|||
129888076|NCT01216293|467547356|FG001|Main Study|Voluntary Withdrawal|2|||
129888077|NCT01216293|467547357|FG002|Main Study|Voluntary Withdrawal|2|||
129888078|NCT01216293|467547355|FG000|Main Study|Other Reason Not Specified|0|||
129888079|NCT01216293|467547356|FG001|Main Study|Other Reason Not Specified|1|||
129888080|NCT01216293|467547357|FG002|Main Study|Other Reason Not Specified|1|||
129888081|NCT01216293|467547355|FG000|Main Study|Randomized, Not Treated|1|||
129888082|NCT01216293|467547356|FG001|Main Study|Randomized, Not Treated|0|||
129888083|NCT01216293|467547357|FG002|Main Study|Randomized, Not Treated|0|||
129888084|NCT01216293|467547355|FG000|Calcium Absorption Substudy|Adverse Event|0|||
129888085|NCT01216293|467547356|FG001|Calcium Absorption Substudy|Adverse Event|2|||
129888086|NCT01216293|467547357|FG002|Calcium Absorption Substudy|Adverse Event|0|||
129888087|NCT01216293|467547355|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
129888088|NCT01216293|467547356|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
129888089|NCT01216293|467547357|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
129888090|NCT01216293|467547355|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
129888091|NCT01216293|467547356|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
129888092|NCT01216293|467547357|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
129888093|NCT01671748|467547358|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
129888094|NCT01671748|467547359|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
129888095|NCT01671748|467547358|FG000|4 Week run-in Phase|Adverse Event|1|||
129888096|NCT01671748|467547359|FG001|4 Week run-in Phase|Adverse Event|0|||
129888097|NCT01671748|467547358|FG000|4 Week run-in Phase|Not eligible|9|||
129888098|NCT01671748|467547359|FG001|4 Week run-in Phase|Not eligible|0|||
129888099|NCT04212169|467549114|FG000|Overall Study|Adverse Event|0|||
129888100|NCT04212169|467549115|FG001|Overall Study|Adverse Event|0|||
129888101|NCT04212169|467549116|FG002|Overall Study|Adverse Event|0|||
129888102|NCT04212169|467549117|FG003|Overall Study|Adverse Event|2|||
129888103|NCT04212169|467549114|FG000|Overall Study|Lost to Follow-up|1|||
129888104|NCT04212169|467549115|FG001|Overall Study|Lost to Follow-up|0|||
129888105|NCT04212169|467549116|FG002|Overall Study|Lost to Follow-up|0|||
129888106|NCT04212169|467549117|FG003|Overall Study|Lost to Follow-up|2|||
129888107|NCT04212169|467549114|FG000|Overall Study|Withdrawal by Subject|10|||
129888108|NCT04212169|467549115|FG001|Overall Study|Withdrawal by Subject|2|||
129888109|NCT04212169|467549116|FG002|Overall Study|Withdrawal by Subject|5|||
129888110|NCT04212169|467549117|FG003|Overall Study|Withdrawal by Subject|7|||
129888111|NCT04212169|467549114|FG000|Overall Study|Other reason, unspecified|3|||
129888112|NCT04212169|467549115|FG001|Overall Study|Other reason, unspecified|1|||
129439402|NCT03945825|465906491|FG004|Overall Study|Lost to Follow-up|2|||
129619485|NCT01495702|466559975|FG000|Randomized Phase|Lack of Efficacy|2|||
129619486|NCT01495702|466559976|FG001|Randomized Phase|Lack of Efficacy|0|||
129619487|NCT01495702|466559975|FG000|Randomized Phase|Investigators Discretion|2|||
129619488|NCT01495702|466559976|FG001|Randomized Phase|Investigators Discretion|0|||
129619489|NCT01495702|466559975|FG000|Randomized Phase|Withdrew Consent|10|||
129619490|NCT01495702|466559976|FG001|Randomized Phase|Withdrew Consent|18|||
129888113|NCT04212169|467549116|FG002|Overall Study|Other reason, unspecified|0|||
129888114|NCT04212169|467549117|FG003|Overall Study|Other reason, unspecified|2|||
129888115|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888116|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
129888117|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
129619491|NCT01495702|466559975|FG000|Randomized Phase|Lost to Follow-up|4|||
129619492|NCT01495702|466559976|FG001|Randomized Phase|Lost to Follow-up|3|||
129619493|NCT01495702|466559975|FG000|Randomized Phase|Participant Noncompliance|1|||
129619494|NCT01495702|466559976|FG001|Randomized Phase|Participant Noncompliance|0|||
129619495|NCT01495702|466559975|FG000|Randomized Phase|Protocol Violation|3|||
129619496|NCT01495702|466559976|FG001|Randomized Phase|Protocol Violation|1|||
129619497|NCT04152863|466559977|FG000|Overall Study|Death|13|||
129619498|NCT04152863|466559978|FG001|Overall Study|Death|12|||
129619499|NCT04152863|466559979|FG002|Overall Study|Death|7|||
129619500|NCT04152863|466559977|FG000|Overall Study|Physician Decision|1|||
129619501|NCT04152863|466559978|FG001|Overall Study|Physician Decision|1|||
129619502|NCT04152863|466559979|FG002|Overall Study|Physician Decision|1|||
129619503|NCT04152863|466559977|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
129619504|NCT04152863|466559978|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
129619505|NCT04152863|466559979|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
129619506|NCT04152863|466559977|FG000|Overall Study|Withdrawal by Subject|2|||
129619507|NCT04152863|466559978|FG001|Overall Study|Withdrawal by Subject|1|||
129619508|NCT04152863|466559979|FG002|Overall Study|Withdrawal by Subject|3|||
129619509|NCT02075515|466559980|FG000|Overall Study|Serious Adverse Event|1|||
129619510|NCT02075515|466559981|FG001|Overall Study|Serious Adverse Event|1|||
129619511|NCT02075515|466559982|FG002|Overall Study|Serious Adverse Event|1|||
129619512|NCT02075515|466559980|FG000|Overall Study|Non-Serious Adverse Event|0|||
129619513|NCT02075515|466559981|FG001|Overall Study|Non-Serious Adverse Event|1|||
129619514|NCT02075515|466559982|FG002|Overall Study|Non-Serious Adverse Event|0|||
129619515|NCT02075515|466559980|FG000|Overall Study|Withdrawal by Subject|2|||
129619516|NCT02075515|466559981|FG001|Overall Study|Withdrawal by Subject|0|||
129619517|NCT02075515|466559982|FG002|Overall Study|Withdrawal by Subject|1|||
129619518|NCT02075515|466559980|FG000|Overall Study|Lost to Follow-up|1|||
129619519|NCT02075515|466559981|FG001|Overall Study|Lost to Follow-up|3|||
129619520|NCT02075515|466559982|FG002|Overall Study|Lost to Follow-up|6|||
129619521|NCT00378573|466559985|FG000|Treatment Period|Adverse Event|9|||
129619522|NCT00378573|466559985|FG000|Treatment Period|Physician Decision|1|||
129619523|NCT00378573|466559985|FG000|Treatment Period|Withdrawal by Subject|2|||
129619524|NCT00378573|466559985|FG000|Treatment Period|Disease Progression|4|||
129619525|NCT00378573|466559985|FG000|Treatment Period|Sponsor decision to close study|1|||
129619526|NCT00378573|466559985|FG000|Follow-up|Death|12|||
129619527|NCT00378573|466559985|FG000|Follow-up|Lost to Follow-up|1|||
129619528|NCT00378573|466559985|FG000|Follow-up|Withdrawal by Subject|1|||
129619529|NCT00196326|466559986|FG000|Overall Study|Did not meet protocol requirements|64|||
129619530|NCT00196326|466559986|FG000|Overall Study|Non-compliance with the protocol|81|||
129619531|NCT00196326|466559986|FG000|Overall Study|Physician Decision|3|||
129619532|NCT00196326|466559986|FG000|Overall Study|Withdrawal by Subject|225|||
129619533|NCT00196326|466559986|FG000|Overall Study|Adverse Event|253|||
129619534|NCT00196326|466559986|FG000|Overall Study|Pregnancy|34|||
129619535|NCT00196326|466559986|FG000|Overall Study|Lost to Follow-up|304|||
129619536|NCT00196326|466559986|FG000|Overall Study|Other|22|||
129619537|NCT02797171|466559987|FG000|Overall Study|Lost to Follow-up|2|||
129619538|NCT02797171|466559988|FG001|Overall Study|Lost to Follow-up|0|||
129439403|NCT03945825|465906492|FG005|Overall Study|Lost to Follow-up|2|||
129439404|NCT03945825|465906487|FG000|Overall Study|Withdrawal by Subject|1|||
129619539|NCT02797171|466559989|FG002|Overall Study|Lost to Follow-up|2|||
129619540|NCT02797171|466559990|FG003|Overall Study|Lost to Follow-up|1|||
129619541|NCT02797171|466559991|FG004|Overall Study|Lost to Follow-up|2|||
129792757|NCT04393298|467209130|FG005|Overall Study|Patient Deceased|0|||
129619542|NCT02797171|466559992|FG005|Overall Study|Lost to Follow-up|0|||
129619543|NCT02797171|466559987|FG000|Overall Study|Withdrawal by Subject|1|||
129619544|NCT02797171|466559988|FG001|Overall Study|Withdrawal by Subject|1|||
129792758|NCT04393298|467209131|FG006|Overall Study|Patient Deceased|0|||
129792759|NCT04393298|467209132|FG007|Overall Study|Patient Deceased|1|||
129439405|NCT03945825|465906488|FG001|Overall Study|Withdrawal by Subject|0|||
129619545|NCT02797171|466559989|FG002|Overall Study|Withdrawal by Subject|0|||
129619546|NCT02797171|466559990|FG003|Overall Study|Withdrawal by Subject|0|||
129619547|NCT02797171|466559991|FG004|Overall Study|Withdrawal by Subject|0|||
129619548|NCT02797171|466559992|FG005|Overall Study|Withdrawal by Subject|0|||
129439406|NCT03945825|465906489|FG002|Overall Study|Withdrawal by Subject|1|||
129619549|NCT02797171|466559987|FG000|Overall Study|Protocol Violation|1|||
129619550|NCT02797171|466559988|FG001|Overall Study|Protocol Violation|0|||
129619551|NCT02797171|466559989|FG002|Overall Study|Protocol Violation|0|||
129619552|NCT02797171|466559990|FG003|Overall Study|Protocol Violation|0|||
129619553|NCT02797171|466559991|FG004|Overall Study|Protocol Violation|0|||
129619554|NCT02797171|466559992|FG005|Overall Study|Protocol Violation|0|||
129619555|NCT02797171|466559987|FG000|Overall Study|Participant unable to adhere|0|||
129619556|NCT02797171|466559988|FG001|Overall Study|Participant unable to adhere|1|||
129619557|NCT02797171|466559989|FG002|Overall Study|Participant unable to adhere|0|||
129619558|NCT02797171|466559990|FG003|Overall Study|Participant unable to adhere|0|||
129619559|NCT02797171|466559991|FG004|Overall Study|Participant unable to adhere|0|||
129619560|NCT02797171|466559992|FG005|Overall Study|Participant unable to adhere|0|||
129619561|NCT02797171|466559987|FG000|Overall Study|Not Randomized|0|||
129619562|NCT02797171|466559988|FG001|Overall Study|Not Randomized|0|||
129619563|NCT02797171|466559989|FG002|Overall Study|Not Randomized|0|||
129619564|NCT02797171|466559990|FG003|Overall Study|Not Randomized|0|||
129619565|NCT02797171|466559991|FG004|Overall Study|Not Randomized|0|||
129619566|NCT02797171|466559992|FG005|Overall Study|Not Randomized|1|||
129619567|NCT02540083|466559993|FG000|Overall Study|Withdrawal by Subject|16|||
129619568|NCT01372748|466559994|FG000|Overall Study|Lost to Follow-up|16|||
129619569|NCT01372748|466559995|FG001|Overall Study|Lost to Follow-up|34|||
129619570|NCT01372748|466559994|FG000|Overall Study|Withdrawal by Subject|7|||
129619571|NCT01372748|466559995|FG001|Overall Study|Withdrawal by Subject|5|||
129619572|NCT00134901|466559996|FG000|Overall Study|Lost to Follow-up|5|||
129619573|NCT00134901|466559997|FG001|Overall Study|Lost to Follow-up|5|||
129619574|NCT00134901|466559996|FG000|Overall Study|discontinued intervention|12|||
129619575|NCT00134901|466559997|FG001|Overall Study|discontinued intervention|10|||
129619576|NCT00445432|466560000|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
129619577|NCT00445432|466560001|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
129619578|NCT00445432|466560002|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
129619579|NCT00445432|466560003|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
129619580|NCT00445432|466560000|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
129619581|NCT00445432|466560001|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
129619582|NCT00445432|466560002|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
129701750|NCT02082977|466869410|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129888118|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
129888119|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
129439407|NCT03945825|465906490|FG003|Overall Study|Withdrawal by Subject|1|||
129439408|NCT03945825|465906491|FG004|Overall Study|Withdrawal by Subject|0|||
129439409|NCT03945825|465906492|FG005|Overall Study|Withdrawal by Subject|1|||
129439410|NCT01592864|465906495|FG000|Overall Study|Withdrawal by Subject|0|||
129439411|NCT01592864|465906496|FG001|Overall Study|Withdrawal by Subject|1|||
129619583|NCT00445432|466560003|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
129619584|NCT00445432|466560000|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
129619585|NCT00445432|466560001|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
129619586|NCT00445432|466560002|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
129619587|NCT00445432|466560003|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
129619588|NCT00445432|466560000|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
129619589|NCT00445432|466560001|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
129619590|NCT00445432|466560002|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
129619591|NCT00445432|466560003|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
129619592|NCT00445432|466560000|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
129619593|NCT00445432|466560001|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
129619594|NCT00445432|466560002|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
129619595|NCT00445432|466560003|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
129619596|NCT00445432|466560000|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
129619597|NCT00445432|466560001|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
129619598|NCT00445432|466560002|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
129619599|NCT00445432|466560003|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
129619600|NCT00445432|466560000|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
129619601|NCT00445432|466560001|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
129619602|NCT00445432|466560002|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
129619603|NCT00445432|466560003|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
129619604|NCT01699815|466560004|FG000|Overall Study|Protocol Violation|4|||
129888120|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
129888121|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129619605|NCT01699815|466560005|FG001|Overall Study|Protocol Violation|7|||
129619606|NCT01699815|466560004|FG000|Overall Study|record could not be located|1|||
129619607|NCT01699815|466560005|FG001|Overall Study|record could not be located|0|||
129619608|NCT01699815|466560004|FG000|Overall Study|Adverse Event|0|||
129439412|NCT01596621|465906499|FG000|Overall Study|Death|4|||
129888122|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888123|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888124|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
129888125|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888126|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888127|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888128|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
129888129|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
129888130|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888131|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888132|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888133|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888134|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
129888135|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888136|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
129888137|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
129888138|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
129439413|NCT01596621|465906499|FG000|Overall Study|Withdrawal by Subject|9|||
129439414|NCT01596621|465906499|FG000|Overall Study|Disease Progression|49|||
129619609|NCT01699815|466560005|FG001|Overall Study|Adverse Event|1|||
129619610|NCT00356525|466560006|FG000|Overall Study|Progressive Disease|8|||
129619611|NCT00356525|466560007|FG001|Overall Study|Progressive Disease|5|||
129619612|NCT00356525|466560008|FG002|Overall Study|Progressive Disease|4|||
129619613|NCT00356525|466560009|FG003|Overall Study|Progressive Disease|2|||
129619614|NCT00356525|466560006|FG000|Overall Study|Adverse Event|1|||
129619615|NCT00356525|466560007|FG001|Overall Study|Adverse Event|3|||
129619616|NCT00356525|466560008|FG002|Overall Study|Adverse Event|1|||
129619617|NCT00356525|466560009|FG003|Overall Study|Adverse Event|1|||
129619618|NCT00356525|466560006|FG000|Overall Study|Lost to Follow-up|1|||
129619619|NCT00356525|466560007|FG001|Overall Study|Lost to Follow-up|0|||
129619620|NCT00356525|466560008|FG002|Overall Study|Lost to Follow-up|0|||
129619621|NCT00356525|466560009|FG003|Overall Study|Lost to Follow-up|0|||
129619622|NCT00356525|466560006|FG000|Overall Study|Physician Decision|2|||
129619623|NCT00356525|466560007|FG001|Overall Study|Physician Decision|2|||
129619624|NCT00356525|466560008|FG002|Overall Study|Physician Decision|2|||
129619625|NCT00356525|466560009|FG003|Overall Study|Physician Decision|1|||
129619626|NCT00356525|466560006|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
129619627|NCT00356525|466560007|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
129619628|NCT00356525|466560008|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
129619629|NCT00356525|466560009|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
129619630|NCT00356525|466560006|FG000|Overall Study|Withdrawal by Subject|1|||
129619631|NCT00356525|466560007|FG001|Overall Study|Withdrawal by Subject|1|||
129619632|NCT00356525|466560008|FG002|Overall Study|Withdrawal by Subject|0|||
129619633|NCT00356525|466560009|FG003|Overall Study|Withdrawal by Subject|3|||
129619634|NCT00356525|466560006|FG000|Overall Study|Death|0|||
129619635|NCT00356525|466560007|FG001|Overall Study|Death|0|||
129619636|NCT00356525|466560008|FG002|Overall Study|Death|0|||
129619637|NCT00356525|466560009|FG003|Overall Study|Death|1|||
129619638|NCT00356525|466560006|FG000|Overall Study|Sponsor Decision|0|||
129619639|NCT00356525|466560007|FG001|Overall Study|Sponsor Decision|0|||
129619640|NCT00356525|466560008|FG002|Overall Study|Sponsor Decision|0|||
129619641|NCT00356525|466560009|FG003|Overall Study|Sponsor Decision|1|||
129888139|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
129439415|NCT01596621|465906499|FG000|Overall Study|Lost to Follow-up|3|||
129439416|NCT01596621|465906499|FG000|Overall Study|Other than specified|13|||
129439417|NCT00421707|465906504|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
129439418|NCT00421707|465906505|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
129619642|NCT01685840|466560025|FG000|Overall Study|Death|77|||
129888140|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
129888141|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129439419|NCT00421707|465906504|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
129619643|NCT01685840|466560026|FG001|Overall Study|Death|66|||
129619644|NCT01685840|466560025|FG000|Overall Study|Lost to Follow-up|27|||
129619645|NCT01685840|466560026|FG001|Overall Study|Lost to Follow-up|25|||
129619646|NCT01685840|466560025|FG000|Overall Study|Physician Decision|3|||
129619647|NCT01685840|466560026|FG001|Overall Study|Physician Decision|7|||
129619648|NCT01685840|466560025|FG000|Overall Study|Withdrawal by Subject|14|||
129619649|NCT01685840|466560026|FG001|Overall Study|Withdrawal by Subject|17|||
129619650|NCT01685840|466560025|FG000|Overall Study|Futility|197|||
129619651|NCT01685840|466560026|FG001|Overall Study|Futility|200|||
129439420|NCT00421707|465906505|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
129619652|NCT01685840|466560025|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
129619653|NCT01685840|466560026|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
129619654|NCT04487067|466560034|FG000|Overall Study|Adverse Event|3|||
129619655|NCT04487067|466560034|FG000|Overall Study|Death Other Than Progressive Disease|60|||
129619656|NCT04487067|466560034|FG000|Overall Study|Death Due To Progressive Disease|40|||
129619657|NCT04487067|466560034|FG000|Overall Study|Lost to Follow-up|3|||
129619658|NCT04487067|466560034|FG000|Overall Study|Progressive Disease|1|||
129619659|NCT04487067|466560034|FG000|Overall Study|Protocol Violation|3|||
129619660|NCT04487067|466560034|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
129619661|NCT04487067|466560034|FG000|Overall Study|Withdrawal by Subject|15|||
129619662|NCT02211417|466560035|FG000|Overall Study|Withdrawal by Subject|11|||
129619663|NCT02211417|466560036|FG001|Overall Study|Withdrawal by Subject|8|||
129619664|NCT02211417|466560035|FG000|Overall Study|Protocol Violation|1|||
129619665|NCT02211417|466560036|FG001|Overall Study|Protocol Violation|0|||
129619666|NCT02211417|466560035|FG000|Overall Study|Pregnancy|0|||
129619667|NCT02211417|466560036|FG001|Overall Study|Pregnancy|1|||
129619668|NCT02211417|466560035|FG000|Overall Study|Lost to Follow-up|2|||
129619669|NCT02211417|466560036|FG001|Overall Study|Lost to Follow-up|3|||
129619670|NCT02211417|466560035|FG000|Overall Study|Adverse Event|1|||
129619671|NCT02211417|466560036|FG001|Overall Study|Adverse Event|4|||
129619672|NCT01755091|466560037|FG000|Overall Study|Withdrawal by Subject|6|||
129619673|NCT01755091|466560038|FG001|Overall Study|Withdrawal by Subject|1|||
129619674|NCT01755091|466560039|FG002|Overall Study|Withdrawal by Subject|3|||
129619675|NCT01755091|466560037|FG000|Overall Study|Adverse Event|1|||
129619676|NCT01755091|466560038|FG001|Overall Study|Adverse Event|1|||
129619677|NCT01755091|466560039|FG002|Overall Study|Adverse Event|1|||
129619678|NCT01755091|466560037|FG000|Overall Study|Lost to Follow-up|1|||
129619679|NCT01755091|466560038|FG001|Overall Study|Lost to Follow-up|0|||
129619680|NCT01755091|466560039|FG002|Overall Study|Lost to Follow-up|1|||
129619681|NCT01755091|466560037|FG000|Overall Study|Physician Decision|1|||
129619682|NCT01755091|466560038|FG001|Overall Study|Physician Decision|1|||
129619683|NCT01755091|466560039|FG002|Overall Study|Physician Decision|2|||
129619684|NCT00490841|466560040|FG000|Overall Study|Death|5|||
129619685|NCT00490841|466560040|FG000|Overall Study|Withdrawal by Subject|4|||
129439421|NCT00421707|465906504|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
129619686|NCT00490841|466560040|FG000|Overall Study|Lost to Follow-up|1|||
129619687|NCT00490841|466560040|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
129619688|NCT06385483|466560043|FG000|Overall Study|Withdrawal by Subject|2|||
129619689|NCT06385483|466560043|FG000|Overall Study|Never start protocol therapy|2|||
129619690|NCT06385483|466560043|FG000|Overall Study|Disease progression|15|||
129792760|NCT04393298|467209133|FG008|Overall Study|Patient Deceased|0|||
129619691|NCT04700137|466560048|FG000|Overall Study|Lost to Follow-up|1|||
129619692|NCT04700137|466560049|FG001|Overall Study|Lost to Follow-up|6|||
129619693|NCT04700137|466560050|FG002|Overall Study|Lost to Follow-up|1|||
129619694|NCT04700137|466560051|FG003|Overall Study|Lost to Follow-up|1|||
129619695|NCT04700137|466560048|FG000|Overall Study|Withdrawal by Subject|0|||
129619696|NCT04700137|466560049|FG001|Overall Study|Withdrawal by Subject|0|||
129619697|NCT04700137|466560050|FG002|Overall Study|Withdrawal by Subject|1|||
129619698|NCT04700137|466560051|FG003|Overall Study|Withdrawal by Subject|0|||
129619699|NCT04700137|466560048|FG000|Overall Study|Death|0|||
129619700|NCT04700137|466560049|FG001|Overall Study|Death|0|||
129619701|NCT04700137|466560050|FG002|Overall Study|Death|1|||
129619702|NCT04700137|466560051|FG003|Overall Study|Death|0|||
129619703|NCT01320150|466560053|FG000|Overall Study|Protocol Violation|15|||
129619704|NCT01320150|466560053|FG000|Overall Study|Withdrawal by Subject|5|||
129619705|NCT01320150|466560053|FG000|Overall Study|Death|2|||
129619706|NCT01320150|466560053|FG000|Overall Study|Lost to Follow-up|44|||
129619707|NCT00919854|466560056|FG000|Overall Study|Adverse Event|1|||
129619708|NCT01862484|466560059|FG000|Overall Study|Lack of Efficacy|1|||
129619709|NCT01862484|466560060|FG001|Overall Study|Lack of Efficacy|1|||
129619710|NCT01862484|466560059|FG000|Overall Study|Lost to Follow-up|1|||
129619711|NCT01862484|466560060|FG001|Overall Study|Lost to Follow-up|2|||
129619712|NCT01862484|466560059|FG000|Overall Study|Protocol Violation|0|||
129701751|NCT02082977|466869411|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
129701752|NCT02082977|466869412|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129701753|NCT02082977|466869413|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129701754|NCT02082977|466869414|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129619713|NCT01862484|466560060|FG001|Overall Study|Protocol Violation|2|||
129619714|NCT01862484|466560059|FG000|Overall Study|Withdrawal by Subject|0|||
129619715|NCT01862484|466560060|FG001|Overall Study|Withdrawal by Subject|3|||
129701755|NCT02082977|466869415|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
129701756|NCT02082977|466869406|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129619716|NCT01632280|466560061|FG000|Overall Study|Withdrawal by Subject|1|||
129619717|NCT01632280|466560062|FG001|Overall Study|Withdrawal by Subject|0|||
129619718|NCT00993421|466560063|FG000|Overall Study|Adverse Event|2|||
129701757|NCT02082977|466869407|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129701758|NCT02082977|466869408|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129701759|NCT02082977|466869409|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129701760|NCT02082977|466869410|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
129701761|NCT02082977|466869411|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
129701762|NCT02082977|466869412|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
129701763|NCT02082977|466869413|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
129701764|NCT02082977|466869414|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
129701765|NCT02082977|466869415|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
129701766|NCT02082977|466869406|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129701767|NCT02082977|466869407|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129701768|NCT02082977|466869408|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129792761|NCT04393298|467209134|FG009|Overall Study|Patient Deceased|0|||
129619719|NCT00993421|466560064|FG001|Overall Study|Adverse Event|7|||
129701769|NCT02082977|466869409|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129619720|NCT00993421|466560065|FG002|Overall Study|Adverse Event|6|||
129619721|NCT00993421|466560066|FG003|Overall Study|Adverse Event|9|||
129619722|NCT00993421|466560067|FG004|Overall Study|Adverse Event|5|||
129619723|NCT00993421|466560068|FG005|Overall Study|Adverse Event|7|||
129619724|NCT00993421|466560069|FG006|Overall Study|Adverse Event|1|||
129619725|NCT00993421|466560063|FG000|Overall Study|Sponsor Decision|36|||
129619726|NCT00993421|466560064|FG001|Overall Study|Sponsor Decision|31|||
129619727|NCT00993421|466560065|FG002|Overall Study|Sponsor Decision|28|||
129619728|NCT00993421|466560066|FG003|Overall Study|Sponsor Decision|30|||
129619729|NCT00993421|466560067|FG004|Overall Study|Sponsor Decision|38|||
129619730|NCT00993421|466560068|FG005|Overall Study|Sponsor Decision|30|||
129619731|NCT00993421|466560069|FG006|Overall Study|Sponsor Decision|29|||
129619732|NCT00993421|466560063|FG000|Overall Study|Lost to Follow-up|3|||
129792762|NCT04393298|467209135|FG010|Overall Study|Patient Deceased|0|||
129792763|NCT04393298|467209136|FG011|Overall Study|Patient Deceased|0|||
129792764|NCT04393298|467209137|FG012|Overall Study|Patient Deceased|0|||
129792765|NCT04393298|467209138|FG013|Overall Study|Patient Deceased|0|||
129792766|NCT04393298|467209139|FG014|Overall Study|Patient Deceased|0|||
129792767|NCT04393298|467209125|FG000|Overall Study|Patient Discharged to Hospice|0|||
129792768|NCT04393298|467209126|FG001|Overall Study|Patient Discharged to Hospice|0|||
129792769|NCT04393298|467209127|FG002|Overall Study|Patient Discharged to Hospice|0|||
129792770|NCT04393298|467209128|FG003|Overall Study|Patient Discharged to Hospice|0|||
129792771|NCT04393298|467209129|FG004|Overall Study|Patient Discharged to Hospice|0|||
129792772|NCT04393298|467209130|FG005|Overall Study|Patient Discharged to Hospice|0|||
129792773|NCT04393298|467209131|FG006|Overall Study|Patient Discharged to Hospice|0|||
129792774|NCT04393298|467209132|FG007|Overall Study|Patient Discharged to Hospice|0|||
129792775|NCT04393298|467209133|FG008|Overall Study|Patient Discharged to Hospice|1|||
129792776|NCT04393298|467209134|FG009|Overall Study|Patient Discharged to Hospice|0|||
129792777|NCT04393298|467209135|FG010|Overall Study|Patient Discharged to Hospice|0|||
129792778|NCT04393298|467209136|FG011|Overall Study|Patient Discharged to Hospice|0|||
129792779|NCT04393298|467209137|FG012|Overall Study|Patient Discharged to Hospice|0|||
129792780|NCT04393298|467209138|FG013|Overall Study|Patient Discharged to Hospice|0|||
129792781|NCT04393298|467209139|FG014|Overall Study|Patient Discharged to Hospice|0|||
129792782|NCT04393298|467209125|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792783|NCT04393298|467209126|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792784|NCT04393298|467209127|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792785|NCT04393298|467209128|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792786|NCT04393298|467209129|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792787|NCT04393298|467209130|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792788|NCT04393298|467209131|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792789|NCT04393298|467209132|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792790|NCT04393298|467209133|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792791|NCT04393298|467209134|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
129792792|NCT04393298|467209135|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792793|NCT04393298|467209136|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792794|NCT04393298|467209137|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792795|NCT04393298|467209138|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792796|NCT04393298|467209139|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
129792797|NCT04393298|467209125|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
129792798|NCT04393298|467209126|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
129792799|NCT04393298|467209127|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
129792800|NCT04393298|467209128|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
129792801|NCT04393298|467209129|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
129792802|NCT04393298|467209130|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
129792803|NCT04393298|467209131|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
129792804|NCT04393298|467209132|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
129792805|NCT04393298|467209133|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
129619733|NCT00993421|466560064|FG001|Overall Study|Lost to Follow-up|5|||
129619734|NCT00993421|466560065|FG002|Overall Study|Lost to Follow-up|5|||
129619735|NCT00993421|466560066|FG003|Overall Study|Lost to Follow-up|0|||
129619736|NCT00993421|466560067|FG004|Overall Study|Lost to Follow-up|0|||
129792806|NCT04393298|467209134|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
129792807|NCT04393298|467209135|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
129792808|NCT04393298|467209136|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
129792809|NCT04393298|467209137|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
129792810|NCT04393298|467209138|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
129619737|NCT00993421|466560068|FG005|Overall Study|Lost to Follow-up|0|||
129619738|NCT00993421|466560069|FG006|Overall Study|Lost to Follow-up|6|||
129619739|NCT00993421|466560063|FG000|Overall Study|Withdrawal by Subject|3|||
129619740|NCT00993421|466560064|FG001|Overall Study|Withdrawal by Subject|2|||
129619741|NCT00993421|466560065|FG002|Overall Study|Withdrawal by Subject|3|||
129619742|NCT00993421|466560066|FG003|Overall Study|Withdrawal by Subject|3|||
129619743|NCT00993421|466560067|FG004|Overall Study|Withdrawal by Subject|3|||
129619744|NCT00993421|466560068|FG005|Overall Study|Withdrawal by Subject|5|||
129619745|NCT00993421|466560069|FG006|Overall Study|Withdrawal by Subject|3|||
129619746|NCT00993421|466560063|FG000|Overall Study|Death|0|||
129619747|NCT00993421|466560064|FG001|Overall Study|Death|0|||
129619748|NCT00993421|466560065|FG002|Overall Study|Death|0|||
129619749|NCT00993421|466560066|FG003|Overall Study|Death|0|||
129619750|NCT00993421|466560067|FG004|Overall Study|Death|0|||
129619751|NCT00993421|466560068|FG005|Overall Study|Death|0|||
129619752|NCT00993421|466560069|FG006|Overall Study|Death|1|||
129619753|NCT00993421|466560063|FG000|Overall Study|Entry Criteria Exclusion|0|||
129619754|NCT00993421|466560064|FG001|Overall Study|Entry Criteria Exclusion|0|||
129619755|NCT00993421|466560065|FG002|Overall Study|Entry Criteria Exclusion|1|||
129619756|NCT00993421|466560066|FG003|Overall Study|Entry Criteria Exclusion|3|||
129619757|NCT00993421|466560067|FG004|Overall Study|Entry Criteria Exclusion|0|||
129619758|NCT00993421|466560068|FG005|Overall Study|Entry Criteria Exclusion|1|||
129619759|NCT00993421|466560069|FG006|Overall Study|Entry Criteria Exclusion|0|||
129619760|NCT00993421|466560063|FG000|Overall Study|Physician Decision|0|||
129619761|NCT00993421|466560064|FG001|Overall Study|Physician Decision|0|||
129619762|NCT00993421|466560065|FG002|Overall Study|Physician Decision|0|||
129619763|NCT00993421|466560066|FG003|Overall Study|Physician Decision|0|||
129619764|NCT00993421|466560067|FG004|Overall Study|Physician Decision|0|||
129619765|NCT00993421|466560068|FG005|Overall Study|Physician Decision|1|||
129619766|NCT00993421|466560069|FG006|Overall Study|Physician Decision|1|||
129619767|NCT00993421|466560063|FG000|Overall Study|Protocol Violation|0|||
129619768|NCT00993421|466560064|FG001|Overall Study|Protocol Violation|0|||
129619769|NCT00993421|466560065|FG002|Overall Study|Protocol Violation|0|||
129619770|NCT00993421|466560066|FG003|Overall Study|Protocol Violation|0|||
129619771|NCT00993421|466560067|FG004|Overall Study|Protocol Violation|0|||
129619772|NCT00993421|466560068|FG005|Overall Study|Protocol Violation|2|||
129619773|NCT00993421|466560069|FG006|Overall Study|Protocol Violation|1|||
129619774|NCT02215967|466560070|FG000|Overall Study|Patient became ineligible for treatment|0|||
129619775|NCT02215967|466560071|FG001|Overall Study|Patient became ineligible for treatment|0|||
129619776|NCT02215967|466560072|FG002|Overall Study|Patient became ineligible for treatment|0|||
129619777|NCT02215967|466560073|FG003|Overall Study|Patient became ineligible for treatment|3|||
129619778|NCT02215967|466560070|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
129619779|NCT02215967|466560071|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
129619780|NCT02215967|466560072|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
129619781|NCT02215967|466560073|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
129619782|NCT00352417|466560074|FG000|Overall Study|Adverse Event|1|||
129619783|NCT00352417|466560075|FG001|Overall Study|Adverse Event|0|||
129619784|NCT00352417|466560074|FG000|Overall Study|Protocol Violation|0|||
129619785|NCT00352417|466560075|FG001|Overall Study|Protocol Violation|2|||
129619786|NCT00352417|466560074|FG000|Overall Study|Withdrawal by Subject|1|||
129619787|NCT00352417|466560075|FG001|Overall Study|Withdrawal by Subject|2|||
129619788|NCT00352417|466560074|FG000|Overall Study|Lost to Follow-up|1|||
129619789|NCT00352417|466560075|FG001|Overall Study|Lost to Follow-up|0|||
129619790|NCT00352417|466560074|FG000|Overall Study|Schedule Change|2|||
129619791|NCT00352417|466560075|FG001|Overall Study|Schedule Change|1|||
129619792|NCT01496976|466561657|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
129619793|NCT05292183|466561669|FG000|Overall Study|Adverse Event|1|||
129619794|NCT00371033|466561670|FG000|Overall Study|Lost to Follow-up|3|||
129619795|NCT00371033|466561671|FG001|Overall Study|Lost to Follow-up|2|||
129619796|NCT00371033|466561670|FG000|Overall Study|No longer interested|2|||
129619797|NCT00371033|466561671|FG001|Overall Study|No longer interested|0|||
129619798|NCT00371033|466561670|FG000|Overall Study|Uknown|3|||
129619799|NCT00371033|466561671|FG001|Overall Study|Uknown|1|||
129619800|NCT03631199|466561672|FG000|Overall Study|Progressive disease|9|||
129619801|NCT03631199|466561673|FG001|Overall Study|Progressive disease|5|||
129619802|NCT03631199|466561674|FG002|Overall Study|Progressive disease|5|||
129619803|NCT03631199|466561675|FG003|Overall Study|Progressive disease|149|||
129619804|NCT03631199|466561676|FG004|Overall Study|Progressive disease|148|||
129619805|NCT03631199|466561672|FG000|Overall Study|Physician Decision|0|||
129619806|NCT03631199|466561673|FG001|Overall Study|Physician Decision|2|||
129619807|NCT03631199|466561674|FG002|Overall Study|Physician Decision|3|||
129619808|NCT03631199|466561675|FG003|Overall Study|Physician Decision|19|||
129619809|NCT03631199|466561676|FG004|Overall Study|Physician Decision|13|||
129619810|NCT03631199|466561672|FG000|Overall Study|Adverse Event|1|||
129619811|NCT03631199|466561673|FG001|Overall Study|Adverse Event|1|||
129619812|NCT03631199|466561674|FG002|Overall Study|Adverse Event|0|||
129619813|NCT03631199|466561675|FG003|Overall Study|Adverse Event|28|||
129619814|NCT03631199|466561676|FG004|Overall Study|Adverse Event|29|||
129619815|NCT03631199|466561672|FG000|Overall Study|Death|0|||
129619816|NCT03631199|466561673|FG001|Overall Study|Death|1|||
129619817|NCT03631199|466561674|FG002|Overall Study|Death|0|||
129619818|NCT03631199|466561675|FG003|Overall Study|Death|35|||
129619819|NCT03631199|466561676|FG004|Overall Study|Death|48|||
129619820|NCT03631199|466561672|FG000|Overall Study|Subject decision|0|||
129619821|NCT03631199|466561673|FG001|Overall Study|Subject decision|1|||
129619822|NCT03631199|466561674|FG002|Overall Study|Subject decision|0|||
129619823|NCT03631199|466561675|FG003|Overall Study|Subject decision|12|||
129619824|NCT03631199|466561676|FG004|Overall Study|Subject decision|12|||
129619825|NCT03631199|466561672|FG000|Overall Study|No treated|0|||
129619826|NCT03631199|466561673|FG001|Overall Study|No treated|0|||
129619827|NCT03631199|466561674|FG002|Overall Study|No treated|0|||
129619828|NCT03631199|466561675|FG003|Overall Study|No treated|0|||
129619829|NCT03631199|466561676|FG004|Overall Study|No treated|1|||
129619830|NCT03631199|466561672|FG000|Overall Study|Treatment ongoing|0|||
129619831|NCT03631199|466561673|FG001|Overall Study|Treatment ongoing|1|||
129619832|NCT03631199|466561674|FG002|Overall Study|Treatment ongoing|1|||
129619833|NCT03631199|466561675|FG003|Overall Study|Treatment ongoing|76|||
129619834|NCT03631199|466561676|FG004|Overall Study|Treatment ongoing|71|||
129619835|NCT03631199|466561672|FG000|Overall Study|Guardian decision|0|||
129619836|NCT03631199|466561673|FG001|Overall Study|Guardian decision|0|||
129619837|NCT03631199|466561674|FG002|Overall Study|Guardian decision|0|||
129619838|NCT03631199|466561675|FG003|Overall Study|Guardian decision|1|||
129619839|NCT03631199|466561676|FG004|Overall Study|Guardian decision|1|||
129619840|NCT03651700|466561677|FG000|Overall Study|Withdrawal by Subject|1|||
129619841|NCT03651700|466561678|FG001|Overall Study|Withdrawal by Subject|0|||
129619842|NCT02847260|466561679|FG000|Overall Study|Adverse Event|3|||
129619843|NCT02847260|466561679|FG000|Overall Study|Withdrawal by Subject|2|||
129619844|NCT02847260|466561679|FG000|Overall Study|Clinical Deterioration|1|||
129619845|NCT02847260|466561679|FG000|Overall Study|Physician Decision|1|||
129619846|NCT03698019|466561680|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
129619847|NCT03698019|466561681|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
129619848|NCT03698019|466561680|FG000|Step 1: Registration|Withdrawal by Subject|7|||
129619849|NCT03698019|466561681|FG001|Step 1: Registration|Withdrawal by Subject|2|||
129619850|NCT03698019|466561680|FG000|Step 1: Registration|Toxicity|0|||
129792811|NCT04393298|467209139|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
129792812|NCT03754972|467209140|FG000|Overall Study|Protocol Violation|25|||
129792813|NCT02311582|467209141|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129792814|NCT02311582|467209142|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129792815|NCT02311582|467209143|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
129792816|NCT02311582|467209144|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
129792817|NCT02311582|467209145|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
129792818|NCT03422627|467209146|FG000|Overall Study|Protocol-specified Criteria|1|||
129792819|NCT03422627|467209147|FG001|Overall Study|Protocol-specified Criteria|1|||
129792820|NCT03422627|467209148|FG002|Overall Study|Protocol-specified Criteria|0|||
129792821|NCT03422627|467209149|FG003|Overall Study|Protocol-specified Criteria|0|||
129792822|NCT03422627|467209150|FG004|Overall Study|Protocol-specified Criteria|2|||
129792823|NCT03422627|467209146|FG000|Overall Study|Requirement for Alternative Therapy|1|||
129792824|NCT03422627|467209147|FG001|Overall Study|Requirement for Alternative Therapy|1|||
129792825|NCT03422627|467209148|FG002|Overall Study|Requirement for Alternative Therapy|2|||
129792826|NCT03422627|467209149|FG003|Overall Study|Requirement for Alternative Therapy|0|||
129792827|NCT03422627|467209150|FG004|Overall Study|Requirement for Alternative Therapy|0|||
129792828|NCT03422627|467209146|FG000|Overall Study|Disease Progression|1|||
129792829|NCT03422627|467209147|FG001|Overall Study|Disease Progression|0|||
129792830|NCT03422627|467209148|FG002|Overall Study|Disease Progression|1|||
129792831|NCT03422627|467209149|FG003|Overall Study|Disease Progression|2|||
129792832|NCT03422627|467209150|FG004|Overall Study|Disease Progression|0|||
129792833|NCT03422627|467209146|FG000|Overall Study|Adverse Event|2|||
129792834|NCT03422627|467209147|FG001|Overall Study|Adverse Event|1|||
129792835|NCT03422627|467209148|FG002|Overall Study|Adverse Event|0|||
129792836|NCT03422627|467209149|FG003|Overall Study|Adverse Event|0|||
129792837|NCT03422627|467209150|FG004|Overall Study|Adverse Event|2|||
129792838|NCT03422627|467209146|FG000|Overall Study|Ineligibility Determined|0|||
129792839|NCT03422627|467209147|FG001|Overall Study|Ineligibility Determined|1|||
129619851|NCT03698019|466561681|FG001|Step 1: Registration|Toxicity|1|||
129619852|NCT03698019|466561680|FG000|Step 1: Registration|Disease Progression|0|||
129619853|NCT03698019|466561681|FG001|Step 1: Registration|Disease Progression|12|||
129619854|NCT03698019|466561680|FG000|Step 1: Registration|Co-morbidities|0|||
129792840|NCT03422627|467209148|FG002|Overall Study|Ineligibility Determined|0|||
129792841|NCT03422627|467209149|FG003|Overall Study|Ineligibility Determined|0|||
129792842|NCT03422627|467209150|FG004|Overall Study|Ineligibility Determined|0|||
129792843|NCT03422627|467209146|FG000|Overall Study|Death|0|||
129792844|NCT03422627|467209147|FG001|Overall Study|Death|1|||
129792845|NCT03422627|467209148|FG002|Overall Study|Death|1|||
129792846|NCT03422627|467209149|FG003|Overall Study|Death|0|||
129792847|NCT03422627|467209150|FG004|Overall Study|Death|0|||
129792848|NCT03422627|467209146|FG000|Overall Study|Withdrawal by Subject|0|||
129792849|NCT03422627|467209147|FG001|Overall Study|Withdrawal by Subject|0|||
129792850|NCT03422627|467209148|FG002|Overall Study|Withdrawal by Subject|0|||
129792851|NCT03422627|467209149|FG003|Overall Study|Withdrawal by Subject|1|||
129619855|NCT03698019|466561681|FG001|Step 1: Registration|Co-morbidities|1|||
129619856|NCT03698019|466561680|FG000|Step 1: Registration|Scheduling Issues|1|||
129619857|NCT03698019|466561681|FG001|Step 1: Registration|Scheduling Issues|0|||
129619858|NCT03698019|466561680|FG000|Step 1: Registration|Participant Refusal|0|||
129619859|NCT03698019|466561681|FG001|Step 1: Registration|Participant Refusal|1|||
129619860|NCT03698019|466561680|FG000|Step 2: Surgery|Participant Refusal|2|||
129619861|NCT03698019|466561681|FG001|Step 2: Surgery|Participant Refusal|1|||
129619862|NCT03698019|466561680|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
129619863|NCT03698019|466561681|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
129619864|NCT03698019|466561680|FG000|Step 2: Surgery|Metastatic Disease|16|||
129619865|NCT03698019|466561681|FG001|Step 2: Surgery|Metastatic Disease|9|||
129619866|NCT03698019|466561680|FG000|Step 2: Surgery|Residual Disease|2|||
129619867|NCT03698019|466561681|FG001|Step 2: Surgery|Residual Disease|1|||
129619868|NCT03698019|466561680|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
129619869|NCT03698019|466561681|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
129619870|NCT03698019|466561680|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
129619871|NCT03698019|466561681|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
129619872|NCT03698019|466561680|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
129619873|NCT03698019|466561681|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
129619874|NCT03698019|466561680|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
129619875|NCT03698019|466561681|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
129619876|NCT03698019|466561680|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
129619877|NCT03698019|466561681|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
129619878|NCT03698019|466561680|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
129619879|NCT03698019|466561681|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
129619880|NCT03698019|466561680|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
129619881|NCT03698019|466561681|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
129619882|NCT03698019|466561680|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
129619883|NCT03698019|466561681|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
129619884|NCT00588770|466561682|FG000|Overall Study|Disease progression|85|||
129619885|NCT00588770|466561683|FG001|Overall Study|Disease progression|68|||
129619886|NCT00588770|466561682|FG000|Overall Study|Adverse Event|29|||
129619887|NCT00588770|466561683|FG001|Overall Study|Adverse Event|58|||
129619888|NCT00588770|466561682|FG000|Overall Study|Death|13|||
129619889|NCT00588770|466561683|FG001|Overall Study|Death|22|||
129619890|NCT00588770|466561682|FG000|Overall Study|Withdrawal by Subject|15|||
129619891|NCT00588770|466561683|FG001|Overall Study|Withdrawal by Subject|25|||
129619892|NCT00588770|466561682|FG000|Overall Study|Alternative therapy|2|||
129619893|NCT00588770|466561683|FG001|Overall Study|Alternative therapy|4|||
129619894|NCT00588770|466561682|FG000|Overall Study|Other complicating disease|3|||
129619895|NCT00588770|466561683|FG001|Overall Study|Other complicating disease|2|||
129619896|NCT00588770|466561682|FG000|Overall Study|Not start protocol therapy|0|||
129619897|NCT00588770|466561683|FG001|Overall Study|Not start protocol therapy|9|||
129619898|NCT00588770|466561682|FG000|Overall Study|Lack of Efficacy|8|||
129619899|NCT00588770|466561683|FG001|Overall Study|Lack of Efficacy|10|||
129619900|NCT00588770|466561682|FG000|Overall Study|Physician discretion|2|||
129619901|NCT00588770|466561683|FG001|Overall Study|Physician discretion|0|||
129619902|NCT00588770|466561682|FG000|Overall Study|Patient non-compliance|2|||
129619903|NCT00588770|466561683|FG001|Overall Study|Patient non-compliance|2|||
129619904|NCT01856192|466561684|FG000|Overall Study|Adverse Event|12|||
129619905|NCT01856192|466561685|FG001|Overall Study|Adverse Event|4|||
129619906|NCT01856192|466561684|FG000|Overall Study|Alternative therapy|0|||
129619907|NCT01856192|466561685|FG001|Overall Study|Alternative therapy|3|||
129619908|NCT01856192|466561684|FG000|Overall Study|Death|3|||
129619909|NCT01856192|466561685|FG001|Overall Study|Death|5|||
129619910|NCT01856192|466561684|FG000|Overall Study|Lack of Efficacy|0|||
129619911|NCT01856192|466561685|FG001|Overall Study|Lack of Efficacy|5|||
129619912|NCT01856192|466561684|FG000|Overall Study|Withdrawal by Subject|1|||
129619913|NCT01856192|466561685|FG001|Overall Study|Withdrawal by Subject|1|||
129619914|NCT01856192|466561684|FG000|Overall Study|Other diseases|1|||
129619915|NCT01856192|466561685|FG001|Overall Study|Other diseases|0|||
129619916|NCT01856192|466561684|FG000|Overall Study|Never started treatment|7|||
129619917|NCT01856192|466561685|FG001|Overall Study|Never started treatment|5|||
129619918|NCT01856192|466561684|FG000|Overall Study|Path ineligible|20|||
129619919|NCT01856192|466561685|FG001|Overall Study|Path ineligible|34|||
129619920|NCT01856192|466561684|FG000|Overall Study|Non-path ineligible|2|||
129619921|NCT01856192|466561685|FG001|Overall Study|Non-path ineligible|2|||
129619922|NCT01856192|466561684|FG000|Overall Study|Physician Decision|1|||
129619923|NCT01856192|466561685|FG001|Overall Study|Physician Decision|1|||
129619924|NCT01856192|466561684|FG000|Overall Study|Suspicion of progressive disease|1|||
129792852|NCT03422627|467209150|FG004|Overall Study|Withdrawal by Subject|0|||
129619925|NCT01856192|466561685|FG001|Overall Study|Suspicion of progressive disease|0|||
129619926|NCT01856192|466561684|FG000|Overall Study|Non-compliance|1|||
129619927|NCT01856192|466561685|FG001|Overall Study|Non-compliance|0|||
129619928|NCT02642042|466561686|FG000|Overall Study|Adverse Event|22|||
129619929|NCT02642042|466561686|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129619930|NCT02642042|466561686|FG000|Overall Study|Progression/Relapse|28|||
129619931|NCT02642042|466561686|FG000|Overall Study|Death|1|||
129619932|NCT02642042|466561686|FG000|Overall Study|Not Protocol Specified|2|||
129619933|NCT04976621|466561687|FG000|Overall Study|Lost to Follow-up|2|||
129619934|NCT04976621|466561688|FG001|Overall Study|Lost to Follow-up|1|||
129619935|NCT04976621|466561687|FG000|Overall Study|Withdrawal by Subject|1|||
129619936|NCT04976621|466561688|FG001|Overall Study|Withdrawal by Subject|0|||
129619937|NCT01625988|466561698|FG000|Overall Study|Lost to Follow-up|5|||
129619938|NCT01625988|466561699|FG001|Overall Study|Lost to Follow-up|6|||
129619939|NCT01625988|466561698|FG000|Overall Study|Withdrawal by Subject|8|||
129619940|NCT01625988|466561699|FG001|Overall Study|Withdrawal by Subject|3|||
129619941|NCT01625988|466561698|FG000|Overall Study|Adverse Event|0|||
129619942|NCT01625988|466561699|FG001|Overall Study|Adverse Event|1|||
129619943|NCT01625988|466561698|FG000|Overall Study|Lack of Efficacy|0|||
129619944|NCT01625988|466561699|FG001|Overall Study|Lack of Efficacy|1|||
129619945|NCT01625988|466561698|FG000|Overall Study|Randomized Inappropriately|1|||
129701770|NCT02082977|466869410|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129619946|NCT01625988|466561699|FG001|Overall Study|Randomized Inappropriately|0|||
129619947|NCT01625988|466561698|FG000|Overall Study|Protocol Violation|0|||
129619948|NCT01625988|466561699|FG001|Overall Study|Protocol Violation|2|||
129619949|NCT01644617|466561700|FG000|Overall Study|Withdrawal by Subject|3|||
129619950|NCT01644617|466561701|FG001|Overall Study|Withdrawal by Subject|4|||
129701771|NCT02082977|466869411|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129792853|NCT04656275|467209153|FG000|Overall Study|Study terminated by sponsor|2|||
129792854|NCT04656275|467209154|FG001|Overall Study|Study terminated by sponsor|4|||
129792855|NCT00934648|467209157|FG000|Overall Study|Failure to return|8|||
129792856|NCT00934648|467209157|FG000|Overall Study|Withdrawal by Subject|1|||
129619951|NCT01644617|466561702|FG002|Overall Study|Withdrawal by Subject|1|||
129792857|NCT03828370|467209158|FG000|3 Month Follow-up|Lost to Follow-up|4|||
129619952|NCT01644617|466561700|FG000|Overall Study|Lost to Follow-up|0|||
129619953|NCT01644617|466561701|FG001|Overall Study|Lost to Follow-up|1|||
129619954|NCT01644617|466561702|FG002|Overall Study|Lost to Follow-up|0|||
129619955|NCT01644617|466561700|FG000|Overall Study|Adverse Event|3|||
129619956|NCT01644617|466561701|FG001|Overall Study|Adverse Event|0|||
129619957|NCT01644617|466561702|FG002|Overall Study|Adverse Event|6|||
129619958|NCT01427608|466561706|FG000|Overall Study|Death|1|||
129619959|NCT01427608|466561707|FG001|Overall Study|Death|0|||
129619960|NCT01427608|466561706|FG000|Overall Study|Withdrawal by Subject|7|||
129619961|NCT01427608|466561707|FG001|Overall Study|Withdrawal by Subject|3|||
129619962|NCT01427608|466561706|FG000|Overall Study|Relapsed-all cause|13|||
129619963|NCT01427608|466561707|FG001|Overall Study|Relapsed-all cause|34|||
129619964|NCT01427608|466561706|FG000|Overall Study|Events not attributed to study meds|0|||
129619965|NCT01427608|466561707|FG001|Overall Study|Events not attributed to study meds|1|||
129619966|NCT03993379|466561708|FG000|Overall Study|The study was terminated early due to business decision.|0|||
129619967|NCT03993379|466561709|FG001|Overall Study|The study was terminated early due to business decision.|2|||
129619968|NCT03993379|466561710|FG002|Overall Study|The study was terminated early due to business decision.|0|||
129619969|NCT03993379|466561711|FG003|Overall Study|The study was terminated early due to business decision.|0|||
129619970|NCT03993379|466561708|FG000|Overall Study|Withdrawal by Subject|0|||
129619971|NCT03993379|466561709|FG001|Overall Study|Withdrawal by Subject|1|||
129619972|NCT03993379|466561710|FG002|Overall Study|Withdrawal by Subject|0|||
129619973|NCT03993379|466561711|FG003|Overall Study|Withdrawal by Subject|0|||
129619974|NCT05223920|466561712|FG000|Overall Study|Adverse Event|6|||
129619975|NCT05223920|466561713|FG001|Overall Study|Adverse Event|3|||
129619976|NCT05223920|466561712|FG000|Overall Study|Death|2|||
129619977|NCT05223920|466561713|FG001|Overall Study|Death|0|||
129619978|NCT05223920|466561712|FG000|Overall Study|Disease Progression|1|||
129619979|NCT05223920|466561713|FG001|Overall Study|Disease Progression|2|||
129619980|NCT05223920|466561712|FG000|Overall Study|Physician Decision|1|||
129619981|NCT05223920|466561713|FG001|Overall Study|Physician Decision|2|||
129619982|NCT05223920|466561712|FG000|Overall Study|Sponsor decision|11|||
129619983|NCT05223920|466561713|FG001|Overall Study|Sponsor decision|9|||
129792858|NCT03828370|467209159|FG001|3 Month Follow-up|Lost to Follow-up|12|||
129792859|NCT03828370|467209158|FG000|9 Month Follow up|Lost to Follow-up|12|||
129792860|NCT03828370|467209159|FG001|9 Month Follow up|Lost to Follow-up|20|||
129792861|NCT02554279|467209162|FG000|Overall Study|Adverse Event|2|||
129792862|NCT02554279|467209163|FG001|Overall Study|Adverse Event|5|||
129792863|NCT02554279|467209162|FG000|Overall Study|Lost to Follow-up|3|||
129792864|NCT02554279|467209163|FG001|Overall Study|Lost to Follow-up|2|||
129792865|NCT02554279|467209162|FG000|Overall Study|Withdrawal by Subject|6|||
129792866|NCT02554279|467209163|FG001|Overall Study|Withdrawal by Subject|4|||
129792867|NCT02554279|467209162|FG000|Overall Study|Protocol Violation|2|||
129792868|NCT02554279|467209163|FG001|Overall Study|Protocol Violation|1|||
129792869|NCT02554279|467209162|FG000|Overall Study|Other reason|19|||
129792870|NCT02554279|467209163|FG001|Overall Study|Other reason|6|||
129792871|NCT00812487|467209164|FG000|Overall Study|Lost to Follow-up|2|||
129792872|NCT00812487|467209165|FG001|Overall Study|Lost to Follow-up|0|||
129792873|NCT00812487|467209164|FG000|Overall Study|Withdrawal by Subject|3|||
129792874|NCT00812487|467209165|FG001|Overall Study|Withdrawal by Subject|2|||
129792875|NCT00812487|467209164|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
129792876|NCT00812487|467209165|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
129792877|NCT00812487|467209164|FG000|Overall Study|Protocol Violation|0|||
129792878|NCT00812487|467209165|FG001|Overall Study|Protocol Violation|1|||
129792879|NCT02360605|467209166|FG000|Overall Study|Withdrawal by Subject|4|||
129619984|NCT05223920|466561712|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
129619985|NCT05223920|466561713|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
129619986|NCT05223920|466561712|FG000|Overall Study|Subject decision|1|||
129619987|NCT05223920|466561713|FG001|Overall Study|Subject decision|0|||
129619988|NCT05223920|466561712|FG000|Overall Study|Withdrawal by Subject|1|||
129792880|NCT02360605|467209167|FG001|Overall Study|Withdrawal by Subject|9|||
129792881|NCT02360605|467209166|FG000|Overall Study|Lost to Follow-up|7|||
129792882|NCT02360605|467209167|FG001|Overall Study|Lost to Follow-up|8|||
129792883|NCT02360605|467209166|FG000|Overall Study|Death|0|||
129792884|NCT02360605|467209167|FG001|Overall Study|Death|1|||
129792885|NCT00290407|467209170|FG000|Overall Study|Physician Decision|2|||
129792886|NCT00723203|467209171|FG000|Overall Study|Withdrawal by Subject|3|||
129792887|NCT00740051|467209172|FG000|Overall Study|Lack of Efficacy|2|||
129792888|NCT00740051|467209173|FG001|Overall Study|Lack of Efficacy|5|||
129701772|NCT02082977|466869412|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129701773|NCT02082977|466869413|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
129701774|NCT02082977|466869414|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129701775|NCT02082977|466869415|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
129701776|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
129701777|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
129701778|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
129701779|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
129701780|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
129701781|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
129701782|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
129701783|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
129701784|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
129701785|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
129701786|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
129701787|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
129701788|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
129701789|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
129701790|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
129701791|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
129701792|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
129701793|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
129701794|NCT00086515|466869416|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
129701795|NCT00086515|466869417|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
129701796|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
129701797|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
129701798|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
129701799|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
129701800|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
129701801|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
129619989|NCT05223920|466561713|FG001|Overall Study|Withdrawal by Subject|6|||
129619990|NCT03790657|466561714|FG000|Overall Study|Adverse Event|1|||
129619991|NCT03790657|466561715|FG001|Overall Study|Adverse Event|1|||
129619992|NCT03790657|466561714|FG000|Overall Study|Withdrawal by Subject|1|||
129619993|NCT03790657|466561715|FG001|Overall Study|Withdrawal by Subject|1|||
129619994|NCT01807065|466561716|FG000|Overall Study|Receive no sip-T due to IV access|1|||
129619995|NCT01807065|466561717|FG001|Overall Study|Receive no sip-T due to IV access|1|||
129619996|NCT05246670|466561722|FG000|Overall Study|Withdrawal by Subject|2|||
129619997|NCT05246670|466561723|FG001|Overall Study|Withdrawal by Subject|3|||
129619998|NCT05246670|466561724|FG002|Overall Study|Withdrawal by Subject|0|||
129619999|NCT05246670|466561725|FG003|Overall Study|Withdrawal by Subject|1|||
129620000|NCT05246670|466561722|FG000|Overall Study|Adverse Event|0|||
129620001|NCT05246670|466561723|FG001|Overall Study|Adverse Event|0|||
129620002|NCT05246670|466561724|FG002|Overall Study|Adverse Event|1|||
129620003|NCT05246670|466561725|FG003|Overall Study|Adverse Event|0|||
129620004|NCT05246670|466561722|FG000|Overall Study|Physician Decision|1|||
129620005|NCT05246670|466561723|FG001|Overall Study|Physician Decision|0|||
129620006|NCT05246670|466561724|FG002|Overall Study|Physician Decision|0|||
129620007|NCT05246670|466561725|FG003|Overall Study|Physician Decision|0|||
129620008|NCT05246670|466561722|FG000|Overall Study|Protocol Violation|1|||
129620009|NCT05246670|466561723|FG001|Overall Study|Protocol Violation|0|||
129620010|NCT05246670|466561724|FG002|Overall Study|Protocol Violation|0|||
129620011|NCT05246670|466561725|FG003|Overall Study|Protocol Violation|0|||
129620012|NCT03154125|466561731|FG000|Overall Study|Lost to Follow-up|11|||
129620013|NCT03154125|466561732|FG001|Overall Study|Lost to Follow-up|11|||
129620014|NCT03154125|466561733|FG002|Overall Study|Lost to Follow-up|0|||
129620015|NCT03154125|466561731|FG000|Overall Study|Withdrawal by Subject|49|||
129620016|NCT03154125|466561732|FG001|Overall Study|Withdrawal by Subject|55|||
129620017|NCT03154125|466561733|FG002|Overall Study|Withdrawal by Subject|8|||
129620018|NCT03154125|466561731|FG000|Overall Study|Physician Decision|13|||
129620019|NCT03154125|466561732|FG001|Overall Study|Physician Decision|6|||
129620020|NCT03154125|466561733|FG002|Overall Study|Physician Decision|0|||
129620021|NCT03154125|466561731|FG000|Overall Study|Protocol Violation|3|||
129620022|NCT03154125|466561732|FG001|Overall Study|Protocol Violation|5|||
129620023|NCT03154125|466561733|FG002|Overall Study|Protocol Violation|0|||
129620024|NCT00799058|466561734|FG000|Overall Study|Withdrawal by Subject|2|||
129620025|NCT00799058|466561735|FG001|Overall Study|Withdrawal by Subject|2|||
129620026|NCT00799058|466561736|FG002|Overall Study|Withdrawal by Subject|2|||
129701802|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
129701803|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
129701804|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
129620027|NCT00799058|466561734|FG000|Overall Study|Lost to Follow-up|1|||
129620028|NCT00799058|466561735|FG001|Overall Study|Lost to Follow-up|2|||
129620029|NCT00799058|466561736|FG002|Overall Study|Lost to Follow-up|1|||
129701805|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
129701806|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
129701807|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
129701808|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
129701809|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
129701810|NCT00086515|466869416|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
129701811|NCT00086515|466869417|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
129701812|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
129701813|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
129701814|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
129701815|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
129701816|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
129701817|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
129701818|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
129701819|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
129701820|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
129701821|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
129701822|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
129701823|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
129701824|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
129620030|NCT00799058|466561734|FG000|Overall Study|Adverse Event|0|||
129620031|NCT00799058|466561735|FG001|Overall Study|Adverse Event|2|||
129620032|NCT00799058|466561736|FG002|Overall Study|Adverse Event|0|||
129620033|NCT00799058|466561734|FG000|Overall Study|Pregnancy|1|||
129620034|NCT00799058|466561735|FG001|Overall Study|Pregnancy|0|||
129620035|NCT00799058|466561736|FG002|Overall Study|Pregnancy|0|||
129620036|NCT00799058|466561734|FG000|Overall Study|Not adherent|3|||
129620037|NCT00799058|466561735|FG001|Overall Study|Not adherent|2|||
129620038|NCT00799058|466561736|FG002|Overall Study|Not adherent|1|||
129620039|NCT00799058|466561734|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
129620040|NCT00799058|466561735|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
129620041|NCT00799058|466561736|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
129620042|NCT00799058|466561734|FG000|Overall Study|IP dispensing error|1|||
129620043|NCT00799058|466561735|FG001|Overall Study|IP dispensing error|0|||
129620044|NCT00799058|466561736|FG002|Overall Study|IP dispensing error|0|||
129701825|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
129701826|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
129701827|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
129701828|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
129620045|NCT00799058|466561734|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
129701829|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
129701830|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
129701831|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
129701832|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
129701833|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
129701834|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
129701835|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
129701836|NCT00086515|466869416|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
129701837|NCT00086515|466869417|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
129701838|NCT02106832|466869418|FG000|Overall Study|Adverse Event|1|||
129701839|NCT02106832|466869419|FG001|Overall Study|Adverse Event|2|||
129701840|NCT02106832|466869420|FG002|Overall Study|Adverse Event|3|||
129701841|NCT02106832|466869421|FG003|Overall Study|Adverse Event|0|||
129701842|NCT02106832|466869418|FG000|Overall Study|Death|4|||
129701843|NCT02106832|466869419|FG001|Overall Study|Death|4|||
129701844|NCT02106832|466869420|FG002|Overall Study|Death|1|||
129701845|NCT02106832|466869421|FG003|Overall Study|Death|4|||
129701846|NCT02106832|466869418|FG000|Overall Study|Deterioration of general conditions|0|||
129701847|NCT02106832|466869419|FG001|Overall Study|Deterioration of general conditions|0|||
129701848|NCT02106832|466869420|FG002|Overall Study|Deterioration of general conditions|1|||
129701849|NCT02106832|466869421|FG003|Overall Study|Deterioration of general conditions|0|||
129701850|NCT02106832|466869418|FG000|Overall Study|Lost to Follow-up|0|||
129701851|NCT02106832|466869419|FG001|Overall Study|Lost to Follow-up|1|||
129701852|NCT02106832|466869420|FG002|Overall Study|Lost to Follow-up|1|||
129701853|NCT02106832|466869421|FG003|Overall Study|Lost to Follow-up|3|||
129701854|NCT02106832|466869418|FG000|Overall Study|Physician Decision|1|||
129701855|NCT02106832|466869419|FG001|Overall Study|Physician Decision|0|||
129620046|NCT00799058|466561735|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
129620047|NCT00799058|466561736|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
129620048|NCT00799058|466561734|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
129620049|NCT00799058|466561735|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
129620050|NCT00799058|466561736|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
129620051|NCT00799058|466561734|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
129620052|NCT00799058|466561735|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
129620053|NCT00799058|466561736|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
129620054|NCT00799058|466561734|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
129620055|NCT00799058|466561735|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
129620056|NCT00799058|466561736|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
129620057|NCT03639779|466561737|FG000|Overall Study|Lost to Follow-up|1|||
129620058|NCT02088697|466561738|FG000|Period I|Physician Decision|1|||
129620059|NCT02088697|466561739|FG001|Period I|Physician Decision|4|||
129620060|NCT02088697|466561738|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
129620061|NCT02088697|466561739|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
129620062|NCT00810511|466561740|FG000|Overall Study|Protocol Violation|0|||
129620063|NCT00810511|466561741|FG001|Overall Study|Protocol Violation|1|||
129620064|NCT00810511|466561740|FG000|Overall Study|Lack of Efficacy|9|||
129620065|NCT00810511|466561741|FG001|Overall Study|Lack of Efficacy|1|||
129620066|NCT00810511|466561740|FG000|Overall Study|death in the family|0|||
129620067|NCT00810511|466561741|FG001|Overall Study|death in the family|1|||
129620068|NCT00810511|466561740|FG000|Overall Study|Lost to Follow-up|1|||
129620069|NCT00810511|466561741|FG001|Overall Study|Lost to Follow-up|0|||
129620070|NCT00810511|466561740|FG000|Overall Study|deposits on contact lens|0|||
129620071|NCT00810511|466561741|FG001|Overall Study|deposits on contact lens|1|||
129620072|NCT00462904|466561742|FG000|Overall Study|Lost to Follow-up|1|||
129620073|NCT05219448|466561743|FG000|Overall Study|Lost to Follow-up|9|||
129620074|NCT05219448|466561744|FG001|Overall Study|Lost to Follow-up|0|||
129620075|NCT00911300|466561748|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
129620076|NCT00911300|466561749|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
129620077|NCT00911300|466561748|FG000|Overall Study|Death|1|||
129620078|NCT00911300|466561749|FG001|Overall Study|Death|0|||
129620079|NCT00911300|466561748|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
129620080|NCT00911300|466561749|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
129620081|NCT00911300|466561748|FG000|Overall Study|Adverse Event|14|||
129620082|NCT00911300|466561749|FG001|Overall Study|Adverse Event|6|||
129620083|NCT00911300|466561748|FG000|Overall Study|Protocol Violation|3|||
129620084|NCT00911300|466561749|FG001|Overall Study|Protocol Violation|2|||
129620085|NCT00911300|466561748|FG000|Overall Study|Consent Withdrawn|4|||
129620086|NCT00911300|466561749|FG001|Overall Study|Consent Withdrawn|12|||
129620087|NCT00911300|466561748|FG000|Overall Study|Coronary Angiography Performed|1|||
129620088|NCT00911300|466561749|FG001|Overall Study|Coronary Angiography Performed|0|||
129620089|NCT00911300|466561748|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
129620090|NCT00911300|466561749|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
129620091|NCT00911300|466561748|FG000|Overall Study|Received Commercial Treatment|1|||
129620092|NCT00911300|466561749|FG001|Overall Study|Received Commercial Treatment|0|||
129620093|NCT00911300|466561748|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
129620094|NCT00911300|466561749|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
129701856|NCT02106832|466869420|FG002|Overall Study|Physician Decision|0|||
129701857|NCT02106832|466869421|FG003|Overall Study|Physician Decision|0|||
129620095|NCT00911300|466561748|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
129620096|NCT00911300|466561749|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
129620097|NCT00911300|466561748|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
129620098|NCT00911300|466561749|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
129620099|NCT00911300|466561748|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
129620100|NCT00911300|466561749|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
129620101|NCT00911300|466561748|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
129701858|NCT02106832|466869418|FG000|Overall Study|Protocol Violation|0|||
129620102|NCT00911300|466561749|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
129620103|NCT00911300|466561748|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
129620104|NCT00911300|466561749|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
129620105|NCT00911300|466561748|FG000|Overall Study|International Normalized Ratio Too High|0|||
129620106|NCT00911300|466561749|FG001|Overall Study|International Normalized Ratio Too High|1|||
129620107|NCT00911300|466561748|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
129620108|NCT00911300|466561749|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
129620109|NCT00911300|466561748|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
129620110|NCT00911300|466561749|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
129620111|NCT00911300|466561748|FG000|Overall Study|Physician Decision|0|||
129620112|NCT00911300|466561749|FG001|Overall Study|Physician Decision|1|||
129620113|NCT00911300|466561748|FG000|Overall Study|Treatment Stopped by Mistake|0|||
129620114|NCT00911300|466561749|FG001|Overall Study|Treatment Stopped by Mistake|1|||
129620115|NCT00911300|466561748|FG000|Overall Study|Randomized; No Study Medication Received|0|||
129620116|NCT00911300|466561749|FG001|Overall Study|Randomized; No Study Medication Received|2|||
129620117|NCT02287922|466561750|FG000|Overall Study|Adverse Event|1|||
129620118|NCT02287922|466561751|FG001|Overall Study|Adverse Event|1|||
129620119|NCT02287922|466561752|FG002|Overall Study|Adverse Event|3|||
129620120|NCT02287922|466561753|FG003|Overall Study|Adverse Event|4|||
129620121|NCT02287922|466561750|FG000|Overall Study|Withdrawal by Subject|1|||
129620122|NCT02287922|466561751|FG001|Overall Study|Withdrawal by Subject|1|||
129620123|NCT02287922|466561752|FG002|Overall Study|Withdrawal by Subject|1|||
129620124|NCT02287922|466561753|FG003|Overall Study|Withdrawal by Subject|2|||
129620125|NCT02287922|466561750|FG000|Overall Study|Lost to Follow-up|0|||
129620126|NCT02287922|466561751|FG001|Overall Study|Lost to Follow-up|0|||
129620127|NCT02287922|466561752|FG002|Overall Study|Lost to Follow-up|1|||
129620128|NCT02287922|466561753|FG003|Overall Study|Lost to Follow-up|0|||
129620129|NCT02287922|466561750|FG000|Overall Study|Sponsor's decision|0|||
129620130|NCT02287922|466561751|FG001|Overall Study|Sponsor's decision|0|||
129620131|NCT02287922|466561752|FG002|Overall Study|Sponsor's decision|0|||
129620132|NCT02287922|466561753|FG003|Overall Study|Sponsor's decision|1|||
129620133|NCT02287922|466561750|FG000|Overall Study|Other|1|||
129620134|NCT02287922|466561751|FG001|Overall Study|Other|0|||
129620135|NCT02287922|466561752|FG002|Overall Study|Other|2|||
129620136|NCT02287922|466561753|FG003|Overall Study|Other|0|||
129620137|NCT04152291|466561754|FG000|Overall Study|Covid-19 restrictions|27|||
129620138|NCT04152291|466561754|FG000|Overall Study|Withdrawal by Subject|3|||
129620139|NCT05124691|466561755|FG000|Phase II|Eligibility criteria|0|||
129620140|NCT05124691|466561756|FG001|Phase II|Eligibility criteria|1|||
129620141|NCT05124691|466561757|FG002|Phase II|Eligibility criteria|0|||
129620142|NCT05124691|466561755|FG000|Phase II|Withdrawal by Subject|6|||
129620143|NCT05124691|466561756|FG001|Phase II|Withdrawal by Subject|2|||
129620144|NCT05124691|466561757|FG002|Phase II|Withdrawal by Subject|3|||
129620145|NCT05124691|466561755|FG000|Phase III|Withdrawal by Subject|6|||
129620146|NCT05124691|466561756|FG001|Phase III|Withdrawal by Subject|4|||
129620147|NCT05124691|466561757|FG002|Phase III|Withdrawal by Subject|4|||
129620148|NCT05124691|466561755|FG000|Phase III|Lost to Follow-up|1|||
129620149|NCT05124691|466561756|FG001|Phase III|Lost to Follow-up|0|||
129620150|NCT05124691|466561757|FG002|Phase III|Lost to Follow-up|0|||
129620151|NCT04223752|466561760|FG000|Overall Study|Participant enrolled in error|0|||
129620152|NCT04223752|466561761|FG001|Overall Study|Participant enrolled in error|0|||
129620153|NCT04223752|466561762|FG002|Overall Study|Participant enrolled in error|0|||
129620154|NCT04223752|466561763|FG003|Overall Study|Participant enrolled in error|0|||
129620155|NCT04223752|466561764|FG004|Overall Study|Participant enrolled in error|1|||
129620156|NCT04223752|466561760|FG000|Overall Study|Death|0|||
129620157|NCT04223752|466561761|FG001|Overall Study|Death|0|||
129620158|NCT04223752|466561762|FG002|Overall Study|Death|0|||
129620159|NCT04223752|466561763|FG003|Overall Study|Death|2|||
129620160|NCT04223752|466561764|FG004|Overall Study|Death|1|||
129620161|NCT00447993|466561767|FG000|Overall Study|Lost to Follow-up|0|||
129792889|NCT00740051|467209172|FG000|Overall Study|Adverse Event|1|||
129792890|NCT00740051|467209173|FG001|Overall Study|Adverse Event|4|||
129792891|NCT00740051|467209172|FG000|Overall Study|Protocol Violation|2|||
129792892|NCT00740051|467209173|FG001|Overall Study|Protocol Violation|6|||
129792893|NCT00740051|467209172|FG000|Overall Study|Lost to Follow-up|3|||
129792894|NCT00740051|467209173|FG001|Overall Study|Lost to Follow-up|8|||
129792895|NCT00740051|467209172|FG000|Overall Study|Withdrawal by Subject|6|||
129792896|NCT00740051|467209173|FG001|Overall Study|Withdrawal by Subject|8|||
129792897|NCT00740051|467209172|FG000|Overall Study|Other reason (not specified)|4|||
129620162|NCT00447993|466561768|FG001|Overall Study|Lost to Follow-up|0|||
129620163|NCT00447993|466561769|FG002|Overall Study|Lost to Follow-up|2|||
129620164|NCT00447993|466561770|FG003|Overall Study|Lost to Follow-up|2|||
129620165|NCT00447993|466561767|FG000|Overall Study|Withdrawal by Subject|0|||
129620166|NCT00447993|466561768|FG001|Overall Study|Withdrawal by Subject|0|||
129620167|NCT00447993|466561769|FG002|Overall Study|Withdrawal by Subject|2|||
129620168|NCT00447993|466561770|FG003|Overall Study|Withdrawal by Subject|2|||
129620169|NCT02503787|466561771|FG000|Enrollment|Withdrawal by Subject|6|||
129620170|NCT02503787|466561771|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
129620171|NCT02503787|466561771|FG000|Enrollment|Physician Decision|2|||
129620172|NCT02503787|466561771|FG000|Enrollment|Insurance issue|2|||
129620173|NCT02503787|466561771|FG000|Enrollment|Lost to Follow-up|1|||
129620174|NCT02503787|466561771|FG000|Enrollment|Study closure|1|||
129620175|NCT02503787|466561771|FG000|Enrollment|Adverse Event|1|||
129620176|NCT02503787|466561771|FG000|Enrollment|Protocol Violation|1|||
129620177|NCT02503787|466561771|FG000|Enrollment|Inability to implant system|1|||
129620178|NCT02503787|466561771|FG000|Enrollment|Unable to be programmed|1|||
129620179|NCT02503787|466561771|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
129620180|NCT02503787|466561771|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
129620181|NCT02503787|466561771|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
129620182|NCT02503787|466561771|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
129620183|NCT02503787|466561771|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
129620184|NCT02503787|466561771|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
129620185|NCT04787627|466561772|FG000|Overall Study|Withdrawal by Subject|3|||
129620186|NCT04787627|466561773|FG001|Overall Study|Withdrawal by Subject|0|||
129620187|NCT04787627|466561772|FG000|Overall Study|Physician Decision|2|||
129620188|NCT04787627|466561773|FG001|Overall Study|Physician Decision|0|||
129620189|NCT04787627|466561772|FG000|Overall Study|Excluded|0|||
129620190|NCT04787627|466561773|FG001|Overall Study|Excluded|1|||
129620191|NCT00174954|466561775|FG000|Overall Study|Adverse Event|2|||
129620192|NCT00174954|466561775|FG000|Overall Study|No tophi found in MRI|1|||
129620193|NCT00174954|466561775|FG000|Overall Study|Physician Decision|1|||
129620194|NCT00839254|466561776|FG000|Overall Study|Protocol Violation|0|||
129620195|NCT00839254|466561777|FG001|Overall Study|Protocol Violation|1|||
129620196|NCT00839254|466561778|FG002|Overall Study|Protocol Violation|1|||
129620197|NCT00839254|466561779|FG003|Overall Study|Protocol Violation|1|||
129620198|NCT00839254|466561780|FG004|Overall Study|Protocol Violation|0|||
129620199|NCT00839254|466561781|FG005|Overall Study|Protocol Violation|0|||
129620200|NCT00839254|466561782|FG006|Overall Study|Protocol Violation|1|||
129620201|NCT00839254|466561783|FG007|Overall Study|Protocol Violation|2|||
129620202|NCT00839254|466561776|FG000|Overall Study|Physician Decision|0|||
129620203|NCT00839254|466561777|FG001|Overall Study|Physician Decision|1|||
129620204|NCT00839254|466561778|FG002|Overall Study|Physician Decision|0|||
129620205|NCT00839254|466561779|FG003|Overall Study|Physician Decision|0|||
129620206|NCT00839254|466561780|FG004|Overall Study|Physician Decision|0|||
129792898|NCT00740051|467209173|FG001|Overall Study|Other reason (not specified)|1|||
129620207|NCT00839254|466561781|FG005|Overall Study|Physician Decision|0|||
129620208|NCT00839254|466561782|FG006|Overall Study|Physician Decision|0|||
129620209|NCT00839254|466561783|FG007|Overall Study|Physician Decision|1|||
129620210|NCT00839254|466561776|FG000|Overall Study|Wrong treatment number allocation|0|||
129620211|NCT00839254|466561777|FG001|Overall Study|Wrong treatment number allocation|1|||
129792899|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
129792900|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
129792901|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
129620212|NCT00839254|466561778|FG002|Overall Study|Wrong treatment number allocation|0|||
129620213|NCT00839254|466561779|FG003|Overall Study|Wrong treatment number allocation|0|||
129620214|NCT00839254|466561780|FG004|Overall Study|Wrong treatment number allocation|0|||
129620215|NCT00839254|466561781|FG005|Overall Study|Wrong treatment number allocation|1|||
129620216|NCT00839254|466561782|FG006|Overall Study|Wrong treatment number allocation|0|||
129620217|NCT00839254|466561783|FG007|Overall Study|Wrong treatment number allocation|0|||
129620218|NCT00839254|466561776|FG000|Overall Study|Adverse Event|12|||
129620219|NCT00839254|466561777|FG001|Overall Study|Adverse Event|6|||
129620220|NCT00839254|466561778|FG002|Overall Study|Adverse Event|3|||
129620221|NCT00839254|466561779|FG003|Overall Study|Adverse Event|5|||
129620222|NCT00839254|466561780|FG004|Overall Study|Adverse Event|2|||
129620223|NCT00839254|466561781|FG005|Overall Study|Adverse Event|1|||
129620224|NCT00839254|466561782|FG006|Overall Study|Adverse Event|0|||
129620225|NCT00839254|466561783|FG007|Overall Study|Adverse Event|1|||
129620226|NCT00839254|466561776|FG000|Overall Study|Withdrawal by Subject|87|||
129620227|NCT00839254|466561777|FG001|Overall Study|Withdrawal by Subject|53|||
129620228|NCT00839254|466561778|FG002|Overall Study|Withdrawal by Subject|54|||
129620229|NCT00839254|466561779|FG003|Overall Study|Withdrawal by Subject|32|||
129620230|NCT00839254|466561780|FG004|Overall Study|Withdrawal by Subject|27|||
129620231|NCT00839254|466561781|FG005|Overall Study|Withdrawal by Subject|15|||
129620232|NCT00839254|466561782|FG006|Overall Study|Withdrawal by Subject|22|||
129620233|NCT00839254|466561783|FG007|Overall Study|Withdrawal by Subject|9|||
129792902|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
129792903|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
129792904|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
129792905|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
129792906|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
129792907|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
129792908|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
129792909|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
129792910|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
129792911|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
129792912|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
129792913|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
129792914|NCT00274924|467209174|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
129792915|NCT00274924|467209175|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
129792916|NCT00274924|467209176|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
129792917|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
129792918|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
129792919|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
129792920|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
129792921|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
129792922|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
129620234|NCT00839254|466561776|FG000|Overall Study|Wrong group allocation|0|||
129620235|NCT00839254|466561777|FG001|Overall Study|Wrong group allocation|0|||
129620236|NCT00839254|466561778|FG002|Overall Study|Wrong group allocation|0|||
129620237|NCT00839254|466561779|FG003|Overall Study|Wrong group allocation|0|||
129620238|NCT00839254|466561780|FG004|Overall Study|Wrong group allocation|0|||
129620239|NCT00839254|466561781|FG005|Overall Study|Wrong group allocation|0|||
129620240|NCT00839254|466561782|FG006|Overall Study|Wrong group allocation|1|||
129620241|NCT00839254|466561783|FG007|Overall Study|Wrong group allocation|0|||
129620242|NCT00839254|466561776|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
129620243|NCT00839254|466561777|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
129620244|NCT00839254|466561778|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
129620245|NCT00839254|466561779|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
129620246|NCT00839254|466561780|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
129620247|NCT00839254|466561781|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
129620248|NCT00839254|466561782|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
129620249|NCT00839254|466561783|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
129620250|NCT00839254|466561776|FG000|Overall Study|Withdrawn due to non-compliance|2|||
129620251|NCT00839254|466561777|FG001|Overall Study|Withdrawn due to non-compliance|0|||
129620252|NCT00839254|466561778|FG002|Overall Study|Withdrawn due to non-compliance|0|||
129620253|NCT00839254|466561779|FG003|Overall Study|Withdrawn due to non-compliance|0|||
129620254|NCT00839254|466561780|FG004|Overall Study|Withdrawn due to non-compliance|0|||
129620255|NCT00839254|466561781|FG005|Overall Study|Withdrawn due to non-compliance|0|||
129620256|NCT00839254|466561782|FG006|Overall Study|Withdrawn due to non-compliance|0|||
129792923|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
129792924|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
129792925|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
129792926|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
129792927|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
129792928|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
129792929|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
129792930|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
129792931|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
129792932|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
129792933|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
129792934|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
129792935|NCT00274924|467209174|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
129792936|NCT00274924|467209175|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
129792937|NCT00274924|467209176|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
129792938|NCT01055496|467209178|FG000|Overall Study|Withdrawal by Subject|2|||
129792939|NCT01055496|467209179|FG001|Overall Study|Withdrawal by Subject|4|||
129792940|NCT01055496|467209178|FG000|Overall Study|Death|13|||
129792941|NCT01055496|467209179|FG001|Overall Study|Death|23|||
129792942|NCT01055496|467209178|FG000|Overall Study|Lost to Follow-up|0|||
129792943|NCT01055496|467209179|FG001|Overall Study|Lost to Follow-up|2|||
129792944|NCT01055496|467209178|FG000|Overall Study|Other - Unspecified|0|||
129792945|NCT01055496|467209179|FG001|Overall Study|Other - Unspecified|1|||
129792946|NCT01673282|467209181|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
129792947|NCT01673282|467209182|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
129792948|NCT01673282|467209181|FG000|Overall Study|Lack of Efficacy|9|||
129792949|NCT01673282|467209182|FG001|Overall Study|Lack of Efficacy|2|||
129792950|NCT01673282|467209181|FG000|Overall Study|Lost to Follow-up|11|||
129792951|NCT01673282|467209182|FG001|Overall Study|Lost to Follow-up|10|||
129792952|NCT01673282|467209181|FG000|Overall Study|Withdrawal by Subject|3|||
129792953|NCT01673282|467209182|FG001|Overall Study|Withdrawal by Subject|3|||
129792954|NCT01673282|467209181|FG000|Overall Study|Other|1|||
129792955|NCT01673282|467209182|FG001|Overall Study|Other|6|||
129792956|NCT01323920|467209188|FG000|Overall Study|Death|5|||
129792957|NCT01323920|467209188|FG000|Overall Study|Withdrawal by Subject|1|||
129792958|NCT02915874|467209189|FG000|Overall Study|Lost to Follow-up|5|||
129792959|NCT02915874|467209190|FG001|Overall Study|Lost to Follow-up|4|||
129792960|NCT02915874|467209189|FG000|Overall Study|Withdrawal by Subject|1|||
129792961|NCT02915874|467209190|FG001|Overall Study|Withdrawal by Subject|1|||
129792962|NCT02915874|467209189|FG000|Overall Study|Started New Anxiety Medication|0|||
129792963|NCT02915874|467209190|FG001|Overall Study|Started New Anxiety Medication|1|||
129792964|NCT02290431|467209191|FG000|Overall Study|Adverse Event|20|||
129792965|NCT02290431|467209191|FG000|Overall Study|Progressive disease|4|||
129792966|NCT02290431|467209191|FG000|Overall Study|Study terminated by Sponsor|1|||
129792967|NCT02290431|467209191|FG000|Overall Study|Physician Decision|2|||
129792968|NCT00821327|467209192|FG000|Overall Study|Adverse Event|13|||
129792969|NCT00821327|467209192|FG000|Overall Study|Patient Request|1|||
129792970|NCT00821327|467209192|FG000|Overall Study|Investigator Request|2|||
129792971|NCT00821327|467209192|FG000|Overall Study|Sponsor Request|1|||
129792972|NCT00821327|467209192|FG000|Overall Study|Disease Progression|13|||
129792973|NCT00821327|467209192|FG000|Overall Study|Other/Unknown|5|||
129792974|NCT02119676|467209193|FG000|Overall Study|Adverse Event|9|||
129792975|NCT02119676|467209194|FG001|Overall Study|Adverse Event|17|||
129792976|NCT02119676|467209195|FG002|Overall Study|Adverse Event|10|||
129792977|NCT02119676|467209196|FG003|Overall Study|Adverse Event|10|||
129792978|NCT02119676|467209193|FG000|Overall Study|Disease progression|53|||
129792979|NCT02119676|467209194|FG001|Overall Study|Disease progression|55|||
129792980|NCT02119676|467209195|FG002|Overall Study|Disease progression|68|||
129792981|NCT02119676|467209196|FG003|Overall Study|Disease progression|73|||
129792982|NCT02119676|467209193|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
129792983|NCT02119676|467209194|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
129792984|NCT02119676|467209195|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
129792985|NCT02119676|467209196|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
129792986|NCT02119676|467209193|FG000|Overall Study|Physician Decision|4|||
129792987|NCT02119676|467209194|FG001|Overall Study|Physician Decision|2|||
129792988|NCT02119676|467209195|FG002|Overall Study|Physician Decision|3|||
129792989|NCT02119676|467209196|FG003|Overall Study|Physician Decision|2|||
129792990|NCT02119676|467209193|FG000|Overall Study|Death|9|||
129792991|NCT02119676|467209194|FG001|Overall Study|Death|3|||
129792992|NCT02119676|467209195|FG002|Overall Study|Death|2|||
129792993|NCT02119676|467209196|FG003|Overall Study|Death|1|||
129792994|NCT02119676|467209193|FG000|Overall Study|Noncompliance|0|||
129792995|NCT02119676|467209194|FG001|Overall Study|Noncompliance|1|||
129792996|NCT02119676|467209195|FG002|Overall Study|Noncompliance|0|||
129792997|NCT02119676|467209196|FG003|Overall Study|Noncompliance|0|||
129792998|NCT02119676|467209193|FG000|Overall Study|Lost to Follow-up|0|||
129620257|NCT00839254|466561783|FG007|Overall Study|Withdrawn due to non-compliance|0|||
129888142|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888143|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888144|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
129888145|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
129620258|NCT00839254|466561776|FG000|Overall Study|Lost to Follow-up|51|||
129620259|NCT00839254|466561777|FG001|Overall Study|Lost to Follow-up|30|||
129620260|NCT00839254|466561778|FG002|Overall Study|Lost to Follow-up|32|||
129620261|NCT00839254|466561779|FG003|Overall Study|Lost to Follow-up|24|||
129888146|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888147|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888148|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
129888149|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
129888150|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888151|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888152|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888153|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888154|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
129888155|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129620262|NCT00839254|466561780|FG004|Overall Study|Lost to Follow-up|8|||
129620263|NCT00839254|466561781|FG005|Overall Study|Lost to Follow-up|8|||
129620264|NCT00839254|466561782|FG006|Overall Study|Lost to Follow-up|4|||
129620265|NCT00839254|466561783|FG007|Overall Study|Lost to Follow-up|2|||
129620266|NCT00985491|466561784|FG000|Overall Study|Adverse Event|8|||
129620267|NCT00985491|466561784|FG000|Overall Study|device migration|7|||
129620268|NCT00985491|466561784|FG000|Overall Study|Withdrawal by Subject|1|||
129620269|NCT00985491|466561784|FG000|Overall Study|implant failure|3|||
129620270|NCT00489827|466561789|FG000|Overall Study|Intraoperative exclusion criteria|1|||
129620271|NCT00489827|466561790|FG001|Overall Study|Intraoperative exclusion criteria|1|||
129620272|NCT00489827|466561789|FG000|Overall Study|Intraoperative exclusion criteria|1|||
129620273|NCT00489827|466561790|FG001|Overall Study|Intraoperative exclusion criteria|1|||
129620274|NCT02296931|466561791|FG000|Overall Study|Protocol Violation|0|||
129620275|NCT02296931|466561792|FG001|Overall Study|Protocol Violation|2|||
129620276|NCT01590277|466561793|FG000|Overall Study|Withdrawal by Subject|3|||
129620277|NCT01590277|466561793|FG000|Overall Study|Withdrawal by Subject|2|||
129620278|NCT01590277|466561793|FG000|Overall Study|Withdrawal by Subject|1|||
129620279|NCT01590277|466561793|FG000|Overall Study|Withdrawal by Subject|1|||
129620280|NCT01377012|466561794|FG000|Core Study|Study terminated by Sponsor|47|||
129620281|NCT01377012|466561795|FG001|Core Study|Study terminated by Sponsor|54|||
129620282|NCT01377012|466561796|FG002|Core Study|Study terminated by Sponsor|46|||
129620283|NCT01377012|466561794|FG000|Core Study|Technical problems|1|||
129620284|NCT01377012|466561795|FG001|Core Study|Technical problems|0|||
129620285|NCT01377012|466561796|FG002|Core Study|Technical problems|0|||
129620286|NCT01377012|466561794|FG000|Core Study|Withdrawal by Subject|15|||
129620287|NCT01377012|466561795|FG001|Core Study|Withdrawal by Subject|23|||
129620288|NCT01377012|466561796|FG002|Core Study|Withdrawal by Subject|18|||
129620289|NCT01377012|466561794|FG000|Core Study|Protocol Violation|7|||
129620290|NCT01377012|466561795|FG001|Core Study|Protocol Violation|3|||
129620291|NCT01377012|466561796|FG002|Core Study|Protocol Violation|2|||
129620292|NCT01377012|466561794|FG000|Core Study|Pregnancy|0|||
129620293|NCT01377012|466561795|FG001|Core Study|Pregnancy|0|||
129620294|NCT01377012|466561796|FG002|Core Study|Pregnancy|1|||
129620295|NCT01377012|466561794|FG000|Core Study|Physician Decision|5|||
129620296|NCT01377012|466561795|FG001|Core Study|Physician Decision|4|||
129620297|NCT01377012|466561796|FG002|Core Study|Physician Decision|10|||
129620298|NCT01377012|466561794|FG000|Core Study|Non-Compliant with study treatment|0|||
129620299|NCT01377012|466561795|FG001|Core Study|Non-Compliant with study treatment|0|||
129620300|NCT01377012|466561796|FG002|Core Study|Non-Compliant with study treatment|1|||
129620301|NCT01377012|466561794|FG000|Core Study|No Longer require treatment|0|||
129620302|NCT01377012|466561795|FG001|Core Study|No Longer require treatment|0|||
129620303|NCT01377012|466561796|FG002|Core Study|No Longer require treatment|1|||
129620304|NCT01377012|466561794|FG000|Core Study|Lost to Follow-up|7|||
129620305|NCT01377012|466561795|FG001|Core Study|Lost to Follow-up|5|||
129620306|NCT01377012|466561796|FG002|Core Study|Lost to Follow-up|4|||
129620307|NCT01377012|466561794|FG000|Core Study|Lack of Efficacy|41|||
129620308|NCT01377012|466561795|FG001|Core Study|Lack of Efficacy|28|||
129620309|NCT01377012|466561796|FG002|Core Study|Lack of Efficacy|37|||
129620310|NCT01377012|466561794|FG000|Core Study|Death|1|||
129620311|NCT01377012|466561795|FG001|Core Study|Death|1|||
129620312|NCT01377012|466561796|FG002|Core Study|Death|1|||
129620313|NCT01377012|466561794|FG000|Core Study|Adverse Event|10|||
129620314|NCT01377012|466561795|FG001|Core Study|Adverse Event|14|||
129620315|NCT01377012|466561796|FG002|Core Study|Adverse Event|13|||
129620316|NCT01377012|466561794|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
129620317|NCT01377012|466561795|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
129620318|NCT01377012|466561796|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
129620319|NCT01377012|466561794|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
129620320|NCT01377012|466561795|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
129620321|NCT01377012|466561796|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
129620322|NCT01377012|466561794|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
129620323|NCT01377012|466561795|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
129620324|NCT01377012|466561796|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
129620325|NCT01377012|466561794|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
129620326|NCT01377012|466561795|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
129620327|NCT01377012|466561796|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
129620328|NCT01377012|466561794|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
129620329|NCT01377012|466561795|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
129620330|NCT01377012|466561796|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
129620331|NCT01377012|466561794|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
129620332|NCT01377012|466561795|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
129620333|NCT01377012|466561796|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
129620334|NCT04380961|466561799|FG000|Overall Study|Lost to Follow-up|17|||
129620335|NCT04380961|466561800|FG001|Overall Study|Lost to Follow-up|11|||
129620336|NCT04380961|466561799|FG000|Overall Study|Withdrawal by Subject|3|||
129620337|NCT04380961|466561800|FG001|Overall Study|Withdrawal by Subject|0|||
129620338|NCT04380961|466561799|FG000|Overall Study|Death|22|||
129620339|NCT04380961|466561800|FG001|Overall Study|Death|16|||
129620340|NCT04380961|466561799|FG000|Overall Study|Other|1|||
129620341|NCT04380961|466561800|FG001|Overall Study|Other|0|||
129620342|NCT04380961|466561799|FG000|Overall Study|Randomized but Not Treated|1|||
129620343|NCT04380961|466561800|FG001|Overall Study|Randomized but Not Treated|2|||
129620344|NCT00805961|466561801|FG000|Modality Therapy|Withdrawal by Subject|1|||
129620345|NCT00805961|466561801|FG000|Modality Therapy|Adverse Event|1|||
129620346|NCT00805961|466561801|FG000|Modality Therapy|Disease Progression|2|||
129620347|NCT00805961|466561801|FG000|Treatment-Free Interval|Adverse Event|3|||
129620348|NCT00805961|466561801|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
129620349|NCT00805961|466561801|FG000|Treatment-Free Interval|Physician Decision|1|||
129620350|NCT00805961|466561801|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
129620351|NCT00805961|466561801|FG000|Maintenance Treatment|Lack of Efficacy|13|||
129620352|NCT00805961|466561801|FG000|Maintenance Treatment|Intercurrent Illness|7|||
129620353|NCT00805961|466561801|FG000|Maintenance Treatment|Adverse Event|6|||
129701859|NCT02106832|466869419|FG001|Overall Study|Protocol Violation|0|||
129620354|NCT00805961|466561801|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
129620355|NCT00805961|466561801|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
129620356|NCT00805961|466561801|FG000|Maintenance Treatment|Withdrawn Consent|1|||
129620357|NCT03736031|466561803|FG000|Overall Study|Death|2|||
129620358|NCT03736031|466561804|FG001|Overall Study|Death|4|||
129620359|NCT03736031|466561803|FG000|Overall Study|Lost to Follow-up|21|||
129620360|NCT03736031|466561804|FG001|Overall Study|Lost to Follow-up|2|||
129620361|NCT03736031|466561803|FG000|Overall Study|Withdrawal by Subject|9|||
129620362|NCT03736031|466561804|FG001|Overall Study|Withdrawal by Subject|0|||
129620363|NCT01954745|466561808|FG000|Overall Study|Radiological Progression|11|||
129620364|NCT01954745|466561808|FG000|Overall Study|Clinical Progression|5|||
129620365|NCT01954745|466561808|FG000|Overall Study|Adverse Event|2|||
129620366|NCT01954745|466561808|FG000|Overall Study|Death|1|||
129620367|NCT03514017|466561809|FG000|Overall Study|Death|1|||
129620368|NCT03514017|466561809|FG000|Overall Study|Adverse Event|1|||
129620369|NCT05938621|466562889|FG000|Overall Study|Lost to Follow-up|1|||
129620370|NCT05938621|466562890|FG001|Overall Study|Lost to Follow-up|5|||
129620371|NCT05938621|466562891|FG002|Overall Study|Lost to Follow-up|2|||
129620372|NCT05938621|466562892|FG003|Overall Study|Lost to Follow-up|2|||
129620373|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
129620374|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
129620375|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
129620376|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
129620377|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
129620378|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
129620379|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
129620380|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
129620381|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
129620382|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
129620383|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
129620384|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
129620385|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129620386|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129620387|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129620388|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
129620389|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129620390|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
129620391|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
129620392|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
129620393|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
129792999|NCT02119676|467209194|FG001|Overall Study|Lost to Follow-up|0|||
129793000|NCT02119676|467209195|FG002|Overall Study|Lost to Follow-up|1|||
129793001|NCT02119676|467209196|FG003|Overall Study|Lost to Follow-up|0|||
129793002|NCT02119676|467209193|FG000|Overall Study|Protocol deviation|0|||
129793003|NCT02119676|467209194|FG001|Overall Study|Protocol deviation|0|||
129793004|NCT02119676|467209195|FG002|Overall Study|Protocol deviation|1|||
129793005|NCT02119676|467209196|FG003|Overall Study|Protocol deviation|0|||
129439422|NCT00421707|465906505|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
129439423|NCT00421707|465906504|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
129439424|NCT00421707|465906505|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
129439425|NCT00421707|465906504|FG000|Period 2: Washout|Adverse Event|1|||
129439426|NCT00421707|465906505|FG001|Period 2: Washout|Adverse Event|1|||
129439427|NCT00421707|465906504|FG000|Period 2: Washout|Withdrawal by Subject|0|||
129439428|NCT00421707|465906505|FG001|Period 2: Washout|Withdrawal by Subject|1|||
129439429|NCT00421707|465906504|FG000|Period 2: Washout|Lost to Follow-up|0|||
129439430|NCT00421707|465906505|FG001|Period 2: Washout|Lost to Follow-up|1|||
129620394|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129620395|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129620396|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129439431|NCT00421707|465906504|FG000|Period 2: Washout|Other: Pregnancy|0|||
129620397|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129620398|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129620399|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
129620400|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
129793006|NCT02119676|467209193|FG000|Overall Study|Other, unspecified|2|||
129793007|NCT02119676|467209194|FG001|Overall Study|Other, unspecified|1|||
129793008|NCT02119676|467209195|FG002|Overall Study|Other, unspecified|3|||
129793009|NCT02119676|467209196|FG003|Overall Study|Other, unspecified|4|||
129439432|NCT00421707|465906505|FG001|Period 2: Washout|Other: Pregnancy|1|||
129620401|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
129793010|NCT02119676|467209193|FG000|Overall Study|Did not receive study med|2|||
129793011|NCT02119676|467209194|FG001|Overall Study|Did not receive study med|2|||
129793012|NCT02119676|467209195|FG002|Overall Study|Did not receive study med|4|||
129793013|NCT02119676|467209196|FG003|Overall Study|Did not receive study med|5|||
129620402|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
129620403|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129439433|NCT00421707|465906504|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
129620404|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129620405|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129620406|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129620407|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129620408|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
129620409|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
129620410|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
129793014|NCT00219544|467209197|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
129793015|NCT00219544|467209198|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
129793016|NCT00219544|467209197|FG000|Single Blind Treatment Period|Adverse Event|9|||
129793017|NCT00219544|467209198|FG001|Single Blind Treatment Period|Adverse Event|0|||
129793018|NCT00219544|467209197|FG000|Single Blind Treatment Period|Protocol Violation|4|||
129793019|NCT00219544|467209198|FG001|Single Blind Treatment Period|Protocol Violation|0|||
129793020|NCT00219544|467209197|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
129620411|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
129620412|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129620413|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129620414|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129620415|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
129620416|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129620417|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
129620418|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
129620419|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620420|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620421|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620422|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620423|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620424|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620425|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620426|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
129620427|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620428|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
129620429|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620430|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620431|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620432|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620433|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620434|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620435|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620436|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620437|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620438|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
129620439|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620440|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620441|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620442|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620443|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620444|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
129620445|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
129620446|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620447|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620448|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620449|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620450|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620451|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620452|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620453|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
129620454|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
129620455|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620456|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620457|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620458|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620459|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620460|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620461|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620462|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
129620463|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
129620464|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620465|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620466|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620467|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620468|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620469|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620470|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620471|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
129620472|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620473|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
129620474|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
129620475|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620476|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620477|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129793021|NCT00219544|467209198|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
129793022|NCT00219544|467209197|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
129793023|NCT00219544|467209198|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
129793024|NCT00219544|467209197|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
129793025|NCT00219544|467209198|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
129793026|NCT01007253|467209201|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
129793027|NCT01007253|467209202|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
129793028|NCT01007253|467209203|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
129793029|NCT01007253|467209204|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
129620478|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620479|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620480|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
129620481|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
129620482|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
129620483|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129620484|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129620485|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129620486|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129620487|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129793030|NCT00814801|467209205|FG000|Overall Study|Adverse Event|15|||
129620488|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129620489|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
129620490|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620491|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
129620492|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620493|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620494|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620495|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620496|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620497|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620498|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
129620499|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620500|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
129620501|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620502|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620503|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620504|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620505|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620506|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620507|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
129620508|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620509|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620510|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
129620511|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620512|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620513|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620514|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620515|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620516|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
129620517|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620518|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620519|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
129620520|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620521|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620522|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620523|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620524|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620525|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
129620526|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620527|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620528|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
129620529|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620530|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620531|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620532|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620533|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129647589|NCT01384019|466665356|FG000|Overall Study|Withdrawal by Subject|3|||
129793031|NCT00814801|467209206|FG001|Overall Study|Adverse Event|16|||
129793032|NCT00814801|467209207|FG002|Overall Study|Adverse Event|19|||
129793033|NCT00814801|467209205|FG000|Overall Study|Withdrawal by Subject|9|||
129620534|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
129620535|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620536|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620537|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620538|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620539|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620540|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620541|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
129620542|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620543|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
129620544|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
129620545|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
129620546|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620547|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620548|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620549|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620550|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620551|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620552|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
129620553|NCT03598790|466562893|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620554|NCT03598790|466562894|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620555|NCT03598790|466562895|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
129620556|NCT03598790|466562896|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620557|NCT03598790|466562897|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620558|NCT03598790|466562898|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620559|NCT03598790|466562899|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620560|NCT03598790|466562900|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129701860|NCT02106832|466869420|FG002|Overall Study|Protocol Violation|0|||
129888156|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888157|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
129888158|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
129888159|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888160|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888161|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888162|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888163|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888164|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
129888165|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888166|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888167|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888168|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888169|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
129888170|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888171|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888172|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888173|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888174|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
129888175|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888176|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888177|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888178|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
129888179|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
129888180|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
129888181|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888182|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888183|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888184|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
129888185|NCT02018861|467549120|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888186|NCT02018861|467549121|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888187|NCT02018861|467549122|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888188|NCT02018861|467549123|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
129888189|NCT02018861|467549124|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
129888190|NCT02018861|467549125|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888191|NCT02018861|467549126|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888192|NCT02018861|467549127|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888193|NCT02018861|467549128|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888194|NCT02018861|467549129|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
129888195|NCT02018861|467549120|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888196|NCT02018861|467549121|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888197|NCT02018861|467549122|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888198|NCT02018861|467549123|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888199|NCT02018861|467549124|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888200|NCT02018861|467549125|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888201|NCT02018861|467549126|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
129888202|NCT02018861|467549127|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
129888203|NCT02018861|467549128|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888204|NCT02018861|467549129|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
129888205|NCT02018861|467549120|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888206|NCT02018861|467549121|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888207|NCT02018861|467549122|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888208|NCT02018861|467549123|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888209|NCT02018861|467549124|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888210|NCT02018861|467549125|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888211|NCT02018861|467549126|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
129888212|NCT02018861|467549127|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
129888213|NCT02018861|467549128|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129793034|NCT00814801|467209206|FG001|Overall Study|Withdrawal by Subject|11|||
129793035|NCT00814801|467209207|FG002|Overall Study|Withdrawal by Subject|14|||
129793036|NCT00814801|467209205|FG000|Overall Study|Inappropriate as a subject|1|||
129793037|NCT00814801|467209206|FG001|Overall Study|Inappropriate as a subject|1|||
129793038|NCT00814801|467209207|FG002|Overall Study|Inappropriate as a subject|1|||
129793039|NCT00814801|467209205|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
129793040|NCT00814801|467209206|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
129793041|NCT00814801|467209207|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
129793042|NCT00814801|467209205|FG000|Overall Study|Missing or change of caregiver|6|||
129793043|NCT00814801|467209206|FG001|Overall Study|Missing or change of caregiver|2|||
129793044|NCT00814801|467209207|FG002|Overall Study|Missing or change of caregiver|4|||
129793045|NCT00814801|467209205|FG000|Overall Study|Non-compliance|0|||
129793046|NCT00814801|467209206|FG001|Overall Study|Non-compliance|1|||
129793047|NCT00814801|467209207|FG002|Overall Study|Non-compliance|1|||
129793048|NCT00814801|467209205|FG000|Overall Study|Other|2|||
129793049|NCT00814801|467209206|FG001|Overall Study|Other|6|||
129793050|NCT00814801|467209207|FG002|Overall Study|Other|4|||
129793051|NCT00586664|467209208|FG000|Overall Study|Withdrawal by Subject|3|||
129793052|NCT00586664|467209209|FG001|Overall Study|Withdrawal by Subject|7|||
129793053|NCT00586664|467209210|FG002|Overall Study|Withdrawal by Subject|1|||
129793054|NCT00586664|467209208|FG000|Overall Study|Exclusion criteria met|2|||
129793055|NCT00586664|467209209|FG001|Overall Study|Exclusion criteria met|0|||
129793056|NCT00586664|467209210|FG002|Overall Study|Exclusion criteria met|0|||
129793057|NCT02751931|467209211|FG000|Overall Study|Adverse Event|3|||
129793058|NCT02751931|467209212|FG001|Overall Study|Adverse Event|0|||
129793059|NCT02751931|467209211|FG000|Overall Study|Other: Miscelleneous|10|||
129793060|NCT02751931|467209212|FG001|Overall Study|Other: Miscelleneous|8|||
129793061|NCT01037088|467209213|FG000|Overall Study|Withdrawal by Subject|3|||
129793062|NCT01585584|467209214|FG000|Overall Study|Lack of Efficacy|1|||
129793063|NCT01585584|467209214|FG000|Overall Study|Withdrawal by Subject|1|||
129793064|NCT01585584|467209214|FG000|Overall Study|Physician Decision|2|||
129793065|NCT00266864|467209215|FG000|Overall Study|Lost to Follow-up|4|||
129793066|NCT00266864|467209216|FG001|Overall Study|Lost to Follow-up|1|||
129793067|NCT00266864|467209215|FG000|Overall Study|Withdrawal by Subject|1|||
129620561|NCT03598790|466562901|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
129620562|NCT03598790|466562893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129620563|NCT03598790|466562894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129620564|NCT03598790|466562895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129620565|NCT03598790|466562896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
129620566|NCT03598790|466562897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
129620567|NCT03598790|466562898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
129620568|NCT03598790|466562899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129620569|NCT03598790|466562900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129620570|NCT03598790|466562901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129620571|NCT03598790|466562893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620572|NCT03598790|466562894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620573|NCT03598790|466562895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620574|NCT03598790|466562896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
129620575|NCT03598790|466562897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620576|NCT03598790|466562898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620577|NCT03598790|466562899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620578|NCT03598790|466562900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620579|NCT03598790|466562901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
129620580|NCT03598790|466562893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620581|NCT03598790|466562894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620582|NCT03598790|466562895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620583|NCT03598790|466562896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
129620584|NCT03598790|466562897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620585|NCT03598790|466562898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620586|NCT03598790|466562899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620587|NCT03598790|466562900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620588|NCT03598790|466562901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129620589|NCT03598790|466562893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129620590|NCT03598790|466562894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129620591|NCT03598790|466562895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129793068|NCT00266864|467209216|FG001|Overall Study|Withdrawal by Subject|1|||
129793069|NCT03036800|467209217|FG000|Overall Study|Protocol Violation|1|||
129620592|NCT03598790|466562896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
129620593|NCT03598790|466562897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
129620594|NCT03598790|466562898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129620595|NCT03598790|466562899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129620596|NCT03598790|466562900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129620597|NCT03598790|466562901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
129620598|NCT03598790|466562893|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620599|NCT03598790|466562894|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620600|NCT03598790|466562895|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620601|NCT03598790|466562896|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
129620602|NCT03598790|466562897|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620603|NCT03598790|466562898|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620604|NCT03598790|466562899|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620605|NCT03598790|466562900|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620606|NCT03598790|466562901|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
129620607|NCT05929651|466562905|FG000|Overall Study|Protocol Deviation|1|||
129620608|NCT05929651|466562905|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
129620609|NCT02260570|466562906|FG000|Overall Study|Withdrawal by Subject|2|||
129620610|NCT02260570|466562907|FG001|Overall Study|Withdrawal by Subject|1|||
129620611|NCT02260570|466562906|FG000|Overall Study|Physician Decision|1|||
129620612|NCT02260570|466562907|FG001|Overall Study|Physician Decision|1|||
129620613|NCT05026177|466562908|FG000|Overall Study|Adverse Event|33|||
129620614|NCT05026177|466562909|FG001|Overall Study|Adverse Event|33|||
129620615|NCT05026177|466562910|FG002|Overall Study|Adverse Event|17|||
129620616|NCT05026177|466562908|FG000|Overall Study|Lost to Follow-up|7|||
129620617|NCT05026177|466562909|FG001|Overall Study|Lost to Follow-up|6|||
129620618|NCT05026177|466562910|FG002|Overall Study|Lost to Follow-up|8|||
129793070|NCT03036800|467209218|FG001|Overall Study|Protocol Violation|0|||
129793071|NCT03036800|467209217|FG000|Overall Study|Non-compliance|1|||
129793072|NCT03036800|467209218|FG001|Overall Study|Non-compliance|0|||
129793073|NCT03036800|467209217|FG000|Overall Study|Lost to Follow-up|1|||
129793074|NCT03036800|467209218|FG001|Overall Study|Lost to Follow-up|0|||
129793075|NCT03036800|467209217|FG000|Overall Study|Death|1|||
129620619|NCT05026177|466562908|FG000|Overall Study|Noncompliance with study drug|6|||
129620620|NCT05026177|466562909|FG001|Overall Study|Noncompliance with study drug|2|||
129620621|NCT05026177|466562910|FG002|Overall Study|Noncompliance with study drug|1|||
129620622|NCT05026177|466562908|FG000|Overall Study|Physician Decision|4|||
129620623|NCT05026177|466562909|FG001|Overall Study|Physician Decision|1|||
129620624|NCT05026177|466562910|FG002|Overall Study|Physician Decision|0|||
129620625|NCT05026177|466562908|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
129620626|NCT05026177|466562909|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
129620627|NCT05026177|466562910|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
129620628|NCT05026177|466562908|FG000|Overall Study|Withdrawal by Subject|53|||
129620629|NCT05026177|466562909|FG001|Overall Study|Withdrawal by Subject|51|||
129620630|NCT05026177|466562910|FG002|Overall Study|Withdrawal by Subject|55|||
129620631|NCT05026177|466562908|FG000|Overall Study|Protocol Violation|0|||
129620632|NCT05026177|466562909|FG001|Overall Study|Protocol Violation|1|||
129620633|NCT05026177|466562910|FG002|Overall Study|Protocol Violation|0|||
129620634|NCT05026177|466562908|FG000|Overall Study|Study terminated by sponsor|70|||
129439434|NCT00421707|465906505|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
129620635|NCT05026177|466562909|FG001|Overall Study|Study terminated by sponsor|74|||
129620636|NCT05026177|466562910|FG002|Overall Study|Study terminated by sponsor|67|||
129701861|NCT02106832|466869421|FG003|Overall Study|Protocol Violation|1|||
129701862|NCT02106832|466869418|FG000|Overall Study|Withdrawal by Subject|17|||
129701863|NCT02106832|466869419|FG001|Overall Study|Withdrawal by Subject|17|||
129701864|NCT02106832|466869420|FG002|Overall Study|Withdrawal by Subject|10|||
129701865|NCT02106832|466869421|FG003|Overall Study|Withdrawal by Subject|7|||
129701866|NCT02106832|466869418|FG000|Overall Study|Technical problems|0|||
129701867|NCT02106832|466869419|FG001|Overall Study|Technical problems|1|||
129701868|NCT02106832|466869420|FG002|Overall Study|Technical problems|0|||
129701869|NCT02106832|466869421|FG003|Overall Study|Technical problems|0|||
129701870|NCT03485157|466869422|FG000|Double Blind Phase|Lost to Follow-up|4|||
129701871|NCT03485157|466869423|FG001|Double Blind Phase|Lost to Follow-up|4|||
129701872|NCT03485157|466869422|FG000|Double Blind Phase|Adverse Event|2|||
129701873|NCT03485157|466869423|FG001|Double Blind Phase|Adverse Event|1|||
129701874|NCT03485157|466869422|FG000|Double Blind Phase|Withdrawal by Subject|6|||
129701875|NCT03485157|466869423|FG001|Double Blind Phase|Withdrawal by Subject|9|||
129701876|NCT03485157|466869422|FG000|Double Blind Phase|Removal by PI|3|||
129701877|NCT03485157|466869423|FG001|Double Blind Phase|Removal by PI|7|||
129701878|NCT03485157|466869422|FG000|Open Label Phase|Lost to Follow-up|1|||
129701879|NCT03485157|466869423|FG001|Open Label Phase|Lost to Follow-up|2|||
129620637|NCT05026177|466562908|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
129620638|NCT05026177|466562909|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
129620639|NCT05026177|466562910|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
129620640|NCT05026177|466562908|FG000|Overall Study|Starting alternative treatment|0|||
129620641|NCT05026177|466562909|FG001|Overall Study|Starting alternative treatment|1|||
129620642|NCT05026177|466562910|FG002|Overall Study|Starting alternative treatment|1|||
129620643|NCT05026177|466562908|FG000|Overall Study|Noncompliance with study procedures|0|||
129620644|NCT05026177|466562909|FG001|Overall Study|Noncompliance with study procedures|1|||
129620645|NCT05026177|466562910|FG002|Overall Study|Noncompliance with study procedures|1|||
129620646|NCT05026177|466562908|FG000|Overall Study|Met stopping criteria|0|||
129620647|NCT05026177|466562909|FG001|Overall Study|Met stopping criteria|0|||
129620648|NCT05026177|466562910|FG002|Overall Study|Met stopping criteria|1|||
129620649|NCT05026177|466562908|FG000|Overall Study|Health issues preventing continuation|0|||
129620650|NCT05026177|466562909|FG001|Overall Study|Health issues preventing continuation|0|||
129620651|NCT05026177|466562910|FG002|Overall Study|Health issues preventing continuation|1|||
129620652|NCT05026177|466562908|FG000|Overall Study|Randomized in error, not treated|0|||
129620653|NCT05026177|466562909|FG001|Overall Study|Randomized in error, not treated|0|||
129620654|NCT05026177|466562910|FG002|Overall Study|Randomized in error, not treated|2|||
129620655|NCT04856917|466562911|FG000|Overall Study|Withdrawal by Subject|4|||
129793076|NCT03036800|467209218|FG001|Overall Study|Death|0|||
129793077|NCT03036800|467209217|FG000|Overall Study|Tolerance|5|||
129793078|NCT03036800|467209218|FG001|Overall Study|Tolerance|0|||
129793079|NCT03036800|467209217|FG000|Overall Study|Unknown/no reason given|50|||
129793080|NCT03036800|467209218|FG001|Overall Study|Unknown/no reason given|39|||
129793081|NCT01077154|467209219|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
129793082|NCT01077154|467209220|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
129793083|NCT01077154|467209219|FG000|Overall Study|Withdrawal by Subject|369|||
129793084|NCT01077154|467209220|FG001|Overall Study|Withdrawal by Subject|385|||
129793085|NCT01077154|467209219|FG000|Overall Study|Death|215|||
129793086|NCT01077154|467209220|FG001|Overall Study|Death|214|||
129793087|NCT01077154|467209219|FG000|Overall Study|Lost to Follow-up|43|||
129793088|NCT01077154|467209220|FG001|Overall Study|Lost to Follow-up|35|||
129793089|NCT01077154|467209219|FG000|Overall Study|Noncompliance|22|||
129793090|NCT01077154|467209220|FG001|Overall Study|Noncompliance|20|||
129793091|NCT01077154|467209219|FG000|Overall Study|Disease Progression|18|||
129793092|NCT01077154|467209220|FG001|Overall Study|Disease Progression|20|||
129793093|NCT01077154|467209219|FG000|Overall Study|Ineligibility Determined|10|||
129793094|NCT01077154|467209220|FG001|Overall Study|Ineligibility Determined|14|||
129793095|NCT01077154|467209219|FG000|Overall Study|Other|14|||
129793096|NCT01077154|467209220|FG001|Overall Study|Other|11|||
129793097|NCT01077154|467209219|FG000|Overall Study|Adverse Event|9|||
129793098|NCT01077154|467209220|FG001|Overall Study|Adverse Event|9|||
129793099|NCT01077154|467209219|FG000|Overall Study|Administrative Decision|1|||
129793100|NCT01077154|467209220|FG001|Overall Study|Administrative Decision|6|||
129793101|NCT01077154|467209219|FG000|Overall Study|Protocol Deviation|1|||
129793102|NCT01077154|467209220|FG001|Overall Study|Protocol Deviation|0|||
129793103|NCT00686998|467209221|FG000|Overall Study|Adverse Event|3|||
129793104|NCT00686998|467209222|FG001|Overall Study|Adverse Event|2|||
129793105|NCT00686998|467209223|FG002|Overall Study|Adverse Event|1|||
129793106|NCT00686998|467209221|FG000|Overall Study|Withdrawal by Subject|2|||
129793107|NCT00686998|467209222|FG001|Overall Study|Withdrawal by Subject|1|||
129793108|NCT00686998|467209223|FG002|Overall Study|Withdrawal by Subject|2|||
129793109|NCT00686998|467209221|FG000|Overall Study|Lack of Efficacy|7|||
129793110|NCT00686998|467209222|FG001|Overall Study|Lack of Efficacy|5|||
129793111|NCT00686998|467209223|FG002|Overall Study|Lack of Efficacy|0|||
129793112|NCT00686998|467209221|FG000|Overall Study|Other|0|||
129793113|NCT00686998|467209222|FG001|Overall Study|Other|0|||
129793114|NCT00686998|467209223|FG002|Overall Study|Other|1|||
129793115|NCT00686998|467209221|FG000|Overall Study|Safety Reasons|1|||
129793116|NCT00686998|467209222|FG001|Overall Study|Safety Reasons|0|||
129793117|NCT00686998|467209223|FG002|Overall Study|Safety Reasons|0|||
129793118|NCT00371761|467210681|FG000|Overall Study|Adverse Event|1|||
129793119|NCT00371761|467210682|FG001|Overall Study|Adverse Event|1|||
129793120|NCT00371761|467210681|FG000|Overall Study|Withdrawal by Subject|1|||
129793121|NCT00371761|467210682|FG001|Overall Study|Withdrawal by Subject|3|||
129793122|NCT00371761|467210681|FG000|Overall Study|Investigator Judgment|2|||
129793123|NCT00371761|467210682|FG001|Overall Study|Investigator Judgment|3|||
129793124|NCT00371761|467210681|FG000|Overall Study|Study termination|4|||
129620656|NCT04856917|466562912|FG001|Overall Study|Withdrawal by Subject|3|||
129620657|NCT04856917|466562913|FG002|Overall Study|Withdrawal by Subject|1|||
129620658|NCT04856917|466562911|FG000|Overall Study|Lost to Follow-up|3|||
129793125|NCT00371761|467210682|FG001|Overall Study|Study termination|3|||
129793126|NCT01736657|467210689|FG000|Overall Study|insufficient vascular access|1|||
129793127|NCT00997438|467210700|FG000|Overall Study|Blood draw difficulty|2|||
129793128|NCT00997438|467210701|FG001|Overall Study|Blood draw difficulty|0|||
129793129|NCT00997438|467210702|FG002|Overall Study|Blood draw difficulty|1|||
129620659|NCT04856917|466562912|FG001|Overall Study|Lost to Follow-up|1|||
129620660|NCT04856917|466562913|FG002|Overall Study|Lost to Follow-up|1|||
129620661|NCT04856917|466562911|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
129620662|NCT04856917|466562912|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
129620663|NCT04856917|466562913|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
129620664|NCT04856917|466562911|FG000|Overall Study|Other|1|||
129620665|NCT04856917|466562912|FG001|Overall Study|Other|1|||
129620666|NCT04856917|466562913|FG002|Overall Study|Other|0|||
129620667|NCT01169337|466562914|FG000|Overall Study|Lack of Efficacy|5|||
129620668|NCT01169337|466562915|FG001|Overall Study|Lack of Efficacy|7|||
129620669|NCT01169337|466562916|FG002|Overall Study|Lack of Efficacy|0|||
129620670|NCT01169337|466562914|FG000|Overall Study|Adverse Event|12|||
129620671|NCT01169337|466562915|FG001|Overall Study|Adverse Event|18|||
129620672|NCT01169337|466562916|FG002|Overall Study|Adverse Event|0|||
129701880|NCT03485157|466869422|FG000|Open Label Phase|Adverse Event|0|||
129701881|NCT03485157|466869423|FG001|Open Label Phase|Adverse Event|1|||
129439435|NCT00421707|465906504|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
129620673|NCT01169337|466562914|FG000|Overall Study|Death|2|||
129620674|NCT01169337|466562915|FG001|Overall Study|Death|0|||
129620675|NCT01169337|466562916|FG002|Overall Study|Death|0|||
129620676|NCT01169337|466562914|FG000|Overall Study|Withdrawal by Subject|11|||
129701882|NCT03485157|466869422|FG000|Open Label Phase|Withdrawal by Subject|1|||
129888214|NCT02018861|467549129|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
129888215|NCT02018861|467549120|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888216|NCT02018861|467549121|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888217|NCT02018861|467549122|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888218|NCT02018861|467549123|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888219|NCT02018861|467549124|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888220|NCT02018861|467549125|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888221|NCT02018861|467549126|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888222|NCT02018861|467549127|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888223|NCT02018861|467549128|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
129888224|NCT02018861|467549129|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
129888225|NCT02018861|467549120|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888226|NCT02018861|467549121|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888227|NCT02018861|467549122|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888228|NCT02018861|467549123|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888229|NCT02018861|467549124|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888230|NCT02018861|467549125|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888231|NCT02018861|467549126|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888232|NCT02018861|467549127|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888233|NCT02018861|467549128|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
129888234|NCT02018861|467549129|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
129888235|NCT02018861|467549120|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888236|NCT02018861|467549121|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888237|NCT02018861|467549122|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888238|NCT02018861|467549123|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888239|NCT02018861|467549124|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888240|NCT02018861|467549125|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888241|NCT02018861|467549126|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888242|NCT02018861|467549127|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888243|NCT02018861|467549128|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
129888244|NCT02018861|467549129|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
129888245|NCT00504348|467549130|FG000|Overall Study|Adverse Event|3|||
129888246|NCT00504348|467549130|FG000|Overall Study|Lack of Efficacy|4|||
129888247|NCT00504348|467549130|FG000|Overall Study|Physician Decision|1|||
129888248|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
129888249|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
129888250|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
129888251|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
129888252|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
129888253|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
129620677|NCT01169337|466562915|FG001|Overall Study|Withdrawal by Subject|11|||
129620678|NCT01169337|466562916|FG002|Overall Study|Withdrawal by Subject|6|||
129620679|NCT01169337|466562914|FG000|Overall Study|Noncompliance|2|||
129620680|NCT01169337|466562915|FG001|Overall Study|Noncompliance|0|||
129620681|NCT01169337|466562916|FG002|Overall Study|Noncompliance|0|||
129620682|NCT01169337|466562914|FG000|Overall Study|Other complicating disease|1|||
129620683|NCT01169337|466562915|FG001|Overall Study|Other complicating disease|1|||
129620684|NCT01169337|466562916|FG002|Overall Study|Other complicating disease|0|||
129620685|NCT01169337|466562914|FG000|Overall Study|Physician Decision|1|||
129620686|NCT01169337|466562915|FG001|Overall Study|Physician Decision|5|||
129620687|NCT01169337|466562916|FG002|Overall Study|Physician Decision|0|||
129620688|NCT01169337|466562914|FG000|Overall Study|Alternative therapy|0|||
129620689|NCT01169337|466562915|FG001|Overall Study|Alternative therapy|2|||
129620690|NCT01169337|466562916|FG002|Overall Study|Alternative therapy|0|||
129620691|NCT01169337|466562914|FG000|Overall Study|Changed hospital|0|||
129620692|NCT01169337|466562915|FG001|Overall Study|Changed hospital|1|||
129620693|NCT01169337|466562916|FG002|Overall Study|Changed hospital|0|||
129620694|NCT01169337|466562914|FG000|Overall Study|Never started treatment|0|||
129620695|NCT01169337|466562915|FG001|Overall Study|Never started treatment|2|||
129620696|NCT01169337|466562916|FG002|Overall Study|Never started treatment|0|||
129620697|NCT01169337|466562914|FG000|Overall Study|Reason not reported|1|||
129620698|NCT01169337|466562915|FG001|Overall Study|Reason not reported|0|||
129620699|NCT01169337|466562916|FG002|Overall Study|Reason not reported|0|||
129620700|NCT01169337|466562914|FG000|Overall Study|Continuing lenalidomide|9|||
129620701|NCT01169337|466562915|FG001|Overall Study|Continuing lenalidomide|43|||
129620702|NCT01169337|466562916|FG002|Overall Study|Continuing lenalidomide|0|||
129620703|NCT03560037|466562917|FG000|Overall Study|Protocol Violation|1|||
129620704|NCT03560037|466562918|FG001|Overall Study|Protocol Violation|0|||
129620705|NCT03560037|466562917|FG000|Overall Study|Physician Decision|0|||
129620706|NCT03560037|466562918|FG001|Overall Study|Physician Decision|1|||
129620707|NCT03816878|466562921|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
129620708|NCT03816878|466562922|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
129620709|NCT03816878|466562921|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
129620710|NCT03816878|466562922|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
129620711|NCT03355469|466562923|FG000|Overall Study|COVID-19|3|||
129620712|NCT03355469|466562924|FG001|Overall Study|COVID-19|2|||
129620713|NCT03355469|466562925|FG002|Overall Study|COVID-19|3|||
129701883|NCT03485157|466869423|FG001|Open Label Phase|Withdrawal by Subject|2|||
129701884|NCT03485157|466869422|FG000|Open Label Phase|Removal by PI|2|||
129701885|NCT03485157|466869423|FG001|Open Label Phase|Removal by PI|0|||
129701886|NCT00265122|466869424|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
129701887|NCT00265122|466869425|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
129701888|NCT00265122|466869426|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
129701889|NCT00265122|466869427|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
129701890|NCT00265122|466869428|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
129701891|NCT00265122|466869429|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
129701892|NCT00265122|466869424|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
129701893|NCT00265122|466869425|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129701894|NCT00265122|466869426|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129701895|NCT00265122|466869427|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
129701896|NCT00265122|466869428|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129701897|NCT00265122|466869429|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
129701898|NCT00265122|466869424|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
129701899|NCT00265122|466869425|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
129701900|NCT00265122|466869426|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
129701901|NCT00265122|466869427|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
129701902|NCT00265122|466869428|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
129701903|NCT00265122|466869429|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
129701904|NCT00265122|466869424|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
129701905|NCT00265122|466869425|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
129701906|NCT00265122|466869426|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
129701907|NCT00265122|466869427|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
129701908|NCT00265122|466869428|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
129701909|NCT00265122|466869429|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
129701910|NCT00265122|466869424|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
129701911|NCT00265122|466869425|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
129701912|NCT00265122|466869426|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
129701913|NCT00265122|466869427|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
129701914|NCT00265122|466869428|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
129701915|NCT00265122|466869429|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
129701916|NCT00265122|466869424|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
129701917|NCT00265122|466869425|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
129701918|NCT00265122|466869426|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
129701919|NCT00265122|466869427|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
129701920|NCT00265122|466869428|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
129701921|NCT00265122|466869429|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
129701922|NCT05205616|466869436|FG000|Overall Study|Lost to Follow-up|4|||
129701923|NCT05205616|466869437|FG001|Overall Study|Lost to Follow-up|4|||
129701924|NCT00663260|466869446|FG000|Overall Study|Lack of Efficacy|2|||
129701925|NCT00663260|466869447|FG001|Overall Study|Lack of Efficacy|0|||
129701926|NCT00663260|466869448|FG002|Overall Study|Lack of Efficacy|0|||
129701927|NCT00663260|466869446|FG000|Overall Study|Adverse Event|12|||
129701928|NCT00663260|466869447|FG001|Overall Study|Adverse Event|7|||
129701929|NCT00663260|466869448|FG002|Overall Study|Adverse Event|6|||
129701930|NCT00663260|466869446|FG000|Overall Study|Withdrawal by Subject|3|||
129701931|NCT00663260|466869447|FG001|Overall Study|Withdrawal by Subject|1|||
129701932|NCT00663260|466869448|FG002|Overall Study|Withdrawal by Subject|6|||
129701933|NCT00663260|466869446|FG000|Overall Study|Death|1|||
129701934|NCT00663260|466869447|FG001|Overall Study|Death|0|||
129701935|NCT00663260|466869448|FG002|Overall Study|Death|1|||
129701936|NCT00663260|466869446|FG000|Overall Study|Lost to Follow-up|0|||
129701937|NCT00663260|466869447|FG001|Overall Study|Lost to Follow-up|1|||
129701938|NCT00663260|466869448|FG002|Overall Study|Lost to Follow-up|0|||
129701939|NCT00663260|466869446|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
129620714|NCT03355469|466562926|FG003|Overall Study|COVID-19|3|||
129701940|NCT00663260|466869447|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
129701941|NCT00663260|466869448|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
129439436|NCT00421707|465906505|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
129439437|NCT00421707|465906504|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
129439438|NCT00421707|465906505|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
129439439|NCT01074216|465906506|FG000|Overall Study|Physician Decision|1|||
129439440|NCT01074216|465906506|FG000|Overall Study|Not Treated|12|||
129439441|NCT01723254|465906507|FG000|Overall Study|Conflict with work schedule|0|||
129439442|NCT01723254|465906508|FG001|Overall Study|Conflict with work schedule|0|||
129439443|NCT01723254|465906509|FG002|Overall Study|Conflict with work schedule|0|||
129439444|NCT01723254|465906510|FG003|Overall Study|Conflict with work schedule|0|||
129439445|NCT01723254|465906511|FG004|Overall Study|Conflict with work schedule|0|||
129620715|NCT03355469|466562923|FG000|Overall Study|Lost to Follow-up|1|||
129620716|NCT03355469|466562924|FG001|Overall Study|Lost to Follow-up|0|||
129620717|NCT03355469|466562925|FG002|Overall Study|Lost to Follow-up|1|||
129439446|NCT01723254|465906512|FG005|Overall Study|Conflict with work schedule|0|||
129439447|NCT01723254|465906513|FG006|Overall Study|Conflict with work schedule|0|||
129620718|NCT03355469|466562926|FG003|Overall Study|Lost to Follow-up|0|||
129439448|NCT01723254|465906514|FG007|Overall Study|Conflict with work schedule|1|||
129620719|NCT03355469|466562923|FG000|Overall Study|Withdrawal by Subject|2|||
129701942|NCT02231580|466869457|FG000|Overall Study|Adverse Event|5|||
129701943|NCT02231580|466869458|FG001|Overall Study|Adverse Event|0|||
129701944|NCT03620981|466869459|FG000|Overall Study|Adverse Event|14|||
129701945|NCT03620981|466869460|FG001|Overall Study|Adverse Event|38|||
129701946|NCT03620981|466869461|FG002|Overall Study|Adverse Event|25|||
129701947|NCT03620981|466869459|FG000|Overall Study|Lack of Efficacy|2|||
129701948|NCT03620981|466869460|FG001|Overall Study|Lack of Efficacy|1|||
129701949|NCT03620981|466869461|FG002|Overall Study|Lack of Efficacy|1|||
129701950|NCT03620981|466869459|FG000|Overall Study|Physician Decision|7|||
129701951|NCT03620981|466869460|FG001|Overall Study|Physician Decision|4|||
129701952|NCT03620981|466869461|FG002|Overall Study|Physician Decision|4|||
129701953|NCT03620981|466869459|FG000|Overall Study|Protocol Violation|1|||
129701954|NCT03620981|466869460|FG001|Overall Study|Protocol Violation|2|||
129701955|NCT03620981|466869461|FG002|Overall Study|Protocol Violation|1|||
129701956|NCT03620981|466869459|FG000|Overall Study|Withdrawal by Legal Representative|2|||
129701957|NCT03620981|466869460|FG001|Overall Study|Withdrawal by Legal Representative|1|||
129701958|NCT03620981|466869461|FG002|Overall Study|Withdrawal by Legal Representative|1|||
129701959|NCT03620981|466869459|FG000|Overall Study|Withdrawal by Care Giver|2|||
129701960|NCT03620981|466869460|FG001|Overall Study|Withdrawal by Care Giver|0|||
129701961|NCT03620981|466869461|FG002|Overall Study|Withdrawal by Care Giver|1|||
129701962|NCT03620981|466869459|FG000|Overall Study|Non-compliance with Study Drug|1|||
129701963|NCT03620981|466869460|FG001|Overall Study|Non-compliance with Study Drug|1|||
129701964|NCT03620981|466869461|FG002|Overall Study|Non-compliance with Study Drug|0|||
129701965|NCT02607722|466869464|FG000|Overall Study|No data reliability|1|||
129701966|NCT02607722|466869464|FG000|Overall Study|no patient visit|18|||
129701967|NCT02607722|466869464|FG000|Overall Study|missing info in CRF|13|||
129701968|NCT02607722|466869464|FG000|Overall Study|Withdrawal by Subject|616|||
129701969|NCT02607722|466869464|FG000|Overall Study|Lost to Follow-up|312|||
129701970|NCT02607722|466869464|FG000|Overall Study|Improved|22|||
129701971|NCT02607722|466869464|FG000|Overall Study|Lack of Efficacy|316|||
129701972|NCT02607722|466869464|FG000|Overall Study|Adverse Event|2553|||
129701973|NCT02607722|466869464|FG000|Overall Study|Not treated|1|||
129701974|NCT02607722|466869464|FG000|Overall Study|No CRF collected|138|||
129701975|NCT02607722|466869464|FG000|Overall Study|without CRF|4225|||
129701976|NCT02607722|466869464|FG000|Overall Study|Physician Decision|367|||
129701977|NCT04347538|466869465|FG000|Overall Study|Lost to Follow-up|4|||
129701978|NCT04347538|466869466|FG001|Overall Study|Lost to Follow-up|5|||
129701979|NCT04347538|466869467|FG002|Overall Study|Lost to Follow-up|7|||
129701980|NCT02135133|466869468|FG000|Overall Study|Adverse Event|10|||
129793130|NCT00997438|467210700|FG000|Overall Study|Withdrawal by Subject|1|||
129793131|NCT00997438|467210701|FG001|Overall Study|Withdrawal by Subject|1|||
129793132|NCT00997438|467210702|FG002|Overall Study|Withdrawal by Subject|0|||
129793133|NCT00997438|467210700|FG000|Overall Study|Exclusion criteria at visit 1|2|||
129793134|NCT00997438|467210701|FG001|Overall Study|Exclusion criteria at visit 1|2|||
129793135|NCT00997438|467210702|FG002|Overall Study|Exclusion criteria at visit 1|3|||
129793136|NCT03505671|467210703|FG000|Overall Study|Withdrawal by Subject|2|||
129793137|NCT03505671|467210704|FG001|Overall Study|Withdrawal by Subject|1|||
129793138|NCT03505671|467210703|FG000|Overall Study|Lost to Follow-up|1|||
129793139|NCT03505671|467210704|FG001|Overall Study|Lost to Follow-up|0|||
129793140|NCT02038829|467210707|FG000|Washout Period 1|Death|0|||
129701981|NCT02135133|466869468|FG000|Overall Study|regulatory mandate|5|||
129701982|NCT03238196|466869469|FG000|Overall Study|Adverse Event|3|||
129701983|NCT03238196|466869470|FG001|Overall Study|Adverse Event|0|||
129701984|NCT03238196|466869471|FG002|Overall Study|Adverse Event|2|||
129793141|NCT02038829|467210708|FG001|Washout Period 1|Death|0|||
129793142|NCT02038829|467210709|FG002|Washout Period 1|Death|0|||
129620720|NCT03355469|466562924|FG001|Overall Study|Withdrawal by Subject|1|||
129620721|NCT03355469|466562925|FG002|Overall Study|Withdrawal by Subject|0|||
129620722|NCT03355469|466562926|FG003|Overall Study|Withdrawal by Subject|3|||
129620723|NCT01708941|466562927|FG000|Overall Study|Adverse Event|4|||
129620724|NCT01708941|466562928|FG001|Overall Study|Adverse Event|6|||
129620725|NCT01708941|466562929|FG002|Overall Study|Adverse Event|1|||
129620726|NCT01708941|466562930|FG003|Overall Study|Adverse Event|0|||
129620727|NCT01708941|466562927|FG000|Overall Study|Death|1|||
129620728|NCT01708941|466562928|FG001|Overall Study|Death|1|||
129620729|NCT01708941|466562929|FG002|Overall Study|Death|2|||
129620730|NCT01708941|466562930|FG003|Overall Study|Death|14|||
129620731|NCT01708941|466562927|FG000|Overall Study|Withdrawal by Subject|1|||
129620732|NCT01708941|466562928|FG001|Overall Study|Withdrawal by Subject|0|||
129620733|NCT01708941|466562929|FG002|Overall Study|Withdrawal by Subject|3|||
129620734|NCT01708941|466562930|FG003|Overall Study|Withdrawal by Subject|4|||
129620735|NCT01708941|466562927|FG000|Overall Study|Disease progression|9|||
129620736|NCT01708941|466562928|FG001|Overall Study|Disease progression|10|||
129620737|NCT01708941|466562929|FG002|Overall Study|Disease progression|8|||
129620738|NCT01708941|466562930|FG003|Overall Study|Disease progression|0|||
129620739|NCT01708941|466562927|FG000|Overall Study|Alternative therapy|0|||
129620740|NCT01708941|466562928|FG001|Overall Study|Alternative therapy|0|||
129620741|NCT01708941|466562929|FG002|Overall Study|Alternative therapy|2|||
129620742|NCT01708941|466562930|FG003|Overall Study|Alternative therapy|0|||
129620743|NCT01708941|466562927|FG000|Overall Study|Ineligible and never started treatment|1|||
129620744|NCT01708941|466562928|FG001|Overall Study|Ineligible and never started treatment|0|||
129620745|NCT01708941|466562929|FG002|Overall Study|Ineligible and never started treatment|1|||
129620746|NCT01708941|466562930|FG003|Overall Study|Ineligible and never started treatment|0|||
129620747|NCT01708941|466562927|FG000|Overall Study|Never started treatment|2|||
129620748|NCT01708941|466562928|FG001|Overall Study|Never started treatment|1|||
129620749|NCT01708941|466562929|FG002|Overall Study|Never started treatment|0|||
129620750|NCT01708941|466562930|FG003|Overall Study|Never started treatment|0|||
129620751|NCT01708941|466562927|FG000|Overall Study|Ineligible|0|||
129620752|NCT01708941|466562928|FG001|Overall Study|Ineligible|0|||
129620753|NCT01708941|466562929|FG002|Overall Study|Ineligible|2|||
129620754|NCT01708941|466562930|FG003|Overall Study|Ineligible|0|||
129620755|NCT01575548|466562931|FG000|Overall Study|Adverse Event|15|||
129620756|NCT01575548|466562932|FG001|Overall Study|Adverse Event|2|||
129620757|NCT01575548|466562931|FG000|Overall Study|Disease progression|12|||
129620758|NCT01575548|466562932|FG001|Overall Study|Disease progression|25|||
129620759|NCT01575548|466562931|FG000|Overall Study|Death|1|||
129620760|NCT01575548|466562932|FG001|Overall Study|Death|0|||
129620761|NCT01575548|466562931|FG000|Overall Study|Other complicating disease|1|||
129620762|NCT01575548|466562932|FG001|Overall Study|Other complicating disease|0|||
129620763|NCT01575548|466562931|FG000|Overall Study|Withdrawal by Subject|7|||
129701985|NCT03238196|466869472|FG003|Overall Study|Adverse Event|2|||
129701986|NCT03238196|466869469|FG000|Overall Study|Withdrawal by Subject|4|||
129701987|NCT03238196|466869470|FG001|Overall Study|Withdrawal by Subject|1|||
129701988|NCT03238196|466869471|FG002|Overall Study|Withdrawal by Subject|1|||
129701989|NCT03238196|466869472|FG003|Overall Study|Withdrawal by Subject|0|||
129701990|NCT03238196|466869469|FG000|Overall Study|Disease progression|14|||
129701991|NCT03238196|466869470|FG001|Overall Study|Disease progression|2|||
129701992|NCT03238196|466869471|FG002|Overall Study|Disease progression|3|||
129701993|NCT03238196|466869472|FG003|Overall Study|Disease progression|2|||
129701994|NCT03238196|466869469|FG000|Overall Study|Still on treatment|1|||
129701995|NCT03238196|466869470|FG001|Overall Study|Still on treatment|0|||
129701996|NCT03238196|466869471|FG002|Overall Study|Still on treatment|0|||
129701997|NCT03238196|466869472|FG003|Overall Study|Still on treatment|0|||
129701998|NCT05081843|466869473|FG000|Overall Study|Lost to Follow-up|135|||
129701999|NCT05081843|466869474|FG001|Overall Study|Lost to Follow-up|145|||
129702000|NCT02303821|466869475|FG000|Overall Study|Withdrawal by Subject|0|||
129702001|NCT02303821|466869476|FG001|Overall Study|Withdrawal by Subject|0|||
129702002|NCT02303821|466869477|FG002|Overall Study|Withdrawal by Subject|0|||
129702003|NCT02303821|466869478|FG003|Overall Study|Withdrawal by Subject|0|||
129702004|NCT02303821|466869479|FG004|Overall Study|Withdrawal by Subject|0|||
129702005|NCT02303821|466869480|FG005|Overall Study|Withdrawal by Subject|0|||
129702006|NCT02303821|466869481|FG006|Overall Study|Withdrawal by Subject|0|||
129620764|NCT01575548|466562932|FG001|Overall Study|Withdrawal by Subject|3|||
129620765|NCT01575548|466562931|FG000|Overall Study|Noncompliance|1|||
129620766|NCT01575548|466562932|FG001|Overall Study|Noncompliance|0|||
129620767|NCT01575548|466562931|FG000|Overall Study|Anticipated surgery|0|||
129620768|NCT01575548|466562932|FG001|Overall Study|Anticipated surgery|1|||
129620769|NCT01575548|466562931|FG000|Overall Study|Never started protocol therapy|3|||
129702007|NCT02303821|466869482|FG007|Overall Study|Withdrawal by Subject|2|||
129702008|NCT02303821|466869475|FG000|Overall Study|Death|0|||
129702009|NCT02303821|466869476|FG001|Overall Study|Death|2|||
129702010|NCT02303821|466869477|FG002|Overall Study|Death|0|||
129620770|NCT01575548|466562932|FG001|Overall Study|Never started protocol therapy|2|||
129620771|NCT04175912|466562933|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
129620772|NCT04175912|466562934|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
129620773|NCT04175912|466562933|FG000|Overall Study|Adverse Event|0|||
129620774|NCT04175912|466562934|FG001|Overall Study|Adverse Event|3|||
129620775|NCT04175912|466562933|FG000|Overall Study|Never started treatment|3|||
129620776|NCT04175912|466562934|FG001|Overall Study|Never started treatment|3|||
129620777|NCT04175912|466562933|FG000|Overall Study|Death|0|||
129620778|NCT04175912|466562934|FG001|Overall Study|Death|1|||
129620779|NCT02048813|466562935|FG000|Overall Study|Still on treatment|279|||
129620780|NCT02048813|466562936|FG001|Overall Study|Still on treatment|0|||
129620781|NCT02048813|466562935|FG000|Overall Study|Adverse Event|40|||
129620782|NCT02048813|466562936|FG001|Overall Study|Adverse Event|38|||
129620783|NCT02048813|466562935|FG000|Overall Study|Disease progression|13|||
129620784|NCT02048813|466562936|FG001|Overall Study|Disease progression|3|||
129620785|NCT02048813|466562935|FG000|Overall Study|Withdrawal by Subject|7|||
129620786|NCT02048813|466562936|FG001|Overall Study|Withdrawal by Subject|8|||
129620787|NCT02048813|466562935|FG000|Overall Study|Death|2|||
129620788|NCT02048813|466562936|FG001|Overall Study|Death|1|||
129620789|NCT02048813|466562935|FG000|Overall Study|Complication|2|||
129620790|NCT02048813|466562936|FG001|Overall Study|Complication|2|||
129620791|NCT02048813|466562935|FG000|Overall Study|Non-protocol therapy|0|||
129620792|NCT02048813|466562936|FG001|Overall Study|Non-protocol therapy|1|||
129620793|NCT02048813|466562935|FG000|Overall Study|Second primary cancer|2|||
129620794|NCT02048813|466562936|FG001|Overall Study|Second primary cancer|0|||
129620795|NCT02048813|466562935|FG000|Overall Study|Insurance|2|||
129620796|NCT02048813|466562936|FG001|Overall Study|Insurance|0|||
129620797|NCT02048813|466562935|FG000|Overall Study|Wound infection/healing|2|||
129620798|NCT02048813|466562936|FG001|Overall Study|Wound infection/healing|0|||
129439449|NCT01723254|465906507|FG000|Overall Study|Personal issues|0|||
129620799|NCT02048813|466562935|FG000|Overall Study|Missed appointment|3|||
129620800|NCT02048813|466562936|FG001|Overall Study|Missed appointment|0|||
129620801|NCT02048813|466562935|FG000|Overall Study|Never started treatment|2|||
129620802|NCT02048813|466562936|FG001|Overall Study|Never started treatment|17|||
129620803|NCT01708954|466562937|FG000|Step 1|Disease progression|26|||
129620804|NCT01708954|466562938|FG001|Step 1|Disease progression|17|||
129620805|NCT01708954|466562939|FG002|Step 1|Disease progression|14|||
129620806|NCT01708954|466562937|FG000|Step 1|Adverse Event|3|||
129620807|NCT01708954|466562938|FG001|Step 1|Adverse Event|11|||
129620808|NCT01708954|466562939|FG002|Step 1|Adverse Event|13|||
129620809|NCT01708954|466562937|FG000|Step 1|Death|3|||
129620810|NCT01708954|466562938|FG001|Step 1|Death|2|||
129620811|NCT01708954|466562939|FG002|Step 1|Death|3|||
129620812|NCT01708954|466562937|FG000|Step 1|Withdrawal by Subject|2|||
129620813|NCT01708954|466562938|FG001|Step 1|Withdrawal by Subject|5|||
129620814|NCT01708954|466562939|FG002|Step 1|Withdrawal by Subject|3|||
129620815|NCT01708954|466562937|FG000|Step 1|Other complicating disease|0|||
129620816|NCT01708954|466562938|FG001|Step 1|Other complicating disease|2|||
129620817|NCT01708954|466562939|FG002|Step 1|Other complicating disease|0|||
129620818|NCT01708954|466562937|FG000|Step 1|Crossed over to Step 2|2|||
129620819|NCT01708954|466562938|FG001|Step 1|Crossed over to Step 2|0|||
129620820|NCT01708954|466562939|FG002|Step 1|Crossed over to Step 2|0|||
129620821|NCT01708954|466562937|FG000|Step 1|Symptomatic deterioration|1|||
129620822|NCT01708954|466562938|FG001|Step 1|Symptomatic deterioration|0|||
129620823|NCT01708954|466562939|FG002|Step 1|Symptomatic deterioration|1|||
129620824|NCT01708954|466562937|FG000|Step 1|Off-treatment reason not submitted|1|||
129620825|NCT01708954|466562938|FG001|Step 1|Off-treatment reason not submitted|1|||
129620826|NCT01708954|466562939|FG002|Step 1|Off-treatment reason not submitted|1|||
129620827|NCT01708954|466562937|FG000|Step 1|Ineligible or never received treatment|4|||
129888254|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
129620828|NCT01708954|466562938|FG001|Step 1|Ineligible or never received treatment|2|||
129620829|NCT01708954|466562939|FG002|Step 1|Ineligible or never received treatment|8|||
129620830|NCT01708954|466562937|FG000|Step 2|Disease progression|9|||
129620831|NCT01708954|466562938|FG001|Step 2|Disease progression|4|||
129620832|NCT01708954|466562939|FG002|Step 2|Disease progression|0|||
129620833|NCT01708954|466562937|FG000|Step 2|Adverse Event|3|||
129620834|NCT01708954|466562938|FG001|Step 2|Adverse Event|2|||
129620835|NCT01708954|466562939|FG002|Step 2|Adverse Event|0|||
129620836|NCT01708954|466562937|FG000|Step 2|Withdrawal by Subject|1|||
129620837|NCT01708954|466562938|FG001|Step 2|Withdrawal by Subject|1|||
129620838|NCT01708954|466562939|FG002|Step 2|Withdrawal by Subject|0|||
129620839|NCT06400251|466562940|FG000|Overall Study|Never Start Protocol Therapy|1|||
129620840|NCT06400251|466562940|FG000|Overall Study|Ineligible|2|||
129620841|NCT06400251|466562940|FG000|Overall Study|Mutation Status Not Confirmed|3|||
129620842|NCT06400251|466562940|FG000|Overall Study|Disease Progression|25|||
129620843|NCT06400251|466562940|FG000|Overall Study|Adverse Event|1|||
129620844|NCT06400251|466562940|FG000|Overall Study|Complicating Disease|1|||
129620845|NCT06400251|466562940|FG000|Overall Study|Physician Decision|2|||
129620846|NCT04759703|466562948|FG000|Overall Study|Withdrawal by Subject|4|||
129620847|NCT04759703|466562949|FG001|Overall Study|Withdrawal by Subject|9|||
129620848|NCT04759703|466562948|FG000|Overall Study|Adverse Event|1|||
129620849|NCT04759703|466562949|FG001|Overall Study|Adverse Event|0|||
129620850|NCT04759703|466562948|FG000|Overall Study|Lost to Follow-up|2|||
129620851|NCT04759703|466562949|FG001|Overall Study|Lost to Follow-up|0|||
129620852|NCT04186845|466562950|FG000|Overall Study|Death|2|||
129620853|NCT04186845|466562950|FG000|Overall Study|Lost to Follow-up|1|||
129620854|NCT04186845|466562950|FG000|Overall Study|Physician Decision|1|||
129620855|NCT04186845|466562950|FG000|Overall Study|Protocol Violation|1|||
129620856|NCT04186845|466562950|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
129620857|NCT04186845|466562950|FG000|Overall Study|Biopsy ordered but not done|1|||
129620858|NCT04186845|466562950|FG000|Overall Study|It was previously confirmed|1|||
129620859|NCT04186845|466562950|FG000|Overall Study|Patient cancelled scheduled scans|2|||
129620860|NCT04186845|466562950|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
129620861|NCT04186845|466562950|FG000|Overall Study|Subject refused confirmatory imaging|1|||
129620862|NCT04186845|466562950|FG000|Overall Study|Too small to biopsy|1|||
129620863|NCT01814553|466562953|FG000|Overall Study|PD per clinical progression|6|||
129620864|NCT01814553|466562954|FG001|Overall Study|PD per clinical progression|8|||
129620865|NCT01814553|466562953|FG000|Overall Study|Other Adverse Event|4|||
129620866|NCT01814553|466562954|FG001|Overall Study|Other Adverse Event|5|||
129620867|NCT01814553|466562953|FG000|Overall Study|Withdrawal by Subject|1|||
129620868|NCT01814553|466562954|FG001|Overall Study|Withdrawal by Subject|1|||
129620869|NCT01814553|466562953|FG000|Overall Study|Other than stated|7|||
129620870|NCT01814553|466562954|FG001|Overall Study|Other than stated|8|||
129620871|NCT04138823|466562955|FG000|Overall Study|Clinical disease progression|0|||
129620872|NCT04138823|466562956|FG001|Overall Study|Clinical disease progression|0|||
129620873|NCT04138823|466562957|FG002|Overall Study|Clinical disease progression|1|||
129620874|NCT04138823|466562955|FG000|Overall Study|Objective disease progression|3|||
129620875|NCT04138823|466562956|FG001|Overall Study|Objective disease progression|2|||
129620876|NCT04138823|466562957|FG002|Overall Study|Objective disease progression|5|||
129620877|NCT02859142|466562958|FG000|Overall Study|Adverse Event|1|||
129620878|NCT02859142|466562959|FG001|Overall Study|Adverse Event|2|||
129620879|NCT02859142|466562958|FG000|Overall Study|Lost to Follow-up|1|||
129620880|NCT02859142|466562959|FG001|Overall Study|Lost to Follow-up|4|||
129620881|NCT02859142|466562958|FG000|Overall Study|Withdrawal by Subject|2|||
129620882|NCT02859142|466562959|FG001|Overall Study|Withdrawal by Subject|0|||
129620883|NCT02859142|466562958|FG000|Overall Study|Scheduling difficulties|0|||
129620884|NCT02859142|466562959|FG001|Overall Study|Scheduling difficulties|3|||
129620885|NCT03290079|466562960|FG000|Overall Study|Death|2|||
129620886|NCT02676765|466562961|FG000|Overall Study|Lost to Follow-up|0|||
129620887|NCT02676765|466562962|FG001|Overall Study|Lost to Follow-up|1|||
129620888|NCT01941498|466562965|FG000|Overall Study|Relocated out of state|1|||
129620889|NCT04877457|466562966|FG000|Overall Study|Early termination of study due to low enrollment|2|||
129620890|NCT04877457|466562967|FG001|Overall Study|Early termination of study due to low enrollment|1|||
129620891|NCT04697069|466562969|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
129620892|NCT04697069|466562970|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
129620893|NCT04697069|466562969|FG000|Overall Study|Study termination|2|||
129620894|NCT04697069|466562970|FG001|Overall Study|Study termination|1|||
129793143|NCT02038829|467210710|FG003|Washout Period 1|Death|0|||
129793144|NCT02038829|467210711|FG004|Washout Period 1|Death|1|||
129793145|NCT02038829|467210712|FG005|Washout Period 1|Death|0|||
129793146|NCT02038829|467210713|FG006|Washout Period 1|Death|0|||
129793147|NCT02038829|467210714|FG007|Washout Period 1|Death|0|||
129793148|NCT02038829|467210715|FG008|Washout Period 1|Death|0|||
129439450|NCT01723254|465906508|FG001|Overall Study|Personal issues|0|||
129793149|NCT02038829|467210716|FG009|Washout Period 1|Death|0|||
129793150|NCT02038829|467210717|FG010|Washout Period 1|Death|0|||
129620895|NCT04739800|466562971|FG000|Overall Study|Adverse Event|2|||
129620896|NCT04739800|466562972|FG001|Overall Study|Adverse Event|1|||
129620897|NCT04739800|466562973|FG002|Overall Study|Adverse Event|4|||
129620898|NCT04739800|466562974|FG003|Overall Study|Adverse Event|5|||
129620899|NCT04739800|466562971|FG000|Overall Study|Never Treated|2|||
129620900|NCT04739800|466562972|FG001|Overall Study|Never Treated|0|||
129793151|NCT02038829|467210718|FG011|Washout Period 1|Death|0|||
129620901|NCT04739800|466562973|FG002|Overall Study|Never Treated|1|||
129620902|NCT04739800|466562974|FG003|Overall Study|Never Treated|1|||
129620903|NCT04739800|466562971|FG000|Overall Study|On Treatment|5|||
129620904|NCT04739800|466562972|FG001|Overall Study|On Treatment|9|||
129620905|NCT04739800|466562973|FG002|Overall Study|On Treatment|9|||
129620906|NCT04739800|466562974|FG003|Overall Study|On Treatment|9|||
129620907|NCT04739800|466562971|FG000|Overall Study|Symptomatic Deterioration|1|||
129888255|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
129888256|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
129888257|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
129888258|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
129888259|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
129888260|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
129620908|NCT04739800|466562972|FG001|Overall Study|Symptomatic Deterioration|1|||
129620909|NCT04739800|466562973|FG002|Overall Study|Symptomatic Deterioration|3|||
129620910|NCT04739800|466562974|FG003|Overall Study|Symptomatic Deterioration|0|||
129620911|NCT04739800|466562971|FG000|Overall Study|Withdrawal by Subject|1|||
129620912|NCT04739800|466562972|FG001|Overall Study|Withdrawal by Subject|2|||
129888261|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
129888262|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
129888263|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
129888264|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
129620913|NCT04739800|466562973|FG002|Overall Study|Withdrawal by Subject|1|||
129620914|NCT04739800|466562974|FG003|Overall Study|Withdrawal by Subject|3|||
129620915|NCT04739800|466562971|FG000|Overall Study|Other Reason|1|||
129620916|NCT04739800|466562972|FG001|Overall Study|Other Reason|3|||
129888265|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
129620917|NCT04739800|466562973|FG002|Overall Study|Other Reason|5|||
129620918|NCT04739800|466562974|FG003|Overall Study|Other Reason|4|||
129620919|NCT02779855|466562975|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
129620920|NCT02779855|466562976|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
129620921|NCT02779855|466562977|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
129620922|NCT04597632|466562978|FG000|Overall Study|Withdrawal by Subject|10|||
129620923|NCT04597632|466562978|FG000|Overall Study|Lost to Follow-up|1|||
129620924|NCT04597632|466562978|FG000|Overall Study|Death|1|||
129620925|NCT04597632|466562978|FG000|Overall Study|Adverse Event|5|||
129620926|NCT01893346|466562981|FG000|Overall Study|Lost to Follow-up|0|||
129620927|NCT01893346|466562982|FG001|Overall Study|Lost to Follow-up|1|||
129620928|NCT01893346|466562983|FG002|Overall Study|Lost to Follow-up|0|||
129620929|NCT01893346|466562984|FG003|Overall Study|Lost to Follow-up|0|||
129620930|NCT01893346|466562981|FG000|Overall Study|Protocol Violation|1|||
129620931|NCT01893346|466562982|FG001|Overall Study|Protocol Violation|0|||
129702011|NCT02303821|466869478|FG003|Overall Study|Death|0|||
129702012|NCT02303821|466869479|FG004|Overall Study|Death|0|||
129702013|NCT02303821|466869480|FG005|Overall Study|Death|3|||
129702014|NCT02303821|466869481|FG006|Overall Study|Death|41|||
129702015|NCT02303821|466869482|FG007|Overall Study|Death|29|||
129702016|NCT02303821|466869475|FG000|Overall Study|Lost to Follow-up|0|||
129702017|NCT02303821|466869476|FG001|Overall Study|Lost to Follow-up|0|||
129702018|NCT02303821|466869477|FG002|Overall Study|Lost to Follow-up|0|||
129702019|NCT02303821|466869478|FG003|Overall Study|Lost to Follow-up|0|||
129702020|NCT02303821|466869479|FG004|Overall Study|Lost to Follow-up|0|||
129702021|NCT02303821|466869480|FG005|Overall Study|Lost to Follow-up|0|||
129702022|NCT02303821|466869481|FG006|Overall Study|Lost to Follow-up|1|||
129702023|NCT02303821|466869482|FG007|Overall Study|Lost to Follow-up|0|||
129702024|NCT02303821|466869475|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702025|NCT02303821|466869476|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702026|NCT02303821|466869477|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702027|NCT02303821|466869478|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702028|NCT02303821|466869479|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702029|NCT02303821|466869480|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702030|NCT02303821|466869481|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
129702031|NCT02303821|466869482|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
129702032|NCT02303821|466869475|FG000|Overall Study|Decision by sponsor|0|||
129702033|NCT02303821|466869476|FG001|Overall Study|Decision by sponsor|0|||
129702034|NCT02303821|466869477|FG002|Overall Study|Decision by sponsor|0|||
129620932|NCT01893346|466562983|FG002|Overall Study|Protocol Violation|0|||
129620933|NCT01893346|466562984|FG003|Overall Study|Protocol Violation|0|||
129620934|NCT01893346|466562981|FG000|Overall Study|Withdrawal by Subject|2|||
129620935|NCT01893346|466562982|FG001|Overall Study|Withdrawal by Subject|0|||
129620936|NCT01893346|466562983|FG002|Overall Study|Withdrawal by Subject|0|||
129620937|NCT01893346|466562984|FG003|Overall Study|Withdrawal by Subject|0|||
129702035|NCT02303821|466869478|FG003|Overall Study|Decision by sponsor|0|||
129702036|NCT02303821|466869479|FG004|Overall Study|Decision by sponsor|0|||
129702037|NCT02303821|466869480|FG005|Overall Study|Decision by sponsor|1|||
129620938|NCT01449812|466562985|FG000|Overall Study|Migrated/moved from study area|1|||
129620939|NCT01449812|466562986|FG001|Overall Study|Migrated/moved from study area|0|||
129620940|NCT01449812|466562987|FG002|Overall Study|Migrated/moved from study area|0|||
129620941|NCT01449812|466562985|FG000|Overall Study|Withdrawal by Subject|0|||
129620942|NCT01449812|466562986|FG001|Overall Study|Withdrawal by Subject|0|||
129620943|NCT01449812|466562987|FG002|Overall Study|Withdrawal by Subject|1|||
129620944|NCT01449812|466562985|FG000|Overall Study|Lost to Follow-up|1|||
129620945|NCT01449812|466562986|FG001|Overall Study|Lost to Follow-up|0|||
129620946|NCT01449812|466562987|FG002|Overall Study|Lost to Follow-up|0|||
129620947|NCT04239027|466562988|FG000|Overall Study|Adverse Event|4|||
129620948|NCT04239027|466562988|FG000|Overall Study|Withdrawal by Subject|9|||
129620949|NCT04239027|466562988|FG000|Overall Study|Death|1|||
129620950|NCT04239027|466562988|FG000|Overall Study|Physician Decision|9|||
129620951|NCT04239027|466562988|FG000|Overall Study|Lost to Follow-up|2|||
129620952|NCT04239027|466562988|FG000|Overall Study|Lack of Efficacy|1|||
129620953|NCT02839707|466562991|FG000|Phase I|Not eligible for analysis|9|||
129620954|NCT02839707|466562992|FG001|Phase I|Not eligible for analysis|0|||
129620955|NCT02839707|466562993|FG002|Phase I|Not eligible for analysis|0|||
129620956|NCT02839707|466562991|FG000|Phase II|Not treated according to protocol|4|||
129620957|NCT02839707|466562992|FG001|Phase II|Not treated according to protocol|0|||
129620958|NCT02839707|466562993|FG002|Phase II|Not treated according to protocol|2|||
129620959|NCT02839707|466562991|FG000|Phase III|Not treated according to protocol|0|||
129620960|NCT02839707|466562992|FG001|Phase III|Not treated according to protocol|0|||
129620961|NCT02839707|466562993|FG002|Phase III|Not treated according to protocol|4|||
129620962|NCT01290302|466565064|FG000|Overall Study|Adverse Event|2|||
129620963|NCT01290302|466565065|FG001|Overall Study|Adverse Event|0|||
129620964|NCT01290302|466565064|FG000|Overall Study|Withdrawal by Subject|1|||
129620965|NCT01290302|466565065|FG001|Overall Study|Withdrawal by Subject|0|||
129620966|NCT01290302|466565064|FG000|Overall Study|Physician Decision|0|||
129620967|NCT01290302|466565065|FG001|Overall Study|Physician Decision|2|||
129620968|NCT01290302|466565064|FG000|Overall Study|Expiration of time for screening window|1|||
129620969|NCT01290302|466565065|FG001|Overall Study|Expiration of time for screening window|0|||
129620970|NCT06419907|466565068|FG000|Overall Study|Protocol Violation|0|||
129620971|NCT06419907|466565069|FG001|Overall Study|Protocol Violation|3|||
129620972|NCT06419907|466565070|FG002|Overall Study|Protocol Violation|0|||
129620973|NCT06419907|466565071|FG003|Overall Study|Protocol Violation|1|||
129620974|NCT06419907|466565068|FG000|Overall Study|Lost to Follow-up|0|||
129620975|NCT06419907|466565069|FG001|Overall Study|Lost to Follow-up|0|||
129620976|NCT06419907|466565070|FG002|Overall Study|Lost to Follow-up|2|||
129620977|NCT06419907|466565071|FG003|Overall Study|Lost to Follow-up|1|||
129620978|NCT02586688|466565074|FG000|Overall Study|Lost to Follow-up|2|||
129620979|NCT02586688|466565075|FG001|Overall Study|Lost to Follow-up|1|||
129620980|NCT02586688|466565074|FG000|Overall Study|Withdrawal by Subject|1|||
129620981|NCT02586688|466565075|FG001|Overall Study|Withdrawal by Subject|1|||
129620982|NCT02586688|466565074|FG000|Overall Study|Adverse Event|3|||
129620983|NCT02586688|466565075|FG001|Overall Study|Adverse Event|1|||
129620984|NCT02454608|466565076|FG000|Double-Blind Period|Lack of Efficacy|0|||
129620985|NCT02454608|466565077|FG001|Double-Blind Period|Lack of Efficacy|2|||
129620986|NCT02454608|466565078|FG002|Double-Blind Period|Lack of Efficacy|0|||
129620987|NCT02454608|466565076|FG000|Open Label Period|Lost to Follow-up|0|||
129620988|NCT02454608|466565077|FG001|Open Label Period|Lost to Follow-up|0|||
129620989|NCT02454608|466565078|FG002|Open Label Period|Lost to Follow-up|11|||
129620990|NCT02454608|466565076|FG000|Open Label Period|Withdrawal by Subject|0|||
129620991|NCT02454608|466565077|FG001|Open Label Period|Withdrawal by Subject|0|||
129620992|NCT02454608|466565078|FG002|Open Label Period|Withdrawal by Subject|8|||
129620993|NCT03573830|466565079|FG000|Overall Study|Dropped without completing treatment|0|||
129620994|NCT03573830|466565080|FG001|Overall Study|Dropped without completing treatment|7|||
129620995|NCT03573830|466565079|FG000|Overall Study|Lost to Follow-up|4|||
129620996|NCT03573830|466565080|FG001|Overall Study|Lost to Follow-up|0|||
129620997|NCT01769456|466565081|FG000|Overall Study|Lost to Follow-up|19|||
129620998|NCT01769456|466565081|FG000|Overall Study|Withdrawal by Subject|3|||
129620999|NCT01769456|466565081|FG000|Overall Study|Did not receive PCC intervention|6|||
129621000|NCT01769456|466565081|FG000|Overall Study|Moved out of the area|3|||
129621001|NCT01769456|466565081|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
129621002|NCT01769456|466565081|FG000|Overall Study|Parental request to youth to withdraw|1|||
129621003|NCT02465398|466565088|FG000|Overall Study|Death|7|||
129621004|NCT02465398|466565088|FG000|Overall Study|Revision|7|||
129621005|NCT02465398|466565088|FG000|Overall Study|did not receive study device|1|||
129621006|NCT02465398|466565088|FG000|Overall Study|Withdrawal by Subject|1|||
129621007|NCT02465398|466565088|FG000|Overall Study|Lost to Follow-up|14|||
129621008|NCT05244122|466565093|FG000|Overall Study|Withdrawal by Subject|318|||
129621009|NCT00064987|466565098|FG000|Overall Study|Physician Decision|3|||
129621010|NCT00064987|466565099|FG001|Overall Study|Physician Decision|0|||
129621011|NCT02969382|466565100|FG000|Overall Study|Adverse Event|8|||
129621012|NCT02969382|466565101|FG001|Overall Study|Adverse Event|10|||
129621013|NCT02969382|466565100|FG000|Overall Study|Lack of Efficacy|4|||
129621014|NCT02969382|466565101|FG001|Overall Study|Lack of Efficacy|5|||
129621015|NCT02969382|466565100|FG000|Overall Study|Death|0|||
129621016|NCT02969382|466565101|FG001|Overall Study|Death|1|||
129621017|NCT02969382|466565100|FG000|Overall Study|PROTOCOL DEVIATION|0|||
129621018|NCT02969382|466565101|FG001|Overall Study|PROTOCOL DEVIATION|1|||
129621019|NCT02969382|466565100|FG000|Overall Study|Withdrawal by Subject|14|||
129621020|NCT02969382|466565101|FG001|Overall Study|Withdrawal by Subject|9|||
129621021|NCT00764881|466565102|FG000|Overall Study|Adverse Event|5|||
129621022|NCT00764881|466565103|FG001|Overall Study|Adverse Event|1|||
129621023|NCT00764881|466565102|FG000|Overall Study|Withdrawal by Subject|1|||
129621024|NCT00764881|466565103|FG001|Overall Study|Withdrawal by Subject|3|||
129621025|NCT00764881|466565102|FG000|Overall Study|Protocol Violation|2|||
129621026|NCT00764881|466565103|FG001|Overall Study|Protocol Violation|2|||
129621027|NCT00764881|466565102|FG000|Overall Study|Lost to Follow-up|2|||
129621028|NCT00764881|466565103|FG001|Overall Study|Lost to Follow-up|0|||
129621029|NCT00764881|466565102|FG000|Overall Study|Noncompliant|1|||
129621030|NCT00764881|466565103|FG001|Overall Study|Noncompliant|0|||
129621031|NCT00764881|466565102|FG000|Overall Study|Accidentally discontinued study drug|1|||
129621032|NCT00764881|466565103|FG001|Overall Study|Accidentally discontinued study drug|0|||
129621033|NCT00764881|466565102|FG000|Overall Study|Wished to become pregnant|1|||
129621034|NCT00764881|466565103|FG001|Overall Study|Wished to become pregnant|0|||
129621035|NCT00764881|466565102|FG000|Overall Study|Carcinoma detected|1|||
129621036|NCT00764881|466565103|FG001|Overall Study|Carcinoma detected|0|||
129621037|NCT00764881|466565102|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
129621038|NCT00764881|466565103|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
129621039|NCT00764881|466565102|FG000|Overall Study|no treatment or no observation|2|||
129621040|NCT00764881|466565103|FG001|Overall Study|no treatment or no observation|2|||
129621041|NCT01567462|466565104|FG000|Overall Study|Withdrawal by Subject|4|||
129621042|NCT01567462|466565105|FG001|Overall Study|Withdrawal by Subject|7|||
129621043|NCT01692626|466565107|FG000|Overall Study|Death|0|||
129621044|NCT01692626|466565108|FG001|Overall Study|Death|1|||
129621045|NCT01692626|466565107|FG000|Overall Study|Adverse Event|2|||
129621046|NCT01692626|466565108|FG001|Overall Study|Adverse Event|3|||
129621047|NCT01692626|466565107|FG000|Overall Study|Protocol Violation|1|||
129621048|NCT01692626|466565108|FG001|Overall Study|Protocol Violation|2|||
129621049|NCT01692626|466565107|FG000|Overall Study|Withdrawal by Subject|1|||
129621050|NCT01692626|466565108|FG001|Overall Study|Withdrawal by Subject|0|||
129621051|NCT00855894|466565111|FG000|Overall Study|Death|31|||
129621052|NCT00855894|466565111|FG000|Overall Study|Patient's decision|1|||
129621053|NCT00855894|466565111|FG000|Overall Study|Disease progression|1|||
129621054|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
129621055|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
129621056|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
129621057|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
129621058|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
129621059|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
129621060|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
129621061|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
129621062|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
129621063|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
129702038|NCT02303821|466869481|FG006|Overall Study|Decision by sponsor|0|||
129702039|NCT02303821|466869482|FG007|Overall Study|Decision by sponsor|0|||
129702040|NCT02303821|466869475|FG000|Overall Study|Protocol-specified criteria|0|||
129702041|NCT02303821|466869476|FG001|Overall Study|Protocol-specified criteria|1|||
129702042|NCT02303821|466869477|FG002|Overall Study|Protocol-specified criteria|0|||
129702043|NCT02303821|466869478|FG003|Overall Study|Protocol-specified criteria|0|||
129702044|NCT02303821|466869479|FG004|Overall Study|Protocol-specified criteria|0|||
129702045|NCT02303821|466869480|FG005|Overall Study|Protocol-specified criteria|1|||
129702046|NCT02303821|466869481|FG006|Overall Study|Protocol-specified criteria|0|||
129702047|NCT02303821|466869482|FG007|Overall Study|Protocol-specified criteria|0|||
129702048|NCT04938427|466869485|FG000|Overall Study|Adverse Event|5|||
129702049|NCT04938427|466869486|FG001|Overall Study|Adverse Event|19|||
129702050|NCT04938427|466869485|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129702051|NCT04938427|466869486|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129702052|NCT04938427|466869485|FG000|Overall Study|Withdrawal by Subject|1|||
129702053|NCT04938427|466869486|FG001|Overall Study|Withdrawal by Subject|0|||
129702054|NCT04938427|466869485|FG000|Overall Study|Reason Not Specified|2|||
129702055|NCT04938427|466869486|FG001|Overall Study|Reason Not Specified|1|||
129702056|NCT05852340|466869495|FG000|Period 5|Not completing the meal|0|||
129702057|NCT05852340|466869496|FG001|Period 5|Not completing the meal|1|||
129702058|NCT05852340|466869497|FG002|Period 5|Not completing the meal|0|||
129702059|NCT05852340|466869498|FG003|Period 5|Not completing the meal|0|||
129702060|NCT05852340|466869495|FG000|Period 5|Adverse Event|0|||
129702061|NCT05852340|466869496|FG001|Period 5|Adverse Event|0|||
129702062|NCT05852340|466869497|FG002|Period 5|Adverse Event|0|||
129621064|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
129621065|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
129621066|NCT02422797|466565112|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
129702063|NCT05852340|466869498|FG003|Period 5|Adverse Event|1|||
129702064|NCT05852470|466869499|FG000|Overall Study|Withdrawal by Subject|0|||
129702065|NCT05852470|466869500|FG001|Overall Study|Withdrawal by Subject|1|||
129702066|NCT01346592|466869506|FG000|Overall Study|Lost to Follow-up|62|||
129702067|NCT01346592|466869507|FG001|Overall Study|Lost to Follow-up|29|||
129702068|NCT01346592|466869508|FG002|Overall Study|Lost to Follow-up|29|||
129702069|NCT01346592|466869506|FG000|Overall Study|Protocol Violation|2|||
129439451|NCT01723254|465906509|FG002|Overall Study|Personal issues|0|||
129439452|NCT01723254|465906510|FG003|Overall Study|Personal issues|0|||
129621067|NCT02422797|466565113|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
129621068|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
129621069|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
129621070|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
129621071|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
129621072|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
129621073|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
129621074|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
129621075|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
129621076|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
129621077|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
129621078|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
129621079|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
129621080|NCT02422797|466565112|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
129621081|NCT02422797|466565113|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
129621082|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
129621083|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
129621084|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
129621085|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
129621086|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
129621087|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
129621088|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
129621089|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
129621090|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
129621091|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
129621092|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
129621093|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
129621094|NCT02422797|466565112|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
129621095|NCT02422797|466565113|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
129621096|NCT04071405|466565114|FG000|Overall Study|Protocol Violation|3|||
129621097|NCT00369941|466565115|FG000|Overall Study|Never Treated|1|||
129702070|NCT01346592|466869507|FG001|Overall Study|Protocol Violation|1|||
129702071|NCT01346592|466869508|FG002|Overall Study|Protocol Violation|0|||
129702072|NCT01346592|466869506|FG000|Overall Study|Death|1|||
129702073|NCT01346592|466869507|FG001|Overall Study|Death|3|||
129702074|NCT01346592|466869508|FG002|Overall Study|Death|4|||
129702075|NCT01346592|466869506|FG000|Overall Study|Adverse Event|0|||
129702076|NCT01346592|466869507|FG001|Overall Study|Adverse Event|1|||
129702077|NCT01346592|466869508|FG002|Overall Study|Adverse Event|0|||
129702078|NCT01346592|466869506|FG000|Overall Study|Withdrawal by Subject|77|||
129702079|NCT01346592|466869507|FG001|Overall Study|Withdrawal by Subject|51|||
129702080|NCT01346592|466869508|FG002|Overall Study|Withdrawal by Subject|38|||
129702081|NCT01346592|466869506|FG000|Overall Study|Inappropriate enrollment|3|||
129621098|NCT00369941|466565116|FG001|Overall Study|Never Treated|2|||
129621099|NCT00369941|466565115|FG000|Overall Study|Adverse Event|14|||
129621100|NCT00369941|466565116|FG001|Overall Study|Adverse Event|28|||
129702082|NCT01346592|466869507|FG001|Overall Study|Inappropriate enrollment|1|||
129621101|NCT00369941|466565115|FG000|Overall Study|Lack of Efficacy|6|||
129621102|NCT00369941|466565116|FG001|Overall Study|Lack of Efficacy|10|||
129621103|NCT00369941|466565115|FG000|Overall Study|Lost to Follow-up|12|||
129621104|NCT00369941|466565116|FG001|Overall Study|Lost to Follow-up|22|||
129621105|NCT00369941|466565115|FG000|Overall Study|Protocol Violation|5|||
129621106|NCT00369941|466565116|FG001|Overall Study|Protocol Violation|3|||
129621107|NCT00369941|466565115|FG000|Overall Study|Withdrawal by Subject|5|||
129621108|NCT00369941|466565116|FG001|Overall Study|Withdrawal by Subject|18|||
129621109|NCT00369941|466565115|FG000|Overall Study|Pregnancy|4|||
129621110|NCT00369941|466565116|FG001|Overall Study|Pregnancy|2|||
129621111|NCT00369941|466565115|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
129621112|NCT00369941|466565116|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
129621113|NCT00369941|466565115|FG000|Overall Study|Moved|11|||
129621114|NCT00369941|466565116|FG001|Overall Study|Moved|5|||
129888266|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
129888267|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
129888268|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
129888269|NCT02718417|467549132|FG000|Chemotherapy Phase (CP)|Other|2|||
129888270|NCT02718417|467549133|FG001|Chemotherapy Phase (CP)|Other|0|||
129888271|NCT02718417|467549134|FG002|Chemotherapy Phase (CP)|Other|1|||
129888272|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Adverse Event|21|||
129888273|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Adverse Event|26|||
129888274|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Adverse Event|0|||
129888275|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
129888276|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
129888277|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
129621115|NCT00369941|466565115|FG000|Overall Study|Treatment with Prohibited Medication|3|||
129621116|NCT00369941|466565116|FG001|Overall Study|Treatment with Prohibited Medication|1|||
129621117|NCT00369941|466565115|FG000|Overall Study|Employment Interfered with Study Visits|1|||
129621118|NCT00369941|466565116|FG001|Overall Study|Employment Interfered with Study Visits|0|||
129621119|NCT00369941|466565115|FG000|Overall Study|Study Site Terminated|2|||
129621120|NCT00369941|466565116|FG001|Overall Study|Study Site Terminated|0|||
129621121|NCT00369941|466565115|FG000|Overall Study|Miscellaneous|3|||
129621122|NCT00369941|466565116|FG001|Overall Study|Miscellaneous|3|||
129621123|NCT00403585|466565117|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
129621124|NCT00403585|466565117|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
129621125|NCT00403585|466565117|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
129621126|NCT02276807|466565118|FG000|Overall Study|Withdrawal by Subject|8|||
129621127|NCT02276807|466565119|FG001|Overall Study|Withdrawal by Subject|7|||
129621128|NCT02276807|466565118|FG000|Overall Study|Lost to Follow-up|10|||
129621129|NCT02276807|466565119|FG001|Overall Study|Lost to Follow-up|10|||
129621130|NCT03971474|466565120|FG000|Overall Study|Adverse Event|11|||
129621131|NCT03971474|466565121|FG001|Overall Study|Adverse Event|7|||
129621132|NCT03971474|466565120|FG000|Overall Study|Refusal unrelated to adverse event|5|||
129621133|NCT03971474|466565121|FG001|Overall Study|Refusal unrelated to adverse event|1|||
129621134|NCT03971474|466565120|FG000|Overall Study|Progression/relapse|40|||
129621135|NCT03971474|466565121|FG001|Overall Study|Progression/relapse|47|||
129621136|NCT03971474|466565120|FG000|Overall Study|Death|6|||
129621137|NCT03971474|466565121|FG001|Overall Study|Death|3|||
129621138|NCT03971474|466565120|FG000|Overall Study|Other - not protocol specified|5|||
129621139|NCT03971474|466565121|FG001|Overall Study|Other - not protocol specified|4|||
129621140|NCT03971474|466565120|FG000|Overall Study|On treatment|0|||
129621141|NCT03971474|466565121|FG001|Overall Study|On treatment|7|||
129621142|NCT00261950|466565122|FG000|Overall Study|Lost to Follow-up|2|||
129621143|NCT00261950|466565122|FG000|Overall Study|Death|6|||
129621144|NCT00261950|466565122|FG000|Overall Study|Withdrawal by Subject|5|||
129621145|NCT00261950|466565122|FG000|Overall Study|Other|1|||
129621146|NCT00261950|466565122|FG000|Overall Study|Physician Decision|1|||
129621147|NCT00261950|466565122|FG000|Overall Study|Protocol specified Criteria|11|||
129621148|NCT01937871|466565129|FG000|Overall Study|Adverse Event|6|||
129621149|NCT01937871|466565130|FG001|Overall Study|Adverse Event|6|||
129621150|NCT01937871|466565131|FG002|Overall Study|Adverse Event|2|||
129621151|NCT01937871|466565129|FG000|Overall Study|Lost to Follow-up|8|||
129621152|NCT01937871|466565130|FG001|Overall Study|Lost to Follow-up|2|||
129621153|NCT01937871|466565131|FG002|Overall Study|Lost to Follow-up|4|||
129621154|NCT01937871|466565129|FG000|Overall Study|Withdrawal by Subject|9|||
129621155|NCT01937871|466565130|FG001|Overall Study|Withdrawal by Subject|6|||
129621156|NCT01937871|466565131|FG002|Overall Study|Withdrawal by Subject|4|||
129621157|NCT01937871|466565129|FG000|Overall Study|Physician Decision|0|||
129621158|NCT01937871|466565130|FG001|Overall Study|Physician Decision|1|||
129621159|NCT01937871|466565131|FG002|Overall Study|Physician Decision|0|||
129621160|NCT01937871|466565129|FG000|Overall Study|Entry Criteria Not Met|1|||
129888278|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
129621161|NCT01937871|466565130|FG001|Overall Study|Entry Criteria Not Met|2|||
129888279|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
129888280|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
129793152|NCT02038829|467210707|FG000|Treatment Period 2|Adverse Event|0|||
129793153|NCT02038829|467210708|FG001|Treatment Period 2|Adverse Event|0|||
129621162|NCT01937871|466565131|FG002|Overall Study|Entry Criteria Not Met|1|||
129621163|NCT00577863|466565138|FG000|Overall Study|Adverse Event|4|||
129621164|NCT00577863|466565139|FG001|Overall Study|Adverse Event|2|||
129621165|NCT00577863|466565138|FG000|Overall Study|Death|1|||
129621166|NCT00577863|466565139|FG001|Overall Study|Death|0|||
129621167|NCT00577863|466565138|FG000|Overall Study|Lost to Follow-up|2|||
129621168|NCT00577863|466565139|FG001|Overall Study|Lost to Follow-up|2|||
129621169|NCT00577863|466565138|FG000|Overall Study|Entry Criteria Exclusion|1|||
129621170|NCT00577863|466565139|FG001|Overall Study|Entry Criteria Exclusion|0|||
129621171|NCT00577863|466565138|FG000|Overall Study|Withdrawal by Subject|0|||
129621172|NCT00577863|466565139|FG001|Overall Study|Withdrawal by Subject|2|||
129621173|NCT00577863|466565138|FG000|Overall Study|Sponsor Decision|2|||
129621174|NCT00577863|466565139|FG001|Overall Study|Sponsor Decision|7|||
129621175|NCT00577863|466565138|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
129621176|NCT00577863|466565139|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
129621177|NCT00668317|466565140|FG000|Overall Study|Adverse Event|2|||
129621178|NCT05211726|466565149|FG000|Overall Study|Withdrawal by Subject|2|||
129621179|NCT05211726|466565150|FG001|Overall Study|Withdrawal by Subject|3|||
129621180|NCT05211726|466565149|FG000|Overall Study|Protocol Violation|0|||
129621181|NCT05211726|466565150|FG001|Overall Study|Protocol Violation|1|||
129621182|NCT03509467|466565151|FG000|Overall Study|Withdrawal by Subject|5|||
129621183|NCT03509467|466565152|FG001|Overall Study|Withdrawal by Subject|1|||
129621184|NCT03509467|466565153|FG002|Overall Study|Withdrawal by Subject|6|||
129621185|NCT03509467|466565154|FG003|Overall Study|Withdrawal by Subject|7|||
129621186|NCT03509467|466565155|FG004|Overall Study|Withdrawal by Subject|10|||
129793154|NCT02038829|467210709|FG002|Treatment Period 2|Adverse Event|0|||
129793155|NCT02038829|467210710|FG003|Treatment Period 2|Adverse Event|0|||
129793156|NCT02038829|467210711|FG004|Treatment Period 2|Adverse Event|0|||
129793157|NCT02038829|467210712|FG005|Treatment Period 2|Adverse Event|0|||
129793158|NCT02038829|467210713|FG006|Treatment Period 2|Adverse Event|0|||
129793159|NCT02038829|467210714|FG007|Treatment Period 2|Adverse Event|0|||
129793160|NCT02038829|467210715|FG008|Treatment Period 2|Adverse Event|0|||
129793161|NCT02038829|467210716|FG009|Treatment Period 2|Adverse Event|0|||
129793162|NCT02038829|467210717|FG010|Treatment Period 2|Adverse Event|1|||
129793163|NCT02038829|467210718|FG011|Treatment Period 2|Adverse Event|0|||
129793164|NCT02038829|467210707|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129793165|NCT02038829|467210708|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129793166|NCT02038829|467210709|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129793167|NCT02038829|467210710|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129793168|NCT02038829|467210711|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129793169|NCT02038829|467210712|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129793170|NCT02038829|467210713|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129793171|NCT02038829|467210714|FG007|Treatment Period 2|Withdrawal by Subject|0|||
129793172|NCT02038829|467210715|FG008|Treatment Period 2|Withdrawal by Subject|0|||
129793173|NCT02038829|467210716|FG009|Treatment Period 2|Withdrawal by Subject|0|||
129793174|NCT02038829|467210717|FG010|Treatment Period 2|Withdrawal by Subject|0|||
129793175|NCT02038829|467210718|FG011|Treatment Period 2|Withdrawal by Subject|0|||
129793176|NCT02038829|467210707|FG000|Washout Period 2|Adverse Event|0|||
129793177|NCT02038829|467210708|FG001|Washout Period 2|Adverse Event|0|||
129793178|NCT02038829|467210709|FG002|Washout Period 2|Adverse Event|0|||
129793179|NCT02038829|467210710|FG003|Washout Period 2|Adverse Event|0|||
129793180|NCT02038829|467210711|FG004|Washout Period 2|Adverse Event|0|||
129793181|NCT02038829|467210712|FG005|Washout Period 2|Adverse Event|0|||
129793182|NCT02038829|467210713|FG006|Washout Period 2|Adverse Event|0|||
129793183|NCT02038829|467210714|FG007|Washout Period 2|Adverse Event|0|||
129793184|NCT02038829|467210715|FG008|Washout Period 2|Adverse Event|1|||
129793185|NCT02038829|467210716|FG009|Washout Period 2|Adverse Event|0|||
129621187|NCT03509467|466565156|FG005|Overall Study|Withdrawal by Subject|10|||
129621188|NCT03509467|466565157|FG006|Overall Study|Withdrawal by Subject|10|||
129621189|NCT03509467|466565158|FG007|Overall Study|Withdrawal by Subject|10|||
129621190|NCT03509467|466565151|FG000|Overall Study|Death|0|||
129621191|NCT03509467|466565152|FG001|Overall Study|Death|0|||
129621192|NCT03509467|466565153|FG002|Overall Study|Death|2|||
129621193|NCT03509467|466565154|FG003|Overall Study|Death|2|||
129621194|NCT03509467|466565155|FG004|Overall Study|Death|1|||
129621195|NCT03509467|466565156|FG005|Overall Study|Death|0|||
129621196|NCT03509467|466565157|FG006|Overall Study|Death|1|||
129621197|NCT03509467|466565158|FG007|Overall Study|Death|0|||
129621198|NCT03509467|466565151|FG000|Overall Study|Proxy Withdrawal|0|||
129621199|NCT03509467|466565152|FG001|Overall Study|Proxy Withdrawal|0|||
129621200|NCT03509467|466565153|FG002|Overall Study|Proxy Withdrawal|0|||
129621201|NCT03509467|466565154|FG003|Overall Study|Proxy Withdrawal|0|||
129621202|NCT03509467|466565155|FG004|Overall Study|Proxy Withdrawal|0|||
129793186|NCT02038829|467210717|FG010|Washout Period 2|Adverse Event|0|||
129702083|NCT01346592|466869508|FG002|Overall Study|Inappropriate enrollment|1|||
129702084|NCT01346592|466869506|FG000|Overall Study|Administrative reason|1|||
129702085|NCT01346592|466869507|FG001|Overall Study|Administrative reason|0|||
129702086|NCT01346592|466869508|FG002|Overall Study|Administrative reason|0|||
129702087|NCT01346592|466869506|FG000|Overall Study|Unable to Classify|7|||
129702088|NCT01346592|466869507|FG001|Overall Study|Unable to Classify|3|||
129702089|NCT01346592|466869508|FG002|Overall Study|Unable to Classify|6|||
129702090|NCT02679274|466869509|FG000|Overall Study|Withdrawal by Subject|1|||
129702091|NCT02679274|466869510|FG001|Overall Study|Withdrawal by Subject|0|||
129702092|NCT02038036|466869513|FG000|Core Study|Adverse Event|7|||
129702093|NCT02038036|466869514|FG001|Core Study|Adverse Event|7|||
129702094|NCT02038036|466869513|FG000|Core Study|Death|1|||
129702095|NCT02038036|466869514|FG001|Core Study|Death|1|||
129702096|NCT02038036|466869513|FG000|Core Study|Disease progression|2|||
129702097|NCT02038036|466869514|FG001|Core Study|Disease progression|2|||
129702098|NCT02038036|466869513|FG000|Core Study|Lost to Follow-up|0|||
129702099|NCT02038036|466869514|FG001|Core Study|Lost to Follow-up|1|||
129702100|NCT02038036|466869513|FG000|Core Study|Physician Decision|2|||
129702101|NCT02038036|466869514|FG001|Core Study|Physician Decision|1|||
129702102|NCT02038036|466869513|FG000|Core Study|Subject/guardian decision|0|||
129702103|NCT02038036|466869514|FG001|Core Study|Subject/guardian decision|1|||
129702104|NCT02038036|466869513|FG000|Core Study|Withdrawal by Subject|3|||
129702105|NCT02038036|466869514|FG001|Core Study|Withdrawal by Subject|1|||
129702106|NCT02038036|466869513|FG000|Crossover Period|Withdrawal by Subject|0|||
129702107|NCT02038036|466869514|FG001|Crossover Period|Withdrawal by Subject|3|||
129702108|NCT02038036|466869513|FG000|Crossover Period|Adverse Event|0|||
129702109|NCT02038036|466869514|FG001|Crossover Period|Adverse Event|9|||
129702110|NCT02038036|466869513|FG000|Crossover Period|Death|0|||
129702111|NCT02038036|466869514|FG001|Crossover Period|Death|2|||
129702112|NCT02038036|466869513|FG000|Crossover Period|Disease progression|0|||
129702113|NCT02038036|466869514|FG001|Crossover Period|Disease progression|3|||
129702114|NCT02038036|466869513|FG000|Crossover Period|Lost to Follow-up|0|||
129702115|NCT02038036|466869514|FG001|Crossover Period|Lost to Follow-up|1|||
129702116|NCT02038036|466869513|FG000|Crossover Period|Physician Decision|0|||
129702117|NCT02038036|466869514|FG001|Crossover Period|Physician Decision|2|||
129702118|NCT01972659|466869522|FG000|Overall Study|Protocol Violation|2|||
129702119|NCT01972659|466869523|FG001|Overall Study|Protocol Violation|2|||
129702120|NCT01972659|466869522|FG000|Overall Study|problems realted to acceleromyograph|2|||
129702121|NCT01972659|466869523|FG001|Overall Study|problems realted to acceleromyograph|1|||
129702122|NCT01397253|466871319|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
129702123|NCT01397253|466871320|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
129702124|NCT01892189|466871321|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
129702125|NCT01892189|466871322|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
129702126|NCT01892189|466871323|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
129702127|NCT01892189|466871324|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
129702128|NCT01892189|466871325|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
129702129|NCT01892189|466871326|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
129702130|NCT01892189|466871327|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
129702131|NCT01892189|466871328|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
129702132|NCT01892189|466871329|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
129702133|NCT01892189|466871321|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129702134|NCT01892189|466871322|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129702135|NCT01892189|466871323|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
129702136|NCT01892189|466871324|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129702137|NCT01892189|466871325|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129702138|NCT01892189|466871326|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129702139|NCT01892189|466871327|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129702140|NCT01892189|466871328|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129702141|NCT01892189|466871329|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129702142|NCT01892189|466871321|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702143|NCT01892189|466871322|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702144|NCT01892189|466871323|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702145|NCT01892189|466871324|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702146|NCT01892189|466871325|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702147|NCT01892189|466871326|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
129702148|NCT01892189|466871327|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702149|NCT01892189|466871328|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702150|NCT01892189|466871329|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
129702151|NCT03322566|466871337|FG000|Overall Study|Death|34|||
129702152|NCT03322566|466871338|FG001|Overall Study|Death|35|||
129702153|NCT03322566|466871339|FG002|Overall Study|Death|23|||
129702154|NCT03322566|466871337|FG000|Overall Study|Physician Decision|6|||
129621203|NCT03509467|466565156|FG005|Overall Study|Proxy Withdrawal|0|||
129621204|NCT03509467|466565157|FG006|Overall Study|Proxy Withdrawal|0|||
129621205|NCT03509467|466565158|FG007|Overall Study|Proxy Withdrawal|1|||
129621206|NCT02829918|466565160|FG000|Overall Study|Death|2|||
129621207|NCT02829918|466565160|FG000|Overall Study|Withdrawal by Subject|4|||
129621208|NCT02829918|466565160|FG000|Overall Study|Adverse Event|1|||
129621209|NCT02829918|466565160|FG000|Overall Study|Progression|1|||
129621210|NCT02466685|466565167|FG000|Overall Study|Adverse Event|5|||
129621211|NCT02466685|466565168|FG001|Overall Study|Adverse Event|2|||
129621212|NCT02466685|466565167|FG000|Overall Study|Lost to Follow-up|1|||
129621213|NCT02466685|466565168|FG001|Overall Study|Lost to Follow-up|1|||
129621214|NCT02466685|466565167|FG000|Overall Study|Withdrawal by Subject|1|||
129621215|NCT02466685|466565168|FG001|Overall Study|Withdrawal by Subject|0|||
129621216|NCT02466685|466565167|FG000|Overall Study|Physician Decision|1|||
129621217|NCT02466685|466565168|FG001|Overall Study|Physician Decision|1|||
129621218|NCT03340974|466565169|FG000|Completion of Study -Long Term Follow up|Death|8|||
129621219|NCT03340974|466565170|FG001|Completion of Study -Long Term Follow up|Death|5|||
129621220|NCT03340974|466565171|FG002|Completion of Study -Long Term Follow up|Death|5|||
129621221|NCT03340974|466565172|FG003|Completion of Study -Long Term Follow up|Death|7|||
129621222|NCT03340974|466565169|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
129621223|NCT03340974|466565170|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
129621224|NCT03340974|466565171|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
129621225|NCT03340974|466565172|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
129621226|NCT03340974|466565169|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
129621227|NCT03340974|466565170|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
129621228|NCT03340974|466565171|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
129621229|NCT03340974|466565172|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
129621230|NCT03340974|466565169|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
129621231|NCT03340974|466565170|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
129621232|NCT03340974|466565171|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
129621233|NCT03340974|466565172|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
129621234|NCT02374346|466565173|FG000|Overall Study|operated or discharged during weekend|48|||
129621235|NCT05299528|466565176|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129621236|NCT05299528|466565177|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
129621237|NCT05299528|466565178|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129621238|NCT05299528|466565179|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129621239|NCT05299528|466565180|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129621240|NCT05299528|466565181|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129621241|NCT05299528|466565182|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
129621242|NCT05299528|466565176|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129621243|NCT05299528|466565177|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129621244|NCT05299528|466565178|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129621245|NCT05299528|466565179|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129621246|NCT05299528|466565180|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129793187|NCT02038829|467210718|FG011|Washout Period 2|Adverse Event|0|||
129793188|NCT02038829|467210707|FG000|Washout Period 2|Withdrawal by Subject|0|||
129793189|NCT02038829|467210708|FG001|Washout Period 2|Withdrawal by Subject|0|||
129793190|NCT02038829|467210709|FG002|Washout Period 2|Withdrawal by Subject|0|||
129793191|NCT02038829|467210710|FG003|Washout Period 2|Withdrawal by Subject|0|||
129793192|NCT02038829|467210711|FG004|Washout Period 2|Withdrawal by Subject|0|||
129793193|NCT02038829|467210712|FG005|Washout Period 2|Withdrawal by Subject|1|||
129793194|NCT02038829|467210713|FG006|Washout Period 2|Withdrawal by Subject|0|||
129793195|NCT02038829|467210714|FG007|Washout Period 2|Withdrawal by Subject|0|||
129793196|NCT02038829|467210715|FG008|Washout Period 2|Withdrawal by Subject|0|||
129793197|NCT02038829|467210716|FG009|Washout Period 2|Withdrawal by Subject|0|||
129793198|NCT02038829|467210717|FG010|Washout Period 2|Withdrawal by Subject|0|||
129793199|NCT02038829|467210718|FG011|Washout Period 2|Withdrawal by Subject|0|||
129793200|NCT02038829|467210707|FG000|Treatment Period 4|Adverse Event|0|||
129793201|NCT02038829|467210708|FG001|Treatment Period 4|Adverse Event|1|||
129793202|NCT02038829|467210709|FG002|Treatment Period 4|Adverse Event|0|||
129793203|NCT02038829|467210710|FG003|Treatment Period 4|Adverse Event|0|||
129793204|NCT02038829|467210711|FG004|Treatment Period 4|Adverse Event|0|||
129621247|NCT05299528|466565181|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
129647590|NCT01384019|466665357|FG001|Overall Study|Withdrawal by Subject|0|||
129793205|NCT02038829|467210712|FG005|Treatment Period 4|Adverse Event|0|||
129793206|NCT02038829|467210713|FG006|Treatment Period 4|Adverse Event|0|||
129793207|NCT02038829|467210714|FG007|Treatment Period 4|Adverse Event|0|||
129793208|NCT02038829|467210715|FG008|Treatment Period 4|Adverse Event|0|||
129702155|NCT03322566|466871338|FG001|Overall Study|Physician Decision|7|||
129702156|NCT03322566|466871339|FG002|Overall Study|Physician Decision|2|||
129621248|NCT05299528|466565182|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
129621249|NCT05299528|466565176|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
129621250|NCT05299528|466565177|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
129621251|NCT05299528|466565178|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
129702157|NCT03322566|466871337|FG000|Overall Study|Withdrawal by Subject|4|||
129702158|NCT03322566|466871338|FG001|Overall Study|Withdrawal by Subject|3|||
129702159|NCT03322566|466871339|FG002|Overall Study|Withdrawal by Subject|6|||
129702160|NCT03322566|466871337|FG000|Overall Study|Lost to Follow-up|0|||
129702161|NCT03322566|466871338|FG001|Overall Study|Lost to Follow-up|0|||
129702162|NCT03322566|466871339|FG002|Overall Study|Lost to Follow-up|1|||
129702163|NCT03322566|466871337|FG000|Overall Study|Study terminated by sponsor|1|||
129702164|NCT03322566|466871338|FG001|Overall Study|Study terminated by sponsor|0|||
129621252|NCT05299528|466565179|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
129621253|NCT05299528|466565180|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
129621254|NCT05299528|466565181|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
129621255|NCT05299528|466565182|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
129702165|NCT03322566|466871339|FG002|Overall Study|Study terminated by sponsor|1|||
129702166|NCT03847519|466871340|FG000|Overall Study|Death|5|||
129702167|NCT03847519|466871341|FG001|Overall Study|Death|8|||
129702168|NCT03847519|466871342|FG002|Overall Study|Death|1|||
129702169|NCT03847519|466871340|FG000|Overall Study|Lost to Follow-up|1|||
129702170|NCT03847519|466871341|FG001|Overall Study|Lost to Follow-up|2|||
129702171|NCT03847519|466871342|FG002|Overall Study|Lost to Follow-up|0|||
129702172|NCT03847519|466871340|FG000|Overall Study|Study Terminated by Sponsor|0|||
129702173|NCT03847519|466871341|FG001|Overall Study|Study Terminated by Sponsor|3|||
129702174|NCT03847519|466871342|FG002|Overall Study|Study Terminated by Sponsor|2|||
129702175|NCT02314923|466871345|FG000|Overall Study|Death|0|||
129702176|NCT02314923|466871346|FG001|Overall Study|Death|0|||
129702177|NCT02314923|466871347|FG002|Overall Study|Death|0|||
129702178|NCT02314923|466871348|FG003|Overall Study|Death|1|||
129702179|NCT02314923|466871349|FG004|Overall Study|Death|0|||
129702180|NCT02314923|466871350|FG005|Overall Study|Death|0|||
129702181|NCT02314923|466871351|FG006|Overall Study|Death|0|||
129702182|NCT02314923|466871352|FG007|Overall Study|Death|0|||
129702183|NCT02314923|466871353|FG008|Overall Study|Death|0|||
129702184|NCT02314923|466871354|FG009|Overall Study|Death|0|||
129702185|NCT02314923|466871345|FG000|Overall Study|Lost to Follow-up|2|||
129702186|NCT02314923|466871346|FG001|Overall Study|Lost to Follow-up|3|||
129702187|NCT02314923|466871347|FG002|Overall Study|Lost to Follow-up|1|||
129702188|NCT02314923|466871348|FG003|Overall Study|Lost to Follow-up|0|||
129702189|NCT02314923|466871349|FG004|Overall Study|Lost to Follow-up|0|||
129702190|NCT02314923|466871350|FG005|Overall Study|Lost to Follow-up|0|||
129702191|NCT02314923|466871351|FG006|Overall Study|Lost to Follow-up|3|||
129702192|NCT02314923|466871352|FG007|Overall Study|Lost to Follow-up|4|||
129702193|NCT02314923|466871353|FG008|Overall Study|Lost to Follow-up|2|||
129702194|NCT02314923|466871354|FG009|Overall Study|Lost to Follow-up|0|||
129702195|NCT02314923|466871345|FG000|Overall Study|Withdrawal by Subject|0|||
129702196|NCT02314923|466871346|FG001|Overall Study|Withdrawal by Subject|0|||
129702197|NCT02314923|466871347|FG002|Overall Study|Withdrawal by Subject|1|||
129702198|NCT02314923|466871348|FG003|Overall Study|Withdrawal by Subject|0|||
129702199|NCT02314923|466871349|FG004|Overall Study|Withdrawal by Subject|1|||
129621256|NCT05180227|466565186|FG000|Overall Study|Hypertension at screening|1|||
129621257|NCT05180227|466565186|FG000|Overall Study|Lost to Follow-up|1|||
129621258|NCT03548337|466565187|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
129621259|NCT03548337|466565188|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
129621260|NCT03548337|466565187|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
129621261|NCT03548337|466565188|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
129621262|NCT03548337|466565187|FG000|Infant Series|Lost to Follow-up|2|||
129702200|NCT02314923|466871350|FG005|Overall Study|Withdrawal by Subject|0|||
129702201|NCT02314923|466871351|FG006|Overall Study|Withdrawal by Subject|1|||
129702202|NCT02314923|466871352|FG007|Overall Study|Withdrawal by Subject|0|||
129702203|NCT02314923|466871353|FG008|Overall Study|Withdrawal by Subject|0|||
129793209|NCT02038829|467210716|FG009|Treatment Period 4|Adverse Event|0|||
129793210|NCT02038829|467210717|FG010|Treatment Period 4|Adverse Event|0|||
129793211|NCT02038829|467210718|FG011|Treatment Period 4|Adverse Event|0|||
129793212|NCT02038829|467210707|FG000|Washout Period 4|Adverse Event|0|||
129793213|NCT02038829|467210708|FG001|Washout Period 4|Adverse Event|0|||
129793214|NCT02038829|467210709|FG002|Washout Period 4|Adverse Event|0|||
129702204|NCT02314923|466871354|FG009|Overall Study|Withdrawal by Subject|0|||
129702205|NCT02314923|466871345|FG000|Overall Study|Physician Decision|0|||
129702206|NCT02314923|466871346|FG001|Overall Study|Physician Decision|1|||
129702207|NCT02314923|466871347|FG002|Overall Study|Physician Decision|0|||
129702208|NCT02314923|466871348|FG003|Overall Study|Physician Decision|0|||
129702209|NCT02314923|466871349|FG004|Overall Study|Physician Decision|0|||
129702210|NCT02314923|466871350|FG005|Overall Study|Physician Decision|0|||
129702211|NCT02314923|466871351|FG006|Overall Study|Physician Decision|0|||
129702212|NCT02314923|466871352|FG007|Overall Study|Physician Decision|0|||
129621263|NCT03548337|466565188|FG001|Infant Series|Lost to Follow-up|1|||
129621264|NCT03548337|466565187|FG000|Infant Series|Adverse Event|0|||
129621265|NCT03548337|466565188|FG001|Infant Series|Adverse Event|2|||
129621266|NCT03548337|466565187|FG000|Infant Series|Randomized but Not Vaccinated|1|||
129621267|NCT03548337|466565188|FG001|Infant Series|Randomized but Not Vaccinated|0|||
129621268|NCT03548337|466565187|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
129621269|NCT03548337|466565188|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
129621270|NCT01911273|466565191|FG000|Overall Study|Progression of Disease|1|||
129621271|NCT01911273|466565192|FG001|Overall Study|Progression of Disease|0|||
129621272|NCT01911273|466565191|FG000|Overall Study|Withdrawal by Subject|0|||
129621273|NCT01911273|466565192|FG001|Overall Study|Withdrawal by Subject|2|||
129621274|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
129621275|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Off-label use|283|||
129621276|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
129621277|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
129621278|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
129621279|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
129621280|NCT01070953|466565193|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
129621281|NCT01070953|466565193|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
129621282|NCT01070953|466565193|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
129621283|NCT01070953|466565193|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
129621284|NCT02445963|466565194|FG000|Overall Study|Lost to Follow-up|1|||
129621285|NCT02445963|466565195|FG001|Overall Study|Lost to Follow-up|0|||
129621286|NCT02445963|466565196|FG002|Overall Study|Lost to Follow-up|0|||
129621287|NCT02445963|466565197|FG003|Overall Study|Lost to Follow-up|0|||
129621288|NCT02445963|466565194|FG000|Overall Study|Change in employment|1|||
129621289|NCT02445963|466565195|FG001|Overall Study|Change in employment|0|||
129621290|NCT02445963|466565196|FG002|Overall Study|Change in employment|0|||
129621291|NCT02445963|466565197|FG003|Overall Study|Change in employment|0|||
129621292|NCT02445963|466565194|FG000|Overall Study|Symptoms post-vaccination|0|||
129621293|NCT02445963|466565195|FG001|Overall Study|Symptoms post-vaccination|0|||
129621294|NCT02445963|466565196|FG002|Overall Study|Symptoms post-vaccination|1|||
129621295|NCT02445963|466565197|FG003|Overall Study|Symptoms post-vaccination|0|||
129621296|NCT01957176|466565201|FG000|Overall Study|Adverse Event|2|||
129621297|NCT01957176|466565202|FG001|Overall Study|Adverse Event|0|||
129621298|NCT01957176|466565201|FG000|Overall Study|Physician Decision|2|||
129621299|NCT01957176|466565202|FG001|Overall Study|Physician Decision|1|||
129621300|NCT01957176|466565201|FG000|Overall Study|Withdrawal by Subject|1|||
129621301|NCT01957176|466565202|FG001|Overall Study|Withdrawal by Subject|0|||
129621302|NCT02359994|466565203|FG000|Overall Population Study|Adverse Event|1|||
129621303|NCT02359994|466565204|FG001|Overall Population Study|Adverse Event|1|||
129621304|NCT02359994|466565203|FG000|Overall Population Study|Death|1|||
129621305|NCT02359994|466565204|FG001|Overall Population Study|Death|5|||
129621306|NCT02359994|466565203|FG000|Overall Population Study|Lost to Follow-up|1|||
129621307|NCT02359994|466565204|FG001|Overall Population Study|Lost to Follow-up|1|||
129621308|NCT02359994|466565203|FG000|Overall Population Study|Withdrawal by Subject|1|||
129621309|NCT02359994|466565204|FG001|Overall Population Study|Withdrawal by Subject|0|||
129621310|NCT02359994|466565203|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
129621311|NCT02359994|466565204|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
129621312|NCT02359994|466565203|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
129621313|NCT02359994|466565204|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
129621314|NCT02359994|466565203|FG000|Extended Oncology 24-Month Survival|Death|19|||
129621315|NCT02359994|466565204|FG001|Extended Oncology 24-Month Survival|Death|21|||
129621316|NCT02359994|466565203|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
129621317|NCT02359994|466565204|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
129621318|NCT01823835|466565207|FG000|Overall Study|Adverse Event|0|||
129621319|NCT01823835|466565208|FG001|Overall Study|Adverse Event|0|||
129621320|NCT01823835|466565209|FG002|Overall Study|Adverse Event|0|||
129621321|NCT01823835|466565210|FG003|Overall Study|Adverse Event|0|||
129621322|NCT01823835|466565211|FG004|Overall Study|Adverse Event|1|||
129621323|NCT01823835|466565212|FG005|Overall Study|Adverse Event|0|||
129621324|NCT01823835|466565213|FG006|Overall Study|Adverse Event|1|||
129621325|NCT01823835|466565214|FG007|Overall Study|Adverse Event|0|||
129621326|NCT01823835|466565215|FG008|Overall Study|Adverse Event|0|||
129621327|NCT01823835|466565216|FG009|Overall Study|Adverse Event|0|||
129621328|NCT01823835|466565217|FG010|Overall Study|Adverse Event|1|||
129621329|NCT01823835|466565218|FG011|Overall Study|Adverse Event|2|||
129621330|NCT01823835|466565219|FG012|Overall Study|Adverse Event|0|||
129621331|NCT01823835|466565220|FG013|Overall Study|Adverse Event|0|||
129621332|NCT01823835|466565221|FG014|Overall Study|Adverse Event|0|||
129621333|NCT01823835|466565207|FG000|Overall Study|Physician Decision|0|||
129621334|NCT01823835|466565208|FG001|Overall Study|Physician Decision|0|||
129621335|NCT01823835|466565209|FG002|Overall Study|Physician Decision|0|||
129621336|NCT01823835|466565210|FG003|Overall Study|Physician Decision|0|||
129621337|NCT01823835|466565211|FG004|Overall Study|Physician Decision|0|||
129621338|NCT01823835|466565212|FG005|Overall Study|Physician Decision|0|||
129621339|NCT01823835|466565213|FG006|Overall Study|Physician Decision|0|||
129621340|NCT01823835|466565214|FG007|Overall Study|Physician Decision|0|||
129621341|NCT01823835|466565215|FG008|Overall Study|Physician Decision|0|||
129621342|NCT01823835|466565216|FG009|Overall Study|Physician Decision|0|||
129621343|NCT01823835|466565217|FG010|Overall Study|Physician Decision|0|||
129621344|NCT01823835|466565218|FG011|Overall Study|Physician Decision|2|||
129621345|NCT01823835|466565219|FG012|Overall Study|Physician Decision|0|||
129621346|NCT01823835|466565220|FG013|Overall Study|Physician Decision|0|||
129621347|NCT01823835|466565221|FG014|Overall Study|Physician Decision|0|||
129621348|NCT01823835|466565207|FG000|Overall Study|Progressive Disease|3|||
129621349|NCT01823835|466565208|FG001|Overall Study|Progressive Disease|4|||
129621350|NCT01823835|466565209|FG002|Overall Study|Progressive Disease|3|||
129621351|NCT01823835|466565210|FG003|Overall Study|Progressive Disease|6|||
129621352|NCT01823835|466565211|FG004|Overall Study|Progressive Disease|4|||
129621353|NCT01823835|466565212|FG005|Overall Study|Progressive Disease|6|||
129621354|NCT01823835|466565213|FG006|Overall Study|Progressive Disease|5|||
129621355|NCT01823835|466565214|FG007|Overall Study|Progressive Disease|3|||
129621356|NCT01823835|466565215|FG008|Overall Study|Progressive Disease|3|||
129621357|NCT01823835|466565216|FG009|Overall Study|Progressive Disease|18|||
129621358|NCT01823835|466565217|FG010|Overall Study|Progressive Disease|8|||
129621359|NCT01823835|466565218|FG011|Overall Study|Progressive Disease|46|||
129621360|NCT01823835|466565219|FG012|Overall Study|Progressive Disease|18|||
129621361|NCT01823835|466565220|FG013|Overall Study|Progressive Disease|4|||
129621362|NCT01823835|466565221|FG014|Overall Study|Progressive Disease|6|||
129621363|NCT01823835|466565207|FG000|Overall Study|Study Termination|0|||
129621364|NCT01823835|466565208|FG001|Overall Study|Study Termination|0|||
129621365|NCT01823835|466565209|FG002|Overall Study|Study Termination|0|||
129621366|NCT01823835|466565210|FG003|Overall Study|Study Termination|0|||
129621367|NCT01823835|466565211|FG004|Overall Study|Study Termination|1|||
129621368|NCT01823835|466565212|FG005|Overall Study|Study Termination|0|||
129621369|NCT01823835|466565213|FG006|Overall Study|Study Termination|0|||
129621370|NCT01823835|466565214|FG007|Overall Study|Study Termination|0|||
129621371|NCT01823835|466565215|FG008|Overall Study|Study Termination|0|||
129621372|NCT01823835|466565216|FG009|Overall Study|Study Termination|0|||
129621373|NCT01823835|466565217|FG010|Overall Study|Study Termination|0|||
129621374|NCT01823835|466565218|FG011|Overall Study|Study Termination|1|||
129621375|NCT01823835|466565219|FG012|Overall Study|Study Termination|0|||
129621376|NCT01823835|466565220|FG013|Overall Study|Study Termination|0|||
129621377|NCT01823835|466565221|FG014|Overall Study|Study Termination|0|||
129621378|NCT01823835|466565207|FG000|Overall Study|Withdrawal by Subject|0|||
129621379|NCT01823835|466565208|FG001|Overall Study|Withdrawal by Subject|0|||
129621380|NCT01823835|466565209|FG002|Overall Study|Withdrawal by Subject|1|||
129621381|NCT01823835|466565210|FG003|Overall Study|Withdrawal by Subject|0|||
129621382|NCT01823835|466565211|FG004|Overall Study|Withdrawal by Subject|0|||
129621383|NCT01823835|466565212|FG005|Overall Study|Withdrawal by Subject|0|||
129621384|NCT01823835|466565213|FG006|Overall Study|Withdrawal by Subject|0|||
129621385|NCT01823835|466565214|FG007|Overall Study|Withdrawal by Subject|0|||
129621386|NCT01823835|466565215|FG008|Overall Study|Withdrawal by Subject|0|||
129621387|NCT01823835|466565216|FG009|Overall Study|Withdrawal by Subject|1|||
129621388|NCT01823835|466565217|FG010|Overall Study|Withdrawal by Subject|1|||
129621389|NCT01823835|466565218|FG011|Overall Study|Withdrawal by Subject|2|||
129621390|NCT01823835|466565219|FG012|Overall Study|Withdrawal by Subject|1|||
129621391|NCT01823835|466565220|FG013|Overall Study|Withdrawal by Subject|0|||
129621392|NCT01823835|466565221|FG014|Overall Study|Withdrawal by Subject|0|||
129702213|NCT02314923|466871353|FG008|Overall Study|Physician Decision|0|||
129621393|NCT03017612|466565222|FG000|Overall Study|Adverse Event|2|||
129621394|NCT04895982|466565223|FG000|Overall Study|Withdrawal by Subject|0|||
129621395|NCT04895982|466565224|FG001|Overall Study|Withdrawal by Subject|0|||
129621396|NCT04895982|466565225|FG002|Overall Study|Withdrawal by Subject|0|||
129621397|NCT04895982|466565226|FG003|Overall Study|Withdrawal by Subject|0|||
129621398|NCT04895982|466565227|FG004|Overall Study|Withdrawal by Subject|0|||
129621399|NCT04895982|466565228|FG005|Overall Study|Withdrawal by Subject|1|||
129621400|NCT04895982|466565229|FG006|Overall Study|Withdrawal by Subject|1|||
129621401|NCT04895982|466565230|FG007|Overall Study|Withdrawal by Subject|0|||
129621402|NCT04895982|466565231|FG008|Overall Study|Withdrawal by Subject|0|||
129621403|NCT04895982|466565232|FG009|Overall Study|Withdrawal by Subject|1|||
129621404|NCT04895982|466565233|FG010|Overall Study|Withdrawal by Subject|0|||
129621405|NCT04895982|466565234|FG011|Overall Study|Withdrawal by Subject|1|||
129621406|NCT04895982|466565223|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129621407|NCT04895982|466565224|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129621408|NCT04895982|466565225|FG002|Overall Study|Withdrawal by parent/guardian|3|||
129621409|NCT04895982|466565226|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129621410|NCT04895982|466565227|FG004|Overall Study|Withdrawal by parent/guardian|3|||
129621411|NCT04895982|466565228|FG005|Overall Study|Withdrawal by parent/guardian|2|||
129621412|NCT04895982|466565229|FG006|Overall Study|Withdrawal by parent/guardian|1|||
129621413|NCT04895982|466565230|FG007|Overall Study|Withdrawal by parent/guardian|0|||
129621414|NCT04895982|466565231|FG008|Overall Study|Withdrawal by parent/guardian|3|||
129621415|NCT04895982|466565232|FG009|Overall Study|Withdrawal by parent/guardian|0|||
129621416|NCT04895982|466565233|FG010|Overall Study|Withdrawal by parent/guardian|0|||
129621417|NCT04895982|466565234|FG011|Overall Study|Withdrawal by parent/guardian|0|||
129621418|NCT04895982|466565223|FG000|Overall Study|Other|0|||
129621419|NCT04895982|466565224|FG001|Overall Study|Other|0|||
129621420|NCT04895982|466565225|FG002|Overall Study|Other|1|||
129621421|NCT04895982|466565226|FG003|Overall Study|Other|1|||
129621422|NCT04895982|466565227|FG004|Overall Study|Other|0|||
129621423|NCT04895982|466565228|FG005|Overall Study|Other|0|||
129621424|NCT04895982|466565229|FG006|Overall Study|Other|0|||
129621425|NCT04895982|466565230|FG007|Overall Study|Other|0|||
129621426|NCT04895982|466565231|FG008|Overall Study|Other|0|||
129621427|NCT04895982|466565232|FG009|Overall Study|Other|1|||
129621428|NCT04895982|466565233|FG010|Overall Study|Other|0|||
129621429|NCT04895982|466565234|FG011|Overall Study|Other|0|||
129621430|NCT04895982|466565223|FG000|Overall Study|Protocol Violation|0|||
129621431|NCT04895982|466565224|FG001|Overall Study|Protocol Violation|0|||
129621432|NCT04895982|466565225|FG002|Overall Study|Protocol Violation|1|||
129621433|NCT04895982|466565226|FG003|Overall Study|Protocol Violation|1|||
129621434|NCT04895982|466565227|FG004|Overall Study|Protocol Violation|1|||
129621435|NCT04895982|466565228|FG005|Overall Study|Protocol Violation|0|||
129621436|NCT04895982|466565229|FG006|Overall Study|Protocol Violation|0|||
129621437|NCT04895982|466565230|FG007|Overall Study|Protocol Violation|1|||
129621438|NCT04895982|466565231|FG008|Overall Study|Protocol Violation|0|||
129621439|NCT04895982|466565232|FG009|Overall Study|Protocol Violation|0|||
129621440|NCT04895982|466565233|FG010|Overall Study|Protocol Violation|0|||
129621441|NCT04895982|466565234|FG011|Overall Study|Protocol Violation|0|||
129621442|NCT04895982|466565223|FG000|Overall Study|Lost to Follow-up|0|||
129621443|NCT04895982|466565224|FG001|Overall Study|Lost to Follow-up|0|||
129621444|NCT04895982|466565225|FG002|Overall Study|Lost to Follow-up|1|||
129621445|NCT04895982|466565226|FG003|Overall Study|Lost to Follow-up|0|||
129621446|NCT04895982|466565227|FG004|Overall Study|Lost to Follow-up|0|||
129621447|NCT04895982|466565228|FG005|Overall Study|Lost to Follow-up|1|||
129621448|NCT04895982|466565229|FG006|Overall Study|Lost to Follow-up|0|||
129621449|NCT04895982|466565230|FG007|Overall Study|Lost to Follow-up|0|||
129621450|NCT04895982|466565231|FG008|Overall Study|Lost to Follow-up|1|||
129621451|NCT04895982|466565232|FG009|Overall Study|Lost to Follow-up|0|||
129621452|NCT04895982|466565233|FG010|Overall Study|Lost to Follow-up|0|||
129621453|NCT04895982|466565234|FG011|Overall Study|Lost to Follow-up|0|||
129621454|NCT04895982|466565223|FG000|Overall Study|Refused further study procedures|0|||
129621455|NCT04895982|466565224|FG001|Overall Study|Refused further study procedures|0|||
129621456|NCT04895982|466565225|FG002|Overall Study|Refused further study procedures|1|||
129621457|NCT04895982|466565226|FG003|Overall Study|Refused further study procedures|0|||
129621458|NCT04895982|466565227|FG004|Overall Study|Refused further study procedures|0|||
129621459|NCT04895982|466565228|FG005|Overall Study|Refused further study procedures|0|||
129621460|NCT04895982|466565229|FG006|Overall Study|Refused further study procedures|0|||
129621461|NCT04895982|466565230|FG007|Overall Study|Refused further study procedures|0|||
129621462|NCT04895982|466565231|FG008|Overall Study|Refused further study procedures|0|||
129621463|NCT04895982|466565232|FG009|Overall Study|Refused further study procedures|0|||
129621464|NCT04895982|466565233|FG010|Overall Study|Refused further study procedures|0|||
129621465|NCT04895982|466565234|FG011|Overall Study|Refused further study procedures|0|||
129621466|NCT01059786|466566925|FG000|Overall Study|Did not receive 6 cycles.|0|||
129439453|NCT01723254|465906511|FG004|Overall Study|Personal issues|0|||
129702214|NCT02314923|466871354|FG009|Overall Study|Physician Decision|0|||
129621467|NCT01059786|466566926|FG001|Overall Study|Did not receive 6 cycles.|0|||
129621468|NCT01059786|466566927|FG002|Overall Study|Did not receive 6 cycles.|4|||
129621469|NCT01059786|466566928|FG003|Overall Study|Did not receive 6 cycles.|1|||
129621470|NCT01059786|466566929|FG004|Overall Study|Did not receive 6 cycles.|0|||
129621471|NCT04460885|466566930|FG000|Overall Study|Withdrawal by Subject|6|||
129621472|NCT04460885|466566931|FG001|Overall Study|Withdrawal by Subject|8|||
129621473|NCT04460885|466566930|FG000|Overall Study|Site closure|1|||
129621474|NCT04460885|466566931|FG001|Overall Study|Site closure|0|||
129621475|NCT04460885|466566930|FG000|Overall Study|Death|5|||
129621476|NCT04460885|466566931|FG001|Overall Study|Death|4|||
129621477|NCT04460885|466566930|FG000|Overall Study|Physician Decision|2|||
129621478|NCT04460885|466566931|FG001|Overall Study|Physician Decision|1|||
129621479|NCT04460885|466566930|FG000|Overall Study|Lost to Follow-up|4|||
129621480|NCT04460885|466566931|FG001|Overall Study|Lost to Follow-up|4|||
129621481|NCT04559347|466566932|FG000|Overall Study|Death|1|||
129621482|NCT04559347|466566933|FG001|Overall Study|Death|0|||
129621483|NCT04559347|466566932|FG000|Overall Study|Thoracotomy conversion|1|||
129621484|NCT04559347|466566933|FG001|Overall Study|Thoracotomy conversion|1|||
129621485|NCT04559347|466566932|FG000|Overall Study|Provider unavailable|2|||
129621486|NCT04559347|466566933|FG001|Overall Study|Provider unavailable|1|||
129621487|NCT04559347|466566932|FG000|Overall Study|Other|2|||
129621488|NCT04559347|466566933|FG001|Overall Study|Other|1|||
129621489|NCT02717455|466566935|FG000|Overall Study|Adverse Event|1|||
129621490|NCT02717455|466566936|FG001|Overall Study|Adverse Event|0|||
129621491|NCT02717455|466566937|FG002|Overall Study|Adverse Event|0|||
129621492|NCT02717455|466566938|FG003|Overall Study|Adverse Event|2|||
129621493|NCT02717455|466566939|FG004|Overall Study|Adverse Event|2|||
129621494|NCT02717455|466566940|FG005|Overall Study|Adverse Event|2|||
129621495|NCT02717455|466566935|FG000|Overall Study|Withdrawal by Subject|1|||
129621496|NCT02717455|466566936|FG001|Overall Study|Withdrawal by Subject|1|||
129621497|NCT02717455|466566937|FG002|Overall Study|Withdrawal by Subject|0|||
129621498|NCT02717455|466566938|FG003|Overall Study|Withdrawal by Subject|2|||
129621499|NCT02717455|466566939|FG004|Overall Study|Withdrawal by Subject|2|||
129621500|NCT02717455|466566940|FG005|Overall Study|Withdrawal by Subject|1|||
129621501|NCT02717455|466566935|FG000|Overall Study|Death|1|||
129621502|NCT02717455|466566936|FG001|Overall Study|Death|0|||
129621503|NCT02717455|466566937|FG002|Overall Study|Death|0|||
129621504|NCT02717455|466566938|FG003|Overall Study|Death|0|||
129621505|NCT02717455|466566939|FG004|Overall Study|Death|1|||
129621506|NCT02717455|466566940|FG005|Overall Study|Death|0|||
129621507|NCT02717455|466566935|FG000|Overall Study|Did not receive study drug|0|||
129621508|NCT02717455|466566936|FG001|Overall Study|Did not receive study drug|0|||
129621509|NCT02717455|466566937|FG002|Overall Study|Did not receive study drug|0|||
129621510|NCT02717455|466566938|FG003|Overall Study|Did not receive study drug|1|||
129621511|NCT02717455|466566939|FG004|Overall Study|Did not receive study drug|0|||
129621512|NCT02717455|466566940|FG005|Overall Study|Did not receive study drug|1|||
129621513|NCT02717455|466566935|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129621514|NCT02717455|466566936|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129621515|NCT02717455|466566937|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129621516|NCT02717455|466566938|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129621517|NCT02717455|466566939|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
129621518|NCT02717455|466566940|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
129621519|NCT02717455|466566935|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
129621520|NCT02717455|466566936|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
129621521|NCT02717455|466566937|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
129621522|NCT02717455|466566938|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
129621523|NCT02717455|466566939|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
129621524|NCT02717455|466566940|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
129621525|NCT01433055|466566941|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
129621526|NCT01433055|466566942|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
129702215|NCT02314923|466871345|FG000|Overall Study|Participant unavailable|0|||
129621527|NCT01433055|466566941|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
129621528|NCT01433055|466566942|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
129621529|NCT00233948|466566950|FG000|Overall Study|Adverse Event|1|||
129621530|NCT00233948|466566951|FG001|Overall Study|Adverse Event|0|||
129621531|NCT00233948|466566952|FG002|Overall Study|Adverse Event|0|||
129621532|NCT00233948|466566953|FG003|Overall Study|Adverse Event|0|||
129621533|NCT00233948|466566954|FG004|Overall Study|Adverse Event|0|||
129621534|NCT00233948|466566955|FG005|Overall Study|Adverse Event|0|||
129621535|NCT01214655|466566956|FG000|Part A|Progressive Disease|7|||
129621536|NCT01214655|466566957|FG001|Part A|Progressive Disease|0|||
129621537|NCT01214655|466566958|FG002|Part A|Progressive Disease|0|||
129621538|NCT01214655|466566956|FG000|Part A|Physician Decision|1|||
129621539|NCT01214655|466566957|FG001|Part A|Physician Decision|0|||
129621540|NCT01214655|466566958|FG002|Part A|Physician Decision|0|||
129621541|NCT01214655|466566956|FG000|Part B|Progressive disease|0|||
129621542|NCT01214655|466566957|FG001|Part B|Progressive disease|10|||
129621543|NCT01214655|466566958|FG002|Part B|Progressive disease|0|||
129621544|NCT01214655|466566956|FG000|Part B|Death|0|||
129621545|NCT01214655|466566957|FG001|Part B|Death|1|||
129621546|NCT01214655|466566958|FG002|Part B|Death|0|||
129621547|NCT01214655|466566956|FG000|Part B|Withdrawal by Subject|0|||
129621548|NCT01214655|466566957|FG001|Part B|Withdrawal by Subject|2|||
129621549|NCT01214655|466566958|FG002|Part B|Withdrawal by Subject|0|||
129621550|NCT01214655|466566956|FG000|Part C|Progressive Disease|0|||
129621551|NCT01214655|466566957|FG001|Part C|Progressive Disease|0|||
129621552|NCT01214655|466566958|FG002|Part C|Progressive Disease|5|||
129621553|NCT01214655|466566956|FG000|Part C|Death|0|||
129621554|NCT01214655|466566957|FG001|Part C|Death|0|||
129621555|NCT01214655|466566958|FG002|Part C|Death|1|||
129702216|NCT02314923|466871346|FG001|Overall Study|Participant unavailable|0|||
129702217|NCT02314923|466871347|FG002|Overall Study|Participant unavailable|0|||
129702218|NCT02314923|466871348|FG003|Overall Study|Participant unavailable|0|||
129702219|NCT02314923|466871349|FG004|Overall Study|Participant unavailable|0|||
129702220|NCT02314923|466871350|FG005|Overall Study|Participant unavailable|1|||
129702221|NCT02314923|466871351|FG006|Overall Study|Participant unavailable|0|||
129702222|NCT02314923|466871352|FG007|Overall Study|Participant unavailable|0|||
129702223|NCT02314923|466871353|FG008|Overall Study|Participant unavailable|0|||
129702224|NCT02314923|466871354|FG009|Overall Study|Participant unavailable|0|||
129888281|NCT02718417|467549132|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
129888282|NCT02718417|467549133|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
129888283|NCT02718417|467549134|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
129888284|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Physician's decision|6|||
129888285|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Physician's decision|7|||
129888286|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Physician's decision|0|||
129621556|NCT01214655|466566956|FG000|Part C|Physician Decision|0|||
129621557|NCT01214655|466566957|FG001|Part C|Physician Decision|0|||
129621558|NCT01214655|466566958|FG002|Part C|Physician Decision|1|||
129621559|NCT05256134|466566962|FG000|Overall Study|Study Terminated by Sponsor|11|||
129621560|NCT05256134|466566963|FG001|Overall Study|Study Terminated by Sponsor|10|||
129621561|NCT05256134|466566962|FG000|Overall Study|Withdrawal by Subject|1|||
129621562|NCT05256134|466566963|FG001|Overall Study|Withdrawal by Subject|3|||
129621563|NCT00886015|466566972|FG000|Overall Study|Death|0|||
129621564|NCT00886015|466566973|FG001|Overall Study|Death|2|||
129621565|NCT01977417|466566974|FG000|Overall Study|Adverse Event|1|||
129621566|NCT01977417|466566975|FG001|Overall Study|Adverse Event|0|||
129621567|NCT01977417|466566974|FG000|Overall Study|Withdrawal by Subject|2|||
129621568|NCT01977417|466566975|FG001|Overall Study|Withdrawal by Subject|4|||
129621569|NCT01977417|466566974|FG000|Overall Study|Female enrollment goal met|0|||
129621570|NCT01977417|466566975|FG001|Overall Study|Female enrollment goal met|2|||
129621571|NCT05490771|466566981|FG000|Overall Study|Disease progression|18|||
129621572|NCT05490771|466566981|FG000|Overall Study|Adverse Event|3|||
129621573|NCT05490771|466566981|FG000|Overall Study|Other complicating disease|1|||
129621574|NCT05490771|466566981|FG000|Overall Study|Withdrawal by Subject|3|||
129621575|NCT05490771|466566981|FG000|Overall Study|Physician Decision|1|||
129621576|NCT05490771|466566981|FG000|Overall Study|Still on treatment|2|||
129621577|NCT05490771|466566981|FG000|Overall Study|Never start protocol therapy|5|||
129621578|NCT05490771|466566981|FG000|Overall Study|Ineligible|2|||
129621579|NCT01720225|466566982|FG000|Overall Study|Withdrawal by Subject|0|||
129621580|NCT01720225|466566983|FG001|Overall Study|Withdrawal by Subject|1|||
129621581|NCT01720225|466566982|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
129621582|NCT01720225|466566983|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
129621583|NCT00661193|466566987|FG000|Overall Study|Adverse Event|2|||
129621584|NCT00661193|466566988|FG001|Overall Study|Adverse Event|1|||
129621585|NCT00661193|466566987|FG000|Overall Study|Withdrawal by Subject|3|||
129621586|NCT00661193|466566988|FG001|Overall Study|Withdrawal by Subject|1|||
129621587|NCT00661193|466566987|FG000|Overall Study|Progression|27|||
129621588|NCT00661193|466566988|FG001|Overall Study|Progression|24|||
129621589|NCT00661193|466566987|FG000|Overall Study|Not protocol specified|1|||
129621590|NCT00661193|466566988|FG001|Overall Study|Not protocol specified|0|||
129621591|NCT02964312|466566995|FG000|Overall Study|Lost to Follow-up|28|||
129621592|NCT02964312|466566995|FG000|Overall Study|Withdrawal by Subject|11|||
129702225|NCT02314923|466871345|FG000|Overall Study|Screen failure|0|||
129702226|NCT02314923|466871346|FG001|Overall Study|Screen failure|0|||
129702227|NCT02314923|466871347|FG002|Overall Study|Screen failure|0|||
129621593|NCT02964312|466566995|FG000|Overall Study|Lack of Efficacy|10|||
129621594|NCT02964312|466566995|FG000|Overall Study|Did not consent to long-term FU|14|||
129621595|NCT02964312|466566995|FG000|Overall Study|Death|1|||
129888287|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Progressive disease|100|||
129621596|NCT02862730|466566998|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129621597|NCT02862730|466566999|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129621598|NCT02862730|466567000|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
129621599|NCT02862730|466567001|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129621600|NCT02862730|466567002|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129621601|NCT02862730|466567003|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129621602|NCT02862730|466567004|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
129621603|NCT02862730|466566998|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
129702228|NCT02314923|466871348|FG003|Overall Study|Screen failure|0|||
129702229|NCT02314923|466871349|FG004|Overall Study|Screen failure|0|||
129702230|NCT02314923|466871350|FG005|Overall Study|Screen failure|0|||
129702231|NCT02314923|466871351|FG006|Overall Study|Screen failure|1|||
129702232|NCT02314923|466871352|FG007|Overall Study|Screen failure|0|||
129702233|NCT02314923|466871353|FG008|Overall Study|Screen failure|0|||
129621604|NCT02862730|466566999|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129621605|NCT02862730|466567000|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129621606|NCT02862730|466567001|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129621607|NCT02862730|466567002|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129621608|NCT02862730|466567003|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129621609|NCT02862730|466567004|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
129621610|NCT02862730|466566998|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129621611|NCT02862730|466566999|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129702234|NCT02314923|466871354|FG009|Overall Study|Screen failure|0|||
129702235|NCT02314923|466871345|FG000|Overall Study|Participant relocation|1|||
129702236|NCT02314923|466871346|FG001|Overall Study|Participant relocation|0|||
129702237|NCT02314923|466871347|FG002|Overall Study|Participant relocation|0|||
129702238|NCT02314923|466871348|FG003|Overall Study|Participant relocation|0|||
129793215|NCT02038829|467210710|FG003|Washout Period 4|Adverse Event|0|||
129793216|NCT02038829|467210711|FG004|Washout Period 4|Adverse Event|0|||
129793217|NCT02038829|467210712|FG005|Washout Period 4|Adverse Event|0|||
129793218|NCT02038829|467210713|FG006|Washout Period 4|Adverse Event|1|||
129793219|NCT02038829|467210714|FG007|Washout Period 4|Adverse Event|0|||
129793220|NCT02038829|467210715|FG008|Washout Period 4|Adverse Event|0|||
129793221|NCT02038829|467210716|FG009|Washout Period 4|Adverse Event|0|||
129793222|NCT02038829|467210717|FG010|Washout Period 4|Adverse Event|0|||
129793223|NCT02038829|467210718|FG011|Washout Period 4|Adverse Event|0|||
129793224|NCT02038829|467210707|FG000|Treatment Period 6|Adverse Event|0|||
129793225|NCT02038829|467210708|FG001|Treatment Period 6|Adverse Event|0|||
129793226|NCT02038829|467210709|FG002|Treatment Period 6|Adverse Event|1|||
129793227|NCT02038829|467210710|FG003|Treatment Period 6|Adverse Event|0|||
129793228|NCT02038829|467210711|FG004|Treatment Period 6|Adverse Event|0|||
129793229|NCT02038829|467210712|FG005|Treatment Period 6|Adverse Event|0|||
129793230|NCT02038829|467210713|FG006|Treatment Period 6|Adverse Event|0|||
129793231|NCT02038829|467210714|FG007|Treatment Period 6|Adverse Event|0|||
129793232|NCT02038829|467210715|FG008|Treatment Period 6|Adverse Event|0|||
129793233|NCT02038829|467210716|FG009|Treatment Period 6|Adverse Event|0|||
129793234|NCT02038829|467210717|FG010|Treatment Period 6|Adverse Event|0|||
129793235|NCT02038829|467210718|FG011|Treatment Period 6|Adverse Event|0|||
129793236|NCT02579928|467210719|FG000|Overall Study|Withdrawal by Subject|1|||
129793237|NCT02579928|467210720|FG001|Overall Study|Withdrawal by Subject|0|||
129793238|NCT01933789|467210729|FG000|Overall Study|Death|0|||
129793239|NCT01933789|467210730|FG001|Overall Study|Death|0|||
129793240|NCT01933789|467210731|FG002|Overall Study|Death|0|||
129793241|NCT01933789|467210732|FG003|Overall Study|Death|0|||
129793242|NCT01933789|467210733|FG004|Overall Study|Death|21|||
129793243|NCT01933789|467210734|FG005|Overall Study|Death|32|||
129793244|NCT01933789|467210735|FG006|Overall Study|Death|0|||
129793245|NCT01933789|467210736|FG007|Overall Study|Death|0|||
129793246|NCT01933789|467210737|FG008|Overall Study|Death|0|||
129793247|NCT01933789|467210729|FG000|Overall Study|Lost to Follow-up|0|||
129793248|NCT01933789|467210730|FG001|Overall Study|Lost to Follow-up|0|||
129793249|NCT01933789|467210731|FG002|Overall Study|Lost to Follow-up|0|||
129793250|NCT01933789|467210732|FG003|Overall Study|Lost to Follow-up|1|||
129793251|NCT01933789|467210733|FG004|Overall Study|Lost to Follow-up|8|||
129793252|NCT01933789|467210734|FG005|Overall Study|Lost to Follow-up|9|||
129793253|NCT01933789|467210735|FG006|Overall Study|Lost to Follow-up|1|||
129793254|NCT01933789|467210736|FG007|Overall Study|Lost to Follow-up|4|||
129793255|NCT01933789|467210737|FG008|Overall Study|Lost to Follow-up|0|||
129793256|NCT01933789|467210729|FG000|Overall Study|Withdrawal by Subject|2|||
129793257|NCT01933789|467210730|FG001|Overall Study|Withdrawal by Subject|1|||
129793258|NCT01933789|467210731|FG002|Overall Study|Withdrawal by Subject|0|||
129793259|NCT01933789|467210732|FG003|Overall Study|Withdrawal by Subject|0|||
129793260|NCT01933789|467210733|FG004|Overall Study|Withdrawal by Subject|17|||
129439454|NCT01723254|465906512|FG005|Overall Study|Personal issues|1|||
129793261|NCT01933789|467210734|FG005|Overall Study|Withdrawal by Subject|16|||
129793262|NCT01933789|467210735|FG006|Overall Study|Withdrawal by Subject|1|||
129793263|NCT01933789|467210736|FG007|Overall Study|Withdrawal by Subject|4|||
129621612|NCT02862730|466567000|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
129621613|NCT02862730|466567001|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129621614|NCT02862730|466567002|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
129621615|NCT02862730|466567003|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129621616|NCT02862730|466567004|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
129621617|NCT02862730|466566998|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129621618|NCT02862730|466566999|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129621619|NCT02862730|466567000|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129621620|NCT02862730|466567001|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
129621621|NCT02862730|466567002|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129621622|NCT02862730|466567003|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129621623|NCT02862730|466567004|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
129621624|NCT03685344|466567005|FG000|Overall Study|Withdrawal by Subject|1|||
129621625|NCT03685344|466567006|FG001|Overall Study|Withdrawal by Subject|1|||
129621626|NCT03685344|466567007|FG002|Overall Study|Withdrawal by Subject|2|||
129621627|NCT03685344|466567008|FG003|Overall Study|Withdrawal by Subject|0|||
129621628|NCT03685344|466567005|FG000|Overall Study|Physician Decision|1|||
129621629|NCT03685344|466567006|FG001|Overall Study|Physician Decision|1|||
129621630|NCT03685344|466567007|FG002|Overall Study|Physician Decision|5|||
129621631|NCT03685344|466567008|FG003|Overall Study|Physician Decision|0|||
129621632|NCT03685344|466567005|FG000|Overall Study|Death|1|||
129621633|NCT03685344|466567006|FG001|Overall Study|Death|1|||
129621634|NCT03685344|466567007|FG002|Overall Study|Death|0|||
129621635|NCT03685344|466567008|FG003|Overall Study|Death|0|||
129621636|NCT03126435|466567010|FG000|Overall Study|Death|90|||
129621637|NCT03126435|466567011|FG001|Overall Study|Death|84|||
129621638|NCT03126435|466567010|FG000|Overall Study|Lost to Follow-up|4|||
129621639|NCT03126435|466567011|FG001|Overall Study|Lost to Follow-up|3|||
129621640|NCT03126435|466567010|FG000|Overall Study|Physician Decision|0|||
129621641|NCT03126435|466567011|FG001|Overall Study|Physician Decision|1|||
129621642|NCT03126435|466567010|FG000|Overall Study|Withdrawal by Subject|6|||
129621643|NCT03126435|466567011|FG001|Overall Study|Withdrawal by Subject|12|||
129621644|NCT03126435|466567010|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
129621645|NCT03126435|466567011|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
129621646|NCT01023035|466567013|FG000|Treatment Period|Adverse Event|27|||
129621647|NCT01023035|466567014|FG001|Treatment Period|Adverse Event|32|||
129621648|NCT01023035|466567015|FG002|Treatment Period|Adverse Event|50|||
129621649|NCT01023035|466567013|FG000|Treatment Period|Non-Medical Reasons|19|||
129621650|NCT01023035|466567014|FG001|Treatment Period|Non-Medical Reasons|22|||
129621651|NCT01023035|466567015|FG002|Treatment Period|Non-Medical Reasons|44|||
129621652|NCT01023035|466567013|FG000|Treatment Period|Treatment Failure|26|||
129621653|NCT01023035|466567014|FG001|Treatment Period|Treatment Failure|31|||
129621654|NCT01023035|466567015|FG002|Treatment Period|Treatment Failure|24|||
129621655|NCT01023035|466567013|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
129621656|NCT01023035|466567014|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
129621657|NCT01023035|466567015|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
129621658|NCT01023035|466567013|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
129621659|NCT01023035|466567014|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
129621660|NCT01023035|466567015|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
129621661|NCT00524420|466567019|FG000|Overall Study|Lack of Efficacy|1|||
129621662|NCT00524420|466567020|FG001|Overall Study|Lack of Efficacy|0|||
129621663|NCT01090414|466567021|FG000|Study 101-99|Progressive Disease|28|||
129621664|NCT01090414|466567022|FG001|Study 101-99|Progressive Disease|48|||
129621665|NCT01090414|466567023|FG002|Study 101-99|Progressive Disease|10|||
129621666|NCT01090414|466567024|FG003|Study 101-99|Progressive Disease|4|||
129621667|NCT01090414|466567021|FG000|Study 101-99|Adverse Event|10|||
129621668|NCT01090414|466567022|FG001|Study 101-99|Adverse Event|28|||
129621669|NCT01090414|466567023|FG002|Study 101-99|Adverse Event|18|||
129621670|NCT01090414|466567024|FG003|Study 101-99|Adverse Event|0|||
129621671|NCT01090414|466567021|FG000|Study 101-99|Investigator Request|1|||
129888288|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Progressive disease|88|||
129621672|NCT01090414|466567022|FG001|Study 101-99|Investigator Request|11|||
129621673|NCT01090414|466567023|FG002|Study 101-99|Investigator Request|4|||
129702239|NCT02314923|466871349|FG004|Overall Study|Participant relocation|0|||
129621674|NCT01090414|466567024|FG003|Study 101-99|Investigator Request|0|||
129621675|NCT01090414|466567021|FG000|Study 101-99|Death|3|||
129621676|NCT01090414|466567022|FG001|Study 101-99|Death|8|||
129621677|NCT01090414|466567023|FG002|Study 101-99|Death|1|||
129621678|NCT01090414|466567024|FG003|Study 101-99|Death|0|||
129702240|NCT02314923|466871350|FG005|Overall Study|Participant relocation|0|||
129702241|NCT02314923|466871351|FG006|Overall Study|Participant relocation|0|||
129702242|NCT02314923|466871352|FG007|Overall Study|Participant relocation|1|||
129621679|NCT01090414|466567021|FG000|Study 101-99|Sponsor Discontinued Study|0|||
129621680|NCT01090414|466567022|FG001|Study 101-99|Sponsor Discontinued Study|7|||
129621681|NCT01090414|466567023|FG002|Study 101-99|Sponsor Discontinued Study|5|||
129621682|NCT01090414|466567024|FG003|Study 101-99|Sponsor Discontinued Study|0|||
129621683|NCT01090414|466567021|FG000|Study 101-99|Other (Unknown Reasons)|3|||
129621684|NCT01090414|466567022|FG001|Study 101-99|Other (Unknown Reasons)|3|||
129621685|NCT01090414|466567023|FG002|Study 101-99|Other (Unknown Reasons)|0|||
129621686|NCT01090414|466567024|FG003|Study 101-99|Other (Unknown Reasons)|0|||
129621687|NCT01090414|466567021|FG000|Study 101-99|Withdrew Consent|0|||
129621688|NCT01090414|466567022|FG001|Study 101-99|Withdrew Consent|2|||
129621689|NCT01090414|466567023|FG002|Study 101-99|Withdrew Consent|3|||
129702243|NCT02314923|466871353|FG008|Overall Study|Participant relocation|0|||
129702244|NCT02314923|466871354|FG009|Overall Study|Participant relocation|0|||
129888289|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Progressive disease|0|||
129888290|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Other|2|||
129702245|NCT00725985|466871355|FG000|ITP- Treatment Disposition|Adverse Event|20|||
129702246|NCT00725985|466871356|FG001|ITP- Treatment Disposition|Adverse Event|10|||
129702247|NCT00725985|466871357|FG002|ITP- Treatment Disposition|Adverse Event|5|||
129702248|NCT00725985|466871358|FG003|ITP- Treatment Disposition|Adverse Event|0|||
129702249|NCT00725985|466871359|FG004|ITP- Treatment Disposition|Adverse Event|0|||
129702250|NCT00725985|466871360|FG005|ITP- Treatment Disposition|Adverse Event|0|||
129702251|NCT00725985|466871361|FG006|ITP- Treatment Disposition|Adverse Event|0|||
129702252|NCT00725985|466871362|FG007|ITP- Treatment Disposition|Adverse Event|0|||
129702253|NCT00725985|466871363|FG008|ITP- Treatment Disposition|Adverse Event|0|||
129702254|NCT00725985|466871364|FG009|ITP- Treatment Disposition|Adverse Event|0|||
129702255|NCT00725985|466871365|FG010|ITP- Treatment Disposition|Adverse Event|0|||
129702256|NCT00725985|466871366|FG011|ITP- Treatment Disposition|Adverse Event|0|||
129702257|NCT00725985|466871355|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702258|NCT00725985|466871356|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702259|NCT00725985|466871357|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
129702260|NCT00725985|466871358|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702261|NCT00725985|466871359|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702262|NCT00725985|466871360|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702263|NCT00725985|466871361|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702264|NCT00725985|466871362|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702265|NCT00725985|466871363|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
129888291|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Other|1|||
129888292|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Other|0|||
129621690|NCT01090414|466567024|FG003|Study 101-99|Withdrew Consent|1|||
129702266|NCT00725985|466871364|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
129621691|NCT01090414|466567021|FG000|Study 101-99|Participant Request|3|||
129621692|NCT01090414|466567022|FG001|Study 101-99|Participant Request|1|||
129621693|NCT01090414|466567023|FG002|Study 101-99|Participant Request|0|||
129621694|NCT01090414|466567024|FG003|Study 101-99|Participant Request|0|||
129621695|NCT02413229|466567034|FG000|Overall Study|Adverse Event|0|||
129621696|NCT02413229|466567035|FG001|Overall Study|Adverse Event|0|||
129621697|NCT02413229|466567036|FG002|Overall Study|Adverse Event|0|||
129621698|NCT02413229|466567037|FG003|Overall Study|Adverse Event|1|||
129621699|NCT02413229|466567038|FG004|Overall Study|Adverse Event|0|||
129621700|NCT02413229|466567039|FG005|Overall Study|Adverse Event|0|||
129621701|NCT02413229|466567040|FG006|Overall Study|Adverse Event|0|||
129621702|NCT02413229|466567041|FG007|Overall Study|Adverse Event|1|||
129621703|NCT02413229|466567034|FG000|Overall Study|Lost to Follow-up|0|||
129621704|NCT02413229|466567035|FG001|Overall Study|Lost to Follow-up|0|||
129621705|NCT02413229|466567036|FG002|Overall Study|Lost to Follow-up|1|||
129621706|NCT02413229|466567037|FG003|Overall Study|Lost to Follow-up|0|||
129621707|NCT02413229|466567038|FG004|Overall Study|Lost to Follow-up|2|||
129621708|NCT02413229|466567039|FG005|Overall Study|Lost to Follow-up|0|||
129621709|NCT02413229|466567040|FG006|Overall Study|Lost to Follow-up|0|||
129439455|NCT01723254|465906513|FG006|Overall Study|Personal issues|0|||
129621710|NCT02413229|466567041|FG007|Overall Study|Lost to Follow-up|0|||
129621711|NCT02413229|466567034|FG000|Overall Study|Withdrawal by Subject|1|||
129702267|NCT00725985|466871365|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
129702268|NCT00725985|466871366|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
129621712|NCT02413229|466567035|FG001|Overall Study|Withdrawal by Subject|1|||
129702269|NCT00725985|466871355|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
129702270|NCT00725985|466871356|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
129621713|NCT02413229|466567036|FG002|Overall Study|Withdrawal by Subject|0|||
129621714|NCT02413229|466567037|FG003|Overall Study|Withdrawal by Subject|0|||
129621715|NCT02413229|466567038|FG004|Overall Study|Withdrawal by Subject|1|||
129621716|NCT02413229|466567039|FG005|Overall Study|Withdrawal by Subject|0|||
129621717|NCT02413229|466567040|FG006|Overall Study|Withdrawal by Subject|0|||
129621718|NCT02413229|466567041|FG007|Overall Study|Withdrawal by Subject|2|||
129621719|NCT02413229|466567034|FG000|Overall Study|Progressive Disease|0|||
129621720|NCT02413229|466567035|FG001|Overall Study|Progressive Disease|0|||
129621721|NCT02413229|466567036|FG002|Overall Study|Progressive Disease|0|||
129621722|NCT02413229|466567037|FG003|Overall Study|Progressive Disease|0|||
129621723|NCT02413229|466567038|FG004|Overall Study|Progressive Disease|0|||
129621724|NCT02413229|466567039|FG005|Overall Study|Progressive Disease|0|||
129621725|NCT02413229|466567040|FG006|Overall Study|Progressive Disease|0|||
129621726|NCT02413229|466567041|FG007|Overall Study|Progressive Disease|1|||
129621727|NCT03594071|466567042|FG000|Overall Study|Re-operation|3|||
129621728|NCT03594071|466567042|FG000|Overall Study|Missed visit|2|||
129621729|NCT03022370|466567043|FG000|Overall Study|Death|6|||
129621730|NCT03022370|466567044|FG001|Overall Study|Death|12|||
129621731|NCT03022370|466567043|FG000|Overall Study|Lost to Follow-up|174|||
129621732|NCT03022370|466567044|FG001|Overall Study|Lost to Follow-up|109|||
129621733|NCT00699816|466567047|FG000|Overall Study|Protocol Violation|1|||
129621734|NCT00699816|466567048|FG001|Overall Study|Protocol Violation|3|||
129621735|NCT02454933|466567049|FG000|Overall Study|Progressive disease|10|||
129621736|NCT02454933|466567050|FG001|Overall Study|Progressive disease|7|||
129621737|NCT02454933|466567049|FG000|Overall Study|Adverse Event|1|||
129621738|NCT02454933|466567050|FG001|Overall Study|Adverse Event|1|||
129621739|NCT02454933|466567049|FG000|Overall Study|Withdrawal by Subject|0|||
129621740|NCT02454933|466567050|FG001|Overall Study|Withdrawal by Subject|3|||
129621741|NCT02454933|466567049|FG000|Overall Study|Lost to Follow-up|1|||
129621742|NCT02454933|466567050|FG001|Overall Study|Lost to Follow-up|0|||
129621743|NCT03668808|466567053|FG000|First Intervention|Withdrawal by Subject|2|||
129621744|NCT03668808|466567054|FG001|First Intervention|Withdrawal by Subject|2|||
129621745|NCT01526655|466567055|FG000|Overall Study|Withdrawal by Subject|0|||
129621746|NCT01526655|466567056|FG001|Overall Study|Withdrawal by Subject|1|||
129621747|NCT05061420|466567070|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
129621748|NCT05061420|466567071|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129621749|NCT05061420|466567072|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129621750|NCT05061420|466567070|FG000|Overall Study|Progressive disease|11|||
129621751|NCT05061420|466567071|FG001|Overall Study|Progressive disease|15|||
129621752|NCT05061420|466567072|FG002|Overall Study|Progressive disease|14|||
129621753|NCT05061420|466567070|FG000|Overall Study|Withdrawal by Subject|2|||
129621754|NCT05061420|466567071|FG001|Overall Study|Withdrawal by Subject|0|||
129621755|NCT05061420|466567072|FG002|Overall Study|Withdrawal by Subject|1|||
129621756|NCT05061420|466567070|FG000|Overall Study|Not related to COVID-19|2|||
129621757|NCT05061420|466567071|FG001|Overall Study|Not related to COVID-19|0|||
129621758|NCT05061420|466567072|FG002|Overall Study|Not related to COVID-19|0|||
129621759|NCT04868500|466567073|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
129621760|NCT04868500|466567074|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
129621761|NCT04868500|466567073|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
129621762|NCT04868500|466567074|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
129621763|NCT04807400|466567076|FG000|Overall Study|Adverse Event|2|||
129621764|NCT04807400|466567077|FG001|Overall Study|Adverse Event|3|||
129621765|NCT04807400|466567078|FG002|Overall Study|Adverse Event|3|||
129621766|NCT04807400|466567076|FG000|Overall Study|Death|2|||
129621767|NCT04807400|466567077|FG001|Overall Study|Death|0|||
129621768|NCT04807400|466567078|FG002|Overall Study|Death|0|||
129621769|NCT04807400|466567076|FG000|Overall Study|Lost to Follow-up|8|||
129621770|NCT04807400|466567077|FG001|Overall Study|Lost to Follow-up|6|||
129621771|NCT04807400|466567078|FG002|Overall Study|Lost to Follow-up|6|||
129621772|NCT04807400|466567076|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129621773|NCT04807400|466567077|FG001|Overall Study|Non-Compliance With Study Drug|4|||
129621774|NCT04807400|466567078|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129621775|NCT04807400|466567076|FG000|Overall Study|Participant Decision|20|||
129621776|NCT04807400|466567077|FG001|Overall Study|Participant Decision|19|||
129621777|NCT04807400|466567078|FG002|Overall Study|Participant Decision|26|||
129621778|NCT04807400|466567076|FG000|Overall Study|Physician Decision|0|||
129621779|NCT04807400|466567077|FG001|Overall Study|Physician Decision|1|||
129621780|NCT04807400|466567078|FG002|Overall Study|Physician Decision|0|||
129621781|NCT04807400|466567076|FG000|Overall Study|Protocol Violation|4|||
129621782|NCT04807400|466567077|FG001|Overall Study|Protocol Violation|3|||
129621783|NCT04807400|466567078|FG002|Overall Study|Protocol Violation|7|||
129621784|NCT04807400|466567076|FG000|Overall Study|Withdrawal by Subject|13|||
129621785|NCT04807400|466567077|FG001|Overall Study|Withdrawal by Subject|9|||
129621786|NCT04807400|466567078|FG002|Overall Study|Withdrawal by Subject|20|||
129621787|NCT04807400|466567076|FG000|Overall Study|Mis-randomized|1|||
129621788|NCT04807400|466567077|FG001|Overall Study|Mis-randomized|0|||
129621789|NCT04807400|466567078|FG002|Overall Study|Mis-randomized|0|||
129621790|NCT01332292|466567083|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
129621791|NCT01332292|466567084|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129621792|NCT01332292|466567083|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
129621793|NCT01332292|466567084|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
129621794|NCT01332292|466567083|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
129621795|NCT01332292|466567084|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
129621796|NCT04650204|466567085|FG000|Overall Study|Study was Terminated|2|||
129621797|NCT04650204|466567086|FG001|Overall Study|Study was Terminated|1|||
129621798|NCT01330303|466567087|FG000|Period 1|Adverse Event|1|||
129621799|NCT01330303|466567088|FG001|Period 1|Adverse Event|0|||
129621800|NCT01330303|466567087|FG000|Period 1|Protocol Violation|0|||
129621801|NCT01330303|466567088|FG001|Period 1|Protocol Violation|1|||
129621802|NCT01330303|466567087|FG000|Period 1|Withdrawal by Subject|0|||
129621803|NCT01330303|466567088|FG001|Period 1|Withdrawal by Subject|1|||
129621804|NCT01107197|466567089|FG000|Overall Study|Death|12|||
129621805|NCT01107197|466567090|FG001|Overall Study|Death|10|||
129621806|NCT01107197|466567089|FG000|Overall Study|Lost to Follow-up|5|||
129621807|NCT01107197|466567090|FG001|Overall Study|Lost to Follow-up|8|||
129621808|NCT01107197|466567089|FG000|Overall Study|Withdrawal by Subject|3|||
129621809|NCT01107197|466567090|FG001|Overall Study|Withdrawal by Subject|5|||
129621810|NCT03999996|466568762|FG000|Prior to Booster|Adverse Event|2|||
129621811|NCT03999996|466568763|FG001|Prior to Booster|Adverse Event|0|||
129621812|NCT03999996|466568764|FG002|Prior to Booster|Adverse Event|0|||
129621813|NCT03999996|466568765|FG003|Prior to Booster|Adverse Event|0|||
129621814|NCT03999996|466568762|FG000|Prior to Booster|Lost to Follow-up|17|||
129621815|NCT03999996|466568763|FG001|Prior to Booster|Lost to Follow-up|22|||
129621816|NCT03999996|466568764|FG002|Prior to Booster|Lost to Follow-up|0|||
129621817|NCT03999996|466568765|FG003|Prior to Booster|Lost to Follow-up|0|||
129621818|NCT03999996|466568762|FG000|Prior to Booster|Withdrawal of Consent|51|||
129793264|NCT01933789|467210737|FG008|Overall Study|Withdrawal by Subject|0|||
129621819|NCT03999996|466568763|FG001|Prior to Booster|Withdrawal of Consent|8|||
129621820|NCT03999996|466568764|FG002|Prior to Booster|Withdrawal of Consent|0|||
129621821|NCT03999996|466568765|FG003|Prior to Booster|Withdrawal of Consent|0|||
129621822|NCT03999996|466568762|FG000|Prior to Booster|Death|0|||
129793265|NCT01933789|467210729|FG000|Overall Study|Became Ineligible|4|||
129621823|NCT03999996|466568763|FG001|Prior to Booster|Death|1|||
129621824|NCT03999996|466568764|FG002|Prior to Booster|Death|0|||
129621825|NCT03999996|466568765|FG003|Prior to Booster|Death|0|||
129621826|NCT03999996|466568762|FG000|Prior to Booster|Reason Not Specified|27|||
129793266|NCT01933789|467210730|FG001|Overall Study|Became Ineligible|0|||
129621827|NCT03999996|466568763|FG001|Prior to Booster|Reason Not Specified|4|||
129621828|NCT03999996|466568764|FG002|Prior to Booster|Reason Not Specified|0|||
129621829|NCT03999996|466568765|FG003|Prior to Booster|Reason Not Specified|0|||
129621830|NCT03999996|466568762|FG000|Booster Phase|Lost to Follow-up|0|||
129621831|NCT03999996|466568763|FG001|Booster Phase|Lost to Follow-up|0|||
129621832|NCT03999996|466568764|FG002|Booster Phase|Lost to Follow-up|3|||
129621833|NCT03999996|466568765|FG003|Booster Phase|Lost to Follow-up|3|||
129621834|NCT03999996|466568762|FG000|Booster Phase|Withdrawal of Consent|0|||
129621835|NCT03999996|466568763|FG001|Booster Phase|Withdrawal of Consent|0|||
129621836|NCT03999996|466568764|FG002|Booster Phase|Withdrawal of Consent|0|||
129621837|NCT03999996|466568765|FG003|Booster Phase|Withdrawal of Consent|1|||
129621838|NCT03999996|466568762|FG000|Booster Phase|Reason Not Specified|0|||
129621839|NCT03999996|466568763|FG001|Booster Phase|Reason Not Specified|0|||
129621840|NCT03999996|466568764|FG002|Booster Phase|Reason Not Specified|0|||
129621841|NCT03999996|466568765|FG003|Booster Phase|Reason Not Specified|1|||
129621842|NCT00733005|466568768|FG000|Overall Study|Adverse Event|0|||
129621843|NCT00733005|466568769|FG001|Overall Study|Adverse Event|1|||
129621844|NCT00733005|466568768|FG000|Overall Study|Treatment Failure|0|||
129621845|NCT00733005|466568769|FG001|Overall Study|Treatment Failure|1|||
129621846|NCT00733005|466568768|FG000|Overall Study|Withdrawal by Subject|0|||
129621847|NCT00733005|466568769|FG001|Overall Study|Withdrawal by Subject|1|||
129621848|NCT00733005|466568768|FG000|Overall Study|Protocol Violation|2|||
129621849|NCT00733005|466568769|FG001|Overall Study|Protocol Violation|0|||
129621850|NCT03410056|466568770|FG000|Overall Study|Decision by Sponsor|0|||
129621851|NCT03410056|466568771|FG001|Overall Study|Decision by Sponsor|0|||
129621852|NCT03410056|466568772|FG002|Overall Study|Decision by Sponsor|3|||
129621853|NCT03410056|466568773|FG003|Overall Study|Decision by Sponsor|0|||
129621854|NCT03410056|466568774|FG004|Overall Study|Decision by Sponsor|0|||
129621855|NCT03410056|466568775|FG005|Overall Study|Decision by Sponsor|0|||
129621856|NCT03410056|466568776|FG006|Overall Study|Decision by Sponsor|0|||
129621857|NCT03410056|466568770|FG000|Overall Study|Withdrawal by Subject|0|||
129621858|NCT03410056|466568771|FG001|Overall Study|Withdrawal by Subject|2|||
129621859|NCT03410056|466568772|FG002|Overall Study|Withdrawal by Subject|5|||
129621860|NCT03410056|466568773|FG003|Overall Study|Withdrawal by Subject|5|||
129621861|NCT03410056|466568774|FG004|Overall Study|Withdrawal by Subject|0|||
129621862|NCT03410056|466568775|FG005|Overall Study|Withdrawal by Subject|0|||
129621863|NCT03410056|466568776|FG006|Overall Study|Withdrawal by Subject|0|||
129621864|NCT00266630|466568777|FG000|Overall Study|Adverse Event|8|||
129621865|NCT00266630|466568778|FG001|Overall Study|Adverse Event|6|||
129621866|NCT00266630|466568777|FG000|Overall Study|Lack of Efficacy|1|||
129621867|NCT00266630|466568778|FG001|Overall Study|Lack of Efficacy|4|||
129621868|NCT00266630|466568777|FG000|Overall Study|Entry Criteria not met|1|||
129621869|NCT00266630|466568778|FG001|Overall Study|Entry Criteria not met|0|||
129621870|NCT00266630|466568777|FG000|Overall Study|Protocol Violation|1|||
129621871|NCT00266630|466568778|FG001|Overall Study|Protocol Violation|3|||
129621872|NCT00266630|466568777|FG000|Overall Study|Physician Decision|1|||
129621873|NCT00266630|466568778|FG001|Overall Study|Physician Decision|2|||
129621874|NCT00266630|466568777|FG000|Overall Study|Withdrawal by Subject|10|||
129621875|NCT00266630|466568778|FG001|Overall Study|Withdrawal by Subject|2|||
129621876|NCT00266630|466568777|FG000|Overall Study|Lost to Follow-up|1|||
129621877|NCT00266630|466568778|FG001|Overall Study|Lost to Follow-up|0|||
129621878|NCT00266630|466568777|FG000|Overall Study|Other|19|||
129621879|NCT00266630|466568778|FG001|Overall Study|Other|11|||
129621880|NCT02548156|466568784|FG000|Washout Period 1|Lost to Follow-up|0|||
129621881|NCT02548156|466568785|FG001|Washout Period 1|Lost to Follow-up|0|||
129621882|NCT02548156|466568786|FG002|Washout Period 1|Lost to Follow-up|0|||
129621883|NCT02548156|466568787|FG003|Washout Period 1|Lost to Follow-up|0|||
129702271|NCT00725985|466871357|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
129702272|NCT00725985|466871358|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
129702273|NCT00725985|466871359|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
129702274|NCT00725985|466871360|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
129702275|NCT00725985|466871361|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
129702276|NCT00725985|466871362|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
129702277|NCT00725985|466871363|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
129702278|NCT00725985|466871364|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
129702279|NCT00725985|466871365|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
129702280|NCT00725985|466871366|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
129702281|NCT00725985|466871355|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
129621884|NCT02548156|466568788|FG004|Washout Period 1|Lost to Follow-up|1|||
129621885|NCT02548156|466568789|FG005|Washout Period 1|Lost to Follow-up|0|||
129621886|NCT01068262|466568794|FG000|Overall Study|Adverse Event|2|||
129621887|NCT01068262|466568795|FG001|Overall Study|Adverse Event|0|||
129621888|NCT01068262|466568796|FG002|Overall Study|Adverse Event|1|||
129621889|NCT01068262|466568797|FG003|Overall Study|Adverse Event|0|||
129621890|NCT01068262|466568794|FG000|Overall Study|Protocol Violation|1|||
129702282|NCT00725985|466871356|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
129702283|NCT00725985|466871357|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
129702284|NCT00725985|466871358|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
129702285|NCT00725985|466871359|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
129702286|NCT00725985|466871360|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
129702287|NCT00725985|466871361|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
129702288|NCT00725985|466871362|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
129702289|NCT00725985|466871363|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
129702290|NCT00725985|466871364|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
129702291|NCT00725985|466871365|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
129702292|NCT00725985|466871366|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
129702293|NCT00725985|466871355|FG000|ITP- Treatment Disposition|Other|50|||
129702294|NCT00725985|466871356|FG001|ITP- Treatment Disposition|Other|38|||
129702295|NCT00725985|466871357|FG002|ITP- Treatment Disposition|Other|24|||
129702296|NCT00725985|466871358|FG003|ITP- Treatment Disposition|Other|0|||
129702297|NCT00725985|466871359|FG004|ITP- Treatment Disposition|Other|0|||
129702298|NCT00725985|466871360|FG005|ITP- Treatment Disposition|Other|0|||
129702299|NCT00725985|466871361|FG006|ITP- Treatment Disposition|Other|0|||
129702300|NCT00725985|466871362|FG007|ITP- Treatment Disposition|Other|0|||
129702301|NCT00725985|466871363|FG008|ITP- Treatment Disposition|Other|0|||
129702302|NCT00725985|466871364|FG009|ITP- Treatment Disposition|Other|0|||
129702303|NCT00725985|466871365|FG010|ITP- Treatment Disposition|Other|0|||
129702304|NCT00725985|466871366|FG011|ITP- Treatment Disposition|Other|0|||
129702305|NCT00725985|466871355|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702306|NCT00725985|466871356|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702307|NCT00725985|466871357|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129621891|NCT01068262|466568795|FG001|Overall Study|Protocol Violation|0|||
129621892|NCT01068262|466568796|FG002|Overall Study|Protocol Violation|0|||
129621893|NCT01068262|466568797|FG003|Overall Study|Protocol Violation|0|||
129621894|NCT01068262|466568794|FG000|Overall Study|Withdrawal by Subject|0|||
129621895|NCT01068262|466568795|FG001|Overall Study|Withdrawal by Subject|1|||
129621896|NCT01068262|466568796|FG002|Overall Study|Withdrawal by Subject|0|||
129621897|NCT01068262|466568797|FG003|Overall Study|Withdrawal by Subject|0|||
129621898|NCT00444587|466568800|FG000|Overall Study|Death|2|||
129621899|NCT00444587|466568801|FG001|Overall Study|Death|1|||
129621900|NCT00444587|466568800|FG000|Overall Study|Progression of the disease|73|||
129621901|NCT00444587|466568801|FG001|Overall Study|Progression of the disease|8|||
129621902|NCT00444587|466568800|FG000|Overall Study|Refused treatment/did not cooperate|4|||
129621903|NCT00444587|466568801|FG001|Overall Study|Refused treatment/did not cooperate|1|||
129621904|NCT00444587|466568800|FG000|Overall Study|Investigator decision|3|||
129621905|NCT00444587|466568801|FG001|Overall Study|Investigator decision|0|||
129621906|NCT00444587|466568800|FG000|Overall Study|Protocol Violation|1|||
129621907|NCT00444587|466568801|FG001|Overall Study|Protocol Violation|0|||
129621908|NCT00444587|466568800|FG000|Overall Study|Missing|0|||
129621909|NCT00444587|466568801|FG001|Overall Study|Missing|5|||
129621910|NCT01473407|466568810|FG000|Overall Study|Physician Decision|1|||
129621911|NCT01473407|466568811|FG001|Overall Study|Physician Decision|4|||
129621912|NCT01473407|466568810|FG000|Overall Study|Lost to Follow-up|10|||
129621913|NCT01473407|466568811|FG001|Overall Study|Lost to Follow-up|4|||
129621914|NCT01473407|466568810|FG000|Overall Study|Adverse Event|8|||
129702308|NCT00725985|466871358|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
129702309|NCT00725985|466871359|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
129702310|NCT00725985|466871360|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
129621915|NCT01473407|466568811|FG001|Overall Study|Adverse Event|8|||
129621916|NCT01473407|466568810|FG000|Overall Study|Randomization Error|3|||
129621917|NCT01473407|466568811|FG001|Overall Study|Randomization Error|1|||
129621918|NCT01473407|466568810|FG000|Overall Study|Withdrawal by Subject|4|||
129621919|NCT01473407|466568811|FG001|Overall Study|Withdrawal by Subject|7|||
129621920|NCT01473407|466568810|FG000|Overall Study|Kidney Transplant|7|||
129702311|NCT00725985|466871361|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702312|NCT00725985|466871362|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702313|NCT00725985|466871363|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702314|NCT00725985|466871364|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702315|NCT00725985|466871365|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129621921|NCT01473407|466568811|FG001|Overall Study|Kidney Transplant|6|||
129702316|NCT00725985|466871366|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
129702317|NCT00725985|466871355|FG000|OLMP (Up to 96 Weeks)|Death|0|||
129702318|NCT00725985|466871356|FG001|OLMP (Up to 96 Weeks)|Death|0|||
129702319|NCT00725985|466871357|FG002|OLMP (Up to 96 Weeks)|Death|0|||
129702320|NCT00725985|466871358|FG003|OLMP (Up to 96 Weeks)|Death|0|||
129702321|NCT00725985|466871359|FG004|OLMP (Up to 96 Weeks)|Death|1|||
129702322|NCT00725985|466871360|FG005|OLMP (Up to 96 Weeks)|Death|0|||
129702323|NCT00725985|466871361|FG006|OLMP (Up to 96 Weeks)|Death|0|||
129621922|NCT01473407|466568810|FG000|Overall Study|Vacation/Travel|1|||
129621923|NCT01473407|466568811|FG001|Overall Study|Vacation/Travel|1|||
129621924|NCT01473407|466568810|FG000|Overall Study|Elevated Hemoglobin|1|||
129621925|NCT01473407|466568811|FG001|Overall Study|Elevated Hemoglobin|0|||
129621926|NCT01473407|466568810|FG000|Overall Study|Patient Received Aranesp|1|||
129621927|NCT01473407|466568811|FG001|Overall Study|Patient Received Aranesp|0|||
129621928|NCT01473407|466568810|FG000|Overall Study|Patient Lost Green Card Status|1|||
129621929|NCT01473407|466568811|FG001|Overall Study|Patient Lost Green Card Status|0|||
129621930|NCT01473407|466568810|FG000|Overall Study|Temperature Excursion|2|||
129621931|NCT01473407|466568811|FG001|Overall Study|Temperature Excursion|3|||
129621932|NCT01473407|466568810|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
129621933|NCT01473407|466568811|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
129621934|NCT01473407|466568810|FG000|Overall Study|Sponsor's Decision|10|||
129621935|NCT01473407|466568811|FG001|Overall Study|Sponsor's Decision|10|||
129621936|NCT01473407|466568810|FG000|Overall Study|Site Closure|1|||
129621937|NCT01473407|466568811|FG001|Overall Study|Site Closure|0|||
129621938|NCT01027702|466568812|FG000|Overall Study|Received subsequent therapy|1|||
129621939|NCT01027702|466568813|FG001|Overall Study|Received subsequent therapy|2|||
129621940|NCT01027702|466568814|FG002|Overall Study|Received subsequent therapy|0|||
129621941|NCT01027702|466568815|FG003|Overall Study|Received subsequent therapy|4|||
129621942|NCT01027702|466568816|FG004|Overall Study|Received subsequent therapy|1|||
129621943|NCT01027702|466568817|FG005|Overall Study|Received subsequent therapy|0|||
129621944|NCT01027702|466568818|FG006|Overall Study|Received subsequent therapy|1|||
129621945|NCT01027702|466568812|FG000|Overall Study|Death|0|||
129621946|NCT01027702|466568813|FG001|Overall Study|Death|0|||
129621947|NCT01027702|466568814|FG002|Overall Study|Death|1|||
129621948|NCT01027702|466568815|FG003|Overall Study|Death|0|||
129621949|NCT01027702|466568816|FG004|Overall Study|Death|0|||
129621950|NCT01027702|466568817|FG005|Overall Study|Death|0|||
129621951|NCT01027702|466568818|FG006|Overall Study|Death|0|||
129621952|NCT02301390|466568819|FG000|Overall Study|Withdrawal by Subject|3|||
129621953|NCT02301390|466568820|FG001|Overall Study|Withdrawal by Subject|5|||
129621954|NCT02301390|466568819|FG000|Overall Study|Protocol Violation|1|||
129621955|NCT02301390|466568820|FG001|Overall Study|Protocol Violation|0|||
129621956|NCT02301390|466568819|FG000|Overall Study|Physician Decision|1|||
129621957|NCT02301390|466568820|FG001|Overall Study|Physician Decision|0|||
129621958|NCT02301390|466568819|FG000|Overall Study|Lost to Follow-up|0|||
129621959|NCT02301390|466568820|FG001|Overall Study|Lost to Follow-up|1|||
129621960|NCT02301390|466568819|FG000|Overall Study|Death|2|||
129621961|NCT02301390|466568820|FG001|Overall Study|Death|2|||
129621962|NCT02301390|466568819|FG000|Overall Study|Procedure not completed|0|||
129621963|NCT02301390|466568820|FG001|Overall Study|Procedure not completed|4|||
129621964|NCT02301390|466568819|FG000|Overall Study|Missed multiple visits|1|||
129621965|NCT02301390|466568820|FG001|Overall Study|Missed multiple visits|1|||
129621966|NCT02301390|466568819|FG000|Overall Study|study terminated|2|||
129621967|NCT02301390|466568820|FG001|Overall Study|study terminated|0|||
129621968|NCT01153425|466568823|FG000|Overall Study|Withdrawal by Subject|3|||
129621969|NCT01153425|466568824|FG001|Overall Study|Withdrawal by Subject|3|||
129621970|NCT02932462|466568825|FG000|Overall Study|Adverse Event|1|||
129621971|NCT02932462|466568826|FG001|Overall Study|Adverse Event|2|||
129621972|NCT02932462|466568825|FG000|Overall Study|Lost to Follow-up|4|||
129621973|NCT02932462|466568826|FG001|Overall Study|Lost to Follow-up|1|||
129621974|NCT02932462|466568825|FG000|Overall Study|Protocol Violation|0|||
129621975|NCT02932462|466568826|FG001|Overall Study|Protocol Violation|5|||
129621976|NCT02932462|466568825|FG000|Overall Study|Withdrawal by Subject|1|||
129621977|NCT02932462|466568826|FG001|Overall Study|Withdrawal by Subject|4|||
129621978|NCT02932462|466568825|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129621979|NCT02932462|466568826|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129621980|NCT02932462|466568825|FG000|Overall Study|Progressive Disease|1|||
129621981|NCT02932462|466568826|FG001|Overall Study|Progressive Disease|0|||
129621982|NCT02652949|466568827|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
129621983|NCT02652949|466568827|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
129621984|NCT02652949|466568827|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
129621985|NCT02652949|466568827|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
129621986|NCT02652949|466568827|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
129621987|NCT02652949|466568827|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
129621988|NCT02652949|466568827|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
129621989|NCT02652949|466568827|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
129621990|NCT02652949|466568827|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
129621991|NCT02652949|466568827|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
129621992|NCT02652949|466568827|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
129621993|NCT02652949|466568827|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
129621994|NCT02652949|466568827|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
129621995|NCT02652949|466568827|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
129621996|NCT02652949|466568827|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
129621997|NCT02652949|466568827|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
129621998|NCT02652949|466568827|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
129702324|NCT00725985|466871362|FG007|OLMP (Up to 96 Weeks)|Death|0|||
129702325|NCT00725985|466871363|FG008|OLMP (Up to 96 Weeks)|Death|0|||
129621999|NCT00280735|466568837|FG000|Overall Study|Adverse Event|5|||
129622000|NCT00280735|466568837|FG000|Overall Study|Lack of Efficacy|3|||
129622001|NCT00280735|466568837|FG000|Overall Study|Withdrawal by Subject|8|||
129622002|NCT00280735|466568837|FG000|Overall Study|Intercurrent Illness|2|||
129622003|NCT04753216|466568838|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
129622004|NCT04753216|466568838|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
129622005|NCT04753216|466568838|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
129622006|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
129622007|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Death|1|||
129622008|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
129622009|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
129622010|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
129622011|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
129622012|NCT02001987|466568840|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
129622013|NCT02001987|466568840|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
129622014|NCT02001987|466568840|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
129622015|NCT02001987|466568840|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
129622016|NCT02001987|466568840|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
129622017|NCT02001987|466568840|FG000|LTE Period (52 Weeks)|Other|3|||
129622018|NCT01965860|466568841|FG000|Overall Study|Pregnancy|1|||
129622019|NCT01965860|466568842|FG001|Overall Study|Pregnancy|0|||
129622020|NCT01965860|466568843|FG002|Overall Study|Pregnancy|1|||
129622021|NCT01965860|466568841|FG000|Overall Study|Logistics|1|||
129622022|NCT01965860|466568842|FG001|Overall Study|Logistics|0|||
129622023|NCT01965860|466568843|FG002|Overall Study|Logistics|0|||
129622024|NCT01895777|466568844|FG000|Overall Study|Adverse Event|1|||
129622025|NCT01895777|466568845|FG001|Overall Study|Adverse Event|2|||
129622026|NCT01895777|466568844|FG000|Overall Study|Lost to Follow-up|2|||
129622027|NCT01895777|466568845|FG001|Overall Study|Lost to Follow-up|0|||
129622028|NCT01895777|466568844|FG000|Overall Study|Not treated|1|||
129622029|NCT01895777|466568845|FG001|Overall Study|Not treated|0|||
129622030|NCT01895777|466568844|FG000|Overall Study|Other reasons|3|||
129622031|NCT01895777|466568845|FG001|Overall Study|Other reasons|2|||
129622032|NCT01895777|466568844|FG000|Overall Study|Non-compliance with the CTP|2|||
129622033|NCT01895777|466568845|FG001|Overall Study|Non-compliance with the CTP|1|||
129622034|NCT02288325|466568849|FG000|Run-in Period|Adverse Event|48|||
129622035|NCT02288325|466568850|FG001|Run-in Period|Adverse Event|0|||
129622036|NCT02288325|466568851|FG002|Run-in Period|Adverse Event|0|||
129622037|NCT02288325|466568849|FG000|Run-in Period|Lack of Efficacy|16|||
129622038|NCT02288325|466568850|FG001|Run-in Period|Lack of Efficacy|0|||
129622039|NCT02288325|466568851|FG002|Run-in Period|Lack of Efficacy|0|||
129622040|NCT02288325|466568849|FG000|Run-in Period|Withdrawal of Consent|28|||
129622041|NCT02288325|466568850|FG001|Run-in Period|Withdrawal of Consent|0|||
129622042|NCT02288325|466568851|FG002|Run-in Period|Withdrawal of Consent|0|||
129622043|NCT02288325|466568849|FG000|Run-in Period|Lost to Follow-up|25|||
129622044|NCT02288325|466568850|FG001|Run-in Period|Lost to Follow-up|0|||
129622045|NCT02288325|466568851|FG002|Run-in Period|Lost to Follow-up|0|||
129622046|NCT02288325|466568849|FG000|Run-in Period|Protocol Violation|17|||
129622047|NCT02288325|466568850|FG001|Run-in Period|Protocol Violation|0|||
129622048|NCT02288325|466568851|FG002|Run-in Period|Protocol Violation|0|||
129622049|NCT02288325|466568849|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
129622050|NCT02288325|466568850|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
129622051|NCT02288325|466568851|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
129622052|NCT02288325|466568849|FG000|Run-in Period|Reason not Specified|8|||
129622053|NCT02288325|466568850|FG001|Run-in Period|Reason not Specified|0|||
129622054|NCT02288325|466568851|FG002|Run-in Period|Reason not Specified|0|||
129622055|NCT02288325|466568849|FG000|Stabilization Period|Adverse Event|13|||
129622056|NCT02288325|466568850|FG001|Stabilization Period|Adverse Event|0|||
129622057|NCT02288325|466568851|FG002|Stabilization Period|Adverse Event|0|||
129622058|NCT02288325|466568849|FG000|Stabilization Period|Lack of Efficacy|22|||
129622059|NCT02288325|466568850|FG001|Stabilization Period|Lack of Efficacy|0|||
129622060|NCT02288325|466568851|FG002|Stabilization Period|Lack of Efficacy|0|||
129622061|NCT02288325|466568849|FG000|Stabilization Period|Withdrawal of Consent|23|||
129622062|NCT02288325|466568850|FG001|Stabilization Period|Withdrawal of Consent|0|||
129622063|NCT02288325|466568851|FG002|Stabilization Period|Withdrawal of Consent|0|||
129622064|NCT02288325|466568849|FG000|Stabilization Period|Lost to Follow-up|12|||
129622065|NCT02288325|466568850|FG001|Stabilization Period|Lost to Follow-up|0|||
129622066|NCT02288325|466568851|FG002|Stabilization Period|Lost to Follow-up|0|||
129622067|NCT02288325|466568849|FG000|Stabilization Period|Protocol Violation|8|||
129622068|NCT02288325|466568850|FG001|Stabilization Period|Protocol Violation|0|||
129622069|NCT02288325|466568851|FG002|Stabilization Period|Protocol Violation|0|||
129622070|NCT02288325|466568849|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
129622071|NCT02288325|466568850|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
129702326|NCT00725985|466871364|FG009|OLMP (Up to 96 Weeks)|Death|0|||
129622072|NCT02288325|466568851|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
129622073|NCT02288325|466568849|FG000|Stabilization Period|Reason not Specified|15|||
129622074|NCT02288325|466568850|FG001|Stabilization Period|Reason not Specified|0|||
129622075|NCT02288325|466568851|FG002|Stabilization Period|Reason not Specified|0|||
129622076|NCT02288325|466568849|FG000|Double-blind Treatment Period|Adverse Event|0|||
129622077|NCT02288325|466568850|FG001|Double-blind Treatment Period|Adverse Event|2|||
129793267|NCT01933789|467210731|FG002|Overall Study|Became Ineligible|0|||
129793268|NCT01933789|467210732|FG003|Overall Study|Became Ineligible|0|||
129793269|NCT01933789|467210733|FG004|Overall Study|Became Ineligible|13|||
129793270|NCT01933789|467210734|FG005|Overall Study|Became Ineligible|10|||
129793271|NCT01933789|467210735|FG006|Overall Study|Became Ineligible|13|||
129793272|NCT01933789|467210736|FG007|Overall Study|Became Ineligible|6|||
129793273|NCT01933789|467210737|FG008|Overall Study|Became Ineligible|0|||
129793274|NCT01117792|467210743|FG000|Overall Study|Death|1|||
129793275|NCT01117792|467210743|FG000|Overall Study|Adverse Event|3|||
129793276|NCT01721577|467210744|FG000|Overall Study|Lack of Efficacy|1|||
129793277|NCT01721577|467210745|FG001|Overall Study|Lack of Efficacy|0|||
129793278|NCT01721577|467210744|FG000|Overall Study|Death|1|||
129793279|NCT01721577|467210745|FG001|Overall Study|Death|0|||
129793280|NCT01721577|467210744|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
129793281|NCT01721577|467210745|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
129793282|NCT01721577|467210744|FG000|Overall Study|Adverse Event|0|||
129793283|NCT01721577|467210745|FG001|Overall Study|Adverse Event|2|||
129793284|NCT02497976|467210748|FG000|Overall Study|Withdrawal by Subject|2|||
129793285|NCT02497976|467210749|FG001|Overall Study|Withdrawal by Subject|0|||
129793286|NCT02497976|467210748|FG000|Overall Study|Moved out of area|0|||
129793287|NCT02497976|467210749|FG001|Overall Study|Moved out of area|1|||
129793288|NCT01966432|467210752|FG000|Overall Study|Lost to Follow-up|3|||
129793289|NCT01966432|467210753|FG001|Overall Study|Lost to Follow-up|2|||
129793290|NCT01966432|467210754|FG002|Overall Study|Lost to Follow-up|5|||
129793291|NCT01966432|467210752|FG000|Overall Study|Withdrawal by Subject|1|||
129793292|NCT01966432|467210753|FG001|Overall Study|Withdrawal by Subject|3|||
129793293|NCT01966432|467210754|FG002|Overall Study|Withdrawal by Subject|0|||
129793294|NCT01966432|467210752|FG000|Overall Study|Subject Incarcerated|0|||
129793295|NCT01966432|467210753|FG001|Overall Study|Subject Incarcerated|0|||
129793296|NCT01966432|467210754|FG002|Overall Study|Subject Incarcerated|1|||
129793297|NCT01966432|467210752|FG000|Overall Study|SBIRT program ended|1|||
129793298|NCT01966432|467210753|FG001|Overall Study|SBIRT program ended|8|||
129793299|NCT01966432|467210754|FG002|Overall Study|SBIRT program ended|20|||
129793300|NCT00584740|467210757|FG000|Overall Study|Adverse Event|1|||
129793301|NCT00584740|467210758|FG001|Overall Study|Adverse Event|1|||
129793302|NCT00584740|467210757|FG000|Overall Study|Lack of Efficacy|8|||
129793303|NCT00584740|467210758|FG001|Overall Study|Lack of Efficacy|2|||
129793304|NCT00584740|467210757|FG000|Overall Study|Withdrawal by Subject|3|||
129793305|NCT00584740|467210758|FG001|Overall Study|Withdrawal by Subject|2|||
129793306|NCT00584740|467210757|FG000|Overall Study|Lost to Follow-up|0|||
129793307|NCT00584740|467210758|FG001|Overall Study|Lost to Follow-up|1|||
129793308|NCT01903525|467210759|FG000|Overall Study|Lost to Follow-up|5|||
129793309|NCT01903525|467210760|FG001|Overall Study|Lost to Follow-up|9|||
129793310|NCT01903525|467210759|FG000|Overall Study|Adverse Event|0|||
129793311|NCT01903525|467210760|FG001|Overall Study|Adverse Event|1|||
129793312|NCT00930982|467210761|FG000|Overall Study|Adverse Event|19|||
129793313|NCT00930982|467210762|FG001|Overall Study|Adverse Event|23|||
129793314|NCT00930982|467210761|FG000|Overall Study|Protocol Violation|1|||
129793315|NCT00930982|467210762|FG001|Overall Study|Protocol Violation|5|||
129793316|NCT00930982|467210761|FG000|Overall Study|Withdrawal by Subject|1|||
129793317|NCT00930982|467210762|FG001|Overall Study|Withdrawal by Subject|1|||
129793318|NCT03915860|467210763|FG000|Overall Study|Adverse Event|3|||
129793319|NCT03915860|467210763|FG000|Overall Study|Withdrawal by Subject|6|||
129793320|NCT03915860|467210763|FG000|Overall Study|Lost to Follow-up|2|||
129793321|NCT03915860|467210763|FG000|Overall Study|Other than specified|3|||
129793322|NCT02195011|467210764|FG000|Overall Study|Adverse Event|4|||
129793323|NCT02195011|467210765|FG001|Overall Study|Adverse Event|0|||
129793324|NCT02195011|467210764|FG000|Overall Study|Progressive Disease|18|||
129793325|NCT02195011|467210765|FG001|Overall Study|Progressive Disease|1|||
129793326|NCT02195011|467210764|FG000|Overall Study|Withdrawal by Subject|3|||
129439456|NCT01723254|465906514|FG007|Overall Study|Personal issues|0|||
129793327|NCT02195011|467210765|FG001|Overall Study|Withdrawal by Subject|0|||
129622078|NCT02288325|466568851|FG002|Double-blind Treatment Period|Adverse Event|5|||
129793328|NCT01853618|467210766|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
129793329|NCT01853618|467210767|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
129622079|NCT02288325|466568849|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
129622080|NCT02288325|466568850|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
129622081|NCT02288325|466568851|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
129622082|NCT02288325|466568849|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129622083|NCT02288325|466568850|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
129622084|NCT02288325|466568851|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
129622085|NCT02288325|466568849|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129622086|NCT02288325|466568850|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129622087|NCT02288325|466568851|FG002|Double-blind Treatment Period|Protocol Violation|2|||
129622088|NCT02288325|466568849|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
129622089|NCT02288325|466568850|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
129622090|NCT02288325|466568851|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
129622091|NCT02288325|466568849|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
129622092|NCT02288325|466568850|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
129622093|NCT02288325|466568851|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
129622094|NCT03735121|466568854|FG000|Overall Study|Death|3|||
129622095|NCT03735121|466568855|FG001|Overall Study|Death|6|||
129622096|NCT03735121|466568856|FG002|Overall Study|Death|8|||
129622097|NCT03735121|466568857|FG003|Overall Study|Death|37|||
129622098|NCT03735121|466568858|FG004|Overall Study|Death|86|||
129622099|NCT03735121|466568854|FG000|Overall Study|Withdrawal by Subject|1|||
129622100|NCT03735121|466568855|FG001|Overall Study|Withdrawal by Subject|1|||
129793330|NCT01853618|467210768|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
129793331|NCT01853618|467210769|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
129793332|NCT01853618|467210770|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
129793333|NCT01853618|467210766|FG000|Overall Study|Progressive disease|1|||
129793334|NCT01853618|467210767|FG001|Overall Study|Progressive disease|1|||
129793335|NCT01853618|467210768|FG002|Overall Study|Progressive disease|1|||
129793336|NCT01853618|467210769|FG003|Overall Study|Progressive disease|1|||
129793337|NCT01853618|467210770|FG004|Overall Study|Progressive disease|2|||
129793338|NCT01853618|467210766|FG000|Overall Study|Physician Decision|0|||
129793339|NCT01853618|467210767|FG001|Overall Study|Physician Decision|1|||
129793340|NCT01853618|467210768|FG002|Overall Study|Physician Decision|1|||
129793341|NCT01853618|467210769|FG003|Overall Study|Physician Decision|0|||
129793342|NCT01853618|467210770|FG004|Overall Study|Physician Decision|0|||
129793343|NCT01853618|467210766|FG000|Overall Study|Refused further treatment|0|||
129793344|NCT01853618|467210767|FG001|Overall Study|Refused further treatment|0|||
129793345|NCT01853618|467210768|FG002|Overall Study|Refused further treatment|0|||
129622101|NCT03735121|466568856|FG002|Overall Study|Withdrawal by Subject|3|||
129622102|NCT03735121|466568857|FG003|Overall Study|Withdrawal by Subject|4|||
129622103|NCT03735121|466568858|FG004|Overall Study|Withdrawal by Subject|2|||
129622104|NCT03735121|466568854|FG000|Overall Study|Progressive Disease|0|||
129622105|NCT03735121|466568855|FG001|Overall Study|Progressive Disease|0|||
129622106|NCT03735121|466568856|FG002|Overall Study|Progressive Disease|1|||
129622107|NCT03735121|466568857|FG003|Overall Study|Progressive Disease|0|||
129622108|NCT03735121|466568858|FG004|Overall Study|Progressive Disease|0|||
129622109|NCT03735121|466568854|FG000|Overall Study|Lost to Follow-up|0|||
129622110|NCT03735121|466568855|FG001|Overall Study|Lost to Follow-up|0|||
129622111|NCT03735121|466568856|FG002|Overall Study|Lost to Follow-up|0|||
129622112|NCT03735121|466568857|FG003|Overall Study|Lost to Follow-up|0|||
129622113|NCT03735121|466568858|FG004|Overall Study|Lost to Follow-up|1|||
129622114|NCT03735121|466568854|FG000|Overall Study|Ongoing|3|||
129622115|NCT03735121|466568855|FG001|Overall Study|Ongoing|3|||
129622116|NCT03735121|466568856|FG002|Overall Study|Ongoing|26|||
129622117|NCT03735121|466568857|FG003|Overall Study|Ongoing|83|||
129622118|NCT03735121|466568858|FG004|Overall Study|Ongoing|158|||
129622119|NCT00344448|466568859|FG000|Screening|Withdrawal by Subject|0|||
129622120|NCT00344448|466568860|FG001|Screening|Withdrawal by Subject|1|||
129622121|NCT00344448|466568859|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
129622122|NCT00344448|466568860|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
129622123|NCT00344448|466568859|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
129622124|NCT00344448|466568860|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
129622125|NCT00344448|466568859|FG000|Open Label|Withdrawal by Subject|1|||
129622126|NCT00344448|466568860|FG001|Open Label|Withdrawal by Subject|1|||
129793346|NCT01853618|467210769|FG003|Overall Study|Refused further treatment|0|||
129793347|NCT01853618|467210770|FG004|Overall Study|Refused further treatment|1|||
129793348|NCT01146860|467210773|FG000|Overall Study|Withdrawal by Subject|0|||
129793349|NCT01146860|467210774|FG001|Overall Study|Withdrawal by Subject|1|||
129793350|NCT01075191|467210775|FG000|Overall Study|Death|1|||
129622127|NCT00344448|466568859|FG000|Open Label|Study terminated|1|||
129622128|NCT00344448|466568860|FG001|Open Label|Study terminated|0|||
129622129|NCT03138655|466568862|FG000|Overall Study|Adverse Event|2|||
129622130|NCT03138655|466568863|FG001|Overall Study|Adverse Event|1|||
129622131|NCT03138655|466568864|FG002|Overall Study|Adverse Event|2|||
129622132|NCT03138655|466568865|FG003|Overall Study|Adverse Event|1|||
129622133|NCT03138655|466568866|FG004|Overall Study|Adverse Event|1|||
129622134|NCT03138655|466568867|FG005|Overall Study|Adverse Event|4|||
129622135|NCT03138655|466568868|FG006|Overall Study|Adverse Event|2|||
129622136|NCT03138655|466568869|FG007|Overall Study|Adverse Event|2|||
129622137|NCT03138655|466568862|FG000|Overall Study|Withdrawal by Subject|0|||
129622138|NCT03138655|466568863|FG001|Overall Study|Withdrawal by Subject|1|||
129622139|NCT03138655|466568864|FG002|Overall Study|Withdrawal by Subject|0|||
129622140|NCT03138655|466568865|FG003|Overall Study|Withdrawal by Subject|0|||
129622141|NCT03138655|466568866|FG004|Overall Study|Withdrawal by Subject|0|||
129622142|NCT03138655|466568867|FG005|Overall Study|Withdrawal by Subject|0|||
129622143|NCT03138655|466568868|FG006|Overall Study|Withdrawal by Subject|1|||
129622144|NCT03138655|466568869|FG007|Overall Study|Withdrawal by Subject|0|||
129622145|NCT03138655|466568862|FG000|Overall Study|Reason not Specified|1|||
129622146|NCT03138655|466568863|FG001|Overall Study|Reason not Specified|0|||
129622147|NCT03138655|466568864|FG002|Overall Study|Reason not Specified|0|||
129622148|NCT03138655|466568865|FG003|Overall Study|Reason not Specified|2|||
129622149|NCT03138655|466568866|FG004|Overall Study|Reason not Specified|1|||
129622150|NCT03138655|466568867|FG005|Overall Study|Reason not Specified|1|||
129622151|NCT03138655|466568868|FG006|Overall Study|Reason not Specified|0|||
129622152|NCT03138655|466568869|FG007|Overall Study|Reason not Specified|0|||
129622153|NCT02565511|466568870|FG000|Overall Study|Study terminated by Sponsor|35|||
129622154|NCT02565511|466568871|FG001|Overall Study|Study terminated by Sponsor|22|||
129622155|NCT02565511|466568872|FG002|Overall Study|Study terminated by Sponsor|235|||
129622156|NCT02565511|466568873|FG003|Overall Study|Study terminated by Sponsor|156|||
129622157|NCT02565511|466568870|FG000|Overall Study|Withdrawal by Subject|3|||
129622158|NCT02565511|466568871|FG001|Overall Study|Withdrawal by Subject|0|||
129622159|NCT02565511|466568872|FG002|Overall Study|Withdrawal by Subject|12|||
129702327|NCT00725985|466871365|FG010|OLMP (Up to 96 Weeks)|Death|0|||
129702328|NCT00725985|466871366|FG011|OLMP (Up to 96 Weeks)|Death|0|||
129702329|NCT00725985|466871355|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702330|NCT00725985|466871356|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702331|NCT00725985|466871357|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702332|NCT00725985|466871358|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
129702333|NCT00725985|466871359|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702334|NCT00725985|466871360|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702335|NCT00725985|466871361|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702336|NCT00725985|466871362|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702337|NCT00725985|466871363|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702338|NCT00725985|466871364|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702339|NCT00725985|466871365|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702340|NCT00725985|466871366|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
129702341|NCT00725985|466871355|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702342|NCT00725985|466871356|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702343|NCT00725985|466871357|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702344|NCT00725985|466871358|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702345|NCT00725985|466871359|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702346|NCT00725985|466871360|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
129702347|NCT00725985|466871361|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702348|NCT00725985|466871362|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702349|NCT00725985|466871363|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702350|NCT00725985|466871364|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702351|NCT00725985|466871365|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702352|NCT00725985|466871366|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
129702353|NCT00725985|466871355|FG000|OLMP (Up to 96 Weeks)|Other|0|||
129702354|NCT00725985|466871356|FG001|OLMP (Up to 96 Weeks)|Other|0|||
129702355|NCT00725985|466871357|FG002|OLMP (Up to 96 Weeks)|Other|0|||
129702356|NCT00725985|466871358|FG003|OLMP (Up to 96 Weeks)|Other|15|||
129702357|NCT00725985|466871359|FG004|OLMP (Up to 96 Weeks)|Other|20|||
129702358|NCT00725985|466871360|FG005|OLMP (Up to 96 Weeks)|Other|44|||
129702359|NCT00725985|466871361|FG006|OLMP (Up to 96 Weeks)|Other|0|||
129702360|NCT00725985|466871362|FG007|OLMP (Up to 96 Weeks)|Other|0|||
129702361|NCT00725985|466871363|FG008|OLMP (Up to 96 Weeks)|Other|0|||
129702362|NCT00725985|466871364|FG009|OLMP (Up to 96 Weeks)|Other|0|||
129702363|NCT00725985|466871365|FG010|OLMP (Up to 96 Weeks)|Other|0|||
129622160|NCT02565511|466568873|FG003|Overall Study|Withdrawal by Subject|5|||
129622161|NCT02565511|466568870|FG000|Overall Study|Adverse Event|0|||
129622162|NCT02565511|466568871|FG001|Overall Study|Adverse Event|0|||
129622163|NCT02565511|466568872|FG002|Overall Study|Adverse Event|1|||
129622164|NCT02565511|466568873|FG003|Overall Study|Adverse Event|1|||
129622165|NCT02565511|466568870|FG000|Overall Study|Lost to Follow-up|4|||
129622166|NCT02565511|466568871|FG001|Overall Study|Lost to Follow-up|1|||
129622167|NCT02565511|466568872|FG002|Overall Study|Lost to Follow-up|0|||
129622168|NCT02565511|466568873|FG003|Overall Study|Lost to Follow-up|1|||
129702364|NCT00725985|466871366|FG011|OLMP (Up to 96 Weeks)|Other|0|||
129888293|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
129888294|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
129888295|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
129888296|NCT02718417|467549132|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
129888297|NCT02718417|467549133|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
129888298|NCT02718417|467549134|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
129888299|NCT02718417|467549132|FG000|Observation Phase (OP)|Adverse Event|0|||
129888300|NCT02718417|467549133|FG001|Observation Phase (OP)|Adverse Event|0|||
129888301|NCT02718417|467549134|FG002|Observation Phase (OP)|Adverse Event|1|||
129888302|NCT02718417|467549132|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
129888303|NCT02718417|467549133|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
129888304|NCT02718417|467549134|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
129888305|NCT02718417|467549132|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
129888306|NCT02718417|467549133|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
129888307|NCT02718417|467549134|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
129888308|NCT02718417|467549132|FG000|Observation Phase (OP)|Physician Decision|0|||
129888309|NCT02718417|467549133|FG001|Observation Phase (OP)|Physician Decision|0|||
129888310|NCT02718417|467549134|FG002|Observation Phase (OP)|Physician Decision|9|||
129888311|NCT02718417|467549132|FG000|Observation Phase (OP)|Progressive disease|0|||
129888312|NCT02718417|467549133|FG001|Observation Phase (OP)|Progressive disease|0|||
129888313|NCT02718417|467549134|FG002|Observation Phase (OP)|Progressive disease|92|||
129888314|NCT02718417|467549132|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
129888315|NCT02718417|467549133|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
129888316|NCT02718417|467549134|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
129888317|NCT02718417|467549132|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
129888318|NCT02718417|467549133|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
129888319|NCT02718417|467549134|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
129888320|NCT02718417|467549132|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
129888321|NCT02718417|467549133|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
129888322|NCT02718417|467549134|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
129702365|NCT00725985|466871355|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702366|NCT00725985|466871356|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702367|NCT00725985|466871357|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702368|NCT00725985|466871358|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702369|NCT00725985|466871359|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702370|NCT00725985|466871360|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702371|NCT00725985|466871361|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702372|NCT00725985|466871362|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
129702373|NCT00725985|466871363|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702374|NCT00725985|466871364|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702375|NCT00725985|466871365|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129888323|NCT02718417|467549132|FG000|Observation Phase (OP)|Other|0|||
129888324|NCT02718417|467549133|FG001|Observation Phase (OP)|Other|0|||
129702376|NCT00725985|466871366|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
129702377|NCT00725985|466871355|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702378|NCT00725985|466871356|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129888325|NCT02718417|467549134|FG002|Observation Phase (OP)|Other|7|||
129622169|NCT02565511|466568870|FG000|Overall Study|Physician Decision|0|||
129622170|NCT02565511|466568871|FG001|Overall Study|Physician Decision|0|||
129622171|NCT02565511|466568872|FG002|Overall Study|Physician Decision|0|||
129622172|NCT02565511|466568873|FG003|Overall Study|Physician Decision|1|||
129622173|NCT02565511|466568870|FG000|Overall Study|Protocol deviation|0|||
129622174|NCT02565511|466568871|FG001|Overall Study|Protocol deviation|0|||
129622175|NCT02565511|466568872|FG002|Overall Study|Protocol deviation|3|||
129622176|NCT02565511|466568873|FG003|Overall Study|Protocol deviation|0|||
129622177|NCT03656744|466568874|FG000|Overall Study|Adverse Event|1|||
129622178|NCT03656744|466568875|FG001|Overall Study|Adverse Event|4|||
129622179|NCT03656744|466568876|FG002|Overall Study|Adverse Event|1|||
129622180|NCT03656744|466568874|FG000|Overall Study|Protocol Violation|1|||
129622181|NCT03656744|466568875|FG001|Overall Study|Protocol Violation|0|||
129622182|NCT03656744|466568876|FG002|Overall Study|Protocol Violation|0|||
129622183|NCT03656744|466568874|FG000|Overall Study|Lost to Follow-up|2|||
129622184|NCT03656744|466568875|FG001|Overall Study|Lost to Follow-up|2|||
129622185|NCT03656744|466568876|FG002|Overall Study|Lost to Follow-up|0|||
129622186|NCT03656744|466568874|FG000|Overall Study|Withdrawal by Subject|0|||
129622187|NCT03656744|466568875|FG001|Overall Study|Withdrawal by Subject|1|||
129622188|NCT03656744|466568876|FG002|Overall Study|Withdrawal by Subject|0|||
129622189|NCT03656744|466568874|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
129622190|NCT03656744|466568875|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
129622191|NCT03656744|466568876|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
129622192|NCT03910673|466568882|FG000|Overall Study|Adverse Event|0|||
129622193|NCT03910673|466568883|FG001|Overall Study|Adverse Event|0|||
129622194|NCT03910673|466568884|FG002|Overall Study|Adverse Event|0|||
129622195|NCT03910673|466568885|FG003|Overall Study|Adverse Event|2|||
129622196|NCT03910673|466568886|FG004|Overall Study|Adverse Event|0|||
129622197|NCT00098774|466568887|FG000|Overall Study|Adverse Event|2|||
129622198|NCT00098774|466568887|FG000|Overall Study|Disease Progression|9|||
129622199|NCT00098774|466568887|FG000|Overall Study|Withdrawal by Subject|1|||
129622200|NCT00098774|466568887|FG000|Overall Study|Failed (to respond) during induction|4|||
129622201|NCT00098774|466568887|FG000|Overall Study|Physician Decision|2|||
129622202|NCT00796757|466568888|FG000|Overall Study|Withdrawal by Subject|14|||
129622203|NCT00796757|466568888|FG000|Overall Study|Death|61|||
129622204|NCT00796757|466568888|FG000|Overall Study|Protocol Violation|1|||
129622205|NCT00796757|466568888|FG000|Overall Study|Participant noncompliance|1|||
129622206|NCT00796757|466568888|FG000|Overall Study|Investigator's decision|2|||
129622207|NCT00796757|466568888|FG000|Overall Study|Other|7|||
129622208|NCT01277211|466568889|FG000|Overall Study|Adverse Event|60|||
129622209|NCT01277211|466568890|FG001|Overall Study|Adverse Event|22|||
129622210|NCT01277211|466568889|FG000|Overall Study|Pregnancy|9|||
129622211|NCT01277211|466568890|FG001|Overall Study|Pregnancy|4|||
129622212|NCT01277211|466568889|FG000|Overall Study|Lost to Follow-up|14|||
129702379|NCT00725985|466871357|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702380|NCT00725985|466871358|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702381|NCT00725985|466871359|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702382|NCT00725985|466871360|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702383|NCT00725985|466871361|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702384|NCT00725985|466871362|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702385|NCT00725985|466871363|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
129702386|NCT00725985|466871364|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702387|NCT00725985|466871365|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702388|NCT00725985|466871366|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
129702389|NCT00725985|466871355|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702390|NCT00725985|466871356|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702391|NCT00725985|466871357|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702392|NCT00725985|466871358|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702393|NCT00725985|466871359|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702394|NCT00725985|466871360|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702395|NCT00725985|466871361|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
129702396|NCT00725985|466871362|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
129702397|NCT00725985|466871363|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
129702398|NCT00725985|466871364|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702399|NCT00725985|466871365|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702400|NCT00725985|466871366|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
129702401|NCT00725985|466871355|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129793351|NCT01075191|467210775|FG000|Overall Study|Intensification|3|||
129793352|NCT01075191|467210775|FG000|Overall Study|Co-morbidities|1|||
129622213|NCT01277211|466568890|FG001|Overall Study|Lost to Follow-up|9|||
129622214|NCT01277211|466568889|FG000|Overall Study|Did not wish to continue|17|||
129622215|NCT01277211|466568890|FG001|Overall Study|Did not wish to continue|0|||
129622216|NCT01277211|466568889|FG000|Overall Study|Withdrew Consent|9|||
129622217|NCT01277211|466568890|FG001|Overall Study|Withdrew Consent|9|||
129622218|NCT01277211|466568889|FG000|Overall Study|Non-compliance with protocol|13|||
129622219|NCT01277211|466568890|FG001|Overall Study|Non-compliance with protocol|4|||
129622220|NCT01277211|466568889|FG000|Overall Study|Did not meet protocol eligibility|1|||
129622221|NCT01277211|466568890|FG001|Overall Study|Did not meet protocol eligibility|0|||
129622222|NCT01277211|466568889|FG000|Overall Study|Administrative|3|||
129622223|NCT01277211|466568890|FG001|Overall Study|Administrative|0|||
129622224|NCT01277211|466568889|FG000|Overall Study|Pregnancy wish|0|||
129622225|NCT01277211|466568890|FG001|Overall Study|Pregnancy wish|2|||
129622226|NCT01277211|466568889|FG000|Overall Study|Discontinued prior to treatment|24|||
129622227|NCT01277211|466568890|FG001|Overall Study|Discontinued prior to treatment|13|||
129622228|NCT00879086|466568891|FG000|Overall Study|Adverse Event|3|||
129622229|NCT00879086|466568892|FG001|Overall Study|Adverse Event|15|||
129622230|NCT00879086|466568891|FG000|Overall Study|Participant choice|2|||
129622231|NCT00879086|466568892|FG001|Overall Study|Participant choice|2|||
129622232|NCT00879086|466568891|FG000|Overall Study|Progression of disease|40|||
129622233|NCT00879086|466568892|FG001|Overall Study|Progression of disease|26|||
129622234|NCT00879086|466568891|FG000|Overall Study|Withdrawal of consent|2|||
129622235|NCT00879086|466568892|FG001|Overall Study|Withdrawal of consent|1|||
129622236|NCT00879086|466568891|FG000|Overall Study|Other|4|||
129622237|NCT00879086|466568892|FG001|Overall Study|Other|6|||
129622238|NCT00879086|466568891|FG000|Overall Study|Death|1|||
129622239|NCT00879086|466568892|FG001|Overall Study|Death|2|||
129622240|NCT01487525|466568893|FG000|Overall Study|Withdrawal by Subject|0|||
129622241|NCT01487525|466568894|FG001|Overall Study|Withdrawal by Subject|1|||
129622242|NCT01855828|466568895|FG000|Overall Study|Adverse Event|1|||
129622243|NCT01855828|466568895|FG000|Overall Study|Withdrawal by Subject|1|||
129622244|NCT01866098|466568900|FG000|Overall Study|Lost to Follow-up|11|||
129622245|NCT01866098|466568901|FG001|Overall Study|Lost to Follow-up|18|||
129622246|NCT01866098|466568902|FG002|Overall Study|Lost to Follow-up|13|||
129622247|NCT01866098|466568900|FG000|Overall Study|Physician Decision|0|||
129622248|NCT01866098|466568901|FG001|Overall Study|Physician Decision|1|||
129622249|NCT01866098|466568902|FG002|Overall Study|Physician Decision|2|||
129622250|NCT01866098|466568900|FG000|Overall Study|Adverse Event|1|||
129622251|NCT01866098|466568901|FG001|Overall Study|Adverse Event|5|||
129622252|NCT01866098|466568902|FG002|Overall Study|Adverse Event|4|||
129622253|NCT01866098|466568900|FG000|Overall Study|Protocol Violation|1|||
129622254|NCT01866098|466568901|FG001|Overall Study|Protocol Violation|0|||
129622255|NCT01866098|466568902|FG002|Overall Study|Protocol Violation|0|||
129702402|NCT00725985|466871356|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702403|NCT00725985|466871357|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702404|NCT00725985|466871358|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702405|NCT00725985|466871359|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702406|NCT00725985|466871360|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702407|NCT00725985|466871361|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702408|NCT00725985|466871362|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702409|NCT00725985|466871363|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
129702410|NCT00725985|466871364|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
129702411|NCT00725985|466871365|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
129702412|NCT00725985|466871366|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
129702413|NCT02546323|466871367|FG000|Overall Study|Withdrawal by Subject|36|||
129702414|NCT02546323|466871368|FG001|Overall Study|Withdrawal by Subject|33|||
129702415|NCT02546323|466871367|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
129702416|NCT02546323|466871368|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
129702417|NCT02546323|466871367|FG000|Overall Study|Adverse Event|17|||
129702418|NCT02546323|466871368|FG001|Overall Study|Adverse Event|11|||
129702419|NCT02546323|466871367|FG000|Overall Study|Patient Specific Reasons|1|||
129702420|NCT02546323|466871368|FG001|Overall Study|Patient Specific Reasons|2|||
129702421|NCT02546323|466871367|FG000|Overall Study|Lost to Follow-up|2|||
129702422|NCT02546323|466871368|FG001|Overall Study|Lost to Follow-up|3|||
129702423|NCT02546323|466871367|FG000|Overall Study|Non-compliance with Study Drug|2|||
129702424|NCT02546323|466871368|FG001|Overall Study|Non-compliance with Study Drug|2|||
129622256|NCT01866098|466568900|FG000|Overall Study|Withdrawal by Subject|1|||
129622257|NCT01866098|466568901|FG001|Overall Study|Withdrawal by Subject|2|||
129622258|NCT01866098|466568902|FG002|Overall Study|Withdrawal by Subject|0|||
129622259|NCT01866098|466568900|FG000|Overall Study|Unrelated Hospitalization|2|||
129622260|NCT01866098|466568901|FG001|Overall Study|Unrelated Hospitalization|0|||
129622261|NCT01866098|466568902|FG002|Overall Study|Unrelated Hospitalization|1|||
129622262|NCT01866098|466568900|FG000|Overall Study|Non-compliance|1|||
129622263|NCT01866098|466568901|FG001|Overall Study|Non-compliance|0|||
129702425|NCT02546323|466871367|FG000|Overall Study|Met Withdrawal Criteria|2|||
129702426|NCT02546323|466871368|FG001|Overall Study|Met Withdrawal Criteria|14|||
129702427|NCT04476784|466871369|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
129622264|NCT01866098|466568902|FG002|Overall Study|Non-compliance|1|||
129622265|NCT01866098|466568900|FG000|Overall Study|Pregnancy|2|||
129622266|NCT01866098|466568901|FG001|Overall Study|Pregnancy|0|||
129622267|NCT01866098|466568902|FG002|Overall Study|Pregnancy|0|||
129622268|NCT01866098|466568900|FG000|Overall Study|Death|0|||
129622269|NCT01866098|466568901|FG001|Overall Study|Death|1|||
129622270|NCT01866098|466568902|FG002|Overall Study|Death|0|||
129622271|NCT03449446|466568909|FG000|Overall Study|Randomized but Never Treated|0|||
129622272|NCT03449446|466568910|FG001|Overall Study|Randomized but Never Treated|0|||
129622273|NCT03449446|466568911|FG002|Overall Study|Randomized but Never Treated|1|||
129622274|NCT03449446|466568912|FG003|Overall Study|Randomized but Never Treated|1|||
129622275|NCT03449446|466568913|FG004|Overall Study|Randomized but Never Treated|1|||
129622276|NCT03449446|466568914|FG005|Overall Study|Randomized but Never Treated|0|||
129622277|NCT03449446|466568915|FG006|Overall Study|Randomized but Never Treated|0|||
129622278|NCT03449446|466568909|FG000|Overall Study|Unknown Reason|33|||
129622279|NCT03449446|466568910|FG001|Overall Study|Unknown Reason|1|||
129622280|NCT03449446|466568911|FG002|Overall Study|Unknown Reason|1|||
129622281|NCT03449446|466568912|FG003|Overall Study|Unknown Reason|1|||
129622282|NCT03449446|466568913|FG004|Overall Study|Unknown Reason|2|||
129622283|NCT03449446|466568914|FG005|Overall Study|Unknown Reason|2|||
129622284|NCT03449446|466568915|FG006|Overall Study|Unknown Reason|0|||
129622285|NCT03449446|466568909|FG000|Overall Study|Withdrew Consent|1|||
129622286|NCT03449446|466568910|FG001|Overall Study|Withdrew Consent|3|||
129622287|NCT03449446|466568911|FG002|Overall Study|Withdrew Consent|1|||
129622288|NCT03449446|466568912|FG003|Overall Study|Withdrew Consent|4|||
129622289|NCT03449446|466568913|FG004|Overall Study|Withdrew Consent|4|||
129793353|NCT01075191|467210775|FG000|Overall Study|Adverse Event|4|||
129793354|NCT01075191|467210775|FG000|Overall Study|Noncompliance|3|||
129793355|NCT01075191|467210775|FG000|Overall Study|Therapy Break|3|||
129793356|NCT01075191|467210775|FG000|Overall Study|Patient's Wish|2|||
129793357|NCT01075191|467210775|FG000|Overall Study|Unknown Reasons|1|||
129793358|NCT02635646|467210781|FG000|Overall Study|Lost to Follow-up|24|||
129793359|NCT02635646|467210782|FG001|Overall Study|Lost to Follow-up|25|||
129793360|NCT02635646|467210781|FG000|Overall Study|Pregnancy|1|||
129793361|NCT02635646|467210782|FG001|Overall Study|Pregnancy|1|||
129793362|NCT00645788|467210783|FG000|Overall Study|Did not receive study drug|1|||
129793363|NCT00645788|467210784|FG001|Overall Study|Did not receive study drug|1|||
129793364|NCT00645788|467210785|FG002|Overall Study|Did not receive study drug|0|||
129793365|NCT00645788|467210786|FG003|Overall Study|Did not receive study drug|0|||
129793366|NCT00645788|467210783|FG000|Overall Study|Adverse Event|4|||
129793367|NCT00645788|467210784|FG001|Overall Study|Adverse Event|9|||
129622290|NCT03449446|466568914|FG005|Overall Study|Withdrew Consent|4|||
129622291|NCT03449446|466568915|FG006|Overall Study|Withdrew Consent|1|||
129622292|NCT03449446|466568909|FG000|Overall Study|Adverse Event|1|||
129622293|NCT03449446|466568910|FG001|Overall Study|Adverse Event|2|||
129622294|NCT03449446|466568911|FG002|Overall Study|Adverse Event|1|||
129622295|NCT03449446|466568912|FG003|Overall Study|Adverse Event|0|||
129793368|NCT00645788|467210785|FG002|Overall Study|Adverse Event|5|||
129793369|NCT00645788|467210786|FG003|Overall Study|Adverse Event|3|||
129793370|NCT00645788|467210783|FG000|Overall Study|Lost to Follow-up|1|||
129793371|NCT00645788|467210784|FG001|Overall Study|Lost to Follow-up|0|||
129793372|NCT00645788|467210785|FG002|Overall Study|Lost to Follow-up|0|||
129793373|NCT00645788|467210786|FG003|Overall Study|Lost to Follow-up|0|||
129622296|NCT03449446|466568913|FG004|Overall Study|Adverse Event|0|||
129622297|NCT03449446|466568914|FG005|Overall Study|Adverse Event|2|||
129622298|NCT03449446|466568915|FG006|Overall Study|Adverse Event|0|||
129622299|NCT03449446|466568909|FG000|Overall Study|Lost to Follow-up|0|||
129622300|NCT03449446|466568910|FG001|Overall Study|Lost to Follow-up|0|||
129622301|NCT03449446|466568911|FG002|Overall Study|Lost to Follow-up|2|||
129622302|NCT03449446|466568912|FG003|Overall Study|Lost to Follow-up|1|||
129622303|NCT03449446|466568913|FG004|Overall Study|Lost to Follow-up|3|||
129622304|NCT03449446|466568914|FG005|Overall Study|Lost to Follow-up|0|||
129622305|NCT03449446|466568915|FG006|Overall Study|Lost to Follow-up|0|||
129622306|NCT03449446|466568909|FG000|Overall Study|Investigator's Discretion|0|||
129622307|NCT03449446|466568910|FG001|Overall Study|Investigator's Discretion|1|||
129622308|NCT03449446|466568911|FG002|Overall Study|Investigator's Discretion|1|||
129622309|NCT03449446|466568912|FG003|Overall Study|Investigator's Discretion|2|||
129622310|NCT03449446|466568913|FG004|Overall Study|Investigator's Discretion|0|||
129793374|NCT00645788|467210783|FG000|Overall Study|Protocol Violation|1|||
129793375|NCT00645788|467210784|FG001|Overall Study|Protocol Violation|0|||
129793376|NCT00645788|467210785|FG002|Overall Study|Protocol Violation|2|||
129793377|NCT00645788|467210786|FG003|Overall Study|Protocol Violation|0|||
129622311|NCT03449446|466568914|FG005|Overall Study|Investigator's Discretion|0|||
129622312|NCT03449446|466568915|FG006|Overall Study|Investigator's Discretion|0|||
129622313|NCT03449446|466568909|FG000|Overall Study|Non Compliance with Study Drug|1|||
129622314|NCT03449446|466568910|FG001|Overall Study|Non Compliance with Study Drug|0|||
129622315|NCT03449446|466568911|FG002|Overall Study|Non Compliance with Study Drug|0|||
129622316|NCT03449446|466568912|FG003|Overall Study|Non Compliance with Study Drug|0|||
129793378|NCT00645788|467210783|FG000|Overall Study|Withdrawal by Subject|0|||
129702428|NCT04476784|466871370|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
129702429|NCT03605693|466871377|FG000|Overall Study|Lost to Follow-up|4|||
129702430|NCT03605693|466871378|FG001|Overall Study|Lost to Follow-up|0|||
129702431|NCT03605693|466871377|FG000|Overall Study|Physician Decision|1|||
129702432|NCT03605693|466871378|FG001|Overall Study|Physician Decision|0|||
129702433|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
129702434|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
129702435|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
129702436|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
129702437|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
129622317|NCT03449446|466568913|FG004|Overall Study|Non Compliance with Study Drug|0|||
129702438|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
129702439|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
129702440|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
129702441|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
129702442|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
129702443|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
129702444|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
129702445|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
129702446|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
129702447|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
129702448|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
129702449|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
129702450|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
129702451|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
129702452|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
129622318|NCT03449446|466568914|FG005|Overall Study|Non Compliance with Study Drug|0|||
129622319|NCT03449446|466568915|FG006|Overall Study|Non Compliance with Study Drug|0|||
129622320|NCT03449446|466568909|FG000|Overall Study|Protocol Violation|0|||
129622321|NCT03449446|466568910|FG001|Overall Study|Protocol Violation|0|||
129622322|NCT03449446|466568911|FG002|Overall Study|Protocol Violation|0|||
129622323|NCT03449446|466568912|FG003|Overall Study|Protocol Violation|0|||
129622324|NCT03449446|466568913|FG004|Overall Study|Protocol Violation|1|||
129622325|NCT03449446|466568914|FG005|Overall Study|Protocol Violation|1|||
129622326|NCT03449446|466568915|FG006|Overall Study|Protocol Violation|0|||
129622327|NCT03449446|466568909|FG000|Overall Study|Death|0|||
129622328|NCT03449446|466568910|FG001|Overall Study|Death|0|||
129702453|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
129702454|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
129702455|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
129702456|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
129702457|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
129702458|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
129702459|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
129702460|NCT03093415|466871379|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
129702461|NCT03093415|466871380|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
129702462|NCT03093415|466871381|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
129702463|NCT03093415|466871379|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
129702464|NCT03093415|466871380|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
129702465|NCT03093415|466871381|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
129702466|NCT04581395|466871386|FG000|Overall Study|Protocol Violation|4|||
129702467|NCT04581395|466871387|FG001|Overall Study|Protocol Violation|3|||
129702468|NCT04581395|466871388|FG002|Overall Study|Protocol Violation|2|||
129702469|NCT04581395|466871386|FG000|Overall Study|Physician Decision|0|||
129702470|NCT04581395|466871387|FG001|Overall Study|Physician Decision|1|||
129702471|NCT04581395|466871388|FG002|Overall Study|Physician Decision|0|||
129702472|NCT00815633|466871389|FG000|Overall Study|study terminated|1|||
129702473|NCT00721110|466871390|FG000|Overall Study|Ultram use|1|||
129702474|NCT00721110|466871391|FG001|Overall Study|Ultram use|0|||
129702475|NCT00721110|466871392|FG002|Overall Study|Ultram use|0|||
129702476|NCT00721110|466871393|FG003|Overall Study|Ultram use|0|||
129702477|NCT00721110|466871390|FG000|Overall Study|vertical incision|0|||
129702478|NCT00721110|466871391|FG001|Overall Study|vertical incision|0|||
129702479|NCT00721110|466871392|FG002|Overall Study|vertical incision|1|||
129622329|NCT03449446|466568911|FG002|Overall Study|Death|0|||
129622330|NCT03449446|466568912|FG003|Overall Study|Death|0|||
129622331|NCT03449446|466568913|FG004|Overall Study|Death|1|||
129622332|NCT03449446|466568914|FG005|Overall Study|Death|0|||
129622333|NCT03449446|466568915|FG006|Overall Study|Death|0|||
129622334|NCT01450683|466568936|FG000|Overall Study|Adverse Event|2|||
129622335|NCT02108912|466568938|FG000|Overall Study|Lost to Follow-up|1|||
129622336|NCT02108912|466568939|FG001|Overall Study|Lost to Follow-up|1|||
129622337|NCT02108912|466568938|FG000|Overall Study|lack of transportation|1|||
129622338|NCT02108912|466568939|FG001|Overall Study|lack of transportation|0|||
129622339|NCT02108912|466568938|FG000|Overall Study|high blood pressure|1|||
129622340|NCT02108912|466568939|FG001|Overall Study|high blood pressure|0|||
129622341|NCT01950390|466568947|FG000|Overall Study|Never started treatment|3|||
129622342|NCT01950390|466568948|FG001|Overall Study|Never started treatment|2|||
129622343|NCT01950390|466568947|FG000|Overall Study|Disease progression|45|||
129622344|NCT01950390|466568948|FG001|Overall Study|Disease progression|52|||
129622345|NCT01950390|466568947|FG000|Overall Study|Adverse Event|22|||
129622346|NCT01950390|466568948|FG001|Overall Study|Adverse Event|16|||
129622347|NCT01950390|466568947|FG000|Overall Study|Death|5|||
129622348|NCT01950390|466568948|FG001|Overall Study|Death|3|||
129622349|NCT01950390|466568947|FG000|Overall Study|Withdrawal by Subject|5|||
129622350|NCT01950390|466568948|FG001|Overall Study|Withdrawal by Subject|1|||
129622351|NCT01950390|466568947|FG000|Overall Study|Alternative therapy|0|||
129622352|NCT01950390|466568948|FG001|Overall Study|Alternative therapy|3|||
129622353|NCT01950390|466568947|FG000|Overall Study|Complicating disease|1|||
129622354|NCT01950390|466568948|FG001|Overall Study|Complicating disease|0|||
129622355|NCT01950390|466568947|FG000|Overall Study|On treatment|1|||
129622356|NCT01950390|466568948|FG001|Overall Study|On treatment|0|||
129622357|NCT01950390|466568947|FG000|Overall Study|Symptomatic deterioration|2|||
129622358|NCT01950390|466568948|FG001|Overall Study|Symptomatic deterioration|1|||
129622359|NCT01950390|466568947|FG000|Overall Study|Physician Decision|0|||
129622360|NCT01950390|466568948|FG001|Overall Study|Physician Decision|4|||
129622361|NCT01950390|466568947|FG000|Overall Study|Lack of clinical benefit|0|||
129622362|NCT01950390|466568948|FG001|Overall Study|Lack of clinical benefit|1|||
129622363|NCT01950390|466568947|FG000|Overall Study|Maintained PR and moved to observation only|0|||
129622364|NCT01950390|466568948|FG001|Overall Study|Maintained PR and moved to observation only|1|||
129622365|NCT01128179|466568949|FG000|Overall Study|Death|1|||
129622366|NCT01128179|466568950|FG001|Overall Study|Death|0|||
129622367|NCT01128179|466568949|FG000|Overall Study|Protocol Violation|1|||
129622368|NCT01128179|466568950|FG001|Overall Study|Protocol Violation|0|||
129622369|NCT01682811|466568951|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129622370|NCT01682811|466568952|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129622371|NCT01682811|466568953|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129622372|NCT01682811|466568954|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129622373|NCT01682811|466568955|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
129622374|NCT01682811|466568956|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129622375|NCT01682811|466568957|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
129622376|NCT01682811|466568951|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
129622377|NCT01682811|466568952|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
129622378|NCT01682811|466568953|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
129622379|NCT01682811|466568954|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
129622380|NCT01682811|466568955|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
129622381|NCT01682811|466568956|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
129622382|NCT01682811|466568957|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
129622383|NCT01682811|466568951|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
129622384|NCT01682811|466568952|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
129622385|NCT01682811|466568953|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
129622386|NCT01682811|466568954|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
129622387|NCT01682811|466568955|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
129622388|NCT01682811|466568956|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
129622389|NCT01682811|466568957|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
129622390|NCT01682811|466568951|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
129622391|NCT01682811|466568952|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
129622392|NCT01682811|466568953|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
129622393|NCT01682811|466568954|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
129622394|NCT01682811|466568955|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
129622395|NCT01682811|466568956|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
129622396|NCT01682811|466568957|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
129622397|NCT05192889|466568958|FG000|Block 1: All Eligible Patients|Death|2|||
129622398|NCT05192889|466568959|FG001|Block 1: All Eligible Patients|Death|0|||
129622399|NCT05192889|466568960|FG002|Block 1: All Eligible Patients|Death|0|||
129622400|NCT05192889|466568958|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
129622401|NCT05192889|466568959|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
129793379|NCT00645788|467210784|FG001|Overall Study|Withdrawal by Subject|1|||
129622402|NCT05192889|466568960|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
129622403|NCT05192889|466568958|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
129622404|NCT05192889|466568959|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
129622405|NCT05192889|466568960|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
129622406|NCT02731638|466571038|FG000|Overall Study|Lost to Follow-up|6|||
129622407|NCT02731638|466571039|FG001|Overall Study|Lost to Follow-up|9|||
129622408|NCT03284723|466571040|FG000|Overall Study|Death|0|||
129622409|NCT03284723|466571041|FG001|Overall Study|Death|0|||
129622410|NCT03284723|466571042|FG002|Overall Study|Death|0|||
129622411|NCT03284723|466571043|FG003|Overall Study|Death|1|||
129622412|NCT03284723|466571044|FG004|Overall Study|Death|0|||
129622413|NCT03284723|466571045|FG005|Overall Study|Death|0|||
129622414|NCT03284723|466571046|FG006|Overall Study|Death|1|||
129622415|NCT03284723|466571047|FG007|Overall Study|Death|0|||
129622416|NCT03284723|466571048|FG008|Overall Study|Death|0|||
129622417|NCT03284723|466571049|FG009|Overall Study|Death|2|||
129622418|NCT03284723|466571050|FG010|Overall Study|Death|1|||
129622419|NCT03284723|466571051|FG011|Overall Study|Death|0|||
129622420|NCT03284723|466571040|FG000|Overall Study|Lost to Follow-up|0|||
129622421|NCT03284723|466571041|FG001|Overall Study|Lost to Follow-up|0|||
129622422|NCT03284723|466571042|FG002|Overall Study|Lost to Follow-up|0|||
129622423|NCT03284723|466571043|FG003|Overall Study|Lost to Follow-up|0|||
129622424|NCT03284723|466571044|FG004|Overall Study|Lost to Follow-up|0|||
129622425|NCT03284723|466571045|FG005|Overall Study|Lost to Follow-up|2|||
129622426|NCT03284723|466571046|FG006|Overall Study|Lost to Follow-up|1|||
129622427|NCT03284723|466571047|FG007|Overall Study|Lost to Follow-up|0|||
129622428|NCT03284723|466571048|FG008|Overall Study|Lost to Follow-up|0|||
129622429|NCT03284723|466571049|FG009|Overall Study|Lost to Follow-up|2|||
129622430|NCT03284723|466571050|FG010|Overall Study|Lost to Follow-up|0|||
129622431|NCT03284723|466571051|FG011|Overall Study|Lost to Follow-up|0|||
129622432|NCT03284723|466571040|FG000|Overall Study|Study Terminated By Sponsor|0|||
129622433|NCT03284723|466571041|FG001|Overall Study|Study Terminated By Sponsor|0|||
129622434|NCT03284723|466571042|FG002|Overall Study|Study Terminated By Sponsor|0|||
129622435|NCT03284723|466571043|FG003|Overall Study|Study Terminated By Sponsor|0|||
129622436|NCT03284723|466571044|FG004|Overall Study|Study Terminated By Sponsor|1|||
129622437|NCT03284723|466571045|FG005|Overall Study|Study Terminated By Sponsor|0|||
129622438|NCT03284723|466571046|FG006|Overall Study|Study Terminated By Sponsor|0|||
129622439|NCT03284723|466571047|FG007|Overall Study|Study Terminated By Sponsor|0|||
129622440|NCT03284723|466571048|FG008|Overall Study|Study Terminated By Sponsor|1|||
129622441|NCT03284723|466571049|FG009|Overall Study|Study Terminated By Sponsor|1|||
129622442|NCT03284723|466571050|FG010|Overall Study|Study Terminated By Sponsor|1|||
129622443|NCT03284723|466571051|FG011|Overall Study|Study Terminated By Sponsor|1|||
129622444|NCT03284723|466571040|FG000|Overall Study|Withdrawal by Subject|0|||
129622445|NCT03284723|466571041|FG001|Overall Study|Withdrawal by Subject|0|||
129622446|NCT03284723|466571042|FG002|Overall Study|Withdrawal by Subject|0|||
129622447|NCT03284723|466571043|FG003|Overall Study|Withdrawal by Subject|0|||
129622448|NCT03284723|466571044|FG004|Overall Study|Withdrawal by Subject|5|||
129622449|NCT03284723|466571045|FG005|Overall Study|Withdrawal by Subject|3|||
129622450|NCT03284723|466571046|FG006|Overall Study|Withdrawal by Subject|1|||
129622451|NCT03284723|466571047|FG007|Overall Study|Withdrawal by Subject|0|||
129622452|NCT03284723|466571048|FG008|Overall Study|Withdrawal by Subject|6|||
129622453|NCT03284723|466571049|FG009|Overall Study|Withdrawal by Subject|0|||
129622454|NCT03284723|466571050|FG010|Overall Study|Withdrawal by Subject|3|||
129622455|NCT03284723|466571051|FG011|Overall Study|Withdrawal by Subject|1|||
129622456|NCT03284723|466571040|FG000|Overall Study|Other|1|||
129622457|NCT03284723|466571041|FG001|Overall Study|Other|0|||
129622458|NCT03284723|466571042|FG002|Overall Study|Other|1|||
129622459|NCT03284723|466571043|FG003|Overall Study|Other|0|||
129622460|NCT03284723|466571044|FG004|Overall Study|Other|1|||
129622461|NCT03284723|466571045|FG005|Overall Study|Other|0|||
129622462|NCT03284723|466571046|FG006|Overall Study|Other|0|||
129622463|NCT03284723|466571047|FG007|Overall Study|Other|0|||
129622464|NCT03284723|466571048|FG008|Overall Study|Other|0|||
129622465|NCT03284723|466571049|FG009|Overall Study|Other|0|||
129622466|NCT03284723|466571050|FG010|Overall Study|Other|1|||
129622467|NCT03284723|466571051|FG011|Overall Study|Other|0|||
129622468|NCT03284723|466571040|FG000|Overall Study|Adverse Event|0|||
129622469|NCT03284723|466571041|FG001|Overall Study|Adverse Event|0|||
129622470|NCT03284723|466571042|FG002|Overall Study|Adverse Event|0|||
129622471|NCT03284723|466571043|FG003|Overall Study|Adverse Event|0|||
129622472|NCT03284723|466571044|FG004|Overall Study|Adverse Event|0|||
129622473|NCT03284723|466571045|FG005|Overall Study|Adverse Event|0|||
129622474|NCT03284723|466571046|FG006|Overall Study|Adverse Event|0|||
129622475|NCT03284723|466571047|FG007|Overall Study|Adverse Event|0|||
129622476|NCT03284723|466571048|FG008|Overall Study|Adverse Event|1|||
129702480|NCT00721110|466871393|FG003|Overall Study|vertical incision|0|||
129702481|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
129622477|NCT03284723|466571049|FG009|Overall Study|Adverse Event|0|||
129622478|NCT03284723|466571050|FG010|Overall Study|Adverse Event|0|||
129622479|NCT03284723|466571051|FG011|Overall Study|Adverse Event|0|||
129622480|NCT00615199|466571052|FG000|Overall Study|Adverse Event|3|||
129622481|NCT00615199|466571053|FG001|Overall Study|Adverse Event|1|||
129622482|NCT00615199|466571054|FG002|Overall Study|Adverse Event|1|||
129622483|NCT00615199|466571055|FG003|Overall Study|Adverse Event|0|||
129622484|NCT00615199|466571052|FG000|Overall Study|Lack of Efficacy|2|||
129622485|NCT00615199|466571053|FG001|Overall Study|Lack of Efficacy|0|||
129622486|NCT00615199|466571054|FG002|Overall Study|Lack of Efficacy|0|||
129622487|NCT00615199|466571055|FG003|Overall Study|Lack of Efficacy|1|||
129888326|NCT02718417|467549132|FG000|Follow-up Phase|Adverse Event|3|||
129888327|NCT02718417|467549133|FG001|Follow-up Phase|Adverse Event|1|||
129888328|NCT02718417|467549134|FG002|Follow-up Phase|Adverse Event|1|||
129888329|NCT02718417|467549132|FG000|Follow-up Phase|Other|4|||
129888330|NCT02718417|467549133|FG001|Follow-up Phase|Other|6|||
129888331|NCT02718417|467549134|FG002|Follow-up Phase|Other|4|||
129622488|NCT00615199|466571052|FG000|Overall Study|Lost to Follow-up|1|||
129622489|NCT00615199|466571053|FG001|Overall Study|Lost to Follow-up|0|||
129622490|NCT00615199|466571054|FG002|Overall Study|Lost to Follow-up|0|||
129622491|NCT00615199|466571055|FG003|Overall Study|Lost to Follow-up|0|||
129622492|NCT00615199|466571052|FG000|Overall Study|Other|0|||
129622493|NCT00615199|466571053|FG001|Overall Study|Other|0|||
129622494|NCT00615199|466571054|FG002|Overall Study|Other|0|||
129622495|NCT00615199|466571055|FG003|Overall Study|Other|1|||
129622496|NCT00615199|466571052|FG000|Overall Study|Withdrawal by Subject|2|||
129622497|NCT00615199|466571053|FG001|Overall Study|Withdrawal by Subject|1|||
129622498|NCT00615199|466571054|FG002|Overall Study|Withdrawal by Subject|0|||
129622499|NCT00615199|466571055|FG003|Overall Study|Withdrawal by Subject|0|||
129622500|NCT01499095|466571056|FG000|Overall Study|Randomized But Not Treated|1|||
129622501|NCT01499095|466571057|FG001|Overall Study|Randomized But Not Treated|1|||
129622502|NCT01499095|466571056|FG000|Overall Study|Adverse Event|12|||
129622503|NCT01499095|466571057|FG001|Overall Study|Adverse Event|7|||
129622504|NCT01499095|466571056|FG000|Overall Study|Lack of Efficacy|2|||
129622505|NCT01499095|466571057|FG001|Overall Study|Lack of Efficacy|1|||
129622506|NCT01499095|466571056|FG000|Overall Study|Protocol Violation|6|||
129622507|NCT01499095|466571057|FG001|Overall Study|Protocol Violation|7|||
129622508|NCT01499095|466571056|FG000|Overall Study|Received Rescue Therapy|32|||
129647591|NCT01384019|466665356|FG000|Overall Study|Death|1|||
129647592|NCT01384019|466665357|FG001|Overall Study|Death|0|||
129647593|NCT01384019|466665356|FG000|Overall Study|MRI refusal|6|||
129647594|NCT01384019|466665357|FG001|Overall Study|MRI refusal|6|||
129647595|NCT00767039|466665360|FG000|Overall Study|Death|5|||
129647596|NCT00767039|466665361|FG001|Overall Study|Death|2|||
129647597|NCT01826370|466665362|FG000|Overall Study|Protocol Violation|6|||
129647598|NCT01826370|466665362|FG000|Overall Study|Lost to Follow-up|12|||
129647599|NCT01826370|466665362|FG000|Overall Study|Other reason not defined above|2|||
129647600|NCT04416737|466665364|FG000|Week 1 (First Injection)|Physician Decision|0|||
129647601|NCT04416737|466665365|FG001|Week 1 (First Injection)|Physician Decision|1|||
129647602|NCT03332628|466665366|FG000|Overall Study|Physician Decision|2|||
129647603|NCT01472757|466665367|FG000|Overall Study|Withdrawal by Subject|1|||
129647604|NCT01472757|466665368|FG001|Overall Study|Withdrawal by Subject|2|||
129647605|NCT01472757|466665369|FG002|Overall Study|Withdrawal by Subject|2|||
129647606|NCT01472757|466665370|FG003|Overall Study|Withdrawal by Subject|0|||
129647607|NCT01472757|466665367|FG000|Overall Study|Asthma exacerbation|4|||
129647608|NCT01472757|466665368|FG001|Overall Study|Asthma exacerbation|1|||
129647609|NCT01472757|466665369|FG002|Overall Study|Asthma exacerbation|2|||
129647610|NCT01472757|466665370|FG003|Overall Study|Asthma exacerbation|1|||
129647611|NCT01472757|466665367|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
129647612|NCT01472757|466665368|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
129647613|NCT01472757|466665369|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
129647614|NCT01472757|466665370|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
129647615|NCT01472757|466665367|FG000|Overall Study|Protocol Violation|3|||
129647616|NCT01472757|466665368|FG001|Overall Study|Protocol Violation|2|||
129647617|NCT01472757|466665369|FG002|Overall Study|Protocol Violation|4|||
129647618|NCT01472757|466665370|FG003|Overall Study|Protocol Violation|4|||
129647619|NCT01472757|466665367|FG000|Overall Study|Other reasons|1|||
129647620|NCT01472757|466665368|FG001|Overall Study|Other reasons|0|||
129647621|NCT01472757|466665369|FG002|Overall Study|Other reasons|2|||
129647622|NCT01472757|466665370|FG003|Overall Study|Other reasons|2|||
129647623|NCT04489381|466665375|FG000|Overall Study|Lost to Follow-up|2|||
129647624|NCT04489381|466665376|FG001|Overall Study|Lost to Follow-up|3|||
129647625|NCT04489381|466665375|FG000|Overall Study|Withdrawal by Subject|1|||
129647626|NCT04489381|466665376|FG001|Overall Study|Withdrawal by Subject|0|||
129647627|NCT01259375|466665382|FG000|Overall Study|Adverse Event|1|||
129647628|NCT00478699|466665385|FG000|Overall Study|Inclusion Error|1|||
129647629|NCT00478699|466665386|FG001|Overall Study|Inclusion Error|7|||
129647630|NCT00478699|466665385|FG000|Overall Study|Not receive study treatment|6|||
129647631|NCT00478699|466665386|FG001|Overall Study|Not receive study treatment|30|||
129647632|NCT01043705|466665391|FG000|Overall Study|Death|28|||
129647633|NCT01043705|466665392|FG001|Overall Study|Death|60|||
129647634|NCT01043705|466665393|FG002|Overall Study|Death|26|||
129647635|NCT01043705|466665391|FG000|Overall Study|Lost to Follow-up|27|||
129647636|NCT01043705|466665392|FG001|Overall Study|Lost to Follow-up|12|||
129647637|NCT01043705|466665393|FG002|Overall Study|Lost to Follow-up|0|||
129647638|NCT01043705|466665391|FG000|Overall Study|Multiple Reasons|4|||
129647639|NCT01043705|466665392|FG001|Overall Study|Multiple Reasons|7|||
129647640|NCT01043705|466665393|FG002|Overall Study|Multiple Reasons|0|||
129647641|NCT01043705|466665391|FG000|Overall Study|Protocol Violation|2|||
129888332|NCT02718417|467549132|FG000|Follow-up Phase|Withdrawal by Subject|19|||
129622509|NCT01499095|466571057|FG001|Overall Study|Received Rescue Therapy|40|||
129622510|NCT01499095|466571056|FG000|Overall Study|Diverse Reasons|22|||
129622511|NCT01499095|466571057|FG001|Overall Study|Diverse Reasons|25|||
129622512|NCT01499095|466571056|FG000|Overall Study|Lost to Follow-up|6|||
129622513|NCT01499095|466571057|FG001|Overall Study|Lost to Follow-up|4|||
129622514|NCT01499095|466571056|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
129622515|NCT01499095|466571057|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
129622516|NCT01499095|466571056|FG000|Overall Study|Hypoglycemia|3|||
129622517|NCT01499095|466571057|FG001|Overall Study|Hypoglycemia|1|||
129622518|NCT01499095|466571056|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
129622519|NCT01499095|466571057|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
129622520|NCT01499095|466571056|FG000|Overall Study|Change in Injection Schedule|2|||
129622521|NCT01499095|466571057|FG001|Overall Study|Change in Injection Schedule|0|||
129622522|NCT01499095|466571056|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129622523|NCT01499095|466571057|FG001|Overall Study|Perceived Lack of Efficacy|1|||
129622524|NCT02121652|466571062|FG000|Overall Study|Lost to Follow-up|2|||
129622525|NCT02121652|466571063|FG001|Overall Study|Lost to Follow-up|1|||
129622526|NCT02121652|466571062|FG000|Overall Study|Death|1|||
129622527|NCT02121652|466571063|FG001|Overall Study|Death|0|||
129622528|NCT02121652|466571062|FG000|Overall Study|Withdrawal by Subject|3|||
129622529|NCT02121652|466571063|FG001|Overall Study|Withdrawal by Subject|3|||
129622530|NCT01811472|466571064|FG000|Overall Study|Adverse Event|1|||
129622531|NCT01811472|466571065|FG001|Overall Study|Adverse Event|0|||
129622532|NCT01811472|466571066|FG002|Overall Study|Adverse Event|4|||
129622533|NCT01811472|466571064|FG000|Overall Study|Lost to Follow-up|0|||
129622534|NCT01811472|466571065|FG001|Overall Study|Lost to Follow-up|0|||
129622535|NCT01811472|466571066|FG002|Overall Study|Lost to Follow-up|1|||
129622536|NCT01811472|466571064|FG000|Overall Study|Subject/guardian decision|1|||
129622537|NCT01811472|466571065|FG001|Overall Study|Subject/guardian decision|0|||
129622538|NCT01811472|466571066|FG002|Overall Study|Subject/guardian decision|0|||
129622539|NCT03280264|466571067|FG000|Overall Study|Adverse Event|1|||
129888333|NCT02718417|467549133|FG001|Follow-up Phase|Withdrawal by Subject|17|||
129888334|NCT02718417|467549134|FG002|Follow-up Phase|Withdrawal by Subject|5|||
129888335|NCT02718417|467549132|FG000|Follow-up Phase|Study terminated by sponsor|100|||
129888336|NCT02718417|467549133|FG001|Follow-up Phase|Study terminated by sponsor|138|||
129888337|NCT02718417|467549134|FG002|Follow-up Phase|Study terminated by sponsor|6|||
129888338|NCT02718417|467549132|FG000|Follow-up Phase|Lost to Follow-up|2|||
129888339|NCT02718417|467549133|FG001|Follow-up Phase|Lost to Follow-up|3|||
129888340|NCT02718417|467549134|FG002|Follow-up Phase|Lost to Follow-up|0|||
129888341|NCT02718417|467549132|FG000|Follow-up Phase|Death leading to discontinuation|7|||
129888342|NCT02718417|467549133|FG001|Follow-up Phase|Death leading to discontinuation|7|||
129888343|NCT02718417|467549134|FG002|Follow-up Phase|Death leading to discontinuation|3|||
129888344|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
129888345|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
129888346|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
129888347|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
129622540|NCT03280264|466571067|FG000|Overall Study|Physician Decision|1|||
129622541|NCT03280264|466571067|FG000|Overall Study|Withdrawal by Subject|1|||
129622542|NCT02738138|466571068|FG000|Overall Study|Adverse Event|0|||
129622543|NCT02738138|466571069|FG001|Overall Study|Adverse Event|1|||
129622544|NCT02738138|466571068|FG000|Overall Study|Lost to Follow-up|2|||
129622545|NCT02738138|466571069|FG001|Overall Study|Lost to Follow-up|0|||
129622546|NCT02738138|466571068|FG000|Overall Study|Other - not further specified|1|||
129622547|NCT02738138|466571069|FG001|Overall Study|Other - not further specified|0|||
129622548|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Other|34|||
129622549|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Other|0|||
129622550|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Other|0|||
129622551|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Other|0|||
129622552|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Death|14|||
129622553|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Death|0|||
129622554|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Death|0|||
129622555|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Death|0|||
129622556|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
129622557|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
129622558|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
129622559|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
129622560|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
129622561|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
129622562|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
129622563|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
129622564|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
129622565|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
129622566|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
129622567|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
129622568|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
129622569|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
129622570|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
129622571|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
129622572|NCT01995513|466571075|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
129622573|NCT01995513|466571076|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
129622574|NCT01995513|466571077|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
129622575|NCT01995513|466571078|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
129622576|NCT01995513|466571075|FG000|Period 1: Second Open Label Treatment|Other|0|||
129622577|NCT01995513|466571076|FG001|Period 1: Second Open Label Treatment|Other|2|||
129622578|NCT01995513|466571077|FG002|Period 1: Second Open Label Treatment|Other|0|||
129622579|NCT01995513|466571078|FG003|Period 1: Second Open Label Treatment|Other|0|||
129622580|NCT01995513|466571075|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
129622581|NCT01995513|466571076|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
129622582|NCT01995513|466571077|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
129622583|NCT01995513|466571078|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
129622584|NCT01995513|466571075|FG000|Period 2: Double Blind Treatment|Death|0|||
129622585|NCT01995513|466571076|FG001|Period 2: Double Blind Treatment|Death|0|||
129622586|NCT01995513|466571077|FG002|Period 2: Double Blind Treatment|Death|0|||
129622587|NCT01995513|466571078|FG003|Period 2: Double Blind Treatment|Death|1|||
129622588|NCT01995513|466571075|FG000|Period 2: Double Blind Treatment|Other|0|||
129622589|NCT01995513|466571076|FG001|Period 2: Double Blind Treatment|Other|0|||
129622590|NCT01995513|466571077|FG002|Period 2: Double Blind Treatment|Other|3|||
129622591|NCT01995513|466571078|FG003|Period 2: Double Blind Treatment|Other|3|||
129622592|NCT01995513|466571075|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
129622593|NCT01995513|466571076|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
129622594|NCT01995513|466571077|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
129622595|NCT01995513|466571078|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
129622596|NCT01995513|466571075|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
129622597|NCT01995513|466571076|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
129622598|NCT01995513|466571077|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
129622599|NCT01995513|466571078|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
129622600|NCT01995513|466571075|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
129622601|NCT01995513|466571076|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
129622602|NCT01995513|466571077|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
129622603|NCT01995513|466571078|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
129622604|NCT01995513|466571075|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
129622605|NCT01995513|466571076|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
129622606|NCT01995513|466571077|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
129622607|NCT01995513|466571078|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
129622608|NCT01232452|466571080|FG000|Overall Study|Adverse Event|17|||
129622609|NCT01232452|466571081|FG001|Overall Study|Adverse Event|15|||
129622610|NCT01232452|466571080|FG000|Overall Study|Withdrawal by Subject|11|||
129622611|NCT01232452|466571081|FG001|Overall Study|Withdrawal by Subject|8|||
129622612|NCT01232452|466571080|FG000|Overall Study|Physician Decision|8|||
129622613|NCT01232452|466571081|FG001|Overall Study|Physician Decision|12|||
129622614|NCT01232452|466571080|FG000|Overall Study|Protocol entry criterion not met|0|||
129622615|NCT01232452|466571081|FG001|Overall Study|Protocol entry criterion not met|2|||
129622616|NCT01232452|466571080|FG000|Overall Study|Sponsor Decision|3|||
129622617|NCT01232452|466571081|FG001|Overall Study|Sponsor Decision|1|||
129622618|NCT01232452|466571080|FG000|Overall Study|Protocol Violation|0|||
129622619|NCT01232452|466571081|FG001|Overall Study|Protocol Violation|1|||
129622620|NCT04108299|466571082|FG000|Overall Study|Not interested in participating|2|||
129622621|NCT04108299|466571083|FG001|Overall Study|Not interested in participating|1|||
129622622|NCT04108299|466571084|FG002|Overall Study|Not interested in participating|2|||
129622623|NCT04108299|466571085|FG003|Overall Study|Not interested in participating|1|||
129622624|NCT05024747|466571086|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
129622625|NCT05024747|466571087|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
129622626|NCT05024747|466571086|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
129622627|NCT05024747|466571087|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
129622628|NCT05024747|466571086|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
129622629|NCT05024747|466571087|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
129622630|NCT00247676|466571088|FG000|Overall Study|Death|5|||
129622631|NCT00247676|466571088|FG000|Overall Study|Adverse Event|11|||
129622632|NCT00247676|466571088|FG000|Overall Study|Lack of Efficacy|15|||
129622633|NCT00247676|466571088|FG000|Overall Study|Other|3|||
129622634|NCT00247676|466571088|FG000|Overall Study|Withdrawal by Subject|2|||
129622635|NCT00662649|466571089|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
129622636|NCT00662649|466571090|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
129622637|NCT00662649|466571091|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
129622638|NCT00662649|466571092|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
129622639|NCT00662649|466571093|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
129622640|NCT00662649|466571089|FG000|Core Study (24 Months)|Adverse Event|22|||
129622641|NCT00662649|466571090|FG001|Core Study (24 Months)|Adverse Event|13|||
129622642|NCT00662649|466571091|FG002|Core Study (24 Months)|Adverse Event|18|||
129622643|NCT00662649|466571092|FG003|Core Study (24 Months)|Adverse Event|0|||
129622644|NCT00662649|466571093|FG004|Core Study (24 Months)|Adverse Event|0|||
129622645|NCT00662649|466571089|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
129622646|NCT00662649|466571090|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
129622647|NCT00662649|466571091|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
129793380|NCT00645788|467210785|FG002|Overall Study|Withdrawal by Subject|0|||
129622648|NCT00662649|466571092|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
129622649|NCT00662649|466571093|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
129622650|NCT00662649|466571089|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
129622651|NCT00662649|466571090|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
129622652|NCT00662649|466571091|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
129622653|NCT00662649|466571092|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
129622654|NCT00662649|466571093|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
129622655|NCT00662649|466571089|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
129622656|NCT00662649|466571090|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
129622657|NCT00662649|466571091|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
129622658|NCT00662649|466571092|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
129622659|NCT00662649|466571093|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
129622660|NCT00662649|466571089|FG000|Core Study (24 Months)|Protocol Violation|5|||
129622661|NCT00662649|466571090|FG001|Core Study (24 Months)|Protocol Violation|5|||
129622662|NCT00662649|466571091|FG002|Core Study (24 Months)|Protocol Violation|4|||
129622663|NCT00662649|466571092|FG003|Core Study (24 Months)|Protocol Violation|0|||
129622664|NCT00662649|466571093|FG004|Core Study (24 Months)|Protocol Violation|0|||
129622665|NCT00662649|466571089|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
129622666|NCT00662649|466571090|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
129622667|NCT00662649|466571091|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
129622668|NCT00662649|466571092|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
129622669|NCT00662649|466571093|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
129622670|NCT00662649|466571089|FG000|Core Study (24 Months)|Death|1|||
129622671|NCT00662649|466571090|FG001|Core Study (24 Months)|Death|0|||
129622672|NCT00662649|466571091|FG002|Core Study (24 Months)|Death|2|||
129622673|NCT00662649|466571092|FG003|Core Study (24 Months)|Death|0|||
129622674|NCT00662649|466571093|FG004|Core Study (24 Months)|Death|0|||
129793381|NCT00645788|467210786|FG003|Overall Study|Withdrawal by Subject|2|||
129793382|NCT00645788|467210783|FG000|Overall Study|Pulmonary exacerbation|13|||
129793383|NCT00645788|467210784|FG001|Overall Study|Pulmonary exacerbation|16|||
129793384|NCT00645788|467210785|FG002|Overall Study|Pulmonary exacerbation|11|||
129793385|NCT00645788|467210786|FG003|Overall Study|Pulmonary exacerbation|9|||
129793386|NCT00459979|467210788|FG000|Overall Study|Withdrawal by Subject|1|||
129793387|NCT00459979|467210788|FG000|Overall Study|Protocol Violation|1|||
129793388|NCT00570232|467210789|FG000|Overall Study|Adverse Event|10|||
129793389|NCT00570232|467210789|FG000|Overall Study|discontinued due to medical condition|3|||
129793390|NCT00570232|467210789|FG000|Overall Study|discontinued due to recurrence|8|||
129793391|NCT00570232|467210789|FG000|Overall Study|discontinued due to noncompliance|2|||
129793392|NCT02207946|467210793|FG000|Overall Study|Lost to Follow-up|1|||
129793393|NCT02207946|467210794|FG001|Overall Study|Lost to Follow-up|0|||
129793394|NCT02207946|467210793|FG000|Overall Study|Adverse Event|0|||
129793395|NCT02207946|467210794|FG001|Overall Study|Adverse Event|1|||
129793396|NCT02361346|467210806|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
129622675|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
129622676|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
129622677|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
129622678|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
129622679|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
129622680|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
129622681|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
129622682|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
129622683|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
129793397|NCT02361346|467210807|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793398|NCT02361346|467210808|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793399|NCT02361346|467210809|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
129793400|NCT02361346|467210810|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
129622684|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
129622685|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
129622686|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
129622687|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
129622688|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
129622689|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
129622690|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
129622691|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
129622692|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
129622693|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
129622694|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
129622695|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
129622696|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
129622697|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
129622698|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
129622699|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
129622700|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
129622701|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
129622702|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
129622703|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
129622704|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
129622705|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
129622706|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
129622707|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
129622708|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
129622709|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
129622710|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129622711|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
129622712|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129622713|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129647642|NCT01043705|466665392|FG001|Overall Study|Protocol Violation|1|||
129647643|NCT01043705|466665393|FG002|Overall Study|Protocol Violation|0|||
129647644|NCT01043705|466665391|FG000|Overall Study|Withdrawal by Subject|8|||
129647645|NCT01043705|466665392|FG001|Overall Study|Withdrawal by Subject|6|||
129647646|NCT01043705|466665393|FG002|Overall Study|Withdrawal by Subject|0|||
129647647|NCT01043705|466665391|FG000|Overall Study|Site Closure|8|||
129647648|NCT01043705|466665392|FG001|Overall Study|Site Closure|0|||
129647649|NCT01043705|466665393|FG002|Overall Study|Site Closure|0|||
129647650|NCT01043705|466665391|FG000|Overall Study|Subsequent Procedure|9|||
129647651|NCT01043705|466665392|FG001|Overall Study|Subsequent Procedure|24|||
129647652|NCT01043705|466665393|FG002|Overall Study|Subsequent Procedure|29|||
129647653|NCT01043705|466665391|FG000|Overall Study|Adverse Event|0|||
129647654|NCT01043705|466665392|FG001|Overall Study|Adverse Event|2|||
129647655|NCT01043705|466665393|FG002|Overall Study|Adverse Event|0|||
129647656|NCT01043705|466665391|FG000|Overall Study|Screen Fail|21|||
129647657|NCT01043705|466665392|FG001|Overall Study|Screen Fail|0|||
129647658|NCT01043705|466665393|FG002|Overall Study|Screen Fail|0|||
129647659|NCT01043705|466665391|FG000|Overall Study|Other|0|||
129647660|NCT01043705|466665392|FG001|Overall Study|Other|19|||
129647661|NCT01043705|466665393|FG002|Overall Study|Other|25|||
129647662|NCT01123941|466665396|FG000|Overall Study|Lost to Follow-up|2|||
129647663|NCT01123941|466665397|FG001|Overall Study|Lost to Follow-up|1|||
129647664|NCT04601103|466665398|FG000|Overall Study|Needed crown & cleaning|0|||
129647665|NCT04601103|466665399|FG001|Overall Study|Needed crown & cleaning|0|||
129647666|NCT04601103|466665400|FG002|Overall Study|Needed crown & cleaning|1|||
129647667|NCT04601103|466665398|FG000|Overall Study|study was terminated|18|||
129647668|NCT04601103|466665399|FG001|Overall Study|study was terminated|18|||
129647669|NCT04601103|466665400|FG002|Overall Study|study was terminated|16|||
129647670|NCT06011161|466665401|FG000|Overall Study|Withdrawal by Subject|2|||
129647671|NCT06011161|466665401|FG000|Overall Study|Lost to Follow-up|5|||
129647672|NCT00381043|466665402|FG000|Overall Study|Lost to Follow-up|8|||
129647673|NCT00381043|466665403|FG001|Overall Study|Lost to Follow-up|6|||
129647674|NCT00381043|466665402|FG000|Overall Study|Withdrawal by Subject|3|||
129647675|NCT00381043|466665403|FG001|Overall Study|Withdrawal by Subject|1|||
129647676|NCT00381043|466665402|FG000|Overall Study|wanted more care|0|||
129647677|NCT00381043|466665403|FG001|Overall Study|wanted more care|1|||
129622714|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
129622715|NCT00662649|466571089|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
129622716|NCT00662649|466571090|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
129622717|NCT00662649|466571091|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
129622718|NCT00662649|466571092|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
129622719|NCT00662649|466571093|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
129622720|NCT02009722|466571100|FG000|Overall Study|Protocol Violation|1|||
129622721|NCT02009722|466571101|FG001|Overall Study|Protocol Violation|2|||
129439457|NCT01723254|465906507|FG000|Overall Study|No longer have time to participate|0|||
129622722|NCT02009722|466571100|FG000|Overall Study|Did not receive intervention|0|||
129622723|NCT02009722|466571101|FG001|Overall Study|Did not receive intervention|1|||
129622724|NCT02955212|466571102|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
129622725|NCT02955212|466571103|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
129622726|NCT02955212|466571102|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
129622727|NCT02955212|466571103|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
129622728|NCT02955212|466571102|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
129622729|NCT02955212|466571103|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
129622730|NCT02955212|466571102|FG000|Period 1: Double-blind Treatment Period|Other|3|||
129622731|NCT02955212|466571103|FG001|Period 1: Double-blind Treatment Period|Other|2|||
129622732|NCT02955212|466571102|FG000|Period 2: Open-label Extension|Adverse Event|11|||
129622733|NCT02955212|466571103|FG001|Period 2: Open-label Extension|Adverse Event|7|||
129622734|NCT02955212|466571102|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
129622735|NCT02955212|466571103|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
129622736|NCT02955212|466571102|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
129622737|NCT02955212|466571103|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
129622738|NCT02955212|466571102|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
129622739|NCT02955212|466571103|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
129622740|NCT02955212|466571102|FG000|Period 2: Open-label Extension|Other|2|||
129622741|NCT02955212|466571103|FG001|Period 2: Open-label Extension|Other|4|||
129622742|NCT00545714|466571106|FG000|Induction Phase (6 Months)|Physician Decision|3|||
129622743|NCT00545714|466571106|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
129622744|NCT00545714|466571106|FG000|Induction Phase (6 Months)|Disease Progression|1|||
129622745|NCT00545714|466571106|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
129622746|NCT00545714|466571106|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
129622747|NCT00545714|466571106|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
129622748|NCT00545714|466571106|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
129622749|NCT00545714|466571106|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
129622750|NCT00545714|466571106|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
129622751|NCT00545714|466571106|FG000|Maintenance Phase (36 Months)|Death|2|||
129622752|NCT04428034|466571111|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
129622753|NCT00560391|466571114|FG000|Overall Study|Still on treatment|0|||
129622754|NCT00560391|466571115|FG001|Overall Study|Still on treatment|0|||
129622755|NCT00560391|466571116|FG002|Overall Study|Still on treatment|0|||
129622756|NCT00560391|466571117|FG003|Overall Study|Still on treatment|1|||
129622757|NCT00560391|466571118|FG004|Overall Study|Still on treatment|2|||
129622758|NCT02556801|466571119|FG000|Overall Study|Lost to Follow-up|1|||
129622759|NCT02556801|466571120|FG001|Overall Study|Lost to Follow-up|0|||
129622760|NCT02556801|466571121|FG002|Overall Study|Lost to Follow-up|2|||
129622761|NCT02556801|466571122|FG003|Overall Study|Lost to Follow-up|0|||
129622762|NCT02556801|466571119|FG000|Overall Study|Withdrawal by Subject|1|||
129622763|NCT02556801|466571120|FG001|Overall Study|Withdrawal by Subject|1|||
129622764|NCT02556801|466571121|FG002|Overall Study|Withdrawal by Subject|1|||
129622765|NCT02556801|466571122|FG003|Overall Study|Withdrawal by Subject|0|||
129622766|NCT02556801|466571119|FG000|Overall Study|Protocol Violation|0|||
129702482|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129702483|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129702484|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129439458|NCT01723254|465906508|FG001|Overall Study|No longer have time to participate|0|||
129622767|NCT02556801|466571120|FG001|Overall Study|Protocol Violation|3|||
129622768|NCT02556801|466571121|FG002|Overall Study|Protocol Violation|1|||
129622769|NCT02556801|466571122|FG003|Overall Study|Protocol Violation|1|||
129622770|NCT02556801|466571119|FG000|Overall Study|Adverse Event|0|||
129622771|NCT02556801|466571120|FG001|Overall Study|Adverse Event|2|||
129622772|NCT02556801|466571121|FG002|Overall Study|Adverse Event|0|||
129622773|NCT02556801|466571122|FG003|Overall Study|Adverse Event|3|||
129622774|NCT02556801|466571119|FG000|Overall Study|Pregnancy|0|||
129622775|NCT02556801|466571120|FG001|Overall Study|Pregnancy|1|||
129622776|NCT02556801|466571121|FG002|Overall Study|Pregnancy|0|||
129622777|NCT02556801|466571122|FG003|Overall Study|Pregnancy|0|||
129622778|NCT02556801|466571119|FG000|Overall Study|Personal reasons patient|0|||
129622779|NCT02556801|466571120|FG001|Overall Study|Personal reasons patient|0|||
129622780|NCT02556801|466571121|FG002|Overall Study|Personal reasons patient|0|||
129622781|NCT02556801|466571122|FG003|Overall Study|Personal reasons patient|1|||
129622782|NCT02071225|466571123|FG000|Overall Study|Withdrawal of Consent|2|||
129622783|NCT02071225|466571123|FG000|Overall Study|Protocol Deviation|1|||
129622784|NCT02071225|466571123|FG000|Overall Study|Lost to Follow-up|2|||
129622785|NCT02071225|466571123|FG000|Overall Study|Death|25|||
129622786|NCT02064296|466571124|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
129622787|NCT02064296|466571125|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
129622788|NCT02064296|466571126|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
129622789|NCT02064296|466571124|FG000|Intervention|Withdrawal by Subject|0|||
129622790|NCT02064296|466571125|FG001|Intervention|Withdrawal by Subject|1|||
129622791|NCT02064296|466571126|FG002|Intervention|Withdrawal by Subject|2|||
129622792|NCT03519087|466571131|FG000|Clinic Evaluation|Physician Decision|15|||
129622793|NCT03519087|466571132|FG001|Clinic Evaluation|Physician Decision|18|||
129622794|NCT03519087|466571133|FG002|Clinic Evaluation|Physician Decision|0|||
129622795|NCT03519087|466571134|FG003|Clinic Evaluation|Physician Decision|0|||
129622796|NCT03519087|466571135|FG004|Clinic Evaluation|Physician Decision|0|||
129622797|NCT03519087|466571131|FG000|Clinic Evaluation|Protocol Violation|1|||
129622798|NCT03519087|466571132|FG001|Clinic Evaluation|Protocol Violation|0|||
129622799|NCT03519087|466571133|FG002|Clinic Evaluation|Protocol Violation|0|||
129622800|NCT03519087|466571134|FG003|Clinic Evaluation|Protocol Violation|0|||
129622801|NCT03519087|466571135|FG004|Clinic Evaluation|Protocol Violation|0|||
129622802|NCT03519087|466571131|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
129622803|NCT03519087|466571132|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
129622804|NCT03519087|466571133|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
129622805|NCT03519087|466571134|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
129622806|NCT03519087|466571135|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
129622807|NCT03519087|466571131|FG000|Re-randomization for Treatment|Not appropriate|2|||
129622808|NCT03519087|466571132|FG001|Re-randomization for Treatment|Not appropriate|3|||
129622809|NCT03519087|466571133|FG002|Re-randomization for Treatment|Not appropriate|0|||
129888348|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
129622810|NCT03519087|466571134|FG003|Re-randomization for Treatment|Not appropriate|0|||
129622811|NCT03519087|466571135|FG004|Re-randomization for Treatment|Not appropriate|0|||
129622812|NCT03519087|466571131|FG000|Laboratory Testing|Lost to Follow-up|0|||
129622813|NCT03519087|466571132|FG001|Laboratory Testing|Lost to Follow-up|0|||
129622814|NCT03519087|466571133|FG002|Laboratory Testing|Lost to Follow-up|2|||
129622815|NCT03519087|466571134|FG003|Laboratory Testing|Lost to Follow-up|3|||
129622816|NCT03519087|466571135|FG004|Laboratory Testing|Lost to Follow-up|6|||
129622817|NCT03519087|466571131|FG000|Laboratory Testing|Protocol Violation|0|||
129622818|NCT03519087|466571132|FG001|Laboratory Testing|Protocol Violation|0|||
129622819|NCT03519087|466571133|FG002|Laboratory Testing|Protocol Violation|0|||
129622820|NCT03519087|466571134|FG003|Laboratory Testing|Protocol Violation|1|||
129622821|NCT03519087|466571135|FG004|Laboratory Testing|Protocol Violation|0|||
129622822|NCT01137071|466571136|FG000|Overall Study|Disease Progression|11|||
129622823|NCT01137071|466571136|FG000|Overall Study|Withdrawal by Subject|2|||
129622824|NCT01137071|466571136|FG000|Overall Study|Wrongly Included|1|||
129622825|NCT02324582|466571137|FG000|Overall Study|Screen Failures|0|||
129622826|NCT02324582|466571138|FG001|Overall Study|Screen Failures|5|||
129622827|NCT04388553|466571141|FG000|Overall Study|Protocol Violation|1|||
129622828|NCT04388553|466571142|FG001|Overall Study|Protocol Violation|0|||
129622829|NCT02123446|466571143|FG000|Washout Period (1 Day)|Physician Decision|1|||
129622830|NCT02123446|466571144|FG001|Washout Period (1 Day)|Physician Decision|0|||
129622831|NCT04604795|466571145|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
129622832|NCT04604795|466571146|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
129622833|NCT04604795|466571147|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129622834|NCT04604795|466571148|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129622835|NCT04604795|466571149|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129622836|NCT04604795|466571150|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129622837|NCT04604795|466571151|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129888349|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
129702485|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129702486|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129702487|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
129702488|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
129702489|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
129702490|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
129702491|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
129702492|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
129702493|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
129702494|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
129702495|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
129702496|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
129702497|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
129702498|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
129702499|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
129702500|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
129702501|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
129702502|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
129702503|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
129702504|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
129702505|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
129702506|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
129702507|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
129702508|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
129702509|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
129702510|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
129702511|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
129702512|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
129702513|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
129702514|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
129702515|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
129702516|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
129702517|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
129702518|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
129702519|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
129702520|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
129702521|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
129702522|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
129702523|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
129702524|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129702525|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129702526|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129702527|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129702528|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129702529|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
129702530|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129702531|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
129702532|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129702533|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129702534|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129702535|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129702536|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
129702537|NCT01362790|466871394|FG000|Pilot Phase & Phase 2|Death on study|0|||
129702538|NCT01362790|466871395|FG001|Pilot Phase & Phase 2|Death on study|0|||
129702539|NCT01362790|466871396|FG002|Pilot Phase & Phase 2|Death on study|0|||
129702540|NCT01362790|466871397|FG003|Pilot Phase & Phase 2|Death on study|1|||
129702541|NCT01362790|466871398|FG004|Pilot Phase & Phase 2|Death on study|0|||
129702542|NCT01362790|466871399|FG005|Pilot Phase & Phase 2|Death on study|0|||
129702543|NCT01362790|466871400|FG006|Pilot Phase & Phase 2|Death on study|0|||
129702544|NCT01362790|466871394|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
129702545|NCT01362790|466871395|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
129702546|NCT01362790|466871396|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
129702547|NCT01362790|466871397|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
129702548|NCT01362790|466871398|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
129702549|NCT01362790|466871399|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
129702550|NCT01362790|466871400|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
129702551|NCT01362790|466871394|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129702552|NCT01362790|466871395|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129702553|NCT01362790|466871396|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129888350|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
129622838|NCT04604795|466571152|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129622839|NCT04604795|466571153|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129622840|NCT04604795|466571154|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
129793401|NCT02361346|467210811|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793402|NCT02361346|467210812|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793403|NCT02361346|467210813|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
129622841|NCT04604795|466571145|FG000|Part B: Up to Day 14|Adverse Event|0|||
129622842|NCT04604795|466571146|FG001|Part B: Up to Day 14|Adverse Event|0|||
129622843|NCT04604795|466571147|FG002|Part B: Up to Day 14|Adverse Event|0|||
129622844|NCT04604795|466571148|FG003|Part B: Up to Day 14|Adverse Event|0|||
129622845|NCT04604795|466571149|FG004|Part B: Up to Day 14|Adverse Event|2|||
129622846|NCT04604795|466571150|FG005|Part B: Up to Day 14|Adverse Event|1|||
129622847|NCT04604795|466571151|FG006|Part B: Up to Day 14|Adverse Event|0|||
129622848|NCT04604795|466571152|FG007|Part B: Up to Day 14|Adverse Event|0|||
129622849|NCT04604795|466571153|FG008|Part B: Up to Day 14|Adverse Event|0|||
129622850|NCT04604795|466571154|FG009|Part B: Up to Day 14|Adverse Event|0|||
129622851|NCT04604795|466571145|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622852|NCT04604795|466571146|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622853|NCT04604795|466571147|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622854|NCT04604795|466571148|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622855|NCT04604795|466571149|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622856|NCT04604795|466571150|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622857|NCT04604795|466571151|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622858|NCT04604795|466571152|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622859|NCT04604795|466571153|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
129622860|NCT04604795|466571154|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
129622861|NCT04604795|466571145|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622862|NCT04604795|466571146|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622863|NCT04604795|466571147|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622864|NCT04604795|466571148|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622865|NCT04604795|466571149|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622866|NCT04604795|466571150|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622867|NCT04604795|466571151|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622868|NCT04604795|466571152|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622869|NCT04604795|466571153|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
129622870|NCT04604795|466571154|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
129622871|NCT04604795|466571145|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622872|NCT04604795|466571146|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622873|NCT04604795|466571147|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622874|NCT04604795|466571148|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622875|NCT04604795|466571149|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622876|NCT04604795|466571150|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622877|NCT04604795|466571151|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622878|NCT04604795|466571152|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622879|NCT04604795|466571153|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
129622880|NCT04604795|466571154|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
129622881|NCT04604795|466571145|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622882|NCT04604795|466571146|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622883|NCT04604795|466571147|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622884|NCT04604795|466571148|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622885|NCT04604795|466571149|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622886|NCT04604795|466571150|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622887|NCT04604795|466571151|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622888|NCT04604795|466571152|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622889|NCT04604795|466571153|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
129793404|NCT02361346|467210814|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
129793405|NCT02361346|467210806|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793406|NCT02361346|467210807|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793407|NCT02361346|467210808|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793408|NCT02361346|467210809|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793409|NCT02361346|467210810|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
129622890|NCT04604795|466571154|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
129622891|NCT04502212|466571160|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
129622892|NCT04502212|466571160|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
129622893|NCT00111241|466571165|FG000|Overall Study|Lost to Follow-up|1|||
129622894|NCT00111241|466571166|FG001|Overall Study|Lost to Follow-up|0|||
129622895|NCT00111241|466571165|FG000|Overall Study|Withdrawal by Subject|4|||
129622896|NCT00111241|466571166|FG001|Overall Study|Withdrawal by Subject|0|||
129622897|NCT00111241|466571165|FG000|Overall Study|Protocol Violation|9|||
129622898|NCT00111241|466571166|FG001|Overall Study|Protocol Violation|8|||
129622899|NCT00111241|466571165|FG000|Overall Study|Adverse Event|1|||
129622900|NCT00111241|466571166|FG001|Overall Study|Adverse Event|0|||
129622901|NCT02096744|466571167|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
129622902|NCT02096744|466571168|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
129622903|NCT02096744|466571167|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
129622904|NCT02096744|466571168|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
129622905|NCT02096744|466571167|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
129622906|NCT02096744|466571168|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
129622907|NCT00952731|466571174|FG000|Overall Study|Drug supply expired|1|||
129622908|NCT00952731|466571175|FG001|Overall Study|Drug supply expired|0|||
129622909|NCT02517463|466571177|FG000|Overall Study|Lost to Follow-up|5|||
129622910|NCT02517463|466571178|FG001|Overall Study|Lost to Follow-up|2|||
129622911|NCT03172494|466571183|FG000|Overall Study|Adverse Event|5|||
129622912|NCT03172494|466571184|FG001|Overall Study|Adverse Event|1|||
129622913|NCT03172494|466571185|FG002|Overall Study|Adverse Event|15|||
129622914|NCT03172494|466571183|FG000|Overall Study|Protocol Violation|3|||
129622915|NCT03172494|466571184|FG001|Overall Study|Protocol Violation|2|||
129622916|NCT03172494|466571185|FG002|Overall Study|Protocol Violation|1|||
129622917|NCT03172494|466571183|FG000|Overall Study|Lack of Efficacy|0|||
129622918|NCT03172494|466571184|FG001|Overall Study|Lack of Efficacy|0|||
129622919|NCT03172494|466571185|FG002|Overall Study|Lack of Efficacy|4|||
129622920|NCT03172494|466571183|FG000|Overall Study|Pregnancy|0|||
129622921|NCT03172494|466571184|FG001|Overall Study|Pregnancy|1|||
129622922|NCT03172494|466571185|FG002|Overall Study|Pregnancy|0|||
129622923|NCT03172494|466571183|FG000|Overall Study|Withdrawal by Subject|10|||
129622924|NCT03172494|466571184|FG001|Overall Study|Withdrawal by Subject|8|||
129622925|NCT03172494|466571185|FG002|Overall Study|Withdrawal by Subject|8|||
129622926|NCT03172494|466571183|FG000|Overall Study|Severe hypoglycaemic episode|0|||
129622927|NCT03172494|466571184|FG001|Overall Study|Severe hypoglycaemic episode|0|||
129622928|NCT03172494|466571185|FG002|Overall Study|Severe hypoglycaemic episode|1|||
129622929|NCT03172494|466571183|FG000|Overall Study|Non-compliance towards treatment|2|||
129622930|NCT03172494|466571184|FG001|Overall Study|Non-compliance towards treatment|0|||
129622931|NCT03172494|466571185|FG002|Overall Study|Non-compliance towards treatment|0|||
129622932|NCT02764151|466571186|FG000|Overall Study|Subject refused further follow-up|0|||
129622933|NCT02764151|466571187|FG001|Overall Study|Subject refused further follow-up|0|||
129622934|NCT02764151|466571188|FG002|Overall Study|Subject refused further follow-up|0|||
129622935|NCT02764151|466571189|FG003|Overall Study|Subject refused further follow-up|1|||
129622936|NCT02764151|466571186|FG000|Overall Study|Other|0|||
129622937|NCT02764151|466571187|FG001|Overall Study|Other|0|||
129622938|NCT02764151|466571188|FG002|Overall Study|Other|0|||
129622939|NCT02764151|466571189|FG003|Overall Study|Other|2|||
129622940|NCT00852202|466571190|FG000|Overall Study|Adverse Event|2|||
129622941|NCT00852202|466571191|FG001|Overall Study|Adverse Event|3|||
129622942|NCT00852202|466571192|FG002|Overall Study|Adverse Event|7|||
129622943|NCT00852202|466571190|FG000|Overall Study|Lack of Efficacy|4|||
129622944|NCT00852202|466571191|FG001|Overall Study|Lack of Efficacy|1|||
129622945|NCT00852202|466571192|FG002|Overall Study|Lack of Efficacy|2|||
129622946|NCT00852202|466571190|FG000|Overall Study|Protocol Violation|2|||
129622947|NCT00852202|466571191|FG001|Overall Study|Protocol Violation|2|||
129793410|NCT02361346|467210811|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793411|NCT02361346|467210812|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793412|NCT02361346|467210813|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793413|NCT02361346|467210814|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
129793414|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
129793415|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
129793416|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
129622948|NCT00852202|466571192|FG002|Overall Study|Protocol Violation|7|||
129622949|NCT00852202|466571190|FG000|Overall Study|Withdrawal by Subject|3|||
129622950|NCT00852202|466571191|FG001|Overall Study|Withdrawal by Subject|1|||
129622951|NCT00852202|466571192|FG002|Overall Study|Withdrawal by Subject|2|||
129622952|NCT00852202|466571190|FG000|Overall Study|Lost to Follow-up|5|||
129622953|NCT00852202|466571191|FG001|Overall Study|Lost to Follow-up|5|||
129622954|NCT00852202|466571192|FG002|Overall Study|Lost to Follow-up|6|||
129793417|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
129793418|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
129622955|NCT00852202|466571190|FG000|Overall Study|pregnancy,moving away and surgery|1|||
129622956|NCT00852202|466571191|FG001|Overall Study|pregnancy,moving away and surgery|0|||
129622957|NCT00852202|466571192|FG002|Overall Study|pregnancy,moving away and surgery|2|||
129622958|NCT05022212|466571195|FG000|Overall Study|Lost to Follow-up|0|||
129622959|NCT05022212|466571196|FG001|Overall Study|Lost to Follow-up|2|||
129622960|NCT02890355|466571197|FG000|Overall Study|Adverse Event|5|||
129622961|NCT02890355|466571198|FG001|Overall Study|Adverse Event|5|||
129622962|NCT02890355|466571197|FG000|Overall Study|Refusal unrelated to adverse event|5|||
129622963|NCT02890355|466571198|FG001|Overall Study|Refusal unrelated to adverse event|10|||
129622964|NCT02890355|466571197|FG000|Overall Study|Progression/relapse|46|||
129622965|NCT02890355|466571198|FG001|Overall Study|Progression/relapse|39|||
129622966|NCT02890355|466571197|FG000|Overall Study|Not protocol specified|3|||
129622967|NCT02890355|466571198|FG001|Overall Study|Not protocol specified|4|||
129622968|NCT02694328|466571199|FG000|Overall Study|Adverse Event|27|||
129622969|NCT02694328|466571200|FG001|Overall Study|Adverse Event|33|||
129622970|NCT02694328|466571199|FG000|Overall Study|Withdrawal by Subject|27|||
129622971|NCT02694328|466571200|FG001|Overall Study|Withdrawal by Subject|23|||
129622972|NCT02694328|466571199|FG000|Overall Study|Lost to Follow-up|26|||
129622973|NCT02694328|466571200|FG001|Overall Study|Lost to Follow-up|22|||
129622974|NCT02694328|466571199|FG000|Overall Study|Noncompliant with study drug|11|||
129622975|NCT02694328|466571200|FG001|Overall Study|Noncompliant with study drug|8|||
129622976|NCT02694328|466571199|FG000|Overall Study|Incarceration|1|||
129622977|NCT02694328|466571200|FG001|Overall Study|Incarceration|1|||
129622978|NCT02694328|466571199|FG000|Overall Study|Lack of Efficacy|1|||
129622979|NCT02694328|466571200|FG001|Overall Study|Lack of Efficacy|2|||
129622980|NCT02694328|466571199|FG000|Overall Study|Pregnancy|1|||
129622981|NCT02694328|466571200|FG001|Overall Study|Pregnancy|1|||
129622982|NCT02694328|466571199|FG000|Overall Study|Protocol Violation|6|||
129622983|NCT02694328|466571200|FG001|Overall Study|Protocol Violation|5|||
129622984|NCT02694328|466571199|FG000|Overall Study|Abnormal Laboratory Value|0|||
129622985|NCT02694328|466571200|FG001|Overall Study|Abnormal Laboratory Value|3|||
129622986|NCT01260701|466571202|FG000|Overall Study|Adverse Event|9|||
129622987|NCT01260701|466571202|FG000|Overall Study|Withdrawal by Subject|2|||
129622988|NCT01260701|466571202|FG000|Overall Study|Progression|53|||
129622989|NCT01260701|466571202|FG000|Overall Study|Death|2|||
129622990|NCT01260701|466571202|FG000|Overall Study|Not protocol specified|3|||
129622991|NCT01260701|466571202|FG000|Overall Study|Under review|1|||
129622992|NCT01260701|466571202|FG000|Overall Study|Ineligible|4|||
129622993|NCT01260701|466571202|FG000|Overall Study|Did not begin protocol therapy|1|||
129622994|NCT00720382|466571203|FG000|Overall Study|Adverse Event|54|||
129622995|NCT00720382|466571204|FG001|Overall Study|Adverse Event|17|||
129622996|NCT00720382|466571203|FG000|Overall Study|Lack of Efficacy|18|||
129622997|NCT00720382|466571204|FG001|Overall Study|Lack of Efficacy|7|||
129622998|NCT00720382|466571203|FG000|Overall Study|Non-Compliance|15|||
129622999|NCT00720382|466571204|FG001|Overall Study|Non-Compliance|5|||
129623000|NCT00720382|466571203|FG000|Overall Study|Withdrawal by Subject|47|||
129623001|NCT00720382|466571204|FG001|Overall Study|Withdrawal by Subject|11|||
129623002|NCT00720382|466571203|FG000|Overall Study|Lost to Follow-up|28|||
129623003|NCT00720382|466571204|FG001|Overall Study|Lost to Follow-up|14|||
129623004|NCT00720382|466571203|FG000|Overall Study|administrative|14|||
129623005|NCT00720382|466571204|FG001|Overall Study|administrative|5|||
129623006|NCT04205812|466572915|FG000|Randomized Treatment Period|Ongoing|28|||
129623007|NCT04205812|466572916|FG001|Randomized Treatment Period|Ongoing|138|||
129623008|NCT04205812|466572915|FG000|Randomized Treatment Period|Death|94|||
129623009|NCT04205812|466572916|FG001|Randomized Treatment Period|Death|226|||
129623010|NCT04205812|466572915|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
129623011|NCT04205812|466572916|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
129623012|NCT04205812|466572915|FG000|Randomized Treatment Period|Physician Decision|1|||
129623013|NCT04205812|466572916|FG001|Randomized Treatment Period|Physician Decision|4|||
129623014|NCT04205812|466572915|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
129623015|NCT04205812|466572916|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
129439459|NCT01723254|465906509|FG002|Overall Study|No longer have time to participate|0|||
129439460|NCT01723254|465906510|FG003|Overall Study|No longer have time to participate|1|||
129439461|NCT01723254|465906511|FG004|Overall Study|No longer have time to participate|0|||
129439462|NCT01723254|465906512|FG005|Overall Study|No longer have time to participate|0|||
129623016|NCT04205812|466572915|FG000|Randomized Treatment Period|Progressive Disease|0|||
129623017|NCT04205812|466572916|FG001|Randomized Treatment Period|Progressive Disease|1|||
129623018|NCT04205812|466572915|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
129702554|NCT01362790|466871397|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129439463|NCT01723254|465906513|FG006|Overall Study|No longer have time to participate|0|||
129439464|NCT01723254|465906514|FG007|Overall Study|No longer have time to participate|0|||
129623019|NCT04205812|466572916|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
129623020|NCT04205812|466572915|FG000|Monotherapy Treatment Period|Ongoing|17|||
129623021|NCT04205812|466572916|FG001|Monotherapy Treatment Period|Ongoing|0|||
129623022|NCT04205812|466572915|FG000|Monotherapy Treatment Period|Death|39|||
129623023|NCT04205812|466572916|FG001|Monotherapy Treatment Period|Death|0|||
129623024|NCT04205812|466572915|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
129623025|NCT04205812|466572916|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
129623026|NCT04205812|466572915|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
129623027|NCT04205812|466572916|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
129623028|NCT05221320|466572917|FG000|Overall Study|Lack of Efficacy|3|||
129623029|NCT05221320|466572918|FG001|Overall Study|Lack of Efficacy|7|||
129623030|NCT05221320|466572919|FG002|Overall Study|Lack of Efficacy|10|||
129623031|NCT05221320|466572920|FG003|Overall Study|Lack of Efficacy|1|||
129623032|NCT05221320|466572921|FG004|Overall Study|Lack of Efficacy|0|||
129623033|NCT05221320|466572922|FG005|Overall Study|Lack of Efficacy|0|||
129623034|NCT05221320|466572917|FG000|Overall Study|Physician Decision|1|||
129623035|NCT05221320|466572918|FG001|Overall Study|Physician Decision|0|||
129623036|NCT05221320|466572919|FG002|Overall Study|Physician Decision|3|||
129623037|NCT05221320|466572920|FG003|Overall Study|Physician Decision|1|||
129623038|NCT05221320|466572921|FG004|Overall Study|Physician Decision|0|||
129623039|NCT05221320|466572922|FG005|Overall Study|Physician Decision|0|||
129623040|NCT05221320|466572917|FG000|Overall Study|Withdrawal by Subject|0|||
129623041|NCT05221320|466572918|FG001|Overall Study|Withdrawal by Subject|3|||
129623042|NCT05221320|466572919|FG002|Overall Study|Withdrawal by Subject|1|||
129623043|NCT05221320|466572920|FG003|Overall Study|Withdrawal by Subject|0|||
129623044|NCT05221320|466572921|FG004|Overall Study|Withdrawal by Subject|0|||
129623045|NCT05221320|466572922|FG005|Overall Study|Withdrawal by Subject|0|||
129623046|NCT05221320|466572917|FG000|Overall Study|Death|0|||
129623047|NCT05221320|466572918|FG001|Overall Study|Death|5|||
129623048|NCT05221320|466572919|FG002|Overall Study|Death|6|||
129623049|NCT05221320|466572920|FG003|Overall Study|Death|0|||
129623050|NCT05221320|466572921|FG004|Overall Study|Death|1|||
129623051|NCT05221320|466572922|FG005|Overall Study|Death|0|||
129623052|NCT06473519|466572923|FG000|Overall Study|Lost to Follow-up|2|||
129623053|NCT06473519|466572924|FG001|Overall Study|Lost to Follow-up|5|||
129623054|NCT06473519|466572923|FG000|Overall Study|Withdrawal by Subject|1|||
129623055|NCT06473519|466572924|FG001|Overall Study|Withdrawal by Subject|4|||
129623056|NCT06473519|466572923|FG000|Overall Study|Randomized but not vaccinated|1|||
129623057|NCT06473519|466572924|FG001|Overall Study|Randomized but not vaccinated|2|||
129623058|NCT02514447|466572926|FG000|Overall Study|Withdrawal by Subject|3|||
129623059|NCT02514447|466572927|FG001|Overall Study|Withdrawal by Subject|1|||
129623060|NCT02514447|466572928|FG002|Overall Study|Withdrawal by Subject|1|||
129623061|NCT02514447|466572929|FG003|Overall Study|Withdrawal by Subject|0|||
129623062|NCT02514447|466572930|FG004|Overall Study|Withdrawal by Subject|0|||
129623063|NCT02514447|466572931|FG005|Overall Study|Withdrawal by Subject|0|||
129623064|NCT02514447|466572932|FG006|Overall Study|Withdrawal by Subject|0|||
129623065|NCT02514447|466572933|FG007|Overall Study|Withdrawal by Subject|1|||
129623066|NCT02514447|466572934|FG008|Overall Study|Withdrawal by Subject|1|||
129623067|NCT02514447|466572926|FG000|Overall Study|Death|24|||
129623068|NCT02514447|466572927|FG001|Overall Study|Death|28|||
129623069|NCT02514447|466572928|FG002|Overall Study|Death|29|||
129623070|NCT02514447|466572929|FG003|Overall Study|Death|0|||
129623071|NCT02514447|466572930|FG004|Overall Study|Death|3|||
129623072|NCT02514447|466572931|FG005|Overall Study|Death|4|||
129623073|NCT02514447|466572932|FG006|Overall Study|Death|8|||
129623074|NCT02514447|466572933|FG007|Overall Study|Death|6|||
129623075|NCT02514447|466572934|FG008|Overall Study|Death|5|||
129623076|NCT02514447|466572926|FG000|Overall Study|Lost to Follow-up|1|||
129623077|NCT02514447|466572927|FG001|Overall Study|Lost to Follow-up|0|||
129623078|NCT02514447|466572928|FG002|Overall Study|Lost to Follow-up|0|||
129623079|NCT02514447|466572929|FG003|Overall Study|Lost to Follow-up|0|||
129623080|NCT02514447|466572930|FG004|Overall Study|Lost to Follow-up|0|||
129623081|NCT02514447|466572931|FG005|Overall Study|Lost to Follow-up|0|||
129623082|NCT02514447|466572932|FG006|Overall Study|Lost to Follow-up|0|||
129623083|NCT02514447|466572933|FG007|Overall Study|Lost to Follow-up|0|||
129623084|NCT02514447|466572934|FG008|Overall Study|Lost to Follow-up|1|||
129623085|NCT02514447|466572926|FG000|Overall Study|Sponsor Termination of Study|0|||
129623086|NCT02514447|466572927|FG001|Overall Study|Sponsor Termination of Study|1|||
129623087|NCT02514447|466572928|FG002|Overall Study|Sponsor Termination of Study|1|||
129623088|NCT02514447|466572929|FG003|Overall Study|Sponsor Termination of Study|0|||
129623089|NCT02514447|466572930|FG004|Overall Study|Sponsor Termination of Study|0|||
129623090|NCT02514447|466572931|FG005|Overall Study|Sponsor Termination of Study|0|||
129623091|NCT02514447|466572932|FG006|Overall Study|Sponsor Termination of Study|0|||
129623092|NCT02514447|466572933|FG007|Overall Study|Sponsor Termination of Study|0|||
129623093|NCT02514447|466572934|FG008|Overall Study|Sponsor Termination of Study|0|||
129623094|NCT02514447|466572926|FG000|Overall Study|Study completion per Investigator|1|||
129623095|NCT02514447|466572927|FG001|Overall Study|Study completion per Investigator|0|||
129623096|NCT02514447|466572928|FG002|Overall Study|Study completion per Investigator|1|||
129623097|NCT02514447|466572929|FG003|Overall Study|Study completion per Investigator|2|||
129702555|NCT01362790|466871398|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
129623098|NCT02514447|466572930|FG004|Overall Study|Study completion per Investigator|0|||
129623099|NCT02514447|466572931|FG005|Overall Study|Study completion per Investigator|0|||
129623100|NCT02514447|466572932|FG006|Overall Study|Study completion per Investigator|0|||
129623101|NCT02514447|466572933|FG007|Overall Study|Study completion per Investigator|0|||
129623102|NCT02514447|466572934|FG008|Overall Study|Study completion per Investigator|1|||
129623103|NCT05626231|466572935|FG000|Provider Enrollment|Worked part-time|4|||
129623104|NCT05626231|466572935|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
129623105|NCT05626231|466572935|FG000|Provider Enrollment|Non-clinical employee|1|||
129623106|NCT05626231|466572935|FG000|Provider Enrollment|Provider does not see clients|3|||
129623107|NCT05626231|466572935|FG000|Provider Enrollment|Other|5|||
129623108|NCT02653625|466572938|FG000|Overall Study|Adverse Event|1|||
129623109|NCT02653625|466572938|FG000|Overall Study|Non-compliance with Study Drug|1|||
129623110|NCT02653625|466572938|FG000|Overall Study|Protocol Violation|1|||
129623111|NCT02653625|466572938|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
129623112|NCT05377749|466572939|FG000|3 Weeks|Lost to Follow-up|2|||
129623113|NCT05377749|466572940|FG001|3 Weeks|Lost to Follow-up|4|||
129623114|NCT05377749|466572939|FG000|3 Weeks|Withdrawal by Subject|1|||
129623115|NCT05377749|466572940|FG001|3 Weeks|Withdrawal by Subject|1|||
129623116|NCT02762929|466572944|FG000|Overall Study|Adverse Event|0|||
129623117|NCT02762929|466572945|FG001|Overall Study|Adverse Event|0|||
129623118|NCT02762929|466572946|FG002|Overall Study|Adverse Event|0|||
129623119|NCT02762929|466572947|FG003|Overall Study|Adverse Event|1|||
129623120|NCT02762929|466572948|FG004|Overall Study|Adverse Event|0|||
129623121|NCT02762929|466572949|FG005|Overall Study|Adverse Event|0|||
129623122|NCT02762929|466572944|FG000|Overall Study|Lost to Follow-up|1|||
129623123|NCT02762929|466572945|FG001|Overall Study|Lost to Follow-up|2|||
129623124|NCT02762929|466572946|FG002|Overall Study|Lost to Follow-up|0|||
129623125|NCT02762929|466572947|FG003|Overall Study|Lost to Follow-up|1|||
129623126|NCT02762929|466572948|FG004|Overall Study|Lost to Follow-up|0|||
129623127|NCT02762929|466572949|FG005|Overall Study|Lost to Follow-up|0|||
129623128|NCT02762929|466572944|FG000|Overall Study|Withdrawal by Subject|0|||
129623129|NCT02762929|466572945|FG001|Overall Study|Withdrawal by Subject|1|||
129623130|NCT02762929|466572946|FG002|Overall Study|Withdrawal by Subject|0|||
129623131|NCT02762929|466572947|FG003|Overall Study|Withdrawal by Subject|0|||
129623132|NCT02762929|466572948|FG004|Overall Study|Withdrawal by Subject|0|||
129623133|NCT02762929|466572949|FG005|Overall Study|Withdrawal by Subject|0|||
129623134|NCT02762929|466572944|FG000|Overall Study|exclusionary medication disclosed late|0|||
129623135|NCT02762929|466572945|FG001|Overall Study|exclusionary medication disclosed late|0|||
129623136|NCT02762929|466572946|FG002|Overall Study|exclusionary medication disclosed late|0|||
129623137|NCT02762929|466572947|FG003|Overall Study|exclusionary medication disclosed late|1|||
129623138|NCT02762929|466572948|FG004|Overall Study|exclusionary medication disclosed late|0|||
129623139|NCT02762929|466572949|FG005|Overall Study|exclusionary medication disclosed late|0|||
129623140|NCT04123405|466572955|FG000|Overall Study|Adverse Event|1|||
129623141|NCT04123405|466572956|FG001|Overall Study|Adverse Event|2|||
129623142|NCT04123405|466572957|FG002|Overall Study|Adverse Event|3|||
129623143|NCT04123405|466572958|FG003|Overall Study|Adverse Event|3|||
129623144|NCT04123405|466572955|FG000|Overall Study|Exclusion criteria met|1|||
129623145|NCT04123405|466572956|FG001|Overall Study|Exclusion criteria met|2|||
129623146|NCT04123405|466572957|FG002|Overall Study|Exclusion criteria met|0|||
129623147|NCT04123405|466572958|FG003|Overall Study|Exclusion criteria met|2|||
129623148|NCT04123405|466572955|FG000|Overall Study|Withdrawal by Subject|1|||
129623149|NCT04123405|466572956|FG001|Overall Study|Withdrawal by Subject|3|||
129623150|NCT04123405|466572957|FG002|Overall Study|Withdrawal by Subject|0|||
129623151|NCT04123405|466572958|FG003|Overall Study|Withdrawal by Subject|2|||
129623152|NCT04123405|466572955|FG000|Overall Study|Contact to subject lost|0|||
129623153|NCT04123405|466572956|FG001|Overall Study|Contact to subject lost|0|||
129623154|NCT04123405|466572957|FG002|Overall Study|Contact to subject lost|0|||
129623155|NCT04123405|466572958|FG003|Overall Study|Contact to subject lost|1|||
129623156|NCT04123405|466572955|FG000|Overall Study|screening failure|1|||
129623157|NCT04123405|466572956|FG001|Overall Study|screening failure|0|||
129623158|NCT04123405|466572957|FG002|Overall Study|screening failure|0|||
129623159|NCT04123405|466572958|FG003|Overall Study|screening failure|0|||
129623160|NCT01026194|466572959|FG000|Period 1：Double Blind Period|Adverse Event|2|||
129623161|NCT01026194|466572960|FG001|Period 1：Double Blind Period|Adverse Event|1|||
129623162|NCT01026194|466572959|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
129793419|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
129623163|NCT01026194|466572960|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
129623164|NCT01026194|466572959|FG000|Period 1：Double Blind Period|Physician Decision|0|||
129623165|NCT01026194|466572960|FG001|Period 1：Double Blind Period|Physician Decision|4|||
129623166|NCT01026194|466572959|FG000|Period 2：Open-label Period|Adverse Event|4|||
129623167|NCT01026194|466572960|FG001|Period 2：Open-label Period|Adverse Event|5|||
129623168|NCT01026194|466572959|FG000|Period 2：Open-label Period|Physician Decision|3|||
129623169|NCT01026194|466572960|FG001|Period 2：Open-label Period|Physician Decision|1|||
129623170|NCT01026194|466572959|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
129623171|NCT01026194|466572960|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
129623172|NCT01750190|466572961|FG000|Overall Study|Adverse Event|47|||
129623173|NCT01750190|466572962|FG001|Overall Study|Adverse Event|19|||
129793420|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
129623174|NCT01750190|466572961|FG000|Overall Study|Death|38|||
129623175|NCT01750190|466572962|FG001|Overall Study|Death|11|||
129623176|NCT01750190|466572961|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
129623177|NCT01750190|466572962|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
129623178|NCT01750190|466572961|FG000|Overall Study|Lost to Follow-up|28|||
129623179|NCT01750190|466572962|FG001|Overall Study|Lost to Follow-up|7|||
129623180|NCT01750190|466572961|FG000|Overall Study|Physician Decision|16|||
129623181|NCT01750190|466572962|FG001|Overall Study|Physician Decision|17|||
129623182|NCT01750190|466572961|FG000|Overall Study|Protocol Violation|6|||
129623183|NCT01750190|466572962|FG001|Overall Study|Protocol Violation|5|||
129623184|NCT01750190|466572961|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
129623185|NCT01750190|466572962|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
129623186|NCT01750190|466572961|FG000|Overall Study|Withdrawal by Subject|83|||
129623187|NCT01750190|466572962|FG001|Overall Study|Withdrawal by Subject|89|||
129623188|NCT01750190|466572961|FG000|Overall Study|Kidney Transplant|8|||
129623189|NCT01750190|466572962|FG001|Overall Study|Kidney Transplant|4|||
129623190|NCT01750190|466572961|FG000|Overall Study|Dialysis|22|||
129623191|NCT01750190|466572962|FG001|Overall Study|Dialysis|8|||
129623192|NCT01750190|466572961|FG000|Overall Study|Other than Specified|13|||
129623193|NCT01750190|466572962|FG001|Overall Study|Other than Specified|4|||
129623194|NCT03934541|466572974|FG000|Overall Study|Study Terminated by Sponsor|0|||
129623195|NCT03934541|466572975|FG001|Overall Study|Study Terminated by Sponsor|1|||
129623196|NCT03934541|466572976|FG002|Overall Study|Study Terminated by Sponsor|0|||
129623197|NCT03934541|466572977|FG003|Overall Study|Study Terminated by Sponsor|0|||
129623198|NCT02673775|466572978|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
129623199|NCT02673775|466572979|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
129623200|NCT02673775|466572978|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
129623201|NCT02673775|466572979|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
129623202|NCT02673775|466572978|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
129623203|NCT02673775|466572979|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
129623204|NCT02673775|466572978|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
129623205|NCT02673775|466572979|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
129623206|NCT02441686|466572980|FG000|Induction|Adverse Event|4|||
129623207|NCT02441686|466572980|FG000|Induction|Complicating disease|1|||
129623208|NCT02441686|466572980|FG000|Induction|Physician Decision|1|||
129623209|NCT02441686|466572980|FG000|Induction|Withdrawal by Subject|1|||
129623210|NCT02441686|466572980|FG000|Induction|Did not receive treatment|1|||
129623211|NCT02441686|466572980|FG000|Maintenance|Remaining on Treatment|23|||
129623212|NCT02441686|466572980|FG000|Maintenance|Physician Decision|1|||
129623213|NCT02441686|466572980|FG000|Maintenance|Adverse Event|3|||
129623214|NCT02441686|466572980|FG000|Maintenance|Progressive Disease|10|||
129623215|NCT02441686|466572980|FG000|Maintenance|Withdrawal by Subject|1|||
129623216|NCT03151304|466572981|FG000|Overall Study|Termination of study by Sponsor|23|||
129623217|NCT03151304|466572981|FG000|Overall Study|missing|3|||
129623218|NCT03151304|466572981|FG000|Overall Study|Withdrawal by Subject|8|||
129623219|NCT03151304|466572981|FG000|Overall Study|multiple reasons|30|||
129623220|NCT04194645|466572984|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623221|NCT04194645|466572985|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623222|NCT04194645|466572986|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623223|NCT04194645|466572987|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623224|NCT04194645|466572988|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623225|NCT04194645|466572989|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623226|NCT04194645|466572990|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623227|NCT04194645|466572991|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623228|NCT04194645|466572992|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623229|NCT04194645|466572993|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
129623230|NCT04194645|466572994|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623231|NCT04194645|466572995|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623232|NCT04194645|466572996|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623233|NCT04194645|466572997|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623234|NCT04194645|466572998|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
129623235|NCT03076775|466572999|FG000|Overall Study|Lost to Follow-up|1|||
129623236|NCT03076775|466573000|FG001|Overall Study|Lost to Follow-up|0|||
129623237|NCT01783886|466573001|FG000|Overall Study|Lost to Follow-up|0|||
129623238|NCT01783886|466573002|FG001|Overall Study|Lost to Follow-up|3|||
129623239|NCT01783886|466573003|FG002|Overall Study|Lost to Follow-up|0|||
129623240|NCT01783886|466573001|FG000|Overall Study|Protocol deviation|0|||
129623241|NCT01783886|466573002|FG001|Overall Study|Protocol deviation|0|||
129623242|NCT01783886|466573003|FG002|Overall Study|Protocol deviation|2|||
129623243|NCT01783886|466573001|FG000|Overall Study|Withdrawal of consent by participant|1|||
129793421|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
129623244|NCT01783886|466573002|FG001|Overall Study|Withdrawal of consent by participant|3|||
129623245|NCT01783886|466573003|FG002|Overall Study|Withdrawal of consent by participant|4|||
129793422|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
129702556|NCT01362790|466871399|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129702557|NCT01362790|466871400|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
129702558|NCT01362790|466871394|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
129702559|NCT01362790|466871395|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
129702560|NCT01362790|466871396|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
129702561|NCT01362790|466871397|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
129702562|NCT01362790|466871398|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
129702563|NCT01362790|466871399|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
129702564|NCT01362790|466871400|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
129702565|NCT02457065|466871401|FG000|Overall Study|Lost to Follow-up|9|||
129702566|NCT02457065|466871402|FG001|Overall Study|Lost to Follow-up|11|||
129702567|NCT01554904|466871403|FG000|Overall Study|Withdrawal by Subject|3|||
129702568|NCT01554904|466871403|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
129702569|NCT01605097|466871405|FG000|Overall Study|Protocol Violation|1|||
129702570|NCT02038647|466871406|FG000|Overall Study|Progressive Disease|50|||
129702571|NCT02038647|466871407|FG001|Overall Study|Progressive Disease|59|||
129702572|NCT02038647|466871406|FG000|Overall Study|Adverse Event|18|||
129702573|NCT02038647|466871407|FG001|Overall Study|Adverse Event|10|||
129702574|NCT02038647|466871406|FG000|Overall Study|Symptomatic Deterioration|7|||
129702575|NCT02038647|466871407|FG001|Overall Study|Symptomatic Deterioration|7|||
129702576|NCT02038647|466871406|FG000|Overall Study|Withdrawal by Subject|5|||
129702577|NCT02038647|466871407|FG001|Overall Study|Withdrawal by Subject|2|||
129702578|NCT02038647|466871406|FG000|Overall Study|Not Reported|0|||
129702579|NCT02038647|466871407|FG001|Overall Study|Not Reported|1|||
129702580|NCT02038647|466871406|FG000|Overall Study|Ongoing at Datacut|9|||
129702581|NCT02038647|466871407|FG001|Overall Study|Ongoing at Datacut|10|||
129702582|NCT02757430|466871408|FG000|Overall Study|Physician Decision|6|||
129702583|NCT02757430|466871408|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
129702584|NCT02757430|466871408|FG000|Overall Study|No informed consent|1|||
129702585|NCT02757430|466871408|FG000|Overall Study|No procedure performed|2|||
129702586|NCT04716894|466871430|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
129702587|NCT04716894|466871430|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
129702588|NCT04507269|466871434|FG000|Overall Study|Withdrawal by Subject|1|||
129702589|NCT04507269|466871435|FG001|Overall Study|Withdrawal by Subject|1|||
129702590|NCT04507269|466871436|FG002|Overall Study|Withdrawal by Subject|0|||
129702591|NCT04507269|466871437|FG003|Overall Study|Withdrawal by Subject|0|||
129702592|NCT04507269|466871438|FG004|Overall Study|Withdrawal by Subject|0|||
129702593|NCT04507269|466871439|FG005|Overall Study|Withdrawal by Subject|0|||
129702594|NCT04507269|466871434|FG000|Overall Study|Lost to Follow-up|0|||
129702595|NCT04507269|466871435|FG001|Overall Study|Lost to Follow-up|0|||
129702596|NCT04507269|466871436|FG002|Overall Study|Lost to Follow-up|0|||
129702597|NCT04507269|466871437|FG003|Overall Study|Lost to Follow-up|0|||
129702598|NCT04507269|466871438|FG004|Overall Study|Lost to Follow-up|1|||
129702599|NCT04507269|466871439|FG005|Overall Study|Lost to Follow-up|0|||
129702600|NCT00071032|466871442|FG000|Overall Study|Lost to Follow-up|1|||
129702601|NCT00071032|466871443|FG001|Overall Study|Lost to Follow-up|1|||
129702602|NCT00071032|466871442|FG000|Overall Study|Withdrawal by Subject|8|||
129702603|NCT00071032|466871443|FG001|Overall Study|Withdrawal by Subject|6|||
129702604|NCT00071032|466871442|FG000|Overall Study|Missing Primary Outcome|0|||
129702605|NCT00071032|466871443|FG001|Overall Study|Missing Primary Outcome|1|||
129702606|NCT06071104|466871445|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
129702607|NCT03518060|466871446|FG000|Overall Study|Death|1|||
129702608|NCT03518060|466871446|FG000|Overall Study|Poor adherence|1|||
129702609|NCT03518060|466871446|FG000|Overall Study|Withdrawal of informed consent|2|||
129702610|NCT03518060|466871446|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
129702611|NCT03518060|466871446|FG000|Overall Study|Physician Decision|7|||
129702612|NCT03518060|466871446|FG000|Overall Study|Adverse drug reactions|23|||
129702613|NCT03518060|466871446|FG000|Overall Study|Withdrawal by Subject|25|||
129702614|NCT03518060|466871446|FG000|Overall Study|Lost to Follow-up|13|||
129702615|NCT01903863|466871448|FG000|Overall Study|Physician Decision|2|||
129702616|NCT01903863|466871449|FG001|Overall Study|Physician Decision|0|||
129702617|NCT04727151|466871454|FG000|Overall Study|Death|0|||
129702618|NCT04727151|466871455|FG001|Overall Study|Death|0|||
129702619|NCT04727151|466871456|FG002|Overall Study|Death|0|||
129702620|NCT04727151|466871457|FG003|Overall Study|Death|0|||
129702621|NCT04727151|466871458|FG004|Overall Study|Death|3|||
129702622|NCT04727151|466871454|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129702623|NCT04727151|466871455|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129702624|NCT04727151|466871456|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129702625|NCT04727151|466871457|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
129702626|NCT04727151|466871458|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
129702627|NCT01969058|466871459|FG000|Overall Study|Withdrawal by Subject|2|||
129702628|NCT01969058|466871460|FG001|Overall Study|Withdrawal by Subject|0|||
129702629|NCT01969058|466871459|FG000|Overall Study|Adverse Event|1|||
129702630|NCT01969058|466871460|FG001|Overall Study|Adverse Event|0|||
129888351|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
129888352|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
129888353|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
129888354|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
129888355|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
129888356|NCT02718417|467549132|FG000|Long-term Follow-up Phase|Other|0|||
129888357|NCT02718417|467549133|FG001|Long-term Follow-up Phase|Other|2|||
129888358|NCT02718417|467549134|FG002|Long-term Follow-up Phase|Other|0|||
129888359|NCT00551213|467549139|FG000|Overall Study|Adverse Event|6|||
129888360|NCT00551213|467549140|FG001|Overall Study|Adverse Event|3|||
129888361|NCT00551213|467549139|FG000|Overall Study|Progressive Disease|41|||
129888362|NCT00551213|467549140|FG001|Overall Study|Progressive Disease|12|||
129888363|NCT00551213|467549139|FG000|Overall Study|Withdrawal by Subject|2|||
129888364|NCT00551213|467549140|FG001|Overall Study|Withdrawal by Subject|0|||
129888365|NCT00551213|467549139|FG000|Overall Study|Not Treated|1|||
129888366|NCT00551213|467549140|FG001|Overall Study|Not Treated|2|||
129888367|NCT01890967|467549141|FG000|Overall Study|Adverse Event|3|||
129888368|NCT01890967|467549142|FG001|Overall Study|Adverse Event|3|||
129888369|NCT01890967|467549143|FG002|Overall Study|Adverse Event|3|||
129888370|NCT01890967|467549144|FG003|Overall Study|Adverse Event|2|||
129888371|NCT01890967|467549145|FG004|Overall Study|Adverse Event|1|||
129888372|NCT01890967|467549146|FG005|Overall Study|Adverse Event|7|||
129888373|NCT01890967|467549141|FG000|Overall Study|Death|1|||
129888374|NCT01890967|467549142|FG001|Overall Study|Death|0|||
129888375|NCT01890967|467549143|FG002|Overall Study|Death|0|||
129888376|NCT01890967|467549144|FG003|Overall Study|Death|0|||
129623246|NCT01783886|466573001|FG000|Overall Study|Adverse Event|4|||
129623247|NCT01783886|466573002|FG001|Overall Study|Adverse Event|5|||
129623248|NCT01783886|466573003|FG002|Overall Study|Adverse Event|4|||
129623249|NCT04542057|466573004|FG000|Overall Study|Death|3|||
129623250|NCT04542057|466573005|FG001|Overall Study|Death|1|||
129623251|NCT04542057|466573004|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
129623252|NCT04542057|466573005|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
129623253|NCT04542057|466573004|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
129623254|NCT04542057|466573005|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
129623255|NCT04542057|466573004|FG000|Overall Study|Adverse Event|15|||
129623256|NCT04542057|466573005|FG001|Overall Study|Adverse Event|6|||
129623257|NCT04542057|466573004|FG000|Overall Study|COVID-19 adverse event|6|||
129623258|NCT04542057|466573005|FG001|Overall Study|COVID-19 adverse event|4|||
129623259|NCT04542057|466573004|FG000|Overall Study|Lack of Efficacy|2|||
129623260|NCT04542057|466573005|FG001|Overall Study|Lack of Efficacy|5|||
129623261|NCT04542057|466573004|FG000|Overall Study|Study terminated by sponsor|1|||
129623262|NCT04542057|466573005|FG001|Overall Study|Study terminated by sponsor|0|||
129623263|NCT04542057|466573004|FG000|Overall Study|Investigator discretion|2|||
129623264|NCT04542057|466573005|FG001|Overall Study|Investigator discretion|1|||
129623265|NCT04542057|466573004|FG000|Overall Study|Withdrawal by Subject|52|||
129623266|NCT04542057|466573005|FG001|Overall Study|Withdrawal by Subject|30|||
129623267|NCT04542057|466573004|FG000|Overall Study|Lost to Follow-up|8|||
129623268|NCT04542057|466573005|FG001|Overall Study|Lost to Follow-up|11|||
129623269|NCT04542057|466573004|FG000|Overall Study|Other|2|||
129623270|NCT04542057|466573005|FG001|Overall Study|Other|2|||
129623271|NCT00104572|466573006|FG000|Overall Study|Withdrawal by Subject|3|||
129623272|NCT00104572|466573007|FG001|Overall Study|Withdrawal by Subject|3|||
129623273|NCT00104572|466573008|FG002|Overall Study|Withdrawal by Subject|0|||
129623274|NCT00940316|466573011|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
129623275|NCT00940316|466573012|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
129623276|NCT00940316|466573013|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
129623277|NCT00940316|466573011|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
129623278|NCT00940316|466573012|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
129623279|NCT00940316|466573013|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
129623280|NCT00940316|466573011|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
129623281|NCT00940316|466573012|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
129623282|NCT00940316|466573013|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
129623283|NCT00940316|466573011|FG000|Treated After Cycle 5|Adverse Event|0|||
129888377|NCT01890967|467549145|FG004|Overall Study|Death|0|||
129888378|NCT01890967|467549146|FG005|Overall Study|Death|0|||
129623284|NCT00940316|466573012|FG001|Treated After Cycle 5|Adverse Event|0|||
129623285|NCT00940316|466573013|FG002|Treated After Cycle 5|Adverse Event|1|||
129623286|NCT00940316|466573011|FG000|Treated After Cycle 5|Progressive disease|0|||
129623287|NCT00940316|466573012|FG001|Treated After Cycle 5|Progressive disease|1|||
129623288|NCT00940316|466573013|FG002|Treated After Cycle 5|Progressive disease|0|||
129888379|NCT01890967|467549141|FG000|Overall Study|Lost to Follow-up|1|||
129888380|NCT01890967|467549142|FG001|Overall Study|Lost to Follow-up|1|||
129623289|NCT02290405|466573017|FG000|Overall Study|Withdrawal by Subject|1|||
129623290|NCT02290405|466573018|FG001|Overall Study|Withdrawal by Subject|0|||
129623291|NCT02016183|466573019|FG000|Overall Study|Case Report Forms Uncollected|13|||
129623292|NCT02016183|466573019|FG000|Overall Study|Protocol Violation|52|||
129623293|NCT00996489|466573020|FG000|Overall Study|Device failure|45|||
129623294|NCT00996489|466573020|FG000|Overall Study|Discontinued|116|||
129623295|NCT03142191|466573021|FG000|Placebo Controlled Period|Death|0|||
129623296|NCT03142191|466573022|FG001|Placebo Controlled Period|Death|1|||
129623297|NCT03142191|466573023|FG002|Placebo Controlled Period|Death|1|||
129623298|NCT03142191|466573024|FG003|Placebo Controlled Period|Death|0|||
129623299|NCT03142191|466573025|FG004|Placebo Controlled Period|Death|0|||
129623300|NCT03142191|466573021|FG000|Placebo Controlled Period|Adverse Event|4|||
129623301|NCT03142191|466573022|FG001|Placebo Controlled Period|Adverse Event|5|||
129623302|NCT03142191|466573023|FG002|Placebo Controlled Period|Adverse Event|1|||
129623303|NCT03142191|466573024|FG003|Placebo Controlled Period|Adverse Event|0|||
129623304|NCT03142191|466573025|FG004|Placebo Controlled Period|Adverse Event|0|||
129888381|NCT01890967|467549143|FG002|Overall Study|Lost to Follow-up|1|||
129623305|NCT03142191|466573021|FG000|Placebo Controlled Period|Progressive Disease|1|||
129623306|NCT03142191|466573022|FG001|Placebo Controlled Period|Progressive Disease|0|||
129647678|NCT00381043|466665402|FG000|Overall Study|incarcerated|1|||
129647679|NCT00381043|466665403|FG001|Overall Study|incarcerated|0|||
129623307|NCT03142191|466573023|FG002|Placebo Controlled Period|Progressive Disease|1|||
129623308|NCT03142191|466573024|FG003|Placebo Controlled Period|Progressive Disease|0|||
129623309|NCT03142191|466573025|FG004|Placebo Controlled Period|Progressive Disease|0|||
129623310|NCT03142191|466573021|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
129623311|NCT03142191|466573022|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
129623312|NCT03142191|466573023|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
129623313|NCT03142191|466573024|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
129623314|NCT03142191|466573025|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
129623315|NCT03142191|466573021|FG000|Placebo Controlled Period|Other Reasons|1|||
129623316|NCT03142191|466573022|FG001|Placebo Controlled Period|Other Reasons|0|||
129623317|NCT03142191|466573023|FG002|Placebo Controlled Period|Other Reasons|0|||
129623318|NCT03142191|466573024|FG003|Placebo Controlled Period|Other Reasons|0|||
129623319|NCT03142191|466573025|FG004|Placebo Controlled Period|Other Reasons|0|||
129623320|NCT03142191|466573021|FG000|Active Treatment Extension Period|Death|2|||
129793423|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793424|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793425|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793426|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793427|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793428|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793429|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793430|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
129793431|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
129793432|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793433|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793434|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793435|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793436|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793437|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129623321|NCT03142191|466573022|FG001|Active Treatment Extension Period|Death|1|||
129623322|NCT03142191|466573023|FG002|Active Treatment Extension Period|Death|1|||
129623323|NCT03142191|466573024|FG003|Active Treatment Extension Period|Death|1|||
129623324|NCT03142191|466573025|FG004|Active Treatment Extension Period|Death|0|||
129623325|NCT03142191|466573021|FG000|Active Treatment Extension Period|Adverse Event|6|||
129623326|NCT03142191|466573022|FG001|Active Treatment Extension Period|Adverse Event|5|||
129623327|NCT03142191|466573023|FG002|Active Treatment Extension Period|Adverse Event|4|||
129623328|NCT03142191|466573024|FG003|Active Treatment Extension Period|Adverse Event|1|||
129623329|NCT03142191|466573025|FG004|Active Treatment Extension Period|Adverse Event|0|||
129623330|NCT03142191|466573021|FG000|Active Treatment Extension Period|Progressive Disease|10|||
129623331|NCT03142191|466573022|FG001|Active Treatment Extension Period|Progressive Disease|5|||
129623332|NCT03142191|466573023|FG002|Active Treatment Extension Period|Progressive Disease|4|||
129623333|NCT03142191|466573024|FG003|Active Treatment Extension Period|Progressive Disease|1|||
129623334|NCT03142191|466573025|FG004|Active Treatment Extension Period|Progressive Disease|2|||
129623335|NCT03142191|466573021|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
129623336|NCT03142191|466573022|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
129623337|NCT03142191|466573023|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
129623338|NCT03142191|466573024|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
129623339|NCT03142191|466573025|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
129623340|NCT03142191|466573021|FG000|Active Treatment Extension Period|Physician Decision|2|||
129623341|NCT03142191|466573022|FG001|Active Treatment Extension Period|Physician Decision|0|||
129623342|NCT03142191|466573023|FG002|Active Treatment Extension Period|Physician Decision|0|||
129623343|NCT03142191|466573024|FG003|Active Treatment Extension Period|Physician Decision|0|||
129623344|NCT03142191|466573025|FG004|Active Treatment Extension Period|Physician Decision|0|||
129623345|NCT03142191|466573021|FG000|Active Treatment Extension Period|Other Reasons|3|||
129623346|NCT03142191|466573022|FG001|Active Treatment Extension Period|Other Reasons|3|||
129623347|NCT03142191|466573023|FG002|Active Treatment Extension Period|Other Reasons|3|||
129623348|NCT03142191|466573024|FG003|Active Treatment Extension Period|Other Reasons|8|||
129623349|NCT03142191|466573025|FG004|Active Treatment Extension Period|Other Reasons|3|||
129623350|NCT03142191|466573021|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
129623351|NCT03142191|466573022|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
129623352|NCT03142191|466573023|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
129623353|NCT03142191|466573024|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
129793438|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793439|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
129793440|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
129793441|NCT02361346|467210806|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129888382|NCT01890967|467549144|FG003|Overall Study|Lost to Follow-up|1|||
129623354|NCT03142191|466573025|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
129623355|NCT00770328|466573028|FG000|Overall Study|Adverse Event|11|||
129623356|NCT00770328|466573029|FG001|Overall Study|Adverse Event|2|||
129623357|NCT00770328|466573028|FG000|Overall Study|Lost to Follow-up|2|||
129623358|NCT00770328|466573029|FG001|Overall Study|Lost to Follow-up|2|||
129623359|NCT01130493|466573030|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
129623360|NCT01130493|466573031|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
129623361|NCT01130493|466573032|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
129623362|NCT01130493|466573030|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
129623363|NCT01130493|466573031|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
129623364|NCT01130493|466573032|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
129623365|NCT01130493|466573030|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
129623366|NCT01130493|466573031|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
129623367|NCT01130493|466573032|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
129623368|NCT01130493|466573030|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
129623369|NCT01130493|466573031|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
129623370|NCT01130493|466573032|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
129623371|NCT01130493|466573030|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
129623372|NCT01130493|466573031|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
129623373|NCT01130493|466573032|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
129623374|NCT01130493|466573030|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
129623375|NCT01130493|466573031|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
129623376|NCT01130493|466573032|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
129623377|NCT01130493|466573030|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
129623378|NCT01130493|466573031|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
129623379|NCT01130493|466573032|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
129793442|NCT02361346|467210807|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793443|NCT02361346|467210808|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793444|NCT02361346|467210809|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793445|NCT02361346|467210810|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793446|NCT02361346|467210811|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793447|NCT02361346|467210812|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793448|NCT02361346|467210813|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
129793449|NCT02361346|467210814|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
129793450|NCT01163318|467210815|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
129793451|NCT01163318|467210815|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
129793452|NCT01163318|467210815|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
129793453|NCT01163318|467210815|FG000|Overall Study|Participants Without Case Report Form|7|||
129793454|NCT01163318|467210815|FG000|Overall Study|Multiple Reasons Per Participant|224|||
129793455|NCT01006603|467210816|FG000|Overall Study|Withdrawal by Subject|17|||
129793456|NCT01006603|467210817|FG001|Overall Study|Withdrawal by Subject|19|||
129793457|NCT01006603|467210816|FG000|Overall Study|Lost to Follow-up|0|||
129888383|NCT01890967|467549145|FG004|Overall Study|Lost to Follow-up|0|||
129623380|NCT01130493|466573030|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
129623381|NCT01130493|466573031|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
129702631|NCT04976855|466871463|FG000|Part I|Withdrawal by Subject|0|||
129888384|NCT01890967|467549146|FG005|Overall Study|Lost to Follow-up|1|||
129623382|NCT01130493|466573032|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
129623383|NCT01130493|466573030|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
129623384|NCT01130493|466573031|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
129702632|NCT04976855|466871464|FG001|Part I|Withdrawal by Subject|1|||
129702633|NCT04976855|466871465|FG002|Part I|Withdrawal by Subject|0|||
129702634|NCT04976855|466871466|FG003|Part I|Withdrawal by Subject|0|||
129702635|NCT04976855|466871467|FG004|Part I|Withdrawal by Subject|0|||
129702636|NCT04976855|466871468|FG005|Part I|Withdrawal by Subject|0|||
129702637|NCT04976855|466871469|FG006|Part I|Withdrawal by Subject|0|||
129702638|NCT04976855|466871463|FG000|Part II|Adverse Event|0|||
129702639|NCT04976855|466871464|FG001|Part II|Adverse Event|0|||
129702640|NCT04976855|466871465|FG002|Part II|Adverse Event|0|||
129702641|NCT04976855|466871466|FG003|Part II|Adverse Event|1|||
129702642|NCT04976855|466871467|FG004|Part II|Adverse Event|0|||
129702643|NCT04976855|466871468|FG005|Part II|Adverse Event|0|||
129702644|NCT04976855|466871469|FG006|Part II|Adverse Event|0|||
129702645|NCT04976855|466871463|FG000|Part II|Withdrawal by Subject|0|||
129793458|NCT01006603|467210817|FG001|Overall Study|Lost to Follow-up|1|||
129793459|NCT01006603|467210816|FG000|Overall Study|Safety reason|1|||
129793460|NCT01006603|467210817|FG001|Overall Study|Safety reason|1|||
129793461|NCT01006603|467210816|FG000|Overall Study|Protocol Violation|1|||
129793462|NCT01006603|467210817|FG001|Overall Study|Protocol Violation|3|||
129793463|NCT01006603|467210816|FG000|Overall Study|Incorrect enrolment|0|||
129793464|NCT01006603|467210817|FG001|Overall Study|Incorrect enrolment|2|||
129793465|NCT01006603|467210816|FG000|Overall Study|Adverse Event|15|||
129702646|NCT04976855|466871464|FG001|Part II|Withdrawal by Subject|0|||
129702647|NCT04976855|466871465|FG002|Part II|Withdrawal by Subject|0|||
129702648|NCT04976855|466871466|FG003|Part II|Withdrawal by Subject|0|||
129623385|NCT01130493|466573032|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
129623386|NCT01130493|466573030|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
129623387|NCT01130493|466573031|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
129623388|NCT01130493|466573032|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
129623389|NCT01130493|466573030|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
129623390|NCT01130493|466573031|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
129702649|NCT04976855|466871467|FG004|Part II|Withdrawal by Subject|1|||
129702650|NCT04976855|466871468|FG005|Part II|Withdrawal by Subject|0|||
129702651|NCT04976855|466871469|FG006|Part II|Withdrawal by Subject|0|||
129702652|NCT04976855|466871463|FG000|Part II|Lost to Follow-up|0|||
129702653|NCT04976855|466871464|FG001|Part II|Lost to Follow-up|0|||
129702654|NCT04976855|466871465|FG002|Part II|Lost to Follow-up|0|||
129702655|NCT04976855|466871466|FG003|Part II|Lost to Follow-up|0|||
129702656|NCT04976855|466871467|FG004|Part II|Lost to Follow-up|0|||
129702657|NCT04976855|466871468|FG005|Part II|Lost to Follow-up|1|||
129702658|NCT04976855|466871469|FG006|Part II|Lost to Follow-up|0|||
129702659|NCT05318287|466871470|FG000|Overall Study|Lost to Follow-up|8|||
129702660|NCT03537508|466871471|FG000|Overall Study|Adverse Event|2|||
129702661|NCT03537508|466871472|FG001|Overall Study|Adverse Event|1|||
129702662|NCT03537508|466871471|FG000|Overall Study|Protocol Violation|65|||
129702663|NCT03537508|466871472|FG001|Overall Study|Protocol Violation|48|||
129702664|NCT03537508|466871471|FG000|Overall Study|Lost to Follow-up|86|||
129702665|NCT03537508|466871472|FG001|Overall Study|Lost to Follow-up|60|||
129702666|NCT03537508|466871471|FG000|Overall Study|Withdrawal by parent/guardian|263|||
129702667|NCT03537508|466871472|FG001|Overall Study|Withdrawal by parent/guardian|149|||
129702668|NCT00835172|466871504|FG000|Washout|Protocol Violation|0|||
129702669|NCT00835172|466871505|FG001|Washout|Protocol Violation|1|||
129702670|NCT02495883|466871506|FG000|Overall Study|Excessive head motion|1|||
129702671|NCT02495883|466871507|FG001|Overall Study|Excessive head motion|0|||
129702672|NCT02776735|466871508|FG000|Overall Study|Adverse Event|0|||
129702673|NCT02776735|466871509|FG001|Overall Study|Adverse Event|0|||
129702674|NCT02776735|466871510|FG002|Overall Study|Adverse Event|0|||
129623391|NCT01130493|466573032|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
129793466|NCT01006603|467210817|FG001|Overall Study|Adverse Event|7|||
129793467|NCT01006603|467210816|FG000|Overall Study|Death|1|||
129793468|NCT01006603|467210817|FG001|Overall Study|Death|1|||
129793469|NCT01006603|467210816|FG000|Overall Study|Study specific discontinuation criteria|33|||
129793470|NCT01006603|467210817|FG001|Overall Study|Study specific discontinuation criteria|34|||
129888385|NCT01890967|467549141|FG000|Overall Study|Protocol Violation|0|||
129623392|NCT01130493|466573030|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
129623393|NCT01130493|466573031|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
129623394|NCT01130493|466573032|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
129623395|NCT01130493|466573030|FG000|Part 2: OLE|Adverse Event|0|||
129623396|NCT01130493|466573031|FG001|Part 2: OLE|Adverse Event|2|||
129623397|NCT01130493|466573032|FG002|Part 2: OLE|Adverse Event|1|||
129623398|NCT01130493|466573030|FG000|Part 2: OLE|Withdrawal by Subject|0|||
129623399|NCT01130493|466573031|FG001|Part 2: OLE|Withdrawal by Subject|1|||
129623400|NCT01130493|466573032|FG002|Part 2: OLE|Withdrawal by Subject|4|||
129623401|NCT03452943|466573033|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
129623402|NCT03452943|466573034|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
129623403|NCT03452943|466573033|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
129623404|NCT03452943|466573034|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
129623405|NCT03452943|466573033|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
129623406|NCT03452943|466573034|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
129623407|NCT03452943|466573033|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
129623408|NCT03452943|466573034|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
129623409|NCT03452943|466573033|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
129623410|NCT03452943|466573034|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
129623411|NCT03452943|466573033|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
129702675|NCT02776735|466871511|FG003|Overall Study|Adverse Event|1|||
129702676|NCT02776735|466871512|FG004|Overall Study|Adverse Event|0|||
129702677|NCT02776735|466871513|FG005|Overall Study|Adverse Event|1|||
129702678|NCT02776735|466871508|FG000|Overall Study|Lost to Follow-up|0|||
129702679|NCT02776735|466871509|FG001|Overall Study|Lost to Follow-up|0|||
129702680|NCT02776735|466871510|FG002|Overall Study|Lost to Follow-up|0|||
129623412|NCT03452943|466573034|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
129623413|NCT03541317|466573035|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
129702681|NCT02776735|466871511|FG003|Overall Study|Lost to Follow-up|1|||
129702682|NCT02776735|466871512|FG004|Overall Study|Lost to Follow-up|0|||
129702683|NCT02776735|466871513|FG005|Overall Study|Lost to Follow-up|0|||
129793471|NCT01006603|467210816|FG000|Overall Study|Other|3|||
129793472|NCT01006603|467210817|FG001|Overall Study|Other|7|||
129793473|NCT05772702|467210825|FG000|Overall Study|Adverse Event|1|||
129793474|NCT00884377|467212666|FG000|Overall Study|Withdrawal by Subject|1|||
129623414|NCT03541317|466573036|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129623415|NCT03541317|466573037|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129623416|NCT03541317|466573038|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129623417|NCT03541317|466573039|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129623418|NCT03541317|466573040|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
129623419|NCT02286843|466573041|FG000|Overall Study|Not Treated|4|||
129623420|NCT02286843|466573041|FG000|Overall Study|Protocol Violation|1|||
129623421|NCT02286843|466573041|FG000|Overall Study|Withdrawal by Subject|1|||
129623422|NCT02536846|466573042|FG000|Overall Study|Withdrawal by Subject|1|||
129623423|NCT02593110|466573043|FG000|Overall Study|Withdrawal by Subject|0|||
129623424|NCT02593110|466573044|FG001|Overall Study|Withdrawal by Subject|3|||
129623425|NCT02593110|466573045|FG002|Overall Study|Withdrawal by Subject|3|||
129702684|NCT02776735|466871508|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129702685|NCT02776735|466871509|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129702686|NCT02776735|466871510|FG002|Overall Study|Withdrawal by parent/guardian|2|||
129702687|NCT02776735|466871511|FG003|Overall Study|Withdrawal by parent/guardian|2|||
129702688|NCT02776735|466871512|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129702689|NCT02776735|466871513|FG005|Overall Study|Withdrawal by parent/guardian|0|||
129702690|NCT02776735|466871508|FG000|Overall Study|Withdrawal by Subject|1|||
129702691|NCT02776735|466871509|FG001|Overall Study|Withdrawal by Subject|0|||
129702692|NCT02776735|466871510|FG002|Overall Study|Withdrawal by Subject|0|||
129702693|NCT02776735|466871511|FG003|Overall Study|Withdrawal by Subject|0|||
129702694|NCT02776735|466871512|FG004|Overall Study|Withdrawal by Subject|0|||
129702695|NCT02776735|466871513|FG005|Overall Study|Withdrawal by Subject|1|||
129702696|NCT02776735|466871508|FG000|Overall Study|Other|0|||
129702697|NCT02776735|466871509|FG001|Overall Study|Other|0|||
129702698|NCT02776735|466871510|FG002|Overall Study|Other|3|||
129702699|NCT02776735|466871511|FG003|Overall Study|Other|0|||
129702700|NCT02776735|466871512|FG004|Overall Study|Other|0|||
129702701|NCT02776735|466871513|FG005|Overall Study|Other|0|||
129702702|NCT00791648|466873118|FG000|Overall Study|Physician Decision|0|||
129702703|NCT00791648|466873119|FG001|Overall Study|Physician Decision|1|||
129702704|NCT00791648|466873118|FG000|Overall Study|Withdrawal by Subject|0|||
129702705|NCT00791648|466873119|FG001|Overall Study|Withdrawal by Subject|1|||
129702706|NCT04976777|466873120|FG000|Overall Study|COVID-19 Infection|1|||
129702707|NCT04976777|466873121|FG001|Overall Study|COVID-19 Infection|0|||
129702708|NCT00462826|466873122|FG000|Overall Study|Ineligible - second primary|1|||
129702709|NCT00462826|466873122|FG000|Overall Study|Ineligible - wrong cell type|1|||
129702710|NCT00462826|466873122|FG000|Overall Study|Ineligible - wrong primary|2|||
129702711|NCT00462826|466873122|FG000|Overall Study|Never treated|1|||
129702712|NCT02332928|466873125|FG000|Overall Study|Withdrawal by Subject|0|||
129702713|NCT02332928|466873126|FG001|Overall Study|Withdrawal by Subject|2|||
129702714|NCT02332928|466873125|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
129702715|NCT02332928|466873126|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
129702716|NCT04484857|466873127|FG000|Overall Study|Adverse Event|2|||
129702717|NCT04484857|466873127|FG000|Overall Study|Death|10|||
129702718|NCT04484857|466873127|FG000|Overall Study|Withdrawal by Subject|3|||
129702719|NCT04484857|466873127|FG000|Overall Study|Transferred/Relocation|5|||
129702720|NCT04484857|466873127|FG000|Overall Study|Kidney Transplant|7|||
129702721|NCT04484857|466873127|FG000|Overall Study|Other than specified|4|||
129702722|NCT04484857|466873127|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
129702723|NCT01822925|466873128|FG000|Overall Study|Adverse Event|1|||
129702724|NCT01822925|466873129|FG001|Overall Study|Adverse Event|1|||
129702725|NCT01822925|466873130|FG002|Overall Study|Adverse Event|1|||
129702726|NCT01822925|466873131|FG003|Overall Study|Adverse Event|1|||
129702727|NCT01822925|466873128|FG000|Overall Study|Lost to Follow-up|0|||
129702728|NCT01822925|466873129|FG001|Overall Study|Lost to Follow-up|1|||
129702729|NCT01822925|466873130|FG002|Overall Study|Lost to Follow-up|0|||
129702730|NCT01822925|466873131|FG003|Overall Study|Lost to Follow-up|0|||
129702731|NCT01822925|466873128|FG000|Overall Study|Protocol Violation|1|||
129702732|NCT01822925|466873129|FG001|Overall Study|Protocol Violation|0|||
129702733|NCT01822925|466873130|FG002|Overall Study|Protocol Violation|0|||
129702734|NCT01822925|466873131|FG003|Overall Study|Protocol Violation|1|||
129702735|NCT01822925|466873128|FG000|Overall Study|Withdrawal by Subject|2|||
129702736|NCT01822925|466873129|FG001|Overall Study|Withdrawal by Subject|0|||
129702737|NCT01822925|466873130|FG002|Overall Study|Withdrawal by Subject|2|||
129702738|NCT01822925|466873131|FG003|Overall Study|Withdrawal by Subject|2|||
129702739|NCT01822925|466873128|FG000|Overall Study|Taking prohibited medication|2|||
129702740|NCT01822925|466873129|FG001|Overall Study|Taking prohibited medication|0|||
129702741|NCT01822925|466873130|FG002|Overall Study|Taking prohibited medication|0|||
129702742|NCT01822925|466873131|FG003|Overall Study|Taking prohibited medication|1|||
129702743|NCT04617860|466873136|FG000|Overall Study|Adverse Event|0|||
129702744|NCT04617860|466873137|FG001|Overall Study|Adverse Event|2|||
129702745|NCT04617860|466873138|FG002|Overall Study|Adverse Event|2|||
129623426|NCT02593110|466573046|FG003|Overall Study|Withdrawal by Subject|2|||
129702746|NCT04617860|466873136|FG000|Overall Study|Withdrawal by Subject|0|||
129623427|NCT02593110|466573043|FG000|Overall Study|Death|0|||
129623428|NCT02593110|466573044|FG001|Overall Study|Death|0|||
129623429|NCT02593110|466573045|FG002|Overall Study|Death|1|||
129623430|NCT02593110|466573046|FG003|Overall Study|Death|0|||
129623431|NCT03086551|466573047|FG000|First Intervention|Failure to meet inclusion criterion|1|||
129623432|NCT03086551|466573048|FG001|First Intervention|Failure to meet inclusion criterion|0|||
129623433|NCT03086551|466573047|FG000|First Intervention|Lost to Follow-up|0|||
129623434|NCT03086551|466573048|FG001|First Intervention|Lost to Follow-up|1|||
129623435|NCT03086551|466573047|FG000|Washout|Lost to Follow-up|1|||
129623436|NCT03086551|466573048|FG001|Washout|Lost to Follow-up|2|||
129623437|NCT03086551|466573047|FG000|Washout|Withdrawal by Subject|2|||
129623438|NCT03086551|466573048|FG001|Washout|Withdrawal by Subject|1|||
129623439|NCT00625872|466573051|FG000|Overall Study|Withdrawal by Subject|1|||
129623440|NCT00625872|466573052|FG001|Overall Study|Withdrawal by Subject|0|||
129623441|NCT00625872|466573051|FG000|Overall Study|Does not meet inclusion criteria|1|||
129623442|NCT00625872|466573052|FG001|Overall Study|Does not meet inclusion criteria|0|||
129623443|NCT00625872|466573051|FG000|Overall Study|Terminated by sponsor|2|||
129623444|NCT00625872|466573052|FG001|Overall Study|Terminated by sponsor|5|||
129623445|NCT00625872|466573051|FG000|Overall Study|Randomized but not treated|0|||
129623446|NCT00625872|466573052|FG001|Overall Study|Randomized but not treated|1|||
129623447|NCT04208750|466573053|FG000|Overall Study|Lost to Follow-up|16|||
129623448|NCT04208750|466573054|FG001|Overall Study|Lost to Follow-up|15|||
129623449|NCT02201277|466573055|FG000|Overall Study|Death|3|||
129623450|NCT02201277|466573056|FG001|Overall Study|Death|4|||
129623451|NCT02201277|466573055|FG000|Overall Study|Lost to Follow-up|2|||
129623452|NCT02201277|466573056|FG001|Overall Study|Lost to Follow-up|1|||
129623453|NCT02201277|466573055|FG000|Overall Study|Failed retrieval|1|||
129623454|NCT02201277|466573056|FG001|Overall Study|Failed retrieval|0|||
129623455|NCT02201277|466573055|FG000|Overall Study|Physician Decision|1|||
129623456|NCT02201277|466573056|FG001|Overall Study|Physician Decision|0|||
129623457|NCT03485352|466573057|FG000|Overall Study|Lost to Follow-up|9|||
129623458|NCT01512160|466573058|FG000|Overall Study|Lost to Follow-up|1|||
129623459|NCT01512160|466573059|FG001|Overall Study|Lost to Follow-up|0|||
129623460|NCT01512160|466573060|FG002|Overall Study|Lost to Follow-up|0|||
129623461|NCT01512160|466573061|FG003|Overall Study|Lost to Follow-up|0|||
129623462|NCT01512160|466573058|FG000|Overall Study|Withdrawal by Subject|1|||
129623463|NCT01512160|466573059|FG001|Overall Study|Withdrawal by Subject|0|||
129623464|NCT01512160|466573060|FG002|Overall Study|Withdrawal by Subject|0|||
129623465|NCT01512160|466573061|FG003|Overall Study|Withdrawal by Subject|1|||
129623466|NCT02163057|466573063|FG000|Overall Study|Participant Refusal to Continue|2|||
129623467|NCT02163057|466573064|FG001|Overall Study|Participant Refusal to Continue|2|||
129623468|NCT02163057|466573063|FG000|Overall Study|Participant Significant Noncompliance|0|||
129623469|NCT02163057|466573064|FG001|Overall Study|Participant Significant Noncompliance|1|||
129623470|NCT02163057|466573063|FG000|Overall Study|Progression of Disease|1|||
129623471|NCT02163057|466573064|FG001|Overall Study|Progression of Disease|2|||
129623472|NCT01959295|466573065|FG000|Overall Study|Adverse Event|2|||
129623473|NCT01959295|466573066|FG001|Overall Study|Adverse Event|0|||
129623474|NCT01959295|466573065|FG000|Overall Study|Lost to Follow-up|0|||
129623475|NCT01959295|466573066|FG001|Overall Study|Lost to Follow-up|2|||
129623476|NCT01959295|466573065|FG000|Overall Study|Physician Decision|2|||
129623477|NCT01959295|466573066|FG001|Overall Study|Physician Decision|3|||
129623478|NCT01959295|466573065|FG000|Overall Study|Protocol Violation|16|||
129623479|NCT01959295|466573066|FG001|Overall Study|Protocol Violation|5|||
129623480|NCT01959295|466573065|FG000|Overall Study|Withdrawal by Subject|3|||
129623481|NCT01959295|466573066|FG001|Overall Study|Withdrawal by Subject|1|||
129623482|NCT01959295|466573065|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
129623483|NCT01959295|466573066|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
129623484|NCT04903288|466574426|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
129623485|NCT04903288|466574426|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
129623486|NCT04903288|466574426|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
129623487|NCT04903288|466574426|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
129623488|NCT05168202|466574430|FG000|Overall Study|Progressive Disease|4|||
129623489|NCT05168202|466574431|FG001|Overall Study|Progressive Disease|4|||
129623490|NCT05168202|466574432|FG002|Overall Study|Progressive Disease|2|||
129623491|NCT05168202|466574433|FG003|Overall Study|Progressive Disease|3|||
129623492|NCT05168202|466574434|FG004|Overall Study|Progressive Disease|2|||
129623493|NCT05168202|466574435|FG005|Overall Study|Progressive Disease|3|||
129623494|NCT05168202|466574436|FG006|Overall Study|Progressive Disease|2|||
129623495|NCT05168202|466574430|FG000|Overall Study|Adverse Event|2|||
129623496|NCT05168202|466574431|FG001|Overall Study|Adverse Event|1|||
129623497|NCT05168202|466574432|FG002|Overall Study|Adverse Event|4|||
129623498|NCT05168202|466574433|FG003|Overall Study|Adverse Event|4|||
129623499|NCT05168202|466574434|FG004|Overall Study|Adverse Event|3|||
129623500|NCT05168202|466574435|FG005|Overall Study|Adverse Event|2|||
129623501|NCT05168202|466574436|FG006|Overall Study|Adverse Event|0|||
129623502|NCT05168202|466574430|FG000|Overall Study|Lack of Efficacy|0|||
129623503|NCT05168202|466574431|FG001|Overall Study|Lack of Efficacy|1|||
129623504|NCT05168202|466574432|FG002|Overall Study|Lack of Efficacy|1|||
129623505|NCT05168202|466574433|FG003|Overall Study|Lack of Efficacy|0|||
129623506|NCT05168202|466574434|FG004|Overall Study|Lack of Efficacy|1|||
129623507|NCT05168202|466574435|FG005|Overall Study|Lack of Efficacy|2|||
129623508|NCT05168202|466574436|FG006|Overall Study|Lack of Efficacy|2|||
129623509|NCT05168202|466574430|FG000|Overall Study|Withdrawal by Subject|0|||
129623510|NCT05168202|466574431|FG001|Overall Study|Withdrawal by Subject|0|||
129623511|NCT05168202|466574432|FG002|Overall Study|Withdrawal by Subject|1|||
129623512|NCT05168202|466574433|FG003|Overall Study|Withdrawal by Subject|1|||
129623513|NCT05168202|466574434|FG004|Overall Study|Withdrawal by Subject|1|||
129623514|NCT05168202|466574435|FG005|Overall Study|Withdrawal by Subject|1|||
129623515|NCT05168202|466574436|FG006|Overall Study|Withdrawal by Subject|0|||
129623516|NCT05168202|466574430|FG000|Overall Study|Disease Relapse|0|||
129793475|NCT00884377|467212667|FG001|Overall Study|Withdrawal by Subject|0|||
129793476|NCT00884377|467212666|FG000|Overall Study|Could not confirm diagnosis|1|||
129793477|NCT00884377|467212667|FG001|Overall Study|Could not confirm diagnosis|0|||
129793478|NCT00884377|467212666|FG000|Overall Study|Physician Decision|0|||
129793479|NCT00884377|467212667|FG001|Overall Study|Physician Decision|1|||
129793480|NCT02003365|467212668|FG000|Overall Study|Lost to Follow-up|0|||
129623517|NCT05168202|466574431|FG001|Overall Study|Disease Relapse|1|||
129623518|NCT05168202|466574432|FG002|Overall Study|Disease Relapse|0|||
129623519|NCT05168202|466574433|FG003|Overall Study|Disease Relapse|1|||
129623520|NCT05168202|466574434|FG004|Overall Study|Disease Relapse|1|||
129623521|NCT05168202|466574435|FG005|Overall Study|Disease Relapse|0|||
129623522|NCT05168202|466574436|FG006|Overall Study|Disease Relapse|0|||
129793481|NCT02003365|467212669|FG001|Overall Study|Lost to Follow-up|0|||
129793482|NCT02003365|467212670|FG002|Overall Study|Lost to Follow-up|1|||
129793483|NCT00622739|467212671|FG000|Overall Study|Physician Decision|1|||
129623523|NCT05168202|466574430|FG000|Overall Study|Other Reasons|0|||
129702747|NCT04617860|466873137|FG001|Overall Study|Withdrawal by Subject|0|||
129702748|NCT04617860|466873138|FG002|Overall Study|Withdrawal by Subject|2|||
129702749|NCT04617860|466873136|FG000|Overall Study|Physician Decision|0|||
129702750|NCT04617860|466873137|FG001|Overall Study|Physician Decision|1|||
129702751|NCT04617860|466873138|FG002|Overall Study|Physician Decision|0|||
129702752|NCT04617860|466873136|FG000|Overall Study|Sponsor Decision|0|||
129702753|NCT04617860|466873137|FG001|Overall Study|Sponsor Decision|3|||
129702754|NCT04617860|466873138|FG002|Overall Study|Sponsor Decision|1|||
129702755|NCT04617860|466873136|FG000|Overall Study|Termination of Study by Sponsor|8|||
129702756|NCT04617860|466873137|FG001|Overall Study|Termination of Study by Sponsor|4|||
129702757|NCT04617860|466873138|FG002|Overall Study|Termination of Study by Sponsor|13|||
129702758|NCT01055028|466873139|FG000|Screening|Screen Failure|1|||
129702759|NCT01055028|466873140|FG001|Screening|Screen Failure|1|||
129702760|NCT01055028|466873139|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
129702761|NCT01055028|466873140|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
129702762|NCT01055028|466873139|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
129702763|NCT01055028|466873140|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
129702764|NCT01055028|466873139|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
129702765|NCT01055028|466873140|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
129702766|NCT06582732|466873141|FG000|Initial Study Period|Adverse Event|0|||
129702767|NCT06582732|466873142|FG001|Initial Study Period|Adverse Event|0|||
129702768|NCT06582732|466873143|FG002|Initial Study Period|Adverse Event|0|||
129702769|NCT06582732|466873144|FG003|Initial Study Period|Adverse Event|2|||
129702770|NCT06582732|466873145|FG004|Initial Study Period|Adverse Event|0|||
129702771|NCT06582732|466873146|FG005|Initial Study Period|Adverse Event|0|||
129702772|NCT06582732|466873147|FG006|Initial Study Period|Adverse Event|0|||
129702773|NCT06582732|466873141|FG000|Initial Study Period|Death|1|||
129702774|NCT06582732|466873142|FG001|Initial Study Period|Death|0|||
129702775|NCT06582732|466873143|FG002|Initial Study Period|Death|0|||
129702776|NCT06582732|466873144|FG003|Initial Study Period|Death|0|||
129702777|NCT06582732|466873145|FG004|Initial Study Period|Death|1|||
129702778|NCT06582732|466873146|FG005|Initial Study Period|Death|0|||
129702779|NCT06582732|466873147|FG006|Initial Study Period|Death|0|||
129702780|NCT06582732|466873141|FG000|Initial Study Period|Lost to Follow-up|0|||
129702781|NCT06582732|466873142|FG001|Initial Study Period|Lost to Follow-up|0|||
129702782|NCT06582732|466873143|FG002|Initial Study Period|Lost to Follow-up|2|||
129702783|NCT06582732|466873144|FG003|Initial Study Period|Lost to Follow-up|0|||
129702784|NCT06582732|466873145|FG004|Initial Study Period|Lost to Follow-up|0|||
129702785|NCT06582732|466873146|FG005|Initial Study Period|Lost to Follow-up|0|||
129702786|NCT06582732|466873147|FG006|Initial Study Period|Lost to Follow-up|0|||
129702787|NCT06582732|466873141|FG000|Initial Study Period|Withdrawal by Subject|0|||
129702788|NCT06582732|466873142|FG001|Initial Study Period|Withdrawal by Subject|1|||
129793484|NCT00622739|467212672|FG001|Overall Study|Physician Decision|0|||
129793485|NCT00622739|467212671|FG000|Overall Study|Adverse Event|1|||
129793486|NCT00622739|467212672|FG001|Overall Study|Adverse Event|2|||
129793487|NCT00622739|467212671|FG000|Overall Study|Lack of Efficacy|0|||
129793488|NCT00622739|467212672|FG001|Overall Study|Lack of Efficacy|2|||
129793489|NCT00622739|467212671|FG000|Overall Study|Withdrawal by Subject|0|||
129793490|NCT00622739|467212672|FG001|Overall Study|Withdrawal by Subject|1|||
129793491|NCT00622739|467212671|FG000|Overall Study|Lost to Follow-up|0|||
129793492|NCT00622739|467212672|FG001|Overall Study|Lost to Follow-up|1|||
129793493|NCT03387150|467212673|FG000|Overall Study|Withdrawal by Subject|3|||
129793494|NCT03387150|467212674|FG001|Overall Study|Withdrawal by Subject|0|||
129793495|NCT03387150|467212675|FG002|Overall Study|Withdrawal by Subject|3|||
129793496|NCT03387150|467212676|FG003|Overall Study|Withdrawal by Subject|4|||
129793497|NCT03387150|467212677|FG004|Overall Study|Withdrawal by Subject|1|||
129793498|NCT03387150|467212678|FG005|Overall Study|Withdrawal by Subject|2|||
129793499|NCT03387150|467212679|FG006|Overall Study|Withdrawal by Subject|0|||
129793500|NCT03387150|467212673|FG000|Overall Study|Lost to Follow-up|3|||
129793501|NCT03387150|467212674|FG001|Overall Study|Lost to Follow-up|2|||
129793502|NCT03387150|467212675|FG002|Overall Study|Lost to Follow-up|2|||
129793503|NCT03387150|467212676|FG003|Overall Study|Lost to Follow-up|3|||
129702789|NCT06582732|466873143|FG002|Initial Study Period|Withdrawal by Subject|0|||
129702790|NCT06582732|466873144|FG003|Initial Study Period|Withdrawal by Subject|1|||
129702791|NCT06582732|466873145|FG004|Initial Study Period|Withdrawal by Subject|3|||
129702792|NCT06582732|466873146|FG005|Initial Study Period|Withdrawal by Subject|1|||
129702793|NCT06582732|466873147|FG006|Initial Study Period|Withdrawal by Subject|2|||
129702794|NCT06582732|466873141|FG000|Initial Study Period|Moved Away|0|||
129702795|NCT06582732|466873142|FG001|Initial Study Period|Moved Away|0|||
129702796|NCT06582732|466873143|FG002|Initial Study Period|Moved Away|0|||
129702797|NCT06582732|466873144|FG003|Initial Study Period|Moved Away|0|||
129702798|NCT06582732|466873145|FG004|Initial Study Period|Moved Away|1|||
129793504|NCT03387150|467212677|FG004|Overall Study|Lost to Follow-up|3|||
129793505|NCT03387150|467212678|FG005|Overall Study|Lost to Follow-up|3|||
129793506|NCT03387150|467212679|FG006|Overall Study|Lost to Follow-up|0|||
129793507|NCT03387150|467212673|FG000|Overall Study|Participant unable to adhere to visit|0|||
129623524|NCT05168202|466574431|FG001|Overall Study|Other Reasons|0|||
129623525|NCT05168202|466574432|FG002|Overall Study|Other Reasons|0|||
129623526|NCT05168202|466574433|FG003|Overall Study|Other Reasons|0|||
129623527|NCT05168202|466574434|FG004|Overall Study|Other Reasons|0|||
129623528|NCT05168202|466574435|FG005|Overall Study|Other Reasons|2|||
129623529|NCT05168202|466574436|FG006|Overall Study|Other Reasons|1|||
129623530|NCT05168202|466574430|FG000|Overall Study|Physician Decision|0|||
129623531|NCT05168202|466574431|FG001|Overall Study|Physician Decision|1|||
129623532|NCT05168202|466574432|FG002|Overall Study|Physician Decision|1|||
129702799|NCT06582732|466873146|FG005|Initial Study Period|Moved Away|0|||
129702800|NCT06582732|466873147|FG006|Initial Study Period|Moved Away|0|||
129702801|NCT01182350|466873148|FG000|Overall Study|Adverse Event|5|||
129702802|NCT01182350|466873149|FG001|Overall Study|Adverse Event|0|||
129702803|NCT01182350|466873150|FG002|Overall Study|Adverse Event|0|||
129702804|NCT01182350|466873151|FG003|Overall Study|Adverse Event|0|||
129702805|NCT01182350|466873152|FG004|Overall Study|Adverse Event|0|||
129702806|NCT01182350|466873148|FG000|Overall Study|Disease Progression|15|||
129702807|NCT01182350|466873149|FG001|Overall Study|Disease Progression|12|||
129702808|NCT01182350|466873150|FG002|Overall Study|Disease Progression|0|||
129702809|NCT01182350|466873151|FG003|Overall Study|Disease Progression|1|||
129702810|NCT01182350|466873152|FG004|Overall Study|Disease Progression|0|||
129702811|NCT01182350|466873148|FG000|Overall Study|Death|0|||
129702812|NCT01182350|466873149|FG001|Overall Study|Death|1|||
129702813|NCT01182350|466873150|FG002|Overall Study|Death|1|||
129702814|NCT01182350|466873151|FG003|Overall Study|Death|0|||
129702815|NCT01182350|466873152|FG004|Overall Study|Death|0|||
129702816|NCT01182350|466873148|FG000|Overall Study|Withdrawal by Subject|3|||
129702817|NCT01182350|466873149|FG001|Overall Study|Withdrawal by Subject|1|||
129702818|NCT01182350|466873150|FG002|Overall Study|Withdrawal by Subject|0|||
129702819|NCT01182350|466873151|FG003|Overall Study|Withdrawal by Subject|1|||
129702820|NCT01182350|466873152|FG004|Overall Study|Withdrawal by Subject|0|||
129702821|NCT01182350|466873148|FG000|Overall Study|Alternative Therapy|2|||
129702822|NCT01182350|466873149|FG001|Overall Study|Alternative Therapy|0|||
129702823|NCT01182350|466873150|FG002|Overall Study|Alternative Therapy|1|||
129702824|NCT01182350|466873151|FG003|Overall Study|Alternative Therapy|0|||
129702825|NCT01182350|466873152|FG004|Overall Study|Alternative Therapy|0|||
129702826|NCT01182350|466873148|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
129702827|NCT01182350|466873149|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
129702828|NCT01182350|466873150|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
129702829|NCT01182350|466873151|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
129702830|NCT01182350|466873152|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
129702831|NCT01182350|466873148|FG000|Overall Study|Unevaluable for Biopsy|0|||
129702832|NCT01182350|466873149|FG001|Overall Study|Unevaluable for Biopsy|0|||
129702833|NCT01182350|466873150|FG002|Overall Study|Unevaluable for Biopsy|0|||
129702834|NCT01182350|466873151|FG003|Overall Study|Unevaluable for Biopsy|0|||
129702835|NCT01182350|466873152|FG004|Overall Study|Unevaluable for Biopsy|3|||
129702836|NCT03898180|466873153|FG000|Overall Study|Death|178|||
129702837|NCT03898180|466873154|FG001|Overall Study|Death|173|||
129702838|NCT03898180|466873153|FG000|Overall Study|Physician Decision|1|||
129702839|NCT03898180|466873154|FG001|Overall Study|Physician Decision|0|||
129702840|NCT03898180|466873153|FG000|Overall Study|Sponsor Decision|3|||
129702841|NCT03898180|466873154|FG001|Overall Study|Sponsor Decision|0|||
129702842|NCT03898180|466873153|FG000|Overall Study|Lost to Follow-up|1|||
129702843|NCT03898180|466873154|FG001|Overall Study|Lost to Follow-up|0|||
129702844|NCT03898180|466873153|FG000|Overall Study|Withdrawal by Subject|5|||
129702845|NCT03898180|466873154|FG001|Overall Study|Withdrawal by Subject|4|||
129702846|NCT02507934|466873155|FG000|Overall Study|Lost to Follow-up|2|||
129702847|NCT02507934|466873156|FG001|Overall Study|Lost to Follow-up|0|||
129702848|NCT02507934|466873155|FG000|Overall Study|Withdrawal by Subject|2|||
129702849|NCT02507934|466873156|FG001|Overall Study|Withdrawal by Subject|0|||
129702850|NCT03559530|466873157|FG000|Overall Study|non-location of medical records|44|||
129702851|NCT03559530|466873158|FG001|Overall Study|non-location of medical records|0|||
129702852|NCT03559530|466873157|FG000|Overall Study|culture results not considered for treat|29|||
129888386|NCT01890967|467549142|FG001|Overall Study|Protocol Violation|3|||
129702853|NCT03559530|466873158|FG001|Overall Study|culture results not considered for treat|0|||
129702854|NCT03559530|466873157|FG000|Overall Study|duplicate cases|8|||
129702855|NCT03559530|466873158|FG001|Overall Study|duplicate cases|0|||
129702856|NCT03559530|466873157|FG000|Overall Study|other species of Acinetobacte|7|||
129702857|NCT03559530|466873158|FG001|Overall Study|other species of Acinetobacte|0|||
129702858|NCT03559530|466873157|FG000|Overall Study|contamination / colonization|3|||
129702859|NCT03559530|466873158|FG001|Overall Study|contamination / colonization|0|||
129702860|NCT03331354|466873159|FG000|Overall Study|Withdrawal by Subject|1|||
129702861|NCT03331354|466873160|FG001|Overall Study|Withdrawal by Subject|3|||
129702862|NCT03331354|466873159|FG000|Overall Study|Lost to Follow-up|3|||
129702863|NCT03331354|466873160|FG001|Overall Study|Lost to Follow-up|3|||
129707774|NCT00542178|466892124|FG005|Overall Study|did not complete year 4 follow-up|89|||
129623533|NCT05168202|466574433|FG003|Overall Study|Physician Decision|0|||
129623534|NCT05168202|466574434|FG004|Overall Study|Physician Decision|0|||
129623535|NCT05168202|466574435|FG005|Overall Study|Physician Decision|0|||
129623536|NCT05168202|466574436|FG006|Overall Study|Physician Decision|0|||
129623537|NCT05168202|466574430|FG000|Overall Study|Study Terminated by Sponsor|0|||
129623538|NCT05168202|466574431|FG001|Overall Study|Study Terminated by Sponsor|0|||
129623539|NCT05168202|466574432|FG002|Overall Study|Study Terminated by Sponsor|0|||
129623540|NCT05168202|466574433|FG003|Overall Study|Study Terminated by Sponsor|1|||
129623541|NCT05168202|466574434|FG004|Overall Study|Study Terminated by Sponsor|0|||
129623542|NCT05168202|466574435|FG005|Overall Study|Study Terminated by Sponsor|0|||
129623543|NCT05168202|466574436|FG006|Overall Study|Study Terminated by Sponsor|0|||
129623544|NCT05878093|466574437|FG000|Overall Study|Withdrawal by Subject|3|||
129623545|NCT05878093|466574438|FG001|Overall Study|Withdrawal by Subject|1|||
129623546|NCT03690388|466574441|FG000|Overall Study|Adverse Event|8|||
129623547|NCT03690388|466574442|FG001|Overall Study|Adverse Event|1|||
129623548|NCT03690388|466574441|FG000|Overall Study|Radiographic Progression|14|||
129623549|NCT03690388|466574442|FG001|Overall Study|Radiographic Progression|29|||
129623550|NCT03690388|466574441|FG000|Overall Study|Clinical deterioration|10|||
129793508|NCT03387150|467212674|FG001|Overall Study|Participant unable to adhere to visit|1|||
129623551|NCT03690388|466574442|FG001|Overall Study|Clinical deterioration|6|||
129793509|NCT03387150|467212675|FG002|Overall Study|Participant unable to adhere to visit|0|||
129793510|NCT03387150|467212676|FG003|Overall Study|Participant unable to adhere to visit|0|||
129793511|NCT03387150|467212677|FG004|Overall Study|Participant unable to adhere to visit|2|||
129793512|NCT03387150|467212678|FG005|Overall Study|Participant unable to adhere to visit|2|||
129793513|NCT03387150|467212679|FG006|Overall Study|Participant unable to adhere to visit|0|||
129793514|NCT02448680|467212681|FG000|Overall Study|Physician Decision|1|||
129623552|NCT03690388|466574441|FG000|Overall Study|Withdrawal by Subject|2|||
129623553|NCT03690388|466574442|FG001|Overall Study|Withdrawal by Subject|0|||
129623554|NCT03690388|466574441|FG000|Overall Study|Lack of Efficacy|1|||
129623555|NCT03690388|466574442|FG001|Overall Study|Lack of Efficacy|0|||
129623556|NCT03690388|466574441|FG000|Overall Study|Lost to Follow-up|1|||
129623557|NCT03690388|466574442|FG001|Overall Study|Lost to Follow-up|0|||
129623558|NCT04100018|466574444|FG000|Pre-Treatment Period|Not Reported|0|||
129623559|NCT04100018|466574445|FG001|Pre-Treatment Period|Not Reported|4|||
129623560|NCT04100018|466574444|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
129623561|NCT04100018|466574445|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
129623562|NCT04100018|466574444|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
129623563|NCT04100018|466574445|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
129623564|NCT04100018|466574444|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
129623565|NCT04100018|466574445|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129623566|NCT04100018|466574444|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129623567|NCT04100018|466574445|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
129623568|NCT04100018|466574444|FG000|Treatment Period|Ongoing Treatment|1|||
129623569|NCT04100018|466574445|FG001|Treatment Period|Ongoing Treatment|0|||
129623570|NCT04100018|466574444|FG000|Treatment Period|Other Reason|26|||
129623571|NCT04100018|466574445|FG001|Treatment Period|Other Reason|37|||
129623572|NCT04100018|466574444|FG000|Treatment Period|Completed treatment as per protocol|1|||
129623573|NCT04100018|466574445|FG001|Treatment Period|Completed treatment as per protocol|2|||
129623574|NCT04100018|466574444|FG000|Treatment Period|Maximum clinical benefit|3|||
129623575|NCT04100018|466574445|FG001|Treatment Period|Maximum clinical benefit|0|||
129623576|NCT04100018|466574444|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
129623577|NCT04100018|466574445|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
129623578|NCT04100018|466574444|FG000|Treatment Period|Study drug toxicity|67|||
129623579|NCT04100018|466574445|FG001|Treatment Period|Study drug toxicity|28|||
129623580|NCT04100018|466574444|FG000|Treatment Period|Disease Progression|284|||
129623581|NCT04100018|466574445|FG001|Treatment Period|Disease Progression|327|||
129623582|NCT04100018|466574444|FG000|Treatment Period|Administrative reasons by sponsor|16|||
129623583|NCT04100018|466574445|FG001|Treatment Period|Administrative reasons by sponsor|30|||
129623584|NCT04100018|466574444|FG000|Treatment Period|Poor/Non-Compliance|1|||
129623585|NCT04100018|466574445|FG001|Treatment Period|Poor/Non-Compliance|0|||
129623586|NCT04100018|466574444|FG000|Treatment Period|Lost to Follow-up|2|||
129623587|NCT04100018|466574445|FG001|Treatment Period|Lost to Follow-up|2|||
129793515|NCT02448680|467212682|FG001|Overall Study|Physician Decision|1|||
129623588|NCT04100018|466574444|FG000|Treatment Period|Death|16|||
129623589|NCT04100018|466574445|FG001|Treatment Period|Death|11|||
129793516|NCT02448680|467212681|FG000|Overall Study|Withdrawal by Subject|0|||
129793517|NCT02448680|467212682|FG001|Overall Study|Withdrawal by Subject|2|||
129623590|NCT04100018|466574444|FG000|Treatment Period|Participant withdrew consent|10|||
129623591|NCT04100018|466574445|FG001|Treatment Period|Participant withdrew consent|10|||
129623592|NCT04100018|466574444|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
129623593|NCT04100018|466574445|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
129623594|NCT04100018|466574444|FG000|Treatment Period|Adverse Event|14|||
129623595|NCT04100018|466574445|FG001|Treatment Period|Adverse Event|6|||
129623596|NCT04100018|466574444|FG000|Treatment Period|Lack of Efficacy|4|||
129623597|NCT04100018|466574445|FG001|Treatment Period|Lack of Efficacy|2|||
129623598|NCT02090725|466574450|FG000|Overall Study|Withdrawal by Subject|1|||
129623599|NCT02090725|466574450|FG000|Overall Study|participants moved from area|3|||
129623600|NCT04358081|466574451|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
129888387|NCT01890967|467549143|FG002|Overall Study|Protocol Violation|3|||
129888388|NCT01890967|467549144|FG003|Overall Study|Protocol Violation|2|||
129888389|NCT01890967|467549145|FG004|Overall Study|Protocol Violation|4|||
129888390|NCT01890967|467549146|FG005|Overall Study|Protocol Violation|1|||
129888391|NCT01890967|467549141|FG000|Overall Study|Sponsor Decision|2|||
129888392|NCT01890967|467549142|FG001|Overall Study|Sponsor Decision|0|||
129888393|NCT01890967|467549143|FG002|Overall Study|Sponsor Decision|1|||
129888394|NCT01890967|467549144|FG003|Overall Study|Sponsor Decision|3|||
129888395|NCT01890967|467549145|FG004|Overall Study|Sponsor Decision|2|||
129888396|NCT01890967|467549146|FG005|Overall Study|Sponsor Decision|3|||
129888397|NCT01890967|467549141|FG000|Overall Study|Withdrawal by Subject|3|||
129888398|NCT01890967|467549142|FG001|Overall Study|Withdrawal by Subject|4|||
129888399|NCT01890967|467549143|FG002|Overall Study|Withdrawal by Subject|2|||
129888400|NCT01890967|467549144|FG003|Overall Study|Withdrawal by Subject|3|||
129888401|NCT01890967|467549145|FG004|Overall Study|Withdrawal by Subject|3|||
129888402|NCT01890967|467549146|FG005|Overall Study|Withdrawal by Subject|1|||
129888403|NCT01383993|467549148|FG000|Overall Study|Adverse Event|1|||
129623601|NCT04358081|466574452|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
129888404|NCT01383993|467549149|FG001|Overall Study|Adverse Event|1|||
129888405|NCT01383993|467549150|FG002|Overall Study|Adverse Event|0|||
129888406|NCT01383993|467549148|FG000|Overall Study|Withdrawal by Subject|0|||
129888407|NCT01383993|467549149|FG001|Overall Study|Withdrawal by Subject|0|||
129888408|NCT01383993|467549150|FG002|Overall Study|Withdrawal by Subject|1|||
129623602|NCT04358081|466574453|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
129623603|NCT04358081|466574451|FG000|Treatment Phase of Study|Adverse Event|1|||
129623604|NCT04358081|466574452|FG001|Treatment Phase of Study|Adverse Event|0|||
129623605|NCT04358081|466574453|FG002|Treatment Phase of Study|Adverse Event|1|||
129623606|NCT04358081|466574451|FG000|Treatment Phase of Study|Physician Decision|2|||
129623607|NCT04358081|466574452|FG001|Treatment Phase of Study|Physician Decision|0|||
129623608|NCT04358081|466574453|FG002|Treatment Phase of Study|Physician Decision|1|||
129623609|NCT04358081|466574451|FG000|Treatment Phase of Study|Protocol Violation|1|||
129623610|NCT04358081|466574452|FG001|Treatment Phase of Study|Protocol Violation|0|||
129623611|NCT04358081|466574453|FG002|Treatment Phase of Study|Protocol Violation|0|||
129623612|NCT04358081|466574451|FG000|Study Completion Phase|Death|0|||
129623613|NCT04358081|466574452|FG001|Study Completion Phase|Death|0|||
129623614|NCT04358081|466574453|FG002|Study Completion Phase|Death|1|||
129623615|NCT04358081|466574451|FG000|Study Completion Phase|Lost to Follow-up|1|||
129623616|NCT04358081|466574452|FG001|Study Completion Phase|Lost to Follow-up|0|||
129623617|NCT04358081|466574453|FG002|Study Completion Phase|Lost to Follow-up|1|||
129623618|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
129623619|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
129623620|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
129623621|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
129623622|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
129623623|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
129623624|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
129623625|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
129623626|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
129623627|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
129623628|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
129623629|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
129623630|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
129623631|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
129623632|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
129623633|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
129623634|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
129623635|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
129623636|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
129623637|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
129623638|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
129623639|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
129623640|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
129623641|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
129623642|NCT01130532|466574454|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
129623643|NCT01130532|466574455|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
129623644|NCT01130532|466574456|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
129623645|NCT01130532|466574457|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
129623646|NCT01130532|466574454|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
129623647|NCT01130532|466574455|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
129623648|NCT01130532|466574456|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
129623649|NCT01130532|466574457|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
129623650|NCT01130532|466574454|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
129623651|NCT01130532|466574455|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
129623652|NCT01130532|466574456|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
129623653|NCT01130532|466574457|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
129623654|NCT01130532|466574454|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
129623655|NCT01130532|466574455|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
129623656|NCT01130532|466574456|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
129623657|NCT01130532|466574457|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
129623658|NCT01130532|466574454|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
129623659|NCT01130532|466574455|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
129623660|NCT01130532|466574456|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
129623661|NCT01130532|466574457|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
129623662|NCT02656303|466574458|FG000|Overall Study|Adverse Event|3|||
129623663|NCT02656303|466574459|FG001|Overall Study|Adverse Event|2|||
129623664|NCT02656303|466574460|FG002|Overall Study|Adverse Event|0|||
129623665|NCT02656303|466574458|FG000|Overall Study|Death|12|||
129623666|NCT02656303|466574459|FG001|Overall Study|Death|4|||
129623667|NCT02656303|466574460|FG002|Overall Study|Death|1|||
129623668|NCT02656303|466574458|FG000|Overall Study|Lack of Efficacy|1|||
129623669|NCT02656303|466574459|FG001|Overall Study|Lack of Efficacy|0|||
129702864|NCT03331354|466873159|FG000|Overall Study|Found employment before initiated active intervention|0|||
129623670|NCT02656303|466574460|FG002|Overall Study|Lack of Efficacy|0|||
129623671|NCT02656303|466574458|FG000|Overall Study|Non-Compliance with Study|1|||
129623672|NCT02656303|466574459|FG001|Overall Study|Non-Compliance with Study|1|||
129623673|NCT02656303|466574460|FG002|Overall Study|Non-Compliance with Study|0|||
129623674|NCT02656303|466574458|FG000|Overall Study|Investigator Decision|2|||
129623675|NCT02656303|466574459|FG001|Overall Study|Investigator Decision|1|||
129702865|NCT03331354|466873160|FG001|Overall Study|Found employment before initiated active intervention|4|||
129623676|NCT02656303|466574460|FG002|Overall Study|Investigator Decision|0|||
129623677|NCT02656303|466574458|FG000|Overall Study|Progressive Disease|25|||
129623678|NCT02656303|466574459|FG001|Overall Study|Progressive Disease|14|||
129623679|NCT02656303|466574460|FG002|Overall Study|Progressive Disease|10|||
129623680|NCT02656303|466574458|FG000|Overall Study|Study Terminated by Sponsor|20|||
129623681|NCT02656303|466574459|FG001|Overall Study|Study Terminated by Sponsor|7|||
129623682|NCT02656303|466574460|FG002|Overall Study|Study Terminated by Sponsor|5|||
129623683|NCT02656303|466574458|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
129623684|NCT02656303|466574459|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
129623685|NCT02656303|466574460|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
129623686|NCT02656303|466574458|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
129623687|NCT02656303|466574459|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
129623688|NCT02656303|466574460|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
129623689|NCT02656303|466574458|FG000|Overall Study|Reason not Specified|1|||
129623690|NCT02656303|466574459|FG001|Overall Study|Reason not Specified|1|||
129623691|NCT02656303|466574460|FG002|Overall Study|Reason not Specified|2|||
129623692|NCT03041311|466574461|FG000|Overall Study|Death|39|||
129623693|NCT03041311|466574462|FG001|Overall Study|Death|42|||
129623694|NCT03041311|466574461|FG000|Overall Study|Lost to Follow-up|0|||
129623695|NCT03041311|466574462|FG001|Overall Study|Lost to Follow-up|1|||
129623696|NCT03041311|466574461|FG000|Overall Study|Withdrawal by Subject|8|||
129623697|NCT03041311|466574462|FG001|Overall Study|Withdrawal by Subject|5|||
129623698|NCT03041311|466574461|FG000|Overall Study|Sponsor Terminated Study|2|||
129623699|NCT03041311|466574462|FG001|Overall Study|Sponsor Terminated Study|4|||
129623700|NCT03041311|466574461|FG000|Overall Study|Disease Progression|3|||
129623701|NCT03041311|466574462|FG001|Overall Study|Disease Progression|1|||
129623702|NCT03041311|466574461|FG000|Overall Study|Randomized in error, did not receive drug|2|||
129623703|NCT03041311|466574462|FG001|Overall Study|Randomized in error, did not receive drug|0|||
129623704|NCT01842438|466574463|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
129623705|NCT01842438|466574464|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
129623706|NCT01842438|466574463|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
129623707|NCT01842438|466574464|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
129623708|NCT01842438|466574463|FG000|T2: 6month Follow-up|Death|0|||
129623709|NCT01842438|466574464|FG001|T2: 6month Follow-up|Death|1|||
129623710|NCT00782626|466574468|FG000|Overall Study|Adverse Event|1|||
129623711|NCT00782626|466574468|FG000|Overall Study|Progressive Disease|5|||
129623712|NCT00782626|466574468|FG000|Overall Study|Other Complicating Disease|1|||
129623713|NCT04909853|466574469|FG000|Part 1|Assigned but not treated|0|||
129623714|NCT04909853|466574470|FG001|Part 1|Assigned but not treated|0|||
129623715|NCT04909853|466574471|FG002|Part 1|Assigned but not treated|1|||
129623716|NCT04909853|466574472|FG003|Part 1|Assigned but not treated|0|||
129623717|NCT04909853|466574469|FG000|Part 2|Adverse Event|0|||
129623718|NCT04909853|466574470|FG001|Part 2|Adverse Event|0|||
129623719|NCT04909853|466574471|FG002|Part 2|Adverse Event|0|||
129623720|NCT04909853|466574472|FG003|Part 2|Adverse Event|1|||
129623721|NCT04054765|466574473|FG000|Baseline|Withdrawal by Subject|5|||
129623722|NCT04054765|466574474|FG001|Baseline|Withdrawal by Subject|3|||
129623723|NCT04054765|466574473|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
129623724|NCT04054765|466574474|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
129623725|NCT04054765|466574473|FG000|3-month Follow up|Withdrawal by Subject|0|||
129623726|NCT04054765|466574474|FG001|3-month Follow up|Withdrawal by Subject|3|||
129623727|NCT04054765|466574473|FG000|6-month Follow up|Lost to Follow-up|32|||
129623728|NCT04054765|466574474|FG001|6-month Follow up|Lost to Follow-up|32|||
129623729|NCT04182490|466574476|FG000|Overall Study|Withdrawal by Subject|3|||
129623730|NCT04182490|466574477|FG001|Overall Study|Withdrawal by Subject|3|||
129623731|NCT04182490|466574476|FG000|Overall Study|Lost to Follow-up|0|||
129623732|NCT04182490|466574477|FG001|Overall Study|Lost to Follow-up|1|||
129623733|NCT04182490|466574476|FG000|Overall Study|Physician Decision|0|||
129623734|NCT04182490|466574477|FG001|Overall Study|Physician Decision|1|||
129623735|NCT00853099|466574478|FG000|Double-blind Period|Adverse Event|7|||
129623736|NCT00853099|466574479|FG001|Double-blind Period|Adverse Event|9|||
129623737|NCT00853099|466574480|FG002|Double-blind Period|Adverse Event|13|||
129623738|NCT00853099|466574481|FG003|Double-blind Period|Adverse Event|0|||
129623739|NCT00853099|466574478|FG000|Double-blind Period|Withdrawal by Subject|2|||
129793518|NCT01857310|467212683|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
129793519|NCT01857310|467212684|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
129793520|NCT00998764|467212685|FG000|Overall Study|Lack of Efficacy|3|||
129793521|NCT00998764|467212686|FG001|Overall Study|Lack of Efficacy|6|||
129793522|NCT00998764|467212685|FG000|Overall Study|Adverse Event|17|||
129793523|NCT00998764|467212686|FG001|Overall Study|Adverse Event|12|||
129793524|NCT00998764|467212685|FG000|Overall Study|Withdrawal by Subject|19|||
129793525|NCT00998764|467212686|FG001|Overall Study|Withdrawal by Subject|25|||
129793526|NCT00998764|467212685|FG000|Overall Study|Physician Decision|3|||
129623740|NCT00853099|466574479|FG001|Double-blind Period|Withdrawal by Subject|3|||
129623741|NCT00853099|466574480|FG002|Double-blind Period|Withdrawal by Subject|0|||
129623742|NCT00853099|466574481|FG003|Double-blind Period|Withdrawal by Subject|0|||
129623743|NCT00853099|466574478|FG000|Double-blind Period|Lack of Efficacy|14|||
129623744|NCT00853099|466574479|FG001|Double-blind Period|Lack of Efficacy|17|||
129623745|NCT00853099|466574480|FG002|Double-blind Period|Lack of Efficacy|16|||
129623746|NCT00853099|466574481|FG003|Double-blind Period|Lack of Efficacy|0|||
129623747|NCT00853099|466574478|FG000|Double-blind Period|Other|0|||
129623748|NCT00853099|466574479|FG001|Double-blind Period|Other|0|||
129623749|NCT00853099|466574480|FG002|Double-blind Period|Other|1|||
129623750|NCT00853099|466574481|FG003|Double-blind Period|Other|0|||
129623751|NCT00853099|466574478|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
129623752|NCT00853099|466574479|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
129623753|NCT00853099|466574480|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
129623754|NCT00853099|466574481|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
129623755|NCT00853099|466574478|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
129623756|NCT00853099|466574479|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
129623757|NCT00853099|466574480|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
129623758|NCT00853099|466574481|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
129623759|NCT00853099|466574478|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
129623760|NCT00853099|466574479|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
129623761|NCT00853099|466574480|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
129623762|NCT00853099|466574481|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
129623763|NCT00853099|466574478|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
129623764|NCT00853099|466574479|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
129623765|NCT00853099|466574480|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
129623766|NCT00853099|466574481|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
129623767|NCT00853099|466574478|FG000|Double-blind + Open-label Periods|Other|0|||
129623768|NCT00853099|466574479|FG001|Double-blind + Open-label Periods|Other|0|||
129623769|NCT00853099|466574480|FG002|Double-blind + Open-label Periods|Other|0|||
129623770|NCT00853099|466574481|FG003|Double-blind + Open-label Periods|Other|6|||
129623771|NCT01342081|466574490|FG000|Overall Study|Did not receive allocated intervention|0|||
129623772|NCT01342081|466574491|FG001|Overall Study|Did not receive allocated intervention|0|||
129623773|NCT01342081|466574492|FG002|Overall Study|Did not receive allocated intervention|1|||
129888409|NCT01383993|467549148|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
129623774|NCT01342081|466574490|FG000|Overall Study|Adverse Event|1|||
129623775|NCT01342081|466574491|FG001|Overall Study|Adverse Event|0|||
129623776|NCT01342081|466574492|FG002|Overall Study|Adverse Event|0|||
129623777|NCT01342081|466574490|FG000|Overall Study|Physician Decision|0|||
129623778|NCT01342081|466574491|FG001|Overall Study|Physician Decision|1|||
129623779|NCT01342081|466574492|FG002|Overall Study|Physician Decision|0|||
129623780|NCT01342081|466574490|FG000|Overall Study|Withdrawal by Subject|1|||
129623781|NCT01342081|466574491|FG001|Overall Study|Withdrawal by Subject|1|||
129623782|NCT01342081|466574492|FG002|Overall Study|Withdrawal by Subject|0|||
129623783|NCT02790437|466574493|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
129623784|NCT02790437|466574494|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
129623785|NCT02790437|466574493|FG000|Overall Study|Adverse Event|1|||
129623786|NCT02790437|466574494|FG001|Overall Study|Adverse Event|0|||
129623787|NCT02790437|466574493|FG000|Overall Study|Withdrawal by Subject|1|||
129623788|NCT02790437|466574494|FG001|Overall Study|Withdrawal by Subject|0|||
129623789|NCT03908125|466574499|FG000|Overall Study|Withdrawal by Subject|92|||
129623790|NCT03908125|466574499|FG000|Overall Study|Lost to Follow-up|8|||
129623791|NCT01071915|466574500|FG000|Overall Study|Adverse Event|3|||
129623792|NCT01071915|466574500|FG000|Overall Study|Physician Decision|2|||
129623793|NCT01071915|466574500|FG000|Overall Study|Withdrawal by Subject|2|||
129623794|NCT01071915|466574500|FG000|Overall Study|Miscellaneous Reasons|2|||
129623795|NCT00114140|466574501|FG000|Overall Study|Protocol Violation|7|||
129623796|NCT00666328|466574505|FG000|Overall Study|Death|2|||
129623797|NCT00666328|466574505|FG000|Overall Study|Lost to Follow-up|2|||
129623798|NCT00666328|466574505|FG000|Overall Study|No longer met eligibility criteria|1|||
129623799|NCT03885661|466574508|FG000|Overall Study|Withdrawal by Subject|0|||
129623800|NCT03885661|466574509|FG001|Overall Study|Withdrawal by Subject|1|||
129623801|NCT03885661|466574508|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
129623802|NCT03885661|466574509|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
129702866|NCT01646827|466873161|FG000|Overall Study|Lost to Follow-up|0|||
129702867|NCT01646827|466873162|FG001|Overall Study|Lost to Follow-up|3|||
129702868|NCT01646827|466873161|FG000|Overall Study|Physician Decision|1|||
129702869|NCT01646827|466873162|FG001|Overall Study|Physician Decision|2|||
129702870|NCT01646827|466873161|FG000|Overall Study|Withdrawal by Subject|1|||
129702871|NCT01646827|466873162|FG001|Overall Study|Withdrawal by Subject|0|||
129702872|NCT00928668|466873165|FG000|Overall Study|Adverse Event|1|||
129702873|NCT00928668|466873166|FG001|Overall Study|Adverse Event|0|||
129702874|NCT00928668|466873167|FG002|Overall Study|Adverse Event|0|||
129888410|NCT01383993|467549149|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
129702875|NCT00928668|466873168|FG003|Overall Study|Adverse Event|0|||
129702876|NCT00928668|466873169|FG004|Overall Study|Adverse Event|0|||
129702877|NCT00928668|466873165|FG000|Overall Study|Protocol Violation|0|||
129702878|NCT00928668|466873166|FG001|Overall Study|Protocol Violation|0|||
129702879|NCT00928668|466873167|FG002|Overall Study|Protocol Violation|0|||
129702880|NCT00928668|466873168|FG003|Overall Study|Protocol Violation|0|||
129702881|NCT00928668|466873169|FG004|Overall Study|Protocol Violation|1|||
129702882|NCT00928668|466873165|FG000|Overall Study|Withdrawal by Subject|0|||
129702883|NCT00928668|466873166|FG001|Overall Study|Withdrawal by Subject|1|||
129702884|NCT00928668|466873167|FG002|Overall Study|Withdrawal by Subject|1|||
129702885|NCT00928668|466873168|FG003|Overall Study|Withdrawal by Subject|0|||
129702886|NCT00928668|466873169|FG004|Overall Study|Withdrawal by Subject|0|||
129702887|NCT00928668|466873165|FG000|Overall Study|Other reasons not listed above|0|||
129702888|NCT00928668|466873166|FG001|Overall Study|Other reasons not listed above|0|||
129702889|NCT00928668|466873167|FG002|Overall Study|Other reasons not listed above|0|||
129702890|NCT00928668|466873168|FG003|Overall Study|Other reasons not listed above|1|||
129702891|NCT00928668|466873169|FG004|Overall Study|Other reasons not listed above|0|||
129702892|NCT01767987|466873173|FG000|Overall Study|Physician Decision|4|||
129702893|NCT01767987|466873174|FG001|Overall Study|Physician Decision|1|||
129702894|NCT03232567|466873175|FG000|Overall Study|Withdrawal by Subject|0|||
129702895|NCT03232567|466873176|FG001|Overall Study|Withdrawal by Subject|1|||
129702896|NCT03232567|466873177|FG002|Overall Study|Withdrawal by Subject|0|||
129702897|NCT03232567|466873178|FG003|Overall Study|Withdrawal by Subject|0|||
129702898|NCT05837481|466873180|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
129702899|NCT05837481|466873181|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
129702900|NCT03038087|466873194|FG000|Overall Study|lost data|1|||
129702901|NCT00654355|466873195|FG000|Overall Study|Lost to Follow-up|2|||
129702902|NCT00654355|466873196|FG001|Overall Study|Lost to Follow-up|2|||
129702903|NCT05805150|466873203|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
129702904|NCT05805150|466873204|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
129793527|NCT00998764|467212686|FG001|Overall Study|Physician Decision|3|||
129793528|NCT00998764|467212685|FG000|Overall Study|Death|3|||
129793529|NCT00998764|467212686|FG001|Overall Study|Death|1|||
129793530|NCT00998764|467212685|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
129793531|NCT00998764|467212686|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
129793532|NCT00998764|467212685|FG000|Overall Study|Protocol Violation|0|||
129793533|NCT00998764|467212686|FG001|Overall Study|Protocol Violation|1|||
129793534|NCT00998764|467212685|FG000|Overall Study|Failed to Return|1|||
129793535|NCT00998764|467212686|FG001|Overall Study|Failed to Return|1|||
129793536|NCT00998764|467212685|FG000|Overall Study|Lost to Follow-up|1|||
129793537|NCT00998764|467212686|FG001|Overall Study|Lost to Follow-up|1|||
129793538|NCT00998764|467212685|FG000|Overall Study|Loss of Caregiver|0|||
129793539|NCT00998764|467212686|FG001|Overall Study|Loss of Caregiver|3|||
129793540|NCT00998764|467212685|FG000|Overall Study|Other|4|||
129793541|NCT00998764|467212686|FG001|Overall Study|Other|4|||
129793542|NCT00998764|467212685|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
129793543|NCT00998764|467212686|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
129793544|NCT04761627|467212687|FG000|Run-in Period|Death|1|||
129793545|NCT04761627|467212688|FG001|Run-in Period|Death|0|||
129793546|NCT04761627|467212689|FG002|Run-in Period|Death|0|||
129793547|NCT04761627|467212687|FG000|Run-in Period|Required alternative therapy|2|||
129793548|NCT04761627|467212688|FG001|Run-in Period|Required alternative therapy|0|||
129793549|NCT04761627|467212689|FG002|Run-in Period|Required alternative therapy|0|||
129793550|NCT04761627|467212687|FG000|Run-in Period|Lost to Follow-up|2|||
129793551|NCT04761627|467212688|FG001|Run-in Period|Lost to Follow-up|0|||
129793552|NCT04761627|467212689|FG002|Run-in Period|Lost to Follow-up|0|||
129793553|NCT04761627|467212687|FG000|Run-in Period|Protocol Violation|3|||
129793554|NCT04761627|467212688|FG001|Run-in Period|Protocol Violation|0|||
129793555|NCT04761627|467212689|FG002|Run-in Period|Protocol Violation|0|||
129793556|NCT04761627|467212687|FG000|Run-in Period|Abnormal liver function|1|||
129702905|NCT02284893|466873205|FG000|26 Week (Short Term)|Adverse Event|1|||
129702906|NCT02284893|466873206|FG001|26 Week (Short Term)|Adverse Event|9|||
129702907|NCT02284893|466873205|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
129793557|NCT04761627|467212688|FG001|Run-in Period|Abnormal liver function|0|||
129793558|NCT04761627|467212689|FG002|Run-in Period|Abnormal liver function|0|||
129793559|NCT04761627|467212687|FG000|Run-in Period|Adverse Event|6|||
129793560|NCT04761627|467212688|FG001|Run-in Period|Adverse Event|0|||
129793561|NCT04761627|467212689|FG002|Run-in Period|Adverse Event|0|||
129623803|NCT05064397|466574510|FG000|Overall Study|Adverse Event|4|||
129623804|NCT05064397|466574510|FG000|Overall Study|Lack of Efficacy|12|||
129623805|NCT05064397|466574510|FG000|Overall Study|Withdrawal by Subject|3|||
129623806|NCT05064397|466574510|FG000|Overall Study|Lost to Follow-up|1|||
129623807|NCT05064397|466574510|FG000|Overall Study|Other reasons|3|||
129623808|NCT02232984|466574511|FG000|Overall Study|Withdrawal by Subject|5|||
129623809|NCT02232984|466574511|FG000|Overall Study|Death|1|||
129623810|NCT02232984|466574511|FG000|Overall Study|Investigator withdrawal|10|||
129623811|NCT02232984|466574511|FG000|Overall Study|Device implant unsuccessful|53|||
129623812|NCT02232984|466574511|FG000|Overall Study|not disclosed by site|7|||
129623813|NCT02232984|466574511|FG000|Overall Study|Protocol Violation|1|||
129623814|NCT00535405|466574516|FG000|Overall Study|Adverse Event|6|||
129623815|NCT00535405|466574517|FG001|Overall Study|Adverse Event|8|||
129623816|NCT00535405|466574518|FG002|Overall Study|Adverse Event|3|||
129623817|NCT00535405|466574519|FG003|Overall Study|Adverse Event|8|||
129623818|NCT00535405|466574520|FG004|Overall Study|Adverse Event|6|||
129623819|NCT00535405|466574516|FG000|Overall Study|Lost to Follow-up|1|||
129623820|NCT00535405|466574517|FG001|Overall Study|Lost to Follow-up|3|||
129623821|NCT00535405|466574518|FG002|Overall Study|Lost to Follow-up|3|||
129623822|NCT00535405|466574519|FG003|Overall Study|Lost to Follow-up|2|||
129623823|NCT00535405|466574520|FG004|Overall Study|Lost to Follow-up|1|||
129623824|NCT00535405|466574516|FG000|Overall Study|Physician Decision|3|||
129623825|NCT00535405|466574517|FG001|Overall Study|Physician Decision|2|||
129623826|NCT00535405|466574518|FG002|Overall Study|Physician Decision|0|||
129623827|NCT00535405|466574519|FG003|Overall Study|Physician Decision|1|||
129623828|NCT00535405|466574520|FG004|Overall Study|Physician Decision|1|||
129623829|NCT00535405|466574516|FG000|Overall Study|Protocol Violation|2|||
129623830|NCT00535405|466574517|FG001|Overall Study|Protocol Violation|2|||
129623831|NCT00535405|466574518|FG002|Overall Study|Protocol Violation|2|||
129623832|NCT00535405|466574519|FG003|Overall Study|Protocol Violation|1|||
129623833|NCT00535405|466574520|FG004|Overall Study|Protocol Violation|0|||
129623834|NCT00535405|466574516|FG000|Overall Study|Withdrawal by Subject|5|||
129623835|NCT00535405|466574517|FG001|Overall Study|Withdrawal by Subject|11|||
129623836|NCT00535405|466574518|FG002|Overall Study|Withdrawal by Subject|10|||
129623837|NCT00535405|466574519|FG003|Overall Study|Withdrawal by Subject|10|||
129623838|NCT00535405|466574520|FG004|Overall Study|Withdrawal by Subject|8|||
129623839|NCT02969044|466574523|FG000|Overall Study|Withdrawal by Subject|2|||
129623840|NCT02969044|466574524|FG001|Overall Study|Withdrawal by Subject|6|||
129623841|NCT02969044|466574523|FG000|Overall Study|Adverse Event|3|||
129623842|NCT02969044|466574524|FG001|Overall Study|Adverse Event|0|||
129623843|NCT04728802|466574525|FG000|Overall Study|Withdrawal by Subject|4|||
129623844|NCT04728802|466574526|FG001|Overall Study|Withdrawal by Subject|20|||
129623845|NCT04728802|466574525|FG000|Overall Study|Physician Decision|7|||
129623846|NCT04728802|466574526|FG001|Overall Study|Physician Decision|7|||
129702908|NCT02284893|466873206|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
129623847|NCT04728802|466574525|FG000|Overall Study|Protocol Violation|10|||
129623848|NCT04728802|466574526|FG001|Overall Study|Protocol Violation|4|||
129623849|NCT04728802|466574525|FG000|Overall Study|Transfer|1|||
129623850|NCT04728802|466574526|FG001|Overall Study|Transfer|0|||
129623851|NCT04728802|466574525|FG000|Overall Study|Death|4|||
129623852|NCT04728802|466574526|FG001|Overall Study|Death|5|||
129623853|NCT04728802|466574525|FG000|Overall Study|Other|3|||
129623854|NCT04728802|466574526|FG001|Overall Study|Other|0|||
129623855|NCT01176513|466574527|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
129623856|NCT03164616|466574531|FG000|Overall Study|Death|250|||
129623857|NCT03164616|466574532|FG001|Overall Study|Death|264|||
129623858|NCT03164616|466574533|FG002|Overall Study|Death|279|||
129623859|NCT03164616|466574531|FG000|Overall Study|Lost to Follow-up|2|||
129623860|NCT03164616|466574532|FG001|Overall Study|Lost to Follow-up|2|||
129623861|NCT03164616|466574533|FG002|Overall Study|Lost to Follow-up|2|||
129623862|NCT03164616|466574531|FG000|Overall Study|Withdrawal by Subject|6|||
129623863|NCT03164616|466574532|FG001|Overall Study|Withdrawal by Subject|7|||
129623864|NCT03164616|466574533|FG002|Overall Study|Withdrawal by Subject|16|||
129623865|NCT00489255|466574545|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
129623866|NCT00489255|466574546|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
129623867|NCT00489255|466574545|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
129623868|NCT00489255|466574546|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
129623869|NCT00489255|466574545|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
129623870|NCT00489255|466574546|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
129623871|NCT00489255|466574545|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
129623872|NCT00489255|466574546|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
129623873|NCT00489255|466574545|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
129623874|NCT00489255|466574546|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
129623875|NCT00489255|466574545|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
129623876|NCT00489255|466574546|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
129623877|NCT00489255|466574545|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
129623878|NCT00489255|466574546|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
129623879|NCT00489255|466574545|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
129623880|NCT00489255|466574546|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
129623881|NCT00489255|466574545|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
129623882|NCT00489255|466574546|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
129623883|NCT00489255|466574545|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
129623884|NCT00489255|466574546|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
129623885|NCT01625091|466574547|FG000|Intervention|Death|1|||
129623886|NCT01625091|466574548|FG001|Intervention|Death|1|||
129623887|NCT01625091|466574547|FG000|Intervention|Withdrawal by Subject|4|||
129623888|NCT01625091|466574548|FG001|Intervention|Withdrawal by Subject|1|||
129623889|NCT01625091|466574547|FG000|Intervention|Adverse Event|0|||
129623890|NCT01625091|466574548|FG001|Intervention|Adverse Event|2|||
129623891|NCT01625091|466574547|FG000|Intervention|Lost to Follow-up|4|||
129888411|NCT01383993|467549150|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
129888412|NCT00795132|467549154|FG000|Overall Study|Death|1|||
129888413|NCT00795132|467549154|FG000|Overall Study|Relapse|2|||
129888414|NCT02561455|467549155|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
129888415|NCT02561455|467549156|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
129888416|NCT02561455|467549157|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
129888417|NCT02561455|467549158|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
129888418|NCT02561455|467549155|FG000|Overall Study|Withdrawal by Subject|1|||
129888419|NCT02561455|467549156|FG001|Overall Study|Withdrawal by Subject|0|||
129888420|NCT02561455|467549157|FG002|Overall Study|Withdrawal by Subject|1|||
129888421|NCT02561455|467549158|FG003|Overall Study|Withdrawal by Subject|0|||
129888422|NCT02561455|467549155|FG000|Overall Study|Disease Progression|0|||
129888423|NCT02561455|467549156|FG001|Overall Study|Disease Progression|1|||
129888424|NCT02561455|467549157|FG002|Overall Study|Disease Progression|0|||
129888425|NCT02561455|467549158|FG003|Overall Study|Disease Progression|0|||
129888426|NCT02451930|467549159|FG000|Overall Study|Death|0|||
129888427|NCT02451930|467549160|FG001|Overall Study|Death|15|||
129888428|NCT02451930|467549159|FG000|Overall Study|Lost to Follow-up|0|||
129888429|NCT02451930|467549160|FG001|Overall Study|Lost to Follow-up|3|||
129888430|NCT02451930|467549159|FG000|Overall Study|Sponsor Decision|2|||
129888431|NCT02451930|467549160|FG001|Overall Study|Sponsor Decision|10|||
129888432|NCT02451930|467549159|FG000|Overall Study|Withdrawal by Subject|0|||
129888433|NCT02451930|467549160|FG001|Overall Study|Withdrawal by Subject|1|||
129888434|NCT02451930|467549159|FG000|Overall Study|Other|0|||
129888435|NCT02451930|467549160|FG001|Overall Study|Other|1|||
129888436|NCT03685708|467549167|FG000|Overall Study|Withdrawal by Subject|0|||
129888437|NCT03685708|467549168|FG001|Overall Study|Withdrawal by Subject|0|||
129888438|NCT03685708|467549169|FG002|Overall Study|Withdrawal by Subject|1|||
129888439|NCT03685708|467549167|FG000|Overall Study|Screen Fail|0|||
129888440|NCT03685708|467549168|FG001|Overall Study|Screen Fail|1|||
129888441|NCT03685708|467549169|FG002|Overall Study|Screen Fail|1|||
129888442|NCT03685708|467549167|FG000|Overall Study|COVID 19 Pandemic|1|||
129888443|NCT03685708|467549168|FG001|Overall Study|COVID 19 Pandemic|1|||
129888444|NCT03685708|467549169|FG002|Overall Study|COVID 19 Pandemic|6|||
129888445|NCT03685708|467549167|FG000|Overall Study|Disease Progression|0|||
129888446|NCT03685708|467549168|FG001|Overall Study|Disease Progression|0|||
129888447|NCT03685708|467549169|FG002|Overall Study|Disease Progression|1|||
129888448|NCT04006366|467549170|FG000|Overall Study|Withdrawal by Subject|1|||
129888449|NCT00627042|467549177|FG000|Overall Study|Withdrawal by Subject|2|||
129888450|NCT02268552|467549178|FG000|Part 1|Death|1|||
129888451|NCT02268552|467549179|FG001|Part 1|Death|1|||
129888452|NCT02268552|467549180|FG002|Part 1|Death|1|||
129888453|NCT02268552|467549181|FG003|Part 1|Death|2|||
129623892|NCT01625091|466574548|FG001|Intervention|Lost to Follow-up|4|||
129623893|NCT01625091|466574547|FG000|Intervention|Study termination|2|||
129623894|NCT01625091|466574548|FG001|Intervention|Study termination|3|||
129623895|NCT01625091|466574547|FG000|Post-intervention|Death|0|||
129623896|NCT01625091|466574548|FG001|Post-intervention|Death|1|||
129623897|NCT01625091|466574547|FG000|Post-intervention|Lost to Follow-up|2|||
129623898|NCT01625091|466574548|FG001|Post-intervention|Lost to Follow-up|0|||
129623899|NCT01625091|466574547|FG000|Post-intervention|Study termination|2|||
129623900|NCT01625091|466574548|FG001|Post-intervention|Study termination|1|||
129647680|NCT03045276|466665406|FG000|Intervention Phase|Withdrawal by Subject|7|||
129647681|NCT03045276|466665407|FG001|Intervention Phase|Withdrawal by Subject|2|||
129647682|NCT03045276|466665408|FG002|Intervention Phase|Withdrawal by Subject|3|||
129888454|NCT02268552|467549182|FG004|Part 1|Death|0|||
129888455|NCT02268552|467549183|FG005|Part 1|Death|0|||
129888456|NCT02268552|467549184|FG006|Part 1|Death|0|||
129647683|NCT03045276|466665409|FG003|Intervention Phase|Withdrawal by Subject|7|||
129647684|NCT03045276|466665406|FG000|Intervention Phase|Developed exclusionary criteria|3|||
129888457|NCT02268552|467549178|FG000|Part 1|Subject/guardian decision|0|||
129888458|NCT02268552|467549179|FG001|Part 1|Subject/guardian decision|0|||
129647685|NCT03045276|466665407|FG001|Intervention Phase|Developed exclusionary criteria|3|||
129888459|NCT02268552|467549180|FG002|Part 1|Subject/guardian decision|0|||
129888460|NCT02268552|467549181|FG003|Part 1|Subject/guardian decision|1|||
129623901|NCT03130777|466576389|FG000|Overall Study|Death|0|||
129623902|NCT03130777|466576390|FG001|Overall Study|Death|1|||
129623903|NCT03130777|466576389|FG000|Overall Study|Did not meet eligibility criteria|1|||
129623904|NCT03130777|466576390|FG001|Overall Study|Did not meet eligibility criteria|0|||
129623905|NCT02498613|466576392|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
129623906|NCT02498613|466576393|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
129623907|NCT02498613|466576394|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
129623908|NCT02498613|466576395|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
129623909|NCT02498613|466576392|FG000|Overall Study|Withdrawal by Subject|3|||
129623910|NCT02498613|466576393|FG001|Overall Study|Withdrawal by Subject|1|||
129623911|NCT02498613|466576394|FG002|Overall Study|Withdrawal by Subject|0|||
129623912|NCT02498613|466576395|FG003|Overall Study|Withdrawal by Subject|0|||
129623913|NCT05109611|466576396|FG000|Overall Study|Adverse Event|13|||
129623914|NCT05109611|466576397|FG001|Overall Study|Adverse Event|10|||
129623915|NCT05109611|466576396|FG000|Overall Study|Withdrawal by Subject|1|||
129623916|NCT05109611|466576397|FG001|Overall Study|Withdrawal by Subject|0|||
129623917|NCT05109611|466576396|FG000|Overall Study|Lost to Follow-up|1|||
129623918|NCT05109611|466576397|FG001|Overall Study|Lost to Follow-up|2|||
129623919|NCT05109611|466576396|FG000|Overall Study|Protocol Violation|0|||
129623920|NCT05109611|466576397|FG001|Overall Study|Protocol Violation|4|||
129623921|NCT05109611|466576396|FG000|Overall Study|Information unavailable|1|||
129623922|NCT05109611|466576397|FG001|Overall Study|Information unavailable|1|||
129623923|NCT06195930|466576400|FG000|Overall Study|Adverse Event|4|||
129623924|NCT04995029|466576401|FG000|Induction Phase|Did not meet eligibility criteria|5|||
129623925|NCT04995029|466576402|FG001|Induction Phase|Did not meet eligibility criteria|2|||
129623926|NCT04995029|466576403|FG002|Induction Phase|Did not meet eligibility criteria|0|||
129623927|NCT04995029|466576404|FG003|Induction Phase|Did not meet eligibility criteria|0|||
129623928|NCT04995029|466576401|FG000|Induction Phase|Withdrawal by Subject|85|||
129623929|NCT04995029|466576402|FG001|Induction Phase|Withdrawal by Subject|42|||
129623930|NCT04995029|466576403|FG002|Induction Phase|Withdrawal by Subject|0|||
129623931|NCT04995029|466576404|FG003|Induction Phase|Withdrawal by Subject|0|||
129623932|NCT04995029|466576401|FG000|Induction Phase|Lost to Follow-up|103|||
129623933|NCT04995029|466576402|FG001|Induction Phase|Lost to Follow-up|67|||
129623934|NCT04995029|466576403|FG002|Induction Phase|Lost to Follow-up|0|||
129623935|NCT04995029|466576404|FG003|Induction Phase|Lost to Follow-up|0|||
129623936|NCT04995029|466576401|FG000|Induction Phase|Adverse Event|5|||
129623937|NCT04995029|466576402|FG001|Induction Phase|Adverse Event|3|||
129623938|NCT04995029|466576403|FG002|Induction Phase|Adverse Event|0|||
129623939|NCT04995029|466576404|FG003|Induction Phase|Adverse Event|0|||
129623940|NCT04995029|466576401|FG000|Induction Phase|Physician Decision|11|||
129623941|NCT04995029|466576402|FG001|Induction Phase|Physician Decision|8|||
129623942|NCT04995029|466576403|FG002|Induction Phase|Physician Decision|0|||
129623943|NCT04995029|466576404|FG003|Induction Phase|Physician Decision|0|||
129623944|NCT04995029|466576401|FG000|Induction Phase|Incarceration|6|||
129623945|NCT04995029|466576402|FG001|Induction Phase|Incarceration|3|||
129623946|NCT04995029|466576403|FG002|Induction Phase|Incarceration|0|||
129623947|NCT04995029|466576404|FG003|Induction Phase|Incarceration|0|||
129623948|NCT04995029|466576401|FG000|Induction Phase|Not otherwise described|5|||
129623949|NCT04995029|466576402|FG001|Induction Phase|Not otherwise described|5|||
129623950|NCT04995029|466576403|FG002|Induction Phase|Not otherwise described|0|||
129623951|NCT04995029|466576404|FG003|Induction Phase|Not otherwise described|0|||
129623952|NCT04995029|466576401|FG000|Maintenance Phase|Lost to Follow-up|0|||
129623953|NCT04995029|466576402|FG001|Maintenance Phase|Lost to Follow-up|0|||
129623954|NCT04995029|466576403|FG002|Maintenance Phase|Lost to Follow-up|51|||
129623955|NCT04995029|466576404|FG003|Maintenance Phase|Lost to Follow-up|44|||
129623956|NCT04995029|466576401|FG000|Maintenance Phase|Did not meet eligibility criteria|0|||
129623957|NCT04995029|466576402|FG001|Maintenance Phase|Did not meet eligibility criteria|0|||
129623958|NCT04995029|466576403|FG002|Maintenance Phase|Did not meet eligibility criteria|0|||
129623959|NCT04995029|466576404|FG003|Maintenance Phase|Did not meet eligibility criteria|1|||
129623960|NCT04995029|466576401|FG000|Maintenance Phase|Adverse Event|0|||
129623961|NCT04995029|466576402|FG001|Maintenance Phase|Adverse Event|0|||
129623962|NCT04995029|466576403|FG002|Maintenance Phase|Adverse Event|0|||
129623963|NCT04995029|466576404|FG003|Maintenance Phase|Adverse Event|1|||
129623964|NCT04995029|466576401|FG000|Maintenance Phase|Physician Decision|0|||
129623965|NCT04995029|466576402|FG001|Maintenance Phase|Physician Decision|0|||
129623966|NCT04995029|466576403|FG002|Maintenance Phase|Physician Decision|8|||
129623967|NCT04995029|466576404|FG003|Maintenance Phase|Physician Decision|4|||
129623968|NCT04995029|466576401|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129623969|NCT04995029|466576402|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129623970|NCT04995029|466576403|FG002|Maintenance Phase|Withdrawal by Subject|17|||
129623971|NCT04995029|466576404|FG003|Maintenance Phase|Withdrawal by Subject|31|||
129623972|NCT04995029|466576401|FG000|Maintenance Phase|Incarceration|0|||
129623973|NCT04995029|466576402|FG001|Maintenance Phase|Incarceration|0|||
129623974|NCT04995029|466576403|FG002|Maintenance Phase|Incarceration|4|||
129702909|NCT02284893|466873205|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
129623975|NCT04995029|466576404|FG003|Maintenance Phase|Incarceration|3|||
129623976|NCT04995029|466576401|FG000|Maintenance Phase|Not otherwise described|0|||
129623977|NCT04995029|466576402|FG001|Maintenance Phase|Not otherwise described|0|||
129623978|NCT04995029|466576403|FG002|Maintenance Phase|Not otherwise described|2|||
129623979|NCT04995029|466576404|FG003|Maintenance Phase|Not otherwise described|3|||
129623980|NCT04995029|466576401|FG000|Maintenance Phase|Pregnancy|0|||
129623981|NCT04995029|466576402|FG001|Maintenance Phase|Pregnancy|0|||
129623982|NCT04995029|466576403|FG002|Maintenance Phase|Pregnancy|2|||
129623983|NCT04995029|466576404|FG003|Maintenance Phase|Pregnancy|2|||
129793562|NCT04761627|467212687|FG000|Run-in Period|Withdrawal by Subject|7|||
129793563|NCT04761627|467212688|FG001|Run-in Period|Withdrawal by Subject|0|||
129793564|NCT04761627|467212689|FG002|Run-in Period|Withdrawal by Subject|0|||
129793565|NCT04761627|467212687|FG000|Run-in Period|Did not meet PASI 50|15|||
129793566|NCT04761627|467212688|FG001|Run-in Period|Did not meet PASI 50|0|||
129793567|NCT04761627|467212689|FG002|Run-in Period|Did not meet PASI 50|0|||
129793568|NCT04761627|467212687|FG000|Run-in Period|Study site closure|2|||
129793569|NCT04761627|467212688|FG001|Run-in Period|Study site closure|0|||
129793570|NCT04761627|467212689|FG002|Run-in Period|Study site closure|0|||
129793571|NCT04761627|467212687|FG000|Run-in Period|Pregnancy|2|||
129793572|NCT04761627|467212688|FG001|Run-in Period|Pregnancy|0|||
129793573|NCT04761627|467212689|FG002|Run-in Period|Pregnancy|0|||
129793574|NCT04761627|467212687|FG000|Post-randomization Period|Military service|0|||
129793575|NCT04761627|467212688|FG001|Post-randomization Period|Military service|1|||
129793576|NCT04761627|467212689|FG002|Post-randomization Period|Military service|0|||
129793577|NCT04761627|467212687|FG000|Post-randomization Period|Adverse Event|0|||
129793578|NCT04761627|467212688|FG001|Post-randomization Period|Adverse Event|4|||
129793579|NCT04761627|467212689|FG002|Post-randomization Period|Adverse Event|2|||
129793580|NCT04761627|467212687|FG000|Post-randomization Period|Lost to Follow-up|0|||
129793581|NCT04761627|467212688|FG001|Post-randomization Period|Lost to Follow-up|6|||
129793582|NCT04761627|467212689|FG002|Post-randomization Period|Lost to Follow-up|6|||
129793583|NCT04761627|467212687|FG000|Post-randomization Period|Withdrawal by Subject|0|||
129623984|NCT00077207|466576407|FG000|Overall Study|Adverse Event|5|||
129623985|NCT00077207|466576407|FG000|Overall Study|Lack of Efficacy|12|||
129623986|NCT00077207|466576407|FG000|Overall Study|Physician Decision|6|||
129623987|NCT00077207|466576407|FG000|Overall Study|Withdrawal by Subject|6|||
129623988|NCT00077207|466576407|FG000|Overall Study|Ineligible|1|||
129623989|NCT00970593|466576412|FG000|Overall Study|Adverse Event|1|||
129623990|NCT00970593|466576413|FG001|Overall Study|Adverse Event|1|||
129623991|NCT00970593|466576414|FG002|Overall Study|Adverse Event|0|||
129623992|NCT00970593|466576415|FG003|Overall Study|Adverse Event|0|||
129623993|NCT00970593|466576416|FG004|Overall Study|Adverse Event|0|||
129623994|NCT00970593|466576417|FG005|Overall Study|Adverse Event|0|||
129623995|NCT00970593|466576418|FG006|Overall Study|Adverse Event|0|||
129623996|NCT00970593|466576412|FG000|Overall Study|Discontinuation of study by sponsor|0|||
129623997|NCT00970593|466576413|FG001|Overall Study|Discontinuation of study by sponsor|0|||
129623998|NCT00970593|466576414|FG002|Overall Study|Discontinuation of study by sponsor|5|||
129623999|NCT00970593|466576415|FG003|Overall Study|Discontinuation of study by sponsor|0|||
129624000|NCT00970593|466576416|FG004|Overall Study|Discontinuation of study by sponsor|0|||
129624001|NCT00970593|466576417|FG005|Overall Study|Discontinuation of study by sponsor|0|||
129624002|NCT00970593|466576418|FG006|Overall Study|Discontinuation of study by sponsor|2|||
129624003|NCT00970593|466576412|FG000|Overall Study|Withdrawal by Subject|0|||
129624004|NCT00970593|466576413|FG001|Overall Study|Withdrawal by Subject|0|||
129624005|NCT00970593|466576414|FG002|Overall Study|Withdrawal by Subject|1|||
129624006|NCT00970593|466576415|FG003|Overall Study|Withdrawal by Subject|0|||
129624007|NCT00970593|466576416|FG004|Overall Study|Withdrawal by Subject|0|||
129624008|NCT00970593|466576417|FG005|Overall Study|Withdrawal by Subject|0|||
129624009|NCT00970593|466576418|FG006|Overall Study|Withdrawal by Subject|0|||
129624010|NCT03889886|466576426|FG000|Overall Study|Other|0|||
129624011|NCT03889886|466576427|FG001|Overall Study|Other|1|||
129624012|NCT03889886|466576428|FG002|Overall Study|Other|0|||
129624013|NCT03889886|466576429|FG003|Overall Study|Other|1|||
129624014|NCT03889886|466576426|FG000|Overall Study|Withdrawal by Subject|0|||
129624015|NCT03889886|466576427|FG001|Overall Study|Withdrawal by Subject|0|||
129624016|NCT03889886|466576428|FG002|Overall Study|Withdrawal by Subject|1|||
129624017|NCT03889886|466576429|FG003|Overall Study|Withdrawal by Subject|0|||
129793584|NCT04761627|467212688|FG001|Post-randomization Period|Withdrawal by Subject|7|||
129793585|NCT04761627|467212689|FG002|Post-randomization Period|Withdrawal by Subject|6|||
129793586|NCT04761627|467212687|FG000|Post-randomization Period|Pregnancy|0|||
129624018|NCT03889886|466576426|FG000|Overall Study|Adverse Event|0|||
129624019|NCT03889886|466576427|FG001|Overall Study|Adverse Event|0|||
129793587|NCT04761627|467212688|FG001|Post-randomization Period|Pregnancy|0|||
129793588|NCT04761627|467212689|FG002|Post-randomization Period|Pregnancy|1|||
129793589|NCT04761627|467212687|FG000|Post-randomization Period|Study site closure|0|||
129624020|NCT03889886|466576428|FG002|Overall Study|Adverse Event|0|||
129624021|NCT03889886|466576429|FG003|Overall Study|Adverse Event|6|||
129624022|NCT04176250|466576430|FG000|Overall Study|Adverse Event|0|||
129624023|NCT04176250|466576431|FG001|Overall Study|Adverse Event|1|||
129624024|NCT04176250|466576432|FG002|Overall Study|Adverse Event|0|||
129624025|NCT04176250|466576433|FG003|Overall Study|Adverse Event|1|||
129624026|NCT04176250|466576434|FG004|Overall Study|Adverse Event|0|||
129624027|NCT04176250|466576435|FG005|Overall Study|Adverse Event|1|||
129624028|NCT04176250|466576430|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129888461|NCT02268552|467549182|FG004|Part 1|Subject/guardian decision|0|||
129888462|NCT02268552|467549183|FG005|Part 1|Subject/guardian decision|0|||
129888463|NCT02268552|467549184|FG006|Part 1|Subject/guardian decision|0|||
129888464|NCT02268552|467549178|FG000|Part 2|Death|0|||
129888465|NCT02268552|467549179|FG001|Part 2|Death|0|||
129888466|NCT02268552|467549180|FG002|Part 2|Death|0|||
129888467|NCT02268552|467549181|FG003|Part 2|Death|0|||
129888468|NCT02268552|467549182|FG004|Part 2|Death|0|||
129888469|NCT02268552|467549183|FG005|Part 2|Death|0|||
129888470|NCT02268552|467549184|FG006|Part 2|Death|2|||
129888471|NCT02268552|467549178|FG000|Part 2|Subject/guardian decision|0|||
129888472|NCT02268552|467549179|FG001|Part 2|Subject/guardian decision|0|||
129888473|NCT02268552|467549180|FG002|Part 2|Subject/guardian decision|0|||
129888474|NCT02268552|467549181|FG003|Part 2|Subject/guardian decision|0|||
129888475|NCT02268552|467549182|FG004|Part 2|Subject/guardian decision|0|||
129888476|NCT02268552|467549183|FG005|Part 2|Subject/guardian decision|0|||
129888477|NCT02268552|467549184|FG006|Part 2|Subject/guardian decision|1|||
129888478|NCT02268552|467549178|FG000|Part 3 Extension|Death|0|||
129888479|NCT02268552|467549179|FG001|Part 3 Extension|Death|1|||
129624029|NCT04176250|466576431|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129624030|NCT04176250|466576432|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
129888480|NCT02268552|467549180|FG002|Part 3 Extension|Death|1|||
129888481|NCT02268552|467549181|FG003|Part 3 Extension|Death|1|||
129888482|NCT02268552|467549182|FG004|Part 3 Extension|Death|1|||
129888483|NCT02268552|467549183|FG005|Part 3 Extension|Death|1|||
129888484|NCT02268552|467549184|FG006|Part 3 Extension|Death|0|||
129888485|NCT02268552|467549178|FG000|Part 3 Extension|Early termination of trial|1|||
129888486|NCT02268552|467549179|FG001|Part 3 Extension|Early termination of trial|0|||
129888487|NCT02268552|467549180|FG002|Part 3 Extension|Early termination of trial|0|||
129888488|NCT02268552|467549181|FG003|Part 3 Extension|Early termination of trial|0|||
129888489|NCT02268552|467549182|FG004|Part 3 Extension|Early termination of trial|2|||
129888490|NCT02268552|467549183|FG005|Part 3 Extension|Early termination of trial|9|||
129888491|NCT02268552|467549184|FG006|Part 3 Extension|Early termination of trial|11|||
129888492|NCT02268552|467549178|FG000|Part 3 Extension|Subject/guardian decision|0|||
129888493|NCT02268552|467549179|FG001|Part 3 Extension|Subject/guardian decision|0|||
129888494|NCT02268552|467549180|FG002|Part 3 Extension|Subject/guardian decision|0|||
129888495|NCT02268552|467549181|FG003|Part 3 Extension|Subject/guardian decision|0|||
129888496|NCT02268552|467549182|FG004|Part 3 Extension|Subject/guardian decision|0|||
129888497|NCT02268552|467549183|FG005|Part 3 Extension|Subject/guardian decision|0|||
129888498|NCT02268552|467549184|FG006|Part 3 Extension|Subject/guardian decision|1|||
129888499|NCT00997243|467549185|FG000|Overall Study|Early termination of study by sponsor|7|||
129888500|NCT01349907|467549190|FG000|Overall Study|Adverse Event|37|||
129888501|NCT01349907|467549191|FG001|Overall Study|Adverse Event|11|||
129888502|NCT01349907|467549190|FG000|Overall Study|Treatment failure|13|||
129888503|NCT01349907|467549191|FG001|Overall Study|Treatment failure|4|||
129888504|NCT01349907|467549190|FG000|Overall Study|Lost to Follow-up|25|||
129888505|NCT01349907|467549191|FG001|Overall Study|Lost to Follow-up|6|||
129888506|NCT01349907|467549190|FG000|Overall Study|Withdrawal by Subject|30|||
129888507|NCT01349907|467549191|FG001|Overall Study|Withdrawal by Subject|8|||
129888508|NCT01349907|467549190|FG000|Overall Study|Protocol Violation|33|||
129888509|NCT01349907|467549191|FG001|Overall Study|Protocol Violation|13|||
129888510|NCT01349907|467549190|FG000|Overall Study|Administrative|1|||
129888511|NCT01349907|467549191|FG001|Overall Study|Administrative|1|||
129888512|NCT04011384|467549207|FG000|Overall Study|Withdrawal by Subject|2|||
129888513|NCT04011384|467549208|FG001|Overall Study|Withdrawal by Subject|0|||
129888514|NCT01686932|467549209|FG000|Period 1|Adverse Event|1|||
129624031|NCT04176250|466576433|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
129624032|NCT04176250|466576434|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129888515|NCT01686932|467549210|FG001|Period 1|Adverse Event|1|||
129888516|NCT01364727|467549213|FG000|Overall Study|Not Eligible|2|||
129888517|NCT04716881|467549214|FG000|Overall Study|Adverse Event|1|||
129888518|NCT04716881|467549214|FG000|Overall Study|Lost to Follow-up|1|||
129888519|NCT01558674|467549215|FG000|Part 1|Study Terminated by Sponsor|10|||
129888520|NCT01558674|467549216|FG001|Part 1|Study Terminated by Sponsor|0|||
129888521|NCT01558674|467549215|FG000|Part 1|Withdrawal by Subject|1|||
129888522|NCT01558674|467549216|FG001|Part 1|Withdrawal by Subject|0|||
129888523|NCT04147260|467549217|FG000|Overall Study|Adverse Event|1|||
129888524|NCT04147260|467549218|FG001|Overall Study|Adverse Event|0|||
129888525|NCT04147260|467549219|FG002|Overall Study|Adverse Event|1|||
129888526|NCT04147260|467549220|FG003|Overall Study|Adverse Event|2|||
129888527|NCT04147260|467549221|FG004|Overall Study|Adverse Event|0|||
129624033|NCT04176250|466576435|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
129624034|NCT04176250|466576430|FG000|Overall Study|Withdrawal by Subject|0|||
129624035|NCT04176250|466576431|FG001|Overall Study|Withdrawal by Subject|0|||
129624036|NCT04176250|466576432|FG002|Overall Study|Withdrawal by Subject|0|||
129624037|NCT04176250|466576433|FG003|Overall Study|Withdrawal by Subject|0|||
129624038|NCT04176250|466576434|FG004|Overall Study|Withdrawal by Subject|0|||
129624039|NCT04176250|466576435|FG005|Overall Study|Withdrawal by Subject|1|||
129624040|NCT04176250|466576430|FG000|Overall Study|Randomized in error|0|||
129624041|NCT04176250|466576431|FG001|Overall Study|Randomized in error|0|||
129624042|NCT04176250|466576432|FG002|Overall Study|Randomized in error|0|||
129624043|NCT04176250|466576433|FG003|Overall Study|Randomized in error|0|||
129624044|NCT04176250|466576434|FG004|Overall Study|Randomized in error|1|||
129624045|NCT04176250|466576435|FG005|Overall Study|Randomized in error|0|||
129624046|NCT01202175|466576447|FG000|Overall Study|Lost to Follow-up|2|||
129624047|NCT01202175|466576447|FG000|Overall Study|Withdrawal by Subject|1|||
129624048|NCT01202175|466576447|FG000|Overall Study|Adverse Event|2|||
129624049|NCT04747470|466576448|FG000|Overall Study|Death|0|||
129624050|NCT04747470|466576449|FG001|Overall Study|Death|3|||
129624051|NCT04747470|466576450|FG002|Overall Study|Death|2|||
129624052|NCT04747470|466576451|FG003|Overall Study|Death|2|||
129624053|NCT04747470|466576452|FG004|Overall Study|Death|2|||
129624054|NCT04747470|466576453|FG005|Overall Study|Death|0|||
129624055|NCT04747470|466576454|FG006|Overall Study|Death|0|||
129624056|NCT04747470|466576455|FG007|Overall Study|Death|0|||
129624057|NCT04747470|466576456|FG008|Overall Study|Death|0|||
129624058|NCT04747470|466576457|FG009|Overall Study|Death|0|||
129624059|NCT04747470|466576458|FG010|Overall Study|Death|0|||
129624060|NCT04747470|466576448|FG000|Overall Study|Withdrew Consent|0|||
129624061|NCT04747470|466576449|FG001|Overall Study|Withdrew Consent|0|||
129624062|NCT04747470|466576450|FG002|Overall Study|Withdrew Consent|0|||
129624063|NCT04747470|466576451|FG003|Overall Study|Withdrew Consent|1|||
129624064|NCT04747470|466576452|FG004|Overall Study|Withdrew Consent|0|||
129624065|NCT04747470|466576453|FG005|Overall Study|Withdrew Consent|0|||
129624066|NCT04747470|466576454|FG006|Overall Study|Withdrew Consent|0|||
129624067|NCT04747470|466576455|FG007|Overall Study|Withdrew Consent|0|||
129624068|NCT04747470|466576456|FG008|Overall Study|Withdrew Consent|0|||
129624069|NCT04747470|466576457|FG009|Overall Study|Withdrew Consent|0|||
129624070|NCT04747470|466576458|FG010|Overall Study|Withdrew Consent|0|||
129624071|NCT04747470|466576448|FG000|Overall Study|Study Terminated by Sponsor|0|||
129624072|NCT04747470|466576449|FG001|Overall Study|Study Terminated by Sponsor|0|||
129624073|NCT04747470|466576450|FG002|Overall Study|Study Terminated by Sponsor|1|||
129624074|NCT04747470|466576451|FG003|Overall Study|Study Terminated by Sponsor|0|||
129793590|NCT04761627|467212688|FG001|Post-randomization Period|Study site closure|0|||
129793591|NCT04761627|467212689|FG002|Post-randomization Period|Study site closure|1|||
129793592|NCT04761627|467212687|FG000|Post-randomization Period|Family planning|0|||
129793593|NCT04761627|467212688|FG001|Post-randomization Period|Family planning|1|||
129793594|NCT04761627|467212689|FG002|Post-randomization Period|Family planning|0|||
129793595|NCT01214174|467212690|FG000|Overall Study|Withdrawal by Subject|0|||
129793596|NCT01214174|467212691|FG001|Overall Study|Withdrawal by Subject|0|||
129793597|NCT01214174|467212692|FG002|Overall Study|Withdrawal by Subject|1|||
129793598|NCT01634178|467212695|FG000|Treatment Period 1|Adverse Event|0|||
129793599|NCT01634178|467212696|FG001|Treatment Period 1|Adverse Event|1|||
129793600|NCT01634178|467212695|FG000|Treatment Period 2|Adverse Event|1|||
129793601|NCT01634178|467212696|FG001|Treatment Period 2|Adverse Event|0|||
129793602|NCT05867342|467212697|FG000|Overall Study|Investigator Decision|3|||
129793603|NCT05867342|467212698|FG001|Overall Study|Investigator Decision|3|||
129793604|NCT00991952|467212700|FG000|Overall Study|Adverse Event|0|||
129793605|NCT00991952|467212701|FG001|Overall Study|Adverse Event|1|||
129793606|NCT00582816|467212702|FG000|Overall Study|Engraftment Failure|3|||
129793607|NCT01609478|467212705|FG000|Overall Study|Adverse Event|3|||
129624075|NCT04747470|466576452|FG004|Overall Study|Study Terminated by Sponsor|2|||
129624076|NCT04747470|466576453|FG005|Overall Study|Study Terminated by Sponsor|0|||
129624077|NCT04747470|466576454|FG006|Overall Study|Study Terminated by Sponsor|0|||
129624078|NCT04747470|466576455|FG007|Overall Study|Study Terminated by Sponsor|0|||
129624079|NCT04747470|466576456|FG008|Overall Study|Study Terminated by Sponsor|0|||
129624080|NCT04747470|466576457|FG009|Overall Study|Study Terminated by Sponsor|0|||
129624081|NCT04747470|466576458|FG010|Overall Study|Study Terminated by Sponsor|0|||
129624082|NCT04720053|466576463|FG000|Overall Study|Lost to Follow-up|12|||
129793608|NCT01609478|467212706|FG001|Overall Study|Adverse Event|1|||
129793609|NCT01609478|467212707|FG002|Overall Study|Adverse Event|5|||
129793610|NCT01609478|467212705|FG000|Overall Study|Protocol Deviation|0|||
129793611|NCT01609478|467212706|FG001|Overall Study|Protocol Deviation|1|||
129793612|NCT01609478|467212707|FG002|Overall Study|Protocol Deviation|1|||
129793613|NCT01609478|467212705|FG000|Overall Study|Non-Compliance with study treatment|1|||
129624083|NCT01942993|466576464|FG000|Overall Study|Lost to Follow-up|1|||
129624084|NCT01942993|466576464|FG000|Overall Study|Physician Decision|1|||
129624085|NCT01350271|466576465|FG000|Overall Study|Lost to Follow-up|21|||
129624086|NCT01350271|466576466|FG001|Overall Study|Lost to Follow-up|17|||
129624087|NCT01350271|466576467|FG002|Overall Study|Lost to Follow-up|26|||
129888528|NCT04147260|467549217|FG000|Overall Study|Withdrawal by Subject|0|||
129888529|NCT04147260|467549218|FG001|Overall Study|Withdrawal by Subject|0|||
129888530|NCT04147260|467549219|FG002|Overall Study|Withdrawal by Subject|1|||
129888531|NCT04147260|467549220|FG003|Overall Study|Withdrawal by Subject|1|||
129888532|NCT04147260|467549221|FG004|Overall Study|Withdrawal by Subject|0|||
129888533|NCT01734850|467549226|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
129888534|NCT01734850|467549227|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
129888535|NCT01734850|467549228|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
129888536|NCT01734850|467549226|FG000|Overall Study|Not infused due to manufacturing failure|0|||
129888537|NCT01734850|467549227|FG001|Overall Study|Not infused due to manufacturing failure|0|||
129888538|NCT01734850|467549228|FG002|Overall Study|Not infused due to manufacturing failure|1|||
129888539|NCT02204293|467549229|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
129888540|NCT02204293|467549230|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
129888541|NCT02204293|467549231|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
129888542|NCT02204293|467549232|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
129888543|NCT02204293|467549233|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
129888544|NCT02204293|467549234|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
129888545|NCT02204293|467549229|FG000|Core Study Part I|Adverse Event|1|||
129888546|NCT02204293|467549230|FG001|Core Study Part I|Adverse Event|0|||
129624088|NCT02906670|466576471|FG000|Cohort 1, QW|Radiological Progression|1|||
129793614|NCT01609478|467212706|FG001|Overall Study|Non-Compliance with study treatment|0|||
129793615|NCT01609478|467212707|FG002|Overall Study|Non-Compliance with study treatment|0|||
129793616|NCT01609478|467212705|FG000|Overall Study|Physician Decision|1|||
129793617|NCT01609478|467212706|FG001|Overall Study|Physician Decision|0|||
129793618|NCT01609478|467212707|FG002|Overall Study|Physician Decision|1|||
129793619|NCT01609478|467212705|FG000|Overall Study|Withdrawal by Subject|2|||
129793620|NCT01609478|467212706|FG001|Overall Study|Withdrawal by Subject|0|||
129793621|NCT01609478|467212707|FG002|Overall Study|Withdrawal by Subject|2|||
129793622|NCT04966741|467212708|FG000|Overall Study|Lost to Follow-up|1|||
129793623|NCT04966741|467212709|FG001|Overall Study|Lost to Follow-up|0|||
129793624|NCT02522871|467212717|FG000|Overall Study|Protocol Violation|1|||
129793625|NCT02522871|467212718|FG001|Overall Study|Protocol Violation|4|||
129793626|NCT02522871|467212717|FG000|Overall Study|Treated without randomization|1|||
129793627|NCT02522871|467212718|FG001|Overall Study|Treated without randomization|0|||
129793628|NCT02522871|467212717|FG000|Overall Study|Death|9|||
129793629|NCT02522871|467212718|FG001|Overall Study|Death|9|||
129793630|NCT02522871|467212717|FG000|Overall Study|Died in operating room prior to transplant|0|||
129793631|NCT02522871|467212718|FG001|Overall Study|Died in operating room prior to transplant|1|||
129793632|NCT00725842|467212719|FG000|Overall Study|Lost to Follow-up|19|||
129793633|NCT00725842|467212719|FG000|Overall Study|Death|1|||
129793634|NCT00725842|467212719|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
129793635|NCT00725842|467212719|FG000|Overall Study|Consent date prior to study start date|5|||
129793636|NCT00725842|467212719|FG000|Overall Study|Inclusion criterion not met|1|||
129793637|NCT00725842|467212719|FG000|Overall Study|No Visit 1 data|1|||
129793638|NCT01715129|467212720|FG000|Overall Study|Adverse Event, fatal|1|||
129793639|NCT01715129|467212720|FG000|Overall Study|Lack of Efficacy|3|||
129793640|NCT01715129|467212720|FG000|Overall Study|Protocol Violation|1|||
129793641|NCT01715129|467212720|FG000|Overall Study|Consent Withdrawn|2|||
129793642|NCT01715129|467212720|FG000|Overall Study|Lost to Follow-up|1|||
129793643|NCT01715129|467212720|FG000|Overall Study|Other|1|||
129793644|NCT02793622|467212721|FG000|Overall Study|Lost to Follow-up|31|||
129624089|NCT02906670|466576472|FG001|Cohort 1, QW|Radiological Progression|0|||
129624090|NCT02906670|466576473|FG002|Cohort 1, QW|Radiological Progression|0|||
129624091|NCT02906670|466576474|FG003|Cohort 1, QW|Radiological Progression|0|||
129624092|NCT02906670|466576475|FG004|Cohort 1, QW|Radiological Progression|0|||
129624093|NCT02906670|466576476|FG005|Cohort 1, QW|Radiological Progression|0|||
129624094|NCT02906670|466576477|FG006|Cohort 1, QW|Radiological Progression|0|||
129624095|NCT02906670|466576478|FG007|Cohort 1, QW|Radiological Progression|0|||
129624096|NCT02906670|466576479|FG008|Cohort 1, QW|Radiological Progression|0|||
129624097|NCT02906670|466576480|FG009|Cohort 1, QW|Radiological Progression|0|||
129793645|NCT02793622|467212722|FG001|Overall Study|Lost to Follow-up|19|||
129793646|NCT02793622|467212721|FG000|Overall Study|Withdrawal by Subject|21|||
129793647|NCT02793622|467212722|FG001|Overall Study|Withdrawal by Subject|17|||
129793648|NCT02793622|467212721|FG000|Overall Study|Adverse Event|0|||
129793649|NCT02793622|467212722|FG001|Overall Study|Adverse Event|1|||
129793650|NCT02793622|467212721|FG000|Overall Study|Protocol Violation|1|||
129793651|NCT02793622|467212722|FG001|Overall Study|Protocol Violation|5|||
129793652|NCT00722371|467212723|FG000|Overall Study|Adverse Event|6|||
129793653|NCT00722371|467212724|FG001|Overall Study|Adverse Event|13|||
129793654|NCT00722371|467212725|FG002|Overall Study|Adverse Event|9|||
129793655|NCT00722371|467212726|FG003|Overall Study|Adverse Event|10|||
129793656|NCT00722371|467212727|FG004|Overall Study|Adverse Event|6|||
129793657|NCT00722371|467212728|FG005|Overall Study|Adverse Event|8|||
129793658|NCT00722371|467212729|FG006|Overall Study|Adverse Event|4|||
129793659|NCT00722371|467212723|FG000|Overall Study|Contraindication|0|||
129793660|NCT00722371|467212724|FG001|Overall Study|Contraindication|0|||
129624098|NCT02906670|466576471|FG000|Cohort 2, QW|Radiological Progression|0|||
129624099|NCT02906670|466576472|FG001|Cohort 2, QW|Radiological Progression|1|||
129624100|NCT02906670|466576473|FG002|Cohort 2, QW|Radiological Progression|0|||
129624101|NCT02906670|466576474|FG003|Cohort 2, QW|Radiological Progression|0|||
129624102|NCT02906670|466576475|FG004|Cohort 2, QW|Radiological Progression|0|||
129624103|NCT02906670|466576476|FG005|Cohort 2, QW|Radiological Progression|0|||
129624104|NCT02906670|466576477|FG006|Cohort 2, QW|Radiological Progression|0|||
129624105|NCT02906670|466576478|FG007|Cohort 2, QW|Radiological Progression|0|||
129624106|NCT02906670|466576479|FG008|Cohort 2, QW|Radiological Progression|0|||
129624107|NCT02906670|466576480|FG009|Cohort 2, QW|Radiological Progression|0|||
129624108|NCT02906670|466576471|FG000|Cohort 3, QW|Radiological Progression|0|||
129624109|NCT02906670|466576472|FG001|Cohort 3, QW|Radiological Progression|0|||
129624110|NCT02906670|466576473|FG002|Cohort 3, QW|Radiological Progression|2|||
129624111|NCT02906670|466576474|FG003|Cohort 3, QW|Radiological Progression|0|||
129624112|NCT02906670|466576475|FG004|Cohort 3, QW|Radiological Progression|0|||
129702910|NCT02284893|466873206|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
129702911|NCT02284893|466873205|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
129702912|NCT02284893|466873206|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
129793661|NCT00722371|467212725|FG002|Overall Study|Contraindication|1|||
129793662|NCT00722371|467212726|FG003|Overall Study|Contraindication|0|||
129793663|NCT00722371|467212727|FG004|Overall Study|Contraindication|0|||
129793664|NCT00722371|467212728|FG005|Overall Study|Contraindication|0|||
129793665|NCT00722371|467212729|FG006|Overall Study|Contraindication|0|||
129793666|NCT00722371|467212723|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
129793667|NCT00722371|467212724|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
129793668|NCT00722371|467212725|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
129793669|NCT00722371|467212726|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
129888547|NCT02204293|467549231|FG002|Core Study Part I|Adverse Event|0|||
129888548|NCT02204293|467549232|FG003|Core Study Part I|Adverse Event|0|||
129439465|NCT01723254|465906507|FG000|Overall Study|Move/Left to another country/city|0|||
129439466|NCT01723254|465906508|FG001|Overall Study|Move/Left to another country/city|0|||
129439467|NCT01723254|465906509|FG002|Overall Study|Move/Left to another country/city|2|||
129439468|NCT01723254|465906510|FG003|Overall Study|Move/Left to another country/city|1|||
129624113|NCT02906670|466576476|FG005|Cohort 3, QW|Radiological Progression|0|||
129624114|NCT02906670|466576477|FG006|Cohort 3, QW|Radiological Progression|0|||
129624115|NCT02906670|466576478|FG007|Cohort 3, QW|Radiological Progression|0|||
129624116|NCT02906670|466576479|FG008|Cohort 3, QW|Radiological Progression|0|||
129624117|NCT02906670|466576480|FG009|Cohort 3, QW|Radiological Progression|0|||
129702913|NCT02284893|466873205|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
129702914|NCT02284893|466873206|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
129702915|NCT02284893|466873205|FG000|26 Week (Short Term)|Other|1|||
129702916|NCT02284893|466873206|FG001|26 Week (Short Term)|Other|1|||
129702917|NCT02284893|466873205|FG000|52 Week (Long Term)|Adverse Event|3|||
129702918|NCT02284893|466873206|FG001|52 Week (Long Term)|Adverse Event|1|||
129793670|NCT00722371|467212727|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
129793671|NCT00722371|467212728|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
129793672|NCT00722371|467212729|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
129793673|NCT00722371|467212723|FG000|Overall Study|Excluded medication|0|||
129793674|NCT00722371|467212724|FG001|Overall Study|Excluded medication|1|||
129793675|NCT00722371|467212725|FG002|Overall Study|Excluded medication|1|||
129793676|NCT00722371|467212726|FG003|Overall Study|Excluded medication|0|||
129624118|NCT02906670|466576471|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624119|NCT02906670|466576472|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624120|NCT02906670|466576473|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
129624121|NCT02906670|466576474|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624122|NCT02906670|466576475|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624123|NCT02906670|466576476|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624124|NCT02906670|466576477|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624125|NCT02906670|466576478|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624126|NCT02906670|466576479|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624127|NCT02906670|466576480|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
129624128|NCT02906670|466576471|FG000|Cohort 4, Q2W|Radiological Progression|0|||
129624129|NCT02906670|466576472|FG001|Cohort 4, Q2W|Radiological Progression|0|||
129624130|NCT02906670|466576473|FG002|Cohort 4, Q2W|Radiological Progression|0|||
129624131|NCT02906670|466576474|FG003|Cohort 4, Q2W|Radiological Progression|0|||
129624132|NCT02906670|466576475|FG004|Cohort 4, Q2W|Radiological Progression|0|||
129793677|NCT00722371|467212727|FG004|Overall Study|Excluded medication|0|||
129793678|NCT00722371|467212728|FG005|Overall Study|Excluded medication|0|||
129793679|NCT00722371|467212729|FG006|Overall Study|Excluded medication|1|||
129793680|NCT00722371|467212723|FG000|Overall Study|Hyperglycemia|2|||
129793681|NCT00722371|467212724|FG001|Overall Study|Hyperglycemia|6|||
129793682|NCT00722371|467212725|FG002|Overall Study|Hyperglycemia|4|||
129793683|NCT00722371|467212726|FG003|Overall Study|Hyperglycemia|2|||
129793684|NCT00722371|467212727|FG004|Overall Study|Hyperglycemia|5|||
129793685|NCT00722371|467212728|FG005|Overall Study|Hyperglycemia|1|||
129793686|NCT00722371|467212729|FG006|Overall Study|Hyperglycemia|1|||
129793687|NCT00722371|467212723|FG000|Overall Study|Hypoglycemia|1|||
129888549|NCT02204293|467549233|FG004|Core Study Part I|Adverse Event|0|||
129624133|NCT02906670|466576476|FG005|Cohort 4, Q2W|Radiological Progression|1|||
129624134|NCT02906670|466576477|FG006|Cohort 4, Q2W|Radiological Progression|0|||
129624135|NCT02906670|466576478|FG007|Cohort 4, Q2W|Radiological Progression|0|||
129624136|NCT02906670|466576479|FG008|Cohort 4, Q2W|Radiological Progression|0|||
129624137|NCT02906670|466576480|FG009|Cohort 4, Q2W|Radiological Progression|0|||
129624138|NCT02906670|466576471|FG000|Cohort 4, Q2W|Clinical Progression|0|||
129624139|NCT02906670|466576472|FG001|Cohort 4, Q2W|Clinical Progression|0|||
129624140|NCT02906670|466576473|FG002|Cohort 4, Q2W|Clinical Progression|0|||
129624141|NCT02906670|466576474|FG003|Cohort 4, Q2W|Clinical Progression|0|||
129624142|NCT02906670|466576475|FG004|Cohort 4, Q2W|Clinical Progression|0|||
129624143|NCT02906670|466576476|FG005|Cohort 4, Q2W|Clinical Progression|2|||
129624144|NCT02906670|466576477|FG006|Cohort 4, Q2W|Clinical Progression|0|||
129624145|NCT02906670|466576478|FG007|Cohort 4, Q2W|Clinical Progression|0|||
129624146|NCT02906670|466576479|FG008|Cohort 4, Q2W|Clinical Progression|0|||
129624147|NCT02906670|466576480|FG009|Cohort 4, Q2W|Clinical Progression|0|||
129624148|NCT02906670|466576471|FG000|Cohort 5, Q2W|Radiological Progression|0|||
129793688|NCT00722371|467212724|FG001|Overall Study|Hypoglycemia|0|||
129793689|NCT00722371|467212725|FG002|Overall Study|Hypoglycemia|0|||
129888550|NCT02204293|467549234|FG005|Core Study Part I|Adverse Event|0|||
129624149|NCT02906670|466576472|FG001|Cohort 5, Q2W|Radiological Progression|0|||
129624150|NCT02906670|466576473|FG002|Cohort 5, Q2W|Radiological Progression|0|||
129793690|NCT00722371|467212726|FG003|Overall Study|Hypoglycemia|0|||
129624151|NCT02906670|466576474|FG003|Cohort 5, Q2W|Radiological Progression|0|||
129624152|NCT02906670|466576475|FG004|Cohort 5, Q2W|Radiological Progression|0|||
129624153|NCT02906670|466576476|FG005|Cohort 5, Q2W|Radiological Progression|0|||
129624154|NCT02906670|466576477|FG006|Cohort 5, Q2W|Radiological Progression|4|||
129624155|NCT02906670|466576478|FG007|Cohort 5, Q2W|Radiological Progression|0|||
129624156|NCT02906670|466576479|FG008|Cohort 5, Q2W|Radiological Progression|0|||
129624157|NCT02906670|466576480|FG009|Cohort 5, Q2W|Radiological Progression|0|||
129624158|NCT02906670|466576471|FG000|Cohort 5, Q2W|Clinical Progression|0|||
129624159|NCT02906670|466576472|FG001|Cohort 5, Q2W|Clinical Progression|0|||
129624160|NCT02906670|466576473|FG002|Cohort 5, Q2W|Clinical Progression|0|||
129624161|NCT02906670|466576474|FG003|Cohort 5, Q2W|Clinical Progression|0|||
129624162|NCT02906670|466576475|FG004|Cohort 5, Q2W|Clinical Progression|0|||
129624163|NCT02906670|466576476|FG005|Cohort 5, Q2W|Clinical Progression|0|||
129624164|NCT02906670|466576477|FG006|Cohort 5, Q2W|Clinical Progression|1|||
129624165|NCT02906670|466576478|FG007|Cohort 5, Q2W|Clinical Progression|0|||
129624166|NCT02906670|466576479|FG008|Cohort 5, Q2W|Clinical Progression|0|||
129624167|NCT02906670|466576480|FG009|Cohort 5, Q2W|Clinical Progression|0|||
129624168|NCT02906670|466576471|FG000|Cohort 5, Q2W|Adverse Event|0|||
129624169|NCT02906670|466576472|FG001|Cohort 5, Q2W|Adverse Event|0|||
129624170|NCT02906670|466576473|FG002|Cohort 5, Q2W|Adverse Event|0|||
129624171|NCT02906670|466576474|FG003|Cohort 5, Q2W|Adverse Event|0|||
129624172|NCT02906670|466576475|FG004|Cohort 5, Q2W|Adverse Event|0|||
129624173|NCT02906670|466576476|FG005|Cohort 5, Q2W|Adverse Event|0|||
129624174|NCT02906670|466576477|FG006|Cohort 5, Q2W|Adverse Event|1|||
129624175|NCT02906670|466576478|FG007|Cohort 5, Q2W|Adverse Event|0|||
129624176|NCT02906670|466576479|FG008|Cohort 5, Q2W|Adverse Event|0|||
129624177|NCT02906670|466576480|FG009|Cohort 5, Q2W|Adverse Event|0|||
129624178|NCT02906670|466576471|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624179|NCT02906670|466576472|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624180|NCT02906670|466576473|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624181|NCT02906670|466576474|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624182|NCT02906670|466576475|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624183|NCT02906670|466576476|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624184|NCT02906670|466576477|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
129624185|NCT02906670|466576478|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624186|NCT02906670|466576479|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624187|NCT02906670|466576480|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
129624188|NCT02906670|466576471|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
129624189|NCT02906670|466576472|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
129624190|NCT02906670|466576473|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
129624191|NCT02906670|466576474|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
129702919|NCT02284893|466873205|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
129439469|NCT01723254|465906511|FG004|Overall Study|Move/Left to another country/city|1|||
129702920|NCT02284893|466873206|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
129702921|NCT02284893|466873205|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
129702922|NCT02284893|466873206|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
129702923|NCT02284893|466873205|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
129702924|NCT02284893|466873206|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
129702925|NCT02284893|466873205|FG000|52 Week (Long Term)|Non-Compliance|2|||
129702926|NCT02284893|466873206|FG001|52 Week (Long Term)|Non-Compliance|3|||
129702927|NCT00105066|466873213|FG000|Overall Study|Adverse Event|2|||
129702928|NCT00105066|466873214|FG001|Overall Study|Adverse Event|5|||
129702929|NCT01506726|466873227|FG000|Overall Study|Adverse Event|1|||
129702930|NCT01506726|466873228|FG001|Overall Study|Adverse Event|2|||
129702931|NCT02259231|466873235|FG000|Overall Study|Adverse Event|1|||
129702932|NCT02259231|466873236|FG001|Overall Study|Adverse Event|1|||
129702933|NCT02259231|466873237|FG002|Overall Study|Adverse Event|2|||
129702934|NCT02259231|466873238|FG003|Overall Study|Adverse Event|0|||
129702935|NCT02259231|466873239|FG004|Overall Study|Adverse Event|0|||
129702936|NCT02259231|466873240|FG005|Overall Study|Adverse Event|0|||
129702937|NCT02259231|466873241|FG006|Overall Study|Adverse Event|0|||
129702938|NCT02259231|466873235|FG000|Overall Study|Progressive Disease|4|||
129702939|NCT02259231|466873236|FG001|Overall Study|Progressive Disease|5|||
129624192|NCT02906670|466576475|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
129624193|NCT02906670|466576476|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
129624194|NCT02906670|466576477|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
129624195|NCT02906670|466576478|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
129624196|NCT02906670|466576479|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
129624197|NCT02906670|466576480|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
129624198|NCT02906670|466576471|FG000|Cohort 5P, Q2W|Adverse Event|0|||
129624199|NCT02906670|466576472|FG001|Cohort 5P, Q2W|Adverse Event|0|||
129624200|NCT02906670|466576473|FG002|Cohort 5P, Q2W|Adverse Event|0|||
129702940|NCT02259231|466873237|FG002|Overall Study|Progressive Disease|4|||
129702941|NCT02259231|466873238|FG003|Overall Study|Progressive Disease|5|||
129702942|NCT02259231|466873239|FG004|Overall Study|Progressive Disease|4|||
129702943|NCT02259231|466873240|FG005|Overall Study|Progressive Disease|5|||
129624201|NCT02906670|466576474|FG003|Cohort 5P, Q2W|Adverse Event|0|||
129624202|NCT02906670|466576475|FG004|Cohort 5P, Q2W|Adverse Event|0|||
129624203|NCT02906670|466576476|FG005|Cohort 5P, Q2W|Adverse Event|0|||
129624204|NCT02906670|466576477|FG006|Cohort 5P, Q2W|Adverse Event|0|||
129624205|NCT02906670|466576478|FG007|Cohort 5P, Q2W|Adverse Event|1|||
129624206|NCT02906670|466576479|FG008|Cohort 5P, Q2W|Adverse Event|0|||
129624207|NCT02906670|466576480|FG009|Cohort 5P, Q2W|Adverse Event|0|||
129624208|NCT02906670|466576471|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
129624209|NCT02906670|466576472|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
129624210|NCT02906670|466576473|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
129624211|NCT02906670|466576474|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
129624212|NCT02906670|466576475|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
129624213|NCT02906670|466576476|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
129624214|NCT02906670|466576477|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
129624215|NCT02906670|466576478|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
129624216|NCT02906670|466576479|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
129624217|NCT02906670|466576480|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
129624218|NCT02906670|466576471|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
129624219|NCT02906670|466576472|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
129624220|NCT02906670|466576473|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
129624221|NCT02906670|466576474|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
129624222|NCT02906670|466576475|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
129624223|NCT02906670|466576476|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
129624224|NCT02906670|466576477|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
129624225|NCT02906670|466576478|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
129624226|NCT02906670|466576479|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
129624227|NCT02906670|466576480|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
129624228|NCT02906670|466576471|FG000|Cohort 4P, QW|Radiological Progression|0|||
129624229|NCT02906670|466576472|FG001|Cohort 4P, QW|Radiological Progression|0|||
129624230|NCT02906670|466576473|FG002|Cohort 4P, QW|Radiological Progression|0|||
129793691|NCT00722371|467212727|FG004|Overall Study|Hypoglycemia|0|||
129793692|NCT00722371|467212728|FG005|Overall Study|Hypoglycemia|0|||
129793693|NCT00722371|467212729|FG006|Overall Study|Hypoglycemia|0|||
129793694|NCT00722371|467212723|FG000|Overall Study|Lack of Efficacy|4|||
129793695|NCT00722371|467212724|FG001|Overall Study|Lack of Efficacy|6|||
129793696|NCT00722371|467212725|FG002|Overall Study|Lack of Efficacy|6|||
129793697|NCT00722371|467212726|FG003|Overall Study|Lack of Efficacy|6|||
129793698|NCT00722371|467212727|FG004|Overall Study|Lack of Efficacy|2|||
129793699|NCT00722371|467212728|FG005|Overall Study|Lack of Efficacy|3|||
129793700|NCT00722371|467212729|FG006|Overall Study|Lack of Efficacy|0|||
129793701|NCT00722371|467212723|FG000|Overall Study|Lost to Follow-up|11|||
129793702|NCT00722371|467212724|FG001|Overall Study|Lost to Follow-up|14|||
129793703|NCT00722371|467212725|FG002|Overall Study|Lost to Follow-up|21|||
129793704|NCT00722371|467212726|FG003|Overall Study|Lost to Follow-up|13|||
129793705|NCT00722371|467212727|FG004|Overall Study|Lost to Follow-up|8|||
129793706|NCT00722371|467212728|FG005|Overall Study|Lost to Follow-up|16|||
129793707|NCT00722371|467212729|FG006|Overall Study|Lost to Follow-up|13|||
129793708|NCT00722371|467212723|FG000|Overall Study|Physician Decision|5|||
129624231|NCT02906670|466576474|FG003|Cohort 4P, QW|Radiological Progression|3|||
129624232|NCT02906670|466576475|FG004|Cohort 4P, QW|Radiological Progression|0|||
129624233|NCT02906670|466576476|FG005|Cohort 4P, QW|Radiological Progression|0|||
129624234|NCT02906670|466576477|FG006|Cohort 4P, QW|Radiological Progression|0|||
129624235|NCT02906670|466576478|FG007|Cohort 4P, QW|Radiological Progression|0|||
129624236|NCT02906670|466576479|FG008|Cohort 4P, QW|Radiological Progression|0|||
129624237|NCT02906670|466576480|FG009|Cohort 4P, QW|Radiological Progression|0|||
129624238|NCT02906670|466576471|FG000|Cohort 7P, Q2W|Adverse Event|0|||
129624239|NCT02906670|466576472|FG001|Cohort 7P, Q2W|Adverse Event|0|||
129624240|NCT02906670|466576473|FG002|Cohort 7P, Q2W|Adverse Event|0|||
129624241|NCT02906670|466576474|FG003|Cohort 7P, Q2W|Adverse Event|0|||
129624242|NCT02906670|466576475|FG004|Cohort 7P, Q2W|Adverse Event|0|||
129624243|NCT02906670|466576476|FG005|Cohort 7P, Q2W|Adverse Event|0|||
129624244|NCT02906670|466576477|FG006|Cohort 7P, Q2W|Adverse Event|0|||
129624245|NCT02906670|466576478|FG007|Cohort 7P, Q2W|Adverse Event|0|||
129793709|NCT00722371|467212724|FG001|Overall Study|Physician Decision|2|||
129793710|NCT00722371|467212725|FG002|Overall Study|Physician Decision|2|||
129624246|NCT02906670|466576479|FG008|Cohort 7P, Q2W|Adverse Event|0|||
129624247|NCT02906670|466576480|FG009|Cohort 7P, Q2W|Adverse Event|1|||
129624248|NCT02906670|466576471|FG000|Cohort 7P, Q2W|Physician Decision|0|||
129624249|NCT02906670|466576472|FG001|Cohort 7P, Q2W|Physician Decision|0|||
129624250|NCT02906670|466576473|FG002|Cohort 7P, Q2W|Physician Decision|0|||
129624251|NCT02906670|466576474|FG003|Cohort 7P, Q2W|Physician Decision|0|||
129624252|NCT02906670|466576475|FG004|Cohort 7P, Q2W|Physician Decision|0|||
129624253|NCT02906670|466576476|FG005|Cohort 7P, Q2W|Physician Decision|0|||
129624254|NCT02906670|466576477|FG006|Cohort 7P, Q2W|Physician Decision|0|||
129624255|NCT02906670|466576478|FG007|Cohort 7P, Q2W|Physician Decision|0|||
129793711|NCT00722371|467212726|FG003|Overall Study|Physician Decision|5|||
129793712|NCT00722371|467212727|FG004|Overall Study|Physician Decision|2|||
129793713|NCT00722371|467212728|FG005|Overall Study|Physician Decision|3|||
129793714|NCT00722371|467212729|FG006|Overall Study|Physician Decision|4|||
129624256|NCT02906670|466576479|FG008|Cohort 7P, Q2W|Physician Decision|0|||
129624257|NCT02906670|466576480|FG009|Cohort 7P, Q2W|Physician Decision|1|||
129624258|NCT02906670|466576471|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624259|NCT02906670|466576472|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624260|NCT02906670|466576473|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624261|NCT02906670|466576474|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624262|NCT02906670|466576475|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624263|NCT02906670|466576476|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624264|NCT02906670|466576477|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624265|NCT02906670|466576478|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624266|NCT02906670|466576479|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
129624267|NCT02906670|466576480|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
129624268|NCT02906670|466576471|FG000|Cohort 5P, QW|Radiological Progression|0|||
129624269|NCT02906670|466576472|FG001|Cohort 5P, QW|Radiological Progression|0|||
129624270|NCT02906670|466576473|FG002|Cohort 5P, QW|Radiological Progression|0|||
129624271|NCT02906670|466576474|FG003|Cohort 5P, QW|Radiological Progression|0|||
129624272|NCT02906670|466576475|FG004|Cohort 5P, QW|Radiological Progression|3|||
129624273|NCT02906670|466576476|FG005|Cohort 5P, QW|Radiological Progression|0|||
129624274|NCT02906670|466576477|FG006|Cohort 5P, QW|Radiological Progression|0|||
129624275|NCT02906670|466576478|FG007|Cohort 5P, QW|Radiological Progression|0|||
129624276|NCT02906670|466576479|FG008|Cohort 5P, QW|Radiological Progression|0|||
129624277|NCT02906670|466576480|FG009|Cohort 5P, QW|Radiological Progression|0|||
129624278|NCT01349192|466576481|FG000|Overall Study|Protocol Violation|0|||
129624279|NCT01349192|466576482|FG001|Overall Study|Protocol Violation|1|||
129624280|NCT01349192|466576481|FG000|Overall Study|Withdrawal by Subject|0|||
129624281|NCT01349192|466576482|FG001|Overall Study|Withdrawal by Subject|2|||
129624282|NCT01349192|466576481|FG000|Overall Study|Lost to Follow-up|1|||
129624283|NCT01349192|466576482|FG001|Overall Study|Lost to Follow-up|3|||
129624284|NCT01349192|466576481|FG000|Overall Study|Failure to adhere to Protocol|2|||
129624285|NCT01349192|466576482|FG001|Overall Study|Failure to adhere to Protocol|0|||
129624286|NCT03749330|466576483|FG000|Overall Study|Clinicians left work in the CICU|0|||
129624287|NCT03749330|466576484|FG001|Overall Study|Clinicians left work in the CICU|2|||
129624288|NCT03749330|466576485|FG002|Overall Study|Clinicians left work in the CICU|0|||
129624289|NCT03749330|466576486|FG003|Overall Study|Clinicians left work in the CICU|0|||
129624290|NCT03749330|466576487|FG004|Overall Study|Clinicians left work in the CICU|0|||
129624291|NCT03749330|466576488|FG005|Overall Study|Clinicians left work in the CICU|0|||
129624292|NCT01973439|466576489|FG000|Overall Study|Lost samples from one PK Day|2|||
129624293|NCT01973439|466576489|FG000|Overall Study|Vomiting after commencing once daily|1|||
129624294|NCT01973439|466576489|FG000|Overall Study|PK curve incomplete|2|||
129624295|NCT02262325|466576491|FG000|Overall Study|Death|16|||
129624296|NCT02262325|466576491|FG000|Overall Study|Lost to Follow-up|1|||
129624297|NCT02815995|466576492|FG000|Overall Study|Disease Progression|3|||
129624298|NCT02815995|466576493|FG001|Overall Study|Disease Progression|7|||
129624299|NCT02815995|466576494|FG002|Overall Study|Disease Progression|2|||
129624300|NCT02815995|466576495|FG003|Overall Study|Disease Progression|4|||
129624301|NCT02815995|466576496|FG004|Overall Study|Disease Progression|3|||
129624302|NCT02815995|466576497|FG005|Overall Study|Disease Progression|9|||
129624303|NCT02815995|466576498|FG006|Overall Study|Disease Progression|3|||
129624304|NCT02815995|466576499|FG007|Overall Study|Disease Progression|1|||
129624305|NCT02815995|466576492|FG000|Overall Study|Adverse Event|1|||
129624306|NCT02815995|466576493|FG001|Overall Study|Adverse Event|2|||
129624307|NCT02815995|466576494|FG002|Overall Study|Adverse Event|2|||
129624308|NCT02815995|466576495|FG003|Overall Study|Adverse Event|0|||
129624309|NCT02815995|466576496|FG004|Overall Study|Adverse Event|0|||
129624310|NCT02815995|466576497|FG005|Overall Study|Adverse Event|1|||
129624311|NCT02815995|466576498|FG006|Overall Study|Adverse Event|0|||
129624312|NCT02815995|466576499|FG007|Overall Study|Adverse Event|0|||
129624313|NCT02815995|466576492|FG000|Overall Study|Pregnancy|0|||
129624314|NCT02815995|466576493|FG001|Overall Study|Pregnancy|0|||
129624315|NCT02815995|466576494|FG002|Overall Study|Pregnancy|0|||
129624316|NCT02815995|466576495|FG003|Overall Study|Pregnancy|0|||
129624317|NCT02815995|466576496|FG004|Overall Study|Pregnancy|0|||
129624318|NCT02815995|466576497|FG005|Overall Study|Pregnancy|0|||
129624319|NCT02815995|466576498|FG006|Overall Study|Pregnancy|1|||
129624320|NCT02815995|466576499|FG007|Overall Study|Pregnancy|0|||
129624321|NCT03404674|466576504|FG000|Overall Study|Inability to Attend Future Visits|0|||
129624322|NCT03404674|466576505|FG001|Overall Study|Inability to Attend Future Visits|1|||
129624323|NCT03404674|466576506|FG002|Overall Study|Inability to Attend Future Visits|1|||
129624324|NCT03404674|466576507|FG003|Overall Study|Inability to Attend Future Visits|0|||
129624325|NCT03404674|466576508|FG004|Overall Study|Inability to Attend Future Visits|0|||
129624326|NCT03404674|466576509|FG005|Overall Study|Inability to Attend Future Visits|0|||
129624327|NCT03404674|466576504|FG000|Overall Study|Behavioral Problems|0|||
129624328|NCT03404674|466576505|FG001|Overall Study|Behavioral Problems|0|||
129888551|NCT02204293|467549229|FG000|Core Study Part I|Physician Decision|0|||
129888552|NCT02204293|467549230|FG001|Core Study Part I|Physician Decision|3|||
129888553|NCT02204293|467549231|FG002|Core Study Part I|Physician Decision|0|||
129888554|NCT02204293|467549232|FG003|Core Study Part I|Physician Decision|0|||
129888555|NCT02204293|467549233|FG004|Core Study Part I|Physician Decision|0|||
129888556|NCT02204293|467549234|FG005|Core Study Part I|Physician Decision|0|||
129888557|NCT02204293|467549229|FG000|LTE Phase|Study Suspended|0|||
129888558|NCT02204293|467549230|FG001|LTE Phase|Study Suspended|0|||
129888559|NCT02204293|467549231|FG002|LTE Phase|Study Suspended|0|||
129888560|NCT02204293|467549232|FG003|LTE Phase|Study Suspended|0|||
129624329|NCT03404674|466576506|FG002|Overall Study|Behavioral Problems|1|||
129624330|NCT03404674|466576507|FG003|Overall Study|Behavioral Problems|0|||
129624331|NCT03404674|466576508|FG004|Overall Study|Behavioral Problems|0|||
129624332|NCT03404674|466576509|FG005|Overall Study|Behavioral Problems|0|||
129624333|NCT03404674|466576504|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
129624334|NCT03404674|466576505|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
129624335|NCT03404674|466576506|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
129624336|NCT03404674|466576507|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
129624337|NCT03404674|466576508|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
129624338|NCT03404674|466576509|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
129624339|NCT00143390|466576518|FG000|Overall Study|Death|2|||
129624340|NCT00143390|466576519|FG001|Overall Study|Death|0|||
129624341|NCT00143390|466576518|FG000|Overall Study|Not meeting entry criteria|2|||
129624342|NCT00143390|466576519|FG001|Overall Study|Not meeting entry criteria|5|||
129624343|NCT00143390|466576518|FG000|Overall Study|Withdrawal by Subject|4|||
129624344|NCT00143390|466576519|FG001|Overall Study|Withdrawal by Subject|4|||
129624345|NCT00143390|466576518|FG000|Overall Study|Progressive disease|119|||
129624346|NCT00143390|466576519|FG001|Overall Study|Progressive disease|115|||
129624347|NCT00143390|466576518|FG000|Overall Study|Protocol Violation|2|||
129624348|NCT00143390|466576519|FG001|Overall Study|Protocol Violation|0|||
129624349|NCT00143390|466576518|FG000|Overall Study|Study termination|10|||
129624350|NCT00143390|466576519|FG001|Overall Study|Study termination|15|||
129624351|NCT00143390|466576518|FG000|Overall Study|Adverse Event|9|||
129624352|NCT00143390|466576519|FG001|Overall Study|Adverse Event|8|||
129624353|NCT00143390|466576518|FG000|Overall Study|Other|1|||
129624354|NCT00143390|466576519|FG001|Overall Study|Other|2|||
129624355|NCT00041132|466576522|FG000|Overall Study|Adverse Event|19|||
129624356|NCT00041132|466576522|FG000|Overall Study|Death|1|||
129624357|NCT00041132|466576522|FG000|Overall Study|Not Eligible|7|||
129624358|NCT00041132|466576522|FG000|Overall Study|Withdrawal by Subject|1|||
129624359|NCT00041132|466576522|FG000|Overall Study|Physician Decision|2|||
129624360|NCT03180645|466576523|FG000|Overall Study|Adverse Event|0|||
129624361|NCT03180645|466576524|FG001|Overall Study|Adverse Event|1|||
129624362|NCT03180645|466576525|FG002|Overall Study|Adverse Event|2|||
129624363|NCT02729909|466576527|FG000|Overall Study|Lost to Follow-up|0|||
129888561|NCT02204293|467549233|FG004|LTE Phase|Study Suspended|0|||
129888562|NCT02204293|467549234|FG005|LTE Phase|Study Suspended|7|||
129624364|NCT02729909|466576528|FG001|Overall Study|Lost to Follow-up|1|||
129624365|NCT02729909|466576527|FG000|Overall Study|Lack of Efficacy|0|||
129888563|NCT02019602|467549235|FG000|Screening Period|Ineligibility|4|||
129888564|NCT02019602|467549236|FG001|Screening Period|Ineligibility|0|||
129624366|NCT02729909|466576528|FG001|Overall Study|Lack of Efficacy|2|||
129624367|NCT02729909|466576527|FG000|Overall Study|Significant Protocol Deviation|0|||
129624368|NCT02729909|466576528|FG001|Overall Study|Significant Protocol Deviation|2|||
129624369|NCT02729909|466576527|FG000|Overall Study|Voluntary Withdrawal|1|||
129624370|NCT02729909|466576528|FG001|Overall Study|Voluntary Withdrawal|0|||
129624371|NCT00866359|466576529|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
129624372|NCT00866359|466576530|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
129624373|NCT00866359|466576531|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
129624374|NCT00866359|466576532|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
129624375|NCT00866359|466576529|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
129624376|NCT00866359|466576530|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
129624377|NCT00866359|466576531|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
129624378|NCT00866359|466576532|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
129624379|NCT00866359|466576529|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
129624380|NCT00866359|466576530|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
129624381|NCT00866359|466576531|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
129624382|NCT00866359|466576532|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
129624383|NCT00866359|466576529|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
129624384|NCT00866359|466576530|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
129624385|NCT00866359|466576531|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
129624386|NCT00866359|466576532|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
129624387|NCT00866359|466576529|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
129624388|NCT00866359|466576530|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
129624389|NCT00866359|466576531|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
129624390|NCT00866359|466576532|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
129624391|NCT00866359|466576529|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
129624392|NCT00866359|466576530|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
129624393|NCT00866359|466576531|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
129624394|NCT00866359|466576532|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
129624395|NCT00768248|466576534|FG000|Overall Study|Research coordinator didn't collect data|1|||
129624396|NCT00768248|466576535|FG001|Overall Study|Research coordinator didn't collect data|1|||
129624397|NCT01547390|466576536|FG000|Overall Study|Withdrawal by Subject|10|||
129624398|NCT01547390|466576537|FG001|Overall Study|Withdrawal by Subject|7|||
129624399|NCT01547390|466576536|FG000|Overall Study|termination of pregnancy|0|||
129624400|NCT01547390|466576537|FG001|Overall Study|termination of pregnancy|1|||
129624401|NCT01547390|466576536|FG000|Overall Study|Lost to Follow-up|0|||
129624402|NCT01547390|466576537|FG001|Overall Study|Lost to Follow-up|2|||
129624403|NCT01547390|466576536|FG000|Overall Study|Adverse Event|3|||
129624404|NCT01547390|466576537|FG001|Overall Study|Adverse Event|0|||
129624405|NCT01459783|466576538|FG000|Baseline to 6 Months|Death|1|||
129624406|NCT01459783|466576539|FG001|Baseline to 6 Months|Death|0|||
129624407|NCT01459783|466576538|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
129624408|NCT01459783|466576539|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
129624409|NCT01459783|466576538|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
129624410|NCT01459783|466576539|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
129624411|NCT01459783|466576538|FG000|6 Months to 12 Months|Death|0|||
129624412|NCT01459783|466576539|FG001|6 Months to 12 Months|Death|1|||
129624413|NCT01459783|466576538|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
129624414|NCT01459783|466576539|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
129624415|NCT01459783|466576538|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
129624416|NCT01459783|466576539|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
129624417|NCT01459783|466576538|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
129624418|NCT01459783|466576539|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
129624419|NCT06018129|466576541|FG000|Overall Study|Death|1|||
129624420|NCT06018129|466576542|FG001|Overall Study|Death|1|||
129624421|NCT06018129|466576543|FG002|Overall Study|Death|2|||
129624422|NCT06018129|466576541|FG000|Overall Study|Sponsor Decision|2|||
129624423|NCT06018129|466576542|FG001|Overall Study|Sponsor Decision|2|||
129624424|NCT06018129|466576543|FG002|Overall Study|Sponsor Decision|1|||
129624425|NCT04917861|466576544|FG000|Main Study (196 Days)|Adverse Event|0|||
129624426|NCT04917861|466576545|FG001|Main Study (196 Days)|Adverse Event|1|||
129624427|NCT04917861|466576546|FG002|Main Study (196 Days)|Adverse Event|0|||
129624428|NCT04917861|466576547|FG003|Main Study (196 Days)|Adverse Event|0|||
129624429|NCT04917861|466576544|FG000|Main Study (196 Days)|Death|0|||
129624430|NCT04917861|466576545|FG001|Main Study (196 Days)|Death|0|||
129624431|NCT04917861|466576546|FG002|Main Study (196 Days)|Death|0|||
129624432|NCT04917861|466576547|FG003|Main Study (196 Days)|Death|1|||
129624433|NCT04917861|466576544|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
129624434|NCT04917861|466576545|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
129624435|NCT04917861|466576546|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
129888565|NCT02019602|467549235|FG000|Screening Period|Adverse Event|1|||
129888566|NCT02019602|467549236|FG001|Screening Period|Adverse Event|0|||
129888567|NCT01058863|467549237|FG000|Overall Study|Lost to Follow-up|1|||
129888568|NCT01058863|467549237|FG000|Overall Study|Withdrawal by Subject|1|||
129888569|NCT01058863|467549237|FG000|Overall Study|Sponsor requested withdrawal|1|||
129888570|NCT01058863|467549237|FG000|Overall Study|Randomized in error|1|||
129888571|NCT00681187|467549238|FG000|Overall Study|Withdrawal by Subject|1|||
129888572|NCT00681187|467549239|FG001|Overall Study|Withdrawal by Subject|0|||
129888573|NCT00681187|467549238|FG000|Overall Study|Death|0|||
129888574|NCT00681187|467549239|FG001|Overall Study|Death|1|||
129624436|NCT04917861|466576547|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
129624437|NCT04917861|466576544|FG000|Main Study (196 Days)|Physician Decision|0|||
129888575|NCT00681187|467549238|FG000|Overall Study|Adverse Event|0|||
129624438|NCT04917861|466576545|FG001|Main Study (196 Days)|Physician Decision|0|||
129624439|NCT04917861|466576546|FG002|Main Study (196 Days)|Physician Decision|0|||
129624440|NCT04917861|466576547|FG003|Main Study (196 Days)|Physician Decision|1|||
129624441|NCT04917861|466576544|FG000|Main Study (196 Days)|Pregnancy|1|||
129624442|NCT04917861|466576545|FG001|Main Study (196 Days)|Pregnancy|1|||
129624443|NCT04917861|466576546|FG002|Main Study (196 Days)|Pregnancy|0|||
129624444|NCT04917861|466576547|FG003|Main Study (196 Days)|Pregnancy|0|||
129624445|NCT04917861|466576544|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
129624446|NCT04917861|466576545|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
129624447|NCT04917861|466576546|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
129624448|NCT04917861|466576547|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
129624449|NCT04917861|466576544|FG000|Main Study (196 Days)|Other Than Specified|1|||
129624450|NCT04917861|466576545|FG001|Main Study (196 Days)|Other Than Specified|0|||
129624451|NCT04917861|466576546|FG002|Main Study (196 Days)|Other Than Specified|1|||
129624452|NCT04917861|466576547|FG003|Main Study (196 Days)|Other Than Specified|2|||
129624453|NCT04917861|466576544|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
129624454|NCT04917861|466576545|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
129624455|NCT04917861|466576546|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
129624456|NCT04917861|466576547|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
129624457|NCT04917861|466576544|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
129888576|NCT00681187|467549239|FG001|Overall Study|Adverse Event|1|||
129888577|NCT02788006|467549241|FG000|Overall Study|Patient not treated|1|||
129888578|NCT02269943|467549244|FG000|Treatment Period|Death|0|||
129888579|NCT02269943|467549245|FG001|Treatment Period|Death|1|||
129624458|NCT04917861|466576545|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
129624459|NCT04917861|466576546|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
129624460|NCT04917861|466576547|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
129624461|NCT04917861|466576544|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
129624462|NCT04917861|466576545|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
129624463|NCT04917861|466576546|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
129624464|NCT04917861|466576547|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
129624465|NCT04917861|466576544|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
129624466|NCT04917861|466576545|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
129624467|NCT04917861|466576546|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
129624468|NCT04917861|466576547|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
129624469|NCT04917861|466576544|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
129624470|NCT04917861|466576545|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
129888580|NCT02269943|467549244|FG000|Treatment Period|Adverse Event|1|||
129888581|NCT02269943|467549245|FG001|Treatment Period|Adverse Event|10|||
129624471|NCT04917861|466576546|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
129888582|NCT02269943|467549244|FG000|Treatment Period|Progressive Disease|5|||
129888583|NCT02269943|467549245|FG001|Treatment Period|Progressive Disease|17|||
129888584|NCT02269943|467549244|FG000|Treatment Period|Symptomatic Deterioration|0|||
129624472|NCT04917861|466576547|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
129624473|NCT04917861|466576544|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
129624474|NCT04917861|466576545|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
129624475|NCT04917861|466576546|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
129702944|NCT02259231|466873241|FG006|Overall Study|Progressive Disease|4|||
129888585|NCT02269943|467549245|FG001|Treatment Period|Symptomatic Deterioration|2|||
129888586|NCT02269943|467549244|FG000|Follow-Up Survival Period|Death|3|||
129888587|NCT02269943|467549245|FG001|Follow-Up Survival Period|Death|16|||
129624476|NCT04917861|466576547|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
129624477|NCT06389487|466576548|FG000|Overall Study|Lost to Follow-up|9|||
129624478|NCT06389487|466576549|FG001|Overall Study|Lost to Follow-up|5|||
129624479|NCT06389487|466576550|FG002|Overall Study|Lost to Follow-up|13|||
129624480|NCT06389487|466576548|FG000|Overall Study|Protocol Violation|0|||
129624481|NCT06389487|466576549|FG001|Overall Study|Protocol Violation|0|||
129624482|NCT06389487|466576550|FG002|Overall Study|Protocol Violation|2|||
129624483|NCT06389487|466576548|FG000|Overall Study|Withdrawal by Subject|2|||
129624484|NCT06389487|466576549|FG001|Overall Study|Withdrawal by Subject|2|||
129624485|NCT06389487|466576550|FG002|Overall Study|Withdrawal by Subject|1|||
129624486|NCT06389487|466576548|FG000|Overall Study|Other|1|||
129624487|NCT06389487|466576549|FG001|Overall Study|Other|0|||
129624488|NCT06389487|466576550|FG002|Overall Study|Other|1|||
129624489|NCT03493685|466578303|FG000|Overall Study|Death|4|||
129624490|NCT03493685|466578304|FG001|Overall Study|Death|3|||
129624491|NCT03493685|466578303|FG000|Overall Study|Lost to Follow-up|3|||
129624492|NCT03493685|466578304|FG001|Overall Study|Lost to Follow-up|2|||
129624493|NCT03493685|466578303|FG000|Overall Study|Physician Decision|2|||
129624494|NCT03493685|466578304|FG001|Overall Study|Physician Decision|0|||
129624495|NCT03493685|466578303|FG000|Overall Study|Withdrawal by Subject|7|||
129624496|NCT03493685|466578304|FG001|Overall Study|Withdrawal by Subject|11|||
129624497|NCT04452669|466578305|FG000|Overall Study|Death|1|||
129624498|NCT04452669|466578306|FG001|Overall Study|Death|4|||
129624499|NCT03300817|466578307|FG000|Overall Study|Withdrawal by Subject|1|||
129624500|NCT03300817|466578307|FG000|Overall Study|Adverse Event|1|||
129624501|NCT03300817|466578307|FG000|Overall Study|Subject Found to be Ineligible|2|||
129624502|NCT03729596|466578310|FG000|Overall Study|Death|3|||
129624503|NCT03729596|466578311|FG001|Overall Study|Death|5|||
129624504|NCT03729596|466578312|FG002|Overall Study|Death|4|||
129624505|NCT03729596|466578313|FG003|Overall Study|Death|1|||
129624506|NCT03729596|466578314|FG004|Overall Study|Death|0|||
129624507|NCT03729596|466578315|FG005|Overall Study|Death|34|||
129624508|NCT03729596|466578316|FG006|Overall Study|Death|18|||
129624509|NCT03729596|466578317|FG007|Overall Study|Death|14|||
129624510|NCT03729596|466578318|FG008|Overall Study|Death|19|||
129624511|NCT03729596|466578319|FG009|Overall Study|Death|9|||
129624512|NCT03729596|466578310|FG000|Overall Study|Lost to Follow-up|0|||
129624513|NCT03729596|466578311|FG001|Overall Study|Lost to Follow-up|0|||
129624514|NCT03729596|466578312|FG002|Overall Study|Lost to Follow-up|0|||
129624515|NCT03729596|466578313|FG003|Overall Study|Lost to Follow-up|0|||
129624516|NCT03729596|466578314|FG004|Overall Study|Lost to Follow-up|0|||
129624517|NCT03729596|466578315|FG005|Overall Study|Lost to Follow-up|0|||
129624518|NCT03729596|466578316|FG006|Overall Study|Lost to Follow-up|1|||
129624519|NCT03729596|466578317|FG007|Overall Study|Lost to Follow-up|0|||
129624520|NCT03729596|466578318|FG008|Overall Study|Lost to Follow-up|0|||
129624521|NCT03729596|466578319|FG009|Overall Study|Lost to Follow-up|1|||
129624522|NCT03729596|466578310|FG000|Overall Study|protocol amendment|0|||
129624523|NCT03729596|466578311|FG001|Overall Study|protocol amendment|1|||
129624524|NCT03729596|466578312|FG002|Overall Study|protocol amendment|3|||
129624525|NCT03729596|466578313|FG003|Overall Study|protocol amendment|6|||
129624526|NCT03729596|466578314|FG004|Overall Study|protocol amendment|5|||
129624527|NCT03729596|466578315|FG005|Overall Study|protocol amendment|0|||
129624528|NCT03729596|466578316|FG006|Overall Study|protocol amendment|0|||
129624529|NCT03729596|466578317|FG007|Overall Study|protocol amendment|0|||
129624530|NCT03729596|466578318|FG008|Overall Study|protocol amendment|0|||
129624531|NCT03729596|466578319|FG009|Overall Study|protocol amendment|0|||
129624532|NCT03729596|466578310|FG000|Overall Study|Withdrawal by Subject|0|||
129624533|NCT03729596|466578311|FG001|Overall Study|Withdrawal by Subject|0|||
129624534|NCT03729596|466578312|FG002|Overall Study|Withdrawal by Subject|0|||
129624535|NCT03729596|466578313|FG003|Overall Study|Withdrawal by Subject|0|||
129624536|NCT03729596|466578314|FG004|Overall Study|Withdrawal by Subject|0|||
129624537|NCT03729596|466578315|FG005|Overall Study|Withdrawal by Subject|4|||
129702945|NCT02259231|466873235|FG000|Overall Study|Sponsor termination of study|1|||
129624538|NCT03729596|466578316|FG006|Overall Study|Withdrawal by Subject|2|||
129624539|NCT03729596|466578317|FG007|Overall Study|Withdrawal by Subject|3|||
129624540|NCT03729596|466578318|FG008|Overall Study|Withdrawal by Subject|2|||
129624541|NCT03729596|466578319|FG009|Overall Study|Withdrawal by Subject|3|||
129624542|NCT03729596|466578310|FG000|Overall Study|study terminated by sponsor|0|||
129624543|NCT03729596|466578311|FG001|Overall Study|study terminated by sponsor|0|||
129624544|NCT03729596|466578312|FG002|Overall Study|study terminated by sponsor|0|||
129624545|NCT03729596|466578313|FG003|Overall Study|study terminated by sponsor|0|||
129624546|NCT03729596|466578314|FG004|Overall Study|study terminated by sponsor|1|||
129624547|NCT03729596|466578315|FG005|Overall Study|study terminated by sponsor|3|||
129624548|NCT03729596|466578316|FG006|Overall Study|study terminated by sponsor|0|||
129624549|NCT03729596|466578317|FG007|Overall Study|study terminated by sponsor|1|||
129624550|NCT03729596|466578318|FG008|Overall Study|study terminated by sponsor|0|||
129702946|NCT02259231|466873236|FG001|Overall Study|Sponsor termination of study|0|||
129702947|NCT02259231|466873237|FG002|Overall Study|Sponsor termination of study|0|||
129624551|NCT03729596|466578319|FG009|Overall Study|study terminated by sponsor|0|||
129624552|NCT03713593|466578320|FG000|Overall Study|Sponsor Decision|73|||
129624553|NCT03713593|466578321|FG001|Overall Study|Sponsor Decision|41|||
129624554|NCT03713593|466578320|FG000|Overall Study|Lost to Follow-up|2|||
129624555|NCT03713593|466578321|FG001|Overall Study|Lost to Follow-up|1|||
129624556|NCT03713593|466578320|FG000|Overall Study|Death|314|||
129624557|NCT03713593|466578321|FG001|Overall Study|Death|349|||
129624558|NCT03713593|466578320|FG000|Overall Study|Withdrawal by Subject|6|||
129624559|NCT03713593|466578321|FG001|Overall Study|Withdrawal by Subject|8|||
129624560|NCT04653454|466578322|FG000|Overall Study|Withdrawal by Subject|1|||
129624561|NCT04653454|466578322|FG000|Overall Study|Physician Decision|40|||
129624562|NCT03620708|466578323|FG000|Overall Study|Lost to Follow-up|1|||
129624563|NCT03620708|466578324|FG001|Overall Study|Lost to Follow-up|1|||
129624564|NCT03620708|466578325|FG002|Overall Study|Lost to Follow-up|2|||
129624565|NCT03620708|466578323|FG000|Overall Study|Withdrawal by Subject|0|||
129624566|NCT03620708|466578324|FG001|Overall Study|Withdrawal by Subject|0|||
129624567|NCT03620708|466578325|FG002|Overall Study|Withdrawal by Subject|1|||
129624568|NCT05126693|466578326|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
129624569|NCT05126693|466578327|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
129624570|NCT05126693|466578326|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
129624571|NCT05126693|466578327|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
129624572|NCT05126693|466578326|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
129624573|NCT05126693|466578327|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
129624574|NCT04011722|466578331|FG000|30 Days|Death|5|||
129624575|NCT04011722|466578332|FG001|30 Days|Death|1|||
129624576|NCT04011722|466578331|FG000|1 Year|Death|13|||
129624577|NCT04011722|466578332|FG001|1 Year|Death|5|||
129624578|NCT04011722|466578331|FG000|1 Year|Withdrawal by Subject|8|||
129624579|NCT04011722|466578332|FG001|1 Year|Withdrawal by Subject|2|||
129624580|NCT04011722|466578331|FG000|1 Year|Missed Visit|6|||
129624581|NCT04011722|466578332|FG001|1 Year|Missed Visit|1|||
129624582|NCT04011722|466578331|FG000|1 Year|Pending Visit|0|||
129624583|NCT04011722|466578332|FG001|1 Year|Pending Visit|11|||
129624584|NCT04011722|466578331|FG000|1 Year|Not Yet Due|0|||
129624585|NCT04011722|466578332|FG001|1 Year|Not Yet Due|9|||
129624586|NCT04011722|466578331|FG000|2 Year|Death|16|||
129624587|NCT04011722|466578332|FG001|2 Year|Death|1|||
129624588|NCT04011722|466578331|FG000|2 Year|Withdrawal by Subject|10|||
129624589|NCT04011722|466578332|FG001|2 Year|Withdrawal by Subject|1|||
129624590|NCT04011722|466578331|FG000|2 Year|Missed Visit|9|||
129624591|NCT04011722|466578332|FG001|2 Year|Missed Visit|0|||
129624592|NCT04011722|466578331|FG000|2 Year|Visit Pending|1|||
129624593|NCT04011722|466578332|FG001|2 Year|Visit Pending|3|||
129624594|NCT04011722|466578331|FG000|2 Year|Not Yet Due|43|||
129624595|NCT04011722|466578332|FG001|2 Year|Not Yet Due|54|||
129624596|NCT04011722|466578331|FG000|3 Year|Death|10|||
129624597|NCT04011722|466578332|FG001|3 Year|Death|0|||
129624598|NCT04011722|466578331|FG000|3 Year|Withdrawal by Subject|2|||
129624599|NCT04011722|466578332|FG001|3 Year|Withdrawal by Subject|0|||
129624600|NCT04011722|466578331|FG000|3 Year|Missed Visit|2|||
129624601|NCT04011722|466578332|FG001|3 Year|Missed Visit|0|||
129624602|NCT04011722|466578331|FG000|3 Year|Pending Visit|34|||
129624603|NCT04011722|466578332|FG001|3 Year|Pending Visit|0|||
129624604|NCT04011722|466578331|FG000|3 Year|Not Yet Due|99|||
129624605|NCT04011722|466578332|FG001|3 Year|Not Yet Due|0|||
129624606|NCT05061134|466578333|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
129624607|NCT05061134|466578334|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
129624608|NCT05061134|466578335|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
129624609|NCT05061134|466578333|FG000|Overall Study|Subject not treated|0|||
129624610|NCT05061134|466578334|FG001|Overall Study|Subject not treated|0|||
129624611|NCT05061134|466578335|FG002|Overall Study|Subject not treated|2|||
129624612|NCT05061134|466578333|FG000|Overall Study|Other|0|||
129624613|NCT05061134|466578334|FG001|Overall Study|Other|0|||
129624614|NCT05061134|466578335|FG002|Overall Study|Other|9|||
129624615|NCT05061134|466578333|FG000|Overall Study|Withdrawal by Subject|9|||
129624616|NCT05061134|466578334|FG001|Overall Study|Withdrawal by Subject|8|||
129624617|NCT05061134|466578335|FG002|Overall Study|Withdrawal by Subject|5|||
129624618|NCT05061134|466578333|FG000|Overall Study|Study Terminated by Sponsor|22|||
129624619|NCT05061134|466578334|FG001|Overall Study|Study Terminated by Sponsor|14|||
129624620|NCT05061134|466578335|FG002|Overall Study|Study Terminated by Sponsor|7|||
129624621|NCT05061134|466578333|FG000|Overall Study|Progressive Disease|1|||
129624622|NCT05061134|466578334|FG001|Overall Study|Progressive Disease|2|||
129624623|NCT05061134|466578335|FG002|Overall Study|Progressive Disease|0|||
129624624|NCT05061134|466578333|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
129624625|NCT05061134|466578334|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
129624626|NCT05061134|466578335|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
129624627|NCT05061134|466578333|FG000|Overall Study|Lost to Follow-up|1|||
129624628|NCT05061134|466578334|FG001|Overall Study|Lost to Follow-up|0|||
129624629|NCT05061134|466578335|FG002|Overall Study|Lost to Follow-up|0|||
129624630|NCT05061134|466578333|FG000|Overall Study|Physician Decision|1|||
129624631|NCT05061134|466578334|FG001|Overall Study|Physician Decision|1|||
129624632|NCT05061134|466578335|FG002|Overall Study|Physician Decision|0|||
129624633|NCT05061134|466578333|FG000|Overall Study|Disease progression|1|||
129624634|NCT05061134|466578334|FG001|Overall Study|Disease progression|0|||
129624635|NCT05061134|466578335|FG002|Overall Study|Disease progression|0|||
129624636|NCT05061134|466578333|FG000|Overall Study|Death|43|||
129624637|NCT05061134|466578334|FG001|Overall Study|Death|23|||
129624638|NCT05061134|466578335|FG002|Overall Study|Death|14|||
129624639|NCT05061134|466578333|FG000|Overall Study|Database lock|2|||
129624640|NCT05061134|466578334|FG001|Overall Study|Database lock|0|||
129624641|NCT05061134|466578335|FG002|Overall Study|Database lock|0|||
129624642|NCT00001521|466578341|FG000|Overall Study|Withdrawal by Subject|3|||
129624643|NCT00001521|466578342|FG001|Overall Study|Withdrawal by Subject|3|||
129624644|NCT00001521|466578341|FG000|Overall Study|Physician Decision|1|||
129624645|NCT00001521|466578342|FG001|Overall Study|Physician Decision|1|||
129624646|NCT00001521|466578341|FG000|Overall Study|Noncompliant|6|||
129624647|NCT00001521|466578342|FG001|Overall Study|Noncompliant|3|||
129624648|NCT02366689|466578347|FG000|Overall Study|Withdrawal by Subject|1|||
129624649|NCT02366689|466578348|FG001|Overall Study|Withdrawal by Subject|0|||
129624650|NCT02366689|466578349|FG002|Overall Study|Withdrawal by Subject|1|||
129624651|NCT02366689|466578347|FG000|Overall Study|Lost to Follow-up|3|||
129624652|NCT02366689|466578348|FG001|Overall Study|Lost to Follow-up|2|||
129624653|NCT02366689|466578349|FG002|Overall Study|Lost to Follow-up|0|||
129624654|NCT02366689|466578347|FG000|Overall Study|Pregnancy|0|||
129624655|NCT02366689|466578348|FG001|Overall Study|Pregnancy|1|||
129624656|NCT02366689|466578349|FG002|Overall Study|Pregnancy|1|||
129624657|NCT03283566|466578350|FG000|Overall Study|Lost to Follow-up|1|||
129624658|NCT03283566|466578351|FG001|Overall Study|Lost to Follow-up|2|||
129624659|NCT03288714|466578354|FG000|Overall Study|Lost to Follow-up|2|||
129624660|NCT03288714|466578355|FG001|Overall Study|Lost to Follow-up|1|||
129624661|NCT03288714|466578354|FG000|Overall Study|Non-compliance with study schedule|2|||
129624662|NCT03288714|466578355|FG001|Overall Study|Non-compliance with study schedule|0|||
129624663|NCT03288714|466578354|FG000|Overall Study|Withdrawal by Subject|3|||
129624664|NCT03288714|466578355|FG001|Overall Study|Withdrawal by Subject|1|||
129624665|NCT03288714|466578354|FG000|Overall Study|Clinical Worsening|2|||
129624666|NCT03288714|466578355|FG001|Overall Study|Clinical Worsening|1|||
129624667|NCT03288714|466578354|FG000|Overall Study|Adverse Event|1|||
129624668|NCT03288714|466578355|FG001|Overall Study|Adverse Event|0|||
129624669|NCT04882241|466578357|FG000|Overall Study|Ongoing in study|46|||
129624670|NCT04882241|466578358|FG001|Overall Study|Ongoing in study|48|||
129624671|NCT04882241|466578359|FG002|Overall Study|Ongoing in study|0|||
129624672|NCT04882241|466578360|FG003|Overall Study|Ongoing in study|0|||
129624673|NCT04882241|466578357|FG000|Overall Study|Death|13|||
129624674|NCT04882241|466578358|FG001|Overall Study|Death|13|||
129624675|NCT04882241|466578359|FG002|Overall Study|Death|0|||
129624676|NCT04882241|466578360|FG003|Overall Study|Death|0|||
129624677|NCT00470535|466578373|FG000|Overall Study|Disease Progression|13|||
129624678|NCT00470535|466578373|FG000|Overall Study|Withdrawal by Subject|1|||
129624679|NCT00470535|466578373|FG000|Overall Study|Adverse Event|1|||
129624680|NCT00470535|466578373|FG000|Overall Study|Death|1|||
129793715|NCT00722371|467212723|FG000|Overall Study|Pregnancy|1|||
129793716|NCT00722371|467212724|FG001|Overall Study|Pregnancy|1|||
129793717|NCT00722371|467212725|FG002|Overall Study|Pregnancy|0|||
129793718|NCT00722371|467212726|FG003|Overall Study|Pregnancy|0|||
129793719|NCT00722371|467212727|FG004|Overall Study|Pregnancy|0|||
129793720|NCT00722371|467212728|FG005|Overall Study|Pregnancy|1|||
129793721|NCT00722371|467212729|FG006|Overall Study|Pregnancy|0|||
129793722|NCT00722371|467212723|FG000|Overall Study|Protocol Violation|6|||
129793723|NCT00722371|467212724|FG001|Overall Study|Protocol Violation|1|||
129793724|NCT00722371|467212725|FG002|Overall Study|Protocol Violation|0|||
129793725|NCT00722371|467212726|FG003|Overall Study|Protocol Violation|1|||
129793726|NCT00722371|467212727|FG004|Overall Study|Protocol Violation|4|||
129793727|NCT00722371|467212728|FG005|Overall Study|Protocol Violation|2|||
129793728|NCT00722371|467212729|FG006|Overall Study|Protocol Violation|1|||
129793729|NCT00722371|467212723|FG000|Overall Study|Withdrawal by Subject|18|||
129793730|NCT00722371|467212724|FG001|Overall Study|Withdrawal by Subject|27|||
129624681|NCT00470535|466578373|FG000|Overall Study|Other|2|||
129624682|NCT02070965|466578378|FG000|Overall Study|Lost to Follow-up|0|||
129624683|NCT02070965|466578379|FG001|Overall Study|Lost to Follow-up|1|||
129793731|NCT00722371|467212725|FG002|Overall Study|Withdrawal by Subject|19|||
129624684|NCT02070965|466578380|FG002|Overall Study|Lost to Follow-up|0|||
129624685|NCT02070965|466578378|FG000|Overall Study|Withdrawal by Subject|1|||
129624686|NCT02070965|466578379|FG001|Overall Study|Withdrawal by Subject|1|||
129624687|NCT02070965|466578380|FG002|Overall Study|Withdrawal by Subject|1|||
129793732|NCT00722371|467212726|FG003|Overall Study|Withdrawal by Subject|23|||
129624688|NCT02070965|466578378|FG000|Overall Study|Subject moved|1|||
129624689|NCT02070965|466578379|FG001|Overall Study|Subject moved|0|||
129624690|NCT02070965|466578380|FG002|Overall Study|Subject moved|0|||
129624691|NCT02515331|466578381|FG000|Overall Study|Withdrawal by Subject|0|||
129624692|NCT02515331|466578382|FG001|Overall Study|Withdrawal by Subject|0|||
129793733|NCT00722371|467212727|FG004|Overall Study|Withdrawal by Subject|19|||
129793734|NCT00722371|467212728|FG005|Overall Study|Withdrawal by Subject|18|||
129793735|NCT00722371|467212729|FG006|Overall Study|Withdrawal by Subject|26|||
129624693|NCT02515331|466578383|FG002|Overall Study|Withdrawal by Subject|1|||
129624694|NCT02515331|466578381|FG000|Overall Study|Protocol deviation|0|||
129624695|NCT02515331|466578382|FG001|Overall Study|Protocol deviation|0|||
129624696|NCT02515331|466578383|FG002|Overall Study|Protocol deviation|3|||
129624697|NCT02515331|466578381|FG000|Overall Study|Adverse Event|2|||
129624698|NCT02515331|466578382|FG001|Overall Study|Adverse Event|0|||
129624699|NCT02515331|466578383|FG002|Overall Study|Adverse Event|0|||
129624700|NCT00124748|466578384|FG000|Overall Study|Adverse Event|8|||
129624701|NCT00124748|466578385|FG001|Overall Study|Adverse Event|39|||
129624702|NCT00124748|466578384|FG000|Overall Study|Abnormal laboratory Value|2|||
129624703|NCT00124748|466578385|FG001|Overall Study|Abnormal laboratory Value|2|||
129624704|NCT00124748|466578384|FG000|Overall Study|Abnormal Procedure|0|||
129624705|NCT00124748|466578385|FG001|Overall Study|Abnormal Procedure|1|||
129624706|NCT00124748|466578384|FG000|Overall Study|Lack of Efficacy|20|||
129624707|NCT00124748|466578385|FG001|Overall Study|Lack of Efficacy|41|||
129624708|NCT00124748|466578384|FG000|Overall Study|No longer requires study drug|1|||
129624709|NCT00124748|466578385|FG001|Overall Study|No longer requires study drug|1|||
129624710|NCT00124748|466578384|FG000|Overall Study|Protocol Violation|3|||
129624711|NCT00124748|466578385|FG001|Overall Study|Protocol Violation|1|||
129624712|NCT00124748|466578384|FG000|Overall Study|Withdrawal by Subject|5|||
129624713|NCT00124748|466578385|FG001|Overall Study|Withdrawal by Subject|15|||
129624714|NCT00124748|466578384|FG000|Overall Study|Lost to Follow-up|2|||
129624715|NCT00124748|466578385|FG001|Overall Study|Lost to Follow-up|7|||
129624716|NCT00124748|466578384|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
129624717|NCT00124748|466578385|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
129624718|NCT00124748|466578384|FG000|Overall Study|Death|1|||
129624719|NCT00124748|466578385|FG001|Overall Study|Death|3|||
129624720|NCT00322712|466578386|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
129624721|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
129624722|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
129624723|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
129624724|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624725|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
129624726|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
129624727|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624728|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624729|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624730|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624731|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624732|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624733|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624734|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624735|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624736|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624737|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
129624738|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
129624739|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624740|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
129624741|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
129624742|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
129624743|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
129624744|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624745|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624746|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624747|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624748|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624749|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624750|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624751|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624752|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624753|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624754|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
129624755|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
129624756|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
129624757|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
129624758|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
129624759|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
129624760|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
129624761|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624762|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129793736|NCT01092832|467212730|FG000|Overall Study|Other|1|||
129793737|NCT01092832|467212731|FG001|Overall Study|Other|0|||
129624763|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624764|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624765|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624766|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624767|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624768|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624769|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624770|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624771|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
129624772|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624773|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
129624774|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
129624775|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624776|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
129624777|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
129624778|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624779|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624780|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624781|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624782|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624783|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624784|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624785|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624786|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624787|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624788|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
129624789|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624790|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624791|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
129624792|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
129624793|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624794|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624795|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624796|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624797|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624798|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624799|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624800|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624801|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624802|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624803|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624804|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624805|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
129624806|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624807|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624808|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624809|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624810|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
129624811|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624812|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624813|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624814|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624815|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624816|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624817|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624818|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624819|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129702948|NCT02259231|466873238|FG003|Overall Study|Sponsor termination of study|1|||
129702949|NCT02259231|466873239|FG004|Overall Study|Sponsor termination of study|2|||
129702950|NCT02259231|466873240|FG005|Overall Study|Sponsor termination of study|1|||
129702951|NCT02259231|466873241|FG006|Overall Study|Sponsor termination of study|1|||
129702952|NCT00847730|466873245|FG000|Overall Study|Multiple interruptions in therapy|8|||
129702953|NCT04116489|466873248|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
129702954|NCT04116489|466873248|FG000|Overall Study|Withdrawal by Subject|1|||
129888588|NCT02269943|467549244|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
129888589|NCT02269943|467549245|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
129624820|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129702955|NCT02255656|466873249|FG000|Overall Study|Adverse Event|11|||
129624821|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624822|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
129624823|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624824|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
129624825|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624826|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624827|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624828|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624829|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624830|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624831|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624832|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624833|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624834|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624835|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624836|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624837|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624838|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624839|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
129624840|NCT00758524|466578387|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624841|NCT00758524|466578388|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
129624842|NCT00758524|466578389|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624843|NCT00758524|466578390|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624844|NCT00758524|466578391|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624845|NCT00758524|466578392|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624846|NCT00758524|466578393|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624847|NCT00758524|466578394|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624848|NCT00758524|466578395|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624849|NCT00758524|466578396|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624850|NCT00758524|466578397|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624851|NCT00758524|466578398|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624852|NCT00758524|466578399|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624853|NCT00758524|466578400|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624854|NCT00758524|466578401|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624855|NCT00758524|466578402|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624856|NCT00758524|466578403|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
129624857|NCT00758524|466578387|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624858|NCT00758524|466578388|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624859|NCT00758524|466578389|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624860|NCT00758524|466578390|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624861|NCT00758524|466578391|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624862|NCT00758524|466578392|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624863|NCT00758524|466578393|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624864|NCT00758524|466578394|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624865|NCT00758524|466578395|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
129624866|NCT00758524|466578396|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624867|NCT00758524|466578397|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624868|NCT00758524|466578398|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624869|NCT00758524|466578399|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624870|NCT00758524|466578400|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129793738|NCT02068768|467212732|FG000|Overall Study|Lost to Follow-up|5|||
129624871|NCT00758524|466578401|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624872|NCT00758524|466578402|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624873|NCT00758524|466578403|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
129624874|NCT00758524|466578387|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624875|NCT00758524|466578388|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624876|NCT00758524|466578389|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624877|NCT00758524|466578390|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624878|NCT00758524|466578391|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129793739|NCT02068768|467212732|FG000|Overall Study|Early Termination by Sponsor|2|||
129624879|NCT00758524|466578392|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129793740|NCT00555425|467212733|FG000|Overall Study|Missed Medication > 1 wk|34|||
129793741|NCT00555425|467212734|FG001|Overall Study|Missed Medication > 1 wk|15|||
129624880|NCT00758524|466578393|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
129624881|NCT00758524|466578394|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624882|NCT00758524|466578395|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624883|NCT00758524|466578396|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624884|NCT00758524|466578397|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624885|NCT00758524|466578398|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624886|NCT00758524|466578399|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624887|NCT00758524|466578400|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624888|NCT00758524|466578401|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624889|NCT00758524|466578402|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624890|NCT00758524|466578403|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
129624891|NCT04688671|466578407|FG000|Overall Study|Adverse Event|3|||
129624892|NCT04688671|466578408|FG001|Overall Study|Adverse Event|1|||
129624893|NCT04688671|466578407|FG000|Overall Study|Withdrawal by Subject|3|||
129624894|NCT04688671|466578408|FG001|Overall Study|Withdrawal by Subject|1|||
129624895|NCT04688671|466578407|FG000|Overall Study|Lack of Efficacy|1|||
129624896|NCT04688671|466578408|FG001|Overall Study|Lack of Efficacy|1|||
129624897|NCT04688671|466578407|FG000|Overall Study|Protocol Violation|1|||
129624898|NCT04688671|466578408|FG001|Overall Study|Protocol Violation|0|||
129624899|NCT04688671|466578407|FG000|Overall Study|Lost to Follow-up|0|||
129624900|NCT04688671|466578408|FG001|Overall Study|Lost to Follow-up|1|||
129624901|NCT01269918|466578409|FG000|Overall Study|Did not receive study drug|0|||
129624902|NCT01269918|466578410|FG001|Overall Study|Did not receive study drug|3|||
129624903|NCT03571828|466578411|FG000|Overall Study|Withdrawal by Subject|1|||
129624904|NCT03571828|466578412|FG001|Overall Study|Withdrawal by Subject|0|||
129624905|NCT03571828|466578411|FG000|Overall Study|Decision by sponsor|5|||
129624906|NCT03571828|466578412|FG001|Overall Study|Decision by sponsor|1|||
129624907|NCT03571828|466578411|FG000|Overall Study|Death|2|||
129624908|NCT03571828|466578412|FG001|Overall Study|Death|0|||
129624909|NCT00769379|466578413|FG000|Overall Study|No follow up data mapped to Other.|3|||
129624910|NCT00769379|466578414|FG001|Overall Study|No follow up data mapped to Other.|13|||
129624911|NCT01928472|466578415|FG000|Overall Study|Death|0|||
129624912|NCT01928472|466578416|FG001|Overall Study|Death|0|||
129624913|NCT01928472|466578417|FG002|Overall Study|Death|1|||
129624914|NCT01928472|466578418|FG003|Overall Study|Death|0|||
129624915|NCT01928472|466578415|FG000|Overall Study|Withdrawal by Subject|4|||
129624916|NCT01928472|466578416|FG001|Overall Study|Withdrawal by Subject|4|||
129624917|NCT01928472|466578417|FG002|Overall Study|Withdrawal by Subject|1|||
129624918|NCT01928472|466578418|FG003|Overall Study|Withdrawal by Subject|2|||
129624919|NCT01928472|466578415|FG000|Overall Study|Lost to Follow-up|2|||
129624920|NCT01928472|466578416|FG001|Overall Study|Lost to Follow-up|3|||
129624921|NCT01928472|466578417|FG002|Overall Study|Lost to Follow-up|4|||
129624922|NCT01928472|466578418|FG003|Overall Study|Lost to Follow-up|0|||
129624923|NCT01928472|466578415|FG000|Overall Study|Administrative Reason|2|||
129624924|NCT01928472|466578416|FG001|Overall Study|Administrative Reason|1|||
129624925|NCT01928472|466578417|FG002|Overall Study|Administrative Reason|0|||
129624926|NCT01928472|466578418|FG003|Overall Study|Administrative Reason|0|||
129624927|NCT01928472|466578415|FG000|Overall Study|Unclassified|0|||
129624928|NCT01928472|466578416|FG001|Overall Study|Unclassified|0|||
129624929|NCT01928472|466578417|FG002|Overall Study|Unclassified|1|||
129624930|NCT01928472|466578418|FG003|Overall Study|Unclassified|0|||
129624931|NCT01308424|466578419|FG000|Baseline Eligibility|Screen Failures|71|||
129624932|NCT01308424|466578420|FG001|Baseline Eligibility|Screen Failures|0|||
129624933|NCT01308424|466578421|FG002|Baseline Eligibility|Screen Failures|0|||
129624934|NCT01308424|466578419|FG000|Randomization|Adverse Event|0|||
129624935|NCT01308424|466578420|FG001|Randomization|Adverse Event|1|||
129624936|NCT01308424|466578421|FG002|Randomization|Adverse Event|1|||
129624937|NCT01308424|466578419|FG000|Randomization|Lost to Follow-up|0|||
129624938|NCT01308424|466578420|FG001|Randomization|Lost to Follow-up|1|||
129624939|NCT01308424|466578421|FG002|Randomization|Lost to Follow-up|0|||
129888590|NCT02269943|467549244|FG000|Follow-Up Survival Period|Alive|2|||
129624940|NCT01308424|466578419|FG000|Randomization|Physician Decision|0|||
129624941|NCT01308424|466578420|FG001|Randomization|Physician Decision|1|||
129624942|NCT01308424|466578421|FG002|Randomization|Physician Decision|1|||
129624943|NCT04471428|466578425|FG000|Overall Study|Withdrawal by Subject|29|||
129624944|NCT04471428|466578426|FG001|Overall Study|Withdrawal by Subject|1|||
129624945|NCT04471428|466578425|FG000|Overall Study|Physician Decision|0|||
129624946|NCT04471428|466578426|FG001|Overall Study|Physician Decision|1|||
129624947|NCT04471428|466578425|FG000|Overall Study|Reason Not Specified|0|||
129624948|NCT04471428|466578426|FG001|Overall Study|Reason Not Specified|2|||
129624949|NCT04471428|466578425|FG000|Overall Study|Death|106|||
129624950|NCT04471428|466578426|FG001|Overall Study|Death|114|||
129624951|NCT04471428|466578425|FG000|Overall Study|Ongoing in the study|45|||
129624952|NCT04471428|466578426|FG001|Overall Study|Ongoing in the study|68|||
129624953|NCT00129545|466578429|FG000|Overall Study|Death|5|||
129624954|NCT00129545|466578430|FG001|Overall Study|Death|60|||
129624955|NCT00129545|466578431|FG002|Overall Study|Death|44|||
129624956|NCT00129545|466578429|FG000|Overall Study|Withdrawal by Subject|3|||
129624957|NCT00129545|466578430|FG001|Overall Study|Withdrawal by Subject|18|||
129624958|NCT00129545|466578431|FG002|Overall Study|Withdrawal by Subject|44|||
129624959|NCT00129545|466578429|FG000|Overall Study|Lost to Follow-up|2|||
129624960|NCT00129545|466578430|FG001|Overall Study|Lost to Follow-up|22|||
129624961|NCT00129545|466578431|FG002|Overall Study|Lost to Follow-up|13|||
129624962|NCT00129545|466578429|FG000|Overall Study|Physician Decision|0|||
129624963|NCT00129545|466578430|FG001|Overall Study|Physician Decision|3|||
129624964|NCT00129545|466578431|FG002|Overall Study|Physician Decision|10|||
129624965|NCT00129545|466578429|FG000|Overall Study|Device not implanted|16|||
129624966|NCT00129545|466578430|FG001|Overall Study|Device not implanted|61|||
129624967|NCT00129545|466578431|FG002|Overall Study|Device not implanted|0|||
129624968|NCT01841593|466578432|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
129624969|NCT01841593|466578433|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
129624970|NCT01841593|466578432|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
129624971|NCT01841593|466578433|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
129624972|NCT00307086|466578434|FG000|Overall Study|ineligible|5|||
129624973|NCT01870778|466578438|FG000|Overall Study|Withdrawal by Subject|8|||
129624974|NCT01870778|466578439|FG001|Overall Study|Withdrawal by Subject|7|||
129624975|NCT01870778|466578438|FG000|Overall Study|Lost to Follow-up|0|||
129624976|NCT01870778|466578439|FG001|Overall Study|Lost to Follow-up|2|||
129624977|NCT00312338|466578440|FG000|Overall Study|Adverse Event|7|||
129624978|NCT00312338|466578441|FG001|Overall Study|Adverse Event|2|||
129624979|NCT00312338|466578440|FG000|Overall Study|Lost to Follow-up|9|||
129624980|NCT00312338|466578441|FG001|Overall Study|Lost to Follow-up|1|||
129624981|NCT00312338|466578440|FG000|Overall Study|Withdrawal by Subject|4|||
129624982|NCT00312338|466578441|FG001|Overall Study|Withdrawal by Subject|0|||
129624983|NCT00312338|466578440|FG000|Overall Study|Subsequent infection|2|||
129624984|NCT00312338|466578441|FG001|Overall Study|Subsequent infection|0|||
129624985|NCT00262028|466578442|FG000|Overall Study|Withdrawal by Subject|6|||
129624986|NCT00262028|466578443|FG001|Overall Study|Withdrawal by Subject|3|||
129624987|NCT00262028|466578444|FG002|Overall Study|Withdrawal by Subject|6|||
129624988|NCT00262028|466578445|FG003|Overall Study|Withdrawal by Subject|5|||
129624989|NCT00262028|466578446|FG004|Overall Study|Withdrawal by Subject|2|||
129624990|NCT00262028|466578447|FG005|Overall Study|Withdrawal by Subject|3|||
129624991|NCT00262028|466578448|FG006|Overall Study|Withdrawal by Subject|5|||
129624992|NCT00262028|466578449|FG007|Overall Study|Withdrawal by Subject|7|||
129624993|NCT00262028|466578450|FG008|Overall Study|Withdrawal by Subject|2|||
129624994|NCT00262028|466578442|FG000|Overall Study|Lost to Follow-up|7|||
129624995|NCT00262028|466578443|FG001|Overall Study|Lost to Follow-up|7|||
129624996|NCT00262028|466578444|FG002|Overall Study|Lost to Follow-up|5|||
129624997|NCT00262028|466578445|FG003|Overall Study|Lost to Follow-up|5|||
129624998|NCT00262028|466578446|FG004|Overall Study|Lost to Follow-up|4|||
129624999|NCT00262028|466578447|FG005|Overall Study|Lost to Follow-up|3|||
129625000|NCT00262028|466578448|FG006|Overall Study|Lost to Follow-up|3|||
129625001|NCT00262028|466578449|FG007|Overall Study|Lost to Follow-up|5|||
129625002|NCT00262028|466578450|FG008|Overall Study|Lost to Follow-up|6|||
129625003|NCT00262028|466578442|FG000|Overall Study|Administrative Reason|11|||
129625004|NCT00262028|466578443|FG001|Overall Study|Administrative Reason|14|||
129625005|NCT00262028|466578444|FG002|Overall Study|Administrative Reason|9|||
129625006|NCT00262028|466578445|FG003|Overall Study|Administrative Reason|12|||
129625007|NCT00262028|466578446|FG004|Overall Study|Administrative Reason|6|||
129625008|NCT00262028|466578447|FG005|Overall Study|Administrative Reason|7|||
129625009|NCT00262028|466578448|FG006|Overall Study|Administrative Reason|4|||
129793742|NCT00555425|467212733|FG000|Overall Study|Missed 3 physician management visits|1|||
129793743|NCT00555425|467212734|FG001|Overall Study|Missed 3 physician management visits|0|||
129793744|NCT00555425|467212733|FG000|Overall Study|Met criteria for protective transfer|16|||
129793745|NCT00555425|467212734|FG001|Overall Study|Met criteria for protective transfer|3|||
129793746|NCT00555425|467212733|FG000|Overall Study|Became pregnant and transferred care|0|||
129793747|NCT00555425|467212734|FG001|Overall Study|Became pregnant and transferred care|1|||
129888591|NCT02269943|467549245|FG001|Follow-Up Survival Period|Alive|8|||
129625010|NCT00262028|466578449|FG007|Overall Study|Administrative Reason|6|||
129625011|NCT00262028|466578450|FG008|Overall Study|Administrative Reason|10|||
129625012|NCT00262028|466578442|FG000|Overall Study|Protocol Violation|0|||
129625013|NCT00262028|466578443|FG001|Overall Study|Protocol Violation|0|||
129625014|NCT00262028|466578444|FG002|Overall Study|Protocol Violation|0|||
129625015|NCT00262028|466578445|FG003|Overall Study|Protocol Violation|1|||
129625016|NCT00262028|466578446|FG004|Overall Study|Protocol Violation|0|||
129625017|NCT00262028|466578447|FG005|Overall Study|Protocol Violation|0|||
129625018|NCT00262028|466578448|FG006|Overall Study|Protocol Violation|0|||
129625019|NCT00262028|466578449|FG007|Overall Study|Protocol Violation|0|||
129625020|NCT00262028|466578450|FG008|Overall Study|Protocol Violation|0|||
129625021|NCT00262028|466578442|FG000|Overall Study|Unable to classify|0|||
129625022|NCT00262028|466578443|FG001|Overall Study|Unable to classify|3|||
129625023|NCT00262028|466578444|FG002|Overall Study|Unable to classify|0|||
129625024|NCT00262028|466578445|FG003|Overall Study|Unable to classify|0|||
129625025|NCT00262028|466578446|FG004|Overall Study|Unable to classify|0|||
129625026|NCT00262028|466578447|FG005|Overall Study|Unable to classify|0|||
129625027|NCT00262028|466578448|FG006|Overall Study|Unable to classify|0|||
129625028|NCT00262028|466578449|FG007|Overall Study|Unable to classify|0|||
129625029|NCT00262028|466578450|FG008|Overall Study|Unable to classify|1|||
129625030|NCT02308124|466578451|FG000|Overall Study|Lost to Follow-up|6|||
129625031|NCT02308124|466578452|FG001|Overall Study|Lost to Follow-up|6|||
129625032|NCT02308124|466578453|FG002|Overall Study|Lost to Follow-up|6|||
129625033|NCT02308124|466578451|FG000|Overall Study|Adverse Event|0|||
129625034|NCT02308124|466578452|FG001|Overall Study|Adverse Event|2|||
129625035|NCT02308124|466578453|FG002|Overall Study|Adverse Event|2|||
129625036|NCT02553772|466578455|FG000|Overall Study|Adverse Event|2|||
129625037|NCT02553772|466578456|FG001|Overall Study|Adverse Event|3|||
129625038|NCT02553772|466578455|FG000|Overall Study|Lost to Follow-up|2|||
129625039|NCT02553772|466578456|FG001|Overall Study|Lost to Follow-up|1|||
129625040|NCT02553772|466578455|FG000|Overall Study|Withdrawal of Consent|1|||
129625041|NCT02553772|466578456|FG001|Overall Study|Withdrawal of Consent|1|||
129625042|NCT02553772|466578455|FG000|Overall Study|Lack of Efficacy|1|||
129625043|NCT02553772|466578456|FG001|Overall Study|Lack of Efficacy|0|||
129625044|NCT02553772|466578455|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129625045|NCT02553772|466578456|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129625046|NCT05724589|466578457|FG000|Overall Study|Lost to Follow-up|1|||
129625047|NCT00786409|466578458|FG000|Overall Study|Withdrawal by Subject|2|||
129625048|NCT00786409|466578458|FG000|Overall Study|Adverse Event|2|||
129625049|NCT00786409|466578458|FG000|Overall Study|Pregnancy|2|||
129625050|NCT00786409|466578458|FG000|Overall Study|Lost to Follow-up|1|||
129625051|NCT00610129|466578459|FG000|Overall Study|Not treated since patients ineligible|3|||
129625052|NCT01042093|466578462|FG000|Overall Study|Protocol Violation|2|||
129625053|NCT01042093|466578463|FG001|Overall Study|Protocol Violation|2|||
129625054|NCT01042093|466578464|FG002|Overall Study|Protocol Violation|2|||
129625055|NCT01042093|466578465|FG003|Overall Study|Protocol Violation|3|||
129625056|NCT01042093|466578462|FG000|Overall Study|Withdrawal by Subject|0|||
129625057|NCT01042093|466578463|FG001|Overall Study|Withdrawal by Subject|0|||
129625058|NCT01042093|466578464|FG002|Overall Study|Withdrawal by Subject|0|||
129625059|NCT01042093|466578465|FG003|Overall Study|Withdrawal by Subject|1|||
129625060|NCT02273388|466578466|FG000|Overall Study|Adverse Event|0|||
129625061|NCT02273388|466578467|FG001|Overall Study|Adverse Event|0|||
129625062|NCT02273388|466578468|FG002|Overall Study|Adverse Event|0|||
129625063|NCT02273388|466578469|FG003|Overall Study|Adverse Event|0|||
129625064|NCT02273388|466578470|FG004|Overall Study|Adverse Event|0|||
129625065|NCT02273388|466578471|FG005|Overall Study|Adverse Event|0|||
129625066|NCT02273388|466578472|FG006|Overall Study|Adverse Event|1|||
129625067|NCT02273388|466578473|FG007|Overall Study|Adverse Event|2|||
129625068|NCT02273388|466578474|FG008|Overall Study|Adverse Event|0|||
129625069|NCT02273388|466578475|FG009|Overall Study|Adverse Event|0|||
129625070|NCT02273388|466578476|FG010|Overall Study|Adverse Event|0|||
129625071|NCT02273388|466578477|FG011|Overall Study|Adverse Event|0|||
129625072|NCT02273388|466578466|FG000|Overall Study|Adverse Event study disease worse|4|||
129625073|NCT02273388|466578467|FG001|Overall Study|Adverse Event study disease worse|3|||
129625074|NCT02273388|466578468|FG002|Overall Study|Adverse Event study disease worse|3|||
129625075|NCT02273388|466578469|FG003|Overall Study|Adverse Event study disease worse|2|||
129625076|NCT02273388|466578470|FG004|Overall Study|Adverse Event study disease worse|4|||
129625077|NCT02273388|466578471|FG005|Overall Study|Adverse Event study disease worse|3|||
129625078|NCT02273388|466578472|FG006|Overall Study|Adverse Event study disease worse|14|||
129625079|NCT02273388|466578473|FG007|Overall Study|Adverse Event study disease worse|6|||
129625080|NCT02273388|466578474|FG008|Overall Study|Adverse Event study disease worse|6|||
129625081|NCT02273388|466578475|FG009|Overall Study|Adverse Event study disease worse|5|||
129625082|NCT02273388|466578476|FG010|Overall Study|Adverse Event study disease worse|10|||
129625083|NCT02273388|466578477|FG011|Overall Study|Adverse Event study disease worse|1|||
129625084|NCT02273388|466578466|FG000|Overall Study|Sponsor decision|0|||
129625085|NCT02273388|466578467|FG001|Overall Study|Sponsor decision|0|||
129625086|NCT02273388|466578468|FG002|Overall Study|Sponsor decision|0|||
129625087|NCT02273388|466578469|FG003|Overall Study|Sponsor decision|0|||
129625088|NCT02273388|466578470|FG004|Overall Study|Sponsor decision|0|||
129625089|NCT02273388|466578471|FG005|Overall Study|Sponsor decision|0|||
129625090|NCT02273388|466578472|FG006|Overall Study|Sponsor decision|0|||
129625091|NCT02273388|466578473|FG007|Overall Study|Sponsor decision|0|||
129625092|NCT02273388|466578474|FG008|Overall Study|Sponsor decision|0|||
129625093|NCT02273388|466578475|FG009|Overall Study|Sponsor decision|0|||
129625094|NCT02273388|466578476|FG010|Overall Study|Sponsor decision|0|||
129625095|NCT02273388|466578477|FG011|Overall Study|Sponsor decision|1|||
129625096|NCT04331808|466578478|FG000|Overall Study|Withdrew consent|1|||
129625097|NCT04331808|466578479|FG001|Overall Study|Withdrew consent|0|||
129625098|NCT04331808|466578480|FG002|Overall Study|Withdrew consent|2|||
129625099|NCT04331808|466578481|FG003|Overall Study|Withdrew consent|3|||
129625100|NCT01184079|466578485|FG000|Overall Study|Lost to Follow-up|14|||
129625101|NCT01184079|466578486|FG001|Overall Study|Lost to Follow-up|2|||
129625102|NCT04233073|466578487|FG000|Overall Study|Death|5|||
129625103|NCT02198963|466578488|FG000|Overall Study|Adverse Event|1|||
129625104|NCT02198963|466578488|FG000|Overall Study|Withdrawal by Subject|6|||
129625105|NCT02603146|466580224|FG000|Overall Study|Lost to Follow-up|5|||
129625106|NCT02603146|466580225|FG001|Overall Study|Lost to Follow-up|6|||
129625107|NCT02603146|466580224|FG000|Overall Study|Withdrawal by Subject|8|||
129625108|NCT02603146|466580225|FG001|Overall Study|Withdrawal by Subject|10|||
129625109|NCT02603146|466580224|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
129625110|NCT02603146|466580225|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
129625111|NCT02603146|466580224|FG000|Overall Study|Participant moved|2|||
129625112|NCT02603146|466580225|FG001|Overall Study|Participant moved|0|||
129625113|NCT02603146|466580224|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
129625114|NCT02603146|466580225|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
129625115|NCT00265759|466580226|FG000|Overall Study|Withdrawal by Subject|0|||
129625116|NCT00265759|466580227|FG001|Overall Study|Withdrawal by Subject|1|||
129625117|NCT00265759|466580228|FG002|Overall Study|Withdrawal by Subject|2|||
129625118|NCT00265759|466580229|FG003|Overall Study|Withdrawal by Subject|2|||
129625119|NCT00265759|466580226|FG000|Overall Study|Cancel|0|||
129625120|NCT00265759|466580227|FG001|Overall Study|Cancel|0|||
129625121|NCT00265759|466580228|FG002|Overall Study|Cancel|0|||
129625122|NCT00265759|466580229|FG003|Overall Study|Cancel|3|||
129625123|NCT00265759|466580226|FG000|Overall Study|Ineligible|0|||
129625124|NCT00265759|466580227|FG001|Overall Study|Ineligible|0|||
129625125|NCT00265759|466580228|FG002|Overall Study|Ineligible|0|||
129625126|NCT00265759|466580229|FG003|Overall Study|Ineligible|1|||
129625127|NCT00265759|466580226|FG000|Overall Study|Bilateral disease|0|||
129625128|NCT00265759|466580227|FG001|Overall Study|Bilateral disease|0|||
129625129|NCT00265759|466580228|FG002|Overall Study|Bilateral disease|0|||
129625130|NCT00265759|466580229|FG003|Overall Study|Bilateral disease|2|||
129625131|NCT00265759|466580226|FG000|Overall Study|Discontinued due to intolerability|0|||
129625132|NCT00265759|466580227|FG001|Overall Study|Discontinued due to intolerability|0|||
129625133|NCT00265759|466580228|FG002|Overall Study|Discontinued due to intolerability|0|||
129625134|NCT00265759|466580229|FG003|Overall Study|Discontinued due to intolerability|1|||
129625135|NCT04467840|466580230|FG000|Overall Study|Death|35|||
129625136|NCT04467840|466580231|FG001|Overall Study|Death|39|||
129625137|NCT04467840|466580230|FG000|Overall Study|Withdrawal by Subject|8|||
129625138|NCT04467840|466580231|FG001|Overall Study|Withdrawal by Subject|4|||
129625139|NCT04467840|466580230|FG000|Overall Study|Adverse Event|2|||
129625140|NCT04467840|466580231|FG001|Overall Study|Adverse Event|0|||
129625141|NCT04467840|466580230|FG000|Overall Study|Lost to Follow-up|1|||
129625142|NCT04467840|466580231|FG001|Overall Study|Lost to Follow-up|3|||
129625143|NCT04467840|466580230|FG000|Overall Study|Physician Decision|1|||
129625144|NCT04467840|466580231|FG001|Overall Study|Physician Decision|0|||
129625145|NCT04467840|466580230|FG000|Overall Study|Other|1|||
129625146|NCT04467840|466580231|FG001|Overall Study|Other|5|||
129625147|NCT04467840|466580230|FG000|Overall Study|Missing study completion status|3|||
129625148|NCT04467840|466580231|FG001|Overall Study|Missing study completion status|1|||
129625149|NCT05201794|466580234|FG000|Overall Study|Withdrawal by Subject|13|||
129625150|NCT05201794|466580235|FG001|Overall Study|Withdrawal by Subject|12|||
129625151|NCT05201794|466580236|FG002|Overall Study|Withdrawal by Subject|14|||
129625152|NCT05201794|466580237|FG003|Overall Study|Withdrawal by Subject|0|||
129625153|NCT05201794|466580234|FG000|Overall Study|Adverse Event|5|||
129625154|NCT05201794|466580235|FG001|Overall Study|Adverse Event|5|||
129888592|NCT03050398|467549246|FG000|Overall Study|Study terminated by sponsor|8|||
129888593|NCT00598481|467549247|FG000|Treatment|Physician Decision|1|||
129625155|NCT05201794|466580236|FG002|Overall Study|Adverse Event|4|||
129625156|NCT05201794|466580237|FG003|Overall Study|Adverse Event|0|||
129625157|NCT05201794|466580234|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
129625158|NCT05201794|466580235|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129625159|NCT05201794|466580236|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
129625160|NCT05201794|466580237|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129625161|NCT05201794|466580234|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129702956|NCT02255656|466873249|FG000|Overall Study|Poor compliance to protocol|3|||
129702957|NCT02255656|466873249|FG000|Overall Study|Lost to Follow-up|30|||
129702958|NCT02255656|466873249|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
129702959|NCT02255656|466873249|FG000|Overall Study|Other|126|||
129702960|NCT03734536|466873250|FG000|Overall Study|Withdrew Consent|1|||
129702961|NCT03734536|466873251|FG001|Overall Study|Withdrew Consent|5|||
129702962|NCT03734536|466873250|FG000|Overall Study|Lost to Follow-up|10|||
129625162|NCT05201794|466580235|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129702963|NCT03734536|466873251|FG001|Overall Study|Lost to Follow-up|7|||
129702964|NCT01877278|466873252|FG000|Overall Study|Lost to Follow-up|3|||
129702965|NCT01877278|466873253|FG001|Overall Study|Lost to Follow-up|3|||
129625163|NCT05201794|466580236|FG002|Overall Study|Non-Compliance With Study Drug|3|||
129625164|NCT05201794|466580237|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129793748|NCT03149848|467212741|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
129793749|NCT03149848|467212741|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
129793750|NCT01244490|467212742|FG000|Overall Study|Lack of Efficacy|14|||
129793751|NCT01244490|467212743|FG001|Overall Study|Lack of Efficacy|5|||
129793752|NCT01244490|467212744|FG002|Overall Study|Lack of Efficacy|5|||
129793753|NCT01244490|467212742|FG000|Overall Study|Withdrawal by Subject|4|||
129793754|NCT01244490|467212743|FG001|Overall Study|Withdrawal by Subject|4|||
129793755|NCT01244490|467212744|FG002|Overall Study|Withdrawal by Subject|9|||
129793756|NCT01244490|467212742|FG000|Overall Study|Adverse Event|1|||
129793757|NCT01244490|467212743|FG001|Overall Study|Adverse Event|9|||
129793758|NCT01244490|467212744|FG002|Overall Study|Adverse Event|5|||
129793759|NCT01244490|467212742|FG000|Overall Study|Lost to Follow-up|0|||
129793760|NCT01244490|467212743|FG001|Overall Study|Lost to Follow-up|6|||
129793761|NCT01244490|467212744|FG002|Overall Study|Lost to Follow-up|3|||
129793762|NCT01244490|467212742|FG000|Overall Study|Other|0|||
129793763|NCT01244490|467212743|FG001|Overall Study|Other|0|||
129793764|NCT01244490|467212744|FG002|Overall Study|Other|1|||
129793765|NCT00400153|467212748|FG000|Overall Study|AE due to study disease worsening|14|||
129793766|NCT00400153|467212749|FG001|Overall Study|AE due to study disease worsening|19|||
129793767|NCT00400153|467212750|FG002|Overall Study|AE due to study disease worsening|20|||
129793768|NCT00400153|467212748|FG000|Overall Study|AE due to other disease worsening|2|||
129888594|NCT01991197|467549248|FG000|Overall Study|Lost to Follow-up|1|||
129888595|NCT01991197|467549249|FG001|Overall Study|Lost to Follow-up|1|||
129888596|NCT01991197|467549248|FG000|Overall Study|Physician Decision|0|||
129625165|NCT05201794|466580234|FG000|Overall Study|Physician Decision|1|||
129625166|NCT05201794|466580235|FG001|Overall Study|Physician Decision|3|||
129625167|NCT05201794|466580236|FG002|Overall Study|Physician Decision|2|||
129625168|NCT05201794|466580237|FG003|Overall Study|Physician Decision|0|||
129625169|NCT05201794|466580234|FG000|Overall Study|Lost to Follow-up|2|||
129625170|NCT05201794|466580235|FG001|Overall Study|Lost to Follow-up|2|||
129625171|NCT05201794|466580236|FG002|Overall Study|Lost to Follow-up|0|||
129625172|NCT05201794|466580237|FG003|Overall Study|Lost to Follow-up|0|||
129625173|NCT05201794|466580234|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
129625174|NCT05201794|466580235|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
129625175|NCT05201794|466580236|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
129625176|NCT05201794|466580237|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
129625177|NCT05201794|466580234|FG000|Overall Study|Protocol Violation|2|||
129625178|NCT05201794|466580235|FG001|Overall Study|Protocol Violation|0|||
129625179|NCT05201794|466580236|FG002|Overall Study|Protocol Violation|1|||
129625180|NCT05201794|466580237|FG003|Overall Study|Protocol Violation|0|||
129625181|NCT05201794|466580234|FG000|Overall Study|Death|1|||
129625182|NCT05201794|466580235|FG001|Overall Study|Death|0|||
129702966|NCT05185453|466873260|FG000|Overall Study|Lost to Follow-up|13|||
129702967|NCT05185453|466873261|FG001|Overall Study|Lost to Follow-up|3|||
129702968|NCT02457793|466873265|FG000|Overall Study|Reason not specified|0|||
129702969|NCT02457793|466873266|FG001|Overall Study|Reason not specified|0|||
129702970|NCT02457793|466873267|FG002|Overall Study|Reason not specified|0|||
129702971|NCT02457793|466873268|FG003|Overall Study|Reason not specified|1|||
129702972|NCT02457793|466873269|FG004|Overall Study|Reason not specified|1|||
129702973|NCT02457793|466873270|FG005|Overall Study|Reason not specified|1|||
129702974|NCT02457793|466873265|FG000|Overall Study|Withdrawal by Subject|0|||
129702975|NCT02457793|466873266|FG001|Overall Study|Withdrawal by Subject|4|||
129702976|NCT02457793|466873267|FG002|Overall Study|Withdrawal by Subject|2|||
129702977|NCT02457793|466873268|FG003|Overall Study|Withdrawal by Subject|2|||
129702978|NCT02457793|466873269|FG004|Overall Study|Withdrawal by Subject|2|||
129702979|NCT02457793|466873270|FG005|Overall Study|Withdrawal by Subject|2|||
129793769|NCT00400153|467212749|FG001|Overall Study|AE due to other disease worsening|1|||
129888597|NCT01991197|467549249|FG001|Overall Study|Physician Decision|2|||
129888598|NCT01991197|467549248|FG000|Overall Study|Withdrawal by Subject|2|||
129625183|NCT05201794|466580236|FG002|Overall Study|Death|0|||
129625184|NCT05201794|466580237|FG003|Overall Study|Death|0|||
129439470|NCT01723254|465906512|FG005|Overall Study|Move/Left to another country/city|0|||
129702980|NCT02457793|466873265|FG000|Overall Study|Adverse Event|0|||
129702981|NCT02457793|466873266|FG001|Overall Study|Adverse Event|0|||
129625185|NCT05201794|466580234|FG000|Overall Study|Site Terminated By Sponsor|0|||
129625186|NCT05201794|466580235|FG001|Overall Study|Site Terminated By Sponsor|1|||
129702982|NCT02457793|466873267|FG002|Overall Study|Adverse Event|0|||
129702983|NCT02457793|466873268|FG003|Overall Study|Adverse Event|1|||
129625187|NCT05201794|466580236|FG002|Overall Study|Site Terminated By Sponsor|0|||
129702984|NCT02457793|466873269|FG004|Overall Study|Adverse Event|0|||
129702985|NCT02457793|466873270|FG005|Overall Study|Adverse Event|0|||
129702986|NCT02457793|466873265|FG000|Overall Study|Physician Decision|1|||
129793770|NCT00400153|467212750|FG002|Overall Study|AE due to other disease worsening|0|||
129625188|NCT05201794|466580237|FG003|Overall Study|Site Terminated By Sponsor|0|||
129625189|NCT05201794|466580234|FG000|Overall Study|Other|3|||
129625190|NCT05201794|466580235|FG001|Overall Study|Other|3|||
129793771|NCT00400153|467212748|FG000|Overall Study|AE due to other condition|3|||
129793772|NCT00400153|467212749|FG001|Overall Study|AE due to other condition|14|||
129625191|NCT05201794|466580236|FG002|Overall Study|Other|3|||
129625192|NCT05201794|466580237|FG003|Overall Study|Other|0|||
129625193|NCT05201794|466580234|FG000|Overall Study|Randomized But Not Treated|1|||
129625194|NCT05201794|466580235|FG001|Overall Study|Randomized But Not Treated|2|||
129625195|NCT05201794|466580236|FG002|Overall Study|Randomized But Not Treated|1|||
129625196|NCT05201794|466580237|FG003|Overall Study|Randomized But Not Treated|0|||
129625197|NCT06082843|466580243|FG000|Overall Study|Withdrawal by Subject|0|||
129625198|NCT06082843|466580244|FG001|Overall Study|Withdrawal by Subject|2|||
129625199|NCT06082843|466580243|FG000|Overall Study|Study terminated by sponsor|12|||
129625200|NCT06082843|466580244|FG001|Overall Study|Study terminated by sponsor|8|||
129625201|NCT04848480|466580248|FG000|Main Phase (26 Weeks)|Death|1|||
129625202|NCT04848480|466580249|FG001|Main Phase (26 Weeks)|Death|0|||
129625203|NCT04848480|466580248|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
129625204|NCT04848480|466580249|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
129625205|NCT04848480|466580248|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
129625206|NCT04848480|466580249|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
129625207|NCT04848480|466580248|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
129625208|NCT04848480|466580249|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
129625209|NCT04848480|466580248|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
129625210|NCT04848480|466580249|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
129625211|NCT04848480|466580248|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
129625212|NCT04848480|466580249|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
129625213|NCT03176134|466580250|FG000|Overall Study|Lost to Follow-up|0|||
129625214|NCT03176134|466580251|FG001|Overall Study|Lost to Follow-up|2|||
129625215|NCT03176134|466580252|FG002|Overall Study|Lost to Follow-up|0|||
129625216|NCT03176134|466580253|FG003|Overall Study|Lost to Follow-up|0|||
129625217|NCT03176134|466580254|FG004|Overall Study|Lost to Follow-up|0|||
129888599|NCT01991197|467549249|FG001|Overall Study|Withdrawal by Subject|0|||
129888600|NCT01010217|467549250|FG000|Overall Study|Lost to Follow-up|4|||
129625218|NCT03176134|466580255|FG005|Overall Study|Lost to Follow-up|0|||
129625219|NCT03176134|466580256|FG006|Overall Study|Lost to Follow-up|0|||
129625220|NCT03176134|466580257|FG007|Overall Study|Lost to Follow-up|0|||
129625221|NCT03176134|466580250|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129625222|NCT03176134|466580251|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129625223|NCT03176134|466580252|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129625224|NCT03176134|466580253|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129625225|NCT03176134|466580254|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129625226|NCT03176134|466580255|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129625227|NCT03176134|466580256|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
129625228|NCT03176134|466580257|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
129625229|NCT01368497|466580258|FG000|Overall Study|Lost to Follow-up|2|||
129625230|NCT05989672|466580260|FG000|Overall Study|Adverse Event|3|||
129625231|NCT05989672|466580261|FG001|Overall Study|Adverse Event|0|||
129625232|NCT05989672|466580262|FG002|Overall Study|Adverse Event|0|||
129625233|NCT00443729|466580263|FG000|Overall Study|Never Treated|0|||
129625234|NCT00443729|466580264|FG001|Overall Study|Never Treated|1|||
129625235|NCT00443729|466580263|FG000|Overall Study|Lack of Efficacy|4|||
129625236|NCT00443729|466580264|FG001|Overall Study|Lack of Efficacy|2|||
129625237|NCT00443729|466580263|FG000|Overall Study|Lost to Follow-up|0|||
129625238|NCT00443729|466580264|FG001|Overall Study|Lost to Follow-up|1|||
129625239|NCT00443729|466580263|FG000|Overall Study|Physician Decision|2|||
129625240|NCT00443729|466580264|FG001|Overall Study|Physician Decision|1|||
129625241|NCT00443729|466580263|FG000|Overall Study|Protocol Violation|1|||
129625242|NCT00443729|466580264|FG001|Overall Study|Protocol Violation|1|||
129625243|NCT00443729|466580263|FG000|Overall Study|Withdrawal by Subject|3|||
129625244|NCT00443729|466580264|FG001|Overall Study|Withdrawal by Subject|1|||
129625245|NCT03718832|466580267|FG000|Analysis Sample|Withdrawal by Subject|18|||
129625246|NCT03718832|466580268|FG001|Analysis Sample|Withdrawal by Subject|15|||
129625247|NCT03718832|466580267|FG000|Analysis Sample|Legal hold on data|1|||
129625248|NCT03718832|466580268|FG001|Analysis Sample|Legal hold on data|0|||
129625249|NCT03718832|466580267|FG000|Analysis Sample|Participant from treated household|0|||
129625250|NCT03718832|466580268|FG001|Analysis Sample|Participant from treated household|1|||
129625251|NCT03718832|466580267|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
129625252|NCT03718832|466580268|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
129625253|NCT00276484|466580272|FG000|Overall Study|Adverse Event|4|||
129625254|NCT00276484|466580273|FG001|Overall Study|Adverse Event|7|||
129625255|NCT00276484|466580272|FG000|Overall Study|Lost to Follow-up|1|||
129625256|NCT00276484|466580273|FG001|Overall Study|Lost to Follow-up|1|||
129625257|NCT00276484|466580272|FG000|Overall Study|Protocol Violation|0|||
129625258|NCT00276484|466580273|FG001|Overall Study|Protocol Violation|1|||
129625259|NCT00276484|466580272|FG000|Overall Study|Withdrawal by Subject|4|||
129888601|NCT01010217|467549251|FG001|Overall Study|Lost to Follow-up|5|||
129888602|NCT01010217|467549252|FG002|Overall Study|Lost to Follow-up|1|||
129888603|NCT01010217|467549253|FG003|Overall Study|Lost to Follow-up|0|||
129625260|NCT00276484|466580273|FG001|Overall Study|Withdrawal by Subject|3|||
129625261|NCT00276484|466580272|FG000|Overall Study|Could not take time off work|0|||
129625262|NCT00276484|466580273|FG001|Overall Study|Could not take time off work|1|||
129625263|NCT01626690|466580274|FG000|Overall Study|Protocol Violation|1|||
129625264|NCT01626690|466580275|FG001|Overall Study|Protocol Violation|0|||
129625265|NCT01626690|466580274|FG000|Overall Study|Adverse Event|1|||
129625266|NCT01626690|466580275|FG001|Overall Study|Adverse Event|0|||
129625267|NCT00110396|466580276|FG000|Overall Study|Adverse Event|15|||
129625268|NCT00110396|466580276|FG000|Overall Study|Lost to Follow-up|1|||
129625269|NCT00110396|466580276|FG000|Overall Study|Administration of plasmapheresis|1|||
129625270|NCT00110396|466580276|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
129625271|NCT00110396|466580276|FG000|Overall Study|Lack of Efficacy|1|||
129702987|NCT02457793|466873266|FG001|Overall Study|Physician Decision|0|||
129702988|NCT02457793|466873267|FG002|Overall Study|Physician Decision|1|||
129702989|NCT02457793|466873268|FG003|Overall Study|Physician Decision|1|||
129702990|NCT02457793|466873269|FG004|Overall Study|Physician Decision|1|||
129702991|NCT02457793|466873270|FG005|Overall Study|Physician Decision|3|||
129702992|NCT02757768|466873275|FG000|Overall Study|Randomized Never Received Study Drug|3|||
129888604|NCT01010217|467549254|FG004|Overall Study|Lost to Follow-up|0|||
129625272|NCT00110396|466580276|FG000|Overall Study|Decided not to continue treatment|1|||
129625273|NCT00110396|466580276|FG000|Overall Study|Patient non-compliance|1|||
129625274|NCT00110396|466580276|FG000|Overall Study|Patient refused to continue|1|||
129625275|NCT00110396|466580276|FG000|Overall Study|Patient refused to participate|1|||
129702993|NCT02757768|466873276|FG001|Overall Study|Randomized Never Received Study Drug|4|||
129702994|NCT02757768|466873275|FG000|Overall Study|Adverse Event|5|||
129888605|NCT01010217|467549250|FG000|Overall Study|Withdrawal by Subject|1|||
129625276|NCT00110396|466580276|FG000|Overall Study|Patient will|1|||
129625277|NCT00110396|466580276|FG000|Overall Study|Patient's decision|1|||
129625278|NCT00110396|466580276|FG000|Overall Study|Participation in MS vaccine study|1|||
129625279|NCT00110396|466580276|FG000|Overall Study|Pregnancy|1|||
129888606|NCT01010217|467549251|FG001|Overall Study|Withdrawal by Subject|0|||
129888607|NCT01010217|467549252|FG002|Overall Study|Withdrawal by Subject|0|||
129888608|NCT01010217|467549253|FG003|Overall Study|Withdrawal by Subject|0|||
129888609|NCT01010217|467549254|FG004|Overall Study|Withdrawal by Subject|0|||
129888610|NCT01010217|467549250|FG000|Overall Study|Physician Decision|0|||
129888611|NCT01010217|467549251|FG001|Overall Study|Physician Decision|0|||
129888612|NCT01010217|467549252|FG002|Overall Study|Physician Decision|0|||
129888613|NCT01010217|467549253|FG003|Overall Study|Physician Decision|6|||
129888614|NCT01010217|467549254|FG004|Overall Study|Physician Decision|3|||
129888615|NCT01439711|467549255|FG000|Overall Study|Ineligible|13|||
129888616|NCT01439711|467549255|FG000|Overall Study|Cancel|3|||
129888617|NCT01439711|467549255|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
129888618|NCT01439711|467549255|FG000|Overall Study|Adverse Event|5|||
129888619|NCT01439711|467549255|FG000|Overall Study|Withdrawal by Subject|3|||
129888620|NCT01439711|467549255|FG000|Overall Study|Progression During Active Tx|3|||
129888621|NCT01439711|467549255|FG000|Overall Study|Noncompliance|3|||
129888622|NCT01439711|467549255|FG000|Overall Study|No MRI|9|||
129888623|NCT04242875|467549256|FG000|Overall Study|Adverse Event|2|||
129888624|NCT02397460|467549257|FG000|Treatment Period 2|Adverse Event|0|||
129888625|NCT02397460|467549258|FG001|Treatment Period 2|Adverse Event|0|||
129888626|NCT02397460|467549259|FG002|Treatment Period 2|Adverse Event|0|||
129888627|NCT02397460|467549260|FG003|Treatment Period 2|Adverse Event|0|||
129888628|NCT02397460|467549261|FG004|Treatment Period 2|Adverse Event|0|||
129888629|NCT02397460|467549262|FG005|Treatment Period 2|Adverse Event|0|||
129625280|NCT00110396|466580276|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
129625281|NCT00110396|466580276|FG000|Overall Study|Protocol Violation|2|||
129625282|NCT00110396|466580276|FG000|Overall Study|Patient refused to come back|1|||
129888630|NCT02397460|467549263|FG006|Treatment Period 2|Adverse Event|0|||
129888631|NCT02397460|467549264|FG007|Treatment Period 2|Adverse Event|1|||
129888632|NCT02397460|467549257|FG000|Treatment Period 4|Adverse Event|0|||
129888633|NCT02397460|467549258|FG001|Treatment Period 4|Adverse Event|1|||
129625283|NCT00110396|466580276|FG000|Overall Study|The patient has refused|2|||
129625284|NCT00110396|466580276|FG000|Overall Study|The patient has refused to visit site|1|||
129625285|NCT00110396|466580276|FG000|Overall Study|Patient is to be administered copaxone|1|||
129625286|NCT02414958|466580277|FG000|Overall Study|Adverse Event|6|||
129625287|NCT02414958|466580278|FG001|Overall Study|Adverse Event|6|||
129625288|NCT02414958|466580279|FG002|Overall Study|Adverse Event|3|||
129625289|NCT02414958|466580277|FG000|Overall Study|Protocol Violation|10|||
129625290|NCT02414958|466580278|FG001|Overall Study|Protocol Violation|3|||
129625291|NCT02414958|466580279|FG002|Overall Study|Protocol Violation|1|||
129625292|NCT02414958|466580277|FG000|Overall Study|Lost to Follow-up|7|||
129625293|NCT02414958|466580278|FG001|Overall Study|Lost to Follow-up|4|||
129625294|NCT02414958|466580279|FG002|Overall Study|Lost to Follow-up|0|||
129625295|NCT02414958|466580277|FG000|Overall Study|Withdrawal by Subject|5|||
129625296|NCT02414958|466580278|FG001|Overall Study|Withdrawal by Subject|3|||
129625297|NCT02414958|466580279|FG002|Overall Study|Withdrawal by Subject|5|||
129625298|NCT02414958|466580277|FG000|Overall Study|Other than specified|4|||
129625299|NCT02414958|466580278|FG001|Overall Study|Other than specified|4|||
129625300|NCT02414958|466580279|FG002|Overall Study|Other than specified|5|||
129625301|NCT00476190|466580282|FG000|Overall Study|Ineligible|1|||
129625302|NCT00476190|466580283|FG001|Overall Study|Ineligible|1|||
129625303|NCT00476190|466580282|FG000|Overall Study|Induction Death|2|||
129625304|NCT00476190|466580283|FG001|Overall Study|Induction Death|0|||
129625305|NCT00476190|466580282|FG000|Overall Study|Induction Failure|2|||
129625306|NCT00476190|466580283|FG001|Overall Study|Induction Failure|4|||
129625307|NCT00476190|466580282|FG000|Overall Study|Lost to Follow-up|1|||
129625308|NCT00476190|466580283|FG001|Overall Study|Lost to Follow-up|0|||
129625309|NCT00476190|466580282|FG000|Overall Study|Relapse/Progression|5|||
129625310|NCT00476190|466580283|FG001|Overall Study|Relapse/Progression|2|||
129625311|NCT00476190|466580282|FG000|Overall Study|Remission Death|0|||
129888634|NCT02397460|467549259|FG002|Treatment Period 4|Adverse Event|0|||
129888635|NCT02397460|467549260|FG003|Treatment Period 4|Adverse Event|0|||
129888636|NCT02397460|467549261|FG004|Treatment Period 4|Adverse Event|0|||
129888637|NCT02397460|467549262|FG005|Treatment Period 4|Adverse Event|0|||
129888638|NCT02397460|467549263|FG006|Treatment Period 4|Adverse Event|0|||
129625312|NCT00476190|466580283|FG001|Overall Study|Remission Death|1|||
129625313|NCT00476190|466580282|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
129888639|NCT02397460|467549264|FG007|Treatment Period 4|Adverse Event|0|||
129625314|NCT00476190|466580283|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
129625315|NCT00476190|466580282|FG000|Overall Study|Withdrawal by Subject|6|||
129888640|NCT02397460|467549257|FG000|Treatment Period 4|Physician Decision|0|||
129888641|NCT02397460|467549258|FG001|Treatment Period 4|Physician Decision|0|||
129888642|NCT02397460|467549259|FG002|Treatment Period 4|Physician Decision|0|||
129888643|NCT02397460|467549260|FG003|Treatment Period 4|Physician Decision|0|||
129625316|NCT00476190|466580283|FG001|Overall Study|Withdrawal by Subject|2|||
129625317|NCT00476190|466580282|FG000|Overall Study|Other|9|||
129625318|NCT00476190|466580283|FG001|Overall Study|Other|10|||
129888644|NCT02397460|467549261|FG004|Treatment Period 4|Physician Decision|1|||
129888645|NCT02397460|467549262|FG005|Treatment Period 4|Physician Decision|0|||
129888646|NCT02397460|467549263|FG006|Treatment Period 4|Physician Decision|0|||
129888647|NCT02397460|467549264|FG007|Treatment Period 4|Physician Decision|0|||
129888648|NCT01406717|467549265|FG000|Overall Study|Subject non-compliance|4|||
129888649|NCT01406717|467549266|FG001|Overall Study|Subject non-compliance|3|||
129888650|NCT01406717|467549265|FG000|Overall Study|Protocol Violation|5|||
129888651|NCT01406717|467549266|FG001|Overall Study|Protocol Violation|1|||
129888652|NCT01406717|467549265|FG000|Overall Study|Lost to Follow-up|14|||
129888653|NCT01406717|467549266|FG001|Overall Study|Lost to Follow-up|8|||
129625319|NCT01329900|466580286|FG000|Overall Study|Elevated creatinine/renal function|1|||
129625320|NCT01808573|466580290|FG000|Overall Study|Death|212|||
129625321|NCT01808573|466580291|FG001|Overall Study|Death|240|||
129625322|NCT01808573|466580290|FG000|Overall Study|Withdrawal by Subject|12|||
129625323|NCT01808573|466580291|FG001|Overall Study|Withdrawal by Subject|10|||
129625324|NCT01808573|466580290|FG000|Overall Study|Lost to Follow-up|3|||
129625325|NCT01808573|466580291|FG001|Overall Study|Lost to Follow-up|0|||
129625326|NCT01808573|466580290|FG000|Overall Study|Discontinuation of study by sponsor|79|||
129625327|NCT01808573|466580291|FG001|Overall Study|Discontinuation of study by sponsor|64|||
129625328|NCT01808573|466580290|FG000|Overall Study|Randomized in Error|1|||
129625329|NCT01808573|466580291|FG001|Overall Study|Randomized in Error|0|||
129625330|NCT00995774|466580292|FG000|Training Period 2|Withdrawal by Subject|2|||
129625331|NCT00995774|466580293|FG001|Training Period 2|Withdrawal by Subject|0|||
129625332|NCT01256502|466580296|FG000|Overall Study|Had scaffold removed|4|||
129625333|NCT01256502|466580296|FG000|Overall Study|Personal reasons|5|||
129625334|NCT01256502|466580296|FG000|Overall Study|Protocol deviation|1|||
129625335|NCT01523002|466580297|FG000|Period 1|Withdrawal by Subject|1|||
129625336|NCT01523002|466580298|FG001|Period 1|Withdrawal by Subject|3|||
129625337|NCT01523002|466580297|FG000|Period 1|Lost to Follow-up|1|||
129625338|NCT01523002|466580298|FG001|Period 1|Lost to Follow-up|0|||
129625339|NCT01523002|466580297|FG000|Period 1|Adverse Event|0|||
129625340|NCT01523002|466580298|FG001|Period 1|Adverse Event|8|||
129625341|NCT01523002|466580297|FG000|Period 2|Withdrawal by Subject|4|||
129625342|NCT01523002|466580298|FG001|Period 2|Withdrawal by Subject|1|||
129625343|NCT01523002|466580297|FG000|Period 2|Adverse Event|2|||
129625344|NCT01523002|466580298|FG001|Period 2|Adverse Event|5|||
129625345|NCT01523002|466580297|FG000|Period 3|Withdrawal by Subject|1|||
129625346|NCT01523002|466580298|FG001|Period 3|Withdrawal by Subject|0|||
129625347|NCT01523002|466580297|FG000|Period 3|Adverse Event|3|||
129625348|NCT01523002|466580298|FG001|Period 3|Adverse Event|0|||
129625349|NCT03953612|466580300|FG000|Overall Study|Randomized but did not start|1|||
129625350|NCT03953612|466580301|FG001|Overall Study|Randomized but did not start|1|||
129625351|NCT03953612|466580302|FG002|Overall Study|Randomized but did not start|1|||
129625352|NCT03953612|466580300|FG000|Overall Study|Withdrawal by Subject|2|||
129625353|NCT03953612|466580301|FG001|Overall Study|Withdrawal by Subject|1|||
129625354|NCT03953612|466580302|FG002|Overall Study|Withdrawal by Subject|0|||
129625355|NCT03200717|466580322|FG000|Overall Study|Progressive disease|24|||
129625356|NCT03200717|466580323|FG001|Overall Study|Progressive disease|5|||
129625357|NCT03200717|466580322|FG000|Overall Study|Adverse Event|11|||
129625358|NCT03200717|466580323|FG001|Overall Study|Adverse Event|8|||
129625359|NCT03200717|466580322|FG000|Overall Study|Physician Decision|3|||
129625360|NCT03200717|466580323|FG001|Overall Study|Physician Decision|2|||
129625361|NCT03200717|466580322|FG000|Overall Study|Death|2|||
129625362|NCT03200717|466580323|FG001|Overall Study|Death|0|||
129625363|NCT03200717|466580322|FG000|Overall Study|Subject/Guardian Decision|1|||
129625364|NCT03200717|466580323|FG001|Overall Study|Subject/Guardian Decision|0|||
129625365|NCT01461538|466580324|FG000|Overall Study|Death|15|||
129625366|NCT01461538|466580325|FG001|Overall Study|Death|6|||
129625367|NCT01461538|466580326|FG002|Overall Study|Death|2|||
129625368|NCT01461538|466580324|FG000|Overall Study|Study Stopped by Sponsor|2|||
129625369|NCT01461538|466580325|FG001|Overall Study|Study Stopped by Sponsor|1|||
129625370|NCT01461538|466580326|FG002|Overall Study|Study Stopped by Sponsor|0|||
129625371|NCT01461538|466580324|FG000|Overall Study|Withdrawal by Subject|1|||
129625372|NCT01461538|466580325|FG001|Overall Study|Withdrawal by Subject|1|||
129625373|NCT01461538|466580326|FG002|Overall Study|Withdrawal by Subject|0|||
129625374|NCT02905032|466580327|FG000|Overall Study|Withdrawal by Subject|2|||
129625375|NCT02905032|466580328|FG001|Overall Study|Withdrawal by Subject|0|||
129625376|NCT02905032|466580329|FG002|Overall Study|Withdrawal by Subject|0|||
129625377|NCT02905032|466580327|FG000|Overall Study|Protocol Violation|6|||
129625378|NCT02905032|466580328|FG001|Overall Study|Protocol Violation|12|||
129625379|NCT02905032|466580329|FG002|Overall Study|Protocol Violation|0|||
129625380|NCT00141778|466580330|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
129625381|NCT00141778|466580331|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
129625382|NCT00141778|466580332|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
129625383|NCT00141778|466580330|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
129625384|NCT00141778|466580331|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
129625385|NCT00141778|466580332|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
129625386|NCT00141778|466580330|FG000|Started Study Medication|Withdrawal by Subject|0|||
129625387|NCT00141778|466580331|FG001|Started Study Medication|Withdrawal by Subject|2|||
129625388|NCT00141778|466580332|FG002|Started Study Medication|Withdrawal by Subject|0|||
129625389|NCT00141778|466580330|FG000|Started Study Medication|Difficulty Swallowing|0|||
129625390|NCT00141778|466580331|FG001|Started Study Medication|Difficulty Swallowing|1|||
129625391|NCT00141778|466580332|FG002|Started Study Medication|Difficulty Swallowing|0|||
129625392|NCT00141778|466580330|FG000|Started Study Medication|Chest Discomfort|0|||
129625393|NCT00141778|466580331|FG001|Started Study Medication|Chest Discomfort|0|||
129625394|NCT00141778|466580332|FG002|Started Study Medication|Chest Discomfort|1|||
129625395|NCT01245283|466580337|FG000|Overall Study|Lost to Follow-up|14|||
129625396|NCT01245283|466580338|FG001|Overall Study|Lost to Follow-up|11|||
129625397|NCT01245283|466580339|FG002|Overall Study|Lost to Follow-up|11|||
129625398|NCT01610492|466580342|FG000|Overall Study|Adverse Event|1|||
129625399|NCT01610492|466580342|FG000|Overall Study|Lack of Efficacy|3|||
129625400|NCT01610492|466580342|FG000|Overall Study|Other: Reached stopping criteria|1|||
129625401|NCT01610492|466580342|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
129625402|NCT01982955|466580343|FG000|Overall Study|Randomized but not treated|0|||
129625403|NCT01982955|466580344|FG001|Overall Study|Randomized but not treated|0|||
129625404|NCT01982955|466580345|FG002|Overall Study|Randomized but not treated|0|||
129625405|NCT01982955|466580346|FG003|Overall Study|Randomized but not treated|1|||
129625406|NCT01982955|466580347|FG004|Overall Study|Randomized but not treated|0|||
129625407|NCT04211831|466580350|FG000|Overall Study|Withdrawal by Subject|4|||
129625408|NCT04211831|466580351|FG001|Overall Study|Withdrawal by Subject|1|||
129625409|NCT04211831|466580352|FG002|Overall Study|Withdrawal by Subject|1|||
129625410|NCT04211831|466580350|FG000|Overall Study|Protocol Violation|0|||
129625411|NCT04211831|466580351|FG001|Overall Study|Protocol Violation|0|||
129625412|NCT04211831|466580352|FG002|Overall Study|Protocol Violation|1|||
129625413|NCT04211831|466580350|FG000|Overall Study|Adverse Event|0|||
129625414|NCT04211831|466580351|FG001|Overall Study|Adverse Event|1|||
129625415|NCT04211831|466580352|FG002|Overall Study|Adverse Event|0|||
129625416|NCT04211831|466580350|FG000|Overall Study|Lack of Efficacy|0|||
129625417|NCT04211831|466580351|FG001|Overall Study|Lack of Efficacy|0|||
129625418|NCT04211831|466580352|FG002|Overall Study|Lack of Efficacy|1|||
129625419|NCT04211831|466580350|FG000|Overall Study|Lost to Follow-up|0|||
129625420|NCT04211831|466580351|FG001|Overall Study|Lost to Follow-up|0|||
129625421|NCT04211831|466580352|FG002|Overall Study|Lost to Follow-up|2|||
129625422|NCT04211831|466580350|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
129625423|NCT04211831|466580351|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
129625424|NCT04211831|466580352|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
129625425|NCT04211831|466580350|FG000|Overall Study|Other|0|||
129625426|NCT04211831|466580351|FG001|Overall Study|Other|1|||
129625427|NCT04211831|466580352|FG002|Overall Study|Other|0|||
129625428|NCT01256879|466580353|FG000|Overall Study|Withdrawal by Subject|1|||
129625429|NCT00397514|466580355|FG000|Overall Study|Withdrawal by Subject|1|||
129625430|NCT00397514|466580355|FG000|Overall Study|Pacing wire malfunction|1|||
129625431|NCT00397514|466580355|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
129625432|NCT00397514|466580355|FG000|Overall Study|early extubation|2|||
129625433|NCT00397514|466580355|FG000|Overall Study|poor echocardiographic windows|1|||
129625434|NCT00640315|466580356|FG000|Overall Study|Withdrawal by Subject|0|||
129625435|NCT00640315|466580357|FG001|Overall Study|Withdrawal by Subject|1|||
129625436|NCT05525520|466582002|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
129625437|NCT05525520|466582003|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
129625438|NCT05525520|466582002|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
129625439|NCT05525520|466582003|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
129625440|NCT03657797|466582004|FG000|Overall Study|Lost to Follow-up|0|||
129625441|NCT03657797|466582005|FG001|Overall Study|Lost to Follow-up|1|||
129625442|NCT03657797|466582006|FG002|Overall Study|Lost to Follow-up|1|||
129625443|NCT03657797|466582007|FG003|Overall Study|Lost to Follow-up|0|||
129625444|NCT03657797|466582004|FG000|Overall Study|Physician Decision|0|||
129625445|NCT03657797|466582005|FG001|Overall Study|Physician Decision|1|||
129625446|NCT03657797|466582006|FG002|Overall Study|Physician Decision|0|||
129625447|NCT03657797|466582007|FG003|Overall Study|Physician Decision|0|||
129625448|NCT03657797|466582004|FG000|Overall Study|Withdrawal by Subject|0|||
129625449|NCT03657797|466582005|FG001|Overall Study|Withdrawal by Subject|1|||
129625450|NCT03657797|466582006|FG002|Overall Study|Withdrawal by Subject|2|||
129625451|NCT03657797|466582007|FG003|Overall Study|Withdrawal by Subject|0|||
129625452|NCT03657797|466582004|FG000|Overall Study|Adverse Event|0|||
129625453|NCT03657797|466582005|FG001|Overall Study|Adverse Event|0|||
129625454|NCT03657797|466582006|FG002|Overall Study|Adverse Event|2|||
129625455|NCT03657797|466582007|FG003|Overall Study|Adverse Event|0|||
129625456|NCT00118157|466582008|FG000|Overall Study|Adverse Event|2|||
129625457|NCT00118157|466582008|FG000|Overall Study|Death|8|||
129625458|NCT00118157|466582008|FG000|Overall Study|Withdrawal by Subject|2|||
129625459|NCT00696423|466582009|FG000|Overall Study|Lost to Follow-up|0|||
129625460|NCT00696423|466582010|FG001|Overall Study|Lost to Follow-up|5|||
129625461|NCT03989102|466582011|FG000|Year 1|Withdrawal by Subject|6|||
129625462|NCT03989102|466582012|FG001|Year 1|Withdrawal by Subject|2|||
129625463|NCT03989102|466582013|FG002|Year 1|Withdrawal by Subject|7|||
129625464|NCT03989102|466582011|FG000|Year 1|Lost to Follow-up|5|||
129625465|NCT03989102|466582012|FG001|Year 1|Lost to Follow-up|2|||
129625466|NCT03989102|466582013|FG002|Year 1|Lost to Follow-up|5|||
129625467|NCT03989102|466582011|FG000|Year 1|Subject met withdrawal criteria|1|||
129625468|NCT03989102|466582012|FG001|Year 1|Subject met withdrawal criteria|0|||
129625469|NCT03989102|466582013|FG002|Year 1|Subject met withdrawal criteria|1|||
129625470|NCT03989102|466582011|FG000|Year 2|Lost to Follow-up|7|||
129625471|NCT03989102|466582012|FG001|Year 2|Lost to Follow-up|3|||
129625472|NCT03989102|466582013|FG002|Year 2|Lost to Follow-up|4|||
129625473|NCT03989102|466582011|FG000|Year 2|Withdrawal by Subject|3|||
129625474|NCT03989102|466582012|FG001|Year 2|Withdrawal by Subject|1|||
129625475|NCT03989102|466582013|FG002|Year 2|Withdrawal by Subject|2|||
129625476|NCT03989102|466582011|FG000|Year 2|Subject non-compliant|3|||
129625477|NCT03989102|466582012|FG001|Year 2|Subject non-compliant|2|||
129625478|NCT03989102|466582013|FG002|Year 2|Subject non-compliant|0|||
129625479|NCT03989102|466582011|FG000|Year 2|Travel|1|||
129625480|NCT03989102|466582012|FG001|Year 2|Travel|0|||
129625481|NCT03989102|466582013|FG002|Year 2|Travel|1|||
129625482|NCT03989102|466582011|FG000|Year 2|P16 missing|4|||
129625483|NCT03989102|466582012|FG001|Year 2|P16 missing|2|||
129625484|NCT03989102|466582013|FG002|Year 2|P16 missing|1|||
129625485|NCT03989102|466582011|FG000|Year 2|P11 missing|1|||
129625486|NCT03989102|466582012|FG001|Year 2|P11 missing|3|||
129625487|NCT03989102|466582013|FG002|Year 2|P11 missing|7|||
129625488|NCT03989102|466582011|FG000|Year 2|Definitive displacement outside the study site|0|||
129625489|NCT03989102|466582012|FG001|Year 2|Definitive displacement outside the study site|1|||
129625490|NCT03989102|466582013|FG002|Year 2|Definitive displacement outside the study site|0|||
129625491|NCT03989102|466582011|FG000|Year 2|Subject missed last study visit|0|||
129625492|NCT03989102|466582012|FG001|Year 2|Subject missed last study visit|1|||
129625493|NCT03989102|466582013|FG002|Year 2|Subject missed last study visit|0|||
129625494|NCT03989102|466582011|FG000|Year 2|Death|0|||
129625495|NCT03989102|466582012|FG001|Year 2|Death|1|||
129625496|NCT03989102|466582013|FG002|Year 2|Death|0|||
129625497|NCT03989102|466582011|FG000|Year 2|Subject not reachable|0|||
129625498|NCT03989102|466582012|FG001|Year 2|Subject not reachable|0|||
129625499|NCT03989102|466582013|FG002|Year 2|Subject not reachable|1|||
129625500|NCT03989102|466582011|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
129625501|NCT03989102|466582012|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
129625502|NCT03989102|466582013|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
129625503|NCT03989102|466582011|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
129625504|NCT03989102|466582012|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
129625505|NCT03989102|466582013|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
129625506|NCT03989102|466582011|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
129625507|NCT03989102|466582012|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
129625508|NCT03989102|466582013|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
129625509|NCT03989102|466582011|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
129625510|NCT03989102|466582012|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
129625511|NCT03989102|466582013|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
129625512|NCT03989102|466582011|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
129625513|NCT03989102|466582012|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
129625514|NCT03989102|466582013|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
129625515|NCT03989102|466582011|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
129625516|NCT03989102|466582012|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
129625517|NCT03989102|466582013|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
129625518|NCT03642262|466582014|FG000|Period 1|Withdrawal by Subject|1|||
129625519|NCT03642262|466582015|FG001|Period 1|Withdrawal by Subject|1|||
129625520|NCT03642262|466582014|FG000|Period 1|Adverse Event|0|||
129625521|NCT03642262|466582015|FG001|Period 1|Adverse Event|1|||
129625522|NCT02760004|466582020|FG000|Overall Study|Lost to Follow-up|13|||
129625523|NCT02760004|466582021|FG001|Overall Study|Lost to Follow-up|22|||
129625524|NCT02203357|466582024|FG000|Overall Study|Lost to Follow-up|58|||
129625525|NCT02203357|466582025|FG001|Overall Study|Lost to Follow-up|66|||
129625526|NCT02203357|466582026|FG002|Overall Study|Lost to Follow-up|70|||
129625527|NCT01431079|466582027|FG000|Overall Study|Lost to Follow-up|35|||
129625528|NCT01431079|466582028|FG001|Overall Study|Lost to Follow-up|39|||
129625529|NCT02038010|466582032|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
129625530|NCT02038010|466582033|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
129625531|NCT02038010|466582034|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
129625532|NCT02038010|466582035|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
129702995|NCT02757768|466873276|FG001|Overall Study|Adverse Event|3|||
129888654|NCT01406717|467549265|FG000|Overall Study|Withdrawal by Subject|19|||
129888655|NCT01406717|467549266|FG001|Overall Study|Withdrawal by Subject|15|||
129888656|NCT01406717|467549265|FG000|Overall Study|Adverse Event|1|||
129888657|NCT01406717|467549266|FG001|Overall Study|Adverse Event|2|||
129888658|NCT01406717|467549265|FG000|Overall Study|Lack of Efficacy|0|||
129888659|NCT01406717|467549266|FG001|Overall Study|Lack of Efficacy|1|||
129888660|NCT01406717|467549265|FG000|Overall Study|Non-completion of visit activity|0|||
129888661|NCT01406717|467549266|FG001|Overall Study|Non-completion of visit activity|1|||
129888662|NCT02584855|467549270|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
129888663|NCT02584855|467549271|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129888664|NCT02584855|467549272|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129888665|NCT02584855|467549273|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
129888666|NCT02584855|467549274|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
129888667|NCT02584855|467549275|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
129888668|NCT02584855|467549270|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
129888669|NCT02584855|467549271|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
129625533|NCT02038010|466582032|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
129625534|NCT02038010|466582033|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
129625535|NCT02038010|466582034|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
129625536|NCT02038010|466582035|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
129625537|NCT02038010|466582032|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
129625538|NCT02038010|466582033|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
129625539|NCT02038010|466582034|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
129625540|NCT02038010|466582035|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
129625541|NCT02038010|466582032|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
129625542|NCT02038010|466582033|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
129625543|NCT02038010|466582034|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
129625544|NCT02038010|466582035|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
129625545|NCT02038010|466582032|FG000|Follow Up|Death|4|||
129625546|NCT02038010|466582033|FG001|Follow Up|Death|3|||
129625547|NCT02038010|466582034|FG002|Follow Up|Death|0|||
129625548|NCT02038010|466582035|FG003|Follow Up|Death|0|||
129625549|NCT02038010|466582032|FG000|Follow Up|Other|3|||
129625550|NCT02038010|466582033|FG001|Follow Up|Other|0|||
129625551|NCT02038010|466582034|FG002|Follow Up|Other|0|||
129625552|NCT02038010|466582035|FG003|Follow Up|Other|0|||
129625553|NCT00245466|466582037|FG000|Overall Study|Adverse Event|2|||
129625554|NCT00245466|466582038|FG001|Overall Study|Adverse Event|8|||
129625555|NCT00245466|466582039|FG002|Overall Study|Adverse Event|4|||
129625556|NCT00245466|466582037|FG000|Overall Study|Low prostate specific antigen suppr|16|||
129625557|NCT00245466|466582038|FG001|Overall Study|Low prostate specific antigen suppr|14|||
129625558|NCT00245466|466582039|FG002|Overall Study|Low prostate specific antigen suppr|5|||
129625559|NCT00245466|466582037|FG000|Overall Study|Insufficient testosterone suppr|12|||
129625560|NCT00245466|466582038|FG001|Overall Study|Insufficient testosterone suppr|12|||
129625561|NCT00245466|466582039|FG002|Overall Study|Insufficient testosterone suppr|21|||
129625562|NCT00245466|466582037|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
129625563|NCT00245466|466582038|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
129625564|NCT00245466|466582039|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
129625565|NCT00245466|466582037|FG000|Overall Study|Withdrawal by Subject|2|||
129625566|NCT00245466|466582038|FG001|Overall Study|Withdrawal by Subject|2|||
129625567|NCT00245466|466582039|FG002|Overall Study|Withdrawal by Subject|1|||
129625568|NCT00245466|466582037|FG000|Overall Study|Lost to Follow-up|3|||
129625569|NCT00245466|466582038|FG001|Overall Study|Lost to Follow-up|0|||
129625570|NCT00245466|466582039|FG002|Overall Study|Lost to Follow-up|0|||
129625571|NCT00245466|466582037|FG000|Overall Study|Disease progression|0|||
129625572|NCT00245466|466582038|FG001|Overall Study|Disease progression|3|||
129625573|NCT00245466|466582039|FG002|Overall Study|Disease progression|1|||
129625574|NCT00245466|466582037|FG000|Overall Study|Protocol Violation|1|||
129625575|NCT00245466|466582038|FG001|Overall Study|Protocol Violation|2|||
129625576|NCT00245466|466582039|FG002|Overall Study|Protocol Violation|2|||
129625577|NCT00245466|466582037|FG000|Overall Study|Death|0|||
129625578|NCT00245466|466582038|FG001|Overall Study|Death|2|||
129625579|NCT00245466|466582039|FG002|Overall Study|Death|0|||
129625580|NCT00245466|466582037|FG000|Overall Study|Administrative reasons|0|||
129625581|NCT00245466|466582038|FG001|Overall Study|Administrative reasons|1|||
129625582|NCT00245466|466582039|FG002|Overall Study|Administrative reasons|0|||
129625583|NCT01958437|466582040|FG000|Overall Study|Incidental MRI findings|0|||
129888670|NCT02584855|467549272|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
129888671|NCT02584855|467549273|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
129888672|NCT02584855|467549274|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
129625584|NCT01958437|466582041|FG001|Overall Study|Incidental MRI findings|0|||
129625585|NCT01958437|466582042|FG002|Overall Study|Incidental MRI findings|1|||
129625586|NCT01958437|466582043|FG003|Overall Study|Incidental MRI findings|1|||
129625587|NCT04886596|466582046|FG000|Overall Study|Adverse Event|442|||
129625588|NCT04886596|466582047|FG001|Overall Study|Adverse Event|441|||
129625589|NCT04886596|466582046|FG000|Overall Study|Lost to Follow-up|448|||
129625590|NCT04886596|466582047|FG001|Overall Study|Lost to Follow-up|465|||
129625591|NCT04886596|466582046|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
129625592|NCT04886596|466582047|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
129625593|NCT04886596|466582046|FG000|Overall Study|Migrated/moved from the study area|201|||
129625594|NCT04886596|466582047|FG001|Overall Study|Migrated/moved from the study area|184|||
129625595|NCT04886596|466582046|FG000|Overall Study|Other|298|||
129625596|NCT04886596|466582047|FG001|Overall Study|Other|326|||
129625597|NCT00948155|466582050|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
129625598|NCT00948155|466582051|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
129625599|NCT00948155|466582050|FG000|Washout 14 Days|Lost to Follow-up|1|||
129625600|NCT00948155|466582051|FG001|Washout 14 Days|Lost to Follow-up|2|||
129625601|NCT03473925|466582052|FG000|Overall Study|Death|48|||
129625602|NCT03473925|466582053|FG001|Overall Study|Death|44|||
129625603|NCT03473925|466582052|FG000|Overall Study|Sponsor Decision|2|||
129625604|NCT03473925|466582053|FG001|Overall Study|Sponsor Decision|7|||
129625605|NCT03473925|466582052|FG000|Overall Study|Withdrawal by Subject|1|||
129625606|NCT03473925|466582053|FG001|Overall Study|Withdrawal by Subject|3|||
129625607|NCT03473925|466582052|FG000|Overall Study|Not Treated|1|||
129625608|NCT03473925|466582053|FG001|Overall Study|Not Treated|1|||
129625609|NCT04661150|466582058|FG000|Overall Study|Ongoing in study|19|||
129625610|NCT04661150|466582059|FG001|Overall Study|Ongoing in study|20|||
129625611|NCT04661150|466582058|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
129625612|NCT04661150|466582059|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
129625613|NCT04661150|466582058|FG000|Overall Study|Death|2|||
129625614|NCT04661150|466582059|FG001|Overall Study|Death|0|||
129625615|NCT05767905|466582060|FG000|Overall Study|Adverse Event|0|||
129625616|NCT05767905|466582061|FG001|Overall Study|Adverse Event|0|||
129625617|NCT05767905|466582062|FG002|Overall Study|Adverse Event|1|||
129625618|NCT03762239|466582063|FG000|Overall Study|Appointment to the doctor|1|||
129625619|NCT03762239|466582064|FG001|Overall Study|Appointment to the doctor|1|||
129625620|NCT03645863|466582065|FG000|Overall Study|Withdrawal by Subject|1|||
129625621|NCT03645863|466582066|FG001|Overall Study|Withdrawal by Subject|0|||
129625622|NCT03645863|466582067|FG002|Overall Study|Withdrawal by Subject|0|||
129625623|NCT03624192|466582077|FG000|Overall Study|Lost to Follow-up|1|||
129625624|NCT03624192|466582078|FG001|Overall Study|Lost to Follow-up|1|||
129625625|NCT04660331|466582083|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
129625626|NCT04660331|466582084|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
129625627|NCT04660331|466582085|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
129625628|NCT02635984|466582086|FG000|Overall Study|Lost to Follow-up|2|||
129625629|NCT02635984|466582087|FG001|Overall Study|Lost to Follow-up|4|||
129793773|NCT00400153|467212750|FG002|Overall Study|AE due to other condition|15|||
129793774|NCT00400153|467212748|FG000|Overall Study|Protocol Violation|7|||
129793775|NCT00400153|467212749|FG001|Overall Study|Protocol Violation|4|||
129793776|NCT00400153|467212750|FG002|Overall Study|Protocol Violation|9|||
129793777|NCT00400153|467212748|FG000|Overall Study|Lost to Follow-up|2|||
129793778|NCT00400153|467212749|FG001|Overall Study|Lost to Follow-up|1|||
129793779|NCT00400153|467212750|FG002|Overall Study|Lost to Follow-up|4|||
129793780|NCT00400153|467212748|FG000|Overall Study|Withdrawal by Subject|12|||
129793781|NCT00400153|467212749|FG001|Overall Study|Withdrawal by Subject|11|||
129793782|NCT00400153|467212750|FG002|Overall Study|Withdrawal by Subject|10|||
129793783|NCT00400153|467212748|FG000|Overall Study|Other reasons - not mentioned above|8|||
129793784|NCT00400153|467212749|FG001|Overall Study|Other reasons - not mentioned above|5|||
129793785|NCT00400153|467212750|FG002|Overall Study|Other reasons - not mentioned above|3|||
129793786|NCT00393042|467212751|FG000|First Intervention|Withdrawal by Subject|1|||
129793787|NCT00393042|467212752|FG001|First Intervention|Withdrawal by Subject|2|||
129793788|NCT00393042|467212751|FG000|First Intervention|Lost to Follow-up|3|||
129793789|NCT00393042|467212752|FG001|First Intervention|Lost to Follow-up|3|||
129793790|NCT00393042|467212751|FG000|First Intervention|Protocol Violation|1|||
129793791|NCT00393042|467212752|FG001|First Intervention|Protocol Violation|0|||
129793792|NCT00393042|467212751|FG000|First Intervention|Adverse Event|0|||
129793793|NCT00393042|467212752|FG001|First Intervention|Adverse Event|1|||
129793794|NCT00393042|467212751|FG000|Second Intervetion|Adverse Event|0|||
129793795|NCT00393042|467212752|FG001|Second Intervetion|Adverse Event|3|||
129625630|NCT02635984|466582086|FG000|Overall Study|Study Arm Closed|1|||
129625631|NCT02635984|466582087|FG001|Overall Study|Study Arm Closed|0|||
129625632|NCT01640249|466582088|FG000|Period 1|Withdrawal by Subject|1|||
129625633|NCT01640249|466582089|FG001|Period 1|Withdrawal by Subject|0|||
129625634|NCT01640249|466582090|FG002|Period 1|Withdrawal by Subject|0|||
129625635|NCT01640249|466582091|FG003|Period 1|Withdrawal by Subject|0|||
129625636|NCT01640249|466582092|FG004|Period 1|Withdrawal by Subject|0|||
129625637|NCT01640249|466582093|FG005|Period 1|Withdrawal by Subject|1|||
129625638|NCT01640249|466582094|FG006|Period 1|Withdrawal by Subject|0|||
129793796|NCT00393042|467212751|FG000|Second Intervetion|Withdrawal by Subject|0|||
129625639|NCT00065156|466582098|FG000|Overall Study|Adverse Event|37|||
129625640|NCT00065156|466582098|FG000|Overall Study|Lack of Efficacy|52|||
129625641|NCT00065156|466582098|FG000|Overall Study|Withdrawal by Subject|8|||
129625642|NCT00065156|466582098|FG000|Overall Study|Lost to Follow-up|1|||
129625643|NCT00065156|466582098|FG000|Overall Study|Death|11|||
129625644|NCT00065156|466582098|FG000|Overall Study|Study Closed by Sponsor|2|||
129625645|NCT00065156|466582098|FG000|Overall Study|Disease Progression|7|||
129625646|NCT00065156|466582098|FG000|Overall Study|Investigator Decision|2|||
129625647|NCT00065156|466582098|FG000|Overall Study|Non-Compliance|2|||
129625648|NCT00065156|466582098|FG000|Overall Study|Loss of Response|1|||
129625649|NCT00065156|466582098|FG000|Overall Study|Secondary Malign Disease|1|||
129625650|NCT01215136|466582099|FG000|Overall Study|Adverse Event|2|||
129625651|NCT01215136|466582100|FG001|Overall Study|Adverse Event|9|||
129625652|NCT01215136|466582099|FG000|Overall Study|Disease Progression|3|||
129625653|NCT01215136|466582100|FG001|Overall Study|Disease Progression|14|||
129625654|NCT01215136|466582099|FG000|Overall Study|Symptomatic Deterioration|1|||
129625655|NCT01215136|466582100|FG001|Overall Study|Symptomatic Deterioration|1|||
129625656|NCT01215136|466582099|FG000|Overall Study|Death|0|||
129625657|NCT01215136|466582100|FG001|Overall Study|Death|2|||
129625658|NCT01215136|466582099|FG000|Overall Study|Withdrawal by Subject|0|||
129625659|NCT01215136|466582100|FG001|Overall Study|Withdrawal by Subject|1|||
129625660|NCT00951496|466582105|FG000|Overall Study|Did not initiate study treatment|10|||
129625661|NCT00951496|466582106|FG001|Overall Study|Did not initiate study treatment|8|||
129625662|NCT00951496|466582107|FG002|Overall Study|Did not initiate study treatment|13|||
129625663|NCT01526057|466582109|FG000|Overall Study|Withdrawal by Subject|3|||
129625664|NCT01526057|466582110|FG001|Overall Study|Withdrawal by Subject|2|||
129625665|NCT01526057|466582111|FG002|Overall Study|Withdrawal by Subject|2|||
129625666|NCT01526057|466582109|FG000|Overall Study|Adverse Event|3|||
129625667|NCT01526057|466582110|FG001|Overall Study|Adverse Event|1|||
129625668|NCT01526057|466582111|FG002|Overall Study|Adverse Event|1|||
129625669|NCT01526057|466582109|FG000|Overall Study|Death|1|||
129625670|NCT01526057|466582110|FG001|Overall Study|Death|0|||
129625671|NCT01526057|466582111|FG002|Overall Study|Death|0|||
129625672|NCT01526057|466582109|FG000|Overall Study|Lost to Follow-up|1|||
129625673|NCT01526057|466582110|FG001|Overall Study|Lost to Follow-up|0|||
129625674|NCT01526057|466582111|FG002|Overall Study|Lost to Follow-up|1|||
129625675|NCT01526057|466582109|FG000|Overall Study|Other|1|||
129625676|NCT01526057|466582110|FG001|Overall Study|Other|0|||
129625677|NCT01526057|466582111|FG002|Overall Study|Other|1|||
129625678|NCT01526057|466582109|FG000|Overall Study|Protocol Violation|0|||
129625679|NCT01526057|466582110|FG001|Overall Study|Protocol Violation|0|||
129625680|NCT01526057|466582111|FG002|Overall Study|Protocol Violation|1|||
129625681|NCT02289729|466582122|FG000|Overall Study|Lack of Efficacy|3|||
129625682|NCT02289729|466582122|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
129625683|NCT02289729|466582122|FG000|Overall Study|Withdrawal by Subject|1|||
129625684|NCT02289729|466582122|FG000|Overall Study|Death|1|||
129625685|NCT04870710|466582126|FG000|Overall Study|Lost to Follow-up|3|||
129625686|NCT00281957|466582141|FG000|Overall Study|Adverse Event|7|||
129625687|NCT00281957|466582142|FG001|Overall Study|Adverse Event|2|||
129625688|NCT00281957|466582141|FG000|Overall Study|Death|1|||
129625689|NCT00281957|466582142|FG001|Overall Study|Death|0|||
129625690|NCT00281957|466582141|FG000|Overall Study|Progression/relapse|47|||
129625691|NCT00281957|466582142|FG001|Overall Study|Progression/relapse|35|||
129625692|NCT00281957|466582141|FG000|Overall Study|Not protocol specified|8|||
129625693|NCT00281957|466582142|FG001|Overall Study|Not protocol specified|1|||
129625694|NCT00281957|466582141|FG000|Overall Study|Not eligible|1|||
129625695|NCT00281957|466582142|FG001|Overall Study|Not eligible|2|||
129625696|NCT00281957|466582141|FG000|Overall Study|Did not start treatment|3|||
129625697|NCT00281957|466582142|FG001|Overall Study|Did not start treatment|1|||
129625698|NCT00281957|466582141|FG000|Overall Study|Refusal unrelated to adverse events|0|||
129625699|NCT00281957|466582142|FG001|Overall Study|Refusal unrelated to adverse events|1|||
129625700|NCT01876446|466582143|FG000|Overall Study|Death|0|||
129625701|NCT01876446|466582144|FG001|Overall Study|Death|1|||
129625702|NCT01876446|466582143|FG000|Overall Study|Withdrawal by Subject|1|||
129625703|NCT01876446|466582144|FG001|Overall Study|Withdrawal by Subject|2|||
129625704|NCT01876446|466582143|FG000|Overall Study|Physician Decision|1|||
129625705|NCT01876446|466582144|FG001|Overall Study|Physician Decision|3|||
129625706|NCT00822692|466582145|FG000|Overall Study|Lost to Follow-up|17|||
129625707|NCT00822692|466582146|FG001|Overall Study|Lost to Follow-up|25|||
129625708|NCT03629184|466582147|FG000|Overall Study|Withdrawal by Subject|2|||
129625709|NCT03629184|466582148|FG001|Overall Study|Withdrawal by Subject|1|||
129625710|NCT03629184|466582147|FG000|Overall Study|Physician Decision|1|||
129625711|NCT03629184|466582148|FG001|Overall Study|Physician Decision|0|||
129625712|NCT02548143|466582150|FG000|Overall Study|Adverse Event|1|||
129625713|NCT02548143|466582151|FG001|Overall Study|Adverse Event|0|||
129625714|NCT02548143|466582150|FG000|Overall Study|Withdrawal by Subject|0|||
129625715|NCT02548143|466582151|FG001|Overall Study|Withdrawal by Subject|1|||
129625716|NCT05620082|466582155|FG000|Overall Study|Discharged before study end|1|||
129625717|NCT05620082|466582156|FG001|Overall Study|Discharged before study end|4|||
129625718|NCT05620082|466582157|FG002|Overall Study|Discharged before study end|0|||
129625719|NCT05620082|466582155|FG000|Overall Study|Moved to a different ward|1|||
129625720|NCT05620082|466582156|FG001|Overall Study|Moved to a different ward|0|||
129625721|NCT05620082|466582157|FG002|Overall Study|Moved to a different ward|0|||
129625722|NCT05620082|466582155|FG000|Overall Study|Feeling too unwell|1|||
129625723|NCT05620082|466582156|FG001|Overall Study|Feeling too unwell|0|||
129625724|NCT05620082|466582157|FG002|Overall Study|Feeling too unwell|0|||
129625725|NCT02721732|466584082|FG000|Overall Study|Adverse Event|2|||
129625726|NCT02721732|466584083|FG001|Overall Study|Adverse Event|0|||
129625727|NCT02721732|466584084|FG002|Overall Study|Adverse Event|2|||
129625728|NCT02721732|466584085|FG003|Overall Study|Adverse Event|0|||
129625729|NCT02721732|466584086|FG004|Overall Study|Adverse Event|1|||
129625730|NCT02721732|466584087|FG005|Overall Study|Adverse Event|0|||
129625731|NCT02721732|466584088|FG006|Overall Study|Adverse Event|1|||
129625732|NCT02721732|466584089|FG007|Overall Study|Adverse Event|0|||
129625733|NCT02721732|466584090|FG008|Overall Study|Adverse Event|1|||
129625734|NCT02721732|466584091|FG009|Overall Study|Adverse Event|1|||
129625735|NCT02721732|466584082|FG000|Overall Study|Death|0|||
129625736|NCT02721732|466584083|FG001|Overall Study|Death|0|||
129625737|NCT02721732|466584084|FG002|Overall Study|Death|0|||
129625738|NCT02721732|466584085|FG003|Overall Study|Death|0|||
129625739|NCT02721732|466584086|FG004|Overall Study|Death|1|||
129625740|NCT02721732|466584087|FG005|Overall Study|Death|0|||
129625741|NCT02721732|466584088|FG006|Overall Study|Death|1|||
129625742|NCT02721732|466584089|FG007|Overall Study|Death|0|||
129625743|NCT02721732|466584090|FG008|Overall Study|Death|0|||
129625744|NCT02721732|466584091|FG009|Overall Study|Death|1|||
129625745|NCT02721732|466584082|FG000|Overall Study|Lack of Efficacy|12|||
129625746|NCT02721732|466584083|FG001|Overall Study|Lack of Efficacy|11|||
129625747|NCT02721732|466584084|FG002|Overall Study|Lack of Efficacy|18|||
129625748|NCT02721732|466584085|FG003|Overall Study|Lack of Efficacy|5|||
129625749|NCT02721732|466584086|FG004|Overall Study|Lack of Efficacy|21|||
129625750|NCT02721732|466584087|FG005|Overall Study|Lack of Efficacy|2|||
129625751|NCT02721732|466584088|FG006|Overall Study|Lack of Efficacy|8|||
129625752|NCT02721732|466584089|FG007|Overall Study|Lack of Efficacy|11|||
129625753|NCT02721732|466584090|FG008|Overall Study|Lack of Efficacy|10|||
129625754|NCT02721732|466584091|FG009|Overall Study|Lack of Efficacy|20|||
129625755|NCT02721732|466584082|FG000|Overall Study|Physician Decision|0|||
129625756|NCT02721732|466584083|FG001|Overall Study|Physician Decision|0|||
129625757|NCT02721732|466584084|FG002|Overall Study|Physician Decision|1|||
129625758|NCT02721732|466584085|FG003|Overall Study|Physician Decision|0|||
129625759|NCT02721732|466584086|FG004|Overall Study|Physician Decision|0|||
129625760|NCT02721732|466584087|FG005|Overall Study|Physician Decision|0|||
129625761|NCT02721732|466584088|FG006|Overall Study|Physician Decision|0|||
129625762|NCT02721732|466584089|FG007|Overall Study|Physician Decision|0|||
129625763|NCT02721732|466584090|FG008|Overall Study|Physician Decision|0|||
129625764|NCT02721732|466584091|FG009|Overall Study|Physician Decision|0|||
129625765|NCT02721732|466584082|FG000|Overall Study|Withdrawal by Subject|1|||
129625766|NCT02721732|466584083|FG001|Overall Study|Withdrawal by Subject|0|||
129625767|NCT02721732|466584084|FG002|Overall Study|Withdrawal by Subject|0|||
129625768|NCT02721732|466584085|FG003|Overall Study|Withdrawal by Subject|0|||
129625769|NCT02721732|466584086|FG004|Overall Study|Withdrawal by Subject|3|||
129625770|NCT02721732|466584087|FG005|Overall Study|Withdrawal by Subject|0|||
129625771|NCT02721732|466584088|FG006|Overall Study|Withdrawal by Subject|1|||
129625772|NCT02721732|466584089|FG007|Overall Study|Withdrawal by Subject|1|||
129625773|NCT02721732|466584090|FG008|Overall Study|Withdrawal by Subject|0|||
129625774|NCT02721732|466584091|FG009|Overall Study|Withdrawal by Subject|1|||
129625775|NCT02721732|466584082|FG000|Overall Study|Participant Choice|1|||
129625776|NCT02721732|466584083|FG001|Overall Study|Participant Choice|0|||
129625777|NCT02721732|466584084|FG002|Overall Study|Participant Choice|0|||
129625778|NCT02721732|466584085|FG003|Overall Study|Participant Choice|0|||
129625779|NCT02721732|466584086|FG004|Overall Study|Participant Choice|0|||
129625780|NCT02721732|466584087|FG005|Overall Study|Participant Choice|0|||
129625781|NCT02721732|466584088|FG006|Overall Study|Participant Choice|0|||
129625782|NCT02721732|466584089|FG007|Overall Study|Participant Choice|0|||
129625783|NCT02721732|466584090|FG008|Overall Study|Participant Choice|0|||
129625784|NCT02721732|466584091|FG009|Overall Study|Participant Choice|1|||
129625785|NCT02721732|466584082|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625786|NCT02721732|466584083|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625787|NCT02721732|466584084|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
129625788|NCT02721732|466584085|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625789|NCT02721732|466584086|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625790|NCT02721732|466584087|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625791|NCT02721732|466584088|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625792|NCT02721732|466584089|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625793|NCT02721732|466584090|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625794|NCT02721732|466584091|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
129625795|NCT02721732|466584082|FG000|Overall Study|Progression and withdrew consent|1|||
129625796|NCT02721732|466584083|FG001|Overall Study|Progression and withdrew consent|1|||
129625797|NCT02721732|466584084|FG002|Overall Study|Progression and withdrew consent|0|||
129625798|NCT02721732|466584085|FG003|Overall Study|Progression and withdrew consent|0|||
129625799|NCT02721732|466584086|FG004|Overall Study|Progression and withdrew consent|0|||
129625800|NCT02721732|466584087|FG005|Overall Study|Progression and withdrew consent|0|||
129625801|NCT02721732|466584088|FG006|Overall Study|Progression and withdrew consent|0|||
129625802|NCT02721732|466584089|FG007|Overall Study|Progression and withdrew consent|0|||
129625803|NCT02721732|466584090|FG008|Overall Study|Progression and withdrew consent|0|||
129625804|NCT02721732|466584091|FG009|Overall Study|Progression and withdrew consent|1|||
129625805|NCT02721732|466584082|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
129625806|NCT02721732|466584083|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
129625807|NCT02721732|466584084|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
129625808|NCT02721732|466584085|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
129625809|NCT02721732|466584086|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
129625810|NCT02721732|466584087|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
129625811|NCT02721732|466584088|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
129625812|NCT02721732|466584089|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
129625813|NCT02721732|466584090|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
129625814|NCT02721732|466584091|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
129625815|NCT01996241|466584092|FG000|Overall Study|Lost to Follow-up|252|||
129625816|NCT01996241|466584093|FG001|Overall Study|Lost to Follow-up|235|||
129625817|NCT04515147|466584095|FG000|Overall Study|Withdrawal by Subject|1|||
129625818|NCT04515147|466584096|FG001|Overall Study|Withdrawal by Subject|0|||
129625819|NCT04515147|466584097|FG002|Overall Study|Withdrawal by Subject|10|||
129625820|NCT04515147|466584098|FG003|Overall Study|Withdrawal by Subject|18|||
129625821|NCT04515147|466584099|FG004|Overall Study|Withdrawal by Subject|1|||
129625822|NCT04515147|466584100|FG005|Overall Study|Withdrawal by Subject|8|||
129625823|NCT04515147|466584095|FG000|Overall Study|Lost to Follow-up|0|||
129625824|NCT04515147|466584096|FG001|Overall Study|Lost to Follow-up|1|||
129625825|NCT04515147|466584097|FG002|Overall Study|Lost to Follow-up|5|||
129625826|NCT04515147|466584098|FG003|Overall Study|Lost to Follow-up|6|||
129625827|NCT04515147|466584099|FG004|Overall Study|Lost to Follow-up|2|||
129625828|NCT04515147|466584100|FG005|Overall Study|Lost to Follow-up|1|||
129625829|NCT04515147|466584095|FG000|Overall Study|Adverse Event|0|||
129625830|NCT04515147|466584096|FG001|Overall Study|Adverse Event|0|||
129625831|NCT04515147|466584097|FG002|Overall Study|Adverse Event|0|||
129625832|NCT04515147|466584098|FG003|Overall Study|Adverse Event|2|||
129625833|NCT04515147|466584099|FG004|Overall Study|Adverse Event|0|||
129625834|NCT04515147|466584100|FG005|Overall Study|Adverse Event|0|||
129625835|NCT04515147|466584095|FG000|Overall Study|Miscellaneous|0|||
129625836|NCT04515147|466584096|FG001|Overall Study|Miscellaneous|0|||
129625837|NCT04515147|466584097|FG002|Overall Study|Miscellaneous|0|||
129625838|NCT04515147|466584098|FG003|Overall Study|Miscellaneous|1|||
129625839|NCT04515147|466584099|FG004|Overall Study|Miscellaneous|0|||
129625840|NCT04515147|466584100|FG005|Overall Study|Miscellaneous|1|||
129625841|NCT03052751|466584101|FG000|Dosing Period 1|Adverse Event|0|||
129625842|NCT03052751|466584102|FG001|Dosing Period 1|Adverse Event|1|||
129625843|NCT03052751|466584103|FG002|Dosing Period 1|Adverse Event|0|||
129625844|NCT03052751|466584104|FG003|Dosing Period 1|Adverse Event|0|||
129625845|NCT03052751|466584105|FG004|Dosing Period 1|Adverse Event|0|||
129625846|NCT03052751|466584106|FG005|Dosing Period 1|Adverse Event|0|||
129625847|NCT03052751|466584101|FG000|Dosing Period 2|Adverse Event|0|||
129625848|NCT03052751|466584102|FG001|Dosing Period 2|Adverse Event|0|||
129625849|NCT03052751|466584103|FG002|Dosing Period 2|Adverse Event|3|||
129625850|NCT03052751|466584104|FG003|Dosing Period 2|Adverse Event|0|||
129625851|NCT03052751|466584105|FG004|Dosing Period 2|Adverse Event|0|||
129625852|NCT03052751|466584106|FG005|Dosing Period 2|Adverse Event|0|||
129625853|NCT03052751|466584101|FG000|Observation Period|Adverse Event|0|||
129625854|NCT03052751|466584102|FG001|Observation Period|Adverse Event|0|||
129625855|NCT03052751|466584103|FG002|Observation Period|Adverse Event|0|||
129625856|NCT03052751|466584104|FG003|Observation Period|Adverse Event|0|||
129625857|NCT03052751|466584105|FG004|Observation Period|Adverse Event|1|||
129625858|NCT03052751|466584106|FG005|Observation Period|Adverse Event|0|||
129625859|NCT02719184|466584107|FG000|Overall Study|Other than listed|1|||
129625860|NCT02719184|466584108|FG001|Overall Study|Other than listed|12|||
129625861|NCT02719184|466584109|FG002|Overall Study|Other than listed|13|||
129625862|NCT02719184|466584110|FG003|Overall Study|Other than listed|22|||
129625863|NCT02719184|466584111|FG004|Overall Study|Other than listed|9|||
129625864|NCT02719184|466584107|FG000|Overall Study|Withdrawal by Subject|5|||
129625865|NCT02719184|466584108|FG001|Overall Study|Withdrawal by Subject|3|||
129625866|NCT02719184|466584109|FG002|Overall Study|Withdrawal by Subject|6|||
129625867|NCT02719184|466584110|FG003|Overall Study|Withdrawal by Subject|6|||
129625868|NCT02719184|466584111|FG004|Overall Study|Withdrawal by Subject|0|||
129625869|NCT02719184|466584107|FG000|Overall Study|Lost to Follow-up|0|||
129625870|NCT02719184|466584108|FG001|Overall Study|Lost to Follow-up|4|||
129625871|NCT02719184|466584109|FG002|Overall Study|Lost to Follow-up|1|||
129702996|NCT02757768|466873275|FG000|Overall Study|Lack of Efficacy|2|||
129702997|NCT02757768|466873276|FG001|Overall Study|Lack of Efficacy|1|||
129702998|NCT02757768|466873275|FG000|Overall Study|Lost to Follow-up|1|||
129702999|NCT02757768|466873276|FG001|Overall Study|Lost to Follow-up|0|||
129703000|NCT02757768|466873275|FG000|Overall Study|Protocol Deviation|2|||
129703001|NCT02757768|466873276|FG001|Overall Study|Protocol Deviation|9|||
129703002|NCT02757768|466873275|FG000|Overall Study|Withdrawal by Subject|16|||
129703003|NCT02757768|466873276|FG001|Overall Study|Withdrawal by Subject|9|||
129703004|NCT02757768|466873275|FG000|Overall Study|Miscellaneous|4|||
129703005|NCT02757768|466873276|FG001|Overall Study|Miscellaneous|2|||
129703006|NCT05929326|466873277|FG000|Overall Study|unqualified sample|2|||
129625872|NCT02719184|466584110|FG003|Overall Study|Lost to Follow-up|3|||
129625873|NCT02719184|466584111|FG004|Overall Study|Lost to Follow-up|0|||
129625874|NCT02719184|466584107|FG000|Overall Study|Protocol Violation|0|||
129625875|NCT02719184|466584108|FG001|Overall Study|Protocol Violation|3|||
129625876|NCT02719184|466584109|FG002|Overall Study|Protocol Violation|0|||
129703007|NCT05929326|466873278|FG001|Overall Study|unqualified sample|3|||
129625877|NCT02719184|466584110|FG003|Overall Study|Protocol Violation|2|||
129625878|NCT02719184|466584111|FG004|Overall Study|Protocol Violation|0|||
129625879|NCT02719184|466584107|FG000|Overall Study|Adverse Event|0|||
129625880|NCT02719184|466584108|FG001|Overall Study|Adverse Event|0|||
129625881|NCT02719184|466584109|FG002|Overall Study|Adverse Event|0|||
129625882|NCT02719184|466584110|FG003|Overall Study|Adverse Event|3|||
129625883|NCT02719184|466584111|FG004|Overall Study|Adverse Event|0|||
129625884|NCT02439216|466584112|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
129703008|NCT05929326|466873279|FG002|Overall Study|unqualified sample|7|||
129703009|NCT04890509|466873280|FG000|Overall Study|Death|4|||
129625885|NCT02439216|466584113|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625886|NCT02439216|466584114|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625887|NCT02439216|466584115|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625888|NCT02439216|466584116|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625889|NCT02439216|466584117|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625890|NCT02439216|466584118|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625891|NCT02439216|466584119|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625892|NCT02439216|466584120|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
129625893|NCT02439216|466584112|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625894|NCT02439216|466584113|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625895|NCT02439216|466584114|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625896|NCT02439216|466584115|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625897|NCT02439216|466584116|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625898|NCT02439216|466584117|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625899|NCT02439216|466584118|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625900|NCT02439216|466584119|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
129625901|NCT02439216|466584120|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
129625902|NCT02439216|466584112|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625903|NCT02439216|466584113|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625904|NCT02439216|466584114|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625905|NCT02439216|466584115|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625906|NCT02439216|466584116|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625907|NCT02439216|466584117|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625908|NCT02439216|466584118|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
129625909|NCT02439216|466584119|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
129625910|NCT02439216|466584120|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
129625911|NCT02439216|466584112|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625912|NCT02439216|466584113|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625913|NCT02439216|466584114|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625914|NCT02439216|466584115|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625915|NCT02439216|466584116|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625916|NCT02439216|466584117|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625917|NCT02439216|466584118|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625918|NCT02439216|466584119|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
129625919|NCT02439216|466584120|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
129625920|NCT02439216|466584112|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625921|NCT02439216|466584113|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625922|NCT02439216|466584114|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625923|NCT02439216|466584115|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625924|NCT02439216|466584116|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625925|NCT02439216|466584117|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625926|NCT02439216|466584118|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
129625927|NCT02439216|466584119|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
129625928|NCT02439216|466584120|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
129625929|NCT02094300|466584121|FG000|Overall Study|Death|7|||
129625930|NCT02094300|466584121|FG000|Overall Study|Lost to Follow-up|10|||
129625931|NCT02094300|466584121|FG000|Overall Study|Still be eligible for follow-up|3|||
129625932|NCT01050530|466584125|FG000|Overall Study|Adverse Event|6|||
129625933|NCT01050530|466584126|FG001|Overall Study|Adverse Event|3|||
129793797|NCT00393042|467212752|FG001|Second Intervetion|Withdrawal by Subject|2|||
129793798|NCT00393042|467212751|FG000|Second Intervetion|Lack of Efficacy|1|||
129793799|NCT00393042|467212752|FG001|Second Intervetion|Lack of Efficacy|0|||
129793800|NCT00393042|467212751|FG000|Second Intervetion|Lost to Follow-up|0|||
129793801|NCT00393042|467212752|FG001|Second Intervetion|Lost to Follow-up|2|||
129793802|NCT00393042|467212751|FG000|Second Intervetion|Protocol Violation|1|||
129793803|NCT00393042|467212752|FG001|Second Intervetion|Protocol Violation|1|||
129793804|NCT01150474|467212757|FG000|Overall Study|Withdrawal by Subject|5|||
129793805|NCT01150474|467212758|FG001|Overall Study|Withdrawal by Subject|2|||
129793806|NCT01150474|467212757|FG000|Overall Study|Cancer found|1|||
129793807|NCT01150474|467212758|FG001|Overall Study|Cancer found|0|||
129793808|NCT01150474|467212757|FG000|Overall Study|Multiple Studies|0|||
129793809|NCT01150474|467212758|FG001|Overall Study|Multiple Studies|1|||
129793810|NCT01150474|467212757|FG000|Overall Study|Rectotomy|1|||
129888673|NCT02584855|467549275|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
129625934|NCT01050530|466584125|FG000|Overall Study|Lack of Efficacy|1|||
129625935|NCT01050530|466584126|FG001|Overall Study|Lack of Efficacy|4|||
129793811|NCT01150474|467212758|FG001|Overall Study|Rectotomy|0|||
129888674|NCT02584855|467549270|FG000|Open-Label Treatment Period|Adverse Event|14|||
129888675|NCT02584855|467549271|FG001|Open-Label Treatment Period|Adverse Event|0|||
129888676|NCT02584855|467549272|FG002|Open-Label Treatment Period|Adverse Event|0|||
129888677|NCT02584855|467549273|FG003|Open-Label Treatment Period|Adverse Event|0|||
129888678|NCT02584855|467549274|FG004|Open-Label Treatment Period|Adverse Event|0|||
129888679|NCT02584855|467549275|FG005|Open-Label Treatment Period|Adverse Event|0|||
129888680|NCT02584855|467549270|FG000|Open-Label Treatment Period|Death|2|||
129888681|NCT02584855|467549271|FG001|Open-Label Treatment Period|Death|0|||
129888682|NCT02584855|467549272|FG002|Open-Label Treatment Period|Death|0|||
129888683|NCT02584855|467549273|FG003|Open-Label Treatment Period|Death|0|||
129888684|NCT02584855|467549274|FG004|Open-Label Treatment Period|Death|0|||
129888685|NCT02584855|467549275|FG005|Open-Label Treatment Period|Death|0|||
129888686|NCT02584855|467549270|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
129888687|NCT02584855|467549271|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
129888688|NCT02584855|467549272|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
129888689|NCT02584855|467549273|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
129888690|NCT02584855|467549274|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
129888691|NCT02584855|467549275|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
129888692|NCT02584855|467549270|FG000|Open-Label Treatment Period|Protocol Violation|1|||
129888693|NCT02584855|467549271|FG001|Open-Label Treatment Period|Protocol Violation|0|||
129888694|NCT02584855|467549272|FG002|Open-Label Treatment Period|Protocol Violation|0|||
129888695|NCT02584855|467549273|FG003|Open-Label Treatment Period|Protocol Violation|0|||
129888696|NCT02584855|467549274|FG004|Open-Label Treatment Period|Protocol Violation|0|||
129888697|NCT02584855|467549275|FG005|Open-Label Treatment Period|Protocol Violation|0|||
129888698|NCT02584855|467549270|FG000|Open-Label Treatment Period|No PI Available|2|||
129888699|NCT02584855|467549271|FG001|Open-Label Treatment Period|No PI Available|0|||
129888700|NCT02584855|467549272|FG002|Open-Label Treatment Period|No PI Available|0|||
129888701|NCT02584855|467549273|FG003|Open-Label Treatment Period|No PI Available|0|||
129888702|NCT02584855|467549274|FG004|Open-Label Treatment Period|No PI Available|0|||
129888703|NCT02584855|467549275|FG005|Open-Label Treatment Period|No PI Available|0|||
129888704|NCT02584855|467549270|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
129888705|NCT02584855|467549271|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
129888706|NCT02584855|467549272|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
129888707|NCT02584855|467549273|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
129888708|NCT02584855|467549274|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
129888709|NCT02584855|467549275|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
129888710|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888711|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888712|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
129888713|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888714|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888715|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
129888716|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
129625936|NCT01050530|466584125|FG000|Overall Study|Withdrawal by Subject|0|||
129625937|NCT01050530|466584126|FG001|Overall Study|Withdrawal by Subject|3|||
129625938|NCT01050530|466584125|FG000|Overall Study|Protocol Violation|1|||
129625939|NCT01050530|466584126|FG001|Overall Study|Protocol Violation|0|||
129625940|NCT02288312|466584129|FG000|Overall Study|Pregnancy|1|||
129625941|NCT02288312|466584130|FG001|Overall Study|Pregnancy|0|||
129625942|NCT02288312|466584131|FG002|Overall Study|Pregnancy|0|||
129625943|NCT01276041|466584132|FG000|Overall Study|Adverse Event|2|||
129625944|NCT01276041|466584132|FG000|Overall Study|Protocol Violation|1|||
129625945|NCT00485264|466584139|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
129625946|NCT00485264|466584140|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
129625947|NCT00485264|466584141|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
129625948|NCT00485264|466584142|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
129625949|NCT00485264|466584143|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
129625950|NCT00485264|466584144|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
129625951|NCT00485264|466584139|FG000|Overall Study|Death|1|||
129625952|NCT00485264|466584140|FG001|Overall Study|Death|0|||
129625953|NCT00485264|466584141|FG002|Overall Study|Death|0|||
129625954|NCT00485264|466584142|FG003|Overall Study|Death|0|||
129888717|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
129888718|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
129888719|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
129888720|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
129439471|NCT01723254|465906513|FG006|Overall Study|Move/Left to another country/city|0|||
129625955|NCT00485264|466584143|FG004|Overall Study|Death|1|||
129625956|NCT00485264|466584144|FG005|Overall Study|Death|0|||
129625957|NCT00485264|466584139|FG000|Overall Study|Adverse Event|1|||
129625958|NCT00485264|466584140|FG001|Overall Study|Adverse Event|0|||
129625959|NCT00485264|466584141|FG002|Overall Study|Adverse Event|2|||
129625960|NCT00485264|466584142|FG003|Overall Study|Adverse Event|3|||
129625961|NCT00485264|466584143|FG004|Overall Study|Adverse Event|1|||
129625962|NCT00485264|466584144|FG005|Overall Study|Adverse Event|3|||
129625963|NCT00485264|466584139|FG000|Overall Study|Pregnancy|4|||
129625964|NCT00485264|466584140|FG001|Overall Study|Pregnancy|0|||
129625965|NCT00485264|466584141|FG002|Overall Study|Pregnancy|0|||
129625966|NCT00485264|466584142|FG003|Overall Study|Pregnancy|0|||
129625967|NCT00485264|466584143|FG004|Overall Study|Pregnancy|0|||
129625968|NCT00485264|466584144|FG005|Overall Study|Pregnancy|0|||
129625969|NCT00485264|466584139|FG000|Overall Study|Disallowed Medication|0|||
129625970|NCT00485264|466584140|FG001|Overall Study|Disallowed Medication|0|||
129625971|NCT00485264|466584141|FG002|Overall Study|Disallowed Medication|0|||
129625972|NCT00485264|466584142|FG003|Overall Study|Disallowed Medication|0|||
129625973|NCT00485264|466584143|FG004|Overall Study|Disallowed Medication|0|||
129625974|NCT00485264|466584144|FG005|Overall Study|Disallowed Medication|1|||
129625975|NCT00485264|466584139|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
129625976|NCT00485264|466584140|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
129625977|NCT00485264|466584141|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
129625978|NCT00485264|466584142|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
129625979|NCT00485264|466584143|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
129625980|NCT00485264|466584144|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
129625981|NCT00485264|466584139|FG000|Overall Study|Lack of Efficacy|0|||
129625982|NCT00485264|466584140|FG001|Overall Study|Lack of Efficacy|1|||
129625983|NCT00485264|466584141|FG002|Overall Study|Lack of Efficacy|0|||
129625984|NCT00485264|466584142|FG003|Overall Study|Lack of Efficacy|0|||
129625985|NCT00485264|466584143|FG004|Overall Study|Lack of Efficacy|0|||
129625986|NCT00485264|466584144|FG005|Overall Study|Lack of Efficacy|0|||
129625987|NCT00485264|466584139|FG000|Overall Study|Guardian Consent Withdrawn|1|||
129625988|NCT00485264|466584140|FG001|Overall Study|Guardian Consent Withdrawn|0|||
129625989|NCT00485264|466584141|FG002|Overall Study|Guardian Consent Withdrawn|0|||
129625990|NCT00485264|466584142|FG003|Overall Study|Guardian Consent Withdrawn|0|||
129625991|NCT00485264|466584143|FG004|Overall Study|Guardian Consent Withdrawn|1|||
129625992|NCT00485264|466584144|FG005|Overall Study|Guardian Consent Withdrawn|0|||
129625993|NCT00485264|466584139|FG000|Overall Study|Physician Decision|0|||
129625994|NCT00485264|466584140|FG001|Overall Study|Physician Decision|2|||
129625995|NCT00485264|466584141|FG002|Overall Study|Physician Decision|0|||
129625996|NCT00485264|466584142|FG003|Overall Study|Physician Decision|0|||
129625997|NCT00485264|466584143|FG004|Overall Study|Physician Decision|0|||
129625998|NCT00485264|466584144|FG005|Overall Study|Physician Decision|0|||
129625999|NCT00485264|466584139|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129626000|NCT00485264|466584140|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129626001|NCT00485264|466584141|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
129626002|NCT00485264|466584142|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129626003|NCT00485264|466584143|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129626004|NCT00485264|466584144|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
129626005|NCT00485264|466584139|FG000|Overall Study|Not Able to Attend Clinic|5|||
129626006|NCT00485264|466584140|FG001|Overall Study|Not Able to Attend Clinic|0|||
129626007|NCT00485264|466584141|FG002|Overall Study|Not Able to Attend Clinic|0|||
129626008|NCT00485264|466584142|FG003|Overall Study|Not Able to Attend Clinic|1|||
129626009|NCT00485264|466584143|FG004|Overall Study|Not Able to Attend Clinic|1|||
129626010|NCT00485264|466584144|FG005|Overall Study|Not Able to Attend Clinic|2|||
129626011|NCT00485264|466584139|FG000|Overall Study|Non-Compliant|17|||
129626012|NCT00485264|466584140|FG001|Overall Study|Non-Compliant|2|||
129626013|NCT00485264|466584141|FG002|Overall Study|Non-Compliant|1|||
129626014|NCT00485264|466584142|FG003|Overall Study|Non-Compliant|0|||
129626015|NCT00485264|466584143|FG004|Overall Study|Non-Compliant|1|||
129626016|NCT00485264|466584144|FG005|Overall Study|Non-Compliant|0|||
129626017|NCT00485264|466584139|FG000|Overall Study|Lost to Follow-up|2|||
129626018|NCT00485264|466584140|FG001|Overall Study|Lost to Follow-up|1|||
129626019|NCT00485264|466584141|FG002|Overall Study|Lost to Follow-up|1|||
129626020|NCT00485264|466584142|FG003|Overall Study|Lost to Follow-up|0|||
129626021|NCT00485264|466584143|FG004|Overall Study|Lost to Follow-up|0|||
129626022|NCT00485264|466584144|FG005|Overall Study|Lost to Follow-up|1|||
129626023|NCT00485264|466584139|FG000|Overall Study|Other Reason|3|||
129626024|NCT00485264|466584140|FG001|Overall Study|Other Reason|0|||
129626025|NCT00485264|466584141|FG002|Overall Study|Other Reason|0|||
129626026|NCT00485264|466584142|FG003|Overall Study|Other Reason|0|||
129626027|NCT00485264|466584143|FG004|Overall Study|Other Reason|0|||
129626028|NCT00485264|466584144|FG005|Overall Study|Other Reason|0|||
129626029|NCT00654095|466584146|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
129626030|NCT00654095|466584146|FG000|Overall Study|Elevated triglyceride level (2)|1|||
129626031|NCT00654095|466584146|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
129626032|NCT00654095|466584146|FG000|Overall Study|Adverse Event|11|||
129626033|NCT00654095|466584146|FG000|Overall Study|Withdrawal by Subject|5|||
129626034|NCT00654095|466584146|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
129626035|NCT00654095|466584146|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
129626036|NCT00654095|466584146|FG000|Overall Study|Did not meet inclusion criteria|1|||
129626037|NCT02440464|466584147|FG000|Overall Study|Withdrawal by Subject|3|||
129626038|NCT02440464|466584148|FG001|Overall Study|Withdrawal by Subject|2|||
129888721|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
129888722|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888723|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
129888724|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888725|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888726|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888727|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
129888728|NCT02584855|467549270|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888729|NCT02584855|467549271|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
129888730|NCT02584855|467549272|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888731|NCT02584855|467549273|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888732|NCT02584855|467549274|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888733|NCT02584855|467549275|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
129888734|NCT02584855|467549270|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129626039|NCT04620746|466584164|FG000|Overall Study|Adverse Event|2|||
129626040|NCT04620746|466584165|FG001|Overall Study|Adverse Event|0|||
129626041|NCT04620746|466584164|FG000|Overall Study|Uniterpretable skin test|1|||
129626042|NCT04620746|466584165|FG001|Overall Study|Uniterpretable skin test|0|||
129626043|NCT04620746|466584164|FG000|Overall Study|Withdrawal by Subject|0|||
129626044|NCT04620746|466584165|FG001|Overall Study|Withdrawal by Subject|1|||
129626045|NCT03411863|466584166|FG000|Overall Study|Withdrawal by Subject|3|||
129626046|NCT03411863|466584167|FG001|Overall Study|Withdrawal by Subject|1|||
129626047|NCT03411863|466584166|FG000|Overall Study|Physician Decision|0|||
129626048|NCT03411863|466584167|FG001|Overall Study|Physician Decision|1|||
129626049|NCT03535740|466584168|FG000|Overall Study|Death|44|||
129626050|NCT03535740|466584168|FG000|Overall Study|Lost to Follow-up|1|||
129626051|NCT03535740|466584168|FG000|Overall Study|Withdrawal by Subject|13|||
129626052|NCT03535740|466584168|FG000|Overall Study|Site terminated by Sponsor|45|||
129888735|NCT02584855|467549271|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888736|NCT02584855|467549272|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888737|NCT02584855|467549273|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888738|NCT02584855|467549274|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
129626053|NCT05198518|466584173|FG000|Screening Visit|Deemed unable to participate|58|||
129626054|NCT05198518|466584174|FG001|Screening Visit|Deemed unable to participate|0|||
129626055|NCT05198518|466584175|FG002|Screening Visit|Deemed unable to participate|0|||
129626056|NCT02756611|466584178|FG000|Overall Study|Death|70|||
129888739|NCT02584855|467549275|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
129888740|NCT02584855|467549270|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
129888741|NCT02584855|467549271|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
129888742|NCT02584855|467549272|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
129888743|NCT02584855|467549273|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
129888744|NCT02584855|467549274|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
129626057|NCT02756611|466584178|FG000|Overall Study|Withdrawal by Subject|2|||
129626058|NCT02756611|466584178|FG000|Overall Study|Lost to Follow-up|3|||
129626059|NCT02756611|466584178|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
129626060|NCT02756611|466584178|FG000|Overall Study|Other|10|||
129626061|NCT03125798|466584180|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
129626062|NCT03125798|466584181|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
129626063|NCT03125798|466584180|FG000|Overall Study|Conversion to thoracotomy|7|||
129626064|NCT03125798|466584181|FG001|Overall Study|Conversion to thoracotomy|7|||
129626065|NCT00100828|466584185|FG000|Overall Study|Physician Decision|6|||
129626066|NCT04583735|466584186|FG000|Double-masked Treatment Period|Adverse Event|0|||
129626067|NCT04583735|466584187|FG001|Double-masked Treatment Period|Adverse Event|1|||
129626068|NCT04583735|466584186|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
129626069|NCT04583735|466584187|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
129626070|NCT04583735|466584186|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
129626071|NCT04583735|466584187|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
129626072|NCT04583735|466584186|FG000|Open-label Treatment Period|Adverse Event|1|||
129626073|NCT04583735|466584187|FG001|Open-label Treatment Period|Adverse Event|1|||
129626074|NCT04583735|466584186|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
129626075|NCT04583735|466584187|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129626076|NCT04583735|466584186|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129626077|NCT04583735|466584187|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
129626078|NCT00124917|466584188|FG000|Overall Study|Physician Decision|3|||
129626079|NCT03518008|466584189|FG000|Period 2, Second Week of Wear|Family emergency|0|||
129626080|NCT03518008|466584190|FG001|Period 2, Second Week of Wear|Family emergency|1|||
129626081|NCT00613171|466584191|FG000|Overall Study|Adverse Event|7|||
129626082|NCT00613171|466584191|FG000|Overall Study|Withdrawal by Subject|3|||
129626083|NCT00613171|466584191|FG000|Overall Study|Reason not Specified|4|||
129626084|NCT01197911|466584192|FG000|Overall Study|Adverse Event|0|||
129626085|NCT01197911|466584193|FG001|Overall Study|Adverse Event|0|||
129626086|NCT01197911|466584194|FG002|Overall Study|Adverse Event|1|||
129626087|NCT01169350|466584195|FG000|Overall Study|Physician Decision|3|||
129793812|NCT01150474|467212757|FG000|Overall Study|Drug did not arrive in time|1|||
129793813|NCT01150474|467212758|FG001|Overall Study|Drug did not arrive in time|0|||
129793814|NCT01150474|467212757|FG000|Overall Study|Drug not administered|1|||
129793815|NCT01150474|467212758|FG001|Overall Study|Drug not administered|0|||
129793816|NCT01150474|467212757|FG000|Overall Study|Surgery Changed|1|||
129793817|NCT01150474|467212758|FG001|Overall Study|Surgery Changed|0|||
129793818|NCT01423604|467212759|FG000|Safety Run-In|Adverse Event|3|||
129793819|NCT01423604|467212760|FG001|Safety Run-In|Adverse Event|0|||
129793820|NCT01423604|467212759|FG000|Safety Run-In|Death|1|||
129793821|NCT01423604|467212760|FG001|Safety Run-In|Death|0|||
129888745|NCT02584855|467549275|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
129626088|NCT01169350|466584195|FG000|Overall Study|Lost to Follow-up|2|||
129626089|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
129626090|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
129626091|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
129626092|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
129626093|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
129626094|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
129793822|NCT01423604|467212759|FG000|Safety Run-In|Physician Decision|1|||
129626095|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
129626096|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
129626097|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
129626098|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
129626099|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
129626100|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
129626101|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
129439472|NCT01723254|465906514|FG007|Overall Study|Move/Left to another country/city|0|||
129439473|NCT01723254|465906507|FG000|Overall Study|Protocol Violation|0|||
129439474|NCT01723254|465906508|FG001|Overall Study|Protocol Violation|1|||
129439475|NCT01723254|465906509|FG002|Overall Study|Protocol Violation|0|||
129439476|NCT01723254|465906510|FG003|Overall Study|Protocol Violation|0|||
129439477|NCT01723254|465906511|FG004|Overall Study|Protocol Violation|0|||
129439478|NCT01723254|465906512|FG005|Overall Study|Protocol Violation|0|||
129439479|NCT01723254|465906513|FG006|Overall Study|Protocol Violation|0|||
129439480|NCT01723254|465906514|FG007|Overall Study|Protocol Violation|0|||
129439481|NCT01723254|465906507|FG000|Overall Study|Withdrawal by Subject|1|||
129439482|NCT01723254|465906508|FG001|Overall Study|Withdrawal by Subject|2|||
129439483|NCT01723254|465906509|FG002|Overall Study|Withdrawal by Subject|1|||
129439484|NCT01723254|465906510|FG003|Overall Study|Withdrawal by Subject|0|||
129439485|NCT01723254|465906511|FG004|Overall Study|Withdrawal by Subject|1|||
129439486|NCT01723254|465906512|FG005|Overall Study|Withdrawal by Subject|1|||
129439487|NCT01723254|465906513|FG006|Overall Study|Withdrawal by Subject|1|||
129439488|NCT01723254|465906514|FG007|Overall Study|Withdrawal by Subject|2|||
129439489|NCT01323634|465906515|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
129439490|NCT01323634|465906516|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
129439491|NCT01323634|465906517|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
129439492|NCT01323634|465906515|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
129439493|NCT01323634|465906516|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
129439494|NCT01323634|465906517|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
129439495|NCT01323634|465906515|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
129439496|NCT01323634|465906516|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129439497|NCT01323634|465906517|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129439498|NCT01323634|465906515|FG000|2-week Run-in Period|Physician Decision|5|||
129439499|NCT01323634|465906516|FG001|2-week Run-in Period|Physician Decision|0|||
129439500|NCT01323634|465906517|FG002|2-week Run-in Period|Physician Decision|0|||
129439501|NCT01323634|465906515|FG000|2-week Run-in Period|Protocol Violation|1|||
129439502|NCT01323634|465906516|FG001|2-week Run-in Period|Protocol Violation|0|||
129439503|NCT01323634|465906517|FG002|2-week Run-in Period|Protocol Violation|0|||
129439504|NCT01323634|465906515|FG000|2-week Run-in Period|Adverse Event|1|||
129439505|NCT01323634|465906516|FG001|2-week Run-in Period|Adverse Event|0|||
129439506|NCT01323634|465906517|FG002|2-week Run-in Period|Adverse Event|0|||
129439507|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
129439508|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
129439509|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
129439510|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129439511|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
129439512|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
129439513|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
129439514|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
129439515|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
129439516|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
129439517|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129439518|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
129439519|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
129793823|NCT01423604|467212760|FG001|Safety Run-In|Physician Decision|0|||
129793824|NCT01423604|467212759|FG000|Safety Run-In|Disease progression|3|||
129793825|NCT01423604|467212760|FG001|Safety Run-In|Disease progression|0|||
129439520|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
129439521|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
129793826|NCT01423604|467212759|FG000|Safety Run-In|Patient decision|1|||
129793827|NCT01423604|467212760|FG001|Safety Run-In|Patient decision|0|||
129793828|NCT01423604|467212759|FG000|Randomized|Adverse Event|4|||
129626102|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
129626103|NCT04338022|466584196|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
129626104|NCT04338022|466584197|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
129626105|NCT04338022|466584196|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
129626106|NCT04338022|466584197|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
129626107|NCT04338022|466584196|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
129626108|NCT04338022|466584197|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
129626109|NCT04338022|466584196|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
129626110|NCT04338022|466584197|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
129888746|NCT02337478|467549276|FG000|Overall Study|Lack of Efficacy|5|||
129888747|NCT03583541|467550882|FG000|Overall Study|Lost to Follow-up|31|||
129888748|NCT03583541|467550883|FG001|Overall Study|Lost to Follow-up|65|||
129888749|NCT04102540|467550884|FG000|Overall Study|Withdrawn by PI|2|||
129888750|NCT04102540|467550884|FG000|Overall Study|Lost to Follow-up|6|||
129888751|NCT00280293|467550887|FG000|Overall Study|Protocol Violation|3|||
129888752|NCT00280293|467550888|FG001|Overall Study|Protocol Violation|0|||
129888753|NCT00280293|467550887|FG000|Overall Study|Physician Decision|5|||
129888754|NCT00280293|467550888|FG001|Overall Study|Physician Decision|4|||
129888755|NCT00280293|467550887|FG000|Overall Study|Lost to Follow-up|14|||
129888756|NCT00280293|467550888|FG001|Overall Study|Lost to Follow-up|12|||
129888757|NCT00280293|467550887|FG000|Overall Study|Withdrawal by Subject|3|||
129888758|NCT00280293|467550888|FG001|Overall Study|Withdrawal by Subject|5|||
129888759|NCT00280293|467550887|FG000|Overall Study|Incarceration/Legal Reasons|1|||
129888760|NCT00280293|467550888|FG001|Overall Study|Incarceration/Legal Reasons|1|||
129888761|NCT00280293|467550887|FG000|Overall Study|Adverse Event|0|||
129888762|NCT00280293|467550888|FG001|Overall Study|Adverse Event|1|||
129888763|NCT01458249|467550889|FG000|Overall Study|Not treated|1|||
129888764|NCT01458249|467550889|FG000|Overall Study|Adverse Event|4|||
129888765|NCT01458249|467550889|FG000|Overall Study|Other|2|||
129888766|NCT01458249|467550889|FG000|Overall Study|Ongoing|1|||
129888767|NCT01348854|467550890|FG000|Overall Study|Lost to Follow-up|2|||
129888768|NCT01348854|467550891|FG001|Overall Study|Lost to Follow-up|1|||
129888769|NCT01348854|467550890|FG000|Overall Study|Withdrawal by Subject|1|||
129888770|NCT01348854|467550891|FG001|Overall Study|Withdrawal by Subject|0|||
129888771|NCT00594932|467550894|FG000|First 3 Months|Withdrawal by Subject|1|||
129888772|NCT00594932|467550895|FG001|First 3 Months|Withdrawal by Subject|3|||
129888773|NCT00594932|467550894|FG000|Final 3 Months|Withdrawal by Subject|4|||
129888774|NCT00594932|467550895|FG001|Final 3 Months|Withdrawal by Subject|3|||
129888775|NCT01094171|467550896|FG000|Overall Study|Lost to Follow-up|2|||
129888776|NCT01094171|467550896|FG000|Overall Study|Informed consent withdrawal|4|||
129888777|NCT01094171|467550896|FG000|Overall Study|Migration from the study area|3|||
129888778|NCT01094171|467550896|FG000|Overall Study|Other|1|||
129888779|NCT01009047|467550898|FG000|Overall Study|Adverse Event|5|||
129888780|NCT01009047|467550899|FG001|Overall Study|Adverse Event|0|||
129888781|NCT01009047|467550898|FG000|Overall Study|Lost to Follow-up|0|||
129888782|NCT01009047|467550899|FG001|Overall Study|Lost to Follow-up|2|||
129888783|NCT01009047|467550898|FG000|Overall Study|Lack of Efficacy|4|||
129439522|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
129626111|NCT04338022|466584196|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
129703010|NCT04890509|466873281|FG001|Overall Study|Death|4|||
129888784|NCT01009047|467550899|FG001|Overall Study|Lack of Efficacy|11|||
129626112|NCT04338022|466584197|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
129626113|NCT04338022|466584196|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
129626114|NCT04338022|466584197|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
129626115|NCT04338022|466584196|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
129626116|NCT04338022|466584197|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
129626117|NCT02860546|466584199|FG000|Overall Study|Clinical Progression|6|||
129626118|NCT02860546|466584199|FG000|Overall Study|Radiological Progression|12|||
129626119|NCT02466321|466584200|FG000|Overall Study|Death|26|||
129626120|NCT02466321|466584200|FG000|Overall Study|Revision|6|||
129626121|NCT02466321|466584200|FG000|Overall Study|Lost to Follow-up|60|||
129626122|NCT02466321|466584200|FG000|Overall Study|Did not receive study device|1|||
129626123|NCT06071754|466584201|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
129626124|NCT02189837|466584205|FG000|Overall Study|Withdrawal by Subject|2|||
129626125|NCT02189837|466584206|FG001|Overall Study|Withdrawal by Subject|1|||
129626126|NCT02189837|466584207|FG002|Overall Study|Withdrawal by Subject|3|||
129626127|NCT02189837|466584208|FG003|Overall Study|Withdrawal by Subject|1|||
129626128|NCT02189837|466584205|FG000|Overall Study|Sponsor Decision|0|||
129626129|NCT02189837|466584206|FG001|Overall Study|Sponsor Decision|0|||
129626130|NCT02189837|466584207|FG002|Overall Study|Sponsor Decision|0|||
129626131|NCT02189837|466584208|FG003|Overall Study|Sponsor Decision|1|||
129626132|NCT02443740|466584212|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626133|NCT02443740|466584213|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626134|NCT02443740|466584214|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626135|NCT02443740|466584215|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626136|NCT02443740|466584216|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626137|NCT02443740|466584217|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
129626138|NCT02443740|466584218|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626139|NCT02443740|466584219|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626140|NCT02443740|466584220|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626141|NCT02443740|466584221|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626142|NCT02443740|466584222|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
129626143|NCT02443740|466584212|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
129626144|NCT02443740|466584213|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626145|NCT02443740|466584214|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626146|NCT02443740|466584215|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626147|NCT02443740|466584216|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626148|NCT02443740|466584217|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626149|NCT02443740|466584218|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
129626150|NCT02443740|466584219|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626151|NCT02443740|466584220|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626152|NCT02443740|466584221|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626153|NCT02443740|466584222|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
129626154|NCT02443740|466584212|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626155|NCT02443740|466584213|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626156|NCT02443740|466584214|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626157|NCT02443740|466584215|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626158|NCT02443740|466584216|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626159|NCT02443740|466584217|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
129626160|NCT02443740|466584218|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626161|NCT02443740|466584219|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626162|NCT02443740|466584220|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626163|NCT02443740|466584221|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129793829|NCT01423604|467212760|FG001|Randomized|Adverse Event|10|||
129793830|NCT01423604|467212759|FG000|Randomized|Death|1|||
129793831|NCT01423604|467212760|FG001|Randomized|Death|0|||
129793832|NCT01423604|467212759|FG000|Randomized|Physician Decision|16|||
129793833|NCT01423604|467212760|FG001|Randomized|Physician Decision|13|||
129793834|NCT01423604|467212759|FG000|Randomized|Other - unspecified|37|||
129793835|NCT01423604|467212760|FG001|Randomized|Other - unspecified|31|||
129793836|NCT01423604|467212759|FG000|Randomized|Patient decision|5|||
129793837|NCT01423604|467212760|FG001|Randomized|Patient decision|9|||
129793838|NCT00424255|467212761|FG000|Overall Study|Death|115|||
129626164|NCT02443740|466584222|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
129626165|NCT00456300|466584223|FG000|Overall Study|Adverse Event|1|||
129626166|NCT00456300|466584224|FG001|Overall Study|Adverse Event|0|||
129626167|NCT01478373|466584226|FG000|Treatment Phase|Protocol Violation|1|||
129626168|NCT01478373|466584226|FG000|Survival Phase|Adverse Event|8|||
129626169|NCT01478373|466584226|FG000|Survival Phase|Protocol Violation|1|||
129626170|NCT01478373|466584226|FG000|Survival Phase|crossover to another study|2|||
129626171|NCT01478373|466584226|FG000|Survival Phase|Progressive Disease|27|||
129626172|NCT01074944|466584229|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
129793839|NCT00424255|467212762|FG001|Overall Study|Death|111|||
129793840|NCT00424255|467212761|FG000|Overall Study|Lost to Follow-up|26|||
129626173|NCT01074944|466584230|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129626174|NCT01074944|466584231|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129626175|NCT01074944|466584232|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129626176|NCT01074944|466584233|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
129626177|NCT01074944|466584229|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
129626178|NCT01074944|466584230|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129626179|NCT01074944|466584231|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129626180|NCT01074944|466584232|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129626181|NCT01074944|466584233|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
129626182|NCT01074944|466584229|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
129626183|NCT01074944|466584230|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129626184|NCT01074944|466584231|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129626185|NCT01074944|466584232|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129626186|NCT01074944|466584233|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
129626187|NCT01074944|466584229|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
129626188|NCT01074944|466584230|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129626189|NCT01074944|466584231|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129626190|NCT01074944|466584232|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129626191|NCT01074944|466584233|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
129626192|NCT01074944|466584229|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
129626193|NCT01074944|466584230|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
129626194|NCT01074944|466584231|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
129626195|NCT01074944|466584232|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
129626196|NCT01074944|466584233|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
129626197|NCT01074944|466584229|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
129626198|NCT01074944|466584230|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
129626199|NCT01074944|466584231|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
129793841|NCT00424255|467212762|FG001|Overall Study|Lost to Follow-up|20|||
129793842|NCT00424255|467212761|FG000|Overall Study|Protocol Violation|0|||
129793843|NCT00424255|467212762|FG001|Overall Study|Protocol Violation|1|||
129626200|NCT01074944|466584232|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
129626201|NCT01074944|466584233|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
129626202|NCT01074944|466584229|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129626203|NCT01074944|466584230|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
129626204|NCT01074944|466584231|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
129626205|NCT01074944|466584232|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129626206|NCT01074944|466584233|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
129626207|NCT01074944|466584229|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129626208|NCT01074944|466584230|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
129626209|NCT01074944|466584231|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129626210|NCT01074944|466584232|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129626211|NCT01074944|466584233|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
129626212|NCT01074944|466584229|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
129626213|NCT01074944|466584230|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
129626214|NCT01074944|466584231|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
129626215|NCT01074944|466584232|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
129626216|NCT01074944|466584233|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
129626217|NCT01074944|466584229|FG000|Long Term Treatment|Adverse Event|0|||
129626218|NCT01074944|466584230|FG001|Long Term Treatment|Adverse Event|0|||
129626219|NCT01074944|466584231|FG002|Long Term Treatment|Adverse Event|0|||
129626220|NCT01074944|466584232|FG003|Long Term Treatment|Adverse Event|3|||
129626221|NCT01074944|466584233|FG004|Long Term Treatment|Adverse Event|0|||
129626222|NCT01074944|466584229|FG000|Long Term Treatment|Lost to Follow-up|0|||
129626223|NCT01074944|466584230|FG001|Long Term Treatment|Lost to Follow-up|0|||
129626224|NCT01074944|466584231|FG002|Long Term Treatment|Lost to Follow-up|0|||
129626225|NCT01074944|466584232|FG003|Long Term Treatment|Lost to Follow-up|2|||
129626226|NCT01074944|466584233|FG004|Long Term Treatment|Lost to Follow-up|0|||
129626227|NCT01074944|466584229|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129626228|NCT01074944|466584230|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129626229|NCT01074944|466584231|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129626230|NCT01074944|466584232|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
129793844|NCT00424255|467212761|FG000|Overall Study|Withdrawal by Subject|34|||
129626231|NCT01074944|466584233|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
129626232|NCT01074944|466584229|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
129793845|NCT00424255|467212762|FG001|Overall Study|Withdrawal by Subject|38|||
129793846|NCT00424255|467212761|FG000|Overall Study|Physician Decision|3|||
129793847|NCT00424255|467212762|FG001|Overall Study|Physician Decision|7|||
129626233|NCT01074944|466584230|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
129626234|NCT01074944|466584231|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
129626235|NCT01074944|466584232|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
129626236|NCT01074944|466584233|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
129626237|NCT01074944|466584229|FG000|Long Term Treatment|Withdrawal by Subject|0|||
129626238|NCT01074944|466584230|FG001|Long Term Treatment|Withdrawal by Subject|0|||
129626239|NCT01074944|466584231|FG002|Long Term Treatment|Withdrawal by Subject|0|||
129626240|NCT01074944|466584232|FG003|Long Term Treatment|Withdrawal by Subject|2|||
129626241|NCT01074944|466584233|FG004|Long Term Treatment|Withdrawal by Subject|0|||
129626242|NCT01074944|466584229|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129626243|NCT01074944|466584230|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129626244|NCT01074944|466584231|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129626245|NCT01074944|466584232|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
129626246|NCT01074944|466584233|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
129626247|NCT01074944|466584229|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129626248|NCT01074944|466584230|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129626249|NCT01074944|466584231|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129626250|NCT01074944|466584232|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
129626251|NCT01074944|466584233|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
129626252|NCT02348112|466584234|FG000|Overall Study|Withdrawal by Subject|32|||
129626253|NCT02348112|466584235|FG001|Overall Study|Withdrawal by Subject|29|||
129626254|NCT02348112|466584234|FG000|Overall Study|Lost to Follow-up|24|||
129626255|NCT02348112|466584235|FG001|Overall Study|Lost to Follow-up|20|||
129626256|NCT02348112|466584234|FG000|Overall Study|Physician Decision|17|||
129626257|NCT02348112|466584235|FG001|Overall Study|Physician Decision|15|||
129626258|NCT02348112|466584234|FG000|Overall Study|Site closed due to PI leaving|0|||
129626259|NCT02348112|466584235|FG001|Overall Study|Site closed due to PI leaving|30|||
129626260|NCT02348112|466584234|FG000|Overall Study|Sponsor withdrawal|0|||
129626261|NCT02348112|466584235|FG001|Overall Study|Sponsor withdrawal|7|||
129626262|NCT02348112|466584234|FG000|Overall Study|Death|0|||
129626263|NCT02348112|466584235|FG001|Overall Study|Death|1|||
129626264|NCT01998841|466584242|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
129626265|NCT01998841|466584243|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
129626266|NCT01998841|466584244|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
129626267|NCT01998841|466584245|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129626268|NCT01998841|466584246|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129626269|NCT01998841|466584242|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129626270|NCT01998841|466584243|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129626271|NCT01998841|466584244|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
129626272|NCT01998841|466584245|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
129626273|NCT01998841|466584246|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
129626274|NCT03447743|466584247|FG000|Overall Study|Withdrawal by Subject|2|||
129626275|NCT03447743|466584247|FG000|Overall Study|Lost to Follow-up|3|||
129626276|NCT03447743|466584247|FG000|Overall Study|Adverse Event|1|||
129626277|NCT03447743|466584247|FG000|Overall Study|Did not meet criteria to continue|1|||
129626278|NCT02046603|466584248|FG000|Overall Study|Other|11|||
129626279|NCT02046603|466584249|FG001|Overall Study|Other|66|||
129626280|NCT02046603|466584248|FG000|Overall Study|Protocol Violation|0|||
129626281|NCT02046603|466584249|FG001|Overall Study|Protocol Violation|1|||
129626282|NCT02046603|466584248|FG000|Overall Study|Participant/legal guardian decision|1|||
129626283|NCT02046603|466584249|FG001|Overall Study|Participant/legal guardian decision|3|||
129626284|NCT02046603|466584248|FG000|Overall Study|Physician Decision|2|||
129626285|NCT02046603|466584249|FG001|Overall Study|Physician Decision|1|||
129626286|NCT02046603|466584248|FG000|Overall Study|Lost to Follow-up|1|||
129626287|NCT02046603|466584249|FG001|Overall Study|Lost to Follow-up|2|||
129626288|NCT02046603|466584248|FG000|Overall Study|Death|0|||
129626289|NCT02046603|466584249|FG001|Overall Study|Death|1|||
129626290|NCT02046603|466584248|FG000|Overall Study|Adverse Event|0|||
129626291|NCT02046603|466584249|FG001|Overall Study|Adverse Event|1|||
129626292|NCT05101343|466584250|FG000|Overall Study|Withdrawal by Subject|2|||
129626293|NCT05101343|466584251|FG001|Overall Study|Withdrawal by Subject|1|||
129626294|NCT00193050|466584252|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
129626295|NCT00193050|466584252|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
129626296|NCT00193050|466584252|FG000|Neoadjuvant Treatment|Physician Decision|2|||
129703011|NCT02278003|466874510|FG000|Overall Study|Withdrawal by Subject|11|||
129703012|NCT02278003|466874511|FG001|Overall Study|Withdrawal by Subject|0|||
129703013|NCT02278003|466874510|FG000|Overall Study|Not Treated|1|||
129703014|NCT02278003|466874511|FG001|Overall Study|Not Treated|0|||
129703015|NCT02278003|466874510|FG000|Overall Study|Recognition task improperly completed|7|||
129703016|NCT02278003|466874511|FG001|Overall Study|Recognition task improperly completed|0|||
129703017|NCT04123704|466874514|FG000|Overall Study|Disease progression|2|||
129703018|NCT00939185|466874515|FG000|Overall Study|Adverse Event|3|||
129703019|NCT00939185|466874515|FG000|Overall Study|Lack of Efficacy|1|||
129703020|NCT00939185|466874515|FG000|Overall Study|Lost to Follow-up|6|||
129703021|NCT00939185|466874515|FG000|Overall Study|Other|3|||
129703022|NCT00939185|466874515|FG000|Overall Study|Withdrawal by Subject|2|||
129703023|NCT00939185|466874515|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
129793848|NCT00424255|467212761|FG000|Overall Study|Cognitive Disturbance|1|||
129793849|NCT00424255|467212762|FG001|Overall Study|Cognitive Disturbance|0|||
129793850|NCT00424255|467212761|FG000|Overall Study|Non-compliance by Participants|1|||
129793851|NCT00424255|467212762|FG001|Overall Study|Non-compliance by Participants|0|||
129793852|NCT00424255|467212761|FG000|Overall Study|Fatigue|1|||
129793853|NCT00424255|467212762|FG001|Overall Study|Fatigue|0|||
129793854|NCT00424255|467212761|FG000|Overall Study|Disease Progression|0|||
129793855|NCT00424255|467212762|FG001|Overall Study|Disease Progression|2|||
129793856|NCT00424255|467212761|FG000|Overall Study|Sponsor Terminated Study|161|||
129793857|NCT00424255|467212762|FG001|Overall Study|Sponsor Terminated Study|167|||
129793858|NCT00327470|467212763|FG000|Overall Study|Randomized, but not treated|0|||
129793859|NCT00327470|467212764|FG001|Overall Study|Randomized, but not treated|2|||
129793860|NCT00327470|467212763|FG000|Overall Study|Adverse Event|9|||
129793861|NCT00327470|467212764|FG001|Overall Study|Adverse Event|14|||
129793862|NCT00327470|467212763|FG000|Overall Study|Lack of Efficacy|7|||
129793863|NCT00327470|467212764|FG001|Overall Study|Lack of Efficacy|19|||
129793864|NCT00327470|467212763|FG000|Overall Study|Other|5|||
129793865|NCT00327470|467212764|FG001|Overall Study|Other|9|||
129793866|NCT00327470|467212763|FG000|Overall Study|Lost to Follow-up|1|||
129793867|NCT00327470|467212764|FG001|Overall Study|Lost to Follow-up|3|||
129793868|NCT00327470|467212763|FG000|Overall Study|Withdrawal by Subject|6|||
129793869|NCT00327470|467212764|FG001|Overall Study|Withdrawal by Subject|12|||
129793870|NCT00327470|467212763|FG000|Overall Study|Death|1|||
129793871|NCT00327470|467212764|FG001|Overall Study|Death|4|||
129793872|NCT01226121|467212765|FG000|Overall Study|Lost to Follow-up|2|||
129793873|NCT01226121|467212766|FG001|Overall Study|Lost to Follow-up|0|||
129793874|NCT01226121|467212767|FG002|Overall Study|Lost to Follow-up|1|||
129793875|NCT02581943|467212768|FG000|Overall Study|Death|5|||
129793876|NCT02581943|467212769|FG001|Overall Study|Death|2|||
129793877|NCT02581943|467212768|FG000|Overall Study|Disease Progression|12|||
129793878|NCT02581943|467212769|FG001|Overall Study|Disease Progression|15|||
129793879|NCT02581943|467212768|FG000|Overall Study|Withdrawal by Subject|1|||
129793880|NCT02581943|467212769|FG001|Overall Study|Withdrawal by Subject|2|||
129793881|NCT03021564|467212770|FG000|Overall Study|Death|84|||
129793882|NCT03021564|467212771|FG001|Overall Study|Death|466|||
129793883|NCT03021564|467212770|FG000|Overall Study|Lost to Follow-up|0|||
129793884|NCT03021564|467212771|FG001|Overall Study|Lost to Follow-up|2|||
129793885|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
129793886|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
129793887|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
129793888|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
129793889|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
129793890|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
129793891|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793892|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
129793893|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793894|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793895|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793896|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
129793897|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
129793898|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
129793899|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
129703024|NCT00363298|466874516|FG000|First Study Week|Lack of Efficacy|6|||
129703025|NCT00363298|466874517|FG001|First Study Week|Lack of Efficacy|5|||
129703026|NCT00363298|466874516|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
129793900|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
129793901|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
129793902|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
129793903|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793904|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
129793905|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793906|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129626297|NCT00193050|466584252|FG000|Neoadjuvant Treatment|Adverse Event|2|||
129626298|NCT00193050|466584252|FG000|Adjuvant|Physician Decision|5|||
129626299|NCT00193050|466584252|FG000|Adjuvant|Intercurrent Hospitalization|3|||
129626300|NCT00193050|466584252|FG000|Adjuvant|Lack of Efficacy|2|||
129626301|NCT00061932|466584253|FG000|Overall Study|Withdrawal by Subject|13|||
129626302|NCT00061932|466584254|FG001|Overall Study|Withdrawal by Subject|4|||
129626303|NCT02575833|466584255|FG000|Overall Study|Withdrawal by Subject|0|||
129626304|NCT02575833|466584256|FG001|Overall Study|Withdrawal by Subject|1|||
129626305|NCT02575833|466584255|FG000|Overall Study|Lost to Follow-up|1|||
129626306|NCT02575833|466584256|FG001|Overall Study|Lost to Follow-up|0|||
129626307|NCT03093259|466584257|FG000|Overall Study|Adverse Event|1|||
129626308|NCT03093259|466584258|FG001|Overall Study|Adverse Event|0|||
129626309|NCT03093259|466584257|FG000|Overall Study|Withdrawal by Subject|1|||
129626310|NCT03093259|466584258|FG001|Overall Study|Withdrawal by Subject|0|||
129626311|NCT00445146|466584259|FG000|Overall Study|Withdrew Consent|29|||
129626312|NCT00445146|466584259|FG000|Overall Study|Lack of Efficacy|28|||
129626313|NCT00445146|466584259|FG000|Overall Study|Investigator's Discretion|22|||
129626314|NCT00445146|466584259|FG000|Overall Study|Adverse Event|13|||
129626315|NCT00445146|466584259|FG000|Overall Study|Lost to Follow-up|13|||
129626316|NCT00445146|466584259|FG000|Overall Study|Death|9|||
129626317|NCT00445146|466584259|FG000|Overall Study|Protocol Violation|4|||
129626318|NCT00445146|466584259|FG000|Overall Study|Pregnancy|1|||
129626319|NCT00625820|466584260|FG000|Overall Study|Withdrawal by Subject|1|||
129626320|NCT00967330|466584261|FG000|Overall Study|Protocol Violation|3|||
129626321|NCT00967330|466584262|FG001|Overall Study|Protocol Violation|4|||
129626322|NCT00967330|466584261|FG000|Overall Study|Regular|10|||
129626323|NCT00967330|466584262|FG001|Overall Study|Regular|3|||
129626324|NCT00967330|466584261|FG000|Overall Study|Withdrawal by Subject|6|||
129626325|NCT00967330|466584262|FG001|Overall Study|Withdrawal by Subject|0|||
129626326|NCT00967330|466584261|FG000|Overall Study|Lost to Follow-up|1|||
129626327|NCT00967330|466584262|FG001|Overall Study|Lost to Follow-up|1|||
129626328|NCT00967330|466584261|FG000|Overall Study|Death|102|||
129626329|NCT00967330|466584262|FG001|Overall Study|Death|51|||
129626330|NCT00967330|466584261|FG000|Overall Study|Severe protocol deviation|0|||
129626331|NCT00967330|466584262|FG001|Overall Study|Severe protocol deviation|1|||
129626332|NCT03759392|466584263|FG000|Overall Study|Adverse Event|12|||
129626333|NCT03759392|466584264|FG001|Overall Study|Adverse Event|4|||
129626334|NCT03759392|466584263|FG000|Overall Study|Death|2|||
129626335|NCT03759392|466584264|FG001|Overall Study|Death|1|||
129439523|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
129439524|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
129439525|NCT01323634|465906515|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
129439526|NCT01323634|465906516|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
129439527|NCT01323634|465906517|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
129439528|NCT05056987|465906518|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
129439529|NCT05056987|465906519|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
129439530|NCT05056987|465906518|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
129439531|NCT05056987|465906519|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
129439532|NCT02409368|465906520|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
129439533|NCT02409368|465906521|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
129439534|NCT02409368|465906522|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
129439535|NCT02409368|465906523|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
129439536|NCT02409368|465906520|FG000|ECOG Reclassification|Death|1|||
129439537|NCT02409368|465906521|FG001|ECOG Reclassification|Death|5|||
129439538|NCT02409368|465906522|FG002|ECOG Reclassification|Death|0|||
129439539|NCT02409368|465906523|FG003|ECOG Reclassification|Death|0|||
129439540|NCT02409368|465906520|FG000|ECOG Reclassification|Disease Progression|113|||
129439541|NCT02409368|465906521|FG001|ECOG Reclassification|Disease Progression|382|||
129439542|NCT02409368|465906522|FG002|ECOG Reclassification|Disease Progression|70|||
129439543|NCT02409368|465906523|FG003|ECOG Reclassification|Disease Progression|1|||
129439544|NCT02409368|465906520|FG000|ECOG Reclassification|Lost to Follow-up|1|||
129439545|NCT02409368|465906521|FG001|ECOG Reclassification|Lost to Follow-up|5|||
129439546|NCT02409368|465906522|FG002|ECOG Reclassification|Lost to Follow-up|0|||
129439547|NCT02409368|465906523|FG003|ECOG Reclassification|Lost to Follow-up|0|||
129439548|NCT02409368|465906520|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
129439549|NCT02409368|465906521|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
129439550|NCT02409368|465906522|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
129439551|NCT02409368|465906523|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
129439552|NCT02409368|465906520|FG000|ECOG Reclassification|Poor/non-compliance|0|||
129439553|NCT02409368|465906521|FG001|ECOG Reclassification|Poor/non-compliance|3|||
129439554|NCT02409368|465906522|FG002|ECOG Reclassification|Poor/non-compliance|2|||
129439555|NCT02409368|465906523|FG003|ECOG Reclassification|Poor/non-compliance|0|||
129439556|NCT02409368|465906520|FG000|ECOG Reclassification|Study drug toxicity|17|||
129439557|NCT02409368|465906521|FG001|ECOG Reclassification|Study drug toxicity|42|||
129439558|NCT02409368|465906522|FG002|ECOG Reclassification|Study drug toxicity|7|||
129439559|NCT02409368|465906523|FG003|ECOG Reclassification|Study drug toxicity|0|||
129439560|NCT02409368|465906520|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
129439561|NCT02409368|465906521|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
129439562|NCT02409368|465906522|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
129439563|NCT02409368|465906523|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
129439564|NCT02409368|465906520|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
129439565|NCT02409368|465906521|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
129439566|NCT02409368|465906522|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
129439567|NCT02409368|465906523|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
129439568|NCT02409368|465906520|FG000|ECOG Reclassification|Participant withdrew consent|2|||
129439569|NCT02409368|465906521|FG001|ECOG Reclassification|Participant withdrew consent|3|||
129439570|NCT02409368|465906522|FG002|ECOG Reclassification|Participant withdrew consent|4|||
129439571|NCT02409368|465906523|FG003|ECOG Reclassification|Participant withdrew consent|0|||
129439572|NCT02409368|465906520|FG000|ECOG Reclassification|Other Reasons|5|||
129439573|NCT02409368|465906521|FG001|ECOG Reclassification|Other Reasons|26|||
129439574|NCT02409368|465906522|FG002|ECOG Reclassification|Other Reasons|2|||
129439575|NCT02409368|465906523|FG003|ECOG Reclassification|Other Reasons|0|||
129439576|NCT02409368|465906520|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
129439577|NCT02409368|465906521|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
129439578|NCT02409368|465906522|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
129793907|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793908|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
129793909|NCT00745615|467212782|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129793910|NCT00745615|467212783|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
129439579|NCT02409368|465906523|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
129793911|NCT00745615|467212784|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129439580|NCT02041520|465906524|FG000|Overall Study|Adverse Event|2|||
129439581|NCT02041520|465906525|FG001|Overall Study|Adverse Event|1|||
129626336|NCT03759392|466584263|FG000|Overall Study|Withdrawal by Subject|2|||
129626337|NCT03759392|466584264|FG001|Overall Study|Withdrawal by Subject|0|||
129626338|NCT03759392|466584263|FG000|Overall Study|Protocol Violation|2|||
129626339|NCT03759392|466584264|FG001|Overall Study|Protocol Violation|0|||
129793912|NCT00745615|467212785|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129626340|NCT03759392|466584263|FG000|Overall Study|Physician Decision|0|||
129626341|NCT03759392|466584264|FG001|Overall Study|Physician Decision|1|||
129626342|NCT03759392|466584263|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
129626343|NCT03759392|466584264|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
129626344|NCT03759392|466584263|FG000|Overall Study|No longer able to take medicines|1|||
129626345|NCT03759392|466584264|FG001|Overall Study|No longer able to take medicines|0|||
129626346|NCT03759392|466584263|FG000|Overall Study|Stopped taking study drug|1|||
129703027|NCT00363298|466874517|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
129703028|NCT03552029|466874518|FG000|Overall Study|Death|3|||
129703029|NCT03552029|466874519|FG001|Overall Study|Death|0|||
129703030|NCT03552029|466874518|FG000|Overall Study|Adverse Event|1|||
129703031|NCT03552029|466874519|FG001|Overall Study|Adverse Event|0|||
129703032|NCT03552029|466874518|FG000|Overall Study|Lack of Efficacy|0|||
129703033|NCT03552029|466874519|FG001|Overall Study|Lack of Efficacy|2|||
129703034|NCT03552029|466874518|FG000|Overall Study|Physician Decision|0|||
129703035|NCT03552029|466874519|FG001|Overall Study|Physician Decision|1|||
129703036|NCT03552029|466874518|FG000|Overall Study|Study terminated by Sponsor|0|||
129626347|NCT03759392|466584264|FG001|Overall Study|Stopped taking study drug|0|||
129703037|NCT03552029|466874519|FG001|Overall Study|Study terminated by Sponsor|1|||
129703038|NCT03552029|466874518|FG000|Overall Study|Other|0|||
129703039|NCT03552029|466874519|FG001|Overall Study|Other|2|||
129439582|NCT02041520|465906524|FG000|Overall Study|Withdrawal by Subject|3|||
129439583|NCT02041520|465906525|FG001|Overall Study|Withdrawal by Subject|4|||
129439584|NCT02041520|465906524|FG000|Overall Study|Protocol Violation|1|||
129439585|NCT02041520|465906525|FG001|Overall Study|Protocol Violation|0|||
129439586|NCT02041520|465906524|FG000|Overall Study|Lost to Follow-up|0|||
129439587|NCT02041520|465906525|FG001|Overall Study|Lost to Follow-up|1|||
129439588|NCT02041520|465906524|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
129439589|NCT02041520|465906525|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
129439590|NCT01759407|465906528|FG000|Overall Study|Protocol Violation|0|||
129439591|NCT01759407|465906529|FG001|Overall Study|Protocol Violation|2|||
129439592|NCT02678247|465906530|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
129439593|NCT02678247|465906531|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
129439594|NCT02678247|465906530|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
129439595|NCT02678247|465906531|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
129439596|NCT02678247|465906530|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
129439597|NCT02678247|465906531|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
129439598|NCT02678247|465906530|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
129439599|NCT02678247|465906531|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
129439600|NCT02678247|465906530|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
129439601|NCT02678247|465906531|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
129439602|NCT02678247|465906530|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
129439603|NCT02678247|465906531|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
129439604|NCT00026208|465906532|FG000|Overall Study|Complications of auto accident|1|||
129439605|NCT00026208|465906533|FG001|Overall Study|Complications of auto accident|0|||
129439606|NCT02225353|465906534|FG000|Overall Study|Lost to Follow-up|0|||
129439607|NCT02225353|465906535|FG001|Overall Study|Lost to Follow-up|1|||
129439608|NCT02225353|465906536|FG002|Overall Study|Lost to Follow-up|3|||
129439609|NCT02225353|465906534|FG000|Overall Study|Protocol Violation|4|||
129439610|NCT02225353|465906535|FG001|Overall Study|Protocol Violation|5|||
129439611|NCT02225353|465906536|FG002|Overall Study|Protocol Violation|12|||
129439612|NCT03604523|465906537|FG000|Overall Study|Physician Decision|1|||
129439613|NCT03604523|465906538|FG001|Overall Study|Physician Decision|0|||
129439614|NCT03442114|465906542|FG000|Overall Study|Lost to Follow-up|13|||
129439615|NCT03442114|465906543|FG001|Overall Study|Lost to Follow-up|13|||
129439616|NCT03442114|465906542|FG000|Overall Study|Physician Decision|2|||
129439617|NCT03442114|465906543|FG001|Overall Study|Physician Decision|2|||
129439618|NCT03442114|465906542|FG000|Overall Study|Protocol Violation|0|||
129439619|NCT03442114|465906543|FG001|Overall Study|Protocol Violation|2|||
129439620|NCT03442114|465906542|FG000|Overall Study|Withdrawal by Subject|1|||
129439621|NCT03442114|465906543|FG001|Overall Study|Withdrawal by Subject|3|||
129439622|NCT03442114|465906542|FG000|Overall Study|Guardianship Change|0|||
129439623|NCT03442114|465906543|FG001|Overall Study|Guardianship Change|1|||
129439624|NCT02903368|465906544|FG000|Part 1|Adverse Event|3|||
129439625|NCT02903368|465906545|FG001|Part 1|Adverse Event|0|||
129439626|NCT02903368|465906546|FG002|Part 1|Adverse Event|0|||
129439627|NCT02903368|465906547|FG003|Part 1|Adverse Event|0|||
129439628|NCT02903368|465906544|FG000|Part 1|Withdrawal by Subject|1|||
129888785|NCT01009047|467550898|FG000|Overall Study|Withdrawal by consent|16|||
129888786|NCT01009047|467550899|FG001|Overall Study|Withdrawal by consent|11|||
129439629|NCT02903368|465906545|FG001|Part 1|Withdrawal by Subject|0|||
129703040|NCT03468998|466874525|FG000|Overall Study|Withdrawal by Subject|1|||
129703041|NCT03468998|466874526|FG001|Overall Study|Withdrawal by Subject|1|||
129703042|NCT03468998|466874527|FG002|Overall Study|Withdrawal by Subject|0|||
129703043|NCT03468998|466874528|FG003|Overall Study|Withdrawal by Subject|4|||
129703044|NCT03468998|466874529|FG004|Overall Study|Withdrawal by Subject|1|||
129703045|NCT03468998|466874530|FG005|Overall Study|Withdrawal by Subject|0|||
129703046|NCT00836706|466874533|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
129703047|NCT00836706|466874534|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
129703048|NCT02989857|466874535|FG000|Randomization Phase|Not Treated|3|||
129703049|NCT02989857|466874536|FG001|Randomization Phase|Not Treated|2|||
129703050|NCT02989857|466874537|FG002|Randomization Phase|Not Treated|0|||
129703051|NCT00633126|466874542|FG000|Overall Study|Did not receive full dose|1|||
129703052|NCT02538614|466874555|FG000|Overall Study|Progressive Disease|2|||
129703053|NCT01425814|466874560|FG000|Period 1|Stability criteria not fulfilled|0|||
129703054|NCT01425814|466874561|FG001|Period 1|Stability criteria not fulfilled|1|||
129703055|NCT01425814|466874562|FG002|Period 1|Stability criteria not fulfilled|0|||
129703056|NCT01425814|466874563|FG003|Period 1|Stability criteria not fulfilled|0|||
129703057|NCT01425814|466874564|FG004|Period 1|Stability criteria not fulfilled|0|||
129888787|NCT01009047|467550898|FG000|Overall Study|Other|3|||
129439630|NCT02903368|465906546|FG002|Part 1|Withdrawal by Subject|0|||
129439631|NCT02903368|465906547|FG003|Part 1|Withdrawal by Subject|0|||
129439632|NCT02903368|465906544|FG000|Part 2|Adverse Event|0|||
129439633|NCT02903368|465906545|FG001|Part 2|Adverse Event|0|||
129439634|NCT02903368|465906546|FG002|Part 2|Adverse Event|5|||
129439635|NCT02903368|465906547|FG003|Part 2|Adverse Event|0|||
129439636|NCT02903368|465906544|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
129439637|NCT02903368|465906545|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
129703058|NCT01425814|466874565|FG005|Period 1|Stability criteria not fulfilled|0|||
129703059|NCT01425814|466874560|FG000|Period 2|Stability criteria not fulfilled|0|||
129703060|NCT01425814|466874561|FG001|Period 2|Stability criteria not fulfilled|1|||
129703061|NCT01425814|466874562|FG002|Period 2|Stability criteria not fulfilled|0|||
129703062|NCT01425814|466874563|FG003|Period 2|Stability criteria not fulfilled|0|||
129703063|NCT01425814|466874564|FG004|Period 2|Stability criteria not fulfilled|0|||
129703064|NCT01425814|466874565|FG005|Period 2|Stability criteria not fulfilled|0|||
129703065|NCT01425814|466874560|FG000|Period 3|Adverse Event|0|||
129703066|NCT01425814|466874561|FG001|Period 3|Adverse Event|0|||
129703067|NCT01425814|466874562|FG002|Period 3|Adverse Event|0|||
129703068|NCT01425814|466874563|FG003|Period 3|Adverse Event|0|||
129703069|NCT01425814|466874564|FG004|Period 3|Adverse Event|0|||
129703070|NCT01425814|466874565|FG005|Period 3|Adverse Event|1|||
129703071|NCT01425814|466874560|FG000|Period 4|Adverse Event|1|||
129703072|NCT01425814|466874561|FG001|Period 4|Adverse Event|0|||
129703073|NCT01425814|466874562|FG002|Period 4|Adverse Event|1|||
129703074|NCT01425814|466874563|FG003|Period 4|Adverse Event|0|||
129439638|NCT02903368|465906546|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
129439639|NCT02903368|465906547|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
129439640|NCT02903368|465906544|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
129439641|NCT02903368|465906545|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
129439642|NCT02903368|465906546|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
129439643|NCT02903368|465906547|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
129439644|NCT02903368|465906544|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
129439645|NCT02903368|465906545|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
129439646|NCT02903368|465906546|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
129439647|NCT02903368|465906547|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
129439648|NCT02544217|465909433|FG000|Overall Study|Withdrawal by Subject|1|||
129439649|NCT02544217|465909434|FG001|Overall Study|Withdrawal by Subject|1|||
129439650|NCT02544217|465909435|FG002|Overall Study|Withdrawal by Subject|0|||
129439651|NCT02544217|465909436|FG003|Overall Study|Withdrawal by Subject|0|||
129439652|NCT02544217|465909437|FG004|Overall Study|Withdrawal by Subject|0|||
129439653|NCT02544217|465909438|FG005|Overall Study|Withdrawal by Subject|0|||
129439654|NCT02901041|465909441|FG000|Overall Study|Withdrawal by PI|4|||
129439655|NCT02901041|465909442|FG001|Overall Study|Withdrawal by PI|8|||
129439656|NCT02901041|465909441|FG000|Overall Study|Withdrawal by Subject|7|||
129439657|NCT02901041|465909442|FG001|Overall Study|Withdrawal by Subject|3|||
129439658|NCT00975507|465909446|FG000|Overall Study|Adverse Event|1|||
129439659|NCT00975507|465909447|FG001|Overall Study|Adverse Event|0|||
129439660|NCT00975507|465909446|FG000|Overall Study|Lost to Follow-up|7|||
129439661|NCT00975507|465909447|FG001|Overall Study|Lost to Follow-up|1|||
129439662|NCT00975507|465909446|FG000|Overall Study|Protocol Violation|2|||
129439663|NCT00975507|465909447|FG001|Overall Study|Protocol Violation|0|||
129439664|NCT00975507|465909446|FG000|Overall Study|Withdrawal by Subject|10|||
129439665|NCT00975507|465909447|FG001|Overall Study|Withdrawal by Subject|3|||
129439666|NCT03249714|465909448|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
129439667|NCT03249714|465909449|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
129439668|NCT03249714|465909448|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
129439669|NCT03249714|465909449|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
129439670|NCT03249714|465909448|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
129439671|NCT03249714|465909449|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
129439672|NCT03249714|465909448|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
129439673|NCT03249714|465909449|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
129439674|NCT01112306|465909452|FG000|Overall Study|Death|175|||
129439675|NCT01112306|465909452|FG000|Overall Study|Lost to Follow-up|9|||
129703075|NCT01425814|466874564|FG004|Period 4|Adverse Event|0|||
129703076|NCT01425814|466874565|FG005|Period 4|Adverse Event|0|||
129703077|NCT01425814|466874560|FG000|Period 5|Stability criteria not fulfilled|0|||
129439676|NCT01112306|465909452|FG000|Overall Study|Withdrawal by Subject|31|||
129439677|NCT01112306|465909452|FG000|Overall Study|Other|70|||
129439678|NCT01607554|465909454|FG000|Overall Study|Disease progression|2|||
129439679|NCT03952806|465909455|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
129439680|NCT03952806|465909456|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
129439681|NCT03952806|465909455|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
129439682|NCT03952806|465909456|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
129439683|NCT03952806|465909455|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
129439684|NCT03952806|465909456|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
129439685|NCT03952806|465909455|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
129439686|NCT03952806|465909456|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
129439687|NCT03952806|465909455|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
129439688|NCT03952806|465909456|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
129439689|NCT03952806|465909455|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
129439690|NCT03952806|465909456|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
129439691|NCT03952806|465909455|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
129439692|NCT03952806|465909456|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
129439693|NCT03952806|465909455|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
129439694|NCT03952806|465909456|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
129439695|NCT03952806|465909455|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
129439696|NCT03952806|465909456|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
129439697|NCT03952806|465909455|FG000|OLE Phase (48 Weeks)|Other|16|||
129439698|NCT03952806|465909456|FG001|OLE Phase (48 Weeks)|Other|13|||
129439699|NCT00655863|465909457|FG000|Overall Study|Lost to Follow-up|0|||
129439700|NCT00655863|465909458|FG001|Overall Study|Lost to Follow-up|0|||
129439701|NCT00655863|465909459|FG002|Overall Study|Lost to Follow-up|1|||
129439702|NCT01138007|465909460|FG000|Overall Study|Adverse Event|4|||
129439703|NCT01138007|465909461|FG001|Overall Study|Adverse Event|12|||
129439704|NCT01138007|465909462|FG002|Overall Study|Adverse Event|9|||
129439705|NCT01138007|465909460|FG000|Overall Study|Lack of Efficacy|2|||
129439706|NCT01138007|465909461|FG001|Overall Study|Lack of Efficacy|0|||
129439707|NCT01138007|465909462|FG002|Overall Study|Lack of Efficacy|6|||
129439708|NCT01138007|465909460|FG000|Overall Study|Protocol Violation|2|||
129626348|NCT02623725|466584265|FG000|Overall Study|Non compliance with protocol|9|||
129439709|NCT01138007|465909461|FG001|Overall Study|Protocol Violation|3|||
129439710|NCT01138007|465909462|FG002|Overall Study|Protocol Violation|2|||
129439711|NCT01138007|465909460|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
129439712|NCT01138007|465909461|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
129439713|NCT01138007|465909462|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
129439714|NCT01138007|465909460|FG000|Overall Study|Lost to Follow-up|3|||
129439715|NCT01138007|465909461|FG001|Overall Study|Lost to Follow-up|3|||
129439716|NCT01138007|465909462|FG002|Overall Study|Lost to Follow-up|5|||
129439717|NCT01138007|465909460|FG000|Overall Study|Physician Decision|0|||
129439718|NCT01138007|465909461|FG001|Overall Study|Physician Decision|5|||
129439719|NCT01138007|465909462|FG002|Overall Study|Physician Decision|3|||
129439720|NCT01138007|465909460|FG000|Overall Study|Withdrawal by Subject|5|||
129439721|NCT01138007|465909461|FG001|Overall Study|Withdrawal by Subject|6|||
129439722|NCT01138007|465909462|FG002|Overall Study|Withdrawal by Subject|15|||
129439723|NCT04661878|465909463|FG000|Overall Study|Lost to Follow-up|6|||
129626349|NCT02623725|466584266|FG001|Overall Study|Non compliance with protocol|3|||
129626350|NCT02623725|466584265|FG000|Overall Study|Serious adverse event|0|||
129626351|NCT02623725|466584266|FG001|Overall Study|Serious adverse event|2|||
129626352|NCT02623725|466584265|FG000|Overall Study|Withdrawal by Subject|7|||
129626353|NCT02623725|466584266|FG001|Overall Study|Withdrawal by Subject|1|||
129626354|NCT02848001|466586857|FG000|Overall Study|other reasons|0|||
129626355|NCT02848001|466586858|FG001|Overall Study|other reasons|0|||
129626356|NCT02848001|466586859|FG002|Overall Study|other reasons|1|||
129626357|NCT02848001|466586860|FG003|Overall Study|other reasons|0|||
129626358|NCT02848001|466586861|FG004|Overall Study|other reasons|4|||
129626359|NCT02848001|466586862|FG005|Overall Study|other reasons|1|||
129626360|NCT02848001|466586863|FG006|Overall Study|other reasons|0|||
129439724|NCT04661878|465909464|FG001|Overall Study|Lost to Follow-up|5|||
129439725|NCT04442737|465909471|FG000|Overall Study|Lost to Follow-up|1|||
129439726|NCT04442737|465909472|FG001|Overall Study|Lost to Follow-up|3|||
129439727|NCT04442737|465909471|FG000|Overall Study|Withdrawal by Subject|3|||
129439728|NCT04442737|465909472|FG001|Overall Study|Withdrawal by Subject|2|||
129439729|NCT04442737|465909471|FG000|Overall Study|Adverse Event|3|||
129439730|NCT04442737|465909472|FG001|Overall Study|Adverse Event|2|||
129439731|NCT04442737|465909471|FG000|Overall Study|Death|0|||
129439732|NCT04442737|465909472|FG001|Overall Study|Death|1|||
129439733|NCT04442737|465909471|FG000|Overall Study|Protocol Violation|0|||
129439734|NCT04442737|465909472|FG001|Overall Study|Protocol Violation|2|||
129439735|NCT04442737|465909471|FG000|Overall Study|Other|1|||
129626361|NCT02848001|466586864|FG007|Overall Study|other reasons|2|||
129626362|NCT02848001|466586865|FG008|Overall Study|other reasons|2|||
129626363|NCT02848001|466586866|FG009|Overall Study|other reasons|3|||
129439736|NCT04442737|465909472|FG001|Overall Study|Other|1|||
129439737|NCT00744523|465909473|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
129439738|NCT00744523|465909474|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
129439739|NCT05333224|465909477|FG000|Overall Study - Infants|Lost to Follow-up|1|||
129439740|NCT05333224|465909478|FG001|Overall Study - Infants|Lost to Follow-up|1|||
129439741|NCT00063154|465909479|FG000|Overall Study|Disease progression|27|||
129439742|NCT00063154|465909479|FG000|Overall Study|Adverse Event|2|||
129439743|NCT00063154|465909479|FG000|Overall Study|Physician Decision|10|||
129439744|NCT00063154|465909479|FG000|Overall Study|Death|3|||
129439745|NCT00063154|465909479|FG000|Overall Study|Reason unspecified|1|||
129793913|NCT00745615|467212786|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129793914|NCT00745615|467212787|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
129793915|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793916|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793917|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793918|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
129793919|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
129793920|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
129793921|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793922|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793923|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793924|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
129793925|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
129793926|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
129793927|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793928|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793929|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793930|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
129793931|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
129793932|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
129793933|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793934|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793935|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793936|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
129793937|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
129793938|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
129793939|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793940|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793941|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793942|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
129793943|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
129793944|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
129793945|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793946|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793947|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793948|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
129793949|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
129793950|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
129793951|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793952|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793953|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793954|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793955|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
129793956|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
129793957|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793958|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
129439746|NCT00063154|465909479|FG000|Overall Study|Did not receive treatment|8|||
129439747|NCT03588728|465909480|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
129793959|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793960|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793961|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
129793962|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
129793963|NCT00745615|467212782|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129888788|NCT01009047|467550899|FG001|Overall Study|Other|2|||
129439748|NCT03588728|465909481|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
129439749|NCT03588728|465909482|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
129439750|NCT03588728|465909483|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
129626364|NCT02848001|466586867|FG010|Overall Study|other reasons|0|||
129793964|NCT00745615|467212783|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129793965|NCT00745615|467212784|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129793966|NCT00745615|467212785|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
129793967|NCT00745615|467212786|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
129793968|NCT00745615|467212787|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
129793969|NCT01163032|467212791|FG000|Randomization Phase|Withdrawal by Subject|2|||
129793970|NCT01163032|467212792|FG001|Randomization Phase|Withdrawal by Subject|3|||
129793971|NCT01163032|467212793|FG002|Randomization Phase|Withdrawal by Subject|0|||
129793972|NCT01163032|467212791|FG000|Randomization Phase|Adverse Event|3|||
129793973|NCT01163032|467212792|FG001|Randomization Phase|Adverse Event|3|||
129793974|NCT01163032|467212793|FG002|Randomization Phase|Adverse Event|0|||
129793975|NCT01163032|467212791|FG000|Randomization Phase|Protocol Violation|0|||
129793976|NCT01163032|467212792|FG001|Randomization Phase|Protocol Violation|1|||
129793977|NCT01163032|467212793|FG002|Randomization Phase|Protocol Violation|0|||
129793978|NCT01163032|467212791|FG000|Randomization Phase|Various*|5|||
129793979|NCT01163032|467212792|FG001|Randomization Phase|Various*|4|||
129793980|NCT01163032|467212793|FG002|Randomization Phase|Various*|0|||
129793981|NCT01163032|467212791|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
129793982|NCT01163032|467212792|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
129793983|NCT01163032|467212793|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
129793984|NCT01163032|467212791|FG000|Open Label Extension Phase|Adverse Event|0|||
129793985|NCT01163032|467212792|FG001|Open Label Extension Phase|Adverse Event|0|||
129793986|NCT01163032|467212793|FG002|Open Label Extension Phase|Adverse Event|3|||
129439751|NCT03588728|465909480|FG000|Overall Study|Lab shut down due to COVID-19|0|||
129793987|NCT01163032|467212791|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
129793988|NCT01163032|467212792|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
129793989|NCT01163032|467212793|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
129793990|NCT01163032|467212791|FG000|Open Label Extension Phase|Protocol Violation|0|||
129439752|NCT03588728|465909481|FG001|Overall Study|Lab shut down due to COVID-19|0|||
129793991|NCT01163032|467212792|FG001|Open Label Extension Phase|Protocol Violation|0|||
129793992|NCT01163032|467212793|FG002|Open Label Extension Phase|Protocol Violation|1|||
129793993|NCT01163032|467212791|FG000|Open Label Extension Phase|Study Termination|0|||
129793994|NCT01163032|467212792|FG001|Open Label Extension Phase|Study Termination|0|||
129793995|NCT01163032|467212793|FG002|Open Label Extension Phase|Study Termination|7|||
129793996|NCT01163032|467212791|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
129793997|NCT01163032|467212792|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
129793998|NCT01163032|467212793|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
129793999|NCT01307020|467212796|FG000|Overall Study|Lost to Follow-up|0|||
129794000|NCT01307020|467212797|FG001|Overall Study|Lost to Follow-up|0|||
129794001|NCT01307020|467212798|FG002|Overall Study|Lost to Follow-up|1|||
129794002|NCT01307020|467212799|FG003|Overall Study|Lost to Follow-up|1|||
129794003|NCT01307020|467212800|FG004|Overall Study|Lost to Follow-up|0|||
129794004|NCT01307020|467212801|FG005|Overall Study|Lost to Follow-up|0|||
129794005|NCT01307020|467212802|FG006|Overall Study|Lost to Follow-up|1|||
129794006|NCT01307020|467212803|FG007|Overall Study|Lost to Follow-up|0|||
129794007|NCT01307020|467212804|FG008|Overall Study|Lost to Follow-up|0|||
129794008|NCT01307020|467212805|FG009|Overall Study|Lost to Follow-up|0|||
129794009|NCT01307020|467212796|FG000|Overall Study|Electronic data capture failure|0|||
129794010|NCT01307020|467212797|FG001|Overall Study|Electronic data capture failure|1|||
129794011|NCT01307020|467212798|FG002|Overall Study|Electronic data capture failure|0|||
129794012|NCT01307020|467212799|FG003|Overall Study|Electronic data capture failure|0|||
129794013|NCT01307020|467212800|FG004|Overall Study|Electronic data capture failure|0|||
129794014|NCT01307020|467212801|FG005|Overall Study|Electronic data capture failure|0|||
129794015|NCT01307020|467212802|FG006|Overall Study|Electronic data capture failure|0|||
129794016|NCT01307020|467212803|FG007|Overall Study|Electronic data capture failure|0|||
129794017|NCT01307020|467212804|FG008|Overall Study|Electronic data capture failure|0|||
129794018|NCT01307020|467212805|FG009|Overall Study|Electronic data capture failure|0|||
129626365|NCT02848001|466586868|FG011|Overall Study|other reasons|1|||
129626366|NCT02848001|466586869|FG012|Overall Study|other reasons|1|||
129626367|NCT02848001|466586870|FG013|Overall Study|other reasons|0|||
129439753|NCT03588728|465909482|FG002|Overall Study|Lab shut down due to COVID-19|0|||
129439754|NCT03588728|465909483|FG003|Overall Study|Lab shut down due to COVID-19|1|||
129439755|NCT03588728|465909480|FG000|Overall Study|multiple technical issues|1|||
129439756|NCT03588728|465909481|FG001|Overall Study|multiple technical issues|0|||
129439757|NCT03588728|465909482|FG002|Overall Study|multiple technical issues|0|||
129439758|NCT03588728|465909483|FG003|Overall Study|multiple technical issues|0|||
129439759|NCT03588728|465909480|FG000|Overall Study|Hospitalized for COVID|1|||
129439760|NCT03588728|465909481|FG001|Overall Study|Hospitalized for COVID|0|||
129439761|NCT03588728|465909482|FG002|Overall Study|Hospitalized for COVID|0|||
129439762|NCT03588728|465909483|FG003|Overall Study|Hospitalized for COVID|0|||
129439763|NCT03588728|465909480|FG000|Overall Study|Schedule change unable to attend sessions|1|||
129439764|NCT03588728|465909481|FG001|Overall Study|Schedule change unable to attend sessions|0|||
129626368|NCT02848001|466586871|FG014|Overall Study|other reasons|0|||
129626369|NCT02848001|466586872|FG015|Overall Study|other reasons|2|||
129626370|NCT02848001|466586873|FG016|Overall Study|other reasons|1|||
129626371|NCT02848001|466586857|FG000|Overall Study|Lack of Efficacy|0|||
129626372|NCT02848001|466586858|FG001|Overall Study|Lack of Efficacy|1|||
129626373|NCT02848001|466586859|FG002|Overall Study|Lack of Efficacy|1|||
129626374|NCT02848001|466586860|FG003|Overall Study|Lack of Efficacy|2|||
129626375|NCT02848001|466586861|FG004|Overall Study|Lack of Efficacy|3|||
129626376|NCT02848001|466586862|FG005|Overall Study|Lack of Efficacy|0|||
129626377|NCT02848001|466586863|FG006|Overall Study|Lack of Efficacy|1|||
129626378|NCT02848001|466586864|FG007|Overall Study|Lack of Efficacy|0|||
129626379|NCT02848001|466586865|FG008|Overall Study|Lack of Efficacy|0|||
129626380|NCT02848001|466586866|FG009|Overall Study|Lack of Efficacy|1|||
129626381|NCT02848001|466586867|FG010|Overall Study|Lack of Efficacy|0|||
129626382|NCT02848001|466586868|FG011|Overall Study|Lack of Efficacy|2|||
129626383|NCT02848001|466586869|FG012|Overall Study|Lack of Efficacy|0|||
129626384|NCT02848001|466586870|FG013|Overall Study|Lack of Efficacy|2|||
129626385|NCT02848001|466586871|FG014|Overall Study|Lack of Efficacy|2|||
129626386|NCT02848001|466586872|FG015|Overall Study|Lack of Efficacy|0|||
129626387|NCT02848001|466586873|FG016|Overall Study|Lack of Efficacy|0|||
129626388|NCT02848001|466586857|FG000|Overall Study|Progressive Disease|2|||
129626389|NCT02848001|466586858|FG001|Overall Study|Progressive Disease|1|||
129626390|NCT02848001|466586859|FG002|Overall Study|Progressive Disease|0|||
129626391|NCT02848001|466586860|FG003|Overall Study|Progressive Disease|4|||
129626392|NCT02848001|466586861|FG004|Overall Study|Progressive Disease|3|||
129626393|NCT02848001|466586862|FG005|Overall Study|Progressive Disease|0|||
129626394|NCT02848001|466586863|FG006|Overall Study|Progressive Disease|4|||
129626395|NCT02848001|466586864|FG007|Overall Study|Progressive Disease|1|||
129626396|NCT02848001|466586865|FG008|Overall Study|Progressive Disease|0|||
129626397|NCT02848001|466586866|FG009|Overall Study|Progressive Disease|2|||
129626398|NCT02848001|466586867|FG010|Overall Study|Progressive Disease|3|||
129626399|NCT02848001|466586868|FG011|Overall Study|Progressive Disease|2|||
129626400|NCT02848001|466586869|FG012|Overall Study|Progressive Disease|1|||
129626401|NCT02848001|466586870|FG013|Overall Study|Progressive Disease|0|||
129626402|NCT02848001|466586871|FG014|Overall Study|Progressive Disease|2|||
129626403|NCT02848001|466586872|FG015|Overall Study|Progressive Disease|4|||
129626404|NCT02848001|466586873|FG016|Overall Study|Progressive Disease|0|||
129626405|NCT02848001|466586857|FG000|Overall Study|Adverse Event|0|||
129626406|NCT02848001|466586858|FG001|Overall Study|Adverse Event|0|||
129626407|NCT02848001|466586859|FG002|Overall Study|Adverse Event|0|||
129626408|NCT02848001|466586860|FG003|Overall Study|Adverse Event|0|||
129626409|NCT02848001|466586861|FG004|Overall Study|Adverse Event|2|||
129626410|NCT02848001|466586862|FG005|Overall Study|Adverse Event|0|||
129626411|NCT02848001|466586863|FG006|Overall Study|Adverse Event|0|||
129626412|NCT02848001|466586864|FG007|Overall Study|Adverse Event|0|||
129626413|NCT02848001|466586865|FG008|Overall Study|Adverse Event|0|||
129626414|NCT02848001|466586866|FG009|Overall Study|Adverse Event|1|||
129703078|NCT01425814|466874561|FG001|Period 5|Stability criteria not fulfilled|0|||
129626415|NCT02848001|466586867|FG010|Overall Study|Adverse Event|0|||
129626416|NCT02848001|466586868|FG011|Overall Study|Adverse Event|1|||
129703079|NCT01425814|466874562|FG002|Period 5|Stability criteria not fulfilled|1|||
129439765|NCT03588728|465909482|FG002|Overall Study|Schedule change unable to attend sessions|0|||
129626417|NCT02848001|466586869|FG012|Overall Study|Adverse Event|1|||
129626418|NCT02848001|466586870|FG013|Overall Study|Adverse Event|0|||
129626419|NCT02848001|466586871|FG014|Overall Study|Adverse Event|2|||
129626420|NCT02848001|466586872|FG015|Overall Study|Adverse Event|0|||
129626421|NCT02848001|466586873|FG016|Overall Study|Adverse Event|0|||
129626422|NCT02848001|466586857|FG000|Overall Study|Death|0|||
129626423|NCT02848001|466586858|FG001|Overall Study|Death|0|||
129626424|NCT02848001|466586859|FG002|Overall Study|Death|0|||
129626425|NCT02848001|466586860|FG003|Overall Study|Death|1|||
129626426|NCT02848001|466586861|FG004|Overall Study|Death|3|||
129626427|NCT02848001|466586862|FG005|Overall Study|Death|1|||
129703080|NCT01425814|466874563|FG003|Period 5|Stability criteria not fulfilled|0|||
129626428|NCT02848001|466586863|FG006|Overall Study|Death|2|||
129626429|NCT02848001|466586864|FG007|Overall Study|Death|3|||
129626430|NCT02848001|466586865|FG008|Overall Study|Death|4|||
129626431|NCT02848001|466586866|FG009|Overall Study|Death|1|||
129439766|NCT03588728|465909483|FG003|Overall Study|Schedule change unable to attend sessions|0|||
129439767|NCT02027701|465909484|FG000|Overall Study|Adverse Event|3|||
129439768|NCT02027701|465909484|FG000|Overall Study|Lack of Efficacy|8|||
129439769|NCT02027701|465909484|FG000|Overall Study|Physician Decision|2|||
129439770|NCT02027701|465909484|FG000|Overall Study|Withdrawal by Subject|3|||
129439771|NCT02982187|465909485|FG000|Overall Study|Withdrawal by Subject|0|||
129439772|NCT02982187|465909486|FG001|Overall Study|Withdrawal by Subject|0|||
129439773|NCT02982187|465909487|FG002|Overall Study|Withdrawal by Subject|0|||
129439774|NCT02982187|465909488|FG003|Overall Study|Withdrawal by Subject|0|||
129439775|NCT02982187|465909489|FG004|Overall Study|Withdrawal by Subject|0|||
129439776|NCT02982187|465909490|FG005|Overall Study|Withdrawal by Subject|0|||
129439777|NCT02982187|465909491|FG006|Overall Study|Withdrawal by Subject|1|||
129439778|NCT02982187|465909492|FG007|Overall Study|Withdrawal by Subject|0|||
129439779|NCT00887679|465909493|FG000|Overall Study|Withdrawal by Subject|1|||
129439780|NCT00887679|465909493|FG000|Overall Study|Lost to Follow-up|4|||
129439781|NCT00887679|465909493|FG000|Overall Study|Physician Decision|5|||
129439782|NCT01026454|465909494|FG000|Second Intervention|Pregnancy|1|||
129439783|NCT01026454|465909495|FG001|Second Intervention|Pregnancy|1|||
129439784|NCT00394953|465909496|FG000|First Treatment Period|Adverse Event|1|||
129439785|NCT00394953|465909497|FG001|First Treatment Period|Adverse Event|2|||
129439786|NCT00394953|465909496|FG000|First Treatment Period|Death|6|||
129439787|NCT00394953|465909497|FG001|First Treatment Period|Death|7|||
129439788|NCT00394953|465909496|FG000|First Treatment Period|Lack of Efficacy|1|||
129439789|NCT00394953|465909497|FG001|First Treatment Period|Lack of Efficacy|1|||
129439790|NCT00394953|465909496|FG000|First Treatment Period|Withdrawal by Subject|6|||
129703081|NCT01425814|466874564|FG004|Period 5|Stability criteria not fulfilled|0|||
129703082|NCT01425814|466874565|FG005|Period 5|Stability criteria not fulfilled|1|||
129703083|NCT00565747|466874567|FG000|Overall Study|No embryo transfer|67|||
129703084|NCT00565747|466874568|FG001|Overall Study|No embryo transfer|73|||
129703085|NCT02684461|466874571|FG000|Overall Study|Adverse Event|1|||
129703086|NCT02684461|466874572|FG001|Overall Study|Adverse Event|0|||
129703087|NCT02684461|466874573|FG002|Overall Study|Adverse Event|0|||
129703088|NCT02684461|466874571|FG000|Overall Study|Lack of Efficacy|1|||
129703089|NCT02684461|466874572|FG001|Overall Study|Lack of Efficacy|2|||
129703090|NCT02684461|466874573|FG002|Overall Study|Lack of Efficacy|0|||
129703091|NCT02390076|466874574|FG000|Overall Study|Lost to Follow-up|2|||
129703092|NCT02390076|466874575|FG001|Overall Study|Lost to Follow-up|1|||
129703093|NCT02390076|466874576|FG002|Overall Study|Lost to Follow-up|4|||
129703094|NCT01358734|466874582|FG000|Overall Study|Adverse Event|4|||
129703095|NCT01358734|466874583|FG001|Overall Study|Adverse Event|7|||
129703096|NCT01358734|466874584|FG002|Overall Study|Adverse Event|3|||
129703097|NCT01358734|466874582|FG000|Overall Study|Lack of Efficacy|0|||
129703098|NCT01358734|466874583|FG001|Overall Study|Lack of Efficacy|1|||
129703099|NCT01358734|466874584|FG002|Overall Study|Lack of Efficacy|3|||
129703100|NCT01358734|466874582|FG000|Overall Study|Withdrawal by Subject|1|||
129703101|NCT01358734|466874583|FG001|Overall Study|Withdrawal by Subject|6|||
129703102|NCT01358734|466874584|FG002|Overall Study|Withdrawal by Subject|3|||
129703103|NCT01358734|466874582|FG000|Overall Study|Death|3|||
129703104|NCT01358734|466874583|FG001|Overall Study|Death|7|||
129703105|NCT01358734|466874584|FG002|Overall Study|Death|2|||
129703106|NCT01358734|466874582|FG000|Overall Study|Progressive Disease|5|||
129703107|NCT01358734|466874583|FG001|Overall Study|Progressive Disease|13|||
129703108|NCT01358734|466874584|FG002|Overall Study|Progressive Disease|16|||
129703109|NCT01358734|466874582|FG000|Overall Study|Non-compliance with study drug|0|||
129703110|NCT01358734|466874583|FG001|Overall Study|Non-compliance with study drug|0|||
129703111|NCT01358734|466874584|FG002|Overall Study|Non-compliance with study drug|1|||
129703112|NCT01358734|466874582|FG000|Overall Study|Other|2|||
129703113|NCT01358734|466874583|FG001|Overall Study|Other|5|||
129703114|NCT01358734|466874584|FG002|Overall Study|Other|4|||
129703115|NCT01358734|466874582|FG000|Overall Study|Protocol Violation|0|||
129703116|NCT01358734|466874583|FG001|Overall Study|Protocol Violation|0|||
129703117|NCT01358734|466874584|FG002|Overall Study|Protocol Violation|2|||
129703118|NCT03243084|466874588|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
129703119|NCT03243084|466874589|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
129703120|NCT02300233|466874590|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
129703121|NCT02300233|466874591|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
129703122|NCT02300233|466874592|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
129703123|NCT02300233|466874590|FG000|Overall Study|Withdrawal by Subject|1|||
129703124|NCT02300233|466874591|FG001|Overall Study|Withdrawal by Subject|0|||
129703125|NCT02300233|466874592|FG002|Overall Study|Withdrawal by Subject|3|||
129703126|NCT02300233|466874590|FG000|Overall Study|Investigator Judgement|0|||
129794019|NCT02380690|467212806|FG000|Overall Study|Lost to Follow-up|14|||
129626432|NCT02848001|466586867|FG010|Overall Study|Death|0|||
129794020|NCT02380690|467212807|FG001|Overall Study|Lost to Follow-up|4|||
129794021|NCT02380690|467212806|FG000|Overall Study|Withdrawal by Subject|20|||
129794022|NCT02380690|467212807|FG001|Overall Study|Withdrawal by Subject|8|||
129794023|NCT00727532|467212808|FG000|Overall Study|Adverse Event|1|||
129794024|NCT00727532|467212808|FG000|Overall Study|Withdrawal by Subject|1|||
129794025|NCT00829933|467212809|FG000|Overall Study|Adverse Event|2|||
129794026|NCT00829933|467212810|FG001|Overall Study|Adverse Event|3|||
129794027|NCT00829933|467212811|FG002|Overall Study|Adverse Event|2|||
129794028|NCT00829933|467212812|FG003|Overall Study|Adverse Event|1|||
129794029|NCT00829933|467212809|FG000|Overall Study|Death|0|||
129794030|NCT00829933|467212810|FG001|Overall Study|Death|0|||
129794031|NCT00829933|467212811|FG002|Overall Study|Death|1|||
129794032|NCT00829933|467212812|FG003|Overall Study|Death|1|||
129794033|NCT00829933|467212809|FG000|Overall Study|Lack of Efficacy|0|||
129794034|NCT00829933|467212810|FG001|Overall Study|Lack of Efficacy|1|||
129794035|NCT00829933|467212811|FG002|Overall Study|Lack of Efficacy|0|||
129794036|NCT00829933|467212812|FG003|Overall Study|Lack of Efficacy|0|||
129794037|NCT00829933|467212809|FG000|Overall Study|Physician Decision|5|||
129794038|NCT00829933|467212810|FG001|Overall Study|Physician Decision|7|||
129794039|NCT00829933|467212811|FG002|Overall Study|Physician Decision|8|||
129794040|NCT00829933|467212812|FG003|Overall Study|Physician Decision|1|||
129794041|NCT00829933|467212809|FG000|Overall Study|Pregnancy|0|||
129794042|NCT00829933|467212810|FG001|Overall Study|Pregnancy|0|||
129794043|NCT00829933|467212811|FG002|Overall Study|Pregnancy|0|||
129794044|NCT00829933|467212812|FG003|Overall Study|Pregnancy|2|||
129794045|NCT00829933|467212809|FG000|Overall Study|Protocol Violation|2|||
129794046|NCT00829933|467212810|FG001|Overall Study|Protocol Violation|1|||
129794047|NCT00829933|467212811|FG002|Overall Study|Protocol Violation|0|||
129794048|NCT00829933|467212812|FG003|Overall Study|Protocol Violation|0|||
129794049|NCT00829933|467212809|FG000|Overall Study|withdrew before treatment started|5|||
129794050|NCT00829933|467212810|FG001|Overall Study|withdrew before treatment started|1|||
129794051|NCT00829933|467212811|FG002|Overall Study|withdrew before treatment started|2|||
129794052|NCT00829933|467212812|FG003|Overall Study|withdrew before treatment started|9|||
129794053|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
129794054|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
129794055|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
129794056|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
129794057|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
129794058|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
129794059|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
129794060|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
129794061|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
129794062|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
129794063|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
129794064|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
129794065|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
129794066|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
129794067|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
129794068|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
129794069|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
129794070|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
129439791|NCT00394953|465909497|FG001|First Treatment Period|Withdrawal by Subject|3|||
129439792|NCT00394953|465909496|FG000|First Treatment Period|Lost to Follow-up|0|||
129439793|NCT00394953|465909497|FG001|First Treatment Period|Lost to Follow-up|1|||
129439794|NCT00394953|465909496|FG000|First Treatment Period|Renal transplant|11|||
129439795|NCT00394953|465909497|FG001|First Treatment Period|Renal transplant|7|||
129439796|NCT00394953|465909496|FG000|First Treatment Period|Not defined|4|||
129439797|NCT00394953|465909497|FG001|First Treatment Period|Not defined|1|||
129439798|NCT00394953|465909496|FG000|Second Treatment Period|Adverse Event|2|||
129439799|NCT00394953|465909497|FG001|Second Treatment Period|Adverse Event|5|||
129439800|NCT00394953|465909496|FG000|Second Treatment Period|Death|8|||
129439801|NCT00394953|465909497|FG001|Second Treatment Period|Death|4|||
129439802|NCT00394953|465909496|FG000|Second Treatment Period|Lack of Efficacy|9|||
129439803|NCT00394953|465909497|FG001|Second Treatment Period|Lack of Efficacy|47|||
129439804|NCT00394953|465909496|FG000|Second Treatment Period|Withdrawal by Subject|3|||
129439805|NCT00394953|465909497|FG001|Second Treatment Period|Withdrawal by Subject|3|||
129439806|NCT00394953|465909496|FG000|Second Treatment Period|Lost to Follow-up|0|||
129439807|NCT00394953|465909497|FG001|Second Treatment Period|Lost to Follow-up|1|||
129439808|NCT00394953|465909496|FG000|Second Treatment Period|Renal transplant|4|||
129439809|NCT00394953|465909497|FG001|Second Treatment Period|Renal transplant|6|||
129439810|NCT00394953|465909496|FG000|Second Treatment Period|Not defined|3|||
129439811|NCT00394953|465909497|FG001|Second Treatment Period|Not defined|8|||
129439812|NCT03181451|465909501|FG000|Overall Study|Adverse Event|0|||
129439813|NCT03181451|465909502|FG001|Overall Study|Adverse Event|1|||
129439814|NCT03181451|465909503|FG002|Overall Study|Adverse Event|0|||
129439815|NCT03181451|465909501|FG000|Overall Study|Withdrawal by Subject|0|||
129439816|NCT03181451|465909502|FG001|Overall Study|Withdrawal by Subject|1|||
129439817|NCT03181451|465909503|FG002|Overall Study|Withdrawal by Subject|0|||
129439818|NCT02196714|465909504|FG000|Overall Study|Protocol Violation|0|||
129439819|NCT02196714|465909505|FG001|Overall Study|Protocol Violation|0|||
129439820|NCT02196714|465909506|FG002|Overall Study|Protocol Violation|1|||
129439821|NCT02196714|465909507|FG003|Overall Study|Protocol Violation|0|||
129439822|NCT01326533|465909510|FG000|Overall Study|Lost to Follow-up|2|||
129439823|NCT01326533|465909511|FG001|Overall Study|Lost to Follow-up|0|||
129439824|NCT01326533|465909510|FG000|Overall Study|Withdrawal by Subject|1|||
129439825|NCT01326533|465909511|FG001|Overall Study|Withdrawal by Subject|0|||
129439826|NCT01326533|465909510|FG000|Overall Study|Adverse Event|1|||
129439827|NCT01326533|465909511|FG001|Overall Study|Adverse Event|0|||
129439828|NCT04079803|465909512|FG000|Overall Study|Withdrawal by Subject|0|||
129439829|NCT04079803|465909513|FG001|Overall Study|Withdrawal by Subject|0|||
129794071|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
129794072|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
129439830|NCT04079803|465909514|FG002|Overall Study|Withdrawal by Subject|1|||
129439831|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
129439832|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
129626433|NCT02848001|466586868|FG011|Overall Study|Death|1|||
129626434|NCT02848001|466586869|FG012|Overall Study|Death|3|||
129626435|NCT02848001|466586870|FG013|Overall Study|Death|0|||
129626436|NCT02848001|466586871|FG014|Overall Study|Death|2|||
129626437|NCT02848001|466586872|FG015|Overall Study|Death|3|||
129626438|NCT02848001|466586873|FG016|Overall Study|Death|0|||
129626439|NCT02848001|466586857|FG000|Overall Study|Physician Decision|0|||
129626440|NCT02848001|466586858|FG001|Overall Study|Physician Decision|0|||
129626441|NCT02848001|466586859|FG002|Overall Study|Physician Decision|0|||
129626442|NCT02848001|466586860|FG003|Overall Study|Physician Decision|0|||
129626443|NCT02848001|466586861|FG004|Overall Study|Physician Decision|0|||
129626444|NCT02848001|466586862|FG005|Overall Study|Physician Decision|0|||
129626445|NCT02848001|466586863|FG006|Overall Study|Physician Decision|0|||
129626446|NCT02848001|466586864|FG007|Overall Study|Physician Decision|0|||
129626447|NCT02848001|466586865|FG008|Overall Study|Physician Decision|1|||
129626448|NCT02848001|466586866|FG009|Overall Study|Physician Decision|1|||
129626449|NCT02848001|466586867|FG010|Overall Study|Physician Decision|0|||
129626450|NCT02848001|466586868|FG011|Overall Study|Physician Decision|0|||
129626451|NCT02848001|466586869|FG012|Overall Study|Physician Decision|2|||
129626452|NCT02848001|466586870|FG013|Overall Study|Physician Decision|0|||
129626453|NCT02848001|466586871|FG014|Overall Study|Physician Decision|0|||
129439833|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
129439834|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
129626454|NCT02848001|466586872|FG015|Overall Study|Physician Decision|0|||
129626455|NCT02848001|466586873|FG016|Overall Study|Physician Decision|0|||
129626456|NCT02848001|466586857|FG000|Overall Study|Withdrawal by Subject|0|||
129626457|NCT02848001|466586858|FG001|Overall Study|Withdrawal by Subject|0|||
129626458|NCT02848001|466586859|FG002|Overall Study|Withdrawal by Subject|0|||
129439835|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
129439836|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
129626459|NCT02848001|466586860|FG003|Overall Study|Withdrawal by Subject|0|||
129626460|NCT02848001|466586861|FG004|Overall Study|Withdrawal by Subject|0|||
129626461|NCT02848001|466586862|FG005|Overall Study|Withdrawal by Subject|1|||
129439837|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
129439838|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
129439839|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
129439840|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
129439841|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
129439842|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
129439843|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
129439844|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
129439845|NCT01294683|465909515|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
129439846|NCT01294683|465909516|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
129439847|NCT01294683|465909515|FG000|Post Crossover (Period III)|Adverse Event|6|||
129626462|NCT02848001|466586863|FG006|Overall Study|Withdrawal by Subject|1|||
129626463|NCT02848001|466586864|FG007|Overall Study|Withdrawal by Subject|1|||
129626464|NCT02848001|466586865|FG008|Overall Study|Withdrawal by Subject|0|||
129626465|NCT02848001|466586866|FG009|Overall Study|Withdrawal by Subject|0|||
129626466|NCT02848001|466586867|FG010|Overall Study|Withdrawal by Subject|0|||
129626467|NCT02848001|466586868|FG011|Overall Study|Withdrawal by Subject|0|||
129626468|NCT02848001|466586869|FG012|Overall Study|Withdrawal by Subject|0|||
129626469|NCT02848001|466586870|FG013|Overall Study|Withdrawal by Subject|0|||
129626470|NCT02848001|466586871|FG014|Overall Study|Withdrawal by Subject|0|||
129626471|NCT02848001|466586872|FG015|Overall Study|Withdrawal by Subject|0|||
129626472|NCT02848001|466586873|FG016|Overall Study|Withdrawal by Subject|0|||
129626473|NCT00725283|466586879|FG000|Overall Study|Missing Code|3|||
129626474|NCT00725283|466586879|FG000|Overall Study|Death|5|||
129626475|NCT00725283|466586879|FG000|Overall Study|Other|6|||
129626476|NCT00725283|466586879|FG000|Overall Study|Withdrawal by Subject|10|||
129626477|NCT00711243|466586880|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
129626478|NCT00711243|466586881|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
129626479|NCT00711243|466586882|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
129626480|NCT00711243|466586883|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
129626481|NCT00711243|466586884|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
129626482|NCT00711243|466586885|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
129626483|NCT00711243|466586880|FG000|Reached First Response/4 Cycles|Death|0|||
129626484|NCT00711243|466586881|FG001|Reached First Response/4 Cycles|Death|0|||
129626485|NCT00711243|466586882|FG002|Reached First Response/4 Cycles|Death|0|||
129626486|NCT00711243|466586883|FG003|Reached First Response/4 Cycles|Death|0|||
129626487|NCT00711243|466586884|FG004|Reached First Response/4 Cycles|Death|0|||
129626488|NCT00711243|466586885|FG005|Reached First Response/4 Cycles|Death|2|||
129626489|NCT00711243|466586880|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
129626490|NCT00711243|466586881|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
129626491|NCT00711243|466586882|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
129626492|NCT00711243|466586883|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
129626493|NCT00711243|466586884|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
129626494|NCT00711243|466586885|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
129439848|NCT01294683|465909516|FG001|Post Crossover (Period III)|Adverse Event|6|||
129439849|NCT01294683|465909515|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
129439850|NCT01294683|465909516|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
129439851|NCT01294683|465909515|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
129439852|NCT01294683|465909516|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
129439853|NCT01294683|465909515|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
129439854|NCT01294683|465909516|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
129439855|NCT01881750|465909517|FG000|Overall Study|Changes in concomitant therapies|2|||
129439856|NCT01881750|465909518|FG001|Overall Study|Changes in concomitant therapies|3|||
129439857|NCT01881750|465909517|FG000|Overall Study|Lost to Follow-up|0|||
129439858|NCT01881750|465909518|FG001|Overall Study|Lost to Follow-up|1|||
129439859|NCT00926211|465909520|FG000|Overall Study|Lost to Follow-up|1|||
129439860|NCT03737474|465909523|FG000|Overall Study|Adverse Event|18|||
129439861|NCT03737474|465909524|FG001|Overall Study|Adverse Event|48|||
129439862|NCT03737474|465909523|FG000|Overall Study|Lack of Efficacy|1|||
129439863|NCT03737474|465909524|FG001|Overall Study|Lack of Efficacy|3|||
129626495|NCT00711243|466586880|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
129626496|NCT00711243|466586881|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
129626497|NCT00711243|466586882|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
129626498|NCT00711243|466586883|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
129626499|NCT00711243|466586884|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
129626500|NCT00711243|466586885|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
129626501|NCT00711243|466586880|FG000|Treated Cycle 5 After First Response|Death|0|||
129439864|NCT03737474|465909523|FG000|Overall Study|Protocol Violation|0|||
129439865|NCT03737474|465909524|FG001|Overall Study|Protocol Violation|8|||
129626502|NCT00711243|466586881|FG001|Treated Cycle 5 After First Response|Death|0|||
129626503|NCT00711243|466586882|FG002|Treated Cycle 5 After First Response|Death|0|||
129626504|NCT00711243|466586883|FG003|Treated Cycle 5 After First Response|Death|0|||
129626505|NCT00711243|466586884|FG004|Treated Cycle 5 After First Response|Death|0|||
129626506|NCT00711243|466586885|FG005|Treated Cycle 5 After First Response|Death|2|||
129626507|NCT00711243|466586880|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
129626508|NCT00711243|466586881|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
129626509|NCT00711243|466586882|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
129626510|NCT00711243|466586883|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
129794073|NCT01986933|467212817|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794074|NCT01986933|467212818|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794075|NCT01986933|467212819|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794076|NCT01986933|467212820|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
129794077|NCT01986933|467212821|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
129794078|NCT01986933|467212817|FG000|Active-to-active (Part B)|Adverse Event|0|||
129794079|NCT01986933|467212818|FG001|Active-to-active (Part B)|Adverse Event|2|||
129794080|NCT01986933|467212819|FG002|Active-to-active (Part B)|Adverse Event|0|||
129794081|NCT01986933|467212820|FG003|Active-to-active (Part B)|Adverse Event|1|||
129794082|NCT01986933|467212821|FG004|Active-to-active (Part B)|Adverse Event|3|||
129794083|NCT01986933|467212817|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
129794084|NCT01986933|467212818|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
129794085|NCT01986933|467212819|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
129794086|NCT01986933|467212820|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
129626511|NCT00711243|466586884|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
129626512|NCT00711243|466586885|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
129626513|NCT00711243|466586880|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129626514|NCT00711243|466586881|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129626515|NCT00711243|466586882|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129626516|NCT00711243|466586883|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129626517|NCT00711243|466586884|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
129626518|NCT00711243|466586885|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
129626519|NCT01402570|466586888|FG000|Overall Study|Adverse Event|1|||
129626520|NCT01962103|466586892|FG000|Phase 1|Adverse Event|4|||
129626521|NCT01962103|466586893|FG001|Phase 1|Adverse Event|0|||
129626522|NCT01962103|466586894|FG002|Phase 1|Adverse Event|2|||
129703127|NCT02300233|466874591|FG001|Overall Study|Investigator Judgement|0|||
129703128|NCT02300233|466874592|FG002|Overall Study|Investigator Judgement|1|||
129626523|NCT01962103|466586895|FG003|Phase 1|Adverse Event|1|||
129703129|NCT02300233|466874590|FG000|Overall Study|Reason Not Specified|0|||
129703130|NCT02300233|466874591|FG001|Overall Study|Reason Not Specified|0|||
129703131|NCT02300233|466874592|FG002|Overall Study|Reason Not Specified|5|||
129703132|NCT00833690|466874593|FG000|Overall Study|Withdrawal by Subject|1|||
129703133|NCT00833690|466874594|FG001|Overall Study|Withdrawal by Subject|0|||
129703134|NCT00833690|466874595|FG002|Overall Study|Withdrawal by Subject|0|||
129703135|NCT00833690|466874593|FG000|Overall Study|Discontinued study drug|3|||
129703136|NCT00833690|466874594|FG001|Overall Study|Discontinued study drug|2|||
129703137|NCT00833690|466874595|FG002|Overall Study|Discontinued study drug|0|||
129703138|NCT05448950|466874596|FG000|Overall Study|Death|2|||
129703139|NCT05448950|466874596|FG000|Overall Study|Withdrawal by Subject|1|||
129703140|NCT05448950|466874596|FG000|Overall Study|AVG abandoned|4|||
129703141|NCT04752566|466874597|FG000|Overall Study|Protocol Violation|0|||
129703142|NCT04752566|466874598|FG001|Overall Study|Protocol Violation|1|||
129703143|NCT04752566|466874597|FG000|Overall Study|Death|1|||
129703144|NCT04752566|466874598|FG001|Overall Study|Death|0|||
129703145|NCT04752566|466874597|FG000|Overall Study|Adverse Event|1|||
129703146|NCT04752566|466874598|FG001|Overall Study|Adverse Event|0|||
129703147|NCT04752566|466874597|FG000|Overall Study|Withdrawal by Subject|2|||
129703148|NCT04752566|466874598|FG001|Overall Study|Withdrawal by Subject|0|||
129703149|NCT04752566|466874597|FG000|Overall Study|Physician Decision|1|||
129703150|NCT04752566|466874598|FG001|Overall Study|Physician Decision|1|||
129703151|NCT01153516|466874599|FG000|Overall Study|Both subjects refused surgery|2|||
129703152|NCT01153516|466874600|FG001|Overall Study|Both subjects refused surgery|0|||
129703153|NCT03773484|466874601|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
129703154|NCT01889251|466874602|FG000|Overall Study|Adverse Event|1|||
129703155|NCT01889251|466874603|FG001|Overall Study|Adverse Event|0|||
129626524|NCT01962103|466586896|FG004|Phase 1|Adverse Event|2|||
129703156|NCT01344226|466874609|FG000|Overall Study|Protocol Violation|2|||
129439866|NCT03737474|465909523|FG000|Overall Study|Withdrawal by Subject|5|||
129439867|NCT03737474|465909524|FG001|Overall Study|Withdrawal by Subject|20|||
129439868|NCT03737474|465909523|FG000|Overall Study|Non-compliance With Study Drug|0|||
129439869|NCT03737474|465909524|FG001|Overall Study|Non-compliance With Study Drug|1|||
129439870|NCT03737474|465909523|FG000|Overall Study|Physician Decision|1|||
129439871|NCT03737474|465909524|FG001|Overall Study|Physician Decision|4|||
129439872|NCT02513745|465909525|FG000|Overall Study|Criteria at time of surgery not met.|3|||
129626525|NCT01962103|466586897|FG005|Phase 1|Adverse Event|2|||
129626526|NCT01962103|466586898|FG006|Phase 1|Adverse Event|0|||
129626527|NCT01962103|466586899|FG007|Phase 1|Adverse Event|0|||
129626528|NCT01962103|466586900|FG008|Phase 1|Adverse Event|0|||
129626529|NCT01962103|466586892|FG000|Phase 1|Progressive Disease|8|||
129626530|NCT01962103|466586893|FG001|Phase 1|Progressive Disease|6|||
129626531|NCT01962103|466586894|FG002|Phase 1|Progressive Disease|8|||
129626532|NCT01962103|466586895|FG003|Phase 1|Progressive Disease|4|||
129626533|NCT01962103|466586896|FG004|Phase 1|Progressive Disease|5|||
129626534|NCT01962103|466586897|FG005|Phase 1|Progressive Disease|4|||
129626535|NCT01962103|466586898|FG006|Phase 1|Progressive Disease|0|||
129626536|NCT01962103|466586899|FG007|Phase 1|Progressive Disease|0|||
129626537|NCT01962103|466586900|FG008|Phase 1|Progressive Disease|0|||
129626538|NCT01962103|466586892|FG000|Phase 1|Withdrawal by Subject|0|||
129626539|NCT01962103|466586893|FG001|Phase 1|Withdrawal by Subject|0|||
129626540|NCT01962103|466586894|FG002|Phase 1|Withdrawal by Subject|0|||
129626541|NCT01962103|466586895|FG003|Phase 1|Withdrawal by Subject|2|||
129626542|NCT01962103|466586896|FG004|Phase 1|Withdrawal by Subject|0|||
129626543|NCT01962103|466586897|FG005|Phase 1|Withdrawal by Subject|0|||
129626544|NCT01962103|466586898|FG006|Phase 1|Withdrawal by Subject|0|||
129626545|NCT01962103|466586899|FG007|Phase 1|Withdrawal by Subject|0|||
129626546|NCT01962103|466586900|FG008|Phase 1|Withdrawal by Subject|0|||
129626547|NCT01962103|466586892|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
129626548|NCT01962103|466586893|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
129626549|NCT01962103|466586894|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
129626550|NCT01962103|466586895|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
129626551|NCT01962103|466586896|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
129626552|NCT01962103|466586897|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
129626553|NCT01962103|466586898|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
129626554|NCT01962103|466586899|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
129626555|NCT01962103|466586900|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
129626556|NCT01962103|466586892|FG000|Phase 1|Physician Decision|0|||
129626557|NCT01962103|466586893|FG001|Phase 1|Physician Decision|0|||
129626558|NCT01962103|466586894|FG002|Phase 1|Physician Decision|0|||
129626559|NCT01962103|466586895|FG003|Phase 1|Physician Decision|1|||
129626560|NCT01962103|466586896|FG004|Phase 1|Physician Decision|0|||
129626561|NCT01962103|466586897|FG005|Phase 1|Physician Decision|0|||
129626562|NCT01962103|466586898|FG006|Phase 1|Physician Decision|0|||
129626563|NCT01962103|466586899|FG007|Phase 1|Physician Decision|0|||
129626564|NCT01962103|466586900|FG008|Phase 1|Physician Decision|0|||
129626565|NCT01962103|466586892|FG000|Phase 1|Symptomatic Deterioration|3|||
129626566|NCT01962103|466586893|FG001|Phase 1|Symptomatic Deterioration|2|||
129626567|NCT01962103|466586894|FG002|Phase 1|Symptomatic Deterioration|2|||
129626568|NCT01962103|466586895|FG003|Phase 1|Symptomatic Deterioration|2|||
129626569|NCT01962103|466586896|FG004|Phase 1|Symptomatic Deterioration|1|||
129626570|NCT01962103|466586897|FG005|Phase 1|Symptomatic Deterioration|1|||
129626571|NCT01962103|466586898|FG006|Phase 1|Symptomatic Deterioration|0|||
129626572|NCT01962103|466586899|FG007|Phase 1|Symptomatic Deterioration|0|||
129626573|NCT01962103|466586900|FG008|Phase 1|Symptomatic Deterioration|0|||
129626574|NCT01962103|466586892|FG000|Phase 1|Miscellaneous|1|||
129626575|NCT01962103|466586893|FG001|Phase 1|Miscellaneous|0|||
129626576|NCT01962103|466586894|FG002|Phase 1|Miscellaneous|0|||
129626577|NCT01962103|466586895|FG003|Phase 1|Miscellaneous|0|||
129626578|NCT01962103|466586896|FG004|Phase 1|Miscellaneous|0|||
129626579|NCT01962103|466586897|FG005|Phase 1|Miscellaneous|0|||
129626580|NCT01962103|466586898|FG006|Phase 1|Miscellaneous|0|||
129626581|NCT01962103|466586899|FG007|Phase 1|Miscellaneous|0|||
129626582|NCT01962103|466586900|FG008|Phase 1|Miscellaneous|0|||
129626583|NCT01962103|466586892|FG000|Phase 2|Adverse Event|0|||
129626584|NCT01962103|466586893|FG001|Phase 2|Adverse Event|0|||
129626585|NCT01962103|466586894|FG002|Phase 2|Adverse Event|0|||
129626586|NCT01962103|466586895|FG003|Phase 2|Adverse Event|0|||
129626587|NCT01962103|466586896|FG004|Phase 2|Adverse Event|0|||
129626588|NCT01962103|466586897|FG005|Phase 2|Adverse Event|0|||
129439873|NCT02513745|465909526|FG001|Overall Study|Criteria at time of surgery not met.|3|||
129439874|NCT01209143|465909527|FG000|Overall Study|Adverse Event|2|||
129439875|NCT01209143|465909528|FG001|Overall Study|Adverse Event|1|||
129439876|NCT01209143|465909527|FG000|Overall Study|Death|0|||
129439877|NCT01209143|465909528|FG001|Overall Study|Death|1|||
129439878|NCT01209143|465909527|FG000|Overall Study|Physician Decision|3|||
129439879|NCT01209143|465909528|FG001|Overall Study|Physician Decision|1|||
129439880|NCT01209143|465909527|FG000|Overall Study|Lost to Follow-up|1|||
129439881|NCT01209143|465909528|FG001|Overall Study|Lost to Follow-up|0|||
129439882|NCT01209143|465909527|FG000|Overall Study|Withdrawal by Subject|2|||
129439883|NCT01209143|465909528|FG001|Overall Study|Withdrawal by Subject|1|||
129439884|NCT01209143|465909527|FG000|Overall Study|Disease progression|11|||
129439885|NCT01209143|465909528|FG001|Overall Study|Disease progression|16|||
129439886|NCT00753272|465909532|FG000|Overall Study|Adverse Event|878|||
129439887|NCT00753272|465909533|FG001|Overall Study|Adverse Event|869|||
129439888|NCT00753272|465909532|FG000|Overall Study|Protocol Violation|28|||
129439889|NCT00753272|465909533|FG001|Overall Study|Protocol Violation|46|||
129439890|NCT00753272|465909532|FG000|Overall Study|Withdrawal by Subject|2481|||
129439891|NCT00753272|465909533|FG001|Overall Study|Withdrawal by Subject|2407|||
129439892|NCT00753272|465909532|FG000|Overall Study|Lost to Follow-up|491|||
129439893|NCT00753272|465909533|FG001|Overall Study|Lost to Follow-up|497|||
129439894|NCT00753272|465909532|FG000|Overall Study|Other|1104|||
129439895|NCT00753272|465909533|FG001|Overall Study|Other|1088|||
129439896|NCT00971243|465909534|FG000|Double Blind Period|Adverse Event|2|||
129439897|NCT00971243|465909535|FG001|Double Blind Period|Adverse Event|3|||
129439898|NCT00971243|465909536|FG002|Double Blind Period|Adverse Event|2|||
129439899|NCT00971243|465909537|FG003|Double Blind Period|Adverse Event|2|||
129626589|NCT01962103|466586898|FG006|Phase 2|Adverse Event|1|||
129626590|NCT01962103|466586899|FG007|Phase 2|Adverse Event|0|||
129626591|NCT01962103|466586900|FG008|Phase 2|Adverse Event|3|||
129626592|NCT01962103|466586892|FG000|Phase 2|Progressive Disease|0|||
129439900|NCT00971243|465909538|FG004|Double Blind Period|Adverse Event|3|||
129439901|NCT00971243|465909534|FG000|Double Blind Period|Lost to Follow-up|0|||
129439902|NCT00971243|465909535|FG001|Double Blind Period|Lost to Follow-up|1|||
129439903|NCT00971243|465909536|FG002|Double Blind Period|Lost to Follow-up|1|||
129439904|NCT00971243|465909537|FG003|Double Blind Period|Lost to Follow-up|0|||
129439905|NCT00971243|465909538|FG004|Double Blind Period|Lost to Follow-up|1|||
129626593|NCT01962103|466586893|FG001|Phase 2|Progressive Disease|0|||
129626594|NCT01962103|466586894|FG002|Phase 2|Progressive Disease|0|||
129626595|NCT01962103|466586895|FG003|Phase 2|Progressive Disease|0|||
129626596|NCT01962103|466586896|FG004|Phase 2|Progressive Disease|0|||
129626597|NCT01962103|466586897|FG005|Phase 2|Progressive Disease|0|||
129626598|NCT01962103|466586898|FG006|Phase 2|Progressive Disease|11|||
129626599|NCT01962103|466586899|FG007|Phase 2|Progressive Disease|12|||
129626600|NCT01962103|466586900|FG008|Phase 2|Progressive Disease|11|||
129626601|NCT01962103|466586892|FG000|Phase 2|Symptomatic Deterioration|0|||
129626602|NCT01962103|466586893|FG001|Phase 2|Symptomatic Deterioration|0|||
129626603|NCT01962103|466586894|FG002|Phase 2|Symptomatic Deterioration|0|||
129626604|NCT01962103|466586895|FG003|Phase 2|Symptomatic Deterioration|0|||
129626605|NCT01962103|466586896|FG004|Phase 2|Symptomatic Deterioration|0|||
129626606|NCT01962103|466586897|FG005|Phase 2|Symptomatic Deterioration|0|||
129626607|NCT01962103|466586898|FG006|Phase 2|Symptomatic Deterioration|2|||
129626608|NCT01962103|466586899|FG007|Phase 2|Symptomatic Deterioration|2|||
129626609|NCT01962103|466586900|FG008|Phase 2|Symptomatic Deterioration|0|||
129703157|NCT01344226|466874609|FG000|Overall Study|Withdrawal by Subject|3|||
129888789|NCT01676220|467550900|FG000|Overall Study|Randomized But Not Treated|4|||
129888790|NCT01676220|467550901|FG001|Overall Study|Randomized But Not Treated|1|||
129888791|NCT01676220|467550900|FG000|Overall Study|Adverse Event|10|||
129439906|NCT00971243|465909534|FG000|Double Blind Period|Physician Decision|10|||
129439907|NCT00971243|465909535|FG001|Double Blind Period|Physician Decision|6|||
129439908|NCT00971243|465909536|FG002|Double Blind Period|Physician Decision|7|||
129439909|NCT00971243|465909537|FG003|Double Blind Period|Physician Decision|6|||
129439910|NCT00971243|465909538|FG004|Double Blind Period|Physician Decision|7|||
129439911|NCT00971243|465909534|FG000|Double Blind Period|Protocol Violation|2|||
129439912|NCT00971243|465909535|FG001|Double Blind Period|Protocol Violation|0|||
129439913|NCT00971243|465909536|FG002|Double Blind Period|Protocol Violation|3|||
129703158|NCT01344226|466874609|FG000|Overall Study|Lack of Efficacy|3|||
129626610|NCT01321749|466586901|FG000|Overall Study|Lost to Follow-up|4|||
129626611|NCT01321749|466586902|FG001|Overall Study|Lost to Follow-up|11|||
129626612|NCT01321749|466586901|FG000|Overall Study|Protocol Violation|4|||
129626613|NCT01321749|466586902|FG001|Overall Study|Protocol Violation|7|||
129888792|NCT01676220|467550901|FG001|Overall Study|Adverse Event|8|||
129439914|NCT00971243|465909537|FG003|Double Blind Period|Protocol Violation|2|||
129439915|NCT00971243|465909538|FG004|Double Blind Period|Protocol Violation|2|||
129439916|NCT00971243|465909534|FG000|Double Blind Period|Withdrawal by Subject|4|||
129626614|NCT01321749|466586901|FG000|Overall Study|Withdrawal by Subject|5|||
129626615|NCT01321749|466586902|FG001|Overall Study|Withdrawal by Subject|4|||
129626616|NCT04179838|466586906|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129703159|NCT02302222|466874612|FG000|Overall Study|Physician Decision|0|||
129888793|NCT01676220|467550900|FG000|Overall Study|Lack of Efficacy|2|||
129888794|NCT01676220|467550901|FG001|Overall Study|Lack of Efficacy|5|||
129888795|NCT01676220|467550900|FG000|Overall Study|Protocol Violation|11|||
129888796|NCT01676220|467550901|FG001|Overall Study|Protocol Violation|12|||
129888797|NCT01676220|467550900|FG000|Overall Study|Received Rescue Therapy|14|||
129888798|NCT01676220|467550901|FG001|Overall Study|Received Rescue Therapy|22|||
129888799|NCT01676220|467550900|FG000|Overall Study|Personal Reason|34|||
129888800|NCT01676220|467550901|FG001|Overall Study|Personal Reason|45|||
129888801|NCT01676220|467550900|FG000|Overall Study|Lost to Follow-up|11|||
129888802|NCT01676220|467550901|FG001|Overall Study|Lost to Follow-up|18|||
129888803|NCT01676220|467550900|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
129888804|NCT01676220|467550901|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
129888805|NCT01676220|467550900|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
129888806|NCT01676220|467550901|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
129888807|NCT01676220|467550900|FG000|Overall Study|Perceived Lack of Efficacy|3|||
129888808|NCT01676220|467550901|FG001|Overall Study|Perceived Lack of Efficacy|1|||
129888809|NCT01676220|467550900|FG000|Overall Study|Non Serious Hypoglycemia|2|||
129888810|NCT01676220|467550901|FG001|Overall Study|Non Serious Hypoglycemia|0|||
129888811|NCT01676220|467550900|FG000|Overall Study|No More Need of Insulin|1|||
129888812|NCT01676220|467550901|FG001|Overall Study|No More Need of Insulin|0|||
129888813|NCT03875911|467550904|FG000|Overall Study|Lost to Follow-up|3|||
129888814|NCT03875911|467550905|FG001|Overall Study|Lost to Follow-up|6|||
129888815|NCT03875911|467550906|FG002|Overall Study|Lost to Follow-up|2|||
129888816|NCT03875911|467550904|FG000|Overall Study|Surgery cancelled|1|||
129888817|NCT03875911|467550905|FG001|Overall Study|Surgery cancelled|0|||
129888818|NCT03875911|467550906|FG002|Overall Study|Surgery cancelled|1|||
129888819|NCT03875911|467550904|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
129888820|NCT03875911|467550905|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
129888821|NCT03875911|467550906|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
129888822|NCT03824938|467550907|FG000|Overall Study|Withdrawal by Subject|2|||
129888823|NCT03824938|467550908|FG001|Overall Study|Withdrawal by Subject|1|||
129888824|NCT03824938|467550909|FG002|Overall Study|Withdrawal by Subject|0|||
129888825|NCT03824938|467550910|FG003|Overall Study|Withdrawal by Subject|2|||
129888826|NCT03824938|467550911|FG004|Overall Study|Withdrawal by Subject|0|||
129888827|NCT03824938|467550912|FG005|Overall Study|Withdrawal by Subject|1|||
129888828|NCT03824938|467550907|FG000|Overall Study|Lost to Follow-up|0|||
129888829|NCT03824938|467550908|FG001|Overall Study|Lost to Follow-up|1|||
129888830|NCT03824938|467550909|FG002|Overall Study|Lost to Follow-up|0|||
129888831|NCT03824938|467550910|FG003|Overall Study|Lost to Follow-up|0|||
129888832|NCT03824938|467550911|FG004|Overall Study|Lost to Follow-up|1|||
129888833|NCT03824938|467550912|FG005|Overall Study|Lost to Follow-up|0|||
129888834|NCT01990300|467550916|FG000|Overall Study|Case Report Forms Uncollected|89|||
129888835|NCT01990300|467550916|FG000|Overall Study|Protocol Deviation|53|||
129888836|NCT04496167|467550919|FG000|Overall Study|Adverse Event|6|||
129888837|NCT04496167|467550920|FG001|Overall Study|Adverse Event|2|||
129888838|NCT04496167|467550919|FG000|Overall Study|Withdrawal by Subject|7|||
129888839|NCT04496167|467550920|FG001|Overall Study|Withdrawal by Subject|6|||
129439917|NCT00971243|465909535|FG001|Double Blind Period|Withdrawal by Subject|1|||
129439918|NCT00971243|465909536|FG002|Double Blind Period|Withdrawal by Subject|4|||
129439919|NCT00971243|465909537|FG003|Double Blind Period|Withdrawal by Subject|4|||
129439920|NCT00971243|465909538|FG004|Double Blind Period|Withdrawal by Subject|4|||
129439921|NCT00971243|465909534|FG000|Double Blind Period|Other reasons|1|||
129439922|NCT00971243|465909535|FG001|Double Blind Period|Other reasons|0|||
129439923|NCT00971243|465909536|FG002|Double Blind Period|Other reasons|2|||
129439924|NCT00971243|465909537|FG003|Double Blind Period|Other reasons|0|||
129439925|NCT00971243|465909538|FG004|Double Blind Period|Other reasons|1|||
129439926|NCT00971243|465909534|FG000|Open-label Period|Adverse Event|1|||
129439927|NCT00971243|465909535|FG001|Open-label Period|Adverse Event|0|||
129439928|NCT00971243|465909536|FG002|Open-label Period|Adverse Event|1|||
129439929|NCT00971243|465909537|FG003|Open-label Period|Adverse Event|1|||
129626617|NCT04179838|466586907|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
129626618|NCT04179838|466586906|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
129626619|NCT04179838|466586907|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
129626620|NCT01290068|466586912|FG000|Overall Study|Adverse Event|1|||
129626621|NCT01290068|466586913|FG001|Overall Study|Adverse Event|3|||
129626622|NCT01290068|466586912|FG000|Overall Study|Lost to Follow-up|3|||
129888840|NCT04496167|467550919|FG000|Overall Study|Lost to Follow-up|3|||
129439930|NCT00971243|465909538|FG004|Open-label Period|Adverse Event|0|||
129888841|NCT04496167|467550920|FG001|Overall Study|Lost to Follow-up|5|||
129626623|NCT01290068|466586913|FG001|Overall Study|Lost to Follow-up|0|||
129439931|NCT00971243|465909534|FG000|Open-label Period|Physician Decision|5|||
129626624|NCT01290068|466586912|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
129439932|NCT00971243|465909535|FG001|Open-label Period|Physician Decision|9|||
129439933|NCT00971243|465909536|FG002|Open-label Period|Physician Decision|3|||
129439934|NCT00971243|465909537|FG003|Open-label Period|Physician Decision|7|||
129626625|NCT01290068|466586913|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
129626626|NCT01290068|466586912|FG000|Overall Study|Other|3|||
129439935|NCT00971243|465909538|FG004|Open-label Period|Physician Decision|2|||
129439936|NCT00971243|465909534|FG000|Open-label Period|Protocol Violation|1|||
129626627|NCT01290068|466586913|FG001|Overall Study|Other|1|||
129626628|NCT00513695|466586914|FG000|Overall Study|Discontinued therapy|2|||
129626629|NCT00513695|466586914|FG000|Overall Study|Progression prior to surgery|3|||
129626630|NCT01417156|466586921|FG000|Overall Study|Adverse Event|12|||
129626631|NCT01417156|466586921|FG000|Overall Study|Protocol Violation|2|||
129626632|NCT00818766|466586924|FG000|Overall Study|Could not be Contacted on Day 28|11|||
129439937|NCT00971243|465909535|FG001|Open-label Period|Protocol Violation|1|||
129439938|NCT00971243|465909536|FG002|Open-label Period|Protocol Violation|1|||
129439939|NCT00971243|465909537|FG003|Open-label Period|Protocol Violation|0|||
129439940|NCT00971243|465909538|FG004|Open-label Period|Protocol Violation|1|||
129439941|NCT00971243|465909534|FG000|Open-label Period|Withdrawal by Subject|1|||
129439942|NCT00971243|465909535|FG001|Open-label Period|Withdrawal by Subject|0|||
129439943|NCT00971243|465909536|FG002|Open-label Period|Withdrawal by Subject|0|||
129439944|NCT00971243|465909537|FG003|Open-label Period|Withdrawal by Subject|2|||
129439945|NCT00971243|465909538|FG004|Open-label Period|Withdrawal by Subject|1|||
129439946|NCT00971243|465909534|FG000|Open-label Period|Other reason|0|||
129439947|NCT00971243|465909535|FG001|Open-label Period|Other reason|0|||
129626633|NCT00818766|466586925|FG001|Overall Study|Could not be Contacted on Day 28|10|||
129626634|NCT00818766|466586924|FG000|Overall Study|Death|1|||
129439948|NCT00971243|465909536|FG002|Open-label Period|Other reason|0|||
129439949|NCT00971243|465909537|FG003|Open-label Period|Other reason|0|||
129439950|NCT00971243|465909538|FG004|Open-label Period|Other reason|2|||
129439951|NCT05266586|465909541|FG000|Overall Study|Adverse Event|2|||
129439952|NCT05266586|465909542|FG001|Overall Study|Adverse Event|2|||
129439953|NCT05266586|465909543|FG002|Overall Study|Adverse Event|1|||
129439954|NCT05266586|465909541|FG000|Overall Study|Withdrawal by Subject|1|||
129439955|NCT05266586|465909542|FG001|Overall Study|Withdrawal by Subject|0|||
129439956|NCT05266586|465909543|FG002|Overall Study|Withdrawal by Subject|1|||
129439957|NCT05266586|465909541|FG000|Overall Study|Non-compliance with study drug|0|||
129439958|NCT05266586|465909542|FG001|Overall Study|Non-compliance with study drug|1|||
129439959|NCT05266586|465909543|FG002|Overall Study|Non-compliance with study drug|0|||
129439960|NCT05266586|465909541|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
129439961|NCT05266586|465909542|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
129626635|NCT00818766|466586925|FG001|Overall Study|Death|0|||
129626636|NCT00818766|466586924|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
129626637|NCT00818766|466586925|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
129626638|NCT00086684|466586926|FG000|Overall Study|Adverse Event|12|||
129626639|NCT00086684|466586927|FG001|Overall Study|Adverse Event|17|||
129626640|NCT00086684|466586928|FG002|Overall Study|Adverse Event|14|||
129626641|NCT00086684|466586926|FG000|Overall Study|Lack of Efficacy|6|||
129626642|NCT00086684|466586927|FG001|Overall Study|Lack of Efficacy|6|||
129626643|NCT00086684|466586928|FG002|Overall Study|Lack of Efficacy|5|||
129626644|NCT00086684|466586926|FG000|Overall Study|Lost to Follow-up|15|||
129626645|NCT00086684|466586927|FG001|Overall Study|Lost to Follow-up|8|||
129626646|NCT00086684|466586928|FG002|Overall Study|Lost to Follow-up|10|||
129626647|NCT00086684|466586926|FG000|Overall Study|Protocol Violation|8|||
129626648|NCT00086684|466586927|FG001|Overall Study|Protocol Violation|3|||
129626649|NCT00086684|466586928|FG002|Overall Study|Protocol Violation|0|||
129626650|NCT00086684|466586926|FG000|Overall Study|Withdrawal by Subject|0|||
129626651|NCT00086684|466586927|FG001|Overall Study|Withdrawal by Subject|4|||
129626652|NCT00086684|466586928|FG002|Overall Study|Withdrawal by Subject|10|||
129626653|NCT00086684|466586926|FG000|Overall Study|NONCOMPLIANCE|5|||
129888842|NCT04496167|467550919|FG000|Overall Study|Not Treated|1|||
129439962|NCT05266586|465909543|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
129626654|NCT00086684|466586927|FG001|Overall Study|NONCOMPLIANCE|7|||
129626655|NCT00086684|466586928|FG002|Overall Study|NONCOMPLIANCE|6|||
129626656|NCT00086684|466586926|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129626657|NCT00086684|466586927|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
129626658|NCT00086684|466586928|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
129626659|NCT00086684|466586926|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
129626660|NCT00086684|466586927|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
129626661|NCT00086684|466586928|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
129626662|NCT00086684|466586926|FG000|Overall Study|Other|4|||
129626663|NCT00086684|466586927|FG001|Overall Study|Other|2|||
129626664|NCT00086684|466586928|FG002|Overall Study|Other|3|||
129626665|NCT00725491|466586938|FG000|Overall Study|Adverse Event|3|||
129626666|NCT00725491|466586939|FG001|Overall Study|Adverse Event|2|||
129626667|NCT00725491|466586938|FG000|Overall Study|Pregnancy|0|||
129626668|NCT00725491|466586939|FG001|Overall Study|Pregnancy|3|||
129626669|NCT00725491|466586938|FG000|Overall Study|Risk for hyperstimulation|2|||
129626670|NCT00725491|466586939|FG001|Overall Study|Risk for hyperstimulation|9|||
129626671|NCT00725491|466586938|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
129626672|NCT00725491|466586939|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
129626673|NCT00725491|466586938|FG000|Overall Study|Fertilization failure|0|||
129626674|NCT00725491|466586939|FG001|Overall Study|Fertilization failure|1|||
129626675|NCT00725491|466586938|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
129626676|NCT00725491|466586939|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
129626677|NCT00882518|466586942|FG000|Overall Study|Adverse Event|9|||
129626678|NCT00882518|466586943|FG001|Overall Study|Adverse Event|18|||
129626679|NCT00882518|466586942|FG000|Overall Study|Withdrawal by Subject|9|||
129626680|NCT00882518|466586943|FG001|Overall Study|Withdrawal by Subject|13|||
129626681|NCT00882518|466586942|FG000|Overall Study|Lack of Efficacy|12|||
129626682|NCT00882518|466586943|FG001|Overall Study|Lack of Efficacy|9|||
129626683|NCT00882518|466586942|FG000|Overall Study|Severe non-compliance to protocol|3|||
129626684|NCT00882518|466586943|FG001|Overall Study|Severe non-compliance to protocol|1|||
129626685|NCT00882518|466586942|FG000|Overall Study|Incorrect enrolment|4|||
129626686|NCT00882518|466586943|FG001|Overall Study|Incorrect enrolment|2|||
129626687|NCT00882518|466586942|FG000|Overall Study|Central lab closure for National day|1|||
129626688|NCT00882518|466586943|FG001|Overall Study|Central lab closure for National day|0|||
129626689|NCT00882518|466586942|FG000|Overall Study|Allocating random number by mistake|0|||
129626690|NCT00882518|466586943|FG001|Overall Study|Allocating random number by mistake|1|||
129626691|NCT02137252|466586944|FG000|Overall Study|trial terminated early|2|||
129626692|NCT02137252|466586945|FG001|Overall Study|trial terminated early|1|||
129626693|NCT04421131|466586948|FG000|Overall Study|Lost to Follow-up|1|||
129626694|NCT04421131|466586948|FG000|Overall Study|Protocol Violation|2|||
129626695|NCT04421131|466586948|FG000|Overall Study|App crashed|5|||
129626696|NCT00729937|466586949|FG000|Overall Study|Lost to Follow-up|49|||
129626697|NCT00729937|466586950|FG001|Overall Study|Lost to Follow-up|58|||
129626698|NCT00729937|466586951|FG002|Overall Study|Lost to Follow-up|18|||
129626699|NCT00729937|466586952|FG003|Overall Study|Lost to Follow-up|33|||
129626700|NCT00729937|466586953|FG004|Overall Study|Lost to Follow-up|18|||
129626701|NCT00729937|466586954|FG005|Overall Study|Lost to Follow-up|23|||
129626702|NCT00729937|466586949|FG000|Overall Study|Physician Decision|7|||
129626703|NCT00729937|466586950|FG001|Overall Study|Physician Decision|16|||
129794087|NCT01986933|467212821|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
129794088|NCT01986933|467212817|FG000|Active-to-active (Part B)|Pregnancy|0|||
129794089|NCT01986933|467212818|FG001|Active-to-active (Part B)|Pregnancy|0|||
129794090|NCT01986933|467212819|FG002|Active-to-active (Part B)|Pregnancy|0|||
129794091|NCT01986933|467212820|FG003|Active-to-active (Part B)|Pregnancy|0|||
129794092|NCT01986933|467212821|FG004|Active-to-active (Part B)|Pregnancy|1|||
129794093|NCT01986933|467212817|FG000|Active-to-active (Part B)|Physician Decision|0|||
129794094|NCT01986933|467212818|FG001|Active-to-active (Part B)|Physician Decision|0|||
129794095|NCT01986933|467212819|FG002|Active-to-active (Part B)|Physician Decision|1|||
129794096|NCT01986933|467212820|FG003|Active-to-active (Part B)|Physician Decision|1|||
129794097|NCT01986933|467212821|FG004|Active-to-active (Part B)|Physician Decision|0|||
129794098|NCT01986933|467212817|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
129794099|NCT01986933|467212818|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
129794100|NCT01986933|467212819|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
129794101|NCT01986933|467212820|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
129794102|NCT01986933|467212821|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
129794103|NCT01986933|467212817|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
129794104|NCT01986933|467212818|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
129794105|NCT01986933|467212819|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
129794106|NCT01986933|467212820|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
129794107|NCT01986933|467212821|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
129888843|NCT04496167|467550920|FG001|Overall Study|Not Treated|2|||
129626704|NCT00729937|466586951|FG002|Overall Study|Physician Decision|2|||
129626705|NCT00729937|466586952|FG003|Overall Study|Physician Decision|0|||
129626706|NCT00729937|466586953|FG004|Overall Study|Physician Decision|5|||
129626707|NCT00729937|466586954|FG005|Overall Study|Physician Decision|8|||
129626708|NCT00729937|466586949|FG000|Overall Study|Death|1|||
129626709|NCT00729937|466586950|FG001|Overall Study|Death|0|||
129626710|NCT00729937|466586951|FG002|Overall Study|Death|1|||
129626711|NCT00729937|466586952|FG003|Overall Study|Death|0|||
129626712|NCT00729937|466586953|FG004|Overall Study|Death|0|||
129626713|NCT00729937|466586954|FG005|Overall Study|Death|1|||
129626714|NCT00729937|466586949|FG000|Overall Study|Withdrawal by Subject|3|||
129626715|NCT00729937|466586950|FG001|Overall Study|Withdrawal by Subject|5|||
129626716|NCT00729937|466586951|FG002|Overall Study|Withdrawal by Subject|6|||
129626717|NCT00729937|466586952|FG003|Overall Study|Withdrawal by Subject|0|||
129626718|NCT00729937|466586953|FG004|Overall Study|Withdrawal by Subject|4|||
129626719|NCT00729937|466586954|FG005|Overall Study|Withdrawal by Subject|2|||
129626720|NCT00729937|466586949|FG000|Overall Study|Randomized but not treated|12|||
129626721|NCT00729937|466586950|FG001|Overall Study|Randomized but not treated|6|||
129626722|NCT00729937|466586951|FG002|Overall Study|Randomized but not treated|1|||
129626723|NCT00729937|466586952|FG003|Overall Study|Randomized but not treated|0|||
129626724|NCT00729937|466586953|FG004|Overall Study|Randomized but not treated|1|||
129626725|NCT00729937|466586954|FG005|Overall Study|Randomized but not treated|3|||
129626726|NCT00729937|466586949|FG000|Overall Study|Did not meet eligibility criteria|2|||
129626727|NCT00729937|466586950|FG001|Overall Study|Did not meet eligibility criteria|1|||
129626728|NCT00729937|466586951|FG002|Overall Study|Did not meet eligibility criteria|0|||
129626729|NCT00729937|466586952|FG003|Overall Study|Did not meet eligibility criteria|0|||
129626730|NCT00729937|466586953|FG004|Overall Study|Did not meet eligibility criteria|0|||
129626731|NCT00729937|466586954|FG005|Overall Study|Did not meet eligibility criteria|0|||
129626732|NCT00729937|466586949|FG000|Overall Study|Incarcerated|0|||
129626733|NCT00729937|466586950|FG001|Overall Study|Incarcerated|2|||
129626734|NCT00729937|466586951|FG002|Overall Study|Incarcerated|1|||
129626735|NCT00729937|466586952|FG003|Overall Study|Incarcerated|1|||
129626736|NCT00729937|466586953|FG004|Overall Study|Incarcerated|0|||
129626737|NCT00729937|466586954|FG005|Overall Study|Incarcerated|0|||
129626738|NCT00243412|466586956|FG000|Overall Study|Death|0|||
129626739|NCT00243412|466586957|FG001|Overall Study|Death|1|||
129626740|NCT00243412|466586956|FG000|Overall Study|Adverse Event|4|||
129626741|NCT00243412|466586957|FG001|Overall Study|Adverse Event|2|||
129626742|NCT00243412|466586956|FG000|Overall Study|Lost to Follow-up|0|||
129626743|NCT00243412|466586957|FG001|Overall Study|Lost to Follow-up|1|||
129626744|NCT00243412|466586956|FG000|Overall Study|Physician Decision|1|||
129626745|NCT00243412|466586957|FG001|Overall Study|Physician Decision|1|||
129626746|NCT00243412|466586956|FG000|Overall Study|Withdrawal by Subject|4|||
129626747|NCT00243412|466586957|FG001|Overall Study|Withdrawal by Subject|5|||
129626748|NCT00243412|466586956|FG000|Overall Study|Other|1|||
129626749|NCT00243412|466586957|FG001|Overall Study|Other|1|||
129626750|NCT03281876|466586965|FG000|Overall Study|Adverse Event|4|||
129626751|NCT03281876|466586966|FG001|Overall Study|Adverse Event|15|||
129626752|NCT03281876|466586965|FG000|Overall Study|Lost to Follow-up|1|||
129626753|NCT03281876|466586966|FG001|Overall Study|Lost to Follow-up|4|||
129626754|NCT03281876|466586965|FG000|Overall Study|Withdrawal by Subject|11|||
129626755|NCT03281876|466586966|FG001|Overall Study|Withdrawal by Subject|15|||
129626756|NCT03281876|466586965|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129626757|NCT03281876|466586966|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129626758|NCT03281876|466586965|FG000|Overall Study|OTHER|5|||
129626759|NCT03281876|466586966|FG001|Overall Study|OTHER|5|||
129626760|NCT02208089|466586967|FG000|Overall Study|Withdrawal by Subject|1|||
129626761|NCT02208089|466586968|FG001|Overall Study|Withdrawal by Subject|0|||
129626762|NCT02208089|466586967|FG000|Overall Study|Lost to Follow-up|6|||
129626763|NCT02208089|466586968|FG001|Overall Study|Lost to Follow-up|0|||
129626764|NCT00683657|466586972|FG000|Overall Study|Adverse Event|0|||
129626765|NCT00683657|466586973|FG001|Overall Study|Adverse Event|1|||
129626766|NCT00683657|466586972|FG000|Overall Study|Subject Withdrew Consent|1|||
129626767|NCT00683657|466586973|FG001|Overall Study|Subject Withdrew Consent|0|||
129626768|NCT01408043|466586978|FG000|Overall Study|unable to collect cells|1|||
129626769|NCT00972595|466586979|FG000|Period 1|Adverse Event|1|||
129626770|NCT00972595|466586980|FG001|Period 1|Adverse Event|0|||
129626771|NCT02552121|466586981|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
129626772|NCT02552121|466586982|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626773|NCT02552121|466586983|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626774|NCT02552121|466586984|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626775|NCT02552121|466586985|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626776|NCT02552121|466586986|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626777|NCT02552121|466586987|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626778|NCT02552121|466586988|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
129626779|NCT02552121|466586981|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
129626780|NCT02552121|466586982|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129626781|NCT02552121|466586983|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129703160|NCT02302222|466874613|FG001|Overall Study|Physician Decision|4|||
129703161|NCT02302222|466874612|FG000|Overall Study|Lost to Follow-up|1|||
129703162|NCT02302222|466874613|FG001|Overall Study|Lost to Follow-up|0|||
129703163|NCT02302222|466874612|FG000|Overall Study|Treatment discontinued before day 5|0|||
129703164|NCT02302222|466874613|FG001|Overall Study|Treatment discontinued before day 5|1|||
129703165|NCT02302222|466874612|FG000|Overall Study|Withdrawn prior to any treatment|0|||
129703166|NCT02302222|466874613|FG001|Overall Study|Withdrawn prior to any treatment|1|||
129703167|NCT03781570|466874619|FG000|Overall Study|Technical Issues (equipment failure)|31|||
129703168|NCT03781570|466874619|FG000|Overall Study|Withdrawal by Subject|7|||
129703169|NCT03781570|466874619|FG000|Overall Study|Physical Constraints|11|||
129703170|NCT01107496|466874620|FG000|Overall Study|Adverse Event|1|||
129703171|NCT01107496|466874621|FG001|Overall Study|Adverse Event|0|||
129626782|NCT02552121|466586984|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129626783|NCT02552121|466586985|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129626784|NCT02552121|466586986|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129626785|NCT02552121|466586987|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129439963|NCT02730598|465909546|FG000|Overall Study|Withdrawal by Subject|3|||
129439964|NCT02730598|465909547|FG001|Overall Study|Withdrawal by Subject|3|||
129439965|NCT02730598|465909546|FG000|Overall Study|Protocol Violation|0|||
129439966|NCT02730598|465909547|FG001|Overall Study|Protocol Violation|1|||
129439967|NCT02730598|465909546|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
129439968|NCT02730598|465909547|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
129439969|NCT03282240|465909548|FG000|Overall Study|Adverse Event|2|||
129439970|NCT03282240|465909549|FG001|Overall Study|Adverse Event|2|||
129439971|NCT03282240|465909550|FG002|Overall Study|Adverse Event|0|||
129439972|NCT03282240|465909548|FG000|Overall Study|Lost to Follow-up|3|||
129439973|NCT03282240|465909549|FG001|Overall Study|Lost to Follow-up|0|||
129439974|NCT03282240|465909550|FG002|Overall Study|Lost to Follow-up|0|||
129439975|NCT03282240|465909548|FG000|Overall Study|Protocol Deviation|4|||
129439976|NCT03282240|465909549|FG001|Overall Study|Protocol Deviation|1|||
129439977|NCT03282240|465909550|FG002|Overall Study|Protocol Deviation|2|||
129439978|NCT03282240|465909548|FG000|Overall Study|Withdrawal by Subject|1|||
129439979|NCT03282240|465909549|FG001|Overall Study|Withdrawal by Subject|0|||
129439980|NCT03282240|465909550|FG002|Overall Study|Withdrawal by Subject|1|||
129439981|NCT01675479|465909551|FG000|Overall Study|Lost to Follow-up|11|||
129439982|NCT03254485|465909552|FG000|Overall Study|Adverse Event|3|||
129439983|NCT03254485|465909553|FG001|Overall Study|Adverse Event|0|||
129439984|NCT03254485|465909554|FG002|Overall Study|Adverse Event|0|||
129439985|NCT03254485|465909555|FG003|Overall Study|Adverse Event|6|||
129439986|NCT03254485|465909552|FG000|Overall Study|Protocol Violation|6|||
129439987|NCT03254485|465909553|FG001|Overall Study|Protocol Violation|0|||
129439988|NCT03254485|465909554|FG002|Overall Study|Protocol Violation|0|||
129439989|NCT03254485|465909555|FG003|Overall Study|Protocol Violation|2|||
129439990|NCT03254485|465909552|FG000|Overall Study|Withdrawal by Subject|1|||
129439991|NCT03254485|465909553|FG001|Overall Study|Withdrawal by Subject|0|||
129439992|NCT03254485|465909554|FG002|Overall Study|Withdrawal by Subject|0|||
129439993|NCT03254485|465909555|FG003|Overall Study|Withdrawal by Subject|4|||
129439994|NCT03254485|465909552|FG000|Overall Study|Death|0|||
129439995|NCT03254485|465909553|FG001|Overall Study|Death|0|||
129439996|NCT03254485|465909554|FG002|Overall Study|Death|0|||
129439997|NCT03254485|465909555|FG003|Overall Study|Death|1|||
129439998|NCT03254485|465909552|FG000|Overall Study|Lost to Follow-up|1|||
129439999|NCT03254485|465909553|FG001|Overall Study|Lost to Follow-up|0|||
129440000|NCT03254485|465909554|FG002|Overall Study|Lost to Follow-up|0|||
129440001|NCT03254485|465909555|FG003|Overall Study|Lost to Follow-up|0|||
129440002|NCT03254485|465909552|FG000|Overall Study|Other|1|||
129440003|NCT03254485|465909553|FG001|Overall Study|Other|0|||
129440004|NCT03254485|465909554|FG002|Overall Study|Other|0|||
129440005|NCT03254485|465909555|FG003|Overall Study|Other|2|||
129440006|NCT02146326|465909556|FG000|Overall Study|Lost to Follow-up|3|||
129440007|NCT02146326|465909557|FG001|Overall Study|Lost to Follow-up|3|||
129440008|NCT02146326|465909558|FG002|Overall Study|Lost to Follow-up|11|||
129888844|NCT04496167|467550919|FG000|Overall Study|Other Than Specified|1|||
129440009|NCT02146326|465909559|FG003|Overall Study|Lost to Follow-up|19|||
129440010|NCT02146326|465909556|FG000|Overall Study|Withdrawal by Subject|2|||
129440011|NCT02146326|465909557|FG001|Overall Study|Withdrawal by Subject|1|||
129440012|NCT02146326|465909558|FG002|Overall Study|Withdrawal by Subject|15|||
129626786|NCT02552121|466586988|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
129626787|NCT02552121|466586981|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626788|NCT02552121|466586982|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
129626789|NCT02552121|466586983|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626790|NCT02552121|466586984|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626791|NCT02552121|466586985|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626792|NCT02552121|466586986|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626793|NCT02552121|466586987|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626794|NCT02552121|466586988|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
129626795|NCT02552121|466586981|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129626796|NCT02552121|466586982|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
129626797|NCT02552121|466586983|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129626798|NCT02552121|466586984|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129626799|NCT02552121|466586985|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129626800|NCT02552121|466586986|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129626801|NCT02552121|466586987|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129440013|NCT02146326|465909559|FG003|Overall Study|Withdrawal by Subject|11|||
129440014|NCT02146326|465909556|FG000|Overall Study|Separated from mental health center|23|||
129440015|NCT02146326|465909557|FG001|Overall Study|Separated from mental health center|33|||
129440016|NCT02146326|465909558|FG002|Overall Study|Separated from mental health center|0|||
129440017|NCT02146326|465909559|FG003|Overall Study|Separated from mental health center|0|||
129440018|NCT02146326|465909556|FG000|Overall Study|Incarcerated|0|||
129440019|NCT02146326|465909557|FG001|Overall Study|Incarcerated|0|||
129440020|NCT02146326|465909558|FG002|Overall Study|Incarcerated|3|||
129440021|NCT02146326|465909559|FG003|Overall Study|Incarcerated|8|||
129440022|NCT02146326|465909556|FG000|Overall Study|Death|0|||
129440023|NCT02146326|465909557|FG001|Overall Study|Death|0|||
129440024|NCT02146326|465909558|FG002|Overall Study|Death|4|||
129440025|NCT02146326|465909559|FG003|Overall Study|Death|4|||
129440026|NCT02146326|465909556|FG000|Overall Study|Unable to complete interview|0|||
129440027|NCT02146326|465909557|FG001|Overall Study|Unable to complete interview|0|||
129440028|NCT02146326|465909558|FG002|Overall Study|Unable to complete interview|10|||
129440029|NCT02146326|465909559|FG003|Overall Study|Unable to complete interview|6|||
129440030|NCT02910739|465909560|FG000|Overall Study|Adverse Event|1|||
129440031|NCT02910739|465909561|FG001|Overall Study|Adverse Event|0|||
129440032|NCT02910739|465909562|FG002|Overall Study|Adverse Event|0|||
129440033|NCT02910739|465909563|FG003|Overall Study|Adverse Event|0|||
129440034|NCT01340651|465909565|FG000|Overall Study|Adverse Event|3|||
129440035|NCT01340651|465909565|FG000|Overall Study|Consent Withdrawn|2|||
129440036|NCT01340651|465909565|FG000|Overall Study|Commercial Supply per Sponsor|12|||
129440037|NCT01696942|465909570|FG000|Overall Study|Withdrawal by Subject|1|||
129440038|NCT01696942|465909571|FG001|Overall Study|Withdrawal by Subject|0|||
129440039|NCT01696942|465909570|FG000|Overall Study|Protocol Violation|1|||
129440040|NCT01696942|465909571|FG001|Overall Study|Protocol Violation|2|||
129440041|NCT01696942|465909570|FG000|Overall Study|screen failure|0|||
129440042|NCT01696942|465909571|FG001|Overall Study|screen failure|1|||
129440043|NCT01598311|465909576|FG000|Overall Study|Physician Decision|4|||
129440044|NCT01598311|465909577|FG001|Overall Study|Physician Decision|5|||
129440045|NCT01598311|465909576|FG000|Overall Study|Adverse Event|9|||
129440046|NCT01598311|465909577|FG001|Overall Study|Adverse Event|13|||
129440047|NCT01598311|465909576|FG000|Overall Study|Lost to Follow-up|7|||
129440048|NCT01598311|465909577|FG001|Overall Study|Lost to Follow-up|12|||
129440049|NCT01598311|465909576|FG000|Overall Study|Withdrawal by Subject|9|||
129440050|NCT01598311|465909577|FG001|Overall Study|Withdrawal by Subject|13|||
129440051|NCT01598311|465909576|FG000|Overall Study|No reason provided.|0|||
129440052|NCT01598311|465909577|FG001|Overall Study|No reason provided.|5|||
129440053|NCT01598311|465909576|FG000|Overall Study|Randomized but never treated|8|||
129440054|NCT01598311|465909577|FG001|Overall Study|Randomized but never treated|5|||
129440055|NCT01598311|465909576|FG000|Overall Study|Treated but no confirmed CDAD|9|||
129794108|NCT01986933|467212817|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
129794109|NCT01986933|467212818|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129794110|NCT01986933|467212819|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
129794111|NCT01986933|467212820|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129794112|NCT01986933|467212821|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
129794113|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
129794114|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
129794115|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
129794116|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
129794117|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
129794118|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794119|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794120|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794121|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
129794122|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
129794123|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
129794124|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
129794125|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
129794126|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
129794127|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
129794128|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
129794129|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
129794130|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
129794131|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
129794132|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
129794133|NCT01986933|467212817|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794134|NCT01986933|467212818|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
129440056|NCT01598311|465909577|FG001|Overall Study|Treated but no confirmed CDAD|8|||
129440057|NCT01598311|465909576|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
129440058|NCT01598311|465909577|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
129440059|NCT00688103|465909578|FG000|Overall Study|Adverse Event|4|||
129440060|NCT00688103|465909579|FG001|Overall Study|Adverse Event|1|||
129440061|NCT00688103|465909578|FG000|Overall Study|Lack of Efficacy|11|||
129440062|NCT00688103|465909579|FG001|Overall Study|Lack of Efficacy|1|||
129440063|NCT00688103|465909578|FG000|Overall Study|Withdrawal by Subject|4|||
129440064|NCT00688103|465909579|FG001|Overall Study|Withdrawal by Subject|2|||
129440065|NCT00688103|465909578|FG000|Overall Study|complex reasons|11|||
129440066|NCT00688103|465909579|FG001|Overall Study|complex reasons|9|||
129440067|NCT01313117|465909580|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
129440068|NCT01313117|465909580|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
129440069|NCT03602261|465909583|FG000|Overall Study|Adverse Event|5|||
129440070|NCT03602261|465909584|FG001|Overall Study|Adverse Event|1|||
129440071|NCT03602261|465909583|FG000|Overall Study|Physician Decision|1|||
129440072|NCT03602261|465909584|FG001|Overall Study|Physician Decision|0|||
129440073|NCT03602261|465909583|FG000|Overall Study|Withdrawal by Subject|1|||
129440074|NCT03602261|465909584|FG001|Overall Study|Withdrawal by Subject|1|||
129440075|NCT03602261|465909583|FG000|Overall Study|Lack of Efficacy|0|||
129440076|NCT03602261|465909584|FG001|Overall Study|Lack of Efficacy|1|||
129440077|NCT03602261|465909583|FG000|Overall Study|Subject moving out of state|1|||
129440078|NCT03602261|465909584|FG001|Overall Study|Subject moving out of state|0|||
129440079|NCT02101034|465911316|FG000|Overall Study|Enrolled but did not start treatment|0|||
129440080|NCT02101034|465911317|FG001|Overall Study|Enrolled but did not start treatment|0|||
129440081|NCT02101034|465911318|FG002|Overall Study|Enrolled but did not start treatment|1|||
129440082|NCT02101034|465911319|FG003|Overall Study|Enrolled but did not start treatment|0|||
129440083|NCT02101034|465911320|FG004|Overall Study|Enrolled but did not start treatment|0|||
129440084|NCT01103245|465911325|FG000|Overall Study|Withdrawal by Subject|1|||
129440085|NCT01103245|465911326|FG001|Overall Study|Withdrawal by Subject|0|||
129440086|NCT01103245|465911327|FG002|Overall Study|Withdrawal by Subject|3|||
129440087|NCT01103245|465911328|FG003|Overall Study|Withdrawal by Subject|0|||
129440088|NCT01103245|465911325|FG000|Overall Study|Inadequate IV access|1|||
129440089|NCT01103245|465911326|FG001|Overall Study|Inadequate IV access|0|||
129440090|NCT01103245|465911327|FG002|Overall Study|Inadequate IV access|0|||
129440091|NCT01103245|465911328|FG003|Overall Study|Inadequate IV access|0|||
129440092|NCT01103245|465911325|FG000|Overall Study|Adverse Event|0|||
129440093|NCT01103245|465911326|FG001|Overall Study|Adverse Event|2|||
129440094|NCT01103245|465911327|FG002|Overall Study|Adverse Event|1|||
129440095|NCT01103245|465911328|FG003|Overall Study|Adverse Event|0|||
129440096|NCT01103245|465911325|FG000|Overall Study|Physician Decision|1|||
129440097|NCT01103245|465911326|FG001|Overall Study|Physician Decision|0|||
129440098|NCT01103245|465911327|FG002|Overall Study|Physician Decision|0|||
129440099|NCT01103245|465911328|FG003|Overall Study|Physician Decision|0|||
129440100|NCT01101477|465911330|FG000|Overall Study|Protocol Violation|5|||
129440101|NCT01101477|465911331|FG001|Overall Study|Protocol Violation|3|||
129440102|NCT01101477|465911332|FG002|Overall Study|Protocol Violation|1|||
129440103|NCT00720941|465911333|FG000|Overall Study|Protocol Violation|1|||
129440104|NCT00720941|465911334|FG001|Overall Study|Protocol Violation|2|||
129440105|NCT00720941|465911333|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
129440106|NCT00720941|465911334|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
129440107|NCT00720941|465911333|FG000|Overall Study|Lost to Follow-up|20|||
129440108|NCT00720941|465911334|FG001|Overall Study|Lost to Follow-up|15|||
129440109|NCT00720941|465911333|FG000|Overall Study|Physician Decision|14|||
129626802|NCT02552121|466586988|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
129626803|NCT02552121|466586981|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129626804|NCT02552121|466586982|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
129626805|NCT02552121|466586983|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129626806|NCT02552121|466586984|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129626807|NCT02552121|466586985|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129626808|NCT02552121|466586986|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129626809|NCT02552121|466586987|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129440110|NCT00720941|465911334|FG001|Overall Study|Physician Decision|12|||
129440111|NCT00720941|465911333|FG000|Overall Study|Withdrawal by Subject|29|||
129440112|NCT00720941|465911334|FG001|Overall Study|Withdrawal by Subject|36|||
129440113|NCT00604279|465911335|FG000|Overall Study|Lack of Efficacy|22|||
129626810|NCT02552121|466586988|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
129440114|NCT00604279|465911336|FG001|Overall Study|Lack of Efficacy|9|||
129440115|NCT00604279|465911335|FG000|Overall Study|Lost to Follow-up|9|||
129440116|NCT00604279|465911336|FG001|Overall Study|Lost to Follow-up|14|||
129440117|NCT00604279|465911335|FG000|Overall Study|Pregnancy|2|||
129440118|NCT00604279|465911336|FG001|Overall Study|Pregnancy|0|||
129440119|NCT00604279|465911335|FG000|Overall Study|Protocol Violation|3|||
129440120|NCT00604279|465911336|FG001|Overall Study|Protocol Violation|1|||
129626811|NCT02552121|466586981|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626812|NCT02552121|466586982|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
129626813|NCT02552121|466586983|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626814|NCT02552121|466586984|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626815|NCT02552121|466586985|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626816|NCT02552121|466586986|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626817|NCT02552121|466586987|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626818|NCT02552121|466586988|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
129626819|NCT02552121|466586981|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
129626820|NCT02552121|466586982|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
129626821|NCT02552121|466586983|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
129626822|NCT02552121|466586984|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
129626823|NCT02552121|466586985|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
129626824|NCT02552121|466586986|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
129626825|NCT02552121|466586987|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
129626826|NCT02552121|466586988|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
129626827|NCT02552121|466586981|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
129626828|NCT02552121|466586982|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
129626829|NCT02552121|466586983|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
129626830|NCT02552121|466586984|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
129626831|NCT02552121|466586985|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
129626832|NCT02552121|466586986|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
129626833|NCT02552121|466586987|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
129440121|NCT00604279|465911335|FG000|Overall Study|Withdrawal by Subject|16|||
129626834|NCT02552121|466586988|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
129626835|NCT02552121|466586981|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
129626836|NCT02552121|466586982|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
129626837|NCT02552121|466586983|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
129626838|NCT02552121|466586984|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
129626839|NCT02552121|466586985|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
129626840|NCT02552121|466586986|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
129626841|NCT02552121|466586987|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
129626842|NCT02552121|466586988|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
129440122|NCT00604279|465911336|FG001|Overall Study|Withdrawal by Subject|5|||
129626843|NCT02552121|466586981|FG000|Part 2: Cohort Expansion|Death|0|||
129626844|NCT02552121|466586982|FG001|Part 2: Cohort Expansion|Death|0|||
129626845|NCT02552121|466586983|FG002|Part 2: Cohort Expansion|Death|1|||
129626846|NCT02552121|466586984|FG003|Part 2: Cohort Expansion|Death|0|||
129626847|NCT02552121|466586985|FG004|Part 2: Cohort Expansion|Death|0|||
129626848|NCT02552121|466586986|FG005|Part 2: Cohort Expansion|Death|0|||
129626849|NCT02552121|466586987|FG006|Part 2: Cohort Expansion|Death|0|||
129626850|NCT02552121|466586988|FG007|Part 2: Cohort Expansion|Death|0|||
129626851|NCT02586155|466586989|FG000|Overall Study|Adverse Event|2|||
129626852|NCT02586155|466586990|FG001|Overall Study|Adverse Event|3|||
129626853|NCT02586155|466586989|FG000|Overall Study|Withdrawal by Subject|31|||
129440123|NCT00604279|465911335|FG000|Overall Study|Adverse Event|4|||
129440124|NCT00604279|465911336|FG001|Overall Study|Adverse Event|5|||
129440125|NCT00604279|465911335|FG000|Overall Study|Other|8|||
129440126|NCT00604279|465911336|FG001|Overall Study|Other|4|||
129440127|NCT00355056|465911337|FG000|Randomization Period|Early Termination|4|||
129440128|NCT00355056|465911338|FG001|Randomization Period|Early Termination|6|||
129440129|NCT01072877|465911344|FG000|Overall Study|Lost to Follow-up|1|||
129440130|NCT01072877|465911345|FG001|Overall Study|Lost to Follow-up|1|||
129440131|NCT01072877|465911346|FG002|Overall Study|Lost to Follow-up|0|||
129440132|NCT01072877|465911347|FG003|Overall Study|Lost to Follow-up|2|||
129440133|NCT01072877|465911348|FG004|Overall Study|Lost to Follow-up|0|||
129440134|NCT02382016|465911351|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
129440135|NCT02382016|465911352|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
129440136|NCT02382016|465911351|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
129440137|NCT02382016|465911352|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
129440138|NCT02382016|465911351|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
129440139|NCT02382016|465911352|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
129440140|NCT02382016|465911351|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
129440141|NCT02382016|465911352|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
129440142|NCT02382016|465911351|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
129440143|NCT02382016|465911352|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
129440144|NCT02382016|465911351|FG000|Open-label (OL) Treatment Period|Death|4|||
129440145|NCT02382016|465911352|FG001|Open-label (OL) Treatment Period|Death|0|||
129440146|NCT02382016|465911351|FG000|OL Extension Period|Physician Decision|3|||
129626854|NCT02586155|466586990|FG001|Overall Study|Withdrawal by Subject|24|||
129626855|NCT02586155|466586989|FG000|Overall Study|Lost to Follow-up|7|||
129626856|NCT02586155|466586990|FG001|Overall Study|Lost to Follow-up|13|||
129626857|NCT02586155|466586989|FG000|Overall Study|Death|61|||
129626858|NCT02586155|466586990|FG001|Overall Study|Death|72|||
129626859|NCT02586155|466586989|FG000|Overall Study|Other reasons|26|||
129626860|NCT02586155|466586990|FG001|Overall Study|Other reasons|15|||
129626861|NCT00739063|466586993|FG000|Overall Study|Screen failures|8|||
129626862|NCT04779879|466586994|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129626863|NCT04779879|466586995|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129626864|NCT04779879|466586996|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129626865|NCT04779879|466586997|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
129626866|NCT04779879|466586998|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129626867|NCT04779879|466586999|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
129440147|NCT02382016|465911352|FG001|OL Extension Period|Physician Decision|0|||
129440148|NCT02382016|465911351|FG000|OL Extension Period|Death|2|||
129440149|NCT02382016|465911352|FG001|OL Extension Period|Death|0|||
129440150|NCT02382016|465911351|FG000|OL Extension Period|Withdrawal by Subject|1|||
129440151|NCT02382016|465911352|FG001|OL Extension Period|Withdrawal by Subject|0|||
129440152|NCT00084266|465911353|FG000|Overall Study|Death|42|||
129440153|NCT00084266|465911354|FG001|Overall Study|Death|39|||
129440154|NCT00084266|465911353|FG000|Overall Study|Adverse Event|8|||
129440155|NCT00084266|465911354|FG001|Overall Study|Adverse Event|5|||
129440156|NCT00084266|465911353|FG000|Overall Study|Lack of Efficacy|2|||
129440157|NCT00084266|465911354|FG001|Overall Study|Lack of Efficacy|4|||
129440158|NCT00084266|465911353|FG000|Overall Study|Lost to Follow-up|5|||
129440159|NCT00084266|465911354|FG001|Overall Study|Lost to Follow-up|3|||
129440160|NCT00084266|465911353|FG000|Overall Study|Participant not willing to participate|3|||
129440161|NCT00084266|465911354|FG001|Overall Study|Participant not willing to participate|8|||
129440162|NCT00084266|465911353|FG000|Overall Study|Other|360|||
129440163|NCT00084266|465911354|FG001|Overall Study|Other|344|||
129440164|NCT00084266|465911353|FG000|Overall Study|Randomized not treated|21|||
129440165|NCT00084266|465911354|FG001|Overall Study|Randomized not treated|20|||
129626868|NCT04779879|466586994|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
129626869|NCT04779879|466586995|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
129626870|NCT04779879|466586996|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
129626871|NCT04779879|466586997|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
129626872|NCT04779879|466586998|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
129794135|NCT01986933|467212819|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794136|NCT01986933|467212820|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794137|NCT01986933|467212821|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
129794138|NCT03119701|467212822|FG000|6-day Dosing|Death|4|||
129440166|NCT00730171|465911355|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
129440167|NCT00730171|465911355|FG000|Overall Study|Adverse Event|193|||
129440168|NCT00730171|465911355|FG000|Overall Study|Protocol Violation|48|||
129626873|NCT04779879|466586999|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
129626874|NCT04779879|466586994|FG000|Part C: Up to Week 36|Death|0|||
129626875|NCT04779879|466586995|FG001|Part C: Up to Week 36|Death|0|||
129440169|NCT00730171|465911355|FG000|Overall Study|Withdrawal by Subject|202|||
129440170|NCT00730171|465911355|FG000|Overall Study|Lost to Follow-up|121|||
129794139|NCT03119701|467212823|FG001|6-day Dosing|Death|1|||
129440171|NCT00730171|465911355|FG000|Overall Study|Insufficient Therapeutic Response|141|||
129440172|NCT00730171|465911355|FG000|Overall Study|Other|61|||
129440173|NCT01729156|465911356|FG000|Overall Study|Withdrawal by Subject|1|||
129440174|NCT01729156|465911357|FG001|Overall Study|Withdrawal by Subject|0|||
129440175|NCT01729156|465911358|FG002|Overall Study|Withdrawal by Subject|0|||
129794140|NCT03119701|467212822|FG000|6-day Dosing|Adverse Event|3|||
129794141|NCT03119701|467212823|FG001|6-day Dosing|Adverse Event|0|||
129794142|NCT03119701|467212822|FG000|6-day Dosing|Physician Decision|0|||
129794143|NCT03119701|467212823|FG001|6-day Dosing|Physician Decision|1|||
129794144|NCT03119701|467212822|FG000|6-day Dosing|Withdrawal by Subject|0|||
129794145|NCT03119701|467212823|FG001|6-day Dosing|Withdrawal by Subject|1|||
129794146|NCT03119701|467212822|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
129794147|NCT03119701|467212823|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
129440176|NCT02952001|465911359|FG000|Overall Study|Adverse Event|3|||
129440177|NCT02952001|465911360|FG001|Overall Study|Adverse Event|0|||
129440178|NCT02952001|465911359|FG000|Overall Study|Prohibited therapy|10|||
129440179|NCT02952001|465911360|FG001|Overall Study|Prohibited therapy|3|||
129440180|NCT02952001|465911359|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
129440181|NCT02952001|465911360|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
129440182|NCT00937833|465911361|FG000|Overall Study|Protocol Violation|1|||
129440183|NCT00937833|465911362|FG001|Overall Study|Protocol Violation|2|||
129440184|NCT00937833|465911361|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
129440185|NCT00937833|465911362|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
129440186|NCT00937833|465911361|FG000|Overall Study|Lost to Follow-up|10|||
129440187|NCT00937833|465911362|FG001|Overall Study|Lost to Follow-up|8|||
129440188|NCT00937833|465911361|FG000|Overall Study|Withdrawal by Subject|4|||
129440189|NCT00937833|465911362|FG001|Overall Study|Withdrawal by Subject|6|||
129440190|NCT03285178|465911364|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
129440191|NCT03285178|465911365|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129440192|NCT03285178|465911366|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129440193|NCT03285178|465911367|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129440194|NCT03285178|465911368|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129440195|NCT03285178|465911369|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129626876|NCT04779879|466586996|FG002|Part C: Up to Week 36|Death|0|||
129626877|NCT04779879|466586997|FG003|Part C: Up to Week 36|Death|0|||
129626878|NCT04779879|466586998|FG004|Part C: Up to Week 36|Death|0|||
129626879|NCT04779879|466586999|FG005|Part C: Up to Week 36|Death|1|||
129626880|NCT04779879|466586994|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
129626881|NCT04779879|466586995|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
129626882|NCT04779879|466586996|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
129626883|NCT04779879|466586997|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
129626884|NCT04779879|466586998|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
129626885|NCT04779879|466586999|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
129626886|NCT02461160|466587000|FG000|Overall Study|Lost to Follow-up|0|||
129626887|NCT02461160|466587001|FG001|Overall Study|Lost to Follow-up|0|||
129626888|NCT02461160|466587002|FG002|Overall Study|Lost to Follow-up|0|||
129626889|NCT02461160|466587003|FG003|Overall Study|Lost to Follow-up|0|||
129626890|NCT02461160|466587004|FG004|Overall Study|Lost to Follow-up|0|||
129626891|NCT02461160|466587005|FG005|Overall Study|Lost to Follow-up|0|||
129626892|NCT02461160|466587006|FG006|Overall Study|Lost to Follow-up|0|||
129703172|NCT01107496|466874620|FG000|Overall Study|Lack of Efficacy|1|||
129703173|NCT01107496|466874621|FG001|Overall Study|Lack of Efficacy|0|||
129703174|NCT01107496|466874620|FG000|Overall Study|Protocol Violation|0|||
129703175|NCT01107496|466874621|FG001|Overall Study|Protocol Violation|1|||
129703176|NCT01107496|466874620|FG000|Overall Study|Lost to Follow-up|0|||
129703177|NCT01107496|466874621|FG001|Overall Study|Lost to Follow-up|1|||
129703178|NCT03709472|466874622|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
129703179|NCT03709472|466874623|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
129794148|NCT00811642|467212832|FG000|Overall Study|Adverse Event|3|||
129794149|NCT00811642|467212832|FG000|Overall Study|Protocol Violation|1|||
129703180|NCT03709472|466874622|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
129794150|NCT00811642|467212832|FG000|Overall Study|Death|2|||
129794151|NCT00811642|467212832|FG000|Overall Study|Withdrawal by Subject|7|||
129794152|NCT00811642|467212832|FG000|Overall Study|Cumulative use of antifungal agent|2|||
129794153|NCT00782795|467212833|FG000|Overall Study|Withdrawal by Subject|1|||
129794154|NCT00782795|467212834|FG001|Overall Study|Withdrawal by Subject|2|||
129794155|NCT00562627|467214272|FG000|Overall Study|Protocol Violation|1|||
129794156|NCT00562627|467214273|FG001|Overall Study|Protocol Violation|1|||
129440196|NCT03285178|465911370|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
129440197|NCT03285178|465911364|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
129794157|NCT00562627|467214274|FG002|Overall Study|Protocol Violation|1|||
129794158|NCT00625742|467214275|FG000|Overall Study|Disease Progression|2|||
129794159|NCT00625742|467214275|FG000|Overall Study|Withdrawal by Subject|1|||
129794160|NCT00625742|467214275|FG000|Overall Study|Adverse Event|4|||
129794161|NCT00625742|467214275|FG000|Overall Study|Lost to Follow-up|4|||
129794162|NCT00625742|467214275|FG000|Overall Study|Ineligible|1|||
129440198|NCT03285178|465911365|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129440199|NCT03285178|465911366|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129626893|NCT02461160|466587007|FG007|Overall Study|Lost to Follow-up|1|||
129626894|NCT02461160|466587008|FG008|Overall Study|Lost to Follow-up|0|||
129626895|NCT02461160|466587009|FG009|Overall Study|Lost to Follow-up|0|||
129626896|NCT02461160|466587010|FG010|Overall Study|Lost to Follow-up|0|||
129626897|NCT02461160|466587011|FG011|Overall Study|Lost to Follow-up|0|||
129626898|NCT02461160|466587012|FG012|Overall Study|Lost to Follow-up|0|||
129626899|NCT02854527|466587013|FG000|Overall Study|Adverse Event|0|||
129626900|NCT02854527|466587014|FG001|Overall Study|Adverse Event|0|||
129794163|NCT01709578|467214276|FG000|Overall Study|Rescued and entered in long term safety|63|||
129794164|NCT01709578|467214277|FG001|Overall Study|Rescued and entered in long term safety|25|||
129794165|NCT01709578|467214278|FG002|Overall Study|Rescued and entered in long term safety|26|||
129794166|NCT01709578|467214276|FG000|Overall Study|Adverse Event|9|||
129794167|NCT01709578|467214277|FG001|Overall Study|Adverse Event|18|||
129794168|NCT01709578|467214278|FG002|Overall Study|Adverse Event|17|||
129626901|NCT02854527|466587015|FG002|Overall Study|Adverse Event|0|||
129626902|NCT02854527|466587016|FG003|Overall Study|Adverse Event|0|||
129626903|NCT02854527|466587017|FG004|Overall Study|Adverse Event|1|||
129626904|NCT02854527|466587018|FG005|Overall Study|Adverse Event|0|||
129626905|NCT02854527|466587019|FG006|Overall Study|Adverse Event|0|||
129794169|NCT01709578|467214276|FG000|Overall Study|Lack of Efficacy|5|||
129794170|NCT01709578|467214277|FG001|Overall Study|Lack of Efficacy|4|||
129794171|NCT01709578|467214278|FG002|Overall Study|Lack of Efficacy|2|||
129888845|NCT04496167|467550920|FG001|Overall Study|Other Than Specified|1|||
129888846|NCT03018106|467550921|FG000|Overall Study|Lost to Follow-up|0|||
129626906|NCT02854527|466587020|FG007|Overall Study|Adverse Event|0|||
129626907|NCT02854527|466587021|FG008|Overall Study|Adverse Event|0|||
129626908|NCT02854527|466587022|FG009|Overall Study|Adverse Event|0|||
129626909|NCT02854527|466587013|FG000|Overall Study|Lost to Follow-up|0|||
129626910|NCT02854527|466587014|FG001|Overall Study|Lost to Follow-up|0|||
129626911|NCT02854527|466587015|FG002|Overall Study|Lost to Follow-up|0|||
129626912|NCT02854527|466587016|FG003|Overall Study|Lost to Follow-up|1|||
129626913|NCT02854527|466587017|FG004|Overall Study|Lost to Follow-up|0|||
129626914|NCT02854527|466587018|FG005|Overall Study|Lost to Follow-up|0|||
129626915|NCT02854527|466587019|FG006|Overall Study|Lost to Follow-up|0|||
129626916|NCT02854527|466587020|FG007|Overall Study|Lost to Follow-up|0|||
129626917|NCT02854527|466587021|FG008|Overall Study|Lost to Follow-up|0|||
129626918|NCT02854527|466587022|FG009|Overall Study|Lost to Follow-up|0|||
129626919|NCT02899962|466587023|FG000|Open-label Phase|Adverse Event|2|||
129626920|NCT02899962|466587024|FG001|Open-label Phase|Adverse Event|0|||
129626921|NCT02899962|466587025|FG002|Open-label Phase|Adverse Event|0|||
129626922|NCT02899962|466587023|FG000|Open-label Phase|Lost to Follow-up|9|||
129626923|NCT02899962|466587024|FG001|Open-label Phase|Lost to Follow-up|0|||
129626924|NCT02899962|466587025|FG002|Open-label Phase|Lost to Follow-up|0|||
129626925|NCT02899962|466587023|FG000|Open-label Phase|Other reasons|9|||
129794172|NCT01709578|467214276|FG000|Overall Study|Poor compliance to protocol|1|||
129888847|NCT03018106|467550922|FG001|Overall Study|Lost to Follow-up|1|||
129888848|NCT03055832|467550923|FG000|Week 2|Withdrawal by Subject|1|||
129888849|NCT03055832|467550924|FG001|Week 2|Withdrawal by Subject|0|||
129626926|NCT02899962|466587024|FG001|Open-label Phase|Other reasons|0|||
129794173|NCT01709578|467214277|FG001|Overall Study|Poor compliance to protocol|2|||
129440200|NCT03285178|465911367|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129440201|NCT03285178|465911368|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129440202|NCT03285178|465911369|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129440203|NCT03285178|465911370|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
129440204|NCT03285178|465911364|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
129440205|NCT03285178|465911365|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
129440206|NCT03285178|465911366|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
129440207|NCT03285178|465911367|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
129440208|NCT03285178|465911368|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
129440209|NCT03285178|465911369|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
129440210|NCT03285178|465911370|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
129440211|NCT03285178|465911364|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
129440212|NCT03285178|465911365|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129626927|NCT02899962|466587025|FG002|Open-label Phase|Other reasons|0|||
129626928|NCT02899962|466587023|FG000|Open-label Phase|Withdrawal by Subject|7|||
129626929|NCT02899962|466587024|FG001|Open-label Phase|Withdrawal by Subject|0|||
129626930|NCT02899962|466587025|FG002|Open-label Phase|Withdrawal by Subject|0|||
129626931|NCT02899962|466587023|FG000|Maintenance Phase|Adverse Event|0|||
129626932|NCT02899962|466587024|FG001|Maintenance Phase|Adverse Event|2|||
129794174|NCT01709578|467214278|FG002|Overall Study|Poor compliance to protocol|1|||
129794175|NCT01709578|467214276|FG000|Overall Study|Other, not related to safety or efficacy|2|||
129794176|NCT01709578|467214277|FG001|Overall Study|Other, not related to safety or efficacy|7|||
129794177|NCT01709578|467214278|FG002|Overall Study|Other, not related to safety or efficacy|5|||
129794178|NCT04050371|467214279|FG000|Overall Study|Withdrawal by Subject|1|||
129794179|NCT04050371|467214280|FG001|Overall Study|Withdrawal by Subject|0|||
129794180|NCT00597701|467214281|FG000|Overall Study|Withdrawal by Subject|5|||
129794181|NCT00597701|467214282|FG001|Overall Study|Withdrawal by Subject|5|||
129794182|NCT00597701|467214281|FG000|Overall Study|Death|0|||
129794183|NCT00597701|467214282|FG001|Overall Study|Death|1|||
129794184|NCT00597701|467214281|FG000|Overall Study|Physician Decision|2|||
129794185|NCT00597701|467214282|FG001|Overall Study|Physician Decision|0|||
129794186|NCT00597701|467214281|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
129794187|NCT00597701|467214282|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
129794188|NCT01107418|467214283|FG000|Overall Study|Disease Progression|45|||
129794189|NCT01107418|467214283|FG000|Overall Study|Adverse Event|3|||
129794190|NCT01107418|467214283|FG000|Overall Study|Withdrawal by Subject|1|||
129794191|NCT01107418|467214283|FG000|Overall Study|Study Closing|1|||
129794192|NCT01107418|467214283|FG000|Overall Study|Started Other Therapy|1|||
129794193|NCT01107418|467214283|FG000|Overall Study|Entered Extension Study|1|||
129794194|NCT00301821|467214290|FG000|Overall Study|Ineligible|25|||
129794195|NCT00301821|467214290|FG000|Overall Study|Cancel|1|||
129794196|NCT03150485|467214293|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129794197|NCT03150485|467214294|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129794198|NCT03150485|467214295|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
129794199|NCT03150485|467214296|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
129626933|NCT02899962|466587025|FG002|Maintenance Phase|Adverse Event|1|||
129626934|NCT02899962|466587023|FG000|Maintenance Phase|Death|0|||
129626935|NCT02899962|466587024|FG001|Maintenance Phase|Death|0|||
129626936|NCT02899962|466587025|FG002|Maintenance Phase|Death|1|||
129626937|NCT02899962|466587023|FG000|Maintenance Phase|Lack of Efficacy|0|||
129626938|NCT02899962|466587024|FG001|Maintenance Phase|Lack of Efficacy|20|||
129626939|NCT02899962|466587025|FG002|Maintenance Phase|Lack of Efficacy|16|||
129626940|NCT02899962|466587023|FG000|Maintenance Phase|Lost to Follow-up|0|||
129626941|NCT02899962|466587024|FG001|Maintenance Phase|Lost to Follow-up|12|||
129626942|NCT02899962|466587025|FG002|Maintenance Phase|Lost to Follow-up|14|||
129626943|NCT02899962|466587023|FG000|Maintenance Phase|Other reasons|0|||
129626944|NCT02899962|466587024|FG001|Maintenance Phase|Other reasons|9|||
129626945|NCT02899962|466587025|FG002|Maintenance Phase|Other reasons|13|||
129794200|NCT03150485|467214297|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
129794201|NCT03150485|467214298|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
129794202|NCT01394718|467214301|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
129794203|NCT01394718|467214302|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
129703181|NCT03709472|466874623|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
129703182|NCT03559556|466874624|FG000|Overall Study|Withdrawal by Subject|1|||
129703183|NCT02496000|466874630|FG000|Overall Study|Withdrawal by Subject|1|||
129703184|NCT02496000|466874631|FG001|Overall Study|Withdrawal by Subject|2|||
129703185|NCT02496000|466874632|FG002|Overall Study|Withdrawal by Subject|0|||
129703186|NCT02496000|466874630|FG000|Overall Study|Lost to Follow-up|1|||
129703187|NCT02496000|466874631|FG001|Overall Study|Lost to Follow-up|0|||
129703188|NCT02496000|466874632|FG002|Overall Study|Lost to Follow-up|1|||
129703189|NCT02496000|466874630|FG000|Overall Study|Protocol Violation|0|||
129703190|NCT02496000|466874631|FG001|Overall Study|Protocol Violation|0|||
129703191|NCT02496000|466874632|FG002|Overall Study|Protocol Violation|1|||
129703192|NCT02496000|466874630|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
129703193|NCT02496000|466874631|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
129703194|NCT02496000|466874632|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
129703195|NCT02496000|466874630|FG000|Overall Study|undetermined|0|||
129703196|NCT02496000|466874631|FG001|Overall Study|undetermined|1|||
129703197|NCT02496000|466874632|FG002|Overall Study|undetermined|0|||
129703198|NCT03274466|466874633|FG000|Overall Study|Withdrawal by Subject|7|||
129703199|NCT03274466|466874634|FG001|Overall Study|Withdrawal by Subject|3|||
129703200|NCT03274466|466874633|FG000|Overall Study|Protocol Specified Withdrawal|5|||
129703201|NCT03274466|466874634|FG001|Overall Study|Protocol Specified Withdrawal|11|||
129703202|NCT03274466|466874633|FG000|Overall Study|Lost to Follow-up|5|||
129703203|NCT03274466|466874634|FG001|Overall Study|Lost to Follow-up|7|||
129703204|NCT03274466|466874633|FG000|Overall Study|Subject Non-compliance|0|||
129703205|NCT03274466|466874634|FG001|Overall Study|Subject Non-compliance|1|||
129703206|NCT03274466|466874633|FG000|Overall Study|Adverse Event|3|||
129703207|NCT03274466|466874634|FG001|Overall Study|Adverse Event|3|||
129703208|NCT03274466|466874633|FG000|Overall Study|Physician Decision|0|||
129703209|NCT03274466|466874634|FG001|Overall Study|Physician Decision|1|||
129703210|NCT03274466|466874633|FG000|Overall Study|Protocol Violation|3|||
129703211|NCT03274466|466874634|FG001|Overall Study|Protocol Violation|3|||
129703212|NCT00618787|466874635|FG000|Overall Study|Adverse Event|0|||
129703213|NCT00618787|466874636|FG001|Overall Study|Adverse Event|1|||
129703214|NCT00618787|466874635|FG000|Overall Study|Withdrawal by Subject|2|||
129703215|NCT00618787|466874636|FG001|Overall Study|Withdrawal by Subject|1|||
129703216|NCT00618787|466874635|FG000|Overall Study|Lost to Follow-up|1|||
129703217|NCT00618787|466874636|FG001|Overall Study|Lost to Follow-up|0|||
129703218|NCT01107886|466874637|FG000|Overall Study|Lost to Follow-up|15|||
129703219|NCT01107886|466874638|FG001|Overall Study|Lost to Follow-up|13|||
129703220|NCT01107886|466874637|FG000|Overall Study|Withdrawal by Subject|180|||
129703221|NCT01107886|466874638|FG001|Overall Study|Withdrawal by Subject|196|||
129703222|NCT01107886|466874637|FG000|Overall Study|Administrative withdrawal of consent|7|||
129703223|NCT01107886|466874638|FG001|Overall Study|Administrative withdrawal of consent|5|||
129703224|NCT01649869|466874643|FG000|Overall Study|Family member illness|1|||
129703225|NCT01649869|466874644|FG001|Overall Study|Family member illness|0|||
129703226|NCT01649869|466874643|FG000|Overall Study|Required treatment outside protocol|1|||
129703227|NCT01649869|466874644|FG001|Overall Study|Required treatment outside protocol|0|||
129703228|NCT01649869|466874643|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
129794204|NCT01362595|467214309|FG000|Overall Study|Screen failure|10|||
129794205|NCT01362595|467214309|FG000|Overall Study|Withdrawal by Subject|2|||
129794206|NCT02469038|467214310|FG000|Overall Study|Physician Decision|4|||
129794207|NCT02469038|467214311|FG001|Overall Study|Physician Decision|5|||
129794208|NCT00636987|467214312|FG000|Overall Study|Death|44|||
129794209|NCT00636987|467214312|FG000|Overall Study|Explanted|13|||
129794210|NCT00636987|467214312|FG000|Overall Study|Lost to Follow-up|63|||
129794211|NCT00636987|467214312|FG000|Overall Study|5 year visit window not complete|69|||
129794212|NCT01251146|467214313|FG000|Overall Study|Lost to Follow-up|3|||
129794213|NCT01251146|467214314|FG001|Overall Study|Lost to Follow-up|10|||
129794214|NCT01739400|467214315|FG000|Overall Study|Physician Decision|3|||
129794215|NCT01739400|467214316|FG001|Overall Study|Physician Decision|0|||
129794216|NCT01739400|467214315|FG000|Overall Study|Lost to Follow-up|2|||
129703229|NCT01649869|466874644|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
129703230|NCT02333799|466877404|FG000|Treatment Period|Withdrawal by Subject|1|||
129703231|NCT02333799|466877404|FG000|Treatment Period|Death|6|||
129703232|NCT02333799|466877404|FG000|6 Month Follow Up Period|Physician Decision|1|||
129703233|NCT02333799|466877404|FG000|6 Month Follow Up Period|Death|1|||
129703234|NCT02333799|466877404|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
129703235|NCT02333799|466877404|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
129703236|NCT01657370|466877408|FG000|Overall Study|Withdrawal by Subject|0|||
129703237|NCT01657370|466877409|FG001|Overall Study|Withdrawal by Subject|0|||
129794217|NCT01739400|467214316|FG001|Overall Study|Lost to Follow-up|0|||
129794218|NCT01739400|467214315|FG000|Overall Study|Death|5|||
129794219|NCT01739400|467214316|FG001|Overall Study|Death|2|||
129794220|NCT01739400|467214315|FG000|Overall Study|Withdrawal by Subject|7|||
129794221|NCT01739400|467214316|FG001|Overall Study|Withdrawal by Subject|7|||
129794222|NCT01083173|467214323|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
129794223|NCT01083173|467214324|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
129794224|NCT01083173|467214323|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
129794225|NCT01083173|467214324|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
129794226|NCT01083173|467214323|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
129794227|NCT01083173|467214324|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
129794228|NCT01083173|467214323|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
129794229|NCT01083173|467214324|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
129794230|NCT01083173|467214323|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
129794231|NCT01083173|467214324|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
129794232|NCT01083173|467214323|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
129794233|NCT01083173|467214324|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
129794234|NCT01083173|467214323|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
129794235|NCT01083173|467214324|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
129794236|NCT01083173|467214323|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
129794237|NCT01083173|467214324|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
129794238|NCT01083173|467214323|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
129794239|NCT01083173|467214324|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
129794240|NCT01083173|467214323|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
129800267|NCT02445391|467236291|FG001|Overall Study|Complicating disease|2|||
129800268|NCT02445391|467236292|FG002|Overall Study|Complicating disease|1|||
129626946|NCT02899962|466587023|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
129440213|NCT03285178|465911366|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129440214|NCT03285178|465911367|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129440215|NCT03285178|465911368|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129440216|NCT03285178|465911369|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129440217|NCT03285178|465911370|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
129440218|NCT03285178|465911364|FG000|Single-Blind Run-In Period|Physician Decision|2|||
129440219|NCT03285178|465911365|FG001|Single-Blind Run-In Period|Physician Decision|0|||
129440220|NCT03285178|465911366|FG002|Single-Blind Run-In Period|Physician Decision|0|||
129440221|NCT03285178|465911367|FG003|Single-Blind Run-In Period|Physician Decision|0|||
129440222|NCT03285178|465911368|FG004|Single-Blind Run-In Period|Physician Decision|0|||
129440223|NCT03285178|465911369|FG005|Single-Blind Run-In Period|Physician Decision|0|||
129440224|NCT03285178|465911370|FG006|Single-Blind Run-In Period|Physician Decision|0|||
129440225|NCT03285178|465911364|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129440226|NCT03285178|465911365|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
129440227|NCT03285178|465911366|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
129440228|NCT03285178|465911367|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129440229|NCT03285178|465911368|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129440230|NCT03285178|465911369|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129440231|NCT03285178|465911370|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
129626947|NCT02899962|466587024|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
129626948|NCT02899962|466587025|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
129626949|NCT02899962|466587023|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
129626950|NCT02899962|466587024|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
129626951|NCT02899962|466587025|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
129626952|NCT02899962|466587023|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129626953|NCT02899962|466587024|FG001|Maintenance Phase|Withdrawal by Subject|30|||
129626954|NCT02899962|466587025|FG002|Maintenance Phase|Withdrawal by Subject|36|||
129626955|NCT03567980|466587032|FG000|Overall Study|Adverse Event|1|||
129626956|NCT01821807|466587034|FG000|Overall Study|Lost to Follow-up|3|||
129626957|NCT01821807|466587035|FG001|Overall Study|Lost to Follow-up|1|||
129626958|NCT02633787|466587037|FG000|Overall Study|Withdrawal by Subject|1|||
129626959|NCT00550459|466587038|FG000|Overall Study|Adverse Event|0|||
129626960|NCT00550459|466587039|FG001|Overall Study|Adverse Event|2|||
129626961|NCT00550459|466587038|FG000|Overall Study|Withdrawal by Subject|1|||
129626962|NCT00550459|466587039|FG001|Overall Study|Withdrawal by Subject|1|||
129440232|NCT03285178|465911364|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129440233|NCT03285178|465911365|FG001|Double-Blind Treatment Period|Adverse Event|0|||
129440234|NCT03285178|465911366|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129440235|NCT03285178|465911367|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129440236|NCT03285178|465911368|FG004|Double-Blind Treatment Period|Adverse Event|0|||
129440237|NCT03285178|465911369|FG005|Double-Blind Treatment Period|Adverse Event|0|||
129440238|NCT03285178|465911370|FG006|Double-Blind Treatment Period|Adverse Event|2|||
129440239|NCT03285178|465911364|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129440240|NCT03285178|465911365|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129440241|NCT03285178|465911366|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
129440242|NCT03285178|465911367|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
129440243|NCT03285178|465911368|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
129626963|NCT02404805|466587040|FG000|Overall Study|Withdrawal by Subject|1|||
129626964|NCT02404805|466587041|FG001|Overall Study|Withdrawal by Subject|0|||
129794241|NCT01083173|467214324|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
129794242|NCT01083173|467214323|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
129794243|NCT01083173|467214324|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
129794244|NCT03410823|467214325|FG000|Overall Study|Death|1|||
129794245|NCT03410823|467214325|FG000|Overall Study|Withdrawal by Subject|2|||
129794246|NCT03410823|467214325|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
129794247|NCT03569293|467214326|FG000|Overall Study|Adverse Event|4|||
129794248|NCT03569293|467214327|FG001|Overall Study|Adverse Event|1|||
129794249|NCT03569293|467214328|FG002|Overall Study|Adverse Event|5|||
129794250|NCT03569293|467214329|FG003|Overall Study|Adverse Event|1|||
129794251|NCT03569293|467214330|FG004|Overall Study|Adverse Event|0|||
129794252|NCT03569293|467214331|FG005|Overall Study|Adverse Event|0|||
129440244|NCT03285178|465911369|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
129440245|NCT03285178|465911370|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
129440246|NCT03285178|465911364|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129440247|NCT03285178|465911365|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129440248|NCT03285178|465911366|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129440249|NCT03285178|465911367|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129440250|NCT03285178|465911368|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129440251|NCT03285178|465911369|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129440252|NCT03285178|465911370|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129440253|NCT03285178|465911364|FG000|Double-Blind Treatment Period|COVID-19|0|||
129440254|NCT03285178|465911365|FG001|Double-Blind Treatment Period|COVID-19|0|||
129440255|NCT03285178|465911366|FG002|Double-Blind Treatment Period|COVID-19|1|||
129440256|NCT03285178|465911367|FG003|Double-Blind Treatment Period|COVID-19|0|||
129440257|NCT03285178|465911368|FG004|Double-Blind Treatment Period|COVID-19|0|||
129440258|NCT03285178|465911369|FG005|Double-Blind Treatment Period|COVID-19|0|||
129440259|NCT03285178|465911370|FG006|Double-Blind Treatment Period|COVID-19|0|||
129440260|NCT01388790|465911371|FG000|Overall Study|Ongoing at data cut-off date|8|||
129440261|NCT01128894|465911372|FG000|Overall Study|Adverse Event|31|||
129626965|NCT02404805|466587042|FG002|Overall Study|Withdrawal by Subject|0|||
129794253|NCT03569293|467214326|FG000|Overall Study|Withdrawal by Subject|16|||
129440262|NCT01128894|465911373|FG001|Overall Study|Adverse Event|41|||
129440263|NCT01128894|465911372|FG000|Overall Study|Protocol Violation|2|||
129440264|NCT01128894|465911373|FG001|Overall Study|Protocol Violation|1|||
129794254|NCT03569293|467214327|FG001|Overall Study|Withdrawal by Subject|2|||
129794255|NCT03569293|467214328|FG002|Overall Study|Withdrawal by Subject|4|||
129794256|NCT03569293|467214329|FG003|Overall Study|Withdrawal by Subject|1|||
129794257|NCT03569293|467214330|FG004|Overall Study|Withdrawal by Subject|0|||
129794258|NCT03569293|467214331|FG005|Overall Study|Withdrawal by Subject|0|||
129794259|NCT03569293|467214326|FG000|Overall Study|Lost to Follow-up|1|||
129794260|NCT03569293|467214327|FG001|Overall Study|Lost to Follow-up|3|||
129794261|NCT03569293|467214328|FG002|Overall Study|Lost to Follow-up|1|||
129794262|NCT03569293|467214329|FG003|Overall Study|Lost to Follow-up|1|||
129794263|NCT03569293|467214330|FG004|Overall Study|Lost to Follow-up|0|||
129794264|NCT03569293|467214331|FG005|Overall Study|Lost to Follow-up|0|||
129794265|NCT03569293|467214326|FG000|Overall Study|Other|8|||
129794266|NCT03569293|467214327|FG001|Overall Study|Other|2|||
129794267|NCT03569293|467214328|FG002|Overall Study|Other|1|||
129888850|NCT03619174|467550925|FG000|Overall Study|Lost to Follow-up|3|||
129440265|NCT01128894|465911372|FG000|Overall Study|Noncompliance|4|||
129440266|NCT01128894|465911373|FG001|Overall Study|Noncompliance|5|||
129440267|NCT01128894|465911372|FG000|Overall Study|Lost to Follow-up|8|||
129440268|NCT01128894|465911373|FG001|Overall Study|Lost to Follow-up|8|||
129440269|NCT01128894|465911372|FG000|Overall Study|Withdrawal by Subject|10|||
129440270|NCT01128894|465911373|FG001|Overall Study|Withdrawal by Subject|12|||
129440271|NCT01128894|465911372|FG000|Overall Study|Physician Decision|2|||
129440272|NCT01128894|465911373|FG001|Overall Study|Physician Decision|1|||
129440273|NCT01128894|465911372|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
129440274|NCT01128894|465911373|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
129440275|NCT00195507|465911374|FG000|Overall Study|Adverse Event|24|||
129440276|NCT00195507|465911375|FG001|Overall Study|Adverse Event|13|||
129626966|NCT02404805|466587043|FG003|Overall Study|Withdrawal by Subject|0|||
129626967|NCT02404805|466587044|FG004|Overall Study|Withdrawal by Subject|0|||
129794268|NCT03569293|467214329|FG003|Overall Study|Other|1|||
129794269|NCT03569293|467214330|FG004|Overall Study|Other|0|||
129794270|NCT03569293|467214331|FG005|Overall Study|Other|0|||
129794271|NCT03569293|467214326|FG000|Overall Study|Ongoing at Time of Analysis|8|||
129794272|NCT03569293|467214327|FG001|Overall Study|Ongoing at Time of Analysis|1|||
129794273|NCT03569293|467214328|FG002|Overall Study|Ongoing at Time of Analysis|3|||
129440277|NCT00195507|465911374|FG000|Overall Study|Death|0|||
129440278|NCT00195507|465911375|FG001|Overall Study|Death|1|||
129440279|NCT00195507|465911374|FG000|Overall Study|Failed to Return|4|||
129440280|NCT00195507|465911375|FG001|Overall Study|Failed to Return|3|||
129440281|NCT00195507|465911374|FG000|Overall Study|Physician Decision|1|||
129440282|NCT00195507|465911375|FG001|Overall Study|Physician Decision|2|||
129703238|NCT01657370|466877410|FG002|Overall Study|Withdrawal by Subject|1|||
129703239|NCT01657370|466877411|FG003|Overall Study|Withdrawal by Subject|0|||
129703240|NCT01657370|466877412|FG004|Overall Study|Withdrawal by Subject|0|||
129703241|NCT01657370|466877413|FG005|Overall Study|Withdrawal by Subject|1|||
129440283|NCT00195507|465911374|FG000|Overall Study|Lost to Follow-up|3|||
129440284|NCT00195507|465911375|FG001|Overall Study|Lost to Follow-up|2|||
129440285|NCT00195507|465911374|FG000|Overall Study|Protocol Violation|5|||
129440286|NCT00195507|465911375|FG001|Overall Study|Protocol Violation|4|||
129440287|NCT00195507|465911374|FG000|Overall Study|Lack of Efficacy|40|||
129440288|NCT00195507|465911375|FG001|Overall Study|Lack of Efficacy|67|||
129440289|NCT00195507|465911374|FG000|Overall Study|Withdrawal by Subject|16|||
129440290|NCT00195507|465911375|FG001|Overall Study|Withdrawal by Subject|23|||
129440291|NCT00195507|465911374|FG000|Overall Study|Protocol Deviation|6|||
129440292|NCT00195507|465911375|FG001|Overall Study|Protocol Deviation|3|||
129440293|NCT00973362|465911376|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
129440294|NCT00973362|465911377|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
129440295|NCT00973362|465911376|FG000|Baseline Evaluation|No colposcopy visit|62|||
129626968|NCT02404805|466587045|FG005|Overall Study|Withdrawal by Subject|0|||
129626969|NCT01742897|466587046|FG000|Overall Study|Adverse Event|3|||
129626970|NCT01742897|466587046|FG000|Overall Study|Withdrawal by Subject|1|||
129626971|NCT01742897|466587046|FG000|Overall Study|Other|1|||
129626972|NCT02456740|466587048|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
129626973|NCT02456740|466587049|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
129626974|NCT02456740|466587050|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
129626975|NCT02456740|466587051|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129626976|NCT02456740|466587052|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129626977|NCT02456740|466587053|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129626978|NCT02456740|466587054|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129626979|NCT02456740|466587055|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129626980|NCT02456740|466587056|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
129626981|NCT02456740|466587048|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
129626982|NCT02456740|466587049|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
129626983|NCT02456740|466587050|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
129626984|NCT02456740|466587051|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129626985|NCT02456740|466587052|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129626986|NCT02456740|466587053|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129626987|NCT02456740|466587054|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129626988|NCT02456740|466587055|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129626989|NCT02456740|466587056|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
129626990|NCT02456740|466587048|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
129626991|NCT02456740|466587049|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
129440296|NCT00973362|465911377|FG001|Baseline Evaluation|No colposcopy visit|0|||
129440297|NCT00973362|465911376|FG000|Baseline Evaluation|Inevaluable|686|||
129440298|NCT00973362|465911377|FG001|Baseline Evaluation|Inevaluable|223|||
129440299|NCT00973362|465911376|FG000|3-Year Follow-up|Lost to Follow-up|17|||
129440300|NCT00973362|465911377|FG001|3-Year Follow-up|Lost to Follow-up|0|||
129440301|NCT01630434|465911384|FG000|Overall Study|Donor lungs turned down|1|||
129440302|NCT01630434|465911385|FG001|Overall Study|Donor lungs turned down|0|||
129440303|NCT01630434|465911384|FG000|Overall Study|Protocol Violation|9|||
129626992|NCT02456740|466587050|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
129626993|NCT02456740|466587051|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129703242|NCT01657370|466877408|FG000|Overall Study|Physician Decision|2|||
129703243|NCT01657370|466877409|FG001|Overall Study|Physician Decision|3|||
129703244|NCT01657370|466877410|FG002|Overall Study|Physician Decision|1|||
129703245|NCT01657370|466877411|FG003|Overall Study|Physician Decision|2|||
129703246|NCT01657370|466877412|FG004|Overall Study|Physician Decision|5|||
129703247|NCT01657370|466877413|FG005|Overall Study|Physician Decision|0|||
129703248|NCT01657370|466877408|FG000|Overall Study|Lack of Qualifying Event|1|||
129703249|NCT01657370|466877409|FG001|Overall Study|Lack of Qualifying Event|0|||
129703250|NCT01657370|466877410|FG002|Overall Study|Lack of Qualifying Event|3|||
129703251|NCT01657370|466877411|FG003|Overall Study|Lack of Qualifying Event|2|||
129703252|NCT01657370|466877412|FG004|Overall Study|Lack of Qualifying Event|1|||
129703253|NCT01657370|466877413|FG005|Overall Study|Lack of Qualifying Event|2|||
129703254|NCT01657370|466877408|FG000|Overall Study|Adverse Event|0|||
129703255|NCT01657370|466877409|FG001|Overall Study|Adverse Event|0|||
129703256|NCT01657370|466877410|FG002|Overall Study|Adverse Event|0|||
129703257|NCT01657370|466877411|FG003|Overall Study|Adverse Event|0|||
129703258|NCT01657370|466877412|FG004|Overall Study|Adverse Event|1|||
129703259|NCT01657370|466877413|FG005|Overall Study|Adverse Event|0|||
129703260|NCT01657370|466877408|FG000|Overall Study|Protocol Violation|1|||
129703261|NCT01657370|466877409|FG001|Overall Study|Protocol Violation|1|||
129703262|NCT01657370|466877410|FG002|Overall Study|Protocol Violation|1|||
129703263|NCT01657370|466877411|FG003|Overall Study|Protocol Violation|1|||
129888851|NCT03619174|467550926|FG001|Overall Study|Lost to Follow-up|0|||
129440304|NCT01630434|465911385|FG001|Overall Study|Protocol Violation|4|||
129440305|NCT01630434|465911384|FG000|Overall Study|Death|20|||
129440306|NCT01630434|465911385|FG001|Overall Study|Death|26|||
129626994|NCT02456740|466587052|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129626995|NCT02456740|466587053|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129626996|NCT02456740|466587054|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129626997|NCT02456740|466587055|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129626998|NCT02456740|466587056|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
129626999|NCT02456740|466587048|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129627000|NCT02456740|466587049|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129627001|NCT02456740|466587050|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129627002|NCT02456740|466587051|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
129627003|NCT02456740|466587052|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
129627004|NCT02456740|466587053|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129627005|NCT02456740|466587054|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129627006|NCT02456740|466587055|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
129627007|NCT02456740|466587056|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
129627008|NCT02456740|466587048|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129627009|NCT02456740|466587049|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129627010|NCT02456740|466587050|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129627011|NCT02456740|466587051|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
129627012|NCT02456740|466587052|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
129627013|NCT02456740|466587053|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
129627014|NCT02456740|466587054|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
129627015|NCT02456740|466587055|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
129627016|NCT02456740|466587056|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
129627017|NCT02456740|466587048|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627018|NCT02456740|466587049|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627019|NCT02456740|466587050|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627020|NCT02456740|466587051|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627021|NCT02456740|466587052|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627022|NCT02456740|466587053|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627023|NCT02456740|466587054|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627024|NCT02456740|466587055|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
129627025|NCT02456740|466587056|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
129627026|NCT02456740|466587048|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129627027|NCT02456740|466587049|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129703264|NCT01657370|466877412|FG004|Overall Study|Protocol Violation|0|||
129703265|NCT01657370|466877413|FG005|Overall Study|Protocol Violation|0|||
129703266|NCT01657370|466877408|FG000|Overall Study|Lost to Follow-up|2|||
129703267|NCT01657370|466877409|FG001|Overall Study|Lost to Follow-up|0|||
129627028|NCT02456740|466587050|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129627029|NCT02456740|466587051|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
129627030|NCT02456740|466587052|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
129627031|NCT02456740|466587053|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
129627032|NCT02456740|466587054|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
129627033|NCT02456740|466587055|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
129627034|NCT02456740|466587056|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
129627035|NCT04720105|466587057|FG000|Overall Study|Lack of Efficacy|1|||
129627036|NCT04720105|466587057|FG000|Overall Study|Lost to Follow-up|1|||
129627037|NCT04720105|466587057|FG000|Overall Study|Withdrawal by Subject|3|||
129627038|NCT04871776|466587060|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
129627039|NCT04871776|466587061|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
129627040|NCT04871776|466587062|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
129627041|NCT04871776|466587060|FG000|Overall Study|Did not meet eligibility criteria|1|||
129627042|NCT04871776|466587061|FG001|Overall Study|Did not meet eligibility criteria|1|||
129627043|NCT04871776|466587062|FG002|Overall Study|Did not meet eligibility criteria|1|||
129627044|NCT04075487|466588548|FG000|Overall Study|Withdrawal by Subject|1|||
129627045|NCT02750618|466588551|FG000|Overall Study|Withdrawal by Subject|1|||
129627046|NCT02572570|466588557|FG000|Overall Study|Study Terminated|27|||
129627047|NCT02763046|466588558|FG000|Overall Study|Adverse Event|5|||
129888852|NCT03619174|467550925|FG000|Overall Study|Withdrawal by Subject|4|||
129888853|NCT03619174|467550926|FG001|Overall Study|Withdrawal by Subject|3|||
129888854|NCT03619174|467550925|FG000|Overall Study|Pregnancy|1|||
129888855|NCT03619174|467550926|FG001|Overall Study|Pregnancy|1|||
129888856|NCT03619174|467550925|FG000|Overall Study|Discomfort during treatment|1|||
129888857|NCT03619174|467550926|FG001|Overall Study|Discomfort during treatment|0|||
129888858|NCT01012973|467550927|FG000|Overall Study|Adverse Event|5|||
129888859|NCT01012973|467550928|FG001|Overall Study|Adverse Event|5|||
129888860|NCT01012973|467550927|FG000|Overall Study|Lack of Efficacy|0|||
129627048|NCT02763046|466588559|FG001|Overall Study|Adverse Event|4|||
129627049|NCT02763046|466588560|FG002|Overall Study|Adverse Event|0|||
129888861|NCT01012973|467550928|FG001|Overall Study|Lack of Efficacy|5|||
129627050|NCT02763046|466588558|FG000|Overall Study|Lack of Efficacy|1|||
129627051|NCT02763046|466588559|FG001|Overall Study|Lack of Efficacy|1|||
129888862|NCT01012973|467550927|FG000|Overall Study|Lost to Follow-up|1|||
129888863|NCT01012973|467550928|FG001|Overall Study|Lost to Follow-up|0|||
129627052|NCT02763046|466588560|FG002|Overall Study|Lack of Efficacy|3|||
129627053|NCT02763046|466588558|FG000|Overall Study|Physician Decision|1|||
129627054|NCT02763046|466588559|FG001|Overall Study|Physician Decision|0|||
129627055|NCT02763046|466588560|FG002|Overall Study|Physician Decision|1|||
129627056|NCT02763046|466588558|FG000|Overall Study|Subject/guardian decision|2|||
129627057|NCT02763046|466588559|FG001|Overall Study|Subject/guardian decision|0|||
129627058|NCT02763046|466588560|FG002|Overall Study|Subject/guardian decision|4|||
129627059|NCT01067105|466588561|FG000|Overall Study|Adverse Event|14|||
129794274|NCT03569293|467214329|FG003|Overall Study|Ongoing at Time of Analysis|0|||
129794275|NCT03569293|467214330|FG004|Overall Study|Ongoing at Time of Analysis|0|||
129794276|NCT03569293|467214331|FG005|Overall Study|Ongoing at Time of Analysis|0|||
129794277|NCT05128929|467214333|FG000|Overall Study|Adverse Event|0|||
129794278|NCT05128929|467214334|FG001|Overall Study|Adverse Event|1|||
129794279|NCT02742246|467214335|FG000|Overall Study|Never initiated treatment|5|||
129794280|NCT02742246|467214336|FG001|Overall Study|Never initiated treatment|3|||
129794281|NCT02742246|467214337|FG002|Overall Study|Never initiated treatment|1|||
129794282|NCT02742246|467214335|FG000|Overall Study|dropped out during treatment|7|||
129794283|NCT02742246|467214336|FG001|Overall Study|dropped out during treatment|13|||
129794284|NCT02742246|467214337|FG002|Overall Study|dropped out during treatment|10|||
129794285|NCT02742246|467214335|FG000|Overall Study|Death|1|||
129794286|NCT02742246|467214336|FG001|Overall Study|Death|0|||
129794287|NCT02742246|467214337|FG002|Overall Study|Death|0|||
129794288|NCT03553836|467214339|FG000|Overall Study|Ongoing in Study|460|||
129794289|NCT03553836|467214340|FG001|Overall Study|Ongoing in Study|459|||
129627060|NCT01067105|466588561|FG000|Overall Study|Protocol Violation|48|||
129794290|NCT03553836|467214339|FG000|Overall Study|Withdrawal by Subject|9|||
129794291|NCT03553836|467214340|FG001|Overall Study|Withdrawal by Subject|10|||
129794292|NCT03553836|467214339|FG000|Overall Study|Lost to Follow-up|1|||
129627061|NCT01067105|466588561|FG000|Overall Study|Withdrawal by Subject|36|||
129627062|NCT01067105|466588561|FG000|Overall Study|Lost to Follow-up|6|||
129627063|NCT01067105|466588561|FG000|Overall Study|Physician Decision|6|||
129627064|NCT01067105|466588561|FG000|Overall Study|Other|31|||
129627065|NCT02302833|466588564|FG000|Overall Study|Lost to Follow-up|3|||
129627066|NCT04878432|466588565|FG000|Overall Study|Adverse Event|1|||
129627067|NCT04878432|466588565|FG000|Overall Study|Death|2|||
129627068|NCT04878432|466588565|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
129627069|NCT04878432|466588565|FG000|Overall Study|Withdrawal by Subject|6|||
129627070|NCT04878432|466588565|FG000|Overall Study|Progressive Disease|7|||
129703268|NCT01657370|466877410|FG002|Overall Study|Lost to Follow-up|1|||
129703269|NCT01657370|466877411|FG003|Overall Study|Lost to Follow-up|0|||
129703270|NCT01657370|466877412|FG004|Overall Study|Lost to Follow-up|0|||
129703271|NCT01657370|466877413|FG005|Overall Study|Lost to Follow-up|1|||
129703272|NCT03440385|466877424|FG000|Overall Study|Other Reason|4|||
129703273|NCT03440385|466877425|FG001|Overall Study|Other Reason|1|||
129703274|NCT03440385|466877424|FG000|Overall Study|Site Closed|1|||
129703275|NCT03440385|466877425|FG001|Overall Study|Site Closed|0|||
129703276|NCT03440385|466877424|FG000|Overall Study|Lost to Follow-up|2|||
129703277|NCT03440385|466877425|FG001|Overall Study|Lost to Follow-up|0|||
129703278|NCT03440385|466877424|FG000|Overall Study|Withdrawal by Subject|12|||
129703279|NCT03440385|466877425|FG001|Overall Study|Withdrawal by Subject|6|||
129703280|NCT03440385|466877424|FG000|Overall Study|Lack of Efficacy|9|||
129703281|NCT03440385|466877425|FG001|Overall Study|Lack of Efficacy|2|||
129703282|NCT03440385|466877424|FG000|Overall Study|Adverse Event|15|||
129703283|NCT03440385|466877425|FG001|Overall Study|Adverse Event|11|||
129703284|NCT01168596|466877431|FG000|Overall Study|Withdrawal by Subject|3|||
129703285|NCT01168596|466877432|FG001|Overall Study|Withdrawal by Subject|1|||
129703286|NCT00876447|466877435|FG000|Overall Study|Other miscellaneous reasons|3|||
129703287|NCT00876447|466877436|FG001|Overall Study|Other miscellaneous reasons|8|||
129703288|NCT00876447|466877435|FG000|Overall Study|Site closure|19|||
129627071|NCT04878432|466588565|FG000|Overall Study|New Therapy for Study Indication|7|||
129627072|NCT04878432|466588565|FG000|Overall Study|Physician Decision|11|||
129627073|NCT05017246|466588566|FG000|Overall Study|Withdrawal by Subject|5|||
129627074|NCT05017246|466588567|FG001|Overall Study|Withdrawal by Subject|3|||
129627075|NCT05017246|466588566|FG000|Overall Study|Determined to be ineligible|0|||
129627076|NCT05017246|466588567|FG001|Overall Study|Determined to be ineligible|1|||
129627077|NCT05017246|466588566|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
129627078|NCT05017246|466588567|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
129627079|NCT05017246|466588566|FG000|Overall Study|Technical failure|1|||
129627080|NCT05017246|466588567|FG001|Overall Study|Technical failure|3|||
129627081|NCT01495000|466588568|FG000|Overall Study|Lost to Follow-up|2|||
129627082|NCT01495000|466588569|FG001|Overall Study|Lost to Follow-up|2|||
129627083|NCT01495000|466588568|FG000|Overall Study|Protocol Violation|1|||
129627084|NCT01495000|466588569|FG001|Overall Study|Protocol Violation|0|||
129627085|NCT01495000|466588568|FG000|Overall Study|Withdrawal by Subject|10|||
129627086|NCT01495000|466588569|FG001|Overall Study|Withdrawal by Subject|10|||
129627087|NCT01514461|466588570|FG000|Overall Study|Adverse Event|2|||
129627088|NCT01514461|466588571|FG001|Overall Study|Adverse Event|1|||
129627089|NCT01514461|466588572|FG002|Overall Study|Adverse Event|3|||
129627090|NCT01514461|466588570|FG000|Overall Study|Physician Decision|1|||
129627091|NCT01514461|466588571|FG001|Overall Study|Physician Decision|1|||
129627092|NCT01514461|466588572|FG002|Overall Study|Physician Decision|0|||
129627093|NCT01514461|466588570|FG000|Overall Study|Patient/guardian decision|1|||
129627094|NCT01514461|466588571|FG001|Overall Study|Patient/guardian decision|1|||
129627095|NCT01514461|466588572|FG002|Overall Study|Patient/guardian decision|1|||
129627096|NCT01514461|466588570|FG000|Overall Study|Death|1|||
129627097|NCT01514461|466588571|FG001|Overall Study|Death|0|||
129627098|NCT01514461|466588572|FG002|Overall Study|Death|0|||
129627099|NCT03499067|466588573|FG000|First Intervention|Physician Decision|2|||
129627100|NCT03499067|466588574|FG001|First Intervention|Physician Decision|1|||
129627101|NCT03499067|466588573|FG000|First Intervention|Withdrawal by Subject|3|||
129627102|NCT03499067|466588574|FG001|First Intervention|Withdrawal by Subject|6|||
129627103|NCT02548832|466588575|FG000|Overall Study|Lost to Follow-up|2|||
129627104|NCT02548832|466588576|FG001|Overall Study|Lost to Follow-up|2|||
129627105|NCT02548832|466588577|FG002|Overall Study|Lost to Follow-up|2|||
129627106|NCT03565900|466588578|FG000|Overall Study|Disposition Unknown|4|||
129627107|NCT03565900|466588579|FG001|Overall Study|Disposition Unknown|1|||
129627108|NCT03565900|466588578|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129627109|NCT03565900|466588579|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
129627110|NCT03565900|466588578|FG000|Overall Study|Withdrawal by Subject|4|||
129627111|NCT03565900|466588579|FG001|Overall Study|Withdrawal by Subject|5|||
129627112|NCT03565900|466588578|FG000|Overall Study|Randomized By Mistake|0|||
129627113|NCT03565900|466588579|FG001|Overall Study|Randomized By Mistake|2|||
129627114|NCT03565900|466588578|FG000|Overall Study|Physician Decision|7|||
129627115|NCT03565900|466588579|FG001|Overall Study|Physician Decision|11|||
129627116|NCT03565900|466588578|FG000|Overall Study|Death|9|||
129627117|NCT03565900|466588579|FG001|Overall Study|Death|7|||
129627118|NCT03359850|466588585|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
129627119|NCT03359850|466588586|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
129627120|NCT03359850|466588585|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
129703289|NCT00876447|466877436|FG001|Overall Study|Site closure|14|||
129703290|NCT00876447|466877435|FG000|Overall Study|Protocol Violation|9|||
129703291|NCT00876447|466877436|FG001|Overall Study|Protocol Violation|3|||
129703292|NCT00876447|466877435|FG000|Overall Study|Personal reasons|30|||
129703293|NCT00876447|466877436|FG001|Overall Study|Personal reasons|28|||
129703294|NCT00876447|466877435|FG000|Overall Study|Lost to Follow-up|6|||
129794293|NCT03553836|467214340|FG001|Overall Study|Lost to Follow-up|3|||
129794294|NCT03553836|467214339|FG000|Overall Study|Death|17|||
129794295|NCT03553836|467214340|FG001|Overall Study|Death|17|||
129627121|NCT03359850|466588586|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
129703295|NCT00876447|466877436|FG001|Overall Study|Lost to Follow-up|15|||
129703296|NCT00876447|466877435|FG000|Overall Study|Pregnancy|4|||
129703297|NCT00876447|466877436|FG001|Overall Study|Pregnancy|2|||
129703298|NCT00876447|466877435|FG000|Overall Study|Lack of Efficacy|5|||
129703299|NCT00876447|466877436|FG001|Overall Study|Lack of Efficacy|3|||
129703300|NCT00876447|466877435|FG000|Overall Study|Adverse Event|4|||
129627122|NCT03359850|466588585|FG000|Extension Phase (Up to 28 Months)|Death|2|||
129627123|NCT03359850|466588586|FG001|Extension Phase (Up to 28 Months)|Death|4|||
129627124|NCT03359850|466588585|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
129627125|NCT03359850|466588586|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
129627126|NCT03359850|466588585|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
129627127|NCT03359850|466588586|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
129627128|NCT00942357|466588594|FG000|Overall Study|Ineligible|37|||
129703301|NCT00876447|466877436|FG001|Overall Study|Adverse Event|8|||
129703302|NCT00189423|466877443|FG000|Overall Study|Death|746|||
129703303|NCT00189423|466877444|FG001|Overall Study|Death|747|||
129703304|NCT00189423|466877443|FG000|Overall Study|Withdrawal by Subject|9|||
129794296|NCT03220438|467214341|FG000|Overall Study|Lost to Follow-up|0|||
129627129|NCT00942357|466588595|FG001|Overall Study|Ineligible|40|||
129627130|NCT01960257|466588598|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
129627131|NCT01960257|466588599|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
129627132|NCT01960257|466588600|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
129627133|NCT01960257|466588598|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
129627134|NCT01960257|466588599|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
129627135|NCT01960257|466588600|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
129627136|NCT01960257|466588598|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
129627137|NCT01960257|466588599|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
129627138|NCT01960257|466588600|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
129627139|NCT02002221|466588601|FG000|Overall Study|Adverse Event|2|||
129627140|NCT02002221|466588602|FG001|Overall Study|Adverse Event|1|||
129627141|NCT02002221|466588601|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129627142|NCT02002221|466588602|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129627143|NCT02002221|466588601|FG000|Overall Study|Patient withdrew consent|0|||
129627144|NCT02002221|466588602|FG001|Overall Study|Patient withdrew consent|1|||
129627145|NCT03347110|466588603|FG000|Overall Study|Other (Participant is incarcerated)|1|||
129627146|NCT03347110|466588603|FG000|Overall Study|Withdrawal by Subject|9|||
129627147|NCT03347110|466588603|FG000|Overall Study|Lost to Follow-up|1|||
129627148|NCT03347110|466588603|FG000|Overall Study|Lack of Efficacy|2|||
129627149|NCT03347110|466588603|FG000|Overall Study|Adverse Event, non-fatal|9|||
129627150|NCT02105467|466588606|FG000|Period 1|Lost to Follow-up|1|||
129627151|NCT02105467|466588607|FG001|Period 1|Lost to Follow-up|0|||
129627152|NCT02105467|466588606|FG000|Period 1|Death|1|||
129627153|NCT02105467|466588607|FG001|Period 1|Death|0|||
129627154|NCT02105467|466588606|FG000|Period 2|Lost to Follow-up|1|||
129627155|NCT02105467|466588607|FG001|Period 2|Lost to Follow-up|0|||
129627156|NCT02105467|466588606|FG000|Period 2|Death|1|||
129627157|NCT02105467|466588607|FG001|Period 2|Death|0|||
129627158|NCT02105467|466588606|FG000|Period 2|Withdrawal by Subject|0|||
129627159|NCT02105467|466588607|FG001|Period 2|Withdrawal by Subject|2|||
129627160|NCT02105467|466588606|FG000|Period 3|Lost to Follow-up|0|||
129627161|NCT02105467|466588607|FG001|Period 3|Lost to Follow-up|1|||
129627162|NCT01518322|466588609|FG000|Overall Study|FeNO measurement was missing|13|||
129627163|NCT02792517|466588614|FG000|Overall Study|Withdrawal by Subject|10|||
129627164|NCT02792517|466588614|FG000|Overall Study|Decision by Sponsor|7|||
129627165|NCT02792517|466588614|FG000|Overall Study|Lost to Follow-up|3|||
129627166|NCT00856193|466588617|FG000|Period 2|Abnormal test procedure results|0|||
129627167|NCT00856193|466588618|FG001|Period 2|Abnormal test procedure results|1|||
129627168|NCT00856193|466588617|FG000|Period 2|Lost to Follow-up|0|||
129627169|NCT00856193|466588618|FG001|Period 2|Lost to Follow-up|1|||
129627170|NCT02766335|466588620|FG000|Initial Registration|Adverse Event|6|||
129627171|NCT02766335|466588621|FG001|Initial Registration|Adverse Event|3|||
129627172|NCT02766335|466588622|FG002|Initial Registration|Adverse Event|0|||
129627173|NCT02766335|466588620|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
129627174|NCT02766335|466588621|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
129627175|NCT02766335|466588622|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
129627176|NCT02766335|466588620|FG000|Initial Registration|Progression/relapse|49|||
129627177|NCT02766335|466588621|FG001|Initial Registration|Progression/relapse|15|||
129627178|NCT02766335|466588622|FG002|Initial Registration|Progression/relapse|0|||
129627179|NCT02766335|466588620|FG000|Initial Registration|Death|1|||
129627180|NCT02766335|466588621|FG001|Initial Registration|Death|3|||
129627181|NCT02766335|466588622|FG002|Initial Registration|Death|0|||
129627182|NCT02766335|466588620|FG000|Initial Registration|not protocol specified|1|||
129627183|NCT02766335|466588621|FG001|Initial Registration|not protocol specified|9|||
129627184|NCT02766335|466588622|FG002|Initial Registration|not protocol specified|0|||
129627185|NCT02766335|466588620|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
129794297|NCT03220438|467214342|FG001|Overall Study|Lost to Follow-up|0|||
129794298|NCT03220438|467214343|FG002|Overall Study|Lost to Follow-up|1|||
129794299|NCT03220438|467214344|FG003|Overall Study|Lost to Follow-up|0|||
129794300|NCT04062123|467214345|FG000|Overall Study|Withdrawal by Subject|0|||
129794301|NCT04062123|467214346|FG001|Overall Study|Withdrawal by Subject|1|||
129627186|NCT02766335|466588621|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
129627187|NCT02766335|466588622|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
129627188|NCT02766335|466588620|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
129627189|NCT02766335|466588621|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
129627190|NCT02766335|466588622|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
129627191|NCT01515423|466588636|FG000|Open Label Phase|Adverse Event|57|||
129627192|NCT01515423|466588637|FG001|Open Label Phase|Adverse Event|0|||
129627193|NCT01515423|466588638|FG002|Open Label Phase|Adverse Event|0|||
129794302|NCT04062123|467214347|FG002|Overall Study|Withdrawal by Subject|0|||
129794303|NCT01479985|467214350|FG000|Overall Study|Tablet malfunction, no data saved|1|||
129627194|NCT01515423|466588636|FG000|Open Label Phase|Death|2|||
129627195|NCT01515423|466588637|FG001|Open Label Phase|Death|0|||
129627196|NCT01515423|466588638|FG002|Open Label Phase|Death|0|||
129627197|NCT01515423|466588636|FG000|Open Label Phase|Lack of Efficacy|117|||
129627198|NCT01515423|466588637|FG001|Open Label Phase|Lack of Efficacy|0|||
129627199|NCT01515423|466588638|FG002|Open Label Phase|Lack of Efficacy|0|||
129627200|NCT01515423|466588636|FG000|Open Label Phase|Lost to Follow-up|21|||
129627201|NCT01515423|466588637|FG001|Open Label Phase|Lost to Follow-up|0|||
129627202|NCT01515423|466588638|FG002|Open Label Phase|Lost to Follow-up|0|||
129627203|NCT01515423|466588636|FG000|Open Label Phase|Withdrawal by Subject|118|||
129627204|NCT01515423|466588637|FG001|Open Label Phase|Withdrawal by Subject|0|||
129627205|NCT01515423|466588638|FG002|Open Label Phase|Withdrawal by Subject|0|||
129627206|NCT01515423|466588636|FG000|Open Label Phase|excluded from DB Phase|70|||
129627207|NCT01515423|466588637|FG001|Open Label Phase|excluded from DB Phase|0|||
129627208|NCT01515423|466588638|FG002|Open Label Phase|excluded from DB Phase|0|||
129627209|NCT01515423|466588636|FG000|Open Label Phase|Other|28|||
129627210|NCT01515423|466588637|FG001|Open Label Phase|Other|0|||
129627211|NCT01515423|466588638|FG002|Open Label Phase|Other|0|||
129627212|NCT01515423|466588636|FG000|DOUBLE BLIND|Adverse Event|0|||
129627213|NCT01515423|466588637|FG001|DOUBLE BLIND|Adverse Event|15|||
129627214|NCT01515423|466588638|FG002|DOUBLE BLIND|Adverse Event|13|||
129627215|NCT01515423|466588636|FG000|DOUBLE BLIND|Death|0|||
129627216|NCT01515423|466588637|FG001|DOUBLE BLIND|Death|1|||
129627217|NCT01515423|466588638|FG002|DOUBLE BLIND|Death|2|||
129627218|NCT01515423|466588636|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
129627219|NCT01515423|466588637|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
129627220|NCT01515423|466588638|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
129627221|NCT01515423|466588636|FG000|DOUBLE BLIND|Pregnancy|0|||
129627222|NCT01515423|466588637|FG001|DOUBLE BLIND|Pregnancy|2|||
129627223|NCT01515423|466588638|FG002|DOUBLE BLIND|Pregnancy|0|||
129627224|NCT01515423|466588636|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
129627225|NCT01515423|466588637|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
129627226|NCT01515423|466588638|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
129627227|NCT01515423|466588636|FG000|DOUBLE BLIND|Other|0|||
129627228|NCT01515423|466588637|FG001|DOUBLE BLIND|Other|6|||
129627229|NCT01515423|466588638|FG002|DOUBLE BLIND|Other|12|||
129627230|NCT01515423|466588636|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
129627231|NCT01515423|466588637|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
129627232|NCT01515423|466588638|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
129627233|NCT01125917|466588641|FG000|Overall Study|Adverse Event|43|||
129627234|NCT01125917|466588641|FG000|Overall Study|Lost to Follow-up|23|||
129627235|NCT01125917|466588641|FG000|Overall Study|Withdrawal by Subject|31|||
129627236|NCT01125917|466588641|FG000|Overall Study|Administrative|223|||
129627237|NCT01125917|466588641|FG000|Overall Study|Lack of Efficacy|19|||
129627238|NCT02501928|466588642|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129627239|NCT02501928|466588643|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129627240|NCT02501928|466588644|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
129627241|NCT02501928|466588645|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
129627242|NCT02501928|466588646|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
129627243|NCT02501928|466588647|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
129627244|NCT00838526|466588655|FG000|Overall Study|Adverse Event|3|||
129627245|NCT00838526|466588656|FG001|Overall Study|Adverse Event|12|||
129627246|NCT00838526|466588655|FG000|Overall Study|Lost to Follow-up|4|||
129627247|NCT00838526|466588656|FG001|Overall Study|Lost to Follow-up|12|||
129627248|NCT00838526|466588655|FG000|Overall Study|Withdrawal by Subject|4|||
129627249|NCT00838526|466588656|FG001|Overall Study|Withdrawal by Subject|5|||
129627250|NCT00838526|466588655|FG000|Overall Study|Lack of Efficacy|2|||
129627251|NCT00838526|466588656|FG001|Overall Study|Lack of Efficacy|3|||
129627252|NCT00838526|466588655|FG000|Overall Study|Other|11|||
129627253|NCT00838526|466588656|FG001|Overall Study|Other|7|||
129627254|NCT01320293|466588657|FG000|Overall Study|Lack of Efficacy|1|||
129627255|NCT01320293|466588657|FG000|Overall Study|Adverse Event|1|||
129703305|NCT00189423|466877444|FG001|Overall Study|Withdrawal by Subject|9|||
129703306|NCT00189423|466877443|FG000|Overall Study|Lost to Follow-up|10|||
129703307|NCT00189423|466877444|FG001|Overall Study|Lost to Follow-up|10|||
129703308|NCT04622592|466877446|FG000|Overall Study|Death|0|||
129703309|NCT04622592|466877447|FG001|Overall Study|Death|0|||
129703310|NCT04622592|466877448|FG002|Overall Study|Death|1|||
129703311|NCT04622592|466877449|FG003|Overall Study|Death|0|||
129703312|NCT04622592|466877450|FG004|Overall Study|Death|0|||
129703313|NCT04622592|466877451|FG005|Overall Study|Death|0|||
129703314|NCT04622592|466877452|FG006|Overall Study|Death|0|||
129627256|NCT00931411|466588658|FG000|First Intervention - 42 Days|Adverse Event|2|||
129627257|NCT00931411|466588659|FG001|First Intervention - 42 Days|Adverse Event|3|||
129627258|NCT00931411|466588658|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
129627259|NCT00931411|466588659|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
129627260|NCT00931411|466588658|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
129627261|NCT00931411|466588659|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
129627262|NCT03483012|466588662|FG000|Overall Study|Lack of Efficacy|6|||
129627263|NCT04782076|466588663|FG000|Overall Study|Family Emergency|1|||
129627264|NCT01949662|466588674|FG000|Overall Study|Death|9|||
129627265|NCT01949662|466588675|FG001|Overall Study|Death|7|||
129703315|NCT04622592|466877453|FG007|Overall Study|Death|1|||
129703316|NCT04622592|466877446|FG000|Overall Study|Lost to Follow-up|0|||
129703317|NCT04622592|466877447|FG001|Overall Study|Lost to Follow-up|0|||
129627266|NCT01949662|466588674|FG000|Overall Study|Discharged before an agitation event|8|||
129627267|NCT01949662|466588675|FG001|Overall Study|Discharged before an agitation event|3|||
129627268|NCT01949662|466588674|FG000|Overall Study|Dropped out|1|||
129627269|NCT01949662|466588675|FG001|Overall Study|Dropped out|3|||
129888864|NCT01012973|467550927|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
129888865|NCT01012973|467550928|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
129888866|NCT01012973|467550927|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
129627270|NCT01949662|466588674|FG000|Overall Study|Ineligible|0|||
129627271|NCT01949662|466588675|FG001|Overall Study|Ineligible|1|||
129627272|NCT04135937|466588677|FG000|Overall Study|Lost to Follow-up|2|||
129627273|NCT04135937|466588677|FG000|Overall Study|Withdrawal by Subject|1|||
129627274|NCT00856492|466588680|FG000|Overall Study|Ineligible or withdrew consent|1|||
129627275|NCT00856492|466588681|FG001|Overall Study|Ineligible or withdrew consent|1|||
129627276|NCT00856492|466588682|FG002|Overall Study|Ineligible or withdrew consent|2|||
129627277|NCT00955617|466588685|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
129627278|NCT00955617|466588686|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
129627279|NCT00955617|466588685|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
129627280|NCT00955617|466588686|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
129627281|NCT00955617|466588685|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
129627282|NCT00955617|466588686|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
129627283|NCT00955617|466588685|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
129627284|NCT00955617|466588686|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
129627285|NCT00070564|466589808|FG000|Overall Study|Progression|2|||
129627286|NCT00070564|466589809|FG001|Overall Study|Progression|4|||
129627287|NCT00070564|466589810|FG002|Overall Study|Progression|7|||
129627288|NCT00070564|466589811|FG003|Overall Study|Progression|7|||
129627289|NCT00070564|466589812|FG004|Overall Study|Progression|1|||
129627290|NCT00070564|466589813|FG005|Overall Study|Progression|0|||
129627291|NCT00070564|466589808|FG000|Overall Study|Delinquent|1|||
129627292|NCT00070564|466589809|FG001|Overall Study|Delinquent|4|||
129627293|NCT00070564|466589810|FG002|Overall Study|Delinquent|2|||
129627294|NCT00070564|466589811|FG003|Overall Study|Delinquent|0|||
129627295|NCT00070564|466589812|FG004|Overall Study|Delinquent|0|||
129627296|NCT00070564|466589813|FG005|Overall Study|Delinquent|0|||
129627297|NCT00070564|466589808|FG000|Overall Study|Adverse Event|150|||
129627298|NCT00070564|466589809|FG001|Overall Study|Adverse Event|142|||
129627299|NCT00070564|466589810|FG002|Overall Study|Adverse Event|120|||
129627300|NCT00070564|466589811|FG003|Overall Study|Adverse Event|108|||
129627301|NCT00070564|466589812|FG004|Overall Study|Adverse Event|63|||
129627302|NCT00070564|466589813|FG005|Overall Study|Adverse Event|36|||
129627303|NCT00070564|466589808|FG000|Overall Study|Death|4|||
129627304|NCT00070564|466589809|FG001|Overall Study|Death|1|||
129627305|NCT00070564|466589810|FG002|Overall Study|Death|5|||
129627306|NCT00070564|466589811|FG003|Overall Study|Death|3|||
129627307|NCT00070564|466589812|FG004|Overall Study|Death|0|||
129627308|NCT00070564|466589813|FG005|Overall Study|Death|1|||
129627309|NCT00070564|466589808|FG000|Overall Study|Other, not protocol specified|17|||
129627310|NCT00070564|466589809|FG001|Overall Study|Other, not protocol specified|15|||
129627311|NCT00070564|466589810|FG002|Overall Study|Other, not protocol specified|14|||
129888867|NCT01012973|467550928|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
129888868|NCT01012973|467550927|FG000|Overall Study|Protocol Violation|5|||
129888869|NCT01012973|467550928|FG001|Overall Study|Protocol Violation|2|||
129888870|NCT01012973|467550927|FG000|Overall Study|Withdrawal by Subject|4|||
129888871|NCT01012973|467550928|FG001|Overall Study|Withdrawal by Subject|6|||
129888872|NCT02213055|467550930|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
129888873|NCT02213055|467550931|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
129888874|NCT02213055|467550930|FG000|Overall Study|Protocol was not Followed during Study|1|||
129888875|NCT02213055|467550931|FG001|Overall Study|Protocol was not Followed during Study|0|||
129888876|NCT02213055|467550930|FG000|Overall Study|Documentation Issue at Enrollment|1|||
129627312|NCT00070564|466589811|FG003|Overall Study|Other, not protocol specified|19|||
129627313|NCT00070564|466589812|FG004|Overall Study|Other, not protocol specified|6|||
129703318|NCT04622592|466877448|FG002|Overall Study|Lost to Follow-up|0|||
129703319|NCT04622592|466877449|FG003|Overall Study|Lost to Follow-up|3|||
129627314|NCT00070564|466589813|FG005|Overall Study|Other, not protocol specified|7|||
129627315|NCT00070564|466589808|FG000|Overall Study|Withdrawal by Subject|26|||
129627316|NCT00070564|466589809|FG001|Overall Study|Withdrawal by Subject|37|||
129627317|NCT00070564|466589810|FG002|Overall Study|Withdrawal by Subject|23|||
129888877|NCT02213055|467550931|FG001|Overall Study|Documentation Issue at Enrollment|0|||
129627318|NCT00070564|466589811|FG003|Overall Study|Withdrawal by Subject|30|||
129627319|NCT00070564|466589812|FG004|Overall Study|Withdrawal by Subject|8|||
129627320|NCT00070564|466589813|FG005|Overall Study|Withdrawal by Subject|8|||
129627321|NCT00070564|466589808|FG000|Overall Study|Not reported|0|||
129627322|NCT00070564|466589809|FG001|Overall Study|Not reported|0|||
129627323|NCT00070564|466589810|FG002|Overall Study|Not reported|0|||
129627324|NCT00070564|466589811|FG003|Overall Study|Not reported|0|||
129888878|NCT02213055|467550930|FG000|Overall Study|Documentation Issue during Study|10|||
129703320|NCT04622592|466877450|FG004|Overall Study|Lost to Follow-up|1|||
129703321|NCT04622592|466877451|FG005|Overall Study|Lost to Follow-up|0|||
129703322|NCT04622592|466877452|FG006|Overall Study|Lost to Follow-up|2|||
129703323|NCT04622592|466877453|FG007|Overall Study|Lost to Follow-up|2|||
129703324|NCT04622592|466877446|FG000|Overall Study|Physician Decision|0|||
129703325|NCT04622592|466877447|FG001|Overall Study|Physician Decision|0|||
129703326|NCT04622592|466877448|FG002|Overall Study|Physician Decision|0|||
129703327|NCT04622592|466877449|FG003|Overall Study|Physician Decision|0|||
129703328|NCT04622592|466877450|FG004|Overall Study|Physician Decision|1|||
129703329|NCT04622592|466877451|FG005|Overall Study|Physician Decision|0|||
129703330|NCT04622592|466877452|FG006|Overall Study|Physician Decision|0|||
129703331|NCT04622592|466877453|FG007|Overall Study|Physician Decision|0|||
129703332|NCT04622592|466877446|FG000|Overall Study|Withdrawal by Subject|1|||
129703333|NCT04622592|466877447|FG001|Overall Study|Withdrawal by Subject|0|||
129703334|NCT04622592|466877448|FG002|Overall Study|Withdrawal by Subject|2|||
129703335|NCT04622592|466877449|FG003|Overall Study|Withdrawal by Subject|0|||
129703336|NCT04622592|466877450|FG004|Overall Study|Withdrawal by Subject|0|||
129703337|NCT04622592|466877451|FG005|Overall Study|Withdrawal by Subject|0|||
129703338|NCT04622592|466877452|FG006|Overall Study|Withdrawal by Subject|1|||
129703339|NCT04622592|466877453|FG007|Overall Study|Withdrawal by Subject|4|||
129703340|NCT04622592|466877446|FG000|Overall Study|Other than specified above|0|||
129703341|NCT04622592|466877447|FG001|Overall Study|Other than specified above|0|||
129703342|NCT04622592|466877448|FG002|Overall Study|Other than specified above|1|||
129703343|NCT04622592|466877449|FG003|Overall Study|Other than specified above|0|||
129703344|NCT04622592|466877450|FG004|Overall Study|Other than specified above|0|||
129703345|NCT04622592|466877451|FG005|Overall Study|Other than specified above|0|||
129703346|NCT04622592|466877452|FG006|Overall Study|Other than specified above|0|||
129703347|NCT04622592|466877453|FG007|Overall Study|Other than specified above|0|||
129703348|NCT00183248|466877458|FG000|Overall Study|Lost to Follow-up|0|||
129703349|NCT00183248|466877459|FG001|Overall Study|Lost to Follow-up|1|||
129703350|NCT00183248|466877458|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
129703351|NCT00183248|466877459|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
129703352|NCT03309202|466877460|FG000|Overall Study|Lost to Follow-up|1|||
129703353|NCT03309202|466877461|FG001|Overall Study|Lost to Follow-up|0|||
129703354|NCT03309202|466877462|FG002|Overall Study|Lost to Follow-up|0|||
129703355|NCT03309202|466877463|FG003|Overall Study|Lost to Follow-up|0|||
129703356|NCT04734210|466877464|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
129703357|NCT04734210|466877465|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
129703358|NCT04734210|466877466|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
129703359|NCT04734210|466877464|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
129703360|NCT04734210|466877465|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
129703361|NCT04734210|466877466|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
129703362|NCT04734210|466877464|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
129703363|NCT04734210|466877465|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
129703364|NCT04734210|466877466|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
129703365|NCT04734210|466877464|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
129703366|NCT04734210|466877465|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
129703367|NCT04734210|466877466|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
129703368|NCT02138825|466877467|FG000|Main Study Treatment|Adverse Event|11|||
129703369|NCT02138825|466877468|FG001|Main Study Treatment|Adverse Event|3|||
129703370|NCT02138825|466877467|FG000|Main Study Treatment|Death|1|||
129703371|NCT02138825|466877468|FG001|Main Study Treatment|Death|2|||
129703372|NCT02138825|466877467|FG000|Main Study Treatment|Protocol Violation|2|||
129703373|NCT02138825|466877468|FG001|Main Study Treatment|Protocol Violation|2|||
129703374|NCT02138825|466877467|FG000|Main Study Treatment|Sponsor decision|12|||
129703375|NCT02138825|466877468|FG001|Main Study Treatment|Sponsor decision|18|||
129703376|NCT02138825|466877467|FG000|Main Study Treatment|Study terminated by sponsor|10|||
129703377|NCT02138825|466877468|FG001|Main Study Treatment|Study terminated by sponsor|9|||
129703378|NCT02138825|466877467|FG000|Main Study Treatment|Withdrawal by Subject|3|||
129703379|NCT02138825|466877468|FG001|Main Study Treatment|Withdrawal by Subject|1|||
129703380|NCT02138825|466877467|FG000|Main Study Treatment|Medical decision|1|||
129703381|NCT02138825|466877468|FG001|Main Study Treatment|Medical decision|0|||
129703382|NCT02138825|466877467|FG000|Long-term Extension|Study termination by sponsor|32|||
129703383|NCT02138825|466877468|FG001|Long-term Extension|Study termination by sponsor|38|||
129703384|NCT02138825|466877467|FG000|Safety Follow-up|Adverse Event|4|||
129703385|NCT02138825|466877468|FG001|Safety Follow-up|Adverse Event|3|||
129703386|NCT02138825|466877467|FG000|Safety Follow-up|Death|11|||
129703387|NCT02138825|466877468|FG001|Safety Follow-up|Death|5|||
129627325|NCT00070564|466589812|FG004|Overall Study|Not reported|1|||
129627326|NCT00070564|466589813|FG005|Overall Study|Not reported|0|||
129627327|NCT00931528|466589814|FG000|Overall Study|Protocol Violation|9|||
129627328|NCT00931528|466589815|FG001|Overall Study|Protocol Violation|12|||
129627329|NCT00931528|466589814|FG000|Overall Study|Withdrawal by Subject|4|||
129627330|NCT00931528|466589815|FG001|Overall Study|Withdrawal by Subject|12|||
129627331|NCT00931528|466589814|FG000|Overall Study|Lost to Follow-up|6|||
129627332|NCT00931528|466589815|FG001|Overall Study|Lost to Follow-up|13|||
129627333|NCT00931528|466589814|FG000|Overall Study|Assessment outside of Time Frame|22|||
129627334|NCT00931528|466589815|FG001|Overall Study|Assessment outside of Time Frame|23|||
129627335|NCT02115269|466589816|FG000|Overall Study|Lost to Follow-up|43|||
129627336|NCT02115269|466589816|FG000|Overall Study|Did not complete patient diary|3|||
129627337|NCT02115269|466589816|FG000|Overall Study|Moved to another city|7|||
129627338|NCT02115269|466589816|FG000|Overall Study|Withdrawal by Subject|2|||
129627339|NCT02115269|466589816|FG000|Overall Study|Didn't take study drug|2|||
129627340|NCT01557504|466589817|FG000|Overall Study|Physician Decision|1|||
129627341|NCT01557504|466589818|FG001|Overall Study|Physician Decision|0|||
129627342|NCT02058069|466589819|FG000|Overall Study|Exclusion due to implant size|5|||
129627343|NCT02058069|466589819|FG000|Overall Study|Withdrawal by Subject|6|||
129627344|NCT02676882|466589823|FG000|Overall Study|Adverse Event|1|||
129627345|NCT02676882|466589824|FG001|Overall Study|Adverse Event|0|||
129627346|NCT02676882|466589823|FG000|Overall Study|Lost to Follow-up|1|||
129627347|NCT02676882|466589824|FG001|Overall Study|Lost to Follow-up|0|||
129627348|NCT02676882|466589823|FG000|Overall Study|Withdrawal by Subject|1|||
129627349|NCT02676882|466589824|FG001|Overall Study|Withdrawal by Subject|2|||
129627350|NCT02568072|466589825|FG000|Overall Study|Unavailable for appointment|23|||
129627351|NCT02568072|466589825|FG000|Overall Study|Unable to contact|3|||
129627352|NCT02568072|466589825|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
129627353|NCT02568072|466589825|FG000|Overall Study|Withdrawal by Subject|1|||
129627354|NCT02568072|466589825|FG000|Overall Study|Sustained injury, marathon not run|24|||
129627355|NCT00958828|466589827|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
129627356|NCT00958828|466589828|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
129627357|NCT00958828|466589827|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
129627358|NCT00958828|466589828|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
129627359|NCT02687451|466589835|FG000|Overall Study|Withdrawal by Subject|1|||
129627360|NCT02687451|466589836|FG001|Overall Study|Withdrawal by Subject|0|||
129627361|NCT02687451|466589837|FG002|Overall Study|Withdrawal by Subject|0|||
129627362|NCT02687451|466589838|FG003|Overall Study|Withdrawal by Subject|0|||
129627363|NCT02687451|466589839|FG004|Overall Study|Withdrawal by Subject|0|||
129627364|NCT02687451|466589840|FG005|Overall Study|Withdrawal by Subject|1|||
129627365|NCT00927589|466589841|FG000|Overall Study|Death|1|||
129627366|NCT00927589|466589841|FG000|Overall Study|Physician Decision|1|||
129627367|NCT00927589|466589841|FG000|Overall Study|Withdrawal by Subject|3|||
129627368|NCT00927589|466589841|FG000|Overall Study|Adverse Event|2|||
129627369|NCT00927589|466589841|FG000|Overall Study|Disease Progression|8|||
129627370|NCT00927589|466589841|FG000|Overall Study|Non-compliance|1|||
129627371|NCT01125189|466589842|FG000|Treatment Period|Lack of Efficacy|15|||
129627372|NCT01125189|466589843|FG001|Treatment Period|Lack of Efficacy|18|||
129627373|NCT01125189|466589844|FG002|Treatment Period|Lack of Efficacy|25|||
129627374|NCT01125189|466589842|FG000|Treatment Period|Adverse Event|7|||
129627375|NCT01125189|466589843|FG001|Treatment Period|Adverse Event|8|||
129627376|NCT01125189|466589844|FG002|Treatment Period|Adverse Event|8|||
129627377|NCT01125189|466589842|FG000|Treatment Period|Withdrawal by Subject|3|||
129627378|NCT01125189|466589843|FG001|Treatment Period|Withdrawal by Subject|1|||
129627379|NCT01125189|466589844|FG002|Treatment Period|Withdrawal by Subject|1|||
129627380|NCT01125189|466589842|FG000|Treatment Period|Death|1|||
129627381|NCT01125189|466589843|FG001|Treatment Period|Death|0|||
129627382|NCT01125189|466589844|FG002|Treatment Period|Death|0|||
129627383|NCT01125189|466589842|FG000|Treatment Period|Lost to Follow-up|1|||
129627384|NCT01125189|466589843|FG001|Treatment Period|Lost to Follow-up|2|||
129627385|NCT01125189|466589844|FG002|Treatment Period|Lost to Follow-up|1|||
129627386|NCT01125189|466589842|FG000|Treatment Period|Poor compliance/noncompliance|0|||
129627387|NCT01125189|466589843|FG001|Treatment Period|Poor compliance/noncompliance|1|||
129627388|NCT01125189|466589844|FG002|Treatment Period|Poor compliance/noncompliance|0|||
129888879|NCT02213055|467550931|FG001|Overall Study|Documentation Issue during Study|0|||
129627389|NCT01125189|466589842|FG000|Treatment Period|Participants requested to discontinue|1|||
129627390|NCT01125189|466589843|FG001|Treatment Period|Participants requested to discontinue|3|||
129627391|NCT01125189|466589844|FG002|Treatment Period|Participants requested to discontinue|4|||
129627392|NCT01125189|466589842|FG000|Treatment Period|Other reasons|1|||
129627393|NCT01125189|466589843|FG001|Treatment Period|Other reasons|1|||
129627394|NCT01125189|466589844|FG002|Treatment Period|Other reasons|0|||
129627395|NCT01125189|466589842|FG000|Treatment Period|Completed 24 week treatment period only|2|||
129627396|NCT01125189|466589843|FG001|Treatment Period|Completed 24 week treatment period only|1|||
129627397|NCT01125189|466589844|FG002|Treatment Period|Completed 24 week treatment period only|2|||
129627398|NCT01125189|466589842|FG000|Follow up Period|Withdrawal by Subject|3|||
129627399|NCT01125189|466589843|FG001|Follow up Period|Withdrawal by Subject|2|||
129627400|NCT01125189|466589844|FG002|Follow up Period|Withdrawal by Subject|5|||
129627401|NCT01125189|466589842|FG000|Follow up Period|Death|1|||
129627402|NCT01125189|466589843|FG001|Follow up Period|Death|0|||
129627403|NCT01125189|466589844|FG002|Follow up Period|Death|0|||
129627404|NCT01125189|466589842|FG000|Follow up Period|Lost to Follow-up|12|||
129627405|NCT01125189|466589843|FG001|Follow up Period|Lost to Follow-up|9|||
129627406|NCT01125189|466589844|FG002|Follow up Period|Lost to Follow-up|6|||
129627407|NCT01125189|466589842|FG000|Follow up Period|Other reasons|4|||
129627408|NCT01125189|466589843|FG001|Follow up Period|Other reasons|4|||
129627409|NCT01125189|466589844|FG002|Follow up Period|Other reasons|5|||
129627410|NCT00707239|466589845|FG000|Overall Study|Adverse Event|5|||
129627411|NCT00707239|466589846|FG001|Overall Study|Adverse Event|3|||
129627412|NCT00707239|466589847|FG002|Overall Study|Adverse Event|2|||
129627413|NCT00707239|466589845|FG000|Overall Study|Death|3|||
129627414|NCT00707239|466589846|FG001|Overall Study|Death|1|||
129627415|NCT00707239|466589847|FG002|Overall Study|Death|3|||
129627416|NCT00707239|466589845|FG000|Overall Study|Physician Decision|1|||
129627417|NCT00707239|466589846|FG001|Overall Study|Physician Decision|1|||
129627418|NCT00707239|466589847|FG002|Overall Study|Physician Decision|2|||
129627419|NCT00707239|466589845|FG000|Overall Study|Protocol Violation|0|||
129627420|NCT00707239|466589846|FG001|Overall Study|Protocol Violation|0|||
129627421|NCT00707239|466589847|FG002|Overall Study|Protocol Violation|1|||
129627422|NCT00707239|466589845|FG000|Overall Study|Lack of Efficacy|1|||
129627423|NCT00707239|466589846|FG001|Overall Study|Lack of Efficacy|2|||
129627424|NCT00707239|466589847|FG002|Overall Study|Lack of Efficacy|0|||
129627425|NCT00707239|466589845|FG000|Overall Study|Randomized, but not treated|1|||
129627426|NCT00707239|466589846|FG001|Overall Study|Randomized, but not treated|1|||
129627427|NCT00707239|466589847|FG002|Overall Study|Randomized, but not treated|1|||
129627428|NCT00707239|466589845|FG000|Overall Study|Other|8|||
129627429|NCT00707239|466589846|FG001|Overall Study|Other|3|||
129627430|NCT00707239|466589847|FG002|Overall Study|Other|5|||
129627431|NCT02088177|466589848|FG000|Overall Study|Lost to Follow-up|3|||
129627432|NCT01778530|466589849|FG000|Overall Study|Progression on study|1|||
129627433|NCT01778530|466589849|FG000|Overall Study|Adverse event/side effect|1|||
129627434|NCT03472014|466589850|FG000|Overall Study|Lost to Follow-up|4|||
129627435|NCT01894919|466589851|FG000|Overall Study|Withdrawal by Subject|1|||
129627436|NCT01894919|466589852|FG001|Overall Study|Withdrawal by Subject|0|||
129627437|NCT01894919|466589853|FG002|Overall Study|Withdrawal by Subject|0|||
129627438|NCT01894919|466589854|FG003|Overall Study|Withdrawal by Subject|0|||
129627439|NCT01894919|466589855|FG004|Overall Study|Withdrawal by Subject|1|||
129627440|NCT01894919|466589856|FG005|Overall Study|Withdrawal by Subject|0|||
129627441|NCT01894919|466589857|FG006|Overall Study|Withdrawal by Subject|0|||
129627442|NCT01894919|466589858|FG007|Overall Study|Withdrawal by Subject|0|||
129627443|NCT01894919|466589859|FG008|Overall Study|Withdrawal by Subject|0|||
129627444|NCT01894919|466589860|FG009|Overall Study|Withdrawal by Subject|1|||
129627445|NCT01894919|466589861|FG010|Overall Study|Withdrawal by Subject|1|||
129627446|NCT01894919|466589862|FG011|Overall Study|Withdrawal by Subject|0|||
129627447|NCT01894919|466589863|FG012|Overall Study|Withdrawal by Subject|0|||
129627448|NCT01894919|466589851|FG000|Overall Study|Adverse Event|0|||
129627449|NCT01894919|466589852|FG001|Overall Study|Adverse Event|0|||
129627450|NCT01894919|466589853|FG002|Overall Study|Adverse Event|0|||
129627451|NCT01894919|466589854|FG003|Overall Study|Adverse Event|0|||
129627452|NCT01894919|466589855|FG004|Overall Study|Adverse Event|0|||
129627453|NCT01894919|466589856|FG005|Overall Study|Adverse Event|0|||
129627454|NCT01894919|466589857|FG006|Overall Study|Adverse Event|0|||
129627455|NCT01894919|466589858|FG007|Overall Study|Adverse Event|0|||
129627456|NCT01894919|466589859|FG008|Overall Study|Adverse Event|0|||
129627457|NCT01894919|466589860|FG009|Overall Study|Adverse Event|0|||
129627458|NCT01894919|466589861|FG010|Overall Study|Adverse Event|1|||
129627459|NCT01894919|466589862|FG011|Overall Study|Adverse Event|0|||
129627460|NCT01894919|466589863|FG012|Overall Study|Adverse Event|0|||
129627461|NCT01894919|466589851|FG000|Overall Study|Other-Unspecified|1|||
129627462|NCT01894919|466589852|FG001|Overall Study|Other-Unspecified|0|||
129627463|NCT01894919|466589853|FG002|Overall Study|Other-Unspecified|0|||
129627464|NCT01894919|466589854|FG003|Overall Study|Other-Unspecified|0|||
129627465|NCT01894919|466589855|FG004|Overall Study|Other-Unspecified|0|||
129627466|NCT01894919|466589856|FG005|Overall Study|Other-Unspecified|0|||
129627467|NCT01894919|466589857|FG006|Overall Study|Other-Unspecified|0|||
129627468|NCT01894919|466589858|FG007|Overall Study|Other-Unspecified|0|||
129627469|NCT01894919|466589859|FG008|Overall Study|Other-Unspecified|0|||
129627470|NCT01894919|466589860|FG009|Overall Study|Other-Unspecified|0|||
129627471|NCT01894919|466589861|FG010|Overall Study|Other-Unspecified|0|||
129627472|NCT01894919|466589862|FG011|Overall Study|Other-Unspecified|0|||
129627473|NCT01894919|466589863|FG012|Overall Study|Other-Unspecified|0|||
129627474|NCT01894919|466589851|FG000|Overall Study|Lost to Follow-up|0|||
129627475|NCT01894919|466589852|FG001|Overall Study|Lost to Follow-up|0|||
129627476|NCT01894919|466589853|FG002|Overall Study|Lost to Follow-up|0|||
129627477|NCT01894919|466589854|FG003|Overall Study|Lost to Follow-up|0|||
129627478|NCT01894919|466589855|FG004|Overall Study|Lost to Follow-up|2|||
129627479|NCT01894919|466589856|FG005|Overall Study|Lost to Follow-up|0|||
129627480|NCT01894919|466589857|FG006|Overall Study|Lost to Follow-up|0|||
129627481|NCT01894919|466589858|FG007|Overall Study|Lost to Follow-up|0|||
129627482|NCT01894919|466589859|FG008|Overall Study|Lost to Follow-up|0|||
129627483|NCT01894919|466589860|FG009|Overall Study|Lost to Follow-up|0|||
129627484|NCT01894919|466589861|FG010|Overall Study|Lost to Follow-up|0|||
129627485|NCT01894919|466589862|FG011|Overall Study|Lost to Follow-up|0|||
129627486|NCT01894919|466589863|FG012|Overall Study|Lost to Follow-up|0|||
129627487|NCT01433471|466589864|FG000|Overall Study|Withdrawal by Subject|0|||
129627488|NCT01433471|466589865|FG001|Overall Study|Withdrawal by Subject|1|||
129627489|NCT03711188|466589866|FG000|Overall Study|Disease progression|11|||
129627490|NCT03711188|466589866|FG000|Overall Study|Adverse Event|1|||
129627491|NCT03743051|466589869|FG000|Overall Study|Adverse Event|5|||
129627492|NCT03743051|466589870|FG001|Overall Study|Adverse Event|9|||
129627493|NCT03743051|466589869|FG000|Overall Study|Death|27|||
129627494|NCT03743051|466589870|FG001|Overall Study|Death|26|||
129627495|NCT03743051|466589869|FG000|Overall Study|Lost to Follow-up|4|||
129627496|NCT03743051|466589870|FG001|Overall Study|Lost to Follow-up|8|||
129627497|NCT03743051|466589869|FG000|Overall Study|Withdrawal by Subject|32|||
129627498|NCT03743051|466589870|FG001|Overall Study|Withdrawal by Subject|19|||
129627499|NCT03743051|466589869|FG000|Overall Study|Physician Decision|10|||
129627500|NCT03743051|466589870|FG001|Overall Study|Physician Decision|15|||
129627501|NCT03743051|466589869|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
129627502|NCT03743051|466589870|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
129627503|NCT00711087|466589875|FG000|Overall Study|Lost to Follow-up|1|||
129627504|NCT00711087|466589876|FG001|Overall Study|Lost to Follow-up|0|||
129627505|NCT00811733|466589877|FG000|Overall Study|Investigator Discretion|10|||
129627506|NCT00811733|466589878|FG001|Overall Study|Investigator Discretion|8|||
129627507|NCT00811733|466589877|FG000|Overall Study|Withdrawal by Subject|1|||
129627508|NCT00811733|466589878|FG001|Overall Study|Withdrawal by Subject|2|||
129627509|NCT00793871|466589879|FG000|Overall Study|Death|50|||
129627510|NCT00793871|466589879|FG000|Overall Study|Lost to Follow-up|3|||
129627511|NCT00793871|466589879|FG000|Overall Study|Study terminated by the Sponsor|7|||
129627512|NCT02500589|466589880|FG000|Overall Study|Withdrawal by Subject|11|||
129627513|NCT02500589|466589881|FG001|Overall Study|Withdrawal by Subject|14|||
129627514|NCT02500589|466589880|FG000|Overall Study|Lost to Follow-up|10|||
129627515|NCT02500589|466589881|FG001|Overall Study|Lost to Follow-up|12|||
129627516|NCT02500589|466589880|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
129627517|NCT02500589|466589881|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
129627518|NCT02500589|466589880|FG000|Overall Study|Death|7|||
129627519|NCT02500589|466589881|FG001|Overall Study|Death|5|||
129627520|NCT01113892|466589884|FG000|Overall Study|Lost to Follow-up|2|||
129627521|NCT01113892|466589885|FG001|Overall Study|Lost to Follow-up|2|||
129627522|NCT01113892|466589884|FG000|Overall Study|Withdrawal by Subject|1|||
129627523|NCT01113892|466589885|FG001|Overall Study|Withdrawal by Subject|1|||
129627524|NCT01113892|466589884|FG000|Overall Study|Death|2|||
129627525|NCT01113892|466589885|FG001|Overall Study|Death|4|||
129627526|NCT01113892|466589884|FG000|Overall Study|Graft no longer evaluable|9|||
129627527|NCT01113892|466589885|FG001|Overall Study|Graft no longer evaluable|9|||
129627528|NCT02569801|466589890|FG000|Overall Study|Withdrawal by Subject|9|||
129627529|NCT02569801|466589891|FG001|Overall Study|Withdrawal by Subject|9|||
129627530|NCT02569801|466589890|FG000|Overall Study|Sponsor Decision|13|||
129627531|NCT02569801|466589891|FG001|Overall Study|Sponsor Decision|14|||
129627532|NCT02569801|466589890|FG000|Overall Study|Progressive Disease|2|||
129627533|NCT02569801|466589891|FG001|Overall Study|Progressive Disease|7|||
129627534|NCT02569801|466589890|FG000|Overall Study|Lost to Follow-up|0|||
129627535|NCT02569801|466589891|FG001|Overall Study|Lost to Follow-up|1|||
129627536|NCT02569801|466589890|FG000|Overall Study|Death|12|||
129627537|NCT02569801|466589891|FG001|Overall Study|Death|4|||
129627538|NCT00428246|466589892|FG000|Overall Study|Withdrawal by Subject|0|||
129627539|NCT00428246|466589893|FG001|Overall Study|Withdrawal by Subject|0|||
129627540|NCT00428246|466589894|FG002|Overall Study|Withdrawal by Subject|1|||
129703388|NCT02138825|466877467|FG000|Safety Follow-up|Withdrawal by Subject|5|||
129703389|NCT02138825|466877468|FG001|Safety Follow-up|Withdrawal by Subject|3|||
129703390|NCT02138825|466877467|FG000|Safety Follow-up|clinic worsening|1|||
129703391|NCT02138825|466877468|FG001|Safety Follow-up|clinic worsening|0|||
129703392|NCT02138825|466877467|FG000|Safety Follow-up|withdrawal by PI|1|||
129703393|NCT02138825|466877468|FG001|Safety Follow-up|withdrawal by PI|0|||
129703394|NCT02138825|466877467|FG000|Safety Follow-up|logistical difficulties|0|||
129703395|NCT02138825|466877468|FG001|Safety Follow-up|logistical difficulties|1|||
129703396|NCT02138825|466877467|FG000|Safety Follow-up|progressive disease|0|||
129703397|NCT02138825|466877468|FG001|Safety Follow-up|progressive disease|2|||
129703398|NCT02138825|466877467|FG000|Safety Follow-up|too unwell to attend the visit|0|||
129703399|NCT02138825|466877468|FG001|Safety Follow-up|too unwell to attend the visit|1|||
129703400|NCT02138825|466877467|FG000|Safety Follow-up|treatment unblinded|0|||
129703401|NCT02138825|466877468|FG001|Safety Follow-up|treatment unblinded|1|||
129703402|NCT02138825|466877467|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
129703403|NCT02138825|466877468|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
129627541|NCT00428246|466589892|FG000|Overall Study|Adverse Event|1|||
129627542|NCT00428246|466589893|FG001|Overall Study|Adverse Event|0|||
129627543|NCT00428246|466589894|FG002|Overall Study|Adverse Event|0|||
129627544|NCT03442751|466589896|FG000|Overall Study|Withdrawal by Subject|3|||
129627545|NCT03442751|466589897|FG001|Overall Study|Withdrawal by Subject|1|||
129627546|NCT03442751|466589896|FG000|Overall Study|Lost to Follow-up|3|||
129627547|NCT03442751|466589897|FG001|Overall Study|Lost to Follow-up|0|||
129627548|NCT02603887|466589898|FG000|Stage 1|Adverse Event|4|||
129627549|NCT02603887|466589898|FG000|Stage 1|Disease progression|1|||
129627550|NCT02603887|466589898|FG000|Stage 2|FDA guidance|1|||
129627551|NCT03164551|466589899|FG000|Overall Study|Imaging discontinued prior completion|8|||
129627552|NCT03164551|466589900|FG001|Overall Study|Imaging discontinued prior completion|0|||
129627553|NCT03164551|466589899|FG000|Overall Study|Participant was non-compliant|1|||
129627554|NCT03164551|466589900|FG001|Overall Study|Participant was non-compliant|0|||
129627555|NCT03164551|466589899|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
129627556|NCT03164551|466589900|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
129627557|NCT03164551|466589899|FG000|Overall Study|Other|8|||
129627558|NCT03164551|466589900|FG001|Overall Study|Other|2|||
129627559|NCT00470470|466589909|FG000|Overall Study|Adverse Event|2|||
129627560|NCT00470470|466589909|FG000|Overall Study|Death|2|||
129627561|NCT00470470|466589909|FG000|Overall Study|Not treated|1|||
129627562|NCT02452476|466589916|FG000|Overall Study|Death|4|||
129627563|NCT02452476|466589917|FG001|Overall Study|Death|7|||
129627564|NCT02452476|466589916|FG000|Overall Study|Lost to Follow-up|1|||
129627565|NCT02452476|466589917|FG001|Overall Study|Lost to Follow-up|1|||
129627566|NCT02452476|466589916|FG000|Overall Study|Physician Decision|1|||
129627567|NCT02452476|466589917|FG001|Overall Study|Physician Decision|1|||
129627568|NCT02452476|466589916|FG000|Overall Study|Not treated|5|||
129627569|NCT02452476|466589917|FG001|Overall Study|Not treated|1|||
129627570|NCT03552380|466589918|FG000|Study Treatment|Disease Progression|3|||
129627571|NCT03552380|466589919|FG001|Study Treatment|Disease Progression|4|||
129627572|NCT03552380|466589918|FG000|Study Treatment|Adverse Event|2|||
129627573|NCT03552380|466589919|FG001|Study Treatment|Adverse Event|2|||
129627574|NCT03552380|466589918|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
129627575|NCT03552380|466589919|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
129627576|NCT03552380|466589918|FG000|Follow up|Death|3|||
129627577|NCT03552380|466589919|FG001|Follow up|Death|4|||
129627578|NCT03552380|466589918|FG000|Follow up|Site IRB terminated|0|||
129627579|NCT03552380|466589919|FG001|Follow up|Site IRB terminated|1|||
129627580|NCT02072980|466589920|FG000|Period 2, Second Wear|Adverse Event|0|||
129627581|NCT02072980|466589921|FG001|Period 2, Second Wear|Adverse Event|1|||
129627582|NCT01757275|466589922|FG000|Overall Study|Lost to Follow-up|1|||
129794304|NCT01479985|467214351|FG001|Overall Study|Tablet malfunction, no data saved|1|||
129794305|NCT01479985|467214350|FG000|Overall Study|No decisional conflict scale responses|0|||
129794306|NCT01479985|467214351|FG001|Overall Study|No decisional conflict scale responses|2|||
129794307|NCT01479985|467214350|FG000|Overall Study|No post-visit survey|5|||
129794308|NCT01479985|467214351|FG001|Overall Study|No post-visit survey|3|||
129794309|NCT00662532|467214357|FG000|Overall Study|Adverse Event|0|||
129794310|NCT00662532|467214358|FG001|Overall Study|Adverse Event|1|||
129794311|NCT00662532|467214357|FG000|Overall Study|Lost to Follow-up|0|||
129794312|NCT00662532|467214358|FG001|Overall Study|Lost to Follow-up|1|||
129794313|NCT01850602|467214359|FG000|Overall Study|Adverse Event|7|||
129794314|NCT01850602|467214360|FG001|Overall Study|Adverse Event|10|||
129794315|NCT01850602|467214359|FG000|Overall Study|Physician Decision|2|||
129794316|NCT01850602|467214360|FG001|Overall Study|Physician Decision|1|||
129794317|NCT01850602|467214359|FG000|Overall Study|Withdrawal by Subject|2|||
129794318|NCT01850602|467214360|FG001|Overall Study|Withdrawal by Subject|4|||
129794319|NCT01850602|467214359|FG000|Overall Study|Decrease in serum calcium|2|||
129794320|NCT01850602|467214360|FG001|Overall Study|Decrease in serum calcium|3|||
129794321|NCT01850602|467214359|FG000|Overall Study|Increase in serum ferritin|1|||
129794322|NCT01850602|467214360|FG001|Overall Study|Increase in serum ferritin|0|||
129794323|NCT00367770|467214361|FG000|Overall Study|Adverse Event|1|||
129627583|NCT01757275|466589923|FG001|Overall Study|Lost to Follow-up|2|||
129794324|NCT00367770|467214361|FG000|Overall Study|Withdrawal by Subject|1|||
129627584|NCT01757275|466589922|FG000|Overall Study|Adverse Event|3|||
129627585|NCT01757275|466589923|FG001|Overall Study|Adverse Event|3|||
129627586|NCT01757275|466589922|FG000|Overall Study|Withdrawal by Subject|2|||
129627587|NCT01757275|466589923|FG001|Overall Study|Withdrawal by Subject|4|||
129627588|NCT01757275|466589922|FG000|Overall Study|Not treated|3|||
129794325|NCT01155479|467214362|FG000|Part I|Adverse Event|13|||
129794326|NCT01155479|467214363|FG001|Part I|Adverse Event|8|||
129794327|NCT01155479|467214364|FG002|Part I|Adverse Event|18|||
129794328|NCT01155479|467214365|FG003|Part I|Adverse Event|7|||
129627589|NCT01757275|466589923|FG001|Overall Study|Not treated|4|||
129794329|NCT01155479|467214366|FG004|Part I|Adverse Event|6|||
129794330|NCT01155479|467214362|FG000|Part I|Administrative|2|||
129627590|NCT01401452|466589926|FG000|Overall Study|Adverse reaction|9|||
129627591|NCT01401452|466589926|FG000|Overall Study|Lost to Follow-up|12|||
129627592|NCT01401452|466589926|FG000|Overall Study|Lack of Efficacy|30|||
129627593|NCT01401452|466589926|FG000|Overall Study|Participant developed breast cancer|1|||
129627594|NCT01401452|466589926|FG000|Overall Study|Tx stopped due to financial reasons|1|||
129627595|NCT01401452|466589926|FG000|Overall Study|Tx stopped by psychiatrist|1|||
129627596|NCT01401452|466589926|FG000|Overall Study|No more visits within the 36 wk followup|4|||
129627597|NCT01401452|466589926|FG000|Overall Study|Subject did not come to follow up visits|2|||
129627598|NCT01401452|466589926|FG000|Overall Study|Subject didn't return for routine visits|1|||
129627599|NCT01401452|466589926|FG000|Overall Study|Subject moved to another city|1|||
129627600|NCT01401452|466589926|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
129627601|NCT01401452|466589926|FG000|Overall Study|Psoriatic arthritis|1|||
129627602|NCT01401452|466589926|FG000|Overall Study|Participant stopped Tx|2|||
129627603|NCT01401452|466589926|FG000|Overall Study|Discontinuation for personal reasons|1|||
129627604|NCT01401452|466589926|FG000|Overall Study|Treatment failure|1|||
129627605|NCT01401452|466589926|FG000|Overall Study|Unsatisfactory output|1|||
129627606|NCT01401452|466589926|FG000|Overall Study|Subject withdrew because of Tx success|1|||
129627607|NCT01401452|466589926|FG000|Overall Study|Subject chose to discontinue treatment|1|||
129627608|NCT01401452|466589926|FG000|Overall Study|Participant withdrew consent|1|||
129627609|NCT02601014|466589927|FG000|Overall Study|Adverse Event|3|||
129627610|NCT02601014|466589928|FG001|Overall Study|Adverse Event|3|||
129627611|NCT02601014|466589927|FG000|Overall Study|Death|3|||
129627612|NCT02601014|466589928|FG001|Overall Study|Death|1|||
129627613|NCT02601014|466589927|FG000|Overall Study|Disease progression|4|||
129627614|NCT02601014|466589928|FG001|Overall Study|Disease progression|8|||
129627615|NCT01168427|466589929|FG000|Overall Study|Patient exited prior to implant|1|||
129627616|NCT01133067|466589934|FG000|Overall Study|Death|136|||
129627617|NCT01133067|466589934|FG000|Overall Study|Lost to Follow-up|3|||
129627618|NCT02654054|466589936|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
129627619|NCT02654054|466589937|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
129627620|NCT02654054|466589938|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
129627621|NCT02654054|466589936|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129627622|NCT02654054|466589937|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129627623|NCT02654054|466589938|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
129627624|NCT02654054|466589936|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
129627625|NCT02654054|466589937|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
129627626|NCT02654054|466589938|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
129627627|NCT02654054|466589936|FG000|Post-Treatment Follow-Up Period|Other|1|||
129627628|NCT02654054|466589937|FG001|Post-Treatment Follow-Up Period|Other|0|||
129627629|NCT02654054|466589938|FG002|Post-Treatment Follow-Up Period|Other|4|||
129627630|NCT02654054|466589936|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129627631|NCT02654054|466589937|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129627632|NCT02654054|466589938|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
129627633|NCT00273182|466589939|FG000|Overall Study|Death|450|||
129627634|NCT00273182|466589939|FG000|Overall Study|Lost to Follow-up|88|||
129627635|NCT00273182|466589939|FG000|Overall Study|Withdrawal by Subject|257|||
129627636|NCT00273182|466589939|FG000|Overall Study|Device/System Explant|154|||
129627637|NCT00273182|466589939|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
129627638|NCT00420420|466589940|FG000|Overall Study|Adverse Event|5|||
129627639|NCT00420420|466589941|FG001|Overall Study|Adverse Event|3|||
129627640|NCT00420420|466589940|FG000|Overall Study|Protocol Violation|1|||
129627641|NCT00420420|466589941|FG001|Overall Study|Protocol Violation|1|||
129627642|NCT00420420|466589940|FG000|Overall Study|Withdrawal by Subject|1|||
129627643|NCT00420420|466589941|FG001|Overall Study|Withdrawal by Subject|0|||
129627644|NCT00420420|466589940|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
129627645|NCT00420420|466589941|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
129627646|NCT03641469|466589942|FG000|Overall Study|Ineligible|2|||
129627647|NCT03641469|466589942|FG000|Overall Study|Withdrawal by Subject|5|||
129627648|NCT03641469|466589942|FG000|Overall Study|Physician Decision|1|||
129627649|NCT03641469|466589942|FG000|Overall Study|Protocol Violation|1|||
129627650|NCT03641469|466589942|FG000|Overall Study|Lost to Follow-up|2|||
129627651|NCT00868530|466589943|FG000|Overall Study|Adverse Event|3|||
129627652|NCT00868530|466589943|FG000|Overall Study|Lost to Follow-up|1|||
129627653|NCT00858273|466589944|FG000|Overall Study|Protocol Violation|3|||
129627654|NCT00858273|466589945|FG001|Overall Study|Protocol Violation|5|||
129627655|NCT02562235|466591824|FG000|Overall Study|Adverse Event|3|||
129627656|NCT05655546|466591827|FG000|Overall Study|Withdrawal by Subject|2|||
129627657|NCT05655546|466591828|FG001|Overall Study|Withdrawal by Subject|4|||
129627658|NCT01168232|466591829|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
129627659|NCT01168232|466591829|FG000|Overall Study|Ineligible- Wrong cell type|6|||
129627660|NCT01168232|466591829|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
129627661|NCT04576507|466591833|FG000|Overall Study|Adverse Event|4|||
129627662|NCT04576507|466591833|FG000|Overall Study|Withdrawal by Subject|1|||
129627663|NCT05012098|466591838|FG000|Overall Study|Disease progression|5|||
129627664|NCT05012098|466591839|FG001|Overall Study|Disease progression|2|||
129627665|NCT05012098|466591838|FG000|Overall Study|Adverse Event|1|||
129627666|NCT05012098|466591839|FG001|Overall Study|Adverse Event|0|||
129888880|NCT02213055|467550930|FG000|Overall Study|Did not have Live Lice|8|||
129627667|NCT05012098|466591838|FG000|Overall Study|Withdrawal by Subject|1|||
129627668|NCT05012098|466591839|FG001|Overall Study|Withdrawal by Subject|0|||
129627669|NCT05012098|466591838|FG000|Overall Study|Discontinuation per protocol|1|||
129627670|NCT05012098|466591839|FG001|Overall Study|Discontinuation per protocol|0|||
129627671|NCT01490086|466591840|FG000|Overall Study|Consent withdrawn|4|||
129627672|NCT01490086|466591841|FG001|Overall Study|Consent withdrawn|4|||
129627673|NCT01490086|466591842|FG002|Overall Study|Consent withdrawn|3|||
129627674|NCT01490086|466591843|FG003|Overall Study|Consent withdrawn|0|||
129627675|NCT01490086|466591844|FG004|Overall Study|Consent withdrawn|1|||
129627676|NCT01490086|466591840|FG000|Overall Study|Non-compliance|0|||
129627677|NCT01490086|466591841|FG001|Overall Study|Non-compliance|1|||
129627678|NCT01490086|466591842|FG002|Overall Study|Non-compliance|0|||
129627679|NCT01490086|466591843|FG003|Overall Study|Non-compliance|0|||
129627680|NCT01490086|466591844|FG004|Overall Study|Non-compliance|0|||
129627681|NCT01490086|466591840|FG000|Overall Study|Abnormal laboratory findings|1|||
129627682|NCT01490086|466591841|FG001|Overall Study|Abnormal laboratory findings|0|||
129627683|NCT01490086|466591842|FG002|Overall Study|Abnormal laboratory findings|0|||
129627684|NCT01490086|466591843|FG003|Overall Study|Abnormal laboratory findings|0|||
129627685|NCT01490086|466591844|FG004|Overall Study|Abnormal laboratory findings|0|||
129627686|NCT01490086|466591840|FG000|Overall Study|Lost to Follow-up|0|||
129627687|NCT01490086|466591841|FG001|Overall Study|Lost to Follow-up|0|||
129627688|NCT01490086|466591842|FG002|Overall Study|Lost to Follow-up|0|||
129627689|NCT01490086|466591843|FG003|Overall Study|Lost to Follow-up|0|||
129627690|NCT01490086|466591844|FG004|Overall Study|Lost to Follow-up|1|||
129794331|NCT01155479|467214363|FG001|Part I|Administrative|2|||
129794332|NCT01155479|467214364|FG002|Part I|Administrative|2|||
129794333|NCT01155479|467214365|FG003|Part I|Administrative|0|||
129794334|NCT01155479|467214366|FG004|Part I|Administrative|0|||
129794335|NCT01155479|467214362|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
129794336|NCT01155479|467214363|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
129794337|NCT01155479|467214364|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
129794338|NCT01155479|467214365|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
129794339|NCT01155479|467214366|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
129794340|NCT01155479|467214362|FG000|Part I|Withdrawal by Subject|11|||
129794341|NCT01155479|467214363|FG001|Part I|Withdrawal by Subject|13|||
129794342|NCT01155479|467214364|FG002|Part I|Withdrawal by Subject|8|||
129794343|NCT01155479|467214365|FG003|Part I|Withdrawal by Subject|8|||
129794344|NCT01155479|467214366|FG004|Part I|Withdrawal by Subject|9|||
129794345|NCT01155479|467214362|FG000|Part I|Lost to Follow-up|0|||
129794346|NCT01155479|467214363|FG001|Part I|Lost to Follow-up|0|||
129794347|NCT01155479|467214364|FG002|Part I|Lost to Follow-up|1|||
129794348|NCT01155479|467214365|FG003|Part I|Lost to Follow-up|1|||
129794349|NCT01155479|467214366|FG004|Part I|Lost to Follow-up|0|||
129794350|NCT01155479|467214362|FG000|Part I|Treatment Failure|3|||
129794351|NCT01155479|467214363|FG001|Part I|Treatment Failure|0|||
129794352|NCT01155479|467214364|FG002|Part I|Treatment Failure|3|||
129794353|NCT01155479|467214365|FG003|Part I|Treatment Failure|1|||
129794354|NCT01155479|467214366|FG004|Part I|Treatment Failure|2|||
129794355|NCT01155479|467214362|FG000|Part I|Did Not Receive Treatment|4|||
129794356|NCT01155479|467214363|FG001|Part I|Did Not Receive Treatment|2|||
129794357|NCT01155479|467214364|FG002|Part I|Did Not Receive Treatment|2|||
129794358|NCT01155479|467214365|FG003|Part I|Did Not Receive Treatment|6|||
129794359|NCT01155479|467214366|FG004|Part I|Did Not Receive Treatment|1|||
129794360|NCT01155479|467214362|FG000|Part I|Non-Compliance with Protocol|2|||
129794361|NCT01155479|467214363|FG001|Part I|Non-Compliance with Protocol|1|||
129794362|NCT01155479|467214364|FG002|Part I|Non-Compliance with Protocol|3|||
129794363|NCT01155479|467214365|FG003|Part I|Non-Compliance with Protocol|3|||
129794364|NCT01155479|467214366|FG004|Part I|Non-Compliance with Protocol|2|||
129794365|NCT01155479|467214362|FG000|Part II|Adverse Event|7|||
129794366|NCT01155479|467214363|FG001|Part II|Adverse Event|6|||
129794367|NCT01155479|467214364|FG002|Part II|Adverse Event|8|||
129888881|NCT02213055|467550931|FG001|Overall Study|Did not have Live Lice|0|||
129627691|NCT01490086|466591840|FG000|Overall Study|Physician Decision|3|||
129627692|NCT01490086|466591841|FG001|Overall Study|Physician Decision|4|||
129627693|NCT01490086|466591842|FG002|Overall Study|Physician Decision|2|||
129794368|NCT01155479|467214365|FG003|Part II|Adverse Event|3|||
129794369|NCT01155479|467214366|FG004|Part II|Adverse Event|4|||
129794370|NCT01155479|467214362|FG000|Part II|Administrative|43|||
129794371|NCT01155479|467214363|FG001|Part II|Administrative|49|||
129794372|NCT01155479|467214364|FG002|Part II|Administrative|36|||
129794373|NCT01155479|467214365|FG003|Part II|Administrative|38|||
129794374|NCT01155479|467214366|FG004|Part II|Administrative|46|||
129794375|NCT01155479|467214362|FG000|Part II|Withdrawal by Subject|8|||
129627694|NCT01490086|466591843|FG003|Overall Study|Physician Decision|3|||
129627695|NCT01490086|466591844|FG004|Overall Study|Physician Decision|1|||
129627696|NCT01490086|466591840|FG000|Overall Study|Adverse Event|0|||
129627697|NCT01490086|466591841|FG001|Overall Study|Adverse Event|0|||
129627698|NCT01490086|466591842|FG002|Overall Study|Adverse Event|1|||
129627699|NCT01490086|466591843|FG003|Overall Study|Adverse Event|2|||
129627700|NCT01490086|466591844|FG004|Overall Study|Adverse Event|0|||
129627701|NCT01490086|466591840|FG000|Overall Study|Lack of Efficacy|0|||
129627702|NCT01490086|466591841|FG001|Overall Study|Lack of Efficacy|3|||
129627703|NCT01490086|466591842|FG002|Overall Study|Lack of Efficacy|1|||
129627704|NCT01490086|466591843|FG003|Overall Study|Lack of Efficacy|0|||
129627705|NCT01490086|466591844|FG004|Overall Study|Lack of Efficacy|8|||
129627706|NCT01490086|466591840|FG000|Overall Study|Worsening of symptoms|0|||
129627707|NCT01490086|466591841|FG001|Overall Study|Worsening of symptoms|1|||
129627708|NCT01490086|466591842|FG002|Overall Study|Worsening of symptoms|0|||
129627709|NCT01490086|466591843|FG003|Overall Study|Worsening of symptoms|1|||
129627710|NCT01490086|466591844|FG004|Overall Study|Worsening of symptoms|0|||
129627711|NCT01490086|466591840|FG000|Overall Study|Subject uncontrollable and abusive|0|||
129627712|NCT01490086|466591841|FG001|Overall Study|Subject uncontrollable and abusive|1|||
129627713|NCT01490086|466591842|FG002|Overall Study|Subject uncontrollable and abusive|0|||
129627714|NCT01490086|466591843|FG003|Overall Study|Subject uncontrollable and abusive|0|||
129627715|NCT01490086|466591844|FG004|Overall Study|Subject uncontrollable and abusive|0|||
129627716|NCT01490086|466591840|FG000|Overall Study|Subject left hospital|0|||
129627717|NCT01490086|466591841|FG001|Overall Study|Subject left hospital|1|||
129627718|NCT01490086|466591842|FG002|Overall Study|Subject left hospital|0|||
129627719|NCT01490086|466591843|FG003|Overall Study|Subject left hospital|1|||
129627720|NCT01490086|466591844|FG004|Overall Study|Subject left hospital|0|||
129627721|NCT05825404|466591845|FG000|First Intervention (Weeks 2-5)|Death|0|||
129627722|NCT05825404|466591846|FG001|First Intervention (Weeks 2-5)|Death|1|||
129627723|NCT05825404|466591845|FG000|Second Intervention (Weeks 8-11)|Death|0|||
129627724|NCT05825404|466591846|FG001|Second Intervention (Weeks 8-11)|Death|1|||
129627725|NCT02157935|466591847|FG000|Overall Study|Withdrawal by Subject|25|||
129627726|NCT02157935|466591848|FG001|Overall Study|Withdrawal by Subject|39|||
129627727|NCT02157935|466591847|FG000|Overall Study|Screen failure|1|||
129627728|NCT02157935|466591848|FG001|Overall Study|Screen failure|2|||
129627729|NCT02157935|466591847|FG000|Overall Study|Protocol Violation|1|||
129627730|NCT02157935|466591848|FG001|Overall Study|Protocol Violation|0|||
129627731|NCT02157935|466591847|FG000|Overall Study|Progressive disease|0|||
129627732|NCT02157935|466591848|FG001|Overall Study|Progressive disease|2|||
129627733|NCT02157935|466591847|FG000|Overall Study|Other|5|||
129627734|NCT02157935|466591848|FG001|Overall Study|Other|12|||
129627735|NCT02157935|466591847|FG000|Overall Study|Lack of Efficacy|0|||
129627736|NCT02157935|466591848|FG001|Overall Study|Lack of Efficacy|1|||
129627737|NCT02157935|466591847|FG000|Overall Study|Death|4|||
129627738|NCT02157935|466591848|FG001|Overall Study|Death|4|||
129627739|NCT02157935|466591847|FG000|Overall Study|Adverse Event|3|||
129627740|NCT02157935|466591848|FG001|Overall Study|Adverse Event|5|||
129627741|NCT01103180|466591857|FG000|Overall Study|Withdrawal by Subject|8|||
129627742|NCT01103180|466591858|FG001|Overall Study|Withdrawal by Subject|13|||
129627743|NCT01103180|466591857|FG000|Overall Study|Lost to Follow-up|13|||
129627744|NCT01103180|466591858|FG001|Overall Study|Lost to Follow-up|7|||
129627745|NCT01103180|466591857|FG000|Overall Study|Physician Decision|1|||
129627746|NCT01103180|466591858|FG001|Overall Study|Physician Decision|0|||
129627747|NCT01103180|466591857|FG000|Overall Study|Protocol Violation|0|||
129627748|NCT01103180|466591858|FG001|Overall Study|Protocol Violation|1|||
129627749|NCT02493660|466591859|FG000|Overall Study|Physician Decision|0|||
129627750|NCT02493660|466591860|FG001|Overall Study|Physician Decision|1|||
129627751|NCT02493660|466591859|FG000|Overall Study|Adverse Event|4|||
129627752|NCT02493660|466591860|FG001|Overall Study|Adverse Event|2|||
129627753|NCT02493660|466591859|FG000|Overall Study|Withdrawal by Subject|2|||
129627754|NCT02493660|466591860|FG001|Overall Study|Withdrawal by Subject|3|||
129627755|NCT02493660|466591859|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
129627756|NCT02493660|466591860|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
129627757|NCT02493660|466591859|FG000|Overall Study|Protocol Violation|0|||
129627758|NCT02493660|466591860|FG001|Overall Study|Protocol Violation|1|||
129627759|NCT02493660|466591859|FG000|Overall Study|Death|0|||
129627760|NCT02493660|466591860|FG001|Overall Study|Death|1|||
129627761|NCT02493660|466591859|FG000|Overall Study|Lost to Follow-up|2|||
129627762|NCT02493660|466591860|FG001|Overall Study|Lost to Follow-up|4|||
129627763|NCT02392481|466591864|FG000|Overall Study|Adverse Event|0|||
129627764|NCT02392481|466591865|FG001|Overall Study|Adverse Event|0|||
129627765|NCT02392481|466591866|FG002|Overall Study|Adverse Event|1|||
129627766|NCT02392481|466591867|FG003|Overall Study|Adverse Event|2|||
129627767|NCT02392481|466591864|FG000|Overall Study|Withdrawal by Subject|0|||
129627768|NCT02392481|466591865|FG001|Overall Study|Withdrawal by Subject|0|||
129627769|NCT02392481|466591866|FG002|Overall Study|Withdrawal by Subject|1|||
129627770|NCT02392481|466591867|FG003|Overall Study|Withdrawal by Subject|0|||
129627771|NCT02502149|466591869|FG000|Intermediate|Discontinued prematurely|1|||
129627772|NCT02502149|466591870|FG001|Intermediate|Discontinued prematurely|0|||
129627773|NCT02502149|466591871|FG002|Intermediate|Discontinued prematurely|0|||
129703404|NCT03493958|466877469|FG000|Overall Study|Withdrawal by Subject|6|||
129703405|NCT03493958|466877469|FG000|Overall Study|Lost to Follow-up|7|||
129703406|NCT03493958|466877469|FG000|Overall Study|Did not complete all required study procedures|2|||
129703407|NCT00904371|466877472|FG000|Overall Study|Adverse Event|2|||
129703408|NCT00904371|466877472|FG000|Overall Study|Lost to Follow-up|4|||
129627774|NCT02502149|466591872|FG003|Intermediate|Discontinued prematurely|0|||
129703409|NCT00904371|466877472|FG000|Overall Study|Discontinued at target blood pressure|2|||
129703410|NCT00904371|466877472|FG000|Overall Study|Continued with Tritace|1|||
129703411|NCT02095106|466877475|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129703412|NCT02095106|466877476|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129703413|NCT00553254|466877479|FG000|Overall Study|Death|3|||
129703414|NCT00553254|466877480|FG001|Overall Study|Death|6|||
129703415|NCT00553254|466877481|FG002|Overall Study|Death|25|||
129703416|NCT00553254|466877479|FG000|Overall Study|Lost to Follow-up|0|||
129703417|NCT00553254|466877480|FG001|Overall Study|Lost to Follow-up|0|||
129703418|NCT00553254|466877481|FG002|Overall Study|Lost to Follow-up|2|||
129703419|NCT00553254|466877479|FG000|Overall Study|Withdrawal by Subject|2|||
129703420|NCT00553254|466877480|FG001|Overall Study|Withdrawal by Subject|0|||
129703421|NCT00553254|466877481|FG002|Overall Study|Withdrawal by Subject|2|||
129703422|NCT00553254|466877479|FG000|Overall Study|Study terminated by Sponsor|0|||
129703423|NCT00553254|466877480|FG001|Overall Study|Study terminated by Sponsor|0|||
129703424|NCT00553254|466877481|FG002|Overall Study|Study terminated by Sponsor|1|||
129703425|NCT00553254|466877479|FG000|Overall Study|Other|1|||
129703426|NCT00553254|466877480|FG001|Overall Study|Other|0|||
129703427|NCT00553254|466877481|FG002|Overall Study|Other|13|||
129703428|NCT00583219|466877491|FG000|Phase 2|Withdrawal by Subject|1|||
129703429|NCT02090764|466877492|FG000|Overall Study|Adverse Event|1|||
129703430|NCT02090764|466877493|FG001|Overall Study|Adverse Event|3|||
129703431|NCT02090764|466877492|FG000|Overall Study|Lack of Efficacy|0|||
129703432|NCT02090764|466877493|FG001|Overall Study|Lack of Efficacy|13|||
129703433|NCT02090764|466877492|FG000|Overall Study|Withdrawal by Subject|2|||
129703434|NCT02090764|466877493|FG001|Overall Study|Withdrawal by Subject|1|||
129703435|NCT02090764|466877492|FG000|Overall Study|Intercurrent illness and other|1|||
129703436|NCT02090764|466877493|FG001|Overall Study|Intercurrent illness and other|1|||
129703437|NCT02090764|466877492|FG000|Overall Study|Lost to Follow-up|2|||
129703438|NCT02090764|466877493|FG001|Overall Study|Lost to Follow-up|2|||
129703439|NCT00754572|466877494|FG000|Overall Study|Adverse Event|19|||
129703440|NCT00754572|466877494|FG000|Overall Study|Other|39|||
129703441|NCT00754572|466877494|FG000|Overall Study|Protocol Violation|3|||
129703442|NCT00754572|466877494|FG000|Overall Study|Withdrawal by Subject|3|||
129703443|NCT00754572|466877494|FG000|Overall Study|Lack of Efficacy|2|||
129703444|NCT00754572|466877494|FG000|Overall Study|Death|1|||
129703445|NCT00754572|466877494|FG000|Overall Study|Administrative Reason|3|||
129703446|NCT00754572|466877494|FG000|Overall Study|Lost to Follow-up|1|||
129703447|NCT02836249|466877497|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129627775|NCT02502149|466591873|FG004|Intermediate|Discontinued prematurely|0|||
129627776|NCT02968576|466591874|FG000|Overall Study|Pregnancy|0|||
129703448|NCT02836249|466877498|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
129703449|NCT02836249|466877499|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129703450|NCT02836249|466877500|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129703451|NCT02836249|466877497|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
129627777|NCT02968576|466591875|FG001|Overall Study|Pregnancy|1|||
129627778|NCT02222922|466591876|FG000|Overall Study|Death|0|||
129627779|NCT02222922|466591877|FG001|Overall Study|Death|0|||
129627780|NCT02222922|466591878|FG002|Overall Study|Death|0|||
129627781|NCT02222922|466591879|FG003|Overall Study|Death|0|||
129627782|NCT02222922|466591880|FG004|Overall Study|Death|13|||
129627783|NCT02222922|466591881|FG005|Overall Study|Death|0|||
129627784|NCT02222922|466591882|FG006|Overall Study|Death|0|||
129627785|NCT02222922|466591883|FG007|Overall Study|Death|0|||
129627786|NCT02222922|466591884|FG008|Overall Study|Death|2|||
129627787|NCT02222922|466591876|FG000|Overall Study|Lost to Follow-up|0|||
129627788|NCT02222922|466591877|FG001|Overall Study|Lost to Follow-up|0|||
129627789|NCT02222922|466591878|FG002|Overall Study|Lost to Follow-up|1|||
129627790|NCT02222922|466591879|FG003|Overall Study|Lost to Follow-up|0|||
129703452|NCT02836249|466877498|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
129703453|NCT02836249|466877499|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
129703454|NCT02836249|466877500|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
129703455|NCT02836249|466877497|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
129703456|NCT02836249|466877498|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
129703457|NCT02836249|466877499|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
129703458|NCT02836249|466877500|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
129794376|NCT01155479|467214363|FG001|Part II|Withdrawal by Subject|4|||
129794377|NCT01155479|467214364|FG002|Part II|Withdrawal by Subject|12|||
129627791|NCT02222922|466591880|FG004|Overall Study|Lost to Follow-up|9|||
129794378|NCT01155479|467214365|FG003|Part II|Withdrawal by Subject|7|||
129627792|NCT02222922|466591881|FG005|Overall Study|Lost to Follow-up|1|||
129703459|NCT02836249|466877497|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129888882|NCT02213055|467550930|FG000|Overall Study|Had another Treatment during the Study|3|||
129888883|NCT02213055|467550931|FG001|Overall Study|Had another Treatment during the Study|0|||
129888884|NCT02213055|467550930|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
129888885|NCT02213055|467550931|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
129888886|NCT02213055|467550930|FG000|Overall Study|Did not Return to School|5|||
129888887|NCT02213055|467550931|FG001|Overall Study|Did not Return to School|0|||
129888888|NCT00231894|467550932|FG000|Overall Study|Withdrawal by Subject|1|||
129888889|NCT00231894|467550933|FG001|Overall Study|Withdrawal by Subject|1|||
129888890|NCT02025205|467550935|FG000|Overall Study|Withdrawal by Subject|1|||
129888891|NCT02025205|467550936|FG001|Overall Study|Withdrawal by Subject|1|||
129888892|NCT02025205|467550935|FG000|Overall Study|Protocol Violation|2|||
129888893|NCT02025205|467550936|FG001|Overall Study|Protocol Violation|1|||
129888894|NCT02025205|467550935|FG000|Overall Study|Death|0|||
129888895|NCT02025205|467550936|FG001|Overall Study|Death|1|||
129888896|NCT01782326|467550937|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
129888897|NCT01782326|467550938|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
129888898|NCT01782326|467550937|FG000|Planned Treatment Epoch|Death|29|||
129888899|NCT01782326|467550938|FG001|Planned Treatment Epoch|Death|30|||
129888900|NCT01782326|467550937|FG000|Planned Treatment Epoch|Physician Decision|18|||
129888901|NCT01782326|467550938|FG001|Planned Treatment Epoch|Physician Decision|16|||
129888902|NCT01782326|467550937|FG000|Planned Treatment Epoch|Protocol deviation|2|||
129888903|NCT01782326|467550938|FG001|Planned Treatment Epoch|Protocol deviation|3|||
129888904|NCT01782326|467550937|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
129888905|NCT01782326|467550938|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
129888906|NCT01782326|467550937|FG000|Planned Treatment Epoch|Technical problems|0|||
129888907|NCT01782326|467550938|FG001|Planned Treatment Epoch|Technical problems|4|||
129888908|NCT01782326|467550937|FG000|Double-blind Treatment|Adverse Event|129|||
129888909|NCT01782326|467550938|FG001|Double-blind Treatment|Adverse Event|145|||
129888910|NCT01782326|467550937|FG000|Double-blind Treatment|Subject/guardian decision|111|||
129627793|NCT02222922|466591882|FG006|Overall Study|Lost to Follow-up|0|||
129627794|NCT02222922|466591883|FG007|Overall Study|Lost to Follow-up|0|||
129627795|NCT02222922|466591884|FG008|Overall Study|Lost to Follow-up|0|||
129627796|NCT02222922|466591876|FG000|Overall Study|Other|0|||
129627797|NCT02222922|466591877|FG001|Overall Study|Other|0|||
129627798|NCT02222922|466591878|FG002|Overall Study|Other|0|||
129627799|NCT02222922|466591879|FG003|Overall Study|Other|2|||
129627800|NCT02222922|466591880|FG004|Overall Study|Other|10|||
129627801|NCT02222922|466591881|FG005|Overall Study|Other|2|||
129627802|NCT02222922|466591882|FG006|Overall Study|Other|2|||
129627803|NCT02222922|466591883|FG007|Overall Study|Other|4|||
129627804|NCT02222922|466591884|FG008|Overall Study|Other|1|||
129627805|NCT02222922|466591876|FG000|Overall Study|Participant refused further follow-up|1|||
129627806|NCT02222922|466591877|FG001|Overall Study|Participant refused further follow-up|0|||
129627807|NCT02222922|466591878|FG002|Overall Study|Participant refused further follow-up|0|||
129627808|NCT02222922|466591879|FG003|Overall Study|Participant refused further follow-up|1|||
129627809|NCT02222922|466591880|FG004|Overall Study|Participant refused further follow-up|6|||
129627810|NCT02222922|466591881|FG005|Overall Study|Participant refused further follow-up|0|||
129627811|NCT02222922|466591882|FG006|Overall Study|Participant refused further follow-up|0|||
129627812|NCT02222922|466591883|FG007|Overall Study|Participant refused further follow-up|0|||
129627813|NCT02222922|466591884|FG008|Overall Study|Participant refused further follow-up|3|||
129627814|NCT01254643|466591885|FG000|Overall Study|Withdrawal by Subject|1|||
129627815|NCT00116779|466591891|FG000|Overall Study|Adverse Event|4|||
129627816|NCT00116779|466591892|FG001|Overall Study|Adverse Event|2|||
129627817|NCT00116779|466591891|FG000|Overall Study|Protocol Violation|1|||
129627818|NCT00116779|466591892|FG001|Overall Study|Protocol Violation|4|||
129627819|NCT00116779|466591891|FG000|Overall Study|Withdrawal by Subject|4|||
129627820|NCT00116779|466591892|FG001|Overall Study|Withdrawal by Subject|1|||
129627821|NCT00116779|466591891|FG000|Overall Study|Inadequate testosterone suppression|7|||
129627822|NCT00116779|466591892|FG001|Overall Study|Inadequate testosterone suppression|9|||
129627823|NCT00116779|466591891|FG000|Overall Study|Physician Decision|3|||
129627824|NCT00116779|466591892|FG001|Overall Study|Physician Decision|1|||
129888911|NCT01782326|467550938|FG001|Double-blind Treatment|Subject/guardian decision|125|||
129888912|NCT01782326|467550937|FG000|Double-blind Treatment|Lack of Efficacy|17|||
129888913|NCT01782326|467550938|FG001|Double-blind Treatment|Lack of Efficacy|22|||
129627825|NCT00116779|466591891|FG000|Overall Study|Elevated PSA levels|2|||
129627826|NCT00116779|466591892|FG001|Overall Study|Elevated PSA levels|2|||
129627827|NCT01037218|466591897|FG000|Overall Study|Adverse Event|4|||
129627828|NCT01037218|466591898|FG001|Overall Study|Adverse Event|2|||
129627829|NCT01037218|466591899|FG002|Overall Study|Adverse Event|2|||
129627830|NCT01037218|466591900|FG003|Overall Study|Adverse Event|1|||
129888914|NCT01782326|467550937|FG000|Double-blind Treatment|Physician Decision|13|||
129888915|NCT01782326|467550938|FG001|Double-blind Treatment|Physician Decision|16|||
129627831|NCT01037218|466591897|FG000|Overall Study|Lack of Efficacy|0|||
129627832|NCT01037218|466591898|FG001|Overall Study|Lack of Efficacy|2|||
129627833|NCT01037218|466591899|FG002|Overall Study|Lack of Efficacy|1|||
129627834|NCT01037218|466591900|FG003|Overall Study|Lack of Efficacy|5|||
129627835|NCT01037218|466591897|FG000|Overall Study|Lost to Follow-up|3|||
129627836|NCT01037218|466591898|FG001|Overall Study|Lost to Follow-up|5|||
129627837|NCT01037218|466591899|FG002|Overall Study|Lost to Follow-up|4|||
129627838|NCT01037218|466591900|FG003|Overall Study|Lost to Follow-up|2|||
129627839|NCT01037218|466591897|FG000|Overall Study|Withdrawal by Subject|6|||
129627840|NCT01037218|466591898|FG001|Overall Study|Withdrawal by Subject|7|||
129627841|NCT01037218|466591899|FG002|Overall Study|Withdrawal by Subject|7|||
129627842|NCT01037218|466591900|FG003|Overall Study|Withdrawal by Subject|4|||
129627843|NCT01037218|466591897|FG000|Overall Study|Partner Withdrew Consent|0|||
129627844|NCT01037218|466591898|FG001|Overall Study|Partner Withdrew Consent|3|||
129627845|NCT01037218|466591899|FG002|Overall Study|Partner Withdrew Consent|2|||
129627846|NCT01037218|466591900|FG003|Overall Study|Partner Withdrew Consent|1|||
129627847|NCT01037218|466591897|FG000|Overall Study|Protocol Violation|0|||
129627848|NCT01037218|466591898|FG001|Overall Study|Protocol Violation|0|||
129627849|NCT01037218|466591899|FG002|Overall Study|Protocol Violation|2|||
129627850|NCT01037218|466591900|FG003|Overall Study|Protocol Violation|2|||
129627851|NCT01037218|466591897|FG000|Overall Study|Various|3|||
129627852|NCT01037218|466591898|FG001|Overall Study|Various|2|||
129627853|NCT01037218|466591899|FG002|Overall Study|Various|3|||
129627854|NCT01037218|466591900|FG003|Overall Study|Various|1|||
129627855|NCT01651117|466591906|FG000|Overall Study|Death|2|||
129627856|NCT01651117|466591907|FG001|Overall Study|Death|3|||
129627857|NCT01651117|466591908|FG002|Overall Study|Death|2|||
129627858|NCT01651117|466591909|FG003|Overall Study|Death|2|||
129627859|NCT02714218|466591910|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129627860|NCT02714218|466591911|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129627861|NCT02714218|466591912|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129627862|NCT02714218|466591910|FG000|Pre-Treatment Period|Other reasons|0|||
129627863|NCT02714218|466591911|FG001|Pre-Treatment Period|Other reasons|1|||
129627864|NCT02714218|466591912|FG002|Pre-Treatment Period|Other reasons|0|||
129627865|NCT02714218|466591910|FG000|Treatment Period|Disease Progression|55|||
129627866|NCT02714218|466591911|FG001|Treatment Period|Disease Progression|52|||
129627867|NCT02714218|466591912|FG002|Treatment Period|Disease Progression|14|||
129627868|NCT02714218|466591910|FG000|Treatment Period|Study drug toxicity|46|||
129627869|NCT02714218|466591911|FG001|Treatment Period|Study drug toxicity|70|||
129627870|NCT02714218|466591912|FG002|Treatment Period|Study drug toxicity|6|||
129627871|NCT02714218|466591910|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
129627872|NCT02714218|466591911|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
129627873|NCT02714218|466591912|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
129627874|NCT02714218|466591910|FG000|Treatment Period|Request to discontinue treatment|1|||
129627875|NCT02714218|466591911|FG001|Treatment Period|Request to discontinue treatment|4|||
129627876|NCT02714218|466591912|FG002|Treatment Period|Request to discontinue treatment|1|||
129627877|NCT02714218|466591910|FG000|Treatment Period|Participant withdrew consent|2|||
129794379|NCT01155479|467214366|FG004|Part II|Withdrawal by Subject|3|||
129794380|NCT01155479|467214362|FG000|Part II|Lost to Follow-up|1|||
129794381|NCT01155479|467214363|FG001|Part II|Lost to Follow-up|0|||
129794382|NCT01155479|467214364|FG002|Part II|Lost to Follow-up|0|||
129794383|NCT01155479|467214365|FG003|Part II|Lost to Follow-up|0|||
129794384|NCT01155479|467214366|FG004|Part II|Lost to Follow-up|1|||
129794385|NCT01155479|467214362|FG000|Part II|Treatment Failure|0|||
129794386|NCT01155479|467214363|FG001|Part II|Treatment Failure|1|||
129794387|NCT01155479|467214364|FG002|Part II|Treatment Failure|2|||
129794388|NCT01155479|467214365|FG003|Part II|Treatment Failure|0|||
129794389|NCT01155479|467214366|FG004|Part II|Treatment Failure|1|||
129794390|NCT01155479|467214362|FG000|Part II|Non-Compliance with Protocol|0|||
129794391|NCT01155479|467214363|FG001|Part II|Non-Compliance with Protocol|1|||
129627878|NCT02714218|466591911|FG001|Treatment Period|Participant withdrew consent|2|||
129627879|NCT02714218|466591912|FG002|Treatment Period|Participant withdrew consent|0|||
129627880|NCT02714218|466591910|FG000|Treatment Period|Maximum clinical benefit|4|||
129627881|NCT02714218|466591911|FG001|Treatment Period|Maximum clinical benefit|2|||
129627882|NCT02714218|466591912|FG002|Treatment Period|Maximum clinical benefit|0|||
129627883|NCT02714218|466591910|FG000|Treatment Period|Administrative reason by sponsor|2|||
129627884|NCT02714218|466591911|FG001|Treatment Period|Administrative reason by sponsor|1|||
129627885|NCT02714218|466591912|FG002|Treatment Period|Administrative reason by sponsor|0|||
129627886|NCT02714218|466591910|FG000|Treatment Period|Other reasons|6|||
129627887|NCT02714218|466591911|FG001|Treatment Period|Other reasons|6|||
129627888|NCT02714218|466591912|FG002|Treatment Period|Other reasons|0|||
129627889|NCT02714218|466591910|FG000|Treatment Period|Completed treatment as per protocol|36|||
129627890|NCT02714218|466591911|FG001|Treatment Period|Completed treatment as per protocol|27|||
129627891|NCT02714218|466591912|FG002|Treatment Period|Completed treatment as per protocol|3|||
129627892|NCT02714218|466591910|FG000|Treatment Period|Not reported|9|||
129627893|NCT02714218|466591911|FG001|Treatment Period|Not reported|6|||
129627894|NCT02714218|466591912|FG002|Treatment Period|Not reported|0|||
129627895|NCT01199939|466591916|FG000|Overall Study|Adverse Event|4|||
129627896|NCT01199939|466591916|FG000|Overall Study|Protocol Violation|3|||
129627897|NCT01199939|466591916|FG000|Overall Study|Lost to Follow-up|2|||
129627898|NCT01199939|466591916|FG000|Overall Study|Reached a virologic endpoint|4|||
129627899|NCT03238651|466591919|FG000|Overall Study|Other|0|||
129627900|NCT03238651|466591920|FG001|Overall Study|Other|0|||
129627901|NCT03238651|466591921|FG002|Overall Study|Other|0|||
129627902|NCT03238651|466591922|FG003|Overall Study|Other|0|||
129627903|NCT03238651|466591923|FG004|Overall Study|Other|1|||
129627904|NCT03238651|466591919|FG000|Overall Study|Progressive Disease|2|||
129627905|NCT03238651|466591920|FG001|Overall Study|Progressive Disease|2|||
129627906|NCT03238651|466591921|FG002|Overall Study|Progressive Disease|2|||
129627907|NCT03238651|466591922|FG003|Overall Study|Progressive Disease|2|||
129627908|NCT03238651|466591923|FG004|Overall Study|Progressive Disease|0|||
129627909|NCT03238651|466591919|FG000|Overall Study|Withdrawal by Subject|0|||
129703460|NCT02836249|466877498|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129703461|NCT02836249|466877499|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129703462|NCT02836249|466877500|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129703463|NCT02836249|466877497|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
129703464|NCT02836249|466877498|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
129703465|NCT02836249|466877499|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
129703466|NCT02836249|466877500|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
129703467|NCT02836249|466877497|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
129703468|NCT02836249|466877498|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129703469|NCT02836249|466877499|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129703470|NCT02836249|466877500|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129703471|NCT02836249|466877497|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129703472|NCT02836249|466877498|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129703473|NCT02836249|466877499|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
129703474|NCT02836249|466877500|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
129703475|NCT02836249|466877497|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129703476|NCT02836249|466877498|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129703477|NCT02836249|466877499|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
129703478|NCT02836249|466877500|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
129703479|NCT02836249|466877497|FG000|Open-Label TAF Treatment Phase|Death|0|||
129703480|NCT02836249|466877498|FG001|Open-Label TAF Treatment Phase|Death|0|||
129703481|NCT02836249|466877499|FG002|Open-Label TAF Treatment Phase|Death|1|||
129703482|NCT02836249|466877500|FG003|Open-Label TAF Treatment Phase|Death|0|||
129703483|NCT02836249|466877497|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
129703484|NCT02836249|466877498|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
129703485|NCT02836249|466877499|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
129703486|NCT02836249|466877500|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
129703487|NCT02836249|466877497|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
129703488|NCT02836249|466877498|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
129703489|NCT02836249|466877499|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
129703490|NCT02836249|466877500|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
129703491|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129627910|NCT03238651|466591920|FG001|Overall Study|Withdrawal by Subject|1|||
129703492|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
129627911|NCT03238651|466591921|FG002|Overall Study|Withdrawal by Subject|0|||
129627912|NCT03238651|466591922|FG003|Overall Study|Withdrawal by Subject|1|||
129627913|NCT03238651|466591923|FG004|Overall Study|Withdrawal by Subject|0|||
129627914|NCT03238651|466591919|FG000|Overall Study|Adverse Event|1|||
129627915|NCT03238651|466591920|FG001|Overall Study|Adverse Event|3|||
129627916|NCT03238651|466591921|FG002|Overall Study|Adverse Event|2|||
129627917|NCT03238651|466591922|FG003|Overall Study|Adverse Event|0|||
129627918|NCT03238651|466591923|FG004|Overall Study|Adverse Event|0|||
129627919|NCT03875508|466591924|FG000|Overall Study|Adverse Event|1|||
129627920|NCT03875508|466591924|FG000|Overall Study|Lost to Follow-up|8|||
129627921|NCT03875508|466591924|FG000|Overall Study|Lack of Efficacy|1|||
129627922|NCT03875508|466591924|FG000|Overall Study|Other, not specified|2|||
129627923|NCT03652051|466591926|FG000|Stage 1|Adverse Event|0|||
129627924|NCT03652051|466591927|FG001|Stage 1|Adverse Event|5|||
129627925|NCT03652051|466591928|FG002|Stage 1|Adverse Event|7|||
129627926|NCT03652051|466591929|FG003|Stage 1|Adverse Event|1|||
129627927|NCT03652051|466591926|FG000|Stage 1|Withdrawal by Subject|0|||
129627928|NCT03652051|466591927|FG001|Stage 1|Withdrawal by Subject|0|||
129627929|NCT03652051|466591928|FG002|Stage 1|Withdrawal by Subject|1|||
129627930|NCT03652051|466591929|FG003|Stage 1|Withdrawal by Subject|0|||
129627931|NCT03652051|466591926|FG000|Stage 2|Adverse Event|0|||
129627932|NCT03652051|466591927|FG001|Stage 2|Adverse Event|2|||
129627933|NCT03652051|466591928|FG002|Stage 2|Adverse Event|1|||
129627934|NCT03652051|466591929|FG003|Stage 2|Adverse Event|0|||
129627935|NCT03652051|466591926|FG000|Stage 2|Protocol Violation|0|||
129627936|NCT03652051|466591927|FG001|Stage 2|Protocol Violation|1|||
129627937|NCT03652051|466591928|FG002|Stage 2|Protocol Violation|6|||
129627938|NCT03652051|466591929|FG003|Stage 2|Protocol Violation|0|||
129627939|NCT03652051|466591926|FG000|Stage 2|Lost to Follow-up|0|||
129627940|NCT03652051|466591927|FG001|Stage 2|Lost to Follow-up|2|||
129627941|NCT03652051|466591928|FG002|Stage 2|Lost to Follow-up|0|||
129627942|NCT03652051|466591929|FG003|Stage 2|Lost to Follow-up|3|||
129627943|NCT03652051|466591926|FG000|Stage 2|Withdrawal by Subject|0|||
129627944|NCT03652051|466591927|FG001|Stage 2|Withdrawal by Subject|11|||
129627945|NCT03652051|466591928|FG002|Stage 2|Withdrawal by Subject|9|||
129627946|NCT03652051|466591929|FG003|Stage 2|Withdrawal by Subject|3|||
129627947|NCT02550561|466591930|FG000|Overall Study|Lost to Follow-up|5|||
129627948|NCT02550561|466591930|FG000|Overall Study|Withdrawal by Subject|1|||
129627949|NCT02394600|466591931|FG000|Overall Study|Adverse Event|3|||
129627950|NCT02394600|466591932|FG001|Overall Study|Adverse Event|0|||
129627951|NCT02394600|466591931|FG000|Overall Study|Lost to Follow-up|0|||
129627952|NCT02394600|466591932|FG001|Overall Study|Lost to Follow-up|1|||
129627953|NCT02394600|466591931|FG000|Overall Study|Withdrawal by Subject|0|||
129627954|NCT02394600|466591932|FG001|Overall Study|Withdrawal by Subject|1|||
129627955|NCT02394600|466591931|FG000|Overall Study|Protocol Violation|1|||
129627956|NCT02394600|466591932|FG001|Overall Study|Protocol Violation|0|||
129627957|NCT01686373|466591933|FG000|Overall Study|Lost to Follow-up|3|||
129627958|NCT01686373|466591934|FG001|Overall Study|Lost to Follow-up|0|||
129627959|NCT01686373|466591933|FG000|Overall Study|Withdrawal by Subject|0|||
129627960|NCT01686373|466591934|FG001|Overall Study|Withdrawal by Subject|1|||
129627961|NCT01686373|466591933|FG000|Overall Study|Adverse Event|0|||
129627962|NCT01686373|466591934|FG001|Overall Study|Adverse Event|1|||
129627963|NCT04052620|466591936|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
129627964|NCT04052620|466591937|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
129627965|NCT04052620|466591936|FG000|Overall Study|Withdrawal by Subject|1|||
129627966|NCT04052620|466591937|FG001|Overall Study|Withdrawal by Subject|0|||
129627967|NCT04052620|466591936|FG000|Overall Study|Lost to Follow-up|1|||
129794392|NCT01155479|467214364|FG002|Part II|Non-Compliance with Protocol|0|||
129794393|NCT01155479|467214365|FG003|Part II|Non-Compliance with Protocol|2|||
129794394|NCT01155479|467214366|FG004|Part II|Non-Compliance with Protocol|0|||
129794395|NCT00470184|467214367|FG000|Overall Study|Not Treated(became ineligible)|4|||
129794396|NCT00470184|467214367|FG000|Overall Study|Not treated (other)|1|||
129794397|NCT00470184|467214367|FG000|Overall Study|disease Progression|4|||
129440307|NCT02578862|465911386|FG000|Overall Study|Withdrawal by Subject|0|||
129440308|NCT02578862|465911387|FG001|Overall Study|Withdrawal by Subject|1|||
129440309|NCT02578862|465911386|FG000|Overall Study|Unplanned unilateral procedure|0|||
129627968|NCT04052620|466591937|FG001|Overall Study|Lost to Follow-up|1|||
129627969|NCT04052620|466591936|FG000|Overall Study|Adverse Event|1|||
129627970|NCT04052620|466591937|FG001|Overall Study|Adverse Event|0|||
129627971|NCT04052620|466591936|FG000|Overall Study|Subject did not meet study Criteria|0|||
129627972|NCT04052620|466591937|FG001|Overall Study|Subject did not meet study Criteria|1|||
129627973|NCT04052620|466591936|FG000|Overall Study|Screened failure, randomized by mistake|0|||
129627974|NCT04052620|466591937|FG001|Overall Study|Screened failure, randomized by mistake|1|||
129627975|NCT04052620|466591936|FG000|Overall Study|Personal reasons|2|||
129627976|NCT04052620|466591937|FG001|Overall Study|Personal reasons|4|||
129627977|NCT04052620|466591936|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
129627978|NCT04052620|466591937|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
129794398|NCT00470184|467214367|FG000|Overall Study|Adverse Event|3|||
129794399|NCT00470184|467214367|FG000|Overall Study|Withdrawal by Subject|4|||
129794400|NCT00470184|467214367|FG000|Overall Study|other|5|||
129627979|NCT02201784|466591938|FG000|Overall Study|Failure to achieve adequate block|2|||
129627980|NCT02201784|466591939|FG001|Overall Study|Failure to achieve adequate block|0|||
129627981|NCT02431364|466591940|FG000|Overall Study|Adverse Event|0|||
129627982|NCT02431364|466591941|FG001|Overall Study|Adverse Event|1|||
129627983|NCT02431364|466591942|FG002|Overall Study|Adverse Event|0|||
129627984|NCT02431364|466591943|FG003|Overall Study|Adverse Event|0|||
129627985|NCT02431364|466591944|FG004|Overall Study|Adverse Event|0|||
129627986|NCT02431364|466591940|FG000|Overall Study|Randomized but never treated|0|||
129627987|NCT02431364|466591941|FG001|Overall Study|Randomized but never treated|0|||
129627988|NCT02431364|466591942|FG002|Overall Study|Randomized but never treated|0|||
129627989|NCT02431364|466591943|FG003|Overall Study|Randomized but never treated|1|||
129627990|NCT02431364|466591944|FG004|Overall Study|Randomized but never treated|0|||
129627991|NCT00916383|466591945|FG000|Overall Study|Adverse Event|1|||
129627992|NCT00916383|466591945|FG000|Overall Study|Death|1|||
129627993|NCT00916383|466591945|FG000|Overall Study|Protocol Violation|1|||
129627994|NCT00258960|466591946|FG000|Overall Study|Death|2|||
129627995|NCT00258960|466591946|FG000|Overall Study|Disease Progression|7|||
129627996|NCT00258960|466591946|FG000|Overall Study|Adverse Event|4|||
129627997|NCT00258960|466591946|FG000|Overall Study|Physician Decision|1|||
129627998|NCT00258960|466591946|FG000|Overall Study|Withdrawal by Subject|1|||
129627999|NCT00258960|466591946|FG000|Overall Study|Mistake|2|||
129628000|NCT01112059|466591947|FG000|Overall Study|Withdrawal by Subject|1|||
129628001|NCT01112059|466591948|FG001|Overall Study|Withdrawal by Subject|0|||
129628002|NCT03323398|466591951|FG000|Overall Study|Other than Specified|0|||
129628003|NCT03323398|466591952|FG001|Overall Study|Other than Specified|1|||
129628004|NCT03323398|466591953|FG002|Overall Study|Other than Specified|2|||
129628005|NCT03323398|466591954|FG003|Overall Study|Other than Specified|0|||
129628006|NCT03323398|466591955|FG004|Overall Study|Other than Specified|0|||
129628007|NCT03323398|466591956|FG005|Overall Study|Other than Specified|0|||
129628008|NCT03323398|466591957|FG006|Overall Study|Other than Specified|1|||
129628009|NCT03323398|466591958|FG007|Overall Study|Other than Specified|0|||
129628010|NCT03323398|466591959|FG008|Overall Study|Other than Specified|2|||
129628011|NCT03323398|466591951|FG000|Overall Study|Lost to Follow-up|1|||
129628012|NCT03323398|466591952|FG001|Overall Study|Lost to Follow-up|2|||
129628013|NCT03323398|466591953|FG002|Overall Study|Lost to Follow-up|1|||
129628014|NCT03323398|466591954|FG003|Overall Study|Lost to Follow-up|0|||
129628015|NCT03323398|466591955|FG004|Overall Study|Lost to Follow-up|0|||
129628016|NCT03323398|466591956|FG005|Overall Study|Lost to Follow-up|0|||
129628017|NCT03323398|466591957|FG006|Overall Study|Lost to Follow-up|0|||
129628018|NCT03323398|466591958|FG007|Overall Study|Lost to Follow-up|0|||
129628019|NCT03323398|466591959|FG008|Overall Study|Lost to Follow-up|0|||
129628020|NCT03323398|466591951|FG000|Overall Study|Death|4|||
129628021|NCT03323398|466591952|FG001|Overall Study|Death|6|||
129628022|NCT03323398|466591953|FG002|Overall Study|Death|2|||
129628023|NCT03323398|466591954|FG003|Overall Study|Death|2|||
129628024|NCT03323398|466591955|FG004|Overall Study|Death|1|||
129628025|NCT03323398|466591956|FG005|Overall Study|Death|2|||
129628026|NCT03323398|466591957|FG006|Overall Study|Death|0|||
129628027|NCT03323398|466591958|FG007|Overall Study|Death|0|||
129628028|NCT03323398|466591959|FG008|Overall Study|Death|6|||
129628029|NCT03323398|466591951|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
129628030|NCT03323398|466591952|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
129794401|NCT00470184|467214367|FG000|Overall Study|recurrence|1|||
129794402|NCT02483533|467214369|FG000|Overall Study|Lack of Efficacy|50|||
129794403|NCT02483533|467214370|FG001|Overall Study|Lack of Efficacy|50|||
129794404|NCT00768469|467214372|FG000|Overall Study|Adverse Event|0|||
129794405|NCT00768469|467214373|FG001|Overall Study|Adverse Event|2|||
129794406|NCT00768469|467214372|FG000|Overall Study|Disease Progression|3|||
129794407|NCT00768469|467214373|FG001|Overall Study|Disease Progression|4|||
129794408|NCT00768469|467214372|FG000|Overall Study|Withdrawal by Subject|0|||
129794409|NCT00768469|467214373|FG001|Overall Study|Withdrawal by Subject|1|||
129794410|NCT02953509|467214376|FG000|Overall Study|Death|1|||
129794411|NCT02953509|467214377|FG001|Overall Study|Death|3|||
129794412|NCT02953509|467214378|FG002|Overall Study|Death|3|||
129888916|NCT01782326|467550937|FG000|Double-blind Treatment|Protocol deviation|8|||
129888917|NCT01782326|467550938|FG001|Double-blind Treatment|Protocol deviation|7|||
129628031|NCT03323398|466591953|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
129628032|NCT03323398|466591954|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
129628033|NCT03323398|466591955|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
129628034|NCT03323398|466591956|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
129628035|NCT03323398|466591957|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
129628036|NCT03323398|466591958|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
129888918|NCT01782326|467550937|FG000|Double-blind Treatment|Technical problems|0|||
129794413|NCT02953509|467214379|FG003|Overall Study|Death|4|||
129794414|NCT02953509|467214380|FG004|Overall Study|Death|12|||
129888919|NCT01782326|467550938|FG001|Double-blind Treatment|Technical problems|5|||
129628037|NCT03323398|466591959|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
129628038|NCT03323398|466591951|FG000|Overall Study|Withdrawal by Subject|2|||
129628039|NCT03323398|466591952|FG001|Overall Study|Withdrawal by Subject|1|||
129628040|NCT03323398|466591953|FG002|Overall Study|Withdrawal by Subject|3|||
129888920|NCT01767129|467550939|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
129888921|NCT01767129|467550940|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129888922|NCT03389893|467550941|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
129888923|NCT03389893|467550942|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
129888924|NCT03389893|467550943|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
129888925|NCT03389893|467550944|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
129888926|NCT03389893|467550941|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
129888927|NCT03389893|467550942|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
129888928|NCT03389893|467550943|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
129628041|NCT03323398|466591954|FG003|Overall Study|Withdrawal by Subject|0|||
129628042|NCT03323398|466591955|FG004|Overall Study|Withdrawal by Subject|0|||
129628043|NCT03323398|466591956|FG005|Overall Study|Withdrawal by Subject|1|||
129628044|NCT03323398|466591957|FG006|Overall Study|Withdrawal by Subject|0|||
129628045|NCT03323398|466591958|FG007|Overall Study|Withdrawal by Subject|0|||
129628046|NCT03323398|466591959|FG008|Overall Study|Withdrawal by Subject|0|||
129628047|NCT03323398|466591951|FG000|Overall Study|Participant was Put on Hospice|0|||
129628048|NCT03323398|466591952|FG001|Overall Study|Participant was Put on Hospice|0|||
129628049|NCT03323398|466591953|FG002|Overall Study|Participant was Put on Hospice|0|||
129628050|NCT03323398|466591954|FG003|Overall Study|Participant was Put on Hospice|0|||
129628051|NCT03323398|466591955|FG004|Overall Study|Participant was Put on Hospice|0|||
129628052|NCT03323398|466591956|FG005|Overall Study|Participant was Put on Hospice|0|||
129628053|NCT03323398|466591957|FG006|Overall Study|Participant was Put on Hospice|1|||
129628054|NCT03323398|466591958|FG007|Overall Study|Participant was Put on Hospice|0|||
129628055|NCT03323398|466591959|FG008|Overall Study|Participant was Put on Hospice|0|||
129628056|NCT03323398|466591951|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
129628057|NCT03323398|466591952|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
129628058|NCT03323398|466591953|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
129628059|NCT03323398|466591954|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
129628060|NCT03323398|466591955|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
129628061|NCT03323398|466591956|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
129628062|NCT03323398|466591957|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
129628063|NCT03323398|466591958|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
129628064|NCT03323398|466591959|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
129628065|NCT02235454|466591960|FG000|Overall Study|Withdrawal by Subject|2|||
129628066|NCT04199104|466593270|FG000|Overall Study|Death|148|||
129628067|NCT04199104|466593271|FG001|Overall Study|Death|134|||
129628068|NCT04199104|466593270|FG000|Overall Study|Lost to Follow-up|1|||
129628069|NCT04199104|466593271|FG001|Overall Study|Lost to Follow-up|1|||
129628070|NCT04199104|466593270|FG000|Overall Study|Withdrawal by Subject|4|||
129628071|NCT04199104|466593271|FG001|Overall Study|Withdrawal by Subject|4|||
129628072|NCT04199104|466593270|FG000|Overall Study|Participants Ongoing|103|||
129628073|NCT04199104|466593271|FG001|Overall Study|Participants Ongoing|116|||
129628074|NCT06025721|466593279|FG000|Overall Study|Physician Decision|1|||
129628075|NCT06025721|466593279|FG000|Overall Study|Protocol Violation|1|||
129628076|NCT06025721|466593279|FG000|Overall Study|Incarceration|1|||
129628077|NCT04510090|466593280|FG000|FE-HS|Withdrawal by Subject|0|||
129628078|NCT04510090|466593281|FG001|FE-HS|Withdrawal by Subject|0|||
129628079|NCT04510090|466593282|FG002|FE-HS|Withdrawal by Subject|0|||
129628080|NCT04510090|466593283|FG003|FE-HS|Withdrawal by Subject|0|||
129628081|NCT04510090|466593284|FG004|FE-HS|Withdrawal by Subject|1|||
129628082|NCT04510090|466593285|FG005|FE-HS|Withdrawal by Subject|0|||
129628083|NCT04510090|466593286|FG006|FE-HS|Withdrawal by Subject|0|||
129888929|NCT03389893|467550944|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
129628084|NCT04510090|466593287|FG007|FE-HS|Withdrawal by Subject|0|||
129628085|NCT01749826|466593288|FG000|Overall Study|Study Terminated|20|||
129628086|NCT01749826|466593289|FG001|Overall Study|Study Terminated|0|||
129628087|NCT05085834|466593290|FG000|Overall Study|Lost to Follow-up|9|||
129628088|NCT05085834|466593291|FG001|Overall Study|Lost to Follow-up|2|||
129628089|NCT05085834|466593290|FG000|Overall Study|Adverse Event|6|||
129628090|NCT05085834|466593291|FG001|Overall Study|Adverse Event|0|||
129628091|NCT05085834|466593290|FG000|Overall Study|Death|1|||
129628092|NCT05085834|466593291|FG001|Overall Study|Death|0|||
129628093|NCT05085834|466593290|FG000|Overall Study|Inability to swallow the pill|0|||
129628094|NCT05085834|466593291|FG001|Overall Study|Inability to swallow the pill|1|||
129628095|NCT05842967|466593292|FG000|Period 1: SSA|Adverse Event|1|||
129628096|NCT05842967|466593293|FG001|Period 1: SSA|Adverse Event|1|||
129628097|NCT05842967|466593294|FG002|Period 1: SSA|Adverse Event|0|||
129628098|NCT05842967|466593295|FG003|Period 1: SSA|Adverse Event|0|||
129628099|NCT05842967|466593292|FG000|Period 1: SSA|Death|1|||
129703493|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129628100|NCT05842967|466593293|FG001|Period 1: SSA|Death|0|||
129628101|NCT05842967|466593294|FG002|Period 1: SSA|Death|0|||
129628102|NCT05842967|466593295|FG003|Period 1: SSA|Death|0|||
129628103|NCT05842967|466593292|FG000|Period 1: SSA|Lost to Follow-up|16|||
129628104|NCT05842967|466593293|FG001|Period 1: SSA|Lost to Follow-up|4|||
129628105|NCT05842967|466593294|FG002|Period 1: SSA|Lost to Follow-up|0|||
129628106|NCT05842967|466593295|FG003|Period 1: SSA|Lost to Follow-up|0|||
129628107|NCT05842967|466593292|FG000|Period 1: SSA|Physician Decision|1|||
129628108|NCT05842967|466593293|FG001|Period 1: SSA|Physician Decision|0|||
129628109|NCT05842967|466593294|FG002|Period 1: SSA|Physician Decision|0|||
129628110|NCT05842967|466593295|FG003|Period 1: SSA|Physician Decision|0|||
129628111|NCT05842967|466593292|FG000|Period 1: SSA|Withdrawal by Subject|2|||
129628112|NCT05842967|466593293|FG001|Period 1: SSA|Withdrawal by Subject|2|||
129628113|NCT05842967|466593294|FG002|Period 1: SSA|Withdrawal by Subject|0|||
129794415|NCT02953509|467214381|FG005|Overall Study|Death|3|||
129794416|NCT02953509|467214382|FG006|Overall Study|Death|25|||
129794417|NCT02953509|467214383|FG007|Overall Study|Death|10|||
129794418|NCT02953509|467214384|FG008|Overall Study|Death|21|||
129794419|NCT02953509|467214385|FG009|Overall Study|Death|20|||
129794420|NCT02953509|467214376|FG000|Overall Study|Reason Not Specified|0|||
129794421|NCT02953509|467214377|FG001|Overall Study|Reason Not Specified|2|||
129794422|NCT02953509|467214378|FG002|Overall Study|Reason Not Specified|8|||
129794423|NCT02953509|467214379|FG003|Overall Study|Reason Not Specified|2|||
129794424|NCT02953509|467214380|FG004|Overall Study|Reason Not Specified|11|||
129794425|NCT02953509|467214381|FG005|Overall Study|Reason Not Specified|4|||
129794426|NCT02953509|467214382|FG006|Overall Study|Reason Not Specified|12|||
129794427|NCT02953509|467214383|FG007|Overall Study|Reason Not Specified|2|||
129794428|NCT02953509|467214384|FG008|Overall Study|Reason Not Specified|7|||
129794429|NCT02953509|467214385|FG009|Overall Study|Reason Not Specified|2|||
129794430|NCT02953509|467214376|FG000|Overall Study|Consent Withdrawn|1|||
129794431|NCT02953509|467214377|FG001|Overall Study|Consent Withdrawn|1|||
129794432|NCT02953509|467214378|FG002|Overall Study|Consent Withdrawn|2|||
129794433|NCT02953509|467214379|FG003|Overall Study|Consent Withdrawn|1|||
129794434|NCT02953509|467214380|FG004|Overall Study|Consent Withdrawn|3|||
129794435|NCT02953509|467214381|FG005|Overall Study|Consent Withdrawn|0|||
129794436|NCT02953509|467214382|FG006|Overall Study|Consent Withdrawn|4|||
129794437|NCT02953509|467214383|FG007|Overall Study|Consent Withdrawn|1|||
129794438|NCT02953509|467214384|FG008|Overall Study|Consent Withdrawn|1|||
129794439|NCT02953509|467214385|FG009|Overall Study|Consent Withdrawn|4|||
129794440|NCT02953509|467214376|FG000|Overall Study|Lost to Follow-up|0|||
129794441|NCT02953509|467214377|FG001|Overall Study|Lost to Follow-up|0|||
129794442|NCT02953509|467214378|FG002|Overall Study|Lost to Follow-up|0|||
129794443|NCT02953509|467214379|FG003|Overall Study|Lost to Follow-up|0|||
129794444|NCT02953509|467214380|FG004|Overall Study|Lost to Follow-up|0|||
129794445|NCT02953509|467214381|FG005|Overall Study|Lost to Follow-up|0|||
129794446|NCT02953509|467214382|FG006|Overall Study|Lost to Follow-up|1|||
129794447|NCT02953509|467214383|FG007|Overall Study|Lost to Follow-up|1|||
129794448|NCT02953509|467214384|FG008|Overall Study|Lost to Follow-up|1|||
129794449|NCT02953509|467214385|FG009|Overall Study|Lost to Follow-up|1|||
129794450|NCT02953509|467214376|FG000|Overall Study|Study terminated by sponsor|1|||
129794451|NCT02953509|467214377|FG001|Overall Study|Study terminated by sponsor|0|||
129794452|NCT02953509|467214378|FG002|Overall Study|Study terminated by sponsor|0|||
129794453|NCT02953509|467214379|FG003|Overall Study|Study terminated by sponsor|0|||
129794454|NCT02953509|467214380|FG004|Overall Study|Study terminated by sponsor|0|||
129794455|NCT02953509|467214381|FG005|Overall Study|Study terminated by sponsor|0|||
129794456|NCT02953509|467214382|FG006|Overall Study|Study terminated by sponsor|1|||
129794457|NCT02953509|467214383|FG007|Overall Study|Study terminated by sponsor|0|||
129794458|NCT02953509|467214384|FG008|Overall Study|Study terminated by sponsor|1|||
129628114|NCT05842967|466593295|FG003|Period 1: SSA|Withdrawal by Subject|0|||
129794459|NCT02953509|467214385|FG009|Overall Study|Study terminated by sponsor|1|||
129794460|NCT00484185|467214386|FG000|Overall Study|Lost to Follow-up|44|||
129794461|NCT00484185|467214386|FG000|Overall Study|Other|20|||
129794462|NCT00484185|467214386|FG000|Overall Study|Randomized but not treated|5|||
129794463|NCT00484185|467214386|FG000|Overall Study|Death|2|||
129794464|NCT00459056|467214387|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
129794465|NCT00459056|467214388|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
129628115|NCT05842967|466593292|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
129794466|NCT02283177|467214389|FG000|Overall Study|Withdrawal by Subject|1|||
129794467|NCT02283177|467214390|FG001|Overall Study|Withdrawal by Subject|1|||
129794468|NCT01101191|467214391|FG000|Period 1|Withdrawal by Subject|1|||
129628116|NCT05842967|466593293|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
129628117|NCT05842967|466593294|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
129628118|NCT05842967|466593295|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
129628119|NCT05842967|466593292|FG000|Period 2: SSB|Adverse Event|0|||
129628120|NCT05842967|466593293|FG001|Period 2: SSB|Adverse Event|0|||
129628121|NCT05842967|466593294|FG002|Period 2: SSB|Adverse Event|2|||
129628122|NCT05842967|466593295|FG003|Period 2: SSB|Adverse Event|0|||
129628123|NCT05842967|466593292|FG000|Period 2: SSB|Lost to Follow-up|0|||
129628124|NCT05842967|466593293|FG001|Period 2: SSB|Lost to Follow-up|0|||
129628125|NCT05842967|466593294|FG002|Period 2: SSB|Lost to Follow-up|4|||
129628126|NCT05842967|466593295|FG003|Period 2: SSB|Lost to Follow-up|3|||
129628127|NCT05842967|466593292|FG000|Period 2: SSB|Withdrawal by Subject|0|||
129628128|NCT05842967|466593293|FG001|Period 2: SSB|Withdrawal by Subject|0|||
129628129|NCT05842967|466593294|FG002|Period 2: SSB|Withdrawal by Subject|1|||
129628130|NCT05842967|466593295|FG003|Period 2: SSB|Withdrawal by Subject|0|||
129628131|NCT05842967|466593292|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
129628132|NCT05842967|466593293|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
129628133|NCT05842967|466593294|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
129628134|NCT05842967|466593295|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
129628135|NCT05842967|466593292|FG000|Period 2: SSB|Protocol Violation|0|||
129628136|NCT05842967|466593293|FG001|Period 2: SSB|Protocol Violation|0|||
129628137|NCT05842967|466593294|FG002|Period 2: SSB|Protocol Violation|0|||
129628138|NCT05842967|466593295|FG003|Period 2: SSB|Protocol Violation|1|||
129628139|NCT01823328|466593297|FG000|Overall Study|Withdrawal by Subject|8|||
129628140|NCT01823328|466593298|FG001|Overall Study|Withdrawal by Subject|6|||
129628141|NCT02547428|466593299|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
129794469|NCT01101191|467214392|FG001|Period 1|Withdrawal by Subject|0|||
129794470|NCT01101191|467214391|FG000|Period 1|Adverse Event|1|||
129794471|NCT01101191|467214392|FG001|Period 1|Adverse Event|2|||
129794472|NCT03761797|467214393|FG000|Overall Study|Changing hospital|11|||
129794473|NCT03761797|467214393|FG000|Overall Study|Improvement/remission|6|||
129794474|NCT03761797|467214393|FG000|Overall Study|Withdrawal by Subject|19|||
129794475|NCT03761797|467214393|FG000|Overall Study|Lost to Follow-up|33|||
129794476|NCT03761797|467214393|FG000|Overall Study|Adverse Event|37|||
129794477|NCT03761797|467214393|FG000|Overall Study|Case report form (CRF) not collected|5|||
129794478|NCT03761797|467214393|FG000|Overall Study|No patient visit after entry|13|||
129794479|NCT03761797|467214393|FG000|Overall Study|Switch to other diabetes medication|10|||
129794480|NCT03761797|467214393|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
129794481|NCT03761797|467214393|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
129794482|NCT03761797|467214393|FG000|Overall Study|Insufficient effectives|2|||
129794483|NCT03761797|467214393|FG000|Overall Study|Excessive alcohol intake|1|||
129794484|NCT00879879|467214394|FG000|Overall Study|Death|1|||
129794485|NCT00879879|467214394|FG000|Overall Study|Withdrawal by Subject|1|||
129794486|NCT00879879|467214394|FG000|Overall Study|Physician Decision|1|||
129888930|NCT03389893|467550941|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
129888931|NCT03389893|467550942|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
129628142|NCT02547428|466593300|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
129628143|NCT02547428|466593299|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
129628144|NCT02547428|466593300|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
129628145|NCT02547428|466593299|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
129628146|NCT02547428|466593300|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
129628147|NCT02547428|466593299|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
129628148|NCT02547428|466593300|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
129703494|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
129703495|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
129703496|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
129703497|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
129703498|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703499|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703500|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703501|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703502|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703503|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703504|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703505|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703506|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
129703507|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
129703508|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
129703509|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
129794487|NCT00989573|467214398|FG000|Overall Study|Adverse Event|8|||
129794488|NCT00989573|467214399|FG001|Overall Study|Adverse Event|12|||
129794489|NCT00989573|467214400|FG002|Overall Study|Adverse Event|4|||
129794490|NCT00989573|467214398|FG000|Overall Study|Physician Decision|0|||
129628149|NCT02547428|466593299|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
129628150|NCT02547428|466593300|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
129628151|NCT02547428|466593299|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
129628152|NCT02547428|466593300|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
129628153|NCT02547428|466593299|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
129628154|NCT02547428|466593300|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
129628155|NCT02547428|466593299|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
129628156|NCT02547428|466593300|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
129628157|NCT01479465|466593301|FG000|Overall Study|Disease Progression|9|||
129628158|NCT01479465|466593302|FG001|Overall Study|Disease Progression|61|||
129628159|NCT01479465|466593303|FG002|Overall Study|Disease Progression|65|||
129628160|NCT01479465|466593304|FG003|Overall Study|Disease Progression|70|||
129628161|NCT01479465|466593301|FG000|Overall Study|Study Discontinued by Sponsor|0|||
129628162|NCT01479465|466593302|FG001|Overall Study|Study Discontinued by Sponsor|7|||
129628163|NCT01479465|466593303|FG002|Overall Study|Study Discontinued by Sponsor|5|||
129628164|NCT01479465|466593304|FG003|Overall Study|Study Discontinued by Sponsor|3|||
129628165|NCT01479465|466593301|FG000|Overall Study|Adverse Event|0|||
129628166|NCT01479465|466593302|FG001|Overall Study|Adverse Event|3|||
129628167|NCT01479465|466593303|FG002|Overall Study|Adverse Event|6|||
129628168|NCT01479465|466593304|FG003|Overall Study|Adverse Event|4|||
129628169|NCT01479465|466593301|FG000|Overall Study|Investigator Discretion|1|||
129628170|NCT01479465|466593302|FG001|Overall Study|Investigator Discretion|4|||
129628171|NCT01479465|466593303|FG002|Overall Study|Investigator Discretion|2|||
129628172|NCT01479465|466593304|FG003|Overall Study|Investigator Discretion|4|||
129628173|NCT01479465|466593301|FG000|Overall Study|Subject Request|1|||
129628174|NCT01479465|466593302|FG001|Overall Study|Subject Request|3|||
129628175|NCT01479465|466593303|FG002|Overall Study|Subject Request|4|||
129628176|NCT01479465|466593304|FG003|Overall Study|Subject Request|2|||
129628177|NCT01479465|466593301|FG000|Overall Study|Subject Withdrew Consent|0|||
129628178|NCT01479465|466593302|FG001|Overall Study|Subject Withdrew Consent|5|||
129628179|NCT01479465|466593303|FG002|Overall Study|Subject Withdrew Consent|2|||
129628180|NCT01479465|466593304|FG003|Overall Study|Subject Withdrew Consent|1|||
129628181|NCT01479465|466593301|FG000|Overall Study|Protocol Violation|0|||
129628182|NCT01479465|466593302|FG001|Overall Study|Protocol Violation|1|||
129628183|NCT01479465|466593303|FG002|Overall Study|Protocol Violation|1|||
129628184|NCT01479465|466593304|FG003|Overall Study|Protocol Violation|0|||
129628185|NCT01479465|466593301|FG000|Overall Study|Death|0|||
129628186|NCT01479465|466593302|FG001|Overall Study|Death|0|||
129628187|NCT01479465|466593303|FG002|Overall Study|Death|0|||
129628188|NCT01479465|466593304|FG003|Overall Study|Death|1|||
129628189|NCT01479465|466593301|FG000|Overall Study|Lost to Follow-up|0|||
129628190|NCT01479465|466593302|FG001|Overall Study|Lost to Follow-up|0|||
129628191|NCT01479465|466593303|FG002|Overall Study|Lost to Follow-up|1|||
129628192|NCT01479465|466593304|FG003|Overall Study|Lost to Follow-up|0|||
129628193|NCT01173523|466593305|FG000|Overall Study|Clinical Progression|1|||
129628194|NCT01173523|466593306|FG001|Overall Study|Clinical Progression|1|||
129628195|NCT01173523|466593305|FG000|Overall Study|Progressive Disease|10|||
129628196|NCT01173523|466593306|FG001|Overall Study|Progressive Disease|8|||
129628197|NCT01173523|466593305|FG000|Overall Study|Other|2|||
129628198|NCT01173523|466593306|FG001|Overall Study|Other|3|||
129628199|NCT02717507|466593311|FG000|Overall Study|Lost to Follow-up|5|||
129628200|NCT02717507|466593312|FG001|Overall Study|Lost to Follow-up|8|||
129628201|NCT02717507|466593311|FG000|Overall Study|Pregnancy|1|||
129628202|NCT02717507|466593312|FG001|Overall Study|Pregnancy|1|||
129628203|NCT02717507|466593311|FG000|Overall Study|Protocol Violation|2|||
129628204|NCT02717507|466593312|FG001|Overall Study|Protocol Violation|2|||
129628205|NCT02717507|466593311|FG000|Overall Study|Withdrawal by Subject|20|||
129628206|NCT02717507|466593312|FG001|Overall Study|Withdrawal by Subject|20|||
129628207|NCT02717507|466593311|FG000|Overall Study|Relapse|1|||
129628208|NCT02717507|466593312|FG001|Overall Study|Relapse|1|||
129628209|NCT02717507|466593311|FG000|Overall Study|Cardiac Event|2|||
129440310|NCT02578862|465911387|FG001|Overall Study|Unplanned unilateral procedure|1|||
129628210|NCT02717507|466593312|FG001|Overall Study|Cardiac Event|6|||
129628211|NCT01439802|466593313|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
129628212|NCT01439802|466593313|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
129628213|NCT01866826|466593314|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
129628214|NCT01866826|466593315|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
129628215|NCT01866826|466593314|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
129628216|NCT01866826|466593315|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
129628217|NCT01866826|466593314|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
129628218|NCT01866826|466593315|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
129628219|NCT00709995|466593316|FG000|Overall Study|Adverse Event|4|||
129628220|NCT00709995|466593317|FG001|Overall Study|Adverse Event|2|||
129628221|NCT00709995|466593316|FG000|Overall Study|Withdrawal by Subject|1|||
129628222|NCT00709995|466593317|FG001|Overall Study|Withdrawal by Subject|3|||
129628223|NCT00742209|466593322|FG000|Overall Study|Adverse Event|11|||
129628224|NCT00742209|466593323|FG001|Overall Study|Adverse Event|4|||
129628225|NCT00742209|466593324|FG002|Overall Study|Adverse Event|17|||
129628226|NCT00742209|466593325|FG003|Overall Study|Adverse Event|16|||
129628227|NCT00742209|466593326|FG004|Overall Study|Adverse Event|13|||
129628228|NCT00742209|466593322|FG000|Overall Study|Participant Withdrew Consent|8|||
129628229|NCT00742209|466593323|FG001|Overall Study|Participant Withdrew Consent|4|||
129628230|NCT00742209|466593324|FG002|Overall Study|Participant Withdrew Consent|14|||
129628231|NCT00742209|466593325|FG003|Overall Study|Participant Withdrew Consent|7|||
129628232|NCT00742209|466593326|FG004|Overall Study|Participant Withdrew Consent|4|||
129628233|NCT00742209|466593322|FG000|Overall Study|Protocol Violation|6|||
129628234|NCT00742209|466593323|FG001|Overall Study|Protocol Violation|5|||
129628235|NCT00742209|466593324|FG002|Overall Study|Protocol Violation|4|||
129628236|NCT00742209|466593325|FG003|Overall Study|Protocol Violation|5|||
129628237|NCT00742209|466593326|FG004|Overall Study|Protocol Violation|3|||
129628238|NCT00742209|466593322|FG000|Overall Study|Lost to Follow-up|3|||
129628239|NCT00742209|466593323|FG001|Overall Study|Lost to Follow-up|4|||
129628240|NCT00742209|466593324|FG002|Overall Study|Lost to Follow-up|5|||
129628241|NCT00742209|466593325|FG003|Overall Study|Lost to Follow-up|5|||
129628242|NCT00742209|466593326|FG004|Overall Study|Lost to Follow-up|3|||
129628243|NCT00742209|466593322|FG000|Overall Study|Lack of Efficacy|6|||
129628244|NCT00742209|466593323|FG001|Overall Study|Lack of Efficacy|1|||
129628245|NCT00742209|466593324|FG002|Overall Study|Lack of Efficacy|1|||
129628246|NCT00742209|466593325|FG003|Overall Study|Lack of Efficacy|3|||
129628247|NCT00742209|466593326|FG004|Overall Study|Lack of Efficacy|1|||
129628248|NCT00742209|466593322|FG000|Overall Study|Investigator Discretion|0|||
129628249|NCT00742209|466593323|FG001|Overall Study|Investigator Discretion|0|||
129628250|NCT00742209|466593324|FG002|Overall Study|Investigator Discretion|5|||
129628251|NCT00742209|466593325|FG003|Overall Study|Investigator Discretion|1|||
129628252|NCT00742209|466593326|FG004|Overall Study|Investigator Discretion|1|||
129628253|NCT00595621|466593330|FG000|Open Label Run in|Adverse Event|1|||
129628254|NCT00595621|466593331|FG001|Open Label Run in|Adverse Event|0|||
129628255|NCT00595621|466593330|FG000|Open Label Run in|Physician Decision|1|||
129628256|NCT00595621|466593331|FG001|Open Label Run in|Physician Decision|0|||
129628257|NCT00595621|466593330|FG000|Open Label Run in|Withdrawal by Subject|1|||
129628258|NCT00595621|466593331|FG001|Open Label Run in|Withdrawal by Subject|0|||
129794491|NCT00989573|467214399|FG001|Overall Study|Physician Decision|2|||
129794492|NCT00989573|467214400|FG002|Overall Study|Physician Decision|0|||
129794493|NCT00989573|467214398|FG000|Overall Study|Protocol Violation|1|||
129794494|NCT00989573|467214399|FG001|Overall Study|Protocol Violation|1|||
129794495|NCT00989573|467214400|FG002|Overall Study|Protocol Violation|1|||
129794496|NCT00989573|467214398|FG000|Overall Study|Withdrawal by Subject|4|||
129794497|NCT00989573|467214399|FG001|Overall Study|Withdrawal by Subject|7|||
129628259|NCT00595621|466593330|FG000|Randomization and Study|Adverse Event|2|||
129628260|NCT00595621|466593331|FG001|Randomization and Study|Adverse Event|0|||
129794498|NCT00989573|467214400|FG002|Overall Study|Withdrawal by Subject|3|||
129794499|NCT03687970|467214401|FG000|Overall Study|visit scheduling conflicts|2|||
129794500|NCT03687970|467214402|FG001|Overall Study|visit scheduling conflicts|0|||
129628261|NCT00595621|466593330|FG000|Randomization and Study|Withdrawal by Subject|0|||
129628262|NCT00595621|466593331|FG001|Randomization and Study|Withdrawal by Subject|1|||
129628263|NCT00324987|466593332|FG000|Overall Study|Adverse Event|2|||
129628264|NCT00324987|466593333|FG001|Overall Study|Adverse Event|1|||
129628265|NCT00324987|466593332|FG000|Overall Study|Withdrawal by Subject|1|||
129628266|NCT00324987|466593333|FG001|Overall Study|Withdrawal by Subject|1|||
129628267|NCT00324987|466593332|FG000|Overall Study|Progression|1|||
129628268|NCT00324987|466593333|FG001|Overall Study|Progression|1|||
129628269|NCT00324987|466593332|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
129628270|NCT00324987|466593333|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
129628271|NCT03817125|466593334|FG000|Overall Study|Adverse Event|1|||
129628272|NCT03817125|466593335|FG001|Overall Study|Adverse Event|0|||
129628273|NCT03817125|466593334|FG000|Overall Study|Physician Decision|0|||
129628274|NCT03817125|466593335|FG001|Overall Study|Physician Decision|1|||
129628275|NCT03817125|466593334|FG000|Overall Study|Lack of Efficacy|1|||
129628276|NCT03817125|466593335|FG001|Overall Study|Lack of Efficacy|5|||
129628277|NCT01998919|466593336|FG000|Overall Study|Death|2|||
129628278|NCT01998919|466593337|FG001|Overall Study|Death|2|||
129628279|NCT01998919|466593336|FG000|Overall Study|Adverse Event|0|||
129628280|NCT01998919|466593337|FG001|Overall Study|Adverse Event|5|||
129628281|NCT01998919|466593336|FG000|Overall Study|Disease progression|31|||
129628282|NCT01998919|466593337|FG001|Overall Study|Disease progression|22|||
129628283|NCT01998919|466593336|FG000|Overall Study|Withdrawal by Subject|2|||
129628284|NCT01998919|466593337|FG001|Overall Study|Withdrawal by Subject|4|||
129628285|NCT01998919|466593336|FG000|Overall Study|Lost to Follow-up|2|||
129628286|NCT01998919|466593337|FG001|Overall Study|Lost to Follow-up|0|||
129628287|NCT01998919|466593336|FG000|Overall Study|Other|5|||
129628288|NCT01998919|466593337|FG001|Overall Study|Other|2|||
129628289|NCT00897715|466593341|FG000|Overall Study|Lost to Follow-up|0|||
129628290|NCT00897715|466593342|FG001|Overall Study|Lost to Follow-up|1|||
129628291|NCT00897715|466593341|FG000|Overall Study|Physician Decision|1|||
129628292|NCT00897715|466593342|FG001|Overall Study|Physician Decision|0|||
129628293|NCT00897715|466593341|FG000|Overall Study|increased risk of infection|1|||
129628294|NCT00897715|466593342|FG001|Overall Study|increased risk of infection|0|||
129628295|NCT00063934|466593343|FG000|Overall Study|Ineligible|1|||
129628296|NCT00840749|466593344|FG000|Overall Study|Death|1|||
129628297|NCT00840749|466593345|FG001|Overall Study|Death|2|||
129628298|NCT00840749|466593344|FG000|Overall Study|not treated on study arm|11|||
129628299|NCT00840749|466593345|FG001|Overall Study|not treated on study arm|11|||
129628300|NCT00840749|466593344|FG000|Overall Study|study closed|19|||
129628301|NCT00840749|466593345|FG001|Overall Study|study closed|14|||
129628302|NCT01960413|466593346|FG000|Overall Study|Withdrawal by Subject|1|||
129628303|NCT01960413|466593347|FG001|Overall Study|Withdrawal by Subject|1|||
129628304|NCT01960413|466593346|FG000|Overall Study|Physician Decision|1|||
129628305|NCT01960413|466593347|FG001|Overall Study|Physician Decision|0|||
129628306|NCT01960413|466593346|FG000|Overall Study|Lost to Follow-up|2|||
129628307|NCT01960413|466593347|FG001|Overall Study|Lost to Follow-up|0|||
129628308|NCT00791778|466593351|FG000|Double-blind Treatment|Adverse Event|49|||
129628309|NCT00791778|466593352|FG001|Double-blind Treatment|Adverse Event|9|||
129628310|NCT00791778|466593351|FG000|Double-blind Treatment|Physician Decision|6|||
129628311|NCT00791778|466593352|FG001|Double-blind Treatment|Physician Decision|26|||
129628312|NCT00791778|466593351|FG000|Double-blind Treatment|Protocol Violation|0|||
129628313|NCT00791778|466593352|FG001|Double-blind Treatment|Protocol Violation|4|||
129628314|NCT00791778|466593351|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
129628315|NCT00791778|466593352|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
129628316|NCT00791778|466593351|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
129628317|NCT00791778|466593352|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
129628318|NCT00791778|466593351|FG000|Follow-up|Withdrawal by Subject|3|||
129628319|NCT00791778|466593352|FG001|Follow-up|Withdrawal by Subject|0|||
129628320|NCT00791778|466593351|FG000|Follow-up|Lost to Follow-up|2|||
129628321|NCT00791778|466593352|FG001|Follow-up|Lost to Follow-up|1|||
129628322|NCT03335475|466593353|FG000|Overall Study|Did not wear accelerometer|4|||
129628323|NCT03335475|466593354|FG001|Overall Study|Did not wear accelerometer|0|||
129628324|NCT03335475|466593353|FG000|Overall Study|Withdrawal by Subject|0|||
129628325|NCT03335475|466593354|FG001|Overall Study|Withdrawal by Subject|1|||
129628326|NCT05921903|466593357|FG000|Overall Study|Unsolicited non-SAE|0|||
129628327|NCT05921903|466593358|FG001|Overall Study|Unsolicited non-SAE|1|||
129440311|NCT02893930|465911388|FG000|Overall Study|Adverse Event|3|||
129440312|NCT02893930|465911388|FG000|Overall Study|Death|1|||
129440313|NCT02893930|465911388|FG000|Overall Study|Disease progression|5|||
129628328|NCT05921903|466593359|FG002|Overall Study|Unsolicited non-SAE|0|||
129628329|NCT05921903|466593357|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
129628330|NCT05921903|466593358|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
129628331|NCT05921903|466593359|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
129628332|NCT05921903|466593357|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
129628333|NCT05921903|466593358|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
129628334|NCT05921903|466593359|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
129628335|NCT05317312|466593362|FG000|Overall Study|Withdrawal by Subject|0|||
129628336|NCT05317312|466593363|FG001|Overall Study|Withdrawal by Subject|1|||
129628337|NCT05317312|466593364|FG002|Overall Study|Withdrawal by Subject|0|||
129628338|NCT05317312|466593365|FG003|Overall Study|Withdrawal by Subject|0|||
129628339|NCT05317312|466593362|FG000|Overall Study|Lost to Follow-up|0|||
129628340|NCT05317312|466593363|FG001|Overall Study|Lost to Follow-up|0|||
129628341|NCT05317312|466593364|FG002|Overall Study|Lost to Follow-up|0|||
129628342|NCT05317312|466593365|FG003|Overall Study|Lost to Follow-up|1|||
129628343|NCT05317312|466593362|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
129628344|NCT05317312|466593363|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
129628345|NCT05317312|466593364|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
129628346|NCT05317312|466593365|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
129628347|NCT00235755|466593366|FG000|4-Week Titration Phase|Adverse Event|6|||
129628348|NCT00235755|466593367|FG001|4-Week Titration Phase|Adverse Event|14|||
129628349|NCT00235755|466593368|FG002|4-Week Titration Phase|Adverse Event|20|||
129628350|NCT00235755|466593366|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
129628351|NCT00235755|466593367|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
129628352|NCT00235755|466593368|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
129628353|NCT00235755|466593366|FG000|4-Week Titration Phase|Protocol Violation|2|||
129628354|NCT00235755|466593367|FG001|4-Week Titration Phase|Protocol Violation|2|||
129628355|NCT00235755|466593368|FG002|4-Week Titration Phase|Protocol Violation|1|||
129628356|NCT00235755|466593366|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
129628357|NCT00235755|466593367|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
129628358|NCT00235755|466593368|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
129628359|NCT00235755|466593366|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
129628360|NCT00235755|466593367|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
129628361|NCT00235755|466593368|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
129628362|NCT00235755|466593366|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
129628363|NCT00235755|466593367|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
129628364|NCT00235755|466593368|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
129628365|NCT00235755|466593366|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
129628366|NCT00235755|466593367|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
129628367|NCT00235755|466593368|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
129628368|NCT00235755|466593366|FG000|12-Week Maintenance Phase|Adverse Event|8|||
129628369|NCT00235755|466593367|FG001|12-Week Maintenance Phase|Adverse Event|12|||
129628370|NCT00235755|466593368|FG002|12-Week Maintenance Phase|Adverse Event|26|||
129628371|NCT00235755|466593366|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
129628372|NCT00235755|466593367|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
129628373|NCT00235755|466593368|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
129628374|NCT00235755|466593366|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
129628375|NCT00235755|466593367|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
129628376|NCT00235755|466593368|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
129628377|NCT00235755|466593366|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
129628378|NCT00235755|466593367|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
129628379|NCT00235755|466593368|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
129628380|NCT00235755|466593366|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
129628381|NCT00235755|466593367|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
129628382|NCT00235755|466593368|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
129628383|NCT00235755|466593366|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
129628384|NCT00235755|466593367|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
129628385|NCT00235755|466593368|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
129628386|NCT02314026|466593369|FG000|Overall Study|Protocol Violation|28|||
129628387|NCT01532934|466593370|FG000|Overall Study|Lost to Follow-up|11|||
129628388|NCT01532934|466593371|FG001|Overall Study|Lost to Follow-up|11|||
129628389|NCT01532934|466593370|FG000|Overall Study|In controlled environment|3|||
129628390|NCT01532934|466593371|FG001|Overall Study|In controlled environment|2|||
129628391|NCT02291237|466593372|FG000|Overall Study|Study Terminated by Sponsor|72|||
129628392|NCT02291237|466593373|FG001|Overall Study|Study Terminated by Sponsor|67|||
129888932|NCT03389893|467550943|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
129888933|NCT03389893|467550944|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
129888934|NCT03389893|467550941|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
129888935|NCT03389893|467550942|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
129888936|NCT03389893|467550943|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
129628393|NCT02291237|466593372|FG000|Overall Study|Adverse Event|1|||
129628394|NCT02291237|466593373|FG001|Overall Study|Adverse Event|3|||
129703510|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
129703511|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
129703512|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
129628395|NCT02291237|466593372|FG000|Overall Study|Investigator's Discretion|0|||
129628396|NCT02291237|466593373|FG001|Overall Study|Investigator's Discretion|3|||
129703513|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
129888937|NCT03389893|467550944|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
129628397|NCT02291237|466593372|FG000|Overall Study|Withdrew Consent|11|||
129628398|NCT02291237|466593373|FG001|Overall Study|Withdrew Consent|11|||
129628399|NCT02291237|466593372|FG000|Overall Study|Lost to Follow-up|0|||
129628400|NCT02291237|466593373|FG001|Overall Study|Lost to Follow-up|2|||
129628401|NCT02291237|466593372|FG000|Overall Study|Subject Required Prohibited Medication|2|||
129628402|NCT02291237|466593373|FG001|Overall Study|Subject Required Prohibited Medication|0|||
129628403|NCT01149863|466593374|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
129628404|NCT01306305|466593375|FG000|Overall Study|Lost to Follow-up|1|||
129794501|NCT00817479|467214403|FG000|Overall Study|Physician Decision|1|||
129794502|NCT00817479|467214404|FG001|Overall Study|Physician Decision|1|||
129794503|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
129794504|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
129794505|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
129794506|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
129794507|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
129794508|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
129794509|NCT04030026|467214406|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
129794510|NCT04030026|467214407|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
129794511|NCT04030026|467214406|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
129794512|NCT04030026|467214407|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
129794513|NCT04030026|467214406|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
129794514|NCT04030026|467214407|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
129794515|NCT04030026|467214406|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
129628405|NCT01306305|466593376|FG001|Overall Study|Lost to Follow-up|0|||
129628406|NCT01306305|466593375|FG000|Overall Study|Withdrew consent|1|||
129628407|NCT01306305|466593376|FG001|Overall Study|Withdrew consent|0|||
129628408|NCT03326193|466593377|FG000|Overall Study|Sponsor decision|35|||
129628409|NCT00699998|466593379|FG000|Overall Study|Withdrawal by Subject|194|||
129794516|NCT04030026|467214407|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
129794517|NCT00523367|467214408|FG000|Overall Study|19 screen failures|19|||
129794518|NCT00523367|467214408|FG000|Overall Study|4 Withdrawn by PI|4|||
129794519|NCT04480424|467214409|FG000|Overall Study|Withdrawal by Subject|0|||
129794520|NCT04480424|467214410|FG001|Overall Study|Withdrawal by Subject|2|||
129794521|NCT04480424|467214409|FG000|Overall Study|Lost to Follow-up|3|||
129794522|NCT04480424|467214410|FG001|Overall Study|Lost to Follow-up|3|||
129794523|NCT04480424|467214409|FG000|Overall Study|Death|14|||
129794524|NCT04480424|467214410|FG001|Overall Study|Death|16|||
129794525|NCT04480424|467214409|FG000|Overall Study|Reason not Specified|5|||
129794526|NCT04480424|467214410|FG001|Overall Study|Reason not Specified|5|||
129628410|NCT00699998|466593380|FG001|Overall Study|Withdrawal by Subject|83|||
129628411|NCT00699998|466593381|FG002|Overall Study|Withdrawal by Subject|202|||
129628412|NCT00699998|466593382|FG003|Overall Study|Withdrawal by Subject|80|||
129628413|NCT00699998|466593379|FG000|Overall Study|Physician Decision|3|||
129628414|NCT00699998|466593380|FG001|Overall Study|Physician Decision|2|||
129628415|NCT00699998|466593381|FG002|Overall Study|Physician Decision|1|||
129628416|NCT00699998|466593382|FG003|Overall Study|Physician Decision|1|||
129628417|NCT00699998|466593379|FG000|Overall Study|Lost to Follow-up|2|||
129628418|NCT00699998|466593380|FG001|Overall Study|Lost to Follow-up|1|||
129628419|NCT00699998|466593381|FG002|Overall Study|Lost to Follow-up|3|||
129628420|NCT00699998|466593382|FG003|Overall Study|Lost to Follow-up|1|||
129628421|NCT01406574|466593383|FG000|Overall Study|Adverse Event|0|||
129628422|NCT01406574|466593384|FG001|Overall Study|Adverse Event|0|||
129628423|NCT01406574|466593385|FG002|Overall Study|Adverse Event|1|||
129628424|NCT01406574|466593386|FG003|Overall Study|Adverse Event|3|||
129628425|NCT01406574|466593383|FG000|Overall Study|Physician Decision|0|||
129628426|NCT01406574|466593384|FG001|Overall Study|Physician Decision|0|||
129628427|NCT01406574|466593385|FG002|Overall Study|Physician Decision|0|||
129628428|NCT01406574|466593386|FG003|Overall Study|Physician Decision|1|||
129628429|NCT01406574|466593383|FG000|Overall Study|Withdrawal by Subject|0|||
129628430|NCT01406574|466593384|FG001|Overall Study|Withdrawal by Subject|1|||
129628431|NCT01406574|466593385|FG002|Overall Study|Withdrawal by Subject|0|||
129628432|NCT01406574|466593386|FG003|Overall Study|Withdrawal by Subject|0|||
129628433|NCT01406574|466593383|FG000|Overall Study|Definite progression of primary disease|1|||
129628434|NCT01406574|466593384|FG001|Overall Study|Definite progression of primary disease|0|||
129628435|NCT01406574|466593385|FG002|Overall Study|Definite progression of primary disease|0|||
129628436|NCT01406574|466593386|FG003|Overall Study|Definite progression of primary disease|0|||
129628437|NCT00473590|466593391|FG000|Overall Study|Adverse Event|3|||
129628438|NCT00473590|466593392|FG001|Overall Study|Adverse Event|3|||
129628439|NCT00473590|466593391|FG000|Overall Study|Death|4|||
129628440|NCT00473590|466593392|FG001|Overall Study|Death|2|||
129628441|NCT00473590|466593391|FG000|Overall Study|Progression not resulting in death|24|||
129628442|NCT00473590|466593392|FG001|Overall Study|Progression not resulting in death|20|||
129628443|NCT00473590|466593391|FG000|Overall Study|Non-protocol-specified therapy|7|||
129628444|NCT00473590|466593392|FG001|Overall Study|Non-protocol-specified therapy|5|||
129628445|NCT00473590|466593391|FG000|Overall Study|Physician Decision|2|||
129628446|NCT00473590|466593392|FG001|Overall Study|Physician Decision|4|||
129628447|NCT00473590|466593391|FG000|Overall Study|Withdrawal by Subject|5|||
129628448|NCT00473590|466593392|FG001|Overall Study|Withdrawal by Subject|3|||
129628449|NCT00473590|466593391|FG000|Overall Study|Other|0|||
129628450|NCT00473590|466593392|FG001|Overall Study|Other|1|||
129628451|NCT03367819|466593395|FG000|Overall Study|Adverse Event|4|||
129628452|NCT03367819|466593396|FG001|Overall Study|Adverse Event|4|||
129628453|NCT03367819|466593395|FG000|Overall Study|Progressive Disease|15|||
129628454|NCT03367819|466593396|FG001|Overall Study|Progressive Disease|13|||
129628455|NCT03367819|466593395|FG000|Overall Study|Withdrawal by Subject|1|||
129628456|NCT03367819|466593396|FG001|Overall Study|Withdrawal by Subject|0|||
129628457|NCT03367819|466593395|FG000|Overall Study|Other|4|||
129628458|NCT03367819|466593396|FG001|Overall Study|Other|2|||
129628459|NCT00584454|466593397|FG000|Overall Study|Adverse Event|1|||
129628460|NCT00584454|466593397|FG000|Overall Study|Relocation|1|||
129628461|NCT00584454|466593397|FG000|Overall Study|Clinical Hold|2|||
129628462|NCT00982657|466593398|FG000|Overall Study|Death|1|||
129628463|NCT00982657|466593399|FG001|Overall Study|Death|0|||
129628464|NCT00982657|466593400|FG002|Overall Study|Death|1|||
129628465|NCT00982657|466593401|FG003|Overall Study|Death|1|||
129628466|NCT00982657|466593398|FG000|Overall Study|Withdrawal by Subject|0|||
129628467|NCT00982657|466593399|FG001|Overall Study|Withdrawal by Subject|0|||
129628468|NCT00982657|466593400|FG002|Overall Study|Withdrawal by Subject|1|||
129628469|NCT00982657|466593401|FG003|Overall Study|Withdrawal by Subject|3|||
129628470|NCT00982657|466593398|FG000|Overall Study|Other|0|||
129628471|NCT00982657|466593399|FG001|Overall Study|Other|0|||
129628472|NCT00982657|466593400|FG002|Overall Study|Other|0|||
129628473|NCT00982657|466593401|FG003|Overall Study|Other|4|||
129628474|NCT00982657|466593398|FG000|Overall Study|On going at date of cut-off|0|||
129628475|NCT00982657|466593399|FG001|Overall Study|On going at date of cut-off|0|||
129628476|NCT00982657|466593400|FG002|Overall Study|On going at date of cut-off|0|||
129628477|NCT00982657|466593401|FG003|Overall Study|On going at date of cut-off|1|||
129628478|NCT00725920|466593402|FG000|Overall Study|Lack of Efficacy|3|||
129628479|NCT00725920|466593403|FG001|Overall Study|Lack of Efficacy|6|||
129628480|NCT05373108|466593404|FG000|Overall Study|Withdrawal by Subject|2|||
129628481|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
129628482|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
129628483|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
129628484|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
129628485|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
129628486|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
129628487|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
129628488|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
129628489|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
129628490|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
129628491|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
129628492|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
129628493|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
129628494|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
129628495|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
129628496|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
129628497|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
129628498|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
129628499|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
129628500|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
129628501|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
129628502|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
129628503|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
129628504|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
129628505|NCT02513160|466595247|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
129628506|NCT02513160|466595248|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
129628507|NCT02513160|466595249|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
129628508|NCT02513160|466595250|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
129628509|NCT02513160|466595247|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
129628510|NCT02513160|466595248|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
129628511|NCT02513160|466595249|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
129628512|NCT02513160|466595250|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
129628513|NCT02513160|466595247|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
129628514|NCT02513160|466595248|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
129628515|NCT02513160|466595249|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
129628516|NCT02513160|466595250|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
129628517|NCT02513160|466595247|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
129628518|NCT02513160|466595248|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
129628519|NCT02513160|466595249|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
129628520|NCT02513160|466595250|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
129628521|NCT02513160|466595247|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
129628522|NCT02513160|466595248|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
129628523|NCT02513160|466595249|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
129628524|NCT02513160|466595250|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
129628525|NCT02513160|466595247|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
129628526|NCT02513160|466595248|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
129628527|NCT02513160|466595249|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
129628528|NCT02513160|466595250|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
129628529|NCT03428958|466595253|FG000|Overall Study|Adverse Event|0|||
129628530|NCT03428958|466595254|FG001|Overall Study|Adverse Event|0|||
129628531|NCT03428958|466595255|FG002|Overall Study|Adverse Event|0|||
129628532|NCT03428958|466595256|FG003|Overall Study|Adverse Event|1|||
129628533|NCT03428958|466595257|FG004|Overall Study|Adverse Event|0|||
129628534|NCT03428958|466595258|FG005|Overall Study|Adverse Event|2|||
129628535|NCT03428958|466595259|FG006|Overall Study|Adverse Event|1|||
129628536|NCT03428958|466595260|FG007|Overall Study|Adverse Event|0|||
129628537|NCT03428958|466595261|FG008|Overall Study|Adverse Event|0|||
129628538|NCT03428958|466595262|FG009|Overall Study|Adverse Event|0|||
129628539|NCT03428958|466595263|FG010|Overall Study|Adverse Event|0|||
129628540|NCT03428958|466595264|FG011|Overall Study|Adverse Event|0|||
129628541|NCT03428958|466595265|FG012|Overall Study|Adverse Event|0|||
129628542|NCT03428958|466595266|FG013|Overall Study|Adverse Event|0|||
129628543|NCT03428958|466595267|FG014|Overall Study|Adverse Event|0|||
129628544|NCT03428958|466595268|FG015|Overall Study|Adverse Event|0|||
129628545|NCT03428958|466595269|FG016|Overall Study|Adverse Event|0|||
129628546|NCT03428958|466595253|FG000|Overall Study|Clinical Progression|2|||
129628547|NCT03428958|466595254|FG001|Overall Study|Clinical Progression|3|||
129628548|NCT03428958|466595255|FG002|Overall Study|Clinical Progression|2|||
129628549|NCT03428958|466595256|FG003|Overall Study|Clinical Progression|1|||
129628550|NCT03428958|466595257|FG004|Overall Study|Clinical Progression|0|||
129628551|NCT03428958|466595258|FG005|Overall Study|Clinical Progression|2|||
129628552|NCT03428958|466595259|FG006|Overall Study|Clinical Progression|0|||
129628553|NCT03428958|466595260|FG007|Overall Study|Clinical Progression|0|||
129628554|NCT03428958|466595261|FG008|Overall Study|Clinical Progression|0|||
129628555|NCT03428958|466595262|FG009|Overall Study|Clinical Progression|0|||
129628556|NCT03428958|466595263|FG010|Overall Study|Clinical Progression|0|||
129628557|NCT03428958|466595264|FG011|Overall Study|Clinical Progression|0|||
129628558|NCT03428958|466595265|FG012|Overall Study|Clinical Progression|0|||
129628559|NCT03428958|466595266|FG013|Overall Study|Clinical Progression|0|||
129628560|NCT03428958|466595267|FG014|Overall Study|Clinical Progression|0|||
129628561|NCT03428958|466595268|FG015|Overall Study|Clinical Progression|0|||
129628562|NCT03428958|466595269|FG016|Overall Study|Clinical Progression|0|||
129628563|NCT03428958|466595253|FG000|Overall Study|Progression per RECIST|6|||
129628564|NCT03428958|466595254|FG001|Overall Study|Progression per RECIST|6|||
129628565|NCT03428958|466595255|FG002|Overall Study|Progression per RECIST|7|||
129628566|NCT03428958|466595256|FG003|Overall Study|Progression per RECIST|4|||
129628567|NCT03428958|466595257|FG004|Overall Study|Progression per RECIST|0|||
129628568|NCT03428958|466595258|FG005|Overall Study|Progression per RECIST|7|||
129628569|NCT03428958|466595259|FG006|Overall Study|Progression per RECIST|8|||
129628570|NCT03428958|466595260|FG007|Overall Study|Progression per RECIST|0|||
129628571|NCT03428958|466595261|FG008|Overall Study|Progression per RECIST|0|||
129628572|NCT03428958|466595262|FG009|Overall Study|Progression per RECIST|0|||
129628573|NCT03428958|466595263|FG010|Overall Study|Progression per RECIST|0|||
129628574|NCT03428958|466595264|FG011|Overall Study|Progression per RECIST|0|||
129628575|NCT03428958|466595265|FG012|Overall Study|Progression per RECIST|1|||
129628576|NCT03428958|466595266|FG013|Overall Study|Progression per RECIST|0|||
129628577|NCT03428958|466595267|FG014|Overall Study|Progression per RECIST|0|||
129628578|NCT03428958|466595268|FG015|Overall Study|Progression per RECIST|0|||
129628579|NCT03428958|466595269|FG016|Overall Study|Progression per RECIST|0|||
129628580|NCT03428958|466595253|FG000|Overall Study|Death|2|||
129628581|NCT03428958|466595254|FG001|Overall Study|Death|2|||
129628582|NCT03428958|466595255|FG002|Overall Study|Death|0|||
129628583|NCT03428958|466595256|FG003|Overall Study|Death|0|||
129628584|NCT03428958|466595257|FG004|Overall Study|Death|0|||
129628585|NCT03428958|466595258|FG005|Overall Study|Death|7|||
129628586|NCT03428958|466595259|FG006|Overall Study|Death|9|||
129628587|NCT03428958|466595260|FG007|Overall Study|Death|6|||
129628588|NCT03428958|466595261|FG008|Overall Study|Death|0|||
129628589|NCT03428958|466595262|FG009|Overall Study|Death|0|||
129628590|NCT03428958|466595263|FG010|Overall Study|Death|3|||
129628591|NCT03428958|466595264|FG011|Overall Study|Death|0|||
129628592|NCT03428958|466595265|FG012|Overall Study|Death|4|||
129628593|NCT03428958|466595266|FG013|Overall Study|Death|0|||
129628594|NCT03428958|466595267|FG014|Overall Study|Death|0|||
129628595|NCT03428958|466595268|FG015|Overall Study|Death|0|||
129628596|NCT03428958|466595269|FG016|Overall Study|Death|0|||
129628597|NCT03428958|466595253|FG000|Overall Study|Lost to Follow-up|0|||
129628598|NCT03428958|466595254|FG001|Overall Study|Lost to Follow-up|0|||
129628599|NCT03428958|466595255|FG002|Overall Study|Lost to Follow-up|0|||
129628600|NCT03428958|466595256|FG003|Overall Study|Lost to Follow-up|0|||
129628601|NCT03428958|466595257|FG004|Overall Study|Lost to Follow-up|0|||
129628602|NCT03428958|466595258|FG005|Overall Study|Lost to Follow-up|1|||
129628603|NCT03428958|466595259|FG006|Overall Study|Lost to Follow-up|1|||
129628604|NCT03428958|466595260|FG007|Overall Study|Lost to Follow-up|0|||
129628605|NCT03428958|466595261|FG008|Overall Study|Lost to Follow-up|0|||
129628606|NCT03428958|466595262|FG009|Overall Study|Lost to Follow-up|0|||
129628607|NCT03428958|466595263|FG010|Overall Study|Lost to Follow-up|0|||
129628608|NCT03428958|466595264|FG011|Overall Study|Lost to Follow-up|0|||
129628609|NCT03428958|466595265|FG012|Overall Study|Lost to Follow-up|0|||
129628610|NCT03428958|466595266|FG013|Overall Study|Lost to Follow-up|0|||
129628611|NCT03428958|466595267|FG014|Overall Study|Lost to Follow-up|0|||
129628612|NCT03428958|466595268|FG015|Overall Study|Lost to Follow-up|0|||
129628613|NCT03428958|466595269|FG016|Overall Study|Lost to Follow-up|0|||
129628614|NCT03428958|466595253|FG000|Overall Study|Physician/Sponsor Decision|1|||
129440314|NCT02893930|465911388|FG000|Overall Study|Withdrawal by Subject|2|||
129440315|NCT02893930|465911388|FG000|Overall Study|Physician Decision|1|||
129440316|NCT02893930|465911388|FG000|Overall Study|Ineligible|1|||
129440317|NCT02804178|465911398|FG000|Overall Study|Adverse Event|1|||
129628615|NCT03428958|466595254|FG001|Overall Study|Physician/Sponsor Decision|0|||
129628616|NCT03428958|466595255|FG002|Overall Study|Physician/Sponsor Decision|1|||
129628617|NCT03428958|466595256|FG003|Overall Study|Physician/Sponsor Decision|0|||
129440318|NCT01106404|465911399|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
129628618|NCT03428958|466595257|FG004|Overall Study|Physician/Sponsor Decision|0|||
129628619|NCT03428958|466595258|FG005|Overall Study|Physician/Sponsor Decision|2|||
129628620|NCT03428958|466595259|FG006|Overall Study|Physician/Sponsor Decision|2|||
129628621|NCT03428958|466595260|FG007|Overall Study|Physician/Sponsor Decision|2|||
129628622|NCT03428958|466595261|FG008|Overall Study|Physician/Sponsor Decision|0|||
129628623|NCT03428958|466595262|FG009|Overall Study|Physician/Sponsor Decision|0|||
129628624|NCT03428958|466595263|FG010|Overall Study|Physician/Sponsor Decision|2|||
129628625|NCT03428958|466595264|FG011|Overall Study|Physician/Sponsor Decision|0|||
129628626|NCT03428958|466595265|FG012|Overall Study|Physician/Sponsor Decision|4|||
129628627|NCT03428958|466595266|FG013|Overall Study|Physician/Sponsor Decision|0|||
129794527|NCT02782923|467214411|FG000|Overall Study|Lost to Follow-up|15|||
129628628|NCT03428958|466595267|FG014|Overall Study|Physician/Sponsor Decision|0|||
129440319|NCT01106404|465911400|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
129440320|NCT01106404|465911399|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
129440321|NCT01106404|465911400|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
129440322|NCT01106404|465911399|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
129440323|NCT01106404|465911400|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
129440324|NCT01106404|465911399|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
129440325|NCT01106404|465911400|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
129440326|NCT01290601|465911401|FG000|Overall Study|Adverse Event|0|||
129440327|NCT01290601|465911402|FG001|Overall Study|Adverse Event|2|||
129440328|NCT01290601|465911403|FG002|Overall Study|Adverse Event|0|||
129440329|NCT01290601|465911404|FG003|Overall Study|Adverse Event|0|||
129440330|NCT01290601|465911401|FG000|Overall Study|Lack of Efficacy|2|||
129440331|NCT01290601|465911402|FG001|Overall Study|Lack of Efficacy|1|||
129440332|NCT01290601|465911403|FG002|Overall Study|Lack of Efficacy|0|||
129440333|NCT01290601|465911404|FG003|Overall Study|Lack of Efficacy|0|||
129440334|NCT01290601|465911401|FG000|Overall Study|Lost to Follow-up|7|||
129440335|NCT01290601|465911402|FG001|Overall Study|Lost to Follow-up|2|||
129440336|NCT01290601|465911403|FG002|Overall Study|Lost to Follow-up|0|||
129440337|NCT01290601|465911404|FG003|Overall Study|Lost to Follow-up|0|||
129440338|NCT01290601|465911401|FG000|Overall Study|Other|1|||
129628629|NCT03428958|466595268|FG015|Overall Study|Physician/Sponsor Decision|0|||
129628630|NCT03428958|466595269|FG016|Overall Study|Physician/Sponsor Decision|0|||
129628631|NCT03428958|466595253|FG000|Overall Study|Withdrawal by Subject|0|||
129628632|NCT03428958|466595254|FG001|Overall Study|Withdrawal by Subject|0|||
129628633|NCT03428958|466595255|FG002|Overall Study|Withdrawal by Subject|2|||
129628634|NCT03428958|466595256|FG003|Overall Study|Withdrawal by Subject|0|||
129628635|NCT03428958|466595257|FG004|Overall Study|Withdrawal by Subject|0|||
129628636|NCT03428958|466595258|FG005|Overall Study|Withdrawal by Subject|2|||
129628637|NCT03428958|466595259|FG006|Overall Study|Withdrawal by Subject|4|||
129628638|NCT03428958|466595260|FG007|Overall Study|Withdrawal by Subject|1|||
129628639|NCT03428958|466595261|FG008|Overall Study|Withdrawal by Subject|0|||
129628640|NCT03428958|466595262|FG009|Overall Study|Withdrawal by Subject|0|||
129628641|NCT03428958|466595263|FG010|Overall Study|Withdrawal by Subject|0|||
129628642|NCT03428958|466595264|FG011|Overall Study|Withdrawal by Subject|0|||
129628643|NCT03428958|466595265|FG012|Overall Study|Withdrawal by Subject|0|||
129628644|NCT03428958|466595266|FG013|Overall Study|Withdrawal by Subject|0|||
129628645|NCT03428958|466595267|FG014|Overall Study|Withdrawal by Subject|0|||
129628646|NCT03428958|466595268|FG015|Overall Study|Withdrawal by Subject|0|||
129628647|NCT03428958|466595269|FG016|Overall Study|Withdrawal by Subject|0|||
129628648|NCT03874117|466595270|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
129628649|NCT03874117|466595271|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
129628650|NCT03874117|466595270|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
129628651|NCT03874117|466595271|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
129628652|NCT03874117|466595270|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129628653|NCT03874117|466595271|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129628654|NCT03874117|466595270|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
129628655|NCT03874117|466595271|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
129628656|NCT03874117|466595270|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129628657|NCT03874117|466595271|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129628658|NCT05258773|466595272|FG000|Overall Study|Screen Failure|1|||
129628659|NCT05258773|466595273|FG001|Overall Study|Screen Failure|1|||
129628660|NCT05258773|466595272|FG000|Overall Study|Adverse Event|1|||
129628661|NCT05258773|466595273|FG001|Overall Study|Adverse Event|0|||
129628662|NCT05258773|466595272|FG000|Overall Study|Withdrawal by Subject|0|||
129628663|NCT05258773|466595273|FG001|Overall Study|Withdrawal by Subject|1|||
129628664|NCT03018288|466595276|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
129628665|NCT03018288|466595277|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
129628666|NCT03018288|466595278|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
129628667|NCT03018288|466595279|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
129628668|NCT03018288|466595276|FG000|Overall Study|Participant withdrew consent.|0|||
129628669|NCT03018288|466595277|FG001|Overall Study|Participant withdrew consent.|0|||
129794528|NCT02418156|467214412|FG000|Overall Study|Lost to Follow-up|12|||
129794529|NCT02418156|467214412|FG000|Overall Study|Death|2|||
129794530|NCT02418156|467214412|FG000|Overall Study|Physician Decision|1|||
129794531|NCT02418156|467214412|FG000|Overall Study|Withdrawal by Subject|1|||
129440339|NCT01290601|465911402|FG001|Overall Study|Other|0|||
129440340|NCT01290601|465911403|FG002|Overall Study|Other|0|||
129440341|NCT01290601|465911404|FG003|Overall Study|Other|0|||
129440342|NCT01290601|465911401|FG000|Overall Study|Protocol Violation|1|||
129440343|NCT01290601|465911402|FG001|Overall Study|Protocol Violation|0|||
129628670|NCT03018288|466595278|FG002|Overall Study|Participant withdrew consent.|1|||
129628671|NCT03018288|466595279|FG003|Overall Study|Participant withdrew consent.|0|||
129628672|NCT03018288|466595276|FG000|Overall Study|Switched to alternative treatment.|0|||
129794532|NCT02418156|467214412|FG000|Overall Study|Subject refused to return|1|||
129628673|NCT03018288|466595277|FG001|Overall Study|Switched to alternative treatment.|0|||
129628674|NCT03018288|466595278|FG002|Overall Study|Switched to alternative treatment.|1|||
129628675|NCT03018288|466595279|FG003|Overall Study|Switched to alternative treatment.|0|||
129628676|NCT03018288|466595276|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
129628677|NCT03018288|466595277|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
129628678|NCT03018288|466595278|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
129628679|NCT03018288|466595279|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
129628680|NCT03018288|466595276|FG000|Overall Study|Screen failures|0|||
129628681|NCT03018288|466595277|FG001|Overall Study|Screen failures|0|||
129628682|NCT03018288|466595278|FG002|Overall Study|Screen failures|0|||
129628683|NCT03018288|466595279|FG003|Overall Study|Screen failures|51|||
129628684|NCT03018288|466595276|FG000|Overall Study|Chose treatment outside of UNC|0|||
129628685|NCT03018288|466595277|FG001|Overall Study|Chose treatment outside of UNC|0|||
129628686|NCT03018288|466595278|FG002|Overall Study|Chose treatment outside of UNC|0|||
129628687|NCT03018288|466595279|FG003|Overall Study|Chose treatment outside of UNC|1|||
129628688|NCT03018288|466595276|FG000|Overall Study|Unable to comply with protocol requirements|1|||
129628689|NCT03018288|466595277|FG001|Overall Study|Unable to comply with protocol requirements|1|||
129628690|NCT03018288|466595278|FG002|Overall Study|Unable to comply with protocol requirements|0|||
129628691|NCT03018288|466595279|FG003|Overall Study|Unable to comply with protocol requirements|1|||
129628692|NCT03018288|466595276|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
129628693|NCT03018288|466595277|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
129628694|NCT03018288|466595278|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
129628695|NCT03018288|466595279|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
129628696|NCT03018288|466595276|FG000|Overall Study|Physician Decision|0|||
129628697|NCT03018288|466595277|FG001|Overall Study|Physician Decision|0|||
129628698|NCT03018288|466595278|FG002|Overall Study|Physician Decision|0|||
129628699|NCT03018288|466595279|FG003|Overall Study|Physician Decision|1|||
129628700|NCT01127256|466595282|FG000|Overall Study|Adverse Event|13|||
129628701|NCT01127256|466595283|FG001|Overall Study|Adverse Event|13|||
129628702|NCT01127256|466595282|FG000|Overall Study|Lack of Efficacy|4|||
129628703|NCT01127256|466595283|FG001|Overall Study|Lack of Efficacy|0|||
129628704|NCT01127256|466595282|FG000|Overall Study|Lost to Follow-up|16|||
129628705|NCT01127256|466595283|FG001|Overall Study|Lost to Follow-up|17|||
129628706|NCT01127256|466595282|FG000|Overall Study|Withdrawal by Subject|5|||
129628707|NCT01127256|466595283|FG001|Overall Study|Withdrawal by Subject|9|||
129628708|NCT01127256|466595282|FG000|Overall Study|Protocol Violation|1|||
129628709|NCT01127256|466595283|FG001|Overall Study|Protocol Violation|0|||
129628710|NCT01415518|466595284|FG000|Overall Study|Withdrawal by Subject|2|||
129628711|NCT01415518|466595285|FG001|Overall Study|Withdrawal by Subject|12|||
129628712|NCT01415518|466595284|FG000|Overall Study|Protocol Violation|6|||
129628713|NCT01415518|466595285|FG001|Overall Study|Protocol Violation|8|||
129628714|NCT01415518|466595284|FG000|Overall Study|Lost to Follow-up|3|||
129628715|NCT01415518|466595285|FG001|Overall Study|Lost to Follow-up|5|||
129628716|NCT01415518|466595284|FG000|Overall Study|Adverse Event|3|||
129628717|NCT01415518|466595285|FG001|Overall Study|Adverse Event|4|||
129628718|NCT01415518|466595284|FG000|Overall Study|Death|1|||
129628719|NCT01415518|466595285|FG001|Overall Study|Death|1|||
129628720|NCT01415518|466595284|FG000|Overall Study|Condition under Investigation Worsened|1|||
129628721|NCT01415518|466595285|FG001|Overall Study|Condition under Investigation Worsened|1|||
129628722|NCT00679211|466595286|FG000|Overall Study|Progressive disease|82|||
129628723|NCT00679211|466595286|FG000|Overall Study|Adverse Event|7|||
129628724|NCT00679211|466595286|FG000|Overall Study|Withdrawal by Subject|2|||
129628725|NCT00679211|466595286|FG000|Overall Study|Physician Decision|5|||
129628726|NCT00679211|466595286|FG000|Overall Study|Refused to undergo protocol procedures|1|||
129703514|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
129703515|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
129703516|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
129703517|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
129703518|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
129703519|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
129703520|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
129703521|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
129703522|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
129703523|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
129703524|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
129703525|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703526|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703527|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129628727|NCT00679211|466595286|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
129628728|NCT00679211|466595286|FG000|Overall Study|Other|1|||
129703528|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129794533|NCT04854642|467216323|FG000|Overall Study|Adverse Event|1|||
129628729|NCT01922037|466595287|FG000|Overall Study|Withdrawal by Subject|2|||
129628730|NCT01922037|466595288|FG001|Overall Study|Withdrawal by Subject|44|||
129628731|NCT01922037|466595287|FG000|Overall Study|Adverse Event|1|||
129628732|NCT01922037|466595288|FG001|Overall Study|Adverse Event|7|||
129628733|NCT01922037|466595287|FG000|Overall Study|Death|0|||
129628734|NCT01922037|466595288|FG001|Overall Study|Death|5|||
129888938|NCT01024751|467550948|FG000|Enrolled Participants|Ineligible at baseline|3|||
129888939|NCT01024751|467550949|FG001|Enrolled Participants|Ineligible at baseline|4|||
129888940|NCT01024751|467550948|FG000|Eligible Participants|Withdrawal by Subject|0|||
129888941|NCT01024751|467550949|FG001|Eligible Participants|Withdrawal by Subject|1|||
129888942|NCT01024751|467550948|FG000|Eligible Participants|Lost to Follow-up|0|||
129888943|NCT01024751|467550949|FG001|Eligible Participants|Lost to Follow-up|1|||
129888944|NCT01024751|467550948|FG000|Eligible Participants|Ineligible|0|||
129628735|NCT01922037|466595287|FG000|Overall Study|Pregnancy|0|||
129628736|NCT01922037|466595288|FG001|Overall Study|Pregnancy|2|||
129628737|NCT01922037|466595287|FG000|Overall Study|Participant non-compliance|4|||
129628738|NCT01922037|466595288|FG001|Overall Study|Participant non-compliance|46|||
129628739|NCT01922037|466595287|FG000|Overall Study|Investigator/Sponsor decision|1|||
129628740|NCT01922037|466595288|FG001|Overall Study|Investigator/Sponsor decision|4|||
129628741|NCT01922037|466595287|FG000|Overall Study|Other unspecified|2|||
129628742|NCT01922037|466595288|FG001|Overall Study|Other unspecified|66|||
129628743|NCT01730053|466595289|FG000|Overall Study|Participant moved|0|||
129628744|NCT01730053|466595290|FG001|Overall Study|Participant moved|0|||
129628745|NCT01730053|466595291|FG002|Overall Study|Participant moved|1|||
129628746|NCT01730053|466595292|FG003|Overall Study|Participant moved|0|||
129628747|NCT01730053|466595293|FG004|Overall Study|Participant moved|0|||
129628748|NCT01730053|466595294|FG005|Overall Study|Participant moved|0|||
129628749|NCT01730053|466595289|FG000|Overall Study|Physician Decision|0|||
129628750|NCT01730053|466595290|FG001|Overall Study|Physician Decision|0|||
129628751|NCT01730053|466595291|FG002|Overall Study|Physician Decision|0|||
129628752|NCT01730053|466595292|FG003|Overall Study|Physician Decision|1|||
129628753|NCT01730053|466595293|FG004|Overall Study|Physician Decision|0|||
129628754|NCT01730053|466595294|FG005|Overall Study|Physician Decision|0|||
129628755|NCT01730053|466595289|FG000|Overall Study|Adverse Event|2|||
129628756|NCT01730053|466595290|FG001|Overall Study|Adverse Event|6|||
129628757|NCT01730053|466595291|FG002|Overall Study|Adverse Event|3|||
129628758|NCT01730053|466595292|FG003|Overall Study|Adverse Event|3|||
129628759|NCT01730053|466595293|FG004|Overall Study|Adverse Event|2|||
129628760|NCT01730053|466595294|FG005|Overall Study|Adverse Event|2|||
129794534|NCT04854642|467216324|FG001|Overall Study|Adverse Event|2|||
129440344|NCT01290601|465911403|FG002|Overall Study|Protocol Violation|0|||
129440345|NCT01290601|465911404|FG003|Overall Study|Protocol Violation|0|||
129628761|NCT01730053|466595289|FG000|Overall Study|Poor compliance to protocol|1|||
129628762|NCT01730053|466595290|FG001|Overall Study|Poor compliance to protocol|2|||
129794535|NCT04854642|467216323|FG000|Overall Study|Withdrawal by Subject|0|||
129794536|NCT04854642|467216324|FG001|Overall Study|Withdrawal by Subject|1|||
129794537|NCT01314911|467216325|FG000|Overall Study|Lost to Follow-up|3|||
129794538|NCT01314911|467216326|FG001|Overall Study|Lost to Follow-up|2|||
129440346|NCT00775450|465911405|FG000|Overall Study|Serious Adverse Event|2|||
129794539|NCT01314911|467216325|FG000|Overall Study|Withdrawal by Subject|1|||
129794540|NCT01314911|467216326|FG001|Overall Study|Withdrawal by Subject|3|||
129794541|NCT01314911|467216325|FG000|Overall Study|Received Non-randomized Study Drug|0|||
129794542|NCT01314911|467216326|FG001|Overall Study|Received Non-randomized Study Drug|1|||
129794543|NCT01314911|467216325|FG000|Overall Study|Never Started Treatment|1|||
129794544|NCT01314911|467216326|FG001|Overall Study|Never Started Treatment|0|||
129794545|NCT04078178|467216334|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
129794546|NCT04078178|467216335|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
129628763|NCT01730053|466595291|FG002|Overall Study|Poor compliance to protocol|2|||
129628764|NCT01730053|466595292|FG003|Overall Study|Poor compliance to protocol|0|||
129628765|NCT01730053|466595293|FG004|Overall Study|Poor compliance to protocol|0|||
129628766|NCT01730053|466595294|FG005|Overall Study|Poor compliance to protocol|2|||
129628767|NCT01730053|466595289|FG000|Overall Study|Other than specified|2|||
129888945|NCT01024751|467550949|FG001|Eligible Participants|Ineligible|1|||
129888946|NCT02448719|467550950|FG000|Overall Study|Withdrawal by Subject|0|||
129440347|NCT00775450|465911406|FG001|Overall Study|Serious Adverse Event|0|||
129628768|NCT01730053|466595290|FG001|Overall Study|Other than specified|6|||
129628769|NCT01730053|466595291|FG002|Overall Study|Other than specified|5|||
129628770|NCT01730053|466595292|FG003|Overall Study|Other than specified|4|||
129628771|NCT01730053|466595293|FG004|Overall Study|Other than specified|7|||
129628772|NCT01730053|466595294|FG005|Overall Study|Other than specified|9|||
129628773|NCT01470248|466595296|FG000|Overall Study|Withdrawal by Subject|1|||
129628774|NCT02243605|466595299|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
129628775|NCT02243605|466595300|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
129628776|NCT02243605|466595299|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
129628777|NCT02243605|466595300|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
129628778|NCT02243605|466595299|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
129628779|NCT02243605|466595300|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
129628780|NCT02243605|466595299|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
129628781|NCT02243605|466595300|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
129628782|NCT02243605|466595299|FG000|Stage 2 - Final Analysis Population|Progression|0|||
129628783|NCT02243605|466595300|FG001|Stage 2 - Final Analysis Population|Progression|1|||
129628784|NCT02019472|466595301|FG000|Overall Study|Adverse Event|14|||
129628785|NCT02019472|466595302|FG001|Overall Study|Adverse Event|23|||
129628786|NCT02019472|466595303|FG002|Overall Study|Adverse Event|17|||
129628787|NCT02019472|466595301|FG000|Overall Study|Death|0|||
129628788|NCT02019472|466595302|FG001|Overall Study|Death|1|||
129628789|NCT02019472|466595303|FG002|Overall Study|Death|1|||
129628790|NCT02019472|466595301|FG000|Overall Study|Lack of Efficacy|7|||
129794547|NCT04078178|467216334|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
129628791|NCT02019472|466595302|FG001|Overall Study|Lack of Efficacy|4|||
129628792|NCT02019472|466595303|FG002|Overall Study|Lack of Efficacy|4|||
129794548|NCT04078178|467216335|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
129794549|NCT04078178|467216334|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
129794550|NCT04078178|467216335|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
129794551|NCT04078178|467216334|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
129794552|NCT04078178|467216335|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
129794553|NCT04078178|467216334|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
129794554|NCT04078178|467216335|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
129794555|NCT04006119|467216336|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
129794556|NCT04006119|467216336|FG000|End of Treatment Veledimex|Adverse Event|2|||
129794557|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
129794558|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
129794559|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
129794560|NCT04006119|467216336|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
129794561|NCT04617795|467216337|FG000|Main Study|Lost to Follow-up|1|||
129794562|NCT04617795|467216338|FG001|Main Study|Lost to Follow-up|0|||
129794563|NCT00472459|467216339|FG000|Overall Study|Adverse Event|13|||
129794564|NCT00472459|467216340|FG001|Overall Study|Adverse Event|13|||
129794565|NCT00472459|467216339|FG000|Overall Study|Withdrawal by Subject|5|||
129794566|NCT00472459|467216340|FG001|Overall Study|Withdrawal by Subject|5|||
129794567|NCT00472459|467216339|FG000|Overall Study|Protocol Violation|3|||
129794568|NCT00472459|467216340|FG001|Overall Study|Protocol Violation|3|||
129794569|NCT00472459|467216339|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
129794570|NCT00472459|467216340|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
129794571|NCT00472459|467216339|FG000|Overall Study|Lost to Follow-up|1|||
129794572|NCT00472459|467216340|FG001|Overall Study|Lost to Follow-up|1|||
129794573|NCT03442764|467216341|FG000|Overall Study|Adverse Event|1|||
129794574|NCT03442764|467216342|FG001|Overall Study|Adverse Event|0|||
129794575|NCT03442764|467216343|FG002|Overall Study|Adverse Event|0|||
129794576|NCT04850313|467216344|FG000|Overall Study|Withdrawal by Subject|0|||
129794577|NCT04850313|467216345|FG001|Overall Study|Withdrawal by Subject|1|||
129794578|NCT02395016|467216346|FG000|Overall Study|Adverse Event|4|||
129794579|NCT02395016|467216347|FG001|Overall Study|Adverse Event|3|||
129794580|NCT02395016|467216346|FG000|Overall Study|Withdrawal by Subject|9|||
129440348|NCT00775450|465911407|FG002|Overall Study|Serious Adverse Event|0|||
129628793|NCT02019472|466595301|FG000|Overall Study|Lost to Follow-up|0|||
129628794|NCT02019472|466595302|FG001|Overall Study|Lost to Follow-up|2|||
129628795|NCT02019472|466595303|FG002|Overall Study|Lost to Follow-up|1|||
129628796|NCT02019472|466595301|FG000|Overall Study|Physician Decision|1|||
129628797|NCT02019472|466595302|FG001|Overall Study|Physician Decision|2|||
129628798|NCT02019472|466595303|FG002|Overall Study|Physician Decision|0|||
129794581|NCT02395016|467216347|FG001|Overall Study|Withdrawal by Subject|6|||
129794582|NCT02395016|467216346|FG000|Overall Study|Protocol Violation|2|||
129794583|NCT02395016|467216347|FG001|Overall Study|Protocol Violation|3|||
129794584|NCT01547780|467216348|FG000|Baseline PET Scan|Physician Decision|1|||
129794585|NCT01547780|467216349|FG001|Baseline PET Scan|Physician Decision|0|||
129794586|NCT01547780|467216350|FG002|Baseline PET Scan|Physician Decision|1|||
129628799|NCT02019472|466595301|FG000|Overall Study|Pregnancy|1|||
129628800|NCT02019472|466595302|FG001|Overall Study|Pregnancy|2|||
129628801|NCT02019472|466595303|FG002|Overall Study|Pregnancy|2|||
129794587|NCT01547780|467216351|FG003|Baseline PET Scan|Physician Decision|0|||
129794588|NCT01547780|467216348|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
129794589|NCT01547780|467216349|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
129888947|NCT02448719|467550951|FG001|Overall Study|Withdrawal by Subject|0|||
129888948|NCT02448719|467550952|FG002|Overall Study|Withdrawal by Subject|0|||
129888949|NCT02448719|467550953|FG003|Overall Study|Withdrawal by Subject|0|||
129888950|NCT02448719|467550954|FG004|Overall Study|Withdrawal by Subject|1|||
129888951|NCT02448719|467550955|FG005|Overall Study|Withdrawal by Subject|0|||
129888952|NCT02448719|467550956|FG006|Overall Study|Withdrawal by Subject|0|||
129888953|NCT02448719|467550957|FG007|Overall Study|Withdrawal by Subject|0|||
129888954|NCT02448719|467550958|FG008|Overall Study|Withdrawal by Subject|0|||
129888955|NCT02448719|467550959|FG009|Overall Study|Withdrawal by Subject|0|||
129888956|NCT02448719|467550960|FG010|Overall Study|Withdrawal by Subject|0|||
129888957|NCT01232556|467550961|FG000|Overall Study|Withdrawal by Subject|21|||
129888958|NCT01232556|467550962|FG001|Overall Study|Withdrawal by Subject|17|||
129794590|NCT01547780|467216350|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
129794591|NCT01547780|467216351|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
129794592|NCT00814879|467216353|FG000|By Week 24|Cancer Diagnosis|1|||
129794593|NCT00814879|467216354|FG001|By Week 24|Cancer Diagnosis|0|||
129794594|NCT00814879|467216353|FG000|By Week 24|Incarceration|0|||
129794595|NCT00814879|467216354|FG001|By Week 24|Incarceration|1|||
129794596|NCT00814879|467216353|FG000|By Week 48|Lost to Follow-up|2|||
129794597|NCT00814879|467216354|FG001|By Week 48|Lost to Follow-up|2|||
129794598|NCT00814879|467216353|FG000|By Week 48|Death|0|||
129888959|NCT01232556|467550961|FG000|Overall Study|Death|97|||
129628802|NCT02019472|466595301|FG000|Overall Study|Withdrawal by Subject|11|||
129628803|NCT02019472|466595302|FG001|Overall Study|Withdrawal by Subject|10|||
129628804|NCT02019472|466595303|FG002|Overall Study|Withdrawal by Subject|11|||
129628805|NCT02019472|466595301|FG000|Overall Study|Other|3|||
129628806|NCT02019472|466595302|FG001|Overall Study|Other|8|||
129628807|NCT02019472|466595303|FG002|Overall Study|Other|6|||
129628808|NCT04429503|466595308|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
129628809|NCT04429503|466595309|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
129628810|NCT04429503|466595310|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129628811|NCT04429503|466595311|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129628812|NCT04429503|466595312|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129628813|NCT04429503|466595313|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
129628814|NCT04429503|466595308|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
129628815|NCT04429503|466595309|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
129628816|NCT04429503|466595310|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
129628817|NCT04429503|466595311|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
129628818|NCT04429503|466595312|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
129628819|NCT04429503|466595313|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
129628820|NCT04429503|466595308|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
129628821|NCT04429503|466595309|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
129628822|NCT04429503|466595310|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
129628823|NCT04429503|466595311|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
129628824|NCT04429503|466595312|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
129628825|NCT04429503|466595313|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
129628826|NCT04429503|466595308|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
129628827|NCT04429503|466595309|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
129628828|NCT04429503|466595310|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
129628829|NCT04429503|466595311|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
129628830|NCT04429503|466595312|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
129628831|NCT04429503|466595313|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
129628832|NCT04429503|466595308|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
129628833|NCT04429503|466595309|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
129628834|NCT04429503|466595310|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
129628835|NCT04429503|466595311|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
129628836|NCT04429503|466595312|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
129628837|NCT04429503|466595313|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
129628838|NCT04429503|466595308|FG000|Main Study (Up to Wk 96)|Death|9|||
129628839|NCT04429503|466595309|FG001|Main Study (Up to Wk 96)|Death|18|||
129628840|NCT04429503|466595310|FG002|Main Study (Up to Wk 96)|Death|5|||
129628841|NCT04429503|466595311|FG003|Main Study (Up to Wk 96)|Death|0|||
129628842|NCT04429503|466595312|FG004|Main Study (Up to Wk 96)|Death|0|||
129628843|NCT04429503|466595313|FG005|Main Study (Up to Wk 96)|Death|0|||
129628844|NCT04429503|466595308|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129794599|NCT00814879|467216354|FG001|By Week 48|Death|1|||
129794600|NCT00588952|467216355|FG000|Overall Study|Adverse Event|0|||
129794601|NCT00588952|467216356|FG001|Overall Study|Adverse Event|2|||
129794602|NCT00588952|467216355|FG000|Overall Study|Withdrawal by Subject|3|||
129888960|NCT01232556|467550962|FG001|Overall Study|Death|97|||
129888961|NCT01232556|467550961|FG000|Overall Study|Lost to Follow-up|0|||
129888962|NCT01232556|467550962|FG001|Overall Study|Lost to Follow-up|2|||
129888963|NCT01232556|467550961|FG000|Overall Study|Terminated by Sponsor|35|||
129888964|NCT01232556|467550962|FG001|Overall Study|Terminated by Sponsor|51|||
129888965|NCT01232556|467550961|FG000|Overall Study|Other|6|||
129888966|NCT01232556|467550962|FG001|Overall Study|Other|4|||
129888967|NCT01473420|467550964|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
129888968|NCT01473420|467550965|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
129888969|NCT01473420|467550964|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
129888970|NCT01473420|467550965|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
129888971|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
129888972|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
129888973|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
129888974|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
129888975|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
129888976|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
129888977|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
129888978|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
129888979|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
129888980|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
129888981|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
129888982|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
129888983|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
129888984|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
129888985|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
129888986|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
129888987|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
129888988|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
129888989|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
129888990|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
129888991|NCT01473420|467550964|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
129628845|NCT04429503|466595309|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129628846|NCT04429503|466595310|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129628847|NCT04429503|466595311|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
129628848|NCT04429503|466595312|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129628849|NCT04429503|466595313|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
129628850|NCT04429503|466595308|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
129628851|NCT04429503|466595309|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
129628852|NCT04429503|466595310|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
129628853|NCT04429503|466595311|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
129628854|NCT04429503|466595312|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
129628855|NCT04429503|466595313|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
129628856|NCT04429503|466595308|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129628857|NCT04429503|466595309|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129628858|NCT04429503|466595310|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129628859|NCT04429503|466595311|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
129628860|NCT04429503|466595312|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
129628861|NCT04429503|466595313|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
129628862|NCT04429503|466595308|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
129628863|NCT04429503|466595309|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
129628864|NCT04429503|466595310|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
129628865|NCT04429503|466595311|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
129628866|NCT04429503|466595312|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
129628867|NCT04429503|466595313|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
129628868|NCT04429503|466595308|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
129628869|NCT04429503|466595309|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
129628870|NCT04429503|466595310|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
129628871|NCT04429503|466595311|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
129628872|NCT04429503|466595312|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
129628873|NCT04429503|466595313|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
129628874|NCT04429503|466595308|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
129628875|NCT04429503|466595309|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
129628876|NCT04429503|466595310|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
129628877|NCT04429503|466595311|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
129628878|NCT04429503|466595312|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
129888992|NCT01473420|467550965|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
129888993|NCT04172987|467550966|FG000|Lead In Period|Adverse Event|1|||
129888994|NCT04172987|467550966|FG000|Lead In Period|Protocol Violation|1|||
129888995|NCT04172987|467550966|FG000|Period 1|Physician Decision|1|||
129888996|NCT04172987|467550966|FG000|Period 2|Adverse Event|5|||
129888997|NCT04172987|467550966|FG000|Period 2|Dosing Termination by Sponsor|4|||
129628879|NCT04429503|466595313|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
129628880|NCT05516108|466595314|FG000|Overall Study|Time Commitment|3|||
129628881|NCT05516108|466595315|FG001|Overall Study|Time Commitment|1|||
129628882|NCT05516108|466595314|FG000|Overall Study|Reason Unknown|2|||
129628883|NCT05516108|466595315|FG001|Overall Study|Reason Unknown|4|||
129628884|NCT02003209|466595316|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
129628885|NCT02003209|466595317|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
129628886|NCT00638508|466595318|FG000|Overall Study|Physician Decision|5|||
129628887|NCT00638508|466595319|FG001|Overall Study|Physician Decision|2|||
129628888|NCT00370552|466595320|FG000|Overall Study|Adverse Event|2|||
129628889|NCT00370552|466595321|FG001|Overall Study|Adverse Event|2|||
129628890|NCT00370552|466595322|FG002|Overall Study|Adverse Event|2|||
129628891|NCT00370552|466595320|FG000|Overall Study|Disease progression|23|||
129628892|NCT00370552|466595321|FG001|Overall Study|Disease progression|23|||
129628893|NCT00370552|466595322|FG002|Overall Study|Disease progression|15|||
129628894|NCT00370552|466595320|FG000|Overall Study|Maximum clinical benefit|3|||
129628895|NCT00370552|466595321|FG001|Overall Study|Maximum clinical benefit|5|||
129628896|NCT00370552|466595322|FG002|Overall Study|Maximum clinical benefit|5|||
129628897|NCT00370552|466595320|FG000|Overall Study|Poor or noncompliance|0|||
129628898|NCT00370552|466595321|FG001|Overall Study|Poor or noncompliance|0|||
129628899|NCT00370552|466595322|FG002|Overall Study|Poor or noncompliance|1|||
129628900|NCT00370552|466595320|FG000|Overall Study|Study drug toxicity|11|||
129628901|NCT00370552|466595321|FG001|Overall Study|Study drug toxicity|8|||
129628902|NCT00370552|466595322|FG002|Overall Study|Study drug toxicity|6|||
129628903|NCT00370552|466595320|FG000|Overall Study|Withdrawal by Subject|2|||
129628904|NCT00370552|466595321|FG001|Overall Study|Withdrawal by Subject|0|||
129628905|NCT00370552|466595322|FG002|Overall Study|Withdrawal by Subject|1|||
129628906|NCT00370552|466595320|FG000|Overall Study|Still on treatment|1|||
129628907|NCT00370552|466595321|FG001|Overall Study|Still on treatment|3|||
129628908|NCT00370552|466595322|FG002|Overall Study|Still on treatment|2|||
129628909|NCT00370552|466595320|FG000|Overall Study|Never treated|1|||
129628910|NCT00370552|466595321|FG001|Overall Study|Never treated|0|||
129628911|NCT00370552|466595322|FG002|Overall Study|Never treated|0|||
129628912|NCT00370552|466595320|FG000|Overall Study|Physician Decision|1|||
129703529|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703530|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129440349|NCT00775450|465911408|FG003|Overall Study|Serious Adverse Event|0|||
129440350|NCT00775450|465911409|FG004|Overall Study|Serious Adverse Event|0|||
129628913|NCT00370552|466595321|FG001|Overall Study|Physician Decision|1|||
129628914|NCT00370552|466595322|FG002|Overall Study|Physician Decision|0|||
129628915|NCT00370552|466595320|FG000|Overall Study|Investigator decision|2|||
129628916|NCT00370552|466595321|FG001|Overall Study|Investigator decision|1|||
129628917|NCT00370552|466595322|FG002|Overall Study|Investigator decision|0|||
129628918|NCT00370552|466595320|FG000|Overall Study|High risk of allergic reaction|0|||
129628919|NCT00370552|466595321|FG001|Overall Study|High risk of allergic reaction|1|||
129628920|NCT00370552|466595322|FG002|Overall Study|High risk of allergic reaction|0|||
129628921|NCT00370552|466595320|FG000|Overall Study|Planned radiation for palliation|0|||
129628922|NCT00370552|466595321|FG001|Overall Study|Planned radiation for palliation|1|||
129628923|NCT00370552|466595322|FG002|Overall Study|Planned radiation for palliation|0|||
129628924|NCT03500198|466595323|FG000|Overall Study|Lost to Follow-up|0|||
129628925|NCT03500198|466595324|FG001|Overall Study|Lost to Follow-up|1|||
129628926|NCT00942084|466595336|FG000|Overall Study|Death|2|||
129628927|NCT04341363|466595337|FG000|Overall Study|Adverse Event|1|||
129628928|NCT04341363|466595337|FG000|Overall Study|Withdrawal by Subject|1|||
129628929|NCT01836471|466595338|FG000|Overall Study|Pregnancy|1|||
129628930|NCT01836471|466595339|FG001|Overall Study|Pregnancy|0|||
129628931|NCT01836471|466595340|FG002|Overall Study|Pregnancy|0|||
129628932|NCT01836471|466595341|FG003|Overall Study|Pregnancy|0|||
129628933|NCT01836471|466595342|FG004|Overall Study|Pregnancy|0|||
129628934|NCT01836471|466595338|FG000|Overall Study|Withdrawal by Subject|3|||
129628935|NCT01836471|466595339|FG001|Overall Study|Withdrawal by Subject|4|||
129628936|NCT01836471|466595340|FG002|Overall Study|Withdrawal by Subject|1|||
129628937|NCT01836471|466595341|FG003|Overall Study|Withdrawal by Subject|0|||
129628938|NCT01836471|466595342|FG004|Overall Study|Withdrawal by Subject|2|||
129628939|NCT01836471|466595338|FG000|Overall Study|Physician Decision|0|||
129628940|NCT01836471|466595339|FG001|Overall Study|Physician Decision|1|||
129628941|NCT01836471|466595340|FG002|Overall Study|Physician Decision|0|||
129703531|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129440351|NCT00775450|465911405|FG000|Overall Study|Protocol Violation|0|||
129440352|NCT00775450|465911406|FG001|Overall Study|Protocol Violation|0|||
129628942|NCT01836471|466595341|FG003|Overall Study|Physician Decision|0|||
129628943|NCT01836471|466595342|FG004|Overall Study|Physician Decision|0|||
129628944|NCT01836471|466595338|FG000|Overall Study|Lost to Follow-up|0|||
129628945|NCT01836471|466595339|FG001|Overall Study|Lost to Follow-up|0|||
129628946|NCT01836471|466595340|FG002|Overall Study|Lost to Follow-up|0|||
129628947|NCT01836471|466595341|FG003|Overall Study|Lost to Follow-up|1|||
129628948|NCT01836471|466595342|FG004|Overall Study|Lost to Follow-up|1|||
129628949|NCT01836471|466595338|FG000|Overall Study|Adverse Event|6|||
129628950|NCT01836471|466595339|FG001|Overall Study|Adverse Event|3|||
129628951|NCT01836471|466595340|FG002|Overall Study|Adverse Event|1|||
129628952|NCT01836471|466595341|FG003|Overall Study|Adverse Event|1|||
129628953|NCT01836471|466595342|FG004|Overall Study|Adverse Event|2|||
129628954|NCT01836471|466595338|FG000|Overall Study|Non compliance with tx|1|||
129628955|NCT01836471|466595339|FG001|Overall Study|Non compliance with tx|1|||
129628956|NCT01836471|466595340|FG002|Overall Study|Non compliance with tx|0|||
129628957|NCT01836471|466595341|FG003|Overall Study|Non compliance with tx|0|||
129628958|NCT01836471|466595342|FG004|Overall Study|Non compliance with tx|0|||
129628959|NCT02285361|466595345|FG000|Overall Study|Protocol Violation|43|||
129628960|NCT02285361|466595345|FG000|Overall Study|Lost to Follow-up|5|||
129628961|NCT02285361|466595345|FG000|Overall Study|Not taken GIOTRIF|2|||
129628962|NCT02285361|466595345|FG000|Overall Study|Consented prior to the contract date|1|||
129628963|NCT03776357|466595349|FG000|Overall Study|Lost to Follow-up|3|||
129628964|NCT02755103|466595352|FG000|Overall Study|Lost to Follow-up|17|||
129628965|NCT02755103|466595353|FG001|Overall Study|Lost to Follow-up|15|||
129628966|NCT02755103|466595352|FG000|Overall Study|Death|0|||
129628967|NCT02755103|466595353|FG001|Overall Study|Death|1|||
129628968|NCT02755103|466595352|FG000|Overall Study|Physician Decision|0|||
129628969|NCT02755103|466595353|FG001|Overall Study|Physician Decision|1|||
129628970|NCT02755103|466595352|FG000|Overall Study|Pregnancy|0|||
129628971|NCT02755103|466595353|FG001|Overall Study|Pregnancy|1|||
129628972|NCT02755103|466595352|FG000|Overall Study|Withdrawal by Subject|3|||
129628973|NCT02755103|466595353|FG001|Overall Study|Withdrawal by Subject|0|||
129628974|NCT00658723|466595357|FG000|Overall Study|Lost to Follow-up|0|||
129628975|NCT00658723|466595358|FG001|Overall Study|Lost to Follow-up|2|||
129628976|NCT00658723|466595359|FG002|Overall Study|Lost to Follow-up|2|||
129628977|NCT00658723|466595357|FG000|Overall Study|Death|2|||
129628978|NCT00658723|466595358|FG001|Overall Study|Death|1|||
129628979|NCT00658723|466595359|FG002|Overall Study|Death|4|||
129628980|NCT00658723|466595357|FG000|Overall Study|Scheduling Issue|1|||
129628981|NCT00658723|466595358|FG001|Overall Study|Scheduling Issue|1|||
129628982|NCT00658723|466595359|FG002|Overall Study|Scheduling Issue|0|||
129628983|NCT00658723|466595357|FG000|Overall Study|Withdrawal by Subject|1|||
129628984|NCT00658723|466595358|FG001|Overall Study|Withdrawal by Subject|0|||
129628985|NCT00658723|466595359|FG002|Overall Study|Withdrawal by Subject|1|||
129794603|NCT00588952|467216356|FG001|Overall Study|Withdrawal by Subject|5|||
129794604|NCT01277042|467216357|FG000|Overall Study|Adverse Event|4|||
129794605|NCT01277042|467216358|FG001|Overall Study|Adverse Event|3|||
129794606|NCT01277042|467216357|FG000|Overall Study|Lost to Follow-up|2|||
129794607|NCT01277042|467216358|FG001|Overall Study|Lost to Follow-up|2|||
129794608|NCT01277042|467216357|FG000|Overall Study|Withdrawal by Subject|2|||
129794609|NCT01277042|467216358|FG001|Overall Study|Withdrawal by Subject|0|||
129794610|NCT01461057|467216359|FG000|Overall Study|Death|10|||
129794611|NCT01461057|467216360|FG001|Overall Study|Death|9|||
129794612|NCT01461057|467216359|FG000|Overall Study|Withdrawal by Subject|2|||
129794613|NCT01461057|467216360|FG001|Overall Study|Withdrawal by Subject|3|||
129794614|NCT01461057|467216359|FG000|Overall Study|Physician Decision|0|||
129794615|NCT01461057|467216360|FG001|Overall Study|Physician Decision|2|||
129794616|NCT01461057|467216359|FG000|Overall Study|Adverse Event|0|||
129794617|NCT01461057|467216360|FG001|Overall Study|Adverse Event|1|||
129794618|NCT01461057|467216359|FG000|Overall Study|Progression of Disease|1|||
129794619|NCT01461057|467216360|FG001|Overall Study|Progression of Disease|0|||
129794620|NCT01461057|467216359|FG000|Overall Study|Study Terminated by Sponsor|2|||
129794621|NCT01461057|467216360|FG001|Overall Study|Study Terminated by Sponsor|0|||
129794622|NCT01288976|467216361|FG000|Overall Study|Withdrawal by Subject|58|||
129794623|NCT01288976|467216362|FG001|Overall Study|Withdrawal by Subject|12|||
129794624|NCT01288976|467216363|FG002|Overall Study|Withdrawal by Subject|9|||
129794625|NCT01288976|467216361|FG000|Overall Study|Death|98|||
129794626|NCT01288976|467216362|FG001|Overall Study|Death|6|||
129794627|NCT01288976|467216363|FG002|Overall Study|Death|4|||
129794628|NCT01288976|467216361|FG000|Overall Study|Data unavailable|22|||
129628986|NCT02411656|466595360|FG000|Overall Study|Adverse Event|4|||
129794629|NCT01288976|467216362|FG001|Overall Study|Data unavailable|9|||
129794630|NCT01288976|467216363|FG002|Overall Study|Data unavailable|7|||
129794631|NCT00959374|467216366|FG000|Overall Study|Withdrawal by Subject|2|||
129794632|NCT00959374|467216366|FG000|Overall Study|Lost to Follow-up|14|||
129794633|NCT00959374|467216366|FG000|Overall Study|Death|1|||
129628987|NCT02411656|466595360|FG000|Overall Study|Clinical Progression|33|||
129628988|NCT06481709|466595361|FG000|Overall Study|Withdrawal by Subject|0|||
129628989|NCT06481709|466595362|FG001|Overall Study|Withdrawal by Subject|0|||
129628990|NCT06481709|466595363|FG002|Overall Study|Withdrawal by Subject|2|||
129628991|NCT06481709|466595364|FG003|Overall Study|Withdrawal by Subject|0|||
129628992|NCT03305848|466595365|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
129628993|NCT03305848|466595365|FG000|Overall Study|Physician Decision|2|||
129628994|NCT05366010|466595369|FG000|Overall Study|Withdrawal by Subject|1|||
129794634|NCT00959374|467216366|FG000|Overall Study|Protocol Violation|1|||
129794635|NCT00959374|467216366|FG000|Overall Study|Implant Removed/Not Replaced|4|||
129794636|NCT00959374|467216366|FG000|Overall Study|Physician Decision|1|||
129628995|NCT05366010|466595369|FG000|Overall Study|Protocol Violation|1|||
129628996|NCT05366010|466595369|FG000|Overall Study|Lost to Follow-up|2|||
129628997|NCT05366010|466595369|FG000|Overall Study|Screen Failure|2|||
129628998|NCT05271175|466595370|FG000|One Week Follow up|Lost to Follow-up|10|||
129628999|NCT05271175|466595371|FG001|One Week Follow up|Lost to Follow-up|7|||
129629000|NCT05271175|466595372|FG002|One Week Follow up|Lost to Follow-up|5|||
129629001|NCT05271175|466595370|FG000|One Month Follow up|Lost to Follow-up|12|||
129629002|NCT05271175|466595371|FG001|One Month Follow up|Lost to Follow-up|7|||
129629003|NCT05271175|466595372|FG002|One Month Follow up|Lost to Follow-up|9|||
129629004|NCT05271175|466595370|FG000|Six Months Follow up|Lost to Follow-up|8|||
129629005|NCT05271175|466595371|FG001|Six Months Follow up|Lost to Follow-up|2|||
129629006|NCT05271175|466595372|FG002|Six Months Follow up|Lost to Follow-up|2|||
129629007|NCT00991887|466595373|FG000|Overall Study|Lost to Follow-up|2|||
129629008|NCT00991887|466595374|FG001|Overall Study|Lost to Follow-up|1|||
129629009|NCT01964976|466595375|FG000|Overall Study|Protocol Violation|31|||
129629010|NCT01891864|466595378|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
129629011|NCT01891864|466595379|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
129629012|NCT01891864|466595380|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129629013|NCT01891864|466595381|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129629014|NCT01891864|466595382|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129629015|NCT01891864|466595383|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
129629016|NCT01891864|466595378|FG000|Treatment Period 1|Physician Decision|0|||
129629017|NCT01891864|466595379|FG001|Treatment Period 1|Physician Decision|1|||
129629018|NCT01891864|466595380|FG002|Treatment Period 1|Physician Decision|0|||
129629019|NCT01891864|466595381|FG003|Treatment Period 1|Physician Decision|0|||
129629020|NCT01891864|466595382|FG004|Treatment Period 1|Physician Decision|0|||
129629021|NCT01891864|466595383|FG005|Treatment Period 1|Physician Decision|0|||
129629022|NCT01891864|466595378|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129703532|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703533|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129629023|NCT01891864|466595379|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
129703534|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703535|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703536|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703537|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703538|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
129703539|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
129703540|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703541|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
129703542|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129703543|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129703544|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129703545|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
129703546|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703547|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703548|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703549|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703550|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703551|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703552|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703553|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703554|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129703555|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703556|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703557|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703558|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
129703559|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703560|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129629024|NCT01891864|466595380|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129629025|NCT01891864|466595381|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129440353|NCT00775450|465911407|FG002|Overall Study|Protocol Violation|0|||
129794637|NCT02284178|467216367|FG000|Overall Study|Met exclusion criteria|49|||
129794638|NCT02284178|467216368|FG001|Overall Study|Met exclusion criteria|54|||
129794639|NCT01483690|467216372|FG000|Overall Study|Adverse Event|1|||
129794640|NCT01483690|467216373|FG001|Overall Study|Adverse Event|2|||
129794641|NCT01483690|467216372|FG000|Overall Study|clinical deterioration|1|||
129794642|NCT01483690|467216373|FG001|Overall Study|clinical deterioration|0|||
129794643|NCT01483690|467216372|FG000|Overall Study|Physician Decision|0|||
129794644|NCT01483690|467216373|FG001|Overall Study|Physician Decision|2|||
129794645|NCT01483690|467216372|FG000|Overall Study|exclusionary procedure|0|||
129629026|NCT01891864|466595382|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129629027|NCT01891864|466595383|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
129629028|NCT01891864|466595378|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
129629029|NCT01891864|466595379|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
129629030|NCT01891864|466595380|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129629031|NCT01891864|466595381|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129629032|NCT01891864|466595382|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129629033|NCT01891864|466595383|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
129629034|NCT01891864|466595378|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129629035|NCT01891864|466595379|FG001|Treatment Period 1|Withdrawal by Subject|5|||
129629036|NCT01891864|466595380|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129629037|NCT01891864|466595381|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129629038|NCT01891864|466595382|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129629039|NCT01891864|466595383|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129629040|NCT01891864|466595378|FG000|Treatment Period 1|Lost to Follow-up|1|||
129629041|NCT01891864|466595379|FG001|Treatment Period 1|Lost to Follow-up|0|||
129629042|NCT01891864|466595380|FG002|Treatment Period 1|Lost to Follow-up|0|||
129629043|NCT01891864|466595381|FG003|Treatment Period 1|Lost to Follow-up|0|||
129629044|NCT01891864|466595382|FG004|Treatment Period 1|Lost to Follow-up|0|||
129629045|NCT01891864|466595383|FG005|Treatment Period 1|Lost to Follow-up|0|||
129629046|NCT01891864|466595378|FG000|Treatment Period 2|Protocol Violation|0|||
129629047|NCT01891864|466595379|FG001|Treatment Period 2|Protocol Violation|0|||
129629048|NCT01891864|466595380|FG002|Treatment Period 2|Protocol Violation|0|||
129629049|NCT01891864|466595381|FG003|Treatment Period 2|Protocol Violation|1|||
129629050|NCT01891864|466595382|FG004|Treatment Period 2|Protocol Violation|0|||
129629051|NCT01891864|466595383|FG005|Treatment Period 2|Protocol Violation|0|||
129629052|NCT01891864|466595378|FG000|Treatment Period 2|Physician Decision|0|||
129629053|NCT01891864|466595379|FG001|Treatment Period 2|Physician Decision|0|||
129629054|NCT01891864|466595380|FG002|Treatment Period 2|Physician Decision|1|||
129629055|NCT01891864|466595381|FG003|Treatment Period 2|Physician Decision|0|||
129629056|NCT01891864|466595382|FG004|Treatment Period 2|Physician Decision|0|||
129629057|NCT01891864|466595383|FG005|Treatment Period 2|Physician Decision|0|||
129629058|NCT01891864|466595378|FG000|Treatment Period 2|Site Termination|0|||
129629059|NCT01891864|466595379|FG001|Treatment Period 2|Site Termination|0|||
129629060|NCT01891864|466595380|FG002|Treatment Period 2|Site Termination|1|||
129629061|NCT01891864|466595381|FG003|Treatment Period 2|Site Termination|2|||
129629062|NCT01891864|466595382|FG004|Treatment Period 2|Site Termination|0|||
129629063|NCT01891864|466595383|FG005|Treatment Period 2|Site Termination|0|||
129629064|NCT01891864|466595378|FG000|Treatment Period 2|Lack of Efficacy|0|||
129629065|NCT01891864|466595379|FG001|Treatment Period 2|Lack of Efficacy|0|||
129629066|NCT01891864|466595380|FG002|Treatment Period 2|Lack of Efficacy|1|||
129629067|NCT01891864|466595381|FG003|Treatment Period 2|Lack of Efficacy|0|||
129629068|NCT01891864|466595382|FG004|Treatment Period 2|Lack of Efficacy|1|||
129629069|NCT01891864|466595383|FG005|Treatment Period 2|Lack of Efficacy|0|||
129629070|NCT01891864|466595378|FG000|Treatment Period 2|Adverse Event|0|||
129629071|NCT01891864|466595379|FG001|Treatment Period 2|Adverse Event|0|||
129629072|NCT01891864|466595380|FG002|Treatment Period 2|Adverse Event|1|||
129629073|NCT01891864|466595381|FG003|Treatment Period 2|Adverse Event|2|||
129629074|NCT01891864|466595382|FG004|Treatment Period 2|Adverse Event|0|||
129629075|NCT01891864|466595383|FG005|Treatment Period 2|Adverse Event|4|||
129629076|NCT01891864|466595378|FG000|Treatment Period 2|Termination of Site|0|||
129629077|NCT01891864|466595379|FG001|Treatment Period 2|Termination of Site|0|||
129629078|NCT01891864|466595380|FG002|Treatment Period 2|Termination of Site|0|||
129888998|NCT00738530|467550976|FG000|Overall Study|Death|220|||
129629079|NCT01891864|466595381|FG003|Treatment Period 2|Termination of Site|0|||
129629080|NCT01891864|466595382|FG004|Treatment Period 2|Termination of Site|2|||
129629081|NCT01891864|466595383|FG005|Treatment Period 2|Termination of Site|0|||
129629082|NCT01891864|466595378|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129794646|NCT01483690|467216373|FG001|Overall Study|exclusionary procedure|1|||
129888999|NCT00738530|467550977|FG001|Overall Study|Death|224|||
129629083|NCT01891864|466595379|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129629084|NCT01891864|466595380|FG002|Treatment Period 2|Withdrawal by Subject|3|||
129794647|NCT00478881|467216379|FG000|Overall Study|Adverse Event|31|||
129794648|NCT00478881|467216380|FG001|Overall Study|Adverse Event|12|||
129794649|NCT00478881|467216379|FG000|Overall Study|Lack of Efficacy|0|||
129794650|NCT00478881|467216380|FG001|Overall Study|Lack of Efficacy|3|||
129794651|NCT00478881|467216379|FG000|Overall Study|Lost to Follow-up|0|||
129629085|NCT01891864|466595381|FG003|Treatment Period 2|Withdrawal by Subject|4|||
129629086|NCT01891864|466595382|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129629087|NCT01891864|466595383|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129629088|NCT01891864|466595378|FG000|Extension Period|Lack of Efficacy|0|||
129629089|NCT01891864|466595379|FG001|Extension Period|Lack of Efficacy|0|||
129629090|NCT01891864|466595380|FG002|Extension Period|Lack of Efficacy|0|||
129629091|NCT01891864|466595381|FG003|Extension Period|Lack of Efficacy|1|||
129629092|NCT01891864|466595382|FG004|Extension Period|Lack of Efficacy|1|||
129629093|NCT01891864|466595383|FG005|Extension Period|Lack of Efficacy|0|||
129629094|NCT01891864|466595378|FG000|Extension Period|Pregnancy|0|||
129629095|NCT01891864|466595379|FG001|Extension Period|Pregnancy|0|||
129629096|NCT01891864|466595380|FG002|Extension Period|Pregnancy|1|||
129629097|NCT01891864|466595381|FG003|Extension Period|Pregnancy|0|||
129629098|NCT01891864|466595382|FG004|Extension Period|Pregnancy|0|||
129629099|NCT01891864|466595383|FG005|Extension Period|Pregnancy|0|||
129629100|NCT01891864|466595378|FG000|Extension Period|Adverse Event|0|||
129629101|NCT01891864|466595379|FG001|Extension Period|Adverse Event|0|||
129629102|NCT01891864|466595380|FG002|Extension Period|Adverse Event|4|||
129629103|NCT01891864|466595381|FG003|Extension Period|Adverse Event|2|||
129629104|NCT01891864|466595382|FG004|Extension Period|Adverse Event|2|||
129629105|NCT01891864|466595383|FG005|Extension Period|Adverse Event|0|||
129629106|NCT01891864|466595378|FG000|Extension Period|Withdrawal by Subject|0|||
129629107|NCT01891864|466595379|FG001|Extension Period|Withdrawal by Subject|0|||
129629108|NCT01891864|466595380|FG002|Extension Period|Withdrawal by Subject|1|||
129629109|NCT01891864|466595381|FG003|Extension Period|Withdrawal by Subject|2|||
129629110|NCT01891864|466595382|FG004|Extension Period|Withdrawal by Subject|4|||
129629111|NCT01891864|466595383|FG005|Extension Period|Withdrawal by Subject|0|||
129629112|NCT01891864|466595378|FG000|Extension Period|Lost to Follow-up|0|||
129629113|NCT01891864|466595379|FG001|Extension Period|Lost to Follow-up|0|||
129629114|NCT01891864|466595380|FG002|Extension Period|Lost to Follow-up|2|||
129629115|NCT01891864|466595381|FG003|Extension Period|Lost to Follow-up|0|||
129629116|NCT01891864|466595382|FG004|Extension Period|Lost to Follow-up|0|||
129629117|NCT01891864|466595383|FG005|Extension Period|Lost to Follow-up|0|||
129629118|NCT02698163|466595384|FG000|Overall Study|Lost to Follow-up|0|||
129629119|NCT02698163|466595385|FG001|Overall Study|Lost to Follow-up|1|||
129629120|NCT02892331|466595386|FG000|Overall Study|Withdrawal by Subject|0|||
129629121|NCT02892331|466595387|FG001|Overall Study|Withdrawal by Subject|1|||
129629122|NCT02892331|466595388|FG002|Overall Study|Withdrawal by Subject|1|||
129629123|NCT02892331|466595386|FG000|Overall Study|Sick family member|0|||
129629124|NCT02892331|466595387|FG001|Overall Study|Sick family member|0|||
129794652|NCT00478881|467216380|FG001|Overall Study|Lost to Follow-up|1|||
129794653|NCT00478881|467216379|FG000|Overall Study|Protocol Violation|2|||
129794654|NCT00478881|467216380|FG001|Overall Study|Protocol Violation|2|||
129794655|NCT00478881|467216379|FG000|Overall Study|Withdrawal by Subject|6|||
129794656|NCT00478881|467216380|FG001|Overall Study|Withdrawal by Subject|2|||
129794657|NCT00478881|467216379|FG000|Overall Study|Non-Compliance with Study Medication|0|||
129794658|NCT00478881|467216380|FG001|Overall Study|Non-Compliance with Study Medication|2|||
129794659|NCT00737464|467216381|FG000|Overall Study|Adverse Event|1|||
129794660|NCT00737464|467216381|FG000|Overall Study|Death|6|||
129794661|NCT00737464|467216381|FG000|Overall Study|Other - Failure to Return|1|||
129794662|NCT00737464|467216381|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
129794663|NCT00737464|467216381|FG000|Overall Study|Other reasons|4|||
129794664|NCT01041495|467216387|FG000|Overall Study|Withdrawal by Subject|2|||
129794665|NCT01041495|467216388|FG001|Overall Study|Withdrawal by Subject|5|||
129794666|NCT01041495|467216387|FG000|Overall Study|Adverse Event|2|||
129629125|NCT02892331|466595388|FG002|Overall Study|Sick family member|1|||
129629126|NCT02892331|466595386|FG000|Overall Study|Corona virus pandemic|1|||
129794667|NCT01041495|467216388|FG001|Overall Study|Adverse Event|1|||
129794668|NCT01041495|467216387|FG000|Overall Study|Lost to Follow-up|0|||
129794669|NCT01041495|467216388|FG001|Overall Study|Lost to Follow-up|1|||
129629127|NCT02892331|466595387|FG001|Overall Study|Corona virus pandemic|0|||
129629128|NCT02892331|466595388|FG002|Overall Study|Corona virus pandemic|1|||
129629129|NCT02892331|466595386|FG000|Overall Study|Lost to Follow-up|1|||
129629130|NCT02892331|466595387|FG001|Overall Study|Lost to Follow-up|0|||
129629131|NCT02892331|466595388|FG002|Overall Study|Lost to Follow-up|1|||
129629132|NCT02892331|466595386|FG000|Overall Study|Blood pressure was too elevated|0|||
129794670|NCT03584373|467216389|FG000|Overall Study|Lost to Follow-up|7|||
129629133|NCT02892331|466595387|FG001|Overall Study|Blood pressure was too elevated|1|||
129629134|NCT02892331|466595388|FG002|Overall Study|Blood pressure was too elevated|0|||
129629135|NCT02892331|466595386|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
129794671|NCT03584373|467216390|FG001|Overall Study|Lost to Follow-up|8|||
129794672|NCT01487577|467216391|FG000|Overall Study|Became ineligible after signing consent|1|||
129794673|NCT03780400|467216393|FG000|Overall Study|Lost to Follow-up|5|||
129794674|NCT03780400|467216393|FG000|Overall Study|Withdrawal by Subject|2|||
129629136|NCT02892331|466595387|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
129629137|NCT02892331|466595388|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
129629138|NCT00752128|466595389|FG000|Overall Study|Withdrawal by Subject|4|||
129629139|NCT00349973|466595393|FG000|Overall Study|Adverse Event|3|||
129629140|NCT00349973|466595394|FG001|Overall Study|Adverse Event|3|||
129629141|NCT00349973|466595393|FG000|Overall Study|Withdrawal by Subject|1|||
129629142|NCT00349973|466595394|FG001|Overall Study|Withdrawal by Subject|0|||
129629143|NCT02286713|466595395|FG000|One Week Follow-Up|Death|1|||
129629144|NCT02286713|466595396|FG001|One Week Follow-Up|Death|0|||
129629145|NCT02286713|466595395|FG000|One Week Follow-Up|Lost to Follow-up|17|||
129629146|NCT02286713|466595396|FG001|One Week Follow-Up|Lost to Follow-up|21|||
129629147|NCT02286713|466595395|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
129889000|NCT00738530|467550976|FG000|Overall Study|Lost to Follow-up|8|||
129889001|NCT00738530|467550977|FG001|Overall Study|Lost to Follow-up|6|||
129889002|NCT00738530|467550976|FG000|Overall Study|Withdrawal by Subject|6|||
129889003|NCT00738530|467550977|FG001|Overall Study|Withdrawal by Subject|8|||
129889004|NCT01628510|467550978|FG000|Overall Study|Withdrawal by Subject|0|||
129889005|NCT01628510|467550979|FG001|Overall Study|Withdrawal by Subject|4|||
129889006|NCT01628510|467550978|FG000|Overall Study|Death|3|||
129889007|NCT01628510|467550979|FG001|Overall Study|Death|1|||
129889008|NCT04179461|467550980|FG000|Overall Study|Lost to Follow-up|4|||
129889009|NCT01653847|467550981|FG000|Overall Study|Withdrawal by Subject|1|||
129889010|NCT01653847|467550982|FG001|Overall Study|Withdrawal by Subject|0|||
129629148|NCT02286713|466595396|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
129629149|NCT02286713|466595395|FG000|Three Month Follow-Up|Death|1|||
129629150|NCT02286713|466595396|FG001|Three Month Follow-Up|Death|1|||
129629151|NCT02286713|466595395|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
129629152|NCT02286713|466595396|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
129629153|NCT02286713|466595395|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
129629154|NCT02286713|466595396|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
129629155|NCT02286713|466595395|FG000|Six Month Follow-Up|Death|2|||
129629156|NCT02286713|466595396|FG001|Six Month Follow-Up|Death|0|||
129629157|NCT02286713|466595395|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
129629158|NCT02286713|466595396|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
129629159|NCT04314037|466595397|FG000|Treatment Period 2|Adverse Event|1|||
129629160|NCT04314037|466595398|FG001|Treatment Period 2|Adverse Event|0|||
129629161|NCT04314037|466595397|FG000|Treatment Period 3|Protocol Violation|1|||
129629162|NCT04314037|466595398|FG001|Treatment Period 3|Protocol Violation|0|||
129629163|NCT04314037|466595397|FG000|Treatment Period 3|Adverse Event|0|||
129889011|NCT04707391|467550983|FG000|Overall Study|Adverse Event|5|||
129889012|NCT04707391|467550984|FG001|Overall Study|Adverse Event|8|||
129889013|NCT04707391|467550983|FG000|Overall Study|Lost to Follow-up|44|||
129889014|NCT04707391|467550984|FG001|Overall Study|Lost to Follow-up|31|||
129889015|NCT04707391|467550983|FG000|Overall Study|Protocol Violation|1|||
129889016|NCT04707391|467550984|FG001|Overall Study|Protocol Violation|5|||
129889017|NCT04707391|467550983|FG000|Overall Study|Withdrawal by Subject|27|||
129889018|NCT04707391|467550984|FG001|Overall Study|Withdrawal by Subject|25|||
129889019|NCT04707391|467550983|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
129889020|NCT04707391|467550984|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
129889021|NCT04707391|467550983|FG000|Overall Study|Other|0|||
129889022|NCT04707391|467550984|FG001|Overall Study|Other|2|||
129629164|NCT04314037|466595398|FG001|Treatment Period 3|Adverse Event|1|||
129629165|NCT03832686|466595401|FG000|Overall Study|Lost to Follow-up|6|||
129629166|NCT03832686|466595402|FG001|Overall Study|Lost to Follow-up|9|||
129629167|NCT03832686|466595401|FG000|Overall Study|Discontinued Intervention|5|||
129629168|NCT03832686|466595402|FG001|Overall Study|Discontinued Intervention|4|||
129629169|NCT05479435|466595403|FG000|Overall Study|Withdrawal by Subject|1|||
129889023|NCT03246672|467550985|FG000|Overall Study|Lost to Follow-up|2|||
129889024|NCT01347645|467550986|FG000|Overall Study|Death|1|||
129889025|NCT01347645|467550987|FG001|Overall Study|Death|5|||
129889026|NCT01347645|467550988|FG002|Overall Study|Death|2|||
129889027|NCT01347645|467550989|FG003|Overall Study|Death|7|||
129889028|NCT01347645|467550990|FG004|Overall Study|Death|7|||
129889029|NCT01347645|467550986|FG000|Overall Study|Lost to Follow-up|1|||
129629170|NCT05479435|466595404|FG001|Overall Study|Withdrawal by Subject|0|||
129629171|NCT05479435|466595405|FG002|Overall Study|Withdrawal by Subject|0|||
129629172|NCT05479435|466595403|FG000|Overall Study|Covid 19|0|||
129629173|NCT05479435|466595404|FG001|Overall Study|Covid 19|0|||
129629174|NCT05479435|466595405|FG002|Overall Study|Covid 19|2|||
129629175|NCT02546986|466597681|FG000|Treatment Period|Progressive Disease|20|||
129629176|NCT02546986|466597682|FG001|Treatment Period|Progressive Disease|22|||
129629177|NCT02546986|466597681|FG000|Treatment Period|Adverse Event|14|||
129629178|NCT02546986|466597682|FG001|Treatment Period|Adverse Event|6|||
129629179|NCT02546986|466597681|FG000|Treatment Period|Symptomatic Deterioration|4|||
129629180|NCT02546986|466597682|FG001|Treatment Period|Symptomatic Deterioration|3|||
129629181|NCT02546986|466597681|FG000|Treatment Period|Death|3|||
129629182|NCT02546986|466597682|FG001|Treatment Period|Death|4|||
129629183|NCT02546986|466597681|FG000|Treatment Period|Physician Decision|1|||
129629184|NCT02546986|466597682|FG001|Treatment Period|Physician Decision|2|||
129629185|NCT02546986|466597681|FG000|Treatment Period|Protocol Violation|1|||
129629186|NCT02546986|466597682|FG001|Treatment Period|Protocol Violation|0|||
129629187|NCT02546986|466597681|FG000|Treatment Period|Withdrawal by Subject|1|||
129629188|NCT02546986|466597682|FG001|Treatment Period|Withdrawal by Subject|1|||
129629189|NCT02546986|466597681|FG000|Treatment Period|Non-compliance with Study Drug|0|||
129629190|NCT02546986|466597682|FG001|Treatment Period|Non-compliance with Study Drug|1|||
129629191|NCT02546986|466597681|FG000|Treatment Period|Study Terminated by Sponsor|0|||
129629192|NCT02546986|466597682|FG001|Treatment Period|Study Terminated by Sponsor|1|||
129629193|NCT02546986|466597681|FG000|Treatment Period|Miscellaneous|7|||
129629194|NCT02546986|466597682|FG001|Treatment Period|Miscellaneous|9|||
129629195|NCT02546986|466597681|FG000|Survival Follow-Up Phase|Missing Status|3|||
129629196|NCT02546986|466597682|FG001|Survival Follow-Up Phase|Missing Status|5|||
129629197|NCT02546986|466597681|FG000|Survival Follow-Up Phase|Death|18|||
129629198|NCT02546986|466597682|FG001|Survival Follow-Up Phase|Death|12|||
129629199|NCT02546986|466597681|FG000|Survival Follow-Up Phase|Alive|13|||
129629200|NCT02546986|466597682|FG001|Survival Follow-Up Phase|Alive|16|||
129629201|NCT02546986|466597681|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
129629202|NCT02546986|466597682|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
129629203|NCT05016960|466597683|FG000|Overall Study|Withdrawal by Subject|1|||
129629204|NCT05016960|466597684|FG001|Overall Study|Withdrawal by Subject|9|||
129629205|NCT04796961|466597685|FG000|Overall Study|Lost to Follow-up|10|||
129629206|NCT04796961|466597685|FG000|Overall Study|Withdrawal by Subject|3|||
129629207|NCT04796961|466597685|FG000|Overall Study|Left Organization|10|||
129629208|NCT02325973|466597686|FG000|Overall Study|Death|5|||
129629209|NCT02325973|466597686|FG000|Overall Study|Withdrawal by subject or investigator|16|||
129629210|NCT02068508|466597687|FG000|Overall Study|Case report forms uncollected|27|||
129629211|NCT02068508|466597687|FG000|Overall Study|Patient did not visit the study site|1|||
129629212|NCT02068508|466597687|FG000|Overall Study|Protocol Violation|4|||
129794675|NCT03823378|467216394|FG000|Overall Study|Adverse Event|2|||
129794676|NCT03823378|467216395|FG001|Overall Study|Adverse Event|2|||
129794677|NCT03823378|467216396|FG002|Overall Study|Adverse Event|0|||
129794678|NCT03823378|467216397|FG003|Overall Study|Adverse Event|0|||
129794679|NCT03823378|467216398|FG004|Overall Study|Adverse Event|0|||
129794680|NCT03823378|467216399|FG005|Overall Study|Adverse Event|0|||
129794681|NCT03823378|467216394|FG000|Overall Study|Lost to Follow-up|0|||
129794682|NCT03823378|467216395|FG001|Overall Study|Lost to Follow-up|1|||
129794683|NCT03823378|467216396|FG002|Overall Study|Lost to Follow-up|0|||
129794684|NCT03823378|467216397|FG003|Overall Study|Lost to Follow-up|0|||
129794685|NCT03823378|467216398|FG004|Overall Study|Lost to Follow-up|1|||
129794686|NCT03823378|467216399|FG005|Overall Study|Lost to Follow-up|0|||
129794687|NCT03823378|467216394|FG000|Overall Study|Withdrawal by Subject|0|||
129794688|NCT03823378|467216395|FG001|Overall Study|Withdrawal by Subject|1|||
129794689|NCT03823378|467216396|FG002|Overall Study|Withdrawal by Subject|4|||
129629213|NCT03511105|466597691|FG000|Overall Study|Adverse Event|1|||
129629214|NCT03511105|466597692|FG001|Overall Study|Adverse Event|0|||
129629215|NCT03511105|466597691|FG000|Overall Study|Withdrew consent|1|||
129629216|NCT03511105|466597692|FG001|Overall Study|Withdrew consent|0|||
129794690|NCT03823378|467216397|FG003|Overall Study|Withdrawal by Subject|2|||
129629217|NCT02810457|466597693|FG000|Overall Study|Randomised but no treatment received|2|||
129629218|NCT02810457|466597694|FG001|Overall Study|Randomised but no treatment received|1|||
129794691|NCT03823378|467216398|FG004|Overall Study|Withdrawal by Subject|0|||
129889030|NCT01347645|467550987|FG001|Overall Study|Lost to Follow-up|1|||
129629219|NCT02810457|466597693|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
129629220|NCT02810457|466597694|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
129794692|NCT03823378|467216399|FG005|Overall Study|Withdrawal by Subject|1|||
129794693|NCT03823378|467216394|FG000|Overall Study|Other, not specified|19|||
129794694|NCT03823378|467216395|FG001|Overall Study|Other, not specified|12|||
129629221|NCT02810457|466597693|FG000|Overall Study|Adverse Event|37|||
129629222|NCT02810457|466597694|FG001|Overall Study|Adverse Event|43|||
129703561|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
129703562|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703563|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703564|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703565|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703566|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703567|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703568|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703569|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703570|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
129703571|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703572|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703573|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
129703574|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703575|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703576|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703577|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703578|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703579|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703580|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703581|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703582|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703583|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703584|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703585|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703586|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
129703587|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129703588|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129703589|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129703590|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703591|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703592|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703593|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703594|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703595|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703596|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703597|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703598|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703599|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703600|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703601|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703602|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129703603|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
129703604|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
129703605|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
129703606|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
129703607|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
129703608|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
129703609|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
129703610|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
129703611|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
129703612|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
129703613|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
129703614|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
129703615|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
129889031|NCT01347645|467550988|FG002|Overall Study|Lost to Follow-up|0|||
129889032|NCT01347645|467550989|FG003|Overall Study|Lost to Follow-up|1|||
129889033|NCT01347645|467550990|FG004|Overall Study|Lost to Follow-up|1|||
129889034|NCT01347645|467550986|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
129889035|NCT01347645|467550987|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
129703616|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
129703617|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
129889036|NCT01347645|467550988|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
129794695|NCT03823378|467216396|FG002|Overall Study|Other, not specified|6|||
129794696|NCT03823378|467216397|FG003|Overall Study|Other, not specified|8|||
129794697|NCT03823378|467216398|FG004|Overall Study|Other, not specified|17|||
129794698|NCT03823378|467216399|FG005|Overall Study|Other, not specified|7|||
129794699|NCT01282203|467216400|FG000|Overall Study|Adverse Event|1|||
129794700|NCT00058539|467216403|FG000|Overall Study|Disease progression|24|||
129794701|NCT00058539|467216403|FG000|Overall Study|Adverse Event|3|||
129794702|NCT00058539|467216403|FG000|Overall Study|Withdrawal by Subject|5|||
129629223|NCT02810457|466597693|FG000|Overall Study|Patient decision|31|||
129629224|NCT02810457|466597694|FG001|Overall Study|Patient decision|35|||
129629225|NCT02810457|466597693|FG000|Overall Study|Patient lost to follow-up|2|||
129629226|NCT02810457|466597694|FG001|Overall Study|Patient lost to follow-up|2|||
129629227|NCT02810457|466597693|FG000|Overall Study|Death|39|||
129629228|NCT02810457|466597694|FG001|Overall Study|Death|28|||
129629229|NCT02810457|466597693|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
129629230|NCT02810457|466597694|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
129629231|NCT02810457|466597693|FG000|Overall Study|Clinical progression|15|||
129629232|NCT02810457|466597694|FG001|Overall Study|Clinical progression|16|||
129629233|NCT02810457|466597693|FG000|Overall Study|Investigator decision|3|||
129629234|NCT02810457|466597694|FG001|Overall Study|Investigator decision|2|||
129629235|NCT02810457|466597693|FG000|Overall Study|Patient ineligibility|3|||
129629236|NCT02810457|466597694|FG001|Overall Study|Patient ineligibility|0|||
129629237|NCT02810457|466597693|FG000|Overall Study|Miscalculated PD|1|||
129629238|NCT02810457|466597694|FG001|Overall Study|Miscalculated PD|0|||
129629239|NCT02810457|466597693|FG000|Overall Study|Physician Decision|0|||
129629240|NCT02810457|466597694|FG001|Overall Study|Physician Decision|1|||
129629241|NCT04173507|466597695|FG000|Overall Study|On Treatment|3|||
129629242|NCT04173507|466597695|FG000|Overall Study|Adverse Event|3|||
129629243|NCT04173507|466597695|FG000|Overall Study|Progression/Relapse|34|||
129629244|NCT04173507|466597695|FG000|Overall Study|Death|2|||
129629245|NCT01217112|466597698|FG000|Overall Study|Adverse Event|0|||
129629246|NCT01217112|466597699|FG001|Overall Study|Adverse Event|2|||
129794703|NCT00058539|467216403|FG000|Overall Study|Physician Decision|9|||
129794704|NCT00058539|467216403|FG000|Overall Study|Death|1|||
129794705|NCT02963831|467216404|FG000|Overall Study|Progressive Disease|3|||
129794706|NCT02963831|467216405|FG001|Overall Study|Progressive Disease|3|||
129794707|NCT02963831|467216406|FG002|Overall Study|Progressive Disease|16|||
129794708|NCT02963831|467216407|FG003|Overall Study|Progressive Disease|27|||
129794709|NCT02963831|467216404|FG000|Overall Study|Withdrawal by Subject|1|||
129794710|NCT02963831|467216405|FG001|Overall Study|Withdrawal by Subject|0|||
129794711|NCT02963831|467216406|FG002|Overall Study|Withdrawal by Subject|2|||
129794712|NCT02963831|467216407|FG003|Overall Study|Withdrawal by Subject|4|||
129794713|NCT02963831|467216404|FG000|Overall Study|Adverse Event|0|||
129794714|NCT02963831|467216405|FG001|Overall Study|Adverse Event|1|||
129794715|NCT02963831|467216406|FG002|Overall Study|Adverse Event|1|||
129794716|NCT02963831|467216407|FG003|Overall Study|Adverse Event|2|||
129794717|NCT02963831|467216404|FG000|Overall Study|Death|0|||
129794718|NCT02963831|467216405|FG001|Overall Study|Death|0|||
129794719|NCT02963831|467216406|FG002|Overall Study|Death|0|||
129794720|NCT02963831|467216407|FG003|Overall Study|Death|2|||
129794721|NCT03977454|467216408|FG000|Overall Study|immediate postoperative revision|2|||
129794722|NCT03977454|467216409|FG001|Overall Study|immediate postoperative revision|2|||
129794723|NCT04365257|467216410|FG000|Overall Study|Physician Decision|1|||
129794724|NCT04365257|467216411|FG001|Overall Study|Physician Decision|0|||
129440354|NCT00775450|465911408|FG003|Overall Study|Protocol Violation|0|||
129629247|NCT01217112|466597700|FG002|Overall Study|Adverse Event|0|||
129629248|NCT01217112|466597701|FG003|Overall Study|Adverse Event|2|||
129629249|NCT01217112|466597702|FG004|Overall Study|Adverse Event|0|||
129629250|NCT01217112|466597698|FG000|Overall Study|Withdrawal by Subject|0|||
129629251|NCT01217112|466597699|FG001|Overall Study|Withdrawal by Subject|0|||
129629252|NCT01217112|466597700|FG002|Overall Study|Withdrawal by Subject|1|||
129629253|NCT01217112|466597701|FG003|Overall Study|Withdrawal by Subject|0|||
129629254|NCT01217112|466597702|FG004|Overall Study|Withdrawal by Subject|0|||
129629255|NCT01217112|466597698|FG000|Overall Study|Physician Decision|0|||
129629256|NCT01217112|466597699|FG001|Overall Study|Physician Decision|0|||
129629257|NCT01217112|466597700|FG002|Overall Study|Physician Decision|0|||
129629258|NCT01217112|466597701|FG003|Overall Study|Physician Decision|0|||
129629259|NCT01217112|466597702|FG004|Overall Study|Physician Decision|1|||
129794725|NCT04365257|467216410|FG000|Overall Study|Patient Noncompliance|1|||
129794726|NCT04365257|467216411|FG001|Overall Study|Patient Noncompliance|0|||
129794727|NCT04365257|467216410|FG000|Overall Study|Withdrawal by Subject|0|||
129629260|NCT03192488|466597703|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
129629261|NCT03192488|466597704|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
129629262|NCT03192488|466597705|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
129794728|NCT04365257|467216411|FG001|Overall Study|Withdrawal by Subject|1|||
129794729|NCT03452527|467216412|FG000|Overall Study|Withdrawal by Subject|1|||
129794730|NCT03452527|467216413|FG001|Overall Study|Withdrawal by Subject|1|||
129629263|NCT03192488|466597706|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
129794731|NCT03452527|467216412|FG000|Overall Study|Study Terminated|2|||
129794732|NCT03452527|467216413|FG001|Overall Study|Study Terminated|3|||
129794733|NCT02129777|467216414|FG000|Double-Blind Period|Adverse Event|0|||
129794734|NCT02129777|467216415|FG001|Double-Blind Period|Adverse Event|0|||
129794735|NCT02129777|467216416|FG002|Double-Blind Period|Adverse Event|0|||
129629264|NCT03192488|466597707|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
129629265|NCT03192488|466597708|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
129629266|NCT03192488|466597703|FG000|Third Intervention (d1)|Adverse Event|0|||
129629267|NCT03192488|466597704|FG001|Third Intervention (d1)|Adverse Event|0|||
129629268|NCT03192488|466597705|FG002|Third Intervention (d1)|Adverse Event|0|||
129629269|NCT03192488|466597706|FG003|Third Intervention (d1)|Adverse Event|0|||
129629270|NCT03192488|466597707|FG004|Third Intervention (d1)|Adverse Event|1|||
129629271|NCT03192488|466597708|FG005|Third Intervention (d1)|Adverse Event|0|||
129629272|NCT01401361|466597709|FG000|Overall Study|Withdrawal by Subject|16|||
129629273|NCT01401361|466597709|FG000|Overall Study|Lack of Efficacy|6|||
129629274|NCT01401361|466597709|FG000|Overall Study|Physician Decision|1|||
129629275|NCT01401361|466597709|FG000|Overall Study|Lost to Follow-up|3|||
129629276|NCT01401361|466597709|FG000|Overall Study|Subject/family decision post procedure|2|||
129629277|NCT02512302|466597711|FG000|Period 1|Adverse Event|0|||
129629278|NCT02512302|466597712|FG001|Period 1|Adverse Event|1|||
129629279|NCT02512302|466597713|FG002|Period 1|Adverse Event|0|||
129629280|NCT02512302|466597714|FG003|Period 1|Adverse Event|0|||
129629281|NCT02512302|466597715|FG004|Period 1|Adverse Event|0|||
129629282|NCT02512302|466597716|FG005|Period 1|Adverse Event|0|||
129629283|NCT02512302|466597717|FG006|Period 1|Adverse Event|0|||
129629284|NCT02512302|466597718|FG007|Period 1|Adverse Event|0|||
129629285|NCT02512302|466597719|FG008|Period 1|Adverse Event|0|||
129629286|NCT02512302|466597720|FG009|Period 1|Adverse Event|0|||
129629287|NCT02512302|466597711|FG000|Period 2|Adverse Event|0|||
129629288|NCT02512302|466597712|FG001|Period 2|Adverse Event|0|||
129629289|NCT02512302|466597713|FG002|Period 2|Adverse Event|0|||
129629290|NCT02512302|466597714|FG003|Period 2|Adverse Event|0|||
129629291|NCT02512302|466597715|FG004|Period 2|Adverse Event|0|||
129629292|NCT02512302|466597716|FG005|Period 2|Adverse Event|0|||
129629293|NCT02512302|466597717|FG006|Period 2|Adverse Event|0|||
129629294|NCT02512302|466597718|FG007|Period 2|Adverse Event|0|||
129629295|NCT02512302|466597719|FG008|Period 2|Adverse Event|0|||
129629296|NCT02512302|466597720|FG009|Period 2|Adverse Event|1|||
129629297|NCT02512302|466597711|FG000|Period 3|Lost to Follow-up|0|||
129629298|NCT02512302|466597712|FG001|Period 3|Lost to Follow-up|0|||
129629299|NCT02512302|466597713|FG002|Period 3|Lost to Follow-up|1|||
129629300|NCT02512302|466597714|FG003|Period 3|Lost to Follow-up|0|||
129629301|NCT02512302|466597715|FG004|Period 3|Lost to Follow-up|0|||
129629302|NCT02512302|466597716|FG005|Period 3|Lost to Follow-up|0|||
129629303|NCT02512302|466597717|FG006|Period 3|Lost to Follow-up|0|||
129629304|NCT02512302|466597718|FG007|Period 3|Lost to Follow-up|0|||
129629305|NCT02512302|466597719|FG008|Period 3|Lost to Follow-up|0|||
129629306|NCT02512302|466597720|FG009|Period 3|Lost to Follow-up|0|||
129629307|NCT02512302|466597711|FG000|Period 4|Adverse Event|0|||
129629308|NCT02512302|466597712|FG001|Period 4|Adverse Event|0|||
129629309|NCT02512302|466597713|FG002|Period 4|Adverse Event|0|||
129629310|NCT02512302|466597714|FG003|Period 4|Adverse Event|0|||
129629311|NCT02512302|466597715|FG004|Period 4|Adverse Event|0|||
129629312|NCT02512302|466597716|FG005|Period 4|Adverse Event|0|||
129629313|NCT02512302|466597717|FG006|Period 4|Adverse Event|1|||
129629314|NCT02512302|466597718|FG007|Period 4|Adverse Event|0|||
129629315|NCT02512302|466597719|FG008|Period 4|Adverse Event|0|||
129629316|NCT02512302|466597720|FG009|Period 4|Adverse Event|0|||
129629317|NCT02764762|466597724|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129629318|NCT02764762|466597724|FG000|Overall Study|Lost to Follow-up|4|||
129629319|NCT02764762|466597724|FG000|Overall Study|Voluntary Withdrawal|8|||
129629320|NCT02764762|466597724|FG000|Overall Study|Site Termination|1|||
129629321|NCT02764762|466597724|FG000|Overall Study|Lack of Efficacy|16|||
129629322|NCT02764762|466597724|FG000|Overall Study|Reason not Specified|1|||
129629323|NCT01002989|466597725|FG000|Overall Study|exclusion criteria, no consent|5|||
129629324|NCT01892501|466597726|FG000|Overall Study|Protocol Violation|2|||
129794736|NCT02129777|467216417|FG003|Double-Blind Period|Adverse Event|0|||
129629325|NCT01892501|466597726|FG000|Overall Study|Puncture not carried out|9|||
129629326|NCT01892501|466597726|FG000|Overall Study|Radiological monitoring not carried out|5|||
129629327|NCT01892501|466597726|FG000|Overall Study|Non-contributory histological result|12|||
129629328|NCT01068860|466597728|FG000|Overall Study|Withdrawal by Subject|0|||
129629329|NCT01068860|466597729|FG001|Overall Study|Withdrawal by Subject|0|||
129629330|NCT01068860|466597730|FG002|Overall Study|Withdrawal by Subject|0|||
129629331|NCT01068860|466597731|FG003|Overall Study|Withdrawal by Subject|0|||
129629332|NCT01068860|466597732|FG004|Overall Study|Withdrawal by Subject|0|||
129629333|NCT01068860|466597733|FG005|Overall Study|Withdrawal by Subject|2|||
129629334|NCT01068860|466597734|FG006|Overall Study|Withdrawal by Subject|0|||
129629335|NCT01068860|466597735|FG007|Overall Study|Withdrawal by Subject|0|||
129629336|NCT01068860|466597736|FG008|Overall Study|Withdrawal by Subject|0|||
129794737|NCT02129777|467216418|FG004|Double-Blind Period|Adverse Event|1|||
129629337|NCT01068860|466597737|FG009|Overall Study|Withdrawal by Subject|3|||
129629338|NCT01068860|466597728|FG000|Overall Study|Administrative problems; misrandomized|0|||
129629339|NCT01068860|466597729|FG001|Overall Study|Administrative problems; misrandomized|0|||
129629340|NCT01068860|466597730|FG002|Overall Study|Administrative problems; misrandomized|0|||
129629341|NCT01068860|466597731|FG003|Overall Study|Administrative problems; misrandomized|1|||
129629342|NCT01068860|466597732|FG004|Overall Study|Administrative problems; misrandomized|0|||
129629343|NCT01068860|466597733|FG005|Overall Study|Administrative problems; misrandomized|0|||
129629344|NCT01068860|466597734|FG006|Overall Study|Administrative problems; misrandomized|0|||
129629345|NCT01068860|466597735|FG007|Overall Study|Administrative problems; misrandomized|0|||
129629346|NCT01068860|466597736|FG008|Overall Study|Administrative problems; misrandomized|0|||
129629347|NCT01068860|466597737|FG009|Overall Study|Administrative problems; misrandomized|1|||
129629348|NCT01068860|466597728|FG000|Overall Study|Lost to Follow-up|0|||
129629349|NCT01068860|466597729|FG001|Overall Study|Lost to Follow-up|1|||
129629350|NCT01068860|466597730|FG002|Overall Study|Lost to Follow-up|0|||
129629351|NCT01068860|466597731|FG003|Overall Study|Lost to Follow-up|0|||
129629352|NCT01068860|466597732|FG004|Overall Study|Lost to Follow-up|0|||
129629353|NCT01068860|466597733|FG005|Overall Study|Lost to Follow-up|0|||
129629354|NCT01068860|466597734|FG006|Overall Study|Lost to Follow-up|0|||
129629355|NCT01068860|466597735|FG007|Overall Study|Lost to Follow-up|0|||
129629356|NCT01068860|466597736|FG008|Overall Study|Lost to Follow-up|0|||
129629357|NCT01068860|466597737|FG009|Overall Study|Lost to Follow-up|0|||
129629358|NCT01321879|466597738|FG000|Overall Study|Lack of Efficacy|5|||
129629359|NCT01321879|466597738|FG000|Overall Study|Adverse Event|5|||
129629360|NCT01321879|466597738|FG000|Overall Study|Death|3|||
129629361|NCT01321879|466597738|FG000|Overall Study|Withdrawal by Subject|1|||
129629362|NCT00513240|466597740|FG000|Overall Study|Did not have intended surgery|3|||
129629363|NCT00513240|466597741|FG001|Overall Study|Did not have intended surgery|0|||
129629364|NCT00513240|466597740|FG000|Overall Study|Death|3|||
129629365|NCT00513240|466597741|FG001|Overall Study|Death|3|||
129629366|NCT00513240|466597740|FG000|Overall Study|Withdrawal by Subject|7|||
129629367|NCT00513240|466597741|FG001|Overall Study|Withdrawal by Subject|4|||
129629368|NCT05263908|466597742|FG000|Overall Study|No informed consent for publication of study results|397|||
129629369|NCT05263908|466597742|FG000|Overall Study|CRF not collected|1|||
129629370|NCT01641640|466597743|FG000|Overall Study|Enrolled but not treated|1|||
129629371|NCT01641640|466597743|FG000|Overall Study|Efficacy failure|29|||
129629372|NCT01641640|466597743|FG000|Overall Study|Lost to Follow-up|3|||
129629373|NCT01641640|466597743|FG000|Overall Study|Withdrawal by Subject|2|||
129629374|NCT01641640|466597743|FG000|Overall Study|Adverse Event|1|||
129629375|NCT01234350|466597745|FG000|Overall Study|Adverse Event|277|||
129629376|NCT01234350|466597746|FG001|Overall Study|Adverse Event|92|||
129629377|NCT01234350|466597745|FG000|Overall Study|Withdrawal by Subject|61|||
129629378|NCT01234350|466597746|FG001|Overall Study|Withdrawal by Subject|36|||
129794738|NCT02129777|467216419|FG005|Double-Blind Period|Adverse Event|0|||
129794739|NCT02129777|467216420|FG006|Double-Blind Period|Adverse Event|0|||
129794740|NCT02129777|467216414|FG000|Double-Blind Period|Lost to Follow-up|1|||
129794741|NCT02129777|467216415|FG001|Double-Blind Period|Lost to Follow-up|1|||
129794742|NCT02129777|467216416|FG002|Double-Blind Period|Lost to Follow-up|1|||
129794743|NCT02129777|467216417|FG003|Double-Blind Period|Lost to Follow-up|2|||
129794744|NCT02129777|467216418|FG004|Double-Blind Period|Lost to Follow-up|0|||
129794745|NCT02129777|467216419|FG005|Double-Blind Period|Lost to Follow-up|0|||
129794746|NCT02129777|467216420|FG006|Double-Blind Period|Lost to Follow-up|0|||
129794747|NCT02129777|467216414|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129794748|NCT02129777|467216415|FG001|Double-Blind Period|Withdrawal by Subject|4|||
129794749|NCT02129777|467216416|FG002|Double-Blind Period|Withdrawal by Subject|3|||
129794750|NCT02129777|467216417|FG003|Double-Blind Period|Withdrawal by Subject|2|||
129794751|NCT02129777|467216418|FG004|Double-Blind Period|Withdrawal by Subject|3|||
129794752|NCT02129777|467216419|FG005|Double-Blind Period|Withdrawal by Subject|0|||
129794753|NCT02129777|467216420|FG006|Double-Blind Period|Withdrawal by Subject|0|||
129794754|NCT02129777|467216414|FG000|Double-Blind Period|Pregnancy|0|||
129794755|NCT02129777|467216415|FG001|Double-Blind Period|Pregnancy|0|||
129794756|NCT02129777|467216416|FG002|Double-Blind Period|Pregnancy|0|||
129794757|NCT02129777|467216417|FG003|Double-Blind Period|Pregnancy|0|||
129794758|NCT02129777|467216418|FG004|Double-Blind Period|Pregnancy|1|||
129629379|NCT01234350|466597745|FG000|Overall Study|Lost to Follow-up|115|||
129629380|NCT01234350|466597746|FG001|Overall Study|Lost to Follow-up|47|||
129794759|NCT02129777|467216419|FG005|Double-Blind Period|Pregnancy|0|||
129794760|NCT02129777|467216420|FG006|Double-Blind Period|Pregnancy|0|||
129794761|NCT02129777|467216414|FG000|Double-Blind Period|Lack of Efficacy|3|||
129794762|NCT02129777|467216415|FG001|Double-Blind Period|Lack of Efficacy|1|||
129794763|NCT02129777|467216416|FG002|Double-Blind Period|Lack of Efficacy|0|||
129794764|NCT02129777|467216417|FG003|Double-Blind Period|Lack of Efficacy|3|||
129794765|NCT02129777|467216418|FG004|Double-Blind Period|Lack of Efficacy|2|||
129794766|NCT02129777|467216419|FG005|Double-Blind Period|Lack of Efficacy|0|||
129794767|NCT02129777|467216420|FG006|Double-Blind Period|Lack of Efficacy|0|||
129794768|NCT02129777|467216414|FG000|Double-Blind Period|Other|1|||
129794769|NCT02129777|467216415|FG001|Double-Blind Period|Other|2|||
129629381|NCT01234350|466597745|FG000|Overall Study|Covers a diverse set of reasons|234|||
129629382|NCT01234350|466597746|FG001|Overall Study|Covers a diverse set of reasons|92|||
129629383|NCT01930162|466597749|FG000|Overall Study|Abnormal test procedure result(s)|4|||
129629384|NCT01930162|466597749|FG000|Overall Study|Death|1|||
129629385|NCT01051960|466597750|FG000|Overall Study|Adverse Event|1|||
129629386|NCT02069015|466597760|FG000|Overall Study|Lost to Follow-up|39|||
129629387|NCT02069015|466597761|FG001|Overall Study|Lost to Follow-up|32|||
129629388|NCT02069015|466597760|FG000|Overall Study|Withdrawal by Subject|1|||
129629389|NCT02069015|466597761|FG001|Overall Study|Withdrawal by Subject|1|||
129629390|NCT01082328|466597762|FG000|Overall Study|Adverse Event|1|||
129629391|NCT00031590|466597763|FG000|Overall Study|Adverse Event|1|||
129629392|NCT00031590|466597763|FG000|Overall Study|Withdrawal by parents|2|||
129629393|NCT05506046|466597764|FG000|Overall Study|Lost to Follow-up|89|||
129629394|NCT05506046|466597765|FG001|Overall Study|Lost to Follow-up|101|||
129629395|NCT05506046|466597766|FG002|Overall Study|Lost to Follow-up|102|||
129629396|NCT05506046|466597767|FG003|Overall Study|Lost to Follow-up|99|||
129629397|NCT03051100|466597769|FG000|Overall Study|Withdrawal by Subject|1|||
129629398|NCT03051100|466597770|FG001|Overall Study|Withdrawal by Subject|0|||
129629399|NCT02059135|466597771|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
129629400|NCT02059135|466597772|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
129629401|NCT02059135|466597771|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
129629402|NCT02059135|466597772|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
129629403|NCT02059135|466597771|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
129629404|NCT02059135|466597772|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
129629405|NCT02059135|466597771|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
129629406|NCT02059135|466597772|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
129629407|NCT02059135|466597771|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
129629408|NCT02059135|466597772|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
129629409|NCT02059135|466597771|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
129629410|NCT02059135|466597772|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
129629411|NCT02059135|466597771|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
129629412|NCT02059135|466597772|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
129629413|NCT02059135|466597771|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
129629414|NCT02059135|466597772|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
129629415|NCT00789854|466597775|FG000|Overall Study|Adverse Event|28|||
129629416|NCT00789854|466597776|FG001|Overall Study|Adverse Event|23|||
129629417|NCT00789854|466597777|FG002|Overall Study|Adverse Event|18|||
129629418|NCT00789854|466597775|FG000|Overall Study|Lost to Follow-up|1|||
129629419|NCT00789854|466597776|FG001|Overall Study|Lost to Follow-up|1|||
129629420|NCT00789854|466597777|FG002|Overall Study|Lost to Follow-up|4|||
129629421|NCT00789854|466597775|FG000|Overall Study|Withdrawal by Subject|9|||
129629422|NCT00789854|466597776|FG001|Overall Study|Withdrawal by Subject|6|||
129629423|NCT00789854|466597777|FG002|Overall Study|Withdrawal by Subject|17|||
129629424|NCT00789854|466597775|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129629425|NCT00789854|466597776|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
129629426|NCT00789854|466597777|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129629427|NCT00789854|466597775|FG000|Overall Study|Severe non-compliance to the protocol|3|||
129629428|NCT00789854|466597776|FG001|Overall Study|Severe non-compliance to the protocol|0|||
129629429|NCT00789854|466597777|FG002|Overall Study|Severe non-compliance to the protocol|0|||
129629430|NCT00789854|466597775|FG000|Overall Study|Safety reasons|0|||
129629431|NCT00789854|466597776|FG001|Overall Study|Safety reasons|0|||
129629432|NCT00789854|466597777|FG002|Overall Study|Safety reasons|2|||
129629433|NCT00789854|466597775|FG000|Overall Study|Other|6|||
129629434|NCT00789854|466597776|FG001|Overall Study|Other|0|||
129629435|NCT00789854|466597777|FG002|Overall Study|Other|5|||
129629436|NCT00923013|466597778|FG000|Overall Study|Refused further treatment|0|||
129629437|NCT00923013|466597779|FG001|Overall Study|Refused further treatment|1|||
129629438|NCT00923013|466597780|FG002|Overall Study|Refused further treatment|2|||
129629439|NCT00923013|466597781|FG003|Overall Study|Refused further treatment|0|||
129629440|NCT00923013|466597782|FG004|Overall Study|Refused further treatment|0|||
129629441|NCT00923013|466597783|FG005|Overall Study|Refused further treatment|0|||
129629442|NCT00923013|466597778|FG000|Overall Study|Switched to alternative treatment|0|||
129629443|NCT00923013|466597779|FG001|Overall Study|Switched to alternative treatment|1|||
129629444|NCT00923013|466597780|FG002|Overall Study|Switched to alternative treatment|0|||
129629445|NCT00923013|466597781|FG003|Overall Study|Switched to alternative treatment|0|||
129629446|NCT00923013|466597782|FG004|Overall Study|Switched to alternative treatment|0|||
129629447|NCT00923013|466597783|FG005|Overall Study|Switched to alternative treatment|0|||
129629448|NCT00923013|466597778|FG000|Overall Study|Death on study|2|||
129629449|NCT00923013|466597779|FG001|Overall Study|Death on study|2|||
129629450|NCT00923013|466597780|FG002|Overall Study|Death on study|0|||
129629451|NCT00923013|466597781|FG003|Overall Study|Death on study|1|||
129629452|NCT00923013|466597782|FG004|Overall Study|Death on study|0|||
129629453|NCT00923013|466597783|FG005|Overall Study|Death on study|0|||
129629454|NCT02224157|466597785|FG000|Overall Study|Severe non-compliance to protocol|2|||
129629455|NCT02224157|466597786|FG001|Overall Study|Severe non-compliance to protocol|2|||
129629456|NCT02224157|466597785|FG000|Overall Study|Other|13|||
129629457|NCT02224157|466597786|FG001|Overall Study|Other|10|||
129629458|NCT02224157|466597785|FG000|Overall Study|Subject decision|58|||
129629459|NCT02224157|466597786|FG001|Overall Study|Subject decision|50|||
129629460|NCT02224157|466597785|FG000|Overall Study|Prematurely closed site|4|||
129629461|NCT02224157|466597786|FG001|Overall Study|Prematurely closed site|2|||
129629462|NCT02224157|466597785|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
129629463|NCT02224157|466597786|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
129629464|NCT02224157|466597785|FG000|Overall Study|Lost to Follow-up|27|||
129629465|NCT02224157|466597786|FG001|Overall Study|Lost to Follow-up|35|||
129629466|NCT02224157|466597785|FG000|Overall Study|Death|1|||
129629467|NCT02224157|466597786|FG001|Overall Study|Death|1|||
129629468|NCT02224157|466597785|FG000|Overall Study|Adverse Event|1|||
129629469|NCT02224157|466597786|FG001|Overall Study|Adverse Event|3|||
129629470|NCT05906628|466597789|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
129629471|NCT05906628|466597790|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
129629472|NCT05906628|466597789|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
129629473|NCT05906628|466597790|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
129794770|NCT02129777|467216416|FG002|Double-Blind Period|Other|0|||
129629474|NCT05906628|466597789|FG000|16-Week DBVC Period|Protocol Violation|4|||
129629475|NCT05906628|466597790|FG001|16-Week DBVC Period|Protocol Violation|2|||
129629476|NCT05906628|466597789|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
129629477|NCT05906628|466597790|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
129794771|NCT02129777|467216417|FG003|Double-Blind Period|Other|0|||
129629478|NCT05906628|466597789|FG000|16-Week OLE Period|Death|1|||
129629479|NCT05906628|466597790|FG001|16-Week OLE Period|Death|0|||
129629480|NCT05906628|466597789|FG000|16-Week OLE Period|Lost to Follow-up|1|||
129629481|NCT05906628|466597790|FG001|16-Week OLE Period|Lost to Follow-up|1|||
129629482|NCT05906628|466597789|FG000|16-Week OLE Period|Protocol Violation|0|||
129629483|NCT05906628|466597790|FG001|16-Week OLE Period|Protocol Violation|1|||
129629484|NCT05906628|466597789|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
129629485|NCT05906628|466597790|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
129629486|NCT04578535|466597791|FG000|Overall Study|Lost to Follow-up|1|||
129629487|NCT04578535|466597792|FG001|Overall Study|Lost to Follow-up|0|||
129629488|NCT04578535|466597793|FG002|Overall Study|Lost to Follow-up|0|||
129794772|NCT02129777|467216418|FG004|Double-Blind Period|Other|0|||
129794773|NCT02129777|467216419|FG005|Double-Blind Period|Other|0|||
129794774|NCT02129777|467216420|FG006|Double-Blind Period|Other|0|||
129794775|NCT02129777|467216414|FG000|Open-Label Period|Lack of Efficacy|0|||
129794776|NCT02129777|467216415|FG001|Open-Label Period|Lack of Efficacy|0|||
129794777|NCT02129777|467216416|FG002|Open-Label Period|Lack of Efficacy|0|||
129794778|NCT02129777|467216417|FG003|Open-Label Period|Lack of Efficacy|0|||
129794779|NCT02129777|467216418|FG004|Open-Label Period|Lack of Efficacy|0|||
129794780|NCT02129777|467216419|FG005|Open-Label Period|Lack of Efficacy|0|||
129794781|NCT02129777|467216420|FG006|Open-Label Period|Lack of Efficacy|5|||
129794782|NCT02129777|467216414|FG000|Open-Label Period|Lost to Follow-up|0|||
129794783|NCT02129777|467216415|FG001|Open-Label Period|Lost to Follow-up|0|||
129794784|NCT02129777|467216416|FG002|Open-Label Period|Lost to Follow-up|0|||
129794785|NCT02129777|467216417|FG003|Open-Label Period|Lost to Follow-up|0|||
129794786|NCT02129777|467216418|FG004|Open-Label Period|Lost to Follow-up|0|||
129794787|NCT02129777|467216419|FG005|Open-Label Period|Lost to Follow-up|1|||
129629489|NCT04578535|466597794|FG003|Overall Study|Lost to Follow-up|1|||
129629490|NCT04578535|466597795|FG004|Overall Study|Lost to Follow-up|0|||
129794788|NCT02129777|467216420|FG006|Open-Label Period|Lost to Follow-up|1|||
129794789|NCT02129777|467216414|FG000|Open-Label Period|Withdrawal by Subject|0|||
129794790|NCT02129777|467216415|FG001|Open-Label Period|Withdrawal by Subject|0|||
129794791|NCT02129777|467216416|FG002|Open-Label Period|Withdrawal by Subject|0|||
129794792|NCT02129777|467216417|FG003|Open-Label Period|Withdrawal by Subject|0|||
129629491|NCT04578535|466597796|FG005|Overall Study|Lost to Follow-up|2|||
129629492|NCT04578535|466597791|FG000|Overall Study|Pregnancy|1|||
129629493|NCT04578535|466597792|FG001|Overall Study|Pregnancy|0|||
129629494|NCT04578535|466597793|FG002|Overall Study|Pregnancy|0|||
129629495|NCT04578535|466597794|FG003|Overall Study|Pregnancy|0|||
129629496|NCT04578535|466597795|FG004|Overall Study|Pregnancy|0|||
129794793|NCT02129777|467216418|FG004|Open-Label Period|Withdrawal by Subject|0|||
129629497|NCT04578535|466597796|FG005|Overall Study|Pregnancy|0|||
129629498|NCT04578535|466597791|FG000|Overall Study|Withdrawal by Subject|0|||
129629499|NCT04578535|466597792|FG001|Overall Study|Withdrawal by Subject|0|||
129794794|NCT02129777|467216419|FG005|Open-Label Period|Withdrawal by Subject|1|||
129794795|NCT02129777|467216420|FG006|Open-Label Period|Withdrawal by Subject|3|||
129629500|NCT04578535|466597793|FG002|Overall Study|Withdrawal by Subject|0|||
129629501|NCT04578535|466597794|FG003|Overall Study|Withdrawal by Subject|1|||
129629502|NCT04578535|466597795|FG004|Overall Study|Withdrawal by Subject|1|||
129629503|NCT04578535|466597796|FG005|Overall Study|Withdrawal by Subject|5|||
129629504|NCT04578535|466597791|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
129629505|NCT04578535|466597792|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
129629506|NCT04578535|466597793|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
129629507|NCT04578535|466597794|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
129629508|NCT04578535|466597795|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
129629509|NCT04578535|466597796|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
129629510|NCT01060072|466597797|FG000|Overall Study|Adverse Event|1|||
129629511|NCT01060072|466597798|FG001|Overall Study|Adverse Event|1|||
129629512|NCT01060072|466597797|FG000|Overall Study|Physician Decision|0|||
129629513|NCT01060072|466597798|FG001|Overall Study|Physician Decision|2|||
129629514|NCT01060072|466597797|FG000|Overall Study|Protocol Violation|0|||
129629515|NCT01060072|466597798|FG001|Overall Study|Protocol Violation|1|||
129629516|NCT01060072|466597797|FG000|Overall Study|Acute cholecystitis|1|||
129629517|NCT01060072|466597798|FG001|Overall Study|Acute cholecystitis|0|||
129629518|NCT01060072|466597797|FG000|Overall Study|Excluded Medications|0|||
129629519|NCT01060072|466597798|FG001|Overall Study|Excluded Medications|1|||
129629520|NCT00837148|466597799|FG000|Overall Study|Adverse Event|1|||
129629521|NCT00837148|466597799|FG000|Overall Study|Death|1|||
129629522|NCT02301169|466597802|FG000|Overall Study|Adverse Event|1|||
129629523|NCT02301169|466597803|FG001|Overall Study|Adverse Event|0|||
129629524|NCT00380874|466597804|FG000|Overall Study|Adverse Event|7|||
129629525|NCT00380874|466597805|FG001|Overall Study|Adverse Event|7|||
129629526|NCT00380874|466597804|FG000|Overall Study|Death|1|||
129629527|NCT00380874|466597805|FG001|Overall Study|Death|0|||
129629528|NCT00380874|466597804|FG000|Overall Study|Withdrawal by Subject|2|||
129629529|NCT00380874|466597805|FG001|Overall Study|Withdrawal by Subject|1|||
129629530|NCT00380874|466597804|FG000|Overall Study|Not related to study drug|3|||
129629531|NCT00380874|466597805|FG001|Overall Study|Not related to study drug|2|||
129629532|NCT03839628|466597806|FG000|Overall Study|Withdrawal by Subject|1|||
129629533|NCT01707290|466597811|FG000|Overall Study|Adverse event (AE)|1|||
129629534|NCT01707290|466597812|FG001|Overall Study|Adverse event (AE)|0|||
129629535|NCT01707290|466597811|FG000|Overall Study|Physician Decision|1|||
129629536|NCT01707290|466597812|FG001|Overall Study|Physician Decision|0|||
129629537|NCT01707290|466597811|FG000|Overall Study|Lost to Follow-up|3|||
129629538|NCT01707290|466597812|FG001|Overall Study|Lost to Follow-up|0|||
129629539|NCT01707290|466597811|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
129629540|NCT01707290|466597812|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
129629541|NCT01707290|466597811|FG000|Overall Study|Commercial drug available|60|||
129629542|NCT01707290|466597812|FG001|Overall Study|Commercial drug available|1|||
129629543|NCT01707290|466597811|FG000|Overall Study|Other unspecified|17|||
129629544|NCT01707290|466597812|FG001|Overall Study|Other unspecified|0|||
129629545|NCT01198470|466597813|FG000|Overall Study|Adverse Event|2|||
129629546|NCT02949973|466597814|FG000|Overall Study|Physician Decision|1|||
129629547|NCT00586703|466597815|FG000|Overall Study|Death|12|||
129629548|NCT01422213|466597816|FG000|Overall Study|Adverse Event|8|||
129629549|NCT01422213|466597817|FG001|Overall Study|Adverse Event|7|||
129629550|NCT01422213|466597818|FG002|Overall Study|Adverse Event|11|||
129629551|NCT01422213|466597816|FG000|Overall Study|Lack of Efficacy|10|||
129629552|NCT01422213|466597817|FG001|Overall Study|Lack of Efficacy|2|||
129703618|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
129629553|NCT01422213|466597818|FG002|Overall Study|Lack of Efficacy|2|||
129629554|NCT01422213|466597816|FG000|Overall Study|Non-compliance with study drug|0|||
129629555|NCT01422213|466597817|FG001|Overall Study|Non-compliance with study drug|1|||
129629556|NCT01422213|466597818|FG002|Overall Study|Non-compliance with study drug|0|||
129703619|NCT02958865|466877501|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703620|NCT02958865|466877502|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703621|NCT02958865|466877503|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703622|NCT02958865|466877504|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703623|NCT02958865|466877505|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
129703624|NCT02958865|466877506|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703625|NCT02958865|466877507|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129629557|NCT01422213|466597816|FG000|Overall Study|Protocol Violation|0|||
129629558|NCT01422213|466597817|FG001|Overall Study|Protocol Violation|2|||
129629559|NCT01422213|466597818|FG002|Overall Study|Protocol Violation|4|||
129629560|NCT01422213|466597816|FG000|Overall Study|Withdrawal of Consent|7|||
129629561|NCT01422213|466597817|FG001|Overall Study|Withdrawal of Consent|3|||
129629562|NCT01422213|466597818|FG002|Overall Study|Withdrawal of Consent|5|||
129629563|NCT01422213|466597816|FG000|Overall Study|Lost to Follow-up|3|||
129629564|NCT01422213|466597817|FG001|Overall Study|Lost to Follow-up|3|||
129629565|NCT01422213|466597818|FG002|Overall Study|Lost to Follow-up|5|||
129629566|NCT01422213|466597816|FG000|Overall Study|Administrative or Other Reason(s)|5|||
129629567|NCT01422213|466597817|FG001|Overall Study|Administrative or Other Reason(s)|4|||
129629568|NCT01422213|466597818|FG002|Overall Study|Administrative or Other Reason(s)|2|||
129629569|NCT02857816|466597819|FG000|Overall Study|Screen Failure|33|||
129629570|NCT02857816|466597819|FG000|Overall Study|Withdrawal by Subject|4|||
129629571|NCT02857816|466597819|FG000|Overall Study|Lost to Follow-up|1|||
129629572|NCT01147068|466597822|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
129629573|NCT01147068|466597823|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129629574|NCT01147068|466597824|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129629575|NCT01147068|466597825|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129629576|NCT01147068|466597826|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129629577|NCT01147068|466597827|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
129629578|NCT01147068|466597828|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
129629579|NCT01147068|466597822|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
129629580|NCT01147068|466597823|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
129629581|NCT01147068|466597824|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
129629582|NCT01147068|466597825|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
129629583|NCT01147068|466597826|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
129629584|NCT01147068|466597827|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
129629585|NCT01147068|466597828|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
129629586|NCT01147068|466597822|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
129629587|NCT01147068|466597823|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
129629588|NCT01147068|466597824|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
129629589|NCT01147068|466597825|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
129629590|NCT01147068|466597826|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
129629591|NCT01147068|466597827|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
129629592|NCT01147068|466597828|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
129629593|NCT01147068|466597822|FG000|Subjects That Received 2nd Dose|Other|0|||
129629594|NCT01147068|466597823|FG001|Subjects That Received 2nd Dose|Other|3|||
129629595|NCT01147068|466597824|FG002|Subjects That Received 2nd Dose|Other|3|||
129629596|NCT01147068|466597825|FG003|Subjects That Received 2nd Dose|Other|0|||
129629597|NCT01147068|466597826|FG004|Subjects That Received 2nd Dose|Other|1|||
129629598|NCT01147068|466597827|FG005|Subjects That Received 2nd Dose|Other|0|||
129629599|NCT01147068|466597828|FG006|Subjects That Received 2nd Dose|Other|0|||
129629600|NCT01147068|466597822|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
129629601|NCT01147068|466597823|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129629602|NCT01147068|466597824|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129629603|NCT01147068|466597825|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129629604|NCT01147068|466597826|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
129629605|NCT01147068|466597827|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
129629606|NCT01147068|466597828|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
129629607|NCT01147068|466597822|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129629608|NCT01147068|466597823|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129629609|NCT01147068|466597824|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129629610|NCT01147068|466597825|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
129629611|NCT01147068|466597826|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129629612|NCT01147068|466597827|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129629613|NCT01147068|466597828|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
129629614|NCT01147068|466597822|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
129629615|NCT01147068|466597823|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
129629616|NCT01147068|466597824|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
129629617|NCT01147068|466597825|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
129629618|NCT01147068|466597826|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
129629619|NCT01147068|466597827|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
129629620|NCT01147068|466597828|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
129629621|NCT04837196|466597838|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
129629622|NCT04837196|466597839|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
129629623|NCT04837196|466597840|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
129629624|NCT04837196|466597841|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
129629625|NCT04837196|466597842|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
129629626|NCT04837196|466597838|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
129629627|NCT04837196|466597839|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
129629628|NCT04837196|466597840|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
129629629|NCT04837196|466597841|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
129629630|NCT04837196|466597842|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
129629631|NCT04837196|466597838|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129629632|NCT04837196|466597839|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
129629633|NCT04837196|466597840|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129629634|NCT04837196|466597841|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129629635|NCT04837196|466597842|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
129629636|NCT04837196|466597838|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129629637|NCT04837196|466597839|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129629638|NCT04837196|466597840|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
129629639|NCT04837196|466597841|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129629640|NCT04837196|466597842|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
129629641|NCT04837196|466597838|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129629642|NCT04837196|466597839|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129629643|NCT04837196|466597840|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
129629644|NCT04837196|466597841|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129629645|NCT04837196|466597842|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
129629646|NCT01522456|466597843|FG000|Overall Study|Adverse Event|2|||
129629647|NCT01522456|466597843|FG000|Overall Study|Lost to Follow-up|2|||
129629648|NCT01522456|466597843|FG000|Overall Study|Withdrawal by Subject|2|||
129629649|NCT01522456|466597843|FG000|Overall Study|Pregnancy|1|||
129629650|NCT01522456|466597843|FG000|Overall Study|Tolerability Assessment|1|||
129629651|NCT01565889|466597847|FG000|Part A|Withdrawal by Subject|1|||
129629652|NCT01565889|466597848|FG001|Part A|Withdrawal by Subject|0|||
129629653|NCT01565889|466597849|FG002|Part A|Withdrawal by Subject|0|||
129629654|NCT01565889|466597850|FG003|Part A|Withdrawal by Subject|0|||
129629655|NCT01565889|466597851|FG004|Part A|Withdrawal by Subject|0|||
129629656|NCT01565889|466597852|FG005|Part A|Withdrawal by Subject|0|||
129629657|NCT01565889|466597847|FG000|Part B|Withdrawal by Subject|0|||
129629658|NCT01565889|466597848|FG001|Part B|Withdrawal by Subject|0|||
129629659|NCT01565889|466597849|FG002|Part B|Withdrawal by Subject|0|||
129629660|NCT01565889|466597850|FG003|Part B|Withdrawal by Subject|0|||
129629661|NCT01565889|466597851|FG004|Part B|Withdrawal by Subject|0|||
129629662|NCT01565889|466597852|FG005|Part B|Withdrawal by Subject|1|||
129629663|NCT01565889|466597847|FG000|Part B|Lack of Efficacy|0|||
129629664|NCT01565889|466597848|FG001|Part B|Lack of Efficacy|0|||
129629665|NCT01565889|466597849|FG002|Part B|Lack of Efficacy|0|||
129629666|NCT01565889|466597850|FG003|Part B|Lack of Efficacy|0|||
129629667|NCT01565889|466597851|FG004|Part B|Lack of Efficacy|0|||
129629668|NCT01565889|466597852|FG005|Part B|Lack of Efficacy|2|||
129629669|NCT01565889|466597847|FG000|Part B|Lost to Follow-up|0|||
129629670|NCT01565889|466597848|FG001|Part B|Lost to Follow-up|0|||
129629671|NCT01565889|466597849|FG002|Part B|Lost to Follow-up|0|||
129629672|NCT01565889|466597850|FG003|Part B|Lost to Follow-up|0|||
129629673|NCT01565889|466597851|FG004|Part B|Lost to Follow-up|0|||
129629674|NCT01565889|466597852|FG005|Part B|Lost to Follow-up|1|||
129629675|NCT02723344|466597853|FG000|Overall Study|Lost to Follow-up|0|||
129629676|NCT02723344|466597854|FG001|Overall Study|Lost to Follow-up|4|||
129629677|NCT01326845|466597857|FG000|Overall Study|Administrative Problems|5|||
129629678|NCT01326845|466597858|FG001|Overall Study|Administrative Problems|2|||
129629679|NCT01326845|466597857|FG000|Overall Study|Adverse Event|1|||
129629680|NCT01326845|466597858|FG001|Overall Study|Adverse Event|0|||
129629681|NCT01326845|466597857|FG000|Overall Study|Misisng|1|||
129629682|NCT01326845|466597858|FG001|Overall Study|Misisng|3|||
129629683|NCT02964247|466597859|FG000|Overall Study|Lost to Follow-up|2|||
129629684|NCT02964247|466597860|FG001|Overall Study|Lost to Follow-up|0|||
129629685|NCT02964247|466597859|FG000|Overall Study|Withdrawal by Subject|1|||
129629686|NCT02964247|466597860|FG001|Overall Study|Withdrawal by Subject|2|||
129629687|NCT03918629|466597861|FG000|Overall Study|Adverse Event|19|||
129629688|NCT03918629|466597862|FG001|Overall Study|Adverse Event|20|||
129629689|NCT03918629|466597861|FG000|Overall Study|Death|14|||
129629690|NCT03918629|466597862|FG001|Overall Study|Death|7|||
129629691|NCT03918629|466597861|FG000|Overall Study|Lost to Follow-up|36|||
129629692|NCT03918629|466597862|FG001|Overall Study|Lost to Follow-up|28|||
129629693|NCT03918629|466597861|FG000|Overall Study|Physician Decision|1|||
129629694|NCT03918629|466597862|FG001|Overall Study|Physician Decision|0|||
129629695|NCT03918629|466597861|FG000|Overall Study|Protocol Violation|7|||
129629696|NCT03918629|466597862|FG001|Overall Study|Protocol Violation|4|||
129629697|NCT03918629|466597861|FG000|Overall Study|Withdrawal by Subject|47|||
129629698|NCT03918629|466597862|FG001|Overall Study|Withdrawal by Subject|47|||
129629699|NCT03918629|466597861|FG000|Overall Study|Other|7|||
129629700|NCT03918629|466597862|FG001|Overall Study|Other|11|||
129629701|NCT03918629|466597861|FG000|Overall Study|Randomized but not vaccinated|2|||
129629702|NCT03918629|466597862|FG001|Overall Study|Randomized but not vaccinated|1|||
129629703|NCT01709500|466597866|FG000|Overall Study|Randomized but not treated|0|||
129629704|NCT01709500|466597867|FG001|Overall Study|Randomized but not treated|1|||
129629705|NCT01709500|466597866|FG000|Overall Study|Adverse Event|5|||
129629706|NCT01709500|466597867|FG001|Overall Study|Adverse Event|1|||
129629707|NCT01709500|466597866|FG000|Overall Study|Poor compliance to protocol|2|||
129889037|NCT01347645|467550989|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
129889038|NCT01347645|467550990|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
129889039|NCT01347645|467550986|FG000|Overall Study|Other|1|||
129889040|NCT01347645|467550987|FG001|Overall Study|Other|0|||
129889041|NCT01347645|467550988|FG002|Overall Study|Other|0|||
129889042|NCT01347645|467550989|FG003|Overall Study|Other|0|||
129889043|NCT01347645|467550990|FG004|Overall Study|Other|1|||
129889044|NCT01347645|467550986|FG000|Overall Study|Withdrawal by Subject|0|||
129889045|NCT01347645|467550987|FG001|Overall Study|Withdrawal by Subject|0|||
129889046|NCT01347645|467550988|FG002|Overall Study|Withdrawal by Subject|0|||
129889047|NCT01347645|467550989|FG003|Overall Study|Withdrawal by Subject|3|||
129629708|NCT01709500|466597867|FG001|Overall Study|Poor compliance to protocol|1|||
129629709|NCT01709500|466597866|FG000|Overall Study|Other|3|||
129629710|NCT01709500|466597867|FG001|Overall Study|Other|1|||
129629711|NCT01709500|466597866|FG000|Overall Study|Related to IMP administration|1|||
129629712|NCT01709500|466597867|FG001|Overall Study|Related to IMP administration|0|||
129629713|NCT01709500|466597866|FG000|Overall Study|Treatment ongoing|156|||
129629714|NCT01709500|466597867|FG001|Overall Study|Treatment ongoing|78|||
129629715|NCT00740636|466597869|FG000|Overall Study|Adverse Event|0|||
129629716|NCT00740636|466597870|FG001|Overall Study|Adverse Event|2|||
129629717|NCT00740636|466597869|FG000|Overall Study|Patient Ineligible|0|||
129629718|NCT00740636|466597870|FG001|Overall Study|Patient Ineligible|1|||
129629719|NCT00740636|466597869|FG000|Overall Study|Patient Not Treated|0|||
129629720|NCT00740636|466597870|FG001|Overall Study|Patient Not Treated|1|||
129629721|NCT00740636|466597869|FG000|Overall Study|Progressive Disease|1|||
129629722|NCT00740636|466597870|FG001|Overall Study|Progressive Disease|0|||
129629723|NCT00740636|466597869|FG000|Overall Study|Death|1|||
129629724|NCT00740636|466597870|FG001|Overall Study|Death|0|||
129629725|NCT02844543|466599574|FG000|Overall Study|Withdrawal by Subject|4|||
129629726|NCT02844543|466599574|FG000|Overall Study|Did not meet eligibility criteria|1|||
129629727|NCT04710576|466599580|FG000|Overall Study|Participants still in the study|73|||
129629728|NCT04710576|466599581|FG001|Overall Study|Participants still in the study|70|||
129629729|NCT04710576|466599582|FG002|Overall Study|Participants still in the study|60|||
129629730|NCT04710576|466599580|FG000|Overall Study|Death|2|||
129889048|NCT01347645|467550990|FG004|Overall Study|Withdrawal by Subject|3|||
129889049|NCT01347645|467550986|FG000|Overall Study|Physician Decision|0|||
129889050|NCT01347645|467550987|FG001|Overall Study|Physician Decision|0|||
129889051|NCT01347645|467550988|FG002|Overall Study|Physician Decision|0|||
129889052|NCT01347645|467550989|FG003|Overall Study|Physician Decision|0|||
129629731|NCT04710576|466599581|FG001|Overall Study|Death|7|||
129629732|NCT04710576|466599582|FG002|Overall Study|Death|12|||
129629733|NCT04710576|466599580|FG000|Overall Study|Withdrawal by Subject|4|||
129629734|NCT04710576|466599581|FG001|Overall Study|Withdrawal by Subject|3|||
129629735|NCT04710576|466599582|FG002|Overall Study|Withdrawal by Subject|7|||
129629736|NCT04710576|466599580|FG000|Overall Study|Sponsor decision|1|||
129629737|NCT04710576|466599581|FG001|Overall Study|Sponsor decision|0|||
129629738|NCT04710576|466599582|FG002|Overall Study|Sponsor decision|0|||
129629739|NCT04581824|466599583|FG000|Overall Study|Lost to Follow-up|1|||
129629740|NCT04581824|466599584|FG001|Overall Study|Lost to Follow-up|0|||
129629741|NCT04581824|466599583|FG000|Overall Study|Withdrawal by Subject|2|||
129629742|NCT04581824|466599584|FG001|Overall Study|Withdrawal by Subject|7|||
129629743|NCT04581824|466599583|FG000|Overall Study|Study terminated by sponsor|37|||
129629744|NCT04581824|466599584|FG001|Overall Study|Study terminated by sponsor|23|||
129629745|NCT04796909|466599585|FG000|Overall Study|Withdrawal by Subject|1|||
129629746|NCT04796909|466599586|FG001|Overall Study|Withdrawal by Subject|1|||
129629747|NCT03879135|466599587|FG000|Overall Study|Physician Decision|0|||
129629748|NCT03879135|466599588|FG001|Overall Study|Physician Decision|0|||
129629749|NCT03879135|466599589|FG002|Overall Study|Physician Decision|0|||
129629750|NCT03879135|466599590|FG003|Overall Study|Physician Decision|1|||
129629751|NCT03879135|466599591|FG004|Overall Study|Physician Decision|0|||
129629752|NCT03879135|466599592|FG005|Overall Study|Physician Decision|0|||
129629753|NCT03879135|466599587|FG000|Overall Study|Withdrawal by Subject|0|||
129629754|NCT03879135|466599588|FG001|Overall Study|Withdrawal by Subject|0|||
129629755|NCT03879135|466599589|FG002|Overall Study|Withdrawal by Subject|0|||
129629756|NCT03879135|466599590|FG003|Overall Study|Withdrawal by Subject|0|||
129629757|NCT03879135|466599591|FG004|Overall Study|Withdrawal by Subject|0|||
129629758|NCT03879135|466599592|FG005|Overall Study|Withdrawal by Subject|1|||
129629759|NCT03879135|466599587|FG000|Overall Study|Site Closed by Sponsor|0|||
129629760|NCT03879135|466599588|FG001|Overall Study|Site Closed by Sponsor|0|||
129629761|NCT03879135|466599589|FG002|Overall Study|Site Closed by Sponsor|0|||
129629762|NCT03879135|466599590|FG003|Overall Study|Site Closed by Sponsor|1|||
129629763|NCT03879135|466599591|FG004|Overall Study|Site Closed by Sponsor|1|||
129629764|NCT03879135|466599592|FG005|Overall Study|Site Closed by Sponsor|0|||
129629765|NCT04162847|466599593|FG000|Overall Study|Withdrawal by Subject|7|||
129629766|NCT04162847|466599594|FG001|Overall Study|Withdrawal by Subject|1|||
129629767|NCT00813150|466599595|FG000|Treatment Period|Adverse Event|16|||
129629768|NCT00813150|466599596|FG001|Treatment Period|Adverse Event|15|||
129629769|NCT00813150|466599595|FG000|Treatment Period|Death|2|||
129629770|NCT00813150|466599596|FG001|Treatment Period|Death|0|||
129629771|NCT00813150|466599595|FG000|Treatment Period|Progressive disease|1|||
129629772|NCT00813150|466599596|FG001|Treatment Period|Progressive disease|0|||
129629773|NCT00813150|466599595|FG000|Treatment Period|Complete response|0|||
129629774|NCT00813150|466599596|FG001|Treatment Period|Complete response|1|||
129629775|NCT00813150|466599595|FG000|Treatment Period|Stable disease|1|||
129629776|NCT00813150|466599596|FG001|Treatment Period|Stable disease|2|||
129629777|NCT00813150|466599595|FG000|Treatment Period|Protocol Violation|3|||
129629778|NCT00813150|466599596|FG001|Treatment Period|Protocol Violation|4|||
129629779|NCT00813150|466599595|FG000|Treatment Period|Withdrawal by Subject|5|||
129629780|NCT00813150|466599596|FG001|Treatment Period|Withdrawal by Subject|3|||
129629781|NCT00813150|466599595|FG000|Treatment Period|Non compliance|0|||
129629782|NCT00813150|466599596|FG001|Treatment Period|Non compliance|1|||
129629783|NCT00813150|466599595|FG000|Treatment Period|Reason not specified|3|||
129629784|NCT00813150|466599596|FG001|Treatment Period|Reason not specified|4|||
129629785|NCT00813150|466599595|FG000|Treatment Period|Data not available|1|||
129629786|NCT00813150|466599596|FG001|Treatment Period|Data not available|2|||
129629787|NCT00813150|466599595|FG000|Long Term Follow-up|Death|0|||
129629788|NCT00813150|466599596|FG001|Long Term Follow-up|Death|4|||
129629789|NCT00813150|466599595|FG000|Long Term Follow-up|Other|0|||
129629790|NCT00813150|466599596|FG001|Long Term Follow-up|Other|3|||
129629791|NCT00813150|466599595|FG000|Long Term Follow-up|Lost to Follow-up|2|||
129629792|NCT00813150|466599596|FG001|Long Term Follow-up|Lost to Follow-up|0|||
129629793|NCT00813150|466599595|FG000|Long Term Follow-up|Progression/Relapse|22|||
129629794|NCT00813150|466599596|FG001|Long Term Follow-up|Progression/Relapse|24|||
129629795|NCT05423093|466599597|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
129629796|NCT05423093|466599597|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
129629797|NCT05423093|466599597|FG000|Attended Intervention Session|Lost to Follow-up|3|||
129629798|NCT05423093|466599597|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
129629799|NCT05423093|466599597|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
129629800|NCT02832687|466599598|FG000|Overall Study|Adverse Event|0|||
129629801|NCT02832687|466599599|FG001|Overall Study|Adverse Event|2|||
129629802|NCT00471822|466599600|FG000|Overall Study|Protocol Violation|2|||
129629803|NCT03664232|466599601|FG000|Overall Study|Withdrawal by Subject|0|||
129629804|NCT03664232|466599602|FG001|Overall Study|Withdrawal by Subject|1|||
129629805|NCT03664232|466599603|FG002|Overall Study|Withdrawal by Subject|0|||
129629806|NCT03664232|466599604|FG003|Overall Study|Withdrawal by Subject|1|||
129629807|NCT03664232|466599601|FG000|Overall Study|Adverse Event|0|||
129629808|NCT03664232|466599602|FG001|Overall Study|Adverse Event|0|||
129629809|NCT03664232|466599603|FG002|Overall Study|Adverse Event|1|||
129629810|NCT03664232|466599604|FG003|Overall Study|Adverse Event|0|||
129629811|NCT03664232|466599601|FG000|Overall Study|Other-Non-compliance with study drug|0|||
129629812|NCT03664232|466599602|FG001|Overall Study|Other-Non-compliance with study drug|1|||
129629813|NCT03664232|466599603|FG002|Overall Study|Other-Non-compliance with study drug|0|||
129629814|NCT03664232|466599604|FG003|Overall Study|Other-Non-compliance with study drug|2|||
129629815|NCT03664232|466599601|FG000|Overall Study|Other-Unspecified|0|||
129629816|NCT03664232|466599602|FG001|Overall Study|Other-Unspecified|3|||
129629817|NCT03664232|466599603|FG002|Overall Study|Other-Unspecified|0|||
129629818|NCT03664232|466599604|FG003|Overall Study|Other-Unspecified|1|||
129629819|NCT03664232|466599601|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
129629820|NCT03664232|466599602|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
129629821|NCT03664232|466599603|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
129629822|NCT03664232|466599604|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
129629823|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
129629824|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
129629825|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
129629826|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
129629827|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
129629828|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629829|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629830|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629831|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629832|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629833|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629834|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629835|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629836|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629837|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
129629838|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
129794796|NCT02129777|467216414|FG000|Open-Label Period|Study Termination|0|||
129794797|NCT02129777|467216415|FG001|Open-Label Period|Study Termination|0|||
129794798|NCT02129777|467216416|FG002|Open-Label Period|Study Termination|0|||
129794799|NCT02129777|467216417|FG003|Open-Label Period|Study Termination|0|||
129794800|NCT02129777|467216418|FG004|Open-Label Period|Study Termination|0|||
129794801|NCT02129777|467216419|FG005|Open-Label Period|Study Termination|10|||
129794802|NCT02129777|467216420|FG006|Open-Label Period|Study Termination|39|||
129794803|NCT01001299|467216421|FG000|Overall Study|Insufficient Therapeutic Response|20|||
129794804|NCT01001299|467216421|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
129794805|NCT01001299|467216421|FG000|Overall Study|Death|1|||
129794806|NCT01001299|467216421|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
129794807|NCT01001299|467216421|FG000|Overall Study|Withdrew Consent|1|||
129794808|NCT01565499|467216422|FG000|Overall Study|Physician Decision|1|||
129794809|NCT01565499|467216422|FG000|Overall Study|Adverse Event|5|||
129794810|NCT01565499|467216422|FG000|Overall Study|Withdrawal by Subject|2|||
129794811|NCT03116347|467216423|FG000|Overall Study|Withdrawal by Subject|1|||
129794812|NCT03116347|467216424|FG001|Overall Study|Withdrawal by Subject|2|||
129794813|NCT01255787|467216425|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
129794814|NCT01255787|467216426|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
129794815|NCT01255787|467216427|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
129794816|NCT01255787|467216428|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
129794817|NCT01255787|467216425|FG000|Overall Study|Major Protocol Deviation|1|||
129794818|NCT01255787|467216426|FG001|Overall Study|Major Protocol Deviation|1|||
129794819|NCT01255787|467216427|FG002|Overall Study|Major Protocol Deviation|0|||
129794820|NCT01255787|467216428|FG003|Overall Study|Major Protocol Deviation|4|||
129794821|NCT01255787|467216425|FG000|Overall Study|Lost to Follow-up|1|||
129794822|NCT01255787|467216426|FG001|Overall Study|Lost to Follow-up|2|||
129794823|NCT01255787|467216427|FG002|Overall Study|Lost to Follow-up|4|||
129794824|NCT01255787|467216428|FG003|Overall Study|Lost to Follow-up|2|||
129794825|NCT01255787|467216425|FG000|Overall Study|Withdrawal of Consent|3|||
129794826|NCT01255787|467216426|FG001|Overall Study|Withdrawal of Consent|9|||
129794827|NCT01255787|467216427|FG002|Overall Study|Withdrawal of Consent|3|||
129794828|NCT01255787|467216428|FG003|Overall Study|Withdrawal of Consent|4|||
129794829|NCT01255787|467216425|FG000|Overall Study|Pregnancy|0|||
129794830|NCT01255787|467216426|FG001|Overall Study|Pregnancy|0|||
129794831|NCT01255787|467216427|FG002|Overall Study|Pregnancy|0|||
129794832|NCT01255787|467216428|FG003|Overall Study|Pregnancy|1|||
129794833|NCT01255787|467216425|FG000|Overall Study|Lack of Efficacy|2|||
129794834|NCT01255787|467216426|FG001|Overall Study|Lack of Efficacy|2|||
129794835|NCT01255787|467216427|FG002|Overall Study|Lack of Efficacy|2|||
129794836|NCT01255787|467216428|FG003|Overall Study|Lack of Efficacy|2|||
129794837|NCT01255787|467216425|FG000|Overall Study|Noncompliance with Study Drug|3|||
129794838|NCT01255787|467216426|FG001|Overall Study|Noncompliance with Study Drug|1|||
129794839|NCT01255787|467216427|FG002|Overall Study|Noncompliance with Study Drug|0|||
129794840|NCT01255787|467216428|FG003|Overall Study|Noncompliance with Study Drug|0|||
129794841|NCT00476047|467216429|FG000|Overall Study|Lost to Follow-up|1|||
129794842|NCT03170232|467216430|FG000|Overall Study|Adverse Event|0|||
129794843|NCT03170232|467216431|FG001|Overall Study|Adverse Event|1|||
129794844|NCT03170232|467216430|FG000|Overall Study|Protocol Violation|0|||
129794845|NCT03170232|467216431|FG001|Overall Study|Protocol Violation|1|||
129794846|NCT03170232|467216430|FG000|Overall Study|Lack of Efficacy|0|||
129794847|NCT03170232|467216431|FG001|Overall Study|Lack of Efficacy|1|||
129794848|NCT03170232|467216430|FG000|Overall Study|Study closed/terminated|26|||
129794849|NCT03170232|467216431|FG001|Overall Study|Study closed/terminated|23|||
129794850|NCT03170232|467216430|FG000|Overall Study|Lost to Follow-up|1|||
129794851|NCT03170232|467216431|FG001|Overall Study|Lost to Follow-up|0|||
129794852|NCT03170232|467216430|FG000|Overall Study|Withdrawal by Subject|0|||
129794853|NCT03170232|467216431|FG001|Overall Study|Withdrawal by Subject|1|||
129794854|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
129794855|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
129794856|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
129794857|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
129629839|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
129629840|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
129629841|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
129629842|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
129629843|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629844|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629845|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629846|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629847|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629848|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629849|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629850|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629851|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629852|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
129629853|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
129629854|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
129629855|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
129629856|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
129629857|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
129629858|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629859|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629860|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629861|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629862|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629863|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629864|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129794858|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
129794859|NCT00586326|467216432|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
129794860|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
129794861|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
129794862|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
129794863|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
129794864|NCT00586326|467216432|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
129794865|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
129794866|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
129794867|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
129629865|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629866|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629867|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
129629868|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
129629869|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
129629870|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
129629871|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
129629872|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
129629873|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629874|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629875|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629876|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629877|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629878|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629879|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629880|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629881|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629882|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
129629883|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
129629884|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629885|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
129629886|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
129629887|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
129629888|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629889|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629890|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629891|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629892|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629893|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629894|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629895|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629896|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629897|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
129629898|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629899|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629900|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629901|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
129629902|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629903|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629904|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629905|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629906|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
129794868|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
129794869|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
129794870|NCT00586326|467216432|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
129794871|NCT03882008|467216433|FG000|Overall Study|Withdrawal by Subject|1|||
129794872|NCT03882008|467216433|FG000|Overall Study|Lost to Follow-up|1|||
129794873|NCT02009384|467216434|FG000|Overall Study|Death|2|||
129794874|NCT00718237|467216436|FG000|Overall Study|Adverse Event|1|||
129794875|NCT00718237|467216437|FG001|Overall Study|Adverse Event|3|||
129794876|NCT00718237|467216436|FG000|Overall Study|Lost to Follow-up|2|||
129794877|NCT00718237|467216437|FG001|Overall Study|Lost to Follow-up|2|||
129794878|NCT00718237|467216436|FG000|Overall Study|Physician Decision|1|||
129794879|NCT00718237|467216437|FG001|Overall Study|Physician Decision|0|||
129794880|NCT00718237|467216436|FG000|Overall Study|Withdrawal by Subject|9|||
129794881|NCT00718237|467216437|FG001|Overall Study|Withdrawal by Subject|10|||
129794882|NCT03189381|467216438|FG000|Overall Study|Death|1|||
129794883|NCT03189381|467216439|FG001|Overall Study|Death|0|||
129629907|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629908|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629909|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629910|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629911|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
129794884|NCT00251004|467216440|FG000|Overall Study|Withdrawal by Subject|23|||
129794885|NCT00251004|467216441|FG001|Overall Study|Withdrawal by Subject|16|||
129629912|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
129629913|NCT03334435|466599605|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629914|NCT03334435|466599606|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
129629915|NCT03334435|466599607|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
129629916|NCT03334435|466599608|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
129629917|NCT03334435|466599609|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
129629918|NCT03334435|466599610|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629919|NCT03334435|466599611|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629920|NCT03334435|466599612|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629921|NCT03334435|466599613|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629922|NCT03334435|466599614|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629923|NCT03334435|466599615|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629924|NCT03334435|466599616|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629925|NCT03334435|466599617|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629926|NCT03334435|466599618|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629927|NCT03334435|466599619|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
129629928|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129629929|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129629930|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129629931|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129629932|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
129629933|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
129629934|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
129629935|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
129629936|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
129629937|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
129629938|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
129629939|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
129629940|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
129629941|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
129629942|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
129629943|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129629944|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129629945|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129629946|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129629947|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
129629948|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
129794886|NCT00251004|467216442|FG002|Overall Study|Withdrawal by Subject|14|||
129794887|NCT00251004|467216440|FG000|Overall Study|Death|9|||
129794888|NCT00251004|467216441|FG001|Overall Study|Death|10|||
129794889|NCT00251004|467216442|FG002|Overall Study|Death|8|||
129794890|NCT00251004|467216440|FG000|Overall Study|Lost to Follow-up|1|||
129794891|NCT00251004|467216441|FG001|Overall Study|Lost to Follow-up|2|||
129794892|NCT00251004|467216442|FG002|Overall Study|Lost to Follow-up|1|||
129794893|NCT00251004|467216440|FG000|Overall Study|Graft Loss|12|||
129794894|NCT00251004|467216441|FG001|Overall Study|Graft Loss|13|||
129794895|NCT00251004|467216442|FG002|Overall Study|Graft Loss|8|||
129794896|NCT03455764|467216443|FG000|Overall Study|Adverse Event|1|||
129794897|NCT03455764|467216444|FG001|Overall Study|Adverse Event|0|||
129794898|NCT03455764|467216445|FG002|Overall Study|Adverse Event|0|||
129794899|NCT03455764|467216446|FG003|Overall Study|Adverse Event|0|||
129794900|NCT03455764|467216447|FG004|Overall Study|Adverse Event|0|||
129794901|NCT03455764|467216443|FG000|Overall Study|Disease Progression|4|||
129794902|NCT03455764|467216444|FG001|Overall Study|Disease Progression|0|||
129794903|NCT03455764|467216445|FG002|Overall Study|Disease Progression|0|||
129794904|NCT03455764|467216446|FG003|Overall Study|Disease Progression|0|||
129794905|NCT03455764|467216447|FG004|Overall Study|Disease Progression|0|||
129794906|NCT03455764|467216443|FG000|Overall Study|On Treatment|1|||
129794907|NCT03455764|467216444|FG001|Overall Study|On Treatment|0|||
129794908|NCT03455764|467216445|FG002|Overall Study|On Treatment|0|||
129794909|NCT03455764|467216446|FG003|Overall Study|On Treatment|0|||
129794910|NCT03455764|467216447|FG004|Overall Study|On Treatment|0|||
129794911|NCT04221230|467216458|FG000|Overall Study|Lost to Follow-up|12|||
129794912|NCT04221230|467216459|FG001|Overall Study|Lost to Follow-up|12|||
129794913|NCT04221230|467216458|FG000|Overall Study|Protocol Violation|2|||
129794914|NCT04221230|467216459|FG001|Overall Study|Protocol Violation|2|||
129794915|NCT04221230|467216458|FG000|Overall Study|Adverse Event|0|||
129794916|NCT04221230|467216459|FG001|Overall Study|Adverse Event|8|||
129794917|NCT04221230|467216458|FG000|Overall Study|Physician Decision|1|||
129794918|NCT04221230|467216459|FG001|Overall Study|Physician Decision|0|||
129794919|NCT04221230|467216458|FG000|Overall Study|Withdrawal by Subject|13|||
129889053|NCT01347645|467550990|FG004|Overall Study|Physician Decision|1|||
129889054|NCT01347645|467550986|FG000|Overall Study|Adverse Event|0|||
129889055|NCT01347645|467550987|FG001|Overall Study|Adverse Event|0|||
129889056|NCT01347645|467550988|FG002|Overall Study|Adverse Event|0|||
129889057|NCT01347645|467550989|FG003|Overall Study|Adverse Event|1|||
129889058|NCT01347645|467550990|FG004|Overall Study|Adverse Event|1|||
129889059|NCT00388362|467550991|FG000|Enrolled|Ineligible|1|||
129889060|NCT00388362|467550991|FG000|Enrolled|Adverse Event|9|||
129889061|NCT00388362|467550991|FG000|Enrolled|Death|1|||
129889062|NCT00388362|467550991|FG000|Enrolled|Loss insurance|1|||
129889063|NCT00388362|467550991|FG000|Enrolled|Withdrawal by Subject|1|||
129889064|NCT00388362|467550991|FG000|Remained on Study Median of 514 Days|Death|2|||
129889065|NCT01141660|467550992|FG000|Overall Study|Physician Decision|0|||
129889066|NCT01141660|467550993|FG001|Overall Study|Physician Decision|12|||
129440355|NCT00775450|465911409|FG004|Overall Study|Protocol Violation|1|||
129629949|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
129629950|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
129629951|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
129629952|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
129629953|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
129629954|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
129629955|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
129629956|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
129629957|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
129629958|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129629959|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129629960|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129629961|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129629962|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129629963|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
129629964|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
129629965|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
129629966|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
129629967|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
129629968|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
129629969|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
129629970|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
129629971|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
129629972|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
129629973|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129629974|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129629975|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129629976|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129889067|NCT00209027|467550995|FG000|Overall Study|study terminated|10|||
129889068|NCT00209027|467550996|FG001|Overall Study|study terminated|0|||
129889069|NCT01163149|467550997|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
129889070|NCT01163149|467550998|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129629977|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
129629978|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
129629979|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
129629980|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
129629981|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
129629982|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
129629983|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
129629984|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
129629985|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
129629986|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
129629987|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
129629988|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129629989|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129629990|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129629991|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129629992|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129629993|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129629994|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
129629995|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
129629996|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
129629997|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
129629998|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
129629999|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
129630000|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
129630001|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
129630002|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
129630003|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630004|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630005|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630006|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630007|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630008|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630009|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630010|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630011|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630012|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630013|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630014|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
129630015|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630016|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
129630017|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
129630018|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630019|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630020|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630021|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630022|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630023|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
129630024|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630025|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630026|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630027|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
129794920|NCT04221230|467216459|FG001|Overall Study|Withdrawal by Subject|11|||
129794921|NCT04221230|467216458|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129794922|NCT04221230|467216459|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129794923|NCT04221230|467216458|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129794924|NCT04221230|467216459|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129794925|NCT04221230|467216458|FG000|Overall Study|Pregnancy|0|||
129794926|NCT04221230|467216459|FG001|Overall Study|Pregnancy|1|||
129794927|NCT04221230|467216458|FG000|Overall Study|Other|1|||
129794928|NCT04221230|467216459|FG001|Overall Study|Other|2|||
129794929|NCT02021656|467216461|FG000|Overall Study|Adverse Event|1|||
129794930|NCT02021656|467216461|FG000|Overall Study|Lack of Efficacy|2|||
129794931|NCT02021656|467216461|FG000|Overall Study|Lost to Follow-up|1|||
129794932|NCT02021656|467216461|FG000|Overall Study|Withdrew Consent|2|||
129889071|NCT01163149|467550999|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
129889072|NCT01163149|467550997|FG000|Extension Treatment Period|Adverse Event|0|||
129630028|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630029|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630030|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630031|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
129630032|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
129630033|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630034|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630035|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630036|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630037|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630038|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129630039|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129630040|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129630041|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129630042|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
129630043|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129630044|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
129630045|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630046|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630047|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
129630048|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630049|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630050|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630051|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630052|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630053|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129630054|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129630055|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630056|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630057|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630058|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
129630059|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129630060|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
129630061|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
129630062|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
129630063|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630064|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630065|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630066|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630067|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630068|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
129630069|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630070|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630071|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630072|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630073|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
129630074|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630075|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630076|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
129630077|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
129630078|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129703626|NCT02958865|466877508|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129630079|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630080|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630081|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630082|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630083|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630084|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630085|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129630086|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129630087|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630088|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129703627|NCT02958865|466877509|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129630089|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
129630090|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
129630091|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630092|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
129630093|NCT03334435|466599605|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630094|NCT03334435|466599606|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630095|NCT03334435|466599607|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630096|NCT03334435|466599608|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630097|NCT03334435|466599609|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630098|NCT03334435|466599610|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630099|NCT03334435|466599611|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630100|NCT03334435|466599612|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630101|NCT03334435|466599613|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630102|NCT03334435|466599614|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630103|NCT03334435|466599615|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630104|NCT03334435|466599616|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
129630105|NCT03334435|466599617|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
129630106|NCT03334435|466599618|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
129630107|NCT03334435|466599619|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
129630108|NCT03922321|466599620|FG000|Overall Study|Participant Moved|1|||
129630109|NCT03922321|466599620|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
129630110|NCT04067050|466599621|FG000|One Month|Lost to Follow-up|4|||
129630111|NCT04067050|466599622|FG001|One Month|Lost to Follow-up|0|||
129630112|NCT04067050|466599621|FG000|Two Month|Lost to Follow-up|1|||
129630113|NCT04067050|466599622|FG001|Two Month|Lost to Follow-up|0|||
129630114|NCT04067050|466599621|FG000|Two Month|Adverse Event|1|||
129630115|NCT04067050|466599622|FG001|Two Month|Adverse Event|0|||
129630116|NCT01062425|466599627|FG000|Overall Study|Protocol Violation|3|||
129630117|NCT01062425|466599628|FG001|Overall Study|Protocol Violation|6|||
129630118|NCT02342678|466599629|FG000|Overall Study|Lost to Follow-up|0|||
129630119|NCT02342678|466599630|FG001|Overall Study|Lost to Follow-up|1|||
129630120|NCT02342678|466599629|FG000|Overall Study|Too busy to complete study|0|||
129630121|NCT02342678|466599630|FG001|Overall Study|Too busy to complete study|2|||
129630122|NCT02342678|466599629|FG000|Overall Study|Family illness/emergency|0|||
129630123|NCT02342678|466599630|FG001|Overall Study|Family illness/emergency|1|||
129630124|NCT02342678|466599629|FG000|Overall Study|Illness/medical reason|1|||
129630125|NCT02342678|466599630|FG001|Overall Study|Illness/medical reason|1|||
129630126|NCT02383017|466599631|FG000|Overall Study|Injury Sustained Outside Study|1|||
129630127|NCT02383017|466599632|FG001|Overall Study|Injury Sustained Outside Study|0|||
129630128|NCT02383017|466599631|FG000|Overall Study|Compliance|3|||
129630129|NCT02383017|466599632|FG001|Overall Study|Compliance|2|||
129630130|NCT02383017|466599631|FG000|Overall Study|Found to be Hypogonadal|1|||
129630131|NCT02383017|466599632|FG001|Overall Study|Found to be Hypogonadal|0|||
129630132|NCT00460603|466599633|FG000|Phase 1|Death|1|||
129630133|NCT00460603|466599634|FG001|Phase 1|Death|0|||
129630134|NCT00460603|466599635|FG002|Phase 1|Death|0|||
129630135|NCT00460603|466599636|FG003|Phase 1|Death|2|||
129630136|NCT00460603|466599637|FG004|Phase 1|Death|0|||
129630137|NCT00460603|466599638|FG005|Phase 1|Death|0|||
129630138|NCT00460603|466599639|FG006|Phase 1|Death|0|||
129630139|NCT00460603|466599640|FG007|Phase 1|Death|0|||
129630140|NCT00460603|466599641|FG008|Phase 1|Death|1|||
129630141|NCT00460603|466599642|FG009|Phase 1|Death|0|||
129630142|NCT00460603|466599643|FG010|Phase 1|Death|0|||
129630143|NCT00460603|466599644|FG011|Phase 1|Death|0|||
129703628|NCT02958865|466877510|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703629|NCT02958865|466877511|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703630|NCT02958865|466877512|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703631|NCT02958865|466877513|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703632|NCT02958865|466877514|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703633|NCT02958865|466877515|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703634|NCT02958865|466877516|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129703635|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703636|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703637|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703638|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703639|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703640|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703641|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129630144|NCT00460603|466599633|FG000|Phase 1|Adverse Event|3|||
129630145|NCT00460603|466599634|FG001|Phase 1|Adverse Event|1|||
129630146|NCT00460603|466599635|FG002|Phase 1|Adverse Event|1|||
129630147|NCT00460603|466599636|FG003|Phase 1|Adverse Event|2|||
129630148|NCT00460603|466599637|FG004|Phase 1|Adverse Event|0|||
129630149|NCT00460603|466599638|FG005|Phase 1|Adverse Event|0|||
129630150|NCT00460603|466599639|FG006|Phase 1|Adverse Event|3|||
129630151|NCT00460603|466599640|FG007|Phase 1|Adverse Event|0|||
129794933|NCT00596362|467216462|FG000|Overall Study|Progressive Disease|1|||
129794934|NCT00282347|467216465|FG000|Treatment Period|Death|2|||
129630152|NCT00460603|466599641|FG008|Phase 1|Adverse Event|4|||
129630153|NCT00460603|466599642|FG009|Phase 1|Adverse Event|0|||
129630154|NCT00460603|466599643|FG010|Phase 1|Adverse Event|0|||
129630155|NCT00460603|466599644|FG011|Phase 1|Adverse Event|0|||
129630156|NCT00460603|466599633|FG000|Phase 1|Lack of Efficacy|1|||
129630157|NCT00460603|466599634|FG001|Phase 1|Lack of Efficacy|0|||
129630158|NCT00460603|466599635|FG002|Phase 1|Lack of Efficacy|1|||
129630159|NCT00460603|466599636|FG003|Phase 1|Lack of Efficacy|2|||
129630160|NCT00460603|466599637|FG004|Phase 1|Lack of Efficacy|2|||
129630161|NCT00460603|466599638|FG005|Phase 1|Lack of Efficacy|2|||
129630162|NCT00460603|466599639|FG006|Phase 1|Lack of Efficacy|2|||
129630163|NCT00460603|466599640|FG007|Phase 1|Lack of Efficacy|2|||
129630164|NCT00460603|466599641|FG008|Phase 1|Lack of Efficacy|11|||
129630165|NCT00460603|466599642|FG009|Phase 1|Lack of Efficacy|0|||
129630166|NCT00460603|466599643|FG010|Phase 1|Lack of Efficacy|0|||
129630167|NCT00460603|466599644|FG011|Phase 1|Lack of Efficacy|0|||
129630168|NCT00460603|466599633|FG000|Phase 1|Withdrawal by Subject|1|||
129630169|NCT00460603|466599634|FG001|Phase 1|Withdrawal by Subject|2|||
129630170|NCT00460603|466599635|FG002|Phase 1|Withdrawal by Subject|1|||
129630171|NCT00460603|466599636|FG003|Phase 1|Withdrawal by Subject|1|||
129630172|NCT00460603|466599637|FG004|Phase 1|Withdrawal by Subject|3|||
129630173|NCT00460603|466599638|FG005|Phase 1|Withdrawal by Subject|0|||
129630174|NCT00460603|466599639|FG006|Phase 1|Withdrawal by Subject|1|||
129630175|NCT00460603|466599640|FG007|Phase 1|Withdrawal by Subject|0|||
129630176|NCT00460603|466599641|FG008|Phase 1|Withdrawal by Subject|2|||
129630177|NCT00460603|466599642|FG009|Phase 1|Withdrawal by Subject|0|||
129630178|NCT00460603|466599643|FG010|Phase 1|Withdrawal by Subject|0|||
129630179|NCT00460603|466599644|FG011|Phase 1|Withdrawal by Subject|0|||
129630180|NCT00460603|466599633|FG000|Phase 1|Other|0|||
129630181|NCT00460603|466599634|FG001|Phase 1|Other|3|||
129630182|NCT00460603|466599635|FG002|Phase 1|Other|1|||
129630183|NCT00460603|466599636|FG003|Phase 1|Other|1|||
129630184|NCT00460603|466599637|FG004|Phase 1|Other|1|||
129630185|NCT00460603|466599638|FG005|Phase 1|Other|2|||
129630186|NCT00460603|466599639|FG006|Phase 1|Other|0|||
129630187|NCT00460603|466599640|FG007|Phase 1|Other|1|||
129630188|NCT00460603|466599641|FG008|Phase 1|Other|0|||
129630189|NCT00460603|466599642|FG009|Phase 1|Other|0|||
129630190|NCT00460603|466599643|FG010|Phase 1|Other|0|||
129630191|NCT00460603|466599644|FG011|Phase 1|Other|0|||
129630192|NCT00460603|466599633|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630193|NCT00460603|466599634|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630194|NCT00460603|466599635|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630195|NCT00460603|466599636|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630196|NCT00460603|466599637|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630197|NCT00460603|466599638|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630198|NCT00460603|466599639|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129703642|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129703643|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129703644|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
129703645|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
129703646|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129703647|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
129703648|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129703649|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
129703650|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
129794935|NCT00282347|467216466|FG001|Treatment Period|Death|0|||
129794936|NCT00282347|467216465|FG000|Treatment Period|Lost to Follow-up|2|||
129794937|NCT00282347|467216466|FG001|Treatment Period|Lost to Follow-up|5|||
129794938|NCT00282347|467216465|FG000|Treatment Period|Withdrawal by Subject|1|||
129794939|NCT00282347|467216466|FG001|Treatment Period|Withdrawal by Subject|3|||
129794940|NCT00282347|467216465|FG000|Treatment Period|Physician Decision|0|||
129794941|NCT00282347|467216466|FG001|Treatment Period|Physician Decision|1|||
129794942|NCT00282347|467216465|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
129794943|NCT00282347|467216466|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
129794944|NCT00282347|467216465|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
129794945|NCT00282347|467216466|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
129794946|NCT00282347|467216465|FG000|Safety Follow-up Period|Physician Decision|1|||
129794947|NCT00282347|467216466|FG001|Safety Follow-up Period|Physician Decision|1|||
129794948|NCT00282347|467216465|FG000|Safety Follow-up Period|Protocol Deviation|0|||
129794949|NCT00282347|467216466|FG001|Safety Follow-up Period|Protocol Deviation|2|||
129794950|NCT00282347|467216465|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
129630199|NCT00460603|466599640|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630200|NCT00460603|466599641|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630201|NCT00460603|466599642|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
129630202|NCT00460603|466599643|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129630203|NCT00460603|466599644|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
129794951|NCT00282347|467216466|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
129794952|NCT00282347|467216465|FG000|B Cell Follow-up Period|Physician Decision|1|||
129794953|NCT00282347|467216466|FG001|B Cell Follow-up Period|Physician Decision|0|||
129630204|NCT00460603|466599633|FG000|Phase 2|Adverse Event|0|||
129630205|NCT00460603|466599634|FG001|Phase 2|Adverse Event|0|||
129630206|NCT00460603|466599635|FG002|Phase 2|Adverse Event|0|||
129630207|NCT00460603|466599636|FG003|Phase 2|Adverse Event|0|||
129630208|NCT00460603|466599637|FG004|Phase 2|Adverse Event|0|||
129630209|NCT00460603|466599638|FG005|Phase 2|Adverse Event|0|||
129630210|NCT00460603|466599639|FG006|Phase 2|Adverse Event|0|||
129630211|NCT00460603|466599640|FG007|Phase 2|Adverse Event|0|||
129630212|NCT00460603|466599641|FG008|Phase 2|Adverse Event|0|||
129630213|NCT00460603|466599642|FG009|Phase 2|Adverse Event|12|||
129630214|NCT00460603|466599643|FG010|Phase 2|Adverse Event|9|||
129630215|NCT00460603|466599644|FG011|Phase 2|Adverse Event|10|||
129630216|NCT00460603|466599633|FG000|Phase 2|Death|0|||
129630217|NCT00460603|466599634|FG001|Phase 2|Death|0|||
129630218|NCT00460603|466599635|FG002|Phase 2|Death|0|||
129630219|NCT00460603|466599636|FG003|Phase 2|Death|0|||
129630220|NCT00460603|466599637|FG004|Phase 2|Death|0|||
129630221|NCT00460603|466599638|FG005|Phase 2|Death|0|||
129630222|NCT00460603|466599639|FG006|Phase 2|Death|0|||
129630223|NCT00460603|466599640|FG007|Phase 2|Death|0|||
129630224|NCT00460603|466599641|FG008|Phase 2|Death|0|||
129630225|NCT00460603|466599642|FG009|Phase 2|Death|4|||
129630226|NCT00460603|466599643|FG010|Phase 2|Death|2|||
129630227|NCT00460603|466599644|FG011|Phase 2|Death|2|||
129630228|NCT00460603|466599633|FG000|Phase 2|Protocol Violation|0|||
129630229|NCT00460603|466599634|FG001|Phase 2|Protocol Violation|0|||
129630230|NCT00460603|466599635|FG002|Phase 2|Protocol Violation|0|||
129630231|NCT00460603|466599636|FG003|Phase 2|Protocol Violation|0|||
129630232|NCT00460603|466599637|FG004|Phase 2|Protocol Violation|0|||
129630233|NCT00460603|466599638|FG005|Phase 2|Protocol Violation|0|||
129630234|NCT00460603|466599639|FG006|Phase 2|Protocol Violation|0|||
129630235|NCT00460603|466599640|FG007|Phase 2|Protocol Violation|0|||
129630236|NCT00460603|466599641|FG008|Phase 2|Protocol Violation|0|||
129630237|NCT00460603|466599642|FG009|Phase 2|Protocol Violation|1|||
129630238|NCT00460603|466599643|FG010|Phase 2|Protocol Violation|1|||
129630239|NCT00460603|466599644|FG011|Phase 2|Protocol Violation|0|||
129630240|NCT00460603|466599633|FG000|Phase 2|Lost to Follow-up|0|||
129630241|NCT00460603|466599634|FG001|Phase 2|Lost to Follow-up|0|||
129630242|NCT00460603|466599635|FG002|Phase 2|Lost to Follow-up|0|||
129630243|NCT00460603|466599636|FG003|Phase 2|Lost to Follow-up|0|||
129630244|NCT00460603|466599637|FG004|Phase 2|Lost to Follow-up|0|||
129630245|NCT00460603|466599638|FG005|Phase 2|Lost to Follow-up|0|||
129630246|NCT00460603|466599639|FG006|Phase 2|Lost to Follow-up|0|||
129630247|NCT00460603|466599640|FG007|Phase 2|Lost to Follow-up|0|||
129630248|NCT00460603|466599641|FG008|Phase 2|Lost to Follow-up|0|||
129630249|NCT00460603|466599642|FG009|Phase 2|Lost to Follow-up|1|||
129630250|NCT00460603|466599643|FG010|Phase 2|Lost to Follow-up|0|||
129630251|NCT00460603|466599644|FG011|Phase 2|Lost to Follow-up|0|||
129630252|NCT00460603|466599633|FG000|Phase 2|Other|0|||
129630253|NCT00460603|466599634|FG001|Phase 2|Other|0|||
129630254|NCT00460603|466599635|FG002|Phase 2|Other|0|||
129630255|NCT00460603|466599636|FG003|Phase 2|Other|0|||
129630256|NCT00460603|466599637|FG004|Phase 2|Other|0|||
129630257|NCT00460603|466599638|FG005|Phase 2|Other|0|||
129630258|NCT00460603|466599639|FG006|Phase 2|Other|0|||
129630259|NCT00460603|466599640|FG007|Phase 2|Other|0|||
129630260|NCT00460603|466599641|FG008|Phase 2|Other|0|||
129630261|NCT00460603|466599642|FG009|Phase 2|Other|6|||
129630262|NCT00460603|466599643|FG010|Phase 2|Other|16|||
129630263|NCT00460603|466599644|FG011|Phase 2|Other|7|||
129630264|NCT00460603|466599633|FG000|Phase 2|Objective Progression or Relapse|0|||
129630265|NCT00460603|466599634|FG001|Phase 2|Objective Progression or Relapse|0|||
129794954|NCT00282347|467216465|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
129630266|NCT00460603|466599635|FG002|Phase 2|Objective Progression or Relapse|0|||
129794955|NCT00282347|467216466|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
129630267|NCT00460603|466599636|FG003|Phase 2|Objective Progression or Relapse|0|||
129630268|NCT00460603|466599637|FG004|Phase 2|Objective Progression or Relapse|0|||
129630269|NCT00460603|466599638|FG005|Phase 2|Objective Progression or Relapse|0|||
129630270|NCT00460603|466599639|FG006|Phase 2|Objective Progression or Relapse|0|||
129630271|NCT00460603|466599640|FG007|Phase 2|Objective Progression or Relapse|0|||
129630272|NCT00460603|466599641|FG008|Phase 2|Objective Progression or Relapse|0|||
129630273|NCT00460603|466599642|FG009|Phase 2|Objective Progression or Relapse|9|||
129630274|NCT00460603|466599643|FG010|Phase 2|Objective Progression or Relapse|10|||
129630275|NCT00460603|466599644|FG011|Phase 2|Objective Progression or Relapse|17|||
129630276|NCT00460603|466599633|FG000|Phase 2|Global Deterioration of Health Status|0|||
129630277|NCT00460603|466599634|FG001|Phase 2|Global Deterioration of Health Status|0|||
129630278|NCT00460603|466599635|FG002|Phase 2|Global Deterioration of Health Status|0|||
129630279|NCT00460603|466599636|FG003|Phase 2|Global Deterioration of Health Status|0|||
129630280|NCT00460603|466599637|FG004|Phase 2|Global Deterioration of Health Status|0|||
129703651|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703652|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703653|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703654|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703655|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703656|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703657|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703658|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703659|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
129703660|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
129703661|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703662|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
129703663|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703664|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
129703665|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
129703666|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
129703667|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703668|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703669|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703670|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703671|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703672|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703673|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703674|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703675|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703676|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
129703677|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703678|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703679|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703680|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703681|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
129703682|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
129703683|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703684|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703685|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703686|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703687|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703688|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703689|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703690|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703691|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703692|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703693|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
129703694|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
129703695|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
129703696|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
129703697|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
129703698|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
129703699|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
129703700|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
129703701|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
129703702|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
129703703|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
129703704|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
129703705|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
129703706|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
129703707|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
129703708|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
129703709|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
129703710|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
129703711|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
129703712|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
129703713|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
129703714|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
129703715|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129630281|NCT00460603|466599638|FG005|Phase 2|Global Deterioration of Health Status|0|||
129630282|NCT00460603|466599639|FG006|Phase 2|Global Deterioration of Health Status|0|||
129630283|NCT00460603|466599640|FG007|Phase 2|Global Deterioration of Health Status|0|||
129630284|NCT00460603|466599641|FG008|Phase 2|Global Deterioration of Health Status|0|||
129630285|NCT00460603|466599642|FG009|Phase 2|Global Deterioration of Health Status|0|||
129630286|NCT00460603|466599643|FG010|Phase 2|Global Deterioration of Health Status|1|||
129630287|NCT00460603|466599644|FG011|Phase 2|Global Deterioration of Health Status|0|||
129630288|NCT00460603|466599633|FG000|Phase 2|Withdrawal by Subject|0|||
129630289|NCT00460603|466599634|FG001|Phase 2|Withdrawal by Subject|0|||
129630290|NCT00460603|466599635|FG002|Phase 2|Withdrawal by Subject|0|||
129630291|NCT00460603|466599636|FG003|Phase 2|Withdrawal by Subject|0|||
129630292|NCT00460603|466599637|FG004|Phase 2|Withdrawal by Subject|0|||
129630293|NCT00460603|466599638|FG005|Phase 2|Withdrawal by Subject|0|||
129630294|NCT00460603|466599639|FG006|Phase 2|Withdrawal by Subject|0|||
129630295|NCT00460603|466599640|FG007|Phase 2|Withdrawal by Subject|0|||
129630296|NCT00460603|466599641|FG008|Phase 2|Withdrawal by Subject|0|||
129630297|NCT00460603|466599642|FG009|Phase 2|Withdrawal by Subject|5|||
129630298|NCT00460603|466599643|FG010|Phase 2|Withdrawal by Subject|4|||
129630299|NCT00460603|466599644|FG011|Phase 2|Withdrawal by Subject|5|||
129630300|NCT00460603|466599633|FG000|Phase 2|Randomized, but not treated|0|||
129630301|NCT00460603|466599634|FG001|Phase 2|Randomized, but not treated|0|||
129630302|NCT00460603|466599635|FG002|Phase 2|Randomized, but not treated|0|||
129630303|NCT00460603|466599636|FG003|Phase 2|Randomized, but not treated|0|||
129630304|NCT00460603|466599637|FG004|Phase 2|Randomized, but not treated|0|||
129630305|NCT00460603|466599638|FG005|Phase 2|Randomized, but not treated|0|||
129630306|NCT00460603|466599639|FG006|Phase 2|Randomized, but not treated|0|||
129630307|NCT00460603|466599640|FG007|Phase 2|Randomized, but not treated|0|||
129630308|NCT00460603|466599641|FG008|Phase 2|Randomized, but not treated|0|||
129630309|NCT00460603|466599642|FG009|Phase 2|Randomized, but not treated|3|||
129630310|NCT00460603|466599643|FG010|Phase 2|Randomized, but not treated|0|||
129630311|NCT00460603|466599644|FG011|Phase 2|Randomized, but not treated|0|||
129630312|NCT00289848|466599645|FG000|Overall Study|Adverse Event|6|||
129630313|NCT00289848|466599646|FG001|Overall Study|Adverse Event|4|||
129630314|NCT00289848|466599645|FG000|Overall Study|Death|1|||
129630315|NCT00289848|466599646|FG001|Overall Study|Death|0|||
129630316|NCT00289848|466599645|FG000|Overall Study|Lack of Efficacy|20|||
129630317|NCT00289848|466599646|FG001|Overall Study|Lack of Efficacy|24|||
129630318|NCT00289848|466599645|FG000|Overall Study|Lost to Follow-up|3|||
129630319|NCT00289848|466599646|FG001|Overall Study|Lost to Follow-up|1|||
129630320|NCT00289848|466599645|FG000|Overall Study|Protocol Violation|5|||
129630321|NCT00289848|466599646|FG001|Overall Study|Protocol Violation|2|||
129630322|NCT00289848|466599645|FG000|Overall Study|Withdrawal by Subject|5|||
129630323|NCT00289848|466599646|FG001|Overall Study|Withdrawal by Subject|11|||
129630324|NCT00289848|466599645|FG000|Overall Study|Patient Moved|6|||
129630325|NCT00289848|466599646|FG001|Overall Study|Patient Moved|2|||
129630326|NCT00289848|466599645|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
129630327|NCT00289848|466599646|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
129630328|NCT03871543|466599649|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
129630329|NCT03871543|466599649|FG000|Period 1|Investigator Error|1|||
129630330|NCT03871543|466599649|FG000|Period 1|Protocol Violation|2|||
129630331|NCT03871543|466599649|FG000|Period 1|COVID-19 Related|1|||
129630332|NCT03871543|466599649|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
129630333|NCT03871543|466599649|FG000|Period 1|Withdrawal by Subject|10|||
129630334|NCT03871543|466599649|FG000|Period 2|Adverse Event|1|||
129630335|NCT03871543|466599649|FG000|Period 2|Withdrawal by Subject|1|||
129630336|NCT03534687|466599654|FG000|Overall Study|Lost to Follow-up|7|||
129630337|NCT03534687|466599655|FG001|Overall Study|Lost to Follow-up|2|||
129630338|NCT00395629|466599656|FG000|Core Study|Adverse Event|0|||
129630339|NCT00395629|466599657|FG001|Core Study|Adverse Event|3|||
129630340|NCT00395629|466599658|FG002|Core Study|Adverse Event|4|||
129630341|NCT00395629|466599656|FG000|Core Study|Abnormal laboratory value(s)|0|||
129630342|NCT00395629|466599657|FG001|Core Study|Abnormal laboratory value(s)|0|||
129630343|NCT00395629|466599658|FG002|Core Study|Abnormal laboratory value(s)|1|||
129630344|NCT00395629|466599656|FG000|Core Study|Protocol Violation|1|||
129630345|NCT00395629|466599657|FG001|Core Study|Protocol Violation|0|||
129630346|NCT00395629|466599658|FG002|Core Study|Protocol Violation|0|||
129630347|NCT00395629|466599656|FG000|Core Study|Withdrawal by Subject|0|||
129630348|NCT00395629|466599657|FG001|Core Study|Withdrawal by Subject|1|||
129630349|NCT00395629|466599658|FG002|Core Study|Withdrawal by Subject|1|||
129630350|NCT00395629|466599656|FG000|Core Study|Lost to Follow-up|0|||
129630351|NCT00395629|466599657|FG001|Core Study|Lost to Follow-up|0|||
129630352|NCT00395629|466599658|FG002|Core Study|Lost to Follow-up|1|||
129630353|NCT00395629|466599656|FG000|Extension Study|Adverse Event|0|||
129630354|NCT00395629|466599657|FG001|Extension Study|Adverse Event|0|||
129630355|NCT00395629|466599658|FG002|Extension Study|Adverse Event|2|||
129630356|NCT00395629|466599656|FG000|Extension Study|Administrative problems|0|||
129630357|NCT00395629|466599657|FG001|Extension Study|Administrative problems|0|||
129630358|NCT00395629|466599658|FG002|Extension Study|Administrative problems|1|||
129630359|NCT02570308|466599659|FG000|Overall Study|Death|1|||
129630360|NCT02570308|466599660|FG001|Overall Study|Death|5|||
129630361|NCT02570308|466599661|FG002|Overall Study|Death|4|||
129630362|NCT02570308|466599662|FG003|Overall Study|Death|4|||
129630363|NCT02570308|466599663|FG004|Overall Study|Death|69|||
129630364|NCT02570308|466599659|FG000|Overall Study|Lost to Follow-up|0|||
129630365|NCT02570308|466599660|FG001|Overall Study|Lost to Follow-up|0|||
129630366|NCT02570308|466599661|FG002|Overall Study|Lost to Follow-up|0|||
129630367|NCT02570308|466599662|FG003|Overall Study|Lost to Follow-up|0|||
129630368|NCT02570308|466599663|FG004|Overall Study|Lost to Follow-up|2|||
129630369|NCT02570308|466599659|FG000|Overall Study|Withdrawal by Subject|0|||
129630370|NCT02570308|466599660|FG001|Overall Study|Withdrawal by Subject|0|||
129630371|NCT02570308|466599661|FG002|Overall Study|Withdrawal by Subject|0|||
129630372|NCT02570308|466599662|FG003|Overall Study|Withdrawal by Subject|0|||
129630373|NCT02570308|466599663|FG004|Overall Study|Withdrawal by Subject|1|||
129630374|NCT02570308|466599659|FG000|Overall Study|Other|0|||
129630375|NCT02570308|466599660|FG001|Overall Study|Other|0|||
129630376|NCT02570308|466599661|FG002|Overall Study|Other|0|||
129630377|NCT02570308|466599662|FG003|Overall Study|Other|0|||
129630378|NCT02570308|466599663|FG004|Overall Study|Other|2|||
129630379|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
129630380|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
129630381|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
129630382|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129630383|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129630384|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129630385|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129630386|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129630387|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129630388|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
129630389|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129630390|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129630391|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129630392|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
129630393|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
129630394|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129630395|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
129630396|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129630397|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129630398|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129630399|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129630400|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
129630401|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129630402|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
129703716|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129794956|NCT00356122|467216467|FG000|TREATMENT|Lack of Efficacy|26|||
129630403|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129630404|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129630405|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129630406|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129630407|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
129630408|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
129630409|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
129630410|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129630411|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129630412|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129630413|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129630414|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129630415|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129630416|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
129630417|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129630418|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129630419|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129630420|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
129630421|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129630422|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129630423|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
129630424|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129630425|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129630426|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129630427|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
129630428|NCT04242498|466599664|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129630429|NCT04242498|466599665|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
129630430|NCT04242498|466599666|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
129630431|NCT04242498|466599667|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129630432|NCT04242498|466599668|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129630433|NCT04242498|466599669|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129630434|NCT04242498|466599670|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129630435|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129630436|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129630437|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129630438|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129630439|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
129630440|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
129630441|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
129630442|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129630443|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129630444|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129703717|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129440356|NCT00775450|465911405|FG000|Overall Study|Withdrawal by Subject|1|||
129440357|NCT00775450|465911406|FG001|Overall Study|Withdrawal by Subject|0|||
129440358|NCT00775450|465911407|FG002|Overall Study|Withdrawal by Subject|0|||
129630445|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129630446|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
129630447|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
129630448|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
129630449|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129630450|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129630451|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129630452|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129630453|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129630454|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
129630455|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
129630456|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129630457|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129630458|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129630459|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
129630460|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
129630461|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
129630462|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
129630463|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129630464|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129630465|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129630466|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
129630467|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
129630468|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
129703718|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703719|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703720|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703721|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703722|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703723|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703724|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703725|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703726|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703727|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703728|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
129703729|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703730|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
129703731|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703732|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703733|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703734|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703735|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703736|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703737|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703738|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703739|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703740|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703741|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703742|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703743|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703744|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
129703745|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129703746|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
129794957|NCT00356122|467216467|FG000|TREATMENT|Adverse Event|10|||
129794958|NCT00356122|467216467|FG000|TREATMENT|Subject's request|4|||
129794959|NCT00356122|467216467|FG000|TREATMENT|Other|4|||
129794960|NCT00356122|467216467|FG000|TREATMENT|Did not receive study medication|1|||
129794961|NCT00356122|467216467|FG000|FOLLOW-UP|Death|37|||
129794962|NCT00356122|467216467|FG000|FOLLOW-UP|Lost to Follow-up|2|||
129794963|NCT00356122|467216467|FG000|FOLLOW-UP|Other|2|||
129794964|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
129794965|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
129794966|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
129794967|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
129794968|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
129794969|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
129794970|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
129794971|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
129630469|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
129630470|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129630471|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129630472|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129630473|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129630474|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
129630475|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129630476|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
129630477|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129630478|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129630479|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129630480|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129630481|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129630482|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
129630483|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
129630484|NCT04242498|466599664|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129630485|NCT04242498|466599665|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129630486|NCT04242498|466599666|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129630487|NCT04242498|466599667|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129630488|NCT04242498|466599668|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
129630489|NCT04242498|466599669|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
129630490|NCT04242498|466599670|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
129630491|NCT00765102|466599671|FG000|Overall Study|Progressive disease|18|||
129630492|NCT00765102|466599671|FG000|Overall Study|Adverse Event|6|||
129630493|NCT00765102|466599671|FG000|Overall Study|Physician Decision|4|||
129630494|NCT00765102|466599671|FG000|Overall Study|Withdrawal by Subject|2|||
129630495|NCT00765102|466599671|FG000|Overall Study|Protocol Violation|1|||
129630496|NCT04129125|466599678|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
129630497|NCT04129125|466599678|FG000|Overall Study|Study device was not used|3|||
129630498|NCT04484142|466599679|FG000|Overall Study|Adverse Event|13|||
129630499|NCT04484142|466599679|FG000|Overall Study|Progressive Disease|87|||
129630500|NCT04484142|466599679|FG000|Overall Study|Clinical Progression|10|||
129630501|NCT04484142|466599679|FG000|Overall Study|Withdrawal by Subject|6|||
129630502|NCT04484142|466599679|FG000|Overall Study|Physician Decision|1|||
129630503|NCT03181633|466599682|FG000|Overall Study|Withdrawal by Subject|1|||
129630504|NCT03181633|466599682|FG000|Overall Study|Missing follow-up visit|1|||
129630505|NCT02962648|466599683|FG000|Overall Study|Withdrawal by Subject|3|||
129630506|NCT02962648|466599683|FG000|Overall Study|Lost to Follow-up|3|||
129703747|NCT02958865|466877501|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703748|NCT02958865|466877502|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703749|NCT02958865|466877503|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703750|NCT02958865|466877504|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703751|NCT02958865|466877505|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703752|NCT02958865|466877506|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703753|NCT02958865|466877507|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703754|NCT02958865|466877508|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703755|NCT02958865|466877509|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703756|NCT02958865|466877510|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
129703757|NCT02958865|466877511|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703758|NCT02958865|466877512|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703759|NCT02958865|466877513|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703760|NCT02958865|466877514|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703761|NCT02958865|466877515|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703762|NCT02958865|466877516|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
129703763|NCT02661815|466877517|FG000|Overall Study|Withdrawal by Subject|1|||
129703764|NCT02661815|466877518|FG001|Overall Study|Withdrawal by Subject|0|||
129703765|NCT02661815|466877519|FG002|Overall Study|Withdrawal by Subject|0|||
129703766|NCT02661815|466877520|FG003|Overall Study|Withdrawal by Subject|0|||
129703767|NCT01728246|466877523|FG000|Overall Study|Participant needed rescue medication|1|||
129703768|NCT01728246|466877524|FG001|Overall Study|Participant needed rescue medication|5|||
129703769|NCT01728246|466877523|FG000|Overall Study|Protocol Violation|1|||
129703770|NCT01728246|466877524|FG001|Overall Study|Protocol Violation|0|||
129703771|NCT01728246|466877523|FG000|Overall Study|Withdrawal by Subject|2|||
129703772|NCT01728246|466877524|FG001|Overall Study|Withdrawal by Subject|3|||
129703773|NCT01728246|466877523|FG000|Overall Study|Lost to Follow-up|23|||
129703774|NCT01728246|466877524|FG001|Overall Study|Lost to Follow-up|22|||
129703775|NCT01728246|466877523|FG000|Overall Study|Lack of Efficacy|1|||
129703776|NCT01728246|466877524|FG001|Overall Study|Lack of Efficacy|1|||
129703777|NCT01728246|466877523|FG000|Overall Study|Adverse Event|8|||
129703778|NCT01728246|466877524|FG001|Overall Study|Adverse Event|5|||
129703779|NCT01983111|466877525|FG000|Overall Study|Withdrawal by Subject|8|||
129703780|NCT01983111|466877526|FG001|Overall Study|Withdrawal by Subject|6|||
129703781|NCT01983111|466877525|FG000|Overall Study|Adverse Event|4|||
129703782|NCT01983111|466877526|FG001|Overall Study|Adverse Event|0|||
129703783|NCT01983111|466877525|FG000|Overall Study|Protocol Violation|0|||
129703784|NCT01983111|466877526|FG001|Overall Study|Protocol Violation|1|||
129703785|NCT03502200|466877527|FG000|Overall Study|Adverse Event|1|||
129703786|NCT03502200|466877528|FG001|Overall Study|Adverse Event|0|||
129703787|NCT03502200|466877527|FG000|Overall Study|Lost to Follow-up|36|||
129703788|NCT03502200|466877528|FG001|Overall Study|Lost to Follow-up|38|||
129703789|NCT03502200|466877527|FG000|Overall Study|Study Team Decision|1|||
129703790|NCT03502200|466877528|FG001|Overall Study|Study Team Decision|1|||
129703791|NCT03502200|466877527|FG000|Overall Study|Withdrawal by Subject|5|||
129703792|NCT03502200|466877528|FG001|Overall Study|Withdrawal by Subject|7|||
129703793|NCT03502200|466877527|FG000|Overall Study|Death|0|||
129703794|NCT03502200|466877528|FG001|Overall Study|Death|2|||
129703795|NCT00855335|466877529|FG000|Overall Study|Lost to Follow-up|0|||
129703796|NCT00855335|466877530|FG001|Overall Study|Lost to Follow-up|0|||
129703797|NCT00855335|466877531|FG002|Overall Study|Lost to Follow-up|3|||
129703798|NCT00855335|466877532|FG003|Overall Study|Lost to Follow-up|1|||
129703799|NCT00855335|466877533|FG004|Overall Study|Lost to Follow-up|0|||
129703800|NCT00855335|466877529|FG000|Overall Study|Withdrawal by Subject|0|||
129703801|NCT00855335|466877530|FG001|Overall Study|Withdrawal by Subject|0|||
129703802|NCT00855335|466877531|FG002|Overall Study|Withdrawal by Subject|0|||
129703803|NCT00855335|466877532|FG003|Overall Study|Withdrawal by Subject|1|||
129703804|NCT00855335|466877533|FG004|Overall Study|Withdrawal by Subject|0|||
129703805|NCT00855335|466877529|FG000|Overall Study|Adverse Event|2|||
129703806|NCT00855335|466877530|FG001|Overall Study|Adverse Event|0|||
129703807|NCT00855335|466877531|FG002|Overall Study|Adverse Event|0|||
129703808|NCT00855335|466877532|FG003|Overall Study|Adverse Event|0|||
129703809|NCT00855335|466877533|FG004|Overall Study|Adverse Event|0|||
129703810|NCT00855335|466877529|FG000|Overall Study|Physician Decision|1|||
129630507|NCT02962648|466599683|FG000|Overall Study|Physician Decision|1|||
129630508|NCT02962648|466599683|FG000|Overall Study|Subject had problems with transportation|2|||
129630509|NCT01597778|466599684|FG000|Overall Study|Death|7|||
129630510|NCT01597778|466599685|FG001|Overall Study|Death|10|||
129630511|NCT01597778|466599684|FG000|Overall Study|Withdrawal by Subject|3|||
129630512|NCT01597778|466599685|FG001|Overall Study|Withdrawal by Subject|4|||
129630513|NCT01597778|466599684|FG000|Overall Study|Adverse Event|1|||
129630514|NCT01597778|466599685|FG001|Overall Study|Adverse Event|1|||
129703811|NCT00855335|466877530|FG001|Overall Study|Physician Decision|1|||
129703812|NCT00855335|466877531|FG002|Overall Study|Physician Decision|0|||
129703813|NCT00855335|466877532|FG003|Overall Study|Physician Decision|0|||
129703814|NCT00855335|466877533|FG004|Overall Study|Physician Decision|0|||
129703815|NCT00855335|466877529|FG000|Overall Study|Other|2|||
129703816|NCT00855335|466877530|FG001|Overall Study|Other|1|||
129630515|NCT01597778|466599684|FG000|Overall Study|Protocol Violation|1|||
129630516|NCT01597778|466599685|FG001|Overall Study|Protocol Violation|11|||
129630517|NCT01597778|466599684|FG000|Overall Study|Transplanted off protocol|2|||
129703817|NCT00855335|466877531|FG002|Overall Study|Other|2|||
129703818|NCT00855335|466877532|FG003|Overall Study|Other|5|||
129703819|NCT00855335|466877533|FG004|Overall Study|Other|1|||
129703820|NCT04380142|466877537|FG000|LD/CD Stabilization Period|Adverse Event|3|||
129703821|NCT04380142|466877538|FG001|LD/CD Stabilization Period|Adverse Event|0|||
129703822|NCT04380142|466877539|FG002|LD/CD Stabilization Period|Adverse Event|0|||
129703823|NCT04380142|466877537|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
129703824|NCT04380142|466877538|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
129703825|NCT04380142|466877539|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
129703826|NCT04380142|466877537|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
129703827|NCT04380142|466877538|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
129703828|NCT04380142|466877539|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
129703829|NCT04380142|466877537|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
129630518|NCT01597778|466599685|FG001|Overall Study|Transplanted off protocol|3|||
129630519|NCT04383327|466599687|FG000|Overall Study|Lost to Follow-up|112|||
129630520|NCT04383327|466599688|FG001|Overall Study|Lost to Follow-up|14|||
129630521|NCT04383327|466599689|FG002|Overall Study|Lost to Follow-up|78|||
129630522|NCT04383327|466599690|FG003|Overall Study|Lost to Follow-up|13|||
129630523|NCT04383327|466599691|FG004|Overall Study|Lost to Follow-up|110|||
129630524|NCT04383327|466599692|FG005|Overall Study|Lost to Follow-up|13|||
129630525|NCT04383327|466599693|FG006|Overall Study|Lost to Follow-up|74|||
129630526|NCT04383327|466599694|FG007|Overall Study|Lost to Follow-up|13|||
129630527|NCT04383327|466599695|FG008|Overall Study|Lost to Follow-up|78|||
129630528|NCT04383327|466599696|FG009|Overall Study|Lost to Follow-up|10|||
129630529|NCT04383327|466599697|FG010|Overall Study|Lost to Follow-up|160|||
129630530|NCT04383327|466599698|FG011|Overall Study|Lost to Follow-up|13|||
129630531|NCT05303194|466599699|FG000|Overall Study|Lost to Follow-up|1|||
129630532|NCT05303194|466599700|FG001|Overall Study|Lost to Follow-up|1|||
129630533|NCT05303194|466599699|FG000|Overall Study|Withdrawal by Subject|0|||
129630534|NCT05303194|466599700|FG001|Overall Study|Withdrawal by Subject|1|||
129630535|NCT01289678|466599701|FG000|Overall Study|Physician Decision|6|||
129630536|NCT04030299|466599702|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
129630537|NCT04030299|466599702|FG000|Overall Study|Withdrawal by Subject|3|||
129630538|NCT01530464|466599707|FG000|Washout (24h)|Withdrawal by Subject|1|||
129630539|NCT01530464|466599708|FG001|Washout (24h)|Withdrawal by Subject|0|||
129630540|NCT01530464|466599707|FG000|Washout (24h)|Withdrawal by Subject|0|||
129630541|NCT01530464|466599708|FG001|Washout (24h)|Withdrawal by Subject|1|||
129630542|NCT00908544|466599709|FG000|Overall Study|Withdrawal by Subject|2|||
129630543|NCT00908544|466599710|FG001|Overall Study|Withdrawal by Subject|4|||
129630544|NCT00908544|466599709|FG000|Overall Study|Lack of Efficacy|0|||
129630545|NCT00908544|466599710|FG001|Overall Study|Lack of Efficacy|1|||
129630546|NCT00908544|466599709|FG000|Overall Study|Pregnancy|1|||
129630547|NCT00908544|466599710|FG001|Overall Study|Pregnancy|0|||
129630548|NCT00908544|466599709|FG000|Overall Study|Relocation abroad|1|||
129630549|NCT00908544|466599710|FG001|Overall Study|Relocation abroad|1|||
129630550|NCT00908544|466599709|FG000|Overall Study|Unable to visit sutdy center|1|||
129630551|NCT00908544|466599710|FG001|Overall Study|Unable to visit sutdy center|0|||
129630552|NCT03539302|466599716|FG000|Overall Study|Spontaneous cardio version|0|||
129630553|NCT03539302|466599717|FG001|Overall Study|Spontaneous cardio version|0|||
129630554|NCT03539302|466599718|FG002|Overall Study|Spontaneous cardio version|0|||
129630555|NCT03539302|466599719|FG003|Overall Study|Spontaneous cardio version|0|||
129630556|NCT03539302|466599720|FG004|Overall Study|Spontaneous cardio version|0|||
129630557|NCT03539302|466599721|FG005|Overall Study|Spontaneous cardio version|1|||
129630558|NCT03539302|466599722|FG006|Overall Study|Spontaneous cardio version|1|||
129630559|NCT02107131|466599724|FG000|Overall Study|Lost to Follow-up|4|||
129630560|NCT02107131|466599725|FG001|Overall Study|Lost to Follow-up|4|||
129630561|NCT02107131|466599724|FG000|Overall Study|Physician Decision|1|||
129630562|NCT02107131|466599725|FG001|Overall Study|Physician Decision|0|||
129630563|NCT02107131|466599724|FG000|Overall Study|Withdrawal by Subject|2|||
129630564|NCT02107131|466599725|FG001|Overall Study|Withdrawal by Subject|0|||
129630565|NCT02107131|466599724|FG000|Overall Study|mental instability|1|||
129630566|NCT02107131|466599725|FG001|Overall Study|mental instability|0|||
129630567|NCT02107131|466599724|FG000|Overall Study|Death|0|||
129630568|NCT02107131|466599725|FG001|Overall Study|Death|1|||
129630569|NCT02107131|466599724|FG000|Overall Study|Protocol Violation|0|||
129630570|NCT02107131|466599725|FG001|Overall Study|Protocol Violation|4|||
129630571|NCT01609790|466599730|FG000|Overall Study|Protocol Violation|1|||
129630572|NCT01609790|466599731|FG001|Overall Study|Protocol Violation|7|||
129630573|NCT01609790|466599732|FG002|Overall Study|Protocol Violation|8|||
129630574|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Adverse Event|7|||
129630575|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
129630576|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Non-compliance|3|||
129630577|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Other|17|||
129630578|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Physician Decision|2|||
129630579|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Pregnancy|1|||
129630580|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
129630581|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
129630582|NCT05207865|466601356|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
129630583|NCT05207865|466601356|FG000|Follow-up Phase|Lost to Follow-up|1|||
129630584|NCT05207865|466601356|FG000|Follow-up Phase|Non-compliance|1|||
129630585|NCT05207865|466601356|FG000|Follow-up Phase|Not reported|2|||
129630586|NCT05207865|466601356|FG000|Follow-up Phase|Not collected|11|||
129630587|NCT05364931|466601374|FG000|Overall Study|Adverse Event|0|||
129630588|NCT05364931|466601375|FG001|Overall Study|Adverse Event|2|||
129630589|NCT05364931|466601376|FG002|Overall Study|Adverse Event|1|||
129630590|NCT05364931|466601377|FG003|Overall Study|Adverse Event|0|||
129630591|NCT05364931|466601374|FG000|Overall Study|Lost to Follow-up|1|||
129630592|NCT05364931|466601375|FG001|Overall Study|Lost to Follow-up|0|||
129630593|NCT05364931|466601376|FG002|Overall Study|Lost to Follow-up|0|||
129630594|NCT05364931|466601377|FG003|Overall Study|Lost to Follow-up|0|||
129630595|NCT05364931|466601374|FG000|Overall Study|Withdrawal by Subject|1|||
129630596|NCT05364931|466601375|FG001|Overall Study|Withdrawal by Subject|1|||
129630597|NCT05364931|466601376|FG002|Overall Study|Withdrawal by Subject|3|||
129630598|NCT05364931|466601377|FG003|Overall Study|Withdrawal by Subject|2|||
129630599|NCT05364931|466601374|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
129630600|NCT05364931|466601375|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
129630601|NCT05364931|466601376|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
129630602|NCT05364931|466601377|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
129630603|NCT05364931|466601374|FG000|Overall Study|Discontinued|1|||
129630604|NCT05364931|466601375|FG001|Overall Study|Discontinued|0|||
129630605|NCT05364931|466601376|FG002|Overall Study|Discontinued|0|||
129630606|NCT05364931|466601377|FG003|Overall Study|Discontinued|0|||
129630607|NCT03593525|466601378|FG000|Overall Study|Withdrawal by Subject|1|||
129630608|NCT03593525|466601379|FG001|Overall Study|Withdrawal by Subject|0|||
129630609|NCT03593525|466601378|FG000|Overall Study|Lost to Follow-up|7|||
129630610|NCT03593525|466601379|FG001|Overall Study|Lost to Follow-up|5|||
129630611|NCT03103087|466601387|FG000|Overall Study|Did not receive any study drug|1|||
129630612|NCT03103087|466601388|FG001|Overall Study|Did not receive any study drug|0|||
129630613|NCT03103087|466601389|FG002|Overall Study|Did not receive any study drug|0|||
129630614|NCT03103087|466601387|FG000|Overall Study|Protocol Violation|1|||
129630615|NCT03103087|466601388|FG001|Overall Study|Protocol Violation|2|||
129630616|NCT03103087|466601389|FG002|Overall Study|Protocol Violation|1|||
129630617|NCT03103087|466601387|FG000|Overall Study|Lack of Efficacy|2|||
129630618|NCT03103087|466601388|FG001|Overall Study|Lack of Efficacy|1|||
129630619|NCT03103087|466601389|FG002|Overall Study|Lack of Efficacy|1|||
129630620|NCT03103087|466601387|FG000|Overall Study|Pregnancy|0|||
129630621|NCT03103087|466601388|FG001|Overall Study|Pregnancy|0|||
129630622|NCT03103087|466601389|FG002|Overall Study|Pregnancy|1|||
129630623|NCT03103087|466601387|FG000|Overall Study|Adverse Event|2|||
129630624|NCT03103087|466601388|FG001|Overall Study|Adverse Event|15|||
129630625|NCT03103087|466601389|FG002|Overall Study|Adverse Event|6|||
129630626|NCT03103087|466601387|FG000|Overall Study|Withdrawal by Subject|13|||
129630627|NCT03103087|466601388|FG001|Overall Study|Withdrawal by Subject|6|||
129630628|NCT03103087|466601389|FG002|Overall Study|Withdrawal by Subject|6|||
129630629|NCT03103087|466601387|FG000|Overall Study|Lost to Follow-up|4|||
129630630|NCT03103087|466601388|FG001|Overall Study|Lost to Follow-up|2|||
129630631|NCT03103087|466601389|FG002|Overall Study|Lost to Follow-up|7|||
129630632|NCT03103087|466601387|FG000|Overall Study|Other reason not reported|1|||
129630633|NCT03103087|466601388|FG001|Overall Study|Other reason not reported|3|||
129630634|NCT03103087|466601389|FG002|Overall Study|Other reason not reported|5|||
129630635|NCT03504397|466601390|FG000|Overall Study|Progressive Disease|151|||
129630636|NCT03504397|466601391|FG001|Overall Study|Progressive Disease|199|||
129630637|NCT03504397|466601390|FG000|Overall Study|Withdrawal by Subject|29|||
129630638|NCT03504397|466601391|FG001|Overall Study|Withdrawal by Subject|17|||
129630639|NCT03504397|466601390|FG000|Overall Study|Lost to Follow-up|1|||
129630640|NCT03504397|466601391|FG001|Overall Study|Lost to Follow-up|0|||
129630641|NCT03504397|466601390|FG000|Overall Study|Death|14|||
129630642|NCT03504397|466601391|FG001|Overall Study|Death|16|||
129630643|NCT03504397|466601390|FG000|Overall Study|Adverse Event|40|||
129630644|NCT03504397|466601391|FG001|Overall Study|Adverse Event|14|||
129630645|NCT03504397|466601390|FG000|Overall Study|miscellaneous|17|||
129630646|NCT03504397|466601391|FG001|Overall Study|miscellaneous|15|||
129630647|NCT03504397|466601390|FG000|Overall Study|Protocol deviation|1|||
129630648|NCT03504397|466601391|FG001|Overall Study|Protocol deviation|0|||
129630649|NCT03504397|466601390|FG000|Overall Study|Participants who did not take the study drug|4|||
129630650|NCT03504397|466601391|FG001|Overall Study|Participants who did not take the study drug|4|||
129630651|NCT00413699|466601392|FG000|Initial Period|Death|25|||
129630652|NCT00413699|466601393|FG001|Initial Period|Death|30|||
129630653|NCT00413699|466601394|FG002|Initial Period|Death|0|||
129630654|NCT00413699|466601392|FG000|Initial Period|Lack of Efficacy|59|||
129630655|NCT00413699|466601393|FG001|Initial Period|Lack of Efficacy|115|||
129630656|NCT00413699|466601394|FG002|Initial Period|Lack of Efficacy|0|||
129630657|NCT00413699|466601392|FG000|Initial Period|Lost to Follow-up|31|||
129630658|NCT00413699|466601393|FG001|Initial Period|Lost to Follow-up|101|||
129630659|NCT00413699|466601394|FG002|Initial Period|Lost to Follow-up|0|||
129630660|NCT00413699|466601392|FG000|Initial Period|Protocol Violation|38|||
129630661|NCT00413699|466601393|FG001|Initial Period|Protocol Violation|89|||
129630662|NCT00413699|466601394|FG002|Initial Period|Protocol Violation|0|||
129630663|NCT00413699|466601392|FG000|Initial Period|Pregnancy|10|||
129630664|NCT00413699|466601393|FG001|Initial Period|Pregnancy|8|||
129889073|NCT01163149|467550998|FG001|Extension Treatment Period|Adverse Event|1|||
129630665|NCT00413699|466601394|FG002|Initial Period|Pregnancy|0|||
129630666|NCT00413699|466601392|FG000|Initial Period|Did not meet entrance criteria|2|||
129630667|NCT00413699|466601393|FG001|Initial Period|Did not meet entrance criteria|2|||
129630668|NCT00413699|466601394|FG002|Initial Period|Did not meet entrance criteria|0|||
129630669|NCT00413699|466601392|FG000|Initial Period|Medication error without adverse event|0|||
129630670|NCT00413699|466601393|FG001|Initial Period|Medication error without adverse event|1|||
129794972|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
129794973|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
129794974|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
129794975|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
129794976|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
129794977|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
129794978|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
129794979|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
129794980|NCT00491556|467216468|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
129794981|NCT00491556|467216469|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
129794982|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
129794983|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
129794984|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
129794985|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
129889074|NCT01163149|467550999|FG002|Extension Treatment Period|Adverse Event|0|||
129889075|NCT01163149|467550997|FG000|Extension Treatment Period|Noncompliance|0|||
129630671|NCT00413699|466601394|FG002|Initial Period|Medication error without adverse event|0|||
129630672|NCT00413699|466601392|FG000|Initial Period|Study terminated by Sponsor|0|||
129630673|NCT00413699|466601393|FG001|Initial Period|Study terminated by Sponsor|1|||
129630674|NCT00413699|466601394|FG002|Initial Period|Study terminated by Sponsor|0|||
129630675|NCT00413699|466601392|FG000|Initial Period|Other|67|||
129630676|NCT00413699|466601393|FG001|Initial Period|Other|211|||
129630677|NCT00413699|466601394|FG002|Initial Period|Other|0|||
129630678|NCT00413699|466601392|FG000|Initial Period|Adverse event related to study drug|178|||
129630679|NCT00413699|466601393|FG001|Initial Period|Adverse event related to study drug|527|||
129630680|NCT00413699|466601394|FG002|Initial Period|Adverse event related to study drug|0|||
129630681|NCT00413699|466601392|FG000|Initial Period|Adverse event not related to study drug|113|||
129630682|NCT00413699|466601393|FG001|Initial Period|Adverse event not related to study drug|248|||
129630683|NCT00413699|466601394|FG002|Initial Period|Adverse event not related to study drug|0|||
129630684|NCT00413699|466601392|FG000|Initial Period|Missing end of study page|0|||
129630685|NCT00413699|466601393|FG001|Initial Period|Missing end of study page|4|||
129630686|NCT00413699|466601394|FG002|Initial Period|Missing end of study page|0|||
129630687|NCT00413699|466601392|FG000|Initial Period|No longer willing to participate|116|||
129630688|NCT00413699|466601393|FG001|Initial Period|No longer willing to participate|368|||
129630689|NCT00413699|466601394|FG002|Initial Period|No longer willing to participate|0|||
129630690|NCT00413699|466601392|FG000|Extension Period|No Longer Willing to Participate|0|||
129630691|NCT00413699|466601393|FG001|Extension Period|No Longer Willing to Participate|0|||
129630692|NCT00413699|466601394|FG002|Extension Period|No Longer Willing to Participate|2|||
129630693|NCT00413699|466601392|FG000|Extension Period|Protocol Violation|0|||
129630694|NCT00413699|466601393|FG001|Extension Period|Protocol Violation|0|||
129630695|NCT00413699|466601394|FG002|Extension Period|Protocol Violation|1|||
129630696|NCT00413699|466601392|FG000|Extension Period|Adverse Event|0|||
129630697|NCT00413699|466601393|FG001|Extension Period|Adverse Event|0|||
129630698|NCT00413699|466601394|FG002|Extension Period|Adverse Event|2|||
129630699|NCT00075816|466601395|FG000|Overall Study|Did not undergo transplantation|14|||
129630700|NCT00075816|466601396|FG001|Overall Study|Did not undergo transplantation|11|||
129630701|NCT04231825|466601397|FG000|Overall Study|Protocol Violation|3|||
129630702|NCT04231825|466601398|FG001|Overall Study|Protocol Violation|3|||
129630703|NCT04231825|466601397|FG000|Overall Study|Lost to Follow-up|0|||
129630704|NCT04231825|466601398|FG001|Overall Study|Lost to Follow-up|1|||
129630705|NCT01662635|466601399|FG000|Overall Study|scarce samples for evaluation|30|||
129630706|NCT02445248|466601400|FG000|Overall Study|Death|45|||
129630707|NCT02445248|466601401|FG001|Overall Study|Death|12|||
129630708|NCT02445248|466601400|FG000|Overall Study|Progressive disease|13|||
129630709|NCT02445248|466601401|FG001|Overall Study|Progressive disease|1|||
129630710|NCT02445248|466601400|FG000|Overall Study|Subject decision|8|||
129630711|NCT02445248|466601401|FG001|Overall Study|Subject decision|0|||
129630712|NCT02445248|466601400|FG000|Overall Study|Physician Decision|5|||
129630713|NCT02445248|466601401|FG001|Overall Study|Physician Decision|0|||
129630714|NCT02445248|466601400|FG000|Overall Study|Adverse Event|1|||
129630715|NCT02445248|466601401|FG001|Overall Study|Adverse Event|0|||
129630716|NCT02445248|466601400|FG000|Overall Study|Lost to Follow-up|1|||
129630717|NCT02445248|466601401|FG001|Overall Study|Lost to Follow-up|0|||
129630718|NCT02596971|466601404|FG000|Overall Study|Death|5|||
129630719|NCT02596971|466601405|FG001|Overall Study|Death|1|||
129630720|NCT02596971|466601406|FG002|Overall Study|Death|5|||
129630721|NCT02596971|466601404|FG000|Overall Study|Withdrawal by Subject|5|||
129630722|NCT02596971|466601405|FG001|Overall Study|Withdrawal by Subject|1|||
129630723|NCT02596971|466601406|FG002|Overall Study|Withdrawal by Subject|4|||
129630724|NCT00595920|466601407|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
129630725|NCT00351468|466601408|FG000|Overall Study|Adverse Event|42|||
129630726|NCT00351468|466601408|FG000|Overall Study|Withdrawal by Subject|39|||
129630727|NCT00351468|466601408|FG000|Overall Study|Various -follow up w clinical team|39|||
129630728|NCT00351468|466601408|FG000|Overall Study|Lack of Efficacy|32|||
129630729|NCT00351468|466601408|FG000|Overall Study|Non-compliance|8|||
129630730|NCT00351468|466601408|FG000|Overall Study|Lost to Follow-up|4|||
129630731|NCT00351468|466601408|FG000|Overall Study|Protocol Violation|3|||
129630732|NCT03588910|466601409|FG000|Overall Study|Withdrawal by Subject|1|||
129630733|NCT03588910|466601410|FG001|Overall Study|Withdrawal by Subject|0|||
129630734|NCT03588910|466601409|FG000|Overall Study|Allergy|2|||
129630735|NCT03588910|466601410|FG001|Overall Study|Allergy|0|||
129630736|NCT03588910|466601409|FG000|Overall Study|Protocol Violation|0|||
129630737|NCT03588910|466601410|FG001|Overall Study|Protocol Violation|3|||
129630738|NCT03588910|466601409|FG000|Overall Study|Did not complete Day 1 Survey|5|||
129630739|NCT03588910|466601410|FG001|Overall Study|Did not complete Day 1 Survey|10|||
129630740|NCT03588910|466601409|FG000|Overall Study|Did not complete Day 7 Survey|5|||
129630741|NCT03588910|466601410|FG001|Overall Study|Did not complete Day 7 Survey|2|||
129630742|NCT00611923|466601411|FG000|Overall Study|Withdrawal by Subject|2|||
129630743|NCT00611923|466601412|FG001|Overall Study|Withdrawal by Subject|2|||
129630744|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
129630745|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
129630746|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
129630747|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
129630748|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
129630749|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
129630750|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
129630751|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
129630752|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
129630753|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
129630754|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
129630755|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
129630756|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129630757|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129630758|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
129630759|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129630760|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
129630761|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
129630762|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
129630763|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
129630764|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
129630765|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
129630766|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
129630767|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
129630768|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
129630769|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
129630770|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
129630771|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
129630772|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
129630773|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
129630774|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
129630775|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
129630776|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
129630777|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
129630778|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
129630779|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
129630780|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
129630781|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
129630782|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
129630783|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
129630784|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
129630785|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
129630786|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
129630787|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
129630788|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
129630789|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
129630790|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
129630791|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
129630792|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
129630793|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
129630794|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
129630795|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
129630796|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Site closed|0|||
129630797|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Site closed|0|||
129630798|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Site closed|1|||
129630799|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Site closed|0|||
129630800|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
129630801|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
129630802|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
129630803|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
129630804|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
129630805|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
129630806|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
129630807|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
129630808|NCT00838903|466601413|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
129630809|NCT00838903|466601414|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
129630810|NCT00838903|466601415|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
129630811|NCT00838903|466601416|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
129630812|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
129630813|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
129630814|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
129630815|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
129630816|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
129630817|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
129630818|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
129630819|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
129703830|NCT04380142|466877538|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
129703831|NCT04380142|466877539|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
129703832|NCT04380142|466877537|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
129703833|NCT04380142|466877538|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
129703834|NCT04380142|466877539|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
129703835|NCT04380142|466877537|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
129703836|NCT04380142|466877538|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
129703837|NCT04380142|466877539|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
129703838|NCT04380142|466877537|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129703839|NCT04380142|466877538|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129703840|NCT04380142|466877539|FG002|Double-Blind Treatment Period|Adverse Event|14|||
129703841|NCT04380142|466877537|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
129703842|NCT04380142|466877538|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
129703843|NCT04380142|466877539|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
129703844|NCT04380142|466877537|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129703845|NCT04380142|466877538|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
129703846|NCT04380142|466877539|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
129703847|NCT04380142|466877537|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
129703848|NCT04380142|466877538|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
129703849|NCT04380142|466877539|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
129703850|NCT04380142|466877537|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
129703851|NCT04380142|466877538|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
129703852|NCT04380142|466877539|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
129703853|NCT04380142|466877537|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
129703854|NCT04380142|466877538|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
129703855|NCT04380142|466877539|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
129703856|NCT00787150|466877542|FG000|Overall Study|Adverse Event|4|||
129703857|NCT00787150|466877543|FG001|Overall Study|Adverse Event|4|||
129703858|NCT00787150|466877544|FG002|Overall Study|Adverse Event|4|||
129703859|NCT00787150|466877542|FG000|Overall Study|Physician Decision|1|||
129703860|NCT00787150|466877543|FG001|Overall Study|Physician Decision|2|||
129703861|NCT00787150|466877544|FG002|Overall Study|Physician Decision|1|||
129703862|NCT00787150|466877542|FG000|Overall Study|Withdrawal by Subject|2|||
129703863|NCT00787150|466877543|FG001|Overall Study|Withdrawal by Subject|1|||
129703864|NCT00787150|466877544|FG002|Overall Study|Withdrawal by Subject|0|||
129703865|NCT00787150|466877542|FG000|Overall Study|Dosing incorrect study durg|2|||
129703866|NCT00787150|466877543|FG001|Overall Study|Dosing incorrect study durg|0|||
129703867|NCT00787150|466877544|FG002|Overall Study|Dosing incorrect study durg|0|||
129703868|NCT01849276|466877549|FG000|Followed for Survival for 5 Years|Death|1|||
129703869|NCT01849276|466877549|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
129794986|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
129794987|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
129703870|NCT00879398|466877552|FG000|Overall Study|Visit Stop|399|||
129630820|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
129630821|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
129630822|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
129630823|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
129630824|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
129630825|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
129630826|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
129630827|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
129630828|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
129630829|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
129630830|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
129630831|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
129630832|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
129630833|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
129630834|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
129630835|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
129630836|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
129630837|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
129630838|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
129630839|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
129630840|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
129630841|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
129630842|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
129630843|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
129630844|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
129630845|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
129630846|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
129630847|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
129630848|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
129630849|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
129630850|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
129630851|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
129630852|NCT00838903|466601413|FG000|Follow-up Period (8 Weeks)|Missing|1|||
129630853|NCT00838903|466601414|FG001|Follow-up Period (8 Weeks)|Missing|2|||
129630854|NCT00838903|466601415|FG002|Follow-up Period (8 Weeks)|Missing|1|||
129630855|NCT00838903|466601416|FG003|Follow-up Period (8 Weeks)|Missing|1|||
129630856|NCT04565145|466601417|FG000|Overall Study|Withdrawal by Subject|1|||
129630857|NCT04565145|466601418|FG001|Overall Study|Withdrawal by Subject|1|||
129703871|NCT00879398|466877552|FG000|Overall Study|Lack of Efficacy|64|||
129703872|NCT00879398|466877552|FG000|Overall Study|Adverse Event|41|||
129703873|NCT00879398|466877552|FG000|Overall Study|Other Reasons|171|||
129703874|NCT01380080|466877554|FG000|Overall Study|Death|36|||
129703875|NCT01380080|466877555|FG001|Overall Study|Death|44|||
129703876|NCT01380080|466877554|FG000|Overall Study|Site is closing|28|||
129703877|NCT01380080|466877555|FG001|Overall Study|Site is closing|31|||
129703878|NCT01380080|466877554|FG000|Overall Study|Not able to get to clinic|7|||
129703879|NCT01380080|466877555|FG001|Overall Study|Not able to get to clinic|1|||
129703880|NCT01380080|466877554|FG000|Overall Study|Not willing to adhere to requirements|6|||
129703881|NCT01380080|466877555|FG001|Overall Study|Not willing to adhere to requirements|2|||
129703882|NCT01380080|466877554|FG000|Overall Study|Withdrawal by Subject|5|||
129703883|NCT01380080|466877555|FG001|Overall Study|Withdrawal by Subject|2|||
129703884|NCT01380080|466877554|FG000|Overall Study|Lost to Follow-up|3|||
129703885|NCT01380080|466877555|FG001|Overall Study|Lost to Follow-up|3|||
129703886|NCT04251533|466877556|FG000|Overall Study|Progressive disease|33|||
129703887|NCT04251533|466877557|FG001|Overall Study|Progressive disease|29|||
129703888|NCT04251533|466877558|FG002|Overall Study|Progressive disease|22|||
129703889|NCT04251533|466877556|FG000|Overall Study|Death|5|||
129703890|NCT04251533|466877557|FG001|Overall Study|Death|1|||
129703891|NCT04251533|466877558|FG002|Overall Study|Death|3|||
129703892|NCT04251533|466877556|FG000|Overall Study|Physician Decision|3|||
129703893|NCT04251533|466877557|FG001|Overall Study|Physician Decision|2|||
129703894|NCT04251533|466877558|FG002|Overall Study|Physician Decision|4|||
129703895|NCT04251533|466877556|FG000|Overall Study|Participant decision|1|||
129703896|NCT04251533|466877557|FG001|Overall Study|Participant decision|3|||
129703897|NCT04251533|466877558|FG002|Overall Study|Participant decision|1|||
129703898|NCT04251533|466877556|FG000|Overall Study|Adverse Event|2|||
129703899|NCT04251533|466877557|FG001|Overall Study|Adverse Event|1|||
129703900|NCT04251533|466877558|FG002|Overall Study|Adverse Event|1|||
129703901|NCT00210132|466877563|FG000|Overall Study|Protocol Violation|1|||
129703902|NCT00210132|466877564|FG001|Overall Study|Protocol Violation|4|||
129703903|NCT01722669|466877569|FG000|Overall Study|Withdrawal by Subject|0|||
129703904|NCT01722669|466877570|FG001|Overall Study|Withdrawal by Subject|0|||
129794988|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
129794989|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
129794990|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
129794991|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
129794992|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
129794993|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
129794994|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
129794995|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
129794996|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
129794997|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
129794998|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
129794999|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
129795000|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
129795001|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
129795002|NCT00491556|467216468|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
129795003|NCT00491556|467216469|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
129795004|NCT00993044|467216471|FG000|Irinotecan 50 mg|Physician Decision|1|||
129795005|NCT00734747|467216472|FG000|SRS Procedure|No staples placed|3|||
129795006|NCT00734747|467216472|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
129795007|NCT01909453|467216476|FG000|Overall Study|Ongoing|118|||
129795008|NCT01909453|467216477|FG001|Overall Study|Ongoing|103|||
129795009|NCT01909453|467216478|FG002|Overall Study|Ongoing|83|||
129795010|NCT01909453|467216479|FG003|Overall Study|Ongoing|164|||
129795011|NCT01909453|467216480|FG004|Overall Study|Ongoing|50|||
129795012|NCT01909453|467216476|FG000|Overall Study|Death|69|||
129795013|NCT01909453|467216477|FG001|Overall Study|Death|74|||
129795014|NCT01909453|467216478|FG002|Overall Study|Death|88|||
129795015|NCT01909453|467216479|FG003|Overall Study|Death|86|||
129795016|NCT01909453|467216480|FG004|Overall Study|Death|29|||
129795017|NCT01909453|467216476|FG000|Overall Study|Lost to Follow-up|3|||
129795018|NCT01909453|467216477|FG001|Overall Study|Lost to Follow-up|4|||
129795019|NCT01909453|467216478|FG002|Overall Study|Lost to Follow-up|4|||
129795020|NCT01909453|467216479|FG003|Overall Study|Lost to Follow-up|3|||
129795021|NCT01909453|467216480|FG004|Overall Study|Lost to Follow-up|3|||
129795022|NCT01909453|467216476|FG000|Overall Study|Withdrawal by Subject|2|||
129795023|NCT01909453|467216477|FG001|Overall Study|Withdrawal by Subject|13|||
129795024|NCT01909453|467216478|FG002|Overall Study|Withdrawal by Subject|16|||
129795025|NCT01909453|467216479|FG003|Overall Study|Withdrawal by Subject|5|||
129795026|NCT01909453|467216480|FG004|Overall Study|Withdrawal by Subject|4|||
129795027|NCT03350984|467217879|FG000|Overall Study|Death|1|||
129795028|NCT03350984|467217880|FG001|Overall Study|Death|0|||
129795029|NCT03350984|467217879|FG000|Overall Study|Lost to Follow-up|5|||
129795030|NCT03350984|467217880|FG001|Overall Study|Lost to Follow-up|6|||
129795031|NCT03350984|467217879|FG000|Overall Study|Protocol Violation|1|||
129795032|NCT03350984|467217880|FG001|Overall Study|Protocol Violation|2|||
129795033|NCT03350984|467217879|FG000|Overall Study|Physician Decision|1|||
129795034|NCT03350984|467217880|FG001|Overall Study|Physician Decision|0|||
129795035|NCT00642473|467217881|FG000|Overall Study|Withdrawal by Subject|0|||
129795036|NCT00642473|467217882|FG001|Overall Study|Withdrawal by Subject|5|||
129795037|NCT00642473|467217881|FG000|Overall Study|Progression or death|2|||
129795038|NCT00642473|467217882|FG001|Overall Study|Progression or death|4|||
129795039|NCT00642473|467217881|FG000|Overall Study|Other|2|||
129795040|NCT00642473|467217882|FG001|Overall Study|Other|2|||
129795041|NCT03981822|467217888|FG000|Overall Study|Lost to Follow-up|0|||
129795042|NCT03981822|467217889|FG001|Overall Study|Lost to Follow-up|1|||
129795043|NCT03981822|467217890|FG002|Overall Study|Lost to Follow-up|1|||
129795044|NCT03981822|467217891|FG003|Overall Study|Lost to Follow-up|0|||
129795045|NCT03981822|467217892|FG004|Overall Study|Lost to Follow-up|6|||
129795046|NCT03981822|467217893|FG005|Overall Study|Lost to Follow-up|4|||
129795047|NCT03981822|467217894|FG006|Overall Study|Lost to Follow-up|4|||
129630858|NCT00683618|466601419|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
129630859|NCT00683618|466601420|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
129795048|NCT03981822|467217895|FG007|Overall Study|Lost to Follow-up|2|||
129795049|NCT03981822|467217888|FG000|Overall Study|Withdrawal by Subject|0|||
129795050|NCT03981822|467217889|FG001|Overall Study|Withdrawal by Subject|1|||
129795051|NCT03981822|467217890|FG002|Overall Study|Withdrawal by Subject|0|||
129795052|NCT03981822|467217891|FG003|Overall Study|Withdrawal by Subject|0|||
129795053|NCT03981822|467217892|FG004|Overall Study|Withdrawal by Subject|0|||
129795054|NCT03981822|467217893|FG005|Overall Study|Withdrawal by Subject|1|||
129795055|NCT03981822|467217894|FG006|Overall Study|Withdrawal by Subject|0|||
129795056|NCT03981822|467217895|FG007|Overall Study|Withdrawal by Subject|2|||
129795057|NCT03981822|467217888|FG000|Overall Study|COVID-19 Related|0|||
129795058|NCT03981822|467217889|FG001|Overall Study|COVID-19 Related|0|||
129795059|NCT03981822|467217890|FG002|Overall Study|COVID-19 Related|0|||
129795060|NCT03981822|467217891|FG003|Overall Study|COVID-19 Related|0|||
129795061|NCT03981822|467217892|FG004|Overall Study|COVID-19 Related|2|||
129795062|NCT03981822|467217893|FG005|Overall Study|COVID-19 Related|1|||
129795063|NCT03981822|467217894|FG006|Overall Study|COVID-19 Related|2|||
129795064|NCT03981822|467217895|FG007|Overall Study|COVID-19 Related|1|||
129795065|NCT06460493|467217896|FG000|Overall Study|Withdrawal by Subject|2|||
129795066|NCT02987660|467217901|FG000|Overall Study|Study terminated by sponsor|10|||
129795067|NCT02987660|467217902|FG001|Overall Study|Study terminated by sponsor|10|||
129795068|NCT03707184|467217903|FG000|Overall Study|Withdrawal by Subject|2|||
129795069|NCT04704154|467217904|FG000|Overall Study|Adverse Event|3|||
129795070|NCT04704154|467217905|FG001|Overall Study|Adverse Event|2|||
129795071|NCT04704154|467217906|FG002|Overall Study|Adverse Event|4|||
129795072|NCT04704154|467217907|FG003|Overall Study|Adverse Event|2|||
129795073|NCT04704154|467217908|FG004|Overall Study|Adverse Event|3|||
129795074|NCT04704154|467217909|FG005|Overall Study|Adverse Event|0|||
129795075|NCT04704154|467217904|FG000|Overall Study|Death|3|||
129795076|NCT04704154|467217905|FG001|Overall Study|Death|0|||
129795077|NCT04704154|467217906|FG002|Overall Study|Death|0|||
129795078|NCT04704154|467217907|FG003|Overall Study|Death|0|||
129795079|NCT04704154|467217908|FG004|Overall Study|Death|3|||
129795080|NCT04704154|467217909|FG005|Overall Study|Death|0|||
129795081|NCT04704154|467217904|FG000|Overall Study|Physician Decision|1|||
129795082|NCT04704154|467217905|FG001|Overall Study|Physician Decision|0|||
129795083|NCT04704154|467217906|FG002|Overall Study|Physician Decision|1|||
129795084|NCT04704154|467217907|FG003|Overall Study|Physician Decision|0|||
129795085|NCT04704154|467217908|FG004|Overall Study|Physician Decision|2|||
129795086|NCT04704154|467217909|FG005|Overall Study|Physician Decision|0|||
129795087|NCT04704154|467217904|FG000|Overall Study|Participant Decision|1|||
129795088|NCT04704154|467217905|FG001|Overall Study|Participant Decision|1|||
129795089|NCT04704154|467217906|FG002|Overall Study|Participant Decision|0|||
129795090|NCT04704154|467217907|FG003|Overall Study|Participant Decision|0|||
129795091|NCT04704154|467217908|FG004|Overall Study|Participant Decision|0|||
129795092|NCT04704154|467217909|FG005|Overall Study|Participant Decision|0|||
129795093|NCT04704154|467217904|FG000|Overall Study|Progressive Disease|19|||
129795094|NCT04704154|467217905|FG001|Overall Study|Progressive Disease|17|||
129795095|NCT04704154|467217906|FG002|Overall Study|Progressive Disease|20|||
129795096|NCT04704154|467217907|FG003|Overall Study|Progressive Disease|18|||
129795097|NCT04704154|467217908|FG004|Overall Study|Progressive Disease|36|||
129795098|NCT04704154|467217909|FG005|Overall Study|Progressive Disease|30|||
129795099|NCT04704154|467217904|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
129795100|NCT04704154|467217905|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
129795101|NCT04704154|467217906|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
129795102|NCT04704154|467217907|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
129795103|NCT04704154|467217908|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
129795104|NCT04704154|467217909|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
129795105|NCT04704154|467217904|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
129795106|NCT04704154|467217905|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795107|NCT04704154|467217906|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
129795108|NCT04704154|467217907|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795109|NCT04704154|467217908|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795110|NCT04704154|467217909|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
129795111|NCT01653782|467217912|FG000|Overall Study|Withdrawal by Subject|9|||
129795112|NCT01653782|467217913|FG001|Overall Study|Withdrawal by Subject|15|||
129795113|NCT01653782|467217914|FG002|Overall Study|Withdrawal by Subject|4|||
129795114|NCT01653782|467217912|FG000|Overall Study|Lost to Follow-up|7|||
129795115|NCT01653782|467217913|FG001|Overall Study|Lost to Follow-up|3|||
129795116|NCT01653782|467217914|FG002|Overall Study|Lost to Follow-up|2|||
129795117|NCT01142128|467217915|FG000|Overall Study|Physician Decision|1|||
129795118|NCT01142128|467217915|FG000|Overall Study|Lost to Follow-up|1|||
129795119|NCT01142128|467217915|FG000|Overall Study|Withdrawal by Subject|2|||
129795120|NCT05442775|467217918|FG000|Overall Study|Trial terminated|61|||
129795121|NCT05442775|467217918|FG000|Overall Study|Lack of Efficacy|4|||
129795122|NCT05442775|467217918|FG000|Overall Study|Withdrawal by Subject|4|||
129795123|NCT05442775|467217918|FG000|Overall Study|Death|1|||
129795124|NCT05442775|467217918|FG000|Overall Study|Participant removed at Sponsor request|1|||
129795125|NCT01606254|467217919|FG000|Overall Study|Withdrawal by Subject|1|||
129795126|NCT01606254|467217920|FG001|Overall Study|Withdrawal by Subject|3|||
129795127|NCT01606254|467217921|FG002|Overall Study|Withdrawal by Subject|0|||
129630860|NCT00683618|466601421|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
129630861|NCT00683618|466601419|FG000|Randomised Treatment Period|Protocol Violation|0|||
129630862|NCT00683618|466601420|FG001|Randomised Treatment Period|Protocol Violation|1|||
129630863|NCT00683618|466601421|FG002|Randomised Treatment Period|Protocol Violation|0|||
129630864|NCT00683618|466601419|FG000|Randomised Treatment Period|Adverse Event|2|||
129630865|NCT00683618|466601420|FG001|Randomised Treatment Period|Adverse Event|0|||
129630866|NCT00683618|466601421|FG002|Randomised Treatment Period|Adverse Event|2|||
129630867|NCT00683618|466601419|FG000|Randomised Treatment Period|Reason not provided|0|||
129630868|NCT00683618|466601420|FG001|Randomised Treatment Period|Reason not provided|0|||
129630869|NCT00683618|466601421|FG002|Randomised Treatment Period|Reason not provided|2|||
129630870|NCT00683618|466601419|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
129630871|NCT00683618|466601420|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129630872|NCT00683618|466601421|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129630873|NCT00683618|466601419|FG000|Extension Treatment Period|Adverse Event|1|||
129630874|NCT00683618|466601420|FG001|Extension Treatment Period|Adverse Event|0|||
129630875|NCT00683618|466601421|FG002|Extension Treatment Period|Adverse Event|0|||
129630876|NCT00683618|466601419|FG000|Extension Treatment Period|Protocol Violation|1|||
129630877|NCT00683618|466601420|FG001|Extension Treatment Period|Protocol Violation|0|||
129630878|NCT00683618|466601421|FG002|Extension Treatment Period|Protocol Violation|0|||
129630879|NCT04570670|466601422|FG000|Overall Study|Withdrawal by Subject|1|||
129630880|NCT04570670|466601423|FG001|Overall Study|Withdrawal by Subject|0|||
129630881|NCT02549859|466601424|FG000|Long-term 60 Hz DBS|Study Closed|1|||
129630882|NCT03003962|466601433|FG000|Overall Study|Withdrawal by Subject|5|||
129630883|NCT03003962|466601434|FG001|Overall Study|Withdrawal by Subject|17|||
129630884|NCT03003962|466601433|FG000|Overall Study|Death|274|||
129630885|NCT03003962|466601434|FG001|Overall Study|Death|277|||
129630886|NCT03003962|466601433|FG000|Overall Study|Participants ongoing at DCO|55|||
129630887|NCT03003962|466601434|FG001|Overall Study|Participants ongoing at DCO|40|||
129630888|NCT03802825|466601442|FG000|Overall Study|Lost to follow-up for intervention|12|||
129630889|NCT03802825|466601443|FG001|Overall Study|Lost to follow-up for intervention|3|||
129630890|NCT03802825|466601442|FG000|Overall Study|Received only 1 component of intervention|0|||
129630891|NCT03802825|466601443|FG001|Overall Study|Received only 1 component of intervention|13|||
129630892|NCT03428152|466601445|FG000|Overall Study|Physician Decision|4|||
129630893|NCT03428152|466601446|FG001|Overall Study|Physician Decision|2|||
129630894|NCT03428152|466601445|FG000|Overall Study|Protocol Violation|3|||
129630895|NCT03428152|466601446|FG001|Overall Study|Protocol Violation|5|||
129630896|NCT03428152|466601445|FG000|Overall Study|Lack of Efficacy|0|||
129630897|NCT03428152|466601446|FG001|Overall Study|Lack of Efficacy|4|||
129630898|NCT01293695|466601453|FG000|Overall Study|Withdrawal by Subject|7|||
129630899|NCT01293695|466601454|FG001|Overall Study|Withdrawal by Subject|1|||
129630900|NCT01293695|466601453|FG000|Overall Study|Lost to Follow-up|8|||
129630901|NCT01293695|466601454|FG001|Overall Study|Lost to Follow-up|6|||
129630902|NCT00468819|466601455|FG000|Overall Study|Withdrawal by Subject|4|||
129630903|NCT00468819|466601456|FG001|Overall Study|Withdrawal by Subject|0|||
129630904|NCT00468819|466601457|FG002|Overall Study|Withdrawal by Subject|1|||
129630905|NCT00468819|466601455|FG000|Overall Study|Lost to Follow-up|0|||
129630906|NCT00468819|466601456|FG001|Overall Study|Lost to Follow-up|0|||
129630907|NCT00468819|466601457|FG002|Overall Study|Lost to Follow-up|1|||
129630908|NCT00468819|466601455|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
129630909|NCT00468819|466601456|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
129630910|NCT00468819|466601457|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
129630911|NCT04616612|466601458|FG000|Overall Study|Lost to Follow-up|6|||
129795128|NCT01606254|467217922|FG003|Overall Study|Withdrawal by Subject|2|||
129795129|NCT01606254|467217919|FG000|Overall Study|Adverse Event|1|||
129795130|NCT01606254|467217920|FG001|Overall Study|Adverse Event|1|||
129630912|NCT04616612|466601459|FG001|Overall Study|Lost to Follow-up|3|||
129630913|NCT04740918|466601460|FG000|Overall Study|Study Terminated by Sponsor|41|||
129795131|NCT01606254|467217921|FG002|Overall Study|Adverse Event|0|||
129630914|NCT04740918|466601461|FG001|Overall Study|Study Terminated by Sponsor|32|||
129630915|NCT04740918|466601460|FG000|Overall Study|Death|3|||
129630916|NCT04740918|466601461|FG001|Overall Study|Death|6|||
129630917|NCT04740918|466601460|FG000|Overall Study|Withdrawal by Subject|5|||
129630918|NCT04740918|466601461|FG001|Overall Study|Withdrawal by Subject|4|||
129630919|NCT04740918|466601460|FG000|Overall Study|Lost to Follow-up|1|||
129630920|NCT04740918|466601461|FG001|Overall Study|Lost to Follow-up|3|||
129630921|NCT04740918|466601460|FG000|Overall Study|Progressive disease|0|||
129630922|NCT04740918|466601461|FG001|Overall Study|Progressive disease|1|||
129630923|NCT02524847|466601462|FG000|Overall Study|Adverse Event|4|||
129630924|NCT02524847|466601462|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
129630925|NCT02524847|466601462|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
129630926|NCT02524847|466601462|FG000|Overall Study|Death|1|||
129630927|NCT02524847|466601462|FG000|Overall Study|Reason not Specified|1|||
129630928|NCT04352101|466601463|FG000|Overall Study|Physician Decision|2|||
129630929|NCT04352101|466601464|FG001|Overall Study|Physician Decision|1|||
129630930|NCT01288079|466601470|FG000|Overall Study|Withdrawal by Subject|2|||
129630931|NCT01288079|466601471|FG001|Overall Study|Withdrawal by Subject|4|||
129630932|NCT01288079|466601472|FG002|Overall Study|Withdrawal by Subject|1|||
129630933|NCT01288079|466601473|FG003|Overall Study|Withdrawal by Subject|0|||
129630934|NCT01288079|466601470|FG000|Overall Study|Adverse Event|2|||
129630935|NCT01288079|466601471|FG001|Overall Study|Adverse Event|1|||
129630936|NCT01288079|466601472|FG002|Overall Study|Adverse Event|2|||
129630937|NCT01288079|466601473|FG003|Overall Study|Adverse Event|3|||
129630938|NCT01288079|466601470|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
129630939|NCT01288079|466601471|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
129630940|NCT01288079|466601472|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
129630941|NCT01288079|466601473|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
129630942|NCT01288079|466601470|FG000|Overall Study|Condition under Investigation Worsened|0|||
129630943|NCT01288079|466601471|FG001|Overall Study|Condition under Investigation Worsened|0|||
129795132|NCT01606254|467217922|FG003|Overall Study|Adverse Event|1|||
129795133|NCT04543409|467217923|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129630944|NCT01288079|466601472|FG002|Overall Study|Condition under Investigation Worsened|0|||
129630945|NCT01288079|466601473|FG003|Overall Study|Condition under Investigation Worsened|1|||
129630946|NCT01288079|466601470|FG000|Overall Study|Lack of Efficacy|2|||
129630947|NCT01288079|466601471|FG001|Overall Study|Lack of Efficacy|2|||
129630948|NCT01288079|466601472|FG002|Overall Study|Lack of Efficacy|0|||
129630949|NCT01288079|466601473|FG003|Overall Study|Lack of Efficacy|2|||
129630950|NCT01288079|466601470|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
129630951|NCT01288079|466601471|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129630952|NCT01288079|466601472|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
129630953|NCT01288079|466601473|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
129630954|NCT01288079|466601470|FG000|Overall Study|Lost to Follow-up|1|||
129630955|NCT01288079|466601471|FG001|Overall Study|Lost to Follow-up|1|||
129630956|NCT01288079|466601472|FG002|Overall Study|Lost to Follow-up|1|||
129630957|NCT01288079|466601473|FG003|Overall Study|Lost to Follow-up|0|||
129630958|NCT01288079|466601470|FG000|Overall Study|Other or Study Termination|11|||
129795134|NCT04543409|467217924|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129795135|NCT04543409|467217923|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
129795136|NCT04543409|467217924|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
129795137|NCT04543409|467217923|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
129795138|NCT04543409|467217924|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
129795139|NCT04543409|467217923|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
129795140|NCT04543409|467217924|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
129795141|NCT04543409|467217923|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
129795142|NCT04543409|467217924|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
129795143|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
129795144|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
129795145|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
129889076|NCT01163149|467550998|FG001|Extension Treatment Period|Noncompliance|0|||
129889077|NCT01163149|467550999|FG002|Extension Treatment Period|Noncompliance|1|||
129630959|NCT01288079|466601471|FG001|Overall Study|Other or Study Termination|15|||
129630960|NCT01288079|466601472|FG002|Overall Study|Other or Study Termination|14|||
129630961|NCT01288079|466601473|FG003|Overall Study|Other or Study Termination|8|||
129630962|NCT02387840|466601474|FG000|Overall Study|Death|0|||
129630963|NCT02387840|466601475|FG001|Overall Study|Death|0|||
129630964|NCT02387840|466601476|FG002|Overall Study|Death|0|||
129630965|NCT02387840|466601477|FG003|Overall Study|Death|0|||
129630966|NCT02387840|466601478|FG004|Overall Study|Death|0|||
129630967|NCT02387840|466601479|FG005|Overall Study|Death|1|||
129630968|NCT03170544|466601480|FG000|Part 1|Lost to Follow-up|1|||
129630969|NCT03170544|466601481|FG001|Part 1|Lost to Follow-up|0|||
129630970|NCT03170544|466601482|FG002|Part 1|Lost to Follow-up|0|||
129795146|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
129795147|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
129630971|NCT03170544|466601483|FG003|Part 1|Lost to Follow-up|0|||
129630972|NCT03170544|466601484|FG004|Part 1|Lost to Follow-up|0|||
129630973|NCT03170544|466601485|FG005|Part 1|Lost to Follow-up|0|||
129630974|NCT03170544|466601486|FG006|Part 1|Lost to Follow-up|0|||
129630975|NCT03170544|466601487|FG007|Part 1|Lost to Follow-up|0|||
129630976|NCT03170544|466601488|FG008|Part 1|Lost to Follow-up|0|||
129630977|NCT03170544|466601489|FG009|Part 1|Lost to Follow-up|0|||
129630978|NCT03170544|466601490|FG010|Part 1|Lost to Follow-up|0|||
129630979|NCT03170544|466601491|FG011|Part 1|Lost to Follow-up|0|||
129630980|NCT03170544|466601480|FG000|Part 1|Not treated|0|||
129630981|NCT03170544|466601481|FG001|Part 1|Not treated|0|||
129630982|NCT03170544|466601482|FG002|Part 1|Not treated|0|||
129630983|NCT03170544|466601483|FG003|Part 1|Not treated|1|||
129630984|NCT03170544|466601484|FG004|Part 1|Not treated|0|||
129630985|NCT03170544|466601485|FG005|Part 1|Not treated|0|||
129630986|NCT03170544|466601486|FG006|Part 1|Not treated|0|||
129630987|NCT03170544|466601487|FG007|Part 1|Not treated|0|||
129630988|NCT03170544|466601488|FG008|Part 1|Not treated|0|||
129630989|NCT03170544|466601489|FG009|Part 1|Not treated|0|||
129630990|NCT03170544|466601490|FG010|Part 1|Not treated|0|||
129630991|NCT03170544|466601491|FG011|Part 1|Not treated|0|||
129630992|NCT02174627|466601494|FG000|Overall Study|Missing|0|||
129630993|NCT02174627|466601495|FG001|Overall Study|Missing|1|||
129630994|NCT02174627|466601494|FG000|Overall Study|Incorrect enrolment before randomization|0|||
129630995|NCT02174627|466601495|FG001|Overall Study|Incorrect enrolment before randomization|1|||
129630996|NCT02174627|466601494|FG000|Overall Study|Participant decision|84|||
129630997|NCT02174627|466601495|FG001|Overall Study|Participant decision|128|||
129630998|NCT04564092|466601496|FG000|Overall Study|Withdrawal by Subject|1|||
129630999|NCT00071110|466601497|FG000|Overall Study|Protocol Violation|0|||
129631000|NCT00071110|466601498|FG001|Overall Study|Protocol Violation|4|||
129631001|NCT02259010|466601502|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
129631002|NCT03578367|466601503|FG000|Overall Study|Adverse Event|0|||
129631003|NCT03578367|466601504|FG001|Overall Study|Adverse Event|3|||
129631004|NCT03578367|466601505|FG002|Overall Study|Adverse Event|0|||
129631005|NCT03578367|466601506|FG003|Overall Study|Adverse Event|5|||
129631006|NCT03578367|466601503|FG000|Overall Study|Withdrawal by Subject|2|||
129631007|NCT03578367|466601504|FG001|Overall Study|Withdrawal by Subject|2|||
129631008|NCT03578367|466601505|FG002|Overall Study|Withdrawal by Subject|1|||
129631009|NCT03578367|466601506|FG003|Overall Study|Withdrawal by Subject|3|||
129631010|NCT03578367|466601503|FG000|Overall Study|Physician Decision|0|||
129631011|NCT03578367|466601504|FG001|Overall Study|Physician Decision|0|||
129631012|NCT03578367|466601505|FG002|Overall Study|Physician Decision|14|||
129631013|NCT03578367|466601506|FG003|Overall Study|Physician Decision|0|||
129631014|NCT03578367|466601503|FG000|Overall Study|Death|1|||
129631015|NCT03578367|466601504|FG001|Overall Study|Death|0|||
129631016|NCT03578367|466601505|FG002|Overall Study|Death|0|||
129631017|NCT03578367|466601506|FG003|Overall Study|Death|0|||
129631018|NCT03578367|466601503|FG000|Overall Study|Not treated|0|||
129631019|NCT03578367|466601504|FG001|Overall Study|Not treated|0|||
129631020|NCT03578367|466601505|FG002|Overall Study|Not treated|1|||
129631021|NCT03578367|466601506|FG003|Overall Study|Not treated|0|||
129631022|NCT02729025|466601510|FG000|Overall Study|Sponsor Decision|0|||
129631023|NCT02729025|466601511|FG001|Overall Study|Sponsor Decision|1|||
129631024|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
129631025|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
129631026|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
129631027|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129631028|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129631029|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129631030|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
129631031|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129631032|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
129631033|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
129631034|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129631035|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129631036|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129631037|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
129631038|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
129631039|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
129631040|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
129631041|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129631042|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129703905|NCT01722669|466877571|FG002|Overall Study|Withdrawal by Subject|0|||
129703906|NCT01722669|466877572|FG003|Overall Study|Withdrawal by Subject|0|||
129631043|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129631044|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
129631045|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
129631046|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
129631047|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
129631048|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129631049|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129631050|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129631051|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
129631052|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
129631053|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129631054|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129631055|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129631056|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129631057|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129631058|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
129631059|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129631060|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129631061|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
129631062|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129631063|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129631064|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129631065|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
129631066|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129631067|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129631068|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
129631069|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129631070|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129631071|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129631072|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
129631073|NCT04242446|466602987|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129631074|NCT04242446|466602988|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
129631075|NCT04242446|466602989|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
129631076|NCT04242446|466602990|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129631077|NCT04242446|466602991|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129631078|NCT04242446|466602992|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129631079|NCT04242446|466602993|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
129631080|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129631081|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129631082|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
129631083|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
129631084|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
129631085|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
129889078|NCT01932996|467551000|FG000|Overall Study|Protocol Violation|2|||
129889079|NCT01932996|467551001|FG001|Overall Study|Protocol Violation|0|||
129631086|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
129631087|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129631088|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129631089|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
129631090|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
129631091|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
129631092|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
129631093|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
129631094|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129631095|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129631096|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
129631097|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
129631098|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
129631099|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
129631100|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
129631101|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129631102|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129631103|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
129631104|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
129631105|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
129631106|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
129631107|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
129631108|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129631109|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129631110|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
129631111|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
129631112|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
129631113|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
129631114|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
129631115|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129631116|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129631117|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129631118|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
129631119|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129631120|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129631121|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
129631122|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129631123|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129631124|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129631125|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129631126|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
129631127|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129631128|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
129631129|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129631130|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129631131|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129631132|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129631133|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
129440359|NCT00775450|465911408|FG003|Overall Study|Withdrawal by Subject|0|||
129440360|NCT00775450|465911409|FG004|Overall Study|Withdrawal by Subject|1|||
129440361|NCT01749540|465911416|FG000|Overall Study|Protocol Violation|0|||
129631134|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129631135|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
129631136|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129631137|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129631138|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129631139|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129631140|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
129631141|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129631142|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
129631143|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129631144|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129631145|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129631146|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129631147|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
129631148|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129631149|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
129631150|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129631151|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129631152|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129631153|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129631154|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
129631155|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129631156|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
129631157|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129631158|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129631159|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129631160|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129631161|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129631162|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
129631163|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
129631164|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129631165|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129631166|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129631167|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129631168|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129631169|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
129631170|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
129631171|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129631172|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129631173|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129631174|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129631175|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129631176|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
129631177|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
129631178|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129795148|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
129795149|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
129795150|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
129795151|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
129795152|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
129795153|NCT04543409|467217923|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
129631179|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129631180|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129631181|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129631182|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129631183|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
129631184|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
129631185|NCT04242446|466602987|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129631186|NCT04242446|466602988|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129631187|NCT04242446|466602989|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129631188|NCT04242446|466602990|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129631189|NCT04242446|466602991|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129631190|NCT04242446|466602992|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
129631191|NCT04242446|466602993|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
129631192|NCT00739882|466602999|FG000|Double-blind Period|Adverse Event|1|||
129631193|NCT00739882|466603000|FG001|Double-blind Period|Adverse Event|2|||
129631194|NCT00739882|466602999|FG000|Double-blind Period|Protocol Violation|1|||
129631195|NCT00739882|466603000|FG001|Double-blind Period|Protocol Violation|0|||
129631196|NCT00739882|466602999|FG000|Double-blind Period|Lack of Efficacy|1|||
129631197|NCT00739882|466603000|FG001|Double-blind Period|Lack of Efficacy|1|||
129631198|NCT00739882|466602999|FG000|Double-blind Period|Other|16|||
129631199|NCT00739882|466603000|FG001|Double-blind Period|Other|8|||
129631200|NCT00739882|466602999|FG000|Open-label Period|Adverse Event|1|||
129631201|NCT00739882|466603000|FG001|Open-label Period|Adverse Event|0|||
129631202|NCT00739882|466602999|FG000|Open-label Period|Other|9|||
129631203|NCT00739882|466603000|FG001|Open-label Period|Other|5|||
129631204|NCT04021914|466603001|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
129631205|NCT00485732|466603002|FG000|Overall Study|Protocol Violation|1|||
129631206|NCT00485732|466603003|FG001|Overall Study|Protocol Violation|3|||
129631207|NCT00485732|466603002|FG000|Overall Study|Withdrawal by Subject|5|||
129631208|NCT00485732|466603003|FG001|Overall Study|Withdrawal by Subject|4|||
129631209|NCT00485732|466603002|FG000|Overall Study|Lost to Follow-up|2|||
129631210|NCT00485732|466603003|FG001|Overall Study|Lost to Follow-up|2|||
129631211|NCT03985800|466603004|FG000|Overall Study|Death|1|||
129631212|NCT03985800|466603005|FG001|Overall Study|Death|2|||
129631213|NCT03985800|466603004|FG000|Overall Study|Withdrawal by Subject|3|||
129631214|NCT03985800|466603005|FG001|Overall Study|Withdrawal by Subject|6|||
129631215|NCT03985800|466603004|FG000|Overall Study|Protocol Violation|2|||
129631216|NCT03985800|466603005|FG001|Overall Study|Protocol Violation|0|||
129631217|NCT04281485|466603006|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
129631218|NCT04281485|466603007|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
129631219|NCT04281485|466603006|FG000|Overall Study|Ongoing (Safety data collection)|10|||
129631220|NCT04281485|466603007|FG001|Overall Study|Ongoing (Safety data collection)|5|||
129631221|NCT03096314|466603010|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
129631222|NCT03096314|466603011|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
129631223|NCT00957801|466603014|FG000|Overall Study|Withdrawal by Subject|0|||
129631224|NCT00957801|466603015|FG001|Overall Study|Withdrawal by Subject|0|||
129631225|NCT00957801|466603016|FG002|Overall Study|Withdrawal by Subject|0|||
129631226|NCT00957801|466603017|FG003|Overall Study|Withdrawal by Subject|1|||
129631227|NCT01778855|466603018|FG000|Overall Study|Death|0|||
129631228|NCT01778855|466603019|FG001|Overall Study|Death|1|||
129631229|NCT00191477|466603020|FG000|Overall Study|Tumor Recurrence|49|||
129631230|NCT00191477|466603021|FG001|Overall Study|Tumor Recurrence|48|||
129631231|NCT00191477|466603020|FG000|Overall Study|Death, Study Disease|1|||
129631232|NCT00191477|466603021|FG001|Overall Study|Death, Study Disease|1|||
129631233|NCT00191477|466603020|FG000|Overall Study|Death, Other Cause|3|||
129703907|NCT01722669|466877573|FG004|Overall Study|Withdrawal by Subject|0|||
129703908|NCT01722669|466877574|FG005|Overall Study|Withdrawal by Subject|2|||
129703909|NCT03211416|466877575|FG000|Overall Study|Adverse Event|7|||
129703910|NCT03211416|466877575|FG000|Overall Study|Lack of Efficacy|2|||
129703911|NCT03211416|466877575|FG000|Overall Study|Physician Decision|1|||
129703912|NCT01587196|466877579|FG000|Overall Study|Lost to Follow-up|50|||
129703913|NCT01587196|466877579|FG000|Overall Study|Withdrawal by Subject|4|||
129703914|NCT00643279|466877585|FG000|Overall Study|Death|13|||
129703915|NCT00643279|466877586|FG001|Overall Study|Death|11|||
129703916|NCT00643279|466877585|FG000|Overall Study|Withdrawal by Subject|3|||
129703917|NCT00643279|466877586|FG001|Overall Study|Withdrawal by Subject|0|||
129631234|NCT00191477|466603021|FG001|Overall Study|Death, Other Cause|6|||
129795154|NCT04543409|467217924|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
129795155|NCT02093026|467217925|FG000|Overall Study|Adverse Event|26|||
129795156|NCT02093026|467217925|FG000|Overall Study|Death|10|||
129703918|NCT00643279|466877585|FG000|Overall Study|Lost to Follow-up|0|||
129703919|NCT00643279|466877586|FG001|Overall Study|Lost to Follow-up|1|||
129703920|NCT00643279|466877585|FG000|Overall Study|Physician Decision|0|||
129703921|NCT00643279|466877586|FG001|Overall Study|Physician Decision|1|||
129703922|NCT05715827|466877587|FG000|Overall Study|Physician Decision|0|||
129703923|NCT05715827|466877588|FG001|Overall Study|Physician Decision|1|||
129703924|NCT05715827|466877587|FG000|Overall Study|console communication error|0|||
129703925|NCT05715827|466877588|FG001|Overall Study|console communication error|1|||
129703926|NCT03814044|466877589|FG000|Overall Study|Protocol deviation|1|||
129703927|NCT03557502|466877590|FG000|Protocol 2|Withdrawal by Subject|1|||
129703928|NCT03557502|466877591|FG001|Protocol 2|Withdrawal by Subject|1|||
129703929|NCT03557502|466877590|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
129703930|NCT03557502|466877591|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
129703931|NCT03021486|466878957|FG000|Overall Study|Withdrawal by Subject|1|||
129703932|NCT03021486|466878958|FG001|Overall Study|Withdrawal by Subject|1|||
129703933|NCT03021486|466878959|FG002|Overall Study|Withdrawal by Subject|3|||
129703934|NCT03021486|466878957|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
129703935|NCT03021486|466878958|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
129703936|NCT03021486|466878959|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
129703937|NCT04887831|466878960|FG000|Overall Study|Death|26|||
129703938|NCT04887831|466878961|FG001|Overall Study|Death|26|||
129703939|NCT04887831|466878960|FG000|Overall Study|Lost to Follow-up|0|||
129703940|NCT04887831|466878961|FG001|Overall Study|Lost to Follow-up|1|||
129795157|NCT02093026|467217925|FG000|Overall Study|Other|157|||
129795158|NCT00518973|467217926|FG000|Overall Study|Withdrawal by Subject|3|||
129795159|NCT00518973|467217927|FG001|Overall Study|Withdrawal by Subject|2|||
129795160|NCT00174291|467217944|FG000|Overall Study|Lost to Follow-up|1|||
129795161|NCT00174291|467217945|FG001|Overall Study|Lost to Follow-up|1|||
129795162|NCT00174291|467217944|FG000|Overall Study|Protocol Violation|0|||
129631235|NCT00191477|466603020|FG000|Overall Study|Lost to Follow-up|23|||
129631236|NCT00191477|466603021|FG001|Overall Study|Lost to Follow-up|21|||
129631237|NCT00191477|466603020|FG000|Overall Study|Protocol Violation|1|||
129631238|NCT00191477|466603021|FG001|Overall Study|Protocol Violation|1|||
129631239|NCT00191477|466603020|FG000|Overall Study|Treatment Change|2|||
129631240|NCT00191477|466603021|FG001|Overall Study|Treatment Change|0|||
129631241|NCT00191477|466603020|FG000|Overall Study|Withdrawal by Subject|2|||
129631242|NCT00191477|466603021|FG001|Overall Study|Withdrawal by Subject|0|||
129631243|NCT00191477|466603020|FG000|Overall Study|Other|2|||
129631244|NCT00191477|466603021|FG001|Overall Study|Other|0|||
129631245|NCT00191477|466603020|FG000|Overall Study|Not Eligible|41|||
129631246|NCT00191477|466603021|FG001|Overall Study|Not Eligible|38|||
129631247|NCT00191477|466603020|FG000|Overall Study|Pathological Specimen Lost|1|||
129631248|NCT00191477|466603021|FG001|Overall Study|Pathological Specimen Lost|0|||
129631249|NCT00191477|466603020|FG000|Overall Study|Discontinued Prior to Instillation|13|||
129631250|NCT00191477|466603021|FG001|Overall Study|Discontinued Prior to Instillation|14|||
129631251|NCT01286467|466603026|FG000|Overall Study|Death|1|||
129631252|NCT01286467|466603027|FG001|Overall Study|Death|1|||
129631253|NCT01286467|466603028|FG002|Overall Study|Death|1|||
129631254|NCT01286467|466603029|FG003|Overall Study|Death|0|||
129631255|NCT01286467|466603026|FG000|Overall Study|Lost to Follow-up|0|||
129631256|NCT01286467|466603027|FG001|Overall Study|Lost to Follow-up|0|||
129631257|NCT01286467|466603028|FG002|Overall Study|Lost to Follow-up|0|||
129631258|NCT01286467|466603029|FG003|Overall Study|Lost to Follow-up|1|||
129631259|NCT01286467|466603026|FG000|Overall Study|Withdrawal by Subject|0|||
129631260|NCT01286467|466603027|FG001|Overall Study|Withdrawal by Subject|0|||
129631261|NCT01286467|466603028|FG002|Overall Study|Withdrawal by Subject|1|||
129631262|NCT01286467|466603029|FG003|Overall Study|Withdrawal by Subject|0|||
129631263|NCT01286467|466603026|FG000|Overall Study|Physician Decision|0|||
129703941|NCT04887831|466878960|FG000|Overall Study|Withdrawal by Subject|2|||
129703942|NCT04887831|466878961|FG001|Overall Study|Withdrawal by Subject|1|||
129703943|NCT04887831|466878960|FG000|Overall Study|Study Terminated by Sponsor|18|||
129703944|NCT04887831|466878961|FG001|Overall Study|Study Terminated by Sponsor|17|||
129795163|NCT00174291|467217945|FG001|Overall Study|Protocol Violation|2|||
129703945|NCT04887831|466878960|FG000|Overall Study|Other|1|||
129795164|NCT00174291|467217944|FG000|Overall Study|Study terminated by sponsor|1|||
129631264|NCT01286467|466603027|FG001|Overall Study|Physician Decision|0|||
129631265|NCT01286467|466603028|FG002|Overall Study|Physician Decision|0|||
129631266|NCT01286467|466603029|FG003|Overall Study|Physician Decision|1|||
129631267|NCT01286467|466603026|FG000|Overall Study|Disease progression|3|||
129631268|NCT01286467|466603027|FG001|Overall Study|Disease progression|2|||
129631269|NCT01286467|466603028|FG002|Overall Study|Disease progression|2|||
129631270|NCT01286467|466603029|FG003|Overall Study|Disease progression|3|||
129631271|NCT01286467|466603026|FG000|Overall Study|Adverse Event|0|||
129631272|NCT01286467|466603027|FG001|Overall Study|Adverse Event|1|||
129631273|NCT01286467|466603028|FG002|Overall Study|Adverse Event|2|||
129631274|NCT01286467|466603029|FG003|Overall Study|Adverse Event|3|||
129631275|NCT01286467|466603026|FG000|Overall Study|Study drug stop longer than 14 days|0|||
129631276|NCT01286467|466603027|FG001|Overall Study|Study drug stop longer than 14 days|0|||
129631277|NCT01286467|466603028|FG002|Overall Study|Study drug stop longer than 14 days|1|||
129631278|NCT01286467|466603029|FG003|Overall Study|Study drug stop longer than 14 days|0|||
129631279|NCT01058642|466603030|FG000|Treatment Period 1|Adverse Event|0|||
129631280|NCT01058642|466603031|FG001|Treatment Period 1|Adverse Event|1|||
129631281|NCT01058642|466603032|FG002|Treatment Period 1|Adverse Event|1|||
129631282|NCT01058642|466603033|FG003|Treatment Period 1|Adverse Event|0|||
129631283|NCT01058642|466603030|FG000|Treatment Period 1|Physician Decision|0|||
129631284|NCT01058642|466603031|FG001|Treatment Period 1|Physician Decision|0|||
129631285|NCT01058642|466603032|FG002|Treatment Period 1|Physician Decision|1|||
129631286|NCT01058642|466603033|FG003|Treatment Period 1|Physician Decision|0|||
129631287|NCT01058642|466603030|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129631288|NCT01058642|466603031|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129631289|NCT01058642|466603032|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129631290|NCT01058642|466603033|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129631291|NCT01058642|466603030|FG000|Treatment Period 1|Lack of Efficacy|0|||
129631292|NCT01058642|466603031|FG001|Treatment Period 1|Lack of Efficacy|0|||
129631293|NCT01058642|466603032|FG002|Treatment Period 1|Lack of Efficacy|0|||
129631294|NCT01058642|466603033|FG003|Treatment Period 1|Lack of Efficacy|1|||
129631295|NCT01058642|466603030|FG000|Treatment Period 1|Protocol Violation|0|||
129631296|NCT01058642|466603031|FG001|Treatment Period 1|Protocol Violation|0|||
129631297|NCT01058642|466603032|FG002|Treatment Period 1|Protocol Violation|0|||
129631298|NCT01058642|466603033|FG003|Treatment Period 1|Protocol Violation|1|||
129631299|NCT01058642|466603030|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
129631300|NCT01058642|466603031|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
129631301|NCT01058642|466603032|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
129631302|NCT01058642|466603033|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
129631303|NCT03876743|466603034|FG000|Overall Study|Lost to Follow-up|6|||
129631304|NCT03876743|466603035|FG001|Overall Study|Lost to Follow-up|4|||
129631305|NCT03876743|466603036|FG002|Overall Study|Lost to Follow-up|4|||
129631306|NCT03876743|466603037|FG003|Overall Study|Lost to Follow-up|7|||
129631307|NCT00092118|466603038|FG000|Overall Study|Adverse Event|35|||
129631308|NCT00092118|466603039|FG001|Overall Study|Adverse Event|32|||
129631309|NCT00092118|466603038|FG000|Overall Study|Lack of Efficacy|12|||
129631310|NCT00092118|466603039|FG001|Overall Study|Lack of Efficacy|14|||
129631311|NCT00092118|466603038|FG000|Overall Study|Lost to Follow-up|4|||
129631312|NCT00092118|466603039|FG001|Overall Study|Lost to Follow-up|3|||
129631313|NCT00092118|466603038|FG000|Overall Study|Protocol Violation|23|||
129631314|NCT00092118|466603039|FG001|Overall Study|Protocol Violation|25|||
129631315|NCT00092118|466603038|FG000|Overall Study|Withdrawal by Subject|4|||
129631316|NCT00092118|466603039|FG001|Overall Study|Withdrawal by Subject|10|||
129631317|NCT00092118|466603038|FG000|Overall Study|Other|6|||
129631318|NCT00092118|466603039|FG001|Overall Study|Other|5|||
129631319|NCT01139125|466603040|FG000|Overall Study|Withdrawal by Subject|1|||
129631320|NCT03751098|466603041|FG000|Overall Study|Withdrawal by Subject|0|||
129631321|NCT03751098|466603042|FG001|Overall Study|Withdrawal by Subject|1|||
129631322|NCT01108718|466603045|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
129631323|NCT01108718|466603046|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
129631324|NCT03380429|466603047|FG000|Overall Study|Physician Decision|0|||
129631325|NCT03380429|466603048|FG001|Overall Study|Physician Decision|1|||
129631326|NCT03380429|466603049|FG002|Overall Study|Physician Decision|0|||
129631327|NCT03380429|466603050|FG003|Overall Study|Physician Decision|1|||
129631328|NCT03380429|466603051|FG004|Overall Study|Physician Decision|1|||
129631329|NCT03380429|466603047|FG000|Overall Study|Withdrawal by Subject|3|||
129631330|NCT03380429|466603048|FG001|Overall Study|Withdrawal by Subject|3|||
129631331|NCT03380429|466603049|FG002|Overall Study|Withdrawal by Subject|5|||
129631332|NCT03380429|466603050|FG003|Overall Study|Withdrawal by Subject|2|||
129631333|NCT03380429|466603051|FG004|Overall Study|Withdrawal by Subject|1|||
129631334|NCT03380429|466603047|FG000|Overall Study|Lost to Follow-up|0|||
129631335|NCT03380429|466603048|FG001|Overall Study|Lost to Follow-up|2|||
129631336|NCT03380429|466603049|FG002|Overall Study|Lost to Follow-up|4|||
129631337|NCT03380429|466603050|FG003|Overall Study|Lost to Follow-up|3|||
129631338|NCT03380429|466603051|FG004|Overall Study|Lost to Follow-up|1|||
129631339|NCT03380429|466603047|FG000|Overall Study|Protocol Violation|1|||
129631340|NCT03380429|466603048|FG001|Overall Study|Protocol Violation|0|||
129631341|NCT03380429|466603049|FG002|Overall Study|Protocol Violation|1|||
129795165|NCT00174291|467217945|FG001|Overall Study|Study terminated by sponsor|0|||
129631342|NCT03380429|466603050|FG003|Overall Study|Protocol Violation|0|||
129631343|NCT03380429|466603051|FG004|Overall Study|Protocol Violation|1|||
129631344|NCT03380429|466603047|FG000|Overall Study|Lack of Efficacy|0|||
129631345|NCT03380429|466603048|FG001|Overall Study|Lack of Efficacy|0|||
129631346|NCT03380429|466603049|FG002|Overall Study|Lack of Efficacy|0|||
129631347|NCT03380429|466603050|FG003|Overall Study|Lack of Efficacy|2|||
129631348|NCT03380429|466603051|FG004|Overall Study|Lack of Efficacy|1|||
129631349|NCT03380429|466603047|FG000|Overall Study|Adverse Event|1|||
129631350|NCT03380429|466603048|FG001|Overall Study|Adverse Event|1|||
129631351|NCT03380429|466603049|FG002|Overall Study|Adverse Event|1|||
129631352|NCT03380429|466603050|FG003|Overall Study|Adverse Event|2|||
129631353|NCT03380429|466603051|FG004|Overall Study|Adverse Event|0|||
129631354|NCT04760626|466603054|FG000|Overall Study|Withdrawal by Subject|24|||
129631355|NCT04760626|466603055|FG001|Overall Study|Withdrawal by Subject|20|||
129631356|NCT04760626|466603054|FG000|Overall Study|Lost to Follow-up|14|||
129631357|NCT04760626|466603055|FG001|Overall Study|Lost to Follow-up|19|||
129631358|NCT04760626|466603054|FG000|Overall Study|Physician Decision|3|||
129631359|NCT04760626|466603055|FG001|Overall Study|Physician Decision|5|||
129631360|NCT04760626|466603054|FG000|Overall Study|Death|3|||
129631361|NCT04760626|466603055|FG001|Overall Study|Death|6|||
129631362|NCT04760626|466603054|FG000|Overall Study|Site closure|1|||
129631363|NCT04760626|466603055|FG001|Overall Study|Site closure|0|||
129631364|NCT03762265|466603058|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
129631365|NCT03762265|466603059|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
129631366|NCT03762265|466603058|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
129631367|NCT03762265|466603059|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
129631368|NCT03762265|466603058|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
129631369|NCT03762265|466603059|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
129631370|NCT03762265|466603058|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
129631371|NCT03762265|466603059|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
129631372|NCT03762265|466603058|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
129631373|NCT03762265|466603059|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
129631374|NCT03762265|466603058|FG000|BT Period: Weeks 1 to 37|Other|0|||
129631375|NCT03762265|466603059|FG001|BT Period: Weeks 1 to 37|Other|1|||
129631376|NCT03762265|466603058|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
129631377|NCT03762265|466603059|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
129631378|NCT03762265|466603058|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
129631379|NCT03762265|466603059|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
129631380|NCT03762265|466603058|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
129631381|NCT03762265|466603059|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
129631382|NCT03762265|466603058|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
129631383|NCT03762265|466603059|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
129631384|NCT03762265|466603058|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
129631385|NCT03762265|466603059|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
129631386|NCT03762265|466603058|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
129631387|NCT03762265|466603059|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
129631388|NCT03762265|466603058|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
129631389|NCT03762265|466603059|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
129631390|NCT03762265|466603058|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
129631391|NCT03762265|466603059|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
129631392|NCT03762265|466603058|FG000|LTE Period: Weeks 61 to 109|Other|1|||
129631393|NCT03762265|466603059|FG001|LTE Period: Weeks 61 to 109|Other|0|||
129631394|NCT00806403|466603062|FG000|Overall Study|Death|4|||
129631395|NCT00806403|466603063|FG001|Overall Study|Death|3|||
129631396|NCT01882985|466603064|FG000|Overall Study|Lost to Follow-up|1|||
129631397|NCT01882985|466603064|FG000|Overall Study|Withdrawal by Subject|1|||
129631398|NCT01383174|466603065|FG000|3 Month Assessment|Death|0|||
129631399|NCT01383174|466603066|FG001|3 Month Assessment|Death|1|||
129631400|NCT01383174|466603065|FG000|3 Month Assessment|Lost to Follow-up|2|||
129631401|NCT01383174|466603066|FG001|3 Month Assessment|Lost to Follow-up|0|||
129631402|NCT01383174|466603065|FG000|3 Month Assessment|Refused to complete|4|||
129631403|NCT01383174|466603066|FG001|3 Month Assessment|Refused to complete|0|||
129795166|NCT00174291|467217944|FG000|Overall Study|Withdrawal by Subject|3|||
129631404|NCT01383174|466603065|FG000|6 Month Assessment|Lost to Follow-up|1|||
129631405|NCT01383174|466603066|FG001|6 Month Assessment|Lost to Follow-up|1|||
129631406|NCT01383174|466603065|FG000|6 Month Assessment|Refused to complete|4|||
129631407|NCT01383174|466603066|FG001|6 Month Assessment|Refused to complete|0|||
129631408|NCT01787292|466603067|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
129631409|NCT01787292|466603068|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
129631410|NCT01787292|466603067|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
129631411|NCT01787292|466603068|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
129631412|NCT01827111|466603069|FG000|Overall Study|Disease Progression|1|||
129631413|NCT02169271|466603070|FG000|Overall Study|Protocol Violation|1|||
129631414|NCT02169271|466603071|FG001|Overall Study|Protocol Violation|2|||
129703946|NCT04887831|466878961|FG001|Overall Study|Other|0|||
129703947|NCT00730327|466878962|FG000|Overall Study|Lost to Follow-up|14|||
129703948|NCT00730327|466878963|FG001|Overall Study|Lost to Follow-up|16|||
129703949|NCT00730327|466878962|FG000|Overall Study|Adverse Event|8|||
129703950|NCT00730327|466878963|FG001|Overall Study|Adverse Event|1|||
129703951|NCT00730327|466878962|FG000|Overall Study|Withdrawal by Subject|3|||
129703952|NCT00730327|466878963|FG001|Overall Study|Withdrawal by Subject|13|||
129703953|NCT00730327|466878962|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
129703954|NCT00730327|466878963|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
129703955|NCT02552225|466878964|FG000|Overall Study|Withdrawal by Subject|1|||
129703956|NCT02552225|466878965|FG001|Overall Study|Withdrawal by Subject|0|||
129703957|NCT02297516|466878966|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
129703958|NCT02297516|466878967|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
129703959|NCT02297516|466878966|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
129703960|NCT02297516|466878967|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
129703961|NCT02297516|466878966|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
129703962|NCT02297516|466878967|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
129703963|NCT03674281|466878968|FG000|Overall Study|screen failure|2|||
129703964|NCT03674281|466878969|FG001|Overall Study|screen failure|0|||
129703965|NCT03674281|466878970|FG002|Overall Study|screen failure|0|||
129703966|NCT03674281|466878968|FG000|Overall Study|Withdrawal by Subject|1|||
129703967|NCT03674281|466878969|FG001|Overall Study|Withdrawal by Subject|3|||
129703968|NCT03674281|466878970|FG002|Overall Study|Withdrawal by Subject|3|||
129703969|NCT00366457|466878973|FG000|Overall Study|never began study therapy|2|||
129703970|NCT01497197|466878974|FG000|Overall Study|Lost to Follow-up|1|||
129703971|NCT01497197|466878975|FG001|Overall Study|Lost to Follow-up|0|||
129703972|NCT01497197|466878974|FG000|Overall Study|Protocol Violation|0|||
129703973|NCT01497197|466878975|FG001|Overall Study|Protocol Violation|2|||
129703974|NCT01497197|466878974|FG000|Overall Study|Withdrawal by Subject|2|||
129703975|NCT01497197|466878975|FG001|Overall Study|Withdrawal by Subject|1|||
129703976|NCT01497197|466878974|FG000|Overall Study|Excessive/lack of response to treatment|1|||
129703977|NCT01497197|466878975|FG001|Overall Study|Excessive/lack of response to treatment|0|||
129703978|NCT01497197|466878974|FG000|Overall Study|Risk of OHSS|1|||
129703979|NCT01497197|466878975|FG001|Overall Study|Risk of OHSS|0|||
129703980|NCT01497197|466878974|FG000|Overall Study|No oocytes retrieved|3|||
129703981|NCT01497197|466878975|FG001|Overall Study|No oocytes retrieved|2|||
129703982|NCT01497197|466878974|FG000|Overall Study|No fertilisation|6|||
129703983|NCT01497197|466878975|FG001|Overall Study|No fertilisation|5|||
129703984|NCT01497197|466878974|FG000|Overall Study|Intention to freeze all embryos|0|||
129703985|NCT01497197|466878975|FG001|Overall Study|Intention to freeze all embryos|1|||
129703986|NCT01497197|466878974|FG000|Overall Study|All embryos discarded|0|||
129703987|NCT01497197|466878975|FG001|Overall Study|All embryos discarded|3|||
129703988|NCT01497197|466878974|FG000|Overall Study|Other|3|||
129703989|NCT01497197|466878975|FG001|Overall Study|Other|1|||
129703990|NCT00415636|466878978|FG000|Overall Study|Symptomatic deterioration|1|||
129703991|NCT00415636|466878979|FG001|Overall Study|Symptomatic deterioration|0|||
129703992|NCT00415636|466878980|FG002|Overall Study|Symptomatic deterioration|1|||
129703993|NCT00415636|466878981|FG003|Overall Study|Symptomatic deterioration|2|||
129703994|NCT00415636|466878982|FG004|Overall Study|Symptomatic deterioration|0|||
129703995|NCT00415636|466878983|FG005|Overall Study|Symptomatic deterioration|1|||
129703996|NCT00415636|466878978|FG000|Overall Study|Adverse Event|0|||
129703997|NCT00415636|466878979|FG001|Overall Study|Adverse Event|0|||
129703998|NCT00415636|466878980|FG002|Overall Study|Adverse Event|0|||
129703999|NCT00415636|466878981|FG003|Overall Study|Adverse Event|1|||
129704000|NCT00415636|466878982|FG004|Overall Study|Adverse Event|1|||
129704001|NCT00415636|466878983|FG005|Overall Study|Adverse Event|0|||
129704002|NCT00415636|466878978|FG000|Overall Study|Withdrawal by Subject|0|||
129704003|NCT00415636|466878979|FG001|Overall Study|Withdrawal by Subject|0|||
129704004|NCT00415636|466878980|FG002|Overall Study|Withdrawal by Subject|0|||
129704005|NCT00415636|466878981|FG003|Overall Study|Withdrawal by Subject|0|||
129704006|NCT00415636|466878982|FG004|Overall Study|Withdrawal by Subject|1|||
129704007|NCT00415636|466878983|FG005|Overall Study|Withdrawal by Subject|0|||
129440362|NCT01749540|465911417|FG001|Overall Study|Protocol Violation|0|||
129704008|NCT00415636|466878978|FG000|Overall Study|Disease progression|0|||
129704009|NCT00415636|466878979|FG001|Overall Study|Disease progression|0|||
129704010|NCT00415636|466878980|FG002|Overall Study|Disease progression|0|||
129704011|NCT00415636|466878981|FG003|Overall Study|Disease progression|3|||
129704012|NCT00415636|466878982|FG004|Overall Study|Disease progression|0|||
129704013|NCT00415636|466878983|FG005|Overall Study|Disease progression|1|||
129704014|NCT05201807|466878986|FG000|Overall Study|Adverse Event|1|||
129704015|NCT05201807|466878986|FG000|Overall Study|COVID-19 Related|1|||
129704016|NCT01209767|466878990|FG000|Overall Study|Withdrawal by Subject|1|||
129704017|NCT01209767|466878990|FG000|Overall Study|Lost to Follow-up|3|||
129704018|NCT04507204|466878991|FG000|Overall Study|Adverse Event|8|||
129704019|NCT04507204|466878992|FG001|Overall Study|Adverse Event|13|||
129704020|NCT04507204|466878991|FG000|Overall Study|Death|0|||
129631415|NCT01924689|466603074|FG000|Overall Study|Death|0|||
129631416|NCT01924689|466603075|FG001|Overall Study|Death|1|||
129631417|NCT01924689|466603076|FG002|Overall Study|Death|0|||
129631418|NCT01924689|466603077|FG003|Overall Study|Death|1|||
129631419|NCT01924689|466603078|FG004|Overall Study|Death|0|||
129631420|NCT01924689|466603079|FG005|Overall Study|Death|0|||
129631421|NCT01924689|466603074|FG000|Overall Study|Disease progression|0|||
129631422|NCT01924689|466603075|FG001|Overall Study|Disease progression|0|||
129631423|NCT01924689|466603076|FG002|Overall Study|Disease progression|2|||
129631424|NCT01924689|466603077|FG003|Overall Study|Disease progression|0|||
129631425|NCT01924689|466603078|FG004|Overall Study|Disease progression|3|||
129631426|NCT01924689|466603079|FG005|Overall Study|Disease progression|2|||
129631427|NCT01924689|466603074|FG000|Overall Study|New therapy or study|3|||
129631428|NCT01924689|466603075|FG001|Overall Study|New therapy or study|2|||
129631429|NCT01924689|466603076|FG002|Overall Study|New therapy or study|1|||
129631430|NCT01924689|466603077|FG003|Overall Study|New therapy or study|4|||
129631431|NCT01924689|466603078|FG004|Overall Study|New therapy or study|2|||
129631432|NCT01924689|466603079|FG005|Overall Study|New therapy or study|0|||
129631433|NCT01924689|466603074|FG000|Overall Study|Withdrawal of consent|0|||
129631434|NCT01924689|466603075|FG001|Overall Study|Withdrawal of consent|0|||
129631435|NCT01924689|466603076|FG002|Overall Study|Withdrawal of consent|1|||
129631436|NCT01924689|466603077|FG003|Overall Study|Withdrawal of consent|1|||
129631437|NCT01924689|466603078|FG004|Overall Study|Withdrawal of consent|0|||
129631438|NCT01924689|466603079|FG005|Overall Study|Withdrawal of consent|0|||
129631439|NCT01924689|466603074|FG000|Overall Study|Other|0|||
129631440|NCT01924689|466603075|FG001|Overall Study|Other|0|||
129631441|NCT01924689|466603076|FG002|Overall Study|Other|0|||
129631442|NCT01924689|466603077|FG003|Overall Study|Other|0|||
129631443|NCT01924689|466603078|FG004|Overall Study|Other|1|||
129631444|NCT01924689|466603079|FG005|Overall Study|Other|0|||
129631445|NCT03267212|466603080|FG000|First Intervention|Lost to Follow-up|0|||
129631446|NCT03267212|466603081|FG001|First Intervention|Lost to Follow-up|2|||
129631447|NCT03267212|466603080|FG000|First Intervention|Withdrawal by Subject|1|||
129631448|NCT03267212|466603081|FG001|First Intervention|Withdrawal by Subject|1|||
129631449|NCT03267212|466603080|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
129631450|NCT03267212|466603081|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
129631451|NCT00226499|466603084|FG000|Overall Study|Adverse Event|10|||
129631452|NCT00226499|466603085|FG001|Overall Study|Adverse Event|6|||
129631453|NCT00226499|466603086|FG002|Overall Study|Adverse Event|3|||
129631454|NCT00226499|466603084|FG000|Overall Study|Others|1064|||
129631455|NCT00226499|466603085|FG001|Overall Study|Others|1066|||
129631456|NCT00226499|466603086|FG002|Overall Study|Others|356|||
129631457|NCT00946920|466603087|FG000|Overall Study|Withdrawal by Subject|28|||
129631458|NCT00946920|466603088|FG001|Overall Study|Withdrawal by Subject|15|||
129631459|NCT00946920|466603087|FG000|Overall Study|Lost to Follow-up|2|||
129631460|NCT00946920|466603088|FG001|Overall Study|Lost to Follow-up|2|||
129631461|NCT00946920|466603087|FG000|Overall Study|Physician Decision|5|||
129631462|NCT00946920|466603088|FG001|Overall Study|Physician Decision|2|||
129631463|NCT00946920|466603087|FG000|Overall Study|Adverse Event|41|||
129631464|NCT00946920|466603088|FG001|Overall Study|Adverse Event|14|||
129631465|NCT00946920|466603087|FG000|Overall Study|Protocol Violation|16|||
129631466|NCT00946920|466603088|FG001|Overall Study|Protocol Violation|8|||
129631467|NCT00946920|466603087|FG000|Overall Study|Miscellaneous reasons|18|||
129631468|NCT00946920|466603088|FG001|Overall Study|Miscellaneous reasons|3|||
129631469|NCT01597973|466603089|FG000|Overall Study|Found ineligible before study medication started|4|||
129631470|NCT01597973|466603090|FG001|Overall Study|Found ineligible before study medication started|2|||
129631471|NCT01597973|466603089|FG000|Overall Study|Eligible pathogen not confirmed|14|||
129631472|NCT01597973|466603090|FG001|Overall Study|Eligible pathogen not confirmed|15|||
129631473|NCT01597973|466603089|FG000|Overall Study|LAR not authorized to consent|0|||
129631474|NCT01597973|466603090|FG001|Overall Study|LAR not authorized to consent|1|||
129631475|NCT01597973|466603089|FG000|Overall Study|Ineligible due to early seizures|1|||
129631476|NCT01597973|466603090|FG001|Overall Study|Ineligible due to early seizures|0|||
129631477|NCT01597973|466603089|FG000|Overall Study|Ineligible due to non-target infection|1|||
129631478|NCT01597973|466603090|FG001|Overall Study|Ineligible due to non-target infection|1|||
129631479|NCT02389829|466603097|FG000|Overall Study|Lost to Follow-up|0|||
129631480|NCT02389829|466603098|FG001|Overall Study|Lost to Follow-up|1|||
129631481|NCT02362360|466603099|FG000|Period 1|Lack of Efficacy|1|||
129631482|NCT02362360|466603100|FG001|Period 1|Lack of Efficacy|0|||
129631483|NCT02362360|466603099|FG000|Period 1|Withdrawal by Subject|2|||
129631484|NCT02362360|466603100|FG001|Period 1|Withdrawal by Subject|1|||
129631485|NCT02208362|466603101|FG000|Overall Study|Participant did not complete treatment|0|||
129631486|NCT02208362|466603102|FG001|Overall Study|Participant did not complete treatment|1|||
129631487|NCT02208362|466603103|FG002|Overall Study|Participant did not complete treatment|0|||
129631488|NCT02208362|466603104|FG003|Overall Study|Participant did not complete treatment|0|||
129631489|NCT02208362|466603105|FG004|Overall Study|Participant did not complete treatment|0|||
129631490|NCT02208362|466603106|FG005|Overall Study|Participant did not complete treatment|0|||
129631491|NCT02208362|466603107|FG006|Overall Study|Participant did not complete treatment|1|||
129795167|NCT00174291|467217945|FG001|Overall Study|Withdrawal by Subject|3|||
129795168|NCT01923168|467217948|FG000|Overall Study|Protocol Violation|1|||
129795169|NCT01923168|467217949|FG001|Overall Study|Protocol Violation|1|||
129795170|NCT01923168|467217950|FG002|Overall Study|Protocol Violation|0|||
129795171|NCT01923168|467217948|FG000|Overall Study|Subject/guardian decision|14|||
129795172|NCT01923168|467217949|FG001|Overall Study|Subject/guardian decision|14|||
129631492|NCT02208362|466603108|FG007|Overall Study|Participant did not complete treatment|1|||
129631493|NCT02208362|466603109|FG008|Overall Study|Participant did not complete treatment|2|||
129631494|NCT02208362|466603110|FG009|Overall Study|Participant did not complete treatment|0|||
129631495|NCT02208362|466603111|FG010|Overall Study|Participant did not complete treatment|1|||
129631496|NCT02208362|466603112|FG011|Overall Study|Participant did not complete treatment|0|||
129631497|NCT02208362|466603101|FG000|Overall Study|Participant received disallowed treatment|0|||
129631498|NCT02208362|466603102|FG001|Overall Study|Participant received disallowed treatment|0|||
129631499|NCT02208362|466603103|FG002|Overall Study|Participant received disallowed treatment|0|||
129631500|NCT02208362|466603104|FG003|Overall Study|Participant received disallowed treatment|0|||
129631501|NCT02208362|466603105|FG004|Overall Study|Participant received disallowed treatment|0|||
129631502|NCT02208362|466603106|FG005|Overall Study|Participant received disallowed treatment|0|||
129631503|NCT02208362|466603107|FG006|Overall Study|Participant received disallowed treatment|0|||
129631504|NCT02208362|466603108|FG007|Overall Study|Participant received disallowed treatment|0|||
129631505|NCT02208362|466603109|FG008|Overall Study|Participant received disallowed treatment|1|||
129631506|NCT02208362|466603110|FG009|Overall Study|Participant received disallowed treatment|0|||
129631507|NCT02208362|466603111|FG010|Overall Study|Participant received disallowed treatment|0|||
129631508|NCT02208362|466603112|FG011|Overall Study|Participant received disallowed treatment|0|||
129631509|NCT05966584|466603117|FG000|Overall Study|Lost to Follow-up|1|||
129631510|NCT03349060|466604501|FG000|Overall Study|Adverse Event|9|||
129631511|NCT03349060|466604502|FG001|Overall Study|Adverse Event|9|||
129631512|NCT03349060|466604503|FG002|Overall Study|Adverse Event|7|||
129631513|NCT03349060|466604501|FG000|Overall Study|Lack of Efficacy|1|||
129631514|NCT03349060|466604502|FG001|Overall Study|Lack of Efficacy|0|||
129631515|NCT03349060|466604503|FG002|Overall Study|Lack of Efficacy|2|||
129631516|NCT03349060|466604501|FG000|Overall Study|Lost to Follow-up|2|||
129631517|NCT03349060|466604502|FG001|Overall Study|Lost to Follow-up|1|||
129631518|NCT03349060|466604503|FG002|Overall Study|Lost to Follow-up|1|||
129631519|NCT03349060|466604501|FG000|Overall Study|Protocol Violation|2|||
129631520|NCT03349060|466604502|FG001|Overall Study|Protocol Violation|2|||
129631521|NCT03349060|466604503|FG002|Overall Study|Protocol Violation|1|||
129631522|NCT03349060|466604501|FG000|Overall Study|Withdrawal by Subject|5|||
129631523|NCT03349060|466604502|FG001|Overall Study|Withdrawal by Subject|3|||
129631524|NCT03349060|466604503|FG002|Overall Study|Withdrawal by Subject|4|||
129631525|NCT03349060|466604501|FG000|Overall Study|Medication error,no linked adverse event|0|||
129631526|NCT03349060|466604502|FG001|Overall Study|Medication error,no linked adverse event|0|||
129631527|NCT03349060|466604503|FG002|Overall Study|Medication error,no linked adverse event|1|||
129631528|NCT03349060|466604501|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129631529|NCT03349060|466604502|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
129631530|NCT03349060|466604503|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
129631531|NCT03349060|466604501|FG000|Overall Study|Other|2|||
129631532|NCT03349060|466604502|FG001|Overall Study|Other|1|||
129631533|NCT03349060|466604503|FG002|Overall Study|Other|0|||
129631534|NCT02861586|466604504|FG000|Overall Study|Withdrawal by Subject|1|||
129631535|NCT02861586|466604505|FG001|Overall Study|Withdrawal by Subject|2|||
129631536|NCT02861586|466604506|FG002|Overall Study|Withdrawal by Subject|0|||
129631537|NCT02861586|466604507|FG003|Overall Study|Withdrawal by Subject|0|||
129631538|NCT02861586|466604508|FG004|Overall Study|Withdrawal by Subject|0|||
129631539|NCT02861586|466604509|FG005|Overall Study|Withdrawal by Subject|1|||
129631540|NCT02861586|466604510|FG006|Overall Study|Withdrawal by Subject|1|||
129631541|NCT02861586|466604511|FG007|Overall Study|Withdrawal by Subject|0|||
129631542|NCT02861586|466604504|FG000|Overall Study|Lost to Follow-up|3|||
129631543|NCT02861586|466604505|FG001|Overall Study|Lost to Follow-up|1|||
129631544|NCT02861586|466604506|FG002|Overall Study|Lost to Follow-up|1|||
129795173|NCT01923168|467217950|FG002|Overall Study|Subject/guardian decision|4|||
129795174|NCT01923168|467217948|FG000|Overall Study|Adverse Event|12|||
129795175|NCT01923168|467217949|FG001|Overall Study|Adverse Event|12|||
129795176|NCT01923168|467217950|FG002|Overall Study|Adverse Event|0|||
129795177|NCT01923168|467217948|FG000|Overall Study|Physician Decision|6|||
129631545|NCT02861586|466604507|FG003|Overall Study|Lost to Follow-up|0|||
129631546|NCT02861586|466604508|FG004|Overall Study|Lost to Follow-up|0|||
129631547|NCT02861586|466604509|FG005|Overall Study|Lost to Follow-up|3|||
129631548|NCT02861586|466604510|FG006|Overall Study|Lost to Follow-up|0|||
129631549|NCT02861586|466604511|FG007|Overall Study|Lost to Follow-up|0|||
129631550|NCT02861586|466604504|FG000|Overall Study|Adverse Event|0|||
129795178|NCT01923168|467217949|FG001|Overall Study|Physician Decision|9|||
129795179|NCT01923168|467217950|FG002|Overall Study|Physician Decision|5|||
129795180|NCT01923168|467217948|FG000|Overall Study|Progressive disease|4|||
129795181|NCT01923168|467217949|FG001|Overall Study|Progressive disease|3|||
129795182|NCT01923168|467217950|FG002|Overall Study|Progressive disease|7|||
129631551|NCT02861586|466604505|FG001|Overall Study|Adverse Event|0|||
129631552|NCT02861586|466604506|FG002|Overall Study|Adverse Event|0|||
129631553|NCT02861586|466604507|FG003|Overall Study|Adverse Event|0|||
129631554|NCT02861586|466604508|FG004|Overall Study|Adverse Event|0|||
129631555|NCT02861586|466604509|FG005|Overall Study|Adverse Event|1|||
129631556|NCT02861586|466604510|FG006|Overall Study|Adverse Event|0|||
129631557|NCT02861586|466604511|FG007|Overall Study|Adverse Event|0|||
129631558|NCT00955409|466604512|FG000|Overall Study|Lack of Efficacy|1|||
129631559|NCT00955409|466604513|FG001|Overall Study|Lack of Efficacy|0|||
129631560|NCT00955409|466604514|FG002|Overall Study|Lack of Efficacy|0|||
129631561|NCT00955409|466604515|FG003|Overall Study|Lack of Efficacy|0|||
129631562|NCT00955409|466604516|FG004|Overall Study|Lack of Efficacy|0|||
129631563|NCT00955409|466604517|FG005|Overall Study|Lack of Efficacy|0|||
129631564|NCT00955409|466604518|FG006|Overall Study|Lack of Efficacy|0|||
129631565|NCT00955409|466604519|FG007|Overall Study|Lack of Efficacy|0|||
129631566|NCT00955409|466604520|FG008|Overall Study|Lack of Efficacy|0|||
129631567|NCT00955409|466604521|FG009|Overall Study|Lack of Efficacy|0|||
129631568|NCT00955409|466604512|FG000|Overall Study|Withdrawal by Subject|1|||
129631569|NCT00955409|466604513|FG001|Overall Study|Withdrawal by Subject|0|||
129631570|NCT00955409|466604514|FG002|Overall Study|Withdrawal by Subject|5|||
129631571|NCT00955409|466604515|FG003|Overall Study|Withdrawal by Subject|2|||
129631572|NCT00955409|466604516|FG004|Overall Study|Withdrawal by Subject|0|||
129631573|NCT00955409|466604517|FG005|Overall Study|Withdrawal by Subject|0|||
129631574|NCT00955409|466604518|FG006|Overall Study|Withdrawal by Subject|2|||
129631575|NCT00955409|466604519|FG007|Overall Study|Withdrawal by Subject|0|||
129631576|NCT00955409|466604520|FG008|Overall Study|Withdrawal by Subject|1|||
129631577|NCT00955409|466604521|FG009|Overall Study|Withdrawal by Subject|0|||
129631578|NCT00955409|466604512|FG000|Overall Study|Caregiver Request|2|||
129631579|NCT00955409|466604513|FG001|Overall Study|Caregiver Request|0|||
129631580|NCT00955409|466604514|FG002|Overall Study|Caregiver Request|6|||
129631581|NCT00955409|466604515|FG003|Overall Study|Caregiver Request|5|||
129631582|NCT00955409|466604516|FG004|Overall Study|Caregiver Request|0|||
129631583|NCT00955409|466604517|FG005|Overall Study|Caregiver Request|2|||
129631584|NCT00955409|466604518|FG006|Overall Study|Caregiver Request|3|||
129631585|NCT00955409|466604519|FG007|Overall Study|Caregiver Request|1|||
129631586|NCT00955409|466604520|FG008|Overall Study|Caregiver Request|3|||
129631587|NCT00955409|466604521|FG009|Overall Study|Caregiver Request|0|||
129631588|NCT00955409|466604512|FG000|Overall Study|Investigator Request|0|||
129631589|NCT00955409|466604513|FG001|Overall Study|Investigator Request|0|||
129631590|NCT00955409|466604514|FG002|Overall Study|Investigator Request|1|||
129631591|NCT00955409|466604515|FG003|Overall Study|Investigator Request|0|||
129631592|NCT00955409|466604516|FG004|Overall Study|Investigator Request|0|||
129631593|NCT00955409|466604517|FG005|Overall Study|Investigator Request|0|||
129631594|NCT00955409|466604518|FG006|Overall Study|Investigator Request|0|||
129631595|NCT00955409|466604519|FG007|Overall Study|Investigator Request|0|||
129631596|NCT00955409|466604520|FG008|Overall Study|Investigator Request|0|||
129631597|NCT00955409|466604521|FG009|Overall Study|Investigator Request|0|||
129631598|NCT00955409|466604512|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
129631599|NCT00955409|466604513|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129631600|NCT00955409|466604514|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
129631601|NCT00955409|466604515|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129704021|NCT04507204|466878992|FG001|Overall Study|Death|1|||
129704022|NCT04507204|466878991|FG000|Overall Study|Lost to Follow-up|15|||
129704023|NCT04507204|466878992|FG001|Overall Study|Lost to Follow-up|14|||
129704024|NCT04507204|466878991|FG000|Overall Study|Poor Compliance with Protocol|2|||
129704025|NCT04507204|466878992|FG001|Overall Study|Poor Compliance with Protocol|4|||
129704026|NCT04507204|466878991|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
129704027|NCT04507204|466878992|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
129704028|NCT04507204|466878991|FG000|Overall Study|Withdrawal of Patient Consent|21|||
129631602|NCT00955409|466604516|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
129631603|NCT00955409|466604517|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
129631604|NCT00955409|466604518|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
129631605|NCT00955409|466604519|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
129631606|NCT00955409|466604520|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
129631607|NCT00955409|466604521|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
129704029|NCT04507204|466878992|FG001|Overall Study|Withdrawal of Patient Consent|13|||
129631608|NCT00955409|466604512|FG000|Overall Study|Lost to Follow-up|0|||
129631609|NCT00955409|466604513|FG001|Overall Study|Lost to Follow-up|0|||
129631610|NCT00955409|466604514|FG002|Overall Study|Lost to Follow-up|1|||
129631611|NCT00955409|466604515|FG003|Overall Study|Lost to Follow-up|0|||
129631612|NCT00955409|466604516|FG004|Overall Study|Lost to Follow-up|0|||
129631613|NCT00955409|466604517|FG005|Overall Study|Lost to Follow-up|0|||
129631614|NCT00955409|466604518|FG006|Overall Study|Lost to Follow-up|1|||
129631615|NCT00955409|466604519|FG007|Overall Study|Lost to Follow-up|0|||
129631616|NCT00955409|466604520|FG008|Overall Study|Lost to Follow-up|0|||
129631617|NCT00955409|466604521|FG009|Overall Study|Lost to Follow-up|0|||
129631618|NCT00955409|466604512|FG000|Overall Study|Failed to Return|2|||
129631619|NCT00955409|466604513|FG001|Overall Study|Failed to Return|0|||
129631620|NCT00955409|466604514|FG002|Overall Study|Failed to Return|0|||
129631621|NCT00955409|466604515|FG003|Overall Study|Failed to Return|0|||
129631622|NCT00955409|466604516|FG004|Overall Study|Failed to Return|0|||
129631623|NCT00955409|466604517|FG005|Overall Study|Failed to Return|0|||
129631624|NCT00955409|466604518|FG006|Overall Study|Failed to Return|0|||
129631625|NCT00955409|466604519|FG007|Overall Study|Failed to Return|2|||
129631626|NCT00955409|466604520|FG008|Overall Study|Failed to Return|0|||
129631627|NCT00955409|466604521|FG009|Overall Study|Failed to Return|0|||
129631628|NCT00955409|466604512|FG000|Overall Study|Adverse Event (AE)|2|||
129631629|NCT00955409|466604513|FG001|Overall Study|Adverse Event (AE)|0|||
129631630|NCT00955409|466604514|FG002|Overall Study|Adverse Event (AE)|0|||
129631631|NCT00955409|466604515|FG003|Overall Study|Adverse Event (AE)|0|||
129631632|NCT00955409|466604516|FG004|Overall Study|Adverse Event (AE)|0|||
129631633|NCT00955409|466604517|FG005|Overall Study|Adverse Event (AE)|1|||
129631634|NCT00955409|466604518|FG006|Overall Study|Adverse Event (AE)|2|||
129631635|NCT00955409|466604519|FG007|Overall Study|Adverse Event (AE)|0|||
129631636|NCT00955409|466604520|FG008|Overall Study|Adverse Event (AE)|2|||
129631637|NCT00955409|466604521|FG009|Overall Study|Adverse Event (AE)|0|||
129631638|NCT00955409|466604512|FG000|Overall Study|Reason not Specified|2|||
129631639|NCT00955409|466604513|FG001|Overall Study|Reason not Specified|1|||
129631640|NCT00955409|466604514|FG002|Overall Study|Reason not Specified|13|||
129631641|NCT00955409|466604515|FG003|Overall Study|Reason not Specified|1|||
129631642|NCT00955409|466604516|FG004|Overall Study|Reason not Specified|2|||
129631643|NCT00955409|466604517|FG005|Overall Study|Reason not Specified|0|||
129631644|NCT00955409|466604518|FG006|Overall Study|Reason not Specified|16|||
129631645|NCT00955409|466604519|FG007|Overall Study|Reason not Specified|0|||
129631646|NCT00955409|466604520|FG008|Overall Study|Reason not Specified|8|||
129631647|NCT00955409|466604521|FG009|Overall Study|Reason not Specified|1|||
129631648|NCT00803790|466604522|FG000|Period 1|Adverse Event|0|||
129631649|NCT00803790|466604523|FG001|Period 1|Adverse Event|1|||
129631650|NCT00803790|466604524|FG002|Period 1|Adverse Event|0|||
129631651|NCT00803790|466604525|FG003|Period 1|Adverse Event|0|||
129631652|NCT00803790|466604522|FG000|Period 1|Lost to Follow-up|1|||
129631653|NCT00803790|466604523|FG001|Period 1|Lost to Follow-up|2|||
129631654|NCT00803790|466604524|FG002|Period 1|Lost to Follow-up|0|||
129631655|NCT00803790|466604525|FG003|Period 1|Lost to Follow-up|0|||
129631656|NCT00803790|466604522|FG000|Period 1|Withdrawal by Subject|8|||
129631657|NCT00803790|466604523|FG001|Period 1|Withdrawal by Subject|6|||
129631658|NCT00803790|466604524|FG002|Period 1|Withdrawal by Subject|0|||
129631659|NCT00803790|466604525|FG003|Period 1|Withdrawal by Subject|0|||
129631660|NCT00803790|466604522|FG000|Period 1|positive drug screen or personal reasons|0|||
129631661|NCT00803790|466604523|FG001|Period 1|positive drug screen or personal reasons|3|||
129631662|NCT00803790|466604524|FG002|Period 1|positive drug screen or personal reasons|0|||
129631663|NCT00803790|466604525|FG003|Period 1|positive drug screen or personal reasons|4|||
129631664|NCT00803790|466604522|FG000|Period 1|Protocol Violation|0|||
129631665|NCT00803790|466604523|FG001|Period 1|Protocol Violation|0|||
129631666|NCT00803790|466604524|FG002|Period 1|Protocol Violation|1|||
129631667|NCT00803790|466604525|FG003|Period 1|Protocol Violation|0|||
129631668|NCT00803790|466604522|FG000|Period 2|Adverse Event|0|||
129704030|NCT01702298|466878993|FG000|Overall Study|Withdrawal by Subject|1|||
129631669|NCT00803790|466604523|FG001|Period 2|Adverse Event|0|||
129631670|NCT00803790|466604524|FG002|Period 2|Adverse Event|1|||
129631671|NCT00803790|466604525|FG003|Period 2|Adverse Event|1|||
129631672|NCT00803790|466604522|FG000|Period 2|Withdrawal by Subject|1|||
129631673|NCT00803790|466604523|FG001|Period 2|Withdrawal by Subject|0|||
129631674|NCT00803790|466604524|FG002|Period 2|Withdrawal by Subject|0|||
129704031|NCT03580044|466878997|FG000|Overall Study|Death|2|||
129704032|NCT03580044|466878998|FG001|Overall Study|Death|1|||
129631675|NCT00803790|466604525|FG003|Period 2|Withdrawal by Subject|0|||
129631676|NCT00803790|466604522|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
129631677|NCT00803790|466604523|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
129631678|NCT00803790|466604524|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
129631679|NCT00803790|466604525|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
129631680|NCT01880554|466604526|FG000|Overall Study|Protocol Violation|14|||
129631681|NCT01880554|466604526|FG000|Overall Study|Simon's design requirements|2|||
129631682|NCT05161481|466604527|FG000|Overall Study|Withdrawal of consent|0|||
129631683|NCT05161481|466604528|FG001|Overall Study|Withdrawal of consent|1|||
129631684|NCT05161481|466604529|FG002|Overall Study|Withdrawal of consent|1|||
129704033|NCT03580044|466878997|FG000|Overall Study|Withdrawal by Subject|1|||
129704034|NCT03580044|466878998|FG001|Overall Study|Withdrawal by Subject|1|||
129631685|NCT05161481|466604527|FG000|Overall Study|Study terminated by sponsor|3|||
129440363|NCT01749540|465911418|FG002|Overall Study|Protocol Violation|0|||
129440364|NCT01749540|465911419|FG003|Overall Study|Protocol Violation|0|||
129440365|NCT01749540|465911420|FG004|Overall Study|Protocol Violation|0|||
129440366|NCT01749540|465911421|FG005|Overall Study|Protocol Violation|1|||
129440367|NCT01749540|465911422|FG006|Overall Study|Protocol Violation|1|||
129440368|NCT01749540|465911416|FG000|Overall Study|Withdrawal by Subject|0|||
129440369|NCT01749540|465911417|FG001|Overall Study|Withdrawal by Subject|0|||
129440370|NCT01749540|465911418|FG002|Overall Study|Withdrawal by Subject|0|||
129440371|NCT01749540|465911419|FG003|Overall Study|Withdrawal by Subject|1|||
129440372|NCT01749540|465911420|FG004|Overall Study|Withdrawal by Subject|0|||
129440373|NCT01749540|465911421|FG005|Overall Study|Withdrawal by Subject|0|||
129440374|NCT01749540|465911422|FG006|Overall Study|Withdrawal by Subject|0|||
129440375|NCT01749540|465911416|FG000|Overall Study|Initiated into extension study A536-06|0|||
129440376|NCT01749540|465911417|FG001|Overall Study|Initiated into extension study A536-06|0|||
129440377|NCT01749540|465911418|FG002|Overall Study|Initiated into extension study A536-06|0|||
129440378|NCT01749540|465911419|FG003|Overall Study|Initiated into extension study A536-06|0|||
129440379|NCT01749540|465911420|FG004|Overall Study|Initiated into extension study A536-06|0|||
129440380|NCT01749540|465911421|FG005|Overall Study|Initiated into extension study A536-06|2|||
129440381|NCT01749540|465911422|FG006|Overall Study|Initiated into extension study A536-06|24|||
129440382|NCT00576836|465911423|FG000|Overall Study|Death|0|||
129440383|NCT00576836|465911424|FG001|Overall Study|Death|1|||
129440384|NCT00576836|465911423|FG000|Overall Study|Physician Decision|0|||
129440385|NCT00576836|465911424|FG001|Overall Study|Physician Decision|1|||
129631686|NCT05161481|466604528|FG001|Overall Study|Study terminated by sponsor|3|||
129631687|NCT05161481|466604529|FG002|Overall Study|Study terminated by sponsor|2|||
129631688|NCT05161481|466604527|FG000|Overall Study|Adverse Event|3|||
129631689|NCT05161481|466604528|FG001|Overall Study|Adverse Event|0|||
129631690|NCT05161481|466604529|FG002|Overall Study|Adverse Event|6|||
129631691|NCT05161481|466604527|FG000|Overall Study|Randomised in error and was not treated|1|||
129631692|NCT05161481|466604528|FG001|Overall Study|Randomised in error and was not treated|0|||
129631693|NCT05161481|466604529|FG002|Overall Study|Randomised in error and was not treated|0|||
129631694|NCT05161481|466604527|FG000|Overall Study|Subject decision|0|||
129631695|NCT05161481|466604528|FG001|Overall Study|Subject decision|0|||
129631696|NCT05161481|466604529|FG002|Overall Study|Subject decision|1|||
129631697|NCT04815083|466604530|FG000|Overall Study|Physician Decision|1|||
129631698|NCT04815083|466604530|FG000|Overall Study|Study pause|2|||
129631699|NCT04815083|466604530|FG000|Overall Study|Screening failure|4|||
129631700|NCT04335123|466604532|FG000|Overall Study|Withdrawal by Subject|2|||
129631701|NCT04335123|466604533|FG001|Overall Study|Withdrawal by Subject|0|||
129631702|NCT04335123|466604532|FG000|Overall Study|Physician Decision|2|||
129631703|NCT04335123|466604533|FG001|Overall Study|Physician Decision|0|||
129631704|NCT01283464|466604534|FG000|Overall Study|Lost to Follow-up|0|||
129631705|NCT01283464|466604535|FG001|Overall Study|Lost to Follow-up|1|||
129631706|NCT01283464|466604534|FG000|Overall Study|Withdrawal by Subject|1|||
129631707|NCT01283464|466604535|FG001|Overall Study|Withdrawal by Subject|0|||
129631708|NCT01283464|466604534|FG000|Overall Study|Physician Decision|1|||
129631709|NCT01283464|466604535|FG001|Overall Study|Physician Decision|0|||
129631710|NCT02626026|466604536|FG000|Overall Study|Randomized but Never Treated|0|||
129631711|NCT02626026|466604537|FG001|Overall Study|Randomized but Never Treated|0|||
129631712|NCT02626026|466604538|FG002|Overall Study|Randomized but Never Treated|0|||
129631713|NCT02626026|466604539|FG003|Overall Study|Randomized but Never Treated|0|||
129631714|NCT02626026|466604540|FG004|Overall Study|Randomized but Never Treated|1|||
129631715|NCT02626026|466604541|FG005|Overall Study|Randomized but Never Treated|0|||
129631716|NCT03922308|466604546|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
129631717|NCT03922308|466604547|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
129631718|NCT03922308|466604548|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
129631719|NCT03922308|466604546|FG000|Overall Study|Lost to Follow-up|1|||
129631720|NCT03922308|466604547|FG001|Overall Study|Lost to Follow-up|0|||
129631721|NCT03922308|466604548|FG002|Overall Study|Lost to Follow-up|0|||
129631722|NCT03922308|466604546|FG000|Overall Study|Reason not Specified|0|||
129631723|NCT03922308|466604547|FG001|Overall Study|Reason not Specified|2|||
129631724|NCT03922308|466604548|FG002|Overall Study|Reason not Specified|1|||
129631725|NCT03376789|466604549|FG000|Overall Study|Withdrawal by Subject|3|||
129440386|NCT00564018|465911425|FG000|Overall Study|Withdrawal by Subject|2|||
129440387|NCT00564018|465911426|FG001|Overall Study|Withdrawal by Subject|3|||
129631726|NCT03376789|466604550|FG001|Overall Study|Withdrawal by Subject|5|||
129631727|NCT03376789|466604549|FG000|Overall Study|Protocol Violation|0|||
129631728|NCT03376789|466604550|FG001|Overall Study|Protocol Violation|1|||
129631729|NCT03376789|466604549|FG000|Overall Study|Adverse Event|0|||
129631730|NCT03376789|466604550|FG001|Overall Study|Adverse Event|1|||
129631731|NCT03376789|466604549|FG000|Overall Study|Lost to Follow-up|1|||
129440388|NCT00564018|465911427|FG002|Overall Study|Withdrawal by Subject|1|||
129631732|NCT03376789|466604550|FG001|Overall Study|Lost to Follow-up|1|||
129631733|NCT03376789|466604549|FG000|Overall Study|Per sponsor due to noncompliance|1|||
129631734|NCT03376789|466604550|FG001|Overall Study|Per sponsor due to noncompliance|0|||
129631735|NCT03376789|466604549|FG000|Overall Study|Subject off study medication|0|||
129631736|NCT03376789|466604550|FG001|Overall Study|Subject off study medication|1|||
129631737|NCT04177095|466604553|FG000|Overall Study|Withdrawal by Subject|3|||
129631738|NCT04177095|466604553|FG000|Overall Study|Screen Failure|3|||
129631739|NCT04177095|466604553|FG000|Overall Study|Problems with the Trugraf assay|1|||
129631740|NCT00777296|466604554|FG000|Overall Study|Adverse Event|0|||
129631741|NCT00777296|466604555|FG001|Overall Study|Adverse Event|1|||
129631742|NCT00777296|466604556|FG002|Overall Study|Adverse Event|0|||
129631743|NCT00777296|466604557|FG003|Overall Study|Adverse Event|1|||
129631744|NCT00777296|466604554|FG000|Overall Study|Withdrawal by Subject|1|||
129631745|NCT00777296|466604555|FG001|Overall Study|Withdrawal by Subject|0|||
129631746|NCT00777296|466604556|FG002|Overall Study|Withdrawal by Subject|0|||
129631747|NCT00777296|466604557|FG003|Overall Study|Withdrawal by Subject|0|||
129631748|NCT00777296|466604554|FG000|Overall Study|CRF form not completed|0|||
129631749|NCT00777296|466604555|FG001|Overall Study|CRF form not completed|0|||
129631750|NCT00777296|466604556|FG002|Overall Study|CRF form not completed|2|||
129631751|NCT00777296|466604557|FG003|Overall Study|CRF form not completed|0|||
129631752|NCT01592786|466604558|FG000|Overall Study|Adverse Event|60|||
129631753|NCT01592786|466604558|FG000|Overall Study|Lack of Efficacy|19|||
129631754|NCT01592786|466604558|FG000|Overall Study|Protocol Violation|14|||
129631755|NCT01592786|466604558|FG000|Overall Study|Withdrawal by Subject|23|||
129631756|NCT01592786|466604558|FG000|Overall Study|Lost to Follow-up|19|||
129631757|NCT01592786|466604558|FG000|Overall Study|Other|3|||
129631758|NCT02172664|466604559|FG000|Overall Study|Lost to Follow-up|4|||
129631759|NCT02172664|466604560|FG001|Overall Study|Lost to Follow-up|4|||
129631760|NCT02172664|466604559|FG000|Overall Study|Death|1|||
129631761|NCT02172664|466604560|FG001|Overall Study|Death|1|||
129631762|NCT02172664|466604559|FG000|Overall Study|Moved out of area|1|||
129631763|NCT02172664|466604560|FG001|Overall Study|Moved out of area|1|||
129631764|NCT04426006|466604561|FG000|Inclusion|Protocol Violation|1|||
129631765|NCT04426006|466604561|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
129631766|NCT04426006|466604561|FG000|Inclusion|Blood sample at inclusion not done|1|||
129631767|NCT04426006|466604561|FG000|3 Months|Lost to Follow-up|17|||
129631768|NCT04426006|466604561|FG000|12 Months|Lost to Follow-up|38|||
129631769|NCT02946463|466604562|FG000|Primary Evaluation Period|Physician Decision|0|||
129631770|NCT02946463|466604563|FG001|Primary Evaluation Period|Physician Decision|1|||
129631771|NCT02946463|466604564|FG002|Primary Evaluation Period|Physician Decision|0|||
129631772|NCT02946463|466604565|FG003|Primary Evaluation Period|Physician Decision|0|||
129631773|NCT02946463|466604562|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
129631774|NCT02946463|466604563|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
129631775|NCT02946463|466604564|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
129631776|NCT02946463|466604565|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
129631777|NCT02946463|466604562|FG000|Extension Period|Death|4|||
129631778|NCT02946463|466604563|FG001|Extension Period|Death|4|||
129631779|NCT02946463|466604564|FG002|Extension Period|Death|0|||
129631780|NCT02946463|466604565|FG003|Extension Period|Death|0|||
129631781|NCT02946463|466604562|FG000|Extension Period|Withdrawal by Subject|4|||
129631782|NCT02946463|466604563|FG001|Extension Period|Withdrawal by Subject|3|||
129631783|NCT02946463|466604564|FG002|Extension Period|Withdrawal by Subject|0|||
129631784|NCT02946463|466604565|FG003|Extension Period|Withdrawal by Subject|0|||
129631785|NCT02946463|466604562|FG000|Extension Period|Other than specified|2|||
129631786|NCT02946463|466604563|FG001|Extension Period|Other than specified|3|||
129631787|NCT02946463|466604564|FG002|Extension Period|Other than specified|2|||
129631788|NCT02946463|466604565|FG003|Extension Period|Other than specified|0|||
129631789|NCT02946463|466604562|FG000|Extension Period|Physician Decision|1|||
129631790|NCT02946463|466604563|FG001|Extension Period|Physician Decision|4|||
129631791|NCT02946463|466604564|FG002|Extension Period|Physician Decision|0|||
129631792|NCT02946463|466604565|FG003|Extension Period|Physician Decision|0|||
129631793|NCT02946463|466604562|FG000|Extension Period|Pregnancy|3|||
129631794|NCT02946463|466604563|FG001|Extension Period|Pregnancy|1|||
129704035|NCT01664624|466879001|FG000|Overall Study|Adverse Event|0|||
129704036|NCT01664624|466879002|FG001|Overall Study|Adverse Event|1|||
129631795|NCT02946463|466604564|FG002|Extension Period|Pregnancy|0|||
129631796|NCT02946463|466604565|FG003|Extension Period|Pregnancy|0|||
129631797|NCT02946463|466604562|FG000|Extension Period|Adverse Event|1|||
129631798|NCT02946463|466604563|FG001|Extension Period|Adverse Event|2|||
129631799|NCT02946463|466604564|FG002|Extension Period|Adverse Event|0|||
129631800|NCT02946463|466604565|FG003|Extension Period|Adverse Event|0|||
129631801|NCT02946463|466604562|FG000|Extension Period|Lost to Follow-up|1|||
129631802|NCT02946463|466604563|FG001|Extension Period|Lost to Follow-up|0|||
129631803|NCT02946463|466604564|FG002|Extension Period|Lost to Follow-up|0|||
129704037|NCT01664624|466879003|FG002|Overall Study|Adverse Event|0|||
129631804|NCT02946463|466604565|FG003|Extension Period|Lost to Follow-up|0|||
129631805|NCT05691712|466604566|FG000|Overall Study|Adverse Event|0|||
129631806|NCT05691712|466604567|FG001|Overall Study|Adverse Event|1|||
129631807|NCT05691712|466604568|FG002|Overall Study|Adverse Event|2|||
129631808|NCT05691712|466604569|FG003|Overall Study|Adverse Event|1|||
129631809|NCT05691712|466604566|FG000|Overall Study|Withdrawal by Subject|2|||
129631810|NCT05691712|466604567|FG001|Overall Study|Withdrawal by Subject|3|||
129631811|NCT05691712|466604568|FG002|Overall Study|Withdrawal by Subject|3|||
129631812|NCT05691712|466604569|FG003|Overall Study|Withdrawal by Subject|1|||
129631813|NCT05691712|466604566|FG000|Overall Study|Death|1|||
129631814|NCT05691712|466604567|FG001|Overall Study|Death|0|||
129631815|NCT05691712|466604568|FG002|Overall Study|Death|0|||
129631816|NCT05691712|466604569|FG003|Overall Study|Death|0|||
129631817|NCT05691712|466604566|FG000|Overall Study|Pregnancy|0|||
129631818|NCT05691712|466604567|FG001|Overall Study|Pregnancy|1|||
129631819|NCT05691712|466604568|FG002|Overall Study|Pregnancy|0|||
129631820|NCT05691712|466604569|FG003|Overall Study|Pregnancy|0|||
129631821|NCT05691712|466604566|FG000|Overall Study|Assigned Treatment by Mistake|1|||
129631822|NCT05691712|466604567|FG001|Overall Study|Assigned Treatment by Mistake|0|||
129631823|NCT05691712|466604568|FG002|Overall Study|Assigned Treatment by Mistake|0|||
129631824|NCT05691712|466604569|FG003|Overall Study|Assigned Treatment by Mistake|1|||
129631825|NCT02166333|466604573|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
129631826|NCT02166333|466604574|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
129631827|NCT02166333|466604575|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
129631828|NCT02166333|466604576|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
129631829|NCT02166333|466604577|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
129631830|NCT02166333|466604578|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
129631831|NCT02166333|466604573|FG000|Stage 1|Death|4|||
129631832|NCT02166333|466604574|FG001|Stage 1|Death|0|||
129631833|NCT02166333|466604575|FG002|Stage 1|Death|2|||
129631834|NCT02166333|466604576|FG003|Stage 1|Death|0|||
129631835|NCT02166333|466604577|FG004|Stage 1|Death|3|||
129631836|NCT02166333|466604578|FG005|Stage 1|Death|2|||
129631837|NCT02166333|466604573|FG000|Stage 1|Lost to Follow-up|12|||
129631838|NCT02166333|466604574|FG001|Stage 1|Lost to Follow-up|0|||
129631839|NCT02166333|466604575|FG002|Stage 1|Lost to Follow-up|6|||
129631840|NCT02166333|466604576|FG003|Stage 1|Lost to Follow-up|0|||
129631841|NCT02166333|466604577|FG004|Stage 1|Lost to Follow-up|3|||
129631842|NCT02166333|466604578|FG005|Stage 1|Lost to Follow-up|3|||
129631843|NCT02166333|466604573|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
129631844|NCT02166333|466604574|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
129631845|NCT02166333|466604575|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
129631846|NCT02166333|466604576|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
129631847|NCT02166333|466604577|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
129631848|NCT02166333|466604578|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
129631849|NCT02166333|466604573|FG000|Stage 2|Death|4|||
129631850|NCT02166333|466604574|FG001|Stage 2|Death|2|||
129631851|NCT02166333|466604575|FG002|Stage 2|Death|1|||
129631852|NCT02166333|466604576|FG003|Stage 2|Death|0|||
129631853|NCT02166333|466604577|FG004|Stage 2|Death|0|||
129631854|NCT02166333|466604578|FG005|Stage 2|Death|1|||
129704038|NCT01664624|466879004|FG003|Overall Study|Adverse Event|0|||
129704039|NCT01206517|466879005|FG000|Overall Study|Withdrawal by Subject|0|||
129704040|NCT01206517|466879006|FG001|Overall Study|Withdrawal by Subject|0|||
129704041|NCT01206517|466879007|FG002|Overall Study|Withdrawal by Subject|2|||
129704042|NCT01206517|466879008|FG003|Overall Study|Withdrawal by Subject|0|||
129704043|NCT01206517|466879009|FG004|Overall Study|Withdrawal by Subject|1|||
129704044|NCT01206517|466879010|FG005|Overall Study|Withdrawal by Subject|0|||
129704045|NCT01029535|466879011|FG000|Overall Study|Lost to Follow-up|24|||
129704046|NCT01029535|466879011|FG000|Overall Study|Protocol Violation|2|||
129704047|NCT01029535|466879011|FG000|Overall Study|Participant Withdrew Consent|2|||
129704048|NCT01029535|466879011|FG000|Overall Study|Adverse Event|1|||
129704049|NCT01029535|466879011|FG000|Overall Study|Use of Another Treatment|1|||
129704050|NCT01029535|466879011|FG000|Overall Study|Death|1|||
129704051|NCT01198587|466879015|FG000|Overall Study|Lost to Follow-up|8|||
129704052|NCT01198587|466879016|FG001|Overall Study|Lost to Follow-up|0|||
129704053|NCT01198587|466879017|FG002|Overall Study|Lost to Follow-up|9|||
129704054|NCT01198587|466879018|FG003|Overall Study|Lost to Follow-up|0|||
129704055|NCT00573768|466879019|FG000|Overall Study|Adverse Event|1|||
129704056|NCT00573768|466879020|FG001|Overall Study|Adverse Event|1|||
129704057|NCT00573768|466879021|FG002|Overall Study|Adverse Event|2|||
129704058|NCT00573768|466879019|FG000|Overall Study|Protocol Violation|1|||
129704059|NCT00573768|466879020|FG001|Overall Study|Protocol Violation|0|||
129704060|NCT00573768|466879021|FG002|Overall Study|Protocol Violation|1|||
129704061|NCT00573768|466879019|FG000|Overall Study|Withdrawal by Subject|0|||
129704062|NCT00573768|466879020|FG001|Overall Study|Withdrawal by Subject|1|||
129704063|NCT00573768|466879021|FG002|Overall Study|Withdrawal by Subject|0|||
129704064|NCT00573768|466879019|FG000|Overall Study|Lost to Follow-up|0|||
129704065|NCT00573768|466879020|FG001|Overall Study|Lost to Follow-up|0|||
129440389|NCT01296347|465911428|FG000|Allocation|Withdrawal by Subject|1|||
129631855|NCT02166333|466604573|FG000|Stage 2|Lost to Follow-up|23|||
129631856|NCT02166333|466604574|FG001|Stage 2|Lost to Follow-up|4|||
129631857|NCT02166333|466604575|FG002|Stage 2|Lost to Follow-up|11|||
129631858|NCT02166333|466604576|FG003|Stage 2|Lost to Follow-up|9|||
129631859|NCT02166333|466604577|FG004|Stage 2|Lost to Follow-up|3|||
129631860|NCT02166333|466604578|FG005|Stage 2|Lost to Follow-up|6|||
129631861|NCT00682786|466604579|FG000|Overall Study|Withdrawal by Subject|2|||
129631862|NCT00682786|466604580|FG001|Overall Study|Withdrawal by Subject|2|||
129631863|NCT00682786|466604579|FG000|Overall Study|Did not receive irinotecan|0|||
129631864|NCT00682786|466604580|FG001|Overall Study|Did not receive irinotecan|1|||
129631865|NCT00359424|466604581|FG000|Overall Study|Death|99|||
129631866|NCT00359424|466604582|FG001|Overall Study|Death|58|||
129631867|NCT00359424|466604581|FG000|Overall Study|Lost to Follow-up|19|||
129631868|NCT00359424|466604582|FG001|Overall Study|Lost to Follow-up|7|||
129631869|NCT00359424|466604581|FG000|Overall Study|Withdrawal by Subject|10|||
129631870|NCT00359424|466604582|FG001|Overall Study|Withdrawal by Subject|2|||
129631871|NCT00359424|466604581|FG000|Overall Study|follow up not conducted|2|||
129631872|NCT00359424|466604582|FG001|Overall Study|follow up not conducted|0|||
129631873|NCT01831635|466604583|FG000|Overall Study|Withdrawal by Subject|0|||
129631874|NCT01831635|466604584|FG001|Overall Study|Withdrawal by Subject|2|||
129631875|NCT01831635|466604585|FG002|Overall Study|Withdrawal by Subject|0|||
129631876|NCT03830333|466604588|FG000|Overall Study|Death|0|||
129631877|NCT03830333|466604589|FG001|Overall Study|Death|1|||
129631878|NCT03830333|466604588|FG000|Overall Study|Withdrawal by Subject|5|||
129631879|NCT03830333|466604589|FG001|Overall Study|Withdrawal by Subject|1|||
129631880|NCT03830333|466604588|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
129631881|NCT03830333|466604589|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
129631882|NCT03805412|466604590|FG000|Overall Study|Lost to Follow-up|0|||
129631883|NCT03805412|466604591|FG001|Overall Study|Lost to Follow-up|1|||
129631884|NCT03525678|466604606|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
129631885|NCT03525678|466604607|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
129631886|NCT03525678|466604608|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
129631887|NCT03525678|466604609|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
129631888|NCT03525678|466604610|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
129631889|NCT03525678|466604606|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
129631890|NCT03525678|466604607|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
129631891|NCT03525678|466604608|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
129631892|NCT03525678|466604609|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
129631893|NCT03525678|466604610|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
129631894|NCT03525678|466604606|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
129631895|NCT03525678|466604607|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
129631896|NCT03525678|466604608|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
129631897|NCT03525678|466604609|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
129631898|NCT03525678|466604610|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
129631899|NCT03525678|466604606|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
129631900|NCT03525678|466604607|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
129631901|NCT03525678|466604608|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
129631902|NCT03525678|466604609|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
129631903|NCT03525678|466604610|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
129631904|NCT03525678|466604606|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
129631905|NCT03525678|466604607|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
129631906|NCT03525678|466604608|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
129631907|NCT03525678|466604609|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
129631908|NCT03525678|466604610|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
129631909|NCT03525678|466604606|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
129631910|NCT03525678|466604607|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
129631911|NCT03525678|466604608|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
129631912|NCT03525678|466604609|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
129631913|NCT03525678|466604610|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
129631914|NCT02747108|466604611|FG000|Overall Study|Death|2|||
129631915|NCT02747108|466604612|FG001|Overall Study|Death|2|||
129631916|NCT02747108|466604611|FG000|Overall Study|Withdrawal by Subject|1|||
129631917|NCT02747108|466604612|FG001|Overall Study|Withdrawal by Subject|0|||
129631918|NCT02747108|466604611|FG000|Overall Study|Protocol Violation|2|||
129631919|NCT02747108|466604612|FG001|Overall Study|Protocol Violation|0|||
129631920|NCT04563754|466605505|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
129631921|NCT04563754|466605506|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
129631922|NCT04563754|466605507|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
129631923|NCT04563754|466605505|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
129631924|NCT04563754|466605506|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
129631925|NCT04563754|466605507|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
129631926|NCT04563754|466605505|FG000|Follow up|Lost to Follow-up|61|||
129631927|NCT04563754|466605506|FG001|Follow up|Lost to Follow-up|23|||
129631928|NCT04563754|466605507|FG002|Follow up|Lost to Follow-up|5|||
129631929|NCT04563754|466605505|FG000|Follow up|Death|0|||
129631930|NCT04563754|466605506|FG001|Follow up|Death|2|||
129631931|NCT04563754|466605507|FG002|Follow up|Death|0|||
129631932|NCT04563754|466605505|FG000|Follow up|Ongoing|0|||
129631933|NCT04563754|466605506|FG001|Follow up|Ongoing|28|||
129631934|NCT04563754|466605507|FG002|Follow up|Ongoing|0|||
129631935|NCT04023396|466605508|FG000|Overall Study|Adverse Event|16|||
129631936|NCT04023396|466605508|FG000|Overall Study|Death|1|||
129631937|NCT04023396|466605508|FG000|Overall Study|Lost to Follow-up|1|||
129631938|NCT04023396|466605508|FG000|Overall Study|Withdrawal by Subject|14|||
129631939|NCT04023396|466605508|FG000|Overall Study|Pregnancy|4|||
129631940|NCT04023396|466605508|FG000|Overall Study|Lack of Efficacy|3|||
129631941|NCT04023396|466605508|FG000|Overall Study|Physician Decision|4|||
129631942|NCT04023396|466605508|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
129631943|NCT04075825|466605509|FG000|Overall Study|Withdrawal by Subject|6|||
129631944|NCT04075825|466605510|FG001|Overall Study|Withdrawal by Subject|8|||
129631945|NCT04075825|466605509|FG000|Overall Study|Physician Decision|3|||
129631946|NCT04075825|466605510|FG001|Overall Study|Physician Decision|1|||
129631947|NCT04075825|466605509|FG000|Overall Study|Lost to Follow-up|5|||
129631948|NCT04075825|466605510|FG001|Overall Study|Lost to Follow-up|1|||
129631949|NCT04075825|466605509|FG000|Overall Study|Participation in New Clinical Trial|1|||
129631950|NCT04075825|466605510|FG001|Overall Study|Participation in New Clinical Trial|1|||
129631951|NCT04075825|466605509|FG000|Overall Study|Reason Not Specified|2|||
129631952|NCT04075825|466605510|FG001|Overall Study|Reason Not Specified|2|||
129631953|NCT04225715|466605511|FG000|Overall Study|Reason not Specified|1|||
129631954|NCT04225715|466605512|FG001|Overall Study|Reason not Specified|0|||
129631955|NCT04225715|466605513|FG002|Overall Study|Reason not Specified|0|||
129631956|NCT04225715|466605514|FG003|Overall Study|Reason not Specified|0|||
129631957|NCT04225715|466605515|FG004|Overall Study|Reason not Specified|0|||
129631958|NCT04225715|466605516|FG005|Overall Study|Reason not Specified|0|||
129631959|NCT04225715|466605517|FG006|Overall Study|Reason not Specified|0|||
129631960|NCT04225715|466605518|FG007|Overall Study|Reason not Specified|0|||
129631961|NCT04225715|466605519|FG008|Overall Study|Reason not Specified|0|||
129631962|NCT04225715|466605511|FG000|Overall Study|Protocol Violation|1|||
129631963|NCT04225715|466605512|FG001|Overall Study|Protocol Violation|0|||
129631964|NCT04225715|466605513|FG002|Overall Study|Protocol Violation|0|||
129631965|NCT04225715|466605514|FG003|Overall Study|Protocol Violation|0|||
129631966|NCT04225715|466605515|FG004|Overall Study|Protocol Violation|0|||
129631967|NCT04225715|466605516|FG005|Overall Study|Protocol Violation|9|||
129631968|NCT04225715|466605517|FG006|Overall Study|Protocol Violation|0|||
129631969|NCT04225715|466605518|FG007|Overall Study|Protocol Violation|0|||
129631970|NCT04225715|466605519|FG008|Overall Study|Protocol Violation|0|||
129631971|NCT04225715|466605511|FG000|Overall Study|Withdrawal by Subject|4|||
129631972|NCT04225715|466605512|FG001|Overall Study|Withdrawal by Subject|1|||
129631973|NCT04225715|466605513|FG002|Overall Study|Withdrawal by Subject|1|||
129631974|NCT04225715|466605514|FG003|Overall Study|Withdrawal by Subject|0|||
129631975|NCT04225715|466605515|FG004|Overall Study|Withdrawal by Subject|3|||
129631976|NCT04225715|466605516|FG005|Overall Study|Withdrawal by Subject|1|||
129631977|NCT04225715|466605517|FG006|Overall Study|Withdrawal by Subject|1|||
129631978|NCT04225715|466605518|FG007|Overall Study|Withdrawal by Subject|1|||
129631979|NCT04225715|466605519|FG008|Overall Study|Withdrawal by Subject|0|||
129631980|NCT04225715|466605511|FG000|Overall Study|Adverse Event|0|||
129631981|NCT04225715|466605512|FG001|Overall Study|Adverse Event|0|||
129631982|NCT04225715|466605513|FG002|Overall Study|Adverse Event|0|||
129631983|NCT04225715|466605514|FG003|Overall Study|Adverse Event|0|||
129631984|NCT04225715|466605515|FG004|Overall Study|Adverse Event|0|||
129704066|NCT00573768|466879021|FG002|Overall Study|Lost to Follow-up|1|||
129889080|NCT01349660|467551007|FG000|Overall Study|Still Receiving Study Treatment|0|||
129889081|NCT01349660|467551008|FG001|Overall Study|Still Receiving Study Treatment|0|||
129631985|NCT04225715|466605516|FG005|Overall Study|Adverse Event|0|||
129631986|NCT04225715|466605517|FG006|Overall Study|Adverse Event|0|||
129631987|NCT04225715|466605518|FG007|Overall Study|Adverse Event|0|||
129631988|NCT04225715|466605519|FG008|Overall Study|Adverse Event|1|||
129631989|NCT04225715|466605511|FG000|Overall Study|Arm Terminated By Sponsor|0|||
129631990|NCT04225715|466605512|FG001|Overall Study|Arm Terminated By Sponsor|0|||
129631991|NCT04225715|466605513|FG002|Overall Study|Arm Terminated By Sponsor|0|||
129631992|NCT04225715|466605514|FG003|Overall Study|Arm Terminated By Sponsor|0|||
129631993|NCT04225715|466605515|FG004|Overall Study|Arm Terminated By Sponsor|0|||
129631994|NCT04225715|466605516|FG005|Overall Study|Arm Terminated By Sponsor|0|||
129631995|NCT04225715|466605517|FG006|Overall Study|Arm Terminated By Sponsor|0|||
129631996|NCT04225715|466605518|FG007|Overall Study|Arm Terminated By Sponsor|17|||
129631997|NCT04225715|466605519|FG008|Overall Study|Arm Terminated By Sponsor|18|||
129631998|NCT03318861|466605527|FG000|Overall Study|Death|2|||
129631999|NCT03318861|466605528|FG001|Overall Study|Death|3|||
129632000|NCT03318861|466605529|FG002|Overall Study|Death|3|||
129632001|NCT03318861|466605530|FG003|Overall Study|Death|2|||
129632002|NCT03318861|466605531|FG004|Overall Study|Death|2|||
129632003|NCT03318861|466605527|FG000|Overall Study|Enrolled But Never Treated|0|||
129632004|NCT03318861|466605528|FG001|Overall Study|Enrolled But Never Treated|1|||
129632005|NCT03318861|466605529|FG002|Overall Study|Enrolled But Never Treated|0|||
129632006|NCT03318861|466605530|FG003|Overall Study|Enrolled But Never Treated|1|||
129632007|NCT03318861|466605531|FG004|Overall Study|Enrolled But Never Treated|1|||
129632008|NCT03318861|466605527|FG000|Overall Study|Informed Consent Withdraw|0|||
129632009|NCT03318861|466605528|FG001|Overall Study|Informed Consent Withdraw|0|||
129632010|NCT03318861|466605529|FG002|Overall Study|Informed Consent Withdraw|0|||
129632011|NCT03318861|466605530|FG003|Overall Study|Informed Consent Withdraw|1|||
129632012|NCT03318861|466605531|FG004|Overall Study|Informed Consent Withdraw|0|||
129632013|NCT03318861|466605527|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
129632014|NCT03318861|466605528|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129632015|NCT03318861|466605529|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129632016|NCT03318861|466605530|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129632017|NCT03318861|466605531|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
129632018|NCT00917852|466605532|FG000|Overall Study|Death|6|||
129632019|NCT00471081|466605533|FG000|Active Phase|Protocol Violation|1|||
129632020|NCT00471081|466605534|FG001|Active Phase|Protocol Violation|1|||
129632021|NCT00471081|466605533|FG000|Active Phase|Withdrawal by Subject|0|||
129632022|NCT00471081|466605534|FG001|Active Phase|Withdrawal by Subject|3|||
129632023|NCT00471081|466605533|FG000|Active Phase|Lost to Follow-up|0|||
129632024|NCT00471081|466605534|FG001|Active Phase|Lost to Follow-up|1|||
129632025|NCT00471081|466605533|FG000|Active Phase|Lost health plan/insurance|1|||
129632026|NCT00471081|466605534|FG001|Active Phase|Lost health plan/insurance|8|||
129632027|NCT00471081|466605533|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
129632028|NCT00471081|466605534|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
129632029|NCT00471081|466605533|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
129632030|NCT00471081|466605534|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
129632031|NCT00471081|466605533|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
129632032|NCT00471081|466605534|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
129632033|NCT02844933|466605535|FG000|Overall Study|Discontinued due to premature termination of study|3|||
129632034|NCT02844933|466605536|FG001|Overall Study|Discontinued due to premature termination of study|2|||
129632035|NCT04537078|466605537|FG000|Overall Study|Protocol Violation|3|||
129632036|NCT04537078|466605538|FG001|Overall Study|Protocol Violation|2|||
129632037|NCT04537078|466605537|FG000|Overall Study|Lost to Follow-up|1|||
129632038|NCT04537078|466605538|FG001|Overall Study|Lost to Follow-up|0|||
129632039|NCT04537078|466605537|FG000|Overall Study|Withdrawal by Subject|0|||
129632040|NCT04537078|466605538|FG001|Overall Study|Withdrawal by Subject|1|||
129632041|NCT01568892|466605540|FG000|Open-label Phase|Adverse Event|2|||
129632042|NCT01568892|466605541|FG001|Open-label Phase|Adverse Event|0|||
129632043|NCT01568892|466605540|FG000|Open-label Phase|Lack of Efficacy|4|||
129632044|NCT01568892|466605541|FG001|Open-label Phase|Lack of Efficacy|2|||
129632045|NCT01568892|466605540|FG000|Open-label Phase|Lost to Follow-up|0|||
129632046|NCT01568892|466605541|FG001|Open-label Phase|Lost to Follow-up|1|||
129632047|NCT01256450|466605544|FG000|Open-label Titration|Adverse Event|39|||
129632048|NCT01256450|466605545|FG001|Open-label Titration|Adverse Event|0|||
129632049|NCT01256450|466605546|FG002|Open-label Titration|Adverse Event|0|||
129632050|NCT01256450|466605544|FG000|Open-label Titration|Lost to Follow-up|7|||
129632051|NCT01256450|466605545|FG001|Open-label Titration|Lost to Follow-up|0|||
129632052|NCT01256450|466605546|FG002|Open-label Titration|Lost to Follow-up|0|||
129632053|NCT01256450|466605544|FG000|Open-label Titration|Lack of analgesic effect|30|||
129632054|NCT01256450|466605545|FG001|Open-label Titration|Lack of analgesic effect|0|||
129632055|NCT01256450|466605546|FG002|Open-label Titration|Lack of analgesic effect|0|||
129632056|NCT01256450|466605544|FG000|Open-label Titration|Non-compliance|9|||
129632057|NCT01256450|466605545|FG001|Open-label Titration|Non-compliance|0|||
129632058|NCT01256450|466605546|FG002|Open-label Titration|Non-compliance|0|||
129632059|NCT01256450|466605544|FG000|Open-label Titration|Screen failure|1|||
129632060|NCT01256450|466605545|FG001|Open-label Titration|Screen failure|0|||
129632061|NCT01256450|466605546|FG002|Open-label Titration|Screen failure|0|||
129632062|NCT01256450|466605544|FG000|Open-label Titration|Other|13|||
129632063|NCT01256450|466605545|FG001|Open-label Titration|Other|0|||
129632064|NCT01256450|466605546|FG002|Open-label Titration|Other|0|||
129632065|NCT01256450|466605544|FG000|Double-blind Treatment|Adverse Event|0|||
129632066|NCT01256450|466605545|FG001|Double-blind Treatment|Adverse Event|8|||
129632067|NCT01256450|466605546|FG002|Double-blind Treatment|Adverse Event|6|||
129632068|NCT01256450|466605544|FG000|Double-blind Treatment|Lost to Follow-up|0|||
129632069|NCT01256450|466605545|FG001|Double-blind Treatment|Lost to Follow-up|1|||
129889082|NCT01349660|467551009|FG002|Overall Study|Still Receiving Study Treatment|1|||
129889083|NCT01349660|467551007|FG000|Overall Study|Disease Progression|2|||
129632070|NCT01256450|466605546|FG002|Double-blind Treatment|Lost to Follow-up|7|||
129632071|NCT01256450|466605544|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
129704067|NCT04067011|466879026|FG000|Overall Study|Not Treated|8|||
129889084|NCT01349660|467551008|FG001|Overall Study|Disease Progression|4|||
129440390|NCT01296347|465911429|FG001|Allocation|Withdrawal by Subject|2|||
129632072|NCT01256450|466605545|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
129632073|NCT01256450|466605546|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
129632074|NCT01256450|466605544|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
129632075|NCT01256450|466605545|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
129632076|NCT01256450|466605546|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
129632077|NCT01256450|466605544|FG000|Double-blind Treatment|Non-compliance|0|||
129632078|NCT01256450|466605545|FG001|Double-blind Treatment|Non-compliance|5|||
129632079|NCT01256450|466605546|FG002|Double-blind Treatment|Non-compliance|4|||
129632080|NCT01256450|466605544|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
129632081|NCT01256450|466605545|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
129632082|NCT01256450|466605546|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
129632083|NCT01256450|466605544|FG000|Double-blind Treatment|Other|0|||
129632084|NCT01256450|466605545|FG001|Double-blind Treatment|Other|9|||
129632085|NCT01256450|466605546|FG002|Double-blind Treatment|Other|12|||
129632086|NCT03889418|466605554|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
129632087|NCT03889418|466605555|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632088|NCT03889418|466605556|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632089|NCT03889418|466605557|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632090|NCT03889418|466605558|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632091|NCT03889418|466605559|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632092|NCT03889418|466605560|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632093|NCT03889418|466605561|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632094|NCT03889418|466605562|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632095|NCT03889418|466605563|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
129632096|NCT03889418|466605554|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632097|NCT03889418|466605555|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
129632098|NCT03889418|466605556|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
129632099|NCT03889418|466605557|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632100|NCT03889418|466605558|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632101|NCT03889418|466605559|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632102|NCT03889418|466605560|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632103|NCT03889418|466605561|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632104|NCT03889418|466605562|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632105|NCT03889418|466605563|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
129632106|NCT03889418|466605554|FG000|October-December 2019 (Month 7-9)|Death|0|||
129632107|NCT03889418|466605555|FG001|October-December 2019 (Month 7-9)|Death|0|||
129632108|NCT03889418|466605556|FG002|October-December 2019 (Month 7-9)|Death|0|||
129632109|NCT03889418|466605557|FG003|October-December 2019 (Month 7-9)|Death|0|||
129632110|NCT03889418|466605558|FG004|October-December 2019 (Month 7-9)|Death|0|||
129632111|NCT03889418|466605559|FG005|October-December 2019 (Month 7-9)|Death|0|||
129632112|NCT03889418|466605560|FG006|October-December 2019 (Month 7-9)|Death|0|||
129632113|NCT03889418|466605561|FG007|October-December 2019 (Month 7-9)|Death|0|||
129632114|NCT03889418|466605562|FG008|October-December 2019 (Month 7-9)|Death|1|||
129632115|NCT03889418|466605563|FG009|October-December 2019 (Month 7-9)|Death|0|||
129632116|NCT03889418|466605554|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632117|NCT03889418|466605555|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632118|NCT03889418|466605556|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632119|NCT03889418|466605557|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
129632120|NCT03889418|466605558|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632121|NCT03889418|466605559|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632122|NCT03889418|466605560|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632123|NCT03889418|466605561|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
129632124|NCT03889418|466605562|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632125|NCT03889418|466605563|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
129632126|NCT03889418|466605554|FG000|April - June 2020 (Month 13-15)|Death|0|||
129632127|NCT03889418|466605555|FG001|April - June 2020 (Month 13-15)|Death|1|||
129632128|NCT03889418|466605556|FG002|April - June 2020 (Month 13-15)|Death|0|||
129632129|NCT03889418|466605557|FG003|April - June 2020 (Month 13-15)|Death|0|||
129632130|NCT03889418|466605558|FG004|April - June 2020 (Month 13-15)|Death|0|||
129632131|NCT03889418|466605559|FG005|April - June 2020 (Month 13-15)|Death|0|||
129632132|NCT03889418|466605560|FG006|April - June 2020 (Month 13-15)|Death|0|||
129632133|NCT03889418|466605561|FG007|April - June 2020 (Month 13-15)|Death|0|||
129632134|NCT03889418|466605562|FG008|April - June 2020 (Month 13-15)|Death|0|||
129632135|NCT03889418|466605563|FG009|April - June 2020 (Month 13-15)|Death|0|||
129632136|NCT03889418|466605554|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632137|NCT03889418|466605555|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129704068|NCT04067011|466879027|FG001|Overall Study|Not Treated|7|||
129704069|NCT04067011|466879028|FG002|Overall Study|Not Treated|5|||
129632138|NCT03889418|466605556|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632139|NCT03889418|466605557|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
129632140|NCT03889418|466605558|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632141|NCT03889418|466605559|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632142|NCT03889418|466605560|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632143|NCT03889418|466605561|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632144|NCT03889418|466605562|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632145|NCT03889418|466605563|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
129632146|NCT03889418|466605554|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
129632147|NCT03889418|466605555|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
129632148|NCT03889418|466605556|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
129632149|NCT03889418|466605557|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
129632150|NCT03889418|466605558|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
129632151|NCT03889418|466605559|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
129632152|NCT03889418|466605560|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
129632153|NCT03889418|466605561|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
129632154|NCT03889418|466605562|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
129632155|NCT03889418|466605563|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
129632156|NCT03889418|466605554|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129632157|NCT03889418|466605555|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
129632158|NCT03889418|466605556|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
129632159|NCT03889418|466605557|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
129632160|NCT03889418|466605558|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129632161|NCT03889418|466605559|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129632162|NCT03889418|466605560|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129632163|NCT03889418|466605561|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
129632164|NCT03889418|466605562|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
129632165|NCT03889418|466605563|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
129632166|NCT01909934|466605570|FG000|Overall Study|Withdrawal by Subject|3|||
129632167|NCT01909934|466605570|FG000|Overall Study|Lost to Follow-up|1|||
129632168|NCT01909934|466605570|FG000|Overall Study|Death|25|||
129632169|NCT01909934|466605570|FG000|Overall Study|Withdrawal of Informed Consent|1|||
129632170|NCT01909934|466605570|FG000|Overall Study|Reason Not Specified|1|||
129632171|NCT03810092|466605571|FG000|Overall Study|no ground support|17|||
129632172|NCT03810092|466605571|FG000|Overall Study|ADL not done at J0|16|||
129632173|NCT03810092|466605571|FG000|Overall Study|No hemoglobin measure at J5|27|||
129632174|NCT01139775|466605577|FG000|Overall Study|Adverse Event|0|||
129632175|NCT01139775|466605578|FG001|Overall Study|Adverse Event|6|||
129632176|NCT01139775|466605579|FG002|Overall Study|Adverse Event|2|||
129632177|NCT01139775|466605577|FG000|Overall Study|Protocol Violation|0|||
129632178|NCT01139775|466605578|FG001|Overall Study|Protocol Violation|5|||
129632179|NCT01139775|466605579|FG002|Overall Study|Protocol Violation|0|||
129632180|NCT01139775|466605577|FG000|Overall Study|Withdrawal by Subject|1|||
129632181|NCT01139775|466605578|FG001|Overall Study|Withdrawal by Subject|0|||
129632182|NCT01139775|466605579|FG002|Overall Study|Withdrawal by Subject|2|||
129632183|NCT01139775|466605577|FG000|Overall Study|Physician Decision|0|||
129632184|NCT01139775|466605578|FG001|Overall Study|Physician Decision|2|||
129632185|NCT01139775|466605579|FG002|Overall Study|Physician Decision|2|||
129632186|NCT01753310|466605582|FG000|Overall Study|Entered into open label extension study|25|||
129632187|NCT01753310|466605583|FG001|Overall Study|Entered into open label extension study|22|||
129632188|NCT01753310|466605582|FG000|Overall Study|Adverse Event|1|||
129632189|NCT01753310|466605583|FG001|Overall Study|Adverse Event|0|||
129632190|NCT01753310|466605582|FG000|Overall Study|Lost to Follow-up|2|||
129632191|NCT01753310|466605583|FG001|Overall Study|Lost to Follow-up|0|||
129632192|NCT01753310|466605582|FG000|Overall Study|Subject decision|2|||
129632193|NCT01753310|466605583|FG001|Overall Study|Subject decision|2|||
129632194|NCT01753310|466605582|FG000|Overall Study|Sponsor decision|1|||
129632195|NCT01753310|466605583|FG001|Overall Study|Sponsor decision|0|||
129632196|NCT01753310|466605582|FG000|Overall Study|Withdrawal by Subject|1|||
129632197|NCT01753310|466605583|FG001|Overall Study|Withdrawal by Subject|0|||
129632198|NCT03193853|466605584|FG000|Overall Study|Death|6|||
129632199|NCT02022202|466605585|FG000|Overall Study|Withdrawal by Subject|2|||
129632200|NCT02022202|466605585|FG000|Overall Study|Disease Progression|3|||
129632201|NCT02022202|466605585|FG000|Overall Study|Desire go to immediately to surgery|3|||
129632202|NCT05581641|466605589|FG000|Overall Study|Withdrawal by Subject|0|||
129632203|NCT05581641|466605590|FG001|Overall Study|Withdrawal by Subject|1|||
129632204|NCT05581641|466605591|FG002|Overall Study|Withdrawal by Subject|3|||
129632205|NCT05581641|466605592|FG003|Overall Study|Withdrawal by Subject|1|||
129632206|NCT05581641|466605589|FG000|Overall Study|Lost to Follow-up|0|||
129632207|NCT05581641|466605590|FG001|Overall Study|Lost to Follow-up|1|||
129632208|NCT05581641|466605591|FG002|Overall Study|Lost to Follow-up|0|||
129632209|NCT05581641|466605592|FG003|Overall Study|Lost to Follow-up|1|||
129632210|NCT05581641|466605589|FG000|Overall Study|Protocol Violation|1|||
129632211|NCT05581641|466605590|FG001|Overall Study|Protocol Violation|0|||
129632212|NCT05581641|466605591|FG002|Overall Study|Protocol Violation|0|||
129632213|NCT05581641|466605592|FG003|Overall Study|Protocol Violation|0|||
129632214|NCT05581641|466605589|FG000|Overall Study|Other|1|||
129632215|NCT05581641|466605590|FG001|Overall Study|Other|0|||
129632216|NCT05581641|466605591|FG002|Overall Study|Other|2|||
129632217|NCT05581641|466605592|FG003|Overall Study|Other|1|||
129632218|NCT00503698|466605601|FG000|Overall Study|Protocol Violation|5|||
129632219|NCT00503698|466605602|FG001|Overall Study|Protocol Violation|6|||
129632220|NCT00503698|466605601|FG000|Overall Study|Adverse Event|52|||
129632221|NCT00503698|466605602|FG001|Overall Study|Adverse Event|41|||
129632222|NCT00503698|466605601|FG000|Overall Study|Death|1|||
129632223|NCT00503698|466605602|FG001|Overall Study|Death|0|||
129632224|NCT00503698|466605601|FG000|Overall Study|Lack of Efficacy|3|||
129632225|NCT00503698|466605602|FG001|Overall Study|Lack of Efficacy|4|||
129632226|NCT00503698|466605601|FG000|Overall Study|Trial terminated|216|||
129632227|NCT00503698|466605602|FG001|Overall Study|Trial terminated|253|||
129632228|NCT00503698|466605601|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
129632229|NCT00503698|466605602|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
129632230|NCT00503698|466605601|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
129632231|NCT00503698|466605602|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
129632232|NCT00503698|466605601|FG000|Overall Study|Any condition in exclusion criteria|4|||
129632233|NCT00503698|466605602|FG001|Overall Study|Any condition in exclusion criteria|6|||
129632234|NCT00503698|466605601|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
129632235|NCT00503698|466605602|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
129632236|NCT00503698|466605601|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
129632237|NCT00503698|466605602|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
129632238|NCT00503698|466605601|FG000|Overall Study|Critically ill|2|||
129632239|NCT00503698|466605602|FG001|Overall Study|Critically ill|0|||
129632240|NCT00503698|466605601|FG000|Overall Study|Unclassified|48|||
129632241|NCT00503698|466605602|FG001|Overall Study|Unclassified|32|||
129632242|NCT00503698|466605601|FG000|Overall Study|Not exposed to trial drug|11|||
129632243|NCT00503698|466605602|FG001|Overall Study|Not exposed to trial drug|6|||
129632244|NCT02462603|466605610|FG000|Overall Study|Investigator Decision|1|||
129632245|NCT02462603|466605610|FG000|Overall Study|Non-Compliance|1|||
129632246|NCT02462603|466605610|FG000|Overall Study|Withdrawal by Subject|2|||
129632247|NCT01591096|466605612|FG000|Overall Study|Adverse Event|1|||
129632248|NCT01445730|466605613|FG000|Overall Study|Adverse Event|1|||
129632249|NCT01445730|466605613|FG000|Overall Study|For the advice of a dentist|1|||
129632250|NCT01445730|466605613|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
129632251|NCT00734994|466605614|FG000|Overall Study|Withdrawal by Subject|1|||
129632252|NCT01546025|466605615|FG000|Overall Study|Lost to Follow-up|0|||
129632253|NCT01546025|466605616|FG001|Overall Study|Lost to Follow-up|1|||
129632254|NCT05514873|466605617|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
129632255|NCT05514873|466605617|FG000|Main Treatment Period|Adverse Event|2|||
129632256|NCT05514873|466605617|FG000|Extension Treatment Period|Lost to Follow-up|3|||
129632257|NCT05177484|466606836|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
129632258|NCT05177484|466606837|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
129632259|NCT05177484|466606836|FG000|Overall Study|Inadvertently withdrawn|3|||
129632260|NCT05177484|466606837|FG001|Overall Study|Inadvertently withdrawn|1|||
129632261|NCT05177484|466606836|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
129632262|NCT05177484|466606837|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
129632263|NCT02393950|466606842|FG000|Overall Study|Adverse Event|1|||
129632264|NCT02393950|466606843|FG001|Overall Study|Adverse Event|0|||
129632265|NCT02393950|466606842|FG000|Overall Study|Withdrawal by Subject|0|||
129632266|NCT02393950|466606843|FG001|Overall Study|Withdrawal by Subject|1|||
129632267|NCT05486091|466606844|FG000|Overall Study|Withdrawal by Subject|1|||
129632268|NCT05486091|466606844|FG000|Overall Study|Lost to Follow-up|2|||
129632269|NCT03971071|466606845|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129632270|NCT03971071|466606846|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
129632271|NCT03971071|466606847|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129704070|NCT04067011|466879026|FG000|Overall Study|Adverse Event|2|||
129704071|NCT04067011|466879027|FG001|Overall Study|Adverse Event|1|||
129704072|NCT04067011|466879028|FG002|Overall Study|Adverse Event|0|||
129704073|NCT04067011|466879026|FG000|Overall Study|Withdrawal by Subject|6|||
129704074|NCT04067011|466879027|FG001|Overall Study|Withdrawal by Subject|2|||
129632272|NCT03971071|466606848|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129632273|NCT03971071|466606849|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
129632274|NCT03971071|466606845|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
129632275|NCT03971071|466606846|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
129632276|NCT03971071|466606847|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
129632277|NCT03971071|466606848|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129632278|NCT03971071|466606849|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129632279|NCT03971071|466606845|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
129632280|NCT03971071|466606846|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
129632281|NCT03971071|466606847|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
129632282|NCT03971071|466606848|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
129632283|NCT03971071|466606849|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
129632284|NCT03971071|466606845|FG000|Open-label Treatment Period|Sponsor decision|0|||
129632285|NCT03971071|466606846|FG001|Open-label Treatment Period|Sponsor decision|0|||
129632286|NCT03971071|466606847|FG002|Open-label Treatment Period|Sponsor decision|0|||
129632287|NCT03971071|466606848|FG003|Open-label Treatment Period|Sponsor decision|0|||
129632288|NCT03971071|466606849|FG004|Open-label Treatment Period|Sponsor decision|1|||
129632289|NCT03971071|466606845|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129632290|NCT03971071|466606846|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129632291|NCT03971071|466606847|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129632292|NCT03971071|466606848|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
129632293|NCT03971071|466606849|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
129632294|NCT03971071|466606845|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129632295|NCT03971071|466606846|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129632296|NCT03971071|466606847|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129632297|NCT03971071|466606848|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
129632298|NCT03971071|466606849|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
129632299|NCT01697748|466606850|FG000|Overall Study|ineligible skin incision|1|||
129632300|NCT01697748|466606851|FG001|Overall Study|ineligible skin incision|2|||
129632301|NCT01697748|466606850|FG000|Overall Study|ineligible uterine incision|4|||
129632302|NCT01697748|466606851|FG001|Overall Study|ineligible uterine incision|1|||
129632303|NCT01697748|466606850|FG000|Overall Study|Lost to Follow-up|53|||
129632304|NCT01697748|466606851|FG001|Overall Study|Lost to Follow-up|65|||
129632305|NCT01704495|466606855|FG000|Subjects Randomized|Other Reason|3|||
129632306|NCT01704495|466606856|FG001|Subjects Randomized|Other Reason|2|||
129632307|NCT01704495|466606857|FG002|Subjects Randomized|Other Reason|3|||
129632308|NCT01704495|466606858|FG003|Subjects Randomized|Other Reason|2|||
129632309|NCT01704495|466606855|FG000|Subjects Randomized|Discontinuation criteria met|4|||
129632310|NCT01704495|466606856|FG001|Subjects Randomized|Discontinuation criteria met|2|||
129632311|NCT01704495|466606857|FG002|Subjects Randomized|Discontinuation criteria met|2|||
129632312|NCT01704495|466606858|FG003|Subjects Randomized|Discontinuation criteria met|0|||
129632313|NCT01704495|466606855|FG000|Subjects Randomized|Adverse Event|8|||
129632314|NCT01704495|466606856|FG001|Subjects Randomized|Adverse Event|2|||
129632315|NCT01704495|466606857|FG002|Subjects Randomized|Adverse Event|0|||
129632316|NCT01704495|466606858|FG003|Subjects Randomized|Adverse Event|7|||
129632317|NCT01704495|466606855|FG000|Subjects Randomized|Withdrawal by Subject|5|||
129632318|NCT01704495|466606856|FG001|Subjects Randomized|Withdrawal by Subject|5|||
129632319|NCT01704495|466606857|FG002|Subjects Randomized|Withdrawal by Subject|5|||
129632320|NCT01704495|466606858|FG003|Subjects Randomized|Withdrawal by Subject|5|||
129632321|NCT01704495|466606855|FG000|Subjects Randomized|Protocol Violation|1|||
129632322|NCT01704495|466606856|FG001|Subjects Randomized|Protocol Violation|1|||
129632323|NCT01704495|466606857|FG002|Subjects Randomized|Protocol Violation|2|||
129632324|NCT01704495|466606858|FG003|Subjects Randomized|Protocol Violation|0|||
129632325|NCT01704495|466606855|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
129632326|NCT01704495|466606856|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
129632327|NCT01704495|466606857|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
129632328|NCT01704495|466606858|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
129632329|NCT01704495|466606855|FG000|Optional Safety Extension|Adverse Event|0|||
129632330|NCT01704495|466606856|FG001|Optional Safety Extension|Adverse Event|4|||
129632331|NCT01704495|466606857|FG002|Optional Safety Extension|Adverse Event|0|||
129632332|NCT01704495|466606858|FG003|Optional Safety Extension|Adverse Event|1|||
129632333|NCT01704495|466606855|FG000|Optional Safety Extension|Other reason|27|||
129632334|NCT01704495|466606856|FG001|Optional Safety Extension|Other reason|29|||
129632335|NCT01704495|466606857|FG002|Optional Safety Extension|Other reason|30|||
129632336|NCT01704495|466606858|FG003|Optional Safety Extension|Other reason|28|||
129632337|NCT01704495|466606855|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
129632338|NCT01704495|466606856|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
129632339|NCT01704495|466606857|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
129632340|NCT01704495|466606858|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
129632341|NCT03866512|466606859|FG000|Overall Study|Lost to Follow-up|1|||
129632342|NCT03866512|466606860|FG001|Overall Study|Lost to Follow-up|2|||
129632343|NCT03866512|466606861|FG002|Overall Study|Lost to Follow-up|1|||
129632344|NCT03866512|466606859|FG000|Overall Study|Cannulation issues|0|||
129632345|NCT03866512|466606860|FG001|Overall Study|Cannulation issues|1|||
129632346|NCT03866512|466606861|FG002|Overall Study|Cannulation issues|2|||
129632347|NCT00997373|466606866|FG000|Overall Study|Withdrawal by Subject|5|||
129632348|NCT00997373|466606867|FG001|Overall Study|Withdrawal by Subject|0|||
129632349|NCT00997373|466606866|FG000|Overall Study|wrong tumor type|4|||
129632350|NCT00997373|466606867|FG001|Overall Study|wrong tumor type|0|||
129440391|NCT01296347|465911428|FG000|Allocation|Lack of Efficacy|1|||
129632351|NCT00997373|466606866|FG000|Overall Study|could not have hysterectomy|6|||
129632352|NCT00997373|466606867|FG001|Overall Study|could not have hysterectomy|0|||
129632353|NCT03210714|466606873|FG000|Overall Study|Adverse Event|6|||
129632354|NCT03210714|466606873|FG000|Overall Study|Physician Decision|1|||
129632355|NCT03210714|466606873|FG000|Overall Study|Progressive disease|11|||
129632356|NCT03210714|466606873|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
129632357|NCT01956773|466606874|FG000|Overall Study|Lost to Follow-up|628|||
129632358|NCT01956773|466606875|FG001|Overall Study|Lost to Follow-up|1|||
129632359|NCT00450437|466606876|FG000|Overall Study|Withdrawal by Subject|10|||
129632360|NCT00450437|466606877|FG001|Overall Study|Withdrawal by Subject|2|||
129632361|NCT00450437|466606878|FG002|Overall Study|Withdrawal by Subject|0|||
129632362|NCT00450437|466606879|FG003|Overall Study|Withdrawal by Subject|1|||
129632363|NCT00450437|466606876|FG000|Overall Study|Lost to Follow-up|31|||
129632364|NCT00450437|466606877|FG001|Overall Study|Lost to Follow-up|12|||
129632365|NCT00450437|466606878|FG002|Overall Study|Lost to Follow-up|19|||
129632366|NCT00450437|466606879|FG003|Overall Study|Lost to Follow-up|9|||
129632367|NCT00450437|466606876|FG000|Overall Study|Protocol Violation|0|||
129632368|NCT00450437|466606877|FG001|Overall Study|Protocol Violation|1|||
129632369|NCT00450437|466606878|FG002|Overall Study|Protocol Violation|0|||
129632370|NCT00450437|466606879|FG003|Overall Study|Protocol Violation|1|||
129632371|NCT00450437|466606876|FG000|Overall Study|Inappropriate enrollment|4|||
129632372|NCT00450437|466606877|FG001|Overall Study|Inappropriate enrollment|1|||
129632373|NCT00450437|466606878|FG002|Overall Study|Inappropriate enrollment|3|||
129632374|NCT00450437|466606879|FG003|Overall Study|Inappropriate enrollment|0|||
129632375|NCT00450437|466606876|FG000|Overall Study|Administrative reason|0|||
129632376|NCT00450437|466606877|FG001|Overall Study|Administrative reason|0|||
129632377|NCT00450437|466606878|FG002|Overall Study|Administrative reason|1|||
129632378|NCT00450437|466606879|FG003|Overall Study|Administrative reason|0|||
129632379|NCT00450437|466606876|FG000|Overall Study|Unable to Classify|1|||
129632380|NCT00450437|466606877|FG001|Overall Study|Unable to Classify|0|||
129632381|NCT00450437|466606878|FG002|Overall Study|Unable to Classify|1|||
129632382|NCT00450437|466606879|FG003|Overall Study|Unable to Classify|0|||
129632383|NCT02492867|466606880|FG000|Overall Study|Alternate therapy|1|||
129632384|NCT02492867|466606880|FG000|Overall Study|Withdrawal by Subject|2|||
129632385|NCT02492867|466606880|FG000|Overall Study|Disease progression after treatment started|1|||
129632386|NCT02492867|466606880|FG000|Overall Study|Death|1|||
129632387|NCT03296527|466606881|FG000|Overall Study|Adverse Event|15|||
129632388|NCT03296527|466606882|FG001|Overall Study|Adverse Event|33|||
129632389|NCT03296527|466606881|FG000|Overall Study|Protocol Deviation|4|||
129632390|NCT03296527|466606882|FG001|Overall Study|Protocol Deviation|0|||
129632391|NCT03296527|466606881|FG000|Overall Study|Participant withdrew consent|3|||
129632392|NCT03296527|466606882|FG001|Overall Study|Participant withdrew consent|1|||
129632393|NCT03296527|466606881|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
129632394|NCT03296527|466606882|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
129632395|NCT03296527|466606881|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
129632396|NCT03296527|466606882|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
129632397|NCT03296527|466606881|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
129632398|NCT03296527|466606882|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
129632399|NCT03296527|466606881|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
129632400|NCT03296527|466606882|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
129632401|NCT03296527|466606881|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
129632402|NCT03296527|466606882|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
129632403|NCT00122382|466606883|FG000|Double-Blind Study|Adverse Event|9|||
129632404|NCT00122382|466606884|FG001|Double-Blind Study|Adverse Event|11|||
129632405|NCT00122382|466606885|FG002|Double-Blind Study|Adverse Event|0|||
129632406|NCT00122382|466606883|FG000|Double-Blind Study|Death|2|||
129632407|NCT00122382|466606884|FG001|Double-Blind Study|Death|2|||
129632408|NCT00122382|466606885|FG002|Double-Blind Study|Death|0|||
129632409|NCT00122382|466606883|FG000|Double-Blind Study|Lack of Efficacy|0|||
129632410|NCT00122382|466606884|FG001|Double-Blind Study|Lack of Efficacy|8|||
129632411|NCT00122382|466606885|FG002|Double-Blind Study|Lack of Efficacy|0|||
129632412|NCT00122382|466606883|FG000|Double-Blind Study|Lost to Follow-up|2|||
129632413|NCT00122382|466606884|FG001|Double-Blind Study|Lost to Follow-up|1|||
129632414|NCT00122382|466606885|FG002|Double-Blind Study|Lost to Follow-up|0|||
129632415|NCT00122382|466606883|FG000|Double-Blind Study|Pregnancy|2|||
129632416|NCT00122382|466606884|FG001|Double-Blind Study|Pregnancy|0|||
129632417|NCT00122382|466606885|FG002|Double-Blind Study|Pregnancy|0|||
129632418|NCT00122382|466606883|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
129632419|NCT00122382|466606884|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
129632420|NCT00122382|466606885|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
129632421|NCT00122382|466606883|FG000|Double-Blind Study|Withdrawal of Consent|7|||
129632422|NCT00122382|466606884|FG001|Double-Blind Study|Withdrawal of Consent|3|||
129632423|NCT00122382|466606885|FG002|Double-Blind Study|Withdrawal of Consent|0|||
129632424|NCT00122382|466606883|FG000|Double-Blind Study|Protocol Violation|1|||
129632425|NCT00122382|466606884|FG001|Double-Blind Study|Protocol Violation|0|||
129632426|NCT00122382|466606885|FG002|Double-Blind Study|Protocol Violation|0|||
129632427|NCT00122382|466606883|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
129632428|NCT00122382|466606884|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
129632429|NCT00122382|466606885|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
129632430|NCT00122382|466606883|FG000|Double-Blind Study|Randomized but not treated|0|||
129632431|NCT00122382|466606884|FG001|Double-Blind Study|Randomized but not treated|2|||
129632432|NCT00122382|466606885|FG002|Double-Blind Study|Randomized but not treated|0|||
129632433|NCT00122382|466606883|FG000|Open-Label Study|Adverse Event|0|||
129632434|NCT00122382|466606884|FG001|Open-Label Study|Adverse Event|0|||
129632435|NCT00122382|466606885|FG002|Open-Label Study|Adverse Event|11|||
129632436|NCT00122382|466606883|FG000|Open-Label Study|Death|0|||
129632437|NCT00122382|466606884|FG001|Open-Label Study|Death|0|||
129632438|NCT00122382|466606885|FG002|Open-Label Study|Death|2|||
129632439|NCT00122382|466606883|FG000|Open-Label Study|Lack of Efficacy|0|||
129632440|NCT00122382|466606884|FG001|Open-Label Study|Lack of Efficacy|0|||
129632441|NCT00122382|466606885|FG002|Open-Label Study|Lack of Efficacy|3|||
129632442|NCT00122382|466606883|FG000|Open-Label Study|Lost to Follow-up|0|||
129632443|NCT00122382|466606884|FG001|Open-Label Study|Lost to Follow-up|0|||
129632444|NCT00122382|466606885|FG002|Open-Label Study|Lost to Follow-up|3|||
129632445|NCT00122382|466606883|FG000|Open-Label Study|Pregnancy|0|||
129632446|NCT00122382|466606884|FG001|Open-Label Study|Pregnancy|0|||
129632447|NCT00122382|466606885|FG002|Open-Label Study|Pregnancy|2|||
129632448|NCT00122382|466606883|FG000|Open-Label Study|Poor/Non-Compliance|0|||
129632449|NCT00122382|466606884|FG001|Open-Label Study|Poor/Non-Compliance|0|||
129632450|NCT00122382|466606885|FG002|Open-Label Study|Poor/Non-Compliance|1|||
129632451|NCT00122382|466606883|FG000|Open-Label Study|Withdrawal of Consent|0|||
129632452|NCT00122382|466606884|FG001|Open-Label Study|Withdrawal of Consent|0|||
129632453|NCT00122382|466606885|FG002|Open-Label Study|Withdrawal of Consent|4|||
129632454|NCT02040805|466606886|FG000|Overall Study|Lost to Follow-up|14|||
129632455|NCT02040805|466606887|FG001|Overall Study|Lost to Follow-up|9|||
129632456|NCT02040805|466606886|FG000|Overall Study|Withdrawal by Subject|28|||
129632457|NCT02040805|466606887|FG001|Overall Study|Withdrawal by Subject|41|||
129632458|NCT01213966|466606889|FG000|Overall Study|Protocol Violation|1|||
129632459|NCT01213966|466606890|FG001|Overall Study|Protocol Violation|0|||
129632460|NCT01213966|466606891|FG002|Overall Study|Protocol Violation|3|||
129632461|NCT01213966|466606892|FG003|Overall Study|Protocol Violation|1|||
129632462|NCT03591874|466606893|FG000|Overall Study|Adverse Event|4|||
129632463|NCT03591874|466606894|FG001|Overall Study|Adverse Event|0|||
129632464|NCT03591874|466606893|FG000|Overall Study|Withdrawal by Subject|2|||
129632465|NCT03591874|466606894|FG001|Overall Study|Withdrawal by Subject|1|||
129632466|NCT03591874|466606893|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
129632467|NCT03591874|466606894|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
129632468|NCT03591874|466606893|FG000|Overall Study|On Study at Time of Study Termination|12|||
129632469|NCT03591874|466606894|FG001|Overall Study|On Study at Time of Study Termination|6|||
129632470|NCT03644342|466606897|FG000|Overall Study|Adverse Event|2|||
129632471|NCT03644342|466606898|FG001|Overall Study|Adverse Event|0|||
129632472|NCT03644342|466606897|FG000|Overall Study|Protocol Violation|0|||
129632473|NCT03644342|466606898|FG001|Overall Study|Protocol Violation|1|||
129632474|NCT03655405|466606899|FG000|Overall Study|Death after initial data collection|4|||
129632475|NCT03655405|466606900|FG001|Overall Study|Death after initial data collection|2|||
129704075|NCT04067011|466879028|FG002|Overall Study|Withdrawal by Subject|1|||
129704076|NCT04067011|466879026|FG000|Overall Study|Lost to Follow-up|0|||
129632476|NCT03655405|466606899|FG000|Overall Study|Died before initial data collection|1|||
129704077|NCT04067011|466879027|FG001|Overall Study|Lost to Follow-up|0|||
129632477|NCT03655405|466606900|FG001|Overall Study|Died before initial data collection|2|||
129632478|NCT03655405|466606899|FG000|Overall Study|Protocol Violation|0|||
129632479|NCT03655405|466606900|FG001|Overall Study|Protocol Violation|1|||
129632480|NCT01991743|466606901|FG000|Overall Study|external cephalic version not performed|0|||
129632481|NCT01991743|466606902|FG001|Overall Study|external cephalic version not performed|0|||
129632482|NCT01991743|466606903|FG002|Overall Study|external cephalic version not performed|1|||
129632483|NCT01991743|466606904|FG003|Overall Study|external cephalic version not performed|0|||
129632484|NCT02859337|466606907|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
129632485|NCT02859337|466606908|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
129632486|NCT02859337|466606909|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
129704078|NCT04067011|466879028|FG002|Overall Study|Lost to Follow-up|1|||
129632487|NCT02859337|466606907|FG000|Overall Study|Withdrawal by Subject|3|||
129632488|NCT02859337|466606908|FG001|Overall Study|Withdrawal by Subject|1|||
129632489|NCT02859337|466606909|FG002|Overall Study|Withdrawal by Subject|0|||
129632490|NCT02859337|466606907|FG000|Overall Study|Lost to Follow-up|1|||
129632491|NCT02859337|466606908|FG001|Overall Study|Lost to Follow-up|0|||
129632492|NCT02859337|466606909|FG002|Overall Study|Lost to Follow-up|0|||
129632493|NCT01167140|466606912|FG000|Overall Study|Withdrawal by Subject|1|||
129632494|NCT04390113|466606913|FG000|Overall Study|Not Treated|0|||
129632495|NCT04390113|466606914|FG001|Overall Study|Not Treated|1|||
129632496|NCT04390113|466606913|FG000|Overall Study|Adverse Event|1|||
129632497|NCT04390113|466606914|FG001|Overall Study|Adverse Event|0|||
129632498|NCT04390113|466606913|FG000|Overall Study|Death|2|||
129632499|NCT04390113|466606914|FG001|Overall Study|Death|1|||
129632500|NCT04390113|466606913|FG000|Overall Study|Physician Decision|1|||
129632501|NCT04390113|466606914|FG001|Overall Study|Physician Decision|3|||
129632502|NCT04390113|466606913|FG000|Overall Study|Study Terminated by Sponsor|5|||
129632503|NCT04390113|466606914|FG001|Overall Study|Study Terminated by Sponsor|3|||
129632504|NCT04390113|466606913|FG000|Overall Study|Withdrawal by Subject|10|||
129632505|NCT04390113|466606914|FG001|Overall Study|Withdrawal by Subject|5|||
129632506|NCT04390113|466606913|FG000|Overall Study|Other|1|||
129632507|NCT04390113|466606914|FG001|Overall Study|Other|0|||
129632508|NCT04390113|466606913|FG000|Overall Study|Missing|0|||
129632509|NCT04390113|466606914|FG001|Overall Study|Missing|1|||
129632510|NCT01611883|466606915|FG000|Overall Study|Adverse Event|1|||
129632511|NCT01611883|466606916|FG001|Overall Study|Adverse Event|1|||
129632512|NCT00030901|466606917|FG000|Initial Registration|Ineligible|167|||
129632513|NCT00030901|466606918|FG001|Initial Registration|Ineligible|0|||
129632514|NCT00030901|466606919|FG002|Initial Registration|Ineligible|0|||
129632515|NCT00030901|466606917|FG000|Randomization|Adverse Event|0|||
129632516|NCT00030901|466606918|FG001|Randomization|Adverse Event|11|||
129632517|NCT00030901|466606919|FG002|Randomization|Adverse Event|7|||
129632518|NCT00030901|466606917|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
129632519|NCT00030901|466606918|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
129632520|NCT00030901|466606919|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
129632521|NCT00030901|466606917|FG000|Randomization|Progression/Relapse|0|||
129632522|NCT00030901|466606918|FG001|Randomization|Progression/Relapse|22|||
129632523|NCT00030901|466606919|FG002|Randomization|Progression/Relapse|21|||
129632524|NCT00030901|466606917|FG000|Randomization|Death|0|||
129704079|NCT04067011|466879026|FG000|Overall Study|Physician Decision|1|||
129704080|NCT04067011|466879027|FG001|Overall Study|Physician Decision|1|||
129704081|NCT04067011|466879028|FG002|Overall Study|Physician Decision|0|||
129704082|NCT04067011|466879026|FG000|Overall Study|Other Reasons|2|||
129704083|NCT04067011|466879027|FG001|Overall Study|Other Reasons|0|||
129704084|NCT04067011|466879028|FG002|Overall Study|Other Reasons|1|||
129704085|NCT04067011|466879026|FG000|Overall Study|Missing|0|||
129704086|NCT04067011|466879027|FG001|Overall Study|Missing|2|||
129704087|NCT04067011|466879028|FG002|Overall Study|Missing|0|||
129704088|NCT03746015|466879029|FG000|Overall Study|Withdrawal of Consent|1|||
129704089|NCT03746015|466879030|FG001|Overall Study|Withdrawal of Consent|0|||
129704090|NCT03746015|466879031|FG002|Overall Study|Withdrawal of Consent|0|||
129704091|NCT05209386|466879032|FG000|Overall Study|Withdrawal by Subject|8|||
129704092|NCT05209386|466879032|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
129704093|NCT05134649|466879033|FG000|Overall Study|Lost to Follow-up|12|||
129704094|NCT05134649|466879033|FG000|Overall Study|Withdrawal by Subject|14|||
129704095|NCT05134649|466879033|FG000|Overall Study|Pregnancy|1|||
129704096|NCT05134649|466879033|FG000|Overall Study|Other, not specified|3|||
129632525|NCT00030901|466606918|FG001|Randomization|Death|1|||
129632526|NCT00030901|466606919|FG002|Randomization|Death|3|||
129632527|NCT00030901|466606917|FG000|Randomization|Other|0|||
129704097|NCT01559935|466879034|FG000|Car Phase|Toxicity|4|||
129704098|NCT01559935|466879034|FG000|Car Phase|Death|1|||
129795183|NCT01923168|467217948|FG000|Overall Study|Death|0|||
129795184|NCT01923168|467217949|FG001|Overall Study|Death|0|||
129632528|NCT00030901|466606918|FG001|Randomization|Other|36|||
129632529|NCT00030901|466606919|FG002|Randomization|Other|33|||
129704099|NCT01559935|466879034|FG000|Car Phase|Lack of Efficacy|2|||
129704100|NCT01559935|466879034|FG000|Car Phase|Lost to Follow-up|1|||
129704101|NCT01559935|466879034|FG000|Car Phase|Physician Decision|1|||
129632530|NCT00030901|466606917|FG000|Randomization|Ineligible|0|||
129632531|NCT00030901|466606918|FG001|Randomization|Ineligible|15|||
129632532|NCT00030901|466606919|FG002|Randomization|Ineligible|14|||
129632533|NCT01806051|466606922|FG000|Overall Study|Withdrawal by Subject|6|||
129632534|NCT02576847|466606923|FG000|Overall Study|Adverse Event|27|||
129632535|NCT02576847|466606923|FG000|Overall Study|Lost to Follow-up|22|||
129632536|NCT02576847|466606923|FG000|Overall Study|Physician Decision|1|||
129632537|NCT02576847|466606923|FG000|Overall Study|Pregnancy|1|||
129704102|NCT01559935|466879034|FG000|Car Phase|Withdrawal by Subject|2|||
129704103|NCT01559935|466879034|FG000|Car Phase|Per protocol|1|||
129704104|NCT01559935|466879034|FG000|Car Phase|Insurance|1|||
129632538|NCT02576847|466606923|FG000|Overall Study|Protocol Violation|3|||
129704105|NCT01559935|466879034|FG000|Car Phase|non-compliance|1|||
129632539|NCT02576847|466606923|FG000|Overall Study|Withdrawal by Subject|78|||
129632540|NCT02576847|466606923|FG000|Overall Study|Other|5|||
129632541|NCT01205776|466606924|FG000|Overall Study|Lost to Follow-up|53|||
129632542|NCT01205776|466606925|FG001|Overall Study|Lost to Follow-up|61|||
129632543|NCT01205776|466606924|FG000|Overall Study|Withdrawal by Subject|11|||
129632544|NCT01205776|466606925|FG001|Overall Study|Withdrawal by Subject|34|||
129632545|NCT05142722|466608084|FG000|Overall Study|Lost to Follow-up|16|||
129632546|NCT05142722|466608085|FG001|Overall Study|Lost to Follow-up|38|||
129632547|NCT05142722|466608084|FG000|Overall Study|Withdrawal by Subject|20|||
129632548|NCT05142722|466608085|FG001|Overall Study|Withdrawal by Subject|27|||
129632549|NCT05142722|466608084|FG000|Overall Study|Death|11|||
129632550|NCT05142722|466608085|FG001|Overall Study|Death|17|||
129632551|NCT05142722|466608084|FG000|Overall Study|Physician Decision|0|||
129632552|NCT05142722|466608085|FG001|Overall Study|Physician Decision|1|||
129632553|NCT05142722|466608084|FG000|Overall Study|Participant Moved Away|0|||
129632554|NCT05142722|466608085|FG001|Overall Study|Participant Moved Away|2|||
129632555|NCT05142722|466608084|FG000|Overall Study|Adverse Event|2|||
129632556|NCT05142722|466608085|FG001|Overall Study|Adverse Event|1|||
129632557|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
129632558|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129632559|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
129632560|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129632561|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
129632562|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129632563|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129632564|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
129632565|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129632566|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129632567|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
129632568|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129632569|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129632570|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
129632571|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129632572|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
129632573|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129632574|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129632575|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
129632576|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129632577|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129632578|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
129632579|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
129632580|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
129632581|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129632582|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129632583|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129632584|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129632585|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129632586|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
129632587|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129632588|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
129632589|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632590|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632591|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
129632592|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632593|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632594|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632595|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
129632596|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632597|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129632598|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129632599|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
129632600|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129632601|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129632602|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
129632603|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
129632604|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
129632605|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
129795185|NCT01923168|467217950|FG002|Overall Study|Death|1|||
129704106|NCT01559935|466879034|FG000|BiRD Phase|Toxicity|1|||
129704107|NCT01559935|466879034|FG000|BiRD Phase|Lack of Efficacy|1|||
129704108|NCT01559935|466879034|FG000|BiRD Phase|Withdrawal by Subject|2|||
129704109|NCT01559935|466879034|FG000|Maintenance Phase|Remains on study|28|||
129704110|NCT01559935|466879034|FG000|Maintenance Phase|Toxicity|1|||
129704111|NCT01559935|466879034|FG000|Maintenance Phase|Lack of Efficacy|18|||
129704112|NCT01559935|466879034|FG000|Maintenance Phase|Withdrawal by Subject|5|||
129704113|NCT01559935|466879034|FG000|Maintenance Phase|Non-compliance|2|||
129704114|NCT01143402|466879038|FG000|Overall Study|Rapid clinical decline|1|||
129632606|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
129632607|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129632608|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129632609|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129632610|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129632611|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129632612|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
129632613|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129632614|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
129632615|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129632616|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129704115|NCT01143402|466879039|FG001|Overall Study|Rapid clinical decline|1|||
129704116|NCT01143402|466879040|FG002|Overall Study|Rapid clinical decline|0|||
129704117|NCT01143402|466879038|FG000|Overall Study|Not Treated|0|||
129704118|NCT01143402|466879039|FG001|Overall Study|Not Treated|0|||
129704119|NCT01143402|466879040|FG002|Overall Study|Not Treated|1|||
129704120|NCT02526290|466879041|FG000|Overall Study|Adverse Event|3|||
129704121|NCT02526290|466879041|FG000|Overall Study|Withdrawal by Subject|4|||
129704122|NCT02526290|466879041|FG000|Overall Study|Physician Decision|1|||
129704123|NCT02706392|466879042|FG000|Overall Study|Death|1|||
129704124|NCT02706392|466879043|FG001|Overall Study|Death|0|||
129704125|NCT02706392|466879044|FG002|Overall Study|Death|2|||
129704126|NCT02706392|466879045|FG003|Overall Study|Death|2|||
129704127|NCT02706392|466879046|FG004|Overall Study|Death|5|||
129704128|NCT02706392|466879047|FG005|Overall Study|Death|2|||
129704129|NCT00619866|466879050|FG000|Weeks 1 - 12|Adverse Event|0|||
129704130|NCT00619866|466879051|FG001|Weeks 1 - 12|Adverse Event|1|||
129704131|NCT00619866|466879052|FG002|Weeks 1 - 12|Adverse Event|2|||
129704132|NCT00619866|466879053|FG003|Weeks 1 - 12|Adverse Event|0|||
129704133|NCT00619866|466879054|FG004|Weeks 1 - 12|Adverse Event|0|||
129704134|NCT00619866|466879050|FG000|Weeks 1 - 12|Non-compliance|0|||
129704135|NCT00619866|466879051|FG001|Weeks 1 - 12|Non-compliance|0|||
129704136|NCT00619866|466879052|FG002|Weeks 1 - 12|Non-compliance|1|||
129704137|NCT00619866|466879053|FG003|Weeks 1 - 12|Non-compliance|0|||
129704138|NCT00619866|466879054|FG004|Weeks 1 - 12|Non-compliance|0|||
129704139|NCT00619866|466879050|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
129704140|NCT00619866|466879051|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
129704141|NCT00619866|466879052|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
129632617|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129704142|NCT00619866|466879053|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
129704143|NCT00619866|466879054|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
129704144|NCT00619866|466879050|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
129704145|NCT00619866|466879051|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
129704146|NCT00619866|466879052|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
129704147|NCT00619866|466879053|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
129704148|NCT00619866|466879054|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
129704149|NCT00619866|466879050|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
129704150|NCT00619866|466879051|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
129704151|NCT00619866|466879052|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
129795186|NCT03418571|467217953|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
129795187|NCT03418571|467217954|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
129795188|NCT02376829|467217955|FG000|Overall Study|Withdrawal by Subject|27|||
129704152|NCT00619866|466879053|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
129704153|NCT00619866|466879054|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
129704154|NCT00619866|466879050|FG000|Weeks 1 - 12|Sponsor Decision|0|||
129704155|NCT00619866|466879051|FG001|Weeks 1 - 12|Sponsor Decision|1|||
129704156|NCT00619866|466879052|FG002|Weeks 1 - 12|Sponsor Decision|0|||
129704157|NCT00619866|466879053|FG003|Weeks 1 - 12|Sponsor Decision|0|||
129704158|NCT00619866|466879054|FG004|Weeks 1 - 12|Sponsor Decision|0|||
129704159|NCT00619866|466879050|FG000|Weeks 13 - 24|Adverse Event|0|||
129704160|NCT00619866|466879051|FG001|Weeks 13 - 24|Adverse Event|0|||
129632618|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129632619|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129632620|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
129632621|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632622|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632623|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632624|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632625|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
129632626|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632627|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632628|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
129632629|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632630|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632631|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632632|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632633|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632634|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
129632635|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632636|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
129632637|NCT03896503|466608086|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129632638|NCT03896503|466608087|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129632639|NCT03896503|466608088|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129632640|NCT03896503|466608089|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129632641|NCT03896503|466608090|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129632642|NCT03896503|466608091|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
129632643|NCT03896503|466608092|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
129632644|NCT03896503|466608093|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
129632645|NCT05734157|466608094|FG000|Overall Study|Death|3|||
129632646|NCT05734157|466608094|FG000|Overall Study|Withdrawal by Subject|2|||
129632647|NCT05734157|466608094|FG000|Overall Study|Lost to Follow-up|1|||
129632648|NCT05734157|466608094|FG000|Overall Study|Telephone call|3|||
129632649|NCT01467713|466608096|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
129632650|NCT01467713|466608097|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
129632651|NCT01467713|466608098|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
129632652|NCT01467713|466608099|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
129632653|NCT01467713|466608096|FG000|Overall Study|Major Protocol Deviation|2|||
129632654|NCT01467713|466608097|FG001|Overall Study|Major Protocol Deviation|4|||
129632655|NCT01467713|466608098|FG002|Overall Study|Major Protocol Deviation|4|||
129632656|NCT01467713|466608099|FG003|Overall Study|Major Protocol Deviation|1|||
129632657|NCT01467713|466608096|FG000|Overall Study|Lost to Follow-up|9|||
129632658|NCT01467713|466608097|FG001|Overall Study|Lost to Follow-up|12|||
129632659|NCT01467713|466608098|FG002|Overall Study|Lost to Follow-up|6|||
129632660|NCT01467713|466608099|FG003|Overall Study|Lost to Follow-up|9|||
129632661|NCT01467713|466608096|FG000|Overall Study|Voluntary Withdrawal|18|||
129632662|NCT01467713|466608097|FG001|Overall Study|Voluntary Withdrawal|14|||
129632663|NCT01467713|466608098|FG002|Overall Study|Voluntary Withdrawal|21|||
129632664|NCT01467713|466608099|FG003|Overall Study|Voluntary Withdrawal|20|||
129632665|NCT01467713|466608096|FG000|Overall Study|Study Termination|23|||
129632666|NCT01467713|466608097|FG001|Overall Study|Study Termination|33|||
129632667|NCT01467713|466608098|FG002|Overall Study|Study Termination|28|||
129632668|NCT01467713|466608099|FG003|Overall Study|Study Termination|29|||
129632669|NCT01467713|466608096|FG000|Overall Study|Pregnancy|0|||
129632670|NCT01467713|466608097|FG001|Overall Study|Pregnancy|1|||
129632671|NCT01467713|466608098|FG002|Overall Study|Pregnancy|1|||
129632672|NCT01467713|466608099|FG003|Overall Study|Pregnancy|3|||
129632673|NCT01467713|466608096|FG000|Overall Study|Relapse|35|||
129632674|NCT01467713|466608097|FG001|Overall Study|Relapse|25|||
129632675|NCT01467713|466608098|FG002|Overall Study|Relapse|28|||
129632676|NCT01467713|466608099|FG003|Overall Study|Relapse|35|||
129632677|NCT01467713|466608096|FG000|Overall Study|Reason not Specified|6|||
129632678|NCT01467713|466608097|FG001|Overall Study|Reason not Specified|11|||
129632679|NCT01467713|466608098|FG002|Overall Study|Reason not Specified|8|||
129632680|NCT01467713|466608099|FG003|Overall Study|Reason not Specified|7|||
129632681|NCT00210210|466608100|FG000|Overall Study|Withdrawal by Subject|3|||
129632682|NCT00210210|466608101|FG001|Overall Study|Withdrawal by Subject|2|||
129632683|NCT00210210|466608100|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
129632684|NCT00210210|466608101|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
129632685|NCT01100086|466608105|FG000|Period 1|Withdrawal by Subject|1|||
129889085|NCT01349660|467551009|FG002|Overall Study|Disease Progression|50|||
129889086|NCT01349660|467551007|FG000|Overall Study|Adverse Event|1|||
129889087|NCT01349660|467551008|FG001|Overall Study|Adverse Event|1|||
129889088|NCT01349660|467551009|FG002|Overall Study|Adverse Event|12|||
129889089|NCT01349660|467551007|FG000|Overall Study|Withdrawal by Subject|2|||
129440392|NCT01296347|465911429|FG001|Allocation|Lack of Efficacy|2|||
129440393|NCT01296347|465911428|FG000|Allocation|not received infusion|1|||
129632686|NCT01100086|466608106|FG001|Period 1|Withdrawal by Subject|0|||
129632687|NCT01611935|466608107|FG000|Overall Study|Family Declined Participation|1|||
129632688|NCT01611935|466608108|FG001|Overall Study|Family Declined Participation|0|||
129632689|NCT02275546|466608116|FG000|Treatment Period 2|Withdrawal by Subject|2|||
129632690|NCT02275546|466608117|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129632691|NCT02275546|466608116|FG000|Treatment Period 2|Protocol Violation|0|||
129632692|NCT02275546|466608117|FG001|Treatment Period 2|Protocol Violation|1|||
129632693|NCT02955355|466608121|FG000|Overall Study|Adverse Event|4|||
129632694|NCT02955355|466608121|FG000|Overall Study|Death|1|||
129632695|NCT02955355|466608121|FG000|Overall Study|Physician Decision|21|||
129632696|NCT02955355|466608121|FG000|Overall Study|Site Terminated by Sponsor|35|||
129632697|NCT02955355|466608121|FG000|Overall Study|Withdrawal by Subject|19|||
129632698|NCT02955355|466608121|FG000|Overall Study|Reason Not Specified|5|||
129632699|NCT02612623|466608122|FG000|Overall Study|Withdrawal by Subject|0|||
129632700|NCT02612623|466608123|FG001|Overall Study|Withdrawal by Subject|1|||
129632701|NCT02612623|466608124|FG002|Overall Study|Withdrawal by Subject|0|||
129632702|NCT02612623|466608125|FG003|Overall Study|Withdrawal by Subject|0|||
129632703|NCT02612623|466608122|FG000|Overall Study|Adverse Event|1|||
129632704|NCT02612623|466608123|FG001|Overall Study|Adverse Event|0|||
129632705|NCT02612623|466608124|FG002|Overall Study|Adverse Event|1|||
129632706|NCT02612623|466608125|FG003|Overall Study|Adverse Event|0|||
129632707|NCT05344560|466608132|FG000|Period 1|Subject out of visit window|1|||
129632708|NCT05344560|466608133|FG001|Period 1|Subject out of visit window|1|||
129632709|NCT05344560|466608132|FG000|Period 2|Covid-19 Related|1|||
129632710|NCT05344560|466608133|FG001|Period 2|Covid-19 Related|0|||
129632711|NCT05344560|466608132|FG000|Period 2|Adverse Event|1|||
129632712|NCT05344560|466608133|FG001|Period 2|Adverse Event|0|||
129632713|NCT05344560|466608132|FG000|Period 2|Subject out of visit window|1|||
129632714|NCT05344560|466608133|FG001|Period 2|Subject out of visit window|1|||
129632715|NCT05344560|466608132|FG000|Period 3|Subject out of visit window|1|||
129632716|NCT05344560|466608133|FG001|Period 3|Subject out of visit window|0|||
129632717|NCT00360282|466608134|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
129632718|NCT00360282|466608135|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
129632719|NCT00360282|466608136|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
129632720|NCT00360282|466608137|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
129632721|NCT00360282|466608134|FG000|Second Intervention|Adverse Event|0|||
129632722|NCT00360282|466608135|FG001|Second Intervention|Adverse Event|1|||
129632723|NCT00360282|466608136|FG002|Second Intervention|Adverse Event|0|||
129632724|NCT00360282|466608137|FG003|Second Intervention|Adverse Event|0|||
129632725|NCT03817853|466608138|FG000|Induction Phase|Adverse Event|5|||
129632726|NCT03817853|466608139|FG001|Induction Phase|Adverse Event|0|||
129632727|NCT03817853|466608140|FG002|Induction Phase|Adverse Event|0|||
129632728|NCT03817853|466608138|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
129632729|NCT03817853|466608139|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
129704161|NCT00619866|466879052|FG002|Weeks 13 - 24|Adverse Event|2|||
129704162|NCT00619866|466879053|FG003|Weeks 13 - 24|Adverse Event|1|||
129704163|NCT00619866|466879054|FG004|Weeks 13 - 24|Adverse Event|0|||
129704164|NCT00619866|466879050|FG000|Weeks 13 - 24|Protocol Deviation|0|||
129704165|NCT00619866|466879051|FG001|Weeks 13 - 24|Protocol Deviation|0|||
129704166|NCT00619866|466879052|FG002|Weeks 13 - 24|Protocol Deviation|0|||
129704167|NCT00619866|466879053|FG003|Weeks 13 - 24|Protocol Deviation|1|||
129704168|NCT00619866|466879054|FG004|Weeks 13 - 24|Protocol Deviation|0|||
129704169|NCT00619866|466879050|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
129704170|NCT00619866|466879051|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
129704171|NCT00619866|466879052|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
129704172|NCT00619866|466879053|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
129704173|NCT00619866|466879054|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
129704174|NCT00619866|466879050|FG000|Weeks 13 - 24|Non-compliance|0|||
129632730|NCT03817853|466608140|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
129632731|NCT03817853|466608138|FG000|Induction Phase|Physician Decision|2|||
129632732|NCT03817853|466608139|FG001|Induction Phase|Physician Decision|0|||
129632733|NCT03817853|466608140|FG002|Induction Phase|Physician Decision|0|||
129632734|NCT03817853|466608138|FG000|Induction Phase|Progressive Disease|6|||
129632735|NCT03817853|466608139|FG001|Induction Phase|Progressive Disease|0|||
129704175|NCT00619866|466879051|FG001|Weeks 13 - 24|Non-compliance|1|||
129704176|NCT00619866|466879052|FG002|Weeks 13 - 24|Non-compliance|1|||
129704177|NCT00619866|466879053|FG003|Weeks 13 - 24|Non-compliance|0|||
129889090|NCT01349660|467551008|FG001|Overall Study|Withdrawal by Subject|0|||
129889091|NCT01349660|467551009|FG002|Overall Study|Withdrawal by Subject|9|||
129795189|NCT02376829|467217956|FG001|Overall Study|Withdrawal by Subject|44|||
129795190|NCT01439347|467217957|FG000|Overall Study|Death|10|||
129795191|NCT01439347|467217958|FG001|Overall Study|Death|9|||
129795192|NCT01439347|467217957|FG000|Overall Study|Withdrawal by Subject|0|||
129795193|NCT01439347|467217958|FG001|Overall Study|Withdrawal by Subject|1|||
129795194|NCT01439347|467217957|FG000|Overall Study|Physician Decision|1|||
129632736|NCT03817853|466608140|FG002|Induction Phase|Progressive Disease|0|||
129632737|NCT03817853|466608138|FG000|Induction Phase|Withdrawal by Subject|4|||
129632738|NCT03817853|466608139|FG001|Induction Phase|Withdrawal by Subject|0|||
129632739|NCT03817853|466608140|FG002|Induction Phase|Withdrawal by Subject|0|||
129632740|NCT03817853|466608138|FG000|Maintenance Phase|Adverse Event|0|||
129632741|NCT03817853|466608139|FG001|Maintenance Phase|Adverse Event|8|||
129632742|NCT03817853|466608140|FG002|Maintenance Phase|Adverse Event|0|||
129632743|NCT03817853|466608138|FG000|Maintenance Phase|Death|0|||
129632744|NCT03817853|466608139|FG001|Maintenance Phase|Death|5|||
129632745|NCT03817853|466608140|FG002|Maintenance Phase|Death|0|||
129632746|NCT03817853|466608138|FG000|Maintenance Phase|Progressive Disease|0|||
129632747|NCT03817853|466608139|FG001|Maintenance Phase|Progressive Disease|7|||
129632748|NCT03817853|466608140|FG002|Maintenance Phase|Progressive Disease|0|||
129632749|NCT03817853|466608138|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129632750|NCT03817853|466608139|FG001|Maintenance Phase|Withdrawal by Subject|2|||
129632751|NCT03817853|466608140|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129632752|NCT03817853|466608138|FG000|Maintenance Phase|Physician Decision|0|||
129632753|NCT03817853|466608139|FG001|Maintenance Phase|Physician Decision|1|||
129632754|NCT03817853|466608140|FG002|Maintenance Phase|Physician Decision|0|||
129632755|NCT03817853|466608138|FG000|Maintenance Phase|Various reasons|0|||
129632756|NCT03817853|466608139|FG001|Maintenance Phase|Various reasons|4|||
129632757|NCT03817853|466608140|FG002|Maintenance Phase|Various reasons|0|||
129632758|NCT03817853|466608138|FG000|Maintenance Phase|Protocol Deviation|0|||
129632759|NCT03817853|466608139|FG001|Maintenance Phase|Protocol Deviation|1|||
129632760|NCT03817853|466608140|FG002|Maintenance Phase|Protocol Deviation|0|||
129632761|NCT03817853|466608138|FG000|Follow-up Phase|Adverse Event|0|||
129632762|NCT03817853|466608139|FG001|Follow-up Phase|Adverse Event|0|||
129632763|NCT03817853|466608140|FG002|Follow-up Phase|Adverse Event|2|||
129632764|NCT03817853|466608138|FG000|Follow-up Phase|Death|0|||
129632765|NCT03817853|466608139|FG001|Follow-up Phase|Death|0|||
129632766|NCT03817853|466608140|FG002|Follow-up Phase|Death|1|||
129632767|NCT03817853|466608138|FG000|Follow-up Phase|Progressive Disease|0|||
129632768|NCT03817853|466608139|FG001|Follow-up Phase|Progressive Disease|0|||
129632769|NCT03817853|466608140|FG002|Follow-up Phase|Progressive Disease|3|||
129632770|NCT03817853|466608138|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129632771|NCT03817853|466608139|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129632772|NCT03817853|466608140|FG002|Follow-up Phase|Withdrawal by Subject|1|||
129632773|NCT00314340|466608141|FG000|Overall Study|lost interest|1|||
129632774|NCT01620138|466608144|FG000|Overall Study|Withdrawal by Subject|3|||
129632775|NCT01620138|466608145|FG001|Overall Study|Withdrawal by Subject|0|||
129632776|NCT01620138|466608144|FG000|Overall Study|Lack of Efficacy|1|||
129632777|NCT01620138|466608145|FG001|Overall Study|Lack of Efficacy|0|||
129632778|NCT01620138|466608144|FG000|Overall Study|Adverse Event|2|||
129632779|NCT01620138|466608145|FG001|Overall Study|Adverse Event|0|||
129632780|NCT00449865|466608148|FG000|Overall Study|Withdrawal by Subject|110|||
129632781|NCT00449865|466608149|FG001|Overall Study|Withdrawal by Subject|110|||
129632782|NCT00449865|466608148|FG000|Overall Study|Lost to Follow-up|36|||
129632783|NCT00449865|466608149|FG001|Overall Study|Lost to Follow-up|37|||
129632784|NCT00449865|466608148|FG000|Overall Study|Physician Decision|13|||
129632785|NCT00449865|466608149|FG001|Overall Study|Physician Decision|12|||
129632786|NCT00449865|466608148|FG000|Overall Study|Death|31|||
129632787|NCT00449865|466608149|FG001|Overall Study|Death|40|||
129632788|NCT00449865|466608148|FG000|Overall Study|Protocol Violation|8|||
129632789|NCT00449865|466608149|FG001|Overall Study|Protocol Violation|7|||
129795195|NCT01439347|467217958|FG001|Overall Study|Physician Decision|0|||
129795196|NCT01439347|467217957|FG000|Overall Study|Sponsor Terminated Study|2|||
129795197|NCT01439347|467217958|FG001|Overall Study|Sponsor Terminated Study|3|||
129889092|NCT01349660|467551007|FG000|Overall Study|Death|1|||
129889093|NCT01349660|467551008|FG001|Overall Study|Death|1|||
129889094|NCT01349660|467551009|FG002|Overall Study|Death|0|||
129889095|NCT01349660|467551007|FG000|Overall Study|Non-Permitted Interventions|0|||
129632790|NCT00449865|466608148|FG000|Overall Study|Study was stopped|324|||
129632791|NCT00449865|466608149|FG001|Overall Study|Study was stopped|328|||
129632792|NCT03252535|466608150|FG000|Overall Study|Withdrawal by Subject|1|||
129632793|NCT03252535|466608151|FG001|Overall Study|Withdrawal by Subject|0|||
129632794|NCT03252535|466608152|FG002|Overall Study|Withdrawal by Subject|0|||
129632795|NCT03252535|466608150|FG000|Overall Study|Physician Decision|0|||
129632796|NCT03252535|466608151|FG001|Overall Study|Physician Decision|1|||
129632797|NCT03252535|466608152|FG002|Overall Study|Physician Decision|0|||
129632798|NCT03252535|466608150|FG000|Overall Study|Met discontinuation criteria|0|||
129632799|NCT03252535|466608151|FG001|Overall Study|Met discontinuation criteria|1|||
129632800|NCT03252535|466608152|FG002|Overall Study|Met discontinuation criteria|0|||
129889096|NCT01349660|467551008|FG001|Overall Study|Non-Permitted Interventions|0|||
129795198|NCT04068896|467217959|FG000|Overall Study|Adverse Event|2|||
129795199|NCT04068896|467217960|FG001|Overall Study|Adverse Event|0|||
129632801|NCT01346059|466608153|FG000|Overall Study|Withdrawal by Subject|1|||
129632802|NCT01346059|466608154|FG001|Overall Study|Withdrawal by Subject|0|||
129632803|NCT05600283|466608158|FG000|Overall Study|Withdrawal by Subject|3|||
129632804|NCT05600283|466608159|FG001|Overall Study|Withdrawal by Subject|8|||
129632805|NCT05600283|466608158|FG000|Overall Study|invalid individual swab|1|||
129632806|NCT05600283|466608159|FG001|Overall Study|invalid individual swab|0|||
129632807|NCT05600283|466608158|FG000|Overall Study|missing clinician collection|3|||
129632808|NCT05600283|466608159|FG001|Overall Study|missing clinician collection|0|||
129632809|NCT05600283|466608158|FG000|Overall Study|screening failure|0|||
129632810|NCT05600283|466608159|FG001|Overall Study|screening failure|2|||
129632811|NCT03907488|466608164|FG000|Overall Study|Adverse Event|20|||
129632812|NCT03907488|466608165|FG001|Overall Study|Adverse Event|20|||
129632813|NCT03907488|466608164|FG000|Overall Study|Withdrawal by Subject|9|||
129632814|NCT03907488|466608165|FG001|Overall Study|Withdrawal by Subject|13|||
129632815|NCT03907488|466608164|FG000|Overall Study|Lack of Efficacy|0|||
129632816|NCT03907488|466608165|FG001|Overall Study|Lack of Efficacy|9|||
129632817|NCT03907488|466608164|FG000|Overall Study|Death|3|||
129632818|NCT03907488|466608165|FG001|Overall Study|Death|8|||
129632819|NCT03907488|466608164|FG000|Overall Study|not protocol specified|5|||
129632820|NCT03907488|466608165|FG001|Overall Study|not protocol specified|8|||
129632821|NCT03907488|466608164|FG000|Overall Study|Ineligible|9|||
129632822|NCT03907488|466608165|FG001|Overall Study|Ineligible|15|||
129632823|NCT02269098|466608166|FG000|Overall Study|Lost to Follow-up|14|||
129632824|NCT02269098|466608167|FG001|Overall Study|Lost to Follow-up|9|||
129632825|NCT03194542|466608170|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
129632826|NCT03194542|466608171|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
129632827|NCT03194542|466608172|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
129632828|NCT03194542|466608173|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
129632829|NCT03194542|466608170|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
129632830|NCT03194542|466608171|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
129632831|NCT03194542|466608172|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
129632832|NCT03194542|466608173|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
129632833|NCT03194542|466608170|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
129632834|NCT03194542|466608171|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
129632835|NCT03194542|466608172|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
129632836|NCT03194542|466608173|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
129632837|NCT03194542|466608170|FG000|Overall Study|Loss of Response|4|||
129632838|NCT03194542|466608171|FG001|Overall Study|Loss of Response|2|||
129632839|NCT03194542|466608172|FG002|Overall Study|Loss of Response|3|||
129632840|NCT03194542|466608173|FG003|Overall Study|Loss of Response|4|||
129632841|NCT03194542|466608170|FG000|Overall Study|Physician Decision|0|||
129632842|NCT03194542|466608171|FG001|Overall Study|Physician Decision|1|||
129632843|NCT03194542|466608172|FG002|Overall Study|Physician Decision|0|||
129632844|NCT03194542|466608173|FG003|Overall Study|Physician Decision|0|||
129632845|NCT03194542|466608170|FG000|Overall Study|Lack of Efficacy|2|||
129632846|NCT03194542|466608171|FG001|Overall Study|Lack of Efficacy|2|||
129632847|NCT03194542|466608172|FG002|Overall Study|Lack of Efficacy|2|||
129632848|NCT03194542|466608173|FG003|Overall Study|Lack of Efficacy|6|||
129632849|NCT03194542|466608170|FG000|Overall Study|Withdrawal by Subject|2|||
129632850|NCT03194542|466608171|FG001|Overall Study|Withdrawal by Subject|1|||
129632851|NCT03194542|466608172|FG002|Overall Study|Withdrawal by Subject|5|||
129632852|NCT03194542|466608173|FG003|Overall Study|Withdrawal by Subject|4|||
129795200|NCT04068896|467217961|FG002|Overall Study|Adverse Event|1|||
129795201|NCT04068896|467217962|FG003|Overall Study|Adverse Event|0|||
129795202|NCT04068896|467217963|FG004|Overall Study|Adverse Event|0|||
129795203|NCT04068896|467217964|FG005|Overall Study|Adverse Event|0|||
129795204|NCT04068896|467217959|FG000|Overall Study|Death|3|||
129632853|NCT03194542|466608170|FG000|Overall Study|Progressive Disease|1|||
129795205|NCT04068896|467217960|FG001|Overall Study|Death|1|||
129795206|NCT04068896|467217961|FG002|Overall Study|Death|3|||
129795207|NCT04068896|467217962|FG003|Overall Study|Death|19|||
129795208|NCT04068896|467217963|FG004|Overall Study|Death|17|||
129795209|NCT04068896|467217964|FG005|Overall Study|Death|0|||
129795210|NCT04068896|467217959|FG000|Overall Study|Physician Decision|0|||
129632854|NCT03194542|466608171|FG001|Overall Study|Progressive Disease|0|||
129632855|NCT03194542|466608172|FG002|Overall Study|Progressive Disease|1|||
129632856|NCT03194542|466608173|FG003|Overall Study|Progressive Disease|1|||
129632857|NCT03194542|466608170|FG000|Overall Study|Adverse Event|1|||
129632858|NCT03194542|466608171|FG001|Overall Study|Adverse Event|2|||
129632859|NCT03194542|466608172|FG002|Overall Study|Adverse Event|0|||
129632860|NCT03194542|466608173|FG003|Overall Study|Adverse Event|5|||
129632861|NCT03194542|466608170|FG000|Overall Study|Death|1|||
129632862|NCT03194542|466608171|FG001|Overall Study|Death|2|||
129632863|NCT03194542|466608172|FG002|Overall Study|Death|0|||
129795211|NCT04068896|467217960|FG001|Overall Study|Physician Decision|0|||
129795212|NCT04068896|467217961|FG002|Overall Study|Physician Decision|0|||
129795213|NCT04068896|467217962|FG003|Overall Study|Physician Decision|1|||
129795214|NCT04068896|467217963|FG004|Overall Study|Physician Decision|0|||
129795215|NCT04068896|467217964|FG005|Overall Study|Physician Decision|0|||
129795216|NCT04068896|467217959|FG000|Overall Study|progressive disease|3|||
129795217|NCT04068896|467217960|FG001|Overall Study|progressive disease|5|||
129795218|NCT04068896|467217961|FG002|Overall Study|progressive disease|3|||
129795219|NCT04068896|467217962|FG003|Overall Study|progressive disease|2|||
129795220|NCT04068896|467217963|FG004|Overall Study|progressive disease|1|||
129795221|NCT04068896|467217964|FG005|Overall Study|progressive disease|2|||
129795222|NCT04068896|467217959|FG000|Overall Study|Study terminated by sponsor|0|||
129795223|NCT04068896|467217960|FG001|Overall Study|Study terminated by sponsor|0|||
129795224|NCT04068896|467217961|FG002|Overall Study|Study terminated by sponsor|1|||
129795225|NCT04068896|467217962|FG003|Overall Study|Study terminated by sponsor|2|||
129795226|NCT04068896|467217963|FG004|Overall Study|Study terminated by sponsor|1|||
129795227|NCT04068896|467217964|FG005|Overall Study|Study terminated by sponsor|4|||
129795228|NCT04068896|467217959|FG000|Overall Study|Protocol Violation|0|||
129795229|NCT04068896|467217960|FG001|Overall Study|Protocol Violation|0|||
129795230|NCT04068896|467217961|FG002|Overall Study|Protocol Violation|0|||
129795231|NCT04068896|467217962|FG003|Overall Study|Protocol Violation|1|||
129795232|NCT04068896|467217963|FG004|Overall Study|Protocol Violation|0|||
129632864|NCT03194542|466608173|FG003|Overall Study|Death|5|||
129632865|NCT03194542|466608170|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
129632866|NCT03194542|466608171|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
129632867|NCT03194542|466608172|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
129632868|NCT03194542|466608173|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
129632869|NCT04762160|466608174|FG000|Overall Study|Study terminated early due to business reasons|5|||
129632870|NCT03817190|466608181|FG000|Overall Study|Early Termination|13|||
129632871|NCT03817190|466608182|FG001|Overall Study|Early Termination|20|||
129632872|NCT03817190|466608181|FG000|Overall Study|Adverse Event|10|||
129632873|NCT03817190|466608182|FG001|Overall Study|Adverse Event|17|||
129632874|NCT03817190|466608181|FG000|Overall Study|Withdrawal by Subject|12|||
129632875|NCT03817190|466608182|FG001|Overall Study|Withdrawal by Subject|8|||
129632876|NCT03817190|466608181|FG000|Overall Study|Lost to Follow-up|11|||
129632877|NCT03817190|466608182|FG001|Overall Study|Lost to Follow-up|7|||
129632878|NCT03817190|466608181|FG000|Overall Study|Lack of Efficacy|7|||
129632879|NCT03817190|466608182|FG001|Overall Study|Lack of Efficacy|5|||
129632880|NCT03817190|466608181|FG000|Overall Study|Investigator Decision|5|||
129632881|NCT03817190|466608182|FG001|Overall Study|Investigator Decision|1|||
129632882|NCT03817190|466608181|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
129632883|NCT03817190|466608182|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
129632884|NCT03817190|466608181|FG000|Overall Study|Lack of Contact|1|||
129632885|NCT03817190|466608182|FG001|Overall Study|Lack of Contact|0|||
129632886|NCT03817190|466608181|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
129632887|NCT03817190|466608182|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
129632888|NCT01622673|466608183|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129632889|NCT01622673|466608184|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129632890|NCT01622673|466608185|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129632891|NCT01622673|466608186|FG003|Treatment Period 1|Withdrawal by Subject|1|||
129632892|NCT01622673|466608187|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129632893|NCT01622673|466608188|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129632894|NCT01622673|466608183|FG000|Treatment Period 1|Protocol Violation|0|||
129632895|NCT01622673|466608184|FG001|Treatment Period 1|Protocol Violation|1|||
129632896|NCT01622673|466608185|FG002|Treatment Period 1|Protocol Violation|0|||
129632897|NCT01622673|466608186|FG003|Treatment Period 1|Protocol Violation|0|||
129795233|NCT04068896|467217964|FG005|Overall Study|Protocol Violation|0|||
129795234|NCT04068896|467217959|FG000|Overall Study|Withdrawal by Subject|0|||
129795235|NCT04068896|467217960|FG001|Overall Study|Withdrawal by Subject|3|||
129795236|NCT04068896|467217961|FG002|Overall Study|Withdrawal by Subject|0|||
129632898|NCT01622673|466608187|FG004|Treatment Period 1|Protocol Violation|0|||
129632899|NCT01622673|466608188|FG005|Treatment Period 1|Protocol Violation|0|||
129632900|NCT01622673|466608183|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129632901|NCT01622673|466608184|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129632902|NCT01622673|466608185|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129632903|NCT01622673|466608186|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129632904|NCT01622673|466608187|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129795237|NCT04068896|467217962|FG003|Overall Study|Withdrawal by Subject|2|||
129632905|NCT01622673|466608188|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129795238|NCT04068896|467217963|FG004|Overall Study|Withdrawal by Subject|1|||
129632906|NCT01622673|466608183|FG000|Treatment Period 3|Protocol Violation|0|||
129795239|NCT04068896|467217964|FG005|Overall Study|Withdrawal by Subject|0|||
129795240|NCT04068896|467217959|FG000|Overall Study|Symptomatic deterioration|2|||
129795241|NCT04068896|467217960|FG001|Overall Study|Symptomatic deterioration|0|||
129795242|NCT04068896|467217961|FG002|Overall Study|Symptomatic deterioration|0|||
129632907|NCT01622673|466608184|FG001|Treatment Period 3|Protocol Violation|1|||
129632908|NCT01622673|466608185|FG002|Treatment Period 3|Protocol Violation|0|||
129632909|NCT01622673|466608186|FG003|Treatment Period 3|Protocol Violation|0|||
129632910|NCT01622673|466608187|FG004|Treatment Period 3|Protocol Violation|0|||
129632911|NCT01622673|466608188|FG005|Treatment Period 3|Protocol Violation|0|||
129632912|NCT04146012|466608189|FG000|Overall Study|Study Terminated|30|||
129632913|NCT04146012|466608190|FG001|Overall Study|Study Terminated|15|||
129632914|NCT05731700|466609152|FG000|Overall Study|Death|1|||
129632915|NCT00437021|466609171|FG000|Overall Study|Adverse Event|0|||
129632916|NCT00437021|466609172|FG001|Overall Study|Adverse Event|0|||
129632917|NCT00437021|466609173|FG002|Overall Study|Adverse Event|0|||
129632918|NCT00437021|466609174|FG003|Overall Study|Adverse Event|0|||
129632919|NCT00437021|466609175|FG004|Overall Study|Adverse Event|0|||
129632920|NCT00437021|466609176|FG005|Overall Study|Adverse Event|0|||
129632921|NCT00437021|466609177|FG006|Overall Study|Adverse Event|1|||
129632922|NCT00437021|466609178|FG007|Overall Study|Adverse Event|0|||
129632923|NCT00437021|466609179|FG008|Overall Study|Adverse Event|0|||
129632924|NCT00437021|466609180|FG009|Overall Study|Adverse Event|0|||
129632925|NCT00437021|466609181|FG010|Overall Study|Adverse Event|0|||
129632926|NCT00437021|466609182|FG011|Overall Study|Adverse Event|0|||
129632927|NCT00437021|466609171|FG000|Overall Study|Lost to Follow-up|0|||
129632928|NCT00437021|466609172|FG001|Overall Study|Lost to Follow-up|3|||
129632929|NCT00437021|466609173|FG002|Overall Study|Lost to Follow-up|0|||
129632930|NCT00437021|466609174|FG003|Overall Study|Lost to Follow-up|0|||
129632931|NCT00437021|466609175|FG004|Overall Study|Lost to Follow-up|0|||
129632932|NCT00437021|466609176|FG005|Overall Study|Lost to Follow-up|2|||
129632933|NCT00437021|466609177|FG006|Overall Study|Lost to Follow-up|0|||
129632934|NCT00437021|466609178|FG007|Overall Study|Lost to Follow-up|1|||
129632935|NCT00437021|466609179|FG008|Overall Study|Lost to Follow-up|0|||
129632936|NCT00437021|466609180|FG009|Overall Study|Lost to Follow-up|0|||
129632937|NCT00437021|466609181|FG010|Overall Study|Lost to Follow-up|0|||
129632938|NCT00437021|466609182|FG011|Overall Study|Lost to Follow-up|0|||
129632939|NCT00437021|466609171|FG000|Overall Study|Withdrawal by Subject|2|||
129632940|NCT00437021|466609172|FG001|Overall Study|Withdrawal by Subject|1|||
129632941|NCT00437021|466609173|FG002|Overall Study|Withdrawal by Subject|0|||
129632942|NCT00437021|466609174|FG003|Overall Study|Withdrawal by Subject|0|||
129632943|NCT00437021|466609175|FG004|Overall Study|Withdrawal by Subject|0|||
129632944|NCT00437021|466609176|FG005|Overall Study|Withdrawal by Subject|0|||
129632945|NCT00437021|466609177|FG006|Overall Study|Withdrawal by Subject|0|||
129632946|NCT00437021|466609178|FG007|Overall Study|Withdrawal by Subject|0|||
129632947|NCT00437021|466609179|FG008|Overall Study|Withdrawal by Subject|0|||
129632948|NCT00437021|466609180|FG009|Overall Study|Withdrawal by Subject|0|||
129632949|NCT00437021|466609181|FG010|Overall Study|Withdrawal by Subject|0|||
129632950|NCT00437021|466609182|FG011|Overall Study|Withdrawal by Subject|0|||
129632951|NCT05468164|466609183|FG000|Treatment Period 4|Adverse Event|0|||
129632952|NCT05468164|466609184|FG001|Treatment Period 4|Adverse Event|0|||
129632953|NCT05468164|466609185|FG002|Treatment Period 4|Adverse Event|0|||
129632954|NCT05468164|466609186|FG003|Treatment Period 4|Adverse Event|1|||
129632955|NCT05573464|466609187|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
129632956|NCT05573464|466609188|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
129632957|NCT05573464|466609187|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
129632958|NCT05573464|466609188|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
129632959|NCT05573464|466609187|FG000|12-week Treatment Period|Protocol Violation|3|||
129632960|NCT05573464|466609188|FG001|12-week Treatment Period|Protocol Violation|1|||
129632961|NCT05573464|466609187|FG000|12-week Treatment Period|Physician Decision|1|||
129632962|NCT05573464|466609188|FG001|12-week Treatment Period|Physician Decision|2|||
129632963|NCT05573464|466609187|FG000|12-week Treatment Period|Lost to Follow-up|2|||
129632964|NCT05573464|466609188|FG001|12-week Treatment Period|Lost to Follow-up|0|||
129632965|NCT05573464|466609187|FG000|12-week Treatment Period|Adverse Event|20|||
129632966|NCT05573464|466609188|FG001|12-week Treatment Period|Adverse Event|9|||
129632967|NCT05573464|466609187|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
129795243|NCT04068896|467217962|FG003|Overall Study|Symptomatic deterioration|0|||
129632968|NCT05573464|466609188|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
129795244|NCT04068896|467217963|FG004|Overall Study|Symptomatic deterioration|0|||
129795245|NCT04068896|467217964|FG005|Overall Study|Symptomatic deterioration|0|||
129795246|NCT02398227|467217965|FG000|Overall Study|Lost to Follow-up|21|||
129632969|NCT05573464|466609187|FG000|12-week Treatment Period|Randomised, not treated|0|||
129632970|NCT05573464|466609188|FG001|12-week Treatment Period|Randomised, not treated|1|||
129632971|NCT05573464|466609187|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
129632972|NCT05573464|466609188|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
129795247|NCT02398227|467217966|FG001|Overall Study|Lost to Follow-up|12|||
129632973|NCT05573464|466609187|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
129632974|NCT05573464|466609188|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
129632975|NCT05573464|466609187|FG000|52-week Treatment Period|Protocol Violation|1|||
129795248|NCT02398227|467217965|FG000|Overall Study|Withdrawal by Subject|5|||
129632976|NCT05573464|466609188|FG001|52-week Treatment Period|Protocol Violation|1|||
129632977|NCT05573464|466609187|FG000|52-week Treatment Period|Physician Decision|2|||
129632978|NCT05573464|466609188|FG001|52-week Treatment Period|Physician Decision|2|||
129632979|NCT05573464|466609187|FG000|52-week Treatment Period|Lost to Follow-up|1|||
129632980|NCT05573464|466609188|FG001|52-week Treatment Period|Lost to Follow-up|1|||
129632981|NCT05573464|466609187|FG000|52-week Treatment Period|Adverse Event|11|||
129632982|NCT05573464|466609188|FG001|52-week Treatment Period|Adverse Event|8|||
129632983|NCT05573464|466609187|FG000|52-week Treatment Period|Death|1|||
129632984|NCT05573464|466609188|FG001|52-week Treatment Period|Death|1|||
129632985|NCT04846569|466609189|FG000|Overall Study|Withdrawal by Subject|3|||
129632986|NCT04846569|466609190|FG001|Overall Study|Withdrawal by Subject|1|||
129632987|NCT00536939|466609195|FG000|Overall Study|Withdrawal by Subject|1|||
129632988|NCT00536939|466609196|FG001|Overall Study|Withdrawal by Subject|0|||
129632989|NCT00536939|466609195|FG000|Overall Study|Other Complicating Disease|1|||
129632990|NCT00536939|466609196|FG001|Overall Study|Other Complicating Disease|0|||
129632991|NCT02954601|466609197|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
129632992|NCT02954601|466609198|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
129632993|NCT02954601|466609199|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
129632994|NCT02954601|466609200|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
129632995|NCT01735916|466609201|FG000|Overall Study|Subject not eligible to be randomized|11|||
129632996|NCT01735916|466609202|FG001|Overall Study|Subject not eligible to be randomized|0|||
129632997|NCT01735916|466609203|FG002|Overall Study|Subject not eligible to be randomized|0|||
129632998|NCT01735916|466609201|FG000|Overall Study|Early termination of study by sponsor|4|||
129632999|NCT01735916|466609202|FG001|Overall Study|Early termination of study by sponsor|19|||
129633000|NCT01735916|466609203|FG002|Overall Study|Early termination of study by sponsor|7|||
129633001|NCT01735916|466609201|FG000|Overall Study|Withdrawal by Subject|3|||
129633002|NCT01735916|466609202|FG001|Overall Study|Withdrawal by Subject|0|||
129633003|NCT01735916|466609203|FG002|Overall Study|Withdrawal by Subject|0|||
129633004|NCT00333983|466609207|FG000|Overall Study|Lost to Follow-up|2|||
129633005|NCT00333983|466609208|FG001|Overall Study|Lost to Follow-up|1|||
129633006|NCT00333983|466609209|FG002|Overall Study|Lost to Follow-up|0|||
129633007|NCT00333983|466609207|FG000|Overall Study|Adverse Event|1|||
129633008|NCT00333983|466609208|FG001|Overall Study|Adverse Event|1|||
129633009|NCT00333983|466609209|FG002|Overall Study|Adverse Event|1|||
129633010|NCT00333983|466609207|FG000|Overall Study|Withdrawal by Subject|0|||
129633011|NCT00333983|466609208|FG001|Overall Study|Withdrawal by Subject|3|||
129633012|NCT00333983|466609209|FG002|Overall Study|Withdrawal by Subject|1|||
129633013|NCT04227197|466609210|FG000|Randomization|Protocol Violation|1|||
129633014|NCT04227197|466609211|FG001|Randomization|Protocol Violation|0|||
129633015|NCT04227197|466609210|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
129633016|NCT04227197|466609211|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
129633017|NCT04227197|466609210|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
129633018|NCT04227197|466609211|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
129633019|NCT04227197|466609210|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
129633020|NCT04227197|466609211|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
129633021|NCT04227197|466609210|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
129633022|NCT04227197|466609211|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
129633023|NCT04227197|466609210|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
129633024|NCT04227197|466609211|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
129633025|NCT04227197|466609210|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
129633026|NCT04227197|466609211|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
129633027|NCT00570141|466609212|FG000|Overall Study|Adverse Event|1|||
129633028|NCT00570141|466609212|FG000|Overall Study|Missed visits|1|||
129633029|NCT00570141|466609212|FG000|Overall Study|Lost to Follow-up|1|||
129633030|NCT01209949|466609222|FG000|Overall Study|Lost to Follow-up|3|||
129633031|NCT00729612|466609227|FG000|Overall Study|Non evaluable for response|10|||
129633032|NCT02075203|466609228|FG000|Overall Study|Withdrawal by Subject|1|||
129633033|NCT02075203|466609229|FG001|Overall Study|Withdrawal by Subject|0|||
129633034|NCT02075203|466609230|FG002|Overall Study|Withdrawal by Subject|1|||
129633035|NCT02075203|466609228|FG000|Overall Study|Adverse Event|1|||
129633036|NCT02075203|466609229|FG001|Overall Study|Adverse Event|0|||
129633037|NCT02075203|466609230|FG002|Overall Study|Adverse Event|0|||
129633038|NCT02075203|466609228|FG000|Overall Study|participant refused to use contraception|1|||
129633039|NCT02075203|466609229|FG001|Overall Study|participant refused to use contraception|0|||
129633040|NCT02075203|466609230|FG002|Overall Study|participant refused to use contraception|0|||
129633041|NCT05266053|466609231|FG000|Overall Study|Withdrawal by Subject|8|||
129633042|NCT05266053|466609232|FG001|Overall Study|Withdrawal by Subject|4|||
129633043|NCT02996968|466609233|FG000|Overall Study|Withdrawal by Subject|1|||
129633044|NCT02996968|466609234|FG001|Overall Study|Withdrawal by Subject|0|||
129704178|NCT00619866|466879054|FG004|Weeks 13 - 24|Non-compliance|0|||
129704179|NCT00619866|466879050|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
129704180|NCT00619866|466879051|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
129633045|NCT00444535|466609237|FG000|Overall Study|Withdrawal by Subject|5|||
129633046|NCT00444535|466609237|FG000|Overall Study|Physician Decision|5|||
129633047|NCT00444535|466609237|FG000|Overall Study|progressive disease|1|||
129633048|NCT00444535|466609237|FG000|Overall Study|Adverse Event|2|||
129633049|NCT02556775|466609238|FG000|Overall Study|Withdrawal by Subject|1|||
129633050|NCT02556775|466609239|FG001|Overall Study|Withdrawal by Subject|0|||
129633051|NCT02556775|466609240|FG002|Overall Study|Withdrawal by Subject|1|||
129633052|NCT02556775|466609241|FG003|Overall Study|Withdrawal by Subject|0|||
129633053|NCT02556775|466609238|FG000|Overall Study|Lost to Follow-up|1|||
129633054|NCT02556775|466609239|FG001|Overall Study|Lost to Follow-up|0|||
129633055|NCT02556775|466609240|FG002|Overall Study|Lost to Follow-up|0|||
129633056|NCT02556775|466609241|FG003|Overall Study|Lost to Follow-up|0|||
129633057|NCT00558467|466609242|FG000|Overall Study|Adverse Event|1|||
129633058|NCT00558467|466609243|FG001|Overall Study|Adverse Event|2|||
129633059|NCT00558467|466609242|FG000|Overall Study|Lack of Efficacy|0|||
129633060|NCT00558467|466609243|FG001|Overall Study|Lack of Efficacy|1|||
129633061|NCT00558467|466609242|FG000|Overall Study|Patient moving out of state|0|||
129633062|NCT00558467|466609243|FG001|Overall Study|Patient moving out of state|1|||
129633063|NCT02025725|466609250|FG000|Overall Study|Adverse Event|5|||
129633064|NCT02025725|466609251|FG001|Overall Study|Adverse Event|0|||
129633065|NCT02025725|466609250|FG000|Overall Study|Lost to Follow-up|2|||
129633066|NCT02025725|466609251|FG001|Overall Study|Lost to Follow-up|0|||
129633067|NCT02025725|466609250|FG000|Overall Study|Protocol Violation|1|||
129633068|NCT02025725|466609251|FG001|Overall Study|Protocol Violation|1|||
129633069|NCT02025725|466609250|FG000|Overall Study|Withdrawal by Subject|3|||
129633070|NCT02025725|466609251|FG001|Overall Study|Withdrawal by Subject|2|||
129633071|NCT02025725|466609250|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
129633072|NCT02025725|466609251|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
129633073|NCT05047211|466609252|FG000|Overall Study|Lost to Follow-up|8|||
129633074|NCT05047211|466609253|FG001|Overall Study|Lost to Follow-up|5|||
129633075|NCT02867592|466609254|FG000|Overall Study|Adverse Event|3|||
129633076|NCT02867592|466609255|FG001|Overall Study|Adverse Event|0|||
129633077|NCT02867592|466609256|FG002|Overall Study|Adverse Event|2|||
129633078|NCT02867592|466609257|FG003|Overall Study|Adverse Event|1|||
129633079|NCT02867592|466609258|FG004|Overall Study|Adverse Event|1|||
129633080|NCT02867592|466609259|FG005|Overall Study|Adverse Event|5|||
129633081|NCT02867592|466609254|FG000|Overall Study|Death|0|||
129633082|NCT02867592|466609255|FG001|Overall Study|Death|0|||
129633083|NCT02867592|466609256|FG002|Overall Study|Death|0|||
129633084|NCT02867592|466609257|FG003|Overall Study|Death|1|||
129633085|NCT02867592|466609258|FG004|Overall Study|Death|0|||
129633086|NCT02867592|466609259|FG005|Overall Study|Death|1|||
129633087|NCT02867592|466609254|FG000|Overall Study|Lack of Efficacy|8|||
129633088|NCT02867592|466609255|FG001|Overall Study|Lack of Efficacy|10|||
129633089|NCT02867592|466609256|FG002|Overall Study|Lack of Efficacy|8|||
129633090|NCT02867592|466609257|FG003|Overall Study|Lack of Efficacy|8|||
129633091|NCT02867592|466609258|FG004|Overall Study|Lack of Efficacy|12|||
129633092|NCT02867592|466609259|FG005|Overall Study|Lack of Efficacy|17|||
129633093|NCT02867592|466609254|FG000|Overall Study|Physician Decision|1|||
129633094|NCT02867592|466609255|FG001|Overall Study|Physician Decision|2|||
129633095|NCT02867592|466609256|FG002|Overall Study|Physician Decision|2|||
129633096|NCT02867592|466609257|FG003|Overall Study|Physician Decision|0|||
129633097|NCT02867592|466609258|FG004|Overall Study|Physician Decision|5|||
129633098|NCT02867592|466609259|FG005|Overall Study|Physician Decision|1|||
129633099|NCT02867592|466609254|FG000|Overall Study|Protocol Violation|0|||
129633100|NCT02867592|466609255|FG001|Overall Study|Protocol Violation|0|||
129633101|NCT02867592|466609256|FG002|Overall Study|Protocol Violation|0|||
129704181|NCT00619866|466879052|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
129704182|NCT00619866|466879053|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
129704183|NCT00619866|466879054|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
129704184|NCT01968980|466879058|FG000|Overall Study|Death|0|||
129704185|NCT01968980|466879059|FG001|Overall Study|Death|1|||
129704186|NCT01968980|466879058|FG000|Overall Study|Adverse Event|1|||
129704187|NCT01968980|466879059|FG001|Overall Study|Adverse Event|3|||
129704188|NCT01968980|466879058|FG000|Overall Study|Does not meet entry criteria|1|||
129704189|NCT01968980|466879059|FG001|Overall Study|Does not meet entry criteria|3|||
129704190|NCT01968980|466879058|FG000|Overall Study|Withdrawal by Subject|13|||
129704191|NCT01968980|466879059|FG001|Overall Study|Withdrawal by Subject|5|||
129704192|NCT01968980|466879058|FG000|Overall Study|Other unspecified|1|||
129704193|NCT01968980|466879059|FG001|Overall Study|Other unspecified|2|||
129633102|NCT02867592|466609257|FG003|Overall Study|Protocol Violation|0|||
129633103|NCT02867592|466609258|FG004|Overall Study|Protocol Violation|1|||
129633104|NCT02867592|466609259|FG005|Overall Study|Protocol Violation|1|||
129633105|NCT02867592|466609254|FG000|Overall Study|Withdrawal by Subject|0|||
129633106|NCT02867592|466609255|FG001|Overall Study|Withdrawal by Subject|1|||
129633107|NCT02867592|466609256|FG002|Overall Study|Withdrawal by Subject|0|||
129633108|NCT02867592|466609257|FG003|Overall Study|Withdrawal by Subject|1|||
129633109|NCT02867592|466609258|FG004|Overall Study|Withdrawal by Subject|3|||
129633110|NCT02867592|466609259|FG005|Overall Study|Withdrawal by Subject|3|||
129633111|NCT02867592|466609254|FG000|Overall Study|Ineligible|1|||
129795249|NCT02398227|467217966|FG001|Overall Study|Withdrawal by Subject|6|||
129795250|NCT02398227|467217965|FG000|Overall Study|Removed from treatment and dropped out|1|||
129633112|NCT02867592|466609255|FG001|Overall Study|Ineligible|1|||
129633113|NCT02867592|466609256|FG002|Overall Study|Ineligible|0|||
129633114|NCT02867592|466609257|FG003|Overall Study|Ineligible|0|||
129633115|NCT02867592|466609258|FG004|Overall Study|Ineligible|2|||
129633116|NCT02867592|466609259|FG005|Overall Study|Ineligible|0|||
129633117|NCT02867592|466609254|FG000|Overall Study|No Treatment|1|||
129633118|NCT02867592|466609255|FG001|Overall Study|No Treatment|0|||
129633119|NCT02867592|466609256|FG002|Overall Study|No Treatment|0|||
129633120|NCT02867592|466609257|FG003|Overall Study|No Treatment|0|||
129633121|NCT02867592|466609258|FG004|Overall Study|No Treatment|0|||
129633122|NCT02867592|466609259|FG005|Overall Study|No Treatment|0|||
129633123|NCT02867592|466609254|FG000|Overall Study|Still on Therapy|0|||
129633124|NCT02867592|466609255|FG001|Overall Study|Still on Therapy|0|||
129633125|NCT02867592|466609256|FG002|Overall Study|Still on Therapy|0|||
129633126|NCT02867592|466609257|FG003|Overall Study|Still on Therapy|0|||
129633127|NCT02867592|466609258|FG004|Overall Study|Still on Therapy|1|||
129633128|NCT02867592|466609259|FG005|Overall Study|Still on Therapy|0|||
129633129|NCT02867592|466609254|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129633130|NCT02867592|466609255|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129633131|NCT02867592|466609256|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129633132|NCT02867592|466609257|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129633133|NCT02867592|466609258|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
129633134|NCT02867592|466609259|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
129633135|NCT02867592|466609254|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
129633136|NCT02867592|466609255|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
129633137|NCT02867592|466609256|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
129633138|NCT02867592|466609257|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
129633139|NCT02867592|466609258|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
129633140|NCT02867592|466609259|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
129633141|NCT00594165|466609260|FG000|Overall Study|Major protocol violation|1|||
129633142|NCT00594165|466609260|FG000|Overall Study|Lack of Efficacy|12|||
129633143|NCT00594165|466609260|FG000|Overall Study|Adverse Event|52|||
129633144|NCT00594165|466609260|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
129633145|NCT00594165|466609260|FG000|Overall Study|Subject withdrew consent|27|||
129633146|NCT00594165|466609260|FG000|Overall Study|Study ended per sponsor|102|||
129633147|NCT00594165|466609260|FG000|Overall Study|Lost to Follow-up|4|||
129633148|NCT00594165|466609260|FG000|Overall Study|Other: PI discretion|5|||
129633149|NCT00594165|466609260|FG000|Overall Study|Other: Subject moving|3|||
129633150|NCT00594165|466609260|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
129633151|NCT00594165|466609260|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
129633152|NCT00594165|466609260|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
129633153|NCT00594165|466609260|FG000|Overall Study|Other: Site terminated participation|2|||
129633154|NCT00571727|466609265|FG000|Overall Study|Did not enter in this study|1|||
129633155|NCT00571727|466609265|FG000|Overall Study|Non-compliance|4|||
129633156|NCT00571727|466609265|FG000|Overall Study|Lost to Follow-up|30|||
129633157|NCT00571727|466609265|FG000|Overall Study|Poor growth|1|||
129633158|NCT00571727|466609265|FG000|Overall Study|Parent/patient decision|2|||
129633159|NCT00571727|466609265|FG000|Overall Study|Participant transferred to commercial drug|14|||
129633160|NCT00571727|466609265|FG000|Overall Study|Unable to provide study drug|6|||
129633161|NCT00571727|466609265|FG000|Overall Study|On-treatment at end of study|8|||
129633162|NCT03581292|466609266|FG000|Overall Study|Physician Decision|9|||
129633163|NCT03581292|466609267|FG001|Overall Study|Physician Decision|5|||
129633164|NCT03581292|466609266|FG000|Overall Study|Withdrawal by Subject|3|||
129633165|NCT03581292|466609267|FG001|Overall Study|Withdrawal by Subject|0|||
129633166|NCT03581292|466609266|FG000|Overall Study|Withdrawal before Therapy Start|1|||
129633167|NCT03581292|466609267|FG001|Overall Study|Withdrawal before Therapy Start|0|||
129633168|NCT03214224|466610658|FG000|Overall Study|Protocol Violation|1|||
129633169|NCT03214224|466610658|FG000|Overall Study|Withdrawal by Subject|2|||
129633170|NCT03214224|466610658|FG000|Overall Study|Practice controls or therapists|6|||
129633171|NCT02712320|466610659|FG000|Overall Study|Lost to Follow-up|1|||
129633172|NCT02712320|466610659|FG000|Overall Study|Withdrawal by Subject|1|||
129633173|NCT02712320|466610659|FG000|Overall Study|Transferred to another facility|1|||
129633174|NCT02712320|466610659|FG000|Overall Study|Treating with the prohibited medications|2|||
129633175|NCT00568451|466610660|FG000|Overall Study|Disease Progression|0|||
129633176|NCT00568451|466610661|FG001|Overall Study|Disease Progression|0|||
129633177|NCT00568451|466610662|FG002|Overall Study|Disease Progression|2|||
129633178|NCT00568451|466610663|FG003|Overall Study|Disease Progression|7|||
129633179|NCT01343043|466610668|FG000|Overall Study|Disease progression before treatment|1|||
129633180|NCT01343043|466610669|FG001|Overall Study|Disease progression before treatment|0|||
129633181|NCT01343043|466610670|FG002|Overall Study|Disease progression before treatment|0|||
129633182|NCT01343043|466610671|FG003|Overall Study|Disease progression before treatment|0|||
129633183|NCT01343043|466610668|FG000|Overall Study|Withdrawal by Subject|1|||
129633184|NCT01343043|466610669|FG001|Overall Study|Withdrawal by Subject|0|||
129633185|NCT01343043|466610670|FG002|Overall Study|Withdrawal by Subject|0|||
129633186|NCT01343043|466610671|FG003|Overall Study|Withdrawal by Subject|0|||
129633187|NCT01343043|466610668|FG000|Overall Study|Death|1|||
129633188|NCT01343043|466610669|FG001|Overall Study|Death|1|||
129633189|NCT01343043|466610670|FG002|Overall Study|Death|0|||
129633190|NCT01343043|466610671|FG003|Overall Study|Death|1|||
129633191|NCT00925704|466610672|FG000|First Intervention|Withdrew consent|0|||
129633192|NCT00925704|466610673|FG001|First Intervention|Withdrew consent|0|||
129633193|NCT00925704|466610674|FG002|First Intervention|Withdrew consent|0|||
129633194|NCT00925704|466610675|FG003|First Intervention|Withdrew consent|1|||
129633195|NCT00925704|466610676|FG004|First Intervention|Withdrew consent|1|||
129633196|NCT00925704|466610677|FG005|First Intervention|Withdrew consent|0|||
129633197|NCT00925704|466610672|FG000|Second Intervention|Withdrawal by Subject|1|||
129633198|NCT00925704|466610673|FG001|Second Intervention|Withdrawal by Subject|0|||
129633199|NCT00925704|466610674|FG002|Second Intervention|Withdrawal by Subject|0|||
129633200|NCT00925704|466610675|FG003|Second Intervention|Withdrawal by Subject|0|||
129633201|NCT00925704|466610676|FG004|Second Intervention|Withdrawal by Subject|1|||
129633202|NCT00925704|466610677|FG005|Second Intervention|Withdrawal by Subject|0|||
129633203|NCT00925704|466610672|FG000|Third Intervention|Withdrew consent|0|||
129633204|NCT00925704|466610673|FG001|Third Intervention|Withdrew consent|0|||
129633205|NCT00925704|466610674|FG002|Third Intervention|Withdrew consent|0|||
129633206|NCT00925704|466610675|FG003|Third Intervention|Withdrew consent|0|||
129633207|NCT00925704|466610676|FG004|Third Intervention|Withdrew consent|0|||
129633208|NCT00925704|466610677|FG005|Third Intervention|Withdrew consent|1|||
129633209|NCT02044302|466610681|FG000|Overall Study|study terminated|2|||
129633210|NCT02044302|466610682|FG001|Overall Study|study terminated|0|||
129633211|NCT03207815|466610683|FG000|Overall Study|Protocol Violation|3|||
129633212|NCT03207815|466610684|FG001|Overall Study|Protocol Violation|1|||
129633213|NCT03207815|466610683|FG000|Overall Study|Adverse Event|1|||
129633214|NCT03207815|466610684|FG001|Overall Study|Adverse Event|2|||
129633215|NCT03207815|466610683|FG000|Overall Study|Lost to Follow-up|1|||
129633216|NCT03207815|466610684|FG001|Overall Study|Lost to Follow-up|2|||
129633217|NCT03207815|466610683|FG000|Overall Study|Investigator's Discretion|1|||
129633218|NCT03207815|466610684|FG001|Overall Study|Investigator's Discretion|1|||
129633219|NCT03207815|466610683|FG000|Overall Study|Lack of Efficacy|0|||
129633220|NCT03207815|466610684|FG001|Overall Study|Lack of Efficacy|1|||
129633221|NCT03207815|466610683|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
129633222|NCT03207815|466610684|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
129633223|NCT03207815|466610683|FG000|Overall Study|Withdrew Consent|1|||
129633224|NCT03207815|466610684|FG001|Overall Study|Withdrew Consent|0|||
129633225|NCT01671007|466610685|FG000|Overall Study|Other reasons than listed|166|||
129633226|NCT01671007|466610686|FG001|Overall Study|Other reasons than listed|373|||
129633227|NCT01671007|466610687|FG002|Overall Study|Other reasons than listed|197|||
129633228|NCT01671007|466610688|FG003|Overall Study|Other reasons than listed|228|||
129633229|NCT01671007|466610689|FG004|Overall Study|Other reasons than listed|14|||
129633230|NCT01671007|466610690|FG005|Overall Study|Other reasons than listed|71|||
129633231|NCT01671007|466610691|FG006|Overall Study|Other reasons than listed|17|||
129633232|NCT01671007|466610692|FG007|Overall Study|Other reasons than listed|66|||
129633233|NCT01671007|466610693|FG008|Overall Study|Other reasons than listed|0|||
129633234|NCT01671007|466610685|FG000|Overall Study|Withdrawal by Subject|36|||
129633235|NCT01671007|466610686|FG001|Overall Study|Withdrawal by Subject|59|||
129633236|NCT01671007|466610687|FG002|Overall Study|Withdrawal by Subject|53|||
129633237|NCT01671007|466610688|FG003|Overall Study|Withdrawal by Subject|58|||
129704194|NCT02589938|466879065|FG000|Overall Study|Withdrawal by Subject|11|||
129633238|NCT01671007|466610689|FG004|Overall Study|Withdrawal by Subject|4|||
129633239|NCT01671007|466610690|FG005|Overall Study|Withdrawal by Subject|15|||
129633240|NCT01671007|466610691|FG006|Overall Study|Withdrawal by Subject|1|||
129633241|NCT01671007|466610692|FG007|Overall Study|Withdrawal by Subject|19|||
129704195|NCT02589938|466879066|FG001|Overall Study|Withdrawal by Subject|5|||
129633242|NCT01671007|466610693|FG008|Overall Study|Withdrawal by Subject|0|||
129633243|NCT01671007|466610685|FG000|Overall Study|Lost to Follow-up|93|||
129633244|NCT01671007|466610686|FG001|Overall Study|Lost to Follow-up|142|||
129633245|NCT01671007|466610687|FG002|Overall Study|Lost to Follow-up|91|||
129633246|NCT01671007|466610688|FG003|Overall Study|Lost to Follow-up|63|||
129633247|NCT01671007|466610689|FG004|Overall Study|Lost to Follow-up|7|||
129633248|NCT01671007|466610690|FG005|Overall Study|Lost to Follow-up|20|||
129633249|NCT01671007|466610691|FG006|Overall Study|Lost to Follow-up|2|||
129704196|NCT02589938|466879067|FG002|Overall Study|Withdrawal by Subject|6|||
129633250|NCT01671007|466610692|FG007|Overall Study|Lost to Follow-up|28|||
129633251|NCT01671007|466610693|FG008|Overall Study|Lost to Follow-up|0|||
129633252|NCT01671007|466610685|FG000|Overall Study|No end of study case report form|3|||
129633253|NCT01671007|466610686|FG001|Overall Study|No end of study case report form|1|||
129633254|NCT01671007|466610687|FG002|Overall Study|No end of study case report form|0|||
129633255|NCT01671007|466610688|FG003|Overall Study|No end of study case report form|2|||
129633256|NCT01671007|466610689|FG004|Overall Study|No end of study case report form|0|||
129633257|NCT01671007|466610690|FG005|Overall Study|No end of study case report form|0|||
129633258|NCT01671007|466610691|FG006|Overall Study|No end of study case report form|0|||
129633259|NCT01671007|466610692|FG007|Overall Study|No end of study case report form|0|||
129633260|NCT01671007|466610693|FG008|Overall Study|No end of study case report form|0|||
129633261|NCT01671007|466610685|FG000|Overall Study|Not eligible|23|||
129633262|NCT01671007|466610686|FG001|Overall Study|Not eligible|76|||
129633263|NCT01671007|466610687|FG002|Overall Study|Not eligible|25|||
129633264|NCT01671007|466610688|FG003|Overall Study|Not eligible|17|||
129633265|NCT01671007|466610689|FG004|Overall Study|Not eligible|0|||
129633266|NCT01671007|466610690|FG005|Overall Study|Not eligible|6|||
129633267|NCT01671007|466610691|FG006|Overall Study|Not eligible|1|||
129633268|NCT01671007|466610692|FG007|Overall Study|Not eligible|19|||
129633269|NCT01671007|466610693|FG008|Overall Study|Not eligible|0|||
129633270|NCT00391768|466610694|FG000|Overall Study|Withdrawal by Subject|0|||
129633271|NCT00391768|466610695|FG001|Overall Study|Withdrawal by Subject|0|||
129633272|NCT00391768|466610696|FG002|Overall Study|Withdrawal by Subject|1|||
129633273|NCT00391768|466610697|FG003|Overall Study|Withdrawal by Subject|0|||
129633274|NCT00391768|466610698|FG004|Overall Study|Withdrawal by Subject|0|||
129633275|NCT00391768|466610699|FG005|Overall Study|Withdrawal by Subject|1|||
129633276|NCT00391768|466610700|FG006|Overall Study|Withdrawal by Subject|1|||
129633277|NCT00391768|466610694|FG000|Overall Study|Lost to Follow-up|0|||
129633278|NCT00391768|466610695|FG001|Overall Study|Lost to Follow-up|0|||
129633279|NCT00391768|466610696|FG002|Overall Study|Lost to Follow-up|0|||
129633280|NCT00391768|466610697|FG003|Overall Study|Lost to Follow-up|1|||
129633281|NCT00391768|466610698|FG004|Overall Study|Lost to Follow-up|2|||
129633282|NCT00391768|466610699|FG005|Overall Study|Lost to Follow-up|2|||
129633283|NCT00391768|466610700|FG006|Overall Study|Lost to Follow-up|3|||
129633284|NCT00406367|466610701|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
129633285|NCT00406367|466610702|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
129633286|NCT00406367|466610701|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
129633287|NCT00406367|466610702|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
129633288|NCT00406367|466610701|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
129633289|NCT00406367|466610702|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
129633290|NCT00406367|466610701|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
129633291|NCT00406367|466610702|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
129633292|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
129633293|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
129633294|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
129633295|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
129633296|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
129633297|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
129633298|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
129633299|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
129633300|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
129633301|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
129633302|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
129633303|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
129633304|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
129633305|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
129633306|NCT00406367|466610701|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
129633307|NCT00406367|466610702|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
129633308|NCT00171210|466610703|FG000|Overall Study|Adverse Event|16|||
129633309|NCT00171210|466610704|FG001|Overall Study|Adverse Event|27|||
129633310|NCT00171210|466610703|FG000|Overall Study|Abnormal laboratory value(s)|6|||
129633311|NCT00171210|466610704|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129633312|NCT00171210|466610703|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129633313|NCT00171210|466610704|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129633314|NCT00171210|466610703|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
129633315|NCT00171210|466610704|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
129633316|NCT00171210|466610703|FG000|Overall Study|Protocol Violation|0|||
129633317|NCT00171210|466610704|FG001|Overall Study|Protocol Violation|2|||
129633318|NCT00171210|466610703|FG000|Overall Study|Withdrawal by Subject|32|||
129889097|NCT01349660|467551009|FG002|Overall Study|Non-Permitted Interventions|2|||
129889098|NCT01349660|467551007|FG000|Overall Study|Study Compliance|0|||
129633319|NCT00171210|466610704|FG001|Overall Study|Withdrawal by Subject|30|||
129633320|NCT00171210|466610703|FG000|Overall Study|Lost to Follow-up|1|||
129633321|NCT00171210|466610704|FG001|Overall Study|Lost to Follow-up|0|||
129633322|NCT00171210|466610703|FG000|Overall Study|Administrative problems|1|||
129633323|NCT00171210|466610704|FG001|Overall Study|Administrative problems|1|||
129633324|NCT00171210|466610703|FG000|Overall Study|Death|2|||
129633325|NCT00171210|466610704|FG001|Overall Study|Death|3|||
129633326|NCT00171210|466610703|FG000|Overall Study|Stopped at end of core|0|||
129633327|NCT00171210|466610704|FG001|Overall Study|Stopped at end of core|32|||
129633328|NCT00171210|466610703|FG000|Overall Study|Stopped at end of extension 1|0|||
129633329|NCT00171210|466610704|FG001|Overall Study|Stopped at end of extension 1|1|||
129633330|NCT03187301|466610707|FG000|Titration Period|Adverse Event|0|||
129633331|NCT03187301|466610708|FG001|Titration Period|Adverse Event|0|||
129633332|NCT03187301|466610709|FG002|Titration Period|Adverse Event|0|||
129633333|NCT03187301|466610710|FG003|Titration Period|Adverse Event|0|||
129633334|NCT03187301|466610711|FG004|Titration Period|Adverse Event|0|||
129633335|NCT03187301|466610712|FG005|Titration Period|Adverse Event|0|||
129633336|NCT03187301|466610713|FG006|Titration Period|Adverse Event|5|||
129633337|NCT03187301|466610707|FG000|Titration Period|Withdrawal by Subject|0|||
129633338|NCT03187301|466610708|FG001|Titration Period|Withdrawal by Subject|0|||
129633339|NCT03187301|466610709|FG002|Titration Period|Withdrawal by Subject|0|||
129633340|NCT03187301|466610710|FG003|Titration Period|Withdrawal by Subject|0|||
129633341|NCT03187301|466610711|FG004|Titration Period|Withdrawal by Subject|0|||
129633342|NCT03187301|466610712|FG005|Titration Period|Withdrawal by Subject|0|||
129633343|NCT03187301|466610713|FG006|Titration Period|Withdrawal by Subject|1|||
129633344|NCT03187301|466610707|FG000|Titration Period|Exclusion Criteria Met|0|||
129633345|NCT03187301|466610708|FG001|Titration Period|Exclusion Criteria Met|0|||
129633346|NCT03187301|466610709|FG002|Titration Period|Exclusion Criteria Met|0|||
129633347|NCT03187301|466610710|FG003|Titration Period|Exclusion Criteria Met|0|||
129633348|NCT03187301|466610711|FG004|Titration Period|Exclusion Criteria Met|0|||
129633349|NCT03187301|466610712|FG005|Titration Period|Exclusion Criteria Met|0|||
129633350|NCT03187301|466610713|FG006|Titration Period|Exclusion Criteria Met|1|||
129633351|NCT03187301|466610707|FG000|Pre-Intervention|Withdrawal by Subject|1|||
129633352|NCT03187301|466610708|FG001|Pre-Intervention|Withdrawal by Subject|0|||
129633353|NCT03187301|466610709|FG002|Pre-Intervention|Withdrawal by Subject|0|||
129633354|NCT03187301|466610710|FG003|Pre-Intervention|Withdrawal by Subject|0|||
129633355|NCT03187301|466610711|FG004|Pre-Intervention|Withdrawal by Subject|0|||
129633356|NCT03187301|466610712|FG005|Pre-Intervention|Withdrawal by Subject|0|||
129633357|NCT03187301|466610713|FG006|Pre-Intervention|Withdrawal by Subject|0|||
129633358|NCT05005507|466610717|FG000|Overall Study|Premature termination of study|1|||
129633359|NCT02182843|466610725|FG000|Overall Study|Withdrawal by Subject|7|||
129633360|NCT02182843|466610725|FG000|Overall Study|Lost to Follow-up|2|||
129633361|NCT02182843|466610725|FG000|Overall Study|Adverse Event|1|||
129633362|NCT02375971|466610726|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
129633363|NCT02375971|466610727|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
129633364|NCT02375971|466610728|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
129633365|NCT02375971|466610726|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
129633366|NCT02375971|466610727|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
129633367|NCT02375971|466610728|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
129633368|NCT02375971|466610726|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
129633369|NCT02375971|466610727|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
129704197|NCT02589938|466879065|FG000|Overall Study|Lost to Follow-up|3|||
129704198|NCT02589938|466879066|FG001|Overall Study|Lost to Follow-up|3|||
129704199|NCT02589938|466879067|FG002|Overall Study|Lost to Follow-up|3|||
129704200|NCT02589938|466879065|FG000|Overall Study|Death|1|||
129704201|NCT02589938|466879066|FG001|Overall Study|Death|0|||
129704202|NCT02589938|466879067|FG002|Overall Study|Death|1|||
129704203|NCT02589938|466879065|FG000|Overall Study|Protocol Violation|6|||
129704204|NCT02589938|466879066|FG001|Overall Study|Protocol Violation|2|||
129704205|NCT02589938|466879067|FG002|Overall Study|Protocol Violation|3|||
129704206|NCT02589938|466879065|FG000|Overall Study|Physician Decision|1|||
129704207|NCT02589938|466879066|FG001|Overall Study|Physician Decision|0|||
129633370|NCT02375971|466610728|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
129633371|NCT02375971|466610726|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
129633372|NCT02375971|466610727|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
129633373|NCT02375971|466610728|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
129633374|NCT02375971|466610726|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
129633375|NCT02375971|466610727|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
129633376|NCT02375971|466610728|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
129633377|NCT02375971|466610726|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
129633378|NCT02375971|466610727|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
129704208|NCT02589938|466879067|FG002|Overall Study|Physician Decision|0|||
129889099|NCT01349660|467551008|FG001|Overall Study|Study Compliance|0|||
129633379|NCT02375971|466610728|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
129633380|NCT02375971|466610726|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
129633381|NCT02375971|466610727|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
129633382|NCT02375971|466610728|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
129633383|NCT02375971|466610726|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
129633384|NCT02375971|466610727|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
129633385|NCT02375971|466610728|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
129633386|NCT00832455|466610730|FG000|Overall Study|Adverse Event|13|||
129633387|NCT00832455|466610730|FG000|Overall Study|Lost to Follow-up|26|||
129633388|NCT00832455|466610730|FG000|Overall Study|Protocol Violation|4|||
129633389|NCT00832455|466610730|FG000|Overall Study|Withdrawal by Subject|17|||
129633390|NCT00832455|466610730|FG000|Overall Study|Screening Failure|2|||
129633391|NCT00832455|466610730|FG000|Overall Study|Stopped Medication|4|||
129633392|NCT00832455|466610730|FG000|Overall Study|Parent misunderstood study|1|||
129633393|NCT00832455|466610730|FG000|Overall Study|Parent dissatisfied|1|||
129633394|NCT00832455|466610730|FG000|Overall Study|No improvement|3|||
129633395|NCT00832455|466610730|FG000|Overall Study|Patient moved|1|||
129633396|NCT00561392|466610734|FG000|Overall Study|Adverse Event|38|||
129633397|NCT00561392|466610734|FG000|Overall Study|Lack of Efficacy|2|||
129633398|NCT00561392|466610734|FG000|Overall Study|Protocol Violation|1|||
129633399|NCT00561392|466610734|FG000|Overall Study|Withdrawal by Subject|8|||
129633400|NCT00561392|466610734|FG000|Overall Study|Administrative problems|4|||
129633401|NCT01741688|466610735|FG000|Overall Study|Lack of insurance coverage|2|||
129633402|NCT01741688|466610735|FG000|Overall Study|Withdrawal by Subject|1|||
129633403|NCT01262872|466610740|FG000|Step 2|Death|0|||
129633404|NCT01262872|466610741|FG001|Step 2|Death|0|||
129633405|NCT01262872|466610742|FG002|Step 2|Death|0|||
129633406|NCT01262872|466610743|FG003|Step 2|Death|1|||
129633407|NCT01262872|466610744|FG004|Step 2|Death|0|||
129633408|NCT01262872|466610745|FG005|Step 2|Death|2|||
129633409|NCT01262872|466610746|FG006|Step 2|Death|2|||
129633410|NCT01262872|466610747|FG007|Step 2|Death|1|||
129633411|NCT01262872|466610740|FG000|Step 2|Protocol Violation|0|||
129633412|NCT01262872|466610741|FG001|Step 2|Protocol Violation|0|||
129633413|NCT01262872|466610742|FG002|Step 2|Protocol Violation|1|||
129633414|NCT01262872|466610743|FG003|Step 2|Protocol Violation|0|||
129633415|NCT01262872|466610744|FG004|Step 2|Protocol Violation|0|||
129633416|NCT01262872|466610745|FG005|Step 2|Protocol Violation|0|||
129633417|NCT01262872|466610746|FG006|Step 2|Protocol Violation|3|||
129633418|NCT01262872|466610747|FG007|Step 2|Protocol Violation|1|||
129633419|NCT01262872|466610740|FG000|Step 2|Withdrawal by Subject|0|||
129633420|NCT01262872|466610741|FG001|Step 2|Withdrawal by Subject|0|||
129633421|NCT01262872|466610742|FG002|Step 2|Withdrawal by Subject|4|||
129633422|NCT01262872|466610743|FG003|Step 2|Withdrawal by Subject|6|||
129633423|NCT01262872|466610744|FG004|Step 2|Withdrawal by Subject|3|||
129704209|NCT02589938|466879065|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
129704210|NCT02589938|466879066|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
129704211|NCT02589938|466879067|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
129704212|NCT02521285|466879068|FG000|Overall Study|Lost to Follow-up|1|||
129704213|NCT02521285|466879069|FG001|Overall Study|Lost to Follow-up|1|||
129704214|NCT02521285|466879068|FG000|Overall Study|Withdrawal by Subject|1|||
129704215|NCT02521285|466879069|FG001|Overall Study|Withdrawal by Subject|1|||
129704216|NCT02521285|466879068|FG000|Overall Study|Adverse Event|0|||
129704217|NCT02521285|466879069|FG001|Overall Study|Adverse Event|1|||
129704218|NCT01121757|466879070|FG000|First Drug|Death|1|||
129704219|NCT01121757|466879071|FG001|First Drug|Death|0|||
129704220|NCT01121757|466879070|FG000|First Drug|Disease Progression|0|||
129704221|NCT01121757|466879071|FG001|First Drug|Disease Progression|2|||
129704222|NCT01121757|466879070|FG000|Combination|Physician Decision|0|||
129704223|NCT01121757|466879071|FG001|Combination|Physician Decision|1|||
129704224|NCT01121757|466879070|FG000|Combination|Disease Progression|2|||
129704225|NCT01121757|466879071|FG001|Combination|Disease Progression|0|||
129704226|NCT03636022|466879072|FG000|Overall Study|Withdrawal by Subject|1|||
129704227|NCT03636022|466879073|FG001|Overall Study|Withdrawal by Subject|3|||
129704228|NCT03189719|466879074|FG000|Overall Study|Death|325|||
129704229|NCT03189719|466879075|FG001|Overall Study|Death|361|||
129704230|NCT03189719|466879074|FG000|Overall Study|Physician Decision|1|||
129704231|NCT03189719|466879075|FG001|Overall Study|Physician Decision|0|||
129633424|NCT01262872|466610745|FG005|Step 2|Withdrawal by Subject|1|||
129633425|NCT01262872|466610746|FG006|Step 2|Withdrawal by Subject|2|||
129633426|NCT01262872|466610747|FG007|Step 2|Withdrawal by Subject|1|||
129633427|NCT01262872|466610740|FG000|Step 2|Migrated/moved from study area|0|||
129633428|NCT01262872|466610741|FG001|Step 2|Migrated/moved from study area|0|||
129633429|NCT01262872|466610742|FG002|Step 2|Migrated/moved from study area|4|||
129633430|NCT01262872|466610743|FG003|Step 2|Migrated/moved from study area|3|||
129633431|NCT01262872|466610744|FG004|Step 2|Migrated/moved from study area|2|||
129633432|NCT01262872|466610745|FG005|Step 2|Migrated/moved from study area|6|||
129633433|NCT01262872|466610746|FG006|Step 2|Migrated/moved from study area|2|||
129633434|NCT01262872|466610747|FG007|Step 2|Migrated/moved from study area|3|||
129633435|NCT00365794|466610750|FG000|Overall Study|Withdrawal by Subject|2|||
129633436|NCT00745901|466610751|FG000|Overall Study|Adverse Event|3|||
129633437|NCT00745901|466610752|FG001|Overall Study|Adverse Event|4|||
129633438|NCT00745901|466610751|FG000|Overall Study|Protocol Violation|0|||
129633439|NCT00745901|466610752|FG001|Overall Study|Protocol Violation|1|||
129633440|NCT00745901|466610751|FG000|Overall Study|Withdrawal by Subject|1|||
129633441|NCT00745901|466610752|FG001|Overall Study|Withdrawal by Subject|0|||
129633442|NCT00745901|466610751|FG000|Overall Study|Lost to Follow-up|7|||
129633443|NCT00745901|466610752|FG001|Overall Study|Lost to Follow-up|4|||
129633444|NCT00745901|466610751|FG000|Overall Study|Pregnancy|2|||
129633445|NCT00745901|466610752|FG001|Overall Study|Pregnancy|4|||
129633446|NCT00745901|466610751|FG000|Overall Study|Lack of compliance|2|||
129633447|NCT00745901|466610752|FG001|Overall Study|Lack of compliance|2|||
129633448|NCT00745901|466610751|FG000|Overall Study|Patient's next menses did not start with|1|||
129633449|NCT00745901|466610752|FG001|Overall Study|Patient's next menses did not start with|0|||
129633450|NCT00745901|466610751|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
129633451|NCT00745901|466610752|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
129633452|NCT00745901|466610751|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
129633453|NCT00745901|466610752|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
129633454|NCT00745901|466610751|FG000|Overall Study|Patient didn't take any study medication|7|||
129633455|NCT00745901|466610752|FG001|Overall Study|Patient didn't take any study medication|3|||
129633456|NCT01804946|466610754|FG000|Overall Study|Protocol Violation|1|||
129633457|NCT01804946|466610755|FG001|Overall Study|Protocol Violation|0|||
129633458|NCT01804946|466610754|FG000|Overall Study|Adverse Event|0|||
129633459|NCT01804946|466610755|FG001|Overall Study|Adverse Event|1|||
129633460|NCT01804946|466610754|FG000|Overall Study|Insufficient data available|0|||
129633461|NCT01804946|466610755|FG001|Overall Study|Insufficient data available|1|||
129633462|NCT01804946|466610754|FG000|Overall Study|Do not meet inclusion criteria|1|||
129633463|NCT01804946|466610755|FG001|Overall Study|Do not meet inclusion criteria|2|||
129633464|NCT00722137|466610757|FG000|Overall Study|Overt Disease Progression|5|||
129633465|NCT00722137|466610758|FG001|Overall Study|Overt Disease Progression|4|||
129633466|NCT00722137|466610757|FG000|Overall Study|Adverse Event|17|||
129633467|NCT00722137|466610758|FG001|Overall Study|Adverse Event|21|||
129633468|NCT00722137|466610757|FG000|Overall Study|Death|12|||
129633469|NCT00722137|466610758|FG001|Overall Study|Death|7|||
129633470|NCT00722137|466610757|FG000|Overall Study|Withdrawal by Subject|6|||
129633471|NCT00722137|466610758|FG001|Overall Study|Withdrawal by Subject|9|||
129633472|NCT00722137|466610757|FG000|Overall Study|Other Reason Unknown|3|||
129633473|NCT00722137|466610758|FG001|Overall Study|Other Reason Unknown|4|||
129633474|NCT00722137|466610757|FG000|Overall Study|Randomized But Not Treated|2|||
129633475|NCT00722137|466610758|FG001|Overall Study|Randomized But Not Treated|3|||
129633476|NCT00848718|466610759|FG000|Overall Study|Adverse Event|2|||
129633477|NCT00848718|466610760|FG001|Overall Study|Adverse Event|2|||
129633478|NCT00848718|466610761|FG002|Overall Study|Adverse Event|1|||
129633479|NCT00848718|466610762|FG003|Overall Study|Adverse Event|1|||
129633480|NCT00848718|466610763|FG004|Overall Study|Adverse Event|1|||
129633481|NCT00848718|466610764|FG005|Overall Study|Adverse Event|0|||
129633482|NCT00848718|466610765|FG006|Overall Study|Adverse Event|0|||
129633483|NCT00848718|466610766|FG007|Overall Study|Adverse Event|1|||
129633484|NCT00848718|466610767|FG008|Overall Study|Adverse Event|1|||
129633485|NCT00848718|466610768|FG009|Overall Study|Adverse Event|0|||
129633486|NCT00848718|466610769|FG010|Overall Study|Adverse Event|0|||
129633487|NCT00848718|466610770|FG011|Overall Study|Adverse Event|0|||
129633488|NCT00848718|466610771|FG012|Overall Study|Adverse Event|2|||
129633489|NCT00848718|466610759|FG000|Overall Study|Lack of Efficacy|0|||
129633490|NCT00848718|466610760|FG001|Overall Study|Lack of Efficacy|0|||
129633491|NCT00848718|466610761|FG002|Overall Study|Lack of Efficacy|1|||
129633492|NCT00848718|466610762|FG003|Overall Study|Lack of Efficacy|0|||
129633493|NCT00848718|466610763|FG004|Overall Study|Lack of Efficacy|0|||
129633494|NCT00848718|466610764|FG005|Overall Study|Lack of Efficacy|0|||
129633495|NCT00848718|466610765|FG006|Overall Study|Lack of Efficacy|1|||
129633496|NCT00848718|466610766|FG007|Overall Study|Lack of Efficacy|0|||
129633497|NCT00848718|466610767|FG008|Overall Study|Lack of Efficacy|0|||
129633498|NCT00848718|466610768|FG009|Overall Study|Lack of Efficacy|0|||
129704232|NCT03189719|466879074|FG000|Overall Study|Sponsor Decision|40|||
129633499|NCT00848718|466610769|FG010|Overall Study|Lack of Efficacy|0|||
129633500|NCT00848718|466610770|FG011|Overall Study|Lack of Efficacy|0|||
129633501|NCT00848718|466610771|FG012|Overall Study|Lack of Efficacy|0|||
129633502|NCT00848718|466610759|FG000|Overall Study|Physician Decision|0|||
129633503|NCT00848718|466610760|FG001|Overall Study|Physician Decision|1|||
129633504|NCT00848718|466610761|FG002|Overall Study|Physician Decision|0|||
129633505|NCT00848718|466610762|FG003|Overall Study|Physician Decision|0|||
129633506|NCT00848718|466610763|FG004|Overall Study|Physician Decision|1|||
129633507|NCT00848718|466610764|FG005|Overall Study|Physician Decision|1|||
129633508|NCT00848718|466610765|FG006|Overall Study|Physician Decision|0|||
129633509|NCT00848718|466610766|FG007|Overall Study|Physician Decision|0|||
129633510|NCT00848718|466610767|FG008|Overall Study|Physician Decision|1|||
129633511|NCT00848718|466610768|FG009|Overall Study|Physician Decision|2|||
129633512|NCT00848718|466610769|FG010|Overall Study|Physician Decision|0|||
129633513|NCT00848718|466610770|FG011|Overall Study|Physician Decision|0|||
129633514|NCT00848718|466610771|FG012|Overall Study|Physician Decision|1|||
129633515|NCT00848718|466610759|FG000|Overall Study|Progressive disease before treatment|1|||
129633516|NCT00848718|466610760|FG001|Overall Study|Progressive disease before treatment|5|||
129633517|NCT00848718|466610761|FG002|Overall Study|Progressive disease before treatment|1|||
129633518|NCT00848718|466610762|FG003|Overall Study|Progressive disease before treatment|3|||
129633519|NCT00848718|466610763|FG004|Overall Study|Progressive disease before treatment|4|||
129633520|NCT00848718|466610764|FG005|Overall Study|Progressive disease before treatment|4|||
129633521|NCT00848718|466610765|FG006|Overall Study|Progressive disease before treatment|2|||
129633522|NCT00848718|466610766|FG007|Overall Study|Progressive disease before treatment|1|||
129633523|NCT00848718|466610767|FG008|Overall Study|Progressive disease before treatment|2|||
129633524|NCT00848718|466610768|FG009|Overall Study|Progressive disease before treatment|7|||
129633525|NCT00848718|466610769|FG010|Overall Study|Progressive disease before treatment|3|||
129633526|NCT00848718|466610770|FG011|Overall Study|Progressive disease before treatment|6|||
129633527|NCT00848718|466610771|FG012|Overall Study|Progressive disease before treatment|2|||
129633528|NCT00848718|466610759|FG000|Overall Study|Protocol Violation|0|||
129633529|NCT00848718|466610760|FG001|Overall Study|Protocol Violation|1|||
129633530|NCT00848718|466610761|FG002|Overall Study|Protocol Violation|0|||
129633531|NCT00848718|466610762|FG003|Overall Study|Protocol Violation|0|||
129633532|NCT00848718|466610763|FG004|Overall Study|Protocol Violation|0|||
129633533|NCT00848718|466610764|FG005|Overall Study|Protocol Violation|0|||
129633534|NCT00848718|466610765|FG006|Overall Study|Protocol Violation|0|||
129633535|NCT00848718|466610766|FG007|Overall Study|Protocol Violation|1|||
129633536|NCT00848718|466610767|FG008|Overall Study|Protocol Violation|0|||
129633537|NCT00848718|466610768|FG009|Overall Study|Protocol Violation|0|||
129633538|NCT00848718|466610769|FG010|Overall Study|Protocol Violation|0|||
129633539|NCT00848718|466610770|FG011|Overall Study|Protocol Violation|0|||
129633540|NCT00848718|466610771|FG012|Overall Study|Protocol Violation|1|||
129633541|NCT00848718|466610759|FG000|Overall Study|Withdrawal by Subject|1|||
129633542|NCT00848718|466610760|FG001|Overall Study|Withdrawal by Subject|0|||
129633543|NCT00848718|466610761|FG002|Overall Study|Withdrawal by Subject|0|||
129633544|NCT00848718|466610762|FG003|Overall Study|Withdrawal by Subject|1|||
129633545|NCT00848718|466610763|FG004|Overall Study|Withdrawal by Subject|0|||
129633546|NCT00848718|466610764|FG005|Overall Study|Withdrawal by Subject|0|||
129633547|NCT00848718|466610765|FG006|Overall Study|Withdrawal by Subject|0|||
129633548|NCT00848718|466610766|FG007|Overall Study|Withdrawal by Subject|0|||
129633549|NCT00848718|466610767|FG008|Overall Study|Withdrawal by Subject|0|||
129633550|NCT00848718|466610768|FG009|Overall Study|Withdrawal by Subject|0|||
129633551|NCT00848718|466610769|FG010|Overall Study|Withdrawal by Subject|1|||
129633552|NCT00848718|466610770|FG011|Overall Study|Withdrawal by Subject|0|||
129633553|NCT00848718|466610771|FG012|Overall Study|Withdrawal by Subject|0|||
129633554|NCT00848718|466610759|FG000|Overall Study|Progressive disease during treatment|3|||
129633555|NCT00848718|466610760|FG001|Overall Study|Progressive disease during treatment|0|||
129633556|NCT00848718|466610761|FG002|Overall Study|Progressive disease during treatment|3|||
129633557|NCT00848718|466610762|FG003|Overall Study|Progressive disease during treatment|0|||
129633558|NCT00848718|466610763|FG004|Overall Study|Progressive disease during treatment|0|||
129633559|NCT00848718|466610764|FG005|Overall Study|Progressive disease during treatment|0|||
129633560|NCT00848718|466610765|FG006|Overall Study|Progressive disease during treatment|0|||
129633561|NCT00848718|466610766|FG007|Overall Study|Progressive disease during treatment|2|||
129633562|NCT00848718|466610767|FG008|Overall Study|Progressive disease during treatment|0|||
129633563|NCT00848718|466610768|FG009|Overall Study|Progressive disease during treatment|0|||
129633564|NCT00848718|466610769|FG010|Overall Study|Progressive disease during treatment|0|||
129633565|NCT00848718|466610770|FG011|Overall Study|Progressive disease during treatment|0|||
129633566|NCT00848718|466610771|FG012|Overall Study|Progressive disease during treatment|2|||
129633567|NCT02431676|466610773|FG000|Overall Study|no lab obtained|0|||
129633568|NCT02431676|466610774|FG001|Overall Study|no lab obtained|1|||
129633569|NCT02431676|466610775|FG002|Overall Study|no lab obtained|2|||
129633570|NCT02525783|466612926|FG000|Overall Study|Lost to Follow-up|10|||
129633571|NCT00824772|466612927|FG000|Overall Study|Withdrawal by Subject|8|||
129633572|NCT01894841|466612930|FG000|Overall Study|Withdrawal by Subject|9|||
129633573|NCT01894841|466612931|FG001|Overall Study|Withdrawal by Subject|4|||
129633574|NCT01894841|466612930|FG000|Overall Study|Withdrawn by investigator|2|||
129633575|NCT01894841|466612931|FG001|Overall Study|Withdrawn by investigator|2|||
129633576|NCT01894841|466612930|FG000|Overall Study|Lost to Follow-up|7|||
129633577|NCT01894841|466612931|FG001|Overall Study|Lost to Follow-up|3|||
129633578|NCT00833105|466612945|FG000|Overall Study|Withdrawal by Subject|1|||
129633579|NCT00833105|466612945|FG000|Overall Study|Adverse Event|2|||
129633580|NCT03656068|466612950|FG000|Overall Study|Withdrawal by Subject|4|||
129633581|NCT03656068|466612950|FG000|Overall Study|Adverse Event|1|||
129633582|NCT05326529|466612951|FG000|Overall Study|Lack of Efficacy|0|||
129633583|NCT05326529|466612952|FG001|Overall Study|Lack of Efficacy|1|||
129633584|NCT05326529|466612953|FG002|Overall Study|Lack of Efficacy|0|||
129633585|NCT05326529|466612951|FG000|Overall Study|Physician Decision|0|||
129633586|NCT05326529|466612952|FG001|Overall Study|Physician Decision|0|||
129633587|NCT05326529|466612953|FG002|Overall Study|Physician Decision|2|||
129633588|NCT01379768|466612954|FG000|Overall Study|Adverse Event|1|||
129633589|NCT01379768|466612955|FG001|Overall Study|Adverse Event|1|||
129633590|NCT01379768|466612956|FG002|Overall Study|Adverse Event|0|||
129633591|NCT01379768|466612954|FG000|Overall Study|Lost to Follow-up|2|||
129633592|NCT01379768|466612955|FG001|Overall Study|Lost to Follow-up|0|||
129633593|NCT01379768|466612956|FG002|Overall Study|Lost to Follow-up|0|||
129633594|NCT00708552|466612957|FG000|Overall Study|Adverse Event|10|||
129633595|NCT00708552|466612958|FG001|Overall Study|Adverse Event|3|||
129633596|NCT00708552|466612959|FG002|Overall Study|Adverse Event|4|||
129633597|NCT00708552|466612960|FG003|Overall Study|Adverse Event|6|||
129633598|NCT00708552|466612957|FG000|Overall Study|Lack of Efficacy|0|||
129633599|NCT00708552|466612958|FG001|Overall Study|Lack of Efficacy|4|||
129633600|NCT00708552|466612959|FG002|Overall Study|Lack of Efficacy|1|||
129633601|NCT00708552|466612960|FG003|Overall Study|Lack of Efficacy|0|||
129633602|NCT00708552|466612957|FG000|Overall Study|Protocol Violation|0|||
129633603|NCT00708552|466612958|FG001|Overall Study|Protocol Violation|0|||
129633604|NCT00708552|466612959|FG002|Overall Study|Protocol Violation|2|||
129633605|NCT00708552|466612960|FG003|Overall Study|Protocol Violation|4|||
129633606|NCT00708552|466612957|FG000|Overall Study|Lost to Follow-up|4|||
129633607|NCT00708552|466612958|FG001|Overall Study|Lost to Follow-up|2|||
129633608|NCT00708552|466612959|FG002|Overall Study|Lost to Follow-up|0|||
129633609|NCT00708552|466612960|FG003|Overall Study|Lost to Follow-up|1|||
129633610|NCT00708552|466612957|FG000|Overall Study|Physician Decision|1|||
129633611|NCT00708552|466612958|FG001|Overall Study|Physician Decision|2|||
129633612|NCT00708552|466612959|FG002|Overall Study|Physician Decision|0|||
129633613|NCT00708552|466612960|FG003|Overall Study|Physician Decision|0|||
129633614|NCT00708552|466612957|FG000|Overall Study|Withdrawal by Subject|12|||
129633615|NCT00708552|466612958|FG001|Overall Study|Withdrawal by Subject|7|||
129633616|NCT00708552|466612959|FG002|Overall Study|Withdrawal by Subject|8|||
129633617|NCT00708552|466612960|FG003|Overall Study|Withdrawal by Subject|10|||
129633618|NCT00455403|466612962|FG000|Overall Study|Lost to Follow-up|2|||
129633619|NCT00455403|466612963|FG001|Overall Study|Lost to Follow-up|1|||
129633620|NCT00455403|466612962|FG000|Overall Study|Withdrawal by Subject|1|||
129633621|NCT00455403|466612963|FG001|Overall Study|Withdrawal by Subject|3|||
129633622|NCT00455403|466612962|FG000|Overall Study|Protocol Violation|0|||
129795251|NCT02398227|467217966|FG001|Overall Study|Removed from treatment and dropped out|0|||
129795252|NCT02694718|467217968|FG000|Overall Study|Death|1|||
129795253|NCT02694718|467217968|FG000|Overall Study|Withdrawal by Subject|1|||
129795254|NCT02925793|467217969|FG000|Overall Study|Adverse Event|3|||
129795255|NCT02925793|467217970|FG001|Overall Study|Adverse Event|3|||
129795256|NCT02925793|467217971|FG002|Overall Study|Adverse Event|6|||
129795257|NCT02925793|467217969|FG000|Overall Study|Withdrawal by Subject|16|||
129795258|NCT02925793|467217970|FG001|Overall Study|Withdrawal by Subject|15|||
129795259|NCT02925793|467217971|FG002|Overall Study|Withdrawal by Subject|13|||
129795260|NCT02925793|467217969|FG000|Overall Study|Investigator Discretion|0|||
129795261|NCT02925793|467217970|FG001|Overall Study|Investigator Discretion|1|||
129795262|NCT02925793|467217971|FG002|Overall Study|Investigator Discretion|1|||
129795263|NCT02925793|467217969|FG000|Overall Study|Lost to Follow-up|2|||
129889100|NCT01349660|467551009|FG002|Overall Study|Study Compliance|1|||
129889101|NCT01349660|467551007|FG000|Overall Study|Declining Performance Status|0|||
129889102|NCT01349660|467551008|FG001|Overall Study|Declining Performance Status|0|||
129889103|NCT01349660|467551009|FG002|Overall Study|Declining Performance Status|1|||
129889104|NCT00519636|467551010|FG000|Treatment Period 1|Adverse Event|1|||
129889105|NCT00519636|467551011|FG001|Treatment Period 1|Adverse Event|0|||
129889106|NCT00519636|467551012|FG002|Treatment Period 1|Adverse Event|1|||
129889107|NCT00519636|467551013|FG003|Treatment Period 1|Adverse Event|0|||
129889108|NCT00519636|467551010|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
129889109|NCT00519636|467551011|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
129889110|NCT00519636|467551012|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
129889111|NCT00519636|467551013|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
129633623|NCT00455403|466612963|FG001|Overall Study|Protocol Violation|2|||
129889112|NCT00519636|467551010|FG000|Washout Period|Adverse Event|2|||
129633624|NCT00350207|466612964|FG000|Overall Study|Adverse Event|5|||
129633625|NCT00350207|466612965|FG001|Overall Study|Adverse Event|2|||
129889113|NCT00519636|467551011|FG001|Washout Period|Adverse Event|1|||
129633626|NCT00350207|466612966|FG002|Overall Study|Adverse Event|2|||
129633627|NCT00350207|466612964|FG000|Overall Study|Lack of Efficacy|1|||
129633628|NCT00350207|466612965|FG001|Overall Study|Lack of Efficacy|0|||
129633629|NCT00350207|466612966|FG002|Overall Study|Lack of Efficacy|2|||
129633630|NCT00350207|466612964|FG000|Overall Study|Lost to Follow-up|1|||
129633631|NCT00350207|466612965|FG001|Overall Study|Lost to Follow-up|0|||
129633632|NCT00350207|466612966|FG002|Overall Study|Lost to Follow-up|1|||
129633633|NCT00350207|466612964|FG000|Overall Study|Withdrawal by Subject|0|||
129795264|NCT02925793|467217970|FG001|Overall Study|Lost to Follow-up|3|||
129795265|NCT02925793|467217971|FG002|Overall Study|Lost to Follow-up|1|||
129633634|NCT00350207|466612965|FG001|Overall Study|Withdrawal by Subject|1|||
129633635|NCT00350207|466612966|FG002|Overall Study|Withdrawal by Subject|1|||
129633636|NCT00350207|466612964|FG000|Overall Study|Other|1|||
129633637|NCT00350207|466612965|FG001|Overall Study|Other|3|||
129889114|NCT00519636|467551012|FG002|Washout Period|Adverse Event|1|||
129633638|NCT00350207|466612966|FG002|Overall Study|Other|1|||
129633639|NCT00495391|466612967|FG000|Overall Study|Lack of Efficacy|34|||
129633640|NCT00495391|466612968|FG001|Overall Study|Lack of Efficacy|18|||
129633641|NCT00495391|466612967|FG000|Overall Study|Withdrawal by Subject|2|||
129633642|NCT00495391|466612968|FG001|Overall Study|Withdrawal by Subject|3|||
129633643|NCT04509076|466612977|FG000|Overall Study|Withdrawal by Subject|1|||
129633644|NCT04509076|466612978|FG001|Overall Study|Withdrawal by Subject|2|||
129633645|NCT04509076|466612977|FG000|Overall Study|Lost to Follow-up|1|||
129633646|NCT04509076|466612978|FG001|Overall Study|Lost to Follow-up|2|||
129633647|NCT00502242|466612983|FG000|Overall Study|Lack of Efficacy|1|||
129633648|NCT00502242|466612984|FG001|Overall Study|Lack of Efficacy|11|||
129633649|NCT00502242|466612983|FG000|Overall Study|Adverse Event|31|||
129633650|NCT00502242|466612984|FG001|Overall Study|Adverse Event|20|||
129633651|NCT00502242|466612983|FG000|Overall Study|Physician Decision|2|||
129633652|NCT00502242|466612984|FG001|Overall Study|Physician Decision|3|||
129633653|NCT00502242|466612983|FG000|Overall Study|Other - Unspecified|8|||
129633654|NCT00502242|466612984|FG001|Overall Study|Other - Unspecified|14|||
129633655|NCT00502242|466612983|FG000|Overall Study|Protocol Violation|3|||
129633656|NCT00502242|466612984|FG001|Overall Study|Protocol Violation|1|||
129633657|NCT00502242|466612983|FG000|Overall Study|Withdrawal by Subject|6|||
129633658|NCT00502242|466612984|FG001|Overall Study|Withdrawal by Subject|7|||
129633659|NCT01812109|466612985|FG000|Overall Study|research personnel delay|16|||
129633660|NCT01812109|466612985|FG000|Overall Study|NIRS Unattainable|17|||
129633661|NCT03313180|466612986|FG000|Overall Study|Adverse Event|120|||
129633662|NCT03313180|466612986|FG000|Overall Study|Lost to Follow-up|3|||
129633663|NCT03313180|466612986|FG000|Overall Study|Withdrawal by Subject|39|||
129633664|NCT03313180|466612986|FG000|Overall Study|Other than listed above|15|||
129633665|NCT03313180|466612986|FG000|Overall Study|Covid-19 related|2|||
129633666|NCT01966120|466612987|FG000|Overall Study|Withdrawal by Subject|0|||
129633667|NCT01966120|466612988|FG001|Overall Study|Withdrawal by Subject|5|||
129633668|NCT01966120|466612987|FG000|Overall Study|Lost to Follow-up|1|||
129633669|NCT01966120|466612988|FG001|Overall Study|Lost to Follow-up|1|||
129633670|NCT00461630|466612989|FG000|Overall Study|Death|798|||
129633671|NCT00461630|466612990|FG001|Overall Study|Death|732|||
129633672|NCT00461630|466612989|FG000|Overall Study|Lost to Follow-up|108|||
129633673|NCT00461630|466612990|FG001|Overall Study|Lost to Follow-up|95|||
129633674|NCT04630002|466612991|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
129633675|NCT04630002|466612992|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129633676|NCT04630002|466612993|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129633677|NCT04630002|466612991|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
129633678|NCT04630002|466612992|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129633679|NCT04630002|466612993|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129633680|NCT04630002|466612991|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
129633681|NCT04630002|466612992|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129633682|NCT04630002|466612993|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129633683|NCT04630002|466612991|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129633684|NCT04630002|466612992|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
129633685|NCT04630002|466612993|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
129633686|NCT04630002|466612991|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129633687|NCT04630002|466612992|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
129889115|NCT00519636|467551013|FG003|Washout Period|Adverse Event|0|||
129704233|NCT03189719|466879075|FG001|Overall Study|Sponsor Decision|12|||
129704234|NCT03189719|466879074|FG000|Overall Study|Withdrawal by Subject|7|||
129704235|NCT03189719|466879075|FG001|Overall Study|Withdrawal by Subject|3|||
129704236|NCT03448393|466879076|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129704237|NCT03448393|466879077|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129704238|NCT03448393|466879078|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
129704239|NCT03448393|466879079|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129889116|NCT00519636|467551010|FG000|Washout Period|Lost to Follow-up|1|||
129889117|NCT00519636|467551011|FG001|Washout Period|Lost to Follow-up|0|||
129889118|NCT00519636|467551012|FG002|Washout Period|Lost to Follow-up|0|||
129889119|NCT00519636|467551013|FG003|Washout Period|Lost to Follow-up|0|||
129889120|NCT00519636|467551010|FG000|Washout Period|Protocol Violation|0|||
129889121|NCT00519636|467551011|FG001|Washout Period|Protocol Violation|0|||
129889122|NCT00519636|467551012|FG002|Washout Period|Protocol Violation|1|||
129889123|NCT00519636|467551013|FG003|Washout Period|Protocol Violation|2|||
129889124|NCT00519636|467551010|FG000|Washout Period|Withdrawal by Subject|1|||
129889125|NCT00519636|467551011|FG001|Washout Period|Withdrawal by Subject|0|||
129889126|NCT00519636|467551012|FG002|Washout Period|Withdrawal by Subject|1|||
129889127|NCT00519636|467551013|FG003|Washout Period|Withdrawal by Subject|0|||
129889128|NCT00519636|467551010|FG000|Washout Period|Failed to meet continuation criteria|14|||
129889129|NCT00519636|467551011|FG001|Washout Period|Failed to meet continuation criteria|11|||
129889130|NCT00519636|467551012|FG002|Washout Period|Failed to meet continuation criteria|9|||
129889131|NCT00519636|467551013|FG003|Washout Period|Failed to meet continuation criteria|3|||
129889132|NCT00519636|467551010|FG000|Washout Period|Out of pollen area > 48 hours|1|||
129889133|NCT00519636|467551011|FG001|Washout Period|Out of pollen area > 48 hours|0|||
129889134|NCT00519636|467551012|FG002|Washout Period|Out of pollen area > 48 hours|0|||
129889135|NCT00519636|467551013|FG003|Washout Period|Out of pollen area > 48 hours|0|||
129889136|NCT00519636|467551010|FG000|Washout Period|Participating in study at another site|1|||
129889137|NCT00519636|467551011|FG001|Washout Period|Participating in study at another site|0|||
129889138|NCT00519636|467551012|FG002|Washout Period|Participating in study at another site|0|||
129889139|NCT00519636|467551013|FG003|Washout Period|Participating in study at another site|0|||
129889140|NCT00519636|467551010|FG000|Washout Period|Non-compliant|0|||
129889141|NCT00519636|467551011|FG001|Washout Period|Non-compliant|1|||
129889142|NCT00519636|467551012|FG002|Washout Period|Non-compliant|0|||
129889143|NCT00519636|467551013|FG003|Washout Period|Non-compliant|0|||
129889144|NCT00519636|467551010|FG000|Washout Period|Per doctors request|0|||
129889145|NCT00519636|467551011|FG001|Washout Period|Per doctors request|1|||
129889146|NCT00519636|467551012|FG002|Washout Period|Per doctors request|0|||
129633688|NCT04630002|466612993|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
129633689|NCT04630002|466612991|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129633690|NCT04630002|466612992|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
129633691|NCT04630002|466612993|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
129633692|NCT04630002|466612991|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
129633693|NCT04630002|466612992|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
129633694|NCT04630002|466612993|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
129633695|NCT04630002|466612991|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
129633696|NCT04630002|466612992|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
129633697|NCT04630002|466612993|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
129633698|NCT00442897|466612995|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
129633699|NCT00442897|466612996|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
129633700|NCT00442897|466612995|FG000|Base Study (12 Week Follow-up)|Death|0|||
129633701|NCT00442897|466612996|FG001|Base Study (12 Week Follow-up)|Death|1|||
129633702|NCT00442897|466612995|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
129633703|NCT00442897|466612996|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
129633704|NCT00442897|466612995|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
129633705|NCT00442897|466612996|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
129633706|NCT00442897|466612995|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
129633707|NCT00442897|466612996|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
129633708|NCT00442897|466612995|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
129633709|NCT00442897|466612996|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
129633710|NCT00442897|466612995|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
129633711|NCT00442897|466612996|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
129633712|NCT00442897|466612995|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
129633713|NCT00442897|466612996|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
129633714|NCT04498182|466612997|FG000|Overall Study|Adverse Event|2|||
129704240|NCT03448393|466879080|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129704241|NCT03448393|466879081|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129633715|NCT04498182|466612998|FG001|Overall Study|Adverse Event|3|||
129633716|NCT04498182|466612999|FG002|Overall Study|Adverse Event|2|||
129633717|NCT04498182|466612997|FG000|Overall Study|Withdrawal of Consent|3|||
129633718|NCT04498182|466612998|FG001|Overall Study|Withdrawal of Consent|4|||
129633719|NCT04498182|466612999|FG002|Overall Study|Withdrawal of Consent|3|||
129633720|NCT04498182|466612997|FG000|Overall Study|Non-Compliant|1|||
129633721|NCT04498182|466612998|FG001|Overall Study|Non-Compliant|0|||
129633722|NCT04498182|466612999|FG002|Overall Study|Non-Compliant|1|||
129633723|NCT04498182|466612997|FG000|Overall Study|Lost to Follow-up|0|||
129633724|NCT04498182|466612998|FG001|Overall Study|Lost to Follow-up|0|||
129633725|NCT04498182|466612999|FG002|Overall Study|Lost to Follow-up|1|||
129633726|NCT04498182|466612997|FG000|Overall Study|Investigator Decision|0|||
129633727|NCT04498182|466612998|FG001|Overall Study|Investigator Decision|0|||
129633728|NCT04498182|466612999|FG002|Overall Study|Investigator Decision|1|||
129633729|NCT04498182|466612997|FG000|Overall Study|Protocol Violation|1|||
129633730|NCT04498182|466612998|FG001|Overall Study|Protocol Violation|0|||
129633731|NCT04498182|466612999|FG002|Overall Study|Protocol Violation|2|||
129633732|NCT00891020|466613004|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
129633733|NCT00891020|466613005|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
129633734|NCT00891020|466613006|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
129633735|NCT00891020|466613004|FG000|24 Week Treatment Period|Death|0|||
129633736|NCT00891020|466613005|FG001|24 Week Treatment Period|Death|2|||
129633737|NCT00891020|466613006|FG002|24 Week Treatment Period|Death|0|||
129633738|NCT00891020|466613004|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
129633739|NCT00891020|466613005|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
129633740|NCT00891020|466613006|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
129633741|NCT00891020|466613004|FG000|24 Week Treatment Period|Failure to return|4|||
129633742|NCT00891020|466613005|FG001|24 Week Treatment Period|Failure to return|5|||
129633743|NCT00891020|466613006|FG002|24 Week Treatment Period|Failure to return|5|||
129633744|NCT00891020|466613004|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
129633745|NCT00891020|466613005|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
129633746|NCT00891020|466613006|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
129633747|NCT00891020|466613004|FG000|24 Week Treatment Period|Other protocol violation|1|||
129633748|NCT00891020|466613005|FG001|24 Week Treatment Period|Other protocol violation|1|||
129633749|NCT00891020|466613006|FG002|24 Week Treatment Period|Other protocol violation|2|||
129633750|NCT00891020|466613004|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
129633751|NCT00891020|466613005|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
129633752|NCT00891020|466613006|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
129633753|NCT00891020|466613004|FG000|24 Week Treatment Period|Withdrew consent|6|||
129633754|NCT00891020|466613005|FG001|24 Week Treatment Period|Withdrew consent|3|||
129633755|NCT00891020|466613006|FG002|24 Week Treatment Period|Withdrew consent|15|||
129633756|NCT00891020|466613004|FG000|24 Week Treatment Period|Administrative/Other|5|||
129633757|NCT00891020|466613005|FG001|24 Week Treatment Period|Administrative/Other|6|||
129633758|NCT00891020|466613006|FG002|24 Week Treatment Period|Administrative/Other|1|||
129633759|NCT00891020|466613004|FG000|Long-term Extension Period|Adverse Event|1|||
129633760|NCT00891020|466613005|FG001|Long-term Extension Period|Adverse Event|11|||
129633761|NCT00891020|466613006|FG002|Long-term Extension Period|Adverse Event|10|||
129633762|NCT00891020|466613004|FG000|Long-term Extension Period|Death|0|||
129633763|NCT00891020|466613005|FG001|Long-term Extension Period|Death|0|||
129633764|NCT00891020|466613006|FG002|Long-term Extension Period|Death|1|||
129633765|NCT00891020|466613004|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
129633766|NCT00891020|466613005|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
129633767|NCT00891020|466613006|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
129633768|NCT00891020|466613004|FG000|Long-term Extension Period|Protocol Violation|0|||
129633769|NCT00891020|466613005|FG001|Long-term Extension Period|Protocol Violation|1|||
129633770|NCT00891020|466613006|FG002|Long-term Extension Period|Protocol Violation|1|||
129633771|NCT00891020|466613004|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
129633772|NCT00891020|466613005|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
129633773|NCT00891020|466613006|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
129633774|NCT00891020|466613004|FG000|Long-term Extension Period|Failure to return|0|||
129704242|NCT03448393|466879082|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129889147|NCT00519636|467551013|FG003|Washout Period|Per doctors request|0|||
129633775|NCT00891020|466613005|FG001|Long-term Extension Period|Failure to return|2|||
129633776|NCT00891020|466613006|FG002|Long-term Extension Period|Failure to return|3|||
129633777|NCT00891020|466613004|FG000|Long-term Extension Period|Administrative|1|||
129633778|NCT00891020|466613005|FG001|Long-term Extension Period|Administrative|2|||
129633779|NCT00891020|466613006|FG002|Long-term Extension Period|Administrative|2|||
129633780|NCT00320710|466613014|FG000|Overall Study|Disease progression|24|||
129633781|NCT00320710|466613015|FG001|Overall Study|Disease progression|19|||
129633782|NCT00320710|466613016|FG002|Overall Study|Disease progression|2|||
129633783|NCT00320710|466613014|FG000|Overall Study|Death|10|||
129633784|NCT00320710|466613015|FG001|Overall Study|Death|7|||
129633785|NCT00320710|466613016|FG002|Overall Study|Death|1|||
129633786|NCT00320710|466613014|FG000|Overall Study|Administrative problems|1|||
129633787|NCT00320710|466613015|FG001|Overall Study|Administrative problems|2|||
129633788|NCT00320710|466613016|FG002|Overall Study|Administrative problems|0|||
129633789|NCT00320710|466613014|FG000|Overall Study|Withdrawal by Subject|20|||
129633790|NCT00320710|466613015|FG001|Overall Study|Withdrawal by Subject|26|||
129795266|NCT02925793|467217969|FG000|Overall Study|Lack of Efficacy|2|||
129795267|NCT02925793|467217970|FG001|Overall Study|Lack of Efficacy|6|||
129795268|NCT02925793|467217971|FG002|Overall Study|Lack of Efficacy|4|||
129633791|NCT00320710|466613016|FG002|Overall Study|Withdrawal by Subject|1|||
129633792|NCT00320710|466613014|FG000|Overall Study|Protocol Violation|6|||
129633793|NCT00320710|466613015|FG001|Overall Study|Protocol Violation|5|||
129633794|NCT00320710|466613016|FG002|Overall Study|Protocol Violation|0|||
129633795|NCT00320710|466613014|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129633796|NCT00320710|466613015|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129633797|NCT00320710|466613016|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129633798|NCT00320710|466613014|FG000|Overall Study|Abnormal laboratory value(s)|12|||
129633799|NCT00320710|466613015|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129633800|NCT00320710|466613016|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129633801|NCT00320710|466613014|FG000|Overall Study|Adverse Event|18|||
129633802|NCT00320710|466613015|FG001|Overall Study|Adverse Event|14|||
129633803|NCT00320710|466613016|FG002|Overall Study|Adverse Event|1|||
129633804|NCT00320710|466613014|FG000|Overall Study|Lost to Follow-up|1|||
129633805|NCT00320710|466613015|FG001|Overall Study|Lost to Follow-up|0|||
129633806|NCT00320710|466613016|FG002|Overall Study|Lost to Follow-up|0|||
129633807|NCT03448419|466613017|FG000|Overall Study|Adverse Event|10|||
129633808|NCT03448419|466613018|FG001|Overall Study|Adverse Event|9|||
129633809|NCT03448419|466613017|FG000|Overall Study|Lost to Follow-up|0|||
129633810|NCT03448419|466613018|FG001|Overall Study|Lost to Follow-up|2|||
129633811|NCT03448419|466613017|FG000|Overall Study|Withdrawal by Subject|3|||
129633812|NCT03448419|466613018|FG001|Overall Study|Withdrawal by Subject|1|||
129633813|NCT03448419|466613017|FG000|Overall Study|Not treated|0|||
129633814|NCT03448419|466613018|FG001|Overall Study|Not treated|1|||
129633815|NCT03448419|466613017|FG000|Overall Study|Patient did not attend all visits|0|||
129633816|NCT03448419|466613018|FG001|Overall Study|Patient did not attend all visits|2|||
129633817|NCT03448419|466613017|FG000|Overall Study|Withdrawn by Sponsor|0|||
129633818|NCT03448419|466613018|FG001|Overall Study|Withdrawn by Sponsor|1|||
129633819|NCT02841995|466613019|FG000|Overall Study|Disease progression|5|||
129633820|NCT02841995|466613020|FG001|Overall Study|Disease progression|11|||
129795269|NCT02925793|467217969|FG000|Overall Study|Other:|2|||
129795270|NCT02925793|467217970|FG001|Overall Study|Other:|1|||
129795271|NCT02925793|467217971|FG002|Overall Study|Other:|3|||
129795272|NCT00256282|467217973|FG000|Overall Study|Disease progression, relapse during acti|12|||
129795273|NCT00256282|467217973|FG000|Overall Study|Adverse Event|3|||
129795274|NCT00256282|467217973|FG000|Overall Study|Physician Decision|1|||
129795275|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
129795276|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
129795277|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Other|2|||
129795278|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Other|2|||
129795279|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Personal reasons|2|||
129795280|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Personal reasons|2|||
129795281|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
129795282|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
129795283|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
129440394|NCT01296347|465911429|FG001|Allocation|not received infusion|0|||
129440395|NCT01296347|465911428|FG000|6 Week Follow up|Death|0|||
129440396|NCT01296347|465911429|FG001|6 Week Follow up|Death|1|||
129440397|NCT01296347|465911428|FG000|3 Month Follow up|Death|1|||
129440398|NCT01296347|465911429|FG001|3 Month Follow up|Death|0|||
129440399|NCT01296347|465911428|FG000|3 Month Follow up|Lost to Follow-up|0|||
129440400|NCT01296347|465911429|FG001|3 Month Follow up|Lost to Follow-up|1|||
129633821|NCT02841995|466613021|FG002|Overall Study|Disease progression|8|||
129633822|NCT02841995|466613019|FG000|Overall Study|Withdrawal by Subject|2|||
129440401|NCT01296347|465911428|FG000|6 Month Follow up|Death|2|||
129440402|NCT01296347|465911429|FG001|6 Month Follow up|Death|1|||
129633823|NCT02841995|466613020|FG001|Overall Study|Withdrawal by Subject|4|||
129633824|NCT02841995|466613021|FG002|Overall Study|Withdrawal by Subject|4|||
129633825|NCT02841995|466613019|FG000|Overall Study|Adverse Event|2|||
129633826|NCT02841995|466613020|FG001|Overall Study|Adverse Event|0|||
129633827|NCT02841995|466613021|FG002|Overall Study|Adverse Event|1|||
129795284|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
129633828|NCT02841995|466613019|FG000|Overall Study|Investigator decision|2|||
129633829|NCT02841995|466613020|FG001|Overall Study|Investigator decision|0|||
129633830|NCT02841995|466613021|FG002|Overall Study|Investigator decision|1|||
129633831|NCT02841995|466613019|FG000|Overall Study|Death|0|||
129795285|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
129795286|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
129795287|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
129795288|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
129795289|NCT00667446|467217974|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
129795290|NCT00667446|467217975|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
129633832|NCT02841995|466613020|FG001|Overall Study|Death|0|||
129633833|NCT02841995|466613021|FG002|Overall Study|Death|2|||
129633834|NCT02841995|466613019|FG000|Overall Study|Noncompliance to protocol|1|||
129633835|NCT02841995|466613020|FG001|Overall Study|Noncompliance to protocol|0|||
129633836|NCT02841995|466613021|FG002|Overall Study|Noncompliance to protocol|0|||
129633837|NCT02841995|466613019|FG000|Overall Study|Sponsor decision|1|||
129633838|NCT02841995|466613020|FG001|Overall Study|Sponsor decision|0|||
129633839|NCT02841995|466613021|FG002|Overall Study|Sponsor decision|0|||
129633840|NCT02841995|466613019|FG000|Overall Study|Other|4|||
129633841|NCT02841995|466613020|FG001|Overall Study|Other|1|||
129633842|NCT02841995|466613021|FG002|Overall Study|Other|5|||
129633843|NCT01703260|466613022|FG000|Overall Study|Adverse Event|1|||
129633844|NCT01703260|466613023|FG001|Overall Study|Adverse Event|2|||
129633845|NCT01703260|466613024|FG002|Overall Study|Adverse Event|2|||
129633846|NCT01703260|466613022|FG000|Overall Study|Lost to Follow-up|1|||
129633847|NCT01703260|466613023|FG001|Overall Study|Lost to Follow-up|0|||
129633848|NCT01703260|466613024|FG002|Overall Study|Lost to Follow-up|0|||
129633849|NCT01703260|466613022|FG000|Overall Study|Withdrawal by Subject|0|||
129633850|NCT01703260|466613023|FG001|Overall Study|Withdrawal by Subject|0|||
129633851|NCT01703260|466613024|FG002|Overall Study|Withdrawal by Subject|1|||
129633852|NCT01703260|466613022|FG000|Overall Study|Study Termination|1|||
129633853|NCT01703260|466613023|FG001|Overall Study|Study Termination|2|||
129633854|NCT01703260|466613024|FG002|Overall Study|Study Termination|0|||
129633855|NCT04548193|466613027|FG000|Overall Study|Lost to Follow-up|0|||
129633856|NCT04548193|466613028|FG001|Overall Study|Lost to Follow-up|1|||
129633857|NCT04548193|466613027|FG000|Overall Study|Death|0|||
129633858|NCT04548193|466613028|FG001|Overall Study|Death|1|||
129633859|NCT04548193|466613027|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
129633860|NCT04548193|466613028|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
129633861|NCT04548193|466613027|FG000|Overall Study|Withdrawal by Subject|2|||
129633862|NCT04548193|466613028|FG001|Overall Study|Withdrawal by Subject|2|||
129633863|NCT00630825|466613030|FG000|Overall Study|Adverse Event|4|||
129633864|NCT00630825|466613031|FG001|Overall Study|Adverse Event|4|||
129633865|NCT00630825|466613032|FG002|Overall Study|Adverse Event|3|||
129633866|NCT00630825|466613033|FG003|Overall Study|Adverse Event|1|||
129633867|NCT00630825|466613030|FG000|Overall Study|Entry Criteria Not Met|1|||
129633868|NCT00630825|466613031|FG001|Overall Study|Entry Criteria Not Met|0|||
129633869|NCT00630825|466613032|FG002|Overall Study|Entry Criteria Not Met|2|||
129633870|NCT00630825|466613033|FG003|Overall Study|Entry Criteria Not Met|1|||
129633871|NCT00630825|466613030|FG000|Overall Study|Lost to Follow-up|1|||
129633872|NCT00630825|466613031|FG001|Overall Study|Lost to Follow-up|1|||
129633873|NCT00630825|466613032|FG002|Overall Study|Lost to Follow-up|1|||
129633874|NCT00630825|466613033|FG003|Overall Study|Lost to Follow-up|1|||
129633875|NCT00630825|466613030|FG000|Overall Study|Physician Decision|1|||
129633876|NCT00630825|466613031|FG001|Overall Study|Physician Decision|0|||
129795291|NCT00667446|467217974|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
129633877|NCT00630825|466613032|FG002|Overall Study|Physician Decision|0|||
129633878|NCT00630825|466613033|FG003|Overall Study|Physician Decision|0|||
129633879|NCT00630825|466613030|FG000|Overall Study|Withdrawal by Subject|2|||
129633880|NCT00630825|466613031|FG001|Overall Study|Withdrawal by Subject|2|||
129633881|NCT00630825|466613032|FG002|Overall Study|Withdrawal by Subject|2|||
129633882|NCT00630825|466613033|FG003|Overall Study|Withdrawal by Subject|3|||
129633883|NCT02275819|466613034|FG000|Overall Study|Adverse Event|0|||
129633884|NCT02275819|466613035|FG001|Overall Study|Adverse Event|1|||
129633885|NCT02211209|466613039|FG000|Overall Study|Investigator judgment|0|||
129633886|NCT02211209|466613040|FG001|Overall Study|Investigator judgment|1|||
129633887|NCT02211209|466613039|FG000|Overall Study|Voluntary withdrawal|1|||
129633888|NCT02211209|466613040|FG001|Overall Study|Voluntary withdrawal|4|||
129633889|NCT02211209|466613039|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
129440403|NCT01296347|465911428|FG000|6 Month Follow up|Lost to Follow-up|0|||
129440404|NCT01296347|465911429|FG001|6 Month Follow up|Lost to Follow-up|1|||
129440405|NCT01296347|465911428|FG000|12 Month Follow up|Lost to Follow-up|3|||
129633890|NCT02211209|466613040|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
129633891|NCT02211209|466613039|FG000|Overall Study|Reason Not Specified|1|||
129633892|NCT02211209|466613040|FG001|Overall Study|Reason Not Specified|0|||
129633893|NCT02792062|466613043|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
129633894|NCT02792062|466613044|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129633895|NCT02792062|466613045|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129633896|NCT02792062|466613046|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129889148|NCT00519636|467551010|FG000|Washout Period|Subject randomized in error|0|||
129795292|NCT00667446|467217975|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
129795293|NCT00322153|467217976|FG000|Overall Study|Adverse Event|21|||
129795294|NCT00322153|467217977|FG001|Overall Study|Adverse Event|34|||
129795295|NCT00322153|467217976|FG000|Overall Study|Protocol Violation|6|||
129795296|NCT00322153|467217977|FG001|Overall Study|Protocol Violation|14|||
129795297|NCT00322153|467217976|FG000|Overall Study|Withdrawal by Subject|18|||
129795298|NCT00322153|467217977|FG001|Overall Study|Withdrawal by Subject|10|||
129795299|NCT00322153|467217976|FG000|Overall Study|Lack of Efficacy|8|||
129795300|NCT00322153|467217977|FG001|Overall Study|Lack of Efficacy|3|||
129795301|NCT00322153|467217976|FG000|Overall Study|Lost to Follow-up|5|||
129795302|NCT00322153|467217977|FG001|Overall Study|Lost to Follow-up|4|||
129795303|NCT00322153|467217976|FG000|Overall Study|Withdrawn for other reasons|5|||
129795304|NCT00322153|467217977|FG001|Overall Study|Withdrawn for other reasons|4|||
129795305|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
129795306|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
129795307|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
129795308|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
129795309|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
129795310|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
129795311|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
129795312|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
129795313|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
129795314|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
129795315|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
129795316|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
129795317|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
129795318|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
129795319|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
129795320|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
129795321|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
129795322|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
129795323|NCT00591578|467217981|FG000|Double-Blind Treatment Phase|Other|4|||
129795324|NCT00591578|467217982|FG001|Double-Blind Treatment Phase|Other|9|||
129795325|NCT00591578|467217983|FG002|Double-Blind Treatment Phase|Other|4|||
129795326|NCT00591578|467217981|FG000|Open-Label Extension Phase|Adverse Event|3|||
129795327|NCT00591578|467217982|FG001|Open-Label Extension Phase|Adverse Event|5|||
129795328|NCT00591578|467217983|FG002|Open-Label Extension Phase|Adverse Event|0|||
129795329|NCT00591578|467217981|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
129795330|NCT00591578|467217982|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
129795331|NCT00591578|467217983|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129795332|NCT00591578|467217981|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
129795333|NCT00591578|467217982|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
129795334|NCT00591578|467217983|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
129795335|NCT00591578|467217981|FG000|Open-Label Extension Phase|Other|1|||
129795336|NCT00591578|467217982|FG001|Open-Label Extension Phase|Other|0|||
129795337|NCT00591578|467217983|FG002|Open-Label Extension Phase|Other|0|||
129795338|NCT02632838|467217984|FG000|Overall Study|Withdrawal by Subject|3|||
129795339|NCT02632838|467217985|FG001|Overall Study|Withdrawal by Subject|0|||
129795340|NCT02632838|467217984|FG000|Overall Study|Lost to Follow-up|0|||
129795341|NCT02632838|467217985|FG001|Overall Study|Lost to Follow-up|2|||
129795342|NCT01343901|467217986|FG000|Overall Study|Death|85|||
129795343|NCT01343901|467217986|FG000|Overall Study|Physician Decision|4|||
129795344|NCT01343901|467217986|FG000|Overall Study|Lost to Follow-up|12|||
129795345|NCT01343901|467217986|FG000|Overall Study|Management by another medical team|11|||
129795346|NCT01343901|467217986|FG000|Overall Study|Participant decision|1|||
129795347|NCT02810340|467217987|FG000|Overall Study|Withdrawal by Subject|1|||
129795348|NCT02810340|467217988|FG001|Overall Study|Withdrawal by Subject|0|||
129795349|NCT02810340|467217989|FG002|Overall Study|Withdrawal by Subject|0|||
129795350|NCT02810340|467217987|FG000|Overall Study|Incarceration|0|||
129795351|NCT02810340|467217988|FG001|Overall Study|Incarceration|1|||
129795352|NCT02810340|467217989|FG002|Overall Study|Incarceration|0|||
129795353|NCT02810340|467217987|FG000|Overall Study|Lost to Follow-up|0|||
129795354|NCT02810340|467217988|FG001|Overall Study|Lost to Follow-up|0|||
129795355|NCT02810340|467217989|FG002|Overall Study|Lost to Follow-up|1|||
129795356|NCT03945175|467217992|FG000|Overall Study|Did not meet inclusion criteria|31|||
129795357|NCT03945175|467217992|FG000|Overall Study|Withdrew consent|2|||
129795358|NCT03945175|467217992|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
129795359|NCT03945175|467217992|FG000|Overall Study|Early termination during Mydayis treatment|1|||
129795360|NCT00870233|467217993|FG000|Overall Study|Withdrawal by Subject|18|||
129795361|NCT00870233|467217993|FG000|Overall Study|Did not undergo laparotomy|3|||
129795362|NCT00870233|467217993|FG000|Overall Study|Incompatible internet browser|2|||
129795363|NCT00870233|467217993|FG000|Overall Study|Death|1|||
129795364|NCT00378079|467217997|FG000|Overall Study|Lost to Follow-up|6|||
129795365|NCT00378079|467217998|FG001|Overall Study|Lost to Follow-up|1|||
129795366|NCT00378079|467217999|FG002|Overall Study|Lost to Follow-up|0|||
129795367|NCT01233687|467218000|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
129795368|NCT01233687|467218000|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
129795369|NCT01233687|467218000|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
129795370|NCT03324581|467218004|FG000|Overall Study|Adverse Event|18|||
129795371|NCT03324581|467218005|FG001|Overall Study|Adverse Event|11|||
129795372|NCT03324581|467218006|FG002|Overall Study|Adverse Event|7|||
129795373|NCT03324581|467218004|FG000|Overall Study|Lack of Efficacy|0|||
129795374|NCT03324581|467218005|FG001|Overall Study|Lack of Efficacy|1|||
129795375|NCT03324581|467218006|FG002|Overall Study|Lack of Efficacy|0|||
129795376|NCT03324581|467218004|FG000|Overall Study|Lost to Follow-up|5|||
129633897|NCT02792062|466613047|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129633898|NCT02792062|466613048|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
129633899|NCT00931255|466613051|FG000|Overall Study|Follow up biopsy not done|2|||
129633900|NCT00931255|466613052|FG001|Overall Study|Follow up biopsy not done|3|||
129633901|NCT01681212|466613058|FG000|Overall Study|No longer met study criteria|5|||
129633902|NCT01681212|466613058|FG000|Overall Study|Administrative reason by sponsor|1|||
129633903|NCT02220764|466613061|FG000|Overall Study|Lost to Follow-up|3|||
129633904|NCT02220764|466613062|FG001|Overall Study|Lost to Follow-up|1|||
129633905|NCT02220764|466613061|FG000|Overall Study|Death|1|||
129633906|NCT02220764|466613062|FG001|Overall Study|Death|0|||
129633907|NCT02198664|466613063|FG000|Overall Study|Adverse Event|2|||
129633908|NCT02198664|466613064|FG001|Overall Study|Adverse Event|0|||
129633909|NCT02198664|466613063|FG000|Overall Study|Withdrawal by Subject|11|||
129633910|NCT02198664|466613064|FG001|Overall Study|Withdrawal by Subject|8|||
129633911|NCT02198664|466613063|FG000|Overall Study|Failure to tolerate|2|||
129633912|NCT02198664|466613064|FG001|Overall Study|Failure to tolerate|0|||
129633913|NCT02198664|466613063|FG000|Overall Study|Not stated|1|||
129633914|NCT02198664|466613064|FG001|Overall Study|Not stated|0|||
129633915|NCT03859427|466613068|FG000|Overall Study|Withdrawal by Subject|4|||
129633916|NCT03859427|466613069|FG001|Overall Study|Withdrawal by Subject|7|||
129633917|NCT03859427|466613068|FG000|Overall Study|Decision by sponsor|0|||
129633918|NCT03859427|466613069|FG001|Overall Study|Decision by sponsor|3|||
129633919|NCT03859427|466613068|FG000|Overall Study|Lost to Follow-up|3|||
129633920|NCT03859427|466613069|FG001|Overall Study|Lost to Follow-up|2|||
129633921|NCT03859427|466613068|FG000|Overall Study|Death|22|||
129633922|NCT03859427|466613069|FG001|Overall Study|Death|25|||
129633923|NCT02503540|466613070|FG000|Overall Study|Death|2|||
129633924|NCT02503540|466613070|FG000|Overall Study|Withdrawal by Subject|1|||
129633925|NCT01662492|466613071|FG000|Overall Study|Other miscellaneous reasons.|1|||
129633926|NCT01662492|466613072|FG001|Overall Study|Other miscellaneous reasons.|0|||
129633927|NCT01662492|466613073|FG002|Overall Study|Other miscellaneous reasons.|1|||
129633928|NCT01662492|466613071|FG000|Overall Study|Withdrawal by Subject|0|||
129633929|NCT01662492|466613072|FG001|Overall Study|Withdrawal by Subject|0|||
129633930|NCT01662492|466613073|FG002|Overall Study|Withdrawal by Subject|1|||
129633931|NCT01662492|466613071|FG000|Overall Study|Protocol Violation|1|||
129633932|NCT01662492|466613072|FG001|Overall Study|Protocol Violation|0|||
129633933|NCT01662492|466613073|FG002|Overall Study|Protocol Violation|0|||
129633934|NCT01662492|466613071|FG000|Overall Study|Lost to Follow-up|0|||
129633935|NCT01662492|466613072|FG001|Overall Study|Lost to Follow-up|0|||
129633936|NCT01662492|466613073|FG002|Overall Study|Lost to Follow-up|2|||
129633937|NCT01662492|466613071|FG000|Overall Study|Lack of Efficacy|1|||
129633938|NCT01662492|466613072|FG001|Overall Study|Lack of Efficacy|1|||
129633939|NCT01662492|466613073|FG002|Overall Study|Lack of Efficacy|2|||
129633940|NCT02418182|466613078|FG000|Overall Study|Unable to re-consent|18|||
129633941|NCT02418182|466613079|FG001|Overall Study|Unable to re-consent|15|||
129633942|NCT02418182|466613078|FG000|Overall Study|Lost to Follow-up|0|||
129633943|NCT02418182|466613079|FG001|Overall Study|Lost to Follow-up|2|||
129633944|NCT00570687|466614956|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633945|NCT00570687|466614957|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633946|NCT00570687|466614958|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129795377|NCT03324581|467218005|FG001|Overall Study|Lost to Follow-up|3|||
129889149|NCT00519636|467551011|FG001|Washout Period|Subject randomized in error|0|||
129889150|NCT00519636|467551012|FG002|Washout Period|Subject randomized in error|1|||
129889151|NCT00519636|467551013|FG003|Washout Period|Subject randomized in error|0|||
129633947|NCT00570687|466614959|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633948|NCT00570687|466614960|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129633949|NCT00570687|466614961|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129633950|NCT00570687|466614962|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
129633951|NCT00570687|466614963|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129633952|NCT00570687|466614964|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
129633953|NCT00570687|466614965|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
129795378|NCT03324581|467218006|FG002|Overall Study|Lost to Follow-up|6|||
129795379|NCT03324581|467218004|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
129795380|NCT03324581|467218005|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
129795381|NCT03324581|467218006|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
129795382|NCT03324581|467218004|FG000|Overall Study|Physician Decision|0|||
129795383|NCT03324581|467218005|FG001|Overall Study|Physician Decision|1|||
129795384|NCT03324581|467218006|FG002|Overall Study|Physician Decision|2|||
129795385|NCT03324581|467218004|FG000|Overall Study|Protocol Deviation|8|||
129795386|NCT03324581|467218005|FG001|Overall Study|Protocol Deviation|9|||
129795387|NCT03324581|467218006|FG002|Overall Study|Protocol Deviation|4|||
129795388|NCT03324581|467218004|FG000|Overall Study|Withdrawal by Subject|6|||
129795389|NCT03324581|467218005|FG001|Overall Study|Withdrawal by Subject|8|||
129795390|NCT03324581|467218006|FG002|Overall Study|Withdrawal by Subject|6|||
129795391|NCT03324581|467218004|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
129795392|NCT03324581|467218005|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
129795393|NCT03324581|467218006|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
129795394|NCT02274038|467218007|FG000|Overall Study|Death|1|||
129795395|NCT03783702|467218008|FG000|Overall Study|Lost to Follow-up|6|||
129795396|NCT03783702|467218009|FG001|Overall Study|Lost to Follow-up|8|||
129633954|NCT00570687|466614956|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633955|NCT00570687|466614957|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633956|NCT00570687|466614958|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633957|NCT00570687|466614959|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633958|NCT00570687|466614960|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633959|NCT00570687|466614961|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633960|NCT00570687|466614962|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633961|NCT00570687|466614963|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633962|NCT00570687|466614964|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
129633963|NCT00570687|466614965|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633964|NCT00570687|466614956|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633965|NCT00570687|466614957|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633966|NCT00570687|466614958|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633967|NCT00570687|466614959|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633968|NCT00570687|466614960|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633969|NCT00570687|466614961|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633970|NCT00570687|466614962|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
129633971|NCT00570687|466614963|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633972|NCT00570687|466614964|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633973|NCT00570687|466614965|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
129633974|NCT01102257|466614973|FG000|Overall Study|Adverse Event|1|||
129633975|NCT01102257|466614974|FG001|Overall Study|Adverse Event|0|||
129633976|NCT01102257|466614973|FG000|Overall Study|Adverse Event|1|||
129633977|NCT01102257|466614974|FG001|Overall Study|Adverse Event|0|||
129633978|NCT01120184|466614975|FG000|Overall Study|Adverse Event|0|||
129795397|NCT03783702|467218008|FG000|Overall Study|Protocol Violation|1|||
129795398|NCT03783702|467218009|FG001|Overall Study|Protocol Violation|3|||
129795399|NCT04473482|467218010|FG000|Overall Study|Death|0|||
129633979|NCT01120184|466614976|FG001|Overall Study|Adverse Event|1|||
129633980|NCT01120184|466614977|FG002|Overall Study|Adverse Event|0|||
129795400|NCT04473482|467218011|FG001|Overall Study|Death|3|||
129795401|NCT04473482|467218010|FG000|Overall Study|Lost to Follow-up|9|||
129795402|NCT04473482|467218011|FG001|Overall Study|Lost to Follow-up|7|||
129795403|NCT04473482|467218010|FG000|Overall Study|Withdrawal by Subject|2|||
129795404|NCT04473482|467218011|FG001|Overall Study|Withdrawal by Subject|1|||
129795405|NCT01306877|467218012|FG000|Overall Study|Lost to Follow-up|3|||
129795406|NCT01306877|467218013|FG001|Overall Study|Lost to Follow-up|3|||
129795407|NCT01306877|467218012|FG000|Overall Study|Physician Decision|0|||
129795408|NCT01306877|467218013|FG001|Overall Study|Physician Decision|1|||
129795409|NCT00006389|467218014|FG000|Overall Study|Adverse Event|1|||
129795410|NCT01076075|467218020|FG000|Overall Study|Adverse Event|3|||
129795411|NCT01076075|467218021|FG001|Overall Study|Adverse Event|9|||
129795412|NCT01076075|467218020|FG000|Overall Study|Lack of Efficacy|5|||
129633981|NCT01120184|466614975|FG000|Overall Study|Lost to Follow-up|13|||
129633982|NCT01120184|466614976|FG001|Overall Study|Lost to Follow-up|13|||
129795413|NCT01076075|467218021|FG001|Overall Study|Lack of Efficacy|4|||
129795414|NCT01076075|467218020|FG000|Overall Study|Lost to Follow-up|6|||
129795415|NCT01076075|467218021|FG001|Overall Study|Lost to Follow-up|5|||
129795416|NCT01076075|467218020|FG000|Overall Study|other|19|||
129795417|NCT01076075|467218021|FG001|Overall Study|other|9|||
129633983|NCT01120184|466614977|FG002|Overall Study|Lost to Follow-up|11|||
129795418|NCT01076075|467218020|FG000|Overall Study|Protocol Violation|0|||
129795419|NCT01076075|467218021|FG001|Overall Study|Protocol Violation|1|||
129795420|NCT01076075|467218020|FG000|Overall Study|Withdrawal by Subject|8|||
129795421|NCT01076075|467218021|FG001|Overall Study|Withdrawal by Subject|19|||
129795422|NCT01445886|467218024|FG000|Overall Study|Lost to Follow-up|2|||
129795423|NCT01445886|467218024|FG000|Overall Study|Protocol Violation|3|||
129795424|NCT00995865|467218027|FG000|Overall Study|Protocol Violation|2|||
129795425|NCT00995865|467218028|FG001|Overall Study|Protocol Violation|0|||
129795426|NCT00995865|467218029|FG002|Overall Study|Protocol Violation|0|||
129889152|NCT00519636|467551010|FG000|Washout Period|Prohibited medications|0|||
129889153|NCT00519636|467551011|FG001|Washout Period|Prohibited medications|0|||
129633984|NCT01120184|466614975|FG000|Overall Study|Physician Decision|9|||
129633985|NCT01120184|466614976|FG001|Overall Study|Physician Decision|1|||
129633986|NCT01120184|466614977|FG002|Overall Study|Physician Decision|3|||
129633987|NCT01120184|466614975|FG000|Overall Study|Reason not Specified|8|||
129633988|NCT01120184|466614976|FG001|Overall Study|Reason not Specified|3|||
129633989|NCT01120184|466614977|FG002|Overall Study|Reason not Specified|12|||
129633990|NCT01120184|466614975|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
129633991|NCT01120184|466614976|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
129633992|NCT01120184|466614977|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
129633993|NCT01120184|466614975|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
129633994|NCT01120184|466614976|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
129633995|NCT01120184|466614977|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
129633996|NCT01120184|466614975|FG000|Overall Study|Death|170|||
129633997|NCT01120184|466614976|FG001|Overall Study|Death|176|||
129633998|NCT01120184|466614977|FG002|Overall Study|Death|169|||
129633999|NCT04003636|466614978|FG000|Overall Study|Death|409|||
129634000|NCT04003636|466614979|FG001|Overall Study|Death|443|||
129634001|NCT04003636|466614978|FG000|Overall Study|Lost to Follow-up|0|||
129634002|NCT04003636|466614979|FG001|Overall Study|Lost to Follow-up|1|||
129634003|NCT04003636|466614978|FG000|Overall Study|Withdrawal by Subject|5|||
129634004|NCT04003636|466614979|FG001|Overall Study|Withdrawal by Subject|2|||
129634005|NCT04003636|466614978|FG000|Overall Study|Participant On-going|119|||
129634006|NCT04003636|466614979|FG001|Overall Study|Participant On-going|90|||
129634007|NCT03048747|466614980|FG000|Overall Study|Adverse Event|2|||
129634008|NCT03048747|466614980|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
129634009|NCT03048747|466614980|FG000|Overall Study|Physician Decision|1|||
129704243|NCT03448393|466879083|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
129634010|NCT00866281|466614981|FG000|Overall Study|Adverse Event|1|||
129634011|NCT00866281|466614982|FG001|Overall Study|Adverse Event|0|||
129634012|NCT00866281|466614981|FG000|Overall Study|Withdrawal by participants|3|||
129634013|NCT00866281|466614982|FG001|Overall Study|Withdrawal by participants|0|||
129704244|NCT03448393|466879084|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
129704245|NCT03448393|466879076|FG000|Dose Expansion|Not treated - screen failure|0|||
129704246|NCT03448393|466879077|FG001|Dose Expansion|Not treated - screen failure|0|||
129704247|NCT03448393|466879078|FG002|Dose Expansion|Not treated - screen failure|0|||
129704248|NCT03448393|466879079|FG003|Dose Expansion|Not treated - screen failure|0|||
129704249|NCT03448393|466879080|FG004|Dose Expansion|Not treated - screen failure|0|||
129704250|NCT03448393|466879081|FG005|Dose Expansion|Not treated - screen failure|0|||
129634014|NCT00866281|466614981|FG000|Overall Study|Disease progression|3|||
129634015|NCT00866281|466614982|FG001|Overall Study|Disease progression|11|||
129634016|NCT00866281|466614981|FG000|Overall Study|New cancer therapy|0|||
129704251|NCT03448393|466879082|FG006|Dose Expansion|Not treated - screen failure|0|||
129704252|NCT03448393|466879083|FG007|Dose Expansion|Not treated - screen failure|0|||
129704253|NCT03448393|466879084|FG008|Dose Expansion|Not treated - screen failure|7|||
129440406|NCT01296347|465911429|FG001|12 Month Follow up|Lost to Follow-up|1|||
129634017|NCT00866281|466614982|FG001|Overall Study|New cancer therapy|4|||
129634018|NCT00529087|466614984|FG000|Overall Study|Adverse Event|10|||
129634019|NCT00529087|466614985|FG001|Overall Study|Adverse Event|13|||
129634020|NCT00529087|466614986|FG002|Overall Study|Adverse Event|4|||
129634021|NCT00529087|466614984|FG000|Overall Study|Lost to Follow-up|6|||
129634022|NCT00529087|466614985|FG001|Overall Study|Lost to Follow-up|4|||
129634023|NCT00529087|466614986|FG002|Overall Study|Lost to Follow-up|1|||
129634024|NCT00529087|466614984|FG000|Overall Study|Protocol Violation|8|||
129634025|NCT00529087|466614985|FG001|Overall Study|Protocol Violation|7|||
129634026|NCT00529087|466614986|FG002|Overall Study|Protocol Violation|6|||
129634027|NCT00529087|466614984|FG000|Overall Study|Withdrawal by Subject|3|||
129634028|NCT00529087|466614985|FG001|Overall Study|Withdrawal by Subject|3|||
129634029|NCT00529087|466614986|FG002|Overall Study|Withdrawal by Subject|3|||
129634030|NCT00529087|466614984|FG000|Overall Study|Protocol deviation|1|||
129634031|NCT00529087|466614985|FG001|Overall Study|Protocol deviation|1|||
129634032|NCT00529087|466614986|FG002|Overall Study|Protocol deviation|2|||
129634033|NCT00318474|466614987|FG000|Overall Study|Adverse Event|1|||
129634034|NCT00318474|466614988|FG001|Overall Study|Adverse Event|1|||
129634035|NCT00318474|466614987|FG000|Overall Study|Lost to Follow-up|0|||
129634036|NCT00318474|466614988|FG001|Overall Study|Lost to Follow-up|1|||
129634037|NCT00318474|466614987|FG000|Overall Study|Pregnancy|0|||
129634038|NCT00318474|466614988|FG001|Overall Study|Pregnancy|2|||
129634039|NCT00318474|466614987|FG000|Overall Study|Protocol Violation|1|||
129634040|NCT00318474|466614988|FG001|Overall Study|Protocol Violation|0|||
129634041|NCT00318474|466614987|FG000|Overall Study|Withdrawal by Subject|3|||
129634042|NCT00318474|466614988|FG001|Overall Study|Withdrawal by Subject|2|||
129634043|NCT00318474|466614987|FG000|Overall Study|Fall in GFR|3|||
129634044|NCT00318474|466614988|FG001|Overall Study|Fall in GFR|3|||
129634045|NCT00318474|466614987|FG000|Overall Study|Post-therapy hyperflycemia|0|||
129634046|NCT00318474|466614988|FG001|Overall Study|Post-therapy hyperflycemia|1|||
129634047|NCT00318474|466614987|FG000|Overall Study|Trial terminated|10|||
129634048|NCT00318474|466614988|FG001|Overall Study|Trial terminated|7|||
129634049|NCT03270657|466614989|FG000|Overall Study|Withdrawal by Subject|1|||
129634050|NCT00162981|466614990|FG000|Overall Study|Adverse Event|2|||
129634051|NCT00162981|466614991|FG001|Overall Study|Adverse Event|5|||
129634052|NCT00162981|466614990|FG000|Overall Study|Withdrawal by Subject|1|||
129634053|NCT00162981|466614991|FG001|Overall Study|Withdrawal by Subject|1|||
129634054|NCT00162981|466614990|FG000|Overall Study|Physician Decision|1|||
129634055|NCT00162981|466614991|FG001|Overall Study|Physician Decision|0|||
129634056|NCT02588612|466614999|FG000|Overall Study|Physician Decision|1|||
129634057|NCT02588612|466614999|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
129634058|NCT02588612|466614999|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
129634059|NCT02588612|466614999|FG000|Overall Study|Death prior to T-cell infusion|1|||
129634060|NCT03809663|466615000|FG000|Overall Study|Decision by sponsor|24|||
129634061|NCT03809663|466615001|FG001|Overall Study|Decision by sponsor|18|||
129795427|NCT00995865|467218027|FG000|Overall Study|Lost to Follow-up|0|||
129795428|NCT00995865|467218028|FG001|Overall Study|Lost to Follow-up|0|||
129795429|NCT00995865|467218029|FG002|Overall Study|Lost to Follow-up|1|||
129795430|NCT05080660|467218030|FG000|Overall Study|Adverse Event|4|||
129795431|NCT05080660|467218031|FG001|Overall Study|Adverse Event|0|||
129795432|NCT05080660|467218030|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
129795433|NCT05080660|467218031|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
129795434|NCT05080660|467218030|FG000|Overall Study|Physician Decision|1|||
129795435|NCT05080660|467218031|FG001|Overall Study|Physician Decision|0|||
129795436|NCT05080660|467218030|FG000|Overall Study|Protocol Deviation|2|||
129795437|NCT05080660|467218031|FG001|Overall Study|Protocol Deviation|0|||
129795438|NCT05080660|467218030|FG000|Overall Study|Withdrawal by Subject|5|||
129795439|NCT05080660|467218031|FG001|Overall Study|Withdrawal by Subject|2|||
129795440|NCT04285580|467219545|FG000|Overall Study|Protocol Violation|0|||
129795441|NCT04285580|467219546|FG001|Overall Study|Protocol Violation|1|||
129795442|NCT00076024|467219547|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
129795443|NCT00076024|467219548|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
129795444|NCT00076024|467219549|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
129795445|NCT00076024|467219550|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
129795446|NCT00076024|467219547|FG000|Phase 1, Lead-in|Adverse Event|1|||
129795447|NCT00076024|467219548|FG001|Phase 1, Lead-in|Adverse Event|0|||
129795448|NCT00076024|467219549|FG002|Phase 1, Lead-in|Adverse Event|0|||
129634062|NCT03809663|466615002|FG002|Overall Study|Decision by sponsor|20|||
129634063|NCT03809663|466615003|FG003|Overall Study|Decision by sponsor|20|||
129634064|NCT03809663|466615004|FG004|Overall Study|Decision by sponsor|0|||
129634065|NCT03809663|466615005|FG005|Overall Study|Decision by sponsor|0|||
129634066|NCT03809663|466615000|FG000|Overall Study|Withdrawal by Subject|26|||
129634067|NCT03809663|466615001|FG001|Overall Study|Withdrawal by Subject|22|||
129634068|NCT03809663|466615002|FG002|Overall Study|Withdrawal by Subject|27|||
129634069|NCT03809663|466615003|FG003|Overall Study|Withdrawal by Subject|26|||
129634070|NCT03809663|466615004|FG004|Overall Study|Withdrawal by Subject|0|||
129634071|NCT03809663|466615005|FG005|Overall Study|Withdrawal by Subject|0|||
129634072|NCT03809663|466615000|FG000|Overall Study|Lost to Follow-up|1|||
129795449|NCT00076024|467219550|FG003|Phase 1, Lead-in|Adverse Event|0|||
129795450|NCT00076024|467219547|FG000|Phase 1, Lead-in|Clinical progression|1|||
129795451|NCT00076024|467219548|FG001|Phase 1, Lead-in|Clinical progression|0|||
129795452|NCT00076024|467219549|FG002|Phase 1, Lead-in|Clinical progression|0|||
129795453|NCT00076024|467219550|FG003|Phase 1, Lead-in|Clinical progression|0|||
129795454|NCT00076024|467219547|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
129795455|NCT00076024|467219548|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
129795456|NCT00076024|467219549|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
129795457|NCT00076024|467219550|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
129795458|NCT00076024|467219547|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
129795459|NCT00076024|467219548|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
129795460|NCT00076024|467219549|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
129795461|NCT00076024|467219550|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
129795462|NCT00076024|467219547|FG000|Phase 2, Double-blind|Adverse Event|0|||
129795463|NCT00076024|467219548|FG001|Phase 2, Double-blind|Adverse Event|25|||
129795464|NCT00076024|467219549|FG002|Phase 2, Double-blind|Adverse Event|6|||
129795465|NCT00076024|467219550|FG003|Phase 2, Double-blind|Adverse Event|0|||
129795466|NCT00076024|467219547|FG000|Phase 2, Double-blind|Un-specified|0|||
129795467|NCT00076024|467219548|FG001|Phase 2, Double-blind|Un-specified|14|||
129795468|NCT00076024|467219549|FG002|Phase 2, Double-blind|Un-specified|6|||
129795469|NCT00076024|467219550|FG003|Phase 2, Double-blind|Un-specified|0|||
129795470|NCT00076024|467219547|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
129795471|NCT00076024|467219548|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
129795472|NCT00076024|467219549|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
129795473|NCT00076024|467219550|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
129795474|NCT00076024|467219547|FG000|Phase 2, Open-label|Adverse Event|0|||
129795475|NCT00076024|467219548|FG001|Phase 2, Open-label|Adverse Event|0|||
129795476|NCT00076024|467219549|FG002|Phase 2, Open-label|Adverse Event|0|||
129795477|NCT00076024|467219550|FG003|Phase 2, Open-label|Adverse Event|2|||
129795478|NCT00076024|467219547|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
129795479|NCT00076024|467219548|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
129795480|NCT00076024|467219549|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
129634073|NCT03809663|466615001|FG001|Overall Study|Lost to Follow-up|4|||
129634074|NCT03809663|466615002|FG002|Overall Study|Lost to Follow-up|1|||
129795481|NCT00076024|467219550|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
129795482|NCT00076024|467219547|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
129795483|NCT00076024|467219548|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
129795484|NCT00076024|467219549|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
129634075|NCT03809663|466615003|FG003|Overall Study|Lost to Follow-up|1|||
129795485|NCT00076024|467219550|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
129795486|NCT00076024|467219547|FG000|Phase 2, Open-label|Other|0|||
129634076|NCT03809663|466615004|FG004|Overall Study|Lost to Follow-up|0|||
129795487|NCT00076024|467219548|FG001|Phase 2, Open-label|Other|0|||
129795488|NCT00076024|467219549|FG002|Phase 2, Open-label|Other|0|||
129795489|NCT00076024|467219550|FG003|Phase 2, Open-label|Other|2|||
129795490|NCT01155219|467219551|FG000|Overall Study|Adverse Event|3|||
129795491|NCT01155219|467219552|FG001|Overall Study|Adverse Event|1|||
129795492|NCT01155219|467219551|FG000|Overall Study|non-medical reason|1|||
129795493|NCT01155219|467219552|FG001|Overall Study|non-medical reason|2|||
129795494|NCT00719264|467219553|FG000|Overall Study|Adverse Event|41|||
129795495|NCT00719264|467219554|FG001|Overall Study|Adverse Event|49|||
129795496|NCT00719264|467219553|FG000|Overall Study|Death|13|||
129795497|NCT00719264|467219554|FG001|Overall Study|Death|10|||
129795498|NCT00719264|467219553|FG000|Overall Study|Administrative Problems|6|||
129889154|NCT00519636|467551012|FG002|Washout Period|Prohibited medications|1|||
129889155|NCT00519636|467551013|FG003|Washout Period|Prohibited medications|0|||
129889156|NCT00519636|467551010|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
129889157|NCT00519636|467551011|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
129889158|NCT00519636|467551012|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
129889159|NCT00519636|467551013|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
129889160|NCT00519636|467551010|FG000|Treatment Period 2|Subject randomized in error|0|||
129795499|NCT00719264|467219554|FG001|Overall Study|Administrative Problems|4|||
129795500|NCT00719264|467219553|FG000|Overall Study|Lost to Follow-up|1|||
129795501|NCT00719264|467219554|FG001|Overall Study|Lost to Follow-up|1|||
129795502|NCT00719264|467219553|FG000|Overall Study|Withdrawal by Subject|12|||
129795503|NCT00719264|467219554|FG001|Overall Study|Withdrawal by Subject|7|||
129795504|NCT00719264|467219553|FG000|Overall Study|Protocol Deviation|1|||
129795505|NCT00719264|467219554|FG001|Overall Study|Protocol Deviation|3|||
129795506|NCT00719264|467219553|FG000|Overall Study|New Cancer Therapy|4|||
129795507|NCT00719264|467219554|FG001|Overall Study|New Cancer Therapy|2|||
129795508|NCT00719264|467219553|FG000|Overall Study|Disease Progression|104|||
129795509|NCT00719264|467219554|FG001|Overall Study|Disease Progression|107|||
129795510|NCT02278341|467219556|FG000|Overall Study|Randomized but never received study drug|1|||
129795511|NCT02278341|467219557|FG001|Overall Study|Randomized but never received study drug|1|||
129795512|NCT02278341|467219556|FG000|Overall Study|Adverse Event|3|||
129795513|NCT02278341|467219557|FG001|Overall Study|Adverse Event|0|||
129795514|NCT02278341|467219556|FG000|Overall Study|Death|68|||
129795515|NCT02278341|467219557|FG001|Overall Study|Death|56|||
129795516|NCT02278341|467219556|FG000|Overall Study|Withdrawal by Subject|30|||
129795517|NCT02278341|467219557|FG001|Overall Study|Withdrawal by Subject|19|||
129795518|NCT02278341|467219556|FG000|Overall Study|Lost to Follow-up|0|||
129795519|NCT02278341|467219557|FG001|Overall Study|Lost to Follow-up|1|||
129795520|NCT02278341|467219556|FG000|Overall Study|Physician Decision|1|||
129795521|NCT02278341|467219557|FG001|Overall Study|Physician Decision|1|||
129795522|NCT02278341|467219556|FG000|Overall Study|Miscellaneous|15|||
129795523|NCT02278341|467219557|FG001|Overall Study|Miscellaneous|14|||
129634077|NCT03809663|466615005|FG005|Overall Study|Lost to Follow-up|0|||
129634078|NCT02042014|466615006|FG000|Overall Study|Adverse Event|1|||
129634079|NCT02042014|466615006|FG000|Overall Study|Physician Decision|7|||
129634080|NCT03309943|466615007|FG000|Overall Study|Withdrawal by Subject|0|||
129634081|NCT03309943|466615008|FG001|Overall Study|Withdrawal by Subject|1|||
129634082|NCT03309943|466615007|FG000|Overall Study|Inappropriate behavior towards staff|0|||
129634083|NCT03309943|466615008|FG001|Overall Study|Inappropriate behavior towards staff|1|||
129634084|NCT01372995|466615009|FG000|Overall Study|Spouse withdrew participant from study|0|||
129634085|NCT01372995|466615010|FG001|Overall Study|Spouse withdrew participant from study|1|||
129634086|NCT01372995|466615011|FG002|Overall Study|Spouse withdrew participant from study|0|||
129634087|NCT01372995|466615009|FG000|Overall Study|Physician Decision|0|||
129634088|NCT01372995|466615010|FG001|Overall Study|Physician Decision|0|||
129634089|NCT01372995|466615011|FG002|Overall Study|Physician Decision|1|||
129634090|NCT03123393|466615012|FG000|Overall Study|Study Terminated by Sponsor|6|||
129634091|NCT03123393|466615013|FG001|Overall Study|Study Terminated by Sponsor|9|||
129634092|NCT03123393|466615012|FG000|Overall Study|Withdrawal by Subject|2|||
129634093|NCT03123393|466615013|FG001|Overall Study|Withdrawal by Subject|1|||
129795524|NCT04902326|467219558|FG000|Overall Study|Withdrawal by Subject|1|||
129795525|NCT04902326|467219559|FG001|Overall Study|Withdrawal by Subject|3|||
129795526|NCT04902326|467219560|FG002|Overall Study|Withdrawal by Subject|0|||
129795527|NCT04902326|467219561|FG003|Overall Study|Withdrawal by Subject|1|||
129795528|NCT04902326|467219558|FG000|Overall Study|Lost to Follow-up|14|||
129889161|NCT00519636|467551011|FG001|Treatment Period 2|Subject randomized in error|1|||
129889162|NCT00519636|467551012|FG002|Treatment Period 2|Subject randomized in error|0|||
129889163|NCT00519636|467551013|FG003|Treatment Period 2|Subject randomized in error|0|||
129795529|NCT04902326|467219559|FG001|Overall Study|Lost to Follow-up|14|||
129634094|NCT03123393|466615012|FG000|Overall Study|Reason not Specified|13|||
129634095|NCT03123393|466615013|FG001|Overall Study|Reason not Specified|13|||
129634096|NCT00558701|466615017|FG000|Overall Study|Protocol Deviations|1|||
129634097|NCT00558701|466615018|FG001|Overall Study|Protocol Deviations|4|||
129634098|NCT00427648|466615019|FG000|Overall Study|Protocol Violation|1|||
129795530|NCT04902326|467219560|FG002|Overall Study|Lost to Follow-up|14|||
129795531|NCT04902326|467219561|FG003|Overall Study|Lost to Follow-up|6|||
129795532|NCT02604017|467219562|FG000|Overall Study|Withdrew Consent|0|||
129889164|NCT00519636|467551010|FG000|Treatment Period 2|Per doctors request|0|||
129795533|NCT02604017|467219563|FG001|Overall Study|Withdrew Consent|2|||
129795534|NCT02604017|467219562|FG000|Overall Study|Lost to Follow-up|5|||
129795535|NCT02604017|467219563|FG001|Overall Study|Lost to Follow-up|6|||
129795536|NCT02604017|467219562|FG000|Overall Study|Other|1|||
129795537|NCT02604017|467219563|FG001|Overall Study|Other|0|||
129795538|NCT00740246|467219564|FG000|Overall Study|Received Blood Transfusion|0|||
129795539|NCT00740246|467219565|FG001|Overall Study|Received Blood Transfusion|1|||
129795540|NCT00740246|467219564|FG000|Overall Study|Adverse Event|1|||
129795541|NCT00740246|467219565|FG001|Overall Study|Adverse Event|2|||
129795542|NCT00740246|467219564|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
129795543|NCT00740246|467219565|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
129795544|NCT00740246|467219564|FG000|Overall Study|Lost to Follow-up|2|||
129795545|NCT00740246|467219565|FG001|Overall Study|Lost to Follow-up|2|||
129795546|NCT00740246|467219564|FG000|Overall Study|Withdrawal by Subject|4|||
129795547|NCT00740246|467219565|FG001|Overall Study|Withdrawal by Subject|3|||
129795548|NCT00740246|467219564|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
129795549|NCT00740246|467219565|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
129795550|NCT00740246|467219564|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
129795551|NCT00740246|467219565|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
129795552|NCT00740246|467219564|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
129795553|NCT00740246|467219565|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
129795554|NCT00740246|467219564|FG000|Overall Study|Unable To Comply With Study Visits|2|||
129795555|NCT00740246|467219565|FG001|Overall Study|Unable To Comply With Study Visits|0|||
129795556|NCT00740246|467219564|FG000|Overall Study|Unable to Access Vein|0|||
129795557|NCT00740246|467219565|FG001|Overall Study|Unable to Access Vein|2|||
129795558|NCT00740246|467219564|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
129795559|NCT00740246|467219565|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
129795560|NCT01117051|467219566|FG000|Overall Study|Withdrawal by Subject|5|||
129795561|NCT01117051|467219567|FG001|Overall Study|Withdrawal by Subject|3|||
129795562|NCT01117051|467219566|FG000|Overall Study|Adverse Event|4|||
129795563|NCT01117051|467219567|FG001|Overall Study|Adverse Event|3|||
129795564|NCT01117051|467219566|FG000|Overall Study|Lost to Follow-up|0|||
129795565|NCT01117051|467219567|FG001|Overall Study|Lost to Follow-up|1|||
129795566|NCT01117051|467219566|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
129795567|NCT01117051|467219567|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
129795568|NCT01117051|467219566|FG000|Overall Study|Sponsor's decision|3|||
129795569|NCT01117051|467219567|FG001|Overall Study|Sponsor's decision|1|||
129795570|NCT01117051|467219566|FG000|Overall Study|Surgical procedure|0|||
129795571|NCT01117051|467219567|FG001|Overall Study|Surgical procedure|1|||
129795572|NCT01117051|467219566|FG000|Overall Study|Randomized by mistake|0|||
129795573|NCT01117051|467219567|FG001|Overall Study|Randomized by mistake|1|||
129795574|NCT01117051|467219566|FG000|Overall Study|Convenience issue|1|||
129795575|NCT01117051|467219567|FG001|Overall Study|Convenience issue|0|||
129795576|NCT00366340|467219568|FG000|Infant Series|Protocol Violation|3|||
129795577|NCT00366340|467219569|FG001|Infant Series|Protocol Violation|4|||
129795578|NCT00366340|467219568|FG000|Infant Series|Withdrawal by Subject|3|||
129795579|NCT00366340|467219569|FG001|Infant Series|Withdrawal by Subject|3|||
129795580|NCT00366340|467219568|FG000|Infant Series|Adverse Event|0|||
129634099|NCT00427648|466615020|FG001|Overall Study|Protocol Violation|2|||
129634100|NCT00427648|466615019|FG000|Overall Study|Adverse Event|0|||
129634101|NCT00427648|466615020|FG001|Overall Study|Adverse Event|1|||
129634102|NCT00105079|466615021|FG000|Overall Study|Adverse Event|5|||
129634103|NCT00105079|466615022|FG001|Overall Study|Adverse Event|12|||
129634104|NCT00105079|466615021|FG000|Overall Study|Death|3|||
129634105|NCT00105079|466615022|FG001|Overall Study|Death|1|||
129634106|NCT00105079|466615021|FG000|Overall Study|Lost to Follow-up|12|||
129634107|NCT00105079|466615022|FG001|Overall Study|Lost to Follow-up|12|||
129634108|NCT00105079|466615021|FG000|Overall Study|Lack of Efficacy|9|||
129795581|NCT00366340|467219569|FG001|Infant Series|Adverse Event|2|||
129795582|NCT00366340|467219568|FG000|Infant Series|Lost to Follow-up|1|||
129795583|NCT00366340|467219569|FG001|Infant Series|Lost to Follow-up|1|||
129795584|NCT00366340|467219568|FG000|Infant Series|Failure to return|1|||
129795585|NCT00366340|467219569|FG001|Infant Series|Failure to return|0|||
129795586|NCT00366340|467219568|FG000|After the Infant Series|Parent/legal guardian request|1|||
129634109|NCT00105079|466615022|FG001|Overall Study|Lack of Efficacy|3|||
129795587|NCT00366340|467219569|FG001|After the Infant Series|Parent/legal guardian request|1|||
129634110|NCT00105079|466615021|FG000|Overall Study|Refused treatment|6|||
129634111|NCT00105079|466615022|FG001|Overall Study|Refused treatment|4|||
129634112|NCT00105079|466615021|FG000|Overall Study|Violation of selection criteria at entry|0|||
129795588|NCT00366340|467219568|FG000|After the Infant Series|Failed to return|0|||
129795589|NCT00366340|467219569|FG001|After the Infant Series|Failed to return|1|||
129795590|NCT00366340|467219568|FG000|After the Infant Series|Protocol Violation|2|||
129795591|NCT00366340|467219569|FG001|After the Infant Series|Protocol Violation|2|||
129795592|NCT00366340|467219568|FG000|After the Infant Series|Adverse Event|0|||
129795593|NCT00366340|467219569|FG001|After the Infant Series|Adverse Event|1|||
129795594|NCT00366340|467219568|FG000|After the Infant Series|Lost to Follow-up|0|||
129795595|NCT00366340|467219569|FG001|After the Infant Series|Lost to Follow-up|1|||
129795596|NCT00366340|467219568|FG000|Toddler Dose|Failed to return|1|||
129795597|NCT00366340|467219569|FG001|Toddler Dose|Failed to return|0|||
129795598|NCT00366340|467219568|FG000|Toddler Dose|Parent/legal guardian request|0|||
129795599|NCT00366340|467219569|FG001|Toddler Dose|Parent/legal guardian request|1|||
129795600|NCT01315236|467219573|FG000|Double-blind Phase|Death|1|||
129795601|NCT01315236|467219574|FG001|Double-blind Phase|Death|0|||
129795602|NCT01315236|467219573|FG000|Double-blind Phase|Adverse Event|1|||
129795603|NCT01315236|467219574|FG001|Double-blind Phase|Adverse Event|0|||
129795604|NCT01315236|467219573|FG000|Double-blind Phase|Withdrawal of Consent|1|||
129795605|NCT01315236|467219574|FG001|Double-blind Phase|Withdrawal of Consent|0|||
129795606|NCT01315236|467219573|FG000|Double-blind Phase|Lost to Follow-up|1|||
129795607|NCT01315236|467219574|FG001|Double-blind Phase|Lost to Follow-up|0|||
129795608|NCT01315236|467219573|FG000|Open-label Phase|Death|1|||
129795609|NCT01315236|467219574|FG001|Open-label Phase|Death|0|||
129795610|NCT01315236|467219573|FG000|Open-label Phase|Adverse Event|0|||
129795611|NCT01315236|467219574|FG001|Open-label Phase|Adverse Event|1|||
129795612|NCT01315236|467219573|FG000|Open-label Phase|Other|0|||
129795613|NCT01315236|467219574|FG001|Open-label Phase|Other|1|||
129795614|NCT01315236|467219573|FG000|12-Month Follow-up Period|Death|0|||
129795615|NCT01315236|467219574|FG001|12-Month Follow-up Period|Death|1|||
129795616|NCT01315236|467219573|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
129795617|NCT01315236|467219574|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
129795618|NCT00442468|467219575|FG000|Overall Study|Adverse Event|4|||
129795619|NCT00442468|467219575|FG000|Overall Study|Withdrawal by Subject|91|||
129795620|NCT00442468|467219575|FG000|Overall Study|Did not complete all study procedures|88|||
129795621|NCT00589784|467219578|FG000|Overall Study|Withdrawal by Subject|0|||
129795622|NCT00589784|467219579|FG001|Overall Study|Withdrawal by Subject|6|||
129795623|NCT00589784|467219578|FG000|Overall Study|Patient inevaluable|1|||
129795624|NCT00589784|467219579|FG001|Overall Study|Patient inevaluable|0|||
129795625|NCT00589784|467219578|FG000|Overall Study|Adverse Event|0|||
129795626|NCT00589784|467219579|FG001|Overall Study|Adverse Event|4|||
129795627|NCT00521001|467219581|FG000|Overall Study|Ineligible|1|||
129795628|NCT02821910|467219582|FG000|Overall Study|Withdrawal by Subject|0|||
129795629|NCT02821910|467219583|FG001|Overall Study|Withdrawal by Subject|0|||
129795630|NCT02821910|467219584|FG002|Overall Study|Withdrawal by Subject|1|||
129795631|NCT02821910|467219585|FG003|Overall Study|Withdrawal by Subject|0|||
129795632|NCT02821910|467219586|FG004|Overall Study|Withdrawal by Subject|0|||
129795633|NCT02821910|467219587|FG005|Overall Study|Withdrawal by Subject|1|||
129795634|NCT02821910|467219582|FG000|Overall Study|Other than specified|1|||
129795635|NCT02821910|467219583|FG001|Overall Study|Other than specified|0|||
129795636|NCT02821910|467219584|FG002|Overall Study|Other than specified|1|||
129795637|NCT02821910|467219585|FG003|Overall Study|Other than specified|0|||
129795638|NCT02821910|467219586|FG004|Overall Study|Other than specified|0|||
129795639|NCT02821910|467219587|FG005|Overall Study|Other than specified|0|||
129795640|NCT01289782|467219588|FG000|Overall Study|Lost to Follow-up|14|||
129795641|NCT01289782|467219589|FG001|Overall Study|Lost to Follow-up|7|||
129795642|NCT01289782|467219588|FG000|Overall Study|Protocol Violation|1|||
129795643|NCT01289782|467219589|FG001|Overall Study|Protocol Violation|1|||
129795644|NCT01289782|467219588|FG000|Overall Study|Withdrawal by Subject|8|||
129795645|NCT01289782|467219589|FG001|Overall Study|Withdrawal by Subject|2|||
129795646|NCT01289782|467219588|FG000|Overall Study|Sponsor's Decision|1|||
129795647|NCT01289782|467219589|FG001|Overall Study|Sponsor's Decision|0|||
129440407|NCT01296347|465911428|FG000|12 Month Follow up|Death|1|||
129634113|NCT00105079|466615022|FG001|Overall Study|Violation of selection criteria at entry|2|||
129634114|NCT00105079|466615021|FG000|Overall Study|Protocol Violation|1|||
129634115|NCT00105079|466615022|FG001|Overall Study|Protocol Violation|0|||
129795648|NCT01289782|467219588|FG000|Overall Study|Reason not specified|1|||
129795649|NCT01289782|467219589|FG001|Overall Study|Reason not specified|2|||
129795650|NCT01025154|467219593|FG000|Overall Study|Lost to Follow-up|1|||
129795651|NCT01025154|467219593|FG000|Overall Study|Withdrawal by Subject|1|||
129634116|NCT00105079|466615021|FG000|Overall Study|Other|3|||
129795652|NCT00542451|467219598|FG000|Overall Study|Adverse Event|31|||
129795653|NCT00542451|467219598|FG000|Overall Study|Withdrawal by Subject|30|||
129795654|NCT00542451|467219598|FG000|Overall Study|Physician Decision|4|||
129795655|NCT00542451|467219598|FG000|Overall Study|Recurrent disease|1|||
129795656|NCT00542451|467219598|FG000|Overall Study|unknown reason|1|||
129795657|NCT00542451|467219598|FG000|Overall Study|Death|2|||
129795658|NCT00542451|467219598|FG000|Overall Study|Lost to Follow-up|10|||
129795659|NCT03519386|467219599|FG000|Overall Study|Withdrawal by Subject|4|||
129795660|NCT03519386|467219600|FG001|Overall Study|Withdrawal by Subject|1|||
129795661|NCT03519386|467219601|FG002|Overall Study|Withdrawal by Subject|2|||
129795662|NCT03519386|467219599|FG000|Overall Study|Physician Decision|1|||
129795663|NCT03519386|467219600|FG001|Overall Study|Physician Decision|1|||
129634117|NCT00105079|466615022|FG001|Overall Study|Other|1|||
129634118|NCT01609296|466615023|FG000|Overall Study|Death|253|||
129634119|NCT01609296|466615023|FG000|Overall Study|Withdrawal by Subject|151|||
129634120|NCT01609296|466615023|FG000|Overall Study|Lost to Follow-up|21|||
129634121|NCT01609296|466615023|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
129634122|NCT01609296|466615023|FG000|Overall Study|missed visit but known to be alive|28|||
129634123|NCT00386360|466615026|FG000|Overall Study|Adverse Event|4|||
129634124|NCT00386360|466615027|FG001|Overall Study|Adverse Event|2|||
129440408|NCT01296347|465911429|FG001|12 Month Follow up|Death|1|||
129634125|NCT00386360|466615026|FG000|Overall Study|Physician Decision|2|||
129634126|NCT00386360|466615027|FG001|Overall Study|Physician Decision|2|||
129704254|NCT03012880|466879085|FG000|Overall Study|Withdrawal by Subject|1|||
129704255|NCT03012880|466879086|FG001|Overall Study|Withdrawal by Subject|0|||
129704256|NCT03012880|466879085|FG000|Overall Study|Ineligible|1|||
129704257|NCT03012880|466879086|FG001|Overall Study|Ineligible|0|||
129704258|NCT04569084|466879087|FG000|Overall Study|Adverse Event|10|||
129704259|NCT04569084|466879088|FG001|Overall Study|Adverse Event|14|||
129704260|NCT04569084|466879087|FG000|Overall Study|Death|2|||
129704261|NCT04569084|466879088|FG001|Overall Study|Death|3|||
129704262|NCT04569084|466879087|FG000|Overall Study|Lost to Follow-up|1|||
129704263|NCT04569084|466879088|FG001|Overall Study|Lost to Follow-up|1|||
129704264|NCT04569084|466879087|FG000|Overall Study|Physician Decision|3|||
129704265|NCT04569084|466879088|FG001|Overall Study|Physician Decision|3|||
129704266|NCT04569084|466879087|FG000|Overall Study|Protocol Violation|2|||
129704267|NCT04569084|466879088|FG001|Overall Study|Protocol Violation|1|||
129704268|NCT04569084|466879087|FG000|Overall Study|Withdrawal by Subject|20|||
129704269|NCT04569084|466879088|FG001|Overall Study|Withdrawal by Subject|21|||
129704270|NCT04569084|466879087|FG000|Overall Study|Study terminated by sponsor|26|||
129704271|NCT04569084|466879088|FG001|Overall Study|Study terminated by sponsor|23|||
129704272|NCT04569084|466879087|FG000|Overall Study|Other|3|||
129704273|NCT04569084|466879088|FG001|Overall Study|Other|5|||
129704274|NCT04795531|466880514|FG000|Overall Study|Withdrawal by Subject|4|||
129704275|NCT04795531|466880515|FG001|Overall Study|Withdrawal by Subject|4|||
129704276|NCT04795531|466880514|FG000|Overall Study|Lost to Follow-up|0|||
129704277|NCT04795531|466880515|FG001|Overall Study|Lost to Follow-up|1|||
129704278|NCT04795531|466880514|FG000|Overall Study|Physician Decision|0|||
129704279|NCT04795531|466880515|FG001|Overall Study|Physician Decision|2|||
129704280|NCT04795531|466880514|FG000|Overall Study|Death|2|||
129704281|NCT04795531|466880515|FG001|Overall Study|Death|1|||
129704282|NCT04043286|466880516|FG000|Overall Study|Withdrawal by Subject|2|||
129704283|NCT04043286|466880517|FG001|Overall Study|Withdrawal by Subject|2|||
129704284|NCT01323192|466880518|FG000|Overall Study|Adverse Event|6|||
129704285|NCT01323192|466880519|FG001|Overall Study|Adverse Event|1|||
129704286|NCT01323192|466880518|FG000|Overall Study|Withdrawal by Subject|3|||
129634127|NCT00386360|466615026|FG000|Overall Study|Lost to Follow-up|0|||
129704287|NCT01323192|466880519|FG001|Overall Study|Withdrawal by Subject|1|||
129704288|NCT01323192|466880518|FG000|Overall Study|Noncompliance with study medication|0|||
129795664|NCT03519386|467219601|FG002|Overall Study|Physician Decision|1|||
129795665|NCT03519386|467219599|FG000|Overall Study|Lost to Follow-up|0|||
129795666|NCT03519386|467219600|FG001|Overall Study|Lost to Follow-up|1|||
129795667|NCT03519386|467219601|FG002|Overall Study|Lost to Follow-up|1|||
129795668|NCT03519386|467219599|FG000|Overall Study|Death|1|||
129795669|NCT03519386|467219600|FG001|Overall Study|Death|0|||
129795670|NCT03519386|467219601|FG002|Overall Study|Death|4|||
129795671|NCT03519386|467219599|FG000|Overall Study|Adverse Event|2|||
129795672|NCT03519386|467219600|FG001|Overall Study|Adverse Event|1|||
129795673|NCT03519386|467219601|FG002|Overall Study|Adverse Event|2|||
129795674|NCT03519386|467219599|FG000|Overall Study|Explanted|2|||
129795675|NCT03519386|467219600|FG001|Overall Study|Explanted|1|||
129795676|NCT03519386|467219601|FG002|Overall Study|Explanted|0|||
129795677|NCT03519386|467219599|FG000|Overall Study|Ongoing in study|190|||
129795678|NCT03519386|467219600|FG001|Overall Study|Ongoing in study|192|||
129795679|NCT03519386|467219601|FG002|Overall Study|Ongoing in study|183|||
129795680|NCT04341662|467219603|FG000|Overall Study|Did not have source-verified blood loss data|423|||
129795681|NCT04341662|467219604|FG001|Overall Study|Did not have source-verified blood loss data|514|||
129795682|NCT01582854|467219605|FG000|Overall Study|Death|8|||
129795683|NCT01582854|467219606|FG001|Overall Study|Death|5|||
129795684|NCT01582854|467219605|FG000|Overall Study|Adverse Event|2|||
129795685|NCT01582854|467219606|FG001|Overall Study|Adverse Event|3|||
129795686|NCT01582854|467219605|FG000|Overall Study|Withdrawal by Participant|8|||
129795687|NCT01582854|467219606|FG001|Overall Study|Withdrawal by Participant|11|||
129795688|NCT01582854|467219605|FG000|Overall Study|Lost to Follow-up|1|||
129795689|NCT01582854|467219606|FG001|Overall Study|Lost to Follow-up|2|||
129795690|NCT01582854|467219605|FG000|Overall Study|Physician Decision|0|||
129795691|NCT01582854|467219606|FG001|Overall Study|Physician Decision|1|||
129795692|NCT01582854|467219605|FG000|Overall Study|Recurrent Stroke|13|||
129795693|NCT01582854|467219606|FG001|Overall Study|Recurrent Stroke|8|||
129795694|NCT01582854|467219605|FG000|Overall Study|Disallowed Concomitant Medication|3|||
129795695|NCT01582854|467219606|FG001|Overall Study|Disallowed Concomitant Medication|2|||
129795696|NCT01582854|467219605|FG000|Overall Study|Carotid or Neurosurgery|0|||
129634128|NCT00386360|466615027|FG001|Overall Study|Lost to Follow-up|2|||
129634129|NCT00386360|466615026|FG000|Overall Study|Protocol Violation|0|||
129795697|NCT01582854|467219606|FG001|Overall Study|Carotid or Neurosurgery|1|||
129795698|NCT01582854|467219605|FG000|Overall Study|General Anaesthesia|0|||
129795699|NCT01582854|467219606|FG001|Overall Study|General Anaesthesia|1|||
129795700|NCT01582854|467219605|FG000|Overall Study|Other Miscellaneous Reason|1|||
129795701|NCT01582854|467219606|FG001|Overall Study|Other Miscellaneous Reason|0|||
129795702|NCT03101267|467219607|FG000|Primary Study Period|Withdrawal by Subject|1|||
129795703|NCT03101267|467219608|FG001|Primary Study Period|Withdrawal by Subject|2|||
129795704|NCT03101267|467219609|FG002|Primary Study Period|Withdrawal by Subject|3|||
129795705|NCT03101267|467219607|FG000|Primary Study Period|Miscellaneous|2|||
129795706|NCT03101267|467219608|FG001|Primary Study Period|Miscellaneous|0|||
129634130|NCT00386360|466615027|FG001|Overall Study|Protocol Violation|3|||
129634131|NCT00386360|466615026|FG000|Overall Study|Withdrawal by Subject|3|||
129634132|NCT00386360|466615027|FG001|Overall Study|Withdrawal by Subject|6|||
129634133|NCT00386360|466615026|FG000|Overall Study|Did not take any study medication|0|||
129634134|NCT00386360|466615027|FG001|Overall Study|Did not take any study medication|2|||
129634135|NCT02230904|466615028|FG000|Overall Study|Safety follow up could not take place|0|||
129634136|NCT02230904|466615029|FG001|Overall Study|Safety follow up could not take place|1|||
129634137|NCT01464424|466615030|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
129634138|NCT01464424|466615031|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
129634139|NCT01464333|466615033|FG000|Overall Study|Adverse Event|34|||
129634140|NCT01464333|466615033|FG000|Overall Study|Lack of Efficacy|72|||
129634141|NCT01464333|466615033|FG000|Overall Study|Withdrawal by Subject|11|||
129634142|NCT01464333|466615033|FG000|Overall Study|Other|4|||
129634143|NCT01464333|466615033|FG000|Overall Study|No Hospital Visit|42|||
129634144|NCT02187198|466615036|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
129795707|NCT03101267|467219609|FG002|Primary Study Period|Miscellaneous|0|||
129795708|NCT01222403|467219610|FG000|Overall Study|Inappropriate enrollment|0|||
129795709|NCT01222403|467219611|FG001|Overall Study|Inappropriate enrollment|2|||
129634145|NCT02187198|466615037|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
129634146|NCT02187198|466615036|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
129634147|NCT02187198|466615037|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
129634148|NCT01532518|466615038|FG000|Overall Study|Withdrawal by Subject|0|||
129634149|NCT01532518|466615039|FG001|Overall Study|Withdrawal by Subject|0|||
129634150|NCT01532518|466615040|FG002|Overall Study|Withdrawal by Subject|1|||
129634151|NCT01575834|466615041|FG000|Overall Study|Withdrawal by Subject|352|||
129634152|NCT01575834|466615042|FG001|Overall Study|Withdrawal by Subject|390|||
129634153|NCT01575834|466615041|FG000|Overall Study|Death|81|||
129634154|NCT01575834|466615042|FG001|Overall Study|Death|74|||
129634155|NCT01575834|466615041|FG000|Overall Study|Other|70|||
129634156|NCT01575834|466615042|FG001|Overall Study|Other|70|||
129634157|NCT01575834|466615041|FG000|Overall Study|Adverse Event|63|||
129634158|NCT01575834|466615042|FG001|Overall Study|Adverse Event|61|||
129634159|NCT01575834|466615041|FG000|Overall Study|Lost to Follow-up|55|||
129634160|NCT01575834|466615042|FG001|Overall Study|Lost to Follow-up|68|||
129634161|NCT01575834|466615041|FG000|Overall Study|Noncompliance|52|||
129634162|NCT01575834|466615042|FG001|Overall Study|Noncompliance|27|||
129634163|NCT01575834|466615041|FG000|Overall Study|Administrative decision|15|||
129634164|NCT01575834|466615042|FG001|Overall Study|Administrative decision|33|||
129634165|NCT01575834|466615041|FG000|Overall Study|Ineligibility Determined|5|||
129634166|NCT01575834|466615042|FG001|Overall Study|Ineligibility Determined|8|||
129634167|NCT01575834|466615041|FG000|Overall Study|Protocol Deviation|4|||
129634168|NCT01575834|466615042|FG001|Overall Study|Protocol Deviation|3|||
129634169|NCT01575834|466615041|FG000|Overall Study|Requirement for Alternative Therapy|2|||
129634170|NCT01575834|466615042|FG001|Overall Study|Requirement for Alternative Therapy|4|||
129634171|NCT02155283|466615043|FG000|Overall Study|Lost to Follow-up|3|||
129634172|NCT02155283|466615043|FG000|Overall Study|Withdrawal by Subject|1|||
129795710|NCT01028378|467219612|FG000|Overall Study|Lost to Follow-up|12|||
129795711|NCT01028378|467219612|FG000|Overall Study|Withdrawal by Subject|1|||
129795712|NCT01028378|467219612|FG000|Overall Study|Adminstrative Reasons|4|||
129795713|NCT01262352|467219613|FG000|Period 1|Illness after randomization|1|||
129795714|NCT01262352|467219614|FG001|Period 1|Illness after randomization|0|||
129795715|NCT01262352|467219613|FG000|Washout|Adverse Event|1|||
129795716|NCT01262352|467219614|FG001|Washout|Adverse Event|1|||
129634173|NCT02155283|466615043|FG000|Overall Study|Protocol Violation|3|||
129634174|NCT05000164|466615050|FG000|Overall Study|Adverse Event|1|||
129634175|NCT05000164|466615050|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129634176|NCT05000164|466615050|FG000|Overall Study|Lens Discomfort|3|||
129634177|NCT05000164|466615050|FG000|Overall Study|Withdrew Consent during Study|2|||
129634178|NCT05000164|466615050|FG000|Overall Study|Subject Withdrawn by PI|2|||
129795717|NCT01262352|467219613|FG000|Washout|Extended Washout|0|||
129634179|NCT05000164|466615050|FG000|Overall Study|Other Fractured Test Article|1|||
129634180|NCT06509438|466615056|FG000|Overall Study|Adverse Event|1|||
129634181|NCT06509438|466615056|FG000|Overall Study|Lost to Follow-up|3|||
129634182|NCT03331796|466615057|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
129634183|NCT03331796|466615058|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
129634184|NCT03331796|466615059|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
129634185|NCT03331796|466615057|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
129634186|NCT03331796|466615058|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
129634187|NCT03331796|466615059|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
129634188|NCT03331796|466615057|FG000|Extended Follow-up|Adverse Event|1|||
129634189|NCT03331796|466615058|FG001|Extended Follow-up|Adverse Event|0|||
129634190|NCT03331796|466615059|FG002|Extended Follow-up|Adverse Event|1|||
129634191|NCT03331796|466615057|FG000|Extended Follow-up|Lost to Follow-up|0|||
129634192|NCT03331796|466615058|FG001|Extended Follow-up|Lost to Follow-up|0|||
129634193|NCT03331796|466615059|FG002|Extended Follow-up|Lost to Follow-up|1|||
129634194|NCT03331796|466615057|FG000|Extended Follow-up|Withdrawal by Subject|1|||
129634195|NCT03331796|466615058|FG001|Extended Follow-up|Withdrawal by Subject|0|||
129634196|NCT03331796|466615059|FG002|Extended Follow-up|Withdrawal by Subject|0|||
129889165|NCT00519636|467551011|FG001|Treatment Period 2|Per doctors request|0|||
129889166|NCT00519636|467551012|FG002|Treatment Period 2|Per doctors request|1|||
129889167|NCT00519636|467551013|FG003|Treatment Period 2|Per doctors request|0|||
129889168|NCT00519636|467551010|FG000|Treatment Period 2|Subject misrandomized|0|||
129889169|NCT00519636|467551011|FG001|Treatment Period 2|Subject misrandomized|0|||
129889170|NCT00519636|467551012|FG002|Treatment Period 2|Subject misrandomized|0|||
129889171|NCT00519636|467551013|FG003|Treatment Period 2|Subject misrandomized|1|||
129889172|NCT00519636|467551010|FG000|Post Study Period|Subject randomized in error|0|||
129889173|NCT00519636|467551011|FG001|Post Study Period|Subject randomized in error|0|||
129889174|NCT00519636|467551012|FG002|Post Study Period|Subject randomized in error|0|||
129889175|NCT00519636|467551013|FG003|Post Study Period|Subject randomized in error|1|||
129889176|NCT02846558|467551018|FG000|Overall Study|Adverse Event|1|||
129889177|NCT02846558|467551019|FG001|Overall Study|Adverse Event|0|||
129889178|NCT02846558|467551020|FG002|Overall Study|Adverse Event|0|||
129889179|NCT02846558|467551021|FG003|Overall Study|Adverse Event|0|||
129889180|NCT02846558|467551018|FG000|Overall Study|Withdrawal by Subject|5|||
129889181|NCT02846558|467551019|FG001|Overall Study|Withdrawal by Subject|4|||
129634197|NCT03331796|466615057|FG000|Extended Follow-up|Termination of Funding|0|||
129634198|NCT03331796|466615058|FG001|Extended Follow-up|Termination of Funding|1|||
129634199|NCT03331796|466615059|FG002|Extended Follow-up|Termination of Funding|0|||
129889182|NCT02846558|467551020|FG002|Overall Study|Withdrawal by Subject|2|||
129795718|NCT01262352|467219614|FG001|Washout|Extended Washout|1|||
129795719|NCT01185834|467219618|FG000|Overall Study|Lost to Follow-up|2|||
129795720|NCT01185834|467219618|FG000|Overall Study|Discomfort|4|||
129795721|NCT01185834|467219618|FG000|Overall Study|Biomicroscopy|4|||
129795722|NCT01185834|467219618|FG000|Overall Study|Time/Job Conflict|2|||
129795723|NCT01185834|467219618|FG000|Overall Study|Early exit - Site error|2|||
129795724|NCT00107952|467219627|FG000|Overall Study|Death|75|||
129795725|NCT00107952|467219628|FG001|Overall Study|Death|61|||
129795726|NCT00107952|467219627|FG000|Overall Study|Lost to Follow-up|0|||
129795727|NCT00107952|467219628|FG001|Overall Study|Lost to Follow-up|3|||
129795728|NCT00107952|467219627|FG000|Overall Study|Withdrawal by Subject|9|||
129795729|NCT00107952|467219628|FG001|Overall Study|Withdrawal by Subject|6|||
129795730|NCT00107952|467219627|FG000|Overall Study|Other|2|||
129795731|NCT00107952|467219628|FG001|Overall Study|Other|5|||
129795732|NCT00107952|467219627|FG000|Overall Study|Never received study treatment|9|||
129795733|NCT00107952|467219628|FG001|Overall Study|Never received study treatment|6|||
129795734|NCT01975831|467219629|FG000|Overall Study|Adverse Event|1|||
129795735|NCT01975831|467219630|FG001|Overall Study|Adverse Event|2|||
129795736|NCT01975831|467219631|FG002|Overall Study|Adverse Event|2|||
129795737|NCT01975831|467219632|FG003|Overall Study|Adverse Event|0|||
129795738|NCT01975831|467219633|FG004|Overall Study|Adverse Event|1|||
129795739|NCT01975831|467219634|FG005|Overall Study|Adverse Event|1|||
129795740|NCT01975831|467219635|FG006|Overall Study|Adverse Event|3|||
129795741|NCT01975831|467219636|FG007|Overall Study|Adverse Event|4|||
129795742|NCT01975831|467219637|FG008|Overall Study|Adverse Event|1|||
129795743|NCT01975831|467219629|FG000|Overall Study|Death|1|||
129795744|NCT01975831|467219630|FG001|Overall Study|Death|1|||
129795745|NCT01975831|467219631|FG002|Overall Study|Death|0|||
129795746|NCT01975831|467219632|FG003|Overall Study|Death|0|||
129795747|NCT01975831|467219633|FG004|Overall Study|Death|1|||
129795748|NCT01975831|467219634|FG005|Overall Study|Death|0|||
129795749|NCT01975831|467219635|FG006|Overall Study|Death|1|||
129795750|NCT01975831|467219636|FG007|Overall Study|Death|0|||
129795751|NCT01975831|467219637|FG008|Overall Study|Death|0|||
129795752|NCT01975831|467219629|FG000|Overall Study|Progressive Disease|1|||
129795753|NCT01975831|467219630|FG001|Overall Study|Progressive Disease|3|||
129795754|NCT01975831|467219631|FG002|Overall Study|Progressive Disease|2|||
129795755|NCT01975831|467219632|FG003|Overall Study|Progressive Disease|4|||
129795756|NCT01975831|467219633|FG004|Overall Study|Progressive Disease|13|||
129795757|NCT01975831|467219634|FG005|Overall Study|Progressive Disease|9|||
129795758|NCT01975831|467219635|FG006|Overall Study|Progressive Disease|10|||
129795759|NCT01975831|467219636|FG007|Overall Study|Progressive Disease|8|||
129795760|NCT01975831|467219637|FG008|Overall Study|Progressive Disease|10|||
129795761|NCT01975831|467219629|FG000|Overall Study|Withdrawal by Subject|0|||
129795762|NCT01975831|467219630|FG001|Overall Study|Withdrawal by Subject|3|||
129795763|NCT01975831|467219631|FG002|Overall Study|Withdrawal by Subject|0|||
129795764|NCT01975831|467219632|FG003|Overall Study|Withdrawal by Subject|0|||
129795765|NCT01975831|467219633|FG004|Overall Study|Withdrawal by Subject|3|||
129795766|NCT01975831|467219634|FG005|Overall Study|Withdrawal by Subject|1|||
129795767|NCT01975831|467219635|FG006|Overall Study|Withdrawal by Subject|1|||
129795768|NCT01975831|467219636|FG007|Overall Study|Withdrawal by Subject|0|||
129795769|NCT01975831|467219637|FG008|Overall Study|Withdrawal by Subject|0|||
129795770|NCT01975831|467219629|FG000|Overall Study|Physician Decision|0|||
129795771|NCT01975831|467219630|FG001|Overall Study|Physician Decision|0|||
129889183|NCT02846558|467551021|FG003|Overall Study|Withdrawal by Subject|2|||
129634200|NCT01753570|466615060|FG000|Overall Study|Adverse Event|1|||
129634201|NCT01753570|466615061|FG001|Overall Study|Adverse Event|0|||
129634202|NCT01753570|466615062|FG002|Overall Study|Adverse Event|1|||
129634203|NCT01753570|466615060|FG000|Overall Study|Physician Decision|0|||
129634204|NCT01753570|466615061|FG001|Overall Study|Physician Decision|1|||
129634205|NCT01753570|466615062|FG002|Overall Study|Physician Decision|0|||
129634206|NCT01753570|466615060|FG000|Overall Study|Withdrawal by Subject|1|||
129634207|NCT01753570|466615061|FG001|Overall Study|Withdrawal by Subject|4|||
129634208|NCT01753570|466615062|FG002|Overall Study|Withdrawal by Subject|0|||
129634209|NCT01000155|466615063|FG000|Overall Study|Withdrawal by Subject|1|||
129634210|NCT01000155|466615063|FG000|Overall Study|Adverse Event|1|||
129795772|NCT01975831|467219631|FG002|Overall Study|Physician Decision|0|||
129795773|NCT01975831|467219632|FG003|Overall Study|Physician Decision|0|||
129795774|NCT01975831|467219633|FG004|Overall Study|Physician Decision|0|||
129795775|NCT01975831|467219634|FG005|Overall Study|Physician Decision|1|||
129795776|NCT01975831|467219635|FG006|Overall Study|Physician Decision|0|||
129795777|NCT01975831|467219636|FG007|Overall Study|Physician Decision|1|||
129795778|NCT01975831|467219637|FG008|Overall Study|Physician Decision|0|||
129634211|NCT00720213|466615066|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
129634212|NCT00720213|466615067|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
129795779|NCT01975831|467219629|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
129795780|NCT01975831|467219630|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
129795781|NCT01975831|467219631|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
129795782|NCT01975831|467219632|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
129889184|NCT02846558|467551018|FG000|Overall Study|Lost to Follow-up|2|||
129795783|NCT01975831|467219633|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
129795784|NCT01975831|467219634|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
129795785|NCT01975831|467219635|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
129795786|NCT01975831|467219636|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
129795787|NCT01975831|467219637|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
129795788|NCT01975831|467219629|FG000|Overall Study|Entered Hospice|0|||
129795789|NCT01975831|467219630|FG001|Overall Study|Entered Hospice|0|||
129795790|NCT01975831|467219631|FG002|Overall Study|Entered Hospice|0|||
129795791|NCT01975831|467219632|FG003|Overall Study|Entered Hospice|0|||
129795792|NCT01975831|467219633|FG004|Overall Study|Entered Hospice|0|||
129795793|NCT01975831|467219634|FG005|Overall Study|Entered Hospice|1|||
129795794|NCT01975831|467219635|FG006|Overall Study|Entered Hospice|0|||
129795795|NCT01975831|467219636|FG007|Overall Study|Entered Hospice|0|||
129795796|NCT01975831|467219637|FG008|Overall Study|Entered Hospice|0|||
129795797|NCT01975831|467219629|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795798|NCT01975831|467219630|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795799|NCT01975831|467219631|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795800|NCT01975831|467219632|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795801|NCT01975831|467219633|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795802|NCT01975831|467219634|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795803|NCT01975831|467219635|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
129795804|NCT01975831|467219636|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
129795805|NCT01975831|467219637|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
129795806|NCT01401959|467219638|FG000|Enrolled|Withdrawal by Subject|1|||
129795807|NCT01401959|467219639|FG001|Enrolled|Withdrawal by Subject|0|||
129795808|NCT01401959|467219640|FG002|Enrolled|Withdrawal by Subject|0|||
129795809|NCT01401959|467219638|FG000|Treated|Disease Progression|2|||
129795810|NCT01401959|467219639|FG001|Treated|Disease Progression|2|||
129889185|NCT02846558|467551019|FG001|Overall Study|Lost to Follow-up|0|||
129440409|NCT01296347|465911428|FG000|12 Month Follow up|Withdrawal by Subject|0|||
129440410|NCT01296347|465911429|FG001|12 Month Follow up|Withdrawal by Subject|1|||
129440411|NCT02240693|465911430|FG000|Overall Study|Adverse Event|0|||
129440412|NCT02240693|465911431|FG001|Overall Study|Adverse Event|0|||
129440413|NCT02240693|465911432|FG002|Overall Study|Adverse Event|0|||
129440414|NCT02240693|465911433|FG003|Overall Study|Adverse Event|0|||
129440415|NCT02240693|465911434|FG004|Overall Study|Adverse Event|1|||
129440416|NCT02240693|465911430|FG000|Overall Study|Withdrawal by Subject|0|||
129634213|NCT00720213|466615068|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
129634214|NCT01808066|466615071|FG000|Overall Study|Withdrawal by Subject|15|||
129634215|NCT01252095|466615073|FG000|Overall Study|Disease progression|1|||
129634216|NCT01252095|466615074|FG001|Overall Study|Disease progression|0|||
129440417|NCT02240693|465911431|FG001|Overall Study|Withdrawal by Subject|0|||
129440418|NCT02240693|465911432|FG002|Overall Study|Withdrawal by Subject|2|||
129440419|NCT02240693|465911433|FG003|Overall Study|Withdrawal by Subject|1|||
129440420|NCT02240693|465911434|FG004|Overall Study|Withdrawal by Subject|0|||
129440421|NCT02240693|465911430|FG000|Overall Study|Other than specified|0|||
129440422|NCT02240693|465911431|FG001|Overall Study|Other than specified|0|||
129440423|NCT02240693|465911432|FG002|Overall Study|Other than specified|2|||
129440424|NCT02240693|465911433|FG003|Overall Study|Other than specified|0|||
129440425|NCT02240693|465911434|FG004|Overall Study|Other than specified|0|||
129440426|NCT01585987|465911435|FG000|Randomized|Withdrawal by Subject|0|||
129440427|NCT01585987|465911436|FG001|Randomized|Withdrawal by Subject|4|||
129440428|NCT01585987|465911435|FG000|Randomized|No longer met criteria|0|||
129440429|NCT01585987|465911436|FG001|Randomized|No longer met criteria|2|||
129440430|NCT01585987|465911435|FG000|Treated|Disease Progression|39|||
129440431|NCT01585987|465911436|FG001|Treated|Disease Progression|36|||
129440432|NCT01585987|465911435|FG000|Treated|Study Drug Toxicity|9|||
129634217|NCT01420068|466615075|FG000|Overall Study|Administrative problems|1|||
129634218|NCT01420068|466615076|FG001|Overall Study|Administrative problems|3|||
129634219|NCT01420068|466615075|FG000|Overall Study|Withdrawal by Subject|1|||
129634220|NCT01420068|466615076|FG001|Overall Study|Withdrawal by Subject|2|||
129634221|NCT02554682|466615077|FG000|Overall Study|Lost to Follow-up|11|||
129440433|NCT01585987|465911436|FG001|Treated|Study Drug Toxicity|5|||
129440434|NCT01585987|465911435|FG000|Treated|Adverse Event|3|||
129634222|NCT02554682|466615078|FG001|Overall Study|Lost to Follow-up|9|||
129795811|NCT01401959|467219640|FG002|Treated|Disease Progression|1|||
129795812|NCT01401959|467219638|FG000|Treated|Adverse Event|4|||
129440435|NCT01585987|465911436|FG001|Treated|Adverse Event|0|||
129440436|NCT01585987|465911435|FG000|Treated|Withdrawal by Subject|1|||
129795813|NCT01401959|467219639|FG001|Treated|Adverse Event|3|||
129795814|NCT01401959|467219640|FG002|Treated|Adverse Event|2|||
129795815|NCT01401959|467219638|FG000|Treated|Withdrawal by Subject|1|||
129440437|NCT01585987|465911436|FG001|Treated|Withdrawal by Subject|2|||
129634223|NCT02554682|466615079|FG002|Overall Study|Lost to Follow-up|4|||
129634224|NCT02554682|466615080|FG003|Overall Study|Lost to Follow-up|3|||
129634225|NCT02554682|466615081|FG004|Overall Study|Lost to Follow-up|2|||
129634226|NCT02554682|466615082|FG005|Overall Study|Lost to Follow-up|1|||
129795816|NCT01401959|467219639|FG001|Treated|Withdrawal by Subject|2|||
129795817|NCT01401959|467219640|FG002|Treated|Withdrawal by Subject|2|||
129795818|NCT01401959|467219638|FG000|Treated|Protocol Violation|0|||
129795819|NCT01401959|467219639|FG001|Treated|Protocol Violation|1|||
129795820|NCT01401959|467219640|FG002|Treated|Protocol Violation|0|||
129795821|NCT00887744|467219641|FG000|Overall Study|Adverse Event|3|||
129795822|NCT00887744|467219641|FG000|Overall Study|Death|1|||
129795823|NCT00887744|467219641|FG000|Overall Study|Lost to Follow-up|3|||
129634227|NCT02554682|466615083|FG006|Overall Study|Lost to Follow-up|6|||
129634228|NCT02554682|466615084|FG007|Overall Study|Lost to Follow-up|6|||
129634229|NCT02554682|466615085|FG008|Overall Study|Lost to Follow-up|2|||
129634230|NCT02554682|466615086|FG009|Overall Study|Lost to Follow-up|2|||
129634231|NCT02554682|466615077|FG000|Overall Study|Withdrawal by Subject|2|||
129634232|NCT02554682|466615078|FG001|Overall Study|Withdrawal by Subject|1|||
129634233|NCT02554682|466615079|FG002|Overall Study|Withdrawal by Subject|0|||
129634234|NCT02554682|466615080|FG003|Overall Study|Withdrawal by Subject|0|||
129634235|NCT02554682|466615081|FG004|Overall Study|Withdrawal by Subject|0|||
129634236|NCT02554682|466615082|FG005|Overall Study|Withdrawal by Subject|0|||
129634237|NCT02554682|466615083|FG006|Overall Study|Withdrawal by Subject|0|||
129634238|NCT02554682|466615084|FG007|Overall Study|Withdrawal by Subject|0|||
129634239|NCT02554682|466615085|FG008|Overall Study|Withdrawal by Subject|0|||
129634240|NCT02554682|466615086|FG009|Overall Study|Withdrawal by Subject|0|||
129634241|NCT02554682|466615077|FG000|Overall Study|Physician Decision|2|||
129795824|NCT00887744|467219641|FG000|Overall Study|Withdrawal by Subject|18|||
129795825|NCT00887744|467219641|FG000|Overall Study|Various reasons|9|||
129795826|NCT00450385|467219648|FG000|Overall Study|Death|3|||
129795827|NCT00450385|467219648|FG000|Overall Study|Protocol Violation|1|||
129795828|NCT00450385|467219648|FG000|Overall Study|Withdrawal by Subject|2|||
129795829|NCT00450385|467219648|FG000|Overall Study|Lack of Efficacy|2|||
129795830|NCT00450385|467219648|FG000|Overall Study|Adverse Event|1|||
129795831|NCT00450385|467219648|FG000|Overall Study|Physician Decision|1|||
129795832|NCT00450385|467219648|FG000|Overall Study|Other|3|||
129795833|NCT01390220|467219654|FG000|Test Dose Phase|Adverse Event|17|||
129795834|NCT01390220|467219655|FG001|Test Dose Phase|Adverse Event|0|||
129795835|NCT01390220|467219656|FG002|Test Dose Phase|Adverse Event|0|||
129795836|NCT01390220|467219654|FG000|Test Dose Phase|Withdrawal by Subject|8|||
129795837|NCT01390220|467219655|FG001|Test Dose Phase|Withdrawal by Subject|0|||
129795838|NCT01390220|467219656|FG002|Test Dose Phase|Withdrawal by Subject|0|||
129795839|NCT01390220|467219654|FG000|Test Dose Phase|Lost to Follow-up|2|||
129795840|NCT01390220|467219655|FG001|Test Dose Phase|Lost to Follow-up|0|||
129795841|NCT01390220|467219656|FG002|Test Dose Phase|Lost to Follow-up|0|||
129634242|NCT02554682|466615078|FG001|Overall Study|Physician Decision|2|||
129634243|NCT02554682|466615079|FG002|Overall Study|Physician Decision|0|||
129634244|NCT02554682|466615080|FG003|Overall Study|Physician Decision|0|||
129795842|NCT01390220|467219654|FG000|Test Dose Phase|Protocol Violation|8|||
129795843|NCT01390220|467219655|FG001|Test Dose Phase|Protocol Violation|0|||
129634245|NCT02554682|466615081|FG004|Overall Study|Physician Decision|0|||
129795844|NCT01390220|467219656|FG002|Test Dose Phase|Protocol Violation|0|||
129795845|NCT01390220|467219654|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
129440438|NCT01585987|465911435|FG000|Treated|Death|1|||
129440439|NCT01585987|465911436|FG001|Treated|Death|0|||
129440440|NCT01585987|465911435|FG000|Treated|Lost to Follow-up|0|||
129440441|NCT01585987|465911436|FG001|Treated|Lost to Follow-up|1|||
129440442|NCT01585987|465911435|FG000|Treated|Maximum Clinical Benefit|0|||
129440443|NCT01585987|465911436|FG001|Treated|Maximum Clinical Benefit|1|||
129440444|NCT01585987|465911435|FG000|Treated|Non-Specified|1|||
129440445|NCT01585987|465911436|FG001|Treated|Non-Specified|2|||
129795846|NCT01390220|467219655|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
129795847|NCT01390220|467219656|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
129795848|NCT01390220|467219654|FG000|Test Dose Phase|Study/Site closure|6|||
129795849|NCT01390220|467219655|FG001|Test Dose Phase|Study/Site closure|0|||
129795850|NCT01390220|467219656|FG002|Test Dose Phase|Study/Site closure|0|||
129795851|NCT01390220|467219654|FG000|Test Dose Phase|Caregiver no longer available|5|||
129440446|NCT01585987|465911435|FG000|Treated|Subject Request|0|||
129795852|NCT01390220|467219655|FG001|Test Dose Phase|Caregiver no longer available|0|||
129795853|NCT01390220|467219656|FG002|Test Dose Phase|Caregiver no longer available|0|||
129795854|NCT01390220|467219654|FG000|Test Dose Phase|Noncompliance|2|||
129795855|NCT01390220|467219655|FG001|Test Dose Phase|Noncompliance|0|||
129795856|NCT01390220|467219656|FG002|Test Dose Phase|Noncompliance|0|||
129795857|NCT01390220|467219654|FG000|Test Dose Phase|Logistical|6|||
129795858|NCT01390220|467219655|FG001|Test Dose Phase|Logistical|0|||
129795859|NCT01390220|467219656|FG002|Test Dose Phase|Logistical|0|||
129795860|NCT01390220|467219654|FG000|Comparative Phase|Withdrawal by Subject|0|||
129795861|NCT01390220|467219655|FG001|Comparative Phase|Withdrawal by Subject|1|||
129795862|NCT01390220|467219656|FG002|Comparative Phase|Withdrawal by Subject|0|||
129795863|NCT03063203|467219657|FG000|Overall Study|Chose alternative therapy|3|||
129795864|NCT03063203|467219657|FG000|Overall Study|Death|2|||
129795865|NCT03063203|467219657|FG000|Overall Study|Disease progression|4|||
129795866|NCT03063203|467219657|FG000|Overall Study|Physician Decision|5|||
129795867|NCT02045303|467219658|FG000|Overall Study|Protocol Violation|2|||
129795868|NCT02045303|467219659|FG001|Overall Study|Protocol Violation|1|||
129795869|NCT02045303|467219660|FG002|Overall Study|Protocol Violation|0|||
129795870|NCT02045303|467219658|FG000|Overall Study|Withdrawal by Subject|0|||
129795871|NCT02045303|467219659|FG001|Overall Study|Withdrawal by Subject|2|||
129795872|NCT02045303|467219660|FG002|Overall Study|Withdrawal by Subject|0|||
129795873|NCT01856023|467219661|FG000|Overall Study|Death|1|||
129795874|NCT01856023|467219662|FG001|Overall Study|Death|2|||
129795875|NCT01856023|467219661|FG000|Overall Study|Adverse Event|2|||
129795876|NCT01856023|467219662|FG001|Overall Study|Adverse Event|1|||
129795877|NCT01856023|467219661|FG000|Overall Study|Lack of Efficacy|5|||
129795878|NCT01856023|467219662|FG001|Overall Study|Lack of Efficacy|5|||
129795879|NCT01856023|467219661|FG000|Overall Study|non compliance, study closure|1|||
129795880|NCT01856023|467219662|FG001|Overall Study|non compliance, study closure|3|||
129795881|NCT01856023|467219661|FG000|Overall Study|Withdrawal by Subject|1|||
129795882|NCT01856023|467219662|FG001|Overall Study|Withdrawal by Subject|1|||
129795883|NCT00829283|467219665|FG000|Overall Study|Lost to Follow-up|7|||
129795884|NCT00829283|467219666|FG001|Overall Study|Lost to Follow-up|25|||
129795885|NCT04718103|467219667|FG000|Overall Study|Adverse Event|1|||
129795886|NCT04718103|467219668|FG001|Overall Study|Adverse Event|1|||
129795887|NCT04718103|467219667|FG000|Overall Study|Lack of Efficacy|4|||
129795888|NCT04718103|467219668|FG001|Overall Study|Lack of Efficacy|1|||
129795889|NCT04718103|467219667|FG000|Overall Study|Lost to Follow-up|2|||
129795890|NCT04718103|467219668|FG001|Overall Study|Lost to Follow-up|2|||
129795891|NCT04718103|467219667|FG000|Overall Study|Physician Decision|2|||
129795892|NCT04718103|467219668|FG001|Overall Study|Physician Decision|0|||
129795893|NCT04718103|467219667|FG000|Overall Study|Pregnancy|0|||
129795894|NCT04718103|467219668|FG001|Overall Study|Pregnancy|1|||
129795895|NCT04718103|467219667|FG000|Overall Study|Withdrawal by Subject|10|||
129795896|NCT04718103|467219668|FG001|Overall Study|Withdrawal by Subject|6|||
129889186|NCT02846558|467551020|FG002|Overall Study|Lost to Follow-up|0|||
129889187|NCT02846558|467551021|FG003|Overall Study|Lost to Follow-up|0|||
129795897|NCT04718103|467219667|FG000|Overall Study|Randomized, not treated|4|||
129795898|NCT04718103|467219668|FG001|Overall Study|Randomized, not treated|1|||
129889188|NCT00904150|467551031|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
129889189|NCT00904150|467551032|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
129440447|NCT01585987|465911436|FG001|Treated|Subject Request|1|||
129440448|NCT01585987|465911435|FG000|Treated|Poor/Non-Compliance|0|||
129795899|NCT04718103|467219667|FG000|Overall Study|GCP violations|7|||
129795900|NCT04718103|467219668|FG001|Overall Study|GCP violations|5|||
129795901|NCT00136604|467219669|FG000|Overall Study|Lost to Follow-up|1|||
129440449|NCT01585987|465911436|FG001|Treated|Poor/Non-Compliance|1|||
129795902|NCT00136604|467219670|FG001|Overall Study|Lost to Follow-up|0|||
129795903|NCT00136604|467219671|FG002|Overall Study|Lost to Follow-up|0|||
129440450|NCT00413972|465911440|FG000|Overall Study|Adverse Event|2|||
129440451|NCT00413972|465911441|FG001|Overall Study|Adverse Event|1|||
129440452|NCT00413972|465911442|FG002|Overall Study|Adverse Event|0|||
129795904|NCT00136604|467219672|FG003|Overall Study|Lost to Follow-up|0|||
129795905|NCT00136604|467219673|FG004|Overall Study|Lost to Follow-up|1|||
129795906|NCT00136604|467219669|FG000|Overall Study|Migrated/moved from study area|0|||
129795907|NCT00136604|467219670|FG001|Overall Study|Migrated/moved from study area|1|||
129795908|NCT00136604|467219671|FG002|Overall Study|Migrated/moved from study area|0|||
129795909|NCT00136604|467219672|FG003|Overall Study|Migrated/moved from study area|0|||
129795910|NCT00136604|467219673|FG004|Overall Study|Migrated/moved from study area|0|||
129795911|NCT01309893|467219675|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
129795912|NCT01309893|467219676|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
129795913|NCT01309893|467219675|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
129795914|NCT01309893|467219676|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
129795915|NCT00321893|467219678|FG000|Overall Study|Non-Compliance/Refusal|16|||
129795916|NCT00321893|467219679|FG001|Overall Study|Non-Compliance/Refusal|10|||
129795917|NCT00321893|467219678|FG000|Overall Study|Lost to Follow-up|2|||
129795918|NCT00321893|467219679|FG001|Overall Study|Lost to Follow-up|1|||
129634246|NCT02554682|466615082|FG005|Overall Study|Physician Decision|0|||
129634247|NCT02554682|466615083|FG006|Overall Study|Physician Decision|0|||
129634248|NCT02554682|466615084|FG007|Overall Study|Physician Decision|0|||
129634249|NCT02554682|466615085|FG008|Overall Study|Physician Decision|0|||
129634250|NCT02554682|466615086|FG009|Overall Study|Physician Decision|0|||
129634251|NCT00884117|466615089|FG000|Overall Study|Adverse Event|2|||
129795919|NCT00321893|467219678|FG000|Overall Study|Adverse Event|6|||
129795920|NCT00321893|467219679|FG001|Overall Study|Adverse Event|3|||
129795921|NCT00769483|467219680|FG000|Overall Study|Withdrawal by Subject|0|||
129795922|NCT00769483|467219681|FG001|Overall Study|Withdrawal by Subject|1|||
129795923|NCT00769483|467219682|FG002|Overall Study|Withdrawal by Subject|0|||
129795924|NCT00769483|467219683|FG003|Overall Study|Withdrawal by Subject|0|||
129795925|NCT00769483|467219684|FG004|Overall Study|Withdrawal by Subject|1|||
129795926|NCT00769483|467219685|FG005|Overall Study|Withdrawal by Subject|0|||
129795927|NCT00999921|467219689|FG000|Overall Study|Lost to Follow-up|10|||
129795928|NCT00999921|467219690|FG001|Overall Study|Lost to Follow-up|19|||
129795929|NCT03500679|467219697|FG000|Overall Study|Lost to Follow-up|6|||
129795930|NCT03500679|467219698|FG001|Overall Study|Lost to Follow-up|3|||
129795931|NCT03500679|467219697|FG000|Overall Study|Withdrawal by Subject|3|||
129795932|NCT03500679|467219698|FG001|Overall Study|Withdrawal by Subject|0|||
129795933|NCT01962922|467219699|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
129795934|NCT01962922|467219700|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
129795935|NCT01962922|467219699|FG000|PK Portion Day 7|non-compliance|1|||
129795936|NCT01962922|467219700|FG001|PK Portion Day 7|non-compliance|0|||
129795937|NCT01962922|467219699|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
129795938|NCT01962922|467219700|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
129795939|NCT01962922|467219699|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
129795940|NCT01962922|467219700|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
129795941|NCT03670836|467219701|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
129795942|NCT03670836|467219702|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
129795943|NCT03670836|467219701|FG000|Per Protocol Population (PP)|Physician Decision|9|||
129795944|NCT03670836|467219702|FG001|Per Protocol Population (PP)|Physician Decision|10|||
129795945|NCT03670836|467219701|FG000|Per Protocol Population (PP)|Physician Decision|4|||
129795946|NCT03670836|467219702|FG001|Per Protocol Population (PP)|Physician Decision|6|||
129795947|NCT03670836|467219701|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
129795948|NCT03670836|467219702|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
129795949|NCT02582255|467221539|FG000|Overall Study|Protocol Violation|0|||
129795950|NCT02582255|467221540|FG001|Overall Study|Protocol Violation|3|||
129795951|NCT03034200|467221545|FG000|Overall Study|Disease progression|8|||
129795952|NCT03034200|467221546|FG001|Overall Study|Disease progression|10|||
129795953|NCT03034200|467221547|FG002|Overall Study|Disease progression|4|||
129795954|NCT03034200|467221545|FG000|Overall Study|Physician Decision|2|||
129795955|NCT03034200|467221546|FG001|Overall Study|Physician Decision|0|||
129795956|NCT03034200|467221547|FG002|Overall Study|Physician Decision|3|||
129795957|NCT03034200|467221545|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
129795958|NCT03034200|467221546|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
129795959|NCT03034200|467221547|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
129795960|NCT03034200|467221545|FG000|Overall Study|Adjuvant Therapy|0|||
129795961|NCT03034200|467221546|FG001|Overall Study|Adjuvant Therapy|0|||
129440453|NCT00413972|465911443|FG003|Overall Study|Adverse Event|0|||
129634252|NCT00884117|466615089|FG000|Overall Study|Withdrawal by Subject|89|||
129634253|NCT00884117|466615089|FG000|Overall Study|Death|3|||
129795962|NCT03034200|467221547|FG002|Overall Study|Adjuvant Therapy|1|||
129795963|NCT01466179|467221548|FG000|Overall Study|Ongoing in core study|2|||
129795964|NCT01466179|467221548|FG000|Overall Study|Physician Decision|46|||
129440454|NCT00413972|465911440|FG000|Overall Study|Lost to Follow-up|1|||
129634254|NCT00884117|466615089|FG000|Overall Study|Lost to Follow-up|143|||
129634255|NCT00884117|466615089|FG000|Overall Study|Other|12|||
129795965|NCT01466179|467221548|FG000|Overall Study|Progressive disease|43|||
129795966|NCT01466179|467221548|FG000|Overall Study|Adverse Event|32|||
129795967|NCT01466179|467221548|FG000|Overall Study|Disease relapse|23|||
129795968|NCT01466179|467221548|FG000|Overall Study|Lack of Efficacy|14|||
129795969|NCT01466179|467221548|FG000|Overall Study|Death|7|||
129795970|NCT01466179|467221548|FG000|Overall Study|Withdrawal by Subject|7|||
129795971|NCT01466179|467221548|FG000|Overall Study|Protocol Violation|2|||
129795972|NCT01466179|467221548|FG000|Overall Study|Other|3|||
129795973|NCT00749580|467221549|FG000|Overall Study|Lost to Follow-up|4|||
129795974|NCT00749580|467221550|FG001|Overall Study|Lost to Follow-up|8|||
129795975|NCT00749580|467221549|FG000|Overall Study|Adverse Event|0|||
129795976|NCT00749580|467221550|FG001|Overall Study|Adverse Event|1|||
129795977|NCT03489551|467221554|FG000|Overall Study|Withdrawal by Subject|2|||
129795978|NCT00054717|467221555|FG000|Overall Study|Randomized but not treated|2|||
129795979|NCT00054717|467221556|FG001|Overall Study|Randomized but not treated|8|||
129795980|NCT00054717|467221555|FG000|Overall Study|Adverse Event|70|||
129795981|NCT00054717|467221556|FG001|Overall Study|Adverse Event|22|||
129795982|NCT00054717|467221555|FG000|Overall Study|Protocol Violation|18|||
129795983|NCT00054717|467221556|FG001|Overall Study|Protocol Violation|19|||
129795984|NCT00054717|467221555|FG000|Overall Study|Lost to Follow-up|23|||
129795985|NCT00054717|467221556|FG001|Overall Study|Lost to Follow-up|13|||
129795986|NCT00054717|467221555|FG000|Overall Study|Withdrawal by Subject|32|||
129795987|NCT00054717|467221556|FG001|Overall Study|Withdrawal by Subject|20|||
129795988|NCT00054717|467221555|FG000|Overall Study|Other reason not defined above|117|||
129795989|NCT00054717|467221556|FG001|Overall Study|Other reason not defined above|217|||
129795990|NCT04565236|467221557|FG000|Overall Study|Patient/Guardian Decision|0|||
129795991|NCT04565236|467221558|FG001|Overall Study|Patient/Guardian Decision|0|||
129795992|NCT04565236|467221559|FG002|Overall Study|Patient/Guardian Decision|1|||
129795993|NCT04565236|467221560|FG003|Overall Study|Patient/Guardian Decision|0|||
129795994|NCT04423939|467221561|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
129795995|NCT04423939|467221562|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
129795996|NCT04423939|467221561|FG000|Overall Study|Death|3|||
129795997|NCT04423939|467221562|FG001|Overall Study|Death|0|||
129795998|NCT04423939|467221561|FG000|Overall Study|Withdrawal by Subject|3|||
129795999|NCT04423939|467221562|FG001|Overall Study|Withdrawal by Subject|0|||
129796000|NCT04423939|467221561|FG000|Overall Study|Caregiver to patient who died|0|||
129796001|NCT04423939|467221562|FG001|Overall Study|Caregiver to patient who died|3|||
129796002|NCT04423939|467221561|FG000|Overall Study|Caregiver to patient who withdrew|0|||
129796003|NCT04423939|467221562|FG001|Overall Study|Caregiver to patient who withdrew|3|||
129796004|NCT04626310|467221565|FG000|Overall Study|4-miss from treatment|6|||
129796005|NCT04626310|467221566|FG001|Overall Study|4-miss from treatment|5|||
129796006|NCT04626310|467221567|FG002|Overall Study|4-miss from treatment|5|||
129796007|NCT04626310|467221565|FG000|Overall Study|Withdrawal by Subject|1|||
129796008|NCT04626310|467221566|FG001|Overall Study|Withdrawal by Subject|0|||
129796009|NCT04626310|467221567|FG002|Overall Study|Withdrawal by Subject|3|||
129796010|NCT00287079|467221569|FG000|Overall Study|Qualifying relapse|12|||
129796011|NCT00287079|467221570|FG001|Overall Study|Qualifying relapse|1|||
129796012|NCT00287079|467221569|FG000|Overall Study|Non-qualifying relapse|1|||
129796013|NCT00287079|467221570|FG001|Overall Study|Non-qualifying relapse|0|||
129796014|NCT00287079|467221569|FG000|Overall Study|Adverse Event|5|||
129796015|NCT00287079|467221570|FG001|Overall Study|Adverse Event|0|||
129796016|NCT00287079|467221569|FG000|Overall Study|Protocol Violation|1|||
129796017|NCT00287079|467221570|FG001|Overall Study|Protocol Violation|0|||
129796018|NCT00287079|467221569|FG000|Overall Study|Other|3|||
129796019|NCT00287079|467221570|FG001|Overall Study|Other|0|||
129796020|NCT00423670|467221573|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
129796021|NCT00423670|467221574|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796022|NCT00423670|467221575|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796023|NCT00423670|467221576|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796024|NCT00423670|467221577|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796025|NCT00423670|467221578|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796026|NCT00423670|467221579|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796027|NCT00423670|467221580|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
129796028|NCT00423670|467221573|FG000|Treatment Period|Adverse Event|8|||
129796029|NCT00423670|467221574|FG001|Treatment Period|Adverse Event|12|||
129796030|NCT00423670|467221575|FG002|Treatment Period|Adverse Event|15|||
129796031|NCT00423670|467221576|FG003|Treatment Period|Adverse Event|20|||
129796032|NCT00423670|467221577|FG004|Treatment Period|Adverse Event|9|||
129634256|NCT04830969|466615092|FG000|Overall Study|Withdrawal by Subject|6|||
129634257|NCT04830969|466615093|FG001|Overall Study|Withdrawal by Subject|2|||
129634258|NCT04830969|466615092|FG000|Overall Study|Protocol Violation|3|||
129796033|NCT00423670|467221578|FG005|Treatment Period|Adverse Event|4|||
129796034|NCT00423670|467221579|FG006|Treatment Period|Adverse Event|7|||
129796035|NCT00423670|467221580|FG007|Treatment Period|Adverse Event|2|||
129634259|NCT04830969|466615093|FG001|Overall Study|Protocol Violation|9|||
129796036|NCT00423670|467221573|FG000|Treatment Period|Protocol-defined clinical event|0|||
129796037|NCT00423670|467221574|FG001|Treatment Period|Protocol-defined clinical event|7|||
129796038|NCT00423670|467221575|FG002|Treatment Period|Protocol-defined clinical event|4|||
129796039|NCT00423670|467221576|FG003|Treatment Period|Protocol-defined clinical event|12|||
129796040|NCT00423670|467221577|FG004|Treatment Period|Protocol-defined clinical event|5|||
129796041|NCT00423670|467221578|FG005|Treatment Period|Protocol-defined clinical event|4|||
129796042|NCT00423670|467221579|FG006|Treatment Period|Protocol-defined clinical event|16|||
129796043|NCT00423670|467221580|FG007|Treatment Period|Protocol-defined clinical event|15|||
129796044|NCT00423670|467221573|FG000|Treatment Period|Lost to Follow-up|2|||
129796045|NCT00423670|467221574|FG001|Treatment Period|Lost to Follow-up|1|||
129796046|NCT00423670|467221575|FG002|Treatment Period|Lost to Follow-up|3|||
129889190|NCT00904150|467551031|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
129889191|NCT00904150|467551032|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
129889192|NCT04129580|467552520|FG000|Overall Study|Lost to Follow-up|14|||
129889193|NCT04129580|467552521|FG001|Overall Study|Lost to Follow-up|25|||
129889194|NCT00224133|467552524|FG000|Overall Study|Adverse Event|93|||
129889195|NCT00224133|467552524|FG000|Overall Study|Protocol Violation|6|||
129889196|NCT00224133|467552524|FG000|Overall Study|Withdrawal by Subject|33|||
129889197|NCT00224133|467552524|FG000|Overall Study|Lack of Efficacy|58|||
129889198|NCT00224133|467552524|FG000|Overall Study|Lost to Follow-up|21|||
129889199|NCT00224133|467552524|FG000|Overall Study|Physician Decision|1|||
129889200|NCT00224133|467552524|FG000|Overall Study|Other|14|||
129889201|NCT02056119|467552529|FG000|Overall Study|Death|1|||
129889202|NCT02056119|467552530|FG001|Overall Study|Death|2|||
129889203|NCT02056119|467552529|FG000|Overall Study|Intubated for less than 24 hrs|2|||
129889204|NCT02056119|467552530|FG001|Overall Study|Intubated for less than 24 hrs|7|||
129889205|NCT02056119|467552529|FG000|Overall Study|No aerosol treatments were given.|3|||
129889206|NCT02056119|467552530|FG001|Overall Study|No aerosol treatments were given.|2|||
129889207|NCT02056119|467552529|FG000|Overall Study|Received Metaneb treatment|0|||
129889208|NCT02056119|467552530|FG001|Overall Study|Received Metaneb treatment|2|||
129889209|NCT02056119|467552529|FG000|Overall Study|Protocol Violation|4|||
129889210|NCT02056119|467552530|FG001|Overall Study|Protocol Violation|7|||
129889211|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
129889212|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
129889213|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
129889214|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
129889215|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
129889216|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
129889217|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
129889218|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
129796047|NCT00423670|467221576|FG003|Treatment Period|Lost to Follow-up|1|||
129634260|NCT04830969|466615092|FG000|Overall Study|Lost to Follow-up|4|||
129634261|NCT04830969|466615093|FG001|Overall Study|Lost to Follow-up|4|||
129634262|NCT01153815|466615098|FG000|Overall Study|Adverse Event|3|||
129634263|NCT01153815|466615099|FG001|Overall Study|Adverse Event|1|||
129634264|NCT01153815|466615098|FG000|Overall Study|Withdrawal by Subject|6|||
129634265|NCT01153815|466615099|FG001|Overall Study|Withdrawal by Subject|4|||
129634266|NCT01786993|466615100|FG000|Overall Study|Death|6|||
129634267|NCT01786993|466615101|FG001|Overall Study|Death|7|||
129634268|NCT01786993|466615100|FG000|Overall Study|Withdrawal by Subject|3|||
129796048|NCT00423670|467221577|FG004|Treatment Period|Lost to Follow-up|6|||
129796049|NCT00423670|467221578|FG005|Treatment Period|Lost to Follow-up|0|||
129796050|NCT00423670|467221579|FG006|Treatment Period|Lost to Follow-up|3|||
129796051|NCT00423670|467221580|FG007|Treatment Period|Lost to Follow-up|1|||
129796052|NCT00423670|467221573|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
129796053|NCT00423670|467221574|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
129634269|NCT01786993|466615101|FG001|Overall Study|Withdrawal by Subject|2|||
129634270|NCT01786993|466615100|FG000|Overall Study|Lost to Follow-up|0|||
129634271|NCT01786993|466615101|FG001|Overall Study|Lost to Follow-up|1|||
129634272|NCT01786993|466615100|FG000|Overall Study|Subject Non-Compliance|1|||
129634273|NCT01786993|466615101|FG001|Overall Study|Subject Non-Compliance|0|||
129634274|NCT01786993|466615100|FG000|Overall Study|System Explant|1|||
129796054|NCT00423670|467221575|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
129796055|NCT00423670|467221576|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
129796056|NCT00423670|467221577|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
129796057|NCT00423670|467221578|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
129634275|NCT01786993|466615101|FG001|Overall Study|System Explant|0|||
129634276|NCT01786993|466615100|FG000|Overall Study|Hospice Admission|1|||
129634277|NCT01786993|466615101|FG001|Overall Study|Hospice Admission|0|||
129634278|NCT01890122|466615102|FG000|Overall Study|Adverse Event|1|||
129634279|NCT01890122|466615103|FG001|Overall Study|Adverse Event|1|||
129796058|NCT00423670|467221579|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
129889219|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
129796059|NCT00423670|467221580|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
129796060|NCT00423670|467221573|FG000|Treatment Period|Investigator decision|0|||
129796061|NCT00423670|467221574|FG001|Treatment Period|Investigator decision|0|||
129796062|NCT00423670|467221575|FG002|Treatment Period|Investigator decision|0|||
129796063|NCT00423670|467221576|FG003|Treatment Period|Investigator decision|0|||
129796064|NCT00423670|467221577|FG004|Treatment Period|Investigator decision|0|||
129796065|NCT00423670|467221578|FG005|Treatment Period|Investigator decision|0|||
129796066|NCT00423670|467221579|FG006|Treatment Period|Investigator decision|0|||
129796067|NCT00423670|467221580|FG007|Treatment Period|Investigator decision|1|||
129796068|NCT00423670|467221573|FG000|Treatment Period|Non-compliance with protocol|3|||
129796069|NCT00423670|467221574|FG001|Treatment Period|Non-compliance with protocol|1|||
129796070|NCT00423670|467221575|FG002|Treatment Period|Non-compliance with protocol|1|||
129796071|NCT00423670|467221576|FG003|Treatment Period|Non-compliance with protocol|3|||
129796072|NCT00423670|467221577|FG004|Treatment Period|Non-compliance with protocol|2|||
129796073|NCT00423670|467221578|FG005|Treatment Period|Non-compliance with protocol|0|||
129796074|NCT00423670|467221579|FG006|Treatment Period|Non-compliance with protocol|2|||
129796075|NCT00423670|467221580|FG007|Treatment Period|Non-compliance with protocol|2|||
129796076|NCT00423670|467221573|FG000|Follow-up Period|Lost to Follow-up|0|||
129796077|NCT00423670|467221574|FG001|Follow-up Period|Lost to Follow-up|12|||
129796078|NCT00423670|467221575|FG002|Follow-up Period|Lost to Follow-up|8|||
129796079|NCT00423670|467221576|FG003|Follow-up Period|Lost to Follow-up|3|||
129796080|NCT00423670|467221577|FG004|Follow-up Period|Lost to Follow-up|1|||
129796081|NCT00423670|467221578|FG005|Follow-up Period|Lost to Follow-up|0|||
129796082|NCT00423670|467221579|FG006|Follow-up Period|Lost to Follow-up|5|||
129796083|NCT00423670|467221580|FG007|Follow-up Period|Lost to Follow-up|0|||
129796084|NCT00423670|467221573|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796085|NCT00423670|467221574|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
129796086|NCT00423670|467221575|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
129796087|NCT00423670|467221576|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796088|NCT00423670|467221577|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796089|NCT00423670|467221578|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
129796090|NCT00423670|467221579|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796091|NCT00423670|467221580|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
129796092|NCT00423670|467221573|FG000|Follow-up Period|Non-compliance with protocol|2|||
129796093|NCT00423670|467221574|FG001|Follow-up Period|Non-compliance with protocol|0|||
129796094|NCT00423670|467221575|FG002|Follow-up Period|Non-compliance with protocol|1|||
129796095|NCT00423670|467221576|FG003|Follow-up Period|Non-compliance with protocol|1|||
129796096|NCT00423670|467221577|FG004|Follow-up Period|Non-compliance with protocol|0|||
129796097|NCT00423670|467221578|FG005|Follow-up Period|Non-compliance with protocol|0|||
129796098|NCT00423670|467221579|FG006|Follow-up Period|Non-compliance with protocol|3|||
129796099|NCT00423670|467221580|FG007|Follow-up Period|Non-compliance with protocol|2|||
129796100|NCT01082640|467221581|FG000|Overall Study|Adverse Event|9|||
129796101|NCT01082640|467221582|FG001|Overall Study|Adverse Event|5|||
129796102|NCT01082640|467221583|FG002|Overall Study|Adverse Event|3|||
129796103|NCT01082640|467221581|FG000|Overall Study|Withdrawal by Subject|3|||
129796104|NCT01082640|467221582|FG001|Overall Study|Withdrawal by Subject|3|||
129796105|NCT01082640|467221583|FG002|Overall Study|Withdrawal by Subject|2|||
129796106|NCT01082640|467221581|FG000|Overall Study|Major protocol deviation|3|||
129796107|NCT01082640|467221582|FG001|Overall Study|Major protocol deviation|3|||
129796108|NCT01082640|467221583|FG002|Overall Study|Major protocol deviation|0|||
129796109|NCT01082640|467221581|FG000|Overall Study|Lost to Follow-up|0|||
129796110|NCT01082640|467221582|FG001|Overall Study|Lost to Follow-up|3|||
129796111|NCT01082640|467221583|FG002|Overall Study|Lost to Follow-up|0|||
129796112|NCT01082640|467221581|FG000|Overall Study|Other|2|||
129796113|NCT01082640|467221582|FG001|Overall Study|Other|1|||
129796114|NCT01082640|467221583|FG002|Overall Study|Other|3|||
129796115|NCT03190369|467221588|FG000|Overall Study|Poor compliance to protocol|0|||
129796116|NCT03190369|467221589|FG001|Overall Study|Poor compliance to protocol|1|||
129796117|NCT03190369|467221588|FG000|Overall Study|Withdraw before treatment|1|||
129796118|NCT03190369|467221589|FG001|Overall Study|Withdraw before treatment|5|||
129796119|NCT03190369|467221588|FG000|Overall Study|Randomized but not treated|0|||
129796120|NCT03190369|467221589|FG001|Overall Study|Randomized but not treated|2|||
129796121|NCT02011893|467221590|FG000|Enrollment to Randomization|Adverse Event|2|||
129796122|NCT02011893|467221591|FG001|Enrollment to Randomization|Adverse Event|0|||
129796123|NCT02011893|467221592|FG002|Enrollment to Randomization|Adverse Event|0|||
129796124|NCT02011893|467221590|FG000|Enrollment to Randomization|Physician Decision|10|||
129796125|NCT02011893|467221591|FG001|Enrollment to Randomization|Physician Decision|0|||
129796126|NCT02011893|467221592|FG002|Enrollment to Randomization|Physician Decision|0|||
129796127|NCT02011893|467221590|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
129796128|NCT02011893|467221591|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
129796129|NCT02011893|467221592|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
129796130|NCT02011893|467221590|FG000|Enrollment to Randomization|Screening Failure|29|||
129440455|NCT00413972|465911441|FG001|Overall Study|Lost to Follow-up|2|||
129704289|NCT01323192|466880519|FG001|Overall Study|Noncompliance with study medication|3|||
129704290|NCT01323192|466880518|FG000|Overall Study|Nonmedical reasons|0|||
129704291|NCT01323192|466880519|FG001|Overall Study|Nonmedical reasons|1|||
129704292|NCT02296476|466880520|FG000|Overall Study|Disease Progression|6|||
129704293|NCT02296476|466880521|FG001|Overall Study|Disease Progression|4|||
129704294|NCT02296476|466880522|FG002|Overall Study|Disease Progression|2|||
129704295|NCT00442702|466880523|FG000|Titration Period|Adverse Event|2|||
129704296|NCT00442702|466880524|FG001|Titration Period|Adverse Event|0|||
129704297|NCT00442702|466880523|FG000|Titration Period|Death|3|||
129704298|NCT00442702|466880524|FG001|Titration Period|Death|2|||
129704299|NCT00442702|466880523|FG000|Titration Period|Insufficient Therapeutic Response|1|||
129704300|NCT00442702|466880524|FG001|Titration Period|Insufficient Therapeutic Response|0|||
129704301|NCT00442702|466880523|FG000|Titration Period|Refused Treatment|4|||
129704302|NCT00442702|466880524|FG001|Titration Period|Refused Treatment|1|||
129704303|NCT00442702|466880523|FG000|Titration Period|Failure to return|1|||
129704304|NCT00442702|466880524|FG001|Titration Period|Failure to return|0|||
129704305|NCT00442702|466880523|FG000|Titration Period|Hospitalized in another hospital|1|||
129704306|NCT00442702|466880524|FG001|Titration Period|Hospitalized in another hospital|0|||
129704307|NCT00442702|466880523|FG000|Evaluation Period|Adverse Event|1|||
129704308|NCT00442702|466880524|FG001|Evaluation Period|Adverse Event|0|||
129704309|NCT00442702|466880523|FG000|Evaluation Period|Death|1|||
129704310|NCT00442702|466880524|FG001|Evaluation Period|Death|1|||
129704311|NCT00442702|466880523|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
129704312|NCT00442702|466880524|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
129704313|NCT00442702|466880523|FG000|Evaluation Period|Refused treatment|1|||
129704314|NCT00442702|466880524|FG001|Evaluation Period|Refused treatment|1|||
129704315|NCT00442702|466880523|FG000|Evaluation Period|Renal transplant|0|||
129704316|NCT00442702|466880524|FG001|Evaluation Period|Renal transplant|1|||
129704317|NCT00442702|466880523|FG000|Evaluation Period|Failure to return|1|||
129704318|NCT00442702|466880524|FG001|Evaluation Period|Failure to return|0|||
129704319|NCT00442702|466880523|FG000|Evaluation Period|Site closure|0|||
129704320|NCT00442702|466880524|FG001|Evaluation Period|Site closure|1|||
129704321|NCT03122184|466880531|FG000|Overall Study|Lost to Follow-up|4|||
129704322|NCT03122184|466880532|FG001|Overall Study|Lost to Follow-up|6|||
129704323|NCT03122184|466880531|FG000|Overall Study|Withdrawal by Subject|3|||
129704324|NCT03122184|466880532|FG001|Overall Study|Withdrawal by Subject|0|||
129704325|NCT03122184|466880531|FG000|Overall Study|Terminated due to cognitive problem|1|||
129704326|NCT03122184|466880532|FG001|Overall Study|Terminated due to cognitive problem|0|||
129704327|NCT02835690|466880533|FG000|Overall Study|Death|12|||
129704328|NCT02835690|466880534|FG001|Overall Study|Death|11|||
129704329|NCT02835690|466880535|FG002|Overall Study|Death|13|||
129704330|NCT02835690|466880533|FG000|Overall Study|Transferred to Extension Study|2|||
129704331|NCT02835690|466880534|FG001|Overall Study|Transferred to Extension Study|2|||
129704332|NCT02835690|466880535|FG002|Overall Study|Transferred to Extension Study|1|||
129704333|NCT02835690|466880533|FG000|Overall Study|Did Not Continue on Extension Study|0|||
129704334|NCT02835690|466880534|FG001|Overall Study|Did Not Continue on Extension Study|0|||
129704335|NCT02835690|466880535|FG002|Overall Study|Did Not Continue on Extension Study|1|||
129704336|NCT02835690|466880533|FG000|Overall Study|Not Treated|0|||
129704337|NCT02835690|466880534|FG001|Overall Study|Not Treated|2|||
129704338|NCT02835690|466880535|FG002|Overall Study|Not Treated|0|||
129704339|NCT00710593|466880536|FG000|Overall Study|Incarceration|1|||
129704340|NCT00710593|466880537|FG001|Overall Study|Incarceration|0|||
129704341|NCT00710593|466880536|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
129704342|NCT00710593|466880537|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
129704343|NCT00710593|466880536|FG000|Overall Study|Lost to Follow-up|3|||
129704344|NCT00710593|466880537|FG001|Overall Study|Lost to Follow-up|1|||
129704345|NCT00710593|466880536|FG000|Overall Study|Moved out of area|1|||
129704346|NCT00710593|466880537|FG001|Overall Study|Moved out of area|0|||
129704347|NCT00710593|466880536|FG000|Overall Study|Failure to adhere or complete study eval|1|||
129704348|NCT00710593|466880537|FG001|Overall Study|Failure to adhere or complete study eval|1|||
129704349|NCT00710593|466880536|FG000|Overall Study|Protocol Violation|1|||
129704350|NCT00710593|466880537|FG001|Overall Study|Protocol Violation|1|||
129704351|NCT00710593|466880536|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
129704352|NCT00710593|466880537|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
129704353|NCT04490278|466880538|FG000|Overall Study|Lost to Follow-up|6|||
129704354|NCT02829996|466880539|FG000|Overall Study|Withdrawal by Subject|1|||
129704355|NCT02829996|466880540|FG001|Overall Study|Withdrawal by Subject|0|||
129704356|NCT02829996|466880541|FG002|Overall Study|Withdrawal by Subject|0|||
129704357|NCT02829996|466880542|FG003|Overall Study|Withdrawal by Subject|0|||
129704358|NCT02829996|466880543|FG004|Overall Study|Withdrawal by Subject|0|||
129704359|NCT03186638|466880544|FG000|Overall Study|Withdrawal by Subject|4|||
129704360|NCT03186638|466880545|FG001|Overall Study|Withdrawal by Subject|4|||
129704361|NCT03186638|466880544|FG000|Overall Study|Withdrawn due to medical problem|3|||
129704362|NCT03186638|466880545|FG001|Overall Study|Withdrawn due to medical problem|2|||
129704363|NCT03186638|466880544|FG000|Overall Study|Lost to Follow-up|1|||
129796131|NCT02011893|467221591|FG001|Enrollment to Randomization|Screening Failure|0|||
129796132|NCT02011893|467221592|FG002|Enrollment to Randomization|Screening Failure|0|||
129796133|NCT02011893|467221590|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
129796134|NCT02011893|467221591|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
129796135|NCT02011893|467221592|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
129796136|NCT02011893|467221590|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
129796137|NCT02011893|467221591|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
129796138|NCT02011893|467221592|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
129634280|NCT01890122|466615104|FG002|Overall Study|Adverse Event|1|||
129634281|NCT01890122|466615105|FG003|Overall Study|Adverse Event|2|||
129634282|NCT01890122|466615102|FG000|Overall Study|Major Protocol Deviation|3|||
129634283|NCT01890122|466615103|FG001|Overall Study|Major Protocol Deviation|1|||
129634284|NCT01890122|466615104|FG002|Overall Study|Major Protocol Deviation|0|||
129634285|NCT01890122|466615105|FG003|Overall Study|Major Protocol Deviation|1|||
129634286|NCT01890122|466615102|FG000|Overall Study|Lost to Follow-up|0|||
129634287|NCT01890122|466615103|FG001|Overall Study|Lost to Follow-up|1|||
129634288|NCT01890122|466615104|FG002|Overall Study|Lost to Follow-up|2|||
129634289|NCT01890122|466615105|FG003|Overall Study|Lost to Follow-up|2|||
129634290|NCT01890122|466615102|FG000|Overall Study|Voluntary Withdrawal|8|||
129634291|NCT01890122|466615103|FG001|Overall Study|Voluntary Withdrawal|8|||
129634292|NCT01890122|466615104|FG002|Overall Study|Voluntary Withdrawal|2|||
129634293|NCT01890122|466615105|FG003|Overall Study|Voluntary Withdrawal|11|||
129634294|NCT01890122|466615102|FG000|Overall Study|Lack of Efficacy|14|||
129634295|NCT01890122|466615103|FG001|Overall Study|Lack of Efficacy|24|||
129634296|NCT01890122|466615104|FG002|Overall Study|Lack of Efficacy|7|||
129634297|NCT01890122|466615105|FG003|Overall Study|Lack of Efficacy|41|||
129634298|NCT01890122|466615102|FG000|Overall Study|Reason not Specified|0|||
129634299|NCT01890122|466615103|FG001|Overall Study|Reason not Specified|1|||
129634300|NCT01890122|466615104|FG002|Overall Study|Reason not Specified|1|||
129634301|NCT01890122|466615105|FG003|Overall Study|Reason not Specified|2|||
129634302|NCT01890122|466615102|FG000|Overall Study|Randomized but not Treated|1|||
129634303|NCT01890122|466615103|FG001|Overall Study|Randomized but not Treated|1|||
129796139|NCT02011893|467221590|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
129796140|NCT02011893|467221591|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
129796141|NCT02011893|467221592|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
129796142|NCT02011893|467221590|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
129796143|NCT02011893|467221591|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
129796144|NCT02011893|467221592|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
129796145|NCT02011893|467221590|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
129796146|NCT02011893|467221591|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
129796147|NCT02011893|467221592|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
129796148|NCT01241240|467221593|FG000|Overall Study|Adverse Event|5|||
129796149|NCT01241240|467221594|FG001|Overall Study|Adverse Event|4|||
129796150|NCT01241240|467221593|FG000|Overall Study|Lost to Follow-up|2|||
129796151|NCT01241240|467221594|FG001|Overall Study|Lost to Follow-up|4|||
129796152|NCT01241240|467221593|FG000|Overall Study|Personal Reasons|1|||
129796153|NCT01241240|467221594|FG001|Overall Study|Personal Reasons|1|||
129796154|NCT00450112|467221595|FG000|Overall Study|Other Treatment Required|5|||
129796155|NCT00450112|467221596|FG001|Overall Study|Other Treatment Required|1|||
129796156|NCT00450112|467221595|FG000|Overall Study|Withdrawal by Subject|4|||
129796157|NCT00450112|467221596|FG001|Overall Study|Withdrawal by Subject|1|||
129796158|NCT00450112|467221595|FG000|Overall Study|Lost to Follow-up|2|||
129796159|NCT00450112|467221596|FG001|Overall Study|Lost to Follow-up|1|||
129796160|NCT00450112|467221595|FG000|Overall Study|Others|2|||
129796161|NCT00450112|467221596|FG001|Overall Study|Others|3|||
129796162|NCT05153473|467221597|FG000|Overall Study|Death|46|||
129796163|NCT05153473|467221597|FG000|Overall Study|Lost to Follow-up|3|||
129634304|NCT01890122|466615104|FG002|Overall Study|Randomized but not Treated|0|||
129634305|NCT01890122|466615105|FG003|Overall Study|Randomized but not Treated|0|||
129634306|NCT02505217|466615109|FG000|Overall Study|Withdrawal by Subject|1|||
129634307|NCT02505217|466615110|FG001|Overall Study|Withdrawal by Subject|2|||
129634308|NCT00153179|466615120|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
129634309|NCT00153179|466615121|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
129634310|NCT00153179|466615122|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
129634311|NCT00153179|466615123|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
129796164|NCT02962765|467221598|FG000|Overall Study|Protocol Violation|9|||
129796165|NCT02962765|467221598|FG000|Overall Study|Withdrawal by Subject|3|||
129796166|NCT02962765|467221598|FG000|Overall Study|Lost to Follow-up|1|||
129796167|NCT02962765|467221598|FG000|Overall Study|Death|1|||
129796168|NCT02962765|467221598|FG000|Overall Study|Limited access to study medication|3|||
129634312|NCT04495829|466615124|FG000|Overall Study|Lost to Follow-up|2|||
129634313|NCT04495829|466615124|FG000|Overall Study|Inclusion criterion not met|3|||
129796169|NCT00064298|467221603|FG000|Overall Study|Withdrawal by Subject|2|||
129796170|NCT00064298|467221604|FG001|Overall Study|Withdrawal by Subject|1|||
129796171|NCT00064298|467221603|FG000|Overall Study|Lost to Follow-up|2|||
129796172|NCT00064298|467221604|FG001|Overall Study|Lost to Follow-up|2|||
129796173|NCT00064298|467221603|FG000|Overall Study|Death|0|||
129796174|NCT00064298|467221604|FG001|Overall Study|Death|1|||
129796175|NCT00064298|467221603|FG000|Overall Study|Disease Progression|2|||
129796176|NCT00064298|467221604|FG001|Overall Study|Disease Progression|1|||
129796177|NCT03614975|467221605|FG000|Overall Study|Physician Decision|7|||
129796178|NCT03614975|467221606|FG001|Overall Study|Physician Decision|5|||
129796179|NCT03614975|467221605|FG000|Overall Study|Withdrawal by Subject|2|||
129796180|NCT03614975|467221606|FG001|Overall Study|Withdrawal by Subject|2|||
129796181|NCT03614975|467221605|FG000|Overall Study|Specimens not in lab batch shipment|1|||
129796182|NCT03614975|467221606|FG001|Overall Study|Specimens not in lab batch shipment|1|||
129796183|NCT01569464|467221607|FG000|Overall Study|Adverse Event|4|||
129796184|NCT01569464|467221608|FG001|Overall Study|Adverse Event|0|||
129796185|NCT01569464|467221607|FG000|Overall Study|Lack of Efficacy|1|||
129796186|NCT01569464|467221608|FG001|Overall Study|Lack of Efficacy|0|||
129796187|NCT01569464|467221607|FG000|Overall Study|Protocol Violation|1|||
129796188|NCT01569464|467221608|FG001|Overall Study|Protocol Violation|0|||
129796189|NCT01569464|467221607|FG000|Overall Study|Lost to Follow-up|2|||
129796190|NCT01569464|467221608|FG001|Overall Study|Lost to Follow-up|3|||
129796191|NCT01569464|467221607|FG000|Overall Study|Withdrawal by Subject|1|||
129796192|NCT01569464|467221608|FG001|Overall Study|Withdrawal by Subject|1|||
129796193|NCT01569464|467221607|FG000|Overall Study|Other|1|||
129796194|NCT01569464|467221608|FG001|Overall Study|Other|1|||
129796195|NCT03533686|467221609|FG000|Overall Study|Withdrawal by Subject|1|||
129796196|NCT03533686|467221610|FG001|Overall Study|Withdrawal by Subject|0|||
129796197|NCT03533686|467221611|FG002|Overall Study|Withdrawal by Subject|0|||
129796198|NCT03533686|467221612|FG003|Overall Study|Withdrawal by Subject|3|||
129796199|NCT03533686|467221613|FG004|Overall Study|Withdrawal by Subject|5|||
129796200|NCT03533686|467221614|FG005|Overall Study|Withdrawal by Subject|1|||
129796201|NCT03533686|467221609|FG000|Overall Study|Lost to Follow-up|0|||
129796202|NCT03533686|467221610|FG001|Overall Study|Lost to Follow-up|1|||
129796203|NCT03533686|467221611|FG002|Overall Study|Lost to Follow-up|0|||
129796204|NCT03533686|467221612|FG003|Overall Study|Lost to Follow-up|0|||
129796205|NCT03533686|467221613|FG004|Overall Study|Lost to Follow-up|2|||
129796206|NCT03533686|467221614|FG005|Overall Study|Lost to Follow-up|0|||
129796207|NCT03533686|467221609|FG000|Overall Study|Screen Failure|0|||
129796208|NCT03533686|467221610|FG001|Overall Study|Screen Failure|0|||
129796209|NCT03533686|467221611|FG002|Overall Study|Screen Failure|0|||
129796210|NCT03533686|467221612|FG003|Overall Study|Screen Failure|2|||
129796211|NCT03533686|467221613|FG004|Overall Study|Screen Failure|0|||
129796212|NCT03533686|467221614|FG005|Overall Study|Screen Failure|0|||
129634314|NCT02712554|466615127|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
129634315|NCT02712554|466615128|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
129634316|NCT02712554|466615127|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
129634317|NCT02712554|466615128|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
129634318|NCT02712554|466615127|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
129634319|NCT02712554|466615128|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
129634320|NCT02712554|466615127|FG000|Part B: Qualification Phase|Adverse Event|0|||
129634321|NCT02712554|466615128|FG001|Part B: Qualification Phase|Adverse Event|1|||
129634322|NCT02712554|466615127|FG000|Part B: Treatment Phase|Adverse Event|0|||
129634323|NCT02712554|466615128|FG001|Part B: Treatment Phase|Adverse Event|1|||
129634324|NCT02712554|466615127|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
129634325|NCT02712554|466615128|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
129634326|NCT02712554|466615127|FG000|Part B: Treatment Phase|Other|0|||
129634327|NCT02712554|466615128|FG001|Part B: Treatment Phase|Other|1|||
129634328|NCT00979654|466615129|FG000|Overall Study|Lost to Follow-up|1|||
129634329|NCT00979654|466615129|FG000|Overall Study|Withdrawal by Subject|22|||
129634330|NCT00979654|466615129|FG000|Overall Study|Death|1|||
129634331|NCT00979654|466615129|FG000|Overall Study|Lack of Efficacy|6|||
129634332|NCT00979654|466615129|FG000|Overall Study|Adverse Event|1|||
129634333|NCT00979654|466615129|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
129634334|NCT00979654|466615129|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
129634335|NCT00979654|466615129|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
129634336|NCT00979654|466615129|FG000|Overall Study|Serious Adverse Event|1|||
129634337|NCT00979654|466615129|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
129634338|NCT01129557|466615130|FG000|Overall Study|Adverse Event|1|||
129634339|NCT01129557|466615131|FG001|Overall Study|Adverse Event|2|||
129634340|NCT01129557|466615132|FG002|Overall Study|Adverse Event|2|||
129634341|NCT01129557|466615130|FG000|Overall Study|Novartis terminated study early|3|||
129634342|NCT01129557|466615131|FG001|Overall Study|Novartis terminated study early|3|||
129796213|NCT00245583|467221615|FG000|Overall Study|Lost to Follow-up|1|||
129796214|NCT00245583|467221616|FG001|Overall Study|Lost to Follow-up|5|||
129796215|NCT00245583|467221615|FG000|Overall Study|Adverse Event|2|||
129796216|NCT00245583|467221616|FG001|Overall Study|Adverse Event|1|||
129796217|NCT00245583|467221615|FG000|Overall Study|Lack of Efficacy|1|||
129796218|NCT00245583|467221616|FG001|Overall Study|Lack of Efficacy|0|||
129796219|NCT00245583|467221615|FG000|Overall Study|Withdrawal by Subject|2|||
129796220|NCT00245583|467221616|FG001|Overall Study|Withdrawal by Subject|3|||
129796221|NCT02414139|467221617|FG000|Treatment Period|Adverse Event|11|||
129796222|NCT02414139|467221618|FG001|Treatment Period|Adverse Event|6|||
129796223|NCT02414139|467221619|FG002|Treatment Period|Adverse Event|8|||
129796224|NCT02414139|467221620|FG003|Treatment Period|Adverse Event|5|||
129796225|NCT02414139|467221621|FG004|Treatment Period|Adverse Event|14|||
129796226|NCT02414139|467221622|FG005|Treatment Period|Adverse Event|3|||
129796227|NCT02414139|467221623|FG006|Treatment Period|Adverse Event|6|||
129796228|NCT02414139|467221624|FG007|Treatment Period|Adverse Event|1|||
129796229|NCT02414139|467221625|FG008|Treatment Period|Adverse Event|6|||
129796230|NCT02414139|467221626|FG009|Treatment Period|Adverse Event|8|||
129796231|NCT02414139|467221617|FG000|Treatment Period|Death|0|||
129796232|NCT02414139|467221618|FG001|Treatment Period|Death|0|||
129796233|NCT02414139|467221619|FG002|Treatment Period|Death|1|||
129796234|NCT02414139|467221620|FG003|Treatment Period|Death|1|||
129796235|NCT02414139|467221621|FG004|Treatment Period|Death|0|||
129796236|NCT02414139|467221622|FG005|Treatment Period|Death|0|||
129796237|NCT02414139|467221623|FG006|Treatment Period|Death|0|||
129796238|NCT02414139|467221624|FG007|Treatment Period|Death|0|||
129796239|NCT02414139|467221625|FG008|Treatment Period|Death|0|||
129796240|NCT02414139|467221626|FG009|Treatment Period|Death|1|||
129796241|NCT02414139|467221617|FG000|Treatment Period|Physician Decision|5|||
129796242|NCT02414139|467221618|FG001|Treatment Period|Physician Decision|4|||
129796243|NCT02414139|467221619|FG002|Treatment Period|Physician Decision|6|||
129796244|NCT02414139|467221620|FG003|Treatment Period|Physician Decision|1|||
129796245|NCT02414139|467221621|FG004|Treatment Period|Physician Decision|4|||
129796246|NCT02414139|467221622|FG005|Treatment Period|Physician Decision|0|||
129796247|NCT02414139|467221623|FG006|Treatment Period|Physician Decision|2|||
129796248|NCT02414139|467221624|FG007|Treatment Period|Physician Decision|0|||
129796249|NCT02414139|467221625|FG008|Treatment Period|Physician Decision|1|||
129796250|NCT02414139|467221626|FG009|Treatment Period|Physician Decision|4|||
129796251|NCT02414139|467221617|FG000|Treatment Period|Progressive disease|48|||
129796252|NCT02414139|467221618|FG001|Treatment Period|Progressive disease|31|||
129796253|NCT02414139|467221619|FG002|Treatment Period|Progressive disease|37|||
129796254|NCT02414139|467221620|FG003|Treatment Period|Progressive disease|21|||
129796255|NCT02414139|467221621|FG004|Treatment Period|Progressive disease|43|||
129796256|NCT02414139|467221622|FG005|Treatment Period|Progressive disease|12|||
129796257|NCT02414139|467221623|FG006|Treatment Period|Progressive disease|16|||
129796258|NCT02414139|467221624|FG007|Treatment Period|Progressive disease|2|||
129796259|NCT02414139|467221625|FG008|Treatment Period|Progressive disease|20|||
129796260|NCT02414139|467221626|FG009|Treatment Period|Progressive disease|14|||
129796261|NCT02414139|467221617|FG000|Treatment Period|Protocol deviation|0|||
129796262|NCT02414139|467221618|FG001|Treatment Period|Protocol deviation|0|||
129796263|NCT02414139|467221619|FG002|Treatment Period|Protocol deviation|1|||
129796264|NCT02414139|467221620|FG003|Treatment Period|Protocol deviation|0|||
129796265|NCT02414139|467221621|FG004|Treatment Period|Protocol deviation|0|||
129796266|NCT02414139|467221622|FG005|Treatment Period|Protocol deviation|0|||
129796267|NCT02414139|467221623|FG006|Treatment Period|Protocol deviation|0|||
129796268|NCT02414139|467221624|FG007|Treatment Period|Protocol deviation|0|||
129796269|NCT02414139|467221625|FG008|Treatment Period|Protocol deviation|0|||
129796270|NCT02414139|467221626|FG009|Treatment Period|Protocol deviation|0|||
129796271|NCT02414139|467221617|FG000|Treatment Period|Subject/Guardian decision|5|||
129796272|NCT02414139|467221618|FG001|Treatment Period|Subject/Guardian decision|1|||
129796273|NCT02414139|467221619|FG002|Treatment Period|Subject/Guardian decision|1|||
129796274|NCT02414139|467221620|FG003|Treatment Period|Subject/Guardian decision|2|||
129796275|NCT02414139|467221621|FG004|Treatment Period|Subject/Guardian decision|5|||
129796276|NCT02414139|467221622|FG005|Treatment Period|Subject/Guardian decision|0|||
129796277|NCT02414139|467221623|FG006|Treatment Period|Subject/Guardian decision|2|||
129796278|NCT02414139|467221624|FG007|Treatment Period|Subject/Guardian decision|0|||
129796279|NCT02414139|467221625|FG008|Treatment Period|Subject/Guardian decision|1|||
129796280|NCT02414139|467221626|FG009|Treatment Period|Subject/Guardian decision|1|||
129796281|NCT02414139|467221617|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796282|NCT02414139|467221618|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796283|NCT02414139|467221619|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796284|NCT02414139|467221620|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796285|NCT02414139|467221621|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
129796286|NCT02414139|467221622|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796287|NCT02414139|467221623|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
129796288|NCT02414139|467221624|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
129796289|NCT02414139|467221625|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
129796290|NCT02414139|467221626|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
129796291|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129796292|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796293|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796294|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796295|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
129796296|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796297|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796298|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796299|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796300|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129796301|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Death|0|||
129796302|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Death|1|||
129796303|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Death|0|||
129796304|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Death|0|||
129796305|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Death|1|||
129796306|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Death|0|||
129796307|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Death|0|||
129796308|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Death|0|||
129796309|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Death|0|||
129796310|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Death|1|||
129796311|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
129796312|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796313|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796314|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796315|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796316|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796317|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796318|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796319|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796320|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129796321|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129796322|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129796323|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129796324|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129796325|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
129796326|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129796327|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129796328|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129796329|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129796330|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129796331|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
129796332|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129796333|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
129796334|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129796335|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
129796336|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
129796337|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
129796338|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
129796339|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129796340|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129796341|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796342|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
129796343|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796344|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796345|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129634343|NCT01129557|466615132|FG002|Overall Study|Novartis terminated study early|2|||
129796346|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796347|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796348|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796349|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
129796350|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
129796351|NCT02414139|467221617|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
129796352|NCT02414139|467221618|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129796353|NCT02414139|467221619|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
129796354|NCT02414139|467221620|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129796355|NCT02414139|467221621|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129796356|NCT02414139|467221622|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129796357|NCT02414139|467221623|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129796358|NCT02414139|467221624|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129796359|NCT02414139|467221625|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129796360|NCT02414139|467221626|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129796361|NCT03631355|467221627|FG000|Overall Study|Lost to Follow-up|1|||
129796362|NCT03631355|467221628|FG001|Overall Study|Lost to Follow-up|2|||
129796363|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
129796364|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
129796365|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
129796366|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
129796367|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
129796368|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
129796369|NCT01369485|467221633|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
129796370|NCT01369485|467221634|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
129796371|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
129796372|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
129796373|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
129796374|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
129796375|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
129796376|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
129796377|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
129796378|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
129796379|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
129796380|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
129796381|NCT01369485|467221633|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
129796382|NCT01369485|467221634|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
129796383|NCT00495131|467221635|FG000|Overall Study|Adverse Event|6|||
129796384|NCT00495131|467221636|FG001|Overall Study|Adverse Event|2|||
129796385|NCT00495131|467221635|FG000|Overall Study|Lack of Efficacy|0|||
129796386|NCT00495131|467221636|FG001|Overall Study|Lack of Efficacy|2|||
129796387|NCT00495131|467221635|FG000|Overall Study|Lost to Follow-up|0|||
129796388|NCT00495131|467221636|FG001|Overall Study|Lost to Follow-up|2|||
129796389|NCT00495131|467221635|FG000|Overall Study|Withdrawal by Subject|1|||
129796390|NCT00495131|467221636|FG001|Overall Study|Withdrawal by Subject|0|||
129796391|NCT00744471|467221637|FG000|Overall Study|Randomized but not treated|1|||
129796392|NCT00744471|467221638|FG001|Overall Study|Randomized but not treated|1|||
129796393|NCT00744471|467221639|FG002|Overall Study|Randomized but not treated|4|||
129796394|NCT00744471|467221640|FG003|Overall Study|Randomized but not treated|0|||
129796395|NCT00744471|467221637|FG000|Overall Study|Death|0|||
129796396|NCT00744471|467221638|FG001|Overall Study|Death|0|||
129796397|NCT00744471|467221639|FG002|Overall Study|Death|0|||
129796398|NCT00744471|467221640|FG003|Overall Study|Death|1|||
129796399|NCT00744471|467221637|FG000|Overall Study|Adverse Event|6|||
129796400|NCT00744471|467221638|FG001|Overall Study|Adverse Event|7|||
129796401|NCT00744471|467221639|FG002|Overall Study|Adverse Event|5|||
129796402|NCT00744471|467221640|FG003|Overall Study|Adverse Event|9|||
129796403|NCT00744471|467221637|FG000|Overall Study|Withdrawal by Subject|9|||
129796404|NCT00744471|467221638|FG001|Overall Study|Withdrawal by Subject|9|||
129796405|NCT00744471|467221639|FG002|Overall Study|Withdrawal by Subject|15|||
129440456|NCT00413972|465911442|FG002|Overall Study|Lost to Follow-up|1|||
129796406|NCT00744471|467221640|FG003|Overall Study|Withdrawal by Subject|12|||
129796407|NCT00744471|467221637|FG000|Overall Study|Protocol Violation|1|||
129796408|NCT00744471|467221638|FG001|Overall Study|Protocol Violation|4|||
129796409|NCT00744471|467221639|FG002|Overall Study|Protocol Violation|1|||
129796410|NCT00744471|467221640|FG003|Overall Study|Protocol Violation|2|||
129796411|NCT00744471|467221637|FG000|Overall Study|Entered extension study|41|||
129796412|NCT00744471|467221638|FG001|Overall Study|Entered extension study|84|||
129796413|NCT00744471|467221639|FG002|Overall Study|Entered extension study|100|||
129796414|NCT00744471|467221640|FG003|Overall Study|Entered extension study|91|||
129796415|NCT00744471|467221637|FG000|Overall Study|Other|2|||
129796416|NCT00744471|467221638|FG001|Overall Study|Other|3|||
129796417|NCT00744471|467221639|FG002|Overall Study|Other|6|||
129796418|NCT00744471|467221640|FG003|Overall Study|Other|2|||
129796419|NCT00744471|467221637|FG000|Overall Study|Lack of Efficacy|83|||
129796420|NCT00744471|467221638|FG001|Overall Study|Lack of Efficacy|37|||
129796421|NCT00744471|467221639|FG002|Overall Study|Lack of Efficacy|19|||
129796422|NCT00744471|467221640|FG003|Overall Study|Lack of Efficacy|31|||
129796423|NCT00744471|467221637|FG000|Overall Study|Lost to Follow-up|0|||
129796424|NCT00744471|467221638|FG001|Overall Study|Lost to Follow-up|0|||
129796425|NCT00744471|467221639|FG002|Overall Study|Lost to Follow-up|2|||
129796426|NCT00744471|467221640|FG003|Overall Study|Lost to Follow-up|0|||
129796427|NCT03224546|467221641|FG000|Overall Study|Lost to Follow-up|9|||
129796428|NCT03224546|467221642|FG001|Overall Study|Lost to Follow-up|8|||
129796429|NCT03224546|467221643|FG002|Overall Study|Lost to Follow-up|3|||
129796430|NCT03224546|467221641|FG000|Overall Study|Withdrawal by Subject|7|||
129796431|NCT03224546|467221642|FG001|Overall Study|Withdrawal by Subject|14|||
129796432|NCT03224546|467221643|FG002|Overall Study|Withdrawal by Subject|12|||
129796433|NCT04706416|467221648|FG000|Overall Study|Lost to Follow-up|2|||
129796434|NCT04706416|467221649|FG001|Overall Study|Lost to Follow-up|0|||
129796435|NCT01539317|467221653|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
129796436|NCT01539317|467221654|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
129796437|NCT00976573|467221661|FG000|Overall Study|Ineligible|0|||
129796438|NCT00976573|467221662|FG001|Overall Study|Ineligible|1|||
129796439|NCT00976573|467221661|FG000|Overall Study|Cancel prior to receiving treatment|4|||
129796440|NCT00976573|467221662|FG001|Overall Study|Cancel prior to receiving treatment|2|||
129796441|NCT02117427|467221663|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
129796442|NCT02117427|467221664|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
129796443|NCT02117427|467221665|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
129796444|NCT02117427|467221663|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
129796445|NCT02117427|467221664|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
129796446|NCT02117427|467221665|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
129796447|NCT02117427|467221663|FG000|Overall Study|Physician Decision|0|||
129796448|NCT02117427|467221664|FG001|Overall Study|Physician Decision|2|||
129796449|NCT02117427|467221665|FG002|Overall Study|Physician Decision|0|||
129796450|NCT02117427|467221663|FG000|Overall Study|No longer meets inclusion criteria|0|||
129796451|NCT02117427|467221664|FG001|Overall Study|No longer meets inclusion criteria|1|||
129796452|NCT02117427|467221665|FG002|Overall Study|No longer meets inclusion criteria|0|||
129796453|NCT02117427|467221663|FG000|Overall Study|Death|0|||
129796454|NCT02117427|467221664|FG001|Overall Study|Death|1|||
129796455|NCT02117427|467221665|FG002|Overall Study|Death|0|||
129796456|NCT02730208|467221666|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129796457|NCT02730208|467221667|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
129796458|NCT00510952|467221673|FG000|Overall Study|Adverse Event|1|||
129796459|NCT00510952|467221674|FG001|Overall Study|Adverse Event|0|||
129796460|NCT00510952|467221673|FG000|Overall Study|Entry Criteria Not Met|3|||
129796461|NCT00510952|467221674|FG001|Overall Study|Entry Criteria Not Met|1|||
129796462|NCT00510952|467221673|FG000|Overall Study|Lost to Follow-up|5|||
129796463|NCT00510952|467221674|FG001|Overall Study|Lost to Follow-up|3|||
129796464|NCT00510952|467221673|FG000|Overall Study|Physician Decision|1|||
129796465|NCT00510952|467221674|FG001|Overall Study|Physician Decision|1|||
129796466|NCT00510952|467221673|FG000|Overall Study|Protocol Violation|7|||
129796467|NCT00510952|467221674|FG001|Overall Study|Protocol Violation|4|||
129796468|NCT00510952|467221673|FG000|Overall Study|Sponsor Decision|1|||
129796469|NCT00510952|467221674|FG001|Overall Study|Sponsor Decision|0|||
129796470|NCT00510952|467221673|FG000|Overall Study|Withdrawal by Subject|6|||
129796471|NCT00510952|467221674|FG001|Overall Study|Withdrawal by Subject|7|||
129796472|NCT00510952|467221673|FG000|Overall Study|Did Not Receive Study Drug|2|||
129796473|NCT00510952|467221674|FG001|Overall Study|Did Not Receive Study Drug|0|||
129796474|NCT02793128|467221684|FG000|Overall Study|Death|4|||
129796475|NCT02793128|467221684|FG000|Overall Study|Withdrawal by Subject|2|||
129796476|NCT02793128|467221684|FG000|Overall Study|Physician Decision|1|||
129796477|NCT02793128|467221684|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
129796478|NCT02793128|467221684|FG000|Overall Study|Patient elected nephroureterectomy|1|||
129796479|NCT02359851|467221685|FG000|Overall Study|Death|1|||
129796480|NCT02359851|467221685|FG000|Overall Study|Disease progression|1|||
129796481|NCT01888003|467221686|FG000|Overall Study|Study Terminated|5|||
129796482|NCT01888003|467221687|FG001|Overall Study|Study Terminated|6|||
129796483|NCT01888003|467221688|FG002|Overall Study|Study Terminated|40|||
129796484|NCT00055471|467221689|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
129889220|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
129796485|NCT00055471|467221690|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
129796486|NCT00055471|467221691|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
129796487|NCT00055471|467221689|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
129796488|NCT00055471|467221690|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
129796489|NCT00055471|467221691|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
129796490|NCT00055471|467221689|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
129796491|NCT00055471|467221690|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
129796492|NCT00055471|467221691|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
129796493|NCT01854944|467221692|FG000|Overall Study|Withdrawal by Subject|0|||
129796494|NCT01854944|467221693|FG001|Overall Study|Withdrawal by Subject|0|||
129796495|NCT01854944|467221694|FG002|Overall Study|Withdrawal by Subject|1|||
129796496|NCT02101112|467221695|FG000|Overall Study|Adverse Event|0|||
129796497|NCT02101112|467221696|FG001|Overall Study|Adverse Event|0|||
129796498|NCT02101112|467221697|FG002|Overall Study|Adverse Event|1|||
129796499|NCT02101112|467221698|FG003|Overall Study|Adverse Event|0|||
129796500|NCT02101112|467221699|FG004|Overall Study|Adverse Event|0|||
129796501|NCT02101112|467221700|FG005|Overall Study|Adverse Event|0|||
129796502|NCT02101112|467221695|FG000|Overall Study|Withdrawal by Subject|0|||
129796503|NCT02101112|467221696|FG001|Overall Study|Withdrawal by Subject|0|||
129796504|NCT02101112|467221697|FG002|Overall Study|Withdrawal by Subject|0|||
129796505|NCT02101112|467221698|FG003|Overall Study|Withdrawal by Subject|0|||
129796506|NCT02101112|467221699|FG004|Overall Study|Withdrawal by Subject|1|||
129796507|NCT02101112|467221700|FG005|Overall Study|Withdrawal by Subject|0|||
129796508|NCT02125604|467221701|FG000|Overall Study|Other|4|||
129796509|NCT02125604|467221701|FG000|Overall Study|Investigator Decision|1|||
129796510|NCT02125604|467221701|FG000|Overall Study|Lost to Follow-up|2|||
129796511|NCT02125604|467221701|FG000|Overall Study|Consent Withdrawn|4|||
129796512|NCT02125604|467221701|FG000|Overall Study|Adverse Event|20|||
129796513|NCT04340063|467221702|FG000|Overall Study|Withdrawal by Subject|1|||
129796514|NCT04340063|467221703|FG001|Overall Study|Withdrawal by Subject|2|||
129796515|NCT04340063|467221702|FG000|Overall Study|Lost to Follow-up|3|||
129796516|NCT04340063|467221703|FG001|Overall Study|Lost to Follow-up|1|||
129796517|NCT04340063|467221702|FG000|Overall Study|Protocol Violation|0|||
129796518|NCT04340063|467221703|FG001|Overall Study|Protocol Violation|1|||
129796519|NCT01876810|467221704|FG000|Overall Study|Physician Decision|0|||
129796520|NCT01876810|467221705|FG001|Overall Study|Physician Decision|1|||
129796521|NCT01683019|467223274|FG000|Overall Study|Withdrawal by Subject|2|||
129796522|NCT01683019|467223275|FG001|Overall Study|Withdrawal by Subject|1|||
129796523|NCT01683019|467223276|FG002|Overall Study|Withdrawal by Subject|4|||
129796524|NCT00543855|467223277|FG000|Overall Study|Adverse Event|3|||
129796525|NCT00543855|467223278|FG001|Overall Study|Adverse Event|1|||
129796526|NCT00543855|467223279|FG002|Overall Study|Adverse Event|3|||
129796527|NCT00543855|467223280|FG003|Overall Study|Adverse Event|4|||
129796528|NCT00543855|467223277|FG000|Overall Study|Lost to Follow-up|0|||
129634344|NCT00669669|466615133|FG000|Overall Study|To late to start treatment|1|||
129634345|NCT01068678|466616676|FG000|Overall Study|Lack of Efficacy|3|||
129634346|NCT01068678|466616677|FG001|Overall Study|Lack of Efficacy|2|||
129796529|NCT00543855|467223278|FG001|Overall Study|Lost to Follow-up|0|||
129796530|NCT00543855|467223279|FG002|Overall Study|Lost to Follow-up|1|||
129796531|NCT00543855|467223280|FG003|Overall Study|Lost to Follow-up|0|||
129796532|NCT00543855|467223277|FG000|Overall Study|Withdrawal by Subject|0|||
129796533|NCT00543855|467223278|FG001|Overall Study|Withdrawal by Subject|1|||
129796534|NCT00543855|467223279|FG002|Overall Study|Withdrawal by Subject|2|||
129796535|NCT00543855|467223280|FG003|Overall Study|Withdrawal by Subject|0|||
129796536|NCT00543855|467223277|FG000|Overall Study|Protocol Violation|1|||
129796537|NCT00543855|467223278|FG001|Overall Study|Protocol Violation|0|||
129796538|NCT00543855|467223279|FG002|Overall Study|Protocol Violation|0|||
129796539|NCT00543855|467223280|FG003|Overall Study|Protocol Violation|0|||
129796540|NCT05828095|467223282|FG000|Overall Study|Lost to Follow-up|1|||
129796541|NCT05828095|467223283|FG001|Overall Study|Lost to Follow-up|0|||
129796542|NCT05828095|467223282|FG000|Overall Study|Reactogenicity symptom|0|||
129796543|NCT05828095|467223283|FG001|Overall Study|Reactogenicity symptom|1|||
129796544|NCT03206073|467223284|FG000|Overall Study|Participant Noncompliance|0|||
129796545|NCT03206073|467223285|FG001|Overall Study|Participant Noncompliance|1|||
129796546|NCT03206073|467223286|FG002|Overall Study|Participant Noncompliance|0|||
129796547|NCT03206073|467223287|FG003|Overall Study|Participant Noncompliance|0|||
129796548|NCT03206073|467223284|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
129796549|NCT03206073|467223285|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
129796550|NCT03206073|467223286|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
129796551|NCT03206073|467223287|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
129796552|NCT03206073|467223284|FG000|Overall Study|Death|0|||
129796553|NCT03206073|467223285|FG001|Overall Study|Death|0|||
129796554|NCT03206073|467223286|FG002|Overall Study|Death|1|||
129796555|NCT03206073|467223287|FG003|Overall Study|Death|0|||
129796556|NCT03206073|467223284|FG000|Overall Study|Taken off active treatment|0|||
129796557|NCT03206073|467223285|FG001|Overall Study|Taken off active treatment|0|||
129796558|NCT03206073|467223286|FG002|Overall Study|Taken off active treatment|3|||
129796559|NCT03206073|467223287|FG003|Overall Study|Taken off active treatment|0|||
129796560|NCT03332771|467223288|FG000|Overall Study|Adverse Event|6|||
129796561|NCT03332771|467223289|FG001|Overall Study|Adverse Event|4|||
129796562|NCT03332771|467223290|FG002|Overall Study|Adverse Event|1|||
129634347|NCT01068678|466616676|FG000|Overall Study|Protocol Violation|5|||
129889221|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
129889222|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
129889223|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
129889224|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
129889225|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
129889226|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
129889227|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
129889228|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
129889229|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
129704364|NCT03186638|466880545|FG001|Overall Study|Lost to Follow-up|0|||
129704365|NCT01263119|466880546|FG000|Period 1|Protocol Violation|2|||
129704366|NCT01263119|466880546|FG000|Period 2|Adverse Event|2|||
129704367|NCT04047446|466880547|FG000|Overall Study|Physician Decision|1|||
129889230|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
129889231|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
129889232|NCT03220737|467552531|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889233|NCT03220737|467552532|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889234|NCT03220737|467552533|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
129889235|NCT03220737|467552534|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889236|NCT03220737|467552535|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889237|NCT03220737|467552536|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889238|NCT03220737|467552537|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
129889239|NCT03220737|467552531|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889240|NCT03220737|467552532|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889241|NCT03220737|467552533|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889242|NCT03220737|467552534|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889243|NCT03220737|467552535|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
129889244|NCT03220737|467552536|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889245|NCT03220737|467552537|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
129889246|NCT03220737|467552531|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
129889247|NCT03220737|467552532|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889248|NCT03220737|467552533|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889249|NCT03220737|467552534|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889250|NCT03220737|467552535|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889251|NCT03220737|467552536|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889252|NCT03220737|467552537|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
129889253|NCT03220737|467552531|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
129889254|NCT03220737|467552532|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889255|NCT03220737|467552533|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889256|NCT03220737|467552534|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889257|NCT03220737|467552535|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889258|NCT03220737|467552536|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889259|NCT03220737|467552537|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
129889260|NCT03220737|467552531|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
129889261|NCT03220737|467552532|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129889262|NCT03220737|467552533|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129704368|NCT04047446|466880548|FG001|Overall Study|Physician Decision|0|||
129704369|NCT02367456|466880549|FG000|Overall Study|Death|8|||
129704370|NCT02367456|466880550|FG001|Overall Study|Death|24|||
129704371|NCT02367456|466880551|FG002|Overall Study|Death|17|||
129704372|NCT02367456|466880549|FG000|Overall Study|Lost to Follow-up|1|||
129704373|NCT02367456|466880550|FG001|Overall Study|Lost to Follow-up|3|||
129704374|NCT02367456|466880551|FG002|Overall Study|Lost to Follow-up|1|||
129704375|NCT02367456|466880549|FG000|Overall Study|Other reason|3|||
129704376|NCT02367456|466880550|FG001|Overall Study|Other reason|3|||
129704377|NCT02367456|466880551|FG002|Overall Study|Other reason|9|||
129704378|NCT02367456|466880549|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
129704379|NCT02367456|466880550|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
129704380|NCT02367456|466880551|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
129704381|NCT04573972|466880554|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
129704382|NCT04573972|466880555|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
129704383|NCT01517984|466880556|FG000|Overall Study|Lost to Follow-up|0|||
129704384|NCT01517984|466880557|FG001|Overall Study|Lost to Follow-up|1|||
129704385|NCT01517984|466880558|FG002|Overall Study|Lost to Follow-up|0|||
129889263|NCT03220737|467552534|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129796563|NCT03332771|467223291|FG003|Overall Study|Adverse Event|3|||
129796564|NCT03332771|467223288|FG000|Overall Study|Poor Compliance to Protocol|0|||
129796565|NCT03332771|467223289|FG001|Overall Study|Poor Compliance to Protocol|1|||
129796566|NCT03332771|467223290|FG002|Overall Study|Poor Compliance to Protocol|0|||
129796567|NCT03332771|467223291|FG003|Overall Study|Poor Compliance to Protocol|1|||
129796568|NCT03332771|467223288|FG000|Overall Study|Lost to Follow-up|2|||
129796569|NCT03332771|467223289|FG001|Overall Study|Lost to Follow-up|2|||
129796570|NCT03332771|467223290|FG002|Overall Study|Lost to Follow-up|1|||
129796571|NCT03332771|467223291|FG003|Overall Study|Lost to Follow-up|2|||
129796572|NCT03332771|467223288|FG000|Overall Study|At the Participant's own request|20|||
129796573|NCT03332771|467223289|FG001|Overall Study|At the Participant's own request|26|||
129796574|NCT03332771|467223290|FG002|Overall Study|At the Participant's own request|14|||
129796575|NCT03332771|467223291|FG003|Overall Study|At the Participant's own request|23|||
129796576|NCT03332771|467223288|FG000|Overall Study|Reason Not Specified|6|||
129796577|NCT03332771|467223289|FG001|Overall Study|Reason Not Specified|18|||
129796578|NCT03332771|467223290|FG002|Overall Study|Reason Not Specified|16|||
129796579|NCT03332771|467223291|FG003|Overall Study|Reason Not Specified|19|||
129796580|NCT00096954|467223292|FG000|Overall Study|Adverse Event|3|||
129796581|NCT00096954|467223293|FG001|Overall Study|Adverse Event|1|||
129796582|NCT00096954|467223292|FG000|Overall Study|Withdrawal by Subject|9|||
129796583|NCT00096954|467223293|FG001|Overall Study|Withdrawal by Subject|8|||
129796584|NCT00096954|467223292|FG000|Overall Study|Physician Decision|1|||
129796585|NCT00096954|467223293|FG001|Overall Study|Physician Decision|1|||
129796586|NCT00096954|467223292|FG000|Overall Study|Sponsors Decision|1|||
129796587|NCT00096954|467223293|FG001|Overall Study|Sponsors Decision|1|||
129796588|NCT00096954|467223292|FG000|Overall Study|Pregnancy|1|||
129796589|NCT00096954|467223293|FG001|Overall Study|Pregnancy|1|||
129796590|NCT00096954|467223292|FG000|Overall Study|Initiation of immunotherapy|1|||
129796591|NCT00096954|467223293|FG001|Overall Study|Initiation of immunotherapy|0|||
129796592|NCT00096954|467223292|FG000|Overall Study|Non-compliance|0|||
129796593|NCT00096954|467223293|FG001|Overall Study|Non-compliance|3|||
129796594|NCT00096954|467223292|FG000|Overall Study|Lost to Follow-up|8|||
129796595|NCT00096954|467223293|FG001|Overall Study|Lost to Follow-up|5|||
129796596|NCT04478123|467223295|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
129796597|NCT04478123|467223295|FG000|Overall Study|NE|1|||
129796598|NCT04444895|467223296|FG000|Overall Study|Adverse Event|2|||
129796599|NCT04444895|467223296|FG000|Overall Study|Lost to Follow-up|2|||
129796600|NCT04444895|467223296|FG000|Overall Study|Withdrawal by Subject|5|||
129796601|NCT03581786|467223299|FG000|Overall Study|Death|67|||
129796602|NCT03581786|467223300|FG001|Overall Study|Death|47|||
129796603|NCT03581786|467223299|FG000|Overall Study|Withdrawal by Subject|2|||
129796604|NCT03581786|467223300|FG001|Overall Study|Withdrawal by Subject|5|||
129796605|NCT03581786|467223299|FG000|Overall Study|Lost to Follow-up|7|||
129796606|NCT03581786|467223300|FG001|Overall Study|Lost to Follow-up|4|||
129796607|NCT03581786|467223299|FG000|Overall Study|reason other than specified above|0|||
129796608|NCT03581786|467223300|FG001|Overall Study|reason other than specified above|1|||
129796609|NCT05523323|467223301|FG000|Overall Study|Death|26|||
129796610|NCT05523323|467223302|FG001|Overall Study|Death|21|||
129796611|NCT05523323|467223301|FG000|Overall Study|Ongoing participants|35|||
129796612|NCT05523323|467223302|FG001|Overall Study|Ongoing participants|30|||
129796613|NCT03435640|467223303|FG000|Overall Study|Withdrawal by Subject|0|||
129796614|NCT03435640|467223304|FG001|Overall Study|Withdrawal by Subject|1|||
129796615|NCT03435640|467223305|FG002|Overall Study|Withdrawal by Subject|0|||
129796616|NCT03435640|467223306|FG003|Overall Study|Withdrawal by Subject|2|||
129796617|NCT03435640|467223307|FG004|Overall Study|Withdrawal by Subject|0|||
129796618|NCT03435640|467223308|FG005|Overall Study|Withdrawal by Subject|0|||
129796619|NCT03435640|467223309|FG006|Overall Study|Withdrawal by Subject|3|||
129889264|NCT03220737|467552535|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129889265|NCT03220737|467552536|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129796620|NCT03435640|467223310|FG007|Overall Study|Withdrawal by Subject|0|||
129796621|NCT03435640|467223311|FG008|Overall Study|Withdrawal by Subject|0|||
129796622|NCT03435640|467223312|FG009|Overall Study|Withdrawal by Subject|2|||
129796623|NCT03435640|467223313|FG010|Overall Study|Withdrawal by Subject|3|||
129796624|NCT03435640|467223303|FG000|Overall Study|Lost to Follow-up|0|||
129796625|NCT03435640|467223304|FG001|Overall Study|Lost to Follow-up|0|||
129796626|NCT03435640|467223305|FG002|Overall Study|Lost to Follow-up|1|||
129796627|NCT03435640|467223306|FG003|Overall Study|Lost to Follow-up|0|||
129796628|NCT03435640|467223307|FG004|Overall Study|Lost to Follow-up|0|||
129796629|NCT03435640|467223308|FG005|Overall Study|Lost to Follow-up|0|||
129796630|NCT03435640|467223309|FG006|Overall Study|Lost to Follow-up|0|||
129796631|NCT03435640|467223310|FG007|Overall Study|Lost to Follow-up|0|||
129796632|NCT03435640|467223311|FG008|Overall Study|Lost to Follow-up|0|||
129796633|NCT03435640|467223312|FG009|Overall Study|Lost to Follow-up|0|||
129796634|NCT03435640|467223313|FG010|Overall Study|Lost to Follow-up|0|||
129796635|NCT01347307|467223316|FG000|Overall Study|Death|0|||
129796636|NCT01347307|467223317|FG001|Overall Study|Death|4|||
129796637|NCT01347307|467223316|FG000|Overall Study|Physician Decision|0|||
129796638|NCT01347307|467223317|FG001|Overall Study|Physician Decision|1|||
129796639|NCT00920829|467223325|FG000|Allocation|No post randomization data|3|||
129796640|NCT00920829|467223326|FG001|Allocation|No post randomization data|1|||
129796641|NCT00920829|467223327|FG002|Allocation|No post randomization data|0|||
129796642|NCT00920829|467223328|FG003|Allocation|No post randomization data|2|||
129796643|NCT00920829|467223325|FG000|Available for Analysis|Withdrawal by Subject|6|||
129796644|NCT00920829|467223326|FG001|Available for Analysis|Withdrawal by Subject|6|||
129796645|NCT00920829|467223327|FG002|Available for Analysis|Withdrawal by Subject|6|||
129796646|NCT00920829|467223328|FG003|Available for Analysis|Withdrawal by Subject|10|||
129796647|NCT00920829|467223325|FG000|Available for Analysis|Required Medical Treatment|0|||
129796648|NCT00920829|467223326|FG001|Available for Analysis|Required Medical Treatment|1|||
129796649|NCT00920829|467223327|FG002|Available for Analysis|Required Medical Treatment|2|||
129796650|NCT00920829|467223328|FG003|Available for Analysis|Required Medical Treatment|0|||
129796651|NCT00920829|467223325|FG000|Available for Analysis|Adverse Event|1|||
129796652|NCT00920829|467223326|FG001|Available for Analysis|Adverse Event|2|||
129796653|NCT00920829|467223327|FG002|Available for Analysis|Adverse Event|1|||
129796654|NCT00920829|467223328|FG003|Available for Analysis|Adverse Event|0|||
129796655|NCT00920829|467223325|FG000|Available for Analysis|Death|1|||
129796656|NCT00920829|467223326|FG001|Available for Analysis|Death|0|||
129796657|NCT00920829|467223327|FG002|Available for Analysis|Death|0|||
129796658|NCT00920829|467223328|FG003|Available for Analysis|Death|0|||
129796659|NCT00920829|467223325|FG000|Available for Analysis|Protocol Violation|0|||
129796660|NCT00920829|467223326|FG001|Available for Analysis|Protocol Violation|0|||
129796661|NCT00920829|467223327|FG002|Available for Analysis|Protocol Violation|1|||
129796662|NCT00920829|467223328|FG003|Available for Analysis|Protocol Violation|0|||
129796663|NCT00920829|467223325|FG000|Available for Analysis|Required more treatment|0|||
129796664|NCT00920829|467223326|FG001|Available for Analysis|Required more treatment|2|||
129796665|NCT00920829|467223327|FG002|Available for Analysis|Required more treatment|0|||
129796666|NCT00920829|467223328|FG003|Available for Analysis|Required more treatment|1|||
129796667|NCT04533880|467223329|FG000|Overall Study|Lost to Follow-up|0|||
129796668|NCT04533880|467223330|FG001|Overall Study|Lost to Follow-up|1|||
129796669|NCT04533880|467223331|FG002|Overall Study|Lost to Follow-up|1|||
129796670|NCT01711879|467223336|FG000|Overall Study|Death|1|||
129796671|NCT01711879|467223337|FG001|Overall Study|Death|0|||
129796672|NCT02239224|467223340|FG000|Overall Study|Administrative|0|||
129796673|NCT02239224|467223341|FG001|Overall Study|Administrative|0|||
129796674|NCT02239224|467223342|FG002|Overall Study|Administrative|3|||
129796675|NCT02239224|467223343|FG003|Overall Study|Administrative|1|||
129796676|NCT03183778|467223346|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
129796677|NCT00721123|467223348|FG000|Overall Study|Adverse Event|96|||
129796678|NCT00721123|467223348|FG000|Overall Study|Death|10|||
129796679|NCT00721123|467223348|FG000|Overall Study|Insufficient Therapeutic Response|21|||
129796680|NCT00721123|467223348|FG000|Overall Study|Protocol Violation|1|||
129796681|NCT00721123|467223348|FG000|Overall Study|Refused Treatment|41|||
129796682|NCT00721123|467223348|FG000|Overall Study|Failure to Return|9|||
129796683|NCT00721123|467223348|FG000|Overall Study|Withdrawal by Subject|5|||
129796684|NCT03954041|467223357|FG000|Overall Study|Lost to Follow-up|3|||
129796685|NCT03954041|467223358|FG001|Overall Study|Lost to Follow-up|3|||
129796686|NCT03954041|467223359|FG002|Overall Study|Lost to Follow-up|6|||
129796687|NCT03954041|467223357|FG000|Overall Study|Death|4|||
129796688|NCT03954041|467223358|FG001|Overall Study|Death|0|||
129796689|NCT03954041|467223359|FG002|Overall Study|Death|1|||
129796690|NCT03954041|467223357|FG000|Overall Study|Death by neurologic criteria|0|||
129796691|NCT03954041|467223358|FG001|Overall Study|Death by neurologic criteria|0|||
129796692|NCT03954041|467223359|FG002|Overall Study|Death by neurologic criteria|1|||
129796693|NCT03954041|467223357|FG000|Overall Study|Reason not specified|7|||
129796694|NCT03954041|467223358|FG001|Overall Study|Reason not specified|4|||
129796695|NCT03954041|467223359|FG002|Overall Study|Reason not specified|2|||
129796696|NCT03954041|467223357|FG000|Overall Study|Withdrew prior to dosing|4|||
129796697|NCT03954041|467223358|FG001|Overall Study|Withdrew prior to dosing|2|||
129796698|NCT03954041|467223359|FG002|Overall Study|Withdrew prior to dosing|0|||
129634348|NCT01068678|466616677|FG001|Overall Study|Protocol Violation|1|||
129634349|NCT01068678|466616676|FG000|Overall Study|Withdrawal criteria|12|||
129634350|NCT01068678|466616677|FG001|Overall Study|Withdrawal criteria|6|||
129634351|NCT01068678|466616676|FG000|Overall Study|Unclassified|18|||
129634352|NCT01068678|466616677|FG001|Overall Study|Unclassified|15|||
129634353|NCT03055338|466616680|FG000|Overall Study|Lost to Follow-up|9|||
129634354|NCT03055338|466616681|FG001|Overall Study|Lost to Follow-up|2|||
129634355|NCT03055338|466616682|FG002|Overall Study|Lost to Follow-up|3|||
129634356|NCT03055338|466616680|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
129634357|NCT03055338|466616681|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
129634358|NCT03055338|466616682|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
129634359|NCT03055338|466616680|FG000|Overall Study|Physician Decision|0|||
129634360|NCT03055338|466616681|FG001|Overall Study|Physician Decision|0|||
129634361|NCT03055338|466616682|FG002|Overall Study|Physician Decision|2|||
129634362|NCT03055338|466616680|FG000|Overall Study|Withdrawal by Subject|9|||
129634363|NCT03055338|466616681|FG001|Overall Study|Withdrawal by Subject|8|||
129634364|NCT03055338|466616682|FG002|Overall Study|Withdrawal by Subject|7|||
129634365|NCT03058705|466616683|FG000|Overall Study|Withdrawal by Subject|2|||
129634366|NCT03058705|466616683|FG000|Overall Study|Physician Decision|2|||
129634367|NCT01682226|466616684|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
129634368|NCT01682226|466616684|FG000|Overall Study|Participants did not receive treatment|2|||
129634369|NCT01682226|466616684|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
129634370|NCT02159053|466616685|FG000|Overall Study|Death|2|||
129634371|NCT02159053|466616686|FG001|Overall Study|Death|0|||
129634372|NCT02159053|466616687|FG002|Overall Study|Death|1|||
129634373|NCT02159053|466616685|FG000|Overall Study|Physician Decision|0|||
129634374|NCT02159053|466616686|FG001|Overall Study|Physician Decision|1|||
129704386|NCT01517984|466880559|FG003|Overall Study|Lost to Follow-up|0|||
129704387|NCT01517984|466880556|FG000|Overall Study|Withdrawal by Subject|1|||
129704388|NCT01517984|466880557|FG001|Overall Study|Withdrawal by Subject|8|||
129704389|NCT01517984|466880558|FG002|Overall Study|Withdrawal by Subject|4|||
129704390|NCT01517984|466880559|FG003|Overall Study|Withdrawal by Subject|1|||
129704391|NCT01517984|466880556|FG000|Overall Study|Screen Failure|4|||
129704392|NCT01517984|466880557|FG001|Overall Study|Screen Failure|0|||
129704393|NCT01517984|466880558|FG002|Overall Study|Screen Failure|0|||
129704394|NCT01517984|466880559|FG003|Overall Study|Screen Failure|0|||
129704395|NCT01517984|466880556|FG000|Overall Study|Ineligible for randomization|0|||
129704396|NCT01517984|466880557|FG001|Overall Study|Ineligible for randomization|14|||
129704397|NCT01517984|466880558|FG002|Overall Study|Ineligible for randomization|0|||
129704398|NCT01517984|466880559|FG003|Overall Study|Ineligible for randomization|0|||
129704399|NCT01500317|466880560|FG000|Overall Study|Withdrawal by Subject|3|||
129704400|NCT01500317|466880561|FG001|Overall Study|Withdrawal by Subject|2|||
129704401|NCT01500317|466880562|FG002|Overall Study|Withdrawal by Subject|0|||
129704402|NCT00335829|466880563|FG000|Overall Study|Withdrawal by Subject|1|||
129704403|NCT00335829|466880563|FG000|Overall Study|Lost to Follow-up|1|||
129704404|NCT00335829|466880563|FG000|Overall Study|Adverse Event|1|||
129704405|NCT01038323|466880568|FG000|Overall Study|Withdrawal by Subject|3|||
129704406|NCT01038323|466880569|FG001|Overall Study|Withdrawal by Subject|2|||
129634375|NCT02159053|466616687|FG002|Overall Study|Physician Decision|1|||
129704407|NCT01038323|466880570|FG002|Overall Study|Withdrawal by Subject|4|||
129704408|NCT05552859|466880572|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
129704409|NCT05552859|466880573|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
129704410|NCT05901636|466880574|FG000|Overall Study|Lost to Follow-up|0|||
129704411|NCT05901636|466880575|FG001|Overall Study|Lost to Follow-up|1|||
129704412|NCT05901636|466880576|FG002|Overall Study|Lost to Follow-up|0|||
129704413|NCT05901636|466880577|FG003|Overall Study|Lost to Follow-up|1|||
129704414|NCT05901636|466880578|FG004|Overall Study|Lost to Follow-up|1|||
129704415|NCT05901636|466880579|FG005|Overall Study|Lost to Follow-up|3|||
129704416|NCT05901636|466880580|FG006|Overall Study|Lost to Follow-up|1|||
129704417|NCT05901636|466880574|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
129704418|NCT05901636|466880575|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
129704419|NCT05901636|466880576|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
129634376|NCT02159053|466616685|FG000|Overall Study|Lack of Efficacy|3|||
129634377|NCT02159053|466616686|FG001|Overall Study|Lack of Efficacy|4|||
129634378|NCT02159053|466616687|FG002|Overall Study|Lack of Efficacy|7|||
129634379|NCT02159053|466616685|FG000|Overall Study|Adverse Event|7|||
129704420|NCT05901636|466880577|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
129634380|NCT02159053|466616686|FG001|Overall Study|Adverse Event|6|||
129634381|NCT02159053|466616687|FG002|Overall Study|Adverse Event|5|||
129704421|NCT05901636|466880578|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
129704422|NCT05901636|466880579|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
129704423|NCT05901636|466880580|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
129796699|NCT03868124|467223360|FG000|Overall Study|Withdrawal by Subject|4|||
129634382|NCT02159053|466616685|FG000|Overall Study|Participants/guardian decision|8|||
129704424|NCT05901636|466880574|FG000|Overall Study|Withdrawal by Subject|1|||
129796700|NCT03868124|467223361|FG001|Overall Study|Withdrawal by Subject|0|||
129796701|NCT03868124|467223362|FG002|Overall Study|Withdrawal by Subject|1|||
129796702|NCT03868124|467223360|FG000|Overall Study|Physician Decision|1|||
129796703|NCT03868124|467223361|FG001|Overall Study|Physician Decision|0|||
129796704|NCT03868124|467223362|FG002|Overall Study|Physician Decision|1|||
129796705|NCT03868124|467223360|FG000|Overall Study|Lost to Follow-up|1|||
129796706|NCT03868124|467223361|FG001|Overall Study|Lost to Follow-up|1|||
129796707|NCT03868124|467223362|FG002|Overall Study|Lost to Follow-up|2|||
129796708|NCT03868124|467223360|FG000|Overall Study|Death|1|||
129796709|NCT03868124|467223361|FG001|Overall Study|Death|1|||
129796710|NCT03868124|467223362|FG002|Overall Study|Death|2|||
129796711|NCT03868124|467223360|FG000|Overall Study|Adverse Event|0|||
129796712|NCT03868124|467223361|FG001|Overall Study|Adverse Event|0|||
129796713|NCT03868124|467223362|FG002|Overall Study|Adverse Event|3|||
129796714|NCT03868124|467223360|FG000|Overall Study|Explanted|2|||
129796715|NCT03868124|467223361|FG001|Overall Study|Explanted|1|||
129796716|NCT03868124|467223362|FG002|Overall Study|Explanted|0|||
129796717|NCT03868124|467223360|FG000|Overall Study|Ongoing in study|176|||
129796718|NCT03868124|467223361|FG001|Overall Study|Ongoing in study|180|||
129796719|NCT03868124|467223362|FG002|Overall Study|Ongoing in study|183|||
129796720|NCT04177355|467223363|FG000|Overall Study|Lost to Follow-up|0|||
129796721|NCT04177355|467223364|FG001|Overall Study|Lost to Follow-up|2|||
129796722|NCT04177355|467223365|FG002|Overall Study|Lost to Follow-up|0|||
129796723|NCT04177355|467223366|FG003|Overall Study|Lost to Follow-up|1|||
129796724|NCT04177355|467223367|FG004|Overall Study|Lost to Follow-up|2|||
129796725|NCT04177355|467223368|FG005|Overall Study|Lost to Follow-up|0|||
129634383|NCT02159053|466616686|FG001|Overall Study|Participants/guardian decision|10|||
129634384|NCT02159053|466616687|FG002|Overall Study|Participants/guardian decision|6|||
129634385|NCT00457002|466616692|FG000|Overall Study|Death|40|||
129634386|NCT00457002|466616693|FG001|Overall Study|Death|47|||
129634387|NCT00457002|466616692|FG000|Overall Study|Adverse Event|284|||
129634388|NCT00457002|466616693|FG001|Overall Study|Adverse Event|260|||
129634389|NCT00457002|466616692|FG000|Overall Study|Withdrawal by Subject|299|||
129634390|NCT00457002|466616693|FG001|Overall Study|Withdrawal by Subject|271|||
129634391|NCT00457002|466616692|FG000|Overall Study|Lost to Follow-up|72|||
129634392|NCT00457002|466616693|FG001|Overall Study|Lost to Follow-up|71|||
129634393|NCT00457002|466616692|FG000|Overall Study|Poor/Non-compliance|46|||
129634394|NCT00457002|466616693|FG001|Overall Study|Poor/Non-compliance|33|||
129634395|NCT00457002|466616692|FG000|Overall Study|No longer met criteria|41|||
129634396|NCT00457002|466616693|FG001|Overall Study|No longer met criteria|37|||
129634397|NCT00457002|466616692|FG000|Overall Study|Administrative reason by Sponsor|1|||
129634398|NCT00457002|466616693|FG001|Overall Study|Administrative reason by Sponsor|0|||
129634399|NCT00457002|466616692|FG000|Overall Study|non-specified|29|||
129634400|NCT00457002|466616693|FG001|Overall Study|non-specified|38|||
129634401|NCT00457002|466616692|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
129796726|NCT04177355|467223369|FG006|Overall Study|Lost to Follow-up|1|||
129796727|NCT04177355|467223370|FG007|Overall Study|Lost to Follow-up|0|||
129796728|NCT04177355|467223371|FG008|Overall Study|Lost to Follow-up|0|||
129796729|NCT04177355|467223372|FG009|Overall Study|Lost to Follow-up|0|||
129796730|NCT04177355|467223373|FG010|Overall Study|Lost to Follow-up|0|||
129796731|NCT04177355|467223363|FG000|Overall Study|Withdrawal by Subject|0|||
129796732|NCT04177355|467223364|FG001|Overall Study|Withdrawal by Subject|0|||
129634402|NCT00457002|466616693|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
129634403|NCT00454246|466616694|FG000|Overall Study|Adverse Event|2|||
129634404|NCT00454246|466616695|FG001|Overall Study|Adverse Event|2|||
129634405|NCT00454246|466616696|FG002|Overall Study|Adverse Event|0|||
129634406|NCT00454246|466616694|FG000|Overall Study|Violation of selection criteria at entry|6|||
129634407|NCT00454246|466616695|FG001|Overall Study|Violation of selection criteria at entry|0|||
129796733|NCT04177355|467223365|FG002|Overall Study|Withdrawal by Subject|0|||
129796734|NCT04177355|467223366|FG003|Overall Study|Withdrawal by Subject|1|||
129796735|NCT04177355|467223367|FG004|Overall Study|Withdrawal by Subject|1|||
129796736|NCT04177355|467223368|FG005|Overall Study|Withdrawal by Subject|0|||
129796737|NCT04177355|467223369|FG006|Overall Study|Withdrawal by Subject|0|||
129796738|NCT04177355|467223370|FG007|Overall Study|Withdrawal by Subject|0|||
129796739|NCT04177355|467223371|FG008|Overall Study|Withdrawal by Subject|1|||
129796740|NCT04177355|467223372|FG009|Overall Study|Withdrawal by Subject|0|||
129796741|NCT04177355|467223373|FG010|Overall Study|Withdrawal by Subject|0|||
129796742|NCT00433511|467223374|FG000|Step 1|Adverse Event|50|||
129796743|NCT00433511|467223375|FG001|Step 1|Adverse Event|157|||
129796744|NCT00433511|467223376|FG002|Step 1|Adverse Event|153|||
129796745|NCT00433511|467223374|FG000|Step 1|Withdrawal by Subject|45|||
129796746|NCT00433511|467223375|FG001|Step 1|Withdrawal by Subject|143|||
129796747|NCT00433511|467223376|FG002|Step 1|Withdrawal by Subject|154|||
129796748|NCT00433511|467223374|FG000|Step 1|Death|3|||
129796749|NCT00433511|467223375|FG001|Step 1|Death|1|||
129796750|NCT00433511|467223376|FG002|Step 1|Death|1|||
129796751|NCT00433511|467223374|FG000|Step 1|Physician Decision|1|||
129634408|NCT00454246|466616696|FG002|Overall Study|Violation of selection criteria at entry|0|||
129796752|NCT00433511|467223375|FG001|Step 1|Physician Decision|4|||
129796753|NCT00433511|467223376|FG002|Step 1|Physician Decision|3|||
129634409|NCT00454246|466616694|FG000|Overall Study|Protocol Violation|1|||
129796754|NCT00433511|467223374|FG000|Step 1|Never started protocol therapy|28|||
129796755|NCT00433511|467223375|FG001|Step 1|Never started protocol therapy|64|||
129796756|NCT00433511|467223376|FG002|Step 1|Never started protocol therapy|66|||
129796757|NCT00433511|467223374|FG000|Step 1|Alternative therapy|2|||
129796758|NCT00433511|467223375|FG001|Step 1|Alternative therapy|1|||
129796759|NCT00433511|467223376|FG002|Step 1|Alternative therapy|3|||
129796760|NCT00433511|467223374|FG000|Step 1|Disease progression, relapse|5|||
129796761|NCT00433511|467223375|FG001|Step 1|Disease progression, relapse|3|||
129796762|NCT00433511|467223376|FG002|Step 1|Disease progression, relapse|3|||
129796763|NCT00433511|467223374|FG000|Step 1|Other complicating disease|2|||
129796764|NCT00433511|467223375|FG001|Step 1|Other complicating disease|6|||
129796765|NCT00433511|467223376|FG002|Step 1|Other complicating disease|3|||
129796766|NCT00433511|467223374|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
129796767|NCT00433511|467223375|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
129796768|NCT00433511|467223376|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
129796769|NCT00433511|467223374|FG000|Step 1|Suspected recurrence|0|||
129796770|NCT00433511|467223375|FG001|Step 1|Suspected recurrence|1|||
129796771|NCT00433511|467223376|FG002|Step 1|Suspected recurrence|0|||
129796772|NCT00433511|467223374|FG000|Step 1|Insurance/drug distribution issues|0|||
129796773|NCT00433511|467223375|FG001|Step 1|Insurance/drug distribution issues|1|||
129796774|NCT00433511|467223376|FG002|Step 1|Insurance/drug distribution issues|2|||
129796775|NCT00433511|467223374|FG000|Step 1|Patient moved|0|||
129796776|NCT00433511|467223375|FG001|Step 1|Patient moved|0|||
129796777|NCT00433511|467223376|FG002|Step 1|Patient moved|1|||
129796778|NCT00433511|467223374|FG000|Step 2 (Arm D)|Adverse Event|0|||
129634410|NCT00454246|466616695|FG001|Overall Study|Protocol Violation|0|||
129796779|NCT00433511|467223375|FG001|Step 2 (Arm D)|Adverse Event|0|||
129796780|NCT00433511|467223376|FG002|Step 2 (Arm D)|Adverse Event|135|||
129796781|NCT00433511|467223374|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
129796782|NCT00433511|467223375|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
129796783|NCT00433511|467223376|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
129796784|NCT00433511|467223374|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
129796785|NCT00433511|467223375|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
129796786|NCT00433511|467223376|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
129796787|NCT00433511|467223374|FG000|Step 2 (Arm D)|Physician Decision|0|||
129796788|NCT00433511|467223375|FG001|Step 2 (Arm D)|Physician Decision|0|||
129796789|NCT00433511|467223376|FG002|Step 2 (Arm D)|Physician Decision|9|||
129796790|NCT00433511|467223374|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
129796791|NCT00433511|467223375|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
129796792|NCT00433511|467223376|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
129796793|NCT00433511|467223374|FG000|Step 2 (Arm D)|Other complicating disease|0|||
129796794|NCT00433511|467223375|FG001|Step 2 (Arm D)|Other complicating disease|0|||
129796795|NCT00433511|467223376|FG002|Step 2 (Arm D)|Other complicating disease|3|||
129796796|NCT00433511|467223374|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
129796797|NCT00433511|467223375|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
129796798|NCT00433511|467223376|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
129796799|NCT00433511|467223374|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
129796800|NCT00433511|467223375|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
129796801|NCT00433511|467223376|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
129796802|NCT00433511|467223374|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
129796803|NCT00433511|467223375|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
129796804|NCT00433511|467223376|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
129796805|NCT00433511|467223374|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
129796806|NCT00433511|467223375|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
129796807|NCT00433511|467223376|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
129796808|NCT02806973|467223378|FG000|Period 1|Withdrawal by Subject|0|||
129796809|NCT02806973|467223379|FG001|Period 1|Withdrawal by Subject|2|||
129796810|NCT02806973|467223380|FG002|Period 1|Withdrawal by Subject|1|||
129634411|NCT00454246|466616696|FG002|Overall Study|Protocol Violation|0|||
129634412|NCT00454246|466616694|FG000|Overall Study|Refused Treatment|1|||
129796811|NCT02806973|467223381|FG003|Period 1|Withdrawal by Subject|1|||
129796812|NCT02806973|467223378|FG000|Period 1|Adverse Event|0|||
129796813|NCT02806973|467223379|FG001|Period 1|Adverse Event|0|||
129796814|NCT02806973|467223380|FG002|Period 1|Adverse Event|0|||
129796815|NCT02806973|467223381|FG003|Period 1|Adverse Event|1|||
129796816|NCT02806973|467223378|FG000|Period 3|Withdrawal by Subject|0|||
129796817|NCT02806973|467223379|FG001|Period 3|Withdrawal by Subject|0|||
129796818|NCT02806973|467223380|FG002|Period 3|Withdrawal by Subject|0|||
129796819|NCT02806973|467223381|FG003|Period 3|Withdrawal by Subject|3|||
129634413|NCT00454246|466616695|FG001|Overall Study|Refused Treatment|1|||
129796820|NCT02806973|467223378|FG000|Period 3|Adverse Event|0|||
129796821|NCT02806973|467223379|FG001|Period 3|Adverse Event|0|||
129796822|NCT02806973|467223380|FG002|Period 3|Adverse Event|1|||
129796823|NCT02806973|467223381|FG003|Period 3|Adverse Event|0|||
129796824|NCT04209426|467223387|FG000|Overall Study|Lost to Follow-up|3|||
129796825|NCT04209426|467223388|FG001|Overall Study|Lost to Follow-up|2|||
129634414|NCT00454246|466616696|FG002|Overall Study|Refused Treatment|0|||
129634415|NCT00454246|466616694|FG000|Overall Study|Failure to return|1|||
129634416|NCT00454246|466616695|FG001|Overall Study|Failure to return|0|||
129634417|NCT00454246|466616696|FG002|Overall Study|Failure to return|0|||
129634418|NCT00454246|466616694|FG000|Overall Study|Early termination of study|62|||
129634419|NCT00454246|466616695|FG001|Overall Study|Early termination of study|26|||
129634420|NCT00454246|466616696|FG002|Overall Study|Early termination of study|9|||
129634421|NCT02283268|466616697|FG000|Overall Study|Withdrawal by Subject|1|||
129634422|NCT01085630|466616709|FG000|Overall Study|Insufficient data|1|||
129634423|NCT01085630|466616710|FG001|Overall Study|Insufficient data|0|||
129634424|NCT01085630|466616709|FG000|Overall Study|Ineligible|3|||
129634425|NCT01085630|466616710|FG001|Overall Study|Ineligible|0|||
129634426|NCT01017874|466616711|FG000|Overall Study|Withdrawal by Subject|23|||
129634427|NCT01017874|466616712|FG001|Overall Study|Withdrawal by Subject|20|||
129634428|NCT01017874|466616711|FG000|Overall Study|Sponsor decision|3|||
129634429|NCT01017874|466616712|FG001|Overall Study|Sponsor decision|1|||
129634430|NCT01017874|466616711|FG000|Overall Study|Lost to Follow-up|3|||
129634431|NCT01017874|466616712|FG001|Overall Study|Lost to Follow-up|2|||
129634432|NCT01017874|466616711|FG000|Overall Study|Physician Decision|1|||
129634433|NCT01017874|466616712|FG001|Overall Study|Physician Decision|3|||
129634434|NCT01346696|466616713|FG000|Overall Study|Death|1|||
129634435|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
129634436|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129634437|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129634438|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129634439|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
129634440|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
129634441|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
129634442|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
129634443|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
129634444|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
129634445|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
129634446|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
129634447|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
129634448|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129634449|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129634450|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129634451|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
129634452|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129634453|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129634454|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129634455|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
129634456|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129634457|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129634458|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129634459|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
129634460|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
129634461|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
129634462|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
129634463|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
129634464|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
129634465|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
129634466|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
129634467|NCT00506415|466616724|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
129634468|NCT00506415|466616725|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129634469|NCT00506415|466616726|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129634470|NCT00506415|466616727|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129634471|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
129634472|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
129796826|NCT03355664|467223394|FG000|Overall Study|Adverse Event|1|||
129634473|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
129634474|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
129634475|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
129634476|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
129634477|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
129634478|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
129796827|NCT03355664|467223395|FG001|Overall Study|Adverse Event|2|||
129796828|NCT03355664|467223394|FG000|Overall Study|Lost to Follow-up|11|||
129796829|NCT03355664|467223395|FG001|Overall Study|Lost to Follow-up|7|||
129796830|NCT03355664|467223394|FG000|Overall Study|Protocol Violation|1|||
129796831|NCT03355664|467223395|FG001|Overall Study|Protocol Violation|2|||
129796832|NCT03355664|467223394|FG000|Overall Study|Withdrawal by Subject|2|||
129796833|NCT03355664|467223395|FG001|Overall Study|Withdrawal by Subject|1|||
129796834|NCT01751802|467223398|FG000|Overall Study|Adverse Event|4|||
129796835|NCT01751802|467223399|FG001|Overall Study|Adverse Event|2|||
129796836|NCT01484938|467223400|FG000|Overall Study|Adverse Event|2|||
129634479|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
129634480|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
129634481|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
129634482|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
129634483|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
129796837|NCT01484938|467223400|FG000|Overall Study|Lost to Follow-up|1|||
129796838|NCT01484938|467223400|FG000|Overall Study|Noncompliance|1|||
129796839|NCT01858636|467223401|FG000|Overall Study|No Device Deployment Attempted|24|||
129634484|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
129634485|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
129634486|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
129634487|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
129634488|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
129634489|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
129634490|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
129634491|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
129634492|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
129634493|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
129634494|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
129634495|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
129634496|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
129634497|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
129634498|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
129634499|NCT00506415|466616724|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
129634500|NCT00506415|466616725|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
129634501|NCT00506415|466616726|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
129634502|NCT00506415|466616727|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
129634503|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
129796840|NCT01858636|467223401|FG000|Overall Study|Physician Decision|1|||
129796841|NCT01858636|467223401|FG000|Overall Study|Death|1|||
129796842|NCT01858636|467223401|FG000|Overall Study|Lost to Follow-up|1|||
129796843|NCT01858636|467223401|FG000|Overall Study|Withdrawal by Subject|1|||
129796844|NCT01227564|467223409|FG000|Overall Study|No Longer Willing to Participate|4|||
129796845|NCT01227564|467223410|FG001|Overall Study|No Longer Willing to Participate|2|||
129796846|NCT01227564|467223411|FG002|Overall Study|No Longer Willing to Participate|5|||
129796847|NCT01227564|467223409|FG000|Overall Study|Participant moved to another town|0|||
129796848|NCT01227564|467223410|FG001|Overall Study|Participant moved to another town|0|||
129796849|NCT01227564|467223411|FG002|Overall Study|Participant moved to another town|1|||
129796850|NCT02862600|467223420|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
129796851|NCT02862600|467223420|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
129796852|NCT02862600|467223420|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
129796853|NCT02862600|467223420|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
129796854|NCT00772070|467223436|FG000|Overall Study|Lost to Follow-up|0|||
129796855|NCT00772070|467223437|FG001|Overall Study|Lost to Follow-up|8|||
129796856|NCT00772070|467223436|FG000|Overall Study|Withdrawal by Subject|0|||
129796857|NCT00772070|467223437|FG001|Overall Study|Withdrawal by Subject|2|||
129796858|NCT00772070|467223436|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
129796859|NCT00772070|467223437|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
129796860|NCT01309308|467223438|FG000|Overall Study|Lost to Follow-up|6|||
129796861|NCT01309308|467223439|FG001|Overall Study|Lost to Follow-up|4|||
129796862|NCT01017575|467223440|FG000|Overall Study|Lack of Efficacy|0|||
129796863|NCT01017575|467223441|FG001|Overall Study|Lack of Efficacy|1|||
129796864|NCT01017575|467223442|FG002|Overall Study|Lack of Efficacy|0|||
129796865|NCT01017575|467223443|FG003|Overall Study|Lack of Efficacy|1|||
129796866|NCT01017575|467223444|FG004|Overall Study|Lack of Efficacy|1|||
129796867|NCT01017575|467223440|FG000|Overall Study|Adverse Event|0|||
129796868|NCT01017575|467223441|FG001|Overall Study|Adverse Event|1|||
129796869|NCT01017575|467223442|FG002|Overall Study|Adverse Event|0|||
129796870|NCT01017575|467223443|FG003|Overall Study|Adverse Event|0|||
129634504|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
129634505|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
129634506|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
129634507|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129634508|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129634509|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
129634510|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
129634511|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129634512|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129634513|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
129634514|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
129634515|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129634516|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129634517|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
129634518|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
129634519|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129634520|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129634521|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
129634522|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
129634523|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129634524|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129634525|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
129634526|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
129634527|NCT00506415|466616724|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
129634528|NCT00506415|466616725|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
129634529|NCT00506415|466616726|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
129634530|NCT00506415|466616727|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
129634531|NCT04578457|466616728|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
129634532|NCT04578457|466616728|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
129634533|NCT04578457|466616728|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
129634534|NCT04578457|466616728|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
129634535|NCT01297517|466616744|FG000|Overall Study|Adverse Event|21|||
129634536|NCT01297517|466616745|FG001|Overall Study|Adverse Event|7|||
129634537|NCT01297517|466616746|FG002|Overall Study|Adverse Event|16|||
129634538|NCT01297517|466616744|FG000|Overall Study|Lost to Follow-up|1|||
129634539|NCT01297517|466616745|FG001|Overall Study|Lost to Follow-up|0|||
129634540|NCT01297517|466616746|FG002|Overall Study|Lost to Follow-up|1|||
129634541|NCT01297517|466616744|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
129634542|NCT01297517|466616745|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
129634543|NCT01297517|466616746|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
129634544|NCT01297517|466616744|FG000|Overall Study|Noncompliance|1|||
129634545|NCT01297517|466616745|FG001|Overall Study|Noncompliance|0|||
129634546|NCT01297517|466616746|FG002|Overall Study|Noncompliance|0|||
129634547|NCT01297517|466616744|FG000|Overall Study|Protocol Violation|1|||
129634548|NCT01297517|466616745|FG001|Overall Study|Protocol Violation|1|||
129634549|NCT01297517|466616746|FG002|Overall Study|Protocol Violation|1|||
129634550|NCT01297517|466616744|FG000|Overall Study|Inadequate Control of IOP|1|||
129634551|NCT01297517|466616745|FG001|Overall Study|Inadequate Control of IOP|1|||
129634552|NCT01297517|466616746|FG002|Overall Study|Inadequate Control of IOP|2|||
129634553|NCT00628212|466616749|FG000|Overall Study|Adverse Event|2|||
129634554|NCT00628212|466616750|FG001|Overall Study|Adverse Event|0|||
129634555|NCT00628212|466616751|FG002|Overall Study|Adverse Event|1|||
129634556|NCT00628212|466616752|FG003|Overall Study|Adverse Event|2|||
129634557|NCT00628212|466616749|FG000|Overall Study|Physician Decision|1|||
129634558|NCT00628212|466616750|FG001|Overall Study|Physician Decision|1|||
129634559|NCT00628212|466616751|FG002|Overall Study|Physician Decision|2|||
129634560|NCT00628212|466616752|FG003|Overall Study|Physician Decision|3|||
129634561|NCT00789373|466616755|FG000|Induction|Adverse Event|64|||
129634562|NCT00789373|466616756|FG001|Induction|Adverse Event|0|||
129634563|NCT00789373|466616757|FG002|Induction|Adverse Event|0|||
129634564|NCT00789373|466616755|FG000|Induction|Death Due to study disease|24|||
129634565|NCT00789373|466616756|FG001|Induction|Death Due to study disease|0|||
129634566|NCT00789373|466616757|FG002|Induction|Death Due to study disease|0|||
129634567|NCT00789373|466616755|FG000|Induction|Death due to adverse event|19|||
129634568|NCT00789373|466616756|FG001|Induction|Death due to adverse event|0|||
129634569|NCT00789373|466616757|FG002|Induction|Death due to adverse event|0|||
129634570|NCT00789373|466616755|FG000|Induction|Death due to toxicity|11|||
129634571|NCT00789373|466616756|FG001|Induction|Death due to toxicity|0|||
129634572|NCT00789373|466616757|FG002|Induction|Death due to toxicity|0|||
129634573|NCT00789373|466616755|FG000|Induction|Death due to procedure|1|||
129634574|NCT00789373|466616756|FG001|Induction|Death due to procedure|0|||
129634575|NCT00789373|466616757|FG002|Induction|Death due to procedure|0|||
129634576|NCT00789373|466616755|FG000|Induction|Investigator decision|7|||
129634577|NCT00789373|466616756|FG001|Induction|Investigator decision|0|||
129634578|NCT00789373|466616757|FG002|Induction|Investigator decision|0|||
129634579|NCT00789373|466616755|FG000|Induction|Protocol entry criteria not met|9|||
129634580|NCT00789373|466616756|FG001|Induction|Protocol entry criteria not met|0|||
129634581|NCT00789373|466616757|FG002|Induction|Protocol entry criteria not met|0|||
129634582|NCT00789373|466616755|FG000|Induction|Lost to Follow-up|6|||
129634583|NCT00789373|466616756|FG001|Induction|Lost to Follow-up|0|||
129634584|NCT00789373|466616757|FG002|Induction|Lost to Follow-up|0|||
129634585|NCT00789373|466616755|FG000|Induction|Protocol Violation|1|||
129634586|NCT00789373|466616756|FG001|Induction|Protocol Violation|0|||
129634587|NCT00789373|466616757|FG002|Induction|Protocol Violation|0|||
129634588|NCT00789373|466616755|FG000|Induction|Progressive Disease|220|||
129634589|NCT00789373|466616756|FG001|Induction|Progressive Disease|0|||
129634590|NCT00789373|466616757|FG002|Induction|Progressive Disease|0|||
129634591|NCT00789373|466616755|FG000|Induction|Withdrawal by Subject|37|||
129634592|NCT00789373|466616756|FG001|Induction|Withdrawal by Subject|0|||
129634593|NCT00789373|466616757|FG002|Induction|Withdrawal by Subject|0|||
129704425|NCT05901636|466880575|FG001|Overall Study|Withdrawal by Subject|1|||
129704426|NCT05901636|466880576|FG002|Overall Study|Withdrawal by Subject|0|||
129704427|NCT05901636|466880577|FG003|Overall Study|Withdrawal by Subject|0|||
129704428|NCT05901636|466880578|FG004|Overall Study|Withdrawal by Subject|1|||
129704429|NCT05901636|466880579|FG005|Overall Study|Withdrawal by Subject|1|||
129704430|NCT05901636|466880580|FG006|Overall Study|Withdrawal by Subject|0|||
129704431|NCT05901636|466880574|FG000|Overall Study|Other|0|||
129704432|NCT05901636|466880575|FG001|Overall Study|Other|0|||
129704433|NCT05901636|466880576|FG002|Overall Study|Other|1|||
129704434|NCT05901636|466880577|FG003|Overall Study|Other|1|||
129704435|NCT05901636|466880578|FG004|Overall Study|Other|0|||
129704436|NCT05901636|466880579|FG005|Overall Study|Other|0|||
129704437|NCT05901636|466880580|FG006|Overall Study|Other|0|||
129704438|NCT00432965|466880581|FG000|Overall Study|Lost to Follow-up|22|||
129704439|NCT00432965|466880582|FG001|Overall Study|Lost to Follow-up|19|||
129704440|NCT00432965|466880581|FG000|Overall Study|Withdrawal by Subject|13|||
129704441|NCT00432965|466880582|FG001|Overall Study|Withdrawal by Subject|13|||
129704442|NCT00432965|466880581|FG000|Overall Study|Physician Decision|14|||
129704443|NCT00432965|466880582|FG001|Overall Study|Physician Decision|13|||
129704444|NCT00432965|466880581|FG000|Overall Study|Lack of Efficacy|8|||
129704445|NCT00432965|466880582|FG001|Overall Study|Lack of Efficacy|13|||
129704446|NCT00432965|466880581|FG000|Overall Study|Non-compliance|7|||
129704447|NCT00432965|466880582|FG001|Overall Study|Non-compliance|0|||
129704448|NCT00432965|466880581|FG000|Overall Study|Adverse Event|22|||
129704449|NCT00432965|466880582|FG001|Overall Study|Adverse Event|19|||
129704450|NCT00432965|466880581|FG000|Overall Study|Death|3|||
129704451|NCT00432965|466880582|FG001|Overall Study|Death|4|||
129704452|NCT00432965|466880581|FG000|Overall Study|Exclusionary Methods|1|||
129704453|NCT00432965|466880582|FG001|Overall Study|Exclusionary Methods|2|||
129704454|NCT00432965|466880581|FG000|Overall Study|Incomplete Data|4|||
129704455|NCT00432965|466880582|FG001|Overall Study|Incomplete Data|3|||
129704456|NCT03330847|466880590|FG000|Overall Study|Patients ongoing study|62|||
129704457|NCT03330847|466880591|FG001|Overall Study|Patients ongoing study|65|||
129704458|NCT03330847|466880592|FG002|Overall Study|Patients ongoing study|15|||
129704459|NCT01355627|466880593|FG000|Overall Study|Request By the Patient to Discontinue|5|||
129704460|NCT01355627|466880594|FG001|Overall Study|Request By the Patient to Discontinue|7|||
129704461|NCT01355627|466880593|FG000|Overall Study|Lost to Follow-up|8|||
129704462|NCT01355627|466880594|FG001|Overall Study|Lost to Follow-up|7|||
129704463|NCT01355627|466880593|FG000|Overall Study|Fatal Adverse Event|19|||
129704464|NCT01355627|466880594|FG001|Overall Study|Fatal Adverse Event|23|||
129704465|NCT01355627|466880593|FG000|Overall Study|Other|1|||
129704466|NCT01355627|466880594|FG001|Overall Study|Other|1|||
129704467|NCT02293551|466880597|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
129704468|NCT02293551|466880598|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
129704469|NCT02293551|466880599|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
129704470|NCT02293551|466880600|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
129704471|NCT02293551|466880601|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
129796871|NCT01017575|467223444|FG004|Overall Study|Adverse Event|2|||
129634594|NCT00789373|466616755|FG000|Maintenance|Adverse Event|0|||
129634595|NCT00789373|466616756|FG001|Maintenance|Adverse Event|65|||
129634596|NCT00789373|466616757|FG002|Maintenance|Adverse Event|12|||
129634597|NCT00789373|466616755|FG000|Maintenance|Death due to study disease|0|||
129704472|NCT02293551|466880602|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
129704473|NCT02293551|466880597|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
129634598|NCT00789373|466616756|FG001|Maintenance|Death due to study disease|3|||
129634599|NCT00789373|466616757|FG002|Maintenance|Death due to study disease|1|||
129704474|NCT02293551|466880598|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
129704475|NCT02293551|466880599|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
129704476|NCT02293551|466880600|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
129704477|NCT02293551|466880601|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
129796872|NCT01017575|467223440|FG000|Overall Study|Withdrawal by Subject|1|||
129796873|NCT01017575|467223441|FG001|Overall Study|Withdrawal by Subject|0|||
129796874|NCT01017575|467223442|FG002|Overall Study|Withdrawal by Subject|0|||
129796875|NCT01017575|467223443|FG003|Overall Study|Withdrawal by Subject|0|||
129796876|NCT01017575|467223444|FG004|Overall Study|Withdrawal by Subject|0|||
129796877|NCT04271280|467223445|FG000|Overall Study|Lost to Follow-up|300|||
129796878|NCT04271280|467223445|FG000|Overall Study|Death|153|||
129796879|NCT04271280|467223445|FG000|Overall Study|Withdrawal of consent by patient|59|||
129796880|NCT04271280|467223445|FG000|Overall Study|Other|51|||
129796881|NCT04271280|467223445|FG000|Overall Study|No end of study information|42|||
129796882|NCT01857583|467223448|FG000|Overall Study|Adverse Event|0|||
129796883|NCT01857583|467223449|FG001|Overall Study|Adverse Event|0|||
129796884|NCT01857583|467223450|FG002|Overall Study|Adverse Event|1|||
129796885|NCT01857583|467223451|FG003|Overall Study|Adverse Event|1|||
129796886|NCT01857583|467223448|FG000|Overall Study|Death|0|||
129796887|NCT01857583|467223449|FG001|Overall Study|Death|1|||
129796888|NCT01857583|467223450|FG002|Overall Study|Death|1|||
129796889|NCT01857583|467223451|FG003|Overall Study|Death|0|||
129796890|NCT01857583|467223448|FG000|Overall Study|Physician Decision|0|||
129796891|NCT01857583|467223449|FG001|Overall Study|Physician Decision|0|||
129796892|NCT01857583|467223450|FG002|Overall Study|Physician Decision|0|||
129796893|NCT01857583|467223451|FG003|Overall Study|Physician Decision|1|||
129796894|NCT01857583|467223448|FG000|Overall Study|Withdrawal by Subject|1|||
129796895|NCT01857583|467223449|FG001|Overall Study|Withdrawal by Subject|0|||
129796896|NCT01857583|467223450|FG002|Overall Study|Withdrawal by Subject|1|||
129796897|NCT01857583|467223451|FG003|Overall Study|Withdrawal by Subject|2|||
129796898|NCT00458536|467223454|FG000|Overall Study|Disease progression prior to treatment|7|||
129796899|NCT00458536|467223454|FG000|Overall Study|Unable to make vaccine|3|||
129796900|NCT00458536|467223454|FG000|Overall Study|No measurable disease after surgery|2|||
129796901|NCT00458536|467223454|FG000|Overall Study|Did not have renal cell carcinoma|2|||
129796902|NCT00458536|467223454|FG000|Overall Study|Patient did not have surgery|1|||
129796903|NCT00458536|467223454|FG000|Overall Study|Ineligible due to toxicity|1|||
129796904|NCT00458536|467223454|FG000|Overall Study|Withdrawal by Subject|1|||
129796905|NCT00458536|467223454|FG000|Overall Study|Progressive disease during treatment|2|||
129796906|NCT03287635|467223457|FG000|Overall Study|Lost to Follow-up|5|||
129796907|NCT03287635|467223457|FG000|Overall Study|Withdrawal by Subject|1|||
129634600|NCT00789373|466616755|FG000|Maintenance|Death due to adverse event|0|||
129634601|NCT00789373|466616756|FG001|Maintenance|Death due to adverse event|4|||
129634602|NCT00789373|466616757|FG002|Maintenance|Death due to adverse event|1|||
129634603|NCT00789373|466616755|FG000|Maintenance|Death due to toxicity|0|||
129634604|NCT00789373|466616756|FG001|Maintenance|Death due to toxicity|1|||
129634605|NCT00789373|466616757|FG002|Maintenance|Death due to toxicity|2|||
129634606|NCT00789373|466616755|FG000|Maintenance|Investigator Decision|0|||
129634607|NCT00789373|466616756|FG001|Maintenance|Investigator Decision|4|||
129796908|NCT03287635|467223457|FG000|Overall Study|Physician Decision|1|||
129796909|NCT00323869|467223458|FG000|Overall Study|Death|1|||
129796910|NCT00206076|467225100|FG000|Overall Study|Physician Decision|2|||
129634608|NCT00789373|466616757|FG002|Maintenance|Investigator Decision|2|||
129634609|NCT00789373|466616755|FG000|Maintenance|Protocol entry criteria not met|0|||
129634610|NCT00789373|466616756|FG001|Maintenance|Protocol entry criteria not met|2|||
129634611|NCT00789373|466616757|FG002|Maintenance|Protocol entry criteria not met|0|||
129634612|NCT00789373|466616755|FG000|Maintenance|Lost to Follow-up|0|||
129634613|NCT00789373|466616756|FG001|Maintenance|Lost to Follow-up|2|||
129634614|NCT00789373|466616757|FG002|Maintenance|Lost to Follow-up|0|||
129634615|NCT00789373|466616755|FG000|Maintenance|Progressive Disease|0|||
129796911|NCT00206076|467225101|FG001|Overall Study|Physician Decision|0|||
129796912|NCT00206076|467225100|FG000|Overall Study|Withdrawal by Subject|1|||
129634616|NCT00789373|466616756|FG001|Maintenance|Progressive Disease|253|||
129796913|NCT00206076|467225101|FG001|Overall Study|Withdrawal by Subject|1|||
129796914|NCT00750880|467225104|FG000|Overall Study|Adverse Event|76|||
129796915|NCT00750880|467225104|FG000|Overall Study|Death|4|||
129796916|NCT00750880|467225104|FG000|Overall Study|Lack of Efficacy|46|||
129796917|NCT00750880|467225104|FG000|Overall Study|Lost to Follow-up|10|||
129634617|NCT00789373|466616757|FG002|Maintenance|Progressive Disease|152|||
129796918|NCT00750880|467225104|FG000|Overall Study|Protocol Violation|15|||
129796919|NCT00750880|467225104|FG000|Overall Study|Withdrawal by Subject|33|||
129796920|NCT00750880|467225104|FG000|Overall Study|Physician Decision|20|||
129796921|NCT00750880|467225104|FG000|Overall Study|Administrative|11|||
129796922|NCT02964507|467225110|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796923|NCT02964507|467225111|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
129796924|NCT02964507|467225112|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
129634618|NCT00789373|466616755|FG000|Maintenance|Withdrawal by Subject|0|||
129634619|NCT00789373|466616756|FG001|Maintenance|Withdrawal by Subject|21|||
129634620|NCT00789373|466616757|FG002|Maintenance|Withdrawal by Subject|8|||
129796925|NCT02964507|467225113|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
129634621|NCT00789373|466616755|FG000|Maintenance|Sponsor Decision|0|||
129796926|NCT02964507|467225114|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
129796927|NCT02964507|467225115|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796928|NCT02964507|467225116|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796929|NCT02964507|467225117|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
129796930|NCT02964507|467225110|FG000|Overall Study|Study terminated by Sponsor|9|||
129796931|NCT02964507|467225111|FG001|Overall Study|Study terminated by Sponsor|1|||
129796932|NCT02964507|467225112|FG002|Overall Study|Study terminated by Sponsor|9|||
129796933|NCT02964507|467225113|FG003|Overall Study|Study terminated by Sponsor|3|||
129796934|NCT02964507|467225114|FG004|Overall Study|Study terminated by Sponsor|3|||
129796935|NCT02964507|467225115|FG005|Overall Study|Study terminated by Sponsor|2|||
129796936|NCT02964507|467225116|FG006|Overall Study|Study terminated by Sponsor|0|||
129796937|NCT02964507|467225117|FG007|Overall Study|Study terminated by Sponsor|0|||
129796938|NCT02964507|467225110|FG000|Overall Study|Other|3|||
129796939|NCT02964507|467225111|FG001|Overall Study|Other|0|||
129796940|NCT02964507|467225112|FG002|Overall Study|Other|0|||
129796941|NCT02964507|467225113|FG003|Overall Study|Other|0|||
129796942|NCT02964507|467225114|FG004|Overall Study|Other|1|||
129796943|NCT02964507|467225115|FG005|Overall Study|Other|0|||
129796944|NCT02964507|467225116|FG006|Overall Study|Other|0|||
129796945|NCT02964507|467225117|FG007|Overall Study|Other|0|||
129796946|NCT02964507|467225110|FG000|Overall Study|Death|11|||
129634622|NCT00789373|466616756|FG001|Maintenance|Sponsor Decision|0|||
129634623|NCT00789373|466616757|FG002|Maintenance|Sponsor Decision|2|||
129634624|NCT00789373|466616755|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
129634625|NCT00789373|466616756|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
129634626|NCT00789373|466616757|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
129634627|NCT00546377|466616758|FG000|Overall Study|Deemed ineligible|1|||
129634628|NCT00546377|466616758|FG000|Overall Study|Adverse Event|6|||
129634629|NCT03321968|466616759|FG000|Overall Study|Withdrawal by Subject|1|||
129634630|NCT03321968|466616760|FG001|Overall Study|Withdrawal by Subject|2|||
129634631|NCT03321968|466616761|FG002|Overall Study|Withdrawal by Subject|1|||
129634632|NCT03321968|466616759|FG000|Overall Study|Lost to Follow-up|2|||
129634633|NCT03321968|466616760|FG001|Overall Study|Lost to Follow-up|0|||
129634634|NCT03321968|466616761|FG002|Overall Study|Lost to Follow-up|1|||
129634635|NCT03321968|466616759|FG000|Overall Study|Other than specified|0|||
129634636|NCT03321968|466616760|FG001|Overall Study|Other than specified|0|||
129634637|NCT03321968|466616761|FG002|Overall Study|Other than specified|1|||
129634638|NCT02282813|466616767|FG000|Overall Study|Withdrawal by Subject|4|||
129634639|NCT02282813|466616768|FG001|Overall Study|Withdrawal by Subject|5|||
129634640|NCT02282813|466616769|FG002|Overall Study|Withdrawal by Subject|0|||
129634641|NCT02282813|466616767|FG000|Overall Study|Adverse Event|3|||
129634642|NCT02282813|466616768|FG001|Overall Study|Adverse Event|10|||
129634643|NCT02282813|466616769|FG002|Overall Study|Adverse Event|1|||
129634644|NCT02282813|466616767|FG000|Overall Study|Subject non-compliance|1|||
129634645|NCT02282813|466616768|FG001|Overall Study|Subject non-compliance|4|||
129634646|NCT02282813|466616769|FG002|Overall Study|Subject non-compliance|0|||
129634647|NCT02282813|466616767|FG000|Overall Study|Physician Decision|0|||
129634648|NCT02282813|466616768|FG001|Overall Study|Physician Decision|3|||
129634649|NCT02282813|466616769|FG002|Overall Study|Physician Decision|1|||
129634650|NCT02282813|466616767|FG000|Overall Study|Lost to Follow-up|2|||
129634651|NCT02282813|466616768|FG001|Overall Study|Lost to Follow-up|0|||
129634652|NCT02282813|466616769|FG002|Overall Study|Lost to Follow-up|1|||
129634653|NCT02282813|466616767|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
129634654|NCT02282813|466616768|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
129634655|NCT02282813|466616769|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
129634656|NCT02282813|466616767|FG000|Overall Study|Lack of Efficacy|1|||
129634657|NCT02282813|466616768|FG001|Overall Study|Lack of Efficacy|0|||
129634658|NCT02282813|466616769|FG002|Overall Study|Lack of Efficacy|0|||
129634659|NCT02282813|466616767|FG000|Overall Study|Administrative reasons|0|||
129634660|NCT02282813|466616768|FG001|Overall Study|Administrative reasons|1|||
129634661|NCT02282813|466616769|FG002|Overall Study|Administrative reasons|0|||
129796947|NCT02964507|467225111|FG001|Overall Study|Death|9|||
129634662|NCT00463047|466616770|FG000|Titration Period 1|Adverse Event|10|||
129634663|NCT00463047|466616771|FG001|Titration Period 1|Adverse Event|8|||
129634664|NCT00463047|466616770|FG000|Titration Period 1|Lack of Efficacy|10|||
129796948|NCT02964507|467225112|FG002|Overall Study|Death|12|||
129796949|NCT02964507|467225113|FG003|Overall Study|Death|2|||
129796950|NCT02964507|467225114|FG004|Overall Study|Death|10|||
129634665|NCT00463047|466616771|FG001|Titration Period 1|Lack of Efficacy|4|||
129634666|NCT00463047|466616770|FG000|Titration Period 1|Lost to Follow-up|2|||
129634667|NCT00463047|466616771|FG001|Titration Period 1|Lost to Follow-up|0|||
129634668|NCT00463047|466616770|FG000|Titration Period 1|Non-compliance with study medication|3|||
129634669|NCT00463047|466616771|FG001|Titration Period 1|Non-compliance with study medication|5|||
129634670|NCT00463047|466616770|FG000|Titration Period 1|Protocol Violation|5|||
129634671|NCT00463047|466616771|FG001|Titration Period 1|Protocol Violation|5|||
129634672|NCT00463047|466616770|FG000|Titration Period 1|Withdrawal by Subject|3|||
129796951|NCT02964507|467225115|FG005|Overall Study|Death|5|||
129796952|NCT02964507|467225116|FG006|Overall Study|Death|0|||
129796953|NCT02964507|467225117|FG007|Overall Study|Death|0|||
129634673|NCT00463047|466616771|FG001|Titration Period 1|Withdrawal by Subject|5|||
129634674|NCT00463047|466616770|FG000|Titration Period 1|Non-compliance procedures|4|||
129634675|NCT00463047|466616771|FG001|Titration Period 1|Non-compliance procedures|10|||
129634676|NCT00463047|466616770|FG000|Titration Period 1|Other|0|||
129889266|NCT03220737|467552537|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
129889267|NCT03486899|467552538|FG000|Overall Study|Lost to Follow-up|4|||
129889268|NCT03486899|467552539|FG001|Overall Study|Lost to Follow-up|1|||
129889269|NCT03486899|467552540|FG002|Overall Study|Lost to Follow-up|4|||
129889270|NCT03486899|467552541|FG003|Overall Study|Lost to Follow-up|3|||
129889271|NCT03486899|467552538|FG000|Overall Study|Death|1|||
129889272|NCT03486899|467552539|FG001|Overall Study|Death|0|||
129634677|NCT00463047|466616771|FG001|Titration Period 1|Other|2|||
129634678|NCT00463047|466616770|FG000|Titration Period 2|Adverse Event|9|||
129634679|NCT00463047|466616771|FG001|Titration Period 2|Adverse Event|9|||
129634680|NCT00463047|466616770|FG000|Titration Period 2|Lack of Efficacy|6|||
129634681|NCT00463047|466616771|FG001|Titration Period 2|Lack of Efficacy|4|||
129634682|NCT00463047|466616770|FG000|Titration Period 2|Withdrawal by Subject|1|||
129634683|NCT00463047|466616771|FG001|Titration Period 2|Withdrawal by Subject|0|||
129634684|NCT00463047|466616770|FG000|Titration Period 2|Protocol Violation|2|||
129634685|NCT00463047|466616771|FG001|Titration Period 2|Protocol Violation|3|||
129704478|NCT02293551|466880602|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
129704479|NCT02293551|466880597|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
129704480|NCT02293551|466880598|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
129704481|NCT02293551|466880599|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
129704482|NCT02293551|466880600|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
129704483|NCT02293551|466880601|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
129704484|NCT02293551|466880602|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
129704485|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
129704486|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
129704487|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
129704488|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
129704489|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
129704490|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
129704491|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
129704492|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
129704493|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
129704494|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
129704495|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
129704496|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
129704497|NCT04532749|466880603|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
129704498|NCT04532749|466880604|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
129704499|NCT04532749|466880603|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
129704500|NCT04532749|466880604|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
129704501|NCT04532749|466880603|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
129704502|NCT04532749|466880604|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
129704503|NCT04532749|466880603|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
129704504|NCT04532749|466880604|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
129704505|NCT02769481|466880605|FG000|Overall Study|Protocol Violation|1|||
129704506|NCT02769481|466880606|FG001|Overall Study|Protocol Violation|0|||
129704507|NCT02769481|466880605|FG000|Overall Study|Adverse Event|3|||
129704508|NCT02769481|466880606|FG001|Overall Study|Adverse Event|6|||
129704509|NCT02769481|466880605|FG000|Overall Study|Entry Criteria Not Met|1|||
129704510|NCT02769481|466880606|FG001|Overall Study|Entry Criteria Not Met|2|||
129704511|NCT02769481|466880605|FG000|Overall Study|Withdrawal by Subject|14|||
129704512|NCT02769481|466880606|FG001|Overall Study|Withdrawal by Subject|16|||
129440457|NCT00413972|465911443|FG003|Overall Study|Lost to Follow-up|0|||
129634686|NCT00463047|466616770|FG000|Titration Period 2|Lost to Follow-up|1|||
129634687|NCT00463047|466616771|FG001|Titration Period 2|Lost to Follow-up|2|||
129704513|NCT02769481|466880605|FG000|Overall Study|Lost to Follow-up|9|||
129704514|NCT02769481|466880606|FG001|Overall Study|Lost to Follow-up|9|||
129704515|NCT02769481|466880605|FG000|Overall Study|Physician Decision|0|||
129889273|NCT03486899|467552540|FG002|Overall Study|Death|0|||
129634688|NCT00463047|466616770|FG000|Titration Period 2|Non-compliance study medication|4|||
129889274|NCT03486899|467552541|FG003|Overall Study|Death|1|||
129796954|NCT02964507|467225110|FG000|Overall Study|Withdrawal by Subject|1|||
129796955|NCT02964507|467225111|FG001|Overall Study|Withdrawal by Subject|0|||
129796956|NCT02964507|467225112|FG002|Overall Study|Withdrawal by Subject|1|||
129796957|NCT02964507|467225113|FG003|Overall Study|Withdrawal by Subject|1|||
129796958|NCT02964507|467225114|FG004|Overall Study|Withdrawal by Subject|0|||
129796959|NCT02964507|467225115|FG005|Overall Study|Withdrawal by Subject|1|||
129796960|NCT02964507|467225116|FG006|Overall Study|Withdrawal by Subject|0|||
129796961|NCT02964507|467225117|FG007|Overall Study|Withdrawal by Subject|0|||
129796962|NCT02964507|467225110|FG000|Overall Study|Physician Decision|2|||
129796963|NCT02964507|467225111|FG001|Overall Study|Physician Decision|0|||
129796964|NCT02964507|467225112|FG002|Overall Study|Physician Decision|3|||
129796965|NCT02964507|467225113|FG003|Overall Study|Physician Decision|0|||
129796966|NCT02964507|467225114|FG004|Overall Study|Physician Decision|1|||
129796967|NCT02964507|467225115|FG005|Overall Study|Physician Decision|0|||
129796968|NCT02964507|467225116|FG006|Overall Study|Physician Decision|0|||
129796969|NCT02964507|467225117|FG007|Overall Study|Physician Decision|0|||
129796970|NCT02495233|467225118|FG000|Overall Study|Miscellaneous|0|||
129796971|NCT02495233|467225119|FG001|Overall Study|Miscellaneous|1|||
129796972|NCT03880461|467225120|FG000|Overall Study|Determined ineligible after enrollment|45|||
129796973|NCT03880461|467225121|FG001|Overall Study|Determined ineligible after enrollment|44|||
129796974|NCT03880461|467225120|FG000|Overall Study|No weight measurement after enrollment|24|||
129796975|NCT03880461|467225121|FG001|Overall Study|No weight measurement after enrollment|17|||
129796976|NCT02652767|467225123|FG000|Overall Study|Death|2|||
129796977|NCT02652767|467225123|FG000|Overall Study|Lost to Follow-up|1|||
129796978|NCT02652767|467225123|FG000|Overall Study|Withdrawal by Subject|1|||
129796979|NCT01115803|467225125|FG000|Overall Study|Withdrawal by Subject|0|||
129796980|NCT01115803|467225126|FG001|Overall Study|Withdrawal by Subject|0|||
129796981|NCT01115803|467225127|FG002|Overall Study|Withdrawal by Subject|0|||
129796982|NCT01115803|467225128|FG003|Overall Study|Withdrawal by Subject|0|||
129796983|NCT01115803|467225129|FG004|Overall Study|Withdrawal by Subject|0|||
129796984|NCT01115803|467225130|FG005|Overall Study|Withdrawal by Subject|0|||
129796985|NCT01115803|467225131|FG006|Overall Study|Withdrawal by Subject|1|||
129796986|NCT01115803|467225125|FG000|Overall Study|Lost to Follow-up|0|||
129796987|NCT01115803|467225126|FG001|Overall Study|Lost to Follow-up|0|||
129796988|NCT01115803|467225127|FG002|Overall Study|Lost to Follow-up|1|||
129796989|NCT01115803|467225128|FG003|Overall Study|Lost to Follow-up|0|||
129796990|NCT01115803|467225129|FG004|Overall Study|Lost to Follow-up|0|||
129796991|NCT01115803|467225130|FG005|Overall Study|Lost to Follow-up|0|||
129796992|NCT01115803|467225131|FG006|Overall Study|Lost to Follow-up|0|||
129796993|NCT01115803|467225125|FG000|Overall Study|Progressive Disease during Cycle1|0|||
129796994|NCT01115803|467225126|FG001|Overall Study|Progressive Disease during Cycle1|0|||
129796995|NCT01115803|467225127|FG002|Overall Study|Progressive Disease during Cycle1|0|||
129796996|NCT01115803|467225128|FG003|Overall Study|Progressive Disease during Cycle1|0|||
129796997|NCT01115803|467225129|FG004|Overall Study|Progressive Disease during Cycle1|0|||
129796998|NCT01115803|467225130|FG005|Overall Study|Progressive Disease during Cycle1|0|||
129796999|NCT01115803|467225131|FG006|Overall Study|Progressive Disease during Cycle1|1|||
129797000|NCT03475875|467225132|FG000|Period 1|Lost to Follow-up|1|||
129797001|NCT03475875|467225133|FG001|Period 1|Lost to Follow-up|0|||
129797002|NCT03475875|467225132|FG000|Period 1|Adverse Event|2|||
129797003|NCT03475875|467225133|FG001|Period 1|Adverse Event|1|||
129797004|NCT03475875|467225132|FG000|Period 2|Adverse Event|3|||
129797005|NCT03475875|467225133|FG001|Period 2|Adverse Event|0|||
129797006|NCT03475875|467225132|FG000|Period 2|Protocol Violation|0|||
129797007|NCT03475875|467225133|FG001|Period 2|Protocol Violation|1|||
129797008|NCT01642407|467225134|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
129797009|NCT01642407|467225134|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
129797010|NCT01642407|467225134|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
129797011|NCT04025710|467225135|FG000|Overall Study|Death|3|||
129797012|NCT04025710|467225135|FG000|Overall Study|Lost to Follow-up|5|||
129889275|NCT03486899|467552538|FG000|Overall Study|Adverse Event|0|||
129889276|NCT03486899|467552539|FG001|Overall Study|Adverse Event|2|||
129889277|NCT03486899|467552540|FG002|Overall Study|Adverse Event|0|||
129797013|NCT04025710|467225135|FG000|Overall Study|Withdrawal by Subject|1|||
129797014|NCT04025710|467225135|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
129797015|NCT04025710|467225135|FG000|Overall Study|Drop-out according to protocol|34|||
129797016|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
129797017|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
129797018|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
129797019|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
129797020|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
129797021|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
129797022|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
129797023|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
129889278|NCT03486899|467552541|FG003|Overall Study|Adverse Event|2|||
129889279|NCT03486899|467552538|FG000|Overall Study|Withdrawal by Subject|3|||
129634689|NCT00463047|466616771|FG001|Titration Period 2|Non-compliance study medication|2|||
129634690|NCT00463047|466616770|FG000|Titration Period 2|Non-compliance procedures|4|||
129634691|NCT00463047|466616771|FG001|Titration Period 2|Non-compliance procedures|1|||
129634692|NCT00463047|466616770|FG000|Titration Period 2|Other|3|||
129634693|NCT00463047|466616771|FG001|Titration Period 2|Other|2|||
129634694|NCT00463047|466616770|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
129634695|NCT00463047|466616771|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
129634696|NCT00463047|466616770|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
129634697|NCT00463047|466616771|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
129634698|NCT00463047|466616770|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
129634699|NCT00463047|466616771|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
129634700|NCT00463047|466616770|FG000|Double-Blind Treatment Period 1|Other|1|||
129634701|NCT00463047|466616771|FG001|Double-Blind Treatment Period 1|Other|0|||
129634702|NCT00463047|466616770|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
129634703|NCT00463047|466616771|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
129704516|NCT02769481|466880606|FG001|Overall Study|Physician Decision|1|||
129704517|NCT02769481|466880605|FG000|Overall Study|Terminated by Sponsor|1|||
129704518|NCT02769481|466880606|FG001|Overall Study|Terminated by Sponsor|0|||
129704519|NCT02769481|466880605|FG000|Overall Study|Death|0|||
129704520|NCT02769481|466880606|FG001|Overall Study|Death|1|||
129704521|NCT02769481|466880605|FG000|Overall Study|Undefined|4|||
129704522|NCT02769481|466880606|FG001|Overall Study|Undefined|1|||
129704523|NCT00642759|466880607|FG000|Overall Study|Protocol Violation|1|||
129704524|NCT03510715|466880608|FG000|Overall Study|Adverse Event|1|||
129704525|NCT03510715|466880609|FG001|Overall Study|Adverse Event|0|||
129704526|NCT03612570|466880616|FG000|Overall Study|Lost to Follow-up|1|||
129704527|NCT04756531|466880617|FG000|Overall Study|Adverse Event|0|||
129704528|NCT04756531|466880618|FG001|Overall Study|Adverse Event|0|||
129704529|NCT04756531|466880619|FG002|Overall Study|Adverse Event|0|||
129704530|NCT04756531|466880620|FG003|Overall Study|Adverse Event|0|||
129704531|NCT04756531|466880621|FG004|Overall Study|Adverse Event|1|||
129704532|NCT04756531|466880622|FG005|Overall Study|Adverse Event|0|||
129704533|NCT04756531|466880623|FG006|Overall Study|Adverse Event|0|||
129704534|NCT04756531|466880624|FG007|Overall Study|Adverse Event|0|||
129704535|NCT04756531|466880625|FG008|Overall Study|Adverse Event|0|||
129704536|NCT04756531|466880626|FG009|Overall Study|Adverse Event|0|||
129704537|NCT04756531|466880627|FG010|Overall Study|Adverse Event|0|||
129704538|NCT04756531|466880628|FG011|Overall Study|Adverse Event|0|||
129704539|NCT04756531|466880629|FG012|Overall Study|Adverse Event|0|||
129704540|NCT04756531|466880630|FG013|Overall Study|Adverse Event|0|||
129704541|NCT04756531|466880631|FG014|Overall Study|Adverse Event|0|||
129704542|NCT04756531|466880632|FG015|Overall Study|Adverse Event|0|||
129704543|NCT04756531|466880633|FG016|Overall Study|Adverse Event|0|||
129704544|NCT04756531|466880634|FG017|Overall Study|Adverse Event|0|||
129704545|NCT04756531|466880617|FG000|Overall Study|Withdrawal by Subject|0|||
129704546|NCT04756531|466880618|FG001|Overall Study|Withdrawal by Subject|0|||
129704547|NCT04756531|466880619|FG002|Overall Study|Withdrawal by Subject|0|||
129704548|NCT04756531|466880620|FG003|Overall Study|Withdrawal by Subject|0|||
129704549|NCT04756531|466880621|FG004|Overall Study|Withdrawal by Subject|0|||
129704550|NCT04756531|466880622|FG005|Overall Study|Withdrawal by Subject|0|||
129704551|NCT04756531|466880623|FG006|Overall Study|Withdrawal by Subject|1|||
129704552|NCT04756531|466880624|FG007|Overall Study|Withdrawal by Subject|0|||
129704553|NCT04756531|466880625|FG008|Overall Study|Withdrawal by Subject|0|||
129704554|NCT04756531|466880626|FG009|Overall Study|Withdrawal by Subject|0|||
129704555|NCT04756531|466880627|FG010|Overall Study|Withdrawal by Subject|0|||
129704556|NCT04756531|466880628|FG011|Overall Study|Withdrawal by Subject|0|||
129704557|NCT04756531|466880629|FG012|Overall Study|Withdrawal by Subject|0|||
129704558|NCT04756531|466880630|FG013|Overall Study|Withdrawal by Subject|0|||
129704559|NCT04756531|466880631|FG014|Overall Study|Withdrawal by Subject|0|||
129704560|NCT04756531|466880632|FG015|Overall Study|Withdrawal by Subject|0|||
129704561|NCT04756531|466880633|FG016|Overall Study|Withdrawal by Subject|0|||
129704562|NCT04756531|466880634|FG017|Overall Study|Withdrawal by Subject|0|||
129704563|NCT01346176|466880635|FG000|Recruited|Protocol Violation|1|||
129704564|NCT01346176|466880636|FG001|Recruited|Protocol Violation|0|||
129704565|NCT01346176|466880637|FG002|Recruited|Protocol Violation|0|||
129704566|NCT01346176|466880635|FG000|Completed Advance Directive|Death|3|||
129704567|NCT01346176|466880636|FG001|Completed Advance Directive|Death|2|||
129704568|NCT01346176|466880637|FG002|Completed Advance Directive|Death|2|||
129704569|NCT01346176|466880635|FG000|Completed Advance Directive|Became Ineligible|3|||
129634704|NCT00463047|466616770|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
129704570|NCT01346176|466880636|FG001|Completed Advance Directive|Became Ineligible|0|||
129704571|NCT01346176|466880637|FG002|Completed Advance Directive|Became Ineligible|1|||
129704572|NCT01346176|466880635|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
129704573|NCT01346176|466880636|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
129704574|NCT01346176|466880637|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
129704575|NCT01346176|466880635|FG000|Completed Satisfaction Survey|Death|3|||
129797024|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
129797025|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
129797026|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
129797027|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
129797028|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
129797029|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
129797030|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
129797031|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
129797032|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
129797033|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
129797034|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
129797035|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
129797036|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
129797037|NCT02431247|467225136|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
129797038|NCT02431247|467225137|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
129797039|NCT02431247|467225138|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
129797040|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129797041|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129797042|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
129797043|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129797044|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129797045|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
129797046|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129797047|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129797048|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
129889280|NCT03486899|467552539|FG001|Overall Study|Withdrawal by Subject|7|||
129889281|NCT03486899|467552540|FG002|Overall Study|Withdrawal by Subject|4|||
129889282|NCT03486899|467552541|FG003|Overall Study|Withdrawal by Subject|3|||
129889283|NCT03486899|467552538|FG000|Overall Study|Other Reasons|0|||
129889284|NCT03486899|467552539|FG001|Overall Study|Other Reasons|1|||
129889285|NCT03486899|467552540|FG002|Overall Study|Other Reasons|0|||
129889286|NCT03486899|467552541|FG003|Overall Study|Other Reasons|1|||
129889287|NCT01848834|467552547|FG000|Overall Study|Adverse Event|3|||
129889288|NCT01848834|467552548|FG001|Overall Study|Adverse Event|11|||
129889289|NCT01848834|467552549|FG002|Overall Study|Adverse Event|3|||
129889290|NCT01848834|467552550|FG003|Overall Study|Adverse Event|5|||
129889291|NCT01848834|467552551|FG004|Overall Study|Adverse Event|9|||
129889292|NCT01848834|467552547|FG000|Overall Study|Death|2|||
129889293|NCT01848834|467552548|FG001|Overall Study|Death|11|||
129889294|NCT01848834|467552549|FG002|Overall Study|Death|1|||
129889295|NCT01848834|467552550|FG003|Overall Study|Death|8|||
129889296|NCT01848834|467552551|FG004|Overall Study|Death|27|||
129889297|NCT01848834|467552547|FG000|Overall Study|Excluded Medication|5|||
129889298|NCT01848834|467552548|FG001|Overall Study|Excluded Medication|4|||
129889299|NCT01848834|467552549|FG002|Overall Study|Excluded Medication|3|||
129889300|NCT01848834|467552550|FG003|Overall Study|Excluded Medication|6|||
129889301|NCT01848834|467552551|FG004|Overall Study|Excluded Medication|6|||
129889302|NCT01848834|467552547|FG000|Overall Study|Lost to Follow-up|5|||
129889303|NCT01848834|467552548|FG001|Overall Study|Lost to Follow-up|5|||
129889304|NCT01848834|467552549|FG002|Overall Study|Lost to Follow-up|3|||
129889305|NCT01848834|467552550|FG003|Overall Study|Lost to Follow-up|0|||
129889306|NCT01848834|467552551|FG004|Overall Study|Lost to Follow-up|3|||
129889307|NCT01848834|467552547|FG000|Overall Study|Physician Decision|1|||
129889308|NCT01848834|467552548|FG001|Overall Study|Physician Decision|3|||
129889309|NCT01848834|467552549|FG002|Overall Study|Physician Decision|4|||
129889310|NCT01848834|467552550|FG003|Overall Study|Physician Decision|0|||
129889311|NCT01848834|467552551|FG004|Overall Study|Physician Decision|11|||
129889312|NCT01848834|467552547|FG000|Overall Study|Protocol Violation|0|||
129889313|NCT01848834|467552548|FG001|Overall Study|Protocol Violation|0|||
129889314|NCT01848834|467552549|FG002|Overall Study|Protocol Violation|0|||
129634705|NCT00463047|466616771|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
129797049|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129797050|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129797051|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
129797052|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129797053|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129797054|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
129797055|NCT02431247|467225136|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129889315|NCT01848834|467552550|FG003|Overall Study|Protocol Violation|0|||
129889316|NCT01848834|467552551|FG004|Overall Study|Protocol Violation|1|||
129889317|NCT01848834|467552547|FG000|Overall Study|Sponsor Decision|1|||
129889318|NCT01848834|467552548|FG001|Overall Study|Sponsor Decision|1|||
129889319|NCT01848834|467552549|FG002|Overall Study|Sponsor Decision|0|||
129889320|NCT01848834|467552550|FG003|Overall Study|Sponsor Decision|1|||
129889321|NCT01848834|467552551|FG004|Overall Study|Sponsor Decision|1|||
129797056|NCT02431247|467225137|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129797057|NCT02431247|467225138|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
129797058|NCT01562873|467225139|FG000|Overall Study|Disease Progression per RECIST|10|||
129797059|NCT01562873|467225140|FG001|Overall Study|Disease Progression per RECIST|0|||
129797060|NCT01562873|467225139|FG000|Overall Study|Adverse Event|1|||
129797061|NCT01562873|467225140|FG001|Overall Study|Adverse Event|0|||
129797062|NCT01562873|467225139|FG000|Overall Study|Clinical Disease Progression|9|||
129797063|NCT01562873|467225140|FG001|Overall Study|Clinical Disease Progression|0|||
129797064|NCT01562873|467225139|FG000|Overall Study|Clinical PD and adverse event|1|||
129797065|NCT01562873|467225140|FG001|Overall Study|Clinical PD and adverse event|0|||
129797066|NCT02942576|467225142|FG000|Overall Study|Adverse Event|28|||
129797067|NCT02942576|467225143|FG001|Overall Study|Adverse Event|6|||
129797068|NCT02942576|467225142|FG000|Overall Study|Withdrawal by Subject|7|||
129797069|NCT02942576|467225143|FG001|Overall Study|Withdrawal by Subject|5|||
129797070|NCT02942576|467225142|FG000|Overall Study|Physician Decision|1|||
129797071|NCT02942576|467225143|FG001|Overall Study|Physician Decision|4|||
129797072|NCT02942576|467225142|FG000|Overall Study|Other|10|||
129797073|NCT02942576|467225143|FG001|Overall Study|Other|8|||
129797074|NCT00938964|467225144|FG000|Overall Study|Death|3|||
129797075|NCT00938964|467225145|FG001|Overall Study|Death|3|||
129797076|NCT00938964|467225144|FG000|Overall Study|Lost to Follow-up|2|||
129797077|NCT00938964|467225145|FG001|Overall Study|Lost to Follow-up|3|||
129797078|NCT00938964|467225144|FG000|Overall Study|Withdrawal by Subject|22|||
129797079|NCT00938964|467225145|FG001|Overall Study|Withdrawal by Subject|18|||
129797080|NCT00938964|467225144|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
129797081|NCT00938964|467225145|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
129797082|NCT03523000|467225147|FG000|Overall Study|Withdrawal by Subject|3|||
129797083|NCT03523000|467225148|FG001|Overall Study|Withdrawal by Subject|0|||
129797084|NCT03523000|467225147|FG000|Overall Study|Unsuccessful trial|2|||
129797085|NCT03523000|467225148|FG001|Overall Study|Unsuccessful trial|0|||
129797086|NCT00194675|467225152|FG000|Overall Study|Lost to Follow-up|1|||
129797087|NCT00194675|467225153|FG001|Overall Study|Lost to Follow-up|1|||
129797088|NCT00194675|467225152|FG000|Overall Study|lack of interest|1|||
129797089|NCT00194675|467225153|FG001|Overall Study|lack of interest|1|||
129797090|NCT00194675|467225152|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
129797091|NCT00194675|467225153|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
129797092|NCT00194675|467225152|FG000|Overall Study|Protocol Violation|1|||
129797093|NCT00194675|467225153|FG001|Overall Study|Protocol Violation|0|||
129797094|NCT00194675|467225152|FG000|Overall Study|Death|1|||
129797095|NCT00194675|467225153|FG001|Overall Study|Death|0|||
129797096|NCT00704808|467225154|FG000|Overall Study|Discontinued prior to starting treatment|14|||
129797097|NCT00704808|467225154|FG000|Overall Study|Death|7|||
129797098|NCT00704808|467225154|FG000|Overall Study|Tumor progression|80|||
129797099|NCT00704808|467225154|FG000|Overall Study|Patient's decision|11|||
129797100|NCT00704808|467225154|FG000|Overall Study|Early therapy discontinuation|16|||
129797101|NCT00704808|467225154|FG000|Overall Study|Adverse Event|1|||
129797102|NCT00704808|467225154|FG000|Overall Study|Lost to Follow-up|1|||
129797103|NCT00704808|467225154|FG000|Overall Study|Treatment change|1|||
129797104|NCT01285960|467225155|FG000|Overall Study|Withdrawal by Subject|2|||
129797105|NCT01285960|467225155|FG000|Overall Study|Lost to Follow-up|2|||
129797106|NCT01285960|467225155|FG000|Overall Study|2 subjects received less 10 sonications|2|||
129797107|NCT01476644|467225159|FG000|Overall Study|Death|5|||
129797108|NCT01476644|467225159|FG000|Overall Study|moved to another state|2|||
129797109|NCT01476644|467225159|FG000|Overall Study|Lost to Follow-up|19|||
129797110|NCT01476644|467225159|FG000|Overall Study|Withdrawal by Subject|13|||
129797111|NCT00095628|467225160|FG000|Overall Study|Disease progression prior to treatment|1|||
129797112|NCT02280473|467225161|FG000|Overall Study|Adverse Event|1|||
129797113|NCT02280473|467225162|FG001|Overall Study|Adverse Event|1|||
129797114|NCT02280473|467225161|FG000|Overall Study|Lack of Efficacy|0|||
129797115|NCT02280473|467225162|FG001|Overall Study|Lack of Efficacy|1|||
129797116|NCT02280473|467225161|FG000|Overall Study|Lost to Follow-up|0|||
129797117|NCT02280473|467225162|FG001|Overall Study|Lost to Follow-up|1|||
129797118|NCT01484054|467225163|FG000|Period 1|Withdrawal by Subject|0|||
129797119|NCT01484054|467225164|FG001|Period 1|Withdrawal by Subject|1|||
129797120|NCT00410202|467225173|FG000|On-Treatment|Continuing treatment|69|||
129797121|NCT00410202|467225174|FG001|On-Treatment|Continuing treatment|71|||
129797122|NCT00410202|467225175|FG002|On-Treatment|Continuing treatment|66|||
129797123|NCT00410202|467225173|FG000|On-Treatment|Adverse Event|1|||
129797124|NCT00410202|467225174|FG001|On-Treatment|Adverse Event|3|||
129797125|NCT00410202|467225175|FG002|On-Treatment|Adverse Event|2|||
129797126|NCT00410202|467225173|FG000|On-Treatment|Death|1|||
129797127|NCT00410202|467225174|FG001|On-Treatment|Death|0|||
129797128|NCT00410202|467225175|FG002|On-Treatment|Death|0|||
129797129|NCT00410202|467225173|FG000|On-Treatment|Lost to Follow-up|1|||
129797130|NCT00410202|467225174|FG001|On-Treatment|Lost to Follow-up|0|||
129797131|NCT00410202|467225175|FG002|On-Treatment|Lost to Follow-up|1|||
129797132|NCT00410202|467225173|FG000|On-Treatment|Lack of Efficacy|1|||
129797133|NCT00410202|467225174|FG001|On-Treatment|Lack of Efficacy|4|||
129797134|NCT00410202|467225175|FG002|On-Treatment|Lack of Efficacy|0|||
129797135|NCT00410202|467225173|FG000|On-Treatment|Withdrawal by Subject|2|||
129797136|NCT00410202|467225174|FG001|On-Treatment|Withdrawal by Subject|1|||
129797137|NCT00410202|467225175|FG002|On-Treatment|Withdrawal by Subject|1|||
129797138|NCT00410202|467225173|FG000|On-Treatment|Other Reason|0|||
129797139|NCT00410202|467225174|FG001|On-Treatment|Other Reason|0|||
129797140|NCT00410202|467225175|FG002|On-Treatment|Other Reason|1|||
129797141|NCT00410202|467225173|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
129797142|NCT00410202|467225174|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
129797143|NCT00410202|467225175|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
129797144|NCT00410202|467225173|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
129797145|NCT00410202|467225174|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
129797146|NCT00410202|467225175|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
129797147|NCT00410202|467225173|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
129797148|NCT00410202|467225174|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
129797149|NCT00410202|467225175|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
129797150|NCT00937391|467225176|FG000|Stage 2|Withdrawal by Subject|1|||
129797151|NCT03194490|467225195|FG000|Overall Study|Lost to Follow-up|1|||
129797152|NCT03194490|467225196|FG001|Overall Study|Lost to Follow-up|3|||
129797153|NCT03194490|467225195|FG000|Overall Study|participant developed specific neck pain|1|||
129797154|NCT03194490|467225196|FG001|Overall Study|participant developed specific neck pain|0|||
129797155|NCT01758289|467225197|FG000|Overall Study|Premature Study Termination|44|||
129797156|NCT01758289|467225197|FG000|Overall Study|Adverse Event|9|||
129797157|NCT01574079|467225198|FG000|Overall Study|Physician Decision|0|||
129797158|NCT01574079|467225199|FG001|Overall Study|Physician Decision|2|||
129797159|NCT01574079|467225198|FG000|Overall Study|Lost to Follow-up|1|||
129797160|NCT01574079|467225199|FG001|Overall Study|Lost to Follow-up|0|||
129797161|NCT03640559|467225203|FG000|Overall Study|Physician Decision|1|||
129797162|NCT03640559|467225204|FG001|Overall Study|Physician Decision|1|||
129797163|NCT03640559|467225203|FG000|Overall Study|Withdrawal by Subject|1|||
129797164|NCT03640559|467225204|FG001|Overall Study|Withdrawal by Subject|0|||
129797165|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
129797166|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
129797167|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
129797168|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
129797169|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
129797170|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
129797171|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
129797172|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
129797173|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
129797174|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
129797175|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
129797176|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
129797177|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
129797178|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129797179|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
129797180|NCT01436162|467225205|FG000|Single-blind Lead-in Phase|Other|107|||
129797181|NCT01436162|467225206|FG001|Single-blind Lead-in Phase|Other|0|||
129797182|NCT01436162|467225207|FG002|Single-blind Lead-in Phase|Other|0|||
129797183|NCT01436162|467225205|FG000|Randomized Phase|Adverse Event|1|||
129797184|NCT01436162|467225206|FG001|Randomized Phase|Adverse Event|5|||
129797185|NCT01436162|467225207|FG002|Randomized Phase|Adverse Event|6|||
129797186|NCT01436162|467225205|FG000|Randomized Phase|Protocol Violation|4|||
129797187|NCT01436162|467225206|FG001|Randomized Phase|Protocol Violation|4|||
129797188|NCT01436162|467225207|FG002|Randomized Phase|Protocol Violation|2|||
129634706|NCT00463047|466616770|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
129634707|NCT00463047|466616771|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
129634708|NCT03020992|466616775|FG000|Overall Study|Adverse Event|5|||
129797189|NCT01436162|467225205|FG000|Randomized Phase|Withdrawal by Subject|16|||
129797190|NCT01436162|467225206|FG001|Randomized Phase|Withdrawal by Subject|9|||
129797191|NCT01436162|467225207|FG002|Randomized Phase|Withdrawal by Subject|8|||
129797192|NCT01436162|467225205|FG000|Randomized Phase|Lost to Follow-up|17|||
129797193|NCT01436162|467225206|FG001|Randomized Phase|Lost to Follow-up|5|||
129797194|NCT01436162|467225207|FG002|Randomized Phase|Lost to Follow-up|4|||
129797195|NCT01436162|467225205|FG000|Randomized Phase|Lack of Efficacy|0|||
129797196|NCT01436162|467225206|FG001|Randomized Phase|Lack of Efficacy|1|||
129797197|NCT01436162|467225207|FG002|Randomized Phase|Lack of Efficacy|1|||
129797198|NCT01436162|467225205|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
129634709|NCT03020992|466616775|FG000|Overall Study|Withdrawal by Subject|1|||
129634710|NCT02861807|466616776|FG000|Overall Study|Lost to Follow-up|7|||
129634711|NCT02861807|466616777|FG001|Overall Study|Lost to Follow-up|6|||
129797199|NCT01436162|467225206|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
129634712|NCT02861807|466616776|FG000|Overall Study|Withdrawal by Subject|5|||
129634713|NCT02861807|466616777|FG001|Overall Study|Withdrawal by Subject|8|||
129634714|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
129634715|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
129634716|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
129634717|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
129634718|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Pregnancy|0|||
129634719|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Pregnancy|1|||
129634720|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
129634721|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
129634722|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
129634723|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
129634724|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
129797200|NCT01436162|467225207|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
129797201|NCT01436162|467225205|FG000|Randomized Phase|Other|2|||
129797202|NCT01436162|467225206|FG001|Randomized Phase|Other|5|||
129797203|NCT01436162|467225207|FG002|Randomized Phase|Other|4|||
129797204|NCT01931202|467225211|FG000|Overall Study|Withdrawal by Subject|0|||
129797205|NCT01931202|467225212|FG001|Overall Study|Withdrawal by Subject|0|||
129797206|NCT01931202|467225213|FG002|Overall Study|Withdrawal by Subject|2|||
129797207|NCT01931202|467225211|FG000|Overall Study|Lost to Follow-up|0|||
129797208|NCT01931202|467225212|FG001|Overall Study|Lost to Follow-up|5|||
129797209|NCT01931202|467225213|FG002|Overall Study|Lost to Follow-up|2|||
129797210|NCT02211638|467225218|FG000|Overall Study|Case Report Forms Uncollected|291|||
129797211|NCT02211638|467225218|FG000|Overall Study|Protocol Violation|692|||
129797212|NCT02775903|467225219|FG000|Overall Study|Death|7|||
129797213|NCT02775903|467225220|FG001|Overall Study|Death|11|||
129797214|NCT02775903|467225221|FG002|Overall Study|Death|12|||
129797215|NCT02775903|467225222|FG003|Overall Study|Death|11|||
129797216|NCT02775903|467225219|FG000|Overall Study|Adverse Event|0|||
129797217|NCT02775903|467225220|FG001|Overall Study|Adverse Event|1|||
129797218|NCT02775903|467225221|FG002|Overall Study|Adverse Event|12|||
129797219|NCT02775903|467225222|FG003|Overall Study|Adverse Event|3|||
129797220|NCT02775903|467225219|FG000|Overall Study|Progressive disease|15|||
129797221|NCT02775903|467225220|FG001|Overall Study|Progressive disease|14|||
129797222|NCT02775903|467225221|FG002|Overall Study|Progressive disease|30|||
129797223|NCT02775903|467225222|FG003|Overall Study|Progressive disease|20|||
129797224|NCT02775903|467225219|FG000|Overall Study|Lack of Efficacy|2|||
129797225|NCT02775903|467225220|FG001|Overall Study|Lack of Efficacy|2|||
129797226|NCT02775903|467225221|FG002|Overall Study|Lack of Efficacy|2|||
129797227|NCT02775903|467225222|FG003|Overall Study|Lack of Efficacy|6|||
129797228|NCT02775903|467225219|FG000|Overall Study|Withdrawal by Subject|7|||
129797229|NCT02775903|467225220|FG001|Overall Study|Withdrawal by Subject|5|||
129797230|NCT02775903|467225221|FG002|Overall Study|Withdrawal by Subject|5|||
129797231|NCT02775903|467225222|FG003|Overall Study|Withdrawal by Subject|8|||
129797232|NCT02775903|467225219|FG000|Overall Study|Other reasons|7|||
129797233|NCT02775903|467225220|FG001|Overall Study|Other reasons|8|||
129797234|NCT02775903|467225221|FG002|Overall Study|Other reasons|2|||
129797235|NCT02775903|467225222|FG003|Overall Study|Other reasons|12|||
129797236|NCT04041700|467225223|FG000|Overall Study|Pregnancy|1|||
129797237|NCT04041700|467225223|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
129797238|NCT04571515|467225226|FG000|Overall Study|Physician Decision|0|||
129797239|NCT04571515|467225227|FG001|Overall Study|Physician Decision|0|||
129797240|NCT04571515|467225228|FG002|Overall Study|Physician Decision|0|||
129634725|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
129634726|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Other|3|||
129797241|NCT04571515|467225229|FG003|Overall Study|Physician Decision|0|||
129797242|NCT04571515|467225230|FG004|Overall Study|Physician Decision|1|||
129797243|NCT04571515|467225226|FG000|Overall Study|Withdrawal by Subject|0|||
129797244|NCT04571515|467225227|FG001|Overall Study|Withdrawal by Subject|0|||
129797245|NCT04571515|467225228|FG002|Overall Study|Withdrawal by Subject|0|||
129634727|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Other|0|||
129634728|NCT01006122|466616780|FG000|First Double-blind Intervention Period|Adverse Event|0|||
129634729|NCT01006122|466616781|FG001|First Double-blind Intervention Period|Adverse Event|4|||
129797246|NCT04571515|467225229|FG003|Overall Study|Withdrawal by Subject|0|||
129797247|NCT04571515|467225230|FG004|Overall Study|Withdrawal by Subject|1|||
129797248|NCT04571515|467225226|FG000|Overall Study|insufficient pain|1|||
129797249|NCT04571515|467225227|FG001|Overall Study|insufficient pain|0|||
129797250|NCT04571515|467225228|FG002|Overall Study|insufficient pain|0|||
129797251|NCT04571515|467225229|FG003|Overall Study|insufficient pain|0|||
129797252|NCT04571515|467225230|FG004|Overall Study|insufficient pain|1|||
129797253|NCT05140382|467225231|FG000|Overall Study|Death|3|||
129634730|NCT01006122|466616780|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
129634731|NCT01006122|466616781|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
129634732|NCT01006122|466616780|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
129634733|NCT01006122|466616781|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
129634734|NCT01006122|466616780|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
129634735|NCT01006122|466616781|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
129634736|NCT01006122|466616780|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
129634737|NCT01006122|466616781|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
129634738|NCT01006122|466616780|FG000|Second Double-blind Intervention Period|Death|0|||
129634739|NCT01006122|466616781|FG001|Second Double-blind Intervention Period|Death|1|||
129634740|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
129634741|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
129634742|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
129634743|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
129634744|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
129634745|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
129634746|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
129634747|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
129634748|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
129634749|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
129634750|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
129634751|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
129634752|NCT03493854|466616782|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
129634753|NCT03493854|466616783|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
129634754|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
129634755|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
129634756|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
129634757|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
129634758|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
129634759|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
129634760|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
129634761|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
129634762|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
129634763|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
129634764|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
129634765|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
129634766|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
129634767|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
129797254|NCT05140382|467225232|FG001|Overall Study|Death|0|||
129797255|NCT05140382|467225233|FG002|Overall Study|Death|0|||
129797256|NCT05140382|467225231|FG000|Overall Study|Investigator decision|1|||
129797257|NCT05140382|467225232|FG001|Overall Study|Investigator decision|0|||
129797258|NCT05140382|467225233|FG002|Overall Study|Investigator decision|0|||
129797259|NCT05140382|467225231|FG000|Overall Study|Other|4|||
129797260|NCT05140382|467225232|FG001|Overall Study|Other|0|||
129797261|NCT05140382|467225233|FG002|Overall Study|Other|1|||
129797262|NCT05140382|467225231|FG000|Overall Study|Progressive disease|20|||
129797263|NCT05140382|467225232|FG001|Overall Study|Progressive disease|1|||
129797264|NCT05140382|467225233|FG002|Overall Study|Progressive disease|12|||
129797265|NCT05140382|467225231|FG000|Overall Study|Subjective disease progression|2|||
129797266|NCT05140382|467225232|FG001|Overall Study|Subjective disease progression|1|||
129797267|NCT05140382|467225233|FG002|Overall Study|Subjective disease progression|0|||
129797268|NCT05140382|467225231|FG000|Overall Study|Unknown at data cut-off|0|||
129797269|NCT05140382|467225232|FG001|Overall Study|Unknown at data cut-off|0|||
129797270|NCT05140382|467225233|FG002|Overall Study|Unknown at data cut-off|1|||
129797271|NCT05140382|467225231|FG000|Overall Study|Withdrawal by Subject|1|||
129797272|NCT05140382|467225232|FG001|Overall Study|Withdrawal by Subject|0|||
129797273|NCT05140382|467225233|FG002|Overall Study|Withdrawal by Subject|4|||
129797274|NCT05140382|467225231|FG000|Overall Study|Withdrawal of consent|0|||
129797275|NCT05140382|467225232|FG001|Overall Study|Withdrawal of consent|0|||
129797276|NCT05140382|467225233|FG002|Overall Study|Withdrawal of consent|1|||
129797277|NCT02294773|467226592|FG000|Overall Study|Withdrawal by Subject|0|||
129797278|NCT02294773|467226593|FG001|Overall Study|Withdrawal by Subject|2|||
129797279|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Adverse Event|2|||
129797280|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Adverse Event|0|||
129797281|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
129797282|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
129797283|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
129797284|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
129797285|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
129797286|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129797287|NCT03052764|467226594|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
129797288|NCT03052764|467226595|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
129797289|NCT04123665|467226598|FG000|Overall Study|Withdrawal by Subject|7|||
129797290|NCT04123665|467226599|FG001|Overall Study|Withdrawal by Subject|0|||
129797291|NCT04123665|467226598|FG000|Overall Study|Lost to Follow-up|1|||
129797292|NCT04123665|467226599|FG001|Overall Study|Lost to Follow-up|0|||
129797293|NCT02237911|467226600|FG000|Overall Study|Withdrawal by Subject|4|||
129797294|NCT02237911|467226601|FG001|Overall Study|Withdrawal by Subject|7|||
129797295|NCT02237911|467226602|FG002|Overall Study|Withdrawal by Subject|2|||
129797296|NCT02237911|467226600|FG000|Overall Study|Lost to Follow-up|3|||
129797297|NCT02237911|467226601|FG001|Overall Study|Lost to Follow-up|1|||
129797298|NCT02237911|467226602|FG002|Overall Study|Lost to Follow-up|1|||
129797299|NCT00053365|467226603|FG000|Overall Study|Incorrect cell type|1|||
129797300|NCT00053365|467226603|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
129797301|NCT00053365|467226603|FG000|Overall Study|Never treated|4|||
129797302|NCT00958789|467226608|FG000|Overall Study|Death|5|||
129797303|NCT00958789|467226608|FG000|Overall Study|Lost to Follow-up|14|||
129797304|NCT00958789|467226608|FG000|Overall Study|Withdrawal by Subject|17|||
129797305|NCT00958789|467226608|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
129797306|NCT00958789|467226608|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
129797307|NCT00958789|467226608|FG000|Overall Study|Subject terminated|2|||
129797308|NCT00958789|467226608|FG000|Overall Study|Revision|7|||
129797309|NCT05007717|467226610|FG000|Overall Study|Death|3|||
129797310|NCT05007717|467226611|FG001|Overall Study|Death|2|||
129797311|NCT00427960|467226613|FG000|Overall Study|Adverse Event|2|||
129797312|NCT00427960|467226614|FG001|Overall Study|Adverse Event|0|||
129634768|NCT03493854|466616782|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
129634769|NCT03493854|466616783|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
129634770|NCT03493854|466616782|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
129797313|NCT00427960|467226613|FG000|Overall Study|Withdrawal by Subject|0|||
129797314|NCT00427960|467226614|FG001|Overall Study|Withdrawal by Subject|3|||
129634771|NCT03493854|466616783|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
129634772|NCT03493854|466616782|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
129634773|NCT03493854|466616783|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
129797315|NCT00427960|467226613|FG000|Overall Study|Other|0|||
129797316|NCT00427960|467226614|FG001|Overall Study|Other|1|||
129797317|NCT03282565|467226617|FG000|Overall Study|COVID-19 Research Shutdown|0|||
129634774|NCT03493854|466616782|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
129634775|NCT03493854|466616783|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
129797318|NCT03282565|467226618|FG001|Overall Study|COVID-19 Research Shutdown|2|||
129797319|NCT03282565|467226619|FG002|Overall Study|COVID-19 Research Shutdown|2|||
129797320|NCT01869725|467226620|FG000|Overall Study|ineligible after registration|1|||
129797321|NCT01869725|467226620|FG000|Overall Study|Death|1|||
129797322|NCT01869725|467226620|FG000|Overall Study|Lost to Follow-up|2|||
129797323|NCT01143207|467226621|FG000|Overall Study|Lost to Follow-up|2|||
129797324|NCT04163718|467226626|FG000|Overall Study|Study terminated|12|||
129797325|NCT03463031|467226635|FG000|Overall Study|Withdrawal by Subject|4|||
129797326|NCT03463031|467226636|FG001|Overall Study|Withdrawal by Subject|2|||
129797327|NCT03463031|467226635|FG000|Overall Study|Investigator/Sponsor Decision|0|||
129797328|NCT03463031|467226636|FG001|Overall Study|Investigator/Sponsor Decision|1|||
129797329|NCT03463031|467226635|FG000|Overall Study|Lost to Follow-up|1|||
129797330|NCT03463031|467226636|FG001|Overall Study|Lost to Follow-up|1|||
129797331|NCT03463031|467226635|FG000|Overall Study|Adverse Event|4|||
129797332|NCT03463031|467226636|FG001|Overall Study|Adverse Event|1|||
129797333|NCT03463031|467226635|FG000|Overall Study|Use of prohibited medication by subject|1|||
129797334|NCT03463031|467226636|FG001|Overall Study|Use of prohibited medication by subject|0|||
129797335|NCT02131532|467226637|FG000|Overall Study|Withdrawal by Subject|1|||
129797336|NCT02131532|467226637|FG000|Overall Study|Physician Decision|1|||
129797337|NCT02131532|467226637|FG000|Overall Study|Other health conditions|2|||
129797338|NCT01466595|467226643|FG000|Overall Study|Withdrawal by Subject|0|||
129797339|NCT01466595|467226644|FG001|Overall Study|Withdrawal by Subject|1|||
129797340|NCT00057954|467226645|FG000|Overall Study|Death|1|||
129440458|NCT00413972|465911440|FG000|Overall Study|Withdrawal by Subject|4|||
129440459|NCT00413972|465911441|FG001|Overall Study|Withdrawal by Subject|5|||
129440460|NCT00413972|465911442|FG002|Overall Study|Withdrawal by Subject|7|||
129440461|NCT00413972|465911443|FG003|Overall Study|Withdrawal by Subject|2|||
129440462|NCT00413972|465911440|FG000|Overall Study|Protocol Violation|0|||
129440463|NCT00413972|465911441|FG001|Overall Study|Protocol Violation|0|||
129440464|NCT00413972|465911442|FG002|Overall Study|Protocol Violation|2|||
129440465|NCT00413972|465911443|FG003|Overall Study|Protocol Violation|0|||
129440466|NCT00413972|465911440|FG000|Overall Study|Other|0|||
129440467|NCT00413972|465911441|FG001|Overall Study|Other|0|||
129440468|NCT00413972|465911442|FG002|Overall Study|Other|0|||
129440469|NCT00413972|465911443|FG003|Overall Study|Other|1|||
129440470|NCT01145755|465911444|FG000|Overall Study|Adverse Event|2|||
129440471|NCT01145755|465911445|FG001|Overall Study|Adverse Event|4|||
129440472|NCT01145755|465911446|FG002|Overall Study|Adverse Event|2|||
129440473|NCT01145755|465911444|FG000|Overall Study|Withdrawal by Subject|2|||
129440474|NCT01145755|465911445|FG001|Overall Study|Withdrawal by Subject|2|||
129440475|NCT01145755|465911446|FG002|Overall Study|Withdrawal by Subject|2|||
129440476|NCT01145755|465911444|FG000|Overall Study|Lost to Follow-up|2|||
129440477|NCT01145755|465911445|FG001|Overall Study|Lost to Follow-up|3|||
129440478|NCT01145755|465911446|FG002|Overall Study|Lost to Follow-up|1|||
129440479|NCT01145755|465911444|FG000|Overall Study|Protocol Violation|0|||
129440480|NCT01145755|465911445|FG001|Overall Study|Protocol Violation|3|||
129440481|NCT01145755|465911446|FG002|Overall Study|Protocol Violation|1|||
129440482|NCT01145755|465911444|FG000|Overall Study|Study Closure|14|||
129440483|NCT01145755|465911445|FG001|Overall Study|Study Closure|14|||
129440484|NCT01145755|465911446|FG002|Overall Study|Study Closure|17|||
129440485|NCT01145755|465911444|FG000|Overall Study|Lack of Efficacy|0|||
129440486|NCT01145755|465911445|FG001|Overall Study|Lack of Efficacy|1|||
129440487|NCT01145755|465911446|FG002|Overall Study|Lack of Efficacy|0|||
129440488|NCT01145755|465911444|FG000|Overall Study|Patient could not swollow medication|0|||
129440489|NCT01145755|465911445|FG001|Overall Study|Patient could not swollow medication|0|||
129440490|NCT01145755|465911446|FG002|Overall Study|Patient could not swollow medication|1|||
129440491|NCT01145755|465911444|FG000|Overall Study|Withdrawal by Subject|0|||
129440492|NCT01145755|465911445|FG001|Overall Study|Withdrawal by Subject|0|||
129634776|NCT00739661|466616786|FG000|Overall Study|Adverse Event|2|||
129634777|NCT00739661|466616787|FG001|Overall Study|Adverse Event|0|||
129634778|NCT00739661|466616786|FG000|Overall Study|Physician decision to withdraw patient|1|||
129797341|NCT00057954|467226645|FG000|Overall Study|Disease progression|1|||
129797342|NCT01264016|467226646|FG000|Overall Study|Withdrawal by Subject|1|||
129797343|NCT01264016|467226646|FG000|Overall Study|Felt faint at sight of blood|1|||
129797344|NCT02147184|467226647|FG000|Overall Study|Lost to Follow-up|28|||
129797345|NCT02147184|467226648|FG001|Overall Study|Lost to Follow-up|15|||
129797346|NCT02147184|467226647|FG000|Overall Study|Study Burden|11|||
129797347|NCT02147184|467226648|FG001|Overall Study|Study Burden|7|||
129797348|NCT02147184|467226647|FG000|Overall Study|Pregnancy|6|||
129889322|NCT01848834|467552547|FG000|Overall Study|Withdrawal by Subject|2|||
129889323|NCT01848834|467552548|FG001|Overall Study|Withdrawal by Subject|13|||
129634779|NCT00739661|466616787|FG001|Overall Study|Physician decision to withdraw patient|0|||
129440493|NCT01145755|465911446|FG002|Overall Study|Withdrawal by Subject|1|||
129440494|NCT01145755|465911444|FG000|Overall Study|Positive urine ethanol|0|||
129440495|NCT01145755|465911445|FG001|Overall Study|Positive urine ethanol|1|||
129440496|NCT01145755|465911446|FG002|Overall Study|Positive urine ethanol|0|||
129634780|NCT00739661|466616786|FG000|Overall Study|Patient decision to withdraw|9|||
129440497|NCT01116882|465911452|FG000|30-day|Lost to Follow-up|50|||
129440498|NCT01116882|465911453|FG001|30-day|Lost to Follow-up|21|||
129440499|NCT01116882|465911452|FG000|30-day|Withdrawal by Subject|2|||
129797349|NCT02147184|467226648|FG001|Overall Study|Pregnancy|0|||
129797350|NCT02147184|467226647|FG000|Overall Study|Moved out of state|3|||
129797351|NCT02147184|467226648|FG001|Overall Study|Moved out of state|3|||
129797352|NCT02147184|467226647|FG000|Overall Study|Physician Decision|0|||
129634781|NCT00739661|466616787|FG001|Overall Study|Patient decision to withdraw|4|||
129634782|NCT00739661|466616786|FG000|Overall Study|Disease progression, radiographic|33|||
129634783|NCT00739661|466616787|FG001|Overall Study|Disease progression, radiographic|37|||
129634784|NCT00739661|466616786|FG000|Overall Study|Reason for discontinuation not available|1|||
129634785|NCT00739661|466616787|FG001|Overall Study|Reason for discontinuation not available|1|||
129634786|NCT00529308|466616788|FG000|Overall Study|Withdrawal by Subject|1|||
129634787|NCT00529308|466616789|FG001|Overall Study|Withdrawal by Subject|1|||
129634788|NCT05343364|466616796|FG000|Overall Study|Miscellaneous|0|||
129634789|NCT05343364|466616797|FG001|Overall Study|Miscellaneous|1|||
129704576|NCT01346176|466880636|FG001|Completed Satisfaction Survey|Death|0|||
129704577|NCT01346176|466880637|FG002|Completed Satisfaction Survey|Death|2|||
129704578|NCT01346176|466880635|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
129704579|NCT01346176|466880636|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
129704580|NCT01346176|466880637|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
129704581|NCT01994876|466880638|FG000|Test Period 1|Withdrawal by Subject|0|||
129704582|NCT01994876|466880639|FG001|Test Period 1|Withdrawal by Subject|1|||
129704583|NCT01994876|466880638|FG000|Test Period 1|Adverse Event|0|||
129704584|NCT01994876|466880639|FG001|Test Period 1|Adverse Event|1|||
129704585|NCT01994876|466880638|FG000|Test Period 2|Adverse Event|1|||
129704586|NCT01994876|466880639|FG001|Test Period 2|Adverse Event|0|||
129704587|NCT01994876|466880638|FG000|Test Period 2|Protocol Violation|0|||
129704588|NCT01994876|466880639|FG001|Test Period 2|Protocol Violation|1|||
129704589|NCT01400412|466880640|FG000|Overall Study|Lost to Follow-up|4|||
129704590|NCT01400412|466880641|FG001|Overall Study|Lost to Follow-up|7|||
129704591|NCT01400412|466880640|FG000|Overall Study|Withdrawal by Subject|3|||
129704592|NCT01400412|466880641|FG001|Overall Study|Withdrawal by Subject|4|||
129704593|NCT01400412|466880640|FG000|Overall Study|Unable to complete|3|||
129704594|NCT01400412|466880641|FG001|Overall Study|Unable to complete|3|||
129704595|NCT01400412|466880640|FG000|Overall Study|Never started study treatment|0|||
129704596|NCT01400412|466880641|FG001|Overall Study|Never started study treatment|3|||
129704597|NCT01441960|466881723|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
129704598|NCT01441960|466881724|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
129704599|NCT01441960|466881723|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
129704600|NCT01441960|466881724|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
129704601|NCT01441960|466881723|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
129704602|NCT01441960|466881724|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
129704603|NCT02986074|466881725|FG000|First Trial Period|Adverse Event|1|||
129704604|NCT02986074|466881726|FG001|First Trial Period|Adverse Event|0|||
129704605|NCT02986074|466881727|FG002|First Trial Period|Adverse Event|0|||
129704606|NCT02986074|466881728|FG003|First Trial Period|Adverse Event|0|||
129704607|NCT02986074|466881725|FG000|Follow up Period|system explant|0|||
129704608|NCT02986074|466881726|FG001|Follow up Period|system explant|0|||
129704609|NCT02986074|466881727|FG002|Follow up Period|system explant|1|||
129704610|NCT02986074|466881728|FG003|Follow up Period|system explant|2|||
129704611|NCT02986074|466881725|FG000|Follow up Period|Physician Decision|0|||
129704612|NCT02986074|466881726|FG001|Follow up Period|Physician Decision|0|||
129704613|NCT02986074|466881727|FG002|Follow up Period|Physician Decision|0|||
129704614|NCT02986074|466881728|FG003|Follow up Period|Physician Decision|1|||
129704615|NCT00069641|466881733|FG000|Overall Study|Death|1|||
129704616|NCT00069641|466881734|FG001|Overall Study|Death|0|||
129704617|NCT00069641|466881735|FG002|Overall Study|Death|1|||
129704618|NCT01948427|466881736|FG000|Overall Study|Serious Adverse Event|3|||
129704619|NCT01948427|466881737|FG001|Overall Study|Serious Adverse Event|0|||
129704620|NCT01948427|466881738|FG002|Overall Study|Serious Adverse Event|0|||
129704621|NCT01948427|466881739|FG003|Overall Study|Serious Adverse Event|0|||
129704622|NCT01948427|466881740|FG004|Overall Study|Serious Adverse Event|1|||
129704623|NCT01948427|466881736|FG000|Overall Study|Investigator Request|0|||
129704624|NCT01948427|466881737|FG001|Overall Study|Investigator Request|8|||
129704625|NCT01948427|466881738|FG002|Overall Study|Investigator Request|0|||
129704626|NCT01948427|466881739|FG003|Overall Study|Investigator Request|0|||
129704627|NCT01948427|466881740|FG004|Overall Study|Investigator Request|6|||
129704628|NCT01948427|466881736|FG000|Overall Study|Lost to Follow-up|1|||
129704629|NCT01948427|466881737|FG001|Overall Study|Lost to Follow-up|0|||
129704630|NCT01948427|466881738|FG002|Overall Study|Lost to Follow-up|0|||
129704631|NCT01948427|466881739|FG003|Overall Study|Lost to Follow-up|0|||
129704632|NCT01948427|466881740|FG004|Overall Study|Lost to Follow-up|4|||
129704633|NCT01948427|466881736|FG000|Overall Study|Withdrawal by Subject|2|||
129704634|NCT01948427|466881737|FG001|Overall Study|Withdrawal by Subject|0|||
129634790|NCT02105987|466616798|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
129634791|NCT02105987|466616799|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129634792|NCT02105987|466616800|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129634793|NCT02105987|466616801|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129634794|NCT02105987|466616802|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129634795|NCT02105987|466616803|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
129634796|NCT02105987|466616798|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
129634797|NCT02105987|466616799|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
129634798|NCT02105987|466616800|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129634799|NCT02105987|466616801|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129634800|NCT02105987|466616802|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129634801|NCT02105987|466616803|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
129634802|NCT02105987|466616798|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
129634803|NCT02105987|466616799|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
129634804|NCT02105987|466616800|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129634805|NCT02105987|466616801|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129704635|NCT01948427|466881738|FG002|Overall Study|Withdrawal by Subject|0|||
129704636|NCT01948427|466881739|FG003|Overall Study|Withdrawal by Subject|0|||
129704637|NCT01948427|466881740|FG004|Overall Study|Withdrawal by Subject|1|||
129704638|NCT01948427|466881736|FG000|Overall Study|Other, Not Specified|1|||
129704639|NCT01948427|466881737|FG001|Overall Study|Other, Not Specified|9|||
129704640|NCT01948427|466881738|FG002|Overall Study|Other, Not Specified|0|||
129704641|NCT01948427|466881739|FG003|Overall Study|Other, Not Specified|0|||
129704642|NCT01948427|466881740|FG004|Overall Study|Other, Not Specified|2|||
129704643|NCT00402987|466881741|FG000|Overall Study|Lack of Efficacy|0|||
129704644|NCT00402987|466881742|FG001|Overall Study|Lack of Efficacy|0|||
129704645|NCT00402987|466881743|FG002|Overall Study|Lack of Efficacy|1|||
129704646|NCT00402987|466881744|FG003|Overall Study|Lack of Efficacy|0|||
129704647|NCT01668004|466881745|FG000|Overall Study|Adverse Event|7|||
129704648|NCT01668004|466881745|FG000|Overall Study|Withdrawal by Subject|2|||
129704649|NCT01668004|466881745|FG000|Overall Study|Lost to Follow-up|5|||
129704650|NCT01668004|466881745|FG000|Overall Study|Lack of Efficacy|9|||
129704651|NCT01668004|466881745|FG000|Overall Study|Non-compliance with treatment|2|||
129704652|NCT02448381|466881750|FG000|Overall Study|Adverse Event|2|||
129704653|NCT02448381|466881751|FG001|Overall Study|Adverse Event|0|||
129704654|NCT02448381|466881750|FG000|Overall Study|Lost to Follow-up|16|||
129704655|NCT02448381|466881751|FG001|Overall Study|Lost to Follow-up|9|||
129704656|NCT02448381|466881750|FG000|Overall Study|Physician Decision|1|||
129704657|NCT02448381|466881751|FG001|Overall Study|Physician Decision|1|||
129704658|NCT02448381|466881750|FG000|Overall Study|Pregnancy|1|||
129704659|NCT02448381|466881751|FG001|Overall Study|Pregnancy|0|||
129704660|NCT02448381|466881750|FG000|Overall Study|Withdrawal by Subject|13|||
129704661|NCT02448381|466881751|FG001|Overall Study|Withdrawal by Subject|9|||
129704662|NCT02448381|466881750|FG000|Overall Study|Noncompliance with Study Procedures|2|||
129704663|NCT02448381|466881751|FG001|Overall Study|Noncompliance with Study Procedures|0|||
129704664|NCT01170663|466881754|FG000|Overall Study|Lost to Follow-up|3|||
129704665|NCT01170663|466881755|FG001|Overall Study|Lost to Follow-up|9|||
129704666|NCT01170663|466881754|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
129704667|NCT01170663|466881755|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
129704668|NCT02303262|466881758|FG000|Overall Study|Withdrawal by Subject|2|||
129704669|NCT04462471|466881759|FG000|Overall Study|Adverse Event|0|||
129704670|NCT04462471|466881760|FG001|Overall Study|Adverse Event|1|||
129704671|NCT04462471|466881761|FG002|Overall Study|Adverse Event|0|||
129704672|NCT04462471|466881762|FG003|Overall Study|Adverse Event|0|||
129704673|NCT04462471|466881759|FG000|Overall Study|Disease progression|1|||
129704674|NCT04462471|466881760|FG001|Overall Study|Disease progression|0|||
129704675|NCT04462471|466881761|FG002|Overall Study|Disease progression|0|||
129634806|NCT02105987|466616802|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129704676|NCT04462471|466881762|FG003|Overall Study|Disease progression|0|||
129704677|NCT04138056|466881767|FG000|Primary Study|Lost to Follow-up|3|||
129704678|NCT04138056|466881768|FG001|Primary Study|Lost to Follow-up|4|||
129704679|NCT04138056|466881769|FG002|Primary Study|Lost to Follow-up|1|||
129704680|NCT04138056|466881770|FG003|Primary Study|Lost to Follow-up|1|||
129889324|NCT01848834|467552549|FG002|Overall Study|Withdrawal by Subject|10|||
129889325|NCT01848834|467552550|FG003|Overall Study|Withdrawal by Subject|6|||
129889326|NCT01848834|467552551|FG004|Overall Study|Withdrawal by Subject|36|||
129889327|NCT02040090|467552552|FG000|Overall Study|Adverse Event|2|||
129889328|NCT02040090|467552553|FG001|Overall Study|Adverse Event|0|||
129889329|NCT02040090|467552552|FG000|Overall Study|Physician Decision|1|||
129634807|NCT02105987|466616803|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129704681|NCT04138056|466881771|FG004|Primary Study|Lost to Follow-up|4|||
129704682|NCT04138056|466881767|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
129704683|NCT04138056|466881768|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
129704684|NCT04138056|466881769|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
129704685|NCT04138056|466881770|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
129704686|NCT04138056|466881771|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
129704687|NCT04138056|466881767|FG000|Extension Study|Lost to Follow-up|1|||
129704688|NCT04138056|466881768|FG001|Extension Study|Lost to Follow-up|2|||
129704689|NCT04138056|466881769|FG002|Extension Study|Lost to Follow-up|1|||
129704690|NCT04138056|466881770|FG003|Extension Study|Lost to Follow-up|0|||
129704691|NCT04138056|466881771|FG004|Extension Study|Lost to Follow-up|1|||
129704692|NCT01656161|466881772|FG000|Overall Study|Death|3|||
129704693|NCT01656161|466881772|FG000|Overall Study|Adverse Event|2|||
129704694|NCT01656161|466881772|FG000|Overall Study|Protocol Violation|1|||
129704695|NCT01656161|466881772|FG000|Overall Study|Withdrawal by Subject|1|||
129704696|NCT01215851|466881773|FG000|Treatment Period|Adverse Event|1|||
129704697|NCT01215851|466881774|FG001|Treatment Period|Adverse Event|1|||
129704698|NCT01215851|466881775|FG002|Treatment Period|Adverse Event|1|||
129704699|NCT01215851|466881776|FG003|Treatment Period|Adverse Event|3|||
129704700|NCT01215851|466881777|FG004|Treatment Period|Adverse Event|0|||
129704701|NCT01215851|466881778|FG005|Treatment Period|Adverse Event|1|||
129704702|NCT01215851|466881773|FG000|Follow up Period|Lost to Follow-up|0|||
129704703|NCT01215851|466881774|FG001|Follow up Period|Lost to Follow-up|0|||
129704704|NCT01215851|466881775|FG002|Follow up Period|Lost to Follow-up|0|||
129704705|NCT01215851|466881776|FG003|Follow up Period|Lost to Follow-up|0|||
129704706|NCT01215851|466881777|FG004|Follow up Period|Lost to Follow-up|0|||
129704707|NCT01215851|466881778|FG005|Follow up Period|Lost to Follow-up|1|||
129704708|NCT03510273|466881779|FG000|Overall Study|Withdrawal by Subject|2|||
129704709|NCT03510273|466881779|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
129704710|NCT03510273|466881779|FG000|Overall Study|Moved away from study area|4|||
129704711|NCT01276106|466881782|FG000|Overall Study|Adverse Event|3|||
129704712|NCT01276106|466881783|FG001|Overall Study|Adverse Event|3|||
129704713|NCT01276106|466881784|FG002|Overall Study|Adverse Event|11|||
129704714|NCT01276106|466881785|FG003|Overall Study|Adverse Event|3|||
129704715|NCT01276106|466881782|FG000|Overall Study|Withdrawal by Subject|6|||
129704716|NCT01276106|466881783|FG001|Overall Study|Withdrawal by Subject|3|||
129704717|NCT01276106|466881784|FG002|Overall Study|Withdrawal by Subject|1|||
129704718|NCT01276106|466881785|FG003|Overall Study|Withdrawal by Subject|6|||
129704719|NCT01276106|466881782|FG000|Overall Study|Lack of Efficacy|0|||
129704720|NCT01276106|466881783|FG001|Overall Study|Lack of Efficacy|1|||
129704721|NCT01276106|466881784|FG002|Overall Study|Lack of Efficacy|0|||
129704722|NCT01276106|466881785|FG003|Overall Study|Lack of Efficacy|1|||
129704723|NCT01276106|466881782|FG000|Overall Study|Lost to Follow-up|2|||
129704724|NCT01276106|466881783|FG001|Overall Study|Lost to Follow-up|1|||
129704725|NCT01276106|466881784|FG002|Overall Study|Lost to Follow-up|1|||
129704726|NCT01276106|466881785|FG003|Overall Study|Lost to Follow-up|0|||
129704727|NCT01276106|466881782|FG000|Overall Study|Physician Decision|0|||
129704728|NCT01276106|466881783|FG001|Overall Study|Physician Decision|0|||
129704729|NCT01276106|466881784|FG002|Overall Study|Physician Decision|1|||
129704730|NCT01276106|466881785|FG003|Overall Study|Physician Decision|1|||
129704731|NCT01276106|466881782|FG000|Overall Study|Protocol Violation|1|||
129704732|NCT01276106|466881783|FG001|Overall Study|Protocol Violation|1|||
129634808|NCT02105987|466616798|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
129634809|NCT02105987|466616799|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
129634810|NCT02105987|466616800|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634811|NCT02105987|466616801|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634812|NCT02105987|466616802|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634813|NCT02105987|466616803|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634814|NCT02105987|466616798|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
129634815|NCT02105987|466616799|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
129634816|NCT02105987|466616800|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129634817|NCT02105987|466616801|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129634818|NCT02105987|466616802|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129634819|NCT02105987|466616803|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
129634820|NCT02105987|466616798|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129634821|NCT02105987|466616799|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
129634822|NCT02105987|466616800|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129634823|NCT02105987|466616801|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129634824|NCT02105987|466616802|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129634825|NCT02105987|466616803|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
129634826|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129634827|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129634828|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
129634829|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
129634830|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129634831|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
129634832|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129634833|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129634834|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
129634835|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
129634836|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129634837|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
129634838|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129634839|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129634840|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
129634841|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
129634842|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129634843|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
129634844|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634845|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634846|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
129704733|NCT01276106|466881784|FG002|Overall Study|Protocol Violation|0|||
129704734|NCT01276106|466881785|FG003|Overall Study|Protocol Violation|2|||
129704735|NCT01276106|466881782|FG000|Overall Study|Insufficient therapeutic effects|0|||
129704736|NCT01276106|466881783|FG001|Overall Study|Insufficient therapeutic effects|0|||
129704737|NCT01276106|466881784|FG002|Overall Study|Insufficient therapeutic effects|2|||
129704738|NCT01276106|466881785|FG003|Overall Study|Insufficient therapeutic effects|0|||
129704739|NCT00862940|466881789|FG000|Overall Study|Adverse Event|15|||
129704740|NCT00862940|466881790|FG001|Overall Study|Adverse Event|12|||
129704741|NCT00862940|466881789|FG000|Overall Study|Lack of Efficacy|1|||
129704742|NCT00862940|466881790|FG001|Overall Study|Lack of Efficacy|3|||
129704743|NCT00862940|466881789|FG000|Overall Study|Protocol Violation|2|||
129704744|NCT00862940|466881790|FG001|Overall Study|Protocol Violation|5|||
129704745|NCT00862940|466881789|FG000|Overall Study|Withdrawal by Subject|4|||
129704746|NCT00862940|466881790|FG001|Overall Study|Withdrawal by Subject|6|||
129704747|NCT00862940|466881789|FG000|Overall Study|Non-compliance|4|||
129704748|NCT00862940|466881790|FG001|Overall Study|Non-compliance|0|||
129704749|NCT00862940|466881789|FG000|Overall Study|Lost to Follow-up|0|||
129704750|NCT00862940|466881790|FG001|Overall Study|Lost to Follow-up|1|||
129704751|NCT00862940|466881789|FG000|Overall Study|Administrative or other reason(s)|4|||
129704752|NCT00862940|466881790|FG001|Overall Study|Administrative or other reason(s)|3|||
129704753|NCT04583618|466881793|FG000|Overall Study|Adverse Event|0|||
129704754|NCT04583618|466881794|FG001|Overall Study|Adverse Event|0|||
129704755|NCT04583618|466881795|FG002|Overall Study|Adverse Event|1|||
129704756|NCT04583618|466881796|FG003|Overall Study|Adverse Event|0|||
129704757|NCT04583618|466881797|FG004|Overall Study|Adverse Event|0|||
129704758|NCT04583618|466881793|FG000|Overall Study|Protocol deviation|1|||
129704759|NCT04583618|466881794|FG001|Overall Study|Protocol deviation|1|||
129634847|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
129634848|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634849|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
129634850|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129634851|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129634852|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
129634853|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129634854|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129634855|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
129634856|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129634857|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129634858|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129634859|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
129634860|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129634861|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
129634862|NCT02105987|466616798|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129634863|NCT02105987|466616799|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129634864|NCT02105987|466616800|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
129634865|NCT02105987|466616801|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129634866|NCT02105987|466616802|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129634867|NCT02105987|466616803|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
129634868|NCT02105987|466616798|FG000|Continuation Phase|Protocol Violation|0|||
129634869|NCT02105987|466616799|FG001|Continuation Phase|Protocol Violation|0|||
129634870|NCT02105987|466616800|FG002|Continuation Phase|Protocol Violation|0|||
129634871|NCT02105987|466616801|FG003|Continuation Phase|Protocol Violation|0|||
129634872|NCT02105987|466616802|FG004|Continuation Phase|Protocol Violation|1|||
129634873|NCT02105987|466616803|FG005|Continuation Phase|Protocol Violation|0|||
129634874|NCT02268916|466616808|FG000|Overall Study|Lost to Follow-up|1|||
129634875|NCT02268916|466616809|FG001|Overall Study|Lost to Follow-up|1|||
129634876|NCT02268916|466616808|FG000|Overall Study|Withdrawal by Subject|6|||
129634877|NCT02268916|466616809|FG001|Overall Study|Withdrawal by Subject|5|||
129634878|NCT02268916|466616808|FG000|Overall Study|Participant did not have diabetes|1|||
129634879|NCT02268916|466616809|FG001|Overall Study|Participant did not have diabetes|0|||
129634880|NCT02268916|466616808|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
129634881|NCT02268916|466616809|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
129634882|NCT02418949|466616810|FG000|Overall Study|Withdrawal by Subject|1|||
129634883|NCT02418949|466616811|FG001|Overall Study|Withdrawal by Subject|0|||
129634884|NCT02418949|466616812|FG002|Overall Study|Withdrawal by Subject|1|||
129634885|NCT02418949|466616813|FG003|Overall Study|Withdrawal by Subject|1|||
129634886|NCT02418949|466616810|FG000|Overall Study|Lost to Follow-up|1|||
129634887|NCT02418949|466616811|FG001|Overall Study|Lost to Follow-up|0|||
129634888|NCT02418949|466616812|FG002|Overall Study|Lost to Follow-up|1|||
129634889|NCT02418949|466616813|FG003|Overall Study|Lost to Follow-up|0|||
129634890|NCT02418949|466616810|FG000|Overall Study|Physician Decision|1|||
129634891|NCT02418949|466616811|FG001|Overall Study|Physician Decision|1|||
129634892|NCT02418949|466616812|FG002|Overall Study|Physician Decision|1|||
129634893|NCT02418949|466616813|FG003|Overall Study|Physician Decision|0|||
129634894|NCT03926117|466616814|FG000|Overall Study|Unclassified|1|||
129634895|NCT03926117|466616815|FG001|Overall Study|Unclassified|4|||
129634896|NCT03926117|466616816|FG002|Overall Study|Unclassified|1|||
129634897|NCT03926117|466616817|FG003|Overall Study|Unclassified|4|||
129634898|NCT03926117|466616814|FG000|Overall Study|Withdrawal by Subject|3|||
129634899|NCT03926117|466616815|FG001|Overall Study|Withdrawal by Subject|0|||
129634900|NCT03926117|466616816|FG002|Overall Study|Withdrawal by Subject|1|||
129634901|NCT03926117|466616817|FG003|Overall Study|Withdrawal by Subject|1|||
129634902|NCT03926117|466616814|FG000|Overall Study|Lost to Follow-up|0|||
129634903|NCT03926117|466616815|FG001|Overall Study|Lost to Follow-up|2|||
129634904|NCT03926117|466616816|FG002|Overall Study|Lost to Follow-up|1|||
129634905|NCT03926117|466616817|FG003|Overall Study|Lost to Follow-up|0|||
129634906|NCT03926117|466616814|FG000|Overall Study|Adverse Event|1|||
129634907|NCT03926117|466616815|FG001|Overall Study|Adverse Event|2|||
129634908|NCT03926117|466616816|FG002|Overall Study|Adverse Event|3|||
129634909|NCT03926117|466616817|FG003|Overall Study|Adverse Event|1|||
129797353|NCT02147184|467226648|FG001|Overall Study|Physician Decision|2|||
129634910|NCT03926117|466616814|FG000|Overall Study|Randomized but not treated|1|||
129634911|NCT03926117|466616815|FG001|Overall Study|Randomized but not treated|1|||
129634912|NCT03926117|466616816|FG002|Overall Study|Randomized but not treated|0|||
129634913|NCT03926117|466616817|FG003|Overall Study|Randomized but not treated|1|||
129634914|NCT04526288|466616820|FG000|Overall Study|Disease Progression|1|||
129634915|NCT04526288|466616821|FG001|Overall Study|Disease Progression|0|||
129634916|NCT02684097|466616824|FG000|Overall Study|Lack of Efficacy|13|||
129634917|NCT02684097|466616825|FG001|Overall Study|Lack of Efficacy|6|||
129634918|NCT00460811|466616826|FG000|Overall Study|Adverse Event|4|||
129797354|NCT02147184|467226647|FG000|Overall Study|Other|1|||
129797355|NCT02147184|467226648|FG001|Overall Study|Other|0|||
129797356|NCT02117414|467226649|FG000|Overall Study|Death|5|||
129797357|NCT02117414|467226650|FG001|Overall Study|Death|2|||
129797358|NCT02117414|467226649|FG000|Overall Study|Withdrawal by Subject|10|||
129797359|NCT02117414|467226650|FG001|Overall Study|Withdrawal by Subject|4|||
129634919|NCT00460811|466616827|FG001|Overall Study|Adverse Event|6|||
129634920|NCT00460811|466616828|FG002|Overall Study|Adverse Event|3|||
129634921|NCT00460811|466616829|FG003|Overall Study|Adverse Event|10|||
129634922|NCT00460811|466616830|FG004|Overall Study|Adverse Event|2|||
129634923|NCT00460811|466616826|FG000|Overall Study|Noncompliance|1|||
129634924|NCT00460811|466616827|FG001|Overall Study|Noncompliance|0|||
129634925|NCT00460811|466616828|FG002|Overall Study|Noncompliance|0|||
129634926|NCT00460811|466616829|FG003|Overall Study|Noncompliance|2|||
129634927|NCT00460811|466616830|FG004|Overall Study|Noncompliance|1|||
129634928|NCT00460811|466616826|FG000|Overall Study|Withdrawal by Subject|7|||
129634929|NCT00460811|466616827|FG001|Overall Study|Withdrawal by Subject|7|||
129634930|NCT00460811|466616828|FG002|Overall Study|Withdrawal by Subject|6|||
129634931|NCT00460811|466616829|FG003|Overall Study|Withdrawal by Subject|3|||
129634932|NCT00460811|466616830|FG004|Overall Study|Withdrawal by Subject|11|||
129634933|NCT00460811|466616826|FG000|Overall Study|Physician Decision|1|||
129634934|NCT00460811|466616827|FG001|Overall Study|Physician Decision|0|||
129634935|NCT00460811|466616828|FG002|Overall Study|Physician Decision|0|||
129634936|NCT00460811|466616829|FG003|Overall Study|Physician Decision|0|||
129634937|NCT00460811|466616830|FG004|Overall Study|Physician Decision|0|||
129440500|NCT01116882|465911453|FG001|30-day|Withdrawal by Subject|4|||
129440501|NCT01116882|465911452|FG000|30-day|Other Reasons|16|||
129634938|NCT00460811|466616826|FG000|Overall Study|Lost to Follow-up|3|||
129634939|NCT00460811|466616827|FG001|Overall Study|Lost to Follow-up|2|||
129634940|NCT00460811|466616828|FG002|Overall Study|Lost to Follow-up|5|||
129634941|NCT00460811|466616829|FG003|Overall Study|Lost to Follow-up|3|||
129634942|NCT00460811|466616830|FG004|Overall Study|Lost to Follow-up|6|||
129634943|NCT02748356|466616831|FG000|Overall Study|Withdrawal by Subject|1|||
129634944|NCT00237458|466616832|FG000|Overall Study|Lack of Efficacy|1|||
129634945|NCT00237458|466616832|FG000|Overall Study|Adverse Event|1|||
129634946|NCT00237458|466616832|FG000|Overall Study|Withdrawal by Subject|1|||
129634947|NCT00952068|466616833|FG000|Overall Study|Adverse Event|3|||
129704760|NCT04583618|466881795|FG002|Overall Study|Protocol deviation|1|||
129704761|NCT04583618|466881796|FG003|Overall Study|Protocol deviation|0|||
129704762|NCT04583618|466881797|FG004|Overall Study|Protocol deviation|0|||
129704763|NCT04583618|466881793|FG000|Overall Study|Withdrawal by Subject|2|||
129704764|NCT04583618|466881794|FG001|Overall Study|Withdrawal by Subject|1|||
129704765|NCT04583618|466881795|FG002|Overall Study|Withdrawal by Subject|3|||
129704766|NCT04583618|466881796|FG003|Overall Study|Withdrawal by Subject|1|||
129704767|NCT04583618|466881797|FG004|Overall Study|Withdrawal by Subject|1|||
129704768|NCT04583618|466881793|FG000|Overall Study|Lost to Follow-up|0|||
129704769|NCT04583618|466881794|FG001|Overall Study|Lost to Follow-up|1|||
129704770|NCT04583618|466881795|FG002|Overall Study|Lost to Follow-up|3|||
129704771|NCT04583618|466881796|FG003|Overall Study|Lost to Follow-up|1|||
129704772|NCT04583618|466881797|FG004|Overall Study|Lost to Follow-up|1|||
129704773|NCT02711202|466881798|FG000|Overall Study|Adverse Event|3|||
129704774|NCT02711202|466881799|FG001|Overall Study|Adverse Event|0|||
129704775|NCT02711202|466881798|FG000|Overall Study|graft loss|1|||
129704776|NCT02711202|466881799|FG001|Overall Study|graft loss|0|||
129704777|NCT05643495|466881806|FG000|Overall Study|Adverse Event|0|||
129704778|NCT05643495|466881807|FG001|Overall Study|Adverse Event|1|||
129704779|NCT05643495|466881806|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129704780|NCT05643495|466881807|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
129704781|NCT02257528|466881808|FG000|Overall Study|Never received study treatment|1|||
129704782|NCT06272383|466881809|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
129704783|NCT06272383|466881810|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
129704784|NCT02661672|466881816|FG000|Overall Study|Lost to Follow-up|1|||
129704785|NCT02661672|466881816|FG000|Overall Study|Death|4|||
129704786|NCT02581930|466881817|FG000|Overall Study|Withdrawal by Subject|1|||
129704787|NCT02581930|466881817|FG000|Overall Study|patient declined further treatment|1|||
129704788|NCT04696146|466884051|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
129704789|NCT04696146|466884052|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
129704790|NCT04696146|466884051|FG000|Overall Study|Off hours issue with product|1|||
129704791|NCT04696146|466884052|FG001|Overall Study|Off hours issue with product|0|||
129704792|NCT00529633|466884057|FG000|Overall Study|Withdrawal by Subject|1|||
129704793|NCT00529633|466884058|FG001|Overall Study|Withdrawal by Subject|1|||
129704794|NCT01576783|466884062|FG000|Overall Study|Change in Medical Care|1|||
129704795|NCT01576783|466884063|FG001|Overall Study|Change in Medical Care|0|||
129704796|NCT01576783|466884062|FG000|Overall Study|Lost to Follow-up|14|||
129704797|NCT01576783|466884063|FG001|Overall Study|Lost to Follow-up|16|||
129704798|NCT01576783|466884062|FG000|Overall Study|Withdrawal by Subject|5|||
129797360|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
129797361|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
129797362|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
129797363|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
129797364|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
129797365|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
129797366|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
129797367|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
129797368|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
129797369|NCT00417482|467226651|FG000|Phase B 1st 16 Weeks|Death|1|||
129797370|NCT00417482|467226652|FG001|Phase B 1st 16 Weeks|Death|0|||
129797371|NCT00417482|467226653|FG002|Phase B 1st 16 Weeks|Death|0|||
129797372|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
129797373|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
129797374|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
129797375|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
129797376|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
129797377|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
129797378|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
129797379|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
129797380|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
129797381|NCT00417482|467226651|FG000|Phase B 2nd 16 Weeks|Death|1|||
129797382|NCT00417482|467226652|FG001|Phase B 2nd 16 Weeks|Death|1|||
129797383|NCT00417482|467226653|FG002|Phase B 2nd 16 Weeks|Death|0|||
129797384|NCT06400979|467226656|FG000|Overall Study|Lost to Follow-up|29|||
129797385|NCT06400979|467226656|FG000|Overall Study|Withdrawal by Subject|1|||
129797386|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
129797387|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
129797388|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
129797389|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
129797390|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129797391|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
129797392|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129797393|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
129797394|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
129797395|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
129797396|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
129797397|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
129797398|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
129797399|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
129797400|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
129797401|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
129440502|NCT01116882|465911453|FG001|30-day|Other Reasons|6|||
129440503|NCT01116882|465911452|FG000|12-month|Lost to Follow-up|111|||
129634948|NCT00952068|466616833|FG000|Overall Study|Withdrawal by Subject|4|||
129797402|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Program Termination|3|||
129797403|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Program Termination|0|||
129797404|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Program Termination|1|||
129797405|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Program Termination|1|||
129797406|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
129797407|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
129797408|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
129797409|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
129797410|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
129634949|NCT05870371|466616834|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
129634950|NCT05870371|466616835|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
129634951|NCT02062450|466616839|FG000|Overall Study|No follow-up visit|124|||
129634952|NCT02907177|466616842|FG000|Overall Study|Death|0|||
129634953|NCT02907177|466616843|FG001|Overall Study|Death|1|||
129634954|NCT02907177|466616842|FG000|Overall Study|Physician Decision|3|||
129634955|NCT02907177|466616843|FG001|Overall Study|Physician Decision|3|||
129634956|NCT02907177|466616842|FG000|Overall Study|Withdrawal by Subject|15|||
129634957|NCT02907177|466616843|FG001|Overall Study|Withdrawal by Subject|7|||
129797411|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
129634958|NCT02907177|466616842|FG000|Overall Study|Sponsor's Decision|50|||
129634959|NCT02907177|466616843|FG001|Overall Study|Sponsor's Decision|57|||
129634960|NCT01537042|466616849|FG000|Overall Study|Adverse Event|0|||
129889330|NCT02040090|467552553|FG001|Overall Study|Physician Decision|0|||
129440504|NCT01116882|465911453|FG001|12-month|Lost to Follow-up|42|||
129634961|NCT01537042|466616850|FG001|Overall Study|Adverse Event|2|||
129797412|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
129634962|NCT01537042|466616849|FG000|Overall Study|Lack of Efficacy|0|||
129634963|NCT01537042|466616850|FG001|Overall Study|Lack of Efficacy|1|||
129634964|NCT01537042|466616849|FG000|Overall Study|Protocol Violation|0|||
129634965|NCT01537042|466616850|FG001|Overall Study|Protocol Violation|1|||
129797413|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
129797414|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
129797415|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
129797416|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
129797417|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
129797418|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
129797419|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
129797420|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
129797421|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
129797422|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
129797423|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
129797424|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
129797425|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
129797426|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
129797427|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
129797428|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
129797429|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
129797430|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
129797431|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
129797432|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
129797433|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
129797434|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
129797435|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
129797436|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
129797437|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
129797438|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
129797439|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
129797440|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
129797441|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
129797442|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
129797443|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
129797444|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
129797445|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
129797446|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
129797447|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
129797448|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
129797449|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
129797450|NCT03739840|467226657|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
129797451|NCT03739840|467226658|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
129797452|NCT03739840|467226659|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
129797453|NCT03739840|467226660|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
129797454|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
129797455|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
129797456|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
129797457|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
129797458|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
129797459|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
129797460|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
129797461|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
129797462|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
129797463|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
129797464|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
129797465|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
129797466|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
129797467|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
129797468|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
129797469|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
129797470|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
129797471|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
129797472|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
129797473|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
129634966|NCT01537042|466616849|FG000|Overall Study|Other|0|||
129797474|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
129634967|NCT01537042|466616850|FG001|Overall Study|Other|1|||
129634968|NCT00975611|466618576|FG000|Overall Study|Screen Fail|16|||
129634969|NCT00975611|466618576|FG000|Overall Study|Physician Decision|1|||
129634970|NCT02151851|466618577|FG000|Overall Study|Lack of Efficacy|67|||
129634971|NCT02151851|466618578|FG001|Overall Study|Lack of Efficacy|94|||
129634972|NCT02151851|466618577|FG000|Overall Study|Protocol Violation|0|||
129634973|NCT02151851|466618578|FG001|Overall Study|Protocol Violation|1|||
129797475|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
129797476|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
129797477|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
129797478|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
129634974|NCT02151851|466618577|FG000|Overall Study|Withdrawal by Subject|2|||
129634975|NCT02151851|466618578|FG001|Overall Study|Withdrawal by Subject|5|||
129634976|NCT02151851|466618577|FG000|Overall Study|Medical impairment|1|||
129634977|NCT02151851|466618578|FG001|Overall Study|Medical impairment|0|||
129634978|NCT02151851|466618577|FG000|Overall Study|Low compliance to study visits|0|||
129634979|NCT02151851|466618578|FG001|Overall Study|Low compliance to study visits|1|||
129634980|NCT02151851|466618577|FG000|Overall Study|Subject entered into study in error|0|||
129634981|NCT02151851|466618578|FG001|Overall Study|Subject entered into study in error|1|||
129797479|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
129797480|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
129797481|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
129797482|NCT03739840|467226657|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
129634982|NCT02151851|466618577|FG000|Overall Study|Adverse Event|6|||
129634983|NCT02151851|466618578|FG001|Overall Study|Adverse Event|28|||
129634984|NCT01540487|466618579|FG000|Overall Study|Protocol Violation|1|||
129634985|NCT01540487|466618580|FG001|Overall Study|Protocol Violation|0|||
129634986|NCT03503370|466618583|FG000|Overall Study|Death|3|||
129634987|NCT03503370|466618584|FG001|Overall Study|Death|1|||
129634988|NCT00298272|466618589|FG000|Double-blind Phase|Adverse Event|2|||
129634989|NCT00298272|466618590|FG001|Double-blind Phase|Adverse Event|0|||
129634990|NCT00298272|466618589|FG000|Double-blind Phase|Failure to Return|2|||
129634991|NCT00298272|466618590|FG001|Double-blind Phase|Failure to Return|0|||
129634992|NCT00298272|466618589|FG000|Double-blind Phase|Protocol Violation|2|||
129634993|NCT00298272|466618590|FG001|Double-blind Phase|Protocol Violation|0|||
129797483|NCT03739840|467226658|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
129797484|NCT03739840|467226659|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
129797485|NCT03739840|467226660|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
129797486|NCT01058265|467226663|FG000|Overall Study|Lost to Follow-up|11|||
129797487|NCT01058265|467226664|FG001|Overall Study|Lost to Follow-up|12|||
129634994|NCT00298272|466618589|FG000|Double-blind Phase|Withdrawal by Subject|2|||
129634995|NCT00298272|466618590|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129634996|NCT00298272|466618589|FG000|Open Label Retreatment Phase|Adverse Event|1|||
129634997|NCT00298272|466618590|FG001|Open Label Retreatment Phase|Adverse Event|2|||
129634998|NCT00298272|466618589|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
129797488|NCT02869438|467226665|FG000|Overall Study|Lost to Follow-up|1|||
129797489|NCT02869438|467226666|FG001|Overall Study|Lost to Follow-up|0|||
129797490|NCT02869438|467226665|FG000|Overall Study|Adverse Event|1|||
129797491|NCT02869438|467226666|FG001|Overall Study|Adverse Event|0|||
129797492|NCT02869438|467226665|FG000|Overall Study|Withdrawal by Subject|1|||
129797493|NCT02869438|467226666|FG001|Overall Study|Withdrawal by Subject|2|||
129797494|NCT02169284|467226669|FG000|Overall Study|Physician Decision|0|||
129797495|NCT02169284|467226670|FG001|Overall Study|Physician Decision|1|||
129797496|NCT00984568|467226671|FG000|Overall Study|Withdrawal by Subject|1|||
129797497|NCT00984568|467226672|FG001|Overall Study|Withdrawal by Subject|2|||
129797498|NCT00984568|467226671|FG000|Overall Study|Lack of Efficacy|2|||
129797499|NCT00984568|467226672|FG001|Overall Study|Lack of Efficacy|0|||
129797500|NCT00984568|467226671|FG000|Overall Study|Adverse Event|2|||
129797501|NCT00984568|467226672|FG001|Overall Study|Adverse Event|0|||
129634999|NCT00298272|466618590|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
129797502|NCT00984568|467226671|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
129797503|NCT00984568|467226672|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
129797504|NCT00984568|467226671|FG000|Overall Study|Lost to Follow-up|0|||
129797505|NCT00984568|467226672|FG001|Overall Study|Lost to Follow-up|1|||
129797506|NCT00984568|467226671|FG000|Overall Study|Opportunistic Infection|1|||
129797507|NCT00984568|467226672|FG001|Overall Study|Opportunistic Infection|0|||
129797508|NCT00984568|467226671|FG000|Overall Study|Unknown Reason|1|||
129797509|NCT00984568|467226672|FG001|Overall Study|Unknown Reason|3|||
129797510|NCT03583073|467226673|FG000|Overall Study|Lost to Follow-up|8|||
129797511|NCT03583073|467226674|FG001|Overall Study|Lost to Follow-up|12|||
129797512|NCT01367119|467226675|FG000|Overall Study|Adverse Event|1|||
129635000|NCT00298272|466618589|FG000|Open Label Retreatment Phase|Failure to Return|1|||
129635001|NCT00298272|466618590|FG001|Open Label Retreatment Phase|Failure to Return|0|||
129635002|NCT00298272|466618589|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
129635003|NCT00298272|466618590|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
129635004|NCT00298272|466618589|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
129797513|NCT01367119|467226676|FG001|Overall Study|Adverse Event|0|||
129797514|NCT01367119|467226675|FG000|Overall Study|Withdrawal by Subject|1|||
129797515|NCT01367119|467226676|FG001|Overall Study|Withdrawal by Subject|1|||
129797516|NCT03180684|467226677|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
129797517|NCT03180684|467226678|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
129797518|NCT03180684|467226677|FG000|Overall Study|Physician Decision|1|||
129797519|NCT03180684|467226678|FG001|Overall Study|Physician Decision|0|||
129797520|NCT03180684|467226677|FG000|Overall Study|Lost to Follow-up|1|||
129797521|NCT03180684|467226678|FG001|Overall Study|Lost to Follow-up|0|||
129797522|NCT03180684|467226677|FG000|Overall Study|Progressive Disease|1|||
129797523|NCT03180684|467226678|FG001|Overall Study|Progressive Disease|0|||
129797524|NCT02675231|467226679|FG000|Overall Study|Withdrawal by Subject|2|||
129797525|NCT02675231|467226680|FG001|Overall Study|Withdrawal by Subject|4|||
129797526|NCT02675231|467226681|FG002|Overall Study|Withdrawal by Subject|2|||
129797527|NCT02675231|467226679|FG000|Overall Study|Lost to Follow-up|3|||
129797528|NCT02675231|467226680|FG001|Overall Study|Lost to Follow-up|4|||
129797529|NCT02675231|467226681|FG002|Overall Study|Lost to Follow-up|3|||
129797530|NCT03370289|467226686|FG000|Overall Study|Screen Failure|1|||
129797531|NCT03370289|467226686|FG000|Overall Study|Sample Size Sufficient|4|||
129797532|NCT02220998|467226688|FG000|Overall Study|Randomized but Never Treated|1|||
129797533|NCT02220998|467226689|FG001|Overall Study|Randomized but Never Treated|2|||
129797534|NCT02220998|467226688|FG000|Overall Study|Death|2|||
129797535|NCT02220998|467226689|FG001|Overall Study|Death|0|||
129797536|NCT02220998|467226688|FG000|Overall Study|Lack of Efficacy|0|||
129797537|NCT02220998|467226689|FG001|Overall Study|Lack of Efficacy|5|||
129797538|NCT02220998|467226688|FG000|Overall Study|Lost to Follow-up|4|||
129797539|NCT02220998|467226689|FG001|Overall Study|Lost to Follow-up|4|||
129797540|NCT00873860|467226690|FG000|Overall Study|Lost to Follow-up|1|||
129797541|NCT00873860|467226691|FG001|Overall Study|Lost to Follow-up|0|||
129797542|NCT00873860|467226692|FG002|Overall Study|Lost to Follow-up|0|||
129797543|NCT00873860|467226693|FG003|Overall Study|Lost to Follow-up|1|||
129797544|NCT00873860|467226690|FG000|Overall Study|Withdrawal by Subject|1|||
129797545|NCT00873860|467226691|FG001|Overall Study|Withdrawal by Subject|0|||
129797546|NCT00873860|467226692|FG002|Overall Study|Withdrawal by Subject|2|||
129797547|NCT00873860|467226693|FG003|Overall Study|Withdrawal by Subject|0|||
129797548|NCT00873860|467226690|FG000|Overall Study|Death|1|||
129797549|NCT00873860|467226691|FG001|Overall Study|Death|0|||
129797550|NCT00873860|467226692|FG002|Overall Study|Death|0|||
129797551|NCT00873860|467226693|FG003|Overall Study|Death|0|||
129797552|NCT00873860|467226690|FG000|Overall Study|Other|1|||
129797553|NCT00873860|467226691|FG001|Overall Study|Other|0|||
129797554|NCT00873860|467226692|FG002|Overall Study|Other|1|||
129635005|NCT00298272|466618590|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
129635006|NCT00298272|466618589|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
129797555|NCT00873860|467226693|FG003|Overall Study|Other|0|||
129797556|NCT01610271|467226710|FG000|Overall Study|Surgery not complete|0|||
129797557|NCT01610271|467226711|FG001|Overall Study|Surgery not complete|1|||
129797558|NCT01610271|467226710|FG000|Overall Study|Prosthesis not implanted|2|||
129797559|NCT01610271|467226711|FG001|Overall Study|Prosthesis not implanted|3|||
129797560|NCT00364130|467226712|FG000|Intervention Period|Lost to Follow-up|4|||
129797561|NCT00364130|467226713|FG001|Intervention Period|Lost to Follow-up|3|||
129797562|NCT00364130|467226712|FG000|Intervention Period|Pregnancy|1|||
129797563|NCT00364130|467226713|FG001|Intervention Period|Pregnancy|0|||
129797564|NCT00364130|467226712|FG000|Intervention Period|Withdrawal by Subject|4|||
129797565|NCT00364130|467226713|FG001|Intervention Period|Withdrawal by Subject|5|||
129797566|NCT00364130|467226712|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
129797567|NCT00364130|467226713|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
129797568|NCT05281601|467226714|FG000|Overall Study|Physician Decision|2|||
129797569|NCT05281601|467226715|FG001|Overall Study|Physician Decision|0|||
129797570|NCT05281601|467226714|FG000|Overall Study|Lost to Follow-up|2|||
129797571|NCT05281601|467226715|FG001|Overall Study|Lost to Follow-up|0|||
129797572|NCT05281601|467226714|FG000|Overall Study|Death|1|||
129797573|NCT05281601|467226715|FG001|Overall Study|Death|0|||
129797574|NCT05281601|467226714|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129797575|NCT05281601|467226715|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129797576|NCT00586846|467226716|FG000|Overall Study|Physician Decision|1|||
129797577|NCT00586846|467226716|FG000|Overall Study|Death|1|||
129797578|NCT00586846|467226716|FG000|Overall Study|Evaluable for Toxicity Only|4|||
129797579|NCT00144027|467226718|FG000|Overall Study|Lost to Follow-up|1|||
129797580|NCT00144027|467226719|FG001|Overall Study|Lost to Follow-up|3|||
129797581|NCT00144027|467226718|FG000|Overall Study|Withdrawal by Subject|2|||
129797582|NCT00144027|467226719|FG001|Overall Study|Withdrawal by Subject|2|||
129440505|NCT01116882|465911452|FG000|12-month|Other Reasons|151|||
129440506|NCT01116882|465911453|FG001|12-month|Other Reasons|49|||
129440507|NCT01116882|465911452|FG000|12-month|Withdrawal by Subject|5|||
129440508|NCT01116882|465911453|FG001|12-month|Withdrawal by Subject|8|||
129440509|NCT01139658|465911456|FG000|Overall Study|Adverse Event|10|||
129440510|NCT01139658|465911457|FG001|Overall Study|Adverse Event|27|||
129440511|NCT01139658|465911456|FG000|Overall Study|Lack of Efficacy|15|||
129440512|NCT01139658|465911457|FG001|Overall Study|Lack of Efficacy|7|||
129440513|NCT01139658|465911456|FG000|Overall Study|Withdrawal by Subject|2|||
129440514|NCT01139658|465911457|FG001|Overall Study|Withdrawal by Subject|4|||
129440515|NCT01139658|465911456|FG000|Overall Study|No documentation of treatment|1|||
129440516|NCT01139658|465911457|FG001|Overall Study|No documentation of treatment|0|||
129440517|NCT01139658|465911456|FG000|Overall Study|Other|28|||
129440518|NCT01139658|465911457|FG001|Overall Study|Other|75|||
129440519|NCT02092220|465911463|FG000|Period 1|Unrelated Illness|0|||
129440520|NCT02092220|465911464|FG001|Period 1|Unrelated Illness|2|||
129440521|NCT02092220|465911463|FG000|Period 2|Severe Hypoglycaemia|1|||
129440522|NCT02092220|465911464|FG001|Period 2|Severe Hypoglycaemia|0|||
129440523|NCT02092220|465911463|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
129440524|NCT02092220|465911464|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
129440525|NCT02739360|465911465|FG000|Overall Study|Adverse Event|1|||
129440526|NCT02739360|465911465|FG000|Overall Study|Study terminated by Sponsor|2|||
129440527|NCT01193920|465911466|FG000|Overall Study|Withdrawal by Subject|1|||
129440528|NCT01193920|465911467|FG001|Overall Study|Withdrawal by Subject|0|||
129440529|NCT01193920|465911468|FG002|Overall Study|Withdrawal by Subject|5|||
129440530|NCT01193920|465911469|FG003|Overall Study|Withdrawal by Subject|1|||
129440531|NCT01193920|465911470|FG004|Overall Study|Withdrawal by Subject|3|||
129440532|NCT01193920|465911471|FG005|Overall Study|Withdrawal by Subject|1|||
129797583|NCT00144027|467226718|FG000|Overall Study|did not complete baseline assessment|0|||
129797584|NCT00144027|467226719|FG001|Overall Study|did not complete baseline assessment|6|||
129797585|NCT04597918|467226720|FG000|Overall Study|Withdrawal by Subject|6|||
129797586|NCT04597918|467226720|FG000|Overall Study|Lost to Follow-up|3|||
129797587|NCT04597918|467226720|FG000|Overall Study|Death|1|||
129797588|NCT00395538|467226721|FG000|Overall Study|Did not re-consent to revised protocol|1|||
129797589|NCT00395538|467226722|FG001|Overall Study|Did not re-consent to revised protocol|10|||
129797590|NCT00395538|467226723|FG002|Overall Study|Did not re-consent to revised protocol|0|||
129797591|NCT00395538|467226721|FG000|Overall Study|FDA partial hold on PTH|0|||
129797592|NCT00395538|467226722|FG001|Overall Study|FDA partial hold on PTH|0|||
129797593|NCT00395538|467226723|FG002|Overall Study|FDA partial hold on PTH|11|||
129797594|NCT00395538|467226721|FG000|Overall Study|Failed screening|0|||
129797595|NCT00395538|467226722|FG001|Overall Study|Failed screening|0|||
129797596|NCT00395538|467226723|FG002|Overall Study|Failed screening|4|||
129797597|NCT00395538|467226721|FG000|Overall Study|Switch to Natpara|0|||
129797598|NCT00395538|467226722|FG001|Overall Study|Switch to Natpara|0|||
129797599|NCT00395538|467226723|FG002|Overall Study|Switch to Natpara|3|||
129797600|NCT00395538|467226721|FG000|Overall Study|Adverse Event|1|||
129797601|NCT00395538|467226722|FG001|Overall Study|Adverse Event|0|||
129797602|NCT00395538|467226723|FG002|Overall Study|Adverse Event|2|||
129797603|NCT00395538|467226721|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
129797604|NCT00395538|467226722|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
129797605|NCT00395538|467226723|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
129797606|NCT00395538|467226721|FG000|Overall Study|Non-compliance with study protocol|0|||
129797607|NCT00395538|467226722|FG001|Overall Study|Non-compliance with study protocol|1|||
129797608|NCT00395538|467226723|FG002|Overall Study|Non-compliance with study protocol|0|||
129797609|NCT00395538|467226721|FG000|Overall Study|PTH resistance|0|||
129797610|NCT00395538|467226722|FG001|Overall Study|PTH resistance|0|||
129889331|NCT02040090|467552552|FG000|Overall Study|Withdrawal by Subject|0|||
129889332|NCT02040090|467552553|FG001|Overall Study|Withdrawal by Subject|1|||
129889333|NCT02040090|467552552|FG000|Overall Study|Lost to Follow-up|0|||
129889334|NCT02040090|467552553|FG001|Overall Study|Lost to Follow-up|1|||
129889335|NCT03259373|467552562|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
129889336|NCT03259373|467552563|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
129889337|NCT03259373|467552562|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
129440533|NCT01193920|465911472|FG006|Overall Study|Withdrawal by Subject|3|||
129440534|NCT01193920|465911473|FG007|Overall Study|Withdrawal by Subject|0|||
129440535|NCT01193920|465911474|FG008|Overall Study|Withdrawal by Subject|1|||
129440536|NCT01193920|465911475|FG009|Overall Study|Withdrawal by Subject|0|||
129440537|NCT01193920|465911466|FG000|Overall Study|Lost to Follow-up|1|||
129440538|NCT01193920|465911467|FG001|Overall Study|Lost to Follow-up|0|||
129440539|NCT01193920|465911468|FG002|Overall Study|Lost to Follow-up|1|||
129440540|NCT01193920|465911469|FG003|Overall Study|Lost to Follow-up|1|||
129797611|NCT00395538|467226723|FG002|Overall Study|PTH resistance|1|||
129797612|NCT00395538|467226721|FG000|Overall Study|Pregnancy|1|||
129440541|NCT01193920|465911470|FG004|Overall Study|Lost to Follow-up|3|||
129797613|NCT00395538|467226722|FG001|Overall Study|Pregnancy|0|||
129797614|NCT00395538|467226723|FG002|Overall Study|Pregnancy|0|||
129797615|NCT00395538|467226721|FG000|Overall Study|Partial recovery of parathyroid function|0|||
129797616|NCT00395538|467226722|FG001|Overall Study|Partial recovery of parathyroid function|0|||
129797617|NCT00395538|467226723|FG002|Overall Study|Partial recovery of parathyroid function|1|||
129797618|NCT00395538|467226721|FG000|Overall Study|Participant elected to discontinue|0|||
129797619|NCT00395538|467226722|FG001|Overall Study|Participant elected to discontinue|0|||
129797620|NCT00395538|467226723|FG002|Overall Study|Participant elected to discontinue|1|||
129797621|NCT00285207|467226726|FG000|Overall Study|Lost to Follow-up|3|||
129797622|NCT00285207|467226727|FG001|Overall Study|Lost to Follow-up|2|||
129797623|NCT00285207|467226726|FG000|Overall Study|Withdrawal by Subject|5|||
129797624|NCT00285207|467226727|FG001|Overall Study|Withdrawal by Subject|2|||
129797625|NCT00285207|467226726|FG000|Overall Study|Pregnancy|1|||
129797626|NCT00285207|467226727|FG001|Overall Study|Pregnancy|1|||
129797627|NCT00285207|467226726|FG000|Overall Study|non-compliance|0|||
129797628|NCT00285207|467226727|FG001|Overall Study|non-compliance|1|||
129797629|NCT05063318|467226728|FG000|Overall Study|Progressive disease|2|||
129797630|NCT05063318|467226729|FG001|Overall Study|Progressive disease|0|||
129797631|NCT05063318|467226730|FG002|Overall Study|Progressive disease|3|||
129797632|NCT05063318|467226728|FG000|Overall Study|Compassionate use|1|||
129797633|NCT05063318|467226729|FG001|Overall Study|Compassionate use|3|||
129797634|NCT05063318|467226730|FG002|Overall Study|Compassionate use|3|||
129797635|NCT05063318|467226728|FG000|Overall Study|Adverse Event|0|||
129797636|NCT05063318|467226729|FG001|Overall Study|Adverse Event|1|||
129797637|NCT05063318|467226730|FG002|Overall Study|Adverse Event|0|||
129797638|NCT05063318|467226728|FG000|Overall Study|Withdrawal by Subject|0|||
129797639|NCT05063318|467226729|FG001|Overall Study|Withdrawal by Subject|1|||
129797640|NCT05063318|467226730|FG002|Overall Study|Withdrawal by Subject|0|||
129797641|NCT01659658|467228176|FG000|Overall Study|Withdrawal by Patient|18|||
129797642|NCT01659658|467228177|FG001|Overall Study|Withdrawal by Patient|4|||
129797643|NCT01659658|467228178|FG002|Overall Study|Withdrawal by Patient|2|||
129797644|NCT01659658|467228179|FG003|Overall Study|Withdrawal by Patient|0|||
129797645|NCT01659658|467228180|FG004|Overall Study|Withdrawal by Patient|11|||
129797646|NCT01659658|467228176|FG000|Overall Study|Study Terminated by Sponsor|9|||
129797647|NCT01659658|467228177|FG001|Overall Study|Study Terminated by Sponsor|7|||
129797648|NCT01659658|467228178|FG002|Overall Study|Study Terminated by Sponsor|0|||
129797649|NCT01659658|467228179|FG003|Overall Study|Study Terminated by Sponsor|1|||
129797650|NCT01659658|467228180|FG004|Overall Study|Study Terminated by Sponsor|4|||
129797651|NCT01659658|467228176|FG000|Overall Study|Reason not Specified|61|||
129797652|NCT01659658|467228177|FG001|Overall Study|Reason not Specified|15|||
129797653|NCT01659658|467228178|FG002|Overall Study|Reason not Specified|8|||
129797654|NCT01659658|467228179|FG003|Overall Study|Reason not Specified|1|||
129797655|NCT01659658|467228180|FG004|Overall Study|Reason not Specified|34|||
129797656|NCT01659658|467228176|FG000|Overall Study|Lost to Follow-up|2|||
129797657|NCT01659658|467228177|FG001|Overall Study|Lost to Follow-up|0|||
129797658|NCT01659658|467228178|FG002|Overall Study|Lost to Follow-up|0|||
129797659|NCT01659658|467228179|FG003|Overall Study|Lost to Follow-up|0|||
129797660|NCT01659658|467228180|FG004|Overall Study|Lost to Follow-up|0|||
129797661|NCT00084838|467228181|FG000|Overall Study|Death|1|||
129797662|NCT00084838|467228181|FG000|Overall Study|Adverse Event|2|||
129797663|NCT00084838|467228181|FG000|Overall Study|Withdrawal by Subject|1|||
129797664|NCT00084838|467228181|FG000|Overall Study|Progressive Disease|4|||
129635007|NCT00298272|466618590|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
129635008|NCT00298272|466618589|FG000|Safety Follow-up Phase|Failure to Return|1|||
129635009|NCT00298272|466618590|FG001|Safety Follow-up Phase|Failure to Return|1|||
129797665|NCT00084838|467228181|FG000|Overall Study|Pt Non-Compliance|1|||
129797666|NCT00084838|467228181|FG000|Overall Study|Ineligible|4|||
129797667|NCT00122278|467228182|FG000|Overall Study|Lost to Follow-up|2|||
129797668|NCT00122278|467228183|FG001|Overall Study|Lost to Follow-up|0|||
129797669|NCT01994590|467228184|FG000|Overall Study|Adverse Event|1|||
129797670|NCT01994590|467228184|FG000|Overall Study|Trial Terminated|1|||
129797671|NCT03228420|467228191|FG000|Overall Study|Lost to Follow-up|5|||
129797672|NCT03228420|467228192|FG001|Overall Study|Lost to Follow-up|3|||
129797673|NCT03228420|467228191|FG000|Overall Study|Withdrawal by Subject|10|||
129797674|NCT03228420|467228192|FG001|Overall Study|Withdrawal by Subject|0|||
129797675|NCT03228420|467228191|FG000|Overall Study|Adverse Event|5|||
129797676|NCT03228420|467228192|FG001|Overall Study|Adverse Event|2|||
129797677|NCT02428608|467228193|FG000|Overall Study|Pregnancy|2|||
129797678|NCT02428608|467228193|FG000|Overall Study|Lost to Follow-up|37|||
129797679|NCT02428608|467228193|FG000|Overall Study|Withdrawal by Subject|2|||
129797680|NCT02428608|467228193|FG000|Overall Study|scheduling conflicts|15|||
129797681|NCT02428608|467228193|FG000|Overall Study|moved away|10|||
129797682|NCT02428608|467228193|FG000|Overall Study|Death|1|||
129797683|NCT02428608|467228193|FG000|Overall Study|various|16|||
129797684|NCT03468985|467228194|FG000|Overall Study|Adverse Event|0|||
129797685|NCT03468985|467228195|FG001|Overall Study|Adverse Event|2|||
129797686|NCT03468985|467228196|FG002|Overall Study|Adverse Event|0|||
129635010|NCT00298272|466618589|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
129635011|NCT00298272|466618590|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
129635012|NCT00298272|466618589|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
129635013|NCT00298272|466618590|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
129635014|NCT04168112|466618591|FG000|Overall Study|Lost to Follow-up|1|||
129635015|NCT04168112|466618592|FG001|Overall Study|Lost to Follow-up|0|||
129797687|NCT03468985|467228197|FG003|Overall Study|Adverse Event|0|||
129797688|NCT03468985|467228194|FG000|Overall Study|Withdrawal by Subject|0|||
129797689|NCT03468985|467228195|FG001|Overall Study|Withdrawal by Subject|0|||
129797690|NCT03468985|467228196|FG002|Overall Study|Withdrawal by Subject|0|||
129797691|NCT03468985|467228197|FG003|Overall Study|Withdrawal by Subject|1|||
129797692|NCT00085709|467228198|FG000|Overall Study|Adverse Event|8|||
129797693|NCT00085709|467228199|FG001|Overall Study|Adverse Event|0|||
129797694|NCT00085709|467228198|FG000|Overall Study|Death|8|||
129797695|NCT00085709|467228199|FG001|Overall Study|Death|2|||
129797696|NCT00085709|467228198|FG000|Overall Study|Refusal unrelated to adverse events|1|||
129797697|NCT00085709|467228199|FG001|Overall Study|Refusal unrelated to adverse events|2|||
129797698|NCT00085709|467228198|FG000|Overall Study|Progression|3|||
129797699|NCT00085709|467228199|FG001|Overall Study|Progression|4|||
129797700|NCT00085709|467228198|FG000|Overall Study|Not protocol specified|12|||
129797701|NCT00085709|467228199|FG001|Overall Study|Not protocol specified|22|||
129797702|NCT00085709|467228198|FG000|Overall Study|Not eligible|19|||
129797703|NCT00085709|467228199|FG001|Overall Study|Not eligible|19|||
129797704|NCT00085709|467228198|FG000|Overall Study|Withdrawal by Subject|2|||
129797705|NCT00085709|467228199|FG001|Overall Study|Withdrawal by Subject|1|||
129797706|NCT00397943|467228200|FG000|Overall Study|Unspecified reasons|12|||
129797707|NCT00397943|467228201|FG001|Overall Study|Unspecified reasons|9|||
129797708|NCT00397943|467228202|FG002|Overall Study|Unspecified reasons|0|||
129797709|NCT00397943|467228203|FG003|Overall Study|Unspecified reasons|0|||
129797710|NCT00397943|467228204|FG004|Overall Study|Unspecified reasons|0|||
129797711|NCT04521777|467228205|FG000|Overall Study|Death|2|||
129797712|NCT04521777|467228205|FG000|Overall Study|Withdrawal by Subject|2|||
129797713|NCT03139604|467228208|FG000|Overall Study|Other|7|||
129797714|NCT03139604|467228209|FG001|Overall Study|Other|3|||
129797715|NCT03139604|467228208|FG000|Overall Study|Withdrawal by Subject|16|||
129797716|NCT03139604|467228209|FG001|Overall Study|Withdrawal by Subject|17|||
129797717|NCT03139604|467228208|FG000|Overall Study|Physician Decision|1|||
129797718|NCT03139604|467228209|FG001|Overall Study|Physician Decision|2|||
129797719|NCT03139604|467228208|FG000|Overall Study|Lost to Follow-up|3|||
129797720|NCT03139604|467228209|FG001|Overall Study|Lost to Follow-up|1|||
129797721|NCT03139604|467228208|FG000|Overall Study|Death|65|||
129797722|NCT03139604|467228209|FG001|Overall Study|Death|67|||
129797723|NCT03139604|467228208|FG000|Overall Study|Study Terminated by Sponsor|122|||
129797724|NCT03139604|467228209|FG001|Overall Study|Study Terminated by Sponsor|127|||
129797725|NCT03139604|467228208|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
129635016|NCT04168112|466618591|FG000|Overall Study|Withdrawal by Subject|1|||
129635017|NCT04168112|466618592|FG001|Overall Study|Withdrawal by Subject|0|||
129635018|NCT05253573|466618595|FG000|Overall Study|Death|1|||
129635019|NCT05253573|466618596|FG001|Overall Study|Death|0|||
129635020|NCT01436370|466618597|FG000|Overall Study|Lost to Follow-up|0|||
129635021|NCT01436370|466618598|FG001|Overall Study|Lost to Follow-up|0|||
129635022|NCT01436370|466618599|FG002|Overall Study|Lost to Follow-up|0|||
129635023|NCT01436370|466618600|FG003|Overall Study|Lost to Follow-up|0|||
129635024|NCT01436370|466618601|FG004|Overall Study|Lost to Follow-up|1|||
129635025|NCT01436370|466618602|FG005|Overall Study|Lost to Follow-up|0|||
129635026|NCT01436370|466618603|FG006|Overall Study|Lost to Follow-up|0|||
129635027|NCT01436370|466618604|FG007|Overall Study|Lost to Follow-up|0|||
129635028|NCT02395848|466618605|FG000|Overall Study|Lost to Follow-up|2|||
129635029|NCT02276560|466618606|FG000|Overall Study|Adverse Event|1|||
129635030|NCT02276560|466618607|FG001|Overall Study|Adverse Event|0|||
129635031|NCT02276560|466618608|FG002|Overall Study|Adverse Event|0|||
129635032|NCT01754129|466618609|FG000|Overall Study|Death|13|||
129635033|NCT01754129|466618609|FG000|Overall Study|Duodopa discontinuation|9|||
129797726|NCT03139604|467228209|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
129440542|NCT01193920|465911471|FG005|Overall Study|Lost to Follow-up|3|||
129440543|NCT01193920|465911472|FG006|Overall Study|Lost to Follow-up|1|||
129635034|NCT01754129|466618609|FG000|Overall Study|Lost to Follow-up|7|||
129797727|NCT04950608|467228210|FG000|Overall Study|Withdrawal by Subject|2|||
129797728|NCT04950608|467228210|FG000|Overall Study|Physician Decision|3|||
129797729|NCT02007512|467228211|FG000|Double Blind Treatment Period|Adverse Event|4|||
129797730|NCT02007512|467228212|FG001|Double Blind Treatment Period|Adverse Event|6|||
129797731|NCT02007512|467228213|FG002|Double Blind Treatment Period|Adverse Event|2|||
129797732|NCT02007512|467228214|FG003|Double Blind Treatment Period|Adverse Event|2|||
129635035|NCT01754129|466618609|FG000|Overall Study|Withdrew consent|1|||
129635036|NCT01754129|466618609|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
129635037|NCT02126579|466618611|FG000|Overall Study|disease progression|0|||
129635038|NCT02126579|466618612|FG001|Overall Study|disease progression|0|||
129635039|NCT02126579|466618613|FG002|Overall Study|disease progression|0|||
129635040|NCT02126579|466618614|FG003|Overall Study|disease progression|1|||
129635041|NCT02126579|466618615|FG004|Overall Study|disease progression|0|||
129635042|NCT02126579|466618616|FG005|Overall Study|disease progression|0|||
129635043|NCT02126579|466618617|FG006|Overall Study|disease progression|1|||
129635044|NCT01780038|466618621|FG000|Overall Study|Lost to Follow-up|4|||
129635045|NCT01780038|466618622|FG001|Overall Study|Lost to Follow-up|1|||
129635046|NCT02609607|466618628|FG000|Overall Study|Lost to Follow-up|0|||
129635047|NCT02609607|466618629|FG001|Overall Study|Lost to Follow-up|1|||
129635048|NCT03168711|466618632|FG000|Overall Study|Adverse Event|2|||
129635049|NCT03168711|466618633|FG001|Overall Study|Adverse Event|0|||
129635050|NCT03168711|466618632|FG000|Overall Study|Withdrawal by Subject|0|||
129635051|NCT03168711|466618633|FG001|Overall Study|Withdrawal by Subject|1|||
129635052|NCT03168711|466618632|FG000|Overall Study|Death|0|||
129635053|NCT03168711|466618633|FG001|Overall Study|Death|1|||
129635054|NCT02877004|466618640|FG000|Overall Study|Pregnancy|0|||
129635055|NCT02877004|466618641|FG001|Overall Study|Pregnancy|0|||
129635056|NCT02877004|466618642|FG002|Overall Study|Pregnancy|1|||
129635057|NCT02633293|466618643|FG000|Overall Study|Death|56|||
129635058|NCT02633293|466618643|FG000|Overall Study|Progressive Disease|12|||
129635059|NCT02633293|466618643|FG000|Overall Study|Adverse Event|29|||
129635060|NCT02633293|466618643|FG000|Overall Study|Withdrawal by Subject|41|||
129635061|NCT02633293|466618643|FG000|Overall Study|Protocol Violation|1|||
129635062|NCT02633293|466618643|FG000|Overall Study|Lost to Follow-up|1|||
129635063|NCT02633293|466618643|FG000|Overall Study|Study Terminated by Sponsor|24|||
129635064|NCT02633293|466618643|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
129635065|NCT02633293|466618643|FG000|Overall Study|Lung Transplant|5|||
129635066|NCT02633293|466618643|FG000|Overall Study|Lack of Efficacy|2|||
129635067|NCT02633293|466618643|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
129635068|NCT00778817|466618644|FG000|Overall Study|Adverse Event|2|||
129635069|NCT00778817|466618644|FG000|Overall Study|Withdrawal by Subject|2|||
129635070|NCT02356588|466618645|FG000|Overall Study|Lack of Efficacy|4|||
129635071|NCT02356588|466618646|FG001|Overall Study|Lack of Efficacy|10|||
129635072|NCT02356588|466618645|FG000|Overall Study|Adverse Event|0|||
129635073|NCT02356588|466618646|FG001|Overall Study|Adverse Event|2|||
129635074|NCT02356588|466618645|FG000|Overall Study|Withdrawal by Subject|1|||
129635075|NCT02356588|466618646|FG001|Overall Study|Withdrawal by Subject|0|||
129635076|NCT02356588|466618645|FG000|Overall Study|Protocol Violation|0|||
129635077|NCT02356588|466618646|FG001|Overall Study|Protocol Violation|1|||
129635078|NCT01418378|466618647|FG000|Overall Study|Death|1|||
129635079|NCT01418378|466618648|FG001|Overall Study|Death|2|||
129635080|NCT01418378|466618647|FG000|Overall Study|Physician Decision|0|||
129635081|NCT01418378|466618648|FG001|Overall Study|Physician Decision|1|||
129635082|NCT01418378|466618647|FG000|Overall Study|ligament imbalance|0|||
129635083|NCT01418378|466618648|FG001|Overall Study|ligament imbalance|1|||
129635084|NCT01418378|466618647|FG000|Overall Study|developed chronic myopathy|0|||
129635085|NCT01418378|466618648|FG001|Overall Study|developed chronic myopathy|1|||
129635086|NCT01790984|466618649|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
129635087|NCT01790984|466618650|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
129635088|NCT01790984|466618651|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
129635089|NCT01790984|466618652|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
129635090|NCT01051791|466618655|FG000|Overall Study|Failed screening|3|||
129635091|NCT01051791|466618655|FG000|Overall Study|Withdrawal by Subject|1|||
129635092|NCT01081769|466618660|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
129635093|NCT01081769|466618661|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
129635094|NCT01081769|466618660|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
129635095|NCT01081769|466618661|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
129635096|NCT01081769|466618660|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
129635097|NCT01081769|466618661|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
129635098|NCT01081769|466618660|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
129635099|NCT01081769|466618661|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
129635100|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Adverse Event|14|||
129635101|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Adverse Event|11|||
129635102|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Death|1|||
129635103|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Death|1|||
129635104|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
129635105|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
129635106|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
129635107|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
129635108|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Pregnancy|1|||
129635109|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Pregnancy|0|||
129635110|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
129635111|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
129635112|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
129635113|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
129635114|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Other|0|||
129635115|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Other|1|||
129635116|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Ineligibility|3|||
129635117|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Ineligibility|4|||
129635118|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
129635119|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
129635120|NCT01081769|466618660|FG000|CORE Intent-To-Treat|Patient Moved|2|||
129635121|NCT01081769|466618661|FG001|CORE Intent-To-Treat|Patient Moved|2|||
129635122|NCT00507455|466618662|FG000|Overall Study|Adverse Event|3|||
129635123|NCT00507455|466618663|FG001|Overall Study|Adverse Event|3|||
129635124|NCT00507455|466618664|FG002|Overall Study|Adverse Event|6|||
129635125|NCT00507455|466618662|FG000|Overall Study|Withdrawal by Subject|2|||
129635126|NCT00507455|466618663|FG001|Overall Study|Withdrawal by Subject|1|||
129635127|NCT00507455|466618664|FG002|Overall Study|Withdrawal by Subject|2|||
129635128|NCT00507455|466618662|FG000|Overall Study|Protocol Violation|4|||
129635129|NCT00507455|466618663|FG001|Overall Study|Protocol Violation|1|||
129635130|NCT00507455|466618664|FG002|Overall Study|Protocol Violation|1|||
129635131|NCT00507455|466618662|FG000|Overall Study|Lost to Follow-up|2|||
129635132|NCT00507455|466618663|FG001|Overall Study|Lost to Follow-up|0|||
129635133|NCT00507455|466618664|FG002|Overall Study|Lost to Follow-up|2|||
129635134|NCT00507455|466618662|FG000|Overall Study|Lack of Efficacy|0|||
129635135|NCT00507455|466618663|FG001|Overall Study|Lack of Efficacy|1|||
129635136|NCT00507455|466618664|FG002|Overall Study|Lack of Efficacy|0|||
129635137|NCT00507455|466618662|FG000|Overall Study|Other - miscellaneous reason|1|||
129635138|NCT00507455|466618663|FG001|Overall Study|Other - miscellaneous reason|0|||
129635139|NCT00507455|466618664|FG002|Overall Study|Other - miscellaneous reason|1|||
129635140|NCT01737710|466618665|FG000|Overall Study|Lost to Follow-up|0|||
129635141|NCT01737710|466618666|FG001|Overall Study|Lost to Follow-up|2|||
129635142|NCT01737710|466618667|FG002|Overall Study|Lost to Follow-up|2|||
129635143|NCT01737710|466618668|FG003|Overall Study|Lost to Follow-up|0|||
129635144|NCT01737710|466618669|FG004|Overall Study|Lost to Follow-up|0|||
129635145|NCT01737710|466618665|FG000|Overall Study|Withdrawal by Subject|1|||
129635146|NCT01737710|466618666|FG001|Overall Study|Withdrawal by Subject|1|||
129635147|NCT01737710|466618667|FG002|Overall Study|Withdrawal by Subject|1|||
129635148|NCT01737710|466618668|FG003|Overall Study|Withdrawal by Subject|0|||
129635149|NCT01737710|466618669|FG004|Overall Study|Withdrawal by Subject|0|||
129635150|NCT01737710|466618665|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
129635151|NCT01737710|466618666|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
129635152|NCT01737710|466618667|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
129635153|NCT01737710|466618668|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
129635154|NCT01737710|466618669|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
129635155|NCT03363776|466618670|FG000|Overall Study|Progressive disease|2|||
129635156|NCT03363776|466618671|FG001|Overall Study|Progressive disease|3|||
129635157|NCT03363776|466618672|FG002|Overall Study|Progressive disease|1|||
129635158|NCT03363776|466618670|FG000|Overall Study|Study drug toxicity|0|||
129635159|NCT03363776|466618671|FG001|Overall Study|Study drug toxicity|0|||
129635160|NCT03363776|466618672|FG002|Overall Study|Study drug toxicity|1|||
129635161|NCT03363776|466618670|FG000|Overall Study|Death|1|||
129635162|NCT03363776|466618671|FG001|Overall Study|Death|0|||
129635163|NCT03363776|466618672|FG002|Overall Study|Death|0|||
129635164|NCT00410813|466618673|FG000|Overall Study|Adverse Event|6|||
129635165|NCT00410813|466618674|FG001|Overall Study|Adverse Event|11|||
129635166|NCT00410813|466618673|FG000|Overall Study|Progression|32|||
129635167|NCT00410813|466618674|FG001|Overall Study|Progression|21|||
129635168|NCT00410813|466618673|FG000|Overall Study|Not protocol specified|3|||
129635169|NCT00410813|466618674|FG001|Overall Study|Not protocol specified|4|||
129635170|NCT00410813|466618673|FG000|Overall Study|Ineligible|2|||
129635171|NCT00410813|466618674|FG001|Overall Study|Ineligible|4|||
129635172|NCT00410813|466618673|FG000|Overall Study|Death|0|||
129635173|NCT00410813|466618674|FG001|Overall Study|Death|2|||
129635174|NCT00812981|466618675|FG000|Overall Study|Other|0|||
129635175|NCT00812981|466618676|FG001|Overall Study|Other|1|||
129635176|NCT02199795|466618677|FG000|Overall Study|no longer met inclusion criteria|1|||
129635177|NCT02199795|466618678|FG001|Overall Study|no longer met inclusion criteria|0|||
129635178|NCT02199795|466618677|FG000|Overall Study|withdrew due to shoulder pain|1|||
129635179|NCT02199795|466618678|FG001|Overall Study|withdrew due to shoulder pain|0|||
129635180|NCT01791894|466618680|FG000|Overall Study|Adverse Event|1|||
129635181|NCT00996125|466618682|FG000|Overall Study|Adverse Event|0|||
129635182|NCT00996125|466618683|FG001|Overall Study|Adverse Event|2|||
129635183|NCT00996125|466618682|FG000|Overall Study|Lost to Follow-up|1|||
129889338|NCT03259373|467552563|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
129889339|NCT03259373|467552562|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
129635184|NCT00996125|466618683|FG001|Overall Study|Lost to Follow-up|6|||
129635185|NCT00996125|466618682|FG000|Overall Study|Withdrawal by Subject|4|||
129635186|NCT00996125|466618683|FG001|Overall Study|Withdrawal by Subject|3|||
129635187|NCT04331067|466618684|FG000|Overall Study|Adverse Event|1|||
129635188|NCT04331067|466618685|FG001|Overall Study|Adverse Event|3|||
129635189|NCT04331067|466618686|FG002|Overall Study|Adverse Event|1|||
129635190|NCT04331067|466618684|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
129635191|NCT04331067|466618685|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
129635192|NCT04331067|466618686|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
129635193|NCT02203721|466618687|FG000|Overall Study|Lost to Follow-up|1|||
129635194|NCT02203721|466618688|FG001|Overall Study|Lost to Follow-up|0|||
129635195|NCT02203721|466618687|FG000|Overall Study|Death|0|||
129635196|NCT02203721|466618688|FG001|Overall Study|Death|2|||
129635197|NCT02203721|466618687|FG000|Overall Study|Illness|0|||
129635198|NCT02203721|466618688|FG001|Overall Study|Illness|1|||
129635199|NCT00708461|466618689|FG000|Overall Study|Lost to Follow-up|18|||
129635200|NCT00708461|466618690|FG001|Overall Study|Lost to Follow-up|11|||
129635201|NCT00708461|466618689|FG000|Overall Study|Withdrawal by Subject|8|||
129635202|NCT00708461|466618690|FG001|Overall Study|Withdrawal by Subject|9|||
129635203|NCT00708461|466618689|FG000|Overall Study|left workforce|115|||
129635204|NCT00708461|466618690|FG001|Overall Study|left workforce|180|||
129635205|NCT01796392|466618695|FG000|Overall Study|Withdrawal by Subject|2|||
129635206|NCT01796392|466618696|FG001|Overall Study|Withdrawal by Subject|0|||
129635207|NCT01796392|466618695|FG000|Overall Study|Death|5|||
129635208|NCT01796392|466618696|FG001|Overall Study|Death|1|||
129635209|NCT01796392|466618695|FG000|Overall Study|Excluded for medical reasons|1|||
129635210|NCT01796392|466618696|FG001|Overall Study|Excluded for medical reasons|2|||
129635211|NCT01796392|466618695|FG000|Overall Study|Lost to Follow-up|1|||
129635212|NCT01796392|466618696|FG001|Overall Study|Lost to Follow-up|0|||
129635213|NCT03517540|466618699|FG000|Overall Study|Protocol Violation|2|||
129635214|NCT03517540|466618700|FG001|Overall Study|Protocol Violation|0|||
129635215|NCT03517540|466618701|FG002|Overall Study|Protocol Violation|0|||
129635216|NCT03517540|466618702|FG003|Overall Study|Protocol Violation|1|||
129635217|NCT03517540|466618699|FG000|Overall Study|Adverse Event|9|||
129635218|NCT03517540|466618700|FG001|Overall Study|Adverse Event|3|||
129635219|NCT03517540|466618701|FG002|Overall Study|Adverse Event|8|||
129635220|NCT03517540|466618702|FG003|Overall Study|Adverse Event|1|||
129635221|NCT03517540|466618699|FG000|Overall Study|Withdrawal by Subject|3|||
129635222|NCT03517540|466618700|FG001|Overall Study|Withdrawal by Subject|4|||
129635223|NCT03517540|466618701|FG002|Overall Study|Withdrawal by Subject|1|||
129635224|NCT03517540|466618702|FG003|Overall Study|Withdrawal by Subject|3|||
129635225|NCT01779440|466618705|FG000|Overall Study|Withdrawal by Subject|3|||
129635226|NCT01779440|466618706|FG001|Overall Study|Withdrawal by Subject|5|||
129635227|NCT01205269|466618707|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129635228|NCT01205269|466618708|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129635229|NCT01205269|466618709|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129635230|NCT01205269|466618710|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
129635231|NCT01205269|466618711|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129635232|NCT01205269|466618712|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
129635233|NCT01408303|466618713|FG000|Overall Study|Adverse Event|3|||
129635234|NCT01408303|466618714|FG001|Overall Study|Adverse Event|7|||
129635235|NCT01408303|466618715|FG002|Overall Study|Adverse Event|2|||
129635236|NCT01408303|466618713|FG000|Overall Study|Lost to Follow-up|0|||
129635237|NCT01408303|466618714|FG001|Overall Study|Lost to Follow-up|1|||
129635238|NCT01408303|466618715|FG002|Overall Study|Lost to Follow-up|2|||
129635239|NCT01408303|466618713|FG000|Overall Study|Withdrawal by Subject|2|||
129635240|NCT01408303|466618714|FG001|Overall Study|Withdrawal by Subject|3|||
129635241|NCT01408303|466618715|FG002|Overall Study|Withdrawal by Subject|1|||
129635242|NCT01408303|466618713|FG000|Overall Study|Protocol Violation|0|||
129635243|NCT01408303|466618714|FG001|Overall Study|Protocol Violation|1|||
129635244|NCT01408303|466618715|FG002|Overall Study|Protocol Violation|0|||
129635245|NCT01408303|466618713|FG000|Overall Study|Noncompliance|1|||
129635246|NCT01408303|466618714|FG001|Overall Study|Noncompliance|0|||
129635247|NCT01408303|466618715|FG002|Overall Study|Noncompliance|1|||
129635248|NCT01207687|466618716|FG000|Overall Study|Adverse Event|1|||
129635249|NCT01207687|466618716|FG000|Overall Study|Withdrawal by Subject|1|||
129635250|NCT01486446|466618717|FG000|Overall Study|Adverse Event|1|||
129635251|NCT01486446|466618718|FG001|Overall Study|Adverse Event|0|||
129635252|NCT00523848|466618719|FG000|Overall Study|Adverse Event|11|||
129635253|NCT00523848|466618719|FG000|Overall Study|Withdrawal by Subject|2|||
129635254|NCT00523848|466618719|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
129635255|NCT00523848|466618719|FG000|Overall Study|Disease Progression|5|||
129635256|NCT00523848|466618719|FG000|Overall Study|Other, unspecified|4|||
129635257|NCT01801865|466618720|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
129635258|NCT01801865|466618720|FG000|Overall Study|Physician Decision|7|||
129635259|NCT01367886|466618721|FG000|Overall Study|Lost to Follow-up|4|||
129635260|NCT01367886|466618721|FG000|Overall Study|Lack of Efficacy|2|||
129635261|NCT01367886|466618721|FG000|Overall Study|Death|1|||
129797733|NCT02007512|467228211|FG000|Double Blind Treatment Period|Death|1|||
129635262|NCT00985504|466618728|FG000|Acute Treatment Period|Adverse Event|3|||
129635263|NCT00985504|466618729|FG001|Acute Treatment Period|Adverse Event|4|||
129635264|NCT00985504|466618728|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
129635265|NCT00985504|466618729|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
129635266|NCT00985504|466618728|FG000|Acute Treatment Period|Protocol Violation|2|||
129635267|NCT00985504|466618729|FG001|Acute Treatment Period|Protocol Violation|0|||
129635268|NCT00985504|466618728|FG000|Acute Treatment Period|Sponsor Decision|0|||
129635269|NCT00985504|466618729|FG001|Acute Treatment Period|Sponsor Decision|1|||
129635270|NCT00985504|466618728|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
129635271|NCT00985504|466618729|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
129635272|NCT00985504|466618728|FG000|Optimization Period|Adverse Event|7|||
129635273|NCT00985504|466618729|FG001|Optimization Period|Adverse Event|9|||
129635274|NCT00985504|466618728|FG000|Optimization Period|Death|0|||
129635275|NCT00985504|466618729|FG001|Optimization Period|Death|1|||
129635276|NCT00985504|466618728|FG000|Optimization Period|Lack of Efficacy|5|||
129635277|NCT00985504|466618729|FG001|Optimization Period|Lack of Efficacy|3|||
129635278|NCT00985504|466618728|FG000|Optimization Period|Lost to Follow-up|0|||
129635279|NCT00985504|466618729|FG001|Optimization Period|Lost to Follow-up|1|||
129635280|NCT00985504|466618728|FG000|Optimization Period|Physician Decision|1|||
129635281|NCT00985504|466618729|FG001|Optimization Period|Physician Decision|0|||
129635282|NCT00985504|466618728|FG000|Optimization Period|Protocol Violation|3|||
129635283|NCT00985504|466618729|FG001|Optimization Period|Protocol Violation|1|||
129635284|NCT00985504|466618728|FG000|Optimization Period|Withdrawal by Subject|10|||
129635285|NCT00985504|466618729|FG001|Optimization Period|Withdrawal by Subject|8|||
129635286|NCT03711786|466618730|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
129635287|NCT03711786|466618731|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
129635288|NCT03711786|466618730|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
129635289|NCT03711786|466618731|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
129635290|NCT03711786|466618730|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
129635291|NCT03711786|466618731|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
129635292|NCT03711786|466618730|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
129635293|NCT03711786|466618731|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
129635294|NCT03711786|466618730|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
129635295|NCT03711786|466618731|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
129635296|NCT03711786|466618730|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
129635297|NCT03711786|466618731|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
129635298|NCT03379727|466618735|FG000|Overall Study|Lack of Efficacy|73|||
129635299|NCT03379727|466618735|FG000|Overall Study|Adverse Event|32|||
129635300|NCT03379727|466618735|FG000|Overall Study|Death|18|||
129635301|NCT03379727|466618735|FG000|Overall Study|Patient/guardian decision|17|||
129635302|NCT03379727|466618735|FG000|Overall Study|Physician Decision|104|||
129635303|NCT03379727|466618735|FG000|Overall Study|Protocol Violation|4|||
129635304|NCT03379727|466618735|FG000|Overall Study|Lost to Follow-up|1|||
129635305|NCT04031846|466618736|FG000|Overall Study|Lost to Follow-up|4|||
129635306|NCT04031846|466618737|FG001|Overall Study|Lost to Follow-up|4|||
129635307|NCT04031846|466618736|FG000|Overall Study|Physician Decision|0|||
129635308|NCT04031846|466618737|FG001|Overall Study|Physician Decision|1|||
129635309|NCT04031846|466618736|FG000|Overall Study|Protocol Violation|1|||
129635310|NCT04031846|466618737|FG001|Overall Study|Protocol Violation|1|||
129635311|NCT04031846|466618736|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
129635312|NCT04031846|466618737|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
129635313|NCT06868654|466618738|FG000|Overall Study|Death|4|||
129635314|NCT06868654|466618739|FG001|Overall Study|Death|14|||
129635315|NCT06868654|466618738|FG000|Overall Study|Lost to Follow-up|0|||
129635316|NCT06868654|466618739|FG001|Overall Study|Lost to Follow-up|1|||
129635317|NCT06868654|466618738|FG000|Overall Study|Withdrawal by Subject|5|||
129635318|NCT06868654|466618739|FG001|Overall Study|Withdrawal by Subject|3|||
129635319|NCT06868654|466618738|FG000|Overall Study|Physician Decision|0|||
129635320|NCT06868654|466618739|FG001|Overall Study|Physician Decision|1|||
129635321|NCT06868654|466618738|FG000|Overall Study|Ongoing|23|||
129635322|NCT06868654|466618739|FG001|Overall Study|Ongoing|21|||
129635323|NCT01777282|466618746|FG000|Overall Study|Persistent Hyperglycemia|0|||
129635324|NCT01777282|466618747|FG001|Overall Study|Persistent Hyperglycemia|0|||
129635325|NCT01777282|466618748|FG002|Overall Study|Persistent Hyperglycemia|1|||
129635326|NCT01777282|466618749|FG003|Overall Study|Persistent Hyperglycemia|0|||
129635327|NCT01777282|466618750|FG004|Overall Study|Persistent Hyperglycemia|0|||
129635328|NCT01777282|466618746|FG000|Overall Study|New Antidiabetic Medication|0|||
129635329|NCT01777282|466618747|FG001|Overall Study|New Antidiabetic Medication|0|||
129635330|NCT01777282|466618748|FG002|Overall Study|New Antidiabetic Medication|1|||
129635331|NCT01777282|466618749|FG003|Overall Study|New Antidiabetic Medication|0|||
129635332|NCT01777282|466618750|FG004|Overall Study|New Antidiabetic Medication|0|||
129635333|NCT01777282|466618746|FG000|Overall Study|Adverse Event|4|||
129635334|NCT01777282|466618747|FG001|Overall Study|Adverse Event|4|||
129635335|NCT01777282|466618748|FG002|Overall Study|Adverse Event|2|||
129635336|NCT01777282|466618749|FG003|Overall Study|Adverse Event|1|||
129635337|NCT01777282|466618750|FG004|Overall Study|Adverse Event|3|||
129635338|NCT01777282|466618746|FG000|Overall Study|Withdrawal by Subject|4|||
129635339|NCT01777282|466618747|FG001|Overall Study|Withdrawal by Subject|0|||
129635340|NCT01777282|466618748|FG002|Overall Study|Withdrawal by Subject|0|||
129635341|NCT01777282|466618749|FG003|Overall Study|Withdrawal by Subject|1|||
129635342|NCT01777282|466618750|FG004|Overall Study|Withdrawal by Subject|2|||
129635343|NCT01777282|466618746|FG000|Overall Study|Protocol Violation|2|||
129635344|NCT01777282|466618747|FG001|Overall Study|Protocol Violation|0|||
129635345|NCT01777282|466618748|FG002|Overall Study|Protocol Violation|1|||
129635346|NCT01777282|466618749|FG003|Overall Study|Protocol Violation|0|||
129635347|NCT01777282|466618750|FG004|Overall Study|Protocol Violation|2|||
129635348|NCT01777282|466618746|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
129440544|NCT01193920|465911473|FG007|Overall Study|Lost to Follow-up|0|||
129440545|NCT01193920|465911474|FG008|Overall Study|Lost to Follow-up|2|||
129440546|NCT01193920|465911475|FG009|Overall Study|Lost to Follow-up|3|||
129440547|NCT01193920|465911466|FG000|Overall Study|Protocol Violation|1|||
129440548|NCT01193920|465911467|FG001|Overall Study|Protocol Violation|0|||
129440549|NCT01193920|465911468|FG002|Overall Study|Protocol Violation|0|||
129440550|NCT01193920|465911469|FG003|Overall Study|Protocol Violation|0|||
129440551|NCT01193920|465911470|FG004|Overall Study|Protocol Violation|0|||
129635349|NCT01777282|466618747|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
129635350|NCT01777282|466618748|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
129635351|NCT01777282|466618749|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
129635352|NCT01777282|466618750|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
129635353|NCT01131455|466618751|FG000|Overall Study|Death of PI|6|||
129635354|NCT01131455|466618752|FG001|Overall Study|Death of PI|4|||
129440552|NCT01193920|465911471|FG005|Overall Study|Protocol Violation|0|||
129440553|NCT01193920|465911472|FG006|Overall Study|Protocol Violation|0|||
129440554|NCT01193920|465911473|FG007|Overall Study|Protocol Violation|0|||
129440555|NCT01193920|465911474|FG008|Overall Study|Protocol Violation|0|||
129440556|NCT01193920|465911475|FG009|Overall Study|Protocol Violation|0|||
129635355|NCT01131455|466618753|FG002|Overall Study|Death of PI|0|||
129635356|NCT00764660|466618754|FG000|Overall Study|Adverse Event|6|||
129635357|NCT00764660|466618755|FG001|Overall Study|Adverse Event|3|||
129635358|NCT00764660|466618754|FG000|Overall Study|Lost to Follow-up|3|||
129635359|NCT00764660|466618755|FG001|Overall Study|Lost to Follow-up|4|||
129635360|NCT00764660|466618754|FG000|Overall Study|Withdrawal by Subject|7|||
129635361|NCT00764660|466618755|FG001|Overall Study|Withdrawal by Subject|3|||
129635362|NCT00764660|466618754|FG000|Overall Study|Noncompliance With Protocol|5|||
129635363|NCT00764660|466618755|FG001|Overall Study|Noncompliance With Protocol|1|||
129635364|NCT00764660|466618754|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
129635365|NCT00764660|466618755|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
129635366|NCT03103152|466618756|FG000|Overall Study|Physician Decision|5|||
129635367|NCT03103152|466618757|FG001|Overall Study|Physician Decision|2|||
129635368|NCT03103152|466618758|FG002|Overall Study|Physician Decision|6|||
129635369|NCT03103152|466618759|FG003|Overall Study|Physician Decision|3|||
129635370|NCT03103152|466618760|FG004|Overall Study|Physician Decision|3|||
129635371|NCT03103152|466618761|FG005|Overall Study|Physician Decision|1|||
129635372|NCT03103152|466618756|FG000|Overall Study|Protocol Violation|2|||
129635373|NCT03103152|466618757|FG001|Overall Study|Protocol Violation|2|||
129635374|NCT03103152|466618758|FG002|Overall Study|Protocol Violation|1|||
129635375|NCT03103152|466618759|FG003|Overall Study|Protocol Violation|2|||
129635376|NCT03103152|466618760|FG004|Overall Study|Protocol Violation|1|||
129635377|NCT03103152|466618761|FG005|Overall Study|Protocol Violation|1|||
129635378|NCT03103152|466618756|FG000|Overall Study|Inter-current illness|0|||
129635379|NCT03103152|466618757|FG001|Overall Study|Inter-current illness|0|||
129635380|NCT03103152|466618758|FG002|Overall Study|Inter-current illness|1|||
129635381|NCT03103152|466618759|FG003|Overall Study|Inter-current illness|0|||
129635382|NCT03103152|466618760|FG004|Overall Study|Inter-current illness|0|||
129635383|NCT03103152|466618761|FG005|Overall Study|Inter-current illness|0|||
129635384|NCT03103152|466618756|FG000|Overall Study|Death|0|||
129635385|NCT03103152|466618757|FG001|Overall Study|Death|1|||
129635386|NCT03103152|466618758|FG002|Overall Study|Death|0|||
129635387|NCT03103152|466618759|FG003|Overall Study|Death|0|||
129635388|NCT03103152|466618760|FG004|Overall Study|Death|0|||
129635389|NCT03103152|466618761|FG005|Overall Study|Death|0|||
129635390|NCT03103152|466618756|FG000|Overall Study|Adverse Event|0|||
129635391|NCT03103152|466618757|FG001|Overall Study|Adverse Event|0|||
129635392|NCT03103152|466618758|FG002|Overall Study|Adverse Event|1|||
129440557|NCT01193920|465911466|FG000|Overall Study|Death|0|||
129440558|NCT01193920|465911467|FG001|Overall Study|Death|0|||
129440559|NCT01193920|465911468|FG002|Overall Study|Death|0|||
129440560|NCT01193920|465911469|FG003|Overall Study|Death|1|||
129440561|NCT01193920|465911470|FG004|Overall Study|Death|0|||
129635393|NCT03103152|466618759|FG003|Overall Study|Adverse Event|0|||
129635394|NCT03103152|466618760|FG004|Overall Study|Adverse Event|0|||
129635395|NCT03103152|466618761|FG005|Overall Study|Adverse Event|1|||
129635396|NCT03103152|466618756|FG000|Overall Study|Withdrawal by Subject|1|||
129440562|NCT01193920|465911471|FG005|Overall Study|Death|0|||
129440563|NCT01193920|465911472|FG006|Overall Study|Death|2|||
129440564|NCT01193920|465911473|FG007|Overall Study|Death|3|||
129635397|NCT03103152|466618757|FG001|Overall Study|Withdrawal by Subject|0|||
129635398|NCT03103152|466618758|FG002|Overall Study|Withdrawal by Subject|1|||
129635399|NCT03103152|466618759|FG003|Overall Study|Withdrawal by Subject|1|||
129635400|NCT03103152|466618760|FG004|Overall Study|Withdrawal by Subject|1|||
129635401|NCT03103152|466618761|FG005|Overall Study|Withdrawal by Subject|1|||
129635402|NCT03103152|466618756|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
129635403|NCT03103152|466618757|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
129635404|NCT03103152|466618758|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
129635405|NCT03103152|466618759|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
129635406|NCT03103152|466618760|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
129635407|NCT03103152|466618761|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
129635408|NCT03103152|466618756|FG000|Overall Study|Unacceptable side effects|0|||
129635409|NCT03103152|466618757|FG001|Overall Study|Unacceptable side effects|0|||
129635410|NCT03103152|466618758|FG002|Overall Study|Unacceptable side effects|0|||
129635411|NCT03103152|466618759|FG003|Overall Study|Unacceptable side effects|0|||
129635412|NCT03103152|466618760|FG004|Overall Study|Unacceptable side effects|0|||
129635413|NCT03103152|466618761|FG005|Overall Study|Unacceptable side effects|1|||
129635414|NCT03103152|466618756|FG000|Overall Study|Lost to Follow-up|0|||
129635415|NCT03103152|466618757|FG001|Overall Study|Lost to Follow-up|1|||
129635416|NCT03103152|466618758|FG002|Overall Study|Lost to Follow-up|0|||
129635417|NCT03103152|466618759|FG003|Overall Study|Lost to Follow-up|1|||
129635418|NCT03103152|466618760|FG004|Overall Study|Lost to Follow-up|0|||
129635419|NCT03103152|466618761|FG005|Overall Study|Lost to Follow-up|1|||
129635420|NCT03103152|466618756|FG000|Overall Study|Testicular pain|0|||
129635421|NCT03103152|466618757|FG001|Overall Study|Testicular pain|0|||
129635422|NCT03103152|466618758|FG002|Overall Study|Testicular pain|0|||
129635423|NCT03103152|466618759|FG003|Overall Study|Testicular pain|1|||
129635424|NCT03103152|466618760|FG004|Overall Study|Testicular pain|0|||
129635425|NCT03103152|466618761|FG005|Overall Study|Testicular pain|0|||
129635426|NCT00684411|466620029|FG000|Overall Study|New Primary Cancer|1|||
129635427|NCT00684411|466620029|FG000|Overall Study|Disease Progression|10|||
129635428|NCT00684411|466620029|FG000|Overall Study|Adverse Event|1|||
129635429|NCT01344824|466620030|FG000|Overall Study|Adverse Event|15|||
129635430|NCT01344824|466620030|FG000|Overall Study|Withdrawal by Subject|6|||
129635431|NCT01344824|466620030|FG000|Overall Study|Other complicating disease|1|||
129635432|NCT01344824|466620030|FG000|Overall Study|Progression|15|||
129635433|NCT01295671|466620033|FG000|Overall Study|Lost to Follow-up|4|||
129635434|NCT01295671|466620034|FG001|Overall Study|Lost to Follow-up|6|||
129635435|NCT01295671|466620035|FG002|Overall Study|Lost to Follow-up|3|||
129635436|NCT01295671|466620033|FG000|Overall Study|Withdrawal by Subject|3|||
129635437|NCT01295671|466620034|FG001|Overall Study|Withdrawal by Subject|1|||
129635438|NCT01295671|466620035|FG002|Overall Study|Withdrawal by Subject|0|||
129635439|NCT02058537|466620036|FG000|Overall Study|Withdrawal by Subject|1|||
129635440|NCT02366637|466620037|FG000|First Intervention Period|Adverse Event|0|||
129635441|NCT02366637|466620038|FG001|First Intervention Period|Adverse Event|1|||
129635442|NCT02366637|466620037|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
129635443|NCT02366637|466620038|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
129635444|NCT02366637|466620037|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
129635445|NCT02366637|466620038|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
129635446|NCT00651261|466620039|FG000|Overall Study|Adverse Event|32|||
129635447|NCT00651261|466620040|FG001|Overall Study|Adverse Event|22|||
129635448|NCT00651261|466620039|FG000|Overall Study|Death|18|||
129635449|NCT00651261|466620040|FG001|Overall Study|Death|18|||
129635450|NCT00651261|466620039|FG000|Overall Study|Withdrawal by Subject|22|||
129635451|NCT00651261|466620040|FG001|Overall Study|Withdrawal by Subject|40|||
129635452|NCT00651261|466620039|FG000|Overall Study|Induction failure|24|||
129635453|NCT00651261|466620040|FG001|Overall Study|Induction failure|35|||
129635454|NCT00651261|466620039|FG000|Overall Study|Disease progression|58|||
129635455|NCT00651261|466620040|FG001|Overall Study|Disease progression|58|||
129635456|NCT00651261|466620039|FG000|Overall Study|Alternative therapy|109|||
129635457|NCT00651261|466620040|FG001|Overall Study|Alternative therapy|107|||
129635458|NCT00651261|466620039|FG000|Overall Study|Other disease or participant decisions|23|||
129635459|NCT00651261|466620040|FG001|Overall Study|Other disease or participant decisions|23|||
129635460|NCT00651261|466620039|FG000|Overall Study|Never treated|5|||
129635461|NCT00651261|466620040|FG001|Overall Study|Never treated|3|||
129635462|NCT01609010|466620041|FG000|Overall Study|Stable disease (SD)|22|||
129635463|NCT01609010|466620042|FG001|Overall Study|Stable disease (SD)|16|||
129635464|NCT01609010|466620041|FG000|Overall Study|Progressive disease (PD)|8|||
129440565|NCT01193920|465911474|FG008|Overall Study|Death|2|||
129635465|NCT01609010|466620042|FG001|Overall Study|Progressive disease (PD)|10|||
129635466|NCT01609010|466620041|FG000|Overall Study|Adverse Event|3|||
129635467|NCT01609010|466620042|FG001|Overall Study|Adverse Event|6|||
129635468|NCT01609010|466620041|FG000|Overall Study|Withdrawal by Subject|2|||
129635469|NCT01609010|466620042|FG001|Overall Study|Withdrawal by Subject|2|||
129635470|NCT01609010|466620041|FG000|Overall Study|Other|2|||
129635471|NCT01609010|466620042|FG001|Overall Study|Other|0|||
129704799|NCT01576783|466884063|FG001|Overall Study|Withdrawal by Subject|1|||
129704800|NCT01083602|466884064|FG000|Overall Study|Adverse Event|11|||
129704801|NCT01083602|466884064|FG000|Overall Study|New Cancer Therapy|2|||
129704802|NCT01083602|466884064|FG000|Overall Study|Death|1|||
129704803|NCT01083602|466884064|FG000|Overall Study|Withdrawal by Subject|5|||
129704804|NCT01083602|466884064|FG000|Overall Study|Lack of Efficacy|36|||
129704805|NCT03698279|466884067|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129704806|NCT03698279|466884068|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129704807|NCT03698279|466884069|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129704808|NCT03698279|466884070|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129704809|NCT03698279|466884071|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129704810|NCT03698279|466884072|FG005|Overall Study|Withdrawal by parent/guardian|0|||
129704811|NCT03698279|466884067|FG000|Overall Study|Protocol deviation|1|||
129704812|NCT03698279|466884068|FG001|Overall Study|Protocol deviation|0|||
129704813|NCT03698279|466884069|FG002|Overall Study|Protocol deviation|1|||
129704814|NCT03698279|466884070|FG003|Overall Study|Protocol deviation|0|||
129704815|NCT03698279|466884071|FG004|Overall Study|Protocol deviation|0|||
129704816|NCT03698279|466884072|FG005|Overall Study|Protocol deviation|0|||
129704817|NCT03698279|466884067|FG000|Overall Study|Withdrawal by Subject|0|||
129704818|NCT03698279|466884068|FG001|Overall Study|Withdrawal by Subject|0|||
129704819|NCT03698279|466884069|FG002|Overall Study|Withdrawal by Subject|1|||
129704820|NCT03698279|466884070|FG003|Overall Study|Withdrawal by Subject|0|||
129704821|NCT03698279|466884071|FG004|Overall Study|Withdrawal by Subject|0|||
129704822|NCT03698279|466884072|FG005|Overall Study|Withdrawal by Subject|0|||
129635472|NCT01609010|466620041|FG000|Overall Study|Other malignancy|1|||
129635473|NCT01609010|466620042|FG001|Overall Study|Other malignancy|0|||
129635474|NCT01609010|466620041|FG000|Overall Study|Pathology review|2|||
129635475|NCT01609010|466620042|FG001|Overall Study|Pathology review|1|||
129635476|NCT01609010|466620041|FG000|Overall Study|Protocol Violation|1|||
129635477|NCT01609010|466620042|FG001|Overall Study|Protocol Violation|1|||
129635478|NCT01609010|466620041|FG000|Overall Study|New cancer|1|||
129635479|NCT01609010|466620042|FG001|Overall Study|New cancer|0|||
129635480|NCT01609010|466620041|FG000|Overall Study|Lost to Follow-up|1|||
129635481|NCT01609010|466620042|FG001|Overall Study|Lost to Follow-up|1|||
129635482|NCT01134107|466620043|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
129635483|NCT01134107|466620044|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
129635484|NCT01134107|466620043|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
129635485|NCT01134107|466620044|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
129440566|NCT01193920|465911475|FG009|Overall Study|Death|4|||
129440567|NCT01193920|465911466|FG000|Overall Study|Unable to classify|0|||
129440568|NCT01193920|465911467|FG001|Overall Study|Unable to classify|0|||
129440569|NCT01193920|465911468|FG002|Overall Study|Unable to classify|0|||
129704823|NCT03698279|466884067|FG000|Overall Study|Lost to Follow-up|3|||
129704824|NCT03698279|466884068|FG001|Overall Study|Lost to Follow-up|1|||
129704825|NCT03698279|466884069|FG002|Overall Study|Lost to Follow-up|4|||
129440570|NCT01193920|465911469|FG003|Overall Study|Unable to classify|1|||
129440571|NCT01193920|465911470|FG004|Overall Study|Unable to classify|0|||
129635486|NCT01134107|466620043|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
129704826|NCT03698279|466884070|FG003|Overall Study|Lost to Follow-up|5|||
129704827|NCT03698279|466884071|FG004|Overall Study|Lost to Follow-up|0|||
129704828|NCT03698279|466884072|FG005|Overall Study|Lost to Follow-up|0|||
129704829|NCT01276704|466884075|FG000|Overall Study|Lost to Follow-up|2|||
129704830|NCT01276704|466884076|FG001|Overall Study|Lost to Follow-up|3|||
129704831|NCT01276704|466884075|FG000|Overall Study|Non-compliant|2|||
129704832|NCT01276704|466884076|FG001|Overall Study|Non-compliant|2|||
129704833|NCT01276704|466884075|FG000|Overall Study|Withdrawal by Subject|7|||
129704834|NCT01276704|466884076|FG001|Overall Study|Withdrawal by Subject|1|||
129704835|NCT01276704|466884075|FG000|Overall Study|Physician Decision|3|||
129704836|NCT01276704|466884076|FG001|Overall Study|Physician Decision|5|||
129704837|NCT02276040|466884077|FG000|Overall Study|Physician Decision|15|||
129704838|NCT03801525|466884078|FG000|Overall Study|Adverse Event|17|||
129704839|NCT03801525|466884079|FG001|Overall Study|Adverse Event|1|||
129704840|NCT03801525|466884080|FG002|Overall Study|Adverse Event|0|||
129704841|NCT03801525|466884078|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
129704842|NCT03801525|466884079|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
129704843|NCT03801525|466884080|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
129704844|NCT03801525|466884078|FG000|Overall Study|Death|29|||
129704845|NCT03801525|466884079|FG001|Overall Study|Death|1|||
129704846|NCT03801525|466884080|FG002|Overall Study|Death|4|||
129704847|NCT03801525|466884078|FG000|Overall Study|Disease Progression|6|||
129704848|NCT03801525|466884079|FG001|Overall Study|Disease Progression|0|||
129704849|NCT03801525|466884080|FG002|Overall Study|Disease Progression|1|||
129704850|NCT03801525|466884078|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
129704851|NCT03801525|466884079|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
129704852|NCT03801525|466884080|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
129704853|NCT03801525|466884078|FG000|Overall Study|Investigator Decision|18|||
129704854|NCT03801525|466884079|FG001|Overall Study|Investigator Decision|1|||
129704855|NCT03801525|466884080|FG002|Overall Study|Investigator Decision|0|||
129704856|NCT03801525|466884078|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
129704857|NCT03801525|466884079|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
129704858|NCT03801525|466884080|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
129704859|NCT03801525|466884078|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
129704860|NCT03801525|466884079|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
129704861|NCT03801525|466884080|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
129704862|NCT03801525|466884078|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
129704863|NCT03801525|466884079|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
129704864|NCT03801525|466884080|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
129704865|NCT03801525|466884078|FG000|Overall Study|Withdrawal of Subject Consent|38|||
129704866|NCT03801525|466884079|FG001|Overall Study|Withdrawal of Subject Consent|2|||
129704867|NCT03801525|466884080|FG002|Overall Study|Withdrawal of Subject Consent|1|||
129704868|NCT03801525|466884078|FG000|Overall Study|Reason not Specified|4|||
129704869|NCT03801525|466884079|FG001|Overall Study|Reason not Specified|0|||
129704870|NCT03801525|466884080|FG002|Overall Study|Reason not Specified|4|||
129704871|NCT04388826|466884082|FG000|Overall Study|Lost to Follow-up|3|||
129704872|NCT04388826|466884083|FG001|Overall Study|Lost to Follow-up|2|||
129797734|NCT02007512|467228212|FG001|Double Blind Treatment Period|Death|0|||
129797735|NCT02007512|467228213|FG002|Double Blind Treatment Period|Death|0|||
129635487|NCT01134107|466620044|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
129635488|NCT01134107|466620043|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
129635489|NCT01134107|466620044|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
129635490|NCT01134107|466620043|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
129635491|NCT01134107|466620044|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
129635492|NCT01134107|466620043|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
129635493|NCT01134107|466620044|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
129635494|NCT01134107|466620043|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
129635495|NCT01134107|466620044|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
129635496|NCT00687271|466620045|FG000|Overall Study|Adverse Event|1|||
129635497|NCT00687271|466620046|FG001|Overall Study|Adverse Event|3|||
129635498|NCT00687271|466620047|FG002|Overall Study|Adverse Event|1|||
129635499|NCT00687271|466620048|FG003|Overall Study|Adverse Event|0|||
129635500|NCT00687271|466620045|FG000|Overall Study|Lost to Follow-up|0|||
129635501|NCT00687271|466620046|FG001|Overall Study|Lost to Follow-up|1|||
129635502|NCT00687271|466620047|FG002|Overall Study|Lost to Follow-up|0|||
129635503|NCT00687271|466620048|FG003|Overall Study|Lost to Follow-up|0|||
129797736|NCT02007512|467228214|FG003|Double Blind Treatment Period|Death|0|||
129704873|NCT04388826|466884082|FG000|Overall Study|Adverse Event|1|||
129704874|NCT04388826|466884083|FG001|Overall Study|Adverse Event|0|||
129704875|NCT00329420|466884084|FG000|Re-induction Phase|Lack of Efficacy|0|||
129704876|NCT00329420|466884085|FG001|Re-induction Phase|Lack of Efficacy|1|||
129704877|NCT00329420|466884086|FG002|Re-induction Phase|Lack of Efficacy|0|||
129704878|NCT00329420|466884084|FG000|Re-induction Phase|Withdrawal of Consent|0|||
129635504|NCT00687271|466620045|FG000|Overall Study|Protocol Violation|2|||
129635505|NCT00687271|466620046|FG001|Overall Study|Protocol Violation|1|||
129635506|NCT00687271|466620047|FG002|Overall Study|Protocol Violation|1|||
129635507|NCT00687271|466620048|FG003|Overall Study|Protocol Violation|0|||
129635508|NCT00687271|466620045|FG000|Overall Study|Withdrawal by Subject|0|||
129635509|NCT00687271|466620046|FG001|Overall Study|Withdrawal by Subject|1|||
129635510|NCT00687271|466620047|FG002|Overall Study|Withdrawal by Subject|3|||
129635511|NCT00687271|466620048|FG003|Overall Study|Withdrawal by Subject|0|||
129635512|NCT05483686|466620055|FG000|Overall Study|Lost to Follow-up|5|||
129635513|NCT05483686|466620056|FG001|Overall Study|Lost to Follow-up|7|||
129635514|NCT03351608|466620060|FG000|Overall Study|Lost to Follow-up|0|||
129635515|NCT03351608|466620061|FG001|Overall Study|Lost to Follow-up|1|||
129635516|NCT03351608|466620062|FG002|Overall Study|Lost to Follow-up|1|||
129635517|NCT03351608|466620063|FG003|Overall Study|Lost to Follow-up|1|||
129635518|NCT03351608|466620064|FG004|Overall Study|Lost to Follow-up|1|||
129635519|NCT03351608|466620060|FG000|Overall Study|Physician Decision|1|||
129635520|NCT03351608|466620061|FG001|Overall Study|Physician Decision|0|||
129635521|NCT03351608|466620062|FG002|Overall Study|Physician Decision|0|||
129635522|NCT03351608|466620063|FG003|Overall Study|Physician Decision|2|||
129635523|NCT03351608|466620064|FG004|Overall Study|Physician Decision|1|||
129635524|NCT03351608|466620060|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
129635525|NCT03351608|466620061|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
129635526|NCT03351608|466620062|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
129635527|NCT03351608|466620063|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
129635528|NCT03351608|466620064|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
129635529|NCT03351608|466620060|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129635530|NCT03351608|466620061|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129635531|NCT03351608|466620062|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129635532|NCT03351608|466620063|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129635533|NCT03351608|466620064|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129635534|NCT03351608|466620060|FG000|Overall Study|Other|0|||
129635535|NCT03351608|466620061|FG001|Overall Study|Other|1|||
129635536|NCT03351608|466620062|FG002|Overall Study|Other|1|||
129635537|NCT03351608|466620063|FG003|Overall Study|Other|3|||
129635538|NCT03351608|466620064|FG004|Overall Study|Other|0|||
129635539|NCT02727478|466620065|FG000|Overall Study|Withdrawal by Subject|8|||
129635540|NCT02727478|466620066|FG001|Overall Study|Withdrawal by Subject|10|||
129635541|NCT00808210|466620067|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
129635542|NCT00808210|466620068|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
129635543|NCT00808210|466620067|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
129635544|NCT00808210|466620068|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
129635545|NCT00808210|466620067|FG000|Double-Blind TX Period|Adverse Event|0|||
129635546|NCT00808210|466620068|FG001|Double-Blind TX Period|Adverse Event|1|||
129635547|NCT00808210|466620067|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
129635548|NCT00808210|466620068|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
129635549|NCT00808210|466620067|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
129635550|NCT00808210|466620068|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
129635551|NCT00808210|466620067|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
129635552|NCT00808210|466620068|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
129635553|NCT03877068|466620072|FG000|Overall Study|Physician Decision|9|||
129635554|NCT03877068|466620073|FG001|Overall Study|Physician Decision|3|||
129635555|NCT03150719|466620076|FG000|Overall Study|Adverse Event|0|||
129635556|NCT03150719|466620077|FG001|Overall Study|Adverse Event|1|||
129635557|NCT03150719|466620076|FG000|Overall Study|Death|0|||
129635558|NCT03150719|466620077|FG001|Overall Study|Death|1|||
129635559|NCT03150719|466620076|FG000|Overall Study|Other|1|||
129635560|NCT03150719|466620077|FG001|Overall Study|Other|0|||
129635561|NCT00288626|466620082|FG000|Overall Study|Death|3|||
129635562|NCT00288626|466620082|FG000|Overall Study|Withdrawal by Subject|4|||
129635563|NCT02019264|466620084|FG000|Overall Study|Not treated|6|||
129635564|NCT02019264|466620085|FG001|Overall Study|Not treated|4|||
129635565|NCT02019264|466620084|FG000|Overall Study|Lost to Follow-up|50|||
129635566|NCT02019264|466620085|FG001|Overall Study|Lost to Follow-up|47|||
129635567|NCT02019264|466620084|FG000|Overall Study|Withdrawal by Subject|142|||
129635568|NCT02019264|466620085|FG001|Overall Study|Withdrawal by Subject|117|||
129635569|NCT02019264|466620084|FG000|Overall Study|Administrative reason|36|||
129635570|NCT02019264|466620085|FG001|Overall Study|Administrative reason|28|||
129635571|NCT02019264|466620084|FG000|Overall Study|Missing|14|||
129635572|NCT02019264|466620085|FG001|Overall Study|Missing|11|||
129635573|NCT02914613|466620086|FG000|Overall Study|Withdrawal by Subject|1|||
129635574|NCT02914613|466620087|FG001|Overall Study|Withdrawal by Subject|2|||
129635575|NCT02914613|466620086|FG000|Overall Study|Adverse Event|1|||
129635576|NCT02914613|466620087|FG001|Overall Study|Adverse Event|0|||
129635577|NCT01964222|466620091|FG000|Overall Study|Lost to Follow-up|7|||
129635578|NCT01964222|466620092|FG001|Overall Study|Lost to Follow-up|5|||
129635579|NCT01964222|466620091|FG000|Overall Study|Withdrawal by Subject|6|||
129635580|NCT01964222|466620092|FG001|Overall Study|Withdrawal by Subject|6|||
129635581|NCT01964222|466620091|FG000|Overall Study|Screening Failure|2|||
129635582|NCT01964222|466620092|FG001|Overall Study|Screening Failure|0|||
129635583|NCT02677922|466620103|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
129635584|NCT02677922|466620104|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
129635585|NCT02677922|466620105|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
129635586|NCT02677922|466620106|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
129635587|NCT02677922|466620107|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
129635588|NCT02677922|466620108|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
129635589|NCT02677922|466620103|FG000|Treatment Period|Adverse Event|0|||
129635590|NCT02677922|466620104|FG001|Treatment Period|Adverse Event|0|||
129635591|NCT02677922|466620105|FG002|Treatment Period|Adverse Event|1|||
129635592|NCT02677922|466620106|FG003|Treatment Period|Adverse Event|3|||
129635593|NCT02677922|466620107|FG004|Treatment Period|Adverse Event|5|||
129635594|NCT02677922|466620108|FG005|Treatment Period|Adverse Event|2|||
129635595|NCT02677922|466620103|FG000|Treatment Period|Progressive Disease|1|||
129635596|NCT02677922|466620104|FG001|Treatment Period|Progressive Disease|1|||
129635597|NCT02677922|466620105|FG002|Treatment Period|Progressive Disease|0|||
129635598|NCT02677922|466620106|FG003|Treatment Period|Progressive Disease|0|||
129635599|NCT02677922|466620107|FG004|Treatment Period|Progressive Disease|8|||
129635600|NCT02677922|466620108|FG005|Treatment Period|Progressive Disease|7|||
129635601|NCT02677922|466620103|FG000|Treatment Period|Lack of Efficacy|0|||
129635602|NCT02677922|466620104|FG001|Treatment Period|Lack of Efficacy|0|||
129635603|NCT02677922|466620105|FG002|Treatment Period|Lack of Efficacy|0|||
129635604|NCT02677922|466620106|FG003|Treatment Period|Lack of Efficacy|1|||
129635605|NCT02677922|466620107|FG004|Treatment Period|Lack of Efficacy|1|||
129635606|NCT02677922|466620108|FG005|Treatment Period|Lack of Efficacy|6|||
129635607|NCT02677922|466620103|FG000|Treatment Period|Withdrawal by Subject|0|||
129635608|NCT02677922|466620104|FG001|Treatment Period|Withdrawal by Subject|0|||
129635609|NCT02677922|466620105|FG002|Treatment Period|Withdrawal by Subject|1|||
129635610|NCT02677922|466620106|FG003|Treatment Period|Withdrawal by Subject|3|||
129635611|NCT02677922|466620107|FG004|Treatment Period|Withdrawal by Subject|5|||
129635612|NCT02677922|466620108|FG005|Treatment Period|Withdrawal by Subject|5|||
129635613|NCT02677922|466620103|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
129635614|NCT02677922|466620104|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
129635615|NCT02677922|466620105|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
129635616|NCT02677922|466620106|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
129635617|NCT02677922|466620107|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
129635618|NCT02677922|466620108|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
129635619|NCT02677922|466620103|FG000|Treatment Period|Disease Relapse|0|||
129635620|NCT02677922|466620104|FG001|Treatment Period|Disease Relapse|0|||
129635621|NCT02677922|466620105|FG002|Treatment Period|Disease Relapse|0|||
129635622|NCT02677922|466620106|FG003|Treatment Period|Disease Relapse|3|||
129635623|NCT02677922|466620107|FG004|Treatment Period|Disease Relapse|6|||
129635624|NCT02677922|466620108|FG005|Treatment Period|Disease Relapse|1|||
129635625|NCT02677922|466620103|FG000|Treatment Period|Allogeneic HSCT|1|||
129635626|NCT02677922|466620104|FG001|Treatment Period|Allogeneic HSCT|0|||
129635627|NCT02677922|466620105|FG002|Treatment Period|Allogeneic HSCT|0|||
129635628|NCT02677922|466620106|FG003|Treatment Period|Allogeneic HSCT|1|||
129635629|NCT02677922|466620107|FG004|Treatment Period|Allogeneic HSCT|4|||
129635630|NCT02677922|466620108|FG005|Treatment Period|Allogeneic HSCT|1|||
129635631|NCT02677922|466620103|FG000|Treatment Period|Other Reasons|0|||
129635632|NCT02677922|466620104|FG001|Treatment Period|Other Reasons|0|||
129635633|NCT02677922|466620105|FG002|Treatment Period|Other Reasons|0|||
129635634|NCT02677922|466620106|FG003|Treatment Period|Other Reasons|1|||
129635635|NCT02677922|466620107|FG004|Treatment Period|Other Reasons|3|||
129635636|NCT02677922|466620108|FG005|Treatment Period|Other Reasons|5|||
129635637|NCT02677922|466620103|FG000|Treatment Period|Death|0|||
129635638|NCT02677922|466620104|FG001|Treatment Period|Death|0|||
129704879|NCT00329420|466884085|FG001|Re-induction Phase|Withdrawal of Consent|0|||
129635639|NCT02677922|466620105|FG002|Treatment Period|Death|0|||
129635640|NCT02677922|466620106|FG003|Treatment Period|Death|0|||
129635641|NCT02677922|466620107|FG004|Treatment Period|Death|12|||
129704880|NCT00329420|466884086|FG002|Re-induction Phase|Withdrawal of Consent|1|||
129635642|NCT02677922|466620108|FG005|Treatment Period|Death|1|||
129635643|NCT02677922|466620103|FG000|Treatment Period|Non-compliance with Study Drug|0|||
129635644|NCT02677922|466620104|FG001|Treatment Period|Non-compliance with Study Drug|0|||
129635645|NCT02677922|466620105|FG002|Treatment Period|Non-compliance with Study Drug|0|||
129635646|NCT02677922|466620106|FG003|Treatment Period|Non-compliance with Study Drug|0|||
129635647|NCT02677922|466620107|FG004|Treatment Period|Non-compliance with Study Drug|1|||
129635648|NCT02677922|466620108|FG005|Treatment Period|Non-compliance with Study Drug|0|||
129635649|NCT02677922|466620103|FG000|Treatment Period|Physician Decision|0|||
129635650|NCT02677922|466620104|FG001|Treatment Period|Physician Decision|0|||
129635651|NCT02677922|466620105|FG002|Treatment Period|Physician Decision|0|||
129635652|NCT02677922|466620106|FG003|Treatment Period|Physician Decision|0|||
129635653|NCT02677922|466620107|FG004|Treatment Period|Physician Decision|0|||
129635654|NCT02677922|466620108|FG005|Treatment Period|Physician Decision|1|||
129635655|NCT02677922|466620103|FG000|Treatment Period|Symptomatic Deterioration|0|||
129635656|NCT02677922|466620104|FG001|Treatment Period|Symptomatic Deterioration|0|||
129635657|NCT02677922|466620105|FG002|Treatment Period|Symptomatic Deterioration|0|||
129635658|NCT02677922|466620106|FG003|Treatment Period|Symptomatic Deterioration|0|||
129635659|NCT02677922|466620107|FG004|Treatment Period|Symptomatic Deterioration|1|||
129635660|NCT02677922|466620108|FG005|Treatment Period|Symptomatic Deterioration|0|||
129635661|NCT05310071|466620109|FG000|Overall Study|Death|0|||
129635662|NCT05310071|466620110|FG001|Overall Study|Death|3|||
129635663|NCT05310071|466620109|FG000|Overall Study|Adverse Event|4|||
129635664|NCT05310071|466620110|FG001|Overall Study|Adverse Event|31|||
129635665|NCT05310071|466620109|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
129635666|NCT05310071|466620110|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
129635667|NCT05310071|466620109|FG000|Overall Study|Protocol Deviation|2|||
129635668|NCT05310071|466620110|FG001|Overall Study|Protocol Deviation|0|||
129635669|NCT05310071|466620109|FG000|Overall Study|Randomized by Mistake|0|||
129635670|NCT05310071|466620110|FG001|Overall Study|Randomized by Mistake|1|||
129635671|NCT05310071|466620109|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
129635672|NCT05310071|466620110|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
129635673|NCT05310071|466620109|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
129635674|NCT05310071|466620110|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
129635675|NCT05310071|466620109|FG000|Overall Study|Site Terminated by Sponsor|0|||
129635676|NCT05310071|466620110|FG001|Overall Study|Site Terminated by Sponsor|2|||
129635677|NCT05310071|466620109|FG000|Overall Study|Study Terminated by Sponsor|282|||
129635678|NCT05310071|466620110|FG001|Overall Study|Study Terminated by Sponsor|559|||
129635679|NCT05310071|466620109|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
129635680|NCT05310071|466620110|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
129635681|NCT05310071|466620109|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
129635682|NCT05310071|466620110|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
129635683|NCT05310071|466620109|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
129635684|NCT05310071|466620110|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
129635685|NCT05310071|466620109|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
129635686|NCT05310071|466620110|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
129635687|NCT05310071|466620109|FG000|Overall Study|Withdrawal by Participant - Other|25|||
129635688|NCT05310071|466620110|FG001|Overall Study|Withdrawal by Participant - Other|30|||
129635689|NCT05310071|466620109|FG000|Overall Study|Lost to Follow-up|2|||
129635690|NCT05310071|466620110|FG001|Overall Study|Lost to Follow-up|4|||
129635691|NCT05310071|466620109|FG000|Overall Study|Reason Not Specified|1|||
129635692|NCT05310071|466620110|FG001|Overall Study|Reason Not Specified|3|||
129635693|NCT03515811|466620115|FG000|Overall Study|Lost to Follow-up|2|||
129635694|NCT03515811|466620116|FG001|Overall Study|Lost to Follow-up|1|||
129635695|NCT03515811|466620115|FG000|Overall Study|Protocol Violation|1|||
129635696|NCT03515811|466620116|FG001|Overall Study|Protocol Violation|1|||
129635697|NCT03515811|466620115|FG000|Overall Study|Death|1|||
129635698|NCT03515811|466620116|FG001|Overall Study|Death|1|||
129635699|NCT03515811|466620115|FG000|Overall Study|Withdrawal by Subject|0|||
129635700|NCT03515811|466620116|FG001|Overall Study|Withdrawal by Subject|2|||
129635701|NCT03515811|466620115|FG000|Overall Study|Technical Problems|1|||
129635702|NCT03515811|466620116|FG001|Overall Study|Technical Problems|0|||
129635703|NCT03515811|466620115|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
129635704|NCT03515811|466620116|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
129635705|NCT03515811|466620115|FG000|Overall Study|COVID-19|0|||
129635706|NCT03515811|466620116|FG001|Overall Study|COVID-19|1|||
129635707|NCT05107492|466620117|FG000|Overall Study|Lost to Follow-up|1|||
129635708|NCT05107492|466620118|FG001|Overall Study|Lost to Follow-up|0|||
129635709|NCT04339062|466620119|FG000|Overall Study|Death|0|||
129635710|NCT04339062|466620120|FG001|Overall Study|Death|1|||
129635711|NCT02589639|466620122|FG000|Overall Study|Lost to Follow-up|1|||
129635712|NCT02589639|466620123|FG001|Overall Study|Lost to Follow-up|0|||
129704881|NCT00329420|466884084|FG000|Re-induction Phase|Did not respond to re-induction|6|||
129635713|NCT02589639|466620124|FG002|Overall Study|Lost to Follow-up|0|||
129635714|NCT02589639|466620122|FG000|Overall Study|Protocol Violation|1|||
129635715|NCT02589639|466620123|FG001|Overall Study|Protocol Violation|0|||
129635716|NCT02589639|466620124|FG002|Overall Study|Protocol Violation|0|||
129635717|NCT02589639|466620122|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
129635718|NCT02589639|466620123|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
129635719|NCT02589639|466620124|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
129635720|NCT02589639|466620122|FG000|Overall Study|Adverse Event|4|||
129635721|NCT02589639|466620123|FG001|Overall Study|Adverse Event|5|||
129635722|NCT02589639|466620124|FG002|Overall Study|Adverse Event|3|||
129635723|NCT02589639|466620122|FG000|Overall Study|Other reason than specified above|1|||
129635724|NCT02589639|466620123|FG001|Overall Study|Other reason than specified above|2|||
129635725|NCT02589639|466620124|FG002|Overall Study|Other reason than specified above|1|||
129635726|NCT02589639|466620122|FG000|Overall Study|Not Treated|0|||
129635727|NCT02589639|466620123|FG001|Overall Study|Not Treated|3|||
129635728|NCT02589639|466620124|FG002|Overall Study|Not Treated|0|||
129635729|NCT00703157|466620125|FG000|Overall Study|Lost to Follow-up|0|||
129635730|NCT00703157|466620126|FG001|Overall Study|Lost to Follow-up|1|||
129635731|NCT00703157|466620125|FG000|Overall Study|source data permanently lost/ other|4|||
129635732|NCT00703157|466620126|FG001|Overall Study|source data permanently lost/ other|1|||
129635733|NCT02968173|466620127|FG000|Overall Study|Withdrawal by Subject|1|||
129635734|NCT02670525|466620128|FG000|Overall Study|Death|94|||
129635735|NCT02670525|466620129|FG001|Overall Study|Death|14|||
129635736|NCT02670525|466620128|FG000|Overall Study|Lost to Follow-up|4|||
129635737|NCT02670525|466620129|FG001|Overall Study|Lost to Follow-up|1|||
129635738|NCT02670525|466620128|FG000|Overall Study|Subject withdrew consent|1|||
129635739|NCT02670525|466620129|FG001|Overall Study|Subject withdrew consent|0|||
129635740|NCT02670525|466620128|FG000|Overall Study|Unknown, data entry delayed|123|||
129635741|NCT02670525|466620129|FG001|Overall Study|Unknown, data entry delayed|78|||
129635742|NCT00591565|466620130|FG000|Overall Study|lost follow up, withdrawn|5|||
129635743|NCT03564119|466620134|FG000|Overall Study|Adverse Event|4|||
129635744|NCT03564119|466620135|FG001|Overall Study|Adverse Event|0|||
129635745|NCT03564119|466620134|FG000|Overall Study|Lost to Follow-up|1|||
129635746|NCT03564119|466620135|FG001|Overall Study|Lost to Follow-up|4|||
129635747|NCT03564119|466620134|FG000|Overall Study|Protocol Violation|1|||
129635748|NCT03564119|466620135|FG001|Overall Study|Protocol Violation|0|||
129635749|NCT03564119|466620134|FG000|Overall Study|Withdrawal by Subject|9|||
129635750|NCT03564119|466620135|FG001|Overall Study|Withdrawal by Subject|4|||
129635751|NCT03564119|466620134|FG000|Overall Study|Other Than Specified|0|||
129635752|NCT03564119|466620135|FG001|Overall Study|Other Than Specified|1|||
129635753|NCT00634036|466620136|FG000|Overall Study|Lost to Follow-up|1|||
129635754|NCT00634036|466620137|FG001|Overall Study|Lost to Follow-up|1|||
129635755|NCT00634036|466620136|FG000|Overall Study|Withdrawal by Subject|1|||
129635756|NCT00634036|466620137|FG001|Overall Study|Withdrawal by Subject|1|||
129635757|NCT03896022|466620142|FG000|Overall Study|Withdrawal by Subject|1|||
129635758|NCT03896022|466620143|FG001|Overall Study|Withdrawal by Subject|0|||
129635759|NCT03896022|466620144|FG002|Overall Study|Withdrawal by Subject|0|||
129635760|NCT03896022|466620142|FG000|Overall Study|Did not have procedure|3|||
129635761|NCT03896022|466620143|FG001|Overall Study|Did not have procedure|0|||
129635762|NCT03896022|466620144|FG002|Overall Study|Did not have procedure|0|||
129635763|NCT00564850|466620150|FG000|Overall Study|Protocol Violation|2|||
129635764|NCT00314327|466620151|FG000|Overall Study|Withdrawal by Subject|1|||
129635765|NCT02741076|466620152|FG000|Overall Study|Adverse Event|0|||
129635766|NCT02741076|466620153|FG001|Overall Study|Adverse Event|1|||
129635767|NCT02741076|466620154|FG002|Overall Study|Adverse Event|1|||
129635768|NCT02741076|466620155|FG003|Overall Study|Adverse Event|0|||
129635769|NCT02741076|466620152|FG000|Overall Study|Lack of Efficacy|1|||
129635770|NCT02741076|466620153|FG001|Overall Study|Lack of Efficacy|0|||
129635771|NCT02741076|466620154|FG002|Overall Study|Lack of Efficacy|0|||
129635772|NCT02741076|466620155|FG003|Overall Study|Lack of Efficacy|0|||
129635773|NCT02741076|466620152|FG000|Overall Study|Withdrawal by Subject|0|||
129635774|NCT02741076|466620153|FG001|Overall Study|Withdrawal by Subject|1|||
129635775|NCT02741076|466620154|FG002|Overall Study|Withdrawal by Subject|0|||
129635776|NCT02741076|466620155|FG003|Overall Study|Withdrawal by Subject|0|||
129635777|NCT02741076|466620152|FG000|Overall Study|Sponsor Request|2|||
129635778|NCT02741076|466620153|FG001|Overall Study|Sponsor Request|3|||
129635779|NCT02741076|466620154|FG002|Overall Study|Sponsor Request|0|||
129635780|NCT02741076|466620155|FG003|Overall Study|Sponsor Request|1|||
129635781|NCT02741076|466620152|FG000|Overall Study|No additional information available|0|||
129635782|NCT02741076|466620153|FG001|Overall Study|No additional information available|0|||
129635783|NCT02741076|466620154|FG002|Overall Study|No additional information available|1|||
129635784|NCT02741076|466620155|FG003|Overall Study|No additional information available|1|||
129635785|NCT01500382|466620158|FG000|Washout Period|Study site went out of business|0|||
129635786|NCT01500382|466620159|FG001|Washout Period|Study site went out of business|0|||
129635787|NCT01500382|466620160|FG002|Washout Period|Study site went out of business|1|||
129635788|NCT01500382|466620161|FG003|Washout Period|Study site went out of business|0|||
129635789|NCT02134015|466620162|FG000|Overall Study|Protocol Violation|0|||
129635790|NCT02134015|466620163|FG001|Overall Study|Protocol Violation|1|||
129635791|NCT02134015|466620162|FG000|Overall Study|Death|2|||
129635792|NCT02134015|466620163|FG001|Overall Study|Death|1|||
129635793|NCT02134015|466620162|FG000|Overall Study|Reason not provided|1|||
129635794|NCT02134015|466620163|FG001|Overall Study|Reason not provided|2|||
129635795|NCT02134015|466620162|FG000|Overall Study|Clinical progression|14|||
129635796|NCT02134015|466620163|FG001|Overall Study|Clinical progression|7|||
129635797|NCT02134015|466620162|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
129635798|NCT02134015|466620163|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
129635799|NCT02134015|466620162|FG000|Overall Study|Study terminated by sponsor|2|||
129635800|NCT02134015|466620163|FG001|Overall Study|Study terminated by sponsor|3|||
129635801|NCT02134015|466620162|FG000|Overall Study|Adverse Event|9|||
129635802|NCT02134015|466620163|FG001|Overall Study|Adverse Event|10|||
129635803|NCT02134015|466620162|FG000|Overall Study|Withdrawal by Subject|3|||
129635804|NCT02134015|466620163|FG001|Overall Study|Withdrawal by Subject|7|||
129635805|NCT03668119|466621998|FG000|Pre-treatment|Disease Progression|1|||
129635806|NCT03668119|466621999|FG001|Pre-treatment|Disease Progression|0|||
129635807|NCT03668119|466621998|FG000|Treatment|Disease Progression|76|||
129635808|NCT03668119|466621999|FG001|Treatment|Disease Progression|57|||
129635809|NCT03668119|466621998|FG000|Treatment|Study drug toxicity|19|||
129635810|NCT03668119|466621999|FG001|Treatment|Study drug toxicity|1|||
129635811|NCT03668119|466621998|FG000|Treatment|Death|3|||
129635812|NCT03668119|466621999|FG001|Treatment|Death|0|||
129635813|NCT03668119|466621998|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
129635814|NCT03668119|466621999|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
129635815|NCT03668119|466621998|FG000|Treatment|Withdrawal by Subject|1|||
129635816|NCT03668119|466621999|FG001|Treatment|Withdrawal by Subject|1|||
129635817|NCT03668119|466621998|FG000|Treatment|Participant request to discontinue study treatment|3|||
129635818|NCT03668119|466621999|FG001|Treatment|Participant request to discontinue study treatment|1|||
129635819|NCT03668119|466621998|FG000|Treatment|Maximum Clinical Benefit|0|||
129635820|NCT03668119|466621999|FG001|Treatment|Maximum Clinical Benefit|1|||
129635821|NCT03668119|466621998|FG000|Treatment|Participants completed treatment|27|||
129635822|NCT03668119|466621999|FG001|Treatment|Participants completed treatment|11|||
129635823|NCT03668119|466621998|FG000|Treatment|Other reasons|2|||
129635824|NCT03668119|466621999|FG001|Treatment|Other reasons|1|||
129635825|NCT05336227|466622000|FG000|Overall Study|Adverse Event|1|||
129635826|NCT05336227|466622001|FG001|Overall Study|Adverse Event|0|||
129635827|NCT05336227|466622000|FG000|Overall Study|Lost to Follow-up|2|||
129635828|NCT05336227|466622001|FG001|Overall Study|Lost to Follow-up|0|||
129635829|NCT05336227|466622000|FG000|Overall Study|Withdrawal by Subject|1|||
129635830|NCT05336227|466622001|FG001|Overall Study|Withdrawal by Subject|0|||
129635831|NCT00347958|466622004|FG000|Overall Study|Adverse Event|1|||
129635832|NCT00347958|466622004|FG000|Overall Study|Protocol Violation|2|||
129635833|NCT00347958|466622004|FG000|Overall Study|Withdrawal by Subject|1|||
129635834|NCT00754234|466622005|FG000|Overall Study|Withdrawal by Subject|3|||
129635835|NCT00915018|466622006|FG000|Overall Study|Death|75|||
129635836|NCT00915018|466622007|FG001|Overall Study|Death|70|||
129635837|NCT00915018|466622006|FG000|Overall Study|Lost to Follow-up|10|||
129635838|NCT00915018|466622007|FG001|Overall Study|Lost to Follow-up|5|||
129635839|NCT00915018|466622006|FG000|Overall Study|Withdrawal by Subject|38|||
129635840|NCT00915018|466622007|FG001|Overall Study|Withdrawal by Subject|27|||
129635841|NCT00915018|466622006|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
129635842|NCT00915018|466622007|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
129635843|NCT00326716|466622008|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
129704882|NCT00329420|466884085|FG001|Re-induction Phase|Did not respond to re-induction|5|||
129704883|NCT00329420|466884086|FG002|Re-induction Phase|Did not respond to re-induction|7|||
129704884|NCT00329420|466884084|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
129704885|NCT00329420|466884085|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
129635844|NCT00326716|466622009|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
129635845|NCT00326716|466622010|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
129635846|NCT00326716|466622011|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
129635847|NCT04134767|466622012|FG000|Overall Study|Death|0|||
129635848|NCT04134767|466622013|FG001|Overall Study|Death|1|||
129635849|NCT04134767|466622012|FG000|Overall Study|Removed for harassing staff|0|||
129704886|NCT00329420|466884086|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
129704887|NCT00329420|466884084|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
129704888|NCT00329420|466884085|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
129704889|NCT00329420|466884086|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
129704890|NCT00329420|466884084|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
129635850|NCT04134767|466622013|FG001|Overall Study|Removed for harassing staff|1|||
129635851|NCT04134767|466622012|FG000|Overall Study|Lost to Follow-up|44|||
129635852|NCT04134767|466622013|FG001|Overall Study|Lost to Follow-up|40|||
129635853|NCT00300885|466622014|FG000|Treatment|Adverse Event|134|||
129635854|NCT00300885|466622015|FG001|Treatment|Adverse Event|82|||
129635855|NCT00300885|466622014|FG000|Treatment|Death|20|||
129635856|NCT00300885|466622015|FG001|Treatment|Death|7|||
129635857|NCT00300885|466622014|FG000|Treatment|Lack of Efficacy|1|||
129635858|NCT00300885|466622015|FG001|Treatment|Lack of Efficacy|1|||
129635859|NCT00300885|466622014|FG000|Treatment|Lost to Follow-up|3|||
129635860|NCT00300885|466622015|FG001|Treatment|Lost to Follow-up|2|||
129635861|NCT00300885|466622014|FG000|Treatment|Physician Decision|4|||
129635862|NCT00300885|466622015|FG001|Treatment|Physician Decision|5|||
129635863|NCT00300885|466622014|FG000|Treatment|Protocol Violation|11|||
129635864|NCT00300885|466622015|FG001|Treatment|Protocol Violation|11|||
129635865|NCT00300885|466622014|FG000|Treatment|Withdrawal by Subject|26|||
129635866|NCT00300885|466622015|FG001|Treatment|Withdrawal by Subject|23|||
129635867|NCT00300885|466622014|FG000|Treatment|Disease progression|171|||
129635868|NCT00300885|466622015|FG001|Treatment|Disease progression|238|||
129635869|NCT00300885|466622014|FG000|Treatment|Random code broken (subject died)|0|||
129635870|NCT00300885|466622015|FG001|Treatment|Random code broken (subject died)|1|||
129635871|NCT00300885|466622014|FG000|Treatment|Non-compliant with study medication|3|||
129635872|NCT00300885|466622015|FG001|Treatment|Non-compliant with study medication|4|||
129635873|NCT00300885|466622014|FG000|Follow-up|Death|141|||
129635874|NCT00300885|466622015|FG001|Follow-up|Death|163|||
129635875|NCT00300885|466622014|FG000|Follow-up|Lost to Follow-up|11|||
129635876|NCT00300885|466622015|FG001|Follow-up|Lost to Follow-up|7|||
129635877|NCT00300885|466622014|FG000|Follow-up|Withdrawal by Subject|26|||
129635878|NCT00300885|466622015|FG001|Follow-up|Withdrawal by Subject|25|||
129635879|NCT02309411|466622024|FG000|Overall Study|Physician Decision|1|||
129635880|NCT02309411|466622025|FG001|Overall Study|Physician Decision|0|||
129635881|NCT02309411|466622026|FG002|Overall Study|Physician Decision|0|||
129635882|NCT02309411|466622024|FG000|Overall Study|Withdrawal by Subject|1|||
129635883|NCT02309411|466622025|FG001|Overall Study|Withdrawal by Subject|1|||
129635884|NCT02309411|466622026|FG002|Overall Study|Withdrawal by Subject|0|||
129635885|NCT03656692|466622027|FG000|Overall Study|Worsening of disease activity|2|||
129635886|NCT03656692|466622027|FG000|Overall Study|Physician Decision|1|||
129635887|NCT02693106|466622028|FG000|Overall Study|No time|3|||
129635888|NCT00839800|466622029|FG000|Overall Study|Adverse Event|8|||
129635889|NCT00839800|466622030|FG001|Overall Study|Adverse Event|12|||
129635890|NCT00839800|466622029|FG000|Overall Study|Lost to Follow-up|31|||
129635891|NCT00839800|466622030|FG001|Overall Study|Lost to Follow-up|26|||
129635892|NCT00839800|466622029|FG000|Overall Study|Withdrawal by Subject|28|||
129635893|NCT00839800|466622030|FG001|Overall Study|Withdrawal by Subject|34|||
129635894|NCT00839800|466622029|FG000|Overall Study|Incorrect Enrolment|3|||
129635895|NCT00839800|466622030|FG001|Overall Study|Incorrect Enrolment|3|||
129635896|NCT00839800|466622029|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
129635897|NCT00839800|466622030|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
129635898|NCT00839800|466622029|FG000|Overall Study|Safety Reasons|2|||
129635899|NCT00839800|466622030|FG001|Overall Study|Safety Reasons|1|||
129635900|NCT00839800|466622029|FG000|Overall Study|Other|8|||
129635901|NCT00839800|466622030|FG001|Overall Study|Other|14|||
129635902|NCT00839800|466622029|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
129635903|NCT00839800|466622030|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
129635904|NCT02801617|466622034|FG000|Overall Study|Protocol Violation|2|||
129635905|NCT02801617|466622035|FG001|Overall Study|Protocol Violation|6|||
129635906|NCT01372618|466622036|FG000|Overall Study|PI Died. Study Terminated|9|||
129635907|NCT01954056|466622037|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
129635908|NCT01954056|466622038|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
129635909|NCT06110494|466622039|FG000|Overall Study|Protocol Violation|2|||
129635910|NCT06110494|466622040|FG001|Overall Study|Protocol Violation|0|||
129635911|NCT06110494|466622041|FG002|Overall Study|Protocol Violation|1|||
129635912|NCT06110494|466622039|FG000|Overall Study|Dixon's test for outlier analysis|1|||
129635913|NCT06110494|466622040|FG001|Overall Study|Dixon's test for outlier analysis|1|||
129635914|NCT06110494|466622041|FG002|Overall Study|Dixon's test for outlier analysis|0|||
129635915|NCT03850496|466622057|FG000|Overall Study|Withdrawal by Subject|1|||
129635916|NCT03850496|466622058|FG001|Overall Study|Withdrawal by Subject|0|||
129635917|NCT03850496|466622059|FG002|Overall Study|Withdrawal by Subject|0|||
129635918|NCT03850496|466622057|FG000|Overall Study|Lost to Follow-up|0|||
129635919|NCT03850496|466622058|FG001|Overall Study|Lost to Follow-up|1|||
129635920|NCT03850496|466622059|FG002|Overall Study|Lost to Follow-up|4|||
129635921|NCT03674112|466622060|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
129635922|NCT03674112|466622061|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
129635923|NCT03674112|466622060|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
129635924|NCT03674112|466622061|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
129635925|NCT03674112|466622060|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
129635926|NCT03674112|466622061|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
129635927|NCT03674112|466622060|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
129635928|NCT03674112|466622061|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
129635929|NCT03674112|466622060|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
129635930|NCT03674112|466622061|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
129635931|NCT03674112|466622060|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
129635932|NCT03674112|466622061|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
129635933|NCT03674112|466622060|FG000|Follow-Up Period (≥3 Years)|Death|2|||
129704891|NCT00329420|466884085|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
129704892|NCT00329420|466884086|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
129704893|NCT02862574|466884087|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129704894|NCT02862574|466884088|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129704895|NCT02862574|466884089|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129704896|NCT02862574|466884087|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
129704897|NCT02862574|466884088|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
129704898|NCT02862574|466884089|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
129635934|NCT03674112|466622061|FG001|Follow-Up Period (≥3 Years)|Death|0|||
129635935|NCT03674112|466622060|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
129635936|NCT03674112|466622061|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
129635937|NCT02097238|466622065|FG000|Overall Study|Death|1|||
129635938|NCT02097238|466622065|FG000|Overall Study|Physician Decision|1|||
129635939|NCT02097238|466622065|FG000|Overall Study|Progressive Disease|17|||
129635940|NCT01106911|466622066|FG000|Overall Study|Physician Decision|2|||
129635941|NCT01106911|466622066|FG000|Overall Study|deemed ineligible after screening|3|||
129635942|NCT01814696|466622074|FG000|Overall Study|Withdrawal by Subject|1|||
129635943|NCT01814696|466622075|FG001|Overall Study|Withdrawal by Subject|0|||
129635944|NCT01814696|466622074|FG000|Overall Study|Randomized to wrong group|1|||
129704899|NCT02862574|466884087|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
129635945|NCT01814696|466622075|FG001|Overall Study|Randomized to wrong group|0|||
129635946|NCT00954941|466622076|FG000|Overall Study|Received treatment at home|1|||
129635947|NCT00954941|466622077|FG001|Overall Study|Received treatment at home|0|||
129635948|NCT00954941|466622076|FG000|Overall Study|Withdrawal by Subject|1|||
129635949|NCT00954941|466622077|FG001|Overall Study|Withdrawal by Subject|0|||
129635950|NCT00954941|466622076|FG000|Overall Study|Insurance Denial|2|||
129635951|NCT00954941|466622077|FG001|Overall Study|Insurance Denial|2|||
129635952|NCT00954941|466622076|FG000|Overall Study|Physician Decision|2|||
129635953|NCT00954941|466622077|FG001|Overall Study|Physician Decision|2|||
129635954|NCT00954941|466622076|FG000|Overall Study|Ineligible|2|||
129635955|NCT00954941|466622077|FG001|Overall Study|Ineligible|2|||
129635956|NCT00954941|466622076|FG000|Overall Study|Adverse Event|0|||
129635957|NCT00954941|466622077|FG001|Overall Study|Adverse Event|1|||
129704900|NCT02862574|466884088|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
129704901|NCT02862574|466884089|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
129704902|NCT03386773|466884090|FG000|Overall Study|Lost to Follow-up|24|||
129704903|NCT03386773|466884091|FG001|Overall Study|Lost to Follow-up|33|||
129704904|NCT03386773|466884090|FG000|Overall Study|Withdrawal by Subject|3|||
129704905|NCT03386773|466884091|FG001|Overall Study|Withdrawal by Subject|2|||
129704906|NCT03639610|466884092|FG000|Overall Study|Adverse Event|7|||
129704907|NCT03639610|466884093|FG001|Overall Study|Adverse Event|1|||
129704908|NCT03639610|466884094|FG002|Overall Study|Adverse Event|0|||
129704909|NCT03639610|466884092|FG000|Overall Study|Physician Decision|3|||
129704910|NCT03639610|466884093|FG001|Overall Study|Physician Decision|1|||
129889340|NCT03259373|467552563|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
129889341|NCT03259373|467552562|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
129635958|NCT00984542|466622094|FG000|Overall Study|disease progression|19|||
129635959|NCT00984542|466622094|FG000|Overall Study|toxicity|7|||
129635960|NCT00984542|466622094|FG000|Overall Study|Death|7|||
129635961|NCT00984542|466622094|FG000|Overall Study|complicating disease|3|||
129635962|NCT00984542|466622094|FG000|Overall Study|Withdrawal by Subject|3|||
129635963|NCT00984542|466622094|FG000|Overall Study|clinical deterioration|2|||
129635964|NCT01422889|466622095|FG000|Overall Study|No Data Entered for Study Stent|9|||
129635965|NCT00488644|466622100|FG000|Overall Study|Not Eligible|1|||
129635966|NCT00488644|466622100|FG000|Overall Study|Not Evaluable|1|||
129635967|NCT02977572|466622101|FG000|Overall Study|Exclusion criterion|2|||
129635968|NCT02977572|466622102|FG001|Overall Study|Exclusion criterion|2|||
129635969|NCT01197534|466622104|FG000|Overall Study|Not reported|16|||
129635970|NCT01197534|466622105|FG001|Overall Study|Not reported|10|||
129704911|NCT03639610|466884094|FG002|Overall Study|Physician Decision|0|||
129704912|NCT03639610|466884092|FG000|Overall Study|Disease progression|8|||
129704913|NCT03639610|466884093|FG001|Overall Study|Disease progression|5|||
129891097|NCT02408549|467559616|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
129635971|NCT01197534|466622106|FG002|Overall Study|Not reported|16|||
129635972|NCT01197534|466622104|FG000|Overall Study|Enrolment in long term extension|57|||
129635973|NCT01197534|466622105|FG001|Overall Study|Enrolment in long term extension|66|||
129635974|NCT01197534|466622106|FG002|Overall Study|Enrolment in long term extension|119|||
129635975|NCT01197534|466622104|FG000|Overall Study|Severe non-compliance to protocol|3|||
129635976|NCT01197534|466622105|FG001|Overall Study|Severe non-compliance to protocol|4|||
129635977|NCT01197534|466622106|FG002|Overall Study|Severe non-compliance to protocol|1|||
129635978|NCT01197534|466622104|FG000|Overall Study|Lack of therapeutic response|9|||
129635979|NCT01197534|466622105|FG001|Overall Study|Lack of therapeutic response|4|||
129635980|NCT01197534|466622106|FG002|Overall Study|Lack of therapeutic response|9|||
129635981|NCT01197534|466622104|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
129635982|NCT01197534|466622105|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
129635983|NCT01197534|466622106|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
129635984|NCT01197534|466622104|FG000|Overall Study|Lost to Follow-up|1|||
129635985|NCT01197534|466622105|FG001|Overall Study|Lost to Follow-up|4|||
129635986|NCT01197534|466622106|FG002|Overall Study|Lost to Follow-up|2|||
129635987|NCT01197534|466622104|FG000|Overall Study|Adverse Event|35|||
129635988|NCT01197534|466622105|FG001|Overall Study|Adverse Event|36|||
129635989|NCT01197534|466622106|FG002|Overall Study|Adverse Event|24|||
129635990|NCT02593097|466622119|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
129635991|NCT02593097|466622120|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
129635992|NCT02593097|466622119|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129635993|NCT02593097|466622120|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
129635994|NCT02593097|466622119|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
129635995|NCT02593097|466622120|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
129635996|NCT02593097|466622119|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
129635997|NCT02593097|466622120|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
129635998|NCT02593097|466622119|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
129635999|NCT02593097|466622120|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
129636000|NCT02522884|466622121|FG000|Overall Study|Withdrawal by Subject|6|||
129636001|NCT02522884|466622121|FG000|Overall Study|Death|3|||
129636002|NCT02522884|466622121|FG000|Overall Study|Missed 12-month Follow-up|9|||
129636003|NCT02630251|466622122|FG000|Overall Study|Physician Decision|0|||
129636004|NCT02630251|466622123|FG001|Overall Study|Physician Decision|0|||
129636005|NCT02630251|466622124|FG002|Overall Study|Physician Decision|1|||
129636006|NCT02630251|466622125|FG003|Overall Study|Physician Decision|0|||
129636007|NCT01863667|466622126|FG000|Overall Study|Adverse Event|1|||
129636008|NCT01863667|466622127|FG001|Overall Study|Adverse Event|0|||
129636009|NCT01863667|466622126|FG000|Overall Study|Study terminated by Sponsor|30|||
129636010|NCT01863667|466622127|FG001|Overall Study|Study terminated by Sponsor|30|||
129636011|NCT01863667|466622126|FG000|Overall Study|Withdrawal by Subject|2|||
129636012|NCT01863667|466622127|FG001|Overall Study|Withdrawal by Subject|2|||
129636013|NCT03627546|466622128|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
129636014|NCT03627546|466622129|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
129636015|NCT03627546|466622130|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
129636016|NCT03627546|466622128|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
129636017|NCT03627546|466622129|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
129636018|NCT03627546|466622130|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
129636019|NCT00615550|466622133|FG000|Overall Study|Lost to Follow-up|6|||
129636020|NCT00615550|466622134|FG001|Overall Study|Lost to Follow-up|1|||
129636021|NCT02640664|466622135|FG000|Epoch 1|Withdrawal of informed consent|1|||
129636022|NCT02640664|466622136|FG001|Epoch 1|Withdrawal of informed consent|0|||
129636023|NCT02640664|466622137|FG002|Epoch 1|Withdrawal of informed consent|0|||
129636024|NCT02640664|466622135|FG000|Epoch 1|Death|0|||
129636025|NCT02640664|466622136|FG001|Epoch 1|Death|0|||
129636026|NCT02640664|466622137|FG002|Epoch 1|Death|1|||
129636027|NCT02640664|466622135|FG000|Epoch 2|Withdrawal of informed consent|3|||
129636028|NCT02640664|466622136|FG001|Epoch 2|Withdrawal of informed consent|4|||
129636029|NCT02640664|466622137|FG002|Epoch 2|Withdrawal of informed consent|2|||
129636030|NCT02640664|466622135|FG000|Epoch 2|Subject/guardian decision|0|||
129636031|NCT02640664|466622136|FG001|Epoch 2|Subject/guardian decision|2|||
129636032|NCT02640664|466622137|FG002|Epoch 2|Subject/guardian decision|2|||
129636033|NCT02640664|466622135|FG000|Epoch 2|Lost to Follow-up|3|||
129636034|NCT02640664|466622136|FG001|Epoch 2|Lost to Follow-up|4|||
129636035|NCT02640664|466622137|FG002|Epoch 2|Lost to Follow-up|1|||
129636036|NCT02640664|466622135|FG000|Epoch 2|Death|0|||
129636037|NCT02640664|466622136|FG001|Epoch 2|Death|0|||
129636038|NCT02640664|466622137|FG002|Epoch 2|Death|1|||
129636039|NCT02965573|466622138|FG000|Overall Study|Lack of Efficacy|1|||
129636040|NCT02965573|466622139|FG001|Overall Study|Lack of Efficacy|0|||
129636041|NCT00315458|466622141|FG000|Overall Study|Administrative|0|||
129636042|NCT00315458|466622142|FG001|Overall Study|Administrative|3|||
129704914|NCT03639610|466884094|FG002|Overall Study|Disease progression|3|||
129704915|NCT03639610|466884092|FG000|Overall Study|Study terminated by sponsor|2|||
129704916|NCT03639610|466884093|FG001|Overall Study|Study terminated by sponsor|1|||
129636043|NCT00315458|466622143|FG002|Overall Study|Administrative|8|||
129636044|NCT00315458|466622144|FG003|Overall Study|Administrative|21|||
129636045|NCT00315458|466622141|FG000|Overall Study|Adverse Event|2|||
129636046|NCT00315458|466622142|FG001|Overall Study|Adverse Event|4|||
129636047|NCT00315458|466622143|FG002|Overall Study|Adverse Event|23|||
129636048|NCT00315458|466622144|FG003|Overall Study|Adverse Event|3|||
129636049|NCT00315458|466622141|FG000|Overall Study|Lost to Follow-up|1|||
129636050|NCT00315458|466622142|FG001|Overall Study|Lost to Follow-up|2|||
129636051|NCT00315458|466622143|FG002|Overall Study|Lost to Follow-up|0|||
129440572|NCT01193920|465911471|FG005|Overall Study|Unable to classify|0|||
129440573|NCT01193920|465911472|FG006|Overall Study|Unable to classify|0|||
129440574|NCT01193920|465911473|FG007|Overall Study|Unable to classify|1|||
129636052|NCT00315458|466622144|FG003|Overall Study|Lost to Follow-up|2|||
129636053|NCT00315458|466622141|FG000|Overall Study|Withdrawal by Subject|0|||
129636054|NCT00315458|466622142|FG001|Overall Study|Withdrawal by Subject|3|||
129636055|NCT00315458|466622143|FG002|Overall Study|Withdrawal by Subject|0|||
129636056|NCT00315458|466622144|FG003|Overall Study|Withdrawal by Subject|2|||
129636057|NCT00315458|466622141|FG000|Overall Study|Lack of Efficacy|0|||
129636058|NCT00315458|466622142|FG001|Overall Study|Lack of Efficacy|0|||
129636059|NCT00315458|466622143|FG002|Overall Study|Lack of Efficacy|20|||
129636060|NCT00315458|466622144|FG003|Overall Study|Lack of Efficacy|1|||
129636061|NCT00315458|466622141|FG000|Overall Study|Did not qualify|0|||
129636062|NCT00315458|466622142|FG001|Overall Study|Did not qualify|0|||
129636063|NCT00315458|466622143|FG002|Overall Study|Did not qualify|1|||
129636064|NCT00315458|466622144|FG003|Overall Study|Did not qualify|0|||
129636065|NCT00987337|466622145|FG000|Overall Study|Adverse Event|10|||
129636066|NCT00987337|466622146|FG001|Overall Study|Adverse Event|9|||
129636067|NCT00987337|466622147|FG002|Overall Study|Adverse Event|8|||
129636068|NCT00987337|466622145|FG000|Overall Study|Insufficient Virologic Response|10|||
129636069|NCT00987337|466622146|FG001|Overall Study|Insufficient Virologic Response|7|||
129636070|NCT00987337|466622147|FG002|Overall Study|Insufficient Virologic Response|12|||
129636071|NCT00987337|466622145|FG000|Overall Study|Virologic Breakthrough|2|||
129636072|NCT00987337|466622146|FG001|Overall Study|Virologic Breakthrough|2|||
129636073|NCT00987337|466622147|FG002|Overall Study|Virologic Breakthrough|8|||
129636074|NCT00987337|466622145|FG000|Overall Study|Lost to Follow-up|10|||
129636075|NCT00987337|466622146|FG001|Overall Study|Lost to Follow-up|6|||
129636076|NCT00987337|466622147|FG002|Overall Study|Lost to Follow-up|2|||
129636077|NCT00987337|466622145|FG000|Overall Study|Withdrawal by Subject|6|||
129636078|NCT00987337|466622146|FG001|Overall Study|Withdrawal by Subject|9|||
129636079|NCT00987337|466622147|FG002|Overall Study|Withdrawal by Subject|9|||
129636080|NCT00987337|466622145|FG000|Overall Study|Other|0|||
129636081|NCT00987337|466622146|FG001|Overall Study|Other|2|||
129636082|NCT00987337|466622147|FG002|Overall Study|Other|5|||
129636083|NCT00987337|466622145|FG000|Overall Study|Protocol Violation|1|||
129636084|NCT00987337|466622146|FG001|Overall Study|Protocol Violation|0|||
129636085|NCT00987337|466622147|FG002|Overall Study|Protocol Violation|2|||
129636086|NCT00987337|466622145|FG000|Overall Study|Participant Relapsed|18|||
129636087|NCT00987337|466622146|FG001|Overall Study|Participant Relapsed|20|||
129636088|NCT00987337|466622147|FG002|Overall Study|Participant Relapsed|5|||
129636089|NCT00086619|466622150|FG000|Overall Study|Withdrawal by Subject|6|||
129636090|NCT00086619|466622151|FG001|Overall Study|Withdrawal by Subject|6|||
129636091|NCT00086619|466622150|FG000|Overall Study|Adverse Event|8|||
129636092|NCT00086619|466622151|FG001|Overall Study|Adverse Event|10|||
129636093|NCT00086619|466622150|FG000|Overall Study|Protocol Violation|1|||
129636094|NCT00086619|466622151|FG001|Overall Study|Protocol Violation|1|||
129636095|NCT00489918|466622152|FG000|Overall Study|Withdrawal by Subject|2|||
129636096|NCT00489918|466622153|FG001|Overall Study|Withdrawal by Subject|1|||
129636097|NCT00489918|466622154|FG002|Overall Study|Withdrawal by Subject|1|||
129636098|NCT00489918|466622155|FG003|Overall Study|Withdrawal by Subject|0|||
129636099|NCT00489918|466622156|FG004|Overall Study|Withdrawal by Subject|1|||
129636100|NCT00489918|466622152|FG000|Overall Study|Adverse Event|0|||
129636101|NCT00489918|466622153|FG001|Overall Study|Adverse Event|1|||
129636102|NCT00489918|466622154|FG002|Overall Study|Adverse Event|1|||
129636103|NCT00489918|466622155|FG003|Overall Study|Adverse Event|0|||
129636104|NCT00489918|466622156|FG004|Overall Study|Adverse Event|0|||
129636105|NCT00489918|466622152|FG000|Overall Study|Lost to Follow-up|0|||
129636106|NCT00489918|466622153|FG001|Overall Study|Lost to Follow-up|0|||
129636107|NCT00489918|466622154|FG002|Overall Study|Lost to Follow-up|1|||
129636108|NCT00489918|466622155|FG003|Overall Study|Lost to Follow-up|1|||
129636109|NCT00489918|466622156|FG004|Overall Study|Lost to Follow-up|0|||
129636110|NCT00489918|466622152|FG000|Overall Study|Physician Decision|0|||
129636111|NCT00489918|466622153|FG001|Overall Study|Physician Decision|0|||
129636112|NCT00489918|466622154|FG002|Overall Study|Physician Decision|1|||
129636113|NCT00489918|466622155|FG003|Overall Study|Physician Decision|0|||
129636114|NCT00489918|466622156|FG004|Overall Study|Physician Decision|0|||
129636115|NCT02748213|466622157|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
129636116|NCT02748213|466622158|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
129636117|NCT02748213|466622157|FG000|Overall Study|Abnormal Laboratory Test|1|||
129636118|NCT02748213|466622158|FG001|Overall Study|Abnormal Laboratory Test|0|||
129636119|NCT02748213|466622157|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
129636120|NCT02748213|466622158|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
129440575|NCT01193920|465911474|FG008|Overall Study|Unable to classify|0|||
129636121|NCT02748213|466622157|FG000|Overall Study|Death|5|||
129636122|NCT02748213|466622158|FG001|Overall Study|Death|3|||
129636123|NCT02748213|466622157|FG000|Overall Study|Insufficient Therapeutic Response|56|||
129636124|NCT02748213|466622158|FG001|Overall Study|Insufficient Therapeutic Response|57|||
129440576|NCT01193920|465911475|FG009|Overall Study|Unable to classify|0|||
129636125|NCT02748213|466622157|FG000|Overall Study|Violation of Selection Criteria|2|||
129636126|NCT02748213|466622158|FG001|Overall Study|Violation of Selection Criteria|0|||
129636127|NCT02748213|466622157|FG000|Overall Study|Protocol Violation|6|||
129636128|NCT02748213|466622158|FG001|Overall Study|Protocol Violation|4|||
129636129|NCT02748213|466622157|FG000|Overall Study|Refused Treatment*|6|||
129636130|NCT02748213|466622158|FG001|Overall Study|Refused Treatment*|6|||
129636131|NCT02748213|466622157|FG000|Overall Study|Failure to Return|1|||
129636132|NCT02748213|466622158|FG001|Overall Study|Failure to Return|0|||
129636133|NCT02748213|466622157|FG000|Overall Study|Other|30|||
129636134|NCT02748213|466622158|FG001|Overall Study|Other|29|||
129636135|NCT01209520|466622160|FG000|Overall Study|Withdrawal by Subject|3|||
129636136|NCT00961350|466622161|FG000|Overall Study|Adverse Event|18|||
129636137|NCT00961350|466622162|FG001|Overall Study|Adverse Event|33|||
129636138|NCT00961350|466622161|FG000|Overall Study|Withdrawal by Subject|10|||
129636139|NCT00961350|466622162|FG001|Overall Study|Withdrawal by Subject|10|||
129636140|NCT00961350|466622161|FG000|Overall Study|Lost to Follow-up|3|||
129636141|NCT00961350|466622162|FG001|Overall Study|Lost to Follow-up|3|||
129636142|NCT00961350|466622161|FG000|Overall Study|Misc|16|||
129636143|NCT00961350|466622162|FG001|Overall Study|Misc|21|||
129636144|NCT00550745|466622163|FG000|Overall Study|Death|20|||
129636145|NCT00550745|466622164|FG001|Overall Study|Death|16|||
129636146|NCT00550745|466622163|FG000|Overall Study|Lost to Follow-up|45|||
129636147|NCT00550745|466622164|FG001|Overall Study|Lost to Follow-up|30|||
129636148|NCT00550745|466622163|FG000|Overall Study|Physician Decision|0|||
129636149|NCT00550745|466622164|FG001|Overall Study|Physician Decision|2|||
129636150|NCT00550745|466622163|FG000|Overall Study|Protocol Violation|4|||
129636151|NCT00550745|466622164|FG001|Overall Study|Protocol Violation|2|||
129636152|NCT00550745|466622163|FG000|Overall Study|Withdrawal by Subject|17|||
129636153|NCT00550745|466622164|FG001|Overall Study|Withdrawal by Subject|10|||
129636154|NCT00550745|466622163|FG000|Overall Study|Screen failure|1|||
129636155|NCT00550745|466622164|FG001|Overall Study|Screen failure|0|||
129636156|NCT00617890|466624114|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
129636157|NCT00617890|466624115|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
129636158|NCT00617890|466624116|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
129636159|NCT00617890|466624117|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
129636160|NCT00617890|466624114|FG000|Overall Study|Lack of Efficacy|23|||
129636161|NCT00617890|466624115|FG001|Overall Study|Lack of Efficacy|26|||
129636162|NCT00617890|466624116|FG002|Overall Study|Lack of Efficacy|30|||
129636163|NCT00617890|466624117|FG003|Overall Study|Lack of Efficacy|97|||
129636164|NCT00617890|466624114|FG000|Overall Study|Lost to Follow-up|0|||
129636165|NCT00617890|466624115|FG001|Overall Study|Lost to Follow-up|0|||
129636166|NCT00617890|466624116|FG002|Overall Study|Lost to Follow-up|1|||
129636167|NCT00617890|466624117|FG003|Overall Study|Lost to Follow-up|2|||
129636168|NCT00617890|466624114|FG000|Overall Study|Withdrawal by Subject|4|||
129636169|NCT00617890|466624115|FG001|Overall Study|Withdrawal by Subject|1|||
129636170|NCT00617890|466624116|FG002|Overall Study|Withdrawal by Subject|0|||
129636171|NCT00617890|466624117|FG003|Overall Study|Withdrawal by Subject|2|||
129636172|NCT00617890|466624114|FG000|Overall Study|Protocol Violation|2|||
129636173|NCT00617890|466624115|FG001|Overall Study|Protocol Violation|1|||
129636174|NCT00617890|466624116|FG002|Overall Study|Protocol Violation|0|||
129636175|NCT00617890|466624117|FG003|Overall Study|Protocol Violation|0|||
129636176|NCT00617890|466624114|FG000|Overall Study|Adverse Event|1|||
129636177|NCT00617890|466624115|FG001|Overall Study|Adverse Event|0|||
129636178|NCT00617890|466624116|FG002|Overall Study|Adverse Event|3|||
129636179|NCT00617890|466624117|FG003|Overall Study|Adverse Event|8|||
129636180|NCT00617890|466624114|FG000|Overall Study|Not treated|1|||
129636181|NCT00617890|466624115|FG001|Overall Study|Not treated|0|||
129636182|NCT00617890|466624116|FG002|Overall Study|Not treated|1|||
129636183|NCT00617890|466624117|FG003|Overall Study|Not treated|1|||
129636184|NCT02640950|466624119|FG000|Overall Study|Adverse Event|1|||
129636185|NCT02640950|466624119|FG000|Overall Study|Withdrawal by Subject|1|||
129636186|NCT00154284|466624120|FG000|Overall Study|Adverse Event|6|||
129636187|NCT00154284|466624121|FG001|Overall Study|Adverse Event|9|||
129636188|NCT00154284|466624120|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129636189|NCT00154284|466624121|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129636190|NCT00154284|466624120|FG000|Overall Study|Lack of Efficacy|1|||
129636191|NCT00154284|466624121|FG001|Overall Study|Lack of Efficacy|2|||
129636192|NCT00154284|466624120|FG000|Overall Study|Protocol Violation|0|||
129636193|NCT00154284|466624121|FG001|Overall Study|Protocol Violation|1|||
129636194|NCT00566020|466624122|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
129636195|NCT00566020|466624123|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
129636196|NCT00566020|466624122|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
129636197|NCT00566020|466624123|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
129636198|NCT00566020|466624122|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
129636199|NCT00566020|466624123|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
129636200|NCT00566020|466624122|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
129636201|NCT00566020|466624123|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
129704917|NCT03639610|466884094|FG002|Overall Study|Study terminated by sponsor|1|||
129636202|NCT00566020|466624122|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
129636203|NCT00566020|466624123|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
129636204|NCT00566020|466624122|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
129636205|NCT00566020|466624123|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
129636206|NCT02582242|466624124|FG000|Overall Study|Adverse Event|4|||
129636207|NCT02582242|466624125|FG001|Overall Study|Adverse Event|3|||
129636208|NCT02582242|466624124|FG000|Overall Study|Protocol Violation|3|||
129636209|NCT02582242|466624125|FG001|Overall Study|Protocol Violation|1|||
129636210|NCT02582242|466624124|FG000|Overall Study|Lost to Follow-up|0|||
129636211|NCT02582242|466624125|FG001|Overall Study|Lost to Follow-up|1|||
129636212|NCT02582242|466624124|FG000|Overall Study|Withdrawal by Subject|11|||
129636213|NCT02582242|466624125|FG001|Overall Study|Withdrawal by Subject|11|||
129636214|NCT02582242|466624124|FG000|Overall Study|Unclassified|2|||
129636215|NCT02582242|466624125|FG001|Overall Study|Unclassified|1|||
129636216|NCT02101736|466624126|FG000|Overall Study|Protocol Violation|3|||
129636217|NCT02101736|466624127|FG001|Overall Study|Protocol Violation|0|||
129636218|NCT02101736|466624126|FG000|Overall Study|Withdrawal by Subject|1|||
129636219|NCT02101736|466624127|FG001|Overall Study|Withdrawal by Subject|1|||
129636220|NCT00459290|466624128|FG000|Overall Study|Adverse Event|3|||
129636221|NCT00459290|466624128|FG000|Overall Study|Ineligible|2|||
129636222|NCT02176655|466624136|FG000|Overall Study|Subjects did not treat|6|||
129636223|NCT01464593|466624139|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
129636224|NCT02476578|466624146|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
129636225|NCT02476578|466624147|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
129636226|NCT02476578|466624146|FG000|Overall Study|Lost to Follow-up|6|||
129636227|NCT02476578|466624147|FG001|Overall Study|Lost to Follow-up|13|||
129636228|NCT04938180|466624148|FG000|Overall Study|Adverse Event|1|||
129636229|NCT01019694|466624149|FG000|Overall Study|Adverse Event|12|||
129636230|NCT01019694|466624150|FG001|Overall Study|Adverse Event|16|||
129636231|NCT01019694|466624151|FG002|Overall Study|Adverse Event|19|||
129636232|NCT01019694|466624149|FG000|Overall Study|Protocol Violation|2|||
129636233|NCT01019694|466624150|FG001|Overall Study|Protocol Violation|6|||
129636234|NCT01019694|466624151|FG002|Overall Study|Protocol Violation|4|||
129636235|NCT01019694|466624149|FG000|Overall Study|Lost to Follow-up|5|||
129636236|NCT01019694|466624150|FG001|Overall Study|Lost to Follow-up|3|||
129636237|NCT01019694|466624151|FG002|Overall Study|Lost to Follow-up|3|||
129636238|NCT01019694|466624149|FG000|Overall Study|Withdrawal by Subject|4|||
129636239|NCT01019694|466624150|FG001|Overall Study|Withdrawal by Subject|6|||
129636240|NCT01019694|466624151|FG002|Overall Study|Withdrawal by Subject|12|||
129636241|NCT01019694|466624149|FG000|Overall Study|Not treated|0|||
129636242|NCT01019694|466624150|FG001|Overall Study|Not treated|2|||
129636243|NCT01019694|466624151|FG002|Overall Study|Not treated|3|||
129636244|NCT01019694|466624149|FG000|Overall Study|Other reason (not specified)|1|||
129636245|NCT01019694|466624150|FG001|Overall Study|Other reason (not specified)|5|||
129636246|NCT01019694|466624151|FG002|Overall Study|Other reason (not specified)|6|||
129636247|NCT00026494|466624158|FG000|Overall Study|Withdrawal by Subject|1|||
129636248|NCT00026494|466624159|FG001|Overall Study|Withdrawal by Subject|0|||
129636249|NCT00026494|466624160|FG002|Overall Study|Withdrawal by Subject|1|||
129636250|NCT00026494|466624161|FG003|Overall Study|Withdrawal by Subject|0|||
129636251|NCT00026494|466624158|FG000|Overall Study|Patient non-compliance|1|||
129636252|NCT00026494|466624159|FG001|Overall Study|Patient non-compliance|0|||
129636253|NCT00026494|466624160|FG002|Overall Study|Patient non-compliance|0|||
129636254|NCT00026494|466624161|FG003|Overall Study|Patient non-compliance|0|||
129636255|NCT00026494|466624158|FG000|Overall Study|Patient not treated|0|||
129636256|NCT00026494|466624159|FG001|Overall Study|Patient not treated|0|||
129636257|NCT00026494|466624160|FG002|Overall Study|Patient not treated|2|||
129636258|NCT00026494|466624161|FG003|Overall Study|Patient not treated|0|||
129636259|NCT00026494|466624158|FG000|Overall Study|Clinical progression|0|||
129636260|NCT00026494|466624159|FG001|Overall Study|Clinical progression|0|||
129636261|NCT00026494|466624160|FG002|Overall Study|Clinical progression|3|||
129636262|NCT00026494|466624161|FG003|Overall Study|Clinical progression|0|||
129636263|NCT01684423|466624162|FG000|Overall Study|Withdrawal by Subject|0|||
129636264|NCT01684423|466624163|FG001|Overall Study|Withdrawal by Subject|0|||
129636265|NCT01684423|466624164|FG002|Overall Study|Withdrawal by Subject|1|||
129636266|NCT01684423|466624165|FG003|Overall Study|Withdrawal by Subject|0|||
129636267|NCT01684423|466624166|FG004|Overall Study|Withdrawal by Subject|0|||
129636268|NCT01455597|466624167|FG000|Overall Study|Adverse Event|7|||
129636269|NCT01455597|466624168|FG001|Overall Study|Adverse Event|0|||
129636270|NCT01455597|466624169|FG002|Overall Study|Adverse Event|5|||
129636271|NCT01455597|466624170|FG003|Overall Study|Adverse Event|1|||
129636272|NCT01455597|466624167|FG000|Overall Study|Lack of Efficacy|0|||
129636273|NCT01455597|466624168|FG001|Overall Study|Lack of Efficacy|1|||
129636274|NCT01455597|466624169|FG002|Overall Study|Lack of Efficacy|2|||
129636275|NCT01455597|466624170|FG003|Overall Study|Lack of Efficacy|0|||
129636276|NCT01455597|466624167|FG000|Overall Study|Lost to Follow-up|3|||
129636277|NCT01455597|466624168|FG001|Overall Study|Lost to Follow-up|0|||
129636278|NCT01455597|466624169|FG002|Overall Study|Lost to Follow-up|2|||
129636279|NCT01455597|466624170|FG003|Overall Study|Lost to Follow-up|1|||
129636280|NCT01455597|466624167|FG000|Overall Study|Withdrew Consent|6|||
129636281|NCT01455597|466624168|FG001|Overall Study|Withdrew Consent|5|||
129636282|NCT01455597|466624169|FG002|Overall Study|Withdrew Consent|8|||
129636283|NCT01455597|466624170|FG003|Overall Study|Withdrew Consent|5|||
129636284|NCT01455597|466624167|FG000|Overall Study|Reason not Specified|1|||
129889342|NCT03259373|467552563|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
129636285|NCT01455597|466624168|FG001|Overall Study|Reason not Specified|2|||
129636286|NCT01455597|466624169|FG002|Overall Study|Reason not Specified|3|||
129636287|NCT01455597|466624170|FG003|Overall Study|Reason not Specified|3|||
129636288|NCT00441129|466624171|FG000|Overall Study|Withdrawal by Subject|6|||
129636289|NCT00441129|466624172|FG001|Overall Study|Withdrawal by Subject|14|||
129636290|NCT03412734|466624175|FG000|Overall Study|Incorrect labeling of samples|2|||
129636291|NCT03412734|466624176|FG001|Overall Study|Incorrect labeling of samples|0|||
129636292|NCT03412734|466624175|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
129636293|NCT03412734|466624176|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
129636294|NCT04747886|466624177|FG000|Overall Study|Withdrawal by Subject|1|||
129636295|NCT04747886|466624178|FG001|Overall Study|Withdrawal by Subject|4|||
129636296|NCT03777436|466624183|FG000|Placebo-controlled Phase|Adverse Event|8|||
129636297|NCT03777436|466624184|FG001|Placebo-controlled Phase|Adverse Event|10|||
129636298|NCT03777436|466624185|FG002|Placebo-controlled Phase|Adverse Event|0|||
129636299|NCT03777436|466624183|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
129636300|NCT03777436|466624184|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
129636301|NCT03777436|466624185|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
129636302|NCT03777436|466624183|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
129636303|NCT03777436|466624184|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
129636304|NCT03777436|466624185|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
129636305|NCT03777436|466624183|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
129636306|NCT03777436|466624184|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
129636307|NCT03777436|466624185|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
129636308|NCT03777436|466624183|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
129636309|NCT03777436|466624184|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
129636310|NCT03777436|466624185|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
129636311|NCT03777436|466624183|FG000|Placebo-controlled Phase|Physician Decision|0|||
129636312|NCT03777436|466624184|FG001|Placebo-controlled Phase|Physician Decision|1|||
129636313|NCT03777436|466624185|FG002|Placebo-controlled Phase|Physician Decision|0|||
129636314|NCT03777436|466624183|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
129636315|NCT03777436|466624184|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
129636316|NCT03777436|466624185|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
129636317|NCT03777436|466624183|FG000|Apremilast Extension Phase|Adverse Event|0|||
129636318|NCT03777436|466624184|FG001|Apremilast Extension Phase|Adverse Event|0|||
129636319|NCT03777436|466624185|FG002|Apremilast Extension Phase|Adverse Event|6|||
129636320|NCT03777436|466624183|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
129636321|NCT03777436|466624184|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
129636322|NCT03777436|466624185|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
129636323|NCT03777436|466624183|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
129636324|NCT03777436|466624184|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
129636325|NCT03777436|466624185|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
129636326|NCT03777436|466624183|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
129636327|NCT03777436|466624184|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
129636328|NCT03777436|466624185|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
129636329|NCT03777436|466624183|FG000|Apremilast Extension Phase|Miscellaneous|0|||
129636330|NCT03777436|466624184|FG001|Apremilast Extension Phase|Miscellaneous|0|||
129636331|NCT03777436|466624185|FG002|Apremilast Extension Phase|Miscellaneous|1|||
129636332|NCT00869999|466624190|FG000|Overall Study|Withdrawal by Subject|1|||
129636333|NCT00869999|466624190|FG000|Overall Study|removed prior to starting therapy|1|||
129636334|NCT04478695|466624191|FG000|Overall Study|Death|1|||
129636335|NCT04478695|466624192|FG001|Overall Study|Death|0|||
129636336|NCT00644917|466624193|FG000|Overall Study|Withdrawal by Subject|2|||
129891098|NCT02408549|467559616|FG000|Overall Study|Subject moved to another place, far from site|1|||
129636337|NCT01136356|466624194|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
129636338|NCT01136356|466624195|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
129636339|NCT01136356|466624194|FG000|First 18-day Withdrawal|Physician Decision|1|||
129636340|NCT01136356|466624195|FG001|First 18-day Withdrawal|Physician Decision|0|||
129636341|NCT01136356|466624194|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
129636342|NCT01136356|466624195|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
129636343|NCT00402688|466624196|FG000|Overall Study|Adverse Event|12|||
129636344|NCT00402688|466624197|FG001|Overall Study|Adverse Event|9|||
129636345|NCT00402688|466624198|FG002|Overall Study|Adverse Event|3|||
129636346|NCT00402688|466624196|FG000|Overall Study|Withdrawal by Subject|3|||
129636347|NCT00402688|466624197|FG001|Overall Study|Withdrawal by Subject|1|||
129636348|NCT00402688|466624198|FG002|Overall Study|Withdrawal by Subject|1|||
129636349|NCT00402688|466624196|FG000|Overall Study|Physician Decision|0|||
129636350|NCT00402688|466624197|FG001|Overall Study|Physician Decision|0|||
129636351|NCT00402688|466624198|FG002|Overall Study|Physician Decision|1|||
129636352|NCT00402688|466624196|FG000|Overall Study|Lack of Efficacy|4|||
129636353|NCT00402688|466624197|FG001|Overall Study|Lack of Efficacy|4|||
129636354|NCT00402688|466624198|FG002|Overall Study|Lack of Efficacy|5|||
129636355|NCT00402688|466624196|FG000|Overall Study|Protocol Violation|1|||
129636356|NCT00402688|466624197|FG001|Overall Study|Protocol Violation|1|||
129636357|NCT00402688|466624198|FG002|Overall Study|Protocol Violation|1|||
129636358|NCT00402688|466624196|FG000|Overall Study|Lost to Follow-up|1|||
129636359|NCT00402688|466624197|FG001|Overall Study|Lost to Follow-up|0|||
129636360|NCT00402688|466624198|FG002|Overall Study|Lost to Follow-up|2|||
129636361|NCT00402688|466624196|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
129636362|NCT00402688|466624197|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
129636363|NCT00402688|466624198|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
129636364|NCT00402688|466624196|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
129636365|NCT00402688|466624197|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
129636366|NCT00402688|466624198|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
129636367|NCT00402688|466624196|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
129636368|NCT00402688|466624197|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
129440577|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
129440578|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
129636369|NCT00402688|466624198|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
129636370|NCT00758485|466624199|FG000|Overall Study|Lost to Follow-up|0|||
129636371|NCT00758485|466624200|FG001|Overall Study|Lost to Follow-up|1|||
129636372|NCT00758485|466624199|FG000|Overall Study|Not Treated|1|||
129636373|NCT00758485|466624200|FG001|Overall Study|Not Treated|2|||
129636374|NCT02347774|466624201|FG000|Study Participation|Lost to Follow-up|3|||
129636375|NCT02347774|466624202|FG001|Study Participation|Lost to Follow-up|6|||
129636376|NCT02347774|466624203|FG002|Study Participation|Lost to Follow-up|2|||
129636377|NCT02347774|466624201|FG000|Study Participation|Withdrawal by Subject|8|||
129636378|NCT02347774|466624202|FG001|Study Participation|Withdrawal by Subject|9|||
129636379|NCT02347774|466624203|FG002|Study Participation|Withdrawal by Subject|15|||
129636380|NCT02347774|466624201|FG000|Study Participation|Adverse Event|1|||
129636381|NCT02347774|466624202|FG001|Study Participation|Adverse Event|4|||
129636382|NCT02347774|466624203|FG002|Study Participation|Adverse Event|6|||
129636383|NCT02347774|466624201|FG000|Study Participation|withdrew consent|1|||
129636384|NCT02347774|466624202|FG001|Study Participation|withdrew consent|1|||
129636385|NCT02347774|466624203|FG002|Study Participation|withdrew consent|1|||
129636386|NCT02347774|466624201|FG000|Study Participation|Met Prolonged QT criteria|1|||
129636387|NCT02347774|466624202|FG001|Study Participation|Met Prolonged QT criteria|0|||
129636388|NCT02347774|466624203|FG002|Study Participation|Met Prolonged QT criteria|0|||
129636389|NCT02347774|466624201|FG000|Study Participation|non-compliance with study drug|0|||
129636390|NCT02347774|466624202|FG001|Study Participation|non-compliance with study drug|1|||
129636391|NCT02347774|466624203|FG002|Study Participation|non-compliance with study drug|0|||
129636392|NCT02347774|466624201|FG000|Study Participation|incarceration|1|||
129636393|NCT02347774|466624202|FG001|Study Participation|incarceration|0|||
129636394|NCT02347774|466624203|FG002|Study Participation|incarceration|0|||
129636395|NCT02347774|466624201|FG000|Study Participation|randomized in error|0|||
129636396|NCT02347774|466624202|FG001|Study Participation|randomized in error|0|||
129636397|NCT02347774|466624203|FG002|Study Participation|randomized in error|1|||
129636398|NCT02347774|466624201|FG000|On Study Treatment|Adverse Event|9|||
129636399|NCT02347774|466624202|FG001|On Study Treatment|Adverse Event|15|||
129636400|NCT02347774|466624203|FG002|On Study Treatment|Adverse Event|19|||
129636401|NCT02347774|466624201|FG000|On Study Treatment|Lack of Efficacy|3|||
129704918|NCT03639610|466884092|FG000|Overall Study|Patient request to stop treatment|1|||
129704919|NCT03639610|466884093|FG001|Overall Study|Patient request to stop treatment|2|||
129636402|NCT02347774|466624202|FG001|On Study Treatment|Lack of Efficacy|0|||
129636403|NCT02347774|466624203|FG002|On Study Treatment|Lack of Efficacy|2|||
129636404|NCT02347774|466624201|FG000|On Study Treatment|non-complicance with study medication|0|||
129636405|NCT02347774|466624202|FG001|On Study Treatment|non-complicance with study medication|2|||
129636406|NCT02347774|466624203|FG002|On Study Treatment|non-complicance with study medication|0|||
129636407|NCT02347774|466624201|FG000|On Study Treatment|Protocol Violation|0|||
129636408|NCT02347774|466624202|FG001|On Study Treatment|Protocol Violation|0|||
129704920|NCT03639610|466884094|FG002|Overall Study|Patient request to stop treatment|0|||
129636409|NCT02347774|466624203|FG002|On Study Treatment|Protocol Violation|1|||
129636410|NCT02347774|466624201|FG000|On Study Treatment|withdrew consent|9|||
129636411|NCT02347774|466624202|FG001|On Study Treatment|withdrew consent|8|||
129636412|NCT02347774|466624203|FG002|On Study Treatment|withdrew consent|12|||
129636413|NCT02347774|466624201|FG000|On Study Treatment|Lost to Follow-up|2|||
129636414|NCT02347774|466624202|FG001|On Study Treatment|Lost to Follow-up|6|||
129636415|NCT02347774|466624203|FG002|On Study Treatment|Lost to Follow-up|1|||
129636416|NCT02347774|466624201|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
129636417|NCT02347774|466624202|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
129636418|NCT02347774|466624203|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
129636419|NCT02347774|466624201|FG000|On Study Treatment|ranomized in error|0|||
129636420|NCT02347774|466624202|FG001|On Study Treatment|ranomized in error|0|||
129636421|NCT02347774|466624203|FG002|On Study Treatment|ranomized in error|1|||
129636422|NCT00656292|466624204|FG000|Overall Study|Withdrawal by Subject|2|||
129636423|NCT00656292|466624205|FG001|Overall Study|Withdrawal by Subject|3|||
129636424|NCT00656292|466624204|FG000|Overall Study|Screen failure|1|||
129636425|NCT00656292|466624205|FG001|Overall Study|Screen failure|2|||
129636426|NCT00921557|466624206|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
129636427|NCT00921557|466624207|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
129636428|NCT00921557|466624208|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
129636429|NCT00921557|466624206|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
129636430|NCT00921557|466624207|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
129636431|NCT00921557|466624208|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
129636432|NCT00921557|466624206|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
129636433|NCT00921557|466624207|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
129636434|NCT00921557|466624208|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
129636435|NCT00921557|466624206|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
129636436|NCT00921557|466624207|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
129636437|NCT00921557|466624208|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
129636438|NCT00921557|466624206|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
129636439|NCT00921557|466624207|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
129636440|NCT00921557|466624208|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
129636441|NCT04112043|466624209|FG000|Overall Study|Withdrawal by Subject|1|||
129636442|NCT04112043|466624210|FG001|Overall Study|Withdrawal by Subject|1|||
129636443|NCT04112043|466624211|FG002|Overall Study|Withdrawal by Subject|1|||
129636444|NCT04112043|466624209|FG000|Overall Study|Taking NR supplement|1|||
129636445|NCT04112043|466624210|FG001|Overall Study|Taking NR supplement|0|||
129636446|NCT04112043|466624211|FG002|Overall Study|Taking NR supplement|0|||
129636447|NCT04112043|466624209|FG000|Overall Study|Adverse Event|0|||
129636448|NCT04112043|466624210|FG001|Overall Study|Adverse Event|1|||
129636449|NCT04112043|466624211|FG002|Overall Study|Adverse Event|0|||
129636450|NCT03259425|466624212|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
129636451|NCT04157296|466624213|FG000|Overall Study|Withdrawal by Subject|0|||
129636452|NCT04157296|466624214|FG001|Overall Study|Withdrawal by Subject|1|||
129636453|NCT04157296|466624213|FG000|Overall Study|Did not obtain second fMRI.|0|||
129636454|NCT04157296|466624214|FG001|Overall Study|Did not obtain second fMRI.|1|||
129636455|NCT04157296|466624213|FG000|Overall Study|MRI failed/no second fMRI|0|||
129636456|NCT04157296|466624214|FG001|Overall Study|MRI failed/no second fMRI|1|||
129704921|NCT02410772|466884097|FG000|Overall Study|Death|3|||
129704922|NCT02410772|466884098|FG001|Overall Study|Death|4|||
129704923|NCT02410772|466884099|FG002|Overall Study|Death|8|||
129704924|NCT02410772|466884097|FG000|Overall Study|Lost to Follow-up|31|||
129636457|NCT02091089|466624218|FG000|Overall Study|Lost to Follow-up|2|||
129636458|NCT01580670|466624219|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
129636459|NCT01580670|466624219|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
129636460|NCT02097745|466624220|FG000|Overall Study|Adverse Event|25|||
129704925|NCT02410772|466884098|FG001|Overall Study|Lost to Follow-up|23|||
129704926|NCT02410772|466884099|FG002|Overall Study|Lost to Follow-up|22|||
129704927|NCT02410772|466884097|FG000|Overall Study|Pregnancy|8|||
129704928|NCT02410772|466884098|FG001|Overall Study|Pregnancy|4|||
129704929|NCT02410772|466884099|FG002|Overall Study|Pregnancy|5|||
129889343|NCT03259373|467552562|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
129636461|NCT02097745|466624220|FG000|Overall Study|Death|16|||
129704930|NCT02410772|466884097|FG000|Overall Study|Protocol Violation|8|||
129704931|NCT02410772|466884098|FG001|Overall Study|Protocol Violation|8|||
129636462|NCT02097745|466624220|FG000|Overall Study|Failure to Return|14|||
129704932|NCT02410772|466884099|FG002|Overall Study|Protocol Violation|4|||
129636463|NCT02097745|466624220|FG000|Overall Study|Administrative/Other|27|||
129704933|NCT02410772|466884097|FG000|Overall Study|Baseline Drug Resistance|49|||
129704934|NCT02410772|466884098|FG001|Overall Study|Baseline Drug Resistance|40|||
129704935|NCT02410772|466884099|FG002|Overall Study|Baseline Drug Resistance|51|||
129636464|NCT02097745|466624220|FG000|Overall Study|Reason Not Specified|96|||
129440579|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
129440580|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
129440581|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
129440582|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
129440583|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
129440584|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
129440585|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
129440586|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
129440587|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
129440588|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
129440589|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
129636465|NCT00425750|466624221|FG000|Overall Study|Death|1|||
129636466|NCT00425750|466624221|FG000|Overall Study|Withdrawal by Subject|3|||
129440590|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
129440591|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
129440592|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
129440593|NCT01231516|465911476|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
129440594|NCT01231516|465911477|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
129636467|NCT00425750|466624221|FG000|Overall Study|Adverse Event|3|||
129636468|NCT00425750|466624221|FG000|Overall Study|Progression of disease|18|||
129636469|NCT01757184|466624222|FG000|Double-blind Period|Adverse Event|1|||
129636470|NCT01757184|466624223|FG001|Double-blind Period|Adverse Event|0|||
129636471|NCT01757184|466624224|FG002|Double-blind Period|Adverse Event|0|||
129636472|NCT01757184|466624225|FG003|Double-blind Period|Adverse Event|0|||
129636473|NCT01757184|466624222|FG000|Open-label Period|Lost to Follow-up|0|||
129636474|NCT01757184|466624223|FG001|Open-label Period|Lost to Follow-up|0|||
129636475|NCT01757184|466624224|FG002|Open-label Period|Lost to Follow-up|2|||
129440595|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
129440596|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
129440597|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
129440598|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
129440599|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
129440600|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
129440601|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
129440602|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
129440603|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
129440604|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
129440605|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
129440606|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
129440607|NCT01231516|465911476|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
129440608|NCT01231516|465911477|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
129440609|NCT03170154|465911478|FG000|Overall Study|Lost to Follow-up|4|||
129440610|NCT03170154|465911478|FG000|Overall Study|Death|2|||
129440611|NCT03170154|465911478|FG000|Overall Study|Withdrawal by Subject|2|||
129440612|NCT01117857|465911479|FG000|Overall Study|Lost to Follow-up|4|||
129636476|NCT01757184|466624225|FG003|Open-label Period|Lost to Follow-up|0|||
129636477|NCT01757184|466624222|FG000|Open-label Period|Withdrawal by Subject|0|||
129636478|NCT01757184|466624223|FG001|Open-label Period|Withdrawal by Subject|0|||
129636479|NCT01757184|466624224|FG002|Open-label Period|Withdrawal by Subject|1|||
129636480|NCT01757184|466624225|FG003|Open-label Period|Withdrawal by Subject|1|||
129636481|NCT01757184|466624222|FG000|Open-label Period|Discontinued by Sponsor|0|||
129636482|NCT01757184|466624223|FG001|Open-label Period|Discontinued by Sponsor|0|||
129636483|NCT01757184|466624224|FG002|Open-label Period|Discontinued by Sponsor|1|||
129636484|NCT01757184|466624225|FG003|Open-label Period|Discontinued by Sponsor|2|||
129636485|NCT00554515|466624226|FG000|Overall Study|Withdrawal by Subject|3|||
129636486|NCT00554515|466624226|FG000|Overall Study|Disease progression|52|||
129636487|NCT00554515|466624226|FG000|Overall Study|Physician Decision|18|||
129440613|NCT01117857|465911479|FG000|Overall Study|Withdrawal by Subject|4|||
129440614|NCT01117857|465911479|FG000|Overall Study|Physician Decision|1|||
129440615|NCT00633061|465911480|FG000|Overall Study|Study closed|86|||
129440616|NCT00633061|465911481|FG001|Overall Study|Study closed|0|||
129440617|NCT05245097|465911482|FG000|Overall Study|Adverse Event|13|||
129440618|NCT05245097|465911483|FG001|Overall Study|Adverse Event|2|||
129440619|NCT05245097|465911482|FG000|Overall Study|Protocol Violation|8|||
129704936|NCT02410772|466884097|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
129636488|NCT00554515|466624226|FG000|Overall Study|Withdrawal by Subject|11|||
129636489|NCT00554515|466624226|FG000|Overall Study|Adverse Event|9|||
129636490|NCT00554515|466624226|FG000|Overall Study|Death|2|||
129704937|NCT02410772|466884098|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
129636491|NCT00554515|466624226|FG000|Overall Study|Achieved Stable Disease|7|||
129636492|NCT00554515|466624226|FG000|Overall Study|Other|1|||
129636493|NCT00554515|466624226|FG000|Overall Study|Misc|15|||
129636494|NCT01276756|466624229|FG000|Overall Study|Lost to Follow-up|2|||
129636495|NCT01276756|466624230|FG001|Overall Study|Lost to Follow-up|0|||
129636496|NCT01276756|466624229|FG000|Overall Study|Adverse Event|3|||
129636497|NCT01276756|466624230|FG001|Overall Study|Adverse Event|2|||
129636498|NCT01554527|466624238|FG000|Overall Study|Withdrawal by Subject|1|||
129636499|NCT01554527|466624239|FG001|Overall Study|Withdrawal by Subject|0|||
129636500|NCT01554527|466624240|FG002|Overall Study|Withdrawal by Subject|3|||
129636501|NCT01554527|466624238|FG000|Overall Study|Lost to Follow-up|0|||
129636502|NCT01554527|466624239|FG001|Overall Study|Lost to Follow-up|0|||
129636503|NCT01554527|466624240|FG002|Overall Study|Lost to Follow-up|4|||
129636504|NCT01554527|466624238|FG000|Overall Study|Physician Decision|0|||
129636505|NCT01554527|466624239|FG001|Overall Study|Physician Decision|0|||
129636506|NCT01554527|466624240|FG002|Overall Study|Physician Decision|1|||
129636507|NCT01052480|466624241|FG000|Overall Study|Lost to Follow-up|3|||
129636508|NCT01052480|466624242|FG001|Overall Study|Lost to Follow-up|3|||
129636509|NCT01052480|466624241|FG000|Overall Study|Protocol Violation|1|||
129636510|NCT01052480|466624242|FG001|Overall Study|Protocol Violation|0|||
129636511|NCT01052480|466624241|FG000|Overall Study|Withdrawal by Subject|3|||
129636512|NCT01052480|466624242|FG001|Overall Study|Withdrawal by Subject|7|||
129636513|NCT01052480|466624241|FG000|Overall Study|Physician Decision|0|||
129636514|NCT01052480|466624242|FG001|Overall Study|Physician Decision|2|||
129636515|NCT01052480|466624241|FG000|Overall Study|Death|1|||
129636516|NCT01052480|466624242|FG001|Overall Study|Death|5|||
129636517|NCT00529373|466624249|FG000|Base Study|Adverse Event|525|||
129636518|NCT00529373|466624250|FG001|Base Study|Adverse Event|470|||
129636519|NCT00529373|466624249|FG000|Base Study|Lack of Efficacy|16|||
129636520|NCT00529373|466624250|FG001|Base Study|Lack of Efficacy|75|||
129636521|NCT00529373|466624249|FG000|Base Study|Lost to Follow-up|221|||
129636522|NCT00529373|466624250|FG001|Base Study|Lost to Follow-up|208|||
129636523|NCT00529373|466624249|FG000|Base Study|Other Protocol Specified Criteria|19|||
129636524|NCT00529373|466624250|FG001|Base Study|Other Protocol Specified Criteria|20|||
129636525|NCT00529373|466624249|FG000|Base Study|Physician Decision|60|||
129636526|NCT00529373|466624250|FG001|Base Study|Physician Decision|52|||
129636527|NCT00529373|466624249|FG000|Base Study|Protocol Violation|48|||
129636528|NCT00529373|466624250|FG001|Base Study|Protocol Violation|38|||
129636529|NCT00529373|466624249|FG000|Base Study|Withdrawal by Subject|1062|||
129636530|NCT00529373|466624250|FG001|Base Study|Withdrawal by Subject|967|||
129636531|NCT00529373|466624249|FG000|Base Study|Did not continue into Extension|1795|||
129636532|NCT00529373|466624250|FG001|Base Study|Did not continue into Extension|2238|||
129636533|NCT00529373|466624249|FG000|First Extension Study|Adverse Event|162|||
129636534|NCT00529373|466624250|FG001|First Extension Study|Adverse Event|142|||
129636535|NCT00529373|466624249|FG000|First Extension Study|Lack of Efficacy|65|||
129636536|NCT00529373|466624250|FG001|First Extension Study|Lack of Efficacy|427|||
129636537|NCT00529373|466624249|FG000|First Extension Study|Lost to Follow-up|41|||
129636538|NCT00529373|466624250|FG001|First Extension Study|Lost to Follow-up|37|||
129636539|NCT00529373|466624249|FG000|First Extension Study|Other|27|||
129704938|NCT02410772|466884099|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
129704939|NCT02410772|466884097|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
129704940|NCT02410772|466884098|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
129704941|NCT02410772|466884099|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
129704942|NCT05067335|466884100|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
129636540|NCT00529373|466624250|FG001|First Extension Study|Other|47|||
129636541|NCT00529373|466624249|FG000|First Extension Study|Physician Decision|50|||
129636542|NCT00529373|466624250|FG001|First Extension Study|Physician Decision|45|||
129636543|NCT00529373|466624249|FG000|First Extension Study|Protocol Violation|16|||
129636544|NCT00529373|466624250|FG001|First Extension Study|Protocol Violation|13|||
129636545|NCT00529373|466624249|FG000|First Extension Study|Withdrawal by Subject|296|||
129636546|NCT00529373|466624250|FG001|First Extension Study|Withdrawal by Subject|287|||
129636547|NCT00529373|466624249|FG000|First Extension Study|Disposition record non-existing|0|||
129636548|NCT00529373|466624250|FG001|First Extension Study|Disposition record non-existing|1|||
129636549|NCT00529373|466624249|FG000|First Extension Study|Discontinued after 5 years completion|208|||
129636550|NCT00529373|466624250|FG001|First Extension Study|Discontinued after 5 years completion|346|||
129636551|NCT00529373|466624249|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
129636552|NCT00529373|466624250|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
129636553|NCT00529373|466624249|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
129636554|NCT00529373|466624250|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
129636555|NCT00529373|466624249|FG000|Second Extension Study|Adverse Event|101|||
129636556|NCT00529373|466624250|FG001|Second Extension Study|Adverse Event|51|||
129636557|NCT00529373|466624249|FG000|Second Extension Study|Lack of Efficacy|7|||
129636558|NCT00529373|466624250|FG001|Second Extension Study|Lack of Efficacy|15|||
129636559|NCT00529373|466624249|FG000|Second Extension Study|Lost to Follow-up|18|||
129636560|NCT00529373|466624250|FG001|Second Extension Study|Lost to Follow-up|12|||
129636561|NCT00529373|466624249|FG000|Second Extension Study|Other|7|||
129636562|NCT00529373|466624250|FG001|Second Extension Study|Other|12|||
129636563|NCT00529373|466624249|FG000|Second Extension Study|Physician Decision|63|||
129636564|NCT00529373|466624250|FG001|Second Extension Study|Physician Decision|26|||
129636565|NCT00529373|466624249|FG000|Second Extension Study|Protocol Violation|2|||
129636566|NCT00529373|466624250|FG001|Second Extension Study|Protocol Violation|1|||
129636567|NCT00529373|466624249|FG000|Second Extension Study|Withdrawal by Subject|97|||
129636568|NCT00529373|466624250|FG001|Second Extension Study|Withdrawal by Subject|75|||
129636569|NCT00529373|466624249|FG000|Second Extension Study|Status Missing|5|||
129636570|NCT00529373|466624250|FG001|Second Extension Study|Status Missing|5|||
129636571|NCT00757042|466624253|FG000|Overall Study|Lost to Follow-up|0|||
129636572|NCT00757042|466624254|FG001|Overall Study|Lost to Follow-up|0|||
129636573|NCT00757042|466624255|FG002|Overall Study|Lost to Follow-up|0|||
129636574|NCT00757042|466624256|FG003|Overall Study|Lost to Follow-up|0|||
129636575|NCT00757042|466624257|FG004|Overall Study|Lost to Follow-up|0|||
129636576|NCT00757042|466624258|FG005|Overall Study|Lost to Follow-up|0|||
129636577|NCT00757042|466624259|FG006|Overall Study|Lost to Follow-up|0|||
129636578|NCT00757042|466624260|FG007|Overall Study|Lost to Follow-up|0|||
129636579|NCT00757042|466624261|FG008|Overall Study|Lost to Follow-up|1|||
129636580|NCT00757042|466624262|FG009|Overall Study|Lost to Follow-up|0|||
129636581|NCT00757042|466624263|FG010|Overall Study|Lost to Follow-up|0|||
129636582|NCT00757042|466624253|FG000|Overall Study|Ineligibility Determined|0|||
129636583|NCT00757042|466624254|FG001|Overall Study|Ineligibility Determined|0|||
129636584|NCT00757042|466624255|FG002|Overall Study|Ineligibility Determined|0|||
129636585|NCT00757042|466624256|FG003|Overall Study|Ineligibility Determined|0|||
129636586|NCT00757042|466624257|FG004|Overall Study|Ineligibility Determined|0|||
129636587|NCT00757042|466624258|FG005|Overall Study|Ineligibility Determined|0|||
129636588|NCT00757042|466624259|FG006|Overall Study|Ineligibility Determined|0|||
129636589|NCT00757042|466624260|FG007|Overall Study|Ineligibility Determined|0|||
129636590|NCT00757042|466624261|FG008|Overall Study|Ineligibility Determined|0|||
129636591|NCT00757042|466624262|FG009|Overall Study|Ineligibility Determined|0|||
129636592|NCT00757042|466624263|FG010|Overall Study|Ineligibility Determined|1|||
129636593|NCT00757042|466624253|FG000|Overall Study|Withdrawal by Subject|0|||
129636594|NCT00757042|466624254|FG001|Overall Study|Withdrawal by Subject|0|||
129636595|NCT00757042|466624255|FG002|Overall Study|Withdrawal by Subject|0|||
129636596|NCT00757042|466624256|FG003|Overall Study|Withdrawal by Subject|0|||
129636597|NCT00757042|466624257|FG004|Overall Study|Withdrawal by Subject|0|||
129636598|NCT00757042|466624258|FG005|Overall Study|Withdrawal by Subject|0|||
129636599|NCT00757042|466624259|FG006|Overall Study|Withdrawal by Subject|0|||
129636600|NCT00757042|466624260|FG007|Overall Study|Withdrawal by Subject|0|||
129636601|NCT00757042|466624261|FG008|Overall Study|Withdrawal by Subject|0|||
129636602|NCT00757042|466624262|FG009|Overall Study|Withdrawal by Subject|1|||
129636603|NCT00757042|466624263|FG010|Overall Study|Withdrawal by Subject|0|||
129636604|NCT01870973|466624267|FG000|Overall Study|Lost to Follow-up|10|||
129636605|NCT01870973|466624268|FG001|Overall Study|Lost to Follow-up|3|||
129636606|NCT01266291|466624270|FG000|Overall Study|Adverse Event|1|||
129636607|NCT03291431|466624271|FG000|Overall Study|Protocol Violation|2|||
129636608|NCT03291431|466624272|FG001|Overall Study|Protocol Violation|1|||
129636609|NCT03291431|466624271|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
129636610|NCT03291431|466624272|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
129636611|NCT03291431|466624271|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
129636612|NCT03291431|466624272|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
129636613|NCT03850483|466624277|FG000|Treatment for Stage 1|Adverse Event|1|||
129636614|NCT03850483|466624278|FG001|Treatment for Stage 1|Adverse Event|1|||
129636615|NCT03850483|466624279|FG002|Treatment for Stage 1|Adverse Event|3|||
129704943|NCT05067335|466884101|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
129704944|NCT05067335|466884102|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
129704945|NCT05067335|466884103|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
129889344|NCT03259373|467552563|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
129636616|NCT03850483|466624280|FG003|Treatment for Stage 1|Adverse Event|0|||
129636617|NCT03850483|466624281|FG004|Treatment for Stage 1|Adverse Event|2|||
129636618|NCT03850483|466624282|FG005|Treatment for Stage 1|Adverse Event|0|||
129636619|NCT03850483|466624283|FG006|Treatment for Stage 1|Adverse Event|2|||
129636620|NCT03850483|466624284|FG007|Treatment for Stage 1|Adverse Event|2|||
129636621|NCT03850483|466624285|FG008|Treatment for Stage 1|Adverse Event|0|||
129636622|NCT03850483|466624286|FG009|Treatment for Stage 1|Adverse Event|0|||
129636623|NCT03850483|466624277|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
129636624|NCT03850483|466624278|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
129636625|NCT03850483|466624279|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
129636626|NCT03850483|466624280|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
129636627|NCT03850483|466624281|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
129636628|NCT03850483|466624282|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
129636629|NCT03850483|466624283|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
129636630|NCT03850483|466624284|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
129636631|NCT03850483|466624285|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
129636632|NCT03850483|466624286|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
129636633|NCT03850483|466624277|FG000|Treatment for Stage 1|Protocol Violation|1|||
129636634|NCT03850483|466624278|FG001|Treatment for Stage 1|Protocol Violation|0|||
129636635|NCT03850483|466624279|FG002|Treatment for Stage 1|Protocol Violation|0|||
129636636|NCT03850483|466624280|FG003|Treatment for Stage 1|Protocol Violation|0|||
129636637|NCT03850483|466624281|FG004|Treatment for Stage 1|Protocol Violation|0|||
129636638|NCT03850483|466624282|FG005|Treatment for Stage 1|Protocol Violation|0|||
129636639|NCT03850483|466624283|FG006|Treatment for Stage 1|Protocol Violation|1|||
129636640|NCT03850483|466624284|FG007|Treatment for Stage 1|Protocol Violation|0|||
129636641|NCT03850483|466624285|FG008|Treatment for Stage 1|Protocol Violation|0|||
129636642|NCT03850483|466624286|FG009|Treatment for Stage 1|Protocol Violation|0|||
129636643|NCT03850483|466624277|FG000|Treatment for Stage 1|Physician Decision|0|||
129636644|NCT03850483|466624278|FG001|Treatment for Stage 1|Physician Decision|0|||
129636645|NCT03850483|466624279|FG002|Treatment for Stage 1|Physician Decision|0|||
129636646|NCT03850483|466624280|FG003|Treatment for Stage 1|Physician Decision|0|||
129636647|NCT03850483|466624281|FG004|Treatment for Stage 1|Physician Decision|0|||
129636648|NCT03850483|466624282|FG005|Treatment for Stage 1|Physician Decision|1|||
129636649|NCT03850483|466624283|FG006|Treatment for Stage 1|Physician Decision|0|||
129636650|NCT03850483|466624284|FG007|Treatment for Stage 1|Physician Decision|0|||
129636651|NCT03850483|466624285|FG008|Treatment for Stage 1|Physician Decision|0|||
129636652|NCT03850483|466624286|FG009|Treatment for Stage 1|Physician Decision|0|||
129636653|NCT03850483|466624277|FG000|Treatment for Stage 1|Other|0|||
129636654|NCT03850483|466624278|FG001|Treatment for Stage 1|Other|0|||
129636655|NCT03850483|466624279|FG002|Treatment for Stage 1|Other|0|||
129636656|NCT03850483|466624280|FG003|Treatment for Stage 1|Other|0|||
129636657|NCT03850483|466624281|FG004|Treatment for Stage 1|Other|2|||
129636658|NCT03850483|466624282|FG005|Treatment for Stage 1|Other|1|||
129636659|NCT03850483|466624283|FG006|Treatment for Stage 1|Other|0|||
129636660|NCT03850483|466624284|FG007|Treatment for Stage 1|Other|0|||
129636661|NCT03850483|466624285|FG008|Treatment for Stage 1|Other|0|||
129636662|NCT03850483|466624286|FG009|Treatment for Stage 1|Other|0|||
129636663|NCT03850483|466624277|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636664|NCT03850483|466624278|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636665|NCT03850483|466624279|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
129636666|NCT03850483|466624280|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636667|NCT03850483|466624281|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636668|NCT03850483|466624282|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636669|NCT03850483|466624283|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636670|NCT03850483|466624284|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636671|NCT03850483|466624285|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636672|NCT03850483|466624286|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
129636673|NCT03850483|466624277|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636674|NCT03850483|466624278|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636675|NCT03850483|466624279|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636676|NCT03850483|466624280|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636677|NCT03850483|466624281|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636678|NCT03850483|466624282|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
129636679|NCT03850483|466624283|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636680|NCT03850483|466624284|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636681|NCT03850483|466624285|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636682|NCT03850483|466624286|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
129636683|NCT03850483|466624277|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
129636684|NCT03850483|466624278|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
129636685|NCT03850483|466624279|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
129636686|NCT03850483|466624280|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
129636687|NCT03850483|466624281|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
129636688|NCT03850483|466624282|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
129636689|NCT03850483|466624283|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
129636690|NCT03850483|466624284|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
129636691|NCT03850483|466624285|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
129636692|NCT03850483|466624286|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
129636693|NCT03850483|466624277|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
129636694|NCT03850483|466624278|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
129636695|NCT03850483|466624279|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
129636696|NCT03850483|466624280|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
129636697|NCT03850483|466624281|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
129636698|NCT03850483|466624282|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
129440620|NCT05245097|465911483|FG001|Overall Study|Protocol Violation|6|||
129440621|NCT05245097|465911482|FG000|Overall Study|Withdrawal by Subject|18|||
129440622|NCT05245097|465911483|FG001|Overall Study|Withdrawal by Subject|0|||
129440623|NCT05245097|465911482|FG000|Overall Study|Death|6|||
129440624|NCT05245097|465911483|FG001|Overall Study|Death|7|||
129440625|NCT05245097|465911482|FG000|Overall Study|Physician Decision|6|||
129636699|NCT03850483|466624283|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
129636700|NCT03850483|466624284|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
129636701|NCT03850483|466624285|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
129636702|NCT03850483|466624286|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
129636703|NCT03850483|466624277|FG000|Treatment for Stage 1|Death|0|||
129636704|NCT03850483|466624278|FG001|Treatment for Stage 1|Death|0|||
129636705|NCT03850483|466624279|FG002|Treatment for Stage 1|Death|0|||
129636706|NCT03850483|466624280|FG003|Treatment for Stage 1|Death|0|||
129636707|NCT03850483|466624281|FG004|Treatment for Stage 1|Death|0|||
129636708|NCT03850483|466624282|FG005|Treatment for Stage 1|Death|1|||
129440626|NCT05245097|465911483|FG001|Overall Study|Physician Decision|0|||
129440627|NCT05245097|465911482|FG000|Overall Study|Relocation|4|||
129440628|NCT05245097|465911483|FG001|Overall Study|Relocation|3|||
129440629|NCT00607022|465911491|FG000|Overall Study|Withdrawal by Subject|1|||
129440630|NCT00607022|465911492|FG001|Overall Study|Withdrawal by Subject|0|||
129440631|NCT00607022|465911493|FG002|Overall Study|Withdrawal by Subject|0|||
129440632|NCT00810394|465911494|FG000|Overall Study|Withdrawal by Subject|3|||
129440633|NCT05677893|465913090|FG000|Overall Study|Withdrawal by Subject|0|||
129440634|NCT05677893|465913091|FG001|Overall Study|Withdrawal by Subject|0|||
129440635|NCT05677893|465913092|FG002|Overall Study|Withdrawal by Subject|0|||
129440636|NCT05677893|465913093|FG003|Overall Study|Withdrawal by Subject|0|||
129440637|NCT05677893|465913094|FG004|Overall Study|Withdrawal by Subject|1|||
129440638|NCT05677893|465913095|FG005|Overall Study|Withdrawal by Subject|1|||
129440639|NCT05677893|465913096|FG006|Overall Study|Withdrawal by Subject|0|||
129440640|NCT05677893|465913090|FG000|Overall Study|Others|1|||
129440641|NCT05677893|465913091|FG001|Overall Study|Others|0|||
129440642|NCT05677893|465913092|FG002|Overall Study|Others|0|||
129440643|NCT05677893|465913093|FG003|Overall Study|Others|0|||
129440644|NCT05677893|465913094|FG004|Overall Study|Others|0|||
129440645|NCT05677893|465913095|FG005|Overall Study|Others|0|||
129440646|NCT05677893|465913096|FG006|Overall Study|Others|0|||
129440647|NCT01485354|465913097|FG000|Overall Study|Withdrawal by Subject|5|||
129440648|NCT00995020|465913098|FG000|Overall Study|margin analysis not performed|2|||
129440649|NCT00995020|465913099|FG001|Overall Study|margin analysis not performed|5|||
129440650|NCT00995020|465913098|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
129440651|NCT00995020|465913099|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
129440652|NCT02720536|465913100|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
129440653|NCT02720536|465913100|FG000|Overall Study|PR - pregnancy|2|||
129440654|NCT02720536|465913100|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
129440655|NCT02720536|465913100|FG000|Overall Study|PR - death|1|||
129440656|NCT02720536|465913100|FG000|Overall Study|PR - adverse event|1|||
129440657|NCT02720536|465913100|FG000|Overall Study|PR - abnormal lab value(s)|1|||
129440658|NCT02720536|465913100|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
129440659|NCT00719563|465913102|FG000|Overall Study|Adverse Event|16|||
129440660|NCT00719563|465913103|FG001|Overall Study|Adverse Event|13|||
129440661|NCT00719563|465913102|FG000|Overall Study|Medical condition changed|3|||
129440662|NCT00719563|465913103|FG001|Overall Study|Medical condition changed|5|||
129440663|NCT00719563|465913102|FG000|Overall Study|Lack of Efficacy|3|||
129440664|NCT00719563|465913103|FG001|Overall Study|Lack of Efficacy|7|||
129440665|NCT00719563|465913102|FG000|Overall Study|Personal reasons|6|||
129440666|NCT00719563|465913103|FG001|Overall Study|Personal reasons|7|||
129440667|NCT00719563|465913102|FG000|Overall Study|Unknown reasons|4|||
129440668|NCT00719563|465913103|FG001|Overall Study|Unknown reasons|6|||
129636709|NCT03850483|466624283|FG006|Treatment for Stage 1|Death|0|||
129636710|NCT03850483|466624284|FG007|Treatment for Stage 1|Death|0|||
129636711|NCT03850483|466624285|FG008|Treatment for Stage 1|Death|0|||
129636712|NCT03850483|466624286|FG009|Treatment for Stage 1|Death|0|||
129636713|NCT03850483|466624277|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
129440669|NCT00719563|465913102|FG000|Overall Study|Noncompliant|1|||
129440670|NCT00719563|465913103|FG001|Overall Study|Noncompliant|1|||
129440671|NCT00719563|465913102|FG000|Overall Study|Lost to Follow-up|5|||
129636714|NCT03850483|466624278|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
129636715|NCT03850483|466624279|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
129636716|NCT03850483|466624280|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
129636717|NCT03850483|466624281|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
129636718|NCT03850483|466624282|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
129636719|NCT03850483|466624283|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
129636720|NCT03850483|466624284|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
129636721|NCT03850483|466624285|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
129636722|NCT03850483|466624286|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
129636723|NCT03850483|466624277|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
129636724|NCT03850483|466624278|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
129636725|NCT03850483|466624279|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
129636726|NCT03850483|466624280|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
129636727|NCT03850483|466624281|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
129636728|NCT03850483|466624282|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
129636729|NCT03850483|466624283|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
129636730|NCT03850483|466624284|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
129636731|NCT03850483|466624285|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
129636732|NCT03850483|466624286|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
129636733|NCT03850483|466624277|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636734|NCT03850483|466624278|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636735|NCT03850483|466624279|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636736|NCT03850483|466624280|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636737|NCT03850483|466624281|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636738|NCT03850483|466624282|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636739|NCT03850483|466624283|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
129636740|NCT03850483|466624284|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
129636741|NCT03850483|466624285|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636742|NCT03850483|466624286|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
129636743|NCT03850483|466624277|FG000|Follow-up for Stage 1|Physician Decision|0|||
129636744|NCT03850483|466624278|FG001|Follow-up for Stage 1|Physician Decision|0|||
129636745|NCT03850483|466624279|FG002|Follow-up for Stage 1|Physician Decision|0|||
129636746|NCT03850483|466624280|FG003|Follow-up for Stage 1|Physician Decision|0|||
129636747|NCT03850483|466624281|FG004|Follow-up for Stage 1|Physician Decision|1|||
129636748|NCT03850483|466624282|FG005|Follow-up for Stage 1|Physician Decision|0|||
129636749|NCT03850483|466624283|FG006|Follow-up for Stage 1|Physician Decision|1|||
129636750|NCT03850483|466624284|FG007|Follow-up for Stage 1|Physician Decision|0|||
129636751|NCT03850483|466624285|FG008|Follow-up for Stage 1|Physician Decision|0|||
129636752|NCT03850483|466624286|FG009|Follow-up for Stage 1|Physician Decision|0|||
129636753|NCT03850483|466624277|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
129636754|NCT03850483|466624278|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
129636755|NCT03850483|466624279|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
129636756|NCT03850483|466624280|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
129636757|NCT03850483|466624281|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
129636758|NCT03850483|466624282|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
129636759|NCT03850483|466624283|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
129636760|NCT03850483|466624284|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
129636761|NCT03850483|466624285|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
129440672|NCT00719563|465913103|FG001|Overall Study|Lost to Follow-up|3|||
129636762|NCT03850483|466624286|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
129636763|NCT03850483|466624277|FG000|Follow-up for Stage 1|Adverse Event|0|||
129636764|NCT03850483|466624278|FG001|Follow-up for Stage 1|Adverse Event|0|||
129636765|NCT03850483|466624279|FG002|Follow-up for Stage 1|Adverse Event|1|||
129636766|NCT03850483|466624280|FG003|Follow-up for Stage 1|Adverse Event|0|||
129636767|NCT03850483|466624281|FG004|Follow-up for Stage 1|Adverse Event|0|||
129636768|NCT03850483|466624282|FG005|Follow-up for Stage 1|Adverse Event|1|||
129636769|NCT03850483|466624283|FG006|Follow-up for Stage 1|Adverse Event|0|||
129636770|NCT03850483|466624284|FG007|Follow-up for Stage 1|Adverse Event|0|||
129636771|NCT03850483|466624285|FG008|Follow-up for Stage 1|Adverse Event|0|||
129636772|NCT03850483|466624286|FG009|Follow-up for Stage 1|Adverse Event|0|||
129636773|NCT03850483|466624277|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129636774|NCT03850483|466624278|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
129636775|NCT03850483|466624279|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129636776|NCT03850483|466624280|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129636777|NCT03850483|466624281|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
129636778|NCT03850483|466624282|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
129636779|NCT03850483|466624283|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129636780|NCT03850483|466624284|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129704946|NCT05067335|466884100|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
129704947|NCT05067335|466884101|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
129704948|NCT05067335|466884102|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
129704949|NCT05067335|466884103|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
129636781|NCT03850483|466624285|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129636782|NCT03850483|466624286|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
129636783|NCT03850483|466624277|FG000|Follow-up for Stage 1|Other|0|||
129636784|NCT03850483|466624278|FG001|Follow-up for Stage 1|Other|2|||
129636785|NCT03850483|466624279|FG002|Follow-up for Stage 1|Other|0|||
129636786|NCT03850483|466624280|FG003|Follow-up for Stage 1|Other|2|||
129636787|NCT03850483|466624281|FG004|Follow-up for Stage 1|Other|0|||
129636788|NCT03850483|466624282|FG005|Follow-up for Stage 1|Other|1|||
129636789|NCT03850483|466624283|FG006|Follow-up for Stage 1|Other|0|||
129636790|NCT03850483|466624284|FG007|Follow-up for Stage 1|Other|0|||
129636791|NCT03850483|466624285|FG008|Follow-up for Stage 1|Other|0|||
129636792|NCT03850483|466624286|FG009|Follow-up for Stage 1|Other|0|||
129636793|NCT03850483|466624277|FG000|Treatment for Stage 2|Adverse Event|0|||
129636794|NCT03850483|466624278|FG001|Treatment for Stage 2|Adverse Event|0|||
129636795|NCT03850483|466624279|FG002|Treatment for Stage 2|Adverse Event|0|||
129636796|NCT03850483|466624280|FG003|Treatment for Stage 2|Adverse Event|0|||
129636797|NCT03850483|466624281|FG004|Treatment for Stage 2|Adverse Event|0|||
129636798|NCT03850483|466624282|FG005|Treatment for Stage 2|Adverse Event|0|||
129636799|NCT03850483|466624283|FG006|Treatment for Stage 2|Adverse Event|0|||
129636800|NCT03850483|466624284|FG007|Treatment for Stage 2|Adverse Event|0|||
129636801|NCT03850483|466624285|FG008|Treatment for Stage 2|Adverse Event|0|||
129636802|NCT03850483|466624286|FG009|Treatment for Stage 2|Adverse Event|1|||
129636803|NCT03850483|466624277|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
129636804|NCT03850483|466624278|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
129636805|NCT03850483|466624279|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
129636806|NCT03850483|466624280|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
129636807|NCT03850483|466624281|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
129636808|NCT03850483|466624282|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
129636809|NCT03850483|466624283|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
129636810|NCT03850483|466624284|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
129636811|NCT03850483|466624285|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
129636812|NCT03850483|466624286|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
129636813|NCT03850483|466624277|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
129636814|NCT03850483|466624278|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
129636815|NCT03850483|466624279|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
129636816|NCT03850483|466624280|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
129636817|NCT03850483|466624281|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
129636818|NCT03850483|466624282|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
129636819|NCT03850483|466624283|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
129636820|NCT03850483|466624284|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
129636821|NCT03850483|466624285|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
129636822|NCT03850483|466624286|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
129636823|NCT03850483|466624277|FG000|Treatment for Stage 2|Physician Decision|0|||
129636824|NCT03850483|466624278|FG001|Treatment for Stage 2|Physician Decision|0|||
129636825|NCT03850483|466624279|FG002|Treatment for Stage 2|Physician Decision|0|||
129704950|NCT05067335|466884100|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
129704951|NCT05067335|466884101|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
129440673|NCT00792805|465913106|FG000|Overall Study|Adverse Event|12|||
129440674|NCT00792805|465913107|FG001|Overall Study|Adverse Event|10|||
129440675|NCT00792805|465913108|FG002|Overall Study|Adverse Event|10|||
129636826|NCT03850483|466624280|FG003|Treatment for Stage 2|Physician Decision|0|||
129636827|NCT03850483|466624281|FG004|Treatment for Stage 2|Physician Decision|0|||
129636828|NCT03850483|466624282|FG005|Treatment for Stage 2|Physician Decision|0|||
129636829|NCT03850483|466624283|FG006|Treatment for Stage 2|Physician Decision|0|||
129636830|NCT03850483|466624284|FG007|Treatment for Stage 2|Physician Decision|0|||
129704952|NCT05067335|466884102|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
129440676|NCT00792805|465913106|FG000|Overall Study|Subject withdrew consent|5|||
129636831|NCT03850483|466624285|FG008|Treatment for Stage 2|Physician Decision|0|||
129636832|NCT03850483|466624286|FG009|Treatment for Stage 2|Physician Decision|1|||
129636833|NCT03850483|466624277|FG000|Treatment for Stage 2|Protocol Violation|0|||
129636834|NCT03850483|466624278|FG001|Treatment for Stage 2|Protocol Violation|0|||
129636835|NCT03850483|466624279|FG002|Treatment for Stage 2|Protocol Violation|0|||
129636836|NCT03850483|466624280|FG003|Treatment for Stage 2|Protocol Violation|0|||
129636837|NCT03850483|466624281|FG004|Treatment for Stage 2|Protocol Violation|0|||
129636838|NCT03850483|466624282|FG005|Treatment for Stage 2|Protocol Violation|0|||
129636839|NCT03850483|466624283|FG006|Treatment for Stage 2|Protocol Violation|0|||
129636840|NCT03850483|466624284|FG007|Treatment for Stage 2|Protocol Violation|0|||
129636841|NCT03850483|466624285|FG008|Treatment for Stage 2|Protocol Violation|1|||
129636842|NCT03850483|466624286|FG009|Treatment for Stage 2|Protocol Violation|0|||
129636843|NCT03850483|466624277|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
129636844|NCT03850483|466624278|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
129440677|NCT00792805|465913107|FG001|Overall Study|Subject withdrew consent|6|||
129440678|NCT00792805|465913108|FG002|Overall Study|Subject withdrew consent|5|||
129440679|NCT00792805|465913106|FG000|Overall Study|Administrative problems|2|||
129440680|NCT00792805|465913107|FG001|Overall Study|Administrative problems|0|||
129440681|NCT00792805|465913108|FG002|Overall Study|Administrative problems|4|||
129440682|NCT00792805|465913106|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129440683|NCT00792805|465913107|FG001|Overall Study|Abnormal test procedure result(s)|2|||
129440684|NCT00792805|465913108|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129440685|NCT00792805|465913106|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129440686|NCT00792805|465913107|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129440687|NCT00792805|465913108|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
129440688|NCT00792805|465913106|FG000|Overall Study|Lost to Follow-up|1|||
129440689|NCT00792805|465913107|FG001|Overall Study|Lost to Follow-up|1|||
129440690|NCT00792805|465913108|FG002|Overall Study|Lost to Follow-up|6|||
129440691|NCT00792805|465913106|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129440692|NCT00792805|465913107|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129440693|NCT00792805|465913108|FG002|Overall Study|Abnormal laboratory value(s)|1|||
129440694|NCT00792805|465913106|FG000|Overall Study|Protocol deviation|0|||
129440695|NCT00792805|465913107|FG001|Overall Study|Protocol deviation|1|||
129440696|NCT00792805|465913108|FG002|Overall Study|Protocol deviation|1|||
129440697|NCT03224325|465913109|FG000|Overall Study|Adverse Event|1|||
129440698|NCT03224325|465913110|FG001|Overall Study|Adverse Event|0|||
129440699|NCT03224325|465913111|FG002|Overall Study|Adverse Event|0|||
129440700|NCT03224325|465913112|FG003|Overall Study|Adverse Event|0|||
129440701|NCT03224325|465913113|FG004|Overall Study|Adverse Event|0|||
129440702|NCT03224325|465913114|FG005|Overall Study|Adverse Event|0|||
129440703|NCT03224325|465913115|FG006|Overall Study|Adverse Event|1|||
129440704|NCT03224325|465913109|FG000|Overall Study|Withdrawal by Subject|0|||
129440705|NCT03224325|465913110|FG001|Overall Study|Withdrawal by Subject|0|||
129440706|NCT03224325|465913111|FG002|Overall Study|Withdrawal by Subject|0|||
129440707|NCT03224325|465913112|FG003|Overall Study|Withdrawal by Subject|1|||
129440708|NCT03224325|465913113|FG004|Overall Study|Withdrawal by Subject|0|||
129440709|NCT03224325|465913114|FG005|Overall Study|Withdrawal by Subject|0|||
129440710|NCT03224325|465913115|FG006|Overall Study|Withdrawal by Subject|0|||
129440711|NCT02120625|465913117|FG000|Overall Study|Physician Decision|2|||
129440712|NCT03278106|465913123|FG000|Overall Study|No protocol treatment|1|||
129440713|NCT00818389|465913124|FG000|Overall Study|Death|1|||
129440714|NCT00818389|465913125|FG001|Overall Study|Death|3|||
129440715|NCT00818389|465913124|FG000|Overall Study|ALS Disease Progression|1|||
129440716|NCT00818389|465913125|FG001|Overall Study|ALS Disease Progression|0|||
129440717|NCT00818389|465913124|FG000|Overall Study|Withdrawal by Subject|2|||
129440718|NCT00818389|465913125|FG001|Overall Study|Withdrawal by Subject|2|||
129440719|NCT00818389|465913124|FG000|Overall Study|Adverse Event|0|||
129440720|NCT00818389|465913125|FG001|Overall Study|Adverse Event|1|||
129440721|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
129440722|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
129440723|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
129440724|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
129440725|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
129440726|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
129440727|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
129440728|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
129440729|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
129440730|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
129440731|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
129440732|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
129440733|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
129440734|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
129440735|NCT03548987|465913126|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
129636845|NCT03850483|466624279|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
129636846|NCT03850483|466624280|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
129440736|NCT03548987|465913127|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
129636847|NCT03850483|466624281|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
129440737|NCT03548987|465913126|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
129440738|NCT03548987|465913127|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
129440739|NCT03548987|465913126|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
129440740|NCT03548987|465913127|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
129440741|NCT03548987|465913126|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
129440742|NCT03548987|465913127|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
129440743|NCT03548987|465913126|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
129440744|NCT03548987|465913127|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
129440745|NCT03548987|465913126|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
129440746|NCT03548987|465913127|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
129440747|NCT03548987|465913126|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
129440748|NCT03548987|465913127|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
129440749|NCT00756470|465913128|FG000|Overall Study|Withdrawal by Subject|1|||
129440750|NCT00756470|465913128|FG000|Overall Study|Adverse Event|4|||
129440751|NCT00820027|465913129|FG000|Overall Study|Adverse Event|15|||
129440752|NCT00820027|465913130|FG001|Overall Study|Adverse Event|8|||
129440753|NCT00820027|465913131|FG002|Overall Study|Adverse Event|10|||
129440754|NCT00820027|465913132|FG003|Overall Study|Adverse Event|5|||
129440755|NCT00820027|465913129|FG000|Overall Study|Lack of Efficacy|2|||
129440756|NCT00820027|465913130|FG001|Overall Study|Lack of Efficacy|1|||
129440757|NCT00820027|465913131|FG002|Overall Study|Lack of Efficacy|2|||
129440758|NCT00820027|465913132|FG003|Overall Study|Lack of Efficacy|2|||
129440759|NCT00820027|465913129|FG000|Overall Study|Physician Decision|0|||
129440760|NCT00820027|465913130|FG001|Overall Study|Physician Decision|1|||
129440761|NCT00820027|465913131|FG002|Overall Study|Physician Decision|1|||
129440762|NCT00820027|465913132|FG003|Overall Study|Physician Decision|0|||
129440763|NCT00820027|465913129|FG000|Overall Study|Protocol Violation|3|||
129440764|NCT00820027|465913130|FG001|Overall Study|Protocol Violation|0|||
129440765|NCT00820027|465913131|FG002|Overall Study|Protocol Violation|4|||
129440766|NCT00820027|465913132|FG003|Overall Study|Protocol Violation|0|||
129440767|NCT00820027|465913129|FG000|Overall Study|Withdrawal by Subject|6|||
129440768|NCT00820027|465913130|FG001|Overall Study|Withdrawal by Subject|4|||
129440769|NCT00820027|465913131|FG002|Overall Study|Withdrawal by Subject|4|||
129440770|NCT00820027|465913132|FG003|Overall Study|Withdrawal by Subject|6|||
129440771|NCT02604433|465913133|FG000|Overall Study|Withdrawal by Subject|37|||
129440772|NCT02604433|465913134|FG001|Overall Study|Withdrawal by Subject|16|||
129440773|NCT02604433|465913133|FG000|Overall Study|Adverse Event|4|||
129440774|NCT02604433|465913134|FG001|Overall Study|Adverse Event|0|||
129440775|NCT02604433|465913133|FG000|Overall Study|Other reasons|3|||
129440776|NCT02604433|465913134|FG001|Overall Study|Other reasons|5|||
129440777|NCT02604433|465913133|FG000|Overall Study|Death|4|||
129440778|NCT02604433|465913134|FG001|Overall Study|Death|1|||
129440779|NCT02604433|465913133|FG000|Overall Study|Transition to Rollover Protocol|169|||
129440780|NCT02604433|465913134|FG001|Overall Study|Transition to Rollover Protocol|82|||
129440781|NCT02604433|465913133|FG000|Overall Study|Physician Decision|1|||
129440782|NCT02604433|465913134|FG001|Overall Study|Physician Decision|1|||
129440783|NCT02604433|465913133|FG000|Overall Study|Lack of Efficacy|0|||
129440784|NCT02604433|465913134|FG001|Overall Study|Lack of Efficacy|1|||
129440785|NCT03437278|465913135|FG000|Overall Study|Adverse Event|0|||
129440786|NCT03437278|465913136|FG001|Overall Study|Adverse Event|0|||
129440787|NCT03437278|465913137|FG002|Overall Study|Adverse Event|1|||
129440788|NCT03437278|465913135|FG000|Overall Study|Progressive disease|1|||
129440789|NCT03437278|465913136|FG001|Overall Study|Progressive disease|0|||
129440790|NCT03437278|465913137|FG002|Overall Study|Progressive disease|0|||
129440791|NCT03437278|465913135|FG000|Overall Study|Physician Decision|1|||
129440792|NCT03437278|465913136|FG001|Overall Study|Physician Decision|0|||
129440793|NCT03437278|465913137|FG002|Overall Study|Physician Decision|1|||
129440794|NCT02202551|465913138|FG000|Overall Study|Adverse Event|8|||
129440795|NCT02202551|465913139|FG001|Overall Study|Adverse Event|19|||
129440796|NCT02202551|465913140|FG002|Overall Study|Adverse Event|5|||
129440797|NCT02202551|465913141|FG003|Overall Study|Adverse Event|9|||
129440798|NCT02202551|465913138|FG000|Overall Study|Death|3|||
129440799|NCT02202551|465913139|FG001|Overall Study|Death|2|||
129440800|NCT02202551|465913140|FG002|Overall Study|Death|1|||
129440801|NCT02202551|465913141|FG003|Overall Study|Death|1|||
129440802|NCT02202551|465913138|FG000|Overall Study|Lost to Follow-up|0|||
129440803|NCT02202551|465913139|FG001|Overall Study|Lost to Follow-up|1|||
129440804|NCT02202551|465913140|FG002|Overall Study|Lost to Follow-up|0|||
129440805|NCT02202551|465913141|FG003|Overall Study|Lost to Follow-up|1|||
129440806|NCT02202551|465913138|FG000|Overall Study|Needed to take excluded medication|0|||
129440807|NCT02202551|465913139|FG001|Overall Study|Needed to take excluded medication|2|||
129440808|NCT02202551|465913140|FG002|Overall Study|Needed to take excluded medication|0|||
129440809|NCT02202551|465913141|FG003|Overall Study|Needed to take excluded medication|1|||
129440810|NCT02202551|465913138|FG000|Overall Study|Subject moved away|0|||
129440811|NCT02202551|465913139|FG001|Overall Study|Subject moved away|1|||
129440812|NCT02202551|465913140|FG002|Overall Study|Subject moved away|0|||
129440813|NCT02202551|465913141|FG003|Overall Study|Subject moved away|0|||
129440814|NCT02202551|465913138|FG000|Overall Study|DBS surgery|3|||
129440815|NCT02202551|465913139|FG001|Overall Study|DBS surgery|0|||
129440816|NCT02202551|465913140|FG002|Overall Study|DBS surgery|0|||
129440817|NCT02202551|465913141|FG003|Overall Study|DBS surgery|0|||
129440818|NCT02202551|465913138|FG000|Overall Study|Dyskinesia upon taper|1|||
129440819|NCT02202551|465913139|FG001|Overall Study|Dyskinesia upon taper|0|||
129440820|NCT02202551|465913140|FG002|Overall Study|Dyskinesia upon taper|0|||
129440821|NCT02202551|465913141|FG003|Overall Study|Dyskinesia upon taper|0|||
129440822|NCT02202551|465913138|FG000|Overall Study|Lack of Efficacy|0|||
129440823|NCT02202551|465913139|FG001|Overall Study|Lack of Efficacy|1|||
129440824|NCT02202551|465913140|FG002|Overall Study|Lack of Efficacy|0|||
129440825|NCT02202551|465913141|FG003|Overall Study|Lack of Efficacy|0|||
129440826|NCT02202551|465913138|FG000|Overall Study|Physician Decision|1|||
129440827|NCT02202551|465913139|FG001|Overall Study|Physician Decision|0|||
129440828|NCT02202551|465913140|FG002|Overall Study|Physician Decision|0|||
129440829|NCT02202551|465913141|FG003|Overall Study|Physician Decision|0|||
129440830|NCT02202551|465913138|FG000|Overall Study|Site closure|3|||
129440831|NCT02202551|465913139|FG001|Overall Study|Site closure|0|||
129440832|NCT02202551|465913140|FG002|Overall Study|Site closure|0|||
129440833|NCT02202551|465913141|FG003|Overall Study|Site closure|1|||
129440834|NCT02202551|465913138|FG000|Overall Study|Unable to complete visits per protocol|1|||
129440835|NCT02202551|465913139|FG001|Overall Study|Unable to complete visits per protocol|0|||
129440836|NCT02202551|465913140|FG002|Overall Study|Unable to complete visits per protocol|0|||
129440837|NCT02202551|465913141|FG003|Overall Study|Unable to complete visits per protocol|0|||
129440838|NCT02202551|465913138|FG000|Overall Study|Worsening Dyskinesia|0|||
129440839|NCT02202551|465913139|FG001|Overall Study|Worsening Dyskinesia|0|||
129440840|NCT02202551|465913140|FG002|Overall Study|Worsening Dyskinesia|0|||
129440841|NCT02202551|465913141|FG003|Overall Study|Worsening Dyskinesia|1|||
129440842|NCT02202551|465913138|FG000|Overall Study|Protocol Violation|0|||
129440843|NCT02202551|465913139|FG001|Overall Study|Protocol Violation|1|||
129440844|NCT02202551|465913140|FG002|Overall Study|Protocol Violation|0|||
129440845|NCT02202551|465913141|FG003|Overall Study|Protocol Violation|0|||
129440846|NCT02202551|465913138|FG000|Overall Study|Sponsor's decision|2|||
129440847|NCT02202551|465913139|FG001|Overall Study|Sponsor's decision|0|||
129440848|NCT02202551|465913140|FG002|Overall Study|Sponsor's decision|0|||
129440849|NCT02202551|465913141|FG003|Overall Study|Sponsor's decision|0|||
129440850|NCT02202551|465913138|FG000|Overall Study|Subject unwilling to proceed|1|||
129440851|NCT02202551|465913139|FG001|Overall Study|Subject unwilling to proceed|5|||
129440852|NCT02202551|465913140|FG002|Overall Study|Subject unwilling to proceed|3|||
129440853|NCT02202551|465913141|FG003|Overall Study|Subject unwilling to proceed|5|||
129440854|NCT02202551|465913138|FG000|Overall Study|Subject consent withdrawn|0|||
129440855|NCT02202551|465913139|FG001|Overall Study|Subject consent withdrawn|3|||
129440856|NCT02202551|465913140|FG002|Overall Study|Subject consent withdrawn|1|||
129440857|NCT02202551|465913141|FG003|Overall Study|Subject consent withdrawn|2|||
129440858|NCT02202551|465913138|FG000|Overall Study|eGFR<50mL/min/m2|2|||
129440859|NCT02202551|465913139|FG001|Overall Study|eGFR<50mL/min/m2|2|||
129440860|NCT02202551|465913140|FG002|Overall Study|eGFR<50mL/min/m2|0|||
129440861|NCT02202551|465913141|FG003|Overall Study|eGFR<50mL/min/m2|1|||
129440862|NCT01776424|465913142|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
129440863|NCT01776424|465913143|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
129440864|NCT01776424|465913144|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
129440865|NCT01776424|465913142|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
129440866|NCT01776424|465913143|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
129440867|NCT01776424|465913144|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
129440868|NCT01776424|465913142|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
129440869|NCT01776424|465913143|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
129440870|NCT01776424|465913144|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
129440871|NCT01776424|465913142|FG000|LTOLE Part (Open Label)|Refused|5|||
129440872|NCT01776424|465913143|FG001|LTOLE Part (Open Label)|Refused|2|||
129440873|NCT01776424|465913144|FG002|LTOLE Part (Open Label)|Refused|11|||
129704953|NCT05067335|466884103|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
129440874|NCT01776424|465913142|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
129440875|NCT01776424|465913143|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
129704954|NCT05067335|466884100|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
129440876|NCT01776424|465913144|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
129440877|NCT00146757|465913145|FG000|Overall Study|Death|1|||
129440878|NCT00146757|465913146|FG001|Overall Study|Death|0|||
129440879|NCT00146757|465913145|FG000|Overall Study|Adverse Event|1|||
129440880|NCT00146757|465913146|FG001|Overall Study|Adverse Event|0|||
129440881|NCT02349360|465913156|FG000|Overall Study|Withdrawal by Subject|0|||
129440882|NCT02349360|465913157|FG001|Overall Study|Withdrawal by Subject|1|||
129440883|NCT01176773|465913158|FG000|Overall Study|Screen Failure|2|||
129440884|NCT01176773|465913158|FG000|Overall Study|Withdrew consent|1|||
129440885|NCT01794923|465913171|FG000|Overall Study|Adverse Event|0|||
129440886|NCT01794923|465913172|FG001|Overall Study|Adverse Event|0|||
129440887|NCT01794923|465913173|FG002|Overall Study|Adverse Event|1|||
129636848|NCT03850483|466624282|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
129636849|NCT03850483|466624283|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
129636850|NCT03850483|466624284|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
129440888|NCT00752622|465913183|FG000|Induction Phase|Adverse Event|3|||
129440889|NCT00752622|465913183|FG000|Induction Phase|Other|3|||
129440890|NCT00752622|465913183|FG000|Induction Phase|Non-responder|14|||
129440891|NCT00752622|465913183|FG000|Induction Phase|Withdrawal by Subject|1|||
129440892|NCT00752622|465913183|FG000|Induction Phase|Premature study termination|14|||
129440893|NCT00752622|465913183|FG000|Observational Phase|Premature Study Termination|36|||
129440894|NCT00752622|465913183|FG000|Observational Phase|Non-responder|2|||
129636851|NCT03850483|466624285|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
129636852|NCT03850483|466624286|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
129636853|NCT03850483|466624277|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636854|NCT03850483|466624278|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636855|NCT03850483|466624279|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636856|NCT03850483|466624280|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636857|NCT03850483|466624281|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636858|NCT03850483|466624282|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636859|NCT03850483|466624283|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636860|NCT03850483|466624284|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129636861|NCT03850483|466624285|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
129440895|NCT00752622|465913183|FG000|Observational Phase|Withdrawal by Subject|2|||
129440896|NCT00752622|465913183|FG000|Observational Phase|Adverse Event|1|||
129440897|NCT00752622|465913183|FG000|Observational Phase|Other|2|||
129440898|NCT00752622|465913183|FG000|Interventional Phase|Non-responder|2|||
129440899|NCT00752622|465913183|FG000|Interventional Phase|Physician Decision|1|||
129440900|NCT00752622|465913183|FG000|Interventional Phase|Premature Study Termination|5|||
129440901|NCT00894686|465913184|FG000|Overall Study|Withdrawal by Subject|50|||
129440902|NCT00894686|465913184|FG000|Overall Study|Physician Decision|1|||
129440903|NCT00894686|465913184|FG000|Overall Study|Other|5|||
129440904|NCT03267940|465913187|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
129440905|NCT03267940|465913188|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
129440906|NCT03267940|465913189|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129440907|NCT03267940|465913190|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129440908|NCT03267940|465913191|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129440909|NCT03267940|465913192|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
129440910|NCT03267940|465913187|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129440911|NCT03267940|465913188|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
129440912|NCT03267940|465913189|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129440913|NCT03267940|465913190|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129440914|NCT03267940|465913191|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129440915|NCT03267940|465913192|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
129440916|NCT03267940|465913187|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129440917|NCT03267940|465913188|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
129440918|NCT03267940|465913189|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129440919|NCT03267940|465913190|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129440920|NCT03267940|465913191|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129440921|NCT03267940|465913192|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
129440922|NCT03267940|465913187|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
129440923|NCT03267940|465913188|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
129440924|NCT03267940|465913189|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129440925|NCT03267940|465913190|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129440926|NCT03267940|465913191|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129440927|NCT03267940|465913192|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
129440928|NCT03267940|465913187|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129440929|NCT03267940|465913188|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129440930|NCT03267940|465913189|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129440931|NCT03267940|465913190|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
129440932|NCT03267940|465913191|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
129440933|NCT03267940|465913192|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
129440934|NCT03267940|465913187|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
129440935|NCT03267940|465913188|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
129440936|NCT03267940|465913189|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
129440937|NCT03267940|465913190|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
129440938|NCT03267940|465913191|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
129440939|NCT03267940|465913192|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
129440940|NCT03267940|465913187|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
129440941|NCT03267940|465913188|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
129440942|NCT03267940|465913189|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
129440943|NCT03267940|465913190|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
129440944|NCT03267940|465913191|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
129440945|NCT03267940|465913192|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
129440946|NCT03267940|465913187|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
129440947|NCT03267940|465913188|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
129440948|NCT03267940|465913189|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
129440949|NCT03267940|465913190|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
129440950|NCT03267940|465913191|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
129440951|NCT03267940|465913192|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
129440952|NCT03267940|465913187|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
129440953|NCT03267940|465913188|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
129440954|NCT03267940|465913189|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
129440955|NCT03267940|465913190|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
129440956|NCT03267940|465913191|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
129440957|NCT03267940|465913192|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
129440958|NCT00388154|465913199|FG000|Overall Study|Withdrawal by Subject|1|||
129440959|NCT01948908|465913202|FG000|Overall Study|Protocol Violation|1|||
129440960|NCT01948908|465913203|FG001|Overall Study|Protocol Violation|0|||
129440961|NCT01948908|465913204|FG002|Overall Study|Protocol Violation|2|||
129440962|NCT03291587|465913205|FG000|Overall Study|Lost to Follow-up|62|||
129440963|NCT03291587|465913206|FG001|Overall Study|Lost to Follow-up|43|||
129440964|NCT03291587|465913205|FG000|Overall Study|Refused to Answer|5|||
129440965|NCT03291587|465913206|FG001|Overall Study|Refused to Answer|2|||
129440966|NCT03291587|465913205|FG000|Overall Study|Death|2|||
129440967|NCT03291587|465913206|FG001|Overall Study|Death|4|||
129440968|NCT03291587|465913205|FG000|Overall Study|Not interested in participating|8|||
129440969|NCT03291587|465913206|FG001|Overall Study|Not interested in participating|6|||
129440970|NCT03291587|465913205|FG000|Overall Study|Too busy to participate|4|||
129440971|NCT03291587|465913206|FG001|Overall Study|Too busy to participate|2|||
129440972|NCT00796120|465913208|FG000|Overall Study|Death|3|||
129440973|NCT00796120|465913209|FG001|Overall Study|Death|0|||
129440974|NCT00796120|465913208|FG000|Overall Study|Adverse Event|11|||
129440975|NCT00796120|465913209|FG001|Overall Study|Adverse Event|6|||
129440976|NCT00796120|465913208|FG000|Overall Study|Progressive disease|22|||
129440977|NCT00796120|465913209|FG001|Overall Study|Progressive disease|13|||
129440978|NCT00796120|465913208|FG000|Overall Study|Participant refusal|3|||
129440979|NCT00796120|465913209|FG001|Overall Study|Participant refusal|4|||
129440980|NCT00796120|465913208|FG000|Overall Study|Other|6|||
129440981|NCT00796120|465913209|FG001|Overall Study|Other|17|||
129440982|NCT00796120|465913208|FG000|Overall Study|Physician Decision|16|||
129440983|NCT00796120|465913209|FG001|Overall Study|Physician Decision|17|||
129440984|NCT00796120|465913208|FG000|Overall Study|Randomized but not treated|0|||
129440985|NCT00796120|465913209|FG001|Overall Study|Randomized but not treated|3|||
129440986|NCT02520284|465913210|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
129440987|NCT02520284|465913211|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
129440988|NCT02520284|465913212|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
129440989|NCT02520284|465913210|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
129440990|NCT02520284|465913211|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
129636862|NCT03850483|466624286|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
129636863|NCT03850483|466624277|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
129636864|NCT03850483|466624278|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
129636865|NCT03850483|466624279|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
129440991|NCT02520284|465913212|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
129440992|NCT02520284|465913210|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
129440993|NCT02520284|465913211|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
129440994|NCT02520284|465913212|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
129440995|NCT02520284|465913210|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
129440996|NCT02520284|465913211|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
129440997|NCT02520284|465913212|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
129440998|NCT02520284|465913210|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
129440999|NCT02520284|465913211|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
129441000|NCT02520284|465913212|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
129441001|NCT02520284|465913210|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
129441002|NCT02520284|465913211|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
129441003|NCT02520284|465913212|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
129441004|NCT02520284|465913210|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
129441005|NCT02520284|465913211|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
129636866|NCT03850483|466624280|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
129636867|NCT03850483|466624281|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
129441006|NCT02520284|465913212|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
129441007|NCT02520284|465913210|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
129441008|NCT02520284|465913211|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
129441009|NCT02520284|465913212|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
129441010|NCT02520284|465913210|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
129441011|NCT02520284|465913211|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
129441012|NCT02520284|465913212|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
129441013|NCT02520284|465913210|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
129441014|NCT02520284|465913211|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
129441015|NCT02520284|465913212|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
129441016|NCT02520284|465913210|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
129441017|NCT02520284|465913211|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
129441018|NCT02520284|465913212|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
129441019|NCT01898923|465913213|FG000|Overall Study|Lack of Efficacy|5|||
129441020|NCT01898923|465913214|FG001|Overall Study|Lack of Efficacy|6|||
129441021|NCT01898923|465913213|FG000|Overall Study|Adverse Event|3|||
129441022|NCT01898923|465913214|FG001|Overall Study|Adverse Event|1|||
129441023|NCT01898923|465913213|FG000|Overall Study|Lost to Follow-up|0|||
129441024|NCT01898923|465913214|FG001|Overall Study|Lost to Follow-up|1|||
129441025|NCT01898923|465913213|FG000|Overall Study|Withdrawal by Subject|4|||
129441026|NCT01898923|465913214|FG001|Overall Study|Withdrawal by Subject|7|||
129441027|NCT01898923|465913213|FG000|Overall Study|Physician Decision|3|||
129441028|NCT01898923|465913214|FG001|Overall Study|Physician Decision|4|||
129441029|NCT01898923|465913213|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
129441030|NCT01898923|465913214|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
129441031|NCT00381303|465913219|FG000|Overall Study|Lost to Follow-up|25|||
129441032|NCT00381303|465913220|FG001|Overall Study|Lost to Follow-up|9|||
129441033|NCT00381303|465913219|FG000|Overall Study|AE/HIV-related event|22|||
129441034|NCT00381303|465913220|FG001|Overall Study|AE/HIV-related event|6|||
129797737|NCT02007512|467228211|FG000|Double Blind Treatment Period|Disease progression|51|||
129441035|NCT00381303|465913219|FG000|Overall Study|Non-Adherence|13|||
129441036|NCT00381303|465913220|FG001|Overall Study|Non-Adherence|6|||
129441037|NCT00381303|465913219|FG000|Overall Study|Withdrawal by Subject|13|||
129441038|NCT00381303|465913220|FG001|Overall Study|Withdrawal by Subject|6|||
129441039|NCT00381303|465913219|FG000|Overall Study|Virologic failure|6|||
129797738|NCT02007512|467228212|FG001|Double Blind Treatment Period|Disease progression|50|||
129797739|NCT02007512|467228213|FG002|Double Blind Treatment Period|Disease progression|57|||
129797740|NCT02007512|467228214|FG003|Double Blind Treatment Period|Disease progression|52|||
129797741|NCT02007512|467228211|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797742|NCT02007512|467228212|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797743|NCT02007512|467228213|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797744|NCT02007512|467228214|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
129797745|NCT02007512|467228211|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129797746|NCT02007512|467228212|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129797747|NCT02007512|467228213|FG002|Double Blind Treatment Period|Protocol Violation|0|||
129797748|NCT02007512|467228214|FG003|Double Blind Treatment Period|Protocol Violation|1|||
129797749|NCT02007512|467228211|FG000|Double Blind Treatment Period|Other|2|||
129797750|NCT02007512|467228212|FG001|Double Blind Treatment Period|Other|1|||
129797751|NCT02007512|467228213|FG002|Double Blind Treatment Period|Other|1|||
129797752|NCT02007512|467228214|FG003|Double Blind Treatment Period|Other|2|||
129797753|NCT02007512|467228211|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
129797754|NCT02007512|467228212|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
129797755|NCT02007512|467228213|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
129797756|NCT02007512|467228214|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
129797757|NCT02007512|467228211|FG000|Open Label Treatment Period|Adverse Event|1|||
129797758|NCT02007512|467228212|FG001|Open Label Treatment Period|Adverse Event|0|||
129797759|NCT02007512|467228213|FG002|Open Label Treatment Period|Adverse Event|0|||
129797760|NCT02007512|467228214|FG003|Open Label Treatment Period|Adverse Event|0|||
129797761|NCT02007512|467228211|FG000|Open Label Treatment Period|Other|1|||
129797762|NCT02007512|467228212|FG001|Open Label Treatment Period|Other|1|||
129797763|NCT02007512|467228213|FG002|Open Label Treatment Period|Other|0|||
129797764|NCT02007512|467228214|FG003|Open Label Treatment Period|Other|0|||
129797765|NCT02007512|467228211|FG000|Open Label Treatment Period|Disease progression|23|||
129797766|NCT02007512|467228212|FG001|Open Label Treatment Period|Disease progression|11|||
129797767|NCT02007512|467228213|FG002|Open Label Treatment Period|Disease progression|0|||
129797768|NCT02007512|467228214|FG003|Open Label Treatment Period|Disease progression|0|||
129636868|NCT03850483|466624282|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
129797769|NCT00900601|467228219|FG000|Overall Study|Physician Decision|1|||
129797770|NCT00608543|467228220|FG000|Overall Study|Adverse Event|4|||
129797771|NCT03026088|467228221|FG000|Overall Study|Study termination|20|||
129441040|NCT00381303|465913220|FG001|Overall Study|Virologic failure|4|||
129441041|NCT00381303|465913219|FG000|Overall Study|Ineligible to continue the trial|2|||
129441042|NCT00381303|465913220|FG001|Overall Study|Ineligible to continue the trial|1|||
129441043|NCT00381303|465913219|FG000|Overall Study|Pregnancy|2|||
129441044|NCT00381303|465913220|FG001|Overall Study|Pregnancy|0|||
129441045|NCT00381303|465913219|FG000|Overall Study|Physician Decision|1|||
129441046|NCT00381303|465913220|FG001|Overall Study|Physician Decision|0|||
129441047|NCT00381303|465913219|FG000|Overall Study|Physician's decision to close the site|3|||
129441048|NCT00381303|465913220|FG001|Overall Study|Physician's decision to close the site|1|||
129441049|NCT00381303|465913219|FG000|Overall Study|Subject moved out of state|2|||
129441050|NCT00381303|465913220|FG001|Overall Study|Subject moved out of state|0|||
129441051|NCT00381303|465913219|FG000|Overall Study|Subject taking too many different meds|1|||
129441052|NCT00381303|465913220|FG001|Overall Study|Subject taking too many different meds|0|||
129441053|NCT00381303|465913219|FG000|Overall Study|No virologic response by week 12|1|||
129441054|NCT00381303|465913220|FG001|Overall Study|No virologic response by week 12|0|||
129441055|NCT00381303|465913219|FG000|Overall Study|Subject was too busy for appointments|1|||
129441056|NCT00381303|465913220|FG001|Overall Study|Subject was too busy for appointments|0|||
129441057|NCT00381303|465913219|FG000|Overall Study|Subject did not continue visits|1|||
129441058|NCT00381303|465913220|FG001|Overall Study|Subject did not continue visits|0|||
129441059|NCT00381303|465913219|FG000|Overall Study|Subject primary physician's decision|1|||
129441060|NCT00381303|465913220|FG001|Overall Study|Subject primary physician's decision|0|||
129441061|NCT01211522|465913221|FG000|Overall Study|Withdrawal by Subject|3|||
129441062|NCT01211522|465913222|FG001|Overall Study|Withdrawal by Subject|7|||
129441063|NCT01211522|465913223|FG002|Overall Study|Withdrawal by Subject|5|||
129441064|NCT00547365|465913225|FG000|Overall Study|Physician Decision|1|||
129441065|NCT00547365|465913225|FG000|Overall Study|Lost to Follow-up|1|||
129441066|NCT00547365|465913225|FG000|Overall Study|Protocol Violation|2|||
129441067|NCT00547365|465913225|FG000|Overall Study|death (not related to study)|4|||
129441068|NCT00504881|465913226|FG000|Overall Study|Lack of Efficacy|1|||
129441069|NCT00504881|465913227|FG001|Overall Study|Lack of Efficacy|5|||
129441070|NCT00504881|465913226|FG000|Overall Study|Lost to Follow-up|0|||
129441071|NCT00504881|465913227|FG001|Overall Study|Lost to Follow-up|2|||
129441072|NCT00504881|465913226|FG000|Overall Study|Withdrawal by Subject|1|||
129441073|NCT00504881|465913227|FG001|Overall Study|Withdrawal by Subject|4|||
129441074|NCT00504881|465913226|FG000|Overall Study|Non-Compliance|1|||
129441075|NCT00504881|465913227|FG001|Overall Study|Non-Compliance|0|||
129441076|NCT00504881|465913226|FG000|Overall Study|No Birth Control|0|||
129441077|NCT00504881|465913227|FG001|Overall Study|No Birth Control|1|||
129441078|NCT00504881|465913226|FG000|Overall Study|Safety Visit not performed|0|||
129441079|NCT00504881|465913227|FG001|Overall Study|Safety Visit not performed|1|||
129441080|NCT00504881|465913226|FG000|Overall Study|AE, serious fatal|0|||
129441081|NCT00504881|465913227|FG001|Overall Study|AE, serious fatal|1|||
129441082|NCT00504881|465913226|FG000|Overall Study|SAE, non-fatal|2|||
129441083|NCT00504881|465913227|FG001|Overall Study|SAE, non-fatal|6|||
129441084|NCT00504881|465913226|FG000|Overall Study|AE, non-serious non-fatal|4|||
129441085|NCT00504881|465913227|FG001|Overall Study|AE, non-serious non-fatal|14|||
129441086|NCT00504881|465913226|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129441087|NCT00504881|465913227|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
129441088|NCT00504881|465913226|FG000|Overall Study|AE of unknown type|1|||
129441089|NCT00504881|465913227|FG001|Overall Study|AE of unknown type|0|||
129441090|NCT01777269|465913228|FG000|Overall Study|Adverse Event|24|||
129441091|NCT01777269|465913229|FG001|Overall Study|Adverse Event|33|||
129441092|NCT01777269|465913228|FG000|Overall Study|Lack of Efficacy|8|||
129441093|NCT01777269|465913229|FG001|Overall Study|Lack of Efficacy|10|||
129441094|NCT01777269|465913228|FG000|Overall Study|Protocol Violation|4|||
129441095|NCT01777269|465913229|FG001|Overall Study|Protocol Violation|4|||
129441096|NCT01777269|465913228|FG000|Overall Study|Participants reached stopping criteria|1|||
129441097|NCT01777269|465913229|FG001|Overall Study|Participants reached stopping criteria|1|||
129441098|NCT01777269|465913228|FG000|Overall Study|Lost to Follow-up|4|||
129441099|NCT01777269|465913229|FG001|Overall Study|Lost to Follow-up|0|||
129441100|NCT01777269|465913228|FG000|Overall Study|Physician Decision|5|||
129441101|NCT01777269|465913229|FG001|Overall Study|Physician Decision|2|||
129441102|NCT01777269|465913228|FG000|Overall Study|Withdrawal by Subject|9|||
129441103|NCT01777269|465913229|FG001|Overall Study|Withdrawal by Subject|9|||
129441104|NCT01966471|465913231|FG000|Overall Study|Death|44|||
129441105|NCT01966471|465913232|FG001|Overall Study|Death|56|||
129636869|NCT03850483|466624283|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
129441106|NCT01966471|465913231|FG000|Overall Study|Lost to Follow-up|46|||
129441107|NCT01966471|465913232|FG001|Overall Study|Lost to Follow-up|39|||
129441108|NCT01966471|465913231|FG000|Overall Study|Various reasons|4|||
129441109|NCT01966471|465913232|FG001|Overall Study|Various reasons|4|||
129441110|NCT01966471|465913231|FG000|Overall Study|Physician Decision|7|||
129441111|NCT01966471|465913232|FG001|Overall Study|Physician Decision|5|||
129441112|NCT01966471|465913231|FG000|Overall Study|Study Terminated By Sponsor|758|||
129441113|NCT01966471|465913232|FG001|Overall Study|Study Terminated By Sponsor|773|||
129441114|NCT01966471|465913231|FG000|Overall Study|Withdrawal by Subject|59|||
129441115|NCT01966471|465913232|FG001|Overall Study|Withdrawal by Subject|51|||
129441116|NCT01030198|465913233|FG000|Overall Study|Could not measure efficacy accurately|0|||
129441117|NCT01030198|465913234|FG001|Overall Study|Could not measure efficacy accurately|7|||
129441118|NCT02370043|465913235|FG000|Overall Study|Withdrawal by Subject|0|||
129441119|NCT02370043|465913236|FG001|Overall Study|Withdrawal by Subject|0|||
129441120|NCT02370043|465913237|FG002|Overall Study|Withdrawal by Subject|0|||
129441121|NCT02370043|465913238|FG003|Overall Study|Withdrawal by Subject|0|||
129441122|NCT02370043|465913239|FG004|Overall Study|Withdrawal by Subject|1|||
129441123|NCT02370043|465913240|FG005|Overall Study|Withdrawal by Subject|1|||
129441124|NCT00688181|465913241|FG000|Overall Study|Lost to Follow-up|17|||
129441125|NCT00688181|465913241|FG000|Overall Study|Unknown Reason|4|||
129441126|NCT00688181|465913241|FG000|Overall Study|Non-clinical Reason|2|||
129441127|NCT01050205|465913242|FG000|Overall Study|Lost to Follow-up|7|||
129441128|NCT01050205|465913243|FG001|Overall Study|Lost to Follow-up|1|||
129441129|NCT01050205|465913242|FG000|Overall Study|Withdrawal by Subject|1|||
129441130|NCT01050205|465913243|FG001|Overall Study|Withdrawal by Subject|1|||
129441131|NCT01050205|465913242|FG000|Overall Study|Relocated from area|1|||
129441132|NCT01050205|465913243|FG001|Overall Study|Relocated from area|2|||
129441133|NCT01050205|465913242|FG000|Overall Study|Discontinued Intervention|2|||
129441134|NCT01050205|465913243|FG001|Overall Study|Discontinued Intervention|0|||
129441135|NCT01119001|465913244|FG000|Overall Study|Withdrawal by Subject|2|||
129441136|NCT00954421|465913245|FG000|Screening|screen failures|3|||
129441137|NCT00954421|465913245|FG000|6 Months of DBS|Withdrawal by Subject|1|||
129441138|NCT00954421|465913245|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
129441139|NCT00777946|465913246|FG000|Overall Study|Adverse Event|11|||
129441140|NCT00777946|465913247|FG001|Overall Study|Adverse Event|1|||
129441141|NCT00777946|465913248|FG002|Overall Study|Adverse Event|3|||
129441142|NCT00777946|465913246|FG000|Overall Study|Lack of Efficacy|0|||
129441143|NCT00777946|465913247|FG001|Overall Study|Lack of Efficacy|0|||
129441144|NCT00777946|465913248|FG002|Overall Study|Lack of Efficacy|9|||
129441145|NCT00777946|465913246|FG000|Overall Study|Condition no longer required study drug|1|||
129441146|NCT00777946|465913247|FG001|Overall Study|Condition no longer required study drug|0|||
129441147|NCT00777946|465913248|FG002|Overall Study|Condition no longer required study drug|0|||
129636870|NCT03850483|466624284|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
129636871|NCT03850483|466624285|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
129636872|NCT03850483|466624286|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
129636873|NCT03850483|466624277|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
129636874|NCT03850483|466624278|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
129636875|NCT03850483|466624279|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
129636876|NCT03850483|466624280|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
129636877|NCT03850483|466624281|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
129636878|NCT03850483|466624282|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
129636879|NCT03850483|466624283|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
129636880|NCT03850483|466624284|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
129636881|NCT03850483|466624285|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
129636882|NCT03850483|466624286|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
129636883|NCT03850483|466624277|FG000|Follow-up For Stage 2|Other|0|||
129636884|NCT03850483|466624278|FG001|Follow-up For Stage 2|Other|0|||
129636885|NCT03850483|466624279|FG002|Follow-up For Stage 2|Other|0|||
129636886|NCT03850483|466624280|FG003|Follow-up For Stage 2|Other|0|||
129636887|NCT03850483|466624281|FG004|Follow-up For Stage 2|Other|0|||
129636888|NCT03850483|466624282|FG005|Follow-up For Stage 2|Other|0|||
129636889|NCT03850483|466624283|FG006|Follow-up For Stage 2|Other|0|||
129636890|NCT03850483|466624284|FG007|Follow-up For Stage 2|Other|0|||
129636891|NCT03850483|466624285|FG008|Follow-up For Stage 2|Other|0|||
129636892|NCT03850483|466624286|FG009|Follow-up For Stage 2|Other|1|||
129636893|NCT04432831|466626113|FG000|Overall Study|Withdrawal by Subject|24|||
129636894|NCT04432831|466626114|FG001|Overall Study|Withdrawal by Subject|28|||
129636895|NCT04432831|466626115|FG002|Overall Study|Withdrawal by Subject|21|||
129441148|NCT00777946|465913246|FG000|Overall Study|Patient withdrew consent|3|||
129441149|NCT00777946|465913247|FG001|Overall Study|Patient withdrew consent|2|||
129441150|NCT00777946|465913248|FG002|Overall Study|Patient withdrew consent|3|||
129441151|NCT00777946|465913246|FG000|Overall Study|Lost to Follow-up|3|||
129441152|NCT00777946|465913247|FG001|Overall Study|Lost to Follow-up|1|||
129441153|NCT00777946|465913248|FG002|Overall Study|Lost to Follow-up|0|||
129441154|NCT00777946|465913246|FG000|Overall Study|Protocol deviation|2|||
129441155|NCT00777946|465913247|FG001|Overall Study|Protocol deviation|1|||
129441156|NCT00777946|465913248|FG002|Overall Study|Protocol deviation|1|||
129441157|NCT00777946|465913246|FG000|Overall Study|Randomized in error|1|||
129441158|NCT00777946|465913247|FG001|Overall Study|Randomized in error|1|||
129636896|NCT04432831|466626113|FG000|Overall Study|Death|23|||
129441159|NCT00777946|465913248|FG002|Overall Study|Randomized in error|0|||
129441160|NCT02805725|465914603|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
129441161|NCT02805725|465914604|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
129441162|NCT02805725|465914605|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
129441163|NCT02805725|465914606|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
129441164|NCT02805725|465914607|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
129441165|NCT02805725|465914603|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
129441166|NCT02805725|465914604|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
129441167|NCT02805725|465914605|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
129441168|NCT02805725|465914606|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
129441169|NCT02805725|465914607|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
129441170|NCT02805725|465914603|FG000|Phase II|Protocol Violation|0|||
129441171|NCT02805725|465914604|FG001|Phase II|Protocol Violation|0|||
129441172|NCT02805725|465914605|FG002|Phase II|Protocol Violation|0|||
129441173|NCT02805725|465914606|FG003|Phase II|Protocol Violation|0|||
129441174|NCT02805725|465914607|FG004|Phase II|Protocol Violation|6|||
129441175|NCT01195545|465914608|FG000|Overall Study|Protocol Violation|4|||
129441176|NCT02425644|465914609|FG000|Overall Study|Lost to Follow-up|2|||
129441177|NCT02425644|465914610|FG001|Overall Study|Lost to Follow-up|3|||
129441178|NCT02425644|465914609|FG000|Overall Study|Withdrawal by Subject|41|||
129441179|NCT02425644|465914610|FG001|Overall Study|Withdrawal by Subject|36|||
129441180|NCT02425644|465914609|FG000|Overall Study|Lack of Efficacy|3|||
129441181|NCT02425644|465914610|FG001|Overall Study|Lack of Efficacy|10|||
129441182|NCT02425644|465914609|FG000|Overall Study|Adverse Event|13|||
129441183|NCT02425644|465914610|FG001|Overall Study|Adverse Event|3|||
129441184|NCT02425644|465914609|FG000|Overall Study|Death|0|||
129441185|NCT02425644|465914610|FG001|Overall Study|Death|2|||
129441186|NCT02425644|465914609|FG000|Overall Study|Other|18|||
129441187|NCT02425644|465914610|FG001|Overall Study|Other|17|||
129441188|NCT00567268|465914611|FG000|Overall Study|Protocol Violation|7|||
129441189|NCT00567268|465914611|FG000|Overall Study|Lost to Follow-up|36|||
129441190|NCT00567268|465914611|FG000|Overall Study|No Visit After First Day of Treatment|2|||
129441191|NCT00567268|465914611|FG000|Overall Study|No Drug Administration|4|||
129441192|NCT00567268|465914611|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
129441193|NCT01717989|465914612|FG000|Overall Study|Ineligibility determined|6|||
129441194|NCT01717989|465914612|FG000|Overall Study|Protocol deviation|6|||
129441195|NCT01717989|465914612|FG000|Overall Study|Withdrawal by Subject|11|||
129441196|NCT01717989|465914612|FG000|Overall Study|Physician Decision|2|||
129441197|NCT01717989|465914612|FG000|Overall Study|Lost to Follow-up|11|||
129441198|NCT01717989|465914612|FG000|Overall Study|Death|439|||
129441199|NCT01717989|465914612|FG000|Overall Study|Protocol-specified criteria|551|||
129441200|NCT01717989|465914612|FG000|Overall Study|Other|40|||
129441201|NCT02824263|465914613|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
129441202|NCT02824263|465914614|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
129441203|NCT02824263|465914613|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
129441204|NCT02824263|465914614|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
129441205|NCT00667355|465914615|FG000|Overall Study|Adverse Event|5|||
129441206|NCT00667355|465914615|FG000|Overall Study|Lost to Follow-up|1|||
129441207|NCT00667355|465914615|FG000|Overall Study|Other reason was not specified|5|||
129441208|NCT00068588|465914620|FG000|Overall Study|Adverse Event|0|||
129441209|NCT00068588|465914621|FG001|Overall Study|Adverse Event|0|||
129636897|NCT04432831|466626114|FG001|Overall Study|Death|23|||
129636898|NCT04432831|466626115|FG002|Overall Study|Death|17|||
129636899|NCT04432831|466626113|FG000|Overall Study|Lost to Follow-up|15|||
129636900|NCT04432831|466626114|FG001|Overall Study|Lost to Follow-up|15|||
129636901|NCT04432831|466626115|FG002|Overall Study|Lost to Follow-up|12|||
129636902|NCT04432831|466626113|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
129636903|NCT04432831|466626114|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
129636904|NCT04432831|466626115|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
129636905|NCT04432831|466626113|FG000|Overall Study|Reason Not Specified|7|||
129636906|NCT04432831|466626114|FG001|Overall Study|Reason Not Specified|11|||
129636907|NCT04432831|466626115|FG002|Overall Study|Reason Not Specified|9|||
129636908|NCT04432831|466626113|FG000|Overall Study|Adverse Event|7|||
129636909|NCT04432831|466626114|FG001|Overall Study|Adverse Event|7|||
129636910|NCT04432831|466626115|FG002|Overall Study|Adverse Event|7|||
129636911|NCT04432831|466626113|FG000|Overall Study|Physician Decision|1|||
129636912|NCT04432831|466626114|FG001|Overall Study|Physician Decision|3|||
129636913|NCT04432831|466626115|FG002|Overall Study|Physician Decision|6|||
129636914|NCT04432831|466626113|FG000|Overall Study|Protocol Violation|1|||
129636915|NCT04432831|466626114|FG001|Overall Study|Protocol Violation|0|||
129636916|NCT04432831|466626115|FG002|Overall Study|Protocol Violation|2|||
129636917|NCT04432831|466626113|FG000|Overall Study|Pregnancy|0|||
129636918|NCT04432831|466626114|FG001|Overall Study|Pregnancy|1|||
129636919|NCT04432831|466626115|FG002|Overall Study|Pregnancy|0|||
129636920|NCT04432831|466626113|FG000|Overall Study|Lack of Efficacy|0|||
129636921|NCT04432831|466626114|FG001|Overall Study|Lack of Efficacy|0|||
129636922|NCT04432831|466626115|FG002|Overall Study|Lack of Efficacy|2|||
129441210|NCT00068588|465914622|FG002|Overall Study|Adverse Event|2|||
129636923|NCT00652626|466626118|FG000|Initial Treatment Phase|Adverse Event|0|||
129636924|NCT00652626|466626119|FG001|Initial Treatment Phase|Adverse Event|0|||
129636925|NCT00652626|466626120|FG002|Initial Treatment Phase|Adverse Event|0|||
129441211|NCT00068588|465914620|FG000|Overall Study|Withdrawal by Subject|0|||
129636926|NCT00652626|466626121|FG003|Initial Treatment Phase|Adverse Event|0|||
129636927|NCT00652626|466626122|FG004|Initial Treatment Phase|Adverse Event|1|||
129636928|NCT00652626|466626123|FG005|Initial Treatment Phase|Adverse Event|0|||
129636929|NCT00652626|466626124|FG006|Initial Treatment Phase|Adverse Event|0|||
129636930|NCT00652626|466626118|FG000|Initial Treatment Phase|Protocol Violation|0|||
129636931|NCT00652626|466626119|FG001|Initial Treatment Phase|Protocol Violation|0|||
129636932|NCT00652626|466626120|FG002|Initial Treatment Phase|Protocol Violation|0|||
129636933|NCT00652626|466626121|FG003|Initial Treatment Phase|Protocol Violation|1|||
129636934|NCT00652626|466626122|FG004|Initial Treatment Phase|Protocol Violation|0|||
129636935|NCT00652626|466626123|FG005|Initial Treatment Phase|Protocol Violation|0|||
129636936|NCT00652626|466626124|FG006|Initial Treatment Phase|Protocol Violation|0|||
129636937|NCT00652626|466626118|FG000|Initial Treatment Phase|Physician Decision|0|||
129636938|NCT00652626|466626119|FG001|Initial Treatment Phase|Physician Decision|0|||
129636939|NCT00652626|466626120|FG002|Initial Treatment Phase|Physician Decision|0|||
129636940|NCT00652626|466626121|FG003|Initial Treatment Phase|Physician Decision|0|||
129636941|NCT00652626|466626122|FG004|Initial Treatment Phase|Physician Decision|1|||
129636942|NCT00652626|466626123|FG005|Initial Treatment Phase|Physician Decision|0|||
129636943|NCT00652626|466626124|FG006|Initial Treatment Phase|Physician Decision|0|||
129636944|NCT00652626|466626118|FG000|Initial Treatment Phase|Sponsor Request|0|||
129636945|NCT00652626|466626119|FG001|Initial Treatment Phase|Sponsor Request|0|||
129636946|NCT00652626|466626120|FG002|Initial Treatment Phase|Sponsor Request|1|||
129636947|NCT00652626|466626121|FG003|Initial Treatment Phase|Sponsor Request|0|||
129636948|NCT00652626|466626122|FG004|Initial Treatment Phase|Sponsor Request|0|||
129636949|NCT00652626|466626123|FG005|Initial Treatment Phase|Sponsor Request|0|||
129636950|NCT00652626|466626124|FG006|Initial Treatment Phase|Sponsor Request|0|||
129889345|NCT03259373|467552562|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
129441212|NCT00068588|465914621|FG001|Overall Study|Withdrawal by Subject|0|||
129441213|NCT00068588|465914622|FG002|Overall Study|Withdrawal by Subject|1|||
129441214|NCT00068588|465914620|FG000|Overall Study|Poor KPS|0|||
129441215|NCT00068588|465914621|FG001|Overall Study|Poor KPS|0|||
129441216|NCT00068588|465914622|FG002|Overall Study|Poor KPS|1|||
129441217|NCT05193500|465914623|FG000|Overall Study|Withdrawal by Subject|7|||
129441218|NCT05193500|465914624|FG001|Overall Study|Withdrawal by Subject|4|||
129441219|NCT05193500|465914625|FG002|Overall Study|Withdrawal by Subject|3|||
129441220|NCT05193500|465914626|FG003|Overall Study|Withdrawal by Subject|5|||
129441221|NCT02147353|465914629|FG000|Overall Study|Lost to Follow-up|2|||
129441222|NCT02147353|465914630|FG001|Overall Study|Lost to Follow-up|0|||
129441223|NCT02147353|465914629|FG000|Overall Study|unable to make visits|4|||
129441224|NCT02147353|465914630|FG001|Overall Study|unable to make visits|0|||
129441225|NCT02147353|465914629|FG000|Overall Study|medication noncompliance|3|||
129441226|NCT02147353|465914630|FG001|Overall Study|medication noncompliance|0|||
129441227|NCT03037619|465914639|FG000|Overall Study|Lost to Follow-up|0|||
129441228|NCT03037619|465914640|FG001|Overall Study|Lost to Follow-up|1|||
129441229|NCT01498289|465914641|FG000|Overall Study|Adverse Event|16|||
129441230|NCT01498289|465914642|FG001|Overall Study|Adverse Event|18|||
129441231|NCT01498289|465914641|FG000|Overall Study|Death|6|||
129441232|NCT01498289|465914642|FG001|Overall Study|Death|8|||
129441233|NCT01498289|465914641|FG000|Overall Study|Withdrawal unrelated to AE|16|||
129441234|NCT01498289|465914642|FG001|Overall Study|Withdrawal unrelated to AE|16|||
129441235|NCT01498289|465914641|FG000|Overall Study|Progression/relapse|53|||
129441236|NCT01498289|465914642|FG001|Overall Study|Progression/relapse|59|||
129441237|NCT01498289|465914641|FG000|Overall Study|Not protocol specified|7|||
129441238|NCT01498289|465914642|FG001|Overall Study|Not protocol specified|2|||
129441239|NCT01498289|465914641|FG000|Overall Study|Reason under review|0|||
129441240|NCT01498289|465914642|FG001|Overall Study|Reason under review|1|||
129441241|NCT02030405|465914650|FG000|Overall Study|Withdrawal by Subject|1|||
129441242|NCT02030405|465914650|FG000|Overall Study|Lost to Follow-up|1|||
129441243|NCT00803270|465914651|FG000|Overall Study|Lost to Follow-up|1|||
129441244|NCT00803270|465914652|FG001|Overall Study|Lost to Follow-up|2|||
129441245|NCT00593957|465914656|FG000|Overall Study|Physician Decision|0|||
129441246|NCT00593957|465914657|FG001|Overall Study|Physician Decision|1|||
129441247|NCT00593957|465914658|FG002|Overall Study|Physician Decision|2|||
129441248|NCT00494481|465914661|FG000|Overall Study|Condition under investigation worsened|11|||
129441249|NCT00494481|465914662|FG001|Overall Study|Condition under investigation worsened|13|||
129441250|NCT00494481|465914661|FG000|Overall Study|Adverse Event|15|||
129441251|NCT00494481|465914662|FG001|Overall Study|Adverse Event|11|||
129441252|NCT00494481|465914661|FG000|Overall Study|Other|1|||
129441253|NCT00494481|465914662|FG001|Overall Study|Other|0|||
129441254|NCT00494481|465914661|FG000|Overall Study|Never received IP|2|||
129441255|NCT00494481|465914662|FG001|Overall Study|Never received IP|0|||
129441256|NCT02973048|465914663|FG000|Overall Study|Epidural catheter insertion failure|1|||
129441257|NCT02973048|465914664|FG001|Overall Study|Epidural catheter insertion failure|0|||
129441258|NCT02973048|465914663|FG000|Overall Study|Withdrawal by Subject|0|||
129636951|NCT00652626|466626118|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
129636952|NCT00652626|466626119|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
129636953|NCT00652626|466626120|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
129636954|NCT00652626|466626121|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
129636955|NCT00652626|466626122|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
129636956|NCT00652626|466626123|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
129636957|NCT00652626|466626124|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
129636958|NCT00652626|466626118|FG000|Extension Phase|Withdrawal by Subject|0|||
129636959|NCT00652626|466626119|FG001|Extension Phase|Withdrawal by Subject|0|||
129636960|NCT00652626|466626120|FG002|Extension Phase|Withdrawal by Subject|0|||
129636961|NCT00652626|466626121|FG003|Extension Phase|Withdrawal by Subject|0|||
129636962|NCT00652626|466626122|FG004|Extension Phase|Withdrawal by Subject|0|||
129636963|NCT00652626|466626123|FG005|Extension Phase|Withdrawal by Subject|2|||
129441259|NCT02973048|465914664|FG001|Overall Study|Withdrawal by Subject|3|||
129441260|NCT00332189|465914665|FG000|Overall Study|Adverse Event|3|||
129441261|NCT00332189|465914665|FG000|Overall Study|Uncooperative/Noncompliant|3|||
129441262|NCT00332189|465914665|FG000|Overall Study|Withdrawal by Subject|9|||
129441263|NCT00332189|465914665|FG000|Overall Study|Lack of Efficacy|4|||
129441264|NCT00332189|465914665|FG000|Overall Study|Moved out of country|2|||
129441265|NCT02279862|465914667|FG000|Overall Study|Study drug toxicity|3|||
129441266|NCT02279862|465914668|FG001|Overall Study|Study drug toxicity|6|||
129441267|NCT02279862|465914667|FG000|Overall Study|No longer meets criteria|0|||
129441268|NCT02279862|465914668|FG001|Overall Study|No longer meets criteria|1|||
129441269|NCT02279862|465914667|FG000|Overall Study|Administrative reason by sponsor|0|||
129441270|NCT02279862|465914668|FG001|Overall Study|Administrative reason by sponsor|1|||
129441271|NCT02279862|465914667|FG000|Overall Study|Disease progression|5|||
129441272|NCT02279862|465914668|FG001|Overall Study|Disease progression|2|||
129441273|NCT02279862|465914667|FG000|Overall Study|Study closed by sponsor|16|||
129441274|NCT02279862|465914668|FG001|Overall Study|Study closed by sponsor|13|||
129441275|NCT02279862|465914667|FG000|Overall Study|Other|1|||
129441276|NCT02279862|465914668|FG001|Overall Study|Other|2|||
129441277|NCT02279862|465914667|FG000|Overall Study|Withdrawal by Subject|1|||
129441278|NCT02279862|465914668|FG001|Overall Study|Withdrawal by Subject|0|||
129441279|NCT03707925|465914670|FG000|Overall Study|Inevaluable|1|||
129636964|NCT00652626|466626124|FG006|Extension Phase|Withdrawal by Subject|0|||
129636965|NCT00652626|466626118|FG000|Extension Phase|Adverse Event|0|||
129636966|NCT00652626|466626119|FG001|Extension Phase|Adverse Event|0|||
129441280|NCT03431857|465914672|FG000|Overall Study|Death|6|||
129441281|NCT03431857|465914672|FG000|Overall Study|Lost to Follow-up|41|||
129441282|NCT03431857|465914672|FG000|Overall Study|Adverse Event|6|||
129441283|NCT03431857|465914672|FG000|Overall Study|Withdrawal by Subject|1|||
129441284|NCT01163721|465914675|FG000|Overall Study|Adverse Event|5|||
129441285|NCT01163721|465914676|FG001|Overall Study|Adverse Event|6|||
129441286|NCT01163721|465914675|FG000|Overall Study|Withdrawal by Subject|3|||
129441287|NCT01163721|465914676|FG001|Overall Study|Withdrawal by Subject|4|||
129441288|NCT01163721|465914675|FG000|Overall Study|Lost to Follow-up|0|||
129441289|NCT01163721|465914676|FG001|Overall Study|Lost to Follow-up|1|||
129441290|NCT01163721|465914675|FG000|Overall Study|Physician Decision|0|||
129441291|NCT01163721|465914676|FG001|Overall Study|Physician Decision|1|||
129441292|NCT01472380|465914679|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
129441293|NCT01472380|465914679|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
129441294|NCT02511678|465914680|FG000|Overall Study|Withdrawal by Subject|2|||
129441295|NCT02511678|465914680|FG000|Overall Study|Lost to Follow-up|4|||
129441296|NCT02511678|465914680|FG000|Overall Study|Death|19|||
129441297|NCT02511678|465914680|FG000|Overall Study|Adverse Event|1|||
129441298|NCT02511678|465914680|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
129441299|NCT02511678|465914680|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
129441300|NCT02511678|465914680|FG000|Overall Study|Required Radiofrequency Ablation|1|||
129441301|NCT02511678|465914680|FG000|Overall Study|Biopsy was Negative|1|||
129441302|NCT02511678|465914680|FG000|Overall Study|Protocol Violation|1|||
129441303|NCT02511678|465914680|FG000|Overall Study|Received Radiation Treatment|1|||
129441304|NCT01295281|465914681|FG000|First Intervention (7 Days)|Death|0|||
129441305|NCT01295281|465914682|FG001|First Intervention (7 Days)|Death|1|||
129441306|NCT00292461|465914683|FG000|Overall Study|Adverse Event|4|||
129441307|NCT00292461|465914684|FG001|Overall Study|Adverse Event|2|||
129441308|NCT00292461|465914683|FG000|Overall Study|Lack of Efficacy|1|||
129441309|NCT00292461|465914684|FG001|Overall Study|Lack of Efficacy|0|||
129441310|NCT00292461|465914683|FG000|Overall Study|Withdrawal by Subject|0|||
129441311|NCT00292461|465914684|FG001|Overall Study|Withdrawal by Subject|1|||
129441312|NCT00292461|465914683|FG000|Overall Study|Protocol Violation|4|||
129441313|NCT00292461|465914684|FG001|Overall Study|Protocol Violation|3|||
129441314|NCT00292461|465914683|FG000|Overall Study|Lost to Follow-up|1|||
129441315|NCT00292461|465914684|FG001|Overall Study|Lost to Follow-up|0|||
129441316|NCT04484259|465914700|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129441317|NCT04484259|465914701|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129441318|NCT04484259|465914702|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129441319|NCT04484259|465914703|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
129441320|NCT04484259|465914704|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
129441321|NCT04484259|465914700|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129636967|NCT00652626|466626120|FG002|Extension Phase|Adverse Event|0|||
129636968|NCT00652626|466626121|FG003|Extension Phase|Adverse Event|0|||
129441322|NCT04484259|465914701|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129441323|NCT04484259|465914702|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129441324|NCT04484259|465914703|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
129441325|NCT04484259|465914704|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
129441326|NCT04484259|465914700|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129441327|NCT04484259|465914701|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129441328|NCT04484259|465914702|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129441329|NCT04484259|465914703|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
129441330|NCT04484259|465914704|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
129441331|NCT04484259|465914700|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129441332|NCT04484259|465914701|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129441333|NCT04484259|465914702|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129441334|NCT04484259|465914703|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
129441335|NCT04484259|465914704|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
129636969|NCT00652626|466626122|FG004|Extension Phase|Adverse Event|0|||
129636970|NCT00652626|466626123|FG005|Extension Phase|Adverse Event|2|||
129636971|NCT00652626|466626124|FG006|Extension Phase|Adverse Event|1|||
129636972|NCT00652626|466626118|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129636973|NCT00652626|466626119|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129636974|NCT00652626|466626120|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129636975|NCT00652626|466626121|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129636976|NCT00652626|466626122|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129636977|NCT00652626|466626123|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
129636978|NCT00652626|466626124|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
129636979|NCT00652626|466626118|FG000|Extension Phase|Physician Decision|0|||
129636980|NCT00652626|466626119|FG001|Extension Phase|Physician Decision|0|||
129636981|NCT00652626|466626120|FG002|Extension Phase|Physician Decision|0|||
129636982|NCT00652626|466626121|FG003|Extension Phase|Physician Decision|0|||
129636983|NCT00652626|466626122|FG004|Extension Phase|Physician Decision|0|||
129636984|NCT00652626|466626123|FG005|Extension Phase|Physician Decision|1|||
129636985|NCT00652626|466626124|FG006|Extension Phase|Physician Decision|1|||
129636986|NCT00652626|466626118|FG000|Extension Phase|Death|0|||
129636987|NCT00652626|466626119|FG001|Extension Phase|Death|0|||
129636988|NCT00652626|466626120|FG002|Extension Phase|Death|0|||
129636989|NCT00652626|466626121|FG003|Extension Phase|Death|0|||
129797772|NCT03416374|467228223|FG000|Between Treatment Period I and II|Other|0|||
129797773|NCT03416374|467228224|FG001|Between Treatment Period I and II|Other|9|||
129797774|NCT03416374|467228223|FG000|Treatment Period II|Lack of Efficacy|3|||
129797775|NCT03416374|467228224|FG001|Treatment Period II|Lack of Efficacy|11|||
129797776|NCT03416374|467228223|FG000|Treatment Period II|Adverse Event|1|||
129797777|NCT03416374|467228224|FG001|Treatment Period II|Adverse Event|4|||
129797778|NCT03416374|467228223|FG000|Treatment Period II|Death|0|||
129797779|NCT03416374|467228224|FG001|Treatment Period II|Death|1|||
129797780|NCT03416374|467228223|FG000|Treatment Period II|Other|0|||
129797781|NCT03416374|467228224|FG001|Treatment Period II|Other|2|||
129797782|NCT03583164|467228225|FG000|Overall Study|Death in Main Phase|35|||
129797783|NCT03583164|467228225|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
129797784|NCT03583164|467228225|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
129797785|NCT03583164|467228225|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
129797786|NCT03583164|467228225|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
129797787|NCT03583164|467228225|FG000|Overall Study|Physician decision in Main Phase|1|||
129797788|NCT03583164|467228225|FG000|Overall Study|Physician decision in Extended Phase|2|||
129797789|NCT03583164|467228225|FG000|Overall Study|Death in Extended Phase|13|||
129797790|NCT03583164|467228225|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
129797791|NCT03583164|467228225|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
129797792|NCT03583164|467228225|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
129797793|NCT03583164|467228225|FG000|Overall Study|Treatment failure in Main Phase|2|||
129797794|NCT03583164|467228225|FG000|Overall Study|Treatment failure in Extended Phase|4|||
129797795|NCT03583164|467228225|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
129797796|NCT03583164|467228225|FG000|Overall Study|Other not specified reason in Main Phase|2|||
129797797|NCT00559754|467228226|FG000|Overall Study|Disease progression|1|||
129797798|NCT00559754|467228226|FG000|Overall Study|Adverse Event|5|||
129797799|NCT00559754|467228226|FG000|Overall Study|Protocol Violation|1|||
129636990|NCT00652626|466626122|FG004|Extension Phase|Death|0|||
129636991|NCT00652626|466626123|FG005|Extension Phase|Death|1|||
129636992|NCT00652626|466626124|FG006|Extension Phase|Death|1|||
129797800|NCT00559754|467228226|FG000|Overall Study|Investigator criteria|2|||
129797801|NCT00559754|467228226|FG000|Overall Study|Withdrawal by Subject|2|||
129797802|NCT00214500|467228231|FG000|Treatment Period|Adverse Event|1|||
129797803|NCT00214500|467228231|FG000|Extension Period|Withdrawal by Subject|2|||
129797804|NCT02537574|467228233|FG000|Overall Study|Adverse Event|1|||
129797805|NCT02537574|467228234|FG001|Overall Study|Adverse Event|3|||
129636993|NCT01623310|466626125|FG000|Overall Study|Adverse Event|21|||
129636994|NCT01623310|466626125|FG000|Overall Study|Lost to Follow-up|18|||
129636995|NCT01623310|466626125|FG000|Overall Study|Lack of Efficacy|6|||
129636996|NCT01623310|466626125|FG000|Overall Study|Protocol Violation|6|||
129636997|NCT01623310|466626125|FG000|Overall Study|Withdrawal by Subject|25|||
129636998|NCT01623310|466626125|FG000|Overall Study|Became potentially child-bearing|1|||
129636999|NCT01623310|466626125|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
129637000|NCT01623310|466626125|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
129637001|NCT02898597|466626126|FG000|Overall Study|Protocol Violation|4|||
129637002|NCT02898597|466626127|FG001|Overall Study|Protocol Violation|2|||
129637003|NCT02898597|466626126|FG000|Overall Study|Lost to Follow-up|0|||
129637004|NCT02898597|466626127|FG001|Overall Study|Lost to Follow-up|9|||
129637005|NCT02898597|466626126|FG000|Overall Study|Death|0|||
129637006|NCT02898597|466626127|FG001|Overall Study|Death|1|||
129441336|NCT04484259|465914700|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129441337|NCT04484259|465914701|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129441338|NCT04484259|465914702|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129441339|NCT04484259|465914703|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
129441340|NCT04484259|465914704|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
129441341|NCT04484259|465914700|FG000|Randomized Treatment|Withdrawal by Subject|1|||
129441342|NCT04484259|465914701|FG001|Randomized Treatment|Withdrawal by Subject|0|||
129441343|NCT04484259|465914702|FG002|Randomized Treatment|Withdrawal by Subject|0|||
129441344|NCT04484259|465914703|FG003|Randomized Treatment|Withdrawal by Subject|0|||
129441345|NCT04484259|465914704|FG004|Randomized Treatment|Withdrawal by Subject|0|||
129441346|NCT04908189|465914705|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
129441347|NCT04908189|465914706|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
129441348|NCT04908189|465914707|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
129441349|NCT04908189|465914705|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
129441350|NCT04908189|465914706|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
129441351|NCT04908189|465914707|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
129441352|NCT04908189|465914705|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
129441353|NCT04908189|465914706|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
129441354|NCT04908189|465914707|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
129441355|NCT04908189|465914705|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
129441356|NCT04908189|465914706|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
129441357|NCT04908189|465914707|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
129441358|NCT04908189|465914705|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
129441359|NCT04908189|465914706|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
129441360|NCT04908189|465914707|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
129441361|NCT04908189|465914705|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
129441362|NCT04908189|465914706|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
129441363|NCT04908189|465914707|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
129441364|NCT04908189|465914705|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
129441365|NCT04908189|465914706|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
129441366|NCT04908189|465914707|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
129441367|NCT04908189|465914705|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
129441368|NCT04908189|465914706|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
129441369|NCT04908189|465914707|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
129441370|NCT04908189|465914705|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
129637007|NCT02530125|466626128|FG000|Completed Treatment|Early termination of study|1|||
129637008|NCT02530125|466626128|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
129637009|NCT01568034|466626129|FG000|Overall Study|Withdrawal by Subject|1|||
129637010|NCT01568034|466626130|FG001|Overall Study|Withdrawal by Subject|0|||
129637011|NCT01568034|466626131|FG002|Overall Study|Withdrawal by Subject|0|||
129637012|NCT01568034|466626132|FG003|Overall Study|Withdrawal by Subject|0|||
129637013|NCT06098339|466626133|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
129441371|NCT04908189|465914706|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
129637014|NCT06098339|466626134|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
129637015|NCT06098339|466626133|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
129637016|NCT06098339|466626134|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
129637017|NCT02492984|466626135|FG000|Overall Study|Adverse Event|1|||
129637018|NCT02492984|466626136|FG001|Overall Study|Adverse Event|0|||
129797806|NCT02537574|467228235|FG002|Overall Study|Adverse Event|2|||
129637019|NCT02492984|466626135|FG000|Overall Study|Protocol Violation|1|||
129637020|NCT02492984|466626136|FG001|Overall Study|Protocol Violation|0|||
129637021|NCT02492984|466626135|FG000|Overall Study|Withdrawal by Subject|1|||
129637022|NCT02492984|466626136|FG001|Overall Study|Withdrawal by Subject|0|||
129637023|NCT02498444|466626137|FG000|Overall Study|Withdrawal by Subject|3|||
129637024|NCT02498444|466626138|FG001|Overall Study|Withdrawal by Subject|0|||
129637025|NCT02498444|466626137|FG000|Overall Study|Physician Decision|1|||
129637026|NCT02498444|466626138|FG001|Overall Study|Physician Decision|0|||
129637027|NCT02027545|466626139|FG000|Overall Study|Failed to sign HIPAA|0|||
129637028|NCT02027545|466626140|FG001|Overall Study|Failed to sign HIPAA|2|||
129637029|NCT02027545|466626139|FG000|Overall Study|Failed to attend study visit|2|||
129637030|NCT02027545|466626140|FG001|Overall Study|Failed to attend study visit|0|||
129889346|NCT03259373|467552563|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
129889347|NCT04894903|467552564|FG000|Overall Study|Death|1|||
129637031|NCT02027545|466626139|FG000|Overall Study|Protocol Violation|1|||
129637032|NCT02027545|466626140|FG001|Overall Study|Protocol Violation|0|||
129889348|NCT04894903|467552565|FG001|Overall Study|Death|0|||
129441372|NCT04908189|465914707|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
129441373|NCT04908189|465914705|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
129441374|NCT04908189|465914706|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
129441375|NCT04908189|465914707|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
129637033|NCT02453334|466626141|FG000|Overall Study|Death|15|||
129441376|NCT04908189|465914705|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
129441377|NCT04908189|465914706|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
129441378|NCT04908189|465914707|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
129441379|NCT04908189|465914705|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
129441380|NCT04908189|465914706|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
129441381|NCT04908189|465914707|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
129637034|NCT02453334|466626142|FG001|Overall Study|Death|13|||
129637035|NCT02453334|466626141|FG000|Overall Study|Adverse Event|2|||
129637036|NCT02453334|466626142|FG001|Overall Study|Adverse Event|1|||
129637037|NCT02453334|466626141|FG000|Overall Study|Lost to Follow-up|5|||
129637038|NCT02453334|466626142|FG001|Overall Study|Lost to Follow-up|9|||
129637039|NCT02453334|466626141|FG000|Overall Study|Physician Decision|1|||
129637040|NCT02453334|466626142|FG001|Overall Study|Physician Decision|0|||
129637041|NCT02453334|466626141|FG000|Overall Study|Withdrawal by Subject|17|||
129637042|NCT02453334|466626142|FG001|Overall Study|Withdrawal by Subject|13|||
129637043|NCT02453334|466626141|FG000|Overall Study|Other reason|1|||
129637044|NCT02453334|466626142|FG001|Overall Study|Other reason|4|||
129637045|NCT04090060|466626145|FG000|Overall Study|Lost to Follow-up|76|||
129637046|NCT04090060|466626146|FG001|Overall Study|Lost to Follow-up|77|||
129637047|NCT03337113|466626153|FG000|Overall Study|Adverse Event|1|||
129637048|NCT03337113|466626154|FG001|Overall Study|Adverse Event|1|||
129637049|NCT03337113|466626155|FG002|Overall Study|Adverse Event|0|||
129637050|NCT03337113|466626156|FG003|Overall Study|Adverse Event|1|||
129637051|NCT03337113|466626153|FG000|Overall Study|Physician Decision|0|||
129441382|NCT01411839|465914709|FG000|Overall Study|Lost to Follow-up|4|||
129441383|NCT01411839|465914710|FG001|Overall Study|Lost to Follow-up|3|||
129441384|NCT05461794|465914713|FG000|Overall Study|Withdrawal by Subject|1|||
129441385|NCT05461794|465914714|FG001|Overall Study|Withdrawal by Subject|1|||
129441386|NCT05461794|465914715|FG002|Overall Study|Withdrawal by Subject|3|||
129441387|NCT05461794|465914713|FG000|Overall Study|Study Terminated By Sponsor|18|||
129441388|NCT05461794|465914714|FG001|Overall Study|Study Terminated By Sponsor|13|||
129441389|NCT05461794|465914715|FG002|Overall Study|Study Terminated By Sponsor|16|||
129441390|NCT05461794|465914713|FG000|Overall Study|Death|20|||
129441391|NCT05461794|465914714|FG001|Overall Study|Death|5|||
129441392|NCT05461794|465914715|FG002|Overall Study|Death|19|||
129441393|NCT00467285|465914716|FG000|Overall Study|Lost to Follow-up|4|||
129441394|NCT00467285|465914717|FG001|Overall Study|Lost to Follow-up|4|||
129441395|NCT01853982|465914718|FG000|Overall Study|Withdrawal by Subject|1|||
129441396|NCT01853982|465914719|FG001|Overall Study|Withdrawal by Subject|0|||
129441397|NCT01853982|465914718|FG000|Overall Study|Death|1|||
129441398|NCT01853982|465914719|FG001|Overall Study|Death|0|||
129441399|NCT01853982|465914718|FG000|Overall Study|Lost to Follow-up|0|||
129441400|NCT01853982|465914719|FG001|Overall Study|Lost to Follow-up|1|||
129441401|NCT05066724|465914725|FG000|Overall Study|Adverse Event|1|||
129441402|NCT05066724|465914725|FG000|Overall Study|Non-Compliance With Study Drug|5|||
129441403|NCT05066724|465914725|FG000|Overall Study|Withdrawal by Subject|6|||
129441404|NCT05066724|465914725|FG000|Overall Study|Physician Decision|2|||
129441405|NCT00475033|465914728|FG000|Infant Series|Failed to return|3|||
129441406|NCT00475033|465914729|FG001|Infant Series|Failed to return|4|||
129441407|NCT00475033|465914728|FG000|Infant Series|Parent or legal guardian request|1|||
129441408|NCT00475033|465914729|FG001|Infant Series|Parent or legal guardian request|5|||
129441409|NCT00475033|465914728|FG000|Infant Series|Protocol Violation|1|||
129441410|NCT00475033|465914729|FG001|Infant Series|Protocol Violation|2|||
129441411|NCT00475033|465914728|FG000|Infant Series|Lost to Follow-up|2|||
129441412|NCT00475033|465914729|FG001|Infant Series|Lost to Follow-up|0|||
129441413|NCT00475033|465914728|FG000|Infant Series|Adverse Event|0|||
129441414|NCT00475033|465914729|FG001|Infant Series|Adverse Event|2|||
129441415|NCT00475033|465914728|FG000|After the Infant Series|Adverse Event|0|||
129441416|NCT00475033|465914729|FG001|After the Infant Series|Adverse Event|4|||
129441417|NCT00475033|465914728|FG000|After the Infant Series|Parent or legal guardian request|2|||
129441418|NCT00475033|465914729|FG001|After the Infant Series|Parent or legal guardian request|2|||
129637052|NCT03337113|466626154|FG001|Overall Study|Physician Decision|2|||
129441419|NCT00475033|465914728|FG000|After the Infant Series|Failed to return|2|||
129441420|NCT00475033|465914729|FG001|After the Infant Series|Failed to return|1|||
129441421|NCT00475033|465914728|FG000|After the Infant Series|Protocol Violation|1|||
129441422|NCT00475033|465914729|FG001|After the Infant Series|Protocol Violation|0|||
129441423|NCT00475033|465914728|FG000|After the Infant Series|Lost to Follow-up|1|||
129637053|NCT03337113|466626155|FG002|Overall Study|Physician Decision|0|||
129637054|NCT03337113|466626156|FG003|Overall Study|Physician Decision|1|||
129637055|NCT03337113|466626153|FG000|Overall Study|Withdrawal by Subject|0|||
129704955|NCT05067335|466884101|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129441424|NCT00475033|465914729|FG001|After the Infant Series|Lost to Follow-up|0|||
129441425|NCT00475033|465914728|FG000|After the Infant Series|Other|0|||
129441426|NCT00475033|465914729|FG001|After the Infant Series|Other|1|||
129441427|NCT00475033|465914728|FG000|Toddler Dose|Parent or legal guardian request|2|||
129441428|NCT00475033|465914729|FG001|Toddler Dose|Parent or legal guardian request|0|||
129441429|NCT00475033|465914728|FG000|Toddler Dose|Failed to return|1|||
129441430|NCT00475033|465914729|FG001|Toddler Dose|Failed to return|0|||
129441431|NCT00475033|465914728|FG000|Toddler Dose|Lost to Follow-up|1|||
129637056|NCT03337113|466626154|FG001|Overall Study|Withdrawal by Subject|0|||
129637057|NCT03337113|466626155|FG002|Overall Study|Withdrawal by Subject|1|||
129637058|NCT03337113|466626156|FG003|Overall Study|Withdrawal by Subject|0|||
129637059|NCT01164579|466626157|FG000|Overall Study|Lack of Efficacy|0|||
129637060|NCT01164579|466626158|FG001|Overall Study|Lack of Efficacy|0|||
129637061|NCT01164579|466626159|FG002|Overall Study|Lack of Efficacy|6|||
129637062|NCT01164579|466626157|FG000|Overall Study|Lost to Follow-up|1|||
129637063|NCT01164579|466626158|FG001|Overall Study|Lost to Follow-up|1|||
129637064|NCT01164579|466626159|FG002|Overall Study|Lost to Follow-up|0|||
129441432|NCT00475033|465914729|FG001|Toddler Dose|Lost to Follow-up|0|||
129441433|NCT03444324|465914732|FG000|Overall Study|Withdrawal by Subject|0|||
129441434|NCT03444324|465914733|FG001|Overall Study|Withdrawal by Subject|1|||
129441435|NCT03444324|465914732|FG000|Overall Study|Lost to Follow-up|4|||
129441436|NCT03444324|465914733|FG001|Overall Study|Lost to Follow-up|2|||
129441437|NCT03444324|465914732|FG000|Overall Study|Protocol Violation|0|||
129441438|NCT03444324|465914733|FG001|Overall Study|Protocol Violation|1|||
129441439|NCT03444324|465914732|FG000|Overall Study|Lack of Trial Compliance|1|||
129441440|NCT03444324|465914733|FG001|Overall Study|Lack of Trial Compliance|1|||
129637065|NCT01164579|466626157|FG000|Overall Study|Withdrawal by Subject|2|||
129637066|NCT01164579|466626158|FG001|Overall Study|Withdrawal by Subject|5|||
129637067|NCT01164579|466626159|FG002|Overall Study|Withdrawal by Subject|3|||
129637068|NCT01164579|466626157|FG000|Overall Study|Protocol Violation|0|||
129637069|NCT01164579|466626158|FG001|Overall Study|Protocol Violation|1|||
129637070|NCT01164579|466626159|FG002|Overall Study|Protocol Violation|2|||
129637071|NCT01164579|466626157|FG000|Overall Study|Adverse Event|4|||
129637072|NCT01164579|466626158|FG001|Overall Study|Adverse Event|2|||
129637073|NCT01164579|466626159|FG002|Overall Study|Adverse Event|5|||
129637074|NCT01164579|466626157|FG000|Overall Study|Reason not specified|1|||
129637075|NCT01164579|466626158|FG001|Overall Study|Reason not specified|0|||
129637076|NCT01164579|466626159|FG002|Overall Study|Reason not specified|0|||
129637077|NCT03491462|466626164|FG000|Overall Study|Lost to Follow-up|2|||
129637078|NCT03491462|466626165|FG001|Overall Study|Lost to Follow-up|0|||
129637079|NCT03491462|466626164|FG000|Overall Study|Adverse Event|11|||
129637080|NCT03491462|466626165|FG001|Overall Study|Adverse Event|1|||
129637081|NCT03491462|466626164|FG000|Overall Study|Physician Decision|3|||
129637082|NCT03491462|466626165|FG001|Overall Study|Physician Decision|0|||
129637083|NCT03491462|466626164|FG000|Overall Study|Withdrawal by Subject|22|||
129637084|NCT03491462|466626165|FG001|Overall Study|Withdrawal by Subject|15|||
129637085|NCT00423332|466626167|FG000|Overall Study|Adverse Event|6|||
129637086|NCT00423332|466626168|FG001|Overall Study|Adverse Event|2|||
129637087|NCT00423332|466626167|FG000|Overall Study|Withdrawal by Subject|1|||
129637088|NCT00423332|466626168|FG001|Overall Study|Withdrawal by Subject|0|||
129637089|NCT00423332|466626167|FG000|Overall Study|Condition under investigation worsened|1|||
129637090|NCT00423332|466626168|FG001|Overall Study|Condition under investigation worsened|1|||
129637091|NCT00423332|466626167|FG000|Overall Study|Progressive at Week 6|0|||
129637092|NCT00423332|466626168|FG001|Overall Study|Progressive at Week 6|1|||
129637093|NCT00423332|466626167|FG000|Overall Study|Unblinded before 12 weeks|1|||
129441441|NCT03444324|465914732|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
129441442|NCT03444324|465914733|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
129441443|NCT00658684|465914734|FG000|Overall Study|Adverse Event|10|||
129441444|NCT00658684|465914735|FG001|Overall Study|Adverse Event|8|||
129441445|NCT00658684|465914736|FG002|Overall Study|Adverse Event|2|||
129441446|NCT00658684|465914737|FG003|Overall Study|Adverse Event|0|||
129441447|NCT00658684|465914734|FG000|Overall Study|Withdrawal by Subject|6|||
129441448|NCT00658684|465914735|FG001|Overall Study|Withdrawal by Subject|4|||
129441449|NCT00658684|465914736|FG002|Overall Study|Withdrawal by Subject|1|||
129441450|NCT00658684|465914737|FG003|Overall Study|Withdrawal by Subject|1|||
129637094|NCT00423332|466626168|FG001|Overall Study|Unblinded before 12 weeks|3|||
129637095|NCT00685399|466626179|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129637096|NCT00685399|466626180|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129637097|NCT00685399|466626181|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129637098|NCT00685399|466626182|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129637099|NCT00685399|466626183|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129637100|NCT00685399|466626184|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129441451|NCT00658684|465914734|FG000|Overall Study|Lack of Efficacy|1|||
129441452|NCT00658684|465914735|FG001|Overall Study|Lack of Efficacy|1|||
129441453|NCT00658684|465914736|FG002|Overall Study|Lack of Efficacy|0|||
129637101|NCT00685399|466626185|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129637102|NCT00685399|466626186|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129441454|NCT00658684|465914737|FG003|Overall Study|Lack of Efficacy|0|||
129441455|NCT00658684|465914734|FG000|Overall Study|Protocol Violation|1|||
129637103|NCT00685399|466626179|FG000|Treatment Period 1|Protocol Violation|1|||
129637104|NCT00685399|466626180|FG001|Treatment Period 1|Protocol Violation|0|||
129637105|NCT00685399|466626181|FG002|Treatment Period 1|Protocol Violation|0|||
129637106|NCT00685399|466626182|FG003|Treatment Period 1|Protocol Violation|0|||
129637107|NCT00685399|466626183|FG004|Treatment Period 1|Protocol Violation|0|||
129637108|NCT00685399|466626184|FG005|Treatment Period 1|Protocol Violation|0|||
129637109|NCT00685399|466626185|FG006|Treatment Period 1|Protocol Violation|0|||
129637110|NCT00685399|466626186|FG007|Treatment Period 1|Protocol Violation|0|||
129637111|NCT00685399|466626179|FG000|Treatment Period 1|Administrative|2|||
129637112|NCT00685399|466626180|FG001|Treatment Period 1|Administrative|0|||
129637113|NCT00685399|466626181|FG002|Treatment Period 1|Administrative|0|||
129637114|NCT00685399|466626182|FG003|Treatment Period 1|Administrative|0|||
129637115|NCT00685399|466626183|FG004|Treatment Period 1|Administrative|0|||
129637116|NCT00685399|466626184|FG005|Treatment Period 1|Administrative|0|||
129637117|NCT00685399|466626185|FG006|Treatment Period 1|Administrative|0|||
129637118|NCT00685399|466626186|FG007|Treatment Period 1|Administrative|0|||
129441456|NCT00658684|465914735|FG001|Overall Study|Protocol Violation|1|||
129441457|NCT00658684|465914736|FG002|Overall Study|Protocol Violation|0|||
129441458|NCT00658684|465914737|FG003|Overall Study|Protocol Violation|0|||
129441459|NCT00658684|465914734|FG000|Overall Study|Pregnancy|1|||
129441460|NCT00658684|465914735|FG001|Overall Study|Pregnancy|1|||
129441461|NCT00658684|465914736|FG002|Overall Study|Pregnancy|0|||
129441462|NCT00658684|465914737|FG003|Overall Study|Pregnancy|0|||
129441463|NCT06515483|465914740|FG000|Overall Study|Subject withdraw due to family issues|1|||
129441464|NCT06515483|465914741|FG001|Overall Study|Subject withdraw due to family issues|0|||
129441465|NCT03217266|465916304|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
129441466|NCT03217266|465916305|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
129441467|NCT03217266|465916306|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
129441468|NCT03217266|465916307|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
129441469|NCT03217266|465916304|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
129637119|NCT00685399|466626179|FG000|Treatment Period 1|Lack of Efficacy|1|||
129637120|NCT00685399|466626180|FG001|Treatment Period 1|Lack of Efficacy|0|||
129637121|NCT00685399|466626181|FG002|Treatment Period 1|Lack of Efficacy|0|||
129637122|NCT00685399|466626182|FG003|Treatment Period 1|Lack of Efficacy|0|||
129637123|NCT00685399|466626183|FG004|Treatment Period 1|Lack of Efficacy|0|||
129637124|NCT00685399|466626184|FG005|Treatment Period 1|Lack of Efficacy|0|||
129637125|NCT00685399|466626185|FG006|Treatment Period 1|Lack of Efficacy|0|||
129637126|NCT00685399|466626186|FG007|Treatment Period 1|Lack of Efficacy|0|||
129637127|NCT00685399|466626179|FG000|Treatment Period 2|Administrative Problems|0|||
129637128|NCT00685399|466626180|FG001|Treatment Period 2|Administrative Problems|2|||
129637129|NCT00685399|466626181|FG002|Treatment Period 2|Administrative Problems|1|||
129637130|NCT00685399|466626182|FG003|Treatment Period 2|Administrative Problems|0|||
129637131|NCT00685399|466626183|FG004|Treatment Period 2|Administrative Problems|0|||
129637132|NCT00685399|466626184|FG005|Treatment Period 2|Administrative Problems|0|||
129637133|NCT00685399|466626185|FG006|Treatment Period 2|Administrative Problems|0|||
129637134|NCT00685399|466626186|FG007|Treatment Period 2|Administrative Problems|0|||
129637135|NCT00685399|466626179|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129637136|NCT00685399|466626180|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129637137|NCT00685399|466626181|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129637138|NCT00685399|466626182|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129637139|NCT00685399|466626183|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129637140|NCT00685399|466626184|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129637141|NCT00685399|466626185|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129637142|NCT00685399|466626186|FG007|Treatment Period 2|Withdrawal by Subject|2|||
129637143|NCT00685399|466626179|FG000|Treatment Period 2|Adverse Event|0|||
129637144|NCT00685399|466626180|FG001|Treatment Period 2|Adverse Event|0|||
129637145|NCT00685399|466626181|FG002|Treatment Period 2|Adverse Event|0|||
129637146|NCT00685399|466626182|FG003|Treatment Period 2|Adverse Event|0|||
129637147|NCT00685399|466626183|FG004|Treatment Period 2|Adverse Event|0|||
129441470|NCT03217266|465916305|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
129441471|NCT03217266|465916306|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
129441472|NCT03217266|465916307|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
129441473|NCT03217266|465916304|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
129441474|NCT03217266|465916305|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
129441475|NCT03217266|465916306|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
129441476|NCT03217266|465916307|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
129441477|NCT01390181|465916308|FG000|Overall Study|Lost to Follow-up|1|||
129441478|NCT01390181|465916308|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
129637148|NCT00685399|466626184|FG005|Treatment Period 2|Adverse Event|1|||
129637149|NCT00685399|466626185|FG006|Treatment Period 2|Adverse Event|0|||
129637150|NCT00685399|466626186|FG007|Treatment Period 2|Adverse Event|0|||
129637151|NCT00685399|466626179|FG000|Treatment Period 2|Lack of Efficacy|0|||
129637152|NCT00685399|466626180|FG001|Treatment Period 2|Lack of Efficacy|10|||
129441479|NCT01256658|465916310|FG000|Period 1|Lost to Follow-up|837|||
129441480|NCT01256658|465916311|FG001|Period 1|Lost to Follow-up|661|||
129441481|NCT01256658|465916310|FG000|Period 1|Withdrawal by Subject|35|||
129441482|NCT01256658|465916311|FG001|Period 1|Withdrawal by Subject|43|||
129441483|NCT01256658|465916310|FG000|Period 1|Death|48|||
129441484|NCT01256658|465916311|FG001|Period 1|Death|44|||
129441485|NCT00909792|465916312|FG000|Period 1|Did not meet inclusion criteria|0|||
129441486|NCT00909792|465916313|FG001|Period 1|Did not meet inclusion criteria|1|||
129441487|NCT00909792|465916312|FG000|Period 2|Biomicroscopy|1|||
129441488|NCT00909792|465916313|FG001|Period 2|Biomicroscopy|0|||
129441489|NCT00909792|465916312|FG000|Period 2|Lost to Follow-up|0|||
129441490|NCT00909792|465916313|FG001|Period 2|Lost to Follow-up|1|||
129441491|NCT02525861|465916319|FG000|Overall Study|Adverse Event|1|||
129441492|NCT02525861|465916320|FG001|Overall Study|Adverse Event|0|||
129441493|NCT02525861|465916319|FG000|Overall Study|Withdrawal by Subject|0|||
129441494|NCT02525861|465916320|FG001|Overall Study|Withdrawal by Subject|1|||
129441495|NCT02525861|465916319|FG000|Overall Study|Physician Decision|0|||
129441496|NCT02525861|465916320|FG001|Overall Study|Physician Decision|1|||
129441497|NCT01794520|465916321|FG000|Overall Study|Adverse events- related to progression|0|||
129441498|NCT01794520|465916322|FG001|Overall Study|Adverse events- related to progression|0|||
129441499|NCT01794520|465916323|FG002|Overall Study|Adverse events- related to progression|1|||
129441500|NCT01794520|465916324|FG003|Overall Study|Adverse events- related to progression|2|||
129441501|NCT01794520|465916325|FG004|Overall Study|Adverse events- related to progression|0|||
129441502|NCT01794520|465916326|FG005|Overall Study|Adverse events- related to progression|1|||
129441503|NCT01794520|465916327|FG006|Overall Study|Adverse events- related to progression|0|||
129441504|NCT01794520|465916321|FG000|Overall Study|Adverse event- not related to progression|1|||
129441505|NCT01794520|465916322|FG001|Overall Study|Adverse event- not related to progression|1|||
129441506|NCT01794520|465916323|FG002|Overall Study|Adverse event- not related to progression|0|||
129441507|NCT01794520|465916324|FG003|Overall Study|Adverse event- not related to progression|0|||
129441508|NCT01794520|465916325|FG004|Overall Study|Adverse event- not related to progression|2|||
129441509|NCT01794520|465916326|FG005|Overall Study|Adverse event- not related to progression|0|||
129441510|NCT01794520|465916327|FG006|Overall Study|Adverse event- not related to progression|0|||
129441511|NCT01794520|465916321|FG000|Overall Study|Progressive disease|5|||
129441512|NCT01794520|465916322|FG001|Overall Study|Progressive disease|6|||
129441513|NCT01794520|465916323|FG002|Overall Study|Progressive disease|2|||
129441514|NCT01794520|465916324|FG003|Overall Study|Progressive disease|5|||
129441515|NCT01794520|465916325|FG004|Overall Study|Progressive disease|27|||
129441516|NCT01794520|465916326|FG005|Overall Study|Progressive disease|18|||
129441517|NCT01794520|465916327|FG006|Overall Study|Progressive disease|0|||
129441518|NCT01794520|465916321|FG000|Overall Study|Withdrew consent|0|||
129441519|NCT01794520|465916322|FG001|Overall Study|Withdrew consent|0|||
129441520|NCT01794520|465916323|FG002|Overall Study|Withdrew consent|1|||
129441521|NCT01794520|465916324|FG003|Overall Study|Withdrew consent|1|||
129441522|NCT01794520|465916325|FG004|Overall Study|Withdrew consent|0|||
129441523|NCT01794520|465916326|FG005|Overall Study|Withdrew consent|0|||
129441524|NCT01794520|465916327|FG006|Overall Study|Withdrew consent|0|||
129441525|NCT01794520|465916321|FG000|Overall Study|Lost to Follow-up|0|||
129441526|NCT01794520|465916322|FG001|Overall Study|Lost to Follow-up|0|||
129441527|NCT01794520|465916323|FG002|Overall Study|Lost to Follow-up|0|||
129441528|NCT01794520|465916324|FG003|Overall Study|Lost to Follow-up|0|||
129441529|NCT01794520|465916325|FG004|Overall Study|Lost to Follow-up|1|||
129441530|NCT01794520|465916326|FG005|Overall Study|Lost to Follow-up|0|||
129441531|NCT01794520|465916327|FG006|Overall Study|Lost to Follow-up|0|||
129441532|NCT01794520|465916321|FG000|Overall Study|Toxicity|0|||
129441533|NCT01794520|465916322|FG001|Overall Study|Toxicity|2|||
129441534|NCT01794520|465916323|FG002|Overall Study|Toxicity|0|||
129441535|NCT01794520|465916324|FG003|Overall Study|Toxicity|0|||
129441536|NCT01794520|465916325|FG004|Overall Study|Toxicity|0|||
129441537|NCT01794520|465916326|FG005|Overall Study|Toxicity|0|||
129441538|NCT01794520|465916327|FG006|Overall Study|Toxicity|0|||
129441539|NCT01794520|465916321|FG000|Overall Study|Study terminated by sponsor|0|||
129441540|NCT01794520|465916322|FG001|Overall Study|Study terminated by sponsor|0|||
129441541|NCT01794520|465916323|FG002|Overall Study|Study terminated by sponsor|1|||
129441542|NCT01794520|465916324|FG003|Overall Study|Study terminated by sponsor|0|||
129441543|NCT01794520|465916325|FG004|Overall Study|Study terminated by sponsor|1|||
129441544|NCT01794520|465916326|FG005|Overall Study|Study terminated by sponsor|0|||
129441545|NCT01794520|465916327|FG006|Overall Study|Study terminated by sponsor|7|||
129441546|NCT01794520|465916321|FG000|Overall Study|Death|0|||
129441547|NCT01794520|465916322|FG001|Overall Study|Death|0|||
129441548|NCT01794520|465916323|FG002|Overall Study|Death|0|||
129441549|NCT01794520|465916324|FG003|Overall Study|Death|0|||
129441550|NCT01794520|465916325|FG004|Overall Study|Death|1|||
129441551|NCT01794520|465916326|FG005|Overall Study|Death|0|||
129441552|NCT01794520|465916327|FG006|Overall Study|Death|22|||
129441553|NCT01794520|465916321|FG000|Overall Study|Other, not specified|0|||
129441554|NCT01794520|465916322|FG001|Overall Study|Other, not specified|0|||
129441555|NCT01794520|465916323|FG002|Overall Study|Other, not specified|1|||
129441556|NCT01794520|465916324|FG003|Overall Study|Other, not specified|1|||
129441557|NCT01794520|465916325|FG004|Overall Study|Other, not specified|4|||
129441558|NCT01794520|465916326|FG005|Overall Study|Other, not specified|1|||
129441559|NCT01794520|465916327|FG006|Overall Study|Other, not specified|2|||
129441560|NCT04796896|465916329|FG000|Overall Study|Adverse Event|1|||
129441561|NCT04796896|465916330|FG001|Overall Study|Adverse Event|0|||
129441562|NCT04796896|465916331|FG002|Overall Study|Adverse Event|0|||
129637153|NCT00685399|466626181|FG002|Treatment Period 2|Lack of Efficacy|2|||
129637154|NCT00685399|466626182|FG003|Treatment Period 2|Lack of Efficacy|0|||
129441563|NCT04796896|465916332|FG003|Overall Study|Adverse Event|0|||
129441564|NCT04796896|465916333|FG004|Overall Study|Adverse Event|0|||
129441565|NCT04796896|465916334|FG005|Overall Study|Adverse Event|1|||
129441566|NCT04796896|465916335|FG006|Overall Study|Adverse Event|1|||
129441567|NCT04796896|465916336|FG007|Overall Study|Adverse Event|0|||
129441568|NCT04796896|465916337|FG008|Overall Study|Adverse Event|1|||
129637155|NCT00685399|466626183|FG004|Treatment Period 2|Lack of Efficacy|0|||
129637156|NCT00685399|466626184|FG005|Treatment Period 2|Lack of Efficacy|1|||
129637157|NCT00685399|466626185|FG006|Treatment Period 2|Lack of Efficacy|0|||
129637158|NCT00685399|466626186|FG007|Treatment Period 2|Lack of Efficacy|0|||
129637159|NCT00685399|466626179|FG000|Extension|Administrative Issues|0|||
129637160|NCT00685399|466626180|FG001|Extension|Administrative Issues|0|||
129637161|NCT00685399|466626181|FG002|Extension|Administrative Issues|0|||
129637162|NCT00685399|466626182|FG003|Extension|Administrative Issues|1|||
129637163|NCT00685399|466626183|FG004|Extension|Administrative Issues|0|||
129637164|NCT00685399|466626184|FG005|Extension|Administrative Issues|0|||
129637165|NCT00685399|466626185|FG006|Extension|Administrative Issues|0|||
129637166|NCT00685399|466626186|FG007|Extension|Administrative Issues|0|||
129637167|NCT00685399|466626179|FG000|Extension|Withdrawal by Subject|0|||
129637168|NCT00685399|466626180|FG001|Extension|Withdrawal by Subject|0|||
129637169|NCT00685399|466626181|FG002|Extension|Withdrawal by Subject|0|||
129637170|NCT00685399|466626182|FG003|Extension|Withdrawal by Subject|1|||
129637171|NCT00685399|466626183|FG004|Extension|Withdrawal by Subject|0|||
129637172|NCT00685399|466626184|FG005|Extension|Withdrawal by Subject|0|||
129637173|NCT00685399|466626185|FG006|Extension|Withdrawal by Subject|0|||
129637174|NCT00685399|466626186|FG007|Extension|Withdrawal by Subject|0|||
129637175|NCT00685399|466626179|FG000|Extension|Protocol Violation|0|||
129637176|NCT00685399|466626180|FG001|Extension|Protocol Violation|0|||
129637177|NCT00685399|466626181|FG002|Extension|Protocol Violation|0|||
129637178|NCT00685399|466626182|FG003|Extension|Protocol Violation|1|||
129637179|NCT00685399|466626183|FG004|Extension|Protocol Violation|0|||
129637180|NCT00685399|466626184|FG005|Extension|Protocol Violation|0|||
129637181|NCT00685399|466626185|FG006|Extension|Protocol Violation|0|||
129637182|NCT00685399|466626186|FG007|Extension|Protocol Violation|0|||
129637183|NCT00685399|466626179|FG000|Extension|Lack of Efficacy|0|||
129637184|NCT00685399|466626180|FG001|Extension|Lack of Efficacy|0|||
129637185|NCT00685399|466626181|FG002|Extension|Lack of Efficacy|0|||
129637186|NCT00685399|466626182|FG003|Extension|Lack of Efficacy|2|||
129637187|NCT00685399|466626183|FG004|Extension|Lack of Efficacy|0|||
129637188|NCT00685399|466626184|FG005|Extension|Lack of Efficacy|0|||
129637189|NCT00685399|466626185|FG006|Extension|Lack of Efficacy|0|||
129637190|NCT00685399|466626186|FG007|Extension|Lack of Efficacy|0|||
129637191|NCT00685399|466626179|FG000|Extension|Adverse Event|0|||
129637192|NCT00685399|466626180|FG001|Extension|Adverse Event|0|||
129637193|NCT00685399|466626181|FG002|Extension|Adverse Event|0|||
129637194|NCT00685399|466626182|FG003|Extension|Adverse Event|2|||
129637195|NCT00685399|466626183|FG004|Extension|Adverse Event|0|||
129637196|NCT00685399|466626184|FG005|Extension|Adverse Event|0|||
129637197|NCT00685399|466626185|FG006|Extension|Adverse Event|0|||
129637198|NCT00685399|466626186|FG007|Extension|Adverse Event|0|||
129637199|NCT00927862|466626187|FG000|Overall Study|Missing data needed for endpt analyses|27|||
129637200|NCT00927862|466626188|FG001|Overall Study|Missing data needed for endpt analyses|45|||
129797807|NCT02537574|467228233|FG000|Overall Study|Lost to Follow-up|40|||
129441569|NCT04796896|465916338|FG009|Overall Study|Adverse Event|1|||
129441570|NCT04796896|465916339|FG010|Overall Study|Adverse Event|1|||
129441571|NCT04796896|465916340|FG011|Overall Study|Adverse Event|0|||
129441572|NCT04796896|465916329|FG000|Overall Study|Lost to Follow-up|24|||
129637201|NCT00820248|466626189|FG000|Overall Study|No treated|4|||
129637202|NCT00820248|466626190|FG001|Overall Study|No treated|1|||
129637203|NCT02237196|466626192|FG000|Overall Study|Adverse Event|0|||
129441573|NCT04796896|465916330|FG001|Overall Study|Lost to Follow-up|15|||
129441574|NCT04796896|465916331|FG002|Overall Study|Lost to Follow-up|6|||
129637204|NCT02237196|466626193|FG001|Overall Study|Adverse Event|1|||
129637205|NCT02237196|466626194|FG002|Overall Study|Adverse Event|1|||
129441575|NCT04796896|465916332|FG003|Overall Study|Lost to Follow-up|4|||
129441576|NCT04796896|465916333|FG004|Overall Study|Lost to Follow-up|21|||
129637206|NCT02237196|466626195|FG003|Overall Study|Adverse Event|0|||
129637207|NCT02237196|466626192|FG000|Overall Study|Lost to Follow-up|4|||
129637208|NCT02237196|466626193|FG001|Overall Study|Lost to Follow-up|2|||
129637209|NCT02237196|466626194|FG002|Overall Study|Lost to Follow-up|4|||
129637210|NCT02237196|466626195|FG003|Overall Study|Lost to Follow-up|6|||
129637211|NCT02237196|466626192|FG000|Overall Study|Physician Decision|2|||
129637212|NCT02237196|466626193|FG001|Overall Study|Physician Decision|0|||
129441577|NCT04796896|465916334|FG005|Overall Study|Lost to Follow-up|55|||
129441578|NCT04796896|465916335|FG006|Overall Study|Lost to Follow-up|237|||
129637213|NCT02237196|466626194|FG002|Overall Study|Physician Decision|0|||
129637214|NCT02237196|466626195|FG003|Overall Study|Physician Decision|1|||
129637215|NCT02237196|466626192|FG000|Overall Study|Pregnancy|0|||
129637216|NCT02237196|466626193|FG001|Overall Study|Pregnancy|0|||
129637217|NCT02237196|466626194|FG002|Overall Study|Pregnancy|1|||
129637218|NCT02237196|466626195|FG003|Overall Study|Pregnancy|1|||
129637219|NCT02237196|466626192|FG000|Overall Study|Withdrawal by Subject|1|||
129889349|NCT04894903|467552564|FG000|Overall Study|Pregnancy|1|||
129441579|NCT04796896|465916336|FG007|Overall Study|Lost to Follow-up|52|||
129441580|NCT04796896|465916337|FG008|Overall Study|Lost to Follow-up|221|||
129441581|NCT04796896|465916338|FG009|Overall Study|Lost to Follow-up|43|||
129441582|NCT04796896|465916339|FG010|Overall Study|Lost to Follow-up|142|||
129441583|NCT04796896|465916340|FG011|Overall Study|Lost to Follow-up|18|||
129441584|NCT04796896|465916329|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
129441585|NCT04796896|465916330|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
129441586|NCT04796896|465916331|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
129441587|NCT04796896|465916332|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
129441588|NCT04796896|465916333|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
129441589|NCT04796896|465916334|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
129441590|NCT04796896|465916335|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
129441591|NCT04796896|465916336|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
129441592|NCT04796896|465916337|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
129441593|NCT04796896|465916338|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
129441594|NCT04796896|465916339|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
129441595|NCT04796896|465916340|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
129441596|NCT04796896|465916329|FG000|Overall Study|Physician Decision|1|||
129441597|NCT04796896|465916330|FG001|Overall Study|Physician Decision|0|||
129441598|NCT04796896|465916331|FG002|Overall Study|Physician Decision|0|||
129441599|NCT04796896|465916332|FG003|Overall Study|Physician Decision|0|||
129441600|NCT04796896|465916333|FG004|Overall Study|Physician Decision|0|||
129441601|NCT04796896|465916334|FG005|Overall Study|Physician Decision|3|||
129441602|NCT04796896|465916335|FG006|Overall Study|Physician Decision|18|||
129637220|NCT02237196|466626193|FG001|Overall Study|Withdrawal by Subject|1|||
129637221|NCT02237196|466626194|FG002|Overall Study|Withdrawal by Subject|4|||
129637222|NCT02237196|466626195|FG003|Overall Study|Withdrawal by Subject|1|||
129637223|NCT02237196|466626192|FG000|Overall Study|Site Error|1|||
129441603|NCT04796896|465916336|FG007|Overall Study|Physician Decision|1|||
129441604|NCT04796896|465916337|FG008|Overall Study|Physician Decision|7|||
129441605|NCT04796896|465916338|FG009|Overall Study|Physician Decision|0|||
129441606|NCT04796896|465916339|FG010|Overall Study|Physician Decision|5|||
129441607|NCT04796896|465916340|FG011|Overall Study|Physician Decision|0|||
129441608|NCT04796896|465916329|FG000|Overall Study|Withdrawal by Subject|36|||
129441609|NCT04796896|465916330|FG001|Overall Study|Withdrawal by Subject|31|||
129441610|NCT04796896|465916331|FG002|Overall Study|Withdrawal by Subject|11|||
129441611|NCT04796896|465916332|FG003|Overall Study|Withdrawal by Subject|8|||
129441612|NCT04796896|465916333|FG004|Overall Study|Withdrawal by Subject|16|||
129441613|NCT04796896|465916334|FG005|Overall Study|Withdrawal by Subject|162|||
129441614|NCT04796896|465916335|FG006|Overall Study|Withdrawal by Subject|299|||
129441615|NCT04796896|465916336|FG007|Overall Study|Withdrawal by Subject|149|||
129441616|NCT04796896|465916337|FG008|Overall Study|Withdrawal by Subject|303|||
129441617|NCT04796896|465916338|FG009|Overall Study|Withdrawal by Subject|94|||
129441618|NCT04796896|465916339|FG010|Overall Study|Withdrawal by Subject|192|||
129441619|NCT04796896|465916340|FG011|Overall Study|Withdrawal by Subject|16|||
129441620|NCT04796896|465916329|FG000|Overall Study|Other Than Specified|6|||
129441621|NCT04796896|465916330|FG001|Overall Study|Other Than Specified|5|||
129441622|NCT04796896|465916331|FG002|Overall Study|Other Than Specified|3|||
129441623|NCT04796896|465916332|FG003|Overall Study|Other Than Specified|2|||
129441624|NCT04796896|465916333|FG004|Overall Study|Other Than Specified|6|||
129441625|NCT04796896|465916334|FG005|Overall Study|Other Than Specified|31|||
129441626|NCT04796896|465916335|FG006|Overall Study|Other Than Specified|86|||
129441627|NCT04796896|465916336|FG007|Overall Study|Other Than Specified|66|||
129441628|NCT04796896|465916337|FG008|Overall Study|Other Than Specified|388|||
129441629|NCT04796896|465916338|FG009|Overall Study|Other Than Specified|48|||
129441630|NCT04796896|465916339|FG010|Overall Study|Other Than Specified|258|||
129441631|NCT04796896|465916340|FG011|Overall Study|Other Than Specified|4|||
129441632|NCT04796896|465916329|FG000|Overall Study|Protocol Deviation|0|||
129441633|NCT04796896|465916330|FG001|Overall Study|Protocol Deviation|0|||
129441634|NCT04796896|465916331|FG002|Overall Study|Protocol Deviation|0|||
129441635|NCT04796896|465916332|FG003|Overall Study|Protocol Deviation|1|||
129441636|NCT04796896|465916333|FG004|Overall Study|Protocol Deviation|1|||
129441637|NCT04796896|465916334|FG005|Overall Study|Protocol Deviation|2|||
129441638|NCT04796896|465916335|FG006|Overall Study|Protocol Deviation|2|||
129441639|NCT04796896|465916336|FG007|Overall Study|Protocol Deviation|2|||
129441640|NCT04796896|465916337|FG008|Overall Study|Protocol Deviation|2|||
129441641|NCT04796896|465916338|FG009|Overall Study|Protocol Deviation|1|||
129441642|NCT04796896|465916339|FG010|Overall Study|Protocol Deviation|0|||
129441643|NCT04796896|465916340|FG011|Overall Study|Protocol Deviation|0|||
129441644|NCT04796896|465916329|FG000|Overall Study|Missing|0|||
129441645|NCT04796896|465916330|FG001|Overall Study|Missing|0|||
129441646|NCT04796896|465916331|FG002|Overall Study|Missing|0|||
129441647|NCT04796896|465916332|FG003|Overall Study|Missing|0|||
129441648|NCT04796896|465916333|FG004|Overall Study|Missing|0|||
129441649|NCT04796896|465916334|FG005|Overall Study|Missing|0|||
129441650|NCT04796896|465916335|FG006|Overall Study|Missing|2|||
129441651|NCT04796896|465916336|FG007|Overall Study|Missing|1|||
129441652|NCT04796896|465916337|FG008|Overall Study|Missing|2|||
129441653|NCT04796896|465916338|FG009|Overall Study|Missing|1|||
129441654|NCT04796896|465916339|FG010|Overall Study|Missing|1|||
129441655|NCT04796896|465916340|FG011|Overall Study|Missing|0|||
129441656|NCT04796896|465916329|FG000|Overall Study|Death|0|||
129441657|NCT04796896|465916330|FG001|Overall Study|Death|0|||
129441658|NCT04796896|465916331|FG002|Overall Study|Death|0|||
129441659|NCT04796896|465916332|FG003|Overall Study|Death|0|||
129441660|NCT04796896|465916333|FG004|Overall Study|Death|0|||
129441661|NCT04796896|465916334|FG005|Overall Study|Death|0|||
129889350|NCT04894903|467552565|FG001|Overall Study|Pregnancy|0|||
129889351|NCT04894903|467552564|FG000|Overall Study|Withdrawal by Subject|1|||
129889352|NCT04894903|467552565|FG001|Overall Study|Withdrawal by Subject|1|||
129441662|NCT04796896|465916335|FG006|Overall Study|Death|0|||
129441663|NCT04796896|465916336|FG007|Overall Study|Death|0|||
129441664|NCT04796896|465916337|FG008|Overall Study|Death|1|||
129441665|NCT04796896|465916338|FG009|Overall Study|Death|0|||
129441666|NCT04796896|465916339|FG010|Overall Study|Death|0|||
129441667|NCT04796896|465916340|FG011|Overall Study|Death|0|||
129441668|NCT04356183|465916341|FG000|Overall Study|Lost to Follow-up|1|||
129441669|NCT04356183|465916342|FG001|Overall Study|Lost to Follow-up|0|||
129889353|NCT04894903|467552564|FG000|Overall Study|moved or exited health system|1|||
129441670|NCT04356183|465916341|FG000|Overall Study|Withdrawal by Subject|1|||
129441671|NCT04356183|465916342|FG001|Overall Study|Withdrawal by Subject|1|||
129441672|NCT01177787|465916343|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
129441673|NCT01177787|465916343|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
129441674|NCT01177787|465916343|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
129441675|NCT00402363|465916346|FG000|Overall Study|Adverse Event|9|||
129441676|NCT00402363|465916347|FG001|Overall Study|Adverse Event|14|||
129441677|NCT00402363|465916348|FG002|Overall Study|Adverse Event|2|||
129441678|NCT00402363|465916349|FG003|Overall Study|Adverse Event|2|||
129441679|NCT00402363|465916346|FG000|Overall Study|Withdrew Consent|10|||
129441680|NCT00402363|465916347|FG001|Overall Study|Withdrew Consent|5|||
129441681|NCT00402363|465916348|FG002|Overall Study|Withdrew Consent|2|||
129441682|NCT00402363|465916349|FG003|Overall Study|Withdrew Consent|1|||
129441683|NCT00402363|465916346|FG000|Overall Study|Protocol Violation|3|||
129441684|NCT00402363|465916347|FG001|Overall Study|Protocol Violation|5|||
129441685|NCT00402363|465916348|FG002|Overall Study|Protocol Violation|0|||
129441686|NCT00402363|465916349|FG003|Overall Study|Protocol Violation|3|||
129441687|NCT00402363|465916346|FG000|Overall Study|Lost to Follow-up|5|||
129441688|NCT00402363|465916347|FG001|Overall Study|Lost to Follow-up|4|||
129441689|NCT00402363|465916348|FG002|Overall Study|Lost to Follow-up|0|||
129441690|NCT00402363|465916349|FG003|Overall Study|Lost to Follow-up|2|||
129441691|NCT00402363|465916346|FG000|Overall Study|"Captured as Other"|6|||
129441692|NCT00402363|465916347|FG001|Overall Study|"Captured as Other"|2|||
129441693|NCT00402363|465916348|FG002|Overall Study|"Captured as Other"|2|||
129441694|NCT00402363|465916349|FG003|Overall Study|"Captured as Other"|2|||
129441695|NCT00293722|465916350|FG000|Overall Study|Other|427|||
129441696|NCT02634346|465916352|FG000|Overall Study|Withdrawal by Subject|8|||
129441697|NCT02634346|465916353|FG001|Overall Study|Withdrawal by Subject|9|||
129637224|NCT02237196|466626193|FG001|Overall Study|Site Error|2|||
129637225|NCT02237196|466626194|FG002|Overall Study|Site Error|0|||
129441698|NCT02634346|465916354|FG002|Overall Study|Withdrawal by Subject|8|||
129637226|NCT02237196|466626195|FG003|Overall Study|Site Error|2|||
129441699|NCT02634346|465916352|FG000|Overall Study|Adverse Event|2|||
129441700|NCT02634346|465916353|FG001|Overall Study|Adverse Event|2|||
129889354|NCT04894903|467552565|FG001|Overall Study|moved or exited health system|3|||
129889355|NCT01923428|467552569|FG000|Overall Study|Adverse Event|8|||
129889356|NCT01923428|467552570|FG001|Overall Study|Adverse Event|6|||
129889357|NCT01923428|467552571|FG002|Overall Study|Adverse Event|3|||
129889358|NCT01923428|467552572|FG003|Overall Study|Adverse Event|3|||
129889359|NCT01923428|467552569|FG000|Overall Study|Withdrawal by Subject|5|||
129889360|NCT01923428|467552570|FG001|Overall Study|Withdrawal by Subject|3|||
129889361|NCT01923428|467552571|FG002|Overall Study|Withdrawal by Subject|0|||
129889362|NCT01923428|467552572|FG003|Overall Study|Withdrawal by Subject|4|||
129889363|NCT01923428|467552569|FG000|Overall Study|Lost to Follow-up|2|||
129889364|NCT01923428|467552570|FG001|Overall Study|Lost to Follow-up|1|||
129889365|NCT01923428|467552571|FG002|Overall Study|Lost to Follow-up|5|||
129889366|NCT01923428|467552572|FG003|Overall Study|Lost to Follow-up|0|||
129889367|NCT01923428|467552569|FG000|Overall Study|Protocol Violation|3|||
129889368|NCT01923428|467552570|FG001|Overall Study|Protocol Violation|0|||
129889369|NCT01923428|467552571|FG002|Overall Study|Protocol Violation|2|||
129889370|NCT01923428|467552572|FG003|Overall Study|Protocol Violation|1|||
129889371|NCT01923428|467552569|FG000|Overall Study|Non Compliance to treatment|1|||
129889372|NCT01923428|467552570|FG001|Overall Study|Non Compliance to treatment|2|||
129889373|NCT01923428|467552571|FG002|Overall Study|Non Compliance to treatment|0|||
129889374|NCT01923428|467552572|FG003|Overall Study|Non Compliance to treatment|1|||
129889375|NCT01923428|467552569|FG000|Overall Study|Lack of Efficacy|0|||
129889376|NCT01923428|467552570|FG001|Overall Study|Lack of Efficacy|0|||
129889377|NCT01923428|467552571|FG002|Overall Study|Lack of Efficacy|1|||
129889378|NCT01923428|467552572|FG003|Overall Study|Lack of Efficacy|1|||
129889379|NCT02550873|467552573|FG000|Randomized Double Blind|Adverse Event|3|||
129889380|NCT02550873|467552574|FG001|Randomized Double Blind|Adverse Event|1|||
129889381|NCT02550873|467552575|FG002|Randomized Double Blind|Adverse Event|0|||
129889382|NCT02550873|467552573|FG000|Randomized Double Blind|Disease progression|1|||
129889383|NCT02550873|467552574|FG001|Randomized Double Blind|Disease progression|1|||
129889384|NCT02550873|467552575|FG002|Randomized Double Blind|Disease progression|0|||
129889385|NCT02550873|467552573|FG000|Open Label Extension|Study ongoing|0|||
129889386|NCT02550873|467552574|FG001|Open Label Extension|Study ongoing|0|||
129889387|NCT02550873|467552575|FG002|Open Label Extension|Study ongoing|111|||
129889388|NCT01822353|467552576|FG000|Overall Study|Adverse Event|1|||
129889389|NCT01822353|467552577|FG001|Overall Study|Adverse Event|3|||
129889390|NCT01822353|467552578|FG002|Overall Study|Adverse Event|1|||
129889391|NCT01822353|467552576|FG000|Overall Study|Pregnancy|0|||
129889392|NCT01822353|467552577|FG001|Overall Study|Pregnancy|1|||
129889393|NCT01822353|467552578|FG002|Overall Study|Pregnancy|0|||
129889394|NCT01822353|467552576|FG000|Overall Study|Withdrawal by Subject|3|||
129889395|NCT01822353|467552577|FG001|Overall Study|Withdrawal by Subject|1|||
129889396|NCT01822353|467552578|FG002|Overall Study|Withdrawal by Subject|0|||
129889397|NCT00895843|467552579|FG000|Overall Study|Protocol Violation|12|||
129889398|NCT00895843|467552580|FG001|Overall Study|Protocol Violation|12|||
129889399|NCT04963062|467552588|FG000|Overall Study|withdrew by the study team|4|||
129889400|NCT04963062|467552589|FG001|Overall Study|withdrew by the study team|2|||
129889401|NCT01857323|467552590|FG000|Overall Study|Adverse Event|1|||
129889402|NCT01857323|467552590|FG000|Overall Study|Withdrawal by Subject|3|||
129637227|NCT01750697|466626198|FG000|Overall Study|Transferred Back to Local Hospital|1|||
129637228|NCT01750697|466626198|FG000|Overall Study|Physician and Family Decision|1|||
129637229|NCT01750697|466626198|FG000|Overall Study|Transferred to Adult Services|5|||
129637230|NCT01750697|466626198|FG000|Overall Study|Physician Decision|1|||
129637231|NCT01750697|466626198|FG000|Overall Study|Withdrawal by Subject|1|||
129637232|NCT01562782|466626208|FG000|Overall Study|Withdrawal by Subject|3|||
129637233|NCT01562782|466626209|FG001|Overall Study|Withdrawal by Subject|3|||
129637234|NCT01562782|466626208|FG000|Overall Study|screen failure|1|||
129637235|NCT01562782|466626209|FG001|Overall Study|screen failure|2|||
129637236|NCT01421225|466626212|FG000|Overall Study|Withdrawal by Subject|0|||
129637237|NCT01421225|466626213|FG001|Overall Study|Withdrawal by Subject|1|||
129637238|NCT02049814|466626216|FG000|Overall Study|Reason not Specified|4|||
129637239|NCT02049814|466626217|FG001|Overall Study|Reason not Specified|3|||
129637240|NCT02049814|466626216|FG000|Overall Study|Pregnancy|1|||
129637241|NCT02049814|466626217|FG001|Overall Study|Pregnancy|0|||
129637242|NCT02049814|466626216|FG000|Overall Study|Lost to Follow-up|2|||
129637243|NCT02049814|466626217|FG001|Overall Study|Lost to Follow-up|3|||
129637244|NCT02049814|466626216|FG000|Overall Study|Serious Protocol Violation|5|||
129637245|NCT02049814|466626217|FG001|Overall Study|Serious Protocol Violation|7|||
129637246|NCT02049814|466626216|FG000|Overall Study|Study Termination|0|||
129637247|NCT02049814|466626217|FG001|Overall Study|Study Termination|1|||
129637248|NCT02049814|466626216|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
129637249|NCT02049814|466626217|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
129637250|NCT02049814|466626216|FG000|Overall Study|Voluntary withdrawal|9|||
129637251|NCT02049814|466626217|FG001|Overall Study|Voluntary withdrawal|8|||
129637252|NCT01282372|466626218|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
129637253|NCT01282372|466626218|FG000|Overall Study|Lost to Follow-up|23|||
129637254|NCT01282372|466626218|FG000|Overall Study|Withdrawal by Subject|11|||
129637255|NCT01282372|466626218|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
129637256|NCT01282372|466626218|FG000|Overall Study|Death|1|||
129637257|NCT01282372|466626218|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
129637258|NCT01282372|466626218|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
129637259|NCT01282372|466626218|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
129637260|NCT01282372|466626218|FG000|Overall Study|Adverse Event|12|||
129637261|NCT02993250|466626220|FG000|Overall Study|Lost to Follow-up|0|||
129637262|NCT02993250|466626221|FG001|Overall Study|Lost to Follow-up|1|||
129637263|NCT02527434|466626222|FG000|Overall Study|Lost to Follow-up|2|||
129637264|NCT02527434|466626223|FG001|Overall Study|Lost to Follow-up|2|||
129637265|NCT02527434|466626224|FG002|Overall Study|Lost to Follow-up|0|||
129637266|NCT02527434|466626222|FG000|Overall Study|Death|19|||
129637267|NCT02527434|466626223|FG001|Overall Study|Death|6|||
129637268|NCT02527434|466626224|FG002|Overall Study|Death|17|||
129637269|NCT02527434|466626222|FG000|Overall Study|Withdrawal by Subject|5|||
129637270|NCT02527434|466626223|FG001|Overall Study|Withdrawal by Subject|3|||
129637271|NCT02527434|466626224|FG002|Overall Study|Withdrawal by Subject|3|||
129637272|NCT02527434|466626222|FG000|Overall Study|Reason Not Specified|1|||
129637273|NCT02527434|466626223|FG001|Overall Study|Reason Not Specified|0|||
129637274|NCT02527434|466626224|FG002|Overall Study|Reason Not Specified|0|||
129637275|NCT02527434|466626222|FG000|Overall Study|Site closure|1|||
129637276|NCT02527434|466626223|FG001|Overall Study|Site closure|0|||
129637277|NCT02527434|466626224|FG002|Overall Study|Site closure|0|||
129889403|NCT01857323|467552590|FG000|Overall Study|Non-compliance|1|||
129889404|NCT01857323|467552590|FG000|Overall Study|Protocol Violation|6|||
129889405|NCT01857323|467552590|FG000|Overall Study|Lost to Follow-up|1|||
129637278|NCT00713258|466626225|FG000|Overall Study|Adverse Event|2|||
129637279|NCT00713258|466626226|FG001|Overall Study|Adverse Event|4|||
129637280|NCT00713258|466626225|FG000|Overall Study|Non-Compliance|2|||
129637281|NCT00713258|466626226|FG001|Overall Study|Non-Compliance|1|||
129637282|NCT00713258|466626225|FG000|Overall Study|Other|1|||
129637283|NCT00713258|466626226|FG001|Overall Study|Other|1|||
129889406|NCT01857323|467552590|FG000|Overall Study|Other|4|||
129637284|NCT01322490|466626227|FG000|Treatment Period|Adverse Event|12|||
129637285|NCT01322490|466626228|FG001|Treatment Period|Adverse Event|18|||
129889407|NCT01857323|467552590|FG000|Overall Study|Did not complete 180 doses|48|||
129637286|NCT01322490|466626229|FG002|Treatment Period|Adverse Event|15|||
129889408|NCT03873246|467552591|FG000|Overall Study|Adverse Event|1|||
129889409|NCT03873246|467552592|FG001|Overall Study|Adverse Event|3|||
129889410|NCT03873246|467552593|FG002|Overall Study|Adverse Event|3|||
129889411|NCT03873246|467552591|FG000|Overall Study|Lost to Follow-up|4|||
129889412|NCT03873246|467552592|FG001|Overall Study|Lost to Follow-up|4|||
129637287|NCT01322490|466626227|FG000|Treatment Period|Death|5|||
129637288|NCT01322490|466626228|FG001|Treatment Period|Death|7|||
129637289|NCT01322490|466626229|FG002|Treatment Period|Death|3|||
129637290|NCT01322490|466626227|FG000|Treatment Period|Lack of Efficacy|89|||
129637291|NCT01322490|466626228|FG001|Treatment Period|Lack of Efficacy|100|||
129637292|NCT01322490|466626229|FG002|Treatment Period|Lack of Efficacy|112|||
129637293|NCT01322490|466626227|FG000|Treatment Period|Physician Decision|0|||
129637294|NCT01322490|466626228|FG001|Treatment Period|Physician Decision|2|||
129637295|NCT01322490|466626229|FG002|Treatment Period|Physician Decision|1|||
129637296|NCT01322490|466626227|FG000|Treatment Period|Protocol Violation|7|||
129637297|NCT01322490|466626228|FG001|Treatment Period|Protocol Violation|5|||
129637298|NCT01322490|466626229|FG002|Treatment Period|Protocol Violation|4|||
129637299|NCT01322490|466626227|FG000|Treatment Period|Withdrawal by Subject|14|||
129637300|NCT01322490|466626228|FG001|Treatment Period|Withdrawal by Subject|16|||
129637301|NCT01322490|466626229|FG002|Treatment Period|Withdrawal by Subject|11|||
129889413|NCT03873246|467552593|FG002|Overall Study|Lost to Follow-up|5|||
129889414|NCT03873246|467552591|FG000|Overall Study|Protocol Violation|0|||
129889415|NCT03873246|467552592|FG001|Overall Study|Protocol Violation|1|||
129889416|NCT03873246|467552593|FG002|Overall Study|Protocol Violation|0|||
129889417|NCT03873246|467552591|FG000|Overall Study|Withdrawal by Subject|0|||
129889418|NCT03873246|467552592|FG001|Overall Study|Withdrawal by Subject|4|||
129889419|NCT03873246|467552593|FG002|Overall Study|Withdrawal by Subject|1|||
129889420|NCT03658811|467552598|FG000|Overall Study|Lost to Follow-up|3|||
129889421|NCT00885495|467552599|FG000|Overall Study|Adverse Event|1|||
129889422|NCT00885495|467552600|FG001|Overall Study|Adverse Event|2|||
129889423|NCT00885495|467552599|FG000|Overall Study|Protocol Violation|0|||
129889424|NCT00885495|467552600|FG001|Overall Study|Protocol Violation|1|||
129889425|NCT00885495|467552599|FG000|Overall Study|Withdrawal by Subject|1|||
129889426|NCT00885495|467552600|FG001|Overall Study|Withdrawal by Subject|0|||
129889427|NCT01400893|467552601|FG000|Overall Study|Death|27|||
129889428|NCT01400893|467552602|FG001|Overall Study|Death|21|||
129889429|NCT01400893|467552601|FG000|Overall Study|Lost to Follow-up|0|||
129889430|NCT01400893|467552602|FG001|Overall Study|Lost to Follow-up|6|||
129889431|NCT00946647|467552606|FG000|Phase 1 Part|Adverse Event|2|||
129889432|NCT00946647|467552607|FG001|Phase 1 Part|Adverse Event|5|||
129889433|NCT00946647|467552608|FG002|Phase 1 Part|Adverse Event|3|||
129889434|NCT00946647|467552609|FG003|Phase 1 Part|Adverse Event|0|||
129889435|NCT00946647|467552610|FG004|Phase 1 Part|Adverse Event|0|||
129889436|NCT00946647|467552606|FG000|Phase 1 Part|Disease progression|3|||
129889437|NCT00946647|467552607|FG001|Phase 1 Part|Disease progression|6|||
129889438|NCT00946647|467552608|FG002|Phase 1 Part|Disease progression|1|||
129889439|NCT00946647|467552609|FG003|Phase 1 Part|Disease progression|0|||
129889440|NCT00946647|467552610|FG004|Phase 1 Part|Disease progression|0|||
129889441|NCT00946647|467552606|FG000|Phase 1 Part|Withdrawal by Subject|1|||
129889442|NCT00946647|467552607|FG001|Phase 1 Part|Withdrawal by Subject|4|||
129889443|NCT00946647|467552608|FG002|Phase 1 Part|Withdrawal by Subject|3|||
129889444|NCT00946647|467552609|FG003|Phase 1 Part|Withdrawal by Subject|0|||
129889445|NCT00946647|467552610|FG004|Phase 1 Part|Withdrawal by Subject|0|||
129637302|NCT01322490|466626227|FG000|Treatment Period|Non-compliance with study drug|0|||
129889446|NCT00946647|467552606|FG000|Phase 1 Part|Abnormal values|0|||
129889447|NCT00946647|467552607|FG001|Phase 1 Part|Abnormal values|2|||
129889448|NCT00946647|467552608|FG002|Phase 1 Part|Abnormal values|0|||
129637303|NCT01322490|466626228|FG001|Treatment Period|Non-compliance with study drug|0|||
129889449|NCT00946647|467552609|FG003|Phase 1 Part|Abnormal values|0|||
129889450|NCT00946647|467552610|FG004|Phase 1 Part|Abnormal values|0|||
129889451|NCT00946647|467552606|FG000|Phase 1 Part|Reason missing|0|||
129637304|NCT01322490|466626229|FG002|Treatment Period|Non-compliance with study drug|1|||
129889452|NCT00946647|467552607|FG001|Phase 1 Part|Reason missing|1|||
129889453|NCT00946647|467552608|FG002|Phase 1 Part|Reason missing|0|||
129637305|NCT01322490|466626227|FG000|Treatment Period|Other per report|2|||
129637306|NCT01322490|466626228|FG001|Treatment Period|Other per report|2|||
129637307|NCT01322490|466626229|FG002|Treatment Period|Other per report|1|||
129637308|NCT01322490|466626227|FG000|Treatment Period|Randomized but Not Treated|3|||
129637309|NCT01322490|466626228|FG001|Treatment Period|Randomized but Not Treated|3|||
129637310|NCT01322490|466626229|FG002|Treatment Period|Randomized but Not Treated|5|||
129637311|NCT01322490|466626227|FG000|Long Term Follow-up Period|Death|235|||
129637312|NCT01322490|466626228|FG001|Long Term Follow-up Period|Death|239|||
129637313|NCT01322490|466626229|FG002|Long Term Follow-up Period|Death|236|||
129637314|NCT01322490|466626227|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
129637315|NCT01322490|466626228|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
129637316|NCT01322490|466626229|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
129637317|NCT01322490|466626227|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
129637318|NCT01322490|466626228|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
129637319|NCT01322490|466626229|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
129637320|NCT01322490|466626227|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
129637321|NCT01322490|466626228|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
129637322|NCT01322490|466626229|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
129637323|NCT01322490|466626227|FG000|Long Term Follow-up Period|Other per report|3|||
129637324|NCT01322490|466626228|FG001|Long Term Follow-up Period|Other per report|2|||
129637325|NCT01322490|466626229|FG002|Long Term Follow-up Period|Other per report|2|||
129637326|NCT01322490|466626227|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
129637327|NCT01322490|466626228|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
129637328|NCT01322490|466626229|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
129637329|NCT01431716|466626230|FG000|Overall Study|Withdrawal of consent|1|||
129637330|NCT00568061|466626231|FG000|Overall Study|Inclusion / exclusion criteria|5|||
129637331|NCT00568061|466626232|FG001|Overall Study|Inclusion / exclusion criteria|1|||
129637332|NCT00568061|466626231|FG000|Overall Study|Adverse Event|0|||
129637333|NCT00568061|466626232|FG001|Overall Study|Adverse Event|1|||
129637334|NCT05027451|466626233|FG000|Overall Study|Lost to Follow-up|1|||
129637335|NCT05027451|466626234|FG001|Overall Study|Lost to Follow-up|1|||
129637336|NCT01896128|466626235|FG000|Overall Study|Withdrawal by Subject|3|||
129637337|NCT01896128|466626236|FG001|Overall Study|Withdrawal by Subject|3|||
129637338|NCT00356148|466626239|FG000|Overall Study|Reoperation within 30 days|2|||
129637339|NCT00356148|466626240|FG001|Overall Study|Reoperation within 30 days|1|||
129637340|NCT02484456|466626241|FG000|Washout Period|Withdrawal by Subject|0|||
129637341|NCT02484456|466626242|FG001|Washout Period|Withdrawal by Subject|1|||
129637342|NCT02484456|466626241|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
129637343|NCT02484456|466626242|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
129637344|NCT02484456|466626241|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
129637345|NCT02484456|466626242|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
129637346|NCT02484456|466626241|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
129637347|NCT02484456|466626242|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
129637348|NCT01996254|466626245|FG000|Overall Study|Change in Eligibility|0|||
129637349|NCT01996254|466626246|FG001|Overall Study|Change in Eligibility|2|||
129637350|NCT01996254|466626247|FG002|Overall Study|Change in Eligibility|0|||
129637351|NCT01996254|466626245|FG000|Overall Study|Withdrawal by Subject|0|||
129637352|NCT01996254|466626246|FG001|Overall Study|Withdrawal by Subject|3|||
129637353|NCT01996254|466626247|FG002|Overall Study|Withdrawal by Subject|4|||
129637354|NCT01996254|466626245|FG000|Overall Study|Lost to Follow-up|1|||
129637355|NCT01996254|466626246|FG001|Overall Study|Lost to Follow-up|0|||
129637356|NCT01996254|466626247|FG002|Overall Study|Lost to Follow-up|4|||
129637357|NCT03348930|466626248|FG000|Washout (1 Week)|Lost to Follow-up|1|||
129637358|NCT03348930|466626249|FG001|Washout (1 Week)|Lost to Follow-up|1|||
129637359|NCT02693002|466626252|FG000|Overall Study|Withdrawal by Subject|1|||
129637360|NCT02693002|466626253|FG001|Overall Study|Withdrawal by Subject|0|||
129637361|NCT00708214|466626254|FG000|Overall Study|Other Adverse Event|3|||
129637362|NCT00708214|466626255|FG001|Overall Study|Other Adverse Event|6|||
129637363|NCT00708214|466626256|FG002|Overall Study|Other Adverse Event|2|||
129637364|NCT00708214|466626254|FG000|Overall Study|Other|0|||
129637365|NCT00708214|466626255|FG001|Overall Study|Other|1|||
129637366|NCT00708214|466626256|FG002|Overall Study|Other|1|||
129637367|NCT00708214|466626254|FG000|Overall Study|Progressive Disease|4|||
129637368|NCT00708214|466626255|FG001|Overall Study|Progressive Disease|6|||
129637369|NCT00708214|466626256|FG002|Overall Study|Progressive Disease|5|||
129637370|NCT02929589|466626291|FG000|Overall Study|Withdrawal by Subject|1|||
129637371|NCT02929589|466626292|FG001|Overall Study|Withdrawal by Subject|0|||
129637372|NCT02929589|466626293|FG002|Overall Study|Withdrawal by Subject|0|||
129637373|NCT02929589|466626294|FG003|Overall Study|Withdrawal by Subject|0|||
129637374|NCT02929589|466626291|FG000|Overall Study|Physician Decision|2|||
129637375|NCT02929589|466626292|FG001|Overall Study|Physician Decision|0|||
129637376|NCT02929589|466626293|FG002|Overall Study|Physician Decision|0|||
129637377|NCT02929589|466626294|FG003|Overall Study|Physician Decision|0|||
129637378|NCT02343939|466626295|FG000|Overall Study|Death|0|||
129637379|NCT02343939|466626296|FG001|Overall Study|Death|15|||
129637380|NCT02343939|466626297|FG002|Overall Study|Death|4|||
129637381|NCT02343939|466626298|FG003|Overall Study|Death|2|||
129637382|NCT02343939|466626299|FG004|Overall Study|Death|5|||
129637383|NCT02343939|466626300|FG005|Overall Study|Death|11|||
129637384|NCT02343939|466626301|FG006|Overall Study|Death|8|||
129637385|NCT02343939|466626302|FG007|Overall Study|Death|22|||
129637386|NCT02343939|466626303|FG008|Overall Study|Death|1|||
129637387|NCT02343939|466626295|FG000|Overall Study|Study terminated by sponsor|0|||
129637388|NCT02343939|466626296|FG001|Overall Study|Study terminated by sponsor|27|||
129637389|NCT02343939|466626297|FG002|Overall Study|Study terminated by sponsor|0|||
129637390|NCT02343939|466626298|FG003|Overall Study|Study terminated by sponsor|1|||
129637391|NCT02343939|466626299|FG004|Overall Study|Study terminated by sponsor|1|||
129637392|NCT02343939|466626300|FG005|Overall Study|Study terminated by sponsor|5|||
129637393|NCT02343939|466626301|FG006|Overall Study|Study terminated by sponsor|3|||
129637394|NCT02343939|466626302|FG007|Overall Study|Study terminated by sponsor|4|||
129637395|NCT02343939|466626303|FG008|Overall Study|Study terminated by sponsor|0|||
129637396|NCT02343939|466626295|FG000|Overall Study|Withdrew consent|3|||
129637397|NCT02343939|466626296|FG001|Overall Study|Withdrew consent|6|||
129637398|NCT02343939|466626297|FG002|Overall Study|Withdrew consent|1|||
129637399|NCT02343939|466626298|FG003|Overall Study|Withdrew consent|2|||
129637400|NCT02343939|466626299|FG004|Overall Study|Withdrew consent|2|||
129637401|NCT02343939|466626300|FG005|Overall Study|Withdrew consent|0|||
129637402|NCT02343939|466626301|FG006|Overall Study|Withdrew consent|0|||
129637403|NCT02343939|466626302|FG007|Overall Study|Withdrew consent|8|||
129637404|NCT02343939|466626303|FG008|Overall Study|Withdrew consent|6|||
129637405|NCT02343939|466626295|FG000|Overall Study|Treatment failure|0|||
129637406|NCT02343939|466626296|FG001|Overall Study|Treatment failure|0|||
129637407|NCT02343939|466626297|FG002|Overall Study|Treatment failure|0|||
129637408|NCT02343939|466626298|FG003|Overall Study|Treatment failure|0|||
129637409|NCT02343939|466626299|FG004|Overall Study|Treatment failure|0|||
129637410|NCT02343939|466626300|FG005|Overall Study|Treatment failure|0|||
129637411|NCT02343939|466626301|FG006|Overall Study|Treatment failure|2|||
129637412|NCT02343939|466626302|FG007|Overall Study|Treatment failure|1|||
129637413|NCT02343939|466626303|FG008|Overall Study|Treatment failure|0|||
129637414|NCT02343939|466626295|FG000|Overall Study|Investigator's discretion|0|||
129637415|NCT02343939|466626296|FG001|Overall Study|Investigator's discretion|0|||
129637416|NCT02343939|466626297|FG002|Overall Study|Investigator's discretion|0|||
129637417|NCT02343939|466626298|FG003|Overall Study|Investigator's discretion|1|||
129637418|NCT02343939|466626299|FG004|Overall Study|Investigator's discretion|0|||
129637419|NCT02343939|466626300|FG005|Overall Study|Investigator's discretion|0|||
129637420|NCT02343939|466626301|FG006|Overall Study|Investigator's discretion|1|||
129637421|NCT02343939|466626302|FG007|Overall Study|Investigator's discretion|0|||
129637422|NCT02343939|466626303|FG008|Overall Study|Investigator's discretion|0|||
129637423|NCT02343939|466626295|FG000|Overall Study|Adverse Event|0|||
129637424|NCT02343939|466626296|FG001|Overall Study|Adverse Event|0|||
129637425|NCT02343939|466626297|FG002|Overall Study|Adverse Event|0|||
129637426|NCT02343939|466626298|FG003|Overall Study|Adverse Event|0|||
129637427|NCT02343939|466626299|FG004|Overall Study|Adverse Event|0|||
129637428|NCT02343939|466626300|FG005|Overall Study|Adverse Event|1|||
129637429|NCT02343939|466626301|FG006|Overall Study|Adverse Event|0|||
129637430|NCT02343939|466626302|FG007|Overall Study|Adverse Event|0|||
129637431|NCT02343939|466626303|FG008|Overall Study|Adverse Event|0|||
129637432|NCT02343939|466626295|FG000|Overall Study|Never Treated With ENTO|0|||
129637433|NCT02343939|466626296|FG001|Overall Study|Never Treated With ENTO|0|||
129637434|NCT02343939|466626297|FG002|Overall Study|Never Treated With ENTO|0|||
129637435|NCT02343939|466626298|FG003|Overall Study|Never Treated With ENTO|0|||
129637436|NCT02343939|466626299|FG004|Overall Study|Never Treated With ENTO|0|||
129637437|NCT02343939|466626300|FG005|Overall Study|Never Treated With ENTO|0|||
129637438|NCT02343939|466626301|FG006|Overall Study|Never Treated With ENTO|1|||
129637439|NCT02343939|466626302|FG007|Overall Study|Never Treated With ENTO|2|||
129637440|NCT02343939|466626303|FG008|Overall Study|Never Treated With ENTO|0|||
129637441|NCT01303172|466626310|FG000|Overall Study|Physician Decision|9|||
129637442|NCT01303172|466626311|FG001|Overall Study|Physician Decision|6|||
129637443|NCT01303172|466626310|FG000|Overall Study|Adverse Event|5|||
129637444|NCT01303172|466626311|FG001|Overall Study|Adverse Event|2|||
129637445|NCT01303172|466626310|FG000|Overall Study|Withdrawal by Subject|4|||
129637446|NCT01303172|466626311|FG001|Overall Study|Withdrawal by Subject|2|||
129637447|NCT01303172|466626310|FG000|Overall Study|Death|20|||
129637448|NCT01303172|466626311|FG001|Overall Study|Death|7|||
129637449|NCT01303172|466626310|FG000|Overall Study|Lack of Efficacy|25|||
129637450|NCT01303172|466626311|FG001|Overall Study|Lack of Efficacy|17|||
129637451|NCT00462709|466626314|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
129637452|NCT00462709|466626314|FG000|Overall Study|Lost to Follow-up|10|||
129637453|NCT00462709|466626314|FG000|Overall Study|Withdrawal by Subject|8|||
129637454|NCT00462709|466626314|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
129637455|NCT00462709|466626314|FG000|Overall Study|Death|2|||
129637456|NCT00462709|466626314|FG000|Overall Study|Logistical reasons|2|||
129637457|NCT00462709|466626314|FG000|Overall Study|Physician Decision|1|||
129441701|NCT02634346|465916354|FG002|Overall Study|Adverse Event|7|||
129441702|NCT02634346|465916352|FG000|Overall Study|Lack of Efficacy|1|||
129441703|NCT02634346|465916353|FG001|Overall Study|Lack of Efficacy|2|||
129441704|NCT02634346|465916354|FG002|Overall Study|Lack of Efficacy|8|||
129441705|NCT02634346|465916352|FG000|Overall Study|Lost to Follow-up|1|||
129441706|NCT02634346|465916353|FG001|Overall Study|Lost to Follow-up|0|||
129441707|NCT02634346|465916354|FG002|Overall Study|Lost to Follow-up|0|||
129441708|NCT02634346|465916352|FG000|Overall Study|Protocol Violation|0|||
129637458|NCT00462709|466626314|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
129889454|NCT00946647|467552609|FG003|Phase 1 Part|Reason missing|0|||
129889455|NCT00946647|467552610|FG004|Phase 1 Part|Reason missing|0|||
129441709|NCT02634346|465916353|FG001|Overall Study|Protocol Violation|1|||
129441710|NCT02634346|465916354|FG002|Overall Study|Protocol Violation|0|||
129441711|NCT00568321|465916355|FG000|Overall Study|Adverse Event|1|||
129441712|NCT00568321|465916356|FG001|Overall Study|Adverse Event|0|||
129441713|NCT00568321|465916357|FG002|Overall Study|Adverse Event|0|||
129441714|NCT00568321|465916355|FG000|Overall Study|Lack of Efficacy|8|||
129441715|NCT00568321|465916356|FG001|Overall Study|Lack of Efficacy|5|||
129441716|NCT00568321|465916357|FG002|Overall Study|Lack of Efficacy|6|||
129441717|NCT00568321|465916355|FG000|Overall Study|Lost to Follow-up|0|||
129441718|NCT00568321|465916356|FG001|Overall Study|Lost to Follow-up|0|||
129441719|NCT00568321|465916357|FG002|Overall Study|Lost to Follow-up|1|||
129441720|NCT00568321|465916355|FG000|Overall Study|Withdrawal by Subject|2|||
129441721|NCT00568321|465916356|FG001|Overall Study|Withdrawal by Subject|0|||
129441722|NCT00568321|465916357|FG002|Overall Study|Withdrawal by Subject|0|||
129441723|NCT00568321|465916355|FG000|Overall Study|Protocol Violation|0|||
129441724|NCT00568321|465916356|FG001|Overall Study|Protocol Violation|0|||
129441725|NCT00568321|465916357|FG002|Overall Study|Protocol Violation|1|||
129441726|NCT00568321|465916355|FG000|Overall Study|Randomized, not treated|2|||
129441727|NCT00568321|465916356|FG001|Overall Study|Randomized, not treated|0|||
129441728|NCT00568321|465916357|FG002|Overall Study|Randomized, not treated|1|||
129441729|NCT01676909|465916358|FG000|Overall Study|Withdrawal by Subject|3|||
129441730|NCT01676909|465916359|FG001|Overall Study|Withdrawal by Subject|5|||
129441731|NCT01676909|465916358|FG000|Overall Study|Lost to Follow-up|15|||
129441732|NCT01676909|465916359|FG001|Overall Study|Lost to Follow-up|9|||
129637459|NCT04468347|466626315|FG000|Overall Study|Withdrawal by Subject|0|||
129637460|NCT04468347|466626316|FG001|Overall Study|Withdrawal by Subject|1|||
129637461|NCT04468347|466626317|FG002|Overall Study|Withdrawal by Subject|3|||
129637462|NCT04468347|466626318|FG003|Overall Study|Withdrawal by Subject|3|||
129637463|NCT04468347|466626315|FG000|Overall Study|Lost to Follow-up|0|||
129637464|NCT04468347|466626316|FG001|Overall Study|Lost to Follow-up|0|||
129637465|NCT04468347|466626317|FG002|Overall Study|Lost to Follow-up|1|||
129637466|NCT04468347|466626318|FG003|Overall Study|Lost to Follow-up|1|||
129637467|NCT04468347|466626315|FG000|Overall Study|Physician Decision|1|||
129637468|NCT04468347|466626316|FG001|Overall Study|Physician Decision|0|||
129637469|NCT04468347|466626317|FG002|Overall Study|Physician Decision|2|||
129637470|NCT04468347|466626318|FG003|Overall Study|Physician Decision|0|||
129889456|NCT00946647|467552606|FG000|Phase ll Part|Untreated|0|||
129441733|NCT02175004|465916360|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
129441734|NCT02175004|465916361|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
129441735|NCT02175004|465916360|FG000|Overall Study|Investigator Judgment|1|||
129637471|NCT04468347|466626315|FG000|Overall Study|Protocol Violation|1|||
129637472|NCT04468347|466626316|FG001|Overall Study|Protocol Violation|0|||
129637473|NCT04468347|466626317|FG002|Overall Study|Protocol Violation|0|||
129704956|NCT05067335|466884102|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129441736|NCT02175004|465916361|FG001|Overall Study|Investigator Judgment|4|||
129441737|NCT02175004|465916360|FG000|Overall Study|Voluntary Withdrawal|6|||
129441738|NCT02175004|465916361|FG001|Overall Study|Voluntary Withdrawal|19|||
129441739|NCT02175004|465916360|FG000|Overall Study|Liver Transplant|1|||
129441740|NCT02175004|465916361|FG001|Overall Study|Liver Transplant|0|||
129637474|NCT04468347|466626318|FG003|Overall Study|Protocol Violation|0|||
129637475|NCT00665431|466626319|FG000|Overall Study|Adverse Event|16|||
129637476|NCT00665431|466626320|FG001|Overall Study|Adverse Event|22|||
129637477|NCT00665431|466626321|FG002|Overall Study|Adverse Event|6|||
129637478|NCT00665431|466626319|FG000|Overall Study|Withdrawal by Subject|17|||
129637479|NCT00665431|466626320|FG001|Overall Study|Withdrawal by Subject|25|||
129637480|NCT00665431|466626321|FG002|Overall Study|Withdrawal by Subject|15|||
129637481|NCT00665431|466626319|FG000|Overall Study|Lost to Follow-up|3|||
129441741|NCT02175004|465916360|FG000|Overall Study|Disease Progression|1|||
129441742|NCT02175004|465916361|FG001|Overall Study|Disease Progression|0|||
129441743|NCT02175004|465916360|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
129441744|NCT02175004|465916361|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
129441745|NCT00221195|465916362|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
129441746|NCT00221195|465916363|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
129637482|NCT00665431|466626320|FG001|Overall Study|Lost to Follow-up|3|||
129637483|NCT00665431|466626321|FG002|Overall Study|Lost to Follow-up|1|||
129637484|NCT00665431|466626319|FG000|Overall Study|Other|4|||
129637485|NCT00665431|466626320|FG001|Overall Study|Other|7|||
129637486|NCT00665431|466626321|FG002|Overall Study|Other|2|||
129637487|NCT03483961|466628342|FG000|Overall Study|Lost to Follow-up|7|||
129637488|NCT03483961|466628343|FG001|Overall Study|Lost to Follow-up|6|||
129637489|NCT03483961|466628344|FG002|Overall Study|Lost to Follow-up|6|||
129637490|NCT03483961|466628345|FG003|Overall Study|Lost to Follow-up|6|||
129637491|NCT03483961|466628346|FG004|Overall Study|Lost to Follow-up|6|||
129637492|NCT03483961|466628347|FG005|Overall Study|Lost to Follow-up|4|||
129637493|NCT03483961|466628348|FG006|Overall Study|Lost to Follow-up|4|||
129637494|NCT03483961|466628349|FG007|Overall Study|Lost to Follow-up|11|||
129637495|NCT03483961|466628350|FG008|Overall Study|Lost to Follow-up|1|||
129637496|NCT03483961|466628351|FG009|Overall Study|Lost to Follow-up|0|||
129637497|NCT03483961|466628342|FG000|Overall Study|Withdrawal by Subject|3|||
129637498|NCT03483961|466628343|FG001|Overall Study|Withdrawal by Subject|4|||
129441747|NCT00221195|465916362|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
129441748|NCT00221195|465916363|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
129441749|NCT00221195|465916362|FG000|Washout Period (Months 7-9)|Death|0|||
129441750|NCT00221195|465916363|FG001|Washout Period (Months 7-9)|Death|1|||
129441751|NCT00221195|465916362|FG000|Therapy 2 (Months 10-15)|Death|1|||
129441752|NCT00221195|465916363|FG001|Therapy 2 (Months 10-15)|Death|0|||
129441753|NCT00221195|465916362|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
129441754|NCT00221195|465916363|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
129441755|NCT00823901|465916364|FG000|Overall Study|Adverse Event|1|||
129441756|NCT00823901|465916365|FG001|Overall Study|Adverse Event|1|||
129441757|NCT00823901|465916364|FG000|Overall Study|Lack of Efficacy|1|||
129441758|NCT00823901|465916365|FG001|Overall Study|Lack of Efficacy|0|||
129441759|NCT00823901|465916364|FG000|Overall Study|Lost to Follow-up|2|||
129441760|NCT00823901|465916365|FG001|Overall Study|Lost to Follow-up|1|||
129441761|NCT01369511|465916366|FG000|Overall Study|Adverse Event|1|||
129441762|NCT01369511|465916367|FG001|Overall Study|Adverse Event|1|||
129441763|NCT01369511|465916368|FG002|Overall Study|Adverse Event|5|||
129637499|NCT03483961|466628344|FG002|Overall Study|Withdrawal by Subject|5|||
129637500|NCT03483961|466628345|FG003|Overall Study|Withdrawal by Subject|3|||
129637501|NCT03483961|466628346|FG004|Overall Study|Withdrawal by Subject|4|||
129637502|NCT03483961|466628347|FG005|Overall Study|Withdrawal by Subject|2|||
129637503|NCT03483961|466628348|FG006|Overall Study|Withdrawal by Subject|1|||
129637504|NCT03483961|466628349|FG007|Overall Study|Withdrawal by Subject|2|||
129637505|NCT03483961|466628350|FG008|Overall Study|Withdrawal by Subject|1|||
129637506|NCT03483961|466628351|FG009|Overall Study|Withdrawal by Subject|0|||
129441764|NCT01369511|465916369|FG003|Overall Study|Adverse Event|0|||
129637507|NCT03483961|466628342|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
129637508|NCT03483961|466628343|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637509|NCT03483961|466628344|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129797808|NCT02537574|467228234|FG001|Overall Study|Lost to Follow-up|51|||
129797809|NCT02537574|467228235|FG002|Overall Study|Lost to Follow-up|55|||
129797810|NCT02537574|467228233|FG000|Overall Study|Noncompliance with study drug|0|||
129797811|NCT02537574|467228234|FG001|Overall Study|Noncompliance with study drug|1|||
129797812|NCT02537574|467228235|FG002|Overall Study|Noncompliance with study drug|1|||
129797813|NCT02537574|467228233|FG000|Overall Study|Physician Decision|2|||
129797814|NCT02537574|467228234|FG001|Overall Study|Physician Decision|0|||
129797815|NCT02537574|467228235|FG002|Overall Study|Physician Decision|0|||
129797816|NCT02537574|467228233|FG000|Overall Study|Protocol Violation|4|||
129797817|NCT02537574|467228234|FG001|Overall Study|Protocol Violation|2|||
129797818|NCT02537574|467228235|FG002|Overall Study|Protocol Violation|3|||
129797819|NCT02537574|467228233|FG000|Overall Study|Withdrawal by Subject|37|||
129441765|NCT01369511|465916366|FG000|Overall Study|Entry criteria not met|2|||
129441766|NCT01369511|465916367|FG001|Overall Study|Entry criteria not met|0|||
129441767|NCT01369511|465916368|FG002|Overall Study|Entry criteria not met|0|||
129441768|NCT01369511|465916369|FG003|Overall Study|Entry criteria not met|1|||
129441769|NCT01369511|465916366|FG000|Overall Study|Lost to Follow-up|0|||
129441770|NCT01369511|465916367|FG001|Overall Study|Lost to Follow-up|1|||
129441771|NCT01369511|465916368|FG002|Overall Study|Lost to Follow-up|1|||
129441772|NCT01369511|465916369|FG003|Overall Study|Lost to Follow-up|2|||
129441773|NCT01369511|465916366|FG000|Overall Study|Protocol Violation|0|||
129441774|NCT01369511|465916367|FG001|Overall Study|Protocol Violation|1|||
129441775|NCT01369511|465916368|FG002|Overall Study|Protocol Violation|0|||
129441776|NCT01369511|465916369|FG003|Overall Study|Protocol Violation|2|||
129441777|NCT01369511|465916366|FG000|Overall Study|Physician Decision|3|||
129441778|NCT01369511|465916367|FG001|Overall Study|Physician Decision|4|||
129441779|NCT01369511|465916368|FG002|Overall Study|Physician Decision|0|||
129441780|NCT01369511|465916369|FG003|Overall Study|Physician Decision|0|||
129441781|NCT01369511|465916366|FG000|Overall Study|Sponsor decision|2|||
129441782|NCT01369511|465916367|FG001|Overall Study|Sponsor decision|0|||
129441783|NCT01369511|465916368|FG002|Overall Study|Sponsor decision|1|||
129637510|NCT03483961|466628345|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637511|NCT03483961|466628346|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637512|NCT03483961|466628347|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637513|NCT03483961|466628348|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129889457|NCT00946647|467552607|FG001|Phase ll Part|Untreated|0|||
129441784|NCT01369511|465916369|FG003|Overall Study|Sponsor decision|0|||
129441785|NCT01369511|465916366|FG000|Overall Study|Withdrawal by Subject|5|||
129441786|NCT01369511|465916367|FG001|Overall Study|Withdrawal by Subject|6|||
129441787|NCT01369511|465916368|FG002|Overall Study|Withdrawal by Subject|4|||
129441788|NCT01369511|465916369|FG003|Overall Study|Withdrawal by Subject|6|||
129441789|NCT01376349|465916372|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
129441790|NCT01376349|465916373|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
129441791|NCT01376349|465916374|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
129441792|NCT01376349|465916372|FG000|Raondomized Treatment|Adverse Event|13|||
129441793|NCT01376349|465916373|FG001|Raondomized Treatment|Adverse Event|17|||
129441794|NCT01376349|465916374|FG002|Raondomized Treatment|Adverse Event|14|||
129441795|NCT01376349|465916372|FG000|Raondomized Treatment|Unkown|1|||
129441796|NCT01376349|465916373|FG001|Raondomized Treatment|Unkown|2|||
129441797|NCT01376349|465916374|FG002|Raondomized Treatment|Unkown|1|||
129441798|NCT01376349|465916372|FG000|Raondomized Treatment|Alternative Treatment|0|||
129441799|NCT01376349|465916373|FG001|Raondomized Treatment|Alternative Treatment|0|||
129441800|NCT01376349|465916374|FG002|Raondomized Treatment|Alternative Treatment|1|||
129441801|NCT01180998|465916375|FG000|Overall Study|Poor Vision|0|||
129441802|NCT01180998|465916376|FG001|Overall Study|Poor Vision|2|||
129441803|NCT01180998|465916377|FG002|Overall Study|Poor Vision|2|||
129441804|NCT01180998|465916375|FG000|Overall Study|Lost to Follow-up|0|||
129441805|NCT01180998|465916376|FG001|Overall Study|Lost to Follow-up|0|||
129441806|NCT01180998|465916377|FG002|Overall Study|Lost to Follow-up|1|||
129441807|NCT01180998|465916375|FG000|Overall Study|Protocol Violation|1|||
129441808|NCT01180998|465916376|FG001|Overall Study|Protocol Violation|2|||
129441809|NCT01180998|465916377|FG002|Overall Study|Protocol Violation|0|||
129441810|NCT01180998|465916375|FG000|Overall Study|Withdrawal by Subject|0|||
129441811|NCT01180998|465916376|FG001|Overall Study|Withdrawal by Subject|0|||
129441812|NCT01180998|465916377|FG002|Overall Study|Withdrawal by Subject|1|||
129441813|NCT01180998|465916375|FG000|Overall Study|Poor comfort|3|||
129441814|NCT01180998|465916376|FG001|Overall Study|Poor comfort|0|||
129441815|NCT01180998|465916377|FG002|Overall Study|Poor comfort|4|||
129441816|NCT01180998|465916375|FG000|Overall Study|Poor lens handling|0|||
129441817|NCT01180998|465916376|FG001|Overall Study|Poor lens handling|0|||
129441818|NCT01180998|465916377|FG002|Overall Study|Poor lens handling|2|||
129441819|NCT00162032|465916378|FG000|Overall Study|Lost to Follow-up|4|||
129441820|NCT00162032|465916379|FG001|Overall Study|Lost to Follow-up|2|||
129441821|NCT00162032|465916378|FG000|Overall Study|Reason not specified|1|||
129441822|NCT00162032|465916379|FG001|Overall Study|Reason not specified|0|||
129441823|NCT01176968|465916380|FG000|Overall Study|Adverse Event|10|||
129441824|NCT01176968|465916381|FG001|Overall Study|Adverse Event|11|||
129441825|NCT01176968|465916380|FG000|Overall Study|Death|2|||
129441826|NCT01176968|465916381|FG001|Overall Study|Death|3|||
129441827|NCT01176968|465916380|FG000|Overall Study|Lack of Efficacy|0|||
129441828|NCT01176968|465916381|FG001|Overall Study|Lack of Efficacy|1|||
129441829|NCT01176968|465916380|FG000|Overall Study|Lost to Follow-up|16|||
129441830|NCT01176968|465916381|FG001|Overall Study|Lost to Follow-up|14|||
129441831|NCT01176968|465916380|FG000|Overall Study|Withdrawal by Subject|48|||
129441832|NCT01176968|465916381|FG001|Overall Study|Withdrawal by Subject|48|||
129441833|NCT01176968|465916380|FG000|Overall Study|Protocol Violation|2|||
129441834|NCT01176968|465916381|FG001|Overall Study|Protocol Violation|1|||
129441835|NCT01176968|465916380|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129637514|NCT03483961|466628349|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637515|NCT03483961|466628350|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637516|NCT03483961|466628351|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
129637517|NCT03483961|466628342|FG000|Overall Study|Adverse Event|0|||
129637518|NCT03483961|466628343|FG001|Overall Study|Adverse Event|0|||
129637519|NCT03483961|466628344|FG002|Overall Study|Adverse Event|1|||
129637520|NCT03483961|466628345|FG003|Overall Study|Adverse Event|0|||
129637521|NCT03483961|466628346|FG004|Overall Study|Adverse Event|0|||
129637522|NCT03483961|466628347|FG005|Overall Study|Adverse Event|0|||
129637523|NCT03483961|466628348|FG006|Overall Study|Adverse Event|0|||
129637524|NCT03483961|466628349|FG007|Overall Study|Adverse Event|0|||
129637525|NCT03483961|466628350|FG008|Overall Study|Adverse Event|0|||
129637526|NCT03483961|466628351|FG009|Overall Study|Adverse Event|0|||
129637527|NCT00356603|466628352|FG000|Overall Study|Other|6|||
129704957|NCT05067335|466884103|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
129889458|NCT00946647|467552608|FG002|Phase ll Part|Untreated|0|||
129441836|NCT01176968|465916381|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
129441837|NCT01176968|465916380|FG000|Overall Study|Study terminated by sponsor|0|||
129441838|NCT01176968|465916381|FG001|Overall Study|Study terminated by sponsor|1|||
129441839|NCT01176968|465916380|FG000|Overall Study|Reason not defined|5|||
129441840|NCT01176968|465916381|FG001|Overall Study|Reason not defined|3|||
129441841|NCT00833911|465916382|FG000|Titration|Adverse Event|18|||
129441842|NCT00833911|465916382|FG000|Titration|Withdrawal by Subject|3|||
129441843|NCT00833911|465916382|FG000|Maintenance Phase I|Adverse Event|73|||
129441844|NCT00833911|465916382|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
129441845|NCT00833911|465916382|FG000|Maintenance Phase I|Physician Decision|10|||
129441846|NCT00833911|465916382|FG000|Maintenance Phase I|Lack of Efficacy|4|||
129441847|NCT00833911|465916382|FG000|Maintenance Phase II|Adverse Event|6|||
129441848|NCT00833911|465916382|FG000|Maintenance Phase II|Physician Decision|2|||
129441849|NCT00833911|465916382|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
129441850|NCT00833911|465916382|FG000|Maintenance Phase II|Lack of Efficacy|1|||
129441851|NCT00718640|465916383|FG000|Overall Study|Adverse Event|4|||
129441852|NCT00718640|465916383|FG000|Overall Study|Death|1|||
129441853|NCT00718640|465916383|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
129889459|NCT00946647|467552609|FG003|Phase ll Part|Untreated|0|||
129889460|NCT00946647|467552610|FG004|Phase ll Part|Untreated|2|||
129889461|NCT00946647|467552606|FG000|Phase ll Part|Adverse Event|0|||
129889462|NCT00946647|467552607|FG001|Phase ll Part|Adverse Event|0|||
129889463|NCT00946647|467552608|FG002|Phase ll Part|Adverse Event|0|||
129889464|NCT00946647|467552609|FG003|Phase ll Part|Adverse Event|10|||
129889465|NCT00946647|467552610|FG004|Phase ll Part|Adverse Event|6|||
129889466|NCT00946647|467552606|FG000|Phase ll Part|Withdrawal by Subject|0|||
129441854|NCT01137955|465916386|FG000|Overall Study|Withdrawal by Subject|5|||
129441855|NCT01137955|465916387|FG001|Overall Study|Withdrawal by Subject|4|||
129441856|NCT01207596|465916388|FG000|Overall Study|Physician Decision|4|||
129441857|NCT01207596|465916388|FG000|Overall Study|Lack of Efficacy|1|||
129441858|NCT01207596|465916388|FG000|Overall Study|Adverse Event|3|||
129441859|NCT01207596|465916388|FG000|Overall Study|Withdrawal by Subject|1|||
129441860|NCT00216203|465916391|FG000|Overall Study|Withdrawal by Subject|2|||
129441861|NCT04098068|465916392|FG000|Overall Study|Disease Progression|7|||
129637528|NCT00356603|466628353|FG001|Overall Study|Other|3|||
129637529|NCT00728468|466628355|FG000|Overall Study|Enrolled but not treated|1|||
129637530|NCT00728468|466628355|FG000|Overall Study|Death|1|||
129637531|NCT00728468|466628355|FG000|Overall Study|Protocol Violation|4|||
129637532|NCT00728468|466628355|FG000|Overall Study|Objective progression or relapse|9|||
129637533|NCT00728468|466628355|FG000|Overall Study|Study terminated by sponsor|1|||
129637534|NCT01262287|466628356|FG000|Overall Study|Lost to Follow-up|2|||
129637535|NCT01262287|466628357|FG001|Overall Study|Lost to Follow-up|1|||
129637536|NCT00932373|466628358|FG000|Overall Study|Progressive disease|3|||
129637537|NCT00932373|466628359|FG001|Overall Study|Progressive disease|1|||
129637538|NCT00932373|466628360|FG002|Overall Study|Progressive disease|0|||
129637539|NCT00932373|466628361|FG003|Overall Study|Progressive disease|0|||
129637540|NCT00932373|466628362|FG004|Overall Study|Progressive disease|10|||
129637541|NCT00932373|466628363|FG005|Overall Study|Progressive disease|1|||
129637542|NCT00932373|466628364|FG006|Overall Study|Progressive disease|0|||
129637543|NCT00932373|466628365|FG007|Overall Study|Progressive disease|2|||
129637544|NCT00932373|466628366|FG008|Overall Study|Progressive disease|1|||
129637545|NCT00932373|466628367|FG009|Overall Study|Progressive disease|9|||
129637546|NCT00932373|466628368|FG010|Overall Study|Progressive disease|2|||
129637547|NCT00932373|466628358|FG000|Overall Study|Adverse Event|0|||
129637548|NCT00932373|466628359|FG001|Overall Study|Adverse Event|0|||
129637549|NCT00932373|466628360|FG002|Overall Study|Adverse Event|0|||
129637550|NCT00932373|466628361|FG003|Overall Study|Adverse Event|0|||
129637551|NCT00932373|466628362|FG004|Overall Study|Adverse Event|2|||
129637552|NCT00932373|466628363|FG005|Overall Study|Adverse Event|1|||
129637553|NCT00932373|466628364|FG006|Overall Study|Adverse Event|0|||
129637554|NCT00932373|466628365|FG007|Overall Study|Adverse Event|1|||
129637555|NCT00932373|466628366|FG008|Overall Study|Adverse Event|0|||
129637556|NCT00932373|466628367|FG009|Overall Study|Adverse Event|2|||
129637557|NCT00932373|466628368|FG010|Overall Study|Adverse Event|1|||
129637558|NCT00932373|466628358|FG000|Overall Study|Physician Decision|0|||
129637559|NCT00932373|466628359|FG001|Overall Study|Physician Decision|0|||
129637560|NCT00932373|466628360|FG002|Overall Study|Physician Decision|1|||
129637561|NCT00932373|466628361|FG003|Overall Study|Physician Decision|0|||
129637562|NCT00932373|466628362|FG004|Overall Study|Physician Decision|2|||
129637563|NCT00932373|466628363|FG005|Overall Study|Physician Decision|0|||
129637564|NCT00932373|466628364|FG006|Overall Study|Physician Decision|0|||
129637565|NCT00932373|466628365|FG007|Overall Study|Physician Decision|0|||
129637566|NCT00932373|466628366|FG008|Overall Study|Physician Decision|0|||
129637567|NCT00932373|466628367|FG009|Overall Study|Physician Decision|1|||
129637568|NCT00932373|466628368|FG010|Overall Study|Physician Decision|0|||
129637569|NCT00932373|466628358|FG000|Overall Study|Dose limiting toxicity|0|||
129637570|NCT00932373|466628359|FG001|Overall Study|Dose limiting toxicity|0|||
129797820|NCT02537574|467228234|FG001|Overall Study|Withdrawal by Subject|27|||
129797821|NCT02537574|467228235|FG002|Overall Study|Withdrawal by Subject|29|||
129441862|NCT04098068|465916392|FG000|Overall Study|Withdrawal by Subject|2|||
129441863|NCT04098068|465916392|FG000|Overall Study|New Cancer Diagnosis|1|||
129441864|NCT03871829|465916393|FG000|Overall Study|Lost to Follow-up|0|||
129441865|NCT03871829|465916394|FG001|Overall Study|Lost to Follow-up|1|||
129441866|NCT03871829|465916393|FG000|Overall Study|Withdrawal by Subject|1|||
129441867|NCT03871829|465916394|FG001|Overall Study|Withdrawal by Subject|1|||
129441868|NCT03871829|465916393|FG000|Overall Study|Death|12|||
129441869|NCT03871829|465916394|FG001|Overall Study|Death|8|||
129441870|NCT03871829|465916393|FG000|Overall Study|Study terminated by sponsor|31|||
129441871|NCT03871829|465916394|FG001|Overall Study|Study terminated by sponsor|34|||
129637571|NCT00932373|466628360|FG002|Overall Study|Dose limiting toxicity|0|||
129637572|NCT00932373|466628361|FG003|Overall Study|Dose limiting toxicity|0|||
129637573|NCT00932373|466628362|FG004|Overall Study|Dose limiting toxicity|0|||
129637574|NCT00932373|466628363|FG005|Overall Study|Dose limiting toxicity|1|||
129637575|NCT00932373|466628364|FG006|Overall Study|Dose limiting toxicity|0|||
129637576|NCT00932373|466628365|FG007|Overall Study|Dose limiting toxicity|0|||
129637577|NCT00932373|466628366|FG008|Overall Study|Dose limiting toxicity|0|||
129637578|NCT00932373|466628367|FG009|Overall Study|Dose limiting toxicity|0|||
129637579|NCT00932373|466628368|FG010|Overall Study|Dose limiting toxicity|0|||
129441872|NCT01106014|465916395|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
129637580|NCT00932373|466628358|FG000|Overall Study|Withdrawal by Subject|0|||
129637581|NCT00932373|466628359|FG001|Overall Study|Withdrawal by Subject|0|||
129637582|NCT00932373|466628360|FG002|Overall Study|Withdrawal by Subject|0|||
129637583|NCT00932373|466628361|FG003|Overall Study|Withdrawal by Subject|0|||
129637584|NCT00932373|466628362|FG004|Overall Study|Withdrawal by Subject|0|||
129637585|NCT00932373|466628363|FG005|Overall Study|Withdrawal by Subject|0|||
129637586|NCT00932373|466628364|FG006|Overall Study|Withdrawal by Subject|0|||
129637587|NCT00932373|466628365|FG007|Overall Study|Withdrawal by Subject|0|||
129637588|NCT00932373|466628366|FG008|Overall Study|Withdrawal by Subject|1|||
129441873|NCT01106014|465916396|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
129441874|NCT01106014|465916395|FG000|Overall Study|Adverse Event|78|||
129441875|NCT01106014|465916396|FG001|Overall Study|Adverse Event|42|||
129441876|NCT01106014|465916395|FG000|Overall Study|Withdrawal by Subject|43|||
129441877|NCT01106014|465916396|FG001|Overall Study|Withdrawal by Subject|37|||
129441878|NCT01106014|465916395|FG000|Overall Study|Administrative reason|7|||
129441879|NCT01106014|465916396|FG001|Overall Study|Administrative reason|6|||
129441880|NCT01106014|465916395|FG000|Overall Study|Lost to Follow-up|2|||
129441881|NCT01106014|465916396|FG001|Overall Study|Lost to Follow-up|3|||
129441882|NCT00784693|465916402|FG000|Overall Study|Lost to Follow-up|0|||
129441883|NCT00784693|465916403|FG001|Overall Study|Lost to Follow-up|1|||
129441884|NCT00784693|465916402|FG000|Overall Study|Lack of Efficacy|1|||
129441885|NCT00784693|465916403|FG001|Overall Study|Lack of Efficacy|1|||
129441886|NCT00784693|465916402|FG000|Overall Study|Withdrawal by Subject|0|||
129441887|NCT00784693|465916403|FG001|Overall Study|Withdrawal by Subject|4|||
129441888|NCT00784693|465916402|FG000|Overall Study|Randomized but not Treated|1|||
129441889|NCT00784693|465916403|FG001|Overall Study|Randomized but not Treated|0|||
129441890|NCT00784693|465916402|FG000|Overall Study|Other|1|||
129441891|NCT00784693|465916403|FG001|Overall Study|Other|0|||
129441892|NCT05458479|465916404|FG000|Overall Study|Lost to Follow-up|1|||
129441893|NCT00908232|465916405|FG000|Cycle 1 to 4|Death|5|||
129441894|NCT00908232|465916406|FG001|Cycle 1 to 4|Death|0|||
129441895|NCT00908232|465916407|FG002|Cycle 1 to 4|Death|0|||
129441896|NCT00908232|465916408|FG003|Cycle 1 to 4|Death|0|||
129441897|NCT00908232|465916405|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
129441898|NCT00908232|465916406|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
129441899|NCT00908232|465916407|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
129441900|NCT00908232|465916408|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
129441901|NCT00908232|465916405|FG000|Cycle 1 to 4|Progressive Disease|6|||
129441902|NCT00908232|465916406|FG001|Cycle 1 to 4|Progressive Disease|0|||
129441903|NCT00908232|465916407|FG002|Cycle 1 to 4|Progressive Disease|0|||
129441904|NCT00908232|465916408|FG003|Cycle 1 to 4|Progressive Disease|0|||
129441905|NCT00908232|465916405|FG000|Cycle 1 to 4|Adverse Event|12|||
129441906|NCT00908232|465916406|FG001|Cycle 1 to 4|Adverse Event|0|||
129441907|NCT00908232|465916407|FG002|Cycle 1 to 4|Adverse Event|0|||
129441908|NCT00908232|465916408|FG003|Cycle 1 to 4|Adverse Event|0|||
129441909|NCT00908232|465916405|FG000|Cycle 1 to 4|Other|1|||
129441910|NCT00908232|465916406|FG001|Cycle 1 to 4|Other|0|||
129441911|NCT00908232|465916407|FG002|Cycle 1 to 4|Other|0|||
129441912|NCT00908232|465916408|FG003|Cycle 1 to 4|Other|0|||
129441913|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
129441914|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
129441915|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
129441916|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
129441917|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
129441918|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
129441919|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
129441920|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
129441921|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
129441922|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
129441923|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
129441924|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
129441925|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
129441926|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
129441927|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
129441928|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
129441929|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
129441930|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
129441931|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
129441932|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
129441933|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
129441934|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
129441935|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
129441936|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
129441937|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
129441938|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
129441939|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
129441940|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
129441941|NCT00908232|465916405|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
129441942|NCT00908232|465916406|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129441943|NCT00908232|465916407|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129441944|NCT00908232|465916408|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
129441945|NCT02260882|465916409|FG000|Overall Study|Protocol Violation|0|||
129441946|NCT02260882|465916410|FG001|Overall Study|Protocol Violation|1|||
129441947|NCT02119325|465916411|FG000|Washout Period 1|Adverse Event|0|||
129441948|NCT02119325|465916412|FG001|Washout Period 1|Adverse Event|1|||
129441949|NCT01386658|465916413|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
129441950|NCT01386658|465916414|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
129441951|NCT01386658|465916413|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
129441952|NCT01386658|465916414|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
129441953|NCT00954174|465916415|FG000|Overall Study|Adverse Event|28|||
129441954|NCT00954174|465916416|FG001|Overall Study|Adverse Event|23|||
129441955|NCT00954174|465916417|FG002|Overall Study|Adverse Event|4|||
129441956|NCT00954174|465916418|FG003|Overall Study|Adverse Event|9|||
129441957|NCT00954174|465916415|FG000|Overall Study|Death|4|||
129441958|NCT00954174|465916416|FG001|Overall Study|Death|2|||
129441959|NCT00954174|465916417|FG002|Overall Study|Death|0|||
129441960|NCT00954174|465916418|FG003|Overall Study|Death|0|||
129441961|NCT00954174|465916415|FG000|Overall Study|Lack of Efficacy|32|||
129441962|NCT00954174|465916416|FG001|Overall Study|Lack of Efficacy|22|||
129441963|NCT00954174|465916417|FG002|Overall Study|Lack of Efficacy|8|||
129441964|NCT00954174|465916418|FG003|Overall Study|Lack of Efficacy|6|||
129441965|NCT00954174|465916415|FG000|Overall Study|Withdrawal by Subject|14|||
129441966|NCT00954174|465916416|FG001|Overall Study|Withdrawal by Subject|10|||
129441967|NCT00954174|465916417|FG002|Overall Study|Withdrawal by Subject|4|||
129441968|NCT00954174|465916418|FG003|Overall Study|Withdrawal by Subject|3|||
129441969|NCT00954174|465916415|FG000|Overall Study|Medical Reason|4|||
129441970|NCT00954174|465916416|FG001|Overall Study|Medical Reason|2|||
129441971|NCT00954174|465916417|FG002|Overall Study|Medical Reason|1|||
129441972|NCT00954174|465916418|FG003|Overall Study|Medical Reason|0|||
129441973|NCT00954174|465916415|FG000|Overall Study|Ineligible|40|||
129441974|NCT00954174|465916416|FG001|Overall Study|Ineligible|47|||
129441975|NCT00954174|465916417|FG002|Overall Study|Ineligible|7|||
129637589|NCT00932373|466628367|FG009|Overall Study|Withdrawal by Subject|0|||
129637590|NCT00932373|466628368|FG010|Overall Study|Withdrawal by Subject|0|||
129637591|NCT00932373|466628358|FG000|Overall Study|Clinical progression|0|||
129637592|NCT00932373|466628359|FG001|Overall Study|Clinical progression|0|||
129637593|NCT00932373|466628360|FG002|Overall Study|Clinical progression|0|||
129637594|NCT00932373|466628361|FG003|Overall Study|Clinical progression|0|||
129637595|NCT00932373|466628362|FG004|Overall Study|Clinical progression|0|||
129637596|NCT00932373|466628363|FG005|Overall Study|Clinical progression|0|||
129441976|NCT00954174|465916418|FG003|Overall Study|Ineligible|4|||
129441977|NCT00954174|465916415|FG000|Overall Study|Never Treated|4|||
129441978|NCT00954174|465916416|FG001|Overall Study|Never Treated|17|||
129797822|NCT02537574|467228233|FG000|Overall Study|Lack of Efficacy|14|||
129441979|NCT00954174|465916417|FG002|Overall Study|Never Treated|0|||
129441980|NCT00954174|465916418|FG003|Overall Study|Never Treated|3|||
129441981|NCT00986440|465916422|FG000|Overall Study|Progressive disease|27|||
129441982|NCT00986440|465916423|FG001|Overall Study|Progressive disease|37|||
129637597|NCT00932373|466628364|FG006|Overall Study|Clinical progression|1|||
129441983|NCT00986440|465916422|FG000|Overall Study|Serious adverse event or adverse event|9|||
129441984|NCT00986440|465916423|FG001|Overall Study|Serious adverse event or adverse event|2|||
129441985|NCT00986440|465916422|FG000|Overall Study|Withdrawal by Subject|1|||
129441986|NCT00986440|465916423|FG001|Overall Study|Withdrawal by Subject|2|||
129441987|NCT00986440|465916422|FG000|Overall Study|Screen failure (not dosed)|4|||
129441988|NCT00986440|465916423|FG001|Overall Study|Screen failure (not dosed)|2|||
129441989|NCT00651157|465916424|FG000|Overall Study|Death|1|||
129441990|NCT00651157|465916424|FG000|Overall Study|Protocol Violation|1|||
129441991|NCT05125679|465916425|FG000|Overall Study|Study Terminated by Sponsor|2|||
129441992|NCT05125679|465916426|FG001|Overall Study|Study Terminated by Sponsor|5|||
129441993|NCT00458341|465916427|FG000|Cycle 1|Adverse Event|1|||
129441994|NCT00458341|465916428|FG001|Cycle 1|Adverse Event|0|||
129441995|NCT02684357|465916431|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
129441996|NCT02684357|465916432|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
129441997|NCT02684357|465916433|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
129637598|NCT00932373|466628365|FG007|Overall Study|Clinical progression|0|||
129441998|NCT02684357|465916434|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
129441999|NCT02684357|465916435|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
129637599|NCT00932373|466628366|FG008|Overall Study|Clinical progression|0|||
129637600|NCT00932373|466628367|FG009|Overall Study|Clinical progression|0|||
129637601|NCT00932373|466628368|FG010|Overall Study|Clinical progression|0|||
129637602|NCT00932373|466628358|FG000|Overall Study|Lack of Efficacy|0|||
129637603|NCT00932373|466628359|FG001|Overall Study|Lack of Efficacy|0|||
129637604|NCT00932373|466628360|FG002|Overall Study|Lack of Efficacy|0|||
129637605|NCT00932373|466628361|FG003|Overall Study|Lack of Efficacy|0|||
129637606|NCT00932373|466628362|FG004|Overall Study|Lack of Efficacy|0|||
129797823|NCT02537574|467228234|FG001|Overall Study|Lack of Efficacy|16|||
129797824|NCT02537574|467228235|FG002|Overall Study|Lack of Efficacy|15|||
129442000|NCT02684357|465916436|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
129442001|NCT02684357|465916431|FG000|Part A|Lost to Follow-up|0|||
129442002|NCT02684357|465916432|FG001|Part A|Lost to Follow-up|2|||
129442003|NCT02684357|465916433|FG002|Part A|Lost to Follow-up|2|||
129442004|NCT02684357|465916434|FG003|Part A|Lost to Follow-up|0|||
129637607|NCT00932373|466628363|FG005|Overall Study|Lack of Efficacy|0|||
129442005|NCT02684357|465916435|FG004|Part A|Lost to Follow-up|0|||
129442006|NCT02684357|465916436|FG005|Part A|Lost to Follow-up|0|||
129637608|NCT00932373|466628364|FG006|Overall Study|Lack of Efficacy|0|||
129442007|NCT02684357|465916431|FG000|Part A|Withdrawal by Subject|3|||
129442008|NCT02684357|465916432|FG001|Part A|Withdrawal by Subject|0|||
129442009|NCT02684357|465916433|FG002|Part A|Withdrawal by Subject|0|||
129442010|NCT02684357|465916434|FG003|Part A|Withdrawal by Subject|0|||
129442011|NCT02684357|465916435|FG004|Part A|Withdrawal by Subject|0|||
129442012|NCT02684357|465916436|FG005|Part A|Withdrawal by Subject|0|||
129637609|NCT00932373|466628365|FG007|Overall Study|Lack of Efficacy|0|||
129637610|NCT00932373|466628366|FG008|Overall Study|Lack of Efficacy|0|||
129637611|NCT00932373|466628367|FG009|Overall Study|Lack of Efficacy|1|||
129637612|NCT00932373|466628368|FG010|Overall Study|Lack of Efficacy|0|||
129637613|NCT01637922|466628369|FG000|Overall Study|Adverse Event|0|||
129637614|NCT01637922|466628370|FG001|Overall Study|Adverse Event|1|||
129637615|NCT01637922|466628369|FG000|Overall Study|Protocol Violation|0|||
129637616|NCT01637922|466628370|FG001|Overall Study|Protocol Violation|1|||
129637617|NCT01637922|466628369|FG000|Overall Study|Withdrawal by Subject|0|||
129637618|NCT01637922|466628370|FG001|Overall Study|Withdrawal by Subject|3|||
129637619|NCT01637922|466628369|FG000|Overall Study|Lost to Follow-up|2|||
129637620|NCT01637922|466628370|FG001|Overall Study|Lost to Follow-up|0|||
129637621|NCT00638404|466628371|FG000|Overall Study|Physician Decision|8|||
129637622|NCT00638404|466628372|FG001|Overall Study|Physician Decision|0|||
129637623|NCT02509507|466628373|FG000|Overall Study|Death|21|||
129637624|NCT02509507|466628374|FG001|Overall Study|Death|3|||
129637625|NCT02509507|466628375|FG002|Overall Study|Death|22|||
129637626|NCT02509507|466628376|FG003|Overall Study|Death|14|||
129637627|NCT02509507|466628377|FG004|Overall Study|Death|8|||
129637628|NCT02509507|466628378|FG005|Overall Study|Death|12|||
129637629|NCT02509507|466628379|FG006|Overall Study|Death|5|||
129637630|NCT02509507|466628380|FG007|Overall Study|Death|4|||
129637631|NCT02509507|466628381|FG008|Overall Study|Death|8|||
129637632|NCT02509507|466628373|FG000|Overall Study|Lost to Follow-up|0|||
129637633|NCT02509507|466628374|FG001|Overall Study|Lost to Follow-up|1|||
129637634|NCT02509507|466628375|FG002|Overall Study|Lost to Follow-up|0|||
129637635|NCT02509507|466628376|FG003|Overall Study|Lost to Follow-up|0|||
129442013|NCT02684357|465916431|FG000|Part A|Other|0|||
129442014|NCT02684357|465916432|FG001|Part A|Other|1|||
129442015|NCT02684357|465916433|FG002|Part A|Other|0|||
129442016|NCT02684357|465916434|FG003|Part A|Other|0|||
129442017|NCT02684357|465916435|FG004|Part A|Other|0|||
129442018|NCT02684357|465916436|FG005|Part A|Other|0|||
129442019|NCT02684357|465916431|FG000|Part B|Adverse Event (Other)|0|||
129442020|NCT02684357|465916432|FG001|Part B|Adverse Event (Other)|0|||
129442021|NCT02684357|465916433|FG002|Part B|Adverse Event (Other)|0|||
129442022|NCT02684357|465916434|FG003|Part B|Adverse Event (Other)|1|||
129637636|NCT02509507|466628377|FG004|Overall Study|Lost to Follow-up|0|||
129637637|NCT02509507|466628378|FG005|Overall Study|Lost to Follow-up|2|||
129442023|NCT02684357|465916435|FG004|Part B|Adverse Event (Other)|1|||
129442024|NCT02684357|465916436|FG005|Part B|Adverse Event (Other)|1|||
129637638|NCT02509507|466628379|FG006|Overall Study|Lost to Follow-up|0|||
129442025|NCT02684357|465916431|FG000|Part B|Lost to Follow-up|0|||
129442026|NCT02684357|465916432|FG001|Part B|Lost to Follow-up|0|||
129442027|NCT02684357|465916433|FG002|Part B|Lost to Follow-up|0|||
129442028|NCT02684357|465916434|FG003|Part B|Lost to Follow-up|1|||
129442029|NCT02684357|465916435|FG004|Part B|Lost to Follow-up|1|||
129442030|NCT02684357|465916436|FG005|Part B|Lost to Follow-up|7|||
129442031|NCT02684357|465916431|FG000|Part B|Withdrawal by Subject|0|||
129442032|NCT02684357|465916432|FG001|Part B|Withdrawal by Subject|0|||
129442033|NCT02684357|465916433|FG002|Part B|Withdrawal by Subject|0|||
129442034|NCT02684357|465916434|FG003|Part B|Withdrawal by Subject|0|||
129442035|NCT02684357|465916435|FG004|Part B|Withdrawal by Subject|2|||
129442036|NCT02684357|465916436|FG005|Part B|Withdrawal by Subject|4|||
129442037|NCT02684357|465916431|FG000|Part B|Other|0|||
129442038|NCT02684357|465916432|FG001|Part B|Other|0|||
129442039|NCT02684357|465916433|FG002|Part B|Other|0|||
129442040|NCT02684357|465916434|FG003|Part B|Other|1|||
129442041|NCT02684357|465916435|FG004|Part B|Other|0|||
129442042|NCT02684357|465916436|FG005|Part B|Other|1|||
129637639|NCT02509507|466628380|FG007|Overall Study|Lost to Follow-up|0|||
129637640|NCT02509507|466628381|FG008|Overall Study|Lost to Follow-up|0|||
129637641|NCT02509507|466628373|FG000|Overall Study|Withdrawal by Subject|2|||
129637642|NCT02509507|466628374|FG001|Overall Study|Withdrawal by Subject|0|||
129637643|NCT02509507|466628375|FG002|Overall Study|Withdrawal by Subject|1|||
129637644|NCT02509507|466628376|FG003|Overall Study|Withdrawal by Subject|4|||
129637645|NCT02509507|466628377|FG004|Overall Study|Withdrawal by Subject|1|||
129637646|NCT02509507|466628378|FG005|Overall Study|Withdrawal by Subject|3|||
129637647|NCT02509507|466628379|FG006|Overall Study|Withdrawal by Subject|4|||
129442043|NCT01079130|465916437|FG000|Overall Study|Adverse Event|1|||
129442044|NCT01079130|465916438|FG001|Overall Study|Adverse Event|1|||
129442045|NCT01079130|465916439|FG002|Overall Study|Adverse Event|0|||
129442046|NCT01079130|465916440|FG003|Overall Study|Adverse Event|1|||
129442047|NCT01079130|465916441|FG004|Overall Study|Adverse Event|5|||
129442048|NCT01079130|465916442|FG005|Overall Study|Adverse Event|1|||
129442049|NCT01079130|465916437|FG000|Overall Study|Administrative problems|1|||
129797825|NCT02537574|467228233|FG000|Overall Study|Duplicate Patient|1|||
129637648|NCT02509507|466628380|FG007|Overall Study|Withdrawal by Subject|0|||
129637649|NCT02509507|466628381|FG008|Overall Study|Withdrawal by Subject|1|||
129637650|NCT02510664|466628385|FG000|Overall Study|Transferred Care|9|||
129637651|NCT02510664|466628386|FG001|Overall Study|Transferred Care|9|||
129637652|NCT02510664|466628387|FG002|Overall Study|Transferred Care|0|||
129442050|NCT01079130|465916438|FG001|Overall Study|Administrative problems|3|||
129442051|NCT01079130|465916439|FG002|Overall Study|Administrative problems|0|||
129442052|NCT01079130|465916440|FG003|Overall Study|Administrative problems|0|||
129442053|NCT01079130|465916441|FG004|Overall Study|Administrative problems|0|||
129442054|NCT01079130|465916442|FG005|Overall Study|Administrative problems|1|||
129442055|NCT01079130|465916437|FG000|Overall Study|Withdrawal by Subject|0|||
129442056|NCT01079130|465916438|FG001|Overall Study|Withdrawal by Subject|1|||
129442057|NCT01079130|465916439|FG002|Overall Study|Withdrawal by Subject|0|||
129442058|NCT01079130|465916440|FG003|Overall Study|Withdrawal by Subject|0|||
129442059|NCT01079130|465916441|FG004|Overall Study|Withdrawal by Subject|1|||
129442060|NCT01079130|465916442|FG005|Overall Study|Withdrawal by Subject|3|||
129442061|NCT01079130|465916437|FG000|Overall Study|Protocol deviation|0|||
129442062|NCT01079130|465916438|FG001|Overall Study|Protocol deviation|2|||
129637653|NCT02510664|466628385|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
129442063|NCT01079130|465916439|FG002|Overall Study|Protocol deviation|1|||
129442064|NCT01079130|465916440|FG003|Overall Study|Protocol deviation|2|||
129442065|NCT01079130|465916441|FG004|Overall Study|Protocol deviation|0|||
129442066|NCT01079130|465916442|FG005|Overall Study|Protocol deviation|0|||
129442067|NCT01079130|465916437|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129442068|NCT01079130|465916438|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129442069|NCT01079130|465916439|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129442070|NCT01079130|465916440|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129442071|NCT01079130|465916441|FG004|Overall Study|Abnormal test procedure result(s)|1|||
129442072|NCT01079130|465916442|FG005|Overall Study|Abnormal test procedure result(s)|0|||
129442073|NCT01079130|465916437|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129442074|NCT01079130|465916438|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129442075|NCT01079130|465916439|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129442076|NCT01079130|465916440|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129442077|NCT01079130|465916441|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
129442078|NCT01079130|465916442|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
129442079|NCT01079130|465916437|FG000|Overall Study|Lost to Follow-up|0|||
129442080|NCT01079130|465916438|FG001|Overall Study|Lost to Follow-up|0|||
129442081|NCT01079130|465916439|FG002|Overall Study|Lost to Follow-up|0|||
129442082|NCT01079130|465916440|FG003|Overall Study|Lost to Follow-up|0|||
129442083|NCT01079130|465916441|FG004|Overall Study|Lost to Follow-up|1|||
129442084|NCT01079130|465916442|FG005|Overall Study|Lost to Follow-up|0|||
129442085|NCT01839487|465916443|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
129442086|NCT01839487|465916444|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129442087|NCT01839487|465916445|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129442088|NCT01839487|465916446|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129442089|NCT01839487|465916447|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129442090|NCT01839487|465916448|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
129442091|NCT01839487|465916443|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
129442092|NCT01839487|465916444|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
129442093|NCT01839487|465916445|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129442094|NCT01839487|465916446|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129442095|NCT01839487|465916447|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129442096|NCT01839487|465916448|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
129442097|NCT01839487|465916443|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129442098|NCT01839487|465916444|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
129442099|NCT01839487|465916445|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129442100|NCT01839487|465916446|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129442101|NCT01839487|465916447|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129442102|NCT01839487|465916448|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
129442103|NCT01839487|465916443|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
129442104|NCT01839487|465916444|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129442105|NCT01839487|465916445|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129442106|NCT01839487|465916446|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129442107|NCT01839487|465916447|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129442108|NCT01839487|465916448|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
129442109|NCT01839487|465916443|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
129442110|NCT01839487|465916444|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
129637654|NCT02510664|466628386|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
129637655|NCT02510664|466628387|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
129637656|NCT02510664|466628385|FG000|Overall Study|Time Constraints|1|||
129442111|NCT01839487|465916445|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
129442112|NCT01839487|465916446|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
129442113|NCT01839487|465916447|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
129442114|NCT01839487|465916448|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
129442115|NCT01839487|465916443|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
129442116|NCT01839487|465916444|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
129442117|NCT01839487|465916445|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
129442118|NCT01839487|465916446|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
129442119|NCT01839487|465916447|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
129442120|NCT01839487|465916448|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
129442121|NCT01839487|465916443|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129442122|NCT01839487|465916444|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129442123|NCT01839487|465916445|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
129442124|NCT01839487|465916446|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129442125|NCT01839487|465916447|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
129442126|NCT01839487|465916448|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
129442127|NCT01839487|465916443|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
129442128|NCT01839487|465916444|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
129442129|NCT01839487|465916445|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
129442130|NCT01839487|465916446|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
129442131|NCT01839487|465916447|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
129442132|NCT01839487|465916448|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
129442133|NCT01839487|465916443|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
129442134|NCT01839487|465916444|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
129442135|NCT01839487|465916445|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
129442136|NCT01839487|465916446|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
129442137|NCT01839487|465916447|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
129442138|NCT01839487|465916448|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
129442139|NCT01658826|465916459|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
129442140|NCT01658826|465916460|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
129442141|NCT01658826|465916459|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
129442142|NCT01658826|465916460|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
129442143|NCT01658826|465916459|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
129442144|NCT01658826|465916460|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
129442145|NCT01658826|465916459|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
129442146|NCT01658826|465916460|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
129442147|NCT01658826|465916459|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
129442148|NCT01658826|465916460|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
129442149|NCT01658826|465916459|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
129442150|NCT01658826|465916460|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
129442151|NCT01658826|465916459|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
129442152|NCT01658826|465916460|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
129442153|NCT01658826|465916459|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
129442154|NCT01658826|465916460|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
129442155|NCT01658826|465916459|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
129442156|NCT01658826|465916460|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
129442157|NCT01422850|465916463|FG000|Overall Study|Physician Decision|3|||
129442158|NCT04484831|465916464|FG000|Overall Study|Withdrawal by Subject|1|||
129442159|NCT04484831|465916465|FG001|Overall Study|Withdrawal by Subject|0|||
129442160|NCT04821869|465916466|FG000|Overall Study|Adverse Event|4|||
129442161|NCT04821869|465916466|FG000|Overall Study|Withdrawal by Subject|2|||
129442162|NCT04821869|465916466|FG000|Overall Study|Did not meet FEV1 criteria|1|||
129442163|NCT03511053|465917604|FG000|Overall Study|Withdrawal by Subject|1|||
129442164|NCT01128361|465917605|FG000|Overall Study|Lost to Follow-up|0|||
129442165|NCT01128361|465917606|FG001|Overall Study|Lost to Follow-up|1|||
129442166|NCT01128361|465917605|FG000|Overall Study|Withdrawal by Subject|5|||
129442167|NCT01128361|465917606|FG001|Overall Study|Withdrawal by Subject|2|||
129442168|NCT01929980|465917607|FG000|Overall Study|Physician Decision|1|||
129442169|NCT00985166|465917608|FG000|Overall Study|Lost to Follow-up|3|||
129442170|NCT00985166|465917609|FG001|Overall Study|Lost to Follow-up|2|||
129442171|NCT00985166|465917610|FG002|Overall Study|Lost to Follow-up|2|||
129442172|NCT00985166|465917608|FG000|Overall Study|Withdrawal by Subject|3|||
129442173|NCT00985166|465917609|FG001|Overall Study|Withdrawal by Subject|2|||
129442174|NCT00985166|465917610|FG002|Overall Study|Withdrawal by Subject|0|||
129637657|NCT02510664|466628386|FG001|Overall Study|Time Constraints|1|||
129637658|NCT02510664|466628387|FG002|Overall Study|Time Constraints|0|||
129442175|NCT00985166|465917608|FG000|Overall Study|Test not done|2|||
129442176|NCT00985166|465917609|FG001|Overall Study|Test not done|0|||
129442177|NCT00985166|465917610|FG002|Overall Study|Test not done|4|||
129442178|NCT00985166|465917608|FG000|Overall Study|Other|1|||
129442179|NCT00985166|465917609|FG001|Overall Study|Other|0|||
129442180|NCT00985166|465917610|FG002|Overall Study|Other|1|||
129442181|NCT01028222|465917611|FG000|Overall Study|Protocol deviation|1|||
129442182|NCT01028222|465917612|FG001|Overall Study|Protocol deviation|0|||
129442183|NCT01028222|465917611|FG000|Overall Study|Disease progression|33|||
129442184|NCT01028222|465917612|FG001|Overall Study|Disease progression|9|||
129442185|NCT01028222|465917611|FG000|Overall Study|Administrative problems|1|||
129442186|NCT01028222|465917612|FG001|Overall Study|Administrative problems|1|||
129442187|NCT01028222|465917611|FG000|Overall Study|Lost to Follow-up|0|||
129442188|NCT01028222|465917612|FG001|Overall Study|Lost to Follow-up|1|||
129442189|NCT01028222|465917611|FG000|Overall Study|Withdrawal by Subject|1|||
129442190|NCT01028222|465917612|FG001|Overall Study|Withdrawal by Subject|0|||
129442191|NCT01028222|465917611|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
129442192|NCT01028222|465917612|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
129442193|NCT01028222|465917611|FG000|Overall Study|Adverse Event|2|||
129442194|NCT01028222|465917612|FG001|Overall Study|Adverse Event|0|||
129442195|NCT00146328|465917615|FG000|Overall Study|Adverse Event|39|||
129442196|NCT00146328|465917616|FG001|Overall Study|Adverse Event|48|||
129442197|NCT00146328|465917617|FG002|Overall Study|Adverse Event|79|||
129442198|NCT00146328|465917615|FG000|Overall Study|Protocol Violation|11|||
129442199|NCT00146328|465917616|FG001|Overall Study|Protocol Violation|6|||
129442200|NCT00146328|465917617|FG002|Overall Study|Protocol Violation|12|||
129442201|NCT00146328|465917615|FG000|Overall Study|Lost to Follow-up|7|||
129442202|NCT00146328|465917616|FG001|Overall Study|Lost to Follow-up|4|||
129442203|NCT00146328|465917617|FG002|Overall Study|Lost to Follow-up|7|||
129637659|NCT00302328|466628398|FG000|Overall Study|Physician Decision|0|||
129637660|NCT00302328|466628399|FG001|Overall Study|Physician Decision|1|||
129637661|NCT00302328|466628400|FG002|Overall Study|Physician Decision|0|||
129637662|NCT00912743|466628405|FG000|Overall Study|Adverse Event|3|||
129442204|NCT00146328|465917615|FG000|Overall Study|Withdrawal by Subject|16|||
129442205|NCT00146328|465917616|FG001|Overall Study|Withdrawal by Subject|16|||
129442206|NCT00146328|465917617|FG002|Overall Study|Withdrawal by Subject|22|||
129442207|NCT00146328|465917615|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
129442208|NCT00146328|465917616|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
129442209|NCT00146328|465917617|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
129442210|NCT00146328|465917615|FG000|Overall Study|Trial ended/site closed|8|||
129442211|NCT00146328|465917616|FG001|Overall Study|Trial ended/site closed|2|||
129442212|NCT00146328|465917617|FG002|Overall Study|Trial ended/site closed|19|||
129442213|NCT00146328|465917615|FG000|Overall Study|Patient decision to end|0|||
129442214|NCT00146328|465917616|FG001|Overall Study|Patient decision to end|1|||
129442215|NCT00146328|465917617|FG002|Overall Study|Patient decision to end|6|||
129442216|NCT00146328|465917615|FG000|Overall Study|Enroll into other trial|2|||
129442217|NCT00146328|465917616|FG001|Overall Study|Enroll into other trial|4|||
129442218|NCT00146328|465917617|FG002|Overall Study|Enroll into other trial|2|||
129442219|NCT00146328|465917615|FG000|Overall Study|Death|0|||
129442220|NCT00146328|465917616|FG001|Overall Study|Death|1|||
129442221|NCT00146328|465917617|FG002|Overall Study|Death|1|||
129442222|NCT00146328|465917615|FG000|Overall Study|Moved|2|||
129442223|NCT00146328|465917616|FG001|Overall Study|Moved|0|||
129442224|NCT00146328|465917617|FG002|Overall Study|Moved|0|||
129442225|NCT00146328|465917615|FG000|Overall Study|Interaction with other medication|2|||
129442226|NCT00146328|465917616|FG001|Overall Study|Interaction with other medication|0|||
129442227|NCT00146328|465917617|FG002|Overall Study|Interaction with other medication|1|||
129442228|NCT00300781|465917618|FG000|Overall Study|Disease Progression|55|||
129442229|NCT00300781|465917619|FG001|Overall Study|Disease Progression|52|||
129442230|NCT00300781|465917618|FG000|Overall Study|Adverse Event|5|||
129442231|NCT00300781|465917619|FG001|Overall Study|Adverse Event|6|||
129442232|NCT00300781|465917618|FG000|Overall Study|Withdrawal by Subject|1|||
129442233|NCT00300781|465917619|FG001|Overall Study|Withdrawal by Subject|2|||
129442234|NCT00300781|465917618|FG000|Overall Study|Physician Decision|1|||
129442235|NCT00300781|465917619|FG001|Overall Study|Physician Decision|0|||
129442236|NCT00300781|465917618|FG000|Overall Study|Not Recorded|0|||
129442237|NCT00300781|465917619|FG001|Overall Study|Not Recorded|1|||
129442238|NCT00300781|465917618|FG000|Overall Study|Symptomatic Deterioration|1|||
129442239|NCT00300781|465917619|FG001|Overall Study|Symptomatic Deterioration|0|||
129442240|NCT00300781|465917618|FG000|Overall Study|Lost to Follow-up|0|||
129442241|NCT00300781|465917619|FG001|Overall Study|Lost to Follow-up|1|||
129442242|NCT02072434|465917620|FG000|Overall Study|Protocol Violation|10|||
129442243|NCT02072434|465917621|FG001|Overall Study|Protocol Violation|9|||
129442244|NCT02072434|465917620|FG000|Overall Study|Physician Decision|5|||
129637663|NCT00912743|466628406|FG001|Overall Study|Adverse Event|1|||
129442245|NCT02072434|465917621|FG001|Overall Study|Physician Decision|10|||
129442246|NCT02072434|465917620|FG000|Overall Study|Adverse event, serious fatal|1|||
129442247|NCT02072434|465917621|FG001|Overall Study|Adverse event, serious fatal|6|||
129442248|NCT02072434|465917620|FG000|Overall Study|Adverse Event|7|||
129442249|NCT02072434|465917621|FG001|Overall Study|Adverse Event|6|||
129442250|NCT02072434|465917620|FG000|Overall Study|Withdrawal by Subject|17|||
129442251|NCT02072434|465917621|FG001|Overall Study|Withdrawal by Subject|29|||
129442252|NCT02072434|465917620|FG000|Overall Study|Other|14|||
129442253|NCT02072434|465917621|FG001|Overall Study|Other|29|||
129442254|NCT02072434|465917620|FG000|Overall Study|Lost to Follow-up|0|||
129442255|NCT02072434|465917621|FG001|Overall Study|Lost to Follow-up|1|||
129442256|NCT02960854|465917626|FG000|Overall Study|Not Disclosed|2|||
129442257|NCT02960854|465917627|FG001|Overall Study|Not Disclosed|2|||
129442258|NCT02960854|465917626|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
129442259|NCT02960854|465917627|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
129442260|NCT02960854|465917626|FG000|Overall Study|Subject Withdrew Consent|0|||
129442261|NCT02960854|465917627|FG001|Overall Study|Subject Withdrew Consent|1|||
129442262|NCT02960854|465917626|FG000|Overall Study|Death|4|||
129442263|NCT02960854|465917627|FG001|Overall Study|Death|6|||
129442264|NCT04288778|465917628|FG000|Overall Study|Withdrawal by Subject|2|||
129442265|NCT04288778|465917628|FG000|Overall Study|Adverse Event|5|||
129442266|NCT04288778|465917628|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129442267|NCT04288778|465917628|FG000|Overall Study|Other|1|||
129442268|NCT04288778|465917628|FG000|Overall Study|Started but not treated|2|||
129442269|NCT01324323|465917629|FG000|Overall Study|Withdrawal by Subject|1|||
129442270|NCT03153137|465917630|FG000|Overall Study|Lost to Follow-up|1|||
129442271|NCT03153137|465917631|FG001|Overall Study|Lost to Follow-up|0|||
129442272|NCT03153137|465917630|FG000|Overall Study|Withdrawal by Subject|2|||
129442273|NCT03153137|465917631|FG001|Overall Study|Withdrawal by Subject|1|||
129442274|NCT03153137|465917630|FG000|Overall Study|Physician Decision|0|||
129442275|NCT03153137|465917631|FG001|Overall Study|Physician Decision|3|||
129442276|NCT00993915|465917638|FG000|Overall Study|Insufficient clinical response|3|||
129442277|NCT00993915|465917638|FG000|Overall Study|Withdrawal by Subject|2|||
129442278|NCT00993915|465917638|FG000|Overall Study|Other|1|||
129442279|NCT00993915|465917638|FG000|Overall Study|Ongoing|3|||
129442280|NCT04209621|465917646|FG000|Overall Study|Death|1|||
129442281|NCT04209621|465917646|FG000|Overall Study|Study Terminated Early|2|||
129442282|NCT02249767|465917647|FG000|Overall Study|Did not use medication|8|||
129442283|NCT02249767|465917648|FG001|Overall Study|Did not use medication|9|||
129442284|NCT02249767|465917649|FG002|Overall Study|Did not use medication|8|||
129442285|NCT01372410|465917650|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
129442286|NCT01372410|465917651|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
129442287|NCT01372410|465917652|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129442288|NCT01372410|465917653|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129442289|NCT01372410|465917654|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
129442290|NCT01372410|465917655|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129442291|NCT01372410|465917656|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129442292|NCT01372410|465917657|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
129442293|NCT01372410|465917650|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
129442294|NCT01372410|465917651|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
129442295|NCT01372410|465917652|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
129442296|NCT01372410|465917653|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
129442297|NCT01372410|465917654|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
129442298|NCT01372410|465917655|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
129442299|NCT01372410|465917656|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
129442300|NCT01372410|465917657|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
129442301|NCT01372410|465917650|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442302|NCT01372410|465917651|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442303|NCT01372410|465917652|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442304|NCT01372410|465917653|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442305|NCT01372410|465917654|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
129442306|NCT01372410|465917655|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442307|NCT01372410|465917656|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442308|NCT01372410|465917657|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129442309|NCT01372410|465917650|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442310|NCT01372410|465917651|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442311|NCT01372410|465917652|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442312|NCT01372410|465917653|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442313|NCT01372410|465917654|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442314|NCT01372410|465917655|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442315|NCT01372410|465917656|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
129442316|NCT01372410|465917657|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
129442317|NCT01372410|465917650|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
129442318|NCT01372410|465917651|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129442319|NCT01372410|465917652|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129442320|NCT01372410|465917653|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129637664|NCT00912743|466628405|FG000|Overall Study|Lack of Efficacy|9|||
129442321|NCT01372410|465917654|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129442322|NCT01372410|465917655|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129442323|NCT01372410|465917656|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
129442324|NCT01372410|465917657|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
129442325|NCT01372410|465917650|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442326|NCT01372410|465917651|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442327|NCT01372410|465917652|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442328|NCT01372410|465917653|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442329|NCT01372410|465917654|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
129442330|NCT01372410|465917655|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442331|NCT01372410|465917656|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442332|NCT01372410|465917657|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
129442333|NCT01372410|465917650|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129442334|NCT01372410|465917651|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129442335|NCT01372410|465917652|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129442336|NCT01372410|465917653|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129442337|NCT01372410|465917654|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
129442338|NCT01372410|465917655|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
129442339|NCT01372410|465917656|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
129442340|NCT01372410|465917657|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
129442341|NCT01372410|465917650|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442342|NCT01372410|465917651|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442343|NCT01372410|465917652|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442344|NCT01372410|465917653|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442345|NCT01372410|465917654|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442346|NCT01372410|465917655|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442347|NCT01372410|465917656|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
129442348|NCT01372410|465917657|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
129442349|NCT01372410|465917650|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442350|NCT01372410|465917651|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442351|NCT01372410|465917652|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
129442352|NCT01372410|465917653|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442353|NCT01372410|465917654|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442354|NCT01372410|465917655|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442355|NCT01372410|465917656|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442356|NCT01372410|465917657|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
129442357|NCT01372410|465917650|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442358|NCT01372410|465917651|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442359|NCT01372410|465917652|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442360|NCT01372410|465917653|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442361|NCT01372410|465917654|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442362|NCT01372410|465917655|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
129442363|NCT01372410|465917656|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442364|NCT01372410|465917657|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
129442365|NCT04585646|465917658|FG000|First Intervention|Physician Decision|1|||
129442366|NCT04585646|465917659|FG001|First Intervention|Physician Decision|0|||
129442367|NCT04585646|465917658|FG000|First Intervention|Lost to Follow-up|0|||
129442368|NCT04585646|465917659|FG001|First Intervention|Lost to Follow-up|3|||
129442369|NCT04585646|465917658|FG000|First Intervention|Withdrawal by Subject|0|||
129442370|NCT04585646|465917659|FG001|First Intervention|Withdrawal by Subject|1|||
129442371|NCT02465463|465917661|FG000|Overall Study|Lost to Follow-up|2|||
129442372|NCT02465463|465917662|FG001|Overall Study|Lost to Follow-up|1|||
129442373|NCT02465463|465917661|FG000|Overall Study|Death|1|||
129442374|NCT02465463|465917662|FG001|Overall Study|Death|0|||
129442375|NCT02465463|465917661|FG000|Overall Study|Protocol Violation|1|||
129442376|NCT02465463|465917662|FG001|Overall Study|Protocol Violation|0|||
129442377|NCT01019317|465917666|FG000|Overall Study|Not Eligible|4|||
129442378|NCT03294109|465917668|FG000|Overall Study|Withdrawal by Subject|6|||
129442379|NCT03294109|465917669|FG001|Overall Study|Withdrawal by Subject|5|||
129442380|NCT04744285|465917670|FG000|Overall Study|Withdrawal by Subject|1|||
129442381|NCT04744285|465917671|FG001|Overall Study|Withdrawal by Subject|1|||
129442382|NCT04744285|465917672|FG002|Overall Study|Withdrawal by Subject|2|||
129442383|NCT04744285|465917673|FG003|Overall Study|Withdrawal by Subject|1|||
129442384|NCT01774084|465917674|FG000|Overall Study|Personal reasons|1|||
129442385|NCT01774084|465917675|FG001|Overall Study|Personal reasons|0|||
129442386|NCT00821431|465917676|FG000|Overall Study|Adverse Event|6|||
129442387|NCT00821431|465917677|FG001|Overall Study|Adverse Event|3|||
129442388|NCT00821431|465917676|FG000|Overall Study|Withdrawal by Subject|5|||
129442389|NCT00821431|465917677|FG001|Overall Study|Withdrawal by Subject|0|||
129442390|NCT00821431|465917676|FG000|Overall Study|Lost to Follow-up|1|||
129442391|NCT00821431|465917677|FG001|Overall Study|Lost to Follow-up|0|||
129442392|NCT00821431|465917676|FG000|Overall Study|Protocol Violation|3|||
129442393|NCT00821431|465917677|FG001|Overall Study|Protocol Violation|1|||
129442394|NCT00821431|465917676|FG000|Overall Study|Physician Decision|0|||
129442395|NCT00821431|465917677|FG001|Overall Study|Physician Decision|1|||
129442396|NCT04526197|465917682|FG000|Period 1|Adverse Event|0|||
129637665|NCT00912743|466628406|FG001|Overall Study|Lack of Efficacy|18|||
129637666|NCT00912743|466628405|FG000|Overall Study|Toxicity|0|||
129637667|NCT00912743|466628406|FG001|Overall Study|Toxicity|1|||
129637668|NCT00912743|466628405|FG000|Overall Study|End of treatment form was not collected|1|||
129637669|NCT00912743|466628406|FG001|Overall Study|End of treatment form was not collected|0|||
129637670|NCT00862823|466628408|FG000|First Intervention|Withdrawal by Subject|1|||
129637671|NCT00862823|466628409|FG001|First Intervention|Withdrawal by Subject|1|||
129637672|NCT02714595|466628413|FG000|Overall Study|Lost to Follow-up|1|||
129637673|NCT02714595|466628414|FG001|Overall Study|Lost to Follow-up|0|||
129637674|NCT02714595|466628413|FG000|Overall Study|Withdrawal by Subject|1|||
129637675|NCT02714595|466628414|FG001|Overall Study|Withdrawal by Subject|2|||
129637676|NCT02714595|466628413|FG000|Overall Study|Lack of Efficacy|0|||
129637677|NCT02714595|466628414|FG001|Overall Study|Lack of Efficacy|1|||
129637678|NCT02714595|466628413|FG000|Overall Study|Death|30|||
129637679|NCT02714595|466628414|FG001|Overall Study|Death|9|||
129637680|NCT02714595|466628413|FG000|Overall Study|Other-Miscellaneous|0|||
129637681|NCT02714595|466628414|FG001|Overall Study|Other-Miscellaneous|1|||
129637682|NCT02411396|466628415|FG000|Overall Study|Lost to Follow-up|31|||
129637683|NCT02411396|466628415|FG000|Overall Study|Death|10|||
129637684|NCT02423343|466628416|FG000|Overall Study|Withdrawal by Subject|0|||
129637685|NCT02423343|466628417|FG001|Overall Study|Withdrawal by Subject|1|||
129637686|NCT02423343|466628418|FG002|Overall Study|Withdrawal by Subject|0|||
129637687|NCT02423343|466628419|FG003|Overall Study|Withdrawal by Subject|0|||
129637688|NCT02423343|466628420|FG004|Overall Study|Withdrawal by Subject|0|||
129637689|NCT02423343|466628421|FG005|Overall Study|Withdrawal by Subject|0|||
129637690|NCT02423343|466628416|FG000|Overall Study|Progressive Disease|0|||
129637691|NCT02423343|466628417|FG001|Overall Study|Progressive Disease|0|||
129797826|NCT02537574|467228234|FG001|Overall Study|Duplicate Patient|0|||
129442397|NCT04526197|465917683|FG001|Period 1|Adverse Event|1|||
129442398|NCT04526197|465917682|FG000|Period 1|Withdrawal by Subject|1|||
129442399|NCT04526197|465917683|FG001|Period 1|Withdrawal by Subject|0|||
129442400|NCT04526197|465917682|FG000|Period 2|Adverse Event|0|||
129442401|NCT04526197|465917683|FG001|Period 2|Adverse Event|1|||
129442402|NCT04526197|465917682|FG000|Period 2|Withdrawal by Subject|0|||
129442403|NCT04526197|465917683|FG001|Period 2|Withdrawal by Subject|1|||
129442404|NCT00372385|465917684|FG000|Overall Study|Adverse Event|6|||
129442405|NCT00372385|465917685|FG001|Overall Study|Adverse Event|11|||
129442406|NCT00372385|465917686|FG002|Overall Study|Adverse Event|9|||
129442407|NCT00372385|465917687|FG003|Overall Study|Adverse Event|7|||
129637692|NCT02423343|466628418|FG002|Overall Study|Progressive Disease|0|||
129637693|NCT02423343|466628419|FG003|Overall Study|Progressive Disease|0|||
129637694|NCT02423343|466628420|FG004|Overall Study|Progressive Disease|2|||
129637695|NCT02423343|466628421|FG005|Overall Study|Progressive Disease|0|||
129637696|NCT02423343|466628416|FG000|Overall Study|Adverse Event|0|||
129637697|NCT02423343|466628417|FG001|Overall Study|Adverse Event|0|||
129637698|NCT02423343|466628418|FG002|Overall Study|Adverse Event|0|||
129637699|NCT02423343|466628419|FG003|Overall Study|Adverse Event|0|||
129637700|NCT02423343|466628420|FG004|Overall Study|Adverse Event|2|||
129797827|NCT02537574|467228235|FG002|Overall Study|Duplicate Patient|0|||
129442408|NCT00372385|465917684|FG000|Overall Study|Noncompliance|0|||
129442409|NCT00372385|465917685|FG001|Overall Study|Noncompliance|1|||
129637701|NCT02423343|466628421|FG005|Overall Study|Adverse Event|0|||
129637702|NCT02423343|466628416|FG000|Overall Study|Death|0|||
129637703|NCT02423343|466628417|FG001|Overall Study|Death|0|||
129637704|NCT02423343|466628418|FG002|Overall Study|Death|0|||
129637705|NCT02423343|466628419|FG003|Overall Study|Death|0|||
129637706|NCT02423343|466628420|FG004|Overall Study|Death|1|||
129637707|NCT02423343|466628421|FG005|Overall Study|Death|0|||
129637708|NCT02865499|466628422|FG000|Baseline|Adverse Event|1|||
129637709|NCT02865499|466628422|FG000|Baseline|Withdrawal by Subject|1|||
129637710|NCT01860040|466628428|FG000|Overall Study|Withdrawal by Subject|1|||
129637711|NCT01860040|466628429|FG001|Overall Study|Withdrawal by Subject|0|||
129442410|NCT00372385|465917686|FG002|Overall Study|Noncompliance|1|||
129442411|NCT00372385|465917687|FG003|Overall Study|Noncompliance|1|||
129442412|NCT00372385|465917684|FG000|Overall Study|Physician Decision|1|||
129442413|NCT00372385|465917685|FG001|Overall Study|Physician Decision|0|||
129442414|NCT00372385|465917686|FG002|Overall Study|Physician Decision|0|||
129442415|NCT00372385|465917687|FG003|Overall Study|Physician Decision|0|||
129442416|NCT00372385|465917684|FG000|Overall Study|Lost to Follow-up|2|||
129442417|NCT00372385|465917685|FG001|Overall Study|Lost to Follow-up|0|||
129442418|NCT00372385|465917686|FG002|Overall Study|Lost to Follow-up|0|||
129442419|NCT00372385|465917687|FG003|Overall Study|Lost to Follow-up|0|||
129442420|NCT00372385|465917684|FG000|Overall Study|Withdrawal by Subject|2|||
129442421|NCT00372385|465917685|FG001|Overall Study|Withdrawal by Subject|1|||
129442422|NCT00372385|465917686|FG002|Overall Study|Withdrawal by Subject|0|||
129442423|NCT00372385|465917687|FG003|Overall Study|Withdrawal by Subject|0|||
129442424|NCT00372385|465917684|FG000|Overall Study|Refusal of Treatment|3|||
129442425|NCT00372385|465917685|FG001|Overall Study|Refusal of Treatment|6|||
129442426|NCT00372385|465917686|FG002|Overall Study|Refusal of Treatment|0|||
129442427|NCT00372385|465917687|FG003|Overall Study|Refusal of Treatment|0|||
129442428|NCT00372385|465917684|FG000|Overall Study|No Response|1|||
129442429|NCT00372385|465917685|FG001|Overall Study|No Response|1|||
129442430|NCT00372385|465917686|FG002|Overall Study|No Response|0|||
129442431|NCT00372385|465917687|FG003|Overall Study|No Response|0|||
129442432|NCT00372385|465917684|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
129442433|NCT00372385|465917685|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129442434|NCT00372385|465917686|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129442435|NCT00372385|465917687|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
129442436|NCT00372385|465917684|FG000|Overall Study|Virologic Stopping Rule|17|||
129442437|NCT00372385|465917685|FG001|Overall Study|Virologic Stopping Rule|0|||
129442438|NCT00372385|465917686|FG002|Overall Study|Virologic Stopping Rule|0|||
129442439|NCT00372385|465917687|FG003|Overall Study|Virologic Stopping Rule|0|||
129442440|NCT02411578|465917690|FG000|Crossover Trial Phase|Pregnancy|0|||
129442441|NCT02411578|465917691|FG001|Crossover Trial Phase|Pregnancy|1|||
129442442|NCT00364156|465917694|FG000|Overall Study|Withdrawal by Subject|73|||
129442443|NCT00364156|465917695|FG001|Overall Study|Withdrawal by Subject|80|||
129442444|NCT00364156|465917694|FG000|Overall Study|Protocol Violation|6|||
129442445|NCT00364156|465917695|FG001|Overall Study|Protocol Violation|1|||
129442446|NCT04683731|465917706|FG000|Overall Study|Withdrawal by Subject|1|||
129442447|NCT04683731|465917707|FG001|Overall Study|Withdrawal by Subject|0|||
129442448|NCT04683731|465917708|FG002|Overall Study|Withdrawal by Subject|3|||
129442449|NCT04683731|465917709|FG003|Overall Study|Withdrawal by Subject|2|||
129442450|NCT04683731|465917706|FG000|Overall Study|Determined patient was not eligible|3|||
129442451|NCT04683731|465917707|FG001|Overall Study|Determined patient was not eligible|3|||
129442452|NCT04683731|465917708|FG002|Overall Study|Determined patient was not eligible|12|||
129442453|NCT04683731|465917709|FG003|Overall Study|Determined patient was not eligible|3|||
129442454|NCT01210118|465917712|FG000|Overall Study|Lost to Follow-up|1|||
129442455|NCT01210118|465917713|FG001|Overall Study|Lost to Follow-up|1|||
129442456|NCT01210118|465917712|FG000|Overall Study|Protocol Violation|1|||
129442457|NCT01210118|465917713|FG001|Overall Study|Protocol Violation|1|||
129442458|NCT01210118|465917712|FG000|Overall Study|Spontaneous abortion|1|||
129442459|NCT01210118|465917713|FG001|Overall Study|Spontaneous abortion|3|||
129442460|NCT02958267|465917716|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
129442461|NCT02958267|465917717|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
129442462|NCT02958267|465917716|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
129442463|NCT02958267|465917717|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
129442464|NCT02958267|465917716|FG000|Follow-up Visits|Additional treatment pursued|2|||
129637712|NCT01931995|466628430|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
129637713|NCT01931995|466628431|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
129637714|NCT01931995|466628430|FG000|First Intervention (1 Day)|Physician Decision|1|||
129442465|NCT02958267|465917717|FG001|Follow-up Visits|Additional treatment pursued|1|||
129442466|NCT02244996|465917718|FG000|Overall Study|Lack of Efficacy|2|||
129442467|NCT02244996|465917719|FG001|Overall Study|Lack of Efficacy|6|||
129442468|NCT01335009|465917720|FG000|Overall Study|Too ill to travel to study sites|1|||
129442469|NCT01335009|465917721|FG001|Overall Study|Too ill to travel to study sites|0|||
129442470|NCT01335009|465917720|FG000|Overall Study|Death|28|||
129442471|NCT01335009|465917721|FG001|Overall Study|Death|32|||
129442472|NCT01335009|465917720|FG000|Overall Study|Withdrawal by Subject|1|||
129637715|NCT01931995|466628431|FG001|First Intervention (1 Day)|Physician Decision|1|||
129637716|NCT01931995|466628430|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
129637717|NCT01931995|466628431|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
129637718|NCT00014495|466628432|FG000|Overall Study|Death|0|||
129637719|NCT00014495|466628433|FG001|Overall Study|Death|0|||
129637720|NCT00014495|466628434|FG002|Overall Study|Death|1|||
129637721|NCT00014495|466628435|FG003|Overall Study|Death|0|||
129637722|NCT00014495|466628432|FG000|Overall Study|Clinical deterioration|0|||
129637723|NCT00014495|466628433|FG001|Overall Study|Clinical deterioration|0|||
129637724|NCT00014495|466628434|FG002|Overall Study|Clinical deterioration|0|||
129637725|NCT00014495|466628435|FG003|Overall Study|Clinical deterioration|1|||
129637726|NCT00403481|466628437|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
129637727|NCT00403481|466628437|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
129637728|NCT00403481|466628437|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
129637729|NCT00403481|466628437|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
129637730|NCT00403481|466628437|FG000|Olm 40 mg|Adverse Event|2|||
129637731|NCT00403481|466628437|FG000|Olm 40 mg|Protocol Violation|1|||
129637732|NCT00403481|466628437|FG000|Olm 40 mg|Withdrawal by Subject|1|||
129637733|NCT00403481|466628437|FG000|Olm 40 mg|Other|1|||
129637734|NCT00403481|466628437|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
129637735|NCT00403481|466628437|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
129637736|NCT00403481|466628437|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
129637737|NCT00403481|466628437|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
129637738|NCT00403481|466628437|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
129637739|NCT00403481|466628437|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
129637740|NCT02099110|466628445|FG000|Overall Study|Protocol Violation|2|||
129637741|NCT02099110|466628446|FG001|Overall Study|Protocol Violation|1|||
129637742|NCT02099110|466628447|FG002|Overall Study|Protocol Violation|0|||
129637743|NCT02099110|466628448|FG003|Overall Study|Protocol Violation|3|||
129637744|NCT02099110|466628449|FG004|Overall Study|Protocol Violation|1|||
129637745|NCT02099110|466628445|FG000|Overall Study|Participant moved|1|||
129637746|NCT02099110|466628446|FG001|Overall Study|Participant moved|1|||
129637747|NCT02099110|466628447|FG002|Overall Study|Participant moved|1|||
129637748|NCT02099110|466628448|FG003|Overall Study|Participant moved|0|||
129637749|NCT02099110|466628449|FG004|Overall Study|Participant moved|2|||
129637750|NCT02099110|466628445|FG000|Overall Study|Withdrawal by Subject|7|||
129637751|NCT02099110|466628446|FG001|Overall Study|Withdrawal by Subject|11|||
129637752|NCT02099110|466628447|FG002|Overall Study|Withdrawal by Subject|13|||
129637753|NCT02099110|466628448|FG003|Overall Study|Withdrawal by Subject|9|||
129637754|NCT02099110|466628449|FG004|Overall Study|Withdrawal by Subject|13|||
129637755|NCT02099110|466628445|FG000|Overall Study|Adverse Event|3|||
129637756|NCT02099110|466628446|FG001|Overall Study|Adverse Event|5|||
129442473|NCT01335009|465917721|FG001|Overall Study|Withdrawal by Subject|1|||
129442474|NCT01335009|465917720|FG000|Overall Study|Lost to Follow-up|1|||
129442475|NCT01335009|465917721|FG001|Overall Study|Lost to Follow-up|0|||
129442476|NCT03971422|465919202|FG000|Overall Study|Lost to Follow-up|0|||
129442477|NCT03971422|465919203|FG001|Overall Study|Lost to Follow-up|1|||
129442478|NCT03971422|465919204|FG002|Overall Study|Lost to Follow-up|0|||
129637757|NCT02099110|466628447|FG002|Overall Study|Adverse Event|2|||
129637758|NCT02099110|466628448|FG003|Overall Study|Adverse Event|3|||
129637759|NCT02099110|466628449|FG004|Overall Study|Adverse Event|2|||
129637760|NCT02099110|466628445|FG000|Overall Study|Lost to Follow-up|6|||
129637761|NCT02099110|466628446|FG001|Overall Study|Lost to Follow-up|12|||
129637762|NCT02099110|466628447|FG002|Overall Study|Lost to Follow-up|11|||
129637763|NCT02099110|466628448|FG003|Overall Study|Lost to Follow-up|5|||
129637764|NCT02099110|466628449|FG004|Overall Study|Lost to Follow-up|6|||
129637765|NCT02099110|466628445|FG000|Overall Study|Death|0|||
129637766|NCT02099110|466628446|FG001|Overall Study|Death|1|||
129637767|NCT02099110|466628447|FG002|Overall Study|Death|0|||
129637768|NCT02099110|466628448|FG003|Overall Study|Death|0|||
129637769|NCT02099110|466628449|FG004|Overall Study|Death|0|||
129637770|NCT02099110|466628445|FG000|Overall Study|Screen failure|0|||
129637771|NCT02099110|466628446|FG001|Overall Study|Screen failure|0|||
129637772|NCT02099110|466628447|FG002|Overall Study|Screen failure|0|||
129637773|NCT02099110|466628448|FG003|Overall Study|Screen failure|0|||
129637774|NCT02099110|466628449|FG004|Overall Study|Screen failure|1|||
129637775|NCT02099110|466628445|FG000|Overall Study|Non-compliance with study drug|2|||
129637776|NCT02099110|466628446|FG001|Overall Study|Non-compliance with study drug|0|||
129637777|NCT02099110|466628447|FG002|Overall Study|Non-compliance with study drug|0|||
129637778|NCT02099110|466628448|FG003|Overall Study|Non-compliance with study drug|0|||
129637779|NCT02099110|466628449|FG004|Overall Study|Non-compliance with study drug|1|||
129637780|NCT02099110|466628445|FG000|Overall Study|Physician Decision|3|||
129637781|NCT02099110|466628446|FG001|Overall Study|Physician Decision|0|||
129637782|NCT02099110|466628447|FG002|Overall Study|Physician Decision|1|||
129637783|NCT02099110|466628448|FG003|Overall Study|Physician Decision|2|||
129637784|NCT02099110|466628449|FG004|Overall Study|Physician Decision|1|||
129637785|NCT02064816|466628450|FG000|Overall Study|Adverse Event|3|||
129637786|NCT02064816|466628451|FG001|Overall Study|Adverse Event|2|||
129637787|NCT02064816|466628450|FG000|Overall Study|Withdrawal by Subject|2|||
129637788|NCT02064816|466628451|FG001|Overall Study|Withdrawal by Subject|1|||
129442479|NCT03971422|465919202|FG000|Overall Study|Lack of Efficacy|5|||
129442480|NCT03971422|465919203|FG001|Overall Study|Lack of Efficacy|1|||
129442481|NCT03971422|465919204|FG002|Overall Study|Lack of Efficacy|1|||
129442482|NCT03971422|465919202|FG000|Overall Study|Adverse event, not fatal|2|||
129442483|NCT03971422|465919203|FG001|Overall Study|Adverse event, not fatal|2|||
129442484|NCT03971422|465919204|FG002|Overall Study|Adverse event, not fatal|5|||
129442485|NCT03971422|465919202|FG000|Overall Study|Worsening of MG Symptoms|1|||
129442486|NCT03971422|465919203|FG001|Overall Study|Worsening of MG Symptoms|4|||
129442487|NCT03971422|465919204|FG002|Overall Study|Worsening of MG Symptoms|2|||
129442488|NCT03971422|465919202|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
129442489|NCT03971422|465919203|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
129442490|NCT03971422|465919204|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
129442491|NCT03971422|465919202|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
129442492|NCT03971422|465919203|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
129442493|NCT03971422|465919204|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
129442494|NCT03971422|465919202|FG000|Overall Study|Due to COVID-19 pandemic|0|||
129442495|NCT03971422|465919203|FG001|Overall Study|Due to COVID-19 pandemic|1|||
129442496|NCT03971422|465919204|FG002|Overall Study|Due to COVID-19 pandemic|1|||
129442497|NCT04751656|465919207|FG000|Overall Study|Lost to Follow-up|1|||
129637789|NCT02064816|466628450|FG000|Overall Study|Lost to Follow-up|2|||
129637790|NCT02064816|466628451|FG001|Overall Study|Lost to Follow-up|1|||
129442498|NCT03566810|465919208|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
129442499|NCT03566810|465919209|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
129442500|NCT03566810|465919210|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
129442501|NCT03566810|465919211|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
129442502|NCT01955122|465919219|FG000|Overall Study|Physician Decision|5|||
129637791|NCT02064816|466628450|FG000|Overall Study|Therapeutic failure|0|||
129637792|NCT02064816|466628451|FG001|Overall Study|Therapeutic failure|1|||
129637793|NCT02064816|466628450|FG000|Overall Study|Other|1|||
129637794|NCT02064816|466628451|FG001|Overall Study|Other|3|||
129637795|NCT01732458|466628456|FG000|Overall Study|Lost to Follow-up|0|||
129637796|NCT01732458|466628457|FG001|Overall Study|Lost to Follow-up|2|||
129637797|NCT01732458|466628458|FG002|Overall Study|Lost to Follow-up|0|||
129637798|NCT01732458|466628459|FG003|Overall Study|Lost to Follow-up|0|||
129637799|NCT01732458|466628456|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129637800|NCT01732458|466628457|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129637801|NCT01732458|466628458|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129637802|NCT01732458|466628459|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129637803|NCT01732458|466628456|FG000|Overall Study|Physician Decision|1|||
129637804|NCT01732458|466628457|FG001|Overall Study|Physician Decision|2|||
129637805|NCT01732458|466628458|FG002|Overall Study|Physician Decision|2|||
129637806|NCT01732458|466628459|FG003|Overall Study|Physician Decision|0|||
129442503|NCT01955122|465919220|FG001|Overall Study|Physician Decision|5|||
129442504|NCT00826111|465919221|FG000|Overall Study|Lost to Follow-up|0|||
129442505|NCT00826111|465919222|FG001|Overall Study|Lost to Follow-up|1|||
129442506|NCT00826111|465919221|FG000|Overall Study|Protocol Violation|1|||
129442507|NCT00826111|465919222|FG001|Overall Study|Protocol Violation|0|||
129442508|NCT00826111|465919221|FG000|Overall Study|Withdrawal by Subject|5|||
129442509|NCT00826111|465919222|FG001|Overall Study|Withdrawal by Subject|0|||
129442510|NCT00826111|465919221|FG000|Overall Study|Physician Decision|1|||
129442511|NCT00826111|465919222|FG001|Overall Study|Physician Decision|1|||
129442512|NCT01672788|465919223|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
129442513|NCT01672788|465919224|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
129442514|NCT01672788|465919225|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
129442515|NCT01672788|465919226|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
129442516|NCT01117454|465919231|FG000|Overall Study|Pregnancy|0|||
129442517|NCT01117454|465919232|FG001|Overall Study|Pregnancy|1|||
129442518|NCT00888433|465919233|FG000|Overall Study|Withdrawal by Subject|1|||
129442519|NCT00888433|465919234|FG001|Overall Study|Withdrawal by Subject|2|||
129442520|NCT00888433|465919233|FG000|Overall Study|Missed Visit|2|||
129442521|NCT00888433|465919234|FG001|Overall Study|Missed Visit|1|||
129442522|NCT01681628|465919235|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
129442523|NCT01681628|465919236|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
129442524|NCT01681628|465919235|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
129442525|NCT01681628|465919236|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
129442526|NCT01681628|465919235|FG000|19 Months Follow-up|Death|1|||
129442527|NCT01681628|465919236|FG001|19 Months Follow-up|Death|0|||
129442528|NCT01681628|465919235|FG000|19 Months Follow-up|Lost to Follow-up|61|||
129442529|NCT01681628|465919236|FG001|19 Months Follow-up|Lost to Follow-up|43|||
129442530|NCT01637623|465919245|FG000|Overall Study|Lost to Follow-up|0|||
129442531|NCT01637623|465919246|FG001|Overall Study|Lost to Follow-up|0|||
129442532|NCT01637623|465919247|FG002|Overall Study|Lost to Follow-up|2|||
129442533|NCT01637623|465919245|FG000|Overall Study|Physician Decision|1|||
129442534|NCT01637623|465919246|FG001|Overall Study|Physician Decision|0|||
129442535|NCT01637623|465919247|FG002|Overall Study|Physician Decision|1|||
129442536|NCT02170389|465919250|FG000|Overall Study|Study terminated prior to start of treat|1|||
129442537|NCT01008696|465919252|FG000|Overall Study|Participant's evasion of hospital visit|5|||
129442538|NCT01008696|465919253|FG001|Overall Study|Participant's evasion of hospital visit|4|||
129442539|NCT01008696|465919252|FG000|Overall Study|Withdrawal by Subject|2|||
129442540|NCT01008696|465919253|FG001|Overall Study|Withdrawal by Subject|4|||
129442541|NCT01008696|465919252|FG000|Overall Study|Physician Decision|5|||
129637807|NCT01732458|466628456|FG000|Overall Study|Protocol Violation|2|||
129637808|NCT01732458|466628457|FG001|Overall Study|Protocol Violation|0|||
129637809|NCT01732458|466628458|FG002|Overall Study|Protocol Violation|0|||
129637810|NCT01732458|466628459|FG003|Overall Study|Protocol Violation|2|||
129637811|NCT01732458|466628456|FG000|Overall Study|Screen Failure|0|||
129637812|NCT01732458|466628457|FG001|Overall Study|Screen Failure|1|||
129637813|NCT01732458|466628458|FG002|Overall Study|Screen Failure|0|||
129637814|NCT01732458|466628459|FG003|Overall Study|Screen Failure|0|||
129637815|NCT00994461|466628460|FG000|Overall Study|Adverse Event|2|||
129637816|NCT00994461|466628461|FG001|Overall Study|Adverse Event|1|||
129637817|NCT00994461|466628462|FG002|Overall Study|Adverse Event|0|||
129637818|NCT02887248|466628468|FG000|Overall Study|Withdrawal by Subject|1|||
129637819|NCT02887248|466628468|FG000|Overall Study|Adverse Event|1|||
129637820|NCT02887248|466628468|FG000|Overall Study|Progressive Disease|1|||
129637821|NCT03759587|466628469|FG000|Overall Study|Adverse Event|5|||
129637822|NCT03759587|466628469|FG000|Overall Study|Progressive Disease|10|||
129637823|NCT03759587|466628469|FG000|Overall Study|Site Terminated by Sponsor|3|||
129637824|NCT03759587|466628469|FG000|Overall Study|Withdrawal by Subject|1|||
129637825|NCT00454363|466628472|FG000|Overall Study|Adverse Event|1|||
129637826|NCT00454363|466628473|FG001|Overall Study|Adverse Event|2|||
129637827|NCT00454363|466628472|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
129637828|NCT00454363|466628473|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
129637829|NCT00570063|466628474|FG000|Overall Study|Adverse Event|4|||
129442542|NCT01008696|465919253|FG001|Overall Study|Physician Decision|1|||
129637830|NCT00570063|466628475|FG001|Overall Study|Adverse Event|1|||
129637831|NCT00570063|466628474|FG000|Overall Study|Lack of Efficacy|0|||
129442543|NCT01008696|465919252|FG000|Overall Study|Adverse Event|1|||
129442544|NCT01008696|465919253|FG001|Overall Study|Adverse Event|0|||
129442545|NCT01008696|465919252|FG000|Overall Study|Participants' non-cooperation|2|||
129442546|NCT01008696|465919253|FG001|Overall Study|Participants' non-cooperation|3|||
129442547|NCT01008696|465919252|FG000|Overall Study|Other|2|||
129442548|NCT01008696|465919253|FG001|Overall Study|Other|3|||
129442549|NCT01008696|465919252|FG000|Overall Study|Other|0|||
129637832|NCT00570063|466628475|FG001|Overall Study|Lack of Efficacy|1|||
129637833|NCT00570063|466628474|FG000|Overall Study|Withdrawal by Subject|4|||
129637834|NCT00570063|466628475|FG001|Overall Study|Withdrawal by Subject|3|||
129637835|NCT00570063|466628474|FG000|Overall Study|Sponsor's Decision|7|||
129637836|NCT00570063|466628475|FG001|Overall Study|Sponsor's Decision|3|||
129637837|NCT00697463|466628476|FG000|Overall Study|Withdrawal by Subject|1|||
129637838|NCT03307252|466628477|FG000|Part 2, Period 1|Treatment not received|0|||
129637839|NCT03307252|466628478|FG001|Part 2, Period 1|Treatment not received|0|||
129637840|NCT03307252|466628479|FG002|Part 2, Period 1|Treatment not received|0|||
129637841|NCT03307252|466628480|FG003|Part 2, Period 1|Treatment not received|0|||
129637842|NCT03307252|466628481|FG004|Part 2, Period 1|Treatment not received|0|||
129637843|NCT03307252|466628482|FG005|Part 2, Period 1|Treatment not received|1|||
129637844|NCT03307252|466628483|FG006|Part 2, Period 1|Treatment not received|0|||
129637845|NCT03307252|466628484|FG007|Part 2, Period 1|Treatment not received|0|||
129637846|NCT03307252|466628485|FG008|Part 2, Period 1|Treatment not received|0|||
129637847|NCT03307252|466628486|FG009|Part 2, Period 1|Treatment not received|0|||
129637848|NCT03307252|466628487|FG010|Part 2, Period 1|Treatment not received|0|||
129637849|NCT03307252|466628477|FG000|Part 2, Period 3|Other than listed|0|||
129637850|NCT03307252|466628478|FG001|Part 2, Period 3|Other than listed|0|||
129637851|NCT03307252|466628479|FG002|Part 2, Period 3|Other than listed|0|||
129637852|NCT03307252|466628480|FG003|Part 2, Period 3|Other than listed|0|||
129637853|NCT03307252|466628481|FG004|Part 2, Period 3|Other than listed|1|||
129637854|NCT03307252|466628482|FG005|Part 2, Period 3|Other than listed|0|||
129637855|NCT03307252|466628483|FG006|Part 2, Period 3|Other than listed|0|||
129637856|NCT03307252|466628484|FG007|Part 2, Period 3|Other than listed|0|||
129637857|NCT03307252|466628485|FG008|Part 2, Period 3|Other than listed|0|||
129442550|NCT01008696|465919253|FG001|Overall Study|Other|2|||
129637858|NCT03307252|466628486|FG009|Part 2, Period 3|Other than listed|0|||
129637859|NCT03307252|466628487|FG010|Part 2, Period 3|Other than listed|0|||
129637860|NCT03307252|466628477|FG000|Part 2, Period 4|Other than listed|0|||
129637861|NCT03307252|466628478|FG001|Part 2, Period 4|Other than listed|0|||
129637862|NCT03307252|466628479|FG002|Part 2, Period 4|Other than listed|0|||
129637863|NCT03307252|466628480|FG003|Part 2, Period 4|Other than listed|0|||
129637864|NCT03307252|466628481|FG004|Part 2, Period 4|Other than listed|0|||
129637865|NCT03307252|466628482|FG005|Part 2, Period 4|Other than listed|0|||
129637866|NCT03307252|466628483|FG006|Part 2, Period 4|Other than listed|1|||
129637867|NCT03307252|466628484|FG007|Part 2, Period 4|Other than listed|0|||
129637868|NCT03307252|466628485|FG008|Part 2, Period 4|Other than listed|0|||
129637869|NCT03307252|466628486|FG009|Part 2, Period 4|Other than listed|0|||
129637870|NCT03307252|466628487|FG010|Part 2, Period 4|Other than listed|0|||
129637871|NCT03307252|466628477|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637872|NCT03307252|466628478|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637873|NCT03307252|466628479|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637874|NCT03307252|466628480|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637875|NCT03307252|466628481|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637876|NCT03307252|466628482|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637877|NCT03307252|466628483|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637878|NCT03307252|466628484|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637879|NCT03307252|466628485|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637880|NCT03307252|466628486|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
129637881|NCT03307252|466628487|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
129637882|NCT03482453|466628488|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637883|NCT03482453|466628489|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637884|NCT03482453|466628490|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637885|NCT03482453|466628491|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637886|NCT03482453|466628492|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637887|NCT03482453|466628493|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129442551|NCT01054144|465919254|FG000|Overall Study|Death|2|||
129442552|NCT04263909|465919256|FG000|Overall Study|Physician Decision|1|||
129442553|NCT04263909|465919257|FG001|Overall Study|Physician Decision|0|||
129637888|NCT03482453|466628494|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637889|NCT03482453|466628495|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637890|NCT03482453|466628496|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637891|NCT03482453|466628497|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637892|NCT03482453|466628498|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
129637893|NCT03482453|466628499|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
129637894|NCT02568189|466628500|FG000|Overall Study|Protocol Violation|0|||
129637895|NCT02568189|466628501|FG001|Overall Study|Protocol Violation|0|||
129637896|NCT02568189|466628502|FG002|Overall Study|Protocol Violation|19|||
129637897|NCT02568189|466628503|FG003|Overall Study|Protocol Violation|18|||
129637898|NCT02157376|466628504|FG000|Overall Study|Death|10|||
129637899|NCT02157376|466628505|FG001|Overall Study|Death|4|||
129637900|NCT02157376|466628504|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129637901|NCT02157376|466628505|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129637902|NCT02157376|466628504|FG000|Overall Study|Withdrawal by Subject|3|||
129442554|NCT04263909|465919258|FG002|Overall Study|Physician Decision|0|||
129637903|NCT02157376|466628505|FG001|Overall Study|Withdrawal by Subject|8|||
129442555|NCT04263909|465919256|FG000|Overall Study|Adverse Event|3|||
129442556|NCT04263909|465919257|FG001|Overall Study|Adverse Event|0|||
129442557|NCT04263909|465919258|FG002|Overall Study|Adverse Event|0|||
129442558|NCT04263909|465919256|FG000|Overall Study|Protocol Violation|5|||
129442559|NCT04263909|465919257|FG001|Overall Study|Protocol Violation|0|||
129442560|NCT04263909|465919258|FG002|Overall Study|Protocol Violation|0|||
129442561|NCT03118674|465919259|FG000|Overall Study|Lost to Follow-up|2|||
129442562|NCT03118674|465919259|FG000|Overall Study|Screen Faliure|8|||
129442563|NCT03118674|465919259|FG000|Overall Study|Withdrawal by Subject|5|||
129442564|NCT01067326|465919264|FG000|Overall Study|Adverse Event|0|||
129442565|NCT01067326|465919265|FG001|Overall Study|Adverse Event|2|||
129442566|NCT01067326|465919264|FG000|Overall Study|Withdrawal by Subject|1|||
129442567|NCT01067326|465919265|FG001|Overall Study|Withdrawal by Subject|0|||
129442568|NCT01067326|465919264|FG000|Overall Study|Early Study Termination|1|||
129442569|NCT01067326|465919265|FG001|Overall Study|Early Study Termination|1|||
129442570|NCT01230788|465919272|FG000|Overall Study|Prescribed exclusion drug|1|||
129442571|NCT00769860|465919273|FG000|Overall Study|Withdrawal by Subject|2|||
129442572|NCT00769860|465919274|FG001|Overall Study|Withdrawal by Subject|0|||
129442573|NCT01603082|465919275|FG000|Overall Study|Adverse Event|0|||
129442574|NCT01603082|465919276|FG001|Overall Study|Adverse Event|1|||
129442575|NCT01603082|465919275|FG000|Overall Study|Withdrawal by Subject|1|||
129442576|NCT01603082|465919276|FG001|Overall Study|Withdrawal by Subject|0|||
129442577|NCT01603082|465919275|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
129442578|NCT01603082|465919276|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
129442579|NCT01699789|465919279|FG000|Overall Study|Withdrawal by Subject|18|||
129442580|NCT01699789|465919280|FG001|Overall Study|Withdrawal by Subject|23|||
129442581|NCT01699789|465919279|FG000|Overall Study|Death|1|||
129442582|NCT01699789|465919280|FG001|Overall Study|Death|2|||
129442583|NCT01699789|465919279|FG000|Overall Study|Lost to Follow-up|83|||
129637904|NCT02157376|466628504|FG000|Overall Study|Not treated|8|||
129637905|NCT02157376|466628505|FG001|Overall Study|Not treated|3|||
129637906|NCT02157376|466628504|FG000|Overall Study|Investigator's misjudgement|1|||
129637907|NCT02157376|466628505|FG001|Overall Study|Investigator's misjudgement|2|||
129637908|NCT01074268|466628508|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
129637909|NCT01074268|466628509|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
129637910|NCT01074268|466628508|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
129637911|NCT01074268|466628509|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
129637912|NCT01074268|466628508|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
129637913|NCT01074268|466628509|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
129637914|NCT01074268|466628508|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
129637915|NCT01074268|466628509|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
129637916|NCT01074268|466628508|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
129637917|NCT01074268|466628509|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
129637918|NCT01074268|466628508|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
129637919|NCT01074268|466628509|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
129637920|NCT01074268|466628508|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
129637921|NCT01074268|466628509|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
129637922|NCT01074268|466628508|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
129637923|NCT01074268|466628509|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
129637924|NCT01074268|466628508|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
129637925|NCT01074268|466628509|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
129637926|NCT01578239|466628510|FG000|Treatment Period|Progressive Disease|19|||
129637927|NCT01578239|466628511|FG001|Treatment Period|Progressive Disease|64|||
129637928|NCT01578239|466628510|FG000|Treatment Period|Physician Decision|17|||
129637929|NCT01578239|466628511|FG001|Treatment Period|Physician Decision|17|||
129637930|NCT01578239|466628510|FG000|Treatment Period|Adverse Event|13|||
129637931|NCT01578239|466628511|FG001|Treatment Period|Adverse Event|10|||
129637932|NCT01578239|466628510|FG000|Treatment Period|Non-compliance|2|||
129637933|NCT01578239|466628511|FG001|Treatment Period|Non-compliance|0|||
129637934|NCT01578239|466628510|FG000|Treatment Period|Withdrawal by Subject|10|||
129637935|NCT01578239|466628511|FG001|Treatment Period|Withdrawal by Subject|9|||
129637936|NCT01578239|466628510|FG000|Treatment Period|Other|6|||
129637937|NCT01578239|466628511|FG001|Treatment Period|Other|1|||
129637938|NCT01578239|466628510|FG000|Long-term Follow-Up Period|Death|69|||
129889467|NCT00946647|467552607|FG001|Phase ll Part|Withdrawal by Subject|0|||
129889468|NCT00946647|467552608|FG002|Phase ll Part|Withdrawal by Subject|0|||
129442584|NCT01699789|465919280|FG001|Overall Study|Lost to Follow-up|101|||
129889469|NCT00946647|467552609|FG003|Phase ll Part|Withdrawal by Subject|8|||
129442585|NCT01906346|465919281|FG000|Overall Study|AEs|1|||
129442586|NCT01323621|465919282|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
129442587|NCT01323621|465919283|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
129442588|NCT01323621|465919284|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
129637939|NCT01578239|466628511|FG001|Long-term Follow-Up Period|Death|64|||
129637940|NCT01578239|466628510|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
129637941|NCT01578239|466628511|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
129637942|NCT01578239|466628510|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
129637943|NCT01578239|466628511|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
129637944|NCT01578239|466628510|FG000|Long-term Follow-Up Period|Other|2|||
129637945|NCT01578239|466628511|FG001|Long-term Follow-Up Period|Other|2|||
129637946|NCT02347813|466628517|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
129637947|NCT02347813|466628518|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
129637948|NCT02347813|466628517|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
129637949|NCT02347813|466628518|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
129637950|NCT02837731|466628521|FG000|Allocation|Admitted to General Floor|3|||
129637951|NCT02837731|466628522|FG001|Allocation|Admitted to General Floor|4|||
129637952|NCT02837731|466628521|FG000|Allocation|Immediate surgery/withdrew|2|||
129637953|NCT02837731|466628522|FG001|Allocation|Immediate surgery/withdrew|0|||
129637954|NCT02837731|466628521|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
129637955|NCT02837731|466628522|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
129637956|NCT02837731|466628521|FG000|Allocation|Withdrawal by Subject|2|||
129637957|NCT02837731|466628522|FG001|Allocation|Withdrawal by Subject|0|||
129637958|NCT02837731|466628521|FG000|Allocation|Device not available|1|||
129637959|NCT02837731|466628522|FG001|Allocation|Device not available|0|||
129637960|NCT02837731|466628521|FG000|Allocation|Protocol not implemented|7|||
129637961|NCT02837731|466628522|FG001|Allocation|Protocol not implemented|0|||
129637962|NCT02837731|466628521|FG000|Allocation|Moribund/Do not resuscitate|2|||
129637963|NCT02837731|466628522|FG001|Allocation|Moribund/Do not resuscitate|0|||
129637964|NCT02837731|466628521|FG000|Allocation|Did not meet sepsis criteria|1|||
129637965|NCT02837731|466628522|FG001|Allocation|Did not meet sepsis criteria|2|||
129637966|NCT02837731|466628521|FG000|Allocation|Known aortic abnormalities|0|||
129637967|NCT02837731|466628522|FG001|Allocation|Known aortic abnormalities|1|||
129637968|NCT01119859|466628523|FG000|Overall Study|Adverse Event|9|||
129637969|NCT01119859|466628524|FG001|Overall Study|Adverse Event|10|||
129637970|NCT01119859|466628523|FG000|Overall Study|Death|2|||
129637971|NCT01119859|466628524|FG001|Overall Study|Death|0|||
129637972|NCT01119859|466628523|FG000|Overall Study|Insufficient therapeutic response|7|||
129637973|NCT01119859|466628524|FG001|Overall Study|Insufficient therapeutic response|14|||
129637974|NCT01119859|466628523|FG000|Overall Study|Refused treatment|3|||
129637975|NCT01119859|466628524|FG001|Overall Study|Refused treatment|6|||
129637976|NCT01119859|466628523|FG000|Overall Study|Failure to return|3|||
129637977|NCT01119859|466628524|FG001|Overall Study|Failure to return|0|||
129637978|NCT04200651|466628525|FG000|Overall Study|Moved to another country during follow-up|2|||
129637979|NCT04200651|466628526|FG001|Overall Study|Moved to another country during follow-up|2|||
129637980|NCT04200651|466628525|FG000|Overall Study|Lost to Follow-up|1|||
129637981|NCT04200651|466628526|FG001|Overall Study|Lost to Follow-up|3|||
129637982|NCT03225105|466628527|FG000|Overall Study|Withdrawal by Subject|1|||
129637983|NCT03225105|466628528|FG001|Overall Study|Withdrawal by Subject|0|||
129637984|NCT03225105|466628529|FG002|Overall Study|Withdrawal by Subject|0|||
129637985|NCT03225105|466628530|FG003|Overall Study|Withdrawal by Subject|0|||
129637986|NCT03225105|466628527|FG000|Overall Study|Death|0|||
129637987|NCT03225105|466628528|FG001|Overall Study|Death|4|||
129637988|NCT03225105|466628529|FG002|Overall Study|Death|2|||
129637989|NCT03225105|466628530|FG003|Overall Study|Death|0|||
129637990|NCT03225105|466628527|FG000|Overall Study|Study termination per Sponsor Decision|2|||
129637991|NCT03225105|466628528|FG001|Overall Study|Study termination per Sponsor Decision|0|||
129637992|NCT03225105|466628529|FG002|Overall Study|Study termination per Sponsor Decision|3|||
129637993|NCT03225105|466628530|FG003|Overall Study|Study termination per Sponsor Decision|3|||
129637994|NCT02887183|466628532|FG000|Overall Study|Adverse Event|44|||
129637995|NCT02887183|466628532|FG000|Overall Study|Death|30|||
129637996|NCT02887183|466628532|FG000|Overall Study|Pregnancy|1|||
129637997|NCT02887183|466628532|FG000|Overall Study|Protocol Violation|6|||
129637998|NCT02887183|466628532|FG000|Overall Study|Technical Problems|2|||
129637999|NCT02887183|466628532|FG000|Overall Study|Lost to Follow-up|13|||
129638000|NCT02887183|466628532|FG000|Overall Study|Physician Decision|10|||
129638001|NCT02887183|466628532|FG000|Overall Study|Withdrawal by Subject|35|||
129638002|NCT01031680|466628533|FG000|Overall Study|Adverse Event|8|||
129638003|NCT01031680|466628534|FG001|Overall Study|Adverse Event|3|||
129638004|NCT01031680|466628533|FG000|Overall Study|Lost to Follow-up|2|||
129638005|NCT01031680|466628534|FG001|Overall Study|Lost to Follow-up|10|||
129638006|NCT01031680|466628533|FG000|Overall Study|Withdrawal by Subject|12|||
129638007|NCT01031680|466628534|FG001|Overall Study|Withdrawal by Subject|16|||
129638008|NCT01031680|466628533|FG000|Overall Study|Death|2|||
129638009|NCT01031680|466628534|FG001|Overall Study|Death|1|||
129638010|NCT01031680|466628533|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
129638011|NCT01031680|466628534|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
129638012|NCT01031680|466628533|FG000|Overall Study|Poor/Non-compliance|5|||
129638013|NCT01031680|466628534|FG001|Overall Study|Poor/Non-compliance|6|||
129638014|NCT01031680|466628533|FG000|Overall Study|Safety|1|||
129638015|NCT01031680|466628534|FG001|Overall Study|Safety|0|||
129638016|NCT01031680|466628533|FG000|Overall Study|Incorrect Enrolment|1|||
129638017|NCT01031680|466628534|FG001|Overall Study|Incorrect Enrolment|2|||
129638018|NCT01031680|466628533|FG000|Overall Study|Administrative Reason by Sponsor|0|||
129638019|NCT01031680|466628534|FG001|Overall Study|Administrative Reason by Sponsor|1|||
129638020|NCT01031680|466628533|FG000|Overall Study|Various|0|||
129638021|NCT01031680|466628534|FG001|Overall Study|Various|2|||
129638022|NCT02654977|466628539|FG000|Overall Study|Death|1|||
129638023|NCT02654977|466628539|FG000|Overall Study|Lost to Follow-up|1|||
129638024|NCT02654977|466628539|FG000|Overall Study|Adverse Event|1|||
129638025|NCT02654977|466628539|FG000|Overall Study|Withdrawal by Subject|1|||
129638026|NCT02654977|466628539|FG000|Overall Study|Lack of Efficacy|3|||
129638027|NCT01921101|466628540|FG000|Overall Study|Death|16|||
129638028|NCT01921101|466628541|FG001|Overall Study|Death|6|||
129638029|NCT01483027|466628542|FG000|Overall Study|Administrative Reasons|2|||
129638030|NCT01483027|466628543|FG001|Overall Study|Administrative Reasons|1|||
129638031|NCT01483027|466628542|FG000|Overall Study|Withdrawal by Subject|21|||
129638032|NCT01483027|466628543|FG001|Overall Study|Withdrawal by Subject|32|||
129638033|NCT01483027|466628542|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
129638034|NCT01483027|466628543|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
129638035|NCT01483027|466628542|FG000|Overall Study|Lost to Follow-up|1|||
129638036|NCT01483027|466628543|FG001|Overall Study|Lost to Follow-up|1|||
129638037|NCT01483027|466628542|FG000|Overall Study|Adverse Event|0|||
129638038|NCT01483027|466628543|FG001|Overall Study|Adverse Event|1|||
129638039|NCT01483027|466628542|FG000|Overall Study|Withdrawal by Subject|0|||
129638040|NCT01483027|466628543|FG001|Overall Study|Withdrawal by Subject|1|||
129638041|NCT03691207|466629749|FG000|Overall Study|Death|41|||
129638042|NCT03691207|466629750|FG001|Overall Study|Death|26|||
129638043|NCT03691207|466629749|FG000|Overall Study|Lost to Follow-up|1|||
129638044|NCT03691207|466629750|FG001|Overall Study|Lost to Follow-up|1|||
129638045|NCT03691207|466629749|FG000|Overall Study|Withdrawal by Subject|2|||
129638046|NCT03691207|466629750|FG001|Overall Study|Withdrawal by Subject|8|||
129638047|NCT03691207|466629749|FG000|Overall Study|Sponsor decision|1|||
129638048|NCT03691207|466629750|FG001|Overall Study|Sponsor decision|7|||
129638049|NCT01288937|466629753|FG000|Overall Study|Adverse Event|1|||
129638050|NCT01288937|466629754|FG001|Overall Study|Adverse Event|0|||
129638051|NCT02490371|466629755|FG000|Overall Study|Lost to Follow-up|1|||
129638052|NCT02490371|466629756|FG001|Overall Study|Lost to Follow-up|1|||
129638053|NCT00610155|466629757|FG000|Period 1|Withdrawal by Subject|0|||
129638054|NCT00610155|466629758|FG001|Period 1|Withdrawal by Subject|0|||
129638055|NCT00610155|466629759|FG002|Period 1|Withdrawal by Subject|1|||
129638056|NCT00610155|466629760|FG003|Period 1|Withdrawal by Subject|0|||
129638057|NCT00610155|466629761|FG004|Period 1|Withdrawal by Subject|0|||
129638058|NCT00610155|466629762|FG005|Period 1|Withdrawal by Subject|0|||
129442589|NCT01323621|465919282|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
129442590|NCT01323621|465919283|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
129442591|NCT01323621|465919284|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
129442592|NCT01323621|465919282|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
129442593|NCT01323621|465919283|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
129442594|NCT01323621|465919284|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
129442595|NCT01323621|465919282|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
129442596|NCT01323621|465919283|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
129442597|NCT01323621|465919284|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
129442598|NCT01323621|465919282|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
129442599|NCT01323621|465919283|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
129442600|NCT01323621|465919284|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
129442601|NCT01323621|465919282|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
129638059|NCT00610155|466629757|FG000|Period 3|Adverse Event|1|||
129638060|NCT00610155|466629758|FG001|Period 3|Adverse Event|0|||
129638061|NCT00610155|466629759|FG002|Period 3|Adverse Event|0|||
129638062|NCT00610155|466629760|FG003|Period 3|Adverse Event|0|||
129638063|NCT00610155|466629761|FG004|Period 3|Adverse Event|0|||
129638064|NCT00610155|466629762|FG005|Period 3|Adverse Event|0|||
129638065|NCT01718535|466629763|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
129638066|NCT01718535|466629764|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
129638067|NCT01718535|466629765|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
129638068|NCT01718535|466629766|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
129638069|NCT01718535|466629767|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
129638070|NCT01718535|466629768|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
129638071|NCT01718535|466629769|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
129638072|NCT01718535|466629770|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
129638073|NCT01718535|466629771|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
129638074|NCT01718535|466629772|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
129638075|NCT03018080|466629778|FG000|Overall Study|Death|12|||
129638076|NCT03018080|466629779|FG001|Overall Study|Death|19|||
129638077|NCT00740792|466629780|FG000|Overall Study|Adverse Event|3|||
129638078|NCT00740792|466629781|FG001|Overall Study|Adverse Event|1|||
129442602|NCT01323621|465919283|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
129442603|NCT01323621|465919284|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
129442604|NCT01323621|465919282|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
129442605|NCT01323621|465919283|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
129442606|NCT01323621|465919284|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
129442607|NCT01323621|465919282|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
129442608|NCT01323621|465919283|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
129442609|NCT01323621|465919284|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
129442610|NCT01323621|465919282|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
129442611|NCT01323621|465919283|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
129638079|NCT00740792|466629782|FG002|Overall Study|Adverse Event|1|||
129638080|NCT00740792|466629783|FG003|Overall Study|Adverse Event|3|||
129638081|NCT00740792|466629780|FG000|Overall Study|Lack of Efficacy|1|||
129638082|NCT00740792|466629781|FG001|Overall Study|Lack of Efficacy|1|||
129638083|NCT00740792|466629782|FG002|Overall Study|Lack of Efficacy|0|||
129638084|NCT00740792|466629783|FG003|Overall Study|Lack of Efficacy|3|||
129638085|NCT00740792|466629780|FG000|Overall Study|Lost to Follow-up|2|||
129638086|NCT00740792|466629781|FG001|Overall Study|Lost to Follow-up|1|||
129638087|NCT00740792|466629782|FG002|Overall Study|Lost to Follow-up|0|||
129638088|NCT00740792|466629783|FG003|Overall Study|Lost to Follow-up|0|||
129442612|NCT01323621|465919284|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
129442613|NCT01323621|465919282|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129442614|NCT01323621|465919283|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129442615|NCT01323621|465919284|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129442616|NCT01323621|465919282|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
129442617|NCT01323621|465919283|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
129442618|NCT01323621|465919284|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
129442619|NCT01323621|465919282|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129442620|NCT01323621|465919283|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
129442621|NCT01323621|465919284|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
129442622|NCT04226833|465919285|FG000|Overall Study|Death|0|||
129442623|NCT04226833|465919286|FG001|Overall Study|Death|0|||
129442624|NCT04226833|465919287|FG002|Overall Study|Death|1|||
129442625|NCT04226833|465919288|FG003|Overall Study|Death|0|||
129442626|NCT02876835|465919291|FG000|Treatment Period (51.1 Month)|Other|1|||
129442627|NCT02876835|465919292|FG001|Treatment Period (51.1 Month)|Other|0|||
129442628|NCT02876835|465919291|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
129442629|NCT02876835|465919292|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
129442630|NCT02876835|465919291|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
129442631|NCT02876835|465919292|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
129442632|NCT02876835|465919291|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
129442633|NCT02876835|465919292|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
129442634|NCT02540538|465919294|FG000|Overall Study|Pregnancy|0|||
129442635|NCT02540538|465919295|FG001|Overall Study|Pregnancy|1|||
129442636|NCT02540538|465919296|FG002|Overall Study|Pregnancy|0|||
129442637|NCT01557348|465919302|FG000|Overall Study|Adverse Event|6|||
129442638|NCT01557348|465919303|FG001|Overall Study|Adverse Event|16|||
129442639|NCT01557348|465919302|FG000|Overall Study|Infusion reaction event|5|||
129442640|NCT01557348|465919303|FG001|Overall Study|Infusion reaction event|5|||
129442641|NCT01557348|465919302|FG000|Overall Study|Death|7|||
129442642|NCT01557348|465919303|FG001|Overall Study|Death|4|||
129442643|NCT01557348|465919302|FG000|Overall Study|Insufficient Therapeutic Response|13|||
129442644|NCT01557348|465919303|FG001|Overall Study|Insufficient Therapeutic Response|28|||
129442645|NCT01557348|465919302|FG000|Overall Study|Withdrawal by Subject|5|||
129442646|NCT01557348|465919303|FG001|Overall Study|Withdrawal by Subject|4|||
129442647|NCT01557348|465919302|FG000|Overall Study|Lost to Follow-up|26|||
129442648|NCT01557348|465919303|FG001|Overall Study|Lost to Follow-up|22|||
129442649|NCT01557348|465919302|FG000|Overall Study|Administrative|18|||
129442650|NCT01557348|465919303|FG001|Overall Study|Administrative|11|||
129442651|NCT01891721|465919304|FG000|Overall Study|Lost to Follow-up|10|||
129442652|NCT01891721|465919305|FG001|Overall Study|Lost to Follow-up|5|||
129442653|NCT01891721|465919306|FG002|Overall Study|Lost to Follow-up|1|||
129442654|NCT02000427|465919307|FG000|Overall Study|Death|22|||
129442655|NCT04343248|465919308|FG000|Overall Study|Withdrawal by Subject|5|||
129638089|NCT00740792|466629780|FG000|Overall Study|Protocol Violation|0|||
129638090|NCT00740792|466629781|FG001|Overall Study|Protocol Violation|1|||
129442656|NCT04343248|465919309|FG001|Overall Study|Withdrawal by Subject|6|||
129442657|NCT04343248|465919308|FG000|Overall Study|Death|1|||
129442658|NCT04343248|465919309|FG001|Overall Study|Death|2|||
129442659|NCT04343248|465919308|FG000|Overall Study|Lost to Follow-up|9|||
129638091|NCT00740792|466629782|FG002|Overall Study|Protocol Violation|0|||
129638092|NCT00740792|466629783|FG003|Overall Study|Protocol Violation|2|||
129638093|NCT00740792|466629780|FG000|Overall Study|Withdrawal by Subject|1|||
129704958|NCT05067335|466884100|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
129638094|NCT00740792|466629781|FG001|Overall Study|Withdrawal by Subject|1|||
129638095|NCT00740792|466629782|FG002|Overall Study|Withdrawal by Subject|0|||
129638096|NCT00740792|466629783|FG003|Overall Study|Withdrawal by Subject|0|||
129638097|NCT00740792|466629780|FG000|Overall Study|administrative|3|||
129638098|NCT00740792|466629781|FG001|Overall Study|administrative|3|||
129638099|NCT00740792|466629782|FG002|Overall Study|administrative|8|||
129638100|NCT00740792|466629783|FG003|Overall Study|administrative|2|||
129638101|NCT00179660|466629784|FG000|Overall Study|Adverse Event|7|||
129638102|NCT00179660|466629784|FG000|Overall Study|Lack of therapeutic effect|28|||
129638103|NCT00179660|466629784|FG000|Overall Study|Withdrawal by Subject|2|||
129638104|NCT00179660|466629784|FG000|Overall Study|Lost to Follow-up|1|||
129638105|NCT00179660|466629784|FG000|Overall Study|Death|3|||
129638106|NCT00179660|466629784|FG000|Overall Study|Other - Unspecified|9|||
129638107|NCT02035202|466629787|FG000|Overall Study|Lost to Follow-up|8|||
129638108|NCT02035202|466629788|FG001|Overall Study|Lost to Follow-up|16|||
129638109|NCT02035202|466629789|FG002|Overall Study|Lost to Follow-up|2|||
129638110|NCT00178685|466629790|FG000|Overall Study|Death|3|||
129638111|NCT00178685|466629791|FG001|Overall Study|Death|3|||
129442660|NCT04343248|465919309|FG001|Overall Study|Lost to Follow-up|6|||
129638112|NCT00178685|466629792|FG002|Overall Study|Death|6|||
129638113|NCT00178685|466629790|FG000|Overall Study|Lost to Follow-up|100|||
129638114|NCT00178685|466629791|FG001|Overall Study|Lost to Follow-up|187|||
129638115|NCT00178685|466629792|FG002|Overall Study|Lost to Follow-up|183|||
129638116|NCT00178685|466629790|FG000|Overall Study|Withdrawal by Subject|8|||
129638117|NCT00178685|466629791|FG001|Overall Study|Withdrawal by Subject|14|||
129442661|NCT04343248|465919308|FG000|Overall Study|Physician Decision|0|||
129442662|NCT04343248|465919309|FG001|Overall Study|Physician Decision|1|||
129442663|NCT04343248|465919308|FG000|Overall Study|Adverse Event|1|||
129638118|NCT00178685|466629792|FG002|Overall Study|Withdrawal by Subject|7|||
129638119|NCT00267969|466629804|FG000|Controlled Period|Adverse Event|6|||
129638120|NCT00267969|466629805|FG001|Controlled Period|Adverse Event|0|||
129638121|NCT00267969|466629806|FG002|Controlled Period|Adverse Event|2|||
129638122|NCT00267969|466629807|FG003|Controlled Period|Adverse Event|0|||
129638123|NCT00267969|466629808|FG004|Controlled Period|Adverse Event|0|||
129638124|NCT00267969|466629809|FG005|Controlled Period|Adverse Event|0|||
129638125|NCT00267969|466629810|FG006|Controlled Period|Adverse Event|0|||
129638126|NCT00267969|466629804|FG000|Controlled Period|Lack of Efficacy|3|||
129638127|NCT00267969|466629805|FG001|Controlled Period|Lack of Efficacy|0|||
129638128|NCT00267969|466629806|FG002|Controlled Period|Lack of Efficacy|1|||
129638129|NCT00267969|466629807|FG003|Controlled Period|Lack of Efficacy|0|||
129638130|NCT00267969|466629808|FG004|Controlled Period|Lack of Efficacy|0|||
129638131|NCT00267969|466629809|FG005|Controlled Period|Lack of Efficacy|0|||
129638132|NCT00267969|466629810|FG006|Controlled Period|Lack of Efficacy|0|||
129638133|NCT00267969|466629804|FG000|Controlled Period|Lost to Follow-up|1|||
129638134|NCT00267969|466629805|FG001|Controlled Period|Lost to Follow-up|0|||
129638135|NCT00267969|466629806|FG002|Controlled Period|Lost to Follow-up|1|||
129638136|NCT00267969|466629807|FG003|Controlled Period|Lost to Follow-up|0|||
129638137|NCT00267969|466629808|FG004|Controlled Period|Lost to Follow-up|0|||
129638138|NCT00267969|466629809|FG005|Controlled Period|Lost to Follow-up|0|||
129638139|NCT00267969|466629810|FG006|Controlled Period|Lost to Follow-up|0|||
129638140|NCT00267969|466629804|FG000|Controlled Period|Randomized but not treated|0|||
129638141|NCT00267969|466629805|FG001|Controlled Period|Randomized but not treated|0|||
129638142|NCT00267969|466629806|FG002|Controlled Period|Randomized but not treated|1|||
129638143|NCT00267969|466629807|FG003|Controlled Period|Randomized but not treated|0|||
129638144|NCT00267969|466629808|FG004|Controlled Period|Randomized but not treated|0|||
129442664|NCT04343248|465919309|FG001|Overall Study|Adverse Event|0|||
129442665|NCT02708095|465919310|FG000|Overall Study|Adverse Event|4|||
129442666|NCT02708095|465919311|FG001|Overall Study|Adverse Event|10|||
129442667|NCT02708095|465919312|FG002|Overall Study|Adverse Event|11|||
129638145|NCT00267969|466629809|FG005|Controlled Period|Randomized but not treated|0|||
129638146|NCT00267969|466629810|FG006|Controlled Period|Randomized but not treated|0|||
129638147|NCT00267969|466629804|FG000|Controlled Period|Other|2|||
129638148|NCT00267969|466629805|FG001|Controlled Period|Other|1|||
129638149|NCT00267969|466629806|FG002|Controlled Period|Other|6|||
129638150|NCT00267969|466629807|FG003|Controlled Period|Other|0|||
129638151|NCT00267969|466629808|FG004|Controlled Period|Other|0|||
129638152|NCT00267969|466629809|FG005|Controlled Period|Other|0|||
129638153|NCT00267969|466629810|FG006|Controlled Period|Other|0|||
129638154|NCT00267969|466629804|FG000|After Controlled Period|Adverse Event|0|||
129638155|NCT00267969|466629805|FG001|After Controlled Period|Adverse Event|0|||
129638156|NCT00267969|466629806|FG002|After Controlled Period|Adverse Event|0|||
129638157|NCT00267969|466629807|FG003|After Controlled Period|Adverse Event|7|||
129638158|NCT00267969|466629808|FG004|After Controlled Period|Adverse Event|8|||
129638159|NCT00267969|466629809|FG005|After Controlled Period|Adverse Event|23|||
129442668|NCT02708095|465919310|FG000|Overall Study|Lack of Efficacy|9|||
129442669|NCT02708095|465919311|FG001|Overall Study|Lack of Efficacy|3|||
129638160|NCT00267969|466629810|FG006|After Controlled Period|Adverse Event|21|||
129638161|NCT00267969|466629804|FG000|After Controlled Period|Death|0|||
129638162|NCT00267969|466629805|FG001|After Controlled Period|Death|0|||
129638163|NCT00267969|466629806|FG002|After Controlled Period|Death|0|||
129638164|NCT00267969|466629807|FG003|After Controlled Period|Death|1|||
129638165|NCT00267969|466629808|FG004|After Controlled Period|Death|2|||
129638166|NCT00267969|466629809|FG005|After Controlled Period|Death|0|||
129638167|NCT00267969|466629810|FG006|After Controlled Period|Death|1|||
129638168|NCT00267969|466629804|FG000|After Controlled Period|Lack of Efficacy|0|||
129638169|NCT00267969|466629805|FG001|After Controlled Period|Lack of Efficacy|0|||
129638170|NCT00267969|466629806|FG002|After Controlled Period|Lack of Efficacy|0|||
129638171|NCT00267969|466629807|FG003|After Controlled Period|Lack of Efficacy|10|||
129638172|NCT00267969|466629808|FG004|After Controlled Period|Lack of Efficacy|6|||
129638173|NCT00267969|466629809|FG005|After Controlled Period|Lack of Efficacy|28|||
129638174|NCT00267969|466629810|FG006|After Controlled Period|Lack of Efficacy|15|||
129638175|NCT00267969|466629804|FG000|After Controlled Period|Lost to Follow-up|0|||
129638176|NCT00267969|466629805|FG001|After Controlled Period|Lost to Follow-up|0|||
129638177|NCT00267969|466629806|FG002|After Controlled Period|Lost to Follow-up|0|||
129638178|NCT00267969|466629807|FG003|After Controlled Period|Lost to Follow-up|5|||
129638179|NCT00267969|466629808|FG004|After Controlled Period|Lost to Follow-up|8|||
129638180|NCT00267969|466629809|FG005|After Controlled Period|Lost to Follow-up|9|||
129638181|NCT00267969|466629810|FG006|After Controlled Period|Lost to Follow-up|10|||
129638182|NCT00267969|466629804|FG000|After Controlled Period|Other|0|||
129638183|NCT00267969|466629805|FG001|After Controlled Period|Other|0|||
129638184|NCT00267969|466629806|FG002|After Controlled Period|Other|0|||
129638185|NCT00267969|466629807|FG003|After Controlled Period|Other|13|||
129638186|NCT00267969|466629808|FG004|After Controlled Period|Other|11|||
129638187|NCT00267969|466629809|FG005|After Controlled Period|Other|22|||
129638188|NCT00267969|466629810|FG006|After Controlled Period|Other|25|||
129638189|NCT01053663|466629814|FG000|Overall Study|Death|2|||
129638190|NCT01053663|466629814|FG000|Overall Study|Lost to Follow-up|1|||
129638191|NCT01053663|466629814|FG000|Overall Study|Poor IV Access|1|||
129638192|NCT01053663|466629814|FG000|Overall Study|Transferred to Another Hospital|1|||
129638193|NCT01053663|466629814|FG000|Overall Study|Negative Influenza Diagnosis|1|||
129638194|NCT03533114|466629815|FG000|Overall|Adverse Event|16|||
129638195|NCT03533114|466629816|FG001|Overall|Adverse Event|11|||
129638196|NCT03533114|466629815|FG000|Overall|Consent Withdrawal by Participant|7|||
129638197|NCT03533114|466629816|FG001|Overall|Consent Withdrawal by Participant|6|||
129638198|NCT03533114|466629815|FG000|Overall|Lack of Efficacy|5|||
129638199|NCT03533114|466629816|FG001|Overall|Lack of Efficacy|3|||
129638200|NCT03533114|466629815|FG000|Overall|Lost to Follow-up|1|||
129638201|NCT03533114|466629816|FG001|Overall|Lost to Follow-up|1|||
129638202|NCT03533114|466629815|FG000|Overall|Physician Decision|0|||
129638203|NCT03533114|466629816|FG001|Overall|Physician Decision|2|||
129638204|NCT03533114|466629815|FG000|Overall|Protocol deviation|1|||
129638205|NCT03533114|466629816|FG001|Overall|Protocol deviation|1|||
129638206|NCT03533114|466629815|FG000|Overall|Failure to meet randomization criteria|1|||
129638207|NCT03533114|466629816|FG001|Overall|Failure to meet randomization criteria|2|||
129638208|NCT03533114|466629815|FG000|Overall|Non-Compliance with study drug|0|||
129638209|NCT03533114|466629816|FG001|Overall|Non-Compliance with study drug|1|||
129638210|NCT03533114|466629815|FG000|Overall|Other|0|||
129638211|NCT03533114|466629816|FG001|Overall|Other|1|||
129638212|NCT03533114|466629815|FG000|Open Label Titration and Optimization|Adverse Event|11|||
129638213|NCT03533114|466629816|FG001|Open Label Titration and Optimization|Adverse Event|8|||
129638214|NCT03533114|466629815|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
129638215|NCT03533114|466629816|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
129638216|NCT03533114|466629815|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
129638217|NCT03533114|466629816|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
129638218|NCT03533114|466629815|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
129638219|NCT03533114|466629816|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
129638220|NCT03533114|466629815|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
129638221|NCT03533114|466629816|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
129638222|NCT03533114|466629815|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
129638223|NCT03533114|466629816|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
129638224|NCT03533114|466629815|FG000|Stable Dose|Adverse Event|0|||
129638225|NCT03533114|466629816|FG001|Stable Dose|Adverse Event|2|||
129638226|NCT03533114|466629815|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
129638227|NCT03533114|466629816|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
129638228|NCT03533114|466629815|FG000|Stable Dose|Lack of Efficacy|1|||
129638229|NCT03533114|466629816|FG001|Stable Dose|Lack of Efficacy|0|||
129638230|NCT03533114|466629815|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
129638231|NCT03533114|466629816|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
129638232|NCT03533114|466629815|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
129638233|NCT03533114|466629816|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
129638234|NCT03533114|466629815|FG000|Open-Label Safety Extension|Adverse Event|3|||
129638235|NCT03533114|466629816|FG001|Open-Label Safety Extension|Adverse Event|0|||
129638236|NCT03533114|466629815|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
129638237|NCT03533114|466629816|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
129638238|NCT03533114|466629815|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
129638239|NCT03533114|466629816|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
129638240|NCT03533114|466629815|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
129638241|NCT03533114|466629816|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
129638242|NCT03533114|466629815|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
129638243|NCT03533114|466629816|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
129638244|NCT01862250|466629817|FG000|Overall Study|Adverse Event|4|||
129638245|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
129638246|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
129638247|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
129638248|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
129638249|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
129638250|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
129638251|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
129638252|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
129638253|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
129638254|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
129638255|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
129638256|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
129638257|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
129638258|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
129638259|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129638260|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129638261|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129638262|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
129638263|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
129638264|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
129889470|NCT00946647|467552610|FG004|Phase ll Part|Withdrawal by Subject|6|||
129638265|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
129638266|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
129638267|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
129638268|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
129638269|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
129638270|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
129889471|NCT00946647|467552606|FG000|Phase ll Part|Administrative problems|0|||
129638271|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
129638272|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
129638273|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
129638274|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
129638275|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
129638276|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
129638277|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129638278|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129638279|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129638280|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
129638281|NCT02016105|466629818|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
129638282|NCT02016105|466629819|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
129638283|NCT02016105|466629820|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129638284|NCT02016105|466629821|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129638285|NCT02016105|466629822|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129638286|NCT02016105|466629823|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
129638287|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
129638288|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
129638289|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
129638290|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
129638291|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
129638292|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
129638293|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
129442670|NCT02708095|465919312|FG002|Overall Study|Lack of Efficacy|0|||
129638294|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
129638295|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
129638296|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
129638297|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
129638298|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
129638299|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
129638300|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
129638301|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
129638302|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
129638303|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
129638304|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
129638305|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Death|0|||
129638306|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Death|0|||
129638307|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Death|0|||
129638308|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Death|0|||
129638309|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Death|0|||
129638310|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Death|1|||
129638311|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
129638312|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
129638313|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
129638314|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
129638315|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
129638316|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
129638317|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
129638318|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
129638319|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
129638320|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
129638321|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
129638322|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
129442671|NCT02708095|465919310|FG000|Overall Study|Lost to Follow-up|2|||
129442672|NCT02708095|465919311|FG001|Overall Study|Lost to Follow-up|0|||
129442673|NCT02708095|465919312|FG002|Overall Study|Lost to Follow-up|0|||
129442674|NCT02708095|465919310|FG000|Overall Study|Physician Decision|2|||
129442675|NCT02708095|465919311|FG001|Overall Study|Physician Decision|3|||
129442676|NCT02708095|465919312|FG002|Overall Study|Physician Decision|2|||
129442677|NCT02708095|465919310|FG000|Overall Study|Protocol Violation|0|||
129442678|NCT02708095|465919311|FG001|Overall Study|Protocol Violation|0|||
129442679|NCT02708095|465919312|FG002|Overall Study|Protocol Violation|1|||
129638323|NCT02016105|466629818|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129638324|NCT02016105|466629819|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129638325|NCT02016105|466629820|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
129638326|NCT02016105|466629821|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129638327|NCT02016105|466629822|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
129638328|NCT02016105|466629823|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
129638329|NCT02016105|466629818|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
129638330|NCT02016105|466629819|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
129638331|NCT02016105|466629820|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
129638332|NCT02016105|466629821|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
129638333|NCT02016105|466629822|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
129638334|NCT02016105|466629823|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
129638335|NCT02016105|466629818|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
129638336|NCT02016105|466629819|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
129638337|NCT02016105|466629820|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
129638338|NCT02016105|466629821|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
129638339|NCT02016105|466629822|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
129638340|NCT02016105|466629823|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
129638341|NCT02016105|466629818|FG000|EXTENSION PERIOD|Adverse Event|0|||
129638342|NCT02016105|466629819|FG001|EXTENSION PERIOD|Adverse Event|0|||
129638343|NCT02016105|466629820|FG002|EXTENSION PERIOD|Adverse Event|2|||
129638344|NCT02016105|466629821|FG003|EXTENSION PERIOD|Adverse Event|0|||
129638345|NCT02016105|466629822|FG004|EXTENSION PERIOD|Adverse Event|1|||
129638346|NCT02016105|466629823|FG005|EXTENSION PERIOD|Adverse Event|0|||
129638347|NCT02016105|466629818|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
129638348|NCT02016105|466629819|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
129638349|NCT02016105|466629820|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
129638350|NCT02016105|466629821|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
129442680|NCT02708095|465919310|FG000|Overall Study|Withdrawal by Subject|5|||
129442681|NCT02708095|465919311|FG001|Overall Study|Withdrawal by Subject|3|||
129638351|NCT02016105|466629822|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
129442682|NCT02708095|465919312|FG002|Overall Study|Withdrawal by Subject|4|||
129638352|NCT02016105|466629823|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
129638353|NCT02016105|466629818|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
129638354|NCT02016105|466629819|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
129638355|NCT02016105|466629820|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
129638356|NCT02016105|466629821|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
129638357|NCT02016105|466629822|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
129638358|NCT02016105|466629823|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
129797828|NCT02537574|467228233|FG000|Overall Study|Patient not Stable|0|||
129797829|NCT02537574|467228234|FG001|Overall Study|Patient not Stable|1|||
129638359|NCT02016105|466629818|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
129638360|NCT02016105|466629819|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
129638361|NCT02016105|466629820|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
129638362|NCT02016105|466629821|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
129638363|NCT02016105|466629822|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
129638364|NCT02016105|466629823|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
129638365|NCT01377922|466629830|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
129638366|NCT01377922|466629831|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
129638367|NCT04615403|466629832|FG000|Overall Study|Death|1|||
129638368|NCT03170362|466629833|FG000|Overall Study|Death|2|||
129638369|NCT03170362|466629834|FG001|Overall Study|Death|2|||
129638370|NCT03170362|466629833|FG000|Overall Study|Withdrawal by Subject|23|||
129638371|NCT03170362|466629834|FG001|Overall Study|Withdrawal by Subject|22|||
129638372|NCT03170362|466629833|FG000|Overall Study|Lost to Follow-up|187|||
129638373|NCT03170362|466629834|FG001|Overall Study|Lost to Follow-up|167|||
129638374|NCT03340454|466629835|FG000|Overall Study|Lost to Follow-up|0|||
129638375|NCT03340454|466629836|FG001|Overall Study|Lost to Follow-up|4|||
129638376|NCT01464164|466629837|FG000|Overall Study|Screen failure|0|||
129638377|NCT01464164|466629838|FG001|Overall Study|Screen failure|1|||
129638378|NCT01464164|466629839|FG002|Overall Study|Screen failure|2|||
129638379|NCT01464164|466629840|FG003|Overall Study|Screen failure|0|||
129638380|NCT01464164|466629841|FG004|Overall Study|Screen failure|0|||
129638381|NCT01464164|466629842|FG005|Overall Study|Screen failure|0|||
129638382|NCT01464164|466629843|FG006|Overall Study|Screen failure|0|||
129638383|NCT01464164|466629837|FG000|Overall Study|Physician Decision|0|||
129638384|NCT01464164|466629838|FG001|Overall Study|Physician Decision|1|||
129638385|NCT01464164|466629839|FG002|Overall Study|Physician Decision|0|||
129638386|NCT01464164|466629840|FG003|Overall Study|Physician Decision|0|||
129638387|NCT01464164|466629841|FG004|Overall Study|Physician Decision|0|||
129638388|NCT01464164|466629842|FG005|Overall Study|Physician Decision|0|||
129638389|NCT01464164|466629843|FG006|Overall Study|Physician Decision|2|||
129638390|NCT03682848|466629844|FG000|Overall Study|Withdrawal by Subject|2|||
129638391|NCT03682848|466629844|FG000|Overall Study|Site closed|5|||
129638392|NCT03682848|466629844|FG000|Overall Study|Protocol Deviation|1|||
129638393|NCT03682848|466629844|FG000|Overall Study|Adverse Event|1|||
129638394|NCT00603473|466629845|FG000|Overall Study|Adverse Event|4|||
129638395|NCT00603473|466629845|FG000|Overall Study|Lack of Efficacy|4|||
129638396|NCT00603473|466629845|FG000|Overall Study|Protocol Violation|1|||
129638397|NCT02644668|466629849|FG000|Overall Study|Adverse Event|2|||
129638398|NCT02644668|466629850|FG001|Overall Study|Adverse Event|0|||
129638399|NCT02644668|466629851|FG002|Overall Study|Adverse Event|1|||
129638400|NCT02644668|466629849|FG000|Overall Study|Protocol Violation|0|||
129638401|NCT02644668|466629850|FG001|Overall Study|Protocol Violation|0|||
129638402|NCT02644668|466629851|FG002|Overall Study|Protocol Violation|1|||
129638403|NCT02644668|466629849|FG000|Overall Study|Withdrawal by Subject|0|||
129638404|NCT02644668|466629850|FG001|Overall Study|Withdrawal by Subject|0|||
129638405|NCT02644668|466629851|FG002|Overall Study|Withdrawal by Subject|1|||
129638406|NCT01134939|466629852|FG000|Overall Study|Adverse Event|9|||
129638407|NCT01134939|466629853|FG001|Overall Study|Adverse Event|3|||
129638408|NCT01134939|466629854|FG002|Overall Study|Adverse Event|4|||
129638409|NCT01134939|466629855|FG003|Overall Study|Adverse Event|5|||
129638410|NCT01134939|466629856|FG004|Overall Study|Adverse Event|5|||
129638411|NCT01134939|466629857|FG005|Overall Study|Adverse Event|5|||
129638412|NCT01134939|466629858|FG006|Overall Study|Adverse Event|1|||
129638413|NCT01134939|466629859|FG007|Overall Study|Adverse Event|0|||
129638414|NCT01134939|466629852|FG000|Overall Study|Lack of Efficacy|2|||
129638415|NCT01134939|466629853|FG001|Overall Study|Lack of Efficacy|5|||
129638416|NCT01134939|466629854|FG002|Overall Study|Lack of Efficacy|1|||
129638417|NCT01134939|466629855|FG003|Overall Study|Lack of Efficacy|0|||
129638418|NCT01134939|466629856|FG004|Overall Study|Lack of Efficacy|3|||
129638419|NCT01134939|466629857|FG005|Overall Study|Lack of Efficacy|0|||
129638420|NCT01134939|466629858|FG006|Overall Study|Lack of Efficacy|1|||
129638421|NCT01134939|466629859|FG007|Overall Study|Lack of Efficacy|0|||
129638422|NCT01134939|466629852|FG000|Overall Study|Lost to Follow-up|2|||
129638423|NCT01134939|466629853|FG001|Overall Study|Lost to Follow-up|3|||
129638424|NCT01134939|466629854|FG002|Overall Study|Lost to Follow-up|0|||
129638425|NCT01134939|466629855|FG003|Overall Study|Lost to Follow-up|1|||
129638426|NCT01134939|466629856|FG004|Overall Study|Lost to Follow-up|2|||
129638427|NCT01134939|466629857|FG005|Overall Study|Lost to Follow-up|1|||
129638428|NCT01134939|466629858|FG006|Overall Study|Lost to Follow-up|0|||
129638429|NCT01134939|466629859|FG007|Overall Study|Lost to Follow-up|0|||
129638430|NCT01134939|466629852|FG000|Overall Study|Death|0|||
129638431|NCT01134939|466629853|FG001|Overall Study|Death|1|||
129638432|NCT01134939|466629854|FG002|Overall Study|Death|0|||
129638433|NCT01134939|466629855|FG003|Overall Study|Death|0|||
129638434|NCT01134939|466629856|FG004|Overall Study|Death|0|||
129638435|NCT01134939|466629857|FG005|Overall Study|Death|0|||
129638436|NCT01134939|466629858|FG006|Overall Study|Death|0|||
129638437|NCT01134939|466629859|FG007|Overall Study|Death|0|||
129638438|NCT01134939|466629852|FG000|Overall Study|Termination page not available|4|||
129797830|NCT02537574|467228235|FG002|Overall Study|Patient not Stable|0|||
129442683|NCT01313650|465919315|FG000|Overall Study|Adverse Event|9|||
129442684|NCT01313650|465919316|FG001|Overall Study|Adverse Event|34|||
129442685|NCT01313650|465919317|FG002|Overall Study|Adverse Event|24|||
129442686|NCT01313650|465919318|FG003|Overall Study|Adverse Event|23|||
129442687|NCT01313650|465919315|FG000|Overall Study|Lack of Efficacy|37|||
129442688|NCT01313650|465919316|FG001|Overall Study|Lack of Efficacy|20|||
129442689|NCT01313650|465919317|FG002|Overall Study|Lack of Efficacy|32|||
129638439|NCT01134939|466629853|FG001|Overall Study|Termination page not available|6|||
129442690|NCT01313650|465919318|FG003|Overall Study|Lack of Efficacy|20|||
129442691|NCT01313650|465919315|FG000|Overall Study|Lost to Follow-up|1|||
129442692|NCT01313650|465919316|FG001|Overall Study|Lost to Follow-up|0|||
129442693|NCT01313650|465919317|FG002|Overall Study|Lost to Follow-up|3|||
129638440|NCT01134939|466629854|FG002|Overall Study|Termination page not available|5|||
129638441|NCT01134939|466629855|FG003|Overall Study|Termination page not available|8|||
129638442|NCT01134939|466629856|FG004|Overall Study|Termination page not available|0|||
129638443|NCT01134939|466629857|FG005|Overall Study|Termination page not available|3|||
129638444|NCT01134939|466629858|FG006|Overall Study|Termination page not available|7|||
129638445|NCT01134939|466629859|FG007|Overall Study|Termination page not available|0|||
129638446|NCT00733421|466629860|FG000|Overall Study|Withdrawal by Subject|1|||
129638447|NCT00733421|466629861|FG001|Overall Study|Withdrawal by Subject|1|||
129638448|NCT02547220|466629869|FG000|Overall Study|Withdrawal by Subject|1|||
129638449|NCT02547220|466629870|FG001|Overall Study|Withdrawal by Subject|0|||
129638450|NCT02547220|466629869|FG000|Overall Study|Study terminated by sponsor|18|||
129638451|NCT02547220|466629870|FG001|Overall Study|Study terminated by sponsor|20|||
129638452|NCT00550043|466629871|FG000|Overall Study|Adverse Event|0|||
129638453|NCT00550043|466629872|FG001|Overall Study|Adverse Event|0|||
129638454|NCT00550043|466629873|FG002|Overall Study|Adverse Event|0|||
129638455|NCT00550043|466629874|FG003|Overall Study|Adverse Event|1|||
129638456|NCT00550043|466629875|FG004|Overall Study|Adverse Event|1|||
129638457|NCT00550043|466629871|FG000|Overall Study|Subject Withdrew Consent|0|||
129638458|NCT00550043|466629872|FG001|Overall Study|Subject Withdrew Consent|2|||
129638459|NCT00550043|466629873|FG002|Overall Study|Subject Withdrew Consent|1|||
129638460|NCT00550043|466629874|FG003|Overall Study|Subject Withdrew Consent|0|||
129638461|NCT00550043|466629875|FG004|Overall Study|Subject Withdrew Consent|0|||
129638462|NCT00550043|466629871|FG000|Overall Study|Other Reasons- Unspecified|0|||
129638463|NCT00550043|466629872|FG001|Overall Study|Other Reasons- Unspecified|1|||
129638464|NCT00550043|466629873|FG002|Overall Study|Other Reasons- Unspecified|0|||
129638465|NCT00550043|466629874|FG003|Overall Study|Other Reasons- Unspecified|1|||
129638466|NCT00550043|466629875|FG004|Overall Study|Other Reasons- Unspecified|0|||
129638467|NCT04185220|466629876|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
129638468|NCT04185220|466629877|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
129638469|NCT04185220|466629876|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
129638470|NCT04185220|466629877|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
129638471|NCT03478644|466629879|FG000|Phase 2|Withdrawal by Subject|2|||
129638472|NCT03478644|466629880|FG001|Phase 2|Withdrawal by Subject|1|||
129638473|NCT03478644|466629879|FG000|Phase 2|Lost to Follow-up|1|||
129638474|NCT03478644|466629880|FG001|Phase 2|Lost to Follow-up|0|||
129638475|NCT01029782|466629881|FG000|Overall Study|Lost to Follow-up|2|||
129638476|NCT01029782|466629882|FG001|Overall Study|Lost to Follow-up|2|||
129638477|NCT01029782|466629881|FG000|Overall Study|Diagnosis changed|1|||
129638478|NCT01029782|466629882|FG001|Overall Study|Diagnosis changed|1|||
129638479|NCT01029782|466629881|FG000|Overall Study|Adverse Event|0|||
129638480|NCT01029782|466629882|FG001|Overall Study|Adverse Event|1|||
129638481|NCT01029782|466629881|FG000|Overall Study|Physician Decision|0|||
129638482|NCT01029782|466629882|FG001|Overall Study|Physician Decision|1|||
129638483|NCT01029782|466629881|FG000|Overall Study|Protocol Violation|0|||
129638484|NCT01029782|466629882|FG001|Overall Study|Protocol Violation|2|||
129638485|NCT01029782|466629881|FG000|Overall Study|Withdrawal by Subject|0|||
129638486|NCT01029782|466629882|FG001|Overall Study|Withdrawal by Subject|1|||
129638487|NCT02195869|466629886|FG000|Overall Study|cGVHD Progression|5|||
129638488|NCT02195869|466629886|FG000|Overall Study|Malignancy Progression/relapse|2|||
129638489|NCT02195869|466629886|FG000|Overall Study|Adverse Event|15|||
129638490|NCT02195869|466629886|FG000|Overall Study|Withdrawal by Subject|7|||
129797831|NCT02537574|467228233|FG000|Overall Study|Incarceration|0|||
129797832|NCT02537574|467228234|FG001|Overall Study|Incarceration|1|||
129638491|NCT02195869|466629886|FG000|Overall Study|Physician Decision|4|||
129638492|NCT02195869|466629886|FG000|Overall Study|Study Terminated by Sponsor|7|||
129638493|NCT02195869|466629886|FG000|Overall Study|Noncompliance with study drug|2|||
129638494|NCT00789698|466629887|FG000|Overall Study|Lack of Efficacy|10|||
129638495|NCT00789698|466629888|FG001|Overall Study|Lack of Efficacy|4|||
129638496|NCT00789698|466629889|FG002|Overall Study|Lack of Efficacy|5|||
129638497|NCT00789698|466629890|FG003|Overall Study|Lack of Efficacy|18|||
129797833|NCT02537574|467228235|FG002|Overall Study|Incarceration|0|||
129442694|NCT01313650|465919318|FG003|Overall Study|Lost to Follow-up|2|||
129442695|NCT01313650|465919315|FG000|Overall Study|Withdrawal by Subject|16|||
129638498|NCT00789698|466629887|FG000|Overall Study|Adverse Event|5|||
129638499|NCT00789698|466629888|FG001|Overall Study|Adverse Event|5|||
129638500|NCT00789698|466629889|FG002|Overall Study|Adverse Event|3|||
129638501|NCT00789698|466629890|FG003|Overall Study|Adverse Event|4|||
129638502|NCT00789698|466629887|FG000|Overall Study|Lost to Follow-up|5|||
129638503|NCT00789698|466629888|FG001|Overall Study|Lost to Follow-up|5|||
129797834|NCT02537574|467228233|FG000|Overall Study|Failed Naloxone Challenge|0|||
129797835|NCT02537574|467228234|FG001|Overall Study|Failed Naloxone Challenge|1|||
129797836|NCT02537574|467228235|FG002|Overall Study|Failed Naloxone Challenge|0|||
129797837|NCT02537574|467228233|FG000|Overall Study|Transportation Issues|0|||
129797838|NCT02537574|467228234|FG001|Overall Study|Transportation Issues|0|||
129797839|NCT02537574|467228235|FG002|Overall Study|Transportation Issues|1|||
129797840|NCT02537574|467228233|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
129797841|NCT02537574|467228234|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
129797842|NCT02537574|467228235|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
129797843|NCT02537574|467228233|FG000|Overall Study|Noncompliance with Protocol|0|||
129797844|NCT02537574|467228234|FG001|Overall Study|Noncompliance with Protocol|0|||
129797845|NCT02537574|467228235|FG002|Overall Study|Noncompliance with Protocol|1|||
129797846|NCT02663687|467228236|FG000|Overall Study|Adverse Event|1|||
129638504|NCT00789698|466629889|FG002|Overall Study|Lost to Follow-up|2|||
129638505|NCT00789698|466629890|FG003|Overall Study|Lost to Follow-up|9|||
129638506|NCT00789698|466629887|FG000|Overall Study|Protocol Violation|6|||
129638507|NCT00789698|466629888|FG001|Overall Study|Protocol Violation|1|||
129638508|NCT00789698|466629889|FG002|Overall Study|Protocol Violation|2|||
129638509|NCT00789698|466629890|FG003|Overall Study|Protocol Violation|1|||
129638510|NCT00789698|466629887|FG000|Overall Study|Withdrawal by Subject|14|||
129638511|NCT00789698|466629888|FG001|Overall Study|Withdrawal by Subject|15|||
129638512|NCT00789698|466629889|FG002|Overall Study|Withdrawal by Subject|12|||
129638513|NCT00789698|466629890|FG003|Overall Study|Withdrawal by Subject|19|||
129638514|NCT00789698|466629887|FG000|Overall Study|Administrative|0|||
129638515|NCT00789698|466629888|FG001|Overall Study|Administrative|3|||
129638516|NCT00789698|466629889|FG002|Overall Study|Administrative|3|||
129638517|NCT00789698|466629890|FG003|Overall Study|Administrative|1|||
129638518|NCT03300505|466631779|FG000|Overall Study|Death|0|||
129638519|NCT03300505|466631780|FG001|Overall Study|Death|1|||
129638520|NCT03300505|466631781|FG002|Overall Study|Death|0|||
129638521|NCT03300505|466631779|FG000|Overall Study|Withdrawal by Subject|0|||
129638522|NCT03300505|466631780|FG001|Overall Study|Withdrawal by Subject|1|||
129638523|NCT03300505|466631781|FG002|Overall Study|Withdrawal by Subject|1|||
129638524|NCT03300505|466631779|FG000|Overall Study|Sponsor Termination|0|||
129638525|NCT03300505|466631780|FG001|Overall Study|Sponsor Termination|1|||
129638526|NCT03300505|466631781|FG002|Overall Study|Sponsor Termination|0|||
129638527|NCT03300505|466631779|FG000|Overall Study|Adverse Event|0|||
129638528|NCT03300505|466631780|FG001|Overall Study|Adverse Event|0|||
129638529|NCT03300505|466631781|FG002|Overall Study|Adverse Event|2|||
129638530|NCT05119595|466631782|FG000|Overall Study|Death|1|||
129638531|NCT05119595|466631782|FG000|Overall Study|Lost to Follow-up|7|||
129638532|NCT03056638|466631785|FG000|Overall Study|Death|1|||
129638533|NCT03056638|466631786|FG001|Overall Study|Death|0|||
129638534|NCT00468481|466631787|FG000|Overall Study|Adverse Event|13|||
129638535|NCT00468481|466631788|FG001|Overall Study|Adverse Event|3|||
129638536|NCT00468481|466631787|FG000|Overall Study|Lost to Follow-up|25|||
129638537|NCT00468481|466631788|FG001|Overall Study|Lost to Follow-up|8|||
129638538|NCT00468481|466631787|FG000|Overall Study|Pregnancy|2|||
129638539|NCT00468481|466631788|FG001|Overall Study|Pregnancy|0|||
129638540|NCT00468481|466631787|FG000|Overall Study|Protocol Violation|18|||
129638541|NCT00468481|466631788|FG001|Overall Study|Protocol Violation|8|||
129638542|NCT00468481|466631787|FG000|Overall Study|Withdrawal by Subject|12|||
129797847|NCT02663687|467228237|FG001|Overall Study|Adverse Event|0|||
129797848|NCT02663687|467228238|FG002|Overall Study|Adverse Event|0|||
129638543|NCT00468481|466631788|FG001|Overall Study|Withdrawal by Subject|3|||
129638544|NCT00468481|466631787|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
129638545|NCT00468481|466631788|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
129797849|NCT02663687|467228239|FG003|Overall Study|Adverse Event|0|||
129638546|NCT00468481|466631787|FG000|Overall Study|Prohibited Medication|1|||
129638547|NCT00468481|466631788|FG001|Overall Study|Prohibited Medication|1|||
129638548|NCT00468481|466631787|FG000|Overall Study|Egg Donor|1|||
129638549|NCT00468481|466631788|FG001|Overall Study|Egg Donor|0|||
129638550|NCT00468481|466631787|FG000|Overall Study|Moved out of area|4|||
129638551|NCT00468481|466631788|FG001|Overall Study|Moved out of area|1|||
129638552|NCT00468481|466631787|FG000|Overall Study|Non-Compliance|5|||
129638553|NCT00468481|466631788|FG001|Overall Study|Non-Compliance|0|||
129638554|NCT00468481|466631787|FG000|Overall Study|Other|6|||
129638555|NCT00468481|466631788|FG001|Overall Study|Other|0|||
129638556|NCT00734162|466631789|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
129797850|NCT02663687|467228240|FG004|Overall Study|Adverse Event|0|||
129797851|NCT02663687|467228236|FG000|Overall Study|Other|1|||
129797852|NCT02663687|467228237|FG001|Overall Study|Other|0|||
129442696|NCT01313650|465919316|FG001|Overall Study|Withdrawal by Subject|20|||
129442697|NCT01313650|465919317|FG002|Overall Study|Withdrawal by Subject|15|||
129442698|NCT01313650|465919318|FG003|Overall Study|Withdrawal by Subject|15|||
129442699|NCT01313650|465919315|FG000|Overall Study|Protocol Violation|4|||
129442700|NCT01313650|465919316|FG001|Overall Study|Protocol Violation|7|||
129442701|NCT01313650|465919317|FG002|Overall Study|Protocol Violation|5|||
129442702|NCT01313650|465919318|FG003|Overall Study|Protocol Violation|6|||
129442703|NCT01313650|465919315|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
129442704|NCT01313650|465919316|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
129442705|NCT01313650|465919317|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
129442706|NCT01313650|465919318|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
129442707|NCT05393037|465919319|FG000|Part A|Death|1|||
129442708|NCT05393037|465919320|FG001|Part A|Death|0|||
129442709|NCT05393037|465919319|FG000|Part A|Lost to Follow-up|1|||
129442710|NCT05393037|465919320|FG001|Part A|Lost to Follow-up|1|||
129442711|NCT05393037|465919319|FG000|Part A|Withdrawal by Subject|2|||
129442712|NCT05393037|465919320|FG001|Part A|Withdrawal by Subject|4|||
129442713|NCT05393037|465919319|FG000|Part B|Lost to Follow-up|1|||
129442714|NCT05393037|465919320|FG001|Part B|Lost to Follow-up|0|||
129442715|NCT04540133|465919321|FG000|Overall Study|Lost to Follow-up|1|||
129442716|NCT04540133|465919322|FG001|Overall Study|Lost to Follow-up|0|||
129442717|NCT03153111|465919323|FG000|Overall Study|Death|2|||
129442718|NCT03153111|465919324|FG001|Overall Study|Death|5|||
129442719|NCT03153111|465919323|FG000|Overall Study|Lost to Follow-up|1|||
129442720|NCT03153111|465919324|FG001|Overall Study|Lost to Follow-up|0|||
129442721|NCT03153111|465919323|FG000|Overall Study|Physician Decision|5|||
129442722|NCT03153111|465919324|FG001|Overall Study|Physician Decision|1|||
129442723|NCT03153111|465919323|FG000|Overall Study|Withdrawal by Subject|3|||
129442724|NCT03153111|465919324|FG001|Overall Study|Withdrawal by Subject|3|||
129442725|NCT03891524|465919325|FG000|Overall Study|Death|0|||
129442726|NCT03891524|465919326|FG001|Overall Study|Death|0|||
129442727|NCT03891524|465919327|FG002|Overall Study|Death|0|||
129442728|NCT03891524|465919328|FG003|Overall Study|Death|0|||
129442729|NCT03891524|465919329|FG004|Overall Study|Death|0|||
129442730|NCT03891524|465919330|FG005|Overall Study|Death|0|||
129442731|NCT03891524|465919331|FG006|Overall Study|Death|0|||
129442732|NCT03891524|465919332|FG007|Overall Study|Death|1|||
129442733|NCT03891524|465919325|FG000|Overall Study|Withdrawal by Subject|0|||
129442734|NCT03891524|465919326|FG001|Overall Study|Withdrawal by Subject|1|||
129442735|NCT03891524|465919327|FG002|Overall Study|Withdrawal by Subject|2|||
129442736|NCT03891524|465919328|FG003|Overall Study|Withdrawal by Subject|1|||
129442737|NCT03891524|465919329|FG004|Overall Study|Withdrawal by Subject|2|||
129442738|NCT03891524|465919330|FG005|Overall Study|Withdrawal by Subject|2|||
129442739|NCT03891524|465919331|FG006|Overall Study|Withdrawal by Subject|2|||
129442740|NCT03891524|465919332|FG007|Overall Study|Withdrawal by Subject|1|||
129442741|NCT00174265|465919336|FG000|Overall Study|Adverse Event|7|||
129442742|NCT00174265|465919337|FG001|Overall Study|Adverse Event|4|||
129442743|NCT00174265|465919336|FG000|Overall Study|Lack of Efficacy|2|||
129442744|NCT00174265|465919337|FG001|Overall Study|Lack of Efficacy|2|||
129797853|NCT02663687|467228238|FG002|Overall Study|Other|1|||
129797854|NCT02663687|467228239|FG003|Overall Study|Other|0|||
129797855|NCT02663687|467228240|FG004|Overall Study|Other|0|||
129797856|NCT03595774|467228241|FG000|Overall Study|Adverse Event|1|||
129797857|NCT03595774|467228242|FG001|Overall Study|Adverse Event|0|||
129797858|NCT03595774|467228243|FG002|Overall Study|Adverse Event|1|||
129797859|NCT03595774|467228244|FG003|Overall Study|Adverse Event|0|||
129797860|NCT03595774|467228241|FG000|Overall Study|screen failure|0|||
129797861|NCT03595774|467228242|FG001|Overall Study|screen failure|1|||
129797862|NCT03595774|467228243|FG002|Overall Study|screen failure|0|||
129638557|NCT00734162|466631790|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
129638558|NCT00734162|466631791|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
129638559|NCT00734162|466631792|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
129638560|NCT00734162|466631789|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
129638561|NCT00734162|466631790|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
129638562|NCT00734162|466631791|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
129638563|NCT00734162|466631792|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
129638564|NCT00734162|466631789|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
129797863|NCT03595774|467228244|FG003|Overall Study|screen failure|1|||
129797864|NCT00117286|467228245|FG000|Overall Study|Adverse Event|12|||
129797865|NCT00117286|467228246|FG001|Overall Study|Adverse Event|6|||
129442745|NCT00174265|465919336|FG000|Overall Study|Withdrawal by Subject|3|||
129442746|NCT00174265|465919337|FG001|Overall Study|Withdrawal by Subject|5|||
129442747|NCT00174265|465919336|FG000|Overall Study|Lost to Follow-up|1|||
129442748|NCT00174265|465919337|FG001|Overall Study|Lost to Follow-up|0|||
129442749|NCT00174265|465919336|FG000|Overall Study|Other (Not specified)|16|||
129442750|NCT00174265|465919337|FG001|Overall Study|Other (Not specified)|10|||
129442751|NCT03471871|465919339|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129797866|NCT00117286|467228245|FG000|Overall Study|Lost to Follow-up|2|||
129797867|NCT00117286|467228246|FG001|Overall Study|Lost to Follow-up|0|||
129638565|NCT00734162|466631790|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
129638566|NCT00734162|466631791|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
129638567|NCT00734162|466631792|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
129638568|NCT00734162|466631789|FG000|Open-Label Phase|Withdrew Consent|1|||
129638569|NCT00734162|466631790|FG001|Open-Label Phase|Withdrew Consent|0|||
129638570|NCT00734162|466631791|FG002|Open-Label Phase|Withdrew Consent|1|||
129638571|NCT00734162|466631792|FG003|Open-Label Phase|Withdrew Consent|1|||
129638572|NCT00734162|466631789|FG000|Open-Label Phase|Lost to Follow-up|1|||
129638573|NCT00734162|466631790|FG001|Open-Label Phase|Lost to Follow-up|2|||
129638574|NCT00734162|466631791|FG002|Open-Label Phase|Lost to Follow-up|0|||
129638575|NCT00734162|466631792|FG003|Open-Label Phase|Lost to Follow-up|1|||
129638576|NCT00734162|466631789|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129638577|NCT00734162|466631790|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129638578|NCT00734162|466631791|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
129638579|NCT00734162|466631792|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
129638580|NCT03831113|466631793|FG000|Overall Study|Withdrawal by Subject|0|||
129638581|NCT03831113|466631794|FG001|Overall Study|Withdrawal by Subject|2|||
129638582|NCT03831113|466631793|FG000|Overall Study|Protocol Violation|0|||
129638583|NCT03831113|466631794|FG001|Overall Study|Protocol Violation|9|||
129638584|NCT03508726|466631795|FG000|Overall Study|Withdrawal by Subject|0|||
129638585|NCT03508726|466631796|FG001|Overall Study|Withdrawal by Subject|1|||
129638586|NCT01515865|466631798|FG000|Part A (Open-label)|Other|3|||
129638587|NCT01515865|466631799|FG001|Part A (Open-label)|Other|0|||
129638588|NCT01515865|466631800|FG002|Part A (Open-label)|Other|0|||
129638589|NCT01515865|466631798|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
129638590|NCT01515865|466631799|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
129638591|NCT01515865|466631800|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
129638592|NCT01515865|466631798|FG000|Part B (Open-label)|Other|1|||
129638593|NCT01515865|466631799|FG001|Part B (Open-label)|Other|0|||
129638594|NCT01515865|466631800|FG002|Part B (Open-label)|Other|0|||
129638595|NCT01073605|466631801|FG000|Overall Study|Ongoing at Cutoff Date|1|||
129638596|NCT01073605|466631802|FG001|Overall Study|Ongoing at Cutoff Date|1|||
129638597|NCT01073605|466631803|FG002|Overall Study|Ongoing at Cutoff Date|0|||
129638598|NCT01073605|466631801|FG000|Overall Study|Adverse Event|2|||
129638599|NCT01073605|466631802|FG001|Overall Study|Adverse Event|1|||
129638600|NCT01073605|466631803|FG002|Overall Study|Adverse Event|0|||
129638601|NCT01073605|466631801|FG000|Overall Study|Lost to Follow-up|3|||
129638602|NCT01073605|466631802|FG001|Overall Study|Lost to Follow-up|4|||
129638603|NCT01073605|466631803|FG002|Overall Study|Lost to Follow-up|9|||
129638604|NCT01073605|466631801|FG000|Overall Study|Other|25|||
129638605|NCT01073605|466631802|FG001|Overall Study|Other|21|||
129638606|NCT01073605|466631803|FG002|Overall Study|Other|29|||
129638607|NCT01073605|466631801|FG000|Overall Study|Withdrawal by Subject|31|||
129638608|NCT01073605|466631802|FG001|Overall Study|Withdrawal by Subject|39|||
129638609|NCT01073605|466631803|FG002|Overall Study|Withdrawal by Subject|22|||
129638610|NCT01073605|466631801|FG000|Overall Study|Randomized But Not Treated|0|||
129638611|NCT01073605|466631802|FG001|Overall Study|Randomized But Not Treated|1|||
129638612|NCT01073605|466631803|FG002|Overall Study|Randomized But Not Treated|1|||
129638613|NCT02875613|466631806|FG000|Overall Study|Withdrawal by Subject|1|||
129797868|NCT00117286|467228245|FG000|Overall Study|Protocol Violation|3|||
129638614|NCT02875613|466631806|FG000|Overall Study|Screen Failure|1|||
129638615|NCT02308540|466631808|FG000|Overall Study|Lost to Follow-up|0|||
129638616|NCT02308540|466631809|FG001|Overall Study|Lost to Follow-up|0|||
129638617|NCT02308540|466631810|FG002|Overall Study|Lost to Follow-up|0|||
129638618|NCT02308540|466631811|FG003|Overall Study|Lost to Follow-up|0|||
129638619|NCT02308540|466631812|FG004|Overall Study|Lost to Follow-up|0|||
129638620|NCT02308540|466631813|FG005|Overall Study|Lost to Follow-up|1|||
129638621|NCT02285166|466631814|FG000|Overall Study|Case Report Forms Uncollected|564|||
129638622|NCT02285166|466631814|FG000|Overall Study|Protocol Deviation|402|||
129638623|NCT00443079|466631815|FG000|Overall Study|Lost to Follow-up|0|||
129638624|NCT00443079|466631816|FG001|Overall Study|Lost to Follow-up|1|||
129638625|NCT02649439|466631817|FG000|Overall Study|Switched to alternative treatment|6|||
129638626|NCT02649439|466631818|FG001|Overall Study|Switched to alternative treatment|4|||
129638627|NCT02649439|466631817|FG000|Overall Study|Patient decision|1|||
129638628|NCT02649439|466631818|FG001|Overall Study|Patient decision|0|||
129638629|NCT02649439|466631817|FG000|Overall Study|Patient going out of country|1|||
129638630|NCT02649439|466631818|FG001|Overall Study|Patient going out of country|0|||
129638631|NCT02649439|466631817|FG000|Overall Study|To start finasteride|1|||
129638632|NCT02649439|466631818|FG001|Overall Study|To start finasteride|0|||
129638633|NCT02649439|466631817|FG000|Overall Study|Physician Decision|1|||
129638634|NCT02649439|466631818|FG001|Overall Study|Physician Decision|0|||
129638635|NCT02649439|466631817|FG000|Overall Study|Disease progression on study|12|||
129638636|NCT02649439|466631818|FG001|Overall Study|Disease progression on study|13|||
129638637|NCT02649439|466631817|FG000|Overall Study|Refused further treatment|1|||
129797869|NCT00117286|467228246|FG001|Overall Study|Protocol Violation|3|||
129797870|NCT00117286|467228245|FG000|Overall Study|Withdrawal by Subject|6|||
129797871|NCT00117286|467228246|FG001|Overall Study|Withdrawal by Subject|2|||
129797872|NCT00117286|467228245|FG000|Overall Study|Physician Decision|3|||
129797873|NCT00117286|467228246|FG001|Overall Study|Physician Decision|7|||
129797874|NCT00117286|467228245|FG000|Overall Study|Lack of Efficacy|2|||
129797875|NCT00117286|467228246|FG001|Overall Study|Lack of Efficacy|1|||
129797876|NCT00117286|467228245|FG000|Overall Study|Research site closing|0|||
129797877|NCT00117286|467228246|FG001|Overall Study|Research site closing|2|||
129797878|NCT00048061|467228248|FG000|Overall Study|Adverse Event|41|||
129797879|NCT00048061|467228249|FG001|Overall Study|Adverse Event|32|||
129797880|NCT00048061|467228250|FG002|Overall Study|Adverse Event|44|||
129797881|NCT00048061|467228251|FG003|Overall Study|Adverse Event|37|||
129797882|NCT00048061|467228248|FG000|Overall Study|Lost to Follow-up|3|||
129797883|NCT00048061|467228249|FG001|Overall Study|Lost to Follow-up|2|||
129797884|NCT00048061|467228250|FG002|Overall Study|Lost to Follow-up|4|||
129797885|NCT00048061|467228251|FG003|Overall Study|Lost to Follow-up|5|||
129797886|NCT00048061|467228248|FG000|Overall Study|Withdrawal by Subject|20|||
129797887|NCT00048061|467228249|FG001|Overall Study|Withdrawal by Subject|29|||
129797888|NCT00048061|467228250|FG002|Overall Study|Withdrawal by Subject|29|||
129797889|NCT00048061|467228251|FG003|Overall Study|Withdrawal by Subject|32|||
129797890|NCT00048061|467228248|FG000|Overall Study|Did not follow-up|5|||
129797891|NCT00048061|467228249|FG001|Overall Study|Did not follow-up|5|||
129797892|NCT00048061|467228250|FG002|Overall Study|Did not follow-up|4|||
129797893|NCT00048061|467228251|FG003|Overall Study|Did not follow-up|5|||
129797894|NCT00048061|467228248|FG000|Overall Study|Early improvement|6|||
129797895|NCT00048061|467228249|FG001|Overall Study|Early improvement|5|||
129797896|NCT00048061|467228250|FG002|Overall Study|Early improvement|3|||
129797897|NCT00048061|467228251|FG003|Overall Study|Early improvement|0|||
129797898|NCT03555435|467228252|FG000|Overall Study|Lost to Follow-up|17|||
129797899|NCT03555435|467228253|FG001|Overall Study|Lost to Follow-up|19|||
129797900|NCT03555435|467228254|FG002|Overall Study|Lost to Follow-up|8|||
129797901|NCT01323946|467228255|FG000|Overall Study|Lost to Follow-up|0|||
129797902|NCT01323946|467228256|FG001|Overall Study|Lost to Follow-up|1|||
129797903|NCT01323946|467228257|FG002|Overall Study|Lost to Follow-up|0|||
129797904|NCT01323946|467228255|FG000|Overall Study|Parents refused the last blood draw|1|||
129797905|NCT01323946|467228256|FG001|Overall Study|Parents refused the last blood draw|0|||
129797906|NCT01323946|467228257|FG002|Overall Study|Parents refused the last blood draw|0|||
129797907|NCT01323946|467228255|FG000|Overall Study|Withdrawal by Subject|2|||
129797908|NCT01323946|467228256|FG001|Overall Study|Withdrawal by Subject|2|||
129442752|NCT03471871|465919340|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129442753|NCT03471871|465919341|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
129638638|NCT02649439|466631818|FG001|Overall Study|Refused further treatment|0|||
129638639|NCT02649439|466631817|FG000|Overall Study|Refused further follow up|2|||
129638640|NCT02649439|466631818|FG001|Overall Study|Refused further follow up|7|||
129638641|NCT02649439|466631817|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
129638642|NCT02649439|466631818|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
129638643|NCT02649439|466631817|FG000|Overall Study|No treatment, per protocol|1|||
129638644|NCT02649439|466631818|FG001|Overall Study|No treatment, per protocol|0|||
129638645|NCT02649439|466631817|FG000|Overall Study|PSA DT makes ineligible|0|||
129638646|NCT02649439|466631818|FG001|Overall Study|PSA DT makes ineligible|1|||
129638647|NCT02649439|466631817|FG000|Overall Study|Rising PSA No Mets|0|||
129638648|NCT02649439|466631818|FG001|Overall Study|Rising PSA No Mets|1|||
129638649|NCT02649439|466631817|FG000|Overall Study|Rising PSA|0|||
129638650|NCT02649439|466631818|FG001|Overall Study|Rising PSA|1|||
129638651|NCT02649439|466631817|FG000|Overall Study|Signed follow up protocol|0|||
129638652|NCT02649439|466631818|FG001|Overall Study|Signed follow up protocol|1|||
129638653|NCT00090493|466631821|FG000|Overall Study|Physician Decision|2|||
129638654|NCT02071706|466631822|FG000|Overall Study|Adverse Event|1|||
129638655|NCT02071706|466631822|FG000|Overall Study|Withdrawal by Subject|2|||
129797909|NCT01323946|467228257|FG002|Overall Study|Withdrawal by Subject|0|||
129889472|NCT00946647|467552607|FG001|Phase ll Part|Administrative problems|0|||
129889473|NCT00946647|467552608|FG002|Phase ll Part|Administrative problems|0|||
129638656|NCT01908829|466631828|FG000|Overall Study|Adverse Event|13|||
129638657|NCT01908829|466631829|FG001|Overall Study|Adverse Event|11|||
129797910|NCT01272661|467228260|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
129889474|NCT00946647|467552609|FG003|Phase ll Part|Administrative problems|3|||
129638658|NCT01908829|466631830|FG002|Overall Study|Adverse Event|13|||
129797911|NCT01272661|467228261|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
129797912|NCT01272661|467228262|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
129797913|NCT01243671|467228263|FG000|Overall Study|Adverse Event|3|||
129797914|NCT01243671|467228263|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
129797915|NCT01243671|467228263|FG000|Overall Study|Other|1|||
129797916|NCT00573248|467228269|FG000|Overall Study|scheduling conflicts|15|||
129797917|NCT00573248|467228270|FG001|Overall Study|scheduling conflicts|11|||
129797918|NCT02017171|467228271|FG000|Overall Study|Death|10|||
129797919|NCT02017171|467228272|FG001|Overall Study|Death|4|||
129638659|NCT01908829|466631828|FG000|Overall Study|Lost to Follow-up|4|||
129638660|NCT01908829|466631829|FG001|Overall Study|Lost to Follow-up|2|||
129638661|NCT01908829|466631830|FG002|Overall Study|Lost to Follow-up|1|||
129638662|NCT01908829|466631828|FG000|Overall Study|Randomized no double-blind drug received|1|||
129638663|NCT01908829|466631829|FG001|Overall Study|Randomized no double-blind drug received|0|||
129638664|NCT01908829|466631830|FG002|Overall Study|Randomized no double-blind drug received|1|||
129638665|NCT01908829|466631828|FG000|Overall Study|Discontinued (no EoT page)|2|||
129638666|NCT01908829|466631829|FG001|Overall Study|Discontinued (no EoT page)|0|||
129638667|NCT01908829|466631830|FG002|Overall Study|Discontinued (no EoT page)|0|||
129638668|NCT01908829|466631828|FG000|Overall Study|Miscellaneous|0|||
129638669|NCT01908829|466631829|FG001|Overall Study|Miscellaneous|2|||
129638670|NCT01908829|466631830|FG002|Overall Study|Miscellaneous|0|||
129638671|NCT01908829|466631828|FG000|Overall Study|Protocol Violation|2|||
129638672|NCT01908829|466631829|FG001|Overall Study|Protocol Violation|2|||
129638673|NCT01908829|466631830|FG002|Overall Study|Protocol Violation|0|||
129638674|NCT01908829|466631828|FG000|Overall Study|Lack of Efficacy|1|||
129638675|NCT01908829|466631829|FG001|Overall Study|Lack of Efficacy|3|||
129638676|NCT01908829|466631830|FG002|Overall Study|Lack of Efficacy|2|||
129638677|NCT01908829|466631828|FG000|Overall Study|Withdrawal by Subject|26|||
129638678|NCT01908829|466631829|FG001|Overall Study|Withdrawal by Subject|29|||
129638679|NCT01908829|466631830|FG002|Overall Study|Withdrawal by Subject|22|||
129638680|NCT02247440|466631831|FG000|Overall Study|Withdrawal by Subject|1|||
129638681|NCT02247440|466631831|FG000|Overall Study|Lack of Efficacy|3|||
129638682|NCT02792192|466631832|FG000|Overall Study|Death|1|||
129638683|NCT02792192|466631833|FG001|Overall Study|Death|0|||
129638684|NCT02792192|466631834|FG002|Overall Study|Death|0|||
129638685|NCT02792192|466631835|FG003|Overall Study|Death|0|||
129638686|NCT02792192|466631832|FG000|Overall Study|Informed Consent Withdrawn|4|||
129638687|NCT02792192|466631833|FG001|Overall Study|Informed Consent Withdrawn|0|||
129638688|NCT02792192|466631834|FG002|Overall Study|Informed Consent Withdrawn|0|||
129638689|NCT02792192|466631835|FG003|Overall Study|Informed Consent Withdrawn|0|||
129638690|NCT02792192|466631832|FG000|Overall Study|Physician Decision|1|||
129638691|NCT02792192|466631833|FG001|Overall Study|Physician Decision|0|||
129638692|NCT02792192|466631834|FG002|Overall Study|Physician Decision|0|||
129638693|NCT02792192|466631835|FG003|Overall Study|Physician Decision|0|||
129638694|NCT02792192|466631832|FG000|Overall Study|Progressive Disease|0|||
129638695|NCT02792192|466631833|FG001|Overall Study|Progressive Disease|1|||
129638696|NCT02792192|466631834|FG002|Overall Study|Progressive Disease|0|||
129638697|NCT02792192|466631835|FG003|Overall Study|Progressive Disease|0|||
129638698|NCT02792192|466631832|FG000|Overall Study|Study Terminated By Sponsor|6|||
129638699|NCT02792192|466631833|FG001|Overall Study|Study Terminated By Sponsor|10|||
129638700|NCT02792192|466631834|FG002|Overall Study|Study Terminated By Sponsor|0|||
129638701|NCT02792192|466631835|FG003|Overall Study|Study Terminated By Sponsor|0|||
129638702|NCT02320058|466631836|FG000|Overall Study|Death|25|||
129638703|NCT02320058|466631837|FG001|Overall Study|Death|10|||
129638704|NCT02320058|466631836|FG000|Overall Study|Lost to Follow-up|4|||
129638705|NCT02320058|466631837|FG001|Overall Study|Lost to Follow-up|0|||
129638706|NCT02320058|466631836|FG000|Overall Study|Other reasons|4|||
129638707|NCT02320058|466631837|FG001|Overall Study|Other reasons|1|||
129638708|NCT02320058|466631836|FG000|Overall Study|Withdrawal by Subject|8|||
129638709|NCT02320058|466631837|FG001|Overall Study|Withdrawal by Subject|2|||
129638710|NCT02320058|466631836|FG000|Overall Study|Not reported|1|||
129638711|NCT02320058|466631837|FG001|Overall Study|Not reported|0|||
129638712|NCT01339923|466631838|FG000|Overall Study|Adverse Event|1|||
129638713|NCT01339923|466631839|FG001|Overall Study|Adverse Event|1|||
129638714|NCT01339923|466631840|FG002|Overall Study|Adverse Event|1|||
129638715|NCT01339923|466631841|FG003|Overall Study|Adverse Event|0|||
129797920|NCT02017171|467228271|FG000|Overall Study|Withdrawal by Subject|23|||
129797921|NCT02017171|467228272|FG001|Overall Study|Withdrawal by Subject|17|||
129797922|NCT02017171|467228271|FG000|Overall Study|Lost to Follow-up|21|||
129638716|NCT01339923|466631842|FG004|Overall Study|Adverse Event|0|||
129638717|NCT01339923|466631843|FG005|Overall Study|Adverse Event|0|||
129638718|NCT01339923|466631844|FG006|Overall Study|Adverse Event|1|||
129638719|NCT01339923|466631838|FG000|Overall Study|Inappropriate Enrollment|1|||
129638720|NCT01339923|466631839|FG001|Overall Study|Inappropriate Enrollment|0|||
129638721|NCT01339923|466631840|FG002|Overall Study|Inappropriate Enrollment|0|||
129638722|NCT01339923|466631841|FG003|Overall Study|Inappropriate Enrollment|0|||
129638723|NCT01339923|466631842|FG004|Overall Study|Inappropriate Enrollment|0|||
129638724|NCT01339923|466631843|FG005|Overall Study|Inappropriate Enrollment|1|||
129638725|NCT01339923|466631844|FG006|Overall Study|Inappropriate Enrollment|0|||
129638726|NCT01339923|466631838|FG000|Overall Study|Lost to Follow-up|4|||
129638727|NCT01339923|466631839|FG001|Overall Study|Lost to Follow-up|4|||
129638728|NCT01339923|466631840|FG002|Overall Study|Lost to Follow-up|0|||
129638729|NCT01339923|466631841|FG003|Overall Study|Lost to Follow-up|3|||
129638730|NCT01339923|466631842|FG004|Overall Study|Lost to Follow-up|1|||
129797923|NCT02017171|467228272|FG001|Overall Study|Lost to Follow-up|20|||
129797924|NCT02017171|467228271|FG000|Overall Study|ESKD|6|||
129638731|NCT01339923|466631843|FG005|Overall Study|Lost to Follow-up|1|||
129638732|NCT01339923|466631844|FG006|Overall Study|Lost to Follow-up|5|||
129797925|NCT02017171|467228272|FG001|Overall Study|ESKD|2|||
129797926|NCT02017171|467228271|FG000|Overall Study|Miscellaneous|2|||
129797927|NCT02017171|467228272|FG001|Overall Study|Miscellaneous|3|||
129797928|NCT03091777|467228273|FG000|Overall Study|Pregnancy|2|||
129797929|NCT03091777|467228274|FG001|Overall Study|Pregnancy|1|||
129797930|NCT03091777|467228275|FG002|Overall Study|Pregnancy|0|||
129797931|NCT03091777|467228273|FG000|Overall Study|Adverse Event|2|||
129797932|NCT03091777|467228274|FG001|Overall Study|Adverse Event|1|||
129797933|NCT03091777|467228275|FG002|Overall Study|Adverse Event|4|||
129797934|NCT03091777|467228273|FG000|Overall Study|Withdrawal by Subject|4|||
129797935|NCT03091777|467228274|FG001|Overall Study|Withdrawal by Subject|2|||
129797936|NCT03091777|467228275|FG002|Overall Study|Withdrawal by Subject|6|||
129797937|NCT03091777|467228273|FG000|Overall Study|Protocol Violation|2|||
129797938|NCT03091777|467228274|FG001|Overall Study|Protocol Violation|1|||
129797939|NCT03091777|467228275|FG002|Overall Study|Protocol Violation|1|||
129797940|NCT03091777|467228273|FG000|Overall Study|Lost to Follow-up|12|||
129797941|NCT03091777|467228274|FG001|Overall Study|Lost to Follow-up|14|||
129797942|NCT03091777|467228275|FG002|Overall Study|Lost to Follow-up|7|||
129797943|NCT03091777|467228273|FG000|Overall Study|Lack of Efficacy|0|||
129797944|NCT03091777|467228274|FG001|Overall Study|Lack of Efficacy|0|||
129797945|NCT03091777|467228275|FG002|Overall Study|Lack of Efficacy|5|||
129797946|NCT03091777|467228273|FG000|Overall Study|Noncompliance with study drug|2|||
129797947|NCT03091777|467228274|FG001|Overall Study|Noncompliance with study drug|3|||
129797948|NCT03091777|467228275|FG002|Overall Study|Noncompliance with study drug|1|||
129797949|NCT03091777|467228273|FG000|Overall Study|Physician Decision|1|||
129797950|NCT03091777|467228274|FG001|Overall Study|Physician Decision|0|||
129797951|NCT03091777|467228275|FG002|Overall Study|Physician Decision|1|||
129797952|NCT03091777|467228273|FG000|Overall Study|Abnormal Laboratory Value|7|||
129797953|NCT03091777|467228274|FG001|Overall Study|Abnormal Laboratory Value|11|||
129797954|NCT03091777|467228275|FG002|Overall Study|Abnormal Laboratory Value|12|||
129797955|NCT02314143|467228276|FG000|Overall Study|Adverse Event|0|||
129889475|NCT00946647|467552610|FG004|Phase ll Part|Administrative problems|8|||
129889476|NCT00946647|467552606|FG000|Phase ll Part|Death|0|||
129638733|NCT01339923|466631838|FG000|Overall Study|Protocol Violation|0|||
129638734|NCT01339923|466631839|FG001|Overall Study|Protocol Violation|0|||
129638735|NCT01339923|466631840|FG002|Overall Study|Protocol Violation|0|||
129638736|NCT01339923|466631841|FG003|Overall Study|Protocol Violation|0|||
129638737|NCT01339923|466631842|FG004|Overall Study|Protocol Violation|0|||
129638738|NCT01339923|466631843|FG005|Overall Study|Protocol Violation|3|||
129638739|NCT01339923|466631844|FG006|Overall Study|Protocol Violation|1|||
129638740|NCT01339923|466631838|FG000|Overall Study|Unable to Classify|1|||
129638741|NCT01339923|466631839|FG001|Overall Study|Unable to Classify|0|||
129638742|NCT01339923|466631840|FG002|Overall Study|Unable to Classify|1|||
129638743|NCT01339923|466631841|FG003|Overall Study|Unable to Classify|0|||
129638744|NCT01339923|466631842|FG004|Overall Study|Unable to Classify|0|||
129638745|NCT01339923|466631843|FG005|Overall Study|Unable to Classify|1|||
129638746|NCT01339923|466631844|FG006|Overall Study|Unable to Classify|5|||
129638747|NCT01339923|466631838|FG000|Overall Study|Withdrawal by Subject|7|||
129638748|NCT01339923|466631839|FG001|Overall Study|Withdrawal by Subject|11|||
129638749|NCT01339923|466631840|FG002|Overall Study|Withdrawal by Subject|6|||
129638750|NCT01339923|466631841|FG003|Overall Study|Withdrawal by Subject|1|||
129638751|NCT01339923|466631842|FG004|Overall Study|Withdrawal by Subject|4|||
129638752|NCT01339923|466631843|FG005|Overall Study|Withdrawal by Subject|3|||
129638753|NCT01339923|466631844|FG006|Overall Study|Withdrawal by Subject|2|||
129638754|NCT00729157|466631845|FG000|Overall Study|Withdrawal by Subject|1|||
129638755|NCT01430403|466631851|FG000|Overall Study|Lost to Follow-up|5|||
129638756|NCT01430403|466631852|FG001|Overall Study|Lost to Follow-up|5|||
129638757|NCT01430403|466631853|FG002|Overall Study|Lost to Follow-up|3|||
129638758|NCT01430403|466631851|FG000|Overall Study|Physician Decision|1|||
129638759|NCT01430403|466631852|FG001|Overall Study|Physician Decision|0|||
129638760|NCT01430403|466631853|FG002|Overall Study|Physician Decision|0|||
129638761|NCT01430403|466631851|FG000|Overall Study|Protocol Violation|2|||
129638762|NCT01430403|466631852|FG001|Overall Study|Protocol Violation|3|||
129638763|NCT01430403|466631853|FG002|Overall Study|Protocol Violation|2|||
129638764|NCT01430403|466631851|FG000|Overall Study|Withdrawal by Subject|9|||
129638765|NCT01430403|466631852|FG001|Overall Study|Withdrawal by Subject|1|||
129638766|NCT01430403|466631853|FG002|Overall Study|Withdrawal by Subject|3|||
129889477|NCT00946647|467552607|FG001|Phase ll Part|Death|0|||
129638767|NCT04481789|466631854|FG000|Period 1|Withdrawal by Subject|1|||
129797956|NCT02314143|467228277|FG001|Overall Study|Adverse Event|6|||
129797957|NCT02314143|467228278|FG002|Overall Study|Adverse Event|4|||
129797958|NCT02314143|467228276|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
129797959|NCT02314143|467228277|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
129797960|NCT02314143|467228278|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
129797961|NCT02314143|467228276|FG000|Overall Study|Physician Decision|2|||
129797962|NCT02314143|467228277|FG001|Overall Study|Physician Decision|1|||
129797963|NCT02314143|467228278|FG002|Overall Study|Physician Decision|0|||
129797964|NCT02314143|467228276|FG000|Overall Study|Withdrawal by Subject|1|||
129797965|NCT02314143|467228277|FG001|Overall Study|Withdrawal by Subject|0|||
129797966|NCT02314143|467228278|FG002|Overall Study|Withdrawal by Subject|1|||
129797967|NCT03172910|467229934|FG000|Overall Study|Adverse Event|0|||
129797968|NCT03172910|467229935|FG001|Overall Study|Adverse Event|0|||
129797969|NCT03172910|467229936|FG002|Overall Study|Adverse Event|0|||
129797970|NCT03172910|467229937|FG003|Overall Study|Adverse Event|0|||
129638768|NCT04481789|466631855|FG001|Period 1|Withdrawal by Subject|0|||
129638769|NCT04481789|466631856|FG002|Period 1|Withdrawal by Subject|0|||
129638770|NCT04481789|466631857|FG003|Period 1|Withdrawal by Subject|0|||
129638771|NCT04481789|466631858|FG004|Period 1|Withdrawal by Subject|0|||
129638772|NCT04481789|466631859|FG005|Period 1|Withdrawal by Subject|0|||
129638773|NCT03124407|466631866|FG000|Overall Study|Lost to Follow-up|1|||
129638774|NCT03124407|466631867|FG001|Overall Study|Lost to Follow-up|0|||
129638775|NCT03124407|466631868|FG002|Overall Study|Lost to Follow-up|0|||
129638776|NCT03124407|466631869|FG003|Overall Study|Lost to Follow-up|0|||
129638777|NCT03124407|466631866|FG000|Overall Study|Adverse Event|0|||
129638778|NCT03124407|466631867|FG001|Overall Study|Adverse Event|0|||
129638779|NCT03124407|466631868|FG002|Overall Study|Adverse Event|1|||
129638780|NCT03124407|466631869|FG003|Overall Study|Adverse Event|0|||
129638781|NCT00396656|466631870|FG000|First Treatment Period|Withdrawal by Subject|0|||
129638782|NCT00396656|466631871|FG001|First Treatment Period|Withdrawal by Subject|2|||
129638783|NCT00396656|466631870|FG000|Second Treatment Period|Adverse Event|0|||
129638784|NCT00396656|466631871|FG001|Second Treatment Period|Adverse Event|1|||
129638785|NCT02821754|466631872|FG000|Overall Study|Procedure not required prior to amendment change|13|||
129638786|NCT02821754|466631873|FG001|Overall Study|Procedure not required prior to amendment change|11|||
129638787|NCT02821754|466631874|FG002|Overall Study|Procedure not required prior to amendment change|0|||
129638788|NCT02821754|466631872|FG000|Overall Study|Participant's Clinical status|2|||
129638789|NCT02821754|466631873|FG001|Overall Study|Participant's Clinical status|0|||
129638790|NCT02821754|466631874|FG002|Overall Study|Participant's Clinical status|0|||
129638791|NCT02821754|466631872|FG000|Overall Study|Participant removed for noncompliance|1|||
129638792|NCT02821754|466631873|FG001|Overall Study|Participant removed for noncompliance|0|||
129638793|NCT02821754|466631874|FG002|Overall Study|Participant removed for noncompliance|0|||
129638794|NCT02821754|466631872|FG000|Overall Study|Drug not available.|0|||
129638795|NCT02821754|466631873|FG001|Overall Study|Drug not available.|0|||
129638796|NCT02821754|466631874|FG002|Overall Study|Drug not available.|1|||
129638797|NCT02821754|466631872|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
129638798|NCT02821754|466631873|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
129638799|NCT02821754|466631874|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
129638800|NCT02477332|466631884|FG000|Overall Study|Adverse Event|0|||
129638801|NCT02477332|466631885|FG001|Overall Study|Adverse Event|1|||
129638802|NCT02477332|466631886|FG002|Overall Study|Adverse Event|1|||
129638803|NCT02477332|466631887|FG003|Overall Study|Adverse Event|2|||
129638804|NCT02477332|466631888|FG004|Overall Study|Adverse Event|1|||
129638805|NCT02477332|466631889|FG005|Overall Study|Adverse Event|2|||
129638806|NCT02477332|466631884|FG000|Overall Study|Lack of Efficacy|1|||
129638807|NCT02477332|466631885|FG001|Overall Study|Lack of Efficacy|2|||
129638808|NCT02477332|466631886|FG002|Overall Study|Lack of Efficacy|1|||
129638809|NCT02477332|466631887|FG003|Overall Study|Lack of Efficacy|2|||
129638810|NCT02477332|466631888|FG004|Overall Study|Lack of Efficacy|1|||
129638811|NCT02477332|466631889|FG005|Overall Study|Lack of Efficacy|1|||
129638812|NCT02477332|466631884|FG000|Overall Study|Non-compliance with study treatment|0|||
129638813|NCT02477332|466631885|FG001|Overall Study|Non-compliance with study treatment|1|||
129638814|NCT02477332|466631886|FG002|Overall Study|Non-compliance with study treatment|2|||
129638815|NCT02477332|466631887|FG003|Overall Study|Non-compliance with study treatment|0|||
129638816|NCT02477332|466631888|FG004|Overall Study|Non-compliance with study treatment|0|||
129638817|NCT02477332|466631889|FG005|Overall Study|Non-compliance with study treatment|0|||
129638818|NCT02477332|466631884|FG000|Overall Study|Pregnancy|0|||
129638819|NCT02477332|466631885|FG001|Overall Study|Pregnancy|0|||
129638820|NCT02477332|466631886|FG002|Overall Study|Pregnancy|0|||
129638821|NCT02477332|466631887|FG003|Overall Study|Pregnancy|1|||
129638822|NCT02477332|466631888|FG004|Overall Study|Pregnancy|0|||
129638823|NCT02477332|466631889|FG005|Overall Study|Pregnancy|0|||
129638824|NCT02477332|466631884|FG000|Overall Study|Protocol Violation|2|||
129638825|NCT02477332|466631885|FG001|Overall Study|Protocol Violation|0|||
129638826|NCT02477332|466631886|FG002|Overall Study|Protocol Violation|3|||
129638827|NCT02477332|466631887|FG003|Overall Study|Protocol Violation|3|||
129638828|NCT02477332|466631888|FG004|Overall Study|Protocol Violation|1|||
129797971|NCT03172910|467229938|FG004|Overall Study|Adverse Event|1|||
129797972|NCT01927341|467229942|FG000|Phase 1b|Lost to Follow-up|1|||
129638829|NCT02477332|466631889|FG005|Overall Study|Protocol Violation|1|||
129638830|NCT02477332|466631884|FG000|Overall Study|Technical problems|0|||
129638831|NCT02477332|466631885|FG001|Overall Study|Technical problems|0|||
129638832|NCT02477332|466631886|FG002|Overall Study|Technical problems|1|||
129638833|NCT02477332|466631887|FG003|Overall Study|Technical problems|0|||
129797973|NCT01927341|467229943|FG001|Phase 1b|Lost to Follow-up|0|||
129797974|NCT01927341|467229944|FG002|Phase 1b|Lost to Follow-up|0|||
129442754|NCT03471871|465919342|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129442755|NCT03471871|465919343|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
129442756|NCT03471871|465919339|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
129442757|NCT03471871|465919340|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
129442758|NCT03471871|465919341|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
129442759|NCT03471871|465919342|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
129797975|NCT01927341|467229945|FG003|Phase 1b|Lost to Follow-up|0|||
129442760|NCT03471871|465919343|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
129442761|NCT03471871|465919339|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129442762|NCT03471871|465919340|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129442763|NCT03471871|465919341|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129442764|NCT03471871|465919342|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
129442765|NCT03471871|465919343|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
129442766|NCT03471871|465919339|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129442767|NCT03471871|465919340|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129442768|NCT03471871|465919341|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129442769|NCT03471871|465919342|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
129442770|NCT03471871|465919343|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
129442771|NCT03471871|465919339|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129442772|NCT03471871|465919340|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129442773|NCT03471871|465919341|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129442774|NCT03471871|465919342|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
129442775|NCT03471871|465919343|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
129442776|NCT03040622|465919344|FG000|Overall Study|unable to implant device|3|||
129442777|NCT01572922|465919345|FG000|Overall Study|Adverse Event|1|||
129442778|NCT01572922|465919345|FG000|Overall Study|Protocol Violation|1|||
129442779|NCT01572922|465919345|FG000|Overall Study|Death|1|||
129442780|NCT00445068|465919346|FG000|Overall Study|Disease progression|26|||
129442781|NCT00445068|465919346|FG000|Overall Study|Adverse Event|5|||
129442782|NCT00445068|465919346|FG000|Overall Study|Abnormal laboratory value|2|||
129442783|NCT00445068|465919346|FG000|Overall Study|Withdrawal by Subject|2|||
129442784|NCT00445068|465919346|FG000|Overall Study|Death|1|||
129442785|NCT04091451|465919347|FG000|Overall Study|Adverse Event|15|||
129442786|NCT04091451|465919348|FG001|Overall Study|Adverse Event|10|||
129442787|NCT04091451|465919347|FG000|Overall Study|Lost to Follow-up|8|||
129442788|NCT04091451|465919348|FG001|Overall Study|Lost to Follow-up|8|||
129442789|NCT04091451|465919347|FG000|Overall Study|Protocol Violation|5|||
129797976|NCT01927341|467229946|FG004|Phase 1b|Lost to Follow-up|0|||
129797977|NCT01927341|467229942|FG000|Phase 1b|Death|2|||
129797978|NCT01927341|467229943|FG001|Phase 1b|Death|0|||
129797979|NCT01927341|467229944|FG002|Phase 1b|Death|0|||
129797980|NCT01927341|467229945|FG003|Phase 1b|Death|0|||
129797981|NCT01927341|467229946|FG004|Phase 1b|Death|0|||
129797982|NCT01927341|467229942|FG000|Phase 1b|Follow-up completed|7|||
129797983|NCT01927341|467229943|FG001|Phase 1b|Follow-up completed|0|||
129797984|NCT01927341|467229944|FG002|Phase 1b|Follow-up completed|0|||
129797985|NCT01927341|467229945|FG003|Phase 1b|Follow-up completed|0|||
129797986|NCT01927341|467229946|FG004|Phase 1b|Follow-up completed|0|||
129797987|NCT01927341|467229942|FG000|Phase 2|Lost to Follow-up|0|||
129797988|NCT01927341|467229943|FG001|Phase 2|Lost to Follow-up|1|||
129797989|NCT01927341|467229944|FG002|Phase 2|Lost to Follow-up|0|||
129797990|NCT01927341|467229945|FG003|Phase 2|Lost to Follow-up|0|||
129797991|NCT01927341|467229946|FG004|Phase 2|Lost to Follow-up|0|||
129797992|NCT01927341|467229942|FG000|Phase 2|Participant withdrew consent|0|||
129797993|NCT01927341|467229943|FG001|Phase 2|Participant withdrew consent|2|||
129797994|NCT01927341|467229944|FG002|Phase 2|Participant withdrew consent|1|||
129797995|NCT01927341|467229945|FG003|Phase 2|Participant withdrew consent|2|||
129797996|NCT01927341|467229946|FG004|Phase 2|Participant withdrew consent|3|||
129797997|NCT01927341|467229942|FG000|Phase 2|Death|0|||
129797998|NCT01927341|467229943|FG001|Phase 2|Death|4|||
129797999|NCT01927341|467229944|FG002|Phase 2|Death|0|||
129442790|NCT04091451|465919348|FG001|Overall Study|Protocol Violation|4|||
129442791|NCT04091451|465919347|FG000|Overall Study|Withdrawal by Subject|21|||
129798000|NCT01927341|467229945|FG003|Phase 2|Death|3|||
129798001|NCT01927341|467229946|FG004|Phase 2|Death|2|||
129442792|NCT04091451|465919348|FG001|Overall Study|Withdrawal by Subject|27|||
129442793|NCT04091451|465919347|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
129798002|NCT01927341|467229942|FG000|Phase 2|New cancer therapy|0|||
129798003|NCT01927341|467229943|FG001|Phase 2|New cancer therapy|1|||
129798004|NCT01927341|467229944|FG002|Phase 2|New cancer therapy|0|||
129798005|NCT01927341|467229945|FG003|Phase 2|New cancer therapy|4|||
129798006|NCT01927341|467229946|FG004|Phase 2|New cancer therapy|1|||
129798007|NCT01927341|467229942|FG000|Phase 2|Disease progression|0|||
129798008|NCT01927341|467229943|FG001|Phase 2|Disease progression|1|||
129798009|NCT01927341|467229944|FG002|Phase 2|Disease progression|1|||
129798010|NCT01927341|467229945|FG003|Phase 2|Disease progression|1|||
129798011|NCT01927341|467229946|FG004|Phase 2|Disease progression|0|||
129798012|NCT01927341|467229942|FG000|Phase 2|Follow-up completed|0|||
129798013|NCT01927341|467229943|FG001|Phase 2|Follow-up completed|6|||
129798014|NCT01927341|467229944|FG002|Phase 2|Follow-up completed|3|||
129798015|NCT01927341|467229945|FG003|Phase 2|Follow-up completed|5|||
129798016|NCT01927341|467229946|FG004|Phase 2|Follow-up completed|2|||
129798017|NCT01397201|467229947|FG000|Overall Study|Not treated|0|||
129798018|NCT01397201|467229948|FG001|Overall Study|Not treated|0|||
129798019|NCT01397201|467229949|FG002|Overall Study|Not treated|1|||
129798020|NCT01397201|467229950|FG003|Overall Study|Not treated|0|||
129798021|NCT01397201|467229951|FG004|Overall Study|Not treated|0|||
129798022|NCT01397201|467229947|FG000|Overall Study|Not yet defined|3|||
129798023|NCT01397201|467229948|FG001|Overall Study|Not yet defined|6|||
129798024|NCT01397201|467229949|FG002|Overall Study|Not yet defined|5|||
129798025|NCT01397201|467229950|FG003|Overall Study|Not yet defined|5|||
129798026|NCT01397201|467229951|FG004|Overall Study|Not yet defined|4|||
129798027|NCT01397201|467229947|FG000|Overall Study|Adverse Event|2|||
129798028|NCT01397201|467229948|FG001|Overall Study|Adverse Event|0|||
129798029|NCT01397201|467229949|FG002|Overall Study|Adverse Event|0|||
129798030|NCT01397201|467229950|FG003|Overall Study|Adverse Event|0|||
129798031|NCT01397201|467229951|FG004|Overall Study|Adverse Event|0|||
129798032|NCT00215683|467229952|FG000|Overall Study|Adverse Event|15|||
129798033|NCT00215683|467229953|FG001|Overall Study|Adverse Event|16|||
129798034|NCT00215683|467229954|FG002|Overall Study|Adverse Event|15|||
129798035|NCT00215683|467229952|FG000|Overall Study|Lack of Efficacy|5|||
129798036|NCT00215683|467229953|FG001|Overall Study|Lack of Efficacy|1|||
129798037|NCT00215683|467229954|FG002|Overall Study|Lack of Efficacy|2|||
129798038|NCT00215683|467229952|FG000|Overall Study|Lost to Follow-up|0|||
129798039|NCT00215683|467229953|FG001|Overall Study|Lost to Follow-up|2|||
129798040|NCT00215683|467229954|FG002|Overall Study|Lost to Follow-up|1|||
129798041|NCT00215683|467229952|FG000|Overall Study|Withdrawal by Subject|9|||
129798042|NCT00215683|467229953|FG001|Overall Study|Withdrawal by Subject|4|||
129798043|NCT00215683|467229954|FG002|Overall Study|Withdrawal by Subject|13|||
129798044|NCT00215683|467229952|FG000|Overall Study|Physician Decision|0|||
129798045|NCT00215683|467229953|FG001|Overall Study|Physician Decision|0|||
129798046|NCT00215683|467229954|FG002|Overall Study|Physician Decision|1|||
129798047|NCT00215683|467229952|FG000|Overall Study|Difficult to attend visits|0|||
129798048|NCT00215683|467229953|FG001|Overall Study|Difficult to attend visits|1|||
129798049|NCT00215683|467229954|FG002|Overall Study|Difficult to attend visits|0|||
129798050|NCT00215683|467229952|FG000|Overall Study|No study drug available|0|||
129798051|NCT00215683|467229953|FG001|Overall Study|No study drug available|1|||
129798052|NCT00215683|467229954|FG002|Overall Study|No study drug available|0|||
129798053|NCT00215683|467229952|FG000|Overall Study|Intermittent therapy required|0|||
129798054|NCT00215683|467229953|FG001|Overall Study|Intermittent therapy required|1|||
129798055|NCT00215683|467229954|FG002|Overall Study|Intermittent therapy required|0|||
129798056|NCT01083485|467229955|FG000|Overall Study|Adverse Event|0|||
129798057|NCT01083485|467229956|FG001|Overall Study|Adverse Event|1|||
129798058|NCT01083485|467229955|FG000|Overall Study|Protocol Violation|1|||
129798059|NCT01083485|467229956|FG001|Overall Study|Protocol Violation|0|||
129798060|NCT01083485|467229955|FG000|Overall Study|Withdrawal by Subject|5|||
129798061|NCT01083485|467229956|FG001|Overall Study|Withdrawal by Subject|2|||
129798062|NCT01083485|467229955|FG000|Overall Study|Other|1|||
129798063|NCT01083485|467229956|FG001|Overall Study|Other|0|||
129798064|NCT04493333|467229963|FG000|Overall Study|Withdrawal by Subject|1|||
129798065|NCT04493333|467229964|FG001|Overall Study|Withdrawal by Subject|1|||
129638834|NCT02477332|466631888|FG004|Overall Study|Technical problems|0|||
129638835|NCT02477332|466631889|FG005|Overall Study|Technical problems|0|||
129638836|NCT02477332|466631884|FG000|Overall Study|Lost to Follow-up|0|||
129638837|NCT02477332|466631885|FG001|Overall Study|Lost to Follow-up|0|||
129638838|NCT02477332|466631886|FG002|Overall Study|Lost to Follow-up|2|||
129638839|NCT02477332|466631887|FG003|Overall Study|Lost to Follow-up|0|||
129638840|NCT02477332|466631888|FG004|Overall Study|Lost to Follow-up|0|||
129638841|NCT02477332|466631889|FG005|Overall Study|Lost to Follow-up|0|||
129638842|NCT02477332|466631884|FG000|Overall Study|Physician Decision|0|||
129638843|NCT02477332|466631885|FG001|Overall Study|Physician Decision|0|||
129638844|NCT02477332|466631886|FG002|Overall Study|Physician Decision|1|||
129638845|NCT02477332|466631887|FG003|Overall Study|Physician Decision|3|||
129798066|NCT04493333|467229963|FG000|Overall Study|Ineligible|0|||
129798067|NCT04493333|467229964|FG001|Overall Study|Ineligible|1|||
129798068|NCT04493333|467229963|FG000|Overall Study|Noncompliance|2|||
129798069|NCT04493333|467229964|FG001|Overall Study|Noncompliance|1|||
129798070|NCT00451451|467229967|FG000|Overall Study|Adverse Event|11|||
129798071|NCT00451451|467229968|FG001|Overall Study|Adverse Event|21|||
129798072|NCT00451451|467229969|FG002|Overall Study|Adverse Event|26|||
129798073|NCT00451451|467229970|FG003|Overall Study|Adverse Event|10|||
129798074|NCT00451451|467229967|FG000|Overall Study|Lost to Follow-up|11|||
129798075|NCT00451451|467229968|FG001|Overall Study|Lost to Follow-up|9|||
129798076|NCT00451451|467229969|FG002|Overall Study|Lost to Follow-up|8|||
129798077|NCT00451451|467229970|FG003|Overall Study|Lost to Follow-up|11|||
129798078|NCT00451451|467229967|FG000|Overall Study|Consent Withdrawn|14|||
129638846|NCT02477332|466631888|FG004|Overall Study|Physician Decision|0|||
129638847|NCT02477332|466631889|FG005|Overall Study|Physician Decision|1|||
129638848|NCT02477332|466631884|FG000|Overall Study|Withdrawal by Subject|0|||
129798079|NCT00451451|467229968|FG001|Overall Study|Consent Withdrawn|9|||
129798080|NCT00451451|467229969|FG002|Overall Study|Consent Withdrawn|17|||
129798081|NCT00451451|467229970|FG003|Overall Study|Consent Withdrawn|17|||
129798082|NCT00451451|467229967|FG000|Overall Study|Investigator Decision|6|||
129798083|NCT00451451|467229968|FG001|Overall Study|Investigator Decision|2|||
129798084|NCT00451451|467229969|FG002|Overall Study|Investigator Decision|1|||
129798085|NCT00451451|467229970|FG003|Overall Study|Investigator Decision|2|||
129798086|NCT00451451|467229967|FG000|Overall Study|Subject Non-Compliance|8|||
129798087|NCT00451451|467229968|FG001|Overall Study|Subject Non-Compliance|4|||
129798088|NCT00451451|467229969|FG002|Overall Study|Subject Non-Compliance|3|||
129798089|NCT00451451|467229970|FG003|Overall Study|Subject Non-Compliance|3|||
129798090|NCT00451451|467229967|FG000|Overall Study|Death|1|||
129798091|NCT00451451|467229968|FG001|Overall Study|Death|0|||
129798092|NCT00451451|467229969|FG002|Overall Study|Death|0|||
129798093|NCT00451451|467229970|FG003|Overall Study|Death|1|||
129798094|NCT00451451|467229967|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
129798095|NCT00451451|467229968|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
129798096|NCT00451451|467229969|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
129798097|NCT00451451|467229970|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
129798098|NCT01002482|467229971|FG000|Overall Study|Withdrawal by Subject|14|||
129798099|NCT01002482|467229972|FG001|Overall Study|Withdrawal by Subject|21|||
129798100|NCT01002482|467229971|FG000|Overall Study|Included twice|1|||
129798101|NCT01002482|467229972|FG001|Overall Study|Included twice|0|||
129798102|NCT01865084|467229973|FG000|Double Blind Period (DB)|Adverse Event|2|||
129798103|NCT01865084|467229974|FG001|Double Blind Period (DB)|Adverse Event|2|||
129798104|NCT01865084|467229975|FG002|Double Blind Period (DB)|Adverse Event|1|||
129798105|NCT01865084|467229973|FG000|Double Blind Period (DB)|Protocol Violation|0|||
129798106|NCT01865084|467229974|FG001|Double Blind Period (DB)|Protocol Violation|0|||
129798107|NCT01865084|467229975|FG002|Double Blind Period (DB)|Protocol Violation|1|||
129798108|NCT01865084|467229973|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
129798109|NCT01865084|467229974|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
129798110|NCT01865084|467229975|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
129798111|NCT01865084|467229973|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
129798112|NCT01865084|467229974|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
129798113|NCT01865084|467229975|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
129798114|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
129798115|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
129889478|NCT00946647|467552608|FG002|Phase ll Part|Death|0|||
129889479|NCT00946647|467552609|FG003|Phase ll Part|Death|7|||
129889480|NCT00946647|467552610|FG004|Phase ll Part|Death|4|||
129638849|NCT02477332|466631885|FG001|Overall Study|Withdrawal by Subject|3|||
129798116|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
129798117|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
129798118|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
129798119|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
129889481|NCT00946647|467552606|FG000|Phase ll Part|Disease progression|0|||
129704959|NCT05067335|466884101|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
129704960|NCT05067335|466884102|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
129704961|NCT05067335|466884103|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
129704962|NCT05067335|466884100|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
129704963|NCT05067335|466884101|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
129704964|NCT05067335|466884102|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
129704965|NCT05067335|466884103|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
129704966|NCT05067335|466884100|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
129704967|NCT05067335|466884101|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
129704968|NCT05067335|466884102|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
129704969|NCT05067335|466884103|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
129704970|NCT05067335|466884100|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
129704971|NCT05067335|466884101|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
129704972|NCT05067335|466884102|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
129704973|NCT05067335|466884103|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
129889482|NCT00946647|467552607|FG001|Phase ll Part|Disease progression|0|||
129442794|NCT04091451|465919348|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
129442795|NCT04091451|465919347|FG000|Overall Study|Migrated/moved from the study area|3|||
129707654|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
129707655|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
129442796|NCT04091451|465919348|FG001|Overall Study|Migrated/moved from the study area|5|||
129707656|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
129707657|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
129707658|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
129707659|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
129707660|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
129707661|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
129704974|NCT05067335|466884100|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
129704975|NCT05067335|466884101|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
129704976|NCT05067335|466884102|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
129704977|NCT05067335|466884103|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
129704978|NCT05067335|466884100|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
129704979|NCT05067335|466884101|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
129704980|NCT05067335|466884102|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
129704981|NCT05067335|466884103|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
129704982|NCT01645176|466884104|FG000|Overall Study|Lack of Efficacy|4|||
129704983|NCT01645176|466884104|FG000|Overall Study|did not complete final MRI|1|||
129704984|NCT02234362|466884105|FG000|Overall Study|Not eligible after first screening visit|17|||
129704985|NCT02234362|466884105|FG000|Overall Study|Lost to Follow-up|6|||
129704986|NCT02234362|466884105|FG000|Overall Study|Withdrawal by Subject|3|||
129704987|NCT00560417|466884106|FG000|Overall Study|Adverse Event|3|||
129704988|NCT00560417|466884107|FG001|Overall Study|Adverse Event|2|||
129704989|NCT00560417|466884106|FG000|Overall Study|Entry Criteria Not Met|1|||
129704990|NCT00560417|466884107|FG001|Overall Study|Entry Criteria Not Met|0|||
129704991|NCT00560417|466884106|FG000|Overall Study|Lost to Follow-up|0|||
129704992|NCT00560417|466884107|FG001|Overall Study|Lost to Follow-up|1|||
129704993|NCT00560417|466884106|FG000|Overall Study|Physician Decision|2|||
129704994|NCT00560417|466884107|FG001|Overall Study|Physician Decision|6|||
129704995|NCT00560417|466884106|FG000|Overall Study|Protocol Violation|6|||
129704996|NCT00560417|466884107|FG001|Overall Study|Protocol Violation|5|||
129704997|NCT00560417|466884106|FG000|Overall Study|Sponsor Decision|2|||
129704998|NCT00560417|466884107|FG001|Overall Study|Sponsor Decision|0|||
129704999|NCT00560417|466884106|FG000|Overall Study|Withdrawal by Subject|3|||
129705000|NCT00560417|466884107|FG001|Overall Study|Withdrawal by Subject|3|||
129705001|NCT02164864|466884108|FG000|Overall Study|Trial disease worsening|7|||
129705002|NCT02164864|466884109|FG001|Overall Study|Trial disease worsening|5|||
129705003|NCT02164864|466884110|FG002|Overall Study|Trial disease worsening|1|||
129705004|NCT02164864|466884108|FG000|Overall Study|Other pre-existing disease worsening|6|||
129705005|NCT02164864|466884109|FG001|Overall Study|Other pre-existing disease worsening|4|||
129705006|NCT02164864|466884110|FG002|Overall Study|Other pre-existing disease worsening|9|||
129705007|NCT02164864|466884108|FG000|Overall Study|Other Adverse Event (AE)|52|||
129705008|NCT02164864|466884109|FG001|Overall Study|Other Adverse Event (AE)|32|||
129705009|NCT02164864|466884110|FG002|Overall Study|Other Adverse Event (AE)|49|||
129705010|NCT02164864|466884108|FG000|Overall Study|Protocol Violation|2|||
129705011|NCT02164864|466884109|FG001|Overall Study|Protocol Violation|4|||
129705012|NCT02164864|466884110|FG002|Overall Study|Protocol Violation|1|||
129705013|NCT02164864|466884108|FG000|Overall Study|Lost to Follow-up|4|||
129442797|NCT04091451|465919347|FG000|Overall Study|Suspected HZ episode|1|||
129442798|NCT04091451|465919348|FG001|Overall Study|Suspected HZ episode|0|||
129442799|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
129442800|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
129442801|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
129442802|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
129442803|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
129442804|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
129442805|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
129442806|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
129442807|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
129442808|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
129442809|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
129442810|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
129442811|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Death|3|||
129442812|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Death|1|||
129442813|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
129442814|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
129442815|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Adverse Event|7|||
129442816|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Adverse Event|8|||
129442817|NCT03236246|465921112|FG000|24-Week Dose Titration Period|Captured as Other|1|||
129442818|NCT03236246|465921113|FG001|24-Week Dose Titration Period|Captured as Other|2|||
129442819|NCT03236246|465921112|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
129442820|NCT03236246|465921113|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
129442821|NCT03236246|465921112|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
129442822|NCT03236246|465921113|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
129442823|NCT03236246|465921112|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
129442824|NCT03236246|465921113|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
129442825|NCT03236246|465921112|FG000|24-Week Dose Maintenance Period|Death|0|||
129442826|NCT03236246|465921113|FG001|24-Week Dose Maintenance Period|Death|1|||
129442827|NCT03236246|465921112|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
129442828|NCT03236246|465921113|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
129442829|NCT02598557|465921114|FG000|Overall Study|Withdrawal by Subject|1|||
129442830|NCT02598557|465921115|FG001|Overall Study|Withdrawal by Subject|0|||
129442831|NCT02598557|465921116|FG002|Overall Study|Withdrawal by Subject|1|||
129442832|NCT02598557|465921114|FG000|Overall Study|Participant did not start treatment|2|||
129442833|NCT02598557|465921115|FG001|Overall Study|Participant did not start treatment|1|||
129442834|NCT02598557|465921116|FG002|Overall Study|Participant did not start treatment|1|||
129442835|NCT02598557|465921114|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
129442836|NCT02598557|465921115|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
129442837|NCT02598557|465921116|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
129442838|NCT02598557|465921114|FG000|Overall Study|Adverse Event|1|||
129442839|NCT02598557|465921115|FG001|Overall Study|Adverse Event|1|||
129442840|NCT02598557|465921116|FG002|Overall Study|Adverse Event|0|||
129442841|NCT02076113|465921119|FG000|Overall Study|Lost to Follow-up|4|||
129442842|NCT02076113|465921120|FG001|Overall Study|Lost to Follow-up|1|||
129442843|NCT02076113|465921119|FG000|Overall Study|Withdrawal by Subject|2|||
129442844|NCT02076113|465921120|FG001|Overall Study|Withdrawal by Subject|3|||
129442845|NCT02076113|465921119|FG000|Overall Study|Death|1|||
129442846|NCT02076113|465921120|FG001|Overall Study|Death|3|||
129442847|NCT01383161|465921123|FG000|Overall Study|Adverse Event|5|||
129442848|NCT01383161|465921124|FG001|Overall Study|Adverse Event|1|||
129442849|NCT01383161|465921123|FG000|Overall Study|Withdrawal by Subject|0|||
129705014|NCT02164864|466884109|FG001|Overall Study|Lost to Follow-up|3|||
129705015|NCT02164864|466884110|FG002|Overall Study|Lost to Follow-up|2|||
129442850|NCT01383161|465921124|FG001|Overall Study|Withdrawal by Subject|2|||
129442851|NCT01383161|465921123|FG000|Overall Study|Lack of Efficacy|0|||
129442852|NCT01383161|465921124|FG001|Overall Study|Lack of Efficacy|1|||
129442853|NCT03942406|465921131|FG000|Overall Study|Lost to Follow-up|4|||
129442854|NCT03942406|465921132|FG001|Overall Study|Lost to Follow-up|5|||
129442855|NCT03942406|465921133|FG002|Overall Study|Lost to Follow-up|3|||
129442856|NCT03942406|465921134|FG003|Overall Study|Lost to Follow-up|7|||
129442857|NCT03942406|465921135|FG004|Overall Study|Lost to Follow-up|1|||
129442858|NCT03942406|465921136|FG005|Overall Study|Lost to Follow-up|0|||
129442859|NCT03942406|465921137|FG006|Overall Study|Lost to Follow-up|0|||
129442860|NCT03942406|465921131|FG000|Overall Study|Withdrawal by Subject|3|||
129442861|NCT03942406|465921132|FG001|Overall Study|Withdrawal by Subject|1|||
129442862|NCT03942406|465921133|FG002|Overall Study|Withdrawal by Subject|1|||
129442863|NCT03942406|465921134|FG003|Overall Study|Withdrawal by Subject|3|||
129442864|NCT03942406|465921135|FG004|Overall Study|Withdrawal by Subject|0|||
129442865|NCT03942406|465921136|FG005|Overall Study|Withdrawal by Subject|0|||
129442866|NCT03942406|465921137|FG006|Overall Study|Withdrawal by Subject|0|||
129442867|NCT03942406|465921131|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
129798120|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
129798121|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
129798122|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
129798123|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
129798124|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
129798125|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
129798126|NCT01865084|467229973|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
129798127|NCT01865084|467229974|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
129798128|NCT01865084|467229975|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
129798129|NCT03607422|467229979|FG000|Overall Study|Adverse Event|7|||
129798130|NCT03607422|467229980|FG001|Overall Study|Adverse Event|3|||
129442868|NCT03942406|465921132|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
129442869|NCT03942406|465921133|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
129442870|NCT03942406|465921134|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
129442871|NCT03942406|465921135|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
129442872|NCT03942406|465921136|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
129442873|NCT03942406|465921137|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
129798131|NCT03607422|467229981|FG002|Overall Study|Adverse Event|2|||
129798132|NCT03607422|467229982|FG003|Overall Study|Adverse Event|0|||
129798133|NCT03607422|467229983|FG004|Overall Study|Adverse Event|2|||
129798134|NCT03607422|467229984|FG005|Overall Study|Adverse Event|0|||
129442874|NCT05628285|465921138|FG000|Overall Study|Lost to Follow-up|1|||
129638850|NCT02477332|466631886|FG002|Overall Study|Withdrawal by Subject|1|||
129798135|NCT03607422|467229979|FG000|Overall Study|Withdrawal by Subject|11|||
129798136|NCT03607422|467229980|FG001|Overall Study|Withdrawal by Subject|3|||
129798137|NCT03607422|467229981|FG002|Overall Study|Withdrawal by Subject|6|||
129798138|NCT03607422|467229982|FG003|Overall Study|Withdrawal by Subject|2|||
129798139|NCT03607422|467229983|FG004|Overall Study|Withdrawal by Subject|0|||
129798140|NCT03607422|467229984|FG005|Overall Study|Withdrawal by Subject|0|||
129798141|NCT03607422|467229979|FG000|Overall Study|Lost to Follow-up|0|||
129798142|NCT03607422|467229980|FG001|Overall Study|Lost to Follow-up|0|||
129798143|NCT03607422|467229981|FG002|Overall Study|Lost to Follow-up|1|||
129798144|NCT03607422|467229982|FG003|Overall Study|Lost to Follow-up|0|||
129798145|NCT03607422|467229983|FG004|Overall Study|Lost to Follow-up|0|||
129798146|NCT03607422|467229984|FG005|Overall Study|Lost to Follow-up|0|||
129798147|NCT03607422|467229979|FG000|Overall Study|Other|12|||
129798148|NCT03607422|467229980|FG001|Overall Study|Other|4|||
129798149|NCT03607422|467229981|FG002|Overall Study|Other|1|||
129798150|NCT03607422|467229982|FG003|Overall Study|Other|2|||
129798151|NCT03607422|467229983|FG004|Overall Study|Other|0|||
129798152|NCT03607422|467229984|FG005|Overall Study|Other|2|||
129889483|NCT00946647|467552608|FG002|Phase ll Part|Disease progression|0|||
129889484|NCT00946647|467552609|FG003|Phase ll Part|Disease progression|6|||
129638851|NCT02477332|466631887|FG003|Overall Study|Withdrawal by Subject|2|||
129638852|NCT02477332|466631888|FG004|Overall Study|Withdrawal by Subject|1|||
129638853|NCT02477332|466631889|FG005|Overall Study|Withdrawal by Subject|0|||
129638854|NCT03793842|466631890|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
129638855|NCT03793842|466631891|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
129638856|NCT03793842|466631890|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
129638857|NCT03793842|466631891|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
129638858|NCT02549287|466631892|FG000|Overall Study|Lost to Follow-up|65|||
129638859|NCT02549287|466631893|FG001|Overall Study|Lost to Follow-up|26|||
129638860|NCT02549287|466631892|FG000|Overall Study|Withdrawal by Subject|15|||
129638861|NCT02549287|466631893|FG001|Overall Study|Withdrawal by Subject|6|||
129638862|NCT00427921|466631894|FG000|Overall Study|Adverse Event|26|||
129638863|NCT00427921|466631894|FG000|Overall Study|Withdrawal by Subject|4|||
129638864|NCT00427921|466631894|FG000|Overall Study|Lost to Follow-up|2|||
129638865|NCT00427921|466631894|FG000|Overall Study|Other reason not specified|10|||
129638866|NCT00427921|466631894|FG000|Overall Study|Adverse Event + Hospitalization|1|||
129638867|NCT00427921|466631894|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
129638868|NCT00427921|466631894|FG000|Overall Study|Adverse Event + No Response|1|||
129638869|NCT00427921|466631894|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
129638870|NCT00427921|466631894|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
129638871|NCT00427921|466631894|FG000|Overall Study|Adverse Event + Lost Response|1|||
129798153|NCT03607422|467229979|FG000|Overall Study|Ongoing at Time of Analysis|8|||
129798154|NCT03607422|467229980|FG001|Overall Study|Ongoing at Time of Analysis|0|||
129889485|NCT00946647|467552610|FG004|Phase ll Part|Disease progression|14|||
129798155|NCT03607422|467229981|FG002|Overall Study|Ongoing at Time of Analysis|2|||
129798156|NCT03607422|467229982|FG003|Overall Study|Ongoing at Time of Analysis|1|||
129798157|NCT03607422|467229983|FG004|Overall Study|Ongoing at Time of Analysis|1|||
129798158|NCT03607422|467229984|FG005|Overall Study|Ongoing at Time of Analysis|1|||
129798159|NCT03693170|467229985|FG000|Overall Study|Disease Progression|48|||
129889486|NCT00946647|467552606|FG000|Phase ll Part|Protocol Violation|0|||
129798160|NCT03693170|467229985|FG000|Overall Study|Adverse Event|16|||
129798161|NCT03693170|467229985|FG000|Overall Study|Physician Decision|6|||
129798162|NCT03693170|467229985|FG000|Overall Study|Protocol Violation|2|||
129798163|NCT03693170|467229985|FG000|Overall Study|Death|1|||
129798164|NCT03693170|467229985|FG000|Overall Study|Non compliance with study drug|1|||
129798165|NCT03693170|467229985|FG000|Overall Study|Withdrawal by Subject|1|||
129798166|NCT01442038|467229988|FG000|Overall Study|Death|35|||
129798167|NCT01442038|467229989|FG001|Overall Study|Death|29|||
129798168|NCT01442038|467229988|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
129798169|NCT01442038|467229989|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
129798170|NCT01442038|467229988|FG000|Overall Study|Participant Withdrew Consent|137|||
129798171|NCT01442038|467229989|FG001|Overall Study|Participant Withdrew Consent|102|||
129798172|NCT01442038|467229988|FG000|Overall Study|Lost to Follow-up|37|||
129798173|NCT01442038|467229989|FG001|Overall Study|Lost to Follow-up|51|||
129798174|NCT01442038|467229988|FG000|Overall Study|Adverse Event|26|||
129798175|NCT01442038|467229989|FG001|Overall Study|Adverse Event|15|||
129798176|NCT01442038|467229988|FG000|Overall Study|Protocol Deviation|9|||
129798177|NCT01442038|467229989|FG001|Overall Study|Protocol Deviation|20|||
129798178|NCT01442038|467229988|FG000|Overall Study|Investigator's Discretion|13|||
129638872|NCT00427921|466631894|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
129638873|NCT00427921|466631894|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
129638874|NCT00900159|466631895|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
129638875|NCT00900159|466631896|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
129638876|NCT01166438|466631897|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
129638877|NCT01166438|466631898|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
129638878|NCT01166438|466631897|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
129638879|NCT01166438|466631898|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
129638880|NCT01166438|466631897|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
129638881|NCT01166438|466631898|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
129638882|NCT01166438|466631897|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
129638883|NCT01166438|466631898|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
129638884|NCT01166438|466631897|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
129638885|NCT01166438|466631898|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
129638886|NCT01166438|466631897|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
129638887|NCT01166438|466631898|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
129638888|NCT00347009|466631903|FG000|Overall Study|Death|1|||
129638889|NCT00347009|466631903|FG000|Overall Study|Adverse Event|6|||
129638890|NCT00347009|466631903|FG000|Overall Study|Withdrawal by Subject|3|||
129638891|NCT00347009|466631903|FG000|Overall Study|Physician Decision|5|||
129638892|NCT00347009|466631903|FG000|Overall Study|Lost to Follow-up|4|||
129638893|NCT00347009|466631903|FG000|Overall Study|Protocol Violation|2|||
129638894|NCT00347009|466631903|FG000|Overall Study|Adverse Laboratory Experience|1|||
129638895|NCT00347009|466631903|FG000|Overall Study|Insufficient Viral Suppression|3|||
129638896|NCT00347009|466631903|FG000|Overall Study|Increased ALT/HBV DNA|1|||
129638897|NCT00347009|466631903|FG000|Overall Study|Serious Adverse Event|1|||
129638898|NCT01972438|466631905|FG000|Baseline-Month 3 Crossover Period|Death|1|||
129638899|NCT01972438|466631906|FG001|Baseline-Month 3 Crossover Period|Death|0|||
129638900|NCT01972438|466631905|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
129638901|NCT01972438|466631906|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
129638902|NCT01972438|466631905|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
129638903|NCT01972438|466631906|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
129798179|NCT01442038|467229989|FG001|Overall Study|Investigator's Discretion|16|||
129798180|NCT01442038|467229988|FG000|Overall Study|Study Terminated By Sponsor|2|||
129798181|NCT01442038|467229989|FG001|Overall Study|Study Terminated By Sponsor|3|||
129798182|NCT00089284|467229990|FG000|Overall Study|Adverse event before starting treatment|0|||
129889487|NCT00946647|467552607|FG001|Phase ll Part|Protocol Violation|0|||
129638904|NCT01972438|466631905|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
129638905|NCT01972438|466631906|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
129638906|NCT01972438|466631905|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
129638907|NCT01972438|466631906|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
129638908|NCT01972438|466631905|FG000|Months 6-12 Study Period|Death|1|||
129638909|NCT01972438|466631906|FG001|Months 6-12 Study Period|Death|0|||
129638910|NCT01972438|466631905|FG000|Months 6-12 Study Period|Early Study Closure|2|||
129638911|NCT01972438|466631906|FG001|Months 6-12 Study Period|Early Study Closure|2|||
129638912|NCT01972438|466631905|FG000|Post Month 12 Study Period|Early Study Closure|3|||
129638913|NCT01972438|466631906|FG001|Post Month 12 Study Period|Early Study Closure|4|||
129638914|NCT01186692|466631909|FG000|Overall Study|Not Catheterized|11|||
129638915|NCT01186692|466631909|FG000|Overall Study|Futher testing contraindicated implant|19|||
129638916|NCT01186692|466631909|FG000|Overall Study|Adverse Event|2|||
129638917|NCT00596817|466631910|FG000|Open-label Period|Adverse Event|0|||
129638918|NCT00596817|466631911|FG001|Open-label Period|Adverse Event|49|||
129638919|NCT00596817|466631910|FG000|Open-label Period|Lack of Efficacy|0|||
129638920|NCT00596817|466631911|FG001|Open-label Period|Lack of Efficacy|33|||
129638921|NCT00596817|466631910|FG000|Open-label Period|Other Reasons|0|||
129638922|NCT00596817|466631911|FG001|Open-label Period|Other Reasons|65|||
129638923|NCT00596817|466631910|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
129638924|NCT00596817|466631911|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
129638925|NCT00596817|466631910|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
129638926|NCT00596817|466631911|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
129638927|NCT00596817|466631910|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
129638928|NCT00596817|466631911|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
129638929|NCT00596817|466631910|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
129638930|NCT00596817|466631911|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
129638931|NCT00596817|466631910|FG000|Double-blind Period|Adverse Event|5|||
129638932|NCT00596817|466631911|FG001|Double-blind Period|Adverse Event|16|||
129638933|NCT00596817|466631910|FG000|Double-blind Period|Lack of Efficacy|52|||
129638934|NCT00596817|466631911|FG001|Double-blind Period|Lack of Efficacy|28|||
129638935|NCT00596817|466631910|FG000|Double-blind Period|Non-compliance With Study Product|3|||
129638936|NCT00596817|466631911|FG001|Double-blind Period|Non-compliance With Study Product|4|||
129638937|NCT00596817|466631910|FG000|Double-blind Period|Protocol Violation|11|||
129638938|NCT00596817|466631911|FG001|Double-blind Period|Protocol Violation|8|||
129638939|NCT00596817|466631910|FG000|Double-blind Period|Withdrawal of Consent|7|||
129638940|NCT00596817|466631911|FG001|Double-blind Period|Withdrawal of Consent|3|||
129638941|NCT00596817|466631910|FG000|Double-blind Period|Lost to Follow-up|0|||
129638942|NCT00596817|466631911|FG001|Double-blind Period|Lost to Follow-up|2|||
129638943|NCT00596817|466631910|FG000|Double-blind Period|Other Reasons|10|||
129638944|NCT00596817|466631911|FG001|Double-blind Period|Other Reasons|18|||
129638945|NCT00679029|466633048|FG000|Overall Study|Adverse Event|3|||
129638946|NCT00679029|466633048|FG000|Overall Study|Withdrawal by Subject|1|||
129638947|NCT00679029|466633048|FG000|Overall Study|Lost to Follow-up|1|||
129638948|NCT01108341|466633049|FG000|Overall Study|Death|2|||
129638949|NCT01108341|466633049|FG000|Overall Study|Withdrawal by Subject|1|||
129638950|NCT01108341|466633049|FG000|Overall Study|Lost to Follow-up|1|||
129638951|NCT01108341|466633049|FG000|Overall Study|Other|1|||
129638952|NCT04402138|466633050|FG000|Overall Study|Progressive Disease|2|||
129638953|NCT04402138|466633050|FG000|Overall Study|Adverse Event|1|||
129638954|NCT00596687|466633053|FG000|Overall Study|< 24 hours of insulin treatment|8|||
129638955|NCT00596687|466633054|FG001|Overall Study|< 24 hours of insulin treatment|6|||
129638956|NCT00596687|466633053|FG000|Overall Study|continuous insulin infusion during TPN|2|||
129638957|NCT00596687|466633054|FG001|Overall Study|continuous insulin infusion during TPN|1|||
129638958|NCT00596687|466633053|FG000|Overall Study|Withdrawal by Subject|3|||
129638959|NCT00596687|466633054|FG001|Overall Study|Withdrawal by Subject|1|||
129638960|NCT00596687|466633053|FG000|Overall Study|cancelled surgery|1|||
129638961|NCT00596687|466633054|FG001|Overall Study|cancelled surgery|1|||
129638962|NCT01284348|466633057|FG000|Overall Study|Death|1|||
129638963|NCT01284348|466633058|FG001|Overall Study|Death|1|||
129638964|NCT01284348|466633057|FG000|Overall Study|Withdrew consent|0|||
129638965|NCT01284348|466633058|FG001|Overall Study|Withdrew consent|1|||
129638966|NCT01284348|466633057|FG000|Overall Study|Status not recorded|9|||
129798183|NCT00089284|467229991|FG001|Overall Study|Adverse event before starting treatment|0|||
129798184|NCT00089284|467229992|FG002|Overall Study|Adverse event before starting treatment|0|||
129638967|NCT01284348|466633058|FG001|Overall Study|Status not recorded|10|||
129638968|NCT03645395|466633065|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
129638969|NCT03645395|466633066|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
129638970|NCT03645395|466633067|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
129638971|NCT03645395|466633068|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
129638972|NCT03645395|466633065|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
129638973|NCT03645395|466633066|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
129638974|NCT03645395|466633067|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
129638975|NCT03645395|466633068|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
129638976|NCT03645395|466633065|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
129638977|NCT03645395|466633066|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
129638978|NCT03645395|466633067|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
129638979|NCT03645395|466633068|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
129638980|NCT03645395|466633065|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
129638981|NCT03645395|466633066|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
129638982|NCT03645395|466633067|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
129638983|NCT03645395|466633068|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
129638984|NCT01057810|466633069|FG000|Overall Study|Disease progression|156|||
129638985|NCT01057810|466633070|FG001|Overall Study|Disease progression|197|||
129638986|NCT01057810|466633069|FG000|Overall Study|Study drug toxicity|5|||
129638987|NCT01057810|466633070|FG001|Overall Study|Study drug toxicity|114|||
129638988|NCT01057810|466633069|FG000|Overall Study|Adverse event unrelated to study drug|13|||
129638989|NCT01057810|466633070|FG001|Overall Study|Adverse event unrelated to study drug|29|||
129638990|NCT01057810|466633069|FG000|Overall Study|Withdrawal by Subject|10|||
129638991|NCT01057810|466633070|FG001|Overall Study|Withdrawal by Subject|25|||
129638992|NCT01057810|466633069|FG000|Overall Study|Death|2|||
129638993|NCT01057810|466633070|FG001|Overall Study|Death|12|||
129638994|NCT01057810|466633069|FG000|Overall Study|Maximum clinical benefit|5|||
129638995|NCT01057810|466633070|FG001|Overall Study|Maximum clinical benefit|5|||
129638996|NCT01057810|466633069|FG000|Overall Study|Poor/non-compliance|0|||
129638997|NCT01057810|466633070|FG001|Overall Study|Poor/non-compliance|1|||
129638998|NCT01057810|466633069|FG000|Overall Study|No longer met study criteria|0|||
129638999|NCT01057810|466633070|FG001|Overall Study|No longer met study criteria|1|||
129639000|NCT01057810|466633069|FG000|Overall Study|Other|7|||
129639001|NCT01057810|466633070|FG001|Overall Study|Other|14|||
129639002|NCT02088905|466633071|FG000|Overall Study|Withdrawal by Subject|5|||
129639003|NCT02088905|466633072|FG001|Overall Study|Withdrawal by Subject|1|||
129639004|NCT01091662|466633073|FG000|Overall Study|Adverse Event|1|||
129639005|NCT01091662|466633074|FG001|Overall Study|Adverse Event|9|||
129639006|NCT01091662|466633073|FG000|Overall Study|Physician Decision|1|||
129639007|NCT01091662|466633074|FG001|Overall Study|Physician Decision|1|||
129639008|NCT01091662|466633073|FG000|Overall Study|Withdrawal by Subject|7|||
129639009|NCT01091662|466633074|FG001|Overall Study|Withdrawal by Subject|6|||
129705016|NCT02164864|466884108|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
129705017|NCT02164864|466884109|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
129705018|NCT02164864|466884110|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
129705019|NCT02164864|466884108|FG000|Overall Study|Other than stated|3|||
129705020|NCT02164864|466884109|FG001|Overall Study|Other than stated|4|||
129705021|NCT02164864|466884110|FG002|Overall Study|Other than stated|14|||
129705022|NCT02569853|466884113|FG000|Overall Study|Adverse Event|2|||
129705023|NCT02569853|466884114|FG001|Overall Study|Adverse Event|0|||
129705024|NCT02569853|466884113|FG000|Overall Study|Withdrawal by Subject|3|||
129705025|NCT02569853|466884114|FG001|Overall Study|Withdrawal by Subject|2|||
129705026|NCT02569853|466884113|FG000|Overall Study|Lost to Follow-up|3|||
129705027|NCT02569853|466884114|FG001|Overall Study|Lost to Follow-up|3|||
129705028|NCT02569853|466884113|FG000|Overall Study|Protocol Violation|1|||
129705029|NCT02569853|466884114|FG001|Overall Study|Protocol Violation|1|||
129705030|NCT02569853|466884113|FG000|Overall Study|Did not experience migraine attack|10|||
129705031|NCT02569853|466884114|FG001|Overall Study|Did not experience migraine attack|7|||
129705032|NCT02569853|466884113|FG000|Overall Study|Physician Decision|1|||
129705033|NCT02569853|466884114|FG001|Overall Study|Physician Decision|1|||
129705034|NCT00261833|466884115|FG000|Overall Study|Death|1|||
129705035|NCT00261833|466884116|FG001|Overall Study|Death|3|||
129705036|NCT00261833|466884115|FG000|Overall Study|Adverse Event|1|||
129705037|NCT00261833|466884116|FG001|Overall Study|Adverse Event|4|||
129705038|NCT00261833|466884115|FG000|Overall Study|Withdrawal by Subject|5|||
129705039|NCT00261833|466884116|FG001|Overall Study|Withdrawal by Subject|7|||
129705040|NCT00261833|466884115|FG000|Overall Study|Protocol Violation|0|||
129705041|NCT00261833|466884116|FG001|Overall Study|Protocol Violation|1|||
129705042|NCT00261833|466884115|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
129705043|NCT00261833|466884116|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
129705044|NCT00261833|466884115|FG000|Overall Study|Lung transplantation|1|||
129705045|NCT00261833|466884116|FG001|Overall Study|Lung transplantation|1|||
129705046|NCT00261833|466884115|FG000|Overall Study|Missing reason|1|||
129639010|NCT01091662|466633073|FG000|Overall Study|met exit criteria|7|||
129639011|NCT01091662|466633074|FG001|Overall Study|met exit criteria|13|||
129705047|NCT00261833|466884116|FG001|Overall Study|Missing reason|0|||
129705048|NCT00261833|466884115|FG000|Overall Study|Not interested in being participant|0|||
129705049|NCT00261833|466884116|FG001|Overall Study|Not interested in being participant|1|||
129705050|NCT00622726|466884117|FG000|March, 2008 to August, 2010|Death|5|||
129705051|NCT00622726|466884118|FG001|March, 2008 to August, 2010|Death|2|||
129705052|NCT00622726|466884117|FG000|August, 2010 to April, 2013|Death|1|||
129889488|NCT00946647|467552608|FG002|Phase ll Part|Protocol Violation|0|||
129639012|NCT01091662|466633073|FG000|Overall Study|met exclusion criteria|1|||
129639013|NCT01091662|466633074|FG001|Overall Study|met exclusion criteria|0|||
129639014|NCT01091662|466633073|FG000|Overall Study|Lost to Follow-up|0|||
129639015|NCT01091662|466633074|FG001|Overall Study|Lost to Follow-up|1|||
129639016|NCT01091662|466633073|FG000|Overall Study|Pregnancy|0|||
129639017|NCT01091662|466633074|FG001|Overall Study|Pregnancy|1|||
129639018|NCT01091662|466633073|FG000|Overall Study|Protocol Violation|0|||
129639019|NCT01091662|466633074|FG001|Overall Study|Protocol Violation|2|||
129639020|NCT01091662|466633073|FG000|Overall Study|unable to swallow capsule|0|||
129639021|NCT01091662|466633074|FG001|Overall Study|unable to swallow capsule|1|||
129639022|NCT01222520|466633075|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
129639023|NCT01222520|466633076|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
129639024|NCT01222520|466633075|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
129639025|NCT01222520|466633076|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
129639026|NCT01222520|466633075|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
129639027|NCT01222520|466633076|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
129639028|NCT01222520|466633075|FG000|Double-blind Period|Adverse Event|0|||
129639029|NCT01222520|466633076|FG001|Double-blind Period|Adverse Event|1|||
129639030|NCT01222520|466633075|FG000|Double-blind Period|Lack of Efficacy|0|||
129639031|NCT01222520|466633076|FG001|Double-blind Period|Lack of Efficacy|1|||
129639032|NCT01222520|466633075|FG000|Double-blind Period|Study medication stolen|1|||
129639033|NCT01222520|466633076|FG001|Double-blind Period|Study medication stolen|0|||
129639034|NCT04109391|466633077|FG000|Overall Study|Adverse Event|2|||
129639035|NCT04109391|466633078|FG001|Overall Study|Adverse Event|2|||
129639036|NCT04109391|466633079|FG002|Overall Study|Adverse Event|0|||
129639037|NCT04109391|466633077|FG000|Overall Study|Withdrawal by Subject|2|||
129639038|NCT04109391|466633078|FG001|Overall Study|Withdrawal by Subject|0|||
129639039|NCT04109391|466633079|FG002|Overall Study|Withdrawal by Subject|0|||
129639040|NCT04109391|466633077|FG000|Overall Study|Pregnancy|1|||
129639041|NCT04109391|466633078|FG001|Overall Study|Pregnancy|0|||
129639042|NCT04109391|466633079|FG002|Overall Study|Pregnancy|0|||
129639043|NCT04109391|466633077|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
129639044|NCT04109391|466633078|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
129639045|NCT04109391|466633079|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
129639046|NCT04109391|466633077|FG000|Overall Study|Lost to Follow-up|0|||
129639047|NCT04109391|466633078|FG001|Overall Study|Lost to Follow-up|0|||
129639048|NCT04109391|466633079|FG002|Overall Study|Lost to Follow-up|1|||
129639049|NCT04109391|466633077|FG000|Overall Study|Lack of Efficacy|2|||
129639050|NCT04109391|466633078|FG001|Overall Study|Lack of Efficacy|2|||
129639051|NCT04109391|466633079|FG002|Overall Study|Lack of Efficacy|3|||
129639052|NCT01089608|466633082|FG000|Overall Study|Adverse Event|0|||
129639053|NCT01089608|466633083|FG001|Overall Study|Adverse Event|4|||
129639054|NCT01089608|466633082|FG000|Overall Study|Lost to Follow-up|0|||
129639055|NCT01089608|466633083|FG001|Overall Study|Lost to Follow-up|2|||
129639056|NCT00384839|466633086|FG000|Overall Study|Adverse Event|4|||
129639057|NCT00384839|466633086|FG000|Overall Study|Investigator Request|1|||
129639058|NCT00384839|466633086|FG000|Overall Study|Patient Request|1|||
129639059|NCT00384839|466633086|FG000|Overall Study|Ineligible|2|||
129639060|NCT00280397|466633087|FG000|Overall Study|Adverse Event|1|||
129639061|NCT02257489|466633088|FG000|Overall Study|Withdrawal by Subject|0|||
129639062|NCT02257489|466633089|FG001|Overall Study|Withdrawal by Subject|0|||
129639063|NCT02257489|466633090|FG002|Overall Study|Withdrawal by Subject|0|||
129639064|NCT02257489|466633091|FG003|Overall Study|Withdrawal by Subject|1|||
129639065|NCT02257489|466633092|FG004|Overall Study|Withdrawal by Subject|0|||
129639066|NCT02257489|466633093|FG005|Overall Study|Withdrawal by Subject|0|||
129639067|NCT02257489|466633094|FG006|Overall Study|Withdrawal by Subject|0|||
129639068|NCT02257489|466633095|FG007|Overall Study|Withdrawal by Subject|0|||
129639069|NCT02257489|466633096|FG008|Overall Study|Withdrawal by Subject|0|||
129639070|NCT04606394|466633097|FG000|Overall Study|Withdrawal by Subject|3|||
129705053|NCT00622726|466884118|FG001|August, 2010 to April, 2013|Death|5|||
129705054|NCT02434081|466884121|FG000|Overall Study|Death (never started treatment)|2|||
129705055|NCT02434081|466884121|FG000|Overall Study|Death|2|||
129705056|NCT02434081|466884121|FG000|Overall Study|Progression|20|||
129705057|NCT02434081|466884121|FG000|Overall Study|Adverse Event|20|||
129705058|NCT02434081|466884121|FG000|Overall Study|Physician Decision|2|||
129705059|NCT02434081|466884121|FG000|Overall Study|Withdrawal by Subject|1|||
129705060|NCT02434081|466884121|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
129705061|NCT00419744|466884122|FG000|Overall Study|Adverse Event|39|||
129705062|NCT00419744|466884123|FG001|Overall Study|Adverse Event|40|||
129705063|NCT00419744|466884124|FG002|Overall Study|Adverse Event|50|||
129705064|NCT00419744|466884122|FG000|Overall Study|Withdrawal by Subject|45|||
129705065|NCT00419744|466884123|FG001|Overall Study|Withdrawal by Subject|49|||
129705066|NCT00419744|466884124|FG002|Overall Study|Withdrawal by Subject|52|||
129705067|NCT00419744|466884122|FG000|Overall Study|Lost to Follow-up|8|||
129639071|NCT04606394|466633097|FG000|Overall Study|Exclusion criteria screen failure|12|||
129639072|NCT00955955|466633098|FG000|Overall Study|Lost to Follow-up|2|||
129639073|NCT00955955|466633099|FG001|Overall Study|Lost to Follow-up|0|||
129639074|NCT00955955|466633100|FG002|Overall Study|Lost to Follow-up|0|||
129639075|NCT03423173|466633101|FG000|Overall Study|Randomized but not vaccinated|1|||
129639076|NCT03423173|466633102|FG001|Overall Study|Randomized but not vaccinated|0|||
129639077|NCT03423173|466633103|FG002|Overall Study|Randomized but not vaccinated|2|||
129639078|NCT03423173|466633104|FG003|Overall Study|Randomized but not vaccinated|1|||
129639079|NCT03423173|466633101|FG000|Overall Study|Adverse Event|1|||
129639080|NCT03423173|466633102|FG001|Overall Study|Adverse Event|1|||
129639081|NCT03423173|466633103|FG002|Overall Study|Adverse Event|1|||
129639082|NCT03423173|466633104|FG003|Overall Study|Adverse Event|1|||
129639083|NCT03423173|466633101|FG000|Overall Study|Lost to Follow-up|10|||
129639084|NCT03423173|466633102|FG001|Overall Study|Lost to Follow-up|19|||
129639085|NCT03423173|466633103|FG002|Overall Study|Lost to Follow-up|17|||
129639086|NCT03423173|466633104|FG003|Overall Study|Lost to Follow-up|22|||
129639087|NCT03423173|466633101|FG000|Overall Study|Withdrawal of consent|4|||
129639088|NCT03423173|466633102|FG001|Overall Study|Withdrawal of consent|10|||
129639089|NCT03423173|466633103|FG002|Overall Study|Withdrawal of consent|4|||
129639090|NCT03423173|466633104|FG003|Overall Study|Withdrawal of consent|5|||
129639091|NCT03423173|466633101|FG000|Overall Study|Death|1|||
129639092|NCT03423173|466633102|FG001|Overall Study|Death|0|||
129639093|NCT03423173|466633103|FG002|Overall Study|Death|0|||
129639094|NCT03423173|466633104|FG003|Overall Study|Death|0|||
129639095|NCT03423173|466633101|FG000|Overall Study|Reason not Specified|2|||
129639096|NCT03423173|466633102|FG001|Overall Study|Reason not Specified|5|||
129639097|NCT03423173|466633103|FG002|Overall Study|Reason not Specified|3|||
129639098|NCT03423173|466633104|FG003|Overall Study|Reason not Specified|1|||
129639099|NCT03852264|466633105|FG000|Third Research Visit|Lost to Follow-up|1|||
129639100|NCT03852264|466633106|FG001|Third Research Visit|Lost to Follow-up|0|||
129639101|NCT02217410|466633112|FG000|Overall Study|Graft Loss|0|||
129639102|NCT02217410|466633113|FG001|Overall Study|Graft Loss|0|||
129639103|NCT02217410|466633114|FG002|Overall Study|Graft Loss|2|||
129639104|NCT02217410|466633112|FG000|Overall Study|Withdrawal by Subject|0|||
129639105|NCT02217410|466633113|FG001|Overall Study|Withdrawal by Subject|0|||
129639106|NCT02217410|466633114|FG002|Overall Study|Withdrawal by Subject|2|||
129639107|NCT02217410|466633112|FG000|Overall Study|Lost to Follow-up|0|||
129639108|NCT02217410|466633113|FG001|Overall Study|Lost to Follow-up|0|||
129639109|NCT02217410|466633114|FG002|Overall Study|Lost to Follow-up|1|||
129639110|NCT02217410|466633112|FG000|Overall Study|Lack of Efficacy|0|||
129639111|NCT02217410|466633113|FG001|Overall Study|Lack of Efficacy|1|||
129639112|NCT02217410|466633114|FG002|Overall Study|Lack of Efficacy|0|||
129639113|NCT02217410|466633112|FG000|Overall Study|Physician Decision|1|||
129639114|NCT02217410|466633113|FG001|Overall Study|Physician Decision|3|||
129639115|NCT02217410|466633114|FG002|Overall Study|Physician Decision|0|||
129639116|NCT00661609|466633116|FG000|Overall Study|Adverse Event|4|||
129639117|NCT00661609|466633116|FG000|Overall Study|Death|20|||
129639118|NCT00661609|466633116|FG000|Overall Study|Withdrawal by Subject|2|||
129639119|NCT00661609|466633116|FG000|Overall Study|PI Decision|1|||
129639120|NCT00661609|466633116|FG000|Overall Study|Survival follow up stage discontinued|11|||
129639121|NCT00661609|466633116|FG000|Overall Study|Disease progression|3|||
129639122|NCT00637000|466633117|FG000|Overall Study|Withdrawal by Subject|4|||
129639123|NCT00637000|466633118|FG001|Overall Study|Withdrawal by Subject|3|||
129639124|NCT02751450|466633121|FG000|Overall Study|Adverse Event|1|||
129639125|NCT02751450|466633122|FG001|Overall Study|Adverse Event|0|||
129639126|NCT00562302|466633123|FG000|Overall Study|Lost to Follow-up|3|||
129639127|NCT00562302|466633124|FG001|Overall Study|Lost to Follow-up|3|||
129639128|NCT00562302|466633123|FG000|Overall Study|Adverse Event|0|||
129639129|NCT00562302|466633124|FG001|Overall Study|Adverse Event|6|||
129639130|NCT00562302|466633123|FG000|Overall Study|Non-compliance|1|||
129639131|NCT00562302|466633124|FG001|Overall Study|Non-compliance|2|||
129639132|NCT00562302|466633123|FG000|Overall Study|Withdrawal by Subject|7|||
129639133|NCT00562302|466633124|FG001|Overall Study|Withdrawal by Subject|8|||
129639134|NCT00562302|466633123|FG000|Overall Study|Death|1|||
129639135|NCT00562302|466633124|FG001|Overall Study|Death|2|||
129639136|NCT00562302|466633123|FG000|Overall Study|Lung resection prior to study completion|7|||
129639137|NCT00562302|466633124|FG001|Overall Study|Lung resection prior to study completion|7|||
129798185|NCT00089284|467229993|FG003|Overall Study|Adverse event before starting treatment|0|||
129639138|NCT00562302|466633123|FG000|Overall Study|Not stated|1|||
129639139|NCT00562302|466633124|FG001|Overall Study|Not stated|4|||
129639140|NCT01290679|466633125|FG000|Overall Study|Adverse Event|2|||
129639141|NCT01290679|466633126|FG001|Overall Study|Adverse Event|0|||
129639142|NCT01290679|466633125|FG000|Overall Study|Lost to Follow-up|8|||
129639143|NCT01290679|466633126|FG001|Overall Study|Lost to Follow-up|10|||
129639144|NCT01290679|466633125|FG000|Overall Study|Protocol Violation|0|||
129639145|NCT01290679|466633126|FG001|Overall Study|Protocol Violation|1|||
129639146|NCT01290679|466633125|FG000|Overall Study|Withdrawal by Subject|6|||
129639147|NCT01290679|466633126|FG001|Overall Study|Withdrawal by Subject|5|||
129639148|NCT01290679|466633125|FG000|Overall Study|Subject Entered Another Trial|0|||
129798186|NCT00089284|467229994|FG004|Overall Study|Adverse event before starting treatment|0|||
129798187|NCT00089284|467229995|FG005|Overall Study|Adverse event before starting treatment|0|||
129798188|NCT00089284|467229996|FG006|Overall Study|Adverse event before starting treatment|1|||
129798189|NCT03646643|467230007|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
129798190|NCT03646643|467230008|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
129798191|NCT03646643|467230007|FG000|Overall Study|Lost to Follow-up|0|||
129798192|NCT03646643|467230008|FG001|Overall Study|Lost to Follow-up|1|||
129798193|NCT04131556|467230009|FG000|Overall Study|Adverse Event|1|||
129798194|NCT04131556|467230009|FG000|Overall Study|Withdrawal by Subject|1|||
129639149|NCT01290679|466633126|FG001|Overall Study|Subject Entered Another Trial|5|||
129639150|NCT01855243|466633127|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
129639151|NCT01855243|466633128|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
129639152|NCT01855243|466633129|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
129639153|NCT03315286|466633130|FG000|Overall Study|Lost to Follow-up|0|||
129639154|NCT03315286|466633131|FG001|Overall Study|Lost to Follow-up|3|||
129639155|NCT03315286|466633130|FG000|Overall Study|Withdrawal by Subject|1|||
129639156|NCT03315286|466633131|FG001|Overall Study|Withdrawal by Subject|0|||
129639157|NCT03315286|466633130|FG000|Overall Study|Protocol Violation|0|||
129639158|NCT03315286|466633131|FG001|Overall Study|Protocol Violation|1|||
129639159|NCT03075891|466633132|FG000|Overall Study|Withdrawal by Subject|3|||
129639160|NCT03075891|466633133|FG001|Overall Study|Withdrawal by Subject|6|||
129639161|NCT03075891|466633132|FG000|Overall Study|Lost to Follow-up|1|||
129639162|NCT03075891|466633133|FG001|Overall Study|Lost to Follow-up|0|||
129639163|NCT03075891|466633132|FG000|Overall Study|Pregnancy|3|||
129639164|NCT03075891|466633133|FG001|Overall Study|Pregnancy|1|||
129639165|NCT03075891|466633132|FG000|Overall Study|visits not performed (no time)|1|||
129639166|NCT03075891|466633133|FG001|Overall Study|visits not performed (no time)|0|||
129639167|NCT03075891|466633132|FG000|Overall Study|Drug abuse relapse issue|0|||
129639168|NCT03075891|466633133|FG001|Overall Study|Drug abuse relapse issue|1|||
129639169|NCT03075891|466633132|FG000|Overall Study|Participant requiring study withdrawal|0|||
129639170|NCT03075891|466633133|FG001|Overall Study|Participant requiring study withdrawal|1|||
129639171|NCT03075891|466633132|FG000|Overall Study|Adverse event, non-fatal|1|||
129639172|NCT03075891|466633133|FG001|Overall Study|Adverse event, non-fatal|4|||
129639173|NCT00828568|466633136|FG000|Randomized|Withdrawal by Subject|1|||
129639174|NCT00828568|466633137|FG001|Randomized|Withdrawal by Subject|0|||
129639175|NCT00828568|466633138|FG002|Randomized|Withdrawal by Subject|2|||
129639176|NCT00828568|466633136|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
129639177|NCT00828568|466633137|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
129639178|NCT00828568|466633138|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
129639179|NCT00828568|466633136|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
129639180|NCT00828568|466633137|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
129639181|NCT00828568|466633138|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
129639182|NCT00828568|466633136|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
129639183|NCT00828568|466633137|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
129639184|NCT00828568|466633138|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
129639185|NCT00828568|466633136|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
129639186|NCT00828568|466633137|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
129639187|NCT00828568|466633138|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
129639188|NCT03474731|466633139|FG000|Overall Study|Withdrawal by Subject|36|||
129639189|NCT03474731|466633140|FG001|Overall Study|Withdrawal by Subject|29|||
129639190|NCT03474731|466633141|FG002|Overall Study|Withdrawal by Subject|11|||
129639191|NCT03474731|466633142|FG003|Overall Study|Withdrawal by Subject|27|||
129639192|NCT03474731|466633139|FG000|Overall Study|COVID|0|||
129639193|NCT03474731|466633140|FG001|Overall Study|COVID|23|||
129639194|NCT03474731|466633141|FG002|Overall Study|COVID|0|||
129639195|NCT03474731|466633142|FG003|Overall Study|COVID|0|||
129639196|NCT03474731|466633139|FG000|Overall Study|Participant moved from area|1|||
129639197|NCT03474731|466633140|FG001|Overall Study|Participant moved from area|0|||
129639198|NCT03474731|466633141|FG002|Overall Study|Participant moved from area|0|||
129798195|NCT04060862|467230012|FG000|Overall Study|Symptomatic Deterioration|1|||
129639199|NCT03474731|466633142|FG003|Overall Study|Participant moved from area|0|||
129639200|NCT03474731|466633139|FG000|Overall Study|Lost to Follow-up|11|||
129639201|NCT03474731|466633140|FG001|Overall Study|Lost to Follow-up|3|||
129639202|NCT03474731|466633141|FG002|Overall Study|Lost to Follow-up|18|||
129639203|NCT03474731|466633142|FG003|Overall Study|Lost to Follow-up|17|||
129639204|NCT03474731|466633139|FG000|Overall Study|Death|0|||
129639205|NCT03474731|466633140|FG001|Overall Study|Death|1|||
129639206|NCT03474731|466633141|FG002|Overall Study|Death|0|||
129639207|NCT03474731|466633142|FG003|Overall Study|Death|0|||
129639208|NCT03474731|466633139|FG000|Overall Study|Participant Removed|0|||
129639209|NCT03474731|466633140|FG001|Overall Study|Participant Removed|0|||
129639210|NCT03474731|466633141|FG002|Overall Study|Participant Removed|0|||
129639211|NCT03474731|466633142|FG003|Overall Study|Participant Removed|1|||
129639212|NCT00766636|466633143|FG000|Overall Study|Withdrawal by Subject|1|||
129639213|NCT00766636|466633144|FG001|Overall Study|Withdrawal by Subject|1|||
129639214|NCT00766636|466633143|FG000|Overall Study|Incomplete Treatment|0|||
129639215|NCT00766636|466633144|FG001|Overall Study|Incomplete Treatment|1|||
129639216|NCT00766636|466633143|FG000|Overall Study|Adverse Event|1|||
129639217|NCT00766636|466633144|FG001|Overall Study|Adverse Event|0|||
129639218|NCT00766636|466633143|FG000|Overall Study|Disease Progression|1|||
129639219|NCT00766636|466633144|FG001|Overall Study|Disease Progression|0|||
129639220|NCT04657198|466633145|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
129639221|NCT04657198|466633146|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
129639222|NCT04657198|466633147|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
129639223|NCT01075256|466633150|FG000|Overall Study|Withdrawal by Subject|1|||
129639224|NCT01075256|466633151|FG001|Overall Study|Withdrawal by Subject|0|||
129639225|NCT01075256|466633152|FG002|Overall Study|Withdrawal by Subject|0|||
129639226|NCT00765336|466633153|FG000|Overall Study|Protocol Violation|4|||
129639227|NCT00765336|466633154|FG001|Overall Study|Protocol Violation|2|||
129639228|NCT00765336|466633153|FG000|Overall Study|Withdrawal by Subject|6|||
129639229|NCT00765336|466633154|FG001|Overall Study|Withdrawal by Subject|4|||
129639230|NCT00765336|466633153|FG000|Overall Study|Lost to Follow-up|7|||
129639231|NCT00765336|466633154|FG001|Overall Study|Lost to Follow-up|9|||
129639232|NCT00765336|466633153|FG000|Overall Study|Adverse Event|2|||
129639233|NCT00765336|466633154|FG001|Overall Study|Adverse Event|1|||
129639234|NCT02858583|466633155|FG000|Overall Study|Declined consent|1|||
129639235|NCT02858583|466633156|FG001|Overall Study|Declined consent|1|||
129639236|NCT01218087|466633157|FG000|Overall Study|Death|2|||
129639237|NCT01218087|466633158|FG001|Overall Study|Death|1|||
129639238|NCT01218087|466633157|FG000|Overall Study|Withdrawal by Subject|5|||
129639239|NCT01218087|466633158|FG001|Overall Study|Withdrawal by Subject|0|||
129639240|NCT01218087|466633157|FG000|Overall Study|Transferred|8|||
129639241|NCT01218087|466633158|FG001|Overall Study|Transferred|5|||
129639242|NCT03232931|466634568|FG000|Overall Study|Physician Decision|1|||
129639243|NCT03232931|466634569|FG001|Overall Study|Physician Decision|1|||
129639244|NCT03232931|466634568|FG000|Overall Study|Withdrawal by Subject|6|||
129639245|NCT03232931|466634569|FG001|Overall Study|Withdrawal by Subject|0|||
129639246|NCT03232931|466634568|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
129639247|NCT03232931|466634569|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
129639248|NCT03232931|466634568|FG000|Overall Study|Parent did not record voice|1|||
129639249|NCT03232931|466634569|FG001|Overall Study|Parent did not record voice|2|||
129639250|NCT03232931|466634568|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
129639251|NCT03232931|466634569|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
129639252|NCT04925557|466634570|FG000|Overall Study|Study closed|5|||
129639253|NCT04925557|466634571|FG001|Overall Study|Study closed|3|||
129639254|NCT05488470|466634572|FG000|Overall Study|Physician Decision|2|||
129639255|NCT05488470|466634572|FG000|Overall Study|Withdrawal by Subject|1|||
129639256|NCT05488470|466634572|FG000|Overall Study|Death|1|||
129639257|NCT04390503|466634579|FG000|Overall Study|Physician Decision|2|||
129639258|NCT04390503|466634580|FG001|Overall Study|Physician Decision|1|||
129705068|NCT00419744|466884123|FG001|Overall Study|Lost to Follow-up|10|||
129705069|NCT00419744|466884124|FG002|Overall Study|Lost to Follow-up|6|||
129705070|NCT00419744|466884122|FG000|Overall Study|Protocol Violation|4|||
129705071|NCT00419744|466884123|FG001|Overall Study|Protocol Violation|7|||
129705072|NCT00419744|466884124|FG002|Overall Study|Protocol Violation|8|||
129705073|NCT00419744|466884122|FG000|Overall Study|Randomized in error|9|||
129705074|NCT00419744|466884123|FG001|Overall Study|Randomized in error|6|||
129705075|NCT00419744|466884124|FG002|Overall Study|Randomized in error|7|||
129705076|NCT00419744|466884122|FG000|Overall Study|Moving out of state|2|||
129705077|NCT00419744|466884123|FG001|Overall Study|Moving out of state|0|||
129705078|NCT00419744|466884124|FG002|Overall Study|Moving out of state|1|||
129705079|NCT00419744|466884122|FG000|Overall Study|Physician Decision|10|||
129705080|NCT00419744|466884123|FG001|Overall Study|Physician Decision|5|||
129705081|NCT00419744|466884124|FG002|Overall Study|Physician Decision|6|||
129705082|NCT00419744|466884122|FG000|Overall Study|Spirometry mouthpiece issues|0|||
129705083|NCT00419744|466884123|FG001|Overall Study|Spirometry mouthpiece issues|1|||
129639259|NCT04390503|466634579|FG000|Overall Study|Adverse Event|1|||
129705084|NCT00419744|466884124|FG002|Overall Study|Spirometry mouthpiece issues|2|||
129705085|NCT00419744|466884122|FG000|Overall Study|Incorrect medication kit dispensed|0|||
129705086|NCT00419744|466884123|FG001|Overall Study|Incorrect medication kit dispensed|0|||
129639260|NCT04390503|466634580|FG001|Overall Study|Adverse Event|0|||
129639261|NCT01068730|466634582|FG000|Period 3|Personal reason|1|||
129639262|NCT01068730|466634583|FG001|Period 3|Personal reason|0|||
129639263|NCT01068730|466634584|FG002|Period 3|Personal reason|0|||
129639264|NCT01068730|466634585|FG003|Period 3|Personal reason|0|||
129639265|NCT01068730|466634582|FG000|Period 4|Family emergency|0|||
129639266|NCT01068730|466634583|FG001|Period 4|Family emergency|1|||
129639267|NCT01068730|466634584|FG002|Period 4|Family emergency|0|||
129705087|NCT00419744|466884124|FG002|Overall Study|Incorrect medication kit dispensed|1|||
129639268|NCT01068730|466634585|FG003|Period 4|Family emergency|0|||
129639269|NCT02448537|466634589|FG000|Overall Study|Withdrawal by Subject|1|||
129639270|NCT02448537|466634590|FG001|Overall Study|Withdrawal by Subject|1|||
129639271|NCT02448537|466634591|FG002|Overall Study|Withdrawal by Subject|1|||
129639272|NCT04725812|466634594|FG000|Overall Study|Withdrawal by Subject|1|||
129639273|NCT04696055|466634599|FG000|Overall Study|Adverse Event|10|||
129639274|NCT04696055|466634600|FG001|Overall Study|Adverse Event|2|||
129639275|NCT04696055|466634599|FG000|Overall Study|Death|4|||
129639276|NCT04696055|466634600|FG001|Overall Study|Death|0|||
129639277|NCT04696055|466634599|FG000|Overall Study|Other|7|||
129639278|NCT04696055|466634600|FG001|Overall Study|Other|2|||
129639279|NCT04696055|466634599|FG000|Overall Study|Physician Decision|3|||
129639280|NCT04696055|466634600|FG001|Overall Study|Physician Decision|0|||
129639281|NCT04696055|466634599|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
129639282|NCT04696055|466634600|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
129639283|NCT04696055|466634599|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
129639284|NCT04696055|466634600|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
129639285|NCT04696055|466634599|FG000|Overall Study|Subject Decision|1|||
129639286|NCT04696055|466634600|FG001|Overall Study|Subject Decision|2|||
129639287|NCT03969901|466634601|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129639288|NCT03969901|466634602|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129639289|NCT03969901|466634603|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129639290|NCT03969901|466634604|FG003|Overall Study|Withdrawal by parent/guardian|0|||
129639291|NCT03969901|466634605|FG004|Overall Study|Withdrawal by parent/guardian|1|||
129639292|NCT03969901|466634606|FG005|Overall Study|Withdrawal by parent/guardian|0|||
129639293|NCT03969901|466634607|FG006|Overall Study|Withdrawal by parent/guardian|0|||
129639294|NCT03969901|466634608|FG007|Overall Study|Withdrawal by parent/guardian|1|||
129639295|NCT03969901|466634609|FG008|Overall Study|Withdrawal by parent/guardian|1|||
129639296|NCT03969901|466634610|FG009|Overall Study|Withdrawal by parent/guardian|0|||
129639297|NCT04411810|466634611|FG000|Overall Study|Screen failure|1|||
129639298|NCT04411810|466634611|FG000|Overall Study|Withdrawal by Subject|1|||
129639299|NCT01920958|466634612|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
129639300|NCT01560234|466634613|FG000|Overall Study|Lost to Follow-up|3|||
129639301|NCT01560234|466634614|FG001|Overall Study|Lost to Follow-up|0|||
129639302|NCT01560234|466634615|FG002|Overall Study|Lost to Follow-up|1|||
129639303|NCT01560234|466634616|FG003|Overall Study|Lost to Follow-up|0|||
129639304|NCT01560234|466634617|FG004|Overall Study|Lost to Follow-up|0|||
129639305|NCT01560234|466634618|FG005|Overall Study|Lost to Follow-up|2|||
129639306|NCT01560234|466634619|FG006|Overall Study|Lost to Follow-up|0|||
129639307|NCT01560234|466634620|FG007|Overall Study|Lost to Follow-up|2|||
129639308|NCT00083759|466634625|FG000|Overall Study|Adverse Event|5|||
129639309|NCT00083759|466634626|FG001|Overall Study|Adverse Event|3|||
129639310|NCT00083759|466634625|FG000|Overall Study|Lost to Follow-up|1|||
129639311|NCT00083759|466634626|FG001|Overall Study|Lost to Follow-up|0|||
129639312|NCT00083759|466634625|FG000|Overall Study|Death|1|||
129639313|NCT00083759|466634626|FG001|Overall Study|Death|1|||
129639314|NCT00083759|466634625|FG000|Overall Study|Inadequate Therapeutic Response|32|||
129639315|NCT00083759|466634626|FG001|Overall Study|Inadequate Therapeutic Response|35|||
129639316|NCT00083759|466634625|FG000|Overall Study|Subject Withdrew Consent|2|||
129639317|NCT00083759|466634626|FG001|Overall Study|Subject Withdrew Consent|2|||
129639318|NCT00083759|466634625|FG000|Overall Study|Non-Compliance|1|||
129639319|NCT00083759|466634626|FG001|Overall Study|Non-Compliance|0|||
129639320|NCT00083759|466634625|FG000|Overall Study|Sponsor's Discretion|28|||
129639321|NCT00083759|466634626|FG001|Overall Study|Sponsor's Discretion|29|||
129639322|NCT00083759|466634625|FG000|Overall Study|Other|14|||
129639323|NCT00083759|466634626|FG001|Overall Study|Other|13|||
129639324|NCT00887315|466634629|FG000|Overall Study|Study termination|7|||
129639325|NCT00887315|466634630|FG001|Overall Study|Study termination|4|||
129639326|NCT00619892|466634631|FG000|Overall Study|Adverse Event|3|||
129639327|NCT00619892|466634632|FG001|Overall Study|Adverse Event|0|||
129639328|NCT00619892|466634631|FG000|Overall Study|Lost to Follow-up|0|||
129639329|NCT00619892|466634632|FG001|Overall Study|Lost to Follow-up|1|||
129639330|NCT00619892|466634631|FG000|Overall Study|Intercurrent illness|0|||
129639331|NCT00619892|466634632|FG001|Overall Study|Intercurrent illness|1|||
129639332|NCT00379080|466634633|FG000|Overall Study|Withdrawal by Subject|0|||
129639333|NCT00379080|466634634|FG001|Overall Study|Withdrawal by Subject|4|||
129639334|NCT00379080|466634635|FG002|Overall Study|Withdrawal by Subject|0|||
129639335|NCT00857896|466634641|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
129639336|NCT02920008|466634646|FG000|Overall Study|Death|117|||
129639337|NCT02920008|466634647|FG001|Overall Study|Death|127|||
129639338|NCT02920008|466634646|FG000|Overall Study|Withdrawal by Subject|3|||
129639339|NCT02920008|466634647|FG001|Overall Study|Withdrawal by Subject|6|||
129798196|NCT04060862|467230012|FG000|Overall Study|Un-specified|6|||
129798197|NCT04060862|467230012|FG000|Overall Study|Progressive disease|12|||
129798198|NCT04060862|467230012|FG000|Overall Study|Physician Decision|1|||
129639340|NCT02920008|466634646|FG000|Overall Study|Lost to Follow-up|0|||
129639341|NCT02920008|466634647|FG001|Overall Study|Lost to Follow-up|1|||
129639342|NCT02737930|466634648|FG000|Overall Study|Withdrawal by Subject|0|||
129639343|NCT02737930|466634649|FG001|Overall Study|Withdrawal by Subject|1|||
129639344|NCT03169881|466634650|FG000|Overall Study|Incomplete Follow-up|10|||
129639345|NCT03169881|466634651|FG001|Overall Study|Incomplete Follow-up|15|||
129639346|NCT03169881|466634650|FG000|Overall Study|Lost to Follow-up|18|||
129639347|NCT03169881|466634651|FG001|Overall Study|Lost to Follow-up|20|||
129639348|NCT03169881|466634650|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
129639349|NCT03169881|466634651|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
129639350|NCT01028014|466634652|FG000|Overall Study|Lost to Follow-up|1|||
129639351|NCT01028014|466634653|FG001|Overall Study|Lost to Follow-up|2|||
129639352|NCT01028014|466634654|FG002|Overall Study|Lost to Follow-up|0|||
129639353|NCT01028014|466634655|FG003|Overall Study|Lost to Follow-up|1|||
129639354|NCT01028014|466634656|FG004|Overall Study|Lost to Follow-up|1|||
129639355|NCT01028014|466634657|FG005|Overall Study|Lost to Follow-up|2|||
129639356|NCT01127451|466634667|FG000|Overall Study|Other|2|||
129639357|NCT01127451|466634668|FG001|Overall Study|Other|1|||
129639358|NCT01127451|466634667|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
129639359|NCT01127451|466634668|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
129639360|NCT01127451|466634667|FG000|Overall Study|Death|22|||
129639361|NCT01127451|466634668|FG001|Overall Study|Death|17|||
129639362|NCT01127451|466634667|FG000|Overall Study|Lost to Follow-up|3|||
129639363|NCT01127451|466634668|FG001|Overall Study|Lost to Follow-up|0|||
129639364|NCT01127451|466634667|FG000|Overall Study|Administrative Reason by Sponsor|2|||
129639365|NCT01127451|466634668|FG001|Overall Study|Administrative Reason by Sponsor|2|||
129639366|NCT00930774|466634669|FG000|Overall Study|Withdrawal by Subject|1|||
129639367|NCT00930774|466634670|FG001|Overall Study|Withdrawal by Subject|9|||
129639368|NCT00930774|466634671|FG002|Overall Study|Withdrawal by Subject|2|||
129639369|NCT00930774|466634672|FG003|Overall Study|Withdrawal by Subject|0|||
129639370|NCT03200704|466634673|FG000|Overall Study|Withdrawal by Subject|1|||
129639371|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
129639372|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
129639373|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
129639374|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
129639375|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
129639376|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
129639377|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
129639378|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
129639379|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
129639380|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
129639381|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
129639382|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
129639383|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
129639384|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
129639385|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
129639386|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
129639387|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
129639388|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
129639389|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
129639390|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
129639391|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
129639392|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
129639393|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
129639394|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
129639395|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
129639396|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
129639397|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
129639398|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
129639399|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
129639400|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
129639401|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
129639402|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
129639403|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
129639404|NCT00839527|466634675|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
129639405|NCT00839527|466634676|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
129798199|NCT01052844|467230017|FG000|Overall Study|Adverse Event|0|||
129798200|NCT01052844|467230018|FG001|Overall Study|Adverse Event|1|||
129639406|NCT00839527|466634677|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
129639407|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
129639408|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
129639409|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
129639410|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
129639411|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
129639412|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
129639413|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
129639414|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
129639415|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
129639416|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
129639417|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
129639418|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
129639419|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
129639420|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
129639421|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
129639422|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
129639423|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
129639424|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
129639425|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
129639426|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
129639427|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
129639428|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
129639429|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
129639430|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
129639431|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
129639432|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
129639433|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
129639434|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
129639435|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
129639436|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
129639437|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
129639438|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
129639439|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
129639440|NCT00839527|466634675|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
129639441|NCT00839527|466634676|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
129639442|NCT00839527|466634677|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
129639443|NCT01704651|466634680|FG000|Overall Study|Pre-op withdrawal by subject|1|||
129639444|NCT01704651|466634681|FG001|Overall Study|Pre-op withdrawal by subject|1|||
129639445|NCT01704651|466634680|FG000|Overall Study|Pre-op change in treatment plan|1|||
129639446|NCT01704651|466634681|FG001|Overall Study|Pre-op change in treatment plan|4|||
129639447|NCT01704651|466634680|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
129639448|NCT01704651|466634681|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
129639449|NCT01704651|466634680|FG000|Overall Study|Post-op did not have laparotomy|2|||
129639450|NCT01704651|466634681|FG001|Overall Study|Post-op did not have laparotomy|1|||
129639451|NCT00634803|466634683|FG000|Overall Study|Lost to Follow-up|6|||
129639452|NCT00634803|466634684|FG001|Overall Study|Lost to Follow-up|7|||
129639453|NCT00634803|466634685|FG002|Overall Study|Lost to Follow-up|7|||
129639454|NCT00364923|466634687|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
129639455|NCT00364923|466634687|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
129639456|NCT04087720|466634691|FG000|Overall Study|Withdrawal by Subject|2|||
129639457|NCT04087720|466634691|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
129639458|NCT03706430|466634694|FG000|Overall Study|No A-Line placed|5|||
129639459|NCT03706430|466634694|FG000|Overall Study|Subject had gel nail polish|1|||
129639460|NCT03706430|466634694|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
129639461|NCT03706430|466634694|FG000|Overall Study|Cancelled Case|6|||
129639462|NCT03706430|466634694|FG000|Overall Study|Physician Decision|2|||
129639463|NCT00520533|466634695|FG000|Overall Study|Death|1|||
129798201|NCT02545075|467230019|FG000|Randomization|Lost to Follow-up|0|||
129798202|NCT02545075|467230020|FG001|Randomization|Lost to Follow-up|1|||
129798203|NCT02545075|467230019|FG000|Randomization|Withdrawal by Subject|0|||
129798204|NCT02545075|467230020|FG001|Randomization|Withdrawal by Subject|6|||
129798205|NCT02545075|467230019|FG000|Treatment|Disease progression|71|||
129798206|NCT02545075|467230020|FG001|Treatment|Disease progression|32|||
129639464|NCT00520533|466634695|FG000|Overall Study|Suspension of the study for safety reasons|1|||
129639465|NCT00520533|466634695|FG000|Overall Study|Withdrawal by Subject|1|||
129798207|NCT02545075|467230019|FG000|Treatment|Participant dicontinued study treatment|7|||
129889489|NCT00946647|467552609|FG003|Phase ll Part|Protocol Violation|4|||
129798208|NCT02545075|467230020|FG001|Treatment|Participant dicontinued study treatment|9|||
129798209|NCT02545075|467230019|FG000|Treatment|Withdrawal by Subject|1|||
129639466|NCT00520533|466634695|FG000|Overall Study|Physician Decision|1|||
129639467|NCT00478777|466634696|FG000|Overall Study|Adverse Event|29|||
129639468|NCT00478777|466634696|FG000|Overall Study|Lack of Efficacy|23|||
129639469|NCT00478777|466634696|FG000|Overall Study|Withdrawal by Subject|4|||
129639470|NCT00478777|466634696|FG000|Overall Study|Death|3|||
129639471|NCT00478777|466634696|FG000|Overall Study|Protocol Violation|3|||
129639472|NCT00478777|466634696|FG000|Overall Study|Lost to Follow-up|3|||
129639473|NCT00478777|466634696|FG000|Overall Study|Physician Decision|1|||
129639474|NCT00478777|466634696|FG000|Overall Study|Intolerance of therapy|1|||
129639475|NCT00478777|466634696|FG000|Overall Study|Lack of compliance|1|||
129639476|NCT00478777|466634696|FG000|Overall Study|Lymphocytes infusion|1|||
129639477|NCT00478777|466634696|FG000|Overall Study|End of therapy|2|||
129639478|NCT00478777|466634696|FG000|Overall Study|Not treated with lenalidomide|6|||
129639479|NCT00552396|466634697|FG000|Overall Study|protocol withdrawal criteria|3|||
129639480|NCT00552396|466634698|FG001|Overall Study|protocol withdrawal criteria|3|||
129639481|NCT00552396|466634699|FG002|Overall Study|protocol withdrawal criteria|3|||
129639482|NCT00552396|466634700|FG003|Overall Study|protocol withdrawal criteria|6|||
129639483|NCT00552396|466634701|FG004|Overall Study|protocol withdrawal criteria|3|||
129639484|NCT00552396|466634702|FG005|Overall Study|protocol withdrawal criteria|3|||
129639485|NCT00552396|466634703|FG006|Overall Study|protocol withdrawal criteria|9|||
129639486|NCT02553499|466634704|FG000|Overall Study|Adverse Event|0|||
129639487|NCT02553499|466634705|FG001|Overall Study|Adverse Event|0|||
129639488|NCT02553499|466634706|FG002|Overall Study|Adverse Event|0|||
129639489|NCT02553499|466634707|FG003|Overall Study|Adverse Event|0|||
129639490|NCT02553499|466634708|FG004|Overall Study|Adverse Event|0|||
129639491|NCT02553499|466634709|FG005|Overall Study|Adverse Event|0|||
129639492|NCT02553499|466634710|FG006|Overall Study|Adverse Event|1|||
129639493|NCT02553499|466634711|FG007|Overall Study|Adverse Event|1|||
129639494|NCT02553499|466634712|FG008|Overall Study|Adverse Event|0|||
129639495|NCT02553499|466634713|FG009|Overall Study|Adverse Event|0|||
129639496|NCT02553499|466634714|FG010|Overall Study|Adverse Event|0|||
129639497|NCT02553499|466634715|FG011|Overall Study|Adverse Event|0|||
129639498|NCT02553499|466634716|FG012|Overall Study|Adverse Event|0|||
129639499|NCT02553499|466634717|FG013|Overall Study|Adverse Event|1|||
129639500|NCT02553499|466634704|FG000|Overall Study|Death|0|||
129639501|NCT02553499|466634705|FG001|Overall Study|Death|1|||
129639502|NCT02553499|466634706|FG002|Overall Study|Death|1|||
129639503|NCT02553499|466634707|FG003|Overall Study|Death|0|||
129639504|NCT02553499|466634708|FG004|Overall Study|Death|1|||
129639505|NCT02553499|466634709|FG005|Overall Study|Death|2|||
129639506|NCT02553499|466634710|FG006|Overall Study|Death|0|||
129639507|NCT02553499|466634711|FG007|Overall Study|Death|0|||
129639508|NCT02553499|466634712|FG008|Overall Study|Death|0|||
129639509|NCT02553499|466634713|FG009|Overall Study|Death|0|||
129639510|NCT02553499|466634714|FG010|Overall Study|Death|1|||
129639511|NCT02553499|466634715|FG011|Overall Study|Death|0|||
129639512|NCT02553499|466634716|FG012|Overall Study|Death|0|||
129639513|NCT02553499|466634717|FG013|Overall Study|Death|0|||
129639514|NCT02553499|466634704|FG000|Overall Study|Lost to Follow-up|0|||
129639515|NCT02553499|466634705|FG001|Overall Study|Lost to Follow-up|0|||
129639516|NCT02553499|466634706|FG002|Overall Study|Lost to Follow-up|0|||
129639517|NCT02553499|466634707|FG003|Overall Study|Lost to Follow-up|0|||
129639518|NCT02553499|466634708|FG004|Overall Study|Lost to Follow-up|0|||
129639519|NCT02553499|466634709|FG005|Overall Study|Lost to Follow-up|0|||
129639520|NCT02553499|466634710|FG006|Overall Study|Lost to Follow-up|1|||
129639521|NCT02553499|466634711|FG007|Overall Study|Lost to Follow-up|0|||
129639522|NCT02553499|466634712|FG008|Overall Study|Lost to Follow-up|0|||
129639523|NCT02553499|466634713|FG009|Overall Study|Lost to Follow-up|0|||
129639524|NCT02553499|466634714|FG010|Overall Study|Lost to Follow-up|0|||
129639525|NCT02553499|466634715|FG011|Overall Study|Lost to Follow-up|0|||
129639526|NCT02553499|466634716|FG012|Overall Study|Lost to Follow-up|0|||
129639527|NCT02553499|466634717|FG013|Overall Study|Lost to Follow-up|0|||
129639528|NCT02553499|466634704|FG000|Overall Study|Physician Decision|0|||
129639529|NCT02553499|466634705|FG001|Overall Study|Physician Decision|1|||
129639530|NCT02553499|466634706|FG002|Overall Study|Physician Decision|1|||
129639531|NCT02553499|466634707|FG003|Overall Study|Physician Decision|0|||
129639532|NCT02553499|466634708|FG004|Overall Study|Physician Decision|1|||
129639533|NCT02553499|466634709|FG005|Overall Study|Physician Decision|0|||
129639534|NCT02553499|466634710|FG006|Overall Study|Physician Decision|0|||
129639535|NCT02553499|466634711|FG007|Overall Study|Physician Decision|1|||
129639536|NCT02553499|466634712|FG008|Overall Study|Physician Decision|1|||
129639537|NCT02553499|466634713|FG009|Overall Study|Physician Decision|2|||
129639538|NCT02553499|466634714|FG010|Overall Study|Physician Decision|1|||
129639539|NCT02553499|466634715|FG011|Overall Study|Physician Decision|3|||
129705088|NCT02037529|466884128|FG000|Overall Study|Withdrawal by Subject|1|||
129705089|NCT02037529|466884129|FG001|Overall Study|Withdrawal by Subject|3|||
129705090|NCT02037529|466884128|FG000|Overall Study|Adverse Event|0|||
129705091|NCT02037529|466884129|FG001|Overall Study|Adverse Event|1|||
129705092|NCT02131766|466884130|FG000|Overall Study|Withdrawal by Subject|4|||
129705093|NCT00718315|466884131|FG000|Overall Study|Adverse Event|1|||
129705094|NCT00718315|466884132|FG001|Overall Study|Adverse Event|2|||
129705095|NCT00718315|466884133|FG002|Overall Study|Adverse Event|3|||
129705096|NCT00718315|466884131|FG000|Overall Study|Death|6|||
129705097|NCT00718315|466884132|FG001|Overall Study|Death|6|||
129705098|NCT00718315|466884133|FG002|Overall Study|Death|5|||
129705099|NCT00718315|466884131|FG000|Overall Study|Lost to Follow-up|2|||
129705100|NCT00718315|466884132|FG001|Overall Study|Lost to Follow-up|3|||
129705101|NCT00718315|466884133|FG002|Overall Study|Lost to Follow-up|4|||
129705102|NCT00718315|466884131|FG000|Overall Study|Protocol Violation|5|||
129705103|NCT00718315|466884132|FG001|Overall Study|Protocol Violation|5|||
129705104|NCT00718315|466884133|FG002|Overall Study|Protocol Violation|3|||
129705105|NCT00718315|466884131|FG000|Overall Study|Erlotinib dose decreased|4|||
129705106|NCT00718315|466884132|FG001|Overall Study|Erlotinib dose decreased|3|||
129705107|NCT00718315|466884133|FG002|Overall Study|Erlotinib dose decreased|1|||
129705108|NCT00718315|466884131|FG000|Overall Study|Use of Minocyclin|1|||
129705109|NCT00718315|466884132|FG001|Overall Study|Use of Minocyclin|1|||
129705110|NCT00718315|466884133|FG002|Overall Study|Use of Minocyclin|1|||
129705111|NCT00718315|466884131|FG000|Overall Study|Disease progression|0|||
129705112|NCT00718315|466884132|FG001|Overall Study|Disease progression|1|||
129705113|NCT00718315|466884133|FG002|Overall Study|Disease progression|1|||
129705114|NCT00718315|466884131|FG000|Overall Study|Other|0|||
129705115|NCT00718315|466884132|FG001|Overall Study|Other|0|||
129705116|NCT00718315|466884133|FG002|Overall Study|Other|1|||
129705117|NCT00718315|466884131|FG000|Overall Study|Use of ATB and Corticoids|0|||
129705118|NCT00718315|466884132|FG001|Overall Study|Use of ATB and Corticoids|1|||
129705119|NCT00718315|466884133|FG002|Overall Study|Use of ATB and Corticoids|2|||
129705120|NCT02006927|466884136|FG000|Overall Study|Adverse Event|2|||
129705121|NCT02006927|466884136|FG000|Overall Study|Withdrawal by Subject|1|||
129705122|NCT02746809|466884141|FG000|Enrollment|Inclusion Exclusion not met|9|||
129705123|NCT02746809|466884141|FG000|Enrollment|Withdrawal by Subject|1|||
129705124|NCT02746809|466884141|FG000|Enrollment|Expected Enrollment Met|2|||
129705125|NCT02746809|466884141|FG000|Procedure|Death|1|||
129705126|NCT02746809|466884141|FG000|1-Month|Death|5|||
129705127|NCT02746809|466884141|FG000|6-Month|Death|2|||
129705128|NCT02746809|466884141|FG000|6-Month|Withdrawal by Subject|1|||
129705129|NCT02746809|466884141|FG000|12-Month|Death|3|||
129705130|NCT02746809|466884141|FG000|12-Month|Withdrawal by Subject|2|||
129705131|NCT02746809|466884141|FG000|24-Month|Death|1|||
129705132|NCT02746809|466884141|FG000|24-Month|Withdrawal by Subject|1|||
129705133|NCT02746809|466884141|FG000|36-Month|Death|8|||
129705134|NCT02746809|466884141|FG000|36-Month|Withdrawal by Subject|1|||
129705135|NCT02746809|466884141|FG000|48-Month|Death|7|||
129705136|NCT02746809|466884141|FG000|48-Month|Withdrawal by Subject|1|||
129705137|NCT02746809|466884141|FG000|60-Month|Death|1|||
129705138|NCT02746809|466884141|FG000|60-Month|Lost to Follow-up|2|||
129705139|NCT00673920|466884142|FG000|Baseline up to Week 48|Withdrew consent|1|||
129705140|NCT00673920|466884143|FG001|Baseline up to Week 48|Withdrew consent|0|||
129705141|NCT00673920|466884144|FG002|Baseline up to Week 48|Withdrew consent|2|||
129705142|NCT00673920|466884145|FG003|Baseline up to Week 48|Withdrew consent|0|||
129705143|NCT00673920|466884146|FG004|Baseline up to Week 48|Withdrew consent|0|||
129705144|NCT00673920|466884147|FG005|Baseline up to Week 48|Withdrew consent|0|||
129705145|NCT00673920|466884148|FG006|Baseline up to Week 48|Withdrew consent|0|||
129705146|NCT00673920|466884149|FG007|Baseline up to Week 48|Withdrew consent|0|||
129705147|NCT00673920|466884142|FG000|Baseline up to Week 48|Refused treatment|1|||
129705148|NCT00673920|466884143|FG001|Baseline up to Week 48|Refused treatment|0|||
129705149|NCT00673920|466884144|FG002|Baseline up to Week 48|Refused treatment|0|||
129705150|NCT00673920|466884145|FG003|Baseline up to Week 48|Refused treatment|0|||
129705151|NCT00673920|466884146|FG004|Baseline up to Week 48|Refused treatment|0|||
129705152|NCT00673920|466884147|FG005|Baseline up to Week 48|Refused treatment|0|||
129705153|NCT00673920|466884148|FG006|Baseline up to Week 48|Refused treatment|0|||
129705154|NCT00673920|466884149|FG007|Baseline up to Week 48|Refused treatment|0|||
129705155|NCT00673920|466884142|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
129705156|NCT00673920|466884143|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
129705157|NCT00673920|466884144|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
129705158|NCT00673920|466884145|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
129705159|NCT00673920|466884146|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
129705160|NCT00673920|466884147|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
129705161|NCT00673920|466884148|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
129705162|NCT00673920|466884149|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
129705163|NCT00673920|466884142|FG000|Baseline up to Week 48|Protocol Violation|0|||
129705164|NCT00673920|466884143|FG001|Baseline up to Week 48|Protocol Violation|0|||
129705165|NCT00673920|466884144|FG002|Baseline up to Week 48|Protocol Violation|1|||
129798210|NCT02545075|467230020|FG001|Treatment|Withdrawal by Subject|0|||
129798211|NCT02545075|467230019|FG000|Treatment|Adverse event not related to study drug|1|||
129639540|NCT02553499|466634716|FG012|Overall Study|Physician Decision|1|||
129639541|NCT02553499|466634717|FG013|Overall Study|Physician Decision|0|||
129639542|NCT02553499|466634704|FG000|Overall Study|Progressive Disease|0|||
129639543|NCT02553499|466634705|FG001|Overall Study|Progressive Disease|0|||
129639544|NCT02553499|466634706|FG002|Overall Study|Progressive Disease|0|||
129639545|NCT02553499|466634707|FG003|Overall Study|Progressive Disease|2|||
129639546|NCT02553499|466634708|FG004|Overall Study|Progressive Disease|1|||
129639547|NCT02553499|466634709|FG005|Overall Study|Progressive Disease|1|||
129639548|NCT02553499|466634710|FG006|Overall Study|Progressive Disease|1|||
129639549|NCT02553499|466634711|FG007|Overall Study|Progressive Disease|0|||
129639550|NCT02553499|466634712|FG008|Overall Study|Progressive Disease|0|||
129639551|NCT02553499|466634713|FG009|Overall Study|Progressive Disease|1|||
129639552|NCT02553499|466634714|FG010|Overall Study|Progressive Disease|0|||
129639553|NCT02553499|466634715|FG011|Overall Study|Progressive Disease|0|||
129639554|NCT02553499|466634716|FG012|Overall Study|Progressive Disease|2|||
129639555|NCT02553499|466634717|FG013|Overall Study|Progressive Disease|1|||
129639556|NCT02553499|466634704|FG000|Overall Study|Study Terminated by Sponsor|0|||
129639557|NCT02553499|466634705|FG001|Overall Study|Study Terminated by Sponsor|0|||
129639558|NCT02553499|466634706|FG002|Overall Study|Study Terminated by Sponsor|0|||
129639559|NCT02553499|466634707|FG003|Overall Study|Study Terminated by Sponsor|0|||
129639560|NCT02553499|466634708|FG004|Overall Study|Study Terminated by Sponsor|0|||
129639561|NCT02553499|466634709|FG005|Overall Study|Study Terminated by Sponsor|0|||
129639562|NCT02553499|466634710|FG006|Overall Study|Study Terminated by Sponsor|0|||
129639563|NCT02553499|466634711|FG007|Overall Study|Study Terminated by Sponsor|0|||
129639564|NCT02553499|466634712|FG008|Overall Study|Study Terminated by Sponsor|1|||
129639565|NCT02553499|466634713|FG009|Overall Study|Study Terminated by Sponsor|0|||
129639566|NCT02553499|466634714|FG010|Overall Study|Study Terminated by Sponsor|0|||
129639567|NCT02553499|466634715|FG011|Overall Study|Study Terminated by Sponsor|0|||
129639568|NCT02553499|466634716|FG012|Overall Study|Study Terminated by Sponsor|0|||
129639569|NCT02553499|466634717|FG013|Overall Study|Study Terminated by Sponsor|0|||
129639570|NCT02553499|466634704|FG000|Overall Study|Withdrawal by Subject|2|||
129639571|NCT02553499|466634705|FG001|Overall Study|Withdrawal by Subject|0|||
129639572|NCT02553499|466634706|FG002|Overall Study|Withdrawal by Subject|0|||
129639573|NCT02553499|466634707|FG003|Overall Study|Withdrawal by Subject|0|||
129639574|NCT02553499|466634708|FG004|Overall Study|Withdrawal by Subject|0|||
129639575|NCT02553499|466634709|FG005|Overall Study|Withdrawal by Subject|0|||
129639576|NCT02553499|466634710|FG006|Overall Study|Withdrawal by Subject|0|||
129639577|NCT02553499|466634711|FG007|Overall Study|Withdrawal by Subject|1|||
129639578|NCT02553499|466634712|FG008|Overall Study|Withdrawal by Subject|1|||
129639579|NCT02553499|466634713|FG009|Overall Study|Withdrawal by Subject|0|||
129639580|NCT02553499|466634714|FG010|Overall Study|Withdrawal by Subject|1|||
129639581|NCT02553499|466634715|FG011|Overall Study|Withdrawal by Subject|0|||
129639582|NCT02553499|466634716|FG012|Overall Study|Withdrawal by Subject|0|||
129639583|NCT02553499|466634717|FG013|Overall Study|Withdrawal by Subject|0|||
129639584|NCT03319732|466634723|FG000|Overall Study|Adverse Event|40|||
129639585|NCT03319732|466634723|FG000|Overall Study|Withdrawal by Subject|50|||
129639586|NCT03319732|466634723|FG000|Overall Study|MS relapse|10|||
129639587|NCT03319732|466634723|FG000|Overall Study|reason not specified|5|||
129639588|NCT00767455|466634724|FG000|Overall Study|Investigator error|19|||
129639589|NCT03386994|466634727|FG000|Overall Study|Lung transplant|1|||
129639590|NCT03386994|466634727|FG000|Overall Study|Adverse Event|14|||
129639591|NCT03386994|466634727|FG000|Overall Study|Lost to Follow-up|4|||
129639592|NCT03386994|466634727|FG000|Overall Study|Withdrawal by Subject|3|||
129639593|NCT03386994|466634727|FG000|Overall Study|Death|16|||
129639594|NCT01314872|466634731|FG000|Treatment Period 1|Protocol Violation|2|||
129639595|NCT01314872|466634732|FG001|Treatment Period 1|Protocol Violation|1|||
129639596|NCT01314872|466634733|FG002|Treatment Period 1|Protocol Violation|1|||
129639597|NCT01314872|466634734|FG003|Treatment Period 1|Protocol Violation|0|||
129639598|NCT01314872|466634735|FG004|Treatment Period 1|Protocol Violation|1|||
129639599|NCT01314872|466634736|FG005|Treatment Period 1|Protocol Violation|0|||
129639600|NCT01314872|466634737|FG006|Treatment Period 1|Protocol Violation|0|||
129639601|NCT01314872|466634738|FG007|Treatment Period 1|Protocol Violation|0|||
129639602|NCT01314872|466634739|FG008|Treatment Period 1|Protocol Violation|0|||
129639603|NCT01314872|466634740|FG009|Treatment Period 1|Protocol Violation|1|||
129639604|NCT01314872|466634741|FG010|Treatment Period 1|Protocol Violation|1|||
129798212|NCT02545075|467230020|FG001|Treatment|Adverse event not related to study drug|0|||
129798213|NCT02545075|467230019|FG000|Treatment|Death|1|||
129639605|NCT01314872|466634742|FG011|Treatment Period 1|Protocol Violation|0|||
129639606|NCT01314872|466634743|FG012|Treatment Period 1|Protocol Violation|0|||
129639607|NCT01314872|466634744|FG013|Treatment Period 1|Protocol Violation|0|||
129639608|NCT01314872|466634745|FG014|Treatment Period 1|Protocol Violation|0|||
129639609|NCT01314872|466634731|FG000|Treatment Period 1|Physician Decision|0|||
129639610|NCT01314872|466634732|FG001|Treatment Period 1|Physician Decision|1|||
129639611|NCT01314872|466634733|FG002|Treatment Period 1|Physician Decision|0|||
129639612|NCT01314872|466634734|FG003|Treatment Period 1|Physician Decision|1|||
129639613|NCT01314872|466634735|FG004|Treatment Period 1|Physician Decision|0|||
129798214|NCT02545075|467230020|FG001|Treatment|Death|0|||
129798215|NCT02545075|467230019|FG000|Treatment|Participant drug toxicity|1|||
129798216|NCT02545075|467230020|FG001|Treatment|Participant drug toxicity|0|||
129798217|NCT02545075|467230019|FG000|Treatment|Completed treatment|40|||
129798218|NCT02545075|467230020|FG001|Treatment|Completed treatment|12|||
129798219|NCT00736879|467230023|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
129798220|NCT00736879|467230024|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
129639614|NCT01314872|466634736|FG005|Treatment Period 1|Physician Decision|0|||
129639615|NCT01314872|466634737|FG006|Treatment Period 1|Physician Decision|0|||
129639616|NCT01314872|466634738|FG007|Treatment Period 1|Physician Decision|0|||
129639617|NCT01314872|466634739|FG008|Treatment Period 1|Physician Decision|0|||
129639618|NCT01314872|466634740|FG009|Treatment Period 1|Physician Decision|1|||
129639619|NCT01314872|466634741|FG010|Treatment Period 1|Physician Decision|0|||
129639620|NCT01314872|466634742|FG011|Treatment Period 1|Physician Decision|0|||
129639621|NCT01314872|466634743|FG012|Treatment Period 1|Physician Decision|0|||
129639622|NCT01314872|466634744|FG013|Treatment Period 1|Physician Decision|0|||
129639623|NCT01314872|466634745|FG014|Treatment Period 1|Physician Decision|0|||
129639624|NCT01314872|466634731|FG000|Treatment Period 1|Lack of Efficacy|1|||
129639625|NCT01314872|466634732|FG001|Treatment Period 1|Lack of Efficacy|0|||
129639626|NCT01314872|466634733|FG002|Treatment Period 1|Lack of Efficacy|0|||
129639627|NCT01314872|466634734|FG003|Treatment Period 1|Lack of Efficacy|0|||
129639628|NCT01314872|466634735|FG004|Treatment Period 1|Lack of Efficacy|0|||
129639629|NCT01314872|466634736|FG005|Treatment Period 1|Lack of Efficacy|1|||
129639630|NCT01314872|466634737|FG006|Treatment Period 1|Lack of Efficacy|0|||
129639631|NCT01314872|466634738|FG007|Treatment Period 1|Lack of Efficacy|2|||
129639632|NCT01314872|466634739|FG008|Treatment Period 1|Lack of Efficacy|0|||
129639633|NCT01314872|466634740|FG009|Treatment Period 1|Lack of Efficacy|0|||
129639634|NCT01314872|466634741|FG010|Treatment Period 1|Lack of Efficacy|0|||
129639635|NCT01314872|466634742|FG011|Treatment Period 1|Lack of Efficacy|0|||
129639636|NCT01314872|466634743|FG012|Treatment Period 1|Lack of Efficacy|0|||
129639637|NCT01314872|466634744|FG013|Treatment Period 1|Lack of Efficacy|0|||
129639638|NCT01314872|466634745|FG014|Treatment Period 1|Lack of Efficacy|0|||
129639639|NCT01314872|466634731|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
129639640|NCT01314872|466634732|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
129639641|NCT01314872|466634733|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
129639642|NCT01314872|466634734|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
129639643|NCT01314872|466634735|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
129639644|NCT01314872|466634736|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
129639645|NCT01314872|466634737|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
129639646|NCT01314872|466634738|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
129639647|NCT01314872|466634739|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
129639648|NCT01314872|466634740|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
129639649|NCT01314872|466634741|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
129639650|NCT01314872|466634742|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
129639651|NCT01314872|466634743|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
129639652|NCT01314872|466634744|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
129639653|NCT01314872|466634745|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
129639654|NCT01314872|466634731|FG000|Treatment Period 1|Withdrawal by Subject|3|||
129639655|NCT01314872|466634732|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129639656|NCT01314872|466634733|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129639657|NCT01314872|466634734|FG003|Treatment Period 1|Withdrawal by Subject|2|||
129639658|NCT01314872|466634735|FG004|Treatment Period 1|Withdrawal by Subject|3|||
129639659|NCT01314872|466634736|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129639660|NCT01314872|466634737|FG006|Treatment Period 1|Withdrawal by Subject|3|||
129639661|NCT01314872|466634738|FG007|Treatment Period 1|Withdrawal by Subject|2|||
129798221|NCT00736879|467230025|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
129798222|NCT00736879|467230026|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
129798223|NCT00736879|467230023|FG000|Double Blind Treatment Period|Adverse Event|0|||
129798224|NCT00736879|467230024|FG001|Double Blind Treatment Period|Adverse Event|1|||
129639662|NCT01314872|466634739|FG008|Treatment Period 1|Withdrawal by Subject|2|||
129798225|NCT00736879|467230025|FG002|Double Blind Treatment Period|Adverse Event|1|||
129798226|NCT00736879|467230026|FG003|Double Blind Treatment Period|Adverse Event|0|||
129798227|NCT00736879|467230023|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
129639663|NCT01314872|466634740|FG009|Treatment Period 1|Withdrawal by Subject|2|||
129639664|NCT01314872|466634741|FG010|Treatment Period 1|Withdrawal by Subject|1|||
129639665|NCT01314872|466634742|FG011|Treatment Period 1|Withdrawal by Subject|0|||
129639666|NCT01314872|466634743|FG012|Treatment Period 1|Withdrawal by Subject|0|||
129639667|NCT01314872|466634744|FG013|Treatment Period 1|Withdrawal by Subject|0|||
129639668|NCT01314872|466634745|FG014|Treatment Period 1|Withdrawal by Subject|0|||
129798228|NCT00736879|467230024|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
129798229|NCT00736879|467230025|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
129705166|NCT00673920|466884145|FG003|Baseline up to Week 48|Protocol Violation|0|||
129705167|NCT00673920|466884146|FG004|Baseline up to Week 48|Protocol Violation|0|||
129705168|NCT00673920|466884147|FG005|Baseline up to Week 48|Protocol Violation|0|||
129705169|NCT00673920|466884148|FG006|Baseline up to Week 48|Protocol Violation|0|||
129705170|NCT00673920|466884149|FG007|Baseline up to Week 48|Protocol Violation|0|||
129705171|NCT00673920|466884142|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129705172|NCT00673920|466884143|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129705173|NCT00673920|466884144|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
129705174|NCT00673920|466884145|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129442875|NCT03801902|465921139|FG000|Overall Study|Did not receive protocol treatment.|1|||
129442876|NCT03801902|465921140|FG001|Overall Study|Did not receive protocol treatment.|0|||
129442877|NCT03801902|465921141|FG002|Overall Study|Did not receive protocol treatment.|0|||
129442878|NCT03801902|465921142|FG003|Overall Study|Did not receive protocol treatment.|0|||
129442879|NCT02310672|465921145|FG000|Overall Study|Death|1|||
129442880|NCT02310672|465921145|FG000|Overall Study|Lost to Follow-up|1|||
129705175|NCT00673920|466884146|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129705176|NCT00673920|466884147|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129705177|NCT00673920|466884148|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129442881|NCT02310672|465921145|FG000|Overall Study|Withdrawal by Subject|1|||
129442882|NCT02310672|465921145|FG000|Overall Study|Sponsor's decision|12|||
129442883|NCT00528866|465921146|FG000|Overall Study|Protocol Violation|6|||
129442884|NCT01601847|465921147|FG000|Overall Study|Death|1|||
129442885|NCT01601847|465921148|FG001|Overall Study|Death|0|||
129442886|NCT01601847|465921147|FG000|Overall Study|Withdrawal by Subject|11|||
129442887|NCT01601847|465921148|FG001|Overall Study|Withdrawal by Subject|7|||
129442888|NCT01601847|465921147|FG000|Overall Study|Lost to Follow-up|1|||
129442889|NCT01601847|465921148|FG001|Overall Study|Lost to Follow-up|3|||
129442890|NCT01284062|465921149|FG000|Overall Study|Adverse Event|4|||
129442891|NCT01284062|465921150|FG001|Overall Study|Adverse Event|5|||
129442892|NCT01284062|465921151|FG002|Overall Study|Adverse Event|0|||
129442893|NCT01284062|465921152|FG003|Overall Study|Adverse Event|5|||
129442894|NCT01284062|465921149|FG000|Overall Study|Lack of Efficacy|3|||
129442895|NCT01284062|465921150|FG001|Overall Study|Lack of Efficacy|2|||
129442896|NCT01284062|465921151|FG002|Overall Study|Lack of Efficacy|2|||
129442897|NCT01284062|465921152|FG003|Overall Study|Lack of Efficacy|1|||
129442898|NCT01284062|465921149|FG000|Overall Study|Medication error without adverse event|0|||
129442899|NCT01284062|465921150|FG001|Overall Study|Medication error without adverse event|0|||
129442900|NCT01284062|465921151|FG002|Overall Study|Medication error without adverse event|1|||
129442901|NCT01284062|465921152|FG003|Overall Study|Medication error without adverse event|0|||
129442902|NCT01284062|465921149|FG000|Overall Study|Protocol Violation|1|||
129442903|NCT01284062|465921150|FG001|Overall Study|Protocol Violation|0|||
129705178|NCT00673920|466884149|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
129705179|NCT00673920|466884142|FG000|Baseline up to Week 48|Administrative/Other|0|||
129705180|NCT00673920|466884143|FG001|Baseline up to Week 48|Administrative/Other|1|||
129705181|NCT00673920|466884144|FG002|Baseline up to Week 48|Administrative/Other|2|||
129705182|NCT00673920|466884145|FG003|Baseline up to Week 48|Administrative/Other|0|||
129705183|NCT00673920|466884146|FG004|Baseline up to Week 48|Administrative/Other|0|||
129705184|NCT00673920|466884147|FG005|Baseline up to Week 48|Administrative/Other|0|||
129705185|NCT00673920|466884148|FG006|Baseline up to Week 48|Administrative/Other|0|||
129705186|NCT00673920|466884149|FG007|Baseline up to Week 48|Administrative/Other|0|||
129705187|NCT00673920|466884142|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129705188|NCT00673920|466884143|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
129705189|NCT00673920|466884144|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
129442904|NCT01284062|465921151|FG002|Overall Study|Protocol Violation|0|||
129442905|NCT01284062|465921152|FG003|Overall Study|Protocol Violation|2|||
129442906|NCT01284062|465921149|FG000|Overall Study|Withdrawal by Subject|3|||
129442907|NCT01284062|465921150|FG001|Overall Study|Withdrawal by Subject|1|||
129442908|NCT01284062|465921151|FG002|Overall Study|Withdrawal by Subject|2|||
129442909|NCT01284062|465921152|FG003|Overall Study|Withdrawal by Subject|5|||
129442910|NCT01284062|465921149|FG000|Overall Study|Other|0|||
129442911|NCT01284062|465921150|FG001|Overall Study|Other|0|||
129442912|NCT01284062|465921151|FG002|Overall Study|Other|0|||
129442913|NCT01284062|465921152|FG003|Overall Study|Other|1|||
129442914|NCT01284062|465921149|FG000|Overall Study|Site Closed|0|||
129442915|NCT01284062|465921150|FG001|Overall Study|Site Closed|0|||
129442916|NCT01284062|465921151|FG002|Overall Study|Site Closed|1|||
129442917|NCT01284062|465921152|FG003|Overall Study|Site Closed|0|||
129442918|NCT02234323|465921153|FG000|All Enrolled|Not Treated: Completed study in database|2|||
129442919|NCT02234323|465921153|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
129442920|NCT02234323|465921153|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
129705190|NCT00673920|466884145|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129705191|NCT00673920|466884146|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129705192|NCT00673920|466884147|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129889490|NCT00946647|467552610|FG004|Phase ll Part|Protocol Violation|2|||
129639669|NCT01314872|466634731|FG000|Treatment Period 1|Lost to Follow-up|0|||
129639670|NCT01314872|466634732|FG001|Treatment Period 1|Lost to Follow-up|1|||
129639671|NCT01314872|466634733|FG002|Treatment Period 1|Lost to Follow-up|2|||
129889491|NCT00946647|467552606|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
129889492|NCT00946647|467552607|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
129889493|NCT00946647|467552608|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
129889494|NCT00946647|467552609|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
129889495|NCT00946647|467552610|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
129889496|NCT01368211|467552611|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
129639672|NCT01314872|466634734|FG003|Treatment Period 1|Lost to Follow-up|2|||
129639673|NCT01314872|466634735|FG004|Treatment Period 1|Lost to Follow-up|1|||
129639674|NCT01314872|466634736|FG005|Treatment Period 1|Lost to Follow-up|1|||
129639675|NCT01314872|466634737|FG006|Treatment Period 1|Lost to Follow-up|1|||
129639676|NCT01314872|466634738|FG007|Treatment Period 1|Lost to Follow-up|1|||
129639677|NCT01314872|466634739|FG008|Treatment Period 1|Lost to Follow-up|1|||
129639678|NCT01314872|466634740|FG009|Treatment Period 1|Lost to Follow-up|0|||
129639679|NCT01314872|466634741|FG010|Treatment Period 1|Lost to Follow-up|0|||
129639680|NCT01314872|466634742|FG011|Treatment Period 1|Lost to Follow-up|0|||
129639681|NCT01314872|466634743|FG012|Treatment Period 1|Lost to Follow-up|0|||
129639682|NCT01314872|466634744|FG013|Treatment Period 1|Lost to Follow-up|0|||
129639683|NCT01314872|466634745|FG014|Treatment Period 1|Lost to Follow-up|0|||
129639684|NCT01314872|466634731|FG000|Period 2|Protocol Violation|0|||
129639685|NCT01314872|466634732|FG001|Period 2|Protocol Violation|0|||
129639686|NCT01314872|466634733|FG002|Period 2|Protocol Violation|0|||
129639687|NCT01314872|466634734|FG003|Period 2|Protocol Violation|0|||
129442921|NCT02234323|465921153|FG000|All Treated|Death|1|||
129639688|NCT01314872|466634735|FG004|Period 2|Protocol Violation|0|||
129639689|NCT01314872|466634736|FG005|Period 2|Protocol Violation|0|||
129639690|NCT01314872|466634737|FG006|Period 2|Protocol Violation|0|||
129639691|NCT01314872|466634738|FG007|Period 2|Protocol Violation|0|||
129705193|NCT00673920|466884148|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129705194|NCT00673920|466884149|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
129705195|NCT00673920|466884142|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705196|NCT00673920|466884143|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705197|NCT00673920|466884144|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705198|NCT00673920|466884145|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705199|NCT00673920|466884146|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705200|NCT00673920|466884147|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705201|NCT00673920|466884148|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
129705202|NCT00673920|466884149|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
129705203|NCT00673920|466884142|FG000|Week 24 to Week 48|Failure to return|0|||
129705204|NCT00673920|466884143|FG001|Week 24 to Week 48|Failure to return|0|||
129705205|NCT00673920|466884144|FG002|Week 24 to Week 48|Failure to return|0|||
129705206|NCT00673920|466884145|FG003|Week 24 to Week 48|Failure to return|0|||
129889497|NCT01368211|467552612|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
129889498|NCT01513967|467552623|FG000|Overall Study|Pregnancy|0|||
129442922|NCT02234323|465921153|FG000|All Treated|Physician Decision|5|||
129442923|NCT02234323|465921153|FG000|All Treated|Lack of Efficacy|3|||
129442924|NCT02234323|465921153|FG000|All Treated|Exceeded lab value limit|2|||
129442925|NCT02234323|465921153|FG000|All Treated|Other|7|||
129442926|NCT04614662|465921154|FG000|Overall Study|Withdrawal by Subject|0|||
129442927|NCT04614662|465921155|FG001|Overall Study|Withdrawal by Subject|1|||
129442928|NCT01717768|465921158|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442929|NCT01717768|465921159|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
129442930|NCT01717768|465921160|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442931|NCT01717768|465921161|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442932|NCT01717768|465921162|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442933|NCT01717768|465921163|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442934|NCT01717768|465921164|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442935|NCT01717768|465921165|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442936|NCT01717768|465921166|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442937|NCT01717768|465921167|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442938|NCT01717768|465921168|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442939|NCT01717768|465921169|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
129442940|NCT01717768|465921158|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442941|NCT01717768|465921159|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442942|NCT01717768|465921160|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442943|NCT01717768|465921161|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442944|NCT01717768|465921162|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442945|NCT01717768|465921163|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129798230|NCT00736879|467230026|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
129798231|NCT00736879|467230023|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
129442946|NCT01717768|465921164|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442947|NCT01717768|465921165|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442948|NCT01717768|465921166|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129442949|NCT01717768|465921167|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129798232|NCT00736879|467230024|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129442950|NCT01717768|465921168|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
129798233|NCT00736879|467230025|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
129798234|NCT00736879|467230026|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
129705207|NCT00673920|466884146|FG004|Week 24 to Week 48|Failure to return|0|||
129705208|NCT00673920|466884147|FG005|Week 24 to Week 48|Failure to return|1|||
129705209|NCT00673920|466884148|FG006|Week 24 to Week 48|Failure to return|0|||
129705210|NCT00673920|466884149|FG007|Week 24 to Week 48|Failure to return|0|||
129705211|NCT00673920|466884142|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705212|NCT00673920|466884143|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705213|NCT00673920|466884144|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705214|NCT00673920|466884145|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705215|NCT00673920|466884146|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705216|NCT00673920|466884147|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
129705217|NCT00673920|466884148|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705218|NCT00673920|466884149|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
129705219|NCT00673920|466884142|FG000|Week 24 to Week 48|Death|0|||
129705220|NCT00673920|466884143|FG001|Week 24 to Week 48|Death|0|||
129705221|NCT00673920|466884144|FG002|Week 24 to Week 48|Death|0|||
129705222|NCT00673920|466884145|FG003|Week 24 to Week 48|Death|0|||
129705223|NCT00673920|466884146|FG004|Week 24 to Week 48|Death|0|||
129705224|NCT00673920|466884147|FG005|Week 24 to Week 48|Death|1|||
129705225|NCT00673920|466884148|FG006|Week 24 to Week 48|Death|0|||
129705226|NCT00673920|466884149|FG007|Week 24 to Week 48|Death|0|||
129705227|NCT00673920|466884142|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
129705228|NCT00673920|466884143|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
129705229|NCT00673920|466884144|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
129705230|NCT00673920|466884145|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
129705231|NCT00673920|466884146|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
129705232|NCT00673920|466884147|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
129705233|NCT00673920|466884148|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
129705234|NCT00673920|466884149|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
129705235|NCT01164007|466884152|FG000|Overall Study|Adverse Event|5|||
129705236|NCT01164007|466884152|FG000|Overall Study|Progression of Disease|30|||
129798235|NCT00736879|467230023|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
129442951|NCT01717768|465921169|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
129705237|NCT01164007|466884152|FG000|Overall Study|Protocol Violation|1|||
129705238|NCT01164007|466884152|FG000|Overall Study|Withdrawal by Subject|1|||
129705239|NCT01164007|466884152|FG000|Overall Study|Medical Decision|3|||
129705240|NCT00894387|466884155|FG000|Overall Study|Adverse Event|44|||
129705241|NCT00894387|466884156|FG001|Overall Study|Adverse Event|45|||
129705242|NCT00894387|466884155|FG000|Overall Study|Abnormal Laboratory values|2|||
129798236|NCT00736879|467230024|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
129798237|NCT00736879|467230025|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
129798238|NCT00736879|467230026|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
129798239|NCT00736879|467230023|FG000|Double Blind Treatment Period|No longer met criteria|0|||
129798240|NCT00736879|467230024|FG001|Double Blind Treatment Period|No longer met criteria|1|||
129798241|NCT00736879|467230025|FG002|Double Blind Treatment Period|No longer met criteria|0|||
129798242|NCT00736879|467230026|FG003|Double Blind Treatment Period|No longer met criteria|0|||
129798243|NCT00736879|467230023|FG000|Double Blind Treatment Period|non-specified|0|||
129798244|NCT00736879|467230024|FG001|Double Blind Treatment Period|non-specified|1|||
129798245|NCT00736879|467230025|FG002|Double Blind Treatment Period|non-specified|0|||
129798246|NCT00736879|467230026|FG003|Double Blind Treatment Period|non-specified|0|||
129798247|NCT00736879|467230023|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
129798248|NCT00736879|467230024|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
129798249|NCT00736879|467230025|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
129798250|NCT00736879|467230026|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
129798251|NCT00736879|467230023|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
129798252|NCT00736879|467230024|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
129798253|NCT00736879|467230025|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
129798254|NCT00736879|467230026|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
129798255|NCT01810432|467230027|FG000|Washout|Protocol Violation|0|||
129798256|NCT01810432|467230028|FG001|Washout|Protocol Violation|1|||
129798257|NCT01810432|467230027|FG000|Washout|Adverse Event|1|||
129798258|NCT01810432|467230028|FG001|Washout|Adverse Event|0|||
129798259|NCT01810432|467230027|FG000|Period 2|Withdrawal by Subject|2|||
129798260|NCT01810432|467230028|FG001|Period 2|Withdrawal by Subject|1|||
129798261|NCT01810432|467230027|FG000|Period 2|Physician Decision|1|||
129798262|NCT01810432|467230028|FG001|Period 2|Physician Decision|0|||
129798263|NCT01810432|467230027|FG000|Period 2|Lost to Follow-up|1|||
129798264|NCT01810432|467230028|FG001|Period 2|Lost to Follow-up|1|||
129798265|NCT02360111|467230029|FG000|Overall Study|Death|2|||
129798266|NCT01933217|467230032|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
129798267|NCT01933217|467230033|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
129798268|NCT01933217|467230032|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
129798269|NCT01933217|467230033|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
129798270|NCT03923738|467230034|FG000|Period 1|Adverse Event|1|||
129798271|NCT03923738|467230034|FG000|Period 1|Withdrawal by Subject|1|||
129798272|NCT00147251|467230037|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
129798273|NCT00147251|467230038|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
129798274|NCT01629706|467230039|FG000|Phase 1 PureVision|Screen Failure|4|||
129798275|NCT01629706|467230039|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
129639692|NCT01314872|466634739|FG008|Period 2|Protocol Violation|0|||
129639693|NCT01314872|466634740|FG009|Period 2|Protocol Violation|0|||
129639694|NCT01314872|466634741|FG010|Period 2|Protocol Violation|0|||
129639695|NCT01314872|466634742|FG011|Period 2|Protocol Violation|3|||
129639696|NCT01314872|466634743|FG012|Period 2|Protocol Violation|3|||
129639697|NCT01314872|466634744|FG013|Period 2|Protocol Violation|2|||
129639698|NCT01314872|466634745|FG014|Period 2|Protocol Violation|0|||
129639699|NCT01314872|466634731|FG000|Period 2|Non-compliance with study drug|0|||
129639700|NCT01314872|466634732|FG001|Period 2|Non-compliance with study drug|0|||
129639701|NCT01314872|466634733|FG002|Period 2|Non-compliance with study drug|0|||
129639702|NCT01314872|466634734|FG003|Period 2|Non-compliance with study drug|0|||
129639703|NCT01314872|466634735|FG004|Period 2|Non-compliance with study drug|0|||
129639704|NCT01314872|466634736|FG005|Period 2|Non-compliance with study drug|0|||
129639705|NCT01314872|466634737|FG006|Period 2|Non-compliance with study drug|0|||
129639706|NCT01314872|466634738|FG007|Period 2|Non-compliance with study drug|0|||
129639707|NCT01314872|466634739|FG008|Period 2|Non-compliance with study drug|0|||
129639708|NCT01314872|466634740|FG009|Period 2|Non-compliance with study drug|0|||
129639709|NCT01314872|466634741|FG010|Period 2|Non-compliance with study drug|0|||
129639710|NCT01314872|466634742|FG011|Period 2|Non-compliance with study drug|3|||
129639711|NCT01314872|466634743|FG012|Period 2|Non-compliance with study drug|3|||
129639712|NCT01314872|466634744|FG013|Period 2|Non-compliance with study drug|1|||
129798276|NCT01629706|467230039|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
129798277|NCT01629706|467230039|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
129798278|NCT01629706|467230039|FG000|Phase 2 Habitual|Screen Failure|6|||
129798279|NCT01629706|467230039|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
129798280|NCT01629706|467230039|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
129798281|NCT01629706|467230039|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
129798282|NCT01629706|467230039|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
129639713|NCT01314872|466634745|FG014|Period 2|Non-compliance with study drug|2|||
129639714|NCT01314872|466634731|FG000|Period 2|Lack of Efficacy|0|||
129639715|NCT01314872|466634732|FG001|Period 2|Lack of Efficacy|0|||
129639716|NCT01314872|466634733|FG002|Period 2|Lack of Efficacy|0|||
129639717|NCT01314872|466634734|FG003|Period 2|Lack of Efficacy|0|||
129639718|NCT01314872|466634735|FG004|Period 2|Lack of Efficacy|0|||
129639719|NCT01314872|466634736|FG005|Period 2|Lack of Efficacy|0|||
129639720|NCT01314872|466634737|FG006|Period 2|Lack of Efficacy|0|||
129639721|NCT01314872|466634738|FG007|Period 2|Lack of Efficacy|0|||
129639722|NCT01314872|466634739|FG008|Period 2|Lack of Efficacy|0|||
129639723|NCT01314872|466634740|FG009|Period 2|Lack of Efficacy|0|||
129639724|NCT01314872|466634741|FG010|Period 2|Lack of Efficacy|0|||
129639725|NCT01314872|466634742|FG011|Period 2|Lack of Efficacy|7|||
129639726|NCT01314872|466634743|FG012|Period 2|Lack of Efficacy|12|||
129639727|NCT01314872|466634744|FG013|Period 2|Lack of Efficacy|9|||
129639728|NCT01314872|466634745|FG014|Period 2|Lack of Efficacy|2|||
129639729|NCT01314872|466634731|FG000|Period 2|Pregnancy|0|||
129639730|NCT01314872|466634732|FG001|Period 2|Pregnancy|0|||
129639731|NCT01314872|466634733|FG002|Period 2|Pregnancy|0|||
129639732|NCT01314872|466634734|FG003|Period 2|Pregnancy|0|||
129639733|NCT01314872|466634735|FG004|Period 2|Pregnancy|0|||
129639734|NCT01314872|466634736|FG005|Period 2|Pregnancy|0|||
129639735|NCT01314872|466634737|FG006|Period 2|Pregnancy|0|||
129639736|NCT01314872|466634738|FG007|Period 2|Pregnancy|0|||
129639737|NCT01314872|466634739|FG008|Period 2|Pregnancy|0|||
129639738|NCT01314872|466634740|FG009|Period 2|Pregnancy|0|||
129639739|NCT01314872|466634741|FG010|Period 2|Pregnancy|0|||
129639740|NCT01314872|466634742|FG011|Period 2|Pregnancy|0|||
129639741|NCT01314872|466634743|FG012|Period 2|Pregnancy|0|||
129639742|NCT01314872|466634744|FG013|Period 2|Pregnancy|0|||
129639743|NCT01314872|466634745|FG014|Period 2|Pregnancy|1|||
129639744|NCT01314872|466634731|FG000|Period 2|Study terminated by Sponsor|0|||
129639745|NCT01314872|466634732|FG001|Period 2|Study terminated by Sponsor|0|||
129639746|NCT01314872|466634733|FG002|Period 2|Study terminated by Sponsor|0|||
129639747|NCT01314872|466634734|FG003|Period 2|Study terminated by Sponsor|0|||
129639748|NCT01314872|466634735|FG004|Period 2|Study terminated by Sponsor|0|||
129639749|NCT01314872|466634736|FG005|Period 2|Study terminated by Sponsor|0|||
129639750|NCT01314872|466634737|FG006|Period 2|Study terminated by Sponsor|0|||
129639751|NCT01314872|466634738|FG007|Period 2|Study terminated by Sponsor|0|||
129639752|NCT01314872|466634739|FG008|Period 2|Study terminated by Sponsor|0|||
129639753|NCT01314872|466634740|FG009|Period 2|Study terminated by Sponsor|0|||
129639754|NCT01314872|466634741|FG010|Period 2|Study terminated by Sponsor|0|||
129639755|NCT01314872|466634742|FG011|Period 2|Study terminated by Sponsor|2|||
129639756|NCT01314872|466634743|FG012|Period 2|Study terminated by Sponsor|2|||
129639757|NCT01314872|466634744|FG013|Period 2|Study terminated by Sponsor|3|||
129639758|NCT01314872|466634745|FG014|Period 2|Study terminated by Sponsor|0|||
129639759|NCT01314872|466634731|FG000|Period 2|Adverse event, non-fatal|0|||
129639760|NCT01314872|466634732|FG001|Period 2|Adverse event, non-fatal|0|||
129639761|NCT01314872|466634733|FG002|Period 2|Adverse event, non-fatal|0|||
129639762|NCT01314872|466634734|FG003|Period 2|Adverse event, non-fatal|0|||
129639763|NCT01314872|466634735|FG004|Period 2|Adverse event, non-fatal|0|||
129639764|NCT01314872|466634736|FG005|Period 2|Adverse event, non-fatal|0|||
129639765|NCT01314872|466634737|FG006|Period 2|Adverse event, non-fatal|0|||
129705243|NCT00894387|466884156|FG001|Overall Study|Abnormal Laboratory values|2|||
129639766|NCT01314872|466634738|FG007|Period 2|Adverse event, non-fatal|0|||
129639767|NCT01314872|466634739|FG008|Period 2|Adverse event, non-fatal|0|||
129639768|NCT01314872|466634740|FG009|Period 2|Adverse event, non-fatal|0|||
129705244|NCT00894387|466884155|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129705245|NCT00894387|466884156|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129705246|NCT00894387|466884155|FG000|Overall Study|Lost to Follow-up|3|||
129705247|NCT00894387|466884156|FG001|Overall Study|Lost to Follow-up|5|||
129705248|NCT00894387|466884155|FG000|Overall Study|Administrative problems|2|||
129705249|NCT00894387|466884156|FG001|Overall Study|Administrative problems|2|||
129705250|NCT00894387|466884155|FG000|Overall Study|Death|77|||
129705251|NCT00894387|466884156|FG001|Overall Study|Death|76|||
129705252|NCT00894387|466884155|FG000|Overall Study|Protocol Deviation|4|||
129705253|NCT00894387|466884156|FG001|Overall Study|Protocol Deviation|0|||
129705254|NCT00894387|466884155|FG000|Overall Study|Patient's request|25|||
129705255|NCT00894387|466884156|FG001|Overall Study|Patient's request|30|||
129639769|NCT01314872|466634741|FG010|Period 2|Adverse event, non-fatal|0|||
129705256|NCT00894387|466884155|FG000|Overall Study|Other (Missing)|5|||
129639770|NCT01314872|466634742|FG011|Period 2|Adverse event, non-fatal|13|||
129889499|NCT01513967|467552624|FG001|Overall Study|Pregnancy|0|||
129639771|NCT01314872|466634743|FG012|Period 2|Adverse event, non-fatal|16|||
129639772|NCT01314872|466634744|FG013|Period 2|Adverse event, non-fatal|24|||
129639773|NCT01314872|466634745|FG014|Period 2|Adverse event, non-fatal|9|||
129639774|NCT01314872|466634731|FG000|Period 2|Withdrawal by Subject|0|||
129639775|NCT01314872|466634732|FG001|Period 2|Withdrawal by Subject|0|||
129639776|NCT01314872|466634733|FG002|Period 2|Withdrawal by Subject|0|||
129639777|NCT01314872|466634734|FG003|Period 2|Withdrawal by Subject|0|||
129705257|NCT00894387|466884156|FG001|Overall Study|Other (Missing)|3|||
129705258|NCT00894387|466884155|FG000|Overall Study|Mis-randomized|13|||
129639778|NCT01314872|466634735|FG004|Period 2|Withdrawal by Subject|0|||
129639779|NCT01314872|466634736|FG005|Period 2|Withdrawal by Subject|0|||
129639780|NCT01314872|466634737|FG006|Period 2|Withdrawal by Subject|0|||
129639781|NCT01314872|466634738|FG007|Period 2|Withdrawal by Subject|0|||
129639782|NCT01314872|466634739|FG008|Period 2|Withdrawal by Subject|0|||
129639783|NCT01314872|466634740|FG009|Period 2|Withdrawal by Subject|0|||
129639784|NCT01314872|466634741|FG010|Period 2|Withdrawal by Subject|0|||
129639785|NCT01314872|466634742|FG011|Period 2|Withdrawal by Subject|14|||
129639786|NCT01314872|466634743|FG012|Period 2|Withdrawal by Subject|17|||
129639787|NCT01314872|466634744|FG013|Period 2|Withdrawal by Subject|12|||
129639788|NCT01314872|466634745|FG014|Period 2|Withdrawal by Subject|4|||
129639789|NCT01314872|466634731|FG000|Period 2|Lost to Follow-up|0|||
129639790|NCT01314872|466634732|FG001|Period 2|Lost to Follow-up|0|||
129639791|NCT01314872|466634733|FG002|Period 2|Lost to Follow-up|0|||
129639792|NCT01314872|466634734|FG003|Period 2|Lost to Follow-up|0|||
129639793|NCT01314872|466634735|FG004|Period 2|Lost to Follow-up|0|||
129639794|NCT01314872|466634736|FG005|Period 2|Lost to Follow-up|0|||
129639795|NCT01314872|466634737|FG006|Period 2|Lost to Follow-up|0|||
129639796|NCT01314872|466634738|FG007|Period 2|Lost to Follow-up|0|||
129639797|NCT01314872|466634739|FG008|Period 2|Lost to Follow-up|0|||
129639798|NCT01314872|466634740|FG009|Period 2|Lost to Follow-up|0|||
129639799|NCT01314872|466634741|FG010|Period 2|Lost to Follow-up|0|||
129639800|NCT01314872|466634742|FG011|Period 2|Lost to Follow-up|6|||
129639801|NCT01314872|466634743|FG012|Period 2|Lost to Follow-up|7|||
129639802|NCT01314872|466634744|FG013|Period 2|Lost to Follow-up|2|||
129639803|NCT01314872|466634745|FG014|Period 2|Lost to Follow-up|6|||
129639804|NCT00068393|466636186|FG000|Overall Study|Adverse Event|2|||
129639805|NCT00068393|466636186|FG000|Overall Study|Death|3|||
129639806|NCT00068393|466636186|FG000|Overall Study|Withdrawal by Subject|3|||
129639807|NCT00068393|466636186|FG000|Overall Study|Alternative treatment|1|||
129639808|NCT00068393|466636186|FG000|Overall Study|Quality of life worsening|1|||
129639809|NCT04981470|466636190|FG000|Overall Study|Device failure in all 4 patients|4|||
129639810|NCT00593684|466636191|FG000|Overall Study|Death|2|||
129639811|NCT00593684|466636192|FG001|Overall Study|Death|1|||
129639812|NCT00078767|466636193|FG000|Overall Study|Withdrawal by Subject|1|||
129639813|NCT00078767|466636194|FG001|Overall Study|Withdrawal by Subject|1|||
129639814|NCT02282631|466636199|FG000|Overall Study|Lost to Follow-up|2|||
129639815|NCT02282631|466636200|FG001|Overall Study|Lost to Follow-up|0|||
129639816|NCT01736397|466636201|FG000|Overall Study|Lack of Efficacy|1|||
129639817|NCT01736397|466636202|FG001|Overall Study|Lack of Efficacy|11|||
129639818|NCT01736397|466636201|FG000|Overall Study|Withdrawal by Subject|6|||
129639819|NCT01736397|466636202|FG001|Overall Study|Withdrawal by Subject|5|||
129639820|NCT01736397|466636201|FG000|Overall Study|Lost to Follow-up|0|||
129639821|NCT01736397|466636202|FG001|Overall Study|Lost to Follow-up|1|||
129639822|NCT01736397|466636201|FG000|Overall Study|Adverse Event|6|||
129639823|NCT01736397|466636202|FG001|Overall Study|Adverse Event|3|||
129639824|NCT01736397|466636201|FG000|Overall Study|Not stated|1|||
129639825|NCT01736397|466636202|FG001|Overall Study|Not stated|4|||
129639826|NCT05088603|466636203|FG000|Overall Study|Protocol Violation|6|||
129639827|NCT05088603|466636204|FG001|Overall Study|Protocol Violation|1|||
129639828|NCT01841762|466636206|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
129639829|NCT01841762|466636206|FG000|Treatment Period|Adverse Event|16|||
129639830|NCT01841762|466636206|FG000|Treatment Period|Death|1|||
129639831|NCT01841762|466636206|FG000|Treatment Period|Withdrawal by Subject|7|||
129639832|NCT01841762|466636206|FG000|Treatment Period|Lost to Follow-up|1|||
129639833|NCT01841762|466636206|FG000|Treatment Period|Physician Decision|2|||
129639834|NCT01841762|466636206|FG000|Treatment Period|Other, including non-compliance|5|||
129639835|NCT01841762|466636206|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
129639836|NCT01841762|466636206|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
129639837|NCT01841762|466636206|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
129639838|NCT01841762|466636206|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
129639839|NCT03260244|466636207|FG000|Overall Study|Death|19|||
129639840|NCT03260244|466636207|FG000|Overall Study|Lost to Follow-up|60|||
129639841|NCT03260244|466636207|FG000|Overall Study|Withdrawal by Subject|48|||
129639842|NCT03260244|466636207|FG000|Overall Study|Procedure Not Performed|21|||
129639843|NCT03260244|466636207|FG000|Overall Study|Enrollment Criteria Not Met|31|||
129639844|NCT03260244|466636207|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
129639845|NCT03260244|466636207|FG000|Overall Study|Subject Noncompliance|6|||
129639846|NCT03260244|466636207|FG000|Overall Study|No inducible Arrhythmia|2|||
129639847|NCT03260244|466636207|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
129639848|NCT03260244|466636207|FG000|Overall Study|Screen Failure|2|||
129639849|NCT03260244|466636207|FG000|Overall Study|Treated Off Label|69|||
129639850|NCT03260244|466636207|FG000|Overall Study|No Radiofrequency Ablation|14|||
129705259|NCT00894387|466884156|FG001|Overall Study|Mis-randomized|9|||
129705260|NCT00894387|466884155|FG000|Overall Study|GCP non-compliance|0|||
129705261|NCT00894387|466884156|FG001|Overall Study|GCP non-compliance|2|||
129798283|NCT01151098|467230040|FG000|Overall Study|Adverse Event|82|||
129798284|NCT01151098|467230040|FG000|Overall Study|Lost to Follow-up|6|||
129798285|NCT01151098|467230040|FG000|Overall Study|Lack of Efficacy|15|||
129442952|NCT01717768|465921158|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442953|NCT01717768|465921159|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442954|NCT01717768|465921160|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129639851|NCT00594100|466636212|FG000|Procedure|Technical Failure|9|||
129639852|NCT00594100|466636212|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
129798286|NCT01151098|467230040|FG000|Overall Study|Protocol Violation|1|||
129798287|NCT01151098|467230040|FG000|Overall Study|Miscellaneous|13|||
129639853|NCT00594100|466636212|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
129639854|NCT00594100|466636212|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
129639855|NCT01270464|466636213|FG000|Overall Study|Protocol Violation|4|||
129639856|NCT01270464|466636214|FG001|Overall Study|Protocol Violation|3|||
129442955|NCT01717768|465921161|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442956|NCT01717768|465921162|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442957|NCT01717768|465921163|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442958|NCT01717768|465921164|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442959|NCT01717768|465921165|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
129442960|NCT01717768|465921166|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442961|NCT01717768|465921167|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442962|NCT01717768|465921168|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442963|NCT01717768|465921169|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
129442964|NCT01717768|465921158|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442965|NCT01717768|465921159|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442966|NCT01717768|465921160|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442967|NCT01717768|465921161|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442968|NCT01717768|465921162|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442969|NCT01717768|465921163|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442970|NCT01717768|465921164|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442971|NCT01717768|465921165|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442972|NCT01717768|465921166|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442973|NCT01717768|465921167|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
129442974|NCT01717768|465921168|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442975|NCT01717768|465921169|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
129442976|NCT04195581|465921172|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
129442977|NCT04195581|465921172|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
129442978|NCT04195581|465921172|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
129442979|NCT04195581|465921172|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
129442980|NCT04195581|465921172|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
129442981|NCT04195581|465921172|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
129442982|NCT01237340|465921173|FG000|Overall Study|Adverse Event|3|||
129442983|NCT01237340|465921173|FG000|Overall Study|Withdrawal by Subject|1|||
129442984|NCT01237340|465921173|FG000|Overall Study|Early termination of the trial|36|||
129442985|NCT01843218|465921174|FG000|Overall Study|Withdrawal by Subject|5|||
129442986|NCT01136811|465921175|FG000|Overall Study|Physician Decision|11|||
129639857|NCT01270464|466636215|FG002|Overall Study|Protocol Violation|2|||
129639858|NCT01270464|466636213|FG000|Overall Study|Lack of Efficacy|2|||
129639859|NCT01270464|466636214|FG001|Overall Study|Lack of Efficacy|3|||
129639860|NCT01270464|466636215|FG002|Overall Study|Lack of Efficacy|1|||
129639861|NCT01270464|466636213|FG000|Overall Study|Adverse Event|9|||
129639862|NCT01270464|466636214|FG001|Overall Study|Adverse Event|1|||
129639863|NCT01270464|466636215|FG002|Overall Study|Adverse Event|7|||
129639864|NCT01270464|466636213|FG000|Overall Study|Withdrawal by Subject|2|||
129639865|NCT01270464|466636214|FG001|Overall Study|Withdrawal by Subject|1|||
129639866|NCT01270464|466636215|FG002|Overall Study|Withdrawal by Subject|4|||
129639867|NCT01270464|466636213|FG000|Overall Study|Lost to Follow-up|2|||
129639868|NCT01270464|466636214|FG001|Overall Study|Lost to Follow-up|3|||
129639869|NCT01270464|466636215|FG002|Overall Study|Lost to Follow-up|1|||
129639870|NCT01270464|466636213|FG000|Overall Study|Other|1|||
129639871|NCT01270464|466636214|FG001|Overall Study|Other|1|||
129798288|NCT03343067|467230047|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
129798289|NCT03343067|467230048|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
129639872|NCT01270464|466636215|FG002|Overall Study|Other|3|||
129639873|NCT03981900|466636217|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
129639874|NCT03981900|466636217|FG000|Overall Study|Adverse Event|5|||
129639875|NCT03981900|466636217|FG000|Overall Study|Protocol Violation|1|||
129798290|NCT03343067|467230049|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
129798291|NCT00116168|467230050|FG000|Overall Study|Lost to Follow-up|6|||
129798292|NCT00116168|467230051|FG001|Overall Study|Lost to Follow-up|5|||
129798293|NCT00116168|467230052|FG002|Overall Study|Lost to Follow-up|0|||
129798294|NCT00116168|467230053|FG003|Overall Study|Lost to Follow-up|0|||
129798295|NCT02788474|467230054|FG000|Double Blind Treatment Period|Not treated|1|||
129798296|NCT02788474|467230055|FG001|Double Blind Treatment Period|Not treated|0|||
129639876|NCT03981900|466636217|FG000|Overall Study|Withdrawal by Subject|7|||
129639877|NCT03981900|466636217|FG000|Overall Study|Lost to Follow-up|46|||
129639878|NCT03981900|466636217|FG000|Overall Study|Decision of the researcher|3|||
129639879|NCT03981900|466636217|FG000|Overall Study|Death|3|||
129639880|NCT03981900|466636217|FG000|Overall Study|Other|5|||
129798297|NCT02788474|467230054|FG000|Double Blind Treatment Period|Patient's refusal|3|||
129798298|NCT02788474|467230055|FG001|Double Blind Treatment Period|Patient's refusal|0|||
129798299|NCT02788474|467230054|FG000|Double Blind Treatment Period|Adverse Event|6|||
129798300|NCT02788474|467230055|FG001|Double Blind Treatment Period|Adverse Event|4|||
129798301|NCT02788474|467230054|FG000|Open Label Treatment Period|Adverse Event|29|||
129798302|NCT02788474|467230055|FG001|Open Label Treatment Period|Adverse Event|9|||
129442987|NCT00403754|465921178|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
129639881|NCT03528369|466636218|FG000|Overall Study|Withdrawal by Subject|2|||
129639882|NCT03528369|466636219|FG001|Overall Study|Withdrawal by Subject|0|||
129639883|NCT03528369|466636220|FG002|Overall Study|Withdrawal by Subject|0|||
129639884|NCT03528369|466636218|FG000|Overall Study|Lost to Follow-up|1|||
129639885|NCT03528369|466636219|FG001|Overall Study|Lost to Follow-up|0|||
129639886|NCT03528369|466636220|FG002|Overall Study|Lost to Follow-up|0|||
129798303|NCT02788474|467230054|FG000|Open Label Treatment Period|Other than reason specified|1|||
129798304|NCT02788474|467230055|FG001|Open Label Treatment Period|Other than reason specified|0|||
129798305|NCT02788474|467230054|FG000|Open Label Treatment Period|Patient's refusal|1|||
129798306|NCT02788474|467230055|FG001|Open Label Treatment Period|Patient's refusal|3|||
129639887|NCT03528369|466636218|FG000|Overall Study|Adverse Event|0|||
129639888|NCT03528369|466636219|FG001|Overall Study|Adverse Event|1|||
129639889|NCT03528369|466636220|FG002|Overall Study|Adverse Event|0|||
129639890|NCT02162719|466636221|FG000|Overall Study|Death|41|||
129639891|NCT02162719|466636222|FG001|Overall Study|Death|46|||
129639892|NCT02162719|466636221|FG000|Overall Study|Lost to Follow-up|1|||
129639893|NCT02162719|466636222|FG001|Overall Study|Lost to Follow-up|3|||
129639894|NCT02162719|466636221|FG000|Overall Study|Disease Progression|2|||
129639895|NCT02162719|466636222|FG001|Overall Study|Disease Progression|1|||
129639896|NCT02162719|466636221|FG000|Overall Study|Withdrawal by Subject|8|||
129639897|NCT02162719|466636222|FG001|Overall Study|Withdrawal by Subject|2|||
129639898|NCT02162719|466636221|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
129639899|NCT02162719|466636222|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
129639900|NCT03555565|466636224|FG000|Overall Study|Case Report Forms Uncollected|2|||
129639901|NCT03555565|466636224|FG000|Overall Study|Protocol Deviation|13|||
129639902|NCT03192306|466636230|FG000|Overall Study|Did not treat cold sore during study|149|||
129639903|NCT03192306|466636231|FG001|Overall Study|Did not treat cold sore during study|143|||
129639904|NCT03192306|466636230|FG000|Overall Study|Withdrawal by Subject|1|||
129639905|NCT03192306|466636231|FG001|Overall Study|Withdrawal by Subject|1|||
129639906|NCT03192306|466636230|FG000|Overall Study|Lost to Follow-up|1|||
129639907|NCT03192306|466636231|FG001|Overall Study|Lost to Follow-up|0|||
129639908|NCT03192306|466636230|FG000|Overall Study|Protocol Violation|1|||
129639909|NCT03192306|466636231|FG001|Overall Study|Protocol Violation|1|||
129639910|NCT02589626|466636236|FG000|Overall Study|Other than the reason specified|1|||
129639911|NCT02589626|466636237|FG001|Overall Study|Other than the reason specified|0|||
129639912|NCT02589626|466636236|FG000|Overall Study|Withdrawal by Subject|1|||
129639913|NCT02589626|466636237|FG001|Overall Study|Withdrawal by Subject|1|||
129639914|NCT02589626|466636236|FG000|Overall Study|Adverse Event|1|||
129639915|NCT02589626|466636237|FG001|Overall Study|Adverse Event|1|||
129639916|NCT02564900|466636238|FG000|Dose Escalation|Progressive disease per RECIST|2|||
129639917|NCT02564900|466636239|FG001|Dose Escalation|Progressive disease per RECIST|3|||
129639918|NCT02564900|466636240|FG002|Dose Escalation|Progressive disease per RECIST|3|||
129639919|NCT02564900|466636241|FG003|Dose Escalation|Progressive disease per RECIST|3|||
129639920|NCT02564900|466636242|FG004|Dose Escalation|Progressive disease per RECIST|3|||
129639921|NCT02564900|466636243|FG005|Dose Escalation|Progressive disease per RECIST|1|||
129639922|NCT02564900|466636244|FG006|Dose Escalation|Progressive disease per RECIST|0|||
129639923|NCT02564900|466636245|FG007|Dose Escalation|Progressive disease per RECIST|0|||
129639924|NCT02564900|466636246|FG008|Dose Escalation|Progressive disease per RECIST|0|||
129639925|NCT02564900|466636247|FG009|Dose Escalation|Progressive disease per RECIST|0|||
129639926|NCT02564900|466636248|FG010|Dose Escalation|Progressive disease per RECIST|0|||
129639927|NCT02564900|466636249|FG011|Dose Escalation|Progressive disease per RECIST|0|||
129639928|NCT02564900|466636250|FG012|Dose Escalation|Progressive disease per RECIST|0|||
129639929|NCT02564900|466636251|FG013|Dose Escalation|Progressive disease per RECIST|0|||
129639930|NCT02564900|466636252|FG014|Dose Escalation|Progressive disease per RECIST|0|||
129639931|NCT02564900|466636238|FG000|Dose Escalation|Ongoing|1|||
129639932|NCT02564900|466636239|FG001|Dose Escalation|Ongoing|0|||
129639933|NCT02564900|466636240|FG002|Dose Escalation|Ongoing|0|||
129639934|NCT02564900|466636241|FG003|Dose Escalation|Ongoing|2|||
129639935|NCT02564900|466636242|FG004|Dose Escalation|Ongoing|2|||
129639936|NCT02564900|466636243|FG005|Dose Escalation|Ongoing|2|||
129639937|NCT02564900|466636244|FG006|Dose Escalation|Ongoing|0|||
129639938|NCT02564900|466636245|FG007|Dose Escalation|Ongoing|0|||
129639939|NCT02564900|466636246|FG008|Dose Escalation|Ongoing|0|||
129639940|NCT02564900|466636247|FG009|Dose Escalation|Ongoing|0|||
129639941|NCT02564900|466636248|FG010|Dose Escalation|Ongoing|0|||
129639942|NCT02564900|466636249|FG011|Dose Escalation|Ongoing|0|||
129639943|NCT02564900|466636250|FG012|Dose Escalation|Ongoing|0|||
129639944|NCT02564900|466636251|FG013|Dose Escalation|Ongoing|0|||
129639945|NCT02564900|466636252|FG014|Dose Escalation|Ongoing|0|||
129639946|NCT02564900|466636238|FG000|Dose Escalation|Adverse Event|0|||
129639947|NCT02564900|466636239|FG001|Dose Escalation|Adverse Event|0|||
129639948|NCT02564900|466636240|FG002|Dose Escalation|Adverse Event|0|||
129639949|NCT02564900|466636241|FG003|Dose Escalation|Adverse Event|1|||
129798307|NCT02788474|467230054|FG000|Open Label Treatment Period|Non-compliance|1|||
129798308|NCT02788474|467230055|FG001|Open Label Treatment Period|Non-compliance|0|||
129798309|NCT05342532|467230058|FG000|Overall Study|Adverse Event|5|||
129639950|NCT02564900|466636242|FG004|Dose Escalation|Adverse Event|1|||
129639951|NCT02564900|466636243|FG005|Dose Escalation|Adverse Event|3|||
129639952|NCT02564900|466636244|FG006|Dose Escalation|Adverse Event|0|||
129639953|NCT02564900|466636245|FG007|Dose Escalation|Adverse Event|0|||
129639954|NCT02564900|466636246|FG008|Dose Escalation|Adverse Event|0|||
129639955|NCT02564900|466636247|FG009|Dose Escalation|Adverse Event|0|||
129798310|NCT05342532|467230059|FG001|Overall Study|Adverse Event|20|||
129639956|NCT02564900|466636248|FG010|Dose Escalation|Adverse Event|0|||
129639957|NCT02564900|466636249|FG011|Dose Escalation|Adverse Event|0|||
129639958|NCT02564900|466636250|FG012|Dose Escalation|Adverse Event|0|||
129798311|NCT05342532|467230058|FG000|Overall Study|Lost to Follow-up|10|||
129798312|NCT05342532|467230059|FG001|Overall Study|Lost to Follow-up|15|||
129639959|NCT02564900|466636251|FG013|Dose Escalation|Adverse Event|0|||
129639960|NCT02564900|466636252|FG014|Dose Escalation|Adverse Event|0|||
129639961|NCT02564900|466636238|FG000|Dose Expansion|Progressive disease per RECIST|0|||
129639962|NCT02564900|466636239|FG001|Dose Expansion|Progressive disease per RECIST|0|||
129639963|NCT02564900|466636240|FG002|Dose Expansion|Progressive disease per RECIST|0|||
129639964|NCT02564900|466636241|FG003|Dose Expansion|Progressive disease per RECIST|0|||
129639965|NCT02564900|466636242|FG004|Dose Expansion|Progressive disease per RECIST|0|||
129639966|NCT02564900|466636243|FG005|Dose Expansion|Progressive disease per RECIST|0|||
129639967|NCT02564900|466636244|FG006|Dose Expansion|Progressive disease per RECIST|19|||
129639968|NCT02564900|466636245|FG007|Dose Expansion|Progressive disease per RECIST|17|||
129639969|NCT02564900|466636246|FG008|Dose Expansion|Progressive disease per RECIST|8|||
129639970|NCT02564900|466636247|FG009|Dose Expansion|Progressive disease per RECIST|16|||
129639971|NCT02564900|466636248|FG010|Dose Expansion|Progressive disease per RECIST|13|||
129639972|NCT02564900|466636249|FG011|Dose Expansion|Progressive disease per RECIST|19|||
129639973|NCT02564900|466636250|FG012|Dose Expansion|Progressive disease per RECIST|10|||
129639974|NCT02564900|466636251|FG013|Dose Expansion|Progressive disease per RECIST|13|||
129639975|NCT02564900|466636252|FG014|Dose Expansion|Progressive disease per RECIST|11|||
129639976|NCT02564900|466636238|FG000|Dose Expansion|Clinical progression|0|||
129639977|NCT02564900|466636239|FG001|Dose Expansion|Clinical progression|0|||
129639978|NCT02564900|466636240|FG002|Dose Expansion|Clinical progression|0|||
129639979|NCT02564900|466636241|FG003|Dose Expansion|Clinical progression|0|||
129639980|NCT02564900|466636242|FG004|Dose Expansion|Clinical progression|0|||
129639981|NCT02564900|466636243|FG005|Dose Expansion|Clinical progression|0|||
129639982|NCT02564900|466636244|FG006|Dose Expansion|Clinical progression|5|||
129639983|NCT02564900|466636245|FG007|Dose Expansion|Clinical progression|12|||
129639984|NCT02564900|466636246|FG008|Dose Expansion|Clinical progression|0|||
129639985|NCT02564900|466636247|FG009|Dose Expansion|Clinical progression|3|||
129639986|NCT02564900|466636248|FG010|Dose Expansion|Clinical progression|2|||
129639987|NCT02564900|466636249|FG011|Dose Expansion|Clinical progression|0|||
129639988|NCT02564900|466636250|FG012|Dose Expansion|Clinical progression|1|||
129639989|NCT02564900|466636251|FG013|Dose Expansion|Clinical progression|3|||
129639990|NCT02564900|466636252|FG014|Dose Expansion|Clinical progression|1|||
129639991|NCT02564900|466636238|FG000|Dose Expansion|Adverse Event|0|||
129639992|NCT02564900|466636239|FG001|Dose Expansion|Adverse Event|0|||
129639993|NCT02564900|466636240|FG002|Dose Expansion|Adverse Event|0|||
129639994|NCT02564900|466636241|FG003|Dose Expansion|Adverse Event|0|||
129639995|NCT02564900|466636242|FG004|Dose Expansion|Adverse Event|0|||
129639996|NCT02564900|466636243|FG005|Dose Expansion|Adverse Event|0|||
129639997|NCT02564900|466636244|FG006|Dose Expansion|Adverse Event|9|||
129639998|NCT02564900|466636245|FG007|Dose Expansion|Adverse Event|22|||
129639999|NCT02564900|466636246|FG008|Dose Expansion|Adverse Event|0|||
129640000|NCT02564900|466636247|FG009|Dose Expansion|Adverse Event|11|||
129640001|NCT02564900|466636248|FG010|Dose Expansion|Adverse Event|0|||
129640002|NCT02564900|466636249|FG011|Dose Expansion|Adverse Event|5|||
129640003|NCT02564900|466636250|FG012|Dose Expansion|Adverse Event|2|||
129640004|NCT02564900|466636251|FG013|Dose Expansion|Adverse Event|2|||
129640005|NCT02564900|466636252|FG014|Dose Expansion|Adverse Event|1|||
129640006|NCT02564900|466636238|FG000|Dose Expansion|Ongoing|0|||
129640007|NCT02564900|466636239|FG001|Dose Expansion|Ongoing|0|||
129640008|NCT02564900|466636240|FG002|Dose Expansion|Ongoing|0|||
129640009|NCT02564900|466636241|FG003|Dose Expansion|Ongoing|0|||
129640010|NCT02564900|466636242|FG004|Dose Expansion|Ongoing|0|||
129640011|NCT02564900|466636243|FG005|Dose Expansion|Ongoing|0|||
129640012|NCT02564900|466636244|FG006|Dose Expansion|Ongoing|9|||
129640013|NCT02564900|466636245|FG007|Dose Expansion|Ongoing|10|||
129640014|NCT02564900|466636246|FG008|Dose Expansion|Ongoing|11|||
129640015|NCT02564900|466636247|FG009|Dose Expansion|Ongoing|3|||
129640016|NCT02564900|466636248|FG010|Dose Expansion|Ongoing|0|||
129640017|NCT02564900|466636249|FG011|Dose Expansion|Ongoing|0|||
129640018|NCT02564900|466636250|FG012|Dose Expansion|Ongoing|4|||
129640019|NCT02564900|466636251|FG013|Dose Expansion|Ongoing|0|||
129640020|NCT02564900|466636252|FG014|Dose Expansion|Ongoing|6|||
129442988|NCT00403754|465921179|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
129640021|NCT02564900|466636238|FG000|Dose Expansion|Death|0|||
129640022|NCT02564900|466636239|FG001|Dose Expansion|Death|0|||
129640023|NCT02564900|466636240|FG002|Dose Expansion|Death|0|||
129640024|NCT02564900|466636241|FG003|Dose Expansion|Death|0|||
129640025|NCT02564900|466636242|FG004|Dose Expansion|Death|0|||
129640026|NCT02564900|466636243|FG005|Dose Expansion|Death|0|||
129640027|NCT02564900|466636244|FG006|Dose Expansion|Death|1|||
129640028|NCT02564900|466636245|FG007|Dose Expansion|Death|0|||
129640029|NCT02564900|466636246|FG008|Dose Expansion|Death|0|||
129640030|NCT02564900|466636247|FG009|Dose Expansion|Death|0|||
129640031|NCT02564900|466636248|FG010|Dose Expansion|Death|1|||
129640032|NCT02564900|466636249|FG011|Dose Expansion|Death|0|||
129640033|NCT02564900|466636250|FG012|Dose Expansion|Death|1|||
129640034|NCT02564900|466636251|FG013|Dose Expansion|Death|1|||
129640035|NCT02564900|466636252|FG014|Dose Expansion|Death|0|||
129640036|NCT02564900|466636238|FG000|Dose Expansion|Withdrawal by Subject|0|||
129640037|NCT02564900|466636239|FG001|Dose Expansion|Withdrawal by Subject|0|||
129798313|NCT02057393|467230060|FG000|Overall Study|Withdrawal by Subject|1|||
129798314|NCT02057393|467230060|FG000|Overall Study|Patient did not meet criteria|1|||
129798315|NCT02140775|467230061|FG000|Overall Study|Withdrawal by Subject|30|||
129442989|NCT00403754|465921180|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
129442990|NCT00403754|465921181|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
129442991|NCT00403754|465921178|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
129442992|NCT00403754|465921179|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
129442993|NCT00403754|465921180|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
129640038|NCT02564900|466636240|FG002|Dose Expansion|Withdrawal by Subject|0|||
129640039|NCT02564900|466636241|FG003|Dose Expansion|Withdrawal by Subject|0|||
129640040|NCT02564900|466636242|FG004|Dose Expansion|Withdrawal by Subject|0|||
129640041|NCT02564900|466636243|FG005|Dose Expansion|Withdrawal by Subject|0|||
129640042|NCT02564900|466636244|FG006|Dose Expansion|Withdrawal by Subject|4|||
129640043|NCT02564900|466636245|FG007|Dose Expansion|Withdrawal by Subject|0|||
129640044|NCT02564900|466636246|FG008|Dose Expansion|Withdrawal by Subject|0|||
129640045|NCT02564900|466636247|FG009|Dose Expansion|Withdrawal by Subject|0|||
129640046|NCT02564900|466636248|FG010|Dose Expansion|Withdrawal by Subject|1|||
129640047|NCT02564900|466636249|FG011|Dose Expansion|Withdrawal by Subject|0|||
129640048|NCT02564900|466636250|FG012|Dose Expansion|Withdrawal by Subject|0|||
129640049|NCT02564900|466636251|FG013|Dose Expansion|Withdrawal by Subject|1|||
129640050|NCT02564900|466636252|FG014|Dose Expansion|Withdrawal by Subject|1|||
129640051|NCT02564900|466636238|FG000|Dose Expansion|Other|0|||
129640052|NCT02564900|466636239|FG001|Dose Expansion|Other|0|||
129640053|NCT02564900|466636240|FG002|Dose Expansion|Other|0|||
129640054|NCT02564900|466636241|FG003|Dose Expansion|Other|0|||
129640055|NCT02564900|466636242|FG004|Dose Expansion|Other|0|||
129640056|NCT02564900|466636243|FG005|Dose Expansion|Other|0|||
129640057|NCT02564900|466636244|FG006|Dose Expansion|Other|1|||
129640058|NCT02564900|466636245|FG007|Dose Expansion|Other|0|||
129640059|NCT02564900|466636246|FG008|Dose Expansion|Other|1|||
129640060|NCT02564900|466636247|FG009|Dose Expansion|Other|0|||
129640061|NCT02564900|466636248|FG010|Dose Expansion|Other|0|||
129640062|NCT02564900|466636249|FG011|Dose Expansion|Other|0|||
129640063|NCT02564900|466636250|FG012|Dose Expansion|Other|0|||
129640064|NCT02564900|466636251|FG013|Dose Expansion|Other|0|||
129640065|NCT02564900|466636252|FG014|Dose Expansion|Other|1|||
129640066|NCT02564900|466636238|FG000|Dose Expansion|Did not receive treatment|0|||
129640067|NCT02564900|466636239|FG001|Dose Expansion|Did not receive treatment|0|||
129640068|NCT02564900|466636240|FG002|Dose Expansion|Did not receive treatment|0|||
129640069|NCT02564900|466636241|FG003|Dose Expansion|Did not receive treatment|0|||
129640070|NCT02564900|466636242|FG004|Dose Expansion|Did not receive treatment|0|||
129640071|NCT02564900|466636243|FG005|Dose Expansion|Did not receive treatment|0|||
129640072|NCT02564900|466636244|FG006|Dose Expansion|Did not receive treatment|1|||
129705262|NCT04856527|466884157|FG000|Overall Study|Unable to complete experimental task|2|||
129705263|NCT04856527|466884158|FG001|Overall Study|Unable to complete experimental task|0|||
129705264|NCT01816295|466884159|FG000|Double Blind Phase|Adverse Event|11|||
129705265|NCT01816295|466884160|FG001|Double Blind Phase|Adverse Event|8|||
129705266|NCT01816295|466884159|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
129705267|NCT01816295|466884160|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
129705268|NCT01816295|466884159|FG000|Double Blind Phase|Lost to Follow-up|3|||
129705269|NCT01816295|466884160|FG001|Double Blind Phase|Lost to Follow-up|5|||
129705270|NCT01816295|466884159|FG000|Double Blind Phase|Physician Decision|2|||
129705271|NCT01816295|466884160|FG001|Double Blind Phase|Physician Decision|2|||
129705272|NCT01816295|466884159|FG000|Double Blind Phase|Protocol Violation|17|||
129705273|NCT01816295|466884160|FG001|Double Blind Phase|Protocol Violation|11|||
129705274|NCT01816295|466884159|FG000|Double Blind Phase|Sponsor Decision|8|||
129705275|NCT01816295|466884160|FG001|Double Blind Phase|Sponsor Decision|8|||
129705276|NCT01816295|466884159|FG000|Double Blind Phase|Withdrawal by Subject|22|||
129705277|NCT01816295|466884160|FG001|Double Blind Phase|Withdrawal by Subject|20|||
129705278|NCT01816295|466884159|FG000|OLE Phase|Adverse Event|17|||
129705279|NCT01816295|466884160|FG001|OLE Phase|Adverse Event|15|||
129705280|NCT01816295|466884159|FG000|OLE Phase|Death|1|||
129705281|NCT01816295|466884160|FG001|OLE Phase|Death|0|||
129705282|NCT01816295|466884159|FG000|OLE Phase|Entry Criteria Not Met|3|||
129705283|NCT01816295|466884160|FG001|OLE Phase|Entry Criteria Not Met|5|||
129705284|NCT01816295|466884159|FG000|OLE Phase|Lost to Follow-up|5|||
129705285|NCT01816295|466884160|FG001|OLE Phase|Lost to Follow-up|5|||
129705286|NCT01816295|466884159|FG000|OLE Phase|Physician Decision|3|||
129889500|NCT01513967|467552625|FG002|Overall Study|Pregnancy|0|||
129640073|NCT02564900|466636245|FG007|Dose Expansion|Did not receive treatment|1|||
129640074|NCT02564900|466636246|FG008|Dose Expansion|Did not receive treatment|0|||
129640075|NCT02564900|466636247|FG009|Dose Expansion|Did not receive treatment|0|||
129640076|NCT02564900|466636248|FG010|Dose Expansion|Did not receive treatment|0|||
129640077|NCT02564900|466636249|FG011|Dose Expansion|Did not receive treatment|0|||
129705287|NCT01816295|466884160|FG001|OLE Phase|Physician Decision|1|||
129705288|NCT01816295|466884159|FG000|OLE Phase|Protocol Violation|4|||
129705289|NCT01816295|466884160|FG001|OLE Phase|Protocol Violation|4|||
129705290|NCT01816295|466884159|FG000|OLE Phase|Sponsor Decision|7|||
129705291|NCT01816295|466884160|FG001|OLE Phase|Sponsor Decision|9|||
129798316|NCT02140775|467230062|FG001|Overall Study|Withdrawal by Subject|7|||
129798317|NCT01172275|467230063|FG000|Overall Study|Lost to Follow-up|1|||
129640078|NCT02564900|466636250|FG012|Dose Expansion|Did not receive treatment|0|||
129640079|NCT02564900|466636251|FG013|Dose Expansion|Did not receive treatment|0|||
129640080|NCT02564900|466636252|FG014|Dose Expansion|Did not receive treatment|1|||
129640081|NCT00892151|466636253|FG000|Overall Study|Protocol Violation|1|||
129640082|NCT01931475|466636255|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
129640083|NCT01931475|466636256|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
129640084|NCT01931475|466636255|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
129640085|NCT01931475|466636256|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
129640086|NCT01931475|466636255|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
129640087|NCT01931475|466636256|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
129640088|NCT01931475|466636255|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
129640089|NCT01931475|466636256|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
129640090|NCT01931475|466636255|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
129640091|NCT01931475|466636256|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
129640092|NCT01931475|466636255|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
129640093|NCT01931475|466636256|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
129640094|NCT01931475|466636255|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
129640095|NCT01931475|466636256|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
129640096|NCT01931475|466636255|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
129640097|NCT01931475|466636256|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
129640098|NCT01931475|466636255|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
129640099|NCT01931475|466636256|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
129640100|NCT01931475|466636255|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
129640101|NCT01931475|466636256|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
129640102|NCT01931475|466636255|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
129640103|NCT01931475|466636256|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
129640104|NCT04292912|466636259|FG000|Overall Study|Physician Decision|1|||
129640105|NCT04292912|466636259|FG000|Overall Study|Protocol Violation|6|||
129640106|NCT02475265|466636269|FG000|Overall Study|Physician Decision|1|||
129640107|NCT02475265|466636269|FG000|Overall Study|Withdrawal by Subject|2|||
129640108|NCT01323387|466636273|FG000|Overall Study|Withdrawal by Subject|41|||
129640109|NCT01323387|466636273|FG000|Overall Study|Radiographic Data Unavailable|1|||
129640110|NCT01323387|466636273|FG000|Overall Study|Revision|14|||
129640111|NCT01323387|466636273|FG000|Overall Study|Protocol Violation|12|||
129640112|NCT01323387|466636273|FG000|Overall Study|Randomized but Never Treated|16|||
129640113|NCT01726270|466636274|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
129640114|NCT01726270|466636274|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
129640115|NCT01726270|466636274|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
129640116|NCT01726270|466636274|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
129640117|NCT01726270|466636274|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
129640118|NCT01726270|466636274|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
129640119|NCT00582608|466636275|FG000|Overall Study|Not Treated|7|||
129640120|NCT00582608|466636275|FG000|Overall Study|Patient Ineligible|1|||
129640121|NCT00582608|466636275|FG000|Overall Study|Lack of accrual|4|||
129640122|NCT02073929|466636291|FG000|Overall Study|Lost to Follow-up|2|||
129640123|NCT02073929|466636292|FG001|Overall Study|Lost to Follow-up|1|||
129640124|NCT02073929|466636291|FG000|Overall Study|Adverse Event|2|||
129640125|NCT02073929|466636292|FG001|Overall Study|Adverse Event|1|||
129640126|NCT02073929|466636291|FG000|Overall Study|Withdrawal by Subject|0|||
129640127|NCT02073929|466636292|FG001|Overall Study|Withdrawal by Subject|1|||
129798318|NCT01172275|467230064|FG001|Overall Study|Lost to Follow-up|0|||
129798319|NCT01172275|467230063|FG000|Overall Study|Protocol Violation|1|||
129798320|NCT01172275|467230064|FG001|Overall Study|Protocol Violation|0|||
129798321|NCT04650854|467230069|FG000|Overall Study|Adverse Event|1|||
129798322|NCT04650854|467230070|FG001|Overall Study|Adverse Event|12|||
129798323|NCT04650854|467230071|FG002|Overall Study|Adverse Event|14|||
129798324|NCT04650854|467230069|FG000|Overall Study|Lack of Efficacy|1|||
129798325|NCT04650854|467230070|FG001|Overall Study|Lack of Efficacy|3|||
129798326|NCT04650854|467230071|FG002|Overall Study|Lack of Efficacy|6|||
129640128|NCT00430573|466636293|FG000|Overall Study|Withdrawal by Subject|5|||
129640129|NCT04463251|466636294|FG000|Overall Study|Death|1|||
129798327|NCT04650854|467230069|FG000|Overall Study|Lost to Follow-up|1|||
129798328|NCT04650854|467230070|FG001|Overall Study|Lost to Follow-up|1|||
129798329|NCT04650854|467230071|FG002|Overall Study|Lost to Follow-up|0|||
129705292|NCT01816295|466884159|FG000|OLE Phase|Withdrawal by Subject|10|||
129705293|NCT01816295|466884160|FG001|OLE Phase|Withdrawal by Subject|10|||
129705294|NCT01816295|466884159|FG000|OLE Phase|Lack of Efficacy|3|||
129705295|NCT01816295|466884160|FG001|OLE Phase|Lack of Efficacy|7|||
129705296|NCT04165824|466884161|FG000|Overall Study|Adverse Event|23|||
129705297|NCT04165824|466884161|FG000|Overall Study|Physician Decision|1|||
129705298|NCT04165824|466884161|FG000|Overall Study|Withdrawal by Subject|17|||
129705299|NCT04165824|466884161|FG000|Overall Study|Other|5|||
129705300|NCT05200845|466884168|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
129705301|NCT05200845|466884169|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
129705302|NCT05200845|466884170|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
129705303|NCT05200845|466884171|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
129705304|NCT05200845|466884168|FG000|Overall Study|Withdrawal by Subject|0|||
129705305|NCT05200845|466884169|FG001|Overall Study|Withdrawal by Subject|1|||
129705306|NCT05200845|466884170|FG002|Overall Study|Withdrawal by Subject|1|||
129705307|NCT05200845|466884171|FG003|Overall Study|Withdrawal by Subject|0|||
129705308|NCT01911260|466884178|FG000|Supplementation Period|transference or evasion of school|7|||
129705309|NCT01911260|466884179|FG001|Supplementation Period|transference or evasion of school|9|||
129705310|NCT01911260|466884180|FG002|Supplementation Period|transference or evasion of school|7|||
129705311|NCT01911260|466884181|FG003|Supplementation Period|transference or evasion of school|6|||
129705312|NCT01911260|466884178|FG000|Supplementation Period|Adverse Event|2|||
129705313|NCT01911260|466884179|FG001|Supplementation Period|Adverse Event|0|||
129705314|NCT01911260|466884180|FG002|Supplementation Period|Adverse Event|1|||
129705315|NCT01911260|466884181|FG003|Supplementation Period|Adverse Event|0|||
129705316|NCT01911260|466884178|FG000|Supplementation Period|refused to receive supplement|1|||
129705317|NCT01911260|466884179|FG001|Supplementation Period|refused to receive supplement|0|||
129705318|NCT01911260|466884180|FG002|Supplementation Period|refused to receive supplement|1|||
129705319|NCT01911260|466884181|FG003|Supplementation Period|refused to receive supplement|0|||
129705320|NCT01911260|466884178|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
129705321|NCT01911260|466884179|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
129705322|NCT01911260|466884180|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
129705323|NCT01911260|466884181|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
129705324|NCT01911260|466884178|FG000|Follow-up Period|transference or evasion of school|13|||
129705325|NCT01911260|466884179|FG001|Follow-up Period|transference or evasion of school|20|||
129705326|NCT01911260|466884180|FG002|Follow-up Period|transference or evasion of school|15|||
129705327|NCT01911260|466884181|FG003|Follow-up Period|transference or evasion of school|12|||
129705328|NCT01242514|466884190|FG000|Overall Study|e.g., project closure|1042|||
129705329|NCT01242514|466884191|FG001|Overall Study|e.g., project closure|305|||
129705330|NCT01242514|466884192|FG002|Overall Study|e.g., project closure|171|||
129705331|NCT01242514|466884190|FG000|Overall Study|Subject decision|33|||
129705332|NCT01242514|466884191|FG001|Overall Study|Subject decision|8|||
129705333|NCT01242514|466884192|FG002|Overall Study|Subject decision|2|||
129705334|NCT01242514|466884190|FG000|Overall Study|Severe non-compliance to protocol|5|||
129705335|NCT01242514|466884191|FG001|Overall Study|Severe non-compliance to protocol|2|||
129705336|NCT01242514|466884192|FG002|Overall Study|Severe non-compliance to protocol|1|||
129705337|NCT01242514|466884190|FG000|Overall Study|Lack of therapeutic response|99|||
129705338|NCT01242514|466884191|FG001|Overall Study|Lack of therapeutic response|16|||
129705339|NCT01242514|466884192|FG002|Overall Study|Lack of therapeutic response|10|||
129705340|NCT01242514|466884190|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
129705341|NCT01242514|466884191|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
129705342|NCT01242514|466884192|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
129705343|NCT01242514|466884190|FG000|Overall Study|Lost to Follow-up|14|||
129705344|NCT01242514|466884191|FG001|Overall Study|Lost to Follow-up|5|||
129705345|NCT01242514|466884192|FG002|Overall Study|Lost to Follow-up|4|||
129705346|NCT01242514|466884190|FG000|Overall Study|Adverse Event|129|||
129705347|NCT01242514|466884191|FG001|Overall Study|Adverse Event|18|||
129705348|NCT01242514|466884192|FG002|Overall Study|Adverse Event|19|||
129705349|NCT04079738|466884206|FG000|Study Treatment|Death|1|||
129705350|NCT04079738|466884207|FG001|Study Treatment|Death|0|||
129705351|NCT04079738|466884208|FG002|Study Treatment|Death|0|||
129705352|NCT04079738|466884209|FG003|Study Treatment|Death|0|||
129705353|NCT04079738|466884206|FG000|Study Treatment|Adverse Event|2|||
129705354|NCT04079738|466884207|FG001|Study Treatment|Adverse Event|0|||
129705355|NCT04079738|466884208|FG002|Study Treatment|Adverse Event|0|||
129705356|NCT04079738|466884209|FG003|Study Treatment|Adverse Event|0|||
129705357|NCT04079738|466884206|FG000|Study Treatment|withdrawal before treatment|1|||
129705358|NCT04079738|466884207|FG001|Study Treatment|withdrawal before treatment|0|||
129705359|NCT04079738|466884208|FG002|Study Treatment|withdrawal before treatment|0|||
129705360|NCT04079738|466884209|FG003|Study Treatment|withdrawal before treatment|0|||
129705361|NCT04079738|466884206|FG000|Study Treatment|symptomatic deterioration|2|||
129705362|NCT04079738|466884207|FG001|Study Treatment|symptomatic deterioration|0|||
129705363|NCT04079738|466884208|FG002|Study Treatment|symptomatic deterioration|0|||
129705364|NCT04079738|466884209|FG003|Study Treatment|symptomatic deterioration|0|||
129705365|NCT04079738|466884206|FG000|Study Treatment|Disease Progression|1|||
129705366|NCT04079738|466884207|FG001|Study Treatment|Disease Progression|0|||
129705367|NCT04079738|466884208|FG002|Study Treatment|Disease Progression|0|||
129705368|NCT04079738|466884209|FG003|Study Treatment|Disease Progression|0|||
129640130|NCT04463251|466636295|FG001|Overall Study|Death|0|||
129640131|NCT04463251|466636296|FG002|Overall Study|Death|1|||
129640132|NCT04463251|466636294|FG000|Overall Study|Adverse Event|0|||
129640133|NCT04463251|466636295|FG001|Overall Study|Adverse Event|1|||
129640134|NCT04463251|466636296|FG002|Overall Study|Adverse Event|0|||
129640135|NCT04463251|466636294|FG000|Overall Study|Lost to Follow-up|0|||
129640136|NCT04463251|466636295|FG001|Overall Study|Lost to Follow-up|1|||
129640137|NCT04463251|466636296|FG002|Overall Study|Lost to Follow-up|0|||
129640138|NCT04463251|466636294|FG000|Overall Study|Withdrawal by Subject|0|||
129640139|NCT04463251|466636295|FG001|Overall Study|Withdrawal by Subject|2|||
129640140|NCT04463251|466636296|FG002|Overall Study|Withdrawal by Subject|2|||
129640141|NCT05020665|466636297|FG000|Overall Study|Study terminated by Sponsor|5|||
129640142|NCT05020665|466636298|FG001|Overall Study|Study terminated by Sponsor|4|||
129640143|NCT05020665|466636297|FG000|Overall Study|Death|2|||
129640144|NCT05020665|466636298|FG001|Overall Study|Death|1|||
129640145|NCT05020665|466636297|FG000|Overall Study|Physician Decision|0|||
129640146|NCT05020665|466636298|FG001|Overall Study|Physician Decision|1|||
129640147|NCT05020665|466636297|FG000|Overall Study|Withdrawal by Subject|0|||
129640148|NCT05020665|466636298|FG001|Overall Study|Withdrawal by Subject|1|||
129889501|NCT01513967|467552626|FG003|Overall Study|Pregnancy|0|||
129442994|NCT00403754|465921181|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
129442995|NCT03829319|465921184|FG000|Overall Study|Sponsor's Decision|4|||
129442996|NCT03829319|465921185|FG001|Overall Study|Sponsor's Decision|90|||
129442997|NCT03829319|465921186|FG002|Overall Study|Sponsor's Decision|102|||
129442998|NCT03829319|465921184|FG000|Overall Study|Withdrawal by Subject|1|||
129442999|NCT03829319|465921185|FG001|Overall Study|Withdrawal by Subject|5|||
129443000|NCT03829319|465921186|FG002|Overall Study|Withdrawal by Subject|4|||
129443001|NCT03829319|465921184|FG000|Overall Study|Physician Decision|0|||
129443002|NCT03829319|465921185|FG001|Overall Study|Physician Decision|3|||
129443003|NCT03829319|465921186|FG002|Overall Study|Physician Decision|0|||
129443004|NCT03829319|465921184|FG000|Overall Study|Lost to Follow-up|0|||
129443005|NCT03829319|465921185|FG001|Overall Study|Lost to Follow-up|0|||
129443006|NCT03829319|465921186|FG002|Overall Study|Lost to Follow-up|1|||
129443007|NCT03829319|465921184|FG000|Overall Study|Death|8|||
129443008|NCT03829319|465921185|FG001|Overall Study|Death|277|||
129443009|NCT03829319|465921186|FG002|Overall Study|Death|266|||
129443010|NCT04498832|465921187|FG000|Overall Study|Adverse Event|1|||
129443011|NCT04498832|465921188|FG001|Overall Study|Adverse Event|3|||
129798330|NCT04650854|467230069|FG000|Overall Study|Withdrawal by Subject|2|||
129443012|NCT04498832|465921187|FG000|Overall Study|Withdrawal by Subject|0|||
129443013|NCT04498832|465921188|FG001|Overall Study|Withdrawal by Subject|1|||
129443014|NCT01012739|465921189|FG000|Treatment Period 1|Adverse Event|0|||
129443015|NCT01012739|465921190|FG001|Treatment Period 1|Adverse Event|0|||
129443016|NCT01012739|465921191|FG002|Treatment Period 1|Adverse Event|0|||
129443017|NCT01012739|465921192|FG003|Treatment Period 1|Adverse Event|1|||
129443018|NCT01012739|465921189|FG000|Treatment Period 2|Abnormal test procedure results|0|||
129443019|NCT01012739|465921190|FG001|Treatment Period 2|Abnormal test procedure results|0|||
129443020|NCT01012739|465921191|FG002|Treatment Period 2|Abnormal test procedure results|0|||
129443021|NCT01012739|465921192|FG003|Treatment Period 2|Abnormal test procedure results|1|||
129443022|NCT03049735|465921197|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
129443023|NCT03049735|465921198|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
129443024|NCT03049735|465921199|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
129443025|NCT03049735|465921197|FG000|Overall Study|Other|5|||
129443026|NCT03049735|465921198|FG001|Overall Study|Other|3|||
129443027|NCT03049735|465921199|FG002|Overall Study|Other|1|||
129443028|NCT03049735|465921197|FG000|Overall Study|Lack of Efficacy|4|||
129443029|NCT03049735|465921198|FG001|Overall Study|Lack of Efficacy|0|||
129443030|NCT03049735|465921199|FG002|Overall Study|Lack of Efficacy|3|||
129443031|NCT03049735|465921197|FG000|Overall Study|Protocol deviation|1|||
129443032|NCT03049735|465921198|FG001|Overall Study|Protocol deviation|0|||
129443033|NCT03049735|465921199|FG002|Overall Study|Protocol deviation|0|||
129443034|NCT03049735|465921197|FG000|Overall Study|Pregnancy|0|||
129443035|NCT03049735|465921198|FG001|Overall Study|Pregnancy|0|||
129443036|NCT03049735|465921199|FG002|Overall Study|Pregnancy|1|||
129443037|NCT03049735|465921197|FG000|Overall Study|Adverse Event|7|||
129443038|NCT03049735|465921198|FG001|Overall Study|Adverse Event|18|||
129443039|NCT03049735|465921199|FG002|Overall Study|Adverse Event|5|||
129443040|NCT03049735|465921197|FG000|Overall Study|Withdrawal by Subject|10|||
129443041|NCT03049735|465921198|FG001|Overall Study|Withdrawal by Subject|3|||
129443042|NCT03049735|465921199|FG002|Overall Study|Withdrawal by Subject|7|||
129640149|NCT05020665|466636297|FG000|Overall Study|Reason not specified|1|||
129640150|NCT05020665|466636298|FG001|Overall Study|Reason not specified|0|||
129640151|NCT01732640|466636299|FG000|Overall Study|Adverse Event|0|||
129640152|NCT01732640|466636300|FG001|Overall Study|Adverse Event|1|||
129640153|NCT01732640|466636299|FG000|Overall Study|Death|0|||
129640154|NCT01732640|466636300|FG001|Overall Study|Death|1|||
129640155|NCT03070002|466636301|FG000|Follow up for 2 Years|Death|1|||
129640156|NCT02147158|466636302|FG000|Treatment Course 1|Adverse Event|1|||
129443043|NCT03049735|465921197|FG000|Overall Study|Lost to Follow-up|1|||
129443044|NCT03049735|465921198|FG001|Overall Study|Lost to Follow-up|5|||
129443045|NCT03049735|465921199|FG002|Overall Study|Lost to Follow-up|5|||
129443046|NCT00390910|465921200|FG000|Overall Study|Adverse Event|1|||
129443047|NCT00390910|465921201|FG001|Overall Study|Adverse Event|0|||
129443048|NCT00390910|465921202|FG002|Overall Study|Adverse Event|0|||
129443049|NCT00390910|465921200|FG000|Overall Study|Lost to Follow-up|0|||
129443050|NCT00390910|465921201|FG001|Overall Study|Lost to Follow-up|1|||
129443051|NCT00390910|465921202|FG002|Overall Study|Lost to Follow-up|5|||
129443052|NCT00390910|465921200|FG000|Overall Study|Withdrawal by Subject|1|||
129443053|NCT00390910|465921201|FG001|Overall Study|Withdrawal by Subject|3|||
129443054|NCT00390910|465921202|FG002|Overall Study|Withdrawal by Subject|2|||
129443055|NCT00390910|465921200|FG000|Overall Study|Migrated/moved from study area|0|||
129443056|NCT00390910|465921201|FG001|Overall Study|Migrated/moved from study area|0|||
129443057|NCT00390910|465921202|FG002|Overall Study|Migrated/moved from study area|3|||
129443058|NCT03231943|465921207|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443059|NCT03231943|465921208|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
129443060|NCT03231943|465921209|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
129640157|NCT02147158|466636303|FG001|Treatment Course 1|Adverse Event|4|||
129640158|NCT02147158|466636304|FG002|Treatment Course 1|Adverse Event|3|||
129640159|NCT02147158|466636305|FG003|Treatment Course 1|Adverse Event|4|||
129640160|NCT02147158|466636306|FG004|Treatment Course 1|Adverse Event|1|||
129640161|NCT02147158|466636307|FG005|Treatment Course 1|Adverse Event|2|||
129640162|NCT02147158|466636302|FG000|Treatment Course 1|Lost to Follow-up|2|||
129640163|NCT02147158|466636303|FG001|Treatment Course 1|Lost to Follow-up|4|||
129640164|NCT02147158|466636304|FG002|Treatment Course 1|Lost to Follow-up|3|||
129640165|NCT02147158|466636305|FG003|Treatment Course 1|Lost to Follow-up|3|||
129640166|NCT02147158|466636306|FG004|Treatment Course 1|Lost to Follow-up|2|||
129640167|NCT02147158|466636307|FG005|Treatment Course 1|Lost to Follow-up|4|||
129640168|NCT02147158|466636302|FG000|Treatment Course 1|Protocol Violation|0|||
129640169|NCT02147158|466636303|FG001|Treatment Course 1|Protocol Violation|0|||
129640170|NCT02147158|466636304|FG002|Treatment Course 1|Protocol Violation|1|||
129640171|NCT02147158|466636305|FG003|Treatment Course 1|Protocol Violation|1|||
129640172|NCT02147158|466636306|FG004|Treatment Course 1|Protocol Violation|0|||
129640173|NCT02147158|466636307|FG005|Treatment Course 1|Protocol Violation|0|||
129640174|NCT02147158|466636302|FG000|Treatment Course 1|Withdrawal of Consent|1|||
129640175|NCT02147158|466636303|FG001|Treatment Course 1|Withdrawal of Consent|1|||
129640176|NCT02147158|466636304|FG002|Treatment Course 1|Withdrawal of Consent|1|||
129640177|NCT02147158|466636305|FG003|Treatment Course 1|Withdrawal of Consent|5|||
129640178|NCT02147158|466636306|FG004|Treatment Course 1|Withdrawal of Consent|3|||
129640179|NCT02147158|466636307|FG005|Treatment Course 1|Withdrawal of Consent|2|||
129640180|NCT02147158|466636302|FG000|Off-Treatment Interval 1|Adverse Event|1|||
129640181|NCT02147158|466636303|FG001|Off-Treatment Interval 1|Adverse Event|0|||
129640182|NCT02147158|466636304|FG002|Off-Treatment Interval 1|Adverse Event|0|||
129640183|NCT02147158|466636305|FG003|Off-Treatment Interval 1|Adverse Event|1|||
129640184|NCT02147158|466636306|FG004|Off-Treatment Interval 1|Adverse Event|0|||
129640185|NCT02147158|466636307|FG005|Off-Treatment Interval 1|Adverse Event|0|||
129640186|NCT02147158|466636302|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
129640187|NCT02147158|466636303|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
129640188|NCT02147158|466636304|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
129640189|NCT02147158|466636305|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
129640190|NCT02147158|466636306|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
129640191|NCT02147158|466636307|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
129640192|NCT02147158|466636302|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
129640193|NCT02147158|466636303|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
129640194|NCT02147158|466636304|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
129640195|NCT02147158|466636305|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
129640196|NCT02147158|466636306|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
129640197|NCT02147158|466636307|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
129640198|NCT02147158|466636302|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
129443061|NCT03231943|465921210|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443062|NCT03231943|465921211|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443063|NCT03231943|465921212|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443064|NCT03231943|465921213|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443065|NCT03231943|465921214|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443066|NCT03231943|465921215|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443067|NCT03231943|465921216|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443068|NCT03231943|465921217|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443069|NCT03231943|465921218|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443070|NCT03231943|465921219|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
129443071|NCT03231943|465921207|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443072|NCT03231943|465921208|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
129443073|NCT03231943|465921209|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443074|NCT03231943|465921210|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443075|NCT03231943|465921211|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443076|NCT03231943|465921212|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443077|NCT03231943|465921213|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443078|NCT03231943|465921214|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443079|NCT03231943|465921215|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443080|NCT03231943|465921216|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443081|NCT03231943|465921217|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443082|NCT03231943|465921218|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129640199|NCT02147158|466636303|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
129705369|NCT04079738|466884206|FG000|Study Treatment|withdrawal after treatment|1|||
129705370|NCT04079738|466884207|FG001|Study Treatment|withdrawal after treatment|0|||
129889502|NCT01513967|467552627|FG004|Overall Study|Pregnancy|0|||
129889503|NCT01513967|467552628|FG005|Overall Study|Pregnancy|0|||
129640200|NCT02147158|466636304|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
129640201|NCT02147158|466636305|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
129640202|NCT02147158|466636306|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
129640203|NCT02147158|466636307|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
129640204|NCT02147158|466636302|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
129889504|NCT01513967|467552629|FG006|Overall Study|Pregnancy|1|||
129889505|NCT01513967|467552630|FG007|Overall Study|Pregnancy|0|||
129443083|NCT03231943|465921219|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
129443084|NCT03231943|465921207|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
129443085|NCT03231943|465921208|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443086|NCT03231943|465921209|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443087|NCT03231943|465921210|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443088|NCT03231943|465921211|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443089|NCT03231943|465921212|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443090|NCT03231943|465921213|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443091|NCT03231943|465921214|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443092|NCT03231943|465921215|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443093|NCT03231943|465921216|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443094|NCT03231943|465921217|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443095|NCT03231943|465921218|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443096|NCT03231943|465921219|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
129443097|NCT03231943|465921207|FG000|Part 2|Adverse Event|0|||
129443098|NCT03231943|465921208|FG001|Part 2|Adverse Event|0|||
129443099|NCT03231943|465921209|FG002|Part 2|Adverse Event|0|||
129443100|NCT03231943|465921210|FG003|Part 2|Adverse Event|0|||
129443101|NCT03231943|465921211|FG004|Part 2|Adverse Event|0|||
129443102|NCT03231943|465921212|FG005|Part 2|Adverse Event|0|||
129443103|NCT03231943|465921213|FG006|Part 2|Adverse Event|0|||
129443104|NCT03231943|465921214|FG007|Part 2|Adverse Event|0|||
129443105|NCT03231943|465921215|FG008|Part 2|Adverse Event|0|||
129443106|NCT03231943|465921216|FG009|Part 2|Adverse Event|0|||
129443107|NCT03231943|465921217|FG010|Part 2|Adverse Event|1|||
129443108|NCT03231943|465921218|FG011|Part 2|Adverse Event|0|||
129443109|NCT03231943|465921219|FG012|Part 2|Adverse Event|0|||
129443110|NCT03231943|465921207|FG000|Part 2|Withdrawal by Subject|0|||
129443111|NCT03231943|465921208|FG001|Part 2|Withdrawal by Subject|0|||
129443112|NCT03231943|465921209|FG002|Part 2|Withdrawal by Subject|0|||
129443113|NCT03231943|465921210|FG003|Part 2|Withdrawal by Subject|0|||
129443114|NCT03231943|465921211|FG004|Part 2|Withdrawal by Subject|0|||
129443115|NCT03231943|465921212|FG005|Part 2|Withdrawal by Subject|0|||
129443116|NCT03231943|465921213|FG006|Part 2|Withdrawal by Subject|0|||
129443117|NCT03231943|465921214|FG007|Part 2|Withdrawal by Subject|0|||
129443118|NCT03231943|465921215|FG008|Part 2|Withdrawal by Subject|0|||
129443119|NCT03231943|465921216|FG009|Part 2|Withdrawal by Subject|0|||
129443120|NCT03231943|465921217|FG010|Part 2|Withdrawal by Subject|0|||
129443121|NCT03231943|465921218|FG011|Part 2|Withdrawal by Subject|1|||
129443122|NCT03231943|465921219|FG012|Part 2|Withdrawal by Subject|0|||
129443123|NCT04824521|465921223|FG000|Overall Study|Lost to Follow-up|1|||
129443124|NCT00447382|465921224|FG000|Overall Study|Adverse Event|1|||
129443125|NCT00447382|465921225|FG001|Overall Study|Adverse Event|1|||
129443126|NCT00447382|465921224|FG000|Overall Study|Lack of Efficacy|1|||
129443127|NCT00447382|465921225|FG001|Overall Study|Lack of Efficacy|0|||
129798331|NCT04650854|467230070|FG001|Overall Study|Withdrawal by Subject|17|||
129798332|NCT04650854|467230071|FG002|Overall Study|Withdrawal by Subject|9|||
129798333|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
129798334|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
129798335|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
129443128|NCT00447382|465921224|FG000|Overall Study|Protocol Violation|2|||
129443129|NCT00447382|465921225|FG001|Overall Study|Protocol Violation|0|||
129443130|NCT00447382|465921224|FG000|Overall Study|Unclassified|2|||
129798336|NCT04650854|467230069|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
129798337|NCT04650854|467230070|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
129798338|NCT04650854|467230071|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
129798339|NCT04650854|467230069|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
129798340|NCT04650854|467230070|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
129798341|NCT04650854|467230071|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
129798342|NCT04650854|467230069|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
129798343|NCT04650854|467230070|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
129798344|NCT04650854|467230071|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
129443131|NCT00447382|465921225|FG001|Overall Study|Unclassified|5|||
129798345|NCT04650854|467230069|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
129798346|NCT04650854|467230070|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
129443132|NCT04600336|465921226|FG000|Initial Treatment|Withdrawal by Subject|1|||
129443133|NCT04600336|465921227|FG001|Initial Treatment|Withdrawal by Subject|2|||
129443134|NCT04600336|465921228|FG002|Initial Treatment|Withdrawal by Subject|0|||
129443135|NCT04600336|465921229|FG003|Initial Treatment|Withdrawal by Subject|0|||
129443136|NCT04600336|465921226|FG000|Initial Treatment|Adverse Event|0|||
129443137|NCT04600336|465921227|FG001|Initial Treatment|Adverse Event|2|||
129443138|NCT04600336|465921228|FG002|Initial Treatment|Adverse Event|0|||
129443139|NCT04600336|465921229|FG003|Initial Treatment|Adverse Event|0|||
129443140|NCT04600336|465921226|FG000|Initial Treatment|Other complicating disease|0|||
129443141|NCT04600336|465921227|FG001|Initial Treatment|Other complicating disease|0|||
129798347|NCT04650854|467230071|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
129798348|NCT04650854|467230069|FG000|Overall Study|Use of Rescue Medication|0|||
129798349|NCT04650854|467230070|FG001|Overall Study|Use of Rescue Medication|0|||
129798350|NCT04650854|467230071|FG002|Overall Study|Use of Rescue Medication|1|||
129798351|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Sponsor|0|||
129798352|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Sponsor|0|||
129798353|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Sponsor|2|||
129798354|NCT04650854|467230069|FG000|Overall Study|Rescue Medication|0|||
129798355|NCT04650854|467230070|FG001|Overall Study|Rescue Medication|0|||
129798356|NCT04650854|467230071|FG002|Overall Study|Rescue Medication|1|||
129798357|NCT04650854|467230069|FG000|Overall Study|Participant Want to Start a Family|0|||
129798358|NCT04650854|467230070|FG001|Overall Study|Participant Want to Start a Family|0|||
129798359|NCT04650854|467230071|FG002|Overall Study|Participant Want to Start a Family|1|||
129798360|NCT04650854|467230069|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
129798361|NCT04650854|467230070|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
129798362|NCT04650854|467230071|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
129798363|NCT04650854|467230069|FG000|Overall Study|Participant Screened For MG0020|0|||
129443142|NCT04600336|465921228|FG002|Initial Treatment|Other complicating disease|1|||
129443143|NCT04600336|465921229|FG003|Initial Treatment|Other complicating disease|0|||
129443144|NCT04600336|465921226|FG000|Crossover Treatment|Withdrawal by Subject|0|||
129443145|NCT04600336|465921227|FG001|Crossover Treatment|Withdrawal by Subject|0|||
129798364|NCT04650854|467230070|FG001|Overall Study|Participant Screened For MG0020|2|||
129798365|NCT04650854|467230071|FG002|Overall Study|Participant Screened For MG0020|3|||
129443146|NCT04600336|465921228|FG002|Crossover Treatment|Withdrawal by Subject|2|||
129443147|NCT04600336|465921229|FG003|Crossover Treatment|Withdrawal by Subject|1|||
129443148|NCT04600336|465921226|FG000|Crossover Treatment|Adverse Event|0|||
129443149|NCT04600336|465921227|FG001|Crossover Treatment|Adverse Event|0|||
129443150|NCT04600336|465921228|FG002|Crossover Treatment|Adverse Event|1|||
129443151|NCT04600336|465921229|FG003|Crossover Treatment|Adverse Event|1|||
129443152|NCT03144804|465921232|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
129443153|NCT03769181|465923039|FG000|Overall Study|Adverse Event|1|||
129443154|NCT03769181|465923040|FG001|Overall Study|Adverse Event|0|||
129443155|NCT03769181|465923041|FG002|Overall Study|Adverse Event|2|||
129443156|NCT03769181|465923042|FG003|Overall Study|Adverse Event|4|||
129443157|NCT03769181|465923039|FG000|Overall Study|Withdrawal by Subject|1|||
129443158|NCT03769181|465923040|FG001|Overall Study|Withdrawal by Subject|0|||
129443159|NCT03769181|465923041|FG002|Overall Study|Withdrawal by Subject|2|||
129443160|NCT03769181|465923042|FG003|Overall Study|Withdrawal by Subject|1|||
129443161|NCT03769181|465923039|FG000|Overall Study|Progressive disease|9|||
129443162|NCT03769181|465923040|FG001|Overall Study|Progressive disease|7|||
129443163|NCT03769181|465923041|FG002|Overall Study|Progressive disease|13|||
129443164|NCT03769181|465923042|FG003|Overall Study|Progressive disease|6|||
129443165|NCT03769181|465923039|FG000|Overall Study|Other - Unspecified|2|||
129443166|NCT03769181|465923040|FG001|Overall Study|Other - Unspecified|1|||
129443167|NCT03769181|465923041|FG002|Overall Study|Other - Unspecified|0|||
129640205|NCT02147158|466636303|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
129798366|NCT04650854|467230069|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
129798367|NCT04650854|467230070|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
129798368|NCT04650854|467230071|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
129798369|NCT04650854|467230069|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
129798370|NCT04650854|467230070|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
129798371|NCT04650854|467230071|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
129798372|NCT04650854|467230069|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
129798373|NCT04650854|467230070|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
129798374|NCT04650854|467230071|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
129798375|NCT04650854|467230069|FG000|Overall Study|End Of Study|0|||
129798376|NCT04650854|467230070|FG001|Overall Study|End Of Study|2|||
129443168|NCT03769181|465923042|FG003|Overall Study|Other - Unspecified|0|||
129640206|NCT02147158|466636304|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
129640207|NCT02147158|466636305|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
129640208|NCT02147158|466636306|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
129640209|NCT02147158|466636307|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
129640210|NCT02147158|466636302|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
129640211|NCT02147158|466636303|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
129640212|NCT02147158|466636304|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
129640213|NCT02147158|466636305|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
129640214|NCT02147158|466636306|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
129640215|NCT02147158|466636307|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
129640216|NCT02147158|466636302|FG000|Treatment Course 2|Adverse Event|0|||
129443169|NCT03078907|465923045|FG000|Overall Study|Adverse Event|2|||
129443170|NCT03078907|465923046|FG001|Overall Study|Adverse Event|0|||
129798377|NCT04650854|467230071|FG002|Overall Study|End Of Study|1|||
129443171|NCT03078907|465923045|FG000|Overall Study|Other|1|||
129640217|NCT02147158|466636303|FG001|Treatment Course 2|Adverse Event|4|||
129443172|NCT03078907|465923046|FG001|Overall Study|Other|0|||
129640218|NCT02147158|466636304|FG002|Treatment Course 2|Adverse Event|2|||
129443173|NCT03078907|465923045|FG000|Overall Study|Protocol Violation|0|||
129640219|NCT02147158|466636305|FG003|Treatment Course 2|Adverse Event|1|||
129640220|NCT02147158|466636306|FG004|Treatment Course 2|Adverse Event|0|||
129640221|NCT02147158|466636307|FG005|Treatment Course 2|Adverse Event|1|||
129640222|NCT02147158|466636302|FG000|Treatment Course 2|Withdrawal of Consent|0|||
129640223|NCT02147158|466636303|FG001|Treatment Course 2|Withdrawal of Consent|1|||
129640224|NCT02147158|466636304|FG002|Treatment Course 2|Withdrawal of Consent|2|||
129640225|NCT02147158|466636305|FG003|Treatment Course 2|Withdrawal of Consent|3|||
129640226|NCT02147158|466636306|FG004|Treatment Course 2|Withdrawal of Consent|0|||
129640227|NCT02147158|466636307|FG005|Treatment Course 2|Withdrawal of Consent|0|||
129640228|NCT02147158|466636302|FG000|Treatment Course 2|Lost to Follow-up|1|||
129640229|NCT02147158|466636303|FG001|Treatment Course 2|Lost to Follow-up|0|||
129640230|NCT02147158|466636304|FG002|Treatment Course 2|Lost to Follow-up|1|||
129640231|NCT02147158|466636305|FG003|Treatment Course 2|Lost to Follow-up|1|||
129640232|NCT02147158|466636306|FG004|Treatment Course 2|Lost to Follow-up|0|||
129640233|NCT02147158|466636307|FG005|Treatment Course 2|Lost to Follow-up|1|||
129640234|NCT02147158|466636302|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
129640235|NCT02147158|466636303|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
129640236|NCT02147158|466636304|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
129640237|NCT02147158|466636305|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
129640238|NCT02147158|466636306|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
129640239|NCT02147158|466636307|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
129640240|NCT02147158|466636302|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
129640241|NCT02147158|466636303|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
129640242|NCT02147158|466636304|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
129640243|NCT02147158|466636305|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
129640244|NCT02147158|466636306|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
129640245|NCT02147158|466636307|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
129640246|NCT02147158|466636302|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
129640247|NCT02147158|466636303|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
129640248|NCT02147158|466636304|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
129640249|NCT02147158|466636305|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
129640250|NCT02147158|466636306|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
129640251|NCT02147158|466636307|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
129640252|NCT02147158|466636302|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
129640253|NCT02147158|466636303|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
129640254|NCT02147158|466636304|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
129640255|NCT02147158|466636305|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
129640256|NCT02147158|466636306|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
129640257|NCT02147158|466636307|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
129640258|NCT02147158|466636302|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
129640259|NCT02147158|466636303|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
129640260|NCT02147158|466636304|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
129640261|NCT02147158|466636305|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
129640262|NCT02147158|466636306|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
129640263|NCT02147158|466636307|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
129640264|NCT03425396|466636308|FG000|Overall Study|Lost to Follow-up|2|||
129640265|NCT03425396|466636309|FG001|Overall Study|Lost to Follow-up|5|||
129640266|NCT03425396|466636310|FG002|Overall Study|Lost to Follow-up|2|||
129640267|NCT03425396|466636311|FG003|Overall Study|Lost to Follow-up|0|||
129640268|NCT03425396|466636312|FG004|Overall Study|Lost to Follow-up|0|||
129640269|NCT03425396|466636308|FG000|Overall Study|Withdrawal by Subject|0|||
129640270|NCT03425396|466636309|FG001|Overall Study|Withdrawal by Subject|1|||
129640271|NCT03425396|466636310|FG002|Overall Study|Withdrawal by Subject|0|||
129640272|NCT03425396|466636311|FG003|Overall Study|Withdrawal by Subject|1|||
129640273|NCT03425396|466636312|FG004|Overall Study|Withdrawal by Subject|0|||
129640274|NCT03425396|466636308|FG000|Overall Study|Other|0|||
129640275|NCT03425396|466636309|FG001|Overall Study|Other|1|||
129640276|NCT03425396|466636310|FG002|Overall Study|Other|1|||
129640277|NCT03425396|466636311|FG003|Overall Study|Other|0|||
129640278|NCT03425396|466636312|FG004|Overall Study|Other|1|||
129640279|NCT01441765|466636314|FG000|Overall Study|Death|1|||
129640280|NCT01441765|466636315|FG001|Overall Study|Death|0|||
129640281|NCT04520997|466636316|FG000|Overall Study|Lost to Follow-up|1|||
129640282|NCT04520997|466636317|FG001|Overall Study|Lost to Follow-up|1|||
129640283|NCT04520997|466636316|FG000|Overall Study|Withdrawal by Subject|1|||
129640284|NCT04520997|466636317|FG001|Overall Study|Withdrawal by Subject|0|||
129640285|NCT04520997|466636316|FG000|Overall Study|Not Treated|0|||
129640286|NCT04520997|466636317|FG001|Overall Study|Not Treated|1|||
129443174|NCT03078907|465923046|FG001|Overall Study|Protocol Violation|1|||
129640287|NCT02981082|466636320|FG000|Overall Study|Withdrawal by Subject|2|||
129640288|NCT02981082|466636321|FG001|Overall Study|Withdrawal by Subject|0|||
129640289|NCT02981082|466636320|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
129443175|NCT03338192|465923047|FG000|Year One to Year Two|High Blood Pressure|7|||
129640290|NCT02981082|466636321|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
129640291|NCT02981082|466636320|FG000|Overall Study|Adverse Event|0|||
129640292|NCT02981082|466636321|FG001|Overall Study|Adverse Event|1|||
129640293|NCT03689374|466636322|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
129640294|NCT03689374|466636323|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
129640295|NCT03689374|466636324|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
129640296|NCT03689374|466636322|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
129640297|NCT03689374|466636323|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
129640298|NCT03689374|466636324|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
129640299|NCT03689374|466636322|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
129640300|NCT03689374|466636323|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
129640301|NCT03689374|466636324|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
129640302|NCT03689374|466636322|FG000|Treatment Period (Week 0 to 52)|Death|0|||
129640303|NCT03689374|466636323|FG001|Treatment Period (Week 0 to 52)|Death|11|||
129640304|NCT03689374|466636324|FG002|Treatment Period (Week 0 to 52)|Death|1|||
129640305|NCT05367973|466636325|FG000|Overall Study|Adverse Event|0|||
129640306|NCT05367973|466636326|FG001|Overall Study|Adverse Event|2|||
129640307|NCT02805660|466636327|FG000|Overall Study|Death|5|||
129640308|NCT02805660|466636328|FG001|Overall Study|Death|2|||
129640309|NCT02805660|466636329|FG002|Overall Study|Death|9|||
129640310|NCT02805660|466636330|FG003|Overall Study|Death|5|||
129640311|NCT02805660|466636331|FG004|Overall Study|Death|0|||
129640312|NCT02805660|466636332|FG005|Overall Study|Death|14|||
129640313|NCT02805660|466636333|FG006|Overall Study|Death|12|||
129640314|NCT02805660|466636327|FG000|Overall Study|Lost to Follow-up|0|||
129640315|NCT02805660|466636328|FG001|Overall Study|Lost to Follow-up|1|||
129640316|NCT02805660|466636329|FG002|Overall Study|Lost to Follow-up|1|||
129640317|NCT02805660|466636330|FG003|Overall Study|Lost to Follow-up|2|||
129640318|NCT02805660|466636331|FG004|Overall Study|Lost to Follow-up|0|||
129640319|NCT02805660|466636332|FG005|Overall Study|Lost to Follow-up|0|||
129640320|NCT02805660|466636333|FG006|Overall Study|Lost to Follow-up|0|||
129640321|NCT02805660|466636327|FG000|Overall Study|Withdrawal by Subject|0|||
129640322|NCT02805660|466636328|FG001|Overall Study|Withdrawal by Subject|0|||
129640323|NCT02805660|466636329|FG002|Overall Study|Withdrawal by Subject|0|||
129640324|NCT02805660|466636330|FG003|Overall Study|Withdrawal by Subject|3|||
129640325|NCT02805660|466636331|FG004|Overall Study|Withdrawal by Subject|1|||
129640326|NCT02805660|466636332|FG005|Overall Study|Withdrawal by Subject|0|||
129640327|NCT02805660|466636333|FG006|Overall Study|Withdrawal by Subject|2|||
129640328|NCT02805660|466636327|FG000|Overall Study|Study terminated by Sponsor|0|||
129640329|NCT02805660|466636328|FG001|Overall Study|Study terminated by Sponsor|0|||
129640330|NCT02805660|466636329|FG002|Overall Study|Study terminated by Sponsor|1|||
129640331|NCT02805660|466636330|FG003|Overall Study|Study terminated by Sponsor|4|||
129640332|NCT02805660|466636331|FG004|Overall Study|Study terminated by Sponsor|2|||
129640333|NCT02805660|466636332|FG005|Overall Study|Study terminated by Sponsor|3|||
129640334|NCT02805660|466636333|FG006|Overall Study|Study terminated by Sponsor|1|||
129640335|NCT02805660|466636327|FG000|Overall Study|Miscellaneous|0|||
129640336|NCT02805660|466636328|FG001|Overall Study|Miscellaneous|1|||
129640337|NCT02805660|466636329|FG002|Overall Study|Miscellaneous|0|||
129640338|NCT02805660|466636330|FG003|Overall Study|Miscellaneous|4|||
129640339|NCT02805660|466636331|FG004|Overall Study|Miscellaneous|0|||
129640340|NCT02805660|466636332|FG005|Overall Study|Miscellaneous|6|||
129640341|NCT02805660|466636333|FG006|Overall Study|Miscellaneous|4|||
129640342|NCT00809471|466637666|FG000|Overall Study|Protocol non-compliance|15|||
129640343|NCT00809471|466637667|FG001|Overall Study|Protocol non-compliance|15|||
129640344|NCT00809471|466637668|FG002|Overall Study|Protocol non-compliance|6|||
129640345|NCT00809471|466637666|FG000|Overall Study|Lost to Follow-up|4|||
129640346|NCT00809471|466637667|FG001|Overall Study|Lost to Follow-up|2|||
129705371|NCT04079738|466884208|FG002|Study Treatment|withdrawal after treatment|0|||
129705372|NCT04079738|466884209|FG003|Study Treatment|withdrawal after treatment|0|||
129705373|NCT04079738|466884206|FG000|Follow up|Withdrawal by Subject|3|||
129705374|NCT04079738|466884207|FG001|Follow up|Withdrawal by Subject|0|||
129705375|NCT04079738|466884208|FG002|Follow up|Withdrawal by Subject|0|||
129705376|NCT04079738|466884209|FG003|Follow up|Withdrawal by Subject|0|||
129705377|NCT04079738|466884206|FG000|Follow up|Death|5|||
129705378|NCT04079738|466884207|FG001|Follow up|Death|0|||
129705379|NCT04079738|466884208|FG002|Follow up|Death|0|||
129705380|NCT04079738|466884209|FG003|Follow up|Death|0|||
129705381|NCT00789555|466884210|FG000|Overall Study|Protocol Amendment|78|||
129705382|NCT00789555|466884211|FG001|Overall Study|Protocol Amendment|76|||
129705383|NCT00789555|466884212|FG002|Overall Study|Protocol Amendment|80|||
129705384|NCT00789555|466884210|FG000|Overall Study|Adverse Event|17|||
129640347|NCT00809471|466637668|FG002|Overall Study|Lost to Follow-up|9|||
129640348|NCT00809471|466637666|FG000|Overall Study|Adverse Event|0|||
129640349|NCT00809471|466637667|FG001|Overall Study|Adverse Event|2|||
129705385|NCT00789555|466884211|FG001|Overall Study|Adverse Event|7|||
129705386|NCT00789555|466884212|FG002|Overall Study|Adverse Event|10|||
129705387|NCT00789555|466884210|FG000|Overall Study|Lost to Follow-up|9|||
129640350|NCT00809471|466637668|FG002|Overall Study|Adverse Event|2|||
129640351|NCT00809471|466637666|FG000|Overall Study|Requirement for restricted medication|1|||
129640352|NCT00809471|466637667|FG001|Overall Study|Requirement for restricted medication|1|||
129640353|NCT00809471|466637668|FG002|Overall Study|Requirement for restricted medication|0|||
129640354|NCT00831311|466637669|FG000|Overall Study|Definitive Contraindication|3|||
129640355|NCT00831311|466637670|FG001|Overall Study|Definitive Contraindication|3|||
129640356|NCT00831311|466637669|FG000|Overall Study|Lost to Follow-up|3|||
129640357|NCT00831311|466637670|FG001|Overall Study|Lost to Follow-up|0|||
129640358|NCT00831311|466637669|FG000|Overall Study|Physician Decision|0|||
129640359|NCT00831311|466637670|FG001|Overall Study|Physician Decision|1|||
129640360|NCT00831311|466637669|FG000|Overall Study|Withdrawal by Subject|6|||
129640361|NCT00831311|466637670|FG001|Overall Study|Withdrawal by Subject|4|||
129640362|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
129640363|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
129640364|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
129640365|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
129640366|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
129640367|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
129640368|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
129640369|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
129798378|NCT04650854|467230069|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
129798379|NCT04650854|467230070|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
129798380|NCT04650854|467230071|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
129798381|NCT04650854|467230069|FG000|Overall Study|Participant Received Rescue Medication|0|||
129798382|NCT04650854|467230070|FG001|Overall Study|Participant Received Rescue Medication|1|||
129640370|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Death|0|||
129640371|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Death|1|||
129640372|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
129640373|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
129640374|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
129640375|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
129798383|NCT04650854|467230071|FG002|Overall Study|Participant Received Rescue Medication|0|||
129640376|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
129798384|NCT04650854|467230069|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
129798385|NCT04650854|467230070|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
129640377|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
129640378|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
129640379|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
129640380|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
129640381|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
129889506|NCT01513967|467552623|FG000|Overall Study|missed a study visit|0|||
129889507|NCT01513967|467552624|FG001|Overall Study|missed a study visit|0|||
129640382|NCT00394836|466637673|FG000|Teatment or Follow-up Phase|Non compliance|0|||
129640383|NCT00394836|466637674|FG001|Teatment or Follow-up Phase|Non compliance|1|||
129640384|NCT00394836|466637673|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
129640385|NCT00394836|466637674|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
129640386|NCT00394836|466637673|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
129640387|NCT00394836|466637674|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
129640388|NCT00394836|466637673|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
129640389|NCT00394836|466637674|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
129640390|NCT00394836|466637673|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
129640391|NCT00394836|466637674|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
129640392|NCT01163851|466637675|FG000|Overall Study|Site Closure|0|||
129640393|NCT01163851|466637676|FG001|Overall Study|Site Closure|1|||
129640394|NCT01163851|466637675|FG000|Overall Study|Enrolled but not treated|1|||
129640395|NCT01163851|466637676|FG001|Overall Study|Enrolled but not treated|0|||
129640396|NCT02028767|466637677|FG000|Treatment Period 2|Non compliant with protocol|1|||
129640397|NCT02028767|466637678|FG001|Treatment Period 2|Non compliant with protocol|0|||
129640398|NCT02028767|466637677|FG000|Treatment Period 2|Reason other than those specified above|1|||
129640399|NCT02028767|466637678|FG001|Treatment Period 2|Reason other than those specified above|0|||
129640400|NCT04075682|466637683|FG000|Overall Study|Lost to Follow-up|5|||
129640401|NCT04075682|466637684|FG001|Overall Study|Lost to Follow-up|5|||
129640402|NCT04075682|466637685|FG002|Overall Study|Lost to Follow-up|2|||
129640403|NCT04075682|466637686|FG003|Overall Study|Lost to Follow-up|2|||
129640404|NCT04075682|466637683|FG000|Overall Study|Withdrawal by Subject|1|||
129640405|NCT04075682|466637684|FG001|Overall Study|Withdrawal by Subject|0|||
129640406|NCT04075682|466637685|FG002|Overall Study|Withdrawal by Subject|1|||
129640407|NCT04075682|466637686|FG003|Overall Study|Withdrawal by Subject|0|||
129640408|NCT04075682|466637683|FG000|Overall Study|Protocol Violation|0|||
129640409|NCT04075682|466637684|FG001|Overall Study|Protocol Violation|1|||
129640410|NCT04075682|466637685|FG002|Overall Study|Protocol Violation|1|||
129640411|NCT04075682|466637686|FG003|Overall Study|Protocol Violation|0|||
129640412|NCT04075682|466637683|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
129640413|NCT04075682|466637684|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
129640414|NCT04075682|466637685|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
129705388|NCT00789555|466884211|FG001|Overall Study|Lost to Follow-up|10|||
129705389|NCT00789555|466884212|FG002|Overall Study|Lost to Follow-up|18|||
129705390|NCT00789555|466884210|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
129705391|NCT00789555|466884211|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
129705392|NCT00789555|466884212|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
129705393|NCT00789555|466884210|FG000|Overall Study|Treatment failure|11|||
129705394|NCT00789555|466884211|FG001|Overall Study|Treatment failure|8|||
129705395|NCT00789555|466884212|FG002|Overall Study|Treatment failure|12|||
129705396|NCT00789555|466884210|FG000|Overall Study|Protocol Violation|6|||
129705397|NCT00789555|466884211|FG001|Overall Study|Protocol Violation|9|||
129705398|NCT00789555|466884212|FG002|Overall Study|Protocol Violation|13|||
129705399|NCT00404248|466884213|FG000|Overall Study|pts declining status|0|||
129705400|NCT00404248|466884214|FG001|Overall Study|pts declining status|1|||
129705401|NCT00404248|466884215|FG002|Overall Study|pts declining status|0|||
129705402|NCT00404248|466884216|FG003|Overall Study|pts declining status|0|||
129705403|NCT00404248|466884217|FG004|Overall Study|pts declining status|0|||
129705404|NCT00404248|466884218|FG005|Overall Study|pts declining status|0|||
129705405|NCT00404248|466884219|FG006|Overall Study|pts declining status|0|||
129705406|NCT00404248|466884220|FG007|Overall Study|pts declining status|0|||
129705407|NCT00404248|466884221|FG008|Overall Study|pts declining status|0|||
129705408|NCT04646005|466884222|FG000|Overall Study|Adverse Event|1|||
129705409|NCT04646005|466884222|FG000|Overall Study|Progressive Disease|71|||
129705410|NCT04646005|466884222|FG000|Overall Study|Death|20|||
129705411|NCT04646005|466884222|FG000|Overall Study|Withdrawal by Subject|12|||
129705412|NCT04646005|466884222|FG000|Overall Study|Sponsor Request|9|||
129705413|NCT04398706|466884223|FG000|Overall Study|Adverse Event|0|||
129705414|NCT04398706|466884224|FG001|Overall Study|Adverse Event|0|||
129705415|NCT04398706|466884225|FG002|Overall Study|Adverse Event|0|||
129705416|NCT04398706|466884226|FG003|Overall Study|Adverse Event|0|||
129705417|NCT04398706|466884227|FG004|Overall Study|Adverse Event|0|||
129705418|NCT04398706|466884228|FG005|Overall Study|Adverse Event|1|||
129705419|NCT04398706|466884229|FG006|Overall Study|Adverse Event|1|||
129705420|NCT04398706|466884230|FG007|Overall Study|Adverse Event|0|||
129705421|NCT04398706|466884223|FG000|Overall Study|Lost to Follow-up|0|||
129705422|NCT04398706|466884224|FG001|Overall Study|Lost to Follow-up|1|||
129705423|NCT04398706|466884225|FG002|Overall Study|Lost to Follow-up|2|||
129443176|NCT03338192|465923048|FG001|Year One to Year Two|High Blood Pressure|1|||
129443177|NCT03338192|465923047|FG000|Year One to Year Two|HIV +|1|||
129443178|NCT03338192|465923048|FG001|Year One to Year Two|HIV +|0|||
129443179|NCT03338192|465923047|FG000|Year Two to Year Four|High Blood Pressure|1|||
129443180|NCT03338192|465923048|FG001|Year Two to Year Four|High Blood Pressure|0|||
129443181|NCT03338192|465923047|FG000|Year Two to Year Four|HIV +|2|||
129443182|NCT03338192|465923048|FG001|Year Two to Year Four|HIV +|0|||
129443183|NCT03338192|465923047|FG000|Year Four to Year Six|High Blood Pressure|2|||
129443184|NCT03338192|465923048|FG001|Year Four to Year Six|High Blood Pressure|1|||
129443185|NCT03808688|465923049|FG000|Overall Study|Adverse Event|13|||
129443186|NCT03808688|465923050|FG001|Overall Study|Adverse Event|17|||
129443187|NCT03808688|465923049|FG000|Overall Study|Lack of Efficacy|2|||
129443188|NCT03808688|465923050|FG001|Overall Study|Lack of Efficacy|0|||
129443189|NCT03808688|465923049|FG000|Overall Study|Lost to Follow-up|0|||
129443190|NCT03808688|465923050|FG001|Overall Study|Lost to Follow-up|2|||
129443191|NCT03808688|465923049|FG000|Overall Study|Withdrawal by Subject|1|||
129443192|NCT03808688|465923050|FG001|Overall Study|Withdrawal by Subject|0|||
129443193|NCT03808688|465923049|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
129443194|NCT03808688|465923050|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
129443195|NCT03808688|465923049|FG000|Overall Study|IOP Too High|1|||
129443196|NCT03808688|465923050|FG001|Overall Study|IOP Too High|1|||
129443197|NCT03808688|465923049|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
129443198|NCT03808688|465923050|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
129443199|NCT03808688|465923049|FG000|Overall Study|Visit Out of Window|0|||
129443200|NCT03808688|465923050|FG001|Overall Study|Visit Out of Window|1|||
129443201|NCT03808688|465923049|FG000|Overall Study|Medication Non-Compliance|0|||
129443202|NCT03808688|465923050|FG001|Overall Study|Medication Non-Compliance|1|||
129443203|NCT03329196|465923051|FG000|Overall Study|Adverse Event|10|||
129443204|NCT03329196|465923052|FG001|Overall Study|Adverse Event|5|||
129443205|NCT03329196|465923051|FG000|Overall Study|Physician Decision|2|||
129443206|NCT03329196|465923052|FG001|Overall Study|Physician Decision|2|||
129443207|NCT03329196|465923051|FG000|Overall Study|Withdrawal by Subject|11|||
129443208|NCT03329196|465923052|FG001|Overall Study|Withdrawal by Subject|3|||
129443209|NCT03329196|465923051|FG000|Overall Study|Hepatic function abnormalities|0|||
129443210|NCT03329196|465923052|FG001|Overall Study|Hepatic function abnormalities|1|||
129443211|NCT03329196|465923051|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
129443212|NCT03329196|465923052|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
129443213|NCT03329196|465923051|FG000|Overall Study|Difficult to control Hb|2|||
129443214|NCT03329196|465923052|FG001|Overall Study|Difficult to control Hb|3|||
129443215|NCT03329196|465923051|FG000|Overall Study|Dialysis or renal transplant|13|||
129443216|NCT03329196|465923052|FG001|Overall Study|Dialysis or renal transplant|15|||
129443217|NCT04175808|465923056|FG000|Part A|Miscellaneous|2|||
129443218|NCT04175808|465923057|FG001|Part A|Miscellaneous|0|||
129443219|NCT04175808|465923058|FG002|Part A|Miscellaneous|0|||
129443220|NCT04175808|465923059|FG003|Part A|Miscellaneous|0|||
129443221|NCT04175808|465923060|FG004|Part A|Miscellaneous|0|||
129443222|NCT04175808|465923061|FG005|Part A|Miscellaneous|0|||
129443223|NCT04175808|465923062|FG006|Part A|Miscellaneous|0|||
129443224|NCT02021292|465923066|FG000|Overall Study|Physician Decision|0|||
129443225|NCT02021292|465923067|FG001|Overall Study|Physician Decision|1|||
129443226|NCT02021292|465923066|FG000|Overall Study|Lost to Follow-up|0|||
129443227|NCT02021292|465923067|FG001|Overall Study|Lost to Follow-up|1|||
129443228|NCT02021292|465923066|FG000|Overall Study|Death|0|||
129443229|NCT02021292|465923067|FG001|Overall Study|Death|1|||
129443230|NCT05972733|465923068|FG000|Overall Study|Lost to Follow-up|2|||
129443231|NCT05972733|465923068|FG000|Overall Study|Withdrawal by Subject|1|||
129443232|NCT04982588|465923071|FG000|Overall Study|Withdrawal by Subject|2|||
129443233|NCT02366728|465923072|FG000|Overall Study|Death|0|||
129443234|NCT02366728|465923073|FG001|Overall Study|Death|0|||
129443235|NCT02366728|465923074|FG002|Overall Study|Death|1|||
129443236|NCT02366728|465923072|FG000|Overall Study|Adverse Event|1|||
129443237|NCT02366728|465923073|FG001|Overall Study|Adverse Event|0|||
129443238|NCT02366728|465923074|FG002|Overall Study|Adverse Event|0|||
129443239|NCT02366728|465923072|FG000|Overall Study|Screen Failure|2|||
129798386|NCT04650854|467230071|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
129798387|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
129798388|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
129798389|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
129798390|NCT04650854|467230069|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
129798391|NCT04650854|467230070|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
129798392|NCT04650854|467230071|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
129443240|NCT02366728|465923073|FG001|Overall Study|Screen Failure|1|||
129798393|NCT04650854|467230069|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
129798394|NCT04650854|467230070|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
129798395|NCT04650854|467230071|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
129798396|NCT04650854|467230069|FG000|Overall Study|Enrollment Cup|0|||
129798397|NCT04650854|467230070|FG001|Overall Study|Enrollment Cup|0|||
129798398|NCT04650854|467230071|FG002|Overall Study|Enrollment Cup|1|||
129798399|NCT05308290|467230072|FG000|Overall Study|Death|1|||
129798400|NCT05308290|467230073|FG001|Overall Study|Death|0|||
129798401|NCT05308290|467230072|FG000|Overall Study|Lost to Follow-up|2|||
129798402|NCT05308290|467230073|FG001|Overall Study|Lost to Follow-up|1|||
129798403|NCT05308290|467230072|FG000|Overall Study|still in study followup|0|||
129798404|NCT05308290|467230073|FG001|Overall Study|still in study followup|1|||
129798405|NCT04437368|467230074|FG000|Overall Study|Death|3|||
129798406|NCT04437368|467230075|FG001|Overall Study|Death|0|||
129798407|NCT04437368|467230076|FG002|Overall Study|Death|2|||
129798408|NCT04437368|467230074|FG000|Overall Study|Study terminated by sponsor|16|||
129798409|NCT04437368|467230075|FG001|Overall Study|Study terminated by sponsor|1|||
129798410|NCT04437368|467230076|FG002|Overall Study|Study terminated by sponsor|25|||
129798411|NCT04437368|467230074|FG000|Overall Study|Withdrawal by Subject|4|||
129798412|NCT04437368|467230075|FG001|Overall Study|Withdrawal by Subject|0|||
129798413|NCT04437368|467230076|FG002|Overall Study|Withdrawal by Subject|3|||
129798414|NCT04437368|467230074|FG000|Overall Study|Sponsor instructions|23|||
129798415|NCT04437368|467230075|FG001|Overall Study|Sponsor instructions|0|||
129798416|NCT04437368|467230076|FG002|Overall Study|Sponsor instructions|0|||
129640415|NCT04075682|466637686|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
129640416|NCT04075682|466637683|FG000|Overall Study|Lost study phone the first day of study participation|0|||
129640417|NCT04075682|466637684|FG001|Overall Study|Lost study phone the first day of study participation|1|||
129640418|NCT04075682|466637685|FG002|Overall Study|Lost study phone the first day of study participation|0|||
129640419|NCT04075682|466637686|FG003|Overall Study|Lost study phone the first day of study participation|0|||
129640420|NCT01289639|466637690|FG000|Overall Study|Lost to Follow-up|1|||
129640421|NCT01289639|466637691|FG001|Overall Study|Lost to Follow-up|0|||
129640422|NCT01289639|466637692|FG002|Overall Study|Lost to Follow-up|0|||
129640423|NCT02780713|466637693|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129640424|NCT02780713|466637694|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129640425|NCT02780713|466637695|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
129640426|NCT02780713|466637696|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129640427|NCT02780713|466637697|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
129640428|NCT05338502|466637700|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
129640429|NCT05338502|466637701|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
129640430|NCT05338502|466637702|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
129640431|NCT05338502|466637700|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
129640432|NCT05338502|466637701|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
129640433|NCT05338502|466637702|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
129640434|NCT03575793|466637703|FG000|Overall Study|Withdrawal by Subject|0|||
129640435|NCT03575793|466637704|FG001|Overall Study|Withdrawal by Subject|1|||
129640436|NCT03575793|466637703|FG000|Overall Study|Never Treated|0|||
129640437|NCT03575793|466637704|FG001|Overall Study|Never Treated|2|||
129640438|NCT01250873|466637705|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
129640439|NCT01250873|466637705|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
129640440|NCT02278939|466637706|FG000|Overall Study|lack of time|1|||
129640441|NCT02278939|466637707|FG001|Overall Study|lack of time|0|||
129640442|NCT02278939|466637706|FG000|Overall Study|Lost to Follow-up|1|||
129640443|NCT02278939|466637707|FG001|Overall Study|Lost to Follow-up|1|||
129640444|NCT02278939|466637706|FG000|Overall Study|death in family|1|||
129640445|NCT02278939|466637707|FG001|Overall Study|death in family|0|||
129640446|NCT02278939|466637706|FG000|Overall Study|family emergency unable to commit|2|||
129640447|NCT02278939|466637707|FG001|Overall Study|family emergency unable to commit|0|||
129640448|NCT03436693|466637710|FG000|Overall Study|Adverse Event|22|||
129640449|NCT03436693|466637711|FG001|Overall Study|Adverse Event|10|||
129640450|NCT03436693|466637710|FG000|Overall Study|Physician Decision|3|||
129798417|NCT01982331|467230077|FG000|Received Vaccination 2|Adverse Event|1|||
129798418|NCT01982331|467230078|FG001|Received Vaccination 2|Adverse Event|2|||
129889508|NCT01513967|467552625|FG002|Overall Study|missed a study visit|0|||
129640451|NCT03436693|466637711|FG001|Overall Study|Physician Decision|3|||
129640452|NCT03436693|466637710|FG000|Overall Study|Withdrawal by Subject|4|||
129640453|NCT03436693|466637711|FG001|Overall Study|Withdrawal by Subject|13|||
129798419|NCT01982331|467230077|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
129798420|NCT01982331|467230078|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
129889509|NCT01513967|467552626|FG003|Overall Study|missed a study visit|0|||
129889510|NCT01513967|467552627|FG004|Overall Study|missed a study visit|0|||
129889511|NCT01513967|467552628|FG005|Overall Study|missed a study visit|0|||
129640454|NCT03436693|466637710|FG000|Overall Study|Progressive Disease|1|||
129640455|NCT03436693|466637711|FG001|Overall Study|Progressive Disease|1|||
129640456|NCT01680861|466637712|FG000|Early Post-transplant Period|Protocol Violation|1|||
129798421|NCT01982331|467230077|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
129798422|NCT01982331|467230078|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
129798423|NCT01280955|467230088|FG000|Overall Study|Death|2|||
129798424|NCT01280955|467230088|FG000|Overall Study|Withdrawal by Subject|1|||
129798425|NCT04223232|467230089|FG000|Overall Study|Withdrawal by Subject|1|||
129798426|NCT02393690|467230091|FG000|Overall Study|Ineligible|0|||
129798427|NCT02393690|467230092|FG001|Overall Study|Ineligible|1|||
129798428|NCT01674634|467230093|FG000|Overall Study|Withdrawal by Subject|3|||
129798429|NCT01674634|467230093|FG000|Overall Study|Lost to Follow-up|3|||
129798430|NCT02567552|467230094|FG000|Overall Study|Adverse Event|0|||
129798431|NCT02567552|467230095|FG001|Overall Study|Adverse Event|1|||
129798432|NCT03187756|467230096|FG000|Overall Study|Termination of study|4|||
129798433|NCT01074047|467230097|FG000|Treatment Phase|Adverse Event|89|||
129798434|NCT01074047|467230098|FG001|Treatment Phase|Adverse Event|66|||
129798435|NCT01074047|467230097|FG000|Treatment Phase|Disease Progression|16|||
129798436|NCT01074047|467230098|FG001|Treatment Phase|Disease Progression|21|||
129798437|NCT01074047|467230097|FG000|Treatment Phase|Withdrawal by Subject|27|||
129798438|NCT01074047|467230098|FG001|Treatment Phase|Withdrawal by Subject|48|||
129798439|NCT01074047|467230097|FG000|Treatment Phase|Death|53|||
129640457|NCT01680861|466637713|FG001|Early Post-transplant Period|Protocol Violation|1|||
129640458|NCT02111577|466637714|FG000|Overall Study|Protocol Violation|2|||
129640459|NCT02111577|466637715|FG001|Overall Study|Protocol Violation|0|||
129640460|NCT02111577|466637714|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
129640461|NCT02111577|466637715|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
129640462|NCT02111577|466637714|FG000|Overall Study|Failure to produce study treatment|6|||
129640463|NCT02111577|466637715|FG001|Overall Study|Failure to produce study treatment|0|||
129640464|NCT02111577|466637714|FG000|Overall Study|Death|518|||
129640465|NCT02111577|466637715|FG001|Overall Study|Death|254|||
129640466|NCT02111577|466637714|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
129640467|NCT02111577|466637715|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
129640468|NCT02111577|466637714|FG000|Overall Study|Adverse Event|1|||
129640469|NCT02111577|466637715|FG001|Overall Study|Adverse Event|1|||
129640470|NCT02111577|466637714|FG000|Overall Study|Withdrawal by Subject|51|||
129640471|NCT02111577|466637715|FG001|Overall Study|Withdrawal by Subject|23|||
129640472|NCT02111577|466637714|FG000|Overall Study|Disease progression|0|||
129640473|NCT02111577|466637715|FG001|Overall Study|Disease progression|1|||
129640474|NCT02111577|466637714|FG000|Overall Study|Lost to Follow-up|19|||
129640475|NCT02111577|466637715|FG001|Overall Study|Lost to Follow-up|10|||
129640476|NCT00654875|466637716|FG000|Overall Study|Adverse Event|5|||
129640477|NCT00654875|466637717|FG001|Overall Study|Adverse Event|5|||
129640478|NCT00654875|466637716|FG000|Overall Study|Withdrawal by Subject|4|||
129640479|NCT00654875|466637717|FG001|Overall Study|Withdrawal by Subject|4|||
129640480|NCT00654875|466637716|FG000|Overall Study|Protocol Violation|3|||
129640481|NCT00654875|466637717|FG001|Overall Study|Protocol Violation|3|||
129640482|NCT00654875|466637716|FG000|Overall Study|Lack of Efficacy|2|||
129640483|NCT00654875|466637717|FG001|Overall Study|Lack of Efficacy|2|||
129640484|NCT00654875|466637716|FG000|Overall Study|Lost to Follow-up|1|||
129640485|NCT00654875|466637717|FG001|Overall Study|Lost to Follow-up|3|||
129640486|NCT00654875|466637716|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129640487|NCT00654875|466637717|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129640488|NCT00654875|466637716|FG000|Overall Study|Administrative Problems|1|||
129640489|NCT00654875|466637717|FG001|Overall Study|Administrative Problems|0|||
129640490|NCT04967885|466637718|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
129640491|NCT04967885|466637719|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
129640492|NCT04967885|466637718|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
129640493|NCT04967885|466637719|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
129640494|NCT04967885|466637718|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
129640495|NCT04967885|466637719|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
129640496|NCT04967885|466637718|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
129640497|NCT04967885|466637719|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
129640498|NCT04967885|466637718|FG000|EMI-II Intervention|Lost to Follow-up|14|||
129640499|NCT04967885|466637719|FG001|EMI-II Intervention|Lost to Follow-up|10|||
129640500|NCT02042950|466637722|FG000|Overall Study|Progressive Disease|4|||
129640501|NCT00886743|466637725|FG000|Overall Study|Adverse Event|3|||
129640502|NCT00886743|466637725|FG000|Overall Study|Other|1|||
129640503|NCT01940887|466637726|FG000|Year 1|Protocol Violation|0|||
129640504|NCT01940887|466637727|FG001|Year 1|Protocol Violation|1|||
129640505|NCT01940887|466637726|FG000|Year 1|Physician Decision|7|||
129798440|NCT01074047|467230098|FG001|Treatment Phase|Death|58|||
129640506|NCT01940887|466637727|FG001|Year 1|Physician Decision|3|||
129640507|NCT01940887|466637726|FG000|Year 1|Death|5|||
129640508|NCT01940887|466637727|FG001|Year 1|Death|3|||
129640509|NCT01940887|466637726|FG000|Year 1|Adverse Event|7|||
129640510|NCT01940887|466637727|FG001|Year 1|Adverse Event|6|||
129640511|NCT01940887|466637726|FG000|Year 1|Withdrawal by Subject|18|||
129640512|NCT01940887|466637727|FG001|Year 1|Withdrawal by Subject|9|||
129640513|NCT01940887|466637726|FG000|Year 1|Lost to Follow-up|2|||
129798441|NCT01074047|467230097|FG000|Treatment Phase|Lost to Follow-up|0|||
129798442|NCT01074047|467230098|FG001|Treatment Phase|Lost to Follow-up|1|||
129798443|NCT01074047|467230097|FG000|Treatment Phase|Protocol Violation|0|||
129798444|NCT01074047|467230098|FG001|Treatment Phase|Protocol Violation|1|||
129798445|NCT01074047|467230097|FG000|Treatment Phase|Miscellaneous|32|||
129443241|NCT02366728|465923074|FG002|Overall Study|Screen Failure|0|||
129443242|NCT02366728|465923072|FG000|Overall Study|Only yielded 2 vaccines|1|||
129443243|NCT02366728|465923073|FG001|Overall Study|Only yielded 2 vaccines|0|||
129443244|NCT02366728|465923074|FG002|Overall Study|Only yielded 2 vaccines|0|||
129443245|NCT00992511|465923076|FG000|Overall Study|Migrated/moved from study area|1|||
129443246|NCT00992511|465923077|FG001|Overall Study|Migrated/moved from study area|0|||
129443247|NCT00992511|465923078|FG002|Overall Study|Migrated/moved from study area|1|||
129443248|NCT00992511|465923079|FG003|Overall Study|Migrated/moved from study area|2|||
129443249|NCT00992511|465923076|FG000|Overall Study|Lost to Follow-up|1|||
129443250|NCT00992511|465923077|FG001|Overall Study|Lost to Follow-up|0|||
129443251|NCT00992511|465923078|FG002|Overall Study|Lost to Follow-up|0|||
129443252|NCT00992511|465923079|FG003|Overall Study|Lost to Follow-up|2|||
129443253|NCT00992511|465923076|FG000|Overall Study|Withdrawal by Subject|0|||
129443254|NCT00992511|465923077|FG001|Overall Study|Withdrawal by Subject|0|||
129443255|NCT00992511|465923078|FG002|Overall Study|Withdrawal by Subject|1|||
129443256|NCT00992511|465923079|FG003|Overall Study|Withdrawal by Subject|1|||
129443257|NCT04498169|465923080|FG000|Study Completion|Adverse Event|1|||
129443258|NCT04498169|465923081|FG001|Study Completion|Adverse Event|1|||
129443259|NCT04615247|465923082|FG000|Overall Study|Adverse Event|0|||
129443260|NCT04615247|465923083|FG001|Overall Study|Adverse Event|2|||
129443261|NCT04615247|465923082|FG000|Overall Study|Withdrawal by Subject|1|||
129443262|NCT04615247|465923083|FG001|Overall Study|Withdrawal by Subject|1|||
129705424|NCT04398706|466884226|FG003|Overall Study|Lost to Follow-up|1|||
129705425|NCT04398706|466884227|FG004|Overall Study|Lost to Follow-up|6|||
129889512|NCT01513967|467552629|FG006|Overall Study|missed a study visit|1|||
129443263|NCT02993523|465923088|FG000|Overall Study|Withdrew Consent|0|||
129443264|NCT02993523|465923089|FG001|Overall Study|Withdrew Consent|0|||
129443265|NCT02993523|465923090|FG002|Overall Study|Withdrew Consent|2|||
129443266|NCT02993523|465923091|FG003|Overall Study|Withdrew Consent|9|||
129443267|NCT02993523|465923092|FG004|Overall Study|Withdrew Consent|0|||
129443268|NCT02993523|465923088|FG000|Overall Study|Lost to Follow-up|0|||
129443269|NCT02993523|465923089|FG001|Overall Study|Lost to Follow-up|0|||
129443270|NCT02993523|465923090|FG002|Overall Study|Lost to Follow-up|3|||
129443271|NCT02993523|465923091|FG003|Overall Study|Lost to Follow-up|6|||
129443272|NCT02993523|465923092|FG004|Overall Study|Lost to Follow-up|0|||
129443273|NCT02993523|465923088|FG000|Overall Study|Death|1|||
129443274|NCT02993523|465923089|FG001|Overall Study|Death|1|||
129443275|NCT02993523|465923090|FG002|Overall Study|Death|138|||
129443276|NCT02993523|465923091|FG003|Overall Study|Death|222|||
129443277|NCT02993523|465923092|FG004|Overall Study|Death|6|||
129443278|NCT02993523|465923088|FG000|Overall Study|Reason not Specified|0|||
129443279|NCT02993523|465923089|FG001|Overall Study|Reason not Specified|0|||
129443280|NCT02993523|465923090|FG002|Overall Study|Reason not Specified|1|||
129443281|NCT02993523|465923091|FG003|Overall Study|Reason not Specified|1|||
129443282|NCT02993523|465923092|FG004|Overall Study|Reason not Specified|0|||
129443283|NCT03694418|465923093|FG000|Overall Study|Lost to Follow-up|115|||
129443284|NCT03694418|465923094|FG001|Overall Study|Lost to Follow-up|23|||
129443285|NCT03694418|465923095|FG002|Overall Study|Lost to Follow-up|12|||
129443286|NCT03694418|465923096|FG003|Overall Study|Lost to Follow-up|12|||
129443287|NCT03694418|465923097|FG004|Overall Study|Lost to Follow-up|13|||
129443288|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
129443289|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
129443290|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
129443291|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
129443292|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
129705426|NCT04398706|466884228|FG005|Overall Study|Lost to Follow-up|3|||
129705427|NCT04398706|466884229|FG006|Overall Study|Lost to Follow-up|8|||
129705428|NCT04398706|466884230|FG007|Overall Study|Lost to Follow-up|2|||
129705429|NCT04398706|466884223|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129705430|NCT04398706|466884224|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129705431|NCT04398706|466884225|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129705432|NCT04398706|466884226|FG003|Overall Study|Withdrawal by parent/guardian|2|||
129705433|NCT04398706|466884227|FG004|Overall Study|Withdrawal by parent/guardian|19|||
129705434|NCT04398706|466884228|FG005|Overall Study|Withdrawal by parent/guardian|23|||
129705435|NCT04398706|466884229|FG006|Overall Study|Withdrawal by parent/guardian|13|||
129705436|NCT04398706|466884230|FG007|Overall Study|Withdrawal by parent/guardian|11|||
129443293|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
129443294|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
129443295|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
129443296|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Death|1|||
129443297|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Death|1|||
129443298|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
129443299|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
129443300|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
129705437|NCT04398706|466884223|FG000|Overall Study|Protocol deviation|0|||
129640514|NCT01940887|466637727|FG001|Year 1|Lost to Follow-up|1|||
129640515|NCT01940887|466637726|FG000|Year 2|Physician Decision|8|||
129640516|NCT01940887|466637727|FG001|Year 2|Physician Decision|1|||
129640517|NCT01940887|466637726|FG000|Year 2|Death|0|||
129640518|NCT01940887|466637727|FG001|Year 2|Death|2|||
129640519|NCT01940887|466637726|FG000|Year 2|Sponsor Decision, early termination|192|||
129640520|NCT01940887|466637727|FG001|Year 2|Sponsor Decision, early termination|203|||
129640521|NCT01940887|466637726|FG000|Year 2|Adverse Event|8|||
129640522|NCT01940887|466637727|FG001|Year 2|Adverse Event|2|||
129640523|NCT01940887|466637726|FG000|Year 2|Withdrawal by Subject|8|||
129640524|NCT01940887|466637727|FG001|Year 2|Withdrawal by Subject|8|||
129640525|NCT01940887|466637726|FG000|Year 2|Lost to Follow-up|1|||
129640526|NCT01940887|466637727|FG001|Year 2|Lost to Follow-up|6|||
129889513|NCT01513967|467552630|FG007|Overall Study|missed a study visit|0|||
129889514|NCT01513967|467552623|FG000|Overall Study|excluded due to positive drug screen|0|||
129889515|NCT01513967|467552624|FG001|Overall Study|excluded due to positive drug screen|0|||
129889516|NCT01513967|467552625|FG002|Overall Study|excluded due to positive drug screen|0|||
129889517|NCT01513967|467552626|FG003|Overall Study|excluded due to positive drug screen|0|||
129889518|NCT01513967|467552627|FG004|Overall Study|excluded due to positive drug screen|0|||
129640527|NCT02429778|466637729|FG000|Overall Study|Lost to Follow-up|2|||
129640528|NCT02429778|466637730|FG001|Overall Study|Lost to Follow-up|0|||
129640529|NCT02429778|466637729|FG000|Overall Study|Withdrawal by Subject|5|||
129640530|NCT02429778|466637730|FG001|Overall Study|Withdrawal by Subject|0|||
129640531|NCT04791319|466637734|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
129640532|NCT04791319|466637735|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
129640533|NCT04791319|466637736|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
129640534|NCT04791319|466637737|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
129640535|NCT04791319|466637738|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640536|NCT04791319|466637739|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640537|NCT04791319|466637740|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640538|NCT04791319|466637741|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640539|NCT04791319|466637742|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640540|NCT04791319|466637743|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640541|NCT04791319|466637744|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
129640542|NCT04791319|466637734|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
129640543|NCT04791319|466637735|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640544|NCT04791319|466637736|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
129640545|NCT04791319|466637737|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
129640546|NCT04791319|466637738|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640547|NCT04791319|466637739|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640548|NCT04791319|466637740|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640549|NCT04791319|466637741|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640550|NCT04791319|466637742|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640551|NCT04791319|466637743|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129640552|NCT04791319|466637744|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
129443301|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
129443302|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
129443303|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
129443304|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
129443305|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
129443306|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
129443307|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
129443308|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
129443309|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
129443310|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
129443311|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
129443312|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
129705438|NCT04398706|466884224|FG001|Overall Study|Protocol deviation|1|||
129705439|NCT04398706|466884225|FG002|Overall Study|Protocol deviation|0|||
129705440|NCT04398706|466884226|FG003|Overall Study|Protocol deviation|0|||
129705441|NCT04398706|466884227|FG004|Overall Study|Protocol deviation|6|||
129705442|NCT04398706|466884228|FG005|Overall Study|Protocol deviation|4|||
129705443|NCT04398706|466884229|FG006|Overall Study|Protocol deviation|6|||
129705444|NCT04398706|466884230|FG007|Overall Study|Protocol deviation|3|||
129705445|NCT04237584|466884231|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
129705446|NCT04237584|466884232|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
129705447|NCT04237584|466884233|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
129705448|NCT04237584|466884234|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
129705449|NCT04237584|466884231|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
129705450|NCT04237584|466884232|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
129705451|NCT04237584|466884233|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
129705452|NCT04237584|466884234|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
129705453|NCT04237584|466884231|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
129705454|NCT04237584|466884232|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
129705455|NCT04237584|466884233|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
129705456|NCT04237584|466884234|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
129705457|NCT04237584|466884231|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
129705458|NCT04237584|466884232|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
129889519|NCT01513967|467552628|FG005|Overall Study|excluded due to positive drug screen|0|||
129889520|NCT01513967|467552629|FG006|Overall Study|excluded due to positive drug screen|0|||
129889521|NCT01513967|467552630|FG007|Overall Study|excluded due to positive drug screen|2|||
129889522|NCT01513967|467552623|FG000|Overall Study|Physician Decision|0|||
129889523|NCT01513967|467552624|FG001|Overall Study|Physician Decision|0|||
129889524|NCT01513967|467552625|FG002|Overall Study|Physician Decision|0|||
129443313|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
129443314|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
129443315|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
129443316|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
129443317|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
129443318|NCT00559585|465923105|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
129443319|NCT00559585|465923106|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
129640553|NCT04791319|466637734|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
129640554|NCT04791319|466637735|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
129640555|NCT04791319|466637736|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
129640556|NCT04791319|466637737|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
129640557|NCT04791319|466637738|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640558|NCT04791319|466637739|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640559|NCT04791319|466637740|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640560|NCT04791319|466637741|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640561|NCT04791319|466637742|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640562|NCT04791319|466637743|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640563|NCT04791319|466637744|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
129640564|NCT04791319|466637734|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
129640565|NCT04791319|466637735|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
129640566|NCT04791319|466637736|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
129640567|NCT04791319|466637737|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
129640568|NCT04791319|466637738|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640569|NCT04791319|466637739|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640570|NCT04791319|466637740|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640571|NCT04791319|466637741|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640572|NCT04791319|466637742|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640573|NCT04791319|466637743|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640574|NCT04791319|466637744|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
129640575|NCT04791319|466637734|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640576|NCT04791319|466637735|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640577|NCT04791319|466637736|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640578|NCT04791319|466637737|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
129640579|NCT04791319|466637738|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640580|NCT04791319|466637739|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640581|NCT04791319|466637740|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640582|NCT04791319|466637741|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640583|NCT04791319|466637742|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640584|NCT04791319|466637743|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640585|NCT04791319|466637744|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
129640586|NCT04791319|466637734|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640587|NCT04791319|466637735|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640588|NCT04791319|466637736|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640589|NCT04791319|466637737|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640590|NCT04791319|466637738|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
129640591|NCT04791319|466637739|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
129640592|NCT04791319|466637740|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
129640593|NCT04791319|466637741|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640594|NCT04791319|466637742|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640595|NCT04791319|466637743|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
129640596|NCT04791319|466637744|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
129640597|NCT04791319|466637734|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640598|NCT04791319|466637735|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640599|NCT04791319|466637736|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640600|NCT04791319|466637737|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129889525|NCT01513967|467552626|FG003|Overall Study|Physician Decision|0|||
129443320|NCT00559585|465923105|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
129640601|NCT04791319|466637738|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640602|NCT04791319|466637739|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640603|NCT04791319|466637740|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640604|NCT04791319|466637741|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640605|NCT04791319|466637742|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640606|NCT04791319|466637743|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
129640607|NCT04791319|466637744|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
129640608|NCT04791319|466637734|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129640609|NCT04791319|466637735|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129640610|NCT04791319|466637736|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129640611|NCT04791319|466637737|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129640612|NCT04791319|466637738|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
129640613|NCT04791319|466637739|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
129640614|NCT04791319|466637740|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
129640615|NCT04791319|466637741|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
129640616|NCT04791319|466637742|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
129640617|NCT04791319|466637743|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
129705459|NCT04237584|466884233|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
129705460|NCT04237584|466884234|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
129705461|NCT04237584|466884231|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
129705462|NCT04237584|466884232|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
129705463|NCT04237584|466884233|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
129705464|NCT04237584|466884234|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
129705465|NCT03586973|466884235|FG000|Overall Study|Death|15|||
129705466|NCT03586973|466884236|FG001|Overall Study|Death|8|||
129705467|NCT03586973|466884235|FG000|Overall Study|Site Terminated by Sponsor|3|||
129705468|NCT03586973|466884236|FG001|Overall Study|Site Terminated by Sponsor|6|||
129705469|NCT03586973|466884235|FG000|Overall Study|Withdrawal by Subject|1|||
129705470|NCT03586973|466884236|FG001|Overall Study|Withdrawal by Subject|0|||
129705471|NCT03586973|466884235|FG000|Overall Study|Lost to Follow-up|1|||
129705472|NCT03586973|466884236|FG001|Overall Study|Lost to Follow-up|0|||
129705473|NCT03423979|466884242|FG000|Overall Study|Death|1|||
129705474|NCT05239221|466884243|FG000|Overall Study|Adverse Event|0|||
129705475|NCT05239221|466884244|FG001|Overall Study|Adverse Event|0|||
129705476|NCT05239221|466884245|FG002|Overall Study|Adverse Event|0|||
129705477|NCT05239221|466884246|FG003|Overall Study|Adverse Event|0|||
129705478|NCT05239221|466884247|FG004|Overall Study|Adverse Event|0|||
129705479|NCT05239221|466884248|FG005|Overall Study|Adverse Event|0|||
129705480|NCT05239221|466884249|FG006|Overall Study|Adverse Event|1|||
129705481|NCT05239221|466884250|FG007|Overall Study|Adverse Event|0|||
129705482|NCT05239221|466884251|FG008|Overall Study|Adverse Event|0|||
129705483|NCT05239221|466884252|FG009|Overall Study|Adverse Event|0|||
129889526|NCT01513967|467552627|FG004|Overall Study|Physician Decision|0|||
129889527|NCT01513967|467552628|FG005|Overall Study|Physician Decision|1|||
129889528|NCT01513967|467552629|FG006|Overall Study|Physician Decision|0|||
129889529|NCT01513967|467552630|FG007|Overall Study|Physician Decision|0|||
129889530|NCT02711826|467552631|FG000|Overall Study|Physician Decision|0|||
129889531|NCT02711826|467552632|FG001|Overall Study|Physician Decision|0|||
129889532|NCT02711826|467552633|FG002|Overall Study|Physician Decision|0|||
129889533|NCT02711826|467552634|FG003|Overall Study|Physician Decision|1|||
129889534|NCT02711826|467552635|FG004|Overall Study|Physician Decision|0|||
129889535|NCT02711826|467552631|FG000|Overall Study|Withdrawal by Subject|0|||
129889536|NCT02711826|467552632|FG001|Overall Study|Withdrawal by Subject|1|||
129889537|NCT02711826|467552633|FG002|Overall Study|Withdrawal by Subject|0|||
129889538|NCT02711826|467552634|FG003|Overall Study|Withdrawal by Subject|4|||
129889539|NCT02711826|467552635|FG004|Overall Study|Withdrawal by Subject|0|||
129889540|NCT02711826|467552631|FG000|Overall Study|Failure to manufacture cellular product|0|||
129889541|NCT02711826|467552632|FG001|Overall Study|Failure to manufacture cellular product|0|||
129889542|NCT02711826|467552633|FG002|Overall Study|Failure to manufacture cellular product|5|||
129889543|NCT02711826|467552634|FG003|Overall Study|Failure to manufacture cellular product|0|||
129889544|NCT02711826|467552635|FG004|Overall Study|Failure to manufacture cellular product|0|||
129889545|NCT02711826|467552631|FG000|Overall Study|Infusion canceled for active infection|0|||
129889546|NCT02711826|467552632|FG001|Overall Study|Infusion canceled for active infection|1|||
129889547|NCT02711826|467552633|FG002|Overall Study|Infusion canceled for active infection|0|||
129889548|NCT02711826|467552634|FG003|Overall Study|Infusion canceled for active infection|0|||
129889549|NCT02711826|467552635|FG004|Overall Study|Infusion canceled for active infection|0|||
129889550|NCT02711826|467552631|FG000|Overall Study|Screen failures|0|||
129889551|NCT02711826|467552632|FG001|Overall Study|Screen failures|0|||
129889552|NCT02711826|467552633|FG002|Overall Study|Screen failures|0|||
129889553|NCT02711826|467552634|FG003|Overall Study|Screen failures|4|||
129798446|NCT01074047|467230098|FG001|Treatment Phase|Miscellaneous|39|||
129798447|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
129640618|NCT04791319|466637744|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
129640619|NCT04791319|466637734|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129640620|NCT04791319|466637735|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129640621|NCT04791319|466637736|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129640622|NCT04791319|466637737|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
129640623|NCT04791319|466637738|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
129640624|NCT04791319|466637739|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
129640625|NCT04791319|466637740|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
129640626|NCT04791319|466637741|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
129640627|NCT04791319|466637742|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
129640628|NCT04791319|466637743|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
129640629|NCT04791319|466637744|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
129640630|NCT00355147|466637749|FG000|Overall Study|Lost to Follow-up|10|||
129640631|NCT00355147|466637750|FG001|Overall Study|Lost to Follow-up|8|||
129640632|NCT00355147|466637749|FG000|Overall Study|Withdrawal by Subject|8|||
129640633|NCT00355147|466637750|FG001|Overall Study|Withdrawal by Subject|12|||
129640634|NCT00072280|466637759|FG000|Treatment|Found ineligible|1|||
129640635|NCT00072280|466637760|FG001|Treatment|Found ineligible|2|||
129798448|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
129798449|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
129798450|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
129798451|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Death|116|||
129798452|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Death|124|||
129798453|NCT01074047|467230097|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
129798454|NCT01074047|467230098|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
129798455|NCT01074047|467230097|FG000|Extension Phase|Physician Decision|1|||
129798456|NCT01074047|467230098|FG001|Extension Phase|Physician Decision|0|||
129798457|NCT01074047|467230097|FG000|Extension Phase|Adverse Event|5|||
129798458|NCT01074047|467230098|FG001|Extension Phase|Adverse Event|0|||
129798459|NCT01074047|467230097|FG000|Extension Phase|Disease Progression|9|||
129798460|NCT01074047|467230098|FG001|Extension Phase|Disease Progression|0|||
129798461|NCT01074047|467230097|FG000|Extension Phase|Withdrawal by Subject|2|||
129798462|NCT01074047|467230098|FG001|Extension Phase|Withdrawal by Subject|0|||
129798463|NCT01074047|467230097|FG000|Extension Phase|Death|5|||
129798464|NCT01074047|467230098|FG001|Extension Phase|Death|0|||
129798465|NCT01801072|467232083|FG000|Overall Study|Lost to Follow-up|17|||
129798466|NCT01801072|467232084|FG001|Overall Study|Lost to Follow-up|14|||
129798467|NCT01801072|467232083|FG000|Overall Study|Physician Decision|2|||
129798468|NCT01801072|467232084|FG001|Overall Study|Physician Decision|3|||
129798469|NCT01801072|467232083|FG000|Overall Study|Withdrawal by Subject|1|||
129640636|NCT00072280|466637759|FG000|Follow-up|Early termination of study|2|||
129798470|NCT01801072|467232084|FG001|Overall Study|Withdrawal by Subject|0|||
129798471|NCT01801072|467232083|FG000|Overall Study|Protocol Violation|2|||
129798472|NCT01801072|467232084|FG001|Overall Study|Protocol Violation|0|||
129798473|NCT01801072|467232083|FG000|Overall Study|Death|7|||
129798474|NCT01801072|467232084|FG001|Overall Study|Death|8|||
129798475|NCT02247531|467232085|FG000|Overall Study|Adverse Event|3|||
129640637|NCT00072280|466637760|FG001|Follow-up|Early termination of study|2|||
129640638|NCT00022698|466637764|FG000|Overall Study|Adverse Event|5|||
129798476|NCT02247531|467232086|FG001|Overall Study|Adverse Event|4|||
129798477|NCT02247531|467232087|FG002|Overall Study|Adverse Event|9|||
129798478|NCT02247531|467232085|FG000|Overall Study|Death|8|||
129798479|NCT02247531|467232086|FG001|Overall Study|Death|9|||
129798480|NCT02247531|467232087|FG002|Overall Study|Death|5|||
129798481|NCT02247531|467232085|FG000|Overall Study|Lost to Follow-up|1|||
129798482|NCT02247531|467232086|FG001|Overall Study|Lost to Follow-up|8|||
129798483|NCT02247531|467232087|FG002|Overall Study|Lost to Follow-up|3|||
129798484|NCT02247531|467232085|FG000|Overall Study|Non-compliance|2|||
129798485|NCT02247531|467232086|FG001|Overall Study|Non-compliance|2|||
129798486|NCT02247531|467232087|FG002|Overall Study|Non-compliance|0|||
129798487|NCT02247531|467232085|FG000|Overall Study|Withdrawal by Subject|26|||
129798488|NCT02247531|467232086|FG001|Overall Study|Withdrawal by Subject|31|||
129798489|NCT02247531|467232087|FG002|Overall Study|Withdrawal by Subject|25|||
129798490|NCT02247531|467232085|FG000|Overall Study|Study Terminated by Sponsor|64|||
129798491|NCT02247531|467232086|FG001|Overall Study|Study Terminated by Sponsor|66|||
129798492|NCT02247531|467232087|FG002|Overall Study|Study Terminated by Sponsor|62|||
129798493|NCT02247531|467232085|FG000|Overall Study|Physician Decision|0|||
129798494|NCT02247531|467232086|FG001|Overall Study|Physician Decision|2|||
129798495|NCT02247531|467232087|FG002|Overall Study|Physician Decision|2|||
129798496|NCT02247531|467232085|FG000|Overall Study|Unspecified Reason|2|||
129798497|NCT02247531|467232086|FG001|Overall Study|Unspecified Reason|3|||
129798498|NCT02247531|467232087|FG002|Overall Study|Unspecified Reason|4|||
129640639|NCT00022698|466637765|FG001|Overall Study|Adverse Event|9|||
129640640|NCT00022698|466637764|FG000|Overall Study|Death|0|||
129640641|NCT00022698|466637765|FG001|Overall Study|Death|2|||
129640642|NCT00022698|466637764|FG000|Overall Study|Failure to return|0|||
129640643|NCT00022698|466637765|FG001|Overall Study|Failure to return|1|||
129640644|NCT00022698|466637764|FG000|Overall Study|Refused treatment|0|||
129640645|NCT00022698|466637765|FG001|Overall Study|Refused treatment|2|||
129640646|NCT00022698|466637764|FG000|Overall Study|Insufficient therapeutic response|2|||
129640647|NCT00022698|466637765|FG001|Overall Study|Insufficient therapeutic response|14|||
129640648|NCT00022698|466637764|FG000|Overall Study|Administrative /other|1|||
129640649|NCT00022698|466637765|FG001|Overall Study|Administrative /other|7|||
129640650|NCT02504827|466637766|FG000|Overall Study|Could not produce sputum|1|||
129640651|NCT00877487|466637775|FG000|Open-label Treatment Phase|Adverse Event|1|||
129640652|NCT00877487|466637776|FG001|Open-label Treatment Phase|Adverse Event|0|||
129640653|NCT00877487|466637775|FG000|Open-label Treatment Phase|Protocol Violation|3|||
129640654|NCT00877487|466637776|FG001|Open-label Treatment Phase|Protocol Violation|0|||
129640655|NCT00877487|466637775|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
129640656|NCT00877487|466637776|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
129640657|NCT00877487|466637775|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
129640658|NCT00877487|466637776|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
129640659|NCT00877487|466637775|FG000|Open-label Treatment Phase|Out of country for business|1|||
129640660|NCT00877487|466637776|FG001|Open-label Treatment Phase|Out of country for business|0|||
129640661|NCT00877487|466637775|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
129640662|NCT00877487|466637776|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
129640663|NCT00877487|466637775|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
129640664|NCT00877487|466637776|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
129640665|NCT00877487|466637775|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
129640666|NCT00877487|466637776|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
129640667|NCT00877487|466637775|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
129640668|NCT00877487|466637776|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
129640669|NCT00712543|466637779|FG000|Day 8-14|Lost to Follow-up|0|||
129640670|NCT00712543|466637780|FG001|Day 8-14|Lost to Follow-up|2|||
129640671|NCT02729051|466637783|FG000|Overall Study|Adverse Event|21|||
129640672|NCT02729051|466637784|FG001|Overall Study|Adverse Event|11|||
129640673|NCT02729051|466637783|FG000|Overall Study|Lack of Efficacy|1|||
129640674|NCT02729051|466637784|FG001|Overall Study|Lack of Efficacy|1|||
129640675|NCT02729051|466637783|FG000|Overall Study|Lost to Follow-up|1|||
129640676|NCT02729051|466637784|FG001|Overall Study|Lost to Follow-up|2|||
129640677|NCT02729051|466637783|FG000|Overall Study|Physician Decision|1|||
129640678|NCT02729051|466637784|FG001|Overall Study|Physician Decision|1|||
129640679|NCT02729051|466637783|FG000|Overall Study|Withdrawal by Subject|6|||
129640680|NCT02729051|466637784|FG001|Overall Study|Withdrawal by Subject|17|||
129640681|NCT02702388|466637785|FG000|Overall Study|Disease Progression|18|||
129640682|NCT02702388|466637786|FG001|Overall Study|Disease Progression|25|||
129640683|NCT02702388|466637785|FG000|Overall Study|Withdrawal by Subject|9|||
129640684|NCT02702388|466637786|FG001|Overall Study|Withdrawal by Subject|7|||
129443321|NCT00559585|465923106|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
129443322|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
129443323|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
129443324|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
129443325|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
129443326|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
129443327|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
129443328|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
129443329|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
129443330|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
129443331|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
129443332|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
129443333|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
129640685|NCT02702388|466637785|FG000|Overall Study|Adverse Event|11|||
129640686|NCT02702388|466637786|FG001|Overall Study|Adverse Event|15|||
129640687|NCT02702388|466637785|FG000|Overall Study|Other|2|||
129640688|NCT02702388|466637786|FG001|Overall Study|Other|4|||
129889554|NCT02711826|467552635|FG004|Overall Study|Screen failures|0|||
129889555|NCT02906202|467552636|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
129889556|NCT01960790|467552637|FG000|Overall Study|Survey forms could not be recovered|3|||
129443334|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
129640689|NCT04740827|466637798|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
129640690|NCT04740827|466637799|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
129640691|NCT04740827|466637798|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
129640692|NCT04740827|466637799|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
129640693|NCT04740827|466637798|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
129640694|NCT04740827|466637799|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
129640695|NCT04740827|466637798|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
129640696|NCT04740827|466637799|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
129640697|NCT04740827|466637798|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
129640698|NCT04740827|466637799|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
129640699|NCT04740827|466637798|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
129640700|NCT04740827|466637799|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
129640701|NCT01190410|466639723|FG000|Overall Study|Adverse Event|0|||
129640702|NCT01190410|466639724|FG001|Overall Study|Adverse Event|3|||
129640703|NCT01190410|466639723|FG000|Overall Study|Lack of Efficacy|0|||
129640704|NCT01190410|466639724|FG001|Overall Study|Lack of Efficacy|2|||
129640705|NCT01190410|466639723|FG000|Overall Study|Withdrawal by Subject|0|||
129640706|NCT01190410|466639724|FG001|Overall Study|Withdrawal by Subject|2|||
129640707|NCT01190410|466639723|FG000|Overall Study|Administrative decision|1|||
129640708|NCT01190410|466639724|FG001|Overall Study|Administrative decision|0|||
129640709|NCT01190410|466639723|FG000|Overall Study|PI discretion|0|||
129640710|NCT01190410|466639724|FG001|Overall Study|PI discretion|2|||
129640711|NCT03652636|466639725|FG000|Overall Study|Withdrawal by Subject|7|||
129443335|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
129640712|NCT00504725|466639734|FG000|Overall Study|Protocol Violation|1|||
129798499|NCT01251744|467232092|FG000|Overall Study|Lost to Follow-up|1|||
129798500|NCT01251744|467232093|FG001|Overall Study|Lost to Follow-up|0|||
129798501|NCT01068652|467232094|FG000|Overall Study|Adverse Event|4|||
129443336|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
129640713|NCT00504725|466639735|FG001|Overall Study|Protocol Violation|0|||
129640714|NCT01435018|466639736|FG000|Overall Study|Death|37|||
129640715|NCT01435018|466639737|FG001|Overall Study|Death|18|||
129798502|NCT01068652|467232095|FG001|Overall Study|Adverse Event|0|||
129443337|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
129443338|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
129443339|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
129443340|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
129443341|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
129443342|NCT00559585|465923105|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
129443343|NCT00559585|465923106|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
129443344|NCT02644941|465923107|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
129443345|NCT02644941|465923108|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
129443346|NCT00448435|465923110|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
129443347|NCT00448435|465923111|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129443348|NCT01387230|465923112|FG000|Overall Study|Adverse Event|0|||
129443349|NCT01387230|465923113|FG001|Overall Study|Adverse Event|1|||
129443350|NCT01387230|465923114|FG002|Overall Study|Adverse Event|3|||
129443351|NCT01387230|465923112|FG000|Overall Study|Lack of Efficacy|8|||
129443352|NCT01387230|465923113|FG001|Overall Study|Lack of Efficacy|5|||
129443353|NCT01387230|465923114|FG002|Overall Study|Lack of Efficacy|4|||
129443354|NCT01387230|465923112|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
129443355|NCT01387230|465923113|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
129443356|NCT01387230|465923114|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
129443357|NCT01387230|465923112|FG000|Overall Study|Lost to Follow-up|0|||
129443358|NCT01387230|465923113|FG001|Overall Study|Lost to Follow-up|0|||
129443359|NCT01387230|465923114|FG002|Overall Study|Lost to Follow-up|1|||
129443360|NCT01387230|465923112|FG000|Overall Study|Withdrawal by Subject|4|||
129443361|NCT01387230|465923113|FG001|Overall Study|Withdrawal by Subject|1|||
129443362|NCT01387230|465923114|FG002|Overall Study|Withdrawal by Subject|0|||
129443363|NCT03027557|465923122|FG000|Overall Study|Adverse Event|1|||
129443364|NCT03027557|465923123|FG001|Overall Study|Adverse Event|0|||
129443365|NCT03027557|465923124|FG002|Overall Study|Adverse Event|0|||
129443366|NCT03836807|465923129|FG000|Overall Study|Physician Decision|1|||
129443367|NCT03836807|465923130|FG001|Overall Study|Physician Decision|0|||
129443368|NCT01009554|465923131|FG000|Overall Study|Adverse Event|1|||
129443369|NCT01009554|465923132|FG001|Overall Study|Adverse Event|1|||
129443370|NCT01009554|465923131|FG000|Overall Study|Withdrawal by Subject|1|||
129443371|NCT01009554|465923132|FG001|Overall Study|Withdrawal by Subject|3|||
129443372|NCT01009554|465923131|FG000|Overall Study|Noncompliant with Study Product|0|||
129443373|NCT01009554|465923132|FG001|Overall Study|Noncompliant with Study Product|3|||
129443374|NCT01605253|465923133|FG000|Overall Study|Physician Decision|3|||
129443375|NCT01605253|465923134|FG001|Overall Study|Physician Decision|2|||
129443376|NCT01605253|465923133|FG000|Overall Study|Lost to Follow-up|3|||
129443377|NCT01605253|465923134|FG001|Overall Study|Lost to Follow-up|1|||
129443378|NCT02038920|465923139|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
129443379|NCT02038920|465923140|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
129443380|NCT02038920|465923141|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129443381|NCT02038920|465923142|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129443382|NCT02038920|465923143|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129443383|NCT02038920|465923144|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
129443384|NCT02038920|465923139|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
129443385|NCT02038920|465923140|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129443386|NCT02038920|465923141|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129443387|NCT02038920|465923142|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129443388|NCT02038920|465923143|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129443389|NCT02038920|465923144|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
129798503|NCT01068652|467232094|FG000|Overall Study|Lack of Efficacy|0|||
129443390|NCT02038920|465923139|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
129443391|NCT02038920|465923140|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
129443392|NCT02038920|465923141|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129443393|NCT02038920|465923142|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129443394|NCT02038920|465923143|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129443395|NCT02038920|465923144|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
129443396|NCT02038920|465923139|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
129443397|NCT02038920|465923140|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
129443398|NCT02038920|465923141|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
129443399|NCT02038920|465923142|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
129798504|NCT01068652|467232095|FG001|Overall Study|Lack of Efficacy|2|||
129798505|NCT01068652|467232094|FG000|Overall Study|Lost to Follow-up|2|||
129443400|NCT02038920|465923143|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
129443401|NCT02038920|465923144|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
129443402|NCT02038920|465923139|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129443403|NCT02038920|465923140|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129443404|NCT02038920|465923141|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
129443405|NCT02038920|465923142|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129443406|NCT02038920|465923143|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129443407|NCT02038920|465923144|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
129443408|NCT02038920|465923139|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
129443409|NCT02038920|465923140|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
129443410|NCT02038920|465923141|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
129443411|NCT02038920|465923142|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
129443412|NCT02038920|465923143|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
129443413|NCT02038920|465923144|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
129443414|NCT02038920|465923139|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129443415|NCT02038920|465923140|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129443416|NCT02038920|465923141|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129443417|NCT02038920|465923142|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129443418|NCT02038920|465923143|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
129443419|NCT02038920|465923144|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
129443420|NCT02038920|465923139|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129443421|NCT02038920|465923140|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129443422|NCT02038920|465923141|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129443423|NCT02038920|465923142|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129443424|NCT02038920|465923143|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
129443425|NCT02038920|465923144|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
129443426|NCT02038920|465923139|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129443427|NCT02038920|465923140|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129889557|NCT01960790|467552637|FG000|Overall Study|Treat with Humira outside survey period|3|||
129889558|NCT01960790|467552637|FG000|Overall Study|Transferred to another hospital|4|||
129889559|NCT01960790|467552637|FG000|Overall Study|Unevaluable for safety|1|||
129889560|NCT01987830|467552638|FG000|Overall Study|Never received baseline scan|1|||
129889561|NCT03990363|467552639|FG000|Overall Study|Withdrawal by Subject|10|||
129889562|NCT03990363|467552640|FG001|Overall Study|Withdrawal by Subject|9|||
129889563|NCT03990363|467552641|FG002|Overall Study|Withdrawal by Subject|18|||
129889564|NCT03990363|467552642|FG003|Overall Study|Withdrawal by Subject|11|||
129889565|NCT03990363|467552643|FG004|Overall Study|Withdrawal by Subject|9|||
129889566|NCT03990363|467552639|FG000|Overall Study|Physician Decision|1|||
129889567|NCT03990363|467552640|FG001|Overall Study|Physician Decision|0|||
129889568|NCT03990363|467552641|FG002|Overall Study|Physician Decision|0|||
129889569|NCT03990363|467552642|FG003|Overall Study|Physician Decision|0|||
129889570|NCT03990363|467552643|FG004|Overall Study|Physician Decision|0|||
129889571|NCT03990363|467552639|FG000|Overall Study|Adverse Event|1|||
129889572|NCT03990363|467552640|FG001|Overall Study|Adverse Event|3|||
129889573|NCT03990363|467552641|FG002|Overall Study|Adverse Event|2|||
129889574|NCT03990363|467552642|FG003|Overall Study|Adverse Event|2|||
129889575|NCT03990363|467552643|FG004|Overall Study|Adverse Event|0|||
129889576|NCT03990363|467552639|FG000|Overall Study|Death|14|||
129889577|NCT03990363|467552640|FG001|Overall Study|Death|8|||
129889578|NCT03990363|467552641|FG002|Overall Study|Death|14|||
129889579|NCT03990363|467552642|FG003|Overall Study|Death|10|||
129889580|NCT03990363|467552643|FG004|Overall Study|Death|11|||
129889581|NCT03990363|467552639|FG000|Overall Study|Failure to meet randomization criteria|0|||
129889582|NCT03990363|467552640|FG001|Overall Study|Failure to meet randomization criteria|1|||
129640716|NCT01435018|466639738|FG002|Overall Study|Death|25|||
129640717|NCT01435018|466639736|FG000|Overall Study|Site is closing|4|||
129640718|NCT01435018|466639737|FG001|Overall Study|Site is closing|9|||
129889583|NCT03990363|467552641|FG002|Overall Study|Failure to meet randomization criteria|1|||
129889584|NCT03990363|467552642|FG003|Overall Study|Failure to meet randomization criteria|0|||
129889585|NCT03990363|467552643|FG004|Overall Study|Failure to meet randomization criteria|0|||
129889586|NCT03990363|467552639|FG000|Overall Study|Lost to Follow-up|0|||
129889587|NCT03990363|467552640|FG001|Overall Study|Lost to Follow-up|0|||
129889588|NCT03990363|467552641|FG002|Overall Study|Lost to Follow-up|0|||
129640719|NCT01435018|466639738|FG002|Overall Study|Site is closing|7|||
129640720|NCT01435018|466639736|FG000|Overall Study|Withdrew consent|0|||
129640721|NCT01435018|466639737|FG001|Overall Study|Withdrew consent|3|||
129640722|NCT01435018|466639738|FG002|Overall Study|Withdrew consent|1|||
129640723|NCT01435018|466639736|FG000|Overall Study|Not willing to adhere to requirements|0|||
129640724|NCT01435018|466639737|FG001|Overall Study|Not willing to adhere to requirements|2|||
129640725|NCT01435018|466639738|FG002|Overall Study|Not willing to adhere to requirements|3|||
129640726|NCT01435018|466639736|FG000|Overall Study|Not able to get to clinic|2|||
129640727|NCT01435018|466639737|FG001|Overall Study|Not able to get to clinic|0|||
129640728|NCT01435018|466639738|FG002|Overall Study|Not able to get to clinic|2|||
129640729|NCT01435018|466639736|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129640730|NCT01435018|466639737|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129640731|NCT01435018|466639738|FG002|Overall Study|Severe debilitation, unable to continue|1|||
129640732|NCT01435018|466639736|FG000|Overall Study|Unable to contact participant/parent|1|||
129640733|NCT01435018|466639737|FG001|Overall Study|Unable to contact participant/parent|1|||
129640734|NCT01435018|466639738|FG002|Overall Study|Unable to contact participant/parent|1|||
129640735|NCT01435018|466639736|FG000|Overall Study|Enrollment Violation|0|||
129640736|NCT01435018|466639737|FG001|Overall Study|Enrollment Violation|1|||
129640737|NCT01435018|466639738|FG002|Overall Study|Enrollment Violation|0|||
129640738|NCT01435018|466639736|FG000|Overall Study|Never started chemotherapy|3|||
129640739|NCT01435018|466639737|FG001|Overall Study|Never started chemotherapy|0|||
129640740|NCT01435018|466639738|FG002|Overall Study|Never started chemotherapy|1|||
129640741|NCT00769067|466639740|FG000|Overall Study|Death|89|||
129640742|NCT00769067|466639741|FG001|Overall Study|Death|86|||
129889589|NCT03990363|467552642|FG003|Overall Study|Lost to Follow-up|1|||
129640743|NCT00769067|466639740|FG000|Overall Study|Lost to Follow-up|3|||
129640744|NCT00769067|466639741|FG001|Overall Study|Lost to Follow-up|1|||
129889590|NCT03990363|467552643|FG004|Overall Study|Lost to Follow-up|2|||
129443428|NCT02038920|465923141|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129443429|NCT02038920|465923142|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129443430|NCT02038920|465923143|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
129640745|NCT00769067|466639740|FG000|Overall Study|Study terminated by sponsor|1|||
129640746|NCT00769067|466639741|FG001|Overall Study|Study terminated by sponsor|3|||
129640747|NCT00769067|466639740|FG000|Overall Study|Other|1|||
129640748|NCT00769067|466639741|FG001|Overall Study|Other|3|||
129640749|NCT00769067|466639740|FG000|Overall Study|Withdrawal by Subject|0|||
129640750|NCT00769067|466639741|FG001|Overall Study|Withdrawal by Subject|1|||
129640751|NCT03806933|466639742|FG000|Main Period|Physician Decision|0|||
129640752|NCT03806933|466639743|FG001|Main Period|Physician Decision|0|||
129640753|NCT03806933|466639744|FG002|Main Period|Physician Decision|0|||
129640754|NCT03806933|466639745|FG003|Main Period|Physician Decision|1|||
129640755|NCT03806933|466639742|FG000|Main Period|Pregnancy|0|||
129640756|NCT03806933|466639743|FG001|Main Period|Pregnancy|0|||
129640757|NCT03806933|466639744|FG002|Main Period|Pregnancy|1|||
129640758|NCT03806933|466639745|FG003|Main Period|Pregnancy|0|||
129640759|NCT03806933|466639742|FG000|Main Period|Withdrawal by Subject|2|||
129640760|NCT03806933|466639743|FG001|Main Period|Withdrawal by Subject|1|||
129640761|NCT03806933|466639744|FG002|Main Period|Withdrawal by Subject|1|||
129640762|NCT03806933|466639745|FG003|Main Period|Withdrawal by Subject|2|||
129640763|NCT03806933|466639742|FG000|Main Period|Lost to Follow-up|2|||
129640764|NCT03806933|466639743|FG001|Main Period|Lost to Follow-up|2|||
129640765|NCT03806933|466639744|FG002|Main Period|Lost to Follow-up|0|||
129640766|NCT03806933|466639745|FG003|Main Period|Lost to Follow-up|0|||
129640767|NCT03806933|466639742|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
129640768|NCT03806933|466639743|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
129640769|NCT03806933|466639744|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
129640770|NCT03806933|466639745|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
129640771|NCT03625466|466639746|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
129640772|NCT03625466|466639747|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
129640773|NCT03625466|466639748|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
129640774|NCT03625466|466639746|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129640775|NCT03625466|466639747|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
129640776|NCT03625466|466639748|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129640777|NCT03625466|466639746|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129640778|NCT03625466|466639747|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
129640779|NCT03625466|466639748|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
129640780|NCT01868438|466639751|FG000|First Intervention|Withdrawal by Subject|5|||
129640781|NCT01868438|466639752|FG001|First Intervention|Withdrawal by Subject|1|||
129640782|NCT01868438|466639751|FG000|First Intervention|Lost to Follow-up|2|||
129640783|NCT01868438|466639752|FG001|First Intervention|Lost to Follow-up|3|||
129640784|NCT01868438|466639751|FG000|First Intervention|Meeting the non-redosing criteria|0|||
129640785|NCT01868438|466639752|FG001|First Intervention|Meeting the non-redosing criteria|1|||
129640786|NCT01868438|466639751|FG000|Second Intervention|Adverse Event|3|||
129640787|NCT01868438|466639752|FG001|Second Intervention|Adverse Event|3|||
129640788|NCT00956592|466639756|FG000|Overall Study|Protocol Violation|1|||
129640789|NCT00956592|466639757|FG001|Overall Study|Protocol Violation|3|||
129640790|NCT02632409|466639758|FG000|Randomized|AE unrelated to study Drug|0|||
129640791|NCT02632409|466639759|FG001|Randomized|AE unrelated to study Drug|1|||
129640792|NCT02632409|466639758|FG000|Randomized|Participant withdrew consent|2|||
129640793|NCT02632409|466639759|FG001|Randomized|Participant withdrew consent|1|||
129640794|NCT02632409|466639758|FG000|Randomized|No Longer meets study criteria|5|||
129640795|NCT02632409|466639759|FG001|Randomized|No Longer meets study criteria|0|||
129640796|NCT02632409|466639758|FG000|Randomized|other reasons|1|||
129640797|NCT02632409|466639759|FG001|Randomized|other reasons|0|||
129640798|NCT02632409|466639758|FG000|Treatment Period|Ongoing Treatment|20|||
129443431|NCT02038920|465923144|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
129443432|NCT02038920|465923139|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129443433|NCT02038920|465923140|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129443434|NCT02038920|465923141|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129443435|NCT02038920|465923142|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129640799|NCT02632409|466639759|FG001|Treatment Period|Ongoing Treatment|21|||
129640800|NCT02632409|466639758|FG000|Treatment Period|Disease Recurrence|147|||
129640801|NCT02632409|466639759|FG001|Treatment Period|Disease Recurrence|90|||
129640802|NCT02632409|466639758|FG000|Treatment Period|Study Drug Toxicity|8|||
129640803|NCT02632409|466639759|FG001|Treatment Period|Study Drug Toxicity|49|||
129640804|NCT02632409|466639758|FG000|Treatment Period|Death|1|||
129640805|NCT02632409|466639759|FG001|Treatment Period|Death|0|||
129640806|NCT02632409|466639758|FG000|Treatment Period|AE unrelated to study drug|15|||
129640807|NCT02632409|466639759|FG001|Treatment Period|AE unrelated to study drug|16|||
129640808|NCT02632409|466639758|FG000|Treatment Period|Request to discontinue treatment|4|||
129640809|NCT02632409|466639759|FG001|Treatment Period|Request to discontinue treatment|19|||
129443436|NCT02038920|465923143|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
129443437|NCT02038920|465923144|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
129443438|NCT02038920|465923139|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129443439|NCT02038920|465923140|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129443440|NCT02038920|465923141|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129443441|NCT02038920|465923142|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129443442|NCT02038920|465923143|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
129443443|NCT02038920|465923144|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
129443444|NCT02038920|465923139|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129443445|NCT02038920|465923140|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129889591|NCT03990363|467552639|FG000|Overall Study|Non-compliance with study drug|2|||
129443446|NCT02038920|465923141|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129443447|NCT02038920|465923142|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129443448|NCT02038920|465923143|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
129443449|NCT02038920|465923144|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
129443450|NCT00047320|465923145|FG000|Overall Study|Lack of Efficacy|8|||
129443451|NCT00047320|465923145|FG000|Overall Study|Lost to Follow-up|1|||
129443452|NCT00047320|465923145|FG000|Overall Study|Physician Decision|8|||
129443453|NCT00047320|465923145|FG000|Overall Study|Withdrawal by Subject|9|||
129889592|NCT03990363|467552640|FG001|Overall Study|Non-compliance with study drug|1|||
129889593|NCT03990363|467552641|FG002|Overall Study|Non-compliance with study drug|2|||
129889594|NCT03990363|467552642|FG003|Overall Study|Non-compliance with study drug|0|||
129889595|NCT03990363|467552643|FG004|Overall Study|Non-compliance with study drug|0|||
129889596|NCT03990363|467552639|FG000|Overall Study|Study terminated by sponsor|0|||
129443454|NCT00047320|465923145|FG000|Overall Study|Ineligible|2|||
129443455|NCT00866697|465923146|FG000|Overall Study|Study closed/terminated|156|||
129443456|NCT00866697|465923147|FG001|Overall Study|Study closed/terminated|138|||
129443457|NCT00866697|465923146|FG000|Overall Study|Lost to Follow-up|22|||
129889597|NCT03990363|467552640|FG001|Overall Study|Study terminated by sponsor|1|||
129443458|NCT00866697|465923147|FG001|Overall Study|Lost to Follow-up|28|||
129443459|NCT00866697|465923146|FG000|Overall Study|Physician Decision|3|||
129443460|NCT00866697|465923147|FG001|Overall Study|Physician Decision|5|||
129443461|NCT00866697|465923146|FG000|Overall Study|Withdrawal by Subject|33|||
129443462|NCT00866697|465923147|FG001|Overall Study|Withdrawal by Subject|57|||
129443463|NCT02906787|465923148|FG000|Overall Study|Withdrawal by Subject|12|||
129443464|NCT02906787|465923149|FG001|Overall Study|Withdrawal by Subject|10|||
129443465|NCT02906787|465923148|FG000|Overall Study|Missed|24|||
129443466|NCT02906787|465923149|FG001|Overall Study|Missed|22|||
129443467|NCT04376060|465923150|FG000|Overall Study|Physician Decision|1|||
129443468|NCT02818920|465923151|FG000|Overall Study|Unresectable|4|||
129443469|NCT02818920|465923151|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
129443470|NCT02818920|465923151|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
129443471|NCT02818920|465923151|FG000|Overall Study|Adverse Event|3|||
129443472|NCT02818920|465923151|FG000|Overall Study|Developed Other Disease|1|||
129443473|NCT02818920|465923151|FG000|Overall Study|Refused Further Treatment|1|||
129443474|NCT04275297|465923152|FG000|Overall Study|Lost to Follow-up|1|||
129443475|NCT04275297|465923153|FG001|Overall Study|Lost to Follow-up|1|||
129443476|NCT02673619|465923154|FG000|Overall Study|Lost to Follow-up|1|||
129443477|NCT02673619|465923155|FG001|Overall Study|Lost to Follow-up|0|||
129443478|NCT02673619|465923156|FG002|Overall Study|Lost to Follow-up|0|||
129443479|NCT02673619|465923157|FG003|Overall Study|Lost to Follow-up|0|||
129443480|NCT02673619|465923154|FG000|Overall Study|Withdrawal by Subject|1|||
129443481|NCT02673619|465923155|FG001|Overall Study|Withdrawal by Subject|1|||
129443482|NCT02673619|465923156|FG002|Overall Study|Withdrawal by Subject|1|||
129443483|NCT02673619|465923157|FG003|Overall Study|Withdrawal by Subject|0|||
129443484|NCT02673619|465923154|FG000|Overall Study|Adverse Event|0|||
129443485|NCT02673619|465923155|FG001|Overall Study|Adverse Event|0|||
129443486|NCT02673619|465923156|FG002|Overall Study|Adverse Event|1|||
129443487|NCT02673619|465923157|FG003|Overall Study|Adverse Event|0|||
129443488|NCT02673619|465923154|FG000|Overall Study|Lack of Efficacy|0|||
129443489|NCT02673619|465923155|FG001|Overall Study|Lack of Efficacy|0|||
129443490|NCT02673619|465923156|FG002|Overall Study|Lack of Efficacy|1|||
129443491|NCT02673619|465923157|FG003|Overall Study|Lack of Efficacy|0|||
129443492|NCT03434353|465924391|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
129443493|NCT03434353|465924392|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
129443494|NCT03434353|465924393|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
129443495|NCT03434353|465924394|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
129443496|NCT03434353|465924395|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
129443497|NCT03434353|465924391|FG000|Overall Study|Withdrew consent|1|||
129443498|NCT03434353|465924392|FG001|Overall Study|Withdrew consent|0|||
129443499|NCT03434353|465924393|FG002|Overall Study|Withdrew consent|3|||
129443500|NCT03434353|465924394|FG003|Overall Study|Withdrew consent|0|||
129443501|NCT03434353|465924395|FG004|Overall Study|Withdrew consent|0|||
129443502|NCT03434353|465924391|FG000|Overall Study|Adverse Event|1|||
129443503|NCT03434353|465924392|FG001|Overall Study|Adverse Event|0|||
129443504|NCT03434353|465924393|FG002|Overall Study|Adverse Event|0|||
129443505|NCT03434353|465924394|FG003|Overall Study|Adverse Event|0|||
129443506|NCT03434353|465924395|FG004|Overall Study|Adverse Event|1|||
129443507|NCT03434353|465924391|FG000|Overall Study|Lost to Follow-up|2|||
129443508|NCT03434353|465924392|FG001|Overall Study|Lost to Follow-up|0|||
129443509|NCT03434353|465924393|FG002|Overall Study|Lost to Follow-up|0|||
129443510|NCT03434353|465924394|FG003|Overall Study|Lost to Follow-up|0|||
129443511|NCT03434353|465924395|FG004|Overall Study|Lost to Follow-up|0|||
129443512|NCT01990534|465924398|FG000|Overall Study|Death|22|||
129443513|NCT01990534|465924398|FG000|Overall Study|Progressive disease|3|||
129443514|NCT01990534|465924398|FG000|Overall Study|Protocol Violation|1|||
129798506|NCT01068652|467232095|FG001|Overall Study|Lost to Follow-up|1|||
129798507|NCT01068652|467232094|FG000|Overall Study|Protocol Violation|3|||
129798508|NCT01068652|467232095|FG001|Overall Study|Protocol Violation|6|||
129798509|NCT01068652|467232094|FG000|Overall Study|Withdrawal criteria|1|||
129798510|NCT01068652|467232095|FG001|Overall Study|Withdrawal criteria|2|||
129798511|NCT01068652|467232094|FG000|Overall Study|Patient was not eligible|1|||
129798512|NCT01068652|467232095|FG001|Overall Study|Patient was not eligible|0|||
129798513|NCT01068652|467232094|FG000|Overall Study|Unclassified|7|||
129798514|NCT01068652|467232095|FG001|Overall Study|Unclassified|4|||
129798515|NCT02694523|467232096|FG000|Part A|Adverse Event|7|||
129640810|NCT02632409|466639758|FG000|Treatment Period|Participant withdrew consent|7|||
129640811|NCT02632409|466639759|FG001|Treatment Period|Participant withdrew consent|5|||
129640812|NCT02632409|466639758|FG000|Treatment Period|Lost to Follow-up|0|||
129640813|NCT02632409|466639759|FG001|Treatment Period|Lost to Follow-up|1|||
129640814|NCT02632409|466639758|FG000|Treatment Period|Maximum clinical benefit|1|||
129640815|NCT02632409|466639759|FG001|Treatment Period|Maximum clinical benefit|0|||
129640816|NCT02632409|466639758|FG000|Treatment Period|No longer meets study criteria|3|||
129640817|NCT02632409|466639759|FG001|Treatment Period|No longer meets study criteria|0|||
129640818|NCT02632409|466639758|FG000|Treatment Period|Administrative Reason by sponsor|0|||
129640819|NCT02632409|466639759|FG001|Treatment Period|Administrative Reason by sponsor|1|||
129640820|NCT02632409|466639758|FG000|Treatment Period|Other Reasons|10|||
129640821|NCT02632409|466639759|FG001|Treatment Period|Other Reasons|6|||
129640822|NCT03521115|466639760|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
129640823|NCT03521115|466639761|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
129640824|NCT03521115|466639760|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
129640825|NCT03521115|466639761|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
129640826|NCT01981954|466639766|FG000|Titration Period|Protocol Deviation|1|||
129640827|NCT01981954|466639766|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
129640828|NCT03655470|466639767|FG000|Overall Study|Lost to Follow-up|6|||
129640829|NCT03655470|466639768|FG001|Overall Study|Lost to Follow-up|7|||
129640830|NCT03063086|466639771|FG000|Overall Study|technical problems|1|||
129640831|NCT03063086|466639772|FG001|Overall Study|technical problems|0|||
129640832|NCT03063086|466639773|FG002|Overall Study|technical problems|0|||
129640833|NCT03063086|466639774|FG003|Overall Study|technical problems|0|||
129640834|NCT03063086|466639775|FG004|Overall Study|technical problems|0|||
129640835|NCT03063086|466639776|FG005|Overall Study|technical problems|0|||
129640836|NCT03063086|466639771|FG000|Overall Study|Adverse Event|1|||
129640837|NCT03063086|466639772|FG001|Overall Study|Adverse Event|1|||
129640838|NCT03063086|466639773|FG002|Overall Study|Adverse Event|1|||
129640839|NCT03063086|466639774|FG003|Overall Study|Adverse Event|1|||
129640840|NCT03063086|466639775|FG004|Overall Study|Adverse Event|0|||
129640841|NCT03063086|466639776|FG005|Overall Study|Adverse Event|0|||
129640842|NCT03063086|466639771|FG000|Overall Study|subject/guardian decision|1|||
129640843|NCT03063086|466639772|FG001|Overall Study|subject/guardian decision|0|||
129640844|NCT03063086|466639773|FG002|Overall Study|subject/guardian decision|0|||
129640845|NCT03063086|466639774|FG003|Overall Study|subject/guardian decision|0|||
129640846|NCT03063086|466639775|FG004|Overall Study|subject/guardian decision|0|||
129640847|NCT03063086|466639776|FG005|Overall Study|subject/guardian decision|0|||
129640848|NCT03063086|466639771|FG000|Overall Study|Non-compliance with study treatment|0|||
129640849|NCT03063086|466639772|FG001|Overall Study|Non-compliance with study treatment|0|||
129640850|NCT03063086|466639773|FG002|Overall Study|Non-compliance with study treatment|0|||
129798516|NCT02694523|467232097|FG001|Part A|Adverse Event|3|||
129798517|NCT02694523|467232098|FG002|Part A|Adverse Event|0|||
129798518|NCT02694523|467232099|FG003|Part A|Adverse Event|0|||
129798519|NCT02694523|467232100|FG004|Part A|Adverse Event|0|||
129798520|NCT02694523|467232101|FG005|Part A|Adverse Event|0|||
129798521|NCT02694523|467232102|FG006|Part A|Adverse Event|0|||
129798522|NCT02694523|467232096|FG000|Part A|Protocol Violation|1|||
129798523|NCT02694523|467232097|FG001|Part A|Protocol Violation|0|||
129798524|NCT02694523|467232098|FG002|Part A|Protocol Violation|0|||
129798525|NCT02694523|467232099|FG003|Part A|Protocol Violation|0|||
129798526|NCT02694523|467232100|FG004|Part A|Protocol Violation|0|||
129798527|NCT02694523|467232101|FG005|Part A|Protocol Violation|0|||
129798528|NCT02694523|467232102|FG006|Part A|Protocol Violation|0|||
129798529|NCT02694523|467232096|FG000|Part A|Lost to Follow-up|1|||
129798530|NCT02694523|467232097|FG001|Part A|Lost to Follow-up|2|||
129798531|NCT02694523|467232098|FG002|Part A|Lost to Follow-up|0|||
129798532|NCT02694523|467232099|FG003|Part A|Lost to Follow-up|0|||
129798533|NCT02694523|467232100|FG004|Part A|Lost to Follow-up|0|||
129798534|NCT02694523|467232101|FG005|Part A|Lost to Follow-up|0|||
129798535|NCT02694523|467232102|FG006|Part A|Lost to Follow-up|0|||
129798536|NCT02694523|467232096|FG000|Part A|Withdrawal by Subject|3|||
129798537|NCT02694523|467232097|FG001|Part A|Withdrawal by Subject|1|||
129798538|NCT02694523|467232098|FG002|Part A|Withdrawal by Subject|0|||
129798539|NCT02694523|467232099|FG003|Part A|Withdrawal by Subject|0|||
129640851|NCT03063086|466639774|FG003|Overall Study|Non-compliance with study treatment|1|||
129640852|NCT03063086|466639775|FG004|Overall Study|Non-compliance with study treatment|0|||
129640853|NCT03063086|466639776|FG005|Overall Study|Non-compliance with study treatment|1|||
129798540|NCT02694523|467232100|FG004|Part A|Withdrawal by Subject|0|||
129640854|NCT03063086|466639771|FG000|Overall Study|Physician Decision|0|||
129640855|NCT03063086|466639772|FG001|Overall Study|Physician Decision|0|||
129640856|NCT03063086|466639773|FG002|Overall Study|Physician Decision|0|||
129640857|NCT03063086|466639774|FG003|Overall Study|Physician Decision|1|||
129640858|NCT03063086|466639775|FG004|Overall Study|Physician Decision|0|||
129798541|NCT02694523|467232101|FG005|Part A|Withdrawal by Subject|0|||
129889598|NCT03990363|467552641|FG002|Overall Study|Study terminated by sponsor|0|||
129640859|NCT03063086|466639776|FG005|Overall Study|Physician Decision|0|||
129798542|NCT02694523|467232102|FG006|Part A|Withdrawal by Subject|0|||
129798543|NCT02694523|467232096|FG000|Part A|Other|1|||
129798544|NCT02694523|467232097|FG001|Part A|Other|1|||
129798545|NCT02694523|467232098|FG002|Part A|Other|0|||
129798546|NCT02694523|467232099|FG003|Part A|Other|0|||
129640860|NCT04590586|466639778|FG000|Overall Study|Death|7|||
129640861|NCT04590586|466639779|FG001|Overall Study|Death|1|||
129640862|NCT04590586|466639780|FG002|Overall Study|Death|37|||
129640863|NCT04590586|466639781|FG003|Overall Study|Death|34|||
129640864|NCT04590586|466639782|FG004|Overall Study|Death|19|||
129640865|NCT04590586|466639783|FG005|Overall Study|Death|3|||
129640866|NCT04590586|466639778|FG000|Overall Study|Lost to Follow-up|3|||
129640867|NCT04590586|466639779|FG001|Overall Study|Lost to Follow-up|0|||
129640868|NCT04590586|466639780|FG002|Overall Study|Lost to Follow-up|11|||
129640869|NCT04590586|466639781|FG003|Overall Study|Lost to Follow-up|11|||
129640870|NCT04590586|466639782|FG004|Overall Study|Lost to Follow-up|6|||
129640871|NCT04590586|466639783|FG005|Overall Study|Lost to Follow-up|0|||
129640872|NCT04590586|466639778|FG000|Overall Study|Withdrawal by Subject|0|||
129640873|NCT04590586|466639779|FG001|Overall Study|Withdrawal by Subject|0|||
129640874|NCT04590586|466639780|FG002|Overall Study|Withdrawal by Subject|6|||
129640875|NCT04590586|466639781|FG003|Overall Study|Withdrawal by Subject|0|||
129640876|NCT04590586|466639782|FG004|Overall Study|Withdrawal by Subject|3|||
129640877|NCT04590586|466639783|FG005|Overall Study|Withdrawal by Subject|0|||
129640878|NCT04590586|466639778|FG000|Overall Study|Other|3|||
129640879|NCT04590586|466639779|FG001|Overall Study|Other|0|||
129640880|NCT04590586|466639780|FG002|Overall Study|Other|1|||
129640881|NCT04590586|466639781|FG003|Overall Study|Other|1|||
129640882|NCT04590586|466639782|FG004|Overall Study|Other|2|||
129640883|NCT04590586|466639783|FG005|Overall Study|Other|1|||
129640884|NCT01893281|466639784|FG000|Overall Study|Adverse Event|1|||
129640885|NCT01893281|466639784|FG000|Overall Study|Protocol Violation|1|||
129640886|NCT01893281|466639784|FG000|Overall Study|Withdrawal by Subject|1|||
129640887|NCT02218736|466639785|FG000|Overall Study|Withdrawal by Subject|10|||
129640888|NCT02218736|466639786|FG001|Overall Study|Withdrawal by Subject|9|||
129640889|NCT02218736|466639785|FG000|Overall Study|Protocol Violation|2|||
129640890|NCT02218736|466639786|FG001|Overall Study|Protocol Violation|0|||
129640891|NCT05481125|466639789|FG000|Overall Study|Adverse Event|1|||
129640892|NCT05481125|466639790|FG001|Overall Study|Adverse Event|0|||
129640893|NCT05481125|466639789|FG000|Overall Study|Lost to Follow-up|0|||
129640894|NCT05481125|466639790|FG001|Overall Study|Lost to Follow-up|1|||
129640895|NCT05481125|466639789|FG000|Overall Study|Withdrawal by Subject|0|||
129640896|NCT05481125|466639790|FG001|Overall Study|Withdrawal by Subject|1|||
129640897|NCT02244463|466639791|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
129640898|NCT02244463|466639792|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129640899|NCT02244463|466639793|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129640900|NCT02244463|466639794|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129640901|NCT02244463|466639795|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129640902|NCT02244463|466639796|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
129640903|NCT02244463|466639791|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
129640904|NCT02244463|466639792|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
129640905|NCT02244463|466639793|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
129640906|NCT02244463|466639794|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
129640907|NCT02244463|466639795|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
129640908|NCT02244463|466639796|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
129640909|NCT02244463|466639791|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129640910|NCT02244463|466639792|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
129640911|NCT02244463|466639793|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129640912|NCT02244463|466639794|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129640913|NCT02244463|466639795|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129640914|NCT02244463|466639796|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
129640915|NCT02244463|466639791|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129640916|NCT02244463|466639792|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129798547|NCT02694523|467232100|FG004|Part A|Other|0|||
129640917|NCT02244463|466639793|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
129640918|NCT02244463|466639794|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129640919|NCT02244463|466639795|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129640920|NCT02244463|466639796|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
129640921|NCT02244463|466639791|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129640922|NCT02244463|466639792|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129640923|NCT02244463|466639793|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129798548|NCT02694523|467232101|FG005|Part A|Other|0|||
129798549|NCT02694523|467232102|FG006|Part A|Other|0|||
129640924|NCT02244463|466639794|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
129640925|NCT02244463|466639795|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129798550|NCT02694523|467232096|FG000|Part B|Adverse Event|0|||
129640926|NCT02244463|466639796|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
129640927|NCT02244463|466639791|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129798551|NCT02694523|467232097|FG001|Part B|Adverse Event|0|||
129640928|NCT02244463|466639792|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129640929|NCT02244463|466639793|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129640930|NCT02244463|466639794|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
129640931|NCT02244463|466639795|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129640932|NCT02244463|466639796|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
129640933|NCT02244463|466639791|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129640934|NCT02244463|466639792|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129640935|NCT02244463|466639793|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129640936|NCT02244463|466639794|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
129640937|NCT02244463|466639795|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129640938|NCT02244463|466639796|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
129640939|NCT02244463|466639791|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129640940|NCT02244463|466639792|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129640941|NCT02244463|466639793|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129640942|NCT02244463|466639794|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
129640943|NCT02244463|466639795|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129640944|NCT02244463|466639796|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
129640945|NCT02244463|466639791|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129640946|NCT02244463|466639792|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129640947|NCT02244463|466639793|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129640948|NCT02244463|466639794|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
129640949|NCT02244463|466639795|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129640950|NCT02244463|466639796|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
129640951|NCT02244463|466639791|FG000|Period 5: Phase II|Disease Progression|0|||
129640952|NCT02244463|466639792|FG001|Period 5: Phase II|Disease Progression|0|||
129640953|NCT02244463|466639793|FG002|Period 5: Phase II|Disease Progression|0|||
129640954|NCT02244463|466639794|FG003|Period 5: Phase II|Disease Progression|0|||
129640955|NCT02244463|466639795|FG004|Period 5: Phase II|Disease Progression|10|||
129640956|NCT02244463|466639796|FG005|Period 5: Phase II|Disease Progression|11|||
129640957|NCT02244463|466639791|FG000|Period 5: Phase II|Physician Decision|0|||
129640958|NCT02244463|466639792|FG001|Period 5: Phase II|Physician Decision|0|||
129640959|NCT02244463|466639793|FG002|Period 5: Phase II|Physician Decision|0|||
129640960|NCT02244463|466639794|FG003|Period 5: Phase II|Physician Decision|0|||
129640961|NCT02244463|466639795|FG004|Period 5: Phase II|Physician Decision|3|||
129640962|NCT02244463|466639796|FG005|Period 5: Phase II|Physician Decision|2|||
129640963|NCT02244463|466639791|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
129640964|NCT02244463|466639792|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
129640965|NCT02244463|466639793|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
129640966|NCT02244463|466639794|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
129640967|NCT02244463|466639795|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
129640968|NCT02244463|466639796|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
129640969|NCT02244463|466639791|FG000|Period 5: Phase II|Intercurrent Illness|0|||
129640970|NCT02244463|466639792|FG001|Period 5: Phase II|Intercurrent Illness|0|||
129640971|NCT02244463|466639793|FG002|Period 5: Phase II|Intercurrent Illness|0|||
129640972|NCT02244463|466639794|FG003|Period 5: Phase II|Intercurrent Illness|0|||
129640973|NCT02244463|466639795|FG004|Period 5: Phase II|Intercurrent Illness|2|||
129640974|NCT02244463|466639796|FG005|Period 5: Phase II|Intercurrent Illness|0|||
129640975|NCT02244463|466639791|FG000|Period 5: Phase II|Adverse Event|0|||
129640976|NCT02244463|466639792|FG001|Period 5: Phase II|Adverse Event|0|||
129640977|NCT02244463|466639793|FG002|Period 5: Phase II|Adverse Event|0|||
129640978|NCT02244463|466639794|FG003|Period 5: Phase II|Adverse Event|0|||
129640979|NCT02244463|466639795|FG004|Period 5: Phase II|Adverse Event|0|||
129640980|NCT02244463|466639796|FG005|Period 5: Phase II|Adverse Event|2|||
129640981|NCT02244463|466639791|FG000|Period 5: Phase II|Still On treatment|0|||
129640982|NCT02244463|466639792|FG001|Period 5: Phase II|Still On treatment|0|||
129640983|NCT02244463|466639793|FG002|Period 5: Phase II|Still On treatment|0|||
129640984|NCT02244463|466639794|FG003|Period 5: Phase II|Still On treatment|0|||
129640985|NCT02244463|466639795|FG004|Period 5: Phase II|Still On treatment|0|||
129640986|NCT02244463|466639796|FG005|Period 5: Phase II|Still On treatment|3|||
129640987|NCT01769508|466639797|FG000|Overall Study|Death|3|||
129640988|NCT01769508|466639797|FG000|Overall Study|Withdrawal by Subject|1|||
129640989|NCT01769508|466639797|FG000|Overall Study|Adverse Event|1|||
129640990|NCT01769508|466639797|FG000|Overall Study|Lost to Follow-up|1|||
129640991|NCT01598090|466639801|FG000|Treatment Period|Poor/non-compliance|0|||
129640992|NCT01598090|466639802|FG001|Treatment Period|Poor/non-compliance|2|||
129640993|NCT01598090|466639803|FG002|Treatment Period|Poor/non-compliance|0|||
129640994|NCT01598090|466639801|FG000|Treatment Period|No longer meet study criteria|0|||
129640995|NCT01598090|466639802|FG001|Treatment Period|No longer meet study criteria|1|||
129640996|NCT01598090|466639803|FG002|Treatment Period|No longer meet study criteria|0|||
129640997|NCT01598090|466639801|FG000|Treatment Period|Lack of Efficacy|5|||
129640998|NCT01598090|466639802|FG001|Treatment Period|Lack of Efficacy|14|||
129640999|NCT01598090|466639803|FG002|Treatment Period|Lack of Efficacy|6|||
129641000|NCT01598090|466639801|FG000|Treatment Period|Adverse Event|2|||
129889599|NCT03990363|467552642|FG003|Overall Study|Study terminated by sponsor|0|||
129889600|NCT03990363|467552643|FG004|Overall Study|Study terminated by sponsor|0|||
129889601|NCT03990363|467552639|FG000|Overall Study|Site terminated by sponsor|2|||
129889602|NCT03990363|467552640|FG001|Overall Study|Site terminated by sponsor|1|||
129889603|NCT03990363|467552641|FG002|Overall Study|Site terminated by sponsor|2|||
129889604|NCT03990363|467552642|FG003|Overall Study|Site terminated by sponsor|0|||
129889605|NCT03990363|467552643|FG004|Overall Study|Site terminated by sponsor|2|||
129889606|NCT03990363|467552639|FG000|Overall Study|Not categorized|5|||
129889607|NCT03990363|467552640|FG001|Overall Study|Not categorized|5|||
129889608|NCT03990363|467552641|FG002|Overall Study|Not categorized|3|||
129889609|NCT03990363|467552642|FG003|Overall Study|Not categorized|2|||
129889610|NCT03990363|467552643|FG004|Overall Study|Not categorized|2|||
129889611|NCT00238420|467552653|FG000|Overall Study|Protocol Violation|1|||
129889612|NCT00238420|467552654|FG001|Overall Study|Protocol Violation|1|||
129889613|NCT00663962|467552655|FG000|Overall Study|somnolence|1|||
129889614|NCT00663962|467552656|FG001|Overall Study|somnolence|0|||
129889615|NCT04140890|467552657|FG000|Overall Study|Withdrawal by Subject|0|||
129889616|NCT04140890|467552658|FG001|Overall Study|Withdrawal by Subject|1|||
129889617|NCT02102464|467552659|FG000|Randomized Study|Withdrawal by Subject|0|||
129889618|NCT02102464|467552660|FG001|Randomized Study|Withdrawal by Subject|1|||
129889619|NCT02102464|467552661|FG002|Randomized Study|Withdrawal by Subject|0|||
129889620|NCT01700348|467552662|FG000|Overall Study|Withdrawal by Subject|22|||
129889621|NCT01700348|467552662|FG000|Overall Study|Lost to Follow-up|1|||
129889622|NCT03958630|467552663|FG000|Overall Study|Withdrawal by Subject|0|||
129889623|NCT03958630|467552664|FG001|Overall Study|Withdrawal by Subject|0|||
129889624|NCT03958630|467552665|FG002|Overall Study|Withdrawal by Subject|1|||
129889625|NCT03958630|467552663|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
129889626|NCT03958630|467552664|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
129889627|NCT03958630|467552665|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
129889628|NCT01824472|467552670|FG000|Overall Study|Lost to Follow-up|0|||
129889629|NCT01824472|467552671|FG001|Overall Study|Lost to Follow-up|0|||
129889630|NCT01824472|467552672|FG002|Overall Study|Lost to Follow-up|1|||
129889631|NCT01824472|467552670|FG000|Overall Study|Withdrawal by Subject|1|||
129889632|NCT01824472|467552671|FG001|Overall Study|Withdrawal by Subject|5|||
129889633|NCT01824472|467552672|FG002|Overall Study|Withdrawal by Subject|3|||
129889634|NCT01824472|467552670|FG000|Overall Study|Ineligible post randomization&screening|0|||
129889635|NCT01824472|467552671|FG001|Overall Study|Ineligible post randomization&screening|2|||
129889636|NCT01824472|467552672|FG002|Overall Study|Ineligible post randomization&screening|0|||
129889637|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
129889638|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
129889639|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
129889640|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
129889641|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
129889642|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
129889643|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
129889644|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
129889645|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
129889646|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
129889647|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
129889648|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
129889649|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
129889650|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
129889651|NCT01815736|467552673|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
129889652|NCT01815736|467552674|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
129889653|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
129889654|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
129889655|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
129889656|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
129889657|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
129889658|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
129889659|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
129889660|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
129889661|NCT01815736|467552673|FG000|Extension Treatment Phase- After Week 96|Death|1|||
129889662|NCT01815736|467552674|FG001|Extension Treatment Phase- After Week 96|Death|0|||
129889663|NCT03040687|467552676|FG000|Overall Study|Withdrawal by Subject|1|||
129889664|NCT03040687|467552677|FG001|Overall Study|Withdrawal by Subject|0|||
129889665|NCT03040687|467552678|FG002|Overall Study|Withdrawal by Subject|0|||
129889666|NCT00810641|467552679|FG000|Overall Study|Withdrawal by Subject|0|||
129889667|NCT00810641|467552680|FG001|Overall Study|Withdrawal by Subject|1|||
129889668|NCT00810641|467552681|FG002|Overall Study|Withdrawal by Subject|2|||
129889669|NCT01556243|467552682|FG000|Overall Study|Ineligible|34|||
129889670|NCT01556243|467552682|FG000|Overall Study|Converted to mastectomy|14|||
129889671|NCT01556243|467552682|FG000|Overall Study|Unable to achieve negative margins|2|||
129889672|NCT01556243|467552682|FG000|Overall Study|Withdrawal by Subject|16|||
129889673|NCT02325713|467552685|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889674|NCT02325713|467552686|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889675|NCT02325713|467552687|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129798552|NCT02694523|467232098|FG002|Part B|Adverse Event|7|||
129798553|NCT02694523|467232099|FG003|Part B|Adverse Event|1|||
129798554|NCT02694523|467232100|FG004|Part B|Adverse Event|1|||
129798555|NCT02694523|467232101|FG005|Part B|Adverse Event|2|||
129798556|NCT02694523|467232102|FG006|Part B|Adverse Event|0|||
129798557|NCT02694523|467232096|FG000|Part B|Protocol Violation|0|||
129798558|NCT02694523|467232097|FG001|Part B|Protocol Violation|0|||
129798559|NCT02694523|467232098|FG002|Part B|Protocol Violation|1|||
129798560|NCT02694523|467232099|FG003|Part B|Protocol Violation|0|||
129798561|NCT02694523|467232100|FG004|Part B|Protocol Violation|0|||
129798562|NCT02694523|467232101|FG005|Part B|Protocol Violation|0|||
129798563|NCT02694523|467232102|FG006|Part B|Protocol Violation|0|||
129798564|NCT02694523|467232096|FG000|Part B|Lost to Follow-up|0|||
129889676|NCT02325713|467552688|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889677|NCT02325713|467552689|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889678|NCT02325713|467552690|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129641001|NCT01598090|466639802|FG001|Treatment Period|Adverse Event|33|||
129798565|NCT02694523|467232097|FG001|Part B|Lost to Follow-up|0|||
129798566|NCT02694523|467232098|FG002|Part B|Lost to Follow-up|2|||
129641002|NCT01598090|466639803|FG002|Treatment Period|Adverse Event|17|||
129798567|NCT02694523|467232099|FG003|Part B|Lost to Follow-up|3|||
129798568|NCT02694523|467232100|FG004|Part B|Lost to Follow-up|2|||
129798569|NCT02694523|467232101|FG005|Part B|Lost to Follow-up|0|||
129798570|NCT02694523|467232102|FG006|Part B|Lost to Follow-up|1|||
129889679|NCT02325713|467552691|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889680|NCT02325713|467552692|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889681|NCT02325713|467552693|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889682|NCT02325713|467552694|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889683|NCT02325713|467552695|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
129889684|NCT02325713|467552696|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889685|NCT02325713|467552697|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889686|NCT02325713|467552698|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889687|NCT02325713|467552699|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889688|NCT02325713|467552700|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
129889689|NCT02325713|467552685|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
129889690|NCT02325713|467552686|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889691|NCT02325713|467552687|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129641003|NCT01598090|466639801|FG000|Treatment Period|Other reasons|0|||
129798571|NCT02694523|467232096|FG000|Part B|Withdrawal by Subject|0|||
129798572|NCT02694523|467232097|FG001|Part B|Withdrawal by Subject|0|||
129798573|NCT02694523|467232098|FG002|Part B|Withdrawal by Subject|9|||
129798574|NCT02694523|467232099|FG003|Part B|Withdrawal by Subject|0|||
129798575|NCT02694523|467232100|FG004|Part B|Withdrawal by Subject|1|||
129798576|NCT02694523|467232101|FG005|Part B|Withdrawal by Subject|3|||
129798577|NCT02694523|467232102|FG006|Part B|Withdrawal by Subject|0|||
129798578|NCT02694523|467232096|FG000|Part B|Other|0|||
129798579|NCT02694523|467232097|FG001|Part B|Other|0|||
129798580|NCT02694523|467232098|FG002|Part B|Other|1|||
129798581|NCT02694523|467232099|FG003|Part B|Other|0|||
129798582|NCT02694523|467232100|FG004|Part B|Other|0|||
129798583|NCT02694523|467232101|FG005|Part B|Other|0|||
129798584|NCT02694523|467232102|FG006|Part B|Other|1|||
129798585|NCT04505540|467232105|FG000|Baseline|Protocol Violation|10|||
129798586|NCT04505540|467232105|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
129798587|NCT04505540|467232105|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
129798588|NCT04505540|467232105|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
129798589|NCT04505540|467232105|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
129798590|NCT04505540|467232105|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
129798591|NCT04505540|467232105|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
129798592|NCT04505540|467232105|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
129798593|NCT04505540|467232105|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
129798594|NCT04505540|467232105|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
129798595|NCT04505540|467232105|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
129798596|NCT04505540|467232105|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
129798597|NCT04505540|467232105|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
129798598|NCT05323656|467232108|FG000|Overall Study|Still On-Treatment|6|||
129798599|NCT05323656|467232109|FG001|Overall Study|Still On-Treatment|6|||
129798600|NCT05323656|467232108|FG000|Overall Study|Progressive Disease|15|||
129798601|NCT05323656|467232109|FG001|Overall Study|Progressive Disease|14|||
129798602|NCT05323656|467232108|FG000|Overall Study|Adverse Event|2|||
129798603|NCT05323656|467232109|FG001|Overall Study|Adverse Event|3|||
129798604|NCT05323656|467232108|FG000|Overall Study|Death|1|||
129798605|NCT05323656|467232109|FG001|Overall Study|Death|2|||
129798606|NCT05323656|467232108|FG000|Overall Study|Withdrawal by Subject|1|||
129798607|NCT05323656|467232109|FG001|Overall Study|Withdrawal by Subject|0|||
129798608|NCT05323656|467232108|FG000|Overall Study|Clinical disease progression|0|||
129798609|NCT05323656|467232109|FG001|Overall Study|Clinical disease progression|1|||
129798610|NCT05323656|467232108|FG000|Overall Study|Patient and Investigator decision|1|||
129798611|NCT05323656|467232109|FG001|Overall Study|Patient and Investigator decision|0|||
129798612|NCT05323656|467232108|FG000|Overall Study|Physician Decision|0|||
129798613|NCT05323656|467232109|FG001|Overall Study|Physician Decision|1|||
129798614|NCT03953183|467232110|FG000|Overall Study|Physician Decision|0|||
129798615|NCT03953183|467232111|FG001|Overall Study|Physician Decision|1|||
129798616|NCT03953183|467232110|FG000|Overall Study|Withdrawal by Subject|0|||
129798617|NCT03953183|467232111|FG001|Overall Study|Withdrawal by Subject|1|||
129798618|NCT04508140|467232112|FG000|Overall Study|Adverse Event|2|||
129798619|NCT04508140|467232113|FG001|Overall Study|Adverse Event|2|||
129798620|NCT04508140|467232112|FG000|Overall Study|Withdrawal by Subject|0|||
129798621|NCT04508140|467232113|FG001|Overall Study|Withdrawal by Subject|2|||
129798622|NCT04508140|467232112|FG000|Overall Study|progressive disease|9|||
129798623|NCT04508140|467232113|FG001|Overall Study|progressive disease|3|||
129798624|NCT01298193|467232114|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
129798625|NCT01298193|467232114|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
129798626|NCT01298193|467232114|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
129798627|NCT01298193|467232114|FG000|Efficacy Phase (Second Cycle)|Death|1|||
129798628|NCT04010539|467232115|FG000|Overall Study|Withdrawal by Subject|4|||
129798629|NCT04010539|467232116|FG001|Overall Study|Withdrawal by Subject|1|||
129641004|NCT01598090|466639802|FG001|Treatment Period|Other reasons|4|||
129641005|NCT01598090|466639803|FG002|Treatment Period|Other reasons|1|||
129641006|NCT01598090|466639801|FG000|Treatment Period|Withdrawal by Subject|3|||
129641007|NCT01598090|466639802|FG001|Treatment Period|Withdrawal by Subject|13|||
129641008|NCT01598090|466639803|FG002|Treatment Period|Withdrawal by Subject|10|||
129641009|NCT01598090|466639801|FG000|Treatment Period|Lost to Follow-up|1|||
129641010|NCT01598090|466639802|FG001|Treatment Period|Lost to Follow-up|5|||
129641011|NCT01598090|466639803|FG002|Treatment Period|Lost to Follow-up|1|||
129641012|NCT01598090|466639801|FG000|Follow-up Period|Death|0|||
129641013|NCT01598090|466639802|FG001|Follow-up Period|Death|1|||
129641014|NCT01598090|466639803|FG002|Follow-up Period|Death|0|||
129641015|NCT01598090|466639801|FG000|Follow-up Period|No longer required per protocol|1|||
129641016|NCT01598090|466639802|FG001|Follow-up Period|No longer required per protocol|3|||
129641017|NCT01598090|466639803|FG002|Follow-up Period|No longer required per protocol|2|||
129641018|NCT01598090|466639801|FG000|Follow-up Period|Not reported|0|||
129641019|NCT01598090|466639802|FG001|Follow-up Period|Not reported|10|||
129641020|NCT01598090|466639803|FG002|Follow-up Period|Not reported|4|||
129641021|NCT01598090|466639801|FG000|Follow-up Period|Withdrawal by Subject|0|||
129641022|NCT01598090|466639802|FG001|Follow-up Period|Withdrawal by Subject|3|||
129641023|NCT01598090|466639803|FG002|Follow-up Period|Withdrawal by Subject|2|||
129641024|NCT01598090|466639801|FG000|Follow-up Period|Other reasons|2|||
129641025|NCT01598090|466639802|FG001|Follow-up Period|Other reasons|8|||
129641026|NCT01598090|466639803|FG002|Follow-up Period|Other reasons|8|||
129641027|NCT01598090|466639801|FG000|Follow-up Period|Lost to Follow-up|2|||
129641028|NCT01598090|466639802|FG001|Follow-up Period|Lost to Follow-up|10|||
129641029|NCT01598090|466639803|FG002|Follow-up Period|Lost to Follow-up|12|||
129641030|NCT03615144|466639804|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
129641031|NCT03615144|466639805|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
129641032|NCT02587598|466639808|FG000|Overall Study|Death|4|||
129641033|NCT02587598|466639809|FG001|Overall Study|Death|8|||
129641034|NCT02587598|466639810|FG002|Overall Study|Death|4|||
129641035|NCT02587598|466639811|FG003|Overall Study|Death|16|||
129641036|NCT02587598|466639812|FG004|Overall Study|Death|9|||
129641037|NCT02587598|466639813|FG005|Overall Study|Death|4|||
129641038|NCT02587598|466639814|FG006|Overall Study|Death|6|||
129641039|NCT02587598|466639815|FG007|Overall Study|Death|7|||
129641040|NCT02587598|466639816|FG008|Overall Study|Death|9|||
129641041|NCT02587598|466639817|FG009|Overall Study|Death|1|||
129641042|NCT02587598|466639818|FG010|Overall Study|Death|3|||
129641043|NCT02587598|466639808|FG000|Overall Study|Study Terminated by the Sponsor|0|||
129641044|NCT02587598|466639809|FG001|Overall Study|Study Terminated by the Sponsor|1|||
129641045|NCT02587598|466639810|FG002|Overall Study|Study Terminated by the Sponsor|0|||
129641046|NCT02587598|466639811|FG003|Overall Study|Study Terminated by the Sponsor|3|||
129641047|NCT02587598|466639812|FG004|Overall Study|Study Terminated by the Sponsor|0|||
129641048|NCT02587598|466639813|FG005|Overall Study|Study Terminated by the Sponsor|1|||
129641049|NCT02587598|466639814|FG006|Overall Study|Study Terminated by the Sponsor|0|||
129641050|NCT02587598|466639815|FG007|Overall Study|Study Terminated by the Sponsor|0|||
129641051|NCT02587598|466639816|FG008|Overall Study|Study Terminated by the Sponsor|0|||
129641052|NCT02587598|466639817|FG009|Overall Study|Study Terminated by the Sponsor|1|||
129641053|NCT02587598|466639818|FG010|Overall Study|Study Terminated by the Sponsor|6|||
129641054|NCT02587598|466639808|FG000|Overall Study|Reason for study withdrawal not specified|0|||
129641055|NCT02587598|466639809|FG001|Overall Study|Reason for study withdrawal not specified|1|||
129641056|NCT02587598|466639810|FG002|Overall Study|Reason for study withdrawal not specified|0|||
129641057|NCT02587598|466639811|FG003|Overall Study|Reason for study withdrawal not specified|0|||
129641058|NCT02587598|466639812|FG004|Overall Study|Reason for study withdrawal not specified|0|||
129641059|NCT02587598|466639813|FG005|Overall Study|Reason for study withdrawal not specified|0|||
129889692|NCT02325713|467552688|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889693|NCT02325713|467552689|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889694|NCT02325713|467552690|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889695|NCT02325713|467552691|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889696|NCT02325713|467552692|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129641060|NCT02587598|466639814|FG006|Overall Study|Reason for study withdrawal not specified|0|||
129641061|NCT02587598|466639815|FG007|Overall Study|Reason for study withdrawal not specified|0|||
129641062|NCT02587598|466639816|FG008|Overall Study|Reason for study withdrawal not specified|0|||
129641063|NCT02587598|466639817|FG009|Overall Study|Reason for study withdrawal not specified|0|||
129641064|NCT02587598|466639818|FG010|Overall Study|Reason for study withdrawal not specified|0|||
129641065|NCT02587598|466639808|FG000|Overall Study|Withdrawal by Subject|0|||
129641066|NCT02587598|466639809|FG001|Overall Study|Withdrawal by Subject|1|||
129641067|NCT02587598|466639810|FG002|Overall Study|Withdrawal by Subject|0|||
129641068|NCT02587598|466639811|FG003|Overall Study|Withdrawal by Subject|2|||
129641069|NCT02587598|466639812|FG004|Overall Study|Withdrawal by Subject|3|||
129641070|NCT02587598|466639813|FG005|Overall Study|Withdrawal by Subject|1|||
129641071|NCT02587598|466639814|FG006|Overall Study|Withdrawal by Subject|0|||
129641072|NCT02587598|466639815|FG007|Overall Study|Withdrawal by Subject|0|||
129641073|NCT02587598|466639816|FG008|Overall Study|Withdrawal by Subject|0|||
129641074|NCT02587598|466639817|FG009|Overall Study|Withdrawal by Subject|1|||
129641075|NCT02587598|466639818|FG010|Overall Study|Withdrawal by Subject|2|||
129641076|NCT02587598|466639808|FG000|Overall Study|Physician Decision|0|||
129641077|NCT02587598|466639809|FG001|Overall Study|Physician Decision|0|||
129641078|NCT02587598|466639810|FG002|Overall Study|Physician Decision|0|||
129641079|NCT02587598|466639811|FG003|Overall Study|Physician Decision|0|||
129641080|NCT02587598|466639812|FG004|Overall Study|Physician Decision|0|||
129641081|NCT02587598|466639813|FG005|Overall Study|Physician Decision|0|||
129641082|NCT02587598|466639814|FG006|Overall Study|Physician Decision|0|||
129641083|NCT02587598|466639815|FG007|Overall Study|Physician Decision|0|||
129641084|NCT02587598|466639816|FG008|Overall Study|Physician Decision|0|||
129641085|NCT02587598|466639817|FG009|Overall Study|Physician Decision|0|||
129641086|NCT02587598|466639818|FG010|Overall Study|Physician Decision|3|||
129641087|NCT02394340|466639823|FG000|Overall Study|Failed drug screen test|1|||
129641088|NCT02394340|466639823|FG000|Overall Study|Adverse Event|1|||
129641089|NCT02828124|466639824|FG000|Overall Study|Disease Progression|1|||
129641090|NCT02828124|466639825|FG001|Overall Study|Disease Progression|2|||
129641091|NCT02828124|466639826|FG002|Overall Study|Disease Progression|1|||
129641092|NCT02828124|466639827|FG003|Overall Study|Disease Progression|4|||
129641093|NCT02828124|466639824|FG000|Overall Study|AE Unrelated to Study Drug|0|||
129641094|NCT02828124|466639825|FG001|Overall Study|AE Unrelated to Study Drug|0|||
129641095|NCT02828124|466639826|FG002|Overall Study|AE Unrelated to Study Drug|0|||
129641096|NCT02828124|466639827|FG003|Overall Study|AE Unrelated to Study Drug|1|||
129641097|NCT02828124|466639824|FG000|Overall Study|Subject Withdrew Consent|0|||
129641098|NCT02828124|466639825|FG001|Overall Study|Subject Withdrew Consent|0|||
129641099|NCT02828124|466639826|FG002|Overall Study|Subject Withdrew Consent|0|||
129641100|NCT02828124|466639827|FG003|Overall Study|Subject Withdrew Consent|1|||
129641101|NCT00256854|466639828|FG000|Overall Study|Withdrawal by Subject|2|||
129641102|NCT00256854|466639829|FG001|Overall Study|Withdrawal by Subject|3|||
129641103|NCT00256854|466639830|FG002|Overall Study|Withdrawal by Subject|0|||
129641104|NCT00256854|466639831|FG003|Overall Study|Withdrawal by Subject|0|||
129641105|NCT00256854|466639832|FG004|Overall Study|Withdrawal by Subject|0|||
129641106|NCT00256854|466639833|FG005|Overall Study|Withdrawal by Subject|0|||
129641107|NCT00256854|466639828|FG000|Overall Study|Lack of Efficacy|1|||
129641108|NCT00256854|466639829|FG001|Overall Study|Lack of Efficacy|0|||
129641109|NCT00256854|466639830|FG002|Overall Study|Lack of Efficacy|0|||
129641110|NCT00256854|466639831|FG003|Overall Study|Lack of Efficacy|0|||
129641111|NCT00256854|466639832|FG004|Overall Study|Lack of Efficacy|0|||
129641112|NCT00256854|466639833|FG005|Overall Study|Lack of Efficacy|0|||
129641113|NCT00256854|466639828|FG000|Overall Study|Protocol Violation|0|||
129641114|NCT00256854|466639829|FG001|Overall Study|Protocol Violation|1|||
129889697|NCT02325713|467552693|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889698|NCT02325713|467552694|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889699|NCT02325713|467552695|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889700|NCT02325713|467552696|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889701|NCT02325713|467552697|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889702|NCT02325713|467552698|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889703|NCT02325713|467552699|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889704|NCT02325713|467552700|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
129889705|NCT02325713|467552685|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889706|NCT02325713|467552686|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889707|NCT02325713|467552687|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889708|NCT02325713|467552688|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889709|NCT02325713|467552689|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129641115|NCT00256854|466639830|FG002|Overall Study|Protocol Violation|1|||
129641116|NCT00256854|466639831|FG003|Overall Study|Protocol Violation|1|||
129641117|NCT00256854|466639832|FG004|Overall Study|Protocol Violation|0|||
129641118|NCT00256854|466639833|FG005|Overall Study|Protocol Violation|0|||
129641119|NCT00256854|466639828|FG000|Overall Study|Adverse Event|0|||
129641120|NCT00256854|466639829|FG001|Overall Study|Adverse Event|0|||
129641121|NCT00256854|466639830|FG002|Overall Study|Adverse Event|2|||
129641122|NCT00256854|466639831|FG003|Overall Study|Adverse Event|2|||
129641123|NCT00256854|466639832|FG004|Overall Study|Adverse Event|0|||
129641124|NCT00256854|466639833|FG005|Overall Study|Adverse Event|1|||
129641125|NCT00256854|466639828|FG000|Overall Study|Not compliant with the study drug|0|||
129641126|NCT00256854|466639829|FG001|Overall Study|Not compliant with the study drug|0|||
129641127|NCT00256854|466639830|FG002|Overall Study|Not compliant with the study drug|0|||
129641128|NCT00256854|466639831|FG003|Overall Study|Not compliant with the study drug|0|||
129641129|NCT00256854|466639832|FG004|Overall Study|Not compliant with the study drug|1|||
129641130|NCT00256854|466639833|FG005|Overall Study|Not compliant with the study drug|0|||
129641131|NCT02353442|466639834|FG000|Overall Study|Withdrawal by Subject|3|||
129641132|NCT02353442|466639835|FG001|Overall Study|Withdrawal by Subject|4|||
129641133|NCT03514485|466639836|FG000|Overall Study|Lost to Follow-up|5|||
129641134|NCT03514485|466639837|FG001|Overall Study|Lost to Follow-up|3|||
129641135|NCT03514485|466639838|FG002|Overall Study|Lost to Follow-up|2|||
129641136|NCT03514485|466639839|FG003|Overall Study|Lost to Follow-up|0|||
129641137|NCT03514485|466639840|FG004|Overall Study|Lost to Follow-up|1|||
129641138|NCT03514485|466639841|FG005|Overall Study|Lost to Follow-up|4|||
129641139|NCT03514485|466639836|FG000|Overall Study|Withdrawal by Subject|0|||
129641140|NCT03514485|466639837|FG001|Overall Study|Withdrawal by Subject|1|||
129641141|NCT03514485|466639838|FG002|Overall Study|Withdrawal by Subject|3|||
129641142|NCT03514485|466639839|FG003|Overall Study|Withdrawal by Subject|1|||
129641143|NCT03514485|466639840|FG004|Overall Study|Withdrawal by Subject|2|||
129641144|NCT03514485|466639841|FG005|Overall Study|Withdrawal by Subject|1|||
129641145|NCT00791661|466639842|FG000|7 Day Wash-out|Adverse Event|0|||
129641146|NCT00791661|466639843|FG001|7 Day Wash-out|Adverse Event|0|||
129641147|NCT00791661|466639844|FG002|7 Day Wash-out|Adverse Event|1|||
129641148|NCT00791661|466639842|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
129641149|NCT00791661|466639843|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
129641150|NCT00791661|466639844|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
129641151|NCT01355575|466639847|FG000|Overall Study|Withdrawal by Subject|2|||
129641152|NCT02294396|466639848|FG000|Overall Study|Adverse Event|26|||
129641153|NCT02294396|466639849|FG001|Overall Study|Adverse Event|25|||
129641154|NCT02294396|466639850|FG002|Overall Study|Adverse Event|21|||
129641155|NCT02294396|466639851|FG003|Overall Study|Adverse Event|24|||
129641156|NCT02294396|466639848|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
129641157|NCT02294396|466639849|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
129641158|NCT02294396|466639850|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
129641159|NCT02294396|466639851|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
129641160|NCT02294396|466639848|FG000|Overall Study|Withdrawal by Subject|8|||
129641161|NCT02294396|466639849|FG001|Overall Study|Withdrawal by Subject|6|||
129641162|NCT02294396|466639850|FG002|Overall Study|Withdrawal by Subject|6|||
129889710|NCT02325713|467552690|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889711|NCT02325713|467552691|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889712|NCT02325713|467552692|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129641163|NCT02294396|466639851|FG003|Overall Study|Withdrawal by Subject|8|||
129889713|NCT02325713|467552693|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129705484|NCT05239221|466884253|FG010|Overall Study|Adverse Event|1|||
129641164|NCT02294396|466639848|FG000|Overall Study|Lost to Follow-up|0|||
129641165|NCT02294396|466639849|FG001|Overall Study|Lost to Follow-up|0|||
129641166|NCT02294396|466639850|FG002|Overall Study|Lost to Follow-up|1|||
129641167|NCT02294396|466639851|FG003|Overall Study|Lost to Follow-up|1|||
129641168|NCT02294396|466639848|FG000|Overall Study|Protocol Deviation|3|||
129641169|NCT02294396|466639849|FG001|Overall Study|Protocol Deviation|2|||
129641170|NCT02294396|466639850|FG002|Overall Study|Protocol Deviation|2|||
129641171|NCT02294396|466639851|FG003|Overall Study|Protocol Deviation|1|||
129641172|NCT02294396|466639848|FG000|Overall Study|Miscellaneous|2|||
129641173|NCT02294396|466639849|FG001|Overall Study|Miscellaneous|0|||
129641174|NCT02294396|466639850|FG002|Overall Study|Miscellaneous|5|||
129641175|NCT02294396|466639851|FG003|Overall Study|Miscellaneous|2|||
129641176|NCT02120833|466639852|FG000|Overall Study|Adverse Event|1|||
129641177|NCT02120833|466639853|FG001|Overall Study|Adverse Event|0|||
129641178|NCT02120833|466639852|FG000|Overall Study|Withdrawal by Subject|2|||
129641179|NCT02120833|466639853|FG001|Overall Study|Withdrawal by Subject|0|||
129641180|NCT02120833|466639852|FG000|Overall Study|Lost to Follow-up|1|||
129641181|NCT02120833|466639853|FG001|Overall Study|Lost to Follow-up|1|||
129641182|NCT02438826|466639854|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
129641183|NCT02438826|466639855|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
129641184|NCT02438826|466639856|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129641185|NCT02438826|466639857|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129641186|NCT02438826|466639854|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
129641187|NCT02438826|466639855|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129641188|NCT02438826|466639856|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129641189|NCT02438826|466639857|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129641190|NCT02438826|466639854|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
129641191|NCT02438826|466639855|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
129641192|NCT02438826|466639856|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129641193|NCT02438826|466639857|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129641194|NCT02438826|466639854|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
129641195|NCT02438826|466639855|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
129641196|NCT02438826|466639856|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129641197|NCT02438826|466639857|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
129641198|NCT02438826|466639854|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
129641199|NCT02438826|466639855|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
129641200|NCT02438826|466639856|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
129641201|NCT02438826|466639857|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
129641202|NCT02438826|466639854|FG000|Open-Label Treatment Phase|Adverse Event|11|||
129641203|NCT02438826|466639855|FG001|Open-Label Treatment Phase|Adverse Event|6|||
129641204|NCT02438826|466639856|FG002|Open-Label Treatment Phase|Adverse Event|0|||
129641205|NCT02438826|466639857|FG003|Open-Label Treatment Phase|Adverse Event|0|||
129641206|NCT02438826|466639854|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
129641207|NCT02438826|466639855|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
129641208|NCT02438826|466639856|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
129641209|NCT02438826|466639857|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
129641210|NCT02438826|466639854|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
129641211|NCT02438826|466639855|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
129641212|NCT02438826|466639856|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
129641213|NCT02438826|466639857|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
129641214|NCT02438826|466639854|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
129641215|NCT02438826|466639855|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
129641216|NCT02438826|466639856|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
129641217|NCT02438826|466639857|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
129641218|NCT02438826|466639854|FG000|Post-Treatment Phase|Adverse Event|3|||
129641219|NCT02438826|466639855|FG001|Post-Treatment Phase|Adverse Event|0|||
129641220|NCT02438826|466639856|FG002|Post-Treatment Phase|Adverse Event|0|||
129641221|NCT02438826|466639857|FG003|Post-Treatment Phase|Adverse Event|0|||
129641222|NCT02438826|466639854|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
129641223|NCT02438826|466639855|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
129641224|NCT02438826|466639856|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
129641225|NCT02438826|466639857|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
129641226|NCT02438826|466639854|FG000|Post-Treatment Phase|Physician Decision|1|||
129641227|NCT02438826|466639855|FG001|Post-Treatment Phase|Physician Decision|0|||
129641228|NCT02438826|466639856|FG002|Post-Treatment Phase|Physician Decision|0|||
129641229|NCT02438826|466639857|FG003|Post-Treatment Phase|Physician Decision|0|||
129641230|NCT02438826|466639854|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
129641231|NCT02438826|466639855|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
129641232|NCT02438826|466639856|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
129641233|NCT02438826|466639857|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
129641234|NCT04105218|466639863|FG000|Overall Study|Withdrawal by Subject|3|||
129641235|NCT04105218|466639864|FG001|Overall Study|Withdrawal by Subject|2|||
129641236|NCT04105218|466639863|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
129641237|NCT04105218|466639864|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
129641238|NCT04105218|466639863|FG000|Overall Study|Failed screening tests|2|||
129641239|NCT04105218|466639864|FG001|Overall Study|Failed screening tests|1|||
129641240|NCT01435460|466639867|FG000|Overall Study|Adverse Event|2|||
129641241|NCT01435460|466639868|FG001|Overall Study|Adverse Event|1|||
129641242|NCT01435460|466639867|FG000|Overall Study|Lost to Follow-up|6|||
129641243|NCT01435460|466639868|FG001|Overall Study|Lost to Follow-up|1|||
129641244|NCT01435460|466639867|FG000|Overall Study|Withdrawal by Subject|1|||
129641245|NCT01435460|466639868|FG001|Overall Study|Withdrawal by Subject|3|||
129641246|NCT01435460|466639867|FG000|Overall Study|Protocol Violation|0|||
129641247|NCT01435460|466639868|FG001|Overall Study|Protocol Violation|1|||
129641248|NCT01435460|466639867|FG000|Overall Study|Did not meet eligibility criteria|2|||
129641249|NCT01435460|466639868|FG001|Overall Study|Did not meet eligibility criteria|0|||
129641250|NCT01706939|466639869|FG000|Pre Randomization|Screen Failure|1|||
129641251|NCT01706939|466639870|FG001|Pre Randomization|Screen Failure|0|||
129641252|NCT01706939|466639871|FG002|Pre Randomization|Screen Failure|0|||
129641253|NCT01706939|466639869|FG000|Pre Randomization|Ineligible for Randomization|1|||
129641254|NCT01706939|466639870|FG001|Pre Randomization|Ineligible for Randomization|0|||
129641255|NCT01706939|466639871|FG002|Pre Randomization|Ineligible for Randomization|0|||
129641256|NCT01706939|466639869|FG000|Pre Randomization|Withdrawal by Subject|1|||
129641257|NCT01706939|466639870|FG001|Pre Randomization|Withdrawal by Subject|0|||
129641258|NCT01706939|466639871|FG002|Pre Randomization|Withdrawal by Subject|0|||
129641259|NCT01706939|466639869|FG000|Randomization|Insufficient QoL survey compliance|0|||
129641260|NCT01706939|466639870|FG001|Randomization|Insufficient QoL survey compliance|1|||
129641261|NCT01706939|466639871|FG002|Randomization|Insufficient QoL survey compliance|1|||
129641262|NCT01706939|466639869|FG000|Randomization|Progression of disease|0|||
129641263|NCT01706939|466639870|FG001|Randomization|Progression of disease|2|||
129641264|NCT01706939|466639871|FG002|Randomization|Progression of disease|1|||
129641265|NCT01046903|466639873|FG000|Overall Study|Lost to Follow-up|16|||
129641266|NCT01046903|466639873|FG000|Overall Study|Adverse Event|4|||
129641267|NCT01046903|466639873|FG000|Overall Study|Withdrawal by Subject|3|||
129641268|NCT01046903|466639873|FG000|Overall Study|Other|5|||
129641269|NCT04152837|466639885|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
129641270|NCT04152837|466639885|FG000|Maintenance Period|Adverse Event|1|||
129641271|NCT04152837|466639885|FG000|Maintenance Period|Withdrawal by Subject|1|||
129641272|NCT04152837|466639885|FG000|Maintenance Period|Sponsor Termination of Study|2|||
129641273|NCT00101166|466639888|FG000|Overall Study|progressive disease|10|||
129641274|NCT00686829|466639889|FG000|Overall Study|Adverse Event|5|||
129641275|NCT00686829|466639889|FG000|Overall Study|Lack of Efficacy|6|||
129641276|NCT00686829|466639889|FG000|Overall Study|Lost to Follow-up|4|||
129641277|NCT00686829|466639889|FG000|Overall Study|Withdrawal by Subject|14|||
129641278|NCT00686829|466639889|FG000|Overall Study|Protocol Violation|3|||
129641279|NCT00686829|466639889|FG000|Overall Study|Sponsor discontinued VCV|47|||
129641280|NCT01217476|466639892|FG000|Overall Study|Adverse Event|6|||
129641281|NCT01217476|466639893|FG001|Overall Study|Adverse Event|1|||
129641282|NCT01217476|466639892|FG000|Overall Study|Physician Decision|0|||
129641283|NCT01217476|466639893|FG001|Overall Study|Physician Decision|1|||
129641284|NCT01217476|466639892|FG000|Overall Study|Withdrawal by Subject|3|||
129641285|NCT01217476|466639893|FG001|Overall Study|Withdrawal by Subject|3|||
129641286|NCT01217476|466639892|FG000|Overall Study|Surgery on the Target Limb|0|||
129641287|NCT01217476|466639893|FG001|Overall Study|Surgery on the Target Limb|2|||
129641288|NCT01217476|466639892|FG000|Overall Study|Protocol Deviation|1|||
129641289|NCT01217476|466639893|FG001|Overall Study|Protocol Deviation|0|||
129641290|NCT01217476|466639892|FG000|Overall Study|Other|2|||
129641291|NCT01217476|466639893|FG001|Overall Study|Other|0|||
129641292|NCT03033602|466639894|FG000|Overall Study|Withdrawal by Subject|11|||
129641293|NCT03033602|466639895|FG001|Overall Study|Withdrawal by Subject|21|||
129641294|NCT03033602|466639894|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
129641295|NCT03033602|466639895|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
129641296|NCT04445714|466639896|FG000|Overall Study|Discontinuation of the study|14|||
129641297|NCT04445714|466639896|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
129641298|NCT04445714|466639896|FG000|Overall Study|Withdrawal of Informed Consent|8|||
129641299|NCT01672710|466639897|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
129641300|NCT01672710|466639898|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
129889714|NCT02325713|467552694|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
129889715|NCT02325713|467552695|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889716|NCT02325713|467552696|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889717|NCT02325713|467552697|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889718|NCT02325713|467552698|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129889719|NCT02325713|467552699|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129641301|NCT01672710|466639897|FG000|3 Month Follow up|Lost to Follow-up|2|||
129641302|NCT01672710|466639898|FG001|3 Month Follow up|Lost to Follow-up|3|||
129641303|NCT01672710|466639897|FG000|3 Month Follow up|follow up due after termination date|4|||
129641304|NCT01672710|466639898|FG001|3 Month Follow up|follow up due after termination date|1|||
129641305|NCT04999163|466639899|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
129641306|NCT04999163|466639900|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
129705485|NCT05239221|466884254|FG011|Overall Study|Adverse Event|1|||
129641307|NCT04999163|466639899|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
129641308|NCT04999163|466639900|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
129641309|NCT04999163|466639899|FG000|Overall Study|Withdrawal by Subject|1|||
129641310|NCT04999163|466639900|FG001|Overall Study|Withdrawal by Subject|0|||
129641311|NCT01399047|466641802|FG000|Overall Study|Withdrawal by Subject|0|||
129641312|NCT01399047|466641803|FG001|Overall Study|Withdrawal by Subject|1|||
129641313|NCT01283334|466641811|FG000|Overall Study|Withdrawal by Subject|1|||
129641314|NCT01283334|466641811|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
129641315|NCT01283334|466641811|FG000|Overall Study|Adverse Event|4|||
129641316|NCT01283334|466641811|FG000|Overall Study|Physician Decision|1|||
129641317|NCT03467217|466641812|FG000|Overall Study|Trial stopped early|5|||
129641318|NCT03467217|466641813|FG001|Overall Study|Trial stopped early|2|||
129641319|NCT03467217|466641812|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
129641320|NCT03467217|466641813|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
129641321|NCT03467217|466641812|FG000|Overall Study|Lost to Follow-up|0|||
129641322|NCT03467217|466641813|FG001|Overall Study|Lost to Follow-up|2|||
129641323|NCT03233529|466641817|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
129641324|NCT03233529|466641817|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
129641325|NCT01177293|466641818|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
129641326|NCT01177293|466641819|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
129641327|NCT00160706|466641821|FG000|Overall Study|Adverse Event|53|||
129641328|NCT00160706|466641821|FG000|Overall Study|Adverse Event and Other Reason|105|||
129641329|NCT00160706|466641821|FG000|Overall Study|Protocol Violation|3|||
129641330|NCT00160706|466641821|FG000|Overall Study|Withdrawal by Subject|41|||
129641331|NCT00160706|466641821|FG000|Overall Study|Withdrawal by Subject and Other|12|||
129641332|NCT00160706|466641821|FG000|Overall Study|Physician Decision|10|||
129641333|NCT00160706|466641821|FG000|Overall Study|Physician Decision and Other|3|||
129641334|NCT00160706|466641821|FG000|Overall Study|Lost to Follow-up|4|||
129641335|NCT00160706|466641821|FG000|Overall Study|Lost to Follow-up and Other|1|||
129641336|NCT00160706|466641821|FG000|Overall Study|Lack of Efficacy|42|||
129641337|NCT00160706|466641821|FG000|Overall Study|Lack of Efficacy and Other|1|||
129641338|NCT00160706|466641821|FG000|Overall Study|Other Reason|11|||
129641339|NCT03214380|466641822|FG000|Lead-in|Adverse Event|3|||
129641340|NCT03214380|466641823|FG001|Lead-in|Adverse Event|0|||
129641341|NCT03214380|466641824|FG002|Lead-in|Adverse Event|0|||
129641342|NCT03214380|466641825|FG003|Lead-in|Adverse Event|1|||
129641343|NCT03214380|466641826|FG004|Lead-in|Adverse Event|0|||
129641344|NCT03214380|466641827|FG005|Lead-in|Adverse Event|0|||
129641345|NCT03214380|466641822|FG000|Lead-in|Lost to Follow-up|4|||
129641346|NCT03214380|466641823|FG001|Lead-in|Lost to Follow-up|0|||
129641347|NCT03214380|466641824|FG002|Lead-in|Lost to Follow-up|0|||
129641348|NCT03214380|466641825|FG003|Lead-in|Lost to Follow-up|1|||
129641349|NCT03214380|466641826|FG004|Lead-in|Lost to Follow-up|0|||
129641350|NCT03214380|466641827|FG005|Lead-in|Lost to Follow-up|0|||
129641351|NCT03214380|466641822|FG000|Lead-in|Eligibility Criteria|3|||
129641352|NCT03214380|466641823|FG001|Lead-in|Eligibility Criteria|0|||
129641353|NCT03214380|466641824|FG002|Lead-in|Eligibility Criteria|0|||
129641354|NCT03214380|466641825|FG003|Lead-in|Eligibility Criteria|0|||
129641355|NCT03214380|466641826|FG004|Lead-in|Eligibility Criteria|0|||
129641356|NCT03214380|466641827|FG005|Lead-in|Eligibility Criteria|0|||
129641357|NCT03214380|466641822|FG000|Lead-in|Physician Decision|6|||
129641358|NCT03214380|466641823|FG001|Lead-in|Physician Decision|0|||
129641359|NCT03214380|466641824|FG002|Lead-in|Physician Decision|0|||
129641360|NCT03214380|466641825|FG003|Lead-in|Physician Decision|0|||
129641361|NCT03214380|466641826|FG004|Lead-in|Physician Decision|0|||
129641362|NCT03214380|466641827|FG005|Lead-in|Physician Decision|0|||
129798630|NCT04010539|467232115|FG000|Overall Study|Physician Decision|0|||
129798631|NCT04010539|467232116|FG001|Overall Study|Physician Decision|2|||
129798632|NCT04010539|467232115|FG000|Overall Study|Lost to Follow-up|10|||
129798633|NCT04010539|467232116|FG001|Overall Study|Lost to Follow-up|14|||
129641363|NCT03214380|466641822|FG000|Lead-in|Protocol Deviation|7|||
129641364|NCT03214380|466641823|FG001|Lead-in|Protocol Deviation|0|||
129641365|NCT03214380|466641824|FG002|Lead-in|Protocol Deviation|0|||
129641366|NCT03214380|466641825|FG003|Lead-in|Protocol Deviation|3|||
129641367|NCT03214380|466641826|FG004|Lead-in|Protocol Deviation|0|||
129641368|NCT03214380|466641827|FG005|Lead-in|Protocol Deviation|0|||
129641369|NCT03214380|466641822|FG000|Lead-in|Withdrawal by Subject|41|||
129641370|NCT03214380|466641823|FG001|Lead-in|Withdrawal by Subject|0|||
129641371|NCT03214380|466641824|FG002|Lead-in|Withdrawal by Subject|0|||
129641372|NCT03214380|466641825|FG003|Lead-in|Withdrawal by Subject|14|||
129641373|NCT03214380|466641826|FG004|Lead-in|Withdrawal by Subject|0|||
129641374|NCT03214380|466641827|FG005|Lead-in|Withdrawal by Subject|0|||
129641375|NCT03214380|466641822|FG000|Lead-in|Family Emergency|1|||
129641376|NCT03214380|466641823|FG001|Lead-in|Family Emergency|0|||
129641377|NCT03214380|466641824|FG002|Lead-in|Family Emergency|0|||
129641378|NCT03214380|466641825|FG003|Lead-in|Family Emergency|0|||
129641379|NCT03214380|466641826|FG004|Lead-in|Family Emergency|0|||
129641380|NCT03214380|466641827|FG005|Lead-in|Family Emergency|0|||
129641381|NCT03214380|466641822|FG000|Lead-in|Natural Disaster|9|||
129641382|NCT03214380|466641823|FG001|Lead-in|Natural Disaster|0|||
129641383|NCT03214380|466641824|FG002|Lead-in|Natural Disaster|0|||
129641384|NCT03214380|466641825|FG003|Lead-in|Natural Disaster|0|||
129798634|NCT04010539|467232115|FG000|Overall Study|Adverse Event|3|||
129798635|NCT04010539|467232116|FG001|Overall Study|Adverse Event|0|||
129798636|NCT04010539|467232115|FG000|Overall Study|Participant Did Not Receive IP|0|||
129798637|NCT04010539|467232116|FG001|Overall Study|Participant Did Not Receive IP|1|||
129798638|NCT04010539|467232115|FG000|Overall Study|Protocol Deviation|0|||
129641385|NCT03214380|466641826|FG004|Lead-in|Natural Disaster|0|||
129641386|NCT03214380|466641827|FG005|Lead-in|Natural Disaster|0|||
129641387|NCT03214380|466641822|FG000|Lead-in|Non Compliance|1|||
129641388|NCT03214380|466641823|FG001|Lead-in|Non Compliance|0|||
129641389|NCT03214380|466641824|FG002|Lead-in|Non Compliance|0|||
129641390|NCT03214380|466641825|FG003|Lead-in|Non Compliance|0|||
129641391|NCT03214380|466641826|FG004|Lead-in|Non Compliance|0|||
129641392|NCT03214380|466641827|FG005|Lead-in|Non Compliance|0|||
129641393|NCT03214380|466641822|FG000|Lead-in|Participant Schedule|2|||
129641394|NCT03214380|466641823|FG001|Lead-in|Participant Schedule|0|||
129641395|NCT03214380|466641824|FG002|Lead-in|Participant Schedule|0|||
129641396|NCT03214380|466641825|FG003|Lead-in|Participant Schedule|0|||
129641397|NCT03214380|466641826|FG004|Lead-in|Participant Schedule|0|||
129641398|NCT03214380|466641827|FG005|Lead-in|Participant Schedule|0|||
129641399|NCT03214380|466641822|FG000|Treatment Period|Adverse Event|0|||
129641400|NCT03214380|466641823|FG001|Treatment Period|Adverse Event|1|||
129641401|NCT03214380|466641824|FG002|Treatment Period|Adverse Event|1|||
129641402|NCT03214380|466641825|FG003|Treatment Period|Adverse Event|0|||
129641403|NCT03214380|466641826|FG004|Treatment Period|Adverse Event|1|||
129641404|NCT03214380|466641827|FG005|Treatment Period|Adverse Event|0|||
129641405|NCT03214380|466641822|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
129641406|NCT03214380|466641823|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
129641407|NCT03214380|466641824|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
129641408|NCT03214380|466641825|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
129641409|NCT03214380|466641826|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
129641410|NCT03214380|466641827|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
129798639|NCT04010539|467232116|FG001|Overall Study|Protocol Deviation|1|||
129798640|NCT04010539|467232115|FG000|Overall Study|Randomized in Error/ Mistake|2|||
129798641|NCT04010539|467232116|FG001|Overall Study|Randomized in Error/ Mistake|0|||
129798642|NCT04010539|467232115|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
129798643|NCT04010539|467232116|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
129798644|NCT00249288|467232117|FG000|Overall Study|Lost to Follow-up|3|||
129641411|NCT03214380|466641822|FG000|Treatment Period|Withdrawal by Subject|0|||
129641412|NCT03214380|466641823|FG001|Treatment Period|Withdrawal by Subject|10|||
129798645|NCT00249288|467232118|FG001|Overall Study|Lost to Follow-up|3|||
129798646|NCT00249288|467232117|FG000|Overall Study|Withdrawal by Subject|2|||
129798647|NCT00249288|467232118|FG001|Overall Study|Withdrawal by Subject|2|||
129798648|NCT03059446|467232119|FG000|Overall Study|Adverse Event|11|||
129889720|NCT02325713|467552700|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
129641413|NCT03214380|466641824|FG002|Treatment Period|Withdrawal by Subject|8|||
129641414|NCT03214380|466641825|FG003|Treatment Period|Withdrawal by Subject|0|||
129641415|NCT03214380|466641826|FG004|Treatment Period|Withdrawal by Subject|7|||
129798649|NCT03059446|467232119|FG000|Overall Study|Withdrawal of Consent|16|||
129798650|NCT03059446|467232119|FG000|Overall Study|Lost to Follow-up|3|||
129641416|NCT03214380|466641827|FG005|Treatment Period|Withdrawal by Subject|11|||
129641417|NCT03214380|466641822|FG000|Treatment Period|Death|0|||
129641418|NCT03214380|466641823|FG001|Treatment Period|Death|1|||
129641419|NCT03214380|466641824|FG002|Treatment Period|Death|2|||
129641420|NCT03214380|466641825|FG003|Treatment Period|Death|0|||
129641421|NCT03214380|466641826|FG004|Treatment Period|Death|0|||
129641422|NCT03214380|466641827|FG005|Treatment Period|Death|0|||
129641423|NCT03214380|466641822|FG000|Treatment Period|Lost to Follow-up|0|||
129641424|NCT03214380|466641823|FG001|Treatment Period|Lost to Follow-up|6|||
129641425|NCT03214380|466641824|FG002|Treatment Period|Lost to Follow-up|3|||
129641426|NCT03214380|466641825|FG003|Treatment Period|Lost to Follow-up|0|||
129641427|NCT03214380|466641826|FG004|Treatment Period|Lost to Follow-up|0|||
129641428|NCT03214380|466641827|FG005|Treatment Period|Lost to Follow-up|0|||
129641429|NCT03214380|466641822|FG000|Treatment Period|Participant schedule|0|||
129641430|NCT03214380|466641823|FG001|Treatment Period|Participant schedule|0|||
129641431|NCT03214380|466641824|FG002|Treatment Period|Participant schedule|1|||
129641432|NCT03214380|466641825|FG003|Treatment Period|Participant schedule|0|||
129641433|NCT03214380|466641826|FG004|Treatment Period|Participant schedule|0|||
129641434|NCT03214380|466641827|FG005|Treatment Period|Participant schedule|0|||
129641435|NCT03214380|466641822|FG000|Treatment Period|Treatment Interruption|0|||
129641436|NCT03214380|466641823|FG001|Treatment Period|Treatment Interruption|0|||
129641437|NCT03214380|466641824|FG002|Treatment Period|Treatment Interruption|1|||
129641438|NCT03214380|466641825|FG003|Treatment Period|Treatment Interruption|0|||
129641439|NCT03214380|466641826|FG004|Treatment Period|Treatment Interruption|0|||
129641440|NCT03214380|466641827|FG005|Treatment Period|Treatment Interruption|0|||
129641441|NCT01905553|466641834|FG000|Period 2|Adverse Event|1|||
129641442|NCT01905553|466641835|FG001|Period 2|Adverse Event|0|||
129641443|NCT00076752|466641841|FG000|Overall Study|Death|2|||
129641444|NCT00076752|466641841|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
129641445|NCT01014988|466641849|FG000|Overall Study|Adverse Event|20|||
129641446|NCT01014988|466641850|FG001|Overall Study|Adverse Event|0|||
129641447|NCT01014988|466641851|FG002|Overall Study|Adverse Event|1|||
129641448|NCT01014988|466641852|FG003|Overall Study|Adverse Event|0|||
129641449|NCT01014988|466641853|FG004|Overall Study|Adverse Event|1|||
129641450|NCT01014988|466641854|FG005|Overall Study|Adverse Event|3|||
129641451|NCT01014988|466641849|FG000|Overall Study|Lost to Follow-up|1|||
129641452|NCT01014988|466641850|FG001|Overall Study|Lost to Follow-up|0|||
129641453|NCT01014988|466641851|FG002|Overall Study|Lost to Follow-up|1|||
129641454|NCT01014988|466641852|FG003|Overall Study|Lost to Follow-up|0|||
129641455|NCT01014988|466641853|FG004|Overall Study|Lost to Follow-up|0|||
129641456|NCT01014988|466641854|FG005|Overall Study|Lost to Follow-up|0|||
129641457|NCT01014988|466641849|FG000|Overall Study|Physician Decision|1|||
129641458|NCT01014988|466641850|FG001|Overall Study|Physician Decision|0|||
129641459|NCT01014988|466641851|FG002|Overall Study|Physician Decision|0|||
129641460|NCT01014988|466641852|FG003|Overall Study|Physician Decision|0|||
129641461|NCT01014988|466641853|FG004|Overall Study|Physician Decision|0|||
129641462|NCT01014988|466641854|FG005|Overall Study|Physician Decision|0|||
129641463|NCT01014988|466641849|FG000|Overall Study|Withdrawal by Subject|1|||
129641464|NCT01014988|466641850|FG001|Overall Study|Withdrawal by Subject|0|||
129641465|NCT01014988|466641851|FG002|Overall Study|Withdrawal by Subject|0|||
129641466|NCT01014988|466641852|FG003|Overall Study|Withdrawal by Subject|0|||
129641467|NCT01014988|466641853|FG004|Overall Study|Withdrawal by Subject|0|||
129641468|NCT01014988|466641854|FG005|Overall Study|Withdrawal by Subject|0|||
129641469|NCT01683266|466641855|FG000|Overall Study|Adverse Event|5|||
129641470|NCT01683266|466641856|FG001|Overall Study|Adverse Event|4|||
129641471|NCT01683266|466641855|FG000|Overall Study|Lack of Efficacy|5|||
129641472|NCT01683266|466641856|FG001|Overall Study|Lack of Efficacy|2|||
129641473|NCT01683266|466641855|FG000|Overall Study|Protocol Violation|13|||
129641474|NCT01683266|466641856|FG001|Overall Study|Protocol Violation|6|||
129641475|NCT01683266|466641855|FG000|Overall Study|Personal Reason|17|||
129641476|NCT01683266|466641856|FG001|Overall Study|Personal Reason|25|||
129641477|NCT01683266|466641855|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
129641478|NCT01683266|466641856|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
129641479|NCT01683266|466641855|FG000|Overall Study|Lost to Follow-up|5|||
129641480|NCT01683266|466641856|FG001|Overall Study|Lost to Follow-up|0|||
129641481|NCT01683266|466641855|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
129641482|NCT01683266|466641856|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
129641483|NCT01683266|466641855|FG000|Overall Study|Nonserious Hypoglycemia|0|||
129641484|NCT01683266|466641856|FG001|Overall Study|Nonserious Hypoglycemia|3|||
129641485|NCT01683266|466641855|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129641486|NCT01683266|466641856|FG001|Overall Study|Perceived Lack of Efficacy|1|||
129641487|NCT01683266|466641855|FG000|Overall Study|Possibly Hypoglycemia|1|||
129641488|NCT01683266|466641856|FG001|Overall Study|Possibly Hypoglycemia|0|||
129641489|NCT01683266|466641855|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
129641490|NCT01683266|466641856|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
129798651|NCT03059446|467232119|FG000|Overall Study|Protocol Violation|1|||
129798652|NCT03059446|467232119|FG000|Overall Study|Study Terminated by Sponsor|131|||
129798653|NCT03059446|467232119|FG000|Overall Study|Reason not Specified|5|||
129798654|NCT02273739|467232120|FG000|Overall Study|Progression of Disease|3|||
129641491|NCT05217641|466641859|FG000|Overall Study|Lost to Follow-up|1|||
129641492|NCT05217641|466641860|FG001|Overall Study|Lost to Follow-up|1|||
129641493|NCT05217641|466641861|FG002|Overall Study|Lost to Follow-up|0|||
129641494|NCT05217641|466641862|FG003|Overall Study|Lost to Follow-up|1|||
129641495|NCT05217641|466641863|FG004|Overall Study|Lost to Follow-up|1|||
129641496|NCT05217641|466641864|FG005|Overall Study|Lost to Follow-up|0|||
129641497|NCT05217641|466641859|FG000|Overall Study|Withdrawal by Subject|0|||
129641498|NCT05217641|466641860|FG001|Overall Study|Withdrawal by Subject|0|||
129641499|NCT05217641|466641861|FG002|Overall Study|Withdrawal by Subject|0|||
129641500|NCT05217641|466641862|FG003|Overall Study|Withdrawal by Subject|3|||
129641501|NCT05217641|466641863|FG004|Overall Study|Withdrawal by Subject|1|||
129641502|NCT05217641|466641864|FG005|Overall Study|Withdrawal by Subject|0|||
129641503|NCT05217641|466641859|FG000|Overall Study|Other: participant did not specify reason|0|||
129641504|NCT05217641|466641860|FG001|Overall Study|Other: participant did not specify reason|0|||
129641505|NCT05217641|466641861|FG002|Overall Study|Other: participant did not specify reason|0|||
129641506|NCT05217641|466641862|FG003|Overall Study|Other: participant did not specify reason|0|||
129641507|NCT05217641|466641863|FG004|Overall Study|Other: participant did not specify reason|1|||
129641508|NCT05217641|466641864|FG005|Overall Study|Other: participant did not specify reason|0|||
129641509|NCT05217641|466641859|FG000|Overall Study|Extended Follow up|1|||
129641510|NCT05217641|466641860|FG001|Overall Study|Extended Follow up|1|||
129641511|NCT05217641|466641861|FG002|Overall Study|Extended Follow up|0|||
129641512|NCT05217641|466641862|FG003|Overall Study|Extended Follow up|0|||
129641513|NCT05217641|466641863|FG004|Overall Study|Extended Follow up|1|||
129641514|NCT05217641|466641864|FG005|Overall Study|Extended Follow up|0|||
129641515|NCT00626821|466641869|FG000|Overall Study|Adverse Event|44|||
129641516|NCT00626821|466641869|FG000|Overall Study|Protocol Violation|33|||
129641517|NCT00626821|466641869|FG000|Overall Study|Withdrawal by Subject|10|||
129641518|NCT00626821|466641869|FG000|Overall Study|Physician Decision|9|||
129641519|NCT00626821|466641869|FG000|Overall Study|Product dysfunction|21|||
129641520|NCT00626821|466641869|FG000|Overall Study|other/unknown reason|104|||
129798655|NCT02273739|467232121|FG001|Overall Study|Progression of Disease|4|||
129798656|NCT02273739|467232122|FG002|Overall Study|Progression of Disease|5|||
129798657|NCT02273739|467232123|FG003|Overall Study|Progression of Disease|2|||
129798658|NCT02273739|467232120|FG000|Overall Study|Death|0|||
129798659|NCT02273739|467232121|FG001|Overall Study|Death|0|||
129798660|NCT02273739|467232122|FG002|Overall Study|Death|0|||
129798661|NCT02273739|467232123|FG003|Overall Study|Death|2|||
129798662|NCT02273739|467232120|FG000|Overall Study|Adverse Event|0|||
129798663|NCT02273739|467232121|FG001|Overall Study|Adverse Event|0|||
129798664|NCT02273739|467232122|FG002|Overall Study|Adverse Event|0|||
129798665|NCT02273739|467232123|FG003|Overall Study|Adverse Event|1|||
129798666|NCT02273739|467232120|FG000|Overall Study|Withdrawal by Subject|0|||
129798667|NCT02273739|467232121|FG001|Overall Study|Withdrawal by Subject|0|||
129798668|NCT02273739|467232122|FG002|Overall Study|Withdrawal by Subject|2|||
129798669|NCT02273739|467232123|FG003|Overall Study|Withdrawal by Subject|1|||
129798670|NCT02273739|467232120|FG000|Overall Study|Physician Decision|0|||
129798671|NCT02273739|467232121|FG001|Overall Study|Physician Decision|0|||
129798672|NCT02273739|467232122|FG002|Overall Study|Physician Decision|0|||
129798673|NCT02273739|467232123|FG003|Overall Study|Physician Decision|1|||
129798674|NCT04795622|467232124|FG000|Overall Study|Adverse Event|1|||
129798675|NCT04795622|467232125|FG001|Overall Study|Adverse Event|0|||
129798676|NCT04795622|467232124|FG000|Overall Study|Withdrawal by Subject|3|||
129798677|NCT04795622|467232125|FG001|Overall Study|Withdrawal by Subject|3|||
129798678|NCT04795622|467232124|FG000|Overall Study|Protocol Violation|0|||
129798679|NCT04795622|467232125|FG001|Overall Study|Protocol Violation|2|||
129798680|NCT04795622|467232124|FG000|Overall Study|Lost to Follow-up|2|||
129798681|NCT04795622|467232125|FG001|Overall Study|Lost to Follow-up|3|||
129798682|NCT04795622|467232124|FG000|Overall Study|Other|7|||
129798683|NCT04795622|467232125|FG001|Overall Study|Other|8|||
129798684|NCT02536833|467232129|FG000|Overall Study|Discontinued Before Treatment|0|||
129798685|NCT02536833|467232130|FG001|Overall Study|Discontinued Before Treatment|0|||
129798686|NCT02536833|467232131|FG002|Overall Study|Discontinued Before Treatment|1|||
129798687|NCT02536833|467232132|FG003|Overall Study|Discontinued Before Treatment|2|||
129798688|NCT02536833|467232129|FG000|Overall Study|Adverse Event|1|||
129798689|NCT02536833|467232130|FG001|Overall Study|Adverse Event|3|||
129798690|NCT02536833|467232131|FG002|Overall Study|Adverse Event|4|||
129798691|NCT02536833|467232132|FG003|Overall Study|Adverse Event|1|||
129798692|NCT02536833|467232129|FG000|Overall Study|Lost to Follow-up|2|||
129798693|NCT02536833|467232130|FG001|Overall Study|Lost to Follow-up|1|||
129798694|NCT02536833|467232131|FG002|Overall Study|Lost to Follow-up|2|||
129798695|NCT02536833|467232132|FG003|Overall Study|Lost to Follow-up|2|||
129798696|NCT02536833|467232129|FG000|Overall Study|Physician Decision|0|||
129798697|NCT02536833|467232130|FG001|Overall Study|Physician Decision|0|||
129798698|NCT02536833|467232131|FG002|Overall Study|Physician Decision|0|||
129798699|NCT02536833|467232132|FG003|Overall Study|Physician Decision|1|||
129798700|NCT02536833|467232129|FG000|Overall Study|Site Terminated by Sponsor|2|||
129798701|NCT02536833|467232130|FG001|Overall Study|Site Terminated by Sponsor|2|||
129798702|NCT02536833|467232131|FG002|Overall Study|Site Terminated by Sponsor|2|||
129798703|NCT02536833|467232132|FG003|Overall Study|Site Terminated by Sponsor|2|||
129641521|NCT01867710|466641873|FG000|Overall Study|Death|25|||
129798704|NCT02536833|467232129|FG000|Overall Study|Subject Non-Compliance|0|||
129798705|NCT02536833|467232130|FG001|Overall Study|Subject Non-Compliance|1|||
129798706|NCT02536833|467232131|FG002|Overall Study|Subject Non-Compliance|1|||
129798707|NCT02536833|467232132|FG003|Overall Study|Subject Non-Compliance|0|||
129798708|NCT02536833|467232129|FG000|Overall Study|Withdrawal by Subject|4|||
129641522|NCT01867710|466641874|FG001|Overall Study|Death|15|||
129641523|NCT01867710|466641875|FG002|Overall Study|Death|27|||
129641524|NCT01867710|466641876|FG003|Overall Study|Death|20|||
129641525|NCT01867710|466641873|FG000|Overall Study|Lost to Follow-up|3|||
129641526|NCT01867710|466641874|FG001|Overall Study|Lost to Follow-up|4|||
129641527|NCT01867710|466641875|FG002|Overall Study|Lost to Follow-up|3|||
129641528|NCT01867710|466641876|FG003|Overall Study|Lost to Follow-up|2|||
129641529|NCT01867710|466641873|FG000|Overall Study|Withdrawal of consent|2|||
129641530|NCT01867710|466641874|FG001|Overall Study|Withdrawal of consent|5|||
129641531|NCT01867710|466641875|FG002|Overall Study|Withdrawal of consent|1|||
129641532|NCT01867710|466641876|FG003|Overall Study|Withdrawal of consent|2|||
129641533|NCT01867710|466641873|FG000|Overall Study|Study Terminated by Sponsor|9|||
129641534|NCT01867710|466641874|FG001|Overall Study|Study Terminated by Sponsor|13|||
129641535|NCT01867710|466641875|FG002|Overall Study|Study Terminated by Sponsor|8|||
129641536|NCT01867710|466641876|FG003|Overall Study|Study Terminated by Sponsor|16|||
129641537|NCT01867710|466641873|FG000|Overall Study|Biochemical progression|0|||
129641538|NCT01867710|466641874|FG001|Overall Study|Biochemical progression|1|||
129641539|NCT01867710|466641875|FG002|Overall Study|Biochemical progression|0|||
129641540|NCT01867710|466641876|FG003|Overall Study|Biochemical progression|0|||
129641541|NCT01867710|466641873|FG000|Overall Study|Clinical progression|0|||
129641542|NCT01867710|466641874|FG001|Overall Study|Clinical progression|0|||
129641543|NCT01867710|466641875|FG002|Overall Study|Clinical progression|1|||
129641544|NCT01867710|466641876|FG003|Overall Study|Clinical progression|0|||
129641545|NCT01867710|466641873|FG000|Overall Study|Disease progression|1|||
129641546|NCT01867710|466641874|FG001|Overall Study|Disease progression|0|||
129641547|NCT01867710|466641875|FG002|Overall Study|Disease progression|0|||
129641548|NCT01867710|466641876|FG003|Overall Study|Disease progression|0|||
129641549|NCT01867710|466641873|FG000|Overall Study|Patient decision|0|||
129641550|NCT01867710|466641874|FG001|Overall Study|Patient decision|0|||
129641551|NCT01867710|466641875|FG002|Overall Study|Patient decision|0|||
129641552|NCT01867710|466641876|FG003|Overall Study|Patient decision|1|||
129641553|NCT01867710|466641873|FG000|Overall Study|Patient to follow subsequent treatment|0|||
129641554|NCT01867710|466641874|FG001|Overall Study|Patient to follow subsequent treatment|1|||
129641555|NCT01867710|466641875|FG002|Overall Study|Patient to follow subsequent treatment|0|||
129641556|NCT01867710|466641876|FG003|Overall Study|Patient to follow subsequent treatment|0|||
129641557|NCT01867710|466641873|FG000|Overall Study|Progressive disease|1|||
129641558|NCT01867710|466641874|FG001|Overall Study|Progressive disease|0|||
129641559|NCT01867710|466641875|FG002|Overall Study|Progressive disease|0|||
129641560|NCT01867710|466641876|FG003|Overall Study|Progressive disease|0|||
129641561|NCT01867710|466641873|FG000|Overall Study|Protocol Violation|0|||
129641562|NCT01867710|466641874|FG001|Overall Study|Protocol Violation|0|||
129641563|NCT01867710|466641875|FG002|Overall Study|Protocol Violation|0|||
129641564|NCT01867710|466641876|FG003|Overall Study|Protocol Violation|1|||
129641565|NCT01867710|466641873|FG000|Overall Study|PSA-progression|0|||
129641566|NCT01867710|466641874|FG001|Overall Study|PSA-progression|1|||
129641567|NCT01867710|466641875|FG002|Overall Study|PSA-progression|0|||
129641568|NCT01867710|466641876|FG003|Overall Study|PSA-progression|0|||
129641569|NCT01867710|466641873|FG000|Overall Study|Study medication no longer effective|0|||
129641570|NCT01867710|466641874|FG001|Overall Study|Study medication no longer effective|1|||
129641571|NCT01867710|466641875|FG002|Overall Study|Study medication no longer effective|0|||
129641572|NCT01867710|466641876|FG003|Overall Study|Study medication no longer effective|0|||
129641573|NCT01062113|466641877|FG000|Overall Study|Adverse Event|1|||
129641574|NCT01062113|466641878|FG001|Overall Study|Adverse Event|0|||
129641575|NCT01062113|466641879|FG002|Overall Study|Adverse Event|0|||
129641576|NCT01062113|466641877|FG000|Overall Study|Lack of Efficacy|38|||
129641577|NCT01062113|466641878|FG001|Overall Study|Lack of Efficacy|22|||
129641578|NCT01062113|466641879|FG002|Overall Study|Lack of Efficacy|31|||
129641579|NCT01062113|466641877|FG000|Overall Study|Withdrawal by Subject|1|||
129798709|NCT02536833|467232130|FG001|Overall Study|Withdrawal by Subject|3|||
129798710|NCT02536833|467232131|FG002|Overall Study|Withdrawal by Subject|5|||
129798711|NCT02536833|467232132|FG003|Overall Study|Withdrawal by Subject|11|||
129798712|NCT03309046|467232133|FG000|Overall Study|Withdrawal by Subject|4|||
129798713|NCT03309046|467232134|FG001|Overall Study|Withdrawal by Subject|17|||
129641580|NCT01062113|466641878|FG001|Overall Study|Withdrawal by Subject|0|||
129641581|NCT01062113|466641879|FG002|Overall Study|Withdrawal by Subject|0|||
129641582|NCT01471340|466641880|FG000|Overall Study|Death|5|||
129641583|NCT01471340|466641881|FG001|Overall Study|Death|4|||
129641584|NCT01471340|466641880|FG000|Overall Study|Lost to Follow-up|0|||
129641585|NCT01471340|466641881|FG001|Overall Study|Lost to Follow-up|1|||
129641586|NCT01471340|466641880|FG000|Overall Study|Investigational site closure|0|||
129641587|NCT01471340|466641881|FG001|Overall Study|Investigational site closure|1|||
129641588|NCT01471340|466641880|FG000|Overall Study|Invalid informed consent|1|||
129641589|NCT01471340|466641881|FG001|Overall Study|Invalid informed consent|0|||
129889721|NCT02684903|467552701|FG000|Overall Study|COVID-19 shutdown of lab|4|||
129889722|NCT02684903|467552702|FG001|Overall Study|COVID-19 shutdown of lab|6|||
129889723|NCT02684903|467552701|FG000|Overall Study|Lost to Follow-up|31|||
129889724|NCT02684903|467552702|FG001|Overall Study|Lost to Follow-up|41|||
129889725|NCT00322868|467554472|FG000|Overall Study|disease progression|1|||
129889726|NCT02176928|467554473|FG000|Overall Study|Lost to Follow-up|2|||
129889727|NCT02176928|467554474|FG001|Overall Study|Lost to Follow-up|4|||
129889728|NCT01440049|467554478|FG000|Overall Study|Adverse Event|5|||
129889729|NCT03415022|467554480|FG000|Overall Study|Withdrawal by Subject|1|||
129889730|NCT03415022|467554481|FG001|Overall Study|Withdrawal by Subject|2|||
129889731|NCT03415022|467554480|FG000|Overall Study|COVID-19 Suspension|2|||
129889732|NCT03415022|467554481|FG001|Overall Study|COVID-19 Suspension|3|||
129889733|NCT03415022|467554480|FG000|Overall Study|Lost to Follow-up|2|||
129889734|NCT03415022|467554481|FG001|Overall Study|Lost to Follow-up|0|||
129889735|NCT04466618|467554482|FG000|Overall Study|Withdrawal by Subject|0|||
129889736|NCT04466618|467554483|FG001|Overall Study|Withdrawal by Subject|1|||
129889737|NCT00884286|467554488|FG000|Overall Study|Progressive disease|21|||
129889738|NCT00884286|467554489|FG001|Overall Study|Progressive disease|28|||
129889739|NCT00884286|467554488|FG000|Overall Study|Toxicity|4|||
129889740|NCT00884286|467554489|FG001|Overall Study|Toxicity|1|||
129889741|NCT00884286|467554488|FG000|Overall Study|Death|2|||
129889742|NCT00884286|467554489|FG001|Overall Study|Death|2|||
129889743|NCT00884286|467554488|FG000|Overall Study|Physician Decision|1|||
129889744|NCT00884286|467554489|FG001|Overall Study|Physician Decision|0|||
129889745|NCT00884286|467554488|FG000|Overall Study|Septic shock|1|||
129889746|NCT00884286|467554489|FG001|Overall Study|Septic shock|0|||
129889747|NCT00884286|467554488|FG000|Overall Study|Thrombus in right auricle|1|||
129798714|NCT02764190|467232136|FG000|Overall Study|Lost to Follow-up|17|||
129798715|NCT02764190|467232137|FG001|Overall Study|Lost to Follow-up|13|||
129798716|NCT00089674|467232138|FG000|Overall Study|Physician Decision|4|||
129798717|NCT00089674|467232139|FG001|Overall Study|Physician Decision|2|||
129798718|NCT00089674|467232138|FG000|Overall Study|Adverse Event|23|||
129798719|NCT00089674|467232139|FG001|Overall Study|Adverse Event|29|||
129798720|NCT00089674|467232138|FG000|Overall Study|Withdrawal by Subject|143|||
129798721|NCT00089674|467232139|FG001|Overall Study|Withdrawal by Subject|127|||
129798722|NCT00089674|467232138|FG000|Overall Study|Death|43|||
129798723|NCT00089674|467232139|FG001|Overall Study|Death|43|||
129889748|NCT00884286|467554489|FG001|Overall Study|Thrombus in right auricle|0|||
129889749|NCT00884286|467554488|FG000|Overall Study|Not treated|2|||
129889750|NCT00884286|467554489|FG001|Overall Study|Not treated|1|||
129889751|NCT00884286|467554488|FG000|Overall Study|Comprised lung carcinoma|0|||
129889752|NCT00884286|467554489|FG001|Overall Study|Comprised lung carcinoma|1|||
129889753|NCT01720797|467554490|FG000|Overall Study|Withdrawal by Subject|3|||
129889754|NCT01720797|467554491|FG001|Overall Study|Withdrawal by Subject|0|||
129889755|NCT00661258|467554504|FG000|Overall Study|Death|1|||
129889756|NCT00661258|467554505|FG001|Overall Study|Death|0|||
129889757|NCT00661258|467554504|FG000|Overall Study|caught by police and in detox center|2|||
129889758|NCT00661258|467554505|FG001|Overall Study|caught by police and in detox center|1|||
129889759|NCT01628874|467554506|FG000|Overall Study|Physician Decision|1|||
129889760|NCT01628874|467554507|FG001|Overall Study|Physician Decision|1|||
129889761|NCT01628874|467554506|FG000|Overall Study|Age >4 months|4|||
129889762|NCT01628874|467554507|FG001|Overall Study|Age >4 months|2|||
129889763|NCT03541642|467554508|FG000|Overall Study|Withdrawal by Subject|1|||
129889764|NCT03541642|467554509|FG001|Overall Study|Withdrawal by Subject|2|||
129443515|NCT01990534|465924398|FG000|Overall Study|Withdrawal of Informed Consent|2|||
129641590|NCT00526669|466641884|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
129641591|NCT00526669|466641885|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
129641592|NCT00526669|466641884|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
129641593|NCT00526669|466641885|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
129798724|NCT00089674|467232138|FG000|Overall Study|Disease progression|21|||
129443516|NCT01990534|465924398|FG000|Overall Study|Symptomatic Deterioration|1|||
129641594|NCT00526669|466641884|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
129641595|NCT00526669|466641885|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
129641596|NCT00526669|466641884|FG000|Combined Treatment Phase|Death|0|||
129641597|NCT00526669|466641885|FG001|Combined Treatment Phase|Death|2|||
129798725|NCT00089674|467232139|FG001|Overall Study|Disease progression|23|||
129889765|NCT03541642|467554508|FG000|Overall Study|Lost to Follow-up|16|||
129889766|NCT03541642|467554509|FG001|Overall Study|Lost to Follow-up|12|||
129889767|NCT03541642|467554508|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
129889768|NCT03541642|467554509|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
129889769|NCT01083160|467554514|FG000|Overall Study|Adverse Event|1|||
129889770|NCT00918749|467554517|FG000|Overall Study|Adverse Event|1|||
129889771|NCT00918749|467554518|FG001|Overall Study|Adverse Event|0|||
129798726|NCT00089674|467232138|FG000|Overall Study|Ineligibility determined|8|||
129798727|NCT00089674|467232139|FG001|Overall Study|Ineligibility determined|10|||
129889772|NCT00918749|467554519|FG002|Overall Study|Adverse Event|1|||
129889773|NCT00918749|467554517|FG000|Overall Study|Lost to Follow-up|0|||
129889774|NCT00918749|467554518|FG001|Overall Study|Lost to Follow-up|0|||
129641598|NCT03499899|466641886|FG000|Overall Study|Adverse Event|2|||
129641599|NCT03499899|466641887|FG001|Overall Study|Adverse Event|3|||
129641600|NCT03499899|466641888|FG002|Overall Study|Adverse Event|3|||
129641601|NCT03499899|466641886|FG000|Overall Study|Death|0|||
129641602|NCT03499899|466641887|FG001|Overall Study|Death|0|||
129641603|NCT03499899|466641888|FG002|Overall Study|Death|1|||
129641604|NCT03499899|466641886|FG000|Overall Study|Physician Decision|3|||
129641605|NCT03499899|466641887|FG001|Overall Study|Physician Decision|6|||
129641606|NCT03499899|466641888|FG002|Overall Study|Physician Decision|6|||
129641607|NCT03499899|466641886|FG000|Overall Study|Progressive disease|15|||
129641608|NCT03499899|466641887|FG001|Overall Study|Progressive disease|23|||
129641609|NCT03499899|466641888|FG002|Overall Study|Progressive disease|23|||
129641610|NCT03499899|466641886|FG000|Overall Study|Patient decision|0|||
129641611|NCT03499899|466641887|FG001|Overall Study|Patient decision|1|||
129641612|NCT03499899|466641888|FG002|Overall Study|Patient decision|1|||
129641613|NCT03499899|466641886|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
129641614|NCT03499899|466641887|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
129641615|NCT03499899|466641888|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
129641616|NCT01082211|466641890|FG000|Overall Study|Protocol Violation|4|||
129641617|NCT01082211|466641890|FG000|Overall Study|No protocol treatment received|3|||
129641618|NCT04016779|466641903|FG000|Overall Study|Adverse Event|9|||
129641619|NCT04016779|466641904|FG001|Overall Study|Adverse Event|17|||
129641620|NCT04016779|466641903|FG000|Overall Study|Lack of Efficacy|4|||
129641621|NCT04016779|466641904|FG001|Overall Study|Lack of Efficacy|1|||
129641622|NCT04016779|466641903|FG000|Overall Study|Lost to Follow-up|5|||
129641623|NCT04016779|466641904|FG001|Overall Study|Lost to Follow-up|14|||
129641624|NCT04016779|466641903|FG000|Overall Study|Physician Decision|1|||
129641625|NCT04016779|466641904|FG001|Overall Study|Physician Decision|3|||
129641626|NCT04016779|466641903|FG000|Overall Study|Withdrawal by Subject|6|||
129641627|NCT04016779|466641904|FG001|Overall Study|Withdrawal by Subject|8|||
129641628|NCT04016779|466641903|FG000|Overall Study|Non-compliance with Study Drug|2|||
129641629|NCT04016779|466641904|FG001|Overall Study|Non-compliance with Study Drug|3|||
129641630|NCT04016779|466641903|FG000|Overall Study|Other, Multiple categories|17|||
129641631|NCT04016779|466641904|FG001|Overall Study|Other, Multiple categories|17|||
129641632|NCT02295020|466641905|FG000|Overall Study|Adverse Event|0|||
129641633|NCT02295020|466641906|FG001|Overall Study|Adverse Event|1|||
129641634|NCT02295020|466641905|FG000|Overall Study|Withdrawal by Subject|3|||
129641635|NCT02295020|466641906|FG001|Overall Study|Withdrawal by Subject|2|||
129641636|NCT06586788|466641908|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
129641637|NCT01053962|466641910|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
129641638|NCT01053962|466641911|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
129641639|NCT01053962|466641912|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
129641640|NCT01053962|466641913|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
129641641|NCT01053962|466641914|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
129641642|NCT01053962|466641910|FG000|Pretreatment Period|Venipuncture Failure|0|||
129641643|NCT01053962|466641911|FG001|Pretreatment Period|Venipuncture Failure|0|||
129641644|NCT01053962|466641912|FG002|Pretreatment Period|Venipuncture Failure|1|||
129641645|NCT01053962|466641913|FG003|Pretreatment Period|Venipuncture Failure|0|||
129641646|NCT01053962|466641914|FG004|Pretreatment Period|Venipuncture Failure|0|||
129641647|NCT01053962|466641910|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129641648|NCT01053962|466641911|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
129641649|NCT01053962|466641912|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129641650|NCT01053962|466641913|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129641651|NCT01053962|466641914|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
129641652|NCT01053962|466641910|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129641653|NCT01053962|466641911|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129641654|NCT01053962|466641912|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129641655|NCT01053962|466641913|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
129641656|NCT01053962|466641914|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
129641657|NCT01053962|466641910|FG000|Treatment Period|Lack of Efficacy|0|||
129641658|NCT01053962|466641911|FG001|Treatment Period|Lack of Efficacy|0|||
129641659|NCT01053962|466641912|FG002|Treatment Period|Lack of Efficacy|0|||
129641660|NCT01053962|466641913|FG003|Treatment Period|Lack of Efficacy|0|||
129641661|NCT01053962|466641914|FG004|Treatment Period|Lack of Efficacy|1|||
129641662|NCT01053962|466641910|FG000|Treatment Period|Adverse Event|0|||
129641663|NCT01053962|466641911|FG001|Treatment Period|Adverse Event|0|||
129641664|NCT01053962|466641912|FG002|Treatment Period|Adverse Event|0|||
129641665|NCT01053962|466641913|FG003|Treatment Period|Adverse Event|0|||
129641666|NCT01053962|466641914|FG004|Treatment Period|Adverse Event|1|||
129641667|NCT01053962|466641910|FG000|Treatment Period|Withdrawal by Subject|0|||
129641668|NCT01053962|466641911|FG001|Treatment Period|Withdrawal by Subject|0|||
129641669|NCT01053962|466641912|FG002|Treatment Period|Withdrawal by Subject|0|||
129641670|NCT01053962|466641913|FG003|Treatment Period|Withdrawal by Subject|0|||
129641671|NCT01053962|466641914|FG004|Treatment Period|Withdrawal by Subject|1|||
129641672|NCT01053962|466641910|FG000|Treatment Period|Noncompliance with protocol|1|||
129641673|NCT01053962|466641911|FG001|Treatment Period|Noncompliance with protocol|0|||
129641674|NCT01053962|466641912|FG002|Treatment Period|Noncompliance with protocol|0|||
129641675|NCT01053962|466641913|FG003|Treatment Period|Noncompliance with protocol|0|||
129641676|NCT01053962|466641914|FG004|Treatment Period|Noncompliance with protocol|0|||
129641677|NCT00679289|466641915|FG000|Overall Study|Progressive disease|4|||
129641678|NCT00679289|466641916|FG001|Overall Study|Progressive disease|5|||
129641679|NCT00679289|466641917|FG002|Overall Study|Progressive disease|18|||
129641680|NCT00679289|466641915|FG000|Overall Study|Withdrawal by Subject|0|||
129641681|NCT00679289|466641916|FG001|Overall Study|Withdrawal by Subject|1|||
129641682|NCT00679289|466641917|FG002|Overall Study|Withdrawal by Subject|1|||
129641683|NCT00679289|466641915|FG000|Overall Study|Adverse Event|0|||
129641684|NCT00679289|466641916|FG001|Overall Study|Adverse Event|0|||
129641685|NCT00679289|466641917|FG002|Overall Study|Adverse Event|3|||
129641686|NCT00679289|466641915|FG000|Overall Study|Physician Decision|1|||
129641687|NCT00679289|466641916|FG001|Overall Study|Physician Decision|0|||
129641688|NCT00679289|466641917|FG002|Overall Study|Physician Decision|1|||
129641689|NCT00937040|466641918|FG000|Overall Study|Adverse Event|5|||
129641690|NCT00937040|466641919|FG001|Overall Study|Adverse Event|8|||
129641691|NCT00937040|466641918|FG000|Overall Study|Lost to Follow-up|12|||
129641692|NCT00937040|466641919|FG001|Overall Study|Lost to Follow-up|12|||
129641693|NCT00937040|466641918|FG000|Overall Study|Protocol Violation|3|||
129641694|NCT00937040|466641919|FG001|Overall Study|Protocol Violation|0|||
129641695|NCT00937040|466641918|FG000|Overall Study|Withdrawal by Subject|13|||
129641696|NCT00937040|466641919|FG001|Overall Study|Withdrawal by Subject|7|||
129641697|NCT00937040|466641918|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
129641698|NCT00937040|466641919|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
129641699|NCT00937040|466641918|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
129641700|NCT00937040|466641919|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
129641701|NCT00638443|466641920|FG000|First Intervention|Adverse Event|2|||
129641702|NCT00638443|466641921|FG001|First Intervention|Adverse Event|1|||
129641703|NCT03502070|466641924|FG000|Overall Study|Withdrawal by Subject|1|||
129641704|NCT03502070|466641924|FG000|Overall Study|Screen Failure|1|||
129641705|NCT00595517|466641927|FG000|Overall Study|Adverse Event|6|||
129641706|NCT00595517|466641927|FG000|Overall Study|Withdrawal by Subject|4|||
129641707|NCT00595517|466641927|FG000|Overall Study|Protocol Violation|2|||
129641708|NCT00595517|466641927|FG000|Overall Study|Recurrence of ulcer|5|||
129641709|NCT00595517|466641927|FG000|Overall Study|usage of prohibited treatment|1|||
129641710|NCT00595517|466641927|FG000|Overall Study|No intention to attend regularly|1|||
129641711|NCT01167881|466641930|FG000|Overall Study|Adverse Event|47|||
129641712|NCT01167881|466641931|FG001|Overall Study|Adverse Event|51|||
129641713|NCT01167881|466641930|FG000|Overall Study|Lack of Efficacy|4|||
129641714|NCT01167881|466641931|FG001|Overall Study|Lack of Efficacy|7|||
129641715|NCT01167881|466641930|FG000|Overall Study|Non compliant with protocol|9|||
129641716|NCT01167881|466641931|FG001|Overall Study|Non compliant with protocol|18|||
129641717|NCT01167881|466641930|FG000|Overall Study|Lost to Follow-up|19|||
129641718|NCT01167881|466641931|FG001|Overall Study|Lost to Follow-up|20|||
129641719|NCT01167881|466641930|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
129641720|NCT01167881|466641931|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
129641721|NCT01167881|466641930|FG000|Overall Study|Not treated|4|||
129641722|NCT01167881|466641931|FG001|Overall Study|Not treated|0|||
129641723|NCT01167881|466641930|FG000|Overall Study|Other not defined above|31|||
129705486|NCT05239221|466884255|FG012|Overall Study|Adverse Event|0|||
129705487|NCT05239221|466884256|FG013|Overall Study|Adverse Event|0|||
129705488|NCT05239221|466884257|FG014|Overall Study|Adverse Event|0|||
129705489|NCT05239221|466884258|FG015|Overall Study|Adverse Event|0|||
129705490|NCT05239221|466884243|FG000|Overall Study|Withdrawal by Subject|0|||
129705491|NCT05239221|466884244|FG001|Overall Study|Withdrawal by Subject|0|||
129705492|NCT05239221|466884245|FG002|Overall Study|Withdrawal by Subject|0|||
129705493|NCT05239221|466884246|FG003|Overall Study|Withdrawal by Subject|0|||
129705494|NCT05239221|466884247|FG004|Overall Study|Withdrawal by Subject|0|||
129705495|NCT05239221|466884248|FG005|Overall Study|Withdrawal by Subject|0|||
129705496|NCT05239221|466884249|FG006|Overall Study|Withdrawal by Subject|0|||
129705497|NCT05239221|466884250|FG007|Overall Study|Withdrawal by Subject|0|||
129705498|NCT05239221|466884251|FG008|Overall Study|Withdrawal by Subject|0|||
129705499|NCT05239221|466884252|FG009|Overall Study|Withdrawal by Subject|0|||
129705500|NCT05239221|466884253|FG010|Overall Study|Withdrawal by Subject|1|||
129705501|NCT05239221|466884254|FG011|Overall Study|Withdrawal by Subject|0|||
129705502|NCT05239221|466884255|FG012|Overall Study|Withdrawal by Subject|0|||
129705503|NCT05239221|466884256|FG013|Overall Study|Withdrawal by Subject|0|||
129705504|NCT05239221|466884257|FG014|Overall Study|Withdrawal by Subject|0|||
129705505|NCT05239221|466884258|FG015|Overall Study|Withdrawal by Subject|1|||
129705506|NCT01897493|466885686|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
129705507|NCT05489328|466885687|FG000|Overall Study|Lost to Follow-up|0|||
129705508|NCT05489328|466885688|FG001|Overall Study|Lost to Follow-up|0|||
129705509|NCT05489328|466885689|FG002|Overall Study|Lost to Follow-up|1|||
129889775|NCT00918749|467554519|FG002|Overall Study|Lost to Follow-up|1|||
129889776|NCT00918749|467554517|FG000|Overall Study|Withdrawal by Subject|5|||
129889777|NCT00918749|467554518|FG001|Overall Study|Withdrawal by Subject|3|||
129889778|NCT00918749|467554519|FG002|Overall Study|Withdrawal by Subject|5|||
129889779|NCT00918749|467554517|FG000|Overall Study|No Study Medication Taken|1|||
129889780|NCT00918749|467554518|FG001|Overall Study|No Study Medication Taken|0|||
129889781|NCT00918749|467554519|FG002|Overall Study|No Study Medication Taken|0|||
129889782|NCT01951092|467554520|FG000|Overall Study|Lost to Follow-up|10|||
129889783|NCT01951092|467554520|FG000|Overall Study|Incarceration|1|||
129889784|NCT01951092|467554520|FG000|Overall Study|Transfer of Care|1|||
129889785|NCT01712789|467554521|FG000|Overall Study|Lack of Efficacy|2|||
129889786|NCT01712789|467554521|FG000|Overall Study|Lost to Follow-up|1|||
129889787|NCT01712789|467554521|FG000|Overall Study|Progressive Disease|504|||
129889788|NCT01712789|467554521|FG000|Overall Study|Death|57|||
129889789|NCT01712789|467554521|FG000|Overall Study|Adverse Event|52|||
129889790|NCT01712789|467554521|FG000|Overall Study|Miscellaneous|31|||
129889791|NCT01712789|467554521|FG000|Overall Study|Withdrawal by Subject|21|||
129889792|NCT01712789|467554521|FG000|Overall Study|Transition to Commercial Treatment|8|||
129889793|NCT01712789|467554521|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
129889794|NCT01708187|467554522|FG000|Overall Study|Lost to Follow-up|0|||
129889795|NCT01708187|467554523|FG001|Overall Study|Lost to Follow-up|1|||
129889796|NCT00873093|467554524|FG000|Overall Study|Adverse Event|0|||
129889797|NCT00873093|467554525|FG001|Overall Study|Adverse Event|2|||
129889798|NCT00873093|467554526|FG002|Overall Study|Adverse Event|0|||
129889799|NCT00873093|467554527|FG003|Overall Study|Adverse Event|0|||
129889800|NCT00873093|467554528|FG004|Overall Study|Adverse Event|0|||
129889801|NCT00873093|467554524|FG000|Overall Study|Death|0|||
129889802|NCT00873093|467554525|FG001|Overall Study|Death|3|||
129889803|NCT00873093|467554526|FG002|Overall Study|Death|2|||
129889804|NCT00873093|467554527|FG003|Overall Study|Death|0|||
129889805|NCT00873093|467554528|FG004|Overall Study|Death|0|||
129889806|NCT00873093|467554524|FG000|Overall Study|Physician Decision|0|||
129889807|NCT00873093|467554525|FG001|Overall Study|Physician Decision|17|||
129889808|NCT00873093|467554526|FG002|Overall Study|Physician Decision|10|||
129889809|NCT00873093|467554527|FG003|Overall Study|Physician Decision|10|||
129889810|NCT00873093|467554528|FG004|Overall Study|Physician Decision|2|||
129889811|NCT00873093|467554524|FG000|Overall Study|Withdrawal by Subject|1|||
129889812|NCT00873093|467554525|FG001|Overall Study|Withdrawal by Subject|4|||
129889813|NCT00873093|467554526|FG002|Overall Study|Withdrawal by Subject|4|||
129889814|NCT00873093|467554527|FG003|Overall Study|Withdrawal by Subject|0|||
129889815|NCT00873093|467554528|FG004|Overall Study|Withdrawal by Subject|0|||
129889816|NCT00873093|467554524|FG000|Overall Study|Ineligible|0|||
129889817|NCT00873093|467554525|FG001|Overall Study|Ineligible|1|||
129889818|NCT00873093|467554526|FG002|Overall Study|Ineligible|0|||
129889819|NCT00873093|467554527|FG003|Overall Study|Ineligible|1|||
129889820|NCT00873093|467554528|FG004|Overall Study|Ineligible|0|||
129889821|NCT00136916|467554530|FG000|Overall Study|Never received study treatment|3|||
129889822|NCT00136916|467554531|FG001|Overall Study|Never received study treatment|5|||
129889823|NCT00136916|467554530|FG000|Overall Study|Death|1|||
129889824|NCT00136916|467554531|FG001|Overall Study|Death|3|||
129889825|NCT00136916|467554530|FG000|Overall Study|Adverse Event|27|||
129889826|NCT00136916|467554531|FG001|Overall Study|Adverse Event|8|||
129889827|NCT00136916|467554530|FG000|Overall Study|Laboratory abnormality|0|||
129889828|NCT00136916|467554531|FG001|Overall Study|Laboratory abnormality|1|||
129889829|NCT00136916|467554530|FG000|Overall Study|Lack of Efficacy|13|||
129889830|NCT00136916|467554531|FG001|Overall Study|Lack of Efficacy|3|||
129889831|NCT00136916|467554530|FG000|Overall Study|Lost to Follow-up|12|||
129889832|NCT00136916|467554531|FG001|Overall Study|Lost to Follow-up|14|||
129798728|NCT00089674|467232138|FG000|Overall Study|Lost to Follow-up|21|||
129798729|NCT00089674|467232139|FG001|Overall Study|Lost to Follow-up|17|||
129798730|NCT00089674|467232138|FG000|Overall Study|Noncompliance|7|||
129798731|NCT00089674|467232139|FG001|Overall Study|Noncompliance|3|||
129798732|NCT00089674|467232138|FG000|Overall Study|Other|5|||
129798733|NCT00089674|467232139|FG001|Overall Study|Other|9|||
129798734|NCT00089674|467232138|FG000|Overall Study|Requirement for alternative therapy|14|||
129798735|NCT00089674|467232139|FG001|Overall Study|Requirement for alternative therapy|4|||
129798736|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
129889833|NCT00136916|467554530|FG000|Overall Study|Withdrawal by Subject|44|||
129889834|NCT00136916|467554531|FG001|Overall Study|Withdrawal by Subject|46|||
129889835|NCT00136916|467554530|FG000|Overall Study|Other|22|||
129889836|NCT00136916|467554531|FG001|Overall Study|Other|24|||
129798737|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
129798738|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
129798739|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
129889837|NCT00136916|467554530|FG000|Overall Study|Discontinued in follow up period|3|||
129889838|NCT00136916|467554531|FG001|Overall Study|Discontinued in follow up period|0|||
129889839|NCT01152554|467554532|FG000|Overall Study|Withdrawal by Subject|73|||
129889840|NCT01152554|467554533|FG001|Overall Study|Withdrawal by Subject|28|||
129889841|NCT01152554|467554532|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
129889842|NCT01152554|467554533|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
129889843|NCT01152554|467554532|FG000|Overall Study|Adverse Event|67|||
129889844|NCT01152554|467554533|FG001|Overall Study|Adverse Event|14|||
129889845|NCT01152554|467554532|FG000|Overall Study|Severe non-compliance to protocol|36|||
129889846|NCT01152554|467554533|FG001|Overall Study|Severe non-compliance to protocol|14|||
129889847|NCT01152554|467554532|FG000|Overall Study|Condition under investigation worsened|5|||
129889848|NCT01152554|467554533|FG001|Overall Study|Condition under investigation worsened|2|||
129889849|NCT01152554|467554532|FG000|Overall Study|Lack of Efficacy|20|||
129889850|NCT01152554|467554533|FG001|Overall Study|Lack of Efficacy|3|||
129889851|NCT01152554|467554532|FG000|Overall Study|Study-specific withdrawal criteria|17|||
129889852|NCT01152554|467554533|FG001|Overall Study|Study-specific withdrawal criteria|8|||
129889853|NCT01152554|467554532|FG000|Overall Study|Lost to Follow-up|87|||
129889854|NCT01152554|467554533|FG001|Overall Study|Lost to Follow-up|32|||
129889855|NCT01152554|467554532|FG000|Overall Study|Other|28|||
129889856|NCT01152554|467554533|FG001|Overall Study|Other|8|||
129889857|NCT01152554|467554532|FG000|Overall Study|Death|1|||
129889858|NCT01152554|467554533|FG001|Overall Study|Death|1|||
129889859|NCT02117544|467554534|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
129889860|NCT02117544|467554535|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
129889861|NCT02559817|467554536|FG000|Treatment Period|Adverse Event|1|||
129889862|NCT02559817|467554537|FG001|Treatment Period|Adverse Event|0|||
129889863|NCT02559817|467554538|FG002|Treatment Period|Adverse Event|1|||
129889864|NCT02559817|467554539|FG003|Treatment Period|Adverse Event|0|||
129889865|NCT02559817|467554540|FG004|Treatment Period|Adverse Event|0|||
129889866|NCT02559817|467554536|FG000|Treatment Period|Lack of Efficacy|0|||
129889867|NCT02559817|467554537|FG001|Treatment Period|Lack of Efficacy|1|||
129889868|NCT02559817|467554538|FG002|Treatment Period|Lack of Efficacy|0|||
129889869|NCT02559817|467554539|FG003|Treatment Period|Lack of Efficacy|0|||
129889870|NCT02559817|467554540|FG004|Treatment Period|Lack of Efficacy|0|||
129889871|NCT02559817|467554536|FG000|Treatment Period|Lost to Follow-up|0|||
129889872|NCT02559817|467554537|FG001|Treatment Period|Lost to Follow-up|1|||
129889873|NCT02559817|467554538|FG002|Treatment Period|Lost to Follow-up|0|||
129889874|NCT02559817|467554539|FG003|Treatment Period|Lost to Follow-up|1|||
129889875|NCT02559817|467554540|FG004|Treatment Period|Lost to Follow-up|0|||
129889876|NCT02559817|467554536|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
129889877|NCT02559817|467554537|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
129889878|NCT02559817|467554538|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
129889879|NCT02559817|467554539|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
129889880|NCT02559817|467554540|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
129889881|NCT02559817|467554536|FG000|Treatment Period|Protocol Violation|0|||
129889882|NCT02559817|467554537|FG001|Treatment Period|Protocol Violation|0|||
129889883|NCT02559817|467554538|FG002|Treatment Period|Protocol Violation|0|||
129889884|NCT02559817|467554539|FG003|Treatment Period|Protocol Violation|1|||
129889885|NCT02559817|467554540|FG004|Treatment Period|Protocol Violation|0|||
129889886|NCT02806336|467554550|FG000|Overall Study|Physician Decision|1|||
129889887|NCT02806336|467554551|FG001|Overall Study|Physician Decision|0|||
129889888|NCT02806336|467554550|FG000|Overall Study|Withdrawal by Subject|2|||
129889889|NCT02806336|467554551|FG001|Overall Study|Withdrawal by Subject|4|||
129889890|NCT02806336|467554550|FG000|Overall Study|COVID-19 research shut down|3|||
129889891|NCT02806336|467554551|FG001|Overall Study|COVID-19 research shut down|4|||
129889892|NCT02806336|467554550|FG000|Overall Study|Lack of Efficacy|0|||
129889893|NCT02806336|467554551|FG001|Overall Study|Lack of Efficacy|1|||
129705510|NCT05489328|466885690|FG003|Overall Study|Lost to Follow-up|0|||
129705511|NCT05489328|466885691|FG004|Overall Study|Lost to Follow-up|2|||
129705512|NCT05489328|466885692|FG005|Overall Study|Lost to Follow-up|0|||
129705513|NCT05489328|466885693|FG006|Overall Study|Lost to Follow-up|0|||
129705514|NCT05489328|466885694|FG007|Overall Study|Lost to Follow-up|1|||
129705515|NCT05489328|466885695|FG008|Overall Study|Lost to Follow-up|0|||
129705516|NCT05489328|466885687|FG000|Overall Study|Withdrawal by Subject|0|||
129705517|NCT05489328|466885688|FG001|Overall Study|Withdrawal by Subject|0|||
129705518|NCT05489328|466885689|FG002|Overall Study|Withdrawal by Subject|0|||
129705519|NCT05489328|466885690|FG003|Overall Study|Withdrawal by Subject|0|||
129705520|NCT05489328|466885691|FG004|Overall Study|Withdrawal by Subject|0|||
129705521|NCT05489328|466885692|FG005|Overall Study|Withdrawal by Subject|0|||
129705522|NCT05489328|466885693|FG006|Overall Study|Withdrawal by Subject|1|||
129705523|NCT05489328|466885694|FG007|Overall Study|Withdrawal by Subject|1|||
129705524|NCT05489328|466885695|FG008|Overall Study|Withdrawal by Subject|0|||
129705525|NCT05489328|466885687|FG000|Overall Study|Other|0|||
129705526|NCT05489328|466885688|FG001|Overall Study|Other|0|||
129705527|NCT05489328|466885689|FG002|Overall Study|Other|0|||
129705528|NCT05489328|466885690|FG003|Overall Study|Other|0|||
129705529|NCT05489328|466885691|FG004|Overall Study|Other|0|||
129705530|NCT05489328|466885692|FG005|Overall Study|Other|0|||
129705531|NCT05489328|466885693|FG006|Overall Study|Other|0|||
129705532|NCT05489328|466885694|FG007|Overall Study|Other|1|||
129705533|NCT05489328|466885695|FG008|Overall Study|Other|1|||
129705534|NCT00805389|466885696|FG000|Overall Study|Adverse Event|0|||
129641724|NCT01167881|466641931|FG001|Overall Study|Other not defined above|55|||
129641725|NCT01894100|466641932|FG000|Overall Study|Lost to Follow-up|0|||
129641726|NCT01894100|466641933|FG001|Overall Study|Lost to Follow-up|1|||
129641727|NCT01894100|466641932|FG000|Overall Study|Withdrawal by Subject|3|||
129641728|NCT01894100|466641933|FG001|Overall Study|Withdrawal by Subject|0|||
129641729|NCT04013672|466641934|FG000|Overall Study|Withdrawal by Subject|3|||
129641730|NCT04013672|466641935|FG001|Overall Study|Withdrawal by Subject|0|||
129641731|NCT04013672|466641934|FG000|Overall Study|Death|1|||
129641732|NCT04013672|466641935|FG001|Overall Study|Death|0|||
129641733|NCT04013672|466641934|FG000|Overall Study|Physician Decision|5|||
129641734|NCT04013672|466641935|FG001|Overall Study|Physician Decision|0|||
129641735|NCT01827267|466641936|FG000|Overall Study|Did not receive study drug|1|||
129641736|NCT01827267|466641937|FG001|Overall Study|Did not receive study drug|1|||
129641737|NCT01827267|466641936|FG000|Overall Study|Physician Decision|1|||
129641738|NCT01827267|466641937|FG001|Overall Study|Physician Decision|0|||
129641739|NCT01827267|466641936|FG000|Overall Study|Disease Progression|1|||
129641740|NCT01827267|466641937|FG001|Overall Study|Disease Progression|1|||
129641741|NCT01827267|466641936|FG000|Overall Study|Sponsor Discontinued Study|2|||
129641742|NCT01827267|466641937|FG001|Overall Study|Sponsor Discontinued Study|8|||
129641743|NCT01827267|466641936|FG000|Overall Study|Still on study|0|||
129641744|NCT01827267|466641937|FG001|Overall Study|Still on study|2|||
129641745|NCT01684943|466641942|FG000|Overall Study|Inadequate Venous Access|3|||
129641746|NCT01684943|466641943|FG001|Overall Study|Inadequate Venous Access|0|||
129641747|NCT01684943|466641944|FG002|Overall Study|Inadequate Venous Access|0|||
129641748|NCT01684943|466641942|FG000|Overall Study|Principal Investigator Determination|1|||
129641749|NCT01684943|466641943|FG001|Overall Study|Principal Investigator Determination|0|||
129641750|NCT01684943|466641944|FG002|Overall Study|Principal Investigator Determination|0|||
129641751|NCT01684943|466641942|FG000|Overall Study|Excluded from Analysis|1|||
129641752|NCT01684943|466641943|FG001|Overall Study|Excluded from Analysis|1|||
129641753|NCT01684943|466641944|FG002|Overall Study|Excluded from Analysis|1|||
129641754|NCT01684943|466641942|FG000|Overall Study|Lost to Follow-up|3|||
129641755|NCT01684943|466641943|FG001|Overall Study|Lost to Follow-up|0|||
129641756|NCT01684943|466641944|FG002|Overall Study|Lost to Follow-up|0|||
129641757|NCT01684943|466641942|FG000|Overall Study|Planning Pregnancy|1|||
129641758|NCT01684943|466641943|FG001|Overall Study|Planning Pregnancy|0|||
129641759|NCT01684943|466641944|FG002|Overall Study|Planning Pregnancy|0|||
129641760|NCT00972816|466644235|FG000|Overall Study|Adverse Event|0|||
129641761|NCT00972816|466644236|FG001|Overall Study|Adverse Event|0|||
129641762|NCT00972816|466644237|FG002|Overall Study|Adverse Event|1|||
129641763|NCT00972816|466644238|FG003|Overall Study|Adverse Event|0|||
129641764|NCT00972816|466644239|FG004|Overall Study|Adverse Event|0|||
129641765|NCT00972816|466644240|FG005|Overall Study|Adverse Event|0|||
129641766|NCT00972816|466644241|FG006|Overall Study|Adverse Event|0|||
129641767|NCT00972816|466644242|FG007|Overall Study|Adverse Event|0|||
129641768|NCT00972816|466644235|FG000|Overall Study|Withdrawal by Subject|4|||
129641769|NCT00972816|466644236|FG001|Overall Study|Withdrawal by Subject|2|||
129641770|NCT00972816|466644237|FG002|Overall Study|Withdrawal by Subject|1|||
129641771|NCT00972816|466644238|FG003|Overall Study|Withdrawal by Subject|3|||
129641772|NCT00972816|466644239|FG004|Overall Study|Withdrawal by Subject|0|||
129641773|NCT00972816|466644240|FG005|Overall Study|Withdrawal by Subject|1|||
129641774|NCT00972816|466644241|FG006|Overall Study|Withdrawal by Subject|1|||
129641775|NCT00972816|466644242|FG007|Overall Study|Withdrawal by Subject|2|||
129641776|NCT00972816|466644235|FG000|Overall Study|Lost to Follow-up|11|||
129641777|NCT00972816|466644236|FG001|Overall Study|Lost to Follow-up|9|||
129641778|NCT00972816|466644237|FG002|Overall Study|Lost to Follow-up|7|||
129641779|NCT00972816|466644238|FG003|Overall Study|Lost to Follow-up|5|||
129641780|NCT00972816|466644239|FG004|Overall Study|Lost to Follow-up|11|||
129641781|NCT00972816|466644240|FG005|Overall Study|Lost to Follow-up|10|||
129641782|NCT00972816|466644241|FG006|Overall Study|Lost to Follow-up|7|||
129641783|NCT00972816|466644242|FG007|Overall Study|Lost to Follow-up|7|||
129641784|NCT00972816|466644235|FG000|Overall Study|Inappropriate enrolment|0|||
129641785|NCT00972816|466644236|FG001|Overall Study|Inappropriate enrolment|0|||
129641786|NCT00972816|466644237|FG002|Overall Study|Inappropriate enrolment|0|||
129889894|NCT01563978|467554554|FG000|Overall Study|Physician Decision|1|||
129889895|NCT01563978|467554555|FG001|Overall Study|Physician Decision|0|||
129889896|NCT01563978|467554554|FG000|Overall Study|Lost to Follow-up|1|||
129641787|NCT00972816|466644238|FG003|Overall Study|Inappropriate enrolment|0|||
129641788|NCT00972816|466644239|FG004|Overall Study|Inappropriate enrolment|0|||
129641789|NCT00972816|466644240|FG005|Overall Study|Inappropriate enrolment|0|||
129641790|NCT00972816|466644241|FG006|Overall Study|Inappropriate enrolment|2|||
129641791|NCT00972816|466644242|FG007|Overall Study|Inappropriate enrolment|0|||
129641792|NCT00972816|466644235|FG000|Overall Study|Unable to classify|2|||
129641793|NCT00972816|466644236|FG001|Overall Study|Unable to classify|0|||
129641794|NCT00972816|466644237|FG002|Overall Study|Unable to classify|0|||
129641795|NCT00972816|466644238|FG003|Overall Study|Unable to classify|0|||
129641796|NCT00972816|466644239|FG004|Overall Study|Unable to classify|1|||
129641797|NCT00972816|466644240|FG005|Overall Study|Unable to classify|0|||
129641798|NCT00972816|466644241|FG006|Overall Study|Unable to classify|0|||
129641799|NCT00972816|466644242|FG007|Overall Study|Unable to classify|0|||
129641800|NCT03854370|466644245|FG000|Overall Study|samples not collected|1|||
129641801|NCT03854370|466644246|FG001|Overall Study|samples not collected|1|||
129641802|NCT03854370|466644247|FG002|Overall Study|samples not collected|1|||
129641803|NCT03854370|466644248|FG003|Overall Study|samples not collected|1|||
129641804|NCT00452673|466644249|FG000|Dose Escalation Period|Disease Progression|6|||
129641805|NCT00452673|466644250|FG001|Dose Escalation Period|Disease Progression|6|||
129641806|NCT00452673|466644251|FG002|Dose Escalation Period|Disease Progression|2|||
129641807|NCT00452673|466644252|FG003|Dose Escalation Period|Disease Progression|6|||
129641808|NCT00452673|466644253|FG004|Dose Escalation Period|Disease Progression|0|||
129641809|NCT00452673|466644249|FG000|Dose Escalation Period|study drug toxicity|1|||
129641810|NCT00452673|466644250|FG001|Dose Escalation Period|study drug toxicity|3|||
129641811|NCT00452673|466644251|FG002|Dose Escalation Period|study drug toxicity|3|||
129641812|NCT00452673|466644252|FG003|Dose Escalation Period|study drug toxicity|1|||
129641813|NCT00452673|466644253|FG004|Dose Escalation Period|study drug toxicity|0|||
129641814|NCT00452673|466644249|FG000|Dose Escalation Period|Other|0|||
129641815|NCT00452673|466644250|FG001|Dose Escalation Period|Other|0|||
129641816|NCT00452673|466644251|FG002|Dose Escalation Period|Other|1|||
129641817|NCT00452673|466644252|FG003|Dose Escalation Period|Other|0|||
129641818|NCT00452673|466644253|FG004|Dose Escalation Period|Other|0|||
129641819|NCT00452673|466644249|FG000|Dose Escalation Period|Adverse Event|0|||
129641820|NCT00452673|466644250|FG001|Dose Escalation Period|Adverse Event|0|||
129641821|NCT00452673|466644251|FG002|Dose Escalation Period|Adverse Event|0|||
129641822|NCT00452673|466644252|FG003|Dose Escalation Period|Adverse Event|1|||
129641823|NCT00452673|466644253|FG004|Dose Escalation Period|Adverse Event|0|||
129641824|NCT00452673|466644249|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
129641825|NCT00452673|466644250|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
129641826|NCT00452673|466644251|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
129641827|NCT00452673|466644252|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
129641828|NCT00452673|466644253|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
129641829|NCT00452673|466644249|FG000|Dose Expansion Period|Disease Progression|0|||
129641830|NCT00452673|466644250|FG001|Dose Expansion Period|Disease Progression|0|||
129641831|NCT00452673|466644251|FG002|Dose Expansion Period|Disease Progression|0|||
129641832|NCT00452673|466644252|FG003|Dose Expansion Period|Disease Progression|0|||
129641833|NCT00452673|466644253|FG004|Dose Expansion Period|Disease Progression|19|||
129641834|NCT00452673|466644249|FG000|Dose Expansion Period|Other|0|||
129641835|NCT00452673|466644250|FG001|Dose Expansion Period|Other|0|||
129641836|NCT00452673|466644251|FG002|Dose Expansion Period|Other|0|||
129641837|NCT00452673|466644252|FG003|Dose Expansion Period|Other|0|||
129641838|NCT00452673|466644253|FG004|Dose Expansion Period|Other|2|||
129641839|NCT02656290|466644254|FG000|Overall Study|Lost to Follow-up|1|||
129641840|NCT02656290|466644254|FG000|Overall Study|Reintervention|3|||
129641841|NCT01608087|466644257|FG000|Overall Study|Lost to Follow-up|0|||
129641842|NCT01608087|466644258|FG001|Overall Study|Lost to Follow-up|1|||
129641843|NCT01608087|466644259|FG002|Overall Study|Lost to Follow-up|0|||
129641844|NCT01608087|466644257|FG000|Overall Study|Other Reason|0|||
129641845|NCT01608087|466644258|FG001|Overall Study|Other Reason|1|||
129641846|NCT01608087|466644259|FG002|Overall Study|Other Reason|0|||
129641847|NCT00348595|466644260|FG000|Overall Study|Adverse Event|5|||
129641848|NCT00348595|466644261|FG001|Overall Study|Adverse Event|8|||
129641849|NCT01942486|466644268|FG000|Overall Study|Lost to Follow-up|27|||
129641850|NCT03728426|466644269|FG000|Overall Study|Death|3|||
129641851|NCT00231114|466644271|FG000|Randomized|Withdrawal by Subject|6|||
129641852|NCT00231114|466644272|FG001|Randomized|Withdrawal by Subject|3|||
129641853|NCT00231114|466644271|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
129641854|NCT00231114|466644272|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
129641855|NCT00231114|466644271|FG000|Post-Treatment Period|Lost to Follow-up|6|||
129889897|NCT01563978|467554555|FG001|Overall Study|Lost to Follow-up|0|||
129889898|NCT01563978|467554554|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
129889899|NCT01563978|467554555|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
129889900|NCT01563978|467554554|FG000|Overall Study|Adverse Event|1|||
129889901|NCT01563978|467554555|FG001|Overall Study|Adverse Event|2|||
129641856|NCT00231114|466644272|FG001|Post-Treatment Period|Lost to Follow-up|1|||
129641857|NCT00231114|466644271|FG000|Post-Treatment Period|Physician Decision|1|||
129641858|NCT00231114|466644272|FG001|Post-Treatment Period|Physician Decision|0|||
129641859|NCT00231114|466644271|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
129641860|NCT00231114|466644272|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
129641861|NCT02048826|466644274|FG000|Overall Study|Withdrawal by Subject|1|||
129641862|NCT02048826|466644275|FG001|Overall Study|Withdrawal by Subject|0|||
129641863|NCT04470544|466644276|FG000|Overall Study|Withdrawal by Subject|4|||
129641864|NCT04470544|466644277|FG001|Overall Study|Withdrawal by Subject|6|||
129641865|NCT00712881|466644278|FG000|Overall Study|Adverse Event|3|||
129641866|NCT00712881|466644279|FG001|Overall Study|Adverse Event|3|||
129641867|NCT00712881|466644278|FG000|Overall Study|Withdrawal by Subject|1|||
129641868|NCT00712881|466644279|FG001|Overall Study|Withdrawal by Subject|1|||
129641869|NCT00712881|466644278|FG000|Overall Study|Disease Progression|2|||
129889902|NCT05764239|467554556|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
129889903|NCT05764239|467554556|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
129889904|NCT05764239|467554556|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
129889905|NCT05764239|467554556|FG000|DEP (Part 1)|Adverse Event|1|||
129889906|NCT05764239|467554556|FG000|DEP (Part 1)|Lost to Follow-up|1|||
129889907|NCT05764239|467554556|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
129889908|NCT05764239|467554556|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
129889909|NCT05764239|467554556|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
129889910|NCT05764239|467554556|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
129889911|NCT00057811|467554557|FG000|Overall Study|Lack of Efficacy|1|||
129889912|NCT00057811|467554558|FG001|Overall Study|Lack of Efficacy|4|||
129889913|NCT00057811|467554557|FG000|Overall Study|Physician Decision|1|||
129889914|NCT00057811|467554558|FG001|Overall Study|Physician Decision|0|||
129641870|NCT00712881|466644279|FG001|Overall Study|Disease Progression|1|||
129641871|NCT00712881|466644278|FG000|Overall Study|Lost to Follow-up|1|||
129641872|NCT00712881|466644279|FG001|Overall Study|Lost to Follow-up|1|||
129641873|NCT00712881|466644278|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
129641874|NCT00712881|466644279|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
129641875|NCT00712881|466644278|FG000|Overall Study|Protocol Violation|1|||
129641876|NCT00712881|466644279|FG001|Overall Study|Protocol Violation|1|||
129641877|NCT00712881|466644278|FG000|Overall Study|Randomized but not treated|1|||
129641878|NCT00712881|466644279|FG001|Overall Study|Randomized but not treated|0|||
129641879|NCT01194999|466644281|FG000|Overall Study|Lost to Follow-up|17|||
129641880|NCT01011465|466644282|FG000|Overall Study|Withdrawal by Subject|2|||
129641881|NCT01011465|466644283|FG001|Overall Study|Withdrawal by Subject|1|||
129641882|NCT01011465|466644284|FG002|Overall Study|Withdrawal by Subject|0|||
129641883|NCT01011465|466644285|FG003|Overall Study|Withdrawal by Subject|0|||
129641884|NCT01011465|466644286|FG004|Overall Study|Withdrawal by Subject|1|||
129641885|NCT01011465|466644287|FG005|Overall Study|Withdrawal by Subject|0|||
129641886|NCT01011465|466644288|FG006|Overall Study|Withdrawal by Subject|1|||
129641887|NCT01011465|466644289|FG007|Overall Study|Withdrawal by Subject|0|||
129641888|NCT00723008|466644291|FG000|Enrollment|Lost to Follow-up|1|||
129641889|NCT00723008|466644292|FG001|Enrollment|Lost to Follow-up|0|||
129641890|NCT00723008|466644291|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
129641891|NCT00723008|466644292|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
129641892|NCT00723008|466644291|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
129641893|NCT00723008|466644292|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
129641894|NCT00723008|466644291|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
129641895|NCT00723008|466644292|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
129641896|NCT00723008|466644291|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
129641897|NCT00723008|466644292|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
129641898|NCT00723008|466644291|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
129641899|NCT00723008|466644292|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
129641900|NCT05835011|466644294|FG000|Overall Study|Study Terminated by the Sponsor|1|||
129641901|NCT05835011|466644294|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
129641902|NCT03702010|466644305|FG000|Follow-up (30days)|Lack of Efficacy|2|||
129641903|NCT03702010|466644306|FG001|Follow-up (30days)|Lack of Efficacy|2|||
129641904|NCT03557931|466644307|FG000|Overall Study|Adverse Event|4|||
129641905|NCT03557931|466644308|FG001|Overall Study|Adverse Event|6|||
129641906|NCT03557931|466644309|FG002|Overall Study|Adverse Event|1|||
129641907|NCT03557931|466644307|FG000|Overall Study|Lost to Follow-up|4|||
129641908|NCT03557931|466644308|FG001|Overall Study|Lost to Follow-up|4|||
129641909|NCT03557931|466644309|FG002|Overall Study|Lost to Follow-up|1|||
129641910|NCT03557931|466644307|FG000|Overall Study|Protocol Violation|1|||
129641911|NCT03557931|466644308|FG001|Overall Study|Protocol Violation|4|||
129641912|NCT03557931|466644309|FG002|Overall Study|Protocol Violation|1|||
129641913|NCT03557931|466644307|FG000|Overall Study|Withdrawal by Subject|14|||
129641914|NCT03557931|466644308|FG001|Overall Study|Withdrawal by Subject|0|||
129641915|NCT03557931|466644309|FG002|Overall Study|Withdrawal by Subject|7|||
129641916|NCT03557931|466644307|FG000|Overall Study|Miscellaneous|8|||
129641917|NCT03557931|466644308|FG001|Overall Study|Miscellaneous|5|||
129889915|NCT00057811|467554557|FG000|Overall Study|Withdrawal by Subject|3|||
129889916|NCT00057811|467554558|FG001|Overall Study|Withdrawal by Subject|4|||
129889917|NCT00057811|467554557|FG000|Overall Study|Ineligible|4|||
129641918|NCT03557931|466644309|FG002|Overall Study|Miscellaneous|3|||
129641919|NCT02829723|466644310|FG000|Overall Study|Adverse Event|0|||
129889918|NCT00057811|467554558|FG001|Overall Study|Ineligible|2|||
129889919|NCT00057811|467554557|FG000|Overall Study|Inevaluable|1|||
129889920|NCT00057811|467554558|FG001|Overall Study|Inevaluable|2|||
129641920|NCT02829723|466644311|FG001|Overall Study|Adverse Event|0|||
129641921|NCT02829723|466644312|FG002|Overall Study|Adverse Event|1|||
129641922|NCT02829723|466644313|FG003|Overall Study|Adverse Event|1|||
129641923|NCT02829723|466644314|FG004|Overall Study|Adverse Event|0|||
129641924|NCT02829723|466644315|FG005|Overall Study|Adverse Event|0|||
129641925|NCT02829723|466644316|FG006|Overall Study|Adverse Event|0|||
129641926|NCT02829723|466644317|FG007|Overall Study|Adverse Event|1|||
129641927|NCT02829723|466644318|FG008|Overall Study|Adverse Event|0|||
129641928|NCT02829723|466644319|FG009|Overall Study|Adverse Event|0|||
129641929|NCT02829723|466644320|FG010|Overall Study|Adverse Event|0|||
129641930|NCT02829723|466644321|FG011|Overall Study|Adverse Event|0|||
129641931|NCT02829723|466644322|FG012|Overall Study|Adverse Event|0|||
129641932|NCT02829723|466644323|FG013|Overall Study|Adverse Event|0|||
129641933|NCT02829723|466644324|FG014|Overall Study|Adverse Event|1|||
129641934|NCT02829723|466644325|FG015|Overall Study|Adverse Event|1|||
129641935|NCT02829723|466644326|FG016|Overall Study|Adverse Event|1|||
129641936|NCT02829723|466644327|FG017|Overall Study|Adverse Event|2|||
129641937|NCT02829723|466644328|FG018|Overall Study|Adverse Event|1|||
129641938|NCT02829723|466644329|FG019|Overall Study|Adverse Event|1|||
129641939|NCT02829723|466644330|FG020|Overall Study|Adverse Event|3|||
129641940|NCT02829723|466644331|FG021|Overall Study|Adverse Event|0|||
129641941|NCT02829723|466644332|FG022|Overall Study|Adverse Event|0|||
129641942|NCT02829723|466644333|FG023|Overall Study|Adverse Event|1|||
129641943|NCT02829723|466644334|FG024|Overall Study|Adverse Event|1|||
129641944|NCT02829723|466644335|FG025|Overall Study|Adverse Event|3|||
129641945|NCT02829723|466644336|FG026|Overall Study|Adverse Event|5|||
129641946|NCT02829723|466644310|FG000|Overall Study|Death|1|||
129641947|NCT02829723|466644311|FG001|Overall Study|Death|0|||
129641948|NCT02829723|466644312|FG002|Overall Study|Death|1|||
129641949|NCT02829723|466644313|FG003|Overall Study|Death|1|||
129641950|NCT02829723|466644314|FG004|Overall Study|Death|0|||
129641951|NCT02829723|466644315|FG005|Overall Study|Death|0|||
129641952|NCT02829723|466644316|FG006|Overall Study|Death|2|||
129641953|NCT02829723|466644317|FG007|Overall Study|Death|0|||
129641954|NCT02829723|466644318|FG008|Overall Study|Death|1|||
129641955|NCT02829723|466644319|FG009|Overall Study|Death|0|||
129641956|NCT02829723|466644320|FG010|Overall Study|Death|0|||
129641957|NCT02829723|466644321|FG011|Overall Study|Death|0|||
129641958|NCT02829723|466644322|FG012|Overall Study|Death|2|||
129641959|NCT02829723|466644323|FG013|Overall Study|Death|1|||
129641960|NCT02829723|466644324|FG014|Overall Study|Death|0|||
129641961|NCT02829723|466644325|FG015|Overall Study|Death|0|||
129641962|NCT02829723|466644326|FG016|Overall Study|Death|0|||
129641963|NCT02829723|466644327|FG017|Overall Study|Death|0|||
129641964|NCT02829723|466644328|FG018|Overall Study|Death|0|||
129641965|NCT02829723|466644329|FG019|Overall Study|Death|0|||
129641966|NCT02829723|466644330|FG020|Overall Study|Death|0|||
129641967|NCT02829723|466644331|FG021|Overall Study|Death|2|||
129641968|NCT02829723|466644332|FG022|Overall Study|Death|0|||
129641969|NCT02829723|466644333|FG023|Overall Study|Death|0|||
129641970|NCT02829723|466644334|FG024|Overall Study|Death|0|||
129641971|NCT02829723|466644335|FG025|Overall Study|Death|1|||
129641972|NCT02829723|466644336|FG026|Overall Study|Death|2|||
129641973|NCT02829723|466644310|FG000|Overall Study|Physician Decision|0|||
129641974|NCT02829723|466644311|FG001|Overall Study|Physician Decision|0|||
129641975|NCT02829723|466644312|FG002|Overall Study|Physician Decision|0|||
129641976|NCT02829723|466644313|FG003|Overall Study|Physician Decision|0|||
129641977|NCT02829723|466644314|FG004|Overall Study|Physician Decision|0|||
129641978|NCT02829723|466644315|FG005|Overall Study|Physician Decision|0|||
129641979|NCT02829723|466644316|FG006|Overall Study|Physician Decision|0|||
129641980|NCT02829723|466644317|FG007|Overall Study|Physician Decision|0|||
129641981|NCT02829723|466644318|FG008|Overall Study|Physician Decision|0|||
129641982|NCT02829723|466644319|FG009|Overall Study|Physician Decision|1|||
129641983|NCT02829723|466644320|FG010|Overall Study|Physician Decision|1|||
129641984|NCT02829723|466644321|FG011|Overall Study|Physician Decision|0|||
129641985|NCT02829723|466644322|FG012|Overall Study|Physician Decision|0|||
129641986|NCT02829723|466644323|FG013|Overall Study|Physician Decision|1|||
129641987|NCT02829723|466644324|FG014|Overall Study|Physician Decision|0|||
129641988|NCT02829723|466644325|FG015|Overall Study|Physician Decision|0|||
129641989|NCT02829723|466644326|FG016|Overall Study|Physician Decision|2|||
129641990|NCT02829723|466644327|FG017|Overall Study|Physician Decision|0|||
129641991|NCT02829723|466644328|FG018|Overall Study|Physician Decision|0|||
129641992|NCT02829723|466644329|FG019|Overall Study|Physician Decision|0|||
129889921|NCT00556374|467554559|FG000|Overall Study|Withdrawal by Subject|235|||
129889922|NCT00556374|467554560|FG001|Overall Study|Withdrawal by Subject|205|||
129641993|NCT02829723|466644330|FG020|Overall Study|Physician Decision|0|||
129641994|NCT02829723|466644331|FG021|Overall Study|Physician Decision|0|||
129641995|NCT02829723|466644332|FG022|Overall Study|Physician Decision|1|||
129641996|NCT02829723|466644333|FG023|Overall Study|Physician Decision|1|||
129641997|NCT02829723|466644334|FG024|Overall Study|Physician Decision|1|||
129641998|NCT02829723|466644335|FG025|Overall Study|Physician Decision|1|||
129641999|NCT02829723|466644336|FG026|Overall Study|Physician Decision|3|||
129642000|NCT02829723|466644310|FG000|Overall Study|Progressive disease|4|||
129642001|NCT02829723|466644311|FG001|Overall Study|Progressive disease|6|||
129642002|NCT02829723|466644312|FG002|Overall Study|Progressive disease|3|||
129642003|NCT02829723|466644313|FG003|Overall Study|Progressive disease|3|||
129642004|NCT02829723|466644314|FG004|Overall Study|Progressive disease|3|||
129642005|NCT02829723|466644315|FG005|Overall Study|Progressive disease|5|||
129642006|NCT02829723|466644316|FG006|Overall Study|Progressive disease|4|||
129642007|NCT02829723|466644317|FG007|Overall Study|Progressive disease|6|||
129642008|NCT02829723|466644318|FG008|Overall Study|Progressive disease|8|||
129642009|NCT02829723|466644319|FG009|Overall Study|Progressive disease|4|||
129642010|NCT02829723|466644320|FG010|Overall Study|Progressive disease|9|||
129642011|NCT02829723|466644321|FG011|Overall Study|Progressive disease|0|||
129642012|NCT02829723|466644322|FG012|Overall Study|Progressive disease|3|||
129642013|NCT02829723|466644323|FG013|Overall Study|Progressive disease|4|||
129642014|NCT02829723|466644324|FG014|Overall Study|Progressive disease|2|||
129642015|NCT02829723|466644325|FG015|Overall Study|Progressive disease|4|||
129642016|NCT02829723|466644326|FG016|Overall Study|Progressive disease|5|||
129642017|NCT02829723|466644327|FG017|Overall Study|Progressive disease|3|||
129642018|NCT02829723|466644328|FG018|Overall Study|Progressive disease|4|||
129642019|NCT02829723|466644329|FG019|Overall Study|Progressive disease|4|||
129642020|NCT02829723|466644330|FG020|Overall Study|Progressive disease|7|||
129798740|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
129798741|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
129798742|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798743|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798744|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
129798745|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
129798746|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798747|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
129798748|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
129798749|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
129798750|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
129798751|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
129798752|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
129798753|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
129798754|NCT03963401|467232140|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798755|NCT03963401|467232141|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
129798756|NCT03963401|467232142|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798757|NCT03963401|467232143|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798758|NCT03963401|467232144|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798759|NCT03963401|467232145|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
129798760|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
129798761|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
129798762|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
129889923|NCT00556374|467554559|FG000|Overall Study|Death|158|||
129889924|NCT00556374|467554560|FG001|Overall Study|Death|127|||
129642021|NCT02829723|466644331|FG021|Overall Study|Progressive disease|6|||
129642022|NCT02829723|466644332|FG022|Overall Study|Progressive disease|3|||
129642023|NCT02829723|466644333|FG023|Overall Study|Progressive disease|3|||
129889925|NCT00556374|467554559|FG000|Overall Study|Lost to Follow-up|24|||
129889926|NCT00556374|467554560|FG001|Overall Study|Lost to Follow-up|17|||
129889927|NCT00556374|467554559|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
129889928|NCT00556374|467554560|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
129889929|NCT02169219|467554561|FG000|Overall Study|Lack of Efficacy|6|||
129889930|NCT04562779|467554565|FG000|Overall Study|Lost to Follow-up|7|||
129889931|NCT04562779|467554566|FG001|Overall Study|Lost to Follow-up|5|||
129889932|NCT04562779|467554567|FG002|Overall Study|Lost to Follow-up|10|||
129889933|NCT04562779|467554565|FG000|Overall Study|Protocol Violation|2|||
129889934|NCT04562779|467554566|FG001|Overall Study|Protocol Violation|2|||
129443517|NCT01990534|465924398|FG000|Overall Study|Withdrawal by Subject|3|||
129443518|NCT01990534|465924398|FG000|Overall Study|Reason not Specified|2|||
129642024|NCT02829723|466644334|FG024|Overall Study|Progressive disease|3|||
129642025|NCT02829723|466644335|FG025|Overall Study|Progressive disease|16|||
129642026|NCT02829723|466644336|FG026|Overall Study|Progressive disease|10|||
129642027|NCT02829723|466644310|FG000|Overall Study|Subject/guardian decision|0|||
129889935|NCT04562779|467554567|FG002|Overall Study|Protocol Violation|0|||
129642028|NCT02829723|466644311|FG001|Overall Study|Subject/guardian decision|1|||
129642029|NCT02829723|466644312|FG002|Overall Study|Subject/guardian decision|0|||
129642030|NCT02829723|466644313|FG003|Overall Study|Subject/guardian decision|1|||
129642031|NCT02829723|466644314|FG004|Overall Study|Subject/guardian decision|0|||
129642032|NCT02829723|466644315|FG005|Overall Study|Subject/guardian decision|0|||
129642033|NCT02829723|466644316|FG006|Overall Study|Subject/guardian decision|0|||
129642034|NCT02829723|466644317|FG007|Overall Study|Subject/guardian decision|1|||
129642035|NCT02829723|466644318|FG008|Overall Study|Subject/guardian decision|0|||
129642036|NCT02829723|466644319|FG009|Overall Study|Subject/guardian decision|0|||
129642037|NCT02829723|466644320|FG010|Overall Study|Subject/guardian decision|0|||
129642038|NCT02829723|466644321|FG011|Overall Study|Subject/guardian decision|0|||
129642039|NCT02829723|466644322|FG012|Overall Study|Subject/guardian decision|0|||
129642040|NCT02829723|466644323|FG013|Overall Study|Subject/guardian decision|0|||
129642041|NCT02829723|466644324|FG014|Overall Study|Subject/guardian decision|1|||
129642042|NCT02829723|466644325|FG015|Overall Study|Subject/guardian decision|0|||
129642043|NCT02829723|466644326|FG016|Overall Study|Subject/guardian decision|1|||
129642044|NCT02829723|466644327|FG017|Overall Study|Subject/guardian decision|0|||
129642045|NCT02829723|466644328|FG018|Overall Study|Subject/guardian decision|1|||
129642046|NCT02829723|466644329|FG019|Overall Study|Subject/guardian decision|0|||
129642047|NCT02829723|466644330|FG020|Overall Study|Subject/guardian decision|1|||
129642048|NCT02829723|466644331|FG021|Overall Study|Subject/guardian decision|0|||
129642049|NCT02829723|466644332|FG022|Overall Study|Subject/guardian decision|0|||
129642050|NCT02829723|466644333|FG023|Overall Study|Subject/guardian decision|1|||
129642051|NCT02829723|466644334|FG024|Overall Study|Subject/guardian decision|0|||
129642052|NCT02829723|466644335|FG025|Overall Study|Subject/guardian decision|1|||
129642053|NCT02829723|466644336|FG026|Overall Study|Subject/guardian decision|1|||
129642054|NCT02829723|466644310|FG000|Overall Study|Study terminated by sponsor|0|||
129642055|NCT02829723|466644311|FG001|Overall Study|Study terminated by sponsor|0|||
129642056|NCT02829723|466644312|FG002|Overall Study|Study terminated by sponsor|0|||
129642057|NCT02829723|466644313|FG003|Overall Study|Study terminated by sponsor|0|||
129642058|NCT02829723|466644314|FG004|Overall Study|Study terminated by sponsor|0|||
129642059|NCT02829723|466644315|FG005|Overall Study|Study terminated by sponsor|0|||
129642060|NCT02829723|466644316|FG006|Overall Study|Study terminated by sponsor|0|||
129642061|NCT02829723|466644317|FG007|Overall Study|Study terminated by sponsor|0|||
129642062|NCT02829723|466644318|FG008|Overall Study|Study terminated by sponsor|0|||
129642063|NCT02829723|466644319|FG009|Overall Study|Study terminated by sponsor|0|||
129642064|NCT02829723|466644320|FG010|Overall Study|Study terminated by sponsor|0|||
129642065|NCT02829723|466644321|FG011|Overall Study|Study terminated by sponsor|0|||
129642066|NCT02829723|466644322|FG012|Overall Study|Study terminated by sponsor|0|||
129642067|NCT02829723|466644323|FG013|Overall Study|Study terminated by sponsor|0|||
129642068|NCT02829723|466644324|FG014|Overall Study|Study terminated by sponsor|0|||
129642069|NCT02829723|466644325|FG015|Overall Study|Study terminated by sponsor|0|||
129642070|NCT02829723|466644326|FG016|Overall Study|Study terminated by sponsor|0|||
129642071|NCT02829723|466644327|FG017|Overall Study|Study terminated by sponsor|0|||
129642072|NCT02829723|466644328|FG018|Overall Study|Study terminated by sponsor|0|||
129642073|NCT02829723|466644329|FG019|Overall Study|Study terminated by sponsor|0|||
129642074|NCT02829723|466644330|FG020|Overall Study|Study terminated by sponsor|0|||
129642075|NCT02829723|466644331|FG021|Overall Study|Study terminated by sponsor|1|||
129642076|NCT02829723|466644332|FG022|Overall Study|Study terminated by sponsor|0|||
129642077|NCT02829723|466644333|FG023|Overall Study|Study terminated by sponsor|0|||
129642078|NCT02829723|466644334|FG024|Overall Study|Study terminated by sponsor|0|||
129642079|NCT02829723|466644335|FG025|Overall Study|Study terminated by sponsor|0|||
129889936|NCT00333138|467554568|FG000|Core Study (6 Months)|Adverse Event|4|||
129889937|NCT00333138|467554569|FG001|Core Study (6 Months)|Adverse Event|5|||
129889938|NCT00333138|467554570|FG002|Core Study (6 Months)|Adverse Event|8|||
129642080|NCT02829723|466644336|FG026|Overall Study|Study terminated by sponsor|0|||
129642081|NCT02989649|466644337|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
129642082|NCT02989649|466644337|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
129642083|NCT02989649|466644337|FG000|Overall Study|Lost For Observation During Study|3|||
129642084|NCT02989649|466644337|FG000|Overall Study|Reason Not Specified|13|||
129642085|NCT02004886|466644338|FG000|Overall Study|Adverse Event|0|||
129642086|NCT02004886|466644339|FG001|Overall Study|Adverse Event|1|||
129642087|NCT02004886|466644340|FG002|Overall Study|Adverse Event|0|||
129642088|NCT02004886|466644341|FG003|Overall Study|Adverse Event|0|||
129889939|NCT00333138|467554568|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
129642089|NCT02004886|466644338|FG000|Overall Study|Unable to attend future visits|1|||
129642090|NCT02004886|466644339|FG001|Overall Study|Unable to attend future visits|0|||
129642091|NCT02004886|466644340|FG002|Overall Study|Unable to attend future visits|0|||
129642092|NCT02004886|466644341|FG003|Overall Study|Unable to attend future visits|0|||
129889940|NCT00333138|467554569|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
129642093|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
129642094|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
129642095|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
129642096|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
129642097|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
129642098|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
129642099|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
129642100|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
129642101|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
129642102|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
129642103|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Death|1|||
129642104|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Death|0|||
129642105|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
129642106|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
129642107|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
129798763|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
129798764|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
129798765|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
129798766|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
129798767|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798768|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
129798769|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798770|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798771|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
129798772|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798773|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798774|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
129798775|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798776|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798777|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
129798778|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
129798779|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798780|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798781|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798782|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798783|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
129798784|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
129798785|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
129798786|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
129798787|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
129798788|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
129798789|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
129798790|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
129798791|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798792|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798793|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798794|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798795|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
129798796|NCT03963401|467232140|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
129798797|NCT03963401|467232141|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
129798798|NCT03963401|467232142|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
129798799|NCT03963401|467232143|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
129798800|NCT03963401|467232144|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
129798801|NCT03963401|467232145|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
129798802|NCT00667420|467232149|FG000|Overall Study|Adverse Event|2|||
129798803|NCT00667420|467232149|FG000|Overall Study|Lack of Efficacy|5|||
129798804|NCT00667420|467232149|FG000|Overall Study|Physician Decision|1|||
129798805|NCT00667420|467232149|FG000|Overall Study|Withdrawal by Subject|2|||
129798806|NCT02961218|467232150|FG000|Overall Study|Lost to Follow-up|0|||
129798807|NCT02961218|467232151|FG001|Overall Study|Lost to Follow-up|2|||
129798808|NCT02961218|467232150|FG000|Overall Study|Physician Decision|0|||
129798809|NCT02961218|467232151|FG001|Overall Study|Physician Decision|2|||
129798810|NCT02961218|467232150|FG000|Overall Study|Subject/Guardian Decision|3|||
129798811|NCT02961218|467232151|FG001|Overall Study|Subject/Guardian Decision|1|||
129798812|NCT00591266|467232154|FG000|Overall Study|Adverse Event|2|||
129798813|NCT00591266|467232155|FG001|Overall Study|Adverse Event|2|||
129798814|NCT00591266|467232156|FG002|Overall Study|Adverse Event|3|||
129798815|NCT00591266|467232154|FG000|Overall Study|Lost to Follow-up|0|||
129798816|NCT00591266|467232155|FG001|Overall Study|Lost to Follow-up|1|||
129647686|NCT03045276|466665408|FG002|Intervention Phase|Developed exclusionary criteria|0|||
129889941|NCT00333138|467554570|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
129889942|NCT00333138|467554568|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
129889943|NCT00333138|467554569|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
129889944|NCT00333138|467554570|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
129889945|NCT00333138|467554568|FG000|Core Study (6 Months)|Protocol Violation|1|||
129889946|NCT00333138|467554569|FG001|Core Study (6 Months)|Protocol Violation|0|||
129889947|NCT00333138|467554570|FG002|Core Study (6 Months)|Protocol Violation|1|||
129889948|NCT00333138|467554568|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
129889949|NCT00333138|467554569|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
129889950|NCT00333138|467554570|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
129889951|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
129889952|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
129889953|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
129889954|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
129889955|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
129705535|NCT00805389|466885697|FG001|Overall Study|Adverse Event|0|||
129705536|NCT00805389|466885698|FG002|Overall Study|Adverse Event|1|||
129705537|NCT00805389|466885699|FG003|Overall Study|Adverse Event|2|||
129705538|NCT00805389|466885700|FG004|Overall Study|Adverse Event|0|||
129705539|NCT00805389|466885696|FG000|Overall Study|Lost to Follow-up|4|||
129705540|NCT00805389|466885697|FG001|Overall Study|Lost to Follow-up|3|||
129705541|NCT00805389|466885698|FG002|Overall Study|Lost to Follow-up|6|||
129705542|NCT00805389|466885699|FG003|Overall Study|Lost to Follow-up|10|||
129705543|NCT00805389|466885700|FG004|Overall Study|Lost to Follow-up|9|||
129705544|NCT00805389|466885696|FG000|Overall Study|Protocol Violation|0|||
129705545|NCT00805389|466885697|FG001|Overall Study|Protocol Violation|0|||
129705546|NCT00805389|466885698|FG002|Overall Study|Protocol Violation|1|||
129705547|NCT00805389|466885699|FG003|Overall Study|Protocol Violation|0|||
129705548|NCT00805389|466885700|FG004|Overall Study|Protocol Violation|0|||
129705549|NCT00805389|466885696|FG000|Overall Study|Withdrawal by Subject|3|||
129705550|NCT00805389|466885697|FG001|Overall Study|Withdrawal by Subject|2|||
129705551|NCT00805389|466885698|FG002|Overall Study|Withdrawal by Subject|4|||
129705552|NCT00805389|466885699|FG003|Overall Study|Withdrawal by Subject|5|||
129705553|NCT00805389|466885700|FG004|Overall Study|Withdrawal by Subject|4|||
129705554|NCT02239926|466885703|FG000|Overall Study|Withdrawal by Subject|0|||
129798817|NCT00591266|467232156|FG002|Overall Study|Lost to Follow-up|0|||
129798818|NCT00591266|467232154|FG000|Overall Study|Protocol Violation|0|||
129798819|NCT00591266|467232155|FG001|Overall Study|Protocol Violation|0|||
129798820|NCT00591266|467232156|FG002|Overall Study|Protocol Violation|1|||
129798821|NCT00591266|467232154|FG000|Overall Study|Withdrawal by Subject|6|||
129705555|NCT02239926|466885704|FG001|Overall Study|Withdrawal by Subject|1|||
129705556|NCT03983421|466885707|FG000|Overall Study|Lost to Follow-up|1|||
129705557|NCT00557193|466885710|FG000|Induction|Adverse Event|2|||
129798822|NCT00591266|467232155|FG001|Overall Study|Withdrawal by Subject|2|||
129642108|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
129642109|NCT01876784|466644344|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
129642110|NCT01876784|466644345|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
129642111|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
129642112|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
129642113|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Adverse Event|2|||
129642114|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Adverse Event|6|||
129642115|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
129642116|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
129642117|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Progressive disease|4|||
129642118|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Progressive disease|35|||
129642119|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
129642120|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
129642121|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
129642122|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
129642123|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Death|0|||
129642124|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Death|1|||
129642125|NCT01876784|466644344|FG000|Open-label Period (31 Months)|Other than specified above|9|||
129642126|NCT01876784|466644345|FG001|Open-label Period (31 Months)|Other than specified above|18|||
129642127|NCT03605862|466644346|FG000|Overall Study|Withdrawal by Subject|12|||
129642128|NCT03605862|466644347|FG001|Overall Study|Withdrawal by Subject|9|||
129642129|NCT03605862|466644346|FG000|Overall Study|Adverse Event|2|||
129642130|NCT03605862|466644347|FG001|Overall Study|Adverse Event|1|||
129642131|NCT03605862|466644346|FG000|Overall Study|Physician Decision|3|||
129642132|NCT03605862|466644347|FG001|Overall Study|Physician Decision|1|||
129642133|NCT03605862|466644346|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
129642134|NCT03605862|466644347|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
129642135|NCT03891862|466644348|FG000|Open-label Period|Adverse Event|2|||
129642136|NCT03891862|466644349|FG001|Open-label Period|Adverse Event|0|||
129642137|NCT03891862|466644350|FG002|Open-label Period|Adverse Event|0|||
129642138|NCT03891862|466644348|FG000|Open-label Period|Protocol Violation|5|||
129642139|NCT03891862|466644349|FG001|Open-label Period|Protocol Violation|0|||
129642140|NCT03891862|466644350|FG002|Open-label Period|Protocol Violation|0|||
129642141|NCT03891862|466644348|FG000|Open-label Period|Withdrawal by Subject|6|||
129642142|NCT03891862|466644349|FG001|Open-label Period|Withdrawal by Subject|0|||
129642143|NCT03891862|466644350|FG002|Open-label Period|Withdrawal by Subject|0|||
129642144|NCT03891862|466644348|FG000|Open-label Period|Death|1|||
129642145|NCT03891862|466644349|FG001|Open-label Period|Death|0|||
129642146|NCT03891862|466644350|FG002|Open-label Period|Death|0|||
129642147|NCT03891862|466644348|FG000|Open-label Period|Lost to Follow-up|2|||
129642148|NCT03891862|466644349|FG001|Open-label Period|Lost to Follow-up|0|||
129642149|NCT03891862|466644350|FG002|Open-label Period|Lost to Follow-up|0|||
129642150|NCT03891862|466644348|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
129642151|NCT03891862|466644349|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
129642152|NCT03891862|466644350|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
129642153|NCT03891862|466644348|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
129642154|NCT03891862|466644349|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
129642155|NCT03891862|466644350|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
129642156|NCT03891862|466644348|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
129642157|NCT03891862|466644349|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
129642158|NCT03891862|466644350|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
129642159|NCT03891862|466644348|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
129642160|NCT03891862|466644349|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
129642161|NCT03891862|466644350|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
129642162|NCT05239494|466644351|FG000|Overall Study|Lost to Follow-up|1|||
129642163|NCT01194531|466644352|FG000|Overall Study|Withdrawal by Subject|1|||
129642164|NCT01194531|466644353|FG001|Overall Study|Withdrawal by Subject|0|||
129642165|NCT01194531|466644352|FG000|Overall Study|Protocol Violation|4|||
129642166|NCT01194531|466644353|FG001|Overall Study|Protocol Violation|1|||
129642167|NCT01194531|466644352|FG000|Overall Study|Physician Decision|0|||
129642168|NCT01194531|466644353|FG001|Overall Study|Physician Decision|2|||
129642169|NCT04603482|466644354|FG000|Overall Study|Lost to Follow-up|15|||
129642170|NCT04603482|466644355|FG001|Overall Study|Lost to Follow-up|15|||
129642171|NCT04603482|466644356|FG002|Overall Study|Lost to Follow-up|15|||
129642172|NCT00179673|466644357|FG000|Overall Study|Adverse Event|7|||
129642173|NCT00179673|466644357|FG000|Overall Study|Lack of Efficacy|15|||
129642174|NCT00179673|466644357|FG000|Overall Study|Withdrawal by Subject|3|||
129642175|NCT00179673|466644357|FG000|Overall Study|Death|4|||
129642176|NCT00179673|466644357|FG000|Overall Study|Other Observations and options|14|||
129642177|NCT02107859|466644360|FG000|Overall Study|Withdrawal by Subject|14|||
129642178|NCT02107859|466644360|FG000|Overall Study|Adverse Event|3|||
129889956|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
129889957|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
129889958|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
129889959|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
129889960|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
129889961|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
129889962|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
129889963|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
129889964|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
129889965|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
129889966|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
129889967|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
129889968|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
129889969|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
129889970|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
129889971|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
129889972|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
129889973|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
129889974|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
129889975|NCT00333138|467554568|FG000|Extension Study (Month6 to End of Study)|Death|0|||
129889976|NCT00333138|467554569|FG001|Extension Study (Month6 to End of Study)|Death|1|||
129889977|NCT00333138|467554570|FG002|Extension Study (Month6 to End of Study)|Death|0|||
129889978|NCT04630756|467554571|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
129889979|NCT04630756|467554572|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
129889980|NCT04630756|467554573|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
129642179|NCT02107859|466644360|FG000|Overall Study|Study closure|41|||
129642180|NCT02107859|466644360|FG000|Overall Study|Other than specified|3|||
129642181|NCT00977314|466644361|FG000|Overall Study|Withdrawal by Subject|1|||
129642182|NCT00977314|466644362|FG001|Overall Study|Withdrawal by Subject|0|||
129642183|NCT00977314|466644361|FG000|Overall Study|Physician Decision|1|||
129642184|NCT00977314|466644362|FG001|Overall Study|Physician Decision|0|||
129642185|NCT01094301|466644365|FG000|Trial Stage|Withdrawal by Subject|1|||
129642186|NCT01094301|466644365|FG000|Implant Stage|Adverse Event|1|||
129642187|NCT01094301|466644365|FG000|Implant Stage|Protocol Violation|1|||
129642188|NCT01094301|466644365|FG000|Implant Stage|Withdrawal by Subject|2|||
129642189|NCT01094301|466644365|FG000|Implant Stage|No return of pain|4|||
129642190|NCT00135512|466644366|FG000|Overall Study|Adverse Event|56|||
129642191|NCT00135512|466644366|FG000|Overall Study|Lack of Efficacy|25|||
129642192|NCT00135512|466644366|FG000|Overall Study|Other|42|||
129642193|NCT02235077|466644367|FG000|Overall Study|Death|5|||
129642194|NCT02235077|466644368|FG001|Overall Study|Death|7|||
129642195|NCT02235077|466644367|FG000|Overall Study|Lost to Follow-up|5|||
129642196|NCT02235077|466644368|FG001|Overall Study|Lost to Follow-up|6|||
129642197|NCT02235077|466644367|FG000|Overall Study|Withdrawal by Subject|8|||
129642198|NCT02235077|466644368|FG001|Overall Study|Withdrawal by Subject|5|||
129642199|NCT02235077|466644367|FG000|Overall Study|Physician Decision|0|||
129642200|NCT02235077|466644368|FG001|Overall Study|Physician Decision|1|||
129642201|NCT03852628|466644369|FG000|Overall Study|Lost to Follow-up|7|||
129642202|NCT03852628|466644370|FG001|Overall Study|Lost to Follow-up|6|||
129642203|NCT03852628|466644369|FG000|Overall Study|Lack of Efficacy|6|||
129642204|NCT03852628|466644370|FG001|Overall Study|Lack of Efficacy|6|||
129642205|NCT00586820|466644372|FG000|Overall Study|Unsuccessful PCI|1|||
129642206|NCT00586820|466644373|FG001|Overall Study|Unsuccessful PCI|0|||
129642207|NCT03887442|466644374|FG000|Overall Study|Adverse Event|1|||
129642208|NCT03887442|466644375|FG001|Overall Study|Adverse Event|0|||
129642209|NCT01868022|466644376|FG000|Overall Study|Withdrawal by Subject|0|||
129642210|NCT01868022|466644377|FG001|Overall Study|Withdrawal by Subject|0|||
129642211|NCT01868022|466644378|FG002|Overall Study|Withdrawal by Subject|1|||
129642212|NCT01868022|466644379|FG003|Overall Study|Withdrawal by Subject|1|||
129642213|NCT01868022|466644380|FG004|Overall Study|Withdrawal by Subject|0|||
129642214|NCT01868022|466644381|FG005|Overall Study|Withdrawal by Subject|0|||
129642215|NCT01868022|466644382|FG006|Overall Study|Withdrawal by Subject|0|||
129889981|NCT00847301|467554574|FG000|Overall Study|Adverse Event|35|||
129642216|NCT01868022|466644383|FG007|Overall Study|Withdrawal by Subject|1|||
129642217|NCT01868022|466644384|FG008|Overall Study|Withdrawal by Subject|0|||
129642218|NCT01868022|466644376|FG000|Overall Study|Adverse Event|0|||
129642219|NCT01868022|466644377|FG001|Overall Study|Adverse Event|0|||
129642220|NCT01868022|466644378|FG002|Overall Study|Adverse Event|0|||
129642221|NCT01868022|466644379|FG003|Overall Study|Adverse Event|0|||
129642222|NCT01868022|466644380|FG004|Overall Study|Adverse Event|2|||
129798823|NCT00591266|467232156|FG002|Overall Study|Withdrawal by Subject|5|||
129798824|NCT00591266|467232154|FG000|Overall Study|Lack of Efficacy|0|||
129798825|NCT00591266|467232155|FG001|Overall Study|Lack of Efficacy|2|||
129798826|NCT00591266|467232156|FG002|Overall Study|Lack of Efficacy|0|||
129798827|NCT00591266|467232154|FG000|Overall Study|Other|1|||
129798828|NCT00591266|467232155|FG001|Overall Study|Other|4|||
129798829|NCT00591266|467232156|FG002|Overall Study|Other|5|||
129798830|NCT03488927|467232157|FG000|Overall Study|Withdrawal by Subject|44|||
129798831|NCT03488927|467232158|FG001|Overall Study|Withdrawal by Subject|118|||
129798832|NCT03488927|467232159|FG002|Overall Study|Withdrawal by Subject|217|||
129798833|NCT00901927|467232162|FG000|Overall Study|Lack of Efficacy|1|||
129642223|NCT01868022|466644381|FG005|Overall Study|Adverse Event|0|||
129642224|NCT01868022|466644382|FG006|Overall Study|Adverse Event|0|||
129642225|NCT01868022|466644383|FG007|Overall Study|Adverse Event|2|||
129642226|NCT01868022|466644384|FG008|Overall Study|Adverse Event|2|||
129642227|NCT01868022|466644376|FG000|Overall Study|Physician Decision|0|||
129642228|NCT01868022|466644377|FG001|Overall Study|Physician Decision|0|||
129642229|NCT01868022|466644378|FG002|Overall Study|Physician Decision|0|||
129642230|NCT01868022|466644379|FG003|Overall Study|Physician Decision|0|||
129642231|NCT01868022|466644380|FG004|Overall Study|Physician Decision|0|||
129642232|NCT01868022|466644381|FG005|Overall Study|Physician Decision|1|||
129642233|NCT01868022|466644382|FG006|Overall Study|Physician Decision|0|||
129642234|NCT01868022|466644383|FG007|Overall Study|Physician Decision|2|||
129642235|NCT01868022|466644384|FG008|Overall Study|Physician Decision|0|||
129642236|NCT01868022|466644376|FG000|Overall Study|Study closed/terminated|0|||
129642237|NCT01868022|466644377|FG001|Overall Study|Study closed/terminated|0|||
129642238|NCT01868022|466644378|FG002|Overall Study|Study closed/terminated|0|||
129642239|NCT01868022|466644379|FG003|Overall Study|Study closed/terminated|0|||
129642240|NCT01868022|466644380|FG004|Overall Study|Study closed/terminated|0|||
129642241|NCT01868022|466644381|FG005|Overall Study|Study closed/terminated|0|||
129642242|NCT01868022|466644382|FG006|Overall Study|Study closed/terminated|0|||
129642243|NCT01868022|466644383|FG007|Overall Study|Study closed/terminated|1|||
129642244|NCT01868022|466644384|FG008|Overall Study|Study closed/terminated|0|||
129642245|NCT01868022|466644376|FG000|Overall Study|Ongoing|0|||
129642246|NCT01868022|466644377|FG001|Overall Study|Ongoing|0|||
129642247|NCT01868022|466644378|FG002|Overall Study|Ongoing|0|||
129642248|NCT01868022|466644379|FG003|Overall Study|Ongoing|0|||
129642249|NCT01868022|466644380|FG004|Overall Study|Ongoing|0|||
129642250|NCT01868022|466644381|FG005|Overall Study|Ongoing|0|||
129642251|NCT01868022|466644382|FG006|Overall Study|Ongoing|0|||
129642252|NCT01868022|466644383|FG007|Overall Study|Ongoing|3|||
129642253|NCT01868022|466644384|FG008|Overall Study|Ongoing|0|||
129642254|NCT01628198|466644385|FG000|Overall Study|Lost to Follow-up|7|||
129642255|NCT01628198|466644385|FG000|Overall Study|Withdrawal by Subject|10|||
129642256|NCT01628198|466644385|FG000|Overall Study|Screen failure|1|||
129642257|NCT00986921|466644394|FG000|Overall Study|Physician Decision|1|||
129642258|NCT00986921|466644395|FG001|Overall Study|Physician Decision|0|||
129642259|NCT00813813|466644396|FG000|Overall Study|Withdrawal by Subject|1|||
129642260|NCT00813813|466644397|FG001|Overall Study|Withdrawal by Subject|1|||
129642261|NCT00813813|466644396|FG000|Overall Study|Lost to Follow-up|2|||
129642262|NCT00813813|466644397|FG001|Overall Study|Lost to Follow-up|7|||
129642263|NCT00813813|466644396|FG000|Overall Study|Other|0|||
129642264|NCT00813813|466644397|FG001|Overall Study|Other|1|||
129642265|NCT00833482|466644398|FG000|Days 11-20|Adverse Event|0|||
129642266|NCT00833482|466644399|FG001|Days 11-20|Adverse Event|2|||
129642267|NCT00833482|466644400|FG002|Days 11-20|Adverse Event|0|||
129642268|NCT00833482|466644401|FG003|Days 11-20|Adverse Event|0|||
129642269|NCT00833482|466644402|FG004|Days 11-20|Adverse Event|0|||
129642270|NCT00833482|466644403|FG005|Days 11-20|Adverse Event|0|||
129642271|NCT00833482|466644398|FG000|Days 11-20|Withdrawal by Subject|0|||
129642272|NCT00833482|466644399|FG001|Days 11-20|Withdrawal by Subject|1|||
129642273|NCT00833482|466644400|FG002|Days 11-20|Withdrawal by Subject|0|||
129642274|NCT00833482|466644401|FG003|Days 11-20|Withdrawal by Subject|0|||
129798834|NCT00901927|467232162|FG000|Overall Study|Protocol Violation|3|||
129798835|NCT00901927|467232162|FG000|Overall Study|Withdrawal by Subject|2|||
129642275|NCT00833482|466644402|FG004|Days 11-20|Withdrawal by Subject|0|||
129642276|NCT00833482|466644403|FG005|Days 11-20|Withdrawal by Subject|0|||
129642277|NCT00833482|466644398|FG000|Days 21-30|Adverse Event|0|||
129798836|NCT05298306|467232163|FG000|Overall Study|Physician Decision|0|||
129798837|NCT05298306|467232164|FG001|Overall Study|Physician Decision|0|||
129443519|NCT01990534|465924398|FG000|Overall Study|Lost to Follow-up|1|||
129642278|NCT00833482|466644399|FG001|Days 21-30|Adverse Event|0|||
129642279|NCT00833482|466644400|FG002|Days 21-30|Adverse Event|1|||
129642280|NCT00833482|466644401|FG003|Days 21-30|Adverse Event|0|||
129642281|NCT00833482|466644402|FG004|Days 21-30|Adverse Event|0|||
129642282|NCT00833482|466644403|FG005|Days 21-30|Adverse Event|0|||
129642283|NCT00833482|466644398|FG000|Days 21-30|Withdrawal by Subject|0|||
129642284|NCT00833482|466644399|FG001|Days 21-30|Withdrawal by Subject|0|||
129642285|NCT00833482|466644400|FG002|Days 21-30|Withdrawal by Subject|0|||
129642286|NCT00833482|466644401|FG003|Days 21-30|Withdrawal by Subject|0|||
129642287|NCT00833482|466644402|FG004|Days 21-30|Withdrawal by Subject|1|||
129642288|NCT00833482|466644403|FG005|Days 21-30|Withdrawal by Subject|0|||
129642289|NCT02778074|466644404|FG000|Overall Study|Lost to Follow-up|7|||
129642290|NCT02778074|466644405|FG001|Overall Study|Lost to Follow-up|10|||
129642291|NCT03489707|466644406|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
129642292|NCT03489707|466644407|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
129642293|NCT03489707|466644406|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
129642294|NCT03489707|466644407|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
129642295|NCT01817582|466644408|FG000|Overall Study|Withdrawal by Subject|0|||
129642296|NCT01817582|466644409|FG001|Overall Study|Withdrawal by Subject|1|||
129642297|NCT01817582|466644410|FG002|Overall Study|Withdrawal by Subject|0|||
129642298|NCT01817582|466644408|FG000|Overall Study|Participant revealed masked treatment|1|||
129642299|NCT01817582|466644409|FG001|Overall Study|Participant revealed masked treatment|0|||
129642300|NCT01817582|466644410|FG002|Overall Study|Participant revealed masked treatment|0|||
129642301|NCT01817582|466644408|FG000|Overall Study|Randomized but exclusion criteria met|1|||
129642302|NCT01817582|466644409|FG001|Overall Study|Randomized but exclusion criteria met|0|||
129642303|NCT01817582|466644410|FG002|Overall Study|Randomized but exclusion criteria met|0|||
129642304|NCT02122887|466644413|FG000|Overall Study|Withdrawal by Subject|20|||
129642305|NCT02122887|466644414|FG001|Overall Study|Withdrawal by Subject|2|||
129642306|NCT00378508|466646122|FG000|Overall Study|Withdrawal by Subject|1|||
129642307|NCT00378508|466646123|FG001|Overall Study|Withdrawal by Subject|3|||
129642308|NCT00378508|466646122|FG000|Overall Study|Lost to Follow-up|1|||
129642309|NCT00378508|466646123|FG001|Overall Study|Lost to Follow-up|0|||
129642310|NCT03917472|466646127|FG000|Overall Study|Physician Decision|4|||
129642311|NCT03917472|466646128|FG001|Overall Study|Physician Decision|0|||
129642312|NCT03917472|466646127|FG000|Overall Study|Adverse Event|3|||
129642313|NCT03917472|466646128|FG001|Overall Study|Adverse Event|1|||
129642314|NCT03917472|466646127|FG000|Overall Study|Death|7|||
129642315|NCT03917472|466646128|FG001|Overall Study|Death|5|||
129642316|NCT03917472|466646127|FG000|Overall Study|Withdrawal by Subject|11|||
129642317|NCT03917472|466646128|FG001|Overall Study|Withdrawal by Subject|4|||
129642318|NCT03917472|466646127|FG000|Overall Study|Lost to Follow-up|10|||
129642319|NCT03917472|466646128|FG001|Overall Study|Lost to Follow-up|5|||
129642320|NCT01953601|466646132|FG000|Part 1 (Base Study)|Adverse Event|24|||
129642321|NCT01953601|466646133|FG001|Part 1 (Base Study)|Adverse Event|37|||
129642322|NCT01953601|466646134|FG002|Part 1 (Base Study)|Adverse Event|15|||
129642323|NCT01953601|466646132|FG000|Part 1 (Base Study)|Death|2|||
129642324|NCT01953601|466646133|FG001|Part 1 (Base Study)|Death|0|||
129642325|NCT01953601|466646134|FG002|Part 1 (Base Study)|Death|3|||
129642326|NCT01953601|466646132|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
129642327|NCT01953601|466646133|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
129642328|NCT01953601|466646134|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
129705558|NCT00557193|466885711|FG001|Induction|Adverse Event|0|||
129705559|NCT00557193|466885712|FG002|Induction|Adverse Event|0|||
129705560|NCT00557193|466885713|FG003|Induction|Adverse Event|0|||
129705561|NCT00557193|466885714|FG004|Induction|Adverse Event|0|||
129705562|NCT00557193|466885715|FG005|Induction|Adverse Event|0|||
129705563|NCT00557193|466885710|FG000|Induction|Death|6|||
129705564|NCT00557193|466885711|FG001|Induction|Death|0|||
129705565|NCT00557193|466885712|FG002|Induction|Death|0|||
129705566|NCT00557193|466885713|FG003|Induction|Death|0|||
129705567|NCT00557193|466885714|FG004|Induction|Death|0|||
129705568|NCT00557193|466885715|FG005|Induction|Death|0|||
129705569|NCT00557193|466885710|FG000|Induction|Physician Decision|3|||
129705570|NCT00557193|466885711|FG001|Induction|Physician Decision|0|||
129705571|NCT00557193|466885712|FG002|Induction|Physician Decision|0|||
129705572|NCT00557193|466885713|FG003|Induction|Physician Decision|0|||
129705573|NCT00557193|466885714|FG004|Induction|Physician Decision|0|||
129705574|NCT00557193|466885715|FG005|Induction|Physician Decision|0|||
129705575|NCT00557193|466885710|FG000|Induction|Withdrawal by Subject|1|||
129705576|NCT00557193|466885711|FG001|Induction|Withdrawal by Subject|0|||
129705577|NCT00557193|466885712|FG002|Induction|Withdrawal by Subject|0|||
129705578|NCT00557193|466885713|FG003|Induction|Withdrawal by Subject|0|||
129705579|NCT00557193|466885714|FG004|Induction|Withdrawal by Subject|0|||
129705580|NCT00557193|466885715|FG005|Induction|Withdrawal by Subject|0|||
129705581|NCT00557193|466885710|FG000|Induction|Refusal of Further Protocol Therapy|2|||
129705582|NCT00557193|466885711|FG001|Induction|Refusal of Further Protocol Therapy|0|||
129705583|NCT00557193|466885712|FG002|Induction|Refusal of Further Protocol Therapy|0|||
129642329|NCT01953601|466646132|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
129642330|NCT01953601|466646133|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
129642331|NCT01953601|466646134|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
129642332|NCT01953601|466646132|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
129705584|NCT00557193|466885713|FG003|Induction|Refusal of Further Protocol Therapy|0|||
129705585|NCT00557193|466885714|FG004|Induction|Refusal of Further Protocol Therapy|0|||
129705586|NCT00557193|466885715|FG005|Induction|Refusal of Further Protocol Therapy|0|||
129705587|NCT00557193|466885710|FG000|Induction|Ineligible|8|||
129705588|NCT00557193|466885711|FG001|Induction|Ineligible|0|||
129705589|NCT00557193|466885712|FG002|Induction|Ineligible|0|||
129705590|NCT00557193|466885713|FG003|Induction|Ineligible|0|||
129705591|NCT00557193|466885714|FG004|Induction|Ineligible|0|||
129705592|NCT00557193|466885715|FG005|Induction|Ineligible|0|||
129705593|NCT00557193|466885710|FG000|Induction|Inevaluable for post Induction|2|||
129705594|NCT00557193|466885711|FG001|Induction|Inevaluable for post Induction|0|||
129705595|NCT00557193|466885712|FG002|Induction|Inevaluable for post Induction|0|||
129705596|NCT00557193|466885713|FG003|Induction|Inevaluable for post Induction|0|||
129705597|NCT00557193|466885714|FG004|Induction|Inevaluable for post Induction|0|||
129705598|NCT00557193|466885715|FG005|Induction|Inevaluable for post Induction|0|||
129705599|NCT00557193|466885710|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
129705600|NCT00557193|466885711|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129705601|NCT00557193|466885712|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129705602|NCT00557193|466885713|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129705603|NCT00557193|466885714|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129889982|NCT00847301|467554574|FG000|Overall Study|Switch to other anticoagulants|16|||
129889983|NCT00847301|467554574|FG000|Overall Study|Lost to Follow-up|1|||
129889984|NCT00847301|467554574|FG000|Overall Study|No prescription after hospital discharge|1|||
129889985|NCT00847301|467554574|FG000|Overall Study|Other reason not defined above|1|||
129889986|NCT05593211|467554575|FG000|Overall Study|Withdrawal by Subject|1|||
129889987|NCT03077620|467554579|FG000|Overall Study|Unable to place lumbar catheter|1|||
129889988|NCT03077620|467554580|FG001|Overall Study|Unable to place lumbar catheter|0|||
129889989|NCT03077620|467554581|FG002|Overall Study|Unable to place lumbar catheter|1|||
129889990|NCT03077620|467554582|FG003|Overall Study|Unable to place lumbar catheter|0|||
129889991|NCT03077620|467554579|FG000|Overall Study|Withdrawal by Subject|0|||
129889992|NCT03077620|467554580|FG001|Overall Study|Withdrawal by Subject|1|||
129889993|NCT03077620|467554581|FG002|Overall Study|Withdrawal by Subject|0|||
129889994|NCT03077620|467554582|FG003|Overall Study|Withdrawal by Subject|0|||
129889995|NCT03077620|467554579|FG000|Overall Study|Physician Decision|0|||
129889996|NCT03077620|467554580|FG001|Overall Study|Physician Decision|0|||
129889997|NCT03077620|467554581|FG002|Overall Study|Physician Decision|1|||
129889998|NCT03077620|467554582|FG003|Overall Study|Physician Decision|0|||
129889999|NCT03225846|467554583|FG000|Overall Study|Adverse Event|0|||
129890000|NCT03225846|467554584|FG001|Overall Study|Adverse Event|0|||
129890001|NCT03225846|467554585|FG002|Overall Study|Adverse Event|0|||
129705604|NCT00557193|466885715|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
129705605|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129705606|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
129705607|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
129705608|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
129705609|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129890002|NCT03225846|467554586|FG003|Overall Study|Adverse Event|0|||
129890003|NCT03225846|467554587|FG004|Overall Study|Adverse Event|0|||
129890004|NCT03225846|467554588|FG005|Overall Study|Adverse Event|0|||
129890005|NCT03225846|467554589|FG006|Overall Study|Adverse Event|6|||
129890006|NCT03225846|467554583|FG000|Overall Study|Withdrawal by Subject|0|||
129890007|NCT03225846|467554584|FG001|Overall Study|Withdrawal by Subject|1|||
129890008|NCT03225846|467554585|FG002|Overall Study|Withdrawal by Subject|0|||
129705610|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
129705611|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
129705612|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
129705613|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
129705614|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
129705615|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
129705616|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
129705617|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
129705618|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
129705619|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
129705620|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
129705621|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
129705622|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
129705623|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
129705624|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
129705625|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
129705626|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
129705627|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
129705628|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
129890009|NCT03225846|467554586|FG003|Overall Study|Withdrawal by Subject|0|||
129890010|NCT03225846|467554587|FG004|Overall Study|Withdrawal by Subject|0|||
129890011|NCT03225846|467554588|FG005|Overall Study|Withdrawal by Subject|0|||
129890012|NCT03225846|467554589|FG006|Overall Study|Withdrawal by Subject|0|||
129642333|NCT01953601|466646133|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
129642334|NCT01953601|466646134|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
129642335|NCT01953601|466646132|FG000|Part 1 (Base Study)|Physician Decision|3|||
129642336|NCT01953601|466646133|FG001|Part 1 (Base Study)|Physician Decision|7|||
129642337|NCT01953601|466646134|FG002|Part 1 (Base Study)|Physician Decision|4|||
129642338|NCT01953601|466646132|FG000|Part 1 (Base Study)|Screen failure|1|||
129642339|NCT01953601|466646133|FG001|Part 1 (Base Study)|Screen failure|0|||
129642340|NCT01953601|466646134|FG002|Part 1 (Base Study)|Screen failure|1|||
129642341|NCT01953601|466646132|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
129642342|NCT01953601|466646133|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
129642343|NCT01953601|466646134|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
129642344|NCT01953601|466646132|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
129642345|NCT01953601|466646133|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
129642346|NCT01953601|466646134|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
129642347|NCT01953601|466646132|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
129642348|NCT01953601|466646133|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
129642349|NCT01953601|466646134|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
129642350|NCT01953601|466646132|FG000|Part 1 (Base Study)|Subject moved|2|||
129642351|NCT01953601|466646133|FG001|Part 1 (Base Study)|Subject moved|2|||
129642352|NCT01953601|466646134|FG002|Part 1 (Base Study)|Subject moved|1|||
129642353|NCT01953601|466646132|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
129642354|NCT01953601|466646133|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
129642355|NCT01953601|466646134|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
129642356|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Adverse Event|1|||
129642357|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Adverse Event|1|||
129642358|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Adverse Event|10|||
129642359|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Death|0|||
129642360|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Death|3|||
129642361|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Death|0|||
129642362|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
129642363|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
129642364|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
129642365|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
129642366|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
129642367|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
129642368|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Physician Decision|2|||
129642369|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Physician Decision|0|||
129642370|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Physician Decision|2|||
129642371|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
129642372|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
129642373|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
129642374|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
129642375|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
129642376|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
129642377|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
129642378|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
129642379|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
129642380|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Subject moved|0|||
129642381|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Subject moved|0|||
129642382|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Subject moved|1|||
129642383|NCT01953601|466646132|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
129642384|NCT01953601|466646133|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
129642385|NCT01953601|466646134|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
129642386|NCT03991299|466646139|FG000|Overall Study|Study closed, sponsor decision|3|||
129642387|NCT03991299|466646139|FG000|Overall Study|Withdrawal by Subject|1|||
129642388|NCT04429555|466646142|FG000|Overall Study|Death|0|||
129642389|NCT04429555|466646143|FG001|Overall Study|Death|2|||
129642390|NCT04429555|466646142|FG000|Overall Study|Other|2|||
129642391|NCT04429555|466646143|FG001|Overall Study|Other|0|||
129642392|NCT00941863|466646146|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
129642393|NCT00941863|466646147|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
129642394|NCT00941863|466646148|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
129642395|NCT00941863|466646149|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
129642396|NCT00941863|466646150|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
129798838|NCT05298306|467232165|FG002|Overall Study|Physician Decision|0|||
129443520|NCT00234494|465924399|FG000|Overall Study|Protocol Violation|2|||
129642397|NCT00941863|466646146|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
129642398|NCT00941863|466646147|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
129642399|NCT00941863|466646148|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
129642400|NCT00941863|466646149|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
129642401|NCT00941863|466646150|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
129705629|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
129705630|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
129705631|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
129705632|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
129705633|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
129705634|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
129705635|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129705636|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129705637|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
129705638|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129705639|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129705640|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
129705641|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129705642|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129707662|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
129707663|NCT01240863|466892085|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
129890013|NCT03225846|467554583|FG000|Overall Study|Death|0|||
129890014|NCT03225846|467554584|FG001|Overall Study|Death|1|||
129890015|NCT03225846|467554585|FG002|Overall Study|Death|0|||
129890016|NCT03225846|467554586|FG003|Overall Study|Death|0|||
129890017|NCT03225846|467554587|FG004|Overall Study|Death|0|||
129890018|NCT03225846|467554588|FG005|Overall Study|Death|0|||
129890019|NCT03225846|467554589|FG006|Overall Study|Death|0|||
129890020|NCT03225846|467554583|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890021|NCT03225846|467554584|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890022|NCT03225846|467554585|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
129890023|NCT03225846|467554586|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890024|NCT03225846|467554587|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890025|NCT03225846|467554588|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890026|NCT03225846|467554589|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
129890027|NCT03225846|467554583|FG000|Overall Study|Patient decision|0|||
129890028|NCT03225846|467554584|FG001|Overall Study|Patient decision|0|||
129890029|NCT03225846|467554585|FG002|Overall Study|Patient decision|0|||
129890030|NCT03225846|467554586|FG003|Overall Study|Patient decision|0|||
129890031|NCT03225846|467554587|FG004|Overall Study|Patient decision|0|||
129890032|NCT03225846|467554588|FG005|Overall Study|Patient decision|0|||
129890033|NCT03225846|467554589|FG006|Overall Study|Patient decision|1|||
129890034|NCT00996580|467554590|FG000|Overall Study|Adverse Event|466|||
129890035|NCT00996580|467554590|FG000|Overall Study|Lost to Follow-up|480|||
129890036|NCT00996580|467554590|FG000|Overall Study|Noncompliance with the protocol|137|||
129890037|NCT00996580|467554590|FG000|Overall Study|Physician Decision|5|||
129890038|NCT00996580|467554590|FG000|Overall Study|Pregnancy|68|||
129890039|NCT00996580|467554590|FG000|Overall Study|Protocol Violation|16|||
129890040|NCT00996580|467554590|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
129890041|NCT00996580|467554590|FG000|Overall Study|Withdrawal by Subject|217|||
129890042|NCT00996580|467554590|FG000|Overall Study|Other|29|||
129890043|NCT04248465|467554591|FG000|Randomized-Controlled Period|Death|12|||
129890044|NCT04248465|467554592|FG001|Randomized-Controlled Period|Death|5|||
129890045|NCT04248465|467554591|FG000|Randomized-Controlled Period|Adverse Event|2|||
129890046|NCT04248465|467554592|FG001|Randomized-Controlled Period|Adverse Event|0|||
129890047|NCT04248465|467554591|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
129890048|NCT04248465|467554592|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
129890049|NCT04248465|467554591|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
129798839|NCT05298306|467232166|FG003|Overall Study|Physician Decision|1|||
129798840|NCT05298306|467232167|FG004|Overall Study|Physician Decision|0|||
129798841|NCT05298306|467232168|FG005|Overall Study|Physician Decision|0|||
129798842|NCT02676466|467232173|FG000|Overall Study|Death|0|||
129798843|NCT02676466|467232174|FG001|Overall Study|Death|2|||
129798844|NCT02676466|467232175|FG002|Overall Study|Death|1|||
129798845|NCT02676466|467232176|FG003|Overall Study|Death|0|||
129798846|NCT02676466|467232177|FG004|Overall Study|Death|0|||
129798847|NCT02676466|467232178|FG005|Overall Study|Death|0|||
129798848|NCT02676466|467232179|FG006|Overall Study|Death|0|||
129798849|NCT02676466|467232180|FG007|Overall Study|Death|0|||
129798850|NCT02676466|467232173|FG000|Overall Study|Withdrawal by Subject|4|||
129890050|NCT04248465|467554592|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
129890051|NCT04248465|467554591|FG000|Randomized-Controlled Period|Physician Decision|1|||
129890052|NCT04248465|467554592|FG001|Randomized-Controlled Period|Physician Decision|1|||
129798851|NCT02676466|467232174|FG001|Overall Study|Withdrawal by Subject|3|||
129890053|NCT04248465|467554591|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
129890054|NCT04248465|467554592|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
129798852|NCT02676466|467232175|FG002|Overall Study|Withdrawal by Subject|1|||
129798853|NCT02676466|467232176|FG003|Overall Study|Withdrawal by Subject|0|||
129890055|NCT04248465|467554591|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
129798854|NCT02676466|467232177|FG004|Overall Study|Withdrawal by Subject|3|||
129798855|NCT02676466|467232178|FG005|Overall Study|Withdrawal by Subject|1|||
129798856|NCT02676466|467232179|FG006|Overall Study|Withdrawal by Subject|1|||
129890056|NCT04248465|467554592|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
129890057|NCT04248465|467554591|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129890058|NCT04248465|467554592|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
129890059|NCT05708846|467554593|FG000|Overall Study|Death|5|||
129642402|NCT00941863|466646146|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
129642403|NCT00941863|466646147|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
129642404|NCT00941863|466646148|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
129642405|NCT00941863|466646149|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
129642406|NCT00941863|466646150|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
129642407|NCT00941863|466646146|FG000|Until Primary Completion Date (PCD)|Death|0|||
129642408|NCT00941863|466646147|FG001|Until Primary Completion Date (PCD)|Death|0|||
129642409|NCT00941863|466646148|FG002|Until Primary Completion Date (PCD)|Death|1|||
129642410|NCT00941863|466646149|FG003|Until Primary Completion Date (PCD)|Death|2|||
129642411|NCT00941863|466646150|FG004|Until Primary Completion Date (PCD)|Death|7|||
129642412|NCT00941863|466646146|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
129642413|NCT00941863|466646147|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
129642414|NCT00941863|466646148|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
129642415|NCT00941863|466646149|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
129642416|NCT00941863|466646150|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
129642417|NCT00941863|466646146|FG000|Continued After PCD|Withdrawal by Subject|0|||
129642418|NCT00941863|466646147|FG001|Continued After PCD|Withdrawal by Subject|0|||
129642419|NCT00941863|466646148|FG002|Continued After PCD|Withdrawal by Subject|0|||
129642420|NCT00941863|466646149|FG003|Continued After PCD|Withdrawal by Subject|0|||
129642421|NCT00941863|466646150|FG004|Continued After PCD|Withdrawal by Subject|1|||
129642422|NCT00941863|466646146|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
129642423|NCT00941863|466646147|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
129642424|NCT00941863|466646148|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
129642425|NCT00941863|466646149|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
129642426|NCT00941863|466646150|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
129642427|NCT04533412|466646151|FG000|Overall Study|Withdrawal by Subject|1|||
129642428|NCT04533412|466646152|FG001|Overall Study|Withdrawal by Subject|1|||
129642429|NCT04533412|466646151|FG000|Overall Study|Lost to Follow-up|1|||
129642430|NCT04533412|466646152|FG001|Overall Study|Lost to Follow-up|4|||
129642431|NCT05113979|466646153|FG000|Overall Study|Death|2|||
129642432|NCT05113979|466646153|FG000|Overall Study|Lost to Follow-up|1|||
129642433|NCT00968981|466646156|FG000|Overall Study|Adverse Event|2|||
129642434|NCT00968981|466646157|FG001|Overall Study|Adverse Event|0|||
129642435|NCT00968981|466646158|FG002|Overall Study|Adverse Event|0|||
129642436|NCT00968981|466646156|FG000|Overall Study|Disease Progression|14|||
129642437|NCT00968981|466646157|FG001|Overall Study|Disease Progression|16|||
129642438|NCT00968981|466646158|FG002|Overall Study|Disease Progression|13|||
129642439|NCT00968981|466646156|FG000|Overall Study|Lost to Follow-up|0|||
129642440|NCT00968981|466646157|FG001|Overall Study|Lost to Follow-up|0|||
129642441|NCT00968981|466646158|FG002|Overall Study|Lost to Follow-up|1|||
129642442|NCT00968981|466646156|FG000|Overall Study|Physician Decision|5|||
129642443|NCT00968981|466646157|FG001|Overall Study|Physician Decision|3|||
129642444|NCT00968981|466646158|FG002|Overall Study|Physician Decision|5|||
129642445|NCT00968981|466646156|FG000|Overall Study|Withdrawal by Subject|1|||
129642446|NCT00968981|466646157|FG001|Overall Study|Withdrawal by Subject|3|||
129642447|NCT00968981|466646158|FG002|Overall Study|Withdrawal by Subject|3|||
129642448|NCT01489254|466646161|FG000|Double-blind Part|Adverse Event|7|||
129642449|NCT01489254|466646162|FG001|Double-blind Part|Adverse Event|2|||
129642450|NCT01489254|466646163|FG002|Double-blind Part|Adverse Event|2|||
129642451|NCT01489254|466646164|FG003|Double-blind Part|Adverse Event|0|||
129642452|NCT01489254|466646161|FG000|Double-blind Part|Pregnancy|1|||
129642453|NCT01489254|466646162|FG001|Double-blind Part|Pregnancy|3|||
129642454|NCT01489254|466646163|FG002|Double-blind Part|Pregnancy|0|||
129642455|NCT01489254|466646164|FG003|Double-blind Part|Pregnancy|0|||
129642456|NCT01489254|466646161|FG000|Double-blind Part|Withdrawal by Subject|12|||
129642457|NCT01489254|466646162|FG001|Double-blind Part|Withdrawal by Subject|20|||
129642458|NCT01489254|466646163|FG002|Double-blind Part|Withdrawal by Subject|1|||
129642459|NCT01489254|466646164|FG003|Double-blind Part|Withdrawal by Subject|0|||
129642460|NCT01489254|466646161|FG000|Double-blind Part|Lost to Follow-up|1|||
129642461|NCT01489254|466646162|FG001|Double-blind Part|Lost to Follow-up|2|||
129642462|NCT01489254|466646163|FG002|Double-blind Part|Lost to Follow-up|0|||
129642463|NCT01489254|466646164|FG003|Double-blind Part|Lost to Follow-up|0|||
129642464|NCT01489254|466646161|FG000|Double-blind Part|Other reasons for not completing study|4|||
129642465|NCT01489254|466646162|FG001|Double-blind Part|Other reasons for not completing study|6|||
129642466|NCT01489254|466646163|FG002|Double-blind Part|Other reasons for not completing study|0|||
129642467|NCT01489254|466646164|FG003|Double-blind Part|Other reasons for not completing study|0|||
129642468|NCT01489254|466646161|FG000|Open-label Extension Part|Adverse Event|0|||
129642469|NCT01489254|466646162|FG001|Open-label Extension Part|Adverse Event|0|||
129642470|NCT01489254|466646163|FG002|Open-label Extension Part|Adverse Event|0|||
129642471|NCT01489254|466646164|FG003|Open-label Extension Part|Adverse Event|10|||
129642472|NCT01489254|466646161|FG000|Open-label Extension Part|Pregnancy|0|||
129642473|NCT01489254|466646162|FG001|Open-label Extension Part|Pregnancy|0|||
129443521|NCT01831544|465924402|FG000|Overall Study|Death|1|||
129642474|NCT01489254|466646163|FG002|Open-label Extension Part|Pregnancy|0|||
129642475|NCT01489254|466646164|FG003|Open-label Extension Part|Pregnancy|3|||
129642476|NCT01489254|466646161|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
129642477|NCT01489254|466646162|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
129642478|NCT01489254|466646163|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
129642479|NCT01489254|466646164|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
129642480|NCT01489254|466646161|FG000|Open-label Extension Part|Protocol Violation|0|||
129642481|NCT01489254|466646162|FG001|Open-label Extension Part|Protocol Violation|0|||
129642482|NCT01489254|466646163|FG002|Open-label Extension Part|Protocol Violation|0|||
129642483|NCT01489254|466646164|FG003|Open-label Extension Part|Protocol Violation|1|||
129642484|NCT01489254|466646161|FG000|Open-label Extension Part|Lost to Follow-up|0|||
129642485|NCT01489254|466646162|FG001|Open-label Extension Part|Lost to Follow-up|0|||
129642486|NCT01489254|466646163|FG002|Open-label Extension Part|Lost to Follow-up|0|||
129642487|NCT01489254|466646164|FG003|Open-label Extension Part|Lost to Follow-up|9|||
129642488|NCT01489254|466646161|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
129642489|NCT01489254|466646162|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
129642490|NCT01489254|466646163|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
129642491|NCT01489254|466646164|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
129642492|NCT01137110|466646170|FG000|Overall Study|Protocol Violation|1|||
129642493|NCT01137110|466646171|FG001|Overall Study|Protocol Violation|0|||
129642494|NCT00281632|466646174|FG000|Overall Study|Adverse Event|7|||
129642495|NCT00281632|466646174|FG000|Overall Study|Withdrawal by Subject|2|||
129642496|NCT00281632|466646174|FG000|Overall Study|Disease Progression|22|||
129642497|NCT00281632|466646174|FG000|Overall Study|Death|1|||
129642498|NCT00281632|466646174|FG000|Overall Study|Physician Decision|1|||
129642499|NCT00281632|466646174|FG000|Overall Study|Ongoing|3|||
129642500|NCT03990571|466646175|FG000|Overall Study|Withdrawal by Subject|1|||
129642501|NCT03990571|466646175|FG000|Overall Study|Insurance Issues|3|||
129642502|NCT03990571|466646175|FG000|Overall Study|Covid Restrictions|2|||
129642503|NCT00782184|466646182|FG000|Overall Study|Adverse Event|1|||
129642504|NCT00782184|466646183|FG001|Overall Study|Adverse Event|2|||
129642505|NCT00782184|466646182|FG000|Overall Study|Protocol Violation|0|||
129642506|NCT00782184|466646183|FG001|Overall Study|Protocol Violation|1|||
129642507|NCT00782184|466646182|FG000|Overall Study|Withdrawal by Subject|3|||
129642508|NCT00782184|466646183|FG001|Overall Study|Withdrawal by Subject|2|||
129642509|NCT03614078|466646184|FG000|Overall Study|Withdrawal by Subject|2|||
129642510|NCT03614078|466646185|FG001|Overall Study|Withdrawal by Subject|2|||
129642511|NCT03614078|466646186|FG002|Overall Study|Withdrawal by Subject|3|||
129642512|NCT03614078|466646184|FG000|Overall Study|Participant Did Not Return for Visit|0|||
129642513|NCT03614078|466646185|FG001|Overall Study|Participant Did Not Return for Visit|1|||
129642514|NCT03614078|466646186|FG002|Overall Study|Participant Did Not Return for Visit|0|||
129642515|NCT03614078|466646184|FG000|Overall Study|High Neutrophils|0|||
129642516|NCT03614078|466646185|FG001|Overall Study|High Neutrophils|0|||
129642517|NCT03614078|466646186|FG002|Overall Study|High Neutrophils|2|||
129642518|NCT03614078|466646184|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
129642519|NCT03614078|466646185|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
129642520|NCT03614078|466646186|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
129642521|NCT03614078|466646184|FG000|Overall Study|Exacerbation of Psoriasis|0|||
129642522|NCT03614078|466646185|FG001|Overall Study|Exacerbation of Psoriasis|1|||
129642523|NCT03614078|466646186|FG002|Overall Study|Exacerbation of Psoriasis|0|||
129642524|NCT03614078|466646184|FG000|Overall Study|Adverse Event|0|||
129642525|NCT03614078|466646185|FG001|Overall Study|Adverse Event|2|||
129642526|NCT03614078|466646186|FG002|Overall Study|Adverse Event|0|||
129642527|NCT03614078|466646184|FG000|Overall Study|Dizziness and Rash|0|||
129642528|NCT03614078|466646185|FG001|Overall Study|Dizziness and Rash|1|||
129642529|NCT03614078|466646186|FG002|Overall Study|Dizziness and Rash|0|||
129642530|NCT04143594|466646189|FG000|Overall Study|Withdrew consent|3|||
129642531|NCT04143594|466646190|FG001|Overall Study|Withdrew consent|10|||
129642532|NCT04143594|466646191|FG002|Overall Study|Withdrew consent|3|||
129642533|NCT04143594|466646192|FG003|Overall Study|Withdrew consent|1|||
129642534|NCT04143594|466646189|FG000|Overall Study|Lost to Follow-up|3|||
129705643|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
129705644|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129705645|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129705646|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
129705647|NCT00557193|466885710|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129705648|NCT00557193|466885711|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129705649|NCT00557193|466885712|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
129642535|NCT04143594|466646190|FG001|Overall Study|Lost to Follow-up|5|||
129642536|NCT04143594|466646191|FG002|Overall Study|Lost to Follow-up|11|||
129642537|NCT04143594|466646192|FG003|Overall Study|Lost to Follow-up|0|||
129642538|NCT04143594|466646189|FG000|Overall Study|Investigator's discretion|2|||
129642539|NCT04143594|466646190|FG001|Overall Study|Investigator's discretion|2|||
129642540|NCT04143594|466646191|FG002|Overall Study|Investigator's discretion|0|||
129642541|NCT04143594|466646192|FG003|Overall Study|Investigator's discretion|0|||
129642542|NCT04143594|466646189|FG000|Overall Study|Randomized but never treated|0|||
129642543|NCT04143594|466646190|FG001|Overall Study|Randomized but never treated|0|||
129642544|NCT04143594|466646191|FG002|Overall Study|Randomized but never treated|0|||
129642545|NCT04143594|466646192|FG003|Overall Study|Randomized but never treated|1|||
129642546|NCT04143594|466646189|FG000|Overall Study|Death|1|||
129642547|NCT04143594|466646190|FG001|Overall Study|Death|0|||
129642548|NCT04143594|466646191|FG002|Overall Study|Death|1|||
129642549|NCT04143594|466646192|FG003|Overall Study|Death|0|||
129642550|NCT04143594|466646189|FG000|Overall Study|Adverse Event|1|||
129642551|NCT04143594|466646190|FG001|Overall Study|Adverse Event|0|||
129642552|NCT04143594|466646191|FG002|Overall Study|Adverse Event|0|||
129642553|NCT04143594|466646192|FG003|Overall Study|Adverse Event|0|||
129642554|NCT04143594|466646189|FG000|Overall Study|Pregnancy|0|||
129642555|NCT04143594|466646190|FG001|Overall Study|Pregnancy|0|||
129642556|NCT04143594|466646191|FG002|Overall Study|Pregnancy|1|||
129642557|NCT04143594|466646192|FG003|Overall Study|Pregnancy|0|||
129642558|NCT04143594|466646189|FG000|Overall Study|Lack of Efficacy|1|||
129642559|NCT04143594|466646190|FG001|Overall Study|Lack of Efficacy|1|||
129642560|NCT04143594|466646191|FG002|Overall Study|Lack of Efficacy|0|||
129642561|NCT04143594|466646192|FG003|Overall Study|Lack of Efficacy|0|||
129642562|NCT01054196|466646193|FG000|Overall Study|Physician Decision|0|||
129642563|NCT01054196|466646194|FG001|Overall Study|Physician Decision|0|||
129642564|NCT01054196|466646195|FG002|Overall Study|Physician Decision|0|||
129642565|NCT01054196|466646196|FG003|Overall Study|Physician Decision|1|||
129642566|NCT01054196|466646197|FG004|Overall Study|Physician Decision|0|||
129642567|NCT01054196|466646198|FG005|Overall Study|Physician Decision|0|||
129642568|NCT01054196|466646199|FG006|Overall Study|Physician Decision|1|||
129642569|NCT00492648|466646200|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
129642570|NCT00492648|466646201|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
129642571|NCT00282113|466646202|FG000|Overall Study|Removed at parents request|1|||
129642572|NCT00282113|466646203|FG001|Overall Study|Removed at parents request|0|||
129642573|NCT00282113|466646204|FG002|Overall Study|Removed at parents request|0|||
129642574|NCT02949843|466646205|FG000|Overall Study|Withdrawal by Subject|0|||
129642575|NCT02949843|466646206|FG001|Overall Study|Withdrawal by Subject|1|||
129642576|NCT02949843|466646207|FG002|Overall Study|Withdrawal by Subject|1|||
129642577|NCT01500187|466646209|FG000|Overall Study|Lost to Follow-up|6|||
129642578|NCT01500187|466646210|FG001|Overall Study|Lost to Follow-up|0|||
129642579|NCT01343277|466646227|FG000|Overall Study|Other|3|||
129642580|NCT01343277|466646228|FG001|Overall Study|Other|3|||
129642581|NCT01343277|466646227|FG000|Overall Study|Withdrawal by Subject|18|||
129642582|NCT01343277|466646228|FG001|Overall Study|Withdrawal by Subject|13|||
129642583|NCT01343277|466646227|FG000|Overall Study|Physician Decision|1|||
129642584|NCT01343277|466646228|FG001|Overall Study|Physician Decision|2|||
129642585|NCT01343277|466646227|FG000|Overall Study|Death|10|||
129642586|NCT01343277|466646228|FG001|Overall Study|Death|1|||
129642587|NCT01343277|466646227|FG000|Overall Study|Adverse Event|67|||
129642588|NCT01343277|466646228|FG001|Overall Study|Adverse Event|13|||
129642589|NCT01343277|466646227|FG000|Overall Study|Disease progression|270|||
129642590|NCT01343277|466646228|FG001|Overall Study|Disease progression|138|||
129642591|NCT01343277|466646227|FG000|Overall Study|Randomized not treated|6|||
129642592|NCT01343277|466646228|FG001|Overall Study|Randomized not treated|21|||
129642593|NCT01343277|466646227|FG000|Overall Study|Treatment ongoing|8|||
129642594|NCT01343277|466646228|FG001|Overall Study|Treatment ongoing|2|||
129642595|NCT01343277|466646227|FG000|Overall Study|Subsequent anticancer therapy|1|||
129642596|NCT01343277|466646228|FG001|Overall Study|Subsequent anticancer therapy|0|||
129642597|NCT01582178|466646229|FG000|Overall Study|Physician Decision|6|||
129642598|NCT01582178|466646230|FG001|Overall Study|Physician Decision|5|||
129642599|NCT00556933|466646238|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
129642600|NCT00556933|466646239|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
129642601|NCT00556933|466646240|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
129642602|NCT00556933|466646241|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
129642603|NCT00556933|466646238|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
129642604|NCT00556933|466646239|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
129642605|NCT00556933|466646240|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
129642606|NCT00556933|466646241|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
129642607|NCT00556933|466646238|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
129443522|NCT01831544|465924402|FG000|Overall Study|Still on original MVAD device|2|||
129642608|NCT00556933|466646239|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
129642609|NCT00556933|466646240|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
129642610|NCT00556933|466646241|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
129642611|NCT00556933|466646238|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
129642612|NCT00556933|466646239|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
129642613|NCT00556933|466646240|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
129642614|NCT00556933|466646241|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
129642615|NCT00556933|466646238|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
129642616|NCT00556933|466646239|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
129642617|NCT00556933|466646240|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
129642618|NCT00556933|466646241|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
129642619|NCT00556933|466646238|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
129642620|NCT00556933|466646239|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
129642621|NCT00556933|466646240|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
129642622|NCT00556933|466646241|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
129642623|NCT00556933|466646238|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
129642624|NCT00556933|466646239|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
129642625|NCT00556933|466646240|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
129642626|NCT00556933|466646241|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
129642627|NCT00556933|466646238|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
129642628|NCT00556933|466646239|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
129642629|NCT00556933|466646240|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
129642630|NCT00556933|466646241|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
129642631|NCT00556933|466646238|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
129642632|NCT00556933|466646239|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
129642633|NCT00556933|466646240|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
129642634|NCT00556933|466646241|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
129642635|NCT00556933|466646238|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
129642636|NCT00556933|466646239|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
129642637|NCT00556933|466646240|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
129642638|NCT00556933|466646241|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
129642639|NCT00556933|466646238|FG000|CNI Withdrawal vs. Minimization|Death|0|||
129642640|NCT00556933|466646239|FG001|CNI Withdrawal vs. Minimization|Death|0|||
129642641|NCT00556933|466646240|FG002|CNI Withdrawal vs. Minimization|Death|0|||
129642642|NCT00556933|466646241|FG003|CNI Withdrawal vs. Minimization|Death|1|||
129642643|NCT01295827|466646244|FG000|Overall Study|Adverse Event|1|||
129642644|NCT01295827|466646245|FG001|Overall Study|Adverse Event|2|||
129642645|NCT01295827|466646246|FG002|Overall Study|Adverse Event|2|||
129642646|NCT01295827|466646247|FG003|Overall Study|Adverse Event|1|||
129642647|NCT01295827|466646248|FG004|Overall Study|Adverse Event|1|||
129642648|NCT01295827|466646249|FG005|Overall Study|Adverse Event|4|||
129642649|NCT01295827|466646250|FG006|Overall Study|Adverse Event|15|||
129642650|NCT01295827|466646251|FG007|Overall Study|Adverse Event|49|||
129642651|NCT01295827|466646252|FG008|Overall Study|Adverse Event|22|||
129642652|NCT01295827|466646253|FG009|Overall Study|Adverse Event|7|||
129642653|NCT01295827|466646254|FG010|Overall Study|Adverse Event|50|||
129642654|NCT01295827|466646255|FG011|Overall Study|Adverse Event|21|||
129642655|NCT01295827|466646256|FG012|Overall Study|Adverse Event|0|||
129642656|NCT01295827|466646257|FG013|Overall Study|Adverse Event|0|||
129642657|NCT01295827|466646258|FG014|Overall Study|Adverse Event|0|||
129642658|NCT01295827|466646244|FG000|Overall Study|Lost to Follow-up|0|||
129642659|NCT01295827|466646245|FG001|Overall Study|Lost to Follow-up|0|||
129642660|NCT01295827|466646246|FG002|Overall Study|Lost to Follow-up|3|||
129642661|NCT01295827|466646247|FG003|Overall Study|Lost to Follow-up|0|||
129642662|NCT01295827|466646248|FG004|Overall Study|Lost to Follow-up|1|||
129642663|NCT01295827|466646249|FG005|Overall Study|Lost to Follow-up|0|||
129642664|NCT01295827|466646250|FG006|Overall Study|Lost to Follow-up|4|||
129642665|NCT01295827|466646251|FG007|Overall Study|Lost to Follow-up|8|||
129642666|NCT01295827|466646252|FG008|Overall Study|Lost to Follow-up|7|||
129642667|NCT01295827|466646253|FG009|Overall Study|Lost to Follow-up|4|||
129642668|NCT01295827|466646254|FG010|Overall Study|Lost to Follow-up|7|||
129642669|NCT01295827|466646255|FG011|Overall Study|Lost to Follow-up|3|||
129642670|NCT01295827|466646256|FG012|Overall Study|Lost to Follow-up|0|||
129642671|NCT01295827|466646257|FG013|Overall Study|Lost to Follow-up|0|||
129642672|NCT01295827|466646258|FG014|Overall Study|Lost to Follow-up|0|||
129642673|NCT01295827|466646244|FG000|Overall Study|Not Reported|0|||
129642674|NCT01295827|466646245|FG001|Overall Study|Not Reported|0|||
129642675|NCT01295827|466646246|FG002|Overall Study|Not Reported|0|||
129642676|NCT01295827|466646247|FG003|Overall Study|Not Reported|1|||
129642677|NCT01295827|466646248|FG004|Overall Study|Not Reported|0|||
129642678|NCT01295827|466646249|FG005|Overall Study|Not Reported|0|||
129642679|NCT01295827|466646250|FG006|Overall Study|Not Reported|24|||
129642680|NCT01295827|466646251|FG007|Overall Study|Not Reported|58|||
129642681|NCT01295827|466646252|FG008|Overall Study|Not Reported|41|||
129642682|NCT01295827|466646253|FG009|Overall Study|Not Reported|2|||
129642683|NCT01295827|466646254|FG010|Overall Study|Not Reported|23|||
129642684|NCT01295827|466646255|FG011|Overall Study|Not Reported|13|||
129642685|NCT01295827|466646256|FG012|Overall Study|Not Reported|0|||
129642686|NCT01295827|466646257|FG013|Overall Study|Not Reported|0|||
129642687|NCT01295827|466646258|FG014|Overall Study|Not Reported|0|||
129642688|NCT01295827|466646244|FG000|Overall Study|Progressive Disease|2|||
129642689|NCT01295827|466646245|FG001|Overall Study|Progressive Disease|1|||
129890060|NCT05708846|467554593|FG000|Overall Study|Withdrawal by Subject|20|||
129890061|NCT02036515|467554594|FG000|Overall Study|Adverse Event|1|||
129890062|NCT02036515|467554595|FG001|Overall Study|Adverse Event|1|||
129890063|NCT02036515|467554596|FG002|Overall Study|Adverse Event|2|||
129890064|NCT02036515|467554594|FG000|Overall Study|Lost to Follow-up|0|||
129890065|NCT02036515|467554595|FG001|Overall Study|Lost to Follow-up|2|||
129890066|NCT02036515|467554596|FG002|Overall Study|Lost to Follow-up|0|||
129890067|NCT02036515|467554594|FG000|Overall Study|Non-compliance with study drug|0|||
129890068|NCT02036515|467554595|FG001|Overall Study|Non-compliance with study drug|0|||
129890069|NCT02036515|467554596|FG002|Overall Study|Non-compliance with study drug|2|||
129705650|NCT00557193|466885713|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129705651|NCT00557193|466885714|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
129705652|NCT00557193|466885715|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
129705653|NCT03984825|466885716|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
129705654|NCT03984825|466885716|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
129705655|NCT03984825|466885716|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
129705656|NCT00976456|466885719|FG000|Overall Study|Adverse Event|17|||
129642690|NCT01295827|466646246|FG002|Overall Study|Progressive Disease|5|||
129642691|NCT01295827|466646247|FG003|Overall Study|Progressive Disease|2|||
129642692|NCT01295827|466646248|FG004|Overall Study|Progressive Disease|0|||
129642693|NCT01295827|466646249|FG005|Overall Study|Progressive Disease|1|||
129642694|NCT01295827|466646250|FG006|Overall Study|Progressive Disease|87|||
129642695|NCT01295827|466646251|FG007|Overall Study|Progressive Disease|144|||
129642696|NCT01295827|466646252|FG008|Overall Study|Progressive Disease|85|||
129642697|NCT01295827|466646253|FG009|Overall Study|Progressive Disease|40|||
129642698|NCT01295827|466646254|FG010|Overall Study|Progressive Disease|175|||
129642699|NCT01295827|466646255|FG011|Overall Study|Progressive Disease|136|||
129642700|NCT01295827|466646256|FG012|Overall Study|Progressive Disease|0|||
129642701|NCT01295827|466646257|FG013|Overall Study|Progressive Disease|0|||
129642702|NCT01295827|466646258|FG014|Overall Study|Progressive Disease|0|||
129642703|NCT01295827|466646244|FG000|Overall Study|Screen Failure|0|||
129642704|NCT01295827|466646245|FG001|Overall Study|Screen Failure|0|||
129642705|NCT01295827|466646246|FG002|Overall Study|Screen Failure|0|||
129642706|NCT01295827|466646247|FG003|Overall Study|Screen Failure|0|||
129642707|NCT01295827|466646248|FG004|Overall Study|Screen Failure|0|||
129642708|NCT01295827|466646249|FG005|Overall Study|Screen Failure|0|||
129642709|NCT01295827|466646250|FG006|Overall Study|Screen Failure|2|||
129642710|NCT01295827|466646251|FG007|Overall Study|Screen Failure|2|||
129642711|NCT01295827|466646252|FG008|Overall Study|Screen Failure|2|||
129705657|NCT00976456|466885720|FG001|Overall Study|Adverse Event|22|||
129705658|NCT00976456|466885719|FG000|Overall Study|Death|7|||
129705659|NCT00976456|466885720|FG001|Overall Study|Death|9|||
129705660|NCT00976456|466885719|FG000|Overall Study|Lack of Efficacy|5|||
129642712|NCT01295827|466646253|FG009|Overall Study|Screen Failure|0|||
129642713|NCT01295827|466646254|FG010|Overall Study|Screen Failure|1|||
129705661|NCT00976456|466885720|FG001|Overall Study|Lack of Efficacy|2|||
129642714|NCT01295827|466646255|FG011|Overall Study|Screen Failure|0|||
129642715|NCT01295827|466646256|FG012|Overall Study|Screen Failure|0|||
129642716|NCT01295827|466646257|FG013|Overall Study|Screen Failure|0|||
129642717|NCT01295827|466646258|FG014|Overall Study|Screen Failure|0|||
129642718|NCT01295827|466646244|FG000|Overall Study|Withdrawal by Subject|1|||
129705662|NCT00976456|466885719|FG000|Overall Study|Withdrawal by Subject|3|||
129890070|NCT02036515|467554594|FG000|Overall Study|Screen failure|0|||
129890071|NCT02036515|467554595|FG001|Overall Study|Screen failure|2|||
129798857|NCT02676466|467232180|FG007|Overall Study|Withdrawal by Subject|1|||
129798858|NCT01178073|467232183|FG000|Overall Study|Adverse Event|34|||
129798859|NCT01178073|467232184|FG001|Overall Study|Adverse Event|27|||
129798860|NCT01178073|467232185|FG002|Overall Study|Adverse Event|24|||
129642719|NCT01295827|466646245|FG001|Overall Study|Withdrawal by Subject|0|||
129642720|NCT01295827|466646246|FG002|Overall Study|Withdrawal by Subject|2|||
129642721|NCT01295827|466646247|FG003|Overall Study|Withdrawal by Subject|0|||
129642722|NCT01295827|466646248|FG004|Overall Study|Withdrawal by Subject|0|||
129642723|NCT01295827|466646249|FG005|Overall Study|Withdrawal by Subject|1|||
129642724|NCT01295827|466646250|FG006|Overall Study|Withdrawal by Subject|13|||
129642725|NCT01295827|466646251|FG007|Overall Study|Withdrawal by Subject|35|||
129642726|NCT01295827|466646252|FG008|Overall Study|Withdrawal by Subject|11|||
129642727|NCT01295827|466646253|FG009|Overall Study|Withdrawal by Subject|2|||
129642728|NCT01295827|466646254|FG010|Overall Study|Withdrawal by Subject|18|||
129642729|NCT01295827|466646255|FG011|Overall Study|Withdrawal by Subject|13|||
129642730|NCT01295827|466646256|FG012|Overall Study|Withdrawal by Subject|0|||
129642731|NCT01295827|466646257|FG013|Overall Study|Withdrawal by Subject|0|||
129642732|NCT01295827|466646258|FG014|Overall Study|Withdrawal by Subject|0|||
129642733|NCT01295827|466646244|FG000|Overall Study|Other|0|||
129642734|NCT01295827|466646245|FG001|Overall Study|Other|0|||
129642735|NCT01295827|466646246|FG002|Overall Study|Other|0|||
129642736|NCT01295827|466646247|FG003|Overall Study|Other|0|||
129642737|NCT01295827|466646248|FG004|Overall Study|Other|0|||
129642738|NCT01295827|466646249|FG005|Overall Study|Other|0|||
129642739|NCT01295827|466646250|FG006|Overall Study|Other|1|||
129642740|NCT01295827|466646251|FG007|Overall Study|Other|1|||
129642741|NCT01295827|466646252|FG008|Overall Study|Other|1|||
129642742|NCT01295827|466646253|FG009|Overall Study|Other|0|||
129642743|NCT01295827|466646254|FG010|Overall Study|Other|2|||
129642744|NCT01295827|466646255|FG011|Overall Study|Other|0|||
129642745|NCT01295827|466646256|FG012|Overall Study|Other|0|||
129642746|NCT01295827|466646257|FG013|Overall Study|Other|0|||
129642747|NCT01295827|466646258|FG014|Overall Study|Other|0|||
129642748|NCT01668173|466646259|FG000|Overall Study|Adverse Event|3|||
129642749|NCT01668173|466646259|FG000|Overall Study|Trial suspension|4|||
129642750|NCT00746564|466646262|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
129642751|NCT02640677|466646266|FG000|Overall Study|Lost to Follow-up|1|||
129642752|NCT02640677|466646266|FG000|Overall Study|Withdrawal by Subject|1|||
129642753|NCT01516008|466646267|FG000|Overall Study|Adverse Event|0|||
129642754|NCT01516008|466646268|FG001|Overall Study|Adverse Event|2|||
129642755|NCT01516008|466646269|FG002|Overall Study|Adverse Event|7|||
129642756|NCT01516008|466646267|FG000|Overall Study|Lack of Efficacy|44|||
129642757|NCT01516008|466646268|FG001|Overall Study|Lack of Efficacy|14|||
129642758|NCT01516008|466646269|FG002|Overall Study|Lack of Efficacy|10|||
129642759|NCT01516008|466646267|FG000|Overall Study|Protocol Violation|1|||
129642760|NCT01516008|466646268|FG001|Overall Study|Protocol Violation|0|||
129642761|NCT01516008|466646269|FG002|Overall Study|Protocol Violation|0|||
129642762|NCT01516008|466646267|FG000|Overall Study|Reason not specified|0|||
129798861|NCT01178073|467232183|FG000|Overall Study|Protocol Violation|1|||
129798862|NCT01178073|467232184|FG001|Overall Study|Protocol Violation|1|||
129798863|NCT01178073|467232185|FG002|Overall Study|Protocol Violation|1|||
129798864|NCT01178073|467232183|FG000|Overall Study|Lost to Follow-up|2|||
129642763|NCT01516008|466646268|FG001|Overall Study|Reason not specified|0|||
129642764|NCT01516008|466646269|FG002|Overall Study|Reason not specified|1|||
129642765|NCT03617770|466646273|FG000|Overall Study|Lost to Follow-up|1|||
129642766|NCT03617770|466646274|FG001|Overall Study|Lost to Follow-up|0|||
129642767|NCT00356135|466646275|FG000|Overall Study|Protocol Violation|1|||
129642768|NCT00356135|466646276|FG001|Overall Study|Protocol Violation|0|||
129642769|NCT00356135|466646277|FG002|Overall Study|Protocol Violation|0|||
129642770|NCT00356135|466646275|FG000|Overall Study|Adverse Event|1|||
129642771|NCT00356135|466646276|FG001|Overall Study|Adverse Event|0|||
129642772|NCT00356135|466646277|FG002|Overall Study|Adverse Event|0|||
129642773|NCT00356135|466646275|FG000|Overall Study|Lost to Follow-up|0|||
129642774|NCT00356135|466646276|FG001|Overall Study|Lost to Follow-up|0|||
129642775|NCT00356135|466646277|FG002|Overall Study|Lost to Follow-up|1|||
129642776|NCT00356135|466646275|FG000|Overall Study|Physician Decision|1|||
129642777|NCT00356135|466646276|FG001|Overall Study|Physician Decision|1|||
129642778|NCT00356135|466646277|FG002|Overall Study|Physician Decision|1|||
129642779|NCT00356135|466646275|FG000|Overall Study|Subject non-compliance|1|||
129642780|NCT00356135|466646276|FG001|Overall Study|Subject non-compliance|1|||
129642781|NCT00356135|466646277|FG002|Overall Study|Subject non-compliance|3|||
129798865|NCT01178073|467232184|FG001|Overall Study|Lost to Follow-up|0|||
129798866|NCT01178073|467232185|FG002|Overall Study|Lost to Follow-up|3|||
129642782|NCT03963232|466646278|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129642783|NCT03963232|466646279|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
129798867|NCT01178073|467232183|FG000|Overall Study|Physician Decision|14|||
129642784|NCT03963232|466646278|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
129642785|NCT03963232|466646279|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129642786|NCT03963232|466646278|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
129642787|NCT03963232|466646279|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
129642788|NCT03963232|466646278|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
129642789|NCT03963232|466646279|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129642790|NCT03963232|466646278|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
129642791|NCT03963232|466646279|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
129642792|NCT03963232|466646278|FG000|Open-Label Treatment Phase|Adverse Event|1|||
129642793|NCT03963232|466646279|FG001|Open-Label Treatment Phase|Adverse Event|2|||
129642794|NCT03963232|466646278|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
129642795|NCT03963232|466646279|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
129642796|NCT03963232|466646278|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
129642797|NCT03963232|466646279|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
129642798|NCT03963232|466646278|FG000|Open-Label Treatment Phase|Pregnancy|1|||
129642799|NCT03963232|466646279|FG001|Open-Label Treatment Phase|Pregnancy|0|||
129642800|NCT03963232|466646278|FG000|Follow-up Phase|Withdrawal by Subject|7|||
129642801|NCT03963232|466646279|FG001|Follow-up Phase|Withdrawal by Subject|5|||
129642802|NCT03963232|466646278|FG000|Follow-up Phase|Protocol Violation|0|||
129642803|NCT03963232|466646279|FG001|Follow-up Phase|Protocol Violation|2|||
129642804|NCT03963232|466646278|FG000|Follow-up Phase|Adverse Event|0|||
129642805|NCT03963232|466646279|FG001|Follow-up Phase|Adverse Event|1|||
129642806|NCT03963232|466646278|FG000|Follow-up Phase|Lost to Follow-up|0|||
129642807|NCT03963232|466646279|FG001|Follow-up Phase|Lost to Follow-up|1|||
129642808|NCT03512210|466646281|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
129642809|NCT03512210|466646281|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
129642810|NCT03512210|466646281|FG000|Step 2:Post-MINMON|Death|2|||
129642811|NCT03512210|466646281|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
129642812|NCT03512210|466646281|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
129642813|NCT03725761|466646282|FG000|Overall Study|still on study|1|||
129642814|NCT02836236|466649013|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
129642815|NCT02836236|466649014|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
129642816|NCT02836236|466649015|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
129642817|NCT02836236|466649016|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
129642818|NCT02836236|466649013|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
129642819|NCT02836236|466649014|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
129642820|NCT02836236|466649015|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129642821|NCT02836236|466649016|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
129642822|NCT02836236|466649013|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129642823|NCT02836236|466649014|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
129642824|NCT02836236|466649015|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129642825|NCT02836236|466649016|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129642826|NCT02836236|466649013|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
129642827|NCT02836236|466649014|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129642828|NCT02836236|466649015|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129642829|NCT02836236|466649016|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
129642830|NCT02836236|466649013|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129642831|NCT02836236|466649014|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
129642832|NCT02836236|466649015|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
129642833|NCT02836236|466649016|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
129642834|NCT02836236|466649013|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129642835|NCT02836236|466649014|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
129642836|NCT02836236|466649015|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
129642837|NCT02836236|466649016|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
129642838|NCT02836236|466649013|FG000|Open-Label TAF Treatment Phase|Death|0|||
129642839|NCT02836236|466649014|FG001|Open-Label TAF Treatment Phase|Death|0|||
129642840|NCT02836236|466649015|FG002|Open-Label TAF Treatment Phase|Death|1|||
129642841|NCT02836236|466649016|FG003|Open-Label TAF Treatment Phase|Death|1|||
129642842|NCT02836236|466649013|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
129642843|NCT02836236|466649014|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
129642844|NCT02836236|466649015|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
129642845|NCT02836236|466649016|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
129642846|NCT01806961|466649017|FG000|Overall Study|sponsor decision|16|||
129642847|NCT00784238|466649018|FG000|Overall Study|Adverse Event|14|||
129798868|NCT01178073|467232184|FG001|Overall Study|Physician Decision|10|||
129798869|NCT01178073|467232185|FG002|Overall Study|Physician Decision|10|||
129642848|NCT00784238|466649018|FG000|Overall Study|Death|2|||
129642849|NCT00784238|466649018|FG000|Overall Study|Lack of Efficacy|33|||
129642850|NCT00784238|466649018|FG000|Overall Study|Lost to Follow-up|29|||
129642851|NCT00784238|466649018|FG000|Overall Study|Pregnancy|1|||
129642852|NCT00784238|466649018|FG000|Overall Study|Withdrawal by Subject|26|||
129443523|NCT01521897|465924405|FG000|Overall Study|Protocol Violation|18|||
129642853|NCT00784238|466649018|FG000|Overall Study|Other|14|||
129642854|NCT03693612|466649019|FG000|Overall Study|Lost to Follow-up|0|||
129642855|NCT03693612|466649020|FG001|Overall Study|Lost to Follow-up|0|||
129642856|NCT03693612|466649021|FG002|Overall Study|Lost to Follow-up|0|||
129642857|NCT03693612|466649022|FG003|Overall Study|Lost to Follow-up|0|||
129642858|NCT03693612|466649023|FG004|Overall Study|Lost to Follow-up|1|||
129642859|NCT03693612|466649024|FG005|Overall Study|Lost to Follow-up|0|||
129642860|NCT03693612|466649025|FG006|Overall Study|Lost to Follow-up|0|||
129642861|NCT03693612|466649019|FG000|Overall Study|Withdrawal by Subject|0|||
129642862|NCT03693612|466649020|FG001|Overall Study|Withdrawal by Subject|0|||
129642863|NCT03693612|466649021|FG002|Overall Study|Withdrawal by Subject|1|||
129642864|NCT03693612|466649022|FG003|Overall Study|Withdrawal by Subject|0|||
129642865|NCT03693612|466649023|FG004|Overall Study|Withdrawal by Subject|2|||
129642866|NCT03693612|466649024|FG005|Overall Study|Withdrawal by Subject|0|||
129642867|NCT03693612|466649025|FG006|Overall Study|Withdrawal by Subject|0|||
129642868|NCT03693612|466649019|FG000|Overall Study|Study Terminated by Sponsor|0|||
129642869|NCT03693612|466649020|FG001|Overall Study|Study Terminated by Sponsor|1|||
129642870|NCT03693612|466649021|FG002|Overall Study|Study Terminated by Sponsor|0|||
129642871|NCT03693612|466649022|FG003|Overall Study|Study Terminated by Sponsor|0|||
129642872|NCT03693612|466649023|FG004|Overall Study|Study Terminated by Sponsor|3|||
129642873|NCT03693612|466649024|FG005|Overall Study|Study Terminated by Sponsor|0|||
129642874|NCT03693612|466649025|FG006|Overall Study|Study Terminated by Sponsor|0|||
129642875|NCT05318092|466649026|FG000|Overall Study|Lost to Follow-up|3|||
129642876|NCT05318092|466649026|FG000|Overall Study|Withdrawal by Subject|1|||
129642877|NCT04434469|466649027|FG000|Overall Study|Death|2|||
129642878|NCT04434469|466649028|FG001|Overall Study|Death|3|||
129642879|NCT04434469|466649029|FG002|Overall Study|Death|2|||
129642880|NCT04434469|466649030|FG003|Overall Study|Death|2|||
129642881|NCT04434469|466649031|FG004|Overall Study|Death|2|||
129642882|NCT04434469|466649032|FG005|Overall Study|Death|0|||
129642883|NCT04434469|466649027|FG000|Overall Study|Lost to Follow-up|0|||
129642884|NCT04434469|466649028|FG001|Overall Study|Lost to Follow-up|0|||
129642885|NCT04434469|466649029|FG002|Overall Study|Lost to Follow-up|0|||
129642886|NCT04434469|466649030|FG003|Overall Study|Lost to Follow-up|1|||
129642887|NCT04434469|466649031|FG004|Overall Study|Lost to Follow-up|1|||
129642888|NCT04434469|466649032|FG005|Overall Study|Lost to Follow-up|0|||
129642889|NCT04434469|466649027|FG000|Overall Study|Study terminated by sponsor|1|||
129642890|NCT04434469|466649028|FG001|Overall Study|Study terminated by sponsor|1|||
129642891|NCT04434469|466649029|FG002|Overall Study|Study terminated by sponsor|1|||
129642892|NCT04434469|466649030|FG003|Overall Study|Study terminated by sponsor|2|||
129642893|NCT04434469|466649031|FG004|Overall Study|Study terminated by sponsor|3|||
129642894|NCT04434469|466649032|FG005|Overall Study|Study terminated by sponsor|3|||
129642895|NCT04434469|466649027|FG000|Overall Study|Withdrawal by Subject|0|||
129642896|NCT04434469|466649028|FG001|Overall Study|Withdrawal by Subject|0|||
129642897|NCT04434469|466649029|FG002|Overall Study|Withdrawal by Subject|1|||
129642898|NCT04434469|466649030|FG003|Overall Study|Withdrawal by Subject|0|||
129642899|NCT04434469|466649031|FG004|Overall Study|Withdrawal by Subject|0|||
129642900|NCT04434469|466649032|FG005|Overall Study|Withdrawal by Subject|0|||
129642901|NCT01154296|466649035|FG000|Randomization and Intervention|Decided to decline|1|||
129642902|NCT01154296|466649036|FG001|Randomization and Intervention|Decided to decline|1|||
129642903|NCT01154296|466649035|FG000|Randomization and Intervention|Declined by staff|1|||
129642904|NCT01154296|466649036|FG001|Randomization and Intervention|Declined by staff|0|||
129642905|NCT01154296|466649035|FG000|Randomization and Intervention|Did not return|1|||
129642906|NCT01154296|466649036|FG001|Randomization and Intervention|Did not return|0|||
129642907|NCT01154296|466649035|FG000|Randomization and Intervention|Left before test|0|||
129705663|NCT00976456|466885720|FG001|Overall Study|Withdrawal by Subject|1|||
129705664|NCT00976456|466885719|FG000|Overall Study|screening failure, unknown|11|||
129705665|NCT00976456|466885720|FG001|Overall Study|screening failure, unknown|4|||
129705666|NCT02735200|466885722|FG000|Overall Study|Lost to Follow-up|0|||
129705667|NCT02735200|466885723|FG001|Overall Study|Lost to Follow-up|5|||
129705668|NCT02735200|466885722|FG000|Overall Study|Withdrawal by Subject|8|||
129705669|NCT02735200|466885723|FG001|Overall Study|Withdrawal by Subject|0|||
129705670|NCT01463527|466885724|FG000|Overall Study|Protocol Violation|1|||
129705671|NCT01463527|466885725|FG001|Overall Study|Protocol Violation|1|||
129642908|NCT01154296|466649036|FG001|Randomization and Intervention|Left before test|1|||
129642909|NCT01154296|466649035|FG000|Randomization and Intervention|Left clinic early|2|||
129642910|NCT01154296|466649036|FG001|Randomization and Intervention|Left clinic early|0|||
129642911|NCT01154296|466649035|FG000|6-month Follow-up|Lost contact|269|||
129642912|NCT01154296|466649036|FG001|6-month Follow-up|Lost contact|275|||
129642913|NCT01154296|466649035|FG000|6-month Follow-up|Incarcerated|37|||
129642914|NCT01154296|466649036|FG001|6-month Follow-up|Incarcerated|32|||
129642915|NCT01154296|466649035|FG000|6-month Follow-up|Withdrew consent|14|||
129642916|NCT01154296|466649036|FG001|6-month Follow-up|Withdrew consent|15|||
129705672|NCT01463527|466885724|FG000|Overall Study|Crying >20% of sedation|5|||
129798870|NCT01178073|467232183|FG000|Overall Study|Withdrawal by Subject|10|||
129642917|NCT01154296|466649035|FG000|6-month Follow-up|Death|3|||
129642918|NCT01154296|466649036|FG001|6-month Follow-up|Death|2|||
129642919|NCT01154296|466649035|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
129642920|NCT01154296|466649036|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
129642921|NCT02759055|466649037|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
129642922|NCT02759055|466649038|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
129642923|NCT03692325|466649050|FG000|Overall Study|Adverse Event|2|||
129642924|NCT03692325|466649050|FG000|Overall Study|Progression/Recurrence|2|||
129642925|NCT01936181|466649055|FG000|Randomised, Double-blind|Adverse Event|27|||
129642926|NCT01936181|466649056|FG001|Randomised, Double-blind|Adverse Event|21|||
129642927|NCT01936181|466649057|FG002|Randomised, Double-blind|Adverse Event|0|||
129642928|NCT01936181|466649058|FG003|Randomised, Double-blind|Adverse Event|0|||
129642929|NCT01936181|466649055|FG000|Randomised, Double-blind|Protocol Violation|1|||
129642930|NCT01936181|466649056|FG001|Randomised, Double-blind|Protocol Violation|5|||
129642931|NCT01936181|466649057|FG002|Randomised, Double-blind|Protocol Violation|0|||
129642932|NCT01936181|466649058|FG003|Randomised, Double-blind|Protocol Violation|0|||
129642933|NCT01936181|466649055|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
129642934|NCT01936181|466649056|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
129642935|NCT01936181|466649057|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
129642936|NCT01936181|466649058|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
129642937|NCT01936181|466649055|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
129642938|NCT01936181|466649056|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
129642939|NCT01936181|466649057|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
129642940|NCT01936181|466649058|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
129642941|NCT01936181|466649055|FG000|Randomised, Double-blind|Pregnancy|0|||
129642942|NCT01936181|466649056|FG001|Randomised, Double-blind|Pregnancy|1|||
129642943|NCT01936181|466649057|FG002|Randomised, Double-blind|Pregnancy|0|||
129642944|NCT01936181|466649058|FG003|Randomised, Double-blind|Pregnancy|0|||
129642945|NCT01936181|466649055|FG000|Randomised, Double-blind|Physician Decision|4|||
129642946|NCT01936181|466649056|FG001|Randomised, Double-blind|Physician Decision|4|||
129642947|NCT01936181|466649057|FG002|Randomised, Double-blind|Physician Decision|0|||
129642948|NCT01936181|466649058|FG003|Randomised, Double-blind|Physician Decision|0|||
129642949|NCT01936181|466649055|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
129642950|NCT01936181|466649056|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
129642951|NCT01936181|466649057|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
129642952|NCT01936181|466649058|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
129642953|NCT01936181|466649055|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
129642954|NCT01936181|466649056|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
129642955|NCT01936181|466649057|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
129642956|NCT01936181|466649058|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
129642957|NCT01936181|466649055|FG000|Transition-extension|Adverse Event|3|||
129642958|NCT01936181|466649056|FG001|Transition-extension|Adverse Event|0|||
129642959|NCT01936181|466649057|FG002|Transition-extension|Adverse Event|3|||
129642960|NCT01936181|466649058|FG003|Transition-extension|Adverse Event|1|||
129642961|NCT01936181|466649055|FG000|Transition-extension|Lost to Follow-up|3|||
129642962|NCT01936181|466649056|FG001|Transition-extension|Lost to Follow-up|0|||
129642963|NCT01936181|466649057|FG002|Transition-extension|Lost to Follow-up|1|||
129642964|NCT01936181|466649058|FG003|Transition-extension|Lost to Follow-up|2|||
129642965|NCT01936181|466649055|FG000|Transition-extension|Physician Decision|2|||
129642966|NCT01936181|466649056|FG001|Transition-extension|Physician Decision|0|||
129642967|NCT01936181|466649057|FG002|Transition-extension|Physician Decision|0|||
129642968|NCT01936181|466649058|FG003|Transition-extension|Physician Decision|1|||
129642969|NCT01936181|466649055|FG000|Transition-extension|Withdrawal by Subject|7|||
129642970|NCT01936181|466649056|FG001|Transition-extension|Withdrawal by Subject|0|||
129642971|NCT01936181|466649057|FG002|Transition-extension|Withdrawal by Subject|2|||
129642972|NCT01936181|466649058|FG003|Transition-extension|Withdrawal by Subject|1|||
129642973|NCT02817516|466649059|FG000|Overall Study|Other|0|||
129642974|NCT02817516|466649060|FG001|Overall Study|Other|0|||
129642975|NCT02817516|466649061|FG002|Overall Study|Other|1|||
129642976|NCT02817516|466649062|FG003|Overall Study|Other|0|||
129642977|NCT00664859|466649063|FG000|Overall Study|Adverse Event|2|||
129642978|NCT00664859|466649064|FG001|Overall Study|Adverse Event|1|||
129642979|NCT00664859|466649065|FG002|Overall Study|Adverse Event|3|||
129642980|NCT00664859|466649063|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
129642981|NCT00664859|466649064|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
129642982|NCT00664859|466649065|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
129642983|NCT00664859|466649063|FG000|Overall Study|Noncompliance with protocol|1|||
129642984|NCT00664859|466649064|FG001|Overall Study|Noncompliance with protocol|0|||
129642985|NCT00664859|466649065|FG002|Overall Study|Noncompliance with protocol|4|||
129642986|NCT00664859|466649063|FG000|Overall Study|Laboratory abnormality|2|||
129642987|NCT00664859|466649064|FG001|Overall Study|Laboratory abnormality|1|||
129642988|NCT00664859|466649065|FG002|Overall Study|Laboratory abnormality|4|||
129642989|NCT00664859|466649063|FG000|Overall Study|Withdrawal by Subject|4|||
129443524|NCT01521897|465924405|FG000|Overall Study|Lost to Follow-up|5|||
129642990|NCT00664859|466649064|FG001|Overall Study|Withdrawal by Subject|1|||
129642991|NCT00664859|466649065|FG002|Overall Study|Withdrawal by Subject|3|||
129642992|NCT00664859|466649063|FG000|Overall Study|Lost to Follow-up|2|||
129642993|NCT00664859|466649064|FG001|Overall Study|Lost to Follow-up|2|||
129642994|NCT00664859|466649065|FG002|Overall Study|Lost to Follow-up|1|||
129642995|NCT00664859|466649063|FG000|Overall Study|Other|0|||
129642996|NCT00664859|466649064|FG001|Overall Study|Other|1|||
129642997|NCT00664859|466649065|FG002|Overall Study|Other|2|||
129642998|NCT01943851|466649066|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129642999|NCT01943851|466649067|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643000|NCT01943851|466649068|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643001|NCT01943851|466649069|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129643002|NCT01943851|466649070|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643003|NCT01943851|466649071|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643004|NCT01943851|466649072|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129643005|NCT01943851|466649073|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129643006|NCT01943851|466649074|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
129643007|NCT01943851|466649075|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643008|NCT01943851|466649076|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643009|NCT01943851|466649077|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643010|NCT01943851|466649078|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643011|NCT01943851|466649079|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643012|NCT01943851|466649080|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643013|NCT01943851|466649081|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643014|NCT01943851|466649082|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643015|NCT01943851|466649083|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
129643016|NCT01943851|466649066|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643017|NCT01943851|466649067|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643018|NCT01943851|466649068|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643019|NCT01943851|466649069|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643020|NCT01943851|466649070|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
129643021|NCT01943851|466649071|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643022|NCT01943851|466649072|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643023|NCT01943851|466649073|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
129643024|NCT01943851|466649074|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643025|NCT01943851|466649075|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643026|NCT01943851|466649076|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643027|NCT01943851|466649077|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643028|NCT01943851|466649078|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643029|NCT01943851|466649079|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643030|NCT01943851|466649080|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643031|NCT01943851|466649081|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643032|NCT01943851|466649082|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643033|NCT01943851|466649083|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
129643034|NCT01943851|466649066|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643035|NCT01943851|466649067|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643036|NCT01943851|466649068|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643037|NCT01943851|466649069|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643038|NCT01943851|466649070|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643039|NCT01943851|466649071|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643040|NCT01943851|466649072|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643041|NCT01943851|466649073|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643042|NCT01943851|466649074|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643043|NCT01943851|466649075|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643044|NCT01943851|466649076|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643045|NCT01943851|466649077|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643046|NCT01943851|466649078|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643047|NCT01943851|466649079|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
129643048|NCT01943851|466649080|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643049|NCT01943851|466649081|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129705673|NCT01463527|466885725|FG001|Overall Study|Crying >20% of sedation|6|||
129705674|NCT05136170|466885728|FG000|Overall Study|Withdrawal by Subject|2|||
129705675|NCT05136170|466885729|FG001|Overall Study|Withdrawal by Subject|2|||
129705676|NCT05136170|466885728|FG000|Overall Study|Can no longer make office visits|1|||
129705677|NCT05136170|466885729|FG001|Overall Study|Can no longer make office visits|0|||
129705678|NCT01493414|466885730|FG000|Overall Study|Adverse Event|405|||
129705679|NCT01493414|466885730|FG000|Overall Study|Disease progression|204|||
129705680|NCT01493414|466885730|FG000|Overall Study|Death|101|||
129705681|NCT01493414|466885730|FG000|Overall Study|Physician Decision|93|||
129705682|NCT01493414|466885730|FG000|Overall Study|Withdrawal by Subject|79|||
129705683|NCT01493414|466885730|FG000|Overall Study|Protocol deviation|27|||
129443525|NCT02194062|465924412|FG000|Overall Study|Lost to Follow-up|2|||
129643050|NCT01943851|466649082|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643051|NCT01943851|466649083|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
129643052|NCT01943851|466649066|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643053|NCT01943851|466649067|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643054|NCT01943851|466649068|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643055|NCT01943851|466649069|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643056|NCT01943851|466649070|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643057|NCT01943851|466649071|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643058|NCT01943851|466649072|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643059|NCT01943851|466649073|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643060|NCT01943851|466649074|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643061|NCT01943851|466649075|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643062|NCT01943851|466649076|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643063|NCT01943851|466649077|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643064|NCT01943851|466649078|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643065|NCT01943851|466649079|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643066|NCT01943851|466649080|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643067|NCT01943851|466649081|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
129643068|NCT01943851|466649082|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643069|NCT01943851|466649083|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
129643070|NCT01943851|466649066|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643071|NCT01943851|466649067|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643072|NCT01943851|466649068|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643073|NCT01943851|466649069|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643074|NCT01943851|466649070|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643075|NCT01943851|466649071|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643076|NCT01943851|466649072|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643077|NCT01943851|466649073|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643078|NCT01943851|466649074|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643079|NCT01943851|466649075|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643080|NCT01943851|466649076|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643081|NCT01943851|466649077|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643082|NCT01943851|466649078|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643083|NCT01943851|466649079|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643084|NCT01943851|466649080|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
129643085|NCT01943851|466649081|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
129643086|NCT01943851|466649082|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
129643087|NCT01943851|466649083|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
129643088|NCT00900757|466649084|FG000|Overall Study|screen failure|19|||
129643089|NCT00748189|466649085|FG000|Overall Study|Death|99|||
129643090|NCT00748189|466649086|FG001|Overall Study|Death|84|||
129643091|NCT00748189|466649085|FG000|Overall Study|Withdrawal by Subject|23|||
129643092|NCT00748189|466649086|FG001|Overall Study|Withdrawal by Subject|29|||
129643093|NCT00748189|466649085|FG000|Overall Study|Physician Decision|16|||
129643094|NCT00748189|466649086|FG001|Overall Study|Physician Decision|5|||
129643095|NCT00748189|466649085|FG000|Overall Study|Lost to Follow-up|8|||
129643096|NCT00748189|466649086|FG001|Overall Study|Lost to Follow-up|15|||
129643097|NCT00748189|466649085|FG000|Overall Study|Study terminated by Sponsor|70|||
129643098|NCT00748189|466649086|FG001|Overall Study|Study terminated by Sponsor|79|||
129643099|NCT03320850|466649087|FG000|Overall Study|Lost to Follow-up|0|||
129643100|NCT03320850|466649088|FG001|Overall Study|Lost to Follow-up|0|||
129643101|NCT03320850|466649089|FG002|Overall Study|Lost to Follow-up|0|||
129643102|NCT03320850|466649090|FG003|Overall Study|Lost to Follow-up|0|||
129643103|NCT03320850|466649091|FG004|Overall Study|Lost to Follow-up|1|||
129643104|NCT03320850|466649092|FG005|Overall Study|Lost to Follow-up|2|||
129643105|NCT03320850|466649093|FG006|Overall Study|Lost to Follow-up|2|||
129643106|NCT03320850|466649094|FG007|Overall Study|Lost to Follow-up|0|||
129643107|NCT03320850|466649095|FG008|Overall Study|Lost to Follow-up|6|||
129643108|NCT03320850|466649096|FG009|Overall Study|Lost to Follow-up|4|||
129643109|NCT03320850|466649087|FG000|Overall Study|Withdrawal by Subject|0|||
129705684|NCT01493414|466885730|FG000|Overall Study|Administrative problems|25|||
129705685|NCT01493414|466885730|FG000|Overall Study|Lost to Follow-up|16|||
129705686|NCT01977222|466885735|FG000|Overall Study|Withdrawal by Subject|1|||
129705687|NCT01612676|466885738|FG000|Overall Study|Adverse Event|2|||
129705688|NCT01612676|466885739|FG001|Overall Study|Adverse Event|3|||
129705689|NCT01612676|466885740|FG002|Overall Study|Adverse Event|1|||
129705690|NCT01612676|466885741|FG003|Overall Study|Adverse Event|3|||
129705691|NCT01612676|466885738|FG000|Overall Study|Protocol Violation|0|||
129705692|NCT01612676|466885739|FG001|Overall Study|Protocol Violation|1|||
129705693|NCT01612676|466885740|FG002|Overall Study|Protocol Violation|0|||
129705694|NCT01612676|466885741|FG003|Overall Study|Protocol Violation|0|||
129643110|NCT03320850|466649088|FG001|Overall Study|Withdrawal by Subject|0|||
129643111|NCT03320850|466649089|FG002|Overall Study|Withdrawal by Subject|0|||
129705695|NCT00107276|466885745|FG000|Overall Study|Progression|46|||
129643112|NCT03320850|466649090|FG003|Overall Study|Withdrawal by Subject|0|||
129643113|NCT03320850|466649091|FG004|Overall Study|Withdrawal by Subject|1|||
129643114|NCT03320850|466649092|FG005|Overall Study|Withdrawal by Subject|2|||
129643115|NCT03320850|466649093|FG006|Overall Study|Withdrawal by Subject|4|||
129643116|NCT03320850|466649094|FG007|Overall Study|Withdrawal by Subject|5|||
129643117|NCT03320850|466649095|FG008|Overall Study|Withdrawal by Subject|2|||
129643118|NCT03320850|466649096|FG009|Overall Study|Withdrawal by Subject|1|||
129643119|NCT03320850|466649087|FG000|Overall Study|Lack of Efficacy|0|||
129643120|NCT03320850|466649088|FG001|Overall Study|Lack of Efficacy|0|||
129643121|NCT03320850|466649089|FG002|Overall Study|Lack of Efficacy|0|||
129643122|NCT03320850|466649090|FG003|Overall Study|Lack of Efficacy|1|||
129643123|NCT03320850|466649091|FG004|Overall Study|Lack of Efficacy|0|||
129643124|NCT03320850|466649092|FG005|Overall Study|Lack of Efficacy|1|||
129643125|NCT03320850|466649093|FG006|Overall Study|Lack of Efficacy|0|||
129643126|NCT03320850|466649094|FG007|Overall Study|Lack of Efficacy|2|||
129643127|NCT03320850|466649095|FG008|Overall Study|Lack of Efficacy|0|||
129643128|NCT03320850|466649096|FG009|Overall Study|Lack of Efficacy|3|||
129643129|NCT03320850|466649087|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
129643130|NCT03320850|466649088|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129643131|NCT03320850|466649089|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129643132|NCT03320850|466649090|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
129643133|NCT03320850|466649091|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
129643134|NCT03320850|466649092|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
129643135|NCT03320850|466649093|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
129643136|NCT03320850|466649094|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
129643137|NCT03320850|466649095|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
129643138|NCT03320850|466649096|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
129643139|NCT03320850|466649087|FG000|Overall Study|Adverse Event|0|||
129643140|NCT03320850|466649088|FG001|Overall Study|Adverse Event|0|||
129643141|NCT03320850|466649089|FG002|Overall Study|Adverse Event|0|||
129643142|NCT03320850|466649090|FG003|Overall Study|Adverse Event|0|||
129643143|NCT03320850|466649091|FG004|Overall Study|Adverse Event|0|||
129643144|NCT03320850|466649092|FG005|Overall Study|Adverse Event|2|||
129643145|NCT03320850|466649093|FG006|Overall Study|Adverse Event|1|||
129643146|NCT03320850|466649094|FG007|Overall Study|Adverse Event|0|||
129643147|NCT03320850|466649095|FG008|Overall Study|Adverse Event|2|||
129643148|NCT03320850|466649096|FG009|Overall Study|Adverse Event|0|||
129643149|NCT03320850|466649087|FG000|Overall Study|Reason Not Specified|0|||
129643150|NCT03320850|466649088|FG001|Overall Study|Reason Not Specified|0|||
129643151|NCT03320850|466649089|FG002|Overall Study|Reason Not Specified|0|||
129643152|NCT03320850|466649090|FG003|Overall Study|Reason Not Specified|0|||
129643153|NCT03320850|466649091|FG004|Overall Study|Reason Not Specified|0|||
129643154|NCT03320850|466649092|FG005|Overall Study|Reason Not Specified|1|||
129643155|NCT03320850|466649093|FG006|Overall Study|Reason Not Specified|0|||
129643156|NCT03320850|466649094|FG007|Overall Study|Reason Not Specified|0|||
129643157|NCT03320850|466649095|FG008|Overall Study|Reason Not Specified|0|||
129643158|NCT03320850|466649096|FG009|Overall Study|Reason Not Specified|1|||
129643159|NCT04481191|466649097|FG000|Overall Study|Withdrawn by parent/guardian|15|||
129643160|NCT04481191|466649098|FG001|Overall Study|Withdrawn by parent/guardian|10|||
129643161|NCT01424514|466649099|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
129643162|NCT01424514|466649100|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
129643163|NCT01424514|466649099|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
129643164|NCT01424514|466649100|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
129643165|NCT00546117|466649101|FG000|Overall Study|Withdrawal by Subject|3|||
129643166|NCT00546117|466649102|FG001|Overall Study|Withdrawal by Subject|0|||
129643167|NCT00546117|466649101|FG000|Overall Study|Inability to schedule follow-up visit|1|||
129643168|NCT00546117|466649102|FG001|Overall Study|Inability to schedule follow-up visit|0|||
129643169|NCT02487771|466649105|FG000|Overall Study|Lost to Follow-up|2|||
129643170|NCT02487771|466649106|FG001|Overall Study|Lost to Follow-up|3|||
129643171|NCT02487771|466649105|FG000|Overall Study|Moved out of area|5|||
129643172|NCT02487771|466649106|FG001|Overall Study|Moved out of area|6|||
129643173|NCT02487771|466649105|FG000|Overall Study|Withdrawal by Subject|3|||
129643174|NCT02487771|466649106|FG001|Overall Study|Withdrawal by Subject|5|||
129643175|NCT02653170|466649107|FG000|Overall Study|Withdrawal by Subject|3|||
129643176|NCT02653170|466649108|FG001|Overall Study|Withdrawal by Subject|8|||
129643177|NCT02653170|466649109|FG002|Overall Study|Withdrawal by Subject|3|||
129643178|NCT02653170|466649107|FG000|Overall Study|withdrawn by study team|2|||
129643179|NCT02653170|466649108|FG001|Overall Study|withdrawn by study team|4|||
129643180|NCT02653170|466649109|FG002|Overall Study|withdrawn by study team|5|||
129643181|NCT02653170|466649107|FG000|Overall Study|Lost to Follow-up|12|||
129643182|NCT02653170|466649108|FG001|Overall Study|Lost to Follow-up|4|||
129643183|NCT02653170|466649109|FG002|Overall Study|Lost to Follow-up|10|||
129643184|NCT04984278|466649120|FG000|Period 1|Withdrawal by Subject|1|||
129643185|NCT04984278|466649121|FG001|Period 1|Withdrawal by Subject|0|||
129643186|NCT04984278|466649120|FG000|Period 1|Other|0|||
129643187|NCT04984278|466649121|FG001|Period 1|Other|1|||
129643188|NCT04984278|466649120|FG000|Period 2|Adverse Event|1|||
129643189|NCT04984278|466649121|FG001|Period 2|Adverse Event|0|||
129643190|NCT04984278|466649120|FG000|Period 2|Other|0|||
129643191|NCT04984278|466649121|FG001|Period 2|Other|1|||
129643192|NCT04304235|466649122|FG000|Overall Study|incomplete triage data|0|||
129643193|NCT04304235|466649123|FG001|Overall Study|incomplete triage data|69|||
129643194|NCT04304235|466649124|FG002|Overall Study|incomplete triage data|0|||
129643195|NCT04304235|466649125|FG003|Overall Study|incomplete triage data|0|||
129643196|NCT04304235|466649126|FG004|Overall Study|incomplete triage data|289|||
129643197|NCT04304235|466649127|FG005|Overall Study|incomplete triage data|123|||
129643198|NCT04304235|466649128|FG006|Overall Study|incomplete triage data|65|||
129643199|NCT00425061|466649129|FG000|Overall Study|Adverse Event|1|||
129643200|NCT00425061|466649130|FG001|Overall Study|Adverse Event|0|||
129643201|NCT00425061|466649131|FG002|Overall Study|Adverse Event|0|||
129643202|NCT00425061|466649132|FG003|Overall Study|Adverse Event|2|||
129643203|NCT00425061|466649133|FG004|Overall Study|Adverse Event|2|||
129643204|NCT00425061|466649134|FG005|Overall Study|Adverse Event|0|||
129643205|NCT00425061|466649135|FG006|Overall Study|Adverse Event|0|||
129643206|NCT00425061|466649129|FG000|Overall Study|Lost to Follow-up|0|||
129643207|NCT00425061|466649130|FG001|Overall Study|Lost to Follow-up|1|||
129643208|NCT00425061|466649131|FG002|Overall Study|Lost to Follow-up|0|||
129643209|NCT00425061|466649132|FG003|Overall Study|Lost to Follow-up|0|||
129643210|NCT00425061|466649133|FG004|Overall Study|Lost to Follow-up|0|||
129643211|NCT00425061|466649134|FG005|Overall Study|Lost to Follow-up|0|||
129643212|NCT00425061|466649135|FG006|Overall Study|Lost to Follow-up|0|||
129643213|NCT00425061|466649129|FG000|Overall Study|Protocol Violation|1|||
129643214|NCT00425061|466649130|FG001|Overall Study|Protocol Violation|0|||
129643215|NCT00425061|466649131|FG002|Overall Study|Protocol Violation|0|||
129643216|NCT00425061|466649132|FG003|Overall Study|Protocol Violation|0|||
129643217|NCT00425061|466649133|FG004|Overall Study|Protocol Violation|0|||
129643218|NCT00425061|466649134|FG005|Overall Study|Protocol Violation|0|||
129643219|NCT00425061|466649135|FG006|Overall Study|Protocol Violation|0|||
129643220|NCT00425061|466649129|FG000|Overall Study|Withdrawal by Subject|0|||
129643221|NCT00425061|466649130|FG001|Overall Study|Withdrawal by Subject|1|||
129643222|NCT00425061|466649131|FG002|Overall Study|Withdrawal by Subject|0|||
129643223|NCT00425061|466649132|FG003|Overall Study|Withdrawal by Subject|0|||
129643224|NCT00425061|466649133|FG004|Overall Study|Withdrawal by Subject|1|||
129643225|NCT00425061|466649134|FG005|Overall Study|Withdrawal by Subject|0|||
129643226|NCT00425061|466649135|FG006|Overall Study|Withdrawal by Subject|3|||
129643227|NCT00425061|466649129|FG000|Overall Study|Sponsor's request|0|||
129643228|NCT00425061|466649130|FG001|Overall Study|Sponsor's request|0|||
129643229|NCT00425061|466649131|FG002|Overall Study|Sponsor's request|0|||
129643230|NCT00425061|466649132|FG003|Overall Study|Sponsor's request|0|||
129643231|NCT00425061|466649133|FG004|Overall Study|Sponsor's request|19|||
129643232|NCT00425061|466649134|FG005|Overall Study|Sponsor's request|4|||
129643233|NCT00425061|466649135|FG006|Overall Study|Sponsor's request|15|||
129643234|NCT00425061|466649129|FG000|Overall Study|Physician Decision|0|||
129643235|NCT00425061|466649130|FG001|Overall Study|Physician Decision|0|||
129643236|NCT00425061|466649131|FG002|Overall Study|Physician Decision|0|||
129643237|NCT00425061|466649132|FG003|Overall Study|Physician Decision|0|||
129643238|NCT00425061|466649133|FG004|Overall Study|Physician Decision|1|||
129643239|NCT00425061|466649134|FG005|Overall Study|Physician Decision|0|||
129643240|NCT00425061|466649135|FG006|Overall Study|Physician Decision|0|||
129643241|NCT00425061|466649129|FG000|Overall Study|Other|0|||
129643242|NCT00425061|466649130|FG001|Overall Study|Other|0|||
129643243|NCT00425061|466649131|FG002|Overall Study|Other|0|||
129643244|NCT00425061|466649132|FG003|Overall Study|Other|0|||
129643245|NCT00425061|466649133|FG004|Overall Study|Other|3|||
129643246|NCT00425061|466649134|FG005|Overall Study|Other|0|||
129705696|NCT00107276|466885745|FG000|Overall Study|Adverse Event|6|||
129705697|NCT00107276|466885745|FG000|Overall Study|M.D. decision|2|||
129705698|NCT00107276|466885745|FG000|Overall Study|Patient refusal|1|||
129705699|NCT00107276|466885745|FG000|Overall Study|Death|1|||
129705700|NCT00107276|466885745|FG000|Overall Study|Ineligible|16|||
129705701|NCT02980107|466885746|FG000|Overall Study|Withdrawal by Subject|51|||
129705702|NCT02980107|466885747|FG001|Overall Study|Withdrawal by Subject|62|||
129705703|NCT00945659|466885748|FG000|Overall Study|Lost to Follow-up|7|||
129705704|NCT00945659|466885749|FG001|Overall Study|Lost to Follow-up|20|||
129705705|NCT00945659|466885750|FG002|Overall Study|Lost to Follow-up|17|||
129705706|NCT04562116|466885751|FG000|Overall Study|Lost to Follow-up|1|||
129643247|NCT00425061|466649135|FG006|Overall Study|Other|1|||
129643248|NCT04720911|466649138|FG000|Overall Study|Withdrawal by Subject|0|||
129705707|NCT04562116|466885751|FG000|Overall Study|Withdrawal by Subject|3|||
129643249|NCT04720911|466649139|FG001|Overall Study|Withdrawal by Subject|1|||
129705708|NCT02412670|466885754|FG000|Overall Study|Adverse Event|4|||
129643250|NCT04720911|466649140|FG002|Overall Study|Withdrawal by Subject|0|||
129643251|NCT00090220|466649141|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
129643252|NCT00090220|466649142|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
129643253|NCT00090220|466649143|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129643254|NCT00090220|466649144|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129643255|NCT00090220|466649145|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129643256|NCT00090220|466649146|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129643257|NCT00090220|466649141|FG000|Base Study Vaccination Period|Adverse Event|6|||
129643258|NCT00090220|466649142|FG001|Base Study Vaccination Period|Adverse Event|1|||
129643259|NCT00090220|466649143|FG002|Base Study Vaccination Period|Adverse Event|0|||
129643260|NCT00090220|466649144|FG003|Base Study Vaccination Period|Adverse Event|0|||
129643261|NCT00090220|466649145|FG004|Base Study Vaccination Period|Adverse Event|0|||
129643262|NCT00090220|466649146|FG005|Base Study Vaccination Period|Adverse Event|0|||
129643263|NCT00090220|466649141|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
129643264|NCT00090220|466649142|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
129643265|NCT00090220|466649143|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
129643266|NCT00090220|466649144|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
129643267|NCT00090220|466649145|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129643268|NCT00090220|466649146|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
129643269|NCT00090220|466649141|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
129643270|NCT00090220|466649142|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
129643271|NCT00090220|466649143|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
129643272|NCT00090220|466649144|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
129643273|NCT00090220|466649145|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129643274|NCT00090220|466649146|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
129643275|NCT00090220|466649141|FG000|Base Study Vaccination Period|Patient Moved|6|||
129643276|NCT00090220|466649142|FG001|Base Study Vaccination Period|Patient Moved|2|||
129643277|NCT00090220|466649143|FG002|Base Study Vaccination Period|Patient Moved|0|||
129643278|NCT00090220|466649144|FG003|Base Study Vaccination Period|Patient Moved|0|||
129643279|NCT00090220|466649145|FG004|Base Study Vaccination Period|Patient Moved|0|||
129643280|NCT00090220|466649146|FG005|Base Study Vaccination Period|Patient Moved|0|||
129643281|NCT00090220|466649141|FG000|Base Study Vaccination Period|Other|4|||
129643282|NCT00090220|466649142|FG001|Base Study Vaccination Period|Other|4|||
129643283|NCT00090220|466649143|FG002|Base Study Vaccination Period|Other|0|||
129643284|NCT00090220|466649144|FG003|Base Study Vaccination Period|Other|0|||
129643285|NCT00090220|466649145|FG004|Base Study Vaccination Period|Other|0|||
129643286|NCT00090220|466649146|FG005|Base Study Vaccination Period|Other|0|||
129643287|NCT00090220|466649141|FG000|Base Study Follow-up Period|Adverse Event|6|||
129643288|NCT00090220|466649142|FG001|Base Study Follow-up Period|Adverse Event|1|||
129643289|NCT00090220|466649143|FG002|Base Study Follow-up Period|Adverse Event|0|||
129643290|NCT00090220|466649144|FG003|Base Study Follow-up Period|Adverse Event|0|||
129643291|NCT00090220|466649145|FG004|Base Study Follow-up Period|Adverse Event|0|||
129643292|NCT00090220|466649146|FG005|Base Study Follow-up Period|Adverse Event|0|||
129643293|NCT00090220|466649141|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
129643294|NCT00090220|466649142|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
129643295|NCT00090220|466649143|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
129643296|NCT00090220|466649144|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
129643297|NCT00090220|466649145|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
129643298|NCT00090220|466649146|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
129643299|NCT00090220|466649141|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
129643300|NCT00090220|466649142|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
129643301|NCT00090220|466649143|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
129643302|NCT00090220|466649144|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
129643303|NCT00090220|466649145|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
129643304|NCT00090220|466649146|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
129643305|NCT00090220|466649141|FG000|Base Study Follow-up Period|Patient Moved|20|||
129643306|NCT00090220|466649142|FG001|Base Study Follow-up Period|Patient Moved|28|||
129643307|NCT00090220|466649143|FG002|Base Study Follow-up Period|Patient Moved|0|||
129643308|NCT00090220|466649144|FG003|Base Study Follow-up Period|Patient Moved|0|||
129643309|NCT00090220|466649145|FG004|Base Study Follow-up Period|Patient Moved|0|||
129643310|NCT00090220|466649146|FG005|Base Study Follow-up Period|Patient Moved|0|||
129643311|NCT00090220|466649141|FG000|Base Study Follow-up Period|Other|19|||
129643312|NCT00090220|466649142|FG001|Base Study Follow-up Period|Other|21|||
129643313|NCT00090220|466649143|FG002|Base Study Follow-up Period|Other|0|||
129643314|NCT00090220|466649144|FG003|Base Study Follow-up Period|Other|0|||
129643315|NCT00090220|466649145|FG004|Base Study Follow-up Period|Other|0|||
129643316|NCT00090220|466649146|FG005|Base Study Follow-up Period|Other|0|||
129643317|NCT00090220|466649141|FG000|Extension 1 (EXT1)|Adverse Event|0|||
129643318|NCT00090220|466649142|FG001|Extension 1 (EXT1)|Adverse Event|0|||
129643319|NCT00090220|466649143|FG002|Extension 1 (EXT1)|Adverse Event|4|||
129643320|NCT00090220|466649144|FG003|Extension 1 (EXT1)|Adverse Event|0|||
129643321|NCT00090220|466649145|FG004|Extension 1 (EXT1)|Adverse Event|0|||
129643322|NCT00090220|466649146|FG005|Extension 1 (EXT1)|Adverse Event|0|||
129643323|NCT00090220|466649141|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
129643324|NCT00090220|466649142|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
129643325|NCT00090220|466649143|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
129643326|NCT00090220|466649144|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
129643327|NCT00090220|466649145|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
129643328|NCT00090220|466649146|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
129643329|NCT00090220|466649141|FG000|Extension 1 (EXT1)|Moved|0|||
129643330|NCT00090220|466649142|FG001|Extension 1 (EXT1)|Moved|0|||
129643331|NCT00090220|466649143|FG002|Extension 1 (EXT1)|Moved|2|||
129643332|NCT00090220|466649144|FG003|Extension 1 (EXT1)|Moved|1|||
129643333|NCT00090220|466649145|FG004|Extension 1 (EXT1)|Moved|0|||
129643334|NCT00090220|466649146|FG005|Extension 1 (EXT1)|Moved|0|||
129643335|NCT00090220|466649141|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129643336|NCT00090220|466649142|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129643337|NCT00090220|466649143|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
129643338|NCT00090220|466649144|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129643339|NCT00090220|466649145|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129643340|NCT00090220|466649146|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
129643341|NCT00090220|466649141|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
129643342|NCT00090220|466649142|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
129643343|NCT00090220|466649143|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
129643344|NCT00090220|466649144|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
129643345|NCT00090220|466649145|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
129643346|NCT00090220|466649146|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
129643347|NCT00090220|466649141|FG000|Extension 1 (EXT1)|Other reason|0|||
129643348|NCT00090220|466649142|FG001|Extension 1 (EXT1)|Other reason|0|||
129643349|NCT00090220|466649143|FG002|Extension 1 (EXT1)|Other reason|2|||
129643350|NCT00090220|466649144|FG003|Extension 1 (EXT1)|Other reason|0|||
129643351|NCT00090220|466649145|FG004|Extension 1 (EXT1)|Other reason|0|||
129643352|NCT00090220|466649146|FG005|Extension 1 (EXT1)|Other reason|0|||
129643353|NCT00090220|466649141|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129643354|NCT00090220|466649142|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129643355|NCT00090220|466649143|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129643356|NCT00090220|466649144|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129643357|NCT00090220|466649145|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
129643358|NCT00090220|466649146|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
129643359|NCT00090220|466649141|FG000|Long-term Follow-up (EXT2)|Death|0|||
129643360|NCT00090220|466649142|FG001|Long-term Follow-up (EXT2)|Death|0|||
129643361|NCT00090220|466649143|FG002|Long-term Follow-up (EXT2)|Death|0|||
129643362|NCT00090220|466649144|FG003|Long-term Follow-up (EXT2)|Death|0|||
129643363|NCT00090220|466649145|FG004|Long-term Follow-up (EXT2)|Death|1|||
129643364|NCT00090220|466649146|FG005|Long-term Follow-up (EXT2)|Death|1|||
129643365|NCT00090220|466649141|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129643366|NCT00090220|466649142|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129643367|NCT00090220|466649143|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129643368|NCT00090220|466649144|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129643369|NCT00090220|466649145|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
129643370|NCT00090220|466649146|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
129643371|NCT00090220|466649141|FG000|Long-term Follow-up (EXT2)|Other|0|||
129643372|NCT00090220|466649142|FG001|Long-term Follow-up (EXT2)|Other|0|||
129643373|NCT00090220|466649143|FG002|Long-term Follow-up (EXT2)|Other|0|||
129643374|NCT00090220|466649144|FG003|Long-term Follow-up (EXT2)|Other|0|||
129643375|NCT00090220|466649145|FG004|Long-term Follow-up (EXT2)|Other|1|||
129643376|NCT00090220|466649146|FG005|Long-term Follow-up (EXT2)|Other|0|||
129643377|NCT02137850|466649147|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
129643378|NCT02137850|466649148|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
129643379|NCT02137850|466649149|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
129643380|NCT02137850|466649147|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
129643381|NCT02137850|466649148|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
129705709|NCT02412670|466885755|FG001|Overall Study|Adverse Event|1|||
129705710|NCT02412670|466885754|FG000|Overall Study|Physician Decision|1|||
129705711|NCT02412670|466885755|FG001|Overall Study|Physician Decision|0|||
129705712|NCT02412670|466885754|FG000|Overall Study|Withdrawal by Subject|1|||
129705713|NCT02412670|466885755|FG001|Overall Study|Withdrawal by Subject|0|||
129705714|NCT02412670|466885754|FG000|Overall Study|Ineligible|1|||
129705715|NCT02412670|466885755|FG001|Overall Study|Ineligible|0|||
129705716|NCT02921256|466885761|FG000|Arm 1a v. Arm II|Adverse Event|6|||
129705717|NCT02921256|466885762|FG001|Arm 1a v. Arm II|Adverse Event|15|||
129705718|NCT02921256|466885763|FG002|Arm 1a v. Arm II|Adverse Event|0|||
129705719|NCT02921256|466885761|FG000|Arm 1a v. Arm II|Death|0|||
129705720|NCT02921256|466885762|FG001|Arm 1a v. Arm II|Death|2|||
129705721|NCT02921256|466885763|FG002|Arm 1a v. Arm II|Death|0|||
129705722|NCT02921256|466885761|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
129705723|NCT02921256|466885762|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
129705724|NCT02921256|466885763|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
129705725|NCT02921256|466885761|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
129705726|NCT02921256|466885762|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
129705727|NCT02921256|466885763|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
129643382|NCT02137850|466649149|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
129643383|NCT02137850|466649147|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
129643384|NCT02137850|466649148|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
129643385|NCT02137850|466649149|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
129643386|NCT02137850|466649147|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
129643387|NCT02137850|466649148|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
129643388|NCT02137850|466649149|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
129643389|NCT02137850|466649147|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
129643390|NCT02137850|466649148|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
129643391|NCT02137850|466649149|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
129643392|NCT02137850|466649147|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
129643393|NCT02137850|466649148|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
129643394|NCT02137850|466649149|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
129643395|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129643396|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
129643397|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129643398|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
129643399|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
129643400|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
129643401|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
129643402|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
129643403|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
129643404|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
129643405|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
129643406|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
129643407|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Other|0|||
129643408|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Other|1|||
129643409|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Other|0|||
129643410|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
129643411|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
129643412|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
129643413|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Early site closure|0|||
129643414|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Early site closure|2|||
129643415|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Early site closure|0|||
129643416|NCT02137850|466649147|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
129643417|NCT02137850|466649148|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
129643418|NCT02137850|466649149|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
129643419|NCT02137850|466649147|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
129643420|NCT02137850|466649148|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
129643421|NCT02137850|466649149|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
129643422|NCT02137850|466649147|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
129643423|NCT02137850|466649148|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
129643424|NCT02137850|466649149|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
129643425|NCT02137850|466649147|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
129643426|NCT02137850|466649148|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
129643427|NCT02137850|466649149|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
129643428|NCT02137850|466649147|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
129643429|NCT02137850|466649148|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
129643430|NCT02137850|466649149|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
129643431|NCT02137850|466649147|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
129643432|NCT02137850|466649148|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
129643433|NCT02137850|466649149|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
129643434|NCT02137850|466649147|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129643435|NCT02137850|466649148|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
129643436|NCT02137850|466649149|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
129643437|NCT02137850|466649147|FG000|Extension Phase: Prophylaxis|Other|0|||
129643438|NCT02137850|466649148|FG001|Extension Phase: Prophylaxis|Other|1|||
129643439|NCT02137850|466649149|FG002|Extension Phase: Prophylaxis|Other|0|||
129643440|NCT02137850|466649147|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
129643441|NCT02137850|466649148|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
129643442|NCT02137850|466649149|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
129643443|NCT02651155|466649150|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129643444|NCT02651155|466649151|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129643445|NCT02651155|466649150|FG000|Overall Study|Voluntary Withdrawal|5|||
129643446|NCT02651155|466649151|FG001|Overall Study|Voluntary Withdrawal|0|||
129643447|NCT00537316|466649152|FG000|Part 1|Adverse Event|7|||
129643448|NCT00537316|466649153|FG001|Part 1|Adverse Event|11|||
129890072|NCT02036515|467554596|FG002|Overall Study|Screen failure|0|||
129643449|NCT00537316|466649154|FG002|Part 1|Adverse Event|8|||
129643450|NCT00537316|466649155|FG003|Part 1|Adverse Event|0|||
129643451|NCT00537316|466649156|FG004|Part 1|Adverse Event|0|||
129890073|NCT02036515|467554594|FG000|Overall Study|Withdrawal by Subject|4|||
129643452|NCT00537316|466649157|FG005|Part 1|Adverse Event|0|||
129643453|NCT00537316|466649158|FG006|Part 1|Adverse Event|0|||
129643454|NCT00537316|466649152|FG000|Part 1|Protocol defined clinical event|1|||
129643455|NCT00537316|466649153|FG001|Part 1|Protocol defined clinical event|0|||
129643456|NCT00537316|466649154|FG002|Part 1|Protocol defined clinical event|0|||
129643457|NCT00537316|466649155|FG003|Part 1|Protocol defined clinical event|0|||
129643458|NCT00537316|466649156|FG004|Part 1|Protocol defined clinical event|0|||
129643459|NCT00537316|466649157|FG005|Part 1|Protocol defined clinical event|0|||
129643460|NCT00537316|466649158|FG006|Part 1|Protocol defined clinical event|0|||
129643461|NCT00537316|466649152|FG000|Part 1|Lost to Follow-up|1|||
129643462|NCT00537316|466649153|FG001|Part 1|Lost to Follow-up|0|||
129643463|NCT00537316|466649154|FG002|Part 1|Lost to Follow-up|0|||
129643464|NCT00537316|466649155|FG003|Part 1|Lost to Follow-up|0|||
129643465|NCT00537316|466649156|FG004|Part 1|Lost to Follow-up|0|||
129643466|NCT00537316|466649157|FG005|Part 1|Lost to Follow-up|0|||
129643467|NCT00537316|466649158|FG006|Part 1|Lost to Follow-up|0|||
129643468|NCT00537316|466649152|FG000|Part 1|Withdrawal by Subject|3|||
129643469|NCT00537316|466649153|FG001|Part 1|Withdrawal by Subject|8|||
129643470|NCT00537316|466649154|FG002|Part 1|Withdrawal by Subject|4|||
129643471|NCT00537316|466649155|FG003|Part 1|Withdrawal by Subject|0|||
129643472|NCT00537316|466649156|FG004|Part 1|Withdrawal by Subject|0|||
129643473|NCT00537316|466649157|FG005|Part 1|Withdrawal by Subject|0|||
129643474|NCT00537316|466649158|FG006|Part 1|Withdrawal by Subject|0|||
129643475|NCT00537316|466649152|FG000|Part 1|Protocol Violation|1|||
129643476|NCT00537316|466649153|FG001|Part 1|Protocol Violation|5|||
129643477|NCT00537316|466649154|FG002|Part 1|Protocol Violation|1|||
129643478|NCT00537316|466649155|FG003|Part 1|Protocol Violation|0|||
129643479|NCT00537316|466649156|FG004|Part 1|Protocol Violation|0|||
129643480|NCT00537316|466649157|FG005|Part 1|Protocol Violation|0|||
129643481|NCT00537316|466649158|FG006|Part 1|Protocol Violation|0|||
129643482|NCT00537316|466649152|FG000|Part 1|Did not meet protocol eligibility|1|||
129643483|NCT00537316|466649153|FG001|Part 1|Did not meet protocol eligibility|3|||
129643484|NCT00537316|466649154|FG002|Part 1|Did not meet protocol eligibility|2|||
129643485|NCT00537316|466649155|FG003|Part 1|Did not meet protocol eligibility|0|||
129643486|NCT00537316|466649156|FG004|Part 1|Did not meet protocol eligibility|0|||
129643487|NCT00537316|466649157|FG005|Part 1|Did not meet protocol eligibility|0|||
129643488|NCT00537316|466649158|FG006|Part 1|Did not meet protocol eligibility|0|||
129643489|NCT00537316|466649152|FG000|Part 1|Administrative|0|||
129643490|NCT00537316|466649153|FG001|Part 1|Administrative|0|||
129643491|NCT00537316|466649154|FG002|Part 1|Administrative|2|||
129643492|NCT00537316|466649155|FG003|Part 1|Administrative|0|||
129643493|NCT00537316|466649156|FG004|Part 1|Administrative|0|||
129643494|NCT00537316|466649157|FG005|Part 1|Administrative|0|||
129643495|NCT00537316|466649158|FG006|Part 1|Administrative|0|||
129643496|NCT00537316|466649152|FG000|Part 2|Never entered follow-up|0|||
129643497|NCT00537316|466649153|FG001|Part 2|Never entered follow-up|0|||
129643498|NCT00537316|466649154|FG002|Part 2|Never entered follow-up|0|||
129643499|NCT00537316|466649155|FG003|Part 2|Never entered follow-up|0|||
129643500|NCT00537316|466649156|FG004|Part 2|Never entered follow-up|0|||
129643501|NCT00537316|466649157|FG005|Part 2|Never entered follow-up|0|||
129643502|NCT00537316|466649158|FG006|Part 2|Never entered follow-up|1|||
129643503|NCT00537316|466649152|FG000|Part 2|Adverse Event|4|||
129643504|NCT00537316|466649153|FG001|Part 2|Adverse Event|0|||
129643505|NCT00537316|466649154|FG002|Part 2|Adverse Event|2|||
129643506|NCT00537316|466649155|FG003|Part 2|Adverse Event|0|||
129643507|NCT00537316|466649156|FG004|Part 2|Adverse Event|0|||
129643508|NCT00537316|466649157|FG005|Part 2|Adverse Event|0|||
129643509|NCT00537316|466649158|FG006|Part 2|Adverse Event|0|||
129643510|NCT00537316|466649152|FG000|Part 2|Lost to Follow-up|1|||
129643511|NCT00537316|466649153|FG001|Part 2|Lost to Follow-up|0|||
129643512|NCT00537316|466649154|FG002|Part 2|Lost to Follow-up|2|||
129643513|NCT00537316|466649155|FG003|Part 2|Lost to Follow-up|0|||
129643514|NCT00537316|466649156|FG004|Part 2|Lost to Follow-up|0|||
129643515|NCT00537316|466649157|FG005|Part 2|Lost to Follow-up|0|||
129643516|NCT00537316|466649158|FG006|Part 2|Lost to Follow-up|0|||
129643517|NCT00537316|466649152|FG000|Part 2|Withdrawal by Subject|5|||
129643518|NCT00537316|466649153|FG001|Part 2|Withdrawal by Subject|1|||
129643519|NCT00537316|466649154|FG002|Part 2|Withdrawal by Subject|4|||
129643520|NCT00537316|466649155|FG003|Part 2|Withdrawal by Subject|0|||
129643521|NCT00537316|466649156|FG004|Part 2|Withdrawal by Subject|0|||
129643522|NCT00537316|466649157|FG005|Part 2|Withdrawal by Subject|0|||
129643523|NCT00537316|466649158|FG006|Part 2|Withdrawal by Subject|0|||
129798871|NCT01178073|467232184|FG001|Overall Study|Withdrawal by Subject|6|||
129798872|NCT01178073|467232185|FG002|Overall Study|Withdrawal by Subject|8|||
129798873|NCT01178073|467232183|FG000|Overall Study|Missing Completion Status|1|||
129643524|NCT00537316|466649152|FG000|Part 2|Administrative|16|||
129643525|NCT00537316|466649153|FG001|Part 2|Administrative|8|||
129798874|NCT01178073|467232184|FG001|Overall Study|Missing Completion Status|0|||
129643526|NCT00537316|466649154|FG002|Part 2|Administrative|24|||
129643527|NCT00537316|466649155|FG003|Part 2|Administrative|3|||
129643528|NCT00537316|466649156|FG004|Part 2|Administrative|1|||
129890074|NCT02036515|467554595|FG001|Overall Study|Withdrawal by Subject|7|||
129890075|NCT02036515|467554596|FG002|Overall Study|Withdrawal by Subject|9|||
129890076|NCT02036515|467554594|FG000|Overall Study|Hyperglycemia|0|||
129890077|NCT02036515|467554595|FG001|Overall Study|Hyperglycemia|0|||
129890078|NCT02036515|467554596|FG002|Overall Study|Hyperglycemia|1|||
129890079|NCT03621982|467554597|FG000|Overall Study|Withdrawal by Subject|1|||
129890080|NCT03621982|467554598|FG001|Overall Study|Withdrawal by Subject|0|||
129890081|NCT03621982|467554599|FG002|Overall Study|Withdrawal by Subject|0|||
129890082|NCT03621982|467554600|FG003|Overall Study|Withdrawal by Subject|1|||
129890083|NCT03621982|467554601|FG004|Overall Study|Withdrawal by Subject|0|||
129890084|NCT03621982|467554602|FG005|Overall Study|Withdrawal by Subject|1|||
129890085|NCT03621982|467554603|FG006|Overall Study|Withdrawal by Subject|1|||
129890086|NCT03621982|467554604|FG007|Overall Study|Withdrawal by Subject|0|||
129890087|NCT03621982|467554605|FG008|Overall Study|Withdrawal by Subject|1|||
129890088|NCT03621982|467554606|FG009|Overall Study|Withdrawal by Subject|0|||
129890089|NCT03621982|467554607|FG010|Overall Study|Withdrawal by Subject|2|||
129890090|NCT03621982|467554608|FG011|Overall Study|Withdrawal by Subject|1|||
129890091|NCT03621982|467554609|FG012|Overall Study|Withdrawal by Subject|2|||
129890092|NCT03621982|467554610|FG013|Overall Study|Withdrawal by Subject|2|||
129890093|NCT03621982|467554597|FG000|Overall Study|Investigator/Sponsor decision|0|||
129890094|NCT03621982|467554598|FG001|Overall Study|Investigator/Sponsor decision|0|||
129890095|NCT03621982|467554599|FG002|Overall Study|Investigator/Sponsor decision|0|||
129890096|NCT03621982|467554600|FG003|Overall Study|Investigator/Sponsor decision|0|||
129890097|NCT03621982|467554601|FG004|Overall Study|Investigator/Sponsor decision|0|||
129890098|NCT03621982|467554602|FG005|Overall Study|Investigator/Sponsor decision|0|||
129890099|NCT03621982|467554603|FG006|Overall Study|Investigator/Sponsor decision|0|||
129890100|NCT03621982|467554604|FG007|Overall Study|Investigator/Sponsor decision|0|||
129890101|NCT03621982|467554605|FG008|Overall Study|Investigator/Sponsor decision|0|||
129890102|NCT03621982|467554606|FG009|Overall Study|Investigator/Sponsor decision|0|||
129890103|NCT03621982|467554607|FG010|Overall Study|Investigator/Sponsor decision|0|||
129890104|NCT03621982|467554608|FG011|Overall Study|Investigator/Sponsor decision|4|||
129890105|NCT03621982|467554609|FG012|Overall Study|Investigator/Sponsor decision|0|||
129890106|NCT03621982|467554610|FG013|Overall Study|Investigator/Sponsor decision|2|||
129890107|NCT03621982|467554597|FG000|Overall Study|Death|2|||
129890108|NCT03621982|467554598|FG001|Overall Study|Death|4|||
129890109|NCT03621982|467554599|FG002|Overall Study|Death|4|||
129890110|NCT03621982|467554600|FG003|Overall Study|Death|3|||
129890111|NCT03621982|467554601|FG004|Overall Study|Death|8|||
129890112|NCT03621982|467554602|FG005|Overall Study|Death|4|||
129890113|NCT03621982|467554603|FG006|Overall Study|Death|6|||
129890114|NCT03621982|467554604|FG007|Overall Study|Death|3|||
129890115|NCT03621982|467554605|FG008|Overall Study|Death|0|||
129890116|NCT03621982|467554606|FG009|Overall Study|Death|3|||
129890117|NCT03621982|467554607|FG010|Overall Study|Death|8|||
129890118|NCT03621982|467554608|FG011|Overall Study|Death|4|||
129890119|NCT03621982|467554609|FG012|Overall Study|Death|2|||
129890120|NCT03621982|467554610|FG013|Overall Study|Death|2|||
129890121|NCT03621982|467554597|FG000|Overall Study|Lost to Follow-up|0|||
129890122|NCT03621982|467554598|FG001|Overall Study|Lost to Follow-up|0|||
129890123|NCT03621982|467554599|FG002|Overall Study|Lost to Follow-up|1|||
129890124|NCT03621982|467554600|FG003|Overall Study|Lost to Follow-up|0|||
129890125|NCT03621982|467554601|FG004|Overall Study|Lost to Follow-up|0|||
129705728|NCT02921256|466885761|FG000|Arm 1a v. Arm II|Physician Decision|1|||
129705729|NCT02921256|466885762|FG001|Arm 1a v. Arm II|Physician Decision|1|||
129705730|NCT02921256|466885763|FG002|Arm 1a v. Arm II|Physician Decision|0|||
129705731|NCT02921256|466885761|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
129705732|NCT02921256|466885762|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
129705733|NCT02921256|466885763|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
129705734|NCT02921256|466885761|FG000|Arm Ib v Arm III|Adverse Event|9|||
129890126|NCT03621982|467554602|FG005|Overall Study|Lost to Follow-up|0|||
129705735|NCT02921256|466885762|FG001|Arm Ib v Arm III|Adverse Event|0|||
129705736|NCT02921256|466885763|FG002|Arm Ib v Arm III|Adverse Event|4|||
129890127|NCT03621982|467554603|FG006|Overall Study|Lost to Follow-up|1|||
129890128|NCT03621982|467554604|FG007|Overall Study|Lost to Follow-up|0|||
129890129|NCT03621982|467554605|FG008|Overall Study|Lost to Follow-up|0|||
129890130|NCT03621982|467554606|FG009|Overall Study|Lost to Follow-up|1|||
129890131|NCT03621982|467554607|FG010|Overall Study|Lost to Follow-up|0|||
129890132|NCT03621982|467554608|FG011|Overall Study|Lost to Follow-up|0|||
129890133|NCT03621982|467554609|FG012|Overall Study|Lost to Follow-up|0|||
129890134|NCT03621982|467554610|FG013|Overall Study|Lost to Follow-up|0|||
129890135|NCT00442286|467554613|FG000|Overall Study|Death|2|||
129890136|NCT00442286|467554614|FG001|Overall Study|Death|2|||
129890137|NCT00442286|467554613|FG000|Overall Study|Lost to Follow-up|1|||
129890138|NCT00442286|467554614|FG001|Overall Study|Lost to Follow-up|0|||
129890139|NCT00442286|467554613|FG000|Overall Study|Withdrawal by Subject|2|||
129705737|NCT02921256|466885761|FG000|Arm Ib v Arm III|Death|1|||
129705738|NCT02921256|466885762|FG001|Arm Ib v Arm III|Death|0|||
129705739|NCT02921256|466885763|FG002|Arm Ib v Arm III|Death|1|||
129890140|NCT00442286|467554614|FG001|Overall Study|Withdrawal by Subject|0|||
129890141|NCT00442286|467554613|FG000|Overall Study|System explanted|1|||
129890142|NCT00442286|467554614|FG001|Overall Study|System explanted|0|||
129890143|NCT00442286|467554613|FG000|Overall Study|Patient Injury|1|||
129890144|NCT00442286|467554614|FG001|Overall Study|Patient Injury|0|||
129705740|NCT02921256|466885761|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
129705741|NCT02921256|466885762|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
129705742|NCT02921256|466885763|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
129705743|NCT02921256|466885761|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
129705744|NCT02921256|466885762|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
129705745|NCT02921256|466885763|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
129705746|NCT02921256|466885761|FG000|Arm Ib v Arm III|Physician Decision|4|||
129705747|NCT02921256|466885762|FG001|Arm Ib v Arm III|Physician Decision|0|||
129705748|NCT02921256|466885763|FG002|Arm Ib v Arm III|Physician Decision|1|||
129705749|NCT02921256|466885761|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
129705750|NCT02921256|466885762|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
129798875|NCT01178073|467232185|FG002|Overall Study|Missing Completion Status|0|||
129798876|NCT01721070|467232186|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
129798877|NCT03497676|467232187|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
129798878|NCT03497676|467232188|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
129798879|NCT03497676|467232189|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
129798880|NCT03497676|467232190|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
129798881|NCT03497676|467232187|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
129798882|NCT03497676|467232188|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
129798883|NCT03497676|467232189|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
129798884|NCT03497676|467232190|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
129798885|NCT03497676|467232187|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
129798886|NCT03497676|467232188|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
129798887|NCT03497676|467232189|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
129798888|NCT03497676|467232190|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
129798889|NCT03497676|467232187|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
129798890|NCT03497676|467232188|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
129798891|NCT03497676|467232189|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
129798892|NCT03497676|467232190|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
129798893|NCT03497676|467232187|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
129798894|NCT03497676|467232188|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
129798895|NCT03497676|467232189|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
129798896|NCT03497676|467232190|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
129798897|NCT03497676|467232187|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
129798898|NCT03497676|467232188|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
129798899|NCT03497676|467232189|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
129798900|NCT03497676|467232190|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
129798901|NCT03497676|467232187|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129798902|NCT03497676|467232188|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129798903|NCT03497676|467232189|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
129798904|NCT03497676|467232190|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
129798905|NCT03497676|467232187|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
129798906|NCT03497676|467232188|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
129798907|NCT03497676|467232189|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
129798908|NCT03497676|467232190|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
129798909|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
129798910|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
129798911|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
129798912|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
129798913|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
129798914|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
129798915|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
129798916|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
129798917|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
129798918|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
129798919|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
129890145|NCT01544582|467554615|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
129443526|NCT02194062|465924413|FG001|Overall Study|Lost to Follow-up|2|||
129705751|NCT02921256|466885763|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
129705752|NCT02943473|466885764|FG000|Overall Study|enrolled but not dosed|1|||
129705753|NCT02943473|466885764|FG000|Overall Study|screen failure|1|||
129890146|NCT01544582|467554616|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
129890147|NCT01544582|467554617|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
129890148|NCT01544582|467554618|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
129890149|NCT01544582|467554615|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
129890150|NCT01544582|467554616|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
129890151|NCT01544582|467554617|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
129890152|NCT01544582|467554618|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
129890153|NCT01544582|467554615|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
129890154|NCT01544582|467554616|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
129890155|NCT01544582|467554617|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
129890156|NCT01544582|467554618|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
129890157|NCT01544582|467554615|FG000|Analysis Population|Physician Decision|0|||
129890158|NCT01544582|467554616|FG001|Analysis Population|Physician Decision|13|||
129890159|NCT01544582|467554617|FG002|Analysis Population|Physician Decision|10|||
129890160|NCT01544582|467554618|FG003|Analysis Population|Physician Decision|9|||
129890161|NCT01544582|467554615|FG000|Analysis Population|Safety Reason|0|||
129890162|NCT01544582|467554616|FG001|Analysis Population|Safety Reason|33|||
129890163|NCT01544582|467554617|FG002|Analysis Population|Safety Reason|31|||
129890164|NCT01544582|467554618|FG003|Analysis Population|Safety Reason|8|||
129890165|NCT01544582|467554615|FG000|Analysis Population|Effectiveness Reason|0|||
129890166|NCT01544582|467554616|FG001|Analysis Population|Effectiveness Reason|48|||
129890167|NCT01544582|467554617|FG002|Analysis Population|Effectiveness Reason|29|||
129890168|NCT01544582|467554618|FG003|Analysis Population|Effectiveness Reason|12|||
129890169|NCT01544582|467554615|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
129890170|NCT01544582|467554616|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
129890171|NCT01544582|467554617|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
129890172|NCT01544582|467554618|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
129890173|NCT01544582|467554615|FG000|Analysis Population|Lost to Follow-up|0|||
129890174|NCT01544582|467554616|FG001|Analysis Population|Lost to Follow-up|6|||
129890175|NCT01544582|467554617|FG002|Analysis Population|Lost to Follow-up|6|||
129890176|NCT01544582|467554618|FG003|Analysis Population|Lost to Follow-up|5|||
129890177|NCT01544582|467554615|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
129890178|NCT01544582|467554616|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
129890179|NCT01544582|467554617|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
129890180|NCT01544582|467554618|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
129890181|NCT01544582|467554615|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129890182|NCT01544582|467554616|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129890183|NCT01544582|467554617|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
129890184|NCT01544582|467554618|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
129890185|NCT01544582|467554615|FG000|Analysis Population|Intolerance|0|||
129890186|NCT01544582|467554616|FG001|Analysis Population|Intolerance|1|||
129890187|NCT01544582|467554617|FG002|Analysis Population|Intolerance|0|||
129890188|NCT01544582|467554618|FG003|Analysis Population|Intolerance|0|||
129890189|NCT01544582|467554615|FG000|Analysis Population|Liver Transplantation|0|||
129890190|NCT01544582|467554616|FG001|Analysis Population|Liver Transplantation|0|||
129890191|NCT01544582|467554617|FG002|Analysis Population|Liver Transplantation|1|||
129890192|NCT01544582|467554618|FG003|Analysis Population|Liver Transplantation|0|||
129890193|NCT01544582|467554615|FG000|Analysis Population|No Social Insurance|0|||
129890194|NCT01544582|467554616|FG001|Analysis Population|No Social Insurance|0|||
129890195|NCT01544582|467554617|FG002|Analysis Population|No Social Insurance|1|||
129890196|NCT01544582|467554618|FG003|Analysis Population|No Social Insurance|0|||
129890197|NCT01544582|467554615|FG000|Analysis Population|Poor Adherence|0|||
129890198|NCT01544582|467554616|FG001|Analysis Population|Poor Adherence|0|||
129890199|NCT01544582|467554617|FG002|Analysis Population|Poor Adherence|1|||
129890200|NCT01544582|467554618|FG003|Analysis Population|Poor Adherence|0|||
129890201|NCT01544582|467554615|FG000|Analysis Population|Poor Participant Compliance|0|||
129890202|NCT01544582|467554616|FG001|Analysis Population|Poor Participant Compliance|1|||
129705754|NCT02943473|466885764|FG000|Overall Study|Physician Decision|4|||
129705755|NCT04211363|466885767|FG000|Overall Study|Adverse Event|5|||
129705756|NCT04211363|466885768|FG001|Overall Study|Adverse Event|2|||
129705757|NCT04211363|466885767|FG000|Overall Study|Physician Decision|0|||
129705758|NCT04211363|466885768|FG001|Overall Study|Physician Decision|1|||
129705759|NCT04211363|466885767|FG000|Overall Study|Protocol Violation|1|||
129705760|NCT04211363|466885768|FG001|Overall Study|Protocol Violation|0|||
129705761|NCT04211363|466885767|FG000|Overall Study|Pregnancy|1|||
129705762|NCT04211363|466885768|FG001|Overall Study|Pregnancy|0|||
129890203|NCT01544582|467554617|FG002|Analysis Population|Poor Participant Compliance|0|||
129890204|NCT01544582|467554618|FG003|Analysis Population|Poor Participant Compliance|0|||
129890205|NCT01544582|467554615|FG000|Analysis Population|Programmed Surgery|0|||
129890206|NCT01544582|467554616|FG001|Analysis Population|Programmed Surgery|1|||
129890207|NCT01544582|467554617|FG002|Analysis Population|Programmed Surgery|0|||
129643529|NCT00537316|466649157|FG005|Part 2|Administrative|4|||
129643530|NCT00537316|466649158|FG006|Part 2|Administrative|1|||
129643531|NCT01609543|466649164|FG000|Overall Study|Disease Progression|28|||
129643532|NCT01609543|466649164|FG000|Overall Study|Adverse Event|5|||
129643533|NCT01609543|466649164|FG000|Overall Study|Withdrawal by Subject|1|||
129643534|NCT01609543|466649164|FG000|Overall Study|Protocol Violation|1|||
129643535|NCT01609543|466649164|FG000|Overall Study|Death|7|||
129643536|NCT00507819|466649165|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
129643537|NCT00507819|466649166|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
129643538|NCT03452488|466649168|FG000|Overall Study|Adverse Event|4|||
129643539|NCT03452488|466649169|FG001|Overall Study|Adverse Event|6|||
129643540|NCT03452488|466649170|FG002|Overall Study|Adverse Event|1|||
129643541|NCT03452488|466649168|FG000|Overall Study|Death|0|||
129643542|NCT03452488|466649169|FG001|Overall Study|Death|0|||
129643543|NCT03452488|466649170|FG002|Overall Study|Death|1|||
129643544|NCT03452488|466649168|FG000|Overall Study|Lost to Follow-up|1|||
129643545|NCT03452488|466649169|FG001|Overall Study|Lost to Follow-up|2|||
129643546|NCT03452488|466649170|FG002|Overall Study|Lost to Follow-up|0|||
129643547|NCT03452488|466649168|FG000|Overall Study|PI Decision|1|||
129643548|NCT03452488|466649169|FG001|Overall Study|PI Decision|0|||
129643549|NCT03452488|466649170|FG002|Overall Study|PI Decision|0|||
129643550|NCT03452488|466649168|FG000|Overall Study|Withdrew consent|4|||
129643551|NCT03452488|466649169|FG001|Overall Study|Withdrew consent|2|||
129643552|NCT03452488|466649170|FG002|Overall Study|Withdrew consent|2|||
129643553|NCT03452488|466649168|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
129643554|NCT03452488|466649169|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
129643555|NCT03452488|466649170|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
129643556|NCT03452488|466649168|FG000|Overall Study|Other|0|||
129643557|NCT03452488|466649169|FG001|Overall Study|Other|2|||
129643558|NCT03452488|466649170|FG002|Overall Study|Other|2|||
129643559|NCT01254318|466649175|FG000|Overall Study|Lost to Follow-up|5|||
129643560|NCT01254318|466649175|FG000|Overall Study|Death|47|||
129643561|NCT00330343|466649180|FG000|Overall Study|Lost to Follow-up|5|||
129643562|NCT01992653|466649181|FG000|Overall Study|Death|0|||
129643563|NCT01992653|466649182|FG001|Overall Study|Death|0|||
129643564|NCT01992653|466649183|FG002|Overall Study|Death|1|||
129643565|NCT01992653|466649184|FG003|Overall Study|Death|0|||
129643566|NCT01992653|466649185|FG004|Overall Study|Death|1|||
129643567|NCT01992653|466649186|FG005|Overall Study|Death|0|||
129643568|NCT01992653|466649187|FG006|Overall Study|Death|4|||
129643569|NCT01992653|466649188|FG007|Overall Study|Death|2|||
129643570|NCT01992653|466649181|FG000|Overall Study|Lost to Follow-up|0|||
129643571|NCT01992653|466649182|FG001|Overall Study|Lost to Follow-up|0|||
129643572|NCT01992653|466649183|FG002|Overall Study|Lost to Follow-up|0|||
129643573|NCT01992653|466649184|FG003|Overall Study|Lost to Follow-up|0|||
129643574|NCT01992653|466649185|FG004|Overall Study|Lost to Follow-up|0|||
129643575|NCT01992653|466649186|FG005|Overall Study|Lost to Follow-up|0|||
129643576|NCT01992653|466649187|FG006|Overall Study|Lost to Follow-up|0|||
129643577|NCT01992653|466649188|FG007|Overall Study|Lost to Follow-up|1|||
129643578|NCT01992653|466649181|FG000|Overall Study|Study Completed|0|||
129643579|NCT01992653|466649182|FG001|Overall Study|Study Completed|0|||
129643580|NCT01992653|466649183|FG002|Overall Study|Study Completed|0|||
129643581|NCT01992653|466649184|FG003|Overall Study|Study Completed|0|||
129643582|NCT01992653|466649185|FG004|Overall Study|Study Completed|0|||
129643583|NCT01992653|466649186|FG005|Overall Study|Study Completed|0|||
129643584|NCT01992653|466649187|FG006|Overall Study|Study Completed|0|||
129643585|NCT01992653|466649188|FG007|Overall Study|Study Completed|1|||
129643586|NCT01992653|466649181|FG000|Overall Study|Disease Progression|0|||
129643587|NCT01992653|466649182|FG001|Overall Study|Disease Progression|0|||
129643588|NCT01992653|466649183|FG002|Overall Study|Disease Progression|0|||
129643589|NCT01992653|466649184|FG003|Overall Study|Disease Progression|0|||
129643590|NCT01992653|466649185|FG004|Overall Study|Disease Progression|0|||
129643591|NCT01992653|466649186|FG005|Overall Study|Disease Progression|0|||
129643592|NCT01992653|466649187|FG006|Overall Study|Disease Progression|4|||
129643593|NCT01992653|466649188|FG007|Overall Study|Disease Progression|0|||
129643594|NCT02964208|466649191|FG000|Overall Study|Death|103|||
129643595|NCT02964208|466649191|FG000|Overall Study|Withdrawal by Subject|6|||
129705763|NCT04211363|466885767|FG000|Overall Study|Lost to Follow-up|12|||
129705764|NCT04211363|466885768|FG001|Overall Study|Lost to Follow-up|4|||
129705765|NCT04211363|466885767|FG000|Overall Study|Withdrawal by Subject|11|||
129643596|NCT02964208|466649191|FG000|Overall Study|Lost to Follow-up|6|||
129643597|NCT02964208|466649191|FG000|Overall Study|Unsuccessful Procedure|5|||
129643598|NCT02964208|466649191|FG000|Overall Study|Device Explant|1|||
129643599|NCT02964208|466649191|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
129643600|NCT01743560|466649192|FG000|Overall Study|Disease progression|26|||
129643601|NCT01743560|466649192|FG000|Overall Study|Adverse Event|8|||
129643602|NCT01743560|466649192|FG000|Overall Study|Death|3|||
129643603|NCT01743560|466649192|FG000|Overall Study|Withdrawal by Subject|2|||
129643604|NCT01743560|466649192|FG000|Overall Study|Protocol Violation|1|||
129643605|NCT01743560|466649192|FG000|Overall Study|>1 dose of study drug|3|||
129643606|NCT03226769|466649193|FG000|Overall Study|Withdrawal by Subject|0|||
129643607|NCT03226769|466649194|FG001|Overall Study|Withdrawal by Subject|1|||
129643608|NCT00940823|466649195|FG000|Overall Study|Death|8|||
129643609|NCT00940823|466649196|FG001|Overall Study|Death|12|||
129643610|NCT00940823|466649195|FG000|Overall Study|Lost to Follow-up|27|||
129643611|NCT00940823|466649196|FG001|Overall Study|Lost to Follow-up|20|||
129643612|NCT01758731|466649197|FG000|Overall Study|Physician Decision|1|||
129643613|NCT05270395|466649210|FG000|Overall Study|Lost to Follow-up|2|||
129643614|NCT05270395|466649211|FG001|Overall Study|Lost to Follow-up|2|||
129643615|NCT05270395|466649210|FG000|Overall Study|Death|1|||
129643616|NCT05270395|466649211|FG001|Overall Study|Death|2|||
129643617|NCT05270395|466649210|FG000|Overall Study|Study Team Withdrew|1|||
129643618|NCT05270395|466649211|FG001|Overall Study|Study Team Withdrew|0|||
129643619|NCT00199797|466651044|FG000|Overall Study|Progressive Disease|1|||
129643620|NCT00199797|466651044|FG000|Overall Study|Adverse Event|1|||
129643621|NCT00199797|466651044|FG000|Overall Study|Physician Decision|1|||
129643622|NCT04250350|466651051|FG000|Overall Study|Withdrawal by Subject|13|||
129643623|NCT04250350|466651051|FG000|Overall Study|Lost to Follow-up|8|||
129643624|NCT04250350|466651051|FG000|Overall Study|Adverse Event|5|||
129643625|NCT04250350|466651051|FG000|Overall Study|Lack of Efficacy|4|||
129643626|NCT04250350|466651051|FG000|Overall Study|Physician Decision|1|||
129643627|NCT04250350|466651051|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
129643628|NCT00784550|466651052|FG000|Overall Study|Adverse Event|12|||
129643629|NCT00784550|466651053|FG001|Overall Study|Adverse Event|10|||
129643630|NCT00784550|466651052|FG000|Overall Study|Lack of Efficacy|0|||
129643631|NCT00784550|466651053|FG001|Overall Study|Lack of Efficacy|1|||
129643632|NCT00784550|466651052|FG000|Overall Study|Protocol Violation|10|||
129643633|NCT00784550|466651053|FG001|Overall Study|Protocol Violation|10|||
129643634|NCT00784550|466651052|FG000|Overall Study|Lost to Follow-up|8|||
129643635|NCT00784550|466651053|FG001|Overall Study|Lost to Follow-up|5|||
129643636|NCT00784550|466651052|FG000|Overall Study|Physician Decision|2|||
129643637|NCT00784550|466651053|FG001|Overall Study|Physician Decision|3|||
129643638|NCT00784550|466651052|FG000|Overall Study|Withdrawal by Subject|4|||
129643639|NCT00784550|466651053|FG001|Overall Study|Withdrawal by Subject|13|||
129643640|NCT00688701|466651054|FG000|Overall Study|Adverse Event|1|||
129643641|NCT00688701|466651055|FG001|Overall Study|Adverse Event|0|||
129643642|NCT00688701|466651056|FG002|Overall Study|Adverse Event|5|||
129643643|NCT00688701|466651057|FG003|Overall Study|Adverse Event|3|||
129643644|NCT00688701|466651054|FG000|Overall Study|Lack of Efficacy|0|||
129643645|NCT00688701|466651055|FG001|Overall Study|Lack of Efficacy|1|||
129643646|NCT00688701|466651056|FG002|Overall Study|Lack of Efficacy|0|||
129643647|NCT00688701|466651057|FG003|Overall Study|Lack of Efficacy|0|||
129643648|NCT00688701|466651054|FG000|Overall Study|Withdrawal by Subject|3|||
129643649|NCT00688701|466651055|FG001|Overall Study|Withdrawal by Subject|3|||
129643650|NCT00688701|466651056|FG002|Overall Study|Withdrawal by Subject|4|||
129643651|NCT00688701|466651057|FG003|Overall Study|Withdrawal by Subject|8|||
129643652|NCT00688701|466651054|FG000|Overall Study|Poor compliance to protocol|0|||
129643653|NCT00688701|466651055|FG001|Overall Study|Poor compliance to protocol|1|||
129643654|NCT00688701|466651056|FG002|Overall Study|Poor compliance to protocol|1|||
129643655|NCT00688701|466651057|FG003|Overall Study|Poor compliance to protocol|0|||
129643656|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
129643657|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
129643658|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
129643659|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
129643660|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Death|0|||
129643661|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Death|0|||
129643662|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Death|1|||
129643663|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Death|0|||
129643664|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
129643665|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
129643666|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
129643667|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
129643668|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
129643669|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
129643670|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
129643671|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
129643672|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
129643673|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
129643674|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
129643675|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
129643676|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
129643677|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
129643678|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
129643679|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
129643680|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
129643681|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
129643682|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
129643683|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
129643684|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
129643685|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
129643686|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
129643687|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
129643688|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129643689|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
129643690|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129643691|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129643692|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
129643693|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
129643694|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
129643695|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
129643696|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
129643697|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
129643698|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
129643699|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
129643700|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Other|8|||
129643701|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Other|14|||
129643702|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Other|8|||
129643703|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Other|23|||
129643704|NCT01106677|466651069|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
129643705|NCT01106677|466651070|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
129643706|NCT01106677|466651071|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
129643707|NCT01106677|466651072|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
129643708|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129643709|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
129643710|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
129643711|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
129643712|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Death|0|||
129643713|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Death|0|||
129643714|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Death|0|||
129643715|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Death|1|||
129890208|NCT01544582|467554618|FG003|Analysis Population|Programmed Surgery|0|||
129890209|NCT01544582|467554615|FG000|Analysis Population|Participant in Jail|0|||
129890210|NCT01544582|467554616|FG001|Analysis Population|Participant in Jail|0|||
129890211|NCT01544582|467554617|FG002|Analysis Population|Participant in Jail|1|||
129890212|NCT01544582|467554618|FG003|Analysis Population|Participant in Jail|0|||
129890213|NCT03428815|467554619|FG000|Overall Study|Lost to Follow-up|2|||
129890214|NCT03428815|467554620|FG001|Overall Study|Lost to Follow-up|2|||
129890215|NCT03428815|467554619|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
129890216|NCT03428815|467554620|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
129890217|NCT03428815|467554619|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
129890218|NCT03428815|467554620|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
129890219|NCT03317379|467554625|FG000|Overall Study|Lost to Follow-up|0|||
129705766|NCT04211363|466885768|FG001|Overall Study|Withdrawal by Subject|11|||
129705767|NCT04211363|466885767|FG000|Overall Study|Other|1|||
129705768|NCT04211363|466885768|FG001|Overall Study|Other|2|||
129705769|NCT03097289|466885769|FG000|Overall Study|Adverse Event|1|||
129705770|NCT03097289|466885769|FG000|Overall Study|Equipment failure|2|||
129705771|NCT03097289|466885769|FG000|Overall Study|Collected platelet product unusable|3|||
129705772|NCT01823289|466885770|FG000|Overall Study|Lost to Follow-up|5|||
129705773|NCT01823289|466885770|FG000|Overall Study|Adverse Event|5|||
129705774|NCT01823289|466885770|FG000|Overall Study|Lack of Efficacy|1|||
129705775|NCT01823289|466885770|FG000|Overall Study|Physician Decision|9|||
129705776|NCT01823289|466885770|FG000|Overall Study|Administered contraindicated medicine|1|||
129705777|NCT01823289|466885770|FG000|Overall Study|Transaminase increased more than 3 times|1|||
129705778|NCT01823289|466885770|FG000|Overall Study|Drug affected efficacy and safety|1|||
129705779|NCT01823289|466885770|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
129705780|NCT01736917|466885771|FG000|Overall Study|Adverse Event|1|||
129705781|NCT01736917|466885771|FG000|Overall Study|Protocol Violation|10|||
129890220|NCT03317379|467554626|FG001|Overall Study|Lost to Follow-up|3|||
129890221|NCT03317379|467554627|FG002|Overall Study|Lost to Follow-up|2|||
129890222|NCT00550173|467554628|FG000|Overall Study|Death|45|||
129890223|NCT00550173|467554629|FG001|Overall Study|Death|38|||
129890224|NCT00550173|467554630|FG002|Overall Study|Death|50|||
129705782|NCT01734902|466885772|FG000|Overall Study|Other than listed|0|||
129705783|NCT01734902|466885773|FG001|Overall Study|Other than listed|2|||
129890225|NCT00550173|467554628|FG000|Overall Study|Physician Decision|1|||
129890226|NCT00550173|467554629|FG001|Overall Study|Physician Decision|2|||
129890227|NCT00550173|467554630|FG002|Overall Study|Physician Decision|2|||
129890228|NCT00550173|467554628|FG000|Overall Study|Withdrawal by Subject|9|||
129705784|NCT00060944|466885774|FG000|Overall Study|Adverse Event|12|||
129705785|NCT00060944|466885775|FG001|Overall Study|Adverse Event|10|||
129705786|NCT00060944|466885774|FG000|Overall Study|Death|2|||
129705787|NCT00060944|466885775|FG001|Overall Study|Death|3|||
129890229|NCT00550173|467554629|FG001|Overall Study|Withdrawal by Subject|12|||
129890230|NCT00550173|467554630|FG002|Overall Study|Withdrawal by Subject|17|||
129890231|NCT00550173|467554628|FG000|Overall Study|Sponsor Decision|13|||
129890232|NCT00550173|467554629|FG001|Overall Study|Sponsor Decision|7|||
129890233|NCT00550173|467554630|FG002|Overall Study|Sponsor Decision|1|||
129890234|NCT00550173|467554628|FG000|Overall Study|Lost to Follow-up|4|||
129890235|NCT00550173|467554629|FG001|Overall Study|Lost to Follow-up|4|||
129890236|NCT00550173|467554630|FG002|Overall Study|Lost to Follow-up|3|||
129890237|NCT01354106|467554632|FG000|Overall Study|Withdrawal by Subject|2|||
129890238|NCT00107380|467556044|FG000|Overall Study|Adverse Event|7|||
129890239|NCT00107380|467556044|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
129890240|NCT00107380|467556044|FG000|Overall Study|Progression/relapse|4|||
129890241|NCT00107380|467556044|FG000|Overall Study|Death|3|||
129890242|NCT00107380|467556044|FG000|Overall Study|Other - not protocol specified|7|||
129890243|NCT00107380|467556044|FG000|Overall Study|Ineligible|2|||
129890244|NCT03673098|467556045|FG000|Overall Study|Lost to Follow-up|2|||
129890245|NCT03673098|467556046|FG001|Overall Study|Lost to Follow-up|3|||
129890246|NCT03673098|467556045|FG000|Overall Study|Withdrawal by Subject|6|||
129890247|NCT03673098|467556046|FG001|Overall Study|Withdrawal by Subject|1|||
129890248|NCT03673098|467556045|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
129705788|NCT00060944|466885774|FG000|Overall Study|Withdrawal by Subject|18|||
129705789|NCT00060944|466885775|FG001|Overall Study|Withdrawal by Subject|5|||
129890249|NCT03673098|467556046|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
129890250|NCT01155726|467556052|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
129890251|NCT01155726|467556053|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
129890252|NCT01155726|467556054|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
129890253|NCT01155726|467556055|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
129890254|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Death|0|||
129890255|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Death|2|||
129890256|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
129890257|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
129705790|NCT00060944|466885774|FG000|Overall Study|Disease Progression|93|||
129705791|NCT00060944|466885775|FG001|Overall Study|Disease Progression|94|||
129890258|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
129890259|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
129890260|NCT02459587|467556056|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
129890261|NCT02459587|467556057|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
129890262|NCT02459587|467556056|FG000|6-month Follow-up Assessment|Death|2|||
129890263|NCT02459587|467556057|FG001|6-month Follow-up Assessment|Death|1|||
129890264|NCT02459587|467556056|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
129890265|NCT02459587|467556057|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
129890266|NCT02459587|467556056|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
129890267|NCT02459587|467556057|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
129890268|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Death|2|||
129890269|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Death|0|||
129890270|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
129890271|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
129890272|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
129890273|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
129890274|NCT02459587|467556056|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
129890275|NCT02459587|467556057|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
129890276|NCT03487666|467556058|FG000|Overall Study|Disease progression|4|||
129890277|NCT03487666|467556059|FG001|Overall Study|Disease progression|2|||
129890278|NCT03487666|467556060|FG002|Overall Study|Disease progression|0|||
129890279|NCT03487666|467556058|FG000|Overall Study|Adverse Event|0|||
129890280|NCT03487666|467556059|FG001|Overall Study|Adverse Event|0|||
129890281|NCT03487666|467556060|FG002|Overall Study|Adverse Event|1|||
129890282|NCT02748512|467556067|FG000|Overall Study|Lost to Follow-up|1|||
129890283|NCT02748512|467556068|FG001|Overall Study|Lost to Follow-up|1|||
129890284|NCT03930186|467556069|FG000|Weeks 0 to 16|Adverse Event|6|||
129798920|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
129798921|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
129798922|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
129798923|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
129798924|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
129643716|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
129643717|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
129643718|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
129643719|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
129643720|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
129798925|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
129798926|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
129798927|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
129798928|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
129798929|NCT01226043|467232200|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
129798930|NCT01226043|467232201|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
129798931|NCT01226043|467232202|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
129798932|NCT01226043|467232203|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
129798933|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Adverse Event|0|||
129798934|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Adverse Event|0|||
129798935|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Adverse Event|1|||
129798936|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Adverse Event|1|||
129798937|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
129798938|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
129798939|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
129798940|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
129798941|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
129798942|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
129798943|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
129798944|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
129798945|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
129798946|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
129798947|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
129798948|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
129798949|NCT01226043|467232200|FG000|6-week Re-randomization Phase|Physician Decision|0|||
129798950|NCT01226043|467232201|FG001|6-week Re-randomization Phase|Physician Decision|0|||
129798951|NCT01226043|467232202|FG002|6-week Re-randomization Phase|Physician Decision|3|||
129890285|NCT03930186|467556069|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
129890286|NCT03930186|467556069|FG000|Weeks 16 to 32|Adverse Event|1|||
129890287|NCT03930186|467556069|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
129890288|NCT02264574|467556072|FG000|Overall Study|Death|21|||
129890289|NCT02264574|467556073|FG001|Overall Study|Death|21|||
129890290|NCT02264574|467556072|FG000|Overall Study|Withdrawal by Subject|8|||
129890291|NCT02264574|467556073|FG001|Overall Study|Withdrawal by Subject|6|||
129890292|NCT02264574|467556072|FG000|Overall Study|Other, Not Specified|0|||
129890293|NCT02264574|467556073|FG001|Overall Study|Other, Not Specified|3|||
129890294|NCT02886728|467556077|FG000|Overall Study|Withdrew Consent|31|||
129890295|NCT02886728|467556078|FG001|Overall Study|Withdrew Consent|13|||
129890296|NCT02886728|467556079|FG002|Overall Study|Withdrew Consent|11|||
129890297|NCT02886728|467556080|FG003|Overall Study|Withdrew Consent|47|||
129890298|NCT02886728|467556077|FG000|Overall Study|Lost to Follow-up|12|||
129890299|NCT02886728|467556078|FG001|Overall Study|Lost to Follow-up|6|||
129890300|NCT02886728|467556079|FG002|Overall Study|Lost to Follow-up|13|||
129890301|NCT02886728|467556080|FG003|Overall Study|Lost to Follow-up|12|||
129890302|NCT02886728|467556077|FG000|Overall Study|Adverse Event|13|||
129890303|NCT02886728|467556078|FG001|Overall Study|Adverse Event|5|||
129890304|NCT02886728|467556079|FG002|Overall Study|Adverse Event|5|||
129890305|NCT02886728|467556080|FG003|Overall Study|Adverse Event|11|||
129890306|NCT02886728|467556077|FG000|Overall Study|Investigator's Discretion|11|||
129890307|NCT02886728|467556078|FG001|Overall Study|Investigator's Discretion|7|||
129890308|NCT02886728|467556079|FG002|Overall Study|Investigator's Discretion|5|||
129890309|NCT02886728|467556080|FG003|Overall Study|Investigator's Discretion|11|||
129890310|NCT02886728|467556077|FG000|Overall Study|Death|3|||
129890311|NCT02886728|467556078|FG001|Overall Study|Death|1|||
129890312|NCT02886728|467556079|FG002|Overall Study|Death|0|||
129890313|NCT02886728|467556080|FG003|Overall Study|Death|0|||
129890314|NCT02886728|467556077|FG000|Overall Study|Protocol Violation|0|||
129890315|NCT02886728|467556078|FG001|Overall Study|Protocol Violation|0|||
129890316|NCT02886728|467556079|FG002|Overall Study|Protocol Violation|0|||
129890317|NCT02886728|467556080|FG003|Overall Study|Protocol Violation|4|||
129890318|NCT02886728|467556077|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129890319|NCT02886728|467556078|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129890320|NCT02886728|467556079|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129890321|NCT02886728|467556080|FG003|Overall Study|Non-Compliance with Study Drug|0|||
129890322|NCT02886728|467556077|FG000|Overall Study|Pregnancy|0|||
129890323|NCT02886728|467556078|FG001|Overall Study|Pregnancy|0|||
129890324|NCT02886728|467556079|FG002|Overall Study|Pregnancy|1|||
129890325|NCT02886728|467556080|FG003|Overall Study|Pregnancy|0|||
129890326|NCT02886728|467556077|FG000|Overall Study|Randomized but Not Dosed|1|||
129890327|NCT02886728|467556078|FG001|Overall Study|Randomized but Not Dosed|0|||
129890328|NCT02886728|467556079|FG002|Overall Study|Randomized but Not Dosed|0|||
129890329|NCT02886728|467556080|FG003|Overall Study|Randomized but Not Dosed|2|||
129890330|NCT04990440|467556085|FG000|Overall Study|Sponsor's Decision|0|||
129705792|NCT00060944|466885774|FG000|Overall Study|Lost to Follow-up|1|||
129705793|NCT00060944|466885775|FG001|Overall Study|Lost to Follow-up|0|||
129705794|NCT00060944|466885774|FG000|Overall Study|Subject Ineligible To Continue|2|||
129705795|NCT00060944|466885775|FG001|Overall Study|Subject Ineligible To Continue|1|||
129705796|NCT00060944|466885774|FG000|Overall Study|Treatment Switch|0|||
129705797|NCT00060944|466885775|FG001|Overall Study|Treatment Switch|13|||
129705798|NCT00060944|466885774|FG000|Overall Study|Other|2|||
129705799|NCT00060944|466885775|FG001|Overall Study|Other|4|||
129705800|NCT00060944|466885774|FG000|Overall Study|randomized but not treated|6|||
129705801|NCT00060944|466885775|FG001|Overall Study|randomized but not treated|4|||
129890331|NCT04990440|467556086|FG001|Overall Study|Sponsor's Decision|0|||
129890332|NCT04990440|467556087|FG002|Overall Study|Sponsor's Decision|1|||
129890333|NCT03712098|467556088|FG000|Overall Study|Lost to Follow-up|3|||
129890334|NCT03712098|467556089|FG001|Overall Study|Lost to Follow-up|7|||
129890335|NCT03712098|467556088|FG000|Overall Study|Withdrawal by Subject|9|||
129705802|NCT03213509|466885777|FG000|Overall Study|Did not consent for verbal autopsy|4|||
129705803|NCT03213509|466885778|FG001|Overall Study|Did not consent for verbal autopsy|5|||
129705804|NCT04549454|466885781|FG000|T1 to T2|Lost to Follow-up|22|||
129705805|NCT04549454|466885782|FG001|T1 to T2|Lost to Follow-up|26|||
129705806|NCT04549454|466885781|FG000|T1 to T3|Lost to Follow-up|31|||
129705807|NCT04549454|466885782|FG001|T1 to T3|Lost to Follow-up|36|||
129705808|NCT00867035|466885783|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
129705809|NCT00867035|466885784|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
129705810|NCT00867035|466885783|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
129705811|NCT00867035|466885784|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
129705812|NCT00016354|466885785|FG000|Overall Study|Lack of Efficacy|0|||
129705813|NCT00016354|466885786|FG001|Overall Study|Lack of Efficacy|0|||
129705814|NCT00016354|466885787|FG002|Overall Study|Lack of Efficacy|0|||
129705815|NCT00016354|466885788|FG003|Overall Study|Lack of Efficacy|0|||
129705816|NCT00016354|466885789|FG004|Overall Study|Lack of Efficacy|0|||
129705817|NCT00016354|466885790|FG005|Overall Study|Lack of Efficacy|0|||
129705818|NCT00016354|466885791|FG006|Overall Study|Lack of Efficacy|0|||
129705819|NCT00016354|466885792|FG007|Overall Study|Lack of Efficacy|1|||
129705820|NCT03110562|466885793|FG000|Initial Treatment Period|Disease Progression|1|||
129705821|NCT03110562|466885794|FG001|Initial Treatment Period|Disease Progression|1|||
129890336|NCT03712098|467556089|FG001|Overall Study|Withdrawal by Subject|4|||
129890337|NCT03712098|467556088|FG000|Overall Study|Protocol Violation|2|||
129890338|NCT03712098|467556089|FG001|Overall Study|Protocol Violation|1|||
129798952|NCT01226043|467232203|FG003|6-week Re-randomization Phase|Physician Decision|2|||
129798953|NCT01226043|467232200|FG000|6-week Re-randomization Phase|completed in error|0|||
129798954|NCT01226043|467232201|FG001|6-week Re-randomization Phase|completed in error|0|||
129798955|NCT01226043|467232202|FG002|6-week Re-randomization Phase|completed in error|0|||
129798956|NCT01226043|467232203|FG003|6-week Re-randomization Phase|completed in error|1|||
129798957|NCT01226043|467232200|FG000|30-week Observational Phase|Adverse Event|0|||
129798958|NCT01226043|467232201|FG001|30-week Observational Phase|Adverse Event|0|||
129798959|NCT01226043|467232202|FG002|30-week Observational Phase|Adverse Event|1|||
129798960|NCT01226043|467232203|FG003|30-week Observational Phase|Adverse Event|1|||
129798961|NCT01226043|467232200|FG000|30-week Observational Phase|Protocol Violation|0|||
129798962|NCT01226043|467232201|FG001|30-week Observational Phase|Protocol Violation|0|||
129798963|NCT01226043|467232202|FG002|30-week Observational Phase|Protocol Violation|0|||
129798964|NCT01226043|467232203|FG003|30-week Observational Phase|Protocol Violation|1|||
129643721|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129643722|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129643723|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129643724|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129643725|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
129643726|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129643727|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
129643728|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129643729|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129643730|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129643731|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129643732|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129643733|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
129643734|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
129643735|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129643736|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
129643737|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
129643738|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
129643739|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
129643740|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129643741|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129643742|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
129643743|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
129643744|NCT01106677|466651069|FG000|Extension Period: Week 26 to Week 52|Other|6|||
129643745|NCT01106677|466651070|FG001|Extension Period: Week 26 to Week 52|Other|5|||
129643746|NCT01106677|466651071|FG002|Extension Period: Week 26 to Week 52|Other|8|||
129643747|NCT01106677|466651072|FG003|Extension Period: Week 26 to Week 52|Other|5|||
129643748|NCT03937908|466651073|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
129643749|NCT03937908|466651074|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
129643750|NCT03875092|466651075|FG000|Overall Study|Adverse Event|2|||
129643751|NCT03875092|466651076|FG001|Overall Study|Adverse Event|5|||
129643752|NCT03875092|466651075|FG000|Overall Study|Death|44|||
129643753|NCT03875092|466651076|FG001|Overall Study|Death|51|||
129643754|NCT03875092|466651075|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
129643755|NCT03875092|466651076|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
129643756|NCT03205761|466651077|FG000|Overall Study|Withdrawal by Subject|1|||
129798965|NCT01226043|467232200|FG000|30-week Observational Phase|Lost to Follow-up|0|||
129798966|NCT01226043|467232201|FG001|30-week Observational Phase|Lost to Follow-up|0|||
129798967|NCT01226043|467232202|FG002|30-week Observational Phase|Lost to Follow-up|2|||
129798968|NCT01226043|467232203|FG003|30-week Observational Phase|Lost to Follow-up|2|||
129643757|NCT03205761|466651077|FG000|Overall Study|Progressive Disease|10|||
129643758|NCT04420585|466651078|FG000|Overall Study|Adverse Event|1|||
129643759|NCT04420585|466651078|FG000|Overall Study|Never initiated medication|2|||
129643760|NCT03558152|466651079|FG000|Overall Study|Adverse Event|0|||
129643761|NCT03558152|466651080|FG001|Overall Study|Adverse Event|0|||
129643762|NCT03558152|466651081|FG002|Overall Study|Adverse Event|1|||
129643763|NCT03558152|466651082|FG003|Overall Study|Adverse Event|1|||
129643764|NCT03558152|466651083|FG004|Overall Study|Adverse Event|2|||
129643765|NCT03558152|466651084|FG005|Overall Study|Adverse Event|1|||
129643766|NCT03558152|466651085|FG006|Overall Study|Adverse Event|1|||
129643767|NCT03558152|466651086|FG007|Overall Study|Adverse Event|0|||
129643768|NCT03558152|466651079|FG000|Overall Study|Death|0|||
129798969|NCT01226043|467232200|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
129705822|NCT03110562|466885795|FG002|Initial Treatment Period|Disease Progression|0|||
129705823|NCT03110562|466885796|FG003|Initial Treatment Period|Disease Progression|0|||
129705824|NCT03110562|466885793|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
129705825|NCT03110562|466885794|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
129705826|NCT03110562|466885795|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
129705827|NCT03110562|466885796|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
129705828|NCT03110562|466885793|FG000|Initial Treatment Period|Adverse Event|1|||
129705829|NCT03110562|466885794|FG001|Initial Treatment Period|Adverse Event|0|||
129705830|NCT03110562|466885795|FG002|Initial Treatment Period|Adverse Event|0|||
129705831|NCT03110562|466885796|FG003|Initial Treatment Period|Adverse Event|0|||
129705832|NCT03110562|466885793|FG000|Initial Treatment Period|Death|74|||
129705833|NCT03110562|466885794|FG001|Initial Treatment Period|Death|82|||
129705834|NCT03110562|466885795|FG002|Initial Treatment Period|Death|0|||
129705835|NCT03110562|466885796|FG003|Initial Treatment Period|Death|0|||
129705836|NCT03110562|466885793|FG000|Initial Treatment Period|Lost to Follow-up|13|||
129705837|NCT03110562|466885794|FG001|Initial Treatment Period|Lost to Follow-up|8|||
129705838|NCT03110562|466885795|FG002|Initial Treatment Period|Lost to Follow-up|0|||
129705839|NCT03110562|466885796|FG003|Initial Treatment Period|Lost to Follow-up|0|||
129705840|NCT03110562|466885793|FG000|Initial Treatment Period|Protocol Deviation|1|||
129705841|NCT03110562|466885794|FG001|Initial Treatment Period|Protocol Deviation|0|||
129705842|NCT03110562|466885795|FG002|Initial Treatment Period|Protocol Deviation|0|||
129705843|NCT03110562|466885796|FG003|Initial Treatment Period|Protocol Deviation|0|||
129705844|NCT03110562|466885793|FG000|Initial Treatment Period|Physician Decision|2|||
129705845|NCT03110562|466885794|FG001|Initial Treatment Period|Physician Decision|1|||
129705846|NCT03110562|466885795|FG002|Initial Treatment Period|Physician Decision|0|||
129705847|NCT03110562|466885796|FG003|Initial Treatment Period|Physician Decision|0|||
129705848|NCT03110562|466885793|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
129705849|NCT03110562|466885794|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
129705850|NCT03110562|466885795|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
129705851|NCT03110562|466885796|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
129705852|NCT03110562|466885793|FG000|Initial Treatment Period|Other|5|||
129890339|NCT00688259|467556095|FG000|Overall Study|Lost to Follow-up|2|||
129890340|NCT00688259|467556096|FG001|Overall Study|Lost to Follow-up|4|||
129890341|NCT00688259|467556095|FG000|Overall Study|Physician Decision|1|||
129705853|NCT03110562|466885794|FG001|Initial Treatment Period|Other|4|||
129705854|NCT03110562|466885795|FG002|Initial Treatment Period|Other|0|||
129705855|NCT03110562|466885796|FG003|Initial Treatment Period|Other|0|||
129705856|NCT03110562|466885793|FG000|Initial Treatment Period|Randomized but never treated|0|||
129705857|NCT03110562|466885794|FG001|Initial Treatment Period|Randomized but never treated|3|||
129705858|NCT03110562|466885795|FG002|Initial Treatment Period|Randomized but never treated|0|||
129705859|NCT03110562|466885796|FG003|Initial Treatment Period|Randomized but never treated|0|||
129705860|NCT03110562|466885793|FG000|Crossover Period|Disease Progression|0|||
129705861|NCT03110562|466885794|FG001|Crossover Period|Disease Progression|0|||
129705862|NCT03110562|466885795|FG002|Crossover Period|Disease Progression|1|||
129705863|NCT03110562|466885796|FG003|Crossover Period|Disease Progression|0|||
129705864|NCT03110562|466885793|FG000|Crossover Period|Withdrawal by Subject|0|||
129705865|NCT03110562|466885794|FG001|Crossover Period|Withdrawal by Subject|0|||
129705866|NCT03110562|466885795|FG002|Crossover Period|Withdrawal by Subject|8|||
129705867|NCT03110562|466885796|FG003|Crossover Period|Withdrawal by Subject|6|||
129705868|NCT03110562|466885793|FG000|Crossover Period|Death|0|||
129705869|NCT03110562|466885794|FG001|Crossover Period|Death|0|||
129705870|NCT03110562|466885795|FG002|Crossover Period|Death|37|||
129705871|NCT03110562|466885796|FG003|Crossover Period|Death|3|||
129705872|NCT03110562|466885793|FG000|Crossover Period|Lost to Follow-up|0|||
129705873|NCT03110562|466885794|FG001|Crossover Period|Lost to Follow-up|0|||
129705874|NCT03110562|466885795|FG002|Crossover Period|Lost to Follow-up|0|||
129705875|NCT03110562|466885796|FG003|Crossover Period|Lost to Follow-up|1|||
129705876|NCT03110562|466885793|FG000|Crossover Period|Other|0|||
129705877|NCT03110562|466885794|FG001|Crossover Period|Other|0|||
129705878|NCT03110562|466885795|FG002|Crossover Period|Other|1|||
129705879|NCT03110562|466885796|FG003|Crossover Period|Other|1|||
129705880|NCT03110562|466885793|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
129705881|NCT03110562|466885794|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
129705882|NCT03110562|466885795|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
129705883|NCT03110562|466885796|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
129705884|NCT02936323|466885799|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129705885|NCT02936323|466885800|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129705886|NCT02936323|466885801|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129890342|NCT00688259|467556096|FG001|Overall Study|Physician Decision|0|||
129890343|NCT00688259|467556095|FG000|Overall Study|Withdrawal by Subject|2|||
129705887|NCT02936323|466885802|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129705888|NCT02936323|466885803|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129643769|NCT03558152|466651080|FG001|Overall Study|Death|0|||
129643770|NCT03558152|466651081|FG002|Overall Study|Death|0|||
129643771|NCT03558152|466651082|FG003|Overall Study|Death|0|||
129643772|NCT03558152|466651083|FG004|Overall Study|Death|1|||
129643773|NCT03558152|466651084|FG005|Overall Study|Death|0|||
129643774|NCT03558152|466651085|FG006|Overall Study|Death|0|||
129643775|NCT03558152|466651086|FG007|Overall Study|Death|0|||
129643776|NCT03558152|466651079|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
129643777|NCT03558152|466651080|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643778|NCT03558152|466651081|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643779|NCT03558152|466651082|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643780|NCT03558152|466651083|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643781|NCT03558152|466651084|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643782|NCT03558152|466651085|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643783|NCT03558152|466651086|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
129643784|NCT03558152|466651079|FG000|Overall Study|Miscalculation in mmcs|0|||
129643785|NCT03558152|466651080|FG001|Overall Study|Miscalculation in mmcs|0|||
129643786|NCT03558152|466651081|FG002|Overall Study|Miscalculation in mmcs|0|||
129643787|NCT03558152|466651082|FG003|Overall Study|Miscalculation in mmcs|0|||
129643788|NCT03558152|466651083|FG004|Overall Study|Miscalculation in mmcs|0|||
129643789|NCT03558152|466651084|FG005|Overall Study|Miscalculation in mmcs|0|||
129643790|NCT03558152|466651085|FG006|Overall Study|Miscalculation in mmcs|1|||
129643791|NCT03558152|466651086|FG007|Overall Study|Miscalculation in mmcs|0|||
129643792|NCT03558152|466651079|FG000|Overall Study|Mistake in calculation|0|||
129643793|NCT03558152|466651080|FG001|Overall Study|Mistake in calculation|0|||
129643794|NCT03558152|466651081|FG002|Overall Study|Mistake in calculation|0|||
129643795|NCT03558152|466651082|FG003|Overall Study|Mistake in calculation|1|||
129643796|NCT03558152|466651083|FG004|Overall Study|Mistake in calculation|0|||
129643797|NCT03558152|466651084|FG005|Overall Study|Mistake in calculation|0|||
129643798|NCT03558152|466651085|FG006|Overall Study|Mistake in calculation|0|||
129643799|NCT03558152|466651086|FG007|Overall Study|Mistake in calculation|0|||
129643800|NCT03558152|466651079|FG000|Overall Study|Mistake in evaluation of disease status|0|||
129643801|NCT03558152|466651080|FG001|Overall Study|Mistake in evaluation of disease status|0|||
129798970|NCT01226043|467232201|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
129798971|NCT01226043|467232202|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
129798972|NCT01226043|467232203|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
129798973|NCT01226043|467232200|FG000|30-week Observational Phase|Physician Decision|0|||
129798974|NCT01226043|467232201|FG001|30-week Observational Phase|Physician Decision|0|||
129798975|NCT01226043|467232202|FG002|30-week Observational Phase|Physician Decision|2|||
129798976|NCT01226043|467232203|FG003|30-week Observational Phase|Physician Decision|2|||
129798977|NCT02204007|467232204|FG000|Overall Study|Surgery Canceled|1|||
129798978|NCT02204007|467232205|FG001|Overall Study|Surgery Canceled|1|||
129798979|NCT00910988|467232206|FG000|Overall Study|Lost to Follow-up|2|||
129798980|NCT00910988|467232207|FG001|Overall Study|Lost to Follow-up|4|||
129798981|NCT00910988|467232208|FG002|Overall Study|Lost to Follow-up|3|||
129798982|NCT00910988|467232209|FG003|Overall Study|Lost to Follow-up|0|||
129798983|NCT03004443|467232210|FG000|Overall Study|Pregnancy|0|||
129798984|NCT03004443|467232211|FG001|Overall Study|Pregnancy|1|||
129798985|NCT00828854|467232212|FG000|Overall Study|Disease Progression|17|||
129798986|NCT00828854|467232212|FG000|Overall Study|Adverse Event|9|||
129798987|NCT00828854|467232212|FG000|Overall Study|Reason not Specified|1|||
129798988|NCT00191646|467232214|FG000|Overall Study|Toxicity|26|||
129798989|NCT00191646|467232215|FG001|Overall Study|Toxicity|37|||
129798990|NCT00191646|467232214|FG000|Overall Study|Disease Progression|5|||
129798991|NCT00191646|467232215|FG001|Overall Study|Disease Progression|6|||
129798992|NCT00191646|467232214|FG000|Overall Study|Physician Decision|20|||
129798993|NCT00191646|467232215|FG001|Overall Study|Physician Decision|11|||
129798994|NCT00191646|467232214|FG000|Overall Study|Withdrawal by Subject|58|||
129798995|NCT00191646|467232215|FG001|Overall Study|Withdrawal by Subject|39|||
129798996|NCT00191646|467232214|FG000|Overall Study|Protocol Violation|5|||
129798997|NCT00191646|467232215|FG001|Overall Study|Protocol Violation|7|||
129643802|NCT03558152|466651081|FG002|Overall Study|Mistake in evaluation of disease status|0|||
129798998|NCT00191646|467232214|FG000|Overall Study|Death|6|||
129798999|NCT00191646|467232215|FG001|Overall Study|Death|8|||
129799000|NCT00191646|467232214|FG000|Overall Study|Other|33|||
129799001|NCT00191646|467232215|FG001|Overall Study|Other|34|||
129799002|NCT00191646|467232214|FG000|Overall Study|Missing Data|18|||
129799003|NCT00191646|467232215|FG001|Overall Study|Missing Data|11|||
129799004|NCT05211284|467232220|FG000|Overall Study|Study Terminated|3|||
129799005|NCT05211284|467232221|FG001|Overall Study|Study Terminated|1|||
129799006|NCT03911843|467232222|FG000|Overall Study|Adverse Event|2|||
129890344|NCT00688259|467556096|FG001|Overall Study|Withdrawal by Subject|0|||
129799007|NCT03911843|467232223|FG001|Overall Study|Adverse Event|0|||
129799008|NCT03911843|467232222|FG000|Overall Study|Protocol Violation|2|||
129799009|NCT03911843|467232223|FG001|Overall Study|Protocol Violation|0|||
129799010|NCT03911843|467232222|FG000|Overall Study|Lost to Follow-up|0|||
129799011|NCT03911843|467232223|FG001|Overall Study|Lost to Follow-up|1|||
129799012|NCT01907100|467232224|FG000|Overall Study|PD based on modified RECIST criteria|31|||
129643803|NCT03558152|466651082|FG003|Overall Study|Mistake in evaluation of disease status|0|||
129643804|NCT03558152|466651083|FG004|Overall Study|Mistake in evaluation of disease status|0|||
129643805|NCT03558152|466651084|FG005|Overall Study|Mistake in evaluation of disease status|0|||
129643806|NCT03558152|466651085|FG006|Overall Study|Mistake in evaluation of disease status|0|||
129643807|NCT03558152|466651086|FG007|Overall Study|Mistake in evaluation of disease status|1|||
129643808|NCT03558152|466651079|FG000|Overall Study|Physician Decision|0|||
129643809|NCT03558152|466651080|FG001|Overall Study|Physician Decision|0|||
129643810|NCT03558152|466651081|FG002|Overall Study|Physician Decision|0|||
129643811|NCT03558152|466651082|FG003|Overall Study|Physician Decision|0|||
129643812|NCT03558152|466651083|FG004|Overall Study|Physician Decision|0|||
129643813|NCT03558152|466651084|FG005|Overall Study|Physician Decision|0|||
129643814|NCT03558152|466651085|FG006|Overall Study|Physician Decision|1|||
129643815|NCT03558152|466651086|FG007|Overall Study|Physician Decision|0|||
129643816|NCT03558152|466651079|FG000|Overall Study|Withdrawal by Subject|2|||
129643817|NCT03558152|466651080|FG001|Overall Study|Withdrawal by Subject|3|||
129643818|NCT03558152|466651081|FG002|Overall Study|Withdrawal by Subject|2|||
129643819|NCT03558152|466651082|FG003|Overall Study|Withdrawal by Subject|1|||
129643820|NCT03558152|466651083|FG004|Overall Study|Withdrawal by Subject|1|||
129643821|NCT03558152|466651084|FG005|Overall Study|Withdrawal by Subject|1|||
129643822|NCT03558152|466651085|FG006|Overall Study|Withdrawal by Subject|3|||
129643823|NCT03558152|466651086|FG007|Overall Study|Withdrawal by Subject|2|||
129643824|NCT03558152|466651079|FG000|Overall Study|Lack of Efficacy|11|||
129643825|NCT03558152|466651080|FG001|Overall Study|Lack of Efficacy|11|||
129643826|NCT03558152|466651081|FG002|Overall Study|Lack of Efficacy|10|||
129643827|NCT03558152|466651082|FG003|Overall Study|Lack of Efficacy|11|||
129643828|NCT03558152|466651083|FG004|Overall Study|Lack of Efficacy|14|||
129643829|NCT03558152|466651084|FG005|Overall Study|Lack of Efficacy|12|||
129643830|NCT03558152|466651085|FG006|Overall Study|Lack of Efficacy|14|||
129643831|NCT03558152|466651086|FG007|Overall Study|Lack of Efficacy|13|||
129643832|NCT03558152|466651079|FG000|Overall Study|Protocol Violation|1|||
129643833|NCT03558152|466651080|FG001|Overall Study|Protocol Violation|1|||
129643834|NCT03558152|466651081|FG002|Overall Study|Protocol Violation|0|||
129643835|NCT03558152|466651082|FG003|Overall Study|Protocol Violation|1|||
129643836|NCT03558152|466651083|FG004|Overall Study|Protocol Violation|1|||
129643837|NCT03558152|466651084|FG005|Overall Study|Protocol Violation|0|||
129799013|NCT01907100|467232225|FG001|Overall Study|PD based on modified RECIST criteria|32|||
129799014|NCT01907100|467232226|FG002|Overall Study|PD based on modified RECIST criteria|95|||
129799015|NCT01907100|467232227|FG003|Overall Study|PD based on modified RECIST criteria|92|||
129799016|NCT01907100|467232224|FG000|Overall Study|Withdrawal by Subject|2|||
129643838|NCT03558152|466651085|FG006|Overall Study|Protocol Violation|2|||
129643839|NCT03558152|466651086|FG007|Overall Study|Protocol Violation|0|||
129643840|NCT01300338|466651092|FG000|Overall Study|Lost to Follow-up|5|||
129799017|NCT01907100|467232225|FG001|Overall Study|Withdrawal by Subject|5|||
129643841|NCT01300338|466651093|FG001|Overall Study|Lost to Follow-up|0|||
129643842|NCT02461524|466651094|FG000|Overall Study|Death|16|||
129643843|NCT02461524|466651094|FG000|Overall Study|Withdrawal by Subject|4|||
129643844|NCT02461524|466651094|FG000|Overall Study|Device Explanted|5|||
129643845|NCT02461524|466651094|FG000|Overall Study|Missed Visit|6|||
129643846|NCT00970632|466651097|FG000|Overall Study|Adverse Event|2|||
129643847|NCT00970632|466651098|FG001|Overall Study|Adverse Event|2|||
129643848|NCT00970632|466651099|FG002|Overall Study|Adverse Event|1|||
129643849|NCT00970632|466651097|FG000|Overall Study|Lack of Efficacy|3|||
129643850|NCT00970632|466651098|FG001|Overall Study|Lack of Efficacy|0|||
129643851|NCT00970632|466651099|FG002|Overall Study|Lack of Efficacy|0|||
129643852|NCT00970632|466651097|FG000|Overall Study|Lost to Follow-up|3|||
129643853|NCT00970632|466651098|FG001|Overall Study|Lost to Follow-up|0|||
129643854|NCT00970632|466651099|FG002|Overall Study|Lost to Follow-up|2|||
129643855|NCT00970632|466651097|FG000|Overall Study|Protocol Violation|8|||
129643856|NCT00970632|466651098|FG001|Overall Study|Protocol Violation|5|||
129643857|NCT00970632|466651099|FG002|Overall Study|Protocol Violation|8|||
129643858|NCT00970632|466651097|FG000|Overall Study|Withdrawal by Subject|7|||
129643859|NCT00970632|466651098|FG001|Overall Study|Withdrawal by Subject|6|||
129643860|NCT00970632|466651099|FG002|Overall Study|Withdrawal by Subject|4|||
129643861|NCT00970632|466651097|FG000|Overall Study|Entry criteria not met|0|||
129643862|NCT00970632|466651098|FG001|Overall Study|Entry criteria not met|2|||
129643863|NCT00970632|466651099|FG002|Overall Study|Entry criteria not met|2|||
129643864|NCT00970632|466651097|FG000|Overall Study|Sponsor decision|1|||
129643865|NCT00970632|466651098|FG001|Overall Study|Sponsor decision|0|||
129643866|NCT00970632|466651099|FG002|Overall Study|Sponsor decision|1|||
129643867|NCT02002533|466651106|FG000|Overall Study|Withdrawal by Subject|6|||
129643868|NCT02002533|466651107|FG001|Overall Study|Withdrawal by Subject|13|||
129643869|NCT02002533|466651106|FG000|Overall Study|Protocol Violation|0|||
129643870|NCT02002533|466651107|FG001|Overall Study|Protocol Violation|1|||
129643871|NCT02002533|466651106|FG000|Overall Study|Adverse Event|0|||
129643872|NCT02002533|466651107|FG001|Overall Study|Adverse Event|3|||
129643873|NCT02002533|466651106|FG000|Overall Study|Lost to Follow-up|0|||
129643874|NCT02002533|466651107|FG001|Overall Study|Lost to Follow-up|1|||
129643875|NCT00976820|466651110|FG000|Overall Study|Lost to Follow-up|5|||
129643876|NCT00976820|466651111|FG001|Overall Study|Lost to Follow-up|16|||
129643877|NCT00976820|466651112|FG002|Overall Study|Lost to Follow-up|2|||
129643878|NCT00976820|466651113|FG003|Overall Study|Lost to Follow-up|3|||
129643879|NCT00976820|466651110|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
129643880|NCT00976820|466651111|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
129643881|NCT00976820|466651112|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
129643882|NCT00976820|466651113|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
129643883|NCT00976820|466651110|FG000|Overall Study|Withdrawal by Subject|2|||
129643884|NCT00976820|466651111|FG001|Overall Study|Withdrawal by Subject|4|||
129643885|NCT00976820|466651112|FG002|Overall Study|Withdrawal by Subject|1|||
129643886|NCT00976820|466651113|FG003|Overall Study|Withdrawal by Subject|4|||
129643887|NCT03261674|466651114|FG000|Overall Study|Lost to Follow-up|6|||
129643888|NCT03261674|466651115|FG001|Overall Study|Lost to Follow-up|7|||
129643889|NCT03261674|466651114|FG000|Overall Study|Protocol Violation|1|||
129643890|NCT03261674|466651115|FG001|Overall Study|Protocol Violation|4|||
129643891|NCT03261674|466651114|FG000|Overall Study|Withdrawal by Subject|1|||
129643892|NCT03261674|466651115|FG001|Overall Study|Withdrawal by Subject|4|||
129643893|NCT03261674|466651114|FG000|Overall Study|Physician Decision|1|||
129643894|NCT03261674|466651115|FG001|Overall Study|Physician Decision|0|||
129643895|NCT00623935|466651118|FG000|Overall Study|Death|1|||
129643896|NCT00623935|466651118|FG000|Overall Study|Patient Declined Transplant|1|||
129643897|NCT00747474|466651119|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643898|NCT00747474|466651120|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643899|NCT00747474|466651121|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643900|NCT00747474|466651122|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129799018|NCT01907100|467232226|FG002|Overall Study|Withdrawal by Subject|10|||
129799019|NCT01907100|467232227|FG003|Overall Study|Withdrawal by Subject|13|||
129799020|NCT01907100|467232224|FG000|Overall Study|Protocol Violation|0|||
129799021|NCT01907100|467232225|FG001|Overall Study|Protocol Violation|0|||
129799022|NCT01907100|467232226|FG002|Overall Study|Protocol Violation|1|||
129799023|NCT01907100|467232227|FG003|Overall Study|Protocol Violation|1|||
129799024|NCT01907100|467232224|FG000|Overall Study|Lost to Follow-up|0|||
129799025|NCT01907100|467232225|FG001|Overall Study|Lost to Follow-up|0|||
129799026|NCT01907100|467232226|FG002|Overall Study|Lost to Follow-up|0|||
129799027|NCT01907100|467232227|FG003|Overall Study|Lost to Follow-up|1|||
129799028|NCT01907100|467232224|FG000|Overall Study|Not treated|2|||
129643901|NCT00747474|466651123|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643902|NCT00747474|466651124|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643903|NCT00747474|466651125|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643904|NCT00747474|466651126|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
129799029|NCT01907100|467232225|FG001|Overall Study|Not treated|0|||
129799030|NCT01907100|467232226|FG002|Overall Study|Not treated|1|||
129799031|NCT01907100|467232227|FG003|Overall Study|Not treated|2|||
129705889|NCT02936323|466885804|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
129705890|NCT02936323|466885805|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129705891|NCT02936323|466885806|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129705892|NCT02936323|466885807|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129705893|NCT02936323|466885808|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
129705894|NCT02936323|466885799|FG000|Phase 1 Dose Escalation|Death|2|||
129705895|NCT02936323|466885800|FG001|Phase 1 Dose Escalation|Death|1|||
129705896|NCT02936323|466885801|FG002|Phase 1 Dose Escalation|Death|3|||
129705897|NCT02936323|466885802|FG003|Phase 1 Dose Escalation|Death|1|||
129705898|NCT02936323|466885803|FG004|Phase 1 Dose Escalation|Death|2|||
129705899|NCT02936323|466885804|FG005|Phase 1 Dose Escalation|Death|3|||
129705900|NCT02936323|466885805|FG006|Phase 1 Dose Escalation|Death|3|||
129705901|NCT02936323|466885806|FG007|Phase 1 Dose Escalation|Death|0|||
129705902|NCT02936323|466885807|FG008|Phase 1 Dose Escalation|Death|0|||
129705903|NCT02936323|466885808|FG009|Phase 1 Dose Escalation|Death|0|||
129705904|NCT02936323|466885799|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705905|NCT02936323|466885800|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705906|NCT02936323|466885801|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705907|NCT02936323|466885802|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705908|NCT02936323|466885803|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705909|NCT02936323|466885804|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
129705910|NCT02936323|466885805|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705911|NCT02936323|466885806|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705912|NCT02936323|466885807|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129705913|NCT02936323|466885808|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
129643905|NCT00747474|466651127|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643906|NCT00747474|466651128|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643907|NCT00747474|466651129|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643908|NCT00747474|466651130|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
129643909|NCT00890084|466651131|FG000|Overall Study|Adverse Event|16|||
129643910|NCT00890084|466651131|FG000|Overall Study|Lost to Follow-up|126|||
129643911|NCT02691936|466651137|FG000|Overall Study|Withdrawal by Subject|2|||
129643912|NCT02691936|466651138|FG001|Overall Study|Withdrawal by Subject|5|||
129643913|NCT01878084|466651139|FG000|Overall Study|Physician Decision|2|||
129643914|NCT00749684|466651140|FG000|Overall Study|Death|1|||
129643915|NCT00749684|466651140|FG000|Overall Study|Adverse Event|27|||
129643916|NCT00749684|466651140|FG000|Overall Study|Participant's Wish|10|||
129643917|NCT00749684|466651140|FG000|Overall Study|Not Documented|1|||
129643918|NCT00749684|466651140|FG000|Overall Study|Progressive Desease|31|||
129643919|NCT00749684|466651140|FG000|Overall Study|Therapy according to protocol + AE|2|||
129643920|NCT00749684|466651140|FG000|Overall Study|AE+discontinuation on participants wish|1|||
129643921|NCT00749684|466651140|FG000|Overall Study|Missing|9|||
129643922|NCT02892422|466651145|FG000|Overall Study|Enrolled not treated|4|||
129643923|NCT02892422|466651145|FG000|Overall Study|Adverse Event|38|||
129643924|NCT02892422|466651145|FG000|Overall Study|Lack of Efficacy|32|||
129643925|NCT02892422|466651145|FG000|Overall Study|Non-compliance with study drug|11|||
129643926|NCT02892422|466651145|FG000|Overall Study|Protocol Violation|4|||
129643927|NCT02892422|466651145|FG000|Overall Study|Withdrawal by Subject|56|||
129643928|NCT02892422|466651145|FG000|Overall Study|Lost to Follow-up|5|||
129643929|NCT02892422|466651145|FG000|Overall Study|sponsor information 16159A results|21|||
129643930|NCT02892422|466651145|FG000|Overall Study|withdrawal of consent|13|||
129643931|NCT02892422|466651145|FG000|Overall Study|exclusion criteria met|3|||
129643932|NCT02892422|466651145|FG000|Overall Study|moving elsewhere|4|||
129643933|NCT02892422|466651145|FG000|Overall Study|non-compliance|10|||
129643934|NCT02892422|466651145|FG000|Overall Study|patient legally incapable|1|||
129705914|NCT02936323|466885799|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129705915|NCT02936323|466885800|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129705916|NCT02936323|466885801|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129705917|NCT02936323|466885802|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129443527|NCT02194062|465924414|FG002|Overall Study|Lost to Follow-up|5|||
129643935|NCT02892422|466651145|FG000|Overall Study|patient decision|7|||
129643936|NCT02892422|466651145|FG000|Overall Study|Investigator decision|1|||
129643937|NCT01023256|466651146|FG000|Overall Study|Protocol Violation|2|||
129643938|NCT01023256|466651147|FG001|Overall Study|Protocol Violation|3|||
129643939|NCT01023256|466651148|FG002|Overall Study|Protocol Violation|0|||
129705918|NCT02936323|466885803|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129705919|NCT02936323|466885804|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129705920|NCT02936323|466885805|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
129643940|NCT01023256|466651149|FG003|Overall Study|Protocol Violation|0|||
129643941|NCT01023256|466651146|FG000|Overall Study|Randomized but not treated|1|||
129643942|NCT01023256|466651147|FG001|Overall Study|Randomized but not treated|0|||
129643943|NCT01023256|466651148|FG002|Overall Study|Randomized but not treated|1|||
129643944|NCT01023256|466651149|FG003|Overall Study|Randomized but not treated|0|||
129643945|NCT01023256|466651146|FG000|Overall Study|Other|1|||
129643946|NCT01023256|466651147|FG001|Overall Study|Other|0|||
129643947|NCT01023256|466651148|FG002|Overall Study|Other|0|||
129643948|NCT01023256|466651149|FG003|Overall Study|Other|2|||
129643949|NCT01023256|466651146|FG000|Overall Study|Adverse Event|0|||
129643950|NCT01023256|466651147|FG001|Overall Study|Adverse Event|0|||
129643951|NCT01023256|466651148|FG002|Overall Study|Adverse Event|0|||
129643952|NCT01023256|466651149|FG003|Overall Study|Adverse Event|1|||
129643953|NCT01023256|466651146|FG000|Overall Study|Withdrawal by Subject|0|||
129643954|NCT01023256|466651147|FG001|Overall Study|Withdrawal by Subject|0|||
129643955|NCT01023256|466651148|FG002|Overall Study|Withdrawal by Subject|0|||
129643956|NCT01023256|466651149|FG003|Overall Study|Withdrawal by Subject|2|||
129643957|NCT03155178|466651150|FG000|Overall Study|Did not meet treatment day baseline|7|||
129643958|NCT03155178|466651151|FG001|Overall Study|Did not meet treatment day baseline|7|||
129643959|NCT03155178|466651152|FG002|Overall Study|Did not meet treatment day baseline|7|||
129643960|NCT03155178|466651153|FG003|Overall Study|Did not meet treatment day baseline|7|||
129643961|NCT03089697|466651154|FG000|Overall Study|Adverse Event|1|||
129643962|NCT03089697|466651155|FG001|Overall Study|Adverse Event|2|||
129643963|NCT03089697|466651154|FG000|Overall Study|Withdrawal by Subject|1|||
129643964|NCT03089697|466651155|FG001|Overall Study|Withdrawal by Subject|0|||
129643965|NCT04323306|466651156|FG000|Overall Study|Physician Decision|1|||
129643966|NCT04323306|466651157|FG001|Overall Study|Physician Decision|0|||
129643967|NCT04323306|466651158|FG002|Overall Study|Physician Decision|0|||
129643968|NCT04323306|466651159|FG003|Overall Study|Physician Decision|0|||
129643969|NCT04323306|466651160|FG004|Overall Study|Physician Decision|0|||
129643970|NCT04323306|466651161|FG005|Overall Study|Physician Decision|0|||
129643971|NCT04323306|466651162|FG006|Overall Study|Physician Decision|0|||
129643972|NCT04323306|466651163|FG007|Overall Study|Physician Decision|0|||
129643973|NCT04323306|466651164|FG008|Overall Study|Physician Decision|0|||
129643974|NCT04323306|466651156|FG000|Overall Study|Withdrawal by Subject|0|||
129643975|NCT04323306|466651157|FG001|Overall Study|Withdrawal by Subject|0|||
129643976|NCT04323306|466651158|FG002|Overall Study|Withdrawal by Subject|0|||
129643977|NCT04323306|466651159|FG003|Overall Study|Withdrawal by Subject|0|||
129643978|NCT04323306|466651160|FG004|Overall Study|Withdrawal by Subject|0|||
129643979|NCT04323306|466651161|FG005|Overall Study|Withdrawal by Subject|1|||
129643980|NCT04323306|466651162|FG006|Overall Study|Withdrawal by Subject|3|||
129643981|NCT04323306|466651163|FG007|Overall Study|Withdrawal by Subject|0|||
129643982|NCT04323306|466651164|FG008|Overall Study|Withdrawal by Subject|1|||
129643983|NCT00834639|466651165|FG000|Second Intervention|Physician Decision|0|||
129643984|NCT00834639|466651166|FG001|Second Intervention|Physician Decision|2|||
129643985|NCT05129137|466651167|FG000|Second Period|Adverse Event|1|||
129643986|NCT05129137|466651168|FG001|Second Period|Adverse Event|0|||
129643987|NCT05129137|466651169|FG002|Second Period|Adverse Event|0|||
129643988|NCT05129137|466651170|FG003|Second Period|Adverse Event|0|||
129643989|NCT05129137|466651167|FG000|Second Period|Protocol Violation|0|||
129643990|NCT05129137|466651168|FG001|Second Period|Protocol Violation|0|||
129643991|NCT05129137|466651169|FG002|Second Period|Protocol Violation|0|||
129643992|NCT05129137|466651170|FG003|Second Period|Protocol Violation|1|||
129643993|NCT05129137|466651167|FG000|Third Period|Protocol Violation|0|||
129643994|NCT05129137|466651168|FG001|Third Period|Protocol Violation|0|||
129643995|NCT05129137|466651169|FG002|Third Period|Protocol Violation|0|||
129643996|NCT05129137|466651170|FG003|Third Period|Protocol Violation|1|||
129643997|NCT05129137|466651167|FG000|Forth Period|Protocol Violation|0|||
129705921|NCT02936323|466885806|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
129705922|NCT02936323|466885807|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
129705923|NCT02936323|466885808|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
129705924|NCT02936323|466885799|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
129890345|NCT00688259|467556095|FG000|Overall Study|Declined Interview|2|||
129443528|NCT02276872|465924415|FG000|Overall Study|Adverse Event|1|||
129643998|NCT05129137|466651168|FG001|Forth Period|Protocol Violation|1|||
129643999|NCT05129137|466651169|FG002|Forth Period|Protocol Violation|0|||
129644000|NCT05129137|466651170|FG003|Forth Period|Protocol Violation|0|||
129644001|NCT05129137|466651167|FG000|Forth Period|Withdrawal by Subject|0|||
129644002|NCT05129137|466651168|FG001|Forth Period|Withdrawal by Subject|0|||
129644003|NCT05129137|466651169|FG002|Forth Period|Withdrawal by Subject|1|||
129644004|NCT05129137|466651170|FG003|Forth Period|Withdrawal by Subject|0|||
129644005|NCT03382834|466651183|FG000|Step 1|Lost to Follow-up|0|||
129644006|NCT03382834|466651184|FG001|Step 1|Lost to Follow-up|1|||
129644007|NCT03382834|466651183|FG000|Step 2|Death|1|||
129644008|NCT03382834|466651184|FG001|Step 2|Death|0|||
129644009|NCT03382834|466651183|FG000|Step 2|Lost to Follow-up|2|||
129644010|NCT03382834|466651184|FG001|Step 2|Lost to Follow-up|2|||
129644011|NCT03382834|466651183|FG000|Step 2|Site Terminated by Sponsor|1|||
129644012|NCT03382834|466651184|FG001|Step 2|Site Terminated by Sponsor|0|||
129644013|NCT02387957|466651185|FG000|Overall Study|The study was discontinued|21|||
129644014|NCT02387957|466651186|FG001|Overall Study|The study was discontinued|21|||
129644015|NCT02387957|466651187|FG002|Overall Study|The study was discontinued|20|||
129644016|NCT03613649|466651188|FG000|Second Treatment|Lost to Follow-up|0|||
129644017|NCT03613649|466651189|FG001|Second Treatment|Lost to Follow-up|0|||
129644018|NCT03613649|466651190|FG002|Second Treatment|Lost to Follow-up|1|||
129644019|NCT03613649|466651191|FG003|Second Treatment|Lost to Follow-up|0|||
129644020|NCT03613649|466651192|FG004|Second Treatment|Lost to Follow-up|0|||
129644021|NCT03613649|466651193|FG005|Second Treatment|Lost to Follow-up|0|||
129644022|NCT03613649|466651194|FG006|Second Treatment|Lost to Follow-up|0|||
129644023|NCT03613649|466651195|FG007|Second Treatment|Lost to Follow-up|0|||
129644024|NCT03613649|466651196|FG008|Second Treatment|Lost to Follow-up|0|||
129644025|NCT03613649|466651197|FG009|Second Treatment|Lost to Follow-up|0|||
129644026|NCT03613649|466651198|FG010|Second Treatment|Lost to Follow-up|0|||
129644027|NCT03613649|466651199|FG011|Second Treatment|Lost to Follow-up|0|||
129644028|NCT03613649|466651188|FG000|Second Treatment|Withdrawal by Subject|0|||
129644029|NCT03613649|466651189|FG001|Second Treatment|Withdrawal by Subject|0|||
129644030|NCT03613649|466651190|FG002|Second Treatment|Withdrawal by Subject|0|||
129644031|NCT03613649|466651191|FG003|Second Treatment|Withdrawal by Subject|0|||
129644032|NCT03613649|466651192|FG004|Second Treatment|Withdrawal by Subject|1|||
129644033|NCT03613649|466651193|FG005|Second Treatment|Withdrawal by Subject|0|||
129644034|NCT03613649|466651194|FG006|Second Treatment|Withdrawal by Subject|0|||
129644035|NCT03613649|466651195|FG007|Second Treatment|Withdrawal by Subject|0|||
129644036|NCT03613649|466651196|FG008|Second Treatment|Withdrawal by Subject|0|||
129644037|NCT03613649|466651197|FG009|Second Treatment|Withdrawal by Subject|0|||
129644038|NCT03613649|466651198|FG010|Second Treatment|Withdrawal by Subject|0|||
129644039|NCT03613649|466651199|FG011|Second Treatment|Withdrawal by Subject|0|||
129644040|NCT03613649|466651188|FG000|Third Treatment|Lost to Follow-up|0|||
129644041|NCT03613649|466651189|FG001|Third Treatment|Lost to Follow-up|0|||
129644042|NCT03613649|466651190|FG002|Third Treatment|Lost to Follow-up|0|||
129644043|NCT03613649|466651191|FG003|Third Treatment|Lost to Follow-up|0|||
129644044|NCT03613649|466651192|FG004|Third Treatment|Lost to Follow-up|1|||
129644045|NCT03613649|466651193|FG005|Third Treatment|Lost to Follow-up|0|||
129644046|NCT03613649|466651194|FG006|Third Treatment|Lost to Follow-up|0|||
129644047|NCT03613649|466651195|FG007|Third Treatment|Lost to Follow-up|0|||
129644048|NCT03613649|466651196|FG008|Third Treatment|Lost to Follow-up|0|||
129644049|NCT03613649|466651197|FG009|Third Treatment|Lost to Follow-up|0|||
129644050|NCT03613649|466651198|FG010|Third Treatment|Lost to Follow-up|0|||
129644051|NCT03613649|466651199|FG011|Third Treatment|Lost to Follow-up|1|||
129644052|NCT03613649|466651188|FG000|Third Treatment|Protocol Violation|0|||
129644053|NCT03613649|466651189|FG001|Third Treatment|Protocol Violation|0|||
129644054|NCT03613649|466651190|FG002|Third Treatment|Protocol Violation|0|||
129644055|NCT03613649|466651191|FG003|Third Treatment|Protocol Violation|0|||
129644056|NCT03613649|466651192|FG004|Third Treatment|Protocol Violation|0|||
129644057|NCT03613649|466651193|FG005|Third Treatment|Protocol Violation|0|||
129644058|NCT03613649|466651194|FG006|Third Treatment|Protocol Violation|1|||
129644059|NCT03613649|466651195|FG007|Third Treatment|Protocol Violation|0|||
129644060|NCT03613649|466651196|FG008|Third Treatment|Protocol Violation|0|||
129644061|NCT03613649|466651197|FG009|Third Treatment|Protocol Violation|0|||
129644062|NCT03613649|466651198|FG010|Third Treatment|Protocol Violation|0|||
129644063|NCT03613649|466651199|FG011|Third Treatment|Protocol Violation|1|||
129644064|NCT03613649|466651188|FG000|Fourth Treatment|Protocol Violation|1|||
129644065|NCT03613649|466651189|FG001|Fourth Treatment|Protocol Violation|0|||
129644066|NCT03613649|466651190|FG002|Fourth Treatment|Protocol Violation|0|||
129644067|NCT03613649|466651191|FG003|Fourth Treatment|Protocol Violation|0|||
129644068|NCT03613649|466651192|FG004|Fourth Treatment|Protocol Violation|1|||
129705925|NCT02936323|466885800|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
129705926|NCT02936323|466885801|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
129705927|NCT02936323|466885802|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
129705928|NCT02936323|466885803|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
129644069|NCT03613649|466651193|FG005|Fourth Treatment|Protocol Violation|0|||
129644070|NCT03613649|466651194|FG006|Fourth Treatment|Protocol Violation|0|||
129644071|NCT03613649|466651195|FG007|Fourth Treatment|Protocol Violation|0|||
129705929|NCT02936323|466885804|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
129644072|NCT03613649|466651196|FG008|Fourth Treatment|Protocol Violation|0|||
129644073|NCT03613649|466651197|FG009|Fourth Treatment|Protocol Violation|0|||
129644074|NCT03613649|466651198|FG010|Fourth Treatment|Protocol Violation|0|||
129644075|NCT03613649|466651199|FG011|Fourth Treatment|Protocol Violation|0|||
129644076|NCT03613649|466651188|FG000|Fourth Treatment|Physician Decision|0|||
129644077|NCT03613649|466651189|FG001|Fourth Treatment|Physician Decision|0|||
129644078|NCT03613649|466651190|FG002|Fourth Treatment|Physician Decision|0|||
129644079|NCT03613649|466651191|FG003|Fourth Treatment|Physician Decision|0|||
129644080|NCT03613649|466651192|FG004|Fourth Treatment|Physician Decision|0|||
129644081|NCT03613649|466651193|FG005|Fourth Treatment|Physician Decision|0|||
129705930|NCT02936323|466885805|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
129705931|NCT02936323|466885806|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
129705932|NCT02936323|466885807|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
129705933|NCT02936323|466885808|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
129705934|NCT02936323|466885799|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705935|NCT02936323|466885800|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705936|NCT02936323|466885801|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705937|NCT02936323|466885802|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705938|NCT02936323|466885803|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705939|NCT02936323|466885804|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705940|NCT02936323|466885805|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705941|NCT02936323|466885806|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
129705942|NCT02936323|466885807|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
129705943|NCT02936323|466885808|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
129705944|NCT02936323|466885799|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705945|NCT02936323|466885800|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705946|NCT02936323|466885801|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705947|NCT02936323|466885802|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705948|NCT02936323|466885803|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705949|NCT02936323|466885804|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705950|NCT02936323|466885805|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705951|NCT02936323|466885806|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705952|NCT02936323|466885807|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
129705953|NCT02936323|466885808|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
129705954|NCT02936323|466885799|FG000|Phase 2a Dose Expansion|Death|0|||
129705955|NCT02936323|466885800|FG001|Phase 2a Dose Expansion|Death|0|||
129705956|NCT02936323|466885801|FG002|Phase 2a Dose Expansion|Death|0|||
129705957|NCT02936323|466885802|FG003|Phase 2a Dose Expansion|Death|0|||
129705958|NCT02936323|466885803|FG004|Phase 2a Dose Expansion|Death|0|||
129705959|NCT02936323|466885804|FG005|Phase 2a Dose Expansion|Death|0|||
129705960|NCT02936323|466885805|FG006|Phase 2a Dose Expansion|Death|0|||
129705961|NCT02936323|466885806|FG007|Phase 2a Dose Expansion|Death|4|||
129705962|NCT02936323|466885807|FG008|Phase 2a Dose Expansion|Death|8|||
129705963|NCT02936323|466885808|FG009|Phase 2a Dose Expansion|Death|10|||
129705964|NCT04577404|466885809|FG000|Overall Study|Adverse Event|31|||
129705965|NCT04577404|466885809|FG000|Overall Study|Death|1|||
129705966|NCT04577404|466885809|FG000|Overall Study|Lack of Efficacy|3|||
129705967|NCT04577404|466885809|FG000|Overall Study|Physician Decision|7|||
129705968|NCT04577404|466885809|FG000|Overall Study|Withdrawal by Subject|21|||
129705969|NCT04577404|466885809|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
129705970|NCT01334918|466886679|FG000|Overall Study|Did not receive study drug|6|||
129705971|NCT01334918|466886680|FG001|Overall Study|Did not receive study drug|0|||
129705972|NCT01334918|466886679|FG000|Overall Study|Adverse Event|2|||
129705973|NCT01334918|466886680|FG001|Overall Study|Adverse Event|0|||
129705974|NCT01334918|466886679|FG000|Overall Study|Withdrawal by Subject|0|||
129705975|NCT01334918|466886680|FG001|Overall Study|Withdrawal by Subject|1|||
129705976|NCT02724839|466886682|FG000|Overall Study|Withdrawal by Subject|1|||
129705977|NCT02724839|466886683|FG001|Overall Study|Withdrawal by Subject|1|||
129705978|NCT02724839|466886684|FG002|Overall Study|Withdrawal by Subject|0|||
129705979|NCT02724839|466886682|FG000|Overall Study|Lost to Follow-up|0|||
129705980|NCT02724839|466886683|FG001|Overall Study|Lost to Follow-up|3|||
129705981|NCT02724839|466886684|FG002|Overall Study|Lost to Follow-up|2|||
129705982|NCT02724839|466886682|FG000|Overall Study|Physician Decision|0|||
129705983|NCT02724839|466886683|FG001|Overall Study|Physician Decision|0|||
129705984|NCT02724839|466886684|FG002|Overall Study|Physician Decision|3|||
129705985|NCT05878067|466886686|FG000|Overall Study|Lost to Follow-up|2|||
129705986|NCT00949533|466886687|FG000|Overall Study|Lost to Follow-up|0|||
129705987|NCT00949533|466886688|FG001|Overall Study|Lost to Follow-up|1|||
129705988|NCT01959529|466886689|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
129890346|NCT00688259|467556096|FG001|Overall Study|Declined Interview|3|||
129705989|NCT01959529|466886690|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
129705990|NCT01959529|466886689|FG000|Overall Study|Lost to Follow-up|4|||
129705991|NCT01959529|466886690|FG001|Overall Study|Lost to Follow-up|1|||
129705992|NCT01959529|466886689|FG000|Overall Study|Other|70|||
129705993|NCT01959529|466886690|FG001|Overall Study|Other|68|||
129705994|NCT01959529|466886689|FG000|Overall Study|Hypoglycaemia|1|||
129705995|NCT01959529|466886690|FG001|Overall Study|Hypoglycaemia|1|||
129705996|NCT01959529|466886689|FG000|Overall Study|Lack of glycaemic control|1|||
129705997|NCT01959529|466886690|FG001|Overall Study|Lack of glycaemic control|1|||
129705998|NCT00399035|466886698|FG000|Overall Study|Death|289|||
129705999|NCT00399035|466886699|FG001|Overall Study|Death|141|||
129706000|NCT00399035|466886700|FG002|Overall Study|Death|234|||
129706001|NCT00399035|466886698|FG000|Overall Study|Lost to Follow-up|2|||
129706002|NCT00399035|466886699|FG001|Overall Study|Lost to Follow-up|1|||
129706003|NCT00399035|466886700|FG002|Overall Study|Lost to Follow-up|5|||
129706004|NCT00399035|466886698|FG000|Overall Study|Withdrawal by Subject|19|||
129706005|NCT00399035|466886699|FG001|Overall Study|Withdrawal by Subject|15|||
129644082|NCT03613649|466651194|FG006|Fourth Treatment|Physician Decision|1|||
129644083|NCT03613649|466651195|FG007|Fourth Treatment|Physician Decision|0|||
129644084|NCT03613649|466651196|FG008|Fourth Treatment|Physician Decision|0|||
129644085|NCT03613649|466651197|FG009|Fourth Treatment|Physician Decision|0|||
129644086|NCT03613649|466651198|FG010|Fourth Treatment|Physician Decision|0|||
129644087|NCT03613649|466651199|FG011|Fourth Treatment|Physician Decision|0|||
129644088|NCT00675428|466651200|FG000|Overall Study|Disease Progression|2|||
129644089|NCT00675428|466651201|FG001|Overall Study|Disease Progression|2|||
129644090|NCT00675428|466651200|FG000|Overall Study|No Disease Response After Cycle 6|0|||
129644091|NCT00675428|466651201|FG001|Overall Study|No Disease Response After Cycle 6|1|||
129644092|NCT00675428|466651200|FG000|Overall Study|Physician Decision|1|||
129644093|NCT00675428|466651201|FG001|Overall Study|Physician Decision|0|||
129644094|NCT00319592|466651202|FG000|Overall Study|Protocol Violation|1|||
129644095|NCT00319592|466651203|FG001|Overall Study|Protocol Violation|0|||
129644096|NCT00319592|466651202|FG000|Overall Study|Physician Decision|0|||
129644097|NCT00319592|466651203|FG001|Overall Study|Physician Decision|1|||
129644098|NCT00750139|466651206|FG000|Overall Study|Adverse Event|1|||
129644099|NCT00750139|466651207|FG001|Overall Study|Adverse Event|2|||
129644100|NCT00750139|466651208|FG002|Overall Study|Adverse Event|0|||
129644101|NCT00750139|466651209|FG003|Overall Study|Adverse Event|1|||
129644102|NCT00750139|466651206|FG000|Overall Study|Lost to Follow-up|17|||
129644103|NCT00750139|466651207|FG001|Overall Study|Lost to Follow-up|12|||
129644104|NCT00750139|466651208|FG002|Overall Study|Lost to Follow-up|15|||
129644105|NCT00750139|466651209|FG003|Overall Study|Lost to Follow-up|6|||
129644106|NCT00750139|466651206|FG000|Overall Study|Withdrawal by Subject|3|||
129644107|NCT00750139|466651207|FG001|Overall Study|Withdrawal by Subject|2|||
129644108|NCT00750139|466651208|FG002|Overall Study|Withdrawal by Subject|6|||
129644109|NCT00750139|466651209|FG003|Overall Study|Withdrawal by Subject|2|||
129644110|NCT00750139|466651206|FG000|Overall Study|Physician Decision|1|||
129644111|NCT00750139|466651207|FG001|Overall Study|Physician Decision|1|||
129644112|NCT00750139|466651208|FG002|Overall Study|Physician Decision|0|||
129644113|NCT00750139|466651209|FG003|Overall Study|Physician Decision|0|||
129644114|NCT00750139|466651206|FG000|Overall Study|Non-compliance|1|||
129644115|NCT00750139|466651207|FG001|Overall Study|Non-compliance|0|||
129644116|NCT00750139|466651208|FG002|Overall Study|Non-compliance|1|||
129644117|NCT00750139|466651209|FG003|Overall Study|Non-compliance|3|||
129644118|NCT00750139|466651206|FG000|Overall Study|Termination by sponsor|4|||
129644119|NCT00750139|466651207|FG001|Overall Study|Termination by sponsor|0|||
129644120|NCT00750139|466651208|FG002|Overall Study|Termination by sponsor|0|||
129644121|NCT00750139|466651209|FG003|Overall Study|Termination by sponsor|1|||
129644122|NCT00750139|466651206|FG000|Overall Study|Non-specific|62|||
129644123|NCT00750139|466651207|FG001|Overall Study|Non-specific|42|||
129644124|NCT00750139|466651208|FG002|Overall Study|Non-specific|79|||
129644125|NCT00750139|466651209|FG003|Overall Study|Non-specific|33|||
129644126|NCT04439214|466651213|FG000|Overall Study|Adverse Event|13|||
129644127|NCT04439214|466651213|FG000|Overall Study|Disease progression|16|||
129644128|NCT04439214|466651213|FG000|Overall Study|Death|1|||
129644129|NCT04439214|466651213|FG000|Overall Study|Withdrawal by Subject|2|||
129644130|NCT04439214|466651213|FG000|Overall Study|Declining health|1|||
129644131|NCT04439214|466651213|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
129644132|NCT04439214|466651213|FG000|Overall Study|Ineligible|5|||
129644133|NCT04553471|466651214|FG000|Overall Study|Did not start treatment on protocol|3|||
129644134|NCT04553471|466651214|FG000|Overall Study|Death|1|||
129644135|NCT04114357|466652615|FG000|Baseline-Randomization|Adverse Event|2|||
129644136|NCT04114357|466652616|FG001|Baseline-Randomization|Adverse Event|1|||
129644137|NCT04114357|466652615|FG000|Baseline-Randomization|Lost to Follow-up|1|||
129644138|NCT04114357|466652616|FG001|Baseline-Randomization|Lost to Follow-up|1|||
129644139|NCT04114357|466652615|FG000|Cross-over|Adverse Event|0|||
129644140|NCT04114357|466652616|FG001|Cross-over|Adverse Event|1|||
129644141|NCT02163226|466652617|FG000|Overall Study|Death|2|||
129644142|NCT02163226|466652618|FG001|Overall Study|Death|1|||
129443529|NCT02276872|465924416|FG001|Overall Study|Adverse Event|0|||
129443530|NCT02276872|465924417|FG002|Overall Study|Adverse Event|0|||
129644143|NCT02163226|466652617|FG000|Overall Study|Withdrawal by Subject|5|||
129644144|NCT02163226|466652618|FG001|Overall Study|Withdrawal by Subject|2|||
129644145|NCT02163226|466652617|FG000|Overall Study|Returned home, local radiotherapy|3|||
129644146|NCT02163226|466652618|FG001|Overall Study|Returned home, local radiotherapy|0|||
129644147|NCT02163226|466652617|FG000|Overall Study|Repeat imaging showed no disease|2|||
129644148|NCT02163226|466652618|FG001|Overall Study|Repeat imaging showed no disease|0|||
129644149|NCT02163226|466652617|FG000|Overall Study|Incomplete radiotherapy|3|||
129644150|NCT02163226|466652618|FG001|Overall Study|Incomplete radiotherapy|0|||
129644151|NCT02163226|466652617|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
129644152|NCT02163226|466652618|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
129644153|NCT02163226|466652617|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
129644154|NCT02163226|466652618|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
129644155|NCT02163226|466652617|FG000|Overall Study|ineligible|0|||
129644156|NCT02163226|466652618|FG001|Overall Study|ineligible|3|||
129644157|NCT00477750|466652619|FG000|Overall Study|Currently Receiving Treatment|11|||
129644158|NCT00601172|466652620|FG000|Overall Study|Adverse Event|43|||
129644159|NCT00601172|466652621|FG001|Overall Study|Adverse Event|32|||
129644160|NCT00601172|466652620|FG000|Overall Study|Lack of Efficacy|11|||
129644161|NCT00601172|466652621|FG001|Overall Study|Lack of Efficacy|12|||
129644162|NCT00601172|466652620|FG000|Overall Study|Protocol Violation|2|||
129644163|NCT00601172|466652621|FG001|Overall Study|Protocol Violation|5|||
129644164|NCT00601172|466652620|FG000|Overall Study|Lost to Follow-up|4|||
129644165|NCT00601172|466652621|FG001|Overall Study|Lost to Follow-up|3|||
129644166|NCT00601172|466652620|FG000|Overall Study|Physician Decision|27|||
129644167|NCT00601172|466652621|FG001|Overall Study|Physician Decision|28|||
129644168|NCT00601172|466652620|FG000|Overall Study|Withdrawal by Subject|35|||
129644169|NCT00601172|466652621|FG001|Overall Study|Withdrawal by Subject|27|||
129644170|NCT00601172|466652620|FG000|Overall Study|Did not meet continuation criteria|19|||
129644171|NCT00601172|466652621|FG001|Overall Study|Did not meet continuation criteria|20|||
129644172|NCT03030989|466652622|FG000|Overall Study|Fever|2|||
129644173|NCT03030989|466652623|FG001|Overall Study|Fever|2|||
129644174|NCT03030989|466652622|FG000|Overall Study|Rash|2|||
129644175|NCT03030989|466652623|FG001|Overall Study|Rash|1|||
129644176|NCT03030989|466652622|FG000|Overall Study|Fatigue/Overwhelmed|1|||
129644177|NCT03030989|466652623|FG001|Overall Study|Fatigue/Overwhelmed|5|||
129644178|NCT03030989|466652622|FG000|Overall Study|Positive Blood Cultures|2|||
129644179|NCT03030989|466652623|FG001|Overall Study|Positive Blood Cultures|1|||
129644180|NCT03030989|466652622|FG000|Overall Study|Line Removed|0|||
129644181|NCT03030989|466652623|FG001|Overall Study|Line Removed|2|||
129644182|NCT03030989|466652622|FG000|Overall Study|No longer interested|5|||
129644183|NCT03030989|466652623|FG001|Overall Study|No longer interested|3|||
129644184|NCT02706886|466652624|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
129644185|NCT02706886|466652625|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
129644186|NCT02706886|466652626|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
129644187|NCT02706886|466652627|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
129644188|NCT02706886|466652628|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
129644189|NCT02706886|466652629|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
129644190|NCT02706886|466652630|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
129644191|NCT02706886|466652631|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
129644192|NCT02706886|466652632|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
129644193|NCT01669174|466652639|FG000|Overall Study|Subject withdrew consent|2|||
129644194|NCT01669174|466652640|FG001|Overall Study|Subject withdrew consent|2|||
129644195|NCT01669174|466652639|FG000|Overall Study|Lost to Follow-up|1|||
129644196|NCT01669174|466652640|FG001|Overall Study|Lost to Follow-up|0|||
129644197|NCT01669174|466652639|FG000|Overall Study|Adverse Event|2|||
129644198|NCT01669174|466652640|FG001|Overall Study|Adverse Event|2|||
129644199|NCT01669174|466652639|FG000|Overall Study|Administrative problems|1|||
129644200|NCT01669174|466652640|FG001|Overall Study|Administrative problems|2|||
129644201|NCT04310397|466652643|FG000|Overall Study|Lack of Efficacy|3|||
129644202|NCT04310397|466652643|FG000|Overall Study|Withdrawal by Subject|1|||
129644203|NCT00614523|466652644|FG000|Overall Study|Adverse Event|4|||
129644204|NCT00614523|466652645|FG001|Overall Study|Adverse Event|20|||
129644205|NCT00614523|466652644|FG000|Overall Study|Death|5|||
129644206|NCT00614523|466652645|FG001|Overall Study|Death|8|||
129644207|NCT00614523|466652644|FG000|Overall Study|Lack of Efficacy|9|||
129644208|NCT00614523|466652645|FG001|Overall Study|Lack of Efficacy|11|||
129644209|NCT00614523|466652644|FG000|Overall Study|Lost to Follow-up|0|||
129644210|NCT00614523|466652645|FG001|Overall Study|Lost to Follow-up|1|||
129644211|NCT00614523|466652644|FG000|Overall Study|Protocol Violation|3|||
129706006|NCT00399035|466886700|FG002|Overall Study|Withdrawal by Subject|12|||
129706007|NCT00399035|466886698|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
129706008|NCT00399035|466886699|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
129706009|NCT00399035|466886700|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
129706010|NCT00399035|466886698|FG000|Overall Study|Severe non-compliance with protocol|2|||
129706011|NCT00399035|466886699|FG001|Overall Study|Severe non-compliance with protocol|1|||
129706012|NCT00399035|466886700|FG002|Overall Study|Severe non-compliance with protocol|0|||
129706013|NCT00854360|466886701|FG000|Overall Study|Adverse Event|0|||
129706014|NCT00854360|466886702|FG001|Overall Study|Adverse Event|1|||
129799032|NCT01907100|467232224|FG000|Overall Study|Other than reasons specified|1|||
129644212|NCT00614523|466652645|FG001|Overall Study|Protocol Violation|2|||
129644213|NCT00614523|466652644|FG000|Overall Study|Withdrawal by Subject|12|||
129644214|NCT00614523|466652645|FG001|Overall Study|Withdrawal by Subject|22|||
129644215|NCT00614523|466652644|FG000|Overall Study|Other|6|||
129644216|NCT00614523|466652645|FG001|Overall Study|Other|11|||
129644217|NCT00614523|466652644|FG000|Overall Study|Ineligibility Determined|1|||
129644218|NCT00614523|466652645|FG001|Overall Study|Ineligibility Determined|2|||
129644219|NCT00614523|466652644|FG000|Overall Study|Disease Progression|0|||
129644220|NCT00614523|466652645|FG001|Overall Study|Disease Progression|8|||
129644221|NCT00614523|466652644|FG000|Overall Study|Administrative Decision|23|||
129644222|NCT00614523|466652645|FG001|Overall Study|Administrative Decision|46|||
129706015|NCT00854360|466886703|FG002|Overall Study|Adverse Event|2|||
129706016|NCT00854360|466886704|FG003|Overall Study|Adverse Event|6|||
129644223|NCT00723255|466652646|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
129644224|NCT00723255|466652646|FG000|Overall Study|Ineligible: Second primary|1|||
129644225|NCT00723255|466652646|FG000|Overall Study|Ineligible: Wrong Primary|2|||
129644226|NCT04598451|466652652|FG000|Overall Study|Adverse Event|3|||
129644227|NCT04598451|466652653|FG001|Overall Study|Adverse Event|2|||
129644228|NCT04598451|466652652|FG000|Overall Study|Withdrawal by Subject|3|||
129644229|NCT04598451|466652653|FG001|Overall Study|Withdrawal by Subject|7|||
129644230|NCT04598451|466652652|FG000|Overall Study|Lost to Follow-up|2|||
129644231|NCT04598451|466652653|FG001|Overall Study|Lost to Follow-up|0|||
129644232|NCT04598451|466652652|FG000|Overall Study|Physician Decision|4|||
129644233|NCT04598451|466652653|FG001|Overall Study|Physician Decision|1|||
129644234|NCT04598451|466652652|FG000|Overall Study|Requires Prohibited Medication|1|||
129644235|NCT04598451|466652653|FG001|Overall Study|Requires Prohibited Medication|0|||
129644236|NCT04598451|466652652|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
129644237|NCT04598451|466652653|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
129644238|NCT01482065|466652656|FG000|Overall Study|Withdrawal by Subject|0|||
129644239|NCT01482065|466652657|FG001|Overall Study|Withdrawal by Subject|1|||
129644240|NCT02005692|466652662|FG000|Overall Study|Protocol Violation|1|||
129644241|NCT02005692|466652662|FG000|Overall Study|Withdrawal by Subject|1|||
129644242|NCT02005692|466652662|FG000|Overall Study|Discharged earlier than anticipated|5|||
129644243|NCT01895270|466652663|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
129644244|NCT01895270|466652664|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
129644245|NCT01895270|466652663|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
129644246|NCT01895270|466652664|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
129644247|NCT01895270|466652663|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
129644248|NCT01895270|466652664|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
129644249|NCT01895270|466652663|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
129644250|NCT01895270|466652664|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
129644251|NCT01895270|466652663|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
129644252|NCT01895270|466652664|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
129644253|NCT01895270|466652663|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
129644254|NCT01895270|466652664|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
129644255|NCT01895270|466652663|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
129644256|NCT01895270|466652664|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
129644257|NCT02091375|466652666|FG000|Overall Study|Adverse Event|8|||
129644258|NCT02091375|466652667|FG001|Overall Study|Adverse Event|1|||
129644259|NCT02091375|466652666|FG000|Overall Study|Lost to Follow-up|0|||
129644260|NCT02091375|466652667|FG001|Overall Study|Lost to Follow-up|1|||
129644261|NCT02091375|466652666|FG000|Overall Study|Withdrawal by Subject|0|||
129644262|NCT02091375|466652667|FG001|Overall Study|Withdrawal by Subject|1|||
129644263|NCT02091375|466652666|FG000|Overall Study|Withdrawn by the investigator|1|||
129644264|NCT02091375|466652667|FG001|Overall Study|Withdrawn by the investigator|0|||
129644265|NCT01741792|466652668|FG000|Overall Study|Death|6|||
129644266|NCT01741792|466652669|FG001|Overall Study|Death|1|||
129644267|NCT01741792|466652670|FG002|Overall Study|Death|12|||
129644268|NCT04507256|466652675|FG000|Overall Study|Withdrawal by Subject|1|||
129644269|NCT04507256|466652676|FG001|Overall Study|Withdrawal by Subject|0|||
129644270|NCT04507256|466652677|FG002|Overall Study|Withdrawal by Subject|0|||
129644271|NCT04507256|466652678|FG003|Overall Study|Withdrawal by Subject|1|||
129644272|NCT04507256|466652679|FG004|Overall Study|Withdrawal by Subject|0|||
129644273|NCT04507256|466652680|FG005|Overall Study|Withdrawal by Subject|0|||
129644274|NCT00631410|466652681|FG000|Overall Study|Adverse Event|1|||
129644275|NCT00631410|466652682|FG001|Overall Study|Adverse Event|3|||
129644276|NCT00631410|466652681|FG000|Overall Study|Objective Progression or Relapse|4|||
129706017|NCT00854360|466886701|FG000|Overall Study|Withdrawal by Subject|0|||
129706018|NCT00854360|466886702|FG001|Overall Study|Withdrawal by Subject|0|||
129706019|NCT00854360|466886703|FG002|Overall Study|Withdrawal by Subject|0|||
129706020|NCT00854360|466886704|FG003|Overall Study|Withdrawal by Subject|1|||
129706021|NCT00854360|466886701|FG000|Overall Study|Pregnancy|0|||
129706022|NCT00854360|466886702|FG001|Overall Study|Pregnancy|1|||
129706023|NCT00854360|466886703|FG002|Overall Study|Pregnancy|0|||
129706024|NCT00854360|466886704|FG003|Overall Study|Pregnancy|0|||
129706025|NCT00854360|466886701|FG000|Overall Study|Lack of Efficacy|2|||
129706026|NCT00854360|466886702|FG001|Overall Study|Lack of Efficacy|1|||
129706027|NCT00854360|466886703|FG002|Overall Study|Lack of Efficacy|0|||
129644277|NCT00631410|466652682|FG001|Overall Study|Objective Progression or Relapse|3|||
129644278|NCT00631410|466652681|FG000|Overall Study|Surgery|1|||
129706028|NCT00854360|466886704|FG003|Overall Study|Lack of Efficacy|0|||
129706029|NCT00854360|466886701|FG000|Overall Study|Other|0|||
129706030|NCT00854360|466886702|FG001|Overall Study|Other|0|||
129706031|NCT00854360|466886703|FG002|Overall Study|Other|0|||
129706032|NCT00854360|466886704|FG003|Overall Study|Other|3|||
129706033|NCT01128569|466886709|FG000|Washout Period 1|Adverse Event|0|||
129644279|NCT00631410|466652682|FG001|Overall Study|Surgery|0|||
129644280|NCT01647516|466652687|FG000|Induction Period (IP)|Physician Decision|2|||
129644281|NCT01647516|466652688|FG001|Induction Period (IP)|Physician Decision|0|||
129644282|NCT01647516|466652689|FG002|Induction Period (IP)|Physician Decision|0|||
129644283|NCT01647516|466652690|FG003|Induction Period (IP)|Physician Decision|0|||
129644284|NCT01647516|466652691|FG004|Induction Period (IP)|Physician Decision|0|||
129644285|NCT01647516|466652692|FG005|Induction Period (IP)|Physician Decision|0|||
129644286|NCT01647516|466652687|FG000|Induction Period (IP)|Adverse Event|1|||
129644287|NCT01647516|466652688|FG001|Induction Period (IP)|Adverse Event|2|||
129644288|NCT01647516|466652689|FG002|Induction Period (IP)|Adverse Event|0|||
129644289|NCT01647516|466652690|FG003|Induction Period (IP)|Adverse Event|0|||
129644290|NCT01647516|466652691|FG004|Induction Period (IP)|Adverse Event|0|||
129644291|NCT01647516|466652692|FG005|Induction Period (IP)|Adverse Event|0|||
129644292|NCT01647516|466652687|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
129644293|NCT01647516|466652688|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
129644294|NCT01647516|466652689|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
129644295|NCT01647516|466652690|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
129644296|NCT01647516|466652691|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
129644297|NCT01647516|466652692|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
129644298|NCT01647516|466652687|FG000|Induction Period (IP)|Participant Choice|0|||
129644299|NCT01647516|466652688|FG001|Induction Period (IP)|Participant Choice|0|||
129644300|NCT01647516|466652689|FG002|Induction Period (IP)|Participant Choice|1|||
129644301|NCT01647516|466652690|FG003|Induction Period (IP)|Participant Choice|0|||
129644302|NCT01647516|466652691|FG004|Induction Period (IP)|Participant Choice|0|||
129644303|NCT01647516|466652692|FG005|Induction Period (IP)|Participant Choice|0|||
129644304|NCT01647516|466652687|FG000|Induction Period (IP)|Lack of Efficacy|1|||
129644305|NCT01647516|466652688|FG001|Induction Period (IP)|Lack of Efficacy|0|||
129644306|NCT01647516|466652689|FG002|Induction Period (IP)|Lack of Efficacy|0|||
129644307|NCT01647516|466652690|FG003|Induction Period (IP)|Lack of Efficacy|0|||
129644308|NCT01647516|466652691|FG004|Induction Period (IP)|Lack of Efficacy|0|||
129644309|NCT01647516|466652692|FG005|Induction Period (IP)|Lack of Efficacy|0|||
129644310|NCT01647516|466652687|FG000|Induction Period (IP)|No study drug received|1|||
129644311|NCT01647516|466652688|FG001|Induction Period (IP)|No study drug received|1|||
129644312|NCT01647516|466652689|FG002|Induction Period (IP)|No study drug received|0|||
129644313|NCT01647516|466652690|FG003|Induction Period (IP)|No study drug received|0|||
129644314|NCT01647516|466652691|FG004|Induction Period (IP)|No study drug received|0|||
129644315|NCT01647516|466652692|FG005|Induction Period (IP)|No study drug received|0|||
129644316|NCT01647516|466652687|FG000|Maintenance Period (MP)|Adverse Event|2|||
129644317|NCT01647516|466652688|FG001|Maintenance Period (MP)|Adverse Event|1|||
129644318|NCT01647516|466652689|FG002|Maintenance Period (MP)|Adverse Event|0|||
129644319|NCT01647516|466652690|FG003|Maintenance Period (MP)|Adverse Event|0|||
129644320|NCT01647516|466652691|FG004|Maintenance Period (MP)|Adverse Event|0|||
129644321|NCT01647516|466652692|FG005|Maintenance Period (MP)|Adverse Event|0|||
129644322|NCT01647516|466652687|FG000|Maintenance Period (MP)|Non-compliance|1|||
129644323|NCT01647516|466652688|FG001|Maintenance Period (MP)|Non-compliance|0|||
129644324|NCT01647516|466652689|FG002|Maintenance Period (MP)|Non-compliance|0|||
129644325|NCT01647516|466652690|FG003|Maintenance Period (MP)|Non-compliance|0|||
129644326|NCT01647516|466652691|FG004|Maintenance Period (MP)|Non-compliance|0|||
129644327|NCT01647516|466652692|FG005|Maintenance Period (MP)|Non-compliance|0|||
129644328|NCT01647516|466652687|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
129644329|NCT01647516|466652688|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
129644330|NCT01647516|466652689|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
129644331|NCT01647516|466652690|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
129644332|NCT01647516|466652691|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
129644333|NCT01647516|466652692|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
129644334|NCT01647516|466652687|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
129644335|NCT01647516|466652688|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
129644336|NCT01647516|466652689|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
129644337|NCT01647516|466652690|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
129890347|NCT00688259|467556095|FG000|Overall Study|Hospitalized at Follow-up|0|||
129890348|NCT00688259|467556096|FG001|Overall Study|Hospitalized at Follow-up|1|||
129890349|NCT01310868|467556098|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
129890350|NCT02411591|467556099|FG000|Overall Study|Adverse Event|0|||
129890351|NCT02411591|467556100|FG001|Overall Study|Adverse Event|4|||
129890352|NCT02411591|467556101|FG002|Overall Study|Adverse Event|2|||
129644338|NCT01647516|466652691|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
129644339|NCT01647516|466652692|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
129890353|NCT02411591|467556099|FG000|Overall Study|Withdrawal by Subject|0|||
129644340|NCT01647516|466652687|FG000|Open-Label Period|Adverse Event|0|||
129644341|NCT01647516|466652688|FG001|Open-Label Period|Adverse Event|0|||
129644342|NCT01647516|466652689|FG002|Open-Label Period|Adverse Event|0|||
129644343|NCT01647516|466652690|FG003|Open-Label Period|Adverse Event|5|||
129644344|NCT01647516|466652691|FG004|Open-Label Period|Adverse Event|6|||
129644345|NCT01647516|466652692|FG005|Open-Label Period|Adverse Event|3|||
129644346|NCT01647516|466652687|FG000|Open-Label Period|Pregnancy|0|||
129644347|NCT01647516|466652688|FG001|Open-Label Period|Pregnancy|0|||
129644348|NCT01647516|466652689|FG002|Open-Label Period|Pregnancy|0|||
129644349|NCT01647516|466652690|FG003|Open-Label Period|Pregnancy|0|||
129644350|NCT01647516|466652691|FG004|Open-Label Period|Pregnancy|0|||
129644351|NCT01647516|466652692|FG005|Open-Label Period|Pregnancy|1|||
129644352|NCT01647516|466652687|FG000|Open-Label Period|Non-compliance|0|||
129644353|NCT01647516|466652688|FG001|Open-Label Period|Non-compliance|0|||
129644354|NCT01647516|466652689|FG002|Open-Label Period|Non-compliance|0|||
129644355|NCT01647516|466652690|FG003|Open-Label Period|Non-compliance|1|||
129644356|NCT01647516|466652691|FG004|Open-Label Period|Non-compliance|0|||
129644357|NCT01647516|466652692|FG005|Open-Label Period|Non-compliance|1|||
129644358|NCT01647516|466652687|FG000|Open-Label Period|Physician Decision|0|||
129644359|NCT01647516|466652688|FG001|Open-Label Period|Physician Decision|0|||
129644360|NCT01647516|466652689|FG002|Open-Label Period|Physician Decision|0|||
129644361|NCT01647516|466652690|FG003|Open-Label Period|Physician Decision|1|||
129644362|NCT01647516|466652691|FG004|Open-Label Period|Physician Decision|1|||
129644363|NCT01647516|466652692|FG005|Open-Label Period|Physician Decision|0|||
129644364|NCT01647516|466652687|FG000|Open-Label Period|Withdrawal by Subject|0|||
129644365|NCT01647516|466652688|FG001|Open-Label Period|Withdrawal by Subject|0|||
129644366|NCT01647516|466652689|FG002|Open-Label Period|Withdrawal by Subject|0|||
129644367|NCT01647516|466652690|FG003|Open-Label Period|Withdrawal by Subject|9|||
129644368|NCT01647516|466652691|FG004|Open-Label Period|Withdrawal by Subject|11|||
129644369|NCT01647516|466652692|FG005|Open-Label Period|Withdrawal by Subject|6|||
129644370|NCT01647516|466652687|FG000|Open-Label Period|Lost to Follow-up|0|||
129644371|NCT01647516|466652688|FG001|Open-Label Period|Lost to Follow-up|0|||
129644372|NCT01647516|466652689|FG002|Open-Label Period|Lost to Follow-up|0|||
129644373|NCT01647516|466652690|FG003|Open-Label Period|Lost to Follow-up|1|||
129644374|NCT01647516|466652691|FG004|Open-Label Period|Lost to Follow-up|0|||
129644375|NCT01647516|466652692|FG005|Open-Label Period|Lost to Follow-up|1|||
129644376|NCT01647516|466652687|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
129644377|NCT01647516|466652688|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
129644378|NCT01647516|466652689|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
129644379|NCT01647516|466652690|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
129799033|NCT01907100|467232225|FG001|Overall Study|Other than reasons specified|0|||
129644380|NCT01647516|466652691|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
129644381|NCT01647516|466652692|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
129799034|NCT01907100|467232226|FG002|Overall Study|Other than reasons specified|10|||
129706034|NCT01128569|466886710|FG001|Washout Period 1|Adverse Event|0|||
129706035|NCT01128569|466886711|FG002|Washout Period 1|Adverse Event|1|||
129706036|NCT01128569|466886712|FG003|Washout Period 1|Adverse Event|0|||
129706037|NCT01128569|466886713|FG004|Washout Period 1|Adverse Event|0|||
129706038|NCT01128569|466886714|FG005|Washout Period 1|Adverse Event|0|||
129706039|NCT01128569|466886709|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129706040|NCT01128569|466886710|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129706041|NCT01128569|466886711|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129799035|NCT01907100|467232227|FG003|Overall Study|Other than reasons specified|6|||
129799036|NCT01907100|467232224|FG000|Overall Study|Adverse event (AE)|6|||
129799037|NCT01907100|467232225|FG001|Overall Study|Adverse event (AE)|3|||
129799038|NCT01907100|467232226|FG002|Overall Study|Adverse event (AE)|22|||
129799039|NCT01907100|467232227|FG003|Overall Study|Adverse event (AE)|23|||
129799040|NCT01907100|467232224|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
129799041|NCT01907100|467232225|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
129799042|NCT01907100|467232226|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
129799043|NCT01907100|467232227|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
129799044|NCT02059005|467232228|FG000|Overall Study|Death|1|||
129799045|NCT02059005|467232229|FG001|Overall Study|Death|3|||
129644382|NCT01647516|466652687|FG000|Open-Label Period|Lack of Efficacy|0|||
129644383|NCT01647516|466652688|FG001|Open-Label Period|Lack of Efficacy|0|||
129644384|NCT01647516|466652689|FG002|Open-Label Period|Lack of Efficacy|0|||
129644385|NCT01647516|466652690|FG003|Open-Label Period|Lack of Efficacy|7|||
129644386|NCT01647516|466652691|FG004|Open-Label Period|Lack of Efficacy|9|||
129644387|NCT01647516|466652692|FG005|Open-Label Period|Lack of Efficacy|10|||
129644388|NCT01647516|466652687|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
129644389|NCT01647516|466652688|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
129644390|NCT01647516|466652689|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
129644391|NCT01647516|466652690|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
129644392|NCT01647516|466652691|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
129644393|NCT01647516|466652692|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
129644394|NCT01647516|466652687|FG000|Open-Label Period|No completion / discontinuation visit|0|||
129644395|NCT01647516|466652688|FG001|Open-Label Period|No completion / discontinuation visit|0|||
129644396|NCT01647516|466652689|FG002|Open-Label Period|No completion / discontinuation visit|0|||
129644397|NCT01647516|466652690|FG003|Open-Label Period|No completion / discontinuation visit|0|||
129644398|NCT01647516|466652691|FG004|Open-Label Period|No completion / discontinuation visit|2|||
129644399|NCT01647516|466652692|FG005|Open-Label Period|No completion / discontinuation visit|1|||
129644400|NCT02980341|466652693|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
129644401|NCT02980341|466652694|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
129644402|NCT02980341|466652695|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
129644403|NCT02980341|466652696|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
129644404|NCT02980341|466652697|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
129644405|NCT02980341|466652698|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129644406|NCT02980341|466652699|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129644407|NCT02980341|466652700|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129644408|NCT02980341|466652701|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129644409|NCT02980341|466652702|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129644410|NCT02980341|466652703|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
129644411|NCT02980341|466652693|FG000|Dose Escalation|Clinical progression|0|||
129644412|NCT02980341|466652694|FG001|Dose Escalation|Clinical progression|0|||
129644413|NCT02980341|466652695|FG002|Dose Escalation|Clinical progression|2|||
129644414|NCT02980341|466652696|FG003|Dose Escalation|Clinical progression|1|||
129644415|NCT02980341|466652697|FG004|Dose Escalation|Clinical progression|0|||
129644416|NCT02980341|466652698|FG005|Dose Escalation|Clinical progression|0|||
129644417|NCT02980341|466652699|FG006|Dose Escalation|Clinical progression|0|||
129644418|NCT02980341|466652700|FG007|Dose Escalation|Clinical progression|0|||
129706042|NCT01128569|466886712|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129799046|NCT02059005|467232228|FG000|Overall Study|Lost to Follow-up|19|||
129799047|NCT02059005|467232229|FG001|Overall Study|Lost to Follow-up|19|||
129799048|NCT02059005|467232228|FG000|Overall Study|Incarceration|0|||
129644419|NCT02980341|466652701|FG008|Dose Escalation|Clinical progression|0|||
129644420|NCT02980341|466652702|FG009|Dose Escalation|Clinical progression|0|||
129644421|NCT02980341|466652703|FG010|Dose Escalation|Clinical progression|0|||
129644422|NCT02980341|466652693|FG000|Dose Escalation|Adverse Event|0|||
129644423|NCT02980341|466652694|FG001|Dose Escalation|Adverse Event|0|||
129644424|NCT02980341|466652695|FG002|Dose Escalation|Adverse Event|1|||
129644425|NCT02980341|466652696|FG003|Dose Escalation|Adverse Event|2|||
129644426|NCT02980341|466652697|FG004|Dose Escalation|Adverse Event|2|||
129706043|NCT01128569|466886713|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129706044|NCT01128569|466886714|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129706045|NCT01561976|466886719|FG000|Period 1|Adverse Event|0|||
129799049|NCT02059005|467232229|FG001|Overall Study|Incarceration|1|||
129799050|NCT02059005|467232228|FG000|Overall Study|Inpatient|0|||
129644427|NCT02980341|466652698|FG005|Dose Escalation|Adverse Event|0|||
129644428|NCT02980341|466652699|FG006|Dose Escalation|Adverse Event|0|||
129644429|NCT02980341|466652700|FG007|Dose Escalation|Adverse Event|0|||
129644430|NCT02980341|466652701|FG008|Dose Escalation|Adverse Event|0|||
129644431|NCT02980341|466652702|FG009|Dose Escalation|Adverse Event|0|||
129644432|NCT02980341|466652703|FG010|Dose Escalation|Adverse Event|0|||
129644433|NCT02980341|466652693|FG000|Dose Escalation|Withdrawal by Subject|0|||
129644434|NCT02980341|466652694|FG001|Dose Escalation|Withdrawal by Subject|0|||
129644435|NCT02980341|466652695|FG002|Dose Escalation|Withdrawal by Subject|1|||
129644436|NCT02980341|466652696|FG003|Dose Escalation|Withdrawal by Subject|0|||
129644437|NCT02980341|466652697|FG004|Dose Escalation|Withdrawal by Subject|0|||
129644438|NCT02980341|466652698|FG005|Dose Escalation|Withdrawal by Subject|0|||
129644439|NCT02980341|466652699|FG006|Dose Escalation|Withdrawal by Subject|0|||
129644440|NCT02980341|466652700|FG007|Dose Escalation|Withdrawal by Subject|0|||
129644441|NCT02980341|466652701|FG008|Dose Escalation|Withdrawal by Subject|0|||
129644442|NCT02980341|466652702|FG009|Dose Escalation|Withdrawal by Subject|0|||
129644443|NCT02980341|466652703|FG010|Dose Escalation|Withdrawal by Subject|0|||
129644444|NCT02980341|466652693|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644445|NCT02980341|466652694|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644446|NCT02980341|466652695|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644447|NCT02980341|466652696|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
129644448|NCT02980341|466652697|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644449|NCT02980341|466652698|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644450|NCT02980341|466652699|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644451|NCT02980341|466652700|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644452|NCT02980341|466652701|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644453|NCT02980341|466652702|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644454|NCT02980341|466652703|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
129644455|NCT02980341|466652693|FG000|Dose Escalation|Due to investigator's decision|0|||
129644456|NCT02980341|466652694|FG001|Dose Escalation|Due to investigator's decision|0|||
129644457|NCT02980341|466652695|FG002|Dose Escalation|Due to investigator's decision|0|||
129644458|NCT02980341|466652696|FG003|Dose Escalation|Due to investigator's decision|0|||
129644459|NCT02980341|466652697|FG004|Dose Escalation|Due to investigator's decision|1|||
129644460|NCT02980341|466652698|FG005|Dose Escalation|Due to investigator's decision|0|||
129644461|NCT02980341|466652699|FG006|Dose Escalation|Due to investigator's decision|0|||
129644462|NCT02980341|466652700|FG007|Dose Escalation|Due to investigator's decision|0|||
129644463|NCT02980341|466652701|FG008|Dose Escalation|Due to investigator's decision|0|||
129644464|NCT02980341|466652702|FG009|Dose Escalation|Due to investigator's decision|0|||
129644465|NCT02980341|466652703|FG010|Dose Escalation|Due to investigator's decision|0|||
129644466|NCT02980341|466652693|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644467|NCT02980341|466652694|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644468|NCT02980341|466652695|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644469|NCT02980341|466652696|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644470|NCT02980341|466652697|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644471|NCT02980341|466652698|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
129644472|NCT02980341|466652699|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
129644473|NCT02980341|466652700|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644474|NCT02980341|466652701|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644475|NCT02980341|466652702|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644476|NCT02980341|466652703|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
129644477|NCT02980341|466652693|FG000|Dose Finding|Adverse Event|0|||
129644478|NCT02980341|466652694|FG001|Dose Finding|Adverse Event|0|||
129644479|NCT02980341|466652695|FG002|Dose Finding|Adverse Event|0|||
129644480|NCT02980341|466652696|FG003|Dose Finding|Adverse Event|0|||
129644481|NCT02980341|466652697|FG004|Dose Finding|Adverse Event|0|||
129644482|NCT02980341|466652698|FG005|Dose Finding|Adverse Event|3|||
129644483|NCT02980341|466652699|FG006|Dose Finding|Adverse Event|0|||
129644484|NCT02980341|466652700|FG007|Dose Finding|Adverse Event|0|||
129644485|NCT02980341|466652701|FG008|Dose Finding|Adverse Event|0|||
129644486|NCT02980341|466652702|FG009|Dose Finding|Adverse Event|0|||
129644487|NCT02980341|466652703|FG010|Dose Finding|Adverse Event|0|||
129644488|NCT02980341|466652693|FG000|Dose Finding|Withdrawal by Subject|0|||
129644489|NCT02980341|466652694|FG001|Dose Finding|Withdrawal by Subject|0|||
129644490|NCT02980341|466652695|FG002|Dose Finding|Withdrawal by Subject|0|||
129644491|NCT02980341|466652696|FG003|Dose Finding|Withdrawal by Subject|0|||
129644492|NCT02980341|466652697|FG004|Dose Finding|Withdrawal by Subject|0|||
129644493|NCT02980341|466652698|FG005|Dose Finding|Withdrawal by Subject|1|||
129644494|NCT02980341|466652699|FG006|Dose Finding|Withdrawal by Subject|1|||
129644495|NCT02980341|466652700|FG007|Dose Finding|Withdrawal by Subject|0|||
129706046|NCT01561976|466886720|FG001|Period 1|Adverse Event|0|||
129706047|NCT01561976|466886721|FG002|Period 1|Adverse Event|1|||
129706048|NCT01561976|466886722|FG003|Period 1|Adverse Event|0|||
129706049|NCT01561976|466886723|FG004|Period 1|Adverse Event|0|||
129706050|NCT01561976|466886724|FG005|Period 1|Adverse Event|0|||
129706051|NCT01561976|466886719|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
129706052|NCT01561976|466886720|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
129706053|NCT01561976|466886721|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
129706054|NCT01561976|466886722|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
129706055|NCT01561976|466886723|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
129706056|NCT01561976|466886724|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
129706057|NCT01561976|466886719|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129706058|NCT01561976|466886720|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129706059|NCT01561976|466886721|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129706060|NCT01561976|466886722|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129706061|NCT01561976|466886723|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
129706062|NCT01561976|466886724|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
129706063|NCT01561976|466886719|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
129706064|NCT01561976|466886720|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
129706065|NCT01561976|466886721|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
129706066|NCT01561976|466886722|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
129706067|NCT01561976|466886723|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
129706068|NCT01561976|466886724|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
129706069|NCT04403919|466886725|FG000|Overall Study|Lost to Follow-up|0|||
129706070|NCT04403919|466886726|FG001|Overall Study|Lost to Follow-up|0|||
129706071|NCT04403919|466886727|FG002|Overall Study|Lost to Follow-up|0|||
129706072|NCT04403919|466886728|FG003|Overall Study|Lost to Follow-up|1|||
129706073|NCT01156844|466886729|FG000|Overall Study|Adverse Event|0|||
129706074|NCT01156844|466886730|FG001|Overall Study|Adverse Event|0|||
129706075|NCT01156844|466886731|FG002|Overall Study|Adverse Event|1|||
129706076|NCT01156844|466886732|FG003|Overall Study|Adverse Event|1|||
129706077|NCT01156844|466886729|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129706078|NCT01156844|466886730|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129706079|NCT01156844|466886731|FG002|Overall Study|Abnormal test procedure result(s)|2|||
129706080|NCT01156844|466886732|FG003|Overall Study|Abnormal test procedure result(s)|2|||
129706081|NCT01156844|466886729|FG000|Overall Study|Withdrawal by Subject|0|||
129706082|NCT01156844|466886730|FG001|Overall Study|Withdrawal by Subject|0|||
129706083|NCT01156844|466886731|FG002|Overall Study|Withdrawal by Subject|2|||
129706084|NCT01156844|466886732|FG003|Overall Study|Withdrawal by Subject|2|||
129706085|NCT01156844|466886729|FG000|Overall Study|Lost to Follow-up|0|||
129706086|NCT01156844|466886730|FG001|Overall Study|Lost to Follow-up|0|||
129706087|NCT01156844|466886731|FG002|Overall Study|Lost to Follow-up|1|||
129706088|NCT01156844|466886732|FG003|Overall Study|Lost to Follow-up|0|||
129706089|NCT01156844|466886729|FG000|Overall Study|Administrative problems|0|||
129706090|NCT01156844|466886730|FG001|Overall Study|Administrative problems|1|||
129706091|NCT01156844|466886731|FG002|Overall Study|Administrative problems|0|||
129706092|NCT01156844|466886732|FG003|Overall Study|Administrative problems|1|||
129706093|NCT01156844|466886729|FG000|Overall Study|Protocol deviation|2|||
129706094|NCT01156844|466886730|FG001|Overall Study|Protocol deviation|0|||
129706095|NCT01156844|466886731|FG002|Overall Study|Protocol deviation|0|||
129706096|NCT01156844|466886732|FG003|Overall Study|Protocol deviation|0|||
129706097|NCT04846231|466886735|FG000|Overall Study|Lost to Follow-up|1|||
129706098|NCT04846231|466886736|FG001|Overall Study|Lost to Follow-up|0|||
129706099|NCT04846231|466886737|FG002|Overall Study|Lost to Follow-up|0|||
129890354|NCT02411591|467556100|FG001|Overall Study|Withdrawal by Subject|3|||
129706100|NCT04846231|466886738|FG003|Overall Study|Lost to Follow-up|0|||
129706101|NCT04846231|466886739|FG004|Overall Study|Lost to Follow-up|0|||
129706102|NCT04846231|466886740|FG005|Overall Study|Lost to Follow-up|0|||
129706103|NCT04846231|466886741|FG006|Overall Study|Lost to Follow-up|0|||
129706104|NCT04846231|466886742|FG007|Overall Study|Lost to Follow-up|1|||
129706105|NCT04846231|466886735|FG000|Overall Study|Withdrawal by Subject|0|||
129706106|NCT04846231|466886736|FG001|Overall Study|Withdrawal by Subject|1|||
129706107|NCT04846231|466886737|FG002|Overall Study|Withdrawal by Subject|2|||
129706108|NCT04846231|466886738|FG003|Overall Study|Withdrawal by Subject|1|||
129706109|NCT04846231|466886739|FG004|Overall Study|Withdrawal by Subject|0|||
129706110|NCT04846231|466886740|FG005|Overall Study|Withdrawal by Subject|0|||
129706111|NCT04846231|466886741|FG006|Overall Study|Withdrawal by Subject|0|||
129706112|NCT04846231|466886742|FG007|Overall Study|Withdrawal by Subject|0|||
129706113|NCT04846231|466886735|FG000|Overall Study|Protocol Violation|0|||
129706114|NCT04846231|466886736|FG001|Overall Study|Protocol Violation|1|||
129706115|NCT04846231|466886737|FG002|Overall Study|Protocol Violation|0|||
129706116|NCT04846231|466886738|FG003|Overall Study|Protocol Violation|0|||
129706117|NCT04846231|466886739|FG004|Overall Study|Protocol Violation|0|||
129706118|NCT04846231|466886740|FG005|Overall Study|Protocol Violation|0|||
129706119|NCT04846231|466886741|FG006|Overall Study|Protocol Violation|0|||
129706120|NCT04846231|466886742|FG007|Overall Study|Protocol Violation|0|||
129706121|NCT04846231|466886735|FG000|Overall Study|Adverse Event|0|||
129706122|NCT04846231|466886736|FG001|Overall Study|Adverse Event|0|||
129706123|NCT04846231|466886737|FG002|Overall Study|Adverse Event|0|||
129706124|NCT04846231|466886738|FG003|Overall Study|Adverse Event|0|||
129890355|NCT02411591|467556101|FG002|Overall Study|Withdrawal by Subject|0|||
129799051|NCT02059005|467232229|FG001|Overall Study|Inpatient|1|||
129799052|NCT00739596|467232230|FG000|Overall Study|Adverse Event|12|||
129799053|NCT00739596|467232231|FG001|Overall Study|Adverse Event|6|||
129799054|NCT00739596|467232230|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
129644496|NCT02980341|466652701|FG008|Dose Finding|Withdrawal by Subject|0|||
129644497|NCT02980341|466652702|FG009|Dose Finding|Withdrawal by Subject|0|||
129644498|NCT02980341|466652703|FG010|Dose Finding|Withdrawal by Subject|0|||
129644499|NCT02980341|466652693|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644500|NCT02980341|466652694|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644501|NCT02980341|466652695|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644502|NCT02980341|466652696|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644503|NCT02980341|466652697|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644504|NCT02980341|466652698|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644505|NCT02980341|466652699|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
129644506|NCT02980341|466652700|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
129644507|NCT02980341|466652701|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
129644508|NCT02980341|466652702|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
129644509|NCT02980341|466652703|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
129644510|NCT02980341|466652693|FG000|Dose Expansion|Clinical progression|0|||
129644511|NCT02980341|466652694|FG001|Dose Expansion|Clinical progression|0|||
129644512|NCT02980341|466652695|FG002|Dose Expansion|Clinical progression|0|||
129644513|NCT02980341|466652696|FG003|Dose Expansion|Clinical progression|0|||
129644514|NCT02980341|466652697|FG004|Dose Expansion|Clinical progression|0|||
129644515|NCT02980341|466652698|FG005|Dose Expansion|Clinical progression|0|||
129644516|NCT02980341|466652699|FG006|Dose Expansion|Clinical progression|0|||
129644517|NCT02980341|466652700|FG007|Dose Expansion|Clinical progression|4|||
129644518|NCT02980341|466652701|FG008|Dose Expansion|Clinical progression|3|||
129644519|NCT02980341|466652702|FG009|Dose Expansion|Clinical progression|1|||
129644520|NCT02980341|466652703|FG010|Dose Expansion|Clinical progression|4|||
129644521|NCT02980341|466652693|FG000|Dose Expansion|Adverse Event|0|||
129644522|NCT02980341|466652694|FG001|Dose Expansion|Adverse Event|0|||
129644523|NCT02980341|466652695|FG002|Dose Expansion|Adverse Event|0|||
129644524|NCT02980341|466652696|FG003|Dose Expansion|Adverse Event|0|||
129644525|NCT02980341|466652697|FG004|Dose Expansion|Adverse Event|0|||
129644526|NCT02980341|466652698|FG005|Dose Expansion|Adverse Event|0|||
129644527|NCT02980341|466652699|FG006|Dose Expansion|Adverse Event|0|||
129644528|NCT02980341|466652700|FG007|Dose Expansion|Adverse Event|3|||
129644529|NCT02980341|466652701|FG008|Dose Expansion|Adverse Event|0|||
129644530|NCT02980341|466652702|FG009|Dose Expansion|Adverse Event|1|||
129644531|NCT02980341|466652703|FG010|Dose Expansion|Adverse Event|3|||
129644532|NCT02980341|466652693|FG000|Dose Expansion|Death|0|||
129644533|NCT02980341|466652694|FG001|Dose Expansion|Death|0|||
129644534|NCT02980341|466652695|FG002|Dose Expansion|Death|0|||
129644535|NCT02980341|466652696|FG003|Dose Expansion|Death|0|||
129644536|NCT02980341|466652697|FG004|Dose Expansion|Death|0|||
129644537|NCT02980341|466652698|FG005|Dose Expansion|Death|0|||
129644538|NCT02980341|466652699|FG006|Dose Expansion|Death|0|||
129799055|NCT00739596|467232231|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129799056|NCT00739596|467232230|FG000|Overall Study|Patient Withdrew Consent|8|||
129799057|NCT00739596|467232231|FG001|Overall Study|Patient Withdrew Consent|8|||
129799058|NCT00739596|467232230|FG000|Overall Study|Lost to Follow-up|0|||
129799059|NCT00739596|467232231|FG001|Overall Study|Lost to Follow-up|2|||
129799060|NCT00739596|467232230|FG000|Overall Study|Protocol Deviation|1|||
129799061|NCT00739596|467232231|FG001|Overall Study|Protocol Deviation|1|||
129799062|NCT00908011|467232236|FG000|Overall Study|Withdrawal by Subject|2|||
129799063|NCT00908011|467232237|FG001|Overall Study|Withdrawal by Subject|2|||
129799064|NCT00644228|467232238|FG000|Randomization & Eligibility|Ineligible|31|||
129799065|NCT00644228|467232239|FG001|Randomization & Eligibility|Ineligible|21|||
129644539|NCT02980341|466652700|FG007|Dose Expansion|Death|0|||
129644540|NCT02980341|466652701|FG008|Dose Expansion|Death|2|||
129644541|NCT02980341|466652702|FG009|Dose Expansion|Death|1|||
129644542|NCT02980341|466652703|FG010|Dose Expansion|Death|0|||
129644543|NCT02980341|466652693|FG000|Dose Expansion|Withdrawal by Subject|0|||
129644544|NCT02980341|466652694|FG001|Dose Expansion|Withdrawal by Subject|0|||
129644545|NCT02980341|466652695|FG002|Dose Expansion|Withdrawal by Subject|0|||
129644546|NCT02980341|466652696|FG003|Dose Expansion|Withdrawal by Subject|0|||
129443531|NCT04147234|465924418|FG000|Overall Study|Clinical deterioration|0|||
129443532|NCT04147234|465924419|FG001|Overall Study|Clinical deterioration|0|||
129644547|NCT02980341|466652697|FG004|Dose Expansion|Withdrawal by Subject|0|||
129644548|NCT02980341|466652698|FG005|Dose Expansion|Withdrawal by Subject|0|||
129644549|NCT02980341|466652699|FG006|Dose Expansion|Withdrawal by Subject|0|||
129644550|NCT02980341|466652700|FG007|Dose Expansion|Withdrawal by Subject|2|||
129644551|NCT02980341|466652701|FG008|Dose Expansion|Withdrawal by Subject|0|||
129644552|NCT02980341|466652702|FG009|Dose Expansion|Withdrawal by Subject|1|||
129799066|NCT00644228|467232238|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
129799067|NCT00644228|467232239|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
129644553|NCT02980341|466652703|FG010|Dose Expansion|Withdrawal by Subject|0|||
129644554|NCT02980341|466652693|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644555|NCT02980341|466652694|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644556|NCT02980341|466652695|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644557|NCT02980341|466652696|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644558|NCT02980341|466652697|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644559|NCT02980341|466652698|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644560|NCT02980341|466652699|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644561|NCT02980341|466652700|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
129644562|NCT02980341|466652701|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644563|NCT02980341|466652702|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644564|NCT02980341|466652703|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
129644565|NCT02980341|466652693|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644566|NCT02980341|466652694|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644567|NCT02980341|466652695|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644568|NCT02980341|466652696|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644569|NCT02980341|466652697|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644570|NCT02980341|466652698|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644571|NCT02980341|466652699|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644572|NCT02980341|466652700|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644573|NCT02980341|466652701|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
129644574|NCT02980341|466652702|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644575|NCT02980341|466652703|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
129644576|NCT02980341|466652693|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644577|NCT02980341|466652694|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644578|NCT02980341|466652695|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644579|NCT02980341|466652696|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644580|NCT02980341|466652697|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644581|NCT02980341|466652698|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644582|NCT02980341|466652699|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644583|NCT02980341|466652700|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129799068|NCT00644228|467232238|FG000|Randomization & Eligibility|Invalid Consent|0|||
129799069|NCT00644228|467232239|FG001|Randomization & Eligibility|Invalid Consent|1|||
129799070|NCT00644228|467232238|FG000|Induction Therapy|Adverse Event|22|||
129799071|NCT00644228|467232239|FG001|Induction Therapy|Adverse Event|55|||
129799072|NCT00644228|467232238|FG000|Induction Therapy|Withdrawal by Subject|10|||
129799073|NCT00644228|467232239|FG001|Induction Therapy|Withdrawal by Subject|3|||
129799074|NCT00644228|467232238|FG000|Induction Therapy|Progression/Relapse|24|||
129799075|NCT00644228|467232239|FG001|Induction Therapy|Progression/Relapse|12|||
129799076|NCT00644228|467232238|FG000|Induction Therapy|Death|3|||
129799077|NCT00644228|467232239|FG001|Induction Therapy|Death|7|||
129799078|NCT00644228|467232238|FG000|Induction Therapy|Not Protocol-Specified|24|||
129799079|NCT00644228|467232239|FG001|Induction Therapy|Not Protocol-Specified|28|||
129799080|NCT00644228|467232238|FG000|Maintenance|Adverse Event|27|||
129799081|NCT00644228|467232239|FG001|Maintenance|Adverse Event|31|||
129799082|NCT00644228|467232238|FG000|Maintenance|Withdrawal by Subject|6|||
129799083|NCT00644228|467232239|FG001|Maintenance|Withdrawal by Subject|4|||
129799084|NCT00644228|467232238|FG000|Maintenance|Progression/Relapse|67|||
129799085|NCT00644228|467232239|FG001|Maintenance|Progression/Relapse|42|||
129799086|NCT00644228|467232238|FG000|Maintenance|Death|3|||
129799087|NCT00644228|467232239|FG001|Maintenance|Death|3|||
129799088|NCT00644228|467232238|FG000|Maintenance|Not Protocol-Specified|14|||
129799089|NCT00644228|467232239|FG001|Maintenance|Not Protocol-Specified|15|||
129799090|NCT00644228|467232238|FG000|Maintenance|On Treatment|26|||
129799091|NCT00644228|467232239|FG001|Maintenance|On Treatment|40|||
129799092|NCT00760084|467232240|FG000|Overall Study|Physician Decision|5|||
129799093|NCT00760084|467232240|FG000|Overall Study|Withdrawal by Subject|2|||
129799094|NCT00760084|467232240|FG000|Overall Study|Progressive Disease|3|||
129799095|NCT02142803|467232241|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
129799096|NCT02142803|467232242|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
129799097|NCT02142803|467232243|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
129799098|NCT02142803|467232244|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
129799099|NCT02718300|467232250|FG000|Overall Study|Death|4|||
129799100|NCT02718300|467232251|FG001|Overall Study|Death|5|||
129706125|NCT04846231|466886739|FG004|Overall Study|Adverse Event|0|||
129706126|NCT04846231|466886740|FG005|Overall Study|Adverse Event|0|||
129706127|NCT04846231|466886741|FG006|Overall Study|Adverse Event|1|||
129706128|NCT04846231|466886742|FG007|Overall Study|Adverse Event|1|||
129706129|NCT01448616|466886743|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
129706130|NCT01448616|466886744|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
129706131|NCT01448616|466886745|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
129706132|NCT01448616|466886746|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
129706133|NCT01448616|466886743|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
129706134|NCT01448616|466886744|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
129706135|NCT01448616|466886745|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
129706136|NCT01448616|466886746|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
129706137|NCT01448616|466886743|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
129706138|NCT01448616|466886744|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
129706139|NCT01448616|466886745|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
129706140|NCT01448616|466886746|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
129706141|NCT01448616|466886743|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
129706142|NCT01448616|466886744|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
129706143|NCT01448616|466886745|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
129706144|NCT01448616|466886746|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
129706145|NCT01448616|466886743|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
129706146|NCT01448616|466886744|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
129706147|NCT01448616|466886745|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
129706148|NCT01448616|466886746|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
129706149|NCT02170064|466886747|FG000|Overall Study|Withdrawal by Subject|5|||
129706150|NCT02170064|466886748|FG001|Overall Study|Withdrawal by Subject|1|||
129706151|NCT02170064|466886749|FG002|Overall Study|Withdrawal by Subject|1|||
129706152|NCT02170064|466886747|FG000|Overall Study|Physician Decision|1|||
129706153|NCT02170064|466886748|FG001|Overall Study|Physician Decision|1|||
129706154|NCT02170064|466886749|FG002|Overall Study|Physician Decision|0|||
129706155|NCT03323164|466886750|FG000|Overall Study|Poor quality imaging/scans|2|||
129706156|NCT03323164|466886751|FG001|Overall Study|Poor quality imaging/scans|2|||
129706157|NCT00654732|466886752|FG000|Overall Study|Adverse Event|4|||
129706158|NCT00654732|466886753|FG001|Overall Study|Adverse Event|6|||
129706159|NCT01959932|466886754|FG000|Overall Study|Withdrawal by Subject|1|||
129706160|NCT01959932|466886755|FG001|Overall Study|Withdrawal by Subject|0|||
129706161|NCT01959932|466886756|FG002|Overall Study|Withdrawal by Subject|0|||
129706162|NCT00397540|466886757|FG000|Overall Study|short follow-up duration < 12 months|1|||
129706163|NCT00397540|466886758|FG001|Overall Study|short follow-up duration < 12 months|0|||
129706164|NCT00776230|466886761|FG000|Overall Study|Lost to Follow-up|2|||
129706165|NCT00776230|466886762|FG001|Overall Study|Lost to Follow-up|1|||
129706166|NCT00776230|466886763|FG002|Overall Study|Lost to Follow-up|5|||
129706167|NCT00776230|466886761|FG000|Overall Study|Not vaccinated at Day 0|1|||
129706168|NCT00776230|466886762|FG001|Overall Study|Not vaccinated at Day 0|0|||
129706169|NCT00776230|466886763|FG002|Overall Study|Not vaccinated at Day 0|0|||
129706170|NCT00776230|466886761|FG000|Overall Study|Withdrawal by Subject|0|||
129706171|NCT00776230|466886762|FG001|Overall Study|Withdrawal by Subject|1|||
129706172|NCT00776230|466886763|FG002|Overall Study|Withdrawal by Subject|0|||
129706173|NCT00776230|466886761|FG000|Overall Study|Subject missed Visit 4|0|||
129706174|NCT00776230|466886762|FG001|Overall Study|Subject missed Visit 4|1|||
129706175|NCT00776230|466886763|FG002|Overall Study|Subject missed Visit 4|0|||
129706176|NCT02993263|466886775|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
129706177|NCT00545779|466886776|FG000|Overall Study|Violation of selection criteria at entry|8|||
129706178|NCT00545779|466886776|FG000|Overall Study|Other protocol violation|1|||
129706179|NCT00545779|466886776|FG000|Overall Study|Did not cooperate|7|||
129706180|NCT00545779|466886776|FG000|Overall Study|Withdrawal by Subject|20|||
129706181|NCT00545779|466886776|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
129706182|NCT00545779|466886776|FG000|Overall Study|Failure to return|3|||
129706183|NCT01405196|466886777|FG000|Overall Study|Study Terminated by Sponsor|0|||
129706184|NCT01405196|466886778|FG001|Overall Study|Study Terminated by Sponsor|0|||
129706185|NCT01405196|466886779|FG002|Overall Study|Study Terminated by Sponsor|9|||
129706186|NCT01405196|466886780|FG003|Overall Study|Study Terminated by Sponsor|0|||
129706187|NCT01405196|466886777|FG000|Overall Study|Other|2|||
129706188|NCT01405196|466886778|FG001|Overall Study|Other|2|||
129706189|NCT01405196|466886779|FG002|Overall Study|Other|5|||
129706190|NCT01405196|466886780|FG003|Overall Study|Other|0|||
129706191|NCT01405196|466886777|FG000|Overall Study|Withdrawal by Subject|4|||
129706192|NCT01405196|466886778|FG001|Overall Study|Withdrawal by Subject|6|||
129706193|NCT01405196|466886779|FG002|Overall Study|Withdrawal by Subject|3|||
129706194|NCT01405196|466886780|FG003|Overall Study|Withdrawal by Subject|6|||
129706195|NCT01405196|466886777|FG000|Overall Study|Adverse Event|2|||
129706196|NCT01405196|466886778|FG001|Overall Study|Adverse Event|2|||
129706197|NCT01405196|466886779|FG002|Overall Study|Adverse Event|0|||
129799101|NCT02718300|467232252|FG002|Overall Study|Death|17|||
129799102|NCT02718300|467232250|FG000|Overall Study|Lost to Follow-up|1|||
129799103|NCT02718300|467232251|FG001|Overall Study|Lost to Follow-up|0|||
129799104|NCT02718300|467232252|FG002|Overall Study|Lost to Follow-up|2|||
129799105|NCT02718300|467232250|FG000|Overall Study|Physician Decision|1|||
129799106|NCT02718300|467232251|FG001|Overall Study|Physician Decision|0|||
129799107|NCT02718300|467232252|FG002|Overall Study|Physician Decision|2|||
129799108|NCT02718300|467232250|FG000|Overall Study|Study Terminated by Sponsor|6|||
129799109|NCT02718300|467232251|FG001|Overall Study|Study Terminated by Sponsor|3|||
129799110|NCT02718300|467232252|FG002|Overall Study|Study Terminated by Sponsor|4|||
129799111|NCT02718300|467232250|FG000|Overall Study|Withdrawal by Subject|0|||
129799112|NCT02718300|467232251|FG001|Overall Study|Withdrawal by Subject|4|||
129799113|NCT02718300|467232252|FG002|Overall Study|Withdrawal by Subject|3|||
129799114|NCT02718300|467232250|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
129799115|NCT02718300|467232251|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
129799116|NCT02718300|467232252|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
129799117|NCT03906461|467233422|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
129799118|NCT03906461|467233422|FG000|Completed 12-month Follow-up|Missed Visit|6|||
129799119|NCT00510874|467233423|FG000|Overall Study|Withdrawal by Subject|1|||
129799120|NCT00510874|467233424|FG001|Overall Study|Withdrawal by Subject|1|||
129799121|NCT00510874|467233425|FG002|Overall Study|Withdrawal by Subject|0|||
129799122|NCT00510874|467233426|FG003|Overall Study|Withdrawal by Subject|0|||
129799123|NCT00510874|467233427|FG004|Overall Study|Withdrawal by Subject|3|||
129799124|NCT00510874|467233428|FG005|Overall Study|Withdrawal by Subject|0|||
129799125|NCT00510874|467233429|FG006|Overall Study|Withdrawal by Subject|0|||
129799126|NCT00510874|467233423|FG000|Overall Study|Lost to Follow-up|2|||
129799127|NCT00510874|467233424|FG001|Overall Study|Lost to Follow-up|3|||
129799128|NCT00510874|467233425|FG002|Overall Study|Lost to Follow-up|1|||
129799129|NCT00510874|467233426|FG003|Overall Study|Lost to Follow-up|3|||
129799130|NCT00510874|467233427|FG004|Overall Study|Lost to Follow-up|4|||
129799131|NCT00510874|467233428|FG005|Overall Study|Lost to Follow-up|0|||
129799132|NCT00510874|467233429|FG006|Overall Study|Lost to Follow-up|1|||
129799133|NCT02423109|467233432|FG000|Lens 1|Adverse Event|1|||
129799134|NCT02423109|467233433|FG001|Lens 1|Adverse Event|0|||
129799135|NCT04622735|467233434|FG000|Overall Study|Lost to Follow-up|1|||
129799136|NCT04622735|467233435|FG001|Overall Study|Lost to Follow-up|2|||
129799137|NCT04622735|467233436|FG002|Overall Study|Lost to Follow-up|1|||
129799138|NCT04622735|467233434|FG000|Overall Study|Adverse Event|0|||
129799139|NCT04622735|467233435|FG001|Overall Study|Adverse Event|0|||
129799140|NCT04622735|467233436|FG002|Overall Study|Adverse Event|1|||
129799141|NCT04622735|467233434|FG000|Overall Study|Protocol Violation|1|||
129799142|NCT04622735|467233435|FG001|Overall Study|Protocol Violation|0|||
129799143|NCT04622735|467233436|FG002|Overall Study|Protocol Violation|0|||
129799144|NCT04073368|467233437|FG000|Overall Study|Adverse Event|2|||
129799145|NCT04073368|467233438|FG001|Overall Study|Adverse Event|0|||
129799146|NCT04073368|467233439|FG002|Overall Study|Adverse Event|1|||
129799147|NCT04073368|467233440|FG003|Overall Study|Adverse Event|1|||
129799148|NCT04073368|467233437|FG000|Overall Study|Withdrawal by Subject|2|||
129799149|NCT04073368|467233438|FG001|Overall Study|Withdrawal by Subject|2|||
129799150|NCT04073368|467233439|FG002|Overall Study|Withdrawal by Subject|1|||
129799151|NCT04073368|467233440|FG003|Overall Study|Withdrawal by Subject|1|||
129799152|NCT04073368|467233437|FG000|Overall Study|Lost to Follow-up|1|||
129799153|NCT04073368|467233438|FG001|Overall Study|Lost to Follow-up|1|||
129799154|NCT04073368|467233439|FG002|Overall Study|Lost to Follow-up|1|||
129799155|NCT04073368|467233440|FG003|Overall Study|Lost to Follow-up|0|||
129799156|NCT04073368|467233437|FG000|Overall Study|Protocol Violation|0|||
129799157|NCT04073368|467233438|FG001|Overall Study|Protocol Violation|1|||
129799158|NCT04073368|467233439|FG002|Overall Study|Protocol Violation|0|||
129799159|NCT04073368|467233440|FG003|Overall Study|Protocol Violation|0|||
129799160|NCT04073368|467233437|FG000|Overall Study|Subject noncompliance|7|||
129799161|NCT04073368|467233438|FG001|Overall Study|Subject noncompliance|4|||
129799162|NCT04073368|467233439|FG002|Overall Study|Subject noncompliance|0|||
129799163|NCT04073368|467233440|FG003|Overall Study|Subject noncompliance|0|||
129799164|NCT01229397|467233441|FG000|Overall Study|Withdrawal by Subject|3|||
129799165|NCT01229397|467233442|FG001|Overall Study|Withdrawal by Subject|3|||
129799166|NCT01229397|467233441|FG000|Overall Study|Lost to Follow-up|7|||
129799167|NCT01229397|467233442|FG001|Overall Study|Lost to Follow-up|6|||
129799168|NCT01229397|467233441|FG000|Overall Study|Migrated/moved from study area|1|||
129799169|NCT01229397|467233442|FG001|Overall Study|Migrated/moved from study area|0|||
129799170|NCT03960554|467233451|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
129799171|NCT03960554|467233452|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
129799172|NCT00735254|467233453|FG000|Overall Study|Protocol Violation|1|||
129799173|NCT00735254|467233454|FG001|Overall Study|Protocol Violation|1|||
129799174|NCT00735254|467233455|FG002|Overall Study|Protocol Violation|1|||
129799175|NCT00735254|467233456|FG003|Overall Study|Protocol Violation|0|||
129799176|NCT00751621|467233457|FG000|Overall Study|Adverse Event|1|||
129799177|NCT00751621|467233457|FG000|Overall Study|Withdrawal by Subject|1|||
129644584|NCT02980341|466652701|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
129644585|NCT02980341|466652702|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644586|NCT02980341|466652703|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
129644587|NCT02980341|466652693|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129706198|NCT01405196|466886780|FG003|Overall Study|Adverse Event|2|||
129706199|NCT01405196|466886777|FG000|Overall Study|Death|1|||
129706200|NCT01405196|466886778|FG001|Overall Study|Death|0|||
129706201|NCT01405196|466886779|FG002|Overall Study|Death|3|||
129706202|NCT01405196|466886780|FG003|Overall Study|Death|0|||
129706203|NCT01405196|466886777|FG000|Overall Study|Lost to Follow-up|2|||
129706204|NCT01405196|466886778|FG001|Overall Study|Lost to Follow-up|2|||
129706205|NCT01405196|466886779|FG002|Overall Study|Lost to Follow-up|3|||
129706206|NCT01405196|466886780|FG003|Overall Study|Lost to Follow-up|1|||
129706207|NCT01729039|466886783|FG000|Overall Study|disqualified|2|||
129706208|NCT01729039|466886784|FG001|Overall Study|disqualified|5|||
129706209|NCT01729039|466886783|FG000|Overall Study|Withdrawal by Subject|8|||
129706210|NCT01729039|466886784|FG001|Overall Study|Withdrawal by Subject|7|||
129706211|NCT00698841|466886785|FG000|Overall Study|Withdrawal by Subject|2|||
129706212|NCT00698841|466886785|FG000|Overall Study|Adverse Event|3|||
129706213|NCT00698841|466886785|FG000|Overall Study|Disease progression|7|||
129706214|NCT00698841|466886785|FG000|Overall Study|Failure to meet eligibility criteria|2|||
129706215|NCT00698841|466886785|FG000|Overall Study|Study drug toxicity|2|||
129706216|NCT00698841|466886785|FG000|Overall Study|Other|2|||
129706217|NCT02611037|466886786|FG000|Overall Study|Withdrawal prior to treatment|2|||
129706218|NCT02611037|466886787|FG001|Overall Study|Withdrawal prior to treatment|0|||
129706219|NCT00829998|466886788|FG000|Washout|Adverse Event|0|||
129706220|NCT00829998|466886789|FG001|Washout|Adverse Event|1|||
129706221|NCT05788991|466886792|FG000|Overall Study|Not treated with study medication|1|||
129706222|NCT05788991|466886793|FG001|Overall Study|Not treated with study medication|3|||
129706223|NCT05788991|466886792|FG000|Overall Study|Withdrawal by Subject|1|||
129706224|NCT05788991|466886793|FG001|Overall Study|Withdrawal by Subject|0|||
129706225|NCT05788991|466886792|FG000|Overall Study|Lack of Efficacy|0|||
129706226|NCT05788991|466886793|FG001|Overall Study|Lack of Efficacy|1|||
129706227|NCT05788991|466886792|FG000|Overall Study|Protocol Violation|1|||
129706228|NCT05788991|466886793|FG001|Overall Study|Protocol Violation|2|||
129706229|NCT05270863|466886794|FG000|Visit 2 First Intervention|Randomization error|0|||
129706230|NCT05270863|466886795|FG001|Visit 2 First Intervention|Randomization error|0|||
129706231|NCT05270863|466886796|FG002|Visit 2 First Intervention|Randomization error|0|||
129706232|NCT05270863|466886797|FG003|Visit 2 First Intervention|Randomization error|1|||
129706233|NCT05270863|466886798|FG004|Visit 2 First Intervention|Randomization error|0|||
129706234|NCT05270863|466886799|FG005|Visit 2 First Intervention|Randomization error|0|||
129706235|NCT05270863|466886794|FG000|First Washout|Withdrawal by Subject|0|||
129706236|NCT05270863|466886795|FG001|First Washout|Withdrawal by Subject|0|||
129706237|NCT05270863|466886796|FG002|First Washout|Withdrawal by Subject|0|||
129799178|NCT00751621|467233457|FG000|Overall Study|Subject moved to another country|1|||
129799179|NCT00751621|467233457|FG000|Overall Study|Poor adherence to asthma treatment|1|||
129799180|NCT02791594|467233458|FG000|Overall Study|Physician Decision|2|||
129799181|NCT02310321|467233459|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
129799182|NCT02310321|467233460|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799183|NCT02310321|467233461|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799184|NCT02310321|467233459|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
129799185|NCT02310321|467233460|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799186|NCT02310321|467233461|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799187|NCT02310321|467233459|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
129799188|NCT02310321|467233460|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799189|NCT02310321|467233461|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
129799190|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
129799191|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
129799192|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
129799193|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799194|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
129799195|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
129799196|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
129799197|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
129799198|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
129799199|NCT02310321|467233459|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
129799200|NCT02310321|467233460|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
129799201|NCT02310321|467233461|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
129799202|NCT02310321|467233459|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
129799203|NCT02310321|467233460|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
129799204|NCT02310321|467233461|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
129799205|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
129799206|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
129799207|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
129799208|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
129799209|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
129799210|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
129799211|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
129799212|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
129799213|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
129799214|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
129799215|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
129799216|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
129799217|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
129799218|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
129799219|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
129799220|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
129799221|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
129799222|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
129799223|NCT02310321|467233459|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
129799224|NCT02310321|467233460|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
129799225|NCT02310321|467233461|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
129799226|NCT02310321|467233459|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
129799227|NCT02310321|467233460|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
129799228|NCT02310321|467233461|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
129799229|NCT02310321|467233459|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
129799230|NCT02310321|467233460|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
129799231|NCT02310321|467233461|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
129799232|NCT02310321|467233459|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
129799233|NCT02310321|467233460|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
129799234|NCT02310321|467233461|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
129799235|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
129799236|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
129644588|NCT02980341|466652694|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644589|NCT02980341|466652695|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644590|NCT02980341|466652696|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129799237|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
129799238|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
129799239|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
129799240|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
129799241|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
129799242|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
129799243|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
129799244|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
129799245|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
129799246|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
129799247|NCT02310321|467233459|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
129799248|NCT02310321|467233460|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
129799249|NCT02310321|467233461|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
129799250|NCT01698905|467233462|FG000|Overall Study|Adverse Event|4|||
129799251|NCT01698905|467233462|FG000|Overall Study|Physician Decision|2|||
129799252|NCT01698905|467233462|FG000|Overall Study|Pregnancy|1|||
129799253|NCT01698905|467233462|FG000|Overall Study|Protocol Violation|1|||
129799254|NCT01698905|467233462|FG000|Overall Study|Subject/guardian decision|2|||
129799255|NCT01698905|467233462|FG000|Overall Study|Death|1|||
129799256|NCT05896748|467233463|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
129799257|NCT05896748|467233463|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
129799258|NCT05896748|467233463|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
129799259|NCT05896748|467233463|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
129799260|NCT05896748|467233463|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
129799261|NCT02325791|467233466|FG000|Overall Study|Adverse Event|0|||
129799262|NCT02325791|467233467|FG001|Overall Study|Adverse Event|1|||
129799263|NCT02325791|467233468|FG002|Overall Study|Adverse Event|1|||
129799264|NCT02325791|467233469|FG003|Overall Study|Adverse Event|0|||
129799265|NCT02325791|467233466|FG000|Overall Study|Death|0|||
129799266|NCT02325791|467233467|FG001|Overall Study|Death|3|||
129799267|NCT02325791|467233468|FG002|Overall Study|Death|0|||
129799268|NCT02325791|467233469|FG003|Overall Study|Death|1|||
129799269|NCT02325791|467233466|FG000|Overall Study|Lost to Follow-up|0|||
129799270|NCT02325791|467233467|FG001|Overall Study|Lost to Follow-up|15|||
129799271|NCT02325791|467233468|FG002|Overall Study|Lost to Follow-up|14|||
129799272|NCT02325791|467233469|FG003|Overall Study|Lost to Follow-up|9|||
129799273|NCT02325791|467233466|FG000|Overall Study|Physician Decision|0|||
129799274|NCT02325791|467233467|FG001|Overall Study|Physician Decision|1|||
129799275|NCT02325791|467233468|FG002|Overall Study|Physician Decision|1|||
129799276|NCT02325791|467233469|FG003|Overall Study|Physician Decision|0|||
129799277|NCT02325791|467233466|FG000|Overall Study|Protocol Violation|0|||
129799278|NCT02325791|467233467|FG001|Overall Study|Protocol Violation|0|||
129799279|NCT02325791|467233468|FG002|Overall Study|Protocol Violation|1|||
129799280|NCT02325791|467233469|FG003|Overall Study|Protocol Violation|0|||
129799281|NCT02325791|467233466|FG000|Overall Study|Withdrawal by Subject|0|||
129799282|NCT02325791|467233467|FG001|Overall Study|Withdrawal by Subject|5|||
129799283|NCT02325791|467233468|FG002|Overall Study|Withdrawal by Subject|8|||
129799284|NCT02325791|467233469|FG003|Overall Study|Withdrawal by Subject|16|||
129799285|NCT01437878|467233470|FG000|Overall Study|Withdrawal by Subject|1|||
129799286|NCT01437878|467233471|FG001|Overall Study|Withdrawal by Subject|0|||
129799287|NCT01070043|467233472|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
129799288|NCT01070043|467233473|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
129799289|NCT01070043|467233474|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
129799290|NCT01070043|467233472|FG000|Double-Blind Treatment|Adverse Event|0|||
129799291|NCT01070043|467233473|FG001|Double-Blind Treatment|Adverse Event|0|||
129799292|NCT01070043|467233474|FG002|Double-Blind Treatment|Adverse Event|2|||
129799293|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Adverse Event|1|||
129799294|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Adverse Event|0|||
129799295|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Adverse Event|0|||
129799296|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Adverse Event|0|||
129799297|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Adverse Event|0|||
129799298|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799299|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
129799300|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799301|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799302|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
129799303|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
129799304|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
129799305|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
129799306|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
129799307|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
129799308|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799309|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
129799310|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799311|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799312|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
129799313|NCT00473746|467233476|FG000|Period 1 (Phase 1)|Reason not specified|0|||
129799314|NCT00473746|467233477|FG001|Period 1 (Phase 1)|Reason not specified|1|||
129799315|NCT00473746|467233478|FG002|Period 1 (Phase 1)|Reason not specified|0|||
129799316|NCT00473746|467233479|FG003|Period 1 (Phase 1)|Reason not specified|0|||
129799317|NCT00473746|467233480|FG004|Period 1 (Phase 1)|Reason not specified|0|||
129799318|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Adverse Event|0|||
129799319|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Adverse Event|0|||
129799320|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Adverse Event|0|||
129799321|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Adverse Event|0|||
129799322|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Adverse Event|3|||
129799323|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Death|0|||
129799324|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Death|0|||
129799325|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Death|0|||
129799326|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Death|0|||
129799327|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Death|1|||
129799328|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
129799329|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
129799330|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
129799331|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
129799332|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
129799333|NCT00473746|467233476|FG000|Period 2 (Phase 2)|Reason not specified|0|||
129799334|NCT00473746|467233477|FG001|Period 2 (Phase 2)|Reason not specified|0|||
129799335|NCT00473746|467233478|FG002|Period 2 (Phase 2)|Reason not specified|0|||
129799336|NCT00473746|467233479|FG003|Period 2 (Phase 2)|Reason not specified|0|||
129799337|NCT00473746|467233480|FG004|Period 2 (Phase 2)|Reason not specified|3|||
129799338|NCT01528215|467233481|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
129799339|NCT01528215|467233482|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
129799340|NCT01528215|467233481|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
129799341|NCT01528215|467233482|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
129799342|NCT01528215|467233481|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
129799343|NCT01528215|467233482|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
129799344|NCT01528215|467233481|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
129799345|NCT01528215|467233482|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
129799346|NCT01462227|467233484|FG000|Second Assignment|Lost to Follow-up|1|||
129799347|NCT01462227|467233485|FG001|Second Assignment|Lost to Follow-up|0|||
129799348|NCT01462227|467233486|FG002|Second Assignment|Lost to Follow-up|0|||
129799349|NCT01462227|467233487|FG003|Second Assignment|Lost to Follow-up|0|||
129799350|NCT01462227|467233484|FG000|Second Assignment|Protocol Violation|0|||
129799351|NCT01462227|467233485|FG001|Second Assignment|Protocol Violation|1|||
129799352|NCT01462227|467233486|FG002|Second Assignment|Protocol Violation|1|||
129799353|NCT01462227|467233487|FG003|Second Assignment|Protocol Violation|0|||
129799354|NCT00586066|467233493|FG000|Overall Study|Lost to Follow-up|6|||
129799355|NCT00586066|467233494|FG001|Overall Study|Lost to Follow-up|3|||
129799356|NCT00586066|467233493|FG000|Overall Study|Lack of Efficacy|5|||
129799357|NCT00586066|467233494|FG001|Overall Study|Lack of Efficacy|3|||
129799358|NCT00586066|467233493|FG000|Overall Study|Adverse Event|2|||
129799359|NCT00586066|467233494|FG001|Overall Study|Adverse Event|2|||
129799360|NCT00586066|467233493|FG000|Overall Study|Physician Decision|1|||
129799361|NCT00586066|467233494|FG001|Overall Study|Physician Decision|0|||
129799362|NCT00586066|467233493|FG000|Overall Study|Withdrawal of consent|4|||
129799363|NCT00586066|467233494|FG001|Overall Study|Withdrawal of consent|2|||
129799364|NCT02750943|467233498|FG000|Overall Study|Lost to Follow-up|1|||
129799365|NCT02750943|467233499|FG001|Overall Study|Lost to Follow-up|2|||
129799366|NCT02750943|467233498|FG000|Overall Study|Withdrawal by Subject|5|||
129799367|NCT02750943|467233499|FG001|Overall Study|Withdrawal by Subject|7|||
129799368|NCT00171054|467233500|FG000|Overall Study|Protocol Violation|1|||
129799369|NCT00171054|467233501|FG001|Overall Study|Protocol Violation|2|||
129799370|NCT00171054|467233500|FG000|Overall Study|Patient withdrew consent|1|||
129799371|NCT00171054|467233501|FG001|Overall Study|Patient withdrew consent|0|||
129799372|NCT00171054|467233500|FG000|Overall Study|Lost to Follow-up|0|||
129799373|NCT00171054|467233501|FG001|Overall Study|Lost to Follow-up|1|||
129799374|NCT00171054|467233500|FG000|Overall Study|Adverse Event|8|||
129799375|NCT00171054|467233501|FG001|Overall Study|Adverse Event|8|||
129799376|NCT00171054|467233500|FG000|Overall Study|Condition no longer required study drug|0|||
129799377|NCT00171054|467233501|FG001|Overall Study|Condition no longer required study drug|1|||
129799378|NCT03635788|467233505|FG000|Step 1|Death|1|||
129799379|NCT03635788|467233506|FG001|Step 1|Death|0|||
129799380|NCT03635788|467233507|FG002|Step 1|Death|0|||
129799381|NCT03635788|467233505|FG000|Step 1|Lost to Follow-up|31|||
129799382|NCT03635788|467233506|FG001|Step 1|Lost to Follow-up|0|||
129799383|NCT03635788|467233507|FG002|Step 1|Lost to Follow-up|0|||
129799384|NCT03635788|467233505|FG000|Step 1|Pregnancy|1|||
129799385|NCT03635788|467233506|FG001|Step 1|Pregnancy|0|||
129799386|NCT03635788|467233507|FG002|Step 1|Pregnancy|0|||
129799387|NCT03635788|467233505|FG000|Step 1|Protocol Violation|8|||
129799388|NCT03635788|467233506|FG001|Step 1|Protocol Violation|0|||
129799389|NCT03635788|467233507|FG002|Step 1|Protocol Violation|0|||
129799390|NCT03635788|467233505|FG000|Step 1|Withdrawal by Subject|13|||
129799391|NCT03635788|467233506|FG001|Step 1|Withdrawal by Subject|0|||
129799392|NCT03635788|467233507|FG002|Step 1|Withdrawal by Subject|0|||
129799393|NCT03635788|467233505|FG000|Step 1|Other reasons|12|||
129799394|NCT03635788|467233506|FG001|Step 1|Other reasons|0|||
129799395|NCT03635788|467233507|FG002|Step 1|Other reasons|0|||
129799396|NCT03635788|467233505|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
129799397|NCT03635788|467233506|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
129799398|NCT03635788|467233507|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
129799399|NCT03635788|467233505|FG000|Step 2|Lost to Follow-up|0|||
129799400|NCT03635788|467233506|FG001|Step 2|Lost to Follow-up|8|||
129799401|NCT03635788|467233507|FG002|Step 2|Lost to Follow-up|15|||
129799402|NCT03635788|467233505|FG000|Step 2|Withdrawal by Subject|0|||
129799403|NCT03635788|467233506|FG001|Step 2|Withdrawal by Subject|6|||
129799404|NCT03635788|467233507|FG002|Step 2|Withdrawal by Subject|6|||
129799405|NCT03635788|467233505|FG000|Step 2|Death|0|||
129799406|NCT03635788|467233506|FG001|Step 2|Death|2|||
129799407|NCT03635788|467233507|FG002|Step 2|Death|0|||
129799408|NCT03635788|467233505|FG000|Step 2|Incarceration|0|||
129799409|NCT03635788|467233506|FG001|Step 2|Incarceration|2|||
129799410|NCT03635788|467233507|FG002|Step 2|Incarceration|0|||
129799411|NCT03635788|467233505|FG000|Step 2|Non-Compliance With Study Requirements|0|||
129799412|NCT03635788|467233506|FG001|Step 2|Non-Compliance With Study Requirements|1|||
129799413|NCT03635788|467233507|FG002|Step 2|Non-Compliance With Study Requirements|1|||
129799414|NCT03635788|467233505|FG000|Step 2|Confounding Medical Condition|0|||
129799415|NCT03635788|467233506|FG001|Step 2|Confounding Medical Condition|0|||
129799416|NCT03635788|467233507|FG002|Step 2|Confounding Medical Condition|1|||
129799417|NCT03635788|467233505|FG000|Step 2|Out Of State With No Plan To Return|0|||
129799418|NCT03635788|467233506|FG001|Step 2|Out Of State With No Plan To Return|1|||
129799419|NCT03635788|467233507|FG002|Step 2|Out Of State With No Plan To Return|0|||
129799420|NCT03635788|467233505|FG000|Step 2|Switched To Injectables|0|||
129799421|NCT03635788|467233506|FG001|Step 2|Switched To Injectables|0|||
129799422|NCT03635788|467233507|FG002|Step 2|Switched To Injectables|1|||
129799423|NCT03635788|467233505|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
129799424|NCT03635788|467233506|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
129799425|NCT03635788|467233507|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
129799426|NCT04669535|467233508|FG000|Overall Study|Death|1|||
129799427|NCT04669535|467233509|FG001|Overall Study|Death|1|||
129799428|NCT04669535|467233510|FG002|Overall Study|Death|0|||
129799429|NCT04669535|467233511|FG003|Overall Study|Death|0|||
129799430|NCT04382755|467233512|FG000|Overall Study|Withdrawal by Subject|1|||
129799431|NCT04382755|467233513|FG001|Overall Study|Withdrawal by Subject|0|||
129799432|NCT04382755|467233512|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
129799433|NCT04382755|467233513|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
129799434|NCT04382755|467233512|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
129799435|NCT04382755|467233513|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
129799436|NCT02452697|467233518|FG000|Overall Study|Physician Decision|4|||
129644591|NCT02980341|466652697|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644592|NCT02980341|466652698|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644593|NCT02980341|466652699|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644594|NCT02980341|466652700|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644595|NCT02980341|466652701|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644596|NCT02980341|466652702|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
129644597|NCT02980341|466652703|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
129644598|NCT03193801|466652704|FG000|Overall Study|Physician Decision|2|||
129644599|NCT03193801|466652704|FG000|Overall Study|Withdrawal by Subject|1|||
129644600|NCT04964544|466652707|FG000|Overall Study|Screen failure or other uncategorised|10|||
129644601|NCT04964544|466652707|FG000|Overall Study|Physician Decision|4|||
129644602|NCT04964544|466652707|FG000|Overall Study|Lost to Follow-up|9|||
129644603|NCT04964544|466652707|FG000|Overall Study|Withdrawal by Subject|18|||
129644604|NCT04964544|466652707|FG000|Overall Study|Death|1|||
129644605|NCT01613222|466652708|FG000|Overall Study|Physician Decision|1|||
129644606|NCT01613222|466652708|FG000|Overall Study|Unable to place arterial line|1|||
129644607|NCT01613222|466652708|FG000|Overall Study|Reused disposable sensors|10|||
129644608|NCT03696108|466652709|FG000|Overall Study|Physician Decision|1|||
129644609|NCT03696108|466652710|FG001|Overall Study|Physician Decision|0|||
129644610|NCT03696108|466652709|FG000|Overall Study|Withdrawal by Subject|3|||
129644611|NCT03696108|466652710|FG001|Overall Study|Withdrawal by Subject|6|||
129644612|NCT01899742|466652711|FG000|Overall Study|Adverse Event|5|||
129799437|NCT02452697|467233519|FG001|Overall Study|Physician Decision|4|||
129799438|NCT02452697|467233520|FG002|Overall Study|Physician Decision|3|||
129799439|NCT02452697|467233521|FG003|Overall Study|Physician Decision|2|||
129799440|NCT02452697|467233518|FG000|Overall Study|Withdrawal by Subject|1|||
129799441|NCT02452697|467233519|FG001|Overall Study|Withdrawal by Subject|0|||
129799442|NCT02452697|467233520|FG002|Overall Study|Withdrawal by Subject|0|||
129799443|NCT02452697|467233521|FG003|Overall Study|Withdrawal by Subject|0|||
129799444|NCT02452697|467233518|FG000|Overall Study|still in follow-up|2|||
129799445|NCT02452697|467233519|FG001|Overall Study|still in follow-up|2|||
129799446|NCT02452697|467233520|FG002|Overall Study|still in follow-up|1|||
129799447|NCT02452697|467233521|FG003|Overall Study|still in follow-up|3|||
129799448|NCT03552965|467233522|FG000|Overall Study|Death|1|||
129799449|NCT03552965|467233523|FG001|Overall Study|Death|1|||
129799450|NCT03552965|467233522|FG000|Overall Study|Lost to Follow-up|1|||
129799451|NCT03552965|467233523|FG001|Overall Study|Lost to Follow-up|1|||
129799452|NCT03552965|467233522|FG000|Overall Study|Physician Decision|1|||
129799453|NCT03552965|467233523|FG001|Overall Study|Physician Decision|1|||
129799454|NCT03552965|467233522|FG000|Overall Study|Withdrawal by Subject|0|||
129799455|NCT03552965|467233523|FG001|Overall Study|Withdrawal by Subject|2|||
129799456|NCT03552965|467233522|FG000|Overall Study|Continuation not in patient best interest|1|||
129799457|NCT03552965|467233523|FG001|Overall Study|Continuation not in patient best interest|0|||
129799458|NCT03552965|467233522|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
129799459|NCT03552965|467233523|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
129799460|NCT03120624|467233524|FG000|Overall Study|Withdrawal by Subject|0|||
129799461|NCT03120624|467233525|FG001|Overall Study|Withdrawal by Subject|1|||
129799462|NCT03120624|467233526|FG002|Overall Study|Withdrawal by Subject|0|||
129799463|NCT03120624|467233527|FG003|Overall Study|Withdrawal by Subject|0|||
129799464|NCT03120624|467233528|FG004|Overall Study|Withdrawal by Subject|0|||
129799465|NCT03120624|467233529|FG005|Overall Study|Withdrawal by Subject|0|||
129799466|NCT03120624|467233530|FG006|Overall Study|Withdrawal by Subject|0|||
129799467|NCT03120624|467233531|FG007|Overall Study|Withdrawal by Subject|0|||
129799468|NCT02477696|467233532|FG000|Overall Study|Death|89|||
129644613|NCT01899742|466652712|FG001|Overall Study|Adverse Event|4|||
129644614|NCT01899742|466652711|FG000|Overall Study|Lack of Efficacy|1|||
129644615|NCT01899742|466652712|FG001|Overall Study|Lack of Efficacy|5|||
129644616|NCT01899742|466652711|FG000|Overall Study|Protocol Violation|2|||
129644617|NCT01899742|466652712|FG001|Overall Study|Protocol Violation|2|||
129644618|NCT01899742|466652711|FG000|Overall Study|Withdrawal by Subject|9|||
129644619|NCT01899742|466652712|FG001|Overall Study|Withdrawal by Subject|5|||
129644620|NCT01154088|466652715|FG000|Overall Study|Lost to Follow-up|4|||
129644621|NCT01154088|466652716|FG001|Overall Study|Lost to Follow-up|6|||
129644622|NCT01154088|466652717|FG002|Overall Study|Lost to Follow-up|7|||
129644623|NCT01104246|466652718|FG000|Overall Study|Withdrawal by Subject|1|||
129644624|NCT01104246|466652718|FG000|Overall Study|did not meet inclusion criteria|4|||
129644625|NCT01475851|466652719|FG000|Overall Study|Protocol defined stopping criteria|1|||
129644626|NCT01475851|466652720|FG001|Overall Study|Protocol defined stopping criteria|0|||
129644627|NCT01867294|466652723|FG000|Overall Study|Withdrawal by Subject|1|||
129644628|NCT01867294|466652724|FG001|Overall Study|Withdrawal by Subject|1|||
129644629|NCT01867294|466652725|FG002|Overall Study|Withdrawal by Subject|0|||
129799469|NCT02477696|467233533|FG001|Overall Study|Death|106|||
129799470|NCT02477696|467233532|FG000|Overall Study|Lost to Follow-up|7|||
129799471|NCT02477696|467233533|FG001|Overall Study|Lost to Follow-up|5|||
129799472|NCT02477696|467233532|FG000|Overall Study|Withdrawal by Subject|37|||
129799473|NCT02477696|467233533|FG001|Overall Study|Withdrawal by Subject|34|||
129799474|NCT02477696|467233532|FG000|Overall Study|Physician Decision|7|||
129799475|NCT02477696|467233533|FG001|Overall Study|Physician Decision|9|||
129799476|NCT02477696|467233532|FG000|Overall Study|Study terminated by sponsor|103|||
129799477|NCT02477696|467233533|FG001|Overall Study|Study terminated by sponsor|99|||
129799478|NCT02477696|467233532|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
129799479|NCT02477696|467233533|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
129799480|NCT02477696|467233532|FG000|Overall Study|Missing/Unknown|2|||
129799481|NCT02477696|467233533|FG001|Overall Study|Missing/Unknown|0|||
129799482|NCT05419908|467233535|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
129799483|NCT05419908|467233536|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
129799484|NCT05419908|467233535|FG000|Overall Study|Serious Adverse Event|0|||
129799485|NCT05419908|467233536|FG001|Overall Study|Serious Adverse Event|2|||
129799486|NCT05419908|467233535|FG000|Overall Study|Withdrawal by Subject|2|||
129799487|NCT05419908|467233536|FG001|Overall Study|Withdrawal by Subject|0|||
129799488|NCT05419908|467233535|FG000|Overall Study|Miscellaneous|1|||
129799489|NCT05419908|467233536|FG001|Overall Study|Miscellaneous|1|||
129799490|NCT02160782|467235130|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
129799491|NCT02160782|467235131|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
129799492|NCT02160782|467235132|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
129799493|NCT02160782|467235133|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
129799494|NCT02160782|467235134|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
129799495|NCT02160782|467235130|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129799496|NCT02160782|467235131|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129799497|NCT02160782|467235132|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129890356|NCT02411591|467556099|FG000|Overall Study|Physician Decision|0|||
129890357|NCT02411591|467556100|FG001|Overall Study|Physician Decision|3|||
129890358|NCT02411591|467556101|FG002|Overall Study|Physician Decision|1|||
129890359|NCT02491892|467556102|FG000|Overall Study|Adverse Event|1|||
129890360|NCT02491892|467556103|FG001|Overall Study|Adverse Event|1|||
129890361|NCT02491892|467556102|FG000|Overall Study|Death|1|||
129890362|NCT02491892|467556103|FG001|Overall Study|Death|1|||
129890363|NCT02491892|467556102|FG000|Overall Study|Lack of Efficacy|37|||
129644630|NCT01867294|466652726|FG003|Overall Study|Withdrawal by Subject|0|||
129644631|NCT02447497|466652727|FG000|Overall Study|Did not meet treatment day baseline.|6|||
129644632|NCT02447497|466652728|FG001|Overall Study|Did not meet treatment day baseline.|5|||
129799498|NCT02160782|467235133|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
129799499|NCT02160782|467235134|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
129799500|NCT02160782|467235130|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129799501|NCT02160782|467235131|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129890364|NCT02491892|467556103|FG001|Overall Study|Lack of Efficacy|36|||
129890365|NCT02491892|467556102|FG000|Overall Study|Refused Treatment|1|||
129890366|NCT02491892|467556103|FG001|Overall Study|Refused Treatment|0|||
129644633|NCT02447497|466652729|FG002|Overall Study|Did not meet treatment day baseline.|2|||
129644634|NCT02447497|466652730|FG003|Overall Study|Did not meet treatment day baseline.|2|||
129644635|NCT02447497|466652727|FG000|Overall Study|Dressing was compromised|0|||
129799502|NCT02160782|467235132|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129799503|NCT02160782|467235133|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
129644636|NCT02447497|466652728|FG001|Overall Study|Dressing was compromised|1|||
129644637|NCT02447497|466652729|FG002|Overall Study|Dressing was compromised|0|||
129644638|NCT02447497|466652730|FG003|Overall Study|Dressing was compromised|0|||
129644639|NCT02017912|466652731|FG000|Overall Study|Withdrawal by Subject|2|||
129799504|NCT02160782|467235134|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
129799505|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799506|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799507|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799508|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
129799509|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
129799510|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799511|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799512|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799513|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
129799514|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
129799515|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799516|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799517|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799518|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
129799519|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
129799520|NCT02160782|467235130|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799521|NCT02160782|467235131|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799522|NCT02160782|467235132|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799523|NCT02160782|467235133|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
129799524|NCT02160782|467235134|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
129799525|NCT01104701|467235137|FG000|Overall Study|Withdrawal by Subject|0|||
129799526|NCT01104701|467235138|FG001|Overall Study|Withdrawal by Subject|1|||
129644640|NCT02017912|466652732|FG001|Overall Study|Withdrawal by Subject|1|||
129644641|NCT02017912|466652731|FG000|Overall Study|miscellaneous|1|||
129644642|NCT02017912|466652732|FG001|Overall Study|miscellaneous|1|||
129644643|NCT01322035|466652733|FG000|Overall Study|Lost to Follow-up|8|||
129644644|NCT01322035|466652734|FG001|Overall Study|Lost to Follow-up|3|||
129644645|NCT02496091|466652738|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129644646|NCT02272842|466652739|FG000|Overall Study|Lost to Follow-up|8|||
129644647|NCT02272842|466652740|FG001|Overall Study|Lost to Follow-up|8|||
129644648|NCT02272842|466652739|FG000|Overall Study|Withdrawal by Subject|8|||
129644649|NCT02272842|466652740|FG001|Overall Study|Withdrawal by Subject|2|||
129644650|NCT02396420|466652743|FG000|Overall Study|Death|1|||
129644651|NCT05033262|466652744|FG000|Overall Study|Lost to Follow-up|1|||
129644652|NCT05033262|466652745|FG001|Overall Study|Lost to Follow-up|0|||
129644653|NCT05033262|466652746|FG002|Overall Study|Lost to Follow-up|0|||
129644654|NCT05033262|466652747|FG003|Overall Study|Lost to Follow-up|1|||
129644655|NCT01273623|466652749|FG000|Overall Study|did not meet IVUS criteria|29|||
129644656|NCT01493284|466652751|FG000|Overall Study|Death|29|||
129644657|NCT01493284|466652751|FG000|Overall Study|Withdrawal by Subject|32|||
129644658|NCT00325156|466652754|FG000|Overall Study|Protocol Violation|8|||
129644659|NCT00325156|466652754|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
129644660|NCT00325156|466652754|FG000|Overall Study|Migrated/moved from study area|12|||
129644661|NCT00325156|466652754|FG000|Overall Study|Adverse event, non-fatal|3|||
129644662|NCT00325156|466652754|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
129644663|NCT00325156|466652754|FG000|Overall Study|Other|1|||
129644664|NCT00325156|466652754|FG000|Overall Study|Withdrawal by Subject|31|||
129644665|NCT00519428|466652755|FG000|Overall Study|Adverse Event|5|||
129799527|NCT01104701|467235139|FG002|Overall Study|Withdrawal by Subject|2|||
129443533|NCT04147234|465924420|FG002|Overall Study|Clinical deterioration|1|||
129644666|NCT00519428|466652756|FG001|Overall Study|Adverse Event|2|||
129644667|NCT00519428|466652757|FG002|Overall Study|Adverse Event|10|||
129644668|NCT00519428|466652755|FG000|Overall Study|Lost to Follow-up|7|||
129644669|NCT00519428|466652756|FG001|Overall Study|Lost to Follow-up|7|||
129644670|NCT00519428|466652757|FG002|Overall Study|Lost to Follow-up|6|||
129644671|NCT00519428|466652755|FG000|Overall Study|Withdrawal by Subject|8|||
129644672|NCT00519428|466652756|FG001|Overall Study|Withdrawal by Subject|3|||
129644673|NCT00519428|466652757|FG002|Overall Study|Withdrawal by Subject|7|||
129644674|NCT00519428|466652755|FG000|Overall Study|unstated|1|||
129644675|NCT00519428|466652756|FG001|Overall Study|unstated|3|||
129644676|NCT00519428|466652757|FG002|Overall Study|unstated|2|||
129644677|NCT04064411|466652758|FG000|Overall Study|Adverse Event|29|||
129644678|NCT04064411|466652759|FG001|Overall Study|Adverse Event|19|||
129644679|NCT04064411|466652758|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
129644680|NCT04064411|466652759|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
129644681|NCT04064411|466652758|FG000|Overall Study|Protocol Deviation|0|||
129644682|NCT04064411|466652759|FG001|Overall Study|Protocol Deviation|2|||
129644683|NCT04064411|466652758|FG000|Overall Study|Withdrawal by Subject|25|||
129644684|NCT04064411|466652759|FG001|Overall Study|Withdrawal by Subject|29|||
129644685|NCT04064411|466652758|FG000|Overall Study|Lost to Follow-up|5|||
129644686|NCT04064411|466652759|FG001|Overall Study|Lost to Follow-up|2|||
129644687|NCT04064411|466652758|FG000|Overall Study|Other than Specified|4|||
129644688|NCT04064411|466652759|FG001|Overall Study|Other than Specified|1|||
129644689|NCT04064411|466652758|FG000|Overall Study|Death|1|||
129644690|NCT04064411|466652759|FG001|Overall Study|Death|0|||
129644691|NCT03395184|466652760|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
129644692|NCT03395184|466652761|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
129644693|NCT03395184|466652762|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
129644694|NCT03395184|466652763|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129644695|NCT03395184|466652764|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129644696|NCT03395184|466652765|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129644697|NCT03395184|466652766|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
129644698|NCT03395184|466652760|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129644699|NCT03395184|466652761|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
129644700|NCT03395184|466652762|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
129644701|NCT03395184|466652763|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129644702|NCT03395184|466652764|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129644703|NCT03395184|466652765|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129644704|NCT03395184|466652766|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
129644705|NCT03395184|466652760|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
129644706|NCT03395184|466652761|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
129644707|NCT03395184|466652762|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129644708|NCT03395184|466652763|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129644709|NCT03395184|466652764|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129644710|NCT03395184|466652765|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129644711|NCT03395184|466652766|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129644712|NCT03395184|466652760|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129644713|NCT03395184|466652761|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
129644714|NCT03395184|466652762|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129644715|NCT03395184|466652763|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129644716|NCT03395184|466652764|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129644717|NCT03395184|466652765|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129644718|NCT03395184|466652766|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
129644719|NCT03395184|466652760|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
129644720|NCT03395184|466652761|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129644721|NCT03395184|466652762|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
129644722|NCT03395184|466652763|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129644723|NCT03395184|466652764|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129644724|NCT03395184|466652765|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129644725|NCT03395184|466652766|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129644726|NCT03395184|466652760|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
129644727|NCT03395184|466652761|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
129644728|NCT03395184|466652762|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
129644729|NCT03395184|466652763|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
129644730|NCT03395184|466652764|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
129644731|NCT03395184|466652765|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
129644732|NCT03395184|466652766|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
129644733|NCT03395184|466652760|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
129644734|NCT03395184|466652761|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
129644735|NCT03395184|466652762|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
129644736|NCT03395184|466652763|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
129644737|NCT03395184|466652764|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
129644738|NCT03395184|466652765|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
129644739|NCT03395184|466652766|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
129644740|NCT03395184|466652760|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
129644741|NCT03395184|466652761|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
129644742|NCT03395184|466652762|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
129644743|NCT03395184|466652763|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
129644744|NCT03395184|466652764|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
129644745|NCT03395184|466652765|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
129644746|NCT03395184|466652766|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
129644747|NCT03395184|466652760|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129644748|NCT03395184|466652761|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129644749|NCT03395184|466652762|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129644750|NCT03395184|466652763|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129644751|NCT03395184|466652764|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
129644752|NCT03395184|466652765|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129644753|NCT03395184|466652766|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
129644754|NCT03395184|466652760|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
129644755|NCT03395184|466652761|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
129644756|NCT03395184|466652762|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
129644757|NCT03395184|466652763|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
129644758|NCT03395184|466652764|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
129644759|NCT03395184|466652765|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
129644760|NCT03395184|466652766|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
129644761|NCT03395184|466652760|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129644762|NCT03395184|466652761|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129644763|NCT03395184|466652762|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129644764|NCT03395184|466652763|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
129644765|NCT03395184|466652764|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129644766|NCT03395184|466652765|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
129644767|NCT03395184|466652766|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
129644768|NCT03395184|466652760|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
129644769|NCT03395184|466652761|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
129644770|NCT03395184|466652762|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
129644771|NCT03395184|466652763|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
129644772|NCT03395184|466652764|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
129644773|NCT03395184|466652765|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
129644774|NCT03395184|466652766|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
129644775|NCT03053063|466652772|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
129644776|NCT03053063|466652773|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
129644777|NCT03053063|466652774|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
129644778|NCT03053063|466652775|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
129644779|NCT03053063|466652772|FG000|Randomized Phase|Withdrew consent|8|||
129644780|NCT03053063|466652773|FG001|Randomized Phase|Withdrew consent|11|||
129644781|NCT03053063|466652774|FG002|Randomized Phase|Withdrew consent|5|||
129644782|NCT03053063|466652775|FG003|Randomized Phase|Withdrew consent|0|||
129644783|NCT03053063|466652772|FG000|Randomized Phase|Investigator's Discretion|8|||
129644784|NCT03053063|466652773|FG001|Randomized Phase|Investigator's Discretion|6|||
129644785|NCT03053063|466652774|FG002|Randomized Phase|Investigator's Discretion|2|||
129644786|NCT03053063|466652775|FG003|Randomized Phase|Investigator's Discretion|0|||
129706238|NCT05270863|466886797|FG003|First Washout|Withdrawal by Subject|0|||
129706239|NCT05270863|466886798|FG004|First Washout|Withdrawal by Subject|1|||
129706240|NCT05270863|466886799|FG005|First Washout|Withdrawal by Subject|1|||
129706241|NCT05270863|466886794|FG000|First Washout|Lost to Follow-up|0|||
129706242|NCT05270863|466886795|FG001|First Washout|Lost to Follow-up|0|||
129706243|NCT05270863|466886796|FG002|First Washout|Lost to Follow-up|0|||
129706244|NCT05270863|466886797|FG003|First Washout|Lost to Follow-up|0|||
129706245|NCT05270863|466886798|FG004|First Washout|Lost to Follow-up|0|||
129706246|NCT05270863|466886799|FG005|First Washout|Lost to Follow-up|1|||
129706247|NCT05270863|466886794|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
129706248|NCT05270863|466886795|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
129706249|NCT05270863|466886796|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
129706250|NCT05270863|466886797|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
129706251|NCT05270863|466886798|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
129706252|NCT05270863|466886799|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
129706253|NCT05270863|466886794|FG000|Second Washout|Withdrawal by Subject|1|||
129706254|NCT05270863|466886795|FG001|Second Washout|Withdrawal by Subject|1|||
129706255|NCT05270863|466886796|FG002|Second Washout|Withdrawal by Subject|0|||
129706256|NCT05270863|466886797|FG003|Second Washout|Withdrawal by Subject|0|||
129706257|NCT05270863|466886798|FG004|Second Washout|Withdrawal by Subject|0|||
129706258|NCT05270863|466886799|FG005|Second Washout|Withdrawal by Subject|0|||
129706259|NCT05270863|466886794|FG000|Second Washout|Lost to Follow-up|0|||
129706260|NCT05270863|466886795|FG001|Second Washout|Lost to Follow-up|0|||
129706261|NCT05270863|466886796|FG002|Second Washout|Lost to Follow-up|0|||
129706262|NCT05270863|466886797|FG003|Second Washout|Lost to Follow-up|1|||
129706263|NCT05270863|466886798|FG004|Second Washout|Lost to Follow-up|0|||
129706264|NCT05270863|466886799|FG005|Second Washout|Lost to Follow-up|0|||
129706265|NCT04464473|466886800|FG000|Overall Study|New piercing could not be removed for scanning|0|||
129706266|NCT04464473|466886801|FG001|Overall Study|New piercing could not be removed for scanning|0|||
129706267|NCT04464473|466886802|FG002|Overall Study|New piercing could not be removed for scanning|0|||
129799528|NCT01104701|467235140|FG003|Overall Study|Withdrawal by Subject|1|||
129799529|NCT01104701|467235137|FG000|Overall Study|Adverse Event|0|||
129799530|NCT01104701|467235138|FG001|Overall Study|Adverse Event|0|||
129644787|NCT03053063|466652772|FG000|Randomized Phase|Lost to Follow-up|3|||
129644788|NCT03053063|466652773|FG001|Randomized Phase|Lost to Follow-up|5|||
129644789|NCT03053063|466652774|FG002|Randomized Phase|Lost to Follow-up|1|||
129644790|NCT03053063|466652775|FG003|Randomized Phase|Lost to Follow-up|0|||
129644791|NCT03053063|466652772|FG000|Randomized Phase|Adverse Event|0|||
129644792|NCT03053063|466652773|FG001|Randomized Phase|Adverse Event|1|||
129644793|NCT03053063|466652774|FG002|Randomized Phase|Adverse Event|0|||
129644794|NCT03053063|466652775|FG003|Randomized Phase|Adverse Event|0|||
129799531|NCT01104701|467235139|FG002|Overall Study|Adverse Event|0|||
129799532|NCT01104701|467235140|FG003|Overall Study|Adverse Event|1|||
129799533|NCT01104701|467235137|FG000|Overall Study|Physician Decision|0|||
129799534|NCT01104701|467235138|FG001|Overall Study|Physician Decision|2|||
129799535|NCT01104701|467235139|FG002|Overall Study|Physician Decision|0|||
129799536|NCT01104701|467235140|FG003|Overall Study|Physician Decision|0|||
129799537|NCT03437512|467235141|FG000|Randomized|Withdrawal by Subject|0|||
129799538|NCT03437512|467235142|FG001|Randomized|Withdrawal by Subject|2|||
129799539|NCT03437512|467235141|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
129799540|NCT03437512|467235142|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
129799541|NCT00674973|467235143|FG000|Overall Study|Insufficient Therapeutic Response|77|||
129799542|NCT00674973|467235144|FG001|Overall Study|Insufficient Therapeutic Response|72|||
129799543|NCT00674973|467235143|FG000|Overall Study|Refused Treatment|1|||
129799544|NCT00674973|467235144|FG001|Overall Study|Refused Treatment|5|||
129799545|NCT00674973|467235143|FG000|Overall Study|Failure to Return|1|||
129644795|NCT03053063|466652772|FG000|Randomized Phase|Randomized but Never Treated|1|||
129644796|NCT03053063|466652773|FG001|Randomized Phase|Randomized but Never Treated|3|||
129644797|NCT03053063|466652774|FG002|Randomized Phase|Randomized but Never Treated|2|||
129644798|NCT03053063|466652775|FG003|Randomized Phase|Randomized but Never Treated|0|||
129644799|NCT03053063|466652772|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
129644800|NCT03053063|466652773|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
129644801|NCT03053063|466652774|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
129644802|NCT03053063|466652775|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
129644803|NCT03053063|466652772|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
129644804|NCT03053063|466652773|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
129644805|NCT03053063|466652774|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
129644806|NCT03053063|466652775|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
129644807|NCT03053063|466652772|FG000|Open-Label Phase|Death|0|||
129644808|NCT03053063|466652773|FG001|Open-Label Phase|Death|0|||
129644809|NCT03053063|466652774|FG002|Open-Label Phase|Death|0|||
129644810|NCT03053063|466652775|FG003|Open-Label Phase|Death|2|||
129644811|NCT03053063|466652772|FG000|Open-Label Phase|Investigator's discretion|0|||
129644812|NCT03053063|466652773|FG001|Open-Label Phase|Investigator's discretion|0|||
129644813|NCT03053063|466652774|FG002|Open-Label Phase|Investigator's discretion|0|||
129644814|NCT03053063|466652775|FG003|Open-Label Phase|Investigator's discretion|2|||
129644815|NCT01970475|466652777|FG000|Overall Study|Withdrawal by Subject|11|||
129644816|NCT01970475|466652778|FG001|Overall Study|Withdrawal by Subject|6|||
129644817|NCT01970475|466652777|FG000|Overall Study|Adverse Event|7|||
129644818|NCT01970475|466652778|FG001|Overall Study|Adverse Event|3|||
129644819|NCT01970475|466652777|FG000|Overall Study|Lost to Follow-up|2|||
129890367|NCT02491892|467556102|FG000|Overall Study|Lost to Follow-up|1|||
129890368|NCT02491892|467556103|FG001|Overall Study|Lost to Follow-up|0|||
129890369|NCT04227340|467556104|FG000|Overall Study|Withdrawal by Subject|3|||
129890370|NCT00683449|467556105|FG000|Overall Study|Lost to Follow-up|0|||
129890371|NCT00683449|467556106|FG001|Overall Study|Lost to Follow-up|1|||
129890372|NCT00683449|467556107|FG002|Overall Study|Lost to Follow-up|0|||
129890373|NCT00683449|467556108|FG003|Overall Study|Lost to Follow-up|0|||
129890374|NCT00683449|467556109|FG004|Overall Study|Lost to Follow-up|0|||
129890375|NCT00577720|467556113|FG000|Overall Study|Adverse Event|2|||
129890376|NCT00577720|467556114|FG001|Overall Study|Adverse Event|1|||
129890377|NCT00577720|467556115|FG002|Overall Study|Adverse Event|0|||
129890378|NCT00577720|467556116|FG003|Overall Study|Adverse Event|4|||
129890379|NCT00577720|467556113|FG000|Overall Study|Lost to Follow-up|0|||
129644820|NCT01970475|466652778|FG001|Overall Study|Lost to Follow-up|2|||
129644821|NCT01970475|466652777|FG000|Overall Study|Protocol Violation|1|||
129799546|NCT00674973|467235144|FG001|Overall Study|Failure to Return|0|||
129644822|NCT01970475|466652778|FG001|Overall Study|Protocol Violation|0|||
129644823|NCT01397786|466655189|FG000|Phase A|Lost to Follow-up|0|||
129644824|NCT01397786|466655190|FG001|Phase A|Lost to Follow-up|0|||
129644825|NCT01397786|466655191|FG002|Phase A|Lost to Follow-up|6|||
129644826|NCT01397786|466655189|FG000|Phase A|Adverse Event|0|||
129644827|NCT01397786|466655190|FG001|Phase A|Adverse Event|0|||
129799547|NCT00674973|467235143|FG000|Overall Study|Adverse Event|2|||
129799548|NCT00674973|467235144|FG001|Overall Study|Adverse Event|9|||
129799549|NCT00674973|467235143|FG000|Overall Study|Death|19|||
129799550|NCT00674973|467235144|FG001|Overall Study|Death|15|||
129799551|NCT00674973|467235143|FG000|Overall Study|Protocol Violation|0|||
129644828|NCT01397786|466655191|FG002|Phase A|Adverse Event|8|||
129890380|NCT00577720|467556114|FG001|Overall Study|Lost to Follow-up|0|||
129890381|NCT00577720|467556115|FG002|Overall Study|Lost to Follow-up|1|||
129644829|NCT01397786|466655189|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
129644830|NCT01397786|466655190|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
129644831|NCT01397786|466655191|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
129644832|NCT01397786|466655189|FG000|Phase A|Physician Decision|0|||
129644833|NCT01397786|466655190|FG001|Phase A|Physician Decision|0|||
129644834|NCT01397786|466655191|FG002|Phase A|Physician Decision|1|||
129644835|NCT01397786|466655189|FG000|Phase A|Withdrawal by Subject|0|||
129644836|NCT01397786|466655190|FG001|Phase A|Withdrawal by Subject|0|||
129644837|NCT01397786|466655191|FG002|Phase A|Withdrawal by Subject|5|||
129644838|NCT01397786|466655189|FG000|Phase A|Lack of Efficacy|0|||
129644839|NCT01397786|466655190|FG001|Phase A|Lack of Efficacy|0|||
129644840|NCT01397786|466655191|FG002|Phase A|Lack of Efficacy|1|||
129644841|NCT01397786|466655189|FG000|Phase B|Lost to Follow-up|22|||
129890382|NCT00577720|467556116|FG003|Overall Study|Lost to Follow-up|0|||
129890383|NCT00577720|467556113|FG000|Overall Study|Protocol Violation|0|||
129890384|NCT00577720|467556114|FG001|Overall Study|Protocol Violation|0|||
129890385|NCT00577720|467556115|FG002|Overall Study|Protocol Violation|0|||
129890386|NCT00577720|467556116|FG003|Overall Study|Protocol Violation|1|||
129890387|NCT00577720|467556113|FG000|Overall Study|Withdrawal by Subject|2|||
129890388|NCT00577720|467556114|FG001|Overall Study|Withdrawal by Subject|0|||
129890389|NCT00577720|467556115|FG002|Overall Study|Withdrawal by Subject|0|||
129890390|NCT00577720|467556116|FG003|Overall Study|Withdrawal by Subject|2|||
129890391|NCT03100838|467556117|FG000|Overall Study|Adverse Event|1|||
129644842|NCT01397786|466655190|FG001|Phase B|Lost to Follow-up|12|||
129644843|NCT01397786|466655191|FG002|Phase B|Lost to Follow-up|22|||
129644844|NCT01397786|466655189|FG000|Phase B|Adverse Event|109|||
129644845|NCT01397786|466655190|FG001|Phase B|Adverse Event|23|||
129644846|NCT01397786|466655191|FG002|Phase B|Adverse Event|27|||
129644847|NCT01397786|466655189|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
129644848|NCT01397786|466655190|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
129644849|NCT01397786|466655191|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
129644850|NCT01397786|466655189|FG000|Phase B|Physician Decision|9|||
129644851|NCT01397786|466655190|FG001|Phase B|Physician Decision|1|||
129644852|NCT01397786|466655191|FG002|Phase B|Physician Decision|3|||
129644853|NCT01397786|466655189|FG000|Phase B|Withdrawal by Subject|102|||
129644854|NCT01397786|466655190|FG001|Phase B|Withdrawal by Subject|45|||
129644855|NCT01397786|466655191|FG002|Phase B|Withdrawal by Subject|30|||
129644856|NCT01397786|466655189|FG000|Phase B|Protocol Deviation|1|||
129644857|NCT01397786|466655190|FG001|Phase B|Protocol Deviation|2|||
129644858|NCT01397786|466655191|FG002|Phase B|Protocol Deviation|4|||
129644859|NCT01397786|466655189|FG000|Phase B|Lack of Efficacy|22|||
129644860|NCT01397786|466655190|FG001|Phase B|Lack of Efficacy|7|||
129644861|NCT01397786|466655191|FG002|Phase B|Lack of Efficacy|14|||
129644862|NCT03339726|466655194|FG000|Overall Study|Withdrawal by Subject|1|||
129706268|NCT04464473|466886803|FG003|Overall Study|New piercing could not be removed for scanning|1|||
129890392|NCT03100838|467556118|FG001|Overall Study|Adverse Event|0|||
129890393|NCT03100838|467556119|FG002|Overall Study|Adverse Event|0|||
129890394|NCT03100838|467556120|FG003|Overall Study|Adverse Event|0|||
129890395|NCT03100838|467556117|FG000|Overall Study|Physician Decision|1|||
129443534|NCT04147234|465924421|FG003|Overall Study|Clinical deterioration|0|||
129706269|NCT04464473|466886804|FG004|Overall Study|New piercing could not be removed for scanning|0|||
129706270|NCT04464473|466886805|FG005|Overall Study|New piercing could not be removed for scanning|0|||
129706271|NCT04464473|466886800|FG000|Overall Study|Adverse Event|0|||
129706272|NCT04464473|466886801|FG001|Overall Study|Adverse Event|0|||
129706273|NCT04464473|466886802|FG002|Overall Study|Adverse Event|0|||
129706274|NCT04464473|466886803|FG003|Overall Study|Adverse Event|1|||
129706275|NCT04464473|466886804|FG004|Overall Study|Adverse Event|0|||
129706276|NCT04464473|466886805|FG005|Overall Study|Adverse Event|0|||
129706277|NCT04464473|466886800|FG000|Overall Study|Lost to Follow-up|0|||
129706278|NCT04464473|466886801|FG001|Overall Study|Lost to Follow-up|0|||
129706279|NCT04464473|466886802|FG002|Overall Study|Lost to Follow-up|0|||
129706280|NCT04464473|466886803|FG003|Overall Study|Lost to Follow-up|1|||
129706281|NCT04464473|466886804|FG004|Overall Study|Lost to Follow-up|0|||
129706282|NCT04464473|466886805|FG005|Overall Study|Lost to Follow-up|0|||
129707664|NCT01240863|466892086|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
129707665|NCT01240863|466892087|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
129707666|NCT03961308|466892094|FG000|Overall Study|Withdrawal by Subject|1|||
129707667|NCT03961308|466892095|FG001|Overall Study|Withdrawal by Subject|0|||
129707668|NCT03961308|466892094|FG000|Overall Study|Other|1|||
129890396|NCT03100838|467556118|FG001|Overall Study|Physician Decision|1|||
129890397|NCT03100838|467556119|FG002|Overall Study|Physician Decision|1|||
129890398|NCT03100838|467556120|FG003|Overall Study|Physician Decision|1|||
129644863|NCT03339726|466655195|FG001|Overall Study|Withdrawal by Subject|0|||
129644864|NCT03339726|466655196|FG002|Overall Study|Withdrawal by Subject|0|||
129644865|NCT03339726|466655194|FG000|Overall Study|Lost to Follow-up|0|||
129644866|NCT03339726|466655195|FG001|Overall Study|Lost to Follow-up|1|||
129644867|NCT03339726|466655196|FG002|Overall Study|Lost to Follow-up|0|||
129644868|NCT01275755|466655197|FG000|Double-blind Treatment Period|Adverse Event|0|||
129644869|NCT01275755|466655198|FG001|Double-blind Treatment Period|Adverse Event|2|||
129644870|NCT01275755|466655197|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129644871|NCT01275755|466655198|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
129644872|NCT01275755|466655197|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129644873|NCT01275755|466655198|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129644874|NCT01275755|466655197|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
129644875|NCT01275755|466655198|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
129644876|NCT00636194|466655205|FG000|Overall Study|Study related symptoms and complaints|1|||
129644877|NCT00636194|466655206|FG001|Overall Study|Study related symptoms and complaints|0|||
129644878|NCT00636194|466655205|FG000|Overall Study|Protocol Violation|2|||
129644879|NCT00636194|466655206|FG001|Overall Study|Protocol Violation|0|||
129644880|NCT03962790|466655210|FG000|Period 1|Adverse Event|0|||
129644881|NCT03962790|466655211|FG001|Period 1|Adverse Event|1|||
129644882|NCT03962790|466655210|FG000|Period 1|Failed to meet all eligibility criteria|1|||
129644883|NCT03962790|466655211|FG001|Period 1|Failed to meet all eligibility criteria|1|||
129644884|NCT03962790|466655210|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
129644885|NCT03962790|466655211|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
129644886|NCT03962790|466655210|FG000|Period 1|Withdrawal by Subject|1|||
129644887|NCT03962790|466655211|FG001|Period 1|Withdrawal by Subject|0|||
129644888|NCT00381238|466655214|FG000|Overall Study|Adverse Event|3|||
129644889|NCT00381238|466655214|FG000|Overall Study|Protocol Violation|1|||
129644890|NCT00381238|466655214|FG000|Overall Study|Withdrawal by Subject|4|||
129644891|NCT00381238|466655214|FG000|Overall Study|Lack of Efficacy|2|||
129644892|NCT00381238|466655214|FG000|Overall Study|Withdrew by physician|1|||
129644893|NCT00381238|466655214|FG000|Overall Study|Disease progression|1|||
129644894|NCT02086448|466655217|FG000|Overall Study|Withdrawal by Subject|1|||
129644895|NCT02086448|466655218|FG001|Overall Study|Withdrawal by Subject|0|||
129644896|NCT02086448|466655219|FG002|Overall Study|Withdrawal by Subject|0|||
129644897|NCT02086448|466655220|FG003|Overall Study|Withdrawal by Subject|2|||
129644898|NCT03535194|466655223|FG000|Induction Period|Adverse Event|2|||
129644899|NCT03535194|466655224|FG001|Induction Period|Adverse Event|2|||
129644900|NCT03535194|466655225|FG002|Induction Period|Adverse Event|1|||
129644901|NCT03535194|466655226|FG003|Induction Period|Adverse Event|3|||
129644902|NCT03535194|466655227|FG004|Induction Period|Adverse Event|0|||
129644903|NCT03535194|466655223|FG000|Induction Period|Death|0|||
129644904|NCT03535194|466655224|FG001|Induction Period|Death|1|||
129644905|NCT03535194|466655225|FG002|Induction Period|Death|0|||
129644906|NCT03535194|466655226|FG003|Induction Period|Death|0|||
129644907|NCT03535194|466655227|FG004|Induction Period|Death|0|||
129644908|NCT03535194|466655223|FG000|Induction Period|Lack of Efficacy|1|||
129644909|NCT03535194|466655224|FG001|Induction Period|Lack of Efficacy|3|||
129644910|NCT03535194|466655225|FG002|Induction Period|Lack of Efficacy|2|||
129644911|NCT03535194|466655226|FG003|Induction Period|Lack of Efficacy|2|||
129644912|NCT03535194|466655227|FG004|Induction Period|Lack of Efficacy|0|||
129644913|NCT03535194|466655223|FG000|Induction Period|Lost to Follow-up|3|||
129644914|NCT03535194|466655224|FG001|Induction Period|Lost to Follow-up|5|||
129644915|NCT03535194|466655225|FG002|Induction Period|Lost to Follow-up|2|||
129644916|NCT03535194|466655226|FG003|Induction Period|Lost to Follow-up|3|||
129644917|NCT03535194|466655227|FG004|Induction Period|Lost to Follow-up|0|||
129644918|NCT03535194|466655223|FG000|Induction Period|Physician Decision|1|||
129644919|NCT03535194|466655224|FG001|Induction Period|Physician Decision|1|||
129644920|NCT03535194|466655225|FG002|Induction Period|Physician Decision|0|||
129644921|NCT03535194|466655226|FG003|Induction Period|Physician Decision|0|||
129644922|NCT03535194|466655227|FG004|Induction Period|Physician Decision|0|||
129644923|NCT03535194|466655223|FG000|Induction Period|Protocol Violation|1|||
129644924|NCT03535194|466655224|FG001|Induction Period|Protocol Violation|0|||
129644925|NCT03535194|466655225|FG002|Induction Period|Protocol Violation|0|||
129644926|NCT03535194|466655226|FG003|Induction Period|Protocol Violation|1|||
129644927|NCT03535194|466655227|FG004|Induction Period|Protocol Violation|0|||
129644928|NCT03535194|466655223|FG000|Induction Period|Screen Failure|0|||
129644929|NCT03535194|466655224|FG001|Induction Period|Screen Failure|1|||
129644930|NCT03535194|466655225|FG002|Induction Period|Screen Failure|0|||
129706283|NCT01585025|466888411|FG000|Overall Study|Withdrawal by Subject|0|||
129706284|NCT01585025|466888412|FG001|Overall Study|Withdrawal by Subject|3|||
129706285|NCT01585025|466888413|FG002|Overall Study|Withdrawal by Subject|4|||
129706286|NCT00503984|466888414|FG000|Overall Study|Protocol Violation|0|||
129706287|NCT00503984|466888415|FG001|Overall Study|Protocol Violation|1|||
129706288|NCT00503984|466888416|FG002|Overall Study|Protocol Violation|0|||
129706289|NCT00503984|466888417|FG003|Overall Study|Protocol Violation|0|||
129706290|NCT00503984|466888418|FG004|Overall Study|Protocol Violation|0|||
129706291|NCT00503984|466888419|FG005|Overall Study|Protocol Violation|0|||
129706292|NCT00503984|466888414|FG000|Overall Study|Adverse Event|0|||
129644931|NCT03535194|466655226|FG003|Induction Period|Screen Failure|0|||
129644932|NCT03535194|466655227|FG004|Induction Period|Screen Failure|0|||
129644933|NCT03535194|466655223|FG000|Induction Period|Withdrawal by Subject|3|||
129644934|NCT03535194|466655224|FG001|Induction Period|Withdrawal by Subject|4|||
129706293|NCT00503984|466888415|FG001|Overall Study|Adverse Event|1|||
129706294|NCT00503984|466888416|FG002|Overall Study|Adverse Event|0|||
129644935|NCT03535194|466655225|FG002|Induction Period|Withdrawal by Subject|3|||
129644936|NCT03535194|466655226|FG003|Induction Period|Withdrawal by Subject|2|||
129644937|NCT03535194|466655227|FG004|Induction Period|Withdrawal by Subject|0|||
129644938|NCT03535194|466655223|FG000|Maintenance Period|Adverse Event|6|||
129644939|NCT03535194|466655224|FG001|Maintenance Period|Adverse Event|5|||
129644940|NCT03535194|466655225|FG002|Maintenance Period|Adverse Event|1|||
129644941|NCT03535194|466655226|FG003|Maintenance Period|Adverse Event|11|||
129644942|NCT03535194|466655227|FG004|Maintenance Period|Adverse Event|4|||
129644943|NCT03535194|466655223|FG000|Maintenance Period|Lack of Efficacy|3|||
129644944|NCT03535194|466655224|FG001|Maintenance Period|Lack of Efficacy|2|||
129644945|NCT03535194|466655225|FG002|Maintenance Period|Lack of Efficacy|5|||
129644946|NCT03535194|466655226|FG003|Maintenance Period|Lack of Efficacy|9|||
129644947|NCT03535194|466655227|FG004|Maintenance Period|Lack of Efficacy|0|||
129644948|NCT03535194|466655223|FG000|Maintenance Period|Lost to Follow-up|4|||
129644949|NCT03535194|466655224|FG001|Maintenance Period|Lost to Follow-up|2|||
129644950|NCT03535194|466655225|FG002|Maintenance Period|Lost to Follow-up|1|||
129644951|NCT03535194|466655226|FG003|Maintenance Period|Lost to Follow-up|5|||
129644952|NCT03535194|466655227|FG004|Maintenance Period|Lost to Follow-up|2|||
129644953|NCT03535194|466655223|FG000|Maintenance Period|Other|1|||
129644954|NCT03535194|466655224|FG001|Maintenance Period|Other|2|||
129644955|NCT03535194|466655225|FG002|Maintenance Period|Other|0|||
129644956|NCT03535194|466655226|FG003|Maintenance Period|Other|0|||
129644957|NCT03535194|466655227|FG004|Maintenance Period|Other|0|||
129644958|NCT03535194|466655223|FG000|Maintenance Period|Physician Decision|1|||
129644959|NCT03535194|466655224|FG001|Maintenance Period|Physician Decision|2|||
129644960|NCT03535194|466655225|FG002|Maintenance Period|Physician Decision|0|||
129644961|NCT03535194|466655226|FG003|Maintenance Period|Physician Decision|2|||
129644962|NCT03535194|466655227|FG004|Maintenance Period|Physician Decision|0|||
129644963|NCT03535194|466655223|FG000|Maintenance Period|Pregnancy|0|||
129644964|NCT03535194|466655224|FG001|Maintenance Period|Pregnancy|0|||
129644965|NCT03535194|466655225|FG002|Maintenance Period|Pregnancy|0|||
129644966|NCT03535194|466655226|FG003|Maintenance Period|Pregnancy|2|||
129644967|NCT03535194|466655227|FG004|Maintenance Period|Pregnancy|0|||
129644968|NCT03535194|466655223|FG000|Maintenance Period|Protocol Violation|0|||
129644969|NCT03535194|466655224|FG001|Maintenance Period|Protocol Violation|1|||
129644970|NCT03535194|466655225|FG002|Maintenance Period|Protocol Violation|0|||
129644971|NCT03535194|466655226|FG003|Maintenance Period|Protocol Violation|0|||
129644972|NCT03535194|466655227|FG004|Maintenance Period|Protocol Violation|0|||
129644973|NCT03535194|466655223|FG000|Maintenance Period|Withdrawal by Subject|7|||
129644974|NCT03535194|466655224|FG001|Maintenance Period|Withdrawal by Subject|2|||
129644975|NCT03535194|466655225|FG002|Maintenance Period|Withdrawal by Subject|1|||
129644976|NCT03535194|466655226|FG003|Maintenance Period|Withdrawal by Subject|8|||
129644977|NCT03535194|466655227|FG004|Maintenance Period|Withdrawal by Subject|0|||
129644978|NCT03535194|466655223|FG000|Post-Treatment Followup Period|Adverse Event|4|||
129644979|NCT03535194|466655224|FG001|Post-Treatment Followup Period|Adverse Event|5|||
129644980|NCT03535194|466655225|FG002|Post-Treatment Followup Period|Adverse Event|1|||
129644981|NCT03535194|466655226|FG003|Post-Treatment Followup Period|Adverse Event|8|||
129644982|NCT03535194|466655227|FG004|Post-Treatment Followup Period|Adverse Event|0|||
129644983|NCT03535194|466655223|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
129644984|NCT03535194|466655224|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
129644985|NCT03535194|466655225|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
129644986|NCT03535194|466655226|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
129644987|NCT03535194|466655227|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
129799552|NCT00674973|467235144|FG001|Overall Study|Protocol Violation|1|||
129799553|NCT05036369|467235147|FG000|Overall Study|Run In non compliance|1|||
129799554|NCT05036369|467235148|FG001|Overall Study|Run In non compliance|2|||
129799555|NCT05036369|467235147|FG000|Overall Study|Change in eligibility criteria|0|||
129799556|NCT05036369|467235148|FG001|Overall Study|Change in eligibility criteria|1|||
129799557|NCT01397162|467235151|FG000|Overall Study|Adverse Event|4|||
129799558|NCT01397162|467235152|FG001|Overall Study|Adverse Event|0|||
129644988|NCT03535194|466655223|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
129644989|NCT03535194|466655224|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
129644990|NCT03535194|466655225|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
129644991|NCT03535194|466655226|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
129644992|NCT03535194|466655227|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
129799559|NCT01397162|467235153|FG002|Overall Study|Adverse Event|0|||
129799560|NCT01397162|467235154|FG003|Overall Study|Adverse Event|0|||
129799561|NCT01397162|467235155|FG004|Overall Study|Adverse Event|0|||
129644993|NCT03535194|466655223|FG000|Post-Treatment Followup Period|Other|1|||
129644994|NCT03535194|466655224|FG001|Post-Treatment Followup Period|Other|0|||
129644995|NCT03535194|466655225|FG002|Post-Treatment Followup Period|Other|0|||
129644996|NCT03535194|466655226|FG003|Post-Treatment Followup Period|Other|5|||
129644997|NCT03535194|466655227|FG004|Post-Treatment Followup Period|Other|0|||
129644998|NCT03535194|466655223|FG000|Post-Treatment Followup Period|Physician Decision|0|||
129644999|NCT03535194|466655224|FG001|Post-Treatment Followup Period|Physician Decision|2|||
129645000|NCT03535194|466655225|FG002|Post-Treatment Followup Period|Physician Decision|1|||
129645001|NCT03535194|466655226|FG003|Post-Treatment Followup Period|Physician Decision|1|||
129645002|NCT03535194|466655227|FG004|Post-Treatment Followup Period|Physician Decision|0|||
129645003|NCT03535194|466655223|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
129645004|NCT03535194|466655224|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
129645005|NCT03535194|466655225|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
129645006|NCT03535194|466655226|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
129645007|NCT03535194|466655227|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129645008|NCT02682823|466655230|FG000|Overall Study|Withdrawal by Subject|0|||
129645009|NCT02682823|466655231|FG001|Overall Study|Withdrawal by Subject|0|||
129645010|NCT02682823|466655232|FG002|Overall Study|Withdrawal by Subject|1|||
129645011|NCT02682823|466655233|FG003|Overall Study|Withdrawal by Subject|0|||
129645012|NCT02682823|466655234|FG004|Overall Study|Withdrawal by Subject|1|||
129645013|NCT02682823|466655230|FG000|Overall Study|Protocol Deviation|0|||
129645014|NCT02682823|466655231|FG001|Overall Study|Protocol Deviation|1|||
129645015|NCT02682823|466655232|FG002|Overall Study|Protocol Deviation|0|||
129645016|NCT02682823|466655233|FG003|Overall Study|Protocol Deviation|0|||
129645017|NCT02682823|466655234|FG004|Overall Study|Protocol Deviation|0|||
129645018|NCT02682823|466655230|FG000|Overall Study|Adverse Event|0|||
129645019|NCT02682823|466655231|FG001|Overall Study|Adverse Event|0|||
129645020|NCT02682823|466655232|FG002|Overall Study|Adverse Event|0|||
129645021|NCT02682823|466655233|FG003|Overall Study|Adverse Event|1|||
129645022|NCT02682823|466655234|FG004|Overall Study|Adverse Event|0|||
129645023|NCT01938430|466655235|FG000|Overall Study|Randomized but Not Treated|0|||
129645024|NCT01938430|466655236|FG001|Overall Study|Randomized but Not Treated|0|||
129645025|NCT01938430|466655237|FG002|Overall Study|Randomized but Not Treated|0|||
129645026|NCT01938430|466655238|FG003|Overall Study|Randomized but Not Treated|0|||
129645027|NCT01938430|466655239|FG004|Overall Study|Randomized but Not Treated|0|||
129645028|NCT01938430|466655240|FG005|Overall Study|Randomized but Not Treated|0|||
129645029|NCT01938430|466655241|FG006|Overall Study|Randomized but Not Treated|0|||
129645030|NCT01938430|466655242|FG007|Overall Study|Randomized but Not Treated|0|||
129645031|NCT01938430|466655243|FG008|Overall Study|Randomized but Not Treated|0|||
129645032|NCT01938430|466655244|FG009|Overall Study|Randomized but Not Treated|0|||
129645033|NCT01938430|466655245|FG010|Overall Study|Randomized but Not Treated|1|||
129645034|NCT01938430|466655246|FG011|Overall Study|Randomized but Not Treated|0|||
129645035|NCT01938430|466655247|FG012|Overall Study|Randomized but Not Treated|0|||
129645036|NCT01938430|466655248|FG013|Overall Study|Randomized but Not Treated|1|||
129645037|NCT01938430|466655235|FG000|Overall Study|Adverse Event|0|||
129645038|NCT01938430|466655236|FG001|Overall Study|Adverse Event|0|||
129645039|NCT01938430|466655237|FG002|Overall Study|Adverse Event|0|||
129645040|NCT01938430|466655238|FG003|Overall Study|Adverse Event|0|||
129645041|NCT01938430|466655239|FG004|Overall Study|Adverse Event|0|||
129645042|NCT01938430|466655240|FG005|Overall Study|Adverse Event|0|||
129645043|NCT01938430|466655241|FG006|Overall Study|Adverse Event|1|||
129645044|NCT01938430|466655242|FG007|Overall Study|Adverse Event|0|||
129645045|NCT01938430|466655243|FG008|Overall Study|Adverse Event|0|||
129645046|NCT01938430|466655244|FG009|Overall Study|Adverse Event|0|||
129645047|NCT01938430|466655245|FG010|Overall Study|Adverse Event|0|||
129645048|NCT01938430|466655246|FG011|Overall Study|Adverse Event|0|||
129645049|NCT01938430|466655247|FG012|Overall Study|Adverse Event|0|||
129645050|NCT01938430|466655248|FG013|Overall Study|Adverse Event|0|||
129645051|NCT01938430|466655235|FG000|Overall Study|Death|1|||
129645052|NCT01938430|466655236|FG001|Overall Study|Death|2|||
129645053|NCT01938430|466655237|FG002|Overall Study|Death|2|||
129645054|NCT01938430|466655238|FG003|Overall Study|Death|1|||
129645055|NCT01938430|466655239|FG004|Overall Study|Death|0|||
129645056|NCT01938430|466655240|FG005|Overall Study|Death|0|||
129645057|NCT01938430|466655241|FG006|Overall Study|Death|1|||
129645058|NCT01938430|466655242|FG007|Overall Study|Death|1|||
129645059|NCT01938430|466655243|FG008|Overall Study|Death|2|||
129645060|NCT01938430|466655244|FG009|Overall Study|Death|3|||
129645061|NCT01938430|466655245|FG010|Overall Study|Death|0|||
129645062|NCT01938430|466655246|FG011|Overall Study|Death|0|||
129645063|NCT01938430|466655247|FG012|Overall Study|Death|0|||
129645064|NCT01938430|466655248|FG013|Overall Study|Death|0|||
129645065|NCT01938430|466655235|FG000|Overall Study|Investigator's Discretion|0|||
129645066|NCT01938430|466655236|FG001|Overall Study|Investigator's Discretion|0|||
129645067|NCT01938430|466655237|FG002|Overall Study|Investigator's Discretion|1|||
129645068|NCT01938430|466655238|FG003|Overall Study|Investigator's Discretion|0|||
129645069|NCT01938430|466655239|FG004|Overall Study|Investigator's Discretion|0|||
129645070|NCT01938430|466655240|FG005|Overall Study|Investigator's Discretion|0|||
129645071|NCT01938430|466655241|FG006|Overall Study|Investigator's Discretion|0|||
129645072|NCT01938430|466655242|FG007|Overall Study|Investigator's Discretion|0|||
129645073|NCT01938430|466655243|FG008|Overall Study|Investigator's Discretion|0|||
129645074|NCT01938430|466655244|FG009|Overall Study|Investigator's Discretion|0|||
129890399|NCT03100838|467556117|FG000|Overall Study|Pregnancy|0|||
129890400|NCT03100838|467556118|FG001|Overall Study|Pregnancy|1|||
129890401|NCT03100838|467556119|FG002|Overall Study|Pregnancy|0|||
129890402|NCT03100838|467556120|FG003|Overall Study|Pregnancy|0|||
129890403|NCT03100838|467556117|FG000|Overall Study|Lost to Follow-up|0|||
129890404|NCT03100838|467556118|FG001|Overall Study|Lost to Follow-up|0|||
129890405|NCT03100838|467556119|FG002|Overall Study|Lost to Follow-up|1|||
129890406|NCT03100838|467556120|FG003|Overall Study|Lost to Follow-up|0|||
129890407|NCT02554513|467556121|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
129890408|NCT02554513|467556122|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
129890409|NCT00184028|467556123|FG000|Overall Study|Death|1|||
129890410|NCT00184028|467556123|FG000|Overall Study|Lack of Efficacy|4|||
129890411|NCT00184028|467556123|FG000|Overall Study|Adverse Event|2|||
129890412|NCT00184028|467556123|FG000|Overall Study|Withdrawal by Subject|1|||
129890413|NCT00184028|467556123|FG000|Overall Study|Non-compliance|2|||
129890414|NCT01354938|467556126|FG000|Overall Study|Lost to Follow-up|1|||
129890415|NCT02335268|467556127|FG000|Overall Study|Physician Decision|5|||
129890416|NCT02335268|467556128|FG001|Overall Study|Physician Decision|1|||
129890417|NCT02335268|467556127|FG000|Overall Study|Lack of Efficacy|2|||
129890418|NCT02335268|467556128|FG001|Overall Study|Lack of Efficacy|1|||
129890419|NCT02335268|467556127|FG000|Overall Study|Adverse Event|5|||
129890420|NCT02335268|467556128|FG001|Overall Study|Adverse Event|2|||
129890421|NCT02335268|467556127|FG000|Overall Study|increase blasts|2|||
129890422|NCT02335268|467556128|FG001|Overall Study|increase blasts|0|||
129890423|NCT02335268|467556127|FG000|Overall Study|Withdrawal by Subject|3|||
129890424|NCT02335268|467556128|FG001|Overall Study|Withdrawal by Subject|2|||
129890425|NCT01192295|467556132|FG000|Overall Study|Adverse Event|3|||
129890426|NCT01192295|467556133|FG001|Overall Study|Adverse Event|7|||
129890427|NCT01192295|467556132|FG000|Overall Study|Withdrawal by Subject|3|||
129890428|NCT01192295|467556133|FG001|Overall Study|Withdrawal by Subject|4|||
129890429|NCT01192295|467556132|FG000|Overall Study|Lost to Follow-up|0|||
129890430|NCT01192295|467556133|FG001|Overall Study|Lost to Follow-up|1|||
129890431|NCT01192295|467556132|FG000|Overall Study|Lack of Efficacy|0|||
129890432|NCT01192295|467556133|FG001|Overall Study|Lack of Efficacy|5|||
129890433|NCT01192295|467556132|FG000|Overall Study|Administrative|4|||
129890434|NCT01192295|467556133|FG001|Overall Study|Administrative|6|||
129890435|NCT03785340|467556136|FG000|Overall Study|Lost to Follow-up|2|||
129890436|NCT03785340|467556137|FG001|Overall Study|Lost to Follow-up|0|||
129890437|NCT03785340|467556136|FG000|Overall Study|Adverse Event|1|||
129890438|NCT03785340|467556137|FG001|Overall Study|Adverse Event|0|||
129890439|NCT01670500|467556143|FG000|Overall Study|Withdrawal by Subject|1|||
129890440|NCT01670500|467556144|FG001|Overall Study|Withdrawal by Subject|0|||
129645075|NCT01938430|466655245|FG010|Overall Study|Investigator's Discretion|0|||
129645076|NCT01938430|466655246|FG011|Overall Study|Investigator's Discretion|0|||
129645077|NCT01938430|466655247|FG012|Overall Study|Investigator's Discretion|0|||
129645078|NCT01938430|466655248|FG013|Overall Study|Investigator's Discretion|0|||
129645079|NCT01938430|466655235|FG000|Overall Study|Lack of Efficacy|3|||
129645080|NCT01938430|466655236|FG001|Overall Study|Lack of Efficacy|1|||
129645081|NCT01938430|466655237|FG002|Overall Study|Lack of Efficacy|1|||
129645082|NCT01938430|466655238|FG003|Overall Study|Lack of Efficacy|1|||
129645083|NCT01938430|466655239|FG004|Overall Study|Lack of Efficacy|0|||
129645084|NCT01938430|466655240|FG005|Overall Study|Lack of Efficacy|0|||
129645085|NCT01938430|466655241|FG006|Overall Study|Lack of Efficacy|0|||
129645086|NCT01938430|466655242|FG007|Overall Study|Lack of Efficacy|0|||
129890441|NCT04320615|467556145|FG000|Overall Study|Withdrawal by Subject|4|||
129645087|NCT01938430|466655243|FG008|Overall Study|Lack of Efficacy|1|||
129890442|NCT04320615|467556146|FG001|Overall Study|Withdrawal by Subject|10|||
129890443|NCT04320615|467556145|FG000|Overall Study|Physician Decision|2|||
129890444|NCT04320615|467556146|FG001|Overall Study|Physician Decision|0|||
129890445|NCT04320615|467556145|FG000|Overall Study|Other|2|||
129890446|NCT04320615|467556146|FG001|Overall Study|Other|0|||
129890447|NCT04320615|467556145|FG000|Overall Study|Lost to Follow-up|5|||
129890448|NCT04320615|467556146|FG001|Overall Study|Lost to Follow-up|23|||
129890449|NCT04320615|467556145|FG000|Overall Study|Death|35|||
129645088|NCT01938430|466655244|FG009|Overall Study|Lack of Efficacy|0|||
129645089|NCT01938430|466655245|FG010|Overall Study|Lack of Efficacy|2|||
129645090|NCT01938430|466655246|FG011|Overall Study|Lack of Efficacy|1|||
129890450|NCT04320615|467556146|FG001|Overall Study|Death|71|||
129890451|NCT01449721|467556147|FG000|Overall Study|Physician Decision|0|||
129890452|NCT01449721|467556148|FG001|Overall Study|Physician Decision|1|||
129890453|NCT01449721|467556147|FG000|Overall Study|Physician Decision|0|||
129890454|NCT01449721|467556148|FG001|Overall Study|Physician Decision|1|||
129890455|NCT00003509|467556149|FG000|Overall Study|Not evaluable|5|||
129890456|NCT03285711|467556150|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
129645091|NCT01938430|466655247|FG012|Overall Study|Lack of Efficacy|0|||
129890457|NCT03285711|467556151|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
129890458|NCT03285711|467556152|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
129645092|NCT01938430|466655248|FG013|Overall Study|Lack of Efficacy|0|||
129890459|NCT03285711|467556153|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
129890460|NCT03285711|467556150|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
129645093|NCT01938430|466655235|FG000|Overall Study|Lost to Follow-up|0|||
129645094|NCT01938430|466655236|FG001|Overall Study|Lost to Follow-up|0|||
129645095|NCT01938430|466655237|FG002|Overall Study|Lost to Follow-up|1|||
129645096|NCT01938430|466655238|FG003|Overall Study|Lost to Follow-up|0|||
129645097|NCT01938430|466655239|FG004|Overall Study|Lost to Follow-up|0|||
129645098|NCT01938430|466655240|FG005|Overall Study|Lost to Follow-up|1|||
129645099|NCT01938430|466655241|FG006|Overall Study|Lost to Follow-up|0|||
129645100|NCT01938430|466655242|FG007|Overall Study|Lost to Follow-up|0|||
129645101|NCT01938430|466655243|FG008|Overall Study|Lost to Follow-up|0|||
129645102|NCT01938430|466655244|FG009|Overall Study|Lost to Follow-up|0|||
129645103|NCT01938430|466655245|FG010|Overall Study|Lost to Follow-up|0|||
129645104|NCT01938430|466655246|FG011|Overall Study|Lost to Follow-up|0|||
129645105|NCT01938430|466655247|FG012|Overall Study|Lost to Follow-up|0|||
129645106|NCT01938430|466655248|FG013|Overall Study|Lost to Follow-up|0|||
129645107|NCT01938430|466655235|FG000|Overall Study|Withdrew Consent|0|||
129645108|NCT01938430|466655236|FG001|Overall Study|Withdrew Consent|0|||
129645109|NCT01938430|466655237|FG002|Overall Study|Withdrew Consent|0|||
129706295|NCT00503984|466888417|FG003|Overall Study|Adverse Event|0|||
129706296|NCT00503984|466888418|FG004|Overall Study|Adverse Event|0|||
129706297|NCT00503984|466888419|FG005|Overall Study|Adverse Event|0|||
129706298|NCT00503984|466888414|FG000|Overall Study|Death|0|||
129706299|NCT00503984|466888415|FG001|Overall Study|Death|0|||
129645110|NCT01938430|466655238|FG003|Overall Study|Withdrew Consent|0|||
129645111|NCT01938430|466655239|FG004|Overall Study|Withdrew Consent|0|||
129645112|NCT01938430|466655240|FG005|Overall Study|Withdrew Consent|0|||
129706300|NCT00503984|466888416|FG002|Overall Study|Death|0|||
129706301|NCT00503984|466888417|FG003|Overall Study|Death|0|||
129706302|NCT00503984|466888418|FG004|Overall Study|Death|1|||
129706303|NCT00503984|466888419|FG005|Overall Study|Death|0|||
129706304|NCT01246960|466888420|FG000|Overall Study|Lost to Follow-up|3|||
129706305|NCT01246960|466888421|FG001|Overall Study|Lost to Follow-up|1|||
129706306|NCT01246960|466888420|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
129706307|NCT01246960|466888421|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
129706308|NCT00140140|466888428|FG000|Overall Study|Unacceptable toxicity|1|||
129706309|NCT00140140|466888429|FG001|Overall Study|Unacceptable toxicity|1|||
129706310|NCT00140140|466888430|FG002|Overall Study|Unacceptable toxicity|2|||
129706311|NCT00140140|466888428|FG000|Overall Study|Physician Decision|1|||
129706312|NCT00140140|466888429|FG001|Overall Study|Physician Decision|1|||
129706313|NCT00140140|466888430|FG002|Overall Study|Physician Decision|0|||
129706314|NCT03376516|466888431|FG000|Overall Study|Not treated|1|||
129706315|NCT03376516|466888431|FG000|Overall Study|Consent withdrawn|1|||
129706316|NCT01359956|466888432|FG000|Overall Study|Death|58|||
129706317|NCT01359956|466888433|FG001|Overall Study|Death|60|||
129706318|NCT01359956|466888434|FG002|Overall Study|Death|66|||
129706319|NCT01359956|466888435|FG003|Overall Study|Death|57|||
129799562|NCT01397162|467235151|FG000|Overall Study|Not yet defined|3|||
129645113|NCT01938430|466655241|FG006|Overall Study|Withdrew Consent|0|||
129645114|NCT01938430|466655242|FG007|Overall Study|Withdrew Consent|0|||
129645115|NCT01938430|466655243|FG008|Overall Study|Withdrew Consent|1|||
129645116|NCT01938430|466655244|FG009|Overall Study|Withdrew Consent|0|||
129645117|NCT01938430|466655245|FG010|Overall Study|Withdrew Consent|0|||
129706320|NCT01359956|466888432|FG000|Overall Study|Lost to Follow-up|3|||
129706321|NCT01359956|466888433|FG001|Overall Study|Lost to Follow-up|4|||
129706322|NCT01359956|466888434|FG002|Overall Study|Lost to Follow-up|1|||
129706323|NCT01359956|466888435|FG003|Overall Study|Lost to Follow-up|1|||
129706324|NCT00582907|466888436|FG000|1st Course|Withdrawal by Subject|1|||
129706325|NCT00582907|466888437|FG001|1st Course|Withdrawal by Subject|0|||
129645118|NCT01938430|466655246|FG011|Overall Study|Withdrew Consent|0|||
129645119|NCT01938430|466655247|FG012|Overall Study|Withdrew Consent|0|||
129799563|NCT01397162|467235152|FG001|Overall Study|Not yet defined|4|||
129799564|NCT01397162|467235153|FG002|Overall Study|Not yet defined|3|||
129645120|NCT01938430|466655248|FG013|Overall Study|Withdrew Consent|0|||
129645121|NCT03505593|466655256|FG000|Overall Study|Withdrawal by Subject|1|||
129645122|NCT03505593|466655256|FG000|Overall Study|Died before procedure|1|||
129645123|NCT03505593|466655256|FG000|Overall Study|Anatomical abnormality|1|||
129645124|NCT03505593|466655256|FG000|Overall Study|Unable to pass through esophagus|1|||
129645125|NCT03505593|466655256|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
129645126|NCT02662764|466655257|FG000|Overall Study|Adverse Event|6|||
129645127|NCT02662764|466655257|FG000|Overall Study|Lack of Efficacy|8|||
129645128|NCT02662764|466655257|FG000|Overall Study|Protocol Violation|1|||
129645129|NCT02662764|466655257|FG000|Overall Study|Withdrawal by Subject|5|||
129645130|NCT02662764|466655257|FG000|Overall Study|Device failure|4|||
129645131|NCT02662764|466655257|FG000|Overall Study|Patient changed treatment|1|||
129645132|NCT02662764|466655257|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
129645133|NCT00089778|466655258|FG000|Overall Study|Protocol Violation|0|||
129645134|NCT00089778|466655259|FG001|Overall Study|Protocol Violation|0|||
129645135|NCT00089778|466655260|FG002|Overall Study|Protocol Violation|1|||
129645136|NCT05178641|466655261|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
129645137|NCT05178641|466655262|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
129645138|NCT05178641|466655261|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
129645139|NCT05178641|466655262|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
129799565|NCT01397162|467235154|FG003|Overall Study|Not yet defined|5|||
129799566|NCT01397162|467235155|FG004|Overall Study|Not yet defined|3|||
129799567|NCT00401531|467235158|FG000|Overall Study|Adverse Event|2|||
129799568|NCT00401531|467235159|FG001|Overall Study|Adverse Event|0|||
129799569|NCT00401531|467235158|FG000|Overall Study|Protocol Violation|3|||
129799570|NCT00401531|467235159|FG001|Overall Study|Protocol Violation|7|||
129799571|NCT00401531|467235158|FG000|Overall Study|Lost to Follow-up|1|||
129645140|NCT01869699|466655263|FG000|Overall Study|Withdrawal by Subject|1|||
129645141|NCT01869699|466655264|FG001|Overall Study|Withdrawal by Subject|0|||
129645142|NCT00732758|466655265|FG000|Overall Study|Lost to Follow-up|8|||
129645143|NCT00732758|466655266|FG001|Overall Study|Lost to Follow-up|16|||
129645144|NCT04240457|466655269|FG000|Overall Study|Lost to Follow-up|5|||
129645145|NCT04240457|466655270|FG001|Overall Study|Lost to Follow-up|1|||
129645146|NCT01508130|466655274|FG000|Overall Study|Adverse Event|81|||
129645147|NCT01508130|466655275|FG001|Overall Study|Adverse Event|28|||
129645148|NCT01508130|466655274|FG000|Overall Study|Death|3|||
129799572|NCT00401531|467235159|FG001|Overall Study|Lost to Follow-up|1|||
129799573|NCT00401531|467235158|FG000|Overall Study|Withdrawal by Subject|3|||
129799574|NCT00401531|467235159|FG001|Overall Study|Withdrawal by Subject|2|||
129799575|NCT03875118|467235160|FG000|Overall Study|Withdrawal by Subject|4|||
129799576|NCT03875118|467235161|FG001|Overall Study|Withdrawal by Subject|4|||
129799577|NCT03956056|467235162|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
129645149|NCT01508130|466655275|FG001|Overall Study|Death|1|||
129645150|NCT01508130|466655274|FG000|Overall Study|Protocol Violation|2|||
129645151|NCT01508130|466655275|FG001|Overall Study|Protocol Violation|0|||
129645152|NCT01508130|466655274|FG000|Overall Study|Lost to Follow-up|25|||
129645153|NCT01508130|466655275|FG001|Overall Study|Lost to Follow-up|2|||
129645154|NCT01508130|466655274|FG000|Overall Study|Withdrawal by Subject|3|||
129799578|NCT03956056|467235162|FG000|Overall Study|Lack of Efficacy|1|||
129799579|NCT03403374|467235163|FG000|Overall Study|Lost to Follow-up|1|||
129890461|NCT03285711|467556151|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
129890462|NCT03285711|467556152|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
129890463|NCT03285711|467556153|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
129890464|NCT03285711|467556150|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
129890465|NCT03285711|467556151|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
129645155|NCT01508130|466655275|FG001|Overall Study|Withdrawal by Subject|3|||
129645156|NCT01508130|466655274|FG000|Overall Study|Subject's substantial non-compliance|25|||
129645157|NCT01508130|466655275|FG001|Overall Study|Subject's substantial non-compliance|9|||
129645158|NCT01508130|466655274|FG000|Overall Study|Insufficient therapeutic response|74|||
129645159|NCT01508130|466655275|FG001|Overall Study|Insufficient therapeutic response|23|||
129645160|NCT01508130|466655274|FG000|Overall Study|Administrative|14|||
129645161|NCT01508130|466655275|FG001|Overall Study|Administrative|3|||
129645162|NCT01680159|466655276|FG000|Screening Period|Not meet criteria for dose-up period|7|||
129890466|NCT03285711|467556152|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
129890467|NCT03285711|467556153|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
129890468|NCT03285711|467556150|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129890469|NCT03285711|467556151|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
129890470|NCT03285711|467556152|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129890471|NCT03285711|467556153|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
129890472|NCT02431533|467556154|FG000|Overall Study|Withdrawal by Subject|1|||
129890473|NCT02431533|467556155|FG001|Overall Study|Withdrawal by Subject|3|||
129890474|NCT02431533|467556154|FG000|Overall Study|Developed Exclusionary criteria|1|||
129890475|NCT02431533|467556155|FG001|Overall Study|Developed Exclusionary criteria|0|||
129890476|NCT02107443|467556156|FG000|Overall Study|Death|42|||
129890477|NCT02107443|467556157|FG001|Overall Study|Death|30|||
129890478|NCT02107443|467556156|FG000|Overall Study|Study Protocol Violation|3|||
129890479|NCT02107443|467556157|FG001|Overall Study|Study Protocol Violation|1|||
129890480|NCT02107443|467556156|FG000|Overall Study|Registered but Not Eligible|0|||
129890481|NCT02107443|467556157|FG001|Overall Study|Registered but Not Eligible|1|||
129890482|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
129890483|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
129890484|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
129890485|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
129645163|NCT01680159|466655276|FG000|Increased Dose Period|Adverse Event|6|||
129645164|NCT01680159|466655276|FG000|Increased Dose Period|Withdrawal by Subject|2|||
129890486|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Changed Mind|2|||
129890487|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Changed Mind|0|||
129890488|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
129890489|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
129890490|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
129890491|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
129890492|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
129890493|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
129890494|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
129890495|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
129890496|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Other Medical|9|||
129890497|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Other Medical|5|||
129890498|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Disease Progression|4|||
129890499|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Disease Progression|2|||
129890500|NCT02107443|467556156|FG000|Overall Study|Withdrawal: Personal Issues|0|||
129890501|NCT02107443|467556157|FG001|Overall Study|Withdrawal: Personal Issues|3|||
129890502|NCT00333788|467556158|FG000|Overall Study|Adverse Event|44|||
129890503|NCT00333788|467556158|FG000|Overall Study|Lack of Efficacy|80|||
129890504|NCT00333788|467556158|FG000|Overall Study|Lost to Follow-up|2|||
129890505|NCT00333788|467556158|FG000|Overall Study|Withdrawal by Subject|24|||
129890506|NCT00333788|467556158|FG000|Overall Study|Other: Non-compliance|2|||
129890507|NCT00333788|467556158|FG000|Overall Study|Other: Moved|2|||
129890508|NCT00333788|467556158|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
129890509|NCT00333788|467556158|FG000|Overall Study|Other: Investigator decision|1|||
129645165|NCT01252563|466655282|FG000|Overall Study|Contract Deviation|41|||
129645166|NCT01252563|466655282|FG000|Overall Study|Centralized Registration Deviation|30|||
129645167|NCT01252563|466655282|FG000|Overall Study|Lost to Follow-up|161|||
129890510|NCT00333788|467556158|FG000|Overall Study|Other: Quality of life concern|1|||
129645168|NCT01252563|466655282|FG000|Overall Study|No visit after first day of treatment|194|||
129645169|NCT01252563|466655282|FG000|Overall Study|No drug administration|6|||
129645170|NCT03429244|466655283|FG000|Overall Study|Withdrawal by Subject|2|||
129645171|NCT03429244|466655284|FG001|Overall Study|Withdrawal by Subject|1|||
129645172|NCT03429244|466655285|FG002|Overall Study|Withdrawal by Subject|1|||
129645173|NCT03843632|466655293|FG000|Overall Study|Withdrawal by Subject|1|||
129645174|NCT03843632|466655294|FG001|Overall Study|Withdrawal by Subject|0|||
129645175|NCT03843632|466655295|FG002|Overall Study|Withdrawal by Subject|0|||
129645176|NCT03843632|466655296|FG003|Overall Study|Withdrawal by Subject|0|||
129890511|NCT00333788|467556158|FG000|Overall Study|Other: Sponsor decision|1|||
129890512|NCT00333788|467556158|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
129890513|NCT00333788|467556158|FG000|Overall Study|Other: Medical monitor decision|1|||
129890514|NCT00333788|467556158|FG000|Overall Study|Other: Physician decision|1|||
129890515|NCT00333788|467556158|FG000|Overall Study|Other: Signed consent for another study|1|||
129890516|NCT00729690|467556159|FG000|Overall Study|IT Catheter Malfunction|0|||
129890517|NCT00729690|467556160|FG001|Overall Study|IT Catheter Malfunction|2|||
129890518|NCT00729690|467556161|FG002|Overall Study|IT Catheter Malfunction|2|||
129890519|NCT02886936|467556167|FG000|Overall Study|Lost to Follow-up|4|||
129890520|NCT02886936|467556168|FG001|Overall Study|Lost to Follow-up|3|||
129890521|NCT02886936|467556169|FG002|Overall Study|Lost to Follow-up|0|||
129890522|NCT02320721|467556170|FG000|Overall Study|Adverse Event|6|||
129890523|NCT02320721|467556171|FG001|Overall Study|Adverse Event|6|||
129890524|NCT02320721|467556170|FG000|Overall Study|Lack of Efficacy|2|||
129890525|NCT02320721|467556171|FG001|Overall Study|Lack of Efficacy|0|||
129890526|NCT02320721|467556170|FG000|Overall Study|Poor compliance to protocol|3|||
129890527|NCT02320721|467556171|FG001|Overall Study|Poor compliance to protocol|7|||
129890528|NCT02320721|467556170|FG000|Overall Study|Randomized but not treated|0|||
129890529|NCT02320721|467556171|FG001|Overall Study|Randomized but not treated|1|||
129645177|NCT01820572|466655297|FG000|Randomization|Not Treated|2|||
129645178|NCT01820572|466655298|FG001|Randomization|Not Treated|1|||
129645179|NCT01820572|466655297|FG000|Treatment Period|Adverse Event|12|||
129645180|NCT01820572|466655298|FG001|Treatment Period|Adverse Event|7|||
129645181|NCT01820572|466655297|FG000|Treatment Period|Death|3|||
129645182|NCT01820572|466655298|FG001|Treatment Period|Death|3|||
129645183|NCT01820572|466655297|FG000|Treatment Period|Lack of Efficacy|1|||
129645184|NCT01820572|466655298|FG001|Treatment Period|Lack of Efficacy|0|||
129645185|NCT01820572|466655297|FG000|Treatment Period|poor/non compliance|0|||
129645186|NCT01820572|466655298|FG001|Treatment Period|poor/non compliance|3|||
129890530|NCT02320721|467556170|FG000|Overall Study|Hypoglycemia|1|||
129890531|NCT02320721|467556171|FG001|Overall Study|Hypoglycemia|0|||
129890532|NCT02320721|467556170|FG000|Overall Study|Other than specified above|15|||
129890533|NCT02320721|467556171|FG001|Overall Study|Other than specified above|20|||
129890534|NCT04131907|467556172|FG000|Overall Study|Adverse Event|2|||
129890535|NCT04131907|467556173|FG001|Overall Study|Adverse Event|0|||
129890536|NCT04131907|467556174|FG002|Overall Study|Adverse Event|0|||
129890537|NCT04131907|467556172|FG000|Overall Study|Physician Decision|4|||
129890538|NCT04131907|467556173|FG001|Overall Study|Physician Decision|22|||
129890539|NCT04131907|467556174|FG002|Overall Study|Physician Decision|0|||
129890540|NCT04131907|467556172|FG000|Overall Study|Withdrawal by Subject|2|||
129890541|NCT04131907|467556173|FG001|Overall Study|Withdrawal by Subject|0|||
129890542|NCT04131907|467556174|FG002|Overall Study|Withdrawal by Subject|1|||
129890543|NCT04131907|467556172|FG000|Overall Study|Treatment failure|2|||
129645187|NCT01820572|466655297|FG000|Treatment Period|request to discontinue|6|||
129645188|NCT01820572|466655298|FG001|Treatment Period|request to discontinue|11|||
129645189|NCT01820572|466655297|FG000|Treatment Period|No longer meets study criteria|3|||
129645190|NCT01820572|466655298|FG001|Treatment Period|No longer meets study criteria|10|||
129890544|NCT04131907|467556173|FG001|Overall Study|Treatment failure|0|||
129890545|NCT04131907|467556174|FG002|Overall Study|Treatment failure|1|||
129890546|NCT00245011|467556175|FG000|Overall Study|Lack of Efficacy|1|||
129890547|NCT01388543|467556183|FG000|Day 14|Adverse Event|1|||
129890548|NCT01388543|467556184|FG001|Day 14|Adverse Event|4|||
129890549|NCT00394095|467557464|FG000|Screening|Withdrawal by Subject|1|||
129645191|NCT01820572|466655297|FG000|Treatment Period|withdrew consent|1|||
129645192|NCT01820572|466655298|FG001|Treatment Period|withdrew consent|2|||
129645193|NCT05036668|466655299|FG000|Overall Study|lost to follow Up|0|||
129645194|NCT05036668|466655300|FG001|Overall Study|lost to follow Up|0|||
129645195|NCT05036668|466655301|FG002|Overall Study|lost to follow Up|1|||
129645196|NCT00658775|466655304|FG000|Overall Study|Adverse Event|4|||
129645197|NCT00658775|466655305|FG001|Overall Study|Adverse Event|6|||
129706326|NCT00582907|466888438|FG002|1st Course|Withdrawal by Subject|0|||
129706327|NCT00582907|466888439|FG003|1st Course|Withdrawal by Subject|0|||
129706328|NCT00582907|466888436|FG000|1st Course|Lost to Follow-up|0|||
129706329|NCT00582907|466888437|FG001|1st Course|Lost to Follow-up|0|||
129706330|NCT00582907|466888438|FG002|1st Course|Lost to Follow-up|0|||
129706331|NCT00582907|466888439|FG003|1st Course|Lost to Follow-up|1|||
129706332|NCT00582907|466888436|FG000|2nd Course|Lack of Efficacy|1|||
129706333|NCT00582907|466888437|FG001|2nd Course|Lack of Efficacy|0|||
129706334|NCT00582907|466888438|FG002|2nd Course|Lack of Efficacy|0|||
129706335|NCT00582907|466888439|FG003|2nd Course|Lack of Efficacy|0|||
129706336|NCT00370292|466888440|FG000|Overall Study|Disease Progression|4|||
129706337|NCT00370292|466888440|FG000|Overall Study|Adverse Event|7|||
129706338|NCT00370292|466888440|FG000|Overall Study|Physician Decision|2|||
129706339|NCT02704208|466888441|FG000|Overall Study|Lost to Follow-up|42|||
129706340|NCT02704208|466888442|FG001|Overall Study|Lost to Follow-up|37|||
129706341|NCT03545672|466888443|FG000|Overall Study|Uncertain diagnosis|2|||
129706342|NCT03545672|466888444|FG001|Overall Study|Uncertain diagnosis|1|||
129706343|NCT03545672|466888443|FG000|Overall Study|Protocol Violation|2|||
129706344|NCT03545672|466888444|FG001|Overall Study|Protocol Violation|2|||
129706345|NCT01628913|466888445|FG000|Overall Study|Adverse Event|12|||
129706346|NCT01628913|466888446|FG001|Overall Study|Adverse Event|5|||
129706347|NCT01628913|466888445|FG000|Overall Study|Disease Progression|11|||
129706348|NCT01628913|466888446|FG001|Overall Study|Disease Progression|14|||
129706349|NCT01628913|466888445|FG000|Overall Study|Protocol Violation|1|||
129706350|NCT01628913|466888446|FG001|Overall Study|Protocol Violation|0|||
129706351|NCT01628913|466888445|FG000|Overall Study|Death|1|||
129706352|NCT01628913|466888446|FG001|Overall Study|Death|0|||
129706353|NCT01628913|466888445|FG000|Overall Study|study terminated by Sponsor|4|||
129706354|NCT01628913|466888446|FG001|Overall Study|study terminated by Sponsor|9|||
129706355|NCT01628913|466888445|FG000|Overall Study|Withdrawal by Subject|1|||
129706356|NCT01628913|466888446|FG001|Overall Study|Withdrawal by Subject|0|||
129706357|NCT01628913|466888445|FG000|Overall Study|Physician Decision|1|||
129706358|NCT01628913|466888446|FG001|Overall Study|Physician Decision|3|||
129706359|NCT04102007|466888448|FG000|Overall Study|Adverse Event|4|||
129890550|NCT00394095|467557465|FG001|Screening|Withdrawal by Subject|0|||
129890551|NCT00394095|467557464|FG000|Randomized|Withdrawal by Subject|5|||
129890552|NCT00394095|467557465|FG001|Randomized|Withdrawal by Subject|1|||
129890553|NCT00394095|467557464|FG000|Randomized|Adverse Event|1|||
129706360|NCT04102007|466888448|FG000|Overall Study|Lost to Follow-up|3|||
129706361|NCT04102007|466888448|FG000|Overall Study|Withdrawal by Subject|12|||
129706362|NCT04102007|466888448|FG000|Overall Study|Eligibility Violation|5|||
129706363|NCT04102007|466888448|FG000|Overall Study|Lack of Efficacy|6|||
129706364|NCT04102007|466888448|FG000|Overall Study|Protocol Deviation|5|||
129706365|NCT04102007|466888448|FG000|Overall Study|Protocol Compliance|1|||
129706366|NCT04102007|466888448|FG000|Overall Study|Withdrew Treatment|2|||
129706367|NCT04102007|466888448|FG000|Overall Study|Pregnancy|1|||
129890554|NCT00394095|467557465|FG001|Randomized|Adverse Event|1|||
129706368|NCT00892008|466888454|FG000|Overall Study|Death|5|||
129706369|NCT00892008|466888454|FG000|Overall Study|Lack of Efficacy|3|||
129706370|NCT00892008|466888454|FG000|Overall Study|Lost to Follow-up|142|||
129706371|NCT00892008|466888454|FG000|Overall Study|Other|378|||
129706372|NCT00892008|466888454|FG000|Overall Study|Adverse Event|37|||
129706373|NCT03610048|466888457|FG000|Overall Study|Study terminated by sponsor|84|||
129799580|NCT01298531|467235164|FG000|Overall Study|Lack of Efficacy|0|||
129799581|NCT01298531|467235165|FG001|Overall Study|Lack of Efficacy|1|||
129799582|NCT01298531|467235164|FG000|Overall Study|Lost to Follow-up|2|||
129799583|NCT01298531|467235165|FG001|Overall Study|Lost to Follow-up|0|||
129799584|NCT01298531|467235164|FG000|Overall Study|Protocol Violation|1|||
129799585|NCT01298531|467235165|FG001|Overall Study|Protocol Violation|1|||
129799586|NCT01298531|467235164|FG000|Overall Study|Adverse Event|4|||
129799587|NCT01298531|467235165|FG001|Overall Study|Adverse Event|3|||
129799588|NCT01298531|467235164|FG000|Overall Study|Does not meet entrance criteria|0|||
129799589|NCT01298531|467235165|FG001|Overall Study|Does not meet entrance criteria|1|||
129799590|NCT01298531|467235164|FG000|Overall Study|Other|2|||
129799591|NCT01298531|467235165|FG001|Overall Study|Other|1|||
129799592|NCT02360995|467235166|FG000|Overall Study|Lost to Follow-up|2|||
129799593|NCT02360995|467235167|FG001|Overall Study|Lost to Follow-up|0|||
129799594|NCT02360995|467235168|FG002|Overall Study|Lost to Follow-up|2|||
129799595|NCT02360995|467235166|FG000|Overall Study|Withdrawal by Subject|0|||
129799596|NCT02360995|467235167|FG001|Overall Study|Withdrawal by Subject|1|||
129799597|NCT02360995|467235168|FG002|Overall Study|Withdrawal by Subject|0|||
129799598|NCT02611960|467235169|FG000|Overall Study|Adverse Event|7|||
129799599|NCT02611960|467235170|FG001|Overall Study|Adverse Event|8|||
129799600|NCT02611960|467235169|FG000|Overall Study|Death|98|||
129799601|NCT02611960|467235170|FG001|Overall Study|Death|92|||
129799602|NCT02611960|467235169|FG000|Overall Study|Withdrawal by Subject|1|||
129799603|NCT02611960|467235170|FG001|Overall Study|Withdrawal by Subject|5|||
129799604|NCT02611960|467235169|FG000|Overall Study|Sponsor Decision|11|||
129799605|NCT02611960|467235170|FG001|Overall Study|Sponsor Decision|11|||
129799606|NCT02395666|467235171|FG000|Overall Study|Physician Decision|3|||
129799607|NCT02395666|467235172|FG001|Overall Study|Physician Decision|0|||
129799608|NCT02395666|467235171|FG000|Overall Study|Lost to Follow-up|1|||
129799609|NCT02395666|467235172|FG001|Overall Study|Lost to Follow-up|0|||
129799610|NCT02395666|467235171|FG000|Overall Study|Withdrawal by Subject|2|||
129799611|NCT02395666|467235172|FG001|Overall Study|Withdrawal by Subject|1|||
129799612|NCT01409434|467235173|FG000|Overall Study|Protocol Violation|4|||
129799613|NCT02213042|467235176|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
129799614|NCT02213042|467235177|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
129799615|NCT02213042|467235178|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
129799616|NCT02213042|467235176|FG000|Overall Study|Adverse Event|2|||
129799617|NCT02213042|467235177|FG001|Overall Study|Adverse Event|1|||
129799618|NCT02213042|467235178|FG002|Overall Study|Adverse Event|0|||
129799619|NCT02213042|467235176|FG000|Overall Study|Withdrawal by Subject|0|||
129799620|NCT02213042|467235177|FG001|Overall Study|Withdrawal by Subject|1|||
129799621|NCT02213042|467235178|FG002|Overall Study|Withdrawal by Subject|1|||
129799622|NCT02213042|467235176|FG000|Overall Study|Protocol Violation|1|||
129799623|NCT02213042|467235177|FG001|Overall Study|Protocol Violation|0|||
129799624|NCT02213042|467235178|FG002|Overall Study|Protocol Violation|0|||
129799625|NCT02213042|467235176|FG000|Overall Study|Investigator discretion|0|||
129799626|NCT02213042|467235177|FG001|Overall Study|Investigator discretion|0|||
129799627|NCT02213042|467235178|FG002|Overall Study|Investigator discretion|1|||
129799628|NCT05314478|467235179|FG000|Overall Study|Physician Decision|1|||
129799629|NCT04629508|467235180|FG000|Overall Study|Adverse Event|1|||
129799630|NCT04629508|467235180|FG000|Overall Study|Death|2|||
129799631|NCT04629508|467235180|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
129799632|NCT02476422|467235181|FG000|Overall Study|Subject/guardian decision|0|||
129799633|NCT02476422|467235182|FG001|Overall Study|Subject/guardian decision|1|||
129799634|NCT00760214|467235184|FG000|Overall Study|Adverse Event|8|||
129799635|NCT00760214|467235185|FG001|Overall Study|Adverse Event|9|||
129799636|NCT00760214|467235186|FG002|Overall Study|Adverse Event|12|||
129799637|NCT00760214|467235184|FG000|Overall Study|Protocol Violation|3|||
129799638|NCT00760214|467235185|FG001|Overall Study|Protocol Violation|0|||
129706374|NCT03610048|466888457|FG000|Overall Study|Adverse Event|32|||
129706375|NCT03610048|466888457|FG000|Overall Study|Withdrawal by Subject|31|||
129706376|NCT03610048|466888457|FG000|Overall Study|Lost to Follow-up|8|||
129799639|NCT00760214|467235186|FG002|Overall Study|Protocol Violation|3|||
129799640|NCT00760214|467235184|FG000|Overall Study|Lost to Follow-up|0|||
129799641|NCT00760214|467235185|FG001|Overall Study|Lost to Follow-up|0|||
129799642|NCT00760214|467235186|FG002|Overall Study|Lost to Follow-up|1|||
129799643|NCT00760214|467235184|FG000|Overall Study|Withdrawal by Subject|12|||
129799644|NCT00760214|467235185|FG001|Overall Study|Withdrawal by Subject|14|||
129706377|NCT03610048|466888457|FG000|Overall Study|Other|4|||
129706378|NCT03610048|466888457|FG000|Overall Study|Physician Decision|1|||
129799645|NCT00760214|467235186|FG002|Overall Study|Withdrawal by Subject|13|||
129799646|NCT00760214|467235184|FG000|Overall Study|Lack of Efficacy|3|||
129890555|NCT00394095|467557464|FG000|Randomized|Overdose|1|||
129890556|NCT00394095|467557465|FG001|Randomized|Overdose|0|||
129890557|NCT00394095|467557464|FG000|Randomized|Lost to Follow-up|1|||
129890558|NCT00394095|467557465|FG001|Randomized|Lost to Follow-up|2|||
129890559|NCT00731042|467557466|FG000|Second Intervention|Did not meet inclusion criteria|0|||
129890560|NCT00731042|467557467|FG001|Second Intervention|Did not meet inclusion criteria|2|||
129890561|NCT04213846|467557468|FG000|Overall Study|Withdrawal by Subject|7|||
129890562|NCT04213846|467557469|FG001|Overall Study|Withdrawal by Subject|6|||
129890563|NCT04213846|467557468|FG000|Overall Study|Lost to Follow-up|15|||
129890564|NCT04213846|467557469|FG001|Overall Study|Lost to Follow-up|21|||
129890565|NCT04423393|467557470|FG000|Overall Study|Withdrawal by Subject|0|||
129890566|NCT04423393|467557471|FG001|Overall Study|Withdrawal by Subject|0|||
129890567|NCT04423393|467557472|FG002|Overall Study|Withdrawal by Subject|0|||
129890568|NCT04423393|467557473|FG003|Overall Study|Withdrawal by Subject|0|||
129890569|NCT04423393|467557474|FG004|Overall Study|Withdrawal by Subject|0|||
129890570|NCT04423393|467557475|FG005|Overall Study|Withdrawal by Subject|1|||
129890571|NCT04423393|467557476|FG006|Overall Study|Withdrawal by Subject|0|||
129890572|NCT04423393|467557477|FG007|Overall Study|Withdrawal by Subject|0|||
129890573|NCT04423393|467557478|FG008|Overall Study|Withdrawal by Subject|0|||
129890574|NCT04423393|467557479|FG009|Overall Study|Withdrawal by Subject|0|||
129890575|NCT04423393|467557480|FG010|Overall Study|Withdrawal by Subject|0|||
129890576|NCT04423393|467557481|FG011|Overall Study|Withdrawal by Subject|0|||
129890577|NCT04423393|467557482|FG012|Overall Study|Withdrawal by Subject|0|||
129645198|NCT00658775|466655304|FG000|Overall Study|Lost to Follow-up|17|||
129645199|NCT00658775|466655305|FG001|Overall Study|Lost to Follow-up|18|||
129645200|NCT00658775|466655304|FG000|Overall Study|Withdrawal by Subject|6|||
129890578|NCT04423393|467557483|FG013|Overall Study|Withdrawal by Subject|1|||
129890579|NCT04423393|467557484|FG014|Overall Study|Withdrawal by Subject|0|||
129890580|NCT04423393|467557485|FG015|Overall Study|Withdrawal by Subject|0|||
129645201|NCT00658775|466655305|FG001|Overall Study|Withdrawal by Subject|4|||
129645202|NCT00658775|466655304|FG000|Overall Study|Withdrawal of consent|8|||
129645203|NCT00658775|466655305|FG001|Overall Study|Withdrawal of consent|7|||
129645204|NCT00658775|466655304|FG000|Overall Study|Other|7|||
129645205|NCT00658775|466655305|FG001|Overall Study|Other|8|||
129645206|NCT00387010|466655306|FG000|Dose Titration Period|Adverse Event|12|||
129645207|NCT00387010|466655306|FG000|Dose Titration Period|Lack of Efficacy|5|||
129645208|NCT00387010|466655306|FG000|Dose Titration Period|Withdrawal by Subject|3|||
129645209|NCT00387010|466655306|FG000|Dose Titration Period|Protocol Violation|1|||
129645210|NCT00387010|466655306|FG000|Dose Titration Period|Lost to Follow-up|2|||
129645211|NCT00387010|466655306|FG000|Dose Titration Period|Noncompliance with study medication|8|||
129645212|NCT00387010|466655306|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
129645213|NCT00387010|466655306|FG000|Treatment Period|Adverse Event|4|||
129645214|NCT00387010|466655306|FG000|Treatment Period|Withdrawal by Subject|1|||
129645215|NCT00387010|466655306|FG000|Treatment Period|Noncompliance with study medication|2|||
129645216|NCT00387010|466655306|FG000|Treatment Period|Noncompliance with study procedures|3|||
129645217|NCT00387010|466655306|FG000|Treatment Period|Participant reported study drug stolen|1|||
129645218|NCT02841280|466655317|FG000|Overall Study|Adverse Event|2|||
129645219|NCT02841280|466655318|FG001|Overall Study|Adverse Event|1|||
129645220|NCT02841280|466655317|FG000|Overall Study|Death|1|||
129645221|NCT02841280|466655318|FG001|Overall Study|Death|0|||
129645222|NCT02841280|466655317|FG000|Overall Study|Lost to Follow-up|2|||
129645223|NCT02841280|466655318|FG001|Overall Study|Lost to Follow-up|2|||
129645224|NCT02841280|466655317|FG000|Overall Study|Withdrawal by Subject|7|||
129645225|NCT02841280|466655318|FG001|Overall Study|Withdrawal by Subject|3|||
129645226|NCT02841280|466655317|FG000|Overall Study|Stop Point: BP above threshold|2|||
129645227|NCT02841280|466655318|FG001|Overall Study|Stop Point: BP above threshold|0|||
129645228|NCT02727777|466655319|FG000|Overall Study|Screen Failure|2|||
129645229|NCT02727777|466655320|FG001|Overall Study|Screen Failure|0|||
129645230|NCT02727777|466655321|FG002|Overall Study|Screen Failure|0|||
129645231|NCT02727777|466655319|FG000|Overall Study|Progressive disease|2|||
129645232|NCT02727777|466655320|FG001|Overall Study|Progressive disease|0|||
129645233|NCT02727777|466655321|FG002|Overall Study|Progressive disease|0|||
129645234|NCT00957268|466655322|FG000|Overall Study|Voluntary Withdrawal|0|||
129645235|NCT00957268|466655323|FG001|Overall Study|Voluntary Withdrawal|0|||
129645236|NCT00957268|466655324|FG002|Overall Study|Voluntary Withdrawal|1|||
129706379|NCT03610048|466888457|FG000|Overall Study|Pregnancy|1|||
129645237|NCT00957268|466655325|FG003|Overall Study|Voluntary Withdrawal|0|||
129645238|NCT00957268|466655326|FG004|Overall Study|Voluntary Withdrawal|0|||
129890581|NCT04423393|467557486|FG016|Overall Study|Withdrawal by Subject|0|||
129890582|NCT04423393|467557487|FG017|Overall Study|Withdrawal by Subject|0|||
129890583|NCT04423393|467557470|FG000|Overall Study|Sponsor Decision|0|||
129890584|NCT04423393|467557471|FG001|Overall Study|Sponsor Decision|0|||
129890585|NCT04423393|467557472|FG002|Overall Study|Sponsor Decision|0|||
129890586|NCT04423393|467557473|FG003|Overall Study|Sponsor Decision|0|||
129890587|NCT04423393|467557474|FG004|Overall Study|Sponsor Decision|0|||
129890588|NCT04423393|467557475|FG005|Overall Study|Sponsor Decision|0|||
129645239|NCT01738503|466655327|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
129645240|NCT01738503|466655328|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
129645241|NCT01738503|466655329|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
129645242|NCT01738503|466655330|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
129645243|NCT01738503|466655331|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
129645244|NCT01738503|466655332|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
129645245|NCT01738503|466655333|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
129645246|NCT01738503|466655327|FG000|Treatment Period|Adverse Event|0|||
129799647|NCT00760214|467235185|FG001|Overall Study|Lack of Efficacy|2|||
129799648|NCT00760214|467235186|FG002|Overall Study|Lack of Efficacy|4|||
129799649|NCT00760214|467235184|FG000|Overall Study|Pregnancy|0|||
129799650|NCT00760214|467235185|FG001|Overall Study|Pregnancy|0|||
129799651|NCT00760214|467235186|FG002|Overall Study|Pregnancy|1|||
129799652|NCT00760214|467235184|FG000|Overall Study|Physician Decision|1|||
129799653|NCT00760214|467235185|FG001|Overall Study|Physician Decision|1|||
129799654|NCT00760214|467235186|FG002|Overall Study|Physician Decision|1|||
129799655|NCT00760214|467235184|FG000|Overall Study|Other|3|||
129799656|NCT00760214|467235185|FG001|Overall Study|Other|4|||
129799657|NCT00760214|467235186|FG002|Overall Study|Other|6|||
129799658|NCT01134315|467235187|FG000|Overall Study|Adverse Event|1|||
129799659|NCT01134315|467235188|FG001|Overall Study|Adverse Event|2|||
129799660|NCT01134315|467235187|FG000|Overall Study|Other Reason|8|||
129799661|NCT01134315|467235188|FG001|Overall Study|Other Reason|17|||
129799662|NCT01086423|467235190|FG000|Overall Study|Protocol Violation|0|||
129799663|NCT01086423|467235191|FG001|Overall Study|Protocol Violation|0|||
129799664|NCT01086423|467235192|FG002|Overall Study|Protocol Violation|1|||
129799665|NCT01086423|467235190|FG000|Overall Study|Migrated/moved from study area|2|||
129799666|NCT01086423|467235191|FG001|Overall Study|Migrated/moved from study area|0|||
129799667|NCT01086423|467235192|FG002|Overall Study|Migrated/moved from study area|4|||
129799668|NCT01086423|467235190|FG000|Overall Study|Adverse event, fatal|1|||
129799669|NCT01086423|467235191|FG001|Overall Study|Adverse event, fatal|1|||
129799670|NCT01086423|467235192|FG002|Overall Study|Adverse event, fatal|0|||
129799671|NCT01086423|467235190|FG000|Overall Study|Adverse event, non-fatal|2|||
129799672|NCT01086423|467235191|FG001|Overall Study|Adverse event, non-fatal|1|||
129799673|NCT01086423|467235192|FG002|Overall Study|Adverse event, non-fatal|0|||
129799674|NCT01086423|467235190|FG000|Overall Study|Withdrawal by Subject|5|||
129799675|NCT01086423|467235191|FG001|Overall Study|Withdrawal by Subject|1|||
129799676|NCT01086423|467235192|FG002|Overall Study|Withdrawal by Subject|3|||
129799677|NCT01086423|467235190|FG000|Overall Study|Lost to Follow-up|0|||
129799678|NCT01086423|467235191|FG001|Overall Study|Lost to Follow-up|0|||
129645247|NCT01738503|466655328|FG001|Treatment Period|Adverse Event|1|||
129799679|NCT01086423|467235192|FG002|Overall Study|Lost to Follow-up|1|||
129799680|NCT01130103|467235197|FG000|Randomized Treatment|Adverse Event|1|||
129799681|NCT01130103|467235198|FG001|Randomized Treatment|Adverse Event|1|||
129799682|NCT01130103|467235197|FG000|Randomized Treatment|Lost to Follow-up|1|||
129799683|NCT01130103|467235198|FG001|Randomized Treatment|Lost to Follow-up|0|||
129799684|NCT01130103|467235197|FG000|Randomized Treatment|Protocol Violation|3|||
129799685|NCT01130103|467235198|FG001|Randomized Treatment|Protocol Violation|2|||
129799686|NCT01130103|467235197|FG000|Randomized Treatment|Withdrawal by Subject|1|||
129799687|NCT01130103|467235198|FG001|Randomized Treatment|Withdrawal by Subject|2|||
129799688|NCT01130103|467235197|FG000|Maintenance Treatment|Lack of Efficacy|0|||
129799689|NCT01130103|467235198|FG001|Maintenance Treatment|Lack of Efficacy|1|||
129799690|NCT01130103|467235197|FG000|Maintenance Treatment|Lost to Follow-up|1|||
129799691|NCT01130103|467235198|FG001|Maintenance Treatment|Lost to Follow-up|1|||
129799692|NCT01130103|467235197|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
129799693|NCT01130103|467235198|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
129799694|NCT01465191|467235199|FG000|Overall Study|Protocol Violation|6|||
129799695|NCT01465191|467235200|FG001|Overall Study|Protocol Violation|3|||
129799696|NCT01465191|467235201|FG002|Overall Study|Protocol Violation|3|||
129799697|NCT01465191|467235199|FG000|Overall Study|Lost to Follow-up|3|||
129799698|NCT01465191|467235200|FG001|Overall Study|Lost to Follow-up|6|||
129799699|NCT01465191|467235201|FG002|Overall Study|Lost to Follow-up|4|||
129799700|NCT02992132|467235202|FG000|Overall Study|Adverse Event|4|||
129645248|NCT01738503|466655329|FG002|Treatment Period|Adverse Event|0|||
129645249|NCT01738503|466655330|FG003|Treatment Period|Adverse Event|1|||
129645250|NCT01738503|466655331|FG004|Treatment Period|Adverse Event|2|||
129799701|NCT02992132|467235203|FG001|Overall Study|Adverse Event|1|||
129799702|NCT02992132|467235204|FG002|Overall Study|Adverse Event|3|||
129799703|NCT02992132|467235202|FG000|Overall Study|Lack of Efficacy|2|||
129799704|NCT02992132|467235203|FG001|Overall Study|Lack of Efficacy|0|||
129799705|NCT02992132|467235204|FG002|Overall Study|Lack of Efficacy|0|||
129799706|NCT02992132|467235202|FG000|Overall Study|Non-compliance with study drug|2|||
129799707|NCT02992132|467235203|FG001|Overall Study|Non-compliance with study drug|0|||
129799708|NCT02992132|467235204|FG002|Overall Study|Non-compliance with study drug|0|||
129799709|NCT02992132|467235202|FG000|Overall Study|Progressive disease|1|||
129799710|NCT02992132|467235203|FG001|Overall Study|Progressive disease|0|||
129645251|NCT01738503|466655332|FG005|Treatment Period|Adverse Event|2|||
129645252|NCT01738503|466655333|FG006|Treatment Period|Adverse Event|2|||
129890589|NCT04423393|467557476|FG006|Overall Study|Sponsor Decision|0|||
129890590|NCT04423393|467557477|FG007|Overall Study|Sponsor Decision|0|||
129890591|NCT04423393|467557478|FG008|Overall Study|Sponsor Decision|0|||
129890592|NCT04423393|467557479|FG009|Overall Study|Sponsor Decision|0|||
129890593|NCT04423393|467557480|FG010|Overall Study|Sponsor Decision|0|||
129890594|NCT04423393|467557481|FG011|Overall Study|Sponsor Decision|0|||
129890595|NCT04423393|467557482|FG012|Overall Study|Sponsor Decision|0|||
129890596|NCT04423393|467557483|FG013|Overall Study|Sponsor Decision|1|||
129890597|NCT04423393|467557484|FG014|Overall Study|Sponsor Decision|0|||
129890598|NCT04423393|467557485|FG015|Overall Study|Sponsor Decision|0|||
129890599|NCT04423393|467557486|FG016|Overall Study|Sponsor Decision|0|||
129890600|NCT04423393|467557487|FG017|Overall Study|Sponsor Decision|0|||
129890601|NCT02692235|467557490|FG000|Overall Study|Withdrawal by Subject|2|||
129890602|NCT02692235|467557491|FG001|Overall Study|Withdrawal by Subject|1|||
129890603|NCT02692235|467557490|FG000|Overall Study|Adverse Event|1|||
129890604|NCT02692235|467557491|FG001|Overall Study|Adverse Event|2|||
129890605|NCT00802841|467557492|FG000|Overall Study|Administrative problems|1|||
129890606|NCT00802841|467557493|FG001|Overall Study|Administrative problems|0|||
129890607|NCT00802841|467557492|FG000|Overall Study|Lost to Follow-up|2|||
129890608|NCT00802841|467557493|FG001|Overall Study|Lost to Follow-up|1|||
129890609|NCT00802841|467557492|FG000|Overall Study|Death|1|||
129890610|NCT00802841|467557493|FG001|Overall Study|Death|2|||
129890611|NCT00802841|467557492|FG000|Overall Study|Adverse Event|8|||
129890612|NCT00802841|467557493|FG001|Overall Study|Adverse Event|2|||
129890613|NCT00802841|467557492|FG000|Overall Study|Disease progression|7|||
129890614|NCT00802841|467557493|FG001|Overall Study|Disease progression|3|||
129890615|NCT00802841|467557492|FG000|Overall Study|Withdrawal by Subject|9|||
129890616|NCT00802841|467557493|FG001|Overall Study|Withdrawal by Subject|5|||
129890617|NCT00802841|467557492|FG000|Overall Study|Protocol deviation|2|||
129890618|NCT00802841|467557493|FG001|Overall Study|Protocol deviation|6|||
129890619|NCT00802841|467557492|FG000|Overall Study|Treatment duration completed|66|||
129890620|NCT00802841|467557493|FG001|Overall Study|Treatment duration completed|76|||
129890621|NCT02711995|467557494|FG000|Washout (90 Days)|Conflicting medication|1|||
129890622|NCT01115998|467557499|FG000|Overall Study|Lost to Follow-up|6|||
129890623|NCT01115998|467557500|FG001|Overall Study|Lost to Follow-up|6|||
129890624|NCT02819479|467557501|FG000|Overall Study|Adverse Event|2|||
129890625|NCT03531905|467557502|FG000|Overall Study|Withdrawal by Subject|3|||
129890626|NCT03531905|467557503|FG001|Overall Study|Withdrawal by Subject|3|||
129890627|NCT03531905|467557504|FG002|Overall Study|Withdrawal by Subject|2|||
129890628|NCT03531905|467557502|FG000|Overall Study|Lost to Follow-up|2|||
129890629|NCT03531905|467557503|FG001|Overall Study|Lost to Follow-up|2|||
129890630|NCT03531905|467557504|FG002|Overall Study|Lost to Follow-up|1|||
129890631|NCT03531905|467557502|FG000|Overall Study|Participant was out of town|1|||
129890632|NCT03531905|467557503|FG001|Overall Study|Participant was out of town|0|||
129645253|NCT01738503|466655327|FG000|Treatment Period|Lost to Follow-up|0|||
129645254|NCT01738503|466655328|FG001|Treatment Period|Lost to Follow-up|0|||
129890633|NCT03531905|467557504|FG002|Overall Study|Participant was out of town|0|||
129890634|NCT03531905|467557502|FG000|Overall Study|Could not speak with the participant|1|||
129890635|NCT03531905|467557503|FG001|Overall Study|Could not speak with the participant|0|||
129890636|NCT03531905|467557504|FG002|Overall Study|Could not speak with the participant|0|||
129890637|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
129890638|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
129890639|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
129443535|NCT04147234|465924422|FG004|Overall Study|Clinical deterioration|0|||
129706380|NCT01155050|466888458|FG000|Overall Study|Lost to Follow-up|15|||
129706381|NCT01155050|466888459|FG001|Overall Study|Lost to Follow-up|20|||
129706382|NCT01155050|466888460|FG002|Overall Study|Lost to Follow-up|19|||
129706383|NCT01155050|466888461|FG003|Overall Study|Lost to Follow-up|22|||
129706384|NCT00652834|466888462|FG000|Overall Study|Withdrawal by Subject|3|||
129706385|NCT00652834|466888462|FG000|Overall Study|Lost to Follow-up|2|||
129706386|NCT00320606|466888463|FG000|Overall Study|Adverse Event|1|||
129706387|NCT00320606|466888463|FG000|Overall Study|Protocol Violation|1|||
129706388|NCT00320606|466888463|FG000|Overall Study|Withdrawal by Subject|1|||
129706389|NCT00806585|466888464|FG000|Overall Study|Study terminated by Sponsor|0|||
129706390|NCT00806585|466888465|FG001|Overall Study|Study terminated by Sponsor|0|||
129706391|NCT00806585|466888466|FG002|Overall Study|Study terminated by Sponsor|1|||
129706392|NCT00806585|466888467|FG003|Overall Study|Study terminated by Sponsor|2|||
129706393|NCT00806585|466888468|FG004|Overall Study|Study terminated by Sponsor|0|||
129706394|NCT00806585|466888464|FG000|Overall Study|Protocol Violation|3|||
129706395|NCT00806585|466888465|FG001|Overall Study|Protocol Violation|1|||
129706396|NCT00806585|466888466|FG002|Overall Study|Protocol Violation|2|||
129706397|NCT00806585|466888467|FG003|Overall Study|Protocol Violation|0|||
129706398|NCT00806585|466888468|FG004|Overall Study|Protocol Violation|0|||
129706399|NCT00806585|466888464|FG000|Overall Study|Physician Decision|0|||
129706400|NCT00806585|466888465|FG001|Overall Study|Physician Decision|2|||
129706401|NCT00806585|466888466|FG002|Overall Study|Physician Decision|3|||
129890640|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
129890641|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
129890642|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
129890643|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
129890644|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
129890645|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
129890646|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
129890647|NCT01646320|467557512|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
129890648|NCT01646320|467557513|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
129890649|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
129890650|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
129890651|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
129890652|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
129890653|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
129890654|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
129890655|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
129890656|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
129890657|NCT01646320|467557512|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
129890658|NCT01646320|467557513|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
129890659|NCT01489020|467557514|FG000|Overall Study|Withdrawal by Subject|1|||
129890660|NCT01489020|467557515|FG001|Overall Study|Withdrawal by Subject|0|||
129890661|NCT01489020|467557516|FG002|Overall Study|Withdrawal by Subject|0|||
129890662|NCT01489020|467557517|FG003|Overall Study|Withdrawal by Subject|0|||
129890663|NCT01489020|467557518|FG004|Overall Study|Withdrawal by Subject|0|||
129890664|NCT01489020|467557519|FG005|Overall Study|Withdrawal by Subject|0|||
129890665|NCT01489020|467557514|FG000|Overall Study|Adverse Event|0|||
129890666|NCT01489020|467557515|FG001|Overall Study|Adverse Event|0|||
129890667|NCT01489020|467557516|FG002|Overall Study|Adverse Event|3|||
129890668|NCT01489020|467557517|FG003|Overall Study|Adverse Event|0|||
129890669|NCT01489020|467557518|FG004|Overall Study|Adverse Event|3|||
129890670|NCT01489020|467557519|FG005|Overall Study|Adverse Event|0|||
129890671|NCT01489020|467557514|FG000|Overall Study|Concomitant disease|0|||
129890672|NCT01489020|467557515|FG001|Overall Study|Concomitant disease|0|||
129890673|NCT01489020|467557516|FG002|Overall Study|Concomitant disease|0|||
129890674|NCT01489020|467557517|FG003|Overall Study|Concomitant disease|0|||
129890675|NCT01489020|467557518|FG004|Overall Study|Concomitant disease|3|||
129890676|NCT01489020|467557519|FG005|Overall Study|Concomitant disease|0|||
129890677|NCT01174550|467557520|FG000|Overall Study|Death|75|||
129890678|NCT01174550|467557521|FG001|Overall Study|Death|74|||
129890679|NCT01174550|467557520|FG000|Overall Study|Lost to Follow-up|652|||
129890680|NCT01174550|467557521|FG001|Overall Study|Lost to Follow-up|510|||
129890681|NCT01174550|467557520|FG000|Overall Study|Withdrawal by Subject|543|||
129890682|NCT01174550|467557521|FG001|Overall Study|Withdrawal by Subject|289|||
129890683|NCT01536262|467557522|FG000|Overall Study|Adverse Event|6|||
129890684|NCT01536262|467557523|FG001|Overall Study|Adverse Event|1|||
129890685|NCT01536262|467557524|FG002|Overall Study|Adverse Event|2|||
129890686|NCT01536262|467557522|FG000|Overall Study|Withdrawal by Subject|1|||
129890687|NCT01536262|467557523|FG001|Overall Study|Withdrawal by Subject|1|||
129890688|NCT01536262|467557524|FG002|Overall Study|Withdrawal by Subject|0|||
129890689|NCT01536262|467557522|FG000|Overall Study|Other than stated above|1|||
129890690|NCT01536262|467557523|FG001|Overall Study|Other than stated above|0|||
129890691|NCT01536262|467557524|FG002|Overall Study|Other than stated above|0|||
129890692|NCT05257837|467557528|FG000|Overall Study|Excluded (did not find the guns)|4|||
129890693|NCT05257837|467557529|FG001|Overall Study|Excluded (did not find the guns)|2|||
129890694|NCT05257837|467557530|FG002|Overall Study|Excluded (did not find the guns)|4|||
129890695|NCT05257837|467557531|FG003|Overall Study|Excluded (did not find the guns)|0|||
129890696|NCT01781611|467557532|FG000|Overall Study|Adverse Event|4|||
129890697|NCT01781611|467557533|FG001|Overall Study|Adverse Event|0|||
129890698|NCT01625338|467557534|FG000|Overall Study|Enrolled but not Treated|0|||
129890699|NCT01625338|467557535|FG001|Overall Study|Enrolled but not Treated|0|||
129890700|NCT01625338|467557536|FG002|Overall Study|Enrolled but not Treated|1|||
129890701|NCT01625338|467557534|FG000|Overall Study|Efficacy Failure|27|||
129890702|NCT01625338|467557535|FG001|Overall Study|Efficacy Failure|39|||
129890703|NCT01625338|467557536|FG002|Overall Study|Efficacy Failure|31|||
129890704|NCT01625338|467557534|FG000|Overall Study|Lost to Follow-up|3|||
129890705|NCT01625338|467557535|FG001|Overall Study|Lost to Follow-up|3|||
129890706|NCT01625338|467557536|FG002|Overall Study|Lost to Follow-up|2|||
129890707|NCT01625338|467557534|FG000|Overall Study|Investigator Decision|0|||
129890708|NCT01625338|467557535|FG001|Overall Study|Investigator Decision|2|||
129890709|NCT01625338|467557536|FG002|Overall Study|Investigator Decision|1|||
129890710|NCT01625338|467557534|FG000|Overall Study|Subject Withdrew Consent|1|||
129890711|NCT01625338|467557535|FG001|Overall Study|Subject Withdrew Consent|0|||
129890712|NCT01625338|467557536|FG002|Overall Study|Subject Withdrew Consent|2|||
129890713|NCT01625338|467557534|FG000|Overall Study|Adverse Event|1|||
129799711|NCT02992132|467235204|FG002|Overall Study|Progressive disease|0|||
129799712|NCT02992132|467235202|FG000|Overall Study|Protocol Violation|2|||
129799713|NCT02992132|467235203|FG001|Overall Study|Protocol Violation|2|||
129799714|NCT02992132|467235204|FG002|Overall Study|Protocol Violation|0|||
129799715|NCT02992132|467235202|FG000|Overall Study|Caregiver withdrew consent|2|||
129799716|NCT02992132|467235203|FG001|Overall Study|Caregiver withdrew consent|3|||
129799717|NCT02992132|467235204|FG002|Overall Study|Caregiver withdrew consent|2|||
129799718|NCT02992132|467235202|FG000|Overall Study|Withdrawal by Subject|0|||
129799719|NCT02992132|467235203|FG001|Overall Study|Withdrawal by Subject|2|||
129799720|NCT02992132|467235204|FG002|Overall Study|Withdrawal by Subject|1|||
129799721|NCT02992132|467235202|FG000|Overall Study|Physician Decision|0|||
129799722|NCT02992132|467235203|FG001|Overall Study|Physician Decision|0|||
129799723|NCT02992132|467235204|FG002|Overall Study|Physician Decision|1|||
129799724|NCT00620464|467235205|FG000|Overall Study|Adverse Event|15|||
129799725|NCT00620464|467235206|FG001|Overall Study|Adverse Event|17|||
129799726|NCT00620464|467235205|FG000|Overall Study|Lost to Follow-up|1|||
129799727|NCT00620464|467235206|FG001|Overall Study|Lost to Follow-up|1|||
129799728|NCT00620464|467235205|FG000|Overall Study|Planning Pregnancy|1|||
129799729|NCT00620464|467235206|FG001|Overall Study|Planning Pregnancy|4|||
129799730|NCT00620464|467235205|FG000|Overall Study|Personal|2|||
129799731|NCT00620464|467235206|FG001|Overall Study|Personal|2|||
129799732|NCT00620464|467235205|FG000|Overall Study|Used prohibited medication|1|||
129799733|NCT00620464|467235206|FG001|Overall Study|Used prohibited medication|0|||
129799734|NCT00467610|467235207|FG000|Overall Study|Withdrawal by Subject|1|||
129799735|NCT01369615|467235208|FG000|Overall Study|Withdrawal by Subject|0|||
129799736|NCT01369615|467235209|FG001|Overall Study|Withdrawal by Subject|1|||
129799737|NCT01369615|467235208|FG000|Overall Study|Lost to Follow-up|0|||
129799738|NCT01369615|467235209|FG001|Overall Study|Lost to Follow-up|1|||
129799739|NCT04263454|467235210|FG000|Overall Study|Adverse Event|0|||
129799740|NCT04263454|467235211|FG001|Overall Study|Adverse Event|2|||
129799741|NCT04263454|467235210|FG000|Overall Study|Physician Decision|3|||
129799742|NCT04263454|467235211|FG001|Overall Study|Physician Decision|5|||
129799743|NCT04263454|467235210|FG000|Overall Study|Poor Data Quality|0|||
129799744|NCT04263454|467235211|FG001|Overall Study|Poor Data Quality|1|||
129799745|NCT00986479|467235212|FG000|Period 1|Improved mood|1|||
129799746|NCT00986479|467235213|FG001|Period 1|Improved mood|0|||
129799747|NCT00986479|467235212|FG000|Period 1|Administrative reasons|1|||
129799748|NCT00986479|467235213|FG001|Period 1|Administrative reasons|0|||
129799749|NCT00237185|467235214|FG000|Core|Adverse Event|3|||
129799750|NCT00237185|467235215|FG001|Core|Adverse Event|4|||
129799751|NCT00237185|467235214|FG000|Core|Abnormal laboratory value|0|||
129799752|NCT00237185|467235215|FG001|Core|Abnormal laboratory value|4|||
129799753|NCT00237185|467235214|FG000|Core|Abnormal test procedure results|1|||
129799754|NCT00237185|467235215|FG001|Core|Abnormal test procedure results|0|||
129799755|NCT00237185|467235214|FG000|Core|Lack of Efficacy|30|||
129799756|NCT00237185|467235215|FG001|Core|Lack of Efficacy|23|||
129799757|NCT00237185|467235214|FG000|Core|Protocol Violation|1|||
129799758|NCT00237185|467235215|FG001|Core|Protocol Violation|1|||
129799759|NCT00237185|467235214|FG000|Core|Withdrawal by Subject|4|||
129799760|NCT00237185|467235215|FG001|Core|Withdrawal by Subject|4|||
129799761|NCT00237185|467235214|FG000|Core|Administrative problems|0|||
129799762|NCT00237185|467235215|FG001|Core|Administrative problems|1|||
129799763|NCT00237185|467235214|FG000|Core|Death|4|||
129799764|NCT00237185|467235215|FG001|Core|Death|0|||
129799765|NCT00237185|467235214|FG000|Core|Determined ineligible post randomization|1|||
129799766|NCT00237185|467235215|FG001|Core|Determined ineligible post randomization|0|||
129799767|NCT00237185|467235214|FG000|Extension|Adverse Event|1|||
129799768|NCT00237185|467235215|FG001|Extension|Adverse Event|0|||
129799769|NCT00237185|467235214|FG000|Extension|Abnormal laboratory value|0|||
129799770|NCT00237185|467235215|FG001|Extension|Abnormal laboratory value|1|||
129799771|NCT00237185|467235214|FG000|Extension|Lack of Efficacy|9|||
129799772|NCT00237185|467235215|FG001|Extension|Lack of Efficacy|14|||
129799773|NCT00237185|467235214|FG000|Extension|Condition no longer required study drug|0|||
129799774|NCT00237185|467235215|FG001|Extension|Condition no longer required study drug|1|||
129799775|NCT00237185|467235214|FG000|Extension|Withdrawal by Subject|3|||
129799776|NCT00237185|467235215|FG001|Extension|Withdrawal by Subject|2|||
129799777|NCT00237185|467235214|FG000|Extension|Lost to Follow-up|1|||
129799778|NCT00237185|467235215|FG001|Extension|Lost to Follow-up|0|||
129799779|NCT00237185|467235214|FG000|Extension|Administrative problems|1|||
129799780|NCT00237185|467235215|FG001|Extension|Administrative problems|0|||
129799781|NCT00237185|467235214|FG000|Extension|Death|1|||
129799782|NCT00237185|467235215|FG001|Extension|Death|1|||
129799783|NCT02035475|467235216|FG000|Overall Study|Withdrawal by Subject|4|||
129799784|NCT02035475|467235216|FG000|Overall Study|Physician Decision|1|||
129799785|NCT02035475|467235216|FG000|Overall Study|Equipment Error|1|||
129799786|NCT01231347|467235217|FG000|Overall Study|Full Consent withdrawn|19|||
129799787|NCT01231347|467235218|FG001|Overall Study|Full Consent withdrawn|19|||
129799788|NCT01231347|467235219|FG002|Overall Study|Full Consent withdrawn|11|||
129799789|NCT01231347|467235217|FG000|Overall Study|Lost to Follow-up|4|||
129799790|NCT01231347|467235218|FG001|Overall Study|Lost to Follow-up|2|||
129645255|NCT01738503|466655329|FG002|Treatment Period|Lost to Follow-up|3|||
129645256|NCT01738503|466655330|FG003|Treatment Period|Lost to Follow-up|4|||
129645257|NCT01738503|466655331|FG004|Treatment Period|Lost to Follow-up|1|||
129645258|NCT01738503|466655332|FG005|Treatment Period|Lost to Follow-up|1|||
129645259|NCT01738503|466655333|FG006|Treatment Period|Lost to Follow-up|5|||
129645260|NCT01738503|466655327|FG000|Treatment Period|Withdrawal by Subject|0|||
129645261|NCT01738503|466655328|FG001|Treatment Period|Withdrawal by Subject|1|||
129645262|NCT01738503|466655329|FG002|Treatment Period|Withdrawal by Subject|0|||
129645263|NCT01738503|466655330|FG003|Treatment Period|Withdrawal by Subject|1|||
129645264|NCT01738503|466655331|FG004|Treatment Period|Withdrawal by Subject|1|||
129645265|NCT01738503|466655332|FG005|Treatment Period|Withdrawal by Subject|1|||
129645266|NCT01738503|466655333|FG006|Treatment Period|Withdrawal by Subject|1|||
129645267|NCT01738503|466655327|FG000|Treatment Period|Protocol Violation|0|||
129645268|NCT01738503|466655328|FG001|Treatment Period|Protocol Violation|3|||
129645269|NCT01738503|466655329|FG002|Treatment Period|Protocol Violation|1|||
129645270|NCT01738503|466655330|FG003|Treatment Period|Protocol Violation|0|||
129645271|NCT01738503|466655331|FG004|Treatment Period|Protocol Violation|4|||
129645272|NCT01738503|466655332|FG005|Treatment Period|Protocol Violation|2|||
129645273|NCT01738503|466655333|FG006|Treatment Period|Protocol Violation|0|||
129645274|NCT01738503|466655327|FG000|Treatment Period|Other|0|||
129645275|NCT01738503|466655328|FG001|Treatment Period|Other|0|||
129645276|NCT01738503|466655329|FG002|Treatment Period|Other|1|||
129645277|NCT01738503|466655330|FG003|Treatment Period|Other|0|||
129645278|NCT01738503|466655331|FG004|Treatment Period|Other|0|||
129645279|NCT01738503|466655332|FG005|Treatment Period|Other|0|||
129645280|NCT01738503|466655333|FG006|Treatment Period|Other|0|||
129645281|NCT01738503|466655327|FG000|PET Imaging Sub-study|Adverse Event|0|||
129645282|NCT01738503|466655328|FG001|PET Imaging Sub-study|Adverse Event|0|||
129645283|NCT01738503|466655329|FG002|PET Imaging Sub-study|Adverse Event|0|||
129645284|NCT01738503|466655330|FG003|PET Imaging Sub-study|Adverse Event|0|||
129645285|NCT01738503|466655331|FG004|PET Imaging Sub-study|Adverse Event|0|||
129645286|NCT01738503|466655332|FG005|PET Imaging Sub-study|Adverse Event|1|||
129645287|NCT01738503|466655333|FG006|PET Imaging Sub-study|Adverse Event|0|||
129645288|NCT01738503|466655327|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129645289|NCT01738503|466655328|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129645290|NCT01738503|466655329|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129645291|NCT01738503|466655330|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129645292|NCT01738503|466655331|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
129645293|NCT01738503|466655332|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
129645294|NCT01738503|466655333|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
129645295|NCT01340027|466655335|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
129645296|NCT01340027|466655336|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
129645297|NCT01340027|466655337|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
129645298|NCT01340027|466655338|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
129645299|NCT01340027|466655339|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
129645300|NCT01340027|466655340|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
129645301|NCT01340027|466655341|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
129645302|NCT01340027|466655342|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
129645303|NCT01340027|466655343|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
129645304|NCT01340027|466655344|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
129645305|NCT01340027|466655345|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
129645306|NCT01340027|466655346|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
129645307|NCT01340027|466655335|FG000|Overall Study|Adverse Event|0|||
129645308|NCT01340027|466655336|FG001|Overall Study|Adverse Event|1|||
129645309|NCT01340027|466655337|FG002|Overall Study|Adverse Event|2|||
129645310|NCT01340027|466655338|FG003|Overall Study|Adverse Event|0|||
129645311|NCT01340027|466655339|FG004|Overall Study|Adverse Event|1|||
129645312|NCT01340027|466655340|FG005|Overall Study|Adverse Event|2|||
129645313|NCT01340027|466655341|FG006|Overall Study|Adverse Event|2|||
129645314|NCT01340027|466655342|FG007|Overall Study|Adverse Event|1|||
129645315|NCT01340027|466655343|FG008|Overall Study|Adverse Event|4|||
129645316|NCT01340027|466655344|FG009|Overall Study|Adverse Event|1|||
129645317|NCT01340027|466655345|FG010|Overall Study|Adverse Event|1|||
129645318|NCT01340027|466655346|FG011|Overall Study|Adverse Event|3|||
129645319|NCT01340027|466655335|FG000|Overall Study|Lack of Efficacy|0|||
129645320|NCT01340027|466655336|FG001|Overall Study|Lack of Efficacy|0|||
129645321|NCT01340027|466655337|FG002|Overall Study|Lack of Efficacy|0|||
129799791|NCT01231347|467235219|FG002|Overall Study|Lost to Follow-up|2|||
129645322|NCT01340027|466655338|FG003|Overall Study|Lack of Efficacy|0|||
129645323|NCT01340027|466655339|FG004|Overall Study|Lack of Efficacy|0|||
129645324|NCT01340027|466655340|FG005|Overall Study|Lack of Efficacy|0|||
129645325|NCT01340027|466655341|FG006|Overall Study|Lack of Efficacy|1|||
129645326|NCT01340027|466655342|FG007|Overall Study|Lack of Efficacy|1|||
129799792|NCT01231347|467235217|FG000|Overall Study|Death|202|||
129799793|NCT01231347|467235218|FG001|Overall Study|Death|210|||
129799794|NCT01231347|467235219|FG002|Overall Study|Death|101|||
129799795|NCT01231347|467235217|FG000|Overall Study|other event|7|||
129645327|NCT01340027|466655343|FG008|Overall Study|Lack of Efficacy|1|||
129645328|NCT01340027|466655344|FG009|Overall Study|Lack of Efficacy|0|||
129645329|NCT01340027|466655345|FG010|Overall Study|Lack of Efficacy|0|||
129645330|NCT01340027|466655346|FG011|Overall Study|Lack of Efficacy|0|||
129443536|NCT04147234|465924423|FG005|Overall Study|Clinical deterioration|0|||
129645331|NCT01340027|466655335|FG000|Overall Study|Lost to Follow-up|0|||
129645332|NCT01340027|466655336|FG001|Overall Study|Lost to Follow-up|1|||
129645333|NCT01340027|466655337|FG002|Overall Study|Lost to Follow-up|0|||
129645334|NCT01340027|466655338|FG003|Overall Study|Lost to Follow-up|0|||
129645335|NCT01340027|466655339|FG004|Overall Study|Lost to Follow-up|0|||
129645336|NCT01340027|466655340|FG005|Overall Study|Lost to Follow-up|0|||
129645337|NCT01340027|466655341|FG006|Overall Study|Lost to Follow-up|1|||
129645338|NCT01340027|466655342|FG007|Overall Study|Lost to Follow-up|0|||
129645339|NCT01340027|466655343|FG008|Overall Study|Lost to Follow-up|0|||
129645340|NCT01340027|466655344|FG009|Overall Study|Lost to Follow-up|1|||
129645341|NCT01340027|466655345|FG010|Overall Study|Lost to Follow-up|0|||
129645342|NCT01340027|466655346|FG011|Overall Study|Lost to Follow-up|0|||
129645343|NCT01340027|466655335|FG000|Overall Study|Protocol Violation|1|||
129645344|NCT01340027|466655336|FG001|Overall Study|Protocol Violation|2|||
129645345|NCT01340027|466655337|FG002|Overall Study|Protocol Violation|0|||
129645346|NCT01340027|466655338|FG003|Overall Study|Protocol Violation|0|||
129799796|NCT01231347|467235218|FG001|Overall Study|other event|9|||
129799797|NCT01231347|467235219|FG002|Overall Study|other event|3|||
129799798|NCT01702571|467235220|FG000|Overall Study|Death|1067|||
129799799|NCT01702571|467235221|FG001|Overall Study|Death|76|||
129799800|NCT01702571|467235220|FG000|Overall Study|Lost to Follow-up|144|||
129799801|NCT01702571|467235221|FG001|Overall Study|Lost to Follow-up|10|||
129799802|NCT01702571|467235220|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
129799803|NCT01702571|467235221|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
129799804|NCT01702571|467235220|FG000|Overall Study|Investigator Decision|5|||
129799805|NCT01702571|467235221|FG001|Overall Study|Investigator Decision|0|||
129799806|NCT01702571|467235220|FG000|Overall Study|Not Classifiable|1|||
129799807|NCT01702571|467235221|FG001|Overall Study|Not Classifiable|0|||
129799808|NCT01702571|467235220|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
129799809|NCT01702571|467235221|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
129799810|NCT01702571|467235220|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
129799811|NCT01702571|467235221|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
129799812|NCT01702571|467235220|FG000|Overall Study|Progressive Disease|3|||
129799813|NCT01702571|467235221|FG001|Overall Study|Progressive Disease|0|||
129799814|NCT01702571|467235220|FG000|Overall Study|Protocol Violation|2|||
129799815|NCT01702571|467235221|FG001|Overall Study|Protocol Violation|0|||
129799816|NCT01702571|467235220|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
129799817|NCT01702571|467235221|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
129799818|NCT01702571|467235220|FG000|Overall Study|Termination By Sponsor|4|||
129799819|NCT01702571|467235221|FG001|Overall Study|Termination By Sponsor|0|||
129799820|NCT01702571|467235220|FG000|Overall Study|Withdrawal by Subject|177|||
129799821|NCT01702571|467235221|FG001|Overall Study|Withdrawal by Subject|29|||
129799822|NCT02322021|467235222|FG000|Core Phase|Adverse Event|1|||
129799823|NCT02322021|467235223|FG001|Core Phase|Adverse Event|3|||
129799824|NCT02322021|467235224|FG002|Core Phase|Adverse Event|4|||
129645347|NCT01340027|466655339|FG004|Overall Study|Protocol Violation|6|||
129645348|NCT01340027|466655340|FG005|Overall Study|Protocol Violation|0|||
129799825|NCT02322021|467235225|FG003|Core Phase|Adverse Event|2|||
129799826|NCT02322021|467235226|FG004|Core Phase|Adverse Event|0|||
129799827|NCT02322021|467235222|FG000|Core Phase|Participant Choice|4|||
129799828|NCT02322021|467235223|FG001|Core Phase|Participant Choice|5|||
129645349|NCT01340027|466655341|FG006|Overall Study|Protocol Violation|0|||
129645350|NCT01340027|466655342|FG007|Overall Study|Protocol Violation|1|||
129645351|NCT01340027|466655343|FG008|Overall Study|Protocol Violation|2|||
129645352|NCT01340027|466655344|FG009|Overall Study|Protocol Violation|2|||
129645353|NCT01340027|466655345|FG010|Overall Study|Protocol Violation|0|||
129645354|NCT01340027|466655346|FG011|Overall Study|Protocol Violation|0|||
129645355|NCT01340027|466655335|FG000|Overall Study|Withdrawal by Subject|4|||
129799829|NCT02322021|467235224|FG002|Core Phase|Participant Choice|4|||
129799830|NCT02322021|467235225|FG003|Core Phase|Participant Choice|2|||
129645356|NCT01340027|466655336|FG001|Overall Study|Withdrawal by Subject|3|||
129645357|NCT01340027|466655337|FG002|Overall Study|Withdrawal by Subject|1|||
129645358|NCT01340027|466655338|FG003|Overall Study|Withdrawal by Subject|3|||
129799831|NCT02322021|467235226|FG004|Core Phase|Participant Choice|0|||
129799832|NCT02322021|467235222|FG000|Core Phase|Lost to Follow-up|0|||
129799833|NCT02322021|467235223|FG001|Core Phase|Lost to Follow-up|0|||
129799834|NCT02322021|467235224|FG002|Core Phase|Lost to Follow-up|0|||
129799835|NCT02322021|467235225|FG003|Core Phase|Lost to Follow-up|1|||
129799836|NCT02322021|467235226|FG004|Core Phase|Lost to Follow-up|0|||
129799837|NCT02322021|467235222|FG000|Core Phase|Other|0|||
129799838|NCT02322021|467235223|FG001|Core Phase|Other|0|||
129799839|NCT02322021|467235224|FG002|Core Phase|Other|1|||
129799840|NCT02322021|467235225|FG003|Core Phase|Other|0|||
129799841|NCT02322021|467235226|FG004|Core Phase|Other|0|||
129799842|NCT02322021|467235222|FG000|Extension Phase|Adverse Event|0|||
129799843|NCT02322021|467235223|FG001|Extension Phase|Adverse Event|0|||
129799844|NCT02322021|467235224|FG002|Extension Phase|Adverse Event|0|||
129799845|NCT02322021|467235225|FG003|Extension Phase|Adverse Event|0|||
129799846|NCT02322021|467235226|FG004|Extension Phase|Adverse Event|3|||
129799847|NCT02322021|467235222|FG000|Extension Phase|Participant Choice|0|||
129890714|NCT01625338|467557535|FG001|Overall Study|Adverse Event|0|||
129890715|NCT01625338|467557536|FG002|Overall Study|Adverse Event|1|||
129890716|NCT01625338|467557534|FG000|Overall Study|Study Discontinued by Sponsor|0|||
129890717|NCT01625338|467557535|FG001|Overall Study|Study Discontinued by Sponsor|0|||
129890718|NCT01625338|467557536|FG002|Overall Study|Study Discontinued by Sponsor|1|||
129799848|NCT02322021|467235223|FG001|Extension Phase|Participant Choice|0|||
129799849|NCT02322021|467235224|FG002|Extension Phase|Participant Choice|0|||
129799850|NCT02322021|467235225|FG003|Extension Phase|Participant Choice|0|||
129645359|NCT01340027|466655339|FG004|Overall Study|Withdrawal by Subject|3|||
129645360|NCT01340027|466655340|FG005|Overall Study|Withdrawal by Subject|2|||
129645361|NCT01340027|466655341|FG006|Overall Study|Withdrawal by Subject|3|||
129645362|NCT01340027|466655342|FG007|Overall Study|Withdrawal by Subject|4|||
129645363|NCT01340027|466655343|FG008|Overall Study|Withdrawal by Subject|1|||
129645364|NCT01340027|466655344|FG009|Overall Study|Withdrawal by Subject|2|||
129443537|NCT04147234|465924424|FG006|Overall Study|Clinical deterioration|0|||
129645365|NCT01340027|466655345|FG010|Overall Study|Withdrawal by Subject|0|||
129645366|NCT01340027|466655346|FG011|Overall Study|Withdrawal by Subject|1|||
129645367|NCT01340027|466655335|FG000|Overall Study|Miscellaneous|0|||
129645368|NCT01340027|466655336|FG001|Overall Study|Miscellaneous|0|||
129645369|NCT01340027|466655337|FG002|Overall Study|Miscellaneous|0|||
129645370|NCT01340027|466655338|FG003|Overall Study|Miscellaneous|1|||
129645371|NCT01340027|466655339|FG004|Overall Study|Miscellaneous|0|||
129645372|NCT01340027|466655340|FG005|Overall Study|Miscellaneous|0|||
129645373|NCT01340027|466655341|FG006|Overall Study|Miscellaneous|0|||
129645374|NCT01340027|466655342|FG007|Overall Study|Miscellaneous|0|||
129645375|NCT01340027|466655343|FG008|Overall Study|Miscellaneous|0|||
129645376|NCT01340027|466655344|FG009|Overall Study|Miscellaneous|0|||
129645377|NCT01340027|466655345|FG010|Overall Study|Miscellaneous|1|||
129645378|NCT01340027|466655346|FG011|Overall Study|Miscellaneous|0|||
129645379|NCT03005327|466655347|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
129645380|NCT03005327|466655348|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
129645381|NCT03005327|466655349|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
129645382|NCT03005327|466655350|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
129645383|NCT03005327|466655347|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129645384|NCT03005327|466655348|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129645385|NCT03005327|466655349|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129645386|NCT03005327|466655350|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129645387|NCT04687072|466655351|FG000|Overall Study|Adverse Event|2|||
129645388|NCT04687072|466655352|FG001|Overall Study|Adverse Event|0|||
129645389|NCT04687072|466655351|FG000|Overall Study|Death|1|||
129645390|NCT04687072|466655352|FG001|Overall Study|Death|0|||
129645391|NCT04687072|466655351|FG000|Overall Study|Lack of Efficacy|2|||
129645392|NCT04687072|466655352|FG001|Overall Study|Lack of Efficacy|1|||
129645393|NCT04687072|466655351|FG000|Overall Study|Physician Decision|1|||
129645394|NCT04687072|466655352|FG001|Overall Study|Physician Decision|0|||
129645395|NCT04687072|466655351|FG000|Overall Study|Pregnancy|1|||
129443538|NCT04147234|465924418|FG000|Overall Study|Withdrawal by Subject|0|||
129645396|NCT04687072|466655352|FG001|Overall Study|Pregnancy|0|||
129645397|NCT04687072|466655351|FG000|Overall Study|Requires Prohibited Medication|2|||
129645398|NCT04687072|466655352|FG001|Overall Study|Requires Prohibited Medication|0|||
129645399|NCT04687072|466655351|FG000|Overall Study|Withdrawal of Consent|11|||
129645400|NCT04687072|466655352|FG001|Overall Study|Withdrawal of Consent|6|||
129645401|NCT04687072|466655351|FG000|Overall Study|Miscellaneous|4|||
129645402|NCT04687072|466655352|FG001|Overall Study|Miscellaneous|1|||
129645403|NCT00915876|466655353|FG000|Overall Study|Adverse Event|0|||
129645404|NCT00915876|466655354|FG001|Overall Study|Adverse Event|1|||
129645405|NCT02572076|466655358|FG000|Overall Study|Protocol Violation|1|||
129645406|NCT00533702|466655361|FG000|Overall Study|Withdrawal by Subject|3|||
129645407|NCT00533702|466655362|FG001|Overall Study|Withdrawal by Subject|1|||
129645408|NCT00533702|466655361|FG000|Overall Study|Found ineligible after randomization|2|||
129645409|NCT00533702|466655362|FG001|Overall Study|Found ineligible after randomization|1|||
129645410|NCT06366087|466657441|FG000|Overall Study|Withdrawal by Subject|0|||
129645411|NCT06366087|466657442|FG001|Overall Study|Withdrawal by Subject|1|||
129645412|NCT00860249|466657444|FG000|Overall Study|trial was terminated prior to completion|21|||
129645413|NCT00860249|466657445|FG001|Overall Study|trial was terminated prior to completion|18|||
129645414|NCT00860249|466657446|FG002|Overall Study|trial was terminated prior to completion|21|||
129645415|NCT00174967|466657447|FG000|Overall Study|Adverse Event|1|||
129645416|NCT00174967|466657448|FG001|Overall Study|Adverse Event|2|||
129645417|NCT00174967|466657449|FG002|Overall Study|Adverse Event|2|||
129645418|NCT00174967|466657450|FG003|Overall Study|Adverse Event|1|||
129645419|NCT00174967|466657447|FG000|Overall Study|Gout Flare|0|||
129645420|NCT00174967|466657448|FG001|Overall Study|Gout Flare|0|||
129645421|NCT00174967|466657449|FG002|Overall Study|Gout Flare|0|||
129645422|NCT00174967|466657450|FG003|Overall Study|Gout Flare|1|||
129645423|NCT00174967|466657447|FG000|Overall Study|Other|0|||
129645424|NCT00174967|466657448|FG001|Overall Study|Other|1|||
129645425|NCT00174967|466657449|FG002|Overall Study|Other|0|||
129645426|NCT00174967|466657450|FG003|Overall Study|Other|0|||
129645427|NCT04934189|466657451|FG000|Overall Study|Lost to Follow-up|4|||
129645428|NCT04934189|466657451|FG000|Overall Study|Withdrawal by Subject|17|||
129645429|NCT01286168|466657459|FG000|Overall Study|Withdrawal by Subject|1|||
129645430|NCT01286168|466657459|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
129645431|NCT00843037|466657461|FG000|Overall Study|Lost to Follow-up|1|||
129645432|NCT02091960|466657462|FG000|Overall Study|Death|7|||
129645433|NCT02091960|466657462|FG000|Overall Study|Withdrawal by Subject|1|||
129645434|NCT02091960|466657462|FG000|Overall Study|Miscellaneous Reasons|37|||
129645435|NCT02738879|466657473|FG000|Overall Study|Adverse Event|1|||
129645436|NCT02738879|466657474|FG001|Overall Study|Adverse Event|1|||
129645437|NCT02738879|466657473|FG000|Overall Study|Death|0|||
129645438|NCT02738879|466657474|FG001|Overall Study|Death|2|||
129645439|NCT02738879|466657473|FG000|Overall Study|Lost to Follow-up|1|||
129645440|NCT02738879|466657474|FG001|Overall Study|Lost to Follow-up|5|||
129645441|NCT02738879|466657473|FG000|Overall Study|Protocol Violation|1|||
129706402|NCT00806585|466888467|FG003|Overall Study|Physician Decision|0|||
129706403|NCT00806585|466888468|FG004|Overall Study|Physician Decision|1|||
129645442|NCT02738879|466657474|FG001|Overall Study|Protocol Violation|3|||
129645443|NCT02738879|466657473|FG000|Overall Study|Physician Decision|3|||
129645444|NCT02738879|466657474|FG001|Overall Study|Physician Decision|4|||
129645445|NCT02738879|466657473|FG000|Overall Study|Pregnancy|0|||
129645446|NCT02738879|466657474|FG001|Overall Study|Pregnancy|1|||
129645447|NCT02738879|466657473|FG000|Overall Study|Screen Failure|1|||
129645448|NCT02738879|466657474|FG001|Overall Study|Screen Failure|2|||
129645449|NCT02738879|466657473|FG000|Overall Study|Site Discontinued Study Participation|1|||
129645450|NCT02738879|466657474|FG001|Overall Study|Site Discontinued Study Participation|0|||
129645451|NCT02738879|466657473|FG000|Overall Study|Withdrawal by Subject|5|||
129645452|NCT02738879|466657474|FG001|Overall Study|Withdrawal by Subject|7|||
129645453|NCT01438294|466657475|FG000|Overall Study|Lost to Follow-up|3|||
129645454|NCT01438294|466657476|FG001|Overall Study|Lost to Follow-up|7|||
129645455|NCT01346189|466657479|FG000|Overall Study|Withdrawal by Subject|7|||
129645456|NCT01346189|466657480|FG001|Overall Study|Withdrawal by Subject|5|||
129645457|NCT01346189|466657481|FG002|Overall Study|Withdrawal by Subject|3|||
129645458|NCT01346189|466657482|FG003|Overall Study|Withdrawal by Subject|5|||
129645459|NCT01346189|466657479|FG000|Overall Study|Physician Decision|4|||
129645460|NCT01346189|466657480|FG001|Overall Study|Physician Decision|0|||
129645461|NCT01346189|466657481|FG002|Overall Study|Physician Decision|0|||
129645462|NCT01346189|466657482|FG003|Overall Study|Physician Decision|0|||
129645463|NCT01346189|466657479|FG000|Overall Study|Moved|3|||
129645464|NCT01346189|466657480|FG001|Overall Study|Moved|0|||
129645465|NCT01346189|466657481|FG002|Overall Study|Moved|4|||
129645466|NCT01346189|466657482|FG003|Overall Study|Moved|0|||
129645467|NCT01346189|466657479|FG000|Overall Study|Other|2|||
129645468|NCT01346189|466657480|FG001|Overall Study|Other|4|||
129645469|NCT01346189|466657481|FG002|Overall Study|Other|7|||
129645470|NCT01346189|466657482|FG003|Overall Study|Other|3|||
129645471|NCT01346189|466657479|FG000|Overall Study|Death|0|||
129645472|NCT01346189|466657480|FG001|Overall Study|Death|3|||
129645473|NCT01346189|466657481|FG002|Overall Study|Death|0|||
129645474|NCT01346189|466657482|FG003|Overall Study|Death|0|||
129645475|NCT01346189|466657479|FG000|Overall Study|Non-health system primary care physician|0|||
129645476|NCT01346189|466657480|FG001|Overall Study|Non-health system primary care physician|5|||
129645477|NCT01346189|466657481|FG002|Overall Study|Non-health system primary care physician|0|||
129645478|NCT01346189|466657482|FG003|Overall Study|Non-health system primary care physician|0|||
129645479|NCT01346189|466657479|FG000|Overall Study|Travel|0|||
129645480|NCT01346189|466657480|FG001|Overall Study|Travel|0|||
129799851|NCT02322021|467235226|FG004|Extension Phase|Participant Choice|6|||
129799852|NCT02322021|467235222|FG000|Extension Phase|Other|0|||
129799853|NCT02322021|467235223|FG001|Extension Phase|Other|0|||
129799854|NCT02322021|467235224|FG002|Extension Phase|Other|0|||
129799855|NCT02322021|467235225|FG003|Extension Phase|Other|0|||
129799856|NCT02322021|467235226|FG004|Extension Phase|Other|3|||
129799857|NCT02322021|467235222|FG000|Extension Phase|Lost to Follow-up|0|||
129799858|NCT02322021|467235223|FG001|Extension Phase|Lost to Follow-up|0|||
129645481|NCT01346189|466657481|FG002|Overall Study|Travel|0|||
129645482|NCT01346189|466657482|FG003|Overall Study|Travel|3|||
129645483|NCT01730534|466657483|FG000|Overall Study|Withdrawal by Subject|97|||
129645484|NCT01730534|466657484|FG001|Overall Study|Withdrawal by Subject|127|||
129645485|NCT01730534|466657483|FG000|Overall Study|Lost to Follow-up|12|||
129645486|NCT01730534|466657484|FG001|Overall Study|Lost to Follow-up|18|||
129645487|NCT01895608|466657485|FG000|Overall Study|change in health status|0|||
129645488|NCT01895608|466657486|FG001|Overall Study|change in health status|1|||
129645489|NCT01895608|466657487|FG002|Overall Study|change in health status|1|||
129645490|NCT01895608|466657488|FG003|Overall Study|change in health status|0|||
129645491|NCT01895608|466657485|FG000|Overall Study|Withdrawal by Subject|0|||
129645492|NCT01895608|466657486|FG001|Overall Study|Withdrawal by Subject|0|||
129645493|NCT01895608|466657487|FG002|Overall Study|Withdrawal by Subject|2|||
129645494|NCT01895608|466657488|FG003|Overall Study|Withdrawal by Subject|0|||
129645495|NCT02855359|466657491|FG000|Overall Study|Death|2|||
129645496|NCT02855359|466657492|FG001|Overall Study|Death|2|||
129645497|NCT02855359|466657493|FG002|Overall Study|Death|0|||
129645498|NCT02855359|466657494|FG003|Overall Study|Death|0|||
129645499|NCT02855359|466657491|FG000|Overall Study|Study Termination by Sponsor|9|||
129645500|NCT02855359|466657492|FG001|Overall Study|Study Termination by Sponsor|11|||
129645501|NCT02855359|466657493|FG002|Overall Study|Study Termination by Sponsor|0|||
129645502|NCT02855359|466657494|FG003|Overall Study|Study Termination by Sponsor|0|||
129645503|NCT02833844|466657495|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129799859|NCT02322021|467235224|FG002|Extension Phase|Lost to Follow-up|0|||
129799860|NCT02322021|467235225|FG003|Extension Phase|Lost to Follow-up|0|||
129645504|NCT02833844|466657496|FG001|Double-Blind Period|Withdrawal by Subject|3|||
129645505|NCT02833844|466657495|FG000|Double-Blind Period|Protocol Violation|0|||
129645506|NCT02833844|466657496|FG001|Double-Blind Period|Protocol Violation|4|||
129645507|NCT02833844|466657495|FG000|Open-Label Period|Death|0|||
129645508|NCT02833844|466657496|FG001|Open-Label Period|Death|2|||
129645509|NCT02833844|466657495|FG000|Open-Label Period|Lost to Follow-up|1|||
129645510|NCT02833844|466657496|FG001|Open-Label Period|Lost to Follow-up|0|||
129645511|NCT02833844|466657495|FG000|Open-Label Period|Withdrawal by Subject|1|||
129799861|NCT02322021|467235226|FG004|Extension Phase|Lost to Follow-up|1|||
129645512|NCT02833844|466657496|FG001|Open-Label Period|Withdrawal by Subject|0|||
129645513|NCT02541669|466657499|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
129645514|NCT02541669|466657500|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
129645515|NCT02541669|466657501|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
129645516|NCT02541669|466657502|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
129799862|NCT02322021|467235222|FG000|Extension Phase|Study terminated by sponsor|0|||
129645517|NCT02541669|466657503|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
129645518|NCT01084668|466657505|FG000|Overall Study|Lack of Efficacy|5|||
129645519|NCT01084668|466657505|FG000|Overall Study|Withdrawal by Subject|2|||
129645520|NCT01084668|466657505|FG000|Overall Study|Pregnancy|1|||
129645521|NCT01084668|466657505|FG000|Overall Study|Non-compliance|1|||
129645522|NCT00655733|466657512|FG000|Overall Study|Lost to Follow-up|2|||
129645523|NCT00655733|466657513|FG001|Overall Study|Lost to Follow-up|2|||
129645524|NCT00655733|466657512|FG000|Overall Study|Adverse Event|2|||
129645525|NCT00655733|466657513|FG001|Overall Study|Adverse Event|2|||
129645526|NCT00655733|466657512|FG000|Overall Study|Withdrawal by Subject|3|||
129645527|NCT00655733|466657513|FG001|Overall Study|Withdrawal by Subject|3|||
129645528|NCT00655733|466657512|FG000|Overall Study|Physician Decision|0|||
129645529|NCT00655733|466657513|FG001|Overall Study|Physician Decision|1|||
129645530|NCT02122770|466657514|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
129645531|NCT02122770|466657515|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
129645532|NCT02122770|466657516|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
129645533|NCT02122770|466657517|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
129645534|NCT02122770|466657518|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
129645535|NCT02122770|466657519|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
129645536|NCT02122770|466657514|FG000|Part A: Drug-drug Interaction 2|Other|0|||
129645537|NCT02122770|466657515|FG001|Part A: Drug-drug Interaction 2|Other|0|||
129645538|NCT02122770|466657516|FG002|Part A: Drug-drug Interaction 2|Other|1|||
129645539|NCT02122770|466657517|FG003|Part A: Drug-drug Interaction 2|Other|0|||
129645540|NCT02122770|466657518|FG004|Part A: Drug-drug Interaction 2|Other|0|||
129645541|NCT02122770|466657519|FG005|Part A: Drug-drug Interaction 2|Other|0|||
129645542|NCT02122770|466657514|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129645543|NCT02122770|466657515|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
129645544|NCT02122770|466657516|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129645545|NCT02122770|466657517|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129645546|NCT02122770|466657518|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129645547|NCT02122770|466657519|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
129706404|NCT00806585|466888464|FG000|Overall Study|Lost to Follow-up|2|||
129706405|NCT00806585|466888465|FG001|Overall Study|Lost to Follow-up|1|||
129706406|NCT00806585|466888466|FG002|Overall Study|Lost to Follow-up|2|||
129706407|NCT00806585|466888467|FG003|Overall Study|Lost to Follow-up|2|||
129706408|NCT00806585|466888468|FG004|Overall Study|Lost to Follow-up|5|||
129706409|NCT00806585|466888464|FG000|Overall Study|Lack of Efficacy|1|||
129706410|NCT00806585|466888465|FG001|Overall Study|Lack of Efficacy|0|||
129706411|NCT00806585|466888466|FG002|Overall Study|Lack of Efficacy|0|||
129706412|NCT00806585|466888467|FG003|Overall Study|Lack of Efficacy|0|||
129706413|NCT00806585|466888468|FG004|Overall Study|Lack of Efficacy|0|||
129706414|NCT00806585|466888464|FG000|Overall Study|Adverse Event|1|||
129706415|NCT00806585|466888465|FG001|Overall Study|Adverse Event|5|||
129706416|NCT00806585|466888466|FG002|Overall Study|Adverse Event|3|||
129706417|NCT00806585|466888467|FG003|Overall Study|Adverse Event|4|||
129706418|NCT00806585|466888468|FG004|Overall Study|Adverse Event|2|||
129706419|NCT00806585|466888464|FG000|Overall Study|Withdrawal by Subject|10|||
129706420|NCT00806585|466888465|FG001|Overall Study|Withdrawal by Subject|8|||
129799863|NCT02322021|467235223|FG001|Extension Phase|Study terminated by sponsor|0|||
129645548|NCT02122770|466657514|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
129645549|NCT02122770|466657515|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
129645550|NCT02122770|466657516|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
129645551|NCT02122770|466657517|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
129645552|NCT02122770|466657518|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
129645553|NCT02122770|466657519|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
129645554|NCT02122770|466657514|FG000|Part B: Standard of Care|Adverse Event|0|||
129645555|NCT02122770|466657515|FG001|Part B: Standard of Care|Adverse Event|0|||
129645556|NCT02122770|466657516|FG002|Part B: Standard of Care|Adverse Event|0|||
129645557|NCT02122770|466657517|FG003|Part B: Standard of Care|Adverse Event|0|||
129645558|NCT02122770|466657518|FG004|Part B: Standard of Care|Adverse Event|4|||
129645559|NCT02122770|466657519|FG005|Part B: Standard of Care|Adverse Event|1|||
129645560|NCT02122770|466657514|FG000|Part B: Standard of Care|Other|0|||
129645561|NCT02122770|466657515|FG001|Part B: Standard of Care|Other|0|||
129645562|NCT02122770|466657516|FG002|Part B: Standard of Care|Other|0|||
129645563|NCT02122770|466657517|FG003|Part B: Standard of Care|Other|0|||
129645564|NCT02122770|466657518|FG004|Part B: Standard of Care|Other|0|||
129645565|NCT02122770|466657519|FG005|Part B: Standard of Care|Other|2|||
129645566|NCT02122770|466657514|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
129645567|NCT02122770|466657515|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
129645568|NCT02122770|466657516|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
129645569|NCT02122770|466657517|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
129645570|NCT02122770|466657518|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
129645571|NCT02122770|466657519|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
129645572|NCT02122770|466657514|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
129645573|NCT02122770|466657515|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
129645574|NCT02122770|466657516|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
129645575|NCT02122770|466657517|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
129645576|NCT02122770|466657518|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
129645577|NCT02122770|466657519|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
129645578|NCT02122770|466657514|FG000|Part B: Standard of Care|Progressive Disease|0|||
129799864|NCT02322021|467235224|FG002|Extension Phase|Study terminated by sponsor|0|||
129799865|NCT02322021|467235225|FG003|Extension Phase|Study terminated by sponsor|0|||
129799866|NCT02322021|467235226|FG004|Extension Phase|Study terminated by sponsor|28|||
129799867|NCT02047227|467235227|FG000|Overall Study|Adverse Event|2|||
129799868|NCT02047227|467235228|FG001|Overall Study|Adverse Event|4|||
129799869|NCT02047227|467235227|FG000|Overall Study|Lost to Follow-up|0|||
129799870|NCT02047227|467235228|FG001|Overall Study|Lost to Follow-up|3|||
129799871|NCT02047227|467235227|FG000|Overall Study|Protocol Violation|1|||
129799872|NCT02047227|467235228|FG001|Overall Study|Protocol Violation|0|||
129799873|NCT02047227|467235227|FG000|Overall Study|Spontaneous pregnancy|1|||
129799874|NCT02047227|467235228|FG001|Overall Study|Spontaneous pregnancy|0|||
129799875|NCT02047227|467235227|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
129799876|NCT02047227|467235228|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
129799877|NCT02047227|467235227|FG000|Overall Study|No oocytes retrieved|21|||
129799878|NCT02047227|467235228|FG001|Overall Study|No oocytes retrieved|20|||
129799879|NCT02047227|467235227|FG000|Overall Study|No fertilization|61|||
129799880|NCT02047227|467235228|FG001|Overall Study|No fertilization|51|||
129799881|NCT02047227|467235227|FG000|Overall Study|Intention to freeze all embryos|1|||
129799882|NCT02047227|467235228|FG001|Overall Study|Intention to freeze all embryos|0|||
129799883|NCT02047227|467235227|FG000|Overall Study|All embryos discarded|12|||
129799884|NCT02047227|467235228|FG001|Overall Study|All embryos discarded|11|||
129799885|NCT02047227|467235227|FG000|Overall Study|Other|10|||
129799886|NCT02047227|467235228|FG001|Overall Study|Other|9|||
129799887|NCT01977937|467235237|FG000|Overall Study|Withdrawal by Subject|2|||
129799888|NCT01977937|467235238|FG001|Overall Study|Withdrawal by Subject|1|||
129799889|NCT01977937|467235237|FG000|Overall Study|Adverse Event|1|||
129799890|NCT01977937|467235238|FG001|Overall Study|Adverse Event|0|||
129799891|NCT01977937|467235237|FG000|Overall Study|Physician Decision|0|||
129799892|NCT01977937|467235238|FG001|Overall Study|Physician Decision|1|||
129799893|NCT00915356|467235239|FG000|Overall Study|Withdrawal by Subject|1|||
129799894|NCT00915356|467235240|FG001|Overall Study|Withdrawal by Subject|0|||
129799895|NCT00915356|467235241|FG002|Overall Study|Withdrawal by Subject|0|||
129799896|NCT00915356|467235242|FG003|Overall Study|Withdrawal by Subject|0|||
129799897|NCT00915356|467235243|FG004|Overall Study|Withdrawal by Subject|0|||
129799898|NCT02819518|467235253|FG000|Overall Study|Death|9|||
129799899|NCT02819518|467235254|FG001|Overall Study|Death|12|||
129799900|NCT02819518|467235255|FG002|Overall Study|Death|9|||
129799901|NCT02819518|467235256|FG003|Overall Study|Death|475|||
129799902|NCT02819518|467235257|FG004|Overall Study|Death|244|||
129645579|NCT02122770|466657515|FG001|Part B: Standard of Care|Progressive Disease|0|||
129645580|NCT02122770|466657516|FG002|Part B: Standard of Care|Progressive Disease|0|||
129645581|NCT02122770|466657517|FG003|Part B: Standard of Care|Progressive Disease|0|||
129799903|NCT02819518|467235253|FG000|Overall Study|Withdrawal by Subject|0|||
129645582|NCT02122770|466657518|FG004|Part B: Standard of Care|Progressive Disease|10|||
129645583|NCT02122770|466657519|FG005|Part B: Standard of Care|Progressive Disease|8|||
129645584|NCT01740128|466657520|FG000|Overall Study|Pregnancy|0|||
129645585|NCT01740128|466657521|FG001|Overall Study|Pregnancy|1|||
129645586|NCT01740128|466657520|FG000|Overall Study|Protocol Violation|1|||
129645587|NCT01740128|466657521|FG001|Overall Study|Protocol Violation|2|||
129645588|NCT01740128|466657520|FG000|Overall Study|Lost to Follow-up|2|||
129645589|NCT01740128|466657521|FG001|Overall Study|Lost to Follow-up|2|||
129645590|NCT01740128|466657520|FG000|Overall Study|Withdrawal by Subject|1|||
129645591|NCT01740128|466657521|FG001|Overall Study|Withdrawal by Subject|0|||
129645592|NCT01740128|466657520|FG000|Overall Study|Insufficient protocol compliance|2|||
129645593|NCT01740128|466657521|FG001|Overall Study|Insufficient protocol compliance|2|||
129645594|NCT02474589|466657522|FG000|Overall Study|Adverse Event|6|||
129645595|NCT02474589|466657523|FG001|Overall Study|Adverse Event|2|||
129645596|NCT02474589|466657522|FG000|Overall Study|Lost to Follow-up|6|||
129645597|NCT02474589|466657523|FG001|Overall Study|Lost to Follow-up|1|||
129645598|NCT02474589|466657522|FG000|Overall Study|Protocol Violation|4|||
129645599|NCT02474589|466657523|FG001|Overall Study|Protocol Violation|1|||
129645600|NCT02474589|466657522|FG000|Overall Study|Withdrawal by Subject|4|||
129706421|NCT00806585|466888466|FG002|Overall Study|Withdrawal by Subject|9|||
129706422|NCT00806585|466888467|FG003|Overall Study|Withdrawal by Subject|3|||
129706423|NCT00806585|466888468|FG004|Overall Study|Withdrawal by Subject|11|||
129706424|NCT00806585|466888464|FG000|Overall Study|Completion status unknown|15|||
129706425|NCT00806585|466888465|FG001|Overall Study|Completion status unknown|14|||
129706426|NCT00806585|466888466|FG002|Overall Study|Completion status unknown|12|||
129706427|NCT00806585|466888467|FG003|Overall Study|Completion status unknown|4|||
129706428|NCT00806585|466888468|FG004|Overall Study|Completion status unknown|12|||
129706429|NCT00474903|466888469|FG000|Overall Study|Protocol Violation|1|||
129706430|NCT00474903|466888470|FG001|Overall Study|Protocol Violation|5|||
129706431|NCT00474903|466888471|FG002|Overall Study|Protocol Violation|2|||
129706432|NCT00399529|466888472|FG000|Overall Study|Off Study Prior to Treatment|2|||
129706433|NCT01936831|466888478|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706434|NCT01936831|466888479|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706435|NCT01936831|466888480|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706436|NCT01936831|466888481|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706437|NCT01936831|466888482|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706438|NCT01936831|466888483|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
129706439|NCT01936831|466888484|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706440|NCT01936831|466888485|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706441|NCT01936831|466888486|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
129706442|NCT03435380|466888487|FG000|Overall Study|Death|1|||
129706443|NCT03435380|466888488|FG001|Overall Study|Death|2|||
129706444|NCT03435380|466888489|FG002|Overall Study|Death|1|||
129706445|NCT03435380|466888487|FG000|Overall Study|Lost to Follow-up|12|||
129706446|NCT03435380|466888488|FG001|Overall Study|Lost to Follow-up|8|||
129706447|NCT03435380|466888489|FG002|Overall Study|Lost to Follow-up|6|||
129706448|NCT03435380|466888487|FG000|Overall Study|Physician Decision|1|||
129706449|NCT03435380|466888488|FG001|Overall Study|Physician Decision|0|||
129706450|NCT03435380|466888489|FG002|Overall Study|Physician Decision|0|||
129706451|NCT03435380|466888487|FG000|Overall Study|Withdrawal by Subject|0|||
129707669|NCT03961308|466892095|FG001|Overall Study|Other|0|||
129707670|NCT03961308|466892094|FG000|Overall Study|Lost to Follow-up|0|||
129645601|NCT02474589|466657523|FG001|Overall Study|Withdrawal by Subject|0|||
129645602|NCT02474589|466657522|FG000|Overall Study|Inability to complete study procedures|5|||
129645603|NCT02474589|466657523|FG001|Overall Study|Inability to complete study procedures|1|||
129645604|NCT02658734|466657526|FG000|Overall Study|Adverse Event|2|||
129645605|NCT02658734|466657526|FG000|Overall Study|Death|4|||
129645606|NCT02658734|466657526|FG000|Overall Study|Lost to Follow-up|7|||
129443539|NCT04147234|465924419|FG001|Overall Study|Withdrawal by Subject|1|||
129443540|NCT04147234|465924420|FG002|Overall Study|Withdrawal by Subject|1|||
129443541|NCT04147234|465924421|FG003|Overall Study|Withdrawal by Subject|0|||
129443542|NCT04147234|465924422|FG004|Overall Study|Withdrawal by Subject|0|||
129645607|NCT02658734|466657526|FG000|Overall Study|Withdrawal of Consent|16|||
129645608|NCT02658734|466657526|FG000|Overall Study|Disease Progression|28|||
129799904|NCT02819518|467235254|FG001|Overall Study|Withdrawal by Subject|0|||
129890719|NCT03639675|467557537|FG000|Overall Study|Withdrawal by Subject|1|||
129890720|NCT02485353|467557538|FG000|Overall Study|Death|1|||
129890721|NCT02485353|467557538|FG000|Overall Study|Disease Progression|1|||
129890722|NCT01021332|467557539|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
129890723|NCT01021332|467557539|FG000|Overall Study|Adverse Event|43|||
129890724|NCT01021332|467557539|FG000|Overall Study|Lack of Efficacy|19|||
129890725|NCT01021332|467557539|FG000|Overall Study|Withdrawal of Consent|23|||
129890726|NCT01021332|467557539|FG000|Overall Study|Lost to Follow-up|4|||
129890727|NCT01021332|467557539|FG000|Overall Study|Protocol Violation|9|||
129890728|NCT01021332|467557539|FG000|Overall Study|Miscellaneous|3|||
129890729|NCT05343455|467557542|FG000|Overall Study|Withdrawal by Subject|4|||
129890730|NCT05343455|467557543|FG001|Overall Study|Withdrawal by Subject|9|||
129890731|NCT05343455|467557544|FG002|Overall Study|Withdrawal by Subject|7|||
129890732|NCT05343455|467557542|FG000|Overall Study|Adverse Event|2|||
129890733|NCT05343455|467557543|FG001|Overall Study|Adverse Event|1|||
129890734|NCT05343455|467557544|FG002|Overall Study|Adverse Event|2|||
129890735|NCT05343455|467557542|FG000|Overall Study|Lost to Follow-up|1|||
129890736|NCT05343455|467557543|FG001|Overall Study|Lost to Follow-up|1|||
129890737|NCT05343455|467557544|FG002|Overall Study|Lost to Follow-up|3|||
129890738|NCT05343455|467557542|FG000|Overall Study|Pregnancy|1|||
129890739|NCT05343455|467557543|FG001|Overall Study|Pregnancy|0|||
129890740|NCT05343455|467557544|FG002|Overall Study|Pregnancy|0|||
129890741|NCT05343455|467557542|FG000|Overall Study|Physician Decision|0|||
129890742|NCT05343455|467557543|FG001|Overall Study|Physician Decision|0|||
129890743|NCT05343455|467557544|FG002|Overall Study|Physician Decision|1|||
129890744|NCT05343455|467557542|FG000|Overall Study|Protocol Violation|0|||
129890745|NCT05343455|467557543|FG001|Overall Study|Protocol Violation|1|||
129890746|NCT05343455|467557544|FG002|Overall Study|Protocol Violation|1|||
129890747|NCT03302910|467557548|FG000|Overall Study|Protocol Violation|1|||
129890748|NCT03302910|467557549|FG001|Overall Study|Protocol Violation|0|||
129645609|NCT00459706|466657528|FG000|Overall Study|Adverse Event|19|||
129645610|NCT00459706|466657529|FG001|Overall Study|Adverse Event|13|||
129645611|NCT00459706|466657528|FG000|Overall Study|Withdrawal by Subject|1|||
129443543|NCT04147234|465924423|FG005|Overall Study|Withdrawal by Subject|0|||
129443544|NCT04147234|465924424|FG006|Overall Study|Withdrawal by Subject|0|||
129443545|NCT04147234|465924418|FG000|Overall Study|Clinical disease progression|1|||
129443546|NCT04147234|465924419|FG001|Overall Study|Clinical disease progression|3|||
129443547|NCT04147234|465924420|FG002|Overall Study|Clinical disease progression|1|||
129443548|NCT04147234|465924421|FG003|Overall Study|Clinical disease progression|1|||
129443549|NCT04147234|465924422|FG004|Overall Study|Clinical disease progression|0|||
129443550|NCT04147234|465924423|FG005|Overall Study|Clinical disease progression|1|||
129443551|NCT04147234|465924424|FG006|Overall Study|Clinical disease progression|0|||
129443552|NCT04147234|465924418|FG000|Overall Study|Objective disease progression|6|||
129443553|NCT04147234|465924419|FG001|Overall Study|Objective disease progression|4|||
129443554|NCT04147234|465924420|FG002|Overall Study|Objective disease progression|3|||
129443555|NCT04147234|465924421|FG003|Overall Study|Objective disease progression|3|||
129443556|NCT04147234|465924422|FG004|Overall Study|Objective disease progression|5|||
129645612|NCT00459706|466657529|FG001|Overall Study|Withdrawal by Subject|6|||
129890749|NCT01477749|467557550|FG000|Overall Study|Physician Decision|4|||
129890750|NCT00724061|467557557|FG000|Dose Escalation Phase|Adverse Event|2|||
129890751|NCT00724061|467557557|FG000|Dose Escalation Phase|Disease Progression|3|||
129890752|NCT00953160|467557560|FG000|Overall Study|Lost to Follow-up|23|||
129645613|NCT00459706|466657528|FG000|Overall Study|Physician Decision|2|||
129645614|NCT00459706|466657529|FG001|Overall Study|Physician Decision|0|||
129890753|NCT00953160|467557560|FG000|Overall Study|Withdrawal by Subject|4|||
129890754|NCT02724020|467557563|FG000|Overall Study|Death|16|||
129890755|NCT02724020|467557564|FG001|Overall Study|Death|18|||
129890756|NCT02724020|467557565|FG002|Overall Study|Death|19|||
129890757|NCT02724020|467557563|FG000|Overall Study|Lost to Follow-up|0|||
129890758|NCT02724020|467557564|FG001|Overall Study|Lost to Follow-up|3|||
129890759|NCT02724020|467557565|FG002|Overall Study|Lost to Follow-up|0|||
129890760|NCT02724020|467557563|FG000|Overall Study|Site Terminated by Sponsor|15|||
129890761|NCT02724020|467557564|FG001|Overall Study|Site Terminated by Sponsor|8|||
129890762|NCT02724020|467557565|FG002|Overall Study|Site Terminated by Sponsor|8|||
129890763|NCT02724020|467557563|FG000|Overall Study|Withdrawal by Subject|1|||
129890764|NCT02724020|467557564|FG001|Overall Study|Withdrawal by Subject|3|||
129890765|NCT02724020|467557565|FG002|Overall Study|Withdrawal by Subject|5|||
129890766|NCT00425503|467557566|FG000|Overall Study|Adverse Event|2|||
129890767|NCT00425503|467557566|FG000|Overall Study|Protocol Violation|1|||
129890768|NCT02118714|467557567|FG000|Overall Study|Lost to Follow-up|2|||
129890769|NCT02118714|467557567|FG000|Overall Study|Protocol Violation|1|||
129890770|NCT02954575|467557568|FG000|Overall Study|Withdrawal by Subject|2|||
129890771|NCT02954575|467557568|FG000|Overall Study|Adverse Event|1|||
129890772|NCT01066156|467557570|FG000|Overall Study|ineligible|2|||
129890773|NCT01066156|467557570|FG000|Overall Study|Lost to Follow-up|7|||
129890774|NCT01066156|467557570|FG000|Overall Study|Withdrawal by Subject|1|||
129890775|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
129890776|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
129890777|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
129890778|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
129890779|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
129890780|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
129890781|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
129890782|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
129890783|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
129890784|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
129890785|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
129890786|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
129890787|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
129890788|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
129890789|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
129890790|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
129890791|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
129890792|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
129890793|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
129890794|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
129890795|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
129890796|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
129890797|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
129890798|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
129890799|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
129890800|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
129645615|NCT00459706|466657528|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
129645616|NCT00459706|466657529|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129645617|NCT00459706|466657528|FG000|Overall Study|Protocol Violation|2|||
129890801|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
129890802|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
129891099|NCT02408549|467559616|FG000|Overall Study|Study terminated at site|1|||
129645618|NCT00459706|466657529|FG001|Overall Study|Protocol Violation|1|||
129645619|NCT00459706|466657528|FG000|Overall Study|Failed to Return|1|||
129706452|NCT03435380|466888488|FG001|Overall Study|Withdrawal by Subject|1|||
129706453|NCT03435380|466888489|FG002|Overall Study|Withdrawal by Subject|1|||
129706454|NCT03435380|466888487|FG000|Overall Study|Ineligible|0|||
129706455|NCT03435380|466888488|FG001|Overall Study|Ineligible|1|||
129706456|NCT03435380|466888489|FG002|Overall Study|Ineligible|1|||
129706457|NCT02133573|466888490|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
129706458|NCT02133573|466888491|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
129706459|NCT02133573|466888490|FG000|Overall Study|Child Deaths|3|||
129706460|NCT02133573|466888491|FG001|Overall Study|Child Deaths|5|||
129706461|NCT02133573|466888490|FG000|Overall Study|Child Declined Follow Ups|2|||
129706462|NCT02133573|466888491|FG001|Overall Study|Child Declined Follow Ups|1|||
129706463|NCT02133573|466888490|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
129706464|NCT02133573|466888491|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
129706465|NCT02519842|466888492|FG000|Base Study: Cycle 1|Screening Failure|1|||
129706466|NCT02519842|466888493|FG001|Base Study: Cycle 1|Screening Failure|1|||
129706467|NCT02519842|466888494|FG002|Base Study: Cycle 1|Screening Failure|0|||
129706468|NCT02519842|466888492|FG000|Base Study: Cycle 1|Adverse Event|1|||
129706469|NCT02519842|466888493|FG001|Base Study: Cycle 1|Adverse Event|0|||
129706470|NCT02519842|466888494|FG002|Base Study: Cycle 1|Adverse Event|0|||
129706471|NCT02519842|466888492|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
129706472|NCT02519842|466888493|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
129706473|NCT02519842|466888494|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
129706474|NCT02519842|466888492|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
129706475|NCT02519842|466888493|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
129706476|NCT02519842|466888494|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
129706477|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
129706478|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
129706479|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
129706480|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
129706481|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
129706482|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
129706483|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129706484|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
129706485|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
129706486|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
129706487|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
129706488|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
129706489|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Death|0|||
129706490|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Death|0|||
129706491|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Death|1|||
129706492|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
129706493|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
129706494|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
129706495|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
129706496|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
129706497|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
129706498|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
129706499|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
129706500|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
129706501|NCT02519842|466888492|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
129706502|NCT02519842|466888493|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
129706503|NCT02519842|466888494|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
129799905|NCT02819518|467235255|FG002|Overall Study|Withdrawal by Subject|0|||
129706504|NCT02115321|466888497|FG000|Overall Study|Death|1|||
129706505|NCT02115321|466888498|FG001|Overall Study|Death|0|||
129706506|NCT02493764|466888500|FG000|Overall Study|Adverse Event|2|||
129706507|NCT02493764|466888501|FG001|Overall Study|Adverse Event|2|||
129706508|NCT02493764|466888500|FG000|Overall Study|Death|44|||
129706509|NCT02493764|466888501|FG001|Overall Study|Death|58|||
129706510|NCT02493764|466888500|FG000|Overall Study|Lost to Follow-up|2|||
129799906|NCT02819518|467235256|FG003|Overall Study|Withdrawal by Subject|25|||
129890803|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
129890804|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
129890805|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
129890806|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
129890807|NCT03890120|467557574|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
129890808|NCT03890120|467557575|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
129890809|NCT03890120|467557576|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
129890810|NCT03890120|467557577|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
129890811|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
129890812|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
129890813|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
129890814|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
129890815|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
129890816|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
129890817|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
129890818|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
129890819|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129890820|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129890821|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
129890822|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
129890823|NCT03890120|467557574|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129890824|NCT03890120|467557575|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129890825|NCT03890120|467557576|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
129890826|NCT03890120|467557577|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
129890827|NCT02400307|467557578|FG000|Overall Study|Enrolled and Never Dosed|1|||
129890828|NCT02400307|467557579|FG001|Overall Study|Enrolled and Never Dosed|0|||
129890829|NCT02839681|467557580|FG000|Overall Study|Death|2|||
129890830|NCT03473756|467557584|FG000|Overall Study|Withdrawal by Subject|1|||
129890831|NCT03473756|467557585|FG001|Overall Study|Withdrawal by Subject|4|||
129890832|NCT03473756|467557584|FG000|Overall Study|Adverse Event|6|||
129890833|NCT03473756|467557585|FG001|Overall Study|Adverse Event|7|||
129890834|NCT03473756|467557584|FG000|Overall Study|Lack of Efficacy|3|||
129890835|NCT03473756|467557585|FG001|Overall Study|Lack of Efficacy|10|||
129890836|NCT03473756|467557584|FG000|Overall Study|Physician Decision|0|||
129890837|NCT03473756|467557585|FG001|Overall Study|Physician Decision|2|||
129890838|NCT03473756|467557584|FG000|Overall Study|End of study treatment|0|||
129890839|NCT03473756|467557585|FG001|Overall Study|End of study treatment|2|||
129890840|NCT03473756|467557584|FG000|Overall Study|Lost to Follow-up|0|||
129890841|NCT03473756|467557585|FG001|Overall Study|Lost to Follow-up|1|||
129890842|NCT02148718|467557586|FG000|Overall Study|Protocol Violation|26|||
129890843|NCT02148718|467557586|FG000|Overall Study|Discontinued Study Prematurely|5|||
129890844|NCT01778062|467557587|FG000|Overall Study|Adverse Event|1|||
129890845|NCT01778062|467557588|FG001|Overall Study|Adverse Event|3|||
129890846|NCT01778062|467557587|FG000|Overall Study|Consent Withdrawal|1|||
129890847|NCT01778062|467557588|FG001|Overall Study|Consent Withdrawal|5|||
129890848|NCT01778062|467557587|FG000|Overall Study|major protocol deviation|4|||
129890849|NCT01778062|467557588|FG001|Overall Study|major protocol deviation|3|||
129890850|NCT03387514|467557589|FG000|Overall Study|Withdrawal by Subject|2|||
129890851|NCT03387514|467557589|FG000|Overall Study|Physician Decision|1|||
129890852|NCT03387514|467557589|FG000|Overall Study|Lost to Follow-up|2|||
129890853|NCT04445155|467557598|FG000|Overall Study|Lost to Follow-up|11|||
129799907|NCT02819518|467235257|FG004|Overall Study|Withdrawal by Subject|8|||
129799908|NCT02819518|467235253|FG000|Overall Study|Lost to Follow-up|0|||
129799909|NCT02819518|467235254|FG001|Overall Study|Lost to Follow-up|0|||
129799910|NCT02819518|467235255|FG002|Overall Study|Lost to Follow-up|0|||
129799911|NCT02819518|467235256|FG003|Overall Study|Lost to Follow-up|0|||
129799912|NCT02819518|467235257|FG004|Overall Study|Lost to Follow-up|1|||
129799913|NCT02819518|467235253|FG000|Overall Study|Sponsor Decision|1|||
129890854|NCT04445155|467557599|FG001|Overall Study|Lost to Follow-up|2|||
129799914|NCT02819518|467235254|FG001|Overall Study|Sponsor Decision|1|||
129799915|NCT02819518|467235255|FG002|Overall Study|Sponsor Decision|0|||
129890855|NCT04445155|467557600|FG002|Overall Study|Lost to Follow-up|3|||
129890856|NCT04445155|467557601|FG003|Overall Study|Lost to Follow-up|0|||
129890857|NCT04445155|467557598|FG000|Overall Study|Withdrawal by Subject|8|||
129890858|NCT04445155|467557599|FG001|Overall Study|Withdrawal by Subject|0|||
129890859|NCT04445155|467557600|FG002|Overall Study|Withdrawal by Subject|0|||
129890860|NCT04445155|467557601|FG003|Overall Study|Withdrawal by Subject|0|||
129890861|NCT04445155|467557598|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
129890862|NCT04445155|467557599|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
129891100|NCT01272011|467559617|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
129645620|NCT00459706|466657529|FG001|Overall Study|Failed to Return|0|||
129645621|NCT00459706|466657528|FG000|Overall Study|Other|0|||
129645622|NCT00459706|466657529|FG001|Overall Study|Other|1|||
129645623|NCT00189306|466657530|FG000|Treatment Period|Withdrawal by Subject|2|||
129645624|NCT00189306|466657530|FG000|Treatment Period|Adverse Event|2|||
129645625|NCT00189306|466657530|FG000|Treatment Period|Protocol Violation|1|||
129645626|NCT00189306|466657530|FG000|Posttreatment Period|Death|1|||
129645627|NCT00189306|466657530|FG000|Posttreatment Period|Withdrawal by Subject|2|||
129706511|NCT02493764|466888501|FG001|Overall Study|Lost to Follow-up|1|||
129706512|NCT02493764|466888500|FG000|Overall Study|Protocol Violation|6|||
129706513|NCT02493764|466888501|FG001|Overall Study|Protocol Violation|7|||
129706514|NCT02493764|466888500|FG000|Overall Study|Physician Decision|1|||
129706515|NCT02493764|466888501|FG001|Overall Study|Physician Decision|1|||
129706516|NCT02493764|466888500|FG000|Overall Study|Participant moved|17|||
129706517|NCT02493764|466888501|FG001|Overall Study|Participant moved|5|||
129706518|NCT02493764|466888500|FG000|Overall Study|Withdrawal parent/guardian|0|||
129706519|NCT02493764|466888501|FG001|Overall Study|Withdrawal parent/guardian|1|||
129706520|NCT02493764|466888500|FG000|Overall Study|Withdrawal by Subject|11|||
129706521|NCT02493764|466888501|FG001|Overall Study|Withdrawal by Subject|7|||
129706522|NCT01307449|466888502|FG000|Overall Study|Adverse Event|1|||
129706523|NCT01307449|466888503|FG001|Overall Study|Adverse Event|0|||
129706524|NCT01307449|466888504|FG002|Overall Study|Adverse Event|0|||
129706525|NCT01307449|466888505|FG003|Overall Study|Adverse Event|0|||
129706526|NCT03218917|466888506|FG000|Overall Study|Adverse Event|3|||
129706527|NCT03218917|466888507|FG001|Overall Study|Adverse Event|3|||
129890863|NCT04445155|467557600|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
129890864|NCT04445155|467557601|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
129890865|NCT04445155|467557598|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
129890866|NCT04445155|467557599|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
129890867|NCT04445155|467557600|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
129890868|NCT04445155|467557601|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
129890869|NCT01213173|467557604|FG000|Overall Study|Protocol Violation|2|||
129890870|NCT01213173|467557605|FG001|Overall Study|Protocol Violation|0|||
129890871|NCT01213173|467557604|FG000|Overall Study|Adverse Event|4|||
129890872|NCT01213173|467557605|FG001|Overall Study|Adverse Event|8|||
129890873|NCT01213173|467557604|FG000|Overall Study|Withdrawal by Subject|5|||
129890874|NCT01213173|467557605|FG001|Overall Study|Withdrawal by Subject|5|||
129890875|NCT01213173|467557604|FG000|Overall Study|Incorrect Enrollment|1|||
129890876|NCT01213173|467557605|FG001|Overall Study|Incorrect Enrollment|3|||
129890877|NCT02353832|467557608|FG000|Overall Study|Ineligible after enrollment|1|||
129890878|NCT02353832|467557608|FG000|Overall Study|Lost to Follow-up|1|||
129890879|NCT04880161|467557609|FG000|Overall Study|Withdrawal by Subject|1|||
129890880|NCT04880161|467557610|FG001|Overall Study|Withdrawal by Subject|0|||
129890881|NCT04880161|467557609|FG000|Overall Study|Lack of Compliance|1|||
129890882|NCT04880161|467557610|FG001|Overall Study|Lack of Compliance|1|||
129890883|NCT04880161|467557609|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
129890884|NCT04880161|467557610|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
129890885|NCT04880161|467557609|FG000|Overall Study|Screen Failure|0|||
129890886|NCT04880161|467557610|FG001|Overall Study|Screen Failure|1|||
129890887|NCT01268059|467559542|FG000|Overall Study|Lost to Follow-up|0|||
129890888|NCT01268059|467559543|FG001|Overall Study|Lost to Follow-up|1|||
129890889|NCT01268059|467559544|FG002|Overall Study|Lost to Follow-up|0|||
129890890|NCT01268059|467559545|FG003|Overall Study|Lost to Follow-up|0|||
129890891|NCT01268059|467559542|FG000|Overall Study|Withdrawal by Subject|7|||
129890892|NCT01268059|467559543|FG001|Overall Study|Withdrawal by Subject|4|||
129890893|NCT01268059|467559544|FG002|Overall Study|Withdrawal by Subject|0|||
129890894|NCT01268059|467559545|FG003|Overall Study|Withdrawal by Subject|0|||
129890895|NCT01268059|467559542|FG000|Overall Study|Death|20|||
129890896|NCT01268059|467559543|FG001|Overall Study|Death|30|||
129890897|NCT01268059|467559544|FG002|Overall Study|Death|3|||
129890898|NCT01268059|467559545|FG003|Overall Study|Death|5|||
129890899|NCT01268059|467559542|FG000|Overall Study|Progression of disease|1|||
129890900|NCT01268059|467559543|FG001|Overall Study|Progression of disease|0|||
129890901|NCT01268059|467559544|FG002|Overall Study|Progression of disease|0|||
129890902|NCT01268059|467559545|FG003|Overall Study|Progression of disease|0|||
129890903|NCT03850444|467559546|FG000|Overall Study|Adverse Event|16|||
129890904|NCT03850444|467559547|FG001|Overall Study|Adverse Event|10|||
129890905|NCT03850444|467559546|FG000|Overall Study|Death|87|||
129890906|NCT03850444|467559547|FG001|Overall Study|Death|107|||
129890907|NCT03850444|467559546|FG000|Overall Study|Lost to Follow-up|1|||
129890908|NCT03850444|467559547|FG001|Overall Study|Lost to Follow-up|1|||
129890909|NCT03850444|467559546|FG000|Overall Study|Withdrawal by Subject|1|||
129890910|NCT03850444|467559547|FG001|Overall Study|Withdrawal by Subject|5|||
129890911|NCT03850444|467559546|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
129890912|NCT03850444|467559547|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
129890913|NCT01460381|467559549|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
129890914|NCT01460381|467559550|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
129890915|NCT01333943|467559555|FG000|Overall Study|Known neuropathy|1|||
129890916|NCT01333943|467559556|FG001|Overall Study|Known neuropathy|0|||
129890917|NCT00557505|467559564|FG000|Overall Study|Death|0|||
129890918|NCT00557505|467559565|FG001|Overall Study|Death|0|||
129890919|NCT00557505|467559566|FG002|Overall Study|Death|0|||
129890920|NCT00557505|467559567|FG003|Overall Study|Death|0|||
129890921|NCT00557505|467559568|FG004|Overall Study|Death|0|||
129890922|NCT00557505|467559569|FG005|Overall Study|Death|0|||
129890923|NCT00557505|467559570|FG006|Overall Study|Death|0|||
129890924|NCT00557505|467559571|FG007|Overall Study|Death|0|||
129890925|NCT00557505|467559572|FG008|Overall Study|Death|1|||
129890926|NCT00557505|467559564|FG000|Overall Study|Adverse Event|0|||
129890927|NCT00557505|467559565|FG001|Overall Study|Adverse Event|0|||
129890928|NCT00557505|467559566|FG002|Overall Study|Adverse Event|1|||
129890929|NCT00557505|467559567|FG003|Overall Study|Adverse Event|0|||
129890930|NCT00557505|467559568|FG004|Overall Study|Adverse Event|0|||
129890931|NCT00557505|467559569|FG005|Overall Study|Adverse Event|0|||
129890932|NCT00557505|467559570|FG006|Overall Study|Adverse Event|1|||
129890933|NCT00557505|467559571|FG007|Overall Study|Adverse Event|0|||
129890934|NCT00557505|467559572|FG008|Overall Study|Adverse Event|0|||
129890935|NCT00557505|467559564|FG000|Overall Study|Global deterioration of health|1|||
129890936|NCT00557505|467559565|FG001|Overall Study|Global deterioration of health|0|||
129890937|NCT00557505|467559566|FG002|Overall Study|Global deterioration of health|0|||
129890938|NCT00557505|467559567|FG003|Overall Study|Global deterioration of health|0|||
129890939|NCT00557505|467559568|FG004|Overall Study|Global deterioration of health|0|||
129890940|NCT00557505|467559569|FG005|Overall Study|Global deterioration of health|0|||
129890941|NCT00557505|467559570|FG006|Overall Study|Global deterioration of health|0|||
129890942|NCT00557505|467559571|FG007|Overall Study|Global deterioration of health|0|||
129890943|NCT00557505|467559572|FG008|Overall Study|Global deterioration of health|0|||
129890944|NCT00557505|467559564|FG000|Overall Study|Objective progression or relapse|2|||
129890945|NCT00557505|467559565|FG001|Overall Study|Objective progression or relapse|3|||
129890946|NCT00557505|467559566|FG002|Overall Study|Objective progression or relapse|3|||
129890947|NCT00557505|467559567|FG003|Overall Study|Objective progression or relapse|2|||
129890948|NCT00557505|467559568|FG004|Overall Study|Objective progression or relapse|2|||
129890949|NCT00557505|467559569|FG005|Overall Study|Objective progression or relapse|3|||
129890950|NCT00557505|467559570|FG006|Overall Study|Objective progression or relapse|2|||
129890951|NCT00557505|467559571|FG007|Overall Study|Objective progression or relapse|5|||
129890952|NCT00557505|467559572|FG008|Overall Study|Objective progression or relapse|15|||
129890953|NCT00557505|467559564|FG000|Overall Study|Withdrawal by Subject|0|||
129890954|NCT00557505|467559565|FG001|Overall Study|Withdrawal by Subject|0|||
129890955|NCT00557505|467559566|FG002|Overall Study|Withdrawal by Subject|0|||
129890956|NCT00557505|467559567|FG003|Overall Study|Withdrawal by Subject|1|||
129890957|NCT00557505|467559568|FG004|Overall Study|Withdrawal by Subject|0|||
129890958|NCT00557505|467559569|FG005|Overall Study|Withdrawal by Subject|0|||
129890959|NCT00557505|467559570|FG006|Overall Study|Withdrawal by Subject|0|||
129645628|NCT00189306|466657530|FG000|Posttreatment Period|Noncompliance|1|||
129645629|NCT00189306|466657530|FG000|Posttreatment Period|Target lesion excised|1|||
129890960|NCT00557505|467559571|FG007|Overall Study|Withdrawal by Subject|0|||
129890961|NCT00557505|467559572|FG008|Overall Study|Withdrawal by Subject|1|||
129890962|NCT00031447|467559573|FG000|Overall Study|Lost to Follow-up|0|||
129890963|NCT00031447|467559574|FG001|Overall Study|Lost to Follow-up|1|||
129890964|NCT00031447|467559573|FG000|Overall Study|Non-compliant|1|||
129890965|NCT00031447|467559574|FG001|Overall Study|Non-compliant|1|||
129890966|NCT00031447|467559573|FG000|Overall Study|Re-activation of Disease|2|||
129890967|NCT00031447|467559574|FG001|Overall Study|Re-activation of Disease|1|||
129645630|NCT00189306|466657530|FG000|Posttreatment Period|Protocol Violation|1|||
129890968|NCT00031447|467559573|FG000|Overall Study|Disruption of blinded study drug supply|7|||
129890969|NCT00031447|467559574|FG001|Overall Study|Disruption of blinded study drug supply|4|||
129890970|NCT01636362|467559575|FG000|Overall Study|Physician Decision|6|||
129443557|NCT04147234|465924423|FG005|Overall Study|Objective disease progression|2|||
129443558|NCT04147234|465924424|FG006|Overall Study|Objective disease progression|3|||
129443559|NCT04147234|465924418|FG000|Overall Study|Adverse Event|0|||
129799916|NCT02819518|467235256|FG003|Overall Study|Sponsor Decision|34|||
129799917|NCT02819518|467235257|FG004|Overall Study|Sponsor Decision|17|||
129799918|NCT02819518|467235253|FG000|Overall Study|Transferred to extension study|1|||
129645631|NCT00189306|466657530|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
129645632|NCT00189306|466657530|FG000|Posttreatment Period|Local skin reaction/sign|1|||
129645633|NCT00189306|466657530|FG000|Long-Term Follow-up|Adverse Event|2|||
129645634|NCT00189306|466657530|FG000|Long-Term Follow-up|Death|4|||
129645635|NCT00189306|466657530|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
129645636|NCT00189306|466657530|FG000|Long-Term Follow-up|Intercurrent disease|2|||
129645637|NCT00189306|466657530|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
129799919|NCT02819518|467235254|FG001|Overall Study|Transferred to extension study|1|||
129645638|NCT00189306|466657530|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
129645639|NCT03640481|466657531|FG000|Overall Study|Death|14|||
129645640|NCT03640481|466657532|FG001|Overall Study|Death|14|||
129645641|NCT03640481|466657533|FG002|Overall Study|Death|0|||
129645642|NCT03640481|466657534|FG003|Overall Study|Death|0|||
129645643|NCT03640481|466657531|FG000|Overall Study|Lost to Follow-up|2|||
129645644|NCT03640481|466657532|FG001|Overall Study|Lost to Follow-up|0|||
129645645|NCT03640481|466657533|FG002|Overall Study|Lost to Follow-up|0|||
129645646|NCT03640481|466657534|FG003|Overall Study|Lost to Follow-up|0|||
129645647|NCT03640481|466657531|FG000|Overall Study|Site terminated by sponsor|1|||
129645648|NCT03640481|466657532|FG001|Overall Study|Site terminated by sponsor|3|||
129645649|NCT03640481|466657533|FG002|Overall Study|Site terminated by sponsor|0|||
129645650|NCT03640481|466657534|FG003|Overall Study|Site terminated by sponsor|0|||
129645651|NCT03640481|466657531|FG000|Overall Study|Study terminated by sponsor|29|||
129645652|NCT03640481|466657532|FG001|Overall Study|Study terminated by sponsor|42|||
129645653|NCT03640481|466657533|FG002|Overall Study|Study terminated by sponsor|1|||
129645654|NCT03640481|466657534|FG003|Overall Study|Study terminated by sponsor|0|||
129645655|NCT03640481|466657531|FG000|Overall Study|Withdrawal by Subject|5|||
129645656|NCT03640481|466657532|FG001|Overall Study|Withdrawal by Subject|4|||
129645657|NCT03640481|466657533|FG002|Overall Study|Withdrawal by Subject|0|||
129645658|NCT03640481|466657534|FG003|Overall Study|Withdrawal by Subject|1|||
129645659|NCT03640481|466657531|FG000|Overall Study|Other|26|||
129645660|NCT03640481|466657532|FG001|Overall Study|Other|12|||
129645661|NCT03640481|466657533|FG002|Overall Study|Other|1|||
129645662|NCT03640481|466657534|FG003|Overall Study|Other|0|||
129645663|NCT03640481|466657531|FG000|Overall Study|Randomized, but not treated|1|||
129645664|NCT03640481|466657532|FG001|Overall Study|Randomized, but not treated|3|||
129706528|NCT03218917|466888508|FG002|Overall Study|Adverse Event|2|||
129706529|NCT03218917|466888506|FG000|Overall Study|Subject withdrew consent|2|||
129645665|NCT03640481|466657533|FG002|Overall Study|Randomized, but not treated|0|||
129706530|NCT03218917|466888507|FG001|Overall Study|Subject withdrew consent|4|||
129706531|NCT03218917|466888508|FG002|Overall Study|Subject withdrew consent|10|||
129706532|NCT03218917|466888506|FG000|Overall Study|Physician Decision|0|||
129706533|NCT03218917|466888507|FG001|Overall Study|Physician Decision|1|||
129706534|NCT03218917|466888508|FG002|Overall Study|Physician Decision|1|||
129706535|NCT03218917|466888506|FG000|Overall Study|Lost to Follow-up|1|||
129706536|NCT03218917|466888507|FG001|Overall Study|Lost to Follow-up|0|||
129706537|NCT03218917|466888508|FG002|Overall Study|Lost to Follow-up|0|||
129645666|NCT03640481|466657534|FG003|Overall Study|Randomized, but not treated|0|||
129645667|NCT00727844|466657535|FG000|Initial Randomization|Physician Decision|2|||
129645668|NCT00727844|466657536|FG001|Initial Randomization|Physician Decision|0|||
129645669|NCT00727844|466657537|FG002|Initial Randomization|Physician Decision|0|||
129645670|NCT00727844|466657538|FG003|Initial Randomization|Physician Decision|0|||
129706538|NCT03218917|466888506|FG000|Overall Study|Reason Missing|0|||
129706539|NCT03218917|466888507|FG001|Overall Study|Reason Missing|2|||
129645671|NCT00373958|466657539|FG000|Infant Series|Withdrawal by Subject|13|||
129706540|NCT03218917|466888508|FG002|Overall Study|Reason Missing|0|||
129706541|NCT03218917|466888506|FG000|Overall Study|Death|0|||
129706542|NCT03218917|466888507|FG001|Overall Study|Death|1|||
129706543|NCT03218917|466888508|FG002|Overall Study|Death|0|||
129706544|NCT03218917|466888506|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129706545|NCT03218917|466888507|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129706546|NCT03218917|466888508|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129706547|NCT01788943|466888511|FG000|Overall Study|Withdrawal by Subject|1|||
129706548|NCT01788943|466888512|FG001|Overall Study|Withdrawal by Subject|0|||
129706549|NCT01119287|466888513|FG000|Overall Study|Patient Decision, not related to AE|0|||
129706550|NCT01119287|466888514|FG001|Overall Study|Patient Decision, not related to AE|0|||
129706551|NCT01119287|466888515|FG002|Overall Study|Patient Decision, not related to AE|2|||
129706552|NCT01119287|466888516|FG003|Overall Study|Patient Decision, not related to AE|2|||
129706553|NCT01119287|466888517|FG004|Overall Study|Patient Decision, not related to AE|1|||
129706554|NCT01119287|466888518|FG005|Overall Study|Patient Decision, not related to AE|0|||
129706555|NCT00565409|466888526|FG000|Period 1 Open Label|Adverse Event|17|||
129706556|NCT00565409|466888527|FG001|Period 1 Open Label|Adverse Event|0|||
129706557|NCT00565409|466888528|FG002|Period 1 Open Label|Adverse Event|0|||
129706558|NCT00565409|466888529|FG003|Period 1 Open Label|Adverse Event|0|||
129706559|NCT00565409|466888526|FG000|Period 1 Open Label|Death|2|||
129706560|NCT00565409|466888527|FG001|Period 1 Open Label|Death|0|||
129706561|NCT00565409|466888528|FG002|Period 1 Open Label|Death|0|||
129706562|NCT00565409|466888529|FG003|Period 1 Open Label|Death|0|||
129706563|NCT00565409|466888526|FG000|Period 1 Open Label|Lost to Follow-up|1|||
129706564|NCT00565409|466888527|FG001|Period 1 Open Label|Lost to Follow-up|0|||
129706565|NCT00565409|466888528|FG002|Period 1 Open Label|Lost to Follow-up|0|||
129706566|NCT00565409|466888529|FG003|Period 1 Open Label|Lost to Follow-up|0|||
129706567|NCT00565409|466888526|FG000|Period 1 Open Label|Other|21|||
129706568|NCT00565409|466888527|FG001|Period 1 Open Label|Other|0|||
129706569|NCT00565409|466888528|FG002|Period 1 Open Label|Other|0|||
129706570|NCT00565409|466888529|FG003|Period 1 Open Label|Other|0|||
129706571|NCT00565409|466888526|FG000|Period 1 Open Label|Protocol Violation|14|||
129706572|NCT00565409|466888527|FG001|Period 1 Open Label|Protocol Violation|0|||
129706573|NCT00565409|466888528|FG002|Period 1 Open Label|Protocol Violation|0|||
129706574|NCT00565409|466888529|FG003|Period 1 Open Label|Protocol Violation|0|||
129706575|NCT00565409|466888526|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
129706576|NCT00565409|466888527|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
129706577|NCT00565409|466888528|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
129706578|NCT00565409|466888529|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
129706579|NCT00565409|466888526|FG000|Period 1 Open Label|no conclusion of participation record|1|||
129706580|NCT00565409|466888527|FG001|Period 1 Open Label|no conclusion of participation record|0|||
129706581|NCT00565409|466888528|FG002|Period 1 Open Label|no conclusion of participation record|0|||
129706582|NCT00565409|466888529|FG003|Period 1 Open Label|no conclusion of participation record|0|||
129706583|NCT00565409|466888526|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
129706584|NCT00565409|466888527|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
129706585|NCT00565409|466888528|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
129706586|NCT00565409|466888529|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
129706587|NCT00565409|466888526|FG000|Period 2 Double-Blind|Adverse Event|0|||
129706588|NCT00565409|466888527|FG001|Period 2 Double-Blind|Adverse Event|7|||
129706589|NCT00565409|466888528|FG002|Period 2 Double-Blind|Adverse Event|4|||
129706590|NCT00565409|466888529|FG003|Period 2 Double-Blind|Adverse Event|5|||
129706591|NCT00565409|466888526|FG000|Period 2 Double-Blind|Death|0|||
129706592|NCT00565409|466888527|FG001|Period 2 Double-Blind|Death|2|||
129706593|NCT00565409|466888528|FG002|Period 2 Double-Blind|Death|0|||
129706594|NCT00565409|466888529|FG003|Period 2 Double-Blind|Death|0|||
129706595|NCT00565409|466888526|FG000|Period 2 Double-Blind|Protocol Violation|0|||
129706596|NCT00565409|466888527|FG001|Period 2 Double-Blind|Protocol Violation|4|||
129799920|NCT02819518|467235255|FG002|Overall Study|Transferred to extension study|1|||
129799921|NCT02819518|467235256|FG003|Overall Study|Transferred to extension study|32|||
129799922|NCT02819518|467235257|FG004|Overall Study|Transferred to extension study|11|||
129799923|NCT00880165|467235258|FG000|Overall Study|Withdrawal by Subject|27|||
129799924|NCT00880165|467235259|FG001|Overall Study|Withdrawal by Subject|23|||
129799925|NCT00880165|467235258|FG000|Overall Study|Not diagnosed with OSA|14|||
129799926|NCT00880165|467235259|FG001|Overall Study|Not diagnosed with OSA|8|||
129799927|NCT00880165|467235258|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
129799928|NCT00880165|467235259|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
129706597|NCT00565409|466888528|FG002|Period 2 Double-Blind|Protocol Violation|6|||
129706598|NCT00565409|466888529|FG003|Period 2 Double-Blind|Protocol Violation|2|||
129706599|NCT00565409|466888526|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
129706600|NCT00565409|466888527|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
129706601|NCT00565409|466888528|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
129706602|NCT00565409|466888529|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
129706603|NCT00565409|466888526|FG000|Period 2 Double-Blind|Other|0|||
129706604|NCT00565409|466888527|FG001|Period 2 Double-Blind|Other|4|||
129706605|NCT00565409|466888528|FG002|Period 2 Double-Blind|Other|5|||
129706606|NCT00565409|466888529|FG003|Period 2 Double-Blind|Other|9|||
129706607|NCT00565409|466888526|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
129706608|NCT00565409|466888527|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
129890971|NCT01636362|467559575|FG000|Overall Study|Subject healed, not returning|1|||
129890972|NCT01636362|467559575|FG000|Overall Study|Withdrawal by Subject|1|||
129890973|NCT01244763|467559576|FG000|Overall Study|Adverse Event|1|||
129890974|NCT01244763|467559577|FG001|Overall Study|Adverse Event|0|||
129890975|NCT01244763|467559578|FG002|Overall Study|Adverse Event|0|||
129890976|NCT01244763|467559579|FG003|Overall Study|Adverse Event|0|||
129890977|NCT01244763|467559580|FG004|Overall Study|Adverse Event|0|||
129890978|NCT01244763|467559581|FG005|Overall Study|Adverse Event|1|||
129890979|NCT01244763|467559576|FG000|Overall Study|Death|1|||
129890980|NCT01244763|467559577|FG001|Overall Study|Death|0|||
129890981|NCT01244763|467559578|FG002|Overall Study|Death|1|||
129890982|NCT01244763|467559579|FG003|Overall Study|Death|0|||
129890983|NCT01244763|467559580|FG004|Overall Study|Death|2|||
129890984|NCT01244763|467559581|FG005|Overall Study|Death|0|||
129890985|NCT01244763|467559576|FG000|Overall Study|Physician Decision|0|||
129890986|NCT01244763|467559577|FG001|Overall Study|Physician Decision|0|||
129890987|NCT01244763|467559578|FG002|Overall Study|Physician Decision|1|||
129890988|NCT01244763|467559579|FG003|Overall Study|Physician Decision|0|||
129890989|NCT01244763|467559580|FG004|Overall Study|Physician Decision|0|||
129890990|NCT01244763|467559581|FG005|Overall Study|Physician Decision|0|||
129706609|NCT00565409|466888528|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
129706610|NCT00565409|466888529|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
129706611|NCT02257684|466888531|FG000|Overall Study|Adverse Event|2|||
129706612|NCT02257684|466888531|FG000|Overall Study|Lack of Efficacy|1|||
129706613|NCT02257684|466888531|FG000|Overall Study|Sponsor's Decision|1|||
129706614|NCT01570387|466888532|FG000|Overall Study|Adverse Event|1|||
129706615|NCT01570387|466888533|FG001|Overall Study|Adverse Event|0|||
129706616|NCT01570387|466888534|FG002|Overall Study|Adverse Event|0|||
129799929|NCT00880165|467235258|FG000|Overall Study|Lost to follow|9|||
129799930|NCT00880165|467235259|FG001|Overall Study|Lost to follow|15|||
129799931|NCT01505647|467235260|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
129799932|NCT01505647|467235261|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
129799933|NCT01505647|467235260|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
129799934|NCT01505647|467235261|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
129799935|NCT01505647|467235260|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
129799936|NCT01505647|467235261|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
129799937|NCT01505647|467235260|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
129799938|NCT01505647|467235261|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
129799939|NCT01505647|467235260|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
129799940|NCT01505647|467235261|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
129799941|NCT00667602|467235262|FG000|Overall Study|Withdrawal by Subject|4|||
129799942|NCT00667602|467235263|FG001|Overall Study|Withdrawal by Subject|9|||
129799943|NCT00667602|467235264|FG002|Overall Study|Withdrawal by Subject|10|||
129799944|NCT00667602|467235262|FG000|Overall Study|Lost to Follow-up|4|||
129799945|NCT00667602|467235263|FG001|Overall Study|Lost to Follow-up|5|||
129799946|NCT00667602|467235264|FG002|Overall Study|Lost to Follow-up|6|||
129799947|NCT00667602|467235262|FG000|Overall Study|Administrative reason|0|||
129706617|NCT01570387|466888535|FG003|Overall Study|Adverse Event|0|||
129706618|NCT01570387|466888532|FG000|Overall Study|Death|0|||
129706619|NCT01570387|466888533|FG001|Overall Study|Death|0|||
129706620|NCT01570387|466888534|FG002|Overall Study|Death|0|||
129706621|NCT01570387|466888535|FG003|Overall Study|Death|1|||
129799948|NCT00667602|467235263|FG001|Overall Study|Administrative reason|0|||
129799949|NCT00667602|467235264|FG002|Overall Study|Administrative reason|2|||
129799950|NCT00667602|467235262|FG000|Overall Study|Protocol Violation|0|||
129799951|NCT00667602|467235263|FG001|Overall Study|Protocol Violation|1|||
129706622|NCT01570387|466888532|FG000|Overall Study|Withdrawal by Subject|0|||
129706623|NCT01570387|466888533|FG001|Overall Study|Withdrawal by Subject|0|||
129706624|NCT01570387|466888534|FG002|Overall Study|Withdrawal by Subject|0|||
129706625|NCT01570387|466888535|FG003|Overall Study|Withdrawal by Subject|1|||
129890991|NCT01244763|467559576|FG000|Overall Study|Withdrawal by Subject|1|||
129890992|NCT01244763|467559577|FG001|Overall Study|Withdrawal by Subject|2|||
129890993|NCT01244763|467559578|FG002|Overall Study|Withdrawal by Subject|0|||
129890994|NCT01244763|467559579|FG003|Overall Study|Withdrawal by Subject|1|||
129890995|NCT01244763|467559580|FG004|Overall Study|Withdrawal by Subject|1|||
129890996|NCT01244763|467559581|FG005|Overall Study|Withdrawal by Subject|2|||
129645672|NCT00373958|466657540|FG001|Infant Series|Withdrawal by Subject|15|||
129645673|NCT00373958|466657539|FG000|Infant Series|Failed to return|8|||
129799952|NCT00667602|467235264|FG002|Overall Study|Protocol Violation|0|||
129799953|NCT00973349|467235272|FG000|Overall Study|Adverse Event|0|||
129799954|NCT00973349|467235273|FG001|Overall Study|Adverse Event|0|||
129799955|NCT00973349|467235274|FG002|Overall Study|Adverse Event|0|||
129799956|NCT00973349|467235275|FG003|Overall Study|Adverse Event|0|||
129799957|NCT00973349|467235276|FG004|Overall Study|Adverse Event|1|||
129799958|NCT00973349|467235277|FG005|Overall Study|Adverse Event|0|||
129799959|NCT00973349|467235278|FG006|Overall Study|Adverse Event|0|||
129799960|NCT00973349|467235279|FG007|Overall Study|Adverse Event|0|||
129799961|NCT00973349|467235280|FG008|Overall Study|Adverse Event|1|||
129799962|NCT00973349|467235281|FG009|Overall Study|Adverse Event|0|||
129799963|NCT00973349|467235282|FG010|Overall Study|Adverse Event|0|||
129799964|NCT00973349|467235283|FG011|Overall Study|Adverse Event|0|||
129799965|NCT00973349|467235284|FG012|Overall Study|Adverse Event|0|||
129799966|NCT00973349|467235285|FG013|Overall Study|Adverse Event|0|||
129799967|NCT00973349|467235286|FG014|Overall Study|Adverse Event|1|||
129799968|NCT00973349|467235287|FG015|Overall Study|Adverse Event|0|||
129799969|NCT00973349|467235272|FG000|Overall Study|Withdrawal by Subject|1|||
129799970|NCT00973349|467235273|FG001|Overall Study|Withdrawal by Subject|2|||
129799971|NCT00973349|467235274|FG002|Overall Study|Withdrawal by Subject|2|||
129799972|NCT00973349|467235275|FG003|Overall Study|Withdrawal by Subject|3|||
129799973|NCT00973349|467235276|FG004|Overall Study|Withdrawal by Subject|2|||
129799974|NCT00973349|467235277|FG005|Overall Study|Withdrawal by Subject|0|||
129799975|NCT00973349|467235278|FG006|Overall Study|Withdrawal by Subject|2|||
129799976|NCT00973349|467235279|FG007|Overall Study|Withdrawal by Subject|2|||
129799977|NCT00973349|467235280|FG008|Overall Study|Withdrawal by Subject|0|||
129799978|NCT00973349|467235281|FG009|Overall Study|Withdrawal by Subject|2|||
129799979|NCT00973349|467235282|FG010|Overall Study|Withdrawal by Subject|0|||
129799980|NCT00973349|467235283|FG011|Overall Study|Withdrawal by Subject|1|||
129799981|NCT00973349|467235284|FG012|Overall Study|Withdrawal by Subject|0|||
129799982|NCT00973349|467235285|FG013|Overall Study|Withdrawal by Subject|0|||
129799983|NCT00973349|467235286|FG014|Overall Study|Withdrawal by Subject|0|||
129799984|NCT00973349|467235287|FG015|Overall Study|Withdrawal by Subject|0|||
129799985|NCT00973349|467235272|FG000|Overall Study|Lost to Follow-up|3|||
129799986|NCT00973349|467235273|FG001|Overall Study|Lost to Follow-up|1|||
129799987|NCT00973349|467235274|FG002|Overall Study|Lost to Follow-up|2|||
129799988|NCT00973349|467235275|FG003|Overall Study|Lost to Follow-up|2|||
129799989|NCT00973349|467235276|FG004|Overall Study|Lost to Follow-up|1|||
129799990|NCT00973349|467235277|FG005|Overall Study|Lost to Follow-up|3|||
129799991|NCT00973349|467235278|FG006|Overall Study|Lost to Follow-up|0|||
129799992|NCT00973349|467235279|FG007|Overall Study|Lost to Follow-up|1|||
129799993|NCT00973349|467235280|FG008|Overall Study|Lost to Follow-up|2|||
129799994|NCT00973349|467235281|FG009|Overall Study|Lost to Follow-up|1|||
129799995|NCT00973349|467235282|FG010|Overall Study|Lost to Follow-up|0|||
129799996|NCT00973349|467235283|FG011|Overall Study|Lost to Follow-up|1|||
129799997|NCT00973349|467235284|FG012|Overall Study|Lost to Follow-up|0|||
129799998|NCT00973349|467235285|FG013|Overall Study|Lost to Follow-up|0|||
129799999|NCT00973349|467235286|FG014|Overall Study|Lost to Follow-up|0|||
129800000|NCT00973349|467235287|FG015|Overall Study|Lost to Follow-up|1|||
129800001|NCT00973349|467235272|FG000|Overall Study|Inappropriate enrolment|0|||
129800002|NCT00973349|467235273|FG001|Overall Study|Inappropriate enrolment|0|||
129800003|NCT00973349|467235274|FG002|Overall Study|Inappropriate enrolment|1|||
129800004|NCT00973349|467235275|FG003|Overall Study|Inappropriate enrolment|0|||
129800005|NCT00973349|467235276|FG004|Overall Study|Inappropriate enrolment|0|||
129800006|NCT00973349|467235277|FG005|Overall Study|Inappropriate enrolment|0|||
129800007|NCT00973349|467235278|FG006|Overall Study|Inappropriate enrolment|0|||
129800008|NCT00973349|467235279|FG007|Overall Study|Inappropriate enrolment|0|||
129800009|NCT00973349|467235280|FG008|Overall Study|Inappropriate enrolment|0|||
129800010|NCT00973349|467235281|FG009|Overall Study|Inappropriate enrolment|2|||
129800011|NCT00973349|467235282|FG010|Overall Study|Inappropriate enrolment|0|||
129800012|NCT00973349|467235283|FG011|Overall Study|Inappropriate enrolment|0|||
129800013|NCT00973349|467235284|FG012|Overall Study|Inappropriate enrolment|1|||
129800014|NCT00973349|467235285|FG013|Overall Study|Inappropriate enrolment|0|||
129800015|NCT00973349|467235286|FG014|Overall Study|Inappropriate enrolment|1|||
129800016|NCT00973349|467235287|FG015|Overall Study|Inappropriate enrolment|1|||
129800017|NCT00973349|467235272|FG000|Overall Study|Protocol Violation|0|||
129800018|NCT00973349|467235273|FG001|Overall Study|Protocol Violation|0|||
129800019|NCT00973349|467235274|FG002|Overall Study|Protocol Violation|0|||
129800020|NCT00973349|467235275|FG003|Overall Study|Protocol Violation|0|||
129800021|NCT00973349|467235276|FG004|Overall Study|Protocol Violation|0|||
129800022|NCT00973349|467235277|FG005|Overall Study|Protocol Violation|0|||
129800023|NCT00973349|467235278|FG006|Overall Study|Protocol Violation|0|||
129800024|NCT00973349|467235279|FG007|Overall Study|Protocol Violation|0|||
129800025|NCT00973349|467235280|FG008|Overall Study|Protocol Violation|1|||
129800026|NCT00973349|467235281|FG009|Overall Study|Protocol Violation|0|||
129800027|NCT00973349|467235282|FG010|Overall Study|Protocol Violation|0|||
129800028|NCT00973349|467235283|FG011|Overall Study|Protocol Violation|0|||
129645674|NCT00373958|466657540|FG001|Infant Series|Failed to return|13|||
129645675|NCT00373958|466657539|FG000|Infant Series|Lost to Follow-up|6|||
129645676|NCT00373958|466657540|FG001|Infant Series|Lost to Follow-up|5|||
129645677|NCT00373958|466657539|FG000|Infant Series|Protocol Violation|3|||
129706626|NCT01987557|466888536|FG000|Overall Study|Protocol Violation|1|||
129645678|NCT00373958|466657540|FG001|Infant Series|Protocol Violation|7|||
129645679|NCT00373958|466657539|FG000|Infant Series|Lost Kaiser coverage|4|||
129645680|NCT00373958|466657540|FG001|Infant Series|Lost Kaiser coverage|0|||
129645681|NCT00373958|466657539|FG000|Infant Series|Child relocated|1|||
129645682|NCT00373958|466657540|FG001|Infant Series|Child relocated|0|||
129645683|NCT00373958|466657539|FG000|Infant Series|Consent was not received|1|||
129645684|NCT00373958|466657540|FG001|Infant Series|Consent was not received|0|||
129645685|NCT00373958|466657539|FG000|Infant Series|Adverse Event|3|||
129645686|NCT00373958|466657540|FG001|Infant Series|Adverse Event|1|||
129645687|NCT00373958|466657539|FG000|Infant Series|Physician Decision|1|||
129645688|NCT00373958|466657540|FG001|Infant Series|Physician Decision|1|||
129645689|NCT00373958|466657539|FG000|Toddler Dose|Lost to Follow-up|5|||
129645690|NCT00373958|466657540|FG001|Toddler Dose|Lost to Follow-up|8|||
129645691|NCT00373958|466657539|FG000|Toddler Dose|Withdrawal by Subject|2|||
129645692|NCT00373958|466657540|FG001|Toddler Dose|Withdrawal by Subject|2|||
129645693|NCT00373958|466657539|FG000|Toddler Dose|Failed to return|1|||
129645694|NCT00373958|466657540|FG001|Toddler Dose|Failed to return|2|||
129645695|NCT00373958|466657539|FG000|Toddler Dose|Protocol Violation|0|||
129645696|NCT00373958|466657540|FG001|Toddler Dose|Protocol Violation|1|||
129645697|NCT00373958|466657539|FG000|Toddler Dose|Withdrawn after infant series|22|||
129645698|NCT00373958|466657540|FG001|Toddler Dose|Withdrawn after infant series|25|||
129645699|NCT01552915|466657541|FG000|Overall Study|Adverse Event|3|||
129645700|NCT01552915|466657542|FG001|Overall Study|Adverse Event|14|||
129645701|NCT01552915|466657543|FG002|Overall Study|Adverse Event|3|||
129645702|NCT01552915|466657541|FG000|Overall Study|Lost to Follow-up|4|||
129645703|NCT01552915|466657542|FG001|Overall Study|Lost to Follow-up|6|||
129645704|NCT01552915|466657543|FG002|Overall Study|Lost to Follow-up|5|||
129645705|NCT01552915|466657541|FG000|Overall Study|Withdrawal by Subject|6|||
129645706|NCT01552915|466657542|FG001|Overall Study|Withdrawal by Subject|4|||
129645707|NCT01552915|466657543|FG002|Overall Study|Withdrawal by Subject|5|||
129645708|NCT01552915|466657541|FG000|Overall Study|Protocol Violation|0|||
129645709|NCT01552915|466657542|FG001|Overall Study|Protocol Violation|4|||
129645710|NCT01552915|466657543|FG002|Overall Study|Protocol Violation|4|||
129645711|NCT01552915|466657541|FG000|Overall Study|Lack of Efficacy|8|||
129645712|NCT01552915|466657542|FG001|Overall Study|Lack of Efficacy|1|||
129645713|NCT01552915|466657543|FG002|Overall Study|Lack of Efficacy|4|||
129645714|NCT01552915|466657541|FG000|Overall Study|Other|2|||
129645715|NCT01552915|466657542|FG001|Overall Study|Other|0|||
129645716|NCT01552915|466657543|FG002|Overall Study|Other|6|||
129645717|NCT02457832|466657546|FG000|Training|Lost to Follow-up|10|||
129645718|NCT02457832|466657547|FG001|Training|Lost to Follow-up|6|||
129645719|NCT02457832|466657548|FG002|Training|Lost to Follow-up|3|||
129645720|NCT02457832|466657546|FG000|One Month Washout|Lost to Follow-up|0|||
129645721|NCT02457832|466657547|FG001|One Month Washout|Lost to Follow-up|1|||
129645722|NCT02457832|466657548|FG002|One Month Washout|Lost to Follow-up|1|||
129645723|NCT01880086|466657549|FG000|Overall Study|Lost to Follow-up|1|||
129645724|NCT01880086|466657550|FG001|Overall Study|Lost to Follow-up|1|||
129645725|NCT03403751|466657554|FG000|Overall Study|Death|5|||
129645726|NCT03403751|466657555|FG001|Overall Study|Death|6|||
129645727|NCT03403751|466657554|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
129645728|NCT03403751|466657555|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
129645729|NCT00520481|466657559|FG000|Overall Study|Adverse Event|4|||
129645730|NCT00520481|466657560|FG001|Overall Study|Adverse Event|1|||
129645731|NCT00520481|466657559|FG000|Overall Study|Withdrawal by Subject|3|||
129645732|NCT00520481|466657560|FG001|Overall Study|Withdrawal by Subject|0|||
129645733|NCT01931956|466657561|FG000|Overall Study|Death|42|||
129645734|NCT01931956|466657562|FG001|Overall Study|Death|7|||
129645735|NCT01931956|466657563|FG002|Overall Study|Death|379|||
129706627|NCT01987557|466888537|FG001|Overall Study|Protocol Violation|0|||
129706628|NCT01987557|466888538|FG002|Overall Study|Protocol Violation|1|||
129706629|NCT01987557|466888536|FG000|Overall Study|Withdrawal by Subject|2|||
129706630|NCT01987557|466888537|FG001|Overall Study|Withdrawal by Subject|1|||
129706631|NCT01987557|466888538|FG002|Overall Study|Withdrawal by Subject|2|||
129706632|NCT01987557|466888536|FG000|Overall Study|Adverse Event|0|||
129706633|NCT01987557|466888537|FG001|Overall Study|Adverse Event|2|||
129706634|NCT01987557|466888538|FG002|Overall Study|Adverse Event|0|||
129706635|NCT00431964|466888547|FG000|Overall Study|Adverse Event|1|||
129706636|NCT00431964|466888548|FG001|Overall Study|Adverse Event|0|||
129706637|NCT00431964|466888547|FG000|Overall Study|Lost to Follow-up|1|||
129706638|NCT00431964|466888548|FG001|Overall Study|Lost to Follow-up|2|||
129645736|NCT01931956|466657564|FG003|Overall Study|Death|96|||
129706639|NCT00431964|466888547|FG000|Overall Study|Physician Decision|2|||
129645737|NCT01931956|466657561|FG000|Overall Study|Withdrawal by Subject|5|||
129443560|NCT04147234|465924419|FG001|Overall Study|Adverse Event|0|||
129645738|NCT01931956|466657562|FG001|Overall Study|Withdrawal by Subject|0|||
129645739|NCT01931956|466657563|FG002|Overall Study|Withdrawal by Subject|70|||
129645740|NCT01931956|466657564|FG003|Overall Study|Withdrawal by Subject|30|||
129645741|NCT01931956|466657561|FG000|Overall Study|Lost to Follow-up|2|||
129645742|NCT01931956|466657562|FG001|Overall Study|Lost to Follow-up|0|||
129645743|NCT01931956|466657563|FG002|Overall Study|Lost to Follow-up|11|||
129645744|NCT01931956|466657564|FG003|Overall Study|Lost to Follow-up|7|||
129645745|NCT01931956|466657561|FG000|Overall Study|Expected|2|||
129645746|NCT01931956|466657562|FG001|Overall Study|Expected|0|||
129645747|NCT01931956|466657563|FG002|Overall Study|Expected|6|||
129645748|NCT01931956|466657564|FG003|Overall Study|Expected|0|||
129645749|NCT01931956|466657561|FG000|Overall Study|Not due|0|||
129645750|NCT01931956|466657562|FG001|Overall Study|Not due|0|||
129645751|NCT01931956|466657563|FG002|Overall Study|Not due|21|||
129645752|NCT01931956|466657564|FG003|Overall Study|Not due|0|||
129645753|NCT02847494|466657565|FG000|Overall Study|Lost to Follow-up|8|||
129645754|NCT02847494|466657566|FG001|Overall Study|Lost to Follow-up|5|||
129645755|NCT01901653|466657567|FG000|Overall Study|Death|2|||
129645756|NCT01901653|466657568|FG001|Overall Study|Death|1|||
129645757|NCT01901653|466657569|FG002|Overall Study|Death|8|||
129645758|NCT01901653|466657570|FG003|Overall Study|Death|3|||
129645759|NCT01901653|466657571|FG004|Overall Study|Death|2|||
129645760|NCT01901653|466657572|FG005|Overall Study|Death|2|||
129645761|NCT01901653|466657573|FG006|Overall Study|Death|6|||
129645762|NCT01901653|466657574|FG007|Overall Study|Death|9|||
129645763|NCT01901653|466657575|FG008|Overall Study|Death|1|||
129645764|NCT01901653|466657576|FG009|Overall Study|Death|16|||
129645765|NCT01901653|466657577|FG010|Overall Study|Death|2|||
129645766|NCT01901653|466657578|FG011|Overall Study|Death|15|||
129645767|NCT01901653|466657579|FG012|Overall Study|Death|4|||
129645768|NCT01901653|466657567|FG000|Overall Study|Lost to Follow-up|1|||
129645769|NCT01901653|466657568|FG001|Overall Study|Lost to Follow-up|0|||
129645770|NCT01901653|466657569|FG002|Overall Study|Lost to Follow-up|2|||
129706640|NCT00431964|466888548|FG001|Overall Study|Physician Decision|2|||
129706641|NCT00431964|466888547|FG000|Overall Study|Withdrawal by Subject|2|||
129706642|NCT00431964|466888548|FG001|Overall Study|Withdrawal by Subject|1|||
129706643|NCT00431964|466888547|FG000|Overall Study|Parental Consent Withdrawn|0|||
129706644|NCT00431964|466888548|FG001|Overall Study|Parental Consent Withdrawn|2|||
129706645|NCT00431964|466888547|FG000|Overall Study|Due to Unstable Health|0|||
129706646|NCT00431964|466888548|FG001|Overall Study|Due to Unstable Health|1|||
129706647|NCT03434834|466888554|FG000|Overall Study|unable to swallow OCT probe|16|||
129706648|NCT00518180|466888557|FG000|Overall Study|Withdrawal by Subject|29|||
129706649|NCT00518180|466888558|FG001|Overall Study|Withdrawal by Subject|30|||
129706650|NCT00518180|466888559|FG002|Overall Study|Withdrawal by Subject|42|||
129706651|NCT00518180|466888557|FG000|Overall Study|Lost to Follow-up|30|||
129706652|NCT00518180|466888558|FG001|Overall Study|Lost to Follow-up|28|||
129706653|NCT00518180|466888559|FG002|Overall Study|Lost to Follow-up|34|||
129706654|NCT00518180|466888557|FG000|Overall Study|Administrative reason|0|||
129706655|NCT00518180|466888558|FG001|Overall Study|Administrative reason|2|||
129706656|NCT00518180|466888559|FG002|Overall Study|Administrative reason|2|||
129706657|NCT00518180|466888557|FG000|Overall Study|Protocol Violation|5|||
129706658|NCT00518180|466888558|FG001|Overall Study|Protocol Violation|7|||
129706659|NCT00518180|466888559|FG002|Overall Study|Protocol Violation|4|||
129706660|NCT00518180|466888557|FG000|Overall Study|Unable to classify|0|||
129706661|NCT00518180|466888558|FG001|Overall Study|Unable to classify|2|||
129706662|NCT00518180|466888559|FG002|Overall Study|Unable to classify|0|||
129706663|NCT00518180|466888557|FG000|Overall Study|Adverse Event|1|||
129706664|NCT00518180|466888558|FG001|Overall Study|Adverse Event|0|||
129706665|NCT00518180|466888559|FG002|Overall Study|Adverse Event|0|||
129706666|NCT00485173|466888564|FG000|Overall Study|Death|4|||
129706667|NCT00485173|466888565|FG001|Overall Study|Death|3|||
129706668|NCT00485173|466888564|FG000|Overall Study|Lost to Follow-up|32|||
129706669|NCT00485173|466888565|FG001|Overall Study|Lost to Follow-up|61|||
129706670|NCT00746811|466888566|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
129706671|NCT00746811|466888567|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
129706672|NCT00829244|466888568|FG000|Overall Study|Adverse Event|1|||
129706673|NCT00829244|466888569|FG001|Overall Study|Adverse Event|3|||
129706674|NCT00829244|466888568|FG000|Overall Study|Protocol Violation|1|||
129706675|NCT00829244|466888569|FG001|Overall Study|Protocol Violation|0|||
129706676|NCT00829244|466888568|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
129706677|NCT00829244|466888569|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
129706678|NCT00829244|466888568|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
129706679|NCT00829244|466888569|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
129706680|NCT00829244|466888568|FG000|Overall Study|No fertilization|2|||
129706681|NCT00829244|466888569|FG001|Overall Study|No fertilization|2|||
129706682|NCT00829244|466888568|FG000|Overall Study|All embryos discarded|0|||
129706683|NCT00829244|466888569|FG001|Overall Study|All embryos discarded|3|||
129706684|NCT00829244|466888568|FG000|Overall Study|No embryo cleavage|0|||
129706685|NCT00829244|466888569|FG001|Overall Study|No embryo cleavage|2|||
129706686|NCT03342560|466888570|FG000|Overall Study|Lost to Follow-up|2|||
129645771|NCT01901653|466657570|FG003|Overall Study|Lost to Follow-up|0|||
129645772|NCT01901653|466657571|FG004|Overall Study|Lost to Follow-up|0|||
129645773|NCT01901653|466657572|FG005|Overall Study|Lost to Follow-up|1|||
129645774|NCT01901653|466657573|FG006|Overall Study|Lost to Follow-up|0|||
129645775|NCT01901653|466657574|FG007|Overall Study|Lost to Follow-up|1|||
129800029|NCT00973349|467235284|FG012|Overall Study|Protocol Violation|0|||
129800030|NCT00973349|467235285|FG013|Overall Study|Protocol Violation|0|||
129645776|NCT01901653|466657575|FG008|Overall Study|Lost to Follow-up|0|||
129645777|NCT01901653|466657576|FG009|Overall Study|Lost to Follow-up|0|||
129645778|NCT01901653|466657577|FG010|Overall Study|Lost to Follow-up|0|||
129706687|NCT02604511|466888571|FG000|Overall Study|Adverse Event|3|||
129706688|NCT02604511|466888571|FG000|Overall Study|Disease Progression|4|||
129706689|NCT02604511|466888571|FG000|Overall Study|Withdrawal by Subject|3|||
129706690|NCT02604511|466888571|FG000|Overall Study|Participant ineligible|1|||
129706691|NCT02604511|466888571|FG000|Overall Study|Intercurrent illness|1|||
129706692|NCT03770286|466888572|FG000|Overall Study|Lost to Follow-up|6|||
129706693|NCT03770286|466888573|FG001|Overall Study|Lost to Follow-up|4|||
129645779|NCT01901653|466657578|FG011|Overall Study|Lost to Follow-up|0|||
129645780|NCT01901653|466657579|FG012|Overall Study|Lost to Follow-up|0|||
129706694|NCT03770286|466888574|FG002|Overall Study|Lost to Follow-up|3|||
129706695|NCT03770286|466888572|FG000|Overall Study|Protocol Violation|1|||
129706696|NCT03770286|466888573|FG001|Overall Study|Protocol Violation|0|||
129706697|NCT03770286|466888574|FG002|Overall Study|Protocol Violation|2|||
129706698|NCT02297412|466888575|FG000|Overall Study|Canceled|1|||
129706699|NCT02297412|466888576|FG001|Overall Study|Canceled|1|||
129706700|NCT04712669|466888581|FG000|Double Blind Phase|Adverse Event|4|||
129706701|NCT04712669|466888582|FG001|Double Blind Phase|Adverse Event|4|||
129706702|NCT04712669|466888583|FG002|Double Blind Phase|Adverse Event|3|||
129706703|NCT04712669|466888584|FG003|Double Blind Phase|Adverse Event|0|||
129706704|NCT04712669|466888585|FG004|Double Blind Phase|Adverse Event|0|||
129706705|NCT04712669|466888586|FG005|Double Blind Phase|Adverse Event|0|||
129706706|NCT04712669|466888587|FG006|Double Blind Phase|Adverse Event|0|||
129706707|NCT04712669|466888588|FG007|Double Blind Phase|Adverse Event|0|||
129706708|NCT04712669|466888581|FG000|Double Blind Phase|Physician Decision|1|||
129706709|NCT04712669|466888582|FG001|Double Blind Phase|Physician Decision|0|||
129706710|NCT04712669|466888583|FG002|Double Blind Phase|Physician Decision|0|||
129706711|NCT04712669|466888584|FG003|Double Blind Phase|Physician Decision|0|||
129706712|NCT04712669|466888585|FG004|Double Blind Phase|Physician Decision|0|||
129706713|NCT04712669|466888586|FG005|Double Blind Phase|Physician Decision|0|||
129706714|NCT04712669|466888587|FG006|Double Blind Phase|Physician Decision|0|||
129706715|NCT04712669|466888588|FG007|Double Blind Phase|Physician Decision|0|||
129706716|NCT04712669|466888581|FG000|Double Blind Phase|Withdrawal by Subject|3|||
129706717|NCT04712669|466888582|FG001|Double Blind Phase|Withdrawal by Subject|6|||
129706718|NCT04712669|466888583|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129706719|NCT04712669|466888584|FG003|Double Blind Phase|Withdrawal by Subject|0|||
129706720|NCT04712669|466888585|FG004|Double Blind Phase|Withdrawal by Subject|0|||
129706721|NCT04712669|466888586|FG005|Double Blind Phase|Withdrawal by Subject|0|||
129706722|NCT04712669|466888587|FG006|Double Blind Phase|Withdrawal by Subject|0|||
129706723|NCT04712669|466888588|FG007|Double Blind Phase|Withdrawal by Subject|0|||
129706724|NCT04712669|466888581|FG000|Double Blind Phase|Termination by Sponsor|0|||
129706725|NCT04712669|466888582|FG001|Double Blind Phase|Termination by Sponsor|0|||
129706726|NCT04712669|466888583|FG002|Double Blind Phase|Termination by Sponsor|1|||
129706727|NCT04712669|466888584|FG003|Double Blind Phase|Termination by Sponsor|0|||
129706728|NCT04712669|466888585|FG004|Double Blind Phase|Termination by Sponsor|0|||
129706729|NCT04712669|466888586|FG005|Double Blind Phase|Termination by Sponsor|0|||
129706730|NCT04712669|466888587|FG006|Double Blind Phase|Termination by Sponsor|0|||
129706731|NCT04712669|466888588|FG007|Double Blind Phase|Termination by Sponsor|0|||
129706732|NCT04712669|466888581|FG000|Open Label Phase|Adverse Event|0|||
129706733|NCT04712669|466888582|FG001|Open Label Phase|Adverse Event|0|||
129706734|NCT04712669|466888583|FG002|Open Label Phase|Adverse Event|0|||
129706735|NCT04712669|466888584|FG003|Open Label Phase|Adverse Event|1|||
129706736|NCT04712669|466888585|FG004|Open Label Phase|Adverse Event|1|||
129706737|NCT04712669|466888586|FG005|Open Label Phase|Adverse Event|3|||
129706738|NCT04712669|466888587|FG006|Open Label Phase|Adverse Event|1|||
129706739|NCT04712669|466888588|FG007|Open Label Phase|Adverse Event|2|||
129706740|NCT04712669|466888581|FG000|Open Label Phase|Death|0|||
129706741|NCT04712669|466888582|FG001|Open Label Phase|Death|0|||
129706742|NCT04712669|466888583|FG002|Open Label Phase|Death|0|||
129706743|NCT04712669|466888584|FG003|Open Label Phase|Death|1|||
129706744|NCT04712669|466888585|FG004|Open Label Phase|Death|0|||
129706745|NCT04712669|466888586|FG005|Open Label Phase|Death|0|||
129706746|NCT04712669|466888587|FG006|Open Label Phase|Death|0|||
129706747|NCT04712669|466888588|FG007|Open Label Phase|Death|0|||
129706748|NCT04712669|466888581|FG000|Open Label Phase|Lack of Efficacy|0|||
129706749|NCT04712669|466888582|FG001|Open Label Phase|Lack of Efficacy|0|||
129706750|NCT04712669|466888583|FG002|Open Label Phase|Lack of Efficacy|0|||
129706751|NCT04712669|466888584|FG003|Open Label Phase|Lack of Efficacy|0|||
129706752|NCT04712669|466888585|FG004|Open Label Phase|Lack of Efficacy|1|||
129706753|NCT04712669|466888586|FG005|Open Label Phase|Lack of Efficacy|0|||
129706754|NCT04712669|466888587|FG006|Open Label Phase|Lack of Efficacy|0|||
129706755|NCT04712669|466888588|FG007|Open Label Phase|Lack of Efficacy|0|||
129706756|NCT04712669|466888581|FG000|Open Label Phase|Lost to Follow-up|0|||
129706757|NCT04712669|466888582|FG001|Open Label Phase|Lost to Follow-up|0|||
129706758|NCT04712669|466888583|FG002|Open Label Phase|Lost to Follow-up|0|||
129706759|NCT04712669|466888584|FG003|Open Label Phase|Lost to Follow-up|0|||
129706760|NCT04712669|466888585|FG004|Open Label Phase|Lost to Follow-up|0|||
129706761|NCT04712669|466888586|FG005|Open Label Phase|Lost to Follow-up|0|||
129706762|NCT04712669|466888587|FG006|Open Label Phase|Lost to Follow-up|1|||
129706763|NCT04712669|466888588|FG007|Open Label Phase|Lost to Follow-up|1|||
129706764|NCT04712669|466888581|FG000|Open Label Phase|Physician Decision|0|||
129706765|NCT04712669|466888582|FG001|Open Label Phase|Physician Decision|0|||
129706766|NCT04712669|466888583|FG002|Open Label Phase|Physician Decision|0|||
129706767|NCT04712669|466888584|FG003|Open Label Phase|Physician Decision|1|||
129706768|NCT04712669|466888585|FG004|Open Label Phase|Physician Decision|0|||
129706769|NCT04712669|466888586|FG005|Open Label Phase|Physician Decision|0|||
129706770|NCT04712669|466888587|FG006|Open Label Phase|Physician Decision|0|||
129706771|NCT04712669|466888588|FG007|Open Label Phase|Physician Decision|0|||
129706772|NCT04712669|466888581|FG000|Open Label Phase|Withdrawal by Subject|0|||
129706773|NCT04712669|466888582|FG001|Open Label Phase|Withdrawal by Subject|0|||
129706774|NCT04712669|466888583|FG002|Open Label Phase|Withdrawal by Subject|0|||
129706775|NCT04712669|466888584|FG003|Open Label Phase|Withdrawal by Subject|1|||
129706776|NCT04712669|466888585|FG004|Open Label Phase|Withdrawal by Subject|5|||
129706777|NCT04712669|466888586|FG005|Open Label Phase|Withdrawal by Subject|5|||
129706778|NCT04712669|466888587|FG006|Open Label Phase|Withdrawal by Subject|0|||
129706779|NCT04712669|466888588|FG007|Open Label Phase|Withdrawal by Subject|4|||
129706780|NCT04712669|466888581|FG000|Open Label Phase|Termination by Sponsor|0|||
129706781|NCT04712669|466888582|FG001|Open Label Phase|Termination by Sponsor|0|||
129706782|NCT04712669|466888583|FG002|Open Label Phase|Termination by Sponsor|0|||
129706783|NCT04712669|466888584|FG003|Open Label Phase|Termination by Sponsor|11|||
129706784|NCT04712669|466888585|FG004|Open Label Phase|Termination by Sponsor|9|||
129706785|NCT04712669|466888586|FG005|Open Label Phase|Termination by Sponsor|14|||
129706786|NCT04712669|466888587|FG006|Open Label Phase|Termination by Sponsor|0|||
129706787|NCT04712669|466888588|FG007|Open Label Phase|Termination by Sponsor|14|||
129706788|NCT03802396|466888589|FG000|Overall Study|Withdrawal by Subject|2|||
129706789|NCT03802396|466888590|FG001|Overall Study|Withdrawal by Subject|0|||
129706790|NCT03802396|466888589|FG000|Overall Study|Surgery Cancelled|1|||
129706791|NCT03802396|466888590|FG001|Overall Study|Surgery Cancelled|0|||
129890997|NCT01244763|467559576|FG000|Overall Study|Lost to Follow-up|0|||
129890998|NCT01244763|467559577|FG001|Overall Study|Lost to Follow-up|1|||
129890999|NCT01244763|467559578|FG002|Overall Study|Lost to Follow-up|0|||
129891000|NCT01244763|467559579|FG003|Overall Study|Lost to Follow-up|0|||
129891001|NCT01244763|467559580|FG004|Overall Study|Lost to Follow-up|0|||
129891002|NCT01244763|467559581|FG005|Overall Study|Lost to Follow-up|0|||
129891003|NCT01244763|467559576|FG000|Overall Study|Enrolled into the Extension Study|0|||
129891004|NCT01244763|467559577|FG001|Overall Study|Enrolled into the Extension Study|0|||
129706792|NCT02561962|466888594|FG000|Overall Study|Withdrawal by Subject|1|||
129706793|NCT02561962|466888595|FG001|Overall Study|Withdrawal by Subject|0|||
129706794|NCT02561962|466888596|FG002|Overall Study|Withdrawal by Subject|0|||
129706795|NCT02561962|466888597|FG003|Overall Study|Withdrawal by Subject|0|||
129706796|NCT02561962|466888598|FG004|Overall Study|Withdrawal by Subject|1|||
129706797|NCT02561962|466888599|FG005|Overall Study|Withdrawal by Subject|1|||
129706798|NCT02561962|466888600|FG006|Overall Study|Withdrawal by Subject|2|||
129706799|NCT02561962|466888601|FG007|Overall Study|Withdrawal by Subject|1|||
129706800|NCT02561962|466888602|FG008|Overall Study|Withdrawal by Subject|0|||
129706801|NCT02561962|466888594|FG000|Overall Study|Decision by sponsor|0|||
129706802|NCT02561962|466888595|FG001|Overall Study|Decision by sponsor|0|||
129706803|NCT02561962|466888596|FG002|Overall Study|Decision by sponsor|0|||
129706804|NCT02561962|466888597|FG003|Overall Study|Decision by sponsor|0|||
129706805|NCT02561962|466888598|FG004|Overall Study|Decision by sponsor|1|||
129706806|NCT02561962|466888599|FG005|Overall Study|Decision by sponsor|1|||
129706807|NCT02561962|466888600|FG006|Overall Study|Decision by sponsor|0|||
129706808|NCT02561962|466888601|FG007|Overall Study|Decision by sponsor|3|||
129706809|NCT02561962|466888602|FG008|Overall Study|Decision by sponsor|0|||
129706810|NCT02561962|466888594|FG000|Overall Study|Lost to Follow-up|0|||
129706811|NCT02561962|466888595|FG001|Overall Study|Lost to Follow-up|0|||
129706812|NCT02561962|466888596|FG002|Overall Study|Lost to Follow-up|0|||
129706813|NCT02561962|466888597|FG003|Overall Study|Lost to Follow-up|0|||
129706814|NCT02561962|466888598|FG004|Overall Study|Lost to Follow-up|0|||
129706815|NCT02561962|466888599|FG005|Overall Study|Lost to Follow-up|1|||
129706816|NCT02561962|466888600|FG006|Overall Study|Lost to Follow-up|0|||
129891005|NCT01244763|467559578|FG002|Overall Study|Enrolled into the Extension Study|0|||
129891006|NCT01244763|467559579|FG003|Overall Study|Enrolled into the Extension Study|0|||
129891007|NCT01244763|467559580|FG004|Overall Study|Enrolled into the Extension Study|0|||
129891008|NCT01244763|467559581|FG005|Overall Study|Enrolled into the Extension Study|1|||
129891009|NCT00519779|467559583|FG000|Overall Study|Withdrawal by Subject|0|||
129706817|NCT02561962|466888601|FG007|Overall Study|Lost to Follow-up|0|||
129706818|NCT02561962|466888602|FG008|Overall Study|Lost to Follow-up|0|||
129706819|NCT01150357|466888603|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
129706820|NCT01150357|466888604|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
129891010|NCT00519779|467559584|FG001|Overall Study|Withdrawal by Subject|1|||
129891011|NCT03330119|467559585|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
129891012|NCT03330119|467559586|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
129706821|NCT01150357|466888605|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
129706822|NCT01150357|466888603|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
129891013|NCT02015663|467559591|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
129706823|NCT01150357|466888604|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
129706824|NCT01150357|466888605|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
129706825|NCT01150357|466888603|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
129706826|NCT01150357|466888604|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
129706827|NCT01150357|466888605|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
129706828|NCT01150357|466888603|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
129706829|NCT01150357|466888604|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
129706830|NCT01150357|466888605|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
129706831|NCT01150357|466888603|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
129706832|NCT01150357|466888604|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
129706833|NCT01150357|466888605|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
129706834|NCT01150357|466888603|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
129706835|NCT01150357|466888604|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
129706836|NCT01150357|466888605|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
129706837|NCT01150357|466888603|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
129706838|NCT01150357|466888604|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
129706839|NCT01150357|466888605|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
129706840|NCT02114177|466890364|FG000|Overall Study|Lost to Follow-up|1|||
129706841|NCT02114177|466890365|FG001|Overall Study|Lost to Follow-up|2|||
129706842|NCT02114177|466890364|FG000|Overall Study|Withdrawal by Subject|6|||
129706843|NCT02114177|466890365|FG001|Overall Study|Withdrawal by Subject|1|||
129706844|NCT02114177|466890364|FG000|Overall Study|Other|2|||
129706845|NCT02114177|466890365|FG001|Overall Study|Other|1|||
129706846|NCT01819272|466890366|FG000|Overall Study|Adverse Event|1|||
129706847|NCT01819272|466890367|FG001|Overall Study|Adverse Event|0|||
129706848|NCT01819272|466890368|FG002|Overall Study|Adverse Event|0|||
129706849|NCT01819272|466890369|FG003|Overall Study|Adverse Event|2|||
129706850|NCT01819272|466890370|FG004|Overall Study|Adverse Event|0|||
129706851|NCT01819272|466890371|FG005|Overall Study|Adverse Event|0|||
129706852|NCT01819272|466890366|FG000|Overall Study|Lost to Follow-up|3|||
129706853|NCT01819272|466890367|FG001|Overall Study|Lost to Follow-up|0|||
129706854|NCT01819272|466890368|FG002|Overall Study|Lost to Follow-up|1|||
129706855|NCT01819272|466890369|FG003|Overall Study|Lost to Follow-up|0|||
129706856|NCT01819272|466890370|FG004|Overall Study|Lost to Follow-up|0|||
129706857|NCT01819272|466890371|FG005|Overall Study|Lost to Follow-up|3|||
129706858|NCT01819272|466890366|FG000|Overall Study|Protocol Violation|0|||
129706859|NCT01819272|466890367|FG001|Overall Study|Protocol Violation|0|||
129706860|NCT01819272|466890368|FG002|Overall Study|Protocol Violation|0|||
129706861|NCT01819272|466890369|FG003|Overall Study|Protocol Violation|1|||
129706862|NCT01819272|466890370|FG004|Overall Study|Protocol Violation|2|||
129706863|NCT01819272|466890371|FG005|Overall Study|Protocol Violation|3|||
129706864|NCT01819272|466890366|FG000|Overall Study|Physician Decision|0|||
129706865|NCT01819272|466890367|FG001|Overall Study|Physician Decision|1|||
129706866|NCT01819272|466890368|FG002|Overall Study|Physician Decision|0|||
129706867|NCT01819272|466890369|FG003|Overall Study|Physician Decision|0|||
129706868|NCT01819272|466890370|FG004|Overall Study|Physician Decision|0|||
129706869|NCT01819272|466890371|FG005|Overall Study|Physician Decision|0|||
129706870|NCT01819272|466890366|FG000|Overall Study|Withdrawal of Consent|0|||
129706871|NCT01819272|466890367|FG001|Overall Study|Withdrawal of Consent|1|||
129706872|NCT01819272|466890368|FG002|Overall Study|Withdrawal of Consent|2|||
129706873|NCT01819272|466890369|FG003|Overall Study|Withdrawal of Consent|1|||
129706874|NCT01819272|466890370|FG004|Overall Study|Withdrawal of Consent|0|||
129706875|NCT01819272|466890371|FG005|Overall Study|Withdrawal of Consent|1|||
129706876|NCT01819272|466890366|FG000|Overall Study|Loss of Glucose Control|2|||
129706877|NCT01819272|466890367|FG001|Overall Study|Loss of Glucose Control|1|||
129706878|NCT01819272|466890368|FG002|Overall Study|Loss of Glucose Control|0|||
129706879|NCT01819272|466890369|FG003|Overall Study|Loss of Glucose Control|1|||
129706880|NCT01819272|466890370|FG004|Overall Study|Loss of Glucose Control|2|||
129706881|NCT01819272|466890371|FG005|Overall Study|Loss of Glucose Control|0|||
129706882|NCT01732536|466890372|FG000|Overall Study|Withdrawal by Subject|1|||
129706883|NCT01732536|466890373|FG001|Overall Study|Withdrawal by Subject|1|||
129706884|NCT01581684|466890374|FG000|Overall Study|Other reason not defined|0|||
129891014|NCT02015663|467559592|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
129706885|NCT01581684|466890375|FG001|Overall Study|Other reason not defined|0|||
129706886|NCT01581684|466890376|FG002|Overall Study|Other reason not defined|0|||
129706887|NCT01581684|466890377|FG003|Overall Study|Other reason not defined|0|||
129706888|NCT01581684|466890378|FG004|Overall Study|Other reason not defined|0|||
129706889|NCT01581684|466890379|FG005|Overall Study|Other reason not defined|0|||
129706890|NCT01581684|466890380|FG006|Overall Study|Other reason not defined|0|||
129706891|NCT01581684|466890381|FG007|Overall Study|Other reason not defined|0|||
129706892|NCT01581684|466890382|FG008|Overall Study|Other reason not defined|1|||
129891015|NCT02015663|467559591|FG000|Overall Study|Withdrawal by Subject|1|||
129706893|NCT01581684|466890383|FG009|Overall Study|Other reason not defined|0|||
129706894|NCT03728933|466890384|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129706895|NCT03728933|466890385|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129706896|NCT03728933|466890386|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129891016|NCT02015663|467559592|FG001|Overall Study|Withdrawal by Subject|0|||
129706897|NCT03728933|466890384|FG000|Overall Study|Withdrawal by Subject|0|||
129706898|NCT03728933|466890385|FG001|Overall Study|Withdrawal by Subject|0|||
129706899|NCT03728933|466890386|FG002|Overall Study|Withdrawal by Subject|1|||
129706900|NCT03728933|466890384|FG000|Overall Study|Lost to Follow-up|0|||
129706901|NCT03728933|466890385|FG001|Overall Study|Lost to Follow-up|1|||
129706902|NCT03728933|466890386|FG002|Overall Study|Lost to Follow-up|0|||
129706903|NCT03728933|466890384|FG000|Overall Study|Adverse Event|1|||
129706904|NCT03728933|466890385|FG001|Overall Study|Adverse Event|0|||
129706905|NCT03728933|466890386|FG002|Overall Study|Adverse Event|0|||
129706906|NCT01784029|466890387|FG000|Overall Study|Lost to Follow-up|19|||
129706907|NCT01784029|466890388|FG001|Overall Study|Lost to Follow-up|20|||
129706908|NCT01784029|466890389|FG002|Overall Study|Lost to Follow-up|22|||
129706909|NCT00639457|466890390|FG000|Overall Study|Withdrawal by Subject|2|||
129706910|NCT00639457|466890391|FG001|Overall Study|Withdrawal by Subject|3|||
129706911|NCT03235050|466890392|FG000|Overall Study|Adverse Event|0|||
129706912|NCT03235050|466890393|FG001|Overall Study|Adverse Event|0|||
129706913|NCT03235050|466890394|FG002|Overall Study|Adverse Event|1|||
129706914|NCT03235050|466890395|FG003|Overall Study|Adverse Event|4|||
129706915|NCT03235050|466890396|FG004|Overall Study|Adverse Event|1|||
129706916|NCT03235050|466890392|FG000|Overall Study|Death|0|||
129706917|NCT03235050|466890393|FG001|Overall Study|Death|0|||
129706918|NCT03235050|466890394|FG002|Overall Study|Death|0|||
129706919|NCT03235050|466890395|FG003|Overall Study|Death|2|||
129706920|NCT03235050|466890396|FG004|Overall Study|Death|1|||
129706921|NCT03235050|466890392|FG000|Overall Study|Lost to Follow-up|1|||
129706922|NCT03235050|466890393|FG001|Overall Study|Lost to Follow-up|2|||
129706923|NCT03235050|466890394|FG002|Overall Study|Lost to Follow-up|1|||
129706924|NCT03235050|466890395|FG003|Overall Study|Lost to Follow-up|2|||
129706925|NCT03235050|466890396|FG004|Overall Study|Lost to Follow-up|0|||
129706926|NCT03235050|466890392|FG000|Overall Study|Withdrawal by Subject|3|||
129706927|NCT03235050|466890393|FG001|Overall Study|Withdrawal by Subject|2|||
129706928|NCT03235050|466890394|FG002|Overall Study|Withdrawal by Subject|2|||
129706929|NCT03235050|466890395|FG003|Overall Study|Withdrawal by Subject|5|||
129800031|NCT00973349|467235286|FG014|Overall Study|Protocol Violation|0|||
129800032|NCT00973349|467235287|FG015|Overall Study|Protocol Violation|0|||
129800033|NCT00973349|467235272|FG000|Overall Study|Unable to classify|0|||
129800034|NCT00973349|467235273|FG001|Overall Study|Unable to classify|0|||
129800035|NCT00973349|467235274|FG002|Overall Study|Unable to classify|0|||
129800036|NCT00973349|467235275|FG003|Overall Study|Unable to classify|0|||
129800037|NCT00973349|467235276|FG004|Overall Study|Unable to classify|1|||
129800038|NCT00973349|467235277|FG005|Overall Study|Unable to classify|1|||
129800039|NCT00973349|467235278|FG006|Overall Study|Unable to classify|0|||
129800040|NCT00973349|467235279|FG007|Overall Study|Unable to classify|0|||
129800041|NCT00973349|467235280|FG008|Overall Study|Unable to classify|0|||
129800042|NCT00973349|467235281|FG009|Overall Study|Unable to classify|1|||
129706930|NCT03235050|466890396|FG004|Overall Study|Withdrawal by Subject|7|||
129706931|NCT03235050|466890392|FG000|Overall Study|Other reasons|0|||
129706932|NCT03235050|466890393|FG001|Overall Study|Other reasons|1|||
129706933|NCT03235050|466890394|FG002|Overall Study|Other reasons|0|||
129706934|NCT03235050|466890395|FG003|Overall Study|Other reasons|1|||
129706935|NCT03235050|466890396|FG004|Overall Study|Other reasons|2|||
129706936|NCT00276419|466890397|FG000|First Intervention|Adverse Event|1|||
129891017|NCT02015663|467559591|FG000|Overall Study|Protocol Violation|0|||
129891018|NCT02015663|467559592|FG001|Overall Study|Protocol Violation|1|||
129706937|NCT00276419|466890398|FG001|First Intervention|Adverse Event|0|||
129706938|NCT00276419|466890397|FG000|First Intervention|Withdrawal by Subject|0|||
129706939|NCT00276419|466890398|FG001|First Intervention|Withdrawal by Subject|2|||
129706940|NCT00598650|466890399|FG000|Overall Study|Withdrawal by Subject|3|||
129706941|NCT00598650|466890399|FG000|Overall Study|Adverse Event|18|||
129706942|NCT00598650|466890399|FG000|Overall Study|No treatment for 3 weeks|1|||
129706943|NCT00598650|466890399|FG000|Overall Study|Not eligible|1|||
129706944|NCT00598650|466890399|FG000|Overall Study|Prohibited Concomitant Medication|2|||
129706945|NCT00598650|466890399|FG000|Overall Study|Physician Decision|2|||
129706946|NCT02415556|466890402|FG000|Overall Study|Adverse Event|3|||
129706947|NCT02415556|466890403|FG001|Overall Study|Adverse Event|4|||
129800043|NCT00973349|467235282|FG010|Overall Study|Unable to classify|0|||
129891019|NCT02015663|467559591|FG000|Overall Study|Adverse Event|3|||
129706948|NCT02415556|466890404|FG002|Overall Study|Adverse Event|2|||
129891020|NCT02015663|467559592|FG001|Overall Study|Adverse Event|0|||
129891021|NCT02015663|467559591|FG000|Overall Study|Administrative problems|10|||
129891022|NCT02015663|467559592|FG001|Overall Study|Administrative problems|11|||
129891023|NCT00479674|467559595|FG000|Overall Study|Adverse Event|18|||
129891024|NCT00479674|467559595|FG000|Overall Study|Withdrawal by Subject|6|||
129891025|NCT00479674|467559595|FG000|Overall Study|Physician Decision|14|||
129891026|NCT00479674|467559595|FG000|Overall Study|none provided|3|||
129891027|NCT00146640|467559601|FG000|Overall Study|Adverse Event|12|||
129891028|NCT00146640|467559602|FG001|Overall Study|Adverse Event|10|||
129891029|NCT00146640|467559601|FG000|Overall Study|Medical Reasons|3|||
129891030|NCT00146640|467559602|FG001|Overall Study|Medical Reasons|0|||
129891031|NCT00146640|467559601|FG000|Overall Study|Non-Medical Reasons|8|||
129891032|NCT00146640|467559602|FG001|Overall Study|Non-Medical Reasons|4|||
129891033|NCT02059161|467559603|FG000|Overall Study|Pregnancy|0|||
129891034|NCT02059161|467559604|FG001|Overall Study|Pregnancy|2|||
129891035|NCT02059161|467559603|FG000|Overall Study|Adverse Event|2|||
129891036|NCT02059161|467559604|FG001|Overall Study|Adverse Event|6|||
129891037|NCT02059161|467559603|FG000|Overall Study|Lost to Follow-up|20|||
129891038|NCT02059161|467559604|FG001|Overall Study|Lost to Follow-up|12|||
129706949|NCT02415556|466890405|FG003|Overall Study|Adverse Event|4|||
129706950|NCT02415556|466890402|FG000|Overall Study|Lost to Follow-up|4|||
129706951|NCT02415556|466890403|FG001|Overall Study|Lost to Follow-up|5|||
129706952|NCT02415556|466890404|FG002|Overall Study|Lost to Follow-up|4|||
129706953|NCT02415556|466890405|FG003|Overall Study|Lost to Follow-up|1|||
129706954|NCT02415556|466890402|FG000|Overall Study|Withdrawal by Subject|13|||
129706955|NCT02415556|466890403|FG001|Overall Study|Withdrawal by Subject|4|||
129706956|NCT02415556|466890404|FG002|Overall Study|Withdrawal by Subject|14|||
129891039|NCT02059161|467559603|FG000|Overall Study|Physician Decision|4|||
129891040|NCT02059161|467559604|FG001|Overall Study|Physician Decision|4|||
129891041|NCT02059161|467559603|FG000|Overall Study|Protocol Violation|1|||
129891042|NCT02059161|467559604|FG001|Overall Study|Protocol Violation|1|||
129891043|NCT02059161|467559603|FG000|Overall Study|Withdrawal by Subject|16|||
129891044|NCT02059161|467559604|FG001|Overall Study|Withdrawal by Subject|13|||
129891045|NCT02059161|467559603|FG000|Overall Study|Randomized in error, no study drug|0|||
129891046|NCT02059161|467559604|FG001|Overall Study|Randomized in error, no study drug|1|||
129891047|NCT02059161|467559603|FG000|Overall Study|Non-compliance with study drug|6|||
129891048|NCT02059161|467559604|FG001|Overall Study|Non-compliance with study drug|2|||
129891049|NCT03293485|467559606|FG000|Overall Study|Death|1|||
129891050|NCT03293485|467559606|FG000|Overall Study|Screen Failure|2|||
129891051|NCT03293485|467559606|FG000|Overall Study|Withdrawal by Subject|2|||
129891052|NCT01723826|467559610|FG000|Overall Study|Adverse Event|4|||
129891053|NCT01723826|467559611|FG001|Overall Study|Adverse Event|1|||
129891054|NCT01723826|467559612|FG002|Overall Study|Adverse Event|4|||
129891055|NCT01723826|467559613|FG003|Overall Study|Adverse Event|5|||
129891056|NCT01723826|467559610|FG000|Overall Study|Death according to AE eCRF|2|||
129891057|NCT01723826|467559611|FG001|Overall Study|Death according to AE eCRF|3|||
129891058|NCT01723826|467559612|FG002|Overall Study|Death according to AE eCRF|3|||
129891059|NCT01723826|467559613|FG003|Overall Study|Death according to AE eCRF|7|||
129891060|NCT01723826|467559610|FG000|Overall Study|Lost to Follow-up|1|||
129891061|NCT01723826|467559611|FG001|Overall Study|Lost to Follow-up|3|||
129891062|NCT01723826|467559612|FG002|Overall Study|Lost to Follow-up|1|||
129891063|NCT01723826|467559613|FG003|Overall Study|Lost to Follow-up|1|||
129891064|NCT01723826|467559610|FG000|Overall Study|Non-compliance|0|||
129891065|NCT01723826|467559611|FG001|Overall Study|Non-compliance|1|||
129891066|NCT01723826|467559612|FG002|Overall Study|Non-compliance|3|||
129891067|NCT01723826|467559613|FG003|Overall Study|Non-compliance|3|||
129891068|NCT01723826|467559610|FG000|Overall Study|Non-compliance With Study Drug|0|||
129706957|NCT02415556|466890405|FG003|Overall Study|Withdrawal by Subject|12|||
129706958|NCT02415556|466890402|FG000|Overall Study|Physician Decision|1|||
129706959|NCT02415556|466890403|FG001|Overall Study|Physician Decision|3|||
129706960|NCT02415556|466890404|FG002|Overall Study|Physician Decision|1|||
129706961|NCT02415556|466890405|FG003|Overall Study|Physician Decision|2|||
129706962|NCT02415556|466890402|FG000|Overall Study|Censored - study completion|4|||
129706963|NCT02415556|466890403|FG001|Overall Study|Censored - study completion|5|||
129706964|NCT02415556|466890404|FG002|Overall Study|Censored - study completion|1|||
129706965|NCT02415556|466890405|FG003|Overall Study|Censored - study completion|0|||
129706966|NCT02415556|466890402|FG000|Overall Study|Family-related issues|0|||
129706967|NCT02415556|466890403|FG001|Overall Study|Family-related issues|0|||
129706968|NCT02415556|466890404|FG002|Overall Study|Family-related issues|0|||
129706969|NCT02415556|466890405|FG003|Overall Study|Family-related issues|1|||
129706970|NCT00105534|466890406|FG000|Overall Study|Adverse Event|2|||
129706971|NCT00105534|466890407|FG001|Overall Study|Adverse Event|5|||
129706972|NCT00105534|466890406|FG000|Overall Study|Protocol Violation|1|||
129706973|NCT00105534|466890407|FG001|Overall Study|Protocol Violation|4|||
129706974|NCT00105534|466890406|FG000|Overall Study|Withdrawal by Subject|6|||
129706975|NCT00105534|466890407|FG001|Overall Study|Withdrawal by Subject|6|||
129706976|NCT00105534|466890406|FG000|Overall Study|Lost to Follow-up|5|||
129891069|NCT01723826|467559611|FG001|Overall Study|Non-compliance With Study Drug|1|||
129706977|NCT00105534|466890407|FG001|Overall Study|Lost to Follow-up|1|||
129706978|NCT00105534|466890406|FG000|Overall Study|Lack of Efficacy|7|||
129706979|NCT00105534|466890407|FG001|Overall Study|Lack of Efficacy|15|||
129706980|NCT00105534|466890406|FG000|Overall Study|Treatment unmasked|1|||
129706981|NCT00105534|466890407|FG001|Overall Study|Treatment unmasked|0|||
129706982|NCT00105534|466890406|FG000|Overall Study|Other Reason|0|||
129706983|NCT00105534|466890407|FG001|Overall Study|Other Reason|2|||
129706984|NCT01621178|466890408|FG000|Overall Study|Adverse Event|5|||
129706985|NCT01621178|466890409|FG001|Overall Study|Adverse Event|2|||
129706986|NCT01621178|466890410|FG002|Overall Study|Adverse Event|8|||
129706987|NCT01621178|466890408|FG000|Overall Study|Death|6|||
129706988|NCT01621178|466890409|FG001|Overall Study|Death|7|||
129706989|NCT01621178|466890410|FG002|Overall Study|Death|2|||
129706990|NCT01621178|466890408|FG000|Overall Study|Lost to Follow-up|1|||
129706991|NCT01621178|466890409|FG001|Overall Study|Lost to Follow-up|2|||
129706992|NCT01621178|466890410|FG002|Overall Study|Lost to Follow-up|1|||
129706993|NCT01621178|466890408|FG000|Overall Study|Withdrawal by Subject|14|||
129706994|NCT01621178|466890409|FG001|Overall Study|Withdrawal by Subject|17|||
129706995|NCT01621178|466890410|FG002|Overall Study|Withdrawal by Subject|18|||
129706996|NCT01621178|466890408|FG000|Overall Study|Physician Decision|5|||
129706997|NCT01621178|466890409|FG001|Overall Study|Physician Decision|2|||
129706998|NCT01621178|466890410|FG002|Overall Study|Physician Decision|7|||
129706999|NCT02935192|466890411|FG000|Overall Study|Withdrawal by Subject|8|||
129707000|NCT02935192|466890412|FG001|Overall Study|Withdrawal by Subject|4|||
129707001|NCT02896257|466890413|FG000|Providers|Without eligible patients|21|||
129707002|NCT02896257|466890414|FG001|Providers|Without eligible patients|28|||
129707003|NCT02896257|466890413|FG000|Patients|PFT entry criteria not met|43|||
129707004|NCT02896257|466890414|FG001|Patients|PFT entry criteria not met|50|||
129707005|NCT02896257|466890413|FG000|Patients|No capacity to review|8|||
129707006|NCT02896257|466890414|FG001|Patients|No capacity to review|11|||
129707007|NCT02896257|466890413|FG000|Patients|Appointment rescheduled/cancelled|5|||
129707008|NCT02896257|466890414|FG001|Patients|Appointment rescheduled/cancelled|7|||
129707009|NCT02896257|466890413|FG000|Patients|PCP not assigned a clinic|4|||
129707010|NCT02896257|466890414|FG001|Patients|PCP not assigned a clinic|0|||
129707011|NCT02896257|466890413|FG000|Patients|No history of COPD|0|||
129707012|NCT02896257|466890414|FG001|Patients|No history of COPD|1|||
129707013|NCT02896257|466890413|FG000|Patients|Deceased between review and index date|0|||
129707014|NCT02896257|466890414|FG001|Patients|Deceased between review and index date|1|||
129707015|NCT02896257|466890413|FG000|Patients|No ICS Rx upon review|1|||
129707016|NCT02896257|466890414|FG001|Patients|No ICS Rx upon review|1|||
129707017|NCT02896257|466890413|FG000|Patients|Protocol Violation|2|||
129707018|NCT02896257|466890414|FG001|Patients|Protocol Violation|1|||
129707019|NCT02896257|466890413|FG000|Patients|Hospice care|0|||
129707020|NCT02896257|466890414|FG001|Patients|Hospice care|1|||
129707021|NCT04778592|466890419|FG000|Overall Study|Adverse Event|1|||
129707022|NCT04778592|466890420|FG001|Overall Study|Adverse Event|2|||
129707023|NCT04778592|466890419|FG000|Overall Study|Withdrawal by Subject|1|||
129707024|NCT04778592|466890420|FG001|Overall Study|Withdrawal by Subject|2|||
129707025|NCT00560508|466890421|FG000|12 Week Double-blind Period|Adverse Event|3|||
129707026|NCT00560508|466890422|FG001|12 Week Double-blind Period|Adverse Event|2|||
129707027|NCT00560508|466890421|FG000|12 Week Double-blind Period|Protocol Violation|1|||
129707028|NCT00560508|466890422|FG001|12 Week Double-blind Period|Protocol Violation|0|||
129707029|NCT00560508|466890421|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
129707030|NCT00560508|466890422|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
129707031|NCT00560508|466890421|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
129707032|NCT00560508|466890422|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
129707033|NCT00560508|466890421|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
129707034|NCT00560508|466890422|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
129707035|NCT00560508|466890421|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
129707036|NCT00560508|466890422|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
129800044|NCT00973349|467235283|FG011|Overall Study|Unable to classify|0|||
129800045|NCT00973349|467235284|FG012|Overall Study|Unable to classify|0|||
129800046|NCT00973349|467235285|FG013|Overall Study|Unable to classify|0|||
129800047|NCT00973349|467235286|FG014|Overall Study|Unable to classify|0|||
129707037|NCT00560508|466890421|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
129707038|NCT00560508|466890422|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
129707039|NCT01192126|466890423|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
129707040|NCT01192126|466890424|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
129707041|NCT01192126|466890423|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
129707042|NCT01192126|466890424|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
129707043|NCT02660229|466890425|FG000|Overall Study|Adverse Event|2|||
129707044|NCT02660229|466890426|FG001|Overall Study|Adverse Event|0|||
129707045|NCT02660229|466890425|FG000|Overall Study|Withdrawal by Subject|0|||
129800048|NCT00973349|467235287|FG015|Overall Study|Unable to classify|0|||
129707046|NCT02660229|466890426|FG001|Overall Study|Withdrawal by Subject|1|||
129645781|NCT01901653|466657567|FG000|Overall Study|Withdrawal by Subject|0|||
129645782|NCT01901653|466657568|FG001|Overall Study|Withdrawal by Subject|0|||
129645783|NCT01901653|466657569|FG002|Overall Study|Withdrawal by Subject|0|||
129645784|NCT01901653|466657570|FG003|Overall Study|Withdrawal by Subject|0|||
129645785|NCT01901653|466657571|FG004|Overall Study|Withdrawal by Subject|0|||
129645786|NCT01901653|466657572|FG005|Overall Study|Withdrawal by Subject|0|||
129645787|NCT01901653|466657573|FG006|Overall Study|Withdrawal by Subject|1|||
129645788|NCT01901653|466657574|FG007|Overall Study|Withdrawal by Subject|0|||
129800049|NCT02301988|467235288|FG000|Overall Study|Withdrawal by Subject|2|||
129800050|NCT02301988|467235289|FG001|Overall Study|Withdrawal by Subject|1|||
129800051|NCT02301988|467235288|FG000|Overall Study|Physician Decision|2|||
129800052|NCT02301988|467235289|FG001|Overall Study|Physician Decision|2|||
129800053|NCT02301988|467235288|FG000|Overall Study|Unknown Reason|1|||
129800054|NCT02301988|467235289|FG001|Overall Study|Unknown Reason|3|||
129800055|NCT02301988|467235288|FG000|Overall Study|Lack of Efficacy|3|||
129800056|NCT02301988|467235289|FG001|Overall Study|Lack of Efficacy|2|||
129800057|NCT02301988|467235288|FG000|Overall Study|Death|1|||
129800058|NCT02301988|467235289|FG001|Overall Study|Death|0|||
129645789|NCT01901653|466657575|FG008|Overall Study|Withdrawal by Subject|0|||
129800059|NCT02301988|467235288|FG000|Overall Study|Adverse Event|1|||
129707047|NCT01146613|466890427|FG000|Overall Study|Lost to Follow-up|3|||
129707048|NCT01146613|466890428|FG001|Overall Study|Lost to Follow-up|8|||
129645790|NCT01901653|466657576|FG009|Overall Study|Withdrawal by Subject|0|||
129645791|NCT01901653|466657577|FG010|Overall Study|Withdrawal by Subject|0|||
129645792|NCT01901653|466657578|FG011|Overall Study|Withdrawal by Subject|0|||
129645793|NCT01901653|466657579|FG012|Overall Study|Withdrawal by Subject|0|||
129645794|NCT01901653|466657567|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
129645795|NCT01901653|466657568|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
129645796|NCT01901653|466657569|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
129645797|NCT01901653|466657570|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
129645798|NCT01901653|466657571|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
129645799|NCT01901653|466657572|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
129645800|NCT01901653|466657573|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
129645801|NCT01901653|466657574|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
129645802|NCT01901653|466657575|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
129645803|NCT01901653|466657576|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
129645804|NCT01901653|466657577|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
129645805|NCT01901653|466657578|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
129645806|NCT01901653|466657579|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
129645807|NCT02091986|466657580|FG000|Overall Study|7 rand in error 1 patient decision|2|||
129645808|NCT02091986|466657581|FG001|Overall Study|7 rand in error 1 patient decision|3|||
129645809|NCT02091986|466657582|FG002|Overall Study|7 rand in error 1 patient decision|3|||
129645810|NCT02091986|466657580|FG000|Overall Study|Lost to Follow-up|1|||
129645811|NCT02091986|466657581|FG001|Overall Study|Lost to Follow-up|0|||
129645812|NCT02091986|466657582|FG002|Overall Study|Lost to Follow-up|0|||
129645813|NCT02091986|466657580|FG000|Overall Study|Withdrawal by Subject|4|||
129645814|NCT02091986|466657581|FG001|Overall Study|Withdrawal by Subject|8|||
129645815|NCT02091986|466657582|FG002|Overall Study|Withdrawal by Subject|3|||
129645816|NCT02091986|466657580|FG000|Overall Study|Adverse Event|0|||
129645817|NCT02091986|466657581|FG001|Overall Study|Adverse Event|0|||
129645818|NCT02091986|466657582|FG002|Overall Study|Adverse Event|2|||
129645819|NCT02537431|466657586|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
129645820|NCT00794040|466657587|FG000|Overall Study|Withdrawal by Subject|3|||
129645821|NCT00794040|466657588|FG001|Overall Study|Withdrawal by Subject|4|||
129645822|NCT00794040|466657587|FG000|Overall Study|Physician Decision|0|||
129645823|NCT00794040|466657588|FG001|Overall Study|Physician Decision|1|||
129645824|NCT03626363|466657589|FG000|Overall Study|Protocol Violation|4|||
129645825|NCT03626363|466657590|FG001|Overall Study|Protocol Violation|0|||
129645826|NCT03626363|466657589|FG000|Overall Study|Lost to Follow-up|5|||
129645827|NCT03626363|466657590|FG001|Overall Study|Lost to Follow-up|7|||
129645828|NCT02600845|466657591|FG000|Overall Study|Reason Not Specified|3|||
129645829|NCT02600845|466657591|FG000|Overall Study|Non-compliance with Study Procedures|10|||
129645830|NCT02600845|466657591|FG000|Overall Study|Consent Withdrawal|5|||
129645831|NCT04413552|466657592|FG000|Overall Study|Adverse Event|0|||
129645832|NCT04413552|466657593|FG001|Overall Study|Adverse Event|0|||
129645833|NCT04413552|466657594|FG002|Overall Study|Adverse Event|0|||
129645834|NCT04413552|466657595|FG003|Overall Study|Adverse Event|0|||
129645835|NCT04413552|466657596|FG004|Overall Study|Adverse Event|0|||
129645836|NCT04413552|466657597|FG005|Overall Study|Adverse Event|0|||
129645837|NCT04413552|466657598|FG006|Overall Study|Adverse Event|1|||
129645838|NCT04413552|466657599|FG007|Overall Study|Adverse Event|0|||
129645839|NCT04413552|466657600|FG008|Overall Study|Adverse Event|0|||
129645840|NCT04413552|466657601|FG009|Overall Study|Adverse Event|0|||
129645841|NCT04852679|466657602|FG000|Main Intervention Period|Withdrawal by Subject|3|||
129645842|NCT04852679|466657602|FG000|Main Intervention Period|Adverse Event|1|||
129707049|NCT01146613|466890427|FG000|Overall Study|Lack of Efficacy|0|||
129645843|NCT04852679|466657602|FG000|Main Intervention Period|Progressive Disease|16|||
129645844|NCT04852679|466657602|FG000|Main Intervention Period|Refused study visit|1|||
129707050|NCT01146613|466890428|FG001|Overall Study|Lack of Efficacy|1|||
129707051|NCT01146613|466890427|FG000|Overall Study|Death|1|||
129707052|NCT01146613|466890428|FG001|Overall Study|Death|0|||
129707053|NCT01146613|466890427|FG000|Overall Study|Physician Decision|1|||
129707054|NCT01146613|466890428|FG001|Overall Study|Physician Decision|0|||
129707055|NCT01146613|466890427|FG000|Overall Study|Withdrawal by Subject|0|||
129707056|NCT01146613|466890428|FG001|Overall Study|Withdrawal by Subject|3|||
129707057|NCT01146613|466890427|FG000|Overall Study|schedule conflict|1|||
129707058|NCT01146613|466890428|FG001|Overall Study|schedule conflict|0|||
129707059|NCT01146613|466890427|FG000|Overall Study|Outpatient detox|1|||
129707060|NCT01146613|466890428|FG001|Overall Study|Outpatient detox|0|||
129707061|NCT02441218|466890435|FG000|Overall Study|Death|503|||
129707062|NCT02441218|466890436|FG001|Overall Study|Death|553|||
129707063|NCT02441218|466890435|FG000|Overall Study|Withdrawal by Subject|73|||
129707064|NCT02441218|466890436|FG001|Overall Study|Withdrawal by Subject|58|||
129707065|NCT02441218|466890435|FG000|Overall Study|Lost to Follow-up|2|||
129707066|NCT02441218|466890436|FG001|Overall Study|Lost to Follow-up|1|||
129707067|NCT01541371|466890437|FG000|Overall Study|Withdrawal by Subject|14|||
129707068|NCT01541371|466890437|FG000|Overall Study|Lost to Follow-up|21|||
129707069|NCT01541371|466890437|FG000|Overall Study|Adverse Event|15|||
129707070|NCT01541371|466890437|FG000|Overall Study|Lack of Efficacy|12|||
129707071|NCT01541371|466890437|FG000|Overall Study|Protocol Violation|6|||
129707072|NCT01541371|466890437|FG000|Overall Study|Study medication non-compliance|3|||
129707073|NCT01541371|466890437|FG000|Overall Study|Other|6|||
129707074|NCT02271880|466890440|FG000|Overall Study|Premature discontinuation of study|3|||
129707075|NCT02271880|466890441|FG001|Overall Study|Premature discontinuation of study|4|||
129707076|NCT02431325|466890442|FG000|Overall Study|Adverse Event|3|||
129707077|NCT02431325|466890443|FG001|Overall Study|Adverse Event|0|||
129707078|NCT02431325|466890442|FG000|Overall Study|Lost to Follow-up|0|||
129707079|NCT02431325|466890443|FG001|Overall Study|Lost to Follow-up|1|||
129707080|NCT02431325|466890442|FG000|Overall Study|Withdrawal by Subject|1|||
129707081|NCT02431325|466890443|FG001|Overall Study|Withdrawal by Subject|2|||
129707082|NCT02431325|466890442|FG000|Overall Study|Declined to take study medication|1|||
129707083|NCT02431325|466890443|FG001|Overall Study|Declined to take study medication|0|||
129707084|NCT02431325|466890442|FG000|Overall Study|Withdrew before starting study medication|1|||
129707085|NCT02431325|466890443|FG001|Overall Study|Withdrew before starting study medication|0|||
129707086|NCT02431325|466890442|FG000|Overall Study|Placebo shortage|2|||
129707087|NCT02431325|466890443|FG001|Overall Study|Placebo shortage|0|||
129707088|NCT00744861|466890444|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
129707089|NCT00744861|466890445|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
129707090|NCT00744861|466890446|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
129707091|NCT00744861|466890447|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
129707092|NCT00744861|466890444|FG000|Feasibility Stage 1|Pregnancy|0|||
129707093|NCT00744861|466890445|FG001|Feasibility Stage 1|Pregnancy|1|||
129707094|NCT00744861|466890446|FG002|Feasibility Stage 1|Pregnancy|0|||
129707095|NCT00744861|466890447|FG003|Feasibility Stage 1|Pregnancy|0|||
129707096|NCT00744861|466890444|FG000|Pivotal Stage 2|Adverse Event|0|||
129707097|NCT00744861|466890445|FG001|Pivotal Stage 2|Adverse Event|0|||
129707098|NCT00744861|466890446|FG002|Pivotal Stage 2|Adverse Event|6|||
129707099|NCT00744861|466890447|FG003|Pivotal Stage 2|Adverse Event|11|||
129707100|NCT00744861|466890444|FG000|Pivotal Stage 2|Death|0|||
129707101|NCT00744861|466890445|FG001|Pivotal Stage 2|Death|0|||
129707102|NCT00744861|466890446|FG002|Pivotal Stage 2|Death|0|||
129707103|NCT00744861|466890447|FG003|Pivotal Stage 2|Death|1|||
129707104|NCT00744861|466890444|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
129707105|NCT00744861|466890445|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
129707106|NCT00744861|466890446|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
129707107|NCT00744861|466890447|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
129707108|NCT00744861|466890444|FG000|Pivotal Stage 2|Physician Decision|0|||
129707109|NCT00744861|466890445|FG001|Pivotal Stage 2|Physician Decision|0|||
129707110|NCT00744861|466890446|FG002|Pivotal Stage 2|Physician Decision|3|||
129707111|NCT00744861|466890447|FG003|Pivotal Stage 2|Physician Decision|1|||
129707112|NCT00744861|466890444|FG000|Pivotal Stage 2|Protocol Violation|0|||
129707113|NCT00744861|466890445|FG001|Pivotal Stage 2|Protocol Violation|0|||
129707114|NCT00744861|466890446|FG002|Pivotal Stage 2|Protocol Violation|0|||
129707115|NCT00744861|466890447|FG003|Pivotal Stage 2|Protocol Violation|1|||
129707116|NCT00744861|466890444|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
129707117|NCT00744861|466890445|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
129707118|NCT00744861|466890446|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
129707119|NCT00744861|466890447|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
129707120|NCT00744861|466890444|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
129707121|NCT00744861|466890445|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
129707122|NCT00744861|466890446|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
129707123|NCT00744861|466890447|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
129707124|NCT00181844|466890448|FG000|Signed Consent|Withdrawal by Subject|5|||
129707125|NCT00181844|466890448|FG000|Signed Consent|Did not meet entrance criteria|7|||
129707126|NCT00181844|466890448|FG000|Exposed to Study Medication|Adverse Event|10|||
129707127|NCT00181844|466890448|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
129707128|NCT00181844|466890448|FG000|Exposed to Study Medication|Non-compliance|2|||
129707129|NCT00181844|466890448|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
129707130|NCT00181844|466890448|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
129707131|NCT04661033|466890449|FG000|Overall Study|Adverse Event|0|||
129707132|NCT04661033|466890450|FG001|Overall Study|Adverse Event|0|||
129707133|NCT04661033|466890451|FG002|Overall Study|Adverse Event|1|||
129707134|NCT04661033|466890452|FG003|Overall Study|Adverse Event|0|||
129707135|NCT04661033|466890449|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
129707136|NCT04661033|466890450|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
129707137|NCT04661033|466890451|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
129707138|NCT04661033|466890452|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
129707139|NCT04661033|466890449|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
129707671|NCT03961308|466892095|FG001|Overall Study|Lost to Follow-up|1|||
129645845|NCT04852679|466657602|FG000|Independent Injection Period|Missed study visit|1|||
129645846|NCT01294696|466657603|FG000|Overall Study|Screening failures|7|||
129645847|NCT01294696|466657603|FG000|Overall Study|Protocol Violation|8|||
129645848|NCT01294696|466657603|FG000|Overall Study|Missing BPI Response|7|||
129645849|NCT01294696|466657603|FG000|Overall Study|Site closure|52|||
129645850|NCT01871402|466659330|FG000|Overall Study|Lost to Follow-up|1|||
129645851|NCT01871402|466659331|FG001|Overall Study|Lost to Follow-up|0|||
129645852|NCT01871402|466659330|FG000|Overall Study|Withdrawal by Subject|0|||
129645853|NCT01871402|466659331|FG001|Overall Study|Withdrawal by Subject|2|||
129645854|NCT01871402|466659330|FG000|Overall Study|Non-compliance|0|||
129645855|NCT01871402|466659331|FG001|Overall Study|Non-compliance|1|||
129645856|NCT04594941|466659332|FG000|Overall Study|Other|0|||
129645857|NCT04594941|466659333|FG001|Overall Study|Other|3|||
129645858|NCT04594941|466659334|FG002|Overall Study|Other|1|||
129645859|NCT04594941|466659335|FG003|Overall Study|Other|0|||
129645860|NCT02424630|466659336|FG000|Overall Study|No rotator cuff tear|1|||
129645861|NCT02424630|466659337|FG001|Overall Study|No rotator cuff tear|2|||
129645862|NCT02424630|466659336|FG000|Overall Study|Open procedure|0|||
129645863|NCT02424630|466659337|FG001|Overall Study|Open procedure|1|||
129645864|NCT02703272|466659338|FG000|Overall Study|Death|4|||
129707140|NCT04661033|466890450|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
129707141|NCT04661033|466890451|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
129707142|NCT04661033|466890452|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
129707143|NCT04661033|466890449|FG000|Overall Study|Early discontinuation as per PI|1|||
129707144|NCT04661033|466890450|FG001|Overall Study|Early discontinuation as per PI|0|||
129707145|NCT04661033|466890451|FG002|Overall Study|Early discontinuation as per PI|0|||
129707146|NCT04661033|466890452|FG003|Overall Study|Early discontinuation as per PI|0|||
129707147|NCT04064905|466890453|FG000|Overall Study|Lost to Follow-up|0|||
129707148|NCT04064905|466890454|FG001|Overall Study|Lost to Follow-up|3|||
129707149|NCT04064905|466890455|FG002|Overall Study|Lost to Follow-up|1|||
129707150|NCT04064905|466890456|FG003|Overall Study|Lost to Follow-up|4|||
129707151|NCT04064905|466890457|FG004|Overall Study|Lost to Follow-up|2|||
129707152|NCT01567722|466890458|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
129707153|NCT01567722|466890459|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
129707154|NCT01567722|466890460|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
129707155|NCT01567722|466890458|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
129707672|NCT03961308|466892094|FG000|Overall Study|Adverse Event|0|||
129645865|NCT02703272|466659339|FG001|Overall Study|Death|9|||
129645866|NCT02703272|466659340|FG002|Overall Study|Death|19|||
129645867|NCT02703272|466659341|FG003|Overall Study|Death|10|||
129707156|NCT01567722|466890459|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
129707157|NCT01567722|466890460|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
129707158|NCT01567722|466890458|FG000|Overall Study|Protocol closure by the OCG|2|||
129707159|NCT01567722|466890459|FG001|Overall Study|Protocol closure by the OCG|0|||
129707160|NCT01567722|466890460|FG002|Overall Study|Protocol closure by the OCG|0|||
129707161|NCT01567722|466890458|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
129891070|NCT01723826|467559612|FG002|Overall Study|Non-compliance With Study Drug|0|||
129891071|NCT01723826|467559613|FG003|Overall Study|Non-compliance With Study Drug|0|||
129891072|NCT01723826|467559610|FG000|Overall Study|Other Reason|8|||
129891073|NCT01723826|467559611|FG001|Overall Study|Other Reason|6|||
129891074|NCT01723826|467559612|FG002|Overall Study|Other Reason|12|||
129891075|NCT01723826|467559613|FG003|Overall Study|Other Reason|14|||
129891076|NCT01723826|467559610|FG000|Overall Study|Physician Decision|1|||
129891077|NCT01723826|467559611|FG001|Overall Study|Physician Decision|3|||
129891078|NCT01723826|467559612|FG002|Overall Study|Physician Decision|4|||
129891079|NCT01723826|467559613|FG003|Overall Study|Physician Decision|11|||
129891080|NCT01723826|467559610|FG000|Overall Study|Protocol Violation|1|||
129891081|NCT01723826|467559611|FG001|Overall Study|Protocol Violation|1|||
129891082|NCT01723826|467559612|FG002|Overall Study|Protocol Violation|3|||
129645868|NCT02703272|466659338|FG000|Overall Study|Withdrawal by Subject|0|||
129645869|NCT02703272|466659339|FG001|Overall Study|Withdrawal by Subject|0|||
129645870|NCT02703272|466659340|FG002|Overall Study|Withdrawal by Subject|4|||
129645871|NCT02703272|466659341|FG003|Overall Study|Withdrawal by Subject|2|||
129645872|NCT02703272|466659338|FG000|Overall Study|Study Terminated by Sponsor|6|||
129645873|NCT02703272|466659339|FG001|Overall Study|Study Terminated by Sponsor|1|||
129645874|NCT02703272|466659340|FG002|Overall Study|Study Terminated by Sponsor|12|||
129645875|NCT02703272|466659341|FG003|Overall Study|Study Terminated by Sponsor|4|||
129645876|NCT02703272|466659338|FG000|Overall Study|Other|1|||
129645877|NCT02703272|466659339|FG001|Overall Study|Other|0|||
129645878|NCT02703272|466659340|FG002|Overall Study|Other|0|||
129645879|NCT02703272|466659341|FG003|Overall Study|Other|0|||
129645880|NCT02637895|466659342|FG000|Overall Study|Lost to Follow-up|4|||
129645881|NCT02637895|466659343|FG001|Overall Study|Lost to Follow-up|0|||
129645882|NCT02637895|466659342|FG000|Overall Study|Protocol Violation|0|||
129645883|NCT02637895|466659343|FG001|Overall Study|Protocol Violation|1|||
129645884|NCT02637895|466659342|FG000|Overall Study|Lack of Efficacy|1|||
129645885|NCT02637895|466659343|FG001|Overall Study|Lack of Efficacy|0|||
129645886|NCT02637895|466659342|FG000|Overall Study|Withdrawal by Subject|1|||
129645887|NCT02637895|466659343|FG001|Overall Study|Withdrawal by Subject|1|||
129645888|NCT02637895|466659342|FG000|Overall Study|Abnormal baseline lab|0|||
129645889|NCT02637895|466659343|FG001|Overall Study|Abnormal baseline lab|1|||
129645890|NCT02031640|466659344|FG000|Screening Period|Adverse Event|1|||
129645891|NCT02031640|466659345|FG001|Screening Period|Adverse Event|0|||
129645892|NCT02031640|466659346|FG002|Screening Period|Adverse Event|0|||
129645893|NCT02031640|466659347|FG003|Screening Period|Adverse Event|0|||
129645894|NCT02031640|466659348|FG004|Screening Period|Adverse Event|0|||
129645895|NCT02031640|466659349|FG005|Screening Period|Adverse Event|0|||
129645896|NCT02031640|466659344|FG000|Screening Period|Withdrawal by Subject|29|||
129645897|NCT02031640|466659345|FG001|Screening Period|Withdrawal by Subject|0|||
129645898|NCT02031640|466659346|FG002|Screening Period|Withdrawal by Subject|0|||
129645899|NCT02031640|466659347|FG003|Screening Period|Withdrawal by Subject|0|||
129645900|NCT02031640|466659348|FG004|Screening Period|Withdrawal by Subject|0|||
129645901|NCT02031640|466659349|FG005|Screening Period|Withdrawal by Subject|0|||
129645902|NCT02031640|466659344|FG000|Screening Period|Inclusion criteria not met|312|||
129645903|NCT02031640|466659345|FG001|Screening Period|Inclusion criteria not met|0|||
129645904|NCT02031640|466659346|FG002|Screening Period|Inclusion criteria not met|0|||
129645905|NCT02031640|466659347|FG003|Screening Period|Inclusion criteria not met|0|||
129645906|NCT02031640|466659348|FG004|Screening Period|Inclusion criteria not met|0|||
129645907|NCT02031640|466659349|FG005|Screening Period|Inclusion criteria not met|0|||
129645908|NCT02031640|466659344|FG000|Screening Period|Exclusion criteria met|30|||
129707162|NCT01567722|466890459|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
129645909|NCT02031640|466659345|FG001|Screening Period|Exclusion criteria met|0|||
129645910|NCT02031640|466659346|FG002|Screening Period|Exclusion criteria met|0|||
129707163|NCT01567722|466890460|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
129891083|NCT01723826|467559613|FG003|Overall Study|Protocol Violation|1|||
129891084|NCT01723826|467559610|FG000|Overall Study|Withdrawal by Subject|10|||
129891085|NCT01723826|467559611|FG001|Overall Study|Withdrawal by Subject|17|||
129645911|NCT02031640|466659347|FG003|Screening Period|Exclusion criteria met|0|||
129645912|NCT02031640|466659348|FG004|Screening Period|Exclusion criteria met|0|||
129645913|NCT02031640|466659349|FG005|Screening Period|Exclusion criteria met|0|||
129800060|NCT02301988|467235289|FG001|Overall Study|Adverse Event|1|||
129800061|NCT05169567|467235290|FG000|Overall Study|On study treatment|116|||
129800062|NCT05169567|467235291|FG001|Overall Study|On study treatment|128|||
129800063|NCT05169567|467235290|FG000|Overall Study|Lost to Follow-up|1|||
129800064|NCT05169567|467235291|FG001|Overall Study|Lost to Follow-up|0|||
129800065|NCT05169567|467235290|FG000|Overall Study|Withdrawal by Subject|25|||
129800066|NCT05169567|467235291|FG001|Overall Study|Withdrawal by Subject|21|||
129800067|NCT01015131|467235292|FG000|Overall Study|Physician Decision|1|||
129800068|NCT01015131|467235292|FG000|Overall Study|Protocol Violation|1|||
129800069|NCT01015131|467235292|FG000|Overall Study|Withdrawal by Subject|2|||
129800070|NCT01015131|467235292|FG000|Overall Study|Other Protocol Specified Criteria|4|||
129645914|NCT02031640|466659344|FG000|Screening Period|Lost to Follow-up|14|||
129645915|NCT02031640|466659345|FG001|Screening Period|Lost to Follow-up|0|||
129645916|NCT02031640|466659346|FG002|Screening Period|Lost to Follow-up|0|||
129645917|NCT02031640|466659347|FG003|Screening Period|Lost to Follow-up|0|||
129645918|NCT02031640|466659348|FG004|Screening Period|Lost to Follow-up|0|||
129645919|NCT02031640|466659349|FG005|Screening Period|Lost to Follow-up|0|||
129645920|NCT02031640|466659344|FG000|Screening Period|Enrollment closed|26|||
129645921|NCT02031640|466659345|FG001|Screening Period|Enrollment closed|0|||
129645922|NCT02031640|466659346|FG002|Screening Period|Enrollment closed|0|||
129645923|NCT02031640|466659347|FG003|Screening Period|Enrollment closed|0|||
129645924|NCT02031640|466659348|FG004|Screening Period|Enrollment closed|0|||
129645925|NCT02031640|466659349|FG005|Screening Period|Enrollment closed|0|||
129645926|NCT02031640|466659344|FG000|Run-In Period|Adverse Event|4|||
129645927|NCT02031640|466659345|FG001|Run-In Period|Adverse Event|0|||
129645928|NCT02031640|466659346|FG002|Run-In Period|Adverse Event|0|||
129645929|NCT02031640|466659347|FG003|Run-In Period|Adverse Event|0|||
129645930|NCT02031640|466659348|FG004|Run-In Period|Adverse Event|0|||
129645931|NCT02031640|466659349|FG005|Run-In Period|Adverse Event|0|||
129645932|NCT02031640|466659344|FG000|Run-In Period|Withdrawal by Subject|17|||
129645933|NCT02031640|466659345|FG001|Run-In Period|Withdrawal by Subject|0|||
129645934|NCT02031640|466659346|FG002|Run-In Period|Withdrawal by Subject|0|||
129645935|NCT02031640|466659347|FG003|Run-In Period|Withdrawal by Subject|0|||
129645936|NCT02031640|466659348|FG004|Run-In Period|Withdrawal by Subject|0|||
129645937|NCT02031640|466659349|FG005|Run-In Period|Withdrawal by Subject|0|||
129645938|NCT02031640|466659344|FG000|Run-In Period|Inclusion criteria not met|38|||
129645939|NCT02031640|466659345|FG001|Run-In Period|Inclusion criteria not met|0|||
129645940|NCT02031640|466659346|FG002|Run-In Period|Inclusion criteria not met|0|||
129645941|NCT02031640|466659347|FG003|Run-In Period|Inclusion criteria not met|0|||
129645942|NCT02031640|466659348|FG004|Run-In Period|Inclusion criteria not met|0|||
129645943|NCT02031640|466659349|FG005|Run-In Period|Inclusion criteria not met|0|||
129645944|NCT02031640|466659344|FG000|Run-In Period|Exclusion criteria met|8|||
129645945|NCT02031640|466659345|FG001|Run-In Period|Exclusion criteria met|0|||
129645946|NCT02031640|466659346|FG002|Run-In Period|Exclusion criteria met|0|||
129645947|NCT02031640|466659347|FG003|Run-In Period|Exclusion criteria met|0|||
129645948|NCT02031640|466659348|FG004|Run-In Period|Exclusion criteria met|0|||
129645949|NCT02031640|466659349|FG005|Run-In Period|Exclusion criteria met|0|||
129707164|NCT00382174|466890462|FG000|Overall Study|Lost to Follow-up|1|||
129707165|NCT00382174|466890463|FG001|Overall Study|Lost to Follow-up|4|||
129707166|NCT00382174|466890464|FG002|Overall Study|Lost to Follow-up|5|||
129707167|NCT00382174|466890462|FG000|Overall Study|Adverse Event|1|||
129707168|NCT00382174|466890463|FG001|Overall Study|Adverse Event|4|||
129707169|NCT00382174|466890464|FG002|Overall Study|Adverse Event|5|||
129707170|NCT00382174|466890462|FG000|Overall Study|Withdrawal by Subject|1|||
129800071|NCT05430022|467235293|FG000|Overall Study|Withdrawal by Subject|4|||
129800072|NCT05430022|467235294|FG001|Overall Study|Withdrawal by Subject|4|||
129800073|NCT05069259|467235298|FG000|Overall Study|Withdrawal by Subject|1|||
129800074|NCT05069259|467235298|FG000|Overall Study|Sponsor decision|1|||
129800075|NCT03148275|467235299|FG000|Overall Study|Death|6|||
129800076|NCT03148275|467235299|FG000|Overall Study|Adverse Event|3|||
129800077|NCT03148275|467235299|FG000|Overall Study|Liver transplant|2|||
129800078|NCT03148275|467235299|FG000|Overall Study|Patient decision|5|||
129800079|NCT03148275|467235299|FG000|Overall Study|transition to commercial drug|1|||
129800080|NCT03148275|467235299|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
129800081|NCT05098938|467235300|FG000|Overall Study|Adverse Event|4|||
129645950|NCT02031640|466659344|FG000|Run-In Period|Randomization criteria not met|85|||
129645951|NCT02031640|466659345|FG001|Run-In Period|Randomization criteria not met|0|||
129645952|NCT02031640|466659346|FG002|Run-In Period|Randomization criteria not met|0|||
129707171|NCT00382174|466890463|FG001|Overall Study|Withdrawal by Subject|4|||
129707172|NCT00382174|466890464|FG002|Overall Study|Withdrawal by Subject|5|||
129800082|NCT05098938|467235301|FG001|Overall Study|Adverse Event|3|||
129645953|NCT02031640|466659347|FG003|Run-In Period|Randomization criteria not met|0|||
129645954|NCT02031640|466659348|FG004|Run-In Period|Randomization criteria not met|0|||
129707173|NCT00382174|466890462|FG000|Overall Study|Non compliance|1|||
129707174|NCT00382174|466890463|FG001|Overall Study|Non compliance|0|||
129707175|NCT00382174|466890464|FG002|Overall Study|Non compliance|1|||
129707176|NCT00382174|466890462|FG000|Overall Study|Physician Decision|0|||
129707177|NCT00382174|466890463|FG001|Overall Study|Physician Decision|2|||
129707178|NCT00382174|466890464|FG002|Overall Study|Physician Decision|2|||
129707179|NCT00382174|466890462|FG000|Overall Study|Failed to meet criteria|0|||
129707180|NCT00382174|466890463|FG001|Overall Study|Failed to meet criteria|1|||
129707181|NCT00382174|466890464|FG002|Overall Study|Failed to meet criteria|1|||
129707182|NCT00382174|466890462|FG000|Overall Study|Wounds merged|0|||
129707183|NCT00382174|466890463|FG001|Overall Study|Wounds merged|2|||
129707184|NCT00382174|466890464|FG002|Overall Study|Wounds merged|2|||
129707185|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
129707186|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
129707187|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
129707188|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Death|0|||
129707189|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Death|0|||
129707190|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Death|1|||
129645955|NCT02031640|466659349|FG005|Run-In Period|Randomization criteria not met|0|||
129645956|NCT02031640|466659344|FG000|Run-In Period|Various administrative reasons|17|||
129645957|NCT02031640|466659345|FG001|Run-In Period|Various administrative reasons|0|||
129645958|NCT02031640|466659346|FG002|Run-In Period|Various administrative reasons|0|||
129645959|NCT02031640|466659347|FG003|Run-In Period|Various administrative reasons|0|||
129645960|NCT02031640|466659348|FG004|Run-In Period|Various administrative reasons|0|||
129645961|NCT02031640|466659349|FG005|Run-In Period|Various administrative reasons|0|||
129645962|NCT02031640|466659344|FG000|Double-blind Treatment Period|Protocol deviation|0|||
129645963|NCT02031640|466659345|FG001|Double-blind Treatment Period|Protocol deviation|2|||
129645964|NCT02031640|466659346|FG002|Double-blind Treatment Period|Protocol deviation|0|||
129645965|NCT02031640|466659347|FG003|Double-blind Treatment Period|Protocol deviation|1|||
129645966|NCT02031640|466659348|FG004|Double-blind Treatment Period|Protocol deviation|3|||
129645967|NCT02031640|466659349|FG005|Double-blind Treatment Period|Protocol deviation|1|||
129645968|NCT02031640|466659344|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129645969|NCT02031640|466659345|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
129645970|NCT02031640|466659346|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
129645971|NCT02031640|466659347|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
129645972|NCT02031640|466659348|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
129645973|NCT02031640|466659349|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
129645974|NCT02031640|466659344|FG000|Double-blind Treatment Period|Non-compliance|0|||
129645975|NCT02031640|466659345|FG001|Double-blind Treatment Period|Non-compliance|1|||
129645976|NCT02031640|466659346|FG002|Double-blind Treatment Period|Non-compliance|0|||
129645977|NCT02031640|466659347|FG003|Double-blind Treatment Period|Non-compliance|1|||
129645978|NCT02031640|466659348|FG004|Double-blind Treatment Period|Non-compliance|1|||
129645979|NCT02031640|466659349|FG005|Double-blind Treatment Period|Non-compliance|0|||
129645980|NCT02031640|466659344|FG000|Double-blind Treatment Period|Adverse Event|0|||
129645981|NCT02031640|466659345|FG001|Double-blind Treatment Period|Adverse Event|0|||
129645982|NCT02031640|466659346|FG002|Double-blind Treatment Period|Adverse Event|0|||
129645983|NCT02031640|466659347|FG003|Double-blind Treatment Period|Adverse Event|2|||
129645984|NCT02031640|466659348|FG004|Double-blind Treatment Period|Adverse Event|0|||
129645985|NCT02031640|466659349|FG005|Double-blind Treatment Period|Adverse Event|0|||
129645986|NCT02031640|466659344|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129645987|NCT02031640|466659345|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129645988|NCT02031640|466659346|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
129645989|NCT02031640|466659347|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
129645990|NCT02031640|466659348|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
129645991|NCT02031640|466659349|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
129707191|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
129707192|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
129707193|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
129707194|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
129707195|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
129707196|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
129707197|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
129707198|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
129707199|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
129707200|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Graft loss|0|||
129707201|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Graft loss|0|||
129707202|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Graft loss|7|||
129800083|NCT05098938|467235300|FG000|Overall Study|inclusion/exclusion criteria change|11|||
129800084|NCT05098938|467235301|FG001|Overall Study|inclusion/exclusion criteria change|5|||
129800085|NCT05098938|467235300|FG000|Overall Study|lack of compliance|26|||
129707203|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
129645992|NCT02031640|466659344|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129645993|NCT02031640|466659345|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
129645994|NCT02031640|466659346|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129645995|NCT02031640|466659347|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129645996|NCT02031640|466659348|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
129645997|NCT02031640|466659349|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
129645998|NCT03085238|466659354|FG000|Overall Study|Adverse Event|2|||
129645999|NCT03085238|466659354|FG000|Overall Study|Death|2|||
129646000|NCT05896527|466659355|FG000|Overall Study|Withdrawal by Subject|11|||
129646001|NCT05896527|466659356|FG001|Overall Study|Withdrawal by Subject|10|||
129646002|NCT05896527|466659357|FG002|Overall Study|Withdrawal by Subject|4|||
129646003|NCT05896527|466659358|FG003|Overall Study|Withdrawal by Subject|3|||
129646004|NCT05896527|466659359|FG004|Overall Study|Withdrawal by Subject|2|||
129646005|NCT05896527|466659355|FG000|Overall Study|Lost to Follow-up|0|||
129646006|NCT05896527|466659356|FG001|Overall Study|Lost to Follow-up|2|||
129646007|NCT05896527|466659357|FG002|Overall Study|Lost to Follow-up|2|||
129646008|NCT05896527|466659358|FG003|Overall Study|Lost to Follow-up|2|||
129646009|NCT05896527|466659359|FG004|Overall Study|Lost to Follow-up|1|||
129646010|NCT05896527|466659355|FG000|Overall Study|Significant protocol noncompliance|0|||
129646011|NCT05896527|466659356|FG001|Overall Study|Significant protocol noncompliance|1|||
129646012|NCT05896527|466659357|FG002|Overall Study|Significant protocol noncompliance|0|||
129646013|NCT05896527|466659358|FG003|Overall Study|Significant protocol noncompliance|0|||
129646014|NCT05896527|466659359|FG004|Overall Study|Significant protocol noncompliance|0|||
129646015|NCT05896527|466659355|FG000|Overall Study|Eligibility criteria not met|1|||
129646016|NCT05896527|466659356|FG001|Overall Study|Eligibility criteria not met|0|||
129646017|NCT05896527|466659357|FG002|Overall Study|Eligibility criteria not met|0|||
129646018|NCT05896527|466659358|FG003|Overall Study|Eligibility criteria not met|0|||
129646019|NCT05896527|466659359|FG004|Overall Study|Eligibility criteria not met|0|||
129646020|NCT05896527|466659355|FG000|Overall Study|Sponsor's decision|0|||
129646021|NCT05896527|466659356|FG001|Overall Study|Sponsor's decision|0|||
129646022|NCT05896527|466659357|FG002|Overall Study|Sponsor's decision|0|||
129646023|NCT05896527|466659358|FG003|Overall Study|Sponsor's decision|1|||
129646024|NCT05896527|466659359|FG004|Overall Study|Sponsor's decision|0|||
129646025|NCT05896527|466659355|FG000|Overall Study|Investigator's decision|0|||
129646026|NCT05896527|466659356|FG001|Overall Study|Investigator's decision|1|||
129646027|NCT05896527|466659357|FG002|Overall Study|Investigator's decision|0|||
129646028|NCT05896527|466659358|FG003|Overall Study|Investigator's decision|0|||
129646029|NCT05896527|466659359|FG004|Overall Study|Investigator's decision|0|||
129646030|NCT05896527|466659355|FG000|Overall Study|Pregnancy of his partner|0|||
129646031|NCT05896527|466659356|FG001|Overall Study|Pregnancy of his partner|0|||
129646032|NCT05896527|466659357|FG002|Overall Study|Pregnancy of his partner|0|||
129646033|NCT05896527|466659358|FG003|Overall Study|Pregnancy of his partner|1|||
129646034|NCT05896527|466659359|FG004|Overall Study|Pregnancy of his partner|0|||
129646035|NCT01279070|466659360|FG000|Overall Study|Withdrawal by Subject|2|||
129646036|NCT01279070|466659361|FG001|Overall Study|Withdrawal by Subject|3|||
129646037|NCT01279070|466659360|FG000|Overall Study|Acute exacerbation|3|||
129646038|NCT01279070|466659361|FG001|Overall Study|Acute exacerbation|1|||
129646039|NCT03781583|466659362|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
129646040|NCT03781583|466659363|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
129646041|NCT03781583|466659364|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
129646042|NCT03781583|466659365|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
129646043|NCT03781583|466659362|FG000|Overall Study|Technology did not work for that person in that environment|1|||
129646044|NCT03781583|466659363|FG001|Overall Study|Technology did not work for that person in that environment|0|||
129646045|NCT03781583|466659364|FG002|Overall Study|Technology did not work for that person in that environment|0|||
129646046|NCT03781583|466659365|FG003|Overall Study|Technology did not work for that person in that environment|0|||
129646047|NCT03781583|466659362|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
129646048|NCT03781583|466659363|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
129646049|NCT03781583|466659364|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
129646050|NCT03781583|466659365|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
129646051|NCT03781583|466659362|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
129646052|NCT03781583|466659363|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
129646053|NCT03781583|466659364|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
129646054|NCT03781583|466659365|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
129646055|NCT05139303|466659366|FG000|Overall Study|Lost to Follow-up|3|||
129646056|NCT05139303|466659367|FG001|Overall Study|Lost to Follow-up|0|||
129646057|NCT05139303|466659366|FG000|Overall Study|Adverse Event|1|||
129646058|NCT05139303|466659367|FG001|Overall Study|Adverse Event|0|||
129646059|NCT02222545|466659368|FG000|Overall Study|Adverse Event|1|||
129646060|NCT02222545|466659369|FG001|Overall Study|Adverse Event|0|||
129646061|NCT02222545|466659370|FG002|Overall Study|Adverse Event|2|||
129646062|NCT02222545|466659368|FG000|Overall Study|Death|0|||
129646063|NCT02222545|466659369|FG001|Overall Study|Death|0|||
129646064|NCT02222545|466659370|FG002|Overall Study|Death|9|||
129646065|NCT02222545|466659368|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
129646066|NCT02222545|466659369|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
129646067|NCT02222545|466659370|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
129646068|NCT02222545|466659368|FG000|Overall Study|Withdrawal by Subject|0|||
129646069|NCT02222545|466659369|FG001|Overall Study|Withdrawal by Subject|0|||
129646070|NCT02222545|466659370|FG002|Overall Study|Withdrawal by Subject|3|||
129646071|NCT02222545|466659368|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
129646072|NCT02222545|466659369|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
129646073|NCT02222545|466659370|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
129646074|NCT00761280|466659371|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
129646075|NCT00761280|466659372|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
129646076|NCT00761280|466659371|FG000|Randomization to First Dose|Sponsor decision|1|||
129646077|NCT00761280|466659372|FG001|Randomization to First Dose|Sponsor decision|0|||
129646078|NCT00761280|466659371|FG000|Randomization to First Dose|Other|1|||
129646079|NCT00761280|466659372|FG001|Randomization to First Dose|Other|0|||
129646080|NCT00761280|466659371|FG000|First Dose to End of Study|End of trial|5|||
129646081|NCT00761280|466659372|FG001|First Dose to End of Study|End of trial|5|||
129646082|NCT00761280|466659371|FG000|First Dose to End of Study|Progressive disease|5|||
129646083|NCT00761280|466659372|FG001|First Dose to End of Study|Progressive disease|3|||
129646084|NCT00761280|466659371|FG000|First Dose to End of Study|Sponsor decision|1|||
129646085|NCT00761280|466659372|FG001|First Dose to End of Study|Sponsor decision|2|||
129646086|NCT00761280|466659371|FG000|First Dose to End of Study|Death|1|||
129646087|NCT00761280|466659372|FG001|First Dose to End of Study|Death|0|||
129646088|NCT00761280|466659371|FG000|First Dose to End of Study|Lost to Follow-up|0|||
129646089|NCT00761280|466659372|FG001|First Dose to End of Study|Lost to Follow-up|1|||
129646090|NCT03875482|466659373|FG000|Overall Study|Adverse Event|0|||
129646091|NCT03875482|466659374|FG001|Overall Study|Adverse Event|1|||
129646092|NCT03875482|466659373|FG000|Overall Study|Withdrew consent|5|||
129646093|NCT03875482|466659374|FG001|Overall Study|Withdrew consent|6|||
129646094|NCT03875482|466659373|FG000|Overall Study|Lost to Follow-up|8|||
129646095|NCT03875482|466659374|FG001|Overall Study|Lost to Follow-up|2|||
129646096|NCT03875482|466659373|FG000|Overall Study|Lack of Efficacy|0|||
129646097|NCT03875482|466659374|FG001|Overall Study|Lack of Efficacy|11|||
129646098|NCT02045862|466659376|FG000|Overall Study|Death|0|||
129646099|NCT02045862|466659377|FG001|Overall Study|Death|0|||
129646100|NCT02045862|466659378|FG002|Overall Study|Death|1|||
129646101|NCT02045862|466659376|FG000|Overall Study|Miscellaneous|5|||
129646102|NCT02045862|466659377|FG001|Overall Study|Miscellaneous|0|||
129646103|NCT02045862|466659378|FG002|Overall Study|Miscellaneous|8|||
129646104|NCT02045862|466659376|FG000|Overall Study|Withdrawal by Patient|18|||
129646105|NCT02045862|466659377|FG001|Overall Study|Withdrawal by Patient|27|||
129646106|NCT02045862|466659378|FG002|Overall Study|Withdrawal by Patient|57|||
129646107|NCT02045862|466659376|FG000|Overall Study|Protocol Violation|0|||
129646108|NCT02045862|466659377|FG001|Overall Study|Protocol Violation|0|||
129646109|NCT02045862|466659378|FG002|Overall Study|Protocol Violation|6|||
129646110|NCT02045862|466659376|FG000|Overall Study|Lack of Efficacy|8|||
129646111|NCT02045862|466659377|FG001|Overall Study|Lack of Efficacy|4|||
129646112|NCT02045862|466659378|FG002|Overall Study|Lack of Efficacy|13|||
129646113|NCT02045862|466659376|FG000|Overall Study|Randomized but not Received Study Drug|0|||
129646114|NCT02045862|466659377|FG001|Overall Study|Randomized but not Received Study Drug|2|||
129646115|NCT02045862|466659378|FG002|Overall Study|Randomized but not Received Study Drug|8|||
129646116|NCT02045862|466659376|FG000|Overall Study|Adverse Event|7|||
129646117|NCT02045862|466659377|FG001|Overall Study|Adverse Event|5|||
129646118|NCT02045862|466659378|FG002|Overall Study|Adverse Event|27|||
129646119|NCT02045862|466659376|FG000|Overall Study|Lost to Follow-up|1|||
129646120|NCT02045862|466659377|FG001|Overall Study|Lost to Follow-up|2|||
129646121|NCT02045862|466659378|FG002|Overall Study|Lost to Follow-up|6|||
129646122|NCT02691013|466659379|FG000|Overall Study|Withdrawal by Subject|3|||
129646123|NCT02691013|466659380|FG001|Overall Study|Withdrawal by Subject|0|||
129646124|NCT02111785|466659384|FG000|Overall Study|Death|0|||
129646125|NCT02111785|466659385|FG001|Overall Study|Death|1|||
129646126|NCT02111785|466659386|FG002|Overall Study|Death|0|||
129646127|NCT02111785|466659387|FG003|Overall Study|Death|0|||
129646128|NCT01075646|466659390|FG000|Overall Study|Lost to Follow-up|4|||
129646129|NCT01075646|466659391|FG001|Overall Study|Lost to Follow-up|3|||
129646130|NCT01075646|466659392|FG002|Overall Study|Lost to Follow-up|1|||
129646131|NCT01075646|466659393|FG003|Overall Study|Lost to Follow-up|2|||
129646132|NCT01676896|466659397|FG000|Overall Study|Withdrawal by Subject|12|||
129646133|NCT01676896|466659398|FG001|Overall Study|Withdrawal by Subject|7|||
129646134|NCT01676896|466659399|FG002|Overall Study|Withdrawal by Subject|19|||
129646135|NCT02256982|466659400|FG000|Overall Study|Disease Progression|0|||
129646136|NCT02256982|466659401|FG001|Overall Study|Disease Progression|1|||
129646137|NCT02822573|466659402|FG000|Overall Study|Lost to Follow-up|5|||
129646138|NCT02822573|466659403|FG001|Overall Study|Lost to Follow-up|3|||
129646139|NCT02822573|466659402|FG000|Overall Study|Physician Decision|1|||
129646140|NCT02822573|466659403|FG001|Overall Study|Physician Decision|1|||
129646141|NCT02822573|466659402|FG000|Overall Study|Withdrawal by Subject|9|||
129646142|NCT02822573|466659403|FG001|Overall Study|Withdrawal by Subject|5|||
129646143|NCT02822573|466659402|FG000|Overall Study|Protocol Violation|6|||
129646144|NCT02822573|466659403|FG001|Overall Study|Protocol Violation|4|||
129646145|NCT02822573|466659402|FG000|Overall Study|Too sick or ill|2|||
129646146|NCT02822573|466659403|FG001|Overall Study|Too sick or ill|1|||
129646147|NCT02822573|466659402|FG000|Overall Study|Disease Progression|1|||
129646148|NCT02822573|466659403|FG001|Overall Study|Disease Progression|1|||
129646149|NCT02822573|466659402|FG000|Overall Study|No reason given|6|||
129646150|NCT02822573|466659403|FG001|Overall Study|No reason given|4|||
129646151|NCT01044290|466659404|FG000|Follow-up 1|Death|3|||
129646152|NCT01044290|466659405|FG001|Follow-up 1|Death|3|||
129646153|NCT01044290|466659406|FG002|Follow-up 1|Death|1|||
129646154|NCT01044290|466659404|FG000|Follow-up 1|Withdrawal by Subject|2|||
129646155|NCT01044290|466659405|FG001|Follow-up 1|Withdrawal by Subject|2|||
129646156|NCT01044290|466659406|FG002|Follow-up 1|Withdrawal by Subject|0|||
129646157|NCT01044290|466659404|FG000|Follow-Up 2|Death|0|||
129646158|NCT01044290|466659405|FG001|Follow-Up 2|Death|1|||
129646159|NCT01044290|466659406|FG002|Follow-Up 2|Death|1|||
129646160|NCT01044290|466659404|FG000|Follow-Up 2|Withdrawal by Subject|0|||
129646161|NCT01044290|466659405|FG001|Follow-Up 2|Withdrawal by Subject|1|||
129646162|NCT01044290|466659406|FG002|Follow-Up 2|Withdrawal by Subject|1|||
129646163|NCT00759785|466659412|FG000|Overall Study|Participant sample not evaluable|11|||
129646164|NCT00759785|466659413|FG001|Overall Study|Participant sample not evaluable|2|||
129646165|NCT00759785|466659412|FG000|Overall Study|Participant sample lost|0|||
129646166|NCT00759785|466659413|FG001|Overall Study|Participant sample lost|1|||
129646167|NCT00759785|466659412|FG000|Overall Study|Protocol Violation|1|||
129646168|NCT00759785|466659413|FG001|Overall Study|Protocol Violation|0|||
129646169|NCT00759785|466659412|FG000|Overall Study|Physician Decision|0|||
129646170|NCT00759785|466659413|FG001|Overall Study|Physician Decision|1|||
129646171|NCT00759785|466659412|FG000|Overall Study|Withdrawal by Subject|0|||
129646172|NCT00759785|466659413|FG001|Overall Study|Withdrawal by Subject|1|||
129646173|NCT01646021|466659414|FG000|Overall Study|Death|77|||
129646174|NCT01646021|466659415|FG001|Overall Study|Death|83|||
129646175|NCT01646021|466659414|FG000|Overall Study|Study Terminated by Sponsor|50|||
129646176|NCT01646021|466659415|FG001|Overall Study|Study Terminated by Sponsor|41|||
129646177|NCT01646021|466659414|FG000|Overall Study|Lost to Follow-up|2|||
129646178|NCT01646021|466659415|FG001|Overall Study|Lost to Follow-up|2|||
129646179|NCT01646021|466659414|FG000|Overall Study|Withdrawal by Subject|10|||
129646180|NCT01646021|466659415|FG001|Overall Study|Withdrawal by Subject|15|||
129646181|NCT01967706|466659421|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
129646182|NCT01967706|466659422|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
129646183|NCT01967706|466659423|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129646184|NCT01967706|466659424|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
129646185|NCT02777970|466659425|FG000|Overall Study|Lost to Follow-up|0|||
129646186|NCT02777970|466659426|FG001|Overall Study|Lost to Follow-up|1|||
129646187|NCT02777970|466659427|FG002|Overall Study|Lost to Follow-up|0|||
129646188|NCT02777970|466659425|FG000|Overall Study|Protocol Violation|1|||
129646189|NCT02777970|466659426|FG001|Overall Study|Protocol Violation|0|||
129646190|NCT02777970|466659427|FG002|Overall Study|Protocol Violation|0|||
129646191|NCT02347891|466659433|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
129646192|NCT02347891|466659434|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
129646193|NCT02347891|466659433|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
129646194|NCT02347891|466659434|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
129646195|NCT01083186|466659437|FG000|Overall Study|Lost to Follow-up|48|||
129646196|NCT01083186|466659437|FG000|Overall Study|Consent Withdrawal|7|||
129646197|NCT01083186|466659437|FG000|Overall Study|Death|3|||
129646198|NCT01083186|466659437|FG000|Overall Study|Adverse Event|3|||
129646199|NCT01083186|466659437|FG000|Overall Study|Lack of Efficacy|2|||
129646200|NCT01083186|466659437|FG000|Overall Study|Hemodialysis Initiation|28|||
129646201|NCT01083186|466659437|FG000|Overall Study|Administrative Reasons|2|||
129646202|NCT01083186|466659437|FG000|Overall Study|Non-compliance to Study Treatment|1|||
129646203|NCT03419598|466659444|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
129646204|NCT04569968|466659445|FG000|Overall Study|Lost to Follow-up|2|||
129646205|NCT04569968|466659446|FG001|Overall Study|Lost to Follow-up|5|||
129646206|NCT04569968|466659445|FG000|Overall Study|Story of head and/or neck surgery|2|||
129646207|NCT04569968|466659446|FG001|Overall Study|Story of head and/or neck surgery|2|||
129646208|NCT04569968|466659445|FG000|Overall Study|Time of stroke onset|8|||
129646209|NCT04569968|466659446|FG001|Overall Study|Time of stroke onset|7|||
129646210|NCT04569968|466659445|FG000|Overall Study|Type of strokr|12|||
129646211|NCT04569968|466659446|FG001|Overall Study|Type of strokr|8|||
129646212|NCT04569968|466659445|FG000|Overall Study|Cooperation|8|||
129646213|NCT04569968|466659446|FG001|Overall Study|Cooperation|8|||
129646214|NCT04569968|466659445|FG000|Overall Study|Age interval|17|||
129646215|NCT04569968|466659446|FG001|Overall Study|Age interval|6|||
129646216|NCT04569968|466659445|FG000|Overall Study|Denial of participation to the study|0|||
129646217|NCT04569968|466659446|FG001|Overall Study|Denial of participation to the study|3|||
129646218|NCT04569968|466659445|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
129646219|NCT04569968|466659446|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
129646220|NCT04569968|466659445|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
129646221|NCT04569968|466659446|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
129646222|NCT04569968|466659445|FG000|Overall Study|Quarantine|1|||
129646223|NCT04569968|466659446|FG001|Overall Study|Quarantine|0|||
129646224|NCT04569968|466659445|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
129646225|NCT04569968|466659446|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
129646226|NCT04569968|466659445|FG000|Overall Study|Repetitive stroke|8|||
129646227|NCT04569968|466659446|FG001|Overall Study|Repetitive stroke|0|||
129646228|NCT04569968|466659445|FG000|Overall Study|Insufficient mastication|1|||
129646229|NCT04569968|466659446|FG001|Overall Study|Insufficient mastication|0|||
129646230|NCT04569968|466659445|FG000|Overall Study|Infection|1|||
129646231|NCT04569968|466659446|FG001|Overall Study|Infection|0|||
129646232|NCT02370667|466659447|FG000|Overall Study|Lost to Follow-up|0|||
129646233|NCT02370667|466659448|FG001|Overall Study|Lost to Follow-up|1|||
129646234|NCT02370667|466659449|FG002|Overall Study|Lost to Follow-up|0|||
129646235|NCT00976209|466659452|FG000|Treatment Period 1|Protocol Violation|1|||
129646236|NCT00976209|466659453|FG001|Treatment Period 1|Protocol Violation|0|||
129646237|NCT00976209|466659452|FG000|Treatment Period 1|Lost to Follow-up|2|||
129646238|NCT00976209|466659453|FG001|Treatment Period 1|Lost to Follow-up|0|||
129646239|NCT00976209|466659452|FG000|Treatment Period 1|Other|0|||
129646240|NCT00976209|466659453|FG001|Treatment Period 1|Other|1|||
129646241|NCT00976209|466659452|FG000|Wash-out Period|Adverse Event|1|||
129646242|NCT00976209|466659453|FG001|Wash-out Period|Adverse Event|2|||
129646243|NCT00976209|466659452|FG000|Wash-out Period|Lost to Follow-up|1|||
129646244|NCT00976209|466659453|FG001|Wash-out Period|Lost to Follow-up|0|||
129646245|NCT00976209|466659452|FG000|Wash-out Period|Protocol Violation|1|||
129646246|NCT00976209|466659453|FG001|Wash-out Period|Protocol Violation|0|||
129646247|NCT00976209|466659452|FG000|Wash-out Period|Other|1|||
129646248|NCT00976209|466659453|FG001|Wash-out Period|Other|0|||
129646249|NCT00976209|466659452|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129646250|NCT00976209|466659453|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129646251|NCT00976209|466659452|FG000|Treatment Period 2|Lost to Follow-up|0|||
129646252|NCT00976209|466659453|FG001|Treatment Period 2|Lost to Follow-up|1|||
129646253|NCT03197870|466659457|FG000|Overall Study|Adverse Event|9|||
129646254|NCT03197870|466659458|FG001|Overall Study|Adverse Event|4|||
129646255|NCT03197870|466659459|FG002|Overall Study|Adverse Event|6|||
129646256|NCT03197870|466659457|FG000|Overall Study|Withdrawal by Subject|2|||
129646257|NCT03197870|466659458|FG001|Overall Study|Withdrawal by Subject|3|||
129646258|NCT03197870|466659459|FG002|Overall Study|Withdrawal by Subject|0|||
129646259|NCT03197870|466659457|FG000|Overall Study|Lost to Follow-up|2|||
129646260|NCT03197870|466659458|FG001|Overall Study|Lost to Follow-up|2|||
129646261|NCT03197870|466659459|FG002|Overall Study|Lost to Follow-up|0|||
129646262|NCT03197870|466659457|FG000|Overall Study|data not available|1|||
129646263|NCT03197870|466659458|FG001|Overall Study|data not available|1|||
129707204|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
129707205|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
129707206|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
129707207|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
129646264|NCT03197870|466659459|FG002|Overall Study|data not available|0|||
129707208|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
129646265|NCT03973918|466659466|FG000|Overall Study|Adverse Event|0|||
129646266|NCT03973918|466659467|FG001|Overall Study|Adverse Event|0|||
129646267|NCT03973918|466659468|FG002|Overall Study|Adverse Event|0|||
129646268|NCT03973918|466659469|FG003|Overall Study|Adverse Event|1|||
129646269|NCT03973918|466659466|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
129646270|NCT03973918|466659467|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
129646271|NCT03973918|466659468|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
129646272|NCT03973918|466659469|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
129646273|NCT00978250|466659470|FG000|Overall Study|Late determination of ineligibility|0|||
129646274|NCT00978250|466659471|FG001|Overall Study|Late determination of ineligibility|1|||
129646275|NCT00978250|466659472|FG002|Overall Study|Late determination of ineligibility|0|||
129800086|NCT05098938|467235301|FG001|Overall Study|lack of compliance|19|||
129800087|NCT05098938|467235300|FG000|Overall Study|Lost to Follow-up|37|||
129800088|NCT05098938|467235301|FG001|Overall Study|Lost to Follow-up|40|||
129800089|NCT05098938|467235300|FG000|Overall Study|Lost in treatment period|17|||
129800090|NCT05098938|467235301|FG001|Overall Study|Lost in treatment period|13|||
129800091|NCT05098938|467235300|FG000|Overall Study|Met an exclusion criterion|0|||
129800092|NCT05098938|467235301|FG001|Overall Study|Met an exclusion criterion|3|||
129646276|NCT00978250|466659473|FG003|Overall Study|Late determination of ineligibility|1|||
129646277|NCT05174949|466659476|FG000|Overall Study|Physician Decision|1|||
129646278|NCT05174949|466659477|FG001|Overall Study|Physician Decision|2|||
129646279|NCT05174949|466659478|FG002|Overall Study|Physician Decision|0|||
129646280|NCT05174949|466659479|FG003|Overall Study|Physician Decision|1|||
129646281|NCT05174949|466659480|FG004|Overall Study|Physician Decision|0|||
129646282|NCT05174949|466659481|FG005|Overall Study|Physician Decision|0|||
129646283|NCT05174949|466659476|FG000|Overall Study|Withdrawal by Subject|0|||
129646284|NCT05174949|466659477|FG001|Overall Study|Withdrawal by Subject|1|||
129646285|NCT05174949|466659478|FG002|Overall Study|Withdrawal by Subject|0|||
129646286|NCT05174949|466659479|FG003|Overall Study|Withdrawal by Subject|0|||
129646287|NCT05174949|466659480|FG004|Overall Study|Withdrawal by Subject|0|||
129646288|NCT05174949|466659481|FG005|Overall Study|Withdrawal by Subject|0|||
129646289|NCT05174949|466659476|FG000|Overall Study|Lost to Follow-up|0|||
129646290|NCT05174949|466659477|FG001|Overall Study|Lost to Follow-up|0|||
129646291|NCT05174949|466659478|FG002|Overall Study|Lost to Follow-up|0|||
129646292|NCT05174949|466659479|FG003|Overall Study|Lost to Follow-up|1|||
129646293|NCT05174949|466659480|FG004|Overall Study|Lost to Follow-up|0|||
129646294|NCT05174949|466659481|FG005|Overall Study|Lost to Follow-up|0|||
129646295|NCT02951533|466659482|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
129646296|NCT02951533|466659483|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
129646297|NCT02951533|466659484|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
129646298|NCT02951533|466659482|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
129646299|NCT02951533|466659483|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
129646300|NCT02951533|466659484|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
129646301|NCT02951533|466659482|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
129646302|NCT02951533|466659483|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
129646303|NCT02951533|466659484|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
129646304|NCT02951533|466659482|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
129646305|NCT02951533|466659483|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
129646306|NCT02951533|466659484|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
129646307|NCT02951533|466659482|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
129646308|NCT02951533|466659483|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
129646309|NCT02951533|466659484|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
129646310|NCT02951533|466659482|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
129646311|NCT02951533|466659483|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
129646312|NCT02951533|466659484|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
129646313|NCT02951533|466659482|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
129646314|NCT02951533|466659483|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
129646315|NCT02951533|466659484|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
129646316|NCT02951533|466659482|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
129646317|NCT02951533|466659483|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
129646318|NCT02951533|466659484|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
129646319|NCT02951533|466659482|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
129646320|NCT02951533|466659483|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
129646321|NCT02951533|466659484|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
129646322|NCT02951533|466659482|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
129646323|NCT02951533|466659483|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
129646324|NCT02951533|466659484|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
129646325|NCT02951533|466659482|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
129646326|NCT02951533|466659483|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
129646327|NCT02951533|466659484|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
129646328|NCT02029989|466659485|FG000|Overall Study|Withdrawal by Subject|1|||
129646329|NCT02029989|466659486|FG001|Overall Study|Withdrawal by Subject|0|||
129646330|NCT02029989|466659485|FG000|Overall Study|Withdrawal: Fear of needles|1|||
129646331|NCT02029989|466659486|FG001|Overall Study|Withdrawal: Fear of needles|0|||
129646332|NCT02029989|466659485|FG000|Overall Study|Change of location|2|||
129646333|NCT02029989|466659486|FG001|Overall Study|Change of location|3|||
129646334|NCT02029989|466659485|FG000|Overall Study|Physician Decision|2|||
129646335|NCT02029989|466659486|FG001|Overall Study|Physician Decision|0|||
129646336|NCT02029989|466659485|FG000|Overall Study|Lost to Follow-up|9|||
129646337|NCT02029989|466659486|FG001|Overall Study|Lost to Follow-up|7|||
129646338|NCT02029989|466659485|FG000|Overall Study|Death|0|||
129800093|NCT05098938|467235300|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
129646339|NCT02029989|466659486|FG001|Overall Study|Death|1|||
129646340|NCT02029989|466659485|FG000|Overall Study|Protocol Violation|1|||
129646341|NCT02029989|466659486|FG001|Overall Study|Protocol Violation|0|||
129646342|NCT04351373|466659487|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
129646343|NCT00742508|466659496|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
129646344|NCT00742508|466659497|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
129646345|NCT00742508|466659496|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
129646346|NCT00742508|466659497|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
129646347|NCT00742508|466659496|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
129646348|NCT00742508|466659497|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
129646349|NCT00742508|466659496|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
129646350|NCT00742508|466659497|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
129646351|NCT00742508|466659496|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
129646352|NCT00742508|466659497|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
129646353|NCT04696354|466659500|FG000|Overall Study|Study termination|6|||
129646354|NCT04696354|466659501|FG001|Overall Study|Study termination|6|||
129646355|NCT02730377|466661847|FG000|Overall Study|Other|5|||
129646356|NCT02730377|466661848|FG001|Overall Study|Other|4|||
129646357|NCT02730377|466661847|FG000|Overall Study|Death|1|||
129646358|NCT02730377|466661848|FG001|Overall Study|Death|8|||
129646359|NCT02730377|466661847|FG000|Overall Study|Inadequate glycaemic control|368|||
129646360|NCT02730377|466661848|FG001|Overall Study|Inadequate glycaemic control|473|||
129646361|NCT02730377|466661847|FG000|Overall Study|Adverse Event|79|||
129646362|NCT02730377|466661848|FG001|Overall Study|Adverse Event|41|||
129646363|NCT02730377|466661847|FG000|Overall Study|Protocol Violation|23|||
129646364|NCT02730377|466661848|FG001|Overall Study|Protocol Violation|30|||
129646365|NCT02730377|466661847|FG000|Overall Study|Lack of Efficacy|4|||
129646366|NCT02730377|466661848|FG001|Overall Study|Lack of Efficacy|13|||
129646367|NCT02730377|466661847|FG000|Overall Study|Pregnancy|0|||
129646368|NCT02730377|466661848|FG001|Overall Study|Pregnancy|1|||
129646369|NCT02730377|466661847|FG000|Overall Study|Withdrawal by Subject|45|||
129646370|NCT02730377|466661848|FG001|Overall Study|Withdrawal by Subject|42|||
129646371|NCT02730377|466661847|FG000|Overall Study|Lost to Follow-up|25|||
129646372|NCT02730377|466661848|FG001|Overall Study|Lost to Follow-up|21|||
129646373|NCT04045132|466661851|FG000|Overall Study|Lost to Follow-up|3|||
129646374|NCT04045132|466661852|FG001|Overall Study|Lost to Follow-up|6|||
129646375|NCT02143791|466661856|FG000|Enrolled|Withdrawal by Subject|4|||
129646376|NCT02143791|466661856|FG000|Trial Stimulation|Lack of Efficacy|21|||
129646377|NCT02143791|466661856|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
129646378|NCT02143791|466661856|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
129646379|NCT02143791|466661856|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
129646380|NCT02143791|466661856|FG000|Any Programming (3-6 Months)|Missing Data|1|||
129646381|NCT02143791|466661856|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
129646382|NCT00401544|466661857|FG000|Overall Study|Adverse Event|5|||
129646383|NCT00401544|466661858|FG001|Overall Study|Adverse Event|1|||
129646384|NCT00401544|466661859|FG002|Overall Study|Adverse Event|1|||
129646385|NCT00401544|466661860|FG003|Overall Study|Adverse Event|1|||
129646386|NCT00401544|466661857|FG000|Overall Study|Death|3|||
129646387|NCT00401544|466661858|FG001|Overall Study|Death|6|||
129646388|NCT00401544|466661859|FG002|Overall Study|Death|2|||
129646389|NCT00401544|466661860|FG003|Overall Study|Death|5|||
129646390|NCT00401544|466661857|FG000|Overall Study|Lost to Follow-up|2|||
129646391|NCT00401544|466661858|FG001|Overall Study|Lost to Follow-up|0|||
129646392|NCT00401544|466661859|FG002|Overall Study|Lost to Follow-up|1|||
129646393|NCT00401544|466661860|FG003|Overall Study|Lost to Follow-up|1|||
129646394|NCT00401544|466661857|FG000|Overall Study|Withdrawal by Subject|7|||
129646395|NCT00401544|466661858|FG001|Overall Study|Withdrawal by Subject|6|||
129646396|NCT00401544|466661859|FG002|Overall Study|Withdrawal by Subject|6|||
129646397|NCT00401544|466661860|FG003|Overall Study|Withdrawal by Subject|5|||
129707209|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
129707210|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
129707211|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
129707212|NCT00956293|466890475|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
129707213|NCT00956293|466890476|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
129646398|NCT00401544|466661857|FG000|Overall Study|Physician Decision|1|||
129646399|NCT00401544|466661858|FG001|Overall Study|Physician Decision|3|||
129646400|NCT00401544|466661859|FG002|Overall Study|Physician Decision|0|||
129646401|NCT00401544|466661860|FG003|Overall Study|Physician Decision|0|||
129646402|NCT00401544|466661857|FG000|Overall Study|Ineligibility determined|0|||
129646403|NCT00401544|466661858|FG001|Overall Study|Ineligibility determined|1|||
129646404|NCT00401544|466661859|FG002|Overall Study|Ineligibility determined|0|||
129646405|NCT00401544|466661860|FG003|Overall Study|Ineligibility determined|2|||
129646406|NCT00401544|466661857|FG000|Overall Study|Disease progression|0|||
129707214|NCT00956293|466890477|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
129646407|NCT00401544|466661858|FG001|Overall Study|Disease progression|1|||
129646408|NCT00401544|466661859|FG002|Overall Study|Disease progression|0|||
129646409|NCT00401544|466661860|FG003|Overall Study|Disease progression|0|||
129646410|NCT00401544|466661857|FG000|Overall Study|Other|0|||
129646411|NCT00401544|466661858|FG001|Overall Study|Other|0|||
129646412|NCT00401544|466661859|FG002|Overall Study|Other|2|||
129646413|NCT00401544|466661860|FG003|Overall Study|Other|2|||
129646414|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Adverse Event|6|||
129646415|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Adverse Event|14|||
129646416|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Death|3|||
129646417|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Death|1|||
129646418|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
129707215|NCT00956293|466890475|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
129707216|NCT00956293|466890476|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
129646419|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
129646420|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
129646421|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
129646422|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
129646423|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
129646424|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
129646425|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
129646426|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
129646427|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
129646428|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Physician Decision|2|||
129646429|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Physician Decision|4|||
129646430|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Pregnancy|2|||
129646431|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Pregnancy|1|||
129646432|NCT02275780|466661874|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
129646433|NCT02275780|466661875|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
129646434|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
129646435|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
129646436|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
129646437|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
129646438|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
129646439|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
129646440|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
129646441|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
129646442|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
129646443|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
129646444|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
129646445|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
129646446|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
129646447|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
129646448|NCT02275780|466661874|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
129646449|NCT02275780|466661875|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
129646450|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
129646451|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
129646452|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
129646453|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
129646454|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
129646455|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
129707217|NCT00956293|466890477|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
129707218|NCT00956293|466890475|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
129707219|NCT00956293|466890476|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
129707220|NCT00956293|466890477|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
129707221|NCT00956293|466890475|FG000|Main Period (Randomization)|Adverse Event|0|||
129707222|NCT00956293|466890476|FG001|Main Period (Randomization)|Adverse Event|15|||
129707223|NCT00956293|466890477|FG002|Main Period (Randomization)|Adverse Event|0|||
129707224|NCT00956293|466890475|FG000|Follow-up Period|Follow-up period was terminated.|20|||
129707225|NCT00956293|466890476|FG001|Follow-up Period|Follow-up period was terminated.|32|||
129707226|NCT00956293|466890477|FG002|Follow-up Period|Follow-up period was terminated.|0|||
129707227|NCT03383666|466890478|FG000|Overall Study|Withdrawal by Subject|2|||
129707228|NCT03383666|466890478|FG000|Overall Study|Lost to Follow-up|2|||
129707229|NCT02081586|466890479|FG000|Overall Study|Lost to Follow-up|0|||
129707230|NCT02081586|466890480|FG001|Overall Study|Lost to Follow-up|1|||
129800094|NCT05098938|467235301|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
129646456|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
129646457|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
129646458|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
129646459|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
129646460|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
129646461|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
129646462|NCT02275780|466661874|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
129646463|NCT02275780|466661875|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
129646464|NCT02275780|466661874|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
129646465|NCT02275780|466661875|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
129646466|NCT02275780|466661874|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
129646467|NCT02275780|466661875|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
129646468|NCT02275780|466661874|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
129646469|NCT02275780|466661875|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
129646470|NCT02275780|466661874|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
129646471|NCT02275780|466661875|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
129646472|NCT02275780|466661874|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
129646473|NCT02275780|466661875|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
129646474|NCT02275780|466661874|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
129646475|NCT02275780|466661875|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
129646476|NCT00738881|466661878|FG000|Overall Study|Withdrawal by Subject|0|||
129646477|NCT00738881|466661879|FG001|Overall Study|Withdrawal by Subject|2|||
129646478|NCT00348790|466661880|FG000|Completed Treatment|Withdrawal by Subject|4|||
129646479|NCT00348790|466661880|FG000|Completed Treatment|Disease progression|14|||
129646480|NCT00348790|466661880|FG000|Completed Treatment|Adverse Event|4|||
129646481|NCT00348790|466661880|FG000|Completed Treatment|Required surgery|2|||
129646482|NCT00348790|466661880|FG000|Completed Treatment|Unable to travel to study site|1|||
129646483|NCT04712019|466661882|FG000|Overall Study|Withdrawal by Subject|2|||
129646484|NCT04712019|466661883|FG001|Overall Study|Withdrawal by Subject|2|||
129646485|NCT04712019|466661882|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
129646486|NCT04712019|466661883|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
129646487|NCT04521621|466661889|FG000|Overall Study|Death|17|||
129646488|NCT04521621|466661890|FG001|Overall Study|Death|8|||
129646489|NCT04521621|466661891|FG002|Overall Study|Death|8|||
129646490|NCT04521621|466661892|FG003|Overall Study|Death|5|||
129646491|NCT04521621|466661893|FG004|Overall Study|Death|2|||
129646492|NCT04521621|466661894|FG005|Overall Study|Death|7|||
129646493|NCT04521621|466661895|FG006|Overall Study|Death|0|||
129646494|NCT04521621|466661896|FG007|Overall Study|Death|0|||
129646495|NCT04521621|466661889|FG000|Overall Study|Study Terminated by Sponsor|4|||
129646496|NCT04521621|466661890|FG001|Overall Study|Study Terminated by Sponsor|6|||
129646497|NCT04521621|466661891|FG002|Overall Study|Study Terminated by Sponsor|8|||
129646498|NCT04521621|466661892|FG003|Overall Study|Study Terminated by Sponsor|0|||
129646499|NCT04521621|466661893|FG004|Overall Study|Study Terminated by Sponsor|1|||
129646500|NCT04521621|466661894|FG005|Overall Study|Study Terminated by Sponsor|7|||
129646501|NCT04521621|466661895|FG006|Overall Study|Study Terminated by Sponsor|0|||
129646502|NCT04521621|466661896|FG007|Overall Study|Study Terminated by Sponsor|0|||
129646503|NCT04521621|466661889|FG000|Overall Study|Withdrawal by Subject|0|||
129646504|NCT04521621|466661890|FG001|Overall Study|Withdrawal by Subject|0|||
129646505|NCT04521621|466661891|FG002|Overall Study|Withdrawal by Subject|1|||
129646506|NCT04521621|466661892|FG003|Overall Study|Withdrawal by Subject|1|||
129646507|NCT04521621|466661893|FG004|Overall Study|Withdrawal by Subject|0|||
129646508|NCT04521621|466661894|FG005|Overall Study|Withdrawal by Subject|0|||
129646509|NCT04521621|466661895|FG006|Overall Study|Withdrawal by Subject|0|||
129646510|NCT04521621|466661896|FG007|Overall Study|Withdrawal by Subject|0|||
129646511|NCT04521621|466661889|FG000|Overall Study|Allocated in error without study intervention|1|||
129646512|NCT04521621|466661890|FG001|Overall Study|Allocated in error without study intervention|0|||
129707231|NCT02081586|466890481|FG002|Overall Study|Lost to Follow-up|0|||
129646513|NCT04521621|466661891|FG002|Overall Study|Allocated in error without study intervention|0|||
129646514|NCT04521621|466661892|FG003|Overall Study|Allocated in error without study intervention|0|||
129646515|NCT04521621|466661893|FG004|Overall Study|Allocated in error without study intervention|0|||
129646516|NCT04521621|466661894|FG005|Overall Study|Allocated in error without study intervention|0|||
129646517|NCT04521621|466661895|FG006|Overall Study|Allocated in error without study intervention|0|||
129646518|NCT04521621|466661896|FG007|Overall Study|Allocated in error without study intervention|0|||
129646519|NCT01282164|466661897|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
129646520|NCT01282164|466661898|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
129646521|NCT05845567|466661901|FG000|Overall Study|Withdrawal by Subject|1|||
129646522|NCT00725608|466661902|FG000|Overall Study|Lost to Follow-up|60|||
129646523|NCT00725608|466661902|FG000|Overall Study|Adverse Event|14|||
129646524|NCT00725608|466661902|FG000|Overall Study|Individual reasons|86|||
129646525|NCT00725608|466661902|FG000|Overall Study|Other|7|||
129646526|NCT03409107|466661903|FG000|Overall Study|Withdrawal by Subject|4|||
129646527|NCT03409107|466661904|FG001|Overall Study|Withdrawal by Subject|2|||
129646528|NCT03409107|466661903|FG000|Overall Study|Physician Decision|1|||
129646529|NCT03409107|466661904|FG001|Overall Study|Physician Decision|0|||
129646530|NCT03409107|466661903|FG000|Overall Study|Lost to Follow-up|7|||
129646531|NCT03409107|466661904|FG001|Overall Study|Lost to Follow-up|2|||
129646532|NCT03409107|466661903|FG000|Overall Study|Adverse Event|5|||
129646533|NCT03409107|466661904|FG001|Overall Study|Adverse Event|3|||
129646534|NCT00535847|466661906|FG000|Overall Study|Adverse Event|5|||
129646535|NCT00535847|466661907|FG001|Overall Study|Adverse Event|3|||
129646536|NCT00535847|466661908|FG002|Overall Study|Adverse Event|2|||
129800095|NCT05098938|467235300|FG000|Overall Study|Physician Decision|25|||
129646537|NCT00535847|466661906|FG000|Overall Study|Non compliance|1|||
129646538|NCT00535847|466661907|FG001|Overall Study|Non compliance|1|||
129443561|NCT04147234|465924420|FG002|Overall Study|Adverse Event|0|||
129646539|NCT00535847|466661908|FG002|Overall Study|Non compliance|0|||
129646540|NCT00535847|466661906|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
129646541|NCT00535847|466661907|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
129646542|NCT00535847|466661908|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
129800096|NCT05098938|467235301|FG001|Overall Study|Physician Decision|32|||
129707232|NCT02081586|466890482|FG003|Overall Study|Lost to Follow-up|1|||
129707233|NCT02081586|466890479|FG000|Overall Study|Head injury not related to study|0|||
129707234|NCT02081586|466890480|FG001|Overall Study|Head injury not related to study|0|||
129707235|NCT02081586|466890481|FG002|Overall Study|Head injury not related to study|1|||
129707236|NCT02081586|466890482|FG003|Overall Study|Head injury not related to study|0|||
129707237|NCT01677988|466890485|FG000|Overall Study|Lack of Efficacy|2|||
129707238|NCT00659425|466890489|FG000|Overall Study|Disease progression|1|||
129707239|NCT00659425|466890490|FG001|Overall Study|Disease progression|0|||
129707240|NCT00659425|466890491|FG002|Overall Study|Disease progression|0|||
129707241|NCT00659425|466890492|FG003|Overall Study|Disease progression|1|||
129707242|NCT00659425|466890493|FG004|Overall Study|Disease progression|0|||
129707243|NCT00659425|466890494|FG005|Overall Study|Disease progression|2|||
129707244|NCT00659425|466890495|FG006|Overall Study|Disease progression|4|||
129707245|NCT00659425|466890496|FG007|Overall Study|Disease progression|3|||
129707246|NCT00659425|466890497|FG008|Overall Study|Disease progression|5|||
129707247|NCT00659425|466890498|FG009|Overall Study|Disease progression|3|||
129707248|NCT00659425|466890489|FG000|Overall Study|Death|0|||
129707249|NCT00659425|466890490|FG001|Overall Study|Death|0|||
129707250|NCT00659425|466890491|FG002|Overall Study|Death|0|||
129707251|NCT00659425|466890492|FG003|Overall Study|Death|1|||
129707252|NCT00659425|466890493|FG004|Overall Study|Death|0|||
129707253|NCT00659425|466890494|FG005|Overall Study|Death|0|||
129707254|NCT00659425|466890495|FG006|Overall Study|Death|1|||
129707255|NCT00659425|466890496|FG007|Overall Study|Death|0|||
129707256|NCT00659425|466890497|FG008|Overall Study|Death|0|||
129707257|NCT00659425|466890498|FG009|Overall Study|Death|0|||
129707258|NCT00659425|466890489|FG000|Overall Study|Adverse Event|0|||
129707259|NCT00659425|466890490|FG001|Overall Study|Adverse Event|0|||
129707260|NCT00659425|466890491|FG002|Overall Study|Adverse Event|0|||
129707261|NCT00659425|466890492|FG003|Overall Study|Adverse Event|0|||
129707262|NCT00659425|466890493|FG004|Overall Study|Adverse Event|0|||
129707263|NCT00659425|466890494|FG005|Overall Study|Adverse Event|1|||
129707264|NCT00659425|466890495|FG006|Overall Study|Adverse Event|0|||
129707265|NCT00659425|466890496|FG007|Overall Study|Adverse Event|3|||
129707266|NCT00659425|466890497|FG008|Overall Study|Adverse Event|1|||
129707267|NCT00659425|466890498|FG009|Overall Study|Adverse Event|4|||
129707268|NCT00659425|466890489|FG000|Overall Study|Investigator Discretion|0|||
129707269|NCT00659425|466890490|FG001|Overall Study|Investigator Discretion|0|||
129707270|NCT00659425|466890491|FG002|Overall Study|Investigator Discretion|0|||
129707271|NCT00659425|466890492|FG003|Overall Study|Investigator Discretion|0|||
129707272|NCT00659425|466890493|FG004|Overall Study|Investigator Discretion|0|||
129707273|NCT00659425|466890494|FG005|Overall Study|Investigator Discretion|1|||
129707274|NCT00659425|466890495|FG006|Overall Study|Investigator Discretion|0|||
129646543|NCT00423189|466661909|FG000|Overall Study|Death|0|||
129646544|NCT00423189|466661910|FG001|Overall Study|Death|1|||
129646545|NCT00423189|466661911|FG002|Overall Study|Death|0|||
129646546|NCT01459718|466661914|FG000|Overall Study|Physician Decision|1|||
129646547|NCT01459718|466661914|FG000|Overall Study|Lost to Follow-up|1|||
129646548|NCT01459718|466661914|FG000|Overall Study|Adverse Event|1|||
129646549|NCT01258075|466661920|FG000|Overall Study|Adverse Event|8|||
129646550|NCT01258075|466661921|FG001|Overall Study|Adverse Event|3|||
129646551|NCT01258075|466661920|FG000|Overall Study|Lost to Follow-up|11|||
129646552|NCT01258075|466661921|FG001|Overall Study|Lost to Follow-up|6|||
129646553|NCT01258075|466661920|FG000|Overall Study|Withdrawal by Subject|10|||
129646554|NCT01258075|466661921|FG001|Overall Study|Withdrawal by Subject|7|||
129646555|NCT01258075|466661920|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
129646556|NCT01258075|466661921|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
129646557|NCT01258075|466661920|FG000|Overall Study|Other|12|||
129646558|NCT01258075|466661921|FG001|Overall Study|Other|5|||
129646559|NCT01618019|466661923|FG000|Overall Study|Withdrawal by Subject|14|||
129646560|NCT01618019|466661924|FG001|Overall Study|Withdrawal by Subject|14|||
129646561|NCT01542034|466661925|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
129646562|NCT01542034|466661926|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
129646563|NCT01542034|466661925|FG000|Overall Study|Administrative decision|0|||
129646564|NCT01542034|466661926|FG001|Overall Study|Administrative decision|3|||
129646565|NCT01542034|466661925|FG000|Overall Study|Subject Noncompliance|1|||
129646566|NCT01542034|466661926|FG001|Overall Study|Subject Noncompliance|0|||
129646567|NCT01542034|466661925|FG000|Overall Study|Adverse Event|2|||
129646568|NCT01542034|466661926|FG001|Overall Study|Adverse Event|2|||
129646569|NCT01542034|466661925|FG000|Overall Study|Lost to Follow-up|7|||
129707275|NCT00659425|466890496|FG007|Overall Study|Investigator Discretion|3|||
129707276|NCT00659425|466890497|FG008|Overall Study|Investigator Discretion|0|||
129707277|NCT00659425|466890498|FG009|Overall Study|Investigator Discretion|0|||
129707278|NCT00659425|466890489|FG000|Overall Study|Other|0|||
129707279|NCT00659425|466890490|FG001|Overall Study|Other|1|||
129707280|NCT00659425|466890491|FG002|Overall Study|Other|1|||
129707281|NCT00659425|466890492|FG003|Overall Study|Other|2|||
129707282|NCT00659425|466890493|FG004|Overall Study|Other|4|||
129707283|NCT00659425|466890494|FG005|Overall Study|Other|0|||
129707284|NCT00659425|466890495|FG006|Overall Study|Other|3|||
129707285|NCT00659425|466890496|FG007|Overall Study|Other|2|||
129707286|NCT00659425|466890497|FG008|Overall Study|Other|0|||
129707287|NCT00659425|466890498|FG009|Overall Study|Other|6|||
129707288|NCT00271544|466890499|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
129707289|NCT00271544|466890499|FG000|Overall Study|Model 4196 lead not attempted|9|||
129707290|NCT00271544|466890499|FG000|Overall Study|Implant not attempted|4|||
129707291|NCT03358030|466890500|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
129707292|NCT03358030|466890501|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
129707293|NCT03358030|466890502|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
129707294|NCT03358030|466890503|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
129707295|NCT03358030|466890500|FG000|Overall Study|Ineligibility|0|||
129707296|NCT03358030|466890501|FG001|Overall Study|Ineligibility|0|||
129707297|NCT03358030|466890502|FG002|Overall Study|Ineligibility|0|||
129707298|NCT03358030|466890503|FG003|Overall Study|Ineligibility|2|||
129707299|NCT03358030|466890500|FG000|Overall Study|Voluntary Withdrawal|1|||
129707300|NCT03358030|466890501|FG001|Overall Study|Voluntary Withdrawal|1|||
129707301|NCT03358030|466890502|FG002|Overall Study|Voluntary Withdrawal|3|||
129707302|NCT03358030|466890503|FG003|Overall Study|Voluntary Withdrawal|1|||
129707303|NCT03358030|466890500|FG000|Overall Study|Other|0|||
129707304|NCT03358030|466890501|FG001|Overall Study|Other|0|||
129707305|NCT03358030|466890502|FG002|Overall Study|Other|1|||
129707306|NCT03358030|466890503|FG003|Overall Study|Other|0|||
129707307|NCT02505425|466890504|FG000|Overall Study|Lost to Follow-up|41|||
129707308|NCT02505425|466890505|FG001|Overall Study|Lost to Follow-up|61|||
129707309|NCT02505425|466890506|FG002|Overall Study|Lost to Follow-up|31|||
129707310|NCT02505425|466890507|FG003|Overall Study|Lost to Follow-up|19|||
129707311|NCT02505425|466890504|FG000|Overall Study|Withdrawal by Subject|39|||
129707312|NCT02505425|466890505|FG001|Overall Study|Withdrawal by Subject|9|||
129707313|NCT02505425|466890506|FG002|Overall Study|Withdrawal by Subject|19|||
129707314|NCT02505425|466890507|FG003|Overall Study|Withdrawal by Subject|7|||
129707315|NCT02505425|466890504|FG000|Overall Study|Death|8|||
129707316|NCT02505425|466890505|FG001|Overall Study|Death|12|||
129707317|NCT02505425|466890506|FG002|Overall Study|Death|0|||
129707318|NCT02505425|466890507|FG003|Overall Study|Death|0|||
129707319|NCT02031302|466890508|FG000|Overall Study|Death|115|||
129707320|NCT02031302|466890509|FG001|Overall Study|Death|0|||
129707321|NCT02031302|466890508|FG000|Overall Study|Not treated with study valve system|18|||
129707322|NCT02031302|466890509|FG001|Overall Study|Not treated with study valve system|0|||
129707323|NCT02031302|466890508|FG000|Overall Study|Missed Follow Up|27|||
129707324|NCT02031302|466890509|FG001|Overall Study|Missed Follow Up|0|||
129707325|NCT02031302|466890508|FG000|Overall Study|Lost to Follow-up|4|||
129707326|NCT02031302|466890509|FG001|Overall Study|Lost to Follow-up|0|||
129707327|NCT02781558|466890513|FG000|Overall Study|Lost to Follow-up|2|||
129707328|NCT02781558|466890514|FG001|Overall Study|Lost to Follow-up|2|||
129707329|NCT02781558|466890513|FG000|Overall Study|Adverse Event|1|||
129707330|NCT02781558|466890514|FG001|Overall Study|Adverse Event|0|||
129707331|NCT04704193|466890515|FG000|Overall Study|Withdrawal by Subject|1|||
129707332|NCT01492426|466891967|FG000|Treatment|Death|0|||
129707333|NCT01492426|466891968|FG001|Treatment|Death|1|||
129707334|NCT01492426|466891967|FG000|Treatment|Other|1|||
129800097|NCT05098938|467235300|FG000|Overall Study|Run in failure in treatment phase|1|||
129800098|NCT05098938|467235301|FG001|Overall Study|Run in failure in treatment phase|1|||
129646570|NCT01542034|466661926|FG001|Overall Study|Lost to Follow-up|6|||
129646571|NCT02612610|466661927|FG000|Overall Study|Withdrawal by Subject|1|||
129646572|NCT02612610|466661928|FG001|Overall Study|Withdrawal by Subject|1|||
129646573|NCT02612610|466661929|FG002|Overall Study|Withdrawal by Subject|0|||
129646574|NCT02612610|466661930|FG003|Overall Study|Withdrawal by Subject|2|||
129646575|NCT02612610|466661927|FG000|Overall Study|Adverse Event|2|||
129646576|NCT02612610|466661928|FG001|Overall Study|Adverse Event|2|||
129646577|NCT02612610|466661929|FG002|Overall Study|Adverse Event|3|||
129646578|NCT02612610|466661930|FG003|Overall Study|Adverse Event|10|||
129646579|NCT02612610|466661927|FG000|Overall Study|Lost to Follow-up|0|||
129646580|NCT02612610|466661928|FG001|Overall Study|Lost to Follow-up|1|||
129646581|NCT02612610|466661929|FG002|Overall Study|Lost to Follow-up|0|||
129646582|NCT02612610|466661930|FG003|Overall Study|Lost to Follow-up|0|||
129646583|NCT02612610|466661927|FG000|Overall Study|Protocol Violation|0|||
129646584|NCT02612610|466661928|FG001|Overall Study|Protocol Violation|1|||
129646585|NCT02612610|466661929|FG002|Overall Study|Protocol Violation|1|||
129646586|NCT02612610|466661930|FG003|Overall Study|Protocol Violation|0|||
129646587|NCT02612610|466661927|FG000|Overall Study|Lack of Efficacy|1|||
129646588|NCT02612610|466661928|FG001|Overall Study|Lack of Efficacy|2|||
129646589|NCT02612610|466661929|FG002|Overall Study|Lack of Efficacy|0|||
129646590|NCT02612610|466661930|FG003|Overall Study|Lack of Efficacy|1|||
129646591|NCT02612610|466661927|FG000|Overall Study|Physician Decision|0|||
129646592|NCT02612610|466661928|FG001|Overall Study|Physician Decision|1|||
129646593|NCT02612610|466661929|FG002|Overall Study|Physician Decision|0|||
129646594|NCT02612610|466661930|FG003|Overall Study|Physician Decision|0|||
129646595|NCT02612610|466661927|FG000|Overall Study|Noncompliance|1|||
129646596|NCT02612610|466661928|FG001|Overall Study|Noncompliance|0|||
129646597|NCT02612610|466661929|FG002|Overall Study|Noncompliance|0|||
129646598|NCT02612610|466661930|FG003|Overall Study|Noncompliance|0|||
129646599|NCT02612610|466661927|FG000|Overall Study|Cough Improvement|0|||
129646600|NCT02612610|466661928|FG001|Overall Study|Cough Improvement|0|||
129646601|NCT02612610|466661929|FG002|Overall Study|Cough Improvement|1|||
129646602|NCT02612610|466661930|FG003|Overall Study|Cough Improvement|0|||
129646603|NCT00176644|466661931|FG000|Overall Study|Withdrawal by Subject|1|||
129646604|NCT01801280|466661932|FG000|Period 1|Withdrawal by Subject|0|||
129646605|NCT01801280|466661933|FG001|Period 1|Withdrawal by Subject|1|||
129646606|NCT01801280|466661934|FG002|Period 1|Withdrawal by Subject|0|||
129646607|NCT01801280|466661935|FG003|Period 1|Withdrawal by Subject|0|||
129646608|NCT01801280|466661932|FG000|Period 2|Withdrawal by Subject|1|||
129646609|NCT01801280|466661933|FG001|Period 2|Withdrawal by Subject|0|||
129646610|NCT01801280|466661934|FG002|Period 2|Withdrawal by Subject|0|||
129646611|NCT01801280|466661935|FG003|Period 2|Withdrawal by Subject|0|||
129646612|NCT01801280|466661932|FG000|Period 4|Protocol Violation|0|||
129646613|NCT01801280|466661933|FG001|Period 4|Protocol Violation|0|||
129646614|NCT01801280|466661934|FG002|Period 4|Protocol Violation|1|||
129646615|NCT01801280|466661935|FG003|Period 4|Protocol Violation|0|||
129646616|NCT02783729|466661936|FG000|Overall Study|Lack of Efficacy|1|||
129646617|NCT02783729|466661937|FG001|Overall Study|Lack of Efficacy|0|||
129646618|NCT02783729|466661938|FG002|Overall Study|Lack of Efficacy|0|||
129646619|NCT02783729|466661939|FG003|Overall Study|Lack of Efficacy|0|||
129646620|NCT02783729|466661936|FG000|Overall Study|Adverse Event|2|||
129646621|NCT02783729|466661937|FG001|Overall Study|Adverse Event|6|||
129646622|NCT02783729|466661938|FG002|Overall Study|Adverse Event|2|||
129646623|NCT02783729|466661939|FG003|Overall Study|Adverse Event|3|||
129646624|NCT02783729|466661936|FG000|Overall Study|Other|1|||
129646625|NCT02783729|466661937|FG001|Overall Study|Other|6|||
129646626|NCT02783729|466661938|FG002|Overall Study|Other|2|||
129646627|NCT02783729|466661939|FG003|Overall Study|Other|3|||
129646628|NCT02783729|466661936|FG000|Overall Study|Withdrawal by Subject|2|||
129646629|NCT02783729|466661937|FG001|Overall Study|Withdrawal by Subject|3|||
129646630|NCT02783729|466661938|FG002|Overall Study|Withdrawal by Subject|1|||
129646631|NCT02783729|466661939|FG003|Overall Study|Withdrawal by Subject|2|||
129646632|NCT02783729|466661936|FG000|Overall Study|Participant's choice|2|||
129646633|NCT02783729|466661937|FG001|Overall Study|Participant's choice|1|||
129646634|NCT02783729|466661938|FG002|Overall Study|Participant's choice|2|||
129646635|NCT02783729|466661939|FG003|Overall Study|Participant's choice|1|||
129646636|NCT02783729|466661936|FG000|Overall Study|Lost to Follow-up|2|||
129646637|NCT02783729|466661937|FG001|Overall Study|Lost to Follow-up|1|||
129646638|NCT02783729|466661938|FG002|Overall Study|Lost to Follow-up|1|||
129646639|NCT02783729|466661939|FG003|Overall Study|Lost to Follow-up|0|||
129646640|NCT02693171|466661940|FG000|Overall Study|Adverse Event|1|||
129646641|NCT02693171|466661940|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
129646642|NCT01866657|466661943|FG000|Overall Study|Surgery canceled|2|||
129646643|NCT01866657|466661944|FG001|Overall Study|Surgery canceled|0|||
129646644|NCT02288091|466661957|FG000|Overall Study|Lost to Follow-up|1|||
129646645|NCT02288091|466661957|FG000|Overall Study|Screen fail|7|||
129646646|NCT04021121|466661958|FG000|Overall Study|Death|3|||
129646647|NCT04021121|466661959|FG001|Overall Study|Death|3|||
129646648|NCT04021121|466661960|FG002|Overall Study|Death|5|||
129646649|NCT04021121|466661961|FG003|Overall Study|Death|4|||
129646650|NCT03099694|466661971|FG000|Overall Study|Withdrawal by Subject|11|||
129646651|NCT03099694|466661972|FG001|Overall Study|Withdrawal by Subject|13|||
129646652|NCT03099694|466661971|FG000|Overall Study|Lost to Follow-up|9|||
129646653|NCT03099694|466661972|FG001|Overall Study|Lost to Follow-up|5|||
129646654|NCT00471718|466661978|FG000|Overall Study|Adverse Event|3|||
129646655|NCT00471718|466661978|FG000|Overall Study|other complicating disease|1|||
129646656|NCT00471718|466661978|FG000|Overall Study|disease progression|22|||
129646657|NCT00471718|466661978|FG000|Overall Study|Withdrawal by Subject|1|||
129646658|NCT02880865|466661979|FG000|Overall Study|Adverse Event|1|||
129646659|NCT02880865|466661980|FG001|Overall Study|Adverse Event|0|||
129646660|NCT02880865|466661979|FG000|Overall Study|Withdrawal by Subject|0|||
129646661|NCT02880865|466661980|FG001|Overall Study|Withdrawal by Subject|2|||
129646662|NCT02880865|466661979|FG000|Overall Study|Physician Decision|0|||
129646663|NCT02880865|466661980|FG001|Overall Study|Physician Decision|1|||
129646664|NCT01446237|466661982|FG000|Overall Study|Adverse Event|1|||
129646665|NCT01446237|466661982|FG000|Overall Study|Lost to Follow-up|2|||
129646666|NCT01446237|466661982|FG000|Overall Study|Withdrawal by Subject|7|||
129646667|NCT01190267|466661985|FG000|Overall Study|Adverse Event|10|||
129646668|NCT01190267|466661986|FG001|Overall Study|Adverse Event|0|||
129646669|NCT01190267|466661985|FG000|Overall Study|Treatment Failure|8|||
129646670|NCT01190267|466661986|FG001|Overall Study|Treatment Failure|2|||
129646671|NCT01190267|466661985|FG000|Overall Study|Lost to Follow-up|2|||
129646672|NCT01190267|466661986|FG001|Overall Study|Lost to Follow-up|0|||
129646673|NCT01190267|466661985|FG000|Overall Study|Withdrawal by Subject|13|||
129646674|NCT01190267|466661986|FG001|Overall Study|Withdrawal by Subject|1|||
129646675|NCT01190267|466661985|FG000|Overall Study|Protocol Violation|8|||
129646676|NCT01190267|466661986|FG001|Overall Study|Protocol Violation|1|||
129646677|NCT04017832|466661989|FG000|Overall Study|Withdrawal by Subject|13|||
129646678|NCT04017832|466661990|FG001|Overall Study|Withdrawal by Subject|12|||
129646679|NCT04017832|466661991|FG002|Overall Study|Withdrawal by Subject|21|||
129646680|NCT04017832|466661992|FG003|Overall Study|Withdrawal by Subject|7|||
129646681|NCT04017832|466661989|FG000|Overall Study|Lost to Follow-up|0|||
129646682|NCT04017832|466661990|FG001|Overall Study|Lost to Follow-up|3|||
129646683|NCT04017832|466661991|FG002|Overall Study|Lost to Follow-up|3|||
129646684|NCT04017832|466661992|FG003|Overall Study|Lost to Follow-up|1|||
129646685|NCT04017832|466661989|FG000|Overall Study|Physician Decision|1|||
129646686|NCT04017832|466661990|FG001|Overall Study|Physician Decision|1|||
129646687|NCT04017832|466661991|FG002|Overall Study|Physician Decision|1|||
129646688|NCT04017832|466661992|FG003|Overall Study|Physician Decision|1|||
129646689|NCT04017832|466661989|FG000|Overall Study|Death|2|||
129646690|NCT04017832|466661990|FG001|Overall Study|Death|2|||
129646691|NCT04017832|466661991|FG002|Overall Study|Death|1|||
129646692|NCT04017832|466661992|FG003|Overall Study|Death|0|||
129646693|NCT00965341|466661997|FG000|Overall Study|Withdrew consent|1|||
129646694|NCT00965341|466661998|FG001|Overall Study|Withdrew consent|5|||
129646695|NCT00965341|466661997|FG000|Overall Study|Lost to Follow-up|1|||
129646696|NCT00965341|466661998|FG001|Overall Study|Lost to Follow-up|0|||
129646697|NCT00965341|466661997|FG000|Overall Study|Transportation issues|4|||
129646698|NCT00965341|466661998|FG001|Overall Study|Transportation issues|3|||
129646699|NCT01077739|466662004|FG000|Overall Study|Premature withdrawal|1|||
129646700|NCT01077739|466662005|FG001|Overall Study|Premature withdrawal|3|||
129646701|NCT01077739|466662004|FG000|Overall Study|Withdrawal by Subject|1|||
129646702|NCT01077739|466662005|FG001|Overall Study|Withdrawal by Subject|0|||
129646703|NCT01077739|466662004|FG000|Overall Study|Death|0|||
129646704|NCT01077739|466662005|FG001|Overall Study|Death|3|||
129646705|NCT01077739|466662004|FG000|Overall Study|Unacceptable toxicity|1|||
129707335|NCT01492426|466891968|FG001|Treatment|Other|0|||
129707336|NCT01492426|466891967|FG000|Treatment|Adverse Event|25|||
129707337|NCT01492426|466891968|FG001|Treatment|Adverse Event|25|||
129707338|NCT01492426|466891967|FG000|Treatment|Lack of Efficacy|38|||
129707339|NCT01492426|466891968|FG001|Treatment|Lack of Efficacy|5|||
129707340|NCT01492426|466891967|FG000|Treatment|Participant withdrew consent|1|||
129707341|NCT01492426|466891968|FG001|Treatment|Participant withdrew consent|2|||
129707342|NCT01492426|466891967|FG000|Treatment|Poor compliance/noncompliance|1|||
129646706|NCT01077739|466662005|FG001|Overall Study|Unacceptable toxicity|2|||
129646707|NCT01077739|466662004|FG000|Overall Study|Other|2|||
129646708|NCT01077739|466662005|FG001|Overall Study|Other|2|||
129646709|NCT00960986|466662006|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
129646710|NCT00960986|466662007|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
129646711|NCT00960986|466662008|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
129646712|NCT00960986|466662009|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
129646713|NCT00960986|466662006|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
129646714|NCT00960986|466662007|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
129646715|NCT00960986|466662008|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
129646716|NCT00960986|466662009|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
129707343|NCT01492426|466891968|FG001|Treatment|Poor compliance/noncompliance|0|||
129707673|NCT03961308|466892095|FG001|Overall Study|Adverse Event|1|||
129646717|NCT00960986|466662006|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
129646718|NCT00960986|466662007|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
129646719|NCT00960986|466662008|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
129646720|NCT00960986|466662009|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
129646721|NCT00960986|466662006|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
129646722|NCT00960986|466662007|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
129646723|NCT00960986|466662008|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
129646724|NCT00960986|466662009|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
129646725|NCT00960986|466662006|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
129646726|NCT00960986|466662007|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
129646727|NCT00960986|466662008|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
129646728|NCT00960986|466662009|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
129646729|NCT00960986|466662006|FG000|Period 3 (7-week Therapy Period)|Death|0|||
129646730|NCT00960986|466662007|FG001|Period 3 (7-week Therapy Period)|Death|0|||
129646731|NCT00960986|466662008|FG002|Period 3 (7-week Therapy Period)|Death|1|||
129646732|NCT00960986|466662009|FG003|Period 3 (7-week Therapy Period)|Death|0|||
129646733|NCT00960986|466662006|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
129646734|NCT00960986|466662007|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
129646735|NCT00960986|466662008|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
129646736|NCT00960986|466662009|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
129646737|NCT00960986|466662006|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
129646738|NCT00960986|466662007|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
129646739|NCT00960986|466662008|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
129646740|NCT00960986|466662009|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
129646741|NCT00960986|466662006|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
129646742|NCT00960986|466662007|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
129646743|NCT00960986|466662008|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
129646744|NCT00960986|466662009|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
129646745|NCT00960986|466662006|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
129646746|NCT00960986|466662007|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
129646747|NCT00960986|466662008|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
129646748|NCT00960986|466662009|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
129646749|NCT04464720|466662010|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
129646750|NCT00954512|466662016|FG000|Overall Study|Withdrawal by Subject|0|||
129646751|NCT00954512|466662017|FG001|Overall Study|Withdrawal by Subject|0|||
129646752|NCT00954512|466662018|FG002|Overall Study|Withdrawal by Subject|0|||
129646753|NCT00954512|466662019|FG003|Overall Study|Withdrawal by Subject|0|||
129646754|NCT00954512|466662020|FG004|Overall Study|Withdrawal by Subject|0|||
129646755|NCT00954512|466662021|FG005|Overall Study|Withdrawal by Subject|1|||
129646756|NCT00954512|466662016|FG000|Overall Study|Adverse Event|0|||
129646757|NCT00954512|466662017|FG001|Overall Study|Adverse Event|0|||
129646758|NCT00954512|466662018|FG002|Overall Study|Adverse Event|0|||
129646759|NCT00954512|466662019|FG003|Overall Study|Adverse Event|0|||
129646760|NCT00954512|466662020|FG004|Overall Study|Adverse Event|1|||
129646761|NCT00954512|466662021|FG005|Overall Study|Adverse Event|2|||
129646762|NCT00954512|466662016|FG000|Overall Study|Physician Decision|0|||
129646763|NCT00954512|466662017|FG001|Overall Study|Physician Decision|1|||
129646764|NCT00954512|466662018|FG002|Overall Study|Physician Decision|0|||
129646765|NCT00954512|466662019|FG003|Overall Study|Physician Decision|1|||
129646766|NCT00954512|466662020|FG004|Overall Study|Physician Decision|0|||
129646767|NCT00954512|466662021|FG005|Overall Study|Physician Decision|0|||
129646768|NCT00954512|466662016|FG000|Overall Study|Symptomatic Deterioration|0|||
129646769|NCT00954512|466662017|FG001|Overall Study|Symptomatic Deterioration|1|||
129646770|NCT00954512|466662018|FG002|Overall Study|Symptomatic Deterioration|0|||
129646771|NCT00954512|466662019|FG003|Overall Study|Symptomatic Deterioration|0|||
129646772|NCT00954512|466662020|FG004|Overall Study|Symptomatic Deterioration|2|||
129646773|NCT00954512|466662021|FG005|Overall Study|Symptomatic Deterioration|0|||
129646774|NCT00954512|466662016|FG000|Overall Study|Progression of Disease|2|||
129646775|NCT00954512|466662017|FG001|Overall Study|Progression of Disease|1|||
129646776|NCT00954512|466662018|FG002|Overall Study|Progression of Disease|0|||
129646777|NCT00954512|466662019|FG003|Overall Study|Progression of Disease|1|||
129646778|NCT00954512|466662020|FG004|Overall Study|Progression of Disease|1|||
129646779|NCT00954512|466662021|FG005|Overall Study|Progression of Disease|1|||
129646780|NCT01794793|466662023|FG000|Treatment Period|Withdrawal by Subject|24|||
129646781|NCT01794793|466662023|FG000|Treatment Period|Lack of Efficacy|22|||
129646782|NCT01794793|466662023|FG000|Treatment Period|Adverse Event|17|||
129646783|NCT01794793|466662023|FG000|Treatment Period|Physician Decision|14|||
129800099|NCT05098938|467235300|FG000|Overall Study|Withdrawal by Subject|0|||
129800100|NCT05098938|467235301|FG001|Overall Study|Withdrawal by Subject|3|||
129646784|NCT01794793|466662023|FG000|Treatment Period|Lost to Follow-up|7|||
129646785|NCT01794793|466662023|FG000|Treatment Period|Death|6|||
129646786|NCT01794793|466662023|FG000|Treatment Period|Protocol Violation|5|||
129646787|NCT01794793|466662023|FG000|Treatment Period|administrative problem|3|||
129646788|NCT01794793|466662023|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
129646789|NCT01794793|466662023|FG000|Post-treatment Follow-up|Adverse Event|8|||
129646790|NCT01794793|466662023|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
129646791|NCT01794793|466662023|FG000|Post-treatment Follow-up|administrative problem|5|||
129646792|NCT01794793|466662023|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
129646793|NCT01794793|466662023|FG000|Post-treatment Follow-up|Protocol Violation|3|||
129646794|NCT03495154|466662024|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
129646795|NCT03495154|466662024|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
129646796|NCT03495154|466662024|FG000|Overall Study|Screen Failures During Surgery|6|||
129646797|NCT03495154|466662024|FG000|Overall Study|Death|2|||
129646798|NCT03495154|466662024|FG000|Overall Study|Lost to Follow-up|16|||
129646799|NCT03495154|466662024|FG000|Overall Study|Withdrawal by Subject|2|||
129646800|NCT03495154|466662024|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
129646801|NCT05685732|466662025|FG000|Overall Study|Withdrawal by Subject|2|||
129646802|NCT05685732|466662026|FG001|Overall Study|Withdrawal by Subject|0|||
129646803|NCT05685732|466662027|FG002|Overall Study|Withdrawal by Subject|2|||
129646804|NCT05685732|466662028|FG003|Overall Study|Withdrawal by Subject|3|||
129646805|NCT05685732|466662025|FG000|Overall Study|Protocol Violation|1|||
129646806|NCT05685732|466662026|FG001|Overall Study|Protocol Violation|2|||
129646807|NCT05685732|466662027|FG002|Overall Study|Protocol Violation|4|||
129646808|NCT05685732|466662028|FG003|Overall Study|Protocol Violation|1|||
129646809|NCT05685732|466662025|FG000|Overall Study|Lost to Follow-up|5|||
129646810|NCT05685732|466662026|FG001|Overall Study|Lost to Follow-up|1|||
129646811|NCT05685732|466662027|FG002|Overall Study|Lost to Follow-up|3|||
129646812|NCT05685732|466662028|FG003|Overall Study|Lost to Follow-up|1|||
129646813|NCT05685732|466662025|FG000|Overall Study|Adverse Event|2|||
129646814|NCT05685732|466662026|FG001|Overall Study|Adverse Event|1|||
129646815|NCT05685732|466662027|FG002|Overall Study|Adverse Event|0|||
129646816|NCT05685732|466662028|FG003|Overall Study|Adverse Event|0|||
129646817|NCT05685732|466662025|FG000|Overall Study|Physician Decision|1|||
129646818|NCT05685732|466662026|FG001|Overall Study|Physician Decision|0|||
129646819|NCT05685732|466662027|FG002|Overall Study|Physician Decision|0|||
129646820|NCT05685732|466662028|FG003|Overall Study|Physician Decision|0|||
129646821|NCT02640404|466662029|FG000|Overall Study|Protocol Violation|1|||
129646822|NCT02640404|466662030|FG001|Overall Study|Protocol Violation|0|||
129646823|NCT02640404|466662029|FG000|Overall Study|Withdrawal by Subject|1|||
129646824|NCT02640404|466662030|FG001|Overall Study|Withdrawal by Subject|0|||
129646825|NCT05397171|466662032|FG000|Overall Study|Death|2|||
129646826|NCT05397171|466662033|FG001|Overall Study|Death|3|||
129646827|NCT05397171|466662034|FG002|Overall Study|Death|3|||
129646828|NCT05397171|466662032|FG000|Overall Study|Study Terminated By Sponsor|1|||
129646829|NCT05397171|466662033|FG001|Overall Study|Study Terminated By Sponsor|2|||
129646830|NCT05397171|466662034|FG002|Overall Study|Study Terminated By Sponsor|3|||
129646831|NCT05397171|466662032|FG000|Overall Study|Withdrawal by Subject|0|||
129646832|NCT05397171|466662033|FG001|Overall Study|Withdrawal by Subject|1|||
129646833|NCT05397171|466662034|FG002|Overall Study|Withdrawal by Subject|1|||
129646834|NCT02100670|466662035|FG000|Overall Study|Adverse Event|10|||
129646835|NCT02100670|466662036|FG001|Overall Study|Adverse Event|3|||
129646836|NCT02100670|466662037|FG002|Overall Study|Adverse Event|3|||
129646837|NCT02100670|466662038|FG003|Overall Study|Adverse Event|0|||
129646838|NCT02100670|466662035|FG000|Overall Study|Lost to Follow-up|1|||
129646839|NCT02100670|466662036|FG001|Overall Study|Lost to Follow-up|0|||
129646840|NCT02100670|466662037|FG002|Overall Study|Lost to Follow-up|0|||
129646841|NCT02100670|466662038|FG003|Overall Study|Lost to Follow-up|0|||
129646842|NCT02100670|466662035|FG000|Overall Study|Protocol Violation|0|||
129646843|NCT02100670|466662036|FG001|Overall Study|Protocol Violation|1|||
129646844|NCT02100670|466662037|FG002|Overall Study|Protocol Violation|0|||
129646845|NCT02100670|466662038|FG003|Overall Study|Protocol Violation|1|||
129646846|NCT02100670|466662035|FG000|Overall Study|Withdrawal of Consent|0|||
129646847|NCT02100670|466662036|FG001|Overall Study|Withdrawal of Consent|1|||
129646848|NCT02100670|466662037|FG002|Overall Study|Withdrawal of Consent|1|||
129646849|NCT02100670|466662038|FG003|Overall Study|Withdrawal of Consent|0|||
129646850|NCT02100670|466662035|FG000|Overall Study|No swelling no pain|1|||
129646851|NCT02100670|466662036|FG001|Overall Study|No swelling no pain|0|||
129646852|NCT02100670|466662037|FG002|Overall Study|No swelling no pain|0|||
129646853|NCT02100670|466662038|FG003|Overall Study|No swelling no pain|0|||
129646854|NCT02100670|466662035|FG000|Overall Study|Poor Efficacy|0|||
129646855|NCT02100670|466662036|FG001|Overall Study|Poor Efficacy|1|||
129646856|NCT02100670|466662037|FG002|Overall Study|Poor Efficacy|0|||
129646857|NCT02100670|466662038|FG003|Overall Study|Poor Efficacy|0|||
129646858|NCT02100670|466662035|FG000|Overall Study|Physician Decision|0|||
129646859|NCT02100670|466662036|FG001|Overall Study|Physician Decision|1|||
129646860|NCT02100670|466662037|FG002|Overall Study|Physician Decision|0|||
129800101|NCT05098938|467235300|FG000|Overall Study|Run-in Failure in early study|505|||
129800102|NCT05098938|467235301|FG001|Overall Study|Run-in Failure in early study|514|||
129800103|NCT05098938|467235300|FG000|Overall Study|IMP delivery missed|1|||
129800104|NCT05098938|467235301|FG001|Overall Study|IMP delivery missed|5|||
129646861|NCT02100670|466662038|FG003|Overall Study|Physician Decision|0|||
129646862|NCT02100670|466662035|FG000|Overall Study|Withdrawal by Subject|1|||
129646863|NCT02100670|466662036|FG001|Overall Study|Withdrawal by Subject|0|||
129646864|NCT02100670|466662037|FG002|Overall Study|Withdrawal by Subject|0|||
129646865|NCT02100670|466662038|FG003|Overall Study|Withdrawal by Subject|0|||
129646866|NCT02234596|466662039|FG000|Overall Study|Participant not treated|2|||
129646867|NCT03634033|466663692|FG000|Overall Study|Did not have a post-assessment|384|||
129646868|NCT03634033|466663693|FG001|Overall Study|Did not have a post-assessment|291|||
129646869|NCT03634033|466663694|FG002|Overall Study|Did not have a post-assessment|114|||
129646870|NCT03634033|466663695|FG003|Overall Study|Did not have a post-assessment|161|||
129646871|NCT03634033|466663696|FG004|Overall Study|Did not have a post-assessment|5|||
129646872|NCT03634033|466663697|FG005|Overall Study|Did not have a post-assessment|0|||
129707344|NCT01492426|466891967|FG000|Treatment|Subject requested discontinue study drug|7|||
129707345|NCT01492426|466891968|FG001|Treatment|Subject requested discontinue study drug|3|||
129646873|NCT03634033|466663698|FG006|Overall Study|Did not have a post-assessment|0|||
129646874|NCT03634033|466663692|FG000|Overall Study|Death|0|||
129707346|NCT01492426|466891967|FG000|Treatment|Lost to Follow-up|9|||
129646875|NCT03634033|466663693|FG001|Overall Study|Death|0|||
129646876|NCT03634033|466663694|FG002|Overall Study|Death|0|||
129646877|NCT03634033|466663695|FG003|Overall Study|Death|0|||
129646878|NCT03634033|466663696|FG004|Overall Study|Death|0|||
129646879|NCT03634033|466663697|FG005|Overall Study|Death|7|||
129646880|NCT03634033|466663698|FG006|Overall Study|Death|7|||
129646881|NCT03634033|466663692|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129646882|NCT03634033|466663693|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129646883|NCT03634033|466663694|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129646884|NCT03634033|466663695|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129646885|NCT03634033|466663696|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
129646886|NCT03634033|466663697|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
129646887|NCT03634033|466663698|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
129646888|NCT03634033|466663692|FG000|Overall Study|Lost to Follow-up|0|||
129646889|NCT03634033|466663693|FG001|Overall Study|Lost to Follow-up|0|||
129646890|NCT03634033|466663694|FG002|Overall Study|Lost to Follow-up|0|||
129646891|NCT03634033|466663695|FG003|Overall Study|Lost to Follow-up|0|||
129646892|NCT03634033|466663696|FG004|Overall Study|Lost to Follow-up|0|||
129646893|NCT03634033|466663697|FG005|Overall Study|Lost to Follow-up|1|||
129646894|NCT03634033|466663698|FG006|Overall Study|Lost to Follow-up|2|||
129646895|NCT03634033|466663692|FG000|Overall Study|Withdrawal by Subject|0|||
129646896|NCT03634033|466663693|FG001|Overall Study|Withdrawal by Subject|0|||
129646897|NCT03634033|466663694|FG002|Overall Study|Withdrawal by Subject|0|||
129646898|NCT03634033|466663695|FG003|Overall Study|Withdrawal by Subject|0|||
129646899|NCT03634033|466663696|FG004|Overall Study|Withdrawal by Subject|0|||
129646900|NCT03634033|466663697|FG005|Overall Study|Withdrawal by Subject|0|||
129646901|NCT03634033|466663698|FG006|Overall Study|Withdrawal by Subject|1|||
129646902|NCT01944670|466663701|FG000|Overall Study|Lost to Follow-up|2|||
129646903|NCT00743288|466663702|FG000|Overall Study|Adverse Event|1|||
129646904|NCT00743288|466663703|FG001|Overall Study|Adverse Event|1|||
129646905|NCT00743288|466663704|FG002|Overall Study|Adverse Event|2|||
129646906|NCT00743288|466663705|FG003|Overall Study|Adverse Event|2|||
129646907|NCT00743288|466663706|FG004|Overall Study|Adverse Event|1|||
129646908|NCT00743288|466663707|FG005|Overall Study|Adverse Event|1|||
129646909|NCT00743288|466663708|FG006|Overall Study|Adverse Event|2|||
129646910|NCT00743288|466663702|FG000|Overall Study|Withdrawal by Subject|0|||
129646911|NCT00743288|466663703|FG001|Overall Study|Withdrawal by Subject|0|||
129646912|NCT00743288|466663704|FG002|Overall Study|Withdrawal by Subject|1|||
129646913|NCT00743288|466663705|FG003|Overall Study|Withdrawal by Subject|0|||
129646914|NCT00743288|466663706|FG004|Overall Study|Withdrawal by Subject|0|||
129646915|NCT00743288|466663707|FG005|Overall Study|Withdrawal by Subject|1|||
129646916|NCT00743288|466663708|FG006|Overall Study|Withdrawal by Subject|1|||
129646917|NCT00743288|466663702|FG000|Overall Study|Progressive disease (PD)|2|||
129646918|NCT00743288|466663703|FG001|Overall Study|Progressive disease (PD)|0|||
129646919|NCT00743288|466663704|FG002|Overall Study|Progressive disease (PD)|1|||
129646920|NCT00743288|466663705|FG003|Overall Study|Progressive disease (PD)|4|||
129646921|NCT00743288|466663706|FG004|Overall Study|Progressive disease (PD)|5|||
129646922|NCT00743288|466663707|FG005|Overall Study|Progressive disease (PD)|3|||
129646923|NCT00743288|466663708|FG006|Overall Study|Progressive disease (PD)|6|||
129646924|NCT00743288|466663702|FG000|Overall Study|Worsening of condition (Not PD)|0|||
129646925|NCT00743288|466663703|FG001|Overall Study|Worsening of condition (Not PD)|2|||
129646926|NCT00743288|466663704|FG002|Overall Study|Worsening of condition (Not PD)|1|||
129646927|NCT00743288|466663705|FG003|Overall Study|Worsening of condition (Not PD)|1|||
129646928|NCT00743288|466663706|FG004|Overall Study|Worsening of condition (Not PD)|0|||
129646929|NCT00743288|466663707|FG005|Overall Study|Worsening of condition (Not PD)|0|||
129646930|NCT00743288|466663708|FG006|Overall Study|Worsening of condition (Not PD)|0|||
129646931|NCT05903924|466663709|FG000|Overall Study|Lost to Follow-up|1|||
129707347|NCT01492426|466891968|FG001|Treatment|Lost to Follow-up|4|||
129707348|NCT01492426|466891967|FG000|Treatment|Participant does not meet study criteria|1|||
129707349|NCT01492426|466891968|FG001|Treatment|Participant does not meet study criteria|0|||
129707350|NCT01492426|466891967|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
129707351|NCT01492426|466891968|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
129707352|NCT01492426|466891967|FG000|Follow-Up|Death|1|||
129707353|NCT01492426|466891968|FG001|Follow-Up|Death|0|||
129707354|NCT01492426|466891967|FG000|Follow-Up|Other|4|||
129707355|NCT01492426|466891968|FG001|Follow-Up|Other|2|||
129707356|NCT01492426|466891967|FG000|Follow-Up|Participant Withdrew Consent|6|||
129707357|NCT01492426|466891968|FG001|Follow-Up|Participant Withdrew Consent|1|||
129707358|NCT01492426|466891967|FG000|Follow-Up|Lost to Follow-up|12|||
129707359|NCT01492426|466891968|FG001|Follow-Up|Lost to Follow-up|6|||
129707360|NCT01978145|466891969|FG000|Treatment Period 1|Adverse Event|1|||
129707361|NCT01978145|466891970|FG001|Treatment Period 1|Adverse Event|9|||
129707362|NCT01978145|466891969|FG000|Treatment Period 1|Physician Decision|1|||
129707363|NCT01978145|466891970|FG001|Treatment Period 1|Physician Decision|0|||
129707364|NCT01978145|466891969|FG000|Treatment Period 1|Withdrawal by Subject|5|||
129707365|NCT01978145|466891970|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129646932|NCT05903924|466663710|FG001|Overall Study|Lost to Follow-up|0|||
129646933|NCT05903924|466663711|FG002|Overall Study|Lost to Follow-up|0|||
129646934|NCT04338269|466663712|FG000|Overall Study|Death|86|||
129646935|NCT04338269|466663713|FG001|Overall Study|Death|89|||
129646936|NCT04338269|466663712|FG000|Overall Study|Lost to Follow-up|1|||
129646937|NCT04338269|466663713|FG001|Overall Study|Lost to Follow-up|2|||
129646938|NCT04338269|466663712|FG000|Overall Study|Physician Decision|1|||
129646939|NCT04338269|466663713|FG001|Overall Study|Physician Decision|0|||
129646940|NCT04338269|466663712|FG000|Overall Study|Withdrawal by Subject|14|||
129646941|NCT04338269|466663713|FG001|Overall Study|Withdrawal by Subject|11|||
129646942|NCT02203851|466663717|FG000|Overall Study|Lost to Follow-up|4|||
129646943|NCT02203851|466663717|FG000|Overall Study|Withdrawal by Subject|6|||
129646944|NCT02203851|466663717|FG000|Overall Study|Other|1|||
129646945|NCT01632150|466663718|FG000|Overall Study|Disease progression|27|||
129646946|NCT01632150|466663718|FG000|Overall Study|Study drug toxicity|1|||
129646947|NCT01632150|466663718|FG000|Overall Study|Unrelated adverse event|7|||
129646948|NCT01632150|466663718|FG000|Overall Study|Withdrawal by Subject|2|||
129646949|NCT01632150|466663718|FG000|Overall Study|Patient underwent autologous transplant|1|||
129646950|NCT01632150|466663718|FG000|Overall Study|Moved to compassionate program|2|||
129646951|NCT01054300|466663722|FG000|Period 1|Adverse Event|1|||
129646952|NCT01054300|466663723|FG001|Period 1|Adverse Event|0|||
129646953|NCT01054300|466663724|FG002|Period 1|Adverse Event|0|||
129646954|NCT01054300|466663725|FG003|Period 1|Adverse Event|0|||
129646955|NCT01054300|466663722|FG000|Period 2|Withdrawal by Subject|0|||
129646956|NCT01054300|466663723|FG001|Period 2|Withdrawal by Subject|0|||
129646957|NCT01054300|466663724|FG002|Period 2|Withdrawal by Subject|1|||
129646958|NCT01054300|466663725|FG003|Period 2|Withdrawal by Subject|0|||
129646959|NCT00308087|466663728|FG000|Overall Study|Progressive Disease|19|||
129646960|NCT00308087|466663729|FG001|Overall Study|Progressive Disease|21|||
129646961|NCT00308087|466663728|FG000|Overall Study|Study Closure|11|||
129646962|NCT00308087|466663729|FG001|Overall Study|Study Closure|12|||
129646963|NCT00308087|466663728|FG000|Overall Study|Withdrawal by Subject|2|||
129646964|NCT00308087|466663729|FG001|Overall Study|Withdrawal by Subject|1|||
129646965|NCT00308087|466663728|FG000|Overall Study|Other|4|||
129646966|NCT00308087|466663729|FG001|Overall Study|Other|3|||
129646967|NCT00177307|466663732|FG000|Overall Study|Withdrawal by Subject|1|||
129646968|NCT02677038|466663736|FG000|Overall Study|Physician Decision|1|||
129646969|NCT02677038|466663736|FG000|Overall Study|Withdrawal by Subject|1|||
129646970|NCT03671564|466663737|FG000|Overall Study|Progressive Disease|3|||
129646971|NCT03671564|466663738|FG001|Overall Study|Progressive Disease|5|||
129646972|NCT03671564|466663739|FG002|Overall Study|Progressive Disease|3|||
129646973|NCT03671564|466663737|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
129646974|NCT03671564|466663738|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
129646975|NCT03671564|466663739|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
129646976|NCT03671564|466663737|FG000|Overall Study|Withdrawal by Subject|1|||
129646977|NCT03671564|466663738|FG001|Overall Study|Withdrawal by Subject|1|||
129646978|NCT03671564|466663739|FG002|Overall Study|Withdrawal by Subject|0|||
129646979|NCT00380081|466663740|FG000|Overall Study|Withdrawal by Subject|0|||
129646980|NCT00380081|466663741|FG001|Overall Study|Withdrawal by Subject|0|||
129646981|NCT00380081|466663742|FG002|Overall Study|Withdrawal by Subject|0|||
129646982|NCT00380081|466663743|FG003|Overall Study|Withdrawal by Subject|0|||
129646983|NCT00380081|466663744|FG004|Overall Study|Withdrawal by Subject|1|||
129646984|NCT00380081|466663745|FG005|Overall Study|Withdrawal by Subject|0|||
129646985|NCT00380081|466663740|FG000|Overall Study|Family Emergency|0|||
129646986|NCT00380081|466663741|FG001|Overall Study|Family Emergency|0|||
129646987|NCT00380081|466663742|FG002|Overall Study|Family Emergency|0|||
129646988|NCT00380081|466663743|FG003|Overall Study|Family Emergency|0|||
129646989|NCT00380081|466663744|FG004|Overall Study|Family Emergency|0|||
129646990|NCT00380081|466663745|FG005|Overall Study|Family Emergency|1|||
129646991|NCT05007041|466663746|FG000|Overall Study|Missing Diary Entries|0|||
129646992|NCT05007041|466663747|FG001|Overall Study|Missing Diary Entries|1|||
129646993|NCT01546168|466663750|FG000|Overall Study|Lost to Follow-up|1|||
129646994|NCT01546168|466663751|FG001|Overall Study|Lost to Follow-up|0|||
129646995|NCT01546168|466663750|FG000|Overall Study|Withdrawal by Subject|1|||
129646996|NCT01546168|466663751|FG001|Overall Study|Withdrawal by Subject|0|||
129707366|NCT01978145|466891969|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
129707367|NCT01978145|466891970|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
129707368|NCT01978145|466891969|FG000|Washout Period 1|Adverse Event|0|||
129707369|NCT01978145|466891970|FG001|Washout Period 1|Adverse Event|1|||
129707370|NCT01978145|466891969|FG000|Washout Period 1|Withdrawal by Subject|1|||
129707371|NCT01978145|466891970|FG001|Washout Period 1|Withdrawal by Subject|1|||
129707372|NCT01978145|466891969|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
129707373|NCT01978145|466891970|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
129707374|NCT01978145|466891969|FG000|Treatment Period 2|Adverse Event|3|||
129707375|NCT01978145|466891970|FG001|Treatment Period 2|Adverse Event|3|||
129646997|NCT01546168|466663750|FG000|Overall Study|ineligible after signing consent|2|||
129646998|NCT01546168|466663751|FG001|Overall Study|ineligible after signing consent|0|||
129646999|NCT02850016|466663752|FG000|Overall Study|Withdrawal by Subject|1|||
129707376|NCT01978145|466891969|FG000|Treatment Period 2|Protocol Violation|0|||
129707377|NCT01978145|466891970|FG001|Treatment Period 2|Protocol Violation|1|||
129707378|NCT01978145|466891969|FG000|Treatment Period 2|Lost to Follow-up|1|||
129707379|NCT01978145|466891970|FG001|Treatment Period 2|Lost to Follow-up|1|||
129707380|NCT01978145|466891969|FG000|Treatment Period 2|Withdrawal by Subject|7|||
129707381|NCT01978145|466891970|FG001|Treatment Period 2|Withdrawal by Subject|4|||
129707382|NCT01978145|466891969|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
129707383|NCT01978145|466891970|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
129707384|NCT01173679|466891975|FG000|Overall Study|Death|1|||
129707385|NCT01250054|466891976|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
129707386|NCT01250054|466891977|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
129707387|NCT02777086|466891978|FG000|Overall Study|Lost to Follow-up|96|||
129707388|NCT02777086|466891979|FG001|Overall Study|Lost to Follow-up|99|||
129707389|NCT01133665|466891982|FG000|Overall Study|Physician Decision|2|||
129707390|NCT02122380|466891983|FG000|First Intervention (30 Days)|Adverse Event|1|||
129707391|NCT02122380|466891984|FG001|First Intervention (30 Days)|Adverse Event|0|||
129707392|NCT02122380|466891983|FG000|First Intervention (30 Days)|Physician Decision|0|||
129707393|NCT02122380|466891984|FG001|First Intervention (30 Days)|Physician Decision|1|||
129707394|NCT02122380|466891983|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
129707395|NCT02122380|466891984|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
129707396|NCT02122380|466891983|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
129707397|NCT02122380|466891984|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
129707398|NCT02122380|466891983|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
129707399|NCT02122380|466891984|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
129707400|NCT02465931|466891987|FG000|Overall Study|Lost to Follow-up|9|||
129707401|NCT02465931|466891988|FG001|Overall Study|Lost to Follow-up|11|||
129707402|NCT02465931|466891987|FG000|Overall Study|Protocol Violation|1|||
129707403|NCT02465931|466891988|FG001|Overall Study|Protocol Violation|0|||
129707404|NCT02465931|466891987|FG000|Overall Study|Withdrawal by Subject|1|||
129707405|NCT02465931|466891988|FG001|Overall Study|Withdrawal by Subject|0|||
129707406|NCT03423602|466891990|FG000|Overall Study|Death|1|||
129707407|NCT03423602|466891990|FG000|Overall Study|Lost to Follow-up|6|||
129707408|NCT03423602|466891990|FG000|Overall Study|Protocol Violation|1|||
129707409|NCT03423602|466891990|FG000|Overall Study|Withdrawal by Subject|4|||
129707410|NCT03423121|466891991|FG000|Overall Study|Lost to Follow-up|2|||
129707411|NCT03423121|466891992|FG001|Overall Study|Lost to Follow-up|6|||
129707412|NCT03423121|466891991|FG000|Overall Study|Adverse Event|1|||
129707413|NCT03423121|466891992|FG001|Overall Study|Adverse Event|0|||
129707414|NCT02136914|466891998|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
129707415|NCT02136914|466891999|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
129707416|NCT02136914|466891998|FG000|Overall Study|Withdrawal by Subject|3|||
129707417|NCT02136914|466891999|FG001|Overall Study|Withdrawal by Subject|10|||
129707418|NCT02136914|466891998|FG000|Overall Study|Subject Unwilling to Proceed|7|||
129707419|NCT02136914|466891999|FG001|Overall Study|Subject Unwilling to Proceed|2|||
129707420|NCT02136914|466891998|FG000|Overall Study|Lost to Follow-up|1|||
129707421|NCT02136914|466891999|FG001|Overall Study|Lost to Follow-up|1|||
129707422|NCT02136914|466891998|FG000|Overall Study|Did Not Receive Study Drug|2|||
129707423|NCT02136914|466891999|FG001|Overall Study|Did Not Receive Study Drug|0|||
129707424|NCT02136914|466891998|FG000|Overall Study|Lack of Efficacy|1|||
129707425|NCT02136914|466891999|FG001|Overall Study|Lack of Efficacy|0|||
129707426|NCT02136914|466891998|FG000|Overall Study|Death|0|||
129707427|NCT02136914|466891999|FG001|Overall Study|Death|1|||
129707428|NCT01493089|466892002|FG000|Overall Study|Protocol Violation|2|||
129707429|NCT01493089|466892003|FG001|Overall Study|Protocol Violation|2|||
129707430|NCT01493089|466892002|FG000|Overall Study|Withdrawal by Subject|1|||
129707431|NCT01493089|466892003|FG001|Overall Study|Withdrawal by Subject|0|||
129707432|NCT01493089|466892002|FG000|Overall Study|Physician Decision|0|||
129707433|NCT01493089|466892003|FG001|Overall Study|Physician Decision|1|||
129707434|NCT00329030|466892004|FG000|Overall Study|Withdrawal by Subject|1|||
129707435|NCT00329030|466892005|FG001|Overall Study|Withdrawal by Subject|3|||
129707436|NCT00329030|466892004|FG000|Overall Study|Progressive Disease|6|||
129707437|NCT00329030|466892005|FG001|Overall Study|Progressive Disease|2|||
129707438|NCT00329030|466892004|FG000|Overall Study|Ineligible Pathology|1|||
129707439|NCT00329030|466892005|FG001|Overall Study|Ineligible Pathology|1|||
129707440|NCT03012334|466892006|FG000|Period 1|Withdrawal by Subject|0|||
129707441|NCT03012334|466892007|FG001|Period 1|Withdrawal by Subject|0|||
129707442|NCT03012334|466892008|FG002|Period 1|Withdrawal by Subject|0|||
129707443|NCT03012334|466892009|FG003|Period 1|Withdrawal by Subject|0|||
129707444|NCT03012334|466892010|FG004|Period 1|Withdrawal by Subject|0|||
129707445|NCT03012334|466892011|FG005|Period 1|Withdrawal by Subject|0|||
129707446|NCT03012334|466892012|FG006|Period 1|Withdrawal by Subject|0|||
129707447|NCT03012334|466892013|FG007|Period 1|Withdrawal by Subject|0|||
129707448|NCT03012334|466892014|FG008|Period 1|Withdrawal by Subject|0|||
129707449|NCT03012334|466892015|FG009|Period 1|Withdrawal by Subject|1|||
129707450|NCT03012334|466892006|FG000|Period 2|Withdrawal by Subject|0|||
129707451|NCT03012334|466892007|FG001|Period 2|Withdrawal by Subject|1|||
129647000|NCT02850016|466663753|FG001|Overall Study|Withdrawal by Subject|2|||
129647001|NCT02954653|466663754|FG000|Overall Study|Death|3|||
129647002|NCT02954653|466663755|FG001|Overall Study|Death|1|||
129647003|NCT02954653|466663756|FG002|Overall Study|Death|0|||
129647004|NCT02954653|466663757|FG003|Overall Study|Death|0|||
129647005|NCT02954653|466663758|FG004|Overall Study|Death|0|||
129647006|NCT02954653|466663759|FG005|Overall Study|Death|0|||
129647007|NCT02954653|466663760|FG006|Overall Study|Death|0|||
129647008|NCT02954653|466663761|FG007|Overall Study|Death|0|||
129647009|NCT02954653|466663762|FG008|Overall Study|Death|0|||
129647010|NCT02954653|466663754|FG000|Overall Study|Randomized but did not receive treatment|1|||
129647011|NCT02954653|466663755|FG001|Overall Study|Randomized but did not receive treatment|0|||
129647012|NCT02954653|466663756|FG002|Overall Study|Randomized but did not receive treatment|0|||
129647013|NCT02954653|466663757|FG003|Overall Study|Randomized but did not receive treatment|0|||
129647014|NCT02954653|466663758|FG004|Overall Study|Randomized but did not receive treatment|0|||
129647015|NCT02954653|466663759|FG005|Overall Study|Randomized but did not receive treatment|0|||
129647016|NCT02954653|466663760|FG006|Overall Study|Randomized but did not receive treatment|0|||
129647017|NCT02954653|466663761|FG007|Overall Study|Randomized but did not receive treatment|0|||
129647018|NCT02954653|466663762|FG008|Overall Study|Randomized but did not receive treatment|0|||
129647019|NCT02954653|466663754|FG000|Overall Study|Started another anti-cancer therapy|0|||
129647020|NCT02954653|466663755|FG001|Overall Study|Started another anti-cancer therapy|1|||
129647021|NCT02954653|466663756|FG002|Overall Study|Started another anti-cancer therapy|0|||
129647022|NCT02954653|466663757|FG003|Overall Study|Started another anti-cancer therapy|0|||
129647023|NCT02954653|466663758|FG004|Overall Study|Started another anti-cancer therapy|0|||
129647024|NCT02954653|466663759|FG005|Overall Study|Started another anti-cancer therapy|0|||
129647025|NCT02954653|466663760|FG006|Overall Study|Started another anti-cancer therapy|0|||
129647026|NCT02954653|466663761|FG007|Overall Study|Started another anti-cancer therapy|0|||
129647027|NCT02954653|466663762|FG008|Overall Study|Started another anti-cancer therapy|0|||
129647028|NCT02954653|466663754|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
129647029|NCT02954653|466663755|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
129647030|NCT02954653|466663756|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
129707452|NCT03012334|466892008|FG002|Period 2|Withdrawal by Subject|0|||
129707453|NCT03012334|466892009|FG003|Period 2|Withdrawal by Subject|0|||
129707454|NCT03012334|466892010|FG004|Period 2|Withdrawal by Subject|0|||
129707455|NCT03012334|466892011|FG005|Period 2|Withdrawal by Subject|0|||
129707456|NCT03012334|466892012|FG006|Period 2|Withdrawal by Subject|0|||
129707457|NCT03012334|466892013|FG007|Period 2|Withdrawal by Subject|0|||
129707458|NCT03012334|466892014|FG008|Period 2|Withdrawal by Subject|0|||
129707459|NCT03012334|466892015|FG009|Period 2|Withdrawal by Subject|0|||
129647031|NCT02954653|466663757|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
129647032|NCT02954653|466663758|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
129647033|NCT02954653|466663759|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
129647034|NCT02954653|466663760|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
129707460|NCT03012334|466892006|FG000|Period 2|Protocol Violation|0|||
129800105|NCT05098938|467235300|FG000|Overall Study|6 months visit was missed|2|||
129800106|NCT05098938|467235301|FG001|Overall Study|6 months visit was missed|0|||
129800107|NCT05098938|467235300|FG000|Overall Study|fit for use was not completed within window|3|||
129800108|NCT05098938|467235301|FG001|Overall Study|fit for use was not completed within window|0|||
129800109|NCT05098938|467235300|FG000|Overall Study|V2 visit was not completed within window|0|||
129800110|NCT05098938|467235301|FG001|Overall Study|V2 visit was not completed within window|1|||
129800111|NCT05098938|467235300|FG000|Overall Study|exclusionary medication use|1|||
129800112|NCT05098938|467235301|FG001|Overall Study|exclusionary medication use|2|||
129800113|NCT05098938|467235300|FG000|Overall Study|change in medication|1|||
129800114|NCT05098938|467235301|FG001|Overall Study|change in medication|0|||
129800115|NCT05098938|467235300|FG000|Overall Study|treatment failure|2|||
129800116|NCT05098938|467235301|FG001|Overall Study|treatment failure|1|||
129800117|NCT01828320|467235302|FG000|Overall Study|Lost to Follow-up|1|||
129800118|NCT01828320|467235303|FG001|Overall Study|Lost to Follow-up|3|||
129800119|NCT01828320|467235302|FG000|Overall Study|Withdrawal by Subject|7|||
129800120|NCT01828320|467235303|FG001|Overall Study|Withdrawal by Subject|2|||
129800121|NCT00426231|467236182|FG000|Overall Study|Withdrawal by Subject|9|||
129800122|NCT00426231|467236183|FG001|Overall Study|Withdrawal by Subject|12|||
129800123|NCT01795638|467236184|FG000|Overall Study|Death|0|||
129800124|NCT01795638|467236185|FG001|Overall Study|Death|3|||
129800125|NCT01795638|467236184|FG000|Overall Study|transferred to quaternary hospital|2|||
129800126|NCT01795638|467236185|FG001|Overall Study|transferred to quaternary hospital|3|||
129800127|NCT01795638|467236184|FG000|Overall Study|Protocol Violation|3|||
129800128|NCT01795638|467236185|FG001|Overall Study|Protocol Violation|0|||
129800129|NCT01795638|467236184|FG000|Overall Study|discharged from hospital|7|||
129800130|NCT01795638|467236185|FG001|Overall Study|discharged from hospital|5|||
129800131|NCT01795638|467236184|FG000|Overall Study|Withdrawal by Subject|1|||
129800132|NCT01795638|467236185|FG001|Overall Study|Withdrawal by Subject|0|||
129800133|NCT00293215|467236186|FG000|Overall Study|Progressive disease|3|||
129800134|NCT00293215|467236187|FG001|Overall Study|Progressive disease|1|||
129800135|NCT00293215|467236186|FG000|Overall Study|Adverse Event|2|||
129800136|NCT00293215|467236187|FG001|Overall Study|Adverse Event|2|||
129800137|NCT01229371|467236188|FG000|Overall Study|Withdrawal by Subject|0|||
129800138|NCT01229371|467236189|FG001|Overall Study|Withdrawal by Subject|1|||
129800139|NCT01229371|467236190|FG002|Overall Study|Withdrawal by Subject|0|||
129800140|NCT01229371|467236191|FG003|Overall Study|Withdrawal by Subject|0|||
129800141|NCT00122109|467236193|FG000|Overall Study|Did not meet criteria|6|||
129800142|NCT00122109|467236194|FG001|Overall Study|Did not meet criteria|7|||
129800143|NCT00267189|467236198|FG000|Overall Study|Patient withdrew consent|1|||
129800144|NCT00267189|467236199|FG001|Overall Study|Patient withdrew consent|1|||
129647035|NCT02954653|466663761|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
129647036|NCT02954653|466663762|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
129647037|NCT00070018|466663766|FG000|Overall Study|Adverse Event|2|||
129647038|NCT00070018|466663766|FG000|Overall Study|Lack of Efficacy|1|||
129647039|NCT00070018|466663766|FG000|Overall Study|Withdrawal by Subject|1|||
129647040|NCT02939716|466663767|FG000|Overall Study|scanner failure|0|||
129647041|NCT02939716|466663768|FG001|Overall Study|scanner failure|0|||
129647042|NCT02939716|466663769|FG002|Overall Study|scanner failure|0|||
129647043|NCT02939716|466663770|FG003|Overall Study|scanner failure|1|||
129647044|NCT02939716|466663771|FG004|Overall Study|scanner failure|1|||
129647045|NCT02939716|466663772|FG005|Overall Study|scanner failure|1|||
129647046|NCT02543892|466663778|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
129647047|NCT02543892|466663779|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
129647048|NCT02543892|466663780|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
129800145|NCT00267189|467236198|FG000|Overall Study|Death|1|||
129800146|NCT00267189|467236199|FG001|Overall Study|Death|0|||
129800147|NCT00267189|467236198|FG000|Overall Study|Missing|3|||
129800148|NCT00267189|467236199|FG001|Overall Study|Missing|0|||
129800149|NCT01578330|467236204|FG000|Overall Study|Adverse Event|2|||
129800150|NCT01578330|467236204|FG000|Overall Study|Protocol Violation|5|||
129647049|NCT02543892|466663781|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
129647050|NCT02543892|466663782|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
129647051|NCT02543892|466663783|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
129800151|NCT03114488|467236207|FG000|Time Period 2|Withdrawal by Subject|1|||
129800152|NCT03114488|467236208|FG001|Time Period 2|Withdrawal by Subject|3|||
129800153|NCT01225887|467236209|FG000|Overall Study|Ineligible:required test not done|2|||
129800154|NCT01225887|467236209|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
129707461|NCT03012334|466892007|FG001|Period 2|Protocol Violation|0|||
129707462|NCT03012334|466892008|FG002|Period 2|Protocol Violation|1|||
129707463|NCT03012334|466892009|FG003|Period 2|Protocol Violation|0|||
129707464|NCT03012334|466892010|FG004|Period 2|Protocol Violation|0|||
129707465|NCT03012334|466892011|FG005|Period 2|Protocol Violation|0|||
129707466|NCT03012334|466892012|FG006|Period 2|Protocol Violation|0|||
129707467|NCT03012334|466892013|FG007|Period 2|Protocol Violation|1|||
129707468|NCT03012334|466892014|FG008|Period 2|Protocol Violation|0|||
129707469|NCT03012334|466892015|FG009|Period 2|Protocol Violation|0|||
129707470|NCT03012334|466892006|FG000|Period 4|Non-Compliance|0|||
129707471|NCT03012334|466892007|FG001|Period 4|Non-Compliance|0|||
129707472|NCT03012334|466892008|FG002|Period 4|Non-Compliance|0|||
129707473|NCT03012334|466892009|FG003|Period 4|Non-Compliance|0|||
129707474|NCT03012334|466892010|FG004|Period 4|Non-Compliance|0|||
129707475|NCT03012334|466892011|FG005|Period 4|Non-Compliance|0|||
129707476|NCT03012334|466892012|FG006|Period 4|Non-Compliance|1|||
129707477|NCT03012334|466892013|FG007|Period 4|Non-Compliance|0|||
129707478|NCT03012334|466892014|FG008|Period 4|Non-Compliance|0|||
129707479|NCT03012334|466892015|FG009|Period 4|Non-Compliance|0|||
129707480|NCT03012334|466892006|FG000|Period 4|Adverse Event|0|||
129707481|NCT03012334|466892007|FG001|Period 4|Adverse Event|0|||
129707482|NCT03012334|466892008|FG002|Period 4|Adverse Event|0|||
129707483|NCT03012334|466892009|FG003|Period 4|Adverse Event|0|||
129707484|NCT03012334|466892010|FG004|Period 4|Adverse Event|0|||
129707485|NCT03012334|466892011|FG005|Period 4|Adverse Event|0|||
129707486|NCT03012334|466892012|FG006|Period 4|Adverse Event|0|||
129707487|NCT03012334|466892013|FG007|Period 4|Adverse Event|0|||
129707488|NCT03012334|466892014|FG008|Period 4|Adverse Event|1|||
129707489|NCT03012334|466892015|FG009|Period 4|Adverse Event|0|||
129707490|NCT00325143|466892016|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
129707491|NCT00325143|466892016|FG000|Overall Study|Migrated/moved from study area|1|||
129707492|NCT00325143|466892016|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
129707493|NCT00325143|466892016|FG000|Overall Study|Withdrawal by Subject|8|||
129707494|NCT00256126|466892017|FG000|Overall Study|Adverse Event|1|||
129707495|NCT00256126|466892018|FG001|Overall Study|Adverse Event|0|||
129707496|NCT00256126|466892017|FG000|Overall Study|Other|1|||
129707497|NCT00256126|466892018|FG001|Overall Study|Other|2|||
129707498|NCT00454116|466892019|FG000|Overall Study|Adverse Event|5|||
129707499|NCT00454116|466892020|FG001|Overall Study|Adverse Event|11|||
129707500|NCT00454116|466892021|FG002|Overall Study|Adverse Event|9|||
129707501|NCT00454116|466892019|FG000|Overall Study|Condition under investigation worsened|17|||
129707502|NCT00454116|466892020|FG001|Overall Study|Condition under investigation worsened|13|||
129707503|NCT00454116|466892021|FG002|Overall Study|Condition under investigation worsened|18|||
129707504|NCT00454116|466892019|FG000|Overall Study|Withdrawal by Subject|3|||
129707505|NCT00454116|466892020|FG001|Overall Study|Withdrawal by Subject|3|||
129707506|NCT00454116|466892021|FG002|Overall Study|Withdrawal by Subject|1|||
129707507|NCT00454116|466892019|FG000|Overall Study|Other|2|||
129707508|NCT00454116|466892020|FG001|Overall Study|Other|2|||
129707509|NCT00454116|466892021|FG002|Overall Study|Other|0|||
129707510|NCT01008618|466892024|FG000|Period 1 (Titration Period)|Physician Decision|2|||
129707511|NCT01008618|466892025|FG001|Period 1 (Titration Period)|Physician Decision|0|||
129707512|NCT01008618|466892026|FG002|Period 1 (Titration Period)|Physician Decision|0|||
129707513|NCT01008618|466892024|FG000|Period 1 (Titration Period)|Adverse Event|33|||
129707514|NCT01008618|466892025|FG001|Period 1 (Titration Period)|Adverse Event|0|||
129707515|NCT01008618|466892026|FG002|Period 1 (Titration Period)|Adverse Event|0|||
129707516|NCT01008618|466892024|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
129707517|NCT01008618|466892025|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129707518|NCT01008618|466892026|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129800155|NCT01225887|467236209|FG000|Overall Study|Ineligible:inadequate pathology|2|||
129800156|NCT01669928|467236210|FG000|First Intervention|Withdrawal by Subject|3|||
129800157|NCT01669928|467236211|FG001|First Intervention|Withdrawal by Subject|5|||
129800158|NCT00925990|467236212|FG000|Overall Study|Adverse Event|1|||
129707519|NCT01008618|466892024|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
129707520|NCT01008618|466892025|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129707521|NCT01008618|466892026|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129707522|NCT01008618|466892024|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
129707523|NCT01008618|466892025|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
129707524|NCT01008618|466892026|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
129800159|NCT00925990|467236213|FG001|Overall Study|Adverse Event|3|||
129707525|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
129707526|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
129707527|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
129707528|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
129707529|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
129707530|NCT01008618|466892026|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
129707531|NCT01008618|466892024|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
129707532|NCT01008618|466892025|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
129647052|NCT02543892|466663784|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
129647053|NCT02543892|466663785|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
129647054|NCT02543892|466663778|FG000|Received Vaccination 2|Physician Decision|0|||
129647055|NCT02543892|466663779|FG001|Received Vaccination 2|Physician Decision|0|||
129647056|NCT02543892|466663780|FG002|Received Vaccination 2|Physician Decision|0|||
129647057|NCT02543892|466663781|FG003|Received Vaccination 2|Physician Decision|0|||
129647058|NCT02543892|466663782|FG004|Received Vaccination 2|Physician Decision|0|||
129647059|NCT02543892|466663783|FG005|Received Vaccination 2|Physician Decision|1|||
129647060|NCT02543892|466663784|FG006|Received Vaccination 2|Physician Decision|0|||
129647061|NCT02543892|466663785|FG007|Received Vaccination 2|Physician Decision|0|||
129800160|NCT00925990|467236212|FG000|Overall Study|Withdrawal by Subject|2|||
129800161|NCT00925990|467236213|FG001|Overall Study|Withdrawal by Subject|2|||
129800162|NCT00925990|467236212|FG000|Overall Study|Lost to Follow-up|1|||
129707775|NCT00542178|466892125|FG006|Overall Study|did not complete year 4 follow-up|87|||
129707776|NCT00542178|466892126|FG007|Overall Study|did not complete year 4 follow-up|85|||
129707777|NCT03984188|466892132|FG000|Overall Study|Death|2|||
129707778|NCT03984188|466892133|FG001|Overall Study|Death|4|||
129707779|NCT03984188|466892132|FG000|Overall Study|Physician Decision|0|||
129707780|NCT03984188|466892133|FG001|Overall Study|Physician Decision|2|||
129707781|NCT03984188|466892132|FG000|Overall Study|Lost to Follow-up|3|||
129707782|NCT03984188|466892133|FG001|Overall Study|Lost to Follow-up|2|||
129707783|NCT03984188|466892132|FG000|Overall Study|Withdrawal by Subject|6|||
129707784|NCT03984188|466892133|FG001|Overall Study|Withdrawal by Subject|0|||
129707785|NCT05111145|466893699|FG000|Overall Study|Commercial drug is available for participant|76|||
129707786|NCT05111145|466893699|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
129707787|NCT02336815|466893700|FG000|Overall Study|Disease Progression|45|||
129707788|NCT02336815|466893701|FG001|Overall Study|Disease Progression|70|||
129707789|NCT02336815|466893700|FG000|Overall Study|Adverse Event|18|||
129707790|NCT02336815|466893701|FG001|Overall Study|Adverse Event|39|||
129707791|NCT02336815|466893700|FG000|Overall Study|Physician Decision|11|||
129707792|NCT02336815|466893701|FG001|Overall Study|Physician Decision|4|||
129707793|NCT02336815|466893700|FG000|Overall Study|Withdrawal by Subject|3|||
129707794|NCT02336815|466893701|FG001|Overall Study|Withdrawal by Subject|2|||
129707795|NCT02336815|466893700|FG000|Overall Study|Lost to Follow-up|1|||
129707796|NCT02336815|466893701|FG001|Overall Study|Lost to Follow-up|3|||
129707797|NCT02336815|466893700|FG000|Overall Study|Other|1|||
129707798|NCT02336815|466893701|FG001|Overall Study|Other|5|||
129707799|NCT04099277|466893702|FG000|Overall Study|Physician Decision|1|||
129707800|NCT04099277|466893702|FG000|Overall Study|Withdrawal by Subject|1|||
129647687|NCT03045276|466665409|FG003|Intervention Phase|Developed exclusionary criteria|0|||
129647688|NCT03045276|466665406|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
129647689|NCT03045276|466665407|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
129647690|NCT03045276|466665408|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
129647691|NCT03045276|466665409|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
129647692|NCT03045276|466665406|FG000|Follow-Up Phase|Lost to Follow-up|0|||
129647693|NCT03045276|466665407|FG001|Follow-Up Phase|Lost to Follow-up|1|||
129647694|NCT03045276|466665408|FG002|Follow-Up Phase|Lost to Follow-up|0|||
129647695|NCT03045276|466665409|FG003|Follow-Up Phase|Lost to Follow-up|1|||
129647696|NCT03045276|466665406|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
129647697|NCT03045276|466665407|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
129647698|NCT03045276|466665408|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
129647699|NCT03045276|466665409|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
129647700|NCT01597375|466665410|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
129647701|NCT01597375|466665411|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
129647702|NCT01597375|466665410|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
129647703|NCT01597375|466665411|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
129647704|NCT01597375|466665410|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129647705|NCT01597375|466665411|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
129647706|NCT01597375|466665410|FG000|Washout (2 Weeks)|Adverse Event|1|||
129647707|NCT01597375|466665411|FG001|Washout (2 Weeks)|Adverse Event|0|||
129647708|NCT01597375|466665410|FG000|Second Intervention|Failed to react at both Aspirin|1|||
129647709|NCT01597375|466665411|FG001|Second Intervention|Failed to react at both Aspirin|1|||
129647710|NCT02225366|466665416|FG000|Overall Study|Lack of Efficacy|1|||
129647711|NCT02225366|466665417|FG001|Overall Study|Lack of Efficacy|0|||
129647712|NCT04713592|466665418|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
129647713|NCT04713592|466665419|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
129647714|NCT04713592|466665420|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
129647715|NCT04713592|466665421|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
129647716|NCT04713592|466665418|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
129647717|NCT04713592|466665419|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
129647718|NCT04713592|466665420|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
129647719|NCT04713592|466665421|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
129647720|NCT04713592|466665418|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
129647721|NCT04713592|466665419|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
129647722|NCT04713592|466665420|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
129647723|NCT04713592|466665421|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
129647724|NCT04713592|466665418|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129647725|NCT04713592|466665419|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
129647726|NCT04713592|466665420|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
129707801|NCT00492557|466893703|FG000|Overall Study|Subject request|12|||
129707802|NCT00492557|466893704|FG001|Overall Study|Subject request|11|||
129707803|NCT00492557|466893703|FG000|Overall Study|Protocol Violation|7|||
129707804|NCT00492557|466893704|FG001|Overall Study|Protocol Violation|8|||
129707805|NCT00492557|466893703|FG000|Overall Study|Other|2|||
129707806|NCT00492557|466893704|FG001|Overall Study|Other|2|||
129707807|NCT00492557|466893703|FG000|Overall Study|Death|1|||
129707808|NCT00492557|466893704|FG001|Overall Study|Death|1|||
129707809|NCT00492557|466893703|FG000|Overall Study|Adverse Event|1|||
129707810|NCT00492557|466893704|FG001|Overall Study|Adverse Event|0|||
129707811|NCT00492557|466893703|FG000|Overall Study|Failed to return|1|||
129707812|NCT00492557|466893704|FG001|Overall Study|Failed to return|0|||
129707813|NCT00492557|466893703|FG000|Overall Study|Lost to Follow-up|0|||
129707814|NCT00492557|466893704|FG001|Overall Study|Lost to Follow-up|1|||
129707815|NCT01354223|466893705|FG000|Overall Study|Withdrawal by Subject|3|||
129707816|NCT01354223|466893706|FG001|Overall Study|Withdrawal by Subject|1|||
129707817|NCT00948688|466893711|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
129707818|NCT00948688|466893712|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
129707819|NCT00948688|466893711|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
129707820|NCT00948688|466893712|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
129707821|NCT00948688|466893711|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
129707822|NCT00948688|466893712|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
129707823|NCT01135992|466893713|FG000|Overall Study|Adverse Event|1|||
129707824|NCT01135992|466893713|FG000|Overall Study|Lack of Efficacy|1|||
129707825|NCT01135992|466893713|FG000|Overall Study|Protocol Violation|2|||
129707826|NCT01135992|466893713|FG000|Overall Study|Withdrawal criteria|10|||
129707827|NCT01135992|466893713|FG000|Overall Study|Unclassified|7|||
129707828|NCT02852967|466893714|FG000|Overall Study|Adverse Event|3|||
129707829|NCT02852967|466893715|FG001|Overall Study|Adverse Event|1|||
129707830|NCT02852967|466893716|FG002|Overall Study|Adverse Event|0|||
129707831|NCT02852967|466893717|FG003|Overall Study|Adverse Event|1|||
129707832|NCT02852967|466893718|FG004|Overall Study|Adverse Event|0|||
129707833|NCT02852967|466893714|FG000|Overall Study|Death|1|||
129707834|NCT02852967|466893715|FG001|Overall Study|Death|0|||
129707835|NCT02852967|466893716|FG002|Overall Study|Death|0|||
129707836|NCT02852967|466893717|FG003|Overall Study|Death|0|||
129707837|NCT02852967|466893718|FG004|Overall Study|Death|0|||
129707838|NCT02852967|466893714|FG000|Overall Study|Lost to Follow-up|1|||
129707839|NCT02852967|466893715|FG001|Overall Study|Lost to Follow-up|2|||
129707840|NCT02852967|466893716|FG002|Overall Study|Lost to Follow-up|3|||
129707841|NCT02852967|466893717|FG003|Overall Study|Lost to Follow-up|4|||
129707842|NCT02852967|466893718|FG004|Overall Study|Lost to Follow-up|4|||
129707843|NCT02852967|466893714|FG000|Overall Study|Withdrawal by Subject|6|||
129707844|NCT02852967|466893715|FG001|Overall Study|Withdrawal by Subject|12|||
129707845|NCT02852967|466893716|FG002|Overall Study|Withdrawal by Subject|7|||
129707846|NCT02852967|466893717|FG003|Overall Study|Withdrawal by Subject|10|||
129707847|NCT02852967|466893718|FG004|Overall Study|Withdrawal by Subject|10|||
129707848|NCT02852967|466893714|FG000|Overall Study|SAE|0|||
129707849|NCT02852967|466893715|FG001|Overall Study|SAE|0|||
129707850|NCT02852967|466893716|FG002|Overall Study|SAE|0|||
129707851|NCT02852967|466893717|FG003|Overall Study|SAE|3|||
129707852|NCT02852967|466893718|FG004|Overall Study|SAE|0|||
129707853|NCT02852967|466893714|FG000|Overall Study|Elevated Liver Enzymes|2|||
129707854|NCT02852967|466893715|FG001|Overall Study|Elevated Liver Enzymes|0|||
129707855|NCT02852967|466893716|FG002|Overall Study|Elevated Liver Enzymes|0|||
129707856|NCT02852967|466893717|FG003|Overall Study|Elevated Liver Enzymes|2|||
129707857|NCT02852967|466893718|FG004|Overall Study|Elevated Liver Enzymes|2|||
129707858|NCT02852967|466893714|FG000|Overall Study|Physician Decision|0|||
129707859|NCT02852967|466893715|FG001|Overall Study|Physician Decision|0|||
129707860|NCT02852967|466893716|FG002|Overall Study|Physician Decision|0|||
129707861|NCT02852967|466893717|FG003|Overall Study|Physician Decision|1|||
129707862|NCT02852967|466893718|FG004|Overall Study|Physician Decision|0|||
129707863|NCT02852967|466893714|FG000|Overall Study|Lack of Efficacy|0|||
129707864|NCT02852967|466893715|FG001|Overall Study|Lack of Efficacy|1|||
129707865|NCT02852967|466893716|FG002|Overall Study|Lack of Efficacy|0|||
129707866|NCT02852967|466893717|FG003|Overall Study|Lack of Efficacy|0|||
129707867|NCT02852967|466893718|FG004|Overall Study|Lack of Efficacy|0|||
129707868|NCT02852967|466893714|FG000|Overall Study|Non-compliance|0|||
129707869|NCT02852967|466893715|FG001|Overall Study|Non-compliance|0|||
129707870|NCT02852967|466893716|FG002|Overall Study|Non-compliance|1|||
129707871|NCT02852967|466893717|FG003|Overall Study|Non-compliance|1|||
129707872|NCT02852967|466893718|FG004|Overall Study|Non-compliance|0|||
129707873|NCT02852967|466893714|FG000|Overall Study|Dispensing Drug Violation|0|||
129707874|NCT02852967|466893715|FG001|Overall Study|Dispensing Drug Violation|0|||
129707875|NCT02852967|466893716|FG002|Overall Study|Dispensing Drug Violation|1|||
129707876|NCT02852967|466893717|FG003|Overall Study|Dispensing Drug Violation|0|||
129707877|NCT02852967|466893718|FG004|Overall Study|Dispensing Drug Violation|0|||
129707878|NCT02852967|466893714|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
129707879|NCT02852967|466893715|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
129707880|NCT02852967|466893716|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
129707881|NCT02852967|466893717|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
129707882|NCT02852967|466893718|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
129707883|NCT01693367|466893719|FG000|Overall Study|Withdrawal by Subject|1|||
129707884|NCT01693367|466893720|FG001|Overall Study|Withdrawal by Subject|1|||
129707885|NCT01693367|466893719|FG000|Overall Study|Physician Decision|0|||
129707886|NCT01693367|466893720|FG001|Overall Study|Physician Decision|1|||
129707887|NCT02286895|466893721|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
129707888|NCT02286895|466893722|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
129707889|NCT02286895|466893721|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
129707890|NCT02286895|466893722|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
129707891|NCT02286895|466893721|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
129707892|NCT02286895|466893722|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
129707893|NCT01073293|466893723|FG000|Overall Study|Lost to Follow-up|0|||
129707894|NCT01073293|466893724|FG001|Overall Study|Lost to Follow-up|1|||
129707895|NCT01073293|466893723|FG000|Overall Study|Withdrawal by Subject|5|||
129707896|NCT01073293|466893724|FG001|Overall Study|Withdrawal by Subject|10|||
129707897|NCT02949011|466893727|FG000|Overall Study|Adverse Event|6|||
129707898|NCT02949011|466893728|FG001|Overall Study|Adverse Event|7|||
129707899|NCT02949011|466893729|FG002|Overall Study|Adverse Event|3|||
129707900|NCT02949011|466893727|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129707901|NCT02949011|466893728|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129707902|NCT02949011|466893729|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
129707903|NCT02949011|466893727|FG000|Overall Study|Protocol Deviation|5|||
129707904|NCT02949011|466893728|FG001|Overall Study|Protocol Deviation|3|||
129707905|NCT02949011|466893729|FG002|Overall Study|Protocol Deviation|3|||
129707906|NCT02949011|466893727|FG000|Overall Study|Lack of Efficacy|0|||
129707907|NCT02949011|466893728|FG001|Overall Study|Lack of Efficacy|2|||
129707908|NCT02949011|466893729|FG002|Overall Study|Lack of Efficacy|0|||
129707909|NCT02949011|466893727|FG000|Overall Study|Withdrawal by Subject|13|||
129707910|NCT02949011|466893728|FG001|Overall Study|Withdrawal by Subject|13|||
129707911|NCT02949011|466893729|FG002|Overall Study|Withdrawal by Subject|21|||
129707912|NCT02949011|466893727|FG000|Overall Study|Lost to Follow-up|7|||
129707913|NCT02949011|466893728|FG001|Overall Study|Lost to Follow-up|5|||
129707914|NCT02949011|466893729|FG002|Overall Study|Lost to Follow-up|5|||
129707915|NCT02949011|466893727|FG000|Overall Study|Death|0|||
129707916|NCT02949011|466893728|FG001|Overall Study|Death|0|||
129707917|NCT02949011|466893729|FG002|Overall Study|Death|1|||
129707918|NCT02949011|466893727|FG000|Overall Study|Miscellaneous|2|||
129707919|NCT02949011|466893728|FG001|Overall Study|Miscellaneous|4|||
129707920|NCT02949011|466893729|FG002|Overall Study|Miscellaneous|6|||
129707921|NCT00163189|466893730|FG000|Overall Study|Other|6|||
129707922|NCT00163189|466893730|FG000|Overall Study|Lost to Follow-up|1|||
129707923|NCT00163189|466893730|FG000|Overall Study|Protocol Violation|2|||
129707924|NCT00163189|466893730|FG000|Overall Study|Death|3|||
129707925|NCT00163189|466893730|FG000|Overall Study|Adverse Event|6|||
129707926|NCT00163189|466893730|FG000|Overall Study|Lack of Efficacy|7|||
129707927|NCT00163189|466893730|FG000|Overall Study|Study terminated by sponsor|11|||
129707928|NCT00163189|466893730|FG000|Overall Study|Withdrawal by Subject|11|||
129707929|NCT00163189|466893730|FG000|Overall Study|Did not meet continuation criterion|16|||
129707930|NCT00506142|466893731|FG000|Overall Study|Adverse Event|8|||
129707931|NCT00506142|466893732|FG001|Overall Study|Adverse Event|7|||
129707932|NCT00506142|466893731|FG000|Overall Study|Lack of Efficacy|21|||
129707933|NCT00506142|466893732|FG001|Overall Study|Lack of Efficacy|7|||
129707934|NCT00506142|466893731|FG000|Overall Study|Withdrawal by Subject|4|||
129707935|NCT00506142|466893732|FG001|Overall Study|Withdrawal by Subject|5|||
129707936|NCT00506142|466893731|FG000|Overall Study|Physician Decision|1|||
129707937|NCT00506142|466893732|FG001|Overall Study|Physician Decision|0|||
129707938|NCT00506142|466893731|FG000|Overall Study|New health condition|1|||
129707939|NCT00506142|466893732|FG001|Overall Study|New health condition|0|||
129707940|NCT02154061|466893733|FG000|Overall Study|Pregnancy|1|||
129707941|NCT02154061|466893734|FG001|Overall Study|Pregnancy|0|||
129707942|NCT02154061|466893733|FG000|Overall Study|enrolled but not vaccinated|1|||
129707943|NCT02154061|466893734|FG001|Overall Study|enrolled but not vaccinated|0|||
129707944|NCT01917318|466893737|FG000|First Treatment|Withdrawal by Subject|0|||
129707945|NCT01917318|466893738|FG001|First Treatment|Withdrawal by Subject|1|||
129707946|NCT00742625|466893739|FG000|Remission Induction|Progression|6|||
129707947|NCT00742625|466893739|FG000|Remission Induction|Failed induction|8|||
129707948|NCT00742625|466893739|FG000|Remission Induction|Adverse Event|3|||
129707949|NCT00742625|466893739|FG000|Remission Induction|Death|10|||
129707950|NCT00742625|466893739|FG000|Remission Induction|Refusal|5|||
129647727|NCT04713592|466665421|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
129647728|NCT04713592|466665418|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
129647729|NCT04713592|466665419|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
129647730|NCT04713592|466665420|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
129647731|NCT04713592|466665421|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
129647732|NCT04713592|466665418|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129647733|NCT04713592|466665419|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
129647734|NCT04713592|466665420|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129647735|NCT04713592|466665421|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
129647736|NCT04713592|466665418|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
129647737|NCT04713592|466665419|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
129647738|NCT04713592|466665420|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
129647739|NCT04713592|466665421|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
129647740|NCT03782298|466665424|FG000|Overall Study|Protocol Deviation|4|||
129647741|NCT01797081|466665427|FG000|Overall Study|Adverse Event|1|||
129647742|NCT01797081|466665428|FG001|Overall Study|Adverse Event|0|||
129647743|NCT01797081|466665429|FG002|Overall Study|Adverse Event|1|||
129647744|NCT01797081|466665430|FG003|Overall Study|Adverse Event|0|||
129647745|NCT01797081|466665427|FG000|Overall Study|Pregnancy|1|||
129647746|NCT01797081|466665428|FG001|Overall Study|Pregnancy|0|||
129647747|NCT01797081|466665429|FG002|Overall Study|Pregnancy|0|||
129647748|NCT01797081|466665430|FG003|Overall Study|Pregnancy|0|||
129647749|NCT01797081|466665427|FG000|Overall Study|Personal Reasons|12|||
129647750|NCT01797081|466665428|FG001|Overall Study|Personal Reasons|4|||
129647751|NCT01797081|466665429|FG002|Overall Study|Personal Reasons|4|||
129647752|NCT01797081|466665430|FG003|Overall Study|Personal Reasons|8|||
129647753|NCT01797081|466665427|FG000|Overall Study|Protocol Violation|0|||
129647754|NCT01797081|466665428|FG001|Overall Study|Protocol Violation|0|||
129647755|NCT01797081|466665429|FG002|Overall Study|Protocol Violation|0|||
129647756|NCT01797081|466665430|FG003|Overall Study|Protocol Violation|1|||
129647757|NCT02484651|466665435|FG000|Overall Study|Patients' data files were corrupted.|1|||
129647758|NCT02484651|466665436|FG001|Overall Study|Patients' data files were corrupted.|1|||
129647759|NCT02484651|466665435|FG000|Overall Study|BIS monitoring failed.|1|||
129647760|NCT02484651|466665436|FG001|Overall Study|BIS monitoring failed.|1|||
129647761|NCT02484651|466665435|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
129647762|NCT02484651|466665436|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
129647763|NCT02375555|466665440|FG000|Induction Period|Adverse Event|7|||
129647764|NCT02375555|466665440|FG000|Induction Period|Withdrawal by Subject|2|||
129647765|NCT02375555|466665440|FG000|Induction Period|Other|1|||
129647766|NCT02375555|466665440|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
129647767|NCT02375555|466665440|FG000|Maintenance Period|Adverse Event|2|||
129647768|NCT02375555|466665440|FG000|Maintenance Period|Withdrawal by Subject|4|||
129647769|NCT02375555|466665440|FG000|Maintenance Period|Death|1|||
129647770|NCT02375555|466665440|FG000|Maintenance Period|Disease Progression|5|||
129647771|NCT02375555|466665440|FG000|Maintenance Period|Patient Non-compliance|1|||
129647772|NCT02375555|466665440|FG000|Maintenance Period|Still on maintenance|16|||
129647773|NCT01744184|466665452|FG000|Overall Study|Adverse Event|1|||
129647774|NCT01744184|466665453|FG001|Overall Study|Adverse Event|0|||
129647775|NCT01744184|466665452|FG000|Overall Study|Withdrawal by Subject|0|||
129647776|NCT01744184|466665453|FG001|Overall Study|Withdrawal by Subject|1|||
129647777|NCT01095978|466665457|FG000|Overall Study|Did not take Klacid SR|2|||
129647778|NCT01095978|466665457|FG000|Overall Study|Adverse Event|1|||
129647779|NCT00808639|466665461|FG000|Overall Study|Disease progression before surgery.|1|||
129647780|NCT03055494|466667188|FG000|Overall Study|Lost to Follow-up|6|||
129647781|NCT03055494|466667189|FG001|Overall Study|Lost to Follow-up|0|||
129647782|NCT03055494|466667188|FG000|Overall Study|Physician Decision|2|||
129647783|NCT03055494|466667189|FG001|Overall Study|Physician Decision|0|||
129647784|NCT03055494|466667188|FG000|Overall Study|Withdrawal by Subject|1|||
129647785|NCT03055494|466667189|FG001|Overall Study|Withdrawal by Subject|0|||
129647786|NCT03055494|466667188|FG000|Overall Study|Adverse Event|0|||
129647787|NCT03055494|466667189|FG001|Overall Study|Adverse Event|1|||
129647788|NCT03055494|466667188|FG000|Overall Study|Non-compliance with study treatment|1|||
129707951|NCT00742625|466893739|FG000|Remission Induction|Non protocol treatment|17|||
129707952|NCT00742625|466893739|FG000|Remission Induction|Other, not specified|5|||
129707953|NCT00742625|466893739|FG000|Consolidation|Progression|5|||
129707954|NCT00742625|466893739|FG000|Consolidation|Adverse Event|1|||
129707955|NCT00742625|466893739|FG000|Consolidation|Death|1|||
129707956|NCT00742625|466893739|FG000|Consolidation|Refused|1|||
129707957|NCT00742625|466893739|FG000|Consolidation|Non protocol therapy|13|||
129707958|NCT01865487|466893742|FG000|Overall Study|Lost to Follow-up|0|||
129707959|NCT01865487|466893743|FG001|Overall Study|Lost to Follow-up|0|||
129707960|NCT01865487|466893744|FG002|Overall Study|Lost to Follow-up|0|||
129707961|NCT01865487|466893745|FG003|Overall Study|Lost to Follow-up|1|||
129707962|NCT01865487|466893746|FG004|Overall Study|Lost to Follow-up|0|||
129707963|NCT01865487|466893747|FG005|Overall Study|Lost to Follow-up|0|||
129707964|NCT01865487|466893748|FG006|Overall Study|Lost to Follow-up|1|||
129707965|NCT01865487|466893749|FG007|Overall Study|Lost to Follow-up|0|||
129707966|NCT01865487|466893750|FG008|Overall Study|Lost to Follow-up|0|||
129707967|NCT01865487|466893751|FG009|Overall Study|Lost to Follow-up|0|||
129707968|NCT01865487|466893742|FG000|Overall Study|Withdrawal by Subject|0|||
129707969|NCT01865487|466893743|FG001|Overall Study|Withdrawal by Subject|0|||
129707970|NCT01865487|466893744|FG002|Overall Study|Withdrawal by Subject|0|||
129707971|NCT01865487|466893745|FG003|Overall Study|Withdrawal by Subject|0|||
129707972|NCT01865487|466893746|FG004|Overall Study|Withdrawal by Subject|1|||
129707973|NCT01865487|466893747|FG005|Overall Study|Withdrawal by Subject|0|||
129707974|NCT01865487|466893748|FG006|Overall Study|Withdrawal by Subject|0|||
129707975|NCT01865487|466893749|FG007|Overall Study|Withdrawal by Subject|0|||
129707976|NCT01865487|466893750|FG008|Overall Study|Withdrawal by Subject|0|||
129707977|NCT01865487|466893751|FG009|Overall Study|Withdrawal by Subject|0|||
129707978|NCT01213082|466893752|FG000|Overall Study|Lost to Follow-up|6|||
129707979|NCT01213082|466893753|FG001|Overall Study|Lost to Follow-up|7|||
129707980|NCT01213082|466893754|FG002|Overall Study|Lost to Follow-up|4|||
129707981|NCT01213082|466893752|FG000|Overall Study|Physician Decision|0|||
129707982|NCT01213082|466893753|FG001|Overall Study|Physician Decision|0|||
129707983|NCT01213082|466893754|FG002|Overall Study|Physician Decision|1|||
129707984|NCT03848416|466893758|FG000|Overall Study|Withdrawal by Subject|1|||
129707985|NCT03848416|466893759|FG001|Overall Study|Withdrawal by Subject|0|||
129707986|NCT03848416|466893760|FG002|Overall Study|Withdrawal by Subject|0|||
129707987|NCT03848416|466893758|FG000|Overall Study|Death|0|||
129707988|NCT03848416|466893759|FG001|Overall Study|Death|0|||
129707989|NCT03848416|466893760|FG002|Overall Study|Death|1|||
129707990|NCT02639390|466893761|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
129707991|NCT02639390|466893762|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
129707992|NCT01908140|466893763|FG000|Overall Study|Other or Progressive Disease|5|||
129707993|NCT01908140|466893764|FG001|Overall Study|Other or Progressive Disease|12|||
129707994|NCT01908140|466893763|FG000|Overall Study|Lack of Efficacy|7|||
129707995|NCT01908140|466893764|FG001|Overall Study|Lack of Efficacy|5|||
129707996|NCT01908140|466893763|FG000|Overall Study|Withdrawal by Subject|23|||
129707997|NCT01908140|466893764|FG001|Overall Study|Withdrawal by Subject|24|||
129707998|NCT01908140|466893763|FG000|Overall Study|Lost to Follow-up|1|||
129707999|NCT01908140|466893764|FG001|Overall Study|Lost to Follow-up|6|||
129708000|NCT01908140|466893763|FG000|Overall Study|Protocol Violation|8|||
129708001|NCT01908140|466893764|FG001|Overall Study|Protocol Violation|9|||
129708002|NCT01908140|466893763|FG000|Overall Study|Adverse Event|22|||
129708003|NCT01908140|466893764|FG001|Overall Study|Adverse Event|23|||
129800269|NCT02445391|467236290|FG000|Overall Study|Withdrawal by Subject|0|||
129800270|NCT02445391|467236291|FG001|Overall Study|Withdrawal by Subject|4|||
129800271|NCT02445391|467236292|FG002|Overall Study|Withdrawal by Subject|9|||
129800272|NCT02445391|467236290|FG000|Overall Study|Financial issue|0|||
129800273|NCT02445391|467236291|FG001|Overall Study|Financial issue|0|||
129800274|NCT02445391|467236292|FG002|Overall Study|Financial issue|2|||
129800275|NCT02445391|467236290|FG000|Overall Study|Still on treatment|0|||
129800276|NCT02445391|467236291|FG001|Overall Study|Still on treatment|7|||
129800277|NCT02445391|467236292|FG002|Overall Study|Still on treatment|16|||
129800278|NCT02445391|467236290|FG000|Overall Study|Not start protocol therapy|0|||
129800279|NCT02445391|467236291|FG001|Overall Study|Not start protocol therapy|12|||
129800280|NCT02445391|467236292|FG002|Overall Study|Not start protocol therapy|9|||
129800281|NCT00560885|467236293|FG000|Overall Study|Death|7|||
129800282|NCT00560885|467236293|FG000|Overall Study|Withdrawal by Subject|1|||
129800283|NCT03803683|467236297|FG000|Overall Study|Lost to Follow-up|41|||
129800284|NCT03803683|467236298|FG001|Overall Study|Lost to Follow-up|18|||
129800285|NCT03803683|467236299|FG002|Overall Study|Lost to Follow-up|12|||
129800286|NCT03803683|467236297|FG000|Overall Study|Withdrawal by Subject|9|||
129800287|NCT03803683|467236298|FG001|Overall Study|Withdrawal by Subject|1|||
129800288|NCT03803683|467236299|FG002|Overall Study|Withdrawal by Subject|4|||
129800289|NCT00492050|467236300|FG000|Overall Study|Adverse Event|1|||
129800290|NCT00492050|467236300|FG000|Overall Study|Lack of Efficacy|1|||
129800291|NCT00492050|467236300|FG000|Overall Study|Withdrawal by Subject|3|||
129800292|NCT00492050|467236300|FG000|Overall Study|Unable to collect SCT|2|||
129708004|NCT02013609|466893765|FG000|Overall Study|Withdrawal by Subject|9|||
129708005|NCT02013609|466893765|FG000|Overall Study|Lost to Follow-up|3|||
129708006|NCT02013609|466893765|FG000|Overall Study|Adverse Event|3|||
129708007|NCT02013609|466893765|FG000|Overall Study|Met Withdrawal Criteria|3|||
129800293|NCT00492050|467236300|FG000|Overall Study|Progressive Disease|2|||
129800294|NCT00518687|467238023|FG000|Overall Study|Adverse Event|201|||
129800295|NCT00518687|467238024|FG001|Overall Study|Adverse Event|177|||
129708008|NCT00783432|466893766|FG000|Overall Study|Adverse Event|22|||
129708009|NCT00783432|466893767|FG001|Overall Study|Adverse Event|17|||
129708010|NCT00783432|466893766|FG000|Overall Study|Lack of Efficacy|20|||
129708011|NCT00783432|466893767|FG001|Overall Study|Lack of Efficacy|21|||
129708012|NCT00783432|466893766|FG000|Overall Study|Lost to Follow-up|11|||
129891101|NCT01272011|467559618|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
129891102|NCT01272011|467559619|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
129708013|NCT00783432|466893767|FG001|Overall Study|Lost to Follow-up|6|||
129708014|NCT00783432|466893766|FG000|Overall Study|Withdrawal by Subject|23|||
129708015|NCT00783432|466893767|FG001|Overall Study|Withdrawal by Subject|20|||
129708016|NCT00783432|466893766|FG000|Overall Study|subject moved|3|||
129708017|NCT00783432|466893767|FG001|Overall Study|subject moved|5|||
129708018|NCT00783432|466893766|FG000|Overall Study|Protocol Violation|6|||
129708019|NCT00783432|466893767|FG001|Overall Study|Protocol Violation|9|||
129708020|NCT01436110|466893768|FG000|Overall Study|Lack of Efficacy|23|||
129708021|NCT01436110|466893769|FG001|Overall Study|Lack of Efficacy|14|||
129708022|NCT01436110|466893770|FG002|Overall Study|Lack of Efficacy|9|||
129708023|NCT01436110|466893768|FG000|Overall Study|Withdrawal by Subject|6|||
129708024|NCT01436110|466893769|FG001|Overall Study|Withdrawal by Subject|8|||
129708025|NCT01436110|466893770|FG002|Overall Study|Withdrawal by Subject|4|||
129708026|NCT01436110|466893768|FG000|Overall Study|Adverse Event|2|||
129708027|NCT01436110|466893769|FG001|Overall Study|Adverse Event|1|||
129708028|NCT01436110|466893770|FG002|Overall Study|Adverse Event|2|||
129708029|NCT01436110|466893768|FG000|Overall Study|Physician Decision|3|||
129708030|NCT01436110|466893769|FG001|Overall Study|Physician Decision|1|||
129708031|NCT01436110|466893770|FG002|Overall Study|Physician Decision|1|||
129708032|NCT01436110|466893768|FG000|Overall Study|Lost to Follow-up|1|||
129708033|NCT01436110|466893769|FG001|Overall Study|Lost to Follow-up|1|||
129708034|NCT01436110|466893770|FG002|Overall Study|Lost to Follow-up|3|||
129708035|NCT01436110|466893768|FG000|Overall Study|Protocol Violation|3|||
129708036|NCT01436110|466893769|FG001|Overall Study|Protocol Violation|1|||
129708037|NCT01436110|466893770|FG002|Overall Study|Protocol Violation|1|||
129708038|NCT01436110|466893768|FG000|Overall Study|Did Not Receive Trial Medication|1|||
129708039|NCT01436110|466893769|FG001|Overall Study|Did Not Receive Trial Medication|0|||
129708040|NCT01436110|466893770|FG002|Overall Study|Did Not Receive Trial Medication|3|||
129708041|NCT03273907|466893772|FG000|Overall Study|Death|1|||
129708042|NCT03273907|466893772|FG000|Overall Study|Lost to Follow-up|4|||
129708043|NCT03273907|466893772|FG000|Overall Study|Withdrawal by Subject|2|||
129708044|NCT03273907|466893772|FG000|Overall Study|COVID 19|2|||
129708045|NCT01531998|466893773|FG000|Overall Study|Withdrawal by Subject|3|||
129708046|NCT02581891|466893774|FG000|Overall Study|Adverse Event|4|||
129708047|NCT02581891|466893775|FG001|Overall Study|Adverse Event|6|||
129708048|NCT02581891|466893774|FG000|Overall Study|Death|3|||
129891103|NCT02013687|467559620|FG000|Overall Study|Lost to Follow-up|0|||
129891104|NCT02013687|467559621|FG001|Overall Study|Lost to Follow-up|0|||
129708049|NCT02581891|466893775|FG001|Overall Study|Death|4|||
129708050|NCT02581891|466893774|FG000|Overall Study|Lost to Follow-up|1|||
129708051|NCT02581891|466893775|FG001|Overall Study|Lost to Follow-up|2|||
129708052|NCT02581891|466893774|FG000|Overall Study|Physician Decision|0|||
129800296|NCT00518687|467238023|FG000|Overall Study|Lost to Follow-up|144|||
129800297|NCT00518687|467238024|FG001|Overall Study|Lost to Follow-up|155|||
129800298|NCT00518687|467238023|FG000|Overall Study|Physician Decision|42|||
129800299|NCT00518687|467238024|FG001|Overall Study|Physician Decision|48|||
129800300|NCT00518687|467238023|FG000|Overall Study|Progressive disease|2|||
129800301|NCT00518687|467238024|FG001|Overall Study|Progressive disease|2|||
129800302|NCT00518687|467238023|FG000|Overall Study|Protocol Violation|8|||
129800303|NCT00518687|467238024|FG001|Overall Study|Protocol Violation|10|||
129800304|NCT00518687|467238023|FG000|Overall Study|Study terminated by sponsor|930|||
129800305|NCT00518687|467238024|FG001|Overall Study|Study terminated by sponsor|918|||
129800306|NCT00518687|467238023|FG000|Overall Study|Withdrawal by Subject|110|||
129800307|NCT00518687|467238024|FG001|Overall Study|Withdrawal by Subject|110|||
129800308|NCT05108922|467238025|FG000|Overall Study|Adverse Event|2|||
129800309|NCT05108922|467238026|FG001|Overall Study|Adverse Event|3|||
129800310|NCT05108922|467238025|FG000|Overall Study|Lost to Follow-up|2|||
129800311|NCT05108922|467238026|FG001|Overall Study|Lost to Follow-up|1|||
129800312|NCT05108922|467238025|FG000|Overall Study|Inadvertent enrollment|0|||
129800313|NCT05108922|467238026|FG001|Overall Study|Inadvertent enrollment|1|||
129800314|NCT05108922|467238025|FG000|Overall Study|Physician Decision|2|||
129708053|NCT02581891|466893775|FG001|Overall Study|Physician Decision|1|||
129708054|NCT02581891|466893774|FG000|Overall Study|Withdrawal by Subject|4|||
129708055|NCT02581891|466893775|FG001|Overall Study|Withdrawal by Subject|5|||
129708056|NCT02581891|466893774|FG000|Overall Study|Other Reasons|3|||
129708057|NCT02581891|466893775|FG001|Overall Study|Other Reasons|1|||
129800315|NCT05108922|467238026|FG001|Overall Study|Physician Decision|3|||
129800316|NCT05108922|467238025|FG000|Overall Study|Protocol deviation|1|||
129708058|NCT02581891|466893774|FG000|Overall Study|Discontinued during followup|1|||
129708059|NCT02581891|466893775|FG001|Overall Study|Discontinued during followup|0|||
129708060|NCT03440008|466893776|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
129800317|NCT05108922|467238026|FG001|Overall Study|Protocol deviation|0|||
129800318|NCT05108922|467238025|FG000|Overall Study|Screen failure|1|||
129708061|NCT03440008|466893777|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
129708062|NCT03440008|466893776|FG000|Overall Study|Withdrawal by Subject|1|||
129708063|NCT03440008|466893777|FG001|Overall Study|Withdrawal by Subject|0|||
129708064|NCT03498716|466893785|FG000|Overall Study|Withdrawal by Subject|88|||
129708065|NCT03498716|466893786|FG001|Overall Study|Withdrawal by Subject|73|||
129708066|NCT03498716|466893785|FG000|Overall Study|Study Terminated By Sponsor|933|||
129708067|NCT03498716|466893786|FG001|Overall Study|Study Terminated By Sponsor|927|||
129708068|NCT03498716|466893785|FG000|Overall Study|Lost to Follow-up|15|||
129708069|NCT03498716|466893786|FG001|Overall Study|Lost to Follow-up|26|||
129708070|NCT03498716|466893785|FG000|Overall Study|Disease Relapse|0|||
129708071|NCT03498716|466893786|FG001|Overall Study|Disease Relapse|1|||
129708072|NCT03498716|466893785|FG000|Overall Study|Death|58|||
129708073|NCT03498716|466893786|FG001|Overall Study|Death|72|||
129708074|NCT03498716|466893785|FG000|Overall Study|Physician Decision|4|||
129708075|NCT03498716|466893786|FG001|Overall Study|Physician Decision|2|||
129708076|NCT01657305|466893790|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
129708077|NCT01657305|466893790|FG000|Overall Study|Withdrawal by Subject|4|||
129708078|NCT01657305|466893790|FG000|Overall Study|Adverse Event|1|||
129708079|NCT01657305|466893790|FG000|Overall Study|Lost to Follow-up|1|||
129708080|NCT01657305|466893790|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
129708081|NCT04103450|466893791|FG000|Overall Study|Adverse Event|4|||
129708082|NCT04103450|466893792|FG001|Overall Study|Adverse Event|2|||
129708083|NCT04103450|466893791|FG000|Overall Study|Lack of Efficacy|3|||
129708084|NCT04103450|466893792|FG001|Overall Study|Lack of Efficacy|0|||
129708085|NCT04103450|466893791|FG000|Overall Study|Withdrawal by Subject|5|||
129708086|NCT04103450|466893792|FG001|Overall Study|Withdrawal by Subject|3|||
129708087|NCT04103450|466893791|FG000|Overall Study|Lost to Follow-up|1|||
129708088|NCT04103450|466893792|FG001|Overall Study|Lost to Follow-up|2|||
129708089|NCT04103450|466893791|FG000|Overall Study|Physician Decision|1|||
129708090|NCT04103450|466893792|FG001|Overall Study|Physician Decision|2|||
129708091|NCT04103450|466893791|FG000|Overall Study|Protocol Violation|1|||
129708092|NCT04103450|466893792|FG001|Overall Study|Protocol Violation|0|||
129708093|NCT04103450|466893791|FG000|Overall Study|Other|1|||
129708094|NCT04103450|466893792|FG001|Overall Study|Other|1|||
129708095|NCT01696643|466893797|FG000|Overall Study|Adverse Event|15|||
129708096|NCT01696643|466893798|FG001|Overall Study|Adverse Event|7|||
129708097|NCT01696643|466893797|FG000|Overall Study|Death|1|||
129708098|NCT01696643|466893798|FG001|Overall Study|Death|2|||
129708099|NCT01696643|466893797|FG000|Overall Study|Lack of Efficacy|3|||
129708100|NCT01696643|466893798|FG001|Overall Study|Lack of Efficacy|0|||
129708101|NCT01696643|466893797|FG000|Overall Study|Lost to Follow-up|67|||
129708102|NCT01696643|466893798|FG001|Overall Study|Lost to Follow-up|67|||
129708103|NCT01696643|466893797|FG000|Overall Study|Physician Decision|3|||
129708104|NCT01696643|466893798|FG001|Overall Study|Physician Decision|2|||
129708105|NCT01696643|466893797|FG000|Overall Study|Pregnancy|0|||
129708106|NCT01696643|466893798|FG001|Overall Study|Pregnancy|1|||
129708107|NCT01696643|466893797|FG000|Overall Study|Protocol Violation|7|||
129708108|NCT01696643|466893798|FG001|Overall Study|Protocol Violation|7|||
129708109|NCT01696643|466893797|FG000|Overall Study|Study Terminated by Sponsor|286|||
129708110|NCT01696643|466893798|FG001|Overall Study|Study Terminated by Sponsor|294|||
129708111|NCT01696643|466893797|FG000|Overall Study|Withdrawal by Subject|142|||
129708112|NCT01696643|466893798|FG001|Overall Study|Withdrawal by Subject|149|||
129708113|NCT01696643|466893797|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
129708114|NCT01696643|466893798|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
129708115|NCT01696643|466893797|FG000|Overall Study|Site Error|2|||
129708116|NCT01696643|466893798|FG001|Overall Study|Site Error|1|||
129708117|NCT01696643|466893797|FG000|Overall Study|Participant Incarcerated|0|||
129708118|NCT01696643|466893798|FG001|Overall Study|Participant Incarcerated|1|||
129708119|NCT01696643|466893797|FG000|Overall Study|Medical Monitor Decision|0|||
129708120|NCT01696643|466893798|FG001|Overall Study|Medical Monitor Decision|2|||
129708121|NCT01696643|466893797|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
129708122|NCT01696643|466893798|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
129708123|NCT02271529|466893801|FG000|Overall Study|Withdrawal by Subject|1|||
129708124|NCT03768427|466893802|FG000|Overall Study|Death|0|||
129708125|NCT03768427|466893803|FG001|Overall Study|Death|0|||
129708126|NCT03768427|466893804|FG002|Overall Study|Death|1|||
129708127|NCT03768427|466893805|FG003|Overall Study|Death|0|||
129708128|NCT03768427|466893802|FG000|Overall Study|Lost to Follow-up|2|||
129708129|NCT03768427|466893803|FG001|Overall Study|Lost to Follow-up|0|||
129647789|NCT03055494|466667189|FG001|Overall Study|Non-compliance with study treatment|0|||
129647790|NCT00197002|466667190|FG000|Overall Study|Adverse Event|0|||
129647791|NCT00197002|466667191|FG001|Overall Study|Adverse Event|1|||
129647792|NCT00197002|466667192|FG002|Overall Study|Adverse Event|0|||
129647793|NCT00197002|466667190|FG000|Overall Study|Protocol Violation|1|||
129647794|NCT00197002|466667191|FG001|Overall Study|Protocol Violation|0|||
129647795|NCT00197002|466667192|FG002|Overall Study|Protocol Violation|2|||
129647796|NCT00197002|466667190|FG000|Overall Study|Withdrawal by Subject|9|||
129647797|NCT00197002|466667191|FG001|Overall Study|Withdrawal by Subject|5|||
129647798|NCT00197002|466667192|FG002|Overall Study|Withdrawal by Subject|7|||
129647799|NCT00197002|466667190|FG000|Overall Study|Migrated/moved from study area|3|||
129647800|NCT00197002|466667191|FG001|Overall Study|Migrated/moved from study area|5|||
129647801|NCT00197002|466667192|FG002|Overall Study|Migrated/moved from study area|1|||
129647802|NCT00197002|466667190|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
129647803|NCT00197002|466667191|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
129647804|NCT00197002|466667192|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
129647805|NCT00197002|466667190|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
129647806|NCT00197002|466667191|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
129647807|NCT00197002|466667192|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
129647808|NCT00197002|466667190|FG000|Overall Study|Others|3|||
129647809|NCT00197002|466667191|FG001|Overall Study|Others|1|||
129647810|NCT00197002|466667192|FG002|Overall Study|Others|1|||
129647811|NCT02017717|466667193|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647812|NCT02017717|466667194|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647813|NCT02017717|466667195|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647814|NCT02017717|466667196|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647815|NCT02017717|466667197|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647816|NCT02017717|466667198|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647817|NCT02017717|466667199|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647818|NCT02017717|466667200|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
129647819|NCT02017717|466667201|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
129647820|NCT02017717|466667193|FG000|Before Treatment Period|Participant request to stop therapy|0|||
129647821|NCT02017717|466667194|FG001|Before Treatment Period|Participant request to stop therapy|0|||
129647822|NCT02017717|466667195|FG002|Before Treatment Period|Participant request to stop therapy|0|||
129647823|NCT02017717|466667196|FG003|Before Treatment Period|Participant request to stop therapy|0|||
129647824|NCT02017717|466667197|FG004|Before Treatment Period|Participant request to stop therapy|0|||
129647825|NCT02017717|466667198|FG005|Before Treatment Period|Participant request to stop therapy|0|||
129647826|NCT02017717|466667199|FG006|Before Treatment Period|Participant request to stop therapy|0|||
129647827|NCT02017717|466667200|FG007|Before Treatment Period|Participant request to stop therapy|0|||
129647828|NCT02017717|466667201|FG008|Before Treatment Period|Participant request to stop therapy|5|||
129647829|NCT02017717|466667193|FG000|Before Treatment Period|Participant withdrew consent|0|||
129647830|NCT02017717|466667194|FG001|Before Treatment Period|Participant withdrew consent|0|||
129647831|NCT02017717|466667195|FG002|Before Treatment Period|Participant withdrew consent|0|||
129647832|NCT02017717|466667196|FG003|Before Treatment Period|Participant withdrew consent|0|||
129647833|NCT02017717|466667197|FG004|Before Treatment Period|Participant withdrew consent|0|||
129647834|NCT02017717|466667198|FG005|Before Treatment Period|Participant withdrew consent|0|||
129647835|NCT02017717|466667199|FG006|Before Treatment Period|Participant withdrew consent|2|||
129647836|NCT02017717|466667200|FG007|Before Treatment Period|Participant withdrew consent|0|||
129647837|NCT02017717|466667201|FG008|Before Treatment Period|Participant withdrew consent|11|||
129647838|NCT02017717|466667193|FG000|Before Treatment Period|Lost to Follow-up|0|||
129647839|NCT02017717|466667194|FG001|Before Treatment Period|Lost to Follow-up|0|||
129708130|NCT03768427|466893804|FG002|Overall Study|Lost to Follow-up|0|||
129708131|NCT03768427|466893805|FG003|Overall Study|Lost to Follow-up|0|||
129708132|NCT03768427|466893802|FG000|Overall Study|Physician Decision|3|||
129708133|NCT03768427|466893803|FG001|Overall Study|Physician Decision|2|||
129708134|NCT03768427|466893804|FG002|Overall Study|Physician Decision|4|||
129708135|NCT03768427|466893805|FG003|Overall Study|Physician Decision|4|||
129708136|NCT03768427|466893802|FG000|Overall Study|Withdrawal by Subject|7|||
129708137|NCT03768427|466893803|FG001|Overall Study|Withdrawal by Subject|2|||
129708138|NCT03768427|466893804|FG002|Overall Study|Withdrawal by Subject|6|||
129708139|NCT03768427|466893805|FG003|Overall Study|Withdrawal by Subject|7|||
129708140|NCT00902330|466893815|FG000|Overall Study|Too overwhelmed by treatment|2|||
129891105|NCT02013687|467559622|FG002|Overall Study|Lost to Follow-up|1|||
129891106|NCT02013687|467559623|FG003|Overall Study|Lost to Follow-up|0|||
129647840|NCT02017717|466667195|FG002|Before Treatment Period|Lost to Follow-up|0|||
129647841|NCT02017717|466667196|FG003|Before Treatment Period|Lost to Follow-up|0|||
129647842|NCT02017717|466667197|FG004|Before Treatment Period|Lost to Follow-up|0|||
129647843|NCT02017717|466667198|FG005|Before Treatment Period|Lost to Follow-up|0|||
129891107|NCT02013687|467559620|FG000|Overall Study|Protocol Violation|0|||
129891108|NCT02013687|467559621|FG001|Overall Study|Protocol Violation|0|||
129891109|NCT02013687|467559622|FG002|Overall Study|Protocol Violation|0|||
129891110|NCT02013687|467559623|FG003|Overall Study|Protocol Violation|1|||
129891111|NCT02013687|467559620|FG000|Overall Study|Withdrawal by Subject|0|||
129708141|NCT00902330|466893816|FG001|Overall Study|Too overwhelmed by treatment|5|||
129708142|NCT00902330|466893815|FG000|Overall Study|Adverse Event|1|||
129708143|NCT00902330|466893816|FG001|Overall Study|Adverse Event|0|||
129647844|NCT02017717|466667199|FG006|Before Treatment Period|Lost to Follow-up|0|||
129647845|NCT02017717|466667200|FG007|Before Treatment Period|Lost to Follow-up|0|||
129647846|NCT02017717|466667201|FG008|Before Treatment Period|Lost to Follow-up|1|||
129647847|NCT02017717|466667193|FG000|Before Treatment Period|Participant no longer met criteria|0|||
129647848|NCT02017717|466667194|FG001|Before Treatment Period|Participant no longer met criteria|0|||
129647849|NCT02017717|466667195|FG002|Before Treatment Period|Participant no longer met criteria|0|||
129647850|NCT02017717|466667196|FG003|Before Treatment Period|Participant no longer met criteria|0|||
129647851|NCT02017717|466667197|FG004|Before Treatment Period|Participant no longer met criteria|0|||
129647852|NCT02017717|466667198|FG005|Before Treatment Period|Participant no longer met criteria|1|||
129647853|NCT02017717|466667199|FG006|Before Treatment Period|Participant no longer met criteria|0|||
129647854|NCT02017717|466667200|FG007|Before Treatment Period|Participant no longer met criteria|1|||
129647855|NCT02017717|466667201|FG008|Before Treatment Period|Participant no longer met criteria|2|||
129647856|NCT02017717|466667193|FG000|Before Treatment Period|other reason|0|||
129647857|NCT02017717|466667194|FG001|Before Treatment Period|other reason|0|||
129647858|NCT02017717|466667195|FG002|Before Treatment Period|other reason|0|||
129647859|NCT02017717|466667196|FG003|Before Treatment Period|other reason|0|||
129647860|NCT02017717|466667197|FG004|Before Treatment Period|other reason|0|||
129647861|NCT02017717|466667198|FG005|Before Treatment Period|other reason|0|||
129647862|NCT02017717|466667199|FG006|Before Treatment Period|other reason|0|||
129647863|NCT02017717|466667200|FG007|Before Treatment Period|other reason|0|||
129647864|NCT02017717|466667201|FG008|Before Treatment Period|other reason|1|||
129647865|NCT02017717|466667193|FG000|Treatment Period|Disease progression|7|||
129647866|NCT02017717|466667194|FG001|Treatment Period|Disease progression|9|||
129647867|NCT02017717|466667195|FG002|Treatment Period|Disease progression|12|||
129647868|NCT02017717|466667196|FG003|Treatment Period|Disease progression|20|||
129647869|NCT02017717|466667197|FG004|Treatment Period|Disease progression|26|||
129647870|NCT02017717|466667198|FG005|Treatment Period|Disease progression|16|||
129647871|NCT02017717|466667199|FG006|Treatment Period|Disease progression|22|||
129647872|NCT02017717|466667200|FG007|Treatment Period|Disease progression|165|||
129647873|NCT02017717|466667201|FG008|Treatment Period|Disease progression|135|||
129647874|NCT02017717|466667193|FG000|Treatment Period|Study drug toxicity|3|||
129647875|NCT02017717|466667194|FG001|Treatment Period|Study drug toxicity|0|||
129647876|NCT02017717|466667195|FG002|Treatment Period|Study drug toxicity|1|||
129647877|NCT02017717|466667196|FG003|Treatment Period|Study drug toxicity|4|||
129647878|NCT02017717|466667197|FG004|Treatment Period|Study drug toxicity|4|||
129647879|NCT02017717|466667198|FG005|Treatment Period|Study drug toxicity|5|||
129647880|NCT02017717|466667199|FG006|Treatment Period|Study drug toxicity|3|||
129647881|NCT02017717|466667200|FG007|Treatment Period|Study drug toxicity|7|||
129647882|NCT02017717|466667201|FG008|Treatment Period|Study drug toxicity|11|||
129647883|NCT02017717|466667193|FG000|Treatment Period|Death|0|||
129647884|NCT02017717|466667194|FG001|Treatment Period|Death|0|||
129647885|NCT02017717|466667195|FG002|Treatment Period|Death|1|||
129647886|NCT02017717|466667196|FG003|Treatment Period|Death|0|||
129647887|NCT02017717|466667197|FG004|Treatment Period|Death|0|||
129647888|NCT02017717|466667198|FG005|Treatment Period|Death|2|||
129647889|NCT02017717|466667199|FG006|Treatment Period|Death|0|||
129647890|NCT02017717|466667200|FG007|Treatment Period|Death|0|||
129647891|NCT02017717|466667201|FG008|Treatment Period|Death|0|||
129647892|NCT02017717|466667193|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
129647893|NCT02017717|466667194|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
129647894|NCT02017717|466667195|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
129647895|NCT02017717|466667196|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
129647896|NCT02017717|466667197|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
129647897|NCT02017717|466667198|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
129647898|NCT02017717|466667199|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
129647899|NCT02017717|466667200|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
129647900|NCT02017717|466667201|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
129647901|NCT02017717|466667193|FG000|Treatment Period|Participant request to stop therapy|0|||
129647902|NCT02017717|466667194|FG001|Treatment Period|Participant request to stop therapy|0|||
129647903|NCT02017717|466667195|FG002|Treatment Period|Participant request to stop therapy|3|||
129647904|NCT02017717|466667196|FG003|Treatment Period|Participant request to stop therapy|6|||
129647905|NCT02017717|466667197|FG004|Treatment Period|Participant request to stop therapy|0|||
129647906|NCT02017717|466667198|FG005|Treatment Period|Participant request to stop therapy|2|||
129647907|NCT02017717|466667199|FG006|Treatment Period|Participant request to stop therapy|1|||
129708144|NCT00902330|466893815|FG000|Overall Study|No post baseline data|1|||
129708145|NCT00902330|466893816|FG001|Overall Study|No post baseline data|0|||
129708146|NCT03950856|466893817|FG000|Overall Study|Death|1|||
129647908|NCT02017717|466667200|FG007|Treatment Period|Participant request to stop therapy|4|||
129647909|NCT02017717|466667201|FG008|Treatment Period|Participant request to stop therapy|7|||
129647910|NCT02017717|466667193|FG000|Treatment Period|Participant withdrew consent|0|||
129647911|NCT02017717|466667194|FG001|Treatment Period|Participant withdrew consent|0|||
129647912|NCT02017717|466667195|FG002|Treatment Period|Participant withdrew consent|1|||
129647913|NCT02017717|466667196|FG003|Treatment Period|Participant withdrew consent|0|||
129647914|NCT02017717|466667197|FG004|Treatment Period|Participant withdrew consent|0|||
129647915|NCT02017717|466667198|FG005|Treatment Period|Participant withdrew consent|2|||
129647916|NCT02017717|466667199|FG006|Treatment Period|Participant withdrew consent|0|||
129647917|NCT02017717|466667200|FG007|Treatment Period|Participant withdrew consent|1|||
129647918|NCT02017717|466667201|FG008|Treatment Period|Participant withdrew consent|4|||
129647919|NCT02017717|466667193|FG000|Treatment Period|Participant no longer met criteria|0|||
129647920|NCT02017717|466667194|FG001|Treatment Period|Participant no longer met criteria|0|||
129647921|NCT02017717|466667195|FG002|Treatment Period|Participant no longer met criteria|0|||
129647922|NCT02017717|466667196|FG003|Treatment Period|Participant no longer met criteria|0|||
129647923|NCT02017717|466667197|FG004|Treatment Period|Participant no longer met criteria|0|||
129647924|NCT02017717|466667198|FG005|Treatment Period|Participant no longer met criteria|0|||
129647925|NCT02017717|466667199|FG006|Treatment Period|Participant no longer met criteria|0|||
129647926|NCT02017717|466667200|FG007|Treatment Period|Participant no longer met criteria|0|||
129647927|NCT02017717|466667201|FG008|Treatment Period|Participant no longer met criteria|1|||
129647928|NCT02017717|466667193|FG000|Treatment Period|Other reasons|0|||
129647929|NCT02017717|466667194|FG001|Treatment Period|Other reasons|0|||
129647930|NCT02017717|466667195|FG002|Treatment Period|Other reasons|0|||
129647931|NCT02017717|466667196|FG003|Treatment Period|Other reasons|1|||
129647932|NCT02017717|466667197|FG004|Treatment Period|Other reasons|0|||
129647933|NCT02017717|466667198|FG005|Treatment Period|Other reasons|1|||
129647934|NCT02017717|466667199|FG006|Treatment Period|Other reasons|1|||
129647935|NCT02017717|466667200|FG007|Treatment Period|Other reasons|1|||
129647936|NCT02017717|466667201|FG008|Treatment Period|Other reasons|1|||
129647937|NCT02017717|466667193|FG000|Treatment Period|Maximum clinical benefit|0|||
129647938|NCT02017717|466667194|FG001|Treatment Period|Maximum clinical benefit|0|||
129647939|NCT02017717|466667195|FG002|Treatment Period|Maximum clinical benefit|0|||
129708147|NCT03950856|466893818|FG001|Overall Study|Death|2|||
129708148|NCT03950856|466893819|FG002|Overall Study|Death|0|||
129708149|NCT03950856|466893820|FG003|Overall Study|Death|0|||
129708150|NCT03950856|466893817|FG000|Overall Study|Lost to Follow-up|5|||
129708151|NCT03950856|466893818|FG001|Overall Study|Lost to Follow-up|6|||
129708152|NCT03950856|466893819|FG002|Overall Study|Lost to Follow-up|8|||
129708153|NCT03950856|466893820|FG003|Overall Study|Lost to Follow-up|2|||
129708154|NCT03950856|466893817|FG000|Overall Study|Protocol Violation|2|||
129708155|NCT03950856|466893818|FG001|Overall Study|Protocol Violation|0|||
129708156|NCT03950856|466893819|FG002|Overall Study|Protocol Violation|0|||
129708157|NCT03950856|466893820|FG003|Overall Study|Protocol Violation|1|||
129708158|NCT03950856|466893817|FG000|Overall Study|Withdrawal by Subject|4|||
129708159|NCT03950856|466893818|FG001|Overall Study|Withdrawal by Subject|1|||
129708160|NCT03950856|466893819|FG002|Overall Study|Withdrawal by Subject|3|||
129708161|NCT03950856|466893820|FG003|Overall Study|Withdrawal by Subject|1|||
129708162|NCT03950856|466893817|FG000|Overall Study|Unable to phone|7|||
129708163|NCT03950856|466893818|FG001|Overall Study|Unable to phone|6|||
129708164|NCT03950856|466893819|FG002|Overall Study|Unable to phone|7|||
129891112|NCT02013687|467559621|FG001|Overall Study|Withdrawal by Subject|0|||
129891113|NCT02013687|467559622|FG002|Overall Study|Withdrawal by Subject|0|||
129891114|NCT02013687|467559623|FG003|Overall Study|Withdrawal by Subject|1|||
129891115|NCT02013687|467559620|FG000|Overall Study|Missed visits due to patient travel|0|||
129891116|NCT02013687|467559621|FG001|Overall Study|Missed visits due to patient travel|0|||
129891117|NCT02013687|467559622|FG002|Overall Study|Missed visits due to patient travel|1|||
129891118|NCT02013687|467559623|FG003|Overall Study|Missed visits due to patient travel|0|||
129891119|NCT01627340|467559624|FG000|Overall Study|Adverse Event|1|||
129891120|NCT01627340|467559625|FG001|Overall Study|Adverse Event|0|||
129891121|NCT01627340|467559624|FG000|Overall Study|Lost to Follow-up|8|||
129647940|NCT02017717|466667196|FG003|Treatment Period|Maximum clinical benefit|0|||
129647941|NCT02017717|466667197|FG004|Treatment Period|Maximum clinical benefit|0|||
129647942|NCT02017717|466667198|FG005|Treatment Period|Maximum clinical benefit|0|||
129708165|NCT03950856|466893820|FG003|Overall Study|Unable to phone|2|||
129708166|NCT01816984|466893821|FG000|Overall Study|declining health status|1|||
129891122|NCT01627340|467559625|FG001|Overall Study|Lost to Follow-up|4|||
129891123|NCT01627340|467559624|FG000|Overall Study|Pregnancy|1|||
129647943|NCT02017717|466667199|FG006|Treatment Period|Maximum clinical benefit|0|||
129708167|NCT02121509|466893824|FG000|Washout Period (35 Days)|Adverse Event|1|||
129708168|NCT02121509|466893825|FG001|Washout Period (35 Days)|Adverse Event|1|||
129708169|NCT02121509|466893826|FG002|Washout Period (35 Days)|Adverse Event|0|||
129891124|NCT01627340|467559625|FG001|Overall Study|Pregnancy|0|||
129708170|NCT02121509|466893827|FG003|Washout Period (35 Days)|Adverse Event|0|||
129708171|NCT02121509|466893824|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
129708172|NCT02121509|466893825|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
129708173|NCT02121509|466893826|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
129708174|NCT02121509|466893827|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
129708175|NCT02121509|466893824|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
129891125|NCT01627340|467559624|FG000|Overall Study|Withdrawal by Subject|2|||
129891126|NCT01627340|467559625|FG001|Overall Study|Withdrawal by Subject|0|||
129891127|NCT01657032|467559626|FG000|Overall Study|Lost to Follow-up|0|||
129708176|NCT02121509|466893825|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
129708177|NCT02121509|466893826|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
129708178|NCT02121509|466893827|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
129708179|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
129708180|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
129708181|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
129708182|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
129708183|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
129708184|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
129708185|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
129708186|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
129708187|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
129708188|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
129708189|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
129708190|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
129708191|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
129708192|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
129708193|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
129708194|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
129708195|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
129708196|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
129708197|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
129708198|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
129708199|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
129708200|NCT04021290|466893828|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
129708201|NCT04021290|466893829|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
129708202|NCT04021290|466893830|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
129708203|NCT04021290|466893828|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
129708204|NCT04021290|466893829|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
129708205|NCT04021290|466893830|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
129708206|NCT04021290|466893828|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
129708207|NCT04021290|466893829|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
129708208|NCT04021290|466893830|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
129708209|NCT04021290|466893828|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
129708210|NCT04021290|466893829|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
129708211|NCT04021290|466893830|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
129708212|NCT04021290|466893828|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
129708213|NCT04021290|466893829|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
129708214|NCT04021290|466893830|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
129708215|NCT00636181|466893831|FG000|Overall Study|Withdrawal by Subject|8|||
129708216|NCT00636181|466893832|FG001|Overall Study|Withdrawal by Subject|6|||
129708217|NCT00636181|466893833|FG002|Overall Study|Withdrawal by Subject|10|||
129708218|NCT05076045|466893841|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
129708219|NCT05076045|466893842|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
129708220|NCT01174563|466893849|FG000|Overall Study|Progressive Disease|45|||
129708221|NCT01174563|466893849|FG000|Overall Study|Death|5|||
129708222|NCT01174563|466893849|FG000|Overall Study|Investigator's Discretion|5|||
129708223|NCT01174563|466893849|FG000|Overall Study|Participant Withdrew Consent|3|||
129708224|NCT01174563|466893849|FG000|Overall Study|Rash Adverse Event|1|||
129708225|NCT01174563|466893849|FG000|Overall Study|Sponsor's decision|1|||
129708226|NCT03402841|466893850|FG000|Overall Study|Withdrawal by Subject|3|||
129708227|NCT03402841|466893850|FG000|Overall Study|Lost to Follow-up|2|||
129708228|NCT03402841|466893850|FG000|Overall Study|Death|146|||
129708229|NCT01542788|466893855|FG000|Overall Study|Randomized but Not Treated|2|||
129708230|NCT01542788|466893856|FG001|Overall Study|Randomized but Not Treated|0|||
129708231|NCT01542788|466893855|FG000|Overall Study|Lack of Efficacy|41|||
129708232|NCT01542788|466893856|FG001|Overall Study|Lack of Efficacy|71|||
129708233|NCT01542788|466893855|FG000|Overall Study|Lost to Follow-up|5|||
129708234|NCT01542788|466893856|FG001|Overall Study|Lost to Follow-up|0|||
129708235|NCT01542788|466893855|FG000|Overall Study|Death|3|||
129708236|NCT01542788|466893856|FG001|Overall Study|Death|0|||
129708237|NCT01542788|466893855|FG000|Overall Study|Protocol Violation|2|||
129708238|NCT01542788|466893856|FG001|Overall Study|Protocol Violation|0|||
129708239|NCT01542788|466893855|FG000|Overall Study|Physician Decision|1|||
129708240|NCT01542788|466893856|FG001|Overall Study|Physician Decision|0|||
129708241|NCT01542788|466893855|FG000|Overall Study|Withdrawal by Subject|1|||
129708242|NCT01542788|466893856|FG001|Overall Study|Withdrawal by Subject|0|||
129708243|NCT00269113|466895897|FG000|Overall Study|Adverse Event|14|||
129708244|NCT00269113|466895898|FG001|Overall Study|Adverse Event|7|||
129708245|NCT00269113|466895897|FG000|Overall Study|Lack of Efficacy|35|||
129708246|NCT00269113|466895898|FG001|Overall Study|Lack of Efficacy|18|||
129708247|NCT00269113|466895897|FG000|Overall Study|Early Improvement|2|||
129708248|NCT00269113|466895898|FG001|Overall Study|Early Improvement|0|||
129708249|NCT00269113|466895897|FG000|Overall Study|Withdrawal by Subject|0|||
129708250|NCT00269113|466895898|FG001|Overall Study|Withdrawal by Subject|2|||
129708251|NCT00269113|466895897|FG000|Overall Study|Death|6|||
129708252|NCT00269113|466895898|FG001|Overall Study|Death|2|||
129708253|NCT00269113|466895897|FG000|Overall Study|Lost to Follow-up|2|||
129708254|NCT00269113|466895898|FG001|Overall Study|Lost to Follow-up|1|||
129708255|NCT00269113|466895897|FG000|Overall Study|Protocol Violation|15|||
129708256|NCT00269113|466895898|FG001|Overall Study|Protocol Violation|5|||
129708257|NCT00269113|466895897|FG000|Overall Study|Other|0|||
129708258|NCT00269113|466895898|FG001|Overall Study|Other|2|||
129708259|NCT00652743|466895899|FG000|Months 12-18|Lost to Follow-up|1|||
129708260|NCT00652743|466895900|FG001|Months 12-18|Lost to Follow-up|2|||
129708261|NCT00652743|466895901|FG002|Months 12-18|Lost to Follow-up|7|||
129708262|NCT00652743|466895899|FG000|Months 24-30|Other|5|||
129708263|NCT00652743|466895900|FG001|Months 24-30|Other|1|||
129708264|NCT00652743|466895901|FG002|Months 24-30|Other|11|||
129708265|NCT00652743|466895899|FG000|Months 36-42|Serious Adverse Events|0|||
129708266|NCT00652743|466895900|FG001|Months 36-42|Serious Adverse Events|1|||
129708267|NCT00652743|466895901|FG002|Months 36-42|Serious Adverse Events|1|||
129708268|NCT00652743|466895899|FG000|Months 36-42|Withdrawal by Subject|1|||
129708269|NCT00652743|466895900|FG001|Months 36-42|Withdrawal by Subject|1|||
129708270|NCT00652743|466895901|FG002|Months 36-42|Withdrawal by Subject|0|||
129708271|NCT00652743|466895899|FG000|Months 36-42|Lost to Follow-up|0|||
129800319|NCT05108922|467238026|FG001|Overall Study|Screen failure|0|||
129800320|NCT05108922|467238025|FG000|Overall Study|Withdrawal by Subject|11|||
129800321|NCT05108922|467238026|FG001|Overall Study|Withdrawal by Subject|8|||
129800322|NCT00282412|467238027|FG000|Overall Study|Death|2|||
129800323|NCT00537238|467238028|FG000|Overall Study|Death|1|||
129800324|NCT00537238|467238029|FG001|Overall Study|Death|2|||
129800325|NCT00537238|467238028|FG000|Overall Study|Adverse Event|31|||
129708272|NCT00652743|466895900|FG001|Months 36-42|Lost to Follow-up|1|||
129708273|NCT00652743|466895901|FG002|Months 36-42|Lost to Follow-up|0|||
129708274|NCT00652743|466895899|FG000|Months 36-42|Migrated/moved from study area|1|||
129708275|NCT00652743|466895900|FG001|Months 36-42|Migrated/moved from study area|0|||
129708276|NCT00652743|466895901|FG002|Months 36-42|Migrated/moved from study area|0|||
129708277|NCT00652743|466895899|FG000|Months 36-42|Other|4|||
129800326|NCT00537238|467238029|FG001|Overall Study|Adverse Event|22|||
129708278|NCT00652743|466895900|FG001|Months 36-42|Other|2|||
129708279|NCT00652743|466895901|FG002|Months 36-42|Other|8|||
129800327|NCT00537238|467238028|FG000|Overall Study|Lack of Efficacy|20|||
129891128|NCT01657032|467559627|FG001|Overall Study|Lost to Follow-up|7|||
129891129|NCT03633903|467559628|FG000|Overall Study|Withdrawal by Subject|1|||
129891130|NCT03633903|467559629|FG001|Overall Study|Withdrawal by Subject|2|||
129708280|NCT00322049|466895902|FG000|Overall Study|Moved out of area|0|||
129708281|NCT00322049|466895903|FG001|Overall Study|Moved out of area|0|||
129708282|NCT00322049|466895904|FG002|Overall Study|Moved out of area|0|||
129708283|NCT00322049|466895905|FG003|Overall Study|Moved out of area|1|||
129708284|NCT00322049|466895902|FG000|Overall Study|Infected with Dengue during study|0|||
129708285|NCT00322049|466895903|FG001|Overall Study|Infected with Dengue during study|1|||
129708286|NCT00322049|466895904|FG002|Overall Study|Infected with Dengue during study|0|||
129708287|NCT00322049|466895905|FG003|Overall Study|Infected with Dengue during study|0|||
129708288|NCT02026011|466895906|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
129708289|NCT02026011|466895907|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
129708290|NCT02026011|466895906|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
129708291|NCT02026011|466895907|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
129708292|NCT02026011|466895906|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
129708293|NCT02026011|466895907|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
129708294|NCT02026011|466895906|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
129708295|NCT02026011|466895907|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
129708296|NCT01770743|466895908|FG000|Overall Study|Adverse Event|1|||
129708297|NCT01770743|466895909|FG001|Overall Study|Adverse Event|0|||
129708298|NCT01770743|466895910|FG002|Overall Study|Adverse Event|0|||
129708299|NCT01770743|466895911|FG003|Overall Study|Adverse Event|0|||
129708300|NCT01770743|466895912|FG004|Overall Study|Adverse Event|0|||
129708301|NCT01770743|466895908|FG000|Overall Study|Withdrawal by Subject|0|||
129708302|NCT01770743|466895909|FG001|Overall Study|Withdrawal by Subject|0|||
129708303|NCT01770743|466895910|FG002|Overall Study|Withdrawal by Subject|1|||
129708304|NCT01770743|466895911|FG003|Overall Study|Withdrawal by Subject|1|||
129647944|NCT02017717|466667200|FG007|Treatment Period|Maximum clinical benefit|0|||
129647945|NCT02017717|466667201|FG008|Treatment Period|Maximum clinical benefit|1|||
129647946|NCT02017717|466667193|FG000|Treatment Period|Not reported|0|||
129647947|NCT02017717|466667194|FG001|Treatment Period|Not reported|1|||
129647948|NCT02017717|466667195|FG002|Treatment Period|Not reported|0|||
129647949|NCT02017717|466667196|FG003|Treatment Period|Not reported|0|||
129647950|NCT02017717|466667197|FG004|Treatment Period|Not reported|0|||
129647951|NCT02017717|466667198|FG005|Treatment Period|Not reported|0|||
129647952|NCT02017717|466667199|FG006|Treatment Period|Not reported|0|||
129647953|NCT02017717|466667200|FG007|Treatment Period|Not reported|0|||
129647954|NCT02017717|466667201|FG008|Treatment Period|Not reported|0|||
129647955|NCT00623597|466667206|FG000|Overall Study|Failed to return|1|||
129647956|NCT00623597|466667207|FG001|Overall Study|Failed to return|0|||
129647957|NCT02339155|466667211|FG000|Overall Study|Adverse Event|0|||
129647958|NCT02339155|466667212|FG001|Overall Study|Adverse Event|6|||
129647959|NCT02339155|466667211|FG000|Overall Study|Death|1|||
129647960|NCT02339155|466667212|FG001|Overall Study|Death|1|||
129647961|NCT02339155|466667211|FG000|Overall Study|Lost to Follow-up|8|||
129647962|NCT02339155|466667212|FG001|Overall Study|Lost to Follow-up|9|||
129647963|NCT02339155|466667211|FG000|Overall Study|Physician Decision|2|||
129647964|NCT02339155|466667212|FG001|Overall Study|Physician Decision|1|||
129647965|NCT02339155|466667211|FG000|Overall Study|Withdrawal by Subject|4|||
129647966|NCT02339155|466667212|FG001|Overall Study|Withdrawal by Subject|4|||
129647967|NCT01214252|466667215|FG000|Overall Study|Not eligible per protocol|82|||
129647968|NCT04327661|466667219|FG000|Overall Study|Withdrawal by Subject|1|||
129647969|NCT04327661|466667220|FG001|Overall Study|Withdrawal by Subject|0|||
129647970|NCT04327661|466667221|FG002|Overall Study|Withdrawal by Subject|0|||
129647971|NCT03427268|466667222|FG000|Overall Study|Progressive disease|25|||
129647972|NCT03427268|466667222|FG000|Overall Study|Never treated|2|||
129647973|NCT03427268|466667222|FG000|Overall Study|Compassionate use|1|||
129647974|NCT03427268|466667222|FG000|Overall Study|Withdrawal by Subject|1|||
129647975|NCT03427268|466667222|FG000|Overall Study|Adverse Event|3|||
129708305|NCT01770743|466895912|FG004|Overall Study|Withdrawal by Subject|1|||
129647976|NCT00345878|466667224|FG000|Overall Study|Adverse Event|1|||
129647977|NCT00345878|466667225|FG001|Overall Study|Adverse Event|0|||
129647978|NCT00345878|466667224|FG000|Overall Study|Lost to Follow-up|2|||
129708306|NCT01770743|466895908|FG000|Overall Study|Lost to Follow-up|0|||
129708307|NCT01770743|466895909|FG001|Overall Study|Lost to Follow-up|2|||
129708308|NCT01770743|466895910|FG002|Overall Study|Lost to Follow-up|0|||
129647979|NCT00345878|466667225|FG001|Overall Study|Lost to Follow-up|1|||
129647980|NCT00345878|466667224|FG000|Overall Study|Other|1|||
129647981|NCT00345878|466667225|FG001|Overall Study|Other|0|||
129647982|NCT00984061|466667227|FG000|Clarithromycin Alone|Protocol Violation|1|||
129708309|NCT01770743|466895911|FG003|Overall Study|Lost to Follow-up|0|||
129708310|NCT01770743|466895912|FG004|Overall Study|Lost to Follow-up|1|||
129708311|NCT01770743|466895908|FG000|Overall Study|Sponsor Terminated Subject|1|||
129891131|NCT03633903|467559628|FG000|Overall Study|Lost to Follow-up|5|||
129647983|NCT02659514|466667230|FG000|Overall Study|Adverse Event|3|||
129647984|NCT02659514|466667231|FG001|Overall Study|Adverse Event|12|||
129708312|NCT01770743|466895909|FG001|Overall Study|Sponsor Terminated Subject|0|||
129708313|NCT01770743|466895910|FG002|Overall Study|Sponsor Terminated Subject|0|||
129708314|NCT01770743|466895911|FG003|Overall Study|Sponsor Terminated Subject|1|||
129708315|NCT01770743|466895912|FG004|Overall Study|Sponsor Terminated Subject|0|||
129708316|NCT01770743|466895908|FG000|Overall Study|Moving Out of State|0|||
129708317|NCT01770743|466895909|FG001|Overall Study|Moving Out of State|1|||
129708318|NCT01770743|466895910|FG002|Overall Study|Moving Out of State|0|||
129708319|NCT01770743|466895911|FG003|Overall Study|Moving Out of State|0|||
129708320|NCT01770743|466895912|FG004|Overall Study|Moving Out of State|0|||
129708321|NCT00755807|466895915|FG000|Acute Phase|Adverse Event|16|||
129708322|NCT00755807|466895916|FG001|Acute Phase|Adverse Event|5|||
129708323|NCT00755807|466895915|FG000|Acute Phase|Protocol Violation|1|||
129708324|NCT00755807|466895916|FG001|Acute Phase|Protocol Violation|3|||
129708325|NCT00755807|466895915|FG000|Acute Phase|Withdrawal by Subject|1|||
129708326|NCT00755807|466895916|FG001|Acute Phase|Withdrawal by Subject|2|||
129708327|NCT00755807|466895915|FG000|Acute Phase|Lack of Efficacy|0|||
129708328|NCT00755807|466895916|FG001|Acute Phase|Lack of Efficacy|1|||
129708329|NCT00755807|466895915|FG000|Acute Phase|Physician Decision|0|||
129708330|NCT00755807|466895916|FG001|Acute Phase|Physician Decision|1|||
129708331|NCT00755807|466895915|FG000|Open-label Extension Phase|Adverse Event|7|||
129708332|NCT00755807|466895916|FG001|Open-label Extension Phase|Adverse Event|7|||
129708333|NCT00755807|466895915|FG000|Open-label Extension Phase|Protocol Violation|5|||
129708334|NCT00755807|466895916|FG001|Open-label Extension Phase|Protocol Violation|2|||
129708335|NCT00755807|466895915|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
129708336|NCT00755807|466895916|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
129708337|NCT00755807|466895915|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
129708338|NCT00755807|466895916|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
129708339|NCT00755807|466895915|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
129708340|NCT00755807|466895916|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
129708341|NCT00755807|466895915|FG000|Open-label Extension Phase|Sponsor Decision|0|||
129708342|NCT00755807|466895916|FG001|Open-label Extension Phase|Sponsor Decision|1|||
129708343|NCT00529243|466895921|FG000|Overall Study|Adverse Event|1|||
129708344|NCT00529243|466895921|FG000|Overall Study|Death|1|||
129708345|NCT00529243|466895921|FG000|Overall Study|Relocated|1|||
129708346|NCT00272792|466895926|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
129708347|NCT00272792|466895927|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
129708348|NCT00272792|466895926|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
129708349|NCT00272792|466895927|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
129708350|NCT00272792|466895926|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
129708351|NCT00272792|466895927|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
129708352|NCT00272792|466895926|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
129708353|NCT00272792|466895927|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
129708354|NCT00952705|466895928|FG000|Overall Study|Lost to Follow-up|24|||
129708355|NCT00952705|466895929|FG001|Overall Study|Lost to Follow-up|8|||
129708356|NCT00952705|466895930|FG002|Overall Study|Lost to Follow-up|9|||
129708357|NCT00952705|466895928|FG000|Overall Study|Withdrawal by Subject|2|||
129708358|NCT00952705|466895929|FG001|Overall Study|Withdrawal by Subject|1|||
129708359|NCT00952705|466895930|FG002|Overall Study|Withdrawal by Subject|1|||
129708360|NCT00952705|466895928|FG000|Overall Study|Death|2|||
129708361|NCT00952705|466895929|FG001|Overall Study|Death|0|||
129708362|NCT00952705|466895930|FG002|Overall Study|Death|0|||
129708363|NCT00952705|466895928|FG000|Overall Study|Incarcerated post dose|5|||
129708364|NCT00952705|466895929|FG001|Overall Study|Incarcerated post dose|0|||
129708365|NCT00952705|466895930|FG002|Overall Study|Incarcerated post dose|0|||
129708366|NCT00952705|466895928|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
129708367|NCT00952705|466895929|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
129708368|NCT00952705|466895930|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
129708369|NCT02921789|466895931|FG000|Overall Study|Adverse Event|0|||
129708370|NCT02921789|466895932|FG001|Overall Study|Adverse Event|1|||
129800328|NCT00537238|467238029|FG001|Overall Study|Lack of Efficacy|21|||
129800329|NCT00537238|467238028|FG000|Overall Study|Lost to Follow-up|12|||
129800330|NCT00537238|467238029|FG001|Overall Study|Lost to Follow-up|8|||
129800331|NCT00537238|467238028|FG000|Overall Study|Withdrawal by Subject|51|||
129708371|NCT02921789|466895931|FG000|Overall Study|Lost to Follow-up|1|||
129708372|NCT02921789|466895932|FG001|Overall Study|Lost to Follow-up|0|||
129800332|NCT00537238|467238029|FG001|Overall Study|Withdrawal by Subject|47|||
129800333|NCT00537238|467238028|FG000|Overall Study|Protocol Violation|15|||
129708373|NCT02921789|466895931|FG000|Overall Study|Protocol Deviation|2|||
129708374|NCT02921789|466895932|FG001|Overall Study|Protocol Deviation|0|||
129708375|NCT02921789|466895931|FG000|Overall Study|Withdrawal by Subject|2|||
129708376|NCT02921789|466895932|FG001|Overall Study|Withdrawal by Subject|1|||
129708377|NCT02921789|466895931|FG000|Overall Study|Miscellaneous|3|||
129708378|NCT02921789|466895932|FG001|Overall Study|Miscellaneous|2|||
129800334|NCT00537238|467238029|FG001|Overall Study|Protocol Violation|19|||
129708379|NCT03759600|466895935|FG000|Overall Study|Adverse Event|2|||
129708380|NCT03759600|466895935|FG000|Overall Study|Progressive Disease|15|||
129708381|NCT03759600|466895935|FG000|Overall Study|Site Terminated by Sponsor|3|||
129708382|NCT05173974|466895936|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
129708383|NCT05173974|466895937|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
129708384|NCT05173974|466895938|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
129708385|NCT05173974|466895939|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
129708386|NCT05173974|466895936|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
129708387|NCT05173974|466895937|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
129708388|NCT05173974|466895938|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
129708389|NCT05173974|466895939|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
129708390|NCT03289143|466895941|FG000|Overall Study|Caregiver Unavailability|1|||
129708391|NCT03289143|466895942|FG001|Overall Study|Caregiver Unavailability|1|||
129708392|NCT03289143|466895943|FG002|Overall Study|Caregiver Unavailability|0|||
129708393|NCT03289143|466895944|FG003|Overall Study|Caregiver Unavailability|0|||
129708394|NCT03289143|466895941|FG000|Overall Study|Research Department Closure|0|||
129708395|NCT03289143|466895942|FG001|Overall Study|Research Department Closure|0|||
129708396|NCT03289143|466895943|FG002|Overall Study|Research Department Closure|1|||
129708397|NCT03289143|466895944|FG003|Overall Study|Research Department Closure|0|||
129708398|NCT03289143|466895941|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
129708399|NCT03289143|466895942|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
129708400|NCT03289143|466895943|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
129708401|NCT03289143|466895944|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
129708402|NCT03289143|466895941|FG000|Overall Study|Medical Monitor Decision|1|||
129708403|NCT03289143|466895942|FG001|Overall Study|Medical Monitor Decision|0|||
129708404|NCT03289143|466895943|FG002|Overall Study|Medical Monitor Decision|0|||
129708405|NCT03289143|466895944|FG003|Overall Study|Medical Monitor Decision|0|||
129708406|NCT03289143|466895941|FG000|Overall Study|Participant Non-Compliance|0|||
129708407|NCT03289143|466895942|FG001|Overall Study|Participant Non-Compliance|0|||
129708408|NCT03289143|466895943|FG002|Overall Study|Participant Non-Compliance|1|||
129708409|NCT03289143|466895944|FG003|Overall Study|Participant Non-Compliance|0|||
129708410|NCT03289143|466895941|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
129708411|NCT03289143|466895942|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
129708412|NCT03289143|466895943|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
129708413|NCT03289143|466895944|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
129708414|NCT03289143|466895941|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
129708415|NCT03289143|466895942|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
129708416|NCT03289143|466895943|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
129708417|NCT03289143|466895944|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
129708418|NCT03289143|466895941|FG000|Overall Study|Caregiver Passed Away|1|||
129708419|NCT03289143|466895942|FG001|Overall Study|Caregiver Passed Away|0|||
129708420|NCT03289143|466895943|FG002|Overall Study|Caregiver Passed Away|0|||
129708421|NCT03289143|466895944|FG003|Overall Study|Caregiver Passed Away|0|||
129708422|NCT03289143|466895941|FG000|Overall Study|Physician Decision|0|||
129708423|NCT03289143|466895942|FG001|Overall Study|Physician Decision|2|||
129708424|NCT03289143|466895943|FG002|Overall Study|Physician Decision|2|||
129708425|NCT03289143|466895944|FG003|Overall Study|Physician Decision|2|||
129708426|NCT03289143|466895941|FG000|Overall Study|Protocol Deviation|2|||
129708427|NCT03289143|466895942|FG001|Overall Study|Protocol Deviation|1|||
129708428|NCT03289143|466895943|FG002|Overall Study|Protocol Deviation|3|||
129708429|NCT03289143|466895944|FG003|Overall Study|Protocol Deviation|1|||
129708430|NCT03289143|466895941|FG000|Overall Study|Study Terminated By Sponsor|101|||
129708431|NCT03289143|466895942|FG001|Overall Study|Study Terminated By Sponsor|75|||
129708432|NCT03289143|466895943|FG002|Overall Study|Study Terminated By Sponsor|100|||
129708433|NCT03289143|466895944|FG003|Overall Study|Study Terminated By Sponsor|69|||
129708434|NCT03289143|466895941|FG000|Overall Study|Withdrawal by Subject|14|||
129708435|NCT03289143|466895942|FG001|Overall Study|Withdrawal by Subject|6|||
129708436|NCT03289143|466895943|FG002|Overall Study|Withdrawal by Subject|14|||
129708437|NCT03289143|466895944|FG003|Overall Study|Withdrawal by Subject|12|||
129800335|NCT00537238|467238028|FG000|Overall Study|Does not meet entrance criteria|0|||
129800336|NCT00537238|467238029|FG001|Overall Study|Does not meet entrance criteria|2|||
129708438|NCT03289143|466895941|FG000|Overall Study|Adverse Event|10|||
129708439|NCT03289143|466895942|FG001|Overall Study|Adverse Event|7|||
129708440|NCT03289143|466895943|FG002|Overall Study|Adverse Event|6|||
129708441|NCT03289143|466895944|FG003|Overall Study|Adverse Event|5|||
129708442|NCT03289143|466895941|FG000|Overall Study|Death|2|||
129708443|NCT03289143|466895942|FG001|Overall Study|Death|0|||
129708444|NCT03289143|466895943|FG002|Overall Study|Death|2|||
129891132|NCT03633903|467559629|FG001|Overall Study|Lost to Follow-up|5|||
129891133|NCT05968482|467559630|FG000|First Crossover Period|Withdrawal by Subject|0|||
129891134|NCT05968482|467559631|FG001|First Crossover Period|Withdrawal by Subject|0|||
129891135|NCT05968482|467559632|FG002|First Crossover Period|Withdrawal by Subject|1|||
129891136|NCT05968482|467559633|FG003|First Crossover Period|Withdrawal by Subject|0|||
129891137|NCT05968482|467559634|FG004|First Crossover Period|Withdrawal by Subject|0|||
129891138|NCT05968482|467559635|FG005|First Crossover Period|Withdrawal by Subject|0|||
129891139|NCT05968482|467559630|FG000|First Crossover Period|Adverse Event|0|||
129891140|NCT05968482|467559631|FG001|First Crossover Period|Adverse Event|0|||
129891141|NCT05968482|467559632|FG002|First Crossover Period|Adverse Event|0|||
129891142|NCT05968482|467559633|FG003|First Crossover Period|Adverse Event|0|||
129891143|NCT05968482|467559634|FG004|First Crossover Period|Adverse Event|0|||
129891144|NCT05968482|467559635|FG005|First Crossover Period|Adverse Event|1|||
129891145|NCT05968482|467559630|FG000|Second Crossover Period|Withdrawal by Subject|0|||
129891146|NCT05968482|467559631|FG001|Second Crossover Period|Withdrawal by Subject|0|||
129891147|NCT05968482|467559632|FG002|Second Crossover Period|Withdrawal by Subject|0|||
129891148|NCT05968482|467559633|FG003|Second Crossover Period|Withdrawal by Subject|0|||
129891149|NCT05968482|467559634|FG004|Second Crossover Period|Withdrawal by Subject|1|||
129891150|NCT05968482|467559635|FG005|Second Crossover Period|Withdrawal by Subject|0|||
129891151|NCT05968482|467559630|FG000|Third Crossover Period|Adverse Event|0|||
129891152|NCT05968482|467559631|FG001|Third Crossover Period|Adverse Event|0|||
129891153|NCT05968482|467559632|FG002|Third Crossover Period|Adverse Event|0|||
129891154|NCT05968482|467559633|FG003|Third Crossover Period|Adverse Event|0|||
129891155|NCT05968482|467559634|FG004|Third Crossover Period|Adverse Event|1|||
129891156|NCT05968482|467559635|FG005|Third Crossover Period|Adverse Event|0|||
129891157|NCT05968482|467559630|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
129891158|NCT05968482|467559631|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
129891159|NCT05968482|467559632|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
129891160|NCT05968482|467559633|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
129891161|NCT05968482|467559634|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
129891162|NCT05968482|467559635|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
129891163|NCT01925170|467559637|FG000|Overall Study|Unverified cancer status|53|||
129891164|NCT00761774|467559638|FG000|Overall Study|Adverse Event|17|||
129891165|NCT00761774|467559638|FG000|Overall Study|Lack of Efficacy|37|||
129891166|NCT00761774|467559638|FG000|Overall Study|Lost to Follow-up|2|||
129891167|NCT00761774|467559638|FG000|Overall Study|Withdrawal by Subject|9|||
129891168|NCT00761774|467559638|FG000|Overall Study|Non-compliance|4|||
129647985|NCT02659514|466667230|FG000|Overall Study|Disease Progression|23|||
129647986|NCT02659514|466667231|FG001|Overall Study|Disease Progression|13|||
129647987|NCT02659514|466667230|FG000|Overall Study|Withdrawal by Subject|0|||
129647988|NCT02659514|466667231|FG001|Overall Study|Withdrawal by Subject|4|||
129647989|NCT02659514|466667230|FG000|Overall Study|Lost to Follow-up|0|||
129647990|NCT02659514|466667231|FG001|Overall Study|Lost to Follow-up|1|||
129647991|NCT02659514|466667230|FG000|Overall Study|Death|6|||
129647992|NCT02659514|466667231|FG001|Overall Study|Death|1|||
129647993|NCT02659514|466667230|FG000|Overall Study|Reason Unspecified|0|||
129647994|NCT02659514|466667231|FG001|Overall Study|Reason Unspecified|3|||
129647995|NCT01968707|466667237|FG000|Overall Study|Did not meet treatment day baseline|49|||
129647996|NCT01968707|466667238|FG001|Overall Study|Did not meet treatment day baseline|12|||
129647997|NCT01968707|466667239|FG002|Overall Study|Did not meet treatment day baseline|41|||
129647998|NCT01968707|466667240|FG003|Overall Study|Did not meet treatment day baseline|44|||
129647999|NCT01968707|466667241|FG004|Overall Study|Did not meet treatment day baseline|36|||
129648000|NCT01968707|466667242|FG005|Overall Study|Did not meet treatment day baseline|11|||
129648001|NCT01968707|466667243|FG006|Overall Study|Did not meet treatment day baseline|34|||
129648002|NCT01968707|466667244|FG007|Overall Study|Did not meet treatment day baseline|35|||
129648003|NCT00916344|466667245|FG000|Overall Study|Death|2|||
129648004|NCT00916344|466667245|FG000|Overall Study|ICD upgrade|1|||
129648005|NCT00916344|466667245|FG000|Overall Study|Drop-out|5|||
129648006|NCT00108485|466667262|FG000|Overall Study|Withdrawal by Subject|3|||
129648007|NCT00108485|466667263|FG001|Overall Study|Withdrawal by Subject|0|||
129648008|NCT00108485|466667262|FG000|Overall Study|Lost to Follow-up|0|||
129708445|NCT03289143|466895944|FG003|Overall Study|Death|1|||
129891169|NCT00761774|467559638|FG000|Overall Study|End of study|2|||
129891170|NCT00761774|467559638|FG000|Overall Study|Reclassification of seizures|1|||
129891171|NCT00761774|467559638|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
129891172|NCT00761774|467559638|FG000|Overall Study|Sponsor decision|1|||
129891173|NCT00761774|467559638|FG000|Overall Study|Investigator clinical judgement|1|||
129891174|NCT00761774|467559638|FG000|Overall Study|Patient moved out of study area|1|||
129648009|NCT00108485|466667263|FG001|Overall Study|Lost to Follow-up|2|||
129648010|NCT02062944|466667264|FG000|Overall Study|Lost to Follow-up|1|||
129648011|NCT02062944|466667264|FG000|Overall Study|New hemotological disorder identified|1|||
129648012|NCT02062944|466667264|FG000|Overall Study|Uncontrolled Hypertension|1|||
129648013|NCT02062944|466667264|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
129648014|NCT01088243|466667266|FG000|Overall Study|Adverse Event|1|||
129648015|NCT01088243|466667267|FG001|Overall Study|Adverse Event|0|||
129648016|NCT01041976|466667268|FG000|Overall Study|Withdrawal by Subject|3|||
129648017|NCT01041976|466667269|FG001|Overall Study|Withdrawal by Subject|0|||
129648018|NCT01041976|466667268|FG000|Overall Study|Incarceration|2|||
129648019|NCT01041976|466667269|FG001|Overall Study|Incarceration|0|||
129648020|NCT01041976|466667268|FG000|Overall Study|Death|0|||
129648021|NCT01041976|466667269|FG001|Overall Study|Death|4|||
129648022|NCT02231879|466667270|FG000|Overall Study|Adverse Event|2|||
129648023|NCT02231879|466667271|FG001|Overall Study|Adverse Event|1|||
129648024|NCT02231879|466667270|FG000|Overall Study|Lack of Efficacy|0|||
129648025|NCT02231879|466667271|FG001|Overall Study|Lack of Efficacy|1|||
129648026|NCT01210495|466667272|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
129648027|NCT01210495|466667273|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
129648028|NCT01210495|466667274|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
129648029|NCT01210495|466667275|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
129648030|NCT01210495|466667272|FG000|Overall Study|Death|14|||
129648031|NCT01210495|466667273|FG001|Overall Study|Death|7|||
129648032|NCT01210495|466667274|FG002|Overall Study|Death|112|||
129648033|NCT01210495|466667275|FG003|Overall Study|Death|54|||
129648034|NCT01210495|466667272|FG000|Overall Study|Study Terminated by Sponsor|0|||
129648035|NCT01210495|466667273|FG001|Overall Study|Study Terminated by Sponsor|0|||
129648036|NCT01210495|466667274|FG002|Overall Study|Study Terminated by Sponsor|4|||
129648037|NCT01210495|466667275|FG003|Overall Study|Study Terminated by Sponsor|11|||
129648038|NCT01210495|466667272|FG000|Overall Study|Lost to Follow-up|0|||
129648039|NCT01210495|466667273|FG001|Overall Study|Lost to Follow-up|0|||
129648040|NCT01210495|466667274|FG002|Overall Study|Lost to Follow-up|1|||
129648041|NCT01210495|466667275|FG003|Overall Study|Lost to Follow-up|1|||
129648042|NCT01210495|466667272|FG000|Overall Study|Other unspecified|0|||
129648043|NCT01210495|466667273|FG001|Overall Study|Other unspecified|0|||
129648044|NCT01210495|466667274|FG002|Overall Study|Other unspecified|6|||
129648045|NCT01210495|466667275|FG003|Overall Study|Other unspecified|0|||
129648046|NCT00454818|466667276|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
129648047|NCT00454818|466667277|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129648048|NCT00454818|466667278|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129648049|NCT00454818|466667279|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129648050|NCT00454818|466667280|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
129648051|NCT00454818|466667276|FG000|Phase I: Open-label Dose-escalation|Death|0|||
129648052|NCT00454818|466667277|FG001|Phase I: Open-label Dose-escalation|Death|1|||
129648053|NCT00454818|466667278|FG002|Phase I: Open-label Dose-escalation|Death|0|||
129648054|NCT00454818|466667279|FG003|Phase I: Open-label Dose-escalation|Death|0|||
129648055|NCT00454818|466667280|FG004|Phase I: Open-label Dose-escalation|Death|0|||
129648056|NCT00454818|466667276|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
129648057|NCT00454818|466667277|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
129648058|NCT00454818|466667278|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
129648059|NCT00454818|466667279|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
129648060|NCT00454818|466667280|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
129648061|NCT00454818|466667276|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
129648062|NCT00454818|466667277|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
129648063|NCT00454818|466667278|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
129648064|NCT00454818|466667279|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
129648065|NCT00454818|466667280|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
129648066|NCT00454818|466667276|FG000|Phase 2: Randomized Double-blind|Death|0|||
129648067|NCT00454818|466667277|FG001|Phase 2: Randomized Double-blind|Death|1|||
129648068|NCT00454818|466667278|FG002|Phase 2: Randomized Double-blind|Death|0|||
129648069|NCT00454818|466667279|FG003|Phase 2: Randomized Double-blind|Death|0|||
129648070|NCT00454818|466667280|FG004|Phase 2: Randomized Double-blind|Death|1|||
129648071|NCT00454818|466667276|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
129648072|NCT00454818|466667277|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
129648073|NCT00454818|466667278|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
129648074|NCT00454818|466667279|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
129648075|NCT00454818|466667280|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
129648076|NCT00454818|466667276|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
129708446|NCT03289143|466895941|FG000|Overall Study|Lost to Follow-up|2|||
129891175|NCT00761774|467559638|FG000|Overall Study|Coordinator leaving site|1|||
129891176|NCT00761774|467559638|FG000|Overall Study|Subject IP non-compliance|1|||
129891177|NCT00761774|467559638|FG000|Overall Study|IP stopped by hospital physician|1|||
129891178|NCT01077024|467559641|FG000|Overall Study|Lost to Follow-up|20|||
129891179|NCT01077024|467559642|FG001|Overall Study|Lost to Follow-up|14|||
129891180|NCT01077024|467559641|FG000|Overall Study|Withdrawal by Subject|0|||
129891181|NCT01077024|467559642|FG001|Overall Study|Withdrawal by Subject|2|||
129708447|NCT03289143|466895942|FG001|Overall Study|Lost to Follow-up|1|||
129708448|NCT03289143|466895943|FG002|Overall Study|Lost to Follow-up|1|||
129648077|NCT00454818|466667277|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
129648078|NCT00454818|466667278|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
129648079|NCT00454818|466667279|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
129648080|NCT00454818|466667280|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
129648081|NCT02505334|466667286|FG000|Main Treatment Period|Adverse Event|3|||
129648082|NCT02505334|466667287|FG001|Main Treatment Period|Adverse Event|3|||
129708449|NCT03289143|466895944|FG003|Overall Study|Lost to Follow-up|0|||
129708450|NCT03289143|466895941|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
129708451|NCT03289143|466895942|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
129708452|NCT03289143|466895943|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
129708453|NCT03289143|466895944|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
129708454|NCT03289143|466895941|FG000|Overall Study|Withdrawal by Caregiver|0|||
129443765|NCT04124614|465924497|FG001|Double Blind Treatment Period|Physician Decision|0|||
129443766|NCT04124614|465924498|FG002|Double Blind Treatment Period|Physician Decision|3|||
129443767|NCT04124614|465924496|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
129443768|NCT04124614|465924497|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
129648083|NCT02505334|466667286|FG000|Main Treatment Period|Lack of Efficacy|7|||
129648084|NCT02505334|466667287|FG001|Main Treatment Period|Lack of Efficacy|17|||
129648085|NCT02505334|466667286|FG000|Main Treatment Period|Protocol Violation|0|||
129648086|NCT02505334|466667287|FG001|Main Treatment Period|Protocol Violation|1|||
129648087|NCT02505334|466667286|FG000|Main Treatment Period|Withdrawal by Subject|1|||
129648088|NCT02505334|466667287|FG001|Main Treatment Period|Withdrawal by Subject|8|||
129648089|NCT02505334|466667286|FG000|Main Treatment Period|Unclassified|4|||
129648090|NCT02505334|466667287|FG001|Main Treatment Period|Unclassified|10|||
129648091|NCT02505334|466667286|FG000|Extension Treatment Period|Adverse Event|5|||
129648092|NCT02505334|466667287|FG001|Extension Treatment Period|Adverse Event|0|||
129648093|NCT02505334|466667286|FG000|Extension Treatment Period|Lack of Efficacy|4|||
129648094|NCT02505334|466667287|FG001|Extension Treatment Period|Lack of Efficacy|0|||
129648095|NCT02505334|466667286|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
129648096|NCT02505334|466667287|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129648097|NCT02505334|466667286|FG000|Extension Treatment Period|Unclassified|3|||
129648098|NCT02505334|466667287|FG001|Extension Treatment Period|Unclassified|0|||
129648099|NCT00581542|466667290|FG000|Overall Study|they met an exclusion criteria|2|||
129648100|NCT00581542|466667291|FG001|Overall Study|they met an exclusion criteria|2|||
129648101|NCT00581542|466667290|FG000|Overall Study|Lost to Follow-up|9|||
129648102|NCT00581542|466667291|FG001|Overall Study|Lost to Follow-up|21|||
129648103|NCT00656851|466667292|FG000|Overall Study|Withdrawal by Subject|0|||
129708455|NCT03289143|466895942|FG001|Overall Study|Withdrawal by Caregiver|1|||
129708456|NCT03289143|466895943|FG002|Overall Study|Withdrawal by Caregiver|0|||
129708457|NCT03289143|466895944|FG003|Overall Study|Withdrawal by Caregiver|0|||
129708458|NCT03289143|466895941|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
129708459|NCT03289143|466895942|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
129708460|NCT03289143|466895943|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
129708461|NCT03289143|466895944|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
129708462|NCT03289143|466895941|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
129708463|NCT03289143|466895942|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
129708464|NCT03289143|466895943|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
129708465|NCT03289143|466895944|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
129708466|NCT00730756|466895945|FG000|Overall Study|Adverse Event|2|||
129708467|NCT00730756|466895946|FG001|Overall Study|Adverse Event|0|||
129708468|NCT00730756|466895945|FG000|Overall Study|Lack of Efficacy|1|||
129708469|NCT00730756|466895946|FG001|Overall Study|Lack of Efficacy|1|||
129708470|NCT00730756|466895945|FG000|Overall Study|Protocol Deviation|1|||
129708471|NCT00730756|466895946|FG001|Overall Study|Protocol Deviation|2|||
129708472|NCT00730756|466895945|FG000|Overall Study|Lost to Follow-up|0|||
129708473|NCT00730756|466895946|FG001|Overall Study|Lost to Follow-up|1|||
129708474|NCT00730756|466895945|FG000|Overall Study|Withdrew Consent|0|||
129708475|NCT00730756|466895946|FG001|Overall Study|Withdrew Consent|1|||
129708476|NCT00305877|466895947|FG000|Overall Study|Lack of Efficacy|6|||
129708477|NCT00305877|466895948|FG001|Overall Study|Lack of Efficacy|9|||
129708478|NCT00305877|466895947|FG000|Overall Study|Adverse Event|9|||
129708479|NCT00305877|466895948|FG001|Overall Study|Adverse Event|14|||
129708480|NCT00305877|466895947|FG000|Overall Study|Death|0|||
129648104|NCT00656851|466667293|FG001|Overall Study|Withdrawal by Subject|4|||
129648105|NCT02291601|466667294|FG000|Abdomen|Did not qualify|333|||
129648106|NCT02291601|466667295|FG001|Abdomen|Did not qualify|54|||
129648107|NCT02291601|466667296|FG002|Abdomen|Did not qualify|339|||
129648108|NCT02291601|466667294|FG000|Groin|Did not qualify|183|||
129648109|NCT02291601|466667295|FG001|Groin|Did not qualify|30|||
129648110|NCT02291601|466667296|FG002|Groin|Did not qualify|177|||
129648111|NCT03379753|466667297|FG000|Overall Study|Withdrawal by Subject|2|||
129648112|NCT03379753|466667298|FG001|Overall Study|Withdrawal by Subject|1|||
129648113|NCT03379753|466667297|FG000|Overall Study|not having correct procedure|1|||
129648114|NCT03379753|466667298|FG001|Overall Study|not having correct procedure|2|||
129648115|NCT03379753|466667297|FG000|Overall Study|No primary outcome|12|||
129648116|NCT03379753|466667298|FG001|Overall Study|No primary outcome|22|||
129648117|NCT01032239|466667299|FG000|Overall Study|Lost to Follow-up|3|||
129648118|NCT01032239|466667300|FG001|Overall Study|Lost to Follow-up|2|||
129648119|NCT01032239|466667299|FG000|Overall Study|Withdrawal by Subject|2|||
129648120|NCT01032239|466667300|FG001|Overall Study|Withdrawal by Subject|3|||
129648121|NCT01032239|466667299|FG000|Overall Study|Death|1|||
129648122|NCT01032239|466667300|FG001|Overall Study|Death|0|||
129648123|NCT01032239|466667299|FG000|Overall Study|Protocol Violation|1|||
129648124|NCT01032239|466667300|FG001|Overall Study|Protocol Violation|0|||
129648125|NCT01940900|466667303|FG000|Overall Study|Physician Decision|4|||
129648126|NCT01940900|466667304|FG001|Overall Study|Physician Decision|0|||
129648127|NCT01940900|466667303|FG000|Overall Study|Adverse Event|10|||
129648128|NCT01940900|466667304|FG001|Overall Study|Adverse Event|15|||
129648129|NCT01940900|466667303|FG000|Overall Study|Withdrawal by Subject|11|||
129648130|NCT01940900|466667304|FG001|Overall Study|Withdrawal by Subject|15|||
129648131|NCT01940900|466667303|FG000|Overall Study|Lost to Follow-up|1|||
129648132|NCT01940900|466667304|FG001|Overall Study|Lost to Follow-up|0|||
129648133|NCT01940900|466667303|FG000|Overall Study|Sponsor Decision|1|||
129648134|NCT01940900|466667304|FG001|Overall Study|Sponsor Decision|0|||
129648135|NCT01940900|466667303|FG000|Overall Study|subject non-compliance|1|||
129648136|NCT01940900|466667304|FG001|Overall Study|subject non-compliance|1|||
129648137|NCT01940900|466667303|FG000|Overall Study|other|1|||
129648138|NCT01940900|466667304|FG001|Overall Study|other|0|||
129648139|NCT04972968|466667307|FG000|Overall Study|Adverse Event|3|||
129648140|NCT04972968|466667308|FG001|Overall Study|Adverse Event|1|||
129648141|NCT04972968|466667309|FG002|Overall Study|Adverse Event|1|||
129648142|NCT04972968|466667310|FG003|Overall Study|Adverse Event|7|||
129648143|NCT04972968|466667307|FG000|Overall Study|Lack of Efficacy|2|||
129648144|NCT04972968|466667308|FG001|Overall Study|Lack of Efficacy|1|||
129648145|NCT04972968|466667309|FG002|Overall Study|Lack of Efficacy|0|||
129648146|NCT04972968|466667310|FG003|Overall Study|Lack of Efficacy|0|||
129648147|NCT04972968|466667307|FG000|Overall Study|Withdrawal by Subject|7|||
129648148|NCT04972968|466667308|FG001|Overall Study|Withdrawal by Subject|4|||
129648149|NCT04972968|466667309|FG002|Overall Study|Withdrawal by Subject|3|||
129648150|NCT04972968|466667310|FG003|Overall Study|Withdrawal by Subject|2|||
129648151|NCT04972968|466667307|FG000|Overall Study|Study Terminated by Sponsor|25|||
129648152|NCT04972968|466667308|FG001|Overall Study|Study Terminated by Sponsor|28|||
129648153|NCT04972968|466667309|FG002|Overall Study|Study Terminated by Sponsor|32|||
129648154|NCT04972968|466667310|FG003|Overall Study|Study Terminated by Sponsor|27|||
129648155|NCT04972968|466667307|FG000|Overall Study|Other|1|||
129648156|NCT04972968|466667308|FG001|Overall Study|Other|0|||
129648157|NCT04972968|466667309|FG002|Overall Study|Other|1|||
129648158|NCT04972968|466667310|FG003|Overall Study|Other|1|||
129648159|NCT01698879|466667311|FG000|Overall Study|Withdrawal by Subject|1|||
129648160|NCT01698879|466667312|FG001|Overall Study|Withdrawal by Subject|0|||
129648161|NCT01698879|466667313|FG002|Overall Study|Withdrawal by Subject|0|||
129648162|NCT02419612|466667319|FG000|Short-term Treatment Period|Adverse Event|1|||
129648163|NCT02419612|466667320|FG001|Short-term Treatment Period|Adverse Event|1|||
129708481|NCT00305877|466895948|FG001|Overall Study|Death|1|||
129648164|NCT02419612|466667319|FG000|Short-term Treatment Period|Death|0|||
129648165|NCT02419612|466667320|FG001|Short-term Treatment Period|Death|2|||
129648166|NCT02419612|466667319|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
129708482|NCT00305877|466895947|FG000|Overall Study|Withdrawal by Subject|4|||
129648167|NCT02419612|466667320|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
129648168|NCT02419612|466667319|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
129648169|NCT02419612|466667320|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
129708483|NCT00305877|466895948|FG001|Overall Study|Withdrawal by Subject|2|||
129648170|NCT02419612|466667319|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
129648171|NCT02419612|466667320|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
129648172|NCT02419612|466667319|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
129708484|NCT00305877|466895947|FG000|Overall Study|Physician Decision|1|||
129708485|NCT00305877|466895948|FG001|Overall Study|Physician Decision|1|||
129708486|NCT00305877|466895947|FG000|Overall Study|Never start treatment|2|||
129708487|NCT00305877|466895948|FG001|Overall Study|Never start treatment|5|||
129708488|NCT00305877|466895947|FG000|Overall Study|Ineligible|2|||
129708489|NCT00305877|466895948|FG001|Overall Study|Ineligible|1|||
129708490|NCT00305877|466895947|FG000|Overall Study|Transportation issue with daily RT|0|||
129708491|NCT00305877|466895948|FG001|Overall Study|Transportation issue with daily RT|1|||
129708492|NCT01126190|466895949|FG000|Double-Blind Phase|Death|0|||
129708493|NCT01126190|466895950|FG001|Double-Blind Phase|Death|1|||
129708494|NCT01126190|466895951|FG002|Double-Blind Phase|Death|0|||
129708495|NCT01126190|466895949|FG000|Double-Blind Phase|Adverse Event|1|||
129708496|NCT01126190|466895950|FG001|Double-Blind Phase|Adverse Event|2|||
129708497|NCT01126190|466895951|FG002|Double-Blind Phase|Adverse Event|0|||
129708498|NCT01126190|466895949|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129708499|NCT01126190|466895950|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
129708500|NCT01126190|466895951|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129708501|NCT01126190|466895949|FG000|Double-Blind Phase|Request of Investigator|1|||
129708502|NCT01126190|466895950|FG001|Double-Blind Phase|Request of Investigator|0|||
129708503|NCT01126190|466895951|FG002|Double-Blind Phase|Request of Investigator|0|||
129708504|NCT01126190|466895949|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
129708505|NCT01126190|466895950|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
129708506|NCT01126190|466895951|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
129708507|NCT01126190|466895949|FG000|Double-Blind Phase|Non-compliance|1|||
129708508|NCT01126190|466895950|FG001|Double-Blind Phase|Non-compliance|0|||
129708509|NCT01126190|466895951|FG002|Double-Blind Phase|Non-compliance|0|||
129708510|NCT01126190|466895949|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129800337|NCT00537238|467238028|FG000|Overall Study|Other|44|||
129800338|NCT00537238|467238029|FG001|Overall Study|Other|52|||
129800339|NCT00422097|467238032|FG000|Dose Level 2|Still on treatment|0|||
129800340|NCT00422097|467238033|FG001|Dose Level 2|Still on treatment|1|||
129800341|NCT00422097|467238034|FG002|Dose Level 2|Still on treatment|0|||
129800342|NCT00422097|467238035|FG003|Dose Level 2|Still on treatment|0|||
129800343|NCT00422097|467238036|FG004|Dose Level 2|Still on treatment|0|||
129800344|NCT00422097|467238037|FG005|Dose Level 2|Still on treatment|0|||
129800345|NCT00422097|467238038|FG006|Dose Level 2|Still on treatment|0|||
129800346|NCT00422097|467238039|FG007|Dose Level 2|Still on treatment|0|||
129800347|NCT00736957|467238040|FG000|Overall Study|Adverse Event|43|||
129800348|NCT00736957|467238040|FG000|Overall Study|Withdrawal by Subject|49|||
129800349|NCT00736957|467238040|FG000|Overall Study|violation of eligibility criteria|2|||
129800350|NCT00736957|467238040|FG000|Overall Study|did not attend hospital appointments|1|||
129800351|NCT00736957|467238040|FG000|Overall Study|not eligible for Treatment Period I|22|||
129800352|NCT00736957|467238040|FG000|Overall Study|Physician Decision|5|||
129800353|NCT00331864|467238041|FG000|Overall Study|Adverse Event|30|||
129800354|NCT00331864|467238042|FG001|Overall Study|Adverse Event|1|||
129800355|NCT00331864|467238041|FG000|Overall Study|Lack of Efficacy|4|||
129800356|NCT00331864|467238042|FG001|Overall Study|Lack of Efficacy|0|||
129800357|NCT00331864|467238041|FG000|Overall Study|Protocol Violation|3|||
129800358|NCT00331864|467238042|FG001|Overall Study|Protocol Violation|0|||
129800359|NCT00331864|467238041|FG000|Overall Study|Withdrawal by Subject|10|||
129800360|NCT00331864|467238042|FG001|Overall Study|Withdrawal by Subject|0|||
129800361|NCT00331864|467238041|FG000|Overall Study|Lost to Follow-up|4|||
129800362|NCT00331864|467238042|FG001|Overall Study|Lost to Follow-up|3|||
129800363|NCT00331864|467238041|FG000|Overall Study|Administrative Problems|1|||
129800364|NCT00331864|467238042|FG001|Overall Study|Administrative Problems|0|||
129800365|NCT00331864|467238041|FG000|Overall Study|Death|6|||
129800366|NCT00331864|467238042|FG001|Overall Study|Death|0|||
129800367|NCT01092507|467238043|FG000|Overall Study|Withdrawal by Subject|2|||
129443769|NCT04124614|465924498|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
129708511|NCT01126190|466895950|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129708512|NCT01126190|466895951|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129708513|NCT01126190|466895949|FG000|Open-Label Phase|Death|0|||
129708514|NCT01126190|466895950|FG001|Open-Label Phase|Death|0|||
129800368|NCT01092507|467238044|FG001|Overall Study|Withdrawal by Subject|0|||
129800369|NCT05061966|467238055|FG000|Overall Study|Lost to Follow-up|13|||
129800370|NCT05061966|467238056|FG001|Overall Study|Lost to Follow-up|13|||
129800371|NCT02923427|467238063|FG000|Overall Study|convert to laparatomy|2|||
129800372|NCT02923427|467238064|FG001|Overall Study|convert to laparatomy|2|||
129800373|NCT02923427|467238063|FG000|Overall Study|destaturation|1|||
129708515|NCT01126190|466895951|FG002|Open-Label Phase|Death|1|||
129708516|NCT01126190|466895949|FG000|Open-Label Phase|Adverse Event|0|||
129708517|NCT01126190|466895950|FG001|Open-Label Phase|Adverse Event|0|||
129708518|NCT01126190|466895951|FG002|Open-Label Phase|Adverse Event|4|||
129708519|NCT01126190|466895949|FG000|Open-Label Phase|Withdrawal by Subject|0|||
129708520|NCT01126190|466895950|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129708521|NCT01126190|466895951|FG002|Open-Label Phase|Withdrawal by Subject|6|||
129708522|NCT00524121|466895954|FG000|Overall Study|Disease progression|6|||
129708523|NCT00524121|466895954|FG000|Overall Study|Adverse Event|4|||
129708524|NCT00524121|466895954|FG000|Overall Study|Patient refused|2|||
129708525|NCT00524121|466895954|FG000|Overall Study|Other|1|||
129708526|NCT00524121|466895954|FG000|Overall Study|Death|1|||
129708527|NCT00524121|466895954|FG000|Overall Study|Not treated (became ineligible)|4|||
129708528|NCT00524121|466895954|FG000|Overall Study|Not treated (changed mind)|1|||
129708529|NCT01114737|466895955|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
129708530|NCT01114737|466895956|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
129708531|NCT01114737|466895955|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
129708532|NCT01114737|466895956|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
129708533|NCT01114737|466895955|FG000|Randomized Treatment Period|Pregnancy|1|||
129708534|NCT01114737|466895956|FG001|Randomized Treatment Period|Pregnancy|0|||
129708535|NCT01114737|466895955|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
129708536|NCT01114737|466895956|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
129708537|NCT01114737|466895955|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
129708538|NCT01114737|466895956|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
129708539|NCT01114737|466895955|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
129708540|NCT01114737|466895956|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
129708541|NCT01446874|466895957|FG000|Overall Study|Not eligible|1|||
129708542|NCT01446874|466895958|FG001|Overall Study|Not eligible|0|||
129708543|NCT01446874|466895959|FG002|Overall Study|Not eligible|0|||
129800374|NCT02923427|467238064|FG001|Overall Study|destaturation|0|||
129800375|NCT02923427|467238063|FG000|Overall Study|can not replace LMA|1|||
129800376|NCT02923427|467238064|FG001|Overall Study|can not replace LMA|0|||
129708544|NCT01446874|466895957|FG000|Overall Study|No surgery/No qualifying surgery|1|||
129800377|NCT01325623|467238065|FG000|Overall Study|Withdrawal by Subject|3|||
129800378|NCT00145600|467238066|FG000|Overall Study|Death|1|||
129800379|NCT00145600|467238067|FG001|Overall Study|Death|2|||
129800380|NCT00145600|467238068|FG002|Overall Study|Death|2|||
129800381|NCT00145600|467238069|FG003|Overall Study|Death|6|||
129800382|NCT00145600|467238066|FG000|Overall Study|Ineligible|3|||
129800383|NCT00145600|467238067|FG001|Overall Study|Ineligible|0|||
129800384|NCT00145600|467238068|FG002|Overall Study|Ineligible|1|||
129800385|NCT00145600|467238069|FG003|Overall Study|Ineligible|5|||
129800386|NCT00145600|467238066|FG000|Overall Study|Lost to Follow-up|2|||
129800387|NCT00145600|467238067|FG001|Overall Study|Lost to Follow-up|6|||
129800388|NCT00145600|467238068|FG002|Overall Study|Lost to Follow-up|2|||
129800389|NCT00145600|467238069|FG003|Overall Study|Lost to Follow-up|4|||
129800390|NCT00145600|467238066|FG000|Overall Study|Noncompliance|1|||
129800391|NCT00145600|467238067|FG001|Overall Study|Noncompliance|0|||
129800392|NCT00145600|467238068|FG002|Overall Study|Noncompliance|0|||
129800393|NCT00145600|467238069|FG003|Overall Study|Noncompliance|0|||
129800394|NCT00145600|467238066|FG000|Overall Study|Withdrawal by Subject|1|||
129800395|NCT00145600|467238067|FG001|Overall Study|Withdrawal by Subject|2|||
129800396|NCT00145600|467238068|FG002|Overall Study|Withdrawal by Subject|0|||
129800397|NCT00145600|467238069|FG003|Overall Study|Withdrawal by Subject|1|||
129800398|NCT01539642|467238071|FG000|Overall Study|Lack of Efficacy|20|||
129800399|NCT01539642|467238072|FG001|Overall Study|Lack of Efficacy|18|||
129800400|NCT01539642|467238071|FG000|Overall Study|Patient ready for early discharge|8|||
129800401|NCT01539642|467238072|FG001|Overall Study|Patient ready for early discharge|7|||
129800402|NCT01539642|467238071|FG000|Overall Study|Adverse Event|6|||
129800403|NCT01539642|467238072|FG001|Overall Study|Adverse Event|4|||
129800404|NCT01539642|467238071|FG000|Overall Study|Withdrawal by Subject|2|||
129800405|NCT01539642|467238072|FG001|Overall Study|Withdrawal by Subject|2|||
129800406|NCT00761579|467238073|FG000|Overall Study|Adverse Event|10|||
129708545|NCT01446874|466895958|FG001|Overall Study|No surgery/No qualifying surgery|0|||
129708546|NCT01446874|466895959|FG002|Overall Study|No surgery/No qualifying surgery|12|||
129708547|NCT01446874|466895957|FG000|Overall Study|Non-compliance|0|||
129800407|NCT00761579|467238073|FG000|Overall Study|Death|2|||
129800408|NCT00761579|467238073|FG000|Overall Study|Lack of Efficacy|21|||
129800409|NCT00761579|467238073|FG000|Overall Study|Lost to Follow-up|16|||
129800410|NCT00761579|467238073|FG000|Overall Study|Pregnancy|1|||
129800411|NCT00761579|467238073|FG000|Overall Study|Withdrawal by Subject|34|||
129800412|NCT00761579|467238073|FG000|Overall Study|Lack of compliance|2|||
129800413|NCT00761579|467238073|FG000|Overall Study|Protocol deviation|1|||
129800414|NCT00761579|467238073|FG000|Overall Study|Drug overdose|1|||
129648173|NCT02419612|466667320|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
129648174|NCT02419612|466667319|FG000|Short-term Treatment Period|Worsening of liver function|0|||
129648175|NCT02419612|466667320|FG001|Short-term Treatment Period|Worsening of liver function|1|||
129648176|NCT02419612|466667319|FG000|Short-term Treatment Period|Subject moved out of state|0|||
129648177|NCT02419612|466667320|FG001|Short-term Treatment Period|Subject moved out of state|1|||
129648178|NCT02419612|466667319|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
129648179|NCT02419612|466667320|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
129648180|NCT02419612|466667319|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
129648181|NCT02419612|466667320|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
129648182|NCT02419612|466667319|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
129648183|NCT02419612|466667320|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
129648184|NCT02419612|466667319|FG000|Long-term Treatment Period|Death|0|||
129648185|NCT02419612|466667320|FG001|Long-term Treatment Period|Death|1|||
129648186|NCT02419612|466667319|FG000|Long-term Treatment Period|Adverse Event|0|||
129648187|NCT02419612|466667320|FG001|Long-term Treatment Period|Adverse Event|5|||
129648188|NCT02419612|466667319|FG000|Long-term Treatment Period|Other|4|||
129648189|NCT02419612|466667320|FG001|Long-term Treatment Period|Other|4|||
129648190|NCT02419612|466667319|FG000|Long-term Treatment Period|Subject Decision|2|||
129648191|NCT02419612|466667320|FG001|Long-term Treatment Period|Subject Decision|4|||
129648192|NCT02419612|466667319|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
129648193|NCT02419612|466667320|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
129648194|NCT00474045|466667327|FG000|Overall Study|Adverse Event|18|||
129648195|NCT00474045|466667328|FG001|Overall Study|Adverse Event|8|||
129648196|NCT00474045|466667327|FG000|Overall Study|Unclassified|1|||
129648197|NCT00474045|466667328|FG001|Overall Study|Unclassified|3|||
129648198|NCT00474045|466667327|FG000|Overall Study|Lack of Efficacy|0|||
129648199|NCT00474045|466667328|FG001|Overall Study|Lack of Efficacy|9|||
129648200|NCT00474045|466667327|FG000|Overall Study|Lost to Follow-up|1|||
129648201|NCT00474045|466667328|FG001|Overall Study|Lost to Follow-up|1|||
129648202|NCT00474045|466667327|FG000|Overall Study|Protocol Violation|10|||
129648203|NCT00474045|466667328|FG001|Overall Study|Protocol Violation|12|||
129648204|NCT00474045|466667327|FG000|Overall Study|Withdrawal by Subject|16|||
129648205|NCT00474045|466667328|FG001|Overall Study|Withdrawal by Subject|18|||
129648206|NCT00474045|466667327|FG000|Overall Study|Withdrawal criteria|60|||
129648207|NCT00474045|466667328|FG001|Overall Study|Withdrawal criteria|50|||
129648208|NCT02009397|466667329|FG000|Overall Study|Protocol Violation|6|||
129648209|NCT02009397|466667329|FG000|Overall Study|Death|8|||
129648210|NCT02009397|466667329|FG000|Overall Study|Lost to Follow-up|6|||
129648211|NCT02278120|466667332|FG000|Treatment Period|Progressive disease|234|||
129648212|NCT02278120|466667333|FG001|Treatment Period|Progressive disease|260|||
129648213|NCT02278120|466667332|FG000|Treatment Period|Subject/guardian decision|23|||
129648214|NCT02278120|466667333|FG001|Treatment Period|Subject/guardian decision|20|||
129648215|NCT02278120|466667332|FG000|Treatment Period|Adverse Event|16|||
129648216|NCT02278120|466667333|FG001|Treatment Period|Adverse Event|14|||
129648217|NCT02278120|466667332|FG000|Treatment Period|Physician Decision|14|||
129648218|NCT02278120|466667333|FG001|Treatment Period|Physician Decision|27|||
129648219|NCT02278120|466667332|FG000|Treatment Period|Death|3|||
129648220|NCT02278120|466667333|FG001|Treatment Period|Death|3|||
129648221|NCT02278120|466667332|FG000|Treatment Period|Lost to Follow-up|2|||
129648222|NCT02278120|466667333|FG001|Treatment Period|Lost to Follow-up|0|||
129648223|NCT02278120|466667332|FG000|Treatment Period|Protocol deviation|0|||
129648224|NCT02278120|466667333|FG001|Treatment Period|Protocol deviation|2|||
129648225|NCT02278120|466667332|FG000|Treatment Period|Study terminated as per protocol|43|||
129648226|NCT02278120|466667333|FG001|Treatment Period|Study terminated as per protocol|11|||
129648227|NCT02278120|466667332|FG000|Post-treatment Efficacy Follow-up|Death|0|||
129648228|NCT02278120|466667333|FG001|Post-treatment Efficacy Follow-up|Death|1|||
129648229|NCT02278120|466667332|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
129648230|NCT02278120|466667333|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129648231|NCT02278120|466667332|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
129708548|NCT01446874|466895958|FG001|Overall Study|Non-compliance|4|||
129708549|NCT01446874|466895959|FG002|Overall Study|Non-compliance|0|||
129708550|NCT01446874|466895957|FG000|Overall Study|Antibiotics for pre-op infection|0|||
129708551|NCT01446874|466895958|FG001|Overall Study|Antibiotics for pre-op infection|0|||
129708552|NCT01446874|466895959|FG002|Overall Study|Antibiotics for pre-op infection|2|||
129708553|NCT01446874|466895957|FG000|Overall Study|Withdrawal by Subject|0|||
129800415|NCT00761579|467238073|FG000|Overall Study|Aggravation of depression|1|||
129648232|NCT02278120|466667333|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
129648233|NCT02278120|466667332|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
129648234|NCT02278120|466667333|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
129648235|NCT02278120|466667332|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129648236|NCT02278120|466667333|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129708554|NCT01446874|466895958|FG001|Overall Study|Withdrawal by Subject|0|||
129708555|NCT01446874|466895959|FG002|Overall Study|Withdrawal by Subject|4|||
129648237|NCT01966068|466667338|FG000|Overall Study|Withdrawal by Subject|57|||
129648238|NCT01966068|466667338|FG000|Overall Study|Lost to Follow-up|81|||
129648239|NCT00191282|466667343|FG000|Overall Study|Adverse Event|5|||
129648240|NCT00191282|466667344|FG001|Overall Study|Adverse Event|6|||
129648241|NCT00191282|466667343|FG000|Overall Study|Death|51|||
129648242|NCT00191282|466667344|FG001|Overall Study|Death|51|||
129648243|NCT00191282|466667343|FG000|Overall Study|Lack of Efficacy|11|||
129648244|NCT00191282|466667344|FG001|Overall Study|Lack of Efficacy|6|||
129648245|NCT00191282|466667343|FG000|Overall Study|Noncompliance|14|||
129648246|NCT00191282|466667344|FG001|Overall Study|Noncompliance|17|||
129648247|NCT00191282|466667343|FG000|Overall Study|Patient moved|11|||
129648248|NCT00191282|466667344|FG001|Overall Study|Patient moved|14|||
129648249|NCT00191282|466667343|FG000|Overall Study|Withdrawal by Subject|59|||
129648250|NCT00191282|466667344|FG001|Overall Study|Withdrawal by Subject|44|||
129648251|NCT00191282|466667343|FG000|Overall Study|Physician Decision|18|||
129648252|NCT00191282|466667344|FG001|Overall Study|Physician Decision|15|||
129648253|NCT00191282|466667343|FG000|Overall Study|Protocol entry criteria not met|14|||
129648254|NCT00191282|466667344|FG001|Overall Study|Protocol entry criteria not met|9|||
129648255|NCT00191282|466667343|FG000|Overall Study|Protocol Violation|9|||
129648256|NCT00191282|466667344|FG001|Overall Study|Protocol Violation|12|||
129648257|NCT00191282|466667343|FG000|Overall Study|Severity of outcome|2|||
129648258|NCT00191282|466667344|FG001|Overall Study|Severity of outcome|5|||
129648259|NCT00191282|466667343|FG000|Overall Study|Sponsor's decision|2|||
129648260|NCT00191282|466667344|FG001|Overall Study|Sponsor's decision|2|||
129648261|NCT00191282|466667343|FG000|Overall Study|Lost to Follow-up|24|||
129648262|NCT00191282|466667344|FG001|Overall Study|Lost to Follow-up|31|||
129648263|NCT00102531|466667345|FG000|Overall Study|Adverse Event|0|||
129648264|NCT00102531|466667346|FG001|Overall Study|Adverse Event|1|||
129648265|NCT00102531|466667345|FG000|Overall Study|Disease Progression|5|||
129648266|NCT00102531|466667346|FG001|Overall Study|Disease Progression|9|||
129648267|NCT00102531|466667345|FG000|Overall Study|Physician Decision|0|||
129648268|NCT00102531|466667346|FG001|Overall Study|Physician Decision|1|||
129648269|NCT04756154|466667347|FG000|Overall Study|Did not meet treatment day baseline|30|||
129648270|NCT04756154|466667348|FG001|Overall Study|Did not meet treatment day baseline|28|||
129648271|NCT04756154|466667349|FG002|Overall Study|Did not meet treatment day baseline|7|||
129648272|NCT04756154|466667347|FG000|Overall Study|Did not return for final sample collection|1|||
129648273|NCT04756154|466667348|FG001|Overall Study|Did not return for final sample collection|1|||
129648274|NCT04756154|466667349|FG002|Overall Study|Did not return for final sample collection|0|||
129648275|NCT01790828|466667350|FG000|Overall Study|Other|34|||
129648276|NCT03589976|466667352|FG000|Overall Study|Death|5|||
129648277|NCT03589976|466667353|FG001|Overall Study|Death|1|||
129648278|NCT03589976|466667352|FG000|Overall Study|Adverse Event|5|||
129648279|NCT03589976|466667353|FG001|Overall Study|Adverse Event|1|||
129648280|NCT03589976|466667352|FG000|Overall Study|Withdrawal by Subject|4|||
129648281|NCT03589976|466667353|FG001|Overall Study|Withdrawal by Subject|1|||
129648282|NCT03589976|466667352|FG000|Overall Study|Lost to Follow-up|1|||
129648283|NCT03589976|466667353|FG001|Overall Study|Lost to Follow-up|0|||
129648284|NCT03589976|466667352|FG000|Overall Study|Other|4|||
129648285|NCT03589976|466667353|FG001|Overall Study|Other|3|||
129648286|NCT03721835|466667354|FG000|Overall Study|Participant not able to return|1|||
129648287|NCT03721835|466667354|FG000|Overall Study|Lost to Follow-up|1|||
129648288|NCT03721835|466667354|FG000|Overall Study|Revision of the components of the study device|2|||
129648289|NCT03721835|466667354|FG000|Overall Study|Sponsor terminated study|6|||
129648290|NCT03721835|466667354|FG000|Overall Study|Death|1|||
129648291|NCT03721835|466667354|FG000|Overall Study|Sponsor decision|1|||
129648292|NCT01390428|466668784|FG000|Overall Study|Elective Surgery|0|||
129648293|NCT01390428|466668785|FG001|Overall Study|Elective Surgery|0|||
129648294|NCT01390428|466668786|FG002|Overall Study|Elective Surgery|0|||
129648295|NCT01390428|466668787|FG003|Overall Study|Elective Surgery|0|||
129648296|NCT01390428|466668788|FG004|Overall Study|Elective Surgery|1|||
129648297|NCT01390428|466668789|FG005|Overall Study|Elective Surgery|0|||
129648298|NCT01390428|466668784|FG000|Overall Study|Withdrawal by Subject|0|||
129648299|NCT01390428|466668785|FG001|Overall Study|Withdrawal by Subject|0|||
129648300|NCT01390428|466668786|FG002|Overall Study|Withdrawal by Subject|1|||
129648301|NCT01390428|466668787|FG003|Overall Study|Withdrawal by Subject|0|||
129648302|NCT01390428|466668788|FG004|Overall Study|Withdrawal by Subject|0|||
129648303|NCT01390428|466668789|FG005|Overall Study|Withdrawal by Subject|0|||
129648304|NCT05079750|466668790|FG000|Overall Study|Lost to Follow-up|0|||
129648305|NCT05079750|466668791|FG001|Overall Study|Lost to Follow-up|0|||
129648306|NCT05079750|466668792|FG002|Overall Study|Lost to Follow-up|1|||
129648307|NCT05897827|466668793|FG000|Overall Study|Lost to Follow-up|33|||
129648308|NCT05897827|466668794|FG001|Overall Study|Lost to Follow-up|14|||
129648309|NCT05897827|466668793|FG000|Overall Study|Withdrawal by Subject|1|||
129648310|NCT05897827|466668794|FG001|Overall Study|Withdrawal by Subject|1|||
129648311|NCT02276053|466668797|FG000|Overall Study|Death|2|||
129648312|NCT02276053|466668797|FG000|Overall Study|Adverse Event|5|||
129648313|NCT02276053|466668797|FG000|Overall Study|Lack of Efficacy|2|||
129648314|NCT02276053|466668797|FG000|Overall Study|Withdrawal by Subject|1|||
129891182|NCT01077024|467559641|FG000|Overall Study|Incarcerated|7|||
129708556|NCT00457392|466895960|FG000|Overall Study|Objective Progression or Relapse|229|||
129708557|NCT00457392|466895961|FG001|Overall Study|Objective Progression or Relapse|296|||
129708558|NCT00457392|466895960|FG000|Overall Study|Death|106|||
129708559|NCT00457392|466895961|FG001|Overall Study|Death|106|||
129708560|NCT00457392|466895960|FG000|Overall Study|Adverse Event|84|||
129708561|NCT00457392|466895961|FG001|Overall Study|Adverse Event|41|||
129708562|NCT00457392|466895960|FG000|Overall Study|Global Deterioration of Health Status|22|||
129708563|NCT00457392|466895961|FG001|Overall Study|Global Deterioration of Health Status|8|||
129708564|NCT00457392|466895960|FG000|Overall Study|Withdrawal by Subject|14|||
129708565|NCT00457392|466895961|FG001|Overall Study|Withdrawal by Subject|8|||
129708566|NCT00457392|466895960|FG000|Overall Study|Lost to Follow-up|6|||
129708567|NCT00457392|466895961|FG001|Overall Study|Lost to Follow-up|7|||
129708568|NCT00457392|466895960|FG000|Overall Study|Protocol Violation|4|||
129708569|NCT00457392|466895961|FG001|Overall Study|Protocol Violation|3|||
129708570|NCT00457392|466895960|FG000|Overall Study|Other|7|||
129708571|NCT00457392|466895961|FG001|Overall Study|Other|4|||
129708572|NCT00457392|466895960|FG000|Overall Study|Study Terminated by Sponsor|1|||
129708573|NCT00457392|466895961|FG001|Overall Study|Study Terminated by Sponsor|4|||
129708574|NCT00457392|466895960|FG000|Overall Study|Randomized, Not Treated|7|||
129708575|NCT00457392|466895961|FG001|Overall Study|Randomized, Not Treated|3|||
129708576|NCT01466491|466895963|FG000|Overall Study|Protocol Violation|0|||
129708577|NCT01466491|466895964|FG001|Overall Study|Protocol Violation|3|||
129708578|NCT01466491|466895965|FG002|Overall Study|Protocol Violation|2|||
129708579|NCT01466491|466895966|FG003|Overall Study|Protocol Violation|0|||
129708580|NCT01466491|466895963|FG000|Overall Study|Missing Data|0|||
129708581|NCT01466491|466895964|FG001|Overall Study|Missing Data|0|||
129708582|NCT01466491|466895965|FG002|Overall Study|Missing Data|1|||
129708583|NCT01466491|466895966|FG003|Overall Study|Missing Data|0|||
129708584|NCT02727322|466895967|FG000|Overall Study|Withdrawal by Subject|1|||
129708585|NCT02727322|466895968|FG001|Overall Study|Withdrawal by Subject|1|||
129708586|NCT02727322|466895967|FG000|Overall Study|Protocol Violation|1|||
129708587|NCT02727322|466895968|FG001|Overall Study|Protocol Violation|0|||
129708588|NCT00339040|466895969|FG000|Stage I|Not able to attend clinic|1|||
129708589|NCT00339040|466895970|FG001|Stage I|Not able to attend clinic|0|||
129708590|NCT00339040|466895969|FG000|Stage I|Protocol Violation|1|||
129708591|NCT00339040|466895970|FG001|Stage I|Protocol Violation|1|||
129708592|NCT00339040|466895969|FG000|Stage II|Lost to Follow-up|3|||
129708593|NCT00339040|466895970|FG001|Stage II|Lost to Follow-up|0|||
129708594|NCT00339040|466895969|FG000|Stage II|Withdrawal by Subject|1|||
129708595|NCT00339040|466895970|FG001|Stage II|Withdrawal by Subject|2|||
129708596|NCT00339040|466895969|FG000|Stage II|Protocol Violation|3|||
129708597|NCT00339040|466895970|FG001|Stage II|Protocol Violation|0|||
129708598|NCT00339040|466895969|FG000|Stage II|Not able to attend clinic|1|||
129708599|NCT00339040|466895970|FG001|Stage II|Not able to attend clinic|0|||
129708600|NCT00339040|466895969|FG000|Stage II|Site closing|2|||
129708601|NCT00339040|466895970|FG001|Stage II|Site closing|0|||
129708602|NCT03046446|466895973|FG000|Overall Study|Lack of Efficacy|7|||
129708603|NCT03046446|466895973|FG000|Overall Study|Adverse Event|6|||
129708604|NCT03046446|466895973|FG000|Overall Study|Lost to Follow-up|3|||
129708605|NCT03046446|466895973|FG000|Overall Study|Withdrawal by Subject|14|||
129708606|NCT03046446|466895973|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
129708607|NCT03046446|466895973|FG000|Overall Study|Disease Progression (see caveats)|25|||
129708608|NCT03046446|466895973|FG000|Overall Study|Non OA related knee surgery|1|||
129708609|NCT02808897|466895974|FG000|Overall Study|Lost to Follow-up|9|||
129708610|NCT02808897|466895975|FG001|Overall Study|Lost to Follow-up|11|||
129708611|NCT01870869|466895976|FG000|Overall Study|Implanted with nonstudy device|1|||
129708612|NCT01870869|466895977|FG001|Overall Study|Implanted with nonstudy device|3|||
129708613|NCT01870869|466895978|FG002|Overall Study|Implanted with nonstudy device|14|||
129708614|NCT01870869|466895979|FG003|Overall Study|Implanted with nonstudy device|4|||
129708615|NCT01870869|466895976|FG000|Overall Study|Death|0|||
129708616|NCT01870869|466895977|FG001|Overall Study|Death|0|||
129708617|NCT01870869|466895978|FG002|Overall Study|Death|7|||
129708618|NCT01870869|466895979|FG003|Overall Study|Death|1|||
129708619|NCT01870869|466895976|FG000|Overall Study|Subject choice|6|||
129708620|NCT01870869|466895977|FG001|Overall Study|Subject choice|2|||
129800416|NCT00761579|467238073|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
129800417|NCT00761579|467238073|FG000|Overall Study|Lost survey form|1|||
129800418|NCT00761579|467238073|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
129800419|NCT03611010|467238074|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
129800420|NCT03611010|467238075|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
129800421|NCT03611010|467238076|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
129800422|NCT03611010|467238077|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
129800423|NCT00950911|467238078|FG000|Overall Study|Adverse Event|0|||
129800424|NCT00950911|467238079|FG001|Overall Study|Adverse Event|2|||
129800425|NCT00950911|467238078|FG000|Overall Study|Death|4|||
129800426|NCT00950911|467238079|FG001|Overall Study|Death|6|||
129800427|NCT00950911|467238078|FG000|Overall Study|Disease progression|2|||
129800428|NCT00950911|467238079|FG001|Overall Study|Disease progression|2|||
129800429|NCT00950911|467238078|FG000|Overall Study|Consent withdrawn|1|||
129800430|NCT00950911|467238079|FG001|Overall Study|Consent withdrawn|3|||
129800431|NCT00950911|467238078|FG000|Overall Study|Administrative decision|3|||
129800432|NCT00950911|467238079|FG001|Overall Study|Administrative decision|1|||
129800433|NCT00950911|467238078|FG000|Overall Study|Ineligibility determined|1|||
129800434|NCT00950911|467238079|FG001|Overall Study|Ineligibility determined|0|||
129800435|NCT00950911|467238078|FG000|Overall Study|Noncompliance|1|||
129800436|NCT00950911|467238079|FG001|Overall Study|Noncompliance|0|||
129800437|NCT00950911|467238078|FG000|Overall Study|Poor performance status|0|||
129800438|NCT00950911|467238079|FG001|Overall Study|Poor performance status|1|||
129800439|NCT02063880|467238082|FG000|Overall Study|Death|21|||
129800440|NCT02063880|467238083|FG001|Overall Study|Death|18|||
129800441|NCT02063880|467238082|FG000|Overall Study|Lost to Follow-up|7|||
129800442|NCT02063880|467238083|FG001|Overall Study|Lost to Follow-up|7|||
129800443|NCT02063880|467238082|FG000|Overall Study|Ineligible|0|||
129800444|NCT02063880|467238083|FG001|Overall Study|Ineligible|2|||
129800445|NCT02600351|467238084|FG000|Overall Study|Lack of Efficacy|3|||
129800446|NCT02600351|467238085|FG001|Overall Study|Lack of Efficacy|0|||
129800447|NCT02600351|467238086|FG002|Overall Study|Lack of Efficacy|5|||
129800448|NCT02600351|467238087|FG003|Overall Study|Lack of Efficacy|2|||
129800449|NCT02600351|467238084|FG000|Overall Study|Lost to Follow-up|1|||
129800450|NCT02600351|467238085|FG001|Overall Study|Lost to Follow-up|0|||
129800451|NCT02600351|467238086|FG002|Overall Study|Lost to Follow-up|0|||
129800452|NCT02600351|467238087|FG003|Overall Study|Lost to Follow-up|0|||
129800453|NCT02600351|467238084|FG000|Overall Study|Randomized but Not Treated|1|||
129800454|NCT02600351|467238085|FG001|Overall Study|Randomized but Not Treated|0|||
129708621|NCT01870869|466895978|FG002|Overall Study|Subject choice|22|||
129708622|NCT01870869|466895979|FG003|Overall Study|Subject choice|8|||
129708623|NCT01870869|466895976|FG000|Overall Study|Lost to Follow-up|10|||
129708624|NCT01870869|466895977|FG001|Overall Study|Lost to Follow-up|2|||
129708625|NCT01870869|466895978|FG002|Overall Study|Lost to Follow-up|25|||
129708626|NCT01870869|466895979|FG003|Overall Study|Lost to Follow-up|3|||
129708627|NCT01870869|466895976|FG000|Overall Study|Reason not Specified|1|||
129708628|NCT01870869|466895977|FG001|Overall Study|Reason not Specified|2|||
129708629|NCT01870869|466895978|FG002|Overall Study|Reason not Specified|20|||
129708630|NCT01870869|466895979|FG003|Overall Study|Reason not Specified|4|||
129708631|NCT01870869|466895976|FG000|Overall Study|Not evaluable|10|||
129708632|NCT01870869|466895977|FG001|Overall Study|Not evaluable|5|||
129708633|NCT01870869|466895978|FG002|Overall Study|Not evaluable|42|||
129708634|NCT01870869|466895979|FG003|Overall Study|Not evaluable|10|||
129443770|NCT04124614|465924496|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
129800455|NCT02600351|467238086|FG002|Overall Study|Randomized but Not Treated|1|||
129800456|NCT02600351|467238087|FG003|Overall Study|Randomized but Not Treated|3|||
129800457|NCT00567593|467238088|FG000|Overall Study|Adverse Event|1|||
129800458|NCT00567593|467238088|FG000|Overall Study|Physician Decision|1|||
129800459|NCT04087213|467238091|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
129800460|NCT04087213|467238091|FG000|In-Facility Introduction|Adverse Event|1|||
129708635|NCT03036852|466895980|FG000|Overall Study|Death|2|||
129708636|NCT03036852|466895980|FG000|Overall Study|Lack of Efficacy|2|||
129708637|NCT03036852|466895980|FG000|Overall Study|Adverse Event|1|||
129708638|NCT03036852|466895980|FG000|Overall Study|Lost to Follow-up|1|||
129708639|NCT00305448|466895983|FG000|Overall Study|Protocol Violation|0|||
129708640|NCT00305448|466895984|FG001|Overall Study|Protocol Violation|1|||
129708641|NCT00305448|466895985|FG002|Overall Study|Protocol Violation|0|||
129708642|NCT00305448|466895983|FG000|Overall Study|Withdrawal by Subject|2|||
129708643|NCT00305448|466895984|FG001|Overall Study|Withdrawal by Subject|0|||
129708644|NCT00305448|466895985|FG002|Overall Study|Withdrawal by Subject|1|||
129708645|NCT00305448|466895983|FG000|Overall Study|Adverse Event|1|||
129708646|NCT00305448|466895984|FG001|Overall Study|Adverse Event|0|||
129708647|NCT00305448|466895985|FG002|Overall Study|Adverse Event|1|||
129708648|NCT00305448|466895983|FG000|Overall Study|Disease Progression|27|||
129708649|NCT00305448|466895984|FG001|Overall Study|Disease Progression|31|||
129708650|NCT00305448|466895985|FG002|Overall Study|Disease Progression|28|||
129708651|NCT00305448|466895983|FG000|Overall Study|Subjective Disease Progression|1|||
129708652|NCT00305448|466895984|FG001|Overall Study|Subjective Disease Progression|2|||
129708653|NCT00305448|466895985|FG002|Overall Study|Subjective Disease Progression|2|||
129708654|NCT00305448|466895983|FG000|Overall Study|Tumor Marker Elevation|0|||
129708655|NCT00305448|466895984|FG001|Overall Study|Tumor Marker Elevation|0|||
129708656|NCT00305448|466895985|FG002|Overall Study|Tumor Marker Elevation|1|||
129708657|NCT00002766|466895986|FG000|Overall Study|Withdrawal by Subject|0|||
129708658|NCT00002766|466895987|FG001|Overall Study|Withdrawal by Subject|1|||
129708659|NCT00002766|466895986|FG000|Overall Study|Patient Not Treated|1|||
129708660|NCT00002766|466895987|FG001|Overall Study|Patient Not Treated|2|||
129708661|NCT00002766|466895986|FG000|Overall Study|Adverse Event|1|||
129708662|NCT00002766|466895987|FG001|Overall Study|Adverse Event|1|||
129708663|NCT00002766|466895986|FG000|Overall Study|Protocol Violation|1|||
129708664|NCT00002766|466895987|FG001|Overall Study|Protocol Violation|0|||
129708665|NCT00328172|466895990|FG000|Overall Study|Adverse Event|3|||
129708666|NCT00328172|466895991|FG001|Overall Study|Adverse Event|2|||
129708667|NCT00328172|466895992|FG002|Overall Study|Adverse Event|1|||
129708668|NCT00328172|466895993|FG003|Overall Study|Adverse Event|2|||
129708669|NCT00328172|466895994|FG004|Overall Study|Adverse Event|1|||
129708670|NCT00328172|466895990|FG000|Overall Study|Protocol Violation|0|||
129708671|NCT00328172|466895991|FG001|Overall Study|Protocol Violation|1|||
129708672|NCT00328172|466895992|FG002|Overall Study|Protocol Violation|1|||
129708673|NCT00328172|466895993|FG003|Overall Study|Protocol Violation|0|||
129708674|NCT00328172|466895994|FG004|Overall Study|Protocol Violation|0|||
129708675|NCT00328172|466895990|FG000|Overall Study|Lost to Follow-up|1|||
129708676|NCT00328172|466895991|FG001|Overall Study|Lost to Follow-up|1|||
129708677|NCT00328172|466895992|FG002|Overall Study|Lost to Follow-up|2|||
129708678|NCT00328172|466895993|FG003|Overall Study|Lost to Follow-up|1|||
129708679|NCT00328172|466895994|FG004|Overall Study|Lost to Follow-up|1|||
129708680|NCT00328172|466895990|FG000|Overall Study|Withdrawal by Subject|1|||
129708681|NCT00328172|466895991|FG001|Overall Study|Withdrawal by Subject|1|||
129708682|NCT00328172|466895992|FG002|Overall Study|Withdrawal by Subject|1|||
129708683|NCT00328172|466895993|FG003|Overall Study|Withdrawal by Subject|6|||
129708684|NCT00328172|466895994|FG004|Overall Study|Withdrawal by Subject|0|||
129708685|NCT00328172|466895990|FG000|Overall Study|Lack of Efficacy|14|||
129708686|NCT00328172|466895991|FG001|Overall Study|Lack of Efficacy|9|||
129708687|NCT00328172|466895992|FG002|Overall Study|Lack of Efficacy|4|||
129708688|NCT00328172|466895993|FG003|Overall Study|Lack of Efficacy|4|||
129708689|NCT00328172|466895994|FG004|Overall Study|Lack of Efficacy|3|||
129708690|NCT00328172|466895990|FG000|Overall Study|Other reason (not specified)|3|||
129708691|NCT00328172|466895991|FG001|Overall Study|Other reason (not specified)|0|||
129708692|NCT00328172|466895992|FG002|Overall Study|Other reason (not specified)|1|||
129708693|NCT00328172|466895993|FG003|Overall Study|Other reason (not specified)|0|||
129708694|NCT00328172|466895994|FG004|Overall Study|Other reason (not specified)|0|||
129708695|NCT00077974|466895995|FG000|Overall Study|Adverse Event|22|||
129708696|NCT00077974|466895995|FG000|Overall Study|Protocol Violation|1|||
129708697|NCT00077974|466895995|FG000|Overall Study|Withdrawal by Subject|3|||
129708698|NCT00077974|466895995|FG000|Overall Study|Lack of Efficacy|76|||
129708699|NCT00077974|466895995|FG000|Overall Study|Decision of Sponsor|2|||
129708700|NCT00558636|466896006|FG000|Treatment|Adverse Event|9|||
129708701|NCT00558636|466896007|FG001|Treatment|Adverse Event|2|||
129708702|NCT00558636|466896006|FG000|Treatment|Withdrawal by Subject|2|||
129708703|NCT00558636|466896007|FG001|Treatment|Withdrawal by Subject|0|||
129708704|NCT00558636|466896006|FG000|Treatment|Premature termination of the study|35|||
129708705|NCT00558636|466896007|FG001|Treatment|Premature termination of the study|37|||
129708706|NCT00558636|466896006|FG000|Treatment|Disease progression|1|||
129708707|NCT00558636|466896007|FG001|Treatment|Disease progression|5|||
129708708|NCT00558636|466896006|FG000|Follow-up|Premature termination of the study|12|||
129708709|NCT00558636|466896007|FG001|Follow-up|Premature termination of the study|7|||
129800461|NCT04087213|467238091|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
129800462|NCT04087213|467238091|FG000|Assisted Evaluable Period|Personal reasons|3|||
129708710|NCT04108273|466896008|FG000|Overall Study|COVID Pandemic|1|||
129708711|NCT04108273|466896009|FG001|Overall Study|COVID Pandemic|0|||
129648315|NCT02276053|466668797|FG000|Overall Study|Patient does not meet selection criteria|3|||
129648316|NCT02276053|466668797|FG000|Overall Study|Patient needs to increase baseline AED|1|||
129648317|NCT04542499|466668800|FG000|Overall Study|Adverse Event|23|||
129648318|NCT04542499|466668801|FG001|Overall Study|Adverse Event|43|||
129648319|NCT04542499|466668800|FG000|Overall Study|Lack of Efficacy|5|||
129648320|NCT04542499|466668801|FG001|Overall Study|Lack of Efficacy|2|||
129648321|NCT04542499|466668800|FG000|Overall Study|Lost to Follow-up|3|||
129648322|NCT04542499|466668801|FG001|Overall Study|Lost to Follow-up|4|||
129648323|NCT04542499|466668800|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
129648324|NCT04542499|466668801|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
129648325|NCT04542499|466668800|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
129648326|NCT04542499|466668801|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
129648327|NCT04542499|466668800|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129648328|NCT04542499|466668801|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129648329|NCT04542499|466668800|FG000|Overall Study|Physician Decision|0|||
129648330|NCT04542499|466668801|FG001|Overall Study|Physician Decision|1|||
129648331|NCT04542499|466668800|FG000|Overall Study|Site Terminated by Sponsor|3|||
129648332|NCT04542499|466668801|FG001|Overall Study|Site Terminated by Sponsor|5|||
129648333|NCT04542499|466668800|FG000|Overall Study|Withdrawal by Subject|12|||
129648334|NCT04542499|466668801|FG001|Overall Study|Withdrawal by Subject|33|||
129648335|NCT04542499|466668800|FG000|Overall Study|Other|2|||
129648336|NCT04542499|466668801|FG001|Overall Study|Other|2|||
129648337|NCT04322539|466668808|FG000|Overall Study|Adverse Event|2|||
129648338|NCT04322539|466668809|FG001|Overall Study|Adverse Event|0|||
129648339|NCT04322539|466668808|FG000|Overall Study|Death|411|||
129648340|NCT04322539|466668809|FG001|Overall Study|Death|203|||
129648341|NCT04322539|466668808|FG000|Overall Study|Lost to Follow-up|3|||
129648342|NCT04322539|466668809|FG001|Overall Study|Lost to Follow-up|1|||
129648343|NCT04322539|466668808|FG000|Overall Study|Withdrawal of consent|14|||
129648344|NCT04322539|466668809|FG001|Overall Study|Withdrawal of consent|8|||
129648345|NCT04322539|466668808|FG000|Overall Study|Radiological Disease Progression|6|||
129648346|NCT04322539|466668809|FG001|Overall Study|Radiological Disease Progression|0|||
129648347|NCT04322539|466668808|FG000|Overall Study|Sponsor Decision|19|||
129648348|NCT04322539|466668809|FG001|Overall Study|Sponsor Decision|14|||
129648349|NCT04322539|466668808|FG000|Overall Study|Other|6|||
129648350|NCT04322539|466668809|FG001|Overall Study|Other|4|||
129648351|NCT03617861|466668812|FG000|Second Intervention (1 Day)|Adverse Event|0|||
129648352|NCT03617861|466668813|FG001|Second Intervention (1 Day)|Adverse Event|0|||
129648353|NCT03617861|466668814|FG002|Second Intervention (1 Day)|Adverse Event|1|||
129648354|NCT03617861|466668815|FG003|Second Intervention (1 Day)|Adverse Event|0|||
129648355|NCT01702532|466668816|FG000|Overall Study|Adverse Event|0|||
129648356|NCT01702532|466668817|FG001|Overall Study|Adverse Event|1|||
129648357|NCT01846221|466668827|FG000|Overall Study|Catheter Failure|2|||
129648358|NCT01846221|466668828|FG001|Overall Study|Catheter Failure|0|||
129648359|NCT01846221|466668827|FG000|Overall Study|Age Exclusion|1|||
129648360|NCT01846221|466668828|FG001|Overall Study|Age Exclusion|0|||
129648361|NCT01668966|466668829|FG000|Overall Study|Withdrawal by Subject|1|||
129648362|NCT01668966|466668829|FG000|Overall Study|Death|1|||
129648363|NCT01668966|466668829|FG000|Overall Study|Not treated|2|||
129648364|NCT02879994|466668830|FG000|Overall Study|off treatment early|7|||
129648365|NCT02879994|466668830|FG000|Overall Study|Adverse Event|2|||
129648366|NCT02879994|466668830|FG000|Overall Study|Death|2|||
129648367|NCT00552032|466668831|FG000|Overall Study|Withdrawal by Subject|2|||
129648368|NCT00552032|466668832|FG001|Overall Study|Withdrawal by Subject|2|||
129648369|NCT00552032|466668831|FG000|Overall Study|Protocol Violation|7|||
129648370|NCT00552032|466668832|FG001|Overall Study|Protocol Violation|12|||
129648371|NCT00552032|466668831|FG000|Overall Study|Lost to Follow-up|8|||
129648372|NCT00552032|466668832|FG001|Overall Study|Lost to Follow-up|5|||
129648373|NCT01643798|466668833|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
129648374|NCT01643798|466668834|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
129648375|NCT01995175|466668838|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
129648376|NCT01995175|466668838|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
129648377|NCT01995175|466668838|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
129648378|NCT01995175|466668838|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
129648379|NCT01995175|466668838|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
129648380|NCT01995175|466668838|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
129708712|NCT00698828|466896011|FG000|Overall Study|Adverse Event|3|||
129708713|NCT00698828|466896012|FG001|Overall Study|Adverse Event|4|||
129708714|NCT00698828|466896013|FG002|Overall Study|Adverse Event|4|||
129648381|NCT01995175|466668838|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
129648382|NCT01995175|466668838|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
129648383|NCT01995175|466668838|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
129648384|NCT01877551|466668839|FG000|Overall Study|Physician Decision|0|||
129648385|NCT01877551|466668840|FG001|Overall Study|Physician Decision|1|||
129648386|NCT03602391|466668842|FG000|Overall Study|COVID-19|7|||
129708715|NCT00698828|466896011|FG000|Overall Study|Death|0|||
129708716|NCT00698828|466896012|FG001|Overall Study|Death|0|||
129708717|NCT00698828|466896013|FG002|Overall Study|Death|1|||
129708718|NCT00698828|466896011|FG000|Overall Study|Exacerbation of COPD|1|||
129708719|NCT00698828|466896012|FG001|Overall Study|Exacerbation of COPD|3|||
129708720|NCT00698828|466896013|FG002|Overall Study|Exacerbation of COPD|0|||
129708721|NCT00698828|466896011|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
129708722|NCT00698828|466896012|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
129708723|NCT00698828|466896013|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
129708724|NCT00698828|466896011|FG000|Overall Study|Investigator/Sponsor decision|1|||
129708725|NCT00698828|466896012|FG001|Overall Study|Investigator/Sponsor decision|0|||
129708726|NCT00698828|466896013|FG002|Overall Study|Investigator/Sponsor decision|2|||
129708727|NCT00698828|466896011|FG000|Overall Study|Lost to Follow-up|1|||
129708728|NCT00698828|466896012|FG001|Overall Study|Lost to Follow-up|1|||
129708729|NCT00698828|466896013|FG002|Overall Study|Lost to Follow-up|0|||
129708730|NCT00698828|466896011|FG000|Overall Study|Withdrew consent|0|||
129708731|NCT00698828|466896012|FG001|Overall Study|Withdrew consent|7|||
129708732|NCT00698828|466896013|FG002|Overall Study|Withdrew consent|4|||
129708733|NCT00698828|466896011|FG000|Overall Study|Withdrew consent (not treated)|2|||
129708734|NCT00698828|466896012|FG001|Overall Study|Withdrew consent (not treated)|0|||
129708735|NCT00698828|466896013|FG002|Overall Study|Withdrew consent (not treated)|0|||
129708736|NCT00856609|466896014|FG000|Overall Study|Adverse Event|1|||
129708737|NCT00856609|466896015|FG001|Overall Study|Adverse Event|0|||
129708738|NCT00110214|466896016|FG000|Overall Study|Never started treatment|21|||
129708739|NCT00110214|466896017|FG001|Overall Study|Never started treatment|20|||
129708740|NCT00110214|466896016|FG000|Overall Study|Disease progression or death|260|||
129708741|NCT00110214|466896017|FG001|Overall Study|Disease progression or death|151|||
129708742|NCT00110214|466896016|FG000|Overall Study|Adverse Event|115|||
129708743|NCT00110214|466896017|FG001|Overall Study|Adverse Event|192|||
129708744|NCT00110214|466896016|FG000|Overall Study|Refused further treatment|52|||
129708745|NCT00110214|466896017|FG001|Overall Study|Refused further treatment|65|||
129708746|NCT00110214|466896016|FG000|Overall Study|Other (not specified)|61|||
129708747|NCT00110214|466896017|FG001|Overall Study|Other (not specified)|75|||
129708748|NCT01088503|466896018|FG000|Overall Study|Withdrawal by Subject|118|||
129708749|NCT01088503|466896019|FG001|Overall Study|Withdrawal by Subject|327|||
129708750|NCT01088503|466896020|FG002|Overall Study|Withdrawal by Subject|10|||
129708751|NCT01088503|466896018|FG000|Overall Study|Death|64|||
129708752|NCT01088503|466896019|FG001|Overall Study|Death|358|||
129708753|NCT01088503|466896020|FG002|Overall Study|Death|7|||
129708754|NCT01016067|466896021|FG000|Overall Study|Lost to Follow-up|1|||
129708755|NCT01016067|466896022|FG001|Overall Study|Lost to Follow-up|2|||
129708756|NCT01016067|466896021|FG000|Overall Study|Physician Decision|1|||
129708757|NCT01016067|466896022|FG001|Overall Study|Physician Decision|1|||
129708758|NCT01016067|466896021|FG000|Overall Study|Withdrew due to Relocation|0|||
129708759|NCT01016067|466896022|FG001|Overall Study|Withdrew due to Relocation|1|||
129708760|NCT01534481|466896029|FG000|Overall Study|Lost to Follow-up|29|||
129708761|NCT01534481|466896030|FG001|Overall Study|Lost to Follow-up|24|||
129708762|NCT01534481|466896029|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
129708763|NCT01534481|466896030|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
129708764|NCT01130337|466896031|FG000|Overall Study|Withdrawal by Subject|3|||
129708765|NCT01130337|466896031|FG000|Overall Study|Principal investigator decision|1|||
129708766|NCT01130337|466896031|FG000|Overall Study|Death|1|||
129708767|NCT01130337|466896031|FG000|Overall Study|Disease progression|1|||
129708768|NCT01130337|466896031|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
129708769|NCT01130337|466896031|FG000|Overall Study|Surgical resection (R2)|1|||
129708770|NCT05525910|466896032|FG000|Period 4|Per sponsor due to study timelines|0|||
129800463|NCT04087213|467238091|FG000|Transition Period B|Renal Transplantation|1|||
129708771|NCT05525910|466896033|FG001|Period 4|Per sponsor due to study timelines|0|||
129708772|NCT05525910|466896034|FG002|Period 4|Per sponsor due to study timelines|1|||
129708773|NCT05525910|466896035|FG003|Period 4|Per sponsor due to study timelines|1|||
129708774|NCT05525910|466896036|FG004|Period 4|Per sponsor due to study timelines|1|||
129708775|NCT03886493|466896037|FG000|Overall Study|Adverse Event|1|||
129800464|NCT01859143|467238092|FG000|Overall Study|Lost to Follow-up|2|||
129800465|NCT01859143|467238093|FG001|Overall Study|Lost to Follow-up|0|||
129708776|NCT03179761|466896039|FG000|Overall Study|Death|2|||
129708777|NCT03179761|466896040|FG001|Overall Study|Death|5|||
129708778|NCT03179761|466896039|FG000|Overall Study|Lost to Follow-up|2|||
129708779|NCT03179761|466896040|FG001|Overall Study|Lost to Follow-up|2|||
129800466|NCT02413372|467238097|FG000|Treatment|Lost to Follow-up|0|||
129708780|NCT03179761|466896039|FG000|Overall Study|Protocol Violation|1|||
129708781|NCT03179761|466896040|FG001|Overall Study|Protocol Violation|0|||
129708782|NCT03179761|466896039|FG000|Overall Study|Withdrawal by Subject|1|||
129648387|NCT03602391|466668843|FG001|Overall Study|COVID-19|6|||
129648388|NCT01097421|466668844|FG000|Overall Study|Adverse Event|8|||
129648389|NCT01097421|466668844|FG000|Overall Study|Protocol Violation|2|||
129648390|NCT01097421|466668844|FG000|Overall Study|Lost to Follow-up|1|||
129648391|NCT01097421|466668844|FG000|Overall Study|Withdrawal by Subject|3|||
129648392|NCT02035748|466668852|FG000|Overall Study|Adverse Event|5|||
129648393|NCT02035748|466668852|FG000|Overall Study|Death|3|||
129648394|NCT02035748|466668852|FG000|Overall Study|Lost to Follow-up|2|||
129648395|NCT02035748|466668852|FG000|Overall Study|Physician Decision|3|||
129648396|NCT02035748|466668852|FG000|Overall Study|Withdrawal by Subject|6|||
129648397|NCT02035748|466668852|FG000|Overall Study|Progressive Disease|1|||
129648398|NCT04495816|466668853|FG000|Overall Study|Lost to Follow-up|10|||
129648399|NCT04495816|466668854|FG001|Overall Study|Lost to Follow-up|4|||
129648400|NCT04495816|466668853|FG000|Overall Study|Withdrawal by Subject|3|||
129648401|NCT04495816|466668854|FG001|Overall Study|Withdrawal by Subject|5|||
129648402|NCT02052596|466668855|FG000|Active Phase|Adverse Event|3|||
129648403|NCT02052596|466668856|FG001|Active Phase|Adverse Event|2|||
129648404|NCT02052596|466668855|FG000|Active Phase|Lost to Follow-up|8|||
129648405|NCT02052596|466668856|FG001|Active Phase|Lost to Follow-up|11|||
129648406|NCT02052596|466668855|FG000|Active Phase|Protocol Violation|1|||
129648407|NCT02052596|466668856|FG001|Active Phase|Protocol Violation|2|||
129648408|NCT02052596|466668855|FG000|Active Phase|Withdrawal by Subject|3|||
129648409|NCT02052596|466668856|FG001|Active Phase|Withdrawal by Subject|4|||
129648410|NCT02052596|466668855|FG000|Active Phase|Enrolled in error|1|||
129648411|NCT02052596|466668856|FG001|Active Phase|Enrolled in error|0|||
129648412|NCT02052596|466668855|FG000|Active Phase|Lost due to Crohn's disease|0|||
129648413|NCT02052596|466668856|FG001|Active Phase|Lost due to Crohn's disease|1|||
129648414|NCT02052596|466668855|FG000|Safety Phase|Adverse Event|6|||
129648415|NCT02052596|466668856|FG001|Safety Phase|Adverse Event|3|||
129648416|NCT02052596|466668855|FG000|Safety Phase|Lost to Follow-up|11|||
129648417|NCT02052596|466668856|FG001|Safety Phase|Lost to Follow-up|18|||
129648418|NCT02052596|466668855|FG000|Safety Phase|Protocol Violation|1|||
129648419|NCT02052596|466668856|FG001|Safety Phase|Protocol Violation|2|||
129648420|NCT02052596|466668855|FG000|Safety Phase|Withdrawal by Subject|8|||
129648421|NCT02052596|466668856|FG001|Safety Phase|Withdrawal by Subject|11|||
129648422|NCT02052596|466668855|FG000|Safety Phase|Enrolled in error|1|||
129648423|NCT02052596|466668856|FG001|Safety Phase|Enrolled in error|0|||
129648424|NCT02052596|466668855|FG000|Safety Phase|Lost due to Crohn's disease|0|||
129648425|NCT02052596|466668856|FG001|Safety Phase|Lost due to Crohn's disease|1|||
129648426|NCT00558896|466668857|FG000|Overall Study|Adverse Event|1|||
129648427|NCT00558896|466668858|FG001|Overall Study|Adverse Event|1|||
129648428|NCT00558896|466668859|FG002|Overall Study|Adverse Event|1|||
129648429|NCT00558896|466668860|FG003|Overall Study|Adverse Event|3|||
129648430|NCT00558896|466668861|FG004|Overall Study|Adverse Event|4|||
129648431|NCT00558896|466668862|FG005|Overall Study|Adverse Event|10|||
129648432|NCT00558896|466668863|FG006|Overall Study|Adverse Event|3|||
129648433|NCT00558896|466668857|FG000|Overall Study|Death|3|||
129648434|NCT00558896|466668858|FG001|Overall Study|Death|0|||
129648435|NCT00558896|466668859|FG002|Overall Study|Death|2|||
129648436|NCT00558896|466668860|FG003|Overall Study|Death|3|||
129648437|NCT00558896|466668861|FG004|Overall Study|Death|2|||
129648438|NCT00558896|466668862|FG005|Overall Study|Death|2|||
129648439|NCT00558896|466668863|FG006|Overall Study|Death|6|||
129648440|NCT00558896|466668857|FG000|Overall Study|Withdrawal by Subject|2|||
129648441|NCT00558896|466668858|FG001|Overall Study|Withdrawal by Subject|1|||
129648442|NCT00558896|466668859|FG002|Overall Study|Withdrawal by Subject|1|||
129648443|NCT00558896|466668860|FG003|Overall Study|Withdrawal by Subject|1|||
129648444|NCT00558896|466668861|FG004|Overall Study|Withdrawal by Subject|1|||
129648445|NCT00558896|466668862|FG005|Overall Study|Withdrawal by Subject|5|||
129648446|NCT00558896|466668863|FG006|Overall Study|Withdrawal by Subject|5|||
129648447|NCT00558896|466668857|FG000|Overall Study|Alternative Treatment|2|||
129648448|NCT00558896|466668858|FG001|Overall Study|Alternative Treatment|2|||
129708783|NCT03179761|466896040|FG001|Overall Study|Withdrawal by Subject|4|||
129648449|NCT00558896|466668859|FG002|Overall Study|Alternative Treatment|0|||
129648450|NCT00558896|466668860|FG003|Overall Study|Alternative Treatment|2|||
129648451|NCT00558896|466668861|FG004|Overall Study|Alternative Treatment|6|||
129648452|NCT00558896|466668862|FG005|Overall Study|Alternative Treatment|7|||
129648453|NCT00558896|466668863|FG006|Overall Study|Alternative Treatment|1|||
129648454|NCT00558896|466668857|FG000|Overall Study|Physician discretion|3|||
129891183|NCT01077024|467559642|FG001|Overall Study|Incarcerated|8|||
129891184|NCT01077024|467559641|FG000|Overall Study|Other|4|||
129891185|NCT01077024|467559642|FG001|Overall Study|Other|4|||
129891186|NCT03379233|467559643|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
129891187|NCT03379233|467559644|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
129891188|NCT01603121|467559645|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
129891189|NCT01603121|467559646|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
129891190|NCT02300311|467559649|FG000|Overall Study|Other than the reason specified|1|||
129648455|NCT00558896|466668858|FG001|Overall Study|Physician discretion|2|||
129648456|NCT00558896|466668859|FG002|Overall Study|Physician discretion|1|||
129648457|NCT00558896|466668860|FG003|Overall Study|Physician discretion|2|||
129648458|NCT00558896|466668861|FG004|Overall Study|Physician discretion|1|||
129648459|NCT00558896|466668862|FG005|Overall Study|Physician discretion|3|||
129648460|NCT00558896|466668863|FG006|Overall Study|Physician discretion|3|||
129648461|NCT00558896|466668857|FG000|Overall Study|Continues on treatment|10|||
129648462|NCT00558896|466668858|FG001|Overall Study|Continues on treatment|1|||
129648463|NCT00558896|466668859|FG002|Overall Study|Continues on treatment|0|||
129648464|NCT00558896|466668860|FG003|Overall Study|Continues on treatment|1|||
129648465|NCT00558896|466668861|FG004|Overall Study|Continues on treatment|9|||
129648466|NCT00558896|466668862|FG005|Overall Study|Continues on treatment|25|||
129648467|NCT00558896|466668863|FG006|Overall Study|Continues on treatment|6|||
129443771|NCT04124614|465924497|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
129443772|NCT04124614|465924498|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
129443773|NCT04124614|465924496|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
129648468|NCT00705718|466668864|FG000|Overall Study|Death|6|||
129708784|NCT03179761|466896039|FG000|Overall Study|Investigator Request|0|||
129443774|NCT04124614|465924497|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
129443775|NCT04124614|465924498|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
129648469|NCT00705718|466668865|FG001|Overall Study|Death|6|||
129648470|NCT00705718|466668864|FG000|Overall Study|Not due for Visit|0|||
129648471|NCT00705718|466668865|FG001|Overall Study|Not due for Visit|12|||
129648472|NCT00705718|466668864|FG000|Overall Study|Follow up not done|1|||
129708785|NCT03179761|466896040|FG001|Overall Study|Investigator Request|2|||
129708786|NCT00448448|466896041|FG000|Overall Study|Withdrawal by Subject|13|||
129708787|NCT00448448|466896042|FG001|Overall Study|Withdrawal by Subject|2|||
129708788|NCT00448448|466896041|FG000|Overall Study|On protocol when study ended|83|||
129708789|NCT00448448|466896042|FG001|Overall Study|On protocol when study ended|36|||
129708790|NCT00448448|466896041|FG000|Overall Study|Lost to Follow-up|2|||
129708791|NCT00448448|466896042|FG001|Overall Study|Lost to Follow-up|1|||
129708792|NCT00448448|466896041|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
129708793|NCT00448448|466896042|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
129708794|NCT00448448|466896041|FG000|Overall Study|Signed consent lost|0|||
129708795|NCT00448448|466896042|FG001|Overall Study|Signed consent lost|1|||
129708796|NCT02284191|466896043|FG000|Overall Study|Withdrawal by Subject|1|||
129708797|NCT02284191|466896044|FG001|Overall Study|Withdrawal by Subject|3|||
129708798|NCT02284191|466896043|FG000|Overall Study|Lost to Follow-up|1|||
129708799|NCT02284191|466896044|FG001|Overall Study|Lost to Follow-up|0|||
129708800|NCT01188967|466896045|FG000|Overall Study|Withdrawal by Subject|1|||
129708801|NCT01188967|466896046|FG001|Overall Study|Withdrawal by Subject|1|||
129708802|NCT01188967|466896045|FG000|Overall Study|Physician Decision|1|||
129708803|NCT01188967|466896046|FG001|Overall Study|Physician Decision|1|||
129708804|NCT01188967|466896045|FG000|Overall Study|Lost to Follow-up|3|||
129708805|NCT01188967|466896046|FG001|Overall Study|Lost to Follow-up|2|||
129708806|NCT01832727|466896049|FG000|Overall Study|Adverse Event|4|||
129891191|NCT02300311|467559650|FG001|Overall Study|Other than the reason specified|0|||
129891192|NCT02300311|467559649|FG000|Overall Study|Refused to continue taking medication|18|||
129891193|NCT02300311|467559650|FG001|Overall Study|Refused to continue taking medication|0|||
129891194|NCT00419003|467559651|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
129891195|NCT00419003|467559652|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
129891196|NCT00419003|467559651|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
129891197|NCT00419003|467559652|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
129891198|NCT01656759|467559653|FG000|Overall Study|Protocol Violation|2|||
129891199|NCT01656759|467559654|FG001|Overall Study|Protocol Violation|3|||
129891200|NCT02687919|467559655|FG000|Overall Study|Withdrawal by Subject|6|||
129891201|NCT02687919|467559656|FG001|Overall Study|Withdrawal by Subject|6|||
129891202|NCT02687919|467559655|FG000|Overall Study|Protocol Violation|2|||
129891203|NCT02687919|467559656|FG001|Overall Study|Protocol Violation|0|||
129891204|NCT02531438|467559657|FG000|Overall Study|Adverse Event|7|||
129891205|NCT02531438|467559658|FG001|Overall Study|Adverse Event|9|||
129891206|NCT02531438|467559657|FG000|Overall Study|Lost to Follow-up|0|||
129891207|NCT02531438|467559658|FG001|Overall Study|Lost to Follow-up|3|||
129891208|NCT02531438|467559657|FG000|Overall Study|Withdrawal by Subject|7|||
129891209|NCT02531438|467559658|FG001|Overall Study|Withdrawal by Subject|8|||
129891210|NCT02531438|467559657|FG000|Overall Study|Physician Decision|0|||
129891211|NCT02531438|467559658|FG001|Overall Study|Physician Decision|1|||
129891212|NCT02531438|467559657|FG000|Overall Study|Death|6|||
129891213|NCT02531438|467559658|FG001|Overall Study|Death|3|||
129891214|NCT02531438|467559657|FG000|Overall Study|Randomized, but Not Treated|4|||
129891215|NCT02531438|467559658|FG001|Overall Study|Randomized, but Not Treated|0|||
129891216|NCT02531438|467559657|FG000|Overall Study|Missed EOT/PTE Visit|5|||
129891217|NCT02531438|467559658|FG001|Overall Study|Missed EOT/PTE Visit|2|||
129891218|NCT02531438|467559657|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
129891219|NCT02531438|467559658|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
129891220|NCT00772928|467559659|FG000|Overall Study|Lost to Follow-up|9|||
129891221|NCT00772928|467559660|FG001|Overall Study|Lost to Follow-up|6|||
129891222|NCT00772928|467559659|FG000|Overall Study|Protocol Violation|10|||
129648473|NCT00705718|466668865|FG001|Overall Study|Follow up not done|4|||
129648474|NCT06137703|466668866|FG000|Overall Study|Other|0|||
129648475|NCT06137703|466668867|FG001|Overall Study|Other|1|||
129648476|NCT06137703|466668868|FG002|Overall Study|Other|0|||
129648477|NCT06137703|466668869|FG003|Overall Study|Other|0|||
129648478|NCT06137703|466668866|FG000|Overall Study|Adverse Event|0|||
129648479|NCT06137703|466668867|FG001|Overall Study|Adverse Event|0|||
129708807|NCT01832727|466896050|FG001|Overall Study|Adverse Event|6|||
129708808|NCT01832727|466896051|FG002|Overall Study|Adverse Event|1|||
129708809|NCT01832727|466896052|FG003|Overall Study|Adverse Event|0|||
129708810|NCT01832727|466896053|FG004|Overall Study|Adverse Event|1|||
129708811|NCT01832727|466896054|FG005|Overall Study|Adverse Event|1|||
129708812|NCT01832727|466896055|FG006|Overall Study|Adverse Event|2|||
129708813|NCT01832727|466896056|FG007|Overall Study|Adverse Event|1|||
129708814|NCT01832727|466896057|FG008|Overall Study|Adverse Event|9|||
129708815|NCT01832727|466896049|FG000|Overall Study|Disease progression|3|||
129708816|NCT01832727|466896050|FG001|Overall Study|Disease progression|0|||
129708817|NCT01832727|466896051|FG002|Overall Study|Disease progression|2|||
129708818|NCT01832727|466896052|FG003|Overall Study|Disease progression|1|||
129708819|NCT01832727|466896053|FG004|Overall Study|Disease progression|3|||
129708820|NCT01832727|466896054|FG005|Overall Study|Disease progression|3|||
129708821|NCT01832727|466896055|FG006|Overall Study|Disease progression|6|||
129708822|NCT01832727|466896056|FG007|Overall Study|Disease progression|2|||
129708823|NCT01832727|466896057|FG008|Overall Study|Disease progression|7|||
129708824|NCT01832727|466896049|FG000|Overall Study|Lost to Follow-up|0|||
129708825|NCT01832727|466896050|FG001|Overall Study|Lost to Follow-up|0|||
129708826|NCT01832727|466896051|FG002|Overall Study|Lost to Follow-up|0|||
129708827|NCT01832727|466896052|FG003|Overall Study|Lost to Follow-up|1|||
129708828|NCT01832727|466896053|FG004|Overall Study|Lost to Follow-up|0|||
129708829|NCT01832727|466896054|FG005|Overall Study|Lost to Follow-up|0|||
129708830|NCT01832727|466896055|FG006|Overall Study|Lost to Follow-up|0|||
129708831|NCT01832727|466896056|FG007|Overall Study|Lost to Follow-up|0|||
129708832|NCT01832727|466896057|FG008|Overall Study|Lost to Follow-up|0|||
129708833|NCT01832727|466896049|FG000|Overall Study|Physician Decision|1|||
129708834|NCT01832727|466896050|FG001|Overall Study|Physician Decision|0|||
129708835|NCT01832727|466896051|FG002|Overall Study|Physician Decision|0|||
129708836|NCT01832727|466896052|FG003|Overall Study|Physician Decision|1|||
129708837|NCT01832727|466896053|FG004|Overall Study|Physician Decision|0|||
129648480|NCT06137703|466668868|FG002|Overall Study|Adverse Event|1|||
129648481|NCT06137703|466668869|FG003|Overall Study|Adverse Event|0|||
129648482|NCT04329091|466668872|FG000|Overall Study|Physician Decision|5|||
129708838|NCT01832727|466896054|FG005|Overall Study|Physician Decision|1|||
129708839|NCT01832727|466896055|FG006|Overall Study|Physician Decision|0|||
129708840|NCT01832727|466896056|FG007|Overall Study|Physician Decision|0|||
129708841|NCT01832727|466896057|FG008|Overall Study|Physician Decision|0|||
129708842|NCT01832727|466896049|FG000|Overall Study|Withdrawal by Subject|1|||
129708843|NCT01832727|466896050|FG001|Overall Study|Withdrawal by Subject|1|||
129708844|NCT01832727|466896051|FG002|Overall Study|Withdrawal by Subject|0|||
129708845|NCT01832727|466896052|FG003|Overall Study|Withdrawal by Subject|1|||
129708846|NCT01832727|466896053|FG004|Overall Study|Withdrawal by Subject|0|||
129708847|NCT01832727|466896054|FG005|Overall Study|Withdrawal by Subject|1|||
129708848|NCT01832727|466896055|FG006|Overall Study|Withdrawal by Subject|0|||
129708849|NCT01832727|466896056|FG007|Overall Study|Withdrawal by Subject|2|||
129708850|NCT01832727|466896057|FG008|Overall Study|Withdrawal by Subject|1|||
129708851|NCT01832727|466896049|FG000|Overall Study|Study terminated by sponsor|0|||
129708852|NCT01832727|466896050|FG001|Overall Study|Study terminated by sponsor|0|||
129708853|NCT01832727|466896051|FG002|Overall Study|Study terminated by sponsor|0|||
129708854|NCT01832727|466896052|FG003|Overall Study|Study terminated by sponsor|0|||
129708855|NCT01832727|466896053|FG004|Overall Study|Study terminated by sponsor|0|||
129708856|NCT01832727|466896054|FG005|Overall Study|Study terminated by sponsor|0|||
129708857|NCT01832727|466896055|FG006|Overall Study|Study terminated by sponsor|0|||
129708858|NCT01832727|466896056|FG007|Overall Study|Study terminated by sponsor|1|||
129708859|NCT01832727|466896057|FG008|Overall Study|Study terminated by sponsor|1|||
129708860|NCT02216526|466896058|FG000|Overall Study|Adverse Event|1|||
129708861|NCT02216526|466896059|FG001|Overall Study|Adverse Event|1|||
129708862|NCT02216526|466896060|FG002|Overall Study|Adverse Event|0|||
129708863|NCT02216526|466896058|FG000|Overall Study|Death|0|||
129708864|NCT02216526|466896059|FG001|Overall Study|Death|1|||
129708865|NCT02216526|466896060|FG002|Overall Study|Death|3|||
129708866|NCT02216526|466896058|FG000|Overall Study|Protocol Violation|2|||
129708867|NCT02216526|466896059|FG001|Overall Study|Protocol Violation|0|||
129708868|NCT02216526|466896060|FG002|Overall Study|Protocol Violation|2|||
129708869|NCT02216526|466896058|FG000|Overall Study|Hospitalization|2|||
129708870|NCT02216526|466896059|FG001|Overall Study|Hospitalization|1|||
129708871|NCT02216526|466896060|FG002|Overall Study|Hospitalization|3|||
129708872|NCT04436744|466896064|FG000|Overall Study|Adverse Event|1|||
129708873|NCT04436744|466896065|FG001|Overall Study|Adverse Event|1|||
129708874|NCT04436744|466896064|FG000|Overall Study|Death|1|||
129708875|NCT04436744|466896065|FG001|Overall Study|Death|0|||
129708876|NCT04436744|466896064|FG000|Overall Study|Lost to Follow-up|0|||
129708877|NCT04436744|466896065|FG001|Overall Study|Lost to Follow-up|2|||
129708878|NCT04436744|466896064|FG000|Overall Study|Physician Decision|0|||
129708879|NCT04436744|466896065|FG001|Overall Study|Physician Decision|1|||
129708880|NCT04436744|466896064|FG000|Overall Study|Progressive Disease|0|||
129708881|NCT04436744|466896065|FG001|Overall Study|Progressive Disease|4|||
129708882|NCT04436744|466896064|FG000|Overall Study|Protocol Deviation|1|||
129708883|NCT04436744|466896065|FG001|Overall Study|Protocol Deviation|1|||
129708884|NCT04436744|466896064|FG000|Overall Study|Withdrawal by Subject|1|||
129708885|NCT04436744|466896065|FG001|Overall Study|Withdrawal by Subject|2|||
129708886|NCT01133847|466896066|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
129708887|NCT01133847|466896067|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
129708888|NCT01133847|466896068|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
129708889|NCT01133847|466896066|FG000|Follow-Up Phase|Lost to Follow-up|1|||
129708890|NCT01133847|466896067|FG001|Follow-Up Phase|Lost to Follow-up|3|||
129891223|NCT00772928|467559660|FG001|Overall Study|Protocol Violation|12|||
129891224|NCT00772928|467559659|FG000|Overall Study|Withdrawal by Subject|25|||
129891225|NCT00772928|467559660|FG001|Overall Study|Withdrawal by Subject|22|||
129891226|NCT00772928|467559659|FG000|Overall Study|Did not receive vaccine|0|||
129891227|NCT00772928|467559660|FG001|Overall Study|Did not receive vaccine|1|||
129891228|NCT00801242|467559667|FG000|Overall Study|Adverse Event|10|||
129708891|NCT01133847|466896068|FG002|Follow-Up Phase|Lost to Follow-up|7|||
129708892|NCT01463033|466896072|FG000|Overall Study|Lost to Follow-up|4|||
129708893|NCT01463033|466896073|FG001|Overall Study|Lost to Follow-up|4|||
129708894|NCT01463033|466896072|FG000|Overall Study|Death|3|||
129708895|NCT01463033|466896073|FG001|Overall Study|Death|2|||
129708896|NCT00967616|466896074|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
129708897|NCT00967616|466896075|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
129708898|NCT00967616|466896074|FG000|Overall Study|Death|0|||
129708899|NCT00967616|466896075|FG001|Overall Study|Death|3|||
129708900|NCT00967616|466896074|FG000|Overall Study|Withdrawal by Subject|8|||
129708901|NCT00967616|466896075|FG001|Overall Study|Withdrawal by Subject|4|||
129708902|NCT00967616|466896074|FG000|Overall Study|Progressive Disease|31|||
129708903|NCT00967616|466896075|FG001|Overall Study|Progressive Disease|18|||
129708904|NCT00967616|466896074|FG000|Overall Study|Other|8|||
129708905|NCT00967616|466896075|FG001|Overall Study|Other|8|||
129708906|NCT00967616|466896074|FG000|Overall Study|Protocol Violation|1|||
129708907|NCT00967616|466896075|FG001|Overall Study|Protocol Violation|0|||
129708908|NCT01368614|466896076|FG000|Screening Period|Screen Failure|58|||
129708909|NCT01368614|466896077|FG001|Screening Period|Screen Failure|0|||
129708910|NCT01368614|466896078|FG002|Screening Period|Screen Failure|0|||
129708911|NCT01368614|466896079|FG003|Screening Period|Screen Failure|0|||
129708912|NCT01368614|466896076|FG000|Study Period|Withdrawal by Subject|0|||
129708913|NCT01368614|466896077|FG001|Study Period|Withdrawal by Subject|1|||
129708914|NCT01368614|466896078|FG002|Study Period|Withdrawal by Subject|1|||
129708915|NCT01368614|466896079|FG003|Study Period|Withdrawal by Subject|3|||
129708916|NCT01368614|466896076|FG000|Study Period|Lost to Follow-up|0|||
129708917|NCT01368614|466896077|FG001|Study Period|Lost to Follow-up|0|||
129708918|NCT01368614|466896078|FG002|Study Period|Lost to Follow-up|1|||
129708919|NCT01368614|466896079|FG003|Study Period|Lost to Follow-up|0|||
129708920|NCT02951780|466896080|FG000|Period 1|Adverse Event|0|||
129708921|NCT02951780|466896081|FG001|Period 1|Adverse Event|0|||
129708922|NCT02951780|466896082|FG002|Period 1|Adverse Event|0|||
129708923|NCT02951780|466896083|FG003|Period 1|Adverse Event|1|||
129708924|NCT02951780|466896084|FG004|Period 1|Adverse Event|0|||
129708925|NCT02951780|466896085|FG005|Period 1|Adverse Event|0|||
129708926|NCT02951780|466896086|FG006|Period 1|Adverse Event|0|||
129708927|NCT02951780|466896087|FG007|Period 1|Adverse Event|0|||
129708928|NCT02951780|466896088|FG008|Period 1|Adverse Event|0|||
129708929|NCT02951780|466896080|FG000|Period 1|Scheduling Conflicts|0|||
129708930|NCT02951780|466896081|FG001|Period 1|Scheduling Conflicts|0|||
129708931|NCT02951780|466896082|FG002|Period 1|Scheduling Conflicts|0|||
129708932|NCT02951780|466896083|FG003|Period 1|Scheduling Conflicts|0|||
129708933|NCT02951780|466896084|FG004|Period 1|Scheduling Conflicts|0|||
129891229|NCT00801242|467559667|FG000|Overall Study|Withdrawal by Subject|13|||
129708934|NCT02951780|466896085|FG005|Period 1|Scheduling Conflicts|0|||
129708935|NCT02951780|466896086|FG006|Period 1|Scheduling Conflicts|0|||
129708936|NCT02951780|466896087|FG007|Period 1|Scheduling Conflicts|1|||
129708937|NCT02951780|466896088|FG008|Period 1|Scheduling Conflicts|0|||
129708938|NCT02951780|466896080|FG000|Period 2|Scheduling Conflicts|0|||
129708939|NCT02951780|466896081|FG001|Period 2|Scheduling Conflicts|0|||
129708940|NCT02951780|466896082|FG002|Period 2|Scheduling Conflicts|0|||
129708941|NCT02951780|466896083|FG003|Period 2|Scheduling Conflicts|0|||
129708942|NCT02951780|466896084|FG004|Period 2|Scheduling Conflicts|0|||
129708943|NCT02951780|466896085|FG005|Period 2|Scheduling Conflicts|0|||
129708944|NCT02951780|466896086|FG006|Period 2|Scheduling Conflicts|0|||
129708945|NCT02951780|466896087|FG007|Period 2|Scheduling Conflicts|1|||
129708946|NCT02951780|466896088|FG008|Period 2|Scheduling Conflicts|0|||
129708947|NCT01374425|466896089|FG000|Overall Study|Radiographic Disease Progression|86|||
129708948|NCT01374425|466896090|FG001|Overall Study|Radiographic Disease Progression|81|||
129708949|NCT01374425|466896089|FG000|Overall Study|Clinical Disease Progression|9|||
129708950|NCT01374425|466896090|FG001|Overall Study|Clinical Disease Progression|6|||
129708951|NCT01374425|466896089|FG000|Overall Study|Adverse Event|29|||
129708952|NCT01374425|466896090|FG001|Overall Study|Adverse Event|18|||
129708953|NCT01374425|466896089|FG000|Overall Study|Death (Progression of Disease)|1|||
129708954|NCT01374425|466896090|FG001|Overall Study|Death (Progression of Disease)|0|||
129708955|NCT01374425|466896089|FG000|Overall Study|Death (Adverse Event)|2|||
129800467|NCT02413372|467238098|FG001|Treatment|Lost to Follow-up|2|||
129800468|NCT02413372|467238099|FG002|Treatment|Lost to Follow-up|1|||
129800469|NCT02413372|467238097|FG000|Treatment|Withdrawal by Subject|1|||
129800470|NCT02413372|467238098|FG001|Treatment|Withdrawal by Subject|0|||
129800471|NCT02413372|467238099|FG002|Treatment|Withdrawal by Subject|0|||
129800472|NCT02413372|467238097|FG000|Follow-up|Lost to Follow-up|1|||
129708956|NCT01374425|466896090|FG001|Overall Study|Death (Adverse Event)|4|||
129708957|NCT01374425|466896089|FG000|Overall Study|Withdrawal by Subject|6|||
129708958|NCT01374425|466896090|FG001|Overall Study|Withdrawal by Subject|7|||
129708959|NCT01374425|466896089|FG000|Overall Study|Refused Treatment|10|||
129708960|NCT01374425|466896090|FG001|Overall Study|Refused Treatment|24|||
129708961|NCT01374425|466896089|FG000|Overall Study|Protocol Violation|2|||
129708962|NCT01374425|466896090|FG001|Overall Study|Protocol Violation|3|||
129708963|NCT01374425|466896089|FG000|Overall Study|Sponsor Decision|0|||
129708964|NCT01374425|466896090|FG001|Overall Study|Sponsor Decision|1|||
129708965|NCT01374425|466896089|FG000|Overall Study|Lost to Follow-up|2|||
129708966|NCT01374425|466896090|FG001|Overall Study|Lost to Follow-up|1|||
129708967|NCT01374425|466896089|FG000|Overall Study|Other|41|||
129800473|NCT02413372|467238098|FG001|Follow-up|Lost to Follow-up|1|||
129800474|NCT02413372|467238099|FG002|Follow-up|Lost to Follow-up|0|||
129800475|NCT02413372|467238097|FG000|Follow-up|Subject Withdrew Consent|1|||
129800476|NCT02413372|467238098|FG001|Follow-up|Subject Withdrew Consent|0|||
129800477|NCT02413372|467238099|FG002|Follow-up|Subject Withdrew Consent|1|||
129800478|NCT02413372|467238097|FG000|Follow-up|Subject unable to return for visit|0|||
129800479|NCT02413372|467238098|FG001|Follow-up|Subject unable to return for visit|0|||
129800480|NCT02413372|467238099|FG002|Follow-up|Subject unable to return for visit|1|||
129800481|NCT02556203|467238106|FG000|Overall Study|Withdrawal by Subject|21|||
129800482|NCT02556203|467238107|FG001|Overall Study|Withdrawal by Subject|21|||
129800483|NCT02556203|467238106|FG000|Overall Study|Lost to Follow-up|5|||
129708968|NCT01374425|466896090|FG001|Overall Study|Other|43|||
129708969|NCT03783780|466896095|FG000|Overall Study|Withdrawn prior to completion|1|||
129708970|NCT02629861|466896096|FG000|Overall Study|Adverse Event|7|||
129708971|NCT02629861|466896097|FG001|Overall Study|Adverse Event|5|||
129708972|NCT02629861|466896098|FG002|Overall Study|Adverse Event|4|||
129708973|NCT02629861|466896096|FG000|Overall Study|Withdrawal by Subject|5|||
129708974|NCT02629861|466896097|FG001|Overall Study|Withdrawal by Subject|8|||
129708975|NCT02629861|466896098|FG002|Overall Study|Withdrawal by Subject|13|||
129708976|NCT02629861|466896096|FG000|Overall Study|Protocol Violation|2|||
129708977|NCT02629861|466896097|FG001|Overall Study|Protocol Violation|3|||
129708978|NCT02629861|466896098|FG002|Overall Study|Protocol Violation|7|||
129708979|NCT02629861|466896096|FG000|Overall Study|Lost to Follow-up|12|||
129708980|NCT02629861|466896097|FG001|Overall Study|Lost to Follow-up|9|||
129708981|NCT02629861|466896098|FG002|Overall Study|Lost to Follow-up|4|||
129708982|NCT02629861|466896096|FG000|Overall Study|Other|1|||
129708983|NCT02629861|466896097|FG001|Overall Study|Other|1|||
129708984|NCT02629861|466896098|FG002|Overall Study|Other|0|||
129708985|NCT02629861|466896096|FG000|Overall Study|Pregnancy|2|||
129708986|NCT02629861|466896097|FG001|Overall Study|Pregnancy|1|||
129708987|NCT02629861|466896098|FG002|Overall Study|Pregnancy|0|||
129708988|NCT00907621|466896099|FG000|Overall Study|Lost to Follow-up|6|||
129708989|NCT00907621|466896100|FG001|Overall Study|Lost to Follow-up|3|||
129891230|NCT00801242|467559667|FG000|Overall Study|Protocol Violation|5|||
129891231|NCT00801242|467559667|FG000|Overall Study|Physician Decision|3|||
129891232|NCT00801242|467559667|FG000|Overall Study|Lost to Follow-up|1|||
129891233|NCT00801242|467559667|FG000|Overall Study|Miscellaneous reasons|20|||
129891234|NCT02015195|467559669|FG000|Overall Study|Adverse Event|0|||
129891235|NCT02015195|467559670|FG001|Overall Study|Adverse Event|0|||
129891236|NCT02015195|467559671|FG002|Overall Study|Adverse Event|0|||
129891237|NCT02015195|467559672|FG003|Overall Study|Adverse Event|1|||
129891238|NCT02015195|467559673|FG004|Overall Study|Adverse Event|0|||
129891239|NCT02015195|467559674|FG005|Overall Study|Adverse Event|0|||
129891240|NCT02015195|467559675|FG006|Overall Study|Adverse Event|0|||
129891241|NCT01318811|467559676|FG000|Overall Study|Physician Decision|1|||
129891242|NCT01318811|467559677|FG001|Overall Study|Physician Decision|1|||
129891243|NCT01318811|467559676|FG000|Overall Study|CRRT stopped for head CT|0|||
129891244|NCT01318811|467559677|FG001|Overall Study|CRRT stopped for head CT|1|||
129891245|NCT01318811|467559676|FG000|Overall Study|Death|0|||
129891246|NCT01318811|467559677|FG001|Overall Study|Death|1|||
129891247|NCT01318811|467559676|FG000|Overall Study|CRRT stopped for head MRI|0|||
129891248|NCT01318811|467559677|FG001|Overall Study|CRRT stopped for head MRI|1|||
129891249|NCT00811187|467559678|FG000|Overall Study|Unable to place device / procedure abort|3|||
129891250|NCT00811187|467559679|FG001|Overall Study|Unable to place device / procedure abort|3|||
129891251|NCT00131911|467559680|FG000|Overall Study|Withdrawal by Subject|1|||
129891252|NCT00131911|467559681|FG001|Overall Study|Withdrawal by Subject|0|||
129891253|NCT00329303|467559682|FG000|Overall Study|Lack of Efficacy|1|||
129891254|NCT00329303|467559683|FG001|Overall Study|Lack of Efficacy|0|||
129891255|NCT00329303|467559682|FG000|Overall Study|Decision of the sponsor|0|||
129891256|NCT00329303|467559683|FG001|Overall Study|Decision of the sponsor|1|||
129891257|NCT00329303|467559682|FG000|Overall Study|Patient no longer available|1|||
129891258|NCT00329303|467559683|FG001|Overall Study|Patient no longer available|0|||
129891259|NCT00329303|467559682|FG000|Overall Study|Patient relocated|0|||
129891260|NCT00329303|467559683|FG001|Overall Study|Patient relocated|1|||
129891261|NCT00994279|467559689|FG000|Overall Study|Withdrawal by Subject|2|||
129891262|NCT00994279|467559690|FG001|Overall Study|Withdrawal by Subject|2|||
129708990|NCT00907621|466896099|FG000|Overall Study|intercurrent febrile illness|1|||
129708991|NCT00907621|466896100|FG001|Overall Study|intercurrent febrile illness|1|||
129800484|NCT02556203|467238107|FG001|Overall Study|Lost to Follow-up|5|||
129800485|NCT02556203|467238106|FG000|Overall Study|Adverse Event|1|||
129800486|NCT02556203|467238107|FG001|Overall Study|Adverse Event|0|||
129891263|NCT00994279|467559689|FG000|Overall Study|Toxicity|1|||
129443776|NCT03872453|465925943|FG000|Overall Study|Adverse Event|1|||
129443777|NCT03872453|465925944|FG001|Overall Study|Adverse Event|1|||
129443778|NCT03872453|465925945|FG002|Overall Study|Adverse Event|0|||
129443779|NCT03872453|465925946|FG003|Overall Study|Adverse Event|0|||
129443780|NCT03872453|465925943|FG000|Overall Study|Lost to Follow-up|8|||
129443781|NCT03872453|465925944|FG001|Overall Study|Lost to Follow-up|7|||
129443782|NCT03872453|465925945|FG002|Overall Study|Lost to Follow-up|4|||
129443783|NCT03872453|465925946|FG003|Overall Study|Lost to Follow-up|4|||
129443784|NCT03872453|465925943|FG000|Overall Study|Never Treated Migraine|19|||
129443785|NCT03872453|465925944|FG001|Overall Study|Never Treated Migraine|17|||
129443786|NCT03872453|465925945|FG002|Overall Study|Never Treated Migraine|13|||
129443787|NCT03872453|465925946|FG003|Overall Study|Never Treated Migraine|12|||
129443788|NCT03872453|465925943|FG000|Overall Study|Pregnancy|1|||
129443789|NCT03872453|465925944|FG001|Overall Study|Pregnancy|0|||
129443790|NCT03872453|465925945|FG002|Overall Study|Pregnancy|0|||
129443791|NCT03872453|465925946|FG003|Overall Study|Pregnancy|0|||
129443792|NCT03872453|465925943|FG000|Overall Study|Protocol Deviation|2|||
129443793|NCT03872453|465925944|FG001|Overall Study|Protocol Deviation|0|||
129708992|NCT01816048|466896103|FG000|Overall Study|Adverse Event|1|||
129443794|NCT03872453|465925945|FG002|Overall Study|Protocol Deviation|0|||
129443795|NCT03872453|465925946|FG003|Overall Study|Protocol Deviation|2|||
129443796|NCT03872453|465925943|FG000|Overall Study|Withdrawal by Subject|0|||
129443797|NCT03872453|465925944|FG001|Overall Study|Withdrawal by Subject|1|||
129443798|NCT03872453|465925945|FG002|Overall Study|Withdrawal by Subject|2|||
129443799|NCT03872453|465925946|FG003|Overall Study|Withdrawal by Subject|0|||
129708993|NCT01816048|466896103|FG000|Overall Study|Death|1|||
129708994|NCT01816048|466896103|FG000|Overall Study|Withdrawal by Subject|1|||
129708995|NCT01816048|466896103|FG000|Overall Study|Disease Progression|3|||
129708996|NCT01088906|466896107|FG000|Overall Study|Inclusion error|1|||
129708997|NCT01088906|466896107|FG000|Overall Study|Did not receive study treatment|3|||
129443800|NCT03872453|465925943|FG000|Overall Study|Other Than Specified|1|||
129443801|NCT03872453|465925944|FG001|Overall Study|Other Than Specified|0|||
129443802|NCT03872453|465925945|FG002|Overall Study|Other Than Specified|0|||
129443803|NCT03872453|465925946|FG003|Overall Study|Other Than Specified|0|||
129443804|NCT00352885|465925947|FG000|Overall Study|Withdrawal by Subject|0|||
129443805|NCT00352885|465925948|FG001|Overall Study|Withdrawal by Subject|3|||
129443806|NCT00352885|465925947|FG000|Overall Study|Development of major depression|0|||
129443807|NCT00352885|465925948|FG001|Overall Study|Development of major depression|1|||
129443808|NCT00352885|465925947|FG000|Overall Study|Progression of metastatic melanoma|5|||
129443809|NCT00352885|465925948|FG001|Overall Study|Progression of metastatic melanoma|3|||
129443810|NCT00352885|465925947|FG000|Overall Study|Side effects of IL-2 administration|1|||
129443811|NCT00352885|465925948|FG001|Overall Study|Side effects of IL-2 administration|0|||
129443812|NCT03756350|465925950|FG000|Overall Study|Lost to Follow-up|1|||
129443813|NCT01131351|465925951|FG000|Overall Study|Adverse Event|0|||
129443814|NCT01131351|465925952|FG001|Overall Study|Adverse Event|2|||
129443815|NCT01131351|465925951|FG000|Overall Study|Protocol Deviation|0|||
129443816|NCT01131351|465925952|FG001|Overall Study|Protocol Deviation|1|||
129443817|NCT01423812|465925954|FG000|Overall Study|Lost to Follow-up|2|||
129443818|NCT01423812|465925955|FG001|Overall Study|Lost to Follow-up|2|||
129443819|NCT01423812|465925954|FG000|Overall Study|Withdrawal by Subject|1|||
129443820|NCT01423812|465925955|FG001|Overall Study|Withdrawal by Subject|2|||
129443821|NCT01179672|465925956|FG000|Overall Study|Adverse Event|17|||
129443822|NCT01179672|465925957|FG001|Overall Study|Adverse Event|8|||
129443823|NCT01179672|465925956|FG000|Overall Study|Withdrawal by Subject|10|||
129443824|NCT01179672|465925957|FG001|Overall Study|Withdrawal by Subject|12|||
129443825|NCT01179672|465925956|FG000|Overall Study|Entry Criteria Not Met|0|||
129443826|NCT01179672|465925957|FG001|Overall Study|Entry Criteria Not Met|2|||
129443827|NCT01179672|465925956|FG000|Overall Study|Lost to Follow-up|0|||
129443828|NCT01179672|465925957|FG001|Overall Study|Lost to Follow-up|1|||
129443829|NCT01179672|465925956|FG000|Overall Study|Protocol Violation|2|||
129443830|NCT01179672|465925957|FG001|Overall Study|Protocol Violation|2|||
129443831|NCT01179672|465925956|FG000|Overall Study|Physician Decision|1|||
129443832|NCT01179672|465925957|FG001|Overall Study|Physician Decision|1|||
129443833|NCT02748018|465925960|FG000|Study Period|Adverse Event|1|||
129443834|NCT02748018|465925961|FG001|Study Period|Adverse Event|3|||
129443835|NCT02748018|465925962|FG002|Study Period|Adverse Event|4|||
129443836|NCT02748018|465925963|FG003|Study Period|Adverse Event|0|||
129443837|NCT02748018|465925964|FG004|Study Period|Adverse Event|3|||
129443838|NCT02748018|465925965|FG005|Study Period|Adverse Event|3|||
129443839|NCT02748018|465925960|FG000|Study Period|Withdrawal by Subject|7|||
129443840|NCT02748018|465925961|FG001|Study Period|Withdrawal by Subject|4|||
129443841|NCT02748018|465925962|FG002|Study Period|Withdrawal by Subject|4|||
129443842|NCT02748018|465925963|FG003|Study Period|Withdrawal by Subject|11|||
129443843|NCT02748018|465925964|FG004|Study Period|Withdrawal by Subject|12|||
129443844|NCT02748018|465925965|FG005|Study Period|Withdrawal by Subject|10|||
129443845|NCT02748018|465925960|FG000|Study Period|Pregnancy|0|||
129443846|NCT02748018|465925961|FG001|Study Period|Pregnancy|1|||
129443847|NCT02748018|465925962|FG002|Study Period|Pregnancy|0|||
129443848|NCT02748018|465925963|FG003|Study Period|Pregnancy|0|||
129443849|NCT02748018|465925964|FG004|Study Period|Pregnancy|1|||
129443850|NCT02748018|465925965|FG005|Study Period|Pregnancy|0|||
129443851|NCT02748018|465925960|FG000|Study Period|Physician Decision|2|||
129443852|NCT02748018|465925961|FG001|Study Period|Physician Decision|2|||
129648483|NCT00741091|466668875|FG000|Overall Study|Death|13|||
129648484|NCT00741091|466668875|FG000|Overall Study|Lost to Follow-up|16|||
129648485|NCT00741091|466668875|FG000|Overall Study|Withdrawal by Subject|6|||
129443853|NCT02748018|465925962|FG002|Study Period|Physician Decision|1|||
129443854|NCT02748018|465925963|FG003|Study Period|Physician Decision|0|||
129648486|NCT00741091|466668875|FG000|Overall Study|Missed Visit|22|||
129648487|NCT01527487|466668878|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
129648488|NCT01527487|466668879|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
129648489|NCT01527487|466668878|FG000|Overall Study|Disease Progression|4|||
129648490|NCT01527487|466668879|FG001|Overall Study|Disease Progression|1|||
129648491|NCT01527487|466668878|FG000|Overall Study|Adverse Event|1|||
129648492|NCT01527487|466668879|FG001|Overall Study|Adverse Event|1|||
129648493|NCT01527487|466668878|FG000|Overall Study|Death|0|||
129648494|NCT01527487|466668879|FG001|Overall Study|Death|1|||
129648495|NCT00723190|466668881|FG000|Overall Study|Withdrawal by Subject|45|||
129648496|NCT00723190|466668881|FG000|Overall Study|Lost to Follow-up|37|||
129648497|NCT00723190|466668881|FG000|Overall Study|Adverse Event|18|||
129648498|NCT00723190|466668881|FG000|Overall Study|Lack of Efficacy|16|||
129648499|NCT00723190|466668881|FG000|Overall Study|Protocol Violation|15|||
129648500|NCT00723190|466668881|FG000|Overall Study|Other-Premature Discontinuation|9|||
129648501|NCT00723190|466668881|FG000|Overall Study|Other-Not included in safety population|2|||
129648502|NCT03181503|466668882|FG000|Overall Study|Adverse Event|2|||
129648503|NCT03181503|466668883|FG001|Overall Study|Adverse Event|2|||
129648504|NCT03181503|466668882|FG000|Overall Study|Protocol Violation|1|||
129648505|NCT03181503|466668883|FG001|Overall Study|Protocol Violation|0|||
129648506|NCT03181503|466668882|FG000|Overall Study|Withdrawal by Subject|3|||
129648507|NCT03181503|466668883|FG001|Overall Study|Withdrawal by Subject|0|||
129648508|NCT03181503|466668882|FG000|Overall Study|Lost to Follow-up|1|||
129648509|NCT03181503|466668883|FG001|Overall Study|Lost to Follow-up|1|||
129648510|NCT00597506|466668884|FG000|Overall Study|Subject is being followed for survival|1|||
129648511|NCT03199612|466668885|FG000|Overall Study|Adverse Event|1|||
129648512|NCT03199612|466668886|FG001|Overall Study|Adverse Event|0|||
129648513|NCT00081731|466668891|FG000|Overall Study|scientific integrity issue|8|||
129648514|NCT00081731|466668892|FG001|Overall Study|scientific integrity issue|8|||
129648515|NCT02386345|466668893|FG000|Overall Study|Not treated|14|||
129648516|NCT02386345|466668893|FG000|Overall Study|Lost to Follow-up|1|||
129648517|NCT02386345|466668893|FG000|Overall Study|Adverse Event|5|||
129648518|NCT02386345|466668893|FG000|Overall Study|Repeat Procedure|10|||
129648519|NCT02386345|466668893|FG000|Overall Study|Did not complete 12-month follow-up|72|||
129648520|NCT02258542|466668894|FG000|Overall Study|eg. not made to the visit|7|||
129648521|NCT02258542|466668895|FG001|Overall Study|eg. not made to the visit|4|||
129648522|NCT02258542|466668896|FG002|Overall Study|eg. not made to the visit|0|||
129648523|NCT02258542|466668897|FG003|Overall Study|eg. not made to the visit|1|||
129648524|NCT02258542|466668894|FG000|Overall Study|study specific discount. criteria|1|||
129648525|NCT02258542|466668895|FG001|Overall Study|study specific discount. criteria|1|||
129648526|NCT02258542|466668896|FG002|Overall Study|study specific discount. criteria|0|||
129648527|NCT02258542|466668897|FG003|Overall Study|study specific discount. criteria|0|||
129648528|NCT02258542|466668894|FG000|Overall Study|Withdrawal by Subject|20|||
129648529|NCT02258542|466668895|FG001|Overall Study|Withdrawal by Subject|20|||
129648530|NCT02258542|466668896|FG002|Overall Study|Withdrawal by Subject|7|||
129648531|NCT02258542|466668897|FG003|Overall Study|Withdrawal by Subject|1|||
129648532|NCT02258542|466668894|FG000|Overall Study|Lost to Follow-up|5|||
129648533|NCT02258542|466668895|FG001|Overall Study|Lost to Follow-up|12|||
129648534|NCT02258542|466668896|FG002|Overall Study|Lost to Follow-up|1|||
129648535|NCT02258542|466668897|FG003|Overall Study|Lost to Follow-up|2|||
129648536|NCT02258542|466668894|FG000|Overall Study|Death|5|||
129648537|NCT02258542|466668895|FG001|Overall Study|Death|4|||
129648538|NCT02258542|466668896|FG002|Overall Study|Death|0|||
129648539|NCT02258542|466668897|FG003|Overall Study|Death|1|||
129648540|NCT02258542|466668894|FG000|Overall Study|Adverse Event|3|||
129708998|NCT01088906|466896107|FG000|Overall Study|Missing data|1|||
129443855|NCT02748018|465925964|FG004|Study Period|Physician Decision|2|||
129443856|NCT02748018|465925965|FG005|Study Period|Physician Decision|0|||
129443857|NCT02748018|465925960|FG000|Study Period|Lost to Follow-up|0|||
129648541|NCT02258542|466668895|FG001|Overall Study|Adverse Event|4|||
129648542|NCT02258542|466668896|FG002|Overall Study|Adverse Event|0|||
129648543|NCT02258542|466668897|FG003|Overall Study|Adverse Event|0|||
129648544|NCT02258542|466668894|FG000|Overall Study|Protocol Violation|1|||
129648545|NCT02258542|466668895|FG001|Overall Study|Protocol Violation|2|||
129648546|NCT02258542|466668896|FG002|Overall Study|Protocol Violation|0|||
129443858|NCT02748018|465925961|FG001|Study Period|Lost to Follow-up|0|||
129648547|NCT02258542|466668897|FG003|Overall Study|Protocol Violation|0|||
129648548|NCT02258542|466668894|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129648549|NCT02258542|466668895|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
129443859|NCT02748018|465925962|FG002|Study Period|Lost to Follow-up|0|||
129708999|NCT00457626|466896108|FG000|Overall Study|Adverse Event|3|||
129709000|NCT00457626|466896108|FG000|Overall Study|Administrative Problems|2|||
129709001|NCT00457626|466896108|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
129709002|NCT03384875|466896109|FG000|Overall Study|Death|1|||
129709003|NCT03384875|466896110|FG001|Overall Study|Death|1|||
129709004|NCT03384875|466896111|FG002|Overall Study|Death|0|||
129709005|NCT03384875|466896109|FG000|Overall Study|Reason not provided|1|||
129709006|NCT03384875|466896110|FG001|Overall Study|Reason not provided|0|||
129800487|NCT04587271|467238108|FG000|Overall Study|Lost to Follow-up|2|||
129443860|NCT02748018|465925963|FG003|Study Period|Lost to Follow-up|2|||
129443861|NCT02748018|465925964|FG004|Study Period|Lost to Follow-up|0|||
129443862|NCT02748018|465925965|FG005|Study Period|Lost to Follow-up|1|||
129443863|NCT02748018|465925960|FG000|Continuation Period|Adverse Event|2|||
129443864|NCT02748018|465925961|FG001|Continuation Period|Adverse Event|0|||
129443865|NCT02748018|465925962|FG002|Continuation Period|Adverse Event|1|||
129443866|NCT02748018|465925963|FG003|Continuation Period|Adverse Event|1|||
129443867|NCT02748018|465925964|FG004|Continuation Period|Adverse Event|1|||
129443868|NCT02748018|465925965|FG005|Continuation Period|Adverse Event|4|||
129443869|NCT02748018|465925960|FG000|Continuation Period|Withdrawal by Subject|3|||
129443870|NCT02748018|465925961|FG001|Continuation Period|Withdrawal by Subject|5|||
129443871|NCT02748018|465925962|FG002|Continuation Period|Withdrawal by Subject|3|||
129443872|NCT02748018|465925963|FG003|Continuation Period|Withdrawal by Subject|9|||
129709007|NCT03384875|466896111|FG002|Overall Study|Reason not provided|0|||
129709008|NCT03549338|466898310|FG000|Overall Study|Progressive Disease|1|||
129709009|NCT03549338|466898311|FG001|Overall Study|Progressive Disease|0|||
129709010|NCT03549338|466898312|FG002|Overall Study|Progressive Disease|0|||
129443873|NCT02748018|465925964|FG004|Continuation Period|Withdrawal by Subject|11|||
129443874|NCT02748018|465925965|FG005|Continuation Period|Withdrawal by Subject|1|||
129443875|NCT02748018|465925960|FG000|Continuation Period|Lost to Follow-up|0|||
129443876|NCT02748018|465925961|FG001|Continuation Period|Lost to Follow-up|2|||
129443877|NCT02748018|465925962|FG002|Continuation Period|Lost to Follow-up|1|||
129443878|NCT02748018|465925963|FG003|Continuation Period|Lost to Follow-up|0|||
129443879|NCT02748018|465925964|FG004|Continuation Period|Lost to Follow-up|1|||
129443880|NCT02748018|465925965|FG005|Continuation Period|Lost to Follow-up|0|||
129443881|NCT02748018|465925960|FG000|Continuation Period|Pregnancy|1|||
129443882|NCT02748018|465925961|FG001|Continuation Period|Pregnancy|2|||
129443883|NCT02748018|465925962|FG002|Continuation Period|Pregnancy|0|||
129443884|NCT02748018|465925963|FG003|Continuation Period|Pregnancy|0|||
129443885|NCT02748018|465925964|FG004|Continuation Period|Pregnancy|0|||
129443886|NCT02748018|465925965|FG005|Continuation Period|Pregnancy|0|||
129443887|NCT02748018|465925960|FG000|Continuation Period|Physician Decision|0|||
129443888|NCT02748018|465925961|FG001|Continuation Period|Physician Decision|1|||
129443889|NCT02748018|465925962|FG002|Continuation Period|Physician Decision|2|||
129443890|NCT02748018|465925963|FG003|Continuation Period|Physician Decision|0|||
129443891|NCT02748018|465925964|FG004|Continuation Period|Physician Decision|2|||
129443892|NCT02748018|465925965|FG005|Continuation Period|Physician Decision|1|||
129443893|NCT02748018|465925960|FG000|Continuation Period|Protocol Violation|0|||
129443894|NCT02748018|465925961|FG001|Continuation Period|Protocol Violation|1|||
129709011|NCT03549338|466898310|FG000|Overall Study|Clinical Progression|0|||
129443895|NCT02748018|465925962|FG002|Continuation Period|Protocol Violation|0|||
129443896|NCT02748018|465925963|FG003|Continuation Period|Protocol Violation|0|||
129443897|NCT02748018|465925964|FG004|Continuation Period|Protocol Violation|0|||
129443898|NCT02748018|465925965|FG005|Continuation Period|Protocol Violation|0|||
129709012|NCT03549338|466898311|FG001|Overall Study|Clinical Progression|1|||
129709013|NCT03549338|466898312|FG002|Overall Study|Clinical Progression|0|||
129709014|NCT01944020|466898314|FG000|Overall Study|Withdrawal by Subject|5|||
129709015|NCT01944020|466898315|FG001|Overall Study|Withdrawal by Subject|0|||
129709016|NCT03257358|466898320|FG000|Overall Study|Adverse Event|25|||
129709017|NCT03257358|466898321|FG001|Overall Study|Adverse Event|12|||
129709018|NCT03257358|466898320|FG000|Overall Study|Lack of Efficacy|1|||
129709019|NCT03257358|466898321|FG001|Overall Study|Lack of Efficacy|1|||
129709020|NCT03257358|466898320|FG000|Overall Study|Lost to Follow-up|12|||
129709021|NCT03257358|466898321|FG001|Overall Study|Lost to Follow-up|4|||
129709022|NCT03257358|466898320|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
129709023|NCT03257358|466898321|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
129709024|NCT03257358|466898320|FG000|Overall Study|Physician Decision|2|||
129709025|NCT03257358|466898321|FG001|Overall Study|Physician Decision|2|||
129709026|NCT03257358|466898320|FG000|Overall Study|Protocol Violation|5|||
129709027|NCT03257358|466898321|FG001|Overall Study|Protocol Violation|3|||
129709028|NCT03257358|466898320|FG000|Overall Study|Technical problems|4|||
129709029|NCT03257358|466898321|FG001|Overall Study|Technical problems|1|||
129709030|NCT03257358|466898320|FG000|Overall Study|Withdrawal by Subject|8|||
129709031|NCT03257358|466898321|FG001|Overall Study|Withdrawal by Subject|3|||
129709032|NCT03257358|466898320|FG000|Overall Study|Withdrawal of informed consent|9|||
129709033|NCT03257358|466898321|FG001|Overall Study|Withdrawal of informed consent|5|||
129709034|NCT03257358|466898320|FG000|Overall Study|New therapy for study indication|1|||
129709035|NCT03257358|466898321|FG001|Overall Study|New therapy for study indication|0|||
129709036|NCT03257358|466898320|FG000|Overall Study|No longer requires treatment|0|||
129709037|NCT03257358|466898321|FG001|Overall Study|No longer requires treatment|1|||
129709038|NCT01977898|466898322|FG000|Overall Study|Non functioning catheter|1|||
129709039|NCT01977898|466898323|FG001|Overall Study|Non functioning catheter|1|||
129709040|NCT01049373|466898324|FG000|Overall Study|Protocol Violation|9|||
129709041|NCT01049373|466898325|FG001|Overall Study|Protocol Violation|9|||
129709042|NCT01049373|466898324|FG000|Overall Study|Withdrawal by Subject|8|||
129709043|NCT01049373|466898325|FG001|Overall Study|Withdrawal by Subject|5|||
129709044|NCT01049373|466898324|FG000|Overall Study|Adverse Event|3|||
129709045|NCT01049373|466898325|FG001|Overall Study|Adverse Event|3|||
129709046|NCT01049373|466898324|FG000|Overall Study|Lost to Follow-up|9|||
129800488|NCT04587271|467238109|FG001|Overall Study|Lost to Follow-up|2|||
129800489|NCT04587271|467238110|FG002|Overall Study|Lost to Follow-up|0|||
129709047|NCT01049373|466898325|FG001|Overall Study|Lost to Follow-up|4|||
129709048|NCT01049373|466898324|FG000|Overall Study|no evaluable study values|9|||
129709049|NCT01049373|466898325|FG001|Overall Study|no evaluable study values|21|||
129709050|NCT01049373|466898324|FG000|Overall Study|Other|1|||
129709051|NCT01049373|466898325|FG001|Overall Study|Other|1|||
129709052|NCT01049373|466898324|FG000|Overall Study|Non-cooperation|0|||
129709053|NCT01049373|466898325|FG001|Overall Study|Non-cooperation|1|||
129800490|NCT04587271|467238111|FG003|Overall Study|Lost to Follow-up|2|||
129800491|NCT04587271|467238112|FG004|Overall Study|Lost to Follow-up|2|||
129648550|NCT02258542|466668896|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129648551|NCT02258542|466668897|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
129648552|NCT00514904|466668912|FG000|Overall Study|Withdrawal by Subject|3|||
129648553|NCT00514904|466668913|FG001|Overall Study|Withdrawal by Subject|2|||
129648554|NCT00514904|466668912|FG000|Overall Study|Lost to Follow-up|21|||
129648555|NCT00514904|466668913|FG001|Overall Study|Lost to Follow-up|3|||
129648556|NCT02417961|466669905|FG000|Overall Study|Adverse Event|1|||
129648557|NCT02417961|466669905|FG000|Overall Study|Lost to Follow-up|1|||
129648558|NCT02417961|466669905|FG000|Overall Study|Withdrawal by Subject|2|||
129648559|NCT03197467|466669908|FG000|Overall Study|Withdrawal by Subject|1|||
129648560|NCT03666533|466669910|FG000|Overall Study|Lost to Follow-up|2|||
129648561|NCT03666533|466669911|FG001|Overall Study|Lost to Follow-up|2|||
129648562|NCT04392167|466669928|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
129648563|NCT04063657|466669930|FG000|Overall Study|Lost to Follow-up|1|||
129648564|NCT04063657|466669931|FG001|Overall Study|Lost to Follow-up|0|||
129648565|NCT03408444|466669932|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
129648566|NCT03408444|466669933|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129648567|NCT03408444|466669934|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129648568|NCT03408444|466669935|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
129648569|NCT03408444|466669932|FG000|Overall Study|Lens Discomfort|0|||
129648570|NCT03408444|466669933|FG001|Overall Study|Lens Discomfort|1|||
129648571|NCT03408444|466669934|FG002|Overall Study|Lens Discomfort|0|||
129648572|NCT03408444|466669935|FG003|Overall Study|Lens Discomfort|0|||
129648573|NCT03408444|466669932|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
129648574|NCT03408444|466669933|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
129648575|NCT03408444|466669934|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
129648576|NCT03408444|466669935|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
129648577|NCT03408444|466669932|FG000|Overall Study|Withdrawal by Subject|0|||
129648578|NCT03408444|466669933|FG001|Overall Study|Withdrawal by Subject|2|||
129648579|NCT03408444|466669934|FG002|Overall Study|Withdrawal by Subject|3|||
129648580|NCT03408444|466669935|FG003|Overall Study|Withdrawal by Subject|0|||
129648581|NCT03408444|466669932|FG000|Overall Study|Lost to Follow-up|0|||
129648582|NCT03408444|466669933|FG001|Overall Study|Lost to Follow-up|0|||
129648583|NCT03408444|466669934|FG002|Overall Study|Lost to Follow-up|1|||
129648584|NCT03408444|466669935|FG003|Overall Study|Lost to Follow-up|0|||
129648585|NCT03408444|466669932|FG000|Overall Study|Adverse Event|0|||
129648586|NCT03408444|466669933|FG001|Overall Study|Adverse Event|0|||
129648587|NCT03408444|466669934|FG002|Overall Study|Adverse Event|0|||
129709054|NCT02391311|466898326|FG000|Overall Study|Lost to Follow-up|2|||
129648588|NCT03408444|466669935|FG003|Overall Study|Adverse Event|1|||
129648589|NCT03408444|466669932|FG000|Overall Study|Lens Handling Difficulties|0|||
129709055|NCT02391311|466898327|FG001|Overall Study|Lost to Follow-up|1|||
129648590|NCT03408444|466669933|FG001|Overall Study|Lens Handling Difficulties|0|||
129648591|NCT03408444|466669934|FG002|Overall Study|Lens Handling Difficulties|1|||
129648592|NCT03408444|466669935|FG003|Overall Study|Lens Handling Difficulties|0|||
129648593|NCT03408444|466669932|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
129648594|NCT03408444|466669933|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
129648595|NCT03408444|466669934|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
129709056|NCT02391311|466898326|FG000|Overall Study|deemed ineligible after baseline|1|||
129800492|NCT04587271|467238113|FG005|Overall Study|Lost to Follow-up|0|||
129443899|NCT01233869|465925966|FG000|Initial Treatment Period (24 Months)|Death|1|||
129443900|NCT01233869|465925967|FG001|Initial Treatment Period (24 Months)|Death|0|||
129443901|NCT01233869|465925968|FG002|Initial Treatment Period (24 Months)|Death|0|||
129443902|NCT01233869|465925969|FG003|Initial Treatment Period (24 Months)|Death|0|||
129443903|NCT01233869|465925966|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
129443904|NCT01233869|465925967|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
129443905|NCT01233869|465925968|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
129443906|NCT01233869|465925969|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
129443907|NCT01233869|465925966|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
129443908|NCT01233869|465925967|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
129443909|NCT01233869|465925968|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
129443910|NCT01233869|465925969|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
129443911|NCT01233869|465925966|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
129443912|NCT01233869|465925967|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
129443913|NCT01233869|465925968|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
129443914|NCT01233869|465925969|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
129443915|NCT01233869|465925966|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
129443916|NCT01233869|465925967|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
129443917|NCT01233869|465925968|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
129443918|NCT01233869|465925969|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
129443919|NCT01233869|465925966|FG000|Extended Treatment Period (46 Months)|Other|3|||
129443920|NCT01233869|465925967|FG001|Extended Treatment Period (46 Months)|Other|0|||
129443921|NCT01233869|465925968|FG002|Extended Treatment Period (46 Months)|Other|0|||
129443922|NCT01233869|465925969|FG003|Extended Treatment Period (46 Months)|Other|3|||
129443923|NCT01233869|465925966|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
129443924|NCT01233869|465925967|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
129443925|NCT01233869|465925968|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
129443926|NCT01233869|465925969|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
129443927|NCT00537485|465925970|FG000|Overall Study|Adverse Event|10|||
129443928|NCT00537485|465925971|FG001|Overall Study|Adverse Event|5|||
129443929|NCT00537485|465925970|FG000|Overall Study|Withdrawal by Subject|3|||
129443930|NCT00537485|465925971|FG001|Overall Study|Withdrawal by Subject|2|||
129443931|NCT00537485|465925970|FG000|Overall Study|Withdrawal by Subject|1|||
129443932|NCT00537485|465925971|FG001|Overall Study|Withdrawal by Subject|3|||
129443933|NCT00537485|465925970|FG000|Overall Study|Physician Decision|1|||
129443934|NCT00537485|465925971|FG001|Overall Study|Physician Decision|0|||
129443935|NCT05696236|465925981|FG000|Overall Study|Lost to Follow-up|1|||
129443936|NCT05696236|465925982|FG001|Overall Study|Lost to Follow-up|0|||
129443937|NCT05696236|465925981|FG000|Overall Study|Later determined to not be eligible for participation|0|||
129443938|NCT05696236|465925982|FG001|Overall Study|Later determined to not be eligible for participation|1|||
129443939|NCT05696236|465925981|FG000|Overall Study|Withdrawal by Subject|2|||
129443940|NCT05696236|465925982|FG001|Overall Study|Withdrawal by Subject|2|||
129443941|NCT01145495|465925985|FG000|Overall Study|Adverse Event|6|||
129443942|NCT01145495|465925985|FG000|Overall Study|Withdrawal by Subject|6|||
129443943|NCT01145495|465925985|FG000|Overall Study|Disease progression after respone|2|||
129443944|NCT00312221|465925986|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
129443945|NCT00312221|465925987|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
129443946|NCT00312221|465925988|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
129443947|NCT00312221|465925989|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
129443948|NCT00312221|465925986|FG000|Open-label Run-in Period|Adverse Event|74|||
129443949|NCT00312221|465925987|FG001|Open-label Run-in Period|Adverse Event|0|||
129709057|NCT02391311|466898327|FG001|Overall Study|deemed ineligible after baseline|1|||
129443950|NCT00312221|465925988|FG002|Open-label Run-in Period|Adverse Event|0|||
129443951|NCT00312221|465925989|FG003|Open-label Run-in Period|Adverse Event|0|||
129443952|NCT00312221|465925986|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
129443953|NCT00312221|465925987|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
129443954|NCT00312221|465925988|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
129443955|NCT00312221|465925989|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
129443956|NCT00312221|465925986|FG000|Open-label Run-in Period|Administrative|42|||
129443957|NCT00312221|465925987|FG001|Open-label Run-in Period|Administrative|0|||
129443958|NCT00312221|465925988|FG002|Open-label Run-in Period|Administrative|0|||
129443959|NCT00312221|465925989|FG003|Open-label Run-in Period|Administrative|0|||
129443960|NCT00312221|465925986|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
129443961|NCT00312221|465925987|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
129443962|NCT00312221|465925988|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
129443963|NCT00312221|465925989|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
129443964|NCT00312221|465925986|FG000|Open-label Run-in Period|Did not qualify|5|||
129443965|NCT00312221|465925987|FG001|Open-label Run-in Period|Did not qualify|0|||
129443966|NCT00312221|465925988|FG002|Open-label Run-in Period|Did not qualify|0|||
129443967|NCT00312221|465925989|FG003|Open-label Run-in Period|Did not qualify|0|||
129443968|NCT00312221|465925986|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129443969|NCT00312221|465925987|FG001|Double-blind Phase|Withdrawal by Subject|6|||
129443970|NCT00312221|465925988|FG002|Double-blind Phase|Withdrawal by Subject|8|||
129443971|NCT00312221|465925989|FG003|Double-blind Phase|Withdrawal by Subject|7|||
129443972|NCT00312221|465925986|FG000|Double-blind Phase|Adverse Event|0|||
129443973|NCT00312221|465925987|FG001|Double-blind Phase|Adverse Event|10|||
129443974|NCT00312221|465925988|FG002|Double-blind Phase|Adverse Event|19|||
129443975|NCT00312221|465925989|FG003|Double-blind Phase|Adverse Event|18|||
129443976|NCT00312221|465925986|FG000|Double-blind Phase|Lost to Follow-up|0|||
129443977|NCT00312221|465925987|FG001|Double-blind Phase|Lost to Follow-up|0|||
129443978|NCT00312221|465925988|FG002|Double-blind Phase|Lost to Follow-up|2|||
129443979|NCT00312221|465925989|FG003|Double-blind Phase|Lost to Follow-up|2|||
129443980|NCT00312221|465925986|FG000|Double-blind Phase|Administrative|0|||
129443981|NCT00312221|465925987|FG001|Double-blind Phase|Administrative|26|||
129443982|NCT00312221|465925988|FG002|Double-blind Phase|Administrative|37|||
129443983|NCT00312221|465925989|FG003|Double-blind Phase|Administrative|33|||
129443984|NCT00312221|465925986|FG000|Double-blind Phase|Lack of Efficacy|0|||
129443985|NCT00312221|465925987|FG001|Double-blind Phase|Lack of Efficacy|17|||
129443986|NCT00312221|465925988|FG002|Double-blind Phase|Lack of Efficacy|6|||
129443987|NCT00312221|465925989|FG003|Double-blind Phase|Lack of Efficacy|10|||
129443988|NCT02060721|465925990|FG000|Overall Study|Lost to Follow-up|1|||
129443989|NCT02060721|465925990|FG000|Overall Study|Physician Decision|2|||
129443990|NCT02060721|465925990|FG000|Overall Study|Death|14|||
129443991|NCT02060721|465925990|FG000|Overall Study|Withdrawal by Subject|2|||
129443992|NCT02060721|465925990|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
129443993|NCT00117507|465925991|FG000|Overall Study|Adverse Event|4|||
129443994|NCT00117507|465925991|FG000|Overall Study|Abnormal laboratory values|3|||
129443995|NCT00117507|465925991|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129443996|NCT00117507|465925991|FG000|Overall Study|Patient withdrew consent|4|||
129443997|NCT00117507|465925991|FG000|Overall Study|Death|3|||
129443998|NCT05105789|465925992|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
129443999|NCT01003990|465925995|FG000|Overall Study|Adverse Event|8|||
129444000|NCT01003990|465925996|FG001|Overall Study|Adverse Event|5|||
129444001|NCT01003990|465925997|FG002|Overall Study|Adverse Event|11|||
129444002|NCT01003990|465925995|FG000|Overall Study|Death|0|||
129444003|NCT01003990|465925996|FG001|Overall Study|Death|8|||
129444004|NCT01003990|465925997|FG002|Overall Study|Death|1|||
129444005|NCT01003990|465925995|FG000|Overall Study|Lack of Efficacy|10|||
129444006|NCT01003990|465925996|FG001|Overall Study|Lack of Efficacy|2|||
129444007|NCT01003990|465925997|FG002|Overall Study|Lack of Efficacy|3|||
129444008|NCT01003990|465925995|FG000|Overall Study|Lost to Follow-up|30|||
129444009|NCT01003990|465925996|FG001|Overall Study|Lost to Follow-up|12|||
129444010|NCT01003990|465925997|FG002|Overall Study|Lost to Follow-up|7|||
129444011|NCT01003990|465925995|FG000|Overall Study|Reasons Not Identified|14|||
129444012|NCT01003990|465925996|FG001|Overall Study|Reasons Not Identified|13|||
129444013|NCT01003990|465925997|FG002|Overall Study|Reasons Not Identified|8|||
129444014|NCT01003990|465925995|FG000|Overall Study|Poor/Non-compliance|4|||
129444015|NCT01003990|465925996|FG001|Overall Study|Poor/Non-compliance|3|||
129444016|NCT01003990|465925997|FG002|Overall Study|Poor/Non-compliance|2|||
129444017|NCT01003990|465925995|FG000|Overall Study|Pregnancy|10|||
129444018|NCT01003990|465925996|FG001|Overall Study|Pregnancy|2|||
129444019|NCT01003990|465925997|FG002|Overall Study|Pregnancy|4|||
129800493|NCT04587271|467238108|FG000|Overall Study|Caregiver brought child to visits|0|||
129800494|NCT04587271|467238109|FG001|Overall Study|Caregiver brought child to visits|0|||
129800495|NCT04587271|467238110|FG002|Overall Study|Caregiver brought child to visits|0|||
129444020|NCT01003990|465925995|FG000|Overall Study|No Longer Met Study Criteria|4|||
129444021|NCT01003990|465925996|FG001|Overall Study|No Longer Met Study Criteria|1|||
129444022|NCT01003990|465925997|FG002|Overall Study|No Longer Met Study Criteria|0|||
129444023|NCT01003990|465925995|FG000|Overall Study|Subject Withdrew Consent|12|||
129800496|NCT04587271|467238111|FG003|Overall Study|Caregiver brought child to visits|1|||
129800497|NCT04587271|467238112|FG004|Overall Study|Caregiver brought child to visits|0|||
129800498|NCT04587271|467238113|FG005|Overall Study|Caregiver brought child to visits|0|||
129800499|NCT02180165|467238119|FG000|Overall Study|Not Treated|0|||
129800500|NCT02180165|467238120|FG001|Overall Study|Not Treated|0|||
129800501|NCT02180165|467238121|FG002|Overall Study|Not Treated|1|||
129800502|NCT02180165|467238122|FG003|Overall Study|Not Treated|0|||
129800503|NCT02180165|467238119|FG000|Overall Study|Adverse Event|7|||
129800504|NCT02180165|467238120|FG001|Overall Study|Adverse Event|0|||
129800505|NCT02180165|467238121|FG002|Overall Study|Adverse Event|18|||
129800506|NCT02180165|467238122|FG003|Overall Study|Adverse Event|3|||
129800507|NCT02180165|467238119|FG000|Overall Study|Lack of Efficacy|0|||
129800508|NCT02180165|467238120|FG001|Overall Study|Lack of Efficacy|1|||
129800509|NCT02180165|467238121|FG002|Overall Study|Lack of Efficacy|3|||
129800510|NCT02180165|467238122|FG003|Overall Study|Lack of Efficacy|2|||
129800511|NCT02180165|467238119|FG000|Overall Study|Physician Decision|1|||
129800512|NCT02180165|467238120|FG001|Overall Study|Physician Decision|0|||
129800513|NCT02180165|467238121|FG002|Overall Study|Physician Decision|5|||
129800514|NCT02180165|467238122|FG003|Overall Study|Physician Decision|0|||
129800515|NCT02180165|467238119|FG000|Overall Study|Withdrawal by Subject|3|||
129800516|NCT02180165|467238120|FG001|Overall Study|Withdrawal by Subject|0|||
129800517|NCT02180165|467238121|FG002|Overall Study|Withdrawal by Subject|2|||
129800518|NCT02180165|467238122|FG003|Overall Study|Withdrawal by Subject|1|||
129800519|NCT05246397|467238123|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
129800520|NCT02943460|467238124|FG000|Blinded Study Phase|Adverse Event|3|||
129800521|NCT02943460|467238125|FG001|Blinded Study Phase|Adverse Event|0|||
129800522|NCT02943460|467238126|FG002|Blinded Study Phase|Adverse Event|0|||
129800523|NCT02943460|467238124|FG000|Blinded Study Phase|Withdrew Consent|0|||
129800524|NCT02943460|467238125|FG001|Blinded Study Phase|Withdrew Consent|1|||
129800525|NCT02943460|467238126|FG002|Blinded Study Phase|Withdrew Consent|0|||
129800526|NCT02943460|467238124|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
129800527|NCT02943460|467238125|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
129800528|NCT02943460|467238126|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
129800529|NCT02943460|467238124|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
129800530|NCT02943460|467238125|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
129800531|NCT02943460|467238126|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
129800532|NCT02943460|467238124|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
129800533|NCT02943460|467238125|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
129800534|NCT02943460|467238126|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
129800535|NCT03875768|467238127|FG000|Overall Study|Lost to Follow-up|16|||
129800536|NCT03875768|467238128|FG001|Overall Study|Lost to Follow-up|13|||
129800537|NCT03875768|467238127|FG000|Overall Study|Withdrawal by Subject|10|||
129800538|NCT03875768|467238128|FG001|Overall Study|Withdrawal by Subject|21|||
129800539|NCT03875768|467238127|FG000|Overall Study|Did not complete assessment|21|||
129800540|NCT03875768|467238128|FG001|Overall Study|Did not complete assessment|12|||
129800541|NCT03875768|467238127|FG000|Overall Study|Became ineligible|1|||
129800542|NCT03875768|467238128|FG001|Overall Study|Became ineligible|0|||
129800543|NCT01925274|467238129|FG000|Overall Study|Death|1|||
129800544|NCT01925274|467238130|FG001|Overall Study|Death|0|||
129891264|NCT00994279|467559690|FG001|Overall Study|Toxicity|0|||
129800545|NCT01925274|467238131|FG002|Overall Study|Death|0|||
129800546|NCT01925274|467238129|FG000|Overall Study|Lost to Follow-up|0|||
129800547|NCT01925274|467238130|FG001|Overall Study|Lost to Follow-up|1|||
129800548|NCT01925274|467238131|FG002|Overall Study|Lost to Follow-up|0|||
129800549|NCT01925274|467238129|FG000|Overall Study|Withdrawal by Subject|1|||
129800550|NCT01925274|467238130|FG001|Overall Study|Withdrawal by Subject|2|||
129800551|NCT01925274|467238131|FG002|Overall Study|Withdrawal by Subject|0|||
129800552|NCT01925274|467238129|FG000|Overall Study|Study terminated by sponsor|4|||
129800553|NCT01925274|467238130|FG001|Overall Study|Study terminated by sponsor|0|||
129800554|NCT01925274|467238131|FG002|Overall Study|Study terminated by sponsor|0|||
129800555|NCT01925274|467238129|FG000|Overall Study|Protocol amendment|1|||
129800556|NCT01925274|467238130|FG001|Overall Study|Protocol amendment|3|||
129800557|NCT01925274|467238131|FG002|Overall Study|Protocol amendment|6|||
129800558|NCT01031381|467238134|FG000|Overall Study|Physician Decision|3|||
129800559|NCT01031381|467238134|FG000|Overall Study|Withdrawal by Subject|6|||
129891265|NCT00994279|467559689|FG000|Overall Study|Multiple reasons|1|||
129800560|NCT00723398|467238135|FG000|Overall Study|Withdrawal by Subject|2|||
129800561|NCT00723398|467238136|FG001|Overall Study|Withdrawal by Subject|6|||
129800562|NCT00723398|467238137|FG002|Overall Study|Withdrawal by Subject|4|||
129800563|NCT00723398|467238138|FG003|Overall Study|Withdrawal by Subject|4|||
129444024|NCT01003990|465925996|FG001|Overall Study|Subject Withdrew Consent|5|||
129444025|NCT01003990|465925997|FG002|Overall Study|Subject Withdrew Consent|7|||
129444026|NCT00634010|465926003|FG000|Overall Study|Adverse Event|2|||
129444027|NCT00634010|465926004|FG001|Overall Study|Adverse Event|5|||
129444028|NCT00634010|465926003|FG000|Overall Study|Withdrawal by Subject|5|||
129444029|NCT00634010|465926004|FG001|Overall Study|Withdrawal by Subject|6|||
129444030|NCT00634010|465926003|FG000|Overall Study|Physician Decision|1|||
129444031|NCT00634010|465926004|FG001|Overall Study|Physician Decision|1|||
129648596|NCT03408444|466669935|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
129648597|NCT04984681|466669936|FG000|Overall Study|Lost to Follow-up|3|||
129648598|NCT04984681|466669937|FG001|Overall Study|Lost to Follow-up|1|||
129648599|NCT01473394|466669940|FG000|Overall Study|Adverse Event|13|||
129648600|NCT01473394|466669941|FG001|Overall Study|Adverse Event|16|||
129648601|NCT01473394|466669940|FG000|Overall Study|Insufficient Therapeutic Response|4|||
129648602|NCT01473394|466669941|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129648603|NCT01473394|466669940|FG000|Overall Study|Protocol Violation|7|||
129648604|NCT01473394|466669941|FG001|Overall Study|Protocol Violation|5|||
129648605|NCT01473394|466669940|FG000|Overall Study|Withdrew Consent|12|||
129648606|NCT01473394|466669941|FG001|Overall Study|Withdrew Consent|10|||
129648607|NCT01473394|466669940|FG000|Overall Study|Lost to Follow-up|9|||
129648608|NCT01473394|466669941|FG001|Overall Study|Lost to Follow-up|11|||
129648609|NCT01482962|466669944|FG000|Overall Study|Progressive Disease|65|||
129648610|NCT01482962|466669945|FG001|Overall Study|Progressive Disease|53|||
129648611|NCT01482962|466669944|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
129648612|NCT01482962|466669945|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
129648613|NCT01482962|466669944|FG000|Overall Study|Adverse Event|18|||
129648614|NCT01482962|466669945|FG001|Overall Study|Adverse Event|22|||
129648615|NCT01482962|466669944|FG000|Overall Study|Withdrawal by Participant|8|||
129648616|NCT01482962|466669945|FG001|Overall Study|Withdrawal by Participant|13|||
129648617|NCT01482962|466669944|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
129648618|NCT01482962|466669945|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
129648619|NCT01482962|466669944|FG000|Overall Study|Other Reason|1|||
129648620|NCT01482962|466669945|FG001|Overall Study|Other Reason|5|||
129648621|NCT01482962|466669944|FG000|Overall Study|Study Terminated by Sponsor|5|||
129648622|NCT01482962|466669945|FG001|Overall Study|Study Terminated by Sponsor|2|||
129648623|NCT01482962|466669944|FG000|Overall Study|Did not Receive Study Drug|1|||
129648624|NCT01482962|466669945|FG001|Overall Study|Did not Receive Study Drug|6|||
129648625|NCT00250458|466669949|FG000|Overall Study|Lost to Follow-up|4|||
129648626|NCT00250458|466669950|FG001|Overall Study|Lost to Follow-up|2|||
129648627|NCT00250458|466669949|FG000|Overall Study|Protocol Violation|0|||
129648628|NCT00250458|466669950|FG001|Overall Study|Protocol Violation|1|||
129800564|NCT00723398|467238139|FG004|Overall Study|Withdrawal by Subject|4|||
129800565|NCT00723398|467238135|FG000|Overall Study|Protocol Violation|2|||
129800566|NCT00723398|467238136|FG001|Overall Study|Protocol Violation|1|||
129800567|NCT00723398|467238137|FG002|Overall Study|Protocol Violation|5|||
129800568|NCT00723398|467238138|FG003|Overall Study|Protocol Violation|0|||
129800569|NCT00723398|467238139|FG004|Overall Study|Protocol Violation|0|||
129800570|NCT00723398|467238135|FG000|Overall Study|Physician Decision|2|||
129800571|NCT00723398|467238136|FG001|Overall Study|Physician Decision|2|||
129800572|NCT00723398|467238137|FG002|Overall Study|Physician Decision|5|||
129800573|NCT00723398|467238138|FG003|Overall Study|Physician Decision|0|||
129800574|NCT00723398|467238139|FG004|Overall Study|Physician Decision|1|||
129800575|NCT00723398|467238135|FG000|Overall Study|Adverse Event|0|||
129800576|NCT00723398|467238136|FG001|Overall Study|Adverse Event|5|||
129800577|NCT00723398|467238137|FG002|Overall Study|Adverse Event|3|||
129800578|NCT00723398|467238138|FG003|Overall Study|Adverse Event|1|||
129648629|NCT00250458|466669949|FG000|Overall Study|Withdrawal by Subject|4|||
129800579|NCT00723398|467238139|FG004|Overall Study|Adverse Event|4|||
129648630|NCT00250458|466669950|FG001|Overall Study|Withdrawal by Subject|2|||
129648631|NCT00250458|466669949|FG000|Overall Study|Lack of Migraine Attack|20|||
129648632|NCT00250458|466669950|FG001|Overall Study|Lack of Migraine Attack|9|||
129648633|NCT00250458|466669949|FG000|Overall Study|Qualifying migraine but did not treat|3|||
129648634|NCT00250458|466669950|FG001|Overall Study|Qualifying migraine but did not treat|3|||
129648635|NCT00250458|466669949|FG000|Overall Study|Other|1|||
129648636|NCT00250458|466669950|FG001|Overall Study|Other|0|||
129800580|NCT00723398|467238135|FG000|Overall Study|Lost to Follow-up|0|||
129800581|NCT00723398|467238136|FG001|Overall Study|Lost to Follow-up|1|||
129800582|NCT00723398|467238137|FG002|Overall Study|Lost to Follow-up|0|||
129800583|NCT00723398|467238138|FG003|Overall Study|Lost to Follow-up|0|||
129800584|NCT00723398|467238139|FG004|Overall Study|Lost to Follow-up|0|||
129800585|NCT00777205|467238142|FG000|Overall Study|Lost to Follow-up|25|||
129800586|NCT00777205|467238143|FG001|Overall Study|Lost to Follow-up|9|||
129800587|NCT00777205|467238142|FG000|Overall Study|Withdrawal by Subject|6|||
129800588|NCT00777205|467238143|FG001|Overall Study|Withdrawal by Subject|4|||
129800589|NCT00777205|467238142|FG000|Overall Study|Death|0|||
129800590|NCT00777205|467238143|FG001|Overall Study|Death|2|||
129800591|NCT00777205|467238142|FG000|Overall Study|Protocol Violation|0|||
129648637|NCT01801358|466669951|FG000|Overall Study|Adverse Event|0|||
129648638|NCT01801358|466669952|FG001|Overall Study|Adverse Event|2|||
129800592|NCT00777205|467238143|FG001|Overall Study|Protocol Violation|56|||
129648639|NCT01801358|466669953|FG002|Overall Study|Adverse Event|1|||
129648640|NCT01801358|466669954|FG003|Overall Study|Adverse Event|0|||
129648641|NCT01801358|466669955|FG004|Overall Study|Adverse Event|0|||
129648642|NCT01801358|466669956|FG005|Overall Study|Adverse Event|1|||
129648643|NCT01801358|466669951|FG000|Overall Study|Physician Decision|0|||
129648644|NCT01801358|466669952|FG001|Overall Study|Physician Decision|0|||
129800593|NCT00100178|467238144|FG000|Overall Study|Lost to Follow-up|0|||
129800594|NCT00100178|467238145|FG001|Overall Study|Lost to Follow-up|6|||
129800595|NCT00100178|467238146|FG002|Overall Study|Lost to Follow-up|5|||
129800596|NCT00100178|467238144|FG000|Overall Study|Adverse Event|2|||
129800597|NCT00100178|467238145|FG001|Overall Study|Adverse Event|2|||
129800598|NCT00100178|467238146|FG002|Overall Study|Adverse Event|1|||
129648645|NCT01801358|466669953|FG002|Overall Study|Physician Decision|1|||
129648646|NCT01801358|466669954|FG003|Overall Study|Physician Decision|0|||
129648647|NCT01801358|466669955|FG004|Overall Study|Physician Decision|0|||
129648648|NCT01801358|466669956|FG005|Overall Study|Physician Decision|0|||
129648649|NCT01801358|466669951|FG000|Overall Study|Progressive Disease|6|||
129648650|NCT01801358|466669952|FG001|Overall Study|Progressive Disease|4|||
129648651|NCT01801358|466669953|FG002|Overall Study|Progressive Disease|4|||
129648652|NCT01801358|466669954|FG003|Overall Study|Progressive Disease|5|||
129648653|NCT01801358|466669955|FG004|Overall Study|Progressive Disease|6|||
129800599|NCT00100178|467238144|FG000|Overall Study|Withdrawal by Subject|1|||
129800600|NCT00100178|467238145|FG001|Overall Study|Withdrawal by Subject|1|||
129648654|NCT01801358|466669956|FG005|Overall Study|Progressive Disease|5|||
129648655|NCT01801358|466669951|FG000|Overall Study|Withdrawal by Subject|0|||
129648656|NCT01801358|466669952|FG001|Overall Study|Withdrawal by Subject|0|||
129648657|NCT01801358|466669953|FG002|Overall Study|Withdrawal by Subject|0|||
129648658|NCT01801358|466669954|FG003|Overall Study|Withdrawal by Subject|1|||
129648659|NCT01801358|466669955|FG004|Overall Study|Withdrawal by Subject|0|||
129648660|NCT01801358|466669956|FG005|Overall Study|Withdrawal by Subject|2|||
129648661|NCT01549041|466669964|FG000|Overall Study|Lack of Efficacy|2|||
129709058|NCT02897115|466898328|FG000|Overall Study|Early termination of study by sponsor|11|||
129709059|NCT02897115|466898329|FG001|Overall Study|Early termination of study by sponsor|8|||
129709060|NCT00487981|466898330|FG000|Overall Study|Hypothyroidism diagnosis|1|||
129709061|NCT00856323|466898331|FG000|Overall Study|Withdrawal by Subject|2|||
129709062|NCT02808429|466898336|FG000|Overall Study|Lost to Follow-up|1|||
129709063|NCT02808429|466898337|FG001|Overall Study|Lost to Follow-up|0|||
129709064|NCT02808429|466898338|FG002|Overall Study|Lost to Follow-up|0|||
129709065|NCT02808429|466898336|FG000|Overall Study|Protocol Violation|0|||
129709066|NCT02808429|466898337|FG001|Overall Study|Protocol Violation|1|||
129709067|NCT02808429|466898338|FG002|Overall Study|Protocol Violation|0|||
129709068|NCT02808429|466898336|FG000|Overall Study|Premature study termination by sponsor|2|||
129709069|NCT02808429|466898337|FG001|Overall Study|Premature study termination by sponsor|0|||
129709070|NCT02808429|466898338|FG002|Overall Study|Premature study termination by sponsor|1|||
129709071|NCT02808429|466898336|FG000|Overall Study|Relocation|0|||
129709072|NCT02808429|466898337|FG001|Overall Study|Relocation|0|||
129709073|NCT02808429|466898338|FG002|Overall Study|Relocation|1|||
129709074|NCT00811954|466898344|FG000|Overall Study|Death|10|||
129800601|NCT00100178|467238146|FG002|Overall Study|Withdrawal by Subject|1|||
129800602|NCT00100178|467238144|FG000|Overall Study|Physician Decision|6|||
129800603|NCT00100178|467238145|FG001|Overall Study|Physician Decision|1|||
129800604|NCT00100178|467238146|FG002|Overall Study|Physician Decision|3|||
129800605|NCT02477839|467238149|FG000|Overall Study|Adverse Event|0|||
129800606|NCT02477839|467238150|FG001|Overall Study|Adverse Event|1|||
129800607|NCT02477839|467238149|FG000|Overall Study|Protocol Violation|0|||
129800608|NCT02477839|467238150|FG001|Overall Study|Protocol Violation|2|||
129800609|NCT02477839|467238149|FG000|Overall Study|Withdrawal by Subject|3|||
129800610|NCT02477839|467238150|FG001|Overall Study|Withdrawal by Subject|3|||
129800611|NCT02477839|467238149|FG000|Overall Study|Participant had PGS during V6|0|||
129800612|NCT02477839|467238150|FG001|Overall Study|Participant had PGS during V6|1|||
129800613|NCT02477839|467238149|FG000|Overall Study|Parents decided to stop medication|0|||
129800614|NCT02477839|467238150|FG001|Overall Study|Parents decided to stop medication|1|||
129800615|NCT02477839|467238149|FG000|Overall Study|Lack of tolerability|0|||
129800616|NCT02477839|467238150|FG001|Overall Study|Lack of tolerability|1|||
129709075|NCT00811954|466898345|FG001|Overall Study|Death|6|||
129709076|NCT00811954|466898346|FG002|Overall Study|Death|13|||
129709077|NCT00811954|466898344|FG000|Overall Study|Lost to Follow-up|29|||
129709078|NCT00811954|466898345|FG001|Overall Study|Lost to Follow-up|23|||
129709079|NCT00811954|466898346|FG002|Overall Study|Lost to Follow-up|34|||
129709080|NCT00811954|466898344|FG000|Overall Study|Not able to get to clinic|28|||
129709081|NCT00811954|466898345|FG001|Overall Study|Not able to get to clinic|35|||
129709082|NCT00811954|466898346|FG002|Overall Study|Not able to get to clinic|30|||
129709083|NCT00811954|466898344|FG000|Overall Study|Not willing to adhere to requirements|12|||
129709084|NCT00811954|466898345|FG001|Overall Study|Not willing to adhere to requirements|2|||
129709085|NCT00811954|466898346|FG002|Overall Study|Not willing to adhere to requirements|16|||
129709086|NCT00811954|466898344|FG000|Overall Study|Withdraw consent prior study completion|4|||
129709087|NCT00811954|466898345|FG001|Overall Study|Withdraw consent prior study completion|6|||
129709088|NCT00811954|466898346|FG002|Overall Study|Withdraw consent prior study completion|5|||
129709089|NCT00811954|466898344|FG000|Overall Study|Site Closure|4|||
129709090|NCT00811954|466898345|FG001|Overall Study|Site Closure|0|||
129709091|NCT00811954|466898346|FG002|Overall Study|Site Closure|1|||
129709092|NCT00811954|466898344|FG000|Overall Study|Severe Debilitation|2|||
129709093|NCT00811954|466898345|FG001|Overall Study|Severe Debilitation|0|||
129709094|NCT00811954|466898346|FG002|Overall Study|Severe Debilitation|1|||
129709095|NCT00811954|466898344|FG000|Overall Study|Complete Protocol: No follow-up|0|||
129709096|NCT00811954|466898345|FG001|Overall Study|Complete Protocol: No follow-up|0|||
129709097|NCT00811954|466898346|FG002|Overall Study|Complete Protocol: No follow-up|1|||
129709098|NCT01063348|466898349|FG000|Overall Study|Lost to Follow-up|3|||
129709099|NCT01063348|466898350|FG001|Overall Study|Lost to Follow-up|10|||
129709100|NCT05518461|466898351|FG000|Overall Study|Lost to Follow-up|25|||
129709101|NCT04828707|466898352|FG000|Overall Study|Lost to Follow-up|3|||
129709102|NCT04828707|466898353|FG001|Overall Study|Lost to Follow-up|2|||
129709103|NCT04828707|466898352|FG000|Overall Study|Withdrawal by Subject|2|||
129709104|NCT04828707|466898353|FG001|Overall Study|Withdrawal by Subject|1|||
129709105|NCT03139448|466898354|FG000|Overall Study|Lack of Efficacy|6|||
129709106|NCT03139448|466898355|FG001|Overall Study|Lack of Efficacy|7|||
129709107|NCT03139448|466898354|FG000|Overall Study|Location of procedure changed|2|||
129709108|NCT03139448|466898355|FG001|Overall Study|Location of procedure changed|8|||
129709109|NCT03139448|466898354|FG000|Overall Study|Withdrawal by Subject|3|||
129709110|NCT03139448|466898355|FG001|Overall Study|Withdrawal by Subject|6|||
129709111|NCT03139448|466898354|FG000|Overall Study|Screen fail|1|||
129709112|NCT03139448|466898355|FG001|Overall Study|Screen fail|3|||
129648662|NCT01549041|466669965|FG001|Overall Study|Lack of Efficacy|4|||
129648663|NCT01549041|466669964|FG000|Overall Study|Adverse Event|0|||
129648664|NCT01549041|466669965|FG001|Overall Study|Adverse Event|4|||
129648665|NCT01537068|466669970|FG000|Overall Study|Lost to Follow-up|2|||
129648666|NCT01537068|466669971|FG001|Overall Study|Lost to Follow-up|1|||
129648667|NCT01537068|466669970|FG000|Overall Study|Adverse Event|0|||
129648668|NCT01537068|466669971|FG001|Overall Study|Adverse Event|1|||
129648669|NCT01537068|466669970|FG000|Overall Study|Withdrawal by Subject|1|||
129648670|NCT01537068|466669971|FG001|Overall Study|Withdrawal by Subject|1|||
129648671|NCT01537068|466669970|FG000|Overall Study|Lack of Efficacy|1|||
129648672|NCT01537068|466669971|FG001|Overall Study|Lack of Efficacy|0|||
129648673|NCT00483704|466669972|FG000|Randomization|Withdrawal by Subject|19|||
129648674|NCT00483704|466669973|FG001|Randomization|Withdrawal by Subject|28|||
129648675|NCT00483704|466669974|FG002|Randomization|Withdrawal by Subject|18|||
129648676|NCT00483704|466669972|FG000|Randomization|Protocol Violation|14|||
129648677|NCT00483704|466669973|FG001|Randomization|Protocol Violation|25|||
129648678|NCT00483704|466669974|FG002|Randomization|Protocol Violation|22|||
129648679|NCT00483704|466669972|FG000|Randomization|Lost to Follow-up|14|||
129648680|NCT00483704|466669973|FG001|Randomization|Lost to Follow-up|14|||
129648681|NCT00483704|466669974|FG002|Randomization|Lost to Follow-up|19|||
129648682|NCT00483704|466669972|FG000|Randomization|Pregnancy|1|||
129648683|NCT00483704|466669973|FG001|Randomization|Pregnancy|0|||
129648684|NCT00483704|466669974|FG002|Randomization|Pregnancy|0|||
129648685|NCT00483704|466669972|FG000|Randomization|Physician Decision|2|||
129648686|NCT00483704|466669973|FG001|Randomization|Physician Decision|4|||
129648687|NCT00483704|466669974|FG002|Randomization|Physician Decision|0|||
129648688|NCT00483704|466669972|FG000|Randomization|Progressive disease|0|||
129648689|NCT00483704|466669973|FG001|Randomization|Progressive disease|0|||
129648690|NCT00483704|466669974|FG002|Randomization|Progressive disease|1|||
129709113|NCT03139448|466898354|FG000|Overall Study|Physician Decision|0|||
129709114|NCT03139448|466898355|FG001|Overall Study|Physician Decision|2|||
129709115|NCT00523978|466898356|FG000|Overall Study|Withdrawal by Subject|3|||
129709116|NCT00523978|466898357|FG001|Overall Study|Withdrawal by Subject|7|||
129648691|NCT00483704|466669972|FG000|Randomization|Lack of qualifying migraines|21|||
129648692|NCT00483704|466669973|FG001|Randomization|Lack of qualifying migraines|25|||
129648693|NCT00483704|466669974|FG002|Randomization|Lack of qualifying migraines|31|||
129648694|NCT00483704|466669972|FG000|Treatment|Lack of qualifying migraines|101|||
129648695|NCT00483704|466669973|FG001|Treatment|Lack of qualifying migraines|99|||
129648696|NCT00483704|466669974|FG002|Treatment|Lack of qualifying migraines|116|||
129648697|NCT00483704|466669972|FG000|Treatment|Adverse Event|3|||
129648698|NCT00483704|466669973|FG001|Treatment|Adverse Event|5|||
129648699|NCT00483704|466669974|FG002|Treatment|Adverse Event|4|||
129648700|NCT00483704|466669972|FG000|Treatment|Withdrawal by Subject|16|||
129648701|NCT00483704|466669973|FG001|Treatment|Withdrawal by Subject|12|||
129648702|NCT00483704|466669974|FG002|Treatment|Withdrawal by Subject|21|||
129648703|NCT00483704|466669972|FG000|Treatment|Protocol Violation|6|||
129648704|NCT00483704|466669973|FG001|Treatment|Protocol Violation|3|||
129648705|NCT00483704|466669974|FG002|Treatment|Protocol Violation|5|||
129648706|NCT00483704|466669972|FG000|Treatment|Lost to Follow-up|2|||
129648707|NCT00483704|466669973|FG001|Treatment|Lost to Follow-up|7|||
129648708|NCT00483704|466669974|FG002|Treatment|Lost to Follow-up|5|||
129648709|NCT00483704|466669972|FG000|Treatment|Lack of Efficacy|1|||
129648710|NCT00483704|466669973|FG001|Treatment|Lack of Efficacy|1|||
129709117|NCT00523978|466898356|FG000|Overall Study|Screen Failures|5|||
129648711|NCT00483704|466669974|FG002|Treatment|Lack of Efficacy|1|||
129648712|NCT00483704|466669972|FG000|Treatment|Pregnancy|0|||
129648713|NCT00483704|466669973|FG001|Treatment|Pregnancy|1|||
129648714|NCT00483704|466669974|FG002|Treatment|Pregnancy|0|||
129648715|NCT00483704|466669972|FG000|Treatment|Physician Decision|0|||
129648716|NCT00483704|466669973|FG001|Treatment|Physician Decision|1|||
129648717|NCT00483704|466669974|FG002|Treatment|Physician Decision|4|||
129648718|NCT04442269|466669975|FG000|Overall Study|Adverse Event|1|||
129648719|NCT04442269|466669976|FG001|Overall Study|Adverse Event|0|||
129648720|NCT04442269|466669975|FG000|Overall Study|Death|0|||
129648721|NCT04442269|466669976|FG001|Overall Study|Death|1|||
129648722|NCT04442269|466669975|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
129648723|NCT04442269|466669976|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
129648724|NCT04442269|466669975|FG000|Overall Study|Lost to Follow-up|1|||
129648725|NCT04442269|466669976|FG001|Overall Study|Lost to Follow-up|0|||
129648726|NCT04442269|466669975|FG000|Overall Study|Withdrawal by Subject|3|||
129648727|NCT04442269|466669976|FG001|Overall Study|Withdrawal by Subject|2|||
129648728|NCT04442269|466669975|FG000|Overall Study|Protocol Deviation|0|||
129709118|NCT00523978|466898357|FG001|Overall Study|Screen Failures|1|||
129648729|NCT04442269|466669976|FG001|Overall Study|Protocol Deviation|1|||
129709119|NCT00523978|466898356|FG000|Overall Study|Death|1|||
129648730|NCT04442269|466669975|FG000|Overall Study|Travel Limitations|1|||
129648731|NCT04442269|466669976|FG001|Overall Study|Travel Limitations|1|||
129648732|NCT01793688|466669977|FG000|Overall Study|Protocol Violation|2|||
129648733|NCT04450407|466669980|FG000|Overall Study|Withdrawal by Subject|10|||
129648734|NCT04450407|466669981|FG001|Overall Study|Withdrawal by Subject|1|||
129648735|NCT04450407|466669982|FG002|Overall Study|Withdrawal by Subject|4|||
129648736|NCT04450407|466669980|FG000|Overall Study|Adverse Event|0|||
129648737|NCT04450407|466669981|FG001|Overall Study|Adverse Event|0|||
129648738|NCT04450407|466669982|FG002|Overall Study|Adverse Event|1|||
129709120|NCT00523978|466898357|FG001|Overall Study|Death|0|||
129709121|NCT02750514|466898360|FG000|Track 1|Disease progression|20|||
129709122|NCT02750514|466898361|FG001|Track 1|Disease progression|1|||
129709123|NCT02750514|466898362|FG002|Track 1|Disease progression|0|||
129709124|NCT02750514|466898363|FG003|Track 1|Disease progression|1|||
129709125|NCT02750514|466898364|FG004|Track 1|Disease progression|0|||
129709126|NCT02750514|466898360|FG000|Track 1|Adverse event unrelated to study drug|1|||
129709127|NCT02750514|466898361|FG001|Track 1|Adverse event unrelated to study drug|0|||
129709128|NCT02750514|466898362|FG002|Track 1|Adverse event unrelated to study drug|0|||
129709129|NCT02750514|466898363|FG003|Track 1|Adverse event unrelated to study drug|0|||
129709130|NCT02750514|466898364|FG004|Track 1|Adverse event unrelated to study drug|0|||
129709131|NCT02750514|466898360|FG000|Track 1|Study drug toxicity|4|||
129709132|NCT02750514|466898361|FG001|Track 1|Study drug toxicity|1|||
129709133|NCT02750514|466898362|FG002|Track 1|Study drug toxicity|0|||
129709134|NCT02750514|466898363|FG003|Track 1|Study drug toxicity|1|||
129709135|NCT02750514|466898364|FG004|Track 1|Study drug toxicity|0|||
129648739|NCT04450407|466669980|FG000|Overall Study|Lost to Follow-up|1|||
129648740|NCT04450407|466669981|FG001|Overall Study|Lost to Follow-up|0|||
129648741|NCT04450407|466669982|FG002|Overall Study|Lost to Follow-up|0|||
129648742|NCT04450407|466669980|FG000|Overall Study|Physician Decision|0|||
129648743|NCT04450407|466669981|FG001|Overall Study|Physician Decision|0|||
129648744|NCT04450407|466669982|FG002|Overall Study|Physician Decision|1|||
129648745|NCT04450407|466669980|FG000|Overall Study|Pregnancy|1|||
129648746|NCT04450407|466669981|FG001|Overall Study|Pregnancy|0|||
129648747|NCT04450407|466669982|FG002|Overall Study|Pregnancy|0|||
129648748|NCT04450407|466669980|FG000|Overall Study|Protocol Violation|2|||
129648749|NCT04450407|466669981|FG001|Overall Study|Protocol Violation|0|||
129648750|NCT04450407|466669982|FG002|Overall Study|Protocol Violation|0|||
129648751|NCT04450407|466669980|FG000|Overall Study|Investigational site terminated by sponsor|3|||
129648752|NCT04450407|466669981|FG001|Overall Study|Investigational site terminated by sponsor|0|||
129648753|NCT04450407|466669982|FG002|Overall Study|Investigational site terminated by sponsor|2|||
129648754|NCT03430895|466669986|FG000|Overall Study|Not Treated|2|||
129648755|NCT01317797|466669987|FG000|Overall Study|Other|0|||
129648756|NCT01317797|466669988|FG001|Overall Study|Other|1|||
129648757|NCT01317797|466669989|FG002|Overall Study|Other|0|||
129648758|NCT01317797|466669987|FG000|Overall Study|Withdrawal of Patient|0|||
129648759|NCT01317797|466669988|FG001|Overall Study|Withdrawal of Patient|0|||
129648760|NCT01317797|466669989|FG002|Overall Study|Withdrawal of Patient|1|||
129648761|NCT01645891|466669996|FG000|Overall Study|Adverse Event|6|||
129648762|NCT01645891|466669997|FG001|Overall Study|Adverse Event|10|||
129648763|NCT01645891|466669996|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
129648764|NCT01645891|466669997|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
129648765|NCT01645891|466669996|FG000|Overall Study|Withdrawal by Subject|3|||
129648766|NCT01645891|466669997|FG001|Overall Study|Withdrawal by Subject|3|||
129648767|NCT01645891|466669996|FG000|Overall Study|Protocol Violation|4|||
129648768|NCT01645891|466669997|FG001|Overall Study|Protocol Violation|0|||
129648769|NCT01645891|466669996|FG000|Overall Study|Lost to Follow-up|4|||
129648770|NCT01645891|466669997|FG001|Overall Study|Lost to Follow-up|1|||
129648771|NCT01645891|466669996|FG000|Overall Study|Death|0|||
129648772|NCT01645891|466669997|FG001|Overall Study|Death|2|||
129648773|NCT03026530|466669998|FG000|Overall Study|Lost to Follow-up|19|||
129648774|NCT03026530|466669999|FG001|Overall Study|Lost to Follow-up|24|||
129648775|NCT03026530|466669998|FG000|Overall Study|Protocol Violation|2|||
129648776|NCT03026530|466669999|FG001|Overall Study|Protocol Violation|5|||
129648777|NCT00138073|466670000|FG000|Overall Study|lack of resources|55|||
129648778|NCT05072964|466670004|FG000|Overall Study|Withdrawal by Subject|4|||
129648779|NCT05072964|466670004|FG000|Overall Study|Death|1|||
129648780|NCT01632904|466671492|FG000|Overall Study|Adverse Event|4|||
129648781|NCT01632904|466671493|FG001|Overall Study|Adverse Event|1|||
129648782|NCT01632904|466671492|FG000|Overall Study|Physician Decision|0|||
129648783|NCT01632904|466671493|FG001|Overall Study|Physician Decision|1|||
129648784|NCT01632904|466671492|FG000|Overall Study|Subject decision|3|||
129648785|NCT01632904|466671493|FG001|Overall Study|Subject decision|2|||
129648786|NCT01632904|466671492|FG000|Overall Study|Disease Progression|0|||
129709136|NCT02750514|466898360|FG000|Track 1|Participant request to discontinue|1|||
129709137|NCT02750514|466898361|FG001|Track 1|Participant request to discontinue|0|||
129709138|NCT02750514|466898362|FG002|Track 1|Participant request to discontinue|0|||
129709139|NCT02750514|466898363|FG003|Track 1|Participant request to discontinue|0|||
129709140|NCT02750514|466898364|FG004|Track 1|Participant request to discontinue|0|||
129709141|NCT02750514|466898360|FG000|Track 1|Other reasons|1|||
129709142|NCT02750514|466898361|FG001|Track 1|Other reasons|0|||
129709143|NCT02750514|466898362|FG002|Track 1|Other reasons|0|||
129709144|NCT02750514|466898363|FG003|Track 1|Other reasons|0|||
129709145|NCT02750514|466898364|FG004|Track 1|Other reasons|0|||
129709146|NCT02750514|466898360|FG000|Track 2|Disease progression|4|||
129709147|NCT02750514|466898361|FG001|Track 2|Disease progression|5|||
129709148|NCT02750514|466898362|FG002|Track 2|Disease progression|2|||
129709149|NCT02750514|466898363|FG003|Track 2|Disease progression|5|||
129709150|NCT02750514|466898364|FG004|Track 2|Disease progression|0|||
129709151|NCT02750514|466898360|FG000|Track 2|Adverse event unrelated to study drug|1|||
129709152|NCT02750514|466898361|FG001|Track 2|Adverse event unrelated to study drug|0|||
129709153|NCT02750514|466898362|FG002|Track 2|Adverse event unrelated to study drug|0|||
129709154|NCT02750514|466898363|FG003|Track 2|Adverse event unrelated to study drug|0|||
129709155|NCT02750514|466898364|FG004|Track 2|Adverse event unrelated to study drug|0|||
129709156|NCT02750514|466898360|FG000|Track 2|Study drug toxicity|1|||
129709157|NCT02750514|466898361|FG001|Track 2|Study drug toxicity|2|||
129709158|NCT02750514|466898362|FG002|Track 2|Study drug toxicity|0|||
129648787|NCT01632904|466671493|FG001|Overall Study|Disease Progression|1|||
129648788|NCT01632904|466671492|FG000|Overall Study|Reason for discontinuation not available|0|||
129648789|NCT01632904|466671493|FG001|Overall Study|Reason for discontinuation not available|1|||
129648790|NCT04743804|466671494|FG000|Overall Study|Other|1|||
129648791|NCT04743804|466671495|FG001|Overall Study|Other|0|||
129648792|NCT04743804|466671494|FG000|Overall Study|Withdrawal by Subject|0|||
129648793|NCT04743804|466671495|FG001|Overall Study|Withdrawal by Subject|1|||
129648794|NCT04743804|466671494|FG000|Overall Study|Study Terminated by Sponsor|1|||
129648795|NCT04743804|466671495|FG001|Overall Study|Study Terminated by Sponsor|4|||
129648796|NCT04743804|466671494|FG000|Overall Study|Physician Decision|0|||
129648797|NCT04743804|466671495|FG001|Overall Study|Physician Decision|1|||
129648798|NCT04743804|466671494|FG000|Overall Study|Death|3|||
129648799|NCT04743804|466671495|FG001|Overall Study|Death|0|||
129648800|NCT02059434|466671499|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
129648801|NCT02059434|466671500|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
129648802|NCT02059434|466671501|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
129648803|NCT02059434|466671502|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
129648804|NCT02059434|466671503|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
129648805|NCT02059434|466671504|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
129648806|NCT02059434|466671505|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
129648807|NCT02059434|466671506|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
129648808|NCT02059434|466671507|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
129648809|NCT02059434|466671499|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
129648810|NCT02059434|466671500|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
129648811|NCT02059434|466671501|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
129648812|NCT02059434|466671502|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
129648813|NCT02059434|466671503|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
129648814|NCT02059434|466671504|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
129648815|NCT02059434|466671505|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
129648816|NCT02059434|466671506|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
129648817|NCT02059434|466671507|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
129648818|NCT02059434|466671499|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
129648819|NCT02059434|466671500|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
129648820|NCT02059434|466671501|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
129648821|NCT02059434|466671502|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
129648822|NCT02059434|466671503|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
129709159|NCT02750514|466898363|FG003|Track 2|Study drug toxicity|2|||
129709160|NCT02750514|466898364|FG004|Track 2|Study drug toxicity|0|||
129444032|NCT00634010|465926003|FG000|Overall Study|Disease Progression|1|||
129648823|NCT02059434|466671504|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
129648824|NCT02059434|466671505|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
129648825|NCT02059434|466671506|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
129709161|NCT02750514|466898360|FG000|Track 2|Participant withdrew consent|0|||
129709162|NCT02750514|466898361|FG001|Track 2|Participant withdrew consent|1|||
129709163|NCT02750514|466898362|FG002|Track 2|Participant withdrew consent|0|||
129709164|NCT02750514|466898363|FG003|Track 2|Participant withdrew consent|0|||
129709165|NCT02750514|466898364|FG004|Track 2|Participant withdrew consent|0|||
129709166|NCT02750514|466898360|FG000|Track 3|Disease progression|0|||
129709167|NCT02750514|466898361|FG001|Track 3|Disease progression|24|||
129709168|NCT02750514|466898362|FG002|Track 3|Disease progression|13|||
129709169|NCT02750514|466898363|FG003|Track 3|Disease progression|14|||
129709170|NCT02750514|466898364|FG004|Track 3|Disease progression|0|||
129709171|NCT02750514|466898360|FG000|Track 3|Adverse event unrelated to study drug|0|||
129709172|NCT02750514|466898361|FG001|Track 3|Adverse event unrelated to study drug|1|||
129709173|NCT02750514|466898362|FG002|Track 3|Adverse event unrelated to study drug|1|||
129709174|NCT02750514|466898363|FG003|Track 3|Adverse event unrelated to study drug|1|||
129709175|NCT02750514|466898364|FG004|Track 3|Adverse event unrelated to study drug|0|||
129709176|NCT02750514|466898360|FG000|Track 3|Study drug toxicity|0|||
129709177|NCT02750514|466898361|FG001|Track 3|Study drug toxicity|3|||
129709178|NCT02750514|466898362|FG002|Track 3|Study drug toxicity|0|||
129709179|NCT02750514|466898363|FG003|Track 3|Study drug toxicity|1|||
129709180|NCT02750514|466898364|FG004|Track 3|Study drug toxicity|0|||
129709181|NCT02750514|466898360|FG000|Track 3|Participant request to discontinue|0|||
129709182|NCT02750514|466898361|FG001|Track 3|Participant request to discontinue|2|||
129709183|NCT02750514|466898362|FG002|Track 3|Participant request to discontinue|0|||
129709184|NCT02750514|466898363|FG003|Track 3|Participant request to discontinue|0|||
129800617|NCT02477839|467238149|FG000|Overall Study|Exclusion criterion|0|||
129800618|NCT02477839|467238150|FG001|Overall Study|Exclusion criterion|1|||
129800619|NCT01439568|467238151|FG000|Overall Study|Lost to Follow-up|1|||
129800620|NCT01439568|467238152|FG001|Overall Study|Lost to Follow-up|0|||
129800621|NCT01439568|467238151|FG000|Overall Study|Withdrawal by Subject|2|||
129800622|NCT01439568|467238152|FG001|Overall Study|Withdrawal by Subject|2|||
129800623|NCT01676727|467238153|FG000|Overall Study|Death|18|||
129800624|NCT01676727|467238153|FG000|Overall Study|Withdrawal by Subject|6|||
129800625|NCT01676727|467238153|FG000|Overall Study|Screening failure|5|||
129800626|NCT01676727|467238153|FG000|Overall Study|Not willing to attend 1-year visit|2|||
129800627|NCT01676727|467238153|FG000|Overall Study|Valve explanted|1|||
129800628|NCT03053271|467238154|FG000|Overall Study|Did not meet randomization criteria|3|||
129800629|NCT03053271|467238154|FG000|Overall Study|Withdrawal by Subject|1|||
129800630|NCT00580970|467238155|FG000|Pre-treatment|Non-compliance|1|||
129800631|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Non-compliance|6|||
129800632|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
129800633|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Physician Decision|4|||
129800634|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
129800635|NCT00580970|467238155|FG000|Treatment (Lovastatin)|Death|1|||
129800636|NCT04137224|467238156|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
129800637|NCT04137224|467238157|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
129800638|NCT04137224|467238156|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
129800639|NCT04137224|467238157|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
129800640|NCT04137224|467238156|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
129709185|NCT02750514|466898364|FG004|Track 3|Participant request to discontinue|0|||
129800641|NCT04137224|467238157|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
129648826|NCT02059434|466671507|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
129648827|NCT02059434|466671499|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
129648828|NCT02059434|466671500|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
129648829|NCT02059434|466671501|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
129648830|NCT02059434|466671502|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
129648831|NCT02059434|466671503|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
129648832|NCT02059434|466671504|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
129648833|NCT02059434|466671505|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
129648834|NCT02059434|466671506|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
129648835|NCT02059434|466671507|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
129648836|NCT02059434|466671499|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648837|NCT02059434|466671500|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648838|NCT02059434|466671501|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648839|NCT02059434|466671502|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648840|NCT02059434|466671503|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648841|NCT02059434|466671504|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648842|NCT02059434|466671505|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648843|NCT02059434|466671506|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
129648844|NCT02059434|466671507|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
129648845|NCT01004406|466671512|FG000|Overall Study|Withdrawal by Subject|2|||
129648846|NCT01004406|466671513|FG001|Overall Study|Withdrawal by Subject|0|||
129648847|NCT01004406|466671512|FG000|Overall Study|Lost to Follow-up|1|||
129648848|NCT01004406|466671513|FG001|Overall Study|Lost to Follow-up|0|||
129648849|NCT02928770|466671514|FG000|Overall Study|Withdrawal by Subject|2|||
129648850|NCT03201874|466671517|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
129648851|NCT03201874|466671518|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
129648852|NCT03201874|466671517|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
129648853|NCT03201874|466671518|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
129648854|NCT02907593|466671519|FG000|Overall Study|Withdrawal by Subject|0|||
129648855|NCT02907593|466671520|FG001|Overall Study|Withdrawal by Subject|0|||
129648856|NCT02907593|466671521|FG002|Overall Study|Withdrawal by Subject|1|||
129648857|NCT02907593|466671522|FG003|Overall Study|Withdrawal by Subject|0|||
129648858|NCT01892085|466671525|FG000|Overall Study|Death|4|||
129648859|NCT01892085|466671526|FG001|Overall Study|Death|1|||
129648860|NCT01892085|466671527|FG002|Overall Study|Death|3|||
129648861|NCT01892085|466671525|FG000|Overall Study|Withdrawal by Subject|2|||
129648862|NCT01892085|466671526|FG001|Overall Study|Withdrawal by Subject|0|||
129648863|NCT01892085|466671527|FG002|Overall Study|Withdrawal by Subject|2|||
129648864|NCT01629823|466671528|FG000|Trial Period|Missed visit|11|||
129648865|NCT01629823|466671529|FG001|Trial Period|Missed visit|9|||
129648866|NCT01629823|466671530|FG002|Trial Period|Missed visit|8|||
129648867|NCT01629823|466671528|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
129648868|NCT01629823|466671529|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
129648869|NCT01629823|466671530|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
129648870|NCT01629823|466671528|FG000|Trial Period|Pregnancy|1|||
129648871|NCT01629823|466671529|FG001|Trial Period|Pregnancy|0|||
129648872|NCT01629823|466671530|FG002|Trial Period|Pregnancy|0|||
129648873|NCT01629823|466671528|FG000|Trial Period|Adverse Event|0|||
129648874|NCT01629823|466671529|FG001|Trial Period|Adverse Event|1|||
129648875|NCT01629823|466671530|FG002|Trial Period|Adverse Event|0|||
129648876|NCT01629823|466671528|FG000|Trial Period|Out-of-window visit|0|||
129648877|NCT01629823|466671529|FG001|Trial Period|Out-of-window visit|2|||
129648878|NCT01629823|466671530|FG002|Trial Period|Out-of-window visit|0|||
129648879|NCT01629823|466671528|FG000|Trial Period|Failed to hold medication|0|||
129648880|NCT01629823|466671529|FG001|Trial Period|Failed to hold medication|0|||
129648881|NCT01629823|466671530|FG002|Trial Period|Failed to hold medication|1|||
129648882|NCT01629823|466671528|FG000|Washout Period|Safety|2|||
129648883|NCT01629823|466671529|FG001|Washout Period|Safety|5|||
129648884|NCT01629823|466671530|FG002|Washout Period|Safety|0|||
129648885|NCT01629823|466671528|FG000|Washout Period|Pregnancy|1|||
129648886|NCT01629823|466671529|FG001|Washout Period|Pregnancy|0|||
129648887|NCT01629823|466671530|FG002|Washout Period|Pregnancy|0|||
129648888|NCT01629823|466671528|FG000|Washout Period|Protocol Violation|0|||
129648889|NCT01629823|466671529|FG001|Washout Period|Protocol Violation|1|||
129648890|NCT01629823|466671530|FG002|Washout Period|Protocol Violation|0|||
129648891|NCT02609724|466671531|FG000|Overall Study|Death|2|||
129648892|NCT02609724|466671532|FG001|Overall Study|Death|0|||
129648893|NCT02609724|466671533|FG002|Overall Study|Death|1|||
129648894|NCT02609724|466671531|FG000|Overall Study|Withdrawal by Subject|1|||
129648895|NCT02609724|466671532|FG001|Overall Study|Withdrawal by Subject|2|||
129648896|NCT02609724|466671533|FG002|Overall Study|Withdrawal by Subject|3|||
129648897|NCT02609724|466671531|FG000|Overall Study|Illness|2|||
129648898|NCT02609724|466671532|FG001|Overall Study|Illness|1|||
129648899|NCT02609724|466671533|FG002|Overall Study|Illness|0|||
129648900|NCT03077659|466671534|FG000|Overall Study|Withdrawal by Subject|0|||
129648901|NCT03077659|466671535|FG001|Overall Study|Withdrawal by Subject|0|||
129648902|NCT03077659|466671536|FG002|Overall Study|Withdrawal by Subject|1|||
129648903|NCT02844907|466671537|FG000|With Dexamethasone|No IV access|1|||
129648904|NCT00550862|466671538|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
129648905|NCT00550862|466671539|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
129648906|NCT00550862|466671540|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
129648907|NCT00550862|466671541|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
129709186|NCT02750514|466898360|FG000|Track 3|Participant withdrew consent|0|||
129709187|NCT02750514|466898361|FG001|Track 3|Participant withdrew consent|3|||
129709188|NCT02750514|466898362|FG002|Track 3|Participant withdrew consent|1|||
129709189|NCT02750514|466898363|FG003|Track 3|Participant withdrew consent|0|||
129709190|NCT02750514|466898364|FG004|Track 3|Participant withdrew consent|0|||
129648908|NCT00550862|466671542|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
129709191|NCT02750514|466898360|FG000|Track 3|Other reasons|0|||
129648909|NCT00550862|466671538|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
129648910|NCT00550862|466671539|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
129648911|NCT00550862|466671540|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
129648912|NCT00550862|466671541|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
129648913|NCT00550862|466671542|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
129709192|NCT02750514|466898361|FG001|Track 3|Other reasons|3|||
129648914|NCT00550862|466671538|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129648915|NCT00550862|466671539|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129648916|NCT00550862|466671540|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
129648917|NCT00550862|466671541|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129648918|NCT00550862|466671542|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
129648919|NCT00550862|466671538|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129800642|NCT00566501|467238160|FG000|Overall Study|Adverse Event|68|||
129800643|NCT00566501|467238161|FG001|Overall Study|Adverse Event|59|||
129800644|NCT00566501|467238160|FG000|Overall Study|Medication Non-compliance|5|||
129800645|NCT00566501|467238161|FG001|Overall Study|Medication Non-compliance|0|||
129800646|NCT00566501|467238160|FG000|Overall Study|Protocol Violation|2|||
129800647|NCT00566501|467238161|FG001|Overall Study|Protocol Violation|2|||
129800648|NCT00566501|467238160|FG000|Overall Study|Request of Investigator or Sponsor|6|||
129800649|NCT00566501|467238161|FG001|Overall Study|Request of Investigator or Sponsor|7|||
129800650|NCT00566501|467238160|FG000|Overall Study|Withdrawal by Subject|33|||
129800651|NCT00566501|467238161|FG001|Overall Study|Withdrawal by Subject|30|||
129800652|NCT00566501|467238160|FG000|Overall Study|Lack of Efficacy|8|||
129800653|NCT00566501|467238161|FG001|Overall Study|Lack of Efficacy|3|||
129800654|NCT00566501|467238160|FG000|Overall Study|Other|25|||
129800655|NCT00566501|467238161|FG001|Overall Study|Other|21|||
129800656|NCT00679055|467238164|FG000|Overall Study|Adverse Event|0|||
129800657|NCT00679055|467238165|FG001|Overall Study|Adverse Event|1|||
129800658|NCT00679055|467238164|FG000|Overall Study|Other|0|||
129800659|NCT00679055|467238165|FG001|Overall Study|Other|3|||
129800660|NCT00679055|467238164|FG000|Overall Study|Study Terminated|2|||
129800661|NCT00679055|467238165|FG001|Overall Study|Study Terminated|1|||
129800662|NCT01368432|467238166|FG000|Overall Study|Lost to Follow-up|0|||
129800663|NCT01368432|467238167|FG001|Overall Study|Lost to Follow-up|1|||
129800664|NCT01008150|467238168|FG000|Overall Study|did not receive study drug|1|||
129709193|NCT02750514|466898362|FG002|Track 3|Other reasons|0|||
129709194|NCT02750514|466898363|FG003|Track 3|Other reasons|0|||
129709195|NCT02750514|466898364|FG004|Track 3|Other reasons|0|||
129709196|NCT02750514|466898360|FG000|Track 4|Study drug toxicity|0|||
129709197|NCT02750514|466898361|FG001|Track 4|Study drug toxicity|6|||
129709198|NCT02750514|466898362|FG002|Track 4|Study drug toxicity|0|||
129709199|NCT02750514|466898363|FG003|Track 4|Study drug toxicity|5|||
129709200|NCT02750514|466898364|FG004|Track 4|Study drug toxicity|0|||
129709201|NCT02750514|466898360|FG000|Track 4|Participant request to discontinue|0|||
129709202|NCT02750514|466898361|FG001|Track 4|Participant request to discontinue|1|||
129709203|NCT02750514|466898362|FG002|Track 4|Participant request to discontinue|0|||
129709204|NCT02750514|466898363|FG003|Track 4|Participant request to discontinue|1|||
129709205|NCT02750514|466898364|FG004|Track 4|Participant request to discontinue|0|||
129709206|NCT02750514|466898360|FG000|Track 4|Participant withdrew consent|0|||
129709207|NCT02750514|466898361|FG001|Track 4|Participant withdrew consent|1|||
129709208|NCT02750514|466898362|FG002|Track 4|Participant withdrew consent|0|||
129709209|NCT02750514|466898363|FG003|Track 4|Participant withdrew consent|0|||
129709210|NCT02750514|466898364|FG004|Track 4|Participant withdrew consent|0|||
129709211|NCT02750514|466898360|FG000|Track 4|Other reasons|0|||
129709212|NCT02750514|466898361|FG001|Track 4|Other reasons|5|||
129800665|NCT01008150|467238169|FG001|Overall Study|did not receive study drug|1|||
129800666|NCT01008150|467238170|FG002|Overall Study|did not receive study drug|1|||
129709213|NCT02750514|466898362|FG002|Track 4|Other reasons|0|||
129709214|NCT02750514|466898363|FG003|Track 4|Other reasons|3|||
129709215|NCT02750514|466898364|FG004|Track 4|Other reasons|0|||
129709216|NCT02750514|466898360|FG000|Track 4|Disease progression|0|||
129709217|NCT02750514|466898361|FG001|Track 4|Disease progression|33|||
129709218|NCT02750514|466898362|FG002|Track 4|Disease progression|0|||
129709219|NCT02750514|466898363|FG003|Track 4|Disease progression|32|||
129709220|NCT02750514|466898364|FG004|Track 4|Disease progression|0|||
129709221|NCT02750514|466898360|FG000|Track 4|Adverse event unrelated to study drug|0|||
129444033|NCT00634010|465926004|FG001|Overall Study|Disease Progression|1|||
129444034|NCT00634010|465926003|FG000|Overall Study|Non-Compliant|1|||
129444035|NCT00634010|465926004|FG001|Overall Study|Non-Compliant|1|||
129444036|NCT03690141|465926008|FG000|Overall Study|Adverse Event|5|||
129444037|NCT03690141|465926008|FG000|Overall Study|Withdrawal by Subject|3|||
129444038|NCT03690141|465926008|FG000|Overall Study|Physician Decision|4|||
129444039|NCT03690141|465926008|FG000|Overall Study|Disease progression|4|||
129444040|NCT01807923|465926009|FG000|Overall Study|Adverse Event|2|||
129444041|NCT01807923|465926010|FG001|Overall Study|Adverse Event|1|||
129444042|NCT01807923|465926011|FG002|Overall Study|Adverse Event|2|||
129444043|NCT01807923|465926009|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
129444044|NCT01807923|465926010|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
129444045|NCT01807923|465926011|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
129444046|NCT01807923|465926009|FG000|Overall Study|Physician Decision|0|||
129444047|NCT01807923|465926010|FG001|Overall Study|Physician Decision|0|||
129444048|NCT01807923|465926011|FG002|Overall Study|Physician Decision|1|||
129444049|NCT01807923|465926009|FG000|Overall Study|Not Eligible (Genotype)|0|||
129444050|NCT01807923|465926010|FG001|Overall Study|Not Eligible (Genotype)|0|||
129444051|NCT01807923|465926011|FG002|Overall Study|Not Eligible (Genotype)|1|||
129444052|NCT01807923|465926009|FG000|Overall Study|Randomized But Not Treated|3|||
129444053|NCT01807923|465926010|FG001|Overall Study|Randomized But Not Treated|2|||
129444054|NCT01807923|465926011|FG002|Overall Study|Randomized But Not Treated|5|||
129444055|NCT01272947|465926013|FG000|Overall Study|Abnormal Laboratory Value|2|||
129444056|NCT01272947|465926014|FG001|Overall Study|Abnormal Laboratory Value|2|||
129444057|NCT02510560|465926018|FG000|Overall Study|Discontinued from Treatment|27|||
129444058|NCT02510560|465926019|FG001|Overall Study|Discontinued from Treatment|18|||
129444059|NCT02510560|465926020|FG002|Overall Study|Discontinued from Treatment|19|||
129444060|NCT02510560|465926018|FG000|Overall Study|Other|4|||
129444061|NCT02510560|465926019|FG001|Overall Study|Other|4|||
129444062|NCT02510560|465926020|FG002|Overall Study|Other|3|||
129444063|NCT00132496|465926021|FG000|Overall Study|Withdrawal by Subject|1|||
129444064|NCT00132496|465926022|FG001|Overall Study|Withdrawal by Subject|2|||
129444065|NCT00132496|465926021|FG000|Overall Study|Physician Decision|1|||
129444066|NCT00132496|465926022|FG001|Overall Study|Physician Decision|0|||
129444067|NCT02014740|465926027|FG000|Overall Study|Lost to Follow-up|4|||
129444068|NCT02014740|465926028|FG001|Overall Study|Lost to Follow-up|4|||
129444069|NCT02014740|465926027|FG000|Overall Study|Withdrawal by Subject|2|||
129444070|NCT02014740|465926028|FG001|Overall Study|Withdrawal by Subject|1|||
129444071|NCT01431534|465926029|FG000|Treatment Phase|Adverse Event|0|||
129444072|NCT01431534|465926030|FG001|Treatment Phase|Adverse Event|0|||
129444073|NCT01431534|465926031|FG002|Treatment Phase|Adverse Event|1|||
129444074|NCT01431534|465926029|FG000|Treatment Phase|Progressive Disease|4|||
129444075|NCT01431534|465926030|FG001|Treatment Phase|Progressive Disease|3|||
129444076|NCT01431534|465926031|FG002|Treatment Phase|Progressive Disease|10|||
129444077|NCT02554903|465926034|FG000|Overall Study|Death|1|||
129444078|NCT02554903|465926035|FG001|Overall Study|Death|1|||
129444079|NCT02554903|465926034|FG000|Overall Study|Physician Decision|2|||
129444080|NCT02554903|465926035|FG001|Overall Study|Physician Decision|2|||
129444081|NCT02554903|465926034|FG000|Overall Study|Heart Transplant|1|||
129444082|NCT02554903|465926035|FG001|Overall Study|Heart Transplant|2|||
129444083|NCT02742766|465926036|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444084|NCT02742766|465926037|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444085|NCT02742766|465926038|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444086|NCT02742766|465926039|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444087|NCT02742766|465926040|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444088|NCT02742766|465926041|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444089|NCT02742766|465926042|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444090|NCT02742766|465926043|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444091|NCT02742766|465926044|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444092|NCT02742766|465926045|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129648920|NCT00550862|466671539|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129444093|NCT02742766|465926046|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444094|NCT02742766|465926047|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444095|NCT02742766|465926048|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129648921|NCT00550862|466671540|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
129444096|NCT02742766|465926049|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
129444097|NCT02742766|465926050|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444098|NCT02742766|465926051|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444099|NCT02742766|465926052|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444100|NCT02742766|465926053|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444101|NCT02742766|465926054|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
129444102|NCT02742766|465926036|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444103|NCT02742766|465926037|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444104|NCT02742766|465926038|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444105|NCT02742766|465926039|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
129648922|NCT00550862|466671541|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129648923|NCT00550862|466671542|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
129648924|NCT00550862|466671538|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129648925|NCT00550862|466671539|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
129648926|NCT00550862|466671540|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129648927|NCT00550862|466671541|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129648928|NCT00550862|466671542|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
129648929|NCT00550862|466671538|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129648930|NCT00550862|466671539|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129648931|NCT00550862|466671540|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129648932|NCT00550862|466671541|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
129648933|NCT00550862|466671542|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
129648934|NCT00550862|466671538|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129648935|NCT00550862|466671539|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129648936|NCT00550862|466671540|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129648937|NCT00550862|466671541|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
129648938|NCT00550862|466671542|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
129648939|NCT00550862|466671538|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129648940|NCT00550862|466671539|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129648941|NCT00550862|466671540|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129648942|NCT00550862|466671541|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
129648943|NCT00550862|466671542|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
129648944|NCT00550862|466671538|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
129648945|NCT00550862|466671539|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
129648946|NCT00550862|466671540|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
129648947|NCT00550862|466671541|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
129648948|NCT00550862|466671542|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
129648949|NCT00550862|466671538|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129648950|NCT00550862|466671539|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129648951|NCT00550862|466671540|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129648952|NCT00550862|466671541|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
129648953|NCT00550862|466671542|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
129648954|NCT03488225|466671545|FG000|Overall Study|Off Protocol Therapy|2|||
129648955|NCT03488225|466671545|FG000|Overall Study|Stem Cell Transplant|2|||
129648956|NCT00986986|466671546|FG000|Overall Study|Lost to Follow-up|0|||
129648957|NCT00986986|466671547|FG001|Overall Study|Lost to Follow-up|1|||
129648958|NCT02003963|466671550|FG000|Overall Study|Lost to Follow-up|2|||
129648959|NCT02003963|466671551|FG001|Overall Study|Lost to Follow-up|1|||
129648960|NCT05020366|466671553|FG000|Overall Study|Lost to Follow-up|2|||
129648961|NCT05020366|466671554|FG001|Overall Study|Lost to Follow-up|0|||
129648962|NCT05020366|466671553|FG000|Overall Study|Withdrawal by Subject|2|||
129648963|NCT05020366|466671554|FG001|Overall Study|Withdrawal by Subject|0|||
129648964|NCT03589326|466671556|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
129648965|NCT03589326|466671557|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
129648966|NCT03589326|466671556|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
129648967|NCT03589326|466671557|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
129648968|NCT03589326|466671556|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
129648969|NCT03589326|466671557|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
129648970|NCT03589326|466671556|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
129648971|NCT03589326|466671557|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
129648972|NCT03589326|466671556|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
129648973|NCT03589326|466671557|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
129648974|NCT04050124|466671558|FG000|Overall Study|Death|1|||
129648975|NCT04050124|466671559|FG001|Overall Study|Death|0|||
129648976|NCT00430352|466671561|FG000|Overall Study|Disease progression|58|||
129709222|NCT02750514|466898361|FG001|Track 4|Adverse event unrelated to study drug|5|||
129648977|NCT00430352|466671561|FG000|Overall Study|Withdrawal by Subject|11|||
129648978|NCT00430352|466671561|FG000|Overall Study|Adverse Event|16|||
129648979|NCT00430352|466671561|FG000|Overall Study|Death|5|||
129709223|NCT02750514|466898362|FG002|Track 4|Adverse event unrelated to study drug|0|||
129648980|NCT00430352|466671561|FG000|Overall Study|Other|48|||
129648981|NCT00819780|466671564|FG000|Overall Study|Did not receive study drug|3|||
129648982|NCT00819780|466671565|FG001|Overall Study|Did not receive study drug|4|||
129648983|NCT00819780|466671564|FG000|Overall Study|Still in treatment|25|||
129648984|NCT00819780|466671565|FG001|Overall Study|Still in treatment|17|||
129648985|NCT00150800|466671566|FG000|Overall Study|Adverse Event|89|||
129648986|NCT00150800|466671566|FG000|Overall Study|Death|18|||
129648987|NCT00150800|466671566|FG000|Overall Study|Lack of Efficacy|166|||
129648988|NCT00150800|466671566|FG000|Overall Study|Lost to Follow-up|58|||
129648989|NCT00150800|466671566|FG000|Overall Study|Subject's choice|90|||
129648990|NCT00150800|466671566|FG000|Overall Study|No compliance|18|||
129648991|NCT00150800|466671566|FG000|Overall Study|IP misshandling|1|||
129648992|NCT00150800|466671566|FG000|Overall Study|Site closure|24|||
129648993|NCT00150800|466671566|FG000|Overall Study|Protocol non-adherence|2|||
129648994|NCT00150800|466671566|FG000|Overall Study|Nobody to accompany patient|1|||
129648995|NCT00150800|466671566|FG000|Overall Study|Distance too long for patient|1|||
129648996|NCT00150800|466671566|FG000|Overall Study|Neurosurgery|2|||
129648997|NCT00150800|466671566|FG000|Overall Study|BRV monotherapy|1|||
129648998|NCT00150800|466671566|FG000|Overall Study|Visit refusal|3|||
129648999|NCT00150800|466671566|FG000|Overall Study|Sponsor's request|2|||
129649000|NCT00150800|466671566|FG000|Overall Study|Generalized Epilepsy|1|||
129649001|NCT00150800|466671566|FG000|Overall Study|Moved from area/country|8|||
129649002|NCT00150800|466671566|FG000|Overall Study|PI retiring|2|||
129649003|NCT00150800|466671566|FG000|Overall Study|PI leaving site|2|||
129649004|NCT00150800|466671566|FG000|Overall Study|Patient insurance|1|||
129649005|NCT00150800|466671566|FG000|Overall Study|Surgical intervention|4|||
129649006|NCT00150800|466671566|FG000|Overall Study|Pregnancy planned|1|||
129649007|NCT00150800|466671566|FG000|Overall Study|PI discontinuation request|1|||
129649008|NCT02089334|466671567|FG000|Overall Study|Withdrawal by Subject|0|||
129649009|NCT02089334|466671568|FG001|Overall Study|Withdrawal by Subject|0|||
129649010|NCT02089334|466671569|FG002|Overall Study|Withdrawal by Subject|0|||
129649011|NCT02089334|466671570|FG003|Overall Study|Withdrawal by Subject|2|||
129649012|NCT02089334|466671567|FG000|Overall Study|Adverse Event|0|||
129649013|NCT02089334|466671568|FG001|Overall Study|Adverse Event|0|||
129649014|NCT02089334|466671569|FG002|Overall Study|Adverse Event|0|||
129649015|NCT02089334|466671570|FG003|Overall Study|Adverse Event|2|||
129649016|NCT02089334|466671567|FG000|Overall Study|Progressive disease|0|||
129649017|NCT02089334|466671568|FG001|Overall Study|Progressive disease|0|||
129649018|NCT02089334|466671569|FG002|Overall Study|Progressive disease|0|||
129649019|NCT02089334|466671570|FG003|Overall Study|Progressive disease|2|||
129649020|NCT02089334|466671567|FG000|Overall Study|Physician Decision|0|||
129649021|NCT02089334|466671568|FG001|Overall Study|Physician Decision|0|||
129649022|NCT02089334|466671569|FG002|Overall Study|Physician Decision|1|||
129649023|NCT02089334|466671570|FG003|Overall Study|Physician Decision|1|||
129649024|NCT02832375|466671571|FG000|Overall Study|Lost to Follow-up|1|||
129649025|NCT02832375|466671572|FG001|Overall Study|Lost to Follow-up|0|||
129649026|NCT02832375|466671571|FG000|Overall Study|Withdrawal of Consent|1|||
129649027|NCT02832375|466671572|FG001|Overall Study|Withdrawal of Consent|0|||
129649028|NCT00084318|466671575|FG000|Overall Study|Withdrawal by Subject|5|||
129649029|NCT00084318|466671576|FG001|Overall Study|Withdrawal by Subject|2|||
129649030|NCT00084318|466671575|FG000|Overall Study|Protocol Violation|15|||
129649031|NCT00084318|466671576|FG001|Overall Study|Protocol Violation|11|||
129649032|NCT00084318|466671575|FG000|Overall Study|No protocol treatment|2|||
129649033|NCT00084318|466671576|FG001|Overall Study|No protocol treatment|0|||
129649034|NCT03301740|466671578|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
129649035|NCT03301740|466671579|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
129649036|NCT03301740|466671578|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
129649037|NCT03301740|466671579|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
129649038|NCT01037127|466671580|FG000|Overall Study|Lost to Follow-up|2|||
129649039|NCT01037127|466671581|FG001|Overall Study|Lost to Follow-up|4|||
129649040|NCT01037127|466671580|FG000|Overall Study|Physician Decision|1|||
129649041|NCT01037127|466671581|FG001|Overall Study|Physician Decision|0|||
129649042|NCT01037127|466671580|FG000|Overall Study|Study Closed Terminated|2|||
129649043|NCT01037127|466671581|FG001|Overall Study|Study Closed Terminated|17|||
129649044|NCT02637713|466671588|FG000|Overall Study|Screen Failure|2|||
129649045|NCT02847182|466671589|FG000|Overall Study|Withdrawal by Subject|0|||
129649046|NCT02847182|466671590|FG001|Overall Study|Withdrawal by Subject|1|||
129649047|NCT02345889|466671591|FG000|Overall Study|Inadequate Bowel Prep|17|||
129649048|NCT02345889|466671592|FG001|Overall Study|Inadequate Bowel Prep|16|||
129649049|NCT02345889|466671593|FG002|Overall Study|Inadequate Bowel Prep|18|||
129649050|NCT02345889|466671594|FG003|Overall Study|Inadequate Bowel Prep|14|||
129649051|NCT02345889|466671591|FG000|Overall Study|Polyposis identified during procedure|1|||
129649052|NCT02345889|466671592|FG001|Overall Study|Polyposis identified during procedure|1|||
129649053|NCT02345889|466671593|FG002|Overall Study|Polyposis identified during procedure|0|||
129649054|NCT02345889|466671594|FG003|Overall Study|Polyposis identified during procedure|1|||
129709224|NCT02750514|466898363|FG003|Track 4|Adverse event unrelated to study drug|0|||
129709225|NCT02750514|466898364|FG004|Track 4|Adverse event unrelated to study drug|0|||
129649055|NCT02345889|466671591|FG000|Overall Study|Recognized ineligible post-randomization|1|||
129649056|NCT02345889|466671592|FG001|Overall Study|Recognized ineligible post-randomization|0|||
129649057|NCT02345889|466671593|FG002|Overall Study|Recognized ineligible post-randomization|2|||
129649058|NCT02345889|466671594|FG003|Overall Study|Recognized ineligible post-randomization|1|||
129649059|NCT02345889|466671591|FG000|Overall Study|Ulcerative Colitis identified|1|||
129649060|NCT02345889|466671592|FG001|Overall Study|Ulcerative Colitis identified|0|||
129649061|NCT02345889|466671593|FG002|Overall Study|Ulcerative Colitis identified|0|||
129649062|NCT02345889|466671594|FG003|Overall Study|Ulcerative Colitis identified|0|||
129649063|NCT02345889|466671591|FG000|Overall Study|Cecum not intubated|1|||
129649064|NCT02345889|466671592|FG001|Overall Study|Cecum not intubated|0|||
129649065|NCT02345889|466671593|FG002|Overall Study|Cecum not intubated|0|||
129649066|NCT02345889|466671594|FG003|Overall Study|Cecum not intubated|0|||
129649067|NCT01173055|466671596|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
129649068|NCT01173055|466671597|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
129649069|NCT01173055|466671596|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
129649070|NCT01173055|466671597|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
129649071|NCT04325698|466671598|FG000|Overall Study|Study Terminated By Sponsor|1|||
129649072|NCT04325698|466671599|FG001|Overall Study|Study Terminated By Sponsor|1|||
129649073|NCT04325698|466671598|FG000|Overall Study|Withdrawal by Subject|0|||
129649074|NCT04325698|466671599|FG001|Overall Study|Withdrawal by Subject|2|||
129649075|NCT04253782|466671600|FG000|Overall Study|Death|2|||
129649076|NCT04253782|466671601|FG001|Overall Study|Death|0|||
129649077|NCT00962091|466671602|FG000|Overall Study|Withdrawal by Subject|1|||
129649078|NCT00962091|466671603|FG001|Overall Study|Withdrawal by Subject|2|||
129649079|NCT00962091|466671604|FG002|Overall Study|Withdrawal by Subject|1|||
129649080|NCT00962091|466671605|FG003|Overall Study|Withdrawal by Subject|1|||
129649081|NCT00962091|466671606|FG004|Overall Study|Withdrawal by Subject|0|||
129649082|NCT00962091|466671607|FG005|Overall Study|Withdrawal by Subject|1|||
129649083|NCT00962091|466671608|FG006|Overall Study|Withdrawal by Subject|0|||
129649084|NCT00962091|466671602|FG000|Overall Study|Adverse Event|0|||
129649085|NCT00962091|466671603|FG001|Overall Study|Adverse Event|0|||
129649086|NCT00962091|466671604|FG002|Overall Study|Adverse Event|0|||
129649087|NCT00962091|466671605|FG003|Overall Study|Adverse Event|0|||
129649088|NCT00962091|466671606|FG004|Overall Study|Adverse Event|0|||
129649089|NCT00962091|466671607|FG005|Overall Study|Adverse Event|0|||
129649090|NCT00962091|466671608|FG006|Overall Study|Adverse Event|1|||
129649091|NCT04216589|466671610|FG000|Overall Study|Withdrawal by Subject|2|||
129649092|NCT04216589|466671610|FG000|Overall Study|Protocol Violation|1|||
129649093|NCT04216589|466671610|FG000|Overall Study|Incarceration|1|||
129649094|NCT02326298|466671615|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649095|NCT02326298|466671616|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129709226|NCT02750514|466898360|FG000|Track 4|Death|0|||
129709227|NCT02750514|466898361|FG001|Track 4|Death|0|||
129709228|NCT02750514|466898362|FG002|Track 4|Death|0|||
129709229|NCT02750514|466898363|FG003|Track 4|Death|1|||
129709230|NCT02750514|466898364|FG004|Track 4|Death|0|||
129709231|NCT02750514|466898360|FG000|Track 5|Disease progression|0|||
129800667|NCT01008150|467238171|FG003|Overall Study|did not receive study drug|0|||
129649096|NCT02326298|466671617|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
129649097|NCT02326298|466671618|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649098|NCT02326298|466671619|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649099|NCT02326298|466671620|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649100|NCT02326298|466671621|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649101|NCT02326298|466671622|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649102|NCT02326298|466671623|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129709232|NCT02750514|466898361|FG001|Track 5|Disease progression|0|||
129709233|NCT02750514|466898362|FG002|Track 5|Disease progression|0|||
129709234|NCT02750514|466898363|FG003|Track 5|Disease progression|0|||
129800668|NCT03845543|467238173|FG000|Overall Study|Death|25|||
129891266|NCT00994279|467559690|FG001|Overall Study|Multiple reasons|3|||
129709235|NCT02750514|466898364|FG004|Track 5|Disease progression|34|||
129709236|NCT02750514|466898360|FG000|Track 5|Adverse event unrelated to study drug|0|||
129444106|NCT02742766|465926040|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444107|NCT02742766|465926041|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444108|NCT02742766|465926042|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444109|NCT02742766|465926043|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444110|NCT02742766|465926044|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444111|NCT02742766|465926045|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444112|NCT02742766|465926046|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444113|NCT02742766|465926047|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444114|NCT02742766|465926048|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
129444115|NCT02742766|465926049|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
129444116|NCT02742766|465926050|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444117|NCT02742766|465926051|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
129444118|NCT02742766|465926052|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444119|NCT02742766|465926053|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444120|NCT02742766|465926054|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
129444121|NCT04427501|465926055|FG000|Overall Study|Death|0|||
129444122|NCT04427501|465926056|FG001|Overall Study|Death|0|||
129444123|NCT04427501|465926057|FG002|Overall Study|Death|0|||
129444124|NCT04427501|465926058|FG003|Overall Study|Death|0|||
129444125|NCT04427501|465926059|FG004|Overall Study|Death|0|||
129444126|NCT04427501|465926060|FG005|Overall Study|Death|15|||
129649103|NCT02326298|466671624|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649104|NCT02326298|466671625|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649105|NCT02326298|466671626|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649106|NCT02326298|466671627|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649107|NCT02326298|466671628|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129649108|NCT02326298|466671615|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
129649109|NCT02326298|466671616|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649110|NCT02326298|466671617|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649111|NCT02326298|466671618|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649112|NCT02326298|466671619|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649113|NCT02326298|466671620|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649114|NCT02326298|466671621|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649115|NCT02326298|466671622|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649116|NCT02326298|466671623|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649117|NCT02326298|466671624|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649118|NCT02326298|466671625|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649119|NCT02326298|466671626|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649120|NCT02326298|466671627|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649121|NCT02326298|466671628|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
129649122|NCT02326298|466671615|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
129649123|NCT02326298|466671616|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
129649124|NCT02326298|466671617|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649125|NCT02326298|466671618|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649126|NCT02326298|466671619|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649127|NCT02326298|466671620|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649128|NCT02326298|466671621|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649129|NCT02326298|466671622|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649130|NCT02326298|466671623|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649131|NCT02326298|466671624|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649132|NCT02326298|466671625|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649133|NCT02326298|466671626|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649134|NCT02326298|466671627|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649135|NCT02326298|466671628|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
129649136|NCT02326298|466671615|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
129649137|NCT02326298|466671616|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
129649138|NCT02326298|466671617|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649139|NCT02326298|466671618|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649140|NCT02326298|466671619|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649141|NCT02326298|466671620|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649142|NCT02326298|466671621|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649143|NCT02326298|466671622|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649144|NCT02326298|466671623|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649145|NCT02326298|466671624|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649146|NCT02326298|466671625|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129444127|NCT04427501|465926061|FG006|Overall Study|Death|0|||
129444128|NCT04427501|465926062|FG007|Overall Study|Death|0|||
129444129|NCT04427501|465926063|FG008|Overall Study|Death|0|||
129800669|NCT03845543|467238173|FG000|Overall Study|Withdrawal by Subject|2|||
129800670|NCT03845543|467238173|FG000|Overall Study|Lost to Follow-up|12|||
129800671|NCT03845543|467238173|FG000|Overall Study|Adverse Event|17|||
129800672|NCT01400815|467238176|FG000|Overall Study|Adverse Event|3|||
129800673|NCT01400815|467238177|FG001|Overall Study|Adverse Event|0|||
129800674|NCT01400815|467238176|FG000|Overall Study|Death|0|||
129800675|NCT01400815|467238177|FG001|Overall Study|Death|1|||
129800676|NCT01400815|467238176|FG000|Overall Study|Lost to Follow-up|18|||
129800677|NCT01400815|467238177|FG001|Overall Study|Lost to Follow-up|11|||
129800678|NCT01400815|467238176|FG000|Overall Study|Protocol Violation|0|||
129800679|NCT01400815|467238177|FG001|Overall Study|Protocol Violation|1|||
129800680|NCT01400815|467238176|FG000|Overall Study|Physician Decision|1|||
129800681|NCT01400815|467238177|FG001|Overall Study|Physician Decision|0|||
129800682|NCT01400815|467238176|FG000|Overall Study|Withdrawal by Subject|15|||
129800683|NCT01400815|467238177|FG001|Overall Study|Withdrawal by Subject|8|||
129800684|NCT01400815|467238176|FG000|Overall Study|Subject in jail|1|||
129800685|NCT01400815|467238177|FG001|Overall Study|Subject in jail|0|||
129800686|NCT01123850|467238179|FG000|Overall Study|Slow enrollment|45|||
129800687|NCT00381381|467238188|FG000|Overall Study|Adverse Event|3|||
129800688|NCT00381381|467238188|FG000|Overall Study|Lost to Follow-up|52|||
129800689|NCT00381381|467238188|FG000|Overall Study|Withdrawal by Subject|9|||
129800690|NCT02001181|467238192|FG000|Overall Study|Adverse Event|0|||
129800691|NCT02001181|467238193|FG001|Overall Study|Adverse Event|2|||
129649147|NCT02326298|466671626|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649148|NCT02326298|466671627|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649149|NCT02326298|466671628|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129649150|NCT02326298|466671615|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649151|NCT02326298|466671616|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649152|NCT02326298|466671617|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
129649153|NCT02326298|466671618|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649154|NCT02326298|466671619|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649155|NCT02326298|466671620|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649156|NCT02326298|466671621|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649157|NCT02326298|466671622|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649158|NCT02326298|466671623|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649159|NCT02326298|466671624|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649160|NCT02326298|466671625|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649161|NCT02326298|466671626|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649162|NCT02326298|466671627|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649163|NCT02326298|466671628|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
129649164|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649165|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649166|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649167|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649168|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649169|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129649170|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
129800692|NCT02001181|467238192|FG000|Overall Study|Lost to Follow-up|1|||
129800693|NCT02001181|467238193|FG001|Overall Study|Lost to Follow-up|0|||
129800694|NCT02001181|467238192|FG000|Overall Study|Withdrawal by Subject|0|||
129800695|NCT02001181|467238193|FG001|Overall Study|Withdrawal by Subject|1|||
129800696|NCT00292318|467238195|FG000|Overall Study|Study terminated by officials|2|||
129800697|NCT00292318|467238196|FG001|Overall Study|Study terminated by officials|1|||
129800698|NCT00771316|467238197|FG000|Overall Study|Adverse Event|0|||
129800699|NCT00771316|467238198|FG001|Overall Study|Adverse Event|1|||
129709237|NCT02750514|466898361|FG001|Track 5|Adverse event unrelated to study drug|0|||
129709238|NCT02750514|466898362|FG002|Track 5|Adverse event unrelated to study drug|0|||
129709239|NCT02750514|466898363|FG003|Track 5|Adverse event unrelated to study drug|0|||
129709240|NCT02750514|466898364|FG004|Track 5|Adverse event unrelated to study drug|2|||
129709241|NCT02750514|466898360|FG000|Track 5|Study drug toxicity|0|||
129709242|NCT02750514|466898361|FG001|Track 5|Study drug toxicity|0|||
129709243|NCT02750514|466898362|FG002|Track 5|Study drug toxicity|0|||
129709244|NCT02750514|466898363|FG003|Track 5|Study drug toxicity|0|||
129709245|NCT02750514|466898364|FG004|Track 5|Study drug toxicity|2|||
129709246|NCT02750514|466898360|FG000|Track 5|Participant request to discontinue|0|||
129709247|NCT02750514|466898361|FG001|Track 5|Participant request to discontinue|0|||
129649171|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129649172|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129649173|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129649174|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649175|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649176|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649177|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129649178|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649179|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649180|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649181|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649182|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649183|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
129649184|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
129649185|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649186|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
129649187|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649188|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649189|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649190|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649191|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
129649192|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649193|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649194|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649195|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649196|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649197|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
129709248|NCT02750514|466898362|FG002|Track 5|Participant request to discontinue|0|||
129709249|NCT02750514|466898363|FG003|Track 5|Participant request to discontinue|0|||
129709250|NCT02750514|466898364|FG004|Track 5|Participant request to discontinue|3|||
129709251|NCT02750514|466898360|FG000|Track 5|Other reasons|0|||
129709252|NCT02750514|466898361|FG001|Track 5|Other reasons|0|||
129709253|NCT02750514|466898362|FG002|Track 5|Other reasons|0|||
129709254|NCT02750514|466898363|FG003|Track 5|Other reasons|0|||
129709255|NCT02750514|466898364|FG004|Track 5|Other reasons|2|||
129709256|NCT02553629|466898365|FG000|Overall Study|Logistic reasons|3|||
129709257|NCT02553629|466898366|FG001|Overall Study|Logistic reasons|6|||
129709258|NCT00696878|466898369|FG000|Overall Study|Adverse Event|8|||
129709259|NCT00696878|466898369|FG000|Overall Study|Withdrawal by Subject|87|||
129709260|NCT00696878|466898369|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
129709261|NCT00696878|466898369|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
129709262|NCT00696878|466898369|FG000|Overall Study|Trial stopped|32|||
129709263|NCT00696878|466898369|FG000|Overall Study|Other reason (not specified)|55|||
129709264|NCT02259114|466898370|FG000|Overall Study|Progressive Disease|14|||
129709265|NCT02259114|466898371|FG001|Overall Study|Progressive Disease|2|||
129709266|NCT02259114|466898372|FG002|Overall Study|Progressive Disease|10|||
129709267|NCT02259114|466898373|FG003|Overall Study|Progressive Disease|2|||
129709268|NCT02259114|466898374|FG004|Overall Study|Progressive Disease|5|||
129709269|NCT02259114|466898370|FG000|Overall Study|Adverse Event|2|||
129709270|NCT02259114|466898371|FG001|Overall Study|Adverse Event|1|||
129709271|NCT02259114|466898372|FG002|Overall Study|Adverse Event|0|||
129709272|NCT02259114|466898373|FG003|Overall Study|Adverse Event|0|||
129709273|NCT02259114|466898374|FG004|Overall Study|Adverse Event|1|||
129709274|NCT02259114|466898370|FG000|Overall Study|Death|3|||
129709275|NCT02259114|466898371|FG001|Overall Study|Death|0|||
129800700|NCT00771316|467238197|FG000|Overall Study|Patient withdrew consent|1|||
129709276|NCT02259114|466898372|FG002|Overall Study|Death|1|||
129709277|NCT02259114|466898373|FG003|Overall Study|Death|0|||
129709278|NCT02259114|466898374|FG004|Overall Study|Death|0|||
129709279|NCT02259114|466898370|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129709280|NCT02259114|466898371|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129709281|NCT02259114|466898372|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
129709282|NCT02259114|466898373|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129709283|NCT02259114|466898374|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
129709284|NCT02259114|466898370|FG000|Overall Study|Withdrawal by Subject|0|||
129709285|NCT02259114|466898371|FG001|Overall Study|Withdrawal by Subject|0|||
129709286|NCT02259114|466898372|FG002|Overall Study|Withdrawal by Subject|1|||
129709287|NCT02259114|466898373|FG003|Overall Study|Withdrawal by Subject|1|||
129709288|NCT02259114|466898374|FG004|Overall Study|Withdrawal by Subject|0|||
129709289|NCT02259114|466898370|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
129709290|NCT02259114|466898371|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
129709291|NCT02259114|466898372|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
129709292|NCT02259114|466898373|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
129709293|NCT02259114|466898374|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
129649198|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129709294|NCT02259114|466898370|FG000|Overall Study|Not Treated|1|||
129709295|NCT02259114|466898371|FG001|Overall Study|Not Treated|0|||
129709296|NCT02259114|466898372|FG002|Overall Study|Not Treated|0|||
129709297|NCT02259114|466898373|FG003|Overall Study|Not Treated|0|||
129709298|NCT02259114|466898374|FG004|Overall Study|Not Treated|0|||
129709299|NCT03937479|466898375|FG000|Overall Study|Adverse Event|2|||
129709300|NCT03937479|466898376|FG001|Overall Study|Adverse Event|3|||
129709301|NCT03937479|466898377|FG002|Overall Study|Adverse Event|0|||
129709302|NCT03937479|466898378|FG003|Overall Study|Adverse Event|0|||
129709303|NCT03937479|466898379|FG004|Overall Study|Adverse Event|1|||
129709304|NCT03937479|466898375|FG000|Overall Study|Withdrawal by Subject|3|||
129709305|NCT03937479|466898376|FG001|Overall Study|Withdrawal by Subject|5|||
129709306|NCT03937479|466898377|FG002|Overall Study|Withdrawal by Subject|2|||
129709307|NCT03937479|466898378|FG003|Overall Study|Withdrawal by Subject|2|||
129709308|NCT03937479|466898379|FG004|Overall Study|Withdrawal by Subject|1|||
129709309|NCT03937479|466898375|FG000|Overall Study|Protocol Violation|5|||
129709310|NCT03937479|466898376|FG001|Overall Study|Protocol Violation|6|||
129709311|NCT03937479|466898377|FG002|Overall Study|Protocol Violation|4|||
129709312|NCT03937479|466898378|FG003|Overall Study|Protocol Violation|3|||
129709313|NCT03937479|466898379|FG004|Overall Study|Protocol Violation|2|||
129709314|NCT03937479|466898375|FG000|Overall Study|Lost to Follow-up|0|||
129709315|NCT03937479|466898376|FG001|Overall Study|Lost to Follow-up|1|||
129709316|NCT03937479|466898377|FG002|Overall Study|Lost to Follow-up|0|||
129709317|NCT03937479|466898378|FG003|Overall Study|Lost to Follow-up|1|||
129709318|NCT03937479|466898379|FG004|Overall Study|Lost to Follow-up|0|||
129709319|NCT03937479|466898375|FG000|Overall Study|Physician Decision|0|||
129709320|NCT03937479|466898376|FG001|Overall Study|Physician Decision|0|||
129709321|NCT03937479|466898377|FG002|Overall Study|Physician Decision|1|||
129709322|NCT03937479|466898378|FG003|Overall Study|Physician Decision|0|||
129709323|NCT03937479|466898379|FG004|Overall Study|Physician Decision|1|||
129649199|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649200|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649201|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649202|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649203|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649204|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649205|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
129649206|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649207|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649208|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649209|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649210|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129709324|NCT02712788|466898380|FG000|Overall Study|Physician Decision|1|||
129709325|NCT02712788|466898381|FG001|Overall Study|Physician Decision|0|||
129709326|NCT02712788|466898380|FG000|Overall Study|Protocol Violation|1|||
129709327|NCT02712788|466898381|FG001|Overall Study|Protocol Violation|0|||
129709328|NCT00940602|466898382|FG000|Overall Study|Administrative problems|1|||
129709329|NCT00940602|466898383|FG001|Overall Study|Administrative problems|1|||
129709330|NCT00940602|466898382|FG000|Overall Study|Patient/guardian decision|13|||
129709331|NCT00940602|466898383|FG001|Overall Study|Patient/guardian decision|28|||
129709332|NCT00940602|466898382|FG000|Overall Study|Physician Decision|8|||
129709333|NCT00940602|466898383|FG001|Overall Study|Physician Decision|5|||
129709334|NCT00940602|466898382|FG000|Overall Study|Pregnancy|1|||
129709335|NCT00940602|466898383|FG001|Overall Study|Pregnancy|0|||
129709336|NCT00940602|466898382|FG000|Overall Study|Protocol Deviation (untreated)|1|||
129709337|NCT00940602|466898383|FG001|Overall Study|Protocol Deviation (untreated)|0|||
129444130|NCT04427501|465926064|FG009|Overall Study|Death|0|||
129444131|NCT04427501|465926065|FG010|Overall Study|Death|0|||
129444132|NCT04427501|465926066|FG011|Overall Study|Death|0|||
129444133|NCT04427501|465926055|FG000|Overall Study|Lost to Follow-up|5|||
129444134|NCT04427501|465926056|FG001|Overall Study|Lost to Follow-up|1|||
129444135|NCT04427501|465926057|FG002|Overall Study|Lost to Follow-up|2|||
129444136|NCT04427501|465926058|FG003|Overall Study|Lost to Follow-up|0|||
129444137|NCT04427501|465926059|FG004|Overall Study|Lost to Follow-up|2|||
129444138|NCT04427501|465926060|FG005|Overall Study|Lost to Follow-up|11|||
129444139|NCT04427501|465926061|FG006|Overall Study|Lost to Follow-up|10|||
129444140|NCT04427501|465926062|FG007|Overall Study|Lost to Follow-up|10|||
129444141|NCT04427501|465926063|FG008|Overall Study|Lost to Follow-up|2|||
129444142|NCT04427501|465926064|FG009|Overall Study|Lost to Follow-up|5|||
129444143|NCT04427501|465926065|FG010|Overall Study|Lost to Follow-up|2|||
129444144|NCT04427501|465926066|FG011|Overall Study|Lost to Follow-up|0|||
129444145|NCT04427501|465926055|FG000|Overall Study|Physician Decision|0|||
129444146|NCT04427501|465926056|FG001|Overall Study|Physician Decision|3|||
129444147|NCT04427501|465926057|FG002|Overall Study|Physician Decision|0|||
129444148|NCT04427501|465926058|FG003|Overall Study|Physician Decision|0|||
129444149|NCT04427501|465926059|FG004|Overall Study|Physician Decision|0|||
129444150|NCT04427501|465926060|FG005|Overall Study|Physician Decision|0|||
129444151|NCT04427501|465926061|FG006|Overall Study|Physician Decision|2|||
129444152|NCT04427501|465926062|FG007|Overall Study|Physician Decision|0|||
129444153|NCT04427501|465926063|FG008|Overall Study|Physician Decision|0|||
129444154|NCT04427501|465926064|FG009|Overall Study|Physician Decision|0|||
129444155|NCT04427501|465926065|FG010|Overall Study|Physician Decision|0|||
129444156|NCT04427501|465926066|FG011|Overall Study|Physician Decision|0|||
129444157|NCT04427501|465926055|FG000|Overall Study|Withdrawal by Subject|9|||
129444158|NCT04427501|465926056|FG001|Overall Study|Withdrawal by Subject|2|||
129444159|NCT04427501|465926057|FG002|Overall Study|Withdrawal by Subject|2|||
129444160|NCT04427501|465926058|FG003|Overall Study|Withdrawal by Subject|3|||
129444161|NCT04427501|465926059|FG004|Overall Study|Withdrawal by Subject|7|||
129444162|NCT04427501|465926060|FG005|Overall Study|Withdrawal by Subject|25|||
129444163|NCT04427501|465926061|FG006|Overall Study|Withdrawal by Subject|15|||
129444164|NCT04427501|465926062|FG007|Overall Study|Withdrawal by Subject|7|||
129444165|NCT04427501|465926063|FG008|Overall Study|Withdrawal by Subject|4|||
129444166|NCT04427501|465926064|FG009|Overall Study|Withdrawal by Subject|1|||
129444167|NCT04427501|465926065|FG010|Overall Study|Withdrawal by Subject|4|||
129444168|NCT04427501|465926066|FG011|Overall Study|Withdrawal by Subject|0|||
129444169|NCT04427501|465926055|FG000|Overall Study|Other - as reported by the investigator|1|||
129444170|NCT04427501|465926056|FG001|Overall Study|Other - as reported by the investigator|0|||
129444171|NCT04427501|465926057|FG002|Overall Study|Other - as reported by the investigator|0|||
129444172|NCT04427501|465926058|FG003|Overall Study|Other - as reported by the investigator|0|||
129444173|NCT04427501|465926059|FG004|Overall Study|Other - as reported by the investigator|0|||
129444174|NCT04427501|465926060|FG005|Overall Study|Other - as reported by the investigator|6|||
129444175|NCT04427501|465926061|FG006|Overall Study|Other - as reported by the investigator|6|||
129444176|NCT04427501|465926062|FG007|Overall Study|Other - as reported by the investigator|0|||
129444177|NCT04427501|465926063|FG008|Overall Study|Other - as reported by the investigator|0|||
129709338|NCT00940602|466898382|FG000|Overall Study|Disease progression|8|||
129709339|NCT00940602|466898383|FG001|Overall Study|Disease progression|2|||
129709340|NCT00940602|466898382|FG000|Overall Study|Death|38|||
129709341|NCT00940602|466898383|FG001|Overall Study|Death|19|||
129891267|NCT01606189|467559691|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891268|NCT01606189|467559692|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891269|NCT01606189|467559693|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891270|NCT01606189|467559694|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891271|NCT01606189|467559695|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
129891272|NCT01606189|467559696|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
129891273|NCT01606189|467559691|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129891274|NCT01606189|467559692|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129891275|NCT01606189|467559693|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129891276|NCT01606189|467559694|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129709342|NCT00940602|466898382|FG000|Overall Study|Lost to Follow-up|3|||
129709343|NCT00940602|466898383|FG001|Overall Study|Lost to Follow-up|1|||
129709344|NCT00940602|466898382|FG000|Overall Study|Patient withdrew consent|26|||
129444178|NCT04427501|465926064|FG009|Overall Study|Other - as reported by the investigator|0|||
129709345|NCT00940602|466898383|FG001|Overall Study|Patient withdrew consent|13|||
129444179|NCT04427501|465926065|FG010|Overall Study|Other - as reported by the investigator|0|||
129444180|NCT04427501|465926066|FG011|Overall Study|Other - as reported by the investigator|0|||
129444181|NCT04427501|465926055|FG000|Overall Study|Other|0|||
129709346|NCT00940602|466898382|FG000|Overall Study|Adverse Event|7|||
129444182|NCT04427501|465926056|FG001|Overall Study|Other|0|||
129444183|NCT04427501|465926057|FG002|Overall Study|Other|0|||
129444184|NCT04427501|465926058|FG003|Overall Study|Other|0|||
129444185|NCT04427501|465926059|FG004|Overall Study|Other|0|||
129709347|NCT00940602|466898383|FG001|Overall Study|Adverse Event|2|||
129649211|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649212|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
129649213|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649214|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649215|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649216|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649217|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649218|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649219|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
129649220|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649221|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649222|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649223|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649224|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649225|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649226|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649227|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
129649228|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649229|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649230|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649231|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649232|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649233|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
129649234|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649235|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649236|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649237|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649238|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649239|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649240|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
129649241|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
129649242|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649243|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649244|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649245|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649246|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129649247|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129800701|NCT00771316|467238198|FG001|Overall Study|Patient withdrew consent|0|||
129800702|NCT00771316|467238197|FG000|Overall Study|Discontinued due to early termination|1|||
129800703|NCT00771316|467238198|FG001|Overall Study|Discontinued due to early termination|0|||
129800704|NCT02027376|467238199|FG000|Overall Study|Death|1|||
129800705|NCT02027376|467238200|FG001|Overall Study|Death|0|||
129800706|NCT02027376|467238201|FG002|Overall Study|Death|0|||
129800707|NCT00843726|467238202|FG000|Overall Study|Death|1|||
129800708|NCT00843726|467238203|FG001|Overall Study|Death|0|||
129800709|NCT00843726|467238202|FG000|Overall Study|Withdrawal by Subject|0|||
129800710|NCT00843726|467238203|FG001|Overall Study|Withdrawal by Subject|1|||
129800711|NCT00406718|467238204|FG000|Overall Study|Withdrawal by Subject|2|||
129800712|NCT00406718|467238205|FG001|Overall Study|Withdrawal by Subject|9|||
129800713|NCT00406718|467238206|FG002|Overall Study|Withdrawal by Subject|4|||
129800714|NCT00406718|467238204|FG000|Overall Study|Lost to Follow-up|2|||
129800715|NCT00406718|467238205|FG001|Overall Study|Lost to Follow-up|5|||
129800716|NCT00406718|467238206|FG002|Overall Study|Lost to Follow-up|4|||
129800717|NCT01897714|467239837|FG000|Phase I (Dose Escalation)|Disease progression|3|||
129800718|NCT01897714|467239838|FG001|Phase I (Dose Escalation)|Disease progression|5|||
129800719|NCT01897714|467239839|FG002|Phase I (Dose Escalation)|Disease progression|1|||
129800720|NCT01897714|467239840|FG003|Phase I (Dose Escalation)|Disease progression|3|||
129444186|NCT04427501|465926060|FG005|Overall Study|Other|0|||
129444187|NCT04427501|465926061|FG006|Overall Study|Other|0|||
129444188|NCT04427501|465926062|FG007|Overall Study|Other|0|||
129444189|NCT04427501|465926063|FG008|Overall Study|Other|0|||
129444190|NCT04427501|465926064|FG009|Overall Study|Other|0|||
129649248|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129800721|NCT01897714|467239841|FG004|Phase I (Dose Escalation)|Disease progression|0|||
129649249|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649250|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649251|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649252|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129800722|NCT01897714|467239842|FG005|Phase I (Dose Escalation)|Disease progression|0|||
129800723|NCT01897714|467239837|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
129800724|NCT01897714|467239838|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
129649253|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649254|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649255|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129649256|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649257|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649258|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649259|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649260|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649261|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129649262|NCT02326298|466671615|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649263|NCT02326298|466671616|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649264|NCT02326298|466671617|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649265|NCT02326298|466671618|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649266|NCT02326298|466671619|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649267|NCT02326298|466671620|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
129649268|NCT02326298|466671621|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649269|NCT02326298|466671622|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649270|NCT02326298|466671623|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649271|NCT02326298|466671624|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649272|NCT02326298|466671625|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649273|NCT02326298|466671626|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649274|NCT02326298|466671627|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649275|NCT02326298|466671628|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
129649276|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
129649277|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
129649278|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
129649279|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
129649280|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
129649281|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
129649282|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
129800725|NCT01897714|467239839|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
129800726|NCT01897714|467239840|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
129800727|NCT01897714|467239841|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
129709348|NCT00940602|466898382|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
129709349|NCT00940602|466898383|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
129709350|NCT01880957|466898384|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
129709351|NCT01880957|466898385|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
129709352|NCT01880957|466898384|FG000|Overall Study|Lost to Follow-up|11|||
129709353|NCT01880957|466898385|FG001|Overall Study|Lost to Follow-up|0|||
129709354|NCT01880957|466898384|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
129709355|NCT01880957|466898385|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
129709356|NCT00575666|466898388|FG000|Overall Study|Withdrawal by Subject|3|||
129709357|NCT00575666|466898389|FG001|Overall Study|Withdrawal by Subject|2|||
129709358|NCT00575666|466898388|FG000|Overall Study|Physician Decision|1|||
129709359|NCT00575666|466898389|FG001|Overall Study|Physician Decision|1|||
129709360|NCT00508482|466898390|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
129709361|NCT00508482|466898391|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
129709362|NCT00508482|466898392|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
129709363|NCT00508482|466898390|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
129709364|NCT00508482|466898391|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
129709365|NCT00508482|466898392|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
129709366|NCT00508482|466898390|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
129709367|NCT00508482|466898391|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
129709368|NCT00508482|466898392|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
129709369|NCT02359903|466898393|FG000|Overall Study|Adverse Event|0|||
129709370|NCT02359903|466898394|FG001|Overall Study|Adverse Event|2|||
129709371|NCT02289469|466898395|FG000|Overall Study|Unable to match a control|6|||
129709372|NCT02289469|466898396|FG001|Overall Study|Unable to match a control|0|||
129709373|NCT00546481|466898397|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
129709374|NCT00546481|466898398|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
129709375|NCT00546481|466898399|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
129709376|NCT00546481|466898397|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
129709377|NCT00546481|466898398|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
129709378|NCT00546481|466898399|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
129709379|NCT00546481|466898397|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
129709380|NCT00546481|466898398|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
129709381|NCT00546481|466898399|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
129709382|NCT00546481|466898397|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
129709383|NCT00546481|466898398|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
129709384|NCT00546481|466898399|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
129709385|NCT00546481|466898397|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
129709386|NCT00546481|466898398|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
129709387|NCT00546481|466898399|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
129709388|NCT00546481|466898397|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
129709389|NCT00546481|466898398|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
129709390|NCT00546481|466898399|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
129709391|NCT00546481|466898397|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
129709392|NCT00546481|466898398|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
129709393|NCT00546481|466898399|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
129709394|NCT00546481|466898397|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
129709395|NCT00546481|466898398|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
129709396|NCT00546481|466898399|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
129709397|NCT00546481|466898397|FG000|Maintenance Phase (CERA)|Other Reason|0|||
129709398|NCT00546481|466898398|FG001|Maintenance Phase (CERA)|Other Reason|0|||
129709399|NCT00546481|466898399|FG002|Maintenance Phase (CERA)|Other Reason|1|||
129709400|NCT01077063|466898403|FG000|Overall Study|Adverse Event|3|||
129709401|NCT01077063|466898404|FG001|Overall Study|Adverse Event|0|||
129709402|NCT01077063|466898403|FG000|Overall Study|Death|1|||
129709403|NCT01077063|466898404|FG001|Overall Study|Death|1|||
129709404|NCT01077063|466898403|FG000|Overall Study|Withdrawal by Subject|0|||
129800728|NCT01897714|467239842|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
129800729|NCT01897714|467239837|FG000|Phase I (Dose Escalation)|Other|0|||
129800730|NCT01897714|467239838|FG001|Phase I (Dose Escalation)|Other|1|||
129800731|NCT01897714|467239839|FG002|Phase I (Dose Escalation)|Other|0|||
129800732|NCT01897714|467239840|FG003|Phase I (Dose Escalation)|Other|0|||
129800733|NCT01897714|467239841|FG004|Phase I (Dose Escalation)|Other|0|||
129709405|NCT01077063|466898404|FG001|Overall Study|Withdrawal by Subject|2|||
129709406|NCT02750930|466898405|FG000|Overall Study|Study closed/terminated|8|||
129709407|NCT02761642|466898407|FG000|Overall Study|Did not Receive Study Treatment|3|||
129709408|NCT02761642|466898407|FG000|Overall Study|Adverse Event|13|||
129800734|NCT01897714|467239842|FG005|Phase I (Dose Escalation)|Other|0|||
129800735|NCT01897714|467239837|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
129709409|NCT02761642|466898407|FG000|Overall Study|Withdrawal by Subject|2|||
129709410|NCT02761642|466898407|FG000|Overall Study|Non-compliant|7|||
129709411|NCT02761642|466898407|FG000|Overall Study|Death|3|||
129709412|NCT02761642|466898407|FG000|Overall Study|Lack of Efficacy|20|||
129709413|NCT02761642|466898407|FG000|Overall Study|Physician Decision|1|||
129709414|NCT02761642|466898407|FG000|Overall Study|Reason Unspecified|21|||
129709415|NCT02756403|466898412|FG000|Overall Study|Unable to swallow medication|0|||
129709416|NCT02756403|466898413|FG001|Overall Study|Unable to swallow medication|1|||
129709417|NCT02756403|466898414|FG002|Overall Study|Unable to swallow medication|1|||
129709418|NCT02756403|466898415|FG003|Overall Study|Unable to swallow medication|1|||
129709419|NCT02756403|466898412|FG000|Overall Study|Did not complete Procedure|0|||
129709420|NCT02756403|466898413|FG001|Overall Study|Did not complete Procedure|1|||
129709421|NCT02756403|466898414|FG002|Overall Study|Did not complete Procedure|0|||
129709422|NCT02756403|466898415|FG003|Overall Study|Did not complete Procedure|0|||
129709423|NCT02756403|466898412|FG000|Overall Study|Changed Mind About Procedure|0|||
129709424|NCT02756403|466898413|FG001|Overall Study|Changed Mind About Procedure|0|||
129709425|NCT02756403|466898414|FG002|Overall Study|Changed Mind About Procedure|1|||
129709426|NCT02756403|466898415|FG003|Overall Study|Changed Mind About Procedure|0|||
129709427|NCT02756403|466898412|FG000|Overall Study|Protocol Violation|0|||
129709428|NCT02756403|466898413|FG001|Overall Study|Protocol Violation|1|||
129709429|NCT02756403|466898414|FG002|Overall Study|Protocol Violation|0|||
129709430|NCT02756403|466898415|FG003|Overall Study|Protocol Violation|1|||
129709431|NCT01644643|466898416|FG000|Overall Study|Death|1|||
129709432|NCT01644643|466898417|FG001|Overall Study|Death|0|||
129709433|NCT01644643|466898418|FG002|Overall Study|Death|3|||
129709434|NCT01644643|466898419|FG003|Overall Study|Death|3|||
129709435|NCT01644643|466898416|FG000|Overall Study|Lost to Follow-up|0|||
129709436|NCT01644643|466898417|FG001|Overall Study|Lost to Follow-up|0|||
129709437|NCT01644643|466898418|FG002|Overall Study|Lost to Follow-up|0|||
129709438|NCT01644643|466898419|FG003|Overall Study|Lost to Follow-up|4|||
129709439|NCT01644643|466898416|FG000|Overall Study|Withdrawal by Subject|1|||
129709440|NCT01644643|466898417|FG001|Overall Study|Withdrawal by Subject|0|||
129709441|NCT01644643|466898418|FG002|Overall Study|Withdrawal by Subject|2|||
129709442|NCT01644643|466898419|FG003|Overall Study|Withdrawal by Subject|1|||
129709443|NCT01644643|466898416|FG000|Overall Study|Other Eligibility criteria|0|||
129709444|NCT01644643|466898417|FG001|Overall Study|Other Eligibility criteria|0|||
129709445|NCT01644643|466898418|FG002|Overall Study|Other Eligibility criteria|0|||
129709446|NCT01644643|466898419|FG003|Overall Study|Other Eligibility criteria|2|||
129709447|NCT00776789|466898424|FG000|Overall Study|Consent refusal|2|||
129709448|NCT00776789|466898425|FG001|Overall Study|Consent refusal|2|||
129709449|NCT00776789|466898424|FG000|Overall Study|Poor quality video|1|||
129709450|NCT00776789|466898425|FG001|Overall Study|Poor quality video|1|||
129709451|NCT02850978|466898428|FG000|Overall Study|Uncollectable CRF|27|||
129709452|NCT02850978|466898428|FG000|Overall Study|No visit since the first visit|35|||
129709453|NCT02850978|466898428|FG000|Overall Study|Adverse Event|81|||
129709454|NCT02850978|466898428|FG000|Overall Study|Lack of Efficacy|40|||
129709455|NCT02850978|466898428|FG000|Overall Study|Improvement in condition|34|||
129709456|NCT02850978|466898428|FG000|Overall Study|Lost to Follow-up|121|||
129709457|NCT02850978|466898428|FG000|Overall Study|Reason not listed|88|||
129709458|NCT00165789|466898432|FG000|Overall Study|Adverse Event|0|||
129709459|NCT00165789|466898433|FG001|Overall Study|Adverse Event|3|||
129709460|NCT00165789|466898434|FG002|Overall Study|Adverse Event|0|||
129709461|NCT00165789|466898435|FG003|Overall Study|Adverse Event|12|||
129709462|NCT00165789|466898432|FG000|Overall Study|Withdrawal by Subject|0|||
129709463|NCT00165789|466898433|FG001|Overall Study|Withdrawal by Subject|1|||
129709464|NCT00165789|466898434|FG002|Overall Study|Withdrawal by Subject|1|||
129709465|NCT00165789|466898435|FG003|Overall Study|Withdrawal by Subject|2|||
129709466|NCT00656370|466898440|FG000|Overall Study|Screen Failures|7|||
129709467|NCT00656370|466898440|FG000|Overall Study|Alternates|3|||
129709468|NCT01342094|466898441|FG000|Overall Study|Adverse Event|5|||
129709469|NCT01342094|466898442|FG001|Overall Study|Adverse Event|0|||
129709470|NCT01342094|466898441|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129709471|NCT01342094|466898442|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
129709472|NCT01342094|466898441|FG000|Overall Study|Withdrawal by Subject|0|||
129709473|NCT01342094|466898442|FG001|Overall Study|Withdrawal by Subject|2|||
129709474|NCT03069716|466898447|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
129709475|NCT03069716|466898448|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
129709476|NCT03069716|466898449|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
129709477|NCT03069716|466898447|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
129709478|NCT03069716|466898448|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
129709479|NCT03069716|466898449|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
129709480|NCT03069716|466898447|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
129709481|NCT03069716|466898448|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
129709482|NCT03069716|466898449|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
129709483|NCT03069716|466898447|FG000|Randomized Treatment|Withdrawal by Subject|0|||
129709484|NCT03069716|466898448|FG001|Randomized Treatment|Withdrawal by Subject|2|||
129709485|NCT03069716|466898449|FG002|Randomized Treatment|Withdrawal by Subject|0|||
129709486|NCT03391882|466898450|FG000|Study Overall|Adverse Event|3|||
129709487|NCT03391882|466898451|FG001|Study Overall|Adverse Event|6|||
129709488|NCT03391882|466898452|FG002|Study Overall|Adverse Event|1|||
129709489|NCT03391882|466898453|FG003|Study Overall|Adverse Event|1|||
129709490|NCT03391882|466898454|FG004|Study Overall|Adverse Event|3|||
129709491|NCT03391882|466898455|FG005|Study Overall|Adverse Event|1|||
129709492|NCT03391882|466898450|FG000|Study Overall|Lack of Efficacy|13|||
129709493|NCT03391882|466898451|FG001|Study Overall|Lack of Efficacy|9|||
129709494|NCT03391882|466898452|FG002|Study Overall|Lack of Efficacy|0|||
129709495|NCT03391882|466898453|FG003|Study Overall|Lack of Efficacy|0|||
129709496|NCT03391882|466898454|FG004|Study Overall|Lack of Efficacy|0|||
129709497|NCT03391882|466898455|FG005|Study Overall|Lack of Efficacy|0|||
129709498|NCT03391882|466898450|FG000|Study Overall|Withdrawal by Subject|3|||
129709499|NCT03391882|466898451|FG001|Study Overall|Withdrawal by Subject|3|||
129709500|NCT03391882|466898452|FG002|Study Overall|Withdrawal by Subject|2|||
129709501|NCT03391882|466898453|FG003|Study Overall|Withdrawal by Subject|2|||
129709502|NCT03391882|466898454|FG004|Study Overall|Withdrawal by Subject|1|||
129709503|NCT03391882|466898455|FG005|Study Overall|Withdrawal by Subject|3|||
129709504|NCT03391882|466898450|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129709505|NCT03391882|466898451|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
129709506|NCT03391882|466898452|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129709507|NCT03391882|466898453|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129709508|NCT03391882|466898454|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129709509|NCT03391882|466898455|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
129709510|NCT03391882|466898450|FG000|Study Overall|Protocol Violation|1|||
129709511|NCT03391882|466898451|FG001|Study Overall|Protocol Violation|0|||
129709512|NCT03391882|466898452|FG002|Study Overall|Protocol Violation|0|||
129709513|NCT03391882|466898453|FG003|Study Overall|Protocol Violation|0|||
129709514|NCT03391882|466898454|FG004|Study Overall|Protocol Violation|0|||
129709515|NCT03391882|466898455|FG005|Study Overall|Protocol Violation|0|||
129709516|NCT03391882|466898450|FG000|Part A - Titration Phase|Adverse Event|3|||
129709517|NCT03391882|466898451|FG001|Part A - Titration Phase|Adverse Event|6|||
129709518|NCT03391882|466898452|FG002|Part A - Titration Phase|Adverse Event|0|||
129709519|NCT03391882|466898453|FG003|Part A - Titration Phase|Adverse Event|0|||
129709520|NCT03391882|466898454|FG004|Part A - Titration Phase|Adverse Event|0|||
129709521|NCT03391882|466898455|FG005|Part A - Titration Phase|Adverse Event|0|||
129709522|NCT03391882|466898450|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
129709523|NCT03391882|466898451|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
129709524|NCT03391882|466898452|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
129709525|NCT03391882|466898453|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
129709526|NCT03391882|466898454|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
129709527|NCT03391882|466898455|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
129709528|NCT03391882|466898450|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
129709529|NCT03391882|466898451|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
129709530|NCT03391882|466898452|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
129709531|NCT03391882|466898453|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
129709532|NCT03391882|466898454|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
129709533|NCT03391882|466898455|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
129709534|NCT03391882|466898450|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129709535|NCT03391882|466898451|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
129709536|NCT03391882|466898452|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129709537|NCT03391882|466898453|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129709538|NCT03391882|466898454|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129709539|NCT03391882|466898455|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
129709540|NCT03391882|466898450|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
129709541|NCT03391882|466898451|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
129709542|NCT03391882|466898452|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
129709543|NCT03391882|466898453|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
129709544|NCT03391882|466898454|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
129709545|NCT03391882|466898455|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
129709546|NCT03391882|466898450|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
129709547|NCT03391882|466898451|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
129709548|NCT03391882|466898452|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
129709549|NCT03391882|466898453|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
129709550|NCT03391882|466898454|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
129709551|NCT03391882|466898455|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
129709552|NCT03391882|466898450|FG000|Part B - Treatment Phase|Adverse Event|0|||
129709553|NCT03391882|466898451|FG001|Part B - Treatment Phase|Adverse Event|0|||
129709554|NCT03391882|466898452|FG002|Part B - Treatment Phase|Adverse Event|1|||
129649283|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
129649284|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
129649285|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
129649286|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
129649287|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
129649288|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
129649289|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
129649290|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649291|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649292|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649293|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649294|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649295|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649296|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649297|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649298|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649299|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649300|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649301|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
129649302|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
129649303|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
129649304|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649305|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649306|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649307|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649308|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649309|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649310|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649311|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649312|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649313|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649314|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649315|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129649316|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129649317|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129649318|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649319|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649320|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649321|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649322|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649323|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649324|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649325|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649326|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649327|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649328|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649329|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649330|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
129649331|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
129649332|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649333|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649334|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649335|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649336|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649337|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649338|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649339|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649340|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649341|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649342|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129649343|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
129649344|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
129649345|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129891277|NCT01606189|467559695|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
129649346|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649347|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649348|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649349|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649350|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649351|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649352|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649353|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649354|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649355|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649356|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
129649357|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
129649358|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
129649359|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
129649360|NCT02326298|466671615|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649361|NCT02326298|466671616|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649362|NCT02326298|466671617|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129709555|NCT03391882|466898453|FG003|Part B - Treatment Phase|Adverse Event|1|||
129709556|NCT03391882|466898454|FG004|Part B - Treatment Phase|Adverse Event|3|||
129709557|NCT03391882|466898455|FG005|Part B - Treatment Phase|Adverse Event|1|||
129709558|NCT03391882|466898450|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
129709559|NCT03391882|466898451|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
129709560|NCT03391882|466898452|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
129709561|NCT03391882|466898453|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
129709562|NCT03391882|466898454|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
129709563|NCT03391882|466898455|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
129709564|NCT03913130|466898456|FG000|Overall Study|Sponsor Decision|1|||
129709565|NCT01085214|466898459|FG000|Overall Study|Alternate treatment required|1|||
129709566|NCT01634152|466898460|FG000|Overall Study|Adverse Event|2|||
129709567|NCT01634152|466898461|FG001|Overall Study|Adverse Event|0|||
129709568|NCT01634152|466898462|FG002|Overall Study|Adverse Event|2|||
129709569|NCT01634152|466898460|FG000|Overall Study|Consent withdrawn not due to AE|1|||
129709570|NCT01634152|466898461|FG001|Overall Study|Consent withdrawn not due to AE|0|||
129709571|NCT01634152|466898462|FG002|Overall Study|Consent withdrawn not due to AE|1|||
129709572|NCT01634152|466898460|FG000|Overall Study|Not treated|0|||
129709573|NCT01634152|466898461|FG001|Overall Study|Not treated|1|||
129709574|NCT01634152|466898462|FG002|Overall Study|Not treated|0|||
129709575|NCT01634152|466898460|FG000|Overall Study|Other reason not defined above|1|||
129709576|NCT01634152|466898461|FG001|Overall Study|Other reason not defined above|0|||
129709577|NCT01634152|466898462|FG002|Overall Study|Other reason not defined above|1|||
129709578|NCT01985022|466898476|FG000|Overall Study|Lost to Follow-up|0|||
129709579|NCT01985022|466898477|FG001|Overall Study|Lost to Follow-up|1|||
129709580|NCT01985022|466898476|FG000|Overall Study|Protocol Violation|0|||
129709581|NCT01985022|466898477|FG001|Overall Study|Protocol Violation|1|||
129709582|NCT01985022|466898476|FG000|Overall Study|Withdrawal by Subject|4|||
129709583|NCT01985022|466898477|FG001|Overall Study|Withdrawal by Subject|1|||
129709584|NCT01152437|466898478|FG000|Overall Study|Other Adverse Event|8|||
129709585|NCT01152437|466898479|FG001|Overall Study|Other Adverse Event|1|||
129709586|NCT01152437|466898480|FG002|Overall Study|Other Adverse Event|7|||
129709587|NCT01152437|466898478|FG000|Overall Study|Not treated|0|||
129800736|NCT01897714|467239838|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
129800737|NCT01897714|467239839|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
129800738|NCT01897714|467239840|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
129800739|NCT01897714|467239841|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
129800740|NCT01897714|467239842|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
129800741|NCT01897714|467239837|FG000|Phase II (MTD)|Lost to Follow-up|0|||
129800742|NCT01897714|467239838|FG001|Phase II (MTD)|Lost to Follow-up|0|||
129800743|NCT01897714|467239839|FG002|Phase II (MTD)|Lost to Follow-up|0|||
129709588|NCT01152437|466898479|FG001|Overall Study|Not treated|1|||
129709589|NCT01152437|466898480|FG002|Overall Study|Not treated|2|||
129709590|NCT01152437|466898478|FG000|Overall Study|Progressive disease|27|||
129709591|NCT01152437|466898479|FG001|Overall Study|Progressive disease|13|||
129709592|NCT01152437|466898480|FG002|Overall Study|Progressive disease|32|||
129709593|NCT01152437|466898478|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
129709594|NCT01152437|466898479|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
129709595|NCT01152437|466898480|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
129800744|NCT01897714|467239840|FG003|Phase II (MTD)|Lost to Follow-up|0|||
129800745|NCT01897714|467239841|FG004|Phase II (MTD)|Lost to Follow-up|1|||
129649363|NCT02326298|466671618|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649364|NCT02326298|466671619|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649365|NCT02326298|466671620|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649366|NCT02326298|466671621|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649367|NCT02326298|466671622|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649368|NCT02326298|466671623|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649369|NCT02326298|466671624|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649370|NCT02326298|466671625|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129649371|NCT02326298|466671626|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
129649372|NCT02326298|466671627|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
129649373|NCT02326298|466671628|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
129649374|NCT03191864|466671630|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
129649375|NCT03191864|466671631|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
129649376|NCT03191864|466671632|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
129649377|NCT03191864|466671633|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
129649378|NCT03191864|466671634|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
129649379|NCT03191864|466671635|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
129649380|NCT03191864|466671630|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129649381|NCT03191864|466671631|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129649382|NCT03191864|466671632|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129649383|NCT03191864|466671633|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129649384|NCT03191864|466671634|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
129649385|NCT03191864|466671635|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
129649386|NCT03191864|466671630|FG000|Baseline Symptom Assessment|Adverse Event|0|||
129649387|NCT03191864|466671631|FG001|Baseline Symptom Assessment|Adverse Event|0|||
129649388|NCT03191864|466671632|FG002|Baseline Symptom Assessment|Adverse Event|0|||
129649389|NCT03191864|466671633|FG003|Baseline Symptom Assessment|Adverse Event|0|||
129649390|NCT03191864|466671634|FG004|Baseline Symptom Assessment|Adverse Event|0|||
129649391|NCT03191864|466671635|FG005|Baseline Symptom Assessment|Adverse Event|2|||
129649392|NCT03191864|466671630|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129649393|NCT03191864|466671631|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129649394|NCT03191864|466671632|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129649395|NCT03191864|466671633|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129649396|NCT03191864|466671634|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
129649397|NCT03191864|466671635|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
129649398|NCT03191864|466671630|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129649399|NCT03191864|466671631|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129649400|NCT03191864|466671632|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129649401|NCT03191864|466671633|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129649402|NCT03191864|466671634|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
129649403|NCT03191864|466671635|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
129649404|NCT03191864|466671630|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129649405|NCT03191864|466671631|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129649406|NCT03191864|466671632|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
129649407|NCT03191864|466671633|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129649408|NCT03191864|466671634|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
129649409|NCT03191864|466671635|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
129649410|NCT03191864|466671630|FG000|Part 1 - Induction|Adverse Event|0|||
129649411|NCT03191864|466671631|FG001|Part 1 - Induction|Adverse Event|2|||
129649412|NCT03191864|466671632|FG002|Part 1 - Induction|Adverse Event|0|||
129649413|NCT03191864|466671633|FG003|Part 1 - Induction|Adverse Event|1|||
129649414|NCT03191864|466671634|FG004|Part 1 - Induction|Adverse Event|0|||
129649415|NCT03191864|466671635|FG005|Part 1 - Induction|Adverse Event|2|||
129649416|NCT03191864|466671630|FG000|Part 1 - Induction|Randomized but never dosed|0|||
129649417|NCT03191864|466671631|FG001|Part 1 - Induction|Randomized but never dosed|0|||
129649418|NCT03191864|466671632|FG002|Part 1 - Induction|Randomized but never dosed|1|||
129649419|NCT03191864|466671633|FG003|Part 1 - Induction|Randomized but never dosed|0|||
129649420|NCT03191864|466671634|FG004|Part 1 - Induction|Randomized but never dosed|0|||
129649421|NCT03191864|466671635|FG005|Part 1 - Induction|Randomized but never dosed|0|||
129649422|NCT03191864|466671630|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
129649423|NCT03191864|466671631|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
129649424|NCT03191864|466671632|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
129649425|NCT03191864|466671633|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
129649426|NCT03191864|466671634|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
129649427|NCT03191864|466671635|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
129649428|NCT03191864|466671630|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129800746|NCT01897714|467239842|FG005|Phase II (MTD)|Lost to Follow-up|0|||
129800747|NCT01897714|467239837|FG000|Phase II (MTD)|Death|0|||
129649429|NCT03191864|466671631|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129649430|NCT03191864|466671632|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
129649431|NCT03191864|466671633|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129649432|NCT03191864|466671634|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129649433|NCT03191864|466671635|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
129649434|NCT03191864|466671630|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
129649435|NCT03191864|466671631|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129649436|NCT03191864|466671632|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129649437|NCT03191864|466671633|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129649438|NCT03191864|466671634|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129649439|NCT03191864|466671635|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
129649440|NCT03191864|466671630|FG000|Part 2 - Maintenance|Physician Decision|1|||
129649441|NCT03191864|466671631|FG001|Part 2 - Maintenance|Physician Decision|0|||
129649442|NCT03191864|466671632|FG002|Part 2 - Maintenance|Physician Decision|0|||
129649443|NCT03191864|466671633|FG003|Part 2 - Maintenance|Physician Decision|0|||
129649444|NCT03191864|466671634|FG004|Part 2 - Maintenance|Physician Decision|0|||
129649445|NCT03191864|466671635|FG005|Part 2 - Maintenance|Physician Decision|0|||
129649446|NCT03191864|466671630|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
129649447|NCT03191864|466671631|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
129649448|NCT03191864|466671632|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
129649449|NCT03191864|466671633|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
129649450|NCT03191864|466671634|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
129649451|NCT03191864|466671635|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
129649452|NCT03191864|466671630|FG000|Part 2 - Maintenance|Adverse Event|0|||
129649453|NCT03191864|466671631|FG001|Part 2 - Maintenance|Adverse Event|0|||
129649454|NCT03191864|466671632|FG002|Part 2 - Maintenance|Adverse Event|0|||
129649455|NCT03191864|466671633|FG003|Part 2 - Maintenance|Adverse Event|0|||
129649456|NCT03191864|466671634|FG004|Part 2 - Maintenance|Adverse Event|1|||
129649457|NCT03191864|466671635|FG005|Part 2 - Maintenance|Adverse Event|0|||
129649458|NCT03191864|466671630|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
129649459|NCT03191864|466671631|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
129649460|NCT03191864|466671632|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
129649461|NCT03191864|466671633|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
129649462|NCT03191864|466671634|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
129649463|NCT03191864|466671635|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
129649464|NCT03191864|466671630|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129649465|NCT03191864|466671631|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129649466|NCT03191864|466671632|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129444191|NCT04427501|465926065|FG010|Overall Study|Other|0|||
129649467|NCT03191864|466671633|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129709596|NCT02317627|466898483|FG000|Overall Study|Withdrawal by Subject|0|||
129709597|NCT02317627|466898484|FG001|Overall Study|Withdrawal by Subject|1|||
129709598|NCT02317627|466898485|FG002|Overall Study|Withdrawal by Subject|1|||
129709599|NCT02317627|466898483|FG000|Overall Study|Lost to Follow-up|2|||
129709600|NCT02317627|466898484|FG001|Overall Study|Lost to Follow-up|0|||
129709601|NCT02317627|466898485|FG002|Overall Study|Lost to Follow-up|0|||
129444192|NCT04427501|465926066|FG011|Overall Study|Other|1|||
129709602|NCT02317627|466898483|FG000|Overall Study|Stopped by Investigator|0|||
129709603|NCT02317627|466898484|FG001|Overall Study|Stopped by Investigator|1|||
129709604|NCT02317627|466898485|FG002|Overall Study|Stopped by Investigator|0|||
129709605|NCT02317627|466898483|FG000|Overall Study|Adverse Event|0|||
129709606|NCT02317627|466898484|FG001|Overall Study|Adverse Event|2|||
129709607|NCT02317627|466898485|FG002|Overall Study|Adverse Event|3|||
129709608|NCT02317627|466898483|FG000|Overall Study|Non-compliance with study drug|0|||
129709609|NCT02317627|466898484|FG001|Overall Study|Non-compliance with study drug|1|||
129709610|NCT02317627|466898485|FG002|Overall Study|Non-compliance with study drug|0|||
129709611|NCT00279214|466898486|FG000|Overall Study|Physician Decision|3|||
129709612|NCT00279214|466898487|FG001|Overall Study|Physician Decision|2|||
129709613|NCT01214837|466898489|FG000|Overall Study|Death|0|||
129709614|NCT01214837|466898490|FG001|Overall Study|Death|0|||
129709615|NCT01214837|466898491|FG002|Overall Study|Death|1|||
129709616|NCT01214837|466898489|FG000|Overall Study|Adverse Event|1|||
129709617|NCT01214837|466898490|FG001|Overall Study|Adverse Event|2|||
129709618|NCT01214837|466898491|FG002|Overall Study|Adverse Event|1|||
129709619|NCT01214837|466898489|FG000|Overall Study|Withdrawal by Subject|27|||
129709620|NCT01214837|466898490|FG001|Overall Study|Withdrawal by Subject|36|||
129709621|NCT01214837|466898491|FG002|Overall Study|Withdrawal by Subject|28|||
129709622|NCT01214837|466898489|FG000|Overall Study|Lost to Follow-up|20|||
129709623|NCT01214837|466898490|FG001|Overall Study|Lost to Follow-up|15|||
129709624|NCT01214837|466898491|FG002|Overall Study|Lost to Follow-up|21|||
129709625|NCT01214837|466898489|FG000|Overall Study|Inappropriate Enrolment|0|||
129709626|NCT01214837|466898490|FG001|Overall Study|Inappropriate Enrolment|1|||
129709627|NCT01214837|466898491|FG002|Overall Study|Inappropriate Enrolment|2|||
129709628|NCT01214837|466898489|FG000|Overall Study|Administrative Reason|2|||
129709629|NCT01214837|466898490|FG001|Overall Study|Administrative Reason|6|||
129709630|NCT01214837|466898491|FG002|Overall Study|Administrative Reason|4|||
129709631|NCT01214837|466898489|FG000|Overall Study|Protocol Violation|3|||
129709632|NCT01214837|466898490|FG001|Overall Study|Protocol Violation|1|||
129709633|NCT01214837|466898491|FG002|Overall Study|Protocol Violation|5|||
129709634|NCT01214837|466898489|FG000|Overall Study|Unable to Classify|1|||
129709635|NCT01214837|466898490|FG001|Overall Study|Unable to Classify|3|||
129709636|NCT01214837|466898491|FG002|Overall Study|Unable to Classify|0|||
129709637|NCT00027560|466898492|FG000|Overall Study|Withdrawal by Subject|1|||
129709638|NCT00939107|466900021|FG000|Overall Study|Lost to Follow-up|14|||
129709639|NCT00939107|466900022|FG001|Overall Study|Lost to Follow-up|12|||
129709640|NCT02903823|466900023|FG000|Overall Study|Physician Decision|5|||
129709641|NCT02903823|466900023|FG000|Overall Study|Could not advance catheter|1|||
129709642|NCT02903823|466900023|FG000|Overall Study|Catheter dislodgement|1|||
129709643|NCT01123148|466900030|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
129709644|NCT01123148|466900030|FG000|Overall Study|Didn't meet milestone criteria|1|||
129709645|NCT00355030|466900031|FG000|Study Period 1 Treatment|Adverse Event|1|||
129709646|NCT00355030|466900032|FG001|Study Period 1 Treatment|Adverse Event|1|||
129709647|NCT00355030|466900031|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
129709648|NCT00355030|466900032|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
129709649|NCT00355030|466900031|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
129709650|NCT00355030|466900032|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
129709651|NCT00355030|466900031|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
129709652|NCT00355030|466900032|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
129709653|NCT00355030|466900031|FG000|Study Period 1 Treatment|Physician Decision|0|||
129709654|NCT00355030|466900032|FG001|Study Period 1 Treatment|Physician Decision|1|||
129709655|NCT00355030|466900031|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
129709656|NCT00355030|466900032|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
129709657|NCT00355030|466900031|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
129709658|NCT00355030|466900032|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
129709659|NCT00355030|466900031|FG000|Study Period 1 Treatment|Other|2|||
129709660|NCT00355030|466900032|FG001|Study Period 1 Treatment|Other|6|||
129709661|NCT00355030|466900031|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
129709662|NCT00355030|466900032|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
129709663|NCT00355030|466900031|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
129709664|NCT00355030|466900032|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
129709665|NCT01747915|466900033|FG000|Overall Study|Other|1|||
129709666|NCT01747915|466900034|FG001|Overall Study|Other|1|||
129709667|NCT01747915|466900035|FG002|Overall Study|Other|1|||
129709668|NCT01747915|466900033|FG000|Overall Study|Adverse Event|8|||
129709669|NCT01747915|466900034|FG001|Overall Study|Adverse Event|5|||
129709670|NCT01747915|466900035|FG002|Overall Study|Adverse Event|2|||
129709671|NCT01747915|466900033|FG000|Overall Study|Death|0|||
129709672|NCT01747915|466900034|FG001|Overall Study|Death|0|||
129709673|NCT01747915|466900035|FG002|Overall Study|Death|1|||
129709674|NCT01747915|466900033|FG000|Overall Study|Lack of Efficacy|0|||
129709675|NCT01747915|466900034|FG001|Overall Study|Lack of Efficacy|1|||
129709676|NCT01747915|466900035|FG002|Overall Study|Lack of Efficacy|0|||
129709677|NCT01747915|466900033|FG000|Overall Study|Lost to Follow-up|1|||
129709678|NCT01747915|466900034|FG001|Overall Study|Lost to Follow-up|0|||
129709679|NCT01747915|466900035|FG002|Overall Study|Lost to Follow-up|0|||
129709680|NCT01747915|466900033|FG000|Overall Study|Withdrawal by Subject|4|||
129709681|NCT01747915|466900034|FG001|Overall Study|Withdrawal by Subject|4|||
129709682|NCT01747915|466900035|FG002|Overall Study|Withdrawal by Subject|1|||
129709683|NCT01747915|466900033|FG000|Overall Study|Protocol Violation|1|||
129709684|NCT01747915|466900034|FG001|Overall Study|Protocol Violation|0|||
129709685|NCT01747915|466900035|FG002|Overall Study|Protocol Violation|0|||
129709686|NCT01747915|466900033|FG000|Overall Study|Pregnancy|0|||
129709687|NCT01747915|466900034|FG001|Overall Study|Pregnancy|0|||
129709688|NCT01747915|466900035|FG002|Overall Study|Pregnancy|1|||
129709689|NCT00812955|466900040|FG000|Overall Study|Adverse Event|7|||
129709690|NCT00812955|466900041|FG001|Overall Study|Adverse Event|6|||
129709691|NCT00812955|466900042|FG002|Overall Study|Adverse Event|3|||
129709692|NCT00812955|466900043|FG003|Overall Study|Adverse Event|4|||
129709693|NCT00812955|466900040|FG000|Overall Study|Lost to Follow-up|2|||
129709694|NCT00812955|466900041|FG001|Overall Study|Lost to Follow-up|1|||
129709695|NCT00812955|466900042|FG002|Overall Study|Lost to Follow-up|1|||
129709696|NCT00812955|466900043|FG003|Overall Study|Lost to Follow-up|2|||
129709697|NCT00812955|466900040|FG000|Overall Study|Withdrawal by Subject|1|||
129709698|NCT00812955|466900041|FG001|Overall Study|Withdrawal by Subject|0|||
129709699|NCT00812955|466900042|FG002|Overall Study|Withdrawal by Subject|1|||
129709700|NCT00812955|466900043|FG003|Overall Study|Withdrawal by Subject|2|||
129709701|NCT00812955|466900040|FG000|Overall Study|randomized in error|0|||
129709702|NCT00812955|466900041|FG001|Overall Study|randomized in error|0|||
129709703|NCT00812955|466900042|FG002|Overall Study|randomized in error|1|||
129709704|NCT00812955|466900043|FG003|Overall Study|randomized in error|0|||
129709705|NCT01772550|466900044|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
129709706|NCT01772550|466900045|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
129709707|NCT01772550|466900046|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
129709708|NCT01772550|466900044|FG000|Overall Study|Adverse Event|0|||
129709709|NCT01772550|466900045|FG001|Overall Study|Adverse Event|0|||
129709710|NCT01772550|466900046|FG002|Overall Study|Adverse Event|1|||
129709711|NCT01815424|466900047|FG000|Week 0 to 16|Adverse Event|1|||
129709712|NCT01815424|466900048|FG001|Week 0 to 16|Adverse Event|3|||
129709713|NCT01815424|466900049|FG002|Week 0 to 16|Adverse Event|3|||
129709714|NCT01815424|466900050|FG003|Week 0 to 16|Adverse Event|0|||
129709715|NCT01815424|466900051|FG004|Week 0 to 16|Adverse Event|0|||
129709716|NCT01815424|466900047|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
129709717|NCT01815424|466900048|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129709718|NCT01815424|466900049|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129709719|NCT01815424|466900050|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129709720|NCT01815424|466900051|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
129709721|NCT01815424|466900047|FG000|Week 0 to 16|Lost to Follow-up|0|||
129709722|NCT01815424|466900048|FG001|Week 0 to 16|Lost to Follow-up|1|||
129709723|NCT01815424|466900049|FG002|Week 0 to 16|Lost to Follow-up|0|||
129709724|NCT01815424|466900050|FG003|Week 0 to 16|Lost to Follow-up|0|||
129709725|NCT01815424|466900051|FG004|Week 0 to 16|Lost to Follow-up|0|||
129709726|NCT01815424|466900047|FG000|Week 0 to 16|Withdrawal by Subject|0|||
129709727|NCT01815424|466900048|FG001|Week 0 to 16|Withdrawal by Subject|0|||
129709728|NCT01815424|466900049|FG002|Week 0 to 16|Withdrawal by Subject|1|||
129709729|NCT01815424|466900050|FG003|Week 0 to 16|Withdrawal by Subject|0|||
129709730|NCT01815424|466900051|FG004|Week 0 to 16|Withdrawal by Subject|0|||
129709731|NCT01815424|466900047|FG000|Week 0 to 16|Other|1|||
129709732|NCT01815424|466900048|FG001|Week 0 to 16|Other|0|||
129709733|NCT01815424|466900049|FG002|Week 0 to 16|Other|3|||
129709734|NCT01815424|466900050|FG003|Week 0 to 16|Other|0|||
129709735|NCT01815424|466900051|FG004|Week 0 to 16|Other|0|||
129709736|NCT01815424|466900047|FG000|Week 0 to 16|Protocol Violation|1|||
129709737|NCT01815424|466900048|FG001|Week 0 to 16|Protocol Violation|0|||
129709738|NCT01815424|466900049|FG002|Week 0 to 16|Protocol Violation|0|||
129709739|NCT01815424|466900050|FG003|Week 0 to 16|Protocol Violation|0|||
129709740|NCT01815424|466900051|FG004|Week 0 to 16|Protocol Violation|0|||
129709741|NCT01815424|466900047|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
129709742|NCT01815424|466900048|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
129709743|NCT01815424|466900049|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
129709744|NCT01815424|466900050|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
129709745|NCT01815424|466900051|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
129709746|NCT01815424|466900047|FG000|Week 16 to 52|Other|0|||
129709747|NCT01815424|466900048|FG001|Week 16 to 52|Other|1|||
129709748|NCT01815424|466900049|FG002|Week 16 to 52|Other|0|||
129709749|NCT01815424|466900050|FG003|Week 16 to 52|Other|0|||
129709750|NCT01815424|466900051|FG004|Week 16 to 52|Other|0|||
129709751|NCT01815424|466900047|FG000|Week 16 to 52|Adverse Event|0|||
129709752|NCT01815424|466900048|FG001|Week 16 to 52|Adverse Event|0|||
129709753|NCT01815424|466900049|FG002|Week 16 to 52|Adverse Event|0|||
129709754|NCT01815424|466900050|FG003|Week 16 to 52|Adverse Event|0|||
129709755|NCT01815424|466900051|FG004|Week 16 to 52|Adverse Event|1|||
129709756|NCT01815424|466900047|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
129709757|NCT01815424|466900048|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
129709758|NCT01815424|466900049|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
129709759|NCT01815424|466900050|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
129709760|NCT01815424|466900051|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
129709761|NCT01815424|466900047|FG000|Week 16 to 52|Lost to Follow-up|0|||
129800748|NCT01897714|467239838|FG001|Phase II (MTD)|Death|0|||
129649468|NCT03191864|466671634|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
129649469|NCT03191864|466671635|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
129649470|NCT02342548|466671638|FG000|Overall Study|Adverse Event|12|||
129649471|NCT02342548|466671639|FG001|Overall Study|Adverse Event|17|||
129649472|NCT02342548|466671640|FG002|Overall Study|Adverse Event|13|||
129649473|NCT02342548|466671638|FG000|Overall Study|Lost to Follow-up|0|||
129649474|NCT02342548|466671639|FG001|Overall Study|Lost to Follow-up|1|||
129649475|NCT02342548|466671640|FG002|Overall Study|Lost to Follow-up|0|||
129649476|NCT02342548|466671638|FG000|Overall Study|Study terminated by sponsor|20|||
129649477|NCT02342548|466671639|FG001|Overall Study|Study terminated by sponsor|39|||
129649478|NCT02342548|466671640|FG002|Overall Study|Study terminated by sponsor|25|||
129649479|NCT02342548|466671638|FG000|Overall Study|Protocol Violation|0|||
129649480|NCT02342548|466671639|FG001|Overall Study|Protocol Violation|1|||
129649481|NCT02342548|466671640|FG002|Overall Study|Protocol Violation|0|||
129649482|NCT02342548|466671638|FG000|Overall Study|Withdrawal by Subject|1|||
129649483|NCT02342548|466671639|FG001|Overall Study|Withdrawal by Subject|3|||
129649484|NCT02342548|466671640|FG002|Overall Study|Withdrawal by Subject|4|||
129649485|NCT02342548|466671638|FG000|Overall Study|Other|1|||
129649486|NCT02342548|466671639|FG001|Overall Study|Other|1|||
129649487|NCT02342548|466671640|FG002|Overall Study|Other|1|||
129649488|NCT01047332|466671641|FG000|Overall Study|SEMS Obstruction|11|||
129649489|NCT01047332|466671642|FG001|Overall Study|SEMS Obstruction|20|||
129649490|NCT01047332|466671641|FG000|Overall Study|Died Unobstructed|38|||
129649491|NCT01047332|466671642|FG001|Overall Study|Died Unobstructed|41|||
129649492|NCT01047332|466671641|FG000|Overall Study|Lost to Follow-up|8|||
129649493|NCT01047332|466671642|FG001|Overall Study|Lost to Follow-up|3|||
129649494|NCT03521817|466671647|FG000|Overall Study|Protocol Violation|0|||
129649495|NCT03521817|466671648|FG001|Overall Study|Protocol Violation|1|||
129649496|NCT04240886|466673175|FG000|Treatment Phase|Death|4|||
129649497|NCT04240886|466673175|FG000|Treatment Phase|Discontinuation by Subject|1|||
129649498|NCT04240886|466673175|FG000|Treatment Phase|Adverse Event|5|||
129649499|NCT04240886|466673175|FG000|Follow-up Phase|Withdrawal by Subject|1|||
129649500|NCT04240886|466673175|FG000|Follow-up Phase|Discontinuation by Subject|1|||
129649501|NCT04240886|466673175|FG000|Follow-up Phase|Death|2|||
129649502|NCT04618471|466673176|FG000|Overall Study|Screen Failure|62|||
129649503|NCT04618471|466673176|FG000|Overall Study|Withdrawal by Subject|6|||
129649504|NCT04618471|466673176|FG000|Overall Study|Physician Decision|2|||
129649505|NCT04618471|466673176|FG000|Overall Study|Lost to Follow-up|1|||
129649506|NCT04618471|466673176|FG000|Overall Study|Various other reasons|2|||
129649507|NCT04618471|466673176|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
129649508|NCT01752634|466673177|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
129649509|NCT01752634|466673178|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
129649510|NCT01752634|466673179|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
129649511|NCT01752634|466673180|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
129649512|NCT01752634|466673181|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
129649513|NCT01752634|466673182|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
129649514|NCT01752634|466673177|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129649515|NCT01752634|466673178|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
129649516|NCT01752634|466673179|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129649517|NCT01752634|466673180|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129649518|NCT01752634|466673181|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129649519|NCT01752634|466673182|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
129649520|NCT01752634|466673177|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
129649521|NCT01752634|466673178|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
129649522|NCT01752634|466673179|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
129649523|NCT01752634|466673180|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
129649524|NCT01752634|466673181|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
129649525|NCT01752634|466673182|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
129649526|NCT01752634|466673177|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
129649527|NCT01752634|466673178|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
129649528|NCT01752634|466673179|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
129649529|NCT01752634|466673180|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
129649530|NCT01752634|466673181|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
129649531|NCT01752634|466673182|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
129649532|NCT01752634|466673177|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
129649533|NCT01752634|466673178|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
129649534|NCT01752634|466673179|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
129649535|NCT01752634|466673180|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
129649536|NCT01752634|466673181|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
129800749|NCT01897714|467239839|FG002|Phase II (MTD)|Death|0|||
129800750|NCT01897714|467239840|FG003|Phase II (MTD)|Death|0|||
129800751|NCT01897714|467239841|FG004|Phase II (MTD)|Death|25|||
129800752|NCT01897714|467239842|FG005|Phase II (MTD)|Death|10|||
129800753|NCT01897714|467239837|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
129800754|NCT01897714|467239838|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
129444193|NCT00999713|465926067|FG000|Overall Study|Physician Decision|2|||
129649537|NCT01752634|466673182|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
129649538|NCT01752634|466673177|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
129649539|NCT01752634|466673178|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
129649540|NCT01752634|466673179|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
129649541|NCT01752634|466673180|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
129649542|NCT01752634|466673181|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
129649543|NCT01752634|466673182|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
129649544|NCT01752634|466673177|FG000|Week 24 to Week 260|Physician Decision|1|||
129649545|NCT01752634|466673178|FG001|Week 24 to Week 260|Physician Decision|2|||
129649546|NCT01752634|466673179|FG002|Week 24 to Week 260|Physician Decision|4|||
129649547|NCT01752634|466673180|FG003|Week 24 to Week 260|Physician Decision|2|||
129649548|NCT01752634|466673181|FG004|Week 24 to Week 260|Physician Decision|1|||
129649549|NCT01752634|466673182|FG005|Week 24 to Week 260|Physician Decision|0|||
129649550|NCT01752634|466673177|FG000|Week 24 to Week 260|Death|0|||
129649551|NCT01752634|466673178|FG001|Week 24 to Week 260|Death|1|||
129649552|NCT01752634|466673179|FG002|Week 24 to Week 260|Death|0|||
129649553|NCT01752634|466673180|FG003|Week 24 to Week 260|Death|0|||
129649554|NCT01752634|466673181|FG004|Week 24 to Week 260|Death|0|||
129649555|NCT01752634|466673182|FG005|Week 24 to Week 260|Death|0|||
129649556|NCT01752634|466673177|FG000|Week 24 to Week 260|Pregnancy|0|||
129649557|NCT01752634|466673178|FG001|Week 24 to Week 260|Pregnancy|0|||
129649558|NCT01752634|466673179|FG002|Week 24 to Week 260|Pregnancy|1|||
129649559|NCT01752634|466673180|FG003|Week 24 to Week 260|Pregnancy|0|||
129649560|NCT01752634|466673181|FG004|Week 24 to Week 260|Pregnancy|0|||
129649561|NCT01752634|466673182|FG005|Week 24 to Week 260|Pregnancy|0|||
129649562|NCT01752634|466673177|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
129649563|NCT01752634|466673178|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
129649564|NCT01752634|466673179|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
129649565|NCT01752634|466673180|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
129649566|NCT01752634|466673181|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
129649567|NCT01752634|466673182|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
129649568|NCT01752634|466673177|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
129649569|NCT01752634|466673178|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
129649570|NCT01752634|466673179|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
129649571|NCT01752634|466673180|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
129649572|NCT01752634|466673181|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
129649573|NCT01752634|466673182|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
129649574|NCT01752634|466673177|FG000|Week 24 to Week 260|Adverse Event|4|||
129649575|NCT01752634|466673178|FG001|Week 24 to Week 260|Adverse Event|8|||
129649576|NCT01752634|466673179|FG002|Week 24 to Week 260|Adverse Event|8|||
129649577|NCT01752634|466673180|FG003|Week 24 to Week 260|Adverse Event|4|||
129649578|NCT01752634|466673181|FG004|Week 24 to Week 260|Adverse Event|2|||
129649579|NCT01752634|466673182|FG005|Week 24 to Week 260|Adverse Event|0|||
129649580|NCT01250171|466673183|FG000|Overall Study|Administrative reasons|1|||
129649581|NCT01250171|466673184|FG001|Overall Study|Administrative reasons|0|||
129649582|NCT01250171|466673185|FG002|Overall Study|Administrative reasons|0|||
129649583|NCT01451164|466673197|FG000|Overall Study|Adverse Event|19|||
129649584|NCT01451164|466673198|FG001|Overall Study|Adverse Event|12|||
129649585|NCT01451164|466673199|FG002|Overall Study|Adverse Event|18|||
129649586|NCT01451164|466673200|FG003|Overall Study|Adverse Event|21|||
129649587|NCT01451164|466673197|FG000|Overall Study|Withdrawal Criteria|1|||
129649588|NCT01451164|466673198|FG001|Overall Study|Withdrawal Criteria|1|||
129649589|NCT01451164|466673199|FG002|Overall Study|Withdrawal Criteria|1|||
129649590|NCT01451164|466673200|FG003|Overall Study|Withdrawal Criteria|1|||
129649591|NCT01451164|466673197|FG000|Overall Study|Physician Decision|2|||
129649592|NCT01451164|466673198|FG001|Overall Study|Physician Decision|0|||
129649593|NCT01451164|466673199|FG002|Overall Study|Physician Decision|1|||
129649594|NCT01451164|466673200|FG003|Overall Study|Physician Decision|0|||
129649595|NCT01451164|466673197|FG000|Overall Study|Withdrawal by Subject|14|||
129649596|NCT01451164|466673198|FG001|Overall Study|Withdrawal by Subject|11|||
129649597|NCT01451164|466673199|FG002|Overall Study|Withdrawal by Subject|16|||
129649598|NCT01451164|466673200|FG003|Overall Study|Withdrawal by Subject|17|||
129649599|NCT01451164|466673197|FG000|Overall Study|Protocol Violation|0|||
129649600|NCT01451164|466673198|FG001|Overall Study|Protocol Violation|1|||
129649601|NCT01451164|466673199|FG002|Overall Study|Protocol Violation|0|||
129649602|NCT01451164|466673200|FG003|Overall Study|Protocol Violation|0|||
129649603|NCT01451164|466673197|FG000|Overall Study|Lack of Efficacy|7|||
129649604|NCT01451164|466673198|FG001|Overall Study|Lack of Efficacy|9|||
129649605|NCT01451164|466673199|FG002|Overall Study|Lack of Efficacy|9|||
129649606|NCT01451164|466673200|FG003|Overall Study|Lack of Efficacy|7|||
129709762|NCT01815424|466900048|FG001|Week 16 to 52|Lost to Follow-up|2|||
129709763|NCT01815424|466900049|FG002|Week 16 to 52|Lost to Follow-up|0|||
129709764|NCT01815424|466900050|FG003|Week 16 to 52|Lost to Follow-up|2|||
129709765|NCT01815424|466900051|FG004|Week 16 to 52|Lost to Follow-up|1|||
129709766|NCT01815424|466900047|FG000|Week 16 to 52|Withdrawal by Subject|1|||
129709767|NCT01815424|466900048|FG001|Week 16 to 52|Withdrawal by Subject|2|||
129709768|NCT01815424|466900049|FG002|Week 16 to 52|Withdrawal by Subject|0|||
129709769|NCT01815424|466900050|FG003|Week 16 to 52|Withdrawal by Subject|0|||
129709770|NCT01815424|466900051|FG004|Week 16 to 52|Withdrawal by Subject|0|||
129709771|NCT01309204|466900052|FG000|Overall Study|Adverse Event|48|||
129709772|NCT01309204|466900053|FG001|Overall Study|Adverse Event|58|||
129709773|NCT01309204|466900052|FG000|Overall Study|Lost to Follow-up|2|||
129709774|NCT01309204|466900053|FG001|Overall Study|Lost to Follow-up|2|||
129709775|NCT01309204|466900052|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
129709776|NCT01309204|466900053|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
129709777|NCT01309204|466900052|FG000|Overall Study|Inadequate control of IOP|4|||
129709778|NCT01309204|466900053|FG001|Overall Study|Inadequate control of IOP|4|||
129709779|NCT01309204|466900052|FG000|Overall Study|Other|4|||
129709780|NCT01309204|466900053|FG001|Overall Study|Other|1|||
129709781|NCT03374358|466900054|FG000|Overall Study|Withdrawal by Subject|0|||
129709782|NCT03374358|466900055|FG001|Overall Study|Withdrawal by Subject|2|||
129709783|NCT03183063|466900056|FG000|Overall Study|Withdrawal by Subject|2|||
129709784|NCT03183063|466900057|FG001|Overall Study|Withdrawal by Subject|0|||
129709785|NCT03183063|466900058|FG002|Overall Study|Withdrawal by Subject|0|||
129709786|NCT03183063|466900056|FG000|Overall Study|Physician Decision|3|||
129709787|NCT03183063|466900057|FG001|Overall Study|Physician Decision|4|||
129709788|NCT03183063|466900058|FG002|Overall Study|Physician Decision|4|||
129709789|NCT01127633|466900059|FG000|Overall Study|Adverse Event|74|||
129709790|NCT01127633|466900060|FG001|Overall Study|Adverse Event|73|||
129709791|NCT01127633|466900059|FG000|Overall Study|Death|40|||
129709792|NCT01127633|466900060|FG001|Overall Study|Death|43|||
129709793|NCT01127633|466900059|FG000|Overall Study|Lost to Follow-up|4|||
129709794|NCT01127633|466900060|FG001|Overall Study|Lost to Follow-up|0|||
129709795|NCT01127633|466900059|FG000|Overall Study|Parent/Caregiver Decision|246|||
129709796|NCT01127633|466900060|FG001|Overall Study|Parent/Caregiver Decision|228|||
129709797|NCT01127633|466900059|FG000|Overall Study|Physician Decision|60|||
129709798|NCT01127633|466900060|FG001|Overall Study|Physician Decision|45|||
129709799|NCT01127633|466900059|FG000|Overall Study|Withdrawal by Subject|57|||
129709800|NCT01127633|466900060|FG001|Overall Study|Withdrawal by Subject|72|||
129709801|NCT01127633|466900059|FG000|Overall Study|Sponsor Decision|163|||
129709802|NCT01127633|466900060|FG001|Overall Study|Sponsor Decision|195|||
129709803|NCT01127633|466900059|FG000|Overall Study|Protocol Violation|8|||
129891278|NCT01606189|467559696|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
129891279|NCT00162942|467559697|FG000|Overall Study|Adverse Event|10|||
129891280|NCT00162942|467559698|FG001|Overall Study|Adverse Event|6|||
129891281|NCT00162942|467559697|FG000|Overall Study|Death|1|||
129709804|NCT01127633|466900060|FG001|Overall Study|Protocol Violation|16|||
129709805|NCT01127633|466900059|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
129709806|NCT01127633|466900060|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
129709807|NCT01127633|466900059|FG000|Overall Study|Not treated|1|||
129649607|NCT04599933|466673201|FG000|Overall Study|Adverse Event|4|||
129649608|NCT04599933|466673202|FG001|Overall Study|Adverse Event|1|||
129649609|NCT04599933|466673201|FG000|Overall Study|Withdrawal by Subject|4|||
129649610|NCT04599933|466673202|FG001|Overall Study|Withdrawal by Subject|2|||
129649611|NCT04599933|466673201|FG000|Overall Study|Lost to Follow-up|0|||
129649612|NCT04599933|466673202|FG001|Overall Study|Lost to Follow-up|1|||
129649613|NCT04599933|466673201|FG000|Overall Study|Physician Decision|0|||
129649614|NCT04599933|466673202|FG001|Overall Study|Physician Decision|1|||
129649615|NCT04599933|466673201|FG000|Overall Study|Screen Failure|1|||
129649616|NCT04599933|466673202|FG001|Overall Study|Screen Failure|2|||
129649617|NCT03226678|466673205|FG000|Part A (Core Study Phase)|Adverse Event|0|||
129649618|NCT03226678|466673206|FG001|Part A (Core Study Phase)|Adverse Event|1|||
129649619|NCT03226678|466673207|FG002|Part A (Core Study Phase)|Adverse Event|0|||
129649620|NCT03226678|466673208|FG003|Part A (Core Study Phase)|Adverse Event|0|||
129649621|NCT03226678|466673209|FG004|Part A (Core Study Phase)|Adverse Event|0|||
129649622|NCT03226678|466673210|FG005|Part A (Core Study Phase)|Adverse Event|0|||
129649623|NCT03226678|466673205|FG000|Part A (Core Study Phase)|Death|0|||
129649624|NCT03226678|466673206|FG001|Part A (Core Study Phase)|Death|0|||
129649625|NCT03226678|466673207|FG002|Part A (Core Study Phase)|Death|1|||
129649626|NCT03226678|466673208|FG003|Part A (Core Study Phase)|Death|0|||
129649627|NCT03226678|466673209|FG004|Part A (Core Study Phase)|Death|0|||
129649628|NCT03226678|466673210|FG005|Part A (Core Study Phase)|Death|0|||
129649629|NCT03226678|466673205|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
129709808|NCT01127633|466900060|FG001|Overall Study|Not treated|0|||
129709809|NCT00688467|466900061|FG000|Treatment Period 1|Adverse Event|2|||
129709810|NCT00688467|466900062|FG001|Treatment Period 1|Adverse Event|1|||
129709811|NCT00688467|466900061|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
129709812|NCT00688467|466900062|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
129709813|NCT00688467|466900061|FG000|Treatment Period 2|Protocol Violation|0|||
129709814|NCT00688467|466900062|FG001|Treatment Period 2|Protocol Violation|1|||
129709815|NCT00688467|466900061|FG000|Treatment Period 2|Adverse Event|0|||
129709816|NCT00688467|466900062|FG001|Treatment Period 2|Adverse Event|1|||
129709817|NCT00925002|466900063|FG000|Overall Study|Other|1|||
129709818|NCT00925002|466900064|FG001|Overall Study|Other|4|||
129709819|NCT00925002|466900065|FG002|Overall Study|Other|0|||
129709820|NCT00925002|466900063|FG000|Overall Study|Death|1|||
129709821|NCT00925002|466900064|FG001|Overall Study|Death|1|||
129709822|NCT00925002|466900065|FG002|Overall Study|Death|5|||
129709823|NCT00925002|466900063|FG000|Overall Study|Adverse Event|3|||
129709824|NCT00925002|466900064|FG001|Overall Study|Adverse Event|1|||
129709825|NCT00925002|466900065|FG002|Overall Study|Adverse Event|2|||
129709826|NCT00925002|466900063|FG000|Overall Study|Participant withdrew consent|1|||
129709827|NCT00925002|466900064|FG001|Overall Study|Participant withdrew consent|3|||
129709828|NCT00925002|466900065|FG002|Overall Study|Participant withdrew consent|3|||
129709829|NCT00690794|466900066|FG000|Overall Study|Adverse Event|12|||
129709830|NCT00690794|466900067|FG001|Overall Study|Adverse Event|10|||
129709831|NCT00690794|466900066|FG000|Overall Study|Lost to Follow-up|1|||
129800755|NCT01897714|467239839|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
129709832|NCT00690794|466900067|FG001|Overall Study|Lost to Follow-up|4|||
129709833|NCT00690794|466900066|FG000|Overall Study|Withdrawal by Subject|0|||
129800756|NCT01897714|467239840|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
129800757|NCT01897714|467239841|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
129800758|NCT01897714|467239842|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
129800759|NCT01897714|467239837|FG000|Phase II (MTD)|Other|0|||
129800760|NCT01897714|467239838|FG001|Phase II (MTD)|Other|0|||
129800761|NCT01897714|467239839|FG002|Phase II (MTD)|Other|0|||
129800762|NCT01897714|467239840|FG003|Phase II (MTD)|Other|0|||
129800763|NCT01897714|467239841|FG004|Phase II (MTD)|Other|3|||
129800764|NCT01897714|467239842|FG005|Phase II (MTD)|Other|0|||
129800765|NCT00423722|467239843|FG000|Overall Study|Death|4|||
129800766|NCT00423722|467239844|FG001|Overall Study|Death|4|||
129800767|NCT00423722|467239843|FG000|Overall Study|Declined to participate|2|||
129800768|NCT00423722|467239844|FG001|Overall Study|Declined to participate|3|||
129800769|NCT00423722|467239843|FG000|Overall Study|Unable to complete questionnaires|4|||
129800770|NCT00423722|467239844|FG001|Overall Study|Unable to complete questionnaires|4|||
129800771|NCT00423722|467239843|FG000|Overall Study|Withdrawal by Subject|4|||
129800772|NCT00423722|467239844|FG001|Overall Study|Withdrawal by Subject|2|||
129800773|NCT01846104|467239849|FG000|Overall Study|Withdrawal by Subject|1|||
129800774|NCT00851630|467239853|FG000|Overall Study|Death|2|||
129800775|NCT00851630|467239854|FG001|Overall Study|Death|1|||
129800776|NCT00851630|467239853|FG000|Overall Study|Clinical failure|0|||
129800777|NCT00851630|467239854|FG001|Overall Study|Clinical failure|1|||
129800778|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
129709834|NCT00690794|466900067|FG001|Overall Study|Withdrawal by Subject|9|||
129709835|NCT00690794|466900066|FG000|Overall Study|Protocol Violation|6|||
129709836|NCT00690794|466900067|FG001|Overall Study|Protocol Violation|7|||
129709837|NCT00690794|466900066|FG000|Overall Study|Noncompliance|1|||
129709838|NCT00690794|466900067|FG001|Overall Study|Noncompliance|2|||
129649630|NCT03226678|466673206|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
129649631|NCT03226678|466673207|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
129649632|NCT03226678|466673208|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
129649633|NCT03226678|466673209|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
129649634|NCT03226678|466673210|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
129649635|NCT03226678|466673205|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129649636|NCT03226678|466673206|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129649637|NCT03226678|466673207|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
129649638|NCT03226678|466673208|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129649639|NCT03226678|466673209|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129649640|NCT03226678|466673210|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
129649641|NCT03226678|466673205|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129649642|NCT03226678|466673206|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129649643|NCT03226678|466673207|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129649644|NCT03226678|466673208|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
129649645|NCT03226678|466673209|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129649646|NCT03226678|466673210|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
129649647|NCT03226678|466673205|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
129649648|NCT03226678|466673206|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
129649649|NCT03226678|466673207|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129649650|NCT03226678|466673208|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129649651|NCT03226678|466673209|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129649652|NCT03226678|466673210|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
129649653|NCT03226678|466673205|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129649654|NCT03226678|466673206|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129649655|NCT03226678|466673207|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129649656|NCT03226678|466673208|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
129649657|NCT03226678|466673209|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
129649658|NCT03226678|466673210|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
129649659|NCT03226678|466673205|FG000|Part B (Long-Term Extension Phase)|Death|0|||
129649660|NCT03226678|466673206|FG001|Part B (Long-Term Extension Phase)|Death|0|||
129649661|NCT03226678|466673207|FG002|Part B (Long-Term Extension Phase)|Death|0|||
129649662|NCT03226678|466673208|FG003|Part B (Long-Term Extension Phase)|Death|0|||
129649663|NCT03226678|466673209|FG004|Part B (Long-Term Extension Phase)|Death|0|||
129649664|NCT03226678|466673210|FG005|Part B (Long-Term Extension Phase)|Death|1|||
129649665|NCT03226678|466673205|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129649666|NCT03226678|466673206|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129649667|NCT03226678|466673207|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129649668|NCT03226678|466673208|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129649669|NCT03226678|466673209|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
129649670|NCT03226678|466673210|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
129649671|NCT03226678|466673205|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129649672|NCT03226678|466673206|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129649673|NCT03226678|466673207|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129649674|NCT03226678|466673208|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
129649675|NCT03226678|466673209|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
129649676|NCT03226678|466673210|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
129649677|NCT03226678|466673205|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129649678|NCT03226678|466673206|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129649679|NCT03226678|466673207|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129649680|NCT03226678|466673208|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129649681|NCT03226678|466673209|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
129649682|NCT03226678|466673210|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
129649683|NCT03117881|466673211|FG000|Baseline|Withdrawal by Subject|21|||
129649684|NCT03117881|466673212|FG001|Baseline|Withdrawal by Subject|10|||
129649685|NCT03117881|466673213|FG002|Baseline|Withdrawal by Subject|0|||
129709839|NCT00690794|466900066|FG000|Overall Study|Other not specified|1|||
129709840|NCT00690794|466900067|FG001|Overall Study|Other not specified|3|||
129709841|NCT01496287|466900068|FG000|Overall Study|Lost to Follow-up|1|||
129709842|NCT01496287|466900068|FG000|Overall Study|Incomplete anesthesia|5|||
129709843|NCT01343888|466900069|FG000|Overall Study|Adverse Event|12|||
129709844|NCT01343888|466900070|FG001|Overall Study|Adverse Event|22|||
129709845|NCT01343888|466900071|FG002|Overall Study|Adverse Event|5|||
129709846|NCT01343888|466900069|FG000|Overall Study|Lack of Efficacy|9|||
129709847|NCT01343888|466900070|FG001|Overall Study|Lack of Efficacy|9|||
129800779|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
129649686|NCT03117881|466673211|FG000|Baseline|Lost to Follow-up|22|||
129649687|NCT03117881|466673212|FG001|Baseline|Lost to Follow-up|25|||
129649688|NCT03117881|466673213|FG002|Baseline|Lost to Follow-up|0|||
129649689|NCT03117881|466673211|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
129649690|NCT03117881|466673212|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
129649691|NCT03117881|466673213|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
129649692|NCT03117881|466673211|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
129649693|NCT03117881|466673212|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
129649694|NCT03117881|466673213|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
129649695|NCT03117881|466673211|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
129649696|NCT03117881|466673212|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
129649697|NCT03117881|466673213|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
129649698|NCT03117881|466673211|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
129649699|NCT03117881|466673212|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
129649700|NCT03117881|466673213|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
129649701|NCT03117881|466673211|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
129649702|NCT03117881|466673212|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
129649703|NCT03117881|466673213|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
129649704|NCT03117881|466673211|FG000|6-Month Follow-Up|Did not complete test|53|||
129649705|NCT03117881|466673212|FG001|6-Month Follow-Up|Did not complete test|25|||
129649706|NCT03117881|466673213|FG002|6-Month Follow-Up|Did not complete test|7|||
129649707|NCT03117881|466673211|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
129649708|NCT03117881|466673212|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
129649709|NCT03117881|466673213|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
129649710|NCT03117881|466673211|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
129649711|NCT03117881|466673212|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
129649712|NCT03117881|466673213|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
129649713|NCT03117881|466673211|FG000|12-Month Follow-Up|Did not complete test|40|||
129649714|NCT03117881|466673212|FG001|12-Month Follow-Up|Did not complete test|0|||
129649715|NCT03117881|466673213|FG002|12-Month Follow-Up|Did not complete test|0|||
129649716|NCT01027897|466673214|FG000|Overall Study|Protocol Violation|1|||
129649717|NCT01027897|466673214|FG000|Overall Study|Withdrawal by Subject|1|||
129649718|NCT02045732|466673217|FG000|Overall Study|At the discretion of the investigator|1|||
129649719|NCT02045732|466673218|FG001|Overall Study|At the discretion of the investigator|1|||
129649720|NCT00473824|466673219|FG000|Overall Study|Virologic Breakthrough|1|||
129649721|NCT00473824|466673220|FG001|Overall Study|Virologic Breakthrough|0|||
129649722|NCT00473824|466673219|FG000|Overall Study|Adverse Event|1|||
129649723|NCT00473824|466673220|FG001|Overall Study|Adverse Event|0|||
129649724|NCT00473824|466673219|FG000|Overall Study|Death|1|||
129649725|NCT00473824|466673220|FG001|Overall Study|Death|0|||
129649726|NCT00473824|466673219|FG000|Overall Study|Lost to Follow-up|1|||
129649727|NCT00473824|466673220|FG001|Overall Study|Lost to Follow-up|0|||
129649728|NCT00473824|466673219|FG000|Overall Study|Withdrawal by physician|1|||
129649729|NCT00473824|466673220|FG001|Overall Study|Withdrawal by physician|0|||
129649730|NCT02560623|466673221|FG000|Overall Study|Unable to swallow sponge|0|||
129649731|NCT02560623|466673222|FG001|Overall Study|Unable to swallow sponge|1|||
129649732|NCT02560623|466673223|FG002|Overall Study|Unable to swallow sponge|0|||
129649733|NCT02560623|466673224|FG003|Overall Study|Unable to swallow sponge|0|||
129649734|NCT02560623|466673221|FG000|Overall Study|Intervention prior to sponge administration|0|||
129649735|NCT02560623|466673222|FG001|Overall Study|Intervention prior to sponge administration|1|||
129649736|NCT02560623|466673223|FG002|Overall Study|Intervention prior to sponge administration|0|||
129649737|NCT02560623|466673224|FG003|Overall Study|Intervention prior to sponge administration|0|||
129649738|NCT05014815|466673225|FG000|Overall Study|Death|63|||
129649739|NCT05014815|466673226|FG001|Overall Study|Death|70|||
129649740|NCT05014815|466673225|FG000|Overall Study|Withdrawal by Subject|10|||
129649741|NCT05014815|466673226|FG001|Overall Study|Withdrawal by Subject|10|||
129649742|NCT05014815|466673225|FG000|Overall Study|Lost to Follow-up|4|||
129649743|NCT05014815|466673226|FG001|Overall Study|Lost to Follow-up|2|||
129649744|NCT05014815|466673225|FG000|Overall Study|Physician Decision|2|||
129649745|NCT05014815|466673226|FG001|Overall Study|Physician Decision|4|||
129649746|NCT04247880|466673227|FG000|Overall Study|Lost to Follow-up|24|||
129649747|NCT04247880|466673228|FG001|Overall Study|Lost to Follow-up|17|||
129649748|NCT04247880|466673227|FG000|Overall Study|Withdrawal by Subject|3|||
129649749|NCT04247880|466673228|FG001|Overall Study|Withdrawal by Subject|0|||
129709848|NCT01343888|466900071|FG002|Overall Study|Lack of Efficacy|13|||
129709849|NCT01343888|466900069|FG000|Overall Study|Lost to Follow-up|0|||
129709850|NCT01343888|466900070|FG001|Overall Study|Lost to Follow-up|2|||
129709851|NCT01343888|466900071|FG002|Overall Study|Lost to Follow-up|1|||
129709852|NCT01343888|466900069|FG000|Overall Study|Protocol Violation|0|||
129709853|NCT01343888|466900070|FG001|Overall Study|Protocol Violation|2|||
129709854|NCT01343888|466900071|FG002|Overall Study|Protocol Violation|0|||
129709855|NCT01343888|466900069|FG000|Overall Study|Withdrawal by Subject|4|||
129709856|NCT01343888|466900070|FG001|Overall Study|Withdrawal by Subject|4|||
129709857|NCT01343888|466900071|FG002|Overall Study|Withdrawal by Subject|2|||
129709858|NCT01343888|466900069|FG000|Overall Study|other than stated above|0|||
129649750|NCT06303167|466673229|FG000|Overall Study|Ineligible|1|||
129649751|NCT06303167|466673229|FG000|Overall Study|Never start protocol therapy|2|||
129649752|NCT06303167|466673229|FG000|Overall Study|Disease progression|16|||
129649753|NCT02453282|466673230|FG000|Overall Study|Death|275|||
129649754|NCT02453282|466673231|FG001|Overall Study|Death|277|||
129649755|NCT02453282|466673232|FG002|Overall Study|Death|296|||
129649756|NCT02453282|466673230|FG000|Overall Study|Lost to Follow-up|1|||
129649757|NCT02453282|466673231|FG001|Overall Study|Lost to Follow-up|0|||
129649758|NCT02453282|466673232|FG002|Overall Study|Lost to Follow-up|2|||
129649759|NCT02453282|466673230|FG000|Overall Study|Withdrawal by Subject|12|||
129649760|NCT02453282|466673231|FG001|Overall Study|Withdrawal by Subject|10|||
129649761|NCT02453282|466673232|FG002|Overall Study|Withdrawal by Subject|11|||
129649762|NCT02453282|466673230|FG000|Overall Study|Participants ongoing at data cut-off|85|||
129649763|NCT02453282|466673231|FG001|Overall Study|Participants ongoing at data cut-off|84|||
129649764|NCT02453282|466673232|FG002|Overall Study|Participants ongoing at data cut-off|62|||
129649765|NCT02453282|466673230|FG000|Overall Study|Other|1|||
129649766|NCT02453282|466673231|FG001|Overall Study|Other|1|||
129649767|NCT02453282|466673232|FG002|Overall Study|Other|1|||
129649768|NCT01661933|466673234|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
129649769|NCT01661933|466673234|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
129649770|NCT03385304|466673235|FG000|Overall Study|Death|19|||
129649771|NCT03385304|466673236|FG001|Overall Study|Death|7|||
129649772|NCT03385304|466673235|FG000|Overall Study|Lost to Follow-up|17|||
129649773|NCT03385304|466673236|FG001|Overall Study|Lost to Follow-up|14|||
129649774|NCT03385304|466673235|FG000|Overall Study|Withdrawal by Subject|3|||
129649775|NCT03385304|466673236|FG001|Overall Study|Withdrawal by Subject|2|||
129649776|NCT03385304|466673235|FG000|Overall Study|Incarceration|2|||
129649777|NCT03385304|466673236|FG001|Overall Study|Incarceration|3|||
129649778|NCT01120249|466673237|FG000|Overall Study|No protocol treatment received|21|||
129649779|NCT01120249|466673238|FG001|Overall Study|No protocol treatment received|15|||
129649780|NCT01120249|466673237|FG000|Overall Study|Disease recurrence|107|||
129649781|NCT01120249|466673238|FG001|Overall Study|Disease recurrence|57|||
129649782|NCT01120249|466673237|FG000|Overall Study|Death|1|||
129649783|NCT01120249|466673238|FG001|Overall Study|Death|0|||
129649784|NCT01120249|466673237|FG000|Overall Study|Adverse Event|40|||
129649785|NCT01120249|466673238|FG001|Overall Study|Adverse Event|276|||
129649786|NCT01120249|466673237|FG000|Overall Study|Participant refusal|34|||
129649787|NCT01120249|466673238|FG001|Overall Study|Participant refusal|42|||
129649788|NCT01120249|466673237|FG000|Overall Study|Other reasons, not protocol specified|29|||
129649789|NCT01120249|466673238|FG001|Overall Study|Other reasons, not protocol specified|22|||
129649790|NCT01447446|466673239|FG000|Overall Study|Death|6|||
129649791|NCT01447446|466673240|FG001|Overall Study|Death|3|||
129649792|NCT01447446|466673241|FG002|Overall Study|Death|2|||
129649793|NCT01447446|466673242|FG003|Overall Study|Death|1|||
129649794|NCT01447446|466673243|FG004|Overall Study|Death|7|||
129649795|NCT01447446|466673244|FG005|Overall Study|Death|0|||
129649796|NCT01447446|466673239|FG000|Overall Study|Adverse Event|3|||
129649797|NCT01447446|466673240|FG001|Overall Study|Adverse Event|0|||
129649798|NCT01447446|466673241|FG002|Overall Study|Adverse Event|1|||
129649799|NCT01447446|466673242|FG003|Overall Study|Adverse Event|0|||
129649800|NCT01447446|466673243|FG004|Overall Study|Adverse Event|2|||
129649801|NCT01447446|466673244|FG005|Overall Study|Adverse Event|0|||
129649802|NCT01447446|466673239|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
129649803|NCT01447446|466673240|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
129649804|NCT01447446|466673241|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
129649805|NCT01447446|466673242|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
129649806|NCT01447446|466673243|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
129649807|NCT01447446|466673244|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
129649808|NCT01447446|466673239|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
129649809|NCT01447446|466673240|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
129649810|NCT01447446|466673241|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
129649811|NCT01447446|466673242|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
129649812|NCT01447446|466673243|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
129649813|NCT01447446|466673244|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
129649814|NCT01447446|466673239|FG000|Overall Study|Administrative/Other|34|||
129649815|NCT01447446|466673240|FG001|Overall Study|Administrative/Other|9|||
129649816|NCT01447446|466673241|FG002|Overall Study|Administrative/Other|10|||
129709859|NCT01343888|466900070|FG001|Overall Study|other than stated above|0|||
129709860|NCT01343888|466900071|FG002|Overall Study|other than stated above|1|||
129709861|NCT01990742|466900072|FG000|Overall Study|Withdrawal by facility|407|||
129709862|NCT01990742|466900073|FG001|Overall Study|Withdrawal by facility|1083|||
129709863|NCT01990742|466900072|FG000|Overall Study|Facility closed|0|||
129649817|NCT01447446|466673242|FG003|Overall Study|Administrative/Other|2|||
129709864|NCT01990742|466900073|FG001|Overall Study|Facility closed|270|||
129649818|NCT01447446|466673243|FG004|Overall Study|Administrative/Other|33|||
129649819|NCT01447446|466673244|FG005|Overall Study|Administrative/Other|4|||
129649820|NCT01447446|466673239|FG000|Overall Study|SVR12 Assessment|13|||
129649821|NCT01447446|466673240|FG001|Overall Study|SVR12 Assessment|1|||
129649822|NCT01447446|466673241|FG002|Overall Study|SVR12 Assessment|2|||
129649823|NCT01447446|466673242|FG003|Overall Study|SVR12 Assessment|1|||
129649824|NCT01447446|466673243|FG004|Overall Study|SVR12 Assessment|5|||
129649825|NCT01447446|466673244|FG005|Overall Study|SVR12 Assessment|5|||
129649826|NCT01447446|466673239|FG000|Overall Study|New Treatment Started|8|||
129649827|NCT01447446|466673240|FG001|Overall Study|New Treatment Started|2|||
129649828|NCT01447446|466673241|FG002|Overall Study|New Treatment Started|1|||
129649829|NCT01447446|466673242|FG003|Overall Study|New Treatment Started|0|||
129649830|NCT01447446|466673243|FG004|Overall Study|New Treatment Started|2|||
129649831|NCT01447446|466673244|FG005|Overall Study|New Treatment Started|0|||
129649832|NCT01447446|466673239|FG000|Overall Study|Reason not Specified|1|||
129649833|NCT01447446|466673240|FG001|Overall Study|Reason not Specified|1|||
129649834|NCT01447446|466673241|FG002|Overall Study|Reason not Specified|1|||
129649835|NCT01447446|466673242|FG003|Overall Study|Reason not Specified|1|||
129649836|NCT01447446|466673243|FG004|Overall Study|Reason not Specified|1|||
129649837|NCT01447446|466673244|FG005|Overall Study|Reason not Specified|0|||
129649838|NCT03536949|466673260|FG000|Overall Study|Adverse Event|4|||
129649839|NCT03536949|466673261|FG001|Overall Study|Adverse Event|0|||
129649840|NCT03536949|466673260|FG000|Overall Study|Lost to Follow-up|2|||
129649841|NCT03536949|466673261|FG001|Overall Study|Lost to Follow-up|1|||
129649842|NCT03536949|466673260|FG000|Overall Study|Withdrawal by Subject|6|||
129649843|NCT03536949|466673261|FG001|Overall Study|Withdrawal by Subject|0|||
129649844|NCT03536949|466673260|FG000|Overall Study|Non-compliance|2|||
129649845|NCT03536949|466673261|FG001|Overall Study|Non-compliance|1|||
129649846|NCT00435487|466673279|FG000|Overall Study|Death|3|||
129649847|NCT00435487|466673280|FG001|Overall Study|Death|4|||
129649848|NCT00435487|466673279|FG000|Overall Study|Adverse Event|0|||
129649849|NCT00435487|466673280|FG001|Overall Study|Adverse Event|3|||
129649850|NCT00435487|466673279|FG000|Overall Study|Lost to Follow-up|2|||
129649851|NCT00435487|466673280|FG001|Overall Study|Lost to Follow-up|2|||
129649852|NCT00435487|466673279|FG000|Overall Study|Other|5|||
129649853|NCT00435487|466673280|FG001|Overall Study|Other|2|||
129649854|NCT00435487|466673279|FG000|Overall Study|Withdrawal by Subject|2|||
129649855|NCT00435487|466673280|FG001|Overall Study|Withdrawal by Subject|1|||
129649856|NCT00435487|466673279|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
129649857|NCT00435487|466673280|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
129649858|NCT00435487|466673279|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
129649859|NCT00435487|466673280|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
129649860|NCT03301844|466673281|FG000|Overall Study|suspected colon cancer|1|||
129649861|NCT03301844|466673282|FG001|Overall Study|suspected colon cancer|1|||
129649862|NCT05087966|466673283|FG000|Overall Study|Lost to Follow-up|1|||
129649863|NCT05087966|466673283|FG000|Overall Study|Withdrawal by Subject|5|||
129649864|NCT01267201|466673284|FG000|First Intervention Period|Withdrawal by Subject|1|||
129649865|NCT01267201|466673285|FG001|First Intervention Period|Withdrawal by Subject|0|||
129649866|NCT01267201|466673286|FG002|First Intervention Period|Withdrawal by Subject|0|||
129649867|NCT01267201|466673287|FG003|First Intervention Period|Withdrawal by Subject|0|||
129649868|NCT01267201|466673288|FG004|First Intervention Period|Withdrawal by Subject|0|||
129649869|NCT01267201|466673289|FG005|First Intervention Period|Withdrawal by Subject|0|||
129649870|NCT01267201|466673284|FG000|Second Intervention Period|Withdrawal by Subject|0|||
129649871|NCT01267201|466673285|FG001|Second Intervention Period|Withdrawal by Subject|1|||
129649872|NCT01267201|466673286|FG002|Second Intervention Period|Withdrawal by Subject|0|||
129649873|NCT01267201|466673287|FG003|Second Intervention Period|Withdrawal by Subject|0|||
129649874|NCT01267201|466673288|FG004|Second Intervention Period|Withdrawal by Subject|0|||
129649875|NCT01267201|466673289|FG005|Second Intervention Period|Withdrawal by Subject|0|||
129649876|NCT00501059|466673290|FG000|Overall Study|Protocol Violation|80|||
129649877|NCT00501059|466673291|FG001|Overall Study|Protocol Violation|69|||
129649878|NCT00501059|466673290|FG000|Overall Study|Death|140|||
129649879|NCT00501059|466673291|FG001|Overall Study|Death|137|||
129649880|NCT00501059|466673290|FG000|Overall Study|Other|236|||
129649881|NCT00501059|466673291|FG001|Overall Study|Other|239|||
129649882|NCT00501059|466673290|FG000|Overall Study|Missing end-of-study page|91|||
129649883|NCT00501059|466673291|FG001|Overall Study|Missing end-of-study page|92|||
129649884|NCT00501059|466673290|FG000|Overall Study|Clinical endpoint reached|110|||
129649885|NCT00501059|466673291|FG001|Overall Study|Clinical endpoint reached|123|||
129649886|NCT00501059|466673290|FG000|Overall Study|Insufficient therapeutic effect|4|||
129649887|NCT00501059|466673291|FG001|Overall Study|Insufficient therapeutic effect|5|||
129649888|NCT00501059|466673290|FG000|Overall Study|Consent withdrawn by subject|817|||
129649889|NCT00501059|466673291|FG001|Overall Study|Consent withdrawn by subject|873|||
129649890|NCT00501059|466673290|FG000|Overall Study|Non-compliant with study treatment|23|||
129649891|NCT00501059|466673291|FG001|Overall Study|Non-compliant with study treatment|16|||
129649892|NCT00501059|466673290|FG000|Overall Study|Reason not given|3|||
129649893|NCT00501059|466673291|FG001|Overall Study|Reason not given|1|||
129649894|NCT00501059|466673290|FG000|Overall Study|Adverse Event|129|||
129649895|NCT00501059|466673291|FG001|Overall Study|Adverse Event|122|||
129649896|NCT00501059|466673290|FG000|Overall Study|Lost to Follow-up|210|||
129649897|NCT00501059|466673291|FG001|Overall Study|Lost to Follow-up|198|||
129649898|NCT00501059|466673290|FG000|Overall Study|Not treated|25|||
129649899|NCT00501059|466673291|FG001|Overall Study|Not treated|17|||
129649900|NCT00955968|466673296|FG000|Overall Study|Death|2|||
129709865|NCT03443687|466900074|FG000|Overall Study|Lost to Follow-up|3|||
129709866|NCT03443687|466900075|FG001|Overall Study|Lost to Follow-up|5|||
129709867|NCT03443687|466900074|FG000|Overall Study|Withdrawal by Subject|1|||
129709868|NCT03443687|466900075|FG001|Overall Study|Withdrawal by Subject|0|||
129709869|NCT03443687|466900074|FG000|Overall Study|Discontinued intervention|1|||
129709870|NCT03443687|466900075|FG001|Overall Study|Discontinued intervention|1|||
129709871|NCT02805790|466900077|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
129709872|NCT02805790|466900078|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
129709873|NCT00800735|466900079|FG000|Overall Study|Administrative/Other|2|||
129709874|NCT00800735|466900079|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129709875|NCT00800735|466900079|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
129709876|NCT00800735|466900079|FG000|Overall Study|Withdrew Consent|3|||
129709877|NCT04460183|466900082|FG000|Overall Study|Lost to Follow-up|3|||
129709878|NCT04460183|466900083|FG001|Overall Study|Lost to Follow-up|1|||
129709879|NCT04460183|466900082|FG000|Overall Study|Withdrawal by Subject|1|||
129709880|NCT04460183|466900083|FG001|Overall Study|Withdrawal by Subject|0|||
129709881|NCT00825994|466900084|FG000|Overall Study|Withdrawal by Subject|2|||
129709882|NCT00825994|466900084|FG000|Overall Study|Lost to Follow-up|1|||
129709883|NCT00825994|466900084|FG000|Overall Study|Protocol Violation|1|||
129709884|NCT00825994|466900084|FG000|Overall Study|Placebo Responder at V2|1|||
129709885|NCT00332696|466900085|FG000|Overall Study|Death|24|||
129709886|NCT00332696|466900086|FG001|Overall Study|Death|14|||
129709887|NCT00332696|466900085|FG000|Overall Study|Insufficient therapeutic effect|4|||
129709888|NCT00332696|466900086|FG001|Overall Study|Insufficient therapeutic effect|11|||
129709889|NCT00332696|466900085|FG000|Overall Study|Adverse Event|1|||
129709890|NCT00332696|466900086|FG001|Overall Study|Adverse Event|2|||
129709891|NCT00332696|466900085|FG000|Overall Study|Condition does not justify treatment|0|||
129709892|NCT00332696|466900086|FG001|Overall Study|Condition does not justify treatment|2|||
129709893|NCT00332696|466900085|FG000|Overall Study|Lost to Follow-up|0|||
129709894|NCT00332696|466900086|FG001|Overall Study|Lost to Follow-up|1|||
129709895|NCT00332696|466900085|FG000|Overall Study|Withdrawal by Subject|1|||
129709896|NCT00332696|466900086|FG001|Overall Study|Withdrawal by Subject|0|||
129709897|NCT00501644|466900088|FG000|Overall Study|Adverse Event|4|||
129709898|NCT00501644|466900088|FG000|Overall Study|Withdrawal by Subject|1|||
129709899|NCT02394561|466900089|FG000|CORE Phase|Adverse Event|7|||
129649901|NCT00955968|466673297|FG001|Overall Study|Death|4|||
129649902|NCT00955968|466673296|FG000|Overall Study|Withdrawal by Subject|35|||
129649903|NCT00955968|466673297|FG001|Overall Study|Withdrawal by Subject|31|||
129709900|NCT02394561|466900090|FG001|CORE Phase|Adverse Event|9|||
129709901|NCT02394561|466900089|FG000|CORE Phase|Death|0|||
129709902|NCT02394561|466900090|FG001|CORE Phase|Death|1|||
129709903|NCT02394561|466900089|FG000|CORE Phase|Pregnancy|1|||
129709904|NCT02394561|466900090|FG001|CORE Phase|Pregnancy|0|||
129800780|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
129800781|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
129800782|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
129800783|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
129800784|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
129800785|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
129800786|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
129800787|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
129800788|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
129800789|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
129891282|NCT00162942|467559698|FG001|Overall Study|Death|0|||
129649904|NCT00955968|466673296|FG000|Overall Study|Lost to Follow-up|45|||
129649905|NCT00955968|466673297|FG001|Overall Study|Lost to Follow-up|39|||
129649906|NCT00955968|466673296|FG000|Overall Study|Site closed|55|||
129649907|NCT00955968|466673297|FG001|Overall Study|Site closed|52|||
129649908|NCT04326439|466673301|FG000|Overall Study|Withdrawal by Subject|1|||
129709905|NCT02394561|466900089|FG000|CORE Phase|Lost to Follow-up|1|||
129709906|NCT02394561|466900090|FG001|CORE Phase|Lost to Follow-up|0|||
129709907|NCT02394561|466900089|FG000|CORE Phase|Physician Decision|1|||
129709908|NCT02394561|466900090|FG001|CORE Phase|Physician Decision|1|||
129709909|NCT02394561|466900089|FG000|CORE Phase|Withdrawal by Subject|2|||
129709910|NCT02394561|466900090|FG001|CORE Phase|Withdrawal by Subject|2|||
129709911|NCT02394561|466900089|FG000|CORE Phase|Lack of Efficacy|1|||
129444194|NCT00999713|465926068|FG001|Overall Study|Physician Decision|0|||
129444195|NCT00639223|465926071|FG000|Overall Study|Lost to Follow-up|0|||
129649909|NCT04326439|466673302|FG001|Overall Study|Withdrawal by Subject|0|||
129649910|NCT04326439|466673301|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
129649911|NCT04326439|466673302|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
129649912|NCT04326439|466673301|FG000|Overall Study|Relapse after Induction 2|0|||
129649913|NCT04326439|466673302|FG001|Overall Study|Relapse after Induction 2|1|||
129649914|NCT04326439|466673301|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
129649915|NCT04326439|466673302|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
129649916|NCT00204477|466673305|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
129649917|NCT00204477|466673306|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
129649918|NCT00204477|466673305|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
129649919|NCT00204477|466673306|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
129649920|NCT04272606|466673309|FG000|Overall Study|Protocol Violation|1|||
129649921|NCT04272606|466673310|FG001|Overall Study|Protocol Violation|1|||
129649922|NCT04272606|466673309|FG000|Overall Study|Physician Decision|0|||
129649923|NCT04272606|466673310|FG001|Overall Study|Physician Decision|1|||
129649924|NCT00710684|466673311|FG000|Overall Study|Adverse Event|11|||
129649925|NCT00710684|466673312|FG001|Overall Study|Adverse Event|19|||
129649926|NCT00710684|466673313|FG002|Overall Study|Adverse Event|16|||
129649927|NCT00710684|466673311|FG000|Overall Study|Lack of Efficacy|4|||
129649928|NCT00710684|466673312|FG001|Overall Study|Lack of Efficacy|3|||
129649929|NCT00710684|466673313|FG002|Overall Study|Lack of Efficacy|5|||
129649930|NCT00710684|466673311|FG000|Overall Study|Protocol Violation|5|||
129649931|NCT00710684|466673312|FG001|Overall Study|Protocol Violation|5|||
129649932|NCT00710684|466673313|FG002|Overall Study|Protocol Violation|5|||
129649933|NCT00710684|466673311|FG000|Overall Study|Lost to Follow-up|4|||
129649934|NCT00710684|466673312|FG001|Overall Study|Lost to Follow-up|6|||
129649935|NCT00710684|466673313|FG002|Overall Study|Lost to Follow-up|7|||
129649936|NCT00710684|466673311|FG000|Overall Study|Physician Decision|0|||
129649937|NCT00710684|466673312|FG001|Overall Study|Physician Decision|2|||
129649938|NCT00710684|466673313|FG002|Overall Study|Physician Decision|4|||
129649939|NCT00710684|466673311|FG000|Overall Study|Withdrawal by Subject|24|||
129649940|NCT00710684|466673312|FG001|Overall Study|Withdrawal by Subject|18|||
129649941|NCT00710684|466673313|FG002|Overall Study|Withdrawal by Subject|11|||
129649942|NCT00710684|466673311|FG000|Overall Study|Missing|1|||
129649943|NCT00710684|466673312|FG001|Overall Study|Missing|0|||
129649944|NCT00710684|466673313|FG002|Overall Study|Missing|0|||
129649945|NCT00710684|466673311|FG000|Overall Study|Did not continue after week 24|25|||
129649946|NCT00710684|466673312|FG001|Overall Study|Did not continue after week 24|21|||
129649947|NCT00710684|466673313|FG002|Overall Study|Did not continue after week 24|16|||
129649948|NCT04778059|466673314|FG000|Overall Study|Death|2|||
129649949|NCT04778059|466673315|FG001|Overall Study|Death|2|||
129649950|NCT04778059|466673316|FG002|Overall Study|Death|1|||
129649951|NCT04778059|466673317|FG003|Overall Study|Death|1|||
129649952|NCT04778059|466673318|FG004|Overall Study|Death|1|||
129649953|NCT04778059|466673314|FG000|Overall Study|Lost to Follow-up|0|||
129649954|NCT04778059|466673315|FG001|Overall Study|Lost to Follow-up|0|||
129649955|NCT04778059|466673316|FG002|Overall Study|Lost to Follow-up|0|||
129649956|NCT04778059|466673317|FG003|Overall Study|Lost to Follow-up|0|||
129649957|NCT04778059|466673318|FG004|Overall Study|Lost to Follow-up|1|||
129649958|NCT04778059|466673314|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
129709912|NCT02394561|466900090|FG001|CORE Phase|Lack of Efficacy|6|||
129709913|NCT02394561|466900089|FG000|Extension Phase|Adverse Event|6|||
129709914|NCT02394561|466900090|FG001|Extension Phase|Adverse Event|1|||
129709915|NCT02394561|466900089|FG000|Extension Phase|Death|0|||
129709916|NCT02394561|466900090|FG001|Extension Phase|Death|1|||
129709917|NCT02394561|466900089|FG000|Extension Phase|Protocol Violation|1|||
129709918|NCT02394561|466900090|FG001|Extension Phase|Protocol Violation|0|||
129709919|NCT02394561|466900089|FG000|Extension Phase|Lost to Follow-up|1|||
129709920|NCT02394561|466900090|FG001|Extension Phase|Lost to Follow-up|0|||
129709921|NCT02394561|466900089|FG000|Extension Phase|Physician Decision|0|||
129709922|NCT02394561|466900090|FG001|Extension Phase|Physician Decision|2|||
129709923|NCT02394561|466900089|FG000|Extension Phase|Withdrawal by Subject|0|||
129709924|NCT02394561|466900090|FG001|Extension Phase|Withdrawal by Subject|5|||
129709925|NCT02394561|466900089|FG000|Extension Phase|Lack of Efficacy|3|||
129649959|NCT04778059|466673315|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
129649960|NCT04778059|466673316|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
129649961|NCT04778059|466673317|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
129649962|NCT04778059|466673318|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
129649963|NCT00157248|466673322|FG000|Overall Study|Adverse Event|36|||
129649964|NCT00157248|466673323|FG001|Overall Study|Adverse Event|25|||
129649965|NCT00157248|466673324|FG002|Overall Study|Adverse Event|13|||
129649966|NCT00157248|466673325|FG003|Overall Study|Adverse Event|33|||
129709926|NCT02394561|466900090|FG001|Extension Phase|Lack of Efficacy|3|||
129709927|NCT01812057|466900091|FG000|Overall Study|Protocol Violation|1|||
129709928|NCT01812057|466900092|FG001|Overall Study|Protocol Violation|0|||
129709929|NCT01812057|466900091|FG000|Overall Study|Physician Decision|1|||
129709930|NCT01812057|466900092|FG001|Overall Study|Physician Decision|0|||
129709931|NCT01882465|466900093|FG000|Period 1|Lens Discomfort|0|||
129709932|NCT01882465|466900094|FG001|Period 1|Lens Discomfort|0|||
129709933|NCT01882465|466900095|FG002|Period 1|Lens Discomfort|0|||
129709934|NCT01882465|466900096|FG003|Period 1|Lens Discomfort|1|||
129709935|NCT01882465|466900097|FG004|Period 1|Lens Discomfort|0|||
129709936|NCT01882465|466900098|FG005|Period 1|Lens Discomfort|0|||
129709937|NCT01882465|466900099|FG006|Period 1|Lens Discomfort|0|||
129709938|NCT01882465|466900093|FG000|Period 1|Withdrawal by Subject|0|||
129709939|NCT01882465|466900094|FG001|Period 1|Withdrawal by Subject|0|||
129709940|NCT01882465|466900095|FG002|Period 1|Withdrawal by Subject|0|||
129709941|NCT01882465|466900096|FG003|Period 1|Withdrawal by Subject|0|||
129709942|NCT01882465|466900097|FG004|Period 1|Withdrawal by Subject|0|||
129709943|NCT01882465|466900098|FG005|Period 1|Withdrawal by Subject|0|||
129709944|NCT01882465|466900099|FG006|Period 1|Withdrawal by Subject|1|||
129709945|NCT01882465|466900093|FG000|Period 2|Protocol Violation|0|||
129709946|NCT01882465|466900094|FG001|Period 2|Protocol Violation|0|||
129709947|NCT01882465|466900095|FG002|Period 2|Protocol Violation|0|||
129709948|NCT01882465|466900096|FG003|Period 2|Protocol Violation|0|||
129709949|NCT01882465|466900097|FG004|Period 2|Protocol Violation|1|||
129709950|NCT01882465|466900098|FG005|Period 2|Protocol Violation|0|||
129709951|NCT01882465|466900099|FG006|Period 2|Protocol Violation|0|||
129709952|NCT01378117|466900106|FG000|Overall Study|withdrawal|2|||
129709953|NCT01378117|466900107|FG001|Overall Study|withdrawal|1|||
129709954|NCT01378117|466900108|FG002|Overall Study|withdrawal|2|||
129709955|NCT01378117|466900106|FG000|Overall Study|discharged before med given|2|||
129709956|NCT01378117|466900107|FG001|Overall Study|discharged before med given|0|||
129709957|NCT01378117|466900108|FG002|Overall Study|discharged before med given|1|||
129709958|NCT02961244|466900110|FG000|Overall Study|Protocol Violation|0|||
129709959|NCT02961244|466900111|FG001|Overall Study|Protocol Violation|1|||
129709960|NCT02961244|466900110|FG000|Overall Study|Withdrawal by Subject|1|||
129709961|NCT02961244|466900111|FG001|Overall Study|Withdrawal by Subject|2|||
129709962|NCT02961244|466900110|FG000|Overall Study|Surgery plan change after study approval|0|||
129709963|NCT02961244|466900111|FG001|Overall Study|Surgery plan change after study approval|2|||
129709964|NCT02961244|466900110|FG000|Overall Study|Lost to Follow-up|0|||
129709965|NCT02961244|466900111|FG001|Overall Study|Lost to Follow-up|2|||
129709966|NCT02961244|466900110|FG000|Overall Study|İnadequate data|0|||
129709967|NCT02961244|466900111|FG001|Overall Study|İnadequate data|2|||
129709968|NCT01854528|466900112|FG000|Overall Study|Adverse Event|0|||
129709969|NCT01854528|466900113|FG001|Overall Study|Adverse Event|4|||
129709970|NCT01854528|466900112|FG000|Overall Study|Withdrawal by Subject|0|||
129709971|NCT01854528|466900113|FG001|Overall Study|Withdrawal by Subject|2|||
129709972|NCT01854528|466900112|FG000|Overall Study|Virologic Failure|0|||
129709973|NCT01854528|466900113|FG001|Overall Study|Virologic Failure|9|||
129709974|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
129709975|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
129709976|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
129709977|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
129709978|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
129709979|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
129709980|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
129709981|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
129709982|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
129709983|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
129709984|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
129709985|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
129709986|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
129709987|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
129709988|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
129709989|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
129709990|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
129709991|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
129709992|NCT03789292|466900114|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
129709993|NCT03789292|466900115|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
129709994|NCT03789292|466900116|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
129709995|NCT03789292|466900114|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
129649967|NCT00157248|466673322|FG000|Overall Study|Protocol Violation|4|||
129649968|NCT00157248|466673323|FG001|Overall Study|Protocol Violation|0|||
129649969|NCT00157248|466673324|FG002|Overall Study|Protocol Violation|2|||
129649970|NCT00157248|466673325|FG003|Overall Study|Protocol Violation|2|||
129649971|NCT00157248|466673322|FG000|Overall Study|Lost to Follow-up|0|||
129649972|NCT00157248|466673323|FG001|Overall Study|Lost to Follow-up|1|||
129649973|NCT00157248|466673324|FG002|Overall Study|Lost to Follow-up|0|||
129649974|NCT00157248|466673325|FG003|Overall Study|Lost to Follow-up|0|||
129649975|NCT00157248|466673322|FG000|Overall Study|Withdrawal by Subject|1|||
129649976|NCT00157248|466673323|FG001|Overall Study|Withdrawal by Subject|4|||
129649977|NCT00157248|466673324|FG002|Overall Study|Withdrawal by Subject|3|||
129649978|NCT00157248|466673325|FG003|Overall Study|Withdrawal by Subject|3|||
129649979|NCT00157248|466673322|FG000|Overall Study|site closures, subject moving|7|||
129649980|NCT00157248|466673323|FG001|Overall Study|site closures, subject moving|7|||
129649981|NCT00157248|466673324|FG002|Overall Study|site closures, subject moving|3|||
129649982|NCT00157248|466673325|FG003|Overall Study|site closures, subject moving|9|||
129649983|NCT01306045|466673328|FG000|Met General Eligibility Criteria|Screen failures|193|||
129649984|NCT01306045|466673329|FG001|Met General Eligibility Criteria|Screen failures|11|||
129649985|NCT01306045|466673330|FG002|Met General Eligibility Criteria|Screen failures|8|||
129649986|NCT00787917|466673332|FG000|Blinded Treatment|Adverse Event|1|||
129649987|NCT00787917|466673333|FG001|Blinded Treatment|Adverse Event|0|||
129649988|NCT00787917|466673332|FG000|Blinded Treatment|Lack of Efficacy|1|||
129649989|NCT00787917|466673333|FG001|Blinded Treatment|Lack of Efficacy|0|||
129649990|NCT00787917|466673332|FG000|Blinded Treatment|Administrative problems|3|||
129649991|NCT00787917|466673333|FG001|Blinded Treatment|Administrative problems|2|||
129649992|NCT00787917|466673332|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
129649993|NCT00787917|466673333|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
129649994|NCT00787917|466673332|FG000|Open Label|Administrative problems|3|||
129649995|NCT00787917|466673333|FG001|Open Label|Administrative problems|0|||
129649996|NCT00778102|466673334|FG000|Overall Study|Adverse Event|8|||
129649997|NCT00778102|466673335|FG001|Overall Study|Adverse Event|5|||
129649998|NCT00778102|466673334|FG000|Overall Study|Death|1|||
129649999|NCT00778102|466673335|FG001|Overall Study|Death|1|||
129650000|NCT00778102|466673334|FG000|Overall Study|Lost to Follow-up|1|||
129650001|NCT00778102|466673335|FG001|Overall Study|Lost to Follow-up|0|||
129650002|NCT00778102|466673334|FG000|Overall Study|Violation of Selection Criteria|1|||
129650003|NCT00778102|466673335|FG001|Overall Study|Violation of Selection Criteria|1|||
129650004|NCT00778102|466673334|FG000|Overall Study|Protocol Violation|0|||
129709996|NCT03789292|466900115|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
129709997|NCT03789292|466900116|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
129709998|NCT03789292|466900114|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
129709999|NCT03789292|466900115|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
129710000|NCT03789292|466900116|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
129710001|NCT03789292|466900114|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
129710002|NCT03789292|466900115|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
129710003|NCT03789292|466900116|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
129710004|NCT03789292|466900114|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
129710005|NCT03789292|466900115|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
129710006|NCT03789292|466900116|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
129710007|NCT03789292|466900114|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
129710008|NCT03789292|466900115|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
129650005|NCT00778102|466673335|FG001|Overall Study|Protocol Violation|1|||
129650006|NCT00778102|466673334|FG000|Overall Study|Refused Treatment|2|||
129650007|NCT00778102|466673335|FG001|Overall Study|Refused Treatment|3|||
129650008|NCT00778102|466673334|FG000|Overall Study|Withdrawal by Subject|1|||
129650009|NCT00778102|466673335|FG001|Overall Study|Withdrawal by Subject|1|||
129650010|NCT00778102|466673334|FG000|Overall Study|Administrative Reason|7|||
129650011|NCT00778102|466673335|FG001|Overall Study|Administrative Reason|10|||
129650012|NCT01328548|466673336|FG000|Overall Study|Death|3|||
129650013|NCT01328548|466673337|FG001|Overall Study|Death|0|||
129710009|NCT03789292|466900116|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
129710010|NCT03789292|466900114|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
129710011|NCT03789292|466900115|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
129710012|NCT03789292|466900116|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
129710013|NCT01904721|466900118|FG000|Overall Study|Other Reasons|0|||
129710014|NCT01904721|466900119|FG001|Overall Study|Other Reasons|0|||
129710015|NCT01904721|466900120|FG002|Overall Study|Other Reasons|1|||
129710016|NCT01904721|466900121|FG003|Overall Study|Other Reasons|1|||
129710017|NCT01904721|466900122|FG004|Overall Study|Other Reasons|2|||
129710018|NCT01904721|466900123|FG005|Overall Study|Other Reasons|2|||
129710019|NCT01904721|466900124|FG006|Overall Study|Other Reasons|2|||
129650014|NCT01328548|466673336|FG000|Overall Study|Protocol Violation|1|||
129650015|NCT01328548|466673337|FG001|Overall Study|Protocol Violation|0|||
129650016|NCT04557124|466675640|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
129650017|NCT04557124|466675641|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
129650018|NCT04557124|466675640|FG000|Mid-point (1 Month)|Missed testing|5|||
129650019|NCT04557124|466675641|FG001|Mid-point (1 Month)|Missed testing|4|||
129650020|NCT04557124|466675640|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
129650021|NCT04557124|466675641|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
129650022|NCT04557124|466675640|FG000|Post-testing (2 Months)|Missed testing|1|||
129650023|NCT04557124|466675641|FG001|Post-testing (2 Months)|Missed testing|5|||
129650024|NCT04557124|466675640|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
129650025|NCT04557124|466675641|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
129650026|NCT04557124|466675640|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
129650027|NCT04557124|466675641|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
129650028|NCT05128773|466675642|FG000|Overall Study|Sponsor decision to terminate study|3|||
129650029|NCT04250714|466675643|FG000|Overall Study|Treatment - withdrawal by subject|14|||
129650030|NCT04250714|466675643|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
129650031|NCT04250714|466675643|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
129650032|NCT04250714|466675643|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
129650033|NCT04250714|466675643|FG000|Overall Study|Treatment - Death|1|||
129650034|NCT04250714|466675643|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
129650035|NCT04250714|466675643|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
129650036|NCT04250714|466675643|FG000|Overall Study|Attempt|2|||
129650037|NCT04250714|466675643|FG000|Overall Study|Intent|7|||
129650038|NCT04676412|466675644|FG000|Overall Study|Death|28|||
129650039|NCT04676412|466675645|FG001|Overall Study|Death|31|||
129650040|NCT04676412|466675644|FG000|Overall Study|Lost to Follow-up|1|||
129650041|NCT04676412|466675645|FG001|Overall Study|Lost to Follow-up|2|||
129650042|NCT04676412|466675644|FG000|Overall Study|Sponsor Decision|20|||
129650043|NCT04676412|466675645|FG001|Overall Study|Sponsor Decision|23|||
129650044|NCT04676412|466675644|FG000|Overall Study|Withdrawal by Subject|0|||
129650045|NCT04676412|466675645|FG001|Overall Study|Withdrawal by Subject|2|||
129650046|NCT04697056|466675646|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
129650047|NCT04697056|466675647|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
129650048|NCT04550832|466675648|FG000|Overall Study|Adverse Event|0|||
129650049|NCT04550832|466675649|FG001|Overall Study|Adverse Event|0|||
129650050|NCT04550832|466675650|FG002|Overall Study|Adverse Event|2|||
129650051|NCT04550832|466675651|FG003|Overall Study|Adverse Event|0|||
129650052|NCT04550832|466675652|FG004|Overall Study|Adverse Event|1|||
129650053|NCT04823130|466675653|FG000|Overall Study|Withdrawal by Subject|2|||
129650054|NCT04823130|466675654|FG001|Overall Study|Withdrawal by Subject|3|||
129650055|NCT04823130|466675653|FG000|Overall Study|Failure to meet inclusion criteria|6|||
129650056|NCT04823130|466675654|FG001|Overall Study|Failure to meet inclusion criteria|4|||
129650057|NCT04823130|466675653|FG000|Overall Study|Other-unspecified|1|||
129650058|NCT04823130|466675654|FG001|Overall Study|Other-unspecified|0|||
129650059|NCT03315455|466675656|FG000|Overall Study|Ongoing in the Study|13|||
129650060|NCT03315455|466675657|FG001|Overall Study|Ongoing in the Study|24|||
129650061|NCT03315455|466675658|FG002|Overall Study|Ongoing in the Study|17|||
129650062|NCT03315455|466675659|FG003|Overall Study|Ongoing in the Study|15|||
129650063|NCT03315455|466675656|FG000|Overall Study|Withdrawal by Subject|0|||
129650064|NCT03315455|466675657|FG001|Overall Study|Withdrawal by Subject|1|||
129650065|NCT03315455|466675658|FG002|Overall Study|Withdrawal by Subject|0|||
129650066|NCT03315455|466675659|FG003|Overall Study|Withdrawal by Subject|0|||
129650067|NCT04439357|466675663|FG000|Overall Study|Disease Progression|4|||
129650068|NCT05906836|466675666|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
129650069|NCT05906836|466675666|FG000|Overall Study|Lost to Follow-up|1|||
129650070|NCT03030118|466675667|FG000|Overall Study|Achieved SLE Diagnosis|11|||
129650071|NCT03030118|466675668|FG001|Overall Study|Achieved SLE Diagnosis|10|||
129650072|NCT03030118|466675667|FG000|Overall Study|Adverse Event|1|||
129650073|NCT03030118|466675668|FG001|Overall Study|Adverse Event|1|||
129650074|NCT03030118|466675667|FG000|Overall Study|Pregnancy|2|||
129650075|NCT03030118|466675668|FG001|Overall Study|Pregnancy|2|||
129650076|NCT03030118|466675667|FG000|Overall Study|Lost to Follow-up|5|||
129650077|NCT03030118|466675668|FG001|Overall Study|Lost to Follow-up|6|||
129650078|NCT03030118|466675667|FG000|Overall Study|Concomitant Medications|1|||
129650079|NCT03030118|466675668|FG001|Overall Study|Concomitant Medications|1|||
129650080|NCT03030118|466675667|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
129650081|NCT03030118|466675668|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
129650082|NCT03030118|466675667|FG000|Overall Study|Other|2|||
129650083|NCT03030118|466675668|FG001|Overall Study|Other|0|||
129444196|NCT00639223|465926072|FG001|Overall Study|Lost to Follow-up|2|||
129650084|NCT03030118|466675667|FG000|Overall Study|Withdrawal by Subject|26|||
129650085|NCT03030118|466675668|FG001|Overall Study|Withdrawal by Subject|21|||
129650086|NCT03030118|466675667|FG000|Overall Study|Protocol Violation|1|||
129650087|NCT03030118|466675668|FG001|Overall Study|Protocol Violation|6|||
129650088|NCT04529850|466675669|FG000|Overall Study|Death|2|||
129800790|NCT02349061|467239856|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
129800791|NCT02349061|467239857|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
129800792|NCT02349061|467239858|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
129800793|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
129800794|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
129800795|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
129800796|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
129800797|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
129800798|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
129800799|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
129800800|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
129800801|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
129800802|NCT02349061|467239856|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
129800803|NCT02349061|467239857|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
129800804|NCT02349061|467239858|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
129800805|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
129800806|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
129800807|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
129800808|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
129800809|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
129800810|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
129800811|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
129800812|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
129800813|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
129800814|NCT02349061|467239856|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
129800815|NCT02349061|467239857|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
129800816|NCT02349061|467239858|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
129800817|NCT00398411|467239859|FG000|Overall Study|Death|0|||
129800818|NCT00398411|467239860|FG001|Overall Study|Death|1|||
129800819|NCT02095223|467239861|FG000|Overall Study|Withdrawal by Subject|1|||
129800820|NCT02095223|467239862|FG001|Overall Study|Withdrawal by Subject|0|||
129800821|NCT02339285|467239863|FG000|Overall Study|Withdrawal by Subject|0|||
129800822|NCT02339285|467239864|FG001|Overall Study|Withdrawal by Subject|1|||
129800823|NCT02339285|467239865|FG002|Overall Study|Withdrawal by Subject|1|||
129800824|NCT02339285|467239863|FG000|Overall Study|Lost to Follow-up|1|||
129800825|NCT02339285|467239864|FG001|Overall Study|Lost to Follow-up|1|||
129800826|NCT02339285|467239865|FG002|Overall Study|Lost to Follow-up|1|||
129800827|NCT02339285|467239863|FG000|Overall Study|Protocol Deviation|0|||
129800828|NCT02339285|467239864|FG001|Overall Study|Protocol Deviation|1|||
129800829|NCT02339285|467239865|FG002|Overall Study|Protocol Deviation|0|||
129800830|NCT01507298|467239866|FG000|Overall Study|Protocol Violation|0|||
129800831|NCT01507298|467239867|FG001|Overall Study|Protocol Violation|6|||
129800832|NCT03061097|467239868|FG000|Overall Study|Withdrawal by Subject|0|||
129800833|NCT03061097|467239869|FG001|Overall Study|Withdrawal by Subject|3|||
129800834|NCT03911713|467239870|FG000|Overall Study|Lost to Follow-up|0|||
129800835|NCT03911713|467239871|FG001|Overall Study|Lost to Follow-up|2|||
129800836|NCT03911713|467239872|FG002|Overall Study|Lost to Follow-up|0|||
129800837|NCT03911713|467239873|FG003|Overall Study|Lost to Follow-up|0|||
129800838|NCT03911713|467239874|FG004|Overall Study|Lost to Follow-up|0|||
129800839|NCT03911713|467239870|FG000|Overall Study|Other|0|||
129800840|NCT03911713|467239871|FG001|Overall Study|Other|0|||
129800841|NCT03911713|467239872|FG002|Overall Study|Other|0|||
129800842|NCT03911713|467239873|FG003|Overall Study|Other|1|||
129800843|NCT03911713|467239874|FG004|Overall Study|Other|0|||
129800844|NCT03911713|467239870|FG000|Overall Study|Randomized, Never Dosed|1|||
129800845|NCT03911713|467239871|FG001|Overall Study|Randomized, Never Dosed|0|||
129800846|NCT03911713|467239872|FG002|Overall Study|Randomized, Never Dosed|0|||
129800847|NCT03911713|467239873|FG003|Overall Study|Randomized, Never Dosed|1|||
129800848|NCT03911713|467239874|FG004|Overall Study|Randomized, Never Dosed|0|||
129800849|NCT01614600|467239875|FG000|Overall Study|Unacceptable fit|1|||
129650089|NCT04529850|466675669|FG000|Overall Study|Physician Decision|1|||
129650090|NCT04529850|466675669|FG000|Overall Study|Withdrawal by Subject|2|||
129650091|NCT01911780|466675670|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
129650092|NCT01911780|466675671|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
129650093|NCT01911780|466675670|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
129650094|NCT01911780|466675671|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
129650095|NCT01911780|466675670|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
129650096|NCT01911780|466675671|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
129650097|NCT01911780|466675670|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
129650098|NCT01911780|466675671|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
129650099|NCT01911780|466675670|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
129650100|NCT01911780|466675671|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
129650101|NCT01911780|466675670|FG000|Extension Period (52 Weeks)|Personal reason|1|||
129650102|NCT01911780|466675671|FG001|Extension Period (52 Weeks)|Personal reason|1|||
129650103|NCT02720744|466675675|FG000|Overall Study|Protocol Violation|0|||
129650104|NCT02720744|466675676|FG001|Overall Study|Protocol Violation|2|||
129650105|NCT02720744|466675675|FG000|Overall Study|Pregnancy|2|||
129650106|NCT02720744|466675676|FG001|Overall Study|Pregnancy|0|||
129650107|NCT02720744|466675675|FG000|Overall Study|Lack of Efficacy|2|||
129650108|NCT02720744|466675676|FG001|Overall Study|Lack of Efficacy|8|||
129650109|NCT02720744|466675675|FG000|Overall Study|Adverse Event|21|||
129650110|NCT02720744|466675676|FG001|Overall Study|Adverse Event|3|||
129650111|NCT02720744|466675675|FG000|Overall Study|Withdrawal by Subject|11|||
129650112|NCT02720744|466675676|FG001|Overall Study|Withdrawal by Subject|11|||
129650113|NCT02720744|466675675|FG000|Overall Study|Lost to follow up|2|||
129650114|NCT02720744|466675676|FG001|Overall Study|Lost to follow up|0|||
129650115|NCT02720744|466675675|FG000|Overall Study|Non Compliance with Investigational Product|0|||
129650116|NCT02720744|466675676|FG001|Overall Study|Non Compliance with Investigational Product|1|||
129650117|NCT02720744|466675675|FG000|Overall Study|Excluded Concomitant Medication|0|||
129650118|NCT02720744|466675676|FG001|Overall Study|Excluded Concomitant Medication|1|||
129650119|NCT01199822|466675678|FG000|Overall Study|Investigator discontinued therapy|0|||
129650120|NCT01199822|466675679|FG001|Overall Study|Investigator discontinued therapy|1|||
129650121|NCT01199822|466675680|FG002|Overall Study|Investigator discontinued therapy|0|||
129650122|NCT00480493|466675681|FG000|Overall Study|moved|2|||
129650123|NCT00480493|466675682|FG001|Overall Study|moved|7|||
129650124|NCT04027075|466675683|FG000|Overall Study|Lost to Follow-up|41|||
129650125|NCT04027075|466675684|FG001|Overall Study|Lost to Follow-up|22|||
129650126|NCT03769675|466675685|FG000|Overall Study|Lost to Follow-up|1|||
129650127|NCT01032070|466675686|FG000|Overall Study|Disease progression|13|||
129650128|NCT01032070|466675687|FG001|Overall Study|Disease progression|8|||
129650129|NCT01032070|466675686|FG000|Overall Study|Medical or ethical reasons|0|||
129650130|NCT01032070|466675687|FG001|Overall Study|Medical or ethical reasons|2|||
129650131|NCT01032070|466675686|FG000|Overall Study|Withdrawal by Subject|0|||
129650132|NCT01032070|466675687|FG001|Overall Study|Withdrawal by Subject|2|||
129650133|NCT02772276|466675688|FG000|Overall Study|Lost to Follow-up|0|||
129650134|NCT02772276|466675689|FG001|Overall Study|Lost to Follow-up|0|||
129650135|NCT02772276|466675690|FG002|Overall Study|Lost to Follow-up|0|||
129650136|NCT02772276|466675691|FG003|Overall Study|Lost to Follow-up|0|||
129650137|NCT02772276|466675692|FG004|Overall Study|Lost to Follow-up|0|||
129650138|NCT02772276|466675693|FG005|Overall Study|Lost to Follow-up|0|||
129650139|NCT02772276|466675694|FG006|Overall Study|Lost to Follow-up|1|||
129650140|NCT02772276|466675695|FG007|Overall Study|Lost to Follow-up|0|||
129650141|NCT02772276|466675696|FG008|Overall Study|Lost to Follow-up|0|||
129650142|NCT02772276|466675697|FG009|Overall Study|Lost to Follow-up|0|||
129650143|NCT02772276|466675698|FG010|Overall Study|Lost to Follow-up|0|||
129650144|NCT02772276|466675699|FG011|Overall Study|Lost to Follow-up|0|||
129650145|NCT02772276|466675700|FG012|Overall Study|Lost to Follow-up|0|||
129650146|NCT02772276|466675688|FG000|Overall Study|Withdrew consent|0|||
129650147|NCT02772276|466675689|FG001|Overall Study|Withdrew consent|0|||
129650148|NCT02772276|466675690|FG002|Overall Study|Withdrew consent|0|||
129650149|NCT02772276|466675691|FG003|Overall Study|Withdrew consent|0|||
129650150|NCT02772276|466675692|FG004|Overall Study|Withdrew consent|0|||
129650151|NCT02772276|466675693|FG005|Overall Study|Withdrew consent|0|||
129650152|NCT02772276|466675694|FG006|Overall Study|Withdrew consent|0|||
129650153|NCT02772276|466675695|FG007|Overall Study|Withdrew consent|1|||
129650154|NCT02772276|466675696|FG008|Overall Study|Withdrew consent|0|||
129650155|NCT02772276|466675697|FG009|Overall Study|Withdrew consent|0|||
129650156|NCT02772276|466675698|FG010|Overall Study|Withdrew consent|0|||
129650157|NCT02772276|466675699|FG011|Overall Study|Withdrew consent|0|||
129650158|NCT02772276|466675700|FG012|Overall Study|Withdrew consent|0|||
129650159|NCT00426660|466675701|FG000|Overall Study|Death|14|||
129650160|NCT00426660|466675701|FG000|Overall Study|Adverse Event|23|||
129710020|NCT01904721|466900118|FG000|Overall Study|Personal Reasons|0|||
129650161|NCT00426660|466675701|FG000|Overall Study|Insufficient Clinical Response|22|||
129650162|NCT00426660|466675701|FG000|Overall Study|Lost to Follow-up|15|||
129650163|NCT00426660|466675701|FG000|Overall Study|Other|23|||
129650164|NCT00426660|466675701|FG000|Overall Study|Withdrawal by Subject|18|||
129710021|NCT01904721|466900119|FG001|Overall Study|Personal Reasons|0|||
129710022|NCT01904721|466900120|FG002|Overall Study|Personal Reasons|0|||
129710023|NCT01904721|466900121|FG003|Overall Study|Personal Reasons|0|||
129710024|NCT01904721|466900122|FG004|Overall Study|Personal Reasons|2|||
129710025|NCT01904721|466900123|FG005|Overall Study|Personal Reasons|3|||
129710026|NCT01904721|466900124|FG006|Overall Study|Personal Reasons|3|||
129710027|NCT01904721|466900118|FG000|Overall Study|Lost to Follow-up|0|||
129710028|NCT01904721|466900119|FG001|Overall Study|Lost to Follow-up|0|||
129800850|NCT01614600|467239875|FG000|Overall Study|Discomfort|1|||
129800851|NCT01614600|467239875|FG000|Overall Study|Unable to remove lens at the end of day|1|||
129800852|NCT01614600|467239875|FG000|Overall Study|Protocol deviation|1|||
129800853|NCT02437513|467239876|FG000|Overall Study|Withdrawal by Subject|2|||
129800854|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
129800855|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
129800856|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
129800857|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
129800858|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
129800859|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
129800860|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
129800861|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
129800862|NCT03347188|467239877|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
129800863|NCT03347188|467239878|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
129800864|NCT03347188|467239877|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
129800865|NCT03347188|467239878|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
129800866|NCT03347188|467239877|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
129800867|NCT03347188|467239878|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
129800868|NCT03347188|467239877|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
129800869|NCT03347188|467239878|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
129800870|NCT01845818|467239879|FG000|Overall Study|Withdrawal by Subject|0|||
129800871|NCT01845818|467239880|FG001|Overall Study|Withdrawal by Subject|1|||
129800872|NCT01845818|467239879|FG000|Overall Study|Lost to Follow-up|7|||
129800873|NCT01845818|467239880|FG001|Overall Study|Lost to Follow-up|5|||
129800874|NCT01845818|467239879|FG000|Overall Study|Administrative Reasons|3|||
129800875|NCT01845818|467239880|FG001|Overall Study|Administrative Reasons|1|||
129800876|NCT01845818|467239879|FG000|Overall Study|Serious Adverse Event|1|||
129800877|NCT01845818|467239880|FG001|Overall Study|Serious Adverse Event|1|||
129800878|NCT01845818|467239879|FG000|Overall Study|Other|25|||
129800879|NCT01845818|467239880|FG001|Overall Study|Other|8|||
129800880|NCT01845818|467239879|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
129800881|NCT01845818|467239880|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
129800882|NCT01845818|467239879|FG000|Overall Study|No Follow-Up Data Available|4|||
129800883|NCT01845818|467239880|FG001|Overall Study|No Follow-Up Data Available|1|||
129800884|NCT02186873|467239881|FG000|Overall Study|Adverse Event|1|||
129800885|NCT02186873|467239882|FG001|Overall Study|Adverse Event|3|||
129800886|NCT02186873|467239881|FG000|Overall Study|Lack of Efficacy|0|||
129800887|NCT02186873|467239882|FG001|Overall Study|Lack of Efficacy|1|||
129800888|NCT02186873|467239881|FG000|Overall Study|Lost to Follow-up|1|||
129800889|NCT02186873|467239882|FG001|Overall Study|Lost to Follow-up|2|||
129800890|NCT02186873|467239881|FG000|Overall Study|Withdrawal by Subject|7|||
129800891|NCT02186873|467239882|FG001|Overall Study|Withdrawal by Subject|2|||
129800892|NCT01680965|467239883|FG000|Overall Study|Death|0|||
129800893|NCT01680965|467239884|FG001|Overall Study|Death|0|||
129800894|NCT01680965|467239885|FG002|Overall Study|Death|0|||
129800895|NCT01680965|467239886|FG003|Overall Study|Death|6|||
129800896|NCT00107783|467239887|FG000|Overall Study|Adverse Event|0|||
129800897|NCT00107783|467239888|FG001|Overall Study|Adverse Event|2|||
129800898|NCT00107783|467239887|FG000|Overall Study|Death|0|||
129800899|NCT00107783|467239888|FG001|Overall Study|Death|1|||
129800900|NCT00107783|467239887|FG000|Overall Study|Withdrawal by Subject|2|||
129800901|NCT00107783|467239888|FG001|Overall Study|Withdrawal by Subject|0|||
129800902|NCT00107783|467239887|FG000|Overall Study|Second hip replacement|1|||
129800903|NCT00107783|467239888|FG001|Overall Study|Second hip replacement|1|||
129800904|NCT02231918|467239890|FG000|Overall Study|Withdrawal by Subject|0|||
129800905|NCT02231918|467239891|FG001|Overall Study|Withdrawal by Subject|1|||
129800906|NCT02231918|467239892|FG002|Overall Study|Withdrawal by Subject|0|||
129800907|NCT02231918|467239890|FG000|Overall Study|Adverse Event|0|||
129800908|NCT02231918|467239891|FG001|Overall Study|Adverse Event|0|||
129800909|NCT02231918|467239892|FG002|Overall Study|Adverse Event|1|||
129800910|NCT00137631|467239893|FG000|Overall Study|Lost to Follow-up|37|||
129800911|NCT00137631|467239894|FG001|Overall Study|Lost to Follow-up|41|||
129800912|NCT01871142|467239897|FG000|Overall Study|Adverse Event|1|||
129800913|NCT00598702|467239906|FG000|Overall Study|Other|0|||
129800914|NCT00598702|467239907|FG001|Overall Study|Other|2|||
129800915|NCT00598702|467239908|FG002|Overall Study|Other|0|||
129800916|NCT00598702|467239909|FG003|Overall Study|Other|0|||
129710029|NCT01904721|466900120|FG002|Overall Study|Lost to Follow-up|0|||
129710030|NCT01904721|466900121|FG003|Overall Study|Lost to Follow-up|0|||
129710031|NCT01904721|466900122|FG004|Overall Study|Lost to Follow-up|1|||
129710032|NCT01904721|466900123|FG005|Overall Study|Lost to Follow-up|3|||
129710033|NCT01904721|466900124|FG006|Overall Study|Lost to Follow-up|1|||
129710034|NCT01904721|466900118|FG000|Overall Study|Lack of Efficacy|0|||
129710035|NCT01904721|466900119|FG001|Overall Study|Lack of Efficacy|0|||
129710036|NCT01904721|466900120|FG002|Overall Study|Lack of Efficacy|0|||
129710037|NCT01904721|466900121|FG003|Overall Study|Lack of Efficacy|0|||
129710038|NCT01904721|466900122|FG004|Overall Study|Lack of Efficacy|0|||
129710039|NCT01904721|466900123|FG005|Overall Study|Lack of Efficacy|0|||
129710040|NCT01904721|466900124|FG006|Overall Study|Lack of Efficacy|1|||
129710041|NCT01904721|466900118|FG000|Overall Study|Adverse Event|0|||
129710042|NCT01904721|466900119|FG001|Overall Study|Adverse Event|0|||
129710043|NCT01904721|466900120|FG002|Overall Study|Adverse Event|0|||
129710044|NCT01904721|466900121|FG003|Overall Study|Adverse Event|0|||
129650165|NCT00426660|466675701|FG000|Overall Study|Protocol Violation|1|||
129650166|NCT00426660|466675701|FG000|Overall Study|Enrolled Not Treated|15|||
129650167|NCT00738062|466675702|FG000|Open Label Treatment|Lack of Efficacy|5|||
129650168|NCT00738062|466675703|FG001|Open Label Treatment|Lack of Efficacy|0|||
129650169|NCT00738062|466675704|FG002|Open Label Treatment|Lack of Efficacy|0|||
129650170|NCT00738062|466675702|FG000|Open Label Treatment|Adverse Event|11|||
129650171|NCT00738062|466675703|FG001|Open Label Treatment|Adverse Event|0|||
129650172|NCT00738062|466675704|FG002|Open Label Treatment|Adverse Event|0|||
129650173|NCT00738062|466675702|FG000|Open Label Treatment|Protocol Violation|2|||
129650174|NCT00738062|466675703|FG001|Open Label Treatment|Protocol Violation|0|||
129650175|NCT00738062|466675704|FG002|Open Label Treatment|Protocol Violation|0|||
129650176|NCT00738062|466675702|FG000|Open Label Treatment|Withdrawal by Subject|9|||
129650177|NCT00738062|466675703|FG001|Open Label Treatment|Withdrawal by Subject|0|||
129650178|NCT00738062|466675704|FG002|Open Label Treatment|Withdrawal by Subject|0|||
129650179|NCT00738062|466675702|FG000|Open Label Treatment|Investigator Decision|1|||
129650180|NCT00738062|466675703|FG001|Open Label Treatment|Investigator Decision|0|||
129650181|NCT00738062|466675704|FG002|Open Label Treatment|Investigator Decision|0|||
129650182|NCT00738062|466675702|FG000|Open-Label Extension|Adverse Event|5|||
129650183|NCT00738062|466675703|FG001|Open-Label Extension|Adverse Event|0|||
129650184|NCT00738062|466675704|FG002|Open-Label Extension|Adverse Event|0|||
129650185|NCT00738062|466675702|FG000|Open-Label Extension|Physician Decision|1|||
129650186|NCT00738062|466675703|FG001|Open-Label Extension|Physician Decision|0|||
129650187|NCT00738062|466675704|FG002|Open-Label Extension|Physician Decision|0|||
129650188|NCT00738062|466675702|FG000|Open-Label Extension|Lack of Efficacy|2|||
129650189|NCT00738062|466675703|FG001|Open-Label Extension|Lack of Efficacy|0|||
129650190|NCT00738062|466675704|FG002|Open-Label Extension|Lack of Efficacy|0|||
129650191|NCT00738062|466675702|FG000|Open-Label Extension|Withdrawal by Subject|6|||
129650192|NCT00738062|466675703|FG001|Open-Label Extension|Withdrawal by Subject|0|||
129650193|NCT00738062|466675704|FG002|Open-Label Extension|Withdrawal by Subject|0|||
129650194|NCT00738062|466675702|FG000|Open-Label Extension|Protocol Violation|1|||
129650195|NCT00738062|466675703|FG001|Open-Label Extension|Protocol Violation|0|||
129650196|NCT00738062|466675704|FG002|Open-Label Extension|Protocol Violation|0|||
129650197|NCT00738062|466675702|FG000|Open-Label Extension|Study Terminated|2|||
129650198|NCT00738062|466675703|FG001|Open-Label Extension|Study Terminated|0|||
129650199|NCT00738062|466675704|FG002|Open-Label Extension|Study Terminated|0|||
129650200|NCT00980174|466675705|FG000|Overall Study|Withdrawal by Subject|1|||
129650201|NCT00980174|466675706|FG001|Overall Study|Withdrawal by Subject|4|||
129650202|NCT00980174|466675705|FG000|Overall Study|Adverse Event|0|||
129650203|NCT00980174|466675706|FG001|Overall Study|Adverse Event|3|||
129650204|NCT00980174|466675705|FG000|Overall Study|Ineligibility determined|2|||
129650205|NCT00980174|466675706|FG001|Overall Study|Ineligibility determined|1|||
129650206|NCT00980174|466675705|FG000|Overall Study|Death|1|||
129650207|NCT00980174|466675706|FG001|Overall Study|Death|1|||
129650208|NCT00980174|466675705|FG000|Overall Study|Other|0|||
129650209|NCT00980174|466675706|FG001|Overall Study|Other|1|||
129650210|NCT00455520|466675707|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
129650211|NCT00455520|466675708|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
129650212|NCT00455520|466675707|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
129650213|NCT00455520|466675708|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
129650214|NCT00455520|466675707|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
129650215|NCT00455520|466675708|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
129650216|NCT00455520|466675707|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
129650217|NCT00455520|466675708|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
129650218|NCT00455520|466675707|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
129650219|NCT00455520|466675708|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
129650220|NCT00455520|466675707|FG000|Open Label Tapentadol Extended Release|All other|33|||
129650221|NCT00455520|466675708|FG001|Open Label Tapentadol Extended Release|All other|0|||
129710045|NCT01904721|466900122|FG004|Overall Study|Adverse Event|3|||
129710046|NCT01904721|466900123|FG005|Overall Study|Adverse Event|1|||
129710047|NCT01904721|466900124|FG006|Overall Study|Adverse Event|0|||
129710048|NCT01957865|466900125|FG000|Overall Study|Found HIV negative|0|||
129710049|NCT01957865|466900126|FG001|Overall Study|Found HIV negative|0|||
129710050|NCT01957865|466900127|FG002|Overall Study|Found HIV negative|1|||
129710051|NCT01957865|466900125|FG000|Overall Study|Lost to Follow-up|0|||
129710052|NCT01957865|466900126|FG001|Overall Study|Lost to Follow-up|2|||
129710053|NCT01957865|466900127|FG002|Overall Study|Lost to Follow-up|2|||
129710054|NCT01082614|466900128|FG000|Overall Study|Adverse Event|1|||
129710055|NCT01082614|466900129|FG001|Overall Study|Adverse Event|4|||
129710056|NCT01082614|466900128|FG000|Overall Study|Equipment Malfunction|0|||
129710057|NCT01082614|466900129|FG001|Overall Study|Equipment Malfunction|1|||
129710058|NCT01082614|466900128|FG000|Overall Study|Physician Decision|2|||
129710059|NCT01082614|466900129|FG001|Overall Study|Physician Decision|0|||
129710060|NCT00811720|466900133|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
129710061|NCT00811720|466900134|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
129710062|NCT00811720|466900133|FG000|All Treated Patients|Adverse Event|20|||
129710063|NCT00811720|466900134|FG001|All Treated Patients|Adverse Event|62|||
129710064|NCT00811720|466900133|FG000|All Treated Patients|Lack of Efficacy|22|||
129710065|NCT00811720|466900134|FG001|All Treated Patients|Lack of Efficacy|18|||
129710066|NCT00811720|466900133|FG000|All Treated Patients|Non-compliance|0|||
129710067|NCT00811720|466900134|FG001|All Treated Patients|Non-compliance|14|||
129710068|NCT00811720|466900133|FG000|All Treated Patients|Protocol Violation|9|||
129710069|NCT00811720|466900134|FG001|All Treated Patients|Protocol Violation|16|||
129710070|NCT00811720|466900133|FG000|All Treated Patients|Withdrawal by Subject|28|||
129710071|NCT00811720|466900134|FG001|All Treated Patients|Withdrawal by Subject|34|||
129710072|NCT00811720|466900133|FG000|All Treated Patients|Lost to Follow-up|10|||
129710073|NCT00811720|466900134|FG001|All Treated Patients|Lost to Follow-up|16|||
129710074|NCT00811720|466900133|FG000|All Treated Patients|Other Reason|7|||
129710075|NCT00811720|466900134|FG001|All Treated Patients|Other Reason|4|||
129710076|NCT00553631|466900135|FG000|Overall Study|Withdrawal by Subject|0|||
129710077|NCT00553631|466900136|FG001|Overall Study|Withdrawal by Subject|1|||
129710078|NCT00553631|466900135|FG000|Overall Study|Lost to Follow-up|1|||
129710079|NCT00553631|466900136|FG001|Overall Study|Lost to Follow-up|0|||
129710080|NCT01055613|466900137|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
129710081|NCT01055613|466900138|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129710082|NCT01055613|466900137|FG000|Overall Study|Unacceptable lens fit|1|||
129710083|NCT01055613|466900138|FG001|Overall Study|Unacceptable lens fit|0|||
129710084|NCT01055613|466900137|FG000|Overall Study|Discomfort|2|||
129710085|NCT01055613|466900138|FG001|Overall Study|Discomfort|1|||
129710086|NCT01055613|466900137|FG000|Overall Study|Lost to Follow-up|1|||
129710087|NCT01055613|466900138|FG001|Overall Study|Lost to Follow-up|1|||
129710088|NCT01055613|466900137|FG000|Overall Study|Protocol Violation|1|||
129710089|NCT01055613|466900138|FG001|Overall Study|Protocol Violation|1|||
129710090|NCT01055613|466900137|FG000|Overall Study|Subject Disinterest|1|||
129710091|NCT01055613|466900138|FG001|Overall Study|Subject Disinterest|1|||
129710092|NCT02765399|466900139|FG000|Overall Study|Nausea|1|||
129710093|NCT02765399|466900140|FG001|Overall Study|Nausea|0|||
129710094|NCT01182298|466900147|FG000|Overall Study|Lack of Efficacy|4|||
129710095|NCT01182298|466900147|FG000|Overall Study|Withdrawal by Subject|2|||
129710096|NCT01822665|466900163|FG000|Overall Study|Adverse Event|3|||
129710097|NCT01822665|466900163|FG000|Overall Study|Other Reason|5|||
129710098|NCT04540367|466900164|FG000|Overall Study|Withdrawal by Subject|0|||
129710099|NCT04540367|466900165|FG001|Overall Study|Withdrawal by Subject|0|||
129710100|NCT04540367|466900166|FG002|Overall Study|Withdrawal by Subject|0|||
129710101|NCT04540367|466900167|FG003|Overall Study|Withdrawal by Subject|2|||
129710102|NCT04540367|466900164|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
129710103|NCT04540367|466900165|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
129710104|NCT04540367|466900166|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
129710105|NCT04540367|466900167|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
129710106|NCT04540367|466900164|FG000|Overall Study|Adverse Event|0|||
129710107|NCT04540367|466900165|FG001|Overall Study|Adverse Event|0|||
129710108|NCT04540367|466900166|FG002|Overall Study|Adverse Event|1|||
129710109|NCT04540367|466900167|FG003|Overall Study|Adverse Event|1|||
129710110|NCT00959907|466900170|FG000|Overall Study|Protocol Violation|0|||
129710111|NCT00959907|466900171|FG001|Overall Study|Protocol Violation|1|||
129710112|NCT00959907|466900170|FG000|Overall Study|Adverse Event|1|||
129710113|NCT00959907|466900171|FG001|Overall Study|Adverse Event|0|||
129710114|NCT00959907|466900170|FG000|Overall Study|Withdrawal by Subject|2|||
129710115|NCT00959907|466900171|FG001|Overall Study|Withdrawal by Subject|0|||
129710116|NCT03958331|466900172|FG000|Overall Study|Withdrawal by Subject|3|||
129710117|NCT03958331|466900173|FG001|Overall Study|Withdrawal by Subject|1|||
129710118|NCT03958331|466900174|FG002|Overall Study|Withdrawal by Subject|5|||
129710119|NCT03958331|466900172|FG000|Overall Study|Weaned from medicine|2|||
129710120|NCT03958331|466900173|FG001|Overall Study|Weaned from medicine|0|||
129710121|NCT03958331|466900174|FG002|Overall Study|Weaned from medicine|0|||
129710122|NCT03958331|466900172|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
129710123|NCT03958331|466900173|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
129710124|NCT03958331|466900174|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
129710125|NCT04290624|466900175|FG000|Overall Study|Adverse Event|1|||
129710126|NCT04290624|466900176|FG001|Overall Study|Adverse Event|0|||
129710127|NCT04422431|466900177|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
129710128|NCT04422431|466900177|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
129710129|NCT04422431|466900177|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
129710130|NCT04422431|466900177|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
129710131|NCT04422431|466900177|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
129710132|NCT04422431|466900177|FG000|Extension Period (48 Weeks)|Other than specified|2|||
129710133|NCT02735421|466901527|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
129710134|NCT02735421|466901527|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
129710135|NCT02735421|466901527|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
129710136|NCT02735421|466901527|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
129710137|NCT02735421|466901527|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
129710138|NCT02735421|466901527|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
129710139|NCT02735421|466901527|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
129710140|NCT05010070|466901528|FG000|Overall Study|Lost to Follow-up|1|||
129710141|NCT05010070|466901528|FG000|Overall Study|Withdrawal by Subject|1|||
129710142|NCT03247829|466901530|FG000|Overall Study|Death|3|||
129710143|NCT03247829|466901531|FG001|Overall Study|Death|4|||
129710144|NCT03247829|466901530|FG000|Overall Study|Enter Hospice Care|1|||
129710145|NCT03247829|466901531|FG001|Overall Study|Enter Hospice Care|0|||
129710146|NCT03247829|466901530|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
129710147|NCT03247829|466901531|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
129710148|NCT03247829|466901530|FG000|Overall Study|LVAD Explant|1|||
129710149|NCT03247829|466901531|FG001|Overall Study|LVAD Explant|1|||
129710150|NCT03247829|466901530|FG000|Overall Study|Transplant|1|||
129710151|NCT03247829|466901531|FG001|Overall Study|Transplant|1|||
129710152|NCT01783444|466901532|FG000|Treatment Phase|Adverse Event|9|||
129710153|NCT01783444|466901533|FG001|Treatment Phase|Adverse Event|20|||
129710154|NCT01783444|466901534|FG002|Treatment Phase|Adverse Event|19|||
129710155|NCT01783444|466901532|FG000|Treatment Phase|Disease Progression|76|||
129710156|NCT01783444|466901533|FG001|Treatment Phase|Disease Progression|66|||
129710157|NCT01783444|466901534|FG002|Treatment Phase|Disease Progression|64|||
129710158|NCT01783444|466901532|FG000|Treatment Phase|Death|2|||
129710159|NCT01783444|466901533|FG001|Treatment Phase|Death|2|||
129710160|NCT01783444|466901534|FG002|Treatment Phase|Death|2|||
129710161|NCT01783444|466901532|FG000|Treatment Phase|Protocol Violation|1|||
129710162|NCT01783444|466901533|FG001|Treatment Phase|Protocol Violation|1|||
129710163|NCT01783444|466901534|FG002|Treatment Phase|Protocol Violation|2|||
129710164|NCT01783444|466901532|FG000|Treatment Phase|Withdrawal by Subject|6|||
129710165|NCT01783444|466901533|FG001|Treatment Phase|Withdrawal by Subject|8|||
129710166|NCT01783444|466901534|FG002|Treatment Phase|Withdrawal by Subject|9|||
129710167|NCT01783444|466901532|FG000|Treatment Phase|Administrative problems|2|||
129710168|NCT01783444|466901533|FG001|Treatment Phase|Administrative problems|0|||
129710169|NCT01783444|466901534|FG002|Treatment Phase|Administrative problems|1|||
129710170|NCT01783444|466901532|FG000|Treatment Phase|Physician Decision|8|||
129710171|NCT01783444|466901533|FG001|Treatment Phase|Physician Decision|6|||
129710172|NCT01783444|466901534|FG002|Treatment Phase|Physician Decision|5|||
129710173|NCT01783444|466901532|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
129710174|NCT01783444|466901533|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
129710175|NCT01783444|466901534|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
129710176|NCT01783444|466901532|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
129710177|NCT01783444|466901533|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
129710178|NCT01783444|466901534|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
129710179|NCT01783444|466901532|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
129800917|NCT00598702|467239910|FG004|Overall Study|Other|0|||
129800918|NCT00598702|467239911|FG005|Overall Study|Other|1|||
129800919|NCT00598702|467239912|FG006|Overall Study|Other|0|||
129800920|NCT00598702|467239913|FG007|Overall Study|Other|0|||
129800921|NCT00598702|467239906|FG000|Overall Study|Early discharge from hospital|0|||
129800922|NCT00598702|467239907|FG001|Overall Study|Early discharge from hospital|0|||
129800923|NCT00598702|467239908|FG002|Overall Study|Early discharge from hospital|2|||
129800924|NCT00598702|467239909|FG003|Overall Study|Early discharge from hospital|5|||
129800925|NCT00598702|467239910|FG004|Overall Study|Early discharge from hospital|0|||
129710180|NCT01783444|466901533|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
129710181|NCT01783444|466901534|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
129710182|NCT01783444|466901532|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
129710183|NCT01783444|466901533|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
129800926|NCT00598702|467239911|FG005|Overall Study|Early discharge from hospital|10|||
129444197|NCT04936841|465926073|FG000|Overall Study|Death|1|||
129650222|NCT00455520|466675707|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
129650223|NCT00455520|466675708|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
129650224|NCT00455520|466675707|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
129650225|NCT00455520|466675708|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
129650226|NCT00455520|466675707|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
129650227|NCT00455520|466675708|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
129650228|NCT00455520|466675707|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
129650229|NCT00455520|466675708|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
129650230|NCT00455520|466675707|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
129650231|NCT00455520|466675708|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
129650232|NCT00455520|466675707|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
129650233|NCT00455520|466675708|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
129650234|NCT00783224|466675713|FG000|Overall Study|Adverse Event|0|||
129650235|NCT00783224|466675714|FG001|Overall Study|Adverse Event|0|||
129650236|NCT00783224|466675715|FG002|Overall Study|Adverse Event|1|||
129650237|NCT00783224|466675716|FG003|Overall Study|Adverse Event|0|||
129650238|NCT00783224|466675713|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
129650239|NCT00783224|466675714|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
129650240|NCT00783224|466675715|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
129650241|NCT00783224|466675716|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
129650242|NCT00783224|466675713|FG000|Overall Study|Inappropriate as a study subject|0|||
129650243|NCT00783224|466675714|FG001|Overall Study|Inappropriate as a study subject|0|||
129650244|NCT00783224|466675715|FG002|Overall Study|Inappropriate as a study subject|0|||
129650245|NCT00783224|466675716|FG003|Overall Study|Inappropriate as a study subject|1|||
129650246|NCT04631107|466675719|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
129650247|NCT04631107|466675719|FG000|Second Intervention (1 Night)|Adverse Event|1|||
129650248|NCT04631107|466675719|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
129650249|NCT04631107|466675719|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
129650250|NCT05385224|466675723|FG000|Overall Study|Unable to swallow capsule|2|||
129650251|NCT05385224|466675723|FG000|Overall Study|Withdrawal by Subject|2|||
129650252|NCT05385224|466675723|FG000|Overall Study|Did not meet study criteria|1|||
129650253|NCT00551161|466675724|FG000|Overall Study|Withdrawal by Subject|1|||
129650254|NCT01935700|466675725|FG000|Overall Study|Withdrawal by Subject|1|||
129650255|NCT01935700|466675726|FG001|Overall Study|Withdrawal by Subject|0|||
129650256|NCT01935700|466675725|FG000|Overall Study|Physician Decision|4|||
129650257|NCT01935700|466675726|FG001|Overall Study|Physician Decision|0|||
129650258|NCT00096993|466675727|FG000|Overall Study|Death|1|||
129650259|NCT00096993|466675728|FG001|Overall Study|Death|0|||
129650260|NCT00096993|466675727|FG000|Overall Study|Disease progression|56|||
129650261|NCT00096993|466675728|FG001|Overall Study|Disease progression|53|||
129650262|NCT00096993|466675727|FG000|Overall Study|Adverse Event|2|||
129650263|NCT00096993|466675728|FG001|Overall Study|Adverse Event|8|||
129650264|NCT00096993|466675727|FG000|Overall Study|Subject's decision|3|||
129650265|NCT00096993|466675728|FG001|Overall Study|Subject's decision|1|||
129650266|NCT00096993|466675727|FG000|Overall Study|Physician Decision|2|||
129650267|NCT00096993|466675728|FG001|Overall Study|Physician Decision|1|||
129650268|NCT00096993|466675727|FG000|Overall Study|Non-compliance|0|||
129650269|NCT00096993|466675728|FG001|Overall Study|Non-compliance|1|||
129650270|NCT00096993|466675727|FG000|Overall Study|Other unspecified|1|||
129650271|NCT00096993|466675728|FG001|Overall Study|Other unspecified|1|||
129650272|NCT01935128|466675729|FG000|Overall Study|Death|1|||
129650273|NCT01935128|466675729|FG000|Overall Study|Adverse Event|6|||
129650274|NCT00772005|466675730|FG000|Overall Study|Adverse Event|9|||
129650275|NCT00772005|466675731|FG001|Overall Study|Adverse Event|14|||
129650276|NCT00772005|466675732|FG002|Overall Study|Adverse Event|10|||
129650277|NCT00772005|466675733|FG003|Overall Study|Adverse Event|13|||
129650278|NCT00772005|466675730|FG000|Overall Study|Lack of Efficacy|0|||
129650279|NCT00772005|466675731|FG001|Overall Study|Lack of Efficacy|1|||
129650280|NCT00772005|466675732|FG002|Overall Study|Lack of Efficacy|0|||
129650281|NCT00772005|466675733|FG003|Overall Study|Lack of Efficacy|0|||
129650282|NCT00772005|466675730|FG000|Overall Study|Withdrawal by Subject|3|||
129650283|NCT00772005|466675731|FG001|Overall Study|Withdrawal by Subject|7|||
129650284|NCT00772005|466675732|FG002|Overall Study|Withdrawal by Subject|10|||
129650285|NCT00772005|466675733|FG003|Overall Study|Withdrawal by Subject|2|||
129650286|NCT00772005|466675730|FG000|Overall Study|Protocol Violation|2|||
129650287|NCT00772005|466675731|FG001|Overall Study|Protocol Violation|4|||
129800927|NCT00598702|467239912|FG006|Overall Study|Early discharge from hospital|1|||
129800928|NCT00598702|467239913|FG007|Overall Study|Early discharge from hospital|0|||
129800929|NCT00598702|467239906|FG000|Overall Study|Adverse Event|0|||
129800930|NCT00598702|467239907|FG001|Overall Study|Adverse Event|0|||
129650288|NCT00772005|466675732|FG002|Overall Study|Protocol Violation|1|||
129650289|NCT00772005|466675733|FG003|Overall Study|Protocol Violation|6|||
129650290|NCT00772005|466675730|FG000|Overall Study|Lost to Follow-up|7|||
129710184|NCT01783444|466901534|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
129710185|NCT01783444|466901532|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
129710186|NCT01783444|466901533|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
129710187|NCT01783444|466901534|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
129710188|NCT01783444|466901532|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
129710189|NCT01783444|466901533|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
129710190|NCT01783444|466901534|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
129710191|NCT01047007|466901540|FG000|Overall Study|Adverse Event|0|||
129710192|NCT01047007|466901541|FG001|Overall Study|Adverse Event|2|||
129710193|NCT01047007|466901542|FG002|Overall Study|Adverse Event|1|||
129710194|NCT01047007|466901543|FG003|Overall Study|Adverse Event|0|||
129710195|NCT01047007|466901540|FG000|Overall Study|Progressive Disease|2|||
129710196|NCT01047007|466901541|FG001|Overall Study|Progressive Disease|4|||
129710197|NCT01047007|466901542|FG002|Overall Study|Progressive Disease|1|||
129710198|NCT01047007|466901543|FG003|Overall Study|Progressive Disease|0|||
129710199|NCT01334554|466901544|FG000|Overall Study|Adverse Event|4|||
129710200|NCT01334554|466901545|FG001|Overall Study|Adverse Event|2|||
129710201|NCT02393859|466901546|FG000|Overall Study|Decision by Sponsor|2|||
129710202|NCT02393859|466901547|FG001|Overall Study|Decision by Sponsor|4|||
129710203|NCT02393859|466901546|FG000|Overall Study|Withdrawal by Subject|11|||
129710204|NCT02393859|466901547|FG001|Overall Study|Withdrawal by Subject|6|||
129710205|NCT02393859|466901546|FG000|Overall Study|Death|27|||
129710206|NCT02393859|466901547|FG001|Overall Study|Death|10|||
129710207|NCT02393859|466901546|FG000|Overall Study|Lost to Follow-up|1|||
129710208|NCT02393859|466901547|FG001|Overall Study|Lost to Follow-up|1|||
129710209|NCT00954447|466901548|FG000|Overall Study|Adverse Event|33|||
129710210|NCT00954447|466901549|FG001|Overall Study|Adverse Event|25|||
129710211|NCT00954447|466901548|FG000|Overall Study|Lack of Efficacy|17|||
129710212|NCT00954447|466901549|FG001|Overall Study|Lack of Efficacy|3|||
129710213|NCT00954447|466901548|FG000|Overall Study|Protocol Violation|5|||
129710214|NCT00954447|466901549|FG001|Overall Study|Protocol Violation|7|||
129710215|NCT00954447|466901548|FG000|Overall Study|Lost to Follow-up|8|||
129710216|NCT00954447|466901549|FG001|Overall Study|Lost to Follow-up|14|||
129710217|NCT00954447|466901548|FG000|Overall Study|Withdrawal by Subject|26|||
129710218|NCT00954447|466901549|FG001|Overall Study|Withdrawal by Subject|21|||
129710219|NCT00954447|466901548|FG000|Overall Study|Other|21|||
129710220|NCT00954447|466901549|FG001|Overall Study|Other|18|||
129710221|NCT04592341|466901550|FG000|Overall Study|Physician Decision|5|||
129710222|NCT04592341|466901550|FG000|Overall Study|Study Terminated by Sponsor|5|||
129710223|NCT04592341|466901550|FG000|Overall Study|Withdrawal by Subject|53|||
129710224|NCT04592341|466901550|FG000|Overall Study|Lost to Follow-up|3|||
129710225|NCT04592341|466901550|FG000|Overall Study|Death|1|||
129710226|NCT04592341|466901550|FG000|Overall Study|Adverse Event|5|||
129710227|NCT04592341|466901550|FG000|Overall Study|other|4|||
129710228|NCT00692003|466901551|FG000|Overall Study|Sponsor Decision|5|||
129710229|NCT00692003|466901552|FG001|Overall Study|Sponsor Decision|1|||
129710230|NCT01248793|466901553|FG000|Overall Study|Lost to Follow-up|0|||
129710231|NCT01248793|466901554|FG001|Overall Study|Lost to Follow-up|1|||
129710232|NCT01248793|466901553|FG000|Overall Study|Adverse Event|1|||
129710233|NCT01248793|466901554|FG001|Overall Study|Adverse Event|1|||
129800931|NCT00598702|467239908|FG002|Overall Study|Adverse Event|0|||
129800932|NCT00598702|467239909|FG003|Overall Study|Adverse Event|1|||
129800933|NCT00598702|467239910|FG004|Overall Study|Adverse Event|0|||
129800934|NCT00598702|467239911|FG005|Overall Study|Adverse Event|0|||
129800935|NCT00598702|467239912|FG006|Overall Study|Adverse Event|0|||
129800936|NCT00598702|467239913|FG007|Overall Study|Adverse Event|0|||
129800937|NCT00598702|467239906|FG000|Overall Study|Withdrawal by Subject|0|||
129800938|NCT00598702|467239907|FG001|Overall Study|Withdrawal by Subject|0|||
129800939|NCT00598702|467239908|FG002|Overall Study|Withdrawal by Subject|0|||
129800940|NCT00598702|467239909|FG003|Overall Study|Withdrawal by Subject|1|||
129800941|NCT00598702|467239910|FG004|Overall Study|Withdrawal by Subject|1|||
129800942|NCT00598702|467239911|FG005|Overall Study|Withdrawal by Subject|0|||
129444198|NCT03739437|465926074|FG000|Overall Study|Lost to Follow-up|2|||
129444199|NCT03739437|465926075|FG001|Overall Study|Lost to Follow-up|5|||
129444200|NCT01395316|465926078|FG000|Overall Study|Lost to Follow-up|2|||
129444201|NCT01395316|465926078|FG000|Overall Study|poor MRI quality|1|||
129710234|NCT01248793|466901553|FG000|Overall Study|Protocol Violation|0|||
129710235|NCT01248793|466901554|FG001|Overall Study|Protocol Violation|1|||
129710236|NCT01248793|466901553|FG000|Overall Study|Withdrawal by Subject|3|||
129800943|NCT00598702|467239912|FG006|Overall Study|Withdrawal by Subject|0|||
129710237|NCT01248793|466901554|FG001|Overall Study|Withdrawal by Subject|3|||
129710238|NCT01840943|466901555|FG000|Overall Study|Withdrawal by Subject|5|||
129710239|NCT01840943|466901556|FG001|Overall Study|Withdrawal by Subject|6|||
129710240|NCT01840943|466901555|FG000|Overall Study|Physician Decision|4|||
129710241|NCT01840943|466901556|FG001|Overall Study|Physician Decision|2|||
129710242|NCT01840943|466901555|FG000|Overall Study|Lost to Follow-up|4|||
129444202|NCT03359590|465926079|FG000|First Intervention|Withdrawal by Subject|1|||
129710243|NCT01840943|466901556|FG001|Overall Study|Lost to Follow-up|4|||
129650291|NCT00772005|466675731|FG001|Overall Study|Lost to Follow-up|3|||
129650292|NCT00772005|466675732|FG002|Overall Study|Lost to Follow-up|6|||
129650293|NCT00772005|466675733|FG003|Overall Study|Lost to Follow-up|3|||
129650294|NCT00772005|466675730|FG000|Overall Study|Non-compliance with study procedures|1|||
129650295|NCT00772005|466675731|FG001|Overall Study|Non-compliance with study procedures|1|||
129650296|NCT00772005|466675732|FG002|Overall Study|Non-compliance with study procedures|0|||
129650297|NCT00772005|466675733|FG003|Overall Study|Non-compliance with study procedures|1|||
129650298|NCT00772005|466675730|FG000|Overall Study|Non-compliance with drug administration|3|||
129650299|NCT00772005|466675731|FG001|Overall Study|Non-compliance with drug administration|0|||
129650300|NCT00772005|466675732|FG002|Overall Study|Non-compliance with drug administration|1|||
129650301|NCT00772005|466675733|FG003|Overall Study|Non-compliance with drug administration|1|||
129650302|NCT01440569|466675737|FG000|Main Study|Enrolled but not treated|1|||
129650303|NCT01440569|466675738|FG001|Main Study|Enrolled but not treated|0|||
129650304|NCT01440569|466675737|FG000|Main Study|Adverse Event|9|||
129650305|NCT01440569|466675738|FG001|Main Study|Adverse Event|0|||
129650306|NCT01440569|466675737|FG000|Main Study|Pregnancy|1|||
129650307|NCT01440569|466675738|FG001|Main Study|Pregnancy|0|||
129650308|NCT01440569|466675737|FG000|Main Study|Investigator's Discretion|1|||
129650309|NCT01440569|466675738|FG001|Main Study|Investigator's Discretion|1|||
129650310|NCT01440569|466675737|FG000|Main Study|Withdrew Consent|7|||
129650311|NCT01440569|466675738|FG001|Main Study|Withdrew Consent|1|||
129650312|NCT01440569|466675737|FG000|Main Study|Lost to Follow-up|13|||
129650313|NCT01440569|466675738|FG001|Main Study|Lost to Follow-up|2|||
129650314|NCT01440569|466675737|FG000|Main Study|Subject Non-Compliance|3|||
129650315|NCT01440569|466675738|FG001|Main Study|Subject Non-Compliance|0|||
129650316|NCT01440569|466675737|FG000|Main Study|Protocol Violation|1|||
129650317|NCT01440569|466675738|FG001|Main Study|Protocol Violation|0|||
129650318|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Adverse Event|3|||
129650319|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Adverse Event|0|||
129650320|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Pregnancy|1|||
129650321|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Pregnancy|0|||
129650322|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
129650323|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
129650324|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
129650325|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
129650326|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
129650327|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
129650328|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
129650329|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
129650330|NCT01440569|466675737|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
129650331|NCT01440569|466675738|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
129650332|NCT02431806|466675741|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
129650333|NCT02431806|466675742|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
129650334|NCT02431806|466675743|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
129650335|NCT02431806|466675744|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
129650336|NCT02431806|466675741|FG000|Double-blind Treatment Period|Adverse Event|4|||
129650337|NCT02431806|466675742|FG001|Double-blind Treatment Period|Adverse Event|7|||
129650338|NCT02431806|466675743|FG002|Double-blind Treatment Period|Adverse Event|11|||
129650339|NCT02431806|466675744|FG003|Double-blind Treatment Period|Adverse Event|7|||
129650340|NCT02431806|466675741|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
129650341|NCT02431806|466675742|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129650342|NCT02431806|466675743|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
129650343|NCT02431806|466675744|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
129650344|NCT02431806|466675741|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
129650345|NCT02431806|466675742|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
129650346|NCT02431806|466675743|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
129710244|NCT02580877|466901559|FG000|Overall Study|Withdrawal by Subject|1|||
129710245|NCT02580877|466901560|FG001|Overall Study|Withdrawal by Subject|3|||
129650347|NCT02431806|466675744|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
129650348|NCT02431806|466675741|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
129710246|NCT02580877|466901559|FG000|Overall Study|Adverse Event|0|||
129710247|NCT02580877|466901560|FG001|Overall Study|Adverse Event|1|||
129650349|NCT02431806|466675742|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
129650350|NCT02431806|466675743|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
129710248|NCT03341637|466901561|FG000|Overall Study|Lost to Follow-up|1|||
129710249|NCT03341637|466901562|FG001|Overall Study|Lost to Follow-up|0|||
129710250|NCT03341637|466901561|FG000|Overall Study|Withdrawal by Subject|3|||
129710251|NCT03341637|466901562|FG001|Overall Study|Withdrawal by Subject|3|||
129710252|NCT03341637|466901561|FG000|Overall Study|Reason not Specified|1|||
129710253|NCT03341637|466901562|FG001|Overall Study|Reason not Specified|1|||
129710254|NCT00887159|466901569|FG000|Overall Study|Disease progression|6|||
129710255|NCT00887159|466901570|FG001|Overall Study|Disease progression|39|||
129710256|NCT00887159|466901571|FG002|Overall Study|Disease progression|33|||
129710257|NCT00887159|466901569|FG000|Overall Study|Adverse Event|3|||
129710258|NCT00887159|466901570|FG001|Overall Study|Adverse Event|4|||
129710259|NCT00887159|466901571|FG002|Overall Study|Adverse Event|17|||
129710260|NCT00887159|466901569|FG000|Overall Study|Death|2|||
129710261|NCT00887159|466901570|FG001|Overall Study|Death|2|||
129710262|NCT00887159|466901571|FG002|Overall Study|Death|0|||
129710263|NCT00887159|466901569|FG000|Overall Study|Withdrawal by Subject|4|||
129710264|NCT00887159|466901570|FG001|Overall Study|Withdrawal by Subject|4|||
129710265|NCT00887159|466901571|FG002|Overall Study|Withdrawal by Subject|2|||
129710266|NCT00887159|466901569|FG000|Overall Study|Alternative therapy|2|||
129710267|NCT00887159|466901570|FG001|Overall Study|Alternative therapy|0|||
129710268|NCT00887159|466901571|FG002|Overall Study|Alternative therapy|0|||
129710269|NCT00887159|466901569|FG000|Overall Study|Physician Decision|1|||
129710270|NCT00887159|466901570|FG001|Overall Study|Physician Decision|1|||
129710271|NCT00887159|466901571|FG002|Overall Study|Physician Decision|0|||
129710272|NCT00887159|466901569|FG000|Overall Study|Sympomatic deterioration|1|||
129710273|NCT00887159|466901570|FG001|Overall Study|Sympomatic deterioration|0|||
129710274|NCT00887159|466901571|FG002|Overall Study|Sympomatic deterioration|0|||
129710275|NCT00887159|466901569|FG000|Overall Study|Treatment delayed|1|||
129710276|NCT00887159|466901570|FG001|Overall Study|Treatment delayed|1|||
129710277|NCT00887159|466901571|FG002|Overall Study|Treatment delayed|0|||
129710278|NCT00887159|466901569|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
129710279|NCT00887159|466901570|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
129710280|NCT00887159|466901571|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
129710281|NCT00887159|466901569|FG000|Overall Study|Received more tx instead of observation|1|||
129710282|NCT00887159|466901570|FG001|Overall Study|Received more tx instead of observation|0|||
129710283|NCT00887159|466901571|FG002|Overall Study|Received more tx instead of observation|0|||
129710284|NCT00887159|466901569|FG000|Overall Study|Ineligible|5|||
129710285|NCT00887159|466901570|FG001|Overall Study|Ineligible|1|||
129710286|NCT00887159|466901571|FG002|Overall Study|Ineligible|0|||
129710287|NCT00887159|466901569|FG000|Overall Study|Never started assigned therapy|3|||
129710288|NCT00887159|466901570|FG001|Overall Study|Never started assigned therapy|3|||
129710289|NCT00887159|466901571|FG002|Overall Study|Never started assigned therapy|4|||
129710290|NCT01823107|466901581|FG000|Overall Study|Withdrawal by Subject|1|||
129710291|NCT01847092|466901583|FG000|Overall Study|Adverse Event|12|||
129710292|NCT01847092|466901584|FG001|Overall Study|Adverse Event|3|||
129710293|NCT01847092|466901583|FG000|Overall Study|Withdrawal by Subject|5|||
129710294|NCT01847092|466901584|FG001|Overall Study|Withdrawal by Subject|5|||
129710295|NCT01847092|466901583|FG000|Overall Study|Protocol Specified|8|||
129710296|NCT01847092|466901584|FG001|Overall Study|Protocol Specified|0|||
129710297|NCT01847092|466901583|FG000|Overall Study|Physician Decision|1|||
129710298|NCT01847092|466901584|FG001|Overall Study|Physician Decision|1|||
129710299|NCT01847092|466901583|FG000|Overall Study|Protocol Violation|0|||
129710300|NCT01847092|466901584|FG001|Overall Study|Protocol Violation|2|||
129710301|NCT01331681|466901585|FG000|Overall Study|Adverse Event|10|||
129710302|NCT01331681|466901586|FG001|Overall Study|Adverse Event|13|||
129710303|NCT01331681|466901587|FG002|Overall Study|Adverse Event|10|||
129710304|NCT01331681|466901585|FG000|Overall Study|Death|6|||
129710305|NCT01331681|466901586|FG001|Overall Study|Death|6|||
129710306|NCT01331681|466901587|FG002|Overall Study|Death|2|||
129710307|NCT01331681|466901585|FG000|Overall Study|Lack of Efficacy|0|||
129710308|NCT01331681|466901586|FG001|Overall Study|Lack of Efficacy|1|||
129710309|NCT01331681|466901587|FG002|Overall Study|Lack of Efficacy|0|||
129710310|NCT01331681|466901585|FG000|Overall Study|Withdrawal by Subject|12|||
129710311|NCT01331681|466901586|FG001|Overall Study|Withdrawal by Subject|8|||
129710312|NCT01331681|466901587|FG002|Overall Study|Withdrawal by Subject|15|||
129710313|NCT01331681|466901585|FG000|Overall Study|Protocol Violation|1|||
129710314|NCT01331681|466901586|FG001|Overall Study|Protocol Violation|1|||
129710315|NCT01331681|466901587|FG002|Overall Study|Protocol Violation|0|||
129710316|NCT01331681|466901585|FG000|Overall Study|Lost to Follow-up|2|||
129710317|NCT01331681|466901586|FG001|Overall Study|Lost to Follow-up|4|||
129710318|NCT01331681|466901587|FG002|Overall Study|Lost to Follow-up|1|||
129710319|NCT01331681|466901585|FG000|Overall Study|Physician Decision|2|||
129710320|NCT01331681|466901586|FG001|Overall Study|Physician Decision|0|||
129710321|NCT01331681|466901587|FG002|Overall Study|Physician Decision|4|||
129710322|NCT01331681|466901585|FG000|Overall Study|Therapeutic procedure required|1|||
129710323|NCT01331681|466901586|FG001|Overall Study|Therapeutic procedure required|0|||
129650351|NCT02431806|466675744|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
129650352|NCT02431806|466675741|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
129650353|NCT02431806|466675742|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
129650354|NCT02431806|466675743|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
129650355|NCT02431806|466675744|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
129650356|NCT02431806|466675741|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
129650357|NCT02431806|466675742|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
129650358|NCT02431806|466675743|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
129650359|NCT02431806|466675744|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
129650360|NCT03627416|466675745|FG000|Overall Study|Adverse Event|0|||
129650361|NCT03627416|466675746|FG001|Overall Study|Adverse Event|1|||
129650362|NCT01294371|466675747|FG000|Overall Study|Adverse Event|1|||
129650363|NCT01294371|466675747|FG000|Overall Study|Withdrawal by Subject|12|||
129650364|NCT01294371|466675747|FG000|Overall Study|Lost to Follow-up|6|||
129650365|NCT01294371|466675747|FG000|Overall Study|Administrative Reason|1|||
129650366|NCT01294371|466675747|FG000|Overall Study|Other|14|||
129650367|NCT05619536|466675748|FG000|Overall Study|Withdrawal by Subject|0|||
129650368|NCT05619536|466675749|FG001|Overall Study|Withdrawal by Subject|1|||
129650369|NCT05619536|466675750|FG002|Overall Study|Withdrawal by Subject|0|||
129650370|NCT05619536|466675751|FG003|Overall Study|Withdrawal by Subject|1|||
129650371|NCT05619536|466675748|FG000|Overall Study|Lost to Follow-up|0|||
129650372|NCT05619536|466675749|FG001|Overall Study|Lost to Follow-up|1|||
129650373|NCT05619536|466675750|FG002|Overall Study|Lost to Follow-up|1|||
129650374|NCT05619536|466675751|FG003|Overall Study|Lost to Follow-up|0|||
129650375|NCT03619902|466675752|FG000|Overall Study|Termination of Study by Investigator|1|||
129650376|NCT03619902|466675752|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
129650377|NCT02923245|466675753|FG000|Overall Study|ultrasound order was cancelled|2|||
129650378|NCT02923245|466675754|FG001|Overall Study|ultrasound order was cancelled|1|||
129650379|NCT02520427|466675755|FG000|Overall Study|Decision by sponsor|0|||
129650380|NCT02520427|466675756|FG001|Overall Study|Decision by sponsor|0|||
129650381|NCT02520427|466675757|FG002|Overall Study|Decision by sponsor|0|||
129650382|NCT02520427|466675758|FG003|Overall Study|Decision by sponsor|0|||
129650383|NCT02520427|466675759|FG004|Overall Study|Decision by sponsor|0|||
129650384|NCT02520427|466675760|FG005|Overall Study|Decision by sponsor|0|||
129650385|NCT02520427|466675761|FG006|Overall Study|Decision by sponsor|0|||
129650386|NCT02520427|466675762|FG007|Overall Study|Decision by sponsor|0|||
129650387|NCT02520427|466675763|FG008|Overall Study|Decision by sponsor|1|||
129650388|NCT02520427|466675764|FG009|Overall Study|Decision by sponsor|1|||
129650389|NCT02520427|466675765|FG010|Overall Study|Decision by sponsor|0|||
129650390|NCT02520427|466675766|FG011|Overall Study|Decision by sponsor|0|||
129650391|NCT02520427|466675767|FG012|Overall Study|Decision by sponsor|0|||
129650392|NCT02520427|466675768|FG013|Overall Study|Decision by sponsor|0|||
129650393|NCT02520427|466675769|FG014|Overall Study|Decision by sponsor|0|||
129650394|NCT02520427|466675770|FG015|Overall Study|Decision by sponsor|0|||
129650395|NCT02520427|466675771|FG016|Overall Study|Decision by sponsor|0|||
129650396|NCT02520427|466675772|FG017|Overall Study|Decision by sponsor|0|||
129650397|NCT02520427|466675773|FG018|Overall Study|Decision by sponsor|0|||
129650398|NCT02520427|466675774|FG019|Overall Study|Decision by sponsor|0|||
129650399|NCT02520427|466675775|FG020|Overall Study|Decision by sponsor|0|||
129650400|NCT02520427|466675776|FG021|Overall Study|Decision by sponsor|0|||
129650401|NCT02520427|466675777|FG022|Overall Study|Decision by sponsor|0|||
129650402|NCT02520427|466675778|FG023|Overall Study|Decision by sponsor|0|||
129650403|NCT02520427|466675779|FG024|Overall Study|Decision by sponsor|0|||
129650404|NCT02520427|466675780|FG025|Overall Study|Decision by sponsor|0|||
129650405|NCT02520427|466675755|FG000|Overall Study|Withdrawal by Subject|0|||
129650406|NCT02520427|466675756|FG001|Overall Study|Withdrawal by Subject|0|||
129650407|NCT02520427|466675757|FG002|Overall Study|Withdrawal by Subject|1|||
129650408|NCT02520427|466675758|FG003|Overall Study|Withdrawal by Subject|0|||
129650409|NCT02520427|466675759|FG004|Overall Study|Withdrawal by Subject|0|||
129650410|NCT02520427|466675760|FG005|Overall Study|Withdrawal by Subject|0|||
129650411|NCT02520427|466675761|FG006|Overall Study|Withdrawal by Subject|0|||
129650412|NCT02520427|466675762|FG007|Overall Study|Withdrawal by Subject|0|||
129650413|NCT02520427|466675763|FG008|Overall Study|Withdrawal by Subject|0|||
129650414|NCT02520427|466675764|FG009|Overall Study|Withdrawal by Subject|0|||
129650415|NCT02520427|466675765|FG010|Overall Study|Withdrawal by Subject|0|||
129650416|NCT02520427|466675766|FG011|Overall Study|Withdrawal by Subject|0|||
129650417|NCT02520427|466675767|FG012|Overall Study|Withdrawal by Subject|1|||
129650418|NCT02520427|466675768|FG013|Overall Study|Withdrawal by Subject|1|||
129650419|NCT02520427|466675769|FG014|Overall Study|Withdrawal by Subject|1|||
129650420|NCT02520427|466675770|FG015|Overall Study|Withdrawal by Subject|0|||
129710324|NCT01331681|466901587|FG002|Overall Study|Therapeutic procedure required|0|||
129650421|NCT02520427|466675771|FG016|Overall Study|Withdrawal by Subject|1|||
129650422|NCT02520427|466675772|FG017|Overall Study|Withdrawal by Subject|0|||
129650423|NCT02520427|466675773|FG018|Overall Study|Withdrawal by Subject|0|||
129650424|NCT02520427|466675774|FG019|Overall Study|Withdrawal by Subject|3|||
129650425|NCT02520427|466675775|FG020|Overall Study|Withdrawal by Subject|2|||
129650426|NCT02520427|466675776|FG021|Overall Study|Withdrawal by Subject|0|||
129650427|NCT02520427|466675777|FG022|Overall Study|Withdrawal by Subject|0|||
129650428|NCT02520427|466675778|FG023|Overall Study|Withdrawal by Subject|0|||
129650429|NCT02520427|466675779|FG024|Overall Study|Withdrawal by Subject|0|||
129650430|NCT02520427|466675780|FG025|Overall Study|Withdrawal by Subject|0|||
129650431|NCT02520427|466675755|FG000|Overall Study|Death|1|||
129650432|NCT02520427|466675756|FG001|Overall Study|Death|0|||
129650433|NCT02520427|466675757|FG002|Overall Study|Death|0|||
129650434|NCT02520427|466675758|FG003|Overall Study|Death|0|||
129650435|NCT02520427|466675759|FG004|Overall Study|Death|0|||
129650436|NCT02520427|466675760|FG005|Overall Study|Death|0|||
129650437|NCT02520427|466675761|FG006|Overall Study|Death|0|||
129650438|NCT02520427|466675762|FG007|Overall Study|Death|0|||
129650439|NCT02520427|466675763|FG008|Overall Study|Death|0|||
129650440|NCT02520427|466675764|FG009|Overall Study|Death|0|||
129650441|NCT02520427|466675765|FG010|Overall Study|Death|0|||
129650442|NCT02520427|466675766|FG011|Overall Study|Death|0|||
129650443|NCT02520427|466675767|FG012|Overall Study|Death|0|||
129650444|NCT02520427|466675768|FG013|Overall Study|Death|0|||
129650445|NCT02520427|466675769|FG014|Overall Study|Death|0|||
129650446|NCT02520427|466675770|FG015|Overall Study|Death|0|||
129650447|NCT02520427|466675771|FG016|Overall Study|Death|2|||
129650448|NCT02520427|466675772|FG017|Overall Study|Death|1|||
129650449|NCT02520427|466675773|FG018|Overall Study|Death|3|||
129650450|NCT02520427|466675774|FG019|Overall Study|Death|2|||
129650451|NCT02520427|466675775|FG020|Overall Study|Death|0|||
129650452|NCT02520427|466675776|FG021|Overall Study|Death|0|||
129650453|NCT02520427|466675777|FG022|Overall Study|Death|1|||
129650454|NCT02520427|466675778|FG023|Overall Study|Death|0|||
129650455|NCT02520427|466675779|FG024|Overall Study|Death|1|||
129650456|NCT02520427|466675780|FG025|Overall Study|Death|0|||
129650457|NCT02987972|466675784|FG000|Overall Study|Adverse Event|1|||
129650458|NCT02987972|466675785|FG001|Overall Study|Adverse Event|1|||
129650459|NCT02987972|466675786|FG002|Overall Study|Adverse Event|0|||
129650460|NCT02987972|466675784|FG000|Overall Study|Death|1|||
129650461|NCT02987972|466675785|FG001|Overall Study|Death|0|||
129650462|NCT02987972|466675786|FG002|Overall Study|Death|0|||
129800944|NCT00598702|467239913|FG007|Overall Study|Withdrawal by Subject|0|||
129800945|NCT00598702|467239906|FG000|Overall Study|Physician Decision|0|||
129800946|NCT00598702|467239907|FG001|Overall Study|Physician Decision|0|||
129800947|NCT00598702|467239908|FG002|Overall Study|Physician Decision|0|||
129800948|NCT00598702|467239909|FG003|Overall Study|Physician Decision|0|||
129800949|NCT00598702|467239910|FG004|Overall Study|Physician Decision|1|||
129800950|NCT00598702|467239911|FG005|Overall Study|Physician Decision|0|||
129800951|NCT00598702|467239912|FG006|Overall Study|Physician Decision|0|||
129800952|NCT00598702|467239913|FG007|Overall Study|Physician Decision|0|||
129800953|NCT00598702|467239906|FG000|Overall Study|Dose limiting toxicity|0|||
129800954|NCT00598702|467239907|FG001|Overall Study|Dose limiting toxicity|0|||
129800955|NCT00598702|467239908|FG002|Overall Study|Dose limiting toxicity|0|||
129800956|NCT00598702|467239909|FG003|Overall Study|Dose limiting toxicity|1|||
129800957|NCT00598702|467239910|FG004|Overall Study|Dose limiting toxicity|1|||
129800958|NCT00598702|467239911|FG005|Overall Study|Dose limiting toxicity|1|||
129800959|NCT00598702|467239912|FG006|Overall Study|Dose limiting toxicity|0|||
129800960|NCT00598702|467239913|FG007|Overall Study|Dose limiting toxicity|0|||
129800961|NCT02106910|467239914|FG000|Overall Study|Lost to Follow-up|1|||
129800962|NCT02106910|467239915|FG001|Overall Study|Lost to Follow-up|1|||
129800963|NCT01675427|467239918|FG000|Overall Study|Withdrawal by Subject|7|||
129650463|NCT02987972|466675784|FG000|Overall Study|Lack of Efficacy|9|||
129800964|NCT01675427|467239918|FG000|Overall Study|Participant Refused Sample Collection|18|||
129800965|NCT01675427|467239918|FG000|Overall Study|Sample not Collected by Mistake|2|||
129650464|NCT02987972|466675785|FG001|Overall Study|Lack of Efficacy|12|||
129800966|NCT01675427|467239918|FG000|Overall Study|Lost to Follow-up|5|||
129650465|NCT02987972|466675786|FG002|Overall Study|Lack of Efficacy|12|||
129650466|NCT02987972|466675784|FG000|Overall Study|Lost to Follow-up|7|||
129650467|NCT02987972|466675785|FG001|Overall Study|Lost to Follow-up|8|||
129650468|NCT02987972|466675786|FG002|Overall Study|Lost to Follow-up|4|||
129650469|NCT02987972|466675784|FG000|Overall Study|Physician Decision|1|||
129650470|NCT02987972|466675785|FG001|Overall Study|Physician Decision|6|||
129650471|NCT02987972|466675786|FG002|Overall Study|Physician Decision|0|||
129650472|NCT02987972|466675784|FG000|Overall Study|Protocol Violation|2|||
129650473|NCT02987972|466675785|FG001|Overall Study|Protocol Violation|1|||
129650474|NCT02987972|466675786|FG002|Overall Study|Protocol Violation|5|||
129650475|NCT02987972|466675784|FG000|Overall Study|Withdrawal by Subject|22|||
129800967|NCT01675427|467239918|FG000|Overall Study|Other|2|||
129800968|NCT00700570|467239919|FG000|Overall Study|Adverse Event|2|||
129800969|NCT00700570|467239920|FG001|Overall Study|Adverse Event|6|||
129800970|NCT00700570|467239919|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
129800971|NCT00700570|467239920|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
129800972|NCT00700570|467239919|FG000|Overall Study|Disease Progression|8|||
129800973|NCT00700570|467239920|FG001|Overall Study|Disease Progression|11|||
129800974|NCT00700570|467239919|FG000|Overall Study|Withdrawal by Subject|1|||
129800975|NCT00700570|467239920|FG001|Overall Study|Withdrawal by Subject|6|||
129800976|NCT00611533|467239921|FG000|First Intervention (6 Weeks)|Never started study|0|||
129800977|NCT00611533|467239922|FG001|First Intervention (6 Weeks)|Never started study|1|||
129800978|NCT00611533|467239921|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
129800979|NCT00611533|467239922|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129800980|NCT00611533|467239921|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
129800981|NCT00611533|467239922|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
129800982|NCT04327674|467239929|FG000|Overall Study|Protocol Violation|19|||
129800983|NCT01461980|467239930|FG000|Overall Study|Other|9|||
129800984|NCT01461980|467239931|FG001|Overall Study|Other|8|||
129800985|NCT01461980|467239932|FG002|Overall Study|Other|6|||
129800986|NCT01461980|467239930|FG000|Overall Study|Medication error|7|||
129800987|NCT01461980|467239931|FG001|Overall Study|Medication error|5|||
129800988|NCT01461980|467239932|FG002|Overall Study|Medication error|6|||
129800989|NCT01461980|467239930|FG000|Overall Study|Adverse Event|12|||
129800990|NCT01461980|467239931|FG001|Overall Study|Adverse Event|5|||
129800991|NCT01461980|467239932|FG002|Overall Study|Adverse Event|6|||
129800992|NCT01461980|467239930|FG000|Overall Study|Protocol Violation|12|||
129800993|NCT01461980|467239931|FG001|Overall Study|Protocol Violation|19|||
129800994|NCT01461980|467239932|FG002|Overall Study|Protocol Violation|16|||
129800995|NCT01461980|467239930|FG000|Overall Study|No longer meets eligibility criteria|18|||
129800996|NCT01461980|467239931|FG001|Overall Study|No longer meets eligibility criteria|9|||
129800997|NCT01461980|467239932|FG002|Overall Study|No longer meets eligibility criteria|19|||
129800998|NCT01461980|467239930|FG000|Overall Study|Lost to Follow-up|52|||
129800999|NCT01461980|467239931|FG001|Overall Study|Lost to Follow-up|53|||
129801000|NCT01461980|467239932|FG002|Overall Study|Lost to Follow-up|51|||
129801001|NCT01461980|467239930|FG000|Overall Study|No longer willing to participate|52|||
129801002|NCT01461980|467239931|FG001|Overall Study|No longer willing to participate|38|||
129801003|NCT01461980|467239932|FG002|Overall Study|No longer willing to participate|54|||
129801004|NCT01461980|467239930|FG000|Overall Study|Randomized but not vaccinated|4|||
129801005|NCT01461980|467239931|FG001|Overall Study|Randomized but not vaccinated|8|||
129801006|NCT01461980|467239932|FG002|Overall Study|Randomized but not vaccinated|7|||
129801007|NCT01938573|467239936|FG000|Overall Study|Lack of Efficacy|1|||
129801008|NCT01938573|467239937|FG001|Overall Study|Lack of Efficacy|0|||
129801009|NCT01938573|467239936|FG000|Overall Study|Operation at other hospital|1|||
129801010|NCT01938573|467239937|FG001|Overall Study|Operation at other hospital|0|||
129801011|NCT01199731|467239941|FG000|Overall Study|Adverse Event|0|||
129801012|NCT01199731|467239942|FG001|Overall Study|Adverse Event|1|||
129801013|NCT01199731|467239943|FG002|Overall Study|Adverse Event|0|||
129801014|NCT01199731|467239941|FG000|Overall Study|Study closed/terminated|7|||
129801015|NCT01199731|467239942|FG001|Overall Study|Study closed/terminated|9|||
129801016|NCT01199731|467239943|FG002|Overall Study|Study closed/terminated|7|||
129801017|NCT01199731|467239941|FG000|Overall Study|Lost to Follow-up|0|||
129801018|NCT01199731|467239942|FG001|Overall Study|Lost to Follow-up|0|||
129801019|NCT01199731|467239943|FG002|Overall Study|Lost to Follow-up|2|||
129801020|NCT01199731|467239941|FG000|Overall Study|Physician Decision|0|||
129801021|NCT01199731|467239942|FG001|Overall Study|Physician Decision|1|||
129801022|NCT01199731|467239943|FG002|Overall Study|Physician Decision|1|||
129801023|NCT01199731|467239941|FG000|Overall Study|Withdrawal by Subject|2|||
129801024|NCT01199731|467239942|FG001|Overall Study|Withdrawal by Subject|0|||
129801025|NCT01199731|467239943|FG002|Overall Study|Withdrawal by Subject|0|||
129444203|NCT03359590|465926080|FG001|First Intervention|Withdrawal by Subject|1|||
129444204|NCT03359590|465926079|FG000|First Intervention|Protocol Violation|0|||
129444205|NCT03359590|465926080|FG001|First Intervention|Protocol Violation|1|||
129444206|NCT04890054|465927246|FG000|Overall Study|Lost to Follow-up|202|||
129801026|NCT00943124|467239944|FG000|Period 1|Withdrawal by Subject|1|||
129801027|NCT00943124|467239945|FG001|Period 1|Withdrawal by Subject|1|||
129801028|NCT00943124|467239944|FG000|Period 1|Did Not Follow Study Procedures|1|||
129801029|NCT00943124|467239945|FG001|Period 1|Did Not Follow Study Procedures|0|||
129801030|NCT00943124|467239944|FG000|Period 1|Personal Reasons|0|||
129801031|NCT00943124|467239945|FG001|Period 1|Personal Reasons|1|||
129801032|NCT02448810|467239947|FG000|Overall Study|Adverse Event|0|||
129801033|NCT02448810|467239948|FG001|Overall Study|Adverse Event|0|||
129801034|NCT02448810|467239949|FG002|Overall Study|Adverse Event|1|||
129801035|NCT02448810|467239950|FG003|Overall Study|Adverse Event|0|||
129801036|NCT02448810|467239951|FG004|Overall Study|Adverse Event|0|||
129801037|NCT02448810|467239952|FG005|Overall Study|Adverse Event|0|||
129801038|NCT02448810|467239953|FG006|Overall Study|Adverse Event|0|||
129801039|NCT02448810|467239954|FG007|Overall Study|Adverse Event|0|||
129710325|NCT01331681|466901585|FG000|Overall Study|Sponsor decision|1|||
129710326|NCT01331681|466901586|FG001|Overall Study|Sponsor decision|1|||
129710327|NCT01331681|466901587|FG002|Overall Study|Sponsor decision|0|||
129710328|NCT01331681|466901585|FG000|Overall Study|Switching to other therapy|0|||
129710329|NCT01331681|466901586|FG001|Overall Study|Switching to other therapy|0|||
129710330|NCT01331681|466901587|FG002|Overall Study|Switching to other therapy|1|||
129710331|NCT01331681|466901585|FG000|Overall Study|Not Received Study Treatment|0|||
129710332|NCT01331681|466901586|FG001|Overall Study|Not Received Study Treatment|0|||
129710333|NCT01331681|466901587|FG002|Overall Study|Not Received Study Treatment|2|||
129710334|NCT00658541|466901589|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
129710335|NCT00658541|466901590|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129710336|NCT00658541|466901589|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129710337|NCT00658541|466901590|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129710338|NCT03326063|466901591|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
129710339|NCT03326063|466901592|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
129710340|NCT01876381|466901593|FG000|Overall Study|Lack of Efficacy|5|||
129710341|NCT01876381|466901593|FG000|Overall Study|Physician Decision|1|||
129710342|NCT01876381|466901593|FG000|Overall Study|Withdrawal by Subject|1|||
129710343|NCT00461708|466901594|FG000|Overall Study|Adverse Event|17|||
129710344|NCT00461708|466901595|FG001|Overall Study|Adverse Event|7|||
129710345|NCT00461708|466901594|FG000|Overall Study|Lack of Efficacy|68|||
129710346|NCT00461708|466901595|FG001|Overall Study|Lack of Efficacy|20|||
129710347|NCT00461708|466901594|FG000|Overall Study|Physician Decision|10|||
129710348|NCT00461708|466901595|FG001|Overall Study|Physician Decision|4|||
129710349|NCT00461708|466901594|FG000|Overall Study|Withdrawal by Subject|8|||
129710350|NCT00461708|466901595|FG001|Overall Study|Withdrawal by Subject|2|||
129710351|NCT00461708|466901594|FG000|Overall Study|Other|4|||
129710352|NCT00461708|466901595|FG001|Overall Study|Other|4|||
129710353|NCT00461708|466901594|FG000|Overall Study|Death|8|||
129710354|NCT00461708|466901595|FG001|Overall Study|Death|1|||
129710355|NCT02803203|466901596|FG000|Overall Study|Adverse Event|4|||
129710356|NCT02803203|466901596|FG000|Overall Study|Death|4|||
129710357|NCT02803203|466901596|FG000|Overall Study|Progressive disease|29|||
129710358|NCT02803203|466901596|FG000|Overall Study|Withdrawal by Subject|8|||
129710359|NCT02803203|466901596|FG000|Overall Study|Complete resection of target disease|2|||
129710360|NCT02803203|466901596|FG000|Overall Study|Switched to commercial Osi|1|||
129710361|NCT02803203|466901596|FG000|Overall Study|Participant moved away|1|||
129710362|NCT04577781|466901597|FG000|Overall Study|Adverse Event|2|||
129710363|NCT04577781|466901598|FG001|Overall Study|Adverse Event|2|||
129710364|NCT04577781|466901597|FG000|Overall Study|Physician Decision|1|||
129710365|NCT04577781|466901598|FG001|Overall Study|Physician Decision|0|||
129710366|NCT03894891|466901599|FG000|Overall Study|Withdrawal by Subject|1|||
129710367|NCT03894891|466901599|FG000|Overall Study|Completed protocol treatment per protocol|5|||
129710368|NCT00950651|466901603|FG000|Overall Study|Adverse Event|17|||
129710369|NCT00950651|466901604|FG001|Overall Study|Adverse Event|20|||
129710370|NCT00950651|466901603|FG000|Overall Study|Death|1|||
129710371|NCT00950651|466901604|FG001|Overall Study|Death|0|||
129710372|NCT00950651|466901603|FG000|Overall Study|Lack of Efficacy|2|||
129710373|NCT00950651|466901604|FG001|Overall Study|Lack of Efficacy|2|||
129710374|NCT00950651|466901603|FG000|Overall Study|Protocol Violation|3|||
129710375|NCT00950651|466901604|FG001|Overall Study|Protocol Violation|4|||
129710376|NCT00950651|466901603|FG000|Overall Study|Withdrawal by Subject|8|||
129710377|NCT00950651|466901604|FG001|Overall Study|Withdrawal by Subject|9|||
129710378|NCT01824290|466901606|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
129710379|NCT01824290|466901607|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
129710380|NCT01824290|466901608|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
129710381|NCT01824290|466901609|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
129710382|NCT01824290|466901606|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
129710383|NCT01824290|466901607|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
129710384|NCT01824290|466901608|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
129710385|NCT01824290|466901609|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
129710386|NCT01824290|466901606|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
129710387|NCT01824290|466901607|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
129801040|NCT02448810|467239947|FG000|Overall Study|Withdrawal by Subject|0|||
129801041|NCT02448810|467239948|FG001|Overall Study|Withdrawal by Subject|0|||
129710388|NCT01824290|466901608|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
129710389|NCT01824290|466901609|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
129710390|NCT01824290|466901606|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
129710391|NCT01824290|466901607|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
129710392|NCT01824290|466901608|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
129710393|NCT01824290|466901609|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
129710394|NCT01824290|466901606|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
129710395|NCT01824290|466901607|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
129710396|NCT01824290|466901608|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
129710397|NCT01824290|466901609|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
129710398|NCT01824290|466901606|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
129710399|NCT01824290|466901607|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
129710400|NCT01824290|466901608|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
129710401|NCT01824290|466901609|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
129710402|NCT00527618|466901610|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
129710403|NCT00527618|466901611|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
129710404|NCT00527618|466901610|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
129710405|NCT00527618|466901611|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
129710406|NCT00527618|466901610|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
129710407|NCT00527618|466901611|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
129710408|NCT00527618|466901610|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
129710409|NCT00527618|466901611|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
129710410|NCT00527618|466901610|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
129710411|NCT00527618|466901611|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
129710412|NCT00527618|466901610|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
129710413|NCT00527618|466901611|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
129710414|NCT00114127|466901615|FG000|Overall Study|Adverse Event|2|||
129710415|NCT00114127|466901616|FG001|Overall Study|Adverse Event|1|||
129710416|NCT00114127|466901615|FG000|Overall Study|Lost to Follow-up|1|||
129710417|NCT00114127|466901616|FG001|Overall Study|Lost to Follow-up|0|||
129710418|NCT00114127|466901615|FG000|Overall Study|Withdrawal by Subject|1|||
129710419|NCT00114127|466901616|FG001|Overall Study|Withdrawal by Subject|3|||
129710420|NCT03188263|466901617|FG000|Overall Study|Withdrawal by Subject|3|||
129710421|NCT03188263|466901618|FG001|Overall Study|Withdrawal by Subject|0|||
129710422|NCT03188263|466901617|FG000|Overall Study|Physician Decision|1|||
129710423|NCT03188263|466901618|FG001|Overall Study|Physician Decision|0|||
129710424|NCT00881894|466901619|FG000|Overall Study|Consent withdrawn|0|||
129710425|NCT00881894|466901620|FG001|Overall Study|Consent withdrawn|1|||
129710426|NCT00881894|466901619|FG000|Overall Study|Other reasons for premature termination|1|||
129710427|NCT00881894|466901620|FG001|Overall Study|Other reasons for premature termination|2|||
129710428|NCT00421148|466901621|FG000|Overall Study|Lost to Follow-up|0|||
129710429|NCT00421148|466901622|FG001|Overall Study|Lost to Follow-up|0|||
129710430|NCT00421148|466901623|FG002|Overall Study|Lost to Follow-up|0|||
129710431|NCT00421148|466901624|FG003|Overall Study|Lost to Follow-up|0|||
129710432|NCT00421148|466901625|FG004|Overall Study|Lost to Follow-up|0|||
129710433|NCT00421148|466901626|FG005|Overall Study|Lost to Follow-up|0|||
129710434|NCT00421148|466901627|FG006|Overall Study|Lost to Follow-up|0|||
129710435|NCT00421148|466901628|FG007|Overall Study|Lost to Follow-up|0|||
129710436|NCT00421148|466901629|FG008|Overall Study|Lost to Follow-up|0|||
129710437|NCT00421148|466901630|FG009|Overall Study|Lost to Follow-up|0|||
129710438|NCT00421148|466901631|FG010|Overall Study|Lost to Follow-up|0|||
129710439|NCT00421148|466901632|FG011|Overall Study|Lost to Follow-up|0|||
129710440|NCT00421148|466901633|FG012|Overall Study|Lost to Follow-up|0|||
129710441|NCT00421148|466901634|FG013|Overall Study|Lost to Follow-up|0|||
129710442|NCT00421148|466901635|FG014|Overall Study|Lost to Follow-up|0|||
129710443|NCT00421148|466901636|FG015|Overall Study|Lost to Follow-up|0|||
129710444|NCT00421148|466901637|FG016|Overall Study|Lost to Follow-up|0|||
129710445|NCT00421148|466901638|FG017|Overall Study|Lost to Follow-up|1|||
129710446|NCT00421148|466901639|FG018|Overall Study|Lost to Follow-up|0|||
129710447|NCT00421148|466901640|FG019|Overall Study|Lost to Follow-up|0|||
129710448|NCT00421148|466901621|FG000|Overall Study|Withdrawal by Subject|0|||
129710449|NCT00421148|466901622|FG001|Overall Study|Withdrawal by Subject|0|||
129710450|NCT00421148|466901623|FG002|Overall Study|Withdrawal by Subject|0|||
129710451|NCT00421148|466901624|FG003|Overall Study|Withdrawal by Subject|0|||
129710452|NCT00421148|466901625|FG004|Overall Study|Withdrawal by Subject|0|||
129710453|NCT00421148|466901626|FG005|Overall Study|Withdrawal by Subject|0|||
129710454|NCT00421148|466901627|FG006|Overall Study|Withdrawal by Subject|0|||
129710455|NCT00421148|466901628|FG007|Overall Study|Withdrawal by Subject|0|||
129710456|NCT00421148|466901629|FG008|Overall Study|Withdrawal by Subject|0|||
129444207|NCT04890054|465927247|FG001|Overall Study|Lost to Follow-up|219|||
129710457|NCT00421148|466901630|FG009|Overall Study|Withdrawal by Subject|0|||
129710458|NCT00421148|466901631|FG010|Overall Study|Withdrawal by Subject|0|||
129710459|NCT00421148|466901632|FG011|Overall Study|Withdrawal by Subject|0|||
129710460|NCT00421148|466901633|FG012|Overall Study|Withdrawal by Subject|0|||
129710461|NCT00421148|466901634|FG013|Overall Study|Withdrawal by Subject|0|||
129710462|NCT00421148|466901635|FG014|Overall Study|Withdrawal by Subject|0|||
129710463|NCT00421148|466901636|FG015|Overall Study|Withdrawal by Subject|0|||
129710464|NCT00421148|466901637|FG016|Overall Study|Withdrawal by Subject|0|||
129710465|NCT00421148|466901638|FG017|Overall Study|Withdrawal by Subject|1|||
129710466|NCT00421148|466901639|FG018|Overall Study|Withdrawal by Subject|0|||
129710467|NCT00421148|466901640|FG019|Overall Study|Withdrawal by Subject|0|||
129710468|NCT00421148|466901621|FG000|Overall Study|Protocol Violation|0|||
129710469|NCT00421148|466901622|FG001|Overall Study|Protocol Violation|0|||
129710470|NCT00421148|466901623|FG002|Overall Study|Protocol Violation|0|||
129710471|NCT00421148|466901624|FG003|Overall Study|Protocol Violation|0|||
129710472|NCT00421148|466901625|FG004|Overall Study|Protocol Violation|0|||
129710473|NCT00421148|466901626|FG005|Overall Study|Protocol Violation|1|||
129710474|NCT00421148|466901627|FG006|Overall Study|Protocol Violation|0|||
129710475|NCT00421148|466901628|FG007|Overall Study|Protocol Violation|0|||
129710476|NCT00421148|466901629|FG008|Overall Study|Protocol Violation|0|||
129710477|NCT00421148|466901630|FG009|Overall Study|Protocol Violation|0|||
129710478|NCT00421148|466901631|FG010|Overall Study|Protocol Violation|0|||
129710479|NCT00421148|466901632|FG011|Overall Study|Protocol Violation|0|||
129710480|NCT00421148|466901633|FG012|Overall Study|Protocol Violation|0|||
129710481|NCT00421148|466901634|FG013|Overall Study|Protocol Violation|0|||
129710482|NCT00421148|466901635|FG014|Overall Study|Protocol Violation|0|||
129710483|NCT00421148|466901636|FG015|Overall Study|Protocol Violation|0|||
129710484|NCT00421148|466901637|FG016|Overall Study|Protocol Violation|0|||
129710485|NCT00421148|466901638|FG017|Overall Study|Protocol Violation|0|||
129710486|NCT00421148|466901639|FG018|Overall Study|Protocol Violation|1|||
129710487|NCT00421148|466901640|FG019|Overall Study|Protocol Violation|0|||
129710488|NCT00469833|466901641|FG000|Overall Study|No IV access|2|||
129650476|NCT02987972|466675785|FG001|Overall Study|Withdrawal by Subject|17|||
129710489|NCT01253369|466901642|FG000|Overall Study|Adverse Event|4|||
129710490|NCT01253369|466901642|FG000|Overall Study|Withdrawal by Subject|2|||
129710491|NCT01253369|466901642|FG000|Overall Study|Death|1|||
129710492|NCT01253369|466901642|FG000|Overall Study|Progressive disease|23|||
129710493|NCT01253369|466901642|FG000|Overall Study|Not Evaluable|3|||
129650477|NCT02987972|466675786|FG002|Overall Study|Withdrawal by Subject|21|||
129650478|NCT00073983|466675789|FG000|Overall Study|not evaluable|1|||
129650479|NCT03800836|466675790|FG000|Overall Study|Other|2|||
129650480|NCT03800836|466675791|FG001|Overall Study|Other|1|||
129650481|NCT03800836|466675792|FG002|Overall Study|Other|0|||
129650482|NCT03800836|466675793|FG003|Overall Study|Other|2|||
129650483|NCT03800836|466675794|FG004|Overall Study|Other|0|||
129650484|NCT03800836|466675795|FG005|Overall Study|Other|1|||
129650485|NCT03800836|466675790|FG000|Overall Study|Lost to Follow-up|2|||
129650486|NCT03800836|466675791|FG001|Overall Study|Lost to Follow-up|0|||
129650487|NCT03800836|466675792|FG002|Overall Study|Lost to Follow-up|1|||
129650488|NCT03800836|466675793|FG003|Overall Study|Lost to Follow-up|1|||
129650489|NCT03800836|466675794|FG004|Overall Study|Lost to Follow-up|3|||
129650490|NCT03800836|466675795|FG005|Overall Study|Lost to Follow-up|0|||
129650491|NCT03800836|466675790|FG000|Overall Study|Withdrawal by Subject|1|||
129650492|NCT03800836|466675791|FG001|Overall Study|Withdrawal by Subject|0|||
129650493|NCT03800836|466675792|FG002|Overall Study|Withdrawal by Subject|0|||
129650494|NCT03800836|466675793|FG003|Overall Study|Withdrawal by Subject|0|||
129650495|NCT03800836|466675794|FG004|Overall Study|Withdrawal by Subject|0|||
129650496|NCT03800836|466675795|FG005|Overall Study|Withdrawal by Subject|0|||
129650497|NCT03800836|466675790|FG000|Overall Study|Physician Decision|31|||
129650498|NCT03800836|466675791|FG001|Overall Study|Physician Decision|3|||
129650499|NCT03800836|466675792|FG002|Overall Study|Physician Decision|6|||
129650500|NCT03800836|466675793|FG003|Overall Study|Physician Decision|4|||
129650501|NCT03800836|466675794|FG004|Overall Study|Physician Decision|4|||
129650502|NCT03800836|466675795|FG005|Overall Study|Physician Decision|5|||
129710494|NCT03289533|466901643|FG000|Overall Study|Death|12|||
129710495|NCT03289533|466901643|FG000|Overall Study|Terminated from study by sponsor|10|||
129710496|NCT01030822|466901644|FG000|Overall Study|Moved/migrated from study area|6|||
129710497|NCT01030822|466901645|FG001|Overall Study|Moved/migrated from study area|7|||
129710498|NCT01030822|466901646|FG002|Overall Study|Moved/migrated from study area|3|||
129710499|NCT01030822|466901644|FG000|Overall Study|Withdrawal by Subject|16|||
129710500|NCT01030822|466901645|FG001|Overall Study|Withdrawal by Subject|13|||
129710501|NCT01030822|466901646|FG002|Overall Study|Withdrawal by Subject|16|||
129710502|NCT01030822|466901644|FG000|Overall Study|Lost to Follow-up|9|||
129710503|NCT01030822|466901645|FG001|Overall Study|Lost to Follow-up|4|||
129710504|NCT01030822|466901646|FG002|Overall Study|Lost to Follow-up|7|||
129710505|NCT00539240|466901647|FG000|Overall Study|Withdrawal by Subject|0|||
129710506|NCT00539240|466901648|FG001|Overall Study|Withdrawal by Subject|2|||
129710507|NCT00539240|466901649|FG002|Overall Study|Withdrawal by Subject|0|||
129710508|NCT00539240|466901647|FG000|Overall Study|Protocol Violation|1|||
129650503|NCT03800836|466675790|FG000|Overall Study|Death|34|||
129710509|NCT00539240|466901648|FG001|Overall Study|Protocol Violation|1|||
129650504|NCT03800836|466675791|FG001|Overall Study|Death|16|||
129650505|NCT03800836|466675792|FG002|Overall Study|Death|5|||
129650506|NCT03800836|466675793|FG003|Overall Study|Death|5|||
129650507|NCT03800836|466675794|FG004|Overall Study|Death|10|||
129710510|NCT00539240|466901649|FG002|Overall Study|Protocol Violation|4|||
129710511|NCT00539240|466901647|FG000|Overall Study|Lost to Follow-up|2|||
129710512|NCT00539240|466901648|FG001|Overall Study|Lost to Follow-up|3|||
129710513|NCT00539240|466901649|FG002|Overall Study|Lost to Follow-up|1|||
129710514|NCT00539240|466901647|FG000|Overall Study|Adverse Event|3|||
129710515|NCT00539240|466901648|FG001|Overall Study|Adverse Event|1|||
129801042|NCT02448810|467239949|FG002|Overall Study|Withdrawal by Subject|1|||
129801043|NCT02448810|467239950|FG003|Overall Study|Withdrawal by Subject|0|||
129801044|NCT02448810|467239951|FG004|Overall Study|Withdrawal by Subject|3|||
129801045|NCT02448810|467239952|FG005|Overall Study|Withdrawal by Subject|5|||
129801046|NCT02448810|467239953|FG006|Overall Study|Withdrawal by Subject|0|||
129801047|NCT02448810|467239954|FG007|Overall Study|Withdrawal by Subject|2|||
129801048|NCT02448810|467239947|FG000|Overall Study|Other (study terminated by sponsor)|0|||
129801049|NCT02448810|467239948|FG001|Overall Study|Other (study terminated by sponsor)|0|||
129801050|NCT02448810|467239949|FG002|Overall Study|Other (study terminated by sponsor)|0|||
129801051|NCT02448810|467239950|FG003|Overall Study|Other (study terminated by sponsor)|0|||
129801052|NCT02448810|467239951|FG004|Overall Study|Other (study terminated by sponsor)|4|||
129801053|NCT02448810|467239952|FG005|Overall Study|Other (study terminated by sponsor)|2|||
129801054|NCT02448810|467239953|FG006|Overall Study|Other (study terminated by sponsor)|2|||
129801055|NCT02448810|467239954|FG007|Overall Study|Other (study terminated by sponsor)|1|||
129650508|NCT03800836|466675795|FG005|Overall Study|Death|0|||
129650509|NCT03800836|466675790|FG000|Overall Study|Symptomatic Deterioration|1|||
129650510|NCT03800836|466675791|FG001|Overall Study|Symptomatic Deterioration|0|||
129650511|NCT03800836|466675792|FG002|Overall Study|Symptomatic Deterioration|1|||
129650512|NCT03800836|466675793|FG003|Overall Study|Symptomatic Deterioration|0|||
129650513|NCT03800836|466675794|FG004|Overall Study|Symptomatic Deterioration|0|||
129801056|NCT02448810|467239947|FG000|Overall Study|Death|1|||
129801057|NCT02448810|467239948|FG001|Overall Study|Death|0|||
129801058|NCT02448810|467239949|FG002|Overall Study|Death|1|||
129801059|NCT02448810|467239950|FG003|Overall Study|Death|0|||
129801060|NCT02448810|467239951|FG004|Overall Study|Death|1|||
129801061|NCT02448810|467239952|FG005|Overall Study|Death|0|||
129801062|NCT02448810|467239953|FG006|Overall Study|Death|0|||
129801063|NCT02448810|467239954|FG007|Overall Study|Death|0|||
129801064|NCT02448810|467239947|FG000|Overall Study|Other (Progressive disease)|2|||
129801065|NCT02448810|467239948|FG001|Overall Study|Other (Progressive disease)|2|||
129801066|NCT02448810|467239949|FG002|Overall Study|Other (Progressive disease)|0|||
129650514|NCT03800836|466675795|FG005|Overall Study|Symptomatic Deterioration|0|||
129710516|NCT00539240|466901649|FG002|Overall Study|Adverse Event|10|||
129710517|NCT01595529|466901650|FG000|Overall Study|Adverse Event|2|||
129710518|NCT01595529|466901651|FG001|Overall Study|Adverse Event|0|||
129710519|NCT01595529|466901650|FG000|Overall Study|Subject Non-Compliant|2|||
129710520|NCT01595529|466901651|FG001|Overall Study|Subject Non-Compliant|0|||
129710521|NCT01595529|466901650|FG000|Overall Study|Lost to Follow-up|8|||
129710522|NCT01595529|466901651|FG001|Overall Study|Lost to Follow-up|14|||
129710523|NCT01595529|466901650|FG000|Overall Study|Protocol Violation|1|||
129710524|NCT01595529|466901651|FG001|Overall Study|Protocol Violation|2|||
129710525|NCT01595529|466901650|FG000|Overall Study|Physician Decision|1|||
129710526|NCT01595529|466901651|FG001|Overall Study|Physician Decision|0|||
129710527|NCT01595529|466901650|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
129710528|NCT01595529|466901651|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
129710529|NCT01595529|466901650|FG000|Overall Study|Administrative Decision|1|||
129710530|NCT01595529|466901651|FG001|Overall Study|Administrative Decision|0|||
129710531|NCT01595529|466901650|FG000|Overall Study|Entry Failure/Screening Failure|6|||
129710532|NCT01595529|466901651|FG001|Overall Study|Entry Failure/Screening Failure|1|||
129710533|NCT04016714|466901652|FG000|Overall Study|Death|1|||
129710534|NCT04016714|466901653|FG001|Overall Study|Death|0|||
129710535|NCT04016714|466901652|FG000|Overall Study|Lost to Follow-up|3|||
129710536|NCT04016714|466901653|FG001|Overall Study|Lost to Follow-up|1|||
129710537|NCT04016714|466901652|FG000|Overall Study|Physician Decision|3|||
129710538|NCT04016714|466901653|FG001|Overall Study|Physician Decision|3|||
129710539|NCT04016714|466901652|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
129710540|NCT04016714|466901653|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
129710541|NCT00730886|466901656|FG000|Overall Study|Lost to Follow-up|1|||
129710542|NCT00730886|466901657|FG001|Overall Study|Lost to Follow-up|0|||
129710543|NCT00730886|466901656|FG000|Overall Study|Physician Decision|1|||
129710544|NCT00730886|466901657|FG001|Overall Study|Physician Decision|0|||
129710545|NCT01991483|466901658|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
129710546|NCT01991483|466901659|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
129801067|NCT02448810|467239950|FG003|Overall Study|Other (Progressive disease)|3|||
129801068|NCT02448810|467239951|FG004|Overall Study|Other (Progressive disease)|23|||
129801069|NCT02448810|467239952|FG005|Overall Study|Other (Progressive disease)|9|||
129801070|NCT02448810|467239953|FG006|Overall Study|Other (Progressive disease)|14|||
129710547|NCT01991483|466901660|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
129710548|NCT01991483|466901661|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
129710549|NCT01991483|466901658|FG000|Dose Level 600 mg|Physician Decision|0|||
129710550|NCT01991483|466901659|FG001|Dose Level 600 mg|Physician Decision|0|||
129710551|NCT01991483|466901660|FG002|Dose Level 600 mg|Physician Decision|1|||
129801071|NCT02448810|467239954|FG007|Overall Study|Other (Progressive disease)|5|||
129801072|NCT02448810|467239947|FG000|Overall Study|Lost to Follow-up|0|||
129801073|NCT02448810|467239948|FG001|Overall Study|Lost to Follow-up|1|||
129710552|NCT01991483|466901661|FG003|Dose Level 600 mg|Physician Decision|0|||
129710553|NCT01991483|466901658|FG000|Dose Level 1000 mg|Protocol Violation|0|||
129710554|NCT01991483|466901659|FG001|Dose Level 1000 mg|Protocol Violation|0|||
129710555|NCT01991483|466901660|FG002|Dose Level 1000 mg|Protocol Violation|0|||
129710556|NCT01991483|466901661|FG003|Dose Level 1000 mg|Protocol Violation|1|||
129710557|NCT01932788|466901669|FG000|Overall Study|Protocol Violation|18|||
129710558|NCT01932788|466901670|FG001|Overall Study|Protocol Violation|0|||
129710559|NCT01932788|466901669|FG000|Overall Study|Lost to Follow-up|18|||
129710560|NCT01932788|466901670|FG001|Overall Study|Lost to Follow-up|46|||
129710561|NCT01932788|466901669|FG000|Overall Study|Lack of Efficacy|2|||
129710562|NCT01932788|466901670|FG001|Overall Study|Lack of Efficacy|0|||
129710563|NCT01932788|466901669|FG000|Overall Study|Withdrawal by Subject|0|||
129710564|NCT01932788|466901670|FG001|Overall Study|Withdrawal by Subject|5|||
129710565|NCT01171677|466901671|FG000|Overall Study|Withdrawal by Subject|0|||
129710566|NCT01171677|466901672|FG001|Overall Study|Withdrawal by Subject|3|||
129710567|NCT01171677|466901671|FG000|Overall Study|Adverse Event|1|||
129710568|NCT01171677|466901672|FG001|Overall Study|Adverse Event|0|||
129801074|NCT02448810|467239949|FG002|Overall Study|Lost to Follow-up|0|||
129801075|NCT02448810|467239950|FG003|Overall Study|Lost to Follow-up|0|||
129801076|NCT02448810|467239951|FG004|Overall Study|Lost to Follow-up|0|||
129801077|NCT02448810|467239952|FG005|Overall Study|Lost to Follow-up|0|||
129801078|NCT02448810|467239953|FG006|Overall Study|Lost to Follow-up|0|||
129801079|NCT02448810|467239954|FG007|Overall Study|Lost to Follow-up|0|||
129801080|NCT02448810|467239947|FG000|Overall Study|Other (unspecified)|0|||
129801081|NCT02448810|467239948|FG001|Overall Study|Other (unspecified)|0|||
129801082|NCT02448810|467239949|FG002|Overall Study|Other (unspecified)|0|||
129801083|NCT02448810|467239950|FG003|Overall Study|Other (unspecified)|0|||
129801084|NCT02448810|467239951|FG004|Overall Study|Other (unspecified)|0|||
129801085|NCT02448810|467239952|FG005|Overall Study|Other (unspecified)|0|||
129801086|NCT02448810|467239953|FG006|Overall Study|Other (unspecified)|2|||
129801087|NCT02448810|467239954|FG007|Overall Study|Other (unspecified)|0|||
129801088|NCT00470847|467239957|FG000|Overall Study|Pt still receiving treatment|1|||
129801089|NCT01912963|467239964|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
129801090|NCT01912963|467239965|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
129801091|NCT01912963|467239966|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
129801092|NCT01912963|467239964|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
129801093|NCT01912963|467239965|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
129801094|NCT01912963|467239966|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
129801095|NCT01912963|467239964|FG000|Overall Study|Adverse Event|0|||
129801096|NCT01912963|467239965|FG001|Overall Study|Adverse Event|1|||
129801097|NCT01912963|467239966|FG002|Overall Study|Adverse Event|1|||
129801098|NCT01912963|467239964|FG000|Overall Study|Withdrawal by Subject|0|||
129801099|NCT01912963|467239965|FG001|Overall Study|Withdrawal by Subject|1|||
129801100|NCT01912963|467239966|FG002|Overall Study|Withdrawal by Subject|0|||
129801101|NCT01912963|467239964|FG000|Overall Study|Sought treatment locally|0|||
129801102|NCT01912963|467239965|FG001|Overall Study|Sought treatment locally|1|||
129801103|NCT01912963|467239966|FG002|Overall Study|Sought treatment locally|0|||
129801104|NCT01147172|467239970|FG000|Overall Study|Withdrawal by Subject|2|||
129801105|NCT01147172|467239970|FG000|Overall Study|Lost to Follow-up|2|||
129801106|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Adverse Event|10|||
129801107|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Adverse Event|0|||
129801108|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
129801109|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
129801110|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
129801111|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
129710569|NCT01171677|466901671|FG000|Overall Study|completed <70% IntenSati classes|5|||
129710570|NCT01171677|466901672|FG001|Overall Study|completed <70% IntenSati classes|0|||
129710571|NCT01847443|466901673|FG000|Study Period 1|Withdrawal by Subject|0|||
129710572|NCT01847443|466901674|FG001|Study Period 1|Withdrawal by Subject|1|||
129710573|NCT01847443|466901675|FG002|Study Period 1|Withdrawal by Subject|0|||
129710574|NCT01847443|466901676|FG003|Study Period 1|Withdrawal by Subject|0|||
129710575|NCT01847443|466901673|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
129710576|NCT01847443|466901674|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
129710577|NCT01847443|466901675|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
129710578|NCT01847443|466901676|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
129710579|NCT01847443|466901673|FG000|Washout Period Before Study Period 2|Other reason|1|||
129710580|NCT01847443|466901674|FG001|Washout Period Before Study Period 2|Other reason|0|||
129710581|NCT01847443|466901675|FG002|Washout Period Before Study Period 2|Other reason|0|||
129710582|NCT01847443|466901676|FG003|Washout Period Before Study Period 2|Other reason|0|||
129710583|NCT01847443|466901673|FG000|Washout Period Before Study Period 3|Other reason|1|||
129710584|NCT01847443|466901674|FG001|Washout Period Before Study Period 3|Other reason|0|||
129710585|NCT01847443|466901675|FG002|Washout Period Before Study Period 3|Other reason|0|||
129710586|NCT01847443|466901676|FG003|Washout Period Before Study Period 3|Other reason|0|||
129710587|NCT01847443|466901673|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
129710588|NCT01847443|466901674|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
129710589|NCT01847443|466901675|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
129710590|NCT01847443|466901676|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
129710591|NCT01847443|466901673|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
129710592|NCT01847443|466901674|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
129710593|NCT01847443|466901675|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
129710594|NCT01847443|466901676|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
129710595|NCT03571971|466901677|FG000|Overall Study|Lost to Follow-up|2|||
129710596|NCT03571971|466901678|FG001|Overall Study|Lost to Follow-up|2|||
129710597|NCT03571971|466901677|FG000|Overall Study|Protocol Violation|2|||
129710598|NCT03571971|466901678|FG001|Overall Study|Protocol Violation|3|||
129710599|NCT03571971|466901677|FG000|Overall Study|Withdrawal by Subject|2|||
129710600|NCT03571971|466901678|FG001|Overall Study|Withdrawal by Subject|0|||
129710601|NCT03571971|466901677|FG000|Overall Study|Incomplete primary outcome data|2|||
129710602|NCT03571971|466901678|FG001|Overall Study|Incomplete primary outcome data|0|||
129710603|NCT02806414|466901686|FG000|Overall Study|Lost to Follow-up|2|||
129710604|NCT00937495|466903053|FG000|Overall Study|Protocol Violation|2|||
129710605|NCT00441272|466903054|FG000|Overall Study|Study terminated prior to enrollment|25|||
129710606|NCT00441272|466903055|FG001|Overall Study|Study terminated prior to enrollment|25|||
129710607|NCT01856322|466903056|FG000|Overall Study|off study due to lack of accrual|0|||
129710608|NCT01856322|466903057|FG001|Overall Study|off study due to lack of accrual|0|||
129710609|NCT01856322|466903058|FG002|Overall Study|off study due to lack of accrual|3|||
129710610|NCT00427011|466903059|FG000|Overall Study|Adverse Event|10|||
129710611|NCT00427011|466903059|FG000|Overall Study|Withdrawal by Subject|1|||
129710612|NCT00427011|466903059|FG000|Overall Study|Lack of Efficacy|2|||
129710613|NCT00427011|466903059|FG000|Overall Study|Other|12|||
129710614|NCT00288015|466903063|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
129710615|NCT00288015|466903063|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
129710616|NCT00288015|466903063|FG000|First Response Assessment|Withdrawal by Subject|1|||
129710617|NCT00288015|466903063|FG000|First Response Assessment|Death|1|||
129710618|NCT00288015|466903063|FG000|First Response Assessment|Physician Decision|2|||
129710619|NCT00288015|466903063|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
129710620|NCT00288015|466903063|FG000|Follow up for Survival x 2 Years|Death|13|||
129710621|NCT00288015|466903063|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
129710622|NCT00288015|466903063|FG000|Follow up for Survival x 2 Years|Other|9|||
129710623|NCT01333722|466903064|FG000|Overall Study|Lack of Efficacy|0|||
129710624|NCT01333722|466903065|FG001|Overall Study|Lack of Efficacy|2|||
129710625|NCT01333722|466903064|FG000|Overall Study|Withdrawal by Subject|0|||
129710626|NCT01333722|466903065|FG001|Overall Study|Withdrawal by Subject|1|||
129710627|NCT00443703|466903066|FG000|Overall Study|Never Treated|3|||
129710628|NCT00443703|466903067|FG001|Overall Study|Never Treated|1|||
129710629|NCT00443703|466903066|FG000|Overall Study|Adverse Event|7|||
129710630|NCT00443703|466903067|FG001|Overall Study|Adverse Event|3|||
129710631|NCT00443703|466903066|FG000|Overall Study|Lack of Efficacy|3|||
129710632|NCT00443703|466903067|FG001|Overall Study|Lack of Efficacy|1|||
129710633|NCT00443703|466903066|FG000|Overall Study|Lost to Follow-up|0|||
129710634|NCT00443703|466903067|FG001|Overall Study|Lost to Follow-up|4|||
129710635|NCT00443703|466903066|FG000|Overall Study|Physician Decision|4|||
129801112|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
129801113|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
129801114|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
129801115|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
129801116|NCT02787551|467239971|FG000|Core Period: 26 Weeks|Other than specified|3|||
129801117|NCT02787551|467239972|FG001|Core Period: 26 Weeks|Other than specified|1|||
129801118|NCT02787551|467239971|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
129801119|NCT02787551|467239972|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
129801120|NCT02787551|467239971|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
129801121|NCT02787551|467239972|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
129801122|NCT02787551|467239971|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
129801123|NCT02787551|467239972|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
129801124|NCT03112590|467239974|FG000|Overall Study|Adverse Event|0|||
129710636|NCT00443703|466903067|FG001|Overall Study|Physician Decision|2|||
129801125|NCT03112590|467239975|FG001|Overall Study|Adverse Event|1|||
129801126|NCT03112590|467239976|FG002|Overall Study|Adverse Event|0|||
129801127|NCT05156073|467239977|FG000|Overall Study|Patient canceled appointment with PCP|1|||
129801128|NCT02734433|467239978|FG000|Overall Study|Disease progression|1|||
129801129|NCT02734433|467239979|FG001|Overall Study|Disease progression|5|||
129801130|NCT02734433|467239978|FG000|Overall Study|Clinical progression|0|||
129710637|NCT00443703|466903066|FG000|Overall Study|Protocol Violation|1|||
129710638|NCT00443703|466903067|FG001|Overall Study|Protocol Violation|1|||
129710639|NCT00443703|466903066|FG000|Overall Study|Withdrawal by Subject|9|||
129710640|NCT00443703|466903067|FG001|Overall Study|Withdrawal by Subject|6|||
129710641|NCT00443703|466903066|FG000|Overall Study|Progressive Disease|1|||
129710642|NCT00443703|466903067|FG001|Overall Study|Progressive Disease|0|||
129710643|NCT04776161|466903069|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
129710644|NCT04776161|466903070|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
129710645|NCT04776161|466903071|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
129710646|NCT04776161|466903069|FG000|Overall Study|Withdrawal by Subject|1|||
129710647|NCT04776161|466903070|FG001|Overall Study|Withdrawal by Subject|0|||
129710648|NCT04776161|466903071|FG002|Overall Study|Withdrawal by Subject|1|||
129710649|NCT04776161|466903069|FG000|Overall Study|Adverse Event|0|||
129710650|NCT04776161|466903070|FG001|Overall Study|Adverse Event|1|||
129710651|NCT04776161|466903071|FG002|Overall Study|Adverse Event|1|||
129710652|NCT00661830|466903075|FG000|Overall Study|Death|37|||
129710653|NCT00661830|466903076|FG001|Overall Study|Death|33|||
129710654|NCT00661830|466903075|FG000|Overall Study|Lost to Follow-up|1|||
129710655|NCT00661830|466903076|FG001|Overall Study|Lost to Follow-up|3|||
129710656|NCT00661830|466903075|FG000|Overall Study|Withdrawal by Subject|1|||
129710657|NCT00661830|466903076|FG001|Overall Study|Withdrawal by Subject|1|||
129710658|NCT00661830|466903075|FG000|Overall Study|Other reason|1|||
129710659|NCT00661830|466903076|FG001|Overall Study|Other reason|5|||
129710660|NCT00488514|466903077|FG000|Overall Study|Adverse Event|41|||
129710661|NCT00488514|466903077|FG000|Overall Study|Lost to Follow-up|44|||
129710662|NCT00488514|466903077|FG000|Overall Study|Protocol Violation|32|||
129710663|NCT00488514|466903077|FG000|Overall Study|Withdrawal by Subject|106|||
129710664|NCT00488514|466903077|FG000|Overall Study|Lack of Efficacy|28|||
129710665|NCT00488514|466903077|FG000|Overall Study|Did not meet criteria for treatment|30|||
129710666|NCT00488514|466903077|FG000|Overall Study|Postive drug screen|1|||
129710667|NCT00488514|466903077|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
129710668|NCT00488514|466903077|FG000|Overall Study|Investigator decision|1|||
129710669|NCT00488514|466903077|FG000|Overall Study|Participant had too few migraines|5|||
129710670|NCT00488514|466903077|FG000|Overall Study|Increase in number of migraines|2|||
129710671|NCT00488514|466903077|FG000|Overall Study|Increased use of concomitant medication|1|||
129710672|NCT00517699|466903078|FG000|Overall Study|Withdrawal by Subject|1|||
129710673|NCT00517699|466903078|FG000|Overall Study|Lack of Efficacy|1|||
129710674|NCT00517699|466903078|FG000|Overall Study|Administrative error|1|||
129710675|NCT00517699|466903078|FG000|Overall Study|Study terminated by Sponsor|2|||
129710676|NCT02332187|466903079|FG000|Overall Study|Withdrawal by Subject|2|||
129710677|NCT02332187|466903080|FG001|Overall Study|Withdrawal by Subject|2|||
129710678|NCT02332187|466903079|FG000|Overall Study|Adverse Event|0|||
129710679|NCT02332187|466903080|FG001|Overall Study|Adverse Event|1|||
129710680|NCT00980148|466903081|FG000|Overall Study|Discharged from facility|89|||
129710681|NCT00980148|466903082|FG001|Overall Study|Discharged from facility|96|||
129710682|NCT00980148|466903081|FG000|Overall Study|Received other antichlamydia treatment|20|||
129710683|NCT00980148|466903082|FG001|Overall Study|Received other antichlamydia treatment|14|||
129710684|NCT00980148|466903081|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
129710685|NCT00980148|466903082|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
129710686|NCT00980148|466903081|FG000|Overall Study|Various other reasons|8|||
129710687|NCT00980148|466903082|FG001|Overall Study|Various other reasons|9|||
129710688|NCT03500211|466903083|FG000|Overall Study|Withdrawal by Subject|1|||
129710689|NCT03500211|466903084|FG001|Overall Study|Withdrawal by Subject|1|||
129710690|NCT01119443|466903088|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
129710691|NCT01119443|466903089|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
129710692|NCT02329743|466903092|FG000|Overall Study|Adverse Event|1|||
129710693|NCT02329743|466903093|FG001|Overall Study|Adverse Event|1|||
129710694|NCT02329743|466903094|FG002|Overall Study|Adverse Event|3|||
129710695|NCT02329743|466903092|FG000|Overall Study|Lost to Follow-up|1|||
129710696|NCT02329743|466903093|FG001|Overall Study|Lost to Follow-up|0|||
129710697|NCT02329743|466903094|FG002|Overall Study|Lost to Follow-up|1|||
129710698|NCT02329743|466903092|FG000|Overall Study|Withdrawal by Subject|4|||
129710699|NCT02329743|466903093|FG001|Overall Study|Withdrawal by Subject|4|||
129710700|NCT02329743|466903094|FG002|Overall Study|Withdrawal by Subject|1|||
129710701|NCT02329743|466903092|FG000|Overall Study|Other|0|||
129710702|NCT02329743|466903093|FG001|Overall Study|Other|2|||
129710703|NCT02329743|466903094|FG002|Overall Study|Other|3|||
129710704|NCT00775268|466903098|FG000|Baseline|Drug not synthesize dose|1|||
129710705|NCT00775268|466903099|FG001|Baseline|Drug not synthesize dose|0|||
129710706|NCT00775268|466903098|FG000|Baseline|Not treated-ineligible per CT|0|||
129710707|NCT00775268|466903099|FG001|Baseline|Not treated-ineligible per CT|1|||
129710708|NCT00775268|466903098|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
129710709|NCT00775268|466903099|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
129710710|NCT00775268|466903098|FG000|After Completion|Participant missed scan appointment|1|||
129801131|NCT02734433|467239979|FG001|Overall Study|Clinical progression|1|||
129444208|NCT01310803|465927251|FG000|Overall Study|Subject terminated by Sponsor|1|||
129710711|NCT00775268|466903099|FG001|After Completion|Participant missed scan appointment|0|||
129710712|NCT03604497|466903100|FG000|Overall Study|Protocol Violation|52|||
129710713|NCT01194245|466903106|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
129710714|NCT01194245|466903107|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129710715|NCT01194245|466903108|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129710716|NCT01194245|466903109|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129710717|NCT01194245|466903110|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
129710718|NCT01194245|466903106|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
129710719|NCT01194245|466903107|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129710720|NCT01194245|466903108|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129710721|NCT01194245|466903109|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129710722|NCT01194245|466903110|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
129710723|NCT01194245|466903106|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
129710724|NCT01194245|466903107|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129710725|NCT01194245|466903108|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129710726|NCT01194245|466903109|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129710727|NCT01194245|466903110|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
129710728|NCT01194245|466903106|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
129710729|NCT01194245|466903107|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129801132|NCT02734433|467239978|FG000|Overall Study|Withdrawal by Subject|1|||
129801133|NCT02734433|467239979|FG001|Overall Study|Withdrawal by Subject|2|||
129801134|NCT03805646|467239981|FG000|Overall Study|Death|40|||
129801135|NCT03805646|467239982|FG001|Overall Study|Death|49|||
129801136|NCT03805646|467239981|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
129801137|NCT03805646|467239982|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
129801138|NCT05521906|467239983|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
129801139|NCT05521906|467239984|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
129801140|NCT00891462|467241929|FG000|Overall Study|Withdrawal by Subject|9|||
129801141|NCT00891462|467241930|FG001|Overall Study|Withdrawal by Subject|6|||
129710730|NCT01194245|466903108|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129710731|NCT01194245|466903109|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129710732|NCT01194245|466903110|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
129710733|NCT01194245|466903106|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129710734|NCT01194245|466903107|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129710735|NCT01194245|466903108|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129710736|NCT01194245|466903109|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129710737|NCT01194245|466903110|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
129710738|NCT01194245|466903106|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129710739|NCT01194245|466903107|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129710740|NCT01194245|466903108|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
129710741|NCT01194245|466903109|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
129710742|NCT01194245|466903110|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
129710743|NCT00269087|466903111|FG000|Overall Study|Adverse Event|20|||
129710744|NCT00269087|466903111|FG000|Overall Study|Withdrawal by Subject|1|||
129710745|NCT00269087|466903111|FG000|Overall Study|Exacerbation of COPD|13|||
129710746|NCT02651116|466903114|FG000|Overall Study|Adverse Event|0|||
129801142|NCT00891462|467241931|FG002|Overall Study|Withdrawal by Subject|7|||
129801143|NCT00891462|467241929|FG000|Overall Study|Adverse Event|7|||
129801144|NCT00891462|467241930|FG001|Overall Study|Adverse Event|8|||
129801145|NCT00891462|467241931|FG002|Overall Study|Adverse Event|7|||
129801146|NCT00891462|467241929|FG000|Overall Study|Lack of Efficacy|10|||
129801147|NCT00891462|467241930|FG001|Overall Study|Lack of Efficacy|5|||
129801148|NCT00891462|467241931|FG002|Overall Study|Lack of Efficacy|1|||
129801149|NCT00891462|467241929|FG000|Overall Study|COPD exacerbation|7|||
129801150|NCT00891462|467241930|FG001|Overall Study|COPD exacerbation|4|||
129801151|NCT00891462|467241931|FG002|Overall Study|COPD exacerbation|1|||
129801152|NCT00891462|467241929|FG000|Overall Study|Other Reason|2|||
129801153|NCT00891462|467241930|FG001|Overall Study|Other Reason|5|||
129801154|NCT00891462|467241931|FG002|Overall Study|Other Reason|3|||
129801155|NCT00891462|467241929|FG000|Overall Study|Protocol Violation|2|||
129801156|NCT00891462|467241930|FG001|Overall Study|Protocol Violation|1|||
129801157|NCT00891462|467241931|FG002|Overall Study|Protocol Violation|3|||
129801158|NCT00891462|467241929|FG000|Overall Study|Inclusion/exclusion criteria|0|||
129801159|NCT00891462|467241930|FG001|Overall Study|Inclusion/exclusion criteria|2|||
129801160|NCT00891462|467241931|FG002|Overall Study|Inclusion/exclusion criteria|2|||
129801161|NCT00891462|467241929|FG000|Overall Study|Lost to Follow-up|0|||
129801162|NCT00891462|467241930|FG001|Overall Study|Lost to Follow-up|2|||
129801163|NCT00891462|467241931|FG002|Overall Study|Lost to Follow-up|0|||
129801164|NCT00257608|467241937|FG000|Chemotherapy Phase|Adverse Event|138|||
129801165|NCT00257608|467241938|FG001|Chemotherapy Phase|Adverse Event|0|||
129444209|NCT01310803|465927252|FG001|Overall Study|Subject terminated by Sponsor|0|||
129710747|NCT02651116|466903115|FG001|Overall Study|Adverse Event|1|||
129710748|NCT02651116|466903114|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
129710749|NCT02651116|466903115|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
129710750|NCT00041470|466903124|FG000|Overall Study|Loss of Funding|38|||
129710751|NCT01193101|466903130|FG000|Overall Study|Adverse Event|0|||
129710752|NCT01193101|466903131|FG001|Overall Study|Adverse Event|1|||
129710753|NCT01193101|466903132|FG002|Overall Study|Adverse Event|1|||
129710754|NCT01193101|466903133|FG003|Overall Study|Adverse Event|3|||
129710755|NCT01193101|466903130|FG000|Overall Study|Lack of Efficacy|3|||
129710756|NCT01193101|466903131|FG001|Overall Study|Lack of Efficacy|1|||
129710757|NCT01193101|466903132|FG002|Overall Study|Lack of Efficacy|0|||
129710758|NCT01193101|466903133|FG003|Overall Study|Lack of Efficacy|8|||
129710759|NCT01193101|466903130|FG000|Overall Study|Withdrawal by Subject|2|||
129710760|NCT01193101|466903131|FG001|Overall Study|Withdrawal by Subject|4|||
129710761|NCT01193101|466903132|FG002|Overall Study|Withdrawal by Subject|1|||
129710762|NCT01193101|466903133|FG003|Overall Study|Withdrawal by Subject|1|||
129710763|NCT01193101|466903130|FG000|Overall Study|Administrative problems|0|||
129710764|NCT01193101|466903131|FG001|Overall Study|Administrative problems|0|||
129710765|NCT01193101|466903132|FG002|Overall Study|Administrative problems|1|||
129710766|NCT01193101|466903133|FG003|Overall Study|Administrative problems|0|||
129710767|NCT01193101|466903130|FG000|Overall Study|Abnormal test procedure results|0|||
129710768|NCT01193101|466903131|FG001|Overall Study|Abnormal test procedure results|1|||
129710769|NCT01193101|466903132|FG002|Overall Study|Abnormal test procedure results|0|||
129710770|NCT01193101|466903133|FG003|Overall Study|Abnormal test procedure results|0|||
129801166|NCT00257608|467241939|FG002|Chemotherapy Phase|Adverse Event|0|||
129801167|NCT00257608|467241937|FG000|Chemotherapy Phase|Disease progression|139|||
129801168|NCT00257608|467241938|FG001|Chemotherapy Phase|Disease progression|0|||
129801169|NCT00257608|467241939|FG002|Chemotherapy Phase|Disease progression|0|||
129801170|NCT00257608|467241937|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
129801171|NCT00257608|467241938|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
129801172|NCT00257608|467241939|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
129801173|NCT00257608|467241937|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
129801174|NCT00257608|467241938|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
129801175|NCT00257608|467241939|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
129801176|NCT00257608|467241937|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
129801177|NCT00257608|467241938|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
129801178|NCT00257608|467241939|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
129801179|NCT00257608|467241937|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
129801180|NCT00257608|467241938|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801181|NCT00257608|467241939|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801182|NCT00257608|467241937|FG000|Chemotherapy Phase|Physician Decision|28|||
129801183|NCT00257608|467241938|FG001|Chemotherapy Phase|Physician Decision|0|||
129801184|NCT00257608|467241939|FG002|Chemotherapy Phase|Physician Decision|0|||
129801185|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Adverse Event|0|||
129801186|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Adverse Event|34|||
129801187|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Adverse Event|38|||
129801188|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Disease progression|0|||
129801189|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Disease progression|204|||
129801190|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Disease progression|168|||
129801191|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
129801192|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
129801193|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
129801194|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
129801195|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
129801196|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
129801197|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
129801198|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
129444210|NCT01306890|465927253|FG000|Overall Study|Adverse Event|2|||
129444211|NCT01306890|465927253|FG000|Overall Study|Death|1223|||
129444212|NCT01306890|465927253|FG000|Overall Study|Lost to Follow-up|58|||
129444213|NCT01306890|465927253|FG000|Overall Study|Withdrawal by Subject|88|||
129710771|NCT02347085|466903134|FG000|Overall Study|Adverse Event|2|||
129710772|NCT02347085|466903134|FG000|Overall Study|Lack of Efficacy|1|||
129710773|NCT02347085|466903134|FG000|Overall Study|Withdrawal by Subject|4|||
129710774|NCT02347085|466903134|FG000|Overall Study|Lost to Follow-up|1|||
129710775|NCT02347085|466903134|FG000|Overall Study|Protocol Criteria|2|||
129710776|NCT00800982|466903135|FG000|Overall Study|Lost to Follow-up|1|||
129801199|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
129801200|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
129710777|NCT00800982|466903136|FG001|Overall Study|Lost to Follow-up|2|||
129710778|NCT00800982|466903135|FG000|Overall Study|Withdrawal by Subject|0|||
129710779|NCT00800982|466903136|FG001|Overall Study|Withdrawal by Subject|1|||
129710780|NCT00800982|466903135|FG000|Overall Study|Patient moved out of state|1|||
129710781|NCT00800982|466903136|FG001|Overall Study|Patient moved out of state|0|||
129710782|NCT00648037|466903137|FG000|Overall Study|Not Treated|1|||
129710783|NCT00648037|466903137|FG000|Overall Study|Withdrawal by Subject|1|||
129710784|NCT00648037|466903137|FG000|Overall Study|Adverse Event|11|||
129710785|NCT00648037|466903137|FG000|Overall Study|Relapse|2|||
129710786|NCT00648037|466903137|FG000|Overall Study|Other|1|||
129710787|NCT00699413|466903148|FG000|Overall Study|Withdrawal by Subject|0|||
129710788|NCT00699413|466903149|FG001|Overall Study|Withdrawal by Subject|2|||
129710789|NCT00699413|466903148|FG000|Overall Study|Study terminated by sponsor|4|||
129710790|NCT00699413|466903149|FG001|Overall Study|Study terminated by sponsor|2|||
129710791|NCT00363311|466903151|FG000|Overall Study|Adverse Event|6|||
129710792|NCT00363311|466903152|FG001|Overall Study|Adverse Event|4|||
129710793|NCT00363311|466903151|FG000|Overall Study|Lost to Follow-up|3|||
129710794|NCT00363311|466903152|FG001|Overall Study|Lost to Follow-up|0|||
129710795|NCT00363311|466903151|FG000|Overall Study|Protocol Violation|1|||
129710796|NCT00363311|466903152|FG001|Overall Study|Protocol Violation|2|||
129710797|NCT00363311|466903151|FG000|Overall Study|Withdrawal by Subject|12|||
129710798|NCT00363311|466903152|FG001|Overall Study|Withdrawal by Subject|6|||
129710799|NCT00363311|466903151|FG000|Overall Study|Physician Decision|1|||
129710800|NCT00363311|466903152|FG001|Overall Study|Physician Decision|1|||
129710801|NCT00363311|466903151|FG000|Overall Study|Sponsor Terminated Study|2|||
129710802|NCT00363311|466903152|FG001|Overall Study|Sponsor Terminated Study|2|||
129710803|NCT00363311|466903151|FG000|Overall Study|Disease Progression|46|||
129710804|NCT00363311|466903152|FG001|Overall Study|Disease Progression|26|||
129710805|NCT00363311|466903151|FG000|Overall Study|Non-Compliance|1|||
129710806|NCT00363311|466903152|FG001|Overall Study|Non-Compliance|1|||
129710807|NCT00363311|466903151|FG000|Overall Study|Participant Refused Biopsy|1|||
129710808|NCT00363311|466903152|FG001|Overall Study|Participant Refused Biopsy|0|||
129710809|NCT00363311|466903151|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
129710810|NCT00363311|466903152|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
129710811|NCT00363311|466903151|FG000|Overall Study|Participant Opted for Treatment|1|||
129710812|NCT00363311|466903152|FG001|Overall Study|Participant Opted for Treatment|0|||
129710813|NCT00363311|466903151|FG000|Overall Study|Participant Moved to Another Country|1|||
129710814|NCT00363311|466903152|FG001|Overall Study|Participant Moved to Another Country|0|||
129710815|NCT00363311|466903151|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
129710816|NCT00363311|466903152|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
129710817|NCT00363311|466903151|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
129710818|NCT00363311|466903152|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
129710819|NCT00363311|466903151|FG000|Overall Study|Participant Moved to Louisiana|0|||
129710820|NCT00363311|466903152|FG001|Overall Study|Participant Moved to Louisiana|1|||
129710821|NCT02103062|466903153|FG000|Overall Study|Adverse Event|1|||
129710822|NCT02103062|466903154|FG001|Overall Study|Adverse Event|2|||
129710823|NCT02103062|466903153|FG000|Overall Study|Progressive Disease|17|||
129710824|NCT02103062|466903154|FG001|Overall Study|Progressive Disease|20|||
129710825|NCT02103062|466903153|FG000|Overall Study|Death|0|||
129710826|NCT02103062|466903154|FG001|Overall Study|Death|1|||
129710827|NCT00120627|466903155|FG000|Overall Study|Withdrawal by Subject|5|||
129710828|NCT00120627|466903156|FG001|Overall Study|Withdrawal by Subject|5|||
129710829|NCT03092479|466903161|FG000|Overall Study|Lost to Follow-up|3|||
129710830|NCT03092479|466903162|FG001|Overall Study|Lost to Follow-up|2|||
129710831|NCT03092479|466903161|FG000|Overall Study|Withdrawal by Subject|4|||
129710832|NCT03092479|466903162|FG001|Overall Study|Withdrawal by Subject|0|||
129801201|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
129801202|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
129801203|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
129710833|NCT00543985|466903165|FG000|Overall Study|Withdrawal by Subject|4|||
129710834|NCT02015039|466903166|FG000|Overall Study|Not eligible|0|||
129710835|NCT02015039|466903167|FG001|Overall Study|Not eligible|1|||
129710836|NCT04046939|466903171|FG000|Primary Assessment Period|Adverse Event|1|||
129710837|NCT04046939|466903172|FG001|Primary Assessment Period|Adverse Event|0|||
129801204|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
129801205|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
129801206|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Physician Decision|0|||
129801207|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Physician Decision|8|||
129801208|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Physician Decision|11|||
129801209|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
129801210|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
129801211|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
129801212|NCT00257608|467241937|FG000|Post Chemotherapy Phase|Not treated|0|||
129801213|NCT00257608|467241938|FG001|Post Chemotherapy Phase|Not treated|4|||
129710838|NCT04046939|466903173|FG002|Primary Assessment Period|Adverse Event|0|||
129710839|NCT04046939|466903174|FG003|Primary Assessment Period|Adverse Event|0|||
129710840|NCT04046939|466903171|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
129710841|NCT04046939|466903172|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
129710842|NCT04046939|466903173|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
129710843|NCT04046939|466903174|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
129710844|NCT04046939|466903171|FG000|Primary Assessment Period|Physician Decision|0|||
129710845|NCT04046939|466903172|FG001|Primary Assessment Period|Physician Decision|0|||
129710846|NCT04046939|466903173|FG002|Primary Assessment Period|Physician Decision|1|||
129710847|NCT04046939|466903174|FG003|Primary Assessment Period|Physician Decision|0|||
129710848|NCT04046939|466903171|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
129710849|NCT04046939|466903172|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
129710850|NCT04046939|466903173|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
129710851|NCT04046939|466903174|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
129710852|NCT00403130|466903175|FG000|2 Years From Start of Treatment|Not Eligible|3|||
129710853|NCT00403130|466903175|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
129710854|NCT00403130|466903175|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
129710855|NCT00403130|466903175|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
129710856|NCT00806260|466903176|FG000|Period 1 (1 Day)|Adverse Event|0|||
129710857|NCT00806260|466903177|FG001|Period 1 (1 Day)|Adverse Event|0|||
129710858|NCT00806260|466903178|FG002|Period 1 (1 Day)|Adverse Event|0|||
129710859|NCT00806260|466903179|FG003|Period 1 (1 Day)|Adverse Event|0|||
129710860|NCT00806260|466903180|FG004|Period 1 (1 Day)|Adverse Event|3|||
129710861|NCT00806260|466903181|FG005|Period 1 (1 Day)|Adverse Event|0|||
129710862|NCT00806260|466903176|FG000|Period 2|Adverse Event|0|||
129710863|NCT00806260|466903177|FG001|Period 2|Adverse Event|0|||
129710864|NCT00806260|466903178|FG002|Period 2|Adverse Event|0|||
129710865|NCT00806260|466903179|FG003|Period 2|Adverse Event|1|||
129710866|NCT00806260|466903180|FG004|Period 2|Adverse Event|0|||
129710867|NCT00806260|466903181|FG005|Period 2|Adverse Event|0|||
129710868|NCT00806260|466903176|FG000|Period 2|Protocol Violation|1|||
129710869|NCT00806260|466903177|FG001|Period 2|Protocol Violation|0|||
129710870|NCT00806260|466903178|FG002|Period 2|Protocol Violation|1|||
129710871|NCT00806260|466903179|FG003|Period 2|Protocol Violation|0|||
129710872|NCT00806260|466903180|FG004|Period 2|Protocol Violation|0|||
129710873|NCT00806260|466903181|FG005|Period 2|Protocol Violation|0|||
129710874|NCT00806260|466903176|FG000|Period 2|Need to take concomitant medication|1|||
129710875|NCT00806260|466903177|FG001|Period 2|Need to take concomitant medication|0|||
129710876|NCT00806260|466903178|FG002|Period 2|Need to take concomitant medication|0|||
129710877|NCT00806260|466903179|FG003|Period 2|Need to take concomitant medication|0|||
129710878|NCT00806260|466903180|FG004|Period 2|Need to take concomitant medication|0|||
129710879|NCT00806260|466903181|FG005|Period 2|Need to take concomitant medication|0|||
129710880|NCT00806260|466903176|FG000|Period 2|sponsor request|0|||
129710881|NCT00806260|466903177|FG001|Period 2|sponsor request|0|||
129710882|NCT00806260|466903178|FG002|Period 2|sponsor request|1|||
129710883|NCT00806260|466903179|FG003|Period 2|sponsor request|1|||
129710884|NCT00806260|466903180|FG004|Period 2|sponsor request|0|||
129710885|NCT00806260|466903181|FG005|Period 2|sponsor request|0|||
129710886|NCT00806260|466903176|FG000|Period 3|Protocol Violation|0|||
129710887|NCT00806260|466903177|FG001|Period 3|Protocol Violation|1|||
129710888|NCT00806260|466903178|FG002|Period 3|Protocol Violation|1|||
129710889|NCT00806260|466903179|FG003|Period 3|Protocol Violation|0|||
129710890|NCT00806260|466903180|FG004|Period 3|Protocol Violation|0|||
129710891|NCT00806260|466903181|FG005|Period 3|Protocol Violation|0|||
129710892|NCT00806260|466903176|FG000|Period 3|Pregnancy|1|||
129710893|NCT00806260|466903177|FG001|Period 3|Pregnancy|0|||
129444214|NCT01306890|465927253|FG000|Overall Study|Unspecified reasons|104|||
129444215|NCT01306890|465927253|FG000|Overall Study|Study Termination|3|||
129444216|NCT01306890|465927253|FG000|Overall Study|No discontinuation documentation|41|||
129444217|NCT03047551|465927258|FG000|Overall Study|Did not receive TAS|1|||
129444218|NCT03047551|465927259|FG001|Overall Study|Did not receive TAS|0|||
129444219|NCT03047551|465927258|FG000|Overall Study|Physician Decision|1|||
129444220|NCT03047551|465927259|FG001|Overall Study|Physician Decision|0|||
129444221|NCT03047551|465927258|FG000|Overall Study|Withdrawal by Subject|0|||
129444222|NCT03047551|465927259|FG001|Overall Study|Withdrawal by Subject|1|||
129444223|NCT03047551|465927258|FG000|Overall Study|Probe malfunction|0|||
129444224|NCT03047551|465927259|FG001|Overall Study|Probe malfunction|1|||
129444225|NCT03047551|465927258|FG000|Overall Study|Ineligible|0|||
129444226|NCT03047551|465927259|FG001|Overall Study|Ineligible|1|||
129444227|NCT00726622|465927260|FG000|Overall Study|Withdrawal by Subject|16|||
129444228|NCT00726622|465927261|FG001|Overall Study|Withdrawal by Subject|2|||
129444229|NCT00726622|465927260|FG000|Overall Study|Physician Decision|0|||
129710894|NCT00806260|466903178|FG002|Period 3|Pregnancy|0|||
129710895|NCT00806260|466903179|FG003|Period 3|Pregnancy|0|||
129710896|NCT00806260|466903180|FG004|Period 3|Pregnancy|0|||
129710897|NCT00806260|466903181|FG005|Period 3|Pregnancy|0|||
129710898|NCT00237042|466903182|FG000|Treatment|Became ineligible post-randomization|0|||
129710899|NCT00237042|466903183|FG001|Treatment|Became ineligible post-randomization|1|||
129710900|NCT00237042|466903184|FG002|Treatment|Became ineligible post-randomization|16|||
129710901|NCT00237042|466903182|FG000|Treatment|Moved out of state|1|||
129710902|NCT00237042|466903183|FG001|Treatment|Moved out of state|1|||
129801214|NCT00257608|467241939|FG002|Post Chemotherapy Phase|Not treated|7|||
129801215|NCT02171065|467241940|FG000|Overall Study|Withdrawal by Subject|1|||
129801216|NCT02171065|467241941|FG001|Overall Study|Withdrawal by Subject|0|||
129801217|NCT02171065|467241942|FG002|Overall Study|Withdrawal by Subject|0|||
129801218|NCT02171065|467241940|FG000|Overall Study|Lost to Follow-up|0|||
129801219|NCT02171065|467241941|FG001|Overall Study|Lost to Follow-up|0|||
129801220|NCT02171065|467241942|FG002|Overall Study|Lost to Follow-up|1|||
129710903|NCT00237042|466903184|FG002|Treatment|Moved out of state|1|||
129710904|NCT00237042|466903182|FG000|Treatment|Completed no treatment|5|||
129710905|NCT00237042|466903183|FG001|Treatment|Completed no treatment|5|||
129710906|NCT00237042|466903184|FG002|Treatment|Completed no treatment|21|||
129710907|NCT00237042|466903182|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
129710908|NCT00237042|466903183|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
129710909|NCT00237042|466903184|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
129710910|NCT00237042|466903182|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
129710911|NCT00237042|466903183|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
129710912|NCT00237042|466903184|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
129801221|NCT02598960|467241943|FG000|Treatment Period|Disease Progression|4|||
129710913|NCT01897532|466903187|FG000|Discontinuation From Treatment|Not Treated|7|||
129710914|NCT01897532|466903188|FG001|Discontinuation From Treatment|Not Treated|5|||
129710915|NCT01897532|466903187|FG000|Discontinuation From Treatment|Other reason than specified|196|||
129710916|NCT01897532|466903188|FG001|Discontinuation From Treatment|Other reason than specified|176|||
129710917|NCT01897532|466903187|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
129710918|NCT01897532|466903188|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
129710919|NCT01897532|466903187|FG000|Discontinuation From Treatment|Non compliance|24|||
129710920|NCT01897532|466903188|FG001|Discontinuation From Treatment|Non compliance|15|||
129710921|NCT01897532|466903187|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
129710922|NCT01897532|466903188|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
129710923|NCT01897532|466903187|FG000|Discontinuation From Trial|Not Treated|7|||
129710924|NCT01897532|466903188|FG001|Discontinuation From Trial|Not Treated|5|||
129710925|NCT01897532|466903187|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
129710926|NCT01897532|466903188|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
129710927|NCT03132467|466903189|FG000|Overall Study|Adverse Event|2|||
129710928|NCT03132467|466903189|FG000|Overall Study|Withdrawal by Subject|2|||
129710929|NCT00038948|466903190|FG000|Overall Study|Adverse Event|131|||
129710930|NCT00038948|466903191|FG001|Overall Study|Adverse Event|43|||
129710931|NCT00038948|466903190|FG000|Overall Study|Lost to Follow-up|4|||
129710932|NCT00038948|466903191|FG001|Overall Study|Lost to Follow-up|4|||
129710933|NCT00038948|466903190|FG000|Overall Study|Nonmedical event|5|||
129710934|NCT00038948|466903191|FG001|Overall Study|Nonmedical event|7|||
129710935|NCT00038948|466903190|FG000|Overall Study|Withdrawal by Subject|23|||
129710936|NCT00038948|466903191|FG001|Overall Study|Withdrawal by Subject|10|||
129710937|NCT00038948|466903190|FG000|Overall Study|Protocol Violation|3|||
129710938|NCT00038948|466903191|FG001|Overall Study|Protocol Violation|7|||
129710939|NCT00038948|466903190|FG000|Overall Study|Lack of Efficacy|3|||
129710940|NCT00038948|466903191|FG001|Overall Study|Lack of Efficacy|6|||
129710941|NCT02670473|466903194|FG000|Overall Study|Withdrawal by Subject|1|||
129710942|NCT05223673|466903195|FG000|Overall Study|Protocol Violation|1|||
129710943|NCT05223673|466903195|FG000|Overall Study|Study termination|6|||
129710944|NCT03559270|466903196|FG000|Overall Study|Adverse Event|6|||
129710945|NCT03559270|466903197|FG001|Overall Study|Adverse Event|5|||
129710946|NCT03559270|466903198|FG002|Overall Study|Adverse Event|3|||
129710947|NCT03559270|466903199|FG003|Overall Study|Adverse Event|0|||
129710948|NCT03559270|466903196|FG000|Overall Study|Lack of Efficacy|34|||
129710949|NCT03559270|466903197|FG001|Overall Study|Lack of Efficacy|52|||
129710950|NCT03559270|466903198|FG002|Overall Study|Lack of Efficacy|37|||
129710951|NCT03559270|466903199|FG003|Overall Study|Lack of Efficacy|2|||
129710952|NCT03559270|466903196|FG000|Overall Study|Death|0|||
129801222|NCT02598960|467241944|FG001|Treatment Period|Disease Progression|4|||
129801223|NCT02598960|467241945|FG002|Treatment Period|Disease Progression|4|||
129801224|NCT02598960|467241946|FG003|Treatment Period|Disease Progression|6|||
129801225|NCT02598960|467241947|FG004|Treatment Period|Disease Progression|8|||
129710953|NCT03559270|466903197|FG001|Overall Study|Death|2|||
129710954|NCT03559270|466903198|FG002|Overall Study|Death|0|||
129710955|NCT03559270|466903199|FG003|Overall Study|Death|0|||
129710956|NCT03559270|466903196|FG000|Overall Study|Lost to Follow-up|16|||
129710957|NCT03559270|466903197|FG001|Overall Study|Lost to Follow-up|4|||
129710958|NCT03559270|466903198|FG002|Overall Study|Lost to Follow-up|12|||
129710959|NCT03559270|466903199|FG003|Overall Study|Lost to Follow-up|3|||
129710960|NCT03559270|466903196|FG000|Overall Study|Sponsor Decision|38|||
129710961|NCT03559270|466903197|FG001|Overall Study|Sponsor Decision|31|||
129710962|NCT03559270|466903198|FG002|Overall Study|Sponsor Decision|35|||
129710963|NCT03559270|466903199|FG003|Overall Study|Sponsor Decision|18|||
129710964|NCT03559270|466903196|FG000|Overall Study|Withdrawal by Subject|19|||
129710965|NCT03559270|466903197|FG001|Overall Study|Withdrawal by Subject|21|||
129710966|NCT03559270|466903198|FG002|Overall Study|Withdrawal by Subject|18|||
129710967|NCT03559270|466903199|FG003|Overall Study|Withdrawal by Subject|7|||
129710968|NCT03559270|466903196|FG000|Overall Study|Physician Decision|3|||
129710969|NCT03559270|466903197|FG001|Overall Study|Physician Decision|2|||
129710970|NCT03559270|466903198|FG002|Overall Study|Physician Decision|1|||
129710971|NCT03559270|466903199|FG003|Overall Study|Physician Decision|0|||
129710972|NCT03559270|466903196|FG000|Overall Study|Pregnancy|0|||
129710973|NCT03559270|466903197|FG001|Overall Study|Pregnancy|1|||
129710974|NCT03559270|466903198|FG002|Overall Study|Pregnancy|0|||
129710975|NCT03559270|466903199|FG003|Overall Study|Pregnancy|0|||
129710976|NCT03559270|466903196|FG000|Overall Study|Protocol Violation|1|||
129710977|NCT03559270|466903197|FG001|Overall Study|Protocol Violation|0|||
129710978|NCT03559270|466903198|FG002|Overall Study|Protocol Violation|2|||
129710979|NCT03559270|466903199|FG003|Overall Study|Protocol Violation|0|||
129710980|NCT04472650|466905399|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
129710981|NCT04472650|466905400|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
129710982|NCT01669902|466905405|FG000|Overall Study|Adverse Event|11|||
129710983|NCT01669902|466905405|FG000|Overall Study|Lack of Efficacy|10|||
129710984|NCT01669902|466905405|FG000|Overall Study|Other|8|||
129710985|NCT01535287|466905406|FG000|Overall Study|drug not prepared in time|5|||
129710986|NCT01535287|466905407|FG001|Overall Study|drug not prepared in time|6|||
129710987|NCT00551031|466905412|FG000|Overall Study|Adverse Event|0|||
129710988|NCT00551031|466905413|FG001|Overall Study|Adverse Event|1|||
129710989|NCT00551031|466905414|FG002|Overall Study|Adverse Event|0|||
129710990|NCT00551031|466905415|FG003|Overall Study|Adverse Event|0|||
129710991|NCT00551031|466905416|FG004|Overall Study|Adverse Event|0|||
129710992|NCT00551031|466905412|FG000|Overall Study|Protocol Violation|1|||
129710993|NCT00551031|466905413|FG001|Overall Study|Protocol Violation|1|||
129710994|NCT00551031|466905414|FG002|Overall Study|Protocol Violation|0|||
129710995|NCT00551031|466905415|FG003|Overall Study|Protocol Violation|0|||
129710996|NCT00551031|466905416|FG004|Overall Study|Protocol Violation|0|||
129710997|NCT00551031|466905412|FG000|Overall Study|Lost to Follow-up|0|||
129710998|NCT00551031|466905413|FG001|Overall Study|Lost to Follow-up|1|||
129710999|NCT00551031|466905414|FG002|Overall Study|Lost to Follow-up|0|||
129711000|NCT00551031|466905415|FG003|Overall Study|Lost to Follow-up|1|||
129711001|NCT00551031|466905416|FG004|Overall Study|Lost to Follow-up|1|||
129711002|NCT00551031|466905412|FG000|Overall Study|Withdrawal by Subject|0|||
129711003|NCT00551031|466905413|FG001|Overall Study|Withdrawal by Subject|4|||
129711004|NCT00551031|466905414|FG002|Overall Study|Withdrawal by Subject|1|||
129711005|NCT00551031|466905415|FG003|Overall Study|Withdrawal by Subject|2|||
129711006|NCT00551031|466905416|FG004|Overall Study|Withdrawal by Subject|0|||
129711007|NCT00551031|466905412|FG000|Overall Study|Serious Adverse Event|0|||
129711008|NCT00551031|466905413|FG001|Overall Study|Serious Adverse Event|2|||
129711009|NCT00551031|466905414|FG002|Overall Study|Serious Adverse Event|1|||
129711010|NCT00551031|466905415|FG003|Overall Study|Serious Adverse Event|0|||
129711011|NCT00551031|466905416|FG004|Overall Study|Serious Adverse Event|0|||
129711012|NCT00551031|466905412|FG000|Overall Study|Did not receive vaccine|1|||
129711013|NCT00551031|466905413|FG001|Overall Study|Did not receive vaccine|2|||
129711014|NCT00551031|466905414|FG002|Overall Study|Did not receive vaccine|0|||
129711015|NCT00551031|466905415|FG003|Overall Study|Did not receive vaccine|0|||
129711016|NCT00551031|466905416|FG004|Overall Study|Did not receive vaccine|0|||
129711017|NCT04567524|466905417|FG000|Overall Study|Adverse Event|1|||
129711018|NCT04567524|466905418|FG001|Overall Study|Adverse Event|1|||
129711019|NCT04567524|466905419|FG002|Overall Study|Adverse Event|0|||
129711020|NCT04567524|466905420|FG003|Overall Study|Adverse Event|0|||
129711021|NCT04567524|466905417|FG000|Overall Study|Withdrawal by Subject|2|||
129711022|NCT04567524|466905418|FG001|Overall Study|Withdrawal by Subject|0|||
129711023|NCT04567524|466905419|FG002|Overall Study|Withdrawal by Subject|0|||
129711024|NCT04567524|466905420|FG003|Overall Study|Withdrawal by Subject|1|||
129711025|NCT02078752|466905430|FG000|Overall Study|Death|0|||
129711026|NCT02078752|466905431|FG001|Overall Study|Death|3|||
129711027|NCT02078752|466905432|FG002|Overall Study|Death|0|||
129711028|NCT02078752|466905433|FG003|Overall Study|Death|0|||
129711029|NCT02078752|466905434|FG004|Overall Study|Death|0|||
129711030|NCT02078752|466905435|FG005|Overall Study|Death|1|||
129711031|NCT02078752|466905436|FG006|Overall Study|Death|0|||
129711032|NCT02078752|466905437|FG007|Overall Study|Death|1|||
129711033|NCT02078752|466905438|FG008|Overall Study|Death|0|||
129711034|NCT02078752|466905439|FG009|Overall Study|Death|4|||
129711035|NCT02078752|466905430|FG000|Overall Study|Lost to Follow-up|1|||
129711036|NCT02078752|466905431|FG001|Overall Study|Lost to Follow-up|0|||
129711037|NCT02078752|466905432|FG002|Overall Study|Lost to Follow-up|0|||
129711038|NCT02078752|466905433|FG003|Overall Study|Lost to Follow-up|1|||
129711039|NCT02078752|466905434|FG004|Overall Study|Lost to Follow-up|0|||
129711040|NCT02078752|466905435|FG005|Overall Study|Lost to Follow-up|0|||
129711041|NCT02078752|466905436|FG006|Overall Study|Lost to Follow-up|0|||
129711042|NCT02078752|466905437|FG007|Overall Study|Lost to Follow-up|0|||
129801226|NCT02598960|467241948|FG005|Treatment Period|Disease Progression|2|||
129801227|NCT02598960|467241949|FG006|Treatment Period|Disease Progression|2|||
129801228|NCT02598960|467241950|FG007|Treatment Period|Disease Progression|3|||
129801229|NCT02598960|467241951|FG008|Treatment Period|Disease Progression|7|||
129801230|NCT02598960|467241952|FG009|Treatment Period|Disease Progression|9|||
129801231|NCT02598960|467241953|FG010|Treatment Period|Disease Progression|7|||
129801232|NCT02598960|467241954|FG011|Treatment Period|Disease Progression|143|||
129801233|NCT02598960|467241955|FG012|Treatment Period|Disease Progression|23|||
129801234|NCT02598960|467241943|FG000|Treatment Period|Study drug toxicity|0|||
129801235|NCT02598960|467241944|FG001|Treatment Period|Study drug toxicity|0|||
129801236|NCT02598960|467241945|FG002|Treatment Period|Study drug toxicity|0|||
129801237|NCT02598960|467241946|FG003|Treatment Period|Study drug toxicity|0|||
129801238|NCT02598960|467241947|FG004|Treatment Period|Study drug toxicity|0|||
129801239|NCT02598960|467241948|FG005|Treatment Period|Study drug toxicity|0|||
129801240|NCT02598960|467241949|FG006|Treatment Period|Study drug toxicity|0|||
129801241|NCT02598960|467241950|FG007|Treatment Period|Study drug toxicity|0|||
129801242|NCT02598960|467241951|FG008|Treatment Period|Study drug toxicity|0|||
129801243|NCT02598960|467241952|FG009|Treatment Period|Study drug toxicity|1|||
129801244|NCT02598960|467241953|FG010|Treatment Period|Study drug toxicity|0|||
129801245|NCT02598960|467241954|FG011|Treatment Period|Study drug toxicity|3|||
129801246|NCT02598960|467241955|FG012|Treatment Period|Study drug toxicity|0|||
129801247|NCT02598960|467241943|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
129801248|NCT02598960|467241944|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
129801249|NCT02598960|467241945|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
129801250|NCT02598960|467241946|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
129801251|NCT02598960|467241947|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
129801252|NCT02598960|467241948|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
129801253|NCT02598960|467241949|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
129801254|NCT02598960|467241950|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
129801255|NCT02598960|467241951|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
129801256|NCT02598960|467241952|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
129801257|NCT02598960|467241953|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
129801258|NCT02598960|467241954|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
129801259|NCT02598960|467241955|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
129801260|NCT02598960|467241943|FG000|Treatment Period|participant request to discontinue|0|||
129801261|NCT02598960|467241944|FG001|Treatment Period|participant request to discontinue|1|||
129801262|NCT02598960|467241945|FG002|Treatment Period|participant request to discontinue|0|||
129801263|NCT02598960|467241946|FG003|Treatment Period|participant request to discontinue|0|||
129801264|NCT02598960|467241947|FG004|Treatment Period|participant request to discontinue|1|||
129801265|NCT02598960|467241948|FG005|Treatment Period|participant request to discontinue|0|||
129801266|NCT02598960|467241949|FG006|Treatment Period|participant request to discontinue|0|||
129801267|NCT02598960|467241950|FG007|Treatment Period|participant request to discontinue|0|||
129801268|NCT02598960|467241951|FG008|Treatment Period|participant request to discontinue|0|||
129801269|NCT02598960|467241952|FG009|Treatment Period|participant request to discontinue|0|||
129801270|NCT02598960|467241953|FG010|Treatment Period|participant request to discontinue|1|||
129801271|NCT02598960|467241954|FG011|Treatment Period|participant request to discontinue|4|||
129801272|NCT02598960|467241955|FG012|Treatment Period|participant request to discontinue|0|||
129801273|NCT02598960|467241943|FG000|Treatment Period|participant withdrew consent|0|||
129711043|NCT02078752|466905438|FG008|Overall Study|Lost to Follow-up|0|||
129711044|NCT02078752|466905439|FG009|Overall Study|Lost to Follow-up|0|||
129711045|NCT02078752|466905430|FG000|Overall Study|Withdrawal by Subject|1|||
129711046|NCT02078752|466905431|FG001|Overall Study|Withdrawal by Subject|1|||
129801274|NCT02598960|467241944|FG001|Treatment Period|participant withdrew consent|0|||
129801275|NCT02598960|467241945|FG002|Treatment Period|participant withdrew consent|0|||
129711047|NCT02078752|466905432|FG002|Overall Study|Withdrawal by Subject|1|||
129801276|NCT02598960|467241946|FG003|Treatment Period|participant withdrew consent|0|||
129711048|NCT02078752|466905433|FG003|Overall Study|Withdrawal by Subject|1|||
129711049|NCT02078752|466905434|FG004|Overall Study|Withdrawal by Subject|0|||
129711050|NCT02078752|466905435|FG005|Overall Study|Withdrawal by Subject|3|||
129801277|NCT02598960|467241947|FG004|Treatment Period|participant withdrew consent|0|||
129801278|NCT02598960|467241948|FG005|Treatment Period|participant withdrew consent|0|||
129711051|NCT02078752|466905436|FG006|Overall Study|Withdrawal by Subject|2|||
129711052|NCT02078752|466905437|FG007|Overall Study|Withdrawal by Subject|1|||
129711053|NCT02078752|466905438|FG008|Overall Study|Withdrawal by Subject|0|||
129711054|NCT02078752|466905439|FG009|Overall Study|Withdrawal by Subject|1|||
129711055|NCT02078752|466905430|FG000|Overall Study|Other|0|||
129711056|NCT02078752|466905431|FG001|Overall Study|Other|3|||
129711057|NCT02078752|466905432|FG002|Overall Study|Other|0|||
129711058|NCT02078752|466905433|FG003|Overall Study|Other|0|||
129711059|NCT02078752|466905434|FG004|Overall Study|Other|1|||
129711060|NCT02078752|466905435|FG005|Overall Study|Other|0|||
129711061|NCT02078752|466905436|FG006|Overall Study|Other|0|||
129711062|NCT02078752|466905437|FG007|Overall Study|Other|1|||
129711063|NCT02078752|466905438|FG008|Overall Study|Other|0|||
129711064|NCT02078752|466905439|FG009|Overall Study|Other|0|||
129711065|NCT02078752|466905430|FG000|Overall Study|Study terminated by sponsor|0|||
129711066|NCT02078752|466905431|FG001|Overall Study|Study terminated by sponsor|0|||
129711067|NCT02078752|466905432|FG002|Overall Study|Study terminated by sponsor|0|||
129711068|NCT02078752|466905433|FG003|Overall Study|Study terminated by sponsor|0|||
129711069|NCT02078752|466905434|FG004|Overall Study|Study terminated by sponsor|0|||
129711070|NCT02078752|466905435|FG005|Overall Study|Study terminated by sponsor|0|||
129711071|NCT02078752|466905436|FG006|Overall Study|Study terminated by sponsor|0|||
129711072|NCT02078752|466905437|FG007|Overall Study|Study terminated by sponsor|0|||
129711073|NCT02078752|466905438|FG008|Overall Study|Study terminated by sponsor|0|||
129711074|NCT02078752|466905439|FG009|Overall Study|Study terminated by sponsor|5|||
129711075|NCT00616642|466905445|FG000|Overall Study|Withdrawal by Subject|0|||
129711076|NCT00616642|466905446|FG001|Overall Study|Withdrawal by Subject|1|||
129711077|NCT01023217|466905455|FG000|Overall Study|Withdrawal by Subject|1|||
129711078|NCT01023217|466905456|FG001|Overall Study|Withdrawal by Subject|0|||
129711079|NCT00589797|466905457|FG000|Overall Study|Death|1|||
129711080|NCT00589797|466905458|FG001|Overall Study|Death|0|||
129711081|NCT00589797|466905457|FG000|Overall Study|Lost to Follow-up|12|||
129711082|NCT00589797|466905458|FG001|Overall Study|Lost to Follow-up|9|||
129711083|NCT00589797|466905457|FG000|Overall Study|Physician Decision|8|||
129711084|NCT00589797|466905458|FG001|Overall Study|Physician Decision|3|||
129711085|NCT00589797|466905457|FG000|Overall Study|Withdrawal by Subject|6|||
129711086|NCT00589797|466905458|FG001|Overall Study|Withdrawal by Subject|5|||
129711087|NCT00589797|466905457|FG000|Overall Study|Non-Randomized Training Subjects|46|||
129711088|NCT00589797|466905458|FG001|Overall Study|Non-Randomized Training Subjects|6|||
129711089|NCT01881009|466905459|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
129711090|NCT01881009|466905460|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
129711091|NCT02457247|466905461|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
129711092|NCT02457247|466905462|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
129711093|NCT02457247|466905463|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
129711094|NCT02457247|466905464|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
129711095|NCT02457247|466905461|FG000|Period 1|Significant Protocol Deviation|1|||
129711096|NCT02457247|466905462|FG001|Period 1|Significant Protocol Deviation|1|||
129711097|NCT02457247|466905463|FG002|Period 1|Significant Protocol Deviation|0|||
129711098|NCT02457247|466905464|FG003|Period 1|Significant Protocol Deviation|0|||
129711099|NCT02457247|466905461|FG000|Period 1|Voluntary Withdrawal|1|||
129711100|NCT02457247|466905462|FG001|Period 1|Voluntary Withdrawal|0|||
129711101|NCT02457247|466905463|FG002|Period 1|Voluntary Withdrawal|0|||
129711102|NCT02457247|466905464|FG003|Period 1|Voluntary Withdrawal|0|||
129711103|NCT02457247|466905461|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
129711104|NCT02457247|466905462|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
129711105|NCT02457247|466905463|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
129711106|NCT02457247|466905464|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
129711107|NCT02457247|466905461|FG000|Period 2|Significant Protocol Deviation|1|||
129711108|NCT02457247|466905462|FG001|Period 2|Significant Protocol Deviation|0|||
129711109|NCT02457247|466905463|FG002|Period 2|Significant Protocol Deviation|0|||
129711110|NCT02457247|466905464|FG003|Period 2|Significant Protocol Deviation|0|||
129711111|NCT02457247|466905461|FG000|Period 2|Lost to Follow-up|0|||
129711112|NCT02457247|466905462|FG001|Period 2|Lost to Follow-up|1|||
129711113|NCT02457247|466905463|FG002|Period 2|Lost to Follow-up|0|||
129711114|NCT02457247|466905464|FG003|Period 2|Lost to Follow-up|0|||
129711115|NCT02457247|466905461|FG000|Period 2|Voluntary Withdrawal|1|||
129711116|NCT02457247|466905462|FG001|Period 2|Voluntary Withdrawal|1|||
129711117|NCT02457247|466905463|FG002|Period 2|Voluntary Withdrawal|0|||
129711118|NCT02457247|466905464|FG003|Period 2|Voluntary Withdrawal|0|||
129711119|NCT01061385|466905465|FG000|Overall Study|Lost to Follow-up|1|||
129711120|NCT01061385|466905466|FG001|Overall Study|Lost to Follow-up|0|||
129711121|NCT01061385|466905465|FG000|Overall Study|subject decision not related to AE|0|||
129711122|NCT01061385|466905466|FG001|Overall Study|subject decision not related to AE|1|||
129711123|NCT01492088|466905467|FG000|Overall Study|Withdrawal by Patient|0|||
129711124|NCT01492088|466905468|FG001|Overall Study|Withdrawal by Patient|2|||
129711125|NCT01492088|466905469|FG002|Overall Study|Withdrawal by Patient|0|||
129711126|NCT01492088|466905467|FG000|Overall Study|Death|1|||
129711127|NCT01492088|466905468|FG001|Overall Study|Death|6|||
129711128|NCT01492088|466905469|FG002|Overall Study|Death|2|||
129711129|NCT01492088|466905467|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
129711130|NCT01492088|466905468|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
129711131|NCT01492088|466905469|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
129711132|NCT01492088|466905467|FG000|Overall Study|Alive at Last Follow-up|0|||
129711133|NCT01492088|466905468|FG001|Overall Study|Alive at Last Follow-up|6|||
129711134|NCT01492088|466905469|FG002|Overall Study|Alive at Last Follow-up|11|||
129711135|NCT00533429|466905470|FG000|Overall Study|Adverse Event|3|||
129711136|NCT00533429|466905471|FG001|Overall Study|Adverse Event|1|||
129711137|NCT00533429|466905470|FG000|Overall Study|Death|1|||
129711138|NCT00533429|466905471|FG001|Overall Study|Death|0|||
129711139|NCT00533429|466905470|FG000|Overall Study|Withdrawal by Subject|2|||
129711140|NCT00533429|466905471|FG001|Overall Study|Withdrawal by Subject|0|||
129711141|NCT00533429|466905470|FG000|Overall Study|Progressive Disease|12|||
129711142|NCT00533429|466905471|FG001|Overall Study|Progressive Disease|13|||
129711143|NCT00533429|466905470|FG000|Overall Study|Symptomatic deterioration|1|||
129711144|NCT00533429|466905471|FG001|Overall Study|Symptomatic deterioration|2|||
129711145|NCT01464879|466905472|FG000|Overall Study|Physician Decision|1|||
129711146|NCT01464879|466905472|FG000|Overall Study|Non-compliance|1|||
129711147|NCT02230189|466905479|FG000|Overall Study|Withdrawal by Subject|3|||
129711148|NCT02230189|466905480|FG001|Overall Study|Withdrawal by Subject|0|||
129711149|NCT02230189|466905481|FG002|Overall Study|Withdrawal by Subject|1|||
129711150|NCT02230189|466905479|FG000|Overall Study|Lost to Follow-up|1|||
129711151|NCT02230189|466905480|FG001|Overall Study|Lost to Follow-up|0|||
129711152|NCT02230189|466905481|FG002|Overall Study|Lost to Follow-up|0|||
129711153|NCT02230189|466905479|FG000|Overall Study|Physician Decision|1|||
129711154|NCT02230189|466905480|FG001|Overall Study|Physician Decision|0|||
129711155|NCT02230189|466905481|FG002|Overall Study|Physician Decision|0|||
129711156|NCT03824392|466905482|FG000|Overall Study|Adverse Event|1|||
129711157|NCT03824392|466905483|FG001|Overall Study|Adverse Event|0|||
129711158|NCT03824392|466905484|FG002|Overall Study|Adverse Event|0|||
129711159|NCT03824392|466905485|FG003|Overall Study|Adverse Event|0|||
129711160|NCT03824392|466905482|FG000|Overall Study|Investigator Decision|0|||
129711161|NCT03824392|466905483|FG001|Overall Study|Investigator Decision|1|||
129711162|NCT03824392|466905484|FG002|Overall Study|Investigator Decision|0|||
129711163|NCT03824392|466905485|FG003|Overall Study|Investigator Decision|0|||
129711164|NCT03824392|466905482|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
129711165|NCT03824392|466905483|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
129711166|NCT03824392|466905484|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
129711167|NCT03824392|466905485|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
129711168|NCT01887717|466905486|FG000|Overall Study|Withdrawal by Subject|1|||
129711169|NCT01887717|466905487|FG001|Overall Study|Withdrawal by Subject|7|||
129711170|NCT01887717|466905486|FG000|Overall Study|Physician Decision|0|||
129711171|NCT01887717|466905487|FG001|Overall Study|Physician Decision|2|||
129711172|NCT01887717|466905486|FG000|Overall Study|Administrative reasons|5|||
129711173|NCT01887717|466905487|FG001|Overall Study|Administrative reasons|2|||
129711174|NCT00244621|466905488|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129711175|NCT00244621|466905489|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129711176|NCT00244621|466905490|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129711177|NCT00244621|466905488|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129711178|NCT00244621|466905489|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129711179|NCT00244621|466905490|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129711180|NCT00244621|466905488|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129711181|NCT00244621|466905489|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
129711182|NCT00244621|466905490|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129711183|NCT00244621|466905488|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
129711184|NCT00244621|466905489|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
129711185|NCT00244621|466905490|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
129711186|NCT00244621|466905488|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129711187|NCT00244621|466905489|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
129711188|NCT00244621|466905490|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129711189|NCT00244621|466905488|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
129711190|NCT00244621|466905489|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129711191|NCT00244621|466905490|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129711192|NCT00244621|466905488|FG000|Open-label Treatment Period|Adverse Event|0|||
129711193|NCT00244621|466905489|FG001|Open-label Treatment Period|Adverse Event|0|||
129711194|NCT00244621|466905490|FG002|Open-label Treatment Period|Adverse Event|1|||
129711195|NCT00244621|466905488|FG000|Open-label Treatment Period|Moved abroad|0|||
129711196|NCT00244621|466905489|FG001|Open-label Treatment Period|Moved abroad|0|||
129711197|NCT00244621|466905490|FG002|Open-label Treatment Period|Moved abroad|1|||
129711198|NCT02834819|466905491|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
129711199|NCT02834819|466905492|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
129711200|NCT04389866|466905494|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
129711201|NCT04389866|466905495|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
129711202|NCT01490918|466905499|FG000|Overall Study|Lost to Follow-up|2|||
129711203|NCT01490918|466905500|FG001|Overall Study|Lost to Follow-up|1|||
129711204|NCT01490918|466905501|FG002|Overall Study|Lost to Follow-up|0|||
129711205|NCT01490918|466905499|FG000|Overall Study|Withdrawal by Subject|7|||
129711206|NCT01490918|466905500|FG001|Overall Study|Withdrawal by Subject|8|||
129711207|NCT01490918|466905501|FG002|Overall Study|Withdrawal by Subject|3|||
129711208|NCT01490918|466905499|FG000|Overall Study|Adverse Event|0|||
129711209|NCT01490918|466905500|FG001|Overall Study|Adverse Event|0|||
129711210|NCT01490918|466905501|FG002|Overall Study|Adverse Event|1|||
129711211|NCT01490918|466905499|FG000|Overall Study|other cause|4|||
129711212|NCT01490918|466905500|FG001|Overall Study|other cause|5|||
129711213|NCT01490918|466905501|FG002|Overall Study|other cause|8|||
129711214|NCT02967679|466905502|FG000|Overall Study|Adverse Event|1|||
129711215|NCT00600067|466905505|FG000|Overall Study|Adverse Event|0|||
129711216|NCT00600067|466905506|FG001|Overall Study|Adverse Event|1|||
129711217|NCT00600067|466905505|FG000|Overall Study|Lost to Follow-up|2|||
129711218|NCT00600067|466905506|FG001|Overall Study|Lost to Follow-up|3|||
129711219|NCT00600067|466905505|FG000|Overall Study|protocol non-compliance|0|||
129711220|NCT00600067|466905506|FG001|Overall Study|protocol non-compliance|3|||
129711221|NCT00600067|466905505|FG000|Overall Study|Lack of Efficacy|1|||
129711222|NCT00600067|466905506|FG001|Overall Study|Lack of Efficacy|0|||
129711223|NCT00003631|466905507|FG000|Overall Study|Patient not treated|1|||
129711224|NCT00003631|466905508|FG001|Overall Study|Patient not treated|0|||
129711225|NCT00003631|466905509|FG002|Overall Study|Patient not treated|1|||
129711226|NCT00003631|466905507|FG000|Overall Study|Protocol Violation|1|||
129711227|NCT00003631|466905508|FG001|Overall Study|Protocol Violation|0|||
129711228|NCT00003631|466905509|FG002|Overall Study|Protocol Violation|0|||
129711229|NCT00003631|466905507|FG000|Overall Study|Adverse Event|1|||
129711230|NCT00003631|466905508|FG001|Overall Study|Adverse Event|1|||
129711231|NCT00003631|466905509|FG002|Overall Study|Adverse Event|5|||
129711232|NCT00003631|466905507|FG000|Overall Study|Death|0|||
129711233|NCT00003631|466905508|FG001|Overall Study|Death|0|||
129711234|NCT00003631|466905509|FG002|Overall Study|Death|1|||
129711235|NCT00003631|466905507|FG000|Overall Study|Evaluable for toxicity only|0|||
129711236|NCT00003631|466905508|FG001|Overall Study|Evaluable for toxicity only|0|||
129711237|NCT00003631|466905509|FG002|Overall Study|Evaluable for toxicity only|2|||
129711238|NCT04339413|466905510|FG000|Overall Study|Reason Not Specified|2|||
129711239|NCT04339413|466905511|FG001|Overall Study|Reason Not Specified|7|||
129711240|NCT04339413|466905510|FG000|Overall Study|Study Terminated by Sponsor|30|||
129711241|NCT04339413|466905511|FG001|Overall Study|Study Terminated by Sponsor|33|||
129711242|NCT04339413|466905510|FG000|Overall Study|Progressive Disease|9|||
129711243|NCT04339413|466905511|FG001|Overall Study|Progressive Disease|6|||
129711244|NCT04339413|466905510|FG000|Overall Study|Withdrawal by Subject|9|||
129711245|NCT04339413|466905511|FG001|Overall Study|Withdrawal by Subject|10|||
129711246|NCT04339413|466905510|FG000|Overall Study|Physician Decision|3|||
129711247|NCT04339413|466905511|FG001|Overall Study|Physician Decision|1|||
129711248|NCT04339413|466905510|FG000|Overall Study|Death|2|||
129711249|NCT04339413|466905511|FG001|Overall Study|Death|0|||
129711250|NCT04339413|466905510|FG000|Overall Study|Adverse Event|3|||
129711251|NCT04339413|466905511|FG001|Overall Study|Adverse Event|0|||
129711252|NCT00251693|466905517|FG000|Overall Study|Adverse Event|17|||
129711253|NCT00251693|466905518|FG001|Overall Study|Adverse Event|9|||
129801279|NCT02598960|467241949|FG006|Treatment Period|participant withdrew consent|0|||
129801280|NCT02598960|467241950|FG007|Treatment Period|participant withdrew consent|0|||
129801281|NCT02598960|467241951|FG008|Treatment Period|participant withdrew consent|0|||
129801282|NCT02598960|467241952|FG009|Treatment Period|participant withdrew consent|0|||
129801283|NCT02598960|467241953|FG010|Treatment Period|participant withdrew consent|0|||
129801284|NCT02598960|467241954|FG011|Treatment Period|participant withdrew consent|3|||
129801285|NCT02598960|467241955|FG012|Treatment Period|participant withdrew consent|0|||
129711254|NCT00251693|466905519|FG002|Overall Study|Adverse Event|9|||
129711255|NCT00251693|466905517|FG000|Overall Study|Protocol Violation|2|||
129711256|NCT00251693|466905518|FG001|Overall Study|Protocol Violation|0|||
129711257|NCT00251693|466905519|FG002|Overall Study|Protocol Violation|2|||
129711258|NCT00251693|466905517|FG000|Overall Study|Lost to Follow-up|12|||
129711259|NCT00251693|466905518|FG001|Overall Study|Lost to Follow-up|7|||
129711260|NCT00251693|466905519|FG002|Overall Study|Lost to Follow-up|8|||
129711261|NCT00251693|466905517|FG000|Overall Study|Withdrawal by Subject|11|||
129711262|NCT00251693|466905518|FG001|Overall Study|Withdrawal by Subject|17|||
129711263|NCT00251693|466905519|FG002|Overall Study|Withdrawal by Subject|14|||
129711264|NCT00251693|466905517|FG000|Overall Study|Lack of Efficacy|0|||
129711265|NCT00251693|466905518|FG001|Overall Study|Lack of Efficacy|1|||
129801286|NCT02598960|467241943|FG000|Treatment Period|No longer meets study criteria|0|||
129711266|NCT00251693|466905519|FG002|Overall Study|Lack of Efficacy|0|||
129711267|NCT00251693|466905517|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
129711268|NCT00251693|466905518|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
129711269|NCT00251693|466905519|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
129711270|NCT00251693|466905517|FG000|Overall Study|Noncompliant|0|||
129801287|NCT02598960|467241944|FG001|Treatment Period|No longer meets study criteria|0|||
129801288|NCT02598960|467241945|FG002|Treatment Period|No longer meets study criteria|0|||
129801289|NCT02598960|467241946|FG003|Treatment Period|No longer meets study criteria|0|||
129801290|NCT02598960|467241947|FG004|Treatment Period|No longer meets study criteria|0|||
129801291|NCT02598960|467241948|FG005|Treatment Period|No longer meets study criteria|0|||
129801292|NCT02598960|467241949|FG006|Treatment Period|No longer meets study criteria|0|||
129801293|NCT02598960|467241950|FG007|Treatment Period|No longer meets study criteria|0|||
129801294|NCT02598960|467241951|FG008|Treatment Period|No longer meets study criteria|0|||
129801295|NCT02598960|467241952|FG009|Treatment Period|No longer meets study criteria|0|||
129801296|NCT02598960|467241953|FG010|Treatment Period|No longer meets study criteria|0|||
129801297|NCT02598960|467241954|FG011|Treatment Period|No longer meets study criteria|1|||
129801298|NCT02598960|467241955|FG012|Treatment Period|No longer meets study criteria|0|||
129801299|NCT02598960|467241943|FG000|Treatment Period|Other Reasons|0|||
129801300|NCT02598960|467241944|FG001|Treatment Period|Other Reasons|0|||
129801301|NCT02598960|467241945|FG002|Treatment Period|Other Reasons|0|||
129801302|NCT02598960|467241946|FG003|Treatment Period|Other Reasons|0|||
129801303|NCT02598960|467241947|FG004|Treatment Period|Other Reasons|0|||
129801304|NCT02598960|467241948|FG005|Treatment Period|Other Reasons|0|||
129801305|NCT02598960|467241949|FG006|Treatment Period|Other Reasons|0|||
129801306|NCT02598960|467241950|FG007|Treatment Period|Other Reasons|0|||
129711271|NCT00251693|466905518|FG001|Overall Study|Noncompliant|0|||
129711272|NCT00251693|466905519|FG002|Overall Study|Noncompliant|2|||
129711273|NCT00251693|466905517|FG000|Overall Study|Possible Barrett's esophagus|3|||
129711274|NCT00251693|466905518|FG001|Overall Study|Possible Barrett's esophagus|5|||
129711275|NCT00251693|466905519|FG002|Overall Study|Possible Barrett's esophagus|2|||
129711276|NCT00251693|466905517|FG000|Overall Study|Subject request/subject unavailable|1|||
129711277|NCT00251693|466905518|FG001|Overall Study|Subject request/subject unavailable|2|||
129711278|NCT00251693|466905519|FG002|Overall Study|Subject request/subject unavailable|0|||
129711279|NCT00251693|466905517|FG000|Overall Study|Abnormal laboratory findings|0|||
129711280|NCT00251693|466905518|FG001|Overall Study|Abnormal laboratory findings|0|||
129711281|NCT00251693|466905519|FG002|Overall Study|Abnormal laboratory findings|1|||
129711282|NCT00401843|466905520|FG000|Overall Study|Achieved Complete Response|1|||
129711283|NCT00401843|466905521|FG001|Overall Study|Achieved Complete Response|5|||
129711284|NCT00401843|466905522|FG002|Overall Study|Achieved Complete Response|11|||
129711285|NCT00401843|466905520|FG000|Overall Study|Adverse Event|7|||
129711286|NCT00401843|466905521|FG001|Overall Study|Adverse Event|26|||
129711287|NCT00401843|466905522|FG002|Overall Study|Adverse Event|27|||
129711288|NCT00401843|466905520|FG000|Overall Study|Death|0|||
129711289|NCT00401843|466905521|FG001|Overall Study|Death|8|||
129711290|NCT00401843|466905522|FG002|Overall Study|Death|10|||
129711291|NCT00401843|466905520|FG000|Overall Study|Disease progression|10|||
129711292|NCT00401843|466905521|FG001|Overall Study|Disease progression|60|||
129711293|NCT00401843|466905522|FG002|Overall Study|Disease progression|49|||
129711294|NCT00401843|466905520|FG000|Overall Study|End of Study|1|||
129711295|NCT00401843|466905521|FG001|Overall Study|End of Study|1|||
129711296|NCT00401843|466905522|FG002|Overall Study|End of Study|2|||
129711297|NCT00401843|466905520|FG000|Overall Study|Lost to Follow-up|0|||
129711298|NCT00401843|466905521|FG001|Overall Study|Lost to Follow-up|0|||
129711299|NCT00401843|466905522|FG002|Overall Study|Lost to Follow-up|2|||
129711300|NCT00401843|466905520|FG000|Overall Study|Other Unspecified|0|||
129711301|NCT00401843|466905521|FG001|Overall Study|Other Unspecified|3|||
129711302|NCT00401843|466905522|FG002|Overall Study|Other Unspecified|5|||
129711303|NCT00401843|466905520|FG000|Overall Study|Physician Decision|0|||
129711304|NCT00401843|466905521|FG001|Overall Study|Physician Decision|16|||
129711305|NCT00401843|466905522|FG002|Overall Study|Physician Decision|10|||
129711306|NCT00401843|466905520|FG000|Overall Study|Protocol Violation|0|||
129711307|NCT00401843|466905521|FG001|Overall Study|Protocol Violation|0|||
129711308|NCT00401843|466905522|FG002|Overall Study|Protocol Violation|1|||
129711309|NCT00401843|466905520|FG000|Overall Study|Withdrawal by Subject|1|||
129711310|NCT00401843|466905521|FG001|Overall Study|Withdrawal by Subject|5|||
129711311|NCT00401843|466905522|FG002|Overall Study|Withdrawal by Subject|5|||
129711312|NCT00401843|466905520|FG000|Overall Study|Withdrawal of consent to study agent|1|||
129711313|NCT00401843|466905521|FG001|Overall Study|Withdrawal of consent to study agent|15|||
129711314|NCT00401843|466905522|FG002|Overall Study|Withdrawal of consent to study agent|17|||
129801307|NCT02598960|467241951|FG008|Treatment Period|Other Reasons|0|||
129801308|NCT02598960|467241952|FG009|Treatment Period|Other Reasons|0|||
129801309|NCT02598960|467241953|FG010|Treatment Period|Other Reasons|0|||
129801310|NCT02598960|467241954|FG011|Treatment Period|Other Reasons|0|||
129801311|NCT02598960|467241955|FG012|Treatment Period|Other Reasons|1|||
129801312|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|Death|1|||
129801313|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|Death|0|||
129801314|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|Death|0|||
129711315|NCT00401843|466905520|FG000|Overall Study|Randomized but not Treated|0|||
129711316|NCT00401843|466905521|FG001|Overall Study|Randomized but not Treated|2|||
129801315|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|Death|0|||
129801316|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|Death|0|||
129801317|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|Death|0|||
129801318|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|Death|0|||
129801319|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|Death|0|||
129801320|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|Death|0|||
129801321|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|Death|1|||
129801322|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|Death|0|||
129801323|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|Death|11|||
129801324|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|Death|2|||
129801325|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801326|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801327|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801328|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801329|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801330|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801331|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801332|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801333|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801334|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801335|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801336|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
129801337|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
129801338|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
129801339|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
129801340|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
129801341|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
129801342|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
129801343|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
129801344|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
129801345|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
129801346|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
129801347|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
129801348|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
129801349|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
129801350|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
129801351|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801352|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801353|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801354|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801355|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801356|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801357|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801358|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801359|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801360|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801361|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801362|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
129801363|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
129801364|NCT02598960|467241943|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
129801365|NCT02598960|467241944|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
129801366|NCT02598960|467241945|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
129801367|NCT02598960|467241946|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
129801368|NCT02598960|467241947|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
129801369|NCT02598960|467241948|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
129801370|NCT02598960|467241949|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
129801371|NCT02598960|467241950|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
129711317|NCT00401843|466905522|FG002|Overall Study|Randomized but not Treated|3|||
129711318|NCT00401843|466905520|FG000|Overall Study|Received incorrect treatment|0|||
129711319|NCT00401843|466905521|FG001|Overall Study|Received incorrect treatment|3|||
129711320|NCT00401843|466905522|FG002|Overall Study|Received incorrect treatment|0|||
129711321|NCT01508910|466905525|FG000|Treatment|Death|2|||
129711322|NCT01508910|466905526|FG001|Treatment|Death|3|||
129711323|NCT01508910|466905527|FG002|Treatment|Death|2|||
129711324|NCT01508910|466905528|FG003|Treatment|Death|0|||
129711325|NCT01508910|466905525|FG000|Treatment|Lost to Follow-up|0|||
129711326|NCT01508910|466905526|FG001|Treatment|Lost to Follow-up|0|||
129711327|NCT01508910|466905527|FG002|Treatment|Lost to Follow-up|2|||
129711328|NCT01508910|466905528|FG003|Treatment|Lost to Follow-up|1|||
129711329|NCT01508910|466905525|FG000|Treatment|Withdrawal by Subject|0|||
129711330|NCT01508910|466905526|FG001|Treatment|Withdrawal by Subject|1|||
129711331|NCT01508910|466905527|FG002|Treatment|Withdrawal by Subject|6|||
129711332|NCT01508910|466905528|FG003|Treatment|Withdrawal by Subject|1|||
129711333|NCT01508910|466905525|FG000|Treatment|Sponsor Decision|0|||
129711334|NCT01508910|466905526|FG001|Treatment|Sponsor Decision|0|||
129711335|NCT01508910|466905527|FG002|Treatment|Sponsor Decision|0|||
129711336|NCT01508910|466905528|FG003|Treatment|Sponsor Decision|1|||
129711337|NCT02030821|466905532|FG000|Overall Study|Physician Decision|2|||
129711338|NCT02030821|466905533|FG001|Overall Study|Physician Decision|2|||
129711339|NCT02030821|466905534|FG002|Overall Study|Physician Decision|5|||
129711340|NCT02030821|466905535|FG003|Overall Study|Physician Decision|2|||
129711341|NCT03192137|466905536|FG000|Overall Study|Adverse Event|10|||
129711342|NCT03192137|466905537|FG001|Overall Study|Adverse Event|11|||
129711343|NCT03192137|466905536|FG000|Overall Study|Physician Decision|1|||
129711344|NCT03192137|466905537|FG001|Overall Study|Physician Decision|0|||
129711345|NCT03192137|466905536|FG000|Overall Study|Lack of Efficacy|20|||
129711346|NCT03192137|466905537|FG001|Overall Study|Lack of Efficacy|37|||
129711347|NCT03192137|466905536|FG000|Overall Study|Withdrawal by Subject|3|||
129711348|NCT03192137|466905537|FG001|Overall Study|Withdrawal by Subject|3|||
129711349|NCT03192137|466905536|FG000|Overall Study|Protocol Violation|4|||
129711350|NCT03192137|466905537|FG001|Overall Study|Protocol Violation|3|||
129711351|NCT03192137|466905536|FG000|Overall Study|Surgery Cancelled|4|||
129711352|NCT03192137|466905537|FG001|Overall Study|Surgery Cancelled|1|||
129711353|NCT03192137|466905536|FG000|Overall Study|Other - Various Administrative Reasons|8|||
129711354|NCT03192137|466905537|FG001|Overall Study|Other - Various Administrative Reasons|3|||
129711355|NCT00657267|466905540|FG000|Overall Study|Progressive disease|45|||
129711356|NCT00657267|466905540|FG000|Overall Study|Adverse Event|9|||
129711357|NCT02737501|466905544|FG000|Randomized Phase|Died|41|||
129711358|NCT02737501|466905545|FG001|Randomized Phase|Died|29|||
129711359|NCT02737501|466905546|FG002|Randomized Phase|Died|0|||
129711360|NCT02737501|466905544|FG000|Randomized Phase|Withdrawal by Subject|16|||
129711361|NCT02737501|466905545|FG001|Randomized Phase|Withdrawal by Subject|6|||
129711362|NCT02737501|466905546|FG002|Randomized Phase|Withdrawal by Subject|0|||
129711363|NCT02737501|466905544|FG000|Randomized Phase|Lost to Follow-up|0|||
129711364|NCT02737501|466905545|FG001|Randomized Phase|Lost to Follow-up|1|||
129711365|NCT02737501|466905546|FG002|Randomized Phase|Lost to Follow-up|0|||
129711366|NCT02737501|466905544|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
129711367|NCT02737501|466905545|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
129711368|NCT02737501|466905546|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
129711369|NCT02737501|466905544|FG000|Randomized Phase|Reason not Specified|1|||
129711370|NCT02737501|466905545|FG001|Randomized Phase|Reason not Specified|1|||
129711371|NCT02737501|466905546|FG002|Randomized Phase|Reason not Specified|0|||
129711372|NCT02737501|466905544|FG000|Randomized Phase|Never Treated|1|||
129711373|NCT02737501|466905545|FG001|Randomized Phase|Never Treated|1|||
129711374|NCT02737501|466905546|FG002|Randomized Phase|Never Treated|0|||
129711375|NCT02737501|466905544|FG000|Crossover Phase|Died|0|||
129711376|NCT02737501|466905545|FG001|Crossover Phase|Died|0|||
129711377|NCT02737501|466905546|FG002|Crossover Phase|Died|22|||
129711378|NCT02737501|466905544|FG000|Crossover Phase|Withdrew Consent|0|||
129711379|NCT02737501|466905545|FG001|Crossover Phase|Withdrew Consent|0|||
129711380|NCT02737501|466905546|FG002|Crossover Phase|Withdrew Consent|9|||
129711381|NCT02737501|466905544|FG000|Crossover Phase|Physician Decision|0|||
129801372|NCT02598960|467241951|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
129801373|NCT02598960|467241952|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
129711382|NCT02737501|466905545|FG001|Crossover Phase|Physician Decision|0|||
129801374|NCT02598960|467241953|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
129711383|NCT02737501|466905546|FG002|Crossover Phase|Physician Decision|1|||
129711384|NCT02737501|466905544|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
129711385|NCT02737501|466905545|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
129711386|NCT02737501|466905546|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
129801375|NCT02598960|467241954|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
129711387|NCT01261975|466905547|FG000|Overall Study|Surgical complication|1|||
129711388|NCT00716274|466905548|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
129711389|NCT00716274|466905549|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129801376|NCT02598960|467241955|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
129801377|NCT03265665|467241960|FG000|24-week Data Collection|Withdrawal by Subject|2|||
129801378|NCT03265665|467241961|FG001|24-week Data Collection|Withdrawal by Subject|2|||
129801379|NCT03265665|467241960|FG000|24-week Data Collection|Lost to Follow-up|4|||
129801380|NCT03265665|467241961|FG001|24-week Data Collection|Lost to Follow-up|5|||
129801381|NCT03265665|467241960|FG000|36-week Data Collection|Lost to Follow-up|6|||
129801382|NCT03265665|467241961|FG001|36-week Data Collection|Lost to Follow-up|8|||
129801383|NCT01193660|467241962|FG000|Overall Study|Withdrawal by Subject|2|||
129801384|NCT01193660|467241963|FG001|Overall Study|Withdrawal by Subject|3|||
129801385|NCT01193660|467241964|FG002|Overall Study|Withdrawal by Subject|1|||
129801386|NCT01193660|467241962|FG000|Overall Study|Death|1|||
129801387|NCT01193660|467241963|FG001|Overall Study|Death|0|||
129801388|NCT01193660|467241964|FG002|Overall Study|Death|0|||
129801389|NCT01193660|467241962|FG000|Overall Study|Physician Decision|1|||
129801390|NCT01193660|467241963|FG001|Overall Study|Physician Decision|0|||
129801391|NCT01193660|467241964|FG002|Overall Study|Physician Decision|1|||
129801392|NCT00195273|467241965|FG000|Overall Study|Adverse Event|9|||
129801393|NCT00195273|467241966|FG001|Overall Study|Adverse Event|9|||
129801394|NCT00195273|467241965|FG000|Overall Study|Protocol deviation|0|||
129801395|NCT00195273|467241966|FG001|Overall Study|Protocol deviation|1|||
129801396|NCT00195273|467241965|FG000|Overall Study|Lack of Efficacy|3|||
129801397|NCT00195273|467241966|FG001|Overall Study|Lack of Efficacy|1|||
129801398|NCT00195273|467241965|FG000|Overall Study|Procedural complications|9|||
129801399|NCT00195273|467241966|FG001|Overall Study|Procedural complications|3|||
129801400|NCT00595465|467241967|FG000|Overall Study|Adverse Event|4|||
129801401|NCT00595465|467241968|FG001|Overall Study|Adverse Event|3|||
129801402|NCT00595465|467241969|FG002|Overall Study|Adverse Event|3|||
129801403|NCT00595465|467241967|FG000|Overall Study|Pregnancy|0|||
129801404|NCT00595465|467241968|FG001|Overall Study|Pregnancy|0|||
129801405|NCT00595465|467241969|FG002|Overall Study|Pregnancy|1|||
129801406|NCT00595465|467241967|FG000|Overall Study|Protocol Violation|2|||
129801407|NCT00595465|467241968|FG001|Overall Study|Protocol Violation|1|||
129801408|NCT00595465|467241969|FG002|Overall Study|Protocol Violation|0|||
129801409|NCT00595465|467241967|FG000|Overall Study|Lost to Follow-up|0|||
129801410|NCT00595465|467241968|FG001|Overall Study|Lost to Follow-up|0|||
129801411|NCT00595465|467241969|FG002|Overall Study|Lost to Follow-up|2|||
129801412|NCT00595465|467241967|FG000|Overall Study|administrative reason|0|||
129801413|NCT00595465|467241968|FG001|Overall Study|administrative reason|0|||
129801414|NCT00595465|467241969|FG002|Overall Study|administrative reason|1|||
129801415|NCT02595970|467241970|FG000|Overall Study|Withdrawal by Subject|2|||
129801416|NCT02595970|467241970|FG000|Overall Study|Physician Decision|2|||
129801417|NCT02595970|467241970|FG000|Overall Study|Protocol Violation|4|||
129801418|NCT02595970|467241970|FG000|Overall Study|Adverse Event|5|||
129801419|NCT02595970|467241970|FG000|Overall Study|Lack of Efficacy|7|||
129711390|NCT00716274|466905550|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129711391|NCT00716274|466905551|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129711392|NCT00716274|466905552|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129711393|NCT00716274|466905553|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
129711394|NCT00716274|466905548|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
129711395|NCT00716274|466905549|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
129711396|NCT00716274|466905550|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
129711397|NCT00716274|466905551|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
129711398|NCT00716274|466905552|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
129711399|NCT00716274|466905553|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
129711400|NCT00716274|466905548|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
129711401|NCT00716274|466905549|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129711402|NCT00716274|466905550|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129711403|NCT00716274|466905551|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129711404|NCT00716274|466905552|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129711405|NCT00716274|466905553|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
129711406|NCT00716274|466905548|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
129711407|NCT00716274|466905549|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
129711408|NCT00716274|466905550|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
129711409|NCT00716274|466905551|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
129711410|NCT00716274|466905552|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
129711411|NCT00716274|466905553|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
129711412|NCT00716274|466905548|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
129711413|NCT00716274|466905549|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
129711414|NCT00716274|466905550|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129801420|NCT04879225|467241971|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
129801421|NCT04879225|467241971|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
129801422|NCT02367131|467241974|FG000|Overall Study|Adverse Event|64|||
129801423|NCT02367131|467241974|FG000|Overall Study|No visit since the first visit|3|||
129801424|NCT02367131|467241974|FG000|Overall Study|Request by patient|53|||
129801425|NCT02367131|467241974|FG000|Overall Study|Improvement/remission|2|||
129801426|NCT02367131|467241974|FG000|Overall Study|No change/progressive disease|78|||
129801427|NCT02367131|467241974|FG000|Overall Study|Other than stated above|20|||
129801428|NCT02367131|467241974|FG000|Overall Study|Not treated|2|||
129801429|NCT02572388|467241975|FG000|Overall Study|Withdrawal by Subject|1|||
129801430|NCT02572388|467241976|FG001|Overall Study|Withdrawal by Subject|1|||
129801431|NCT02572388|467241977|FG002|Overall Study|Withdrawal by Subject|2|||
129801432|NCT02572388|467241978|FG003|Overall Study|Withdrawal by Subject|2|||
129801433|NCT01973569|467241979|FG000|Overall Study|Adverse Event|9|||
129801434|NCT01973569|467241980|FG001|Overall Study|Adverse Event|2|||
129801435|NCT01973569|467241981|FG002|Overall Study|Adverse Event|4|||
129801436|NCT01973569|467241979|FG000|Overall Study|Protocol Violation|2|||
129801437|NCT01973569|467241980|FG001|Overall Study|Protocol Violation|1|||
129801438|NCT01973569|467241981|FG002|Overall Study|Protocol Violation|3|||
129801439|NCT01973569|467241979|FG000|Overall Study|Withdrawal by Subject|7|||
129801440|NCT01973569|467241980|FG001|Overall Study|Withdrawal by Subject|5|||
129801441|NCT01973569|467241981|FG002|Overall Study|Withdrawal by Subject|2|||
129801442|NCT01973569|467241979|FG000|Overall Study|Invasive dental treatment|3|||
129801443|NCT01973569|467241980|FG001|Overall Study|Invasive dental treatment|5|||
129801444|NCT01973569|467241981|FG002|Overall Study|Invasive dental treatment|6|||
129801445|NCT01973569|467241979|FG000|Overall Study|Prohibited concomitant d|1|||
129801446|NCT01973569|467241980|FG001|Overall Study|Prohibited concomitant d|5|||
129801447|NCT01973569|467241981|FG002|Overall Study|Prohibited concomitant d|0|||
129711415|NCT00716274|466905551|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129801448|NCT01973569|467241979|FG000|Overall Study|Disease progression|0|||
129801449|NCT01973569|467241980|FG001|Overall Study|Disease progression|3|||
129801450|NCT01973569|467241981|FG002|Overall Study|Disease progression|0|||
129801451|NCT01973569|467241979|FG000|Overall Study|Other|1|||
129801452|NCT01973569|467241980|FG001|Overall Study|Other|1|||
129801453|NCT01973569|467241981|FG002|Overall Study|Other|0|||
129801454|NCT01973569|467241979|FG000|Overall Study|Did not receive study drug|6|||
129801455|NCT01973569|467241980|FG001|Overall Study|Did not receive study drug|3|||
129801456|NCT01973569|467241981|FG002|Overall Study|Did not receive study drug|3|||
129801457|NCT01051466|467241984|FG000|Overall Study|Adverse Event|1|||
129801458|NCT01051466|467241985|FG001|Overall Study|Adverse Event|0|||
129801459|NCT01051466|467241984|FG000|Overall Study|Lost to Follow-up|1|||
129801460|NCT01051466|467241985|FG001|Overall Study|Lost to Follow-up|1|||
129801461|NCT01051466|467241984|FG000|Overall Study|Withdrawal by Subject|5|||
129801462|NCT01051466|467241985|FG001|Overall Study|Withdrawal by Subject|1|||
129711416|NCT00716274|466905552|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129711417|NCT00716274|466905553|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
129711418|NCT00716274|466905548|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129711419|NCT00716274|466905549|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
129711420|NCT00716274|466905550|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129711421|NCT00716274|466905551|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129711422|NCT00716274|466905552|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129711423|NCT00716274|466905553|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
129711424|NCT00716274|466905548|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129711425|NCT00716274|466905549|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129711426|NCT00716274|466905550|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
129711427|NCT00716274|466905551|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129711428|NCT00716274|466905552|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129711429|NCT00716274|466905553|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
129711430|NCT00716274|466905548|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
129711431|NCT00716274|466905549|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
129711432|NCT00716274|466905550|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
129711433|NCT00716274|466905551|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
129711434|NCT00716274|466905552|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
129711435|NCT00716274|466905553|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
129711436|NCT00716274|466905548|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129801463|NCT01051466|467241984|FG000|Overall Study|Entry Criteria Not Met|0|||
129801464|NCT01051466|467241985|FG001|Overall Study|Entry Criteria Not Met|3|||
129801465|NCT01051466|467241984|FG000|Overall Study|Physician Decision|1|||
129801466|NCT01051466|467241985|FG001|Overall Study|Physician Decision|0|||
129711437|NCT00716274|466905549|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129711438|NCT00716274|466905550|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129801467|NCT00810108|467241986|FG000|Overall Study|Withdrawal by Subject|1|||
129801468|NCT00810108|467241987|FG001|Overall Study|Withdrawal by Subject|0|||
129801469|NCT02486302|467241995|FG000|Overall Study|Discontinued prematurely|410|||
129801470|NCT02486302|467241995|FG000|Overall Study|Documentation not completed|255|||
129801471|NCT02486302|467241995|FG000|Overall Study|Excluded due to legal reasons|8|||
129711439|NCT00716274|466905551|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
129801472|NCT02486302|467241995|FG000|Overall Study|Not treated|3|||
129801473|NCT04171765|467241997|FG000|Overall Study|Adverse Event|2|||
129801474|NCT04171765|467241998|FG001|Overall Study|Adverse Event|0|||
129711440|NCT00716274|466905552|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
129711441|NCT00716274|466905553|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
129711442|NCT00716274|466905548|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
129711443|NCT00716274|466905549|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
129711444|NCT00716274|466905550|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
129711445|NCT00716274|466905551|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
129711446|NCT00716274|466905552|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
129711447|NCT00716274|466905553|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
129801475|NCT04171765|467241999|FG002|Overall Study|Adverse Event|1|||
129801476|NCT04171765|467242000|FG003|Overall Study|Adverse Event|0|||
129801477|NCT04171765|467241997|FG000|Overall Study|Lost to Follow-up|0|||
129801478|NCT04171765|467241998|FG001|Overall Study|Lost to Follow-up|2|||
129801479|NCT04171765|467241999|FG002|Overall Study|Lost to Follow-up|2|||
129801480|NCT04171765|467242000|FG003|Overall Study|Lost to Follow-up|2|||
129801481|NCT04171765|467241997|FG000|Overall Study|Week 58 visit missed|0|||
129801482|NCT04171765|467241998|FG001|Overall Study|Week 58 visit missed|0|||
129801483|NCT04171765|467241999|FG002|Overall Study|Week 58 visit missed|1|||
129801484|NCT04171765|467242000|FG003|Overall Study|Week 58 visit missed|0|||
129801485|NCT04171765|467241997|FG000|Overall Study|Study terminated by sponsor|2|||
129801486|NCT04171765|467241998|FG001|Overall Study|Study terminated by sponsor|0|||
129801487|NCT04171765|467241999|FG002|Overall Study|Study terminated by sponsor|0|||
129801488|NCT04171765|467242000|FG003|Overall Study|Study terminated by sponsor|0|||
129801489|NCT04171765|467241997|FG000|Overall Study|Withdrawal by Subject|1|||
129801490|NCT04171765|467241998|FG001|Overall Study|Withdrawal by Subject|0|||
129801491|NCT04171765|467241999|FG002|Overall Study|Withdrawal by Subject|0|||
129801492|NCT04171765|467242000|FG003|Overall Study|Withdrawal by Subject|3|||
129801493|NCT00809354|467242001|FG000|Overall Study|Adverse Event|32|||
129801494|NCT00809354|467242002|FG001|Overall Study|Adverse Event|45|||
129801495|NCT00809354|467242003|FG002|Overall Study|Adverse Event|37|||
129801496|NCT00809354|467242004|FG003|Overall Study|Adverse Event|53|||
129801497|NCT00809354|467242005|FG004|Overall Study|Adverse Event|26|||
129801498|NCT00809354|467242006|FG005|Overall Study|Adverse Event|33|||
129801499|NCT00809354|467242007|FG006|Overall Study|Adverse Event|44|||
129801500|NCT00809354|467242008|FG007|Overall Study|Adverse Event|40|||
129801501|NCT00809354|467242009|FG008|Overall Study|Adverse Event|46|||
129801502|NCT00809354|467242010|FG009|Overall Study|Adverse Event|26|||
129801503|NCT00809354|467242001|FG000|Overall Study|Lack of Efficacy|23|||
129801504|NCT00809354|467242002|FG001|Overall Study|Lack of Efficacy|23|||
129801505|NCT00809354|467242003|FG002|Overall Study|Lack of Efficacy|22|||
129801506|NCT00809354|467242004|FG003|Overall Study|Lack of Efficacy|15|||
129801507|NCT00809354|467242005|FG004|Overall Study|Lack of Efficacy|40|||
129801508|NCT00809354|467242006|FG005|Overall Study|Lack of Efficacy|19|||
129801509|NCT00809354|467242007|FG006|Overall Study|Lack of Efficacy|21|||
129801510|NCT00809354|467242008|FG007|Overall Study|Lack of Efficacy|15|||
129801511|NCT00809354|467242009|FG008|Overall Study|Lack of Efficacy|18|||
129801512|NCT00809354|467242010|FG009|Overall Study|Lack of Efficacy|38|||
129801513|NCT00809354|467242001|FG000|Overall Study|Lost to Follow-up|10|||
129801514|NCT00809354|467242002|FG001|Overall Study|Lost to Follow-up|11|||
129801515|NCT00809354|467242003|FG002|Overall Study|Lost to Follow-up|8|||
129801516|NCT00809354|467242004|FG003|Overall Study|Lost to Follow-up|13|||
129801517|NCT00809354|467242005|FG004|Overall Study|Lost to Follow-up|6|||
129801518|NCT00809354|467242006|FG005|Overall Study|Lost to Follow-up|2|||
129801519|NCT00809354|467242007|FG006|Overall Study|Lost to Follow-up|0|||
129801520|NCT00809354|467242008|FG007|Overall Study|Lost to Follow-up|5|||
129801521|NCT00809354|467242009|FG008|Overall Study|Lost to Follow-up|4|||
129801522|NCT00809354|467242010|FG009|Overall Study|Lost to Follow-up|0|||
129801523|NCT00809354|467242001|FG000|Overall Study|Protocol Violation|7|||
129801524|NCT00809354|467242002|FG001|Overall Study|Protocol Violation|14|||
129801525|NCT00809354|467242003|FG002|Overall Study|Protocol Violation|14|||
129801526|NCT00809354|467242004|FG003|Overall Study|Protocol Violation|12|||
129801527|NCT00809354|467242005|FG004|Overall Study|Protocol Violation|14|||
129801528|NCT00809354|467242006|FG005|Overall Study|Protocol Violation|6|||
129801529|NCT00809354|467242007|FG006|Overall Study|Protocol Violation|4|||
129801530|NCT00809354|467242008|FG007|Overall Study|Protocol Violation|6|||
129801531|NCT00809354|467242009|FG008|Overall Study|Protocol Violation|9|||
129801532|NCT00809354|467242010|FG009|Overall Study|Protocol Violation|3|||
129801533|NCT00809354|467242001|FG000|Overall Study|Withdrawal by Subject|32|||
129801534|NCT00809354|467242002|FG001|Overall Study|Withdrawal by Subject|27|||
129801535|NCT00809354|467242003|FG002|Overall Study|Withdrawal by Subject|31|||
129801536|NCT00809354|467242004|FG003|Overall Study|Withdrawal by Subject|33|||
129801537|NCT00809354|467242005|FG004|Overall Study|Withdrawal by Subject|34|||
129801538|NCT00809354|467242006|FG005|Overall Study|Withdrawal by Subject|29|||
129801539|NCT00809354|467242007|FG006|Overall Study|Withdrawal by Subject|27|||
129801540|NCT00809354|467242008|FG007|Overall Study|Withdrawal by Subject|19|||
129801541|NCT00809354|467242009|FG008|Overall Study|Withdrawal by Subject|18|||
129801542|NCT00809354|467242010|FG009|Overall Study|Withdrawal by Subject|20|||
129801543|NCT00809354|467242001|FG000|Overall Study|Other|10|||
129801544|NCT00809354|467242002|FG001|Overall Study|Other|2|||
129801545|NCT00809354|467242003|FG002|Overall Study|Other|7|||
129801546|NCT00809354|467242004|FG003|Overall Study|Other|10|||
129801547|NCT00809354|467242005|FG004|Overall Study|Other|5|||
129801548|NCT00809354|467242006|FG005|Overall Study|Other|3|||
129801549|NCT00809354|467242007|FG006|Overall Study|Other|2|||
129801550|NCT00809354|467242008|FG007|Overall Study|Other|3|||
129801551|NCT00809354|467242009|FG008|Overall Study|Other|4|||
129801552|NCT00809354|467242010|FG009|Overall Study|Other|3|||
129801553|NCT00809354|467242001|FG000|Overall Study|Study terminated by sponsor|138|||
129801554|NCT00809354|467242002|FG001|Overall Study|Study terminated by sponsor|134|||
129801555|NCT00809354|467242003|FG002|Overall Study|Study terminated by sponsor|129|||
129801556|NCT00809354|467242004|FG003|Overall Study|Study terminated by sponsor|120|||
129801557|NCT00809354|467242005|FG004|Overall Study|Study terminated by sponsor|126|||
129801558|NCT00809354|467242006|FG005|Overall Study|Study terminated by sponsor|133|||
129801559|NCT00809354|467242007|FG006|Overall Study|Study terminated by sponsor|124|||
129801560|NCT00809354|467242008|FG007|Overall Study|Study terminated by sponsor|148|||
129801561|NCT00809354|467242009|FG008|Overall Study|Study terminated by sponsor|127|||
129801562|NCT00809354|467242010|FG009|Overall Study|Study terminated by sponsor|135|||
129801563|NCT00809354|467242001|FG000|Overall Study|Withdrawn due to pregnancy|0|||
129801564|NCT00809354|467242002|FG001|Overall Study|Withdrawn due to pregnancy|1|||
129801565|NCT00809354|467242003|FG002|Overall Study|Withdrawn due to pregnancy|0|||
129801566|NCT00809354|467242004|FG003|Overall Study|Withdrawn due to pregnancy|0|||
129801567|NCT00809354|467242005|FG004|Overall Study|Withdrawn due to pregnancy|0|||
129801568|NCT00809354|467242006|FG005|Overall Study|Withdrawn due to pregnancy|0|||
129801569|NCT00809354|467242007|FG006|Overall Study|Withdrawn due to pregnancy|0|||
129801570|NCT00809354|467242008|FG007|Overall Study|Withdrawn due to pregnancy|0|||
129801571|NCT00809354|467242009|FG008|Overall Study|Withdrawn due to pregnancy|0|||
129801572|NCT00809354|467242010|FG009|Overall Study|Withdrawn due to pregnancy|0|||
129801573|NCT00809354|467242001|FG000|Overall Study|Randomized but not Treated|3|||
129801574|NCT00809354|467242002|FG001|Overall Study|Randomized but not Treated|1|||
129801575|NCT00809354|467242003|FG002|Overall Study|Randomized but not Treated|6|||
129801576|NCT00809354|467242004|FG003|Overall Study|Randomized but not Treated|0|||
129801577|NCT00809354|467242005|FG004|Overall Study|Randomized but not Treated|5|||
129801578|NCT00809354|467242006|FG005|Overall Study|Randomized but not Treated|0|||
129801579|NCT00809354|467242007|FG006|Overall Study|Randomized but not Treated|1|||
129801580|NCT00809354|467242008|FG007|Overall Study|Randomized but not Treated|1|||
129801581|NCT00809354|467242009|FG008|Overall Study|Randomized but not Treated|2|||
129801582|NCT00809354|467242010|FG009|Overall Study|Randomized but not Treated|1|||
129801583|NCT00809354|467242001|FG000|Overall Study|Death|0|||
129801584|NCT00809354|467242002|FG001|Overall Study|Death|0|||
129801585|NCT00809354|467242003|FG002|Overall Study|Death|0|||
129801586|NCT00809354|467242004|FG003|Overall Study|Death|0|||
129801587|NCT00809354|467242005|FG004|Overall Study|Death|0|||
129801588|NCT00809354|467242006|FG005|Overall Study|Death|0|||
129801589|NCT00809354|467242007|FG006|Overall Study|Death|0|||
129801590|NCT00809354|467242008|FG007|Overall Study|Death|1|||
129801591|NCT00809354|467242009|FG008|Overall Study|Death|0|||
129801592|NCT00809354|467242010|FG009|Overall Study|Death|0|||
129801593|NCT03257371|467242013|FG000|Overall Study|Lost to Follow-up|1|||
129801594|NCT00631696|467242018|FG000|Overall Study|Entered, not randomized to treatment|1|||
129801595|NCT00631696|467242019|FG001|Overall Study|Entered, not randomized to treatment|1|||
129801596|NCT00631696|467242018|FG000|Overall Study|Discontinued after database release date|1|||
129801597|NCT00631696|467242019|FG001|Overall Study|Discontinued after database release date|0|||
129801598|NCT00631696|467242018|FG000|Overall Study|Follow up after database release date|1|||
129801599|NCT00631696|467242019|FG001|Overall Study|Follow up after database release date|0|||
129801600|NCT00631696|467242018|FG000|Overall Study|Lost to Follow-up|7|||
129801601|NCT00631696|467242019|FG001|Overall Study|Lost to Follow-up|10|||
129801602|NCT00631696|467242018|FG000|Overall Study|Withdrawal by Subject|2|||
129801603|NCT00631696|467242019|FG001|Overall Study|Withdrawal by Subject|9|||
129801604|NCT00631696|467242018|FG000|Overall Study|Other|8|||
129801605|NCT00631696|467242019|FG001|Overall Study|Other|8|||
129801606|NCT00631696|467242018|FG000|Overall Study|Protocol Violation|9|||
129801607|NCT00631696|467242019|FG001|Overall Study|Protocol Violation|9|||
129801608|NCT00631696|467242018|FG000|Overall Study|Study terminated by sponsor|3|||
129801609|NCT00631696|467242019|FG001|Overall Study|Study terminated by sponsor|3|||
129801610|NCT00631696|467242018|FG000|Overall Study|Adverse Event|5|||
129801611|NCT00631696|467242019|FG001|Overall Study|Adverse Event|0|||
129444230|NCT00726622|465927261|FG001|Overall Study|Physician Decision|1|||
129801612|NCT03198078|467242025|FG000|Overall Study|Adverse Event|0|||
129801613|NCT03198078|467242026|FG001|Overall Study|Adverse Event|1|||
129444231|NCT00726622|465927260|FG000|Overall Study|Metastasis|2|||
129444232|NCT00726622|465927261|FG001|Overall Study|Metastasis|0|||
129444233|NCT01940354|465927262|FG000|Overall Study|Withdrawal by Subject|4|||
129444234|NCT01940354|465927263|FG001|Overall Study|Withdrawal by Subject|2|||
129444235|NCT03873493|465927264|FG000|Overall Study|Withdrawal by Subject|1|||
129444236|NCT03873493|465927264|FG000|Overall Study|Death|9|||
129801614|NCT03198078|467242027|FG002|Overall Study|Adverse Event|2|||
129801615|NCT03198078|467242025|FG000|Overall Study|Lack of Efficacy|0|||
129444237|NCT03873493|465927264|FG000|Overall Study|Lost to Follow-up|1|||
129711448|NCT04819113|466905556|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129711449|NCT04819113|466905556|FG000|Overall Study|Lost to Follow-up|1|||
129711450|NCT04819113|466905556|FG000|Overall Study|Withdrawn before vaccination|2|||
129711451|NCT04067492|466905557|FG000|Overall Study|Lost to Follow-up|0|||
129711452|NCT04067492|466905558|FG001|Overall Study|Lost to Follow-up|0|||
129711453|NCT04067492|466905559|FG002|Overall Study|Lost to Follow-up|0|||
129711454|NCT04067492|466905560|FG003|Overall Study|Lost to Follow-up|0|||
129711455|NCT04067492|466905561|FG004|Overall Study|Lost to Follow-up|0|||
129711456|NCT04067492|466905562|FG005|Overall Study|Lost to Follow-up|1|||
129711457|NCT04067492|466905557|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129711458|NCT04067492|466905558|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
129711459|NCT04067492|466905559|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129711460|NCT04067492|466905560|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129711461|NCT04067492|466905561|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129711462|NCT04067492|466905562|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
129711463|NCT04067492|466905557|FG000|Overall Study|COVID-19 epidemiological situation|0|||
129711464|NCT04067492|466905558|FG001|Overall Study|COVID-19 epidemiological situation|0|||
129711465|NCT04067492|466905559|FG002|Overall Study|COVID-19 epidemiological situation|0|||
129711466|NCT04067492|466905560|FG003|Overall Study|COVID-19 epidemiological situation|1|||
129711467|NCT04067492|466905561|FG004|Overall Study|COVID-19 epidemiological situation|0|||
129711468|NCT04067492|466905562|FG005|Overall Study|COVID-19 epidemiological situation|0|||
129711469|NCT00833027|466905563|FG000|Overall Study|Adverse Event|33|||
129711470|NCT00833027|466905563|FG000|Overall Study|Death|1|||
129711471|NCT00833027|466905563|FG000|Overall Study|Lack of Efficacy|12|||
129711472|NCT00833027|466905563|FG000|Overall Study|Lost to Follow-up|24|||
129711473|NCT00833027|466905563|FG000|Overall Study|Protocol Violation|115|||
129711474|NCT00833027|466905563|FG000|Overall Study|Withdrawal by Subject|16|||
129711475|NCT00833027|466905563|FG000|Overall Study|Missing|10|||
129711476|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Death|2|||
129711477|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
129711478|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
129711479|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Physician Decision|1|||
129711480|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
129711481|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
129711482|NCT00786422|466905565|FG000|Rivaroxaban Treatment|Adverse Event|2|||
129711483|NCT00786422|466905565|FG000|Follow-up Period|Death|1|||
129711484|NCT00786422|466905565|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
129711485|NCT00444106|466905577|FG000|Overall Study|Lost to Follow-up|2|||
129711486|NCT00444106|466905578|FG001|Overall Study|Lost to Follow-up|1|||
129711487|NCT00444106|466905579|FG002|Overall Study|Lost to Follow-up|0|||
129711488|NCT00444106|466905577|FG000|Overall Study|Abnormal Test Procedure Results|0|||
129711489|NCT00444106|466905578|FG001|Overall Study|Abnormal Test Procedure Results|0|||
129711490|NCT00444106|466905579|FG002|Overall Study|Abnormal Test Procedure Results|1|||
129711491|NCT04570384|466905580|FG000|Overall Study|Adverse Event|2|||
129711492|NCT04570384|466905581|FG001|Overall Study|Adverse Event|1|||
129711493|NCT04570384|466905580|FG000|Overall Study|Death|2|||
129711494|NCT04570384|466905581|FG001|Overall Study|Death|5|||
129711495|NCT04570384|466905580|FG000|Overall Study|Lost to Follow-up|1|||
129711496|NCT04570384|466905581|FG001|Overall Study|Lost to Follow-up|0|||
129711497|NCT04570384|466905580|FG000|Overall Study|Other|1|||
129711498|NCT04570384|466905581|FG001|Overall Study|Other|0|||
129711499|NCT04570384|466905580|FG000|Overall Study|Protocol Violation|0|||
129711500|NCT04570384|466905581|FG001|Overall Study|Protocol Violation|1|||
129711501|NCT04570384|466905580|FG000|Overall Study|Sponsor Decision|1|||
129711502|NCT04570384|466905581|FG001|Overall Study|Sponsor Decision|0|||
129711503|NCT04570384|466905580|FG000|Overall Study|Withdrawal by Subject|4|||
129711504|NCT04570384|466905581|FG001|Overall Study|Withdrawal by Subject|2|||
129711505|NCT01900665|466905582|FG000|Placebo Controlled Period|Death|9|||
129711506|NCT01900665|466905583|FG001|Placebo Controlled Period|Death|16|||
129711507|NCT01900665|466905582|FG000|Placebo Controlled Period|Adverse Event|48|||
129711508|NCT01900665|466905583|FG001|Placebo Controlled Period|Adverse Event|39|||
129711509|NCT01900665|466905582|FG000|Placebo Controlled Period|Protocol Violation|1|||
129711510|NCT01900665|466905583|FG001|Placebo Controlled Period|Protocol Violation|7|||
129711511|NCT01900665|466905582|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
129711512|NCT01900665|466905583|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
129711513|NCT01900665|466905582|FG000|Placebo Controlled Period|Physician Decision|11|||
129711514|NCT01900665|466905583|FG001|Placebo Controlled Period|Physician Decision|7|||
129711515|NCT01900665|466905582|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
129711516|NCT01900665|466905583|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
129711517|NCT01900665|466905582|FG000|Placebo Controlled Period|Caregiver Decision|33|||
129711518|NCT01900665|466905583|FG001|Placebo Controlled Period|Caregiver Decision|41|||
129711519|NCT01900665|466905582|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
129711520|NCT01900665|466905583|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
129711521|NCT01900665|466905582|FG000|Open Label Period|Adverse Event|16|||
129711522|NCT01900665|466905583|FG001|Open Label Period|Adverse Event|20|||
129711523|NCT01900665|466905582|FG000|Open Label Period|Death|5|||
129711524|NCT01900665|466905583|FG001|Open Label Period|Death|6|||
129711525|NCT01900665|466905582|FG000|Open Label Period|Lost to Follow-up|1|||
129711526|NCT01900665|466905583|FG001|Open Label Period|Lost to Follow-up|1|||
129711527|NCT01900665|466905582|FG000|Open Label Period|Parent/Caregiver Decision|33|||
129711528|NCT01900665|466905583|FG001|Open Label Period|Parent/Caregiver Decision|34|||
129711529|NCT01900665|466905582|FG000|Open Label Period|Physician Decision|4|||
129711530|NCT01900665|466905583|FG001|Open Label Period|Physician Decision|4|||
129711531|NCT01900665|466905582|FG000|Open Label Period|Protocol Violation|0|||
129711532|NCT01900665|466905583|FG001|Open Label Period|Protocol Violation|1|||
129711533|NCT01900665|466905582|FG000|Open Label Period|Sponsor Decision|802|||
129711534|NCT01900665|466905583|FG001|Open Label Period|Sponsor Decision|765|||
129711535|NCT01900665|466905582|FG000|Open Label Period|Withdrawal by Subject|20|||
129711536|NCT01900665|466905583|FG001|Open Label Period|Withdrawal by Subject|28|||
129711537|NCT04749914|466905584|FG000|Period 1|Adverse Event|1|||
129711538|NCT04749914|466905585|FG001|Period 1|Adverse Event|0|||
129711539|NCT04749914|466905586|FG002|Period 1|Adverse Event|0|||
129711540|NCT04749914|466905587|FG003|Period 1|Adverse Event|0|||
129711541|NCT04749914|466905584|FG000|Period 1|Withdrawal by Subject|1|||
129711542|NCT04749914|466905585|FG001|Period 1|Withdrawal by Subject|0|||
129711543|NCT04749914|466905586|FG002|Period 1|Withdrawal by Subject|1|||
129711544|NCT04749914|466905587|FG003|Period 1|Withdrawal by Subject|0|||
129711545|NCT01673126|466905588|FG000|Overall Study|change of diagnosis|4|||
129711546|NCT01673126|466905589|FG001|Overall Study|change of diagnosis|3|||
129711547|NCT01074931|466905594|FG000|Overall Study|Economic reasons|1|||
129711548|NCT01074931|466905594|FG000|Overall Study|Death|5|||
129711549|NCT00953706|466905595|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
129711550|NCT00953706|466905596|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
129711551|NCT00953706|466905597|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
129711552|NCT00953706|466905598|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
129711553|NCT00953706|466905595|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
129711554|NCT00953706|466905596|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
129711555|NCT00953706|466905597|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
129711556|NCT00953706|466905598|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
129711557|NCT00953706|466905595|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
129711558|NCT00953706|466905596|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
129711559|NCT00953706|466905597|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
129711560|NCT00953706|466905598|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
129711561|NCT00953706|466905595|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
129711562|NCT00953706|466905596|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
129711563|NCT00953706|466905597|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
129711564|NCT00953706|466905598|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
129801616|NCT03198078|467242026|FG001|Overall Study|Lack of Efficacy|0|||
129801617|NCT03198078|467242027|FG002|Overall Study|Lack of Efficacy|3|||
129801618|NCT03198078|467242025|FG000|Overall Study|Lost to Follow-up|1|||
129801619|NCT03198078|467242026|FG001|Overall Study|Lost to Follow-up|0|||
129801620|NCT03198078|467242027|FG002|Overall Study|Lost to Follow-up|0|||
129801621|NCT03198078|467242025|FG000|Overall Study|Pregnancy|0|||
129801622|NCT03198078|467242026|FG001|Overall Study|Pregnancy|1|||
129801623|NCT03198078|467242027|FG002|Overall Study|Pregnancy|0|||
129801624|NCT03198078|467242025|FG000|Overall Study|Withdrawal by Subject|1|||
129801625|NCT03198078|467242026|FG001|Overall Study|Withdrawal by Subject|0|||
129801626|NCT03198078|467242027|FG002|Overall Study|Withdrawal by Subject|2|||
129801627|NCT03198078|467242025|FG000|Overall Study|Withdrawal by Caregiver|1|||
129801628|NCT03198078|467242026|FG001|Overall Study|Withdrawal by Caregiver|3|||
129801629|NCT03198078|467242027|FG002|Overall Study|Withdrawal by Caregiver|5|||
129801630|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
129801631|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
129801632|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
129801633|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
129711565|NCT00953706|466905595|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
129711566|NCT00953706|466905596|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
129711567|NCT00953706|466905597|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
129711568|NCT00953706|466905598|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
129711569|NCT00953706|466905595|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
129711570|NCT00953706|466905596|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
129711571|NCT00953706|466905597|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
129711572|NCT00953706|466905598|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
129711573|NCT00953706|466905595|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
129711574|NCT00953706|466905596|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
129711575|NCT00953706|466905597|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
129711576|NCT00953706|466905598|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
129711577|NCT00953706|466905595|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
129711578|NCT00953706|466905596|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
129711579|NCT00953706|466905597|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
129711580|NCT00953706|466905598|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
129711581|NCT00953706|466905595|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
129711582|NCT00953706|466905596|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
129711583|NCT00953706|466905597|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
129711584|NCT00953706|466905598|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
129711585|NCT00953706|466905595|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
129711586|NCT00953706|466905596|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
129711587|NCT00953706|466905597|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
129711588|NCT00953706|466905598|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
129711589|NCT00953706|466905595|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
129711590|NCT00953706|466905596|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
129711591|NCT00953706|466905597|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
129711592|NCT00953706|466905598|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
129711593|NCT01404234|466905599|FG000|Overall Study|Withdrawal by Subject|2|||
129711594|NCT01475721|466907114|FG000|Overall Study|Death|3|||
129711595|NCT01475721|466907115|FG001|Overall Study|Death|6|||
129711596|NCT01475721|466907114|FG000|Overall Study|Withdrawal by Subject|8|||
129711597|NCT01475721|466907115|FG001|Overall Study|Withdrawal by Subject|8|||
129711598|NCT00803738|466907117|FG000|Overall Study|Adverse Event|3|||
129711599|NCT00803738|466907118|FG001|Overall Study|Adverse Event|5|||
129711600|NCT00803738|466907117|FG000|Overall Study|Lost to Follow-up|4|||
129711601|NCT00803738|466907118|FG001|Overall Study|Lost to Follow-up|4|||
129711602|NCT00803738|466907117|FG000|Overall Study|Protocol Violation|18|||
129711603|NCT00803738|466907118|FG001|Overall Study|Protocol Violation|10|||
129711604|NCT00803738|466907117|FG000|Overall Study|Withdrawal by Subject|1|||
129711605|NCT00803738|466907118|FG001|Overall Study|Withdrawal by Subject|4|||
129711606|NCT00803738|466907117|FG000|Overall Study|Lack of Efficacy|10|||
129711607|NCT00803738|466907118|FG001|Overall Study|Lack of Efficacy|16|||
129711608|NCT00803738|466907117|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
129711609|NCT00803738|466907118|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
129711610|NCT00803738|466907117|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
129711611|NCT00803738|466907118|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
129711612|NCT02364037|466907119|FG000|Overall Study|Withdrawal by Subject|7|||
129711613|NCT02364037|466907120|FG001|Overall Study|Withdrawal by Subject|4|||
129711614|NCT02364037|466907119|FG000|Overall Study|Lost to Follow-up|37|||
129711615|NCT02364037|466907120|FG001|Overall Study|Lost to Follow-up|49|||
129711616|NCT00387088|466907123|FG000|Overall Study|Adverse Event|143|||
129711617|NCT00387088|466907124|FG001|Overall Study|Adverse Event|156|||
129711618|NCT00387088|466907123|FG000|Overall Study|Protocol Violation|47|||
129711619|NCT00387088|466907124|FG001|Overall Study|Protocol Violation|35|||
129711620|NCT00387088|466907123|FG000|Overall Study|Withdrawal by Subject|20|||
129711621|NCT00387088|466907124|FG001|Overall Study|Withdrawal by Subject|35|||
129711622|NCT00387088|466907123|FG000|Overall Study|Lack of Efficacy|28|||
129711623|NCT00387088|466907124|FG001|Overall Study|Lack of Efficacy|67|||
129711624|NCT00387088|466907123|FG000|Overall Study|Lost to Follow-up|22|||
129711625|NCT00387088|466907124|FG001|Overall Study|Lost to Follow-up|28|||
129711626|NCT00387088|466907123|FG000|Overall Study|Other|58|||
129711627|NCT00387088|466907124|FG001|Overall Study|Other|52|||
129711628|NCT02848092|466907127|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
129711629|NCT02848092|466907128|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
129711630|NCT02848092|466907127|FG000|1-month Post-training Follow-up|Adverse Event|2|||
129711631|NCT02848092|466907128|FG001|1-month Post-training Follow-up|Adverse Event|1|||
129711632|NCT02848092|466907127|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
129711633|NCT02848092|466907128|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
129711634|NCT02848092|466907127|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
129711635|NCT02848092|466907128|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
129711636|NCT02848092|466907127|FG000|1-month Post-training Follow-up|fatigue|0|||
129711637|NCT02848092|466907128|FG001|1-month Post-training Follow-up|fatigue|1|||
129711638|NCT02848092|466907127|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
129711639|NCT02848092|466907128|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
129711640|NCT02848092|466907127|FG000|6-month Post-training Follow-up|Adverse Event|1|||
129711641|NCT02848092|466907128|FG001|6-month Post-training Follow-up|Adverse Event|1|||
129711642|NCT02848092|466907127|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
129711643|NCT02848092|466907128|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
129711644|NCT02848092|466907127|FG000|6-month Post-training Follow-up|frustrated with task|1|||
129711645|NCT02848092|466907128|FG001|6-month Post-training Follow-up|frustrated with task|0|||
129711646|NCT02848092|466907127|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
129711647|NCT02848092|466907128|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
129711648|NCT02848092|466907127|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
129711649|NCT02848092|466907128|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
129711650|NCT01639469|466907129|FG000|Overall Study|Death|4|||
129711651|NCT01639469|466907130|FG001|Overall Study|Death|2|||
129711652|NCT01639469|466907129|FG000|Overall Study|Lost to Follow-up|1|||
129711653|NCT01639469|466907130|FG001|Overall Study|Lost to Follow-up|1|||
129711654|NCT00420381|466907131|FG000|Overall Study|Protocol Violation|1|||
129711655|NCT00592631|466907132|FG000|Overall Study|Lost to Follow-up|0|||
129711656|NCT00592631|466907133|FG001|Overall Study|Lost to Follow-up|2|||
129711657|NCT02383862|466907136|FG000|3 Month Follow up|Lost to Follow-up|23|||
129711658|NCT02383862|466907137|FG001|3 Month Follow up|Lost to Follow-up|21|||
129711659|NCT01833494|466907138|FG000|Overall Study|Adverse Event|24|||
129711660|NCT01833494|466907138|FG000|Overall Study|Physician Decision|6|||
129711661|NCT01833494|466907138|FG000|Overall Study|Withdrawal by Subject|6|||
129711662|NCT01833494|466907138|FG000|Overall Study|Decrease in serum phosphorus|4|||
129711663|NCT01833494|466907138|FG000|Overall Study|Decrease in serum calcium|4|||
129711664|NCT01833494|466907138|FG000|Overall Study|Increase in serum ferritin|1|||
129711665|NCT01694433|466907139|FG000|Overall Study|Adverse Event|7|||
129711666|NCT01694433|466907140|FG001|Overall Study|Adverse Event|0|||
129711667|NCT01694433|466907139|FG000|Overall Study|Physician Decision|1|||
129711668|NCT01694433|466907140|FG001|Overall Study|Physician Decision|0|||
129711669|NCT01694433|466907139|FG000|Overall Study|Withdrawal by Subject|3|||
129711670|NCT01694433|466907140|FG001|Overall Study|Withdrawal by Subject|4|||
129711671|NCT00374595|466907143|FG000|Overall Study|Death|23|||
129711672|NCT00374595|466907143|FG000|Overall Study|Withdrawal by Subject|39|||
129711673|NCT00374595|466907143|FG000|Overall Study|Lost to Follow-up|3|||
129711674|NCT00374595|466907143|FG000|Overall Study|too much time commitment|1|||
129711675|NCT00374595|466907143|FG000|Overall Study|transfer care to other clinical site|1|||
129711676|NCT00374595|466907143|FG000|Overall Study|relocation|3|||
129711677|NCT03745768|466907145|FG000|Overall Study|discontinued study|2|||
129711678|NCT03745768|466907146|FG001|Overall Study|discontinued study|0|||
129711679|NCT00443118|466907147|FG000|Overall Study|unknown primary outcome|3|||
129711680|NCT00443118|466907148|FG001|Overall Study|unknown primary outcome|1|||
129711681|NCT00443118|466907149|FG002|Overall Study|unknown primary outcome|0|||
129711682|NCT00443118|466907147|FG000|Overall Study|Withdrawal by Subject|1|||
129711683|NCT00443118|466907148|FG001|Overall Study|Withdrawal by Subject|0|||
129711684|NCT00443118|466907149|FG002|Overall Study|Withdrawal by Subject|0|||
129711685|NCT01664247|466907152|FG000|Overall Study|Adverse Event|5|||
129711686|NCT01664247|466907153|FG001|Overall Study|Adverse Event|3|||
129711687|NCT01664247|466907152|FG000|Overall Study|Protocol Violation|3|||
129711688|NCT01664247|466907153|FG001|Overall Study|Protocol Violation|5|||
129711689|NCT01664247|466907152|FG000|Overall Study|Withdrawal Criteria|1|||
129711690|NCT01664247|466907153|FG001|Overall Study|Withdrawal Criteria|4|||
129711691|NCT01664247|466907152|FG000|Overall Study|Unclassified|5|||
129711692|NCT01664247|466907153|FG001|Overall Study|Unclassified|29|||
129711693|NCT01106157|466907154|FG000|Overall Study|Withdrawal by Subject|1|||
129711694|NCT01106157|466907155|FG001|Overall Study|Withdrawal by Subject|0|||
129711695|NCT01673646|466907159|FG000|Overall Study|Adverse Event|2|||
129711696|NCT01673646|466907160|FG001|Overall Study|Adverse Event|1|||
129711697|NCT01673646|466907161|FG002|Overall Study|Adverse Event|1|||
129711698|NCT01673646|466907159|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129711699|NCT01673646|466907160|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129711700|NCT01673646|466907161|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129711701|NCT01673646|466907159|FG000|Overall Study|Condition no longer requires study drug|0|||
129711702|NCT01673646|466907160|FG001|Overall Study|Condition no longer requires study drug|1|||
129711703|NCT01673646|466907161|FG002|Overall Study|Condition no longer requires study drug|0|||
129711704|NCT01673646|466907159|FG000|Overall Study|Withdrawal by Subject|0|||
129711705|NCT01673646|466907160|FG001|Overall Study|Withdrawal by Subject|2|||
129711706|NCT01673646|466907161|FG002|Overall Study|Withdrawal by Subject|2|||
129711707|NCT01673646|466907159|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
129711708|NCT01673646|466907160|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
129711709|NCT01673646|466907161|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
129711710|NCT03064074|466907162|FG000|Overall Study|Physician Decision|0|||
129711711|NCT03064074|466907163|FG001|Overall Study|Physician Decision|0|||
129711712|NCT03064074|466907164|FG002|Overall Study|Physician Decision|0|||
129711713|NCT03064074|466907165|FG003|Overall Study|Physician Decision|1|||
129711714|NCT02141672|466907169|FG000|Overall Study|Adverse Event|0|||
129711715|NCT02141672|466907170|FG001|Overall Study|Adverse Event|1|||
129711716|NCT02141672|466907171|FG002|Overall Study|Adverse Event|0|||
129711717|NCT02141672|466907169|FG000|Overall Study|Death|10|||
129711718|NCT02141672|466907170|FG001|Overall Study|Death|2|||
129711719|NCT02141672|466907171|FG002|Overall Study|Death|1|||
129711720|NCT02141672|466907169|FG000|Overall Study|Lack of Efficacy|0|||
129711721|NCT02141672|466907170|FG001|Overall Study|Lack of Efficacy|0|||
129711722|NCT02141672|466907171|FG002|Overall Study|Lack of Efficacy|2|||
129711723|NCT02141672|466907169|FG000|Overall Study|Lost to Follow-up|1|||
129711724|NCT02141672|466907170|FG001|Overall Study|Lost to Follow-up|1|||
129711725|NCT02141672|466907171|FG002|Overall Study|Lost to Follow-up|3|||
129711726|NCT02141672|466907169|FG000|Overall Study|Physician Decision|1|||
129711727|NCT02141672|466907170|FG001|Overall Study|Physician Decision|2|||
129711728|NCT02141672|466907171|FG002|Overall Study|Physician Decision|5|||
129711729|NCT02141672|466907169|FG000|Overall Study|Protocol Violation|0|||
129711730|NCT02141672|466907170|FG001|Overall Study|Protocol Violation|0|||
129711731|NCT02141672|466907171|FG002|Overall Study|Protocol Violation|1|||
129711732|NCT02141672|466907169|FG000|Overall Study|Withdrawal by Subject|3|||
129711733|NCT02141672|466907170|FG001|Overall Study|Withdrawal by Subject|2|||
129801634|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
129801635|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
129801636|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
129801637|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
129801638|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
129801639|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
129801640|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
129801641|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
129801642|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
129801643|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
129801644|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
129801645|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
129801646|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
129801647|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
129801648|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
129801649|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
129801650|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
129801651|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
129801652|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
129801653|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
129801654|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Death|2|||
129801655|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Death|1|||
129711734|NCT02141672|466907171|FG002|Overall Study|Withdrawal by Subject|5|||
129711735|NCT02141672|466907169|FG000|Overall Study|refused to follow-up|1|||
129711736|NCT02141672|466907170|FG001|Overall Study|refused to follow-up|0|||
129711737|NCT02141672|466907171|FG002|Overall Study|refused to follow-up|1|||
129711738|NCT01118780|466907172|FG000|Overall Study|Adverse Event|15|||
129711739|NCT01118780|466907173|FG001|Overall Study|Adverse Event|15|||
129711740|NCT01118780|466907172|FG000|Overall Study|Death|1|||
129711741|NCT01118780|466907173|FG001|Overall Study|Death|0|||
129711742|NCT01118780|466907172|FG000|Overall Study|Lack of Efficacy|2|||
129711743|NCT01118780|466907173|FG001|Overall Study|Lack of Efficacy|6|||
129711744|NCT01118780|466907172|FG000|Overall Study|Physician Decision|2|||
129711745|NCT01118780|466907173|FG001|Overall Study|Physician Decision|0|||
129711746|NCT01118780|466907172|FG000|Overall Study|Protocol Violation|3|||
129711747|NCT01118780|466907173|FG001|Overall Study|Protocol Violation|6|||
129711748|NCT01118780|466907172|FG000|Overall Study|Withdrawal by Subject|13|||
129711749|NCT01118780|466907173|FG001|Overall Study|Withdrawal by Subject|8|||
129711750|NCT03962855|466907181|FG000|Overall Study|Death|0|||
129711751|NCT03962855|466907182|FG001|Overall Study|Death|1|||
129711752|NCT03962855|466907181|FG000|Overall Study|Lost to Follow-up|0|||
129711753|NCT03962855|466907182|FG001|Overall Study|Lost to Follow-up|1|||
129711754|NCT03962855|466907181|FG000|Overall Study|Adverse Event|0|||
129711755|NCT03962855|466907182|FG001|Overall Study|Adverse Event|1|||
129711756|NCT03962855|466907181|FG000|Overall Study|Physician Decision|0|||
129711757|NCT03962855|466907182|FG001|Overall Study|Physician Decision|2|||
129711758|NCT00127855|466907183|FG000|Primary Vaccination Course|Adverse Event|0|||
129711759|NCT00127855|466907184|FG001|Primary Vaccination Course|Adverse Event|0|||
129711760|NCT00127855|466907185|FG002|Primary Vaccination Course|Adverse Event|1|||
129711761|NCT00127855|466907186|FG003|Primary Vaccination Course|Adverse Event|0|||
129711762|NCT00127855|466907187|FG004|Primary Vaccination Course|Adverse Event|0|||
129711763|NCT00127855|466907183|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
129711764|NCT00127855|466907184|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
129711765|NCT00127855|466907185|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
129711766|NCT00127855|466907186|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
129711767|NCT00127855|466907187|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
129711768|NCT00127855|466907183|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
129711769|NCT00127855|466907184|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
129711770|NCT00127855|466907185|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
129711771|NCT00127855|466907186|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
129711772|NCT00127855|466907187|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
129711773|NCT00127855|466907183|FG000|Primary Vaccination Course|Other|0|||
129711774|NCT00127855|466907184|FG001|Primary Vaccination Course|Other|0|||
129711775|NCT00127855|466907185|FG002|Primary Vaccination Course|Other|0|||
129711776|NCT00127855|466907186|FG003|Primary Vaccination Course|Other|0|||
129801656|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Death|0|||
129801657|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Death|0|||
129801658|NCT02607930|467242028|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
129801659|NCT02607930|467242029|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
129801660|NCT02607930|467242030|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
129801661|NCT02607930|467242031|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
129801662|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129801663|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
129801664|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
129801665|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
129801666|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
129801667|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
129801668|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
129801669|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
129801670|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
129801671|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
129711777|NCT00127855|466907187|FG004|Primary Vaccination Course|Other|1|||
129801672|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
129711778|NCT02343302|466907188|FG000|Overall Study|Physician Decision|1|||
129801673|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
129801674|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
129711779|NCT02343302|466907189|FG001|Overall Study|Physician Decision|1|||
129711780|NCT02655887|466907190|FG000|Overall Study|Lost to Follow-up|3|||
129711781|NCT02655887|466907190|FG000|Overall Study|Death|4|||
129711782|NCT02655887|466907190|FG000|Overall Study|Withdrawal by Subject|3|||
129711783|NCT02655887|466907190|FG000|Overall Study|Missed 12-month follow-up visit|4|||
129711784|NCT03465722|466907196|FG000|Overall Study|Withdrawal by Subject|21|||
129801675|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
129801676|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
129801677|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
129801678|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
129801679|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
129801680|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
129801681|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
129801682|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
129801683|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
129801684|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
129801685|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
129801686|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
129801687|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
129801688|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
129801689|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
129801690|NCT02607930|467242028|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
129711785|NCT03465722|466907197|FG001|Overall Study|Withdrawal by Subject|14|||
129801691|NCT02607930|467242029|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
129801692|NCT02607930|467242030|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
129801693|NCT02607930|467242031|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
129801694|NCT01050543|467242032|FG000|Overall Study|Withdrawal by Subject|0|||
129801695|NCT01050543|467242033|FG001|Overall Study|Withdrawal by Subject|2|||
129801696|NCT01050543|467242032|FG000|Overall Study|Protocol Violation|0|||
129801697|NCT01050543|467242033|FG001|Overall Study|Protocol Violation|1|||
129801698|NCT01050543|467242032|FG000|Overall Study|Administrative|4|||
129801699|NCT01050543|467242033|FG001|Overall Study|Administrative|1|||
129711786|NCT03465722|466907196|FG000|Overall Study|Death|89|||
129711787|NCT03465722|466907197|FG001|Overall Study|Death|87|||
129801700|NCT00570765|467242034|FG000|DB Phase|Withdrawal by Subject|1|||
129801701|NCT00570765|467242035|FG001|DB Phase|Withdrawal by Subject|0|||
129801702|NCT00570765|467242036|FG002|DB Phase|Withdrawal by Subject|0|||
129801703|NCT00570765|467242037|FG003|DB Phase|Withdrawal by Subject|0|||
129801704|NCT00570765|467242034|FG000|DB Phase|Protocol Violation|0|||
129801705|NCT00570765|467242035|FG001|DB Phase|Protocol Violation|1|||
129801706|NCT00570765|467242036|FG002|DB Phase|Protocol Violation|0|||
129801707|NCT00570765|467242037|FG003|DB Phase|Protocol Violation|0|||
129801708|NCT00570765|467242034|FG000|DB Phase|Adverse Event|3|||
129711788|NCT03465722|466907196|FG000|Overall Study|Lost to Follow-up|5|||
129711789|NCT03465722|466907197|FG001|Overall Study|Lost to Follow-up|3|||
129711790|NCT03465722|466907196|FG000|Overall Study|Administrative/Other|33|||
129711791|NCT03465722|466907197|FG001|Overall Study|Administrative/Other|32|||
129711792|NCT03465722|466907196|FG000|Overall Study|Not treated|1|||
129711793|NCT03465722|466907197|FG001|Overall Study|Not treated|2|||
129711794|NCT03465722|466907196|FG000|Overall Study|Sponsor decision|91|||
129711795|NCT03465722|466907197|FG001|Overall Study|Sponsor decision|98|||
129711796|NCT04940130|466907200|FG000|Overall Study|Travel|1|||
129711797|NCT04940130|466907201|FG001|Overall Study|Travel|0|||
129711798|NCT04940130|466907202|FG002|Overall Study|Travel|2|||
129711799|NCT04940130|466907200|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
129711800|NCT04940130|466907201|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
129711801|NCT04940130|466907202|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
129711802|NCT04940130|466907200|FG000|Overall Study|Adverse Event|0|||
129711803|NCT04940130|466907201|FG001|Overall Study|Adverse Event|0|||
129711804|NCT04940130|466907202|FG002|Overall Study|Adverse Event|2|||
129711805|NCT04940130|466907200|FG000|Overall Study|Disease progression/treatment failure|0|||
129711806|NCT04940130|466907201|FG001|Overall Study|Disease progression/treatment failure|0|||
129711807|NCT04940130|466907202|FG002|Overall Study|Disease progression/treatment failure|1|||
129711808|NCT04940130|466907200|FG000|Overall Study|Participant refusal|0|||
129711809|NCT04940130|466907201|FG001|Overall Study|Participant refusal|0|||
129711810|NCT04940130|466907202|FG002|Overall Study|Participant refusal|1|||
129801709|NCT00570765|467242035|FG001|DB Phase|Adverse Event|6|||
129801710|NCT00570765|467242036|FG002|DB Phase|Adverse Event|0|||
129801711|NCT00570765|467242037|FG003|DB Phase|Adverse Event|0|||
129801712|NCT00570765|467242034|FG000|DB Phase|Did Not Receive Study Drug|0|||
129801713|NCT00570765|467242035|FG001|DB Phase|Did Not Receive Study Drug|0|||
129801714|NCT00570765|467242036|FG002|DB Phase|Did Not Receive Study Drug|1|||
129801715|NCT00570765|467242037|FG003|DB Phase|Did Not Receive Study Drug|0|||
129801716|NCT00570765|467242034|FG000|LTSE Phase|Withdrawal by Subject|0|||
129801717|NCT00570765|467242035|FG001|LTSE Phase|Withdrawal by Subject|0|||
129711811|NCT02240121|466907205|FG000|Overall Study|Protocol Violation|1|||
129711812|NCT02240121|466907206|FG001|Overall Study|Protocol Violation|2|||
129711813|NCT02240121|466907205|FG000|Overall Study|Physician Decision|0|||
129711814|NCT02240121|466907206|FG001|Overall Study|Physician Decision|1|||
129711815|NCT02240121|466907205|FG000|Overall Study|Change in protocol interpretation|1|||
129711816|NCT02240121|466907206|FG001|Overall Study|Change in protocol interpretation|0|||
129711817|NCT02240121|466907205|FG000|Overall Study|Lack of Efficacy|2|||
129711818|NCT02240121|466907206|FG001|Overall Study|Lack of Efficacy|3|||
129711819|NCT02240121|466907205|FG000|Overall Study|Site closed|1|||
129711820|NCT02240121|466907206|FG001|Overall Study|Site closed|1|||
129711821|NCT02240121|466907205|FG000|Overall Study|Pregnancy|1|||
129711822|NCT02240121|466907206|FG001|Overall Study|Pregnancy|0|||
129711823|NCT02240121|466907205|FG000|Overall Study|Adverse Event|2|||
129711824|NCT02240121|466907206|FG001|Overall Study|Adverse Event|4|||
129711825|NCT02240121|466907205|FG000|Overall Study|Withdrawal by Subject|6|||
129711826|NCT02240121|466907206|FG001|Overall Study|Withdrawal by Subject|2|||
129711827|NCT02240121|466907205|FG000|Overall Study|Lost to Follow-up|3|||
129711828|NCT02240121|466907206|FG001|Overall Study|Lost to Follow-up|4|||
129711829|NCT02240121|466907205|FG000|Overall Study|Other than specified|1|||
129711830|NCT02240121|466907206|FG001|Overall Study|Other than specified|3|||
129711831|NCT04419467|466907209|FG000|Overall Study|Not treated with IP|0|||
129711832|NCT04419467|466907210|FG001|Overall Study|Not treated with IP|0|||
129711833|NCT04419467|466907211|FG002|Overall Study|Not treated with IP|2|||
129711834|NCT04419467|466907209|FG000|Overall Study|Adverse Event|0|||
129711835|NCT04419467|466907210|FG001|Overall Study|Adverse Event|2|||
129711836|NCT04419467|466907211|FG002|Overall Study|Adverse Event|0|||
129711837|NCT04419467|466907209|FG000|Overall Study|Death|1|||
129711838|NCT04419467|466907210|FG001|Overall Study|Death|0|||
129711839|NCT04419467|466907211|FG002|Overall Study|Death|0|||
129711840|NCT04419467|466907209|FG000|Overall Study|Lost to Follow-up|0|||
129711841|NCT04419467|466907210|FG001|Overall Study|Lost to Follow-up|1|||
129711842|NCT04419467|466907211|FG002|Overall Study|Lost to Follow-up|2|||
129711843|NCT04419467|466907209|FG000|Overall Study|Withdrawal by Subject|0|||
129711844|NCT04419467|466907210|FG001|Overall Study|Withdrawal by Subject|0|||
129711845|NCT04419467|466907211|FG002|Overall Study|Withdrawal by Subject|4|||
129711846|NCT04419467|466907209|FG000|Overall Study|Pandemic related|0|||
129711847|NCT04419467|466907210|FG001|Overall Study|Pandemic related|0|||
129711848|NCT04419467|466907211|FG002|Overall Study|Pandemic related|1|||
129711849|NCT04419467|466907209|FG000|Overall Study|Reason not known|1|||
129711850|NCT04419467|466907210|FG001|Overall Study|Reason not known|0|||
129711851|NCT04419467|466907211|FG002|Overall Study|Reason not known|0|||
129711852|NCT01925768|466907212|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129711853|NCT01925768|466907213|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129711854|NCT01925768|466907212|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129711855|NCT01925768|466907213|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
129711856|NCT01925768|466907212|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
129711857|NCT01925768|466907213|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
129711858|NCT01925768|466907212|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
129711859|NCT01925768|466907213|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
129711860|NCT01925768|466907212|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
129711861|NCT01925768|466907213|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
129711862|NCT01925768|466907212|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
129711863|NCT01925768|466907213|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
129711864|NCT01925768|466907212|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
129711865|NCT01925768|466907213|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
129711866|NCT01925768|466907212|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
129711867|NCT01925768|466907213|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
129711868|NCT01925768|466907212|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
129711869|NCT01925768|466907213|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
129711870|NCT01925768|466907212|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
129711871|NCT01925768|466907213|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
129711872|NCT01925768|466907212|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
129711873|NCT01925768|466907213|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
129711874|NCT02779777|466907216|FG000|Overall Study|Disease Progression|1|||
129711875|NCT02779777|466907217|FG001|Overall Study|Disease Progression|0|||
129711876|NCT02779777|466907218|FG002|Overall Study|Disease Progression|0|||
129711877|NCT02779777|466907216|FG000|Overall Study|Adverse Event|3|||
129711878|NCT02779777|466907217|FG001|Overall Study|Adverse Event|1|||
129711879|NCT02779777|466907218|FG002|Overall Study|Adverse Event|0|||
129711880|NCT02779777|466907216|FG000|Overall Study|Physician Decision|9|||
129711881|NCT02779777|466907217|FG001|Overall Study|Physician Decision|0|||
129711882|NCT02779777|466907218|FG002|Overall Study|Physician Decision|1|||
129711883|NCT02779777|466907216|FG000|Overall Study|Withdrawal by Subject|1|||
129711884|NCT02779777|466907217|FG001|Overall Study|Withdrawal by Subject|0|||
129711885|NCT02779777|466907218|FG002|Overall Study|Withdrawal by Subject|0|||
129711886|NCT04571060|466907219|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
129711887|NCT04571060|466907220|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
129711888|NCT04571060|466907219|FG000|Overall Study|Never treated migraine|47|||
129711889|NCT04571060|466907220|FG001|Overall Study|Never treated migraine|36|||
129711890|NCT04571060|466907219|FG000|Overall Study|Protocol Violation|4|||
129711891|NCT04571060|466907220|FG001|Overall Study|Protocol Violation|2|||
129711892|NCT04571060|466907219|FG000|Overall Study|Withdrawal by Subject|6|||
129711893|NCT04571060|466907220|FG001|Overall Study|Withdrawal by Subject|2|||
129711894|NCT04571060|466907219|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
129711895|NCT04571060|466907220|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
129711896|NCT00442416|466907221|FG000|Overall Study|Adverse Event|4|||
129711897|NCT00442416|466907222|FG001|Overall Study|Adverse Event|1|||
129711898|NCT00442416|466907221|FG000|Overall Study|Death|1|||
129711899|NCT00442416|466907222|FG001|Overall Study|Death|0|||
129711900|NCT00442416|466907221|FG000|Overall Study|Lack of Efficacy|2|||
129711901|NCT00442416|466907222|FG001|Overall Study|Lack of Efficacy|0|||
129711902|NCT00442416|466907221|FG000|Overall Study|Protocol Violation|2|||
129711903|NCT00442416|466907222|FG001|Overall Study|Protocol Violation|3|||
129711904|NCT00442416|466907221|FG000|Overall Study|Withdrew consent|1|||
129711905|NCT00442416|466907222|FG001|Overall Study|Withdrew consent|2|||
129711906|NCT00442416|466907221|FG000|Overall Study|Administrative/Other|27|||
129711907|NCT00442416|466907222|FG001|Overall Study|Administrative/Other|33|||
129711908|NCT00087698|466907223|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
129711909|NCT00087698|466907223|FG000|Overall Study|Death from Other Causes|3|||
129711910|NCT00087698|466907223|FG000|Overall Study|Adverse Event|4|||
129711911|NCT00087698|466907223|FG000|Overall Study|Withdrawal by Subject|4|||
129711912|NCT00087698|466907223|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
129711913|NCT00087698|466907223|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
129711914|NCT00087698|466907223|FG000|Overall Study|Clinical Relapse|1|||
129711915|NCT00087698|466907223|FG000|Overall Study|Death from Study Disease|2|||
129711916|NCT00087698|466907223|FG000|Overall Study|Death from Study Drug Toxicity|2|||
129711917|NCT00087698|466907223|FG000|Overall Study|Protocol Violation|1|||
129711918|NCT01284959|466907227|FG000|Overall Study|Withdrawal by Subject|1|||
129711919|NCT01284959|466907228|FG001|Overall Study|Withdrawal by Subject|0|||
129711920|NCT01284959|466907229|FG002|Overall Study|Withdrawal by Subject|0|||
129711921|NCT01284959|466907227|FG000|Overall Study|Adverse Event|0|||
129711922|NCT01284959|466907228|FG001|Overall Study|Adverse Event|0|||
129711923|NCT01284959|466907229|FG002|Overall Study|Adverse Event|1|||
129711924|NCT00142792|466907230|FG000|Overall Study|Death|0|||
129711925|NCT00142792|466907231|FG001|Overall Study|Death|0|||
129711926|NCT00142792|466907232|FG002|Overall Study|Death|1|||
129711927|NCT00142792|466907230|FG000|Overall Study|Withdrawal by Subject|3|||
129711928|NCT00142792|466907231|FG001|Overall Study|Withdrawal by Subject|2|||
129801718|NCT00570765|467242036|FG002|LTSE Phase|Withdrawal by Subject|0|||
129801719|NCT00570765|467242037|FG003|LTSE Phase|Withdrawal by Subject|1|||
129801720|NCT00570765|467242034|FG000|LTSE Phase|Adverse Event|0|||
129801721|NCT00570765|467242035|FG001|LTSE Phase|Adverse Event|0|||
129711929|NCT00142792|466907232|FG002|Overall Study|Withdrawal by Subject|3|||
129711930|NCT00142792|466907230|FG000|Overall Study|Lost to Follow-up|8|||
129711931|NCT00142792|466907231|FG001|Overall Study|Lost to Follow-up|11|||
129711932|NCT00142792|466907232|FG002|Overall Study|Lost to Follow-up|7|||
129711933|NCT00142792|466907230|FG000|Overall Study|No category|1|||
129711934|NCT00142792|466907231|FG001|Overall Study|No category|2|||
129711935|NCT00142792|466907232|FG002|Overall Study|No category|1|||
129711936|NCT03816176|466907237|FG000|Overall Study|Miscellaneous|5|||
129711937|NCT03816176|466907237|FG000|Overall Study|Lack of Efficacy|4|||
129711938|NCT03816176|466907237|FG000|Overall Study|Adverse Event|3|||
129711939|NCT00756275|466908480|FG000|Overall Study|Lost to Follow-up|25|||
129711940|NCT00756275|466908481|FG001|Overall Study|Lost to Follow-up|21|||
129801722|NCT00570765|467242036|FG002|LTSE Phase|Adverse Event|0|||
129711941|NCT00756275|466908480|FG000|Overall Study|Withdrawal by Subject|4|||
129711942|NCT00756275|466908481|FG001|Overall Study|Withdrawal by Subject|7|||
129711943|NCT00938912|466908482|FG000|Overall Study|Withdrawal by Subject|28|||
129801723|NCT00570765|467242037|FG003|LTSE Phase|Adverse Event|7|||
129711944|NCT00938912|466908482|FG000|Overall Study|Lost to Follow-up|4|||
129711945|NCT00938912|466908482|FG000|Overall Study|Lack of Efficacy|43|||
129711946|NCT00938912|466908482|FG000|Overall Study|Adverse event, non-fatal|24|||
129711947|NCT00938912|466908482|FG000|Overall Study|Adverse event, fatal|1|||
129711948|NCT00938912|466908482|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
129444238|NCT03873493|465927264|FG000|Overall Study|Study Terminated by Sponsor|1|||
129444239|NCT03873493|465927264|FG000|Overall Study|Other|2|||
129444240|NCT00440700|465927267|FG000|Overall Study|Withdrawal by Subject|8|||
129444241|NCT00440700|465927268|FG001|Overall Study|Withdrawal by Subject|8|||
129711949|NCT00938912|466908482|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
129711950|NCT00938912|466908482|FG000|Overall Study|Participant needed prohibit medication|1|||
129711951|NCT00938912|466908482|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
129711952|NCT00938912|466908482|FG000|Overall Study|Did not meet Eligibility criteria|1|||
129711953|NCT00938912|466908482|FG000|Overall Study|Participant relocated not related to AE|1|||
129711954|NCT00938912|466908482|FG000|Overall Study|Participant moved to another city|1|||
129711955|NCT00938912|466908482|FG000|Overall Study|Participant experienced break through seizures|1|||
129711956|NCT00938912|466908482|FG000|Overall Study|No longer wished to participate in the study|1|||
129711957|NCT00938912|466908482|FG000|Overall Study|Protocol Deviation|2|||
129711958|NCT00456755|466908486|FG000|Overall Study|Lost to Follow-up|2|||
129711959|NCT00456755|466908487|FG001|Overall Study|Lost to Follow-up|1|||
129711960|NCT06164691|466908488|FG000|Overall Study|Withdrawal by Subject|2|||
129711961|NCT06164691|466908489|FG001|Overall Study|Withdrawal by Subject|0|||
129711962|NCT06164691|466908490|FG002|Overall Study|Withdrawal by Subject|0|||
129711963|NCT02477527|466908493|FG000|Overall Study|Lost to Follow-up|2|||
129711964|NCT02477527|466908493|FG000|Overall Study|Withdrawal by Subject|1|||
129711965|NCT02477527|466908493|FG000|Overall Study|Screen Failure|3|||
129711966|NCT01428219|466908503|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
129711967|NCT03432494|466908504|FG000|Overall Study|Death|1|||
129711968|NCT03432494|466908504|FG000|Overall Study|Noncompliance|1|||
129711969|NCT01696773|466908505|FG000|Days 15-27, Washout|Adverse Event|1|||
129711970|NCT01696773|466908506|FG001|Days 15-27, Washout|Adverse Event|0|||
129711971|NCT00347932|466908509|FG000|Overall Study|Adverse Event|4|||
129711972|NCT00347932|466908510|FG001|Overall Study|Adverse Event|5|||
129711973|NCT00347932|466908509|FG000|Overall Study|Lack of Efficacy|3|||
129711974|NCT00347932|466908510|FG001|Overall Study|Lack of Efficacy|14|||
129711975|NCT00347932|466908509|FG000|Overall Study|Lost to Follow-up|10|||
129711976|NCT00347932|466908510|FG001|Overall Study|Lost to Follow-up|9|||
129711977|NCT00347932|466908509|FG000|Overall Study|Withdrawal by Subject|10|||
129711978|NCT00347932|466908510|FG001|Overall Study|Withdrawal by Subject|16|||
129711979|NCT00347932|466908509|FG000|Overall Study|Did not meet inclusion criteria|4|||
129711980|NCT00347932|466908510|FG001|Overall Study|Did not meet inclusion criteria|8|||
129711981|NCT04512001|466908511|FG000|Week 0 to Week 24|Adverse Event|14|||
129711982|NCT04512001|466908512|FG001|Week 0 to Week 24|Adverse Event|10|||
129711983|NCT04512001|466908513|FG002|Week 0 to Week 24|Adverse Event|0|||
129711984|NCT04512001|466908514|FG003|Week 0 to Week 24|Adverse Event|0|||
129711985|NCT04512001|466908515|FG004|Week 0 to Week 24|Adverse Event|0|||
129711986|NCT04512001|466908511|FG000|Week 0 to Week 24|Death|0|||
129711987|NCT04512001|466908512|FG001|Week 0 to Week 24|Death|2|||
129711988|NCT04512001|466908513|FG002|Week 0 to Week 24|Death|0|||
129711989|NCT04512001|466908514|FG003|Week 0 to Week 24|Death|0|||
129711990|NCT04512001|466908515|FG004|Week 0 to Week 24|Death|0|||
129711991|NCT04512001|466908511|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
129711992|NCT04512001|466908512|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
129711993|NCT04512001|466908513|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
129711994|NCT04512001|466908514|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
129711995|NCT04512001|466908515|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
129711996|NCT04512001|466908511|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
129711997|NCT04512001|466908512|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
129711998|NCT04512001|466908513|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
129711999|NCT04512001|466908514|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
129712000|NCT04512001|466908515|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
129712001|NCT04512001|466908511|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
129712002|NCT04512001|466908512|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129712003|NCT04512001|466908513|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129712004|NCT04512001|466908514|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129712005|NCT04512001|466908515|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
129712006|NCT04512001|466908511|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129444242|NCT00440700|465927269|FG002|Overall Study|Withdrawal by Subject|4|||
129712007|NCT04512001|466908512|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
129712008|NCT04512001|466908513|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129712009|NCT04512001|466908514|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129712010|NCT04512001|466908515|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
129712011|NCT04512001|466908511|FG000|Week 24 to Week 63|Adverse Event|0|||
129712012|NCT04512001|466908512|FG001|Week 24 to Week 63|Adverse Event|0|||
129712013|NCT04512001|466908513|FG002|Week 24 to Week 63|Adverse Event|13|||
129712014|NCT04512001|466908514|FG003|Week 24 to Week 63|Adverse Event|8|||
129444243|NCT01096342|465927270|FG000|Overall Study|Protocol Violation|1|||
129712015|NCT04512001|466908515|FG004|Week 24 to Week 63|Adverse Event|6|||
129712016|NCT04512001|466908511|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
129712017|NCT04512001|466908512|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
129712018|NCT04512001|466908513|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
129712019|NCT04512001|466908514|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
129712020|NCT04512001|466908515|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
129712021|NCT04512001|466908511|FG000|Week 24 to Week 63|Death|0|||
129712022|NCT04512001|466908512|FG001|Week 24 to Week 63|Death|0|||
129712023|NCT04512001|466908513|FG002|Week 24 to Week 63|Death|0|||
129712024|NCT04512001|466908514|FG003|Week 24 to Week 63|Death|1|||
129712025|NCT04512001|466908515|FG004|Week 24 to Week 63|Death|1|||
129712026|NCT04512001|466908511|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
129712027|NCT04512001|466908512|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
129891283|NCT00162942|467559697|FG000|Overall Study|Withdrawal by Subject|3|||
129891284|NCT00162942|467559698|FG001|Overall Study|Withdrawal by Subject|6|||
129891285|NCT00162942|467559697|FG000|Overall Study|Physician Decision|1|||
129891286|NCT00162942|467559698|FG001|Overall Study|Physician Decision|0|||
129712028|NCT04512001|466908513|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
129712029|NCT04512001|466908514|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
129712030|NCT04512001|466908515|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
129712031|NCT04512001|466908511|FG000|Week 24 to Week 63|Miscellaneous|0|||
129712032|NCT04512001|466908512|FG001|Week 24 to Week 63|Miscellaneous|0|||
129712033|NCT04512001|466908513|FG002|Week 24 to Week 63|Miscellaneous|3|||
129712034|NCT04512001|466908514|FG003|Week 24 to Week 63|Miscellaneous|2|||
129712035|NCT04512001|466908515|FG004|Week 24 to Week 63|Miscellaneous|1|||
129712036|NCT02776683|466908516|FG000|Pre-switch Period|Protocol Violation|1|||
129712037|NCT02776683|466908517|FG001|Pre-switch Period|Protocol Violation|0|||
129712038|NCT02776683|466908516|FG000|Pre-switch Period|Adverse Event|21|||
129712039|NCT02776683|466908517|FG001|Pre-switch Period|Adverse Event|0|||
129712040|NCT02776683|466908516|FG000|Pre-switch Period|Withdrawal by Subject|9|||
129712041|NCT02776683|466908517|FG001|Pre-switch Period|Withdrawal by Subject|0|||
129712042|NCT02776683|466908516|FG000|Pre-switch Period|Physician Decision|7|||
129712043|NCT02776683|466908517|FG001|Pre-switch Period|Physician Decision|0|||
129712044|NCT02776683|466908516|FG000|Pre-switch Period|Progressive disease|39|||
129712045|NCT02776683|466908517|FG001|Pre-switch Period|Progressive disease|0|||
129712046|NCT02776683|466908516|FG000|Pre-switch Period|Other than listed|3|||
129712047|NCT02776683|466908517|FG001|Pre-switch Period|Other than listed|0|||
129712048|NCT02776683|466908516|FG000|Post-switch Period|Adverse Event|0|||
129712049|NCT02776683|466908517|FG001|Post-switch Period|Adverse Event|3|||
129712050|NCT02776683|466908516|FG000|Post-switch Period|Withdrawal by Subject|0|||
129712051|NCT02776683|466908517|FG001|Post-switch Period|Withdrawal by Subject|2|||
129712052|NCT02776683|466908516|FG000|Post-switch Period|Physician Decision|0|||
129712053|NCT02776683|466908517|FG001|Post-switch Period|Physician Decision|3|||
129712054|NCT02776683|466908516|FG000|Post-switch Period|Progressive disease|0|||
129801724|NCT00570765|467242034|FG000|LTSE Phase|Physician Decision|0|||
129801725|NCT00570765|467242035|FG001|LTSE Phase|Physician Decision|0|||
129801726|NCT00570765|467242036|FG002|LTSE Phase|Physician Decision|0|||
129801727|NCT00570765|467242037|FG003|LTSE Phase|Physician Decision|4|||
129801728|NCT03711266|467242038|FG000|Overall Study|Lost to Follow-up|10|||
129801729|NCT00057876|467242039|FG000|Overall Study|Adverse Event|8|||
129801730|NCT00057876|467242040|FG001|Overall Study|Adverse Event|8|||
129801731|NCT00057876|467242039|FG000|Overall Study|Death|2|||
129801732|NCT00057876|467242040|FG001|Overall Study|Death|1|||
129801733|NCT00057876|467242039|FG000|Overall Study|Withdrawal by Subject|5|||
129801734|NCT00057876|467242040|FG001|Overall Study|Withdrawal by Subject|6|||
129801735|NCT00057876|467242039|FG000|Overall Study|Lack of Efficacy|10|||
129801736|NCT00057876|467242040|FG001|Overall Study|Lack of Efficacy|8|||
129801737|NCT00057876|467242039|FG000|Overall Study|Ineligible|1|||
129712055|NCT02776683|466908517|FG001|Post-switch Period|Progressive disease|20|||
129712056|NCT02776683|466908516|FG000|Post-switch Period|Other than listed|0|||
129712057|NCT02776683|466908517|FG001|Post-switch Period|Other than listed|15|||
129712058|NCT04232943|466908522|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
129712059|NCT04232943|466908523|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
129891287|NCT00162942|467559697|FG000|Overall Study|Enter Open-Label Study|76|||
129891288|NCT00162942|467559698|FG001|Overall Study|Enter Open-Label Study|35|||
129712060|NCT04232943|466908524|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
129712061|NCT04232943|466908522|FG000|Overall Study|Withdrawal by Subject|1|||
129712062|NCT04232943|466908523|FG001|Overall Study|Withdrawal by Subject|1|||
129712063|NCT04232943|466908524|FG002|Overall Study|Withdrawal by Subject|0|||
129712064|NCT02298868|466908526|FG000|Overall Study|Adverse Event|1|||
129801738|NCT00057876|467242040|FG001|Overall Study|Ineligible|2|||
129801739|NCT00057876|467242039|FG000|Overall Study|other reason|2|||
129801740|NCT00057876|467242040|FG001|Overall Study|other reason|2|||
129801741|NCT00057876|467242039|FG000|Overall Study|other complicating disease|1|||
129801742|NCT00057876|467242040|FG001|Overall Study|other complicating disease|0|||
129801743|NCT00437320|467242043|FG000|Overall Study|Participant request|2|||
129801744|NCT00437320|467242044|FG001|Overall Study|Participant request|1|||
129801745|NCT00437320|467242045|FG002|Overall Study|Participant request|4|||
129801746|NCT01649804|467242052|FG000|Overall Study|Administrative/Other|8|||
129801747|NCT02456103|467242053|FG000|Overall Study|Study Closure|207|||
129801748|NCT02456103|467242053|FG000|Overall Study|Physician Decision|1|||
129712065|NCT02298868|466908526|FG000|Overall Study|Death|1|||
129712066|NCT02298868|466908526|FG000|Overall Study|Patient underwent transplant|1|||
129712067|NCT01000506|466908527|FG000|Overall Study|Adverse Event|6|||
129712068|NCT01000506|466908528|FG001|Overall Study|Adverse Event|5|||
129712069|NCT01000506|466908529|FG002|Overall Study|Adverse Event|8|||
129712070|NCT01000506|466908530|FG003|Overall Study|Adverse Event|9|||
129712071|NCT01000506|466908527|FG000|Overall Study|Lack of Efficacy|8|||
129712072|NCT01000506|466908528|FG001|Overall Study|Lack of Efficacy|6|||
129712073|NCT01000506|466908529|FG002|Overall Study|Lack of Efficacy|4|||
129712074|NCT01000506|466908530|FG003|Overall Study|Lack of Efficacy|4|||
129712075|NCT01000506|466908527|FG000|Overall Study|Protocol Violation|1|||
129712076|NCT01000506|466908528|FG001|Overall Study|Protocol Violation|1|||
129712077|NCT01000506|466908529|FG002|Overall Study|Protocol Violation|0|||
129712078|NCT01000506|466908530|FG003|Overall Study|Protocol Violation|0|||
129712079|NCT01000506|466908527|FG000|Overall Study|Lost to Follow-up|1|||
129712080|NCT01000506|466908528|FG001|Overall Study|Lost to Follow-up|1|||
129712081|NCT01000506|466908529|FG002|Overall Study|Lost to Follow-up|4|||
129712082|NCT01000506|466908530|FG003|Overall Study|Lost to Follow-up|0|||
129712083|NCT01000506|466908527|FG000|Overall Study|Physician Decision|1|||
129712084|NCT01000506|466908528|FG001|Overall Study|Physician Decision|3|||
129712085|NCT01000506|466908529|FG002|Overall Study|Physician Decision|3|||
129712086|NCT01000506|466908530|FG003|Overall Study|Physician Decision|3|||
129712087|NCT01000506|466908527|FG000|Overall Study|Withdrawal by Subject|11|||
129712088|NCT01000506|466908528|FG001|Overall Study|Withdrawal by Subject|8|||
129712089|NCT01000506|466908529|FG002|Overall Study|Withdrawal by Subject|2|||
129712090|NCT01000506|466908530|FG003|Overall Study|Withdrawal by Subject|7|||
129712091|NCT02379052|466908531|FG000|Overall Study|Protocol Violation|0|||
129712092|NCT02379052|466908532|FG001|Overall Study|Protocol Violation|1|||
129712093|NCT02379052|466908531|FG000|Overall Study|Adverse Event|0|||
129712094|NCT02379052|466908532|FG001|Overall Study|Adverse Event|1|||
129712095|NCT02379052|466908531|FG000|Overall Study|Physician Decision|1|||
129712096|NCT02379052|466908532|FG001|Overall Study|Physician Decision|1|||
129712097|NCT02379052|466908531|FG000|Overall Study|Withdrawal by Subject|2|||
129712098|NCT02379052|466908532|FG001|Overall Study|Withdrawal by Subject|0|||
129712099|NCT02379052|466908531|FG000|Overall Study|Lost to Follow-up|2|||
129712100|NCT02379052|466908532|FG001|Overall Study|Lost to Follow-up|1|||
129712101|NCT02379052|466908531|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
129712102|NCT02379052|466908532|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
129712103|NCT02379052|466908531|FG000|Overall Study|Subject was Incarcerated|0|||
129712104|NCT02379052|466908532|FG001|Overall Study|Subject was Incarcerated|1|||
129712105|NCT03637491|466908533|FG000|Overall Study|Death|9|||
129712106|NCT03637491|466908534|FG001|Overall Study|Death|9|||
129712107|NCT03637491|466908535|FG002|Overall Study|Death|5|||
129712108|NCT03637491|466908536|FG003|Overall Study|Death|3|||
129712109|NCT03637491|466908533|FG000|Overall Study|Lost to Follow-up|0|||
129712110|NCT03637491|466908534|FG001|Overall Study|Lost to Follow-up|1|||
129712111|NCT03637491|466908535|FG002|Overall Study|Lost to Follow-up|0|||
129712112|NCT03637491|466908536|FG003|Overall Study|Lost to Follow-up|1|||
129712113|NCT03637491|466908533|FG000|Overall Study|Study Terminated By Sponsor|0|||
129712114|NCT03637491|466908534|FG001|Overall Study|Study Terminated By Sponsor|2|||
129712115|NCT03637491|466908535|FG002|Overall Study|Study Terminated By Sponsor|1|||
129801749|NCT02456103|467242053|FG000|Overall Study|Required prohibited medications|5|||
129444244|NCT04906616|465927271|FG000|Overall Study|Divorce|3|||
129712116|NCT03637491|466908536|FG003|Overall Study|Study Terminated By Sponsor|0|||
129712117|NCT03637491|466908533|FG000|Overall Study|Withdrawal by Subject|1|||
129444245|NCT04906616|465927272|FG001|Overall Study|Divorce|2|||
129712118|NCT03637491|466908534|FG001|Overall Study|Withdrawal by Subject|0|||
129712119|NCT03637491|466908535|FG002|Overall Study|Withdrawal by Subject|1|||
129712120|NCT03637491|466908536|FG003|Overall Study|Withdrawal by Subject|2|||
129712121|NCT00532844|466908537|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
129712122|NCT00532844|466908538|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
129712123|NCT00532844|466908537|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
129801750|NCT02456103|467242053|FG000|Overall Study|Protocol Violation|1|||
129801751|NCT02456103|467242053|FG000|Overall Study|Adverse Event|5|||
129801752|NCT02456103|467242053|FG000|Overall Study|Abnormal Laboratory Value|2|||
129801753|NCT02456103|467242053|FG000|Overall Study|Lost to Follow-up|1|||
129801754|NCT02456103|467242053|FG000|Overall Study|Withdrawal by Subject|24|||
129801755|NCT02028871|467242056|FG000|Overall Study|Positive urine drug screen|1|||
129801756|NCT02028871|467242057|FG001|Overall Study|Positive urine drug screen|1|||
129801757|NCT02028871|467242056|FG000|Overall Study|Withdrawal by Subject|1|||
129801758|NCT02028871|467242057|FG001|Overall Study|Withdrawal by Subject|2|||
129801759|NCT02028871|467242056|FG000|Overall Study|IV placement difficulty|1|||
129801760|NCT02028871|467242057|FG001|Overall Study|IV placement difficulty|0|||
129801761|NCT02028871|467242056|FG000|Overall Study|Current Illness|1|||
129801762|NCT02028871|467242057|FG001|Overall Study|Current Illness|0|||
129801763|NCT01916967|467242063|FG000|Overall Study|Adverse Event|0|||
129801764|NCT01916967|467242064|FG001|Overall Study|Adverse Event|0|||
129801765|NCT01916967|467242065|FG002|Overall Study|Adverse Event|2|||
129801766|NCT01916967|467242063|FG000|Overall Study|Lack of Efficacy|0|||
129801767|NCT01916967|467242064|FG001|Overall Study|Lack of Efficacy|0|||
129801768|NCT01916967|467242065|FG002|Overall Study|Lack of Efficacy|6|||
129801769|NCT01916967|467242063|FG000|Overall Study|Physician Decision|0|||
129712124|NCT00532844|466908538|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
129712125|NCT00532844|466908537|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
129712126|NCT00532844|466908538|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
129712127|NCT00532844|466908537|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
129712128|NCT00532844|466908538|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
129712129|NCT00532844|466908537|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
129712130|NCT00532844|466908538|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
129712131|NCT00003869|466908554|FG000|Overall Study|Adverse Event|14|||
129712132|NCT00003869|466908555|FG001|Overall Study|Adverse Event|3|||
129712133|NCT00003869|466908554|FG000|Overall Study|Withdrawal by Subject|21|||
129712134|NCT00003869|466908555|FG001|Overall Study|Withdrawal by Subject|3|||
129712135|NCT00003869|466908554|FG000|Overall Study|Death|1|||
129712136|NCT00003869|466908555|FG001|Overall Study|Death|2|||
129712137|NCT00003869|466908554|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
129712138|NCT00003869|466908555|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
129712139|NCT03364231|466908556|FG000|Overall Study|Adverse Event|1|||
129712140|NCT03364231|466908557|FG001|Overall Study|Adverse Event|4|||
129712141|NCT03364231|466908556|FG000|Overall Study|Death|1|||
129712142|NCT03364231|466908557|FG001|Overall Study|Death|0|||
129712143|NCT03364231|466908556|FG000|Overall Study|Investigator Decision|2|||
129712144|NCT03364231|466908557|FG001|Overall Study|Investigator Decision|2|||
129712145|NCT03364231|466908556|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
129712146|NCT03364231|466908557|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
129712147|NCT03364231|466908556|FG000|Overall Study|Withdrawal of Subject Consent|1|||
129712148|NCT03364231|466908557|FG001|Overall Study|Withdrawal of Subject Consent|0|||
129712149|NCT03364231|466908556|FG000|Overall Study|Reason Not Specified|1|||
129712150|NCT03364231|466908557|FG001|Overall Study|Reason Not Specified|0|||
129712151|NCT03364231|466908556|FG000|Overall Study|Disease Progression|0|||
129712152|NCT03364231|466908557|FG001|Overall Study|Disease Progression|6|||
129712153|NCT04068922|466908558|FG000|Overall Study|Lost to Follow-up|5|||
129712154|NCT04068922|466908558|FG000|Overall Study|Withdrawal by Subject|7|||
129712155|NCT04068922|466908558|FG000|Overall Study|Adverse Event|1|||
129712156|NCT03542266|466908559|FG000|Treatment Phase|Withdrawal by Subject|1|||
129712157|NCT03542266|466908559|FG000|Treatment Phase|Adverse Event|1|||
129712158|NCT03542266|466908559|FG000|Treatment Phase|PD|1|||
129712159|NCT01070979|466908567|FG000|Overall Study|Adverse Event|2|||
129712160|NCT01070979|466908568|FG001|Overall Study|Adverse Event|3|||
129712161|NCT01070979|466908569|FG002|Overall Study|Adverse Event|3|||
129712162|NCT01070979|466908567|FG000|Overall Study|Lost to Follow-up|2|||
129712163|NCT01070979|466908568|FG001|Overall Study|Lost to Follow-up|1|||
129712164|NCT01070979|466908569|FG002|Overall Study|Lost to Follow-up|1|||
129712165|NCT01070979|466908567|FG000|Overall Study|Protocol Violation|0|||
129712166|NCT01070979|466908568|FG001|Overall Study|Protocol Violation|2|||
129712167|NCT01070979|466908569|FG002|Overall Study|Protocol Violation|6|||
129712168|NCT01070979|466908567|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
129712169|NCT01070979|466908568|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
129712170|NCT01070979|466908569|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
129712171|NCT01070979|466908567|FG000|Overall Study|Withdrawal by Subject|3|||
129712172|NCT01070979|466908568|FG001|Overall Study|Withdrawal by Subject|1|||
129712173|NCT01070979|466908569|FG002|Overall Study|Withdrawal by Subject|1|||
129712174|NCT01070979|466908567|FG000|Overall Study|No study drug taken|0|||
129712175|NCT01070979|466908568|FG001|Overall Study|No study drug taken|1|||
129712176|NCT01070979|466908569|FG002|Overall Study|No study drug taken|0|||
129712177|NCT03484429|466908571|FG000|Overall Study|Withdrawal by Subject|1|||
129712178|NCT03484429|466908572|FG001|Overall Study|Withdrawal by Subject|0|||
129712179|NCT03484429|466908571|FG000|Overall Study|Adverse Event|2|||
129712180|NCT03484429|466908572|FG001|Overall Study|Adverse Event|0|||
129712181|NCT05653700|466908573|FG000|Overall Study|Non Responders|9|||
129712182|NCT05653700|466908574|FG001|Overall Study|Non Responders|0|||
129712183|NCT02573948|466908577|FG000|Longitudinal Cohort|Death|9|||
129712184|NCT02573948|466908577|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
129712185|NCT02573948|466908577|FG000|Longitudinal Cohort|Incarcerated|25|||
129712186|NCT00707993|466908578|FG000|Overall Study|Adverse Event|16|||
129712187|NCT00707993|466908579|FG001|Overall Study|Adverse Event|20|||
129712188|NCT00707993|466908578|FG000|Overall Study|Protocol Violation|4|||
129712189|NCT00707993|466908579|FG001|Overall Study|Protocol Violation|7|||
129712190|NCT00707993|466908578|FG000|Overall Study|Lost to Follow-up|0|||
129712191|NCT00707993|466908579|FG001|Overall Study|Lost to Follow-up|4|||
129712192|NCT00707993|466908578|FG000|Overall Study|Withdrawal by Subject|12|||
129712193|NCT00707993|466908579|FG001|Overall Study|Withdrawal by Subject|16|||
129712194|NCT00707993|466908578|FG000|Overall Study|Hyperglycemic Rescue|55|||
129712195|NCT00707993|466908579|FG001|Overall Study|Hyperglycemic Rescue|47|||
129712196|NCT00707993|466908578|FG000|Overall Study|Other|2|||
129712197|NCT00707993|466908579|FG001|Overall Study|Other|0|||
129712198|NCT01913327|466908584|FG000|Overall Study|Withdrawal by Subject|0|||
129712199|NCT01913327|466908585|FG001|Overall Study|Withdrawal by Subject|1|||
129712200|NCT05414175|466908592|FG000|Overall Study|Withdrawal by Subject|1|||
129712201|NCT05414175|466908592|FG000|Overall Study|Other Reasons|1|||
129712202|NCT02112656|466908595|FG000|Overall Study|Death|78|||
129712203|NCT02112656|466908596|FG001|Overall Study|Death|82|||
129712204|NCT02112656|466908595|FG000|Overall Study|Withdrawal by Subject|9|||
129712205|NCT02112656|466908596|FG001|Overall Study|Withdrawal by Subject|11|||
129712206|NCT02112656|466908595|FG000|Overall Study|Lost to Follow-up|2|||
129712207|NCT02112656|466908596|FG001|Overall Study|Lost to Follow-up|4|||
129712208|NCT02112656|466908595|FG000|Overall Study|Noncompliance|1|||
129712209|NCT02112656|466908596|FG001|Overall Study|Noncompliance|2|||
129712210|NCT03761056|466908597|FG000|Overall Study|Death|8|||
129712211|NCT03761056|466908597|FG000|Overall Study|Enrolled but never treated|2|||
129712212|NCT03761056|466908597|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
129712213|NCT03761056|466908597|FG000|Overall Study|Investigator decision|1|||
129712214|NCT04749745|466908598|FG000|Overall Study|Withdrawal by Subject|1|||
129712215|NCT04749745|466908599|FG001|Overall Study|Withdrawal by Subject|0|||
129712216|NCT03965403|466908606|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
129712217|NCT00552071|466909850|FG000|Overall Study|Adverse Event|1|||
129712218|NCT00552071|466909851|FG001|Overall Study|Adverse Event|0|||
129712219|NCT00552071|466909850|FG000|Overall Study|Lack of Efficacy|1|||
129712220|NCT00552071|466909851|FG001|Overall Study|Lack of Efficacy|0|||
129712221|NCT00552071|466909850|FG000|Overall Study|Physician Decision|1|||
129712222|NCT00552071|466909851|FG001|Overall Study|Physician Decision|0|||
129712223|NCT00552071|466909850|FG000|Overall Study|Pregnancy|1|||
129712224|NCT00552071|466909851|FG001|Overall Study|Pregnancy|0|||
129712225|NCT00552071|466909850|FG000|Overall Study|Death|0|||
129712226|NCT00552071|466909851|FG001|Overall Study|Death|1|||
129712227|NCT00552071|466909850|FG000|Overall Study|Withdrawal by Subject|0|||
129712228|NCT00552071|466909851|FG001|Overall Study|Withdrawal by Subject|1|||
129712229|NCT01979614|466909852|FG000|Overall Study|Adverse Event|1|||
129712230|NCT01979614|466909853|FG001|Overall Study|Adverse Event|1|||
129712231|NCT03333928|466909854|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
129712232|NCT03333928|466909855|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
129712233|NCT03333928|466909856|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
129712234|NCT03333928|466909854|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
129712235|NCT03333928|466909855|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
129712236|NCT03333928|466909856|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
129712237|NCT03333928|466909854|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
129801770|NCT01916967|467242064|FG001|Overall Study|Physician Decision|0|||
129801771|NCT01916967|467242065|FG002|Overall Study|Physician Decision|1|||
129712238|NCT03333928|466909855|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
129712239|NCT03333928|466909856|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
129712240|NCT03333928|466909854|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
129712241|NCT03333928|466909855|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
129712242|NCT03333928|466909856|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
129712243|NCT03333928|466909854|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
129712244|NCT03333928|466909855|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
129712245|NCT03333928|466909856|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
129712246|NCT03333928|466909854|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
129712247|NCT03333928|466909855|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
129712248|NCT03333928|466909856|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
129712249|NCT03333928|466909854|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
129712250|NCT03333928|466909855|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
129712251|NCT03333928|466909856|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
129712252|NCT03333928|466909854|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
129712253|NCT03333928|466909855|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
129712254|NCT03333928|466909856|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
129712255|NCT04072835|466909857|FG000|Overall Study|Overall trial ended|603|||
129712256|NCT04072835|466909857|FG000|Overall Study|Ablation|97|||
129712257|NCT04072835|466909857|FG000|Overall Study|Withdrawal of consent|66|||
129712258|NCT04072835|466909857|FG000|Overall Study|Physician Decision|50|||
129712259|NCT04072835|466909857|FG000|Overall Study|Lost to Follow-up|39|||
129712260|NCT04072835|466909857|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
129712261|NCT04072835|466909857|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
129712262|NCT04072835|466909857|FG000|Overall Study|Adverse Event|25|||
129712263|NCT04072835|466909857|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
129712264|NCT04072835|466909857|FG000|Overall Study|Death|11|||
129712265|NCT04072835|466909857|FG000|Overall Study|Participant felt the drug did not work|8|||
129712266|NCT04072835|466909857|FG000|Overall Study|Participant tolerability|5|||
129712267|NCT04072835|466909857|FG000|Overall Study|Missing|5|||
129712268|NCT04072835|466909857|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
129712269|NCT04072835|466909857|FG000|Overall Study|Pregnancy|3|||
129712270|NCT04723355|466909858|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
129712271|NCT04723355|466909858|FG000|Overall Study|Errors in the informed consent form|2|||
129712272|NCT00841776|466909861|FG000|Overall Study|Lack of Efficacy|0|||
129712273|NCT00841776|466909862|FG001|Overall Study|Lack of Efficacy|1|||
129712274|NCT00841776|466909861|FG000|Overall Study|Lost to Follow-up|2|||
129712275|NCT00841776|466909862|FG001|Overall Study|Lost to Follow-up|1|||
129712276|NCT00841776|466909861|FG000|Overall Study|Withdrawal by Subject|0|||
129712277|NCT00841776|466909862|FG001|Overall Study|Withdrawal by Subject|1|||
129712278|NCT02479880|466909871|FG000|Overall Study|Study Terminated by Sponsor|13|||
129712279|NCT02479880|466909872|FG001|Overall Study|Study Terminated by Sponsor|12|||
129712280|NCT02479880|466909871|FG000|Overall Study|Pregnancy|0|||
129712281|NCT02479880|466909872|FG001|Overall Study|Pregnancy|1|||
129712282|NCT00856635|466909886|FG000|Overall Study|Lost to Follow-up|2|||
129712283|NCT00856635|466909887|FG001|Overall Study|Lost to Follow-up|5|||
129712284|NCT00856635|466909886|FG000|Overall Study|Pregnancy|1|||
129712285|NCT00856635|466909887|FG001|Overall Study|Pregnancy|0|||
129712286|NCT00856635|466909886|FG000|Overall Study|Withdrawal by Subject|3|||
129712287|NCT00856635|466909887|FG001|Overall Study|Withdrawal by Subject|1|||
129712288|NCT00856635|466909886|FG000|Overall Study|Serious Adverse Event|1|||
129712289|NCT00856635|466909887|FG001|Overall Study|Serious Adverse Event|0|||
129712290|NCT00856635|466909886|FG000|Overall Study|Other|1|||
129712291|NCT00856635|466909887|FG001|Overall Study|Other|0|||
129712292|NCT00856635|466909886|FG000|Overall Study|Discontinued at Randomization|2|||
129712293|NCT00856635|466909887|FG001|Overall Study|Discontinued at Randomization|2|||
129712294|NCT01244035|466909888|FG000|Part 1: Period 1|Adverse Event|0|||
129712295|NCT01244035|466909889|FG001|Part 1: Period 1|Adverse Event|0|||
129712296|NCT01244035|466909890|FG002|Part 1: Period 1|Adverse Event|0|||
129801772|NCT01916967|467242063|FG000|Overall Study|Protocol Violation|0|||
129801773|NCT01916967|467242064|FG001|Overall Study|Protocol Violation|1|||
129801774|NCT01916967|467242065|FG002|Overall Study|Protocol Violation|0|||
129801775|NCT00568685|467242066|FG000|Overall Study|Adverse Event|2|||
129801776|NCT00568685|467242067|FG001|Overall Study|Adverse Event|3|||
129801777|NCT00568685|467242068|FG002|Overall Study|Adverse Event|3|||
129801778|NCT00568685|467242066|FG000|Overall Study|Withdrawal by Subject|7|||
129444246|NCT03739762|465927273|FG000|Overall Study|Lost to Follow-up|1|||
129712297|NCT01244035|466909891|FG003|Part 1: Period 1|Adverse Event|0|||
129712298|NCT01244035|466909892|FG004|Part 1: Period 1|Adverse Event|0|||
129712299|NCT01244035|466909893|FG005|Part 1: Period 1|Adverse Event|1|||
129712300|NCT01244035|466909888|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
129712301|NCT01244035|466909889|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
129801779|NCT00568685|467242067|FG001|Overall Study|Withdrawal by Subject|2|||
129801780|NCT00568685|467242068|FG002|Overall Study|Withdrawal by Subject|2|||
129801781|NCT00568685|467242066|FG000|Overall Study|Protocol Violation|1|||
129801782|NCT00568685|467242067|FG001|Overall Study|Protocol Violation|0|||
129801783|NCT00568685|467242068|FG002|Overall Study|Protocol Violation|0|||
129801784|NCT02038452|467242069|FG000|Overall Study|Withdrawal by Subject|7|||
129712302|NCT01244035|466909890|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
129712303|NCT01244035|466909891|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
129712304|NCT01244035|466909892|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
129801785|NCT02038452|467242070|FG001|Overall Study|Withdrawal by Subject|9|||
129801786|NCT02038452|467242069|FG000|Overall Study|Lost to Follow-up|31|||
129801787|NCT02038452|467242070|FG001|Overall Study|Lost to Follow-up|28|||
129712305|NCT01244035|466909893|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
129712306|NCT01244035|466909888|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
129712307|NCT01244035|466909889|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
129712308|NCT01244035|466909890|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
129712309|NCT01244035|466909891|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
129712310|NCT01244035|466909892|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
129712311|NCT01244035|466909893|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
129712312|NCT01244035|466909888|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129712313|NCT01244035|466909889|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129712314|NCT01244035|466909890|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
129712315|NCT01244035|466909891|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129712316|NCT01244035|466909892|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129712317|NCT01244035|466909893|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
129712318|NCT01244035|466909888|FG000|Part 1: Period 3|Adverse Event|0|||
129712319|NCT01244035|466909889|FG001|Part 1: Period 3|Adverse Event|0|||
129712320|NCT01244035|466909890|FG002|Part 1: Period 3|Adverse Event|0|||
129712321|NCT01244035|466909891|FG003|Part 1: Period 3|Adverse Event|0|||
129712322|NCT01244035|466909892|FG004|Part 1: Period 3|Adverse Event|0|||
129712323|NCT01244035|466909893|FG005|Part 1: Period 3|Adverse Event|1|||
129712324|NCT01244035|466909888|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
129712325|NCT01244035|466909889|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
129712326|NCT01244035|466909890|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
129712327|NCT01244035|466909891|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
129712328|NCT01244035|466909892|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
129712329|NCT01244035|466909893|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
129712330|NCT01244035|466909888|FG000|Part 1: Period 3|Protocol Deviation|0|||
129712331|NCT01244035|466909889|FG001|Part 1: Period 3|Protocol Deviation|1|||
129712332|NCT01244035|466909890|FG002|Part 1: Period 3|Protocol Deviation|0|||
129712333|NCT01244035|466909891|FG003|Part 1: Period 3|Protocol Deviation|0|||
129712334|NCT01244035|466909892|FG004|Part 1: Period 3|Protocol Deviation|0|||
129712335|NCT01244035|466909893|FG005|Part 1: Period 3|Protocol Deviation|0|||
129444247|NCT03739762|465927274|FG001|Overall Study|Lost to Follow-up|1|||
129444248|NCT03739762|465927273|FG000|Overall Study|Withdrawal by Subject|2|||
129444249|NCT03739762|465927274|FG001|Overall Study|Withdrawal by Subject|6|||
129444250|NCT02464228|465927277|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
129444251|NCT02464228|465927278|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
129444252|NCT02464228|465927279|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
129444253|NCT02464228|465927280|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
129444254|NCT02464228|465927277|FG000|Overall Study|Physician Decision|2|||
129444255|NCT02464228|465927278|FG001|Overall Study|Physician Decision|0|||
129444256|NCT02464228|465927279|FG002|Overall Study|Physician Decision|1|||
129444257|NCT02464228|465927280|FG003|Overall Study|Physician Decision|0|||
129712336|NCT03688919|466909896|FG000|Overall Study|Lost to Follow-up|2|||
129712337|NCT03688919|466909897|FG001|Overall Study|Lost to Follow-up|1|||
129712338|NCT03688919|466909896|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
129712339|NCT03688919|466909897|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
129712340|NCT02370368|466909898|FG000|Overall Study|Adverse Event|1|||
129712341|NCT02370368|466909899|FG001|Overall Study|Adverse Event|2|||
129444258|NCT02464228|465927277|FG000|Overall Study|Miscellaneous|1|||
129444259|NCT02464228|465927278|FG001|Overall Study|Miscellaneous|0|||
129712342|NCT02370368|466909898|FG000|Overall Study|Withdrawal by Subject|5|||
129712343|NCT02370368|466909899|FG001|Overall Study|Withdrawal by Subject|4|||
129712344|NCT03389308|466909902|FG000|Overall Study|Withdrawal by Subject|5|||
129712345|NCT03389308|466909902|FG000|Overall Study|Lost to Follow-up|3|||
129712346|NCT03389308|466909902|FG000|Overall Study|Adverse Event|2|||
129712347|NCT03389308|466909902|FG000|Overall Study|Sponsor Request|2|||
129712348|NCT03198767|466909903|FG000|Overall Study|Protocol Violation|0|||
129712349|NCT03198767|466909904|FG001|Overall Study|Protocol Violation|0|||
129712350|NCT03198767|466909905|FG002|Overall Study|Protocol Violation|0|||
129712351|NCT03198767|466909906|FG003|Overall Study|Protocol Violation|6|||
129712352|NCT03198767|466909907|FG004|Overall Study|Protocol Violation|0|||
129712353|NCT03198767|466909908|FG005|Overall Study|Protocol Violation|0|||
129712354|NCT03198767|466909909|FG006|Overall Study|Protocol Violation|0|||
129712355|NCT00570323|466909910|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
129712356|NCT00570323|466909911|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
129712357|NCT00570323|466909910|FG000|Started Treatment After Randomization|Protocol Violation|1|||
129712358|NCT00570323|466909911|FG001|Started Treatment After Randomization|Protocol Violation|0|||
129712359|NCT00570323|466909910|FG000|Started Treatment After Randomization|Physician Decision|1|||
129712360|NCT00570323|466909911|FG001|Started Treatment After Randomization|Physician Decision|0|||
129712361|NCT00570323|466909910|FG000|Complete Study After Start|Lost to Follow-up|0|||
129712362|NCT00570323|466909911|FG001|Complete Study After Start|Lost to Follow-up|1|||
129712363|NCT00570323|466909910|FG000|Complete Study After Start|Withdrawal by Subject|2|||
129712364|NCT00570323|466909911|FG001|Complete Study After Start|Withdrawal by Subject|0|||
129712365|NCT00570323|466909910|FG000|Complete Study After Start|Physician Decision|1|||
129712366|NCT00570323|466909911|FG001|Complete Study After Start|Physician Decision|0|||
129712367|NCT03896477|466909912|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
129712368|NCT03896477|466909913|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
129712369|NCT03896477|466909914|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
129712370|NCT03896477|466909912|FG000|Overall Study|Parent Requested Withdrawal|8|||
129712371|NCT03896477|466909913|FG001|Overall Study|Parent Requested Withdrawal|12|||
129712372|NCT03896477|466909914|FG002|Overall Study|Parent Requested Withdrawal|9|||
129712373|NCT03896477|466909912|FG000|Overall Study|Adverse Event|0|||
129712374|NCT03896477|466909913|FG001|Overall Study|Adverse Event|0|||
129712375|NCT03896477|466909914|FG002|Overall Study|Adverse Event|1|||
129712376|NCT03896477|466909912|FG000|Overall Study|Death|1|||
129712377|NCT03896477|466909913|FG001|Overall Study|Death|0|||
129712378|NCT03896477|466909914|FG002|Overall Study|Death|0|||
129712379|NCT03896477|466909912|FG000|Overall Study|Other|5|||
129712380|NCT03896477|466909913|FG001|Overall Study|Other|6|||
129712381|NCT03896477|466909914|FG002|Overall Study|Other|7|||
129801788|NCT01090973|467242075|FG000|Overall Study|Disease progression|1|||
129801789|NCT01626495|467242077|FG000|Overall Study|Adverse Event|3|||
129801790|NCT01626495|467242077|FG000|Overall Study|Disease progression|27|||
129801791|NCT01626495|467242077|FG000|Overall Study|Withdrawal by Subject|1|||
129801792|NCT01626495|467242077|FG000|Overall Study|Administrative problem|1|||
129801793|NCT01626495|467242077|FG000|Overall Study|Death|2|||
129801794|NCT01626495|467242077|FG000|Overall Study|Physician Decision|1|||
129801795|NCT01626495|467242077|FG000|Overall Study|New cancer therapy|16|||
129801796|NCT01626495|467242077|FG000|Overall Study|Manufacturing failure|1|||
129801797|NCT03643159|467242078|FG000|Overall Study|Adverse Event|1|||
129801798|NCT03643159|467242078|FG000|Overall Study|Withdrawal by Subject|1|||
129801799|NCT02887859|467242081|FG000|Overall Study|Ongoing|6|||
129801800|NCT02887859|467242081|FG000|Overall Study|Adverse Event|7|||
129801801|NCT02887859|467242081|FG000|Overall Study|Death|1|||
129801802|NCT02887859|467242081|FG000|Overall Study|Physician Decision|1|||
129801803|NCT01920555|467243385|FG000|Overall Study|Physician Decision|1|||
129801804|NCT01920555|467243386|FG001|Overall Study|Physician Decision|2|||
129444260|NCT02464228|465927279|FG002|Overall Study|Miscellaneous|1|||
129444261|NCT02464228|465927280|FG003|Overall Study|Miscellaneous|0|||
129444262|NCT02464228|465927277|FG000|Overall Study|Adverse Event|9|||
129712382|NCT03896477|466909912|FG000|Overall Study|Lost to Follow-up|2|||
129712383|NCT03896477|466909913|FG001|Overall Study|Lost to Follow-up|1|||
129712384|NCT03896477|466909914|FG002|Overall Study|Lost to Follow-up|1|||
129712385|NCT01791517|466909915|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
129712386|NCT01791517|466909916|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
129712387|NCT01791517|466909917|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
129712388|NCT01791517|466909918|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
129712389|NCT01791517|466909919|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
129712390|NCT01791517|466909920|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
129712391|NCT01791517|466909921|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
129712392|NCT01791517|466909922|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
129712393|NCT01791517|466909923|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
129801805|NCT01920555|467243387|FG002|Overall Study|Physician Decision|1|||
129801806|NCT01920555|467243388|FG003|Overall Study|Physician Decision|2|||
129801807|NCT01920555|467243389|FG004|Overall Study|Physician Decision|0|||
129712394|NCT01791517|466909924|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
129712395|NCT01791517|466909925|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
129712396|NCT01791517|466909926|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
129712397|NCT01791517|466909915|FG000|Phase I: Period 1|Adverse Event|0|||
129712398|NCT01791517|466909916|FG001|Phase I: Period 1|Adverse Event|0|||
129712399|NCT01791517|466909917|FG002|Phase I: Period 1|Adverse Event|1|||
129712400|NCT01791517|466909918|FG003|Phase I: Period 1|Adverse Event|1|||
129712401|NCT01791517|466909919|FG004|Phase I: Period 1|Adverse Event|0|||
129712402|NCT01791517|466909920|FG005|Phase I: Period 1|Adverse Event|0|||
129712403|NCT01791517|466909921|FG006|Phase I: Period 1|Adverse Event|0|||
129712404|NCT01791517|466909922|FG007|Phase I: Period 1|Adverse Event|0|||
129712405|NCT01791517|466909923|FG008|Phase I: Period 1|Adverse Event|0|||
129712406|NCT01791517|466909924|FG009|Phase I: Period 1|Adverse Event|0|||
129712407|NCT01791517|466909925|FG010|Phase I: Period 1|Adverse Event|0|||
129712408|NCT01791517|466909926|FG011|Phase I: Period 1|Adverse Event|0|||
129712409|NCT01791517|466909915|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
129712410|NCT01791517|466909916|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712411|NCT01791517|466909917|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712412|NCT01791517|466909918|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712413|NCT01791517|466909919|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712414|NCT01791517|466909920|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712415|NCT01791517|466909921|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712416|NCT01791517|466909922|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712417|NCT01791517|466909923|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712418|NCT01791517|466909924|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712419|NCT01791517|466909925|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712420|NCT01791517|466909926|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
129712421|NCT01791517|466909915|FG000|Phase I: Period 1|Protocol Violation|0|||
129712422|NCT01791517|466909916|FG001|Phase I: Period 1|Protocol Violation|1|||
129712423|NCT01791517|466909917|FG002|Phase I: Period 1|Protocol Violation|0|||
129712424|NCT01791517|466909918|FG003|Phase I: Period 1|Protocol Violation|0|||
129712425|NCT01791517|466909919|FG004|Phase I: Period 1|Protocol Violation|0|||
129712426|NCT01791517|466909920|FG005|Phase I: Period 1|Protocol Violation|0|||
129712427|NCT01791517|466909921|FG006|Phase I: Period 1|Protocol Violation|0|||
129712428|NCT01791517|466909922|FG007|Phase I: Period 1|Protocol Violation|0|||
129712429|NCT01791517|466909923|FG008|Phase I: Period 1|Protocol Violation|0|||
129712430|NCT01791517|466909924|FG009|Phase I: Period 1|Protocol Violation|0|||
129712431|NCT01791517|466909925|FG010|Phase I: Period 1|Protocol Violation|0|||
129712432|NCT01791517|466909926|FG011|Phase I: Period 1|Protocol Violation|0|||
129801808|NCT01920555|467243385|FG000|Overall Study|Lack of Efficacy|2|||
129801809|NCT01920555|467243386|FG001|Overall Study|Lack of Efficacy|0|||
129801810|NCT01920555|467243387|FG002|Overall Study|Lack of Efficacy|0|||
129801811|NCT01920555|467243388|FG003|Overall Study|Lack of Efficacy|0|||
129801812|NCT01920555|467243389|FG004|Overall Study|Lack of Efficacy|0|||
129801813|NCT01920555|467243385|FG000|Overall Study|Travel Difficulties|1|||
129801814|NCT01920555|467243386|FG001|Overall Study|Travel Difficulties|1|||
129801815|NCT01920555|467243387|FG002|Overall Study|Travel Difficulties|0|||
129801816|NCT01920555|467243388|FG003|Overall Study|Travel Difficulties|0|||
129801817|NCT01920555|467243389|FG004|Overall Study|Travel Difficulties|1|||
129801818|NCT01920555|467243385|FG000|Overall Study|Lost to Follow-up|0|||
129801819|NCT01920555|467243386|FG001|Overall Study|Lost to Follow-up|1|||
129801820|NCT01920555|467243387|FG002|Overall Study|Lost to Follow-up|0|||
129801821|NCT01920555|467243388|FG003|Overall Study|Lost to Follow-up|1|||
129801822|NCT01920555|467243389|FG004|Overall Study|Lost to Follow-up|0|||
129712433|NCT01791517|466909915|FG000|Phase I: Period 1|Lost to Follow-up|0|||
129712434|NCT01791517|466909916|FG001|Phase I: Period 1|Lost to Follow-up|0|||
129801823|NCT01858376|467243390|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
129801824|NCT01886716|467243393|FG000|Week 1|Lost to Follow-up|0|||
129801825|NCT01886716|467243394|FG001|Week 1|Lost to Follow-up|0|||
129801826|NCT01886716|467243395|FG002|Week 1|Lost to Follow-up|2|||
129801827|NCT01886716|467243396|FG003|Week 1|Lost to Follow-up|2|||
129801828|NCT01886716|467243393|FG000|Week 2|Lost to Follow-up|3|||
129801829|NCT01886716|467243394|FG001|Week 2|Lost to Follow-up|2|||
129801830|NCT01886716|467243395|FG002|Week 2|Lost to Follow-up|1|||
129801831|NCT01886716|467243396|FG003|Week 2|Lost to Follow-up|3|||
129801832|NCT01886716|467243393|FG000|Week 3|Lost to Follow-up|1|||
129801833|NCT01886716|467243394|FG001|Week 3|Lost to Follow-up|1|||
129801834|NCT01886716|467243395|FG002|Week 3|Lost to Follow-up|0|||
129891289|NCT00162942|467559697|FG000|Overall Study|Alternate Therapy|6|||
129891290|NCT00162942|467559698|FG001|Overall Study|Alternate Therapy|2|||
129891291|NCT00162942|467559697|FG000|Overall Study|Lack of Efficacy|1|||
129891292|NCT00162942|467559698|FG001|Overall Study|Lack of Efficacy|0|||
129891293|NCT00162942|467559697|FG000|Overall Study|Flare During Active Treatment|7|||
129891294|NCT00162942|467559698|FG001|Overall Study|Flare During Active Treatment|3|||
129444263|NCT02464228|465927278|FG001|Overall Study|Adverse Event|0|||
129801835|NCT01886716|467243396|FG003|Week 3|Lost to Follow-up|1|||
129801836|NCT03387683|467243400|FG000|Overall Study|In receipt of disallowed medication|1|||
129801837|NCT03387683|467243401|FG001|Overall Study|In receipt of disallowed medication|0|||
129801838|NCT03387683|467243400|FG000|Overall Study|Did not receive treatment|1|||
129801839|NCT03387683|467243401|FG001|Overall Study|Did not receive treatment|0|||
129801840|NCT01954342|467243402|FG000|Overall Study|Missing data from 13-16week study visit|0|||
129801841|NCT01954342|467243403|FG001|Overall Study|Missing data from 13-16week study visit|0|||
129801842|NCT01954342|467243404|FG002|Overall Study|Missing data from 13-16week study visit|0|||
129801843|NCT01954342|467243405|FG003|Overall Study|Missing data from 13-16week study visit|1|||
129801844|NCT01954342|467243402|FG000|Overall Study|Miscarriage|0|||
129801845|NCT01954342|467243403|FG001|Overall Study|Miscarriage|0|||
129801846|NCT01954342|467243404|FG002|Overall Study|Miscarriage|0|||
129801847|NCT01954342|467243405|FG003|Overall Study|Miscarriage|3|||
129801848|NCT01954342|467243402|FG000|Overall Study|Lost to Follow-up|0|||
129801849|NCT01954342|467243403|FG001|Overall Study|Lost to Follow-up|0|||
129801850|NCT01954342|467243404|FG002|Overall Study|Lost to Follow-up|0|||
129801851|NCT01954342|467243405|FG003|Overall Study|Lost to Follow-up|5|||
129801852|NCT01954342|467243402|FG000|Overall Study|Preterm delivery|0|||
129801853|NCT01954342|467243403|FG001|Overall Study|Preterm delivery|0|||
129801854|NCT01954342|467243404|FG002|Overall Study|Preterm delivery|0|||
129801855|NCT01954342|467243405|FG003|Overall Study|Preterm delivery|3|||
129801856|NCT01954342|467243402|FG000|Overall Study|Pre-eclampsia|0|||
129801857|NCT01954342|467243403|FG001|Overall Study|Pre-eclampsia|0|||
129801858|NCT01954342|467243404|FG002|Overall Study|Pre-eclampsia|0|||
129801859|NCT01954342|467243405|FG003|Overall Study|Pre-eclampsia|4|||
129801860|NCT01954342|467243402|FG000|Overall Study|Unreliable Data|0|||
129801861|NCT01954342|467243403|FG001|Overall Study|Unreliable Data|0|||
129801862|NCT01954342|467243404|FG002|Overall Study|Unreliable Data|0|||
129801863|NCT01954342|467243405|FG003|Overall Study|Unreliable Data|2|||
129801864|NCT01646073|467243406|FG000|Period A (12 Weeks)|Adverse Event|0|||
129801865|NCT01646073|467243407|FG001|Period A (12 Weeks)|Adverse Event|2|||
129801866|NCT01646073|467243406|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
129801867|NCT01646073|467243407|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
129801868|NCT01646073|467243406|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
129801869|NCT01646073|467243407|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
129801870|NCT01646073|467243406|FG000|Period A (12 Weeks)|Protocol Violation|0|||
129801871|NCT01646073|467243407|FG001|Period A (12 Weeks)|Protocol Violation|1|||
129801872|NCT01646073|467243406|FG000|Period A (12 Weeks)|Other|0|||
129801873|NCT01646073|467243407|FG001|Period A (12 Weeks)|Other|1|||
129801874|NCT01646073|467243406|FG000|Period B (12 Weeks)|Adverse Event|0|||
129801875|NCT01646073|467243407|FG001|Period B (12 Weeks)|Adverse Event|7|||
129801876|NCT01646073|467243406|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
129801877|NCT01646073|467243407|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
129801878|NCT01646073|467243406|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
129801879|NCT01646073|467243407|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
129801880|NCT02410551|467243409|FG000|Overall Study|Adverse Event|1|||
129801881|NCT02410551|467243409|FG000|Overall Study|Withdrawal by Subject|1|||
129801882|NCT02410551|467243409|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
129801883|NCT01739309|467243410|FG000|Overall Study|Adverse Event|1|||
129801884|NCT01739309|467243410|FG000|Overall Study|Withdrawal by Subject|1|||
129801885|NCT01495975|467243411|FG000|Overall Study|Lost to Follow-up|1|||
129801886|NCT01495975|467243412|FG001|Overall Study|Lost to Follow-up|0|||
129801887|NCT05447897|467243415|FG000|Overall Study|Did not participate in survey|2|||
129801888|NCT01934972|467243416|FG000|Overall Study|Withdrawal by Subject|9|||
129801889|NCT01934972|467243417|FG001|Overall Study|Withdrawal by Subject|6|||
129891295|NCT00162942|467559697|FG000|Overall Study|2 or more consecutive treatments missed|1|||
129891296|NCT00162942|467559698|FG001|Overall Study|2 or more consecutive treatments missed|0|||
129891297|NCT02162732|467559699|FG000|Overall Study|Biopsy not performed.|18|||
129712435|NCT01791517|466909917|FG002|Phase I: Period 1|Lost to Follow-up|0|||
129712436|NCT01791517|466909918|FG003|Phase I: Period 1|Lost to Follow-up|1|||
129712437|NCT01791517|466909919|FG004|Phase I: Period 1|Lost to Follow-up|0|||
129712438|NCT01791517|466909920|FG005|Phase I: Period 1|Lost to Follow-up|0|||
129712439|NCT01791517|466909921|FG006|Phase I: Period 1|Lost to Follow-up|1|||
129712440|NCT01791517|466909922|FG007|Phase I: Period 1|Lost to Follow-up|0|||
129712441|NCT01791517|466909923|FG008|Phase I: Period 1|Lost to Follow-up|1|||
129712442|NCT01791517|466909924|FG009|Phase I: Period 1|Lost to Follow-up|1|||
129712443|NCT01791517|466909925|FG010|Phase I: Period 1|Lost to Follow-up|0|||
129712444|NCT01791517|466909926|FG011|Phase I: Period 1|Lost to Follow-up|0|||
129712445|NCT01791517|466909915|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712446|NCT01791517|466909916|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712447|NCT01791517|466909917|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712448|NCT01791517|466909918|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712449|NCT01791517|466909919|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712450|NCT01791517|466909920|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712451|NCT01791517|466909921|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712452|NCT01791517|466909922|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712453|NCT01791517|466909923|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712454|NCT01791517|466909924|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712455|NCT01791517|466909925|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
129712456|NCT01791517|466909926|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
129712457|NCT01791517|466909915|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
129712458|NCT01791517|466909916|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712459|NCT01791517|466909917|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712460|NCT01791517|466909918|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712461|NCT01791517|466909919|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129801890|NCT03131453|467243418|FG000|Overall Study|Study terminated by Sponsor|424|||
129712462|NCT01791517|466909920|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129801891|NCT03131453|467243419|FG001|Overall Study|Study terminated by Sponsor|222|||
129712463|NCT01791517|466909921|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712464|NCT01791517|466909922|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712465|NCT01791517|466909923|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129801892|NCT03131453|467243420|FG002|Overall Study|Study terminated by Sponsor|438|||
129801893|NCT03131453|467243418|FG000|Overall Study|Withdrawal by Subject|18|||
129801894|NCT03131453|467243419|FG001|Overall Study|Withdrawal by Subject|7|||
129801895|NCT03131453|467243420|FG002|Overall Study|Withdrawal by Subject|13|||
129801896|NCT03131453|467243418|FG000|Overall Study|Adverse Event|10|||
129801897|NCT03131453|467243419|FG001|Overall Study|Adverse Event|3|||
129801898|NCT03131453|467243420|FG002|Overall Study|Adverse Event|3|||
129801899|NCT03131453|467243418|FG000|Overall Study|Lost to Follow-up|1|||
129801900|NCT03131453|467243419|FG001|Overall Study|Lost to Follow-up|0|||
129801901|NCT03131453|467243420|FG002|Overall Study|Lost to Follow-up|1|||
129801902|NCT03131453|467243418|FG000|Overall Study|Physician Decision|1|||
129801903|NCT03131453|467243419|FG001|Overall Study|Physician Decision|0|||
129801904|NCT03131453|467243420|FG002|Overall Study|Physician Decision|1|||
129801905|NCT03131453|467243418|FG000|Overall Study|Non-compliance with study treatment|1|||
129801906|NCT03131453|467243419|FG001|Overall Study|Non-compliance with study treatment|0|||
129801907|NCT03131453|467243420|FG002|Overall Study|Non-compliance with study treatment|0|||
129801908|NCT03131453|467243418|FG000|Overall Study|Technical problems|1|||
129801909|NCT03131453|467243419|FG001|Overall Study|Technical problems|0|||
129801910|NCT03131453|467243420|FG002|Overall Study|Technical problems|0|||
129801911|NCT03131453|467243418|FG000|Overall Study|Protocol deviation|0|||
129801912|NCT03131453|467243419|FG001|Overall Study|Protocol deviation|1|||
129801913|NCT03131453|467243420|FG002|Overall Study|Protocol deviation|0|||
129801914|NCT02770170|467243423|FG000|Overall Study|Withdrawal by Subject|0|||
129801915|NCT02770170|467243424|FG001|Overall Study|Withdrawal by Subject|0|||
129801916|NCT02770170|467243425|FG002|Overall Study|Withdrawal by Subject|0|||
129801917|NCT02770170|467243426|FG003|Overall Study|Withdrawal by Subject|2|||
129801918|NCT02770170|467243423|FG000|Overall Study|due to pregnancy|1|||
129801919|NCT02770170|467243424|FG001|Overall Study|due to pregnancy|0|||
129801920|NCT02770170|467243425|FG002|Overall Study|due to pregnancy|0|||
129801921|NCT02770170|467243426|FG003|Overall Study|due to pregnancy|0|||
129801922|NCT02770170|467243423|FG000|Overall Study|Lack of Efficacy|2|||
129801923|NCT02770170|467243424|FG001|Overall Study|Lack of Efficacy|0|||
129801924|NCT02770170|467243425|FG002|Overall Study|Lack of Efficacy|0|||
129801925|NCT02770170|467243426|FG003|Overall Study|Lack of Efficacy|1|||
129801926|NCT02770170|467243423|FG000|Overall Study|Adverse Event|4|||
129801927|NCT02770170|467243424|FG001|Overall Study|Adverse Event|3|||
129801928|NCT02770170|467243425|FG002|Overall Study|Adverse Event|5|||
129801929|NCT02770170|467243426|FG003|Overall Study|Adverse Event|3|||
129801930|NCT02770170|467243423|FG000|Overall Study|due to disease worsening|0|||
129801931|NCT02770170|467243424|FG001|Overall Study|due to disease worsening|0|||
129801932|NCT02770170|467243425|FG002|Overall Study|due to disease worsening|0|||
129801933|NCT02770170|467243426|FG003|Overall Study|due to disease worsening|1|||
129801934|NCT00445978|467243427|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
129801935|NCT00445978|467243427|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
129801936|NCT00445978|467243427|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
129801937|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
129801938|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
129801939|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
129801940|NCT00445978|467243427|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
129801941|NCT00445978|467243427|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
129801942|NCT00445978|467243427|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
129801943|NCT01822496|467243430|FG000|Overall Study|Protocol Violation|2|||
129801944|NCT01822496|467243431|FG001|Overall Study|Protocol Violation|2|||
129801945|NCT01822496|467243432|FG002|Overall Study|Protocol Violation|0|||
129801946|NCT01822496|467243433|FG003|Overall Study|Protocol Violation|1|||
129801947|NCT01822496|467243430|FG000|Overall Study|Withdrawal by Subject|0|||
129801948|NCT01822496|467243431|FG001|Overall Study|Withdrawal by Subject|0|||
129801949|NCT01822496|467243432|FG002|Overall Study|Withdrawal by Subject|0|||
129801950|NCT01822496|467243433|FG003|Overall Study|Withdrawal by Subject|3|||
129801951|NCT00304239|467243434|FG000|Overall Study|Protocol Deviations/Violations|15|||
129801952|NCT00304239|467243435|FG001|Overall Study|Protocol Deviations/Violations|0|||
129801953|NCT00304239|467243434|FG000|Overall Study|Adverse Event|2|||
129801954|NCT00304239|467243435|FG001|Overall Study|Adverse Event|0|||
129801955|NCT02979197|467243436|FG000|Overall Study|Adverse Event|4|||
129712466|NCT01791517|466909924|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712467|NCT01791517|466909925|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712468|NCT01791517|466909926|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
129712469|NCT01791517|466909915|FG000|Phase I: Period 2|Protocol Violation|0|||
129712470|NCT01791517|466909916|FG001|Phase I: Period 2|Protocol Violation|0|||
129712471|NCT01791517|466909917|FG002|Phase I: Period 2|Protocol Violation|0|||
129712472|NCT01791517|466909918|FG003|Phase I: Period 2|Protocol Violation|1|||
129712473|NCT01791517|466909919|FG004|Phase I: Period 2|Protocol Violation|0|||
129712474|NCT01791517|466909920|FG005|Phase I: Period 2|Protocol Violation|0|||
129712475|NCT01791517|466909921|FG006|Phase I: Period 2|Protocol Violation|0|||
129712476|NCT01791517|466909922|FG007|Phase I: Period 2|Protocol Violation|0|||
129712477|NCT01791517|466909923|FG008|Phase I: Period 2|Protocol Violation|0|||
129712478|NCT01791517|466909924|FG009|Phase I: Period 2|Protocol Violation|0|||
129801956|NCT02979197|467243437|FG001|Overall Study|Adverse Event|2|||
129801957|NCT02979197|467243438|FG002|Overall Study|Adverse Event|0|||
129801958|NCT02979197|467243436|FG000|Overall Study|Protocol Violation|0|||
129801959|NCT02979197|467243437|FG001|Overall Study|Protocol Violation|1|||
129801960|NCT02979197|467243438|FG002|Overall Study|Protocol Violation|0|||
129891298|NCT00410384|467559700|FG000|Overall Study|Withdrawal by Subject|28|||
129891299|NCT00410384|467559701|FG001|Overall Study|Withdrawal by Subject|17|||
129891300|NCT00410384|467559702|FG002|Overall Study|Withdrawal by Subject|20|||
129891301|NCT00410384|467559700|FG000|Overall Study|Adverse Event|23|||
129891302|NCT00410384|467559701|FG001|Overall Study|Adverse Event|18|||
129891303|NCT00410384|467559702|FG002|Overall Study|Adverse Event|23|||
129891304|NCT00410384|467559700|FG000|Overall Study|Lack of Efficacy|20|||
129891305|NCT00410384|467559701|FG001|Overall Study|Lack of Efficacy|12|||
129891306|NCT00410384|467559702|FG002|Overall Study|Lack of Efficacy|17|||
129891307|NCT00410384|467559700|FG000|Overall Study|Lack of Compliance|2|||
129891308|NCT00410384|467559701|FG001|Overall Study|Lack of Compliance|2|||
129891309|NCT00410384|467559702|FG002|Overall Study|Lack of Compliance|2|||
129891310|NCT00410384|467559700|FG000|Overall Study|Lost to Follow-up|4|||
129891311|NCT00410384|467559701|FG001|Overall Study|Lost to Follow-up|6|||
129712479|NCT01791517|466909925|FG010|Phase I: Period 2|Protocol Violation|0|||
129712480|NCT01791517|466909926|FG011|Phase I: Period 2|Protocol Violation|0|||
129712481|NCT01791517|466909915|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
129712482|NCT01791517|466909916|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
129712483|NCT01791517|466909917|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
129712484|NCT01791517|466909918|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
129712485|NCT01791517|466909919|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
129712486|NCT01791517|466909920|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
129712487|NCT01791517|466909921|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
129712488|NCT01791517|466909922|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
129712489|NCT01791517|466909923|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
129712490|NCT01791517|466909924|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
129712491|NCT01791517|466909925|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
129712492|NCT01791517|466909926|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
129712493|NCT01791517|466909915|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712494|NCT01791517|466909916|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712495|NCT01791517|466909917|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712496|NCT01791517|466909918|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712497|NCT01791517|466909919|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712498|NCT01791517|466909920|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129801961|NCT02979197|467243436|FG000|Overall Study|Subject unable to commit to study dates|0|||
129801962|NCT02979197|467243437|FG001|Overall Study|Subject unable to commit to study dates|1|||
129801963|NCT02979197|467243438|FG002|Overall Study|Subject unable to commit to study dates|0|||
129801964|NCT03438383|467243439|FG000|Overall Study|Protocol Violation|9|||
129801965|NCT03438383|467243440|FG001|Overall Study|Protocol Violation|3|||
129801966|NCT02766465|467243441|FG000|Overall Study|Withdrawal by Subject|0|||
129801967|NCT02766465|467243442|FG001|Overall Study|Withdrawal by Subject|10|||
129801968|NCT01631812|467243443|FG000|Overall Study|Adverse Event|25|||
129801969|NCT01631812|467243443|FG000|Overall Study|Lack of Efficacy|5|||
129801970|NCT01631812|467243443|FG000|Overall Study|Withdrawal by Subject|4|||
129801971|NCT01631812|467243443|FG000|Overall Study|Physician Decision|3|||
129801972|NCT02435069|467243444|FG000|Dose Response - First Intervention|Adverse Event|0|||
129801973|NCT02435069|467243445|FG001|Dose Response - First Intervention|Adverse Event|1|||
129801974|NCT02435069|467243446|FG002|Dose Response - First Intervention|Adverse Event|1|||
129801975|NCT02435069|467243447|FG003|Dose Response - First Intervention|Adverse Event|0|||
129801976|NCT02435069|467243448|FG004|Dose Response - First Intervention|Adverse Event|0|||
129801977|NCT02435069|467243444|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801978|NCT02435069|467243445|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801979|NCT02435069|467243446|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801980|NCT02435069|467243447|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
129801981|NCT02435069|467243448|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
129801982|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
129801983|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
129801984|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
129801985|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
129801986|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|Death|2|||
129712499|NCT01791517|466909921|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712500|NCT01791517|466909922|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712501|NCT01791517|466909923|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129801987|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|Death|2|||
129712502|NCT01791517|466909924|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712503|NCT01791517|466909925|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
129712504|NCT01791517|466909926|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
129712505|NCT01791517|466909915|FG000|Phase I: Period 2|Lens Discomfort|0|||
129712506|NCT01791517|466909916|FG001|Phase I: Period 2|Lens Discomfort|0|||
129891312|NCT00410384|467559702|FG002|Overall Study|Lost to Follow-up|6|||
129712507|NCT01791517|466909917|FG002|Phase I: Period 2|Lens Discomfort|0|||
129712508|NCT01791517|466909918|FG003|Phase I: Period 2|Lens Discomfort|0|||
129712509|NCT01791517|466909919|FG004|Phase I: Period 2|Lens Discomfort|0|||
129712510|NCT01791517|466909920|FG005|Phase I: Period 2|Lens Discomfort|1|||
129712511|NCT01791517|466909921|FG006|Phase I: Period 2|Lens Discomfort|0|||
129712512|NCT01791517|466909922|FG007|Phase I: Period 2|Lens Discomfort|0|||
129712513|NCT01791517|466909923|FG008|Phase I: Period 2|Lens Discomfort|0|||
129712514|NCT01791517|466909924|FG009|Phase I: Period 2|Lens Discomfort|0|||
129712515|NCT01791517|466909925|FG010|Phase I: Period 2|Lens Discomfort|0|||
129712516|NCT01791517|466909926|FG011|Phase I: Period 2|Lens Discomfort|0|||
129712517|NCT01791517|466909915|FG000|Phase I: Period 2|Lost to Follow-up|0|||
129712518|NCT01791517|466909916|FG001|Phase I: Period 2|Lost to Follow-up|3|||
129712519|NCT01791517|466909917|FG002|Phase I: Period 2|Lost to Follow-up|2|||
129712520|NCT01791517|466909918|FG003|Phase I: Period 2|Lost to Follow-up|0|||
129712521|NCT01791517|466909919|FG004|Phase I: Period 2|Lost to Follow-up|0|||
129712522|NCT01791517|466909920|FG005|Phase I: Period 2|Lost to Follow-up|0|||
129712523|NCT01791517|466909921|FG006|Phase I: Period 2|Lost to Follow-up|0|||
129712524|NCT01791517|466909922|FG007|Phase I: Period 2|Lost to Follow-up|0|||
129712525|NCT01791517|466909923|FG008|Phase I: Period 2|Lost to Follow-up|0|||
129712526|NCT01791517|466909924|FG009|Phase I: Period 2|Lost to Follow-up|0|||
129712527|NCT01791517|466909925|FG010|Phase I: Period 2|Lost to Follow-up|0|||
129712528|NCT01791517|466909926|FG011|Phase I: Period 2|Lost to Follow-up|0|||
129712529|NCT01791517|466909915|FG000|Phase I: Period 3|Lens Discomfort|0|||
129712530|NCT01791517|466909916|FG001|Phase I: Period 3|Lens Discomfort|0|||
129712531|NCT01791517|466909917|FG002|Phase I: Period 3|Lens Discomfort|0|||
129712532|NCT01791517|466909918|FG003|Phase I: Period 3|Lens Discomfort|0|||
129712533|NCT01791517|466909919|FG004|Phase I: Period 3|Lens Discomfort|0|||
129712534|NCT01791517|466909920|FG005|Phase I: Period 3|Lens Discomfort|0|||
129712535|NCT01791517|466909921|FG006|Phase I: Period 3|Lens Discomfort|0|||
129712536|NCT01791517|466909922|FG007|Phase I: Period 3|Lens Discomfort|0|||
129712537|NCT01791517|466909923|FG008|Phase I: Period 3|Lens Discomfort|0|||
129712538|NCT01791517|466909924|FG009|Phase I: Period 3|Lens Discomfort|0|||
129712539|NCT01791517|466909925|FG010|Phase I: Period 3|Lens Discomfort|0|||
129712540|NCT01791517|466909926|FG011|Phase I: Period 3|Lens Discomfort|1|||
129712541|NCT01791517|466909915|FG000|Phase I: Period 3|Lost to Follow-up|0|||
129712542|NCT01791517|466909916|FG001|Phase I: Period 3|Lost to Follow-up|1|||
129712543|NCT01791517|466909917|FG002|Phase I: Period 3|Lost to Follow-up|0|||
129712544|NCT01791517|466909918|FG003|Phase I: Period 3|Lost to Follow-up|0|||
129712545|NCT01791517|466909919|FG004|Phase I: Period 3|Lost to Follow-up|1|||
129712546|NCT01791517|466909920|FG005|Phase I: Period 3|Lost to Follow-up|0|||
129712547|NCT01791517|466909921|FG006|Phase I: Period 3|Lost to Follow-up|0|||
129712548|NCT01791517|466909922|FG007|Phase I: Period 3|Lost to Follow-up|0|||
129712549|NCT01791517|466909923|FG008|Phase I: Period 3|Lost to Follow-up|0|||
129712550|NCT01791517|466909924|FG009|Phase I: Period 3|Lost to Follow-up|0|||
129712551|NCT01791517|466909925|FG010|Phase I: Period 3|Lost to Follow-up|0|||
129712552|NCT01791517|466909926|FG011|Phase I: Period 3|Lost to Follow-up|0|||
129712553|NCT01791517|466909915|FG000|Phase I: Period 3|Adverse Event|0|||
129712554|NCT01791517|466909916|FG001|Phase I: Period 3|Adverse Event|0|||
129712555|NCT01791517|466909917|FG002|Phase I: Period 3|Adverse Event|0|||
129712556|NCT01791517|466909918|FG003|Phase I: Period 3|Adverse Event|1|||
129712557|NCT01791517|466909919|FG004|Phase I: Period 3|Adverse Event|0|||
129712558|NCT01791517|466909920|FG005|Phase I: Period 3|Adverse Event|0|||
129712559|NCT01791517|466909921|FG006|Phase I: Period 3|Adverse Event|0|||
129712560|NCT01791517|466909922|FG007|Phase I: Period 3|Adverse Event|0|||
129712561|NCT01791517|466909923|FG008|Phase I: Period 3|Adverse Event|0|||
129712562|NCT01791517|466909924|FG009|Phase I: Period 3|Adverse Event|0|||
129712563|NCT01791517|466909925|FG010|Phase I: Period 3|Adverse Event|0|||
129712564|NCT01791517|466909926|FG011|Phase I: Period 3|Adverse Event|0|||
129712565|NCT01791517|466909915|FG000|Phase II|Lost to Follow-up|1|||
129712566|NCT01791517|466909916|FG001|Phase II|Lost to Follow-up|0|||
129712567|NCT01791517|466909917|FG002|Phase II|Lost to Follow-up|1|||
129712568|NCT01791517|466909918|FG003|Phase II|Lost to Follow-up|0|||
129712569|NCT01791517|466909919|FG004|Phase II|Lost to Follow-up|1|||
129712570|NCT01791517|466909920|FG005|Phase II|Lost to Follow-up|2|||
129712571|NCT01791517|466909921|FG006|Phase II|Lost to Follow-up|0|||
129712572|NCT01791517|466909922|FG007|Phase II|Lost to Follow-up|1|||
129712573|NCT01791517|466909923|FG008|Phase II|Lost to Follow-up|1|||
129712574|NCT01791517|466909924|FG009|Phase II|Lost to Follow-up|1|||
129712575|NCT01791517|466909925|FG010|Phase II|Lost to Follow-up|0|||
129712576|NCT01791517|466909926|FG011|Phase II|Lost to Follow-up|0|||
129712577|NCT01791517|466909915|FG000|Phase II|Withdrawal by Subject|1|||
129712578|NCT01791517|466909916|FG001|Phase II|Withdrawal by Subject|0|||
129712579|NCT01791517|466909917|FG002|Phase II|Withdrawal by Subject|0|||
129712580|NCT01791517|466909918|FG003|Phase II|Withdrawal by Subject|0|||
129712581|NCT01791517|466909919|FG004|Phase II|Withdrawal by Subject|0|||
129712582|NCT01791517|466909920|FG005|Phase II|Withdrawal by Subject|2|||
129712583|NCT01791517|466909921|FG006|Phase II|Withdrawal by Subject|0|||
129712584|NCT01791517|466909922|FG007|Phase II|Withdrawal by Subject|1|||
129712585|NCT01791517|466909923|FG008|Phase II|Withdrawal by Subject|0|||
129712586|NCT01791517|466909924|FG009|Phase II|Withdrawal by Subject|0|||
129712587|NCT01791517|466909925|FG010|Phase II|Withdrawal by Subject|1|||
129712588|NCT01791517|466909926|FG011|Phase II|Withdrawal by Subject|0|||
129712589|NCT01791517|466909915|FG000|Phase II|Lack of Efficacy|0|||
129712590|NCT01791517|466909916|FG001|Phase II|Lack of Efficacy|0|||
129712591|NCT01791517|466909917|FG002|Phase II|Lack of Efficacy|0|||
129712592|NCT01791517|466909918|FG003|Phase II|Lack of Efficacy|0|||
129712593|NCT01791517|466909919|FG004|Phase II|Lack of Efficacy|1|||
129891313|NCT00410384|467559700|FG000|Overall Study|Protocol Violation|6|||
129891314|NCT00410384|467559701|FG001|Overall Study|Protocol Violation|6|||
129891315|NCT00410384|467559702|FG002|Overall Study|Protocol Violation|6|||
129891316|NCT00410384|467559700|FG000|Overall Study|Physician Decision|3|||
129891317|NCT00410384|467559701|FG001|Overall Study|Physician Decision|3|||
129891318|NCT00410384|467559702|FG002|Overall Study|Physician Decision|4|||
129891319|NCT00410384|467559700|FG000|Overall Study|Other|3|||
129891320|NCT00410384|467559701|FG001|Overall Study|Other|8|||
129712594|NCT01791517|466909920|FG005|Phase II|Lack of Efficacy|0|||
129712595|NCT01791517|466909921|FG006|Phase II|Lack of Efficacy|0|||
129712596|NCT01791517|466909922|FG007|Phase II|Lack of Efficacy|0|||
129712597|NCT01791517|466909923|FG008|Phase II|Lack of Efficacy|0|||
129712598|NCT01791517|466909924|FG009|Phase II|Lack of Efficacy|0|||
129712599|NCT01791517|466909925|FG010|Phase II|Lack of Efficacy|0|||
129712600|NCT01791517|466909926|FG011|Phase II|Lack of Efficacy|0|||
129712601|NCT01791517|466909915|FG000|Phase II|Adverse Event|0|||
129712602|NCT01791517|466909916|FG001|Phase II|Adverse Event|0|||
129712603|NCT01791517|466909917|FG002|Phase II|Adverse Event|0|||
129712604|NCT01791517|466909918|FG003|Phase II|Adverse Event|0|||
129712605|NCT01791517|466909919|FG004|Phase II|Adverse Event|0|||
129712606|NCT01791517|466909920|FG005|Phase II|Adverse Event|0|||
129712607|NCT01791517|466909921|FG006|Phase II|Adverse Event|2|||
129712608|NCT01791517|466909922|FG007|Phase II|Adverse Event|1|||
129712609|NCT01791517|466909923|FG008|Phase II|Adverse Event|0|||
129712610|NCT01791517|466909924|FG009|Phase II|Adverse Event|1|||
129712611|NCT01791517|466909925|FG010|Phase II|Adverse Event|0|||
129712612|NCT01791517|466909926|FG011|Phase II|Adverse Event|0|||
129712613|NCT01791517|466909915|FG000|Phase II|Lens Handling Difficulties|0|||
129712614|NCT01791517|466909916|FG001|Phase II|Lens Handling Difficulties|0|||
129712615|NCT01791517|466909917|FG002|Phase II|Lens Handling Difficulties|0|||
129712616|NCT01791517|466909918|FG003|Phase II|Lens Handling Difficulties|0|||
129712617|NCT01791517|466909919|FG004|Phase II|Lens Handling Difficulties|0|||
129712618|NCT01791517|466909920|FG005|Phase II|Lens Handling Difficulties|0|||
129712619|NCT01791517|466909921|FG006|Phase II|Lens Handling Difficulties|0|||
129712620|NCT01791517|466909922|FG007|Phase II|Lens Handling Difficulties|0|||
129712621|NCT01791517|466909923|FG008|Phase II|Lens Handling Difficulties|1|||
129712622|NCT01791517|466909924|FG009|Phase II|Lens Handling Difficulties|0|||
129712623|NCT01791517|466909925|FG010|Phase II|Lens Handling Difficulties|0|||
129712624|NCT01791517|466909926|FG011|Phase II|Lens Handling Difficulties|0|||
129712625|NCT01791517|466909915|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
129712626|NCT01791517|466909916|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
129712627|NCT01791517|466909917|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
129712628|NCT01791517|466909918|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
129712629|NCT01791517|466909919|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
129712630|NCT01791517|466909920|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
129712631|NCT01791517|466909921|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
129712632|NCT01791517|466909922|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
129712633|NCT01791517|466909923|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
129712634|NCT01791517|466909924|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
129712635|NCT01791517|466909925|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
129891321|NCT00410384|467559702|FG002|Overall Study|Other|4|||
129891322|NCT01167023|467559703|FG000|Overall Study|Lost to Follow-up|0|||
129891323|NCT01167023|467559704|FG001|Overall Study|Lost to Follow-up|1|||
129891324|NCT01167023|467559705|FG002|Overall Study|Lost to Follow-up|1|||
129444264|NCT02464228|465927279|FG002|Overall Study|Adverse Event|3|||
129444265|NCT02464228|465927280|FG003|Overall Study|Adverse Event|0|||
129712636|NCT01791517|466909926|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
129712637|NCT01791517|466909915|FG000|Phase II|Pre-Existing Ocular Issue|0|||
129712638|NCT01791517|466909916|FG001|Phase II|Pre-Existing Ocular Issue|0|||
129712639|NCT01791517|466909917|FG002|Phase II|Pre-Existing Ocular Issue|0|||
129712640|NCT01791517|466909918|FG003|Phase II|Pre-Existing Ocular Issue|0|||
129712641|NCT01791517|466909919|FG004|Phase II|Pre-Existing Ocular Issue|0|||
129712642|NCT01791517|466909920|FG005|Phase II|Pre-Existing Ocular Issue|0|||
129712643|NCT01791517|466909921|FG006|Phase II|Pre-Existing Ocular Issue|0|||
129712644|NCT01791517|466909922|FG007|Phase II|Pre-Existing Ocular Issue|0|||
129712645|NCT01791517|466909923|FG008|Phase II|Pre-Existing Ocular Issue|0|||
129712646|NCT01791517|466909924|FG009|Phase II|Pre-Existing Ocular Issue|0|||
129712647|NCT01791517|466909925|FG010|Phase II|Pre-Existing Ocular Issue|0|||
129712648|NCT01791517|466909926|FG011|Phase II|Pre-Existing Ocular Issue|1|||
129712649|NCT04011735|466909927|FG000|Overall Study|Withdrawal by Subject|1|||
129891325|NCT01167023|467559703|FG000|Overall Study|Screen Failure|0|||
129891326|NCT01167023|467559704|FG001|Overall Study|Screen Failure|1|||
129891327|NCT01167023|467559705|FG002|Overall Study|Screen Failure|0|||
129891328|NCT01167023|467559703|FG000|Overall Study|Sponsor Decision|0|||
129891329|NCT01167023|467559704|FG001|Overall Study|Sponsor Decision|1|||
129891330|NCT01167023|467559705|FG002|Overall Study|Sponsor Decision|0|||
129891331|NCT01167023|467559703|FG000|Overall Study|Withdrawal by Subject|0|||
129891332|NCT01167023|467559704|FG001|Overall Study|Withdrawal by Subject|0|||
129891333|NCT01167023|467559705|FG002|Overall Study|Withdrawal by Subject|1|||
129891334|NCT01253200|467559708|FG000|Overall Study|Death|1|||
129891335|NCT01253200|467559709|FG001|Overall Study|Death|0|||
129891336|NCT01253200|467559710|FG002|Overall Study|Death|0|||
129891337|NCT01253200|467559711|FG003|Overall Study|Death|0|||
129891338|NCT01253200|467559712|FG004|Overall Study|Death|0|||
129891339|NCT01253200|467559708|FG000|Overall Study|Lost to Follow-up|1|||
129891340|NCT01253200|467559709|FG001|Overall Study|Lost to Follow-up|1|||
129891341|NCT01253200|467559710|FG002|Overall Study|Lost to Follow-up|0|||
129891342|NCT01253200|467559711|FG003|Overall Study|Lost to Follow-up|0|||
129891343|NCT01253200|467559712|FG004|Overall Study|Lost to Follow-up|0|||
129891344|NCT01253200|467559708|FG000|Overall Study|Withdrawal by Subject|2|||
129891345|NCT01253200|467559709|FG001|Overall Study|Withdrawal by Subject|0|||
129891346|NCT01253200|467559710|FG002|Overall Study|Withdrawal by Subject|0|||
129891347|NCT01253200|467559711|FG003|Overall Study|Withdrawal by Subject|0|||
129891348|NCT01253200|467559712|FG004|Overall Study|Withdrawal by Subject|0|||
129891349|NCT01253200|467559708|FG000|Overall Study|Protocol Violation|1|||
129891350|NCT01253200|467559709|FG001|Overall Study|Protocol Violation|4|||
129891351|NCT01253200|467559710|FG002|Overall Study|Protocol Violation|0|||
129891352|NCT01253200|467559711|FG003|Overall Study|Protocol Violation|0|||
129891353|NCT01253200|467559712|FG004|Overall Study|Protocol Violation|5|||
129891354|NCT01253200|467559708|FG000|Overall Study|intents|10|||
129891355|NCT01253200|467559709|FG001|Overall Study|intents|10|||
129891356|NCT01253200|467559710|FG002|Overall Study|intents|1|||
129891357|NCT01253200|467559711|FG003|Overall Study|intents|3|||
129891358|NCT01253200|467559712|FG004|Overall Study|intents|0|||
129891359|NCT01253200|467559708|FG000|Overall Study|Attempts|6|||
129891360|NCT01253200|467559709|FG001|Overall Study|Attempts|4|||
129891361|NCT01253200|467559710|FG002|Overall Study|Attempts|1|||
129891362|NCT01253200|467559711|FG003|Overall Study|Attempts|2|||
129891363|NCT01253200|467559712|FG004|Overall Study|Attempts|0|||
129891364|NCT02049437|467559713|FG000|Period 1|Adverse Event|1|||
129891365|NCT02049437|467559714|FG001|Period 1|Adverse Event|1|||
129891366|NCT02049437|467559713|FG000|Period 1|Adverse Event|1|||
129891367|NCT02049437|467559714|FG001|Period 1|Adverse Event|0|||
129891368|NCT04529538|467559715|FG000|Overall Study|Lost to Follow-up|3|||
129891369|NCT04529538|467559716|FG001|Overall Study|Lost to Follow-up|2|||
129891370|NCT04529538|467559717|FG002|Overall Study|Lost to Follow-up|1|||
129891371|NCT04529538|467559718|FG003|Overall Study|Lost to Follow-up|0|||
129891372|NCT04529538|467559719|FG004|Overall Study|Lost to Follow-up|1|||
129891373|NCT04529538|467559720|FG005|Overall Study|Lost to Follow-up|1|||
129891374|NCT04529538|467559721|FG006|Overall Study|Lost to Follow-up|2|||
129891375|NCT04529538|467559722|FG007|Overall Study|Lost to Follow-up|0|||
129891376|NCT04529538|467559715|FG000|Overall Study|Not eligible at enrollment|0|||
129891377|NCT04529538|467559716|FG001|Overall Study|Not eligible at enrollment|1|||
129712650|NCT04011735|466909928|FG001|Overall Study|Withdrawal by Subject|0|||
129712651|NCT04011735|466909929|FG002|Overall Study|Withdrawal by Subject|1|||
129712652|NCT04011735|466909927|FG000|Overall Study|Met exclusion criteria after study entry|0|||
129712653|NCT04011735|466909928|FG001|Overall Study|Met exclusion criteria after study entry|1|||
129712654|NCT04011735|466909929|FG002|Overall Study|Met exclusion criteria after study entry|0|||
129712655|NCT00739310|466909934|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
129712656|NCT00739310|466909934|FG000|Overall Study|Withdrawal by Subject|1|||
129712657|NCT00739310|466909934|FG000|Overall Study|Lost to Follow-up|2|||
129712658|NCT02954887|466909935|FG000|Overall Study|Withdrawal by Subject|3|||
129712659|NCT02954887|466909935|FG000|Overall Study|Lack of Efficacy|3|||
129712660|NCT02954887|466909935|FG000|Overall Study|Other|1|||
129712661|NCT01071954|466909936|FG000|Overall Study|Noncompliance|4|||
129712662|NCT01071954|466909936|FG000|Overall Study|Adverse Event|1|||
129712663|NCT01071954|466909936|FG000|Overall Study|Withdrawal by Subject|11|||
129891378|NCT04529538|467559717|FG002|Overall Study|Not eligible at enrollment|2|||
129891379|NCT04529538|467559718|FG003|Overall Study|Not eligible at enrollment|1|||
129891380|NCT04529538|467559719|FG004|Overall Study|Not eligible at enrollment|0|||
129891381|NCT04529538|467559720|FG005|Overall Study|Not eligible at enrollment|0|||
129891382|NCT04529538|467559721|FG006|Overall Study|Not eligible at enrollment|0|||
129891383|NCT04529538|467559722|FG007|Overall Study|Not eligible at enrollment|1|||
129891384|NCT04529538|467559715|FG000|Overall Study|Withdrawal by Subject|0|||
129891385|NCT04529538|467559716|FG001|Overall Study|Withdrawal by Subject|1|||
129891386|NCT04529538|467559717|FG002|Overall Study|Withdrawal by Subject|1|||
129891387|NCT04529538|467559718|FG003|Overall Study|Withdrawal by Subject|2|||
129891388|NCT04529538|467559719|FG004|Overall Study|Withdrawal by Subject|0|||
129891389|NCT04529538|467559720|FG005|Overall Study|Withdrawal by Subject|2|||
129891390|NCT04529538|467559721|FG006|Overall Study|Withdrawal by Subject|3|||
129712664|NCT01071954|466909936|FG000|Overall Study|Requirement for Alternative Therapy|5|||
129712665|NCT01071954|466909936|FG000|Overall Study|Administrative Decision|5|||
129712666|NCT01071954|466909936|FG000|Overall Study|Protocol Specified Criteria|1|||
129712667|NCT01459666|466909937|FG000|Overall Study|PI left institution|5|||
129712668|NCT01459666|466909938|FG001|Overall Study|PI left institution|4|||
129712669|NCT00590967|466909940|FG000|Overall Study|Withdrawal by Subject|1|||
129712670|NCT00590967|466909941|FG001|Overall Study|Withdrawal by Subject|1|||
129712671|NCT00590967|466909940|FG000|Overall Study|Ineligible|1|||
129712672|NCT00590967|466909941|FG001|Overall Study|Ineligible|0|||
129712673|NCT00590967|466909940|FG000|Overall Study|Poor performance status|0|||
129712674|NCT00590967|466909941|FG001|Overall Study|Poor performance status|1|||
129712675|NCT00590967|466909940|FG000|Overall Study|Non-compliant|0|||
129712676|NCT00590967|466909941|FG001|Overall Study|Non-compliant|2|||
129712677|NCT00590967|466909940|FG000|Overall Study|Did not sign consent form|0|||
129712678|NCT00590967|466909941|FG001|Overall Study|Did not sign consent form|1|||
129712679|NCT00590967|466909940|FG000|Overall Study|Did not receive chemo per protocol|1|||
129712680|NCT00590967|466909941|FG001|Overall Study|Did not receive chemo per protocol|0|||
129712681|NCT01847755|466909944|FG000|Overall Study|Adverse Event|2|||
129712682|NCT01847755|466909944|FG000|Overall Study|Withdrawal by Subject|2|||
129712683|NCT01847755|466909944|FG000|Overall Study|Physician Decision|1|||
129712684|NCT00920556|466909945|FG000|Overall Study|Adverse Event|16|||
129712685|NCT00920556|466909945|FG000|Overall Study|Physician Decision|7|||
129712686|NCT00920556|466909945|FG000|Overall Study|Withdrawal by Subject|1|||
129712687|NCT01299389|466909946|FG000|Double-blind|Adverse Event|45|||
129712688|NCT01299389|466909947|FG001|Double-blind|Adverse Event|27|||
129712689|NCT01299389|466909948|FG002|Double-blind|Adverse Event|0|||
129712690|NCT01299389|466909949|FG003|Double-blind|Adverse Event|0|||
129712691|NCT01299389|466909946|FG000|Double-blind|Lack of Efficacy|45|||
129712692|NCT01299389|466909947|FG001|Double-blind|Lack of Efficacy|21|||
129712693|NCT01299389|466909948|FG002|Double-blind|Lack of Efficacy|0|||
129712694|NCT01299389|466909949|FG003|Double-blind|Lack of Efficacy|0|||
129712695|NCT01299389|466909946|FG000|Double-blind|Lost to Follow-up|2|||
129712696|NCT01299389|466909947|FG001|Double-blind|Lost to Follow-up|1|||
129712697|NCT01299389|466909948|FG002|Double-blind|Lost to Follow-up|0|||
129712698|NCT01299389|466909949|FG003|Double-blind|Lost to Follow-up|0|||
129712699|NCT01299389|466909946|FG000|Double-blind|Withdrawal by Subject|16|||
129712700|NCT01299389|466909947|FG001|Double-blind|Withdrawal by Subject|13|||
129712701|NCT01299389|466909948|FG002|Double-blind|Withdrawal by Subject|0|||
129712702|NCT01299389|466909949|FG003|Double-blind|Withdrawal by Subject|0|||
129712703|NCT01299389|466909946|FG000|Double-blind|Other|1|||
129712704|NCT01299389|466909947|FG001|Double-blind|Other|1|||
129712705|NCT01299389|466909948|FG002|Double-blind|Other|0|||
129712706|NCT01299389|466909949|FG003|Double-blind|Other|0|||
129712707|NCT01299389|466909946|FG000|Double-blind|"fail to meet study population criteria"|0|||
129712708|NCT01299389|466909947|FG001|Double-blind|"fail to meet study population criteria"|1|||
129712709|NCT01299389|466909948|FG002|Double-blind|"fail to meet study population criteria"|0|||
129712710|NCT01299389|466909949|FG003|Double-blind|"fail to meet study population criteria"|0|||
129712711|NCT01299389|466909946|FG000|Post-observational|Other|0|||
129712712|NCT01299389|466909947|FG001|Post-observational|Other|0|||
129712713|NCT01299389|466909948|FG002|Post-observational|Other|12|||
129712714|NCT01299389|466909949|FG003|Post-observational|Other|6|||
129712715|NCT04245709|466909950|FG000|Overall Study|Adverse Event|13|||
129712716|NCT04245709|466909950|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
129712717|NCT00889707|466909954|FG000|Overall Study|Adverse Event|1|||
129712718|NCT00889707|466909955|FG001|Overall Study|Adverse Event|0|||
129712719|NCT00889707|466909954|FG000|Overall Study|Withdrawal by Subject|4|||
129712720|NCT00889707|466909955|FG001|Overall Study|Withdrawal by Subject|3|||
129712721|NCT00889707|466909954|FG000|Overall Study|Lost to Follow-up|0|||
129712722|NCT00889707|466909955|FG001|Overall Study|Lost to Follow-up|2|||
129712723|NCT00889707|466909954|FG000|Overall Study|Lack of Efficacy|2|||
129712724|NCT00889707|466909955|FG001|Overall Study|Lack of Efficacy|5|||
129712725|NCT02185534|466909956|FG000|First Period|Withdrawal by Subject|0|||
129712726|NCT02185534|466909957|FG001|First Period|Withdrawal by Subject|0|||
129712727|NCT02185534|466909958|FG002|First Period|Withdrawal by Subject|0|||
129712728|NCT02185534|466909959|FG003|First Period|Withdrawal by Subject|1|||
129712729|NCT02185534|466909960|FG004|First Period|Withdrawal by Subject|0|||
129712730|NCT02185534|466909961|FG005|First Period|Withdrawal by Subject|0|||
129712731|NCT02185534|466909956|FG000|First Washout Period|Withdrawal by Subject|1|||
129712732|NCT02185534|466909957|FG001|First Washout Period|Withdrawal by Subject|0|||
129712733|NCT02185534|466909958|FG002|First Washout Period|Withdrawal by Subject|0|||
129712734|NCT02185534|466909959|FG003|First Washout Period|Withdrawal by Subject|0|||
129712735|NCT02185534|466909960|FG004|First Washout Period|Withdrawal by Subject|1|||
129712736|NCT02185534|466909961|FG005|First Washout Period|Withdrawal by Subject|0|||
129712737|NCT02185534|466909956|FG000|First Washout Period|Protocol Violation|0|||
129712738|NCT02185534|466909957|FG001|First Washout Period|Protocol Violation|0|||
129712739|NCT02185534|466909958|FG002|First Washout Period|Protocol Violation|0|||
129712740|NCT02185534|466909959|FG003|First Washout Period|Protocol Violation|0|||
129712741|NCT02185534|466909960|FG004|First Washout Period|Protocol Violation|0|||
129712742|NCT02185534|466909961|FG005|First Washout Period|Protocol Violation|1|||
129712743|NCT02948582|466909962|FG000|Washout Period 1|Adverse Event|0|||
129712744|NCT02948582|466909963|FG001|Washout Period 1|Adverse Event|2|||
129712745|NCT02948582|466909964|FG002|Washout Period 1|Adverse Event|0|||
129712746|NCT02948582|466909965|FG003|Washout Period 1|Adverse Event|0|||
129712747|NCT02948582|466909966|FG004|Washout Period 1|Adverse Event|0|||
129712748|NCT02948582|466909967|FG005|Washout Period 1|Adverse Event|0|||
129712749|NCT02948582|466909962|FG000|Washout Period 1|Protocol Violation|0|||
129712750|NCT02948582|466909963|FG001|Washout Period 1|Protocol Violation|0|||
129712751|NCT02948582|466909964|FG002|Washout Period 1|Protocol Violation|0|||
129712752|NCT02948582|466909965|FG003|Washout Period 1|Protocol Violation|0|||
129712753|NCT02948582|466909966|FG004|Washout Period 1|Protocol Violation|0|||
129712754|NCT02948582|466909967|FG005|Washout Period 1|Protocol Violation|1|||
129712755|NCT02948582|466909962|FG000|Washout Period 2|Adverse Event|0|||
129712756|NCT02948582|466909963|FG001|Washout Period 2|Adverse Event|1|||
129712757|NCT02948582|466909964|FG002|Washout Period 2|Adverse Event|0|||
129712758|NCT02948582|466909965|FG003|Washout Period 2|Adverse Event|0|||
129712759|NCT02948582|466909966|FG004|Washout Period 2|Adverse Event|0|||
129712760|NCT02948582|466909967|FG005|Washout Period 2|Adverse Event|0|||
129712761|NCT02948582|466909962|FG000|Washout Period 2|personal reasons|0|||
129712762|NCT02948582|466909963|FG001|Washout Period 2|personal reasons|0|||
129712763|NCT02948582|466909964|FG002|Washout Period 2|personal reasons|0|||
129712764|NCT02948582|466909965|FG003|Washout Period 2|personal reasons|1|||
129712765|NCT02948582|466909966|FG004|Washout Period 2|personal reasons|0|||
129712766|NCT02948582|466909967|FG005|Washout Period 2|personal reasons|0|||
129712767|NCT02948582|466909962|FG000|Washout Period 4|Adverse Event|1|||
129712768|NCT02948582|466909963|FG001|Washout Period 4|Adverse Event|0|||
129712769|NCT02948582|466909964|FG002|Washout Period 4|Adverse Event|1|||
129712770|NCT02948582|466909965|FG003|Washout Period 4|Adverse Event|0|||
129712771|NCT02948582|466909966|FG004|Washout Period 4|Adverse Event|0|||
129712772|NCT02948582|466909967|FG005|Washout Period 4|Adverse Event|0|||
129712773|NCT01151020|466909971|FG000|Overall Study|Death|25|||
129712774|NCT01151020|466909971|FG000|Overall Study|Conversion to open repair|1|||
129712775|NCT01151020|466909971|FG000|Overall Study|Lost to Follow-up|4|||
129712776|NCT01151020|466909971|FG000|Overall Study|Withdrawal by Subject|22|||
129712777|NCT01151020|466909971|FG000|Overall Study|Patients did not receive the device|2|||
129712778|NCT02389465|466909972|FG000|Overall Study|Lost to Follow-up|1|||
129712779|NCT02389465|466909973|FG001|Overall Study|Lost to Follow-up|3|||
129712780|NCT02389465|466909974|FG002|Overall Study|Lost to Follow-up|3|||
129712781|NCT02389465|466909975|FG003|Overall Study|Lost to Follow-up|0|||
129712782|NCT02389465|466909972|FG000|Overall Study|Physician Decision|0|||
129712783|NCT02389465|466909973|FG001|Overall Study|Physician Decision|0|||
129712784|NCT02389465|466909974|FG002|Overall Study|Physician Decision|0|||
129712785|NCT02389465|466909975|FG003|Overall Study|Physician Decision|1|||
129712786|NCT02389465|466909972|FG000|Overall Study|Withdrawal by Subject|0|||
129712787|NCT02389465|466909973|FG001|Overall Study|Withdrawal by Subject|1|||
129712788|NCT02389465|466909974|FG002|Overall Study|Withdrawal by Subject|2|||
129712789|NCT02389465|466909975|FG003|Overall Study|Withdrawal by Subject|2|||
129712790|NCT00846846|466909976|FG000|Overall Study|Death|56|||
129712791|NCT00846846|466909976|FG000|Overall Study|Withdrawal by Subject|19|||
129712792|NCT01220401|466909980|FG000|Overall Study|Withdrawal by Subject|2|||
129712793|NCT01220401|466909980|FG000|Overall Study|Protocol Violation|1|||
129712794|NCT04179305|466909982|FG000|Overall Study|Death|1|||
129712795|NCT04179305|466909983|FG001|Overall Study|Death|1|||
129712796|NCT04179305|466909984|FG002|Overall Study|Death|0|||
129712797|NCT04179305|466909985|FG003|Overall Study|Death|0|||
129712798|NCT04179305|466909982|FG000|Overall Study|Lost to Follow-up|1|||
129712799|NCT04179305|466909983|FG001|Overall Study|Lost to Follow-up|1|||
129712800|NCT04179305|466909984|FG002|Overall Study|Lost to Follow-up|0|||
129712801|NCT04179305|466909985|FG003|Overall Study|Lost to Follow-up|0|||
129712802|NCT04179305|466909982|FG000|Overall Study|Withdrawal by Subject|0|||
129712803|NCT04179305|466909983|FG001|Overall Study|Withdrawal by Subject|1|||
129712804|NCT04179305|466909984|FG002|Overall Study|Withdrawal by Subject|0|||
129712805|NCT04179305|466909985|FG003|Overall Study|Withdrawal by Subject|0|||
129712806|NCT04179305|466909982|FG000|Overall Study|Did not have scan|1|||
129712807|NCT04179305|466909983|FG001|Overall Study|Did not have scan|0|||
129712808|NCT04179305|466909984|FG002|Overall Study|Did not have scan|0|||
129712809|NCT04179305|466909985|FG003|Overall Study|Did not have scan|0|||
129712810|NCT04179305|466909982|FG000|Overall Study|In hospice care|3|||
129712811|NCT04179305|466909983|FG001|Overall Study|In hospice care|0|||
129712812|NCT04179305|466909984|FG002|Overall Study|In hospice care|0|||
129712813|NCT04179305|466909985|FG003|Overall Study|In hospice care|0|||
129712814|NCT00503425|466909988|FG000|Overall Study|Participant files lost|6|||
129712815|NCT00503425|466909988|FG000|Overall Study|Adverse Event|5|||
129712816|NCT00503425|466909988|FG000|Overall Study|Lack of Efficacy|25|||
129712817|NCT00503425|466909988|FG000|Overall Study|Withdrawal by Subject|8|||
129712818|NCT00503425|466909988|FG000|Overall Study|Lost to Follow-up|3|||
129712819|NCT00503425|466909988|FG000|Overall Study|Death|3|||
129712820|NCT00503425|466909988|FG000|Overall Study|Missing Data/Unknown|4|||
129712821|NCT00326599|466909989|FG000|Overall Study|Withdrawal by Subject|1|||
129712822|NCT00326599|466909990|FG001|Overall Study|Withdrawal by Subject|0|||
129712823|NCT00326599|466909991|FG002|Overall Study|Withdrawal by Subject|5|||
129712824|NCT00326599|466909992|FG003|Overall Study|Withdrawal by Subject|2|||
129712825|NCT00326599|466909989|FG000|Overall Study|Adverse Event|1|||
129712826|NCT00326599|466909990|FG001|Overall Study|Adverse Event|0|||
129712827|NCT00326599|466909991|FG002|Overall Study|Adverse Event|32|||
129712828|NCT00326599|466909992|FG003|Overall Study|Adverse Event|3|||
129712829|NCT00326599|466909989|FG000|Overall Study|Disease Progression|3|||
129712830|NCT00326599|466909990|FG001|Overall Study|Disease Progression|1|||
129712831|NCT00326599|466909991|FG002|Overall Study|Disease Progression|13|||
129712832|NCT00326599|466909992|FG003|Overall Study|Disease Progression|11|||
129712833|NCT00326599|466909989|FG000|Overall Study|Alternate Treatment|1|||
129712834|NCT00326599|466909990|FG001|Overall Study|Alternate Treatment|0|||
129712835|NCT00326599|466909991|FG002|Overall Study|Alternate Treatment|0|||
129712836|NCT00326599|466909992|FG003|Overall Study|Alternate Treatment|0|||
129712837|NCT00326599|466909989|FG000|Overall Study|Death|0|||
129712838|NCT00326599|466909990|FG001|Overall Study|Death|0|||
129712839|NCT00326599|466909991|FG002|Overall Study|Death|1|||
129712840|NCT00326599|466909992|FG003|Overall Study|Death|2|||
129712841|NCT00326599|466909989|FG000|Overall Study|Other Unspecified Reason|0|||
129712842|NCT00326599|466909990|FG001|Overall Study|Other Unspecified Reason|0|||
129712843|NCT00326599|466909991|FG002|Overall Study|Other Unspecified Reason|2|||
129712844|NCT00326599|466909992|FG003|Overall Study|Other Unspecified Reason|1|||
129712845|NCT00437268|466909997|FG000|Overall Study|Adverse Event|1|||
129712846|NCT00437268|466909998|FG001|Overall Study|Adverse Event|1|||
129712847|NCT00437268|466909997|FG000|Overall Study|Withdrawal by Subject|2|||
129712848|NCT00437268|466909998|FG001|Overall Study|Withdrawal by Subject|2|||
129712849|NCT00437268|466909997|FG000|Overall Study|Progressive disease|9|||
129712850|NCT00437268|466909998|FG001|Overall Study|Progressive disease|9|||
129712851|NCT00437268|466909997|FG000|Overall Study|Physician Decision|1|||
129712852|NCT00437268|466909998|FG001|Overall Study|Physician Decision|0|||
129712853|NCT00437268|466909997|FG000|Overall Study|Death|0|||
129712854|NCT00437268|466909998|FG001|Overall Study|Death|1|||
129712855|NCT00444925|466909999|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
129712856|NCT00444925|466910000|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
129712857|NCT00444925|466910001|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
129712858|NCT00444925|466909999|FG000|Double-blind Treatment Period|Death|2|||
129712859|NCT00444925|466910000|FG001|Double-blind Treatment Period|Death|0|||
129712860|NCT00444925|466910001|FG002|Double-blind Treatment Period|Death|0|||
129712861|NCT00444925|466909999|FG000|Double-blind Treatment Period|Adverse Event|6|||
129712862|NCT00444925|466910000|FG001|Double-blind Treatment Period|Adverse Event|28|||
129712863|NCT00444925|466910001|FG002|Double-blind Treatment Period|Adverse Event|44|||
129712864|NCT00444925|466909999|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
129712865|NCT00444925|466910000|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
129712866|NCT00444925|466910001|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
129712867|NCT00444925|466909999|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
129712868|NCT00444925|466910000|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
129712869|NCT00444925|466910001|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
129712870|NCT00444925|466909999|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
129712871|NCT00444925|466910000|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
129712872|NCT00444925|466910001|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
129712873|NCT00444925|466909999|FG000|Double-blind Treatment Period|Other|7|||
129712874|NCT00444925|466910000|FG001|Double-blind Treatment Period|Other|7|||
129712875|NCT00444925|466910001|FG002|Double-blind Treatment Period|Other|12|||
129712876|NCT00714948|466910008|FG000|Overall Study|Adverse Event|2|||
129712877|NCT03382912|466910009|FG000|Overall Study|Physician Decision|0|||
129712878|NCT03382912|466910010|FG001|Overall Study|Physician Decision|1|||
129712879|NCT03382912|466910009|FG000|Overall Study|Sponsor Decision|6|||
129712880|NCT03382912|466910010|FG001|Overall Study|Sponsor Decision|6|||
129712881|NCT03382912|466910009|FG000|Overall Study|Withdrawal by Subject|0|||
129712882|NCT03382912|466910010|FG001|Overall Study|Withdrawal by Subject|5|||
129712883|NCT05588440|466910011|FG000|Overall Study|Sponsor Decision|2|||
129712884|NCT05588440|466910012|FG001|Overall Study|Sponsor Decision|0|||
129712885|NCT05588440|466910013|FG002|Overall Study|Sponsor Decision|1|||
129801988|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
129801989|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
129801990|NCT01528033|467243449|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
129801991|NCT01528033|467243450|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
129801992|NCT01528033|467243449|FG000|Follow Up|No data available|46|||
129801993|NCT01528033|467243450|FG001|Follow Up|No data available|44|||
129801994|NCT02436681|467243453|FG000|Overall Study|Lost to Follow-up|10|||
129801995|NCT02436681|467243453|FG000|Overall Study|Withdrawal by Subject|2|||
129801996|NCT02436681|467243453|FG000|Overall Study|Death|2|||
129801997|NCT02030938|467243456|FG000|Overall Study|Lost to Follow-up|4|||
129801998|NCT02030938|467243456|FG000|Overall Study|Withdrawal by Subject|1|||
129801999|NCT02520661|467243458|FG000|Overall Study|Lost to Follow-up|7|||
129802000|NCT02520661|467243459|FG001|Overall Study|Lost to Follow-up|3|||
129802001|NCT02520661|467243458|FG000|Overall Study|Admitted from ED|49|||
129802002|NCT02520661|467243459|FG001|Overall Study|Admitted from ED|48|||
129802003|NCT02520661|467243458|FG000|Overall Study|ED greater than 24 hours|29|||
129802004|NCT02520661|467243459|FG001|Overall Study|ED greater than 24 hours|38|||
129802005|NCT02520661|467243458|FG000|Overall Study|other ineligibility|14|||
129712886|NCT05588440|466910011|FG000|Overall Study|Death|1|||
129712887|NCT05588440|466910012|FG001|Overall Study|Death|1|||
129712888|NCT05588440|466910013|FG002|Overall Study|Death|1|||
129712889|NCT05588440|466910011|FG000|Overall Study|Screen Fail|0|||
129712890|NCT05588440|466910012|FG001|Overall Study|Screen Fail|1|||
129712891|NCT05588440|466910013|FG002|Overall Study|Screen Fail|1|||
129712892|NCT05588440|466910011|FG000|Overall Study|Withdrawal by Subject|0|||
129712893|NCT05588440|466910012|FG001|Overall Study|Withdrawal by Subject|0|||
129712894|NCT05588440|466910013|FG002|Overall Study|Withdrawal by Subject|1|||
129712895|NCT02137070|466910014|FG000|Overall Study|Adverse Event|12|||
129712896|NCT02137070|466910015|FG001|Overall Study|Adverse Event|3|||
129712897|NCT02137070|466910014|FG000|Overall Study|Death|2|||
129712898|NCT02137070|466910015|FG001|Overall Study|Death|0|||
129712899|NCT02137070|466910014|FG000|Overall Study|Lost to Follow-up|24|||
129712900|NCT02137070|466910015|FG001|Overall Study|Lost to Follow-up|9|||
129712901|NCT02137070|466910014|FG000|Overall Study|Physician Decision|0|||
129712902|NCT02137070|466910015|FG001|Overall Study|Physician Decision|1|||
129712903|NCT02137070|466910014|FG000|Overall Study|Protocol Violation|18|||
129712904|NCT02137070|466910015|FG001|Overall Study|Protocol Violation|4|||
129712905|NCT02137070|466910014|FG000|Overall Study|Withdrawal by Subject|18|||
129712906|NCT02137070|466910015|FG001|Overall Study|Withdrawal by Subject|1|||
129712907|NCT00972023|466912238|FG000|Overall Study|Withdrawal by Subject|1|||
129712908|NCT02628444|466912239|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
129712909|NCT02628444|466912240|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712910|NCT02628444|466912241|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712911|NCT02628444|466912242|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712912|NCT02628444|466912243|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712913|NCT02628444|466912244|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712914|NCT02628444|466912245|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712915|NCT02628444|466912246|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712916|NCT02628444|466912247|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
129712917|NCT02628444|466912239|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712918|NCT02628444|466912240|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
129712919|NCT02628444|466912241|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
129712920|NCT02628444|466912242|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712921|NCT02628444|466912243|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712922|NCT02628444|466912244|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712923|NCT02628444|466912245|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712924|NCT02628444|466912246|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712925|NCT02628444|466912247|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
129712926|NCT02628444|466912239|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
129712927|NCT02628444|466912240|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
129712928|NCT02628444|466912241|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
129712929|NCT02628444|466912242|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712930|NCT02628444|466912243|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712931|NCT02628444|466912244|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712932|NCT02628444|466912245|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712933|NCT02628444|466912246|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129802006|NCT02520661|467243459|FG001|Overall Study|other ineligibility|22|||
129802007|NCT02520661|467243458|FG000|Overall Study|Withdrawal by Subject|7|||
129802008|NCT02520661|467243459|FG001|Overall Study|Withdrawal by Subject|16|||
129802009|NCT03954132|467243460|FG000|Overall Study|Adverse Event|2|||
129802010|NCT03954132|467243461|FG001|Overall Study|Adverse Event|0|||
129802011|NCT03954132|467243460|FG000|Overall Study|Patient's wish|5|||
129802012|NCT03954132|467243461|FG001|Overall Study|Patient's wish|0|||
129802013|NCT03954132|467243460|FG000|Overall Study|Lost to Follow-up|10|||
129802014|NCT03954132|467243461|FG001|Overall Study|Lost to Follow-up|0|||
129802015|NCT03954132|467243460|FG000|Overall Study|Screening failure|0|||
129802016|NCT03954132|467243461|FG001|Overall Study|Screening failure|1|||
129802017|NCT03954132|467243460|FG000|Overall Study|No registration after Visit 1|5|||
129802018|NCT03954132|467243461|FG001|Overall Study|No registration after Visit 1|2|||
129802019|NCT03954132|467243460|FG000|Overall Study|Other reason than listed|2|||
129802020|NCT03954132|467243461|FG001|Overall Study|Other reason than listed|2|||
129802021|NCT03954132|467243460|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
129802022|NCT03954132|467243461|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
129802023|NCT03954132|467243460|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
129802024|NCT03954132|467243461|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
129802025|NCT00072176|467243464|FG000|Overall Study|Withdrawal by Subject|1|||
129802026|NCT00072176|467243465|FG001|Overall Study|Withdrawal by Subject|0|||
129802027|NCT00072176|467243464|FG000|Overall Study|Protocol Violation|0|||
129802028|NCT00072176|467243465|FG001|Overall Study|Protocol Violation|1|||
129802029|NCT04502979|467243471|FG000|Overall Study|Lost to Follow-up|1|||
129802030|NCT04502979|467243472|FG001|Overall Study|Lost to Follow-up|3|||
129802031|NCT04502979|467243471|FG000|Overall Study|Withdrawal by Subject|2|||
129802032|NCT04502979|467243472|FG001|Overall Study|Withdrawal by Subject|1|||
129802033|NCT00932737|467243480|FG000|Overall Study|Not treated in second episode|1|||
129802034|NCT00932737|467243481|FG001|Overall Study|Not treated in second episode|0|||
129802035|NCT00932737|467243480|FG000|Overall Study|Adverse Event|0|||
129802036|NCT00932737|467243481|FG001|Overall Study|Adverse Event|1|||
129802037|NCT02906332|467243486|FG000|Overall Study|Withdrawal by Subject|1|||
129802038|NCT02949700|467243487|FG000|Phase I|Withdrawal by Subject|1|||
129802039|NCT02949700|467243488|FG001|Phase I|Withdrawal by Subject|1|||
129802040|NCT02949700|467243489|FG002|Phase I|Withdrawal by Subject|0|||
129802041|NCT02949700|467243490|FG003|Phase I|Withdrawal by Subject|0|||
129802042|NCT02949700|467243487|FG000|Phase I|Protocol Violation|1|||
129802043|NCT02949700|467243488|FG001|Phase I|Protocol Violation|0|||
129802044|NCT02949700|467243489|FG002|Phase I|Protocol Violation|0|||
129802045|NCT02949700|467243490|FG003|Phase I|Protocol Violation|0|||
129802046|NCT02949700|467243487|FG000|Phase II|Withdrawal by Subject|0|||
129802047|NCT02949700|467243488|FG001|Phase II|Withdrawal by Subject|0|||
129802048|NCT02949700|467243489|FG002|Phase II|Withdrawal by Subject|0|||
129802049|NCT02949700|467243490|FG003|Phase II|Withdrawal by Subject|2|||
129802050|NCT02949700|467243487|FG000|Phase II|Protocol Violation|0|||
129802051|NCT02949700|467243488|FG001|Phase II|Protocol Violation|0|||
129802052|NCT02949700|467243489|FG002|Phase II|Protocol Violation|1|||
129802053|NCT02949700|467243490|FG003|Phase II|Protocol Violation|3|||
129802054|NCT04399837|467243494|FG000|Overall Study|Other than listed|0|||
129802055|NCT04399837|467243495|FG001|Overall Study|Other than listed|2|||
129802056|NCT04399837|467243496|FG002|Overall Study|Other than listed|2|||
129802057|NCT04399837|467243497|FG003|Overall Study|Other than listed|3|||
129802058|NCT04399837|467243494|FG000|Overall Study|Withdrawal by Subject|1|||
129802059|NCT04399837|467243495|FG001|Overall Study|Withdrawal by Subject|2|||
129802060|NCT04399837|467243496|FG002|Overall Study|Withdrawal by Subject|1|||
129802061|NCT04399837|467243497|FG003|Overall Study|Withdrawal by Subject|1|||
129802062|NCT02628769|467243509|FG000|First Intervention|Adverse Event|1|||
129802063|NCT02628769|467243510|FG001|First Intervention|Adverse Event|0|||
129802064|NCT02628769|467243509|FG000|First Intervention|Withdrawal by Subject|0|||
129802065|NCT02628769|467243510|FG001|First Intervention|Withdrawal by Subject|1|||
129802066|NCT02628769|467243509|FG000|Second Intervention|Adverse Event|2|||
129802067|NCT02628769|467243510|FG001|Second Intervention|Adverse Event|0|||
129802068|NCT02628769|467243509|FG000|Second Intervention|Physician Decision|0|||
129802069|NCT02628769|467243510|FG001|Second Intervention|Physician Decision|1|||
129802070|NCT02024555|467243511|FG000|Overall Study|Lost to Follow-up|1|||
129802071|NCT02024555|467243512|FG001|Overall Study|Lost to Follow-up|1|||
129802072|NCT02024555|467243511|FG000|Overall Study|Withdrawal by Subject|5|||
129802073|NCT02024555|467243512|FG001|Overall Study|Withdrawal by Subject|1|||
129802074|NCT02719327|467243515|FG000|Overall Study|Withdrawal by Subject|11|||
129802075|NCT02719327|467243516|FG001|Overall Study|Withdrawal by Subject|8|||
129802076|NCT03350620|467243517|FG000|Stage 2|Adverse Event|0|||
129802077|NCT03350620|467243518|FG001|Stage 2|Adverse Event|1|||
129802078|NCT03350620|467243519|FG002|Stage 2|Adverse Event|1|||
129802079|NCT03350620|467243517|FG000|Stage 2|Lack of Efficacy|0|||
129802080|NCT03350620|467243518|FG001|Stage 2|Lack of Efficacy|2|||
129802081|NCT03350620|467243519|FG002|Stage 2|Lack of Efficacy|0|||
129802082|NCT03350620|467243517|FG000|Stage 2|Lost to Follow-up|1|||
129802083|NCT03350620|467243518|FG001|Stage 2|Lost to Follow-up|2|||
129802084|NCT03350620|467243519|FG002|Stage 2|Lost to Follow-up|2|||
129891391|NCT04529538|467559722|FG007|Overall Study|Withdrawal by Subject|0|||
129712934|NCT02628444|466912247|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712935|NCT02628444|466912239|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
129712936|NCT02628444|466912240|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
129712937|NCT02628444|466912241|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
129712938|NCT02628444|466912242|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129712939|NCT02628444|466912243|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129712940|NCT02628444|466912244|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129712941|NCT02628444|466912245|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129712942|NCT02628444|466912246|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129712943|NCT02628444|466912247|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
129712944|NCT02628444|466912239|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
129712945|NCT02628444|466912240|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
129712946|NCT02628444|466912241|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
129712947|NCT02628444|466912242|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129712948|NCT02628444|466912243|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129712949|NCT02628444|466912244|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129712950|NCT02628444|466912245|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129712951|NCT02628444|466912246|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129712952|NCT02628444|466912247|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
129712953|NCT02628444|466912239|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712954|NCT02628444|466912240|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712955|NCT02628444|466912241|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712956|NCT02628444|466912242|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
129712957|NCT02628444|466912243|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712958|NCT02628444|466912244|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712959|NCT02628444|466912245|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712960|NCT02628444|466912246|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712961|NCT02628444|466912247|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
129712962|NCT02628444|466912239|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
129712963|NCT02628444|466912240|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
129712964|NCT02628444|466912241|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
129712965|NCT02628444|466912242|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
129712966|NCT02628444|466912243|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
129712967|NCT02628444|466912244|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
129712968|NCT02628444|466912245|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
129712969|NCT02628444|466912246|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
129712970|NCT02628444|466912247|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
129712971|NCT02628444|466912239|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712972|NCT02628444|466912240|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712973|NCT02628444|466912241|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
129712974|NCT02628444|466912242|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
129712975|NCT02628444|466912243|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
129712976|NCT02628444|466912244|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
129712977|NCT02628444|466912245|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
129712978|NCT02628444|466912246|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
129712979|NCT02628444|466912247|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
129712980|NCT02628444|466912239|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129712981|NCT02628444|466912240|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129712982|NCT02628444|466912241|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129712983|NCT02628444|466912242|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129712984|NCT02628444|466912243|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
129712985|NCT02628444|466912244|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129712986|NCT02628444|466912245|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
129802085|NCT03350620|467243517|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
129802086|NCT03350620|467243518|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
129712987|NCT02628444|466912246|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
129712988|NCT02628444|466912247|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
129712989|NCT02628444|466912239|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
129712990|NCT02628444|466912240|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
129712991|NCT02628444|466912241|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
129712992|NCT02628444|466912242|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
129802087|NCT03350620|467243519|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
129802088|NCT01066000|467243522|FG000|Overall Study|Protocol Violation|4|||
129802089|NCT01066000|467243522|FG000|Overall Study|Death|3|||
129802090|NCT01066000|467243522|FG000|Overall Study|Withdrawal by Subject|1|||
129802091|NCT01066000|467243522|FG000|Overall Study|Adverse Event|1|||
129802092|NCT05268055|467243523|FG000|Overall Study|Lost to Follow-up|68|||
129802093|NCT05268055|467243524|FG001|Overall Study|Lost to Follow-up|68|||
129802094|NCT05268055|467243523|FG000|Overall Study|Withdrawal by Subject|12|||
129802095|NCT05268055|467243524|FG001|Overall Study|Withdrawal by Subject|8|||
129802096|NCT01854658|467245168|FG000|Overall Study|Protocol Violation|6|||
129802097|NCT01854658|467245169|FG001|Overall Study|Protocol Violation|2|||
129802098|NCT01854658|467245170|FG002|Overall Study|Protocol Violation|2|||
129802099|NCT01854658|467245171|FG003|Overall Study|Protocol Violation|1|||
129802100|NCT01854658|467245168|FG000|Overall Study|Physician Decision|7|||
129802101|NCT01854658|467245169|FG001|Overall Study|Physician Decision|5|||
129802102|NCT01854658|467245170|FG002|Overall Study|Physician Decision|2|||
129802103|NCT01854658|467245171|FG003|Overall Study|Physician Decision|4|||
129802104|NCT01854658|467245168|FG000|Overall Study|Lost to Follow-up|8|||
129802105|NCT01854658|467245169|FG001|Overall Study|Lost to Follow-up|9|||
129802106|NCT01854658|467245170|FG002|Overall Study|Lost to Follow-up|8|||
129802107|NCT01854658|467245171|FG003|Overall Study|Lost to Follow-up|4|||
129802108|NCT01854658|467245168|FG000|Overall Study|Withdrawal by Subject|28|||
129802109|NCT01854658|467245169|FG001|Overall Study|Withdrawal by Subject|21|||
129802110|NCT01854658|467245170|FG002|Overall Study|Withdrawal by Subject|29|||
129802111|NCT01854658|467245171|FG003|Overall Study|Withdrawal by Subject|15|||
129802112|NCT01854658|467245168|FG000|Overall Study|Protocol-specified criteria|15|||
129802113|NCT01854658|467245169|FG001|Overall Study|Protocol-specified criteria|15|||
129802114|NCT01854658|467245170|FG002|Overall Study|Protocol-specified criteria|10|||
129712993|NCT02628444|466912243|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
129712994|NCT02628444|466912244|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
129712995|NCT02628444|466912245|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
129712996|NCT02628444|466912246|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
129712997|NCT02628444|466912247|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
129712998|NCT00532129|466912248|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
129712999|NCT00532129|466912248|FG000|Treatment Period|Physician Decision|15|||
129713000|NCT00532129|466912248|FG000|Treatment Period|Disease progression|3|||
129713001|NCT00532129|466912248|FG000|Treatment Period|Protocol Violation|1|||
129713002|NCT00532129|466912248|FG000|Treatment Period|Other|5|||
129713003|NCT00532129|466912248|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
129713004|NCT00532129|466912248|FG000|Follow-up Period|Disease progression|57|||
129713005|NCT00532129|466912248|FG000|Follow-up Period|Lost to Follow-up|1|||
129713006|NCT00532129|466912248|FG000|Follow-up Period|Other|6|||
129713007|NCT00784368|466912251|FG000|Overall Study|Physician Decision|0|||
129713008|NCT00784368|466912252|FG001|Overall Study|Physician Decision|0|||
129713009|NCT00784368|466912253|FG002|Overall Study|Physician Decision|6|||
129713010|NCT00784368|466912251|FG000|Overall Study|Lack of Efficacy|2|||
129713011|NCT00784368|466912252|FG001|Overall Study|Lack of Efficacy|0|||
129713012|NCT00784368|466912253|FG002|Overall Study|Lack of Efficacy|1|||
129713013|NCT00784368|466912251|FG000|Overall Study|Adverse Event|6|||
129713014|NCT00784368|466912252|FG001|Overall Study|Adverse Event|9|||
129713015|NCT00784368|466912253|FG002|Overall Study|Adverse Event|2|||
129713016|NCT00784368|466912251|FG000|Overall Study|Diagnosis of fever|0|||
129802115|NCT01854658|467245171|FG003|Overall Study|Protocol-specified criteria|7|||
129802116|NCT01854658|467245168|FG000|Overall Study|Lack of Efficacy|3|||
129802117|NCT01854658|467245169|FG001|Overall Study|Lack of Efficacy|8|||
129802118|NCT01854658|467245170|FG002|Overall Study|Lack of Efficacy|4|||
129802119|NCT01854658|467245171|FG003|Overall Study|Lack of Efficacy|7|||
129802120|NCT01854658|467245168|FG000|Overall Study|Adverse Event|21|||
129802121|NCT01854658|467245169|FG001|Overall Study|Adverse Event|14|||
129802122|NCT01854658|467245170|FG002|Overall Study|Adverse Event|23|||
129802123|NCT01854658|467245171|FG003|Overall Study|Adverse Event|19|||
129802124|NCT01854658|467245168|FG000|Overall Study|Administrative reasons|5|||
129802125|NCT01854658|467245169|FG001|Overall Study|Administrative reasons|1|||
129713017|NCT00784368|466912252|FG001|Overall Study|Diagnosis of fever|0|||
129713018|NCT00784368|466912253|FG002|Overall Study|Diagnosis of fever|1|||
129713019|NCT00784368|466912251|FG000|Overall Study|Worsening of complications|0|||
129713020|NCT00784368|466912252|FG001|Overall Study|Worsening of complications|0|||
129713021|NCT00784368|466912253|FG002|Overall Study|Worsening of complications|1|||
129713022|NCT00784368|466912251|FG000|Overall Study|Worsening of symptoms|0|||
129713023|NCT00784368|466912252|FG001|Overall Study|Worsening of symptoms|1|||
129713024|NCT00784368|466912253|FG002|Overall Study|Worsening of symptoms|0|||
129713025|NCT00784368|466912251|FG000|Overall Study|Withdrawal of informed consent|0|||
129802126|NCT01854658|467245170|FG002|Overall Study|Administrative reasons|2|||
129802127|NCT01854658|467245171|FG003|Overall Study|Administrative reasons|2|||
129802128|NCT00697073|467245172|FG000|Overall Study|Withdrawal by Subject|2|||
129802129|NCT00697073|467245172|FG000|Overall Study|Pregnancy|1|||
129802130|NCT00697073|467245172|FG000|Overall Study|non compliance and other|6|||
129802131|NCT02203071|467245173|FG000|Overall Study|Lost to Follow-up|3|||
129802132|NCT02203071|467245174|FG001|Overall Study|Lost to Follow-up|1|||
129802133|NCT03894046|467245175|FG000|Overall Study|Protocol Violation|1|||
129802134|NCT03894046|467245176|FG001|Overall Study|Protocol Violation|0|||
129802135|NCT03894046|467245177|FG002|Overall Study|Protocol Violation|0|||
129802136|NCT03894046|467245175|FG000|Overall Study|Adverse Event|0|||
129802137|NCT03894046|467245176|FG001|Overall Study|Adverse Event|1|||
129802138|NCT03894046|467245177|FG002|Overall Study|Adverse Event|0|||
129802139|NCT03894046|467245175|FG000|Overall Study|Withdrawal by Subject|2|||
129802140|NCT03894046|467245176|FG001|Overall Study|Withdrawal by Subject|3|||
129802141|NCT03894046|467245177|FG002|Overall Study|Withdrawal by Subject|1|||
129802142|NCT03894046|467245175|FG000|Overall Study|Death|15|||
129802143|NCT03894046|467245176|FG001|Overall Study|Death|21|||
129802144|NCT03894046|467245177|FG002|Overall Study|Death|4|||
129802145|NCT03894046|467245175|FG000|Overall Study|No growth of ABC|2|||
129802146|NCT03894046|467245176|FG001|Overall Study|No growth of ABC|1|||
129802147|NCT03894046|467245177|FG002|Overall Study|No growth of ABC|0|||
129802148|NCT03894046|467245175|FG000|Overall Study|Physician Decision|1|||
129802149|NCT03894046|467245176|FG001|Overall Study|Physician Decision|1|||
129802150|NCT03894046|467245177|FG002|Overall Study|Physician Decision|1|||
129713026|NCT00784368|466912252|FG001|Overall Study|Withdrawal of informed consent|1|||
129713027|NCT00784368|466912253|FG002|Overall Study|Withdrawal of informed consent|0|||
129713028|NCT02237001|466912254|FG000|Overall Study|Lost to Follow-up|2|||
129713029|NCT02237001|466912254|FG000|Overall Study|Withdrawal by Subject|1|||
129713030|NCT02237001|466912254|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
129713031|NCT02237001|466912254|FG000|Overall Study|Re-operation|4|||
129713032|NCT02237001|466912254|FG000|Overall Study|Incarceration|1|||
129713033|NCT00342628|466912255|FG000|Overall Study|Withdrawal by Subject|19|||
129713034|NCT00342628|466912256|FG001|Overall Study|Withdrawal by Subject|19|||
129713035|NCT00342628|466912257|FG002|Overall Study|Withdrawal by Subject|18|||
129713036|NCT00342628|466912255|FG000|Overall Study|Death|1|||
129713037|NCT00342628|466912256|FG001|Overall Study|Death|1|||
129713038|NCT00342628|466912257|FG002|Overall Study|Death|0|||
129713039|NCT00342628|466912255|FG000|Overall Study|moved residence|0|||
129713040|NCT00342628|466912256|FG001|Overall Study|moved residence|1|||
129713041|NCT00342628|466912257|FG002|Overall Study|moved residence|1|||
129713042|NCT04551898|466912258|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
129713043|NCT04551898|466912259|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
129713044|NCT04551898|466912260|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
129713045|NCT04551898|466912261|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
129713046|NCT04551898|466912258|FG000|Overall Study|Withdrawal by Subject|5|||
129713047|NCT04551898|466912259|FG001|Overall Study|Withdrawal by Subject|1|||
129713048|NCT04551898|466912260|FG002|Overall Study|Withdrawal by Subject|2|||
129802151|NCT03894046|467245175|FG000|Overall Study|Prohibited concomitant medication|1|||
129802152|NCT03894046|467245176|FG001|Overall Study|Prohibited concomitant medication|0|||
129802153|NCT03894046|467245177|FG002|Overall Study|Prohibited concomitant medication|0|||
129802154|NCT03894046|467245175|FG000|Overall Study|Transferred to other arm/group|1|||
129802155|NCT03894046|467245176|FG001|Overall Study|Transferred to other arm/group|1|||
129802156|NCT03894046|467245177|FG002|Overall Study|Transferred to other arm/group|0|||
129802157|NCT02436304|467245187|FG000|Overall Study|Lost to Follow-up|0|||
129802158|NCT02436304|467245188|FG001|Overall Study|Lost to Follow-up|1|||
129802159|NCT02436304|467245189|FG002|Overall Study|Lost to Follow-up|0|||
129802160|NCT02436304|467245187|FG000|Overall Study|Withdrawal by Subject|0|||
129802161|NCT02436304|467245188|FG001|Overall Study|Withdrawal by Subject|1|||
129802162|NCT02436304|467245189|FG002|Overall Study|Withdrawal by Subject|0|||
129713049|NCT04551898|466912261|FG003|Overall Study|Withdrawal by Subject|2|||
129713050|NCT04551898|466912258|FG000|Overall Study|Lost to Follow-up|2|||
129713051|NCT04551898|466912259|FG001|Overall Study|Lost to Follow-up|1|||
129713052|NCT04551898|466912260|FG002|Overall Study|Lost to Follow-up|2|||
129802163|NCT02436304|467245187|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
129802164|NCT02436304|467245188|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
129802165|NCT02436304|467245189|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
129802166|NCT03793556|467245190|FG000|Overall Study|Withdrawal by Subject|12|||
129802167|NCT03793556|467245191|FG001|Overall Study|Withdrawal by Subject|1|||
129802168|NCT03793556|467245190|FG000|Overall Study|Lost to Follow-up|1|||
129713053|NCT04551898|466912261|FG003|Overall Study|Lost to Follow-up|2|||
129713054|NCT04551898|466912258|FG000|Overall Study|Death|1|||
129713055|NCT04551898|466912259|FG001|Overall Study|Death|0|||
129713056|NCT04551898|466912260|FG002|Overall Study|Death|0|||
129713057|NCT04551898|466912261|FG003|Overall Study|Death|0|||
129713058|NCT04551898|466912258|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
129713059|NCT04551898|466912259|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
129713060|NCT04551898|466912260|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
129713061|NCT04551898|466912261|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
129713062|NCT03427814|466912262|FG000|Overall Study|Withdrawal by Subject|4|||
129713063|NCT03427814|466912263|FG001|Overall Study|Withdrawal by Subject|4|||
129713064|NCT03427814|466912262|FG000|Overall Study|Lost to Follow-up|0|||
129713065|NCT03427814|466912263|FG001|Overall Study|Lost to Follow-up|2|||
129713066|NCT03427814|466912262|FG000|Overall Study|Death|42|||
129713067|NCT03427814|466912263|FG001|Overall Study|Death|31|||
129713068|NCT03427814|466912262|FG000|Overall Study|Sponsor's Decision|1|||
129713069|NCT03427814|466912263|FG001|Overall Study|Sponsor's Decision|0|||
129713070|NCT03427814|466912262|FG000|Overall Study|Investigator's Decision|1|||
129713071|NCT03427814|466912263|FG001|Overall Study|Investigator's Decision|2|||
129713072|NCT03427814|466912262|FG000|Overall Study|Disease progression|1|||
129713073|NCT03427814|466912263|FG001|Overall Study|Disease progression|0|||
129713074|NCT03427814|466912262|FG000|Overall Study|Treatment Completed|0|||
129713075|NCT03427814|466912263|FG001|Overall Study|Treatment Completed|1|||
129713076|NCT03427814|466912262|FG000|Overall Study|Sponsor's Decision to End study|21|||
129713077|NCT03427814|466912263|FG001|Overall Study|Sponsor's Decision to End study|25|||
129713078|NCT03427814|466912262|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
129713079|NCT03427814|466912263|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
129713080|NCT04971967|466912266|FG000|Overall Study|Lost to Follow-up|6|||
129802169|NCT03793556|467245191|FG001|Overall Study|Lost to Follow-up|1|||
129802170|NCT04416633|467245192|FG000|Overall Study|Death|1|||
129802171|NCT04416633|467245192|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
129802172|NCT04416633|467245192|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
129802173|NCT04416633|467245192|FG000|Overall Study|Adverse Event|6|||
129713081|NCT04971967|466912267|FG001|Overall Study|Lost to Follow-up|7|||
129713082|NCT00682929|466912270|FG000|Overall Study|Adverse Event|4|||
129713083|NCT00682929|466912271|FG001|Overall Study|Adverse Event|1|||
129713084|NCT00682929|466912272|FG002|Overall Study|Adverse Event|1|||
129713085|NCT00682929|466912270|FG000|Overall Study|Withdrawal by Subject|1|||
129713086|NCT00682929|466912271|FG001|Overall Study|Withdrawal by Subject|2|||
129713087|NCT00682929|466912272|FG002|Overall Study|Withdrawal by Subject|1|||
129713088|NCT00682929|466912270|FG000|Overall Study|dosing compliance < 80%|0|||
129713089|NCT00682929|466912271|FG001|Overall Study|dosing compliance < 80%|2|||
129713090|NCT00682929|466912272|FG002|Overall Study|dosing compliance < 80%|0|||
129713091|NCT00682929|466912270|FG000|Overall Study|lag in DEA renewal|1|||
129713092|NCT00682929|466912271|FG001|Overall Study|lag in DEA renewal|0|||
129713093|NCT00682929|466912272|FG002|Overall Study|lag in DEA renewal|0|||
129713094|NCT01462929|466912273|FG000|Overall Study|Adverse Event|3|||
129713095|NCT01462929|466912274|FG001|Overall Study|Adverse Event|3|||
129713096|NCT01462929|466912275|FG002|Overall Study|Adverse Event|4|||
129713097|NCT01462929|466912273|FG000|Overall Study|Withdrawal by Subject|2|||
129713098|NCT01462929|466912274|FG001|Overall Study|Withdrawal by Subject|1|||
129713099|NCT01462929|466912275|FG002|Overall Study|Withdrawal by Subject|0|||
129713100|NCT01462929|466912273|FG000|Overall Study|Lack of Efficacy|0|||
129713101|NCT01462929|466912274|FG001|Overall Study|Lack of Efficacy|0|||
129713102|NCT01462929|466912275|FG002|Overall Study|Lack of Efficacy|1|||
129713103|NCT00399568|466912276|FG000|Overall Study|Adverse Event|1|||
129713104|NCT00399568|466912277|FG001|Overall Study|Adverse Event|2|||
129713105|NCT00399568|466912276|FG000|Overall Study|Withdrawal by Subject|7|||
129713106|NCT00399568|466912277|FG001|Overall Study|Withdrawal by Subject|3|||
129713107|NCT00399568|466912276|FG000|Overall Study|Protocol non-compliance|2|||
129713108|NCT00399568|466912277|FG001|Overall Study|Protocol non-compliance|2|||
129802174|NCT04416633|467245192|FG000|Overall Study|Withdrawal by Subject|6|||
129802175|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Death|1|||
129802176|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Death|1|||
129802177|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Death|0|||
129713109|NCT00399568|466912276|FG000|Overall Study|Lost to Follow-up|2|||
129713110|NCT00399568|466912277|FG001|Overall Study|Lost to Follow-up|2|||
129713111|NCT00506779|466912279|FG000|Overall Study|Withdrawal by Subject|1|||
129713112|NCT00506779|466912280|FG001|Overall Study|Withdrawal by Subject|0|||
129802178|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Death|0|||
129802179|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
129713113|NCT00506779|466912281|FG002|Overall Study|Withdrawal by Subject|1|||
129713114|NCT00506779|466912282|FG003|Overall Study|Withdrawal by Subject|0|||
129713115|NCT00506779|466912279|FG000|Overall Study|Adverse Event|0|||
129713116|NCT00506779|466912280|FG001|Overall Study|Adverse Event|1|||
129713117|NCT00506779|466912281|FG002|Overall Study|Adverse Event|1|||
129713118|NCT00506779|466912282|FG003|Overall Study|Adverse Event|1|||
129713119|NCT02639247|466912285|FG000|Overall Study|Lost to Follow-up|2|||
129713120|NCT02639247|466912286|FG001|Overall Study|Lost to Follow-up|1|||
129713121|NCT02639247|466912285|FG000|Overall Study|Death|2|||
129713122|NCT02639247|466912286|FG001|Overall Study|Death|0|||
129713123|NCT02639247|466912285|FG000|Overall Study|Withdrew Consent|0|||
129713124|NCT02639247|466912286|FG001|Overall Study|Withdrew Consent|1|||
129713125|NCT02639247|466912285|FG000|Overall Study|Protocol Violation|1|||
129713126|NCT02639247|466912286|FG001|Overall Study|Protocol Violation|0|||
129713127|NCT03462758|466912287|FG000|Overall Study|Chose no or other method of contraception|20|||
129713128|NCT03462758|466912288|FG001|Overall Study|Chose no or other method of contraception|23|||
129713129|NCT03462758|466912287|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
129713130|NCT03462758|466912288|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
129713131|NCT03462758|466912287|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
129713132|NCT03462758|466912288|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
129713133|NCT03462758|466912287|FG000|Overall Study|Medical contraindication|2|||
129713134|NCT03462758|466912288|FG001|Overall Study|Medical contraindication|2|||
129713135|NCT03462758|466912287|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
129713136|NCT03462758|466912288|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
129713137|NCT02820844|466912290|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
129713138|NCT02820844|466912291|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
129713139|NCT02820844|466912292|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129713140|NCT02820844|466912293|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129713141|NCT02820844|466912294|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129713142|NCT02820844|466912295|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
129713143|NCT02820844|466912290|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
129713144|NCT02820844|466912291|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
129713145|NCT02820844|466912292|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129713146|NCT02820844|466912293|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129713147|NCT02820844|466912294|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129713148|NCT02820844|466912295|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
129713149|NCT02820844|466912290|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129713150|NCT02820844|466912291|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
129713151|NCT02820844|466912292|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129713152|NCT02820844|466912293|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129713153|NCT02820844|466912294|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129713154|NCT02820844|466912295|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
129713155|NCT02820844|466912290|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
129713156|NCT02820844|466912291|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
129713157|NCT02820844|466912292|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129713158|NCT02820844|466912293|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129713159|NCT02820844|466912294|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129713160|NCT02820844|466912295|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
129713161|NCT02820844|466912290|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
129713162|NCT02820844|466912291|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129713163|NCT02820844|466912292|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129713164|NCT02820844|466912293|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129713165|NCT02820844|466912294|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129713166|NCT02820844|466912295|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
129713167|NCT02820844|466912290|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129891392|NCT04529538|467559715|FG000|Overall Study|Other|0|||
129713168|NCT02820844|466912291|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129713169|NCT02820844|466912292|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
129713170|NCT02820844|466912293|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
129713171|NCT02820844|466912294|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129713172|NCT02820844|466912295|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
129713173|NCT02820844|466912290|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129713174|NCT02820844|466912291|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129713175|NCT02820844|466912292|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
129713176|NCT02820844|466912293|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129713177|NCT02820844|466912294|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129713178|NCT02820844|466912295|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
129713179|NCT02820844|466912290|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713180|NCT02820844|466912291|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713181|NCT02820844|466912292|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
129713182|NCT02820844|466912293|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
129713183|NCT02820844|466912294|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713184|NCT02820844|466912295|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713185|NCT02820844|466912290|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129713186|NCT02820844|466912291|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129713187|NCT02820844|466912292|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129713188|NCT02820844|466912293|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129713189|NCT02820844|466912294|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
129713190|NCT02820844|466912295|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
129713191|NCT02820844|466912290|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713192|NCT02820844|466912291|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713193|NCT02820844|466912292|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713194|NCT02820844|466912293|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713195|NCT02820844|466912294|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
129713196|NCT02820844|466912295|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
129713197|NCT02266147|466912296|FG000|PART 1: Dose Escalation|Physician Decision|0|||
129713198|NCT02266147|466912297|FG001|PART 1: Dose Escalation|Physician Decision|0|||
129713199|NCT02266147|466912298|FG002|PART 1: Dose Escalation|Physician Decision|1|||
129713200|NCT02266147|466912299|FG003|PART 1: Dose Escalation|Physician Decision|0|||
129713201|NCT02266147|466912296|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
129713202|NCT02266147|466912297|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
129713203|NCT02266147|466912298|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
129713204|NCT02266147|466912299|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
129713205|NCT02266147|466912296|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
129713206|NCT02266147|466912297|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
129713207|NCT02266147|466912298|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
129713208|NCT02266147|466912299|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
129713209|NCT02266147|466912296|FG000|PART 1: Dose Escalation|Other|1|||
129713210|NCT02266147|466912297|FG001|PART 1: Dose Escalation|Other|1|||
129713211|NCT02266147|466912298|FG002|PART 1: Dose Escalation|Other|0|||
129713212|NCT02266147|466912299|FG003|PART 1: Dose Escalation|Other|0|||
129713213|NCT02266147|466912296|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
129713214|NCT02266147|466912297|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
129713215|NCT02266147|466912298|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
129713216|NCT02266147|466912299|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
129713217|NCT02266147|466912296|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
129713218|NCT02266147|466912297|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
129713219|NCT02266147|466912298|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
129713220|NCT02266147|466912299|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
129713221|NCT01456130|466912300|FG000|Overall Study|Adverse Event|4|||
129713222|NCT01456130|466912300|FG000|Overall Study|Voluntary Withdrawal|1|||
129713223|NCT01456130|466912300|FG000|Overall Study|Lack of Efficacy|4|||
129713224|NCT01456130|466912300|FG000|Overall Study|Other|1|||
129713225|NCT00413660|466912303|FG000|Up To Week 12|Adverse Event|1|||
129713226|NCT00413660|466912304|FG001|Up To Week 12|Adverse Event|3|||
129713227|NCT00413660|466912305|FG002|Up To Week 12|Adverse Event|1|||
129713228|NCT00413660|466912306|FG003|Up To Week 12|Adverse Event|4|||
129713229|NCT00413660|466912307|FG004|Up To Week 12|Adverse Event|6|||
129713230|NCT00413660|466912308|FG005|Up To Week 12|Adverse Event|4|||
129713231|NCT00413660|466912309|FG006|Up To Week 12|Adverse Event|1|||
129713232|NCT00413660|466912310|FG007|Up To Week 12|Adverse Event|0|||
129713233|NCT00413660|466912311|FG008|Up To Week 12|Adverse Event|0|||
129713234|NCT00413660|466912312|FG009|Up To Week 12|Adverse Event|0|||
129713235|NCT00413660|466912313|FG010|Up To Week 12|Adverse Event|0|||
129713236|NCT00413660|466912303|FG000|Up To Week 12|Lack of Efficacy|2|||
129713237|NCT00413660|466912304|FG001|Up To Week 12|Lack of Efficacy|0|||
129713238|NCT00413660|466912305|FG002|Up To Week 12|Lack of Efficacy|0|||
129713239|NCT00413660|466912306|FG003|Up To Week 12|Lack of Efficacy|0|||
129713240|NCT00413660|466912307|FG004|Up To Week 12|Lack of Efficacy|0|||
129713241|NCT00413660|466912308|FG005|Up To Week 12|Lack of Efficacy|0|||
129713242|NCT00413660|466912309|FG006|Up To Week 12|Lack of Efficacy|5|||
129713243|NCT00413660|466912310|FG007|Up To Week 12|Lack of Efficacy|0|||
129713244|NCT00413660|466912311|FG008|Up To Week 12|Lack of Efficacy|0|||
129713245|NCT00413660|466912312|FG009|Up To Week 12|Lack of Efficacy|0|||
129713246|NCT00413660|466912313|FG010|Up To Week 12|Lack of Efficacy|0|||
129713247|NCT00413660|466912303|FG000|Up To Week 12|Lost to Follow-up|0|||
129713248|NCT00413660|466912304|FG001|Up To Week 12|Lost to Follow-up|1|||
129713249|NCT00413660|466912305|FG002|Up To Week 12|Lost to Follow-up|0|||
129713250|NCT00413660|466912306|FG003|Up To Week 12|Lost to Follow-up|0|||
129713251|NCT00413660|466912307|FG004|Up To Week 12|Lost to Follow-up|1|||
129713252|NCT00413660|466912308|FG005|Up To Week 12|Lost to Follow-up|0|||
129713253|NCT00413660|466912309|FG006|Up To Week 12|Lost to Follow-up|0|||
129713254|NCT00413660|466912310|FG007|Up To Week 12|Lost to Follow-up|0|||
129713255|NCT00413660|466912311|FG008|Up To Week 12|Lost to Follow-up|0|||
129713256|NCT00413660|466912312|FG009|Up To Week 12|Lost to Follow-up|0|||
129713257|NCT00413660|466912313|FG010|Up To Week 12|Lost to Follow-up|0|||
129713258|NCT00413660|466912303|FG000|Up To Week 12|Withdrawal by Subject|0|||
129713259|NCT00413660|466912304|FG001|Up To Week 12|Withdrawal by Subject|2|||
129713260|NCT00413660|466912305|FG002|Up To Week 12|Withdrawal by Subject|0|||
129713261|NCT00413660|466912306|FG003|Up To Week 12|Withdrawal by Subject|2|||
129713262|NCT00413660|466912307|FG004|Up To Week 12|Withdrawal by Subject|0|||
129713263|NCT00413660|466912308|FG005|Up To Week 12|Withdrawal by Subject|2|||
129713264|NCT00413660|466912309|FG006|Up To Week 12|Withdrawal by Subject|2|||
129713265|NCT00413660|466912310|FG007|Up To Week 12|Withdrawal by Subject|0|||
129713266|NCT00413660|466912311|FG008|Up To Week 12|Withdrawal by Subject|0|||
129713267|NCT00413660|466912312|FG009|Up To Week 12|Withdrawal by Subject|0|||
129713268|NCT00413660|466912313|FG010|Up To Week 12|Withdrawal by Subject|0|||
129713269|NCT00413660|466912303|FG000|Up To Week 12|Randomized, Not Treated|1|||
129713270|NCT00413660|466912304|FG001|Up To Week 12|Randomized, Not Treated|0|||
129713271|NCT00413660|466912305|FG002|Up To Week 12|Randomized, Not Treated|0|||
129713272|NCT00413660|466912306|FG003|Up To Week 12|Randomized, Not Treated|1|||
129713273|NCT00413660|466912307|FG004|Up To Week 12|Randomized, Not Treated|0|||
129713274|NCT00413660|466912308|FG005|Up To Week 12|Randomized, Not Treated|0|||
129713275|NCT00413660|466912309|FG006|Up To Week 12|Randomized, Not Treated|0|||
129713276|NCT00413660|466912310|FG007|Up To Week 12|Randomized, Not Treated|0|||
129713277|NCT00413660|466912311|FG008|Up To Week 12|Randomized, Not Treated|0|||
129713278|NCT00413660|466912312|FG009|Up To Week 12|Randomized, Not Treated|0|||
129713279|NCT00413660|466912313|FG010|Up To Week 12|Randomized, Not Treated|0|||
129713280|NCT00413660|466912303|FG000|Up To Week 12|Other|3|||
129713281|NCT00413660|466912304|FG001|Up To Week 12|Other|1|||
129713282|NCT00413660|466912305|FG002|Up To Week 12|Other|6|||
129713283|NCT00413660|466912306|FG003|Up To Week 12|Other|1|||
129713284|NCT00413660|466912307|FG004|Up To Week 12|Other|2|||
129713285|NCT00413660|466912308|FG005|Up To Week 12|Other|4|||
129713286|NCT00413660|466912309|FG006|Up To Week 12|Other|3|||
129713287|NCT00413660|466912310|FG007|Up To Week 12|Other|0|||
129713288|NCT00413660|466912311|FG008|Up To Week 12|Other|0|||
129713289|NCT00413660|466912312|FG009|Up To Week 12|Other|0|||
129713290|NCT00413660|466912313|FG010|Up To Week 12|Other|0|||
129713291|NCT00413660|466912303|FG000|Post Week 12|Adverse Event|2|||
129713292|NCT00413660|466912304|FG001|Post Week 12|Adverse Event|0|||
129713293|NCT00413660|466912305|FG002|Post Week 12|Adverse Event|2|||
129713294|NCT00413660|466912306|FG003|Post Week 12|Adverse Event|1|||
129713295|NCT00413660|466912307|FG004|Post Week 12|Adverse Event|4|||
129713296|NCT00413660|466912308|FG005|Post Week 12|Adverse Event|2|||
129713297|NCT00413660|466912309|FG006|Post Week 12|Adverse Event|2|||
129713298|NCT00413660|466912310|FG007|Post Week 12|Adverse Event|0|||
129713299|NCT00413660|466912311|FG008|Post Week 12|Adverse Event|0|||
129713300|NCT00413660|466912312|FG009|Post Week 12|Adverse Event|0|||
129713301|NCT00413660|466912313|FG010|Post Week 12|Adverse Event|0|||
129713302|NCT00413660|466912303|FG000|Post Week 12|Lack of Efficacy|0|||
129713303|NCT00413660|466912304|FG001|Post Week 12|Lack of Efficacy|0|||
129713304|NCT00413660|466912305|FG002|Post Week 12|Lack of Efficacy|1|||
129713305|NCT00413660|466912306|FG003|Post Week 12|Lack of Efficacy|0|||
129713306|NCT00413660|466912307|FG004|Post Week 12|Lack of Efficacy|0|||
129713307|NCT00413660|466912308|FG005|Post Week 12|Lack of Efficacy|0|||
129713308|NCT00413660|466912309|FG006|Post Week 12|Lack of Efficacy|0|||
129713309|NCT00413660|466912310|FG007|Post Week 12|Lack of Efficacy|0|||
129713310|NCT00413660|466912311|FG008|Post Week 12|Lack of Efficacy|0|||
129713311|NCT00413660|466912312|FG009|Post Week 12|Lack of Efficacy|1|||
129713312|NCT00413660|466912313|FG010|Post Week 12|Lack of Efficacy|0|||
129713313|NCT00413660|466912303|FG000|Post Week 12|Lost to Follow-up|0|||
129713314|NCT00413660|466912304|FG001|Post Week 12|Lost to Follow-up|1|||
129713315|NCT00413660|466912305|FG002|Post Week 12|Lost to Follow-up|1|||
129713316|NCT00413660|466912306|FG003|Post Week 12|Lost to Follow-up|0|||
129713317|NCT00413660|466912307|FG004|Post Week 12|Lost to Follow-up|0|||
129713318|NCT00413660|466912308|FG005|Post Week 12|Lost to Follow-up|0|||
129713319|NCT00413660|466912309|FG006|Post Week 12|Lost to Follow-up|0|||
129713320|NCT00413660|466912310|FG007|Post Week 12|Lost to Follow-up|0|||
129713321|NCT00413660|466912311|FG008|Post Week 12|Lost to Follow-up|0|||
129713322|NCT00413660|466912312|FG009|Post Week 12|Lost to Follow-up|0|||
129713323|NCT00413660|466912313|FG010|Post Week 12|Lost to Follow-up|0|||
129713324|NCT00413660|466912303|FG000|Post Week 12|Withdrawal by Subject|0|||
129713325|NCT00413660|466912304|FG001|Post Week 12|Withdrawal by Subject|1|||
129713326|NCT00413660|466912305|FG002|Post Week 12|Withdrawal by Subject|1|||
129713327|NCT00413660|466912306|FG003|Post Week 12|Withdrawal by Subject|0|||
129713328|NCT00413660|466912307|FG004|Post Week 12|Withdrawal by Subject|1|||
129713329|NCT00413660|466912308|FG005|Post Week 12|Withdrawal by Subject|0|||
129713330|NCT00413660|466912309|FG006|Post Week 12|Withdrawal by Subject|0|||
129713331|NCT00413660|466912310|FG007|Post Week 12|Withdrawal by Subject|0|||
129713332|NCT00413660|466912311|FG008|Post Week 12|Withdrawal by Subject|0|||
129713333|NCT00413660|466912312|FG009|Post Week 12|Withdrawal by Subject|0|||
129713334|NCT00413660|466912313|FG010|Post Week 12|Withdrawal by Subject|1|||
129713335|NCT00413660|466912303|FG000|Post Week 12|Other|1|||
129713336|NCT00413660|466912304|FG001|Post Week 12|Other|2|||
129713337|NCT00413660|466912305|FG002|Post Week 12|Other|3|||
129713338|NCT00413660|466912306|FG003|Post Week 12|Other|0|||
129713339|NCT00413660|466912307|FG004|Post Week 12|Other|1|||
129713340|NCT00413660|466912308|FG005|Post Week 12|Other|1|||
129713341|NCT00413660|466912309|FG006|Post Week 12|Other|1|||
129713342|NCT00413660|466912310|FG007|Post Week 12|Other|0|||
129713343|NCT00413660|466912311|FG008|Post Week 12|Other|0|||
129713344|NCT00413660|466912312|FG009|Post Week 12|Other|0|||
129713345|NCT00413660|466912313|FG010|Post Week 12|Other|0|||
129713346|NCT00400517|466912317|FG000|Overall Study|Withdrawal by Subject|1|||
129713347|NCT00400517|466912317|FG000|Overall Study|Physician Decision|1|||
129713348|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
129713349|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
129713350|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
129713351|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
129713352|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
129713353|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
129713354|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
129713355|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
129713356|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
129713357|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
129713358|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
129713359|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
129713360|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
129713361|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
129713362|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
129713363|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
129713364|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
129713365|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
129713366|NCT02831855|466912322|FG000|Open Label Phase (24 Weeks)|Other|4|||
129713367|NCT02831855|466912323|FG001|Open Label Phase (24 Weeks)|Other|0|||
129713368|NCT02831855|466912324|FG002|Open Label Phase (24 Weeks)|Other|0|||
129713369|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
129713370|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
129713371|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
129713372|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Death|0|||
129713373|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Death|0|||
129713374|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Death|2|||
129713375|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
129713376|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
129713377|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
129802180|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
129802181|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
129802182|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
129802183|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
129802184|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
129802185|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
129802186|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
129802187|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
129802188|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
129802189|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
129802190|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
129802191|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
129802192|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
129802193|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
129802194|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
129802195|NCT04612790|467245193|FG000|DB Period (Up to 36 Weeks)|Other|1|||
129802196|NCT04612790|467245194|FG001|DB Period (Up to 36 Weeks)|Other|0|||
129802197|NCT04612790|467245195|FG002|DB Period (Up to 36 Weeks)|Other|0|||
129802198|NCT04612790|467245196|FG003|DB Period (Up to 36 Weeks)|Other|0|||
129802199|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
129713378|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
129713379|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
129713380|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
129713381|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
129713382|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
129713383|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
129713384|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Other|0|||
129713385|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Other|2|||
129713386|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Other|5|||
129713387|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
129713388|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
129713389|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
129713390|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
129713391|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
129713392|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
129713393|NCT02831855|466912322|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
129713394|NCT02831855|466912323|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
129713395|NCT02831855|466912324|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
129713396|NCT01722994|466912325|FG000|Overall Study|Missing data|25|||
129713397|NCT01722994|466912326|FG001|Overall Study|Missing data|17|||
129713398|NCT01803880|466912330|FG000|Overall Study|Adverse Event|1|||
129713399|NCT01803880|466912331|FG001|Overall Study|Adverse Event|0|||
129713400|NCT01803880|466912332|FG002|Overall Study|Adverse Event|0|||
129713401|NCT01803880|466912330|FG000|Overall Study|Withdrawal by Subject|1|||
129713402|NCT01803880|466912331|FG001|Overall Study|Withdrawal by Subject|1|||
129713403|NCT01803880|466912332|FG002|Overall Study|Withdrawal by Subject|4|||
129713404|NCT01803880|466912330|FG000|Overall Study|Physician Decision|0|||
129713405|NCT01803880|466912331|FG001|Overall Study|Physician Decision|0|||
129713406|NCT01803880|466912332|FG002|Overall Study|Physician Decision|1|||
129713407|NCT01803880|466912330|FG000|Overall Study|Unable to return for follow-up visits|0|||
129713408|NCT01803880|466912331|FG001|Overall Study|Unable to return for follow-up visits|1|||
129713409|NCT01803880|466912332|FG002|Overall Study|Unable to return for follow-up visits|2|||
129713410|NCT01803880|466912330|FG000|Overall Study|Lost to Follow-up|1|||
129713411|NCT01803880|466912331|FG001|Overall Study|Lost to Follow-up|2|||
129713412|NCT01803880|466912332|FG002|Overall Study|Lost to Follow-up|3|||
129713413|NCT01803880|466912330|FG000|Overall Study|Protocol Violation|1|||
129713414|NCT01803880|466912331|FG001|Overall Study|Protocol Violation|0|||
129713415|NCT01803880|466912332|FG002|Overall Study|Protocol Violation|0|||
129713416|NCT01803880|466912330|FG000|Overall Study|Early study termination|0|||
129713417|NCT01803880|466912331|FG001|Overall Study|Early study termination|6|||
129713418|NCT01803880|466912332|FG002|Overall Study|Early study termination|5|||
129713419|NCT01803880|466912330|FG000|Overall Study|Incomplete data entry by sites|2|||
129713420|NCT01803880|466912331|FG001|Overall Study|Incomplete data entry by sites|0|||
129713421|NCT01803880|466912332|FG002|Overall Study|Incomplete data entry by sites|0|||
129713422|NCT05384834|466912333|FG000|Overall Study|Lost to Follow-up|43|||
129713423|NCT05384834|466912333|FG000|Overall Study|Withdrawal by Subject|5|||
129802200|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
129802201|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
129802202|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
129802203|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
129802204|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
129802205|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
129802206|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
129802207|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
129802208|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
129802209|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
129713424|NCT01881789|466912335|FG000|Overall Study|Withdrawal by Subject|0|||
129713425|NCT01881789|466912336|FG001|Overall Study|Withdrawal by Subject|2|||
129713426|NCT01881789|466912337|FG002|Overall Study|Withdrawal by Subject|1|||
129713427|NCT01881789|466912338|FG003|Overall Study|Withdrawal by Subject|0|||
129713428|NCT01881789|466912339|FG004|Overall Study|Withdrawal by Subject|1|||
129713429|NCT01881789|466912340|FG005|Overall Study|Withdrawal by Subject|1|||
129713430|NCT01881789|466912335|FG000|Overall Study|Study Terminated by Sponsor|0|||
129713431|NCT01881789|466912336|FG001|Overall Study|Study Terminated by Sponsor|0|||
129713432|NCT01881789|466912337|FG002|Overall Study|Study Terminated by Sponsor|0|||
129713433|NCT01881789|466912338|FG003|Overall Study|Study Terminated by Sponsor|0|||
129713434|NCT01881789|466912339|FG004|Overall Study|Study Terminated by Sponsor|0|||
129713435|NCT01881789|466912340|FG005|Overall Study|Study Terminated by Sponsor|1|||
129713436|NCT01881789|466912335|FG000|Overall Study|Other|3|||
129713437|NCT01881789|466912336|FG001|Overall Study|Other|5|||
129713438|NCT01881789|466912337|FG002|Overall Study|Other|2|||
129713439|NCT01881789|466912338|FG003|Overall Study|Other|3|||
129713440|NCT01881789|466912339|FG004|Overall Study|Other|1|||
129713441|NCT01881789|466912340|FG005|Overall Study|Other|1|||
129713442|NCT02041299|466912343|FG000|Overall Study|Adverse Event|9|||
129713443|NCT02041299|466912344|FG001|Overall Study|Adverse Event|3|||
129713444|NCT02041299|466912343|FG000|Overall Study|Lost to Follow-up|4|||
129713445|NCT02041299|466912344|FG001|Overall Study|Lost to Follow-up|1|||
129802210|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
129802211|NCT04612790|467245193|FG000|OLE Period (Up to 1 Year)|Other|0|||
129802212|NCT04612790|467245194|FG001|OLE Period (Up to 1 Year)|Other|0|||
129802213|NCT04612790|467245195|FG002|OLE Period (Up to 1 Year)|Other|0|||
129802214|NCT04612790|467245196|FG003|OLE Period (Up to 1 Year)|Other|1|||
129802215|NCT00785928|467245197|FG000|Treatment Phase|Adverse Event|1|||
129802216|NCT00785928|467245198|FG001|Treatment Phase|Adverse Event|1|||
129802217|NCT00785928|467245199|FG002|Treatment Phase|Adverse Event|2|||
129802218|NCT00785928|467245200|FG003|Treatment Phase|Adverse Event|0|||
129802219|NCT00785928|467245201|FG004|Treatment Phase|Adverse Event|0|||
129802220|NCT00785928|467245202|FG005|Treatment Phase|Adverse Event|0|||
129802221|NCT00785928|467245203|FG006|Treatment Phase|Adverse Event|2|||
129802222|NCT00785928|467245197|FG000|Treatment Phase|Inadequate Response|0|||
129802223|NCT00785928|467245198|FG001|Treatment Phase|Inadequate Response|1|||
129802224|NCT00785928|467245199|FG002|Treatment Phase|Inadequate Response|0|||
129802225|NCT00785928|467245200|FG003|Treatment Phase|Inadequate Response|0|||
129802226|NCT00785928|467245201|FG004|Treatment Phase|Inadequate Response|0|||
129802227|NCT00785928|467245202|FG005|Treatment Phase|Inadequate Response|0|||
129802228|NCT00785928|467245203|FG006|Treatment Phase|Inadequate Response|0|||
129802229|NCT00785928|467245197|FG000|Treatment Phase|Lack of Efficacy|0|||
129802230|NCT00785928|467245198|FG001|Treatment Phase|Lack of Efficacy|1|||
129802231|NCT00785928|467245199|FG002|Treatment Phase|Lack of Efficacy|1|||
129802232|NCT00785928|467245200|FG003|Treatment Phase|Lack of Efficacy|0|||
129802233|NCT00785928|467245201|FG004|Treatment Phase|Lack of Efficacy|0|||
129802234|NCT00785928|467245202|FG005|Treatment Phase|Lack of Efficacy|0|||
129802235|NCT00785928|467245203|FG006|Treatment Phase|Lack of Efficacy|0|||
129802236|NCT00785928|467245197|FG000|Treatment Phase|Physician Decision|0|||
129802237|NCT00785928|467245198|FG001|Treatment Phase|Physician Decision|0|||
129802238|NCT00785928|467245199|FG002|Treatment Phase|Physician Decision|0|||
129802239|NCT00785928|467245200|FG003|Treatment Phase|Physician Decision|0|||
129802240|NCT00785928|467245201|FG004|Treatment Phase|Physician Decision|1|||
129802241|NCT00785928|467245202|FG005|Treatment Phase|Physician Decision|0|||
129713446|NCT02041299|466912343|FG000|Overall Study|Physician Decision|1|||
129713447|NCT02041299|466912344|FG001|Overall Study|Physician Decision|1|||
129713448|NCT02041299|466912343|FG000|Overall Study|Withdrawal by Subject|13|||
129713449|NCT02041299|466912344|FG001|Overall Study|Withdrawal by Subject|7|||
129713450|NCT02041299|466912343|FG000|Overall Study|Protocol Violation|11|||
129802242|NCT00785928|467245203|FG006|Treatment Phase|Physician Decision|0|||
129802243|NCT00785928|467245197|FG000|Treatment Phase|Sponsor Decision|1|||
129713451|NCT02041299|466912344|FG001|Overall Study|Protocol Violation|4|||
129802244|NCT00785928|467245198|FG001|Treatment Phase|Sponsor Decision|0|||
129802245|NCT00785928|467245199|FG002|Treatment Phase|Sponsor Decision|0|||
129802246|NCT00785928|467245200|FG003|Treatment Phase|Sponsor Decision|0|||
129802247|NCT00785928|467245201|FG004|Treatment Phase|Sponsor Decision|0|||
129802248|NCT00785928|467245202|FG005|Treatment Phase|Sponsor Decision|0|||
129802249|NCT00785928|467245203|FG006|Treatment Phase|Sponsor Decision|1|||
129891393|NCT04529538|467559716|FG001|Overall Study|Other|1|||
129713452|NCT02041299|466912343|FG000|Overall Study|Termination of the study|7|||
129713453|NCT02041299|466912344|FG001|Overall Study|Termination of the study|3|||
129713454|NCT02041299|466912343|FG000|Overall Study|Required bone marrow transplant|0|||
129713455|NCT02041299|466912344|FG001|Overall Study|Required bone marrow transplant|1|||
129713456|NCT02041299|466912343|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
129713457|NCT02041299|466912344|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
129713458|NCT01635998|466912345|FG000|Overall Study|Death|1|||
129713459|NCT01635998|466912346|FG001|Overall Study|Death|1|||
129713460|NCT01635998|466912345|FG000|Overall Study|Lost to Follow-up|2|||
129713461|NCT01635998|466912346|FG001|Overall Study|Lost to Follow-up|1|||
129713462|NCT01635998|466912345|FG000|Overall Study|Withdrawal by Subject|1|||
129713463|NCT01635998|466912346|FG001|Overall Study|Withdrawal by Subject|5|||
129713464|NCT01162473|466912350|FG000|Overall Study|Adverse Event|2|||
129713465|NCT01162473|466912351|FG001|Overall Study|Adverse Event|1|||
129713466|NCT01162473|466912350|FG000|Overall Study|Withdrawal by Subject|0|||
129713467|NCT01162473|466912351|FG001|Overall Study|Withdrawal by Subject|4|||
129713468|NCT00943761|466912362|FG000|Overall Study|Lost to Follow-up|2|||
129713469|NCT00943761|466912363|FG001|Overall Study|Lost to Follow-up|0|||
129713470|NCT00943761|466912362|FG000|Overall Study|Withdrawal by Subject|2|||
129713471|NCT00943761|466912363|FG001|Overall Study|Withdrawal by Subject|1|||
129713472|NCT02268383|466912364|FG000|Overall Study|Death|12|||
129713473|NCT02268383|466912364|FG000|Overall Study|Lost to Follow-up|2|||
129713474|NCT02268383|466912364|FG000|Overall Study|Withdrawal by Subject|9|||
129713475|NCT02268383|466912364|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
129713476|NCT02268383|466912364|FG000|Overall Study|Protocol deviation|3|||
129713477|NCT02268383|466912364|FG000|Overall Study|Sponsor decision|22|||
129713478|NCT02268383|466912364|FG000|Overall Study|Not reported|12|||
129713479|NCT02708680|466912365|FG000|Overall Study|Withdrawal by Subject|4|||
129713480|NCT02708680|466912366|FG001|Overall Study|Withdrawal by Subject|12|||
129713481|NCT02708680|466912367|FG002|Overall Study|Withdrawal by Subject|12|||
129713482|NCT02708680|466912365|FG000|Overall Study|Death|4|||
129713483|NCT02708680|466912366|FG001|Overall Study|Death|19|||
129713484|NCT02708680|466912367|FG002|Overall Study|Death|21|||
129713485|NCT02708680|466912365|FG000|Overall Study|Lost to Follow-up|0|||
129713486|NCT02708680|466912366|FG001|Overall Study|Lost to Follow-up|3|||
129713487|NCT02708680|466912367|FG002|Overall Study|Lost to Follow-up|3|||
129713488|NCT02708680|466912365|FG000|Overall Study|Study Terminated By Sponsor|0|||
129713489|NCT02708680|466912366|FG001|Overall Study|Study Terminated By Sponsor|5|||
129713490|NCT02708680|466912367|FG002|Overall Study|Study Terminated By Sponsor|4|||
129713491|NCT02708680|466912365|FG000|Overall Study|Other than Specified|0|||
129713492|NCT02708680|466912366|FG001|Overall Study|Other than Specified|0|||
129713493|NCT02708680|466912367|FG002|Overall Study|Other than Specified|1|||
129713494|NCT02708680|466912365|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
129713495|NCT02708680|466912366|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
129713496|NCT02708680|466912367|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
129713497|NCT01342926|466912368|FG000|Overall Study|Adverse Event|5|||
129713498|NCT01342926|466912369|FG001|Overall Study|Adverse Event|8|||
129713499|NCT01342926|466912370|FG002|Overall Study|Adverse Event|10|||
129713500|NCT01342926|466912371|FG003|Overall Study|Adverse Event|7|||
129713501|NCT01342926|466912368|FG000|Overall Study|Lost to Follow-up|0|||
129713502|NCT01342926|466912369|FG001|Overall Study|Lost to Follow-up|1|||
129713503|NCT01342926|466912370|FG002|Overall Study|Lost to Follow-up|1|||
129713504|NCT01342926|466912371|FG003|Overall Study|Lost to Follow-up|0|||
129713505|NCT01342926|466912368|FG000|Overall Study|Investigator Discretion|2|||
129713506|NCT01342926|466912369|FG001|Overall Study|Investigator Discretion|2|||
129713507|NCT01342926|466912370|FG002|Overall Study|Investigator Discretion|0|||
129713508|NCT01342926|466912371|FG003|Overall Study|Investigator Discretion|0|||
129713509|NCT01342926|466912368|FG000|Overall Study|Withdrawal by Subject|2|||
129713510|NCT01342926|466912369|FG001|Overall Study|Withdrawal by Subject|4|||
129713511|NCT01342926|466912370|FG002|Overall Study|Withdrawal by Subject|3|||
129713512|NCT01342926|466912371|FG003|Overall Study|Withdrawal by Subject|5|||
129713513|NCT04162470|466912372|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
129713514|NCT01544348|466912379|FG000|Overall Study|Lost to Follow-up|1|||
129713515|NCT01544348|466912380|FG001|Overall Study|Lost to Follow-up|0|||
129713516|NCT01544348|466912381|FG002|Overall Study|Lost to Follow-up|0|||
129713517|NCT01544348|466912382|FG003|Overall Study|Lost to Follow-up|0|||
129713518|NCT01544348|466912383|FG004|Overall Study|Lost to Follow-up|0|||
129713519|NCT01544348|466912384|FG005|Overall Study|Lost to Follow-up|0|||
129713520|NCT01544348|466912385|FG006|Overall Study|Lost to Follow-up|1|||
129713521|NCT01544348|466912386|FG007|Overall Study|Lost to Follow-up|0|||
129713522|NCT01544348|466912379|FG000|Overall Study|Withdrawal by Subject|1|||
129713523|NCT01544348|466912380|FG001|Overall Study|Withdrawal by Subject|0|||
129713524|NCT01544348|466912381|FG002|Overall Study|Withdrawal by Subject|0|||
129713525|NCT01544348|466912382|FG003|Overall Study|Withdrawal by Subject|0|||
129713526|NCT01544348|466912383|FG004|Overall Study|Withdrawal by Subject|1|||
129713527|NCT01544348|466912384|FG005|Overall Study|Withdrawal by Subject|2|||
129713528|NCT01544348|466912385|FG006|Overall Study|Withdrawal by Subject|1|||
129713529|NCT01544348|466912386|FG007|Overall Study|Withdrawal by Subject|0|||
129713530|NCT01544348|466912379|FG000|Overall Study|Physician Decision|0|||
129713531|NCT01544348|466912380|FG001|Overall Study|Physician Decision|0|||
129713532|NCT01544348|466912381|FG002|Overall Study|Physician Decision|0|||
129713533|NCT01544348|466912382|FG003|Overall Study|Physician Decision|0|||
129713534|NCT01544348|466912383|FG004|Overall Study|Physician Decision|0|||
129713535|NCT01544348|466912384|FG005|Overall Study|Physician Decision|1|||
129713536|NCT01544348|466912385|FG006|Overall Study|Physician Decision|0|||
129713537|NCT01544348|466912386|FG007|Overall Study|Physician Decision|0|||
129713538|NCT01445847|466912387|FG000|Overall Study|Protocol Violation|13|||
129713539|NCT01445847|466912388|FG001|Overall Study|Protocol Violation|14|||
129713540|NCT01445847|466912387|FG000|Overall Study|Missed Data|1|||
129713541|NCT01445847|466912388|FG001|Overall Study|Missed Data|0|||
129713542|NCT03008070|466912391|FG000|Overall Study|Adverse Event|3|||
129713543|NCT03008070|466912392|FG001|Overall Study|Adverse Event|3|||
129713544|NCT03008070|466912393|FG002|Overall Study|Adverse Event|3|||
129713545|NCT03008070|466912391|FG000|Overall Study|Lost to Follow-up|1|||
129713546|NCT03008070|466912392|FG001|Overall Study|Lost to Follow-up|1|||
129713547|NCT03008070|466912393|FG002|Overall Study|Lost to Follow-up|0|||
129713548|NCT03008070|466912391|FG000|Overall Study|Non compliance|0|||
129713549|NCT03008070|466912392|FG001|Overall Study|Non compliance|1|||
129713550|NCT03008070|466912393|FG002|Overall Study|Non compliance|1|||
129713551|NCT03008070|466912391|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
129713552|NCT03008070|466912392|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
129713553|NCT03008070|466912393|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
129713554|NCT03008070|466912391|FG000|Overall Study|Withdrawal by Subject|2|||
129713555|NCT03008070|466912392|FG001|Overall Study|Withdrawal by Subject|0|||
129713556|NCT03008070|466912393|FG002|Overall Study|Withdrawal by Subject|1|||
129713557|NCT03008070|466912391|FG000|Overall Study|Use of prohibited drug|0|||
129713558|NCT03008070|466912392|FG001|Overall Study|Use of prohibited drug|0|||
129713559|NCT03008070|466912393|FG002|Overall Study|Use of prohibited drug|2|||
129713560|NCT04409834|466912396|FG000|Overall Study|Death|55|||
129713561|NCT04409834|466912397|FG001|Overall Study|Death|62|||
129713562|NCT01365455|466912398|FG000|Induction Period|Adverse Event|5|||
129713563|NCT01365455|466912399|FG001|Induction Period|Adverse Event|3|||
129713564|NCT01365455|466912400|FG002|Induction Period|Adverse Event|4|||
129713565|NCT01365455|466912401|FG003|Induction Period|Adverse Event|0|||
129713566|NCT01365455|466912402|FG004|Induction Period|Adverse Event|0|||
129713567|NCT01365455|466912398|FG000|Induction Period|Lack of Efficacy|1|||
129713568|NCT01365455|466912399|FG001|Induction Period|Lack of Efficacy|1|||
129713569|NCT01365455|466912400|FG002|Induction Period|Lack of Efficacy|0|||
129713570|NCT01365455|466912401|FG003|Induction Period|Lack of Efficacy|0|||
129713571|NCT01365455|466912402|FG004|Induction Period|Lack of Efficacy|0|||
129713572|NCT01365455|466912398|FG000|Induction Period|Pregnancy|0|||
129713573|NCT01365455|466912399|FG001|Induction Period|Pregnancy|1|||
129713574|NCT01365455|466912400|FG002|Induction Period|Pregnancy|0|||
129713575|NCT01365455|466912401|FG003|Induction Period|Pregnancy|0|||
129713576|NCT01365455|466912402|FG004|Induction Period|Pregnancy|0|||
129713577|NCT01365455|466912398|FG000|Induction Period|Protocol deviation|0|||
129713578|NCT01365455|466912399|FG001|Induction Period|Protocol deviation|1|||
129713579|NCT01365455|466912400|FG002|Induction Period|Protocol deviation|1|||
129713580|NCT01365455|466912401|FG003|Induction Period|Protocol deviation|0|||
129713581|NCT01365455|466912402|FG004|Induction Period|Protocol deviation|0|||
129713582|NCT01365455|466912398|FG000|Induction Period|Subject/guardian decision|9|||
129713583|NCT01365455|466912399|FG001|Induction Period|Subject/guardian decision|1|||
129713584|NCT01365455|466912400|FG002|Induction Period|Subject/guardian decision|8|||
129713585|NCT01365455|466912401|FG003|Induction Period|Subject/guardian decision|0|||
129713586|NCT01365455|466912402|FG004|Induction Period|Subject/guardian decision|0|||
129713587|NCT01365455|466912398|FG000|Induction Period|Lost to Follow-up|0|||
129713588|NCT01365455|466912399|FG001|Induction Period|Lost to Follow-up|0|||
129713589|NCT01365455|466912400|FG002|Induction Period|Lost to Follow-up|3|||
129713590|NCT01365455|466912401|FG003|Induction Period|Lost to Follow-up|0|||
129713591|NCT01365455|466912402|FG004|Induction Period|Lost to Follow-up|0|||
129713592|NCT01365455|466912398|FG000|Maintenance Period|Adverse Event|12|||
129713593|NCT01365455|466912399|FG001|Maintenance Period|Adverse Event|5|||
129713594|NCT01365455|466912400|FG002|Maintenance Period|Adverse Event|1|||
129713595|NCT01365455|466912401|FG003|Maintenance Period|Adverse Event|2|||
129713596|NCT01365455|466912402|FG004|Maintenance Period|Adverse Event|4|||
129713597|NCT01365455|466912398|FG000|Maintenance Period|Lack of Efficacy|10|||
129713598|NCT01365455|466912399|FG001|Maintenance Period|Lack of Efficacy|2|||
129713599|NCT01365455|466912400|FG002|Maintenance Period|Lack of Efficacy|0|||
129713600|NCT01365455|466912401|FG003|Maintenance Period|Lack of Efficacy|2|||
129713601|NCT01365455|466912402|FG004|Maintenance Period|Lack of Efficacy|2|||
129713602|NCT01365455|466912398|FG000|Maintenance Period|Lost to Follow-up|2|||
129713603|NCT01365455|466912399|FG001|Maintenance Period|Lost to Follow-up|4|||
129713604|NCT01365455|466912400|FG002|Maintenance Period|Lost to Follow-up|0|||
129713605|NCT01365455|466912401|FG003|Maintenance Period|Lost to Follow-up|0|||
129713606|NCT01365455|466912402|FG004|Maintenance Period|Lost to Follow-up|3|||
129713607|NCT01365455|466912398|FG000|Maintenance Period|Non-compliance with study treatment|0|||
129713608|NCT01365455|466912399|FG001|Maintenance Period|Non-compliance with study treatment|0|||
129713609|NCT01365455|466912400|FG002|Maintenance Period|Non-compliance with study treatment|0|||
129713610|NCT01365455|466912401|FG003|Maintenance Period|Non-compliance with study treatment|1|||
129713611|NCT01365455|466912402|FG004|Maintenance Period|Non-compliance with study treatment|0|||
129713612|NCT01365455|466912398|FG000|Maintenance Period|Physician Decision|0|||
129713613|NCT01365455|466912399|FG001|Maintenance Period|Physician Decision|1|||
129713614|NCT01365455|466912400|FG002|Maintenance Period|Physician Decision|0|||
129713615|NCT01365455|466912401|FG003|Maintenance Period|Physician Decision|0|||
129713616|NCT01365455|466912402|FG004|Maintenance Period|Physician Decision|1|||
129713617|NCT01365455|466912398|FG000|Maintenance Period|Pregnancy|0|||
129713618|NCT01365455|466912399|FG001|Maintenance Period|Pregnancy|4|||
129713619|NCT01365455|466912400|FG002|Maintenance Period|Pregnancy|0|||
129713620|NCT01365455|466912401|FG003|Maintenance Period|Pregnancy|0|||
129713621|NCT01365455|466912402|FG004|Maintenance Period|Pregnancy|2|||
129713622|NCT01365455|466912398|FG000|Maintenance Period|Protocol deviation|1|||
129713623|NCT01365455|466912399|FG001|Maintenance Period|Protocol deviation|1|||
129713624|NCT01365455|466912400|FG002|Maintenance Period|Protocol deviation|0|||
129713625|NCT01365455|466912401|FG003|Maintenance Period|Protocol deviation|0|||
129713626|NCT01365455|466912402|FG004|Maintenance Period|Protocol deviation|0|||
129713627|NCT01365455|466912398|FG000|Maintenance Period|Subject/guardian decision|4|||
129713628|NCT01365455|466912399|FG001|Maintenance Period|Subject/guardian decision|6|||
129713629|NCT01365455|466912400|FG002|Maintenance Period|Subject/guardian decision|2|||
129713630|NCT01365455|466912401|FG003|Maintenance Period|Subject/guardian decision|4|||
129713631|NCT01365455|466912402|FG004|Maintenance Period|Subject/guardian decision|1|||
129713632|NCT00928187|466912403|FG000|Overall Study|Death|1|||
129713633|NCT00928187|466912404|FG001|Overall Study|Death|2|||
129713634|NCT00928187|466912405|FG002|Overall Study|Death|3|||
129713635|NCT00928187|466912403|FG000|Overall Study|Lost to Follow-up|1|||
129713636|NCT00928187|466912404|FG001|Overall Study|Lost to Follow-up|2|||
129713637|NCT00928187|466912405|FG002|Overall Study|Lost to Follow-up|1|||
129713638|NCT00928187|466912403|FG000|Overall Study|Withdrawal by Subject|0|||
129713639|NCT00928187|466912404|FG001|Overall Study|Withdrawal by Subject|1|||
129713640|NCT00928187|466912405|FG002|Overall Study|Withdrawal by Subject|1|||
129713641|NCT00928187|466912403|FG000|Overall Study|Protocol Violation|0|||
129713642|NCT00928187|466912404|FG001|Overall Study|Protocol Violation|1|||
129713643|NCT00928187|466912405|FG002|Overall Study|Protocol Violation|0|||
129713644|NCT04790279|466913624|FG000|Overall Study|Did not meet medication start criteria|27|||
129713645|NCT04790279|466913625|FG001|Overall Study|Did not meet medication start criteria|15|||
129713646|NCT04790279|466913624|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
129713647|NCT04790279|466913625|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
129713648|NCT04790279|466913624|FG000|Overall Study|Protocol Violation|8|||
129713649|NCT04790279|466913625|FG001|Overall Study|Protocol Violation|3|||
129713650|NCT04790279|466913624|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
129713651|NCT04790279|466913625|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
129713652|NCT00810277|466913638|FG000|Overall Study|Adverse Event|1|||
129713653|NCT00678288|466913645|FG000|Overall Study|Adverse Event|0|||
129713654|NCT00678288|466913646|FG001|Overall Study|Adverse Event|2|||
129713655|NCT00678288|466913645|FG000|Overall Study|Withdrawal by Subject|1|||
129713656|NCT00678288|466913646|FG001|Overall Study|Withdrawal by Subject|1|||
129713657|NCT00678288|466913645|FG000|Overall Study|Study terminated by the sponsor|2|||
129713658|NCT00678288|466913646|FG001|Overall Study|Study terminated by the sponsor|0|||
129713659|NCT00678288|466913645|FG000|Overall Study|Not compliant with study medication|0|||
129713660|NCT00678288|466913646|FG001|Overall Study|Not compliant with study medication|1|||
129713661|NCT00678288|466913645|FG000|Overall Study|Switch to commercial drug|0|||
129713662|NCT00678288|466913646|FG001|Overall Study|Switch to commercial drug|1|||
129713663|NCT00678288|466913645|FG000|Overall Study|Reason not reported|1|||
129713664|NCT00678288|466913646|FG001|Overall Study|Reason not reported|0|||
129713665|NCT00678288|466913645|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
129713666|NCT00678288|466913646|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
129713667|NCT02549989|466913647|FG000|Overall Study|Adverse Event|4|||
129713668|NCT02549989|466913647|FG000|Overall Study|Death|1|||
129713669|NCT02549989|466913647|FG000|Overall Study|Lack of Efficacy|19|||
129713670|NCT02549989|466913647|FG000|Overall Study|Withdrawal by Subject|3|||
129713671|NCT02079909|466913648|FG000|Overall Study|Adverse Event|23|||
129713672|NCT02079909|466913649|FG001|Overall Study|Adverse Event|23|||
129713673|NCT02079909|466913650|FG002|Overall Study|Adverse Event|7|||
129713674|NCT02079909|466913648|FG000|Overall Study|Withdrawal by Subject|9|||
129713675|NCT02079909|466913649|FG001|Overall Study|Withdrawal by Subject|17|||
129713676|NCT02079909|466913650|FG002|Overall Study|Withdrawal by Subject|4|||
129713677|NCT02079909|466913648|FG000|Overall Study|Lost to Follow-up|2|||
129713678|NCT02079909|466913649|FG001|Overall Study|Lost to Follow-up|3|||
129713679|NCT02079909|466913650|FG002|Overall Study|Lost to Follow-up|1|||
129713680|NCT02079909|466913648|FG000|Overall Study|Death|2|||
129713681|NCT02079909|466913649|FG001|Overall Study|Death|2|||
129713682|NCT02079909|466913650|FG002|Overall Study|Death|0|||
129713683|NCT02079909|466913648|FG000|Overall Study|Lack of Efficacy|0|||
129713684|NCT02079909|466913649|FG001|Overall Study|Lack of Efficacy|0|||
129713685|NCT02079909|466913650|FG002|Overall Study|Lack of Efficacy|1|||
129713686|NCT02079909|466913648|FG000|Overall Study|Protocol Violation|0|||
129713687|NCT02079909|466913649|FG001|Overall Study|Protocol Violation|1|||
129713688|NCT02079909|466913650|FG002|Overall Study|Protocol Violation|1|||
129713689|NCT02079909|466913648|FG000|Overall Study|Physician Decision|0|||
129713690|NCT02079909|466913649|FG001|Overall Study|Physician Decision|1|||
129713691|NCT02079909|466913650|FG002|Overall Study|Physician Decision|1|||
129713692|NCT02079909|466913648|FG000|Overall Study|Relocation etc.|2|||
129713693|NCT02079909|466913649|FG001|Overall Study|Relocation etc.|2|||
129713694|NCT02079909|466913650|FG002|Overall Study|Relocation etc.|3|||
129713695|NCT00720356|466913655|FG000|Registration to Study|Determined to have methylated MGMT|67|||
129713696|NCT00720356|466913655|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
129713697|NCT00720356|466913655|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
129713698|NCT00720356|466913655|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
129713699|NCT00720356|466913655|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
129713700|NCT00720356|466913655|FG000|Follow up Until Death|Withdrawal by Subject|1|||
129713701|NCT00720356|466913655|FG000|Follow up Until Death|Alive at last data collection|4|||
129713702|NCT01713582|466913658|FG000|Overall Study|Disease progression|3|||
129713703|NCT01713582|466913659|FG001|Overall Study|Disease progression|3|||
129713704|NCT01713582|466913660|FG002|Overall Study|Disease progression|3|||
129713705|NCT01713582|466913661|FG003|Overall Study|Disease progression|2|||
129713706|NCT01713582|466913662|FG004|Overall Study|Disease progression|3|||
129713707|NCT01713582|466913663|FG005|Overall Study|Disease progression|3|||
129713708|NCT01713582|466913664|FG006|Overall Study|Disease progression|3|||
129713709|NCT01713582|466913665|FG007|Overall Study|Disease progression|3|||
129713710|NCT01713582|466913666|FG008|Overall Study|Disease progression|3|||
129713711|NCT01713582|466913667|FG009|Overall Study|Disease progression|11|||
129713712|NCT01713582|466913668|FG010|Overall Study|Disease progression|10|||
129713713|NCT01713582|466913669|FG011|Overall Study|Disease progression|5|||
129713714|NCT01713582|466913670|FG012|Overall Study|Disease progression|3|||
129713715|NCT01713582|466913671|FG013|Overall Study|Disease progression|3|||
129713716|NCT01713582|466913672|FG014|Overall Study|Disease progression|6|||
129713717|NCT01713582|466913673|FG015|Overall Study|Disease progression|6|||
129713718|NCT01713582|466913674|FG016|Overall Study|Disease progression|5|||
129713719|NCT01713582|466913675|FG017|Overall Study|Disease progression|2|||
129713720|NCT01713582|466913676|FG018|Overall Study|Disease progression|3|||
129713721|NCT01713582|466913677|FG019|Overall Study|Disease progression|5|||
129713722|NCT01713582|466913678|FG020|Overall Study|Disease progression|15|||
129713723|NCT01713582|466913658|FG000|Overall Study|Death|0|||
129713724|NCT01713582|466913659|FG001|Overall Study|Death|0|||
129713725|NCT01713582|466913660|FG002|Overall Study|Death|0|||
129713726|NCT01713582|466913661|FG003|Overall Study|Death|1|||
129713727|NCT01713582|466913662|FG004|Overall Study|Death|1|||
129713728|NCT01713582|466913663|FG005|Overall Study|Death|3|||
129713729|NCT01713582|466913664|FG006|Overall Study|Death|3|||
129713730|NCT01713582|466913665|FG007|Overall Study|Death|2|||
129713731|NCT01713582|466913666|FG008|Overall Study|Death|3|||
129713732|NCT01713582|466913667|FG009|Overall Study|Death|4|||
129713733|NCT01713582|466913668|FG010|Overall Study|Death|3|||
129713734|NCT01713582|466913669|FG011|Overall Study|Death|0|||
129713735|NCT01713582|466913670|FG012|Overall Study|Death|0|||
129713736|NCT01713582|466913671|FG013|Overall Study|Death|0|||
129713737|NCT01713582|466913672|FG014|Overall Study|Death|0|||
129713738|NCT01713582|466913673|FG015|Overall Study|Death|0|||
129713739|NCT01713582|466913674|FG016|Overall Study|Death|0|||
129713740|NCT01713582|466913675|FG017|Overall Study|Death|0|||
129713741|NCT01713582|466913676|FG018|Overall Study|Death|0|||
129713742|NCT01713582|466913677|FG019|Overall Study|Death|0|||
129713743|NCT01713582|466913678|FG020|Overall Study|Death|0|||
129713744|NCT01713582|466913658|FG000|Overall Study|Adverse event-related|0|||
129713745|NCT01713582|466913659|FG001|Overall Study|Adverse event-related|0|||
129713746|NCT01713582|466913660|FG002|Overall Study|Adverse event-related|0|||
129713747|NCT01713582|466913661|FG003|Overall Study|Adverse event-related|0|||
129713748|NCT01713582|466913662|FG004|Overall Study|Adverse event-related|0|||
129713749|NCT01713582|466913663|FG005|Overall Study|Adverse event-related|0|||
129713750|NCT01713582|466913664|FG006|Overall Study|Adverse event-related|0|||
129713751|NCT01713582|466913665|FG007|Overall Study|Adverse event-related|0|||
129713752|NCT01713582|466913666|FG008|Overall Study|Adverse event-related|0|||
129713753|NCT01713582|466913667|FG009|Overall Study|Adverse event-related|1|||
129713754|NCT01713582|466913668|FG010|Overall Study|Adverse event-related|1|||
129802250|NCT00785928|467245197|FG000|Treatment Phase|Withdrawal by Subject|1|||
129802251|NCT00785928|467245198|FG001|Treatment Phase|Withdrawal by Subject|2|||
129802252|NCT00785928|467245199|FG002|Treatment Phase|Withdrawal by Subject|0|||
129802253|NCT00785928|467245200|FG003|Treatment Phase|Withdrawal by Subject|0|||
129802254|NCT00785928|467245201|FG004|Treatment Phase|Withdrawal by Subject|1|||
129802255|NCT00785928|467245202|FG005|Treatment Phase|Withdrawal by Subject|0|||
129802256|NCT00785928|467245203|FG006|Treatment Phase|Withdrawal by Subject|0|||
129802257|NCT05021081|467245208|FG000|Phase 2|Subject enrolled in error|1|||
129802258|NCT05021081|467245209|FG001|Phase 2|Subject enrolled in error|1|||
129802259|NCT05021081|467245210|FG002|Phase 2|Subject enrolled in error|0|||
129802260|NCT00369122|467245211|FG000|Overall Study|Ineligible|10|||
129802261|NCT00369122|467245211|FG000|Overall Study|No protocol treatment|1|||
129802262|NCT00408629|467245212|FG000|Overall Study|Adverse Event|13|||
129802263|NCT00408629|467245213|FG001|Overall Study|Adverse Event|27|||
129802264|NCT00408629|467245212|FG000|Overall Study|Withdrawal by Subject|8|||
129802265|NCT00408629|467245213|FG001|Overall Study|Withdrawal by Subject|4|||
129802266|NCT00408629|467245212|FG000|Overall Study|Lost to Follow-up|1|||
129802267|NCT00408629|467245213|FG001|Overall Study|Lost to Follow-up|1|||
129802268|NCT00408629|467245212|FG000|Overall Study|Lack of Efficacy|63|||
129802269|NCT00408629|467245213|FG001|Overall Study|Lack of Efficacy|73|||
129802270|NCT00408629|467245212|FG000|Overall Study|Protocol Violation|1|||
129802271|NCT00408629|467245213|FG001|Overall Study|Protocol Violation|5|||
129802272|NCT00408629|467245212|FG000|Overall Study|Miscellaneous|11|||
129802273|NCT00408629|467245213|FG001|Overall Study|Miscellaneous|15|||
129802274|NCT00191906|467245214|FG000|Study Period II|Adverse Event|0|||
129802275|NCT00191906|467245215|FG001|Study Period II|Adverse Event|1|||
129802276|NCT00191906|467245216|FG002|Study Period II|Adverse Event|0|||
129802277|NCT00191906|467245217|FG003|Study Period II|Adverse Event|0|||
129802278|NCT00191906|467245214|FG000|Study Period II|Withdrawal by Subject|0|||
129802279|NCT00191906|467245215|FG001|Study Period II|Withdrawal by Subject|3|||
129802280|NCT00191906|467245216|FG002|Study Period II|Withdrawal by Subject|0|||
129802281|NCT00191906|467245217|FG003|Study Period II|Withdrawal by Subject|0|||
129802282|NCT00191906|467245214|FG000|Study Period II|Parent/Caregiver Decision|0|||
129802283|NCT00191906|467245215|FG001|Study Period II|Parent/Caregiver Decision|1|||
129802284|NCT00191906|467245216|FG002|Study Period II|Parent/Caregiver Decision|0|||
129802285|NCT00191906|467245217|FG003|Study Period II|Parent/Caregiver Decision|0|||
129802286|NCT00191906|467245214|FG000|Study Period II|Entry Criteria Exclusion|0|||
129802287|NCT00191906|467245215|FG001|Study Period II|Entry Criteria Exclusion|0|||
129802288|NCT00191906|467245216|FG002|Study Period II|Entry Criteria Exclusion|1|||
129802289|NCT00191906|467245217|FG003|Study Period II|Entry Criteria Exclusion|0|||
129802290|NCT00191906|467245214|FG000|Study Period III|Adverse Event|1|||
129802291|NCT00191906|467245215|FG001|Study Period III|Adverse Event|0|||
129802292|NCT00191906|467245216|FG002|Study Period III|Adverse Event|0|||
129802293|NCT00191906|467245217|FG003|Study Period III|Adverse Event|0|||
129802294|NCT00191906|467245214|FG000|Study Period III|Lost to Follow-up|0|||
129802295|NCT00191906|467245215|FG001|Study Period III|Lost to Follow-up|1|||
129802296|NCT00191906|467245216|FG002|Study Period III|Lost to Follow-up|0|||
129802297|NCT00191906|467245217|FG003|Study Period III|Lost to Follow-up|0|||
129802298|NCT00191906|467245214|FG000|Study Period III|Parent/Caregiver Decision|1|||
129802299|NCT00191906|467245215|FG001|Study Period III|Parent/Caregiver Decision|0|||
129802300|NCT00191906|467245216|FG002|Study Period III|Parent/Caregiver Decision|0|||
129802301|NCT00191906|467245217|FG003|Study Period III|Parent/Caregiver Decision|0|||
129713755|NCT01713582|466913669|FG011|Overall Study|Adverse event-related|0|||
129444266|NCT02464228|465927277|FG000|Overall Study|Withdrawal by Subject|1|||
129444267|NCT02464228|465927278|FG001|Overall Study|Withdrawal by Subject|1|||
129444268|NCT02464228|465927279|FG002|Overall Study|Withdrawal by Subject|1|||
129444269|NCT02464228|465927280|FG003|Overall Study|Withdrawal by Subject|0|||
129713756|NCT01713582|466913670|FG012|Overall Study|Adverse event-related|0|||
129802302|NCT00191906|467245214|FG000|Study Period III|Lack of Efficacy|3|||
129802303|NCT00191906|467245215|FG001|Study Period III|Lack of Efficacy|3|||
129802304|NCT00191906|467245216|FG002|Study Period III|Lack of Efficacy|0|||
129802305|NCT00191906|467245217|FG003|Study Period III|Lack of Efficacy|0|||
129802306|NCT00573937|467245218|FG000|Overall Study|Study Terminated|0|||
129802307|NCT00573937|467245219|FG001|Overall Study|Study Terminated|1|||
129802308|NCT00333801|467245220|FG000|Overall Study|Moved to another state|5|||
129802309|NCT00333801|467245221|FG001|Overall Study|Moved to another state|3|||
129802310|NCT00333801|467245220|FG000|Overall Study|Lost to Follow-up|2|||
129802311|NCT00333801|467245221|FG001|Overall Study|Lost to Follow-up|0|||
129713757|NCT01713582|466913671|FG013|Overall Study|Adverse event-related|0|||
129713758|NCT01713582|466913672|FG014|Overall Study|Adverse event-related|0|||
129713759|NCT01713582|466913673|FG015|Overall Study|Adverse event-related|0|||
129713760|NCT01713582|466913674|FG016|Overall Study|Adverse event-related|0|||
129713761|NCT01713582|466913675|FG017|Overall Study|Adverse event-related|0|||
129713762|NCT01713582|466913676|FG018|Overall Study|Adverse event-related|1|||
129713763|NCT01713582|466913677|FG019|Overall Study|Adverse event-related|0|||
129713764|NCT01713582|466913678|FG020|Overall Study|Adverse event-related|0|||
129713765|NCT01713582|466913658|FG000|Overall Study|Adverse event-unrelated|0|||
129713766|NCT01713582|466913659|FG001|Overall Study|Adverse event-unrelated|0|||
129713767|NCT01713582|466913660|FG002|Overall Study|Adverse event-unrelated|0|||
129713768|NCT01713582|466913661|FG003|Overall Study|Adverse event-unrelated|0|||
129713769|NCT01713582|466913662|FG004|Overall Study|Adverse event-unrelated|0|||
129713770|NCT01713582|466913663|FG005|Overall Study|Adverse event-unrelated|1|||
129713771|NCT01713582|466913664|FG006|Overall Study|Adverse event-unrelated|1|||
129713772|NCT01713582|466913665|FG007|Overall Study|Adverse event-unrelated|1|||
129713773|NCT01713582|466913666|FG008|Overall Study|Adverse event-unrelated|0|||
129713774|NCT01713582|466913667|FG009|Overall Study|Adverse event-unrelated|0|||
129713775|NCT01713582|466913668|FG010|Overall Study|Adverse event-unrelated|0|||
129713776|NCT01713582|466913669|FG011|Overall Study|Adverse event-unrelated|0|||
129713777|NCT01713582|466913670|FG012|Overall Study|Adverse event-unrelated|0|||
129713778|NCT01713582|466913671|FG013|Overall Study|Adverse event-unrelated|1|||
129713779|NCT01713582|466913672|FG014|Overall Study|Adverse event-unrelated|1|||
129713780|NCT01713582|466913673|FG015|Overall Study|Adverse event-unrelated|0|||
129713781|NCT01713582|466913674|FG016|Overall Study|Adverse event-unrelated|0|||
129713782|NCT01713582|466913675|FG017|Overall Study|Adverse event-unrelated|0|||
129713783|NCT01713582|466913676|FG018|Overall Study|Adverse event-unrelated|0|||
129713784|NCT01713582|466913677|FG019|Overall Study|Adverse event-unrelated|0|||
129713785|NCT01713582|466913678|FG020|Overall Study|Adverse event-unrelated|0|||
129713786|NCT01713582|466913658|FG000|Overall Study|Withdrawal of consent|0|||
129713787|NCT01713582|466913659|FG001|Overall Study|Withdrawal of consent|0|||
129713788|NCT01713582|466913660|FG002|Overall Study|Withdrawal of consent|1|||
129713789|NCT01713582|466913661|FG003|Overall Study|Withdrawal of consent|0|||
129713790|NCT01713582|466913662|FG004|Overall Study|Withdrawal of consent|0|||
129713791|NCT01713582|466913663|FG005|Overall Study|Withdrawal of consent|1|||
129713792|NCT01713582|466913664|FG006|Overall Study|Withdrawal of consent|0|||
129713793|NCT01713582|466913665|FG007|Overall Study|Withdrawal of consent|0|||
129713794|NCT01713582|466913666|FG008|Overall Study|Withdrawal of consent|0|||
129713795|NCT01713582|466913667|FG009|Overall Study|Withdrawal of consent|1|||
129713796|NCT01713582|466913668|FG010|Overall Study|Withdrawal of consent|0|||
129713797|NCT01713582|466913669|FG011|Overall Study|Withdrawal of consent|0|||
129713798|NCT01713582|466913670|FG012|Overall Study|Withdrawal of consent|0|||
129713799|NCT01713582|466913671|FG013|Overall Study|Withdrawal of consent|0|||
129713800|NCT01713582|466913672|FG014|Overall Study|Withdrawal of consent|0|||
129713801|NCT01713582|466913673|FG015|Overall Study|Withdrawal of consent|0|||
129713802|NCT01713582|466913674|FG016|Overall Study|Withdrawal of consent|0|||
129713803|NCT01713582|466913675|FG017|Overall Study|Withdrawal of consent|0|||
129713804|NCT01713582|466913676|FG018|Overall Study|Withdrawal of consent|1|||
129713805|NCT01713582|466913677|FG019|Overall Study|Withdrawal of consent|0|||
129713806|NCT01713582|466913678|FG020|Overall Study|Withdrawal of consent|0|||
129713807|NCT01713582|466913658|FG000|Overall Study|Lack of Efficacy|0|||
129713808|NCT01713582|466913659|FG001|Overall Study|Lack of Efficacy|0|||
129713809|NCT01713582|466913660|FG002|Overall Study|Lack of Efficacy|0|||
129713810|NCT01713582|466913661|FG003|Overall Study|Lack of Efficacy|0|||
129802312|NCT00333801|467245220|FG000|Overall Study|Incarcerated|1|||
129802313|NCT00333801|467245221|FG001|Overall Study|Incarcerated|2|||
129713811|NCT01713582|466913662|FG004|Overall Study|Lack of Efficacy|0|||
129713812|NCT01713582|466913663|FG005|Overall Study|Lack of Efficacy|0|||
129802314|NCT00333801|467245220|FG000|Overall Study|Withdrawal by Subject|0|||
129802315|NCT00333801|467245221|FG001|Overall Study|Withdrawal by Subject|1|||
129713813|NCT01713582|466913664|FG006|Overall Study|Lack of Efficacy|0|||
129713814|NCT01713582|466913665|FG007|Overall Study|Lack of Efficacy|0|||
129802316|NCT01999114|467245224|FG000|Overall Study|Adverse Event|8|||
129802317|NCT01999114|467245225|FG001|Overall Study|Adverse Event|7|||
129713815|NCT01713582|466913666|FG008|Overall Study|Lack of Efficacy|0|||
129713816|NCT01713582|466913667|FG009|Overall Study|Lack of Efficacy|1|||
129713817|NCT01713582|466913668|FG010|Overall Study|Lack of Efficacy|2|||
129713818|NCT01713582|466913669|FG011|Overall Study|Lack of Efficacy|0|||
129713819|NCT01713582|466913670|FG012|Overall Study|Lack of Efficacy|0|||
129713820|NCT01713582|466913671|FG013|Overall Study|Lack of Efficacy|0|||
129713821|NCT01713582|466913672|FG014|Overall Study|Lack of Efficacy|0|||
129802318|NCT01999114|467245226|FG002|Overall Study|Adverse Event|2|||
129713822|NCT01713582|466913673|FG015|Overall Study|Lack of Efficacy|0|||
129713823|NCT01713582|466913674|FG016|Overall Study|Lack of Efficacy|0|||
129713824|NCT01713582|466913675|FG017|Overall Study|Lack of Efficacy|0|||
129713825|NCT01713582|466913676|FG018|Overall Study|Lack of Efficacy|0|||
129713826|NCT01713582|466913677|FG019|Overall Study|Lack of Efficacy|0|||
129713827|NCT01713582|466913678|FG020|Overall Study|Lack of Efficacy|0|||
129713828|NCT01713582|466913658|FG000|Overall Study|Withdrawal by Subject|0|||
129713829|NCT01713582|466913659|FG001|Overall Study|Withdrawal by Subject|0|||
129713830|NCT01713582|466913660|FG002|Overall Study|Withdrawal by Subject|0|||
129713831|NCT01713582|466913661|FG003|Overall Study|Withdrawal by Subject|0|||
129713832|NCT01713582|466913662|FG004|Overall Study|Withdrawal by Subject|0|||
129713833|NCT01713582|466913663|FG005|Overall Study|Withdrawal by Subject|0|||
129713834|NCT01713582|466913664|FG006|Overall Study|Withdrawal by Subject|0|||
129713835|NCT01713582|466913665|FG007|Overall Study|Withdrawal by Subject|0|||
129713836|NCT01713582|466913666|FG008|Overall Study|Withdrawal by Subject|0|||
129713837|NCT01713582|466913667|FG009|Overall Study|Withdrawal by Subject|0|||
129713838|NCT01713582|466913668|FG010|Overall Study|Withdrawal by Subject|0|||
129713839|NCT01713582|466913669|FG011|Overall Study|Withdrawal by Subject|0|||
129713840|NCT01713582|466913670|FG012|Overall Study|Withdrawal by Subject|0|||
129713841|NCT01713582|466913671|FG013|Overall Study|Withdrawal by Subject|0|||
129713842|NCT01713582|466913672|FG014|Overall Study|Withdrawal by Subject|0|||
129713843|NCT01713582|466913673|FG015|Overall Study|Withdrawal by Subject|0|||
129713844|NCT01713582|466913674|FG016|Overall Study|Withdrawal by Subject|0|||
129713845|NCT01713582|466913675|FG017|Overall Study|Withdrawal by Subject|1|||
129713846|NCT01713582|466913676|FG018|Overall Study|Withdrawal by Subject|0|||
129713847|NCT01713582|466913677|FG019|Overall Study|Withdrawal by Subject|0|||
129713848|NCT01713582|466913678|FG020|Overall Study|Withdrawal by Subject|0|||
129713849|NCT01713582|466913658|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
129713850|NCT01713582|466913659|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
129713851|NCT01713582|466913660|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
129713852|NCT01713582|466913661|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
129713853|NCT01713582|466913662|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
129713854|NCT01713582|466913663|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
129713855|NCT01713582|466913664|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
129713856|NCT01713582|466913665|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
129713857|NCT01713582|466913666|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
129713858|NCT01713582|466913667|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
129713859|NCT01713582|466913668|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
129713860|NCT01713582|466913669|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
129713861|NCT01713582|466913670|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
129713862|NCT01713582|466913671|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
129713863|NCT01713582|466913672|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
129713864|NCT01713582|466913673|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
129713865|NCT01713582|466913674|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
129713866|NCT01713582|466913675|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
129713867|NCT01713582|466913676|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
129713868|NCT01713582|466913677|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
129713869|NCT01713582|466913678|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
129713870|NCT01713582|466913658|FG000|Overall Study|Disease progression and adverse event|0|||
129713871|NCT01713582|466913659|FG001|Overall Study|Disease progression and adverse event|0|||
129713872|NCT01713582|466913660|FG002|Overall Study|Disease progression and adverse event|0|||
129713873|NCT01713582|466913661|FG003|Overall Study|Disease progression and adverse event|0|||
129713874|NCT01713582|466913662|FG004|Overall Study|Disease progression and adverse event|0|||
129713875|NCT01713582|466913663|FG005|Overall Study|Disease progression and adverse event|0|||
129713876|NCT01713582|466913664|FG006|Overall Study|Disease progression and adverse event|0|||
129713877|NCT01713582|466913665|FG007|Overall Study|Disease progression and adverse event|0|||
129713878|NCT01713582|466913666|FG008|Overall Study|Disease progression and adverse event|0|||
129802319|NCT01999114|467245227|FG003|Overall Study|Adverse Event|2|||
129802320|NCT01999114|467245228|FG004|Overall Study|Adverse Event|1|||
129713879|NCT01713582|466913667|FG009|Overall Study|Disease progression and adverse event|0|||
129713880|NCT01713582|466913668|FG010|Overall Study|Disease progression and adverse event|0|||
129713881|NCT01713582|466913669|FG011|Overall Study|Disease progression and adverse event|0|||
129713882|NCT01713582|466913670|FG012|Overall Study|Disease progression and adverse event|0|||
129713883|NCT01713582|466913671|FG013|Overall Study|Disease progression and adverse event|0|||
129713884|NCT01713582|466913672|FG014|Overall Study|Disease progression and adverse event|0|||
129713885|NCT01713582|466913673|FG015|Overall Study|Disease progression and adverse event|0|||
129802321|NCT01999114|467245224|FG000|Overall Study|Withdrawal by Subject|0|||
129802322|NCT01999114|467245225|FG001|Overall Study|Withdrawal by Subject|0|||
129802323|NCT01999114|467245226|FG002|Overall Study|Withdrawal by Subject|1|||
129802324|NCT01999114|467245227|FG003|Overall Study|Withdrawal by Subject|0|||
129802325|NCT01999114|467245228|FG004|Overall Study|Withdrawal by Subject|1|||
129802326|NCT01999114|467245224|FG000|Overall Study|Lost to Follow-up|0|||
129802327|NCT01999114|467245225|FG001|Overall Study|Lost to Follow-up|0|||
129802328|NCT01999114|467245226|FG002|Overall Study|Lost to Follow-up|1|||
129802329|NCT01999114|467245227|FG003|Overall Study|Lost to Follow-up|0|||
129802330|NCT01999114|467245228|FG004|Overall Study|Lost to Follow-up|0|||
129802331|NCT01999114|467245224|FG000|Overall Study|Administrative|0|||
129802332|NCT01999114|467245225|FG001|Overall Study|Administrative|0|||
129802333|NCT01999114|467245226|FG002|Overall Study|Administrative|1|||
129802334|NCT01999114|467245227|FG003|Overall Study|Administrative|1|||
129802335|NCT01999114|467245228|FG004|Overall Study|Administrative|2|||
129802336|NCT01497275|467245231|FG000|Overall Study|Death|1|||
129802337|NCT01497275|467245231|FG000|Overall Study|Adverse Event|1|||
129802338|NCT01950169|467245232|FG000|Overall Study|Withdrawal by Subject|2|||
129802339|NCT01950169|467245233|FG001|Overall Study|Withdrawal by Subject|8|||
129802340|NCT01950169|467245234|FG002|Overall Study|Withdrawal by Subject|1|||
129802341|NCT01950169|467245232|FG000|Overall Study|Death|1|||
129713886|NCT01713582|466913674|FG016|Overall Study|Disease progression and adverse event|1|||
129713887|NCT01713582|466913675|FG017|Overall Study|Disease progression and adverse event|0|||
129713888|NCT01713582|466913676|FG018|Overall Study|Disease progression and adverse event|0|||
129713889|NCT01713582|466913677|FG019|Overall Study|Disease progression and adverse event|0|||
129713890|NCT01713582|466913678|FG020|Overall Study|Disease progression and adverse event|0|||
129713891|NCT03145064|466913681|FG000|Overall Study|Death|24|||
129713892|NCT03145064|466913681|FG000|Overall Study|Lost to Follow-up|3|||
129713893|NCT03145064|466913681|FG000|Overall Study|Withdrawal by Subject|6|||
129713894|NCT03145064|466913681|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
129713895|NCT03145064|466913681|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
129713896|NCT03846427|466913682|FG000|Overall Study|Death|13|||
129713897|NCT03846427|466913682|FG000|Overall Study|Withdrawal by Subject|3|||
129713898|NCT03846427|466913682|FG000|Overall Study|Physician Decision|1|||
129713899|NCT01693250|466913683|FG000|Overall Study|Lost to Follow-up|2|||
129713900|NCT01693250|466913684|FG001|Overall Study|Lost to Follow-up|2|||
129713901|NCT00628446|466913685|FG000|Overall Study|Lost to Follow-up|3|||
129713902|NCT00628446|466913685|FG000|Overall Study|Withdrawal by Subject|1|||
129713903|NCT00628446|466913685|FG000|Overall Study|Protocol Violation|3|||
129713904|NCT01396187|466913686|FG000|Overall Study|Adverse Event|0|||
129713905|NCT01396187|466913687|FG001|Overall Study|Adverse Event|1|||
129713906|NCT01396187|466913688|FG002|Overall Study|Adverse Event|0|||
129713907|NCT01396187|466913689|FG003|Overall Study|Adverse Event|0|||
129713908|NCT01396187|466913690|FG004|Overall Study|Adverse Event|0|||
129713909|NCT01396187|466913686|FG000|Overall Study|Withdrawal by Subject|0|||
129713910|NCT01396187|466913687|FG001|Overall Study|Withdrawal by Subject|1|||
129713911|NCT01396187|466913688|FG002|Overall Study|Withdrawal by Subject|1|||
129713912|NCT01396187|466913689|FG003|Overall Study|Withdrawal by Subject|0|||
129713913|NCT01396187|466913690|FG004|Overall Study|Withdrawal by Subject|0|||
129713914|NCT01396187|466913686|FG000|Overall Study|Other|1|||
129713915|NCT01396187|466913687|FG001|Overall Study|Other|1|||
129802342|NCT01950169|467245233|FG001|Overall Study|Death|0|||
129802343|NCT01950169|467245234|FG002|Overall Study|Death|0|||
129802344|NCT02083081|467245240|FG000|Overall Study|Lost to Follow-up|31|||
129802345|NCT02083081|467245241|FG001|Overall Study|Lost to Follow-up|9|||
129802346|NCT01104155|467245242|FG000|Overall Study|Adverse Event|15|||
129802347|NCT01104155|467245243|FG001|Overall Study|Adverse Event|8|||
129802348|NCT01104155|467245242|FG000|Overall Study|Participant choice|6|||
129802349|NCT01104155|467245243|FG001|Overall Study|Participant choice|5|||
129802350|NCT01104155|467245242|FG000|Overall Study|Withdrawal of consent|1|||
129802351|NCT01104155|467245243|FG001|Overall Study|Withdrawal of consent|1|||
129802352|NCT01104155|467245242|FG000|Overall Study|Other|3|||
129802353|NCT01104155|467245243|FG001|Overall Study|Other|4|||
129713916|NCT01396187|466913688|FG002|Overall Study|Other|0|||
129444270|NCT02464228|465927277|FG000|Overall Study|Disease Progression|22|||
129713917|NCT01396187|466913689|FG003|Overall Study|Other|0|||
129802354|NCT01484132|467245249|FG000|Overall Study|Lost to Follow-up|8|||
129802355|NCT01484132|467245249|FG000|Overall Study|Difficulty with time commitment|2|||
129802356|NCT01484132|467245249|FG000|Overall Study|Ineligible|1|||
129802357|NCT01484132|467245249|FG000|Overall Study|No pre-treatment urine sample collected|1|||
129802358|NCT01484132|467245249|FG000|Overall Study|No post-treatment urine sample collected|10|||
129713918|NCT01396187|466913690|FG004|Overall Study|Other|1|||
129713919|NCT01898286|466913691|FG000|Overall Study|Withdrawal by Subject|1|||
129713920|NCT01898286|466913691|FG000|Overall Study|Protocol Violation|1|||
129802359|NCT03799211|467245250|FG000|Overall Study|Lost to Follow-up|2|||
129802360|NCT03799211|467245251|FG001|Overall Study|Lost to Follow-up|13|||
129891394|NCT04529538|467559717|FG002|Overall Study|Other|0|||
129713921|NCT01898286|466913691|FG000|Overall Study|Lost to Follow-up|1|||
129713922|NCT02257242|466913692|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
129713923|NCT02257242|466913693|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713924|NCT02257242|466913694|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713925|NCT02257242|466913695|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713926|NCT02257242|466913696|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713927|NCT02257242|466913697|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713928|NCT02257242|466913698|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713929|NCT02257242|466913699|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713930|NCT02257242|466913700|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
129713931|NCT01650831|466913707|FG000|Overall Study|Screen failure|1|||
129713932|NCT01048242|466913710|FG000|Overall Study|See study flow chart|4|||
129713933|NCT01048242|466913711|FG001|Overall Study|See study flow chart|2|||
129713934|NCT02964273|466913712|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
129713935|NCT02964273|466913713|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129713936|NCT02964273|466913714|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129713937|NCT02964273|466913715|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
129713938|NCT02964273|466913712|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129713939|NCT02964273|466913713|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
129713940|NCT02964273|466913714|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129713941|NCT02964273|466913715|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
129713942|NCT02964273|466913712|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
129713943|NCT02964273|466913713|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
129713944|NCT02964273|466913714|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
129713945|NCT02964273|466913715|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
129713946|NCT02964273|466913712|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
129713947|NCT02964273|466913713|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
129713948|NCT02964273|466913714|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
129713949|NCT02964273|466913715|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
129713950|NCT02964273|466913712|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
129713951|NCT02964273|466913713|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
129713952|NCT02964273|466913714|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
129713953|NCT02964273|466913715|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
129713954|NCT02964273|466913712|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
129713955|NCT02964273|466913713|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
129713956|NCT02964273|466913714|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
129713957|NCT02964273|466913715|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
129713958|NCT01453036|466913717|FG000|Overall Study|Lost to Follow-up|26|||
129713959|NCT01453036|466913718|FG001|Overall Study|Lost to Follow-up|115|||
129713960|NCT01453036|466913719|FG002|Overall Study|Lost to Follow-up|31|||
129713961|NCT00559104|466913720|FG000|Overall Study|Lack of Efficacy|9|||
129713962|NCT00559104|466913721|FG001|Overall Study|Lack of Efficacy|0|||
129713963|NCT01336712|466913722|FG000|Overall Study|Death|2|||
129713964|NCT01336712|466913722|FG000|Overall Study|Lack of Efficacy|1|||
129713965|NCT00620373|466913724|FG000|Overall Study|Unverified cancer status|33|||
129713966|NCT03073525|466913725|FG000|Overall Study|Withdrawal by Subject|0|||
129713967|NCT03073525|466913726|FG001|Overall Study|Withdrawal by Subject|0|||
129713968|NCT03073525|466913727|FG002|Overall Study|Withdrawal by Subject|3|||
129713969|NCT01273038|466913728|FG000|Second Intervention (14 Days)|Adverse Event|0|||
129713970|NCT01273038|466913729|FG001|Second Intervention (14 Days)|Adverse Event|1|||
129713971|NCT01273038|466913728|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129713972|NCT01273038|466913729|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129713973|NCT01976299|466913730|FG000|Overall Study|Withdrawal by Subject|3|||
129713974|NCT01976299|466913731|FG001|Overall Study|Withdrawal by Subject|1|||
129713975|NCT01976299|466913730|FG000|Overall Study|Death|4|||
129713976|NCT01976299|466913731|FG001|Overall Study|Death|2|||
129713977|NCT01976299|466913730|FG000|Overall Study|Lost to Follow-up|7|||
129713978|NCT01976299|466913731|FG001|Overall Study|Lost to Follow-up|1|||
129713979|NCT01976299|466913730|FG000|Overall Study|See clarification above in comments|9|||
129713980|NCT01976299|466913731|FG001|Overall Study|See clarification above in comments|2|||
129713981|NCT01306643|466913732|FG000|Overall Study|Adverse Event|5|||
129713982|NCT01306643|466913732|FG000|Overall Study|Disease Progression|7|||
129713983|NCT01306643|466913732|FG000|Overall Study|Other: Change in Eligibility Status|1|||
129713984|NCT02071771|466913735|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
129713985|NCT02071771|466913736|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
129713986|NCT02071771|466913735|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
129713987|NCT02071771|466913736|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
129713988|NCT00355368|466913740|FG000|Overall Study|Protocol Violation|8|||
129713989|NCT00355368|466913741|FG001|Overall Study|Protocol Violation|7|||
129713990|NCT00355368|466913740|FG000|Overall Study|cardiac arrest prior to intubation|2|||
129713991|NCT00355368|466913741|FG001|Overall Study|cardiac arrest prior to intubation|2|||
129713992|NCT01152788|466913745|FG000|Overall Study|Withdrawal by Subject|0|||
129713993|NCT01152788|466913746|FG001|Overall Study|Withdrawal by Subject|3|||
129713994|NCT01152788|466913745|FG000|Overall Study|No treatment|0|||
129713995|NCT01152788|466913746|FG001|Overall Study|No treatment|1|||
129713996|NCT01282866|466913747|FG000|Overall Study|Adverse Event|1|||
129713997|NCT01964378|466913752|FG000|Overall Study|Disc. due to death before first dosing|0|||
129713998|NCT01964378|466913753|FG001|Overall Study|Disc. due to death before first dosing|1|||
129713999|NCT01964378|466913752|FG000|Overall Study|Disc. due to AE before first dosing|1|||
129714000|NCT01964378|466913753|FG001|Overall Study|Disc. due to AE before first dosing|0|||
129714001|NCT01964378|466913752|FG000|Overall Study|Death|3|||
129714002|NCT01964378|466913753|FG001|Overall Study|Death|2|||
129714003|NCT01964378|466913752|FG000|Overall Study|Adverse Event|12|||
129714004|NCT01964378|466913753|FG001|Overall Study|Adverse Event|5|||
129714005|NCT01964378|466913752|FG000|Overall Study|Lack of Efficacy|0|||
129714006|NCT01964378|466913753|FG001|Overall Study|Lack of Efficacy|1|||
129714007|NCT01964378|466913752|FG000|Overall Study|Protocol Violation|0|||
129714008|NCT01964378|466913753|FG001|Overall Study|Protocol Violation|1|||
129714009|NCT01964378|466913752|FG000|Overall Study|Lost to Follow-up|0|||
129714010|NCT01964378|466913753|FG001|Overall Study|Lost to Follow-up|1|||
129714011|NCT01964378|466913752|FG000|Overall Study|Withdrawal by Subject|7|||
129714012|NCT01964378|466913753|FG001|Overall Study|Withdrawal by Subject|5|||
129714013|NCT01964378|466913752|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
129714014|NCT01964378|466913753|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
129714015|NCT01964378|466913752|FG000|Overall Study|Other|1|||
129714016|NCT01964378|466913753|FG001|Overall Study|Other|2|||
129714017|NCT01928433|466913760|FG000|Overall Study|Adverse Event|5|||
129714018|NCT01928433|466913761|FG001|Overall Study|Adverse Event|2|||
129714019|NCT01928433|466913762|FG002|Overall Study|Adverse Event|5|||
129714020|NCT01928433|466913760|FG000|Overall Study|Protocol Violation|0|||
129714021|NCT01928433|466913761|FG001|Overall Study|Protocol Violation|0|||
129714022|NCT01928433|466913762|FG002|Overall Study|Protocol Violation|2|||
129714023|NCT01928433|466913760|FG000|Overall Study|Lack of Efficacy|5|||
129714024|NCT01928433|466913761|FG001|Overall Study|Lack of Efficacy|4|||
129714025|NCT01928433|466913762|FG002|Overall Study|Lack of Efficacy|4|||
129714026|NCT01928433|466913760|FG000|Overall Study|Withdrawal by Subject|0|||
129714027|NCT01928433|466913761|FG001|Overall Study|Withdrawal by Subject|4|||
129714028|NCT01928433|466913762|FG002|Overall Study|Withdrawal by Subject|0|||
129714029|NCT01928433|466913760|FG000|Overall Study|Negative screening urine culture|7|||
129714030|NCT01928433|466913761|FG001|Overall Study|Negative screening urine culture|6|||
129714031|NCT01928433|466913762|FG002|Overall Study|Negative screening urine culture|10|||
129714032|NCT01928433|466913760|FG000|Overall Study|Lost to Follow-up|0|||
129714033|NCT01928433|466913761|FG001|Overall Study|Lost to Follow-up|2|||
129714034|NCT01928433|466913762|FG002|Overall Study|Lost to Follow-up|3|||
129714035|NCT01928433|466913760|FG000|Overall Study|Other reasons|3|||
129714036|NCT01928433|466913761|FG001|Overall Study|Other reasons|3|||
129714037|NCT01928433|466913762|FG002|Overall Study|Other reasons|4|||
129714038|NCT01392573|466913763|FG000|Overall Study|Adverse Event|1|||
129714039|NCT01392573|466913764|FG001|Overall Study|Adverse Event|3|||
129714040|NCT01392573|466913763|FG000|Overall Study|Lack of Efficacy|1|||
129714041|NCT01392573|466913764|FG001|Overall Study|Lack of Efficacy|2|||
129714042|NCT01392573|466913763|FG000|Overall Study|Protocol Violation|0|||
129714043|NCT01392573|466913764|FG001|Overall Study|Protocol Violation|2|||
129714044|NCT01392573|466913763|FG000|Overall Study|Withdrawal Criteria|13|||
129714045|NCT01392573|466913764|FG001|Overall Study|Withdrawal Criteria|15|||
129714046|NCT01392573|466913763|FG000|Overall Study|Site closure|8|||
129714047|NCT01392573|466913764|FG001|Overall Study|Site closure|7|||
129714048|NCT01392573|466913763|FG000|Overall Study|Unclassified|9|||
129714049|NCT01392573|466913764|FG001|Overall Study|Unclassified|6|||
129714050|NCT00436436|466913765|FG000|Overall Study|Progression|4|||
129714051|NCT00436436|466913765|FG000|Overall Study|Adverse Event|2|||
129714052|NCT00436436|466913765|FG000|Overall Study|Death|6|||
129714053|NCT01102491|466913772|FG000|Overall Study|Protocol Violation|11|||
129714054|NCT01102491|466913773|FG001|Overall Study|Protocol Violation|12|||
129714055|NCT02151786|466913774|FG000|Overall Study|Unavailability of Case Report Form|26|||
129714056|NCT02151786|466913774|FG000|Overall Study|Outside the Contract Period|1|||
129714057|NCT02151786|466913774|FG000|Overall Study|Randomized, not Treated|1|||
129714058|NCT02151786|466913774|FG000|Overall Study|Unavailability of Information|8|||
129714059|NCT03533660|466913775|FG000|Overall Study|Withdrawal by Subject|2|||
129714060|NCT03533660|466913776|FG001|Overall Study|Withdrawal by Subject|2|||
129714061|NCT03533660|466913775|FG000|Overall Study|Death|2|||
129891395|NCT04529538|467559718|FG003|Overall Study|Other|0|||
129714062|NCT03533660|466913776|FG001|Overall Study|Death|4|||
129714063|NCT03533660|466913775|FG000|Overall Study|Adverse Event|0|||
129714064|NCT03533660|466913776|FG001|Overall Study|Adverse Event|2|||
129714065|NCT00996658|466913777|FG000|Overall Study|Adverse Event|2|||
129714066|NCT00996658|466913778|FG001|Overall Study|Adverse Event|5|||
129714067|NCT00996658|466913777|FG000|Overall Study|Protocol Violation|0|||
129714068|NCT00996658|466913778|FG001|Overall Study|Protocol Violation|1|||
129714069|NCT00996658|466913777|FG000|Overall Study|Lost to Follow-up|2|||
129714070|NCT00996658|466913778|FG001|Overall Study|Lost to Follow-up|5|||
129714071|NCT00996658|466913777|FG000|Overall Study|Non-compliance issues|3|||
129714072|NCT00996658|466913778|FG001|Overall Study|Non-compliance issues|3|||
129714073|NCT00996658|466913777|FG000|Overall Study|Other|9|||
129714074|NCT00996658|466913778|FG001|Overall Study|Other|7|||
129714075|NCT03692403|466915865|FG000|Overall Study|Withdrawal by Subject|1|||
129714076|NCT03692403|466915866|FG001|Overall Study|Withdrawal by Subject|0|||
129714077|NCT03692403|466915867|FG002|Overall Study|Withdrawal by Subject|1|||
129714078|NCT03692403|466915868|FG003|Overall Study|Withdrawal by Subject|0|||
129714079|NCT03692403|466915865|FG000|Overall Study|Adverse Event|0|||
129714080|NCT03692403|466915866|FG001|Overall Study|Adverse Event|0|||
129714081|NCT03692403|466915867|FG002|Overall Study|Adverse Event|0|||
129714082|NCT03692403|466915868|FG003|Overall Study|Adverse Event|1|||
129714083|NCT03692403|466915865|FG000|Overall Study|Pregnancy|0|||
129714084|NCT03692403|466915866|FG001|Overall Study|Pregnancy|1|||
129714085|NCT03692403|466915867|FG002|Overall Study|Pregnancy|0|||
129714086|NCT03692403|466915868|FG003|Overall Study|Pregnancy|0|||
129714087|NCT03692403|466915865|FG000|Overall Study|Other|0|||
129714088|NCT03692403|466915866|FG001|Overall Study|Other|0|||
129714089|NCT03692403|466915867|FG002|Overall Study|Other|1|||
129714090|NCT03692403|466915868|FG003|Overall Study|Other|0|||
129714091|NCT01408277|466915872|FG000|Overall Study|Adverse Event|3|||
129714092|NCT01408277|466915873|FG001|Overall Study|Adverse Event|4|||
129714093|NCT01408277|466915872|FG000|Overall Study|Lost to Follow-up|1|||
129714094|NCT01408277|466915873|FG001|Overall Study|Lost to Follow-up|0|||
129714095|NCT01408277|466915872|FG000|Overall Study|Withdrawal by Subject|2|||
129714096|NCT01408277|466915873|FG001|Overall Study|Withdrawal by Subject|0|||
129714097|NCT01408277|466915872|FG000|Overall Study|Protocol Violation|2|||
129714098|NCT01408277|466915873|FG001|Overall Study|Protocol Violation|0|||
129714099|NCT01349673|466915874|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
129714100|NCT01349673|466915874|FG000|Overall Study|No Longer Qualified For Study|1|||
129714101|NCT01349673|466915874|FG000|Overall Study|Site Closure|10|||
129714102|NCT01349673|466915874|FG000|Overall Study|Withdrawal by Subject|21|||
129714103|NCT01349673|466915874|FG000|Overall Study|Lost to Follow-up|6|||
129714104|NCT01349673|466915874|FG000|Overall Study|Adverse Event|17|||
129714105|NCT01349673|466915874|FG000|Overall Study|Study Terminated By Sponsor|50|||
129714106|NCT01349673|466915874|FG000|Overall Study|Lack of Efficacy|8|||
129714107|NCT04263766|466915877|FG000|Overall Study|Withdrawal by Subject|6|||
129714108|NCT04263766|466915878|FG001|Overall Study|Withdrawal by Subject|4|||
129714109|NCT04263766|466915877|FG000|Overall Study|Lack of Efficacy|1|||
129714110|NCT04263766|466915878|FG001|Overall Study|Lack of Efficacy|3|||
129714111|NCT01891396|466915880|FG000|Overall Study|Withdrawal by Subject|4|||
129714112|NCT01891396|466915881|FG001|Overall Study|Withdrawal by Subject|4|||
129714113|NCT01891396|466915882|FG002|Overall Study|Withdrawal by Subject|3|||
129714114|NCT01891396|466915880|FG000|Overall Study|Lost to Follow-up|0|||
129714115|NCT01891396|466915881|FG001|Overall Study|Lost to Follow-up|1|||
129714116|NCT01891396|466915882|FG002|Overall Study|Lost to Follow-up|0|||
129802361|NCT03799211|467245250|FG000|Overall Study|Withdrawal by Subject|2|||
129444271|NCT02464228|465927278|FG001|Overall Study|Disease Progression|12|||
129714117|NCT00540592|466915883|FG000|Overall Study|Adverse Event|0|||
129714118|NCT00540592|466915884|FG001|Overall Study|Adverse Event|1|||
129714119|NCT00540592|466915885|FG002|Overall Study|Adverse Event|0|||
129714120|NCT00540592|466915886|FG003|Overall Study|Adverse Event|0|||
129714121|NCT00540592|466915887|FG004|Overall Study|Adverse Event|1|||
129714122|NCT00540592|466915888|FG005|Overall Study|Adverse Event|0|||
129714123|NCT00540592|466915889|FG006|Overall Study|Adverse Event|0|||
129714124|NCT00540592|466915890|FG007|Overall Study|Adverse Event|1|||
129714125|NCT00540592|466915891|FG008|Overall Study|Adverse Event|1|||
129714126|NCT00540592|466915892|FG009|Overall Study|Adverse Event|2|||
129714127|NCT00540592|466915883|FG000|Overall Study|Lost to Follow-up|2|||
129714128|NCT00540592|466915884|FG001|Overall Study|Lost to Follow-up|0|||
129714129|NCT00540592|466915885|FG002|Overall Study|Lost to Follow-up|0|||
129714130|NCT00540592|466915886|FG003|Overall Study|Lost to Follow-up|0|||
129714131|NCT00540592|466915887|FG004|Overall Study|Lost to Follow-up|0|||
129714132|NCT00540592|466915888|FG005|Overall Study|Lost to Follow-up|0|||
129714133|NCT00540592|466915889|FG006|Overall Study|Lost to Follow-up|0|||
129714134|NCT00540592|466915890|FG007|Overall Study|Lost to Follow-up|0|||
129714135|NCT00540592|466915891|FG008|Overall Study|Lost to Follow-up|0|||
129714136|NCT00540592|466915892|FG009|Overall Study|Lost to Follow-up|0|||
129714137|NCT00540592|466915883|FG000|Overall Study|Withdrawal by Subject|0|||
129714138|NCT00540592|466915884|FG001|Overall Study|Withdrawal by Subject|0|||
129714139|NCT00540592|466915885|FG002|Overall Study|Withdrawal by Subject|1|||
129714140|NCT00540592|466915886|FG003|Overall Study|Withdrawal by Subject|1|||
129714141|NCT00540592|466915887|FG004|Overall Study|Withdrawal by Subject|0|||
129714142|NCT00540592|466915888|FG005|Overall Study|Withdrawal by Subject|0|||
129714143|NCT00540592|466915889|FG006|Overall Study|Withdrawal by Subject|0|||
129714144|NCT00540592|466915890|FG007|Overall Study|Withdrawal by Subject|0|||
129714145|NCT00540592|466915891|FG008|Overall Study|Withdrawal by Subject|0|||
129714146|NCT00540592|466915892|FG009|Overall Study|Withdrawal by Subject|0|||
129714147|NCT01766037|466915893|FG000|Overall Study|Adverse Event|1|||
129714148|NCT01766037|466915894|FG001|Overall Study|Adverse Event|0|||
129714149|NCT01766037|466915893|FG000|Overall Study|Lack of Efficacy|1|||
129714150|NCT01766037|466915894|FG001|Overall Study|Lack of Efficacy|0|||
129714151|NCT01766037|466915893|FG000|Overall Study|Lost to Follow-up|0|||
129714152|NCT01766037|466915894|FG001|Overall Study|Lost to Follow-up|10|||
129714153|NCT01766037|466915893|FG000|Overall Study|Physician Decision|0|||
129714154|NCT01766037|466915894|FG001|Overall Study|Physician Decision|1|||
129714155|NCT01766037|466915893|FG000|Overall Study|Withdrawal by Subject|18|||
129714156|NCT01766037|466915894|FG001|Overall Study|Withdrawal by Subject|16|||
129714157|NCT01766037|466915893|FG000|Overall Study|Moved from area|5|||
129714158|NCT01766037|466915894|FG001|Overall Study|Moved from area|0|||
129714159|NCT01766037|466915893|FG000|Overall Study|medical - unrelated|1|||
129714160|NCT01766037|466915894|FG001|Overall Study|medical - unrelated|2|||
129714161|NCT01766037|466915893|FG000|Overall Study|nausea / discomfort|3|||
129714162|NCT01766037|466915894|FG001|Overall Study|nausea / discomfort|0|||
129714163|NCT02413996|466915895|FG000|Overall Study|not comfortable with the intervention|9|||
129714164|NCT02413996|466915896|FG001|Overall Study|not comfortable with the intervention|2|||
129714165|NCT03810014|466915899|FG000|Overall Study|Pregnancy|2|||
129714166|NCT03810014|466915900|FG001|Overall Study|Pregnancy|2|||
129714167|NCT03810014|466915901|FG002|Overall Study|Pregnancy|0|||
129714168|NCT03810014|466915902|FG003|Overall Study|Pregnancy|2|||
129714169|NCT03606486|466915903|FG000|Overall Study|Unable to collect sample|5|||
129714170|NCT01853462|466915912|FG000|Overall Study|Withdrawal by Subject|1|||
129714171|NCT01853462|466915913|FG001|Overall Study|Withdrawal by Subject|1|||
129714172|NCT03943290|466915914|FG000|Overall Study|Sponsor Terminated Study|6|||
129714173|NCT03943290|466915915|FG001|Overall Study|Sponsor Terminated Study|1|||
129714174|NCT03943290|466915916|FG002|Overall Study|Sponsor Terminated Study|11|||
129714175|NCT03943290|466915917|FG003|Overall Study|Sponsor Terminated Study|6|||
129714176|NCT03943290|466915918|FG004|Overall Study|Sponsor Terminated Study|7|||
129714177|NCT03943290|466915919|FG005|Overall Study|Sponsor Terminated Study|6|||
129714178|NCT03943290|466915920|FG006|Overall Study|Sponsor Terminated Study|6|||
129714179|NCT03943290|466915921|FG007|Overall Study|Sponsor Terminated Study|7|||
129714180|NCT03943290|466915922|FG008|Overall Study|Sponsor Terminated Study|8|||
129714181|NCT03943290|466915914|FG000|Overall Study|Lost to Follow-up|1|||
129714182|NCT03943290|466915915|FG001|Overall Study|Lost to Follow-up|0|||
129714183|NCT03943290|466915916|FG002|Overall Study|Lost to Follow-up|1|||
129714184|NCT03943290|466915917|FG003|Overall Study|Lost to Follow-up|0|||
129714185|NCT03943290|466915918|FG004|Overall Study|Lost to Follow-up|0|||
129714186|NCT03943290|466915919|FG005|Overall Study|Lost to Follow-up|0|||
129714187|NCT03943290|466915920|FG006|Overall Study|Lost to Follow-up|0|||
129714188|NCT03943290|466915921|FG007|Overall Study|Lost to Follow-up|1|||
129714189|NCT03943290|466915922|FG008|Overall Study|Lost to Follow-up|0|||
129714190|NCT03943290|466915914|FG000|Overall Study|Withdrawal by Subject|0|||
129714191|NCT03943290|466915915|FG001|Overall Study|Withdrawal by Subject|0|||
129714192|NCT03943290|466915916|FG002|Overall Study|Withdrawal by Subject|1|||
129714193|NCT03943290|466915917|FG003|Overall Study|Withdrawal by Subject|0|||
129714194|NCT03943290|466915918|FG004|Overall Study|Withdrawal by Subject|0|||
129714195|NCT03943290|466915919|FG005|Overall Study|Withdrawal by Subject|0|||
129714196|NCT03943290|466915920|FG006|Overall Study|Withdrawal by Subject|0|||
129714197|NCT03943290|466915921|FG007|Overall Study|Withdrawal by Subject|0|||
129714198|NCT03943290|466915922|FG008|Overall Study|Withdrawal by Subject|0|||
129714199|NCT00955474|466915923|FG000|Overall Study|Physician Decision|7|||
129714200|NCT00955474|466915924|FG001|Overall Study|Physician Decision|5|||
129714201|NCT01737762|466915925|FG000|Overall Study|Adverse Event|2|||
129714202|NCT01737762|466915926|FG001|Overall Study|Adverse Event|2|||
129714203|NCT01737762|466915925|FG000|Overall Study|Lost to Follow-up|1|||
129714204|NCT01737762|466915926|FG001|Overall Study|Lost to Follow-up|0|||
129714205|NCT01737762|466915925|FG000|Overall Study|Withdrawal by Subject|2|||
129714206|NCT01737762|466915926|FG001|Overall Study|Withdrawal by Subject|2|||
129714207|NCT01737762|466915925|FG000|Overall Study|Progressive disease|1|||
129714208|NCT01737762|466915926|FG001|Overall Study|Progressive disease|2|||
129714209|NCT01737762|466915925|FG000|Overall Study|Physician Decision|1|||
129714210|NCT01737762|466915926|FG001|Overall Study|Physician Decision|1|||
129714211|NCT01737762|466915925|FG000|Overall Study|Moved from area|2|||
129714212|NCT01737762|466915926|FG001|Overall Study|Moved from area|1|||
129714213|NCT01737762|466915925|FG000|Overall Study|Trial termination|11|||
129714214|NCT01737762|466915926|FG001|Overall Study|Trial termination|9|||
129714215|NCT02148263|466915927|FG000|Overall Study|Withdrawal by Subject|3|||
129714216|NCT02148263|466915928|FG001|Overall Study|Withdrawal by Subject|2|||
129714217|NCT03386435|466915929|FG000|Overall Study|Protocol Violation|5|||
129714218|NCT03386435|466915930|FG001|Overall Study|Protocol Violation|7|||
129714219|NCT00625586|466915931|FG000|Overall Study|Adverse Event|1|||
129714220|NCT00625586|466915931|FG000|Overall Study|Progressive disease|1|||
129714221|NCT03083665|466915932|FG000|Double-Blind Period|Adverse Event|5|||
129714222|NCT03083665|466915933|FG001|Double-Blind Period|Adverse Event|4|||
129714223|NCT03083665|466915934|FG002|Double-Blind Period|Adverse Event|5|||
129714224|NCT03083665|466915935|FG003|Double-Blind Period|Adverse Event|0|||
129714225|NCT03083665|466915936|FG004|Double-Blind Period|Adverse Event|0|||
129714226|NCT03083665|466915937|FG005|Double-Blind Period|Adverse Event|0|||
129714227|NCT03083665|466915932|FG000|Double-Blind Period|Lack of Efficacy|0|||
129714228|NCT03083665|466915933|FG001|Double-Blind Period|Lack of Efficacy|0|||
129714229|NCT03083665|466915934|FG002|Double-Blind Period|Lack of Efficacy|1|||
129714230|NCT03083665|466915935|FG003|Double-Blind Period|Lack of Efficacy|0|||
129714231|NCT03083665|466915936|FG004|Double-Blind Period|Lack of Efficacy|0|||
129714232|NCT03083665|466915937|FG005|Double-Blind Period|Lack of Efficacy|0|||
129714233|NCT03083665|466915932|FG000|Double-Blind Period|Protocol Violation|1|||
129714234|NCT03083665|466915933|FG001|Double-Blind Period|Protocol Violation|0|||
129714235|NCT03083665|466915934|FG002|Double-Blind Period|Protocol Violation|1|||
129714236|NCT03083665|466915935|FG003|Double-Blind Period|Protocol Violation|0|||
129714237|NCT03083665|466915936|FG004|Double-Blind Period|Protocol Violation|0|||
129714238|NCT03083665|466915937|FG005|Double-Blind Period|Protocol Violation|0|||
129714239|NCT03083665|466915932|FG000|Double-Blind Period|Lost to Follow-up|1|||
129714240|NCT03083665|466915933|FG001|Double-Blind Period|Lost to Follow-up|0|||
129714241|NCT03083665|466915934|FG002|Double-Blind Period|Lost to Follow-up|1|||
129714242|NCT03083665|466915935|FG003|Double-Blind Period|Lost to Follow-up|0|||
129714243|NCT03083665|466915936|FG004|Double-Blind Period|Lost to Follow-up|0|||
129714244|NCT03083665|466915937|FG005|Double-Blind Period|Lost to Follow-up|0|||
129714245|NCT03083665|466915932|FG000|Double-Blind Period|Withdrawal by Subject|3|||
129714246|NCT03083665|466915933|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129714247|NCT03083665|466915934|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129714248|NCT03083665|466915935|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129714249|NCT03083665|466915936|FG004|Double-Blind Period|Withdrawal by Subject|0|||
129714250|NCT03083665|466915937|FG005|Double-Blind Period|Withdrawal by Subject|0|||
129714251|NCT03083665|466915932|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
129802362|NCT03799211|467245251|FG001|Overall Study|Withdrawal by Subject|0|||
129802363|NCT00764491|467245252|FG000|Overall Study|Lost to Follow-up|35|||
129802364|NCT00764491|467245253|FG001|Overall Study|Lost to Follow-up|17|||
129802365|NCT03139279|467245256|FG000|Overall Study|Physician Decision|2|||
129802366|NCT03139279|467245257|FG001|Overall Study|Physician Decision|0|||
129802367|NCT03139279|467245256|FG000|Overall Study|Protocol Violation|5|||
129802368|NCT03139279|467245257|FG001|Overall Study|Protocol Violation|4|||
129802369|NCT03139279|467245256|FG000|Overall Study|Withdrawal by Subject|0|||
129802370|NCT03139279|467245257|FG001|Overall Study|Withdrawal by Subject|2|||
129802371|NCT01336569|467245258|FG000|Overall Study|Lost to Follow-up|4|||
129802372|NCT02337738|467245259|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
129714252|NCT03083665|466915933|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129714253|NCT03083665|466915934|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129714254|NCT03083665|466915935|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129714255|NCT03083665|466915936|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129714256|NCT03083665|466915937|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
129714257|NCT03083665|466915932|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
129714258|NCT03083665|466915933|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
129714259|NCT03083665|466915934|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
129802373|NCT02337738|467245260|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
129802374|NCT02337738|467245261|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
129891396|NCT04529538|467559719|FG004|Overall Study|Other|0|||
129714260|NCT03083665|466915935|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
129714261|NCT03083665|466915936|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
129714262|NCT03083665|466915937|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
129714263|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129714264|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129714265|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129714266|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
129714267|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129714268|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
129714269|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129714270|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129714271|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129714272|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129714273|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
129714274|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
129714275|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
129714276|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
129714277|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
129714278|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
129714279|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
129714280|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
129714281|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129714282|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129714283|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129714284|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129714285|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
129714286|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
129714287|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129714288|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129714289|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129714290|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
129714291|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129714292|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
129714293|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129714294|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129714295|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129714296|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129714297|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
129714298|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
129714299|NCT03083665|466915932|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129714300|NCT03083665|466915933|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129714301|NCT03083665|466915934|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129714302|NCT03083665|466915935|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129714303|NCT03083665|466915936|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
129714304|NCT03083665|466915937|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
129714305|NCT01467466|466915940|FG000|Overall Study|Withdrawal by Subject|15|||
129714306|NCT01467466|466915941|FG001|Overall Study|Withdrawal by Subject|18|||
129714307|NCT01467466|466915942|FG002|Overall Study|Withdrawal by Subject|13|||
129714308|NCT01467466|466915943|FG003|Overall Study|Withdrawal by Subject|11|||
129714309|NCT01467466|466915940|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
129714310|NCT01467466|466915941|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
129714311|NCT01467466|466915942|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
129714312|NCT01467466|466915943|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
129714313|NCT01467466|466915940|FG000|Overall Study|Procedure Cancelled|46|||
129802375|NCT02337738|467245259|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129802376|NCT02337738|467245260|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
129802377|NCT02337738|467245261|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
129802378|NCT02337738|467245259|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
129802379|NCT02337738|467245260|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
129802380|NCT02337738|467245261|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
129802381|NCT02337738|467245259|FG000|Overall Study|Voluntary Withdrawal|10|||
129714314|NCT01467466|466915941|FG001|Overall Study|Procedure Cancelled|45|||
129802382|NCT02337738|467245260|FG001|Overall Study|Voluntary Withdrawal|5|||
129891397|NCT04529538|467559720|FG005|Overall Study|Other|0|||
129802383|NCT02337738|467245261|FG002|Overall Study|Voluntary Withdrawal|2|||
129802384|NCT02337738|467245259|FG000|Overall Study|Lack of Efficacy|2|||
129714315|NCT01467466|466915942|FG002|Overall Study|Procedure Cancelled|25|||
129714316|NCT01467466|466915943|FG003|Overall Study|Procedure Cancelled|29|||
129714317|NCT01467466|466915940|FG000|Overall Study|No Endpoint Blood Draw|38|||
129714318|NCT01467466|466915941|FG001|Overall Study|No Endpoint Blood Draw|32|||
129714319|NCT01467466|466915942|FG002|Overall Study|No Endpoint Blood Draw|51|||
129714320|NCT01467466|466915943|FG003|Overall Study|No Endpoint Blood Draw|43|||
129714321|NCT01144416|466915948|FG000|Intervention Period|Adverse Event|5|||
129714322|NCT01144416|466915949|FG001|Intervention Period|Adverse Event|6|||
129714323|NCT01144416|466915948|FG000|Intervention Period|Insufficient ovarian response|11|||
129714324|NCT01144416|466915949|FG001|Intervention Period|Insufficient ovarian response|17|||
129714325|NCT01144416|466915948|FG000|Intervention Period|Risk of OHSS|0|||
129714326|NCT01144416|466915949|FG001|Intervention Period|Risk of OHSS|1|||
129714327|NCT01144416|466915948|FG000|Intervention Period|Too high ovarian response|4|||
129714328|NCT01144416|466915949|FG001|Intervention Period|Too high ovarian response|2|||
129714329|NCT01144416|466915948|FG000|Intervention Period|No/too few/bad oocytes|7|||
129714330|NCT01144416|466915949|FG001|Intervention Period|No/too few/bad oocytes|5|||
129714331|NCT01144416|466915948|FG000|Intervention Period|No or abnormal fertilization|25|||
129714332|NCT01144416|466915949|FG001|Intervention Period|No or abnormal fertilization|10|||
129714333|NCT01144416|466915948|FG000|Intervention Period|No/too few/bad quality embryos|3|||
129714334|NCT01144416|466915949|FG001|Intervention Period|No/too few/bad quality embryos|3|||
129714335|NCT01144416|466915948|FG000|Intervention Period|Other|7|||
129714336|NCT01144416|466915949|FG001|Intervention Period|Other|5|||
129714337|NCT00124072|466915950|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
129714338|NCT00124072|466915951|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
129714339|NCT00124072|466915952|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
129714340|NCT00124072|466915953|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
129714341|NCT00124072|466915950|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
129714342|NCT00124072|466915951|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
129714343|NCT00124072|466915952|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
129714344|NCT00124072|466915953|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
129714345|NCT00124072|466915950|FG000|Overall Study|Death|499|||
129714346|NCT00124072|466915951|FG001|Overall Study|Death|484|||
129714347|NCT00124072|466915952|FG002|Overall Study|Death|471|||
129714348|NCT00124072|466915953|FG003|Overall Study|Death|480|||
129714349|NCT02534883|466915954|FG000|Overall Study|Early Termination|8|||
129714350|NCT02534883|466915955|FG001|Overall Study|Early Termination|3|||
129714351|NCT00886769|466915956|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129714352|NCT00886769|466915957|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
129714353|NCT03328832|466915958|FG000|Overall Study|Lost to Follow-up|0|||
129714354|NCT03328832|466915959|FG001|Overall Study|Lost to Follow-up|1|||
129714355|NCT00778336|466915960|FG000|Index Procedure-Discharge|Death|6|||
129714356|NCT00778336|466915961|FG001|Index Procedure-Discharge|Death|3|||
129714357|NCT00778336|466915962|FG002|Index Procedure-Discharge|Death|2|||
129714358|NCT00778336|466915963|FG003|Index Procedure-Discharge|Death|0|||
129714359|NCT00778336|466915960|FG000|3 Month Follow Up|Lost to Follow-up|15|||
129714360|NCT00778336|466915961|FG001|3 Month Follow Up|Lost to Follow-up|20|||
129714361|NCT00778336|466915962|FG002|3 Month Follow Up|Lost to Follow-up|3|||
129714362|NCT00778336|466915963|FG003|3 Month Follow Up|Lost to Follow-up|0|||
129802385|NCT02337738|467245260|FG001|Overall Study|Lack of Efficacy|4|||
129802386|NCT02337738|467245261|FG002|Overall Study|Lack of Efficacy|0|||
129714363|NCT00778336|466915960|FG000|3 Month Follow Up|Death|8|||
129714364|NCT00778336|466915961|FG001|3 Month Follow Up|Death|3|||
129714365|NCT00778336|466915962|FG002|3 Month Follow Up|Death|2|||
129714366|NCT00778336|466915963|FG003|3 Month Follow Up|Death|0|||
129714367|NCT00414076|466915966|FG000|Overall Study|Progression|1|||
129714368|NCT00414076|466915967|FG001|Overall Study|Progression|2|||
129714369|NCT00414076|466915966|FG000|Overall Study|Withdrawal by Subject|1|||
129714370|NCT00414076|466915967|FG001|Overall Study|Withdrawal by Subject|3|||
129802387|NCT02337738|467245259|FG000|Overall Study|Investigator's Judgment|1|||
129802388|NCT02337738|467245260|FG001|Overall Study|Investigator's Judgment|1|||
129802389|NCT02337738|467245261|FG002|Overall Study|Investigator's Judgment|3|||
129802390|NCT00406354|467245262|FG000|All Randomized Patients|Protocol Violation|0|||
129714371|NCT00414076|466915966|FG000|Overall Study|Adverse Event|1|||
129714372|NCT00414076|466915967|FG001|Overall Study|Adverse Event|0|||
129714373|NCT00049257|466915968|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
129714374|NCT00049257|466915968|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
129714375|NCT00049257|466915968|FG000|Carboplatin, Paclitaxel|Death|2|||
129714376|NCT00049257|466915968|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
129714377|NCT04721158|466915969|FG000|Overall Study|Lost to Follow-up|4|||
129714378|NCT04721158|466915969|FG000|Overall Study|Device did not connect|1|||
129714379|NCT03929913|466915970|FG000|Overall Study|Death|4|||
129714380|NCT03929913|466915970|FG000|Overall Study|Lost to Follow-up|1|||
129714381|NCT03929913|466915970|FG000|Overall Study|Failed Procedure|2|||
129802391|NCT00406354|467245263|FG001|All Randomized Patients|Protocol Violation|0|||
129802392|NCT00406354|467245264|FG002|All Randomized Patients|Protocol Violation|1|||
129714382|NCT02891226|466915971|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
129714383|NCT02891226|466915972|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
129714384|NCT02891226|466915973|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
129714385|NCT02891226|466915974|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714386|NCT02891226|466915975|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714387|NCT02891226|466915976|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714388|NCT02891226|466915977|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714389|NCT02891226|466915978|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714390|NCT02891226|466915979|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714391|NCT02891226|466915980|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714392|NCT02891226|466915981|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714393|NCT02891226|466915982|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714394|NCT02891226|466915983|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714395|NCT02891226|466915984|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714396|NCT02891226|466915985|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714397|NCT02891226|466915986|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
129714398|NCT02891226|466915971|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
129714399|NCT02891226|466915972|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
129714400|NCT02891226|466915973|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714401|NCT02891226|466915974|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714402|NCT02891226|466915975|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714403|NCT02891226|466915976|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714404|NCT02891226|466915977|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714405|NCT02891226|466915978|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714406|NCT02891226|466915979|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714407|NCT02891226|466915980|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714408|NCT02891226|466915981|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714409|NCT02891226|466915982|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714410|NCT02891226|466915983|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714411|NCT02891226|466915984|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714412|NCT02891226|466915985|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714413|NCT02891226|466915986|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
129714414|NCT02891226|466915971|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714415|NCT02891226|466915972|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714416|NCT02891226|466915973|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714417|NCT02891226|466915974|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
129714418|NCT02891226|466915975|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714419|NCT02891226|466915976|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714420|NCT02891226|466915977|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714421|NCT02891226|466915978|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714422|NCT02891226|466915979|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714423|NCT02891226|466915980|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714424|NCT02891226|466915981|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714425|NCT02891226|466915982|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714426|NCT02891226|466915983|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714427|NCT02891226|466915984|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714428|NCT02891226|466915985|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714429|NCT02891226|466915986|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
129714430|NCT02891226|466915971|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714431|NCT02891226|466915972|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714432|NCT02891226|466915973|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
129714433|NCT02891226|466915974|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714434|NCT02891226|466915975|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714435|NCT02891226|466915976|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714436|NCT02891226|466915977|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714437|NCT02891226|466915978|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714438|NCT02891226|466915979|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714439|NCT02891226|466915980|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714440|NCT02891226|466915981|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714441|NCT02891226|466915982|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714442|NCT02891226|466915983|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714443|NCT02891226|466915984|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714444|NCT02891226|466915985|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714445|NCT02891226|466915986|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
129714446|NCT02891226|466915971|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714447|NCT02891226|466915972|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714448|NCT02891226|466915973|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714449|NCT02891226|466915974|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
129714450|NCT02891226|466915975|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714451|NCT02891226|466915976|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714452|NCT02891226|466915977|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714453|NCT02891226|466915978|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129802393|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
129802394|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
129802395|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
129802396|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Adverse Event|6|||
129802397|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Adverse Event|2|||
129802398|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Adverse Event|1|||
129802399|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
129802400|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
129802401|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
129802402|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
129802403|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
129802404|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
129802405|NCT00406354|467245262|FG000|All Randomized and Treated Patients|Physician Decision|0|||
129802406|NCT00406354|467245263|FG001|All Randomized and Treated Patients|Physician Decision|0|||
129802407|NCT00406354|467245264|FG002|All Randomized and Treated Patients|Physician Decision|1|||
129802408|NCT01460368|467245265|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802409|NCT01460368|467245266|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802410|NCT01460368|467245267|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802411|NCT01460368|467245268|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802412|NCT01460368|467245269|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
129802413|NCT01460368|467245270|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802414|NCT01460368|467245271|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
129802415|NCT01460368|467245265|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802416|NCT01460368|467245266|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
129802417|NCT01460368|467245267|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802418|NCT01460368|467245268|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802419|NCT01460368|467245269|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802420|NCT01460368|467245270|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
129802421|NCT01460368|467245271|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
129802422|NCT01460368|467245265|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802423|NCT01460368|467245266|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
129802424|NCT01460368|467245267|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802425|NCT01460368|467245268|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802426|NCT01460368|467245269|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802427|NCT01460368|467245270|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802428|NCT01460368|467245271|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
129802429|NCT01460368|467245265|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802430|NCT01460368|467245266|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802431|NCT01460368|467245267|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
129802432|NCT01460368|467245268|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802433|NCT01460368|467245269|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802434|NCT01460368|467245270|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129802435|NCT01460368|467245271|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
129714454|NCT02891226|466915979|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714455|NCT02891226|466915980|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714456|NCT02891226|466915981|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714457|NCT02891226|466915982|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714458|NCT02891226|466915983|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714459|NCT02891226|466915984|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714460|NCT02891226|466915985|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714461|NCT02891226|466915986|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
129714462|NCT02891226|466915971|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714463|NCT02891226|466915972|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714464|NCT02891226|466915973|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714465|NCT02891226|466915974|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
129714466|NCT02891226|466915975|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714467|NCT02891226|466915976|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714468|NCT02891226|466915977|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714469|NCT02891226|466915978|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714470|NCT02891226|466915979|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714471|NCT02891226|466915980|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714472|NCT02891226|466915981|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714473|NCT02891226|466915982|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714474|NCT02891226|466915983|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714475|NCT02891226|466915984|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714476|NCT02891226|466915985|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714477|NCT02891226|466915986|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
129714478|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714479|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714480|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714481|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714482|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714483|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714484|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
129714485|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
129444272|NCT02464228|465927279|FG002|Overall Study|Disease Progression|5|||
129444273|NCT02464228|465927280|FG003|Overall Study|Disease Progression|2|||
129444274|NCT03308942|465927283|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
129444275|NCT03308942|465927284|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
129444276|NCT03308942|465927285|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
129714486|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
129714487|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
129714488|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714489|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714490|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714491|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714492|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714493|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
129714494|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714495|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714496|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714497|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714498|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714499|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
129714500|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714501|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714502|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714503|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
129714504|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714505|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714506|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714507|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714508|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714509|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
129714510|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714511|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714512|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714513|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714514|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714515|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714516|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
129714517|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
129714518|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
129444277|NCT03308942|465927286|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
129444278|NCT03308942|465927287|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
129444279|NCT03308942|465927283|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
129444280|NCT03308942|465927284|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
129444281|NCT03308942|465927285|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
129444282|NCT03308942|465927286|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
129444283|NCT03308942|465927287|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
129444284|NCT03308942|465927283|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
129444285|NCT03308942|465927284|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
129444286|NCT03308942|465927285|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
129444287|NCT03308942|465927286|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
129714519|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
129714520|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714521|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714522|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714523|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129444288|NCT03308942|465927287|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
129714524|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714525|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
129714526|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714527|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714528|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714529|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714530|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
129714531|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714532|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714533|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129802436|NCT01460368|467245265|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802437|NCT01460368|467245266|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802438|NCT01460368|467245267|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
129802439|NCT01460368|467245268|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
129802440|NCT01460368|467245269|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129802441|NCT01460368|467245270|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
129802442|NCT01460368|467245271|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
129714534|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714535|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714536|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714537|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129802443|NCT00747461|467245278|FG000|Overall Study|study terminated by sponsor|5|||
129802444|NCT00299182|467245294|FG000|Overall Study|Withdrawal by Subject|0|||
129802445|NCT00299182|467245295|FG001|Overall Study|Withdrawal by Subject|0|||
129802446|NCT00299182|467245296|FG002|Overall Study|Withdrawal by Subject|1|||
129802447|NCT00299182|467245297|FG003|Overall Study|Withdrawal by Subject|0|||
129802448|NCT00299182|467245298|FG004|Overall Study|Withdrawal by Subject|1|||
129802449|NCT00299182|467245299|FG005|Overall Study|Withdrawal by Subject|2|||
129802450|NCT00299182|467245300|FG006|Overall Study|Withdrawal by Subject|0|||
129802451|NCT00299182|467245294|FG000|Overall Study|Chemotherapy Changed|0|||
129802452|NCT00299182|467245295|FG001|Overall Study|Chemotherapy Changed|0|||
129802453|NCT00299182|467245296|FG002|Overall Study|Chemotherapy Changed|1|||
129802454|NCT00299182|467245297|FG003|Overall Study|Chemotherapy Changed|0|||
129802455|NCT00299182|467245298|FG004|Overall Study|Chemotherapy Changed|1|||
129802456|NCT00299182|467245299|FG005|Overall Study|Chemotherapy Changed|0|||
129802457|NCT00299182|467245300|FG006|Overall Study|Chemotherapy Changed|1|||
129714538|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714539|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714540|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714541|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
129714542|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714543|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714544|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714545|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714546|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714547|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714548|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
129714549|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714550|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714551|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714552|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714553|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714554|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714555|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129802458|NCT00299182|467245294|FG000|Overall Study|Adverse Event|0|||
129802459|NCT00299182|467245295|FG001|Overall Study|Adverse Event|0|||
129802460|NCT00299182|467245296|FG002|Overall Study|Adverse Event|0|||
129802461|NCT00299182|467245297|FG003|Overall Study|Adverse Event|0|||
129802462|NCT00299182|467245298|FG004|Overall Study|Adverse Event|0|||
129802463|NCT00299182|467245299|FG005|Overall Study|Adverse Event|1|||
129802464|NCT00299182|467245300|FG006|Overall Study|Adverse Event|0|||
129802465|NCT00299182|467245294|FG000|Overall Study|Not Eligible|0|||
129802466|NCT00299182|467245295|FG001|Overall Study|Not Eligible|0|||
129802467|NCT00299182|467245296|FG002|Overall Study|Not Eligible|0|||
129714556|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714557|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
129714558|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714559|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714560|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714561|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714562|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714563|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714564|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714565|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
129714566|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
129714567|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
129714568|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714569|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714570|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714571|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714572|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714573|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
129714574|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714575|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714576|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714577|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714578|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714579|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714580|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714581|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
129714582|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714583|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714584|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714585|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714586|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714587|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714588|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714589|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
129714590|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714591|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714592|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714593|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714594|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714595|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714596|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714597|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714598|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
129714599|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714600|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714601|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714602|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714603|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714604|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714605|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
129714606|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714607|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714608|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714609|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714610|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714611|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714612|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714613|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714614|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714615|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
129714616|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714617|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129802468|NCT00299182|467245297|FG003|Overall Study|Not Eligible|0|||
129714618|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714619|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714620|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714621|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
129714622|NCT02891226|466915971|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714623|NCT02891226|466915972|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714624|NCT02891226|466915973|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714625|NCT02891226|466915974|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714626|NCT02891226|466915975|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714627|NCT02891226|466915976|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714628|NCT02891226|466915977|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714629|NCT02891226|466915978|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714630|NCT02891226|466915979|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714631|NCT02891226|466915980|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
129714632|NCT02891226|466915981|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714633|NCT02891226|466915982|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714634|NCT02891226|466915983|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714635|NCT02891226|466915984|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714636|NCT02891226|466915985|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714637|NCT02891226|466915986|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
129714638|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714639|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714640|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714641|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714642|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714643|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714644|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714645|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714646|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714647|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714648|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
129714649|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714650|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714651|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714652|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714653|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
129714654|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714655|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714656|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714657|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714658|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714659|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714660|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714661|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714662|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714663|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714664|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
129802469|NCT00299182|467245298|FG004|Overall Study|Not Eligible|1|||
129802470|NCT00299182|467245299|FG005|Overall Study|Not Eligible|0|||
129802471|NCT00299182|467245300|FG006|Overall Study|Not Eligible|0|||
129802472|NCT01565642|467245305|FG000|Overall Study|Withdrawal by Subject|2|||
129802473|NCT01565642|467245306|FG001|Overall Study|Withdrawal by Subject|1|||
129802474|NCT01898208|467245309|FG000|Overall Study|Positive blood culture|17|||
129802475|NCT01898208|467245310|FG001|Overall Study|Positive blood culture|23|||
129802476|NCT01898208|467245311|FG002|Overall Study|Positive blood culture|15|||
129802477|NCT01898208|467245309|FG000|Overall Study|Death/comfort care within 24 hours|10|||
129802478|NCT01898208|467245310|FG001|Overall Study|Death/comfort care within 24 hours|9|||
129802479|NCT01898208|467245311|FG002|Overall Study|Death/comfort care within 24 hours|8|||
129802480|NCT01898208|467245309|FG000|Overall Study|Negative Gram Stain|6|||
129802481|NCT01898208|467245310|FG001|Overall Study|Negative Gram Stain|9|||
129891398|NCT04529538|467559721|FG006|Overall Study|Other|0|||
129714665|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714666|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129802482|NCT01898208|467245311|FG002|Overall Study|Negative Gram Stain|6|||
129802483|NCT01898208|467245309|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
129802484|NCT01898208|467245310|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
129802485|NCT01898208|467245311|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
129802486|NCT01898208|467245309|FG000|Overall Study|System/Technical Error|1|||
129802487|NCT01898208|467245310|FG001|Overall Study|System/Technical Error|2|||
129802488|NCT01898208|467245311|FG002|Overall Study|System/Technical Error|3|||
129891399|NCT04529538|467559722|FG007|Overall Study|Other|0|||
129444289|NCT03308942|465927283|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
129714667|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714668|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714669|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
129714670|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714671|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714672|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714673|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714674|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714675|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714676|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714677|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714678|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714679|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714680|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
129714681|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714682|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714683|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714684|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714685|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
129714686|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714687|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714688|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714689|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714690|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714691|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714692|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714693|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714694|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714695|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714696|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
129714697|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714698|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714699|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714700|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714701|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
129714702|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714703|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714704|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714705|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714706|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714707|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714708|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714709|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714710|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714711|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714712|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
129714713|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714714|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714715|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714716|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714717|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
129714718|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714719|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714720|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714721|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714722|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714723|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714724|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714725|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714726|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714727|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129444290|NCT03308942|465927284|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
129444291|NCT03308942|465927285|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
129714728|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
129714729|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714730|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714731|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714732|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714733|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
129714734|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714735|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714736|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714737|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714738|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714739|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714740|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714741|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714742|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714743|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714744|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
129714745|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714746|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714747|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714748|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714749|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
129714750|NCT02891226|466915971|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714751|NCT02891226|466915972|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714752|NCT02891226|466915973|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714753|NCT02891226|466915974|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714754|NCT02891226|466915975|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714755|NCT02891226|466915976|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714756|NCT02891226|466915977|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714757|NCT02891226|466915978|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714758|NCT02891226|466915979|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714759|NCT02891226|466915980|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714760|NCT02891226|466915981|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
129714761|NCT02891226|466915982|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714762|NCT02891226|466915983|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714763|NCT02891226|466915984|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714764|NCT02891226|466915985|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714765|NCT02891226|466915986|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
129714766|NCT02891226|466915971|FG000|Follow-up Period|Withdrawal by Subject|0|||
129714767|NCT02891226|466915972|FG001|Follow-up Period|Withdrawal by Subject|0|||
129714768|NCT02891226|466915973|FG002|Follow-up Period|Withdrawal by Subject|0|||
129714769|NCT02891226|466915974|FG003|Follow-up Period|Withdrawal by Subject|0|||
129714770|NCT02891226|466915975|FG004|Follow-up Period|Withdrawal by Subject|0|||
129714771|NCT02891226|466915976|FG005|Follow-up Period|Withdrawal by Subject|0|||
129714772|NCT02891226|466915977|FG006|Follow-up Period|Withdrawal by Subject|0|||
129714773|NCT02891226|466915978|FG007|Follow-up Period|Withdrawal by Subject|0|||
129714774|NCT02891226|466915979|FG008|Follow-up Period|Withdrawal by Subject|0|||
129714775|NCT02891226|466915980|FG009|Follow-up Period|Withdrawal by Subject|0|||
129714776|NCT02891226|466915981|FG010|Follow-up Period|Withdrawal by Subject|0|||
129714777|NCT02891226|466915982|FG011|Follow-up Period|Withdrawal by Subject|1|||
129714778|NCT02891226|466915983|FG012|Follow-up Period|Withdrawal by Subject|0|||
129714779|NCT02891226|466915984|FG013|Follow-up Period|Withdrawal by Subject|0|||
129714780|NCT02891226|466915985|FG014|Follow-up Period|Withdrawal by Subject|1|||
129714781|NCT02891226|466915986|FG015|Follow-up Period|Withdrawal by Subject|1|||
129714782|NCT00145626|466915987|FG000|Overall Study|Did not have NK infusions|2|||
129714783|NCT00145626|466915987|FG000|Overall Study|Turned 2 years old before treatment|1|||
129714784|NCT00145626|466915987|FG000|Overall Study|Death|1|||
129714785|NCT00145626|466915987|FG000|Overall Study|Withdrawal by Subject|1|||
129714786|NCT03381287|466915988|FG000|Overall Study|Withdrawal by Subject|0|||
129714787|NCT03381287|466915989|FG001|Overall Study|Withdrawal by Subject|1|||
129714788|NCT03381287|466915990|FG002|Overall Study|Withdrawal by Subject|0|||
129714789|NCT03381287|466915991|FG003|Overall Study|Withdrawal by Subject|0|||
129714790|NCT03381287|466915988|FG000|Overall Study|Adverse Event|0|||
129714791|NCT03381287|466915989|FG001|Overall Study|Adverse Event|0|||
129714792|NCT03381287|466915990|FG002|Overall Study|Adverse Event|0|||
129714793|NCT03381287|466915991|FG003|Overall Study|Adverse Event|1|||
129714794|NCT03381287|466915988|FG000|Overall Study|Physician Decision|0|||
129714795|NCT03381287|466915989|FG001|Overall Study|Physician Decision|0|||
129714796|NCT03381287|466915990|FG002|Overall Study|Physician Decision|0|||
129714797|NCT03381287|466915991|FG003|Overall Study|Physician Decision|1|||
129714798|NCT03654274|466915992|FG000|Overall Study|Adverse Event|19|||
129714799|NCT03654274|466915993|FG001|Overall Study|Adverse Event|23|||
129714800|NCT03654274|466915994|FG002|Overall Study|Adverse Event|24|||
129714801|NCT03654274|466915992|FG000|Overall Study|Protocol Deviation|0|||
129714802|NCT03654274|466915993|FG001|Overall Study|Protocol Deviation|2|||
129714803|NCT03654274|466915994|FG002|Overall Study|Protocol Deviation|0|||
129714804|NCT03654274|466915992|FG000|Overall Study|Lost to Follow-up|8|||
129714805|NCT03654274|466915993|FG001|Overall Study|Lost to Follow-up|6|||
129714806|NCT03654274|466915994|FG002|Overall Study|Lost to Follow-up|5|||
129714807|NCT03654274|466915992|FG000|Overall Study|Withdrawal by Subject|46|||
129714808|NCT03654274|466915993|FG001|Overall Study|Withdrawal by Subject|25|||
129714809|NCT03654274|466915994|FG002|Overall Study|Withdrawal by Subject|33|||
129714810|NCT03654274|466915992|FG000|Overall Study|Lack of Efficacy|4|||
129714811|NCT03654274|466915993|FG001|Overall Study|Lack of Efficacy|5|||
129714812|NCT03654274|466915994|FG002|Overall Study|Lack of Efficacy|7|||
129714813|NCT03654274|466915992|FG000|Overall Study|Pregnancy|2|||
129714814|NCT03654274|466915993|FG001|Overall Study|Pregnancy|2|||
129714815|NCT03654274|466915994|FG002|Overall Study|Pregnancy|1|||
129714816|NCT03654274|466915992|FG000|Overall Study|Other|27|||
129714817|NCT03654274|466915993|FG001|Overall Study|Other|29|||
129714818|NCT03654274|466915994|FG002|Overall Study|Other|32|||
129714819|NCT03654274|466915992|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
129714820|NCT03654274|466915993|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
129714821|NCT03654274|466915994|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
129714822|NCT01265992|466915995|FG000|Overall Study|Lost to Follow-up|1|||
129714823|NCT01265992|466915995|FG000|Overall Study|Withdrawal by Subject|1|||
129714824|NCT01265992|466915995|FG000|Overall Study|Adverse Event|1|||
129714825|NCT01265992|466915995|FG000|Overall Study|Administrative reasons|2|||
129714826|NCT01265992|466915995|FG000|Overall Study|Stopped treatment|3|||
129714827|NCT01265992|466915995|FG000|Overall Study|Did not receive treatment|1|||
129714828|NCT05005273|466915996|FG000|Overall Study|Study Terminated|1|||
129714829|NCT05005273|466915997|FG001|Overall Study|Study Terminated|0|||
129714830|NCT03154476|466916002|FG000|Overall Study|Lost to Follow-up|4|||
129714831|NCT03154476|466916003|FG001|Overall Study|Lost to Follow-up|4|||
129714832|NCT02685826|466916004|FG000|Overall Study|Adverse Event|2|||
129714833|NCT02685826|466916005|FG001|Overall Study|Adverse Event|0|||
129714834|NCT02685826|466916006|FG002|Overall Study|Adverse Event|1|||
129714835|NCT02685826|466916004|FG000|Overall Study|Progressive Disease|2|||
129714836|NCT02685826|466916005|FG001|Overall Study|Progressive Disease|1|||
129714837|NCT02685826|466916006|FG002|Overall Study|Progressive Disease|0|||
129714838|NCT02685826|466916004|FG000|Overall Study|Withdrawal by Subject|2|||
129714839|NCT02685826|466916005|FG001|Overall Study|Withdrawal by Subject|0|||
129714840|NCT02685826|466916006|FG002|Overall Study|Withdrawal by Subject|0|||
129714841|NCT02685826|466916004|FG000|Overall Study|Full Clinical Hold by FDA|19|||
129714842|NCT02685826|466916005|FG001|Overall Study|Full Clinical Hold by FDA|9|||
129714843|NCT02685826|466916006|FG002|Overall Study|Full Clinical Hold by FDA|20|||
129714844|NCT00200967|466916007|FG000|First Treatment Period|Withdrawal by Subject|5|||
129714845|NCT00200967|466916008|FG001|First Treatment Period|Withdrawal by Subject|1|||
129714846|NCT00200967|466916007|FG000|First Treatment Period|Pregnancy|1|||
129714847|NCT00200967|466916008|FG001|First Treatment Period|Pregnancy|0|||
129714848|NCT00200967|466916007|FG000|Wash-out Period|Lost to Follow-up|0|||
129714849|NCT00200967|466916008|FG001|Wash-out Period|Lost to Follow-up|1|||
129714850|NCT00200967|466916007|FG000|Second Treatment Period|Withdrawal by Subject|1|||
129714851|NCT00200967|466916008|FG001|Second Treatment Period|Withdrawal by Subject|2|||
129714852|NCT00200967|466916007|FG000|Run-out Period|Lost to Follow-up|1|||
129714853|NCT00200967|466916008|FG001|Run-out Period|Lost to Follow-up|0|||
129714854|NCT01444430|466916011|FG000|Overall Study|Withdrawal by Subject|53|||
129714855|NCT01444430|466916012|FG001|Overall Study|Withdrawal by Subject|72|||
129714856|NCT01444430|466916011|FG000|Overall Study|Death|6|||
129714857|NCT01444430|466916012|FG001|Overall Study|Death|8|||
129714858|NCT01444430|466916011|FG000|Overall Study|Lost to Follow-up|2|||
129714859|NCT01444430|466916012|FG001|Overall Study|Lost to Follow-up|0|||
129714860|NCT01444430|466916011|FG000|Overall Study|CRF termination module not completed.|0|||
129714861|NCT01444430|466916012|FG001|Overall Study|CRF termination module not completed.|1|||
129714862|NCT04245449|466917348|FG000|Overall Study|COVID shutdown|7|||
129714863|NCT02197572|466917353|FG000|Overall Study|Progressive Disease|28|||
129714864|NCT02197572|466917353|FG000|Overall Study|Withdrawal by Subject|9|||
129714865|NCT02197572|466917353|FG000|Overall Study|Adverse Event|3|||
129714866|NCT02197572|466917353|FG000|Overall Study|Reason Not Specified|4|||
129714867|NCT01147393|466917354|FG000|Dose Level 1|Dose limiting Toxicity|2|||
129714868|NCT01147393|466917354|FG000|Dose Level -1|Dose Limited Toxicity|1|||
129714869|NCT03801928|466917355|FG000|Overall Study|Adverse Event|1|||
129802489|NCT01898208|467245309|FG000|Overall Study|Lost to Follow-up|3|||
129802490|NCT01898208|467245310|FG001|Overall Study|Lost to Follow-up|1|||
129802491|NCT01898208|467245311|FG002|Overall Study|Lost to Follow-up|1|||
129802492|NCT03001882|467245314|FG000|Overall Study|Death|1|||
129802493|NCT03001882|467245315|FG001|Overall Study|Death|0|||
129802494|NCT03001882|467245316|FG002|Overall Study|Death|0|||
129802495|NCT03001882|467245317|FG003|Overall Study|Death|3|||
129802496|NCT03001882|467245314|FG000|Overall Study|Participant withdrew consent|0|||
129802497|NCT03001882|467245315|FG001|Overall Study|Participant withdrew consent|1|||
129802498|NCT03001882|467245316|FG002|Overall Study|Participant withdrew consent|0|||
129802499|NCT03001882|467245317|FG003|Overall Study|Participant withdrew consent|5|||
129802500|NCT03001882|467245314|FG000|Overall Study|Other reasons|1|||
129802501|NCT03001882|467245315|FG001|Overall Study|Other reasons|2|||
129802502|NCT03001882|467245316|FG002|Overall Study|Other reasons|0|||
129802503|NCT03001882|467245317|FG003|Overall Study|Other reasons|5|||
129802504|NCT03001882|467245314|FG000|Overall Study|Administrative reason by sponsor|0|||
129802505|NCT03001882|467245315|FG001|Overall Study|Administrative reason by sponsor|0|||
129802506|NCT03001882|467245316|FG002|Overall Study|Administrative reason by sponsor|0|||
129802507|NCT03001882|467245317|FG003|Overall Study|Administrative reason by sponsor|1|||
129802508|NCT03001882|467245314|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
129714870|NCT03801928|466917356|FG001|Overall Study|Adverse Event|0|||
129714871|NCT03801928|466917357|FG002|Overall Study|Adverse Event|1|||
129714872|NCT03801928|466917358|FG003|Overall Study|Adverse Event|2|||
129714873|NCT03801928|466917359|FG004|Overall Study|Adverse Event|0|||
129714874|NCT03801928|466917360|FG005|Overall Study|Adverse Event|2|||
129714875|NCT03801928|466917355|FG000|Overall Study|Lack of Efficacy|0|||
129714876|NCT03801928|466917356|FG001|Overall Study|Lack of Efficacy|0|||
129714877|NCT03801928|466917357|FG002|Overall Study|Lack of Efficacy|1|||
129714878|NCT03801928|466917358|FG003|Overall Study|Lack of Efficacy|0|||
129714879|NCT03801928|466917359|FG004|Overall Study|Lack of Efficacy|0|||
129714880|NCT03801928|466917360|FG005|Overall Study|Lack of Efficacy|0|||
129714881|NCT03801928|466917355|FG000|Overall Study|Lost to Follow-up|5|||
129714882|NCT03801928|466917356|FG001|Overall Study|Lost to Follow-up|1|||
129714883|NCT03801928|466917357|FG002|Overall Study|Lost to Follow-up|1|||
129714884|NCT03801928|466917358|FG003|Overall Study|Lost to Follow-up|4|||
129714885|NCT03801928|466917359|FG004|Overall Study|Lost to Follow-up|4|||
129714886|NCT03801928|466917360|FG005|Overall Study|Lost to Follow-up|2|||
129714887|NCT03801928|466917355|FG000|Overall Study|Withdrawal by Subject|0|||
129714888|NCT03801928|466917356|FG001|Overall Study|Withdrawal by Subject|0|||
129714889|NCT03801928|466917357|FG002|Overall Study|Withdrawal by Subject|2|||
129714890|NCT03801928|466917358|FG003|Overall Study|Withdrawal by Subject|1|||
129714891|NCT03801928|466917359|FG004|Overall Study|Withdrawal by Subject|0|||
129714892|NCT03801928|466917360|FG005|Overall Study|Withdrawal by Subject|0|||
129714893|NCT03801928|466917355|FG000|Overall Study|Other|0|||
129714894|NCT03801928|466917356|FG001|Overall Study|Other|2|||
129714895|NCT03801928|466917357|FG002|Overall Study|Other|0|||
129714896|NCT03801928|466917358|FG003|Overall Study|Other|1|||
129714897|NCT03801928|466917359|FG004|Overall Study|Other|0|||
129714898|NCT03801928|466917360|FG005|Overall Study|Other|1|||
129714899|NCT01014767|466917365|FG000|Overall Study|PI left institution, data unavailable|12|||
129714900|NCT01014767|466917366|FG001|Overall Study|PI left institution, data unavailable|1|||
129714901|NCT01014767|466917367|FG002|Overall Study|PI left institution, data unavailable|4|||
129714902|NCT01014767|466917368|FG003|Overall Study|PI left institution, data unavailable|1|||
129714903|NCT00564733|466917369|FG000|Overall Study|Withdrawal by Subject|4|||
129714904|NCT00564733|466917369|FG000|Overall Study|Ineligible|5|||
129714905|NCT01484496|466917370|FG000|Period 1|Protocol Violation|3|||
129714906|NCT01484496|466917371|FG001|Period 1|Protocol Violation|4|||
129714907|NCT01484496|466917372|FG002|Period 1|Protocol Violation|0|||
129714908|NCT01484496|466917373|FG003|Period 1|Protocol Violation|0|||
129714909|NCT01484496|466917370|FG000|Period 1|Physician Decision|5|||
129714910|NCT01484496|466917371|FG001|Period 1|Physician Decision|1|||
129714911|NCT01484496|466917372|FG002|Period 1|Physician Decision|0|||
129714912|NCT01484496|466917373|FG003|Period 1|Physician Decision|0|||
129714913|NCT01484496|466917370|FG000|Period 1|Lack of Efficacy|10|||
129714914|NCT01484496|466917371|FG001|Period 1|Lack of Efficacy|15|||
129714915|NCT01484496|466917372|FG002|Period 1|Lack of Efficacy|0|||
129802509|NCT03001882|467245315|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
129802510|NCT03001882|467245316|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
129714916|NCT01484496|466917373|FG003|Period 1|Lack of Efficacy|0|||
129714917|NCT01484496|466917370|FG000|Period 1|Adverse Event|25|||
129714918|NCT01484496|466917371|FG001|Period 1|Adverse Event|40|||
129714919|NCT01484496|466917372|FG002|Period 1|Adverse Event|0|||
129714920|NCT01484496|466917373|FG003|Period 1|Adverse Event|0|||
129802511|NCT03001882|467245317|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
129802512|NCT03001882|467245314|FG000|Overall Study|Not reported|0|||
129714921|NCT01484496|466917370|FG000|Period 1|Withdrawal by Subject|15|||
129714922|NCT01484496|466917371|FG001|Period 1|Withdrawal by Subject|12|||
129714923|NCT01484496|466917372|FG002|Period 1|Withdrawal by Subject|0|||
129714924|NCT01484496|466917373|FG003|Period 1|Withdrawal by Subject|0|||
129714925|NCT01484496|466917370|FG000|Period 1|Lost to Follow-up|2|||
129714926|NCT01484496|466917371|FG001|Period 1|Lost to Follow-up|6|||
129714927|NCT01484496|466917372|FG002|Period 1|Lost to Follow-up|0|||
129714928|NCT01484496|466917373|FG003|Period 1|Lost to Follow-up|0|||
129714929|NCT01484496|466917370|FG000|Period 1|Positive Pregnancy|1|||
129714930|NCT01484496|466917371|FG001|Period 1|Positive Pregnancy|6|||
129714931|NCT01484496|466917372|FG002|Period 1|Positive Pregnancy|0|||
129714932|NCT01484496|466917373|FG003|Period 1|Positive Pregnancy|0|||
129714933|NCT01484496|466917370|FG000|Period 1|Treatment Failure|3|||
129714934|NCT01484496|466917371|FG001|Period 1|Treatment Failure|6|||
129714935|NCT01484496|466917372|FG002|Period 1|Treatment Failure|0|||
129714936|NCT01484496|466917373|FG003|Period 1|Treatment Failure|0|||
129714937|NCT01484496|466917370|FG000|Period 1|Lack of Compliance|2|||
129714938|NCT01484496|466917371|FG001|Period 1|Lack of Compliance|1|||
129714939|NCT01484496|466917372|FG002|Period 1|Lack of Compliance|0|||
129714940|NCT01484496|466917373|FG003|Period 1|Lack of Compliance|0|||
129714941|NCT01484496|466917370|FG000|Period 1|Unable to Visit Site|0|||
129714942|NCT01484496|466917371|FG001|Period 1|Unable to Visit Site|2|||
129714943|NCT01484496|466917372|FG002|Period 1|Unable to Visit Site|0|||
129714944|NCT01484496|466917373|FG003|Period 1|Unable to Visit Site|0|||
129714945|NCT01484496|466917370|FG000|Period 2|Lack of Efficacy|0|||
129714946|NCT01484496|466917371|FG001|Period 2|Lack of Efficacy|0|||
129714947|NCT01484496|466917372|FG002|Period 2|Lack of Efficacy|1|||
129714948|NCT01484496|466917373|FG003|Period 2|Lack of Efficacy|3|||
129714949|NCT01484496|466917370|FG000|Period 2|Adverse Event|0|||
129714950|NCT01484496|466917371|FG001|Period 2|Adverse Event|0|||
129714951|NCT01484496|466917372|FG002|Period 2|Adverse Event|5|||
129714952|NCT01484496|466917373|FG003|Period 2|Adverse Event|13|||
129714953|NCT01484496|466917370|FG000|Period 2|Other|0|||
129714954|NCT01484496|466917371|FG001|Period 2|Other|0|||
129714955|NCT01484496|466917372|FG002|Period 2|Other|9|||
129714956|NCT01484496|466917373|FG003|Period 2|Other|6|||
129714957|NCT01645735|466917374|FG000|Overall Study|Physician Decision|2|||
129714958|NCT01645735|466917375|FG001|Overall Study|Physician Decision|0|||
129714959|NCT01645735|466917374|FG000|Overall Study|Withdrawal by Subject|1|||
129714960|NCT01645735|466917375|FG001|Overall Study|Withdrawal by Subject|0|||
129714961|NCT01645735|466917374|FG000|Overall Study|Protocol Violation|1|||
129714962|NCT01645735|466917375|FG001|Overall Study|Protocol Violation|0|||
129714963|NCT01645735|466917374|FG000|Overall Study|Adverse Event|0|||
129714964|NCT01645735|466917375|FG001|Overall Study|Adverse Event|1|||
129714965|NCT00573391|466917378|FG000|Overall Study|study stopped|2|||
129714966|NCT00573391|466917379|FG001|Overall Study|study stopped|2|||
129714967|NCT00573391|466917378|FG000|Overall Study|Death|1|||
129714968|NCT00573391|466917379|FG001|Overall Study|Death|0|||
129714969|NCT03369665|466917380|FG000|Overall Study|Adverse Event|3|||
129714970|NCT03369665|466917380|FG000|Overall Study|Lost to Follow-up|7|||
129714971|NCT03369665|466917380|FG000|Overall Study|Withdrawal by Subject|15|||
129714972|NCT03369665|466917380|FG000|Overall Study|Progression Disease|2|||
129714973|NCT03369665|466917380|FG000|Overall Study|Not classified|3|||
129714974|NCT02553928|466917381|FG000|Overall Study|Adverse Event|2|||
129714975|NCT02553928|466917382|FG001|Overall Study|Adverse Event|1|||
129714976|NCT02553928|466917381|FG000|Overall Study|Lost to Follow-up|0|||
129714977|NCT02553928|466917382|FG001|Overall Study|Lost to Follow-up|1|||
129714978|NCT02553928|466917381|FG000|Overall Study|Administrative reason(s)|0|||
129714979|NCT02553928|466917382|FG001|Overall Study|Administrative reason(s)|1|||
129714980|NCT01206140|466917388|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
129714981|NCT01206140|466917389|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
129714982|NCT02688192|466917390|FG000|Overall Study|Lost to Follow-up|11|||
129714983|NCT02688192|466917391|FG001|Overall Study|Lost to Follow-up|5|||
129714984|NCT02688192|466917390|FG000|Overall Study|Physician Decision|1|||
129714985|NCT02688192|466917391|FG001|Overall Study|Physician Decision|0|||
129714986|NCT00075764|466917392|FG000|Overall Study|Adverse Event|5|||
129714987|NCT00075764|466917393|FG001|Overall Study|Adverse Event|12|||
129714988|NCT00075764|466917392|FG000|Overall Study|Death|4|||
129714989|NCT00075764|466917393|FG001|Overall Study|Death|8|||
129714990|NCT00075764|466917392|FG000|Overall Study|Withdrawal by Subject|28|||
129714991|NCT00075764|466917393|FG001|Overall Study|Withdrawal by Subject|18|||
129714992|NCT00075764|466917392|FG000|Overall Study|Progression|269|||
129802513|NCT03001882|467245315|FG001|Overall Study|Not reported|0|||
129802514|NCT03001882|467245316|FG002|Overall Study|Not reported|0|||
129714993|NCT00075764|466917393|FG001|Overall Study|Progression|274|||
129714994|NCT00075764|466917392|FG000|Overall Study|Still on treatment|8|||
129714995|NCT00075764|466917393|FG001|Overall Study|Still on treatment|15|||
129714996|NCT00075764|466917392|FG000|Overall Study|Delinquent|4|||
129714997|NCT00075764|466917393|FG001|Overall Study|Delinquent|2|||
129714998|NCT00075764|466917392|FG000|Overall Study|Not protocol specified|27|||
129714999|NCT00075764|466917393|FG001|Overall Study|Not protocol specified|19|||
129715000|NCT00075764|466917392|FG000|Overall Study|Under review|0|||
129715001|NCT00075764|466917393|FG001|Overall Study|Under review|1|||
129715002|NCT02817594|466917394|FG000|Overall Study|Withdrawal by Subject|1|||
129715003|NCT02817594|466917394|FG000|Overall Study|Other|1|||
129715004|NCT02817594|466917394|FG000|Overall Study|Did Not Receive Treatment|1|||
129715005|NCT02010593|466917395|FG000|Overall Study|Lost to Follow-up|1|||
129715006|NCT02010593|466917396|FG001|Overall Study|Lost to Follow-up|0|||
129715007|NCT02010593|466917395|FG000|Overall Study|Physician Decision|1|||
129715008|NCT02010593|466917396|FG001|Overall Study|Physician Decision|0|||
129715009|NCT02010593|466917395|FG000|Overall Study|Unable to adhere to visit schedule|0|||
129715010|NCT02010593|466917396|FG001|Overall Study|Unable to adhere to visit schedule|2|||
129715011|NCT01773967|466917397|FG000|Overall Study|Lost to Follow-up|15|||
129715012|NCT01773967|466917398|FG001|Overall Study|Lost to Follow-up|13|||
129715013|NCT01135459|466917399|FG000|Overall Study|Adverse Event|8|||
129715014|NCT01135459|466917400|FG001|Overall Study|Adverse Event|10|||
129715015|NCT01135459|466917399|FG000|Overall Study|Lack of Efficacy|3|||
129715016|NCT01135459|466917400|FG001|Overall Study|Lack of Efficacy|1|||
129715017|NCT01135459|466917399|FG000|Overall Study|Withdrawal by Subject|2|||
129715018|NCT01135459|466917400|FG001|Overall Study|Withdrawal by Subject|3|||
129802515|NCT03001882|467245317|FG003|Overall Study|Not reported|6|||
129802516|NCT03001882|467245314|FG000|Overall Study|Maximum clinical benefit|2|||
129802517|NCT03001882|467245315|FG001|Overall Study|Maximum clinical benefit|3|||
129802518|NCT03001882|467245316|FG002|Overall Study|Maximum clinical benefit|0|||
129802519|NCT03001882|467245317|FG003|Overall Study|Maximum clinical benefit|10|||
129802520|NCT03001882|467245314|FG000|Overall Study|AE unrelated to study drug|3|||
129802521|NCT03001882|467245315|FG001|Overall Study|AE unrelated to study drug|3|||
129802522|NCT03001882|467245316|FG002|Overall Study|AE unrelated to study drug|0|||
129802523|NCT03001882|467245317|FG003|Overall Study|AE unrelated to study drug|11|||
129802524|NCT03001882|467245314|FG000|Overall Study|Study Drug Toxicity|8|||
129802525|NCT03001882|467245315|FG001|Overall Study|Study Drug Toxicity|5|||
129802526|NCT03001882|467245316|FG002|Overall Study|Study Drug Toxicity|0|||
129802527|NCT03001882|467245317|FG003|Overall Study|Study Drug Toxicity|37|||
129802528|NCT03001882|467245314|FG000|Overall Study|Disease progression|16|||
129802529|NCT03001882|467245315|FG001|Overall Study|Disease progression|14|||
129802530|NCT03001882|467245316|FG002|Overall Study|Disease progression|1|||
129802531|NCT03001882|467245317|FG003|Overall Study|Disease progression|90|||
129802532|NCT01067976|467245318|FG000|Overall Study|Study drug never administered|20|||
129802533|NCT01067976|467245318|FG000|Overall Study|Study prematurely discontinued|2|||
129802534|NCT00589290|467245319|FG000|Overall Study|Withdrawal by Subject|1|||
129802535|NCT00566111|467245320|FG000|Overall Study|Adverse Event|0|||
129802536|NCT00566111|467245321|FG001|Overall Study|Adverse Event|2|||
129802537|NCT01554397|467245324|FG000|Overall Study|Withdrawal by Subject|1|||
129802538|NCT01554397|467245325|FG001|Overall Study|Withdrawal by Subject|0|||
129802539|NCT01554397|467245324|FG000|Overall Study|Ineligible|7|||
129715019|NCT01135459|466917399|FG000|Overall Study|Protocol Violation|5|||
129715020|NCT01135459|466917400|FG001|Overall Study|Protocol Violation|3|||
129715021|NCT01135459|466917399|FG000|Overall Study|Lost to Follow-up|2|||
129715022|NCT01135459|466917400|FG001|Overall Study|Lost to Follow-up|1|||
129715023|NCT01135459|466917399|FG000|Overall Study|Non-compliance to study procedures|0|||
129715024|NCT01135459|466917400|FG001|Overall Study|Non-compliance to study procedures|1|||
129715025|NCT01135459|466917399|FG000|Overall Study|Other than specified|1|||
129715026|NCT01135459|466917400|FG001|Overall Study|Other than specified|1|||
129715027|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
129715028|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
129715029|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715030|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715031|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715032|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715033|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715034|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715035|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715036|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
129715037|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
129715038|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
129715039|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129715040|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129802540|NCT01554397|467245325|FG001|Overall Study|Ineligible|0|||
129802541|NCT03633617|467247399|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
129802542|NCT03633617|467247400|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
129444292|NCT03308942|465927286|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
129715041|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129715042|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129715043|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129715044|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129802543|NCT03633617|467247401|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802544|NCT03633617|467247402|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802545|NCT03633617|467247403|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802546|NCT03633617|467247404|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802547|NCT03633617|467247405|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802548|NCT03633617|467247406|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802549|NCT03633617|467247407|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802550|NCT03633617|467247408|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802551|NCT03633617|467247409|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
129802552|NCT03633617|467247399|FG000|Part A|Unconfirmed early termination visit|1|||
129802553|NCT03633617|467247400|FG001|Part A|Unconfirmed early termination visit|0|||
129802554|NCT03633617|467247401|FG002|Part A|Unconfirmed early termination visit|0|||
129802555|NCT03633617|467247402|FG003|Part A|Unconfirmed early termination visit|0|||
129802556|NCT03633617|467247403|FG004|Part A|Unconfirmed early termination visit|0|||
129715045|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129715046|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
129715047|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
129715048|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715049|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715050|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715051|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715052|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715053|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715054|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715055|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715056|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
129715057|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
129715058|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
129715059|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715060|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715061|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715062|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715063|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715064|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715065|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715066|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
129715067|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715068|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
129715069|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715070|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715071|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715072|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715073|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715074|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715075|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715076|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
129715077|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
129715078|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
129715079|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715080|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715081|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715082|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715083|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715084|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715085|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715086|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
129715087|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
129715088|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
129715089|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129444293|NCT03308942|465927287|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
129715090|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129802557|NCT03633617|467247404|FG005|Part A|Unconfirmed early termination visit|0|||
129715091|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129715092|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129715093|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129715094|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129802558|NCT03633617|467247405|FG006|Part A|Unconfirmed early termination visit|0|||
129802559|NCT03633617|467247406|FG007|Part A|Unconfirmed early termination visit|0|||
129802560|NCT03633617|467247407|FG008|Part A|Unconfirmed early termination visit|0|||
129802561|NCT03633617|467247408|FG009|Part A|Unconfirmed early termination visit|0|||
129802562|NCT03633617|467247409|FG010|Part A|Unconfirmed early termination visit|0|||
129802563|NCT03633617|467247399|FG000|Part A|Adverse Event|0|||
129802564|NCT03633617|467247400|FG001|Part A|Adverse Event|1|||
129802565|NCT03633617|467247401|FG002|Part A|Adverse Event|0|||
129802566|NCT03633617|467247402|FG003|Part A|Adverse Event|0|||
129802567|NCT03633617|467247403|FG004|Part A|Adverse Event|0|||
129802568|NCT03633617|467247404|FG005|Part A|Adverse Event|0|||
129802569|NCT03633617|467247405|FG006|Part A|Adverse Event|0|||
129802570|NCT03633617|467247406|FG007|Part A|Adverse Event|0|||
129802571|NCT03633617|467247407|FG008|Part A|Adverse Event|0|||
129802572|NCT03633617|467247408|FG009|Part A|Adverse Event|0|||
129802573|NCT03633617|467247409|FG010|Part A|Adverse Event|0|||
129802574|NCT03633617|467247399|FG000|Part A|Pregnancy|1|||
129802575|NCT03633617|467247400|FG001|Part A|Pregnancy|0|||
129802576|NCT03633617|467247401|FG002|Part A|Pregnancy|0|||
129802577|NCT03633617|467247402|FG003|Part A|Pregnancy|0|||
129802578|NCT03633617|467247403|FG004|Part A|Pregnancy|0|||
129802579|NCT03633617|467247404|FG005|Part A|Pregnancy|0|||
129802580|NCT03633617|467247405|FG006|Part A|Pregnancy|0|||
129802581|NCT03633617|467247406|FG007|Part A|Pregnancy|0|||
129802582|NCT03633617|467247407|FG008|Part A|Pregnancy|0|||
129802583|NCT03633617|467247408|FG009|Part A|Pregnancy|0|||
129802584|NCT03633617|467247409|FG010|Part A|Pregnancy|0|||
129802585|NCT03633617|467247399|FG000|Part A|Withdrawal by Subject|0|||
129802586|NCT03633617|467247400|FG001|Part A|Withdrawal by Subject|1|||
129802587|NCT03633617|467247401|FG002|Part A|Withdrawal by Subject|0|||
129802588|NCT03633617|467247402|FG003|Part A|Withdrawal by Subject|0|||
129802589|NCT03633617|467247403|FG004|Part A|Withdrawal by Subject|0|||
129802590|NCT03633617|467247404|FG005|Part A|Withdrawal by Subject|0|||
129802591|NCT03633617|467247405|FG006|Part A|Withdrawal by Subject|0|||
129715095|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129715096|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
129715097|NCT01194219|466917401|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
129715098|NCT01194219|466917402|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
129715099|NCT01194219|466917403|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715100|NCT01194219|466917404|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715101|NCT01194219|466917405|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715102|NCT01194219|466917406|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715103|NCT01194219|466917407|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715104|NCT01194219|466917408|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715105|NCT01194219|466917409|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715106|NCT01194219|466917410|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
129715107|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715108|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715109|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
129715110|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
129715111|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715112|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
129802592|NCT03633617|467247406|FG007|Part A|Withdrawal by Subject|0|||
129802593|NCT03633617|467247407|FG008|Part A|Withdrawal by Subject|0|||
129802594|NCT03633617|467247408|FG009|Part A|Withdrawal by Subject|0|||
129802595|NCT03633617|467247409|FG010|Part A|Withdrawal by Subject|0|||
129802596|NCT03633617|467247399|FG000|Part B|Adverse Event|0|||
129802597|NCT03633617|467247400|FG001|Part B|Adverse Event|0|||
129802598|NCT03633617|467247401|FG002|Part B|Adverse Event|2|||
129802599|NCT03633617|467247402|FG003|Part B|Adverse Event|2|||
129802600|NCT03633617|467247403|FG004|Part B|Adverse Event|1|||
129802601|NCT03633617|467247404|FG005|Part B|Adverse Event|0|||
129802602|NCT03633617|467247405|FG006|Part B|Adverse Event|0|||
129802603|NCT03633617|467247406|FG007|Part B|Adverse Event|0|||
129802604|NCT03633617|467247407|FG008|Part B|Adverse Event|0|||
129802605|NCT03633617|467247408|FG009|Part B|Adverse Event|0|||
129802606|NCT03633617|467247409|FG010|Part B|Adverse Event|0|||
129802607|NCT03633617|467247399|FG000|Part B|Withdrawal by Subject|0|||
129802608|NCT03633617|467247400|FG001|Part B|Withdrawal by Subject|0|||
129802609|NCT03633617|467247401|FG002|Part B|Withdrawal by Subject|1|||
129802610|NCT03633617|467247402|FG003|Part B|Withdrawal by Subject|0|||
129802611|NCT03633617|467247403|FG004|Part B|Withdrawal by Subject|2|||
129802612|NCT03633617|467247404|FG005|Part B|Withdrawal by Subject|0|||
129802613|NCT03633617|467247405|FG006|Part B|Withdrawal by Subject|0|||
129802614|NCT03633617|467247406|FG007|Part B|Withdrawal by Subject|0|||
129715113|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715114|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715115|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715116|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
129715117|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715118|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715119|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
129715120|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
129715121|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715122|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715123|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715124|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715125|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715126|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
129715127|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715128|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715129|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
129715130|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
129715131|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715132|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715133|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715134|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715135|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715136|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
129715137|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715138|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715139|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
129715140|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
129715141|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715142|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715143|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715144|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715145|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715146|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
129715147|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715148|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715149|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
129715150|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715151|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715152|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715153|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715154|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715155|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715156|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
129715157|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715158|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715159|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715160|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
129715161|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715162|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715163|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715164|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715165|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715166|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
129715167|NCT01194219|466917401|FG000|Maintenance Phase Weeks16-32|Other|0|||
129715168|NCT01194219|466917402|FG001|Maintenance Phase Weeks16-32|Other|0|||
129715169|NCT01194219|466917403|FG002|Maintenance Phase Weeks16-32|Other|2|||
129715170|NCT01194219|466917404|FG003|Maintenance Phase Weeks16-32|Other|1|||
129715171|NCT01194219|466917405|FG004|Maintenance Phase Weeks16-32|Other|0|||
129715172|NCT01194219|466917406|FG005|Maintenance Phase Weeks16-32|Other|0|||
129715173|NCT01194219|466917407|FG006|Maintenance Phase Weeks16-32|Other|0|||
129715174|NCT01194219|466917408|FG007|Maintenance Phase Weeks16-32|Other|0|||
129715175|NCT01194219|466917409|FG008|Maintenance Phase Weeks16-32|Other|0|||
129715176|NCT01194219|466917410|FG009|Maintenance Phase Weeks16-32|Other|0|||
129715177|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129715178|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129802615|NCT03633617|467247407|FG008|Part B|Withdrawal by Subject|0|||
129802616|NCT03633617|467247408|FG009|Part B|Withdrawal by Subject|0|||
129802617|NCT03633617|467247409|FG010|Part B|Withdrawal by Subject|0|||
129802618|NCT03633617|467247399|FG000|Part B|Lost to Follow-up|0|||
129802619|NCT03633617|467247400|FG001|Part B|Lost to Follow-up|0|||
129802620|NCT03633617|467247401|FG002|Part B|Lost to Follow-up|0|||
129802621|NCT03633617|467247402|FG003|Part B|Lost to Follow-up|0|||
129802622|NCT03633617|467247403|FG004|Part B|Lost to Follow-up|1|||
129802623|NCT03633617|467247404|FG005|Part B|Lost to Follow-up|0|||
129802624|NCT03633617|467247405|FG006|Part B|Lost to Follow-up|0|||
129802625|NCT03633617|467247406|FG007|Part B|Lost to Follow-up|0|||
129802626|NCT03633617|467247407|FG008|Part B|Lost to Follow-up|0|||
129802627|NCT03633617|467247408|FG009|Part B|Lost to Follow-up|0|||
129802628|NCT03633617|467247409|FG010|Part B|Lost to Follow-up|0|||
129802629|NCT03633617|467247399|FG000|Part B|Physician Decision|0|||
129802630|NCT03633617|467247400|FG001|Part B|Physician Decision|0|||
129802631|NCT03633617|467247401|FG002|Part B|Physician Decision|0|||
129802632|NCT03633617|467247402|FG003|Part B|Physician Decision|0|||
129802633|NCT03633617|467247403|FG004|Part B|Physician Decision|1|||
129802634|NCT03633617|467247404|FG005|Part B|Physician Decision|0|||
129802635|NCT03633617|467247405|FG006|Part B|Physician Decision|0|||
129802636|NCT03633617|467247406|FG007|Part B|Physician Decision|0|||
129802637|NCT03633617|467247407|FG008|Part B|Physician Decision|0|||
129802638|NCT03633617|467247408|FG009|Part B|Physician Decision|0|||
129802639|NCT03633617|467247409|FG010|Part B|Physician Decision|0|||
129802640|NCT03633617|467247399|FG000|Part B|COVID-19 Restrictions|0|||
129802641|NCT03633617|467247400|FG001|Part B|COVID-19 Restrictions|0|||
129802642|NCT03633617|467247401|FG002|Part B|COVID-19 Restrictions|1|||
129802643|NCT03633617|467247402|FG003|Part B|COVID-19 Restrictions|0|||
129802644|NCT03633617|467247403|FG004|Part B|COVID-19 Restrictions|0|||
129802645|NCT03633617|467247404|FG005|Part B|COVID-19 Restrictions|0|||
129802646|NCT03633617|467247405|FG006|Part B|COVID-19 Restrictions|0|||
129715179|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129715180|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129715181|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129715182|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
129715183|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
129715184|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
129715185|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129715186|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
129715187|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129715188|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129715189|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129715190|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129715191|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
129715192|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
129715193|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
129715194|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
129715195|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129715196|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
129802647|NCT03633617|467247406|FG007|Part B|COVID-19 Restrictions|0|||
129802648|NCT03633617|467247407|FG008|Part B|COVID-19 Restrictions|0|||
129802649|NCT03633617|467247408|FG009|Part B|COVID-19 Restrictions|0|||
129802650|NCT03633617|467247409|FG010|Part B|COVID-19 Restrictions|0|||
129802651|NCT03633617|467247399|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802652|NCT03633617|467247400|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802653|NCT03633617|467247401|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
129802654|NCT03633617|467247402|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802655|NCT03633617|467247403|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802656|NCT03633617|467247404|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802657|NCT03633617|467247405|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802658|NCT03633617|467247406|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802659|NCT03633617|467247407|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802660|NCT03633617|467247408|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129715197|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129802661|NCT03633617|467247409|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
129802662|NCT03633617|467247399|FG000|Part C (& Follow-up)|Adverse Event|0|||
129802663|NCT03633617|467247400|FG001|Part C (& Follow-up)|Adverse Event|0|||
129802664|NCT03633617|467247401|FG002|Part C (& Follow-up)|Adverse Event|0|||
129802665|NCT03633617|467247402|FG003|Part C (& Follow-up)|Adverse Event|0|||
129891400|NCT04529538|467559715|FG000|Overall Study|Adverse Event|0|||
129891401|NCT04529538|467559716|FG001|Overall Study|Adverse Event|0|||
129891402|NCT04529538|467559717|FG002|Overall Study|Adverse Event|0|||
129891403|NCT04529538|467559718|FG003|Overall Study|Adverse Event|1|||
129891404|NCT04529538|467559719|FG004|Overall Study|Adverse Event|0|||
129891405|NCT04529538|467559720|FG005|Overall Study|Adverse Event|0|||
129715198|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715199|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715200|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715201|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
129715202|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715203|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
129715204|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715205|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715206|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
129715207|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715208|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715209|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715210|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715211|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
129715212|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715213|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
129715214|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
129715215|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715216|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
129715217|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715218|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715219|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715220|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715221|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
129715222|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
129715223|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
129715224|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715225|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715226|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
129715227|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715228|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715229|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715230|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715231|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715232|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715233|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715234|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
129715235|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715236|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
129715237|NCT01194219|466917401|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715238|NCT01194219|466917402|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715239|NCT01194219|466917403|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715240|NCT01194219|466917404|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715241|NCT01194219|466917405|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715242|NCT01194219|466917406|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715243|NCT01194219|466917407|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
129715244|NCT01194219|466917408|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715245|NCT01194219|466917409|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715246|NCT01194219|466917410|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
129715247|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715248|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715249|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715250|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129891406|NCT04529538|467559721|FG006|Overall Study|Adverse Event|0|||
129891407|NCT04529538|467559722|FG007|Overall Study|Adverse Event|0|||
129715251|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715252|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715253|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715254|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
129715255|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
129715256|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
129715257|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715258|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715259|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715260|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715261|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715262|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715263|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715264|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
129715265|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
129715266|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
129715267|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715268|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715269|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715270|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715271|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715272|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715273|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715274|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
129715275|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
129715276|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
129715277|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715278|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715279|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715280|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715281|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715282|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715283|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715284|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
129715285|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
129715286|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
129715287|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
129715288|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
129715289|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
129715290|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
129715291|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
129715292|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
129715293|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
129715294|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
129715295|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
129715296|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
129715297|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715298|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715299|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715300|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715301|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715302|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715303|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129715304|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
129802666|NCT03633617|467247403|FG004|Part C (& Follow-up)|Adverse Event|0|||
129802667|NCT03633617|467247404|FG005|Part C (& Follow-up)|Adverse Event|1|||
129802668|NCT03633617|467247405|FG006|Part C (& Follow-up)|Adverse Event|0|||
129802669|NCT03633617|467247406|FG007|Part C (& Follow-up)|Adverse Event|1|||
129802670|NCT03633617|467247407|FG008|Part C (& Follow-up)|Adverse Event|0|||
129715305|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
129715306|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
129715307|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715308|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715309|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715310|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715311|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715312|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129802671|NCT03633617|467247408|FG009|Part C (& Follow-up)|Adverse Event|0|||
129802672|NCT03633617|467247409|FG010|Part C (& Follow-up)|Adverse Event|0|||
129802673|NCT03633617|467247399|FG000|Part C (& Follow-up)|Pregnancy|0|||
129802674|NCT03633617|467247400|FG001|Part C (& Follow-up)|Pregnancy|0|||
129802675|NCT03633617|467247401|FG002|Part C (& Follow-up)|Pregnancy|0|||
129802676|NCT03633617|467247402|FG003|Part C (& Follow-up)|Pregnancy|0|||
129802677|NCT03633617|467247403|FG004|Part C (& Follow-up)|Pregnancy|0|||
129802678|NCT03633617|467247404|FG005|Part C (& Follow-up)|Pregnancy|0|||
129802679|NCT03633617|467247405|FG006|Part C (& Follow-up)|Pregnancy|0|||
129802680|NCT03633617|467247406|FG007|Part C (& Follow-up)|Pregnancy|0|||
129802681|NCT03633617|467247407|FG008|Part C (& Follow-up)|Pregnancy|0|||
129802682|NCT03633617|467247408|FG009|Part C (& Follow-up)|Pregnancy|1|||
129802683|NCT03633617|467247409|FG010|Part C (& Follow-up)|Pregnancy|0|||
129802684|NCT03633617|467247399|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802685|NCT03633617|467247400|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802686|NCT03633617|467247401|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802687|NCT03633617|467247402|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802688|NCT03633617|467247403|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802689|NCT03633617|467247404|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
129802690|NCT03633617|467247405|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
129802691|NCT03633617|467247406|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
129802692|NCT03633617|467247407|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
129802693|NCT03633617|467247408|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
129802694|NCT03633617|467247409|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
129802695|NCT03633617|467247399|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
129802696|NCT03633617|467247400|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
129802697|NCT03633617|467247401|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
129891408|NCT04529538|467559715|FG000|Overall Study|Protocol Deviation|0|||
129715313|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715314|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129444294|NCT03308942|465927283|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
129444295|NCT03308942|465927284|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
129715315|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
129715316|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
129715317|NCT01194219|466917401|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715318|NCT01194219|466917402|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715319|NCT01194219|466917403|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715320|NCT01194219|466917404|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715321|NCT01194219|466917405|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715322|NCT01194219|466917406|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715323|NCT01194219|466917407|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715324|NCT01194219|466917408|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
129715325|NCT01194219|466917409|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
129715326|NCT01194219|466917410|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
129715327|NCT00292045|466917411|FG000|Core Study (Through Week 13)|Adverse Event|1|||
129715328|NCT00292045|466917411|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
129715329|NCT04474197|466917412|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
129715330|NCT04474197|466917413|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
129715331|NCT04474197|466917414|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
129715332|NCT04474197|466917415|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
129715333|NCT01871545|466917416|FG000|Overall Study|Death|2|||
129715334|NCT01871545|466917417|FG001|Overall Study|Death|0|||
129715335|NCT01871545|466917416|FG000|Overall Study|Lack of Efficacy|11|||
129715336|NCT01871545|466917417|FG001|Overall Study|Lack of Efficacy|2|||
129715337|NCT01871545|466917416|FG000|Overall Study|Physician Decision|4|||
129715338|NCT01871545|466917417|FG001|Overall Study|Physician Decision|0|||
129715339|NCT01871545|466917416|FG000|Overall Study|Withdrawal by Subject|0|||
129715340|NCT01871545|466917417|FG001|Overall Study|Withdrawal by Subject|1|||
129715341|NCT04834726|466917420|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
129802698|NCT03633617|467247402|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
129802699|NCT03633617|467247403|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
129802700|NCT03633617|467247404|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
129802701|NCT03633617|467247405|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
129891409|NCT04529538|467559716|FG001|Overall Study|Protocol Deviation|0|||
129802702|NCT03633617|467247406|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
129715342|NCT04834726|466917421|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
129715343|NCT04834726|466917422|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
129715344|NCT04834726|466917423|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
129715345|NCT04834726|466917424|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
129715346|NCT04834726|466917425|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
129715347|NCT04834726|466917426|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
129802703|NCT03633617|467247407|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
129802704|NCT03633617|467247408|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
129802705|NCT03633617|467247409|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
129802706|NCT03633617|467247399|FG000|Part C (& Follow-up)|Physician Decision|0|||
129802707|NCT03633617|467247400|FG001|Part C (& Follow-up)|Physician Decision|0|||
129802708|NCT03633617|467247401|FG002|Part C (& Follow-up)|Physician Decision|0|||
129802709|NCT03633617|467247402|FG003|Part C (& Follow-up)|Physician Decision|0|||
129802710|NCT03633617|467247403|FG004|Part C (& Follow-up)|Physician Decision|0|||
129802711|NCT03633617|467247404|FG005|Part C (& Follow-up)|Physician Decision|0|||
129802712|NCT03633617|467247405|FG006|Part C (& Follow-up)|Physician Decision|0|||
129802713|NCT03633617|467247406|FG007|Part C (& Follow-up)|Physician Decision|1|||
129802714|NCT03633617|467247407|FG008|Part C (& Follow-up)|Physician Decision|0|||
129802715|NCT03633617|467247408|FG009|Part C (& Follow-up)|Physician Decision|0|||
129802716|NCT03633617|467247409|FG010|Part C (& Follow-up)|Physician Decision|1|||
129802717|NCT03633617|467247399|FG000|Part C (& Follow-up)|COVID-19 related|0|||
129802718|NCT03633617|467247400|FG001|Part C (& Follow-up)|COVID-19 related|0|||
129802719|NCT03633617|467247401|FG002|Part C (& Follow-up)|COVID-19 related|0|||
129802720|NCT03633617|467247402|FG003|Part C (& Follow-up)|COVID-19 related|0|||
129802721|NCT03633617|467247403|FG004|Part C (& Follow-up)|COVID-19 related|0|||
129802722|NCT03633617|467247404|FG005|Part C (& Follow-up)|COVID-19 related|1|||
129802723|NCT03633617|467247405|FG006|Part C (& Follow-up)|COVID-19 related|0|||
129802724|NCT03633617|467247406|FG007|Part C (& Follow-up)|COVID-19 related|0|||
129802725|NCT03633617|467247407|FG008|Part C (& Follow-up)|COVID-19 related|0|||
129802726|NCT03633617|467247408|FG009|Part C (& Follow-up)|COVID-19 related|0|||
129802727|NCT03633617|467247409|FG010|Part C (& Follow-up)|COVID-19 related|0|||
129802728|NCT03633617|467247399|FG000|Part C (& Follow-up)|Protocol Violation|0|||
129802729|NCT03633617|467247400|FG001|Part C (& Follow-up)|Protocol Violation|0|||
129802730|NCT03633617|467247401|FG002|Part C (& Follow-up)|Protocol Violation|0|||
129802731|NCT03633617|467247402|FG003|Part C (& Follow-up)|Protocol Violation|0|||
129715348|NCT04834726|466917427|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
129715349|NCT04834726|466917428|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
129715350|NCT00363142|466917429|FG000|Overall Study|Adverse Event|2|||
129715351|NCT00363142|466917430|FG001|Overall Study|Adverse Event|0|||
129715352|NCT00363142|466917429|FG000|Overall Study|Lack of Efficacy|0|||
129715353|NCT00363142|466917430|FG001|Overall Study|Lack of Efficacy|1|||
129715354|NCT00363142|466917429|FG000|Overall Study|Lost to Follow-up|1|||
129715355|NCT00363142|466917430|FG001|Overall Study|Lost to Follow-up|0|||
129715356|NCT00363142|466917429|FG000|Overall Study|Non-compliance|1|||
129715357|NCT00363142|466917430|FG001|Overall Study|Non-compliance|1|||
129715358|NCT00363142|466917429|FG000|Overall Study|Withdrawal by Subject|3|||
129715359|NCT00363142|466917430|FG001|Overall Study|Withdrawal by Subject|1|||
129715360|NCT00132301|466917437|FG000|Overall Study|Death|7|||
129715361|NCT00132301|466917438|FG001|Overall Study|Death|6|||
129715362|NCT00132301|466917437|FG000|Overall Study|Withdrawal by Subject|5|||
129715363|NCT00132301|466917438|FG001|Overall Study|Withdrawal by Subject|2|||
129715364|NCT00132301|466917437|FG000|Overall Study|Physician Decision|1|||
129715365|NCT00132301|466917438|FG001|Overall Study|Physician Decision|1|||
129715366|NCT00132301|466917437|FG000|Overall Study|Lost to Follow-up|5|||
129802732|NCT03633617|467247403|FG004|Part C (& Follow-up)|Protocol Violation|0|||
129802733|NCT03633617|467247404|FG005|Part C (& Follow-up)|Protocol Violation|0|||
129802734|NCT03633617|467247405|FG006|Part C (& Follow-up)|Protocol Violation|0|||
129802735|NCT03633617|467247406|FG007|Part C (& Follow-up)|Protocol Violation|0|||
129802736|NCT03633617|467247407|FG008|Part C (& Follow-up)|Protocol Violation|0|||
129802737|NCT03633617|467247408|FG009|Part C (& Follow-up)|Protocol Violation|3|||
129802738|NCT03633617|467247409|FG010|Part C (& Follow-up)|Protocol Violation|1|||
129802739|NCT03633617|467247399|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
129802740|NCT03633617|467247400|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
129802741|NCT03633617|467247401|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
129802742|NCT03633617|467247402|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
129802743|NCT03633617|467247403|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
129802744|NCT03633617|467247404|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
129802745|NCT03633617|467247405|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
129802746|NCT03633617|467247406|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
129802747|NCT03633617|467247407|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
129802748|NCT03633617|467247408|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
129802749|NCT03633617|467247409|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
129802750|NCT00629772|467247414|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
129802751|NCT00629772|467247415|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
129802752|NCT00629772|467247414|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
129802753|NCT00629772|467247415|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
129802754|NCT01393301|467247416|FG000|Overall Study|Lost to Follow-up|5|||
129802755|NCT01393301|467247417|FG001|Overall Study|Lost to Follow-up|3|||
129802756|NCT01393301|467247416|FG000|Overall Study|Withdrawal by Subject|2|||
129802757|NCT01393301|467247417|FG001|Overall Study|Withdrawal by Subject|0|||
129802758|NCT01393301|467247416|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
129802759|NCT01393301|467247417|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
129802760|NCT00853073|467247418|FG000|Overall Study|Withdrawal by Subject|3|||
129802761|NCT00853073|467247419|FG001|Overall Study|Withdrawal by Subject|2|||
129715367|NCT00132301|466917438|FG001|Overall Study|Lost to Follow-up|3|||
129715368|NCT00132301|466917437|FG000|Overall Study|Other|1|||
129715369|NCT00132301|466917438|FG001|Overall Study|Other|1|||
129715370|NCT00132301|466917437|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
129715371|NCT00132301|466917438|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
129715372|NCT02012218|466917439|FG000|Overall Study|Withdrawal by Subject|1|||
129715373|NCT02012218|466917440|FG001|Overall Study|Withdrawal by Subject|0|||
129715374|NCT02012218|466917441|FG002|Overall Study|Withdrawal by Subject|1|||
129715375|NCT02012218|466917442|FG003|Overall Study|Withdrawal by Subject|1|||
129715376|NCT02012218|466917443|FG004|Overall Study|Withdrawal by Subject|1|||
129715377|NCT02012218|466917439|FG000|Overall Study|Adverse Event|1|||
129715378|NCT02012218|466917440|FG001|Overall Study|Adverse Event|0|||
129715379|NCT02012218|466917441|FG002|Overall Study|Adverse Event|0|||
129715380|NCT02012218|466917442|FG003|Overall Study|Adverse Event|1|||
129715381|NCT02012218|466917443|FG004|Overall Study|Adverse Event|0|||
129715382|NCT02012218|466917439|FG000|Overall Study|Lost to Follow-up|0|||
129715383|NCT02012218|466917440|FG001|Overall Study|Lost to Follow-up|1|||
129715384|NCT02012218|466917441|FG002|Overall Study|Lost to Follow-up|1|||
129715385|NCT02012218|466917442|FG003|Overall Study|Lost to Follow-up|0|||
129715386|NCT02012218|466917443|FG004|Overall Study|Lost to Follow-up|0|||
129715387|NCT02012218|466917439|FG000|Overall Study|Protocol Specified|1|||
129715388|NCT02012218|466917440|FG001|Overall Study|Protocol Specified|0|||
129715389|NCT02012218|466917441|FG002|Overall Study|Protocol Specified|0|||
129715390|NCT02012218|466917442|FG003|Overall Study|Protocol Specified|0|||
129715391|NCT02012218|466917443|FG004|Overall Study|Protocol Specified|0|||
129715392|NCT02012218|466917439|FG000|Overall Study|Protocol Deviation|1|||
129715393|NCT02012218|466917440|FG001|Overall Study|Protocol Deviation|0|||
129715394|NCT02012218|466917441|FG002|Overall Study|Protocol Deviation|0|||
129715395|NCT02012218|466917442|FG003|Overall Study|Protocol Deviation|0|||
129715396|NCT02012218|466917443|FG004|Overall Study|Protocol Deviation|0|||
129715397|NCT04872569|466917447|FG000|Overall Study|Withdrawal by Subject|2|||
129715398|NCT02382991|466917453|FG000|Overall Study|Adverse Event|1|||
129715399|NCT02382991|466917454|FG001|Overall Study|Adverse Event|2|||
129802762|NCT02758171|467247420|FG000|Wash-out|Withdrawal by Subject|1|||
129802763|NCT02758171|467247421|FG001|Wash-out|Withdrawal by Subject|0|||
129802764|NCT02758171|467247420|FG000|Wash-out|Other reason|1|||
129715400|NCT02382991|466917453|FG000|Overall Study|Lost to Follow-up|1|||
129715401|NCT02382991|466917454|FG001|Overall Study|Lost to Follow-up|0|||
129715402|NCT02382991|466917453|FG000|Overall Study|Withdrawal by Subject|0|||
129715403|NCT02382991|466917454|FG001|Overall Study|Withdrawal by Subject|1|||
129715404|NCT01890265|466917456|FG000|Overall Study|Other (Unspecified reason)|0|||
129715405|NCT01890265|466917457|FG001|Overall Study|Other (Unspecified reason)|1|||
129715406|NCT01890265|466917458|FG002|Overall Study|Other (Unspecified reason)|0|||
129715407|NCT01890265|466917459|FG003|Overall Study|Other (Unspecified reason)|0|||
129715408|NCT01890265|466917460|FG004|Overall Study|Other (Unspecified reason)|0|||
129715409|NCT01890265|466917461|FG005|Overall Study|Other (Unspecified reason)|0|||
129715410|NCT01890265|466917456|FG000|Overall Study|Progressive disease|6|||
129715411|NCT01890265|466917457|FG001|Overall Study|Progressive disease|6|||
129715412|NCT01890265|466917458|FG002|Overall Study|Progressive disease|0|||
129802765|NCT02758171|467247421|FG001|Wash-out|Other reason|0|||
129802766|NCT00722423|467247422|FG000|Overall Study|Protocol Violation|0|||
129802767|NCT00722423|467247423|FG001|Overall Study|Protocol Violation|1|||
129802768|NCT01309165|467247424|FG000|Overall Study|Lost to Follow-up|4|||
129802769|NCT01309165|467247425|FG001|Overall Study|Lost to Follow-up|3|||
129802770|NCT01309165|467247424|FG000|Overall Study|Return to work|1|||
129802771|NCT01309165|467247425|FG001|Overall Study|Return to work|2|||
129802772|NCT01309165|467247424|FG000|Overall Study|Left country|0|||
129802773|NCT01309165|467247425|FG001|Overall Study|Left country|1|||
129802774|NCT01309165|467247424|FG000|Overall Study|No transportation|0|||
129802775|NCT01309165|467247425|FG001|Overall Study|No transportation|1|||
129891410|NCT04529538|467559717|FG002|Overall Study|Protocol Deviation|0|||
129715413|NCT01890265|466917459|FG003|Overall Study|Progressive disease|0|||
129715414|NCT01890265|466917460|FG004|Overall Study|Progressive disease|0|||
129715415|NCT01890265|466917461|FG005|Overall Study|Progressive disease|0|||
129715416|NCT01890265|466917456|FG000|Overall Study|Adverse Event|2|||
129715417|NCT01890265|466917457|FG001|Overall Study|Adverse Event|1|||
129715418|NCT01890265|466917458|FG002|Overall Study|Adverse Event|0|||
129715419|NCT01890265|466917459|FG003|Overall Study|Adverse Event|0|||
129715420|NCT01890265|466917460|FG004|Overall Study|Adverse Event|0|||
129715421|NCT01890265|466917461|FG005|Overall Study|Adverse Event|0|||
129715422|NCT01890265|466917456|FG000|Overall Study|Death|2|||
129715423|NCT01890265|466917457|FG001|Overall Study|Death|3|||
129715424|NCT01890265|466917458|FG002|Overall Study|Death|1|||
129715425|NCT01890265|466917459|FG003|Overall Study|Death|0|||
129715426|NCT01890265|466917460|FG004|Overall Study|Death|0|||
129715427|NCT01890265|466917461|FG005|Overall Study|Death|0|||
129715428|NCT01890265|466917456|FG000|Overall Study|Withdrawal by Subject|0|||
129715429|NCT01890265|466917457|FG001|Overall Study|Withdrawal by Subject|2|||
129715430|NCT01890265|466917458|FG002|Overall Study|Withdrawal by Subject|3|||
129715431|NCT01890265|466917459|FG003|Overall Study|Withdrawal by Subject|0|||
129715432|NCT01890265|466917460|FG004|Overall Study|Withdrawal by Subject|2|||
129715433|NCT01890265|466917461|FG005|Overall Study|Withdrawal by Subject|0|||
129715434|NCT01445613|466917462|FG000|30-day Follow-up|Withdrawal by Subject|6|||
129715435|NCT01445613|466917462|FG000|30-day Follow-up|Physician Decision|3|||
129715436|NCT01445613|466917462|FG000|30-day Follow-up|Missed visit|23|||
129715437|NCT01445613|466917462|FG000|30-day Follow-up|Death|3|||
129715438|NCT01445613|466917462|FG000|1-year Follow-up|Withdrawal by Subject|12|||
129715439|NCT01445613|466917462|FG000|1-year Follow-up|Missed visit|29|||
129715440|NCT01445613|466917462|FG000|1-year Follow-up|Lost to Follow-up|2|||
129715441|NCT01445613|466917462|FG000|1-year Follow-up|Death|30|||
129715442|NCT01445613|466917462|FG000|1-year Follow-up|Physician Decision|2|||
129715443|NCT01445613|466917462|FG000|1-year Follow-up|Received a non-study stent|2|||
129715444|NCT04466384|466917463|FG000|First Phase|Protocol Violation|1|||
129715445|NCT04466384|466917464|FG001|First Phase|Protocol Violation|0|||
129715446|NCT04466384|466917463|FG000|First Phase|Missing data|1|||
129715447|NCT04466384|466917464|FG001|First Phase|Missing data|0|||
129715448|NCT04466384|466917463|FG000|Cross Over Phase|Physician Decision|1|||
129715449|NCT04466384|466917464|FG001|Cross Over Phase|Physician Decision|0|||
129715450|NCT04466384|466917463|FG000|Cross Over Phase|Withdrawal by Subject|0|||
129715451|NCT04466384|466917464|FG001|Cross Over Phase|Withdrawal by Subject|1|||
129715452|NCT03666988|466917465|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
129715453|NCT03666988|466917466|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
129715454|NCT03666988|466917467|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
129715455|NCT03666988|466917468|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
129715456|NCT03666988|466917469|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
129715457|NCT03666988|466917470|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
129715458|NCT03666988|466917465|FG000|Part 1 (Up to 28 Months)|Other|0|||
129715459|NCT03666988|466917466|FG001|Part 1 (Up to 28 Months)|Other|1|||
129715460|NCT03666988|466917467|FG002|Part 1 (Up to 28 Months)|Other|1|||
129715461|NCT03666988|466917468|FG003|Part 1 (Up to 28 Months)|Other|0|||
129715462|NCT03666988|466917469|FG004|Part 1 (Up to 28 Months)|Other|0|||
129715463|NCT03666988|466917470|FG005|Part 1 (Up to 28 Months)|Other|0|||
129715464|NCT03666988|466917465|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
129715465|NCT03666988|466917466|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
129715466|NCT03666988|466917467|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
129715467|NCT03666988|466917468|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
129715468|NCT03666988|466917469|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
129715469|NCT03666988|466917470|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
129715470|NCT03666988|466917465|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
129715471|NCT03666988|466917466|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
129715472|NCT03666988|466917467|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
129715473|NCT03666988|466917468|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
129715474|NCT03666988|466917469|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
129715475|NCT03666988|466917470|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
129715476|NCT03666988|466917465|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
129715477|NCT03666988|466917466|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129715478|NCT03666988|466917467|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129715479|NCT03666988|466917468|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129715480|NCT03666988|466917469|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129715481|NCT03666988|466917470|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
129715482|NCT03554018|466917479|FG000|Overall Study|Lost to Follow-up|3|||
129715483|NCT03554018|466917480|FG001|Overall Study|Lost to Follow-up|7|||
129715484|NCT01402869|466917481|FG000|Overall Study|Required Tooth Extraction|0|||
129715485|NCT01402869|466917482|FG001|Overall Study|Required Tooth Extraction|0|||
129715486|NCT01402869|466917483|FG002|Overall Study|Required Tooth Extraction|1|||
129715487|NCT01154452|466917484|FG000|Phase Ib|Not Treated|1|||
129715488|NCT01154452|466917485|FG001|Phase Ib|Not Treated|0|||
129715489|NCT01154452|466917486|FG002|Phase Ib|Not Treated|0|||
129715490|NCT01154452|466917487|FG003|Phase Ib|Not Treated|0|||
129715491|NCT01154452|466917484|FG000|Phase Ib|Adverse Event|2|||
129715492|NCT01154452|466917485|FG001|Phase Ib|Adverse Event|1|||
129715493|NCT01154452|466917486|FG002|Phase Ib|Adverse Event|0|||
129715494|NCT01154452|466917487|FG003|Phase Ib|Adverse Event|0|||
129715495|NCT01154452|466917484|FG000|Phase II|Withdrawal by Subject|0|||
129715496|NCT01154452|466917485|FG001|Phase II|Withdrawal by Subject|0|||
129715497|NCT01154452|466917486|FG002|Phase II|Withdrawal by Subject|1|||
129715498|NCT01154452|466917487|FG003|Phase II|Withdrawal by Subject|2|||
129715499|NCT01154452|466917484|FG000|Phase II|Adverse Event|0|||
129715500|NCT01154452|466917485|FG001|Phase II|Adverse Event|0|||
129715501|NCT01154452|466917486|FG002|Phase II|Adverse Event|4|||
129715502|NCT01154452|466917487|FG003|Phase II|Adverse Event|4|||
129715503|NCT01837680|466917490|FG000|Overall Study|Lost to Follow-up|2|||
129715504|NCT01837680|466917491|FG001|Overall Study|Lost to Follow-up|2|||
129715505|NCT01837680|466917490|FG000|Overall Study|lack of insurance|0|||
129715506|NCT01837680|466917491|FG001|Overall Study|lack of insurance|2|||
129715507|NCT01837680|466917490|FG000|Overall Study|allergic reaction|6|||
129715508|NCT01837680|466917491|FG001|Overall Study|allergic reaction|0|||
129715509|NCT01837680|466917490|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
129715510|NCT01837680|466917491|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
129715511|NCT02297815|466918716|FG000|Overall Study|Lost to Follow-up|236|||
129715512|NCT02297815|466918717|FG001|Overall Study|Lost to Follow-up|140|||
129715513|NCT00662831|466918718|FG000|Overall Study|Death|4|||
129715514|NCT00662831|466918719|FG001|Overall Study|Death|1|||
129715515|NCT00662831|466918718|FG000|Overall Study|Lack of Efficacy|6|||
129715516|NCT00662831|466918719|FG001|Overall Study|Lack of Efficacy|6|||
129715517|NCT00662831|466918718|FG000|Overall Study|Lost to Follow-up|1|||
129715518|NCT00662831|466918719|FG001|Overall Study|Lost to Follow-up|0|||
129715519|NCT00662831|466918718|FG000|Overall Study|Withdrawal by Subject|2|||
129715520|NCT00662831|466918719|FG001|Overall Study|Withdrawal by Subject|1|||
129715521|NCT00662831|466918718|FG000|Overall Study|Other|62|||
129715522|NCT00662831|466918719|FG001|Overall Study|Other|31|||
129715523|NCT00662831|466918718|FG000|Overall Study|Protocol Violation|8|||
129715524|NCT00662831|466918719|FG001|Overall Study|Protocol Violation|4|||
129715525|NCT00662831|466918718|FG000|Overall Study|Adverse Event|23|||
129715526|NCT00662831|466918719|FG001|Overall Study|Adverse Event|16|||
129715527|NCT01061723|466918722|FG000|Overall Study|Adverse Event|0|||
129715528|NCT01061723|466918723|FG001|Overall Study|Adverse Event|2|||
129715529|NCT01061723|466918724|FG002|Overall Study|Adverse Event|5|||
129715530|NCT01061723|466918725|FG003|Overall Study|Adverse Event|5|||
129715531|NCT01061723|466918726|FG004|Overall Study|Adverse Event|2|||
129715532|NCT01061723|466918727|FG005|Overall Study|Adverse Event|6|||
129715533|NCT01061723|466918722|FG000|Overall Study|Lack of Efficacy|2|||
129715534|NCT01061723|466918723|FG001|Overall Study|Lack of Efficacy|3|||
129715535|NCT01061723|466918724|FG002|Overall Study|Lack of Efficacy|4|||
129715536|NCT01061723|466918725|FG003|Overall Study|Lack of Efficacy|2|||
129715537|NCT01061723|466918726|FG004|Overall Study|Lack of Efficacy|1|||
129715538|NCT01061723|466918727|FG005|Overall Study|Lack of Efficacy|1|||
129715539|NCT01061723|466918722|FG000|Overall Study|Randomized but not treated|0|||
129715540|NCT01061723|466918723|FG001|Overall Study|Randomized but not treated|0|||
129715541|NCT01061723|466918724|FG002|Overall Study|Randomized but not treated|0|||
129715542|NCT01061723|466918725|FG003|Overall Study|Randomized but not treated|0|||
129715543|NCT01061723|466918726|FG004|Overall Study|Randomized but not treated|0|||
129715544|NCT01061723|466918727|FG005|Overall Study|Randomized but not treated|1|||
129715545|NCT01061723|466918722|FG000|Overall Study|Other than specified above|2|||
129715546|NCT01061723|466918723|FG001|Overall Study|Other than specified above|1|||
129715547|NCT01061723|466918724|FG002|Overall Study|Other than specified above|1|||
129715548|NCT01061723|466918725|FG003|Overall Study|Other than specified above|1|||
129715549|NCT01061723|466918726|FG004|Overall Study|Other than specified above|0|||
129715550|NCT01061723|466918727|FG005|Overall Study|Other than specified above|1|||
129715551|NCT02840253|466918728|FG000|Overall Study|Unsuccessful block|4|||
129715552|NCT03783962|466918729|FG000|Overall Study|Lost to Follow-up|3|||
129715553|NCT03783962|466918730|FG001|Overall Study|Lost to Follow-up|6|||
129715554|NCT03783962|466918729|FG000|Overall Study|Protocol Violation|0|||
129715555|NCT03783962|466918730|FG001|Overall Study|Protocol Violation|1|||
129715556|NCT03458325|466918731|FG000|Overall Study|Withdrawal by Subject|1|||
129715557|NCT00460655|466918736|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
129715558|NCT00460655|466918737|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129715559|NCT00460655|466918738|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129715560|NCT00460655|466918739|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129715561|NCT00460655|466918736|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
129715562|NCT00460655|466918737|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129715563|NCT00460655|466918738|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129715564|NCT00460655|466918739|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129715565|NCT00460655|466918736|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
129715566|NCT00460655|466918737|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
129715567|NCT00460655|466918738|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
129715568|NCT00460655|466918739|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
129715569|NCT00460655|466918736|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129715570|NCT00460655|466918737|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129715571|NCT00460655|466918738|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
129715572|NCT00460655|466918739|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
129715573|NCT00460655|466918736|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129715574|NCT00460655|466918737|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129715575|NCT00460655|466918738|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
129715576|NCT00460655|466918739|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
129715577|NCT00460655|466918736|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
129715578|NCT00460655|466918737|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
129715579|NCT00460655|466918738|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
129715580|NCT00460655|466918739|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
129715581|NCT01724216|466918740|FG000|Overall Study|Scan was not completed|1|||
129715582|NCT00175916|466918741|FG000|Overall Study|Death|19|||
129715583|NCT00175916|466918741|FG000|Overall Study|Adverse Event|81|||
129715584|NCT00175916|466918741|FG000|Overall Study|Lack of Efficacy|354|||
129715585|NCT00175916|466918741|FG000|Overall Study|Lost to Follow-up|17|||
129715586|NCT00175916|466918741|FG000|Overall Study|Subject Choice|98|||
129715587|NCT00175916|466918741|FG000|Overall Study|Lack of compliance|8|||
129715588|NCT00175916|466918741|FG000|Overall Study|Patient cannot record seizures|1|||
129715589|NCT00175916|466918741|FG000|Overall Study|Sponsor decision|17|||
129715590|NCT00175916|466918741|FG000|Overall Study|Vigabatrin intake|1|||
129715591|NCT00175916|466918741|FG000|Overall Study|Suicidal behaviour|1|||
129715592|NCT00175916|466918741|FG000|Overall Study|Withdrawal by Subject|1|||
129715593|NCT00175916|466918741|FG000|Overall Study|Seizure - free|4|||
129715594|NCT00175916|466918741|FG000|Overall Study|Administrative reason|1|||
129715595|NCT00175916|466918741|FG000|Overall Study|Pregnancy|1|||
129715596|NCT00175916|466918741|FG000|Overall Study|Patient's request|2|||
129715597|NCT00175916|466918741|FG000|Overall Study|Treating physiciant's choice|1|||
129715598|NCT00175916|466918741|FG000|Overall Study|Moved overseas|1|||
129715599|NCT00175916|466918741|FG000|Overall Study|Loss of job and economic burden|1|||
129715600|NCT00175916|466918741|FG000|Overall Study|Site was closed|9|||
129715601|NCT00175916|466918741|FG000|Overall Study|Patient went to prison|1|||
129715602|NCT03650413|466918742|FG000|Overall Study|Adverse Event|1|||
129715603|NCT03650413|466918742|FG000|Overall Study|Lack of Efficacy|17|||
129715604|NCT03650413|466918742|FG000|Overall Study|Other|9|||
129715605|NCT03650413|466918742|FG000|Overall Study|Physician Decision|2|||
129715606|NCT03650413|466918742|FG000|Overall Study|Study Terminated By Sponsor|16|||
129715607|NCT03650413|466918742|FG000|Overall Study|Withdrawal by Subject|16|||
129715608|NCT03654040|466918743|FG000|Overall Study|Death|1|||
129715609|NCT03654040|466918744|FG001|Overall Study|Death|0|||
129715610|NCT03654040|466918743|FG000|Overall Study|Withdrawal by Subject|1|||
129715611|NCT03654040|466918744|FG001|Overall Study|Withdrawal by Subject|0|||
129715612|NCT03654040|466918743|FG000|Overall Study|Study terminated by sponsor|8|||
129715613|NCT03654040|466918744|FG001|Overall Study|Study terminated by sponsor|2|||
129715614|NCT03654040|466918743|FG000|Overall Study|Failure to initiate study therapy|2|||
129715615|NCT03654040|466918744|FG001|Overall Study|Failure to initiate study therapy|0|||
129715616|NCT03654040|466918743|FG000|Overall Study|Transplanted at another center|2|||
129715617|NCT03654040|466918744|FG001|Overall Study|Transplanted at another center|0|||
129715618|NCT03654040|466918743|FG000|Overall Study|Failure to meet eligibility criteria|14|||
129715619|NCT03654040|466918744|FG001|Overall Study|Failure to meet eligibility criteria|2|||
129715620|NCT03654040|466918743|FG000|Overall Study|No longer transplant candidate|1|||
129715621|NCT03654040|466918744|FG001|Overall Study|No longer transplant candidate|0|||
129715622|NCT03654040|466918743|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
129715623|NCT03654040|466918744|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
129715624|NCT03654040|466918743|FG000|Overall Study|Recipient ineligible|0|||
129715625|NCT03654040|466918744|FG001|Overall Study|Recipient ineligible|2|||
129715626|NCT03654040|466918743|FG000|Overall Study|Received deceased liver|0|||
129715627|NCT03654040|466918744|FG001|Overall Study|Received deceased liver|1|||
129715628|NCT00310375|466918750|FG000|Primary Reporting Phase|Adverse Event|28|||
129715629|NCT00310375|466918751|FG001|Primary Reporting Phase|Adverse Event|22|||
129715630|NCT00310375|466918752|FG002|Primary Reporting Phase|Adverse Event|0|||
129715631|NCT00310375|466918750|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
129715632|NCT00310375|466918751|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
129715633|NCT00310375|466918752|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
129715634|NCT00310375|466918750|FG000|Primary Reporting Phase|Pregnancy|2|||
129715635|NCT00310375|466918751|FG001|Primary Reporting Phase|Pregnancy|2|||
129891411|NCT04529538|467559718|FG003|Overall Study|Protocol Deviation|1|||
129715636|NCT00310375|466918752|FG002|Primary Reporting Phase|Pregnancy|0|||
129715637|NCT00310375|466918750|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
129715638|NCT00310375|466918751|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
129715639|NCT00310375|466918752|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
129715640|NCT00310375|466918750|FG000|Primary Reporting Phase|Protocol Violation|8|||
129715641|NCT00310375|466918751|FG001|Primary Reporting Phase|Protocol Violation|5|||
129715642|NCT00310375|466918752|FG002|Primary Reporting Phase|Protocol Violation|0|||
129715643|NCT00310375|466918750|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
129715644|NCT00310375|466918751|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
129715645|NCT00310375|466918752|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
129715646|NCT00310375|466918750|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
129715647|NCT00310375|466918751|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
129715648|NCT00310375|466918752|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
129715649|NCT00310375|466918750|FG000|Primary Reporting Phase|Physician Decision|5|||
129715650|NCT00310375|466918751|FG001|Primary Reporting Phase|Physician Decision|3|||
129715651|NCT00310375|466918752|FG002|Primary Reporting Phase|Physician Decision|0|||
129715652|NCT00310375|466918750|FG000|Primary Reporting Phase|Request of the sponsor|2|||
129715653|NCT00310375|466918751|FG001|Primary Reporting Phase|Request of the sponsor|2|||
129715654|NCT00310375|466918752|FG002|Primary Reporting Phase|Request of the sponsor|0|||
129715655|NCT00310375|466918750|FG000|Primary Reporting Phase|Failed to return|1|||
129715656|NCT00310375|466918751|FG001|Primary Reporting Phase|Failed to return|3|||
129715657|NCT00310375|466918752|FG002|Primary Reporting Phase|Failed to return|0|||
129715658|NCT00310375|466918750|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
129715659|NCT00310375|466918751|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
129715660|NCT00310375|466918752|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
129715661|NCT00310375|466918750|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
129715662|NCT00310375|466918751|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
129715663|NCT00310375|466918752|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
129715664|NCT00310375|466918750|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
129715665|NCT00310375|466918751|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
129715666|NCT00310375|466918752|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
129715667|NCT00310375|466918750|FG000|Primary Reporting Phase|Site closure|3|||
129715668|NCT00310375|466918751|FG001|Primary Reporting Phase|Site closure|0|||
129715669|NCT00310375|466918752|FG002|Primary Reporting Phase|Site closure|0|||
129891412|NCT04529538|467559719|FG004|Overall Study|Protocol Deviation|0|||
129891413|NCT04529538|467559720|FG005|Overall Study|Protocol Deviation|0|||
129891414|NCT04529538|467559721|FG006|Overall Study|Protocol Deviation|0|||
129891415|NCT04529538|467559722|FG007|Overall Study|Protocol Deviation|0|||
129891416|NCT04529538|467559715|FG000|Overall Study|Physician Decision|0|||
129891417|NCT04529538|467559716|FG001|Overall Study|Physician Decision|0|||
129891418|NCT04529538|467559717|FG002|Overall Study|Physician Decision|0|||
129891419|NCT04529538|467559718|FG003|Overall Study|Physician Decision|0|||
129891420|NCT04529538|467559719|FG004|Overall Study|Physician Decision|0|||
129891421|NCT04529538|467559720|FG005|Overall Study|Physician Decision|1|||
129891422|NCT04529538|467559721|FG006|Overall Study|Physician Decision|0|||
129891423|NCT04529538|467559722|FG007|Overall Study|Physician Decision|1|||
129891424|NCT00235495|467559725|FG000|Overall Study|Death|52|||
129891425|NCT00235495|467559726|FG001|Overall Study|Death|42|||
129891426|NCT00235495|467559725|FG000|Overall Study|Withdrawal by Subject|5|||
129891427|NCT00235495|467559726|FG001|Overall Study|Withdrawal by Subject|3|||
129891428|NCT00235495|467559725|FG000|Overall Study|Lost to Follow-up|11|||
129715670|NCT00310375|466918750|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
129715671|NCT00310375|466918751|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
129891429|NCT00235495|467559726|FG001|Overall Study|Lost to Follow-up|13|||
129891430|NCT00235495|467559725|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
129891431|NCT00235495|467559726|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
129979652|NCT00403767|467889417|FG000|Overall Study|Investigator dec./not protocol-related|191|||
129715672|NCT00310375|466918752|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
129715673|NCT00310375|466918750|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
129715674|NCT00310375|466918751|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
129715675|NCT00310375|466918752|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
129715676|NCT00310375|466918750|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
129715677|NCT00310375|466918751|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
129715678|NCT00310375|466918752|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
129715679|NCT00310375|466918750|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
129715680|NCT00310375|466918751|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
129715681|NCT00310375|466918752|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
129715682|NCT00131352|466918753|FG000|Initial Treatment Period|Adverse Event|1|||
129715683|NCT00131352|466918754|FG001|Initial Treatment Period|Adverse Event|3|||
129715684|NCT00131352|466918753|FG000|Initial Treatment Period|Non-compliant|1|||
129715685|NCT00131352|466918754|FG001|Initial Treatment Period|Non-compliant|2|||
129715686|NCT00131352|466918753|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
129715687|NCT00131352|466918754|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
129715688|NCT00131352|466918753|FG000|Initial Treatment Period|Lack of Efficacy|6|||
129715689|NCT00131352|466918754|FG001|Initial Treatment Period|Lack of Efficacy|4|||
129715690|NCT00131352|466918753|FG000|Initial Treatment Period|Other|0|||
129715691|NCT00131352|466918754|FG001|Initial Treatment Period|Other|2|||
129715692|NCT00131352|466918753|FG000|Repeat Treatment Period|Adverse Event|1|||
129715693|NCT00131352|466918754|FG001|Repeat Treatment Period|Adverse Event|0|||
129715694|NCT00131352|466918753|FG000|Repeat Treatment Period|Other|1|||
129715695|NCT00131352|466918754|FG001|Repeat Treatment Period|Other|0|||
129715696|NCT03230318|466918755|FG000|Overall Study|Radiographic disease progression|72|||
129715697|NCT03230318|466918756|FG001|Overall Study|Radiographic disease progression|19|||
129715698|NCT03230318|466918755|FG000|Overall Study|Clinical progression|17|||
129715699|NCT03230318|466918756|FG001|Overall Study|Clinical progression|7|||
129715700|NCT03230318|466918755|FG000|Overall Study|Adverse Event|5|||
129715701|NCT03230318|466918756|FG001|Overall Study|Adverse Event|3|||
129715702|NCT03230318|466918755|FG000|Overall Study|Physician Decision|2|||
129715703|NCT03230318|466918756|FG001|Overall Study|Physician Decision|3|||
129715704|NCT03230318|466918755|FG000|Overall Study|Death|3|||
129715705|NCT03230318|466918756|FG001|Overall Study|Death|2|||
129715706|NCT03230318|466918755|FG000|Overall Study|Lost to Follow-up|1|||
129715707|NCT03230318|466918756|FG001|Overall Study|Lost to Follow-up|0|||
129715708|NCT03230318|466918755|FG000|Overall Study|Withdrawal by Subject|1|||
129715709|NCT03230318|466918756|FG001|Overall Study|Withdrawal by Subject|3|||
129715710|NCT03230318|466918755|FG000|Overall Study|Other|3|||
129715711|NCT03230318|466918756|FG001|Overall Study|Other|7|||
129715712|NCT00211172|466918758|FG000|Overall Study|Died or lost health plan eligibility|39|||
129715713|NCT00211172|466918759|FG001|Overall Study|Died or lost health plan eligibility|32|||
129715714|NCT00770562|466918765|FG000|Overall Study|Did not take treatment|1|||
129715715|NCT00770562|466918766|FG001|Overall Study|Did not take treatment|1|||
129715716|NCT01643408|466918767|FG000|Overall Study|Adverse Event|12|||
129715717|NCT01643408|466918767|FG000|Overall Study|Other|2|||
129715718|NCT01057693|466918770|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
129715719|NCT01057693|466918771|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
129715720|NCT01057693|466918772|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
129715721|NCT01057693|466918770|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
129715722|NCT01057693|466918771|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
129715723|NCT01057693|466918772|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
129715724|NCT01057693|466918770|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
129715725|NCT01057693|466918771|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
129715726|NCT01057693|466918772|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
129715727|NCT01057693|466918770|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
129715728|NCT01057693|466918771|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
129715729|NCT01057693|466918772|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
129715730|NCT01057693|466918770|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
129715731|NCT01057693|466918771|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
129715732|NCT01057693|466918772|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
129715733|NCT01057693|466918770|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
129715734|NCT01057693|466918771|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
129715735|NCT01057693|466918772|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
129715736|NCT01057693|466918770|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
129715737|NCT01057693|466918771|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
129715738|NCT01057693|466918772|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
129715739|NCT01057693|466918770|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
129715740|NCT01057693|466918771|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
129715741|NCT01057693|466918772|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
129715742|NCT01057693|466918770|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
129715743|NCT01057693|466918771|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
129715744|NCT01057693|466918772|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
129715745|NCT01057693|466918770|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
129715746|NCT01057693|466918771|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
129715747|NCT01057693|466918772|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
129715748|NCT01057693|466918770|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
129715749|NCT01057693|466918771|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
129715750|NCT01057693|466918772|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
129715751|NCT01057693|466918770|FG000|Between Single-Blind and Double-Blind|Other|6|||
129715752|NCT01057693|466918771|FG001|Between Single-Blind and Double-Blind|Other|0|||
129715753|NCT01057693|466918772|FG002|Between Single-Blind and Double-Blind|Other|0|||
129715754|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
129715755|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
129715756|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
129715757|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
129715758|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
129715759|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
129715760|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
129715761|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
129715762|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
129715763|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
129715764|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
129715765|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
129715766|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
129715767|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
129715768|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
129715769|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
129715770|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
129715771|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
129715772|NCT01057693|466918770|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
129715773|NCT01057693|466918771|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
129715774|NCT01057693|466918772|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
129715775|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
129715776|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
129715777|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
129715778|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
129715779|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
129715780|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
129715781|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
129715782|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
129715783|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
129715784|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
129715785|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
129715786|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
129715787|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
129715788|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
129715789|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
129715790|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
129715791|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
129715792|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
129715793|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
129715794|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
129715795|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
129715796|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
129715797|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
129715798|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
129715799|NCT01672879|466918780|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
129715800|NCT01672879|466918781|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
129715801|NCT01672879|466918782|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
129715802|NCT01672879|466918780|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
129715803|NCT01672879|466918781|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
129715804|NCT01672879|466918782|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
129715805|NCT01672879|466918780|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
129715806|NCT01672879|466918781|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
129715807|NCT01672879|466918782|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
129715808|NCT01672879|466918780|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
129715809|NCT01672879|466918781|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
129715810|NCT01672879|466918782|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
129715811|NCT01672879|466918780|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
129715812|NCT01672879|466918781|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
129715813|NCT01672879|466918782|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
129715814|NCT04860869|466918783|FG000|Overall Study|Withdrawal by Subject|1|||
129715815|NCT04860869|466918784|FG001|Overall Study|Withdrawal by Subject|0|||
129715816|NCT03951766|466918785|FG000|Treatment Phase|Lost to Follow-up|1|||
129715817|NCT03951766|466918785|FG000|Follow-up Phase|Lost to Follow-up|10|||
129715818|NCT01541865|466918787|FG000|Overall Study|Lost to Follow-up|11|||
129715819|NCT01541865|466918787|FG000|Overall Study|Withdrawal by Subject|9|||
129715820|NCT01541865|466918787|FG000|Overall Study|Adverse Event|1|||
129715821|NCT01541865|466918787|FG000|Overall Study|Protocol Violation|1|||
129715822|NCT00295646|466918789|FG000|Overall Study|Protocol Violation|18|||
129715823|NCT00295646|466918790|FG001|Overall Study|Protocol Violation|20|||
129715824|NCT00295646|466918791|FG002|Overall Study|Protocol Violation|20|||
129715825|NCT00295646|466918792|FG003|Overall Study|Protocol Violation|18|||
129715826|NCT00295646|466918789|FG000|Overall Study|Withdrawal by Subject|8|||
129715827|NCT00295646|466918790|FG001|Overall Study|Withdrawal by Subject|9|||
129715828|NCT00295646|466918791|FG002|Overall Study|Withdrawal by Subject|11|||
129715829|NCT00295646|466918792|FG003|Overall Study|Withdrawal by Subject|14|||
129715830|NCT00295646|466918789|FG000|Overall Study|Lost to Follow-up|0|||
129715831|NCT00295646|466918790|FG001|Overall Study|Lost to Follow-up|5|||
129715832|NCT00295646|466918791|FG002|Overall Study|Lost to Follow-up|1|||
129715833|NCT00295646|466918792|FG003|Overall Study|Lost to Follow-up|5|||
129715834|NCT00295646|466918789|FG000|Overall Study|Death|9|||
129715835|NCT00295646|466918790|FG001|Overall Study|Death|7|||
129715836|NCT00295646|466918791|FG002|Overall Study|Death|18|||
129715837|NCT00295646|466918792|FG003|Overall Study|Death|8|||
129715838|NCT01232127|466918797|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
129715839|NCT01232127|466918798|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
129715840|NCT01232127|466918799|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
129715841|NCT02720523|466918800|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
129715842|NCT02720523|466918801|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
129715843|NCT02720523|466918802|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
129715844|NCT02720523|466918803|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
129715845|NCT02720523|466918804|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
129715846|NCT02720523|466918805|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
129715847|NCT02720523|466918806|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
129715848|NCT02720523|466918800|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
129715849|NCT02720523|466918801|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129715850|NCT02720523|466918802|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129715851|NCT02720523|466918803|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129715852|NCT02720523|466918804|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129715853|NCT02720523|466918805|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129715854|NCT02720523|466918806|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
129715855|NCT02720523|466918800|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
129715856|NCT02720523|466918801|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129715857|NCT02720523|466918802|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129715858|NCT02720523|466918803|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129715859|NCT02720523|466918804|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129715860|NCT02720523|466918805|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129715861|NCT02720523|466918806|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
129715862|NCT02720523|466918800|FG000|Period 1: Placebo-controlled Period|Other|0|||
129715863|NCT02720523|466918801|FG001|Period 1: Placebo-controlled Period|Other|0|||
129715864|NCT02720523|466918802|FG002|Period 1: Placebo-controlled Period|Other|1|||
129715865|NCT02720523|466918803|FG003|Period 1: Placebo-controlled Period|Other|1|||
129715866|NCT02720523|466918804|FG004|Period 1: Placebo-controlled Period|Other|0|||
129715867|NCT02720523|466918805|FG005|Period 1: Placebo-controlled Period|Other|0|||
129715868|NCT02720523|466918806|FG006|Period 1: Placebo-controlled Period|Other|0|||
129715869|NCT02720523|466918800|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
129715870|NCT02720523|466918801|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
129715871|NCT02720523|466918802|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
129715872|NCT02720523|466918803|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
129715873|NCT02720523|466918804|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
129715874|NCT02720523|466918805|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
129715875|NCT02720523|466918806|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
129715876|NCT02720523|466918800|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
129715877|NCT02720523|466918801|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
129715878|NCT02720523|466918802|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
129715879|NCT02720523|466918803|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
129715880|NCT02720523|466918804|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
129715881|NCT02720523|466918805|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
129715882|NCT02720523|466918806|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
129715883|NCT02720523|466918800|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129715884|NCT02720523|466918801|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129715885|NCT02720523|466918802|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129715886|NCT02720523|466918803|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
129715887|NCT02720523|466918804|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
129715888|NCT02720523|466918805|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
129715889|NCT02720523|466918806|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
129715890|NCT02720523|466918800|FG000|Period 2: Long-term Extension Period|Other|0|||
129715891|NCT02720523|466918801|FG001|Period 2: Long-term Extension Period|Other|0|||
129715892|NCT02720523|466918802|FG002|Period 2: Long-term Extension Period|Other|0|||
129715893|NCT02720523|466918803|FG003|Period 2: Long-term Extension Period|Other|0|||
129715894|NCT02720523|466918804|FG004|Period 2: Long-term Extension Period|Other|2|||
129715895|NCT02720523|466918805|FG005|Period 2: Long-term Extension Period|Other|0|||
129715896|NCT02720523|466918806|FG006|Period 2: Long-term Extension Period|Other|3|||
129715897|NCT01740687|466918816|FG000|Overall Study|Lost to Follow-up|11|||
129715898|NCT01740687|466918816|FG000|Overall Study|Withdrawal by Subject|2|||
129715899|NCT01740687|466918816|FG000|Overall Study|other reason|22|||
129715900|NCT01740687|466918816|FG000|Overall Study|treatment not received|2|||
129715901|NCT00326001|466918817|FG000|Overall Study|Adverse Event|4|||
129715902|NCT00326001|466918818|FG001|Overall Study|Adverse Event|5|||
129715903|NCT00326001|466918817|FG000|Overall Study|Physician Decision|3|||
129715904|NCT00326001|466918818|FG001|Overall Study|Physician Decision|3|||
129715905|NCT00104728|466918819|FG000|Overall Study|screen failures|19|||
129715906|NCT01963767|466918820|FG000|Overall Study|Withdrawal by Subject|4|||
129715907|NCT01963767|466918821|FG001|Overall Study|Withdrawal by Subject|2|||
129715908|NCT01963767|466918820|FG000|Overall Study|Adverse Event|2|||
129715909|NCT01963767|466918821|FG001|Overall Study|Adverse Event|0|||
129715910|NCT03960684|466918822|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
129715911|NCT03941483|466918823|FG000|Overall Study|Miscellaneous|2|||
129715912|NCT03941483|466918824|FG001|Overall Study|Miscellaneous|3|||
129715913|NCT03941483|466918825|FG002|Overall Study|Miscellaneous|0|||
129715914|NCT03941483|466918823|FG000|Overall Study|Study Terminated by Sponsor|1|||
129715915|NCT03941483|466918824|FG001|Overall Study|Study Terminated by Sponsor|0|||
129715916|NCT03941483|466918825|FG002|Overall Study|Study Terminated by Sponsor|0|||
129715917|NCT03941483|466918823|FG000|Overall Study|Withdrawal by Subject|1|||
129715918|NCT03941483|466918824|FG001|Overall Study|Withdrawal by Subject|4|||
129715919|NCT03941483|466918825|FG002|Overall Study|Withdrawal by Subject|1|||
129715920|NCT03941483|466918823|FG000|Overall Study|Lost to Follow-up|2|||
129715921|NCT03941483|466918824|FG001|Overall Study|Lost to Follow-up|1|||
129715922|NCT03941483|466918825|FG002|Overall Study|Lost to Follow-up|8|||
129715923|NCT03941483|466918823|FG000|Overall Study|Death|3|||
129715924|NCT03941483|466918824|FG001|Overall Study|Death|2|||
129715925|NCT03941483|466918825|FG002|Overall Study|Death|6|||
129715926|NCT01082081|466918826|FG000|Overall Study|Lost to Follow-up|0|||
129715927|NCT01082081|466918827|FG001|Overall Study|Lost to Follow-up|0|||
129715928|NCT01082081|466918828|FG002|Overall Study|Lost to Follow-up|1|||
129715929|NCT01082081|466918826|FG000|Overall Study|Withdrawal by Subject|0|||
129715930|NCT01082081|466918827|FG001|Overall Study|Withdrawal by Subject|0|||
129715931|NCT01082081|466918828|FG002|Overall Study|Withdrawal by Subject|1|||
129715932|NCT01082081|466918826|FG000|Overall Study|Other Reason|0|||
129715933|NCT01082081|466918827|FG001|Overall Study|Other Reason|1|||
129715934|NCT01082081|466918828|FG002|Overall Study|Other Reason|0|||
129715935|NCT00670930|466918831|FG000|Overall Study|Adminstrative Problem|0|||
129715936|NCT00670930|466918832|FG001|Overall Study|Adminstrative Problem|1|||
129715937|NCT00670930|466918831|FG000|Overall Study|Lost to Follow-up|1|||
129802776|NCT01309165|467247424|FG000|Overall Study|Admitted to hospital for second stroke|1|||
129802777|NCT01309165|467247425|FG001|Overall Study|Admitted to hospital for second stroke|0|||
129802778|NCT05085730|467247427|FG000|Overall Study|Withdrawal by Subject|4|||
129802779|NCT05085730|467247427|FG000|Overall Study|Physician Decision|1|||
129715938|NCT00670930|466918832|FG001|Overall Study|Lost to Follow-up|0|||
129715939|NCT03493451|466920044|FG000|Overall Study|Death|11|||
129715940|NCT03493451|466920045|FG001|Overall Study|Death|26|||
129715941|NCT03493451|466920046|FG002|Overall Study|Death|3|||
129715942|NCT03493451|466920044|FG000|Overall Study|Lost to Follow-up|1|||
129715943|NCT03493451|466920045|FG001|Overall Study|Lost to Follow-up|4|||
129715944|NCT03493451|466920046|FG002|Overall Study|Lost to Follow-up|1|||
129715945|NCT03493451|466920044|FG000|Overall Study|Withdrawal by Subject|1|||
129715946|NCT03493451|466920045|FG001|Overall Study|Withdrawal by Subject|1|||
129715947|NCT03493451|466920046|FG002|Overall Study|Withdrawal by Subject|2|||
129715948|NCT03493451|466920044|FG000|Overall Study|Progressive Disease|1|||
129715949|NCT03493451|466920045|FG001|Overall Study|Progressive Disease|0|||
129715950|NCT03493451|466920046|FG002|Overall Study|Progressive Disease|0|||
129715951|NCT03493451|466920044|FG000|Overall Study|Transferred to long term extension study|8|||
129715952|NCT03493451|466920045|FG001|Overall Study|Transferred to long term extension study|13|||
129802780|NCT02038881|467247428|FG000|Overall Study|Withdrawal by Subject|0|||
129802781|NCT02038881|467247429|FG001|Overall Study|Withdrawal by Subject|0|||
129715953|NCT03493451|466920046|FG002|Overall Study|Transferred to long term extension study|5|||
129715954|NCT01238991|466920047|FG000|Overall Study|Adverse Event|1|||
129715955|NCT01238991|466920048|FG001|Overall Study|Adverse Event|0|||
129715956|NCT01238991|466920049|FG002|Overall Study|Adverse Event|3|||
129715957|NCT01238991|466920050|FG003|Overall Study|Adverse Event|1|||
129715958|NCT01238991|466920051|FG004|Overall Study|Adverse Event|1|||
129715959|NCT01238991|466920052|FG005|Overall Study|Adverse Event|0|||
129802782|NCT02038881|467247430|FG002|Overall Study|Withdrawal by Subject|1|||
129802783|NCT02038881|467247428|FG000|Overall Study|Lost to Follow-up|2|||
129715960|NCT01238991|466920053|FG006|Overall Study|Adverse Event|1|||
129715961|NCT01238991|466920054|FG007|Overall Study|Adverse Event|1|||
129715962|NCT01238991|466920055|FG008|Overall Study|Adverse Event|0|||
129715963|NCT01238991|466920056|FG009|Overall Study|Adverse Event|0|||
129715964|NCT01238991|466920047|FG000|Overall Study|Death|0|||
129715965|NCT01238991|466920048|FG001|Overall Study|Death|0|||
129715966|NCT01238991|466920049|FG002|Overall Study|Death|0|||
129715967|NCT01238991|466920050|FG003|Overall Study|Death|1|||
129715968|NCT01238991|466920051|FG004|Overall Study|Death|0|||
129715969|NCT01238991|466920052|FG005|Overall Study|Death|0|||
129715970|NCT01238991|466920053|FG006|Overall Study|Death|0|||
129715971|NCT01238991|466920054|FG007|Overall Study|Death|0|||
129715972|NCT01238991|466920055|FG008|Overall Study|Death|0|||
129715973|NCT01238991|466920056|FG009|Overall Study|Death|0|||
129715974|NCT01238991|466920047|FG000|Overall Study|Lack of Efficacy|0|||
129715975|NCT01238991|466920048|FG001|Overall Study|Lack of Efficacy|0|||
129715976|NCT01238991|466920049|FG002|Overall Study|Lack of Efficacy|1|||
129715977|NCT01238991|466920050|FG003|Overall Study|Lack of Efficacy|0|||
129715978|NCT01238991|466920051|FG004|Overall Study|Lack of Efficacy|0|||
129715979|NCT01238991|466920052|FG005|Overall Study|Lack of Efficacy|0|||
129715980|NCT01238991|466920053|FG006|Overall Study|Lack of Efficacy|0|||
129715981|NCT01238991|466920054|FG007|Overall Study|Lack of Efficacy|0|||
129715982|NCT01238991|466920055|FG008|Overall Study|Lack of Efficacy|1|||
129715983|NCT01238991|466920056|FG009|Overall Study|Lack of Efficacy|0|||
129715984|NCT01238991|466920047|FG000|Overall Study|Withdrawal by Subject|0|||
129715985|NCT01238991|466920048|FG001|Overall Study|Withdrawal by Subject|0|||
129715986|NCT01238991|466920049|FG002|Overall Study|Withdrawal by Subject|1|||
129715987|NCT01238991|466920050|FG003|Overall Study|Withdrawal by Subject|0|||
129715988|NCT01238991|466920051|FG004|Overall Study|Withdrawal by Subject|0|||
129715989|NCT01238991|466920052|FG005|Overall Study|Withdrawal by Subject|0|||
129715990|NCT01238991|466920053|FG006|Overall Study|Withdrawal by Subject|0|||
129715991|NCT01238991|466920054|FG007|Overall Study|Withdrawal by Subject|0|||
129802784|NCT02038881|467247429|FG001|Overall Study|Lost to Follow-up|0|||
129802785|NCT02038881|467247430|FG002|Overall Study|Lost to Follow-up|0|||
129802786|NCT02038881|467247428|FG000|Overall Study|incarcerated|1|||
129715992|NCT01238991|466920055|FG008|Overall Study|Withdrawal by Subject|0|||
129715993|NCT01238991|466920056|FG009|Overall Study|Withdrawal by Subject|0|||
129715994|NCT01238991|466920047|FG000|Overall Study|Study Terminated by Sponsor|0|||
129715995|NCT01238991|466920048|FG001|Overall Study|Study Terminated by Sponsor|0|||
129715996|NCT01238991|466920049|FG002|Overall Study|Study Terminated by Sponsor|0|||
129715997|NCT01238991|466920050|FG003|Overall Study|Study Terminated by Sponsor|0|||
129715998|NCT01238991|466920051|FG004|Overall Study|Study Terminated by Sponsor|1|||
129715999|NCT01238991|466920052|FG005|Overall Study|Study Terminated by Sponsor|0|||
129716000|NCT01238991|466920053|FG006|Overall Study|Study Terminated by Sponsor|7|||
129716001|NCT01238991|466920054|FG007|Overall Study|Study Terminated by Sponsor|4|||
129716002|NCT01238991|466920055|FG008|Overall Study|Study Terminated by Sponsor|2|||
129716003|NCT01238991|466920056|FG009|Overall Study|Study Terminated by Sponsor|2|||
129716004|NCT01238991|466920047|FG000|Overall Study|Caregiver's request|0|||
129716005|NCT01238991|466920048|FG001|Overall Study|Caregiver's request|0|||
129716006|NCT01238991|466920049|FG002|Overall Study|Caregiver's request|0|||
129716007|NCT01238991|466920050|FG003|Overall Study|Caregiver's request|0|||
129802787|NCT02038881|467247429|FG001|Overall Study|incarcerated|0|||
129802788|NCT02038881|467247430|FG002|Overall Study|incarcerated|0|||
129802789|NCT00333840|467247431|FG000|First-line Treatment Period|Adverse Event|38|||
129716008|NCT01238991|466920051|FG004|Overall Study|Caregiver's request|0|||
129716009|NCT01238991|466920052|FG005|Overall Study|Caregiver's request|0|||
129716010|NCT01238991|466920053|FG006|Overall Study|Caregiver's request|0|||
129716011|NCT01238991|466920054|FG007|Overall Study|Caregiver's request|0|||
129716012|NCT01238991|466920055|FG008|Overall Study|Caregiver's request|1|||
129716013|NCT01238991|466920056|FG009|Overall Study|Caregiver's request|0|||
129716014|NCT01238991|466920047|FG000|Overall Study|Admission to a nursing home|1|||
129716015|NCT01238991|466920048|FG001|Overall Study|Admission to a nursing home|0|||
129716016|NCT01238991|466920049|FG002|Overall Study|Admission to a nursing home|1|||
129716017|NCT01238991|466920050|FG003|Overall Study|Admission to a nursing home|0|||
129716018|NCT01238991|466920051|FG004|Overall Study|Admission to a nursing home|0|||
129716019|NCT01238991|466920052|FG005|Overall Study|Admission to a nursing home|0|||
129716020|NCT01238991|466920053|FG006|Overall Study|Admission to a nursing home|0|||
129716021|NCT01238991|466920054|FG007|Overall Study|Admission to a nursing home|0|||
129716022|NCT01238991|466920055|FG008|Overall Study|Admission to a nursing home|0|||
129716023|NCT01238991|466920056|FG009|Overall Study|Admission to a nursing home|0|||
129716024|NCT03370419|466920057|FG000|Overall Study|Lost to Follow-up|16|||
129716025|NCT00600106|466920063|FG000|Overall Study|Withdrawal by Subject|1|||
129716026|NCT00600106|466920064|FG001|Overall Study|Withdrawal by Subject|1|||
129716027|NCT01897727|466920065|FG000|Overall Study|Exclusion: central sleep apnea|0|||
129716028|NCT01897727|466920066|FG001|Overall Study|Exclusion: central sleep apnea|1|||
129716029|NCT03015363|466920067|FG000|Overall Study|Physician Decision|14|||
129716030|NCT03015363|466920067|FG000|Overall Study|Withdrawal by Subject|3|||
129716031|NCT00078806|466920068|FG000|Part 1A|Adverse Event|2|||
129716032|NCT00078806|466920069|FG001|Part 1A|Adverse Event|0|||
129716033|NCT00078806|466920070|FG002|Part 1A|Adverse Event|0|||
129716034|NCT00078806|466920071|FG003|Part 1A|Adverse Event|0|||
129716035|NCT00078806|466920068|FG000|Part 1A|Lack of Efficacy|7|||
129716036|NCT00078806|466920069|FG001|Part 1A|Lack of Efficacy|0|||
129716037|NCT00078806|466920070|FG002|Part 1A|Lack of Efficacy|0|||
129716038|NCT00078806|466920071|FG003|Part 1A|Lack of Efficacy|0|||
129716039|NCT00078806|466920068|FG000|Part 1A|Other|1|||
129716040|NCT00078806|466920069|FG001|Part 1A|Other|0|||
129716041|NCT00078806|466920070|FG002|Part 1A|Other|0|||
129716042|NCT00078806|466920071|FG003|Part 1A|Other|0|||
129716043|NCT00078806|466920068|FG000|Part 1B|Adverse Event|1|||
129802790|NCT00333840|467247432|FG001|First-line Treatment Period|Adverse Event|37|||
129802791|NCT00333840|467247433|FG002|First-line Treatment Period|Adverse Event|0|||
129802792|NCT00333840|467247434|FG003|First-line Treatment Period|Adverse Event|0|||
129891432|NCT02192359|467559730|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
129891433|NCT02192359|467559731|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
129891434|NCT02192359|467559732|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
129891435|NCT02192359|467559733|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
129891436|NCT02192359|467559730|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
129716044|NCT00078806|466920069|FG001|Part 1B|Adverse Event|0|||
129716045|NCT00078806|466920070|FG002|Part 1B|Adverse Event|0|||
129716046|NCT00078806|466920071|FG003|Part 1B|Adverse Event|0|||
129716047|NCT00078806|466920068|FG000|Part 1B|Lack of Efficacy|7|||
129716048|NCT00078806|466920069|FG001|Part 1B|Lack of Efficacy|0|||
129716049|NCT00078806|466920070|FG002|Part 1B|Lack of Efficacy|0|||
129802793|NCT00333840|467247431|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
129802794|NCT00333840|467247432|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
129802795|NCT00333840|467247433|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
129802796|NCT00333840|467247434|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
129891437|NCT02192359|467559731|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
129716050|NCT00078806|466920071|FG003|Part 1B|Lack of Efficacy|0|||
129716051|NCT00078806|466920068|FG000|Part 2|Adverse Event|0|||
129716052|NCT00078806|466920069|FG001|Part 2|Adverse Event|1|||
129716053|NCT00078806|466920070|FG002|Part 2|Adverse Event|0|||
129444296|NCT03308942|465927285|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
129444297|NCT03308942|465927286|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
129444298|NCT03308942|465927287|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
129444299|NCT03308942|465927283|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
129444300|NCT03308942|465927284|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
129444301|NCT03308942|465927285|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
129444302|NCT03308942|465927286|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
129444303|NCT03308942|465927287|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
129444304|NCT03308942|465927283|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
129444305|NCT03308942|465927284|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
129444306|NCT03308942|465927285|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
129444307|NCT03308942|465927286|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
129444308|NCT03308942|465927287|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
129444309|NCT02294682|465927288|FG000|Overall Study|Could not swallow pills|1|||
129444310|NCT02294682|465927289|FG001|Overall Study|Could not swallow pills|0|||
129444311|NCT03422172|465927292|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
129444312|NCT03422172|465927292|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
129444313|NCT03422172|465927292|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
129444314|NCT01187550|465927295|FG000|Overall Study|Protocol Violation|3|||
129716054|NCT00078806|466920071|FG003|Part 2|Adverse Event|0|||
129716055|NCT01734785|466920074|FG000|Open-Label Period|Adverse Event|0|||
129716056|NCT01734785|466920075|FG001|Open-Label Period|Adverse Event|0|||
129716057|NCT01734785|466920076|FG002|Open-Label Period|Adverse Event|0|||
129716058|NCT01734785|466920077|FG003|Open-Label Period|Adverse Event|9|||
129716059|NCT01734785|466920074|FG000|Open-Label Period|Lack of Efficacy|0|||
129716060|NCT01734785|466920075|FG001|Open-Label Period|Lack of Efficacy|0|||
129716061|NCT01734785|466920076|FG002|Open-Label Period|Lack of Efficacy|0|||
129716062|NCT01734785|466920077|FG003|Open-Label Period|Lack of Efficacy|1|||
129716063|NCT01734785|466920074|FG000|Open-Label Period|Protocol Violation|0|||
129716064|NCT01734785|466920075|FG001|Open-Label Period|Protocol Violation|0|||
129716065|NCT01734785|466920076|FG002|Open-Label Period|Protocol Violation|0|||
129716066|NCT01734785|466920077|FG003|Open-Label Period|Protocol Violation|13|||
129716067|NCT01734785|466920074|FG000|Open-Label Period|Lost to Follow-up|0|||
129716068|NCT01734785|466920075|FG001|Open-Label Period|Lost to Follow-up|0|||
129716069|NCT01734785|466920076|FG002|Open-Label Period|Lost to Follow-up|0|||
129716070|NCT01734785|466920077|FG003|Open-Label Period|Lost to Follow-up|14|||
129716071|NCT01734785|466920074|FG000|Open-Label Period|Withdrawal by Subject|0|||
129716072|NCT01734785|466920075|FG001|Open-Label Period|Withdrawal by Subject|0|||
129716073|NCT01734785|466920076|FG002|Open-Label Period|Withdrawal by Subject|0|||
129716074|NCT01734785|466920077|FG003|Open-Label Period|Withdrawal by Subject|12|||
129716075|NCT01734785|466920074|FG000|Open-Label Period|Other Reasons|0|||
129716076|NCT01734785|466920075|FG001|Open-Label Period|Other Reasons|0|||
129716077|NCT01734785|466920076|FG002|Open-Label Period|Other Reasons|0|||
129716078|NCT01734785|466920077|FG003|Open-Label Period|Other Reasons|224|||
129716079|NCT01734785|466920074|FG000|Double-Blind Period|Adverse Event|0|||
129716080|NCT01734785|466920075|FG001|Double-Blind Period|Adverse Event|3|||
129716081|NCT01734785|466920076|FG002|Double-Blind Period|Adverse Event|2|||
129716082|NCT01734785|466920077|FG003|Double-Blind Period|Adverse Event|0|||
129716083|NCT01734785|466920074|FG000|Double-Blind Period|Lack of Efficacy|0|||
129716084|NCT01734785|466920075|FG001|Double-Blind Period|Lack of Efficacy|1|||
129716085|NCT01734785|466920076|FG002|Double-Blind Period|Lack of Efficacy|0|||
129716086|NCT01734785|466920077|FG003|Double-Blind Period|Lack of Efficacy|0|||
129716087|NCT01734785|466920074|FG000|Double-Blind Period|Protocol Violation|0|||
129716088|NCT01734785|466920075|FG001|Double-Blind Period|Protocol Violation|1|||
129716089|NCT01734785|466920076|FG002|Double-Blind Period|Protocol Violation|1|||
129716090|NCT01734785|466920077|FG003|Double-Blind Period|Protocol Violation|0|||
129716091|NCT01734785|466920074|FG000|Double-Blind Period|Lost to Follow-up|2|||
129716092|NCT01734785|466920075|FG001|Double-Blind Period|Lost to Follow-up|4|||
129716093|NCT01734785|466920076|FG002|Double-Blind Period|Lost to Follow-up|2|||
129716094|NCT01734785|466920077|FG003|Double-Blind Period|Lost to Follow-up|0|||
129716095|NCT01734785|466920074|FG000|Double-Blind Period|Withdrawal by Subject|2|||
129716096|NCT01734785|466920075|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129716097|NCT01734785|466920076|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129716098|NCT01734785|466920077|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129716099|NCT01734785|466920074|FG000|Double-Blind Period|Not treated|1|||
129716100|NCT01734785|466920075|FG001|Double-Blind Period|Not treated|0|||
129716101|NCT01734785|466920076|FG002|Double-Blind Period|Not treated|0|||
129716102|NCT01734785|466920077|FG003|Double-Blind Period|Not treated|0|||
129716103|NCT00566982|466920078|FG000|Overall Study|Adverse Event|6|||
129716104|NCT00566982|466920079|FG001|Overall Study|Adverse Event|48|||
129716105|NCT00566982|466920078|FG000|Overall Study|Withdrawal by Subject|1|||
129716106|NCT00566982|466920079|FG001|Overall Study|Withdrawal by Subject|14|||
129716107|NCT00566982|466920078|FG000|Overall Study|Protocol Violation|1|||
129716108|NCT00566982|466920079|FG001|Overall Study|Protocol Violation|4|||
129716109|NCT00566982|466920078|FG000|Overall Study|Lost to Follow-up|0|||
129716110|NCT00566982|466920079|FG001|Overall Study|Lost to Follow-up|1|||
129716111|NCT00566982|466920078|FG000|Overall Study|Other-family problems & doctor's request|0|||
129716112|NCT00566982|466920079|FG001|Overall Study|Other-family problems & doctor's request|2|||
129716113|NCT02013778|466920085|FG000|Overall Study|Death|4|||
129716114|NCT02013778|466920085|FG000|Overall Study|Withdrawal by Subject|1|||
129716115|NCT02013778|466920085|FG000|Overall Study|Physician Decision|1|||
129716116|NCT02013778|466920085|FG000|Overall Study|Adverse Event|1|||
129716117|NCT00293813|466920086|FG000|Overall Study|Physician Decision|0|||
129716118|NCT00293813|466920087|FG001|Overall Study|Physician Decision|1|||
129716119|NCT00293813|466920088|FG002|Overall Study|Physician Decision|0|||
129716120|NCT00293813|466920086|FG000|Overall Study|Adverse Event|3|||
129716121|NCT00293813|466920087|FG001|Overall Study|Adverse Event|1|||
129716122|NCT00293813|466920088|FG002|Overall Study|Adverse Event|1|||
129716123|NCT00293813|466920086|FG000|Overall Study|Withdrawal by Subject|7|||
129716124|NCT00293813|466920087|FG001|Overall Study|Withdrawal by Subject|4|||
129716125|NCT00293813|466920088|FG002|Overall Study|Withdrawal by Subject|4|||
129716126|NCT00293813|466920086|FG000|Overall Study|Lost to Follow-up|3|||
129716127|NCT00293813|466920087|FG001|Overall Study|Lost to Follow-up|2|||
129716128|NCT00293813|466920088|FG002|Overall Study|Lost to Follow-up|3|||
129716129|NCT00293813|466920086|FG000|Overall Study|Noncompliance|0|||
129802797|NCT00333840|467247431|FG000|First-line Treatment Period|Abnormal procedure|2|||
129802798|NCT00333840|467247432|FG001|First-line Treatment Period|Abnormal procedure|0|||
129802799|NCT00333840|467247433|FG002|First-line Treatment Period|Abnormal procedure|0|||
129802800|NCT00333840|467247434|FG003|First-line Treatment Period|Abnormal procedure|0|||
129802801|NCT00333840|467247431|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
129802802|NCT00333840|467247432|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
129802803|NCT00333840|467247433|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129716130|NCT00293813|466920087|FG001|Overall Study|Noncompliance|1|||
129716131|NCT00293813|466920088|FG002|Overall Study|Noncompliance|0|||
129716132|NCT01465386|466920092|FG000|Overall Study|Lack of Efficacy|3|||
129716133|NCT01465386|466920092|FG000|Overall Study|Adverse Event|1|||
129716134|NCT00473889|466920093|FG000|Overall Study|Did not receive study medication|1|||
129716135|NCT00473889|466920094|FG001|Overall Study|Did not receive study medication|4|||
129716136|NCT00473889|466920093|FG000|Overall Study|Adverse Event|30|||
129716137|NCT00473889|466920094|FG001|Overall Study|Adverse Event|17|||
129716138|NCT00473889|466920093|FG000|Overall Study|Protocol Violation|4|||
129716139|NCT00473889|466920094|FG001|Overall Study|Protocol Violation|2|||
129716140|NCT00473889|466920093|FG000|Overall Study|Lack of Efficacy|28|||
129716141|NCT00473889|466920094|FG001|Overall Study|Lack of Efficacy|29|||
129716142|NCT00473889|466920093|FG000|Overall Study|Lost to Follow-up|2|||
129716143|NCT00473889|466920094|FG001|Overall Study|Lost to Follow-up|1|||
129716144|NCT00473889|466920093|FG000|Overall Study|Physician Decision|10|||
129716145|NCT00473889|466920094|FG001|Overall Study|Physician Decision|5|||
129716146|NCT00473889|466920093|FG000|Overall Study|Trial Terminated|3|||
129716147|NCT00473889|466920094|FG001|Overall Study|Trial Terminated|6|||
129716148|NCT00473889|466920093|FG000|Overall Study|Withdrawal by Subject|5|||
129716149|NCT00473889|466920094|FG001|Overall Study|Withdrawal by Subject|0|||
129716150|NCT00833469|466920095|FG000|Overall Study|Withdrawal by Subject|1|||
129716151|NCT00833469|466920095|FG000|Overall Study|Lost to Follow-up|1|||
129716152|NCT03592771|466920096|FG000|Overall Study|Adverse Event|2|||
129716153|NCT03592771|466920097|FG001|Overall Study|Adverse Event|0|||
129716154|NCT03592771|466920098|FG002|Overall Study|Adverse Event|1|||
129716155|NCT03592771|466920096|FG000|Overall Study|Death|0|||
129716156|NCT03592771|466920097|FG001|Overall Study|Death|1|||
129716157|NCT03592771|466920098|FG002|Overall Study|Death|1|||
129716158|NCT03592771|466920096|FG000|Overall Study|Lost to Follow-up|5|||
129716159|NCT03592771|466920097|FG001|Overall Study|Lost to Follow-up|11|||
129716160|NCT03592771|466920098|FG002|Overall Study|Lost to Follow-up|15|||
129716161|NCT03592771|466920096|FG000|Overall Study|Withdrawal by Subject|0|||
129716162|NCT03592771|466920097|FG001|Overall Study|Withdrawal by Subject|2|||
129716163|NCT03592771|466920098|FG002|Overall Study|Withdrawal by Subject|0|||
129716164|NCT04830215|466920099|FG000|Overall Study|Adverse Event|6|||
129716165|NCT04830215|466920099|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
129716166|NCT04830215|466920099|FG000|Overall Study|Withdrawal by Subject|3|||
129716167|NCT04830215|466920099|FG000|Overall Study|Protocol Deviation|1|||
129716168|NCT02236572|466920100|FG000|Overall Study|Withdrawal by Subject|1|||
129716169|NCT02236572|466920100|FG000|Overall Study|Protocol Violation|1|||
129716170|NCT02236572|466920100|FG000|Overall Study|Lost to Follow-up|1|||
129716171|NCT02443337|466920101|FG000|Overall Study|Adverse Event|0|||
129716172|NCT02443337|466920102|FG001|Overall Study|Adverse Event|1|||
129716173|NCT02443337|466920101|FG000|Overall Study|Clinical Progressive Disease|3|||
129716174|NCT02443337|466920102|FG001|Overall Study|Clinical Progressive Disease|0|||
129716175|NCT02443337|466920101|FG000|Overall Study|Withdrawal by Subject|2|||
129716176|NCT02443337|466920102|FG001|Overall Study|Withdrawal by Subject|1|||
129716177|NCT00709319|466920103|FG000|Overall Study|Death|4|||
129716178|NCT00709319|466920103|FG000|Overall Study|Withdrawal by Subject|2|||
129716179|NCT00579553|466920104|FG000|Overall Study|Lost to Follow-up|16|||
129716180|NCT00579553|466920105|FG001|Overall Study|Lost to Follow-up|13|||
129716181|NCT00635349|466920106|FG000|Overall Study|Other|8|||
129716182|NCT00635349|466920107|FG001|Overall Study|Other|6|||
129716183|NCT00635349|466920106|FG000|Overall Study|Protocol Violation|18|||
129716184|NCT00635349|466920107|FG001|Overall Study|Protocol Violation|22|||
129716185|NCT00635349|466920106|FG000|Overall Study|Withdrawal by Subject|3|||
129716186|NCT00635349|466920107|FG001|Overall Study|Withdrawal by Subject|8|||
129716187|NCT00635349|466920106|FG000|Overall Study|Lost to Follow-up|4|||
129716188|NCT00635349|466920107|FG001|Overall Study|Lost to Follow-up|3|||
129716189|NCT00635349|466920106|FG000|Overall Study|Adverse Event|11|||
129716190|NCT00635349|466920107|FG001|Overall Study|Adverse Event|9|||
129716191|NCT00049322|466920109|FG000|Overall Study|disease burden|0|||
129716192|NCT00049322|466920110|FG001|Overall Study|disease burden|3|||
129716193|NCT00049322|466920109|FG000|Overall Study|Adverse Event|1|||
129716194|NCT00049322|466920110|FG001|Overall Study|Adverse Event|0|||
129716195|NCT00049322|466920109|FG000|Overall Study|refused angio|0|||
129716196|NCT00049322|466920110|FG001|Overall Study|refused angio|3|||
129716197|NCT03072043|466920111|FG000|Overall Study|Death|0|||
129716198|NCT03072043|466920112|FG001|Overall Study|Death|0|||
129716199|NCT03072043|466920113|FG002|Overall Study|Death|3|||
129716200|NCT03072043|466920111|FG000|Overall Study|Adverse Event|0|||
129716201|NCT03072043|466920112|FG001|Overall Study|Adverse Event|0|||
129716202|NCT03072043|466920113|FG002|Overall Study|Adverse Event|2|||
129716203|NCT03072043|466920111|FG000|Overall Study|Withdrawal by Subject|0|||
129716204|NCT03072043|466920112|FG001|Overall Study|Withdrawal by Subject|0|||
129716205|NCT03072043|466920113|FG002|Overall Study|Withdrawal by Subject|4|||
129716206|NCT01340664|466920114|FG000|Overall Study|Adverse Event|0|||
129716207|NCT01340664|466920115|FG001|Overall Study|Adverse Event|1|||
129716208|NCT01340664|466920116|FG002|Overall Study|Adverse Event|7|||
129716209|NCT01340664|466920114|FG000|Overall Study|Lost to Follow-up|2|||
129716210|NCT01340664|466920115|FG001|Overall Study|Lost to Follow-up|0|||
129716211|NCT01340664|466920116|FG002|Overall Study|Lost to Follow-up|2|||
129716212|NCT01340664|466920114|FG000|Overall Study|Withdrawal by Subject|2|||
129716213|NCT01340664|466920115|FG001|Overall Study|Withdrawal by Subject|4|||
129802804|NCT00333840|467247434|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802805|NCT00333840|467247431|FG000|First-line Treatment Period|No longer required study drug|21|||
129802806|NCT00333840|467247432|FG001|First-line Treatment Period|No longer required study drug|8|||
129802807|NCT00333840|467247433|FG002|First-line Treatment Period|No longer required study drug|0|||
129802808|NCT00333840|467247434|FG003|First-line Treatment Period|No longer required study drug|0|||
129802809|NCT00333840|467247431|FG000|First-line Treatment Period|Protocol Violation|17|||
129802810|NCT00333840|467247432|FG001|First-line Treatment Period|Protocol Violation|17|||
129802811|NCT00333840|467247433|FG002|First-line Treatment Period|Protocol Violation|0|||
129802812|NCT00333840|467247434|FG003|First-line Treatment Period|Protocol Violation|0|||
129802813|NCT00333840|467247431|FG000|First-line Treatment Period|Subject withdrew consent|57|||
129802814|NCT00333840|467247432|FG001|First-line Treatment Period|Subject withdrew consent|77|||
129802815|NCT00333840|467247433|FG002|First-line Treatment Period|Subject withdrew consent|0|||
129802816|NCT00333840|467247434|FG003|First-line Treatment Period|Subject withdrew consent|0|||
129716214|NCT01340664|466920116|FG002|Overall Study|Withdrawal by Subject|0|||
129802817|NCT00333840|467247431|FG000|First-line Treatment Period|Lost to Follow-up|15|||
129802818|NCT00333840|467247432|FG001|First-line Treatment Period|Lost to Follow-up|6|||
129802819|NCT00333840|467247433|FG002|First-line Treatment Period|Lost to Follow-up|0|||
129802820|NCT00333840|467247434|FG003|First-line Treatment Period|Lost to Follow-up|0|||
129802821|NCT00333840|467247431|FG000|First-line Treatment Period|Administrative problems|12|||
129802822|NCT00333840|467247432|FG001|First-line Treatment Period|Administrative problems|6|||
129802823|NCT00333840|467247433|FG002|First-line Treatment Period|Administrative problems|0|||
129802824|NCT00333840|467247434|FG003|First-line Treatment Period|Administrative problems|0|||
129802825|NCT00333840|467247431|FG000|First-line Treatment Period|Death|19|||
129802826|NCT00333840|467247432|FG001|First-line Treatment Period|Death|2|||
129802827|NCT00333840|467247433|FG002|First-line Treatment Period|Death|0|||
129802828|NCT00333840|467247434|FG003|First-line Treatment Period|Death|0|||
129802829|NCT00333840|467247431|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
129802830|NCT00333840|467247432|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
129802831|NCT00333840|467247433|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
129802832|NCT00333840|467247434|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
129802833|NCT00333840|467247431|FG000|Second-line Treatment Period|Adverse Event|0|||
129802834|NCT00333840|467247432|FG001|Second-line Treatment Period|Adverse Event|0|||
129802835|NCT00333840|467247433|FG002|Second-line Treatment Period|Adverse Event|3|||
129802836|NCT00333840|467247434|FG003|Second-line Treatment Period|Adverse Event|34|||
129802837|NCT00333840|467247431|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
129891438|NCT02192359|467559732|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
129891439|NCT02192359|467559733|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
129891440|NCT02192359|467559730|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
129891441|NCT02192359|467559731|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
129891442|NCT02192359|467559732|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
129891443|NCT02192359|467559733|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
129891444|NCT04951479|467559734|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
129891445|NCT05567952|467561109|FG000|Overall Study|Lost to Follow-up|3|||
129891446|NCT05567952|467561110|FG001|Overall Study|Lost to Follow-up|2|||
129891447|NCT05567952|467561109|FG000|Overall Study|Withdrawal by Subject|6|||
129716215|NCT01340664|466920114|FG000|Overall Study|Glycemic withdrawal criteria|2|||
129716216|NCT01340664|466920115|FG001|Overall Study|Glycemic withdrawal criteria|0|||
129716217|NCT01340664|466920116|FG002|Overall Study|Glycemic withdrawal criteria|0|||
129716218|NCT01340664|466920114|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
129716219|NCT01340664|466920115|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
129716220|NCT01340664|466920116|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
129716221|NCT01340664|466920114|FG000|Overall Study|Other|1|||
129716222|NCT01340664|466920115|FG001|Overall Study|Other|2|||
129716223|NCT01340664|466920116|FG002|Overall Study|Other|2|||
129716224|NCT01140867|466920119|FG000|Overall Study|Adverse Event|22|||
129716225|NCT01140867|466920119|FG000|Overall Study|Lack of Efficacy|3|||
129716226|NCT01140867|466920119|FG000|Overall Study|Lost to Follow-up|2|||
129716227|NCT01140867|466920119|FG000|Overall Study|Withdrawal by Subject|1|||
129716228|NCT01140867|466920119|FG000|Overall Study|Protocol Violation|1|||
129716229|NCT01140867|466920119|FG000|Overall Study|Uncooperative patient|2|||
129716230|NCT01140867|466920119|FG000|Overall Study|Medication Noncompliance|2|||
129716231|NCT02997865|466920121|FG000|Overall Study|Death|2|||
129716232|NCT02997865|466920122|FG001|Overall Study|Death|1|||
129802838|NCT00333840|467247432|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
129891448|NCT05567952|467561110|FG001|Overall Study|Withdrawal by Subject|3|||
129891449|NCT05567952|467561109|FG000|Overall Study|Other|3|||
129891450|NCT05567952|467561110|FG001|Overall Study|Other|1|||
129891451|NCT00777803|467561111|FG000|Overall Study|Lost to Follow-up|12|||
129891452|NCT00777803|467561112|FG001|Overall Study|Lost to Follow-up|5|||
129891453|NCT00777803|467561111|FG000|Overall Study|Adverse Event|1|||
129716233|NCT02997865|466920121|FG000|Overall Study|Lost to Follow-up|6|||
129716234|NCT02997865|466920122|FG001|Overall Study|Lost to Follow-up|3|||
129716235|NCT02997865|466920121|FG000|Overall Study|Withdrawal by Subject|5|||
129716236|NCT02997865|466920122|FG001|Overall Study|Withdrawal by Subject|0|||
129716237|NCT01926444|466920123|FG000|Overall Study|Colonoscopy not performed|0|||
129716238|NCT01926444|466920124|FG001|Overall Study|Colonoscopy not performed|0|||
129716239|NCT01926444|466920125|FG002|Overall Study|Colonoscopy not performed|4|||
129716240|NCT01926444|466920126|FG003|Overall Study|Colonoscopy not performed|2|||
129716241|NCT02441101|466920133|FG000|Overall Study|Withdrawal by Subject|1|||
129716242|NCT02441101|466920134|FG001|Overall Study|Withdrawal by Subject|0|||
129716243|NCT02441101|466920133|FG000|Overall Study|Lost to Follow-up|1|||
129716244|NCT02441101|466920134|FG001|Overall Study|Lost to Follow-up|0|||
129716245|NCT02441101|466920133|FG000|Overall Study|PI relocated and study terminated|1|||
129716246|NCT02441101|466920134|FG001|Overall Study|PI relocated and study terminated|0|||
129716247|NCT02528942|466920136|FG000|Overall Study|Did not meet imaging criteria|9|||
129716248|NCT02528942|466920136|FG000|Overall Study|Lost to Follow-up|25|||
129716249|NCT00881530|466920137|FG000|Overall Study|Adverse Event|5|||
129716250|NCT00881530|466920138|FG001|Overall Study|Adverse Event|1|||
129716251|NCT00881530|466920139|FG002|Overall Study|Adverse Event|1|||
129716252|NCT00881530|466920140|FG003|Overall Study|Adverse Event|4|||
129716253|NCT00881530|466920141|FG004|Overall Study|Adverse Event|10|||
129716254|NCT00881530|466920142|FG005|Overall Study|Adverse Event|2|||
129716255|NCT00881530|466920137|FG000|Overall Study|Lack of Efficacy|1|||
129716256|NCT00881530|466920138|FG001|Overall Study|Lack of Efficacy|0|||
129716257|NCT00881530|466920139|FG002|Overall Study|Lack of Efficacy|0|||
129716258|NCT00881530|466920140|FG003|Overall Study|Lack of Efficacy|0|||
129716259|NCT00881530|466920141|FG004|Overall Study|Lack of Efficacy|1|||
129716260|NCT00881530|466920142|FG005|Overall Study|Lack of Efficacy|1|||
129716261|NCT00881530|466920137|FG000|Overall Study|Not compliant with the protocol|0|||
129716262|NCT00881530|466920138|FG001|Overall Study|Not compliant with the protocol|0|||
129716263|NCT00881530|466920139|FG002|Overall Study|Not compliant with the protocol|0|||
129716264|NCT00881530|466920140|FG003|Overall Study|Not compliant with the protocol|0|||
129716265|NCT00881530|466920141|FG004|Overall Study|Not compliant with the protocol|2|||
129716266|NCT00881530|466920142|FG005|Overall Study|Not compliant with the protocol|0|||
129716267|NCT00881530|466920137|FG000|Overall Study|Lost to Follow-up|0|||
129716268|NCT00881530|466920138|FG001|Overall Study|Lost to Follow-up|1|||
129716269|NCT00881530|466920139|FG002|Overall Study|Lost to Follow-up|1|||
129716270|NCT00881530|466920140|FG003|Overall Study|Lost to Follow-up|3|||
129716271|NCT00881530|466920141|FG004|Overall Study|Lost to Follow-up|1|||
129716272|NCT00881530|466920142|FG005|Overall Study|Lost to Follow-up|0|||
129716273|NCT00881530|466920137|FG000|Overall Study|Refused to continue medication|7|||
129716274|NCT00881530|466920138|FG001|Overall Study|Refused to continue medication|2|||
129716275|NCT00881530|466920139|FG002|Overall Study|Refused to continue medication|1|||
129716276|NCT00881530|466920140|FG003|Overall Study|Refused to continue medication|2|||
129716277|NCT00881530|466920141|FG004|Overall Study|Refused to continue medication|0|||
129716278|NCT00881530|466920142|FG005|Overall Study|Refused to continue medication|0|||
129716279|NCT00881530|466920137|FG000|Overall Study|Other reason not defined above|1|||
129716280|NCT00881530|466920138|FG001|Overall Study|Other reason not defined above|1|||
129716281|NCT00881530|466920139|FG002|Overall Study|Other reason not defined above|2|||
129716282|NCT00881530|466920140|FG003|Overall Study|Other reason not defined above|0|||
129716283|NCT00881530|466920141|FG004|Overall Study|Other reason not defined above|0|||
129716284|NCT00881530|466920142|FG005|Overall Study|Other reason not defined above|2|||
129716285|NCT01509846|466920143|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
129716286|NCT01509846|466920144|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
129716287|NCT01509846|466920145|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
129716288|NCT01509846|466920146|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
129716289|NCT01509846|466920147|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
129716290|NCT01509846|466920143|FG000|Received Vaccination 2|Illness|0|||
129716291|NCT01509846|466920144|FG001|Received Vaccination 2|Illness|0|||
129716292|NCT01509846|466920145|FG002|Received Vaccination 2|Illness|0|||
129716293|NCT01509846|466920146|FG003|Received Vaccination 2|Illness|0|||
129716294|NCT01509846|466920147|FG004|Received Vaccination 2|Illness|1|||
129716295|NCT01509846|466920143|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
129716296|NCT01509846|466920144|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
129802839|NCT00333840|467247433|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
129716297|NCT01509846|466920145|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
129716298|NCT01509846|466920146|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
129802840|NCT00333840|467247434|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
129802841|NCT00333840|467247431|FG000|Second-line Treatment Period|Abnormal procedure|0|||
129716299|NCT01509846|466920147|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
129716300|NCT01509846|466920143|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
129716301|NCT01509846|466920144|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
129716302|NCT01509846|466920145|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
129716303|NCT01509846|466920146|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
129716304|NCT01509846|466920147|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
129716305|NCT01509846|466920143|FG000|Received Vaccination 3|Pregnancy|0|||
129802842|NCT00333840|467247432|FG001|Second-line Treatment Period|Abnormal procedure|0|||
129802843|NCT00333840|467247433|FG002|Second-line Treatment Period|Abnormal procedure|0|||
129802844|NCT00333840|467247434|FG003|Second-line Treatment Period|Abnormal procedure|1|||
129802845|NCT00333840|467247431|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802846|NCT00333840|467247432|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
129802847|NCT00333840|467247433|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
129802848|NCT00333840|467247434|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
129802849|NCT00333840|467247431|FG000|Second-line Treatment Period|No longer required study drug|0|||
129802850|NCT00333840|467247432|FG001|Second-line Treatment Period|No longer required study drug|0|||
129802851|NCT00333840|467247433|FG002|Second-line Treatment Period|No longer required study drug|1|||
129802852|NCT00333840|467247434|FG003|Second-line Treatment Period|No longer required study drug|14|||
129802853|NCT00333840|467247431|FG000|Second-line Treatment Period|Protocol Violation|0|||
129802854|NCT00333840|467247432|FG001|Second-line Treatment Period|Protocol Violation|0|||
129802855|NCT00333840|467247433|FG002|Second-line Treatment Period|Protocol Violation|1|||
129802856|NCT00333840|467247434|FG003|Second-line Treatment Period|Protocol Violation|10|||
129802857|NCT00333840|467247431|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
129802858|NCT00333840|467247432|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
129802859|NCT00333840|467247433|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
129802860|NCT00333840|467247434|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
129802861|NCT00333840|467247431|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
129802862|NCT00333840|467247432|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
129802863|NCT00333840|467247433|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
129802864|NCT00333840|467247434|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
129802865|NCT00333840|467247431|FG000|Second-line Treatment Period|Administrative problems|0|||
129802866|NCT00333840|467247432|FG001|Second-line Treatment Period|Administrative problems|0|||
129802867|NCT00333840|467247433|FG002|Second-line Treatment Period|Administrative problems|0|||
129802868|NCT00333840|467247434|FG003|Second-line Treatment Period|Administrative problems|7|||
129802869|NCT00333840|467247431|FG000|Second-line Treatment Period|Death|0|||
129802870|NCT00333840|467247432|FG001|Second-line Treatment Period|Death|0|||
129802871|NCT00333840|467247433|FG002|Second-line Treatment Period|Death|0|||
129802872|NCT00333840|467247434|FG003|Second-line Treatment Period|Death|9|||
129802873|NCT01453725|467247435|FG000|Overall Study|Adverse Event|3|||
129802874|NCT01453725|467247436|FG001|Overall Study|Adverse Event|3|||
129802875|NCT01453725|467247435|FG000|Overall Study|Lost to Follow-up|4|||
129802876|NCT01453725|467247436|FG001|Overall Study|Lost to Follow-up|0|||
129891454|NCT00777803|467561112|FG001|Overall Study|Adverse Event|0|||
129716306|NCT01509846|466920144|FG001|Received Vaccination 3|Pregnancy|0|||
129716307|NCT01509846|466920145|FG002|Received Vaccination 3|Pregnancy|0|||
129716308|NCT01509846|466920146|FG003|Received Vaccination 3|Pregnancy|1|||
129716309|NCT01509846|466920147|FG004|Received Vaccination 3|Pregnancy|0|||
129716310|NCT01509846|466920143|FG000|Received Vaccination 3|Lost to Follow-up|0|||
129716311|NCT01509846|466920144|FG001|Received Vaccination 3|Lost to Follow-up|0|||
129716312|NCT01509846|466920145|FG002|Received Vaccination 3|Lost to Follow-up|1|||
129716313|NCT01509846|466920146|FG003|Received Vaccination 3|Lost to Follow-up|0|||
129716314|NCT01509846|466920147|FG004|Received Vaccination 3|Lost to Follow-up|0|||
129716315|NCT01637584|466920148|FG000|Overall Study|Withdrawal by Subject|1|||
129716316|NCT01637584|466920149|FG001|Overall Study|Withdrawal by Subject|3|||
129716317|NCT02969915|466920151|FG000|Overall Study|Death|104|||
129716318|NCT02969915|466920152|FG001|Overall Study|Death|125|||
129716319|NCT02969915|466920151|FG000|Overall Study|Lost to Follow-up|108|||
129716320|NCT02969915|466920152|FG001|Overall Study|Lost to Follow-up|112|||
129716321|NCT02969915|466920151|FG000|Overall Study|Censored due to COVID-19|481|||
129716322|NCT02969915|466920152|FG001|Overall Study|Censored due to COVID-19|471|||
129716323|NCT01393899|466920153|FG000|Overall Study|Study terminated by sponsor|1|||
129716324|NCT01393899|466920154|FG001|Overall Study|Study terminated by sponsor|0|||
129891455|NCT00777803|467561111|FG000|Overall Study|Non-compliance|2|||
129891456|NCT00777803|467561112|FG001|Overall Study|Non-compliance|2|||
129891457|NCT04096365|467561128|FG000|Overall Study|Adverse Event|1|||
129891458|NCT05310084|467561129|FG000|Overall Study|Withdrawal by Subject|2|||
129891459|NCT05310084|467561130|FG001|Overall Study|Withdrawal by Subject|3|||
129802877|NCT01453725|467247435|FG000|Overall Study|Non-compliance With Protocol|1|||
129891460|NCT05310084|467561129|FG000|Overall Study|Participant availability|0|||
129716325|NCT01393899|466920155|FG002|Overall Study|Study terminated by sponsor|1|||
129716326|NCT01393899|466920153|FG000|Overall Study|Other|1|||
129716327|NCT01393899|466920154|FG001|Overall Study|Other|0|||
129716328|NCT01393899|466920155|FG002|Overall Study|Other|0|||
129716329|NCT01393899|466920153|FG000|Overall Study|Withdrawal by Subject|2|||
129716330|NCT01393899|466920154|FG001|Overall Study|Withdrawal by Subject|2|||
129716331|NCT01393899|466920155|FG002|Overall Study|Withdrawal by Subject|1|||
129716332|NCT01393899|466920153|FG000|Overall Study|Lost to Follow-up|0|||
129716333|NCT01393899|466920154|FG001|Overall Study|Lost to Follow-up|0|||
129716334|NCT01393899|466920155|FG002|Overall Study|Lost to Follow-up|1|||
129716335|NCT01393899|466920153|FG000|Overall Study|Does not meet entrance criteria|1|||
129716336|NCT01393899|466920154|FG001|Overall Study|Does not meet entrance criteria|0|||
129716337|NCT01393899|466920155|FG002|Overall Study|Does not meet entrance criteria|1|||
129716338|NCT01393899|466920153|FG000|Overall Study|Lack of Efficacy|26|||
129716339|NCT01393899|466920154|FG001|Overall Study|Lack of Efficacy|21|||
129716340|NCT01393899|466920155|FG002|Overall Study|Lack of Efficacy|16|||
129716341|NCT01393899|466920153|FG000|Overall Study|Adverse Event|1|||
129716342|NCT01393899|466920154|FG001|Overall Study|Adverse Event|5|||
129716343|NCT01393899|466920155|FG002|Overall Study|Adverse Event|3|||
129716344|NCT02503085|466920158|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
129716345|NCT02503085|466920159|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
129716346|NCT02503085|466920160|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
129716347|NCT02503085|466920161|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
129716348|NCT00995436|466920162|FG000|Overall Study|Withdrawal by Subject|2|||
129716349|NCT00995436|466920163|FG001|Overall Study|Withdrawal by Subject|5|||
129716350|NCT00995436|466920164|FG002|Overall Study|Withdrawal by Subject|0|||
129716351|NCT02131662|466920165|FG000|Overall Study|Protocol Violation|1|||
129716352|NCT02131662|466920166|FG001|Overall Study|Protocol Violation|0|||
129716353|NCT02131662|466920167|FG002|Overall Study|Protocol Violation|0|||
129716354|NCT02131662|466920168|FG003|Overall Study|Protocol Violation|0|||
129716355|NCT02131662|466920169|FG004|Overall Study|Protocol Violation|0|||
129716356|NCT02131662|466920165|FG000|Overall Study|Other|2|||
129716357|NCT02131662|466920166|FG001|Overall Study|Other|4|||
129716358|NCT02131662|466920167|FG002|Overall Study|Other|3|||
129716359|NCT02131662|466920168|FG003|Overall Study|Other|3|||
129716360|NCT02131662|466920169|FG004|Overall Study|Other|4|||
129716361|NCT02131662|466920165|FG000|Overall Study|Adverse Event|0|||
129716362|NCT02131662|466920166|FG001|Overall Study|Adverse Event|1|||
129716363|NCT02131662|466920167|FG002|Overall Study|Adverse Event|1|||
129716364|NCT02131662|466920168|FG003|Overall Study|Adverse Event|1|||
129716365|NCT02131662|466920169|FG004|Overall Study|Adverse Event|3|||
129716366|NCT02131662|466920165|FG000|Overall Study|Pregnancy|0|||
129716367|NCT02131662|466920166|FG001|Overall Study|Pregnancy|1|||
129716368|NCT02131662|466920167|FG002|Overall Study|Pregnancy|0|||
129716369|NCT02131662|466920168|FG003|Overall Study|Pregnancy|1|||
129716370|NCT02131662|466920169|FG004|Overall Study|Pregnancy|0|||
129716371|NCT02131662|466920165|FG000|Overall Study|Wish for pregnancy|0|||
129716372|NCT02131662|466920166|FG001|Overall Study|Wish for pregnancy|0|||
129716373|NCT02131662|466920167|FG002|Overall Study|Wish for pregnancy|0|||
129716374|NCT02131662|466920168|FG003|Overall Study|Wish for pregnancy|0|||
129716375|NCT02131662|466920169|FG004|Overall Study|Wish for pregnancy|1|||
129716376|NCT02131662|466920165|FG000|Overall Study|Lack of Efficacy|1|||
129716377|NCT02131662|466920166|FG001|Overall Study|Lack of Efficacy|0|||
129716378|NCT02131662|466920167|FG002|Overall Study|Lack of Efficacy|0|||
129716379|NCT02131662|466920168|FG003|Overall Study|Lack of Efficacy|0|||
129716380|NCT02131662|466920169|FG004|Overall Study|Lack of Efficacy|1|||
129716381|NCT02131662|466920165|FG000|Overall Study|Withdrawal by Subject|1|||
129716382|NCT02131662|466920166|FG001|Overall Study|Withdrawal by Subject|5|||
129716383|NCT02131662|466920167|FG002|Overall Study|Withdrawal by Subject|1|||
129716384|NCT02131662|466920168|FG003|Overall Study|Withdrawal by Subject|5|||
129716385|NCT02131662|466920169|FG004|Overall Study|Withdrawal by Subject|6|||
129716386|NCT02131662|466920165|FG000|Overall Study|Lost to Follow-up|1|||
129716387|NCT02131662|466920166|FG001|Overall Study|Lost to Follow-up|3|||
129716388|NCT02131662|466920167|FG002|Overall Study|Lost to Follow-up|0|||
129716389|NCT02131662|466920168|FG003|Overall Study|Lost to Follow-up|9|||
129716390|NCT02131662|466920169|FG004|Overall Study|Lost to Follow-up|0|||
129716391|NCT02131662|466920165|FG000|Overall Study|Not treated|2|||
129716392|NCT02131662|466920166|FG001|Overall Study|Not treated|0|||
129716393|NCT02131662|466920167|FG002|Overall Study|Not treated|2|||
129716394|NCT02131662|466920168|FG003|Overall Study|Not treated|2|||
129716395|NCT02131662|466920169|FG004|Overall Study|Not treated|3|||
129716396|NCT00809926|466920171|FG000|Overall Study|Adverse Event|18|||
129716397|NCT00809926|466920172|FG001|Overall Study|Adverse Event|10|||
129716398|NCT00809926|466920171|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129802878|NCT01453725|467247436|FG001|Overall Study|Non-compliance With Protocol|2|||
129802879|NCT01453725|467247435|FG000|Overall Study|Protocol Violation|1|||
129802880|NCT01453725|467247436|FG001|Overall Study|Protocol Violation|0|||
129802881|NCT01453725|467247435|FG000|Overall Study|Withdrawal by Subject|2|||
129802882|NCT01453725|467247436|FG001|Overall Study|Withdrawal by Subject|3|||
129802883|NCT01453725|467247435|FG000|Overall Study|Pregnancy Wish|0|||
129802884|NCT01453725|467247436|FG001|Overall Study|Pregnancy Wish|2|||
129802885|NCT01453725|467247435|FG000|Overall Study|Pregnancy|1|||
129802886|NCT01453725|467247436|FG001|Overall Study|Pregnancy|0|||
129802887|NCT01453725|467247435|FG000|Overall Study|Physician Decision|1|||
129802888|NCT01453725|467247436|FG001|Overall Study|Physician Decision|1|||
129802889|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
129891461|NCT05310084|467561130|FG001|Overall Study|Participant availability|4|||
129891462|NCT05310084|467561129|FG000|Overall Study|Lost to Follow-up|1|||
129716399|NCT00809926|466920172|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129716400|NCT00809926|466920171|FG000|Overall Study|Patient withdrew consent|8|||
129716401|NCT00809926|466920172|FG001|Overall Study|Patient withdrew consent|6|||
129716402|NCT00809926|466920171|FG000|Overall Study|Lost to Follow-up|2|||
129716403|NCT00809926|466920172|FG001|Overall Study|Lost to Follow-up|1|||
129716404|NCT00809926|466920171|FG000|Overall Study|Administrative Problems|0|||
129716405|NCT00809926|466920172|FG001|Overall Study|Administrative Problems|1|||
129716406|NCT00809926|466920171|FG000|Overall Study|Protocol deviation|0|||
129716407|NCT00809926|466920172|FG001|Overall Study|Protocol deviation|2|||
129716408|NCT00130039|466920177|FG000|Overall Study|Withdrawal by Subject|15|||
129716409|NCT00130039|466920178|FG001|Overall Study|Withdrawal by Subject|11|||
129716410|NCT00130039|466920177|FG000|Overall Study|Lost to Follow-up|3|||
129716411|NCT00130039|466920178|FG001|Overall Study|Lost to Follow-up|1|||
129716412|NCT00130039|466920177|FG000|Overall Study|Adverse Event|4|||
129716413|NCT00130039|466920178|FG001|Overall Study|Adverse Event|2|||
129716414|NCT00130039|466920177|FG000|Overall Study|Physician Decision|3|||
129716415|NCT00130039|466920178|FG001|Overall Study|Physician Decision|0|||
129716416|NCT00130039|466920177|FG000|Overall Study|clinical events without follow up MRI|5|||
129716417|NCT00130039|466920178|FG001|Overall Study|clinical events without follow up MRI|4|||
129716418|NCT00100802|466920190|FG000|Overall Study|Adverse Event|9|||
129716419|NCT00100802|466920190|FG000|Overall Study|Death|1|||
129716420|NCT00100802|466920190|FG000|Overall Study|Lack of Efficacy|47|||
129716421|NCT00100802|466920190|FG000|Overall Study|Physician Decision|5|||
129716422|NCT00100802|466920190|FG000|Overall Study|Protocol Violation|1|||
129716423|NCT00100802|466920190|FG000|Overall Study|Withdrawal by Subject|5|||
129716424|NCT00100802|466920190|FG000|Overall Study|Ineligible|12|||
129716425|NCT02712996|466920191|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
129716426|NCT02712996|466920192|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
129716427|NCT02709720|466920194|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
129716428|NCT02709720|466920194|FG000|Overall Study|Protocol Violation|1|||
129716429|NCT02709720|466920194|FG000|Overall Study|Not take study medication|1|||
129716430|NCT03265145|466920196|FG000|Overall Study|Protocol Violation|2|||
129716431|NCT03265145|466920197|FG001|Overall Study|Protocol Violation|0|||
129716432|NCT03265145|466920196|FG000|Overall Study|Adverse Event|1|||
129716433|NCT03265145|466920197|FG001|Overall Study|Adverse Event|0|||
129716434|NCT03265145|466920196|FG000|Overall Study|Withdrawal by Subject|23|||
129716435|NCT03265145|466920197|FG001|Overall Study|Withdrawal by Subject|19|||
129716436|NCT03265145|466920196|FG000|Overall Study|Death|12|||
129716437|NCT03265145|466920197|FG001|Overall Study|Death|12|||
129716438|NCT03265145|466920196|FG000|Overall Study|Lost to Follow-up|13|||
129716439|NCT03265145|466920197|FG001|Overall Study|Lost to Follow-up|9|||
129716440|NCT03265145|466920196|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
129716441|NCT03265145|466920197|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
129716442|NCT03265145|466920196|FG000|Overall Study|Switched back to previous medication|1|||
129716443|NCT03265145|466920197|FG001|Overall Study|Switched back to previous medication|0|||
129716444|NCT03265145|466920196|FG000|Overall Study|Did not want to take medication|1|||
129716445|NCT03265145|466920197|FG001|Overall Study|Did not want to take medication|0|||
129716446|NCT03265145|466920196|FG000|Overall Study|Subject could not afford medication|0|||
129716447|NCT03265145|466920197|FG001|Overall Study|Subject could not afford medication|1|||
129802890|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
129802891|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
129891463|NCT05310084|467561130|FG001|Overall Study|Lost to Follow-up|1|||
129891464|NCT05310084|467561129|FG000|Overall Study|Adverse Event|1|||
129716448|NCT03265145|466920196|FG000|Overall Study|Site closed|2|||
129716449|NCT03265145|466920197|FG001|Overall Study|Site closed|3|||
129716450|NCT03265145|466920196|FG000|Overall Study|Incorrectly randomized|16|||
129716451|NCT03265145|466920197|FG001|Overall Study|Incorrectly randomized|6|||
129891465|NCT05310084|467561130|FG001|Overall Study|Adverse Event|1|||
129716452|NCT03265145|466920196|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
129802892|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
129891466|NCT05310084|467561129|FG000|Overall Study|Randomized but not vaccinated|4|||
129444315|NCT01187550|465927296|FG001|Overall Study|Protocol Violation|1|||
129444316|NCT01187550|465927295|FG000|Overall Study|Other|3|||
129716453|NCT03265145|466920197|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
129716454|NCT03265145|466920196|FG000|Overall Study|Physician Decision|0|||
129716455|NCT03265145|466920197|FG001|Overall Study|Physician Decision|3|||
129716456|NCT03265145|466920196|FG000|Overall Study|Subject transferred to another facility|0|||
129716457|NCT03265145|466920197|FG001|Overall Study|Subject transferred to another facility|1|||
129716458|NCT00283803|466922124|FG000|Overall Study|Physician Decision|9|||
129716459|NCT00283803|466922124|FG000|Overall Study|Withdrawal by Subject|4|||
129716460|NCT01127607|466922125|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
129716461|NCT01127607|466922126|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
129716462|NCT01127607|466922125|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
129716463|NCT01127607|466922126|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
129716464|NCT03640325|466922127|FG000|Overall Study|Withdrawal by Subject|4|||
129716465|NCT03640325|466922128|FG001|Overall Study|Withdrawal by Subject|1|||
129716466|NCT03640325|466922129|FG002|Overall Study|Withdrawal by Subject|0|||
129716467|NCT03640325|466922127|FG000|Overall Study|Lost to Follow-up|4|||
129716468|NCT03640325|466922128|FG001|Overall Study|Lost to Follow-up|5|||
129716469|NCT03640325|466922129|FG002|Overall Study|Lost to Follow-up|21|||
129716470|NCT03640325|466922127|FG000|Overall Study|Death|5|||
129716471|NCT03640325|466922128|FG001|Overall Study|Death|5|||
129716472|NCT03640325|466922129|FG002|Overall Study|Death|0|||
129716473|NCT01133756|466922133|FG000|Overall Study|Adverse Event|1|||
129716474|NCT01133756|466922134|FG001|Overall Study|Adverse Event|2|||
129716475|NCT01133756|466922135|FG002|Overall Study|Adverse Event|1|||
129716476|NCT01133756|466922133|FG000|Overall Study|Investigator Decision|1|||
129716477|NCT01133756|466922134|FG001|Overall Study|Investigator Decision|0|||
129716478|NCT01133756|466922135|FG002|Overall Study|Investigator Decision|0|||
129716479|NCT01133756|466922133|FG000|Overall Study|Withdrawal by Subject|0|||
129716480|NCT01133756|466922134|FG001|Overall Study|Withdrawal by Subject|1|||
129716481|NCT01133756|466922135|FG002|Overall Study|Withdrawal by Subject|0|||
129716482|NCT01133756|466922133|FG000|Overall Study|Progression of Disease|0|||
129716483|NCT01133756|466922134|FG001|Overall Study|Progression of Disease|0|||
129716484|NCT01133756|466922135|FG002|Overall Study|Progression of Disease|1|||
129716485|NCT01566149|466922136|FG000|Overall Study|Adverse Event|0|||
129716486|NCT01566149|466922137|FG001|Overall Study|Adverse Event|1|||
129716487|NCT01566149|466922136|FG000|Overall Study|Non-compliance with study medication|2|||
129716488|NCT01566149|466922137|FG001|Overall Study|Non-compliance with study medication|0|||
129716489|NCT01566149|466922136|FG000|Overall Study|Protocol Violation|0|||
129716490|NCT01566149|466922137|FG001|Overall Study|Protocol Violation|1|||
129716491|NCT01566149|466922136|FG000|Overall Study|Withdrawal by Subject|1|||
129716492|NCT01566149|466922137|FG001|Overall Study|Withdrawal by Subject|0|||
129716493|NCT03276728|466922141|FG000|Overall Study|Lost to Follow-up|0|||
129716494|NCT03276728|466922142|FG001|Overall Study|Lost to Follow-up|0|||
129716495|NCT03276728|466922143|FG002|Overall Study|Lost to Follow-up|2|||
129716496|NCT03276728|466922144|FG003|Overall Study|Lost to Follow-up|2|||
129716497|NCT03276728|466922145|FG004|Overall Study|Lost to Follow-up|0|||
129716498|NCT03276728|466922146|FG005|Overall Study|Lost to Follow-up|0|||
129716499|NCT03276728|466922147|FG006|Overall Study|Lost to Follow-up|0|||
129716500|NCT03276728|466922148|FG007|Overall Study|Lost to Follow-up|0|||
129716501|NCT03276728|466922141|FG000|Overall Study|Withdrawal by Subject|0|||
129716502|NCT03276728|466922142|FG001|Overall Study|Withdrawal by Subject|0|||
129716503|NCT03276728|466922143|FG002|Overall Study|Withdrawal by Subject|0|||
129716504|NCT03276728|466922144|FG003|Overall Study|Withdrawal by Subject|3|||
129716505|NCT03276728|466922145|FG004|Overall Study|Withdrawal by Subject|0|||
129716506|NCT03276728|466922146|FG005|Overall Study|Withdrawal by Subject|0|||
129716507|NCT03276728|466922147|FG006|Overall Study|Withdrawal by Subject|0|||
129716508|NCT03276728|466922148|FG007|Overall Study|Withdrawal by Subject|0|||
129716509|NCT03276728|466922141|FG000|Overall Study|Decision by sponsor|0|||
129716510|NCT03276728|466922142|FG001|Overall Study|Decision by sponsor|0|||
129716511|NCT03276728|466922143|FG002|Overall Study|Decision by sponsor|0|||
129716512|NCT03276728|466922144|FG003|Overall Study|Decision by sponsor|0|||
129716513|NCT03276728|466922145|FG004|Overall Study|Decision by sponsor|1|||
129716514|NCT03276728|466922146|FG005|Overall Study|Decision by sponsor|0|||
129716515|NCT03276728|466922147|FG006|Overall Study|Decision by sponsor|2|||
129716516|NCT03276728|466922148|FG007|Overall Study|Decision by sponsor|1|||
129716517|NCT03941873|466922155|FG000|Overall Study|Death|0|||
129716518|NCT03941873|466922156|FG001|Overall Study|Death|12|||
129716519|NCT03941873|466922157|FG002|Overall Study|Death|2|||
129716520|NCT03941873|466922158|FG003|Overall Study|Death|53|||
129716521|NCT03941873|466922155|FG000|Overall Study|Withdrawal by Subject|1|||
129716522|NCT03941873|466922156|FG001|Overall Study|Withdrawal by Subject|1|||
129716523|NCT03941873|466922157|FG002|Overall Study|Withdrawal by Subject|0|||
129716524|NCT03941873|466922158|FG003|Overall Study|Withdrawal by Subject|5|||
129716525|NCT03941873|466922155|FG000|Overall Study|Lost to Follow-up|1|||
129716526|NCT03941873|466922156|FG001|Overall Study|Lost to Follow-up|2|||
129716527|NCT03941873|466922157|FG002|Overall Study|Lost to Follow-up|0|||
129716528|NCT03941873|466922158|FG003|Overall Study|Lost to Follow-up|0|||
129716529|NCT03941873|466922155|FG000|Overall Study|Sponsor Decision|0|||
129716530|NCT03941873|466922156|FG001|Overall Study|Sponsor Decision|6|||
129716531|NCT03941873|466922157|FG002|Overall Study|Sponsor Decision|0|||
129716532|NCT03941873|466922158|FG003|Overall Study|Sponsor Decision|15|||
129716533|NCT02982772|466922161|FG000|Intervention|Lost to Follow-up|19|||
129716534|NCT02982772|466922162|FG001|Intervention|Lost to Follow-up|13|||
129716535|NCT02982772|466922161|FG000|1M Follow-Up|Lost to Follow-up|21|||
129716536|NCT02982772|466922162|FG001|1M Follow-Up|Lost to Follow-up|18|||
129716537|NCT02982772|466922161|FG000|3M Follow-Up|Lost to Follow-up|17|||
129716538|NCT02982772|466922162|FG001|3M Follow-Up|Lost to Follow-up|11|||
129716539|NCT02982772|466922161|FG000|6M Follow-Up|Lost to Follow-up|11|||
129716540|NCT02982772|466922162|FG001|6M Follow-Up|Lost to Follow-up|9|||
129716541|NCT02982772|466922161|FG000|12M Follow-Up|Lost to Follow-up|11|||
129716542|NCT02982772|466922162|FG001|12M Follow-Up|Lost to Follow-up|5|||
129716543|NCT01234480|466922163|FG000|Overall Study|Pregnancy|88|||
129716544|NCT01234480|466922163|FG000|Overall Study|>36/Normal History|50|||
129716545|NCT01234480|466922163|FG000|Overall Study|Age|3|||
129716546|NCT01234480|466922163|FG000|Overall Study|HPV Vaccine History|28|||
129716547|NCT01234480|466922163|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
129716548|NCT01234480|466922163|FG000|Overall Study|Hysterectomy|2|||
129716549|NCT01234480|466922163|FG000|Overall Study|Hysterectomy post enrollment|1|||
129716550|NCT01234480|466922163|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
129716551|NCT01234480|466922163|FG000|Overall Study|Informed Consent Form Violation|30|||
129716552|NCT01234480|466922163|FG000|Overall Study|Incorrect Visit|3|||
129716553|NCT01234480|466922163|FG000|Overall Study|No Florida Lab License|20|||
129716554|NCT01234480|466922163|FG000|Overall Study|Out of Window|42|||
129716555|NCT01234480|466922163|FG000|Overall Study|Sample Processing/Storage|92|||
129716556|NCT01234480|466922163|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
129716557|NCT01234480|466922163|FG000|Overall Study|Site/Subject non-compliance|44|||
129716558|NCT01234480|466922163|FG000|Overall Study|Missing Sample|9|||
129716559|NCT02974140|466922164|FG000|Overall Study|Adverse Event|2|||
129716560|NCT02974140|466922164|FG000|Overall Study|Lost to Follow-up|1|||
129716561|NCT02974140|466922164|FG000|Overall Study|Study Terminated by Sponsor|36|||
129716562|NCT00617084|466922165|FG000|Overall Study|Withdrawal by Subject|5|||
129716563|NCT00617084|466922166|FG001|Overall Study|Withdrawal by Subject|7|||
129716564|NCT00617084|466922165|FG000|Overall Study|Missed 12 Months visit|16|||
129716565|NCT00617084|466922166|FG001|Overall Study|Missed 12 Months visit|19|||
129716566|NCT02522429|466922167|FG000|Overall Study|Lost to Follow-up|8|||
129716567|NCT02522429|466922167|FG000|Overall Study|Adverse Event|2|||
129716568|NCT02522429|466922167|FG000|Overall Study|Death|1|||
129716569|NCT02522429|466922167|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
129716570|NCT01521923|466922173|FG000|Overall Study|AE, serious fatal|1|||
129716571|NCT01521923|466922174|FG001|Overall Study|AE, serious fatal|0|||
129716572|NCT01521923|466922175|FG002|Overall Study|AE, serious fatal|0|||
129716573|NCT01521923|466922176|FG003|Overall Study|AE, serious fatal|0|||
129716574|NCT01521923|466922173|FG000|Overall Study|SAE, non-fatal|0|||
129716575|NCT01521923|466922174|FG001|Overall Study|SAE, non-fatal|2|||
129444317|NCT01187550|465927296|FG001|Overall Study|Other|0|||
129716576|NCT01521923|466922175|FG002|Overall Study|SAE, non-fatal|2|||
129716577|NCT01521923|466922176|FG003|Overall Study|SAE, non-fatal|0|||
129716578|NCT01521923|466922173|FG000|Overall Study|AE, non-serious, non-fatal|1|||
129716579|NCT01521923|466922174|FG001|Overall Study|AE, non-serious, non-fatal|3|||
129716580|NCT01521923|466922175|FG002|Overall Study|AE, non-serious, non-fatal|6|||
129716581|NCT01521923|466922176|FG003|Overall Study|AE, non-serious, non-fatal|2|||
129716582|NCT01521923|466922173|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
129716583|NCT01521923|466922174|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
129716584|NCT01521923|466922175|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
129716585|NCT01521923|466922176|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
129444318|NCT01187550|465927295|FG000|Overall Study|Randomized but not treated|8|||
129716586|NCT01521923|466922173|FG000|Overall Study|Lack of Efficacy|1|||
129716587|NCT01521923|466922174|FG001|Overall Study|Lack of Efficacy|1|||
129444319|NCT01187550|465927296|FG001|Overall Study|Randomized but not treated|0|||
129444320|NCT00129623|465927297|FG000|Overall Study|Adverse Event|3|||
129444321|NCT00129623|465927298|FG001|Overall Study|Adverse Event|7|||
129716588|NCT01521923|466922175|FG002|Overall Study|Lack of Efficacy|0|||
129716589|NCT01521923|466922176|FG003|Overall Study|Lack of Efficacy|0|||
129716590|NCT01521923|466922173|FG000|Overall Study|Protocol Violation|0|||
129716591|NCT01521923|466922174|FG001|Overall Study|Protocol Violation|0|||
129716592|NCT01521923|466922175|FG002|Overall Study|Protocol Violation|1|||
129716593|NCT01521923|466922176|FG003|Overall Study|Protocol Violation|0|||
129716594|NCT01521923|466922173|FG000|Overall Study|Lost to Follow-up|1|||
129716595|NCT01521923|466922174|FG001|Overall Study|Lost to Follow-up|0|||
129716596|NCT01521923|466922175|FG002|Overall Study|Lost to Follow-up|2|||
129716597|NCT01521923|466922176|FG003|Overall Study|Lost to Follow-up|1|||
129716598|NCT01521923|466922173|FG000|Overall Study|Withdrawal by Subject|1|||
129716599|NCT01521923|466922174|FG001|Overall Study|Withdrawal by Subject|1|||
129716600|NCT01521923|466922175|FG002|Overall Study|Withdrawal by Subject|1|||
129716601|NCT01521923|466922176|FG003|Overall Study|Withdrawal by Subject|2|||
129716602|NCT01521923|466922173|FG000|Overall Study|Other|2|||
129716603|NCT01521923|466922174|FG001|Overall Study|Other|1|||
129716604|NCT01521923|466922175|FG002|Overall Study|Other|3|||
129716605|NCT01521923|466922176|FG003|Overall Study|Other|6|||
129716606|NCT01521923|466922173|FG000|Overall Study|AE, captured in Period 1|0|||
129716607|NCT01521923|466922174|FG001|Overall Study|AE, captured in Period 1|1|||
129716608|NCT01521923|466922175|FG002|Overall Study|AE, captured in Period 1|0|||
129716609|NCT01521923|466922176|FG003|Overall Study|AE, captured in Period 1|1|||
129716610|NCT01279044|466922177|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
129716611|NCT01279044|466922178|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
129716612|NCT01279044|466922179|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
129716613|NCT01279044|466922177|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
129716614|NCT01279044|466922178|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
129716615|NCT01279044|466922179|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
129716616|NCT01279044|466922177|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
129716617|NCT01279044|466922178|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
129716618|NCT01279044|466922179|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
129716619|NCT01582009|466922180|FG000|Overall Study|Withdrawal by Subject|1|||
129716620|NCT01582009|466922180|FG000|Overall Study|Physician Decision|1|||
129716621|NCT01665911|466922181|FG000|Overall Study|Protocol Violation|4|||
129716622|NCT01665911|466922181|FG000|Overall Study|Withdrawal by Subject|1|||
129716623|NCT01665911|466922181|FG000|Overall Study|Adverse Event|1|||
129716624|NCT00735553|466922182|FG000|Overall Study|Study prematurely terminated|77|||
129716625|NCT03726658|466922188|FG000|Overall Study|Lost to Follow-up|0|||
129716626|NCT03726658|466922189|FG001|Overall Study|Lost to Follow-up|0|||
129716627|NCT03726658|466922190|FG002|Overall Study|Lost to Follow-up|2|||
129716628|NCT03726658|466922191|FG003|Overall Study|Lost to Follow-up|0|||
129716629|NCT03726658|466922192|FG004|Overall Study|Lost to Follow-up|0|||
129716630|NCT03726658|466922193|FG005|Overall Study|Lost to Follow-up|1|||
129716631|NCT03726658|466922194|FG006|Overall Study|Lost to Follow-up|1|||
129716632|NCT03726658|466922188|FG000|Overall Study|Withdrawal by Subject|1|||
129716633|NCT03726658|466922189|FG001|Overall Study|Withdrawal by Subject|0|||
129716634|NCT03726658|466922190|FG002|Overall Study|Withdrawal by Subject|0|||
129716635|NCT03726658|466922191|FG003|Overall Study|Withdrawal by Subject|0|||
129716636|NCT03726658|466922192|FG004|Overall Study|Withdrawal by Subject|6|||
129716637|NCT03726658|466922193|FG005|Overall Study|Withdrawal by Subject|4|||
129716638|NCT03726658|466922194|FG006|Overall Study|Withdrawal by Subject|2|||
129716639|NCT03726658|466922188|FG000|Overall Study|Pregnancy|0|||
129716640|NCT03726658|466922189|FG001|Overall Study|Pregnancy|0|||
129716641|NCT03726658|466922190|FG002|Overall Study|Pregnancy|0|||
129716642|NCT03726658|466922191|FG003|Overall Study|Pregnancy|0|||
129716643|NCT03726658|466922192|FG004|Overall Study|Pregnancy|0|||
129716644|NCT03726658|466922193|FG005|Overall Study|Pregnancy|0|||
129716645|NCT03726658|466922194|FG006|Overall Study|Pregnancy|1|||
129716646|NCT03726658|466922188|FG000|Overall Study|Not Reported|0|||
129716647|NCT03726658|466922189|FG001|Overall Study|Not Reported|0|||
129716648|NCT03726658|466922190|FG002|Overall Study|Not Reported|0|||
129716649|NCT03726658|466922191|FG003|Overall Study|Not Reported|0|||
129716650|NCT03726658|466922192|FG004|Overall Study|Not Reported|0|||
129716651|NCT03726658|466922193|FG005|Overall Study|Not Reported|0|||
129716652|NCT03726658|466922194|FG006|Overall Study|Not Reported|1|||
129716653|NCT00090779|466922195|FG000|Step 1|Withdrawal by Subject|4|||
129716654|NCT00090779|466922196|FG001|Step 1|Withdrawal by Subject|2|||
129716655|NCT00090779|466922195|FG000|Step 1|Lost to Follow-up|3|||
129716656|NCT00090779|466922196|FG001|Step 1|Lost to Follow-up|2|||
129716657|NCT00090779|466922195|FG000|Step 1|Death|0|||
129716658|NCT00090779|466922196|FG001|Step 1|Death|2|||
129716659|NCT00090779|466922195|FG000|Step 1|Physician Decision|1|||
129716660|NCT00090779|466922196|FG001|Step 1|Physician Decision|0|||
129716661|NCT00090779|466922195|FG000|Step 1|Pregnancy|1|||
129716662|NCT00090779|466922196|FG001|Step 1|Pregnancy|0|||
129716663|NCT00090779|466922195|FG000|Step 1|Non-compliance to study requirements|0|||
129716664|NCT00090779|466922196|FG001|Step 1|Non-compliance to study requirements|1|||
129716665|NCT00090779|466922195|FG000|Step 1|Subject relocated|2|||
129716666|NCT00090779|466922196|FG001|Step 1|Subject relocated|8|||
129716667|NCT00090779|466922195|FG000|Step 2|Off study per study closure|6|||
129716668|NCT00090779|466922196|FG001|Step 2|Off study per study closure|16|||
129716669|NCT00090779|466922195|FG000|Step 2|Subject relocated|0|||
129716670|NCT00090779|466922196|FG001|Step 2|Subject relocated|1|||
129716671|NCT00090779|466922195|FG000|Step 2|Non-compliance to study requirements|0|||
129716672|NCT00090779|466922196|FG001|Step 2|Non-compliance to study requirements|1|||
129716673|NCT00090779|466922195|FG000|Step 3|Initiation of ART and off extended study|3|||
129716674|NCT00090779|466922196|FG001|Step 3|Initiation of ART and off extended study|2|||
129716675|NCT00090779|466922195|FG000|Step 3|Off extended study due to study closure|4|||
129716676|NCT00090779|466922196|FG001|Step 3|Off extended study due to study closure|3|||
129716677|NCT01318135|466922197|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
129716678|NCT01318135|466922198|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716679|NCT01318135|466922199|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716680|NCT01318135|466922200|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716681|NCT01318135|466922201|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716682|NCT01318135|466922202|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716683|NCT01318135|466922203|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716684|NCT01318135|466922204|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129716685|NCT01318135|466922197|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
129716686|NCT01318135|466922198|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716687|NCT01318135|466922199|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716688|NCT01318135|466922200|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716689|NCT01318135|466922201|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716690|NCT01318135|466922202|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716691|NCT01318135|466922203|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716692|NCT01318135|466922204|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
129716693|NCT01318135|466922197|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
129716694|NCT01318135|466922198|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
129716695|NCT01318135|466922199|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
129716696|NCT01318135|466922200|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
129716697|NCT01318135|466922201|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
129716698|NCT01318135|466922202|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
129716699|NCT01318135|466922203|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
129716700|NCT01318135|466922204|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
129716701|NCT01318135|466922197|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
129716702|NCT01318135|466922198|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
129716703|NCT01318135|466922199|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
129716704|NCT01318135|466922200|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
129716705|NCT01318135|466922201|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
129716706|NCT01318135|466922202|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
129716707|NCT01318135|466922203|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
129716708|NCT01318135|466922204|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
129716709|NCT01318135|466922197|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129716710|NCT01318135|466922198|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129716711|NCT01318135|466922199|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129716712|NCT01318135|466922200|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129802893|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
129802894|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
129802895|NCT00875979|467247445|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
129802896|NCT00875979|467247446|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
129802897|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
129802898|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
129802899|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
129802900|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
129802901|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
129802902|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
129802903|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
129716713|NCT01318135|466922201|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129716714|NCT01318135|466922202|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129716715|NCT01318135|466922203|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129716716|NCT01318135|466922204|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129716717|NCT01318135|466922197|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
129716718|NCT01318135|466922198|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
129716719|NCT01318135|466922199|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129444322|NCT00129623|465927297|FG000|Overall Study|Refused Treatment|5|||
129716720|NCT01318135|466922200|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
129716721|NCT01318135|466922201|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129716722|NCT01318135|466922202|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129716723|NCT01318135|466922203|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129716724|NCT01318135|466922204|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129716725|NCT01318135|466922197|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716726|NCT01318135|466922198|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716727|NCT01318135|466922199|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716728|NCT01318135|466922200|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716729|NCT01318135|466922201|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716730|NCT01318135|466922202|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716731|NCT01318135|466922203|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
129716732|NCT01318135|466922204|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
129716733|NCT01775553|466922209|FG000|Overall Study|Adverse Event|1|||
129716734|NCT01775553|466922209|FG000|Overall Study|Disease Progression|12|||
129716735|NCT00988052|466922210|FG000|Overall Study|Missing|1|||
129716736|NCT00988052|466922211|FG001|Overall Study|Missing|0|||
129716737|NCT00988052|466922210|FG000|Overall Study|Teva requested subject withdrawal|3|||
129716738|NCT00988052|466922211|FG001|Overall Study|Teva requested subject withdrawal|1|||
129716739|NCT00988052|466922210|FG000|Overall Study|Death|1|||
129716740|NCT00988052|466922211|FG001|Overall Study|Death|3|||
129716741|NCT00988052|466922210|FG000|Overall Study|Protocol Violation|6|||
129716742|NCT00988052|466922211|FG001|Overall Study|Protocol Violation|5|||
129716743|NCT00988052|466922210|FG000|Overall Study|Pregnancy|6|||
129716744|NCT00988052|466922211|FG001|Overall Study|Pregnancy|6|||
129716745|NCT00988052|466922210|FG000|Overall Study|Lack of Efficacy|8|||
129716746|NCT00988052|466922211|FG001|Overall Study|Lack of Efficacy|7|||
129716747|NCT00988052|466922210|FG000|Overall Study|Lost to Follow-up|6|||
129716748|NCT00988052|466922211|FG001|Overall Study|Lost to Follow-up|11|||
129716749|NCT00988052|466922210|FG000|Overall Study|Physician Decision|27|||
129716750|NCT00988052|466922211|FG001|Overall Study|Physician Decision|28|||
129716751|NCT00988052|466922210|FG000|Overall Study|Adverse Event|35|||
129716752|NCT00988052|466922211|FG001|Overall Study|Adverse Event|28|||
129716753|NCT00988052|466922210|FG000|Overall Study|Withdrawal by Subject|90|||
129716754|NCT00988052|466922211|FG001|Overall Study|Withdrawal by Subject|91|||
129716755|NCT00988052|466922210|FG000|Overall Study|Study terminated by sponsor|240|||
129716756|NCT00988052|466922211|FG001|Overall Study|Study terminated by sponsor|236|||
129716757|NCT01523743|466922212|FG000|Period 1|Adverse Event|1|||
129716758|NCT01523743|466922213|FG001|Period 1|Adverse Event|0|||
129716759|NCT01523743|466922212|FG000|Period 1|Withdrawal by Subject|6|||
129716760|NCT01523743|466922213|FG001|Period 1|Withdrawal by Subject|2|||
129716761|NCT01523743|466922212|FG000|Period 1|Lost to Follow-up|1|||
129716762|NCT01523743|466922213|FG001|Period 1|Lost to Follow-up|0|||
129716763|NCT01523743|466922212|FG000|Period 1|Lack of Efficacy|1|||
129716764|NCT01523743|466922213|FG001|Period 1|Lack of Efficacy|0|||
129716765|NCT01523743|466922212|FG000|Period 1|Felt unable to empty bladder|1|||
129716766|NCT01523743|466922213|FG001|Period 1|Felt unable to empty bladder|0|||
129716767|NCT01523743|466922212|FG000|Period 2|Withdrawal by Subject|0|||
129716768|NCT01523743|466922213|FG001|Period 2|Withdrawal by Subject|2|||
129716769|NCT01523743|466922212|FG000|Period 2|Adverse Event|1|||
129716770|NCT01523743|466922213|FG001|Period 2|Adverse Event|0|||
129716771|NCT02569476|466922214|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
129716772|NCT02569476|466922214|FG000|Overall Study|Death|33|||
129716773|NCT02569476|466922214|FG000|Overall Study|Withdrawal by Subject|9|||
129716774|NCT02569476|466922214|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
129716775|NCT02569476|466922214|FG000|Overall Study|Palliative care|1|||
129716776|NCT02569476|466922214|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
129716777|NCT02569476|466922214|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
129716778|NCT03782064|466922215|FG000|Overall Study|Lack of Efficacy|2|||
129716779|NCT03782064|466922215|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
129716780|NCT02446769|466922218|FG000|Screening Period|Screen Failure|11|||
129716781|NCT02446769|466922219|FG001|Screening Period|Screen Failure|0|||
129716782|NCT02446769|466922220|FG002|Screening Period|Screen Failure|0|||
129716783|NCT02446769|466922218|FG000|Study Period|Randomized in Error|0|||
129716784|NCT02446769|466922219|FG001|Study Period|Randomized in Error|2|||
129716785|NCT02446769|466922220|FG002|Study Period|Randomized in Error|0|||
129716786|NCT00703963|466922221|FG000|Overall Study|Withdrawal by Subject|7|||
129716787|NCT00703963|466922222|FG001|Overall Study|Withdrawal by Subject|13|||
129716788|NCT00703963|466922221|FG000|Overall Study|Physician Decision|0|||
129716789|NCT00703963|466922222|FG001|Overall Study|Physician Decision|1|||
129716790|NCT00645840|466922223|FG000|Overall Study|Protocol Violation|3|||
129716791|NCT00402324|466922224|FG000|Overall Study|Lost to Follow-up|11|||
129716792|NCT00402324|466922225|FG001|Overall Study|Lost to Follow-up|11|||
129716793|NCT00402324|466922224|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
129716794|NCT00402324|466922225|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
129802904|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
129802905|NCT00875979|467247445|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
129802906|NCT00875979|467247446|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
129802907|NCT03719586|467247447|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
129802908|NCT03719586|467247448|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
129802909|NCT03719586|467247449|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
129802910|NCT03719586|467247450|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
129802911|NCT00178633|467247451|FG000|Overall Study|Lost to Follow-up|6|||
129802912|NCT04810481|467247453|FG000|Overall Study|Disqualified data sets|10|||
129802913|NCT04810481|467247454|FG001|Overall Study|Disqualified data sets|28|||
129802914|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
129802915|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
129802916|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
129802917|NCT00369707|467247457|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
129802918|NCT00369707|467247457|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
129891467|NCT05310084|467561130|FG001|Overall Study|Randomized but not vaccinated|2|||
129891468|NCT01598987|467561132|FG000|Baseline to Month 12|Administrative problems|2|||
129891469|NCT01598987|467561132|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
129891470|NCT01598987|467561132|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
129716795|NCT00402324|466922224|FG000|Overall Study|Protocol Violation|8|||
129716796|NCT00402324|466922225|FG001|Overall Study|Protocol Violation|7|||
129716797|NCT00402324|466922224|FG000|Overall Study|Withdrawal by Subject|5|||
129716798|NCT00402324|466922225|FG001|Overall Study|Withdrawal by Subject|2|||
129716799|NCT00402324|466922224|FG000|Overall Study|Physician Decision|2|||
129716800|NCT00402324|466922225|FG001|Overall Study|Physician Decision|4|||
129716801|NCT00402324|466922224|FG000|Overall Study|Sponsor Decision|4|||
129716802|NCT00402324|466922225|FG001|Overall Study|Sponsor Decision|5|||
129716803|NCT00402324|466922224|FG000|Overall Study|Lack of Efficacy|1|||
129716804|NCT00402324|466922225|FG001|Overall Study|Lack of Efficacy|4|||
129716805|NCT00402324|466922224|FG000|Overall Study|Adverse Event|6|||
129716806|NCT00402324|466922225|FG001|Overall Study|Adverse Event|4|||
129716807|NCT00402324|466922224|FG000|Overall Study|Death|1|||
129716808|NCT00402324|466922225|FG001|Overall Study|Death|0|||
129716809|NCT03994211|466922226|FG000|Core Phase|Adverse Event|0|||
129716810|NCT03994211|466922227|FG001|Core Phase|Adverse Event|1|||
129716811|NCT03994211|466922228|FG002|Core Phase|Adverse Event|0|||
129716812|NCT03994211|466922226|FG000|Extension Phase|Adverse Event|0|||
129716813|NCT03994211|466922227|FG001|Extension Phase|Adverse Event|0|||
129716814|NCT03994211|466922228|FG002|Extension Phase|Adverse Event|1|||
129716815|NCT03994211|466922226|FG000|Extension Phase|Physician Decision|0|||
129716816|NCT03994211|466922227|FG001|Extension Phase|Physician Decision|0|||
129716817|NCT03994211|466922228|FG002|Extension Phase|Physician Decision|1|||
129716818|NCT03994211|466922226|FG000|Extension Phase|Progressive Disease|0|||
129716819|NCT03994211|466922227|FG001|Extension Phase|Progressive Disease|0|||
129716820|NCT03994211|466922228|FG002|Extension Phase|Progressive Disease|20|||
129716821|NCT03994211|466922226|FG000|Extension Phase|Withdrawal by Subject|0|||
129716822|NCT03994211|466922227|FG001|Extension Phase|Withdrawal by Subject|0|||
129716823|NCT03994211|466922228|FG002|Extension Phase|Withdrawal by Subject|2|||
129716824|NCT02625220|466922229|FG000|Overall Study|Adverse Event|2|||
129716825|NCT02625220|466922229|FG000|Overall Study|Lost to Follow-up|2|||
129716826|NCT02625220|466922229|FG000|Overall Study|Protocol Violation|1|||
129716827|NCT02625220|466922229|FG000|Overall Study|Study discontinued at site|2|||
129716828|NCT04599803|466922232|FG000|Overall Study|Withdrawal by Subject|5|||
129716829|NCT04599803|466922232|FG000|Overall Study|Lost to Follow-up|26|||
129716830|NCT02484443|466922233|FG000|Overall Study|Lack of Efficacy|28|||
129716831|NCT02484443|466922233|FG000|Overall Study|Physician Decision|2|||
129716832|NCT02484443|466922233|FG000|Overall Study|Ineligible|2|||
129716833|NCT04677543|466922234|FG000|Overall Study|Withdrawal by Subject|4|||
129716834|NCT04677543|466922235|FG001|Overall Study|Withdrawal by Subject|1|||
129716835|NCT04677543|466922234|FG000|Overall Study|Physician Decision|0|||
129716836|NCT04677543|466922235|FG001|Overall Study|Physician Decision|1|||
129716837|NCT04677543|466922234|FG000|Overall Study|Adverse Event|0|||
129716838|NCT04677543|466922235|FG001|Overall Study|Adverse Event|1|||
129716839|NCT03799952|466922236|FG000|Overall Study|Program was too easy, discontinued|1|||
129716840|NCT03799952|466922237|FG001|Overall Study|Program was too easy, discontinued|0|||
129716841|NCT03799952|466922236|FG000|Overall Study|Lost to Follow-up|0|||
129716842|NCT03799952|466922237|FG001|Overall Study|Lost to Follow-up|2|||
129716843|NCT02595866|466922238|FG000|Overall Study|Adverse Event|2|||
129716844|NCT02595866|466922239|FG001|Overall Study|Adverse Event|5|||
129716845|NCT02595866|466922238|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
129716846|NCT02595866|466922239|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
129716847|NCT02595866|466922238|FG000|Overall Study|Death|0|||
129716848|NCT02595866|466922239|FG001|Overall Study|Death|1|||
129716849|NCT02595866|466922238|FG000|Overall Study|Incarceration|1|||
129802919|NCT00369707|467247457|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
129802920|NCT00369707|467247457|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
129802921|NCT00369707|467247457|FG000|Follow up for 2 Years After Treatment|Death|1|||
129802922|NCT00369707|467247457|FG000|Follow up for 2 Years After Treatment|Other|2|||
129716850|NCT02595866|466922239|FG001|Overall Study|Incarceration|0|||
129716851|NCT02595866|466922238|FG000|Overall Study|Lack of Efficacy|17|||
129716852|NCT02595866|466922239|FG001|Overall Study|Lack of Efficacy|7|||
129716853|NCT02595866|466922238|FG000|Overall Study|Physician Decision|4|||
129716854|NCT02595866|466922239|FG001|Overall Study|Physician Decision|3|||
129716855|NCT02595866|466922238|FG000|Overall Study|Switched to Alternative Treatment|1|||
129716856|NCT02595866|466922239|FG001|Overall Study|Switched to Alternative Treatment|0|||
129716857|NCT02595866|466922238|FG000|Overall Study|Study Terminated|0|||
129716858|NCT02595866|466922239|FG001|Overall Study|Study Terminated|4|||
129716859|NCT02595866|466922238|FG000|Overall Study|Withdrawal by Subject|6|||
129716860|NCT02595866|466922239|FG001|Overall Study|Withdrawal by Subject|1|||
129716861|NCT02520388|466922240|FG000|Overall Study|Physician Decision|1|||
129716862|NCT02520388|466922241|FG001|Overall Study|Physician Decision|0|||
129716863|NCT02520388|466922240|FG000|Overall Study|Subject or parent/guardian request|0|||
129716864|NCT02520388|466922241|FG001|Overall Study|Subject or parent/guardian request|6|||
129716865|NCT02520388|466922240|FG000|Overall Study|Adverse Event|1|||
129716866|NCT02520388|466922241|FG001|Overall Study|Adverse Event|4|||
129716867|NCT02520388|466922240|FG000|Overall Study|Lost to Follow-up|3|||
129716868|NCT02520388|466922241|FG001|Overall Study|Lost to Follow-up|2|||
129716869|NCT02520388|466922240|FG000|Overall Study|Other (reason not defined)|4|||
129716870|NCT02520388|466922241|FG001|Overall Study|Other (reason not defined)|4|||
129716871|NCT03035864|466922245|FG000|Treatment Period|Adverse Event|1|||
129716872|NCT03035864|466922246|FG001|Treatment Period|Adverse Event|0|||
129716873|NCT03035864|466922245|FG000|Treatment Period|Other|3|||
129716874|NCT03035864|466922246|FG001|Treatment Period|Other|1|||
129716875|NCT03035864|466922245|FG000|Follow-up Period|Adverse Event|1|||
129716876|NCT03035864|466922246|FG001|Follow-up Period|Adverse Event|0|||
129716877|NCT03035864|466922245|FG000|Follow-up Period|Lost to Follow-up|6|||
129716878|NCT03035864|466922246|FG001|Follow-up Period|Lost to Follow-up|2|||
129716879|NCT03035864|466922245|FG000|Follow-up Period|Physician Decision|1|||
129716880|NCT03035864|466922246|FG001|Follow-up Period|Physician Decision|0|||
129716881|NCT03035864|466922245|FG000|Follow-up Period|Other|3|||
129716882|NCT03035864|466922246|FG001|Follow-up Period|Other|2|||
129716883|NCT02375373|466922247|FG000|Overall Study|Withdrawal by Subject|11|||
129716884|NCT00577707|466922248|FG000|Overall Study|Withdrawal by Subject|3|||
129716885|NCT03299244|466922249|FG000|Overall Study|Withdrawal by Subject|34|||
129716886|NCT03299244|466922250|FG001|Overall Study|Withdrawal by Subject|29|||
129716887|NCT03299244|466922249|FG000|Overall Study|Decision by Sponsor|4|||
129716888|NCT03299244|466922250|FG001|Overall Study|Decision by Sponsor|5|||
129716889|NCT03299244|466922249|FG000|Overall Study|Death|9|||
129716890|NCT03299244|466922250|FG001|Overall Study|Death|4|||
129716891|NCT00431444|466922251|FG000|Overall Study|Protocol Violation|1|||
129716892|NCT00431444|466922252|FG001|Overall Study|Protocol Violation|4|||
129716893|NCT00431444|466922251|FG000|Overall Study|Adverse Event|2|||
129716894|NCT00431444|466922252|FG001|Overall Study|Adverse Event|1|||
129716895|NCT00431444|466922251|FG000|Overall Study|Withdrawal by Subject|1|||
129716896|NCT00431444|466922252|FG001|Overall Study|Withdrawal by Subject|1|||
129716897|NCT00431444|466922251|FG000|Overall Study|Lost to Follow-up|1|||
129716898|NCT00431444|466922252|FG001|Overall Study|Lost to Follow-up|0|||
129716899|NCT00431444|466922251|FG000|Overall Study|Administrative Problems|0|||
129716900|NCT00431444|466922252|FG001|Overall Study|Administrative Problems|1|||
129802923|NCT01254292|467247462|FG000|Comparative Phase|Adverse Event|25|||
129802924|NCT01254292|467247463|FG001|Comparative Phase|Adverse Event|25|||
129802925|NCT01254292|467247462|FG000|Comparative Phase|Lost to Follow-up|3|||
129802926|NCT01254292|467247463|FG001|Comparative Phase|Lost to Follow-up|21|||
129802927|NCT01254292|467247462|FG000|Comparative Phase|Pregnancy|2|||
129802928|NCT01254292|467247463|FG001|Comparative Phase|Pregnancy|6|||
129802929|NCT01254292|467247462|FG000|Comparative Phase|Withdrawal by Subject|20|||
129444323|NCT00129623|465927298|FG001|Overall Study|Refused Treatment|3|||
129444324|NCT00129623|465927297|FG000|Overall Study|Failure to Return|1|||
129716901|NCT01603043|466922253|FG000|Overall Study|Study Futility|7|||
129716902|NCT01603043|466922254|FG001|Overall Study|Study Futility|3|||
129716903|NCT00642707|466922269|FG000|Overall Study|Adverse Event|0|||
129716904|NCT00642707|466922270|FG001|Overall Study|Adverse Event|0|||
129716905|NCT00642707|466922271|FG002|Overall Study|Adverse Event|0|||
129716906|NCT00642707|466922272|FG003|Overall Study|Adverse Event|2|||
129716907|NCT00642707|466922269|FG000|Overall Study|Withdrawal by Subject|1|||
129716908|NCT00642707|466922270|FG001|Overall Study|Withdrawal by Subject|0|||
129716909|NCT00642707|466922271|FG002|Overall Study|Withdrawal by Subject|0|||
129716910|NCT00642707|466922272|FG003|Overall Study|Withdrawal by Subject|0|||
129716911|NCT01016132|466922273|FG000|Overall Study|Discomfort|1|||
129716912|NCT01451749|466922274|FG000|Overall Study|Protocol Violation|14|||
129716913|NCT01451749|466922275|FG001|Overall Study|Protocol Violation|7|||
129716914|NCT01451749|466922274|FG000|Overall Study|Lost to Follow-up|15|||
129802930|NCT01254292|467247463|FG001|Comparative Phase|Withdrawal by Subject|21|||
129802931|NCT01254292|467247462|FG000|Comparative Phase|Protocol Violation|1|||
129802932|NCT01254292|467247463|FG001|Comparative Phase|Protocol Violation|2|||
129802933|NCT01254292|467247462|FG000|Comparative Phase|Wish for pregnancy|4|||
129802934|NCT01254292|467247463|FG001|Comparative Phase|Wish for pregnancy|6|||
129802935|NCT01254292|467247462|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
129802936|NCT01254292|467247463|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
129802937|NCT01254292|467247462|FG000|LCS12 Extension Phase|Adverse Event|9|||
129802938|NCT01254292|467247463|FG001|LCS12 Extension Phase|Adverse Event|0|||
129802939|NCT01254292|467247462|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
129802940|NCT01254292|467247463|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
129802941|NCT01254292|467247462|FG000|LCS12 Extension Phase|Other unknown|4|||
129802942|NCT01254292|467247463|FG001|LCS12 Extension Phase|Other unknown|0|||
129802943|NCT01254292|467247462|FG000|LCS12 Extension Phase|Pregnancy|2|||
129802944|NCT01254292|467247463|FG001|LCS12 Extension Phase|Pregnancy|0|||
129802945|NCT01254292|467247462|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
129802946|NCT01254292|467247463|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
129802947|NCT04674644|467247469|FG000|Overall Study|with missing data|37|||
129802948|NCT01230710|467247475|FG000|Overall Study|Disease Progression|41|||
129802949|NCT01230710|467247475|FG000|Overall Study|Lost to Follow-up|3|||
129802950|NCT01230710|467247475|FG000|Overall Study|Death|4|||
129802951|NCT01230710|467247475|FG000|Overall Study|Withdrawal of Consent|1|||
129802952|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
129802953|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
129802954|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Physician Decision|1|||
129802955|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Physician Decision|0|||
129802956|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
129802957|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
129802958|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
129802959|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
129802960|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Adverse Event|15|||
129802961|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Adverse Event|0|||
129802962|NCT03277690|467247476|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
129802963|NCT03277690|467247477|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
129802964|NCT03277690|467247476|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
129802965|NCT03277690|467247477|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
129802966|NCT01691898|467247478|FG000|Overall Study|Death|34|||
129802967|NCT01691898|467247479|FG001|Overall Study|Death|32|||
129802968|NCT01691898|467247480|FG002|Overall Study|Death|6|||
129802969|NCT01691898|467247481|FG003|Overall Study|Death|3|||
129802970|NCT01691898|467247482|FG004|Overall Study|Death|8|||
129802971|NCT01691898|467247483|FG005|Overall Study|Death|31|||
129802972|NCT01691898|467247478|FG000|Overall Study|Adverse Event|0|||
129802973|NCT01691898|467247479|FG001|Overall Study|Adverse Event|1|||
129444325|NCT00129623|465927298|FG001|Overall Study|Failure to Return|1|||
129444326|NCT00129623|465927297|FG000|Overall Study|Relocated job out of state|1|||
129444327|NCT00129623|465927298|FG001|Overall Study|Relocated job out of state|0|||
129716915|NCT01451749|466922275|FG001|Overall Study|Lost to Follow-up|5|||
129716916|NCT01451749|466922274|FG000|Overall Study|Meet the exclusion criteria,and|1|||
129716917|NCT01451749|466922275|FG001|Overall Study|Meet the exclusion criteria,and|1|||
129716918|NCT01451749|466922274|FG000|Overall Study|Adverse Event|2|||
129716919|NCT01451749|466922275|FG001|Overall Study|Adverse Event|0|||
129716920|NCT01451749|466922274|FG000|Overall Study|Withdrawal by Subject|0|||
129716921|NCT01451749|466922275|FG001|Overall Study|Withdrawal by Subject|1|||
129716922|NCT01198574|466922285|FG000|Overall Study|Resigned from schools|4|||
129716923|NCT01198574|466922286|FG001|Overall Study|Resigned from schools|1|||
129716924|NCT01198574|466922287|FG002|Overall Study|Resigned from schools|1|||
129716925|NCT01198574|466922288|FG003|Overall Study|Resigned from schools|4|||
129716926|NCT00556439|466922318|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
129716927|NCT00556439|466922319|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
129716928|NCT00556439|466922320|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
129716929|NCT00556439|466922321|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
129716930|NCT00556439|466922318|FG000|Study Entry to Week 12|Physician Decision|1|||
129716931|NCT00556439|466922319|FG001|Study Entry to Week 12|Physician Decision|0|||
129716932|NCT00556439|466922320|FG002|Study Entry to Week 12|Physician Decision|0|||
129716933|NCT00556439|466922321|FG003|Study Entry to Week 12|Physician Decision|0|||
129716934|NCT00556439|466922318|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
129802974|NCT01691898|467247480|FG002|Overall Study|Adverse Event|0|||
129802975|NCT01691898|467247481|FG003|Overall Study|Adverse Event|1|||
129802976|NCT01691898|467247482|FG004|Overall Study|Adverse Event|1|||
129716935|NCT00556439|466922319|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
129716936|NCT00556439|466922320|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
129802977|NCT01691898|467247483|FG005|Overall Study|Adverse Event|0|||
129802978|NCT01691898|467247478|FG000|Overall Study|Progression of Disease|1|||
129444328|NCT00129623|465927297|FG000|Overall Study|Uncertainty to return|0|||
129716937|NCT00556439|466922321|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
129716938|NCT00556439|466922318|FG000|Study Entry to Week 12|Recurrent infection|1|||
129716939|NCT00556439|466922319|FG001|Study Entry to Week 12|Recurrent infection|0|||
129716940|NCT00556439|466922320|FG002|Study Entry to Week 12|Recurrent infection|0|||
129716941|NCT00556439|466922321|FG003|Study Entry to Week 12|Recurrent infection|0|||
129716942|NCT00556439|466922318|FG000|Study Entry to Week 12|Malignancy|0|||
129716943|NCT00556439|466922319|FG001|Study Entry to Week 12|Malignancy|0|||
129716944|NCT00556439|466922320|FG002|Study Entry to Week 12|Malignancy|1|||
129716945|NCT00556439|466922321|FG003|Study Entry to Week 12|Malignancy|0|||
129716946|NCT00556439|466922318|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
129716947|NCT00556439|466922319|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
129716948|NCT00556439|466922320|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
129716949|NCT00556439|466922321|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
129716950|NCT00556439|466922318|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
129716951|NCT00556439|466922319|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
129716952|NCT00556439|466922320|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
129716953|NCT00556439|466922321|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
129716954|NCT00556439|466922318|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
129716955|NCT00556439|466922319|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
129716956|NCT00556439|466922320|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
129716957|NCT00556439|466922321|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
129716958|NCT00556439|466922318|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
129716959|NCT00556439|466922319|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
129716960|NCT00556439|466922320|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
129716961|NCT00556439|466922321|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
129716962|NCT02100423|466922322|FG000|Overall Study|Death|1|||
129716963|NCT02100423|466922322|FG000|Overall Study|Withdrawal by Subject|3|||
129716964|NCT02100423|466922322|FG000|Overall Study|Adverse Event|1|||
129716965|NCT02100423|466922322|FG000|Overall Study|Physician Decision|1|||
129716966|NCT00325130|466922323|FG000|Overall Study|Lost to Follow-up|6|||
129716967|NCT00325130|466922324|FG001|Overall Study|Lost to Follow-up|14|||
129716968|NCT00325130|466922323|FG000|Overall Study|Withdrawal by Subject|12|||
129716969|NCT00325130|466922324|FG001|Overall Study|Withdrawal by Subject|14|||
129716970|NCT00325130|466922323|FG000|Overall Study|Protocol Deviation|0|||
129716971|NCT00325130|466922324|FG001|Overall Study|Protocol Deviation|1|||
129716972|NCT00325130|466922323|FG000|Overall Study|Moved|0|||
129716973|NCT00325130|466922324|FG001|Overall Study|Moved|1|||
129716974|NCT00325130|466922323|FG000|Overall Study|Patient Discontinued for Other|1|||
129716975|NCT00325130|466922324|FG001|Overall Study|Patient Discontinued for Other|0|||
129716976|NCT02454530|466922325|FG000|Overall Study|Other|8|||
129716977|NCT02454530|466922326|FG001|Overall Study|Other|13|||
129716978|NCT02454530|466922325|FG000|Overall Study|Missing information|56|||
129716979|NCT02454530|466922326|FG001|Overall Study|Missing information|69|||
129716980|NCT02454530|466922325|FG000|Overall Study|Death|2|||
129716981|NCT02454530|466922326|FG001|Overall Study|Death|41|||
129716982|NCT02454530|466922325|FG000|Overall Study|Lost to Follow-up|4|||
129716983|NCT02454530|466922326|FG001|Overall Study|Lost to Follow-up|4|||
129716984|NCT02949024|466922329|FG000|Overall Study|Withdrawal by Subject|0|||
129716985|NCT02949024|466922330|FG001|Overall Study|Withdrawal by Subject|1|||
129716986|NCT03159468|466922331|FG000|Overall Study|Withdrawal by Subject|0|||
129716987|NCT03159468|466922332|FG001|Overall Study|Withdrawal by Subject|0|||
129716988|NCT03159468|466922333|FG002|Overall Study|Withdrawal by Subject|3|||
129716989|NCT03159468|466922334|FG003|Overall Study|Withdrawal by Subject|0|||
129716990|NCT03159468|466922335|FG004|Overall Study|Withdrawal by Subject|0|||
129716991|NCT03159468|466922336|FG005|Overall Study|Withdrawal by Subject|0|||
129716992|NCT02524145|466922337|FG000|Overall Study|Withdrawal by Subject|2|||
129716993|NCT02524145|466922338|FG001|Overall Study|Withdrawal by Subject|2|||
129716994|NCT02524145|466922339|FG002|Overall Study|Withdrawal by Subject|3|||
129716995|NCT00500357|466924011|FG000|Overall Study|Death|1|||
129716996|NCT00161616|466924012|FG000|Overall Study|Withdrawal by Subject|6|||
129716997|NCT00161616|466924013|FG001|Overall Study|Withdrawal by Subject|5|||
129716998|NCT00161616|466924012|FG000|Overall Study|Physician Decision|1|||
129716999|NCT00161616|466924013|FG001|Overall Study|Physician Decision|0|||
129717000|NCT00161616|466924012|FG000|Overall Study|Death|1|||
129717001|NCT00161616|466924013|FG001|Overall Study|Death|1|||
129717002|NCT00161616|466924012|FG000|Overall Study|Lost to Follow-up|17|||
129717003|NCT00161616|466924013|FG001|Overall Study|Lost to Follow-up|13|||
129717004|NCT00161616|466924012|FG000|Overall Study|Protocol deviation|1|||
129717005|NCT00161616|466924013|FG001|Overall Study|Protocol deviation|0|||
129717006|NCT00854724|466924014|FG000|First Intervention|Withdrawal by Subject|1|||
129717007|NCT00854724|466924015|FG001|First Intervention|Withdrawal by Subject|1|||
129717008|NCT00854724|466924014|FG000|Washout|Protocol Violation|1|||
129717009|NCT00854724|466924015|FG001|Washout|Protocol Violation|0|||
129717010|NCT00854724|466924014|FG000|Washout|Withdrawal by Subject|0|||
129717011|NCT00854724|466924015|FG001|Washout|Withdrawal by Subject|1|||
129891471|NCT01598987|467561132|FG000|Baseline to 24 Month|Administrative problems|2|||
129891472|NCT01598987|467561132|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
129891473|NCT02107274|467561133|FG000|Treatment vs. Placebo|Adverse Event|3|||
129891474|NCT02107274|467561134|FG001|Treatment vs. Placebo|Adverse Event|0|||
129717012|NCT00854724|466924014|FG000|Second Intervention|Protocol Violation|1|||
129717013|NCT00854724|466924015|FG001|Second Intervention|Protocol Violation|0|||
129717014|NCT00854724|466924014|FG000|Second Intervention|Physician Decision|0|||
129717015|NCT00854724|466924015|FG001|Second Intervention|Physician Decision|1|||
129717016|NCT02141633|466924016|FG000|Overall Study|Physician Decision|1|||
129717017|NCT02141633|466924017|FG001|Overall Study|Physician Decision|0|||
129717018|NCT02140970|466924026|FG000|Overall Study|Lost to Follow-up|1|||
129717019|NCT02140970|466924027|FG001|Overall Study|Lost to Follow-up|2|||
129717020|NCT02140970|466924026|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
129717021|NCT02140970|466924027|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
129717022|NCT02140970|466924026|FG000|Overall Study|Did not meet inclusion criteria|0|||
129717023|NCT02140970|466924027|FG001|Overall Study|Did not meet inclusion criteria|1|||
129717024|NCT01947283|466924031|FG000|Overall Study|Death|1|||
129717025|NCT01947283|466924032|FG001|Overall Study|Death|1|||
129717026|NCT01947283|466924033|FG002|Overall Study|Death|1|||
129717027|NCT01947283|466924034|FG003|Overall Study|Death|0|||
129717028|NCT01947283|466924035|FG004|Overall Study|Death|0|||
129717029|NCT01947283|466924036|FG005|Overall Study|Death|0|||
129717030|NCT01947283|466924037|FG006|Overall Study|Death|0|||
129717031|NCT01947283|466924031|FG000|Overall Study|Lost to Follow-up|4|||
129717032|NCT01947283|466924032|FG001|Overall Study|Lost to Follow-up|6|||
129717033|NCT01947283|466924033|FG002|Overall Study|Lost to Follow-up|5|||
129717034|NCT01947283|466924034|FG003|Overall Study|Lost to Follow-up|5|||
129717035|NCT01947283|466924035|FG004|Overall Study|Lost to Follow-up|0|||
129717036|NCT01947283|466924036|FG005|Overall Study|Lost to Follow-up|2|||
129717037|NCT01947283|466924037|FG006|Overall Study|Lost to Follow-up|5|||
129717038|NCT01947283|466924031|FG000|Overall Study|Withdrawal by Subject|10|||
129717039|NCT01947283|466924032|FG001|Overall Study|Withdrawal by Subject|8|||
129717040|NCT01947283|466924033|FG002|Overall Study|Withdrawal by Subject|4|||
129717041|NCT01947283|466924034|FG003|Overall Study|Withdrawal by Subject|1|||
129717042|NCT01947283|466924035|FG004|Overall Study|Withdrawal by Subject|0|||
129717043|NCT01947283|466924036|FG005|Overall Study|Withdrawal by Subject|0|||
129717044|NCT01947283|466924037|FG006|Overall Study|Withdrawal by Subject|2|||
129717045|NCT01947283|466924031|FG000|Overall Study|No Clinical Recording|12|||
129717046|NCT01947283|466924032|FG001|Overall Study|No Clinical Recording|6|||
129717047|NCT01947283|466924033|FG002|Overall Study|No Clinical Recording|8|||
129717048|NCT01947283|466924034|FG003|Overall Study|No Clinical Recording|10|||
129717049|NCT01947283|466924035|FG004|Overall Study|No Clinical Recording|0|||
129717050|NCT01947283|466924036|FG005|Overall Study|No Clinical Recording|0|||
129717051|NCT01947283|466924037|FG006|Overall Study|No Clinical Recording|0|||
129717052|NCT01947283|466924031|FG000|Overall Study|Non-coding Clinical Recording language|0|||
129717053|NCT01947283|466924032|FG001|Overall Study|Non-coding Clinical Recording language|0|||
129717054|NCT01947283|466924033|FG002|Overall Study|Non-coding Clinical Recording language|0|||
129717055|NCT01947283|466924034|FG003|Overall Study|Non-coding Clinical Recording language|1|||
129717056|NCT01947283|466924035|FG004|Overall Study|Non-coding Clinical Recording language|0|||
129717057|NCT01947283|466924036|FG005|Overall Study|Non-coding Clinical Recording language|0|||
129717058|NCT01947283|466924037|FG006|Overall Study|Non-coding Clinical Recording language|0|||
129717059|NCT01947283|466924031|FG000|Overall Study|Missing Follow-up Assessment|2|||
129717060|NCT01947283|466924032|FG001|Overall Study|Missing Follow-up Assessment|2|||
129717061|NCT01947283|466924033|FG002|Overall Study|Missing Follow-up Assessment|3|||
129717062|NCT01947283|466924034|FG003|Overall Study|Missing Follow-up Assessment|0|||
129717063|NCT01947283|466924035|FG004|Overall Study|Missing Follow-up Assessment|0|||
129717064|NCT01947283|466924036|FG005|Overall Study|Missing Follow-up Assessment|2|||
129717065|NCT01947283|466924037|FG006|Overall Study|Missing Follow-up Assessment|0|||
129717066|NCT01947283|466924031|FG000|Overall Study|No patients were enrolled in study|0|||
129717067|NCT01947283|466924032|FG001|Overall Study|No patients were enrolled in study|0|||
129717068|NCT01947283|466924033|FG002|Overall Study|No patients were enrolled in study|0|||
129717069|NCT01947283|466924034|FG003|Overall Study|No patients were enrolled in study|0|||
129717070|NCT01947283|466924035|FG004|Overall Study|No patients were enrolled in study|0|||
129717071|NCT01947283|466924036|FG005|Overall Study|No patients were enrolled in study|3|||
129717072|NCT01947283|466924037|FG006|Overall Study|No patients were enrolled in study|1|||
129717073|NCT03782259|466924038|FG000|Overall Study|Lost to Follow-up|1|||
129717074|NCT03782259|466924039|FG001|Overall Study|Lost to Follow-up|1|||
129717075|NCT03782259|466924038|FG000|Overall Study|Moved out of state|0|||
129717076|NCT03782259|466924039|FG001|Overall Study|Moved out of state|2|||
129717077|NCT03782259|466924038|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
129717078|NCT03782259|466924039|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
129717079|NCT03782259|466924038|FG000|Overall Study|Subject discontinued intervention|1|||
129717080|NCT03782259|466924039|FG001|Overall Study|Subject discontinued intervention|0|||
129891475|NCT02107274|467561133|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
129717081|NCT00603941|466924043|FG000|Overall Study|Disease progression|6|||
129717082|NCT00603941|466924044|FG001|Overall Study|Disease progression|7|||
129717083|NCT00603941|466924045|FG002|Overall Study|Disease progression|1|||
129717084|NCT00603941|466924043|FG000|Overall Study|Adverse Event|1|||
129717085|NCT00603941|466924044|FG001|Overall Study|Adverse Event|0|||
129717086|NCT00603941|466924045|FG002|Overall Study|Adverse Event|1|||
129717087|NCT00603941|466924043|FG000|Overall Study|Physician Decision|0|||
129717088|NCT00603941|466924044|FG001|Overall Study|Physician Decision|1|||
129717089|NCT00603941|466924045|FG002|Overall Study|Physician Decision|0|||
129717090|NCT00603941|466924043|FG000|Overall Study|Withdrawal by Subject|0|||
129717091|NCT00603941|466924044|FG001|Overall Study|Withdrawal by Subject|2|||
129802979|NCT01691898|467247479|FG001|Overall Study|Progression of Disease|2|||
129717092|NCT00603941|466924045|FG002|Overall Study|Withdrawal by Subject|0|||
129717093|NCT05069597|466924046|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129717094|NCT05069597|466924047|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
129717095|NCT02705105|466924048|FG000|Treatment|Objective Disease Progression|1|||
129717096|NCT02705105|466924049|FG001|Treatment|Objective Disease Progression|50|||
129717097|NCT02705105|466924048|FG000|Treatment|Withdrawal by Subject|3|||
129717098|NCT02705105|466924049|FG001|Treatment|Withdrawal by Subject|5|||
129717099|NCT02705105|466924048|FG000|Treatment|Adverse Event|0|||
129717100|NCT02705105|466924049|FG001|Treatment|Adverse Event|17|||
129717101|NCT02705105|466924048|FG000|Treatment|Clinical Disease Progression|0|||
129717102|NCT02705105|466924049|FG001|Treatment|Clinical Disease Progression|32|||
129717103|NCT02705105|466924048|FG000|Treatment|Physician Decision|0|||
129717104|NCT02705105|466924049|FG001|Treatment|Physician Decision|3|||
129717105|NCT02705105|466924048|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
129717106|NCT02705105|466924049|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
129717107|NCT02705105|466924048|FG000|Follow-Up|Death|3|||
129717108|NCT02705105|466924049|FG001|Follow-Up|Death|68|||
129717109|NCT02705105|466924048|FG000|Follow-Up|Withdrawal by Subject|1|||
129717110|NCT02705105|466924049|FG001|Follow-Up|Withdrawal by Subject|14|||
129717111|NCT02705105|466924048|FG000|Follow-Up|Study Terminated|0|||
129717112|NCT02705105|466924049|FG001|Follow-Up|Study Terminated|26|||
129717113|NCT02705105|466924048|FG000|Follow-Up|Discontinued per Amendment 3|0|||
129717114|NCT02705105|466924049|FG001|Follow-Up|Discontinued per Amendment 3|2|||
129717115|NCT01709110|466924050|FG000|Overall Study|Adverse Event|56|||
129717116|NCT01709110|466924051|FG001|Overall Study|Adverse Event|48|||
129717117|NCT01709110|466924050|FG000|Overall Study|Death|14|||
129717118|NCT01709110|466924051|FG001|Overall Study|Death|6|||
129717119|NCT01709110|466924050|FG000|Overall Study|Lost to Follow-up|7|||
129717120|NCT01709110|466924051|FG001|Overall Study|Lost to Follow-up|5|||
129717121|NCT01709110|466924050|FG000|Overall Study|Protocol Violation|4|||
129717122|NCT01709110|466924051|FG001|Overall Study|Protocol Violation|6|||
129717123|NCT01709110|466924050|FG000|Overall Study|Withdrawal by Subject|96|||
129717124|NCT01709110|466924051|FG001|Overall Study|Withdrawal by Subject|89|||
129717125|NCT01709110|466924050|FG000|Overall Study|Physician Decision|4|||
129717126|NCT01709110|466924051|FG001|Overall Study|Physician Decision|10|||
129717127|NCT01709110|466924050|FG000|Overall Study|Sponsor Decision|2|||
129717128|NCT01709110|466924051|FG001|Overall Study|Sponsor Decision|2|||
129717129|NCT01709110|466924050|FG000|Overall Study|Lack of Efficacy|1|||
129717130|NCT01709110|466924051|FG001|Overall Study|Lack of Efficacy|1|||
129717131|NCT01709110|466924050|FG000|Overall Study|Caregiver Decision|1|||
129717132|NCT01709110|466924051|FG001|Overall Study|Caregiver Decision|1|||
129717133|NCT04556591|466924052|FG000|Overall Study|Lost to Follow-up|1|||
129717134|NCT04556591|466924053|FG001|Overall Study|Lost to Follow-up|0|||
129717135|NCT04556591|466924052|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
129717136|NCT04556591|466924053|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
129717137|NCT03332173|466924054|FG000|Overall Study|Death|7|||
129717138|NCT03332173|466924054|FG000|Overall Study|Withdrawal by Subject|6|||
129717139|NCT03332173|466924054|FG000|Overall Study|Lost to Follow-up|2|||
129717140|NCT03332173|466924054|FG000|Overall Study|Transferred to long-term extension study|29|||
129717141|NCT02168101|466924055|FG000|Overall Study|Death|2|||
129717142|NCT02168101|466924056|FG001|Overall Study|Death|2|||
129717143|NCT02168101|466924057|FG002|Overall Study|Death|1|||
129717144|NCT05507567|466924058|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
129802980|NCT01691898|467247480|FG002|Overall Study|Progression of Disease|1|||
129717145|NCT05507567|466924059|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
129717146|NCT05507567|466924060|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
129717147|NCT05507567|466924058|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
129717148|NCT05507567|466924059|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
129717149|NCT05507567|466924060|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
129717150|NCT05507567|466924058|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
129717151|NCT05507567|466924059|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
129717152|NCT05507567|466924060|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
129717153|NCT05507567|466924058|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
129717154|NCT05507567|466924059|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
129717155|NCT05507567|466924060|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
129717156|NCT00910910|466924061|FG000|Overall Study|Adverse Event|63|||
129717157|NCT00910910|466924062|FG001|Overall Study|Adverse Event|35|||
129717158|NCT00910910|466924061|FG000|Overall Study|PD without histologic change|27|||
129717159|NCT00910910|466924062|FG001|Overall Study|PD without histologic change|23|||
129717160|NCT00910910|466924061|FG000|Overall Study|PD with histologic change|0|||
129717161|NCT00910910|466924062|FG001|Overall Study|PD with histologic change|2|||
129717162|NCT00910910|466924061|FG000|Overall Study|Withdrawal by Subject|7|||
129717163|NCT00910910|466924062|FG001|Overall Study|Withdrawal by Subject|5|||
129717164|NCT00910910|466924061|FG000|Overall Study|Lost to Follow-up|2|||
129717165|NCT00910910|466924062|FG001|Overall Study|Lost to Follow-up|2|||
129717166|NCT00910910|466924061|FG000|Overall Study|Death|9|||
129717167|NCT00910910|466924062|FG001|Overall Study|Death|3|||
129717168|NCT00910910|466924061|FG000|Overall Study|Protocol Violation|2|||
129717169|NCT00910910|466924062|FG001|Overall Study|Protocol Violation|2|||
129717170|NCT00910910|466924061|FG000|Overall Study|Completed 13 cycles of treatment|0|||
129717171|NCT00910910|466924062|FG001|Overall Study|Completed 13 cycles of treatment|118|||
129717172|NCT00910910|466924061|FG000|Overall Study|Other|114|||
129717173|NCT00910910|466924062|FG001|Overall Study|Other|32|||
129717174|NCT00910910|466924061|FG000|Overall Study|Untreated before cycle 1|1|||
129717175|NCT00910910|466924062|FG001|Overall Study|Untreated before cycle 1|2|||
129717176|NCT01973231|466924063|FG000|Overall Study|Protocol Violation|1|||
129717177|NCT01973231|466924064|FG001|Overall Study|Protocol Violation|1|||
129717178|NCT01973231|466924063|FG000|Overall Study|Lost to Follow-up|1|||
129717179|NCT01973231|466924064|FG001|Overall Study|Lost to Follow-up|1|||
129717180|NCT01973231|466924063|FG000|Overall Study|unclassified|2|||
129717181|NCT01973231|466924064|FG001|Overall Study|unclassified|1|||
129717182|NCT01973231|466924063|FG000|Overall Study|Withdrawal by Subject|7|||
129717183|NCT01973231|466924064|FG001|Overall Study|Withdrawal by Subject|9|||
129717184|NCT01434654|466924067|FG000|Overall Study|Withdrawal by Subject|1|||
129717185|NCT01434654|466924068|FG001|Overall Study|Withdrawal by Subject|0|||
129717186|NCT01434654|466924067|FG000|Overall Study|Lost to Follow-up|1|||
129717187|NCT01434654|466924068|FG001|Overall Study|Lost to Follow-up|0|||
129717188|NCT01277822|466924071|FG000|Overall Study|Adverse Event|2|||
129717189|NCT01277822|466924072|FG001|Overall Study|Adverse Event|1|||
129717190|NCT01277822|466924071|FG000|Overall Study|Withdrawal by Subject|6|||
129717191|NCT01277822|466924072|FG001|Overall Study|Withdrawal by Subject|7|||
129717192|NCT01277822|466924071|FG000|Overall Study|Physician Decision|1|||
129717193|NCT01277822|466924072|FG001|Overall Study|Physician Decision|1|||
129717194|NCT01277822|466924071|FG000|Overall Study|Protocol Violation|1|||
129717195|NCT01277822|466924072|FG001|Overall Study|Protocol Violation|0|||
129717196|NCT01277822|466924071|FG000|Overall Study|Lost to Follow-up|2|||
129717197|NCT01277822|466924072|FG001|Overall Study|Lost to Follow-up|1|||
129717198|NCT01277822|466924071|FG000|Overall Study|Contraindicated medication used|2|||
129717199|NCT01277822|466924072|FG001|Overall Study|Contraindicated medication used|1|||
129717200|NCT01277822|466924071|FG000|Overall Study|Participant moved|1|||
129717201|NCT01277822|466924072|FG001|Overall Study|Participant moved|0|||
129717202|NCT02923531|466924073|FG000|Overall Study|Adverse Event|4|||
129717203|NCT02923531|466924073|FG000|Overall Study|Clinical Deterioration|1|||
129717204|NCT02923531|466924073|FG000|Overall Study|Disease Progression|3|||
129717205|NCT02923531|466924073|FG000|Overall Study|Study Termination|1|||
129717206|NCT00997984|466924074|FG000|Overall Study|Adverse Event|1|||
129717207|NCT00997984|466924075|FG001|Overall Study|Adverse Event|8|||
129717208|NCT00997984|466924076|FG002|Overall Study|Adverse Event|8|||
129717209|NCT00997984|466924074|FG000|Overall Study|Protocol Violation|1|||
129717210|NCT00997984|466924075|FG001|Overall Study|Protocol Violation|3|||
129717211|NCT00997984|466924076|FG002|Overall Study|Protocol Violation|0|||
129717212|NCT00997984|466924074|FG000|Overall Study|Withdrawal by Subject|6|||
129717213|NCT00997984|466924075|FG001|Overall Study|Withdrawal by Subject|9|||
129717214|NCT00997984|466924076|FG002|Overall Study|Withdrawal by Subject|5|||
129717215|NCT00997984|466924074|FG000|Overall Study|Lost to Follow-up|8|||
129717216|NCT00997984|466924075|FG001|Overall Study|Lost to Follow-up|5|||
129717217|NCT00997984|466924076|FG002|Overall Study|Lost to Follow-up|4|||
129717218|NCT00997984|466924074|FG000|Overall Study|Lack of Efficacy|20|||
129717219|NCT00997984|466924075|FG001|Overall Study|Lack of Efficacy|6|||
129717220|NCT00997984|466924076|FG002|Overall Study|Lack of Efficacy|3|||
129717221|NCT00997984|466924074|FG000|Overall Study|Met exclusion criteria|1|||
129717222|NCT00997984|466924075|FG001|Overall Study|Met exclusion criteria|0|||
129717223|NCT00997984|466924076|FG002|Overall Study|Met exclusion criteria|0|||
129717224|NCT00997984|466924074|FG000|Overall Study|non-compliance|0|||
129717225|NCT00997984|466924075|FG001|Overall Study|non-compliance|2|||
129717226|NCT00997984|466924076|FG002|Overall Study|non-compliance|3|||
129717227|NCT00997984|466924074|FG000|Overall Study|Wrong medication dispensed|0|||
129717228|NCT00997984|466924075|FG001|Overall Study|Wrong medication dispensed|1|||
129717229|NCT00997984|466924076|FG002|Overall Study|Wrong medication dispensed|0|||
129717230|NCT00997984|466924074|FG000|Overall Study|Suicidal ideation|0|||
129717231|NCT00997984|466924075|FG001|Overall Study|Suicidal ideation|0|||
129717232|NCT00997984|466924076|FG002|Overall Study|Suicidal ideation|1|||
129717233|NCT00997984|466924074|FG000|Overall Study|Work schedule|0|||
129717234|NCT00997984|466924075|FG001|Overall Study|Work schedule|0|||
129717235|NCT00997984|466924076|FG002|Overall Study|Work schedule|2|||
129717236|NCT01119066|466924078|FG000|Overall Study|Withdrawal by Subject|4|||
129717237|NCT01119066|466924079|FG001|Overall Study|Withdrawal by Subject|6|||
129717238|NCT01119066|466924080|FG002|Overall Study|Withdrawal by Subject|0|||
129717239|NCT01119066|466924081|FG003|Overall Study|Withdrawal by Subject|0|||
129717240|NCT01119066|466924078|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
129717241|NCT01119066|466924079|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
129717242|NCT01119066|466924080|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
129717243|NCT01119066|466924081|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
129717244|NCT01119066|466924078|FG000|Overall Study|Relapse identified before transplant|1|||
129717245|NCT01119066|466924079|FG001|Overall Study|Relapse identified before transplant|0|||
129717246|NCT01119066|466924080|FG002|Overall Study|Relapse identified before transplant|0|||
129717247|NCT01119066|466924081|FG003|Overall Study|Relapse identified before transplant|0|||
129717248|NCT01119066|466924078|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
129717249|NCT01119066|466924079|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
129717250|NCT01119066|466924080|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
129717251|NCT01119066|466924081|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
129717252|NCT01119066|466924078|FG000|Overall Study|Relapse identified before transplant|0|||
129717253|NCT01119066|466924079|FG001|Overall Study|Relapse identified before transplant|4|||
129717254|NCT01119066|466924080|FG002|Overall Study|Relapse identified before transplant|0|||
129717255|NCT01119066|466924081|FG003|Overall Study|Relapse identified before transplant|0|||
129717256|NCT00271856|466924084|FG000|Overall Study|Withdrawal by Subject|1|||
129717257|NCT00271856|466924085|FG001|Overall Study|Withdrawal by Subject|7|||
129717258|NCT00271856|466924084|FG000|Overall Study|Lost to Follow-up|10|||
129717259|NCT00271856|466924085|FG001|Overall Study|Lost to Follow-up|11|||
129717260|NCT02366923|466924086|FG000|Overall Study|Withdrawal by Subject|1|||
129717261|NCT02366923|466924086|FG000|Overall Study|Positive Slit Lamp Findings|2|||
129717262|NCT02366923|466924086|FG000|Overall Study|High Astigmatism|3|||
129717263|NCT01437111|466924091|FG000|Overall Study|Adverse Event|2|||
129717264|NCT01437111|466924091|FG000|Overall Study|Withdrawal by Subject|4|||
129717265|NCT01437111|466924091|FG000|Overall Study|Not reported|5|||
129717266|NCT01437111|466924091|FG000|Overall Study|Physician Decision|1|||
129717267|NCT01437111|466924091|FG000|Overall Study|Lost to Follow-up|5|||
129717268|NCT01437111|466924091|FG000|Overall Study|Protocol Violation|1|||
129717269|NCT02131311|466924093|FG000|Overall Study|Adverse Event|2|||
129717270|NCT02131311|466924093|FG000|Overall Study|Protocol Violation|1|||
129717271|NCT02131311|466924093|FG000|Overall Study|Lost to Follow-up|1|||
129717272|NCT02623205|466924095|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
129717273|NCT02623205|466924096|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
129717274|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
129717275|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
129717276|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
129717277|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
129717278|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
129717279|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
129717280|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
129717281|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
129717282|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
129717283|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
129717284|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
129717285|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
129717286|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
129717287|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
129717288|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
129717289|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
129717290|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
129717291|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
129717292|NCT03162796|466924097|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
129717293|NCT03162796|466924098|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
129717294|NCT03162796|466924099|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
129717295|NCT03162796|466924097|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
129717296|NCT03162796|466924098|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
129717297|NCT03162796|466924099|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
129717298|NCT03162796|466924097|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
129717299|NCT03162796|466924098|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
129717300|NCT03162796|466924099|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
129717301|NCT03162796|466924097|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
129717302|NCT03162796|466924098|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
129717303|NCT03162796|466924099|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
129717304|NCT03162796|466924097|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
129717305|NCT03162796|466924098|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
129717306|NCT03162796|466924099|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
129717307|NCT02342288|466924100|FG000|Overall Study|no protocol anesthesiologist available|3|||
129717308|NCT02342288|466924101|FG001|Overall Study|no protocol anesthesiologist available|2|||
129717309|NCT02342288|466924100|FG000|Overall Study|anesthesia leak in system|1|||
129717310|NCT02342288|466924101|FG001|Overall Study|anesthesia leak in system|0|||
129717311|NCT02342288|466924100|FG000|Overall Study|Withdrawal by Subject|1|||
129717312|NCT02342288|466924101|FG001|Overall Study|Withdrawal by Subject|0|||
129717313|NCT02342288|466924100|FG000|Overall Study|coordinator contaminated with blood|0|||
129717314|NCT02342288|466924101|FG001|Overall Study|coordinator contaminated with blood|1|||
129802981|NCT01691898|467247481|FG003|Overall Study|Progression of Disease|0|||
129802982|NCT01691898|467247482|FG004|Overall Study|Progression of Disease|0|||
129802983|NCT01691898|467247483|FG005|Overall Study|Progression of Disease|1|||
129802984|NCT01691898|467247478|FG000|Overall Study|Lost to Follow-up|3|||
129802985|NCT01691898|467247479|FG001|Overall Study|Lost to Follow-up|1|||
129802986|NCT01691898|467247480|FG002|Overall Study|Lost to Follow-up|0|||
129802987|NCT01691898|467247481|FG003|Overall Study|Lost to Follow-up|0|||
129802988|NCT01691898|467247482|FG004|Overall Study|Lost to Follow-up|1|||
129802989|NCT01691898|467247483|FG005|Overall Study|Lost to Follow-up|0|||
129802990|NCT01691898|467247478|FG000|Overall Study|Withdrawal by Subject|9|||
129802991|NCT01691898|467247479|FG001|Overall Study|Withdrawal by Subject|8|||
129802992|NCT01691898|467247480|FG002|Overall Study|Withdrawal by Subject|2|||
129802993|NCT01691898|467247481|FG003|Overall Study|Withdrawal by Subject|1|||
129802994|NCT01691898|467247482|FG004|Overall Study|Withdrawal by Subject|3|||
129802995|NCT01691898|467247483|FG005|Overall Study|Withdrawal by Subject|3|||
129802996|NCT01691898|467247478|FG000|Overall Study|Non-Compliance|0|||
129802997|NCT01691898|467247479|FG001|Overall Study|Non-Compliance|0|||
129802998|NCT01691898|467247480|FG002|Overall Study|Non-Compliance|0|||
129891476|NCT02107274|467561134|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
129891477|NCT02107274|467561133|FG000|Control Phase|Lost to Follow-up|1|||
129717315|NCT02342288|466924100|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
129717316|NCT02342288|466924101|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
129717317|NCT02342288|466924100|FG000|Overall Study|coordinator not available|0|||
129717318|NCT02342288|466924101|FG001|Overall Study|coordinator not available|2|||
129717319|NCT03082677|466924102|FG000|Overall Study|Not Treated|2|||
129717320|NCT01916824|466924107|FG000|Overall Study|Lost to Follow-up|3|||
129717321|NCT01916824|466924108|FG001|Overall Study|Lost to Follow-up|6|||
129717322|NCT01916824|466924107|FG000|Overall Study|Physician Decision|2|||
129717323|NCT01916824|466924108|FG001|Overall Study|Physician Decision|0|||
129717324|NCT01916824|466924107|FG000|Overall Study|Withdrawal by Subject|2|||
129717325|NCT01916824|466924108|FG001|Overall Study|Withdrawal by Subject|3|||
129717326|NCT00771927|466924111|FG000|Overall Study|Adverse Event|100|||
129717327|NCT00771927|466924112|FG001|Overall Study|Adverse Event|105|||
129717328|NCT00771927|466924111|FG000|Overall Study|Lack of Efficacy|70|||
129891478|NCT02107274|467561134|FG001|Control Phase|Lost to Follow-up|1|||
129891479|NCT02107274|467561133|FG000|Control Phase|Death|2|||
129891480|NCT02107274|467561134|FG001|Control Phase|Death|0|||
129717329|NCT00771927|466924112|FG001|Overall Study|Lack of Efficacy|42|||
129717330|NCT00771927|466924111|FG000|Overall Study|Lost to Follow-up|46|||
129717331|NCT00771927|466924112|FG001|Overall Study|Lost to Follow-up|46|||
129717332|NCT00771927|466924111|FG000|Overall Study|Withdrawal by Subject|16|||
129717333|NCT00771927|466924112|FG001|Overall Study|Withdrawal by Subject|17|||
129717334|NCT00771927|466924111|FG000|Overall Study|Other reason|23|||
129802999|NCT01691898|467247481|FG003|Overall Study|Non-Compliance|0|||
129803000|NCT01691898|467247482|FG004|Overall Study|Non-Compliance|1|||
129803001|NCT01691898|467247483|FG005|Overall Study|Non-Compliance|0|||
129803002|NCT00747812|467247484|FG000|Overall Study|Research Site Staff Relocation|5|||
129803003|NCT00747812|467247485|FG001|Overall Study|Research Site Staff Relocation|3|||
129891481|NCT02107274|467561133|FG000|Control Phase|Adverse Event|0|||
129891482|NCT02107274|467561134|FG001|Control Phase|Adverse Event|1|||
129803004|NCT01708161|467247486|FG000|Overall Study|Adverse Event|1|||
129803005|NCT01708161|467247487|FG001|Overall Study|Adverse Event|3|||
129803006|NCT01708161|467247488|FG002|Overall Study|Adverse Event|4|||
129803007|NCT01708161|467247489|FG003|Overall Study|Adverse Event|2|||
129803008|NCT01708161|467247490|FG004|Overall Study|Adverse Event|3|||
129803009|NCT01708161|467247491|FG005|Overall Study|Adverse Event|0|||
129803010|NCT01708161|467247486|FG000|Overall Study|Death|0|||
129803011|NCT01708161|467247487|FG001|Overall Study|Death|0|||
129803012|NCT01708161|467247488|FG002|Overall Study|Death|0|||
129803013|NCT01708161|467247489|FG003|Overall Study|Death|1|||
129803014|NCT01708161|467247490|FG004|Overall Study|Death|0|||
129803015|NCT01708161|467247491|FG005|Overall Study|Death|1|||
129803016|NCT01708161|467247486|FG000|Overall Study|Withdrawal by Subject|0|||
129803017|NCT01708161|467247487|FG001|Overall Study|Withdrawal by Subject|1|||
129803018|NCT01708161|467247488|FG002|Overall Study|Withdrawal by Subject|1|||
129803019|NCT01708161|467247489|FG003|Overall Study|Withdrawal by Subject|0|||
129803020|NCT01708161|467247490|FG004|Overall Study|Withdrawal by Subject|0|||
129803021|NCT01708161|467247491|FG005|Overall Study|Withdrawal by Subject|0|||
129803022|NCT01708161|467247486|FG000|Overall Study|Administrative problems|0|||
129803023|NCT01708161|467247487|FG001|Overall Study|Administrative problems|1|||
129803024|NCT01708161|467247488|FG002|Overall Study|Administrative problems|0|||
129803025|NCT01708161|467247489|FG003|Overall Study|Administrative problems|0|||
129803026|NCT01708161|467247490|FG004|Overall Study|Administrative problems|0|||
129803027|NCT01708161|467247491|FG005|Overall Study|Administrative problems|0|||
129803028|NCT01708161|467247486|FG000|Overall Study|Disease progression|3|||
129803029|NCT01708161|467247487|FG001|Overall Study|Disease progression|5|||
129803030|NCT01708161|467247488|FG002|Overall Study|Disease progression|5|||
129803031|NCT01708161|467247489|FG003|Overall Study|Disease progression|13|||
129803032|NCT01708161|467247490|FG004|Overall Study|Disease progression|3|||
129803033|NCT01708161|467247491|FG005|Overall Study|Disease progression|0|||
129803034|NCT02019277|467247492|FG000|Overall Study|Withdrawal by Subject|3|||
129803035|NCT02019277|467247492|FG000|Overall Study|Death|7|||
129803036|NCT02019277|467247492|FG000|Overall Study|Did no Cooperate|1|||
129803037|NCT02019277|467247492|FG000|Overall Study|Adverse Event|1|||
129717335|NCT00771927|466924112|FG001|Overall Study|Other reason|27|||
129717336|NCT03711370|466924113|FG000|Overall Study|Lost to Follow-up|16|||
129717337|NCT03711370|466924114|FG001|Overall Study|Lost to Follow-up|10|||
129717338|NCT03711370|466924113|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
129717339|NCT03711370|466924114|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
129717340|NCT00407602|466924115|FG000|Overall Study|Death - unrelated to device|1|||
129717341|NCT00407602|466924115|FG000|Overall Study|Device explanted|5|||
129717342|NCT00407602|466924115|FG000|Overall Study|Withdrawal by Subject|1|||
129717343|NCT02063984|466924116|FG000|Overall Study|Lost to Follow-up|6|||
129717344|NCT02063984|466924117|FG001|Overall Study|Lost to Follow-up|5|||
129717345|NCT02517398|466924118|FG000|Overall Study|Death|2|||
129717346|NCT02517398|466924119|FG001|Overall Study|Death|3|||
129717347|NCT02517398|466924120|FG002|Overall Study|Death|4|||
129717348|NCT02517398|466924121|FG003|Overall Study|Death|2|||
129717349|NCT02517398|466924122|FG004|Overall Study|Death|3|||
129717350|NCT02517398|466924123|FG005|Overall Study|Death|8|||
129717351|NCT02517398|466924124|FG006|Overall Study|Death|3|||
129717352|NCT02517398|466924125|FG007|Overall Study|Death|2|||
129717353|NCT02517398|466924126|FG008|Overall Study|Death|6|||
129717354|NCT02517398|466924127|FG009|Overall Study|Death|24|||
129717355|NCT02517398|466924128|FG010|Overall Study|Death|53|||
129717356|NCT02517398|466924129|FG011|Overall Study|Death|25|||
129717357|NCT02517398|466924130|FG012|Overall Study|Death|73|||
129717358|NCT02517398|466924131|FG013|Overall Study|Death|29|||
129717359|NCT02517398|466924132|FG014|Overall Study|Death|26|||
129717360|NCT02517398|466924133|FG015|Overall Study|Death|23|||
129717361|NCT02517398|466924134|FG016|Overall Study|Death|26|||
129717362|NCT02517398|466924135|FG017|Overall Study|Death|25|||
129803038|NCT02633501|467247494|FG000|Overall Study|Adverse Event|0|||
129803039|NCT02633501|467247495|FG001|Overall Study|Adverse Event|0|||
129803040|NCT02633501|467247496|FG002|Overall Study|Adverse Event|1|||
129803041|NCT02633501|467247497|FG003|Overall Study|Adverse Event|0|||
129803042|NCT02633501|467247498|FG004|Overall Study|Adverse Event|1|||
129803043|NCT02633501|467247499|FG005|Overall Study|Adverse Event|1|||
129717363|NCT02517398|466924136|FG018|Overall Study|Death|22|||
129717364|NCT02517398|466924137|FG019|Overall Study|Death|7|||
129803044|NCT02633501|467247494|FG000|Overall Study|Withdrawal by Subject|2|||
129803045|NCT02633501|467247495|FG001|Overall Study|Withdrawal by Subject|1|||
129803046|NCT02633501|467247496|FG002|Overall Study|Withdrawal by Subject|2|||
129803047|NCT02633501|467247497|FG003|Overall Study|Withdrawal by Subject|2|||
129803048|NCT02633501|467247498|FG004|Overall Study|Withdrawal by Subject|1|||
129717365|NCT02517398|466924138|FG020|Overall Study|Death|26|||
129717366|NCT02517398|466924139|FG021|Overall Study|Death|30|||
129717367|NCT02517398|466924140|FG022|Overall Study|Death|20|||
129717368|NCT02517398|466924118|FG000|Overall Study|Other|0|||
129803049|NCT02633501|467247499|FG005|Overall Study|Withdrawal by Subject|3|||
129717369|NCT02517398|466924119|FG001|Overall Study|Other|0|||
129444329|NCT00129623|465927298|FG001|Overall Study|Uncertainty to return|1|||
129444330|NCT02616614|465927299|FG000|Overall Study|Withdrawal by Subject|10|||
129717370|NCT02517398|466924120|FG002|Overall Study|Other|0|||
129717371|NCT02517398|466924121|FG003|Overall Study|Other|1|||
129717372|NCT02517398|466924122|FG004|Overall Study|Other|0|||
129717373|NCT02517398|466924123|FG005|Overall Study|Other|0|||
129717374|NCT02517398|466924124|FG006|Overall Study|Other|0|||
129717375|NCT02517398|466924125|FG007|Overall Study|Other|0|||
129717376|NCT02517398|466924126|FG008|Overall Study|Other|0|||
129717377|NCT02517398|466924127|FG009|Overall Study|Other|1|||
129717378|NCT02517398|466924128|FG010|Overall Study|Other|0|||
129717379|NCT02517398|466924129|FG011|Overall Study|Other|0|||
129717380|NCT02517398|466924130|FG012|Overall Study|Other|0|||
129717381|NCT02517398|466924131|FG013|Overall Study|Other|1|||
129717382|NCT02517398|466924132|FG014|Overall Study|Other|0|||
129717383|NCT02517398|466924133|FG015|Overall Study|Other|1|||
129717384|NCT02517398|466924134|FG016|Overall Study|Other|1|||
129717385|NCT02517398|466924135|FG017|Overall Study|Other|0|||
129717386|NCT02517398|466924136|FG018|Overall Study|Other|0|||
129717387|NCT02517398|466924137|FG019|Overall Study|Other|1|||
129717388|NCT02517398|466924138|FG020|Overall Study|Other|0|||
129717389|NCT02517398|466924139|FG021|Overall Study|Other|0|||
129717390|NCT02517398|466924140|FG022|Overall Study|Other|0|||
129717391|NCT02517398|466924118|FG000|Overall Study|Lost to Follow-up|0|||
129717392|NCT02517398|466924119|FG001|Overall Study|Lost to Follow-up|0|||
129717393|NCT02517398|466924120|FG002|Overall Study|Lost to Follow-up|0|||
129717394|NCT02517398|466924121|FG003|Overall Study|Lost to Follow-up|0|||
129717395|NCT02517398|466924122|FG004|Overall Study|Lost to Follow-up|0|||
129717396|NCT02517398|466924123|FG005|Overall Study|Lost to Follow-up|0|||
129717397|NCT02517398|466924124|FG006|Overall Study|Lost to Follow-up|0|||
129717398|NCT02517398|466924125|FG007|Overall Study|Lost to Follow-up|0|||
129717399|NCT02517398|466924126|FG008|Overall Study|Lost to Follow-up|0|||
129717400|NCT02517398|466924127|FG009|Overall Study|Lost to Follow-up|1|||
129717401|NCT02517398|466924128|FG010|Overall Study|Lost to Follow-up|0|||
129717402|NCT02517398|466924129|FG011|Overall Study|Lost to Follow-up|2|||
129717403|NCT02517398|466924130|FG012|Overall Study|Lost to Follow-up|2|||
129717404|NCT02517398|466924131|FG013|Overall Study|Lost to Follow-up|0|||
129717405|NCT02517398|466924132|FG014|Overall Study|Lost to Follow-up|1|||
129717406|NCT02517398|466924133|FG015|Overall Study|Lost to Follow-up|1|||
129717407|NCT02517398|466924134|FG016|Overall Study|Lost to Follow-up|0|||
129717408|NCT02517398|466924135|FG017|Overall Study|Lost to Follow-up|3|||
129717409|NCT02517398|466924136|FG018|Overall Study|Lost to Follow-up|1|||
129717410|NCT02517398|466924137|FG019|Overall Study|Lost to Follow-up|0|||
129717411|NCT02517398|466924138|FG020|Overall Study|Lost to Follow-up|1|||
129717412|NCT02517398|466924139|FG021|Overall Study|Lost to Follow-up|0|||
129717413|NCT02517398|466924140|FG022|Overall Study|Lost to Follow-up|2|||
129717414|NCT02517398|466924118|FG000|Overall Study|Withdrew Consent|0|||
129717415|NCT02517398|466924119|FG001|Overall Study|Withdrew Consent|0|||
129717416|NCT02517398|466924120|FG002|Overall Study|Withdrew Consent|0|||
129717417|NCT02517398|466924121|FG003|Overall Study|Withdrew Consent|0|||
129717418|NCT02517398|466924122|FG004|Overall Study|Withdrew Consent|0|||
129717419|NCT02517398|466924123|FG005|Overall Study|Withdrew Consent|0|||
129717420|NCT02517398|466924124|FG006|Overall Study|Withdrew Consent|1|||
129717421|NCT02517398|466924125|FG007|Overall Study|Withdrew Consent|0|||
129717422|NCT02517398|466924126|FG008|Overall Study|Withdrew Consent|0|||
129717423|NCT02517398|466924127|FG009|Overall Study|Withdrew Consent|2|||
129717424|NCT02517398|466924128|FG010|Overall Study|Withdrew Consent|7|||
129717425|NCT02517398|466924129|FG011|Overall Study|Withdrew Consent|1|||
129717426|NCT02517398|466924130|FG012|Overall Study|Withdrew Consent|5|||
129717427|NCT02517398|466924131|FG013|Overall Study|Withdrew Consent|4|||
129717428|NCT02517398|466924132|FG014|Overall Study|Withdrew Consent|2|||
129717429|NCT02517398|466924133|FG015|Overall Study|Withdrew Consent|5|||
129444331|NCT02616614|465927300|FG001|Overall Study|Withdrawal by Subject|5|||
129717430|NCT02517398|466924134|FG016|Overall Study|Withdrew Consent|4|||
129717431|NCT02517398|466924135|FG017|Overall Study|Withdrew Consent|2|||
129717432|NCT02517398|466924136|FG018|Overall Study|Withdrew Consent|3|||
129717433|NCT02517398|466924137|FG019|Overall Study|Withdrew Consent|2|||
129717434|NCT02517398|466924138|FG020|Overall Study|Withdrew Consent|9|||
129717435|NCT02517398|466924139|FG021|Overall Study|Withdrew Consent|3|||
129717436|NCT02517398|466924140|FG022|Overall Study|Withdrew Consent|1|||
129717437|NCT00005947|466924142|FG000|Overall Study|Death|54|||
129717438|NCT00005947|466924143|FG001|Overall Study|Death|40|||
129717439|NCT00005947|466924142|FG000|Overall Study|Patient Refused to Continue|2|||
129717440|NCT00005947|466924143|FG001|Overall Study|Patient Refused to Continue|1|||
129717441|NCT00005947|466924142|FG000|Overall Study|Site Closure|1|||
129717442|NCT00005947|466924143|FG001|Overall Study|Site Closure|0|||
129717443|NCT00429182|466924144|FG000|Overall Study|Not evaluable, Disease Progression|2|||
129717444|NCT00429182|466924144|FG000|Overall Study|Not eligible|5|||
129717445|NCT00790582|466924146|FG000|Overall Study|Death|14|||
129717446|NCT00790582|466924147|FG001|Overall Study|Death|32|||
129717447|NCT00790582|466924146|FG000|Overall Study|Physician Decision|7|||
129717448|NCT00790582|466924147|FG001|Overall Study|Physician Decision|1|||
129717449|NCT00790582|466924146|FG000|Overall Study|Lost to Follow-up|3|||
129717450|NCT00790582|466924147|FG001|Overall Study|Lost to Follow-up|3|||
129717451|NCT00790582|466924146|FG000|Overall Study|Withdrawal by Subject|7|||
129717452|NCT00790582|466924147|FG001|Overall Study|Withdrawal by Subject|51|||
129717453|NCT02195700|466924149|FG000|Overall Study|Protocol Violation|0|||
129717454|NCT02195700|466924150|FG001|Overall Study|Protocol Violation|2|||
129717455|NCT02195700|466924149|FG000|Overall Study|Noncompliance|1|||
129717456|NCT02195700|466924150|FG001|Overall Study|Noncompliance|0|||
129717457|NCT02195700|466924149|FG000|Overall Study|Adverse Event|1|||
129717458|NCT02195700|466924150|FG001|Overall Study|Adverse Event|2|||
129717459|NCT02195700|466924149|FG000|Overall Study|Withdrawal by Subject|3|||
129717460|NCT02195700|466924150|FG001|Overall Study|Withdrawal by Subject|2|||
129717461|NCT02195700|466924149|FG000|Overall Study|Lost to Follow-up|1|||
129717462|NCT02195700|466924150|FG001|Overall Study|Lost to Follow-up|1|||
129717463|NCT02931838|466924151|FG000|Overall Study|Reason not provided by investigator|1|||
129717464|NCT02931838|466924152|FG001|Overall Study|Reason not provided by investigator|0|||
129717465|NCT02931838|466924153|FG002|Overall Study|Reason not provided by investigator|1|||
129717466|NCT02931838|466924154|FG003|Overall Study|Reason not provided by investigator|0|||
129717467|NCT02931838|466924155|FG004|Overall Study|Reason not provided by investigator|0|||
129717468|NCT02931838|466924156|FG005|Overall Study|Reason not provided by investigator|0|||
129717469|NCT02931838|466924151|FG000|Overall Study|Poor/non-compliance|0|||
129717470|NCT02931838|466924152|FG001|Overall Study|Poor/non-compliance|0|||
129717471|NCT02931838|466924153|FG002|Overall Study|Poor/non-compliance|1|||
129717472|NCT02931838|466924154|FG003|Overall Study|Poor/non-compliance|0|||
129717473|NCT02931838|466924155|FG004|Overall Study|Poor/non-compliance|0|||
129717474|NCT02931838|466924156|FG005|Overall Study|Poor/non-compliance|0|||
129717475|NCT02931838|466924151|FG000|Overall Study|Lack of Efficacy|5|||
129717476|NCT02931838|466924152|FG001|Overall Study|Lack of Efficacy|4|||
129717477|NCT02931838|466924153|FG002|Overall Study|Lack of Efficacy|0|||
129717478|NCT02931838|466924154|FG003|Overall Study|Lack of Efficacy|0|||
129717479|NCT02931838|466924155|FG004|Overall Study|Lack of Efficacy|0|||
129717480|NCT02931838|466924156|FG005|Overall Study|Lack of Efficacy|1|||
129717481|NCT02931838|466924151|FG000|Overall Study|Lost to Follow-up|1|||
129717482|NCT02931838|466924152|FG001|Overall Study|Lost to Follow-up|0|||
129717483|NCT02931838|466924153|FG002|Overall Study|Lost to Follow-up|1|||
129717484|NCT02931838|466924154|FG003|Overall Study|Lost to Follow-up|1|||
129717485|NCT02931838|466924155|FG004|Overall Study|Lost to Follow-up|2|||
129717486|NCT02931838|466924156|FG005|Overall Study|Lost to Follow-up|0|||
129717487|NCT02931838|466924151|FG000|Overall Study|Subject request to discontinue treatment|4|||
129717488|NCT02931838|466924152|FG001|Overall Study|Subject request to discontinue treatment|3|||
129717489|NCT02931838|466924153|FG002|Overall Study|Subject request to discontinue treatment|3|||
129717490|NCT02931838|466924154|FG003|Overall Study|Subject request to discontinue treatment|0|||
129717491|NCT02931838|466924155|FG004|Overall Study|Subject request to discontinue treatment|1|||
129803050|NCT02633501|467247494|FG000|Overall Study|Various other reasons|0|||
129803051|NCT02633501|467247495|FG001|Overall Study|Various other reasons|2|||
129803052|NCT02633501|467247496|FG002|Overall Study|Various other reasons|4|||
129803053|NCT02633501|467247497|FG003|Overall Study|Various other reasons|1|||
129803054|NCT02633501|467247498|FG004|Overall Study|Various other reasons|7|||
129803055|NCT02633501|467247499|FG005|Overall Study|Various other reasons|11|||
129803056|NCT02633501|467247494|FG000|Overall Study|Lost to Follow-up|0|||
129803057|NCT02633501|467247495|FG001|Overall Study|Lost to Follow-up|0|||
129803058|NCT02633501|467247496|FG002|Overall Study|Lost to Follow-up|0|||
129803059|NCT02633501|467247497|FG003|Overall Study|Lost to Follow-up|1|||
129803060|NCT02633501|467247498|FG004|Overall Study|Lost to Follow-up|2|||
129803061|NCT02633501|467247499|FG005|Overall Study|Lost to Follow-up|0|||
129803062|NCT01986140|467247501|FG000|Overall Study|Withdrawal by Subject|31|||
129803063|NCT01986140|467247502|FG001|Overall Study|Withdrawal by Subject|25|||
129803064|NCT01986140|467247501|FG000|Overall Study|alternative treatment|1|||
129803065|NCT01986140|467247502|FG001|Overall Study|alternative treatment|1|||
129803066|NCT01986140|467247501|FG000|Overall Study|found not eligible|3|||
129803067|NCT01986140|467247502|FG001|Overall Study|found not eligible|0|||
129803068|NCT01986140|467247501|FG000|Overall Study|Adverse Event|0|||
129803069|NCT01986140|467247502|FG001|Overall Study|Adverse Event|1|||
129803070|NCT01986140|467247501|FG000|Overall Study|progression disease|0|||
129803071|NCT01986140|467247502|FG001|Overall Study|progression disease|1|||
129717492|NCT02931838|466924156|FG005|Overall Study|Subject request to discontinue treatment|0|||
129717493|NCT02931838|466924151|FG000|Overall Study|Withdrawal by Subject|1|||
129717494|NCT02931838|466924152|FG001|Overall Study|Withdrawal by Subject|2|||
129717495|NCT02931838|466924153|FG002|Overall Study|Withdrawal by Subject|0|||
129717496|NCT02931838|466924154|FG003|Overall Study|Withdrawal by Subject|1|||
129717497|NCT02931838|466924155|FG004|Overall Study|Withdrawal by Subject|0|||
129803072|NCT02808650|467247508|FG000|Overall Study|Death|0|||
129803073|NCT02808650|467247509|FG001|Overall Study|Death|0|||
129803074|NCT02808650|467247510|FG002|Overall Study|Death|0|||
129803075|NCT02808650|467247511|FG003|Overall Study|Death|0|||
129803076|NCT02808650|467247512|FG004|Overall Study|Death|1|||
129803077|NCT02808650|467247508|FG000|Overall Study|Lack of Efficacy|5|||
129803078|NCT02808650|467247509|FG001|Overall Study|Lack of Efficacy|5|||
129803079|NCT02808650|467247510|FG002|Overall Study|Lack of Efficacy|6|||
129717498|NCT02931838|466924156|FG005|Overall Study|Withdrawal by Subject|0|||
129717499|NCT02931838|466924151|FG000|Overall Study|Adverse Event|2|||
129717500|NCT02931838|466924152|FG001|Overall Study|Adverse Event|1|||
129717501|NCT02931838|466924153|FG002|Overall Study|Adverse Event|2|||
129717502|NCT02931838|466924154|FG003|Overall Study|Adverse Event|1|||
129717503|NCT02931838|466924155|FG004|Overall Study|Adverse Event|3|||
129717504|NCT02931838|466924156|FG005|Overall Study|Adverse Event|1|||
129717505|NCT03110029|466924157|FG000|Overall Study|Withdrawal by Subject|1|||
129717506|NCT03110029|466924158|FG001|Overall Study|Withdrawal by Subject|1|||
129717507|NCT01042158|466924159|FG000|Overall Study|Physician Decision|1|||
129717508|NCT05823974|466926461|FG000|Overall Study|Lost to Follow-up|0|||
129717509|NCT05823974|466926462|FG001|Overall Study|Lost to Follow-up|3|||
129717510|NCT05823974|466926463|FG002|Overall Study|Lost to Follow-up|1|||
129717511|NCT05823974|466926464|FG003|Overall Study|Lost to Follow-up|0|||
129717512|NCT05823974|466926465|FG004|Overall Study|Lost to Follow-up|1|||
129717513|NCT05823974|466926466|FG005|Overall Study|Lost to Follow-up|0|||
129717514|NCT05823974|466926467|FG006|Overall Study|Lost to Follow-up|1|||
129717515|NCT05823974|466926468|FG007|Overall Study|Lost to Follow-up|0|||
129717516|NCT05823974|466926469|FG008|Overall Study|Lost to Follow-up|0|||
129717517|NCT05823974|466926470|FG009|Overall Study|Lost to Follow-up|1|||
129717518|NCT05823974|466926471|FG010|Overall Study|Lost to Follow-up|1|||
129717519|NCT05823974|466926472|FG011|Overall Study|Lost to Follow-up|0|||
129717520|NCT05823974|466926473|FG012|Overall Study|Lost to Follow-up|1|||
129717521|NCT05823974|466926474|FG013|Overall Study|Lost to Follow-up|2|||
129717522|NCT05823974|466926475|FG014|Overall Study|Lost to Follow-up|1|||
129717523|NCT05823974|466926476|FG015|Overall Study|Lost to Follow-up|1|||
129717524|NCT05823974|466926477|FG016|Overall Study|Lost to Follow-up|1|||
129717525|NCT05823974|466926478|FG017|Overall Study|Lost to Follow-up|0|||
129717526|NCT05823974|466926479|FG018|Overall Study|Lost to Follow-up|0|||
129717527|NCT05823974|466926480|FG019|Overall Study|Lost to Follow-up|2|||
129717528|NCT05823974|466926481|FG020|Overall Study|Lost to Follow-up|0|||
129717529|NCT05823974|466926461|FG000|Overall Study|Physician Decision|0|||
129717530|NCT05823974|466926462|FG001|Overall Study|Physician Decision|0|||
129717531|NCT05823974|466926463|FG002|Overall Study|Physician Decision|0|||
129717532|NCT05823974|466926464|FG003|Overall Study|Physician Decision|0|||
129717533|NCT05823974|466926465|FG004|Overall Study|Physician Decision|0|||
129717534|NCT05823974|466926466|FG005|Overall Study|Physician Decision|0|||
129717535|NCT05823974|466926467|FG006|Overall Study|Physician Decision|0|||
129717536|NCT05823974|466926468|FG007|Overall Study|Physician Decision|0|||
129717537|NCT05823974|466926469|FG008|Overall Study|Physician Decision|0|||
129717538|NCT05823974|466926470|FG009|Overall Study|Physician Decision|0|||
129717539|NCT05823974|466926471|FG010|Overall Study|Physician Decision|0|||
129717540|NCT05823974|466926472|FG011|Overall Study|Physician Decision|0|||
129717541|NCT05823974|466926473|FG012|Overall Study|Physician Decision|0|||
129717542|NCT05823974|466926474|FG013|Overall Study|Physician Decision|0|||
129717543|NCT05823974|466926475|FG014|Overall Study|Physician Decision|0|||
129717544|NCT05823974|466926476|FG015|Overall Study|Physician Decision|1|||
129717545|NCT05823974|466926477|FG016|Overall Study|Physician Decision|0|||
129717546|NCT05823974|466926478|FG017|Overall Study|Physician Decision|1|||
129717547|NCT05823974|466926479|FG018|Overall Study|Physician Decision|1|||
129717548|NCT05823974|466926480|FG019|Overall Study|Physician Decision|0|||
129717549|NCT05823974|466926481|FG020|Overall Study|Physician Decision|0|||
129717550|NCT05823974|466926461|FG000|Overall Study|Withdrawal by Subject|1|||
129717551|NCT05823974|466926462|FG001|Overall Study|Withdrawal by Subject|1|||
129717552|NCT05823974|466926463|FG002|Overall Study|Withdrawal by Subject|2|||
129717553|NCT05823974|466926464|FG003|Overall Study|Withdrawal by Subject|0|||
129717554|NCT05823974|466926465|FG004|Overall Study|Withdrawal by Subject|2|||
129717555|NCT05823974|466926466|FG005|Overall Study|Withdrawal by Subject|3|||
129717556|NCT05823974|466926467|FG006|Overall Study|Withdrawal by Subject|1|||
129717557|NCT05823974|466926468|FG007|Overall Study|Withdrawal by Subject|1|||
129717558|NCT05823974|466926469|FG008|Overall Study|Withdrawal by Subject|2|||
129717559|NCT05823974|466926470|FG009|Overall Study|Withdrawal by Subject|1|||
129717560|NCT05823974|466926471|FG010|Overall Study|Withdrawal by Subject|1|||
129717561|NCT05823974|466926472|FG011|Overall Study|Withdrawal by Subject|0|||
129717562|NCT05823974|466926473|FG012|Overall Study|Withdrawal by Subject|0|||
129717563|NCT05823974|466926474|FG013|Overall Study|Withdrawal by Subject|1|||
129717564|NCT05823974|466926475|FG014|Overall Study|Withdrawal by Subject|1|||
129717565|NCT05823974|466926476|FG015|Overall Study|Withdrawal by Subject|3|||
129717566|NCT05823974|466926477|FG016|Overall Study|Withdrawal by Subject|0|||
129717567|NCT05823974|466926478|FG017|Overall Study|Withdrawal by Subject|2|||
129717568|NCT05823974|466926479|FG018|Overall Study|Withdrawal by Subject|2|||
129717569|NCT05823974|466926480|FG019|Overall Study|Withdrawal by Subject|0|||
129717570|NCT05823974|466926481|FG020|Overall Study|Withdrawal by Subject|1|||
129717571|NCT05823974|466926461|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717572|NCT05823974|466926462|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717573|NCT05823974|466926463|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129717574|NCT05823974|466926464|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717575|NCT05823974|466926465|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717576|NCT05823974|466926466|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717577|NCT05823974|466926467|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717578|NCT05823974|466926468|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717579|NCT05823974|466926469|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717580|NCT05823974|466926470|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717581|NCT05823974|466926471|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717582|NCT05823974|466926472|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717583|NCT05823974|466926473|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717584|NCT05823974|466926474|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717585|NCT05823974|466926475|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129717586|NCT05823974|466926476|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717587|NCT05823974|466926477|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717588|NCT05823974|466926478|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717589|NCT05823974|466926479|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717590|NCT05823974|466926480|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717591|NCT05823974|466926481|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129717592|NCT05823974|466926461|FG000|Overall Study|Other|0|||
129717593|NCT05823974|466926462|FG001|Overall Study|Other|1|||
129717594|NCT05823974|466926463|FG002|Overall Study|Other|1|||
129717595|NCT05823974|466926464|FG003|Overall Study|Other|1|||
129717596|NCT05823974|466926465|FG004|Overall Study|Other|0|||
129717597|NCT05823974|466926466|FG005|Overall Study|Other|1|||
129717598|NCT05823974|466926467|FG006|Overall Study|Other|1|||
129717599|NCT05823974|466926468|FG007|Overall Study|Other|1|||
129717600|NCT05823974|466926469|FG008|Overall Study|Other|1|||
129717601|NCT05823974|466926470|FG009|Overall Study|Other|0|||
129717602|NCT05823974|466926471|FG010|Overall Study|Other|0|||
129717603|NCT05823974|466926472|FG011|Overall Study|Other|0|||
129717604|NCT05823974|466926473|FG012|Overall Study|Other|2|||
129717605|NCT05823974|466926474|FG013|Overall Study|Other|1|||
129891483|NCT01036087|467561136|FG000|Overall Study|Adverse Event|2|||
129717606|NCT05823974|466926475|FG014|Overall Study|Other|0|||
129717607|NCT05823974|466926476|FG015|Overall Study|Other|1|||
129717608|NCT05823974|466926477|FG016|Overall Study|Other|0|||
129717609|NCT05823974|466926478|FG017|Overall Study|Other|0|||
129717610|NCT05823974|466926479|FG018|Overall Study|Other|0|||
129717611|NCT05823974|466926480|FG019|Overall Study|Other|0|||
129717612|NCT05823974|466926481|FG020|Overall Study|Other|0|||
129717613|NCT00316706|466926482|FG000|Overall Study|Lost to Follow-up|38|||
129717614|NCT00316706|466926483|FG001|Overall Study|Lost to Follow-up|48|||
129717615|NCT02220855|466926484|FG000|Overall Study|Adverse Event|8|||
129717616|NCT02220855|466926484|FG000|Overall Study|Disease Progression|5|||
129717617|NCT02220855|466926484|FG000|Overall Study|Withdrawal by Subject|1|||
129717618|NCT03280303|466926485|FG000|Overall Study|Death|505|||
129717619|NCT03280303|466926485|FG000|Overall Study|Study terminated by sponsor|383|||
129717620|NCT03280303|466926485|FG000|Overall Study|Other|148|||
129717621|NCT03280303|466926485|FG000|Overall Study|No longer willing to participate in study|101|||
129717622|NCT03280303|466926485|FG000|Overall Study|Lost to follow up|39|||
129717623|NCT03280303|466926485|FG000|Overall Study|Adverse Event|20|||
129717624|NCT03419897|466926486|FG000|Overall Study|Death|180|||
129717625|NCT03419897|466926486|FG000|Overall Study|Lost to Follow-up|1|||
129717626|NCT03419897|466926486|FG000|Overall Study|Withdrawal by Subject|6|||
129717627|NCT03419897|466926486|FG000|Overall Study|Sponsor Decision|61|||
129717628|NCT03419897|466926486|FG000|Overall Study|Physician Decision|1|||
129717629|NCT02222688|466926499|FG000|Overall Study|Withdrawal by Subject|0|||
129717630|NCT02222688|466926500|FG001|Overall Study|Withdrawal by Subject|0|||
129717631|NCT02222688|466926501|FG002|Overall Study|Withdrawal by Subject|0|||
129717632|NCT02222688|466926502|FG003|Overall Study|Withdrawal by Subject|2|||
129717633|NCT02222688|466926503|FG004|Overall Study|Withdrawal by Subject|1|||
129717634|NCT02222688|466926504|FG005|Overall Study|Withdrawal by Subject|0|||
129717635|NCT02222688|466926505|FG006|Overall Study|Withdrawal by Subject|1|||
129717636|NCT02222688|466926499|FG000|Overall Study|Disease progression|1|||
129717637|NCT02222688|466926500|FG001|Overall Study|Disease progression|0|||
129717638|NCT02222688|466926501|FG002|Overall Study|Disease progression|0|||
129717639|NCT02222688|466926502|FG003|Overall Study|Disease progression|0|||
129717640|NCT02222688|466926503|FG004|Overall Study|Disease progression|0|||
129891484|NCT01036087|467561136|FG000|Overall Study|Lack of Efficacy|1|||
129717641|NCT02222688|466926504|FG005|Overall Study|Disease progression|0|||
129891485|NCT01021878|467561139|FG000|Overall Study|Lost to Follow-up|4|||
129717642|NCT02222688|466926505|FG006|Overall Study|Disease progression|0|||
129717643|NCT03107052|466926515|FG000|Overall Study|Adverse Event|6|||
129717644|NCT03107052|466926516|FG001|Overall Study|Adverse Event|1|||
129717645|NCT03107052|466926517|FG002|Overall Study|Adverse Event|2|||
129717646|NCT03107052|466926515|FG000|Overall Study|Withdrawal by Subject|9|||
129717647|NCT03107052|466926516|FG001|Overall Study|Withdrawal by Subject|5|||
129717648|NCT03107052|466926517|FG002|Overall Study|Withdrawal by Subject|8|||
129803080|NCT02808650|467247511|FG003|Overall Study|Lack of Efficacy|5|||
129803081|NCT02808650|467247512|FG004|Overall Study|Lack of Efficacy|4|||
129803082|NCT02808650|467247508|FG000|Overall Study|Physician Decision|1|||
129717649|NCT03107052|466926515|FG000|Overall Study|Protocol Violation|6|||
129717650|NCT03107052|466926516|FG001|Overall Study|Protocol Violation|0|||
129717651|NCT03107052|466926517|FG002|Overall Study|Protocol Violation|3|||
129717652|NCT03107052|466926515|FG000|Overall Study|Lost to Follow-up|4|||
129717653|NCT03107052|466926516|FG001|Overall Study|Lost to Follow-up|0|||
129717654|NCT03107052|466926517|FG002|Overall Study|Lost to Follow-up|1|||
129717655|NCT03107052|466926515|FG000|Overall Study|Lack of Efficacy|23|||
129717656|NCT03107052|466926516|FG001|Overall Study|Lack of Efficacy|7|||
129717657|NCT03107052|466926517|FG002|Overall Study|Lack of Efficacy|4|||
129717658|NCT03107052|466926515|FG000|Overall Study|Other than specified|4|||
129717659|NCT03107052|466926516|FG001|Overall Study|Other than specified|2|||
129717660|NCT03107052|466926517|FG002|Overall Study|Other than specified|0|||
129717661|NCT03107052|466926515|FG000|Overall Study|Study terminated due to futility|67|||
129717662|NCT03107052|466926516|FG001|Overall Study|Study terminated due to futility|31|||
129717663|NCT03107052|466926517|FG002|Overall Study|Study terminated due to futility|23|||
129717664|NCT00958360|466926518|FG000|Overall Study|Withdrawal by Subject|3|||
129717665|NCT00958360|466926519|FG001|Overall Study|Withdrawal by Subject|1|||
129717666|NCT00958360|466926518|FG000|Overall Study|Death|6|||
129717667|NCT00958360|466926519|FG001|Overall Study|Death|7|||
129717668|NCT00958360|466926518|FG000|Overall Study|Physician Decision|2|||
129717669|NCT00958360|466926519|FG001|Overall Study|Physician Decision|1|||
129717670|NCT00958360|466926518|FG000|Overall Study|Lost to Follow-up|0|||
129717671|NCT00958360|466926519|FG001|Overall Study|Lost to Follow-up|1|||
129717672|NCT02719691|466926521|FG000|Overall Study|Physician Decision|0|||
129717673|NCT02719691|466926522|FG001|Overall Study|Physician Decision|0|||
129717674|NCT02719691|466926523|FG002|Overall Study|Physician Decision|1|||
129717675|NCT02719691|466926524|FG003|Overall Study|Physician Decision|0|||
129717676|NCT02719691|466926525|FG004|Overall Study|Physician Decision|0|||
129717677|NCT02719691|466926526|FG005|Overall Study|Physician Decision|0|||
129717678|NCT02719691|466926527|FG006|Overall Study|Physician Decision|0|||
129717679|NCT02719691|466926521|FG000|Overall Study|Withdrawal by Subject|0|||
129717680|NCT02719691|466926522|FG001|Overall Study|Withdrawal by Subject|0|||
129717681|NCT02719691|466926523|FG002|Overall Study|Withdrawal by Subject|0|||
129717682|NCT02719691|466926524|FG003|Overall Study|Withdrawal by Subject|0|||
129717683|NCT02719691|466926525|FG004|Overall Study|Withdrawal by Subject|0|||
129717684|NCT02719691|466926526|FG005|Overall Study|Withdrawal by Subject|1|||
129717685|NCT02719691|466926527|FG006|Overall Study|Withdrawal by Subject|0|||
129717686|NCT00336284|466926530|FG000|Overall Study|Death|52|||
129717687|NCT00336284|466926531|FG001|Overall Study|Death|26|||
129717688|NCT00336284|466926530|FG000|Overall Study|Lost to Follow-up|82|||
129717689|NCT00336284|466926531|FG001|Overall Study|Lost to Follow-up|61|||
129717690|NCT00336284|466926530|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
129717691|NCT00336284|466926531|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
129717692|NCT00861757|466926534|FG000|Overall Study|Adverse Event|1|||
129717693|NCT00861757|466926535|FG001|Overall Study|Adverse Event|5|||
129717694|NCT00861757|466926536|FG002|Overall Study|Adverse Event|7|||
129717695|NCT00861757|466926537|FG003|Overall Study|Adverse Event|2|||
129717696|NCT00861757|466926534|FG000|Overall Study|Entry Criteria Not Met|1|||
129717697|NCT00861757|466926535|FG001|Overall Study|Entry Criteria Not Met|2|||
129717698|NCT00861757|466926536|FG002|Overall Study|Entry Criteria Not Met|1|||
129717699|NCT00861757|466926537|FG003|Overall Study|Entry Criteria Not Met|1|||
129717700|NCT00861757|466926534|FG000|Overall Study|Lack of Efficacy|3|||
129717701|NCT00861757|466926535|FG001|Overall Study|Lack of Efficacy|1|||
129717702|NCT00861757|466926536|FG002|Overall Study|Lack of Efficacy|0|||
129717703|NCT00861757|466926537|FG003|Overall Study|Lack of Efficacy|1|||
129803083|NCT02808650|467247509|FG001|Overall Study|Physician Decision|1|||
129803084|NCT02808650|467247510|FG002|Overall Study|Physician Decision|0|||
129717704|NCT00861757|466926534|FG000|Overall Study|Lost to Follow-up|1|||
129717705|NCT00861757|466926535|FG001|Overall Study|Lost to Follow-up|0|||
129803085|NCT02808650|467247511|FG003|Overall Study|Physician Decision|0|||
129717706|NCT00861757|466926536|FG002|Overall Study|Lost to Follow-up|1|||
129717707|NCT00861757|466926537|FG003|Overall Study|Lost to Follow-up|1|||
129717708|NCT00861757|466926534|FG000|Overall Study|Physician Decision|0|||
129717709|NCT00861757|466926535|FG001|Overall Study|Physician Decision|0|||
129717710|NCT00861757|466926536|FG002|Overall Study|Physician Decision|0|||
129717711|NCT00861757|466926537|FG003|Overall Study|Physician Decision|1|||
129717712|NCT00861757|466926534|FG000|Overall Study|Protocol Violation|2|||
129803086|NCT02808650|467247512|FG004|Overall Study|Physician Decision|0|||
129717713|NCT00861757|466926535|FG001|Overall Study|Protocol Violation|2|||
129717714|NCT00861757|466926536|FG002|Overall Study|Protocol Violation|4|||
129717715|NCT00861757|466926537|FG003|Overall Study|Protocol Violation|1|||
129717716|NCT00861757|466926534|FG000|Overall Study|Withdrawal by Subject|1|||
129803087|NCT02808650|467247508|FG000|Overall Study|Withdrawal by Subject|0|||
129803088|NCT02808650|467247509|FG001|Overall Study|Withdrawal by Subject|0|||
129803089|NCT02808650|467247510|FG002|Overall Study|Withdrawal by Subject|0|||
129803090|NCT02808650|467247511|FG003|Overall Study|Withdrawal by Subject|1|||
129803091|NCT02808650|467247512|FG004|Overall Study|Withdrawal by Subject|1|||
129803092|NCT01069627|467247515|FG000|Overall Study|Disease progression|7|||
129803093|NCT01069627|467247515|FG000|Overall Study|Adverse Event|12|||
129803094|NCT01069627|467247515|FG000|Overall Study|Protocol Violation|1|||
129803095|NCT02939079|467247519|FG000|Overall Study|Adverse Event|2|||
129803096|NCT02939079|467247520|FG001|Overall Study|Adverse Event|1|||
129803097|NCT02939079|467247519|FG000|Overall Study|Lost to Follow-up|0|||
129803098|NCT02939079|467247520|FG001|Overall Study|Lost to Follow-up|2|||
129803099|NCT02939079|467247519|FG000|Overall Study|Protocol Violation|1|||
129803100|NCT02939079|467247520|FG001|Overall Study|Protocol Violation|0|||
129803101|NCT02939079|467247519|FG000|Overall Study|Withdrawal by Subject|0|||
129803102|NCT02939079|467247520|FG001|Overall Study|Withdrawal by Subject|1|||
129803103|NCT02939079|467247519|FG000|Overall Study|relapse during the study|1|||
129803104|NCT02939079|467247520|FG001|Overall Study|relapse during the study|1|||
129803105|NCT04093414|467247521|FG000|3 Month Follow up|Physician Decision|0|||
129803106|NCT04093414|467247522|FG001|3 Month Follow up|Physician Decision|1|||
129803107|NCT04093414|467247521|FG000|6month Follow up|Physician Decision|1|||
129803108|NCT04093414|467247522|FG001|6month Follow up|Physician Decision|3|||
129803109|NCT04209348|467247523|FG000|Overall Study|Lost to Follow-up|1|||
129803110|NCT04209348|467247524|FG001|Overall Study|Lost to Follow-up|0|||
129803111|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
129803112|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
129803113|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Death|1|||
129803114|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Death|0|||
129803115|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
129803116|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
129803117|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
129803118|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
129803119|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
129803120|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
129803121|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
129803122|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
129803123|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
129803124|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
129803125|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
129891486|NCT01021878|467561140|FG001|Overall Study|Lost to Follow-up|3|||
129717717|NCT00861757|466926535|FG001|Overall Study|Withdrawal by Subject|5|||
129717718|NCT00861757|466926536|FG002|Overall Study|Withdrawal by Subject|5|||
129717719|NCT00861757|466926537|FG003|Overall Study|Withdrawal by Subject|2|||
129717720|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
129717721|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
129717722|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
129717723|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
129717724|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
129717725|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
129717726|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
129717727|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
129717728|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
129717729|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
129717730|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
129717731|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
129717732|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
129717733|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
129717734|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
129717735|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
129717736|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
129717737|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
129717738|NCT03308968|466926538|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
129717739|NCT03308968|466926539|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
129717740|NCT03308968|466926540|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
129717741|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
129717742|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
129803126|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
129803127|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
129803128|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
129717743|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
129717744|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
129717745|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
129717746|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
129717747|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
129717748|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
129717749|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
129717750|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
129717751|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
129717752|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
129717753|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
129717754|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
129717755|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
129717756|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
129717757|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
129717758|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
129717759|NCT03308968|466926538|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
129717760|NCT03308968|466926539|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
129717761|NCT03308968|466926540|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
129717762|NCT01961297|466926546|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
129717763|NCT01961297|466926547|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
129717764|NCT02482298|466926548|FG000|Overall Study|Withdrawal by Subject|2|||
129717765|NCT02482298|466926549|FG001|Overall Study|Withdrawal by Subject|1|||
129717766|NCT02482298|466926550|FG002|Overall Study|Withdrawal by Subject|2|||
129717767|NCT02482298|466926548|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
129717768|NCT02482298|466926549|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
129717769|NCT02482298|466926550|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
129717770|NCT02482298|466926548|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
129717771|NCT02482298|466926549|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
129717772|NCT02482298|466926550|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
129717773|NCT02482298|466926548|FG000|Overall Study|Lost to Follow-up|0|||
129717774|NCT02482298|466926549|FG001|Overall Study|Lost to Follow-up|1|||
129717775|NCT02482298|466926550|FG002|Overall Study|Lost to Follow-up|0|||
129717776|NCT01188551|466926551|FG000|Overall Study|Pharmacy issues|1|||
129717777|NCT01188551|466926552|FG001|Overall Study|Pharmacy issues|0|||
129717778|NCT01188551|466926553|FG002|Overall Study|Pharmacy issues|0|||
129717779|NCT01188551|466926554|FG003|Overall Study|Pharmacy issues|0|||
129717780|NCT03012828|466926564|FG000|Overall Study|Lost to Follow-up|1|||
129717781|NCT03012828|466926565|FG001|Overall Study|Lost to Follow-up|0|||
129717782|NCT03012828|466926566|FG002|Overall Study|Lost to Follow-up|1|||
129717783|NCT03012828|466926567|FG003|Overall Study|Lost to Follow-up|0|||
129717784|NCT03012828|466926568|FG004|Overall Study|Lost to Follow-up|1|||
129717785|NCT03012828|466926569|FG005|Overall Study|Lost to Follow-up|0|||
129717786|NCT03012828|466926564|FG000|Overall Study|Withdrawal by Subject|0|||
129717787|NCT03012828|466926565|FG001|Overall Study|Withdrawal by Subject|0|||
129717788|NCT03012828|466926566|FG002|Overall Study|Withdrawal by Subject|1|||
129717789|NCT03012828|466926567|FG003|Overall Study|Withdrawal by Subject|0|||
129717790|NCT03012828|466926568|FG004|Overall Study|Withdrawal by Subject|0|||
129717791|NCT03012828|466926569|FG005|Overall Study|Withdrawal by Subject|1|||
129717792|NCT03012828|466926564|FG000|Overall Study|Non-compliance with protocol|0|||
129717793|NCT03012828|466926565|FG001|Overall Study|Non-compliance with protocol|0|||
129717794|NCT03012828|466926566|FG002|Overall Study|Non-compliance with protocol|0|||
129717795|NCT03012828|466926567|FG003|Overall Study|Non-compliance with protocol|0|||
129717796|NCT03012828|466926568|FG004|Overall Study|Non-compliance with protocol|1|||
129717797|NCT03012828|466926569|FG005|Overall Study|Non-compliance with protocol|0|||
129717798|NCT03012828|466926564|FG000|Overall Study|Delay to last visit would delay DBL|0|||
129717799|NCT03012828|466926565|FG001|Overall Study|Delay to last visit would delay DBL|0|||
129717800|NCT03012828|466926566|FG002|Overall Study|Delay to last visit would delay DBL|0|||
129717801|NCT03012828|466926567|FG003|Overall Study|Delay to last visit would delay DBL|0|||
129717802|NCT03012828|466926568|FG004|Overall Study|Delay to last visit would delay DBL|0|||
129717803|NCT03012828|466926569|FG005|Overall Study|Delay to last visit would delay DBL|1|||
129717804|NCT03900728|466926570|FG000|Overall Study|No text responses|0|||
129717805|NCT03900728|466926571|FG001|Overall Study|No text responses|0|||
129717806|NCT03900728|466926572|FG002|Overall Study|No text responses|4|||
129717807|NCT00763256|466926575|FG000|Overall Study|Didn't return for appointments|7|||
129717808|NCT00763256|466926576|FG001|Overall Study|Didn't return for appointments|10|||
129717809|NCT02544750|466926577|FG000|Overall Study|Physician Decision|3|||
129717810|NCT02544750|466926578|FG001|Overall Study|Physician Decision|1|||
129717811|NCT02544750|466926577|FG000|Overall Study|Other reasons|69|||
129717812|NCT02544750|466926578|FG001|Overall Study|Other reasons|39|||
129891487|NCT01021878|467561139|FG000|Overall Study|Death|0|||
129803129|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
129803130|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
129803131|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
129803132|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
129803133|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
129803134|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
129803135|NCT02927262|467247527|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
129803136|NCT02927262|467247528|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
129803137|NCT02927262|467247527|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
129803138|NCT02927262|467247528|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
129803139|NCT02927262|467247527|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
129803140|NCT02927262|467247528|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
129803141|NCT02927262|467247527|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
129803142|NCT02927262|467247528|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
129803143|NCT00923936|467247529|FG000|Overall Study|progressive disease on study|2|||
129803144|NCT00923936|467247530|FG001|Overall Study|progressive disease on study|1|||
129803145|NCT00923936|467247529|FG000|Overall Study|Adverse Event|2|||
129803146|NCT00923936|467247530|FG001|Overall Study|Adverse Event|1|||
129803147|NCT00923936|467247529|FG000|Overall Study|Lost to follow up|2|||
129803148|NCT00923936|467247530|FG001|Overall Study|Lost to follow up|0|||
129717813|NCT02544750|466926577|FG000|Overall Study|Met withdrawal criteria|2|||
129717814|NCT02544750|466926578|FG001|Overall Study|Met withdrawal criteria|2|||
129717815|NCT02544750|466926577|FG000|Overall Study|Transition To Commercial Product|1|||
129717816|NCT02544750|466926578|FG001|Overall Study|Transition To Commercial Product|0|||
129717817|NCT02544750|466926577|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
129717818|NCT02544750|466926578|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
129717819|NCT02544750|466926577|FG000|Overall Study|Adverse Event|8|||
129717820|NCT02544750|466926578|FG001|Overall Study|Adverse Event|10|||
129717821|NCT02544750|466926577|FG000|Overall Study|Withdrawal by Subject|10|||
129717822|NCT02544750|466926578|FG001|Overall Study|Withdrawal by Subject|4|||
129717823|NCT02544750|466926577|FG000|Overall Study|Lost to Follow-up|1|||
129717824|NCT02544750|466926578|FG001|Overall Study|Lost to Follow-up|0|||
129717825|NCT04396795|466926581|FG000|Month 1|Lost to Follow-up|2|||
129717826|NCT04396795|466926582|FG001|Month 1|Lost to Follow-up|3|||
129717827|NCT04396795|466926581|FG000|Month 3|Lost to Follow-up|1|||
129717828|NCT04396795|466926582|FG001|Month 3|Lost to Follow-up|3|||
129717829|NCT04396795|466926581|FG000|Month 6|Lost to Follow-up|3|||
129717830|NCT04396795|466926582|FG001|Month 6|Lost to Follow-up|3|||
129717831|NCT03902392|466926586|FG000|Overall Study|Lost to Follow-up|7|||
129717832|NCT03902392|466926587|FG001|Overall Study|Lost to Follow-up|7|||
129717833|NCT00244725|466926588|FG000|Overall Study|Lost to Follow-up|3|||
129717834|NCT00244725|466926589|FG001|Overall Study|Lost to Follow-up|4|||
129717835|NCT00244725|466926590|FG002|Overall Study|Lost to Follow-up|9|||
129717836|NCT00244725|466926591|FG003|Overall Study|Lost to Follow-up|2|||
129717837|NCT00244725|466926588|FG000|Overall Study|Withdrawal by Subject|9|||
129717838|NCT00244725|466926589|FG001|Overall Study|Withdrawal by Subject|7|||
129717839|NCT00244725|466926590|FG002|Overall Study|Withdrawal by Subject|7|||
129717840|NCT00244725|466926591|FG003|Overall Study|Withdrawal by Subject|8|||
129717841|NCT00244725|466926588|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
129717842|NCT00244725|466926589|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
129717843|NCT00244725|466926590|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
129717844|NCT00244725|466926591|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
129803149|NCT00923936|467247529|FG000|Overall Study|Continuing in follow up period|2|||
129803150|NCT00923936|467247530|FG001|Overall Study|Continuing in follow up period|1|||
129803151|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
129803152|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
129803153|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
129803154|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
129717845|NCT00244725|466926588|FG000|Overall Study|Physician Decision|3|||
129717846|NCT00244725|466926589|FG001|Overall Study|Physician Decision|0|||
129717847|NCT00244725|466926590|FG002|Overall Study|Physician Decision|1|||
129717848|NCT00244725|466926591|FG003|Overall Study|Physician Decision|2|||
129717849|NCT00244725|466926588|FG000|Overall Study|Adverse Events|3|||
129803155|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
129891488|NCT01021878|467561140|FG001|Overall Study|Death|1|||
129717850|NCT00244725|466926589|FG001|Overall Study|Adverse Events|1|||
129717851|NCT00244725|466926590|FG002|Overall Study|Adverse Events|4|||
129717852|NCT00244725|466926591|FG003|Overall Study|Adverse Events|4|||
129717853|NCT00244725|466926588|FG000|Overall Study|Withdrwal by participant|1|||
129717854|NCT00244725|466926589|FG001|Overall Study|Withdrwal by participant|0|||
129717855|NCT00244725|466926590|FG002|Overall Study|Withdrwal by participant|0|||
129803156|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
129891489|NCT01021878|467561139|FG000|Overall Study|Adverse Event|6|||
129717856|NCT00244725|466926591|FG003|Overall Study|Withdrwal by participant|1|||
129717857|NCT00244725|466926588|FG000|Overall Study|Liver function test abnormality|2|||
129717858|NCT00244725|466926589|FG001|Overall Study|Liver function test abnormality|0|||
129717859|NCT00244725|466926590|FG002|Overall Study|Liver function test abnormality|0|||
129717860|NCT00244725|466926591|FG003|Overall Study|Liver function test abnormality|1|||
129717861|NCT00244725|466926588|FG000|Overall Study|Sponsor withdrew the participant|1|||
129717862|NCT00244725|466926589|FG001|Overall Study|Sponsor withdrew the participant|0|||
129717863|NCT00244725|466926590|FG002|Overall Study|Sponsor withdrew the participant|0|||
129717864|NCT00244725|466926591|FG003|Overall Study|Sponsor withdrew the participant|1|||
129717865|NCT00244725|466926588|FG000|Overall Study|Mediciation Error|0|||
129717866|NCT00244725|466926589|FG001|Overall Study|Mediciation Error|1|||
129717867|NCT00244725|466926590|FG002|Overall Study|Mediciation Error|0|||
129717868|NCT00244725|466926591|FG003|Overall Study|Mediciation Error|0|||
129717869|NCT00244725|466926588|FG000|Overall Study|Rehab Refused to allow participantion|0|||
129717870|NCT00244725|466926589|FG001|Overall Study|Rehab Refused to allow participantion|1|||
129717871|NCT00244725|466926590|FG002|Overall Study|Rehab Refused to allow participantion|0|||
129717872|NCT00244725|466926591|FG003|Overall Study|Rehab Refused to allow participantion|0|||
129717873|NCT00244725|466926588|FG000|Overall Study|Headache|0|||
129717874|NCT00244725|466926589|FG001|Overall Study|Headache|1|||
129717875|NCT00244725|466926590|FG002|Overall Study|Headache|0|||
129717876|NCT00244725|466926591|FG003|Overall Study|Headache|0|||
129717877|NCT00244725|466926588|FG000|Overall Study|Received prohibited medication|0|||
129717878|NCT00244725|466926589|FG001|Overall Study|Received prohibited medication|1|||
129717879|NCT00244725|466926590|FG002|Overall Study|Received prohibited medication|0|||
129717880|NCT00244725|466926591|FG003|Overall Study|Received prohibited medication|1|||
129717881|NCT00244725|466926588|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
129717882|NCT00244725|466926589|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
129717883|NCT00244725|466926590|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
129717884|NCT00244725|466926591|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
129717885|NCT00244725|466926588|FG000|Overall Study|Administrative reason|0|||
129717886|NCT00244725|466926589|FG001|Overall Study|Administrative reason|0|||
129717887|NCT00244725|466926590|FG002|Overall Study|Administrative reason|1|||
129717888|NCT00244725|466926591|FG003|Overall Study|Administrative reason|0|||
129717889|NCT00244725|466926588|FG000|Overall Study|Vomit|0|||
129717890|NCT00244725|466926589|FG001|Overall Study|Vomit|0|||
129717891|NCT00244725|466926590|FG002|Overall Study|Vomit|1|||
129717892|NCT00244725|466926591|FG003|Overall Study|Vomit|0|||
129717893|NCT00244725|466926588|FG000|Overall Study|Failed to follow-up|0|||
129717894|NCT00244725|466926589|FG001|Overall Study|Failed to follow-up|0|||
129717895|NCT00244725|466926590|FG002|Overall Study|Failed to follow-up|1|||
129717896|NCT00244725|466926591|FG003|Overall Study|Failed to follow-up|1|||
129717897|NCT03248167|466926592|FG000|Overall Study|Withdrawal by Subject|2|||
129717898|NCT03248167|466926593|FG001|Overall Study|Withdrawal by Subject|2|||
129717899|NCT03248167|466926592|FG000|Overall Study|Physician Decision|0|||
129717900|NCT03248167|466926593|FG001|Overall Study|Physician Decision|1|||
129717901|NCT03248167|466926592|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
129717902|NCT03248167|466926593|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
129717903|NCT03248167|466926592|FG000|Overall Study|Lost to Follow-up|1|||
129717904|NCT03248167|466926593|FG001|Overall Study|Lost to Follow-up|0|||
129717905|NCT02122146|466926594|FG000|Part 1: Dose Escalation|Death|0|||
129717906|NCT02122146|466926595|FG001|Part 1: Dose Escalation|Death|1|||
129717907|NCT02122146|466926596|FG002|Part 1: Dose Escalation|Death|1|||
129717908|NCT02122146|466926597|FG003|Part 1: Dose Escalation|Death|0|||
129803157|NCT01697358|467247531|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
129803158|NCT01697358|467247532|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
129803159|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
129717909|NCT02122146|466926598|FG004|Part 1: Dose Escalation|Death|0|||
129717910|NCT02122146|466926599|FG005|Part 1: Dose Escalation|Death|0|||
129717911|NCT02122146|466926600|FG006|Part 1: Dose Escalation|Death|0|||
129717912|NCT02122146|466926601|FG007|Part 1: Dose Escalation|Death|0|||
129717913|NCT02122146|466926594|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
129717914|NCT02122146|466926595|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
129717915|NCT02122146|466926596|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
129717916|NCT02122146|466926597|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
129717917|NCT02122146|466926598|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
129803160|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
129803161|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
129717918|NCT02122146|466926599|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
129717919|NCT02122146|466926600|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
129717920|NCT02122146|466926601|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
129717921|NCT02122146|466926594|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717922|NCT02122146|466926595|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717923|NCT02122146|466926596|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717924|NCT02122146|466926597|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129717925|NCT02122146|466926598|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717926|NCT02122146|466926599|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717927|NCT02122146|466926600|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717928|NCT02122146|466926601|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129717929|NCT02122146|466926594|FG000|Part 1: Dose Escalation|Other|1|||
129717930|NCT02122146|466926595|FG001|Part 1: Dose Escalation|Other|0|||
129717931|NCT02122146|466926596|FG002|Part 1: Dose Escalation|Other|0|||
129717932|NCT02122146|466926597|FG003|Part 1: Dose Escalation|Other|0|||
129717933|NCT02122146|466926598|FG004|Part 1: Dose Escalation|Other|0|||
129717934|NCT02122146|466926599|FG005|Part 1: Dose Escalation|Other|1|||
129717935|NCT02122146|466926600|FG006|Part 1: Dose Escalation|Other|1|||
129717936|NCT02122146|466926601|FG007|Part 1: Dose Escalation|Other|2|||
129717937|NCT03472495|466926602|FG000|Overall Study|Treatment no longer indicated|1|||
129717938|NCT03472495|466926603|FG001|Overall Study|Treatment no longer indicated|2|||
129717939|NCT03472495|466926602|FG000|Overall Study|Physician Decision|0|||
129717940|NCT03472495|466926603|FG001|Overall Study|Physician Decision|2|||
129717941|NCT01107392|466926605|FG000|Overall Study|Adverse Event|2|||
129717942|NCT01107392|466926606|FG001|Overall Study|Adverse Event|0|||
129717943|NCT01107392|466926605|FG000|Overall Study|Personal Reasons|2|||
129717944|NCT01107392|466926606|FG001|Overall Study|Personal Reasons|3|||
129717945|NCT01107392|466926605|FG000|Overall Study|Administrative decision|1|||
129717946|NCT01107392|466926606|FG001|Overall Study|Administrative decision|0|||
129717947|NCT02998671|466926609|FG000|Period 1|Study Terminated By Sponsor|2|||
129717948|NCT02998671|466926610|FG001|Period 1|Study Terminated By Sponsor|1|||
129717949|NCT02998671|466926611|FG002|Period 1|Study Terminated By Sponsor|0|||
129717950|NCT02998671|466926612|FG003|Period 1|Study Terminated By Sponsor|0|||
129717951|NCT02998671|466926613|FG004|Period 1|Study Terminated By Sponsor|1|||
129717952|NCT02998671|466926609|FG000|Period 1|Withdrawal by Subject|1|||
129717953|NCT02998671|466926610|FG001|Period 1|Withdrawal by Subject|2|||
129717954|NCT02998671|466926611|FG002|Period 1|Withdrawal by Subject|0|||
129717955|NCT02998671|466926612|FG003|Period 1|Withdrawal by Subject|0|||
129717956|NCT02998671|466926613|FG004|Period 1|Withdrawal by Subject|2|||
129717957|NCT02998671|466926609|FG000|Period 1|Pregnancy|1|||
129717958|NCT02998671|466926610|FG001|Period 1|Pregnancy|0|||
129717959|NCT02998671|466926611|FG002|Period 1|Pregnancy|0|||
129717960|NCT02998671|466926612|FG003|Period 1|Pregnancy|0|||
129717961|NCT02998671|466926613|FG004|Period 1|Pregnancy|0|||
129717962|NCT02998671|466926609|FG000|Period 1|Adverse Event|0|||
129717963|NCT02998671|466926610|FG001|Period 1|Adverse Event|0|||
129717964|NCT02998671|466926611|FG002|Period 1|Adverse Event|0|||
129717965|NCT02998671|466926612|FG003|Period 1|Adverse Event|0|||
129717966|NCT02998671|466926613|FG004|Period 1|Adverse Event|1|||
129717967|NCT02998671|466926609|FG000|Period 2|Adverse Event|0|||
129717968|NCT02998671|466926610|FG001|Period 2|Adverse Event|1|||
129717969|NCT02998671|466926611|FG002|Period 2|Adverse Event|0|||
129717970|NCT02998671|466926612|FG003|Period 2|Adverse Event|0|||
129717971|NCT02998671|466926613|FG004|Period 2|Adverse Event|0|||
129717972|NCT02998671|466926609|FG000|Period 2|Study Terminated By Sponsor|3|||
129717973|NCT02998671|466926610|FG001|Period 2|Study Terminated By Sponsor|5|||
129717974|NCT02998671|466926611|FG002|Period 2|Study Terminated By Sponsor|1|||
129717975|NCT02998671|466926612|FG003|Period 2|Study Terminated By Sponsor|3|||
129717976|NCT02998671|466926613|FG004|Period 2|Study Terminated By Sponsor|0|||
129717977|NCT02998671|466926609|FG000|Period 2|Withdrawal by Subject|0|||
129717978|NCT02998671|466926610|FG001|Period 2|Withdrawal by Subject|1|||
129717979|NCT02998671|466926611|FG002|Period 2|Withdrawal by Subject|0|||
129717980|NCT02998671|466926612|FG003|Period 2|Withdrawal by Subject|0|||
129717981|NCT02998671|466926613|FG004|Period 2|Withdrawal by Subject|0|||
129717982|NCT02998671|466926609|FG000|Period 2|Lost to Follow-up|0|||
129717983|NCT02998671|466926610|FG001|Period 2|Lost to Follow-up|0|||
129717984|NCT02998671|466926611|FG002|Period 2|Lost to Follow-up|0|||
129717985|NCT02998671|466926612|FG003|Period 2|Lost to Follow-up|1|||
129717986|NCT02998671|466926613|FG004|Period 2|Lost to Follow-up|0|||
129717987|NCT02038946|466926615|FG000|Overall Study|Death|5|||
129717988|NCT02038946|466926615|FG000|Overall Study|Withdrawal by Subject|3|||
129717989|NCT02038946|466926615|FG000|Overall Study|Lost to Follow-up|2|||
129717990|NCT02038946|466926615|FG000|Overall Study|Other reasons|2|||
129717991|NCT02473471|466926616|FG000|Overall Study|poor oral hygiene|2|||
129717992|NCT02473471|466926616|FG000|Overall Study|Lost to Follow-up|1|||
129717993|NCT02725476|466926619|FG000|Overall Study|Physician Decision|2|||
129717994|NCT02725476|466926620|FG001|Overall Study|Physician Decision|0|||
129717995|NCT02725476|466926619|FG000|Overall Study|Adverse Event|1|||
129717996|NCT02725476|466926620|FG001|Overall Study|Adverse Event|1|||
129717997|NCT02455336|466926625|FG000|Overall Study|Withdrawal by Subject|0|||
129717998|NCT02455336|466926626|FG001|Overall Study|Withdrawal by Subject|2|||
129717999|NCT02455336|466926625|FG000|Overall Study|Adverse Event|3|||
129803162|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
129803163|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
129803164|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
129803165|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
129803166|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
129803167|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
129803168|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
129803169|NCT01697358|467247531|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
129803170|NCT01697358|467247532|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
129718000|NCT02455336|466926626|FG001|Overall Study|Adverse Event|0|||
129718001|NCT02455336|466926625|FG000|Overall Study|Non-responder to treatment|2|||
129803171|NCT00471146|467247533|FG000|Overall Study|Adverse Event|32|||
129803172|NCT00471146|467247534|FG001|Overall Study|Adverse Event|33|||
129803173|NCT00471146|467247533|FG000|Overall Study|Withdrawal by Subject|14|||
129803174|NCT00471146|467247534|FG001|Overall Study|Withdrawal by Subject|11|||
129803175|NCT00471146|467247533|FG000|Overall Study|Death|11|||
129803176|NCT00471146|467247534|FG001|Overall Study|Death|12|||
129803177|NCT00471146|467247533|FG000|Overall Study|Lost to Follow-up|4|||
129803178|NCT00471146|467247534|FG001|Overall Study|Lost to Follow-up|2|||
129803179|NCT00471146|467247533|FG000|Overall Study|Protocol Violation|2|||
129803180|NCT00471146|467247534|FG001|Overall Study|Protocol Violation|2|||
129803181|NCT00471146|467247533|FG000|Overall Study|Objective progression or relapse|84|||
129803182|NCT00471146|467247534|FG001|Overall Study|Objective progression or relapse|87|||
129803183|NCT00471146|467247533|FG000|Overall Study|Global deterioration of health status|12|||
129803184|NCT00471146|467247534|FG001|Overall Study|Global deterioration of health status|14|||
129803185|NCT00471146|467247533|FG000|Overall Study|Randomized but not treated|9|||
129803186|NCT00471146|467247534|FG001|Overall Study|Randomized but not treated|8|||
129803187|NCT00471146|467247533|FG000|Overall Study|Other|4|||
129803188|NCT00471146|467247534|FG001|Overall Study|Other|5|||
129803189|NCT05394350|467247535|FG000|Overall Study|Death|2|||
129803190|NCT05394350|467247536|FG001|Overall Study|Death|2|||
129803191|NCT05394350|467247537|FG002|Overall Study|Death|4|||
129718002|NCT02455336|466926626|FG001|Overall Study|Non-responder to treatment|0|||
129718003|NCT00391430|466926627|FG000|Overall Study|Withdrawal by Subject|3|||
129718004|NCT00391430|466926628|FG001|Overall Study|Withdrawal by Subject|0|||
129718005|NCT00391430|466926629|FG002|Overall Study|Withdrawal by Subject|12|||
129718006|NCT02467192|466926630|FG000|Overall Study|Death|1|||
129718007|NCT02467192|466926630|FG000|Overall Study|revealed to have pneumonia before|2|||
129718008|NCT03146663|466926634|FG000|Overall Study|Did not receive study treatment|1|||
129718009|NCT03146663|466926635|FG001|Overall Study|Did not receive study treatment|1|||
129718010|NCT03089047|466926636|FG000|Overall Study|Lost to Follow-up|1|||
129718011|NCT03089047|466926637|FG001|Overall Study|Lost to Follow-up|0|||
129718012|NCT03599518|466926638|FG000|Overall Study|Clinical progression|0|||
129718013|NCT03599518|466926639|FG001|Overall Study|Clinical progression|0|||
129718014|NCT03599518|466926640|FG002|Overall Study|Clinical progression|0|||
129718015|NCT03599518|466926641|FG003|Overall Study|Clinical progression|0|||
129718016|NCT03599518|466926642|FG004|Overall Study|Clinical progression|1|||
129803192|NCT05394350|467247538|FG003|Overall Study|Death|0|||
129718017|NCT03599518|466926638|FG000|Overall Study|Adverse Event|0|||
129803193|NCT05394350|467247539|FG004|Overall Study|Death|1|||
129718018|NCT03599518|466926639|FG001|Overall Study|Adverse Event|0|||
129803194|NCT05394350|467247540|FG005|Overall Study|Death|0|||
129803195|NCT05394350|467247535|FG000|Overall Study|Study terminated by sponsor|1|||
129803196|NCT05394350|467247536|FG001|Overall Study|Study terminated by sponsor|1|||
129803197|NCT05394350|467247537|FG002|Overall Study|Study terminated by sponsor|7|||
129803198|NCT05394350|467247538|FG003|Overall Study|Study terminated by sponsor|3|||
129803199|NCT05394350|467247539|FG004|Overall Study|Study terminated by sponsor|2|||
129803200|NCT05394350|467247540|FG005|Overall Study|Study terminated by sponsor|4|||
129803201|NCT02963935|467247543|FG000|Overall Study|Adverse Event|12|||
129803202|NCT02963935|467247544|FG001|Overall Study|Adverse Event|6|||
129803203|NCT02963935|467247543|FG000|Overall Study|Protocol Violation|2|||
129803204|NCT02963935|467247544|FG001|Overall Study|Protocol Violation|1|||
129803205|NCT02963935|467247543|FG000|Overall Study|Lack of Efficacy|0|||
129803206|NCT02963935|467247544|FG001|Overall Study|Lack of Efficacy|2|||
129803207|NCT02963935|467247543|FG000|Overall Study|Lost to Follow-up|1|||
129803208|NCT02963935|467247544|FG001|Overall Study|Lost to Follow-up|6|||
129803209|NCT02963935|467247543|FG000|Overall Study|Unclassified|13|||
129718019|NCT03599518|466926640|FG002|Overall Study|Adverse Event|0|||
129718020|NCT03599518|466926641|FG003|Overall Study|Adverse Event|0|||
129718021|NCT03599518|466926642|FG004|Overall Study|Adverse Event|1|||
129718022|NCT03599518|466926638|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
129718023|NCT03599518|466926639|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
129718024|NCT03599518|466926640|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
129718025|NCT03599518|466926641|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
129718026|NCT03599518|466926642|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
129718027|NCT03599518|466926638|FG000|Overall Study|Participant withdrawal from study treatment|0|||
129718028|NCT03599518|466926639|FG001|Overall Study|Participant withdrawal from study treatment|0|||
129718029|NCT03599518|466926640|FG002|Overall Study|Participant withdrawal from study treatment|1|||
129718030|NCT03599518|466926641|FG003|Overall Study|Participant withdrawal from study treatment|0|||
129718031|NCT03599518|466926642|FG004|Overall Study|Participant withdrawal from study treatment|0|||
129718032|NCT02701764|466926643|FG000|Overall Study|Lost to Follow-up|0|||
129718033|NCT02701764|466926644|FG001|Overall Study|Lost to Follow-up|1|||
129718034|NCT01027650|466926645|FG000|Overall Study|Personal Reasons|0|||
129718035|NCT01027650|466926646|FG001|Overall Study|Personal Reasons|0|||
129718036|NCT01027650|466926647|FG002|Overall Study|Personal Reasons|0|||
129718037|NCT01027650|466926648|FG003|Overall Study|Personal Reasons|0|||
129718038|NCT01027650|466926649|FG004|Overall Study|Personal Reasons|2|||
129718039|NCT01027650|466926650|FG005|Overall Study|Personal Reasons|1|||
129718040|NCT01027650|466926651|FG006|Overall Study|Personal Reasons|0|||
129718041|NCT01027650|466926652|FG007|Overall Study|Personal Reasons|0|||
129718042|NCT01027650|466926645|FG000|Overall Study|Lost to Follow-up|0|||
129718043|NCT01027650|466926646|FG001|Overall Study|Lost to Follow-up|0|||
129718044|NCT01027650|466926647|FG002|Overall Study|Lost to Follow-up|0|||
129718045|NCT01027650|466926648|FG003|Overall Study|Lost to Follow-up|0|||
129718046|NCT01027650|466926649|FG004|Overall Study|Lost to Follow-up|0|||
129718047|NCT01027650|466926650|FG005|Overall Study|Lost to Follow-up|0|||
129718048|NCT01027650|466926651|FG006|Overall Study|Lost to Follow-up|1|||
129718049|NCT01027650|466926652|FG007|Overall Study|Lost to Follow-up|0|||
129718050|NCT01027650|466926645|FG000|Overall Study|Lack of Efficacy|0|||
129718051|NCT01027650|466926646|FG001|Overall Study|Lack of Efficacy|0|||
129718052|NCT01027650|466926647|FG002|Overall Study|Lack of Efficacy|0|||
129718053|NCT01027650|466926648|FG003|Overall Study|Lack of Efficacy|0|||
129718054|NCT01027650|466926649|FG004|Overall Study|Lack of Efficacy|0|||
129718055|NCT01027650|466926650|FG005|Overall Study|Lack of Efficacy|1|||
129718056|NCT01027650|466926651|FG006|Overall Study|Lack of Efficacy|0|||
129718057|NCT01027650|466926652|FG007|Overall Study|Lack of Efficacy|0|||
129718058|NCT00912782|466926653|FG000|Overall Study|Death|2|||
129718059|NCT00912782|466926654|FG001|Overall Study|Death|1|||
129718060|NCT00912782|466926653|FG000|Overall Study|Lost to Follow-up|0|||
129718061|NCT00912782|466926654|FG001|Overall Study|Lost to Follow-up|1|||
129718062|NCT00912782|466926653|FG000|Overall Study|Did not receive vascular access type|1|||
129718063|NCT00912782|466926654|FG001|Overall Study|Did not receive vascular access type|2|||
129718064|NCT00912782|466926653|FG000|Overall Study|Relocated before study completion|0|||
129718065|NCT00912782|466926654|FG001|Overall Study|Relocated before study completion|1|||
129718066|NCT00294671|466928243|FG000|Overall Study|Lack of Efficacy|11|||
129718067|NCT00294671|466928244|FG001|Overall Study|Lack of Efficacy|23|||
129718068|NCT00294671|466928243|FG000|Overall Study|Liver transplant|7|||
129718069|NCT00294671|466928244|FG001|Overall Study|Liver transplant|9|||
129718070|NCT00294671|466928243|FG000|Overall Study|Drug related adverse event (AE)|4|||
129718071|NCT00294671|466928244|FG001|Overall Study|Drug related adverse event (AE)|2|||
129718072|NCT00294671|466928243|FG000|Overall Study|Non-drug related AE|3|||
129718073|NCT00294671|466928244|FG001|Overall Study|Non-drug related AE|2|||
129718074|NCT00294671|466928243|FG000|Overall Study|Lost to Follow-up|1|||
129718075|NCT00294671|466928244|FG001|Overall Study|Lost to Follow-up|3|||
129718076|NCT00294671|466928243|FG000|Overall Study|Non-compliance|1|||
129718077|NCT00294671|466928244|FG001|Overall Study|Non-compliance|0|||
129718078|NCT00294671|466928243|FG000|Overall Study|Death|0|||
129718079|NCT00294671|466928244|FG001|Overall Study|Death|1|||
129718080|NCT02263326|466928251|FG000|Overall Study|Lost to Follow-up|1|||
129718081|NCT02263326|466928252|FG001|Overall Study|Lost to Follow-up|1|||
129718082|NCT01893411|466928253|FG000|Overall Study|Protocol Violation|1|||
129718083|NCT01893411|466928254|FG001|Overall Study|Protocol Violation|0|||
129718084|NCT01893411|466928255|FG002|Overall Study|Protocol Violation|0|||
129718085|NCT01893411|466928253|FG000|Overall Study|Physician Decision|1|||
129718086|NCT01893411|466928254|FG001|Overall Study|Physician Decision|1|||
129718087|NCT01893411|466928255|FG002|Overall Study|Physician Decision|2|||
129718088|NCT01893411|466928253|FG000|Overall Study|Lack of Efficacy|2|||
129718089|NCT01893411|466928254|FG001|Overall Study|Lack of Efficacy|1|||
129718090|NCT01893411|466928255|FG002|Overall Study|Lack of Efficacy|0|||
129718091|NCT01893411|466928253|FG000|Overall Study|Other|3|||
129718092|NCT01893411|466928254|FG001|Overall Study|Other|1|||
129718093|NCT01893411|466928255|FG002|Overall Study|Other|3|||
129718094|NCT01893411|466928253|FG000|Overall Study|Adverse Event|1|||
129718095|NCT01893411|466928254|FG001|Overall Study|Adverse Event|0|||
129718096|NCT01893411|466928255|FG002|Overall Study|Adverse Event|0|||
129718097|NCT01893411|466928253|FG000|Overall Study|Withdrawal by Subject|7|||
129718098|NCT01893411|466928254|FG001|Overall Study|Withdrawal by Subject|4|||
129718099|NCT01893411|466928255|FG002|Overall Study|Withdrawal by Subject|3|||
129718100|NCT01893411|466928253|FG000|Overall Study|Lost to Follow-up|2|||
129718101|NCT01893411|466928254|FG001|Overall Study|Lost to Follow-up|0|||
129718102|NCT01893411|466928255|FG002|Overall Study|Lost to Follow-up|1|||
129718103|NCT02397915|466928256|FG000|Period 1|Protocol Violation|0|||
129718104|NCT02397915|466928257|FG001|Period 1|Protocol Violation|1|||
129718105|NCT02397915|466928258|FG002|Period 1|Protocol Violation|0|||
129718106|NCT02397915|466928259|FG003|Period 1|Protocol Violation|0|||
129718107|NCT02397915|466928256|FG000|Period 1|Physician Decision|1|||
129718108|NCT02397915|466928257|FG001|Period 1|Physician Decision|0|||
129718109|NCT02397915|466928258|FG002|Period 1|Physician Decision|0|||
129718110|NCT02397915|466928259|FG003|Period 1|Physician Decision|0|||
129718111|NCT03292874|466928260|FG000|Overall Study|Due to pandemic|5|||
129718112|NCT00933608|466928261|FG000|Overall Study|Adverse Event|4|||
129718113|NCT00933608|466928262|FG001|Overall Study|Adverse Event|2|||
129718114|NCT00933608|466928261|FG000|Overall Study|Physician Decision|1|||
129718115|NCT00933608|466928262|FG001|Overall Study|Physician Decision|0|||
129718116|NCT03053440|466928265|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
129718117|NCT03053440|466928266|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
129718118|NCT03053440|466928265|FG000|Overall Study|Death|18|||
129718119|NCT03053440|466928266|FG001|Overall Study|Death|14|||
129718120|NCT03053440|466928265|FG000|Overall Study|Withdrawal by Subject|9|||
129718121|NCT03053440|466928266|FG001|Overall Study|Withdrawal by Subject|8|||
129718122|NCT03053440|466928265|FG000|Overall Study|Lost to Follow-up|1|||
129718123|NCT03053440|466928266|FG001|Overall Study|Lost to Follow-up|0|||
129718124|NCT03053440|466928265|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
129718125|NCT03053440|466928266|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
129718126|NCT03053440|466928265|FG000|Overall Study|Physician Decision|2|||
129718127|NCT03053440|466928266|FG001|Overall Study|Physician Decision|1|||
129718128|NCT03053440|466928265|FG000|Overall Study|Participant Randomized but died before dosing|1|||
129718129|NCT03053440|466928266|FG001|Overall Study|Participant Randomized but died before dosing|0|||
129718130|NCT00391053|466928267|FG000|Overall Study|Serious Adverse Events|1|||
129718131|NCT00391053|466928268|FG001|Overall Study|Serious Adverse Events|0|||
129718132|NCT00391053|466928269|FG002|Overall Study|Serious Adverse Events|1|||
129718133|NCT00391053|466928270|FG003|Overall Study|Serious Adverse Events|4|||
129718134|NCT00391053|466928267|FG000|Overall Study|Protocol Violation|2|||
129718135|NCT00391053|466928268|FG001|Overall Study|Protocol Violation|0|||
129718136|NCT00391053|466928269|FG002|Overall Study|Protocol Violation|0|||
129718137|NCT00391053|466928270|FG003|Overall Study|Protocol Violation|0|||
129718138|NCT00391053|466928267|FG000|Overall Study|Lost to Follow-up|1|||
129718139|NCT00391053|466928268|FG001|Overall Study|Lost to Follow-up|0|||
129718140|NCT00391053|466928269|FG002|Overall Study|Lost to Follow-up|0|||
129718141|NCT00391053|466928270|FG003|Overall Study|Lost to Follow-up|5|||
129718142|NCT00391053|466928267|FG000|Overall Study|Withdrawal by Subject|5|||
129718143|NCT00391053|466928268|FG001|Overall Study|Withdrawal by Subject|1|||
129718144|NCT00391053|466928269|FG002|Overall Study|Withdrawal by Subject|1|||
129718145|NCT00391053|466928270|FG003|Overall Study|Withdrawal by Subject|1|||
129718146|NCT05002985|466928271|FG000|Overall Study|Withdrawal by Subject|1|||
129718147|NCT02943070|466928272|FG000|Overall Study|Physician Decision|1|||
129718148|NCT02943070|466928272|FG000|Overall Study|Adverse Event|2|||
129718149|NCT02943070|466928272|FG000|Overall Study|Death|2|||
129718150|NCT02943070|466928272|FG000|Overall Study|Withdrawal by Subject|3|||
129718151|NCT02943070|466928272|FG000|Overall Study|Lost to Follow-up|4|||
129718152|NCT02943070|466928272|FG000|Overall Study|Retreatment or TURP|13|||
129718153|NCT02943070|466928272|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
129718154|NCT04123093|466928273|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
129718155|NCT04123093|466928274|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
129718156|NCT04123093|466928273|FG000|Phase 2|Physician Decision|0|||
129718157|NCT04123093|466928274|FG001|Phase 2|Physician Decision|1|||
129718158|NCT04123093|466928273|FG000|Phase 2|Withdrawal by Subject|0|||
129718159|NCT04123093|466928274|FG001|Phase 2|Withdrawal by Subject|1|||
129718160|NCT01485796|466928276|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
129718161|NCT01485796|466928276|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
129718162|NCT01485796|466928276|FG000|Period 2: Epoch 2|Adverse Event|3|||
129718163|NCT01485796|466928276|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
129718164|NCT01485796|466928276|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
129718165|NCT01485796|466928276|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
129718166|NCT01485796|466928276|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
129718167|NCT01485796|466928276|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
129718168|NCT00606411|466928286|FG000|Overall Study|Adverse Event|1|||
129718169|NCT00606411|466928287|FG001|Overall Study|Adverse Event|2|||
129718170|NCT00606411|466928286|FG000|Overall Study|Lack of Adherence|1|||
129718171|NCT00606411|466928287|FG001|Overall Study|Lack of Adherence|1|||
129718172|NCT00606411|466928286|FG000|Overall Study|Lack of Efficacy|1|||
129718173|NCT00606411|466928287|FG001|Overall Study|Lack of Efficacy|1|||
129718174|NCT00606411|466928286|FG000|Overall Study|Withdrawal by Subject|2|||
129718175|NCT00606411|466928287|FG001|Overall Study|Withdrawal by Subject|0|||
129718176|NCT00606411|466928286|FG000|Overall Study|Lost to Follow-up|1|||
129718177|NCT00606411|466928287|FG001|Overall Study|Lost to Follow-up|2|||
129718178|NCT00606411|466928286|FG000|Overall Study|Move out of state|0|||
129718179|NCT00606411|466928287|FG001|Overall Study|Move out of state|1|||
129718180|NCT02526212|466928288|FG000|Overall Study|Incarceration|1|||
129718181|NCT02526212|466928289|FG001|Overall Study|Incarceration|0|||
129718182|NCT02526212|466928288|FG000|Overall Study|Lost to Follow-up|1|||
129718183|NCT02526212|466928289|FG001|Overall Study|Lost to Follow-up|0|||
129718184|NCT02526212|466928288|FG000|Overall Study|Death|0|||
129718185|NCT02526212|466928289|FG001|Overall Study|Death|1|||
129718186|NCT01390298|466928290|FG000|Overall Study|Death|1|||
129718187|NCT01390298|466928290|FG000|Overall Study|long term ICU admission|1|||
129718188|NCT01390298|466928290|FG000|Overall Study|Withdrawal by Subject|14|||
129718189|NCT01390298|466928290|FG000|Overall Study|Lost to Follow-up|7|||
129718190|NCT01390298|466928290|FG000|Overall Study|Surgery cancelled|1|||
129718191|NCT00040742|466928297|FG000|Overall Study|Death|0|||
129718192|NCT00040742|466928298|FG001|Overall Study|Death|0|||
129718193|NCT00040742|466928299|FG002|Overall Study|Death|1|||
129718194|NCT00040742|466928300|FG003|Overall Study|Death|0|||
129718195|NCT00040742|466928297|FG000|Overall Study|Adverse Event|15|||
129718196|NCT00040742|466928298|FG001|Overall Study|Adverse Event|16|||
129718197|NCT00040742|466928299|FG002|Overall Study|Adverse Event|21|||
129718198|NCT00040742|466928300|FG003|Overall Study|Adverse Event|9|||
129718199|NCT00040742|466928297|FG000|Overall Study|Withdrawal by Subject|7|||
129718200|NCT00040742|466928298|FG001|Overall Study|Withdrawal by Subject|15|||
129718201|NCT00040742|466928299|FG002|Overall Study|Withdrawal by Subject|10|||
129718202|NCT00040742|466928300|FG003|Overall Study|Withdrawal by Subject|13|||
129718203|NCT00040742|466928297|FG000|Overall Study|Chemotoxicity|4|||
129718204|NCT00040742|466928298|FG001|Overall Study|Chemotoxicity|3|||
129718205|NCT00040742|466928299|FG002|Overall Study|Chemotoxicity|5|||
129718206|NCT00040742|466928300|FG003|Overall Study|Chemotoxicity|2|||
129718207|NCT00040742|466928297|FG000|Overall Study|Incomplete Forms|6|||
129718208|NCT00040742|466928298|FG001|Overall Study|Incomplete Forms|10|||
129718209|NCT00040742|466928299|FG002|Overall Study|Incomplete Forms|4|||
129718210|NCT00040742|466928300|FG003|Overall Study|Incomplete Forms|5|||
129718211|NCT00040742|466928297|FG000|Overall Study|Other medical|7|||
129718212|NCT00040742|466928298|FG001|Overall Study|Other medical|5|||
129718213|NCT00040742|466928299|FG002|Overall Study|Other medical|5|||
129718214|NCT00040742|466928300|FG003|Overall Study|Other medical|5|||
129718215|NCT03520920|466928303|FG000|Overall Study|Death|13|||
129718216|NCT03520920|466928304|FG001|Overall Study|Death|1|||
129718217|NCT03520920|466928305|FG002|Overall Study|Death|0|||
129718218|NCT03520920|466928303|FG000|Overall Study|Withdrawal by Subject|2|||
129718219|NCT03520920|466928304|FG001|Overall Study|Withdrawal by Subject|1|||
129718220|NCT03520920|466928305|FG002|Overall Study|Withdrawal by Subject|0|||
129718221|NCT03520920|466928303|FG000|Overall Study|Study Terminated by the Sponsor|5|||
129718222|NCT03520920|466928304|FG001|Overall Study|Study Terminated by the Sponsor|14|||
129718223|NCT03520920|466928305|FG002|Overall Study|Study Terminated by the Sponsor|5|||
129718224|NCT00405392|466928306|FG000|Overall Study|Adverse Event|15|||
129718225|NCT00405392|466928307|FG001|Overall Study|Adverse Event|14|||
129803210|NCT02963935|467247544|FG001|Overall Study|Unclassified|22|||
129803211|NCT00464269|467247545|FG000|Overall Study|Lack of Efficacy|1|||
129803212|NCT00464269|467247546|FG001|Overall Study|Lack of Efficacy|0|||
129803213|NCT00464269|467247547|FG002|Overall Study|Lack of Efficacy|0|||
129803214|NCT00464269|467247548|FG003|Overall Study|Lack of Efficacy|0|||
129803215|NCT00464269|467247545|FG000|Overall Study|Lost to Follow-up|0|||
129718226|NCT00405392|466928306|FG000|Overall Study|Did not meet Eligibility criteria|7|||
129718227|NCT00405392|466928307|FG001|Overall Study|Did not meet Eligibility criteria|2|||
129803216|NCT00464269|467247546|FG001|Overall Study|Lost to Follow-up|4|||
129718228|NCT00405392|466928306|FG000|Overall Study|Withdrawal by Subject|4|||
129718229|NCT00405392|466928307|FG001|Overall Study|Withdrawal by Subject|3|||
129718230|NCT00405392|466928306|FG000|Overall Study|Lost to Follow-up|1|||
129803217|NCT00464269|467247547|FG002|Overall Study|Lost to Follow-up|0|||
129803218|NCT00464269|467247548|FG003|Overall Study|Lost to Follow-up|1|||
129803219|NCT00464269|467247545|FG000|Overall Study|Withdrawal by Subject|0|||
129718231|NCT00405392|466928307|FG001|Overall Study|Lost to Follow-up|2|||
129803220|NCT00464269|467247546|FG001|Overall Study|Withdrawal by Subject|2|||
129803221|NCT00464269|467247547|FG002|Overall Study|Withdrawal by Subject|1|||
129718232|NCT00405392|466928306|FG000|Overall Study|Data missing|2|||
129718233|NCT00405392|466928307|FG001|Overall Study|Data missing|0|||
129718234|NCT00405392|466928306|FG000|Overall Study|Non-compliance|0|||
129718235|NCT00405392|466928307|FG001|Overall Study|Non-compliance|1|||
129718236|NCT00405392|466928306|FG000|Overall Study|Other|1|||
129718237|NCT00405392|466928307|FG001|Overall Study|Other|5|||
129718238|NCT00412958|466928308|FG000|Overall Study|Withdrawal by Subject|3|||
129718239|NCT00412958|466928309|FG001|Overall Study|Withdrawal by Subject|0|||
129718240|NCT00412958|466928310|FG002|Overall Study|Withdrawal by Subject|0|||
129718241|NCT00412958|466928311|FG003|Overall Study|Withdrawal by Subject|1|||
129718242|NCT00412958|466928308|FG000|Overall Study|Adverse Event|0|||
129718243|NCT00412958|466928309|FG001|Overall Study|Adverse Event|1|||
129718244|NCT00412958|466928310|FG002|Overall Study|Adverse Event|0|||
129718245|NCT00412958|466928311|FG003|Overall Study|Adverse Event|0|||
129718246|NCT00412958|466928308|FG000|Overall Study|Lost to Follow-up|0|||
129718247|NCT00412958|466928309|FG001|Overall Study|Lost to Follow-up|1|||
129718248|NCT00412958|466928310|FG002|Overall Study|Lost to Follow-up|0|||
129718249|NCT00412958|466928311|FG003|Overall Study|Lost to Follow-up|0|||
129718250|NCT00412958|466928308|FG000|Overall Study|Death|0|||
129718251|NCT00412958|466928309|FG001|Overall Study|Death|1|||
129718252|NCT00412958|466928310|FG002|Overall Study|Death|0|||
129718253|NCT00412958|466928311|FG003|Overall Study|Death|0|||
129718254|NCT00412958|466928308|FG000|Overall Study|Transport issue|0|||
129718255|NCT00412958|466928309|FG001|Overall Study|Transport issue|1|||
129718256|NCT00412958|466928310|FG002|Overall Study|Transport issue|0|||
129718257|NCT00412958|466928311|FG003|Overall Study|Transport issue|0|||
129718258|NCT01703091|466928322|FG000|Overall Study|Adverse Event|5|||
129718259|NCT01703091|466928323|FG001|Overall Study|Adverse Event|3|||
129718260|NCT01703091|466928322|FG000|Overall Study|Physician Decision|2|||
129718261|NCT01703091|466928323|FG001|Overall Study|Physician Decision|1|||
129718262|NCT01703091|466928322|FG000|Overall Study|Withdrawal by Subject|1|||
129718263|NCT01703091|466928323|FG001|Overall Study|Withdrawal by Subject|0|||
129718264|NCT01703091|466928322|FG000|Overall Study|Sponsor Decision|1|||
129718265|NCT01703091|466928323|FG001|Overall Study|Sponsor Decision|0|||
129718266|NCT02819297|466928329|FG000|Overall Study|Withdrawal by Subject|25|||
129718267|NCT02819297|466928330|FG001|Overall Study|Withdrawal by Subject|13|||
129718268|NCT02819297|466928329|FG000|Overall Study|Lost to Follow-up|12|||
129718269|NCT02819297|466928330|FG001|Overall Study|Lost to Follow-up|14|||
129718270|NCT02819297|466928329|FG000|Overall Study|Adverse Event|12|||
129891490|NCT01021878|467561140|FG001|Overall Study|Adverse Event|5|||
129891491|NCT01021878|467561139|FG000|Overall Study|Transplantation|6|||
129891492|NCT01021878|467561140|FG001|Overall Study|Transplantation|1|||
129891493|NCT02424344|467561141|FG000|Overall Study|Lack of Efficacy|0|||
129718271|NCT02819297|466928330|FG001|Overall Study|Adverse Event|10|||
129718272|NCT02819297|466928329|FG000|Overall Study|Physician Decision|5|||
129891494|NCT02424344|467561142|FG001|Overall Study|Lack of Efficacy|1|||
129891495|NCT02424344|467561141|FG000|Overall Study|Withdrawal by Subject|2|||
129891496|NCT02424344|467561142|FG001|Overall Study|Withdrawal by Subject|1|||
129891497|NCT02424344|467561141|FG000|Overall Study|Lost to Follow-up|1|||
129891498|NCT02424344|467561142|FG001|Overall Study|Lost to Follow-up|0|||
129891499|NCT02424344|467561141|FG000|Overall Study|Adverse Event|4|||
129891500|NCT02424344|467561142|FG001|Overall Study|Adverse Event|8|||
129891501|NCT01511536|467561145|FG000|Phase 1|Other|0|||
129891502|NCT01511536|467561146|FG001|Phase 1|Other|1|||
129891503|NCT01511536|467561147|FG002|Phase 1|Other|0|||
129891504|NCT01511536|467561145|FG000|Phase 2|Other|0|||
129891505|NCT01511536|467561146|FG001|Phase 2|Other|0|||
129891506|NCT01511536|467561147|FG002|Phase 2|Other|9|||
129891507|NCT00765362|467561148|FG000|Overall Study|Death|9|||
129718273|NCT02819297|466928330|FG001|Overall Study|Physician Decision|5|||
129718274|NCT02819297|466928329|FG000|Overall Study|Lack of Efficacy|5|||
129718275|NCT02819297|466928330|FG001|Overall Study|Lack of Efficacy|8|||
129718276|NCT02819297|466928329|FG000|Overall Study|Protocol Violation|1|||
129718277|NCT02819297|466928330|FG001|Overall Study|Protocol Violation|2|||
129718278|NCT02858440|466928331|FG000|Overall Study|Lost to Follow-up|3|||
129718279|NCT02858440|466928331|FG000|Overall Study|Protocol Violation|2|||
129718280|NCT02858440|466928331|FG000|Overall Study|Consent withdrawal|3|||
129718281|NCT02858440|466928331|FG000|Overall Study|Migrated/moved from study area|4|||
129718282|NCT01670279|466928332|FG000|Overall Study|Adverse Event|0|||
129718283|NCT01670279|466928333|FG001|Overall Study|Adverse Event|1|||
129718284|NCT01670279|466928334|FG002|Overall Study|Adverse Event|0|||
129718285|NCT01670279|466928335|FG003|Overall Study|Adverse Event|0|||
129718286|NCT01670279|466928332|FG000|Overall Study|Physician Decision|0|||
129444332|NCT02616614|465927301|FG002|Overall Study|Withdrawal by Subject|6|||
129444333|NCT02616614|465927299|FG000|Overall Study|Physician Decision|2|||
129718287|NCT01670279|466928333|FG001|Overall Study|Physician Decision|1|||
129718288|NCT01670279|466928334|FG002|Overall Study|Physician Decision|0|||
129718289|NCT01670279|466928335|FG003|Overall Study|Physician Decision|0|||
129718290|NCT01670279|466928332|FG000|Overall Study|Participant met withdrawal criteria|0|||
129718291|NCT01670279|466928333|FG001|Overall Study|Participant met withdrawal criteria|0|||
129891508|NCT00765362|467561148|FG000|Overall Study|Adverse Event|2|||
129718292|NCT01670279|466928334|FG002|Overall Study|Participant met withdrawal criteria|0|||
129718293|NCT01670279|466928335|FG003|Overall Study|Participant met withdrawal criteria|1|||
129718294|NCT01901614|466928336|FG000|Overall Study|Adverse Event|0|||
129891509|NCT00765362|467561148|FG000|Overall Study|Protocol Violation|18|||
129891510|NCT00765362|467561148|FG000|Overall Study|Withdrawal by Subject|13|||
129891511|NCT00765362|467561148|FG000|Overall Study|Lost to Follow-up|95|||
129718295|NCT01901614|466928337|FG001|Overall Study|Adverse Event|1|||
129718296|NCT01901614|466928336|FG000|Overall Study|Lost to Follow-up|1|||
129718297|NCT01901614|466928337|FG001|Overall Study|Lost to Follow-up|0|||
129718298|NCT01901614|466928336|FG000|Overall Study|Screen Fail|1|||
129718299|NCT01901614|466928337|FG001|Overall Study|Screen Fail|0|||
129718300|NCT01823198|466928339|FG000|Overall Study|Physician Decision|0|||
129718301|NCT01823198|466928340|FG001|Overall Study|Physician Decision|1|||
129718302|NCT01823198|466928341|FG002|Overall Study|Physician Decision|0|||
129718303|NCT01823198|466928342|FG003|Overall Study|Physician Decision|0|||
129718304|NCT01823198|466928343|FG004|Overall Study|Physician Decision|0|||
129718305|NCT01823198|466928344|FG005|Overall Study|Physician Decision|3|||
129718306|NCT01823198|466928345|FG006|Overall Study|Physician Decision|3|||
129718307|NCT01262638|466928346|FG000|Overall Study|Adverse Event|3|||
129718308|NCT01262638|466928347|FG001|Overall Study|Adverse Event|4|||
129718309|NCT01262638|466928348|FG002|Overall Study|Adverse Event|3|||
129718310|NCT01262638|466928349|FG003|Overall Study|Adverse Event|4|||
129718311|NCT01262638|466928346|FG000|Overall Study|Protocol Violation|1|||
129718312|NCT01262638|466928347|FG001|Overall Study|Protocol Violation|0|||
129718313|NCT01262638|466928348|FG002|Overall Study|Protocol Violation|0|||
129718314|NCT01262638|466928349|FG003|Overall Study|Protocol Violation|1|||
129718315|NCT01262638|466928346|FG000|Overall Study|Withdrawal by Subject|2|||
129718316|NCT01262638|466928347|FG001|Overall Study|Withdrawal by Subject|1|||
129718317|NCT01262638|466928348|FG002|Overall Study|Withdrawal by Subject|0|||
129718318|NCT01262638|466928349|FG003|Overall Study|Withdrawal by Subject|1|||
129718319|NCT01262638|466928346|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129718320|NCT01262638|466928347|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129718321|NCT01262638|466928348|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
129718322|NCT01262638|466928349|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129718323|NCT01262638|466928346|FG000|Overall Study|Lost to Follow-up|1|||
129718324|NCT01262638|466928347|FG001|Overall Study|Lost to Follow-up|1|||
129718325|NCT01262638|466928348|FG002|Overall Study|Lost to Follow-up|1|||
129718326|NCT01262638|466928349|FG003|Overall Study|Lost to Follow-up|1|||
129718327|NCT01262638|466928346|FG000|Overall Study|Participant Went Out of Town|0|||
129718328|NCT01262638|466928347|FG001|Overall Study|Participant Went Out of Town|0|||
129718329|NCT01262638|466928348|FG002|Overall Study|Participant Went Out of Town|1|||
129718330|NCT01262638|466928349|FG003|Overall Study|Participant Went Out of Town|0|||
129718331|NCT02243371|466928354|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
129718332|NCT02243371|466928355|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
129718333|NCT02243371|466928354|FG000|Overall Study|Death (unrelated)|2|||
129718334|NCT02243371|466928355|FG001|Overall Study|Death (unrelated)|4|||
129718335|NCT02243371|466928354|FG000|Overall Study|Adverse Event (unrelated)|0|||
129718336|NCT02243371|466928355|FG001|Overall Study|Adverse Event (unrelated)|1|||
129718337|NCT02243371|466928354|FG000|Overall Study|Lack of Clinical Benefit|0|||
129718338|NCT02243371|466928355|FG001|Overall Study|Lack of Clinical Benefit|1|||
129718339|NCT02243371|466928354|FG000|Overall Study|Withdrawal by Subject|0|||
129718340|NCT02243371|466928355|FG001|Overall Study|Withdrawal by Subject|2|||
129718341|NCT01369199|466928356|FG000|Overall Study|Withdrawal by Subject|1|||
129803222|NCT00464269|467247548|FG003|Overall Study|Withdrawal by Subject|1|||
129803223|NCT00464269|467247545|FG000|Overall Study|Other reason|3|||
129803224|NCT00464269|467247546|FG001|Overall Study|Other reason|3|||
129803225|NCT00464269|467247547|FG002|Overall Study|Other reason|1|||
129803226|NCT00464269|467247548|FG003|Overall Study|Other reason|1|||
129718342|NCT01369199|466928356|FG000|Overall Study|Lost to Follow-up|2|||
129803227|NCT00464269|467247545|FG000|Overall Study|AE, serious fatal|0|||
129718343|NCT01071252|466928357|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
129718344|NCT01071252|466928358|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
129803228|NCT00464269|467247546|FG001|Overall Study|AE, serious fatal|0|||
129803229|NCT00464269|467247547|FG002|Overall Study|AE, serious fatal|1|||
129803230|NCT00464269|467247548|FG003|Overall Study|AE, serious fatal|1|||
129803231|NCT00464269|467247545|FG000|Overall Study|SAE, non-fatal|0|||
129803232|NCT00464269|467247546|FG001|Overall Study|SAE, non-fatal|0|||
129718345|NCT01071252|466928359|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
129718346|NCT01071252|466928360|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
129718347|NCT01071252|466928361|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
129718348|NCT01071252|466928357|FG000|Overall Study|Withdrawal by Subject|8|||
129718349|NCT01071252|466928358|FG001|Overall Study|Withdrawal by Subject|2|||
129718350|NCT01071252|466928359|FG002|Overall Study|Withdrawal by Subject|1|||
129718351|NCT01071252|466928360|FG003|Overall Study|Withdrawal by Subject|2|||
129718352|NCT01071252|466928361|FG004|Overall Study|Withdrawal by Subject|3|||
129718353|NCT01071252|466928357|FG000|Overall Study|administrative problems|1|||
129718354|NCT01071252|466928358|FG001|Overall Study|administrative problems|1|||
129718355|NCT01071252|466928359|FG002|Overall Study|administrative problems|0|||
129718356|NCT01071252|466928360|FG003|Overall Study|administrative problems|2|||
129718357|NCT01071252|466928361|FG004|Overall Study|administrative problems|1|||
129718358|NCT01071252|466928357|FG000|Overall Study|Lost to Follow-up|1|||
129718359|NCT01071252|466928358|FG001|Overall Study|Lost to Follow-up|0|||
129718360|NCT01071252|466928359|FG002|Overall Study|Lost to Follow-up|1|||
129718361|NCT01071252|466928360|FG003|Overall Study|Lost to Follow-up|2|||
129718362|NCT01071252|466928361|FG004|Overall Study|Lost to Follow-up|0|||
129718363|NCT01071252|466928357|FG000|Overall Study|Adverse Event|1|||
129718364|NCT01071252|466928358|FG001|Overall Study|Adverse Event|1|||
129718365|NCT01071252|466928359|FG002|Overall Study|Adverse Event|0|||
129718366|NCT01071252|466928360|FG003|Overall Study|Adverse Event|1|||
129718367|NCT01071252|466928361|FG004|Overall Study|Adverse Event|0|||
129718368|NCT01071252|466928357|FG000|Overall Study|Death|0|||
129718369|NCT01071252|466928358|FG001|Overall Study|Death|0|||
129718370|NCT01071252|466928359|FG002|Overall Study|Death|0|||
129718371|NCT01071252|466928360|FG003|Overall Study|Death|0|||
129718372|NCT01071252|466928361|FG004|Overall Study|Death|1|||
129718373|NCT03928418|466928362|FG000|Overall Study|Lost to Follow-up|5|||
129718374|NCT03928418|466928363|FG001|Overall Study|Lost to Follow-up|3|||
129718375|NCT03928418|466928364|FG002|Overall Study|Lost to Follow-up|5|||
129718376|NCT03928418|466928362|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
129718377|NCT03928418|466928363|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
129718378|NCT03928418|466928364|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
129718379|NCT00470262|466928365|FG000|Overall Study|Withdrawal by Subject|2|||
129718380|NCT00470262|466928366|FG001|Overall Study|Withdrawal by Subject|0|||
129718381|NCT00553436|466928369|FG000|Overall Study|Conversion to another procedure|1|||
129718382|NCT04188834|466928370|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
129718383|NCT01030952|466928371|FG000|Overall Study|Protocol Violation|0|||
129718384|NCT01030952|466928372|FG001|Overall Study|Protocol Violation|1|||
129718385|NCT01030952|466928371|FG000|Overall Study|Informed consent withdrawal|1|||
129718386|NCT01030952|466928372|FG001|Overall Study|Informed consent withdrawal|0|||
129718387|NCT01030952|466928371|FG000|Overall Study|Lost to Follow-up|0|||
129718388|NCT01030952|466928372|FG001|Overall Study|Lost to Follow-up|1|||
129718389|NCT01030952|466928371|FG000|Overall Study|Unexplained|1|||
129718390|NCT01030952|466928372|FG001|Overall Study|Unexplained|1|||
129718391|NCT01814046|466928373|FG000|Drug Administration|Death due to complications of RSV|1|||
129718392|NCT01814046|466928374|FG001|Drug Administration|Death due to complications of RSV|0|||
129718393|NCT01814046|466928375|FG002|Drug Administration|Death due to complications of RSV|0|||
129718394|NCT00958347|466928376|FG000|Overall Study|Death|43|||
129718395|NCT00958347|466928376|FG000|Overall Study|Withdrawal by Subject|23|||
129718396|NCT00958347|466928376|FG000|Overall Study|Lost to Follow-up|15|||
129718397|NCT00958347|466928376|FG000|Overall Study|revision/removal|10|||
129718398|NCT00958347|466928376|FG000|Overall Study|study termination|135|||
129718399|NCT02311881|466928404|FG000|Overall Study|Did not meet the study criteria|2|||
129718400|NCT02311881|466928405|FG001|Overall Study|Did not meet the study criteria|2|||
129718401|NCT02311881|466928406|FG002|Overall Study|Did not meet the study criteria|0|||
129718402|NCT02311881|466928404|FG000|Overall Study|Adverse Event|7|||
129718403|NCT02311881|466928405|FG001|Overall Study|Adverse Event|15|||
129718404|NCT02311881|466928406|FG002|Overall Study|Adverse Event|8|||
129718405|NCT02311881|466928404|FG000|Overall Study|Lost to Follow-up|3|||
129718406|NCT02311881|466928405|FG001|Overall Study|Lost to Follow-up|3|||
129718407|NCT02311881|466928406|FG002|Overall Study|Lost to Follow-up|2|||
129718408|NCT02311881|466928404|FG000|Overall Study|Protocol Violation|1|||
129718409|NCT02311881|466928405|FG001|Overall Study|Protocol Violation|2|||
129718410|NCT02311881|466928406|FG002|Overall Study|Protocol Violation|3|||
129718411|NCT02311881|466928404|FG000|Overall Study|Withdrawal of consent|14|||
129718412|NCT02311881|466928405|FG001|Overall Study|Withdrawal of consent|16|||
129718413|NCT02311881|466928406|FG002|Overall Study|Withdrawal of consent|17|||
129718414|NCT02311881|466928404|FG000|Overall Study|Other|0|||
129803233|NCT00464269|467247547|FG002|Overall Study|SAE, non-fatal|0|||
129718415|NCT02311881|466928405|FG001|Overall Study|Other|0|||
129718416|NCT02311881|466928406|FG002|Overall Study|Other|1|||
129718417|NCT02311881|466928404|FG000|Overall Study|Lack of Efficacy|1|||
129718418|NCT02311881|466928405|FG001|Overall Study|Lack of Efficacy|2|||
129803234|NCT00464269|467247548|FG003|Overall Study|SAE, non-fatal|1|||
129803235|NCT00464269|467247545|FG000|Overall Study|AE, non-serious non-fatal|2|||
129803236|NCT00464269|467247546|FG001|Overall Study|AE, non-serious non-fatal|8|||
129718419|NCT02311881|466928406|FG002|Overall Study|Lack of Efficacy|0|||
129718420|NCT02311881|466928404|FG000|Overall Study|Subject has border line pregnancy test|1|||
129718421|NCT02311881|466928405|FG001|Overall Study|Subject has border line pregnancy test|0|||
129718422|NCT02311881|466928406|FG002|Overall Study|Subject has border line pregnancy test|0|||
129718423|NCT02311881|466928404|FG000|Overall Study|Withdrawal by Subject|3|||
129718424|NCT02311881|466928405|FG001|Overall Study|Withdrawal by Subject|1|||
129803237|NCT00464269|467247547|FG002|Overall Study|AE, non-serious non-fatal|3|||
129803238|NCT00464269|467247548|FG003|Overall Study|AE, non-serious non-fatal|4|||
129718425|NCT02311881|466928406|FG002|Overall Study|Withdrawal by Subject|4|||
129718426|NCT02311881|466928404|FG000|Overall Study|Sponsor Decision|1|||
129718427|NCT02311881|466928405|FG001|Overall Study|Sponsor Decision|1|||
129718428|NCT02311881|466928406|FG002|Overall Study|Sponsor Decision|1|||
129718429|NCT02311881|466928404|FG000|Overall Study|Protocol Deviation|1|||
129718430|NCT02311881|466928405|FG001|Overall Study|Protocol Deviation|0|||
129718431|NCT02311881|466928406|FG002|Overall Study|Protocol Deviation|0|||
129718432|NCT02311881|466928404|FG000|Overall Study|Non-Compliance|1|||
129718433|NCT02311881|466928405|FG001|Overall Study|Non-Compliance|0|||
129718434|NCT02311881|466928406|FG002|Overall Study|Non-Compliance|2|||
129718435|NCT02311881|466928404|FG000|Overall Study|Physician Decision|0|||
129718436|NCT02311881|466928405|FG001|Overall Study|Physician Decision|0|||
129718437|NCT02311881|466928406|FG002|Overall Study|Physician Decision|1|||
129718438|NCT02311881|466928404|FG000|Overall Study|Medical Monitor Discretion|0|||
129718439|NCT02311881|466928405|FG001|Overall Study|Medical Monitor Discretion|0|||
129718440|NCT02311881|466928406|FG002|Overall Study|Medical Monitor Discretion|1|||
129718441|NCT02311881|466928404|FG000|Overall Study|Participant taking another medication|0|||
129718442|NCT02311881|466928405|FG001|Overall Study|Participant taking another medication|0|||
129718443|NCT02311881|466928406|FG002|Overall Study|Participant taking another medication|1|||
129718444|NCT02311881|466928404|FG000|Overall Study|Serious Adverse Event|0|||
129718445|NCT02311881|466928405|FG001|Overall Study|Serious Adverse Event|1|||
129718446|NCT02311881|466928406|FG002|Overall Study|Serious Adverse Event|0|||
129718447|NCT00819156|466928407|FG000|Overall Study|Adverse Event|1|||
129718448|NCT00819156|466928408|FG001|Overall Study|Adverse Event|4|||
129718449|NCT00819156|466928409|FG002|Overall Study|Adverse Event|2|||
129718450|NCT00819156|466928410|FG003|Overall Study|Adverse Event|1|||
129718451|NCT00819156|466928411|FG004|Overall Study|Adverse Event|2|||
129718452|NCT00819156|466928412|FG005|Overall Study|Adverse Event|3|||
129718453|NCT00819156|466928407|FG000|Overall Study|Withdrawal by Subject|0|||
129718454|NCT00819156|466928408|FG001|Overall Study|Withdrawal by Subject|3|||
129718455|NCT00819156|466928409|FG002|Overall Study|Withdrawal by Subject|2|||
129718456|NCT00819156|466928410|FG003|Overall Study|Withdrawal by Subject|0|||
129718457|NCT00819156|466928411|FG004|Overall Study|Withdrawal by Subject|1|||
129718458|NCT00819156|466928412|FG005|Overall Study|Withdrawal by Subject|0|||
129718459|NCT00819156|466928407|FG000|Overall Study|Protocol Violation|1|||
129718460|NCT00819156|466928408|FG001|Overall Study|Protocol Violation|0|||
129718461|NCT00819156|466928409|FG002|Overall Study|Protocol Violation|1|||
129718462|NCT00819156|466928410|FG003|Overall Study|Protocol Violation|0|||
129718463|NCT00819156|466928411|FG004|Overall Study|Protocol Violation|0|||
129718464|NCT00819156|466928412|FG005|Overall Study|Protocol Violation|1|||
129718465|NCT00819156|466928407|FG000|Overall Study|Lost to Follow-up|0|||
129718466|NCT00819156|466928408|FG001|Overall Study|Lost to Follow-up|1|||
129718467|NCT00819156|466928409|FG002|Overall Study|Lost to Follow-up|0|||
129718468|NCT00819156|466928410|FG003|Overall Study|Lost to Follow-up|0|||
129718469|NCT00819156|466928411|FG004|Overall Study|Lost to Follow-up|0|||
129718470|NCT00819156|466928412|FG005|Overall Study|Lost to Follow-up|2|||
129718471|NCT00819156|466928407|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
129718472|NCT00819156|466928408|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
129718473|NCT00819156|466928409|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
129718474|NCT00819156|466928410|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
129718475|NCT00819156|466928411|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
129718476|NCT00819156|466928412|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
129718477|NCT00819156|466928407|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
129718478|NCT00819156|466928408|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129718479|NCT00819156|466928409|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129718480|NCT00819156|466928410|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129718481|NCT00819156|466928411|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
129718482|NCT00819156|466928412|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
129718483|NCT00819156|466928407|FG000|Overall Study|Prostate-specific antigen progression|0|||
129718484|NCT00819156|466928408|FG001|Overall Study|Prostate-specific antigen progression|0|||
129718485|NCT00819156|466928409|FG002|Overall Study|Prostate-specific antigen progression|0|||
129718486|NCT00819156|466928410|FG003|Overall Study|Prostate-specific antigen progression|0|||
129718487|NCT00819156|466928411|FG004|Overall Study|Prostate-specific antigen progression|1|||
129718488|NCT00819156|466928412|FG005|Overall Study|Prostate-specific antigen progression|0|||
129718489|NCT00803595|466928413|FG000|Overall Study|Adverse Event|3|||
129718490|NCT00803595|466928414|FG001|Overall Study|Adverse Event|4|||
129718491|NCT00803595|466928415|FG002|Overall Study|Adverse Event|1|||
129718492|NCT00803595|466928413|FG000|Overall Study|Protocol Violation|7|||
129718493|NCT00803595|466928414|FG001|Overall Study|Protocol Violation|2|||
129718494|NCT00803595|466928415|FG002|Overall Study|Protocol Violation|12|||
129718495|NCT00803595|466928413|FG000|Overall Study|Withdrawal by Subject|5|||
129718496|NCT00803595|466928414|FG001|Overall Study|Withdrawal by Subject|2|||
129718497|NCT00803595|466928415|FG002|Overall Study|Withdrawal by Subject|3|||
129444334|NCT02616614|465927300|FG001|Overall Study|Physician Decision|1|||
129718498|NCT01575808|466928418|FG000|Overall Study|Death|2|||
129718499|NCT01575808|466928419|FG001|Overall Study|Death|0|||
129718500|NCT01575808|466928418|FG000|Overall Study|Withdrawal by Subject|1|||
129718501|NCT01575808|466928419|FG001|Overall Study|Withdrawal by Subject|0|||
129718502|NCT02403817|466930082|FG000|Overall Study|Withdrawal by Subject|5|||
129718503|NCT02403817|466930083|FG001|Overall Study|Withdrawal by Subject|0|||
129718504|NCT04908384|466930084|FG000|Overall Study|Lost to Follow-up|4|||
129718505|NCT04908384|466930085|FG001|Overall Study|Lost to Follow-up|4|||
129718506|NCT04908384|466930086|FG002|Overall Study|Lost to Follow-up|0|||
129718507|NCT04908384|466930087|FG003|Overall Study|Lost to Follow-up|0|||
129718508|NCT00430989|466930088|FG000|Overall Study|Lost to Follow-up|2|||
129718509|NCT00430989|466930089|FG001|Overall Study|Lost to Follow-up|3|||
129718510|NCT00430989|466930088|FG000|Overall Study|Withdrawal by Subject|15|||
129718511|NCT00430989|466930089|FG001|Overall Study|Withdrawal by Subject|14|||
129718512|NCT00430989|466930088|FG000|Overall Study|Protocol Violation|30|||
129718513|NCT00430989|466930089|FG001|Overall Study|Protocol Violation|37|||
129718514|NCT00430989|466930088|FG000|Overall Study|Not eligible|13|||
129718515|NCT00430989|466930089|FG001|Overall Study|Not eligible|6|||
129718516|NCT03050450|466930090|FG000|Overall Study|Physician Decision|1|||
129718517|NCT03050450|466930091|FG001|Overall Study|Physician Decision|0|||
129718518|NCT03050450|466930092|FG002|Overall Study|Physician Decision|0|||
129718519|NCT03050450|466930093|FG003|Overall Study|Physician Decision|0|||
129718520|NCT03050450|466930094|FG004|Overall Study|Physician Decision|0|||
129718521|NCT01642901|466930095|FG000|12-month Follow-up|Withdrawal by Subject|1|||
129718522|NCT01642901|466930096|FG001|12-month Follow-up|Withdrawal by Subject|0|||
129718523|NCT01701362|466930098|FG000|Overall Study|Adverse events not related to study drug|1|||
129718524|NCT01701362|466930099|FG001|Overall Study|Adverse events not related to study drug|6|||
129718525|NCT01701362|466930098|FG000|Overall Study|Adverse events related to study drug|12|||
129718526|NCT01701362|466930099|FG001|Overall Study|Adverse events related to study drug|10|||
129718527|NCT01701362|466930098|FG000|Overall Study|Protocol Violation|5|||
129718528|NCT01701362|466930099|FG001|Overall Study|Protocol Violation|3|||
129718529|NCT01701362|466930098|FG000|Overall Study|No longer willing to participate|8|||
129718530|NCT01701362|466930099|FG001|Overall Study|No longer willing to participate|14|||
129718531|NCT01701362|466930098|FG000|Overall Study|Lost to Follow-up|6|||
129718532|NCT01701362|466930099|FG001|Overall Study|Lost to Follow-up|9|||
129718533|NCT01701362|466930098|FG000|Overall Study|Insufficient clinical response|6|||
129718534|NCT01701362|466930099|FG001|Overall Study|Insufficient clinical response|6|||
129718535|NCT01701362|466930098|FG000|Overall Study|Death|0|||
129718536|NCT01701362|466930099|FG001|Overall Study|Death|1|||
129718537|NCT01701362|466930098|FG000|Overall Study|Randomized but not treated|1|||
129718538|NCT01701362|466930099|FG001|Overall Study|Randomized but not treated|2|||
129718539|NCT01701362|466930098|FG000|Overall Study|Reasons other than those mentioned above|3|||
129718540|NCT01701362|466930099|FG001|Overall Study|Reasons other than those mentioned above|5|||
129718541|NCT00570778|466930100|FG000|Overall Study|Protocol deviation|2|||
129718542|NCT00570778|466930101|FG001|Overall Study|Protocol deviation|1|||
129718543|NCT00570778|466930102|FG002|Overall Study|Protocol deviation|2|||
129718544|NCT00570778|466930103|FG003|Overall Study|Protocol deviation|2|||
129718545|NCT00570778|466930100|FG000|Overall Study|Adverse Event|0|||
129718546|NCT00570778|466930101|FG001|Overall Study|Adverse Event|1|||
129718547|NCT00570778|466930102|FG002|Overall Study|Adverse Event|4|||
129718548|NCT00570778|466930103|FG003|Overall Study|Adverse Event|1|||
129718549|NCT00570778|466930100|FG000|Overall Study|Subject withdrew consent|0|||
129718550|NCT00570778|466930101|FG001|Overall Study|Subject withdrew consent|1|||
129718551|NCT00570778|466930102|FG002|Overall Study|Subject withdrew consent|0|||
129718552|NCT00570778|466930103|FG003|Overall Study|Subject withdrew consent|1|||
129718553|NCT00570778|466930100|FG000|Overall Study|Abnormal test procedure|1|||
129718554|NCT00570778|466930101|FG001|Overall Study|Abnormal test procedure|0|||
129718555|NCT00570778|466930102|FG002|Overall Study|Abnormal test procedure|0|||
129718556|NCT00570778|466930103|FG003|Overall Study|Abnormal test procedure|0|||
129718557|NCT00570778|466930100|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129718558|NCT00570778|466930101|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129718559|NCT00570778|466930102|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129718560|NCT00570778|466930103|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129718561|NCT00570778|466930100|FG000|Overall Study|Lost to Follow-up|0|||
129718562|NCT00570778|466930101|FG001|Overall Study|Lost to Follow-up|0|||
129718563|NCT00570778|466930102|FG002|Overall Study|Lost to Follow-up|1|||
129718564|NCT00570778|466930103|FG003|Overall Study|Lost to Follow-up|0|||
129718565|NCT00570778|466930100|FG000|Overall Study|Subject no longer requires study drug|0|||
129718566|NCT00570778|466930101|FG001|Overall Study|Subject no longer requires study drug|1|||
129718567|NCT00570778|466930102|FG002|Overall Study|Subject no longer requires study drug|0|||
129718568|NCT00570778|466930103|FG003|Overall Study|Subject no longer requires study drug|0|||
129718569|NCT00711594|466930104|FG000|Overall Study|Progressive disease|2|||
129718570|NCT00711594|466930105|FG001|Overall Study|Progressive disease|2|||
129718571|NCT00711594|466930106|FG002|Overall Study|Progressive disease|6|||
129718572|NCT00711594|466930107|FG003|Overall Study|Progressive disease|44|||
129718573|NCT00711594|466930104|FG000|Overall Study|Other Adverse Event|1|||
129718574|NCT00711594|466930105|FG001|Overall Study|Other Adverse Event|0|||
129718575|NCT00711594|466930106|FG002|Overall Study|Other Adverse Event|0|||
129718576|NCT00711594|466930107|FG003|Overall Study|Other Adverse Event|16|||
129718577|NCT00711594|466930104|FG000|Overall Study|Withdrawal by Subject|0|||
129718578|NCT00711594|466930105|FG001|Overall Study|Withdrawal by Subject|1|||
129718579|NCT00711594|466930106|FG002|Overall Study|Withdrawal by Subject|0|||
129718580|NCT00711594|466930107|FG003|Overall Study|Withdrawal by Subject|2|||
129718581|NCT00443872|466930108|FG000|Overall Study|Protocol Violation|7|||
129718582|NCT00443872|466930108|FG000|Overall Study|Lost to Follow-up|2|||
129718583|NCT00443872|466930108|FG000|Overall Study|Adverse Event|8|||
129718584|NCT00485758|466930114|FG000|Overall Study|Adverse Event|102|||
129718585|NCT00485758|466930115|FG001|Overall Study|Adverse Event|31|||
129718586|NCT00485758|466930114|FG000|Overall Study|Death|0|||
129718587|NCT00485758|466930115|FG001|Overall Study|Death|1|||
129718588|NCT00485758|466930114|FG000|Overall Study|Lost to Follow-up|5|||
129718589|NCT00485758|466930115|FG001|Overall Study|Lost to Follow-up|1|||
129718590|NCT00485758|466930114|FG000|Overall Study|Physician Decision|3|||
129718591|NCT00485758|466930115|FG001|Overall Study|Physician Decision|3|||
129718592|NCT00485758|466930114|FG000|Overall Study|Protocol Violation|11|||
129718593|NCT00485758|466930115|FG001|Overall Study|Protocol Violation|2|||
129718594|NCT00485758|466930114|FG000|Overall Study|Withdrawal by Subject|32|||
129718595|NCT00485758|466930115|FG001|Overall Study|Withdrawal by Subject|27|||
129718596|NCT00485758|466930114|FG000|Overall Study|Study Terminated by Sponsor|3|||
129718597|NCT00485758|466930115|FG001|Overall Study|Study Terminated by Sponsor|0|||
129718598|NCT04551963|466930116|FG000|Overall Study|Physician Decision|1|||
129718599|NCT04551963|466930117|FG001|Overall Study|Physician Decision|1|||
129718600|NCT04551963|466930116|FG000|Overall Study|Death|1|||
129718601|NCT04551963|466930117|FG001|Overall Study|Death|0|||
129718602|NCT03379259|466930118|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
129718603|NCT03379259|466930119|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
129718604|NCT03379259|466930120|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
129718605|NCT03379259|466930121|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
129718606|NCT03379259|466930122|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
129718607|NCT03379259|466930123|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
129718608|NCT03379259|466930118|FG000|Overall Study|Death|0|||
129718609|NCT03379259|466930119|FG001|Overall Study|Death|1|||
129718610|NCT03379259|466930120|FG002|Overall Study|Death|2|||
129718611|NCT03379259|466930121|FG003|Overall Study|Death|1|||
129718612|NCT03379259|466930122|FG004|Overall Study|Death|4|||
129718613|NCT03379259|466930123|FG005|Overall Study|Death|2|||
129718614|NCT03379259|466930118|FG000|Overall Study|Withdrawal by Subject|0|||
129718615|NCT03379259|466930119|FG001|Overall Study|Withdrawal by Subject|0|||
129718616|NCT03379259|466930120|FG002|Overall Study|Withdrawal by Subject|1|||
129718617|NCT03379259|466930121|FG003|Overall Study|Withdrawal by Subject|0|||
129718618|NCT03379259|466930122|FG004|Overall Study|Withdrawal by Subject|2|||
129718619|NCT03379259|466930123|FG005|Overall Study|Withdrawal by Subject|0|||
129718620|NCT03379259|466930118|FG000|Overall Study|Study terminated by sponsor|0|||
129718621|NCT03379259|466930119|FG001|Overall Study|Study terminated by sponsor|0|||
129718622|NCT03379259|466930120|FG002|Overall Study|Study terminated by sponsor|0|||
129718623|NCT03379259|466930121|FG003|Overall Study|Study terminated by sponsor|1|||
129718624|NCT03379259|466930122|FG004|Overall Study|Study terminated by sponsor|1|||
129718625|NCT03379259|466930123|FG005|Overall Study|Study terminated by sponsor|4|||
129718626|NCT03379259|466930118|FG000|Overall Study|Disease progression|0|||
129718627|NCT03379259|466930119|FG001|Overall Study|Disease progression|0|||
129718628|NCT03379259|466930120|FG002|Overall Study|Disease progression|0|||
129718629|NCT03379259|466930121|FG003|Overall Study|Disease progression|1|||
129718630|NCT03379259|466930122|FG004|Overall Study|Disease progression|0|||
129718631|NCT03379259|466930123|FG005|Overall Study|Disease progression|1|||
129718632|NCT03379259|466930118|FG000|Overall Study|Lost to Follow-up|0|||
129718633|NCT03379259|466930119|FG001|Overall Study|Lost to Follow-up|0|||
129718634|NCT03379259|466930120|FG002|Overall Study|Lost to Follow-up|0|||
129718635|NCT03379259|466930121|FG003|Overall Study|Lost to Follow-up|0|||
129718636|NCT03379259|466930122|FG004|Overall Study|Lost to Follow-up|1|||
129718637|NCT03379259|466930123|FG005|Overall Study|Lost to Follow-up|0|||
129718638|NCT03379259|466930118|FG000|Overall Study|Deteriorating condition|0|||
129718639|NCT03379259|466930119|FG001|Overall Study|Deteriorating condition|0|||
129718640|NCT03379259|466930120|FG002|Overall Study|Deteriorating condition|0|||
129718641|NCT03379259|466930121|FG003|Overall Study|Deteriorating condition|0|||
129803239|NCT00464269|467247545|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129803240|NCT00464269|467247546|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129803241|NCT00464269|467247547|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
129803242|NCT00464269|467247548|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129803243|NCT05055128|467247549|FG000|Overall Study|Adverse Event|0|||
129803244|NCT05055128|467247550|FG001|Overall Study|Adverse Event|0|||
129803245|NCT05055128|467247551|FG002|Overall Study|Adverse Event|0|||
129803246|NCT05055128|467247552|FG003|Overall Study|Adverse Event|1|||
129718642|NCT03379259|466930122|FG004|Overall Study|Deteriorating condition|1|||
129718643|NCT03379259|466930123|FG005|Overall Study|Deteriorating condition|0|||
129718644|NCT00700622|466930124|FG000|Overall Study|Adverse Event|4|||
129718645|NCT00700622|466930125|FG001|Overall Study|Adverse Event|0|||
129718646|NCT00700622|466930124|FG000|Overall Study|Lost to Follow-up|0|||
129718647|NCT00700622|466930125|FG001|Overall Study|Lost to Follow-up|1|||
129718648|NCT00700622|466930124|FG000|Overall Study|Physician Decision|2|||
129718649|NCT00700622|466930125|FG001|Overall Study|Physician Decision|1|||
129718650|NCT00700622|466930124|FG000|Overall Study|Protocol Violation|0|||
129718651|NCT00700622|466930125|FG001|Overall Study|Protocol Violation|1|||
129718652|NCT00700622|466930124|FG000|Overall Study|Withdrawal by Subject|4|||
129718653|NCT00700622|466930125|FG001|Overall Study|Withdrawal by Subject|1|||
129718654|NCT00700622|466930124|FG000|Overall Study|Other|3|||
129718655|NCT00700622|466930125|FG001|Overall Study|Other|1|||
129718656|NCT00383331|466930126|FG000|Overall Study|Protocol Violation|0|||
129718657|NCT00383331|466930127|FG001|Overall Study|Protocol Violation|1|||
129718658|NCT00375427|466930128|FG000|Overall Study|Adverse Event|21|||
129718659|NCT00375427|466930129|FG001|Overall Study|Adverse Event|27|||
129718660|NCT00375427|466930128|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129718661|NCT00375427|466930129|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129718662|NCT00375427|466930128|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129718663|NCT00375427|466930129|FG001|Overall Study|Abnormal laboratory value(s)|2|||
129718664|NCT00375427|466930128|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129718665|NCT00375427|466930129|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129718666|NCT00375427|466930128|FG000|Overall Study|Patient no longer requires study drug|3|||
129718667|NCT00375427|466930129|FG001|Overall Study|Patient no longer requires study drug|7|||
129718668|NCT00375427|466930128|FG000|Overall Study|Protocol Violation|10|||
129718669|NCT00375427|466930129|FG001|Overall Study|Protocol Violation|8|||
129718670|NCT00375427|466930128|FG000|Overall Study|Withdrawal by Subject|9|||
129718671|NCT00375427|466930129|FG001|Overall Study|Withdrawal by Subject|13|||
129718672|NCT00375427|466930128|FG000|Overall Study|Lost to Follow-up|1|||
129718673|NCT00375427|466930129|FG001|Overall Study|Lost to Follow-up|1|||
129718674|NCT00375427|466930128|FG000|Overall Study|Administrative reasons|0|||
129803247|NCT05055128|467247553|FG004|Overall Study|Adverse Event|1|||
129803248|NCT05055128|467247549|FG000|Overall Study|Protocol Violation|0|||
129803249|NCT05055128|467247550|FG001|Overall Study|Protocol Violation|0|||
129803250|NCT05055128|467247551|FG002|Overall Study|Protocol Violation|0|||
129803251|NCT05055128|467247552|FG003|Overall Study|Protocol Violation|1|||
129803252|NCT05055128|467247553|FG004|Overall Study|Protocol Violation|0|||
129803253|NCT05055128|467247549|FG000|Overall Study|Withdrawal by Subject|5|||
129718675|NCT00375427|466930129|FG001|Overall Study|Administrative reasons|1|||
129718676|NCT00375427|466930128|FG000|Overall Study|Death|11|||
129718677|NCT00375427|466930129|FG001|Overall Study|Death|10|||
129718678|NCT03850093|466930130|FG000|Overall Study|Withdrawal by Subject|1|||
129718679|NCT03850093|466930131|FG001|Overall Study|Withdrawal by Subject|0|||
129718680|NCT03850093|466930132|FG002|Overall Study|Withdrawal by Subject|2|||
129718681|NCT03226249|466930138|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
129718682|NCT03226249|466930138|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
129718683|NCT03226249|466930138|FG000|Survival Follow-up|Patients still in follow-up.|30|||
129718684|NCT01532921|466930139|FG000|Overall Study|Death|3|||
129803254|NCT05055128|467247550|FG001|Overall Study|Withdrawal by Subject|2|||
129803255|NCT05055128|467247551|FG002|Overall Study|Withdrawal by Subject|2|||
129803256|NCT05055128|467247552|FG003|Overall Study|Withdrawal by Subject|4|||
129891512|NCT03019458|467561152|FG000|Overall Study|Death|0|||
129718685|NCT01532921|466930139|FG000|Overall Study|Withdrawal by Subject|2|||
129718686|NCT01532921|466930139|FG000|Overall Study|Lost to Follow-up|3|||
129718687|NCT01532921|466930139|FG000|Overall Study|Physician Decision|7|||
129803257|NCT05055128|467247553|FG004|Overall Study|Withdrawal by Subject|2|||
129803258|NCT05055128|467247549|FG000|Overall Study|Randomized By Mistake|0|||
129718688|NCT01532921|466930139|FG000|Overall Study|Device was explanted during procedure|1|||
129718689|NCT00070109|466930140|FG000|Overall Study|Death|1|||
129718690|NCT00070109|466930141|FG001|Overall Study|Death|1|||
129718691|NCT00070109|466930142|FG002|Overall Study|Death|0|||
129718692|NCT00070109|466930143|FG003|Overall Study|Death|0|||
129718693|NCT00070109|466930144|FG004|Overall Study|Death|1|||
129718694|NCT00070109|466930140|FG000|Overall Study|Lack of Efficacy|6|||
129718695|NCT00070109|466930141|FG001|Overall Study|Lack of Efficacy|4|||
129803259|NCT05055128|467247550|FG001|Overall Study|Randomized By Mistake|1|||
129891513|NCT03019458|467561153|FG001|Overall Study|Death|1|||
129718696|NCT00070109|466930142|FG002|Overall Study|Lack of Efficacy|5|||
129718697|NCT00070109|466930143|FG003|Overall Study|Lack of Efficacy|15|||
129718698|NCT00070109|466930144|FG004|Overall Study|Lack of Efficacy|5|||
129718699|NCT00070109|466930140|FG000|Overall Study|Physician Decision|1|||
129718700|NCT00070109|466930141|FG001|Overall Study|Physician Decision|0|||
129718701|NCT00070109|466930142|FG002|Overall Study|Physician Decision|0|||
129718702|NCT00070109|466930143|FG003|Overall Study|Physician Decision|0|||
129718703|NCT00070109|466930144|FG004|Overall Study|Physician Decision|0|||
129718704|NCT00070109|466930140|FG000|Overall Study|Withdrawal by Subject|0|||
129718705|NCT00070109|466930141|FG001|Overall Study|Withdrawal by Subject|1|||
129718706|NCT00070109|466930142|FG002|Overall Study|Withdrawal by Subject|1|||
129718707|NCT00070109|466930143|FG003|Overall Study|Withdrawal by Subject|0|||
129718708|NCT00070109|466930144|FG004|Overall Study|Withdrawal by Subject|0|||
129718709|NCT00070109|466930140|FG000|Overall Study|Adverse Event|0|||
129718710|NCT00070109|466930141|FG001|Overall Study|Adverse Event|0|||
129718711|NCT00070109|466930142|FG002|Overall Study|Adverse Event|2|||
129718712|NCT00070109|466930143|FG003|Overall Study|Adverse Event|4|||
129718713|NCT00070109|466930144|FG004|Overall Study|Adverse Event|2|||
129718714|NCT00070109|466930140|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
129718715|NCT00070109|466930141|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
129718716|NCT00070109|466930142|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
129718717|NCT00070109|466930143|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
129718718|NCT00070109|466930144|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
129718719|NCT00624468|466930147|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
129718720|NCT00624468|466930148|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
129718721|NCT00624468|466930149|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
129718722|NCT00624468|466930150|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
129718723|NCT00624468|466930147|FG000|Double-blind Period|Withdrew Prematurely|1|||
129718724|NCT00624468|466930148|FG001|Double-blind Period|Withdrew Prematurely|1|||
129718725|NCT00624468|466930149|FG002|Double-blind Period|Withdrew Prematurely|0|||
129718726|NCT00624468|466930150|FG003|Double-blind Period|Withdrew Prematurely|0|||
129718727|NCT00624468|466930147|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
129718728|NCT00624468|466930148|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
129718729|NCT00624468|466930149|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
129718730|NCT00624468|466930150|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
129718731|NCT00624468|466930147|FG000|Safety Follow-up (SFU) Period|Other|0|||
129718732|NCT00624468|466930148|FG001|Safety Follow-up (SFU) Period|Other|0|||
129718733|NCT00624468|466930149|FG002|Safety Follow-up (SFU) Period|Other|1|||
129718734|NCT00624468|466930150|FG003|Safety Follow-up (SFU) Period|Other|1|||
129444335|NCT02616614|465927301|FG002|Overall Study|Physician Decision|0|||
129718735|NCT02550288|466930151|FG000|Overall Study|Adverse Event|0|||
129718736|NCT02550288|466930152|FG001|Overall Study|Adverse Event|1|||
129718737|NCT02550288|466930153|FG002|Overall Study|Adverse Event|0|||
129718738|NCT02550288|466930154|FG003|Overall Study|Adverse Event|0|||
129718739|NCT02550288|466930155|FG004|Overall Study|Adverse Event|0|||
129718740|NCT02550288|466930151|FG000|Overall Study|Physician Decision|0|||
129718741|NCT02550288|466930152|FG001|Overall Study|Physician Decision|0|||
129718742|NCT02550288|466930153|FG002|Overall Study|Physician Decision|0|||
129718743|NCT02550288|466930154|FG003|Overall Study|Physician Decision|1|||
129718744|NCT02550288|466930155|FG004|Overall Study|Physician Decision|0|||
129718745|NCT02550288|466930151|FG000|Overall Study|Protocol Violation|2|||
129718746|NCT02550288|466930152|FG001|Overall Study|Protocol Violation|2|||
129718747|NCT02550288|466930153|FG002|Overall Study|Protocol Violation|1|||
129718748|NCT02550288|466930154|FG003|Overall Study|Protocol Violation|0|||
129718749|NCT02550288|466930155|FG004|Overall Study|Protocol Violation|3|||
129718750|NCT02550288|466930151|FG000|Overall Study|Participant moved|0|||
129718751|NCT02550288|466930152|FG001|Overall Study|Participant moved|0|||
129718752|NCT02550288|466930153|FG002|Overall Study|Participant moved|0|||
129718753|NCT02550288|466930154|FG003|Overall Study|Participant moved|1|||
129718754|NCT02550288|466930155|FG004|Overall Study|Participant moved|0|||
129718755|NCT02550288|466930151|FG000|Overall Study|Withdrawal by Subject|0|||
129718756|NCT02550288|466930152|FG001|Overall Study|Withdrawal by Subject|0|||
129718757|NCT02550288|466930153|FG002|Overall Study|Withdrawal by Subject|0|||
129718758|NCT02550288|466930154|FG003|Overall Study|Withdrawal by Subject|1|||
129718759|NCT02550288|466930155|FG004|Overall Study|Withdrawal by Subject|0|||
129718760|NCT00803361|466930157|FG000|Overall Study|Adverse Event|13|||
129718761|NCT00803361|466930158|FG001|Overall Study|Adverse Event|3|||
129718762|NCT00803361|466930157|FG000|Overall Study|Lack of Efficacy|4|||
129718763|NCT00803361|466930158|FG001|Overall Study|Lack of Efficacy|13|||
129718764|NCT00803361|466930157|FG000|Overall Study|Lost to Follow-up|1|||
129718765|NCT00803361|466930158|FG001|Overall Study|Lost to Follow-up|2|||
129718766|NCT00803361|466930157|FG000|Overall Study|Physician Decision|1|||
129718767|NCT00803361|466930158|FG001|Overall Study|Physician Decision|0|||
129718768|NCT00803361|466930157|FG000|Overall Study|Protocol Violation|2|||
129718769|NCT00803361|466930158|FG001|Overall Study|Protocol Violation|4|||
129718770|NCT00803361|466930157|FG000|Overall Study|Withdrawal by Subject|5|||
129718771|NCT00803361|466930158|FG001|Overall Study|Withdrawal by Subject|6|||
129718772|NCT03629223|466930159|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
129718773|NCT03629223|466930160|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
129718774|NCT03629223|466930161|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
129718775|NCT03629223|466930162|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
129718776|NCT03629223|466930163|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
129718777|NCT03629223|466930164|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
129718778|NCT03629223|466930159|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129718779|NCT03629223|466930160|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129718780|NCT03629223|466930161|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129718781|NCT03629223|466930162|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
129718782|NCT03629223|466930163|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129718783|NCT03629223|466930164|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
129718784|NCT03629223|466930159|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129718785|NCT03629223|466930160|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
129718786|NCT03629223|466930161|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129718787|NCT03629223|466930162|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129718788|NCT03629223|466930163|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129718789|NCT03629223|466930164|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
129718790|NCT03629223|466930159|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129718791|NCT03629223|466930160|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
129718792|NCT03629223|466930161|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129718793|NCT03629223|466930162|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129718794|NCT03629223|466930163|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129718795|NCT03629223|466930164|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
129718796|NCT03629223|466930159|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
129718797|NCT03629223|466930160|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129803260|NCT05055128|467247551|FG002|Overall Study|Randomized By Mistake|0|||
129718798|NCT03629223|466930161|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129718799|NCT03629223|466930162|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129803261|NCT05055128|467247552|FG003|Overall Study|Randomized By Mistake|0|||
129803262|NCT05055128|467247553|FG004|Overall Study|Randomized By Mistake|0|||
129718800|NCT03629223|466930163|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129718801|NCT03629223|466930164|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
129718802|NCT01534351|466930165|FG000|Overall Study|Study Terminated Early|1|||
129718803|NCT01534351|466930166|FG001|Overall Study|Study Terminated Early|0|||
129718804|NCT01534351|466930167|FG002|Overall Study|Study Terminated Early|0|||
129718805|NCT02702609|466930168|FG000|Overall Study|Lost to Follow-up|8|||
129718806|NCT02702609|466930169|FG001|Overall Study|Lost to Follow-up|4|||
129803263|NCT05055128|467247549|FG000|Overall Study|Other|1|||
129444336|NCT02616614|465927299|FG000|Overall Study|Adverse Event|1|||
129444337|NCT02616614|465927300|FG001|Overall Study|Adverse Event|4|||
129444338|NCT02616614|465927301|FG002|Overall Study|Adverse Event|1|||
129444339|NCT02616614|465927299|FG000|Overall Study|Protocol Violation|0|||
129444340|NCT02616614|465927300|FG001|Overall Study|Protocol Violation|3|||
129444341|NCT02616614|465927301|FG002|Overall Study|Protocol Violation|1|||
129444342|NCT02616614|465927299|FG000|Overall Study|Prohibited Medication|12|||
129444343|NCT02616614|465927300|FG001|Overall Study|Prohibited Medication|9|||
129444344|NCT02616614|465927301|FG002|Overall Study|Prohibited Medication|5|||
129444345|NCT02616614|465927299|FG000|Overall Study|More than 3 applications missed|6|||
129444346|NCT02616614|465927300|FG001|Overall Study|More than 3 applications missed|8|||
129444347|NCT02616614|465927301|FG002|Overall Study|More than 3 applications missed|1|||
129444348|NCT02616614|465927299|FG000|Overall Study|Lost to Follow-up|31|||
129444349|NCT02616614|465927300|FG001|Overall Study|Lost to Follow-up|28|||
129444350|NCT02616614|465927301|FG002|Overall Study|Lost to Follow-up|13|||
129444351|NCT02616614|465927299|FG000|Overall Study|Pregnancy|2|||
129444352|NCT02616614|465927300|FG001|Overall Study|Pregnancy|0|||
129444353|NCT02616614|465927301|FG002|Overall Study|Pregnancy|1|||
129444354|NCT02616614|465927299|FG000|Overall Study|Other|1|||
129718807|NCT02702609|466930168|FG000|Overall Study|Physician Decision|1|||
129718808|NCT02702609|466930169|FG001|Overall Study|Physician Decision|0|||
129718809|NCT02674464|466930170|FG000|Overall Study|Death|10|||
129718810|NCT02674464|466930171|FG001|Overall Study|Death|21|||
129718811|NCT02674464|466930170|FG000|Overall Study|Withdrawal by Subject|24|||
129718812|NCT02674464|466930171|FG001|Overall Study|Withdrawal by Subject|44|||
129718813|NCT02674464|466930170|FG000|Overall Study|Lost to Follow-up|97|||
129718814|NCT02674464|466930171|FG001|Overall Study|Lost to Follow-up|92|||
129718815|NCT02674464|466930170|FG000|Overall Study|Outside survey window|6|||
129718816|NCT02674464|466930171|FG001|Overall Study|Outside survey window|3|||
129718817|NCT00783835|466930172|FG000|Overall Study|Adverse Event|3|||
129718818|NCT00783835|466930172|FG000|Overall Study|Medical Criteria|1|||
129718819|NCT00783835|466930172|FG000|Overall Study|Withdrawal by Subject|2|||
129718820|NCT00783835|466930172|FG000|Overall Study|Lost to Follow-up|1|||
129718821|NCT00783835|466930172|FG000|Overall Study|Participant not Adherent|3|||
129718822|NCT03835481|466930173|FG000|Double-blind Period|Other not stated below|0|||
129718823|NCT03835481|466930174|FG001|Double-blind Period|Other not stated below|0|||
129718824|NCT03835481|466930175|FG002|Double-blind Period|Other not stated below|0|||
129718825|NCT03835481|466930176|FG003|Double-blind Period|Other not stated below|1|||
129718826|NCT03835481|466930177|FG004|Double-blind Period|Other not stated below|1|||
129718827|NCT03835481|466930173|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
129718828|NCT03835481|466930174|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
129718829|NCT03835481|466930175|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
129718830|NCT03835481|466930176|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
129718831|NCT03835481|466930177|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
129718832|NCT03835481|466930173|FG000|Double-blind Period|Withdrawal by Subject|0|||
129718833|NCT03835481|466930174|FG001|Double-blind Period|Withdrawal by Subject|0|||
129718834|NCT03835481|466930175|FG002|Double-blind Period|Withdrawal by Subject|1|||
129718835|NCT03835481|466930176|FG003|Double-blind Period|Withdrawal by Subject|0|||
129718836|NCT03835481|466930177|FG004|Double-blind Period|Withdrawal by Subject|5|||
129718837|NCT03835481|466930173|FG000|Double-blind Period|Lost to Follow-up|0|||
129718838|NCT03835481|466930174|FG001|Double-blind Period|Lost to Follow-up|0|||
129718839|NCT03835481|466930175|FG002|Double-blind Period|Lost to Follow-up|0|||
129718840|NCT03835481|466930176|FG003|Double-blind Period|Lost to Follow-up|1|||
129718841|NCT03835481|466930177|FG004|Double-blind Period|Lost to Follow-up|0|||
129803264|NCT05055128|467247550|FG001|Overall Study|Other|0|||
129803265|NCT05055128|467247551|FG002|Overall Study|Other|0|||
129803266|NCT05055128|467247552|FG003|Overall Study|Other|0|||
129803267|NCT05055128|467247553|FG004|Overall Study|Other|0|||
129803268|NCT02149875|467247554|FG000|Overall Study|Lost to Follow-up|3|||
129803269|NCT02149875|467247555|FG001|Overall Study|Lost to Follow-up|4|||
129803270|NCT02149875|467247556|FG002|Overall Study|Lost to Follow-up|5|||
129803271|NCT02149875|467247554|FG000|Overall Study|Withdrawal by Subject|3|||
129803272|NCT02149875|467247555|FG001|Overall Study|Withdrawal by Subject|2|||
129718842|NCT03835481|466930173|FG000|Double-blind Period|Protocol Violation|0|||
129718843|NCT03835481|466930174|FG001|Double-blind Period|Protocol Violation|2|||
129718844|NCT03835481|466930175|FG002|Double-blind Period|Protocol Violation|0|||
129718845|NCT03835481|466930176|FG003|Double-blind Period|Protocol Violation|1|||
129803273|NCT02149875|467247556|FG002|Overall Study|Withdrawal by Subject|2|||
129444355|NCT02616614|465927300|FG001|Overall Study|Other|2|||
129444356|NCT02616614|465927301|FG002|Overall Study|Other|1|||
129444357|NCT02315898|465927302|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
129718846|NCT03835481|466930177|FG004|Double-blind Period|Protocol Violation|0|||
129718847|NCT03835481|466930173|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
129718848|NCT03835481|466930174|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
129718849|NCT03835481|466930175|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
129803274|NCT02149875|467247554|FG000|Overall Study|Physician Decision|1|||
129718850|NCT03835481|466930176|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
129718851|NCT03835481|466930177|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
129718852|NCT03835481|466930173|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
129718853|NCT03835481|466930174|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
129718854|NCT03835481|466930175|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
129718855|NCT03835481|466930176|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
129718856|NCT03835481|466930177|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
129718857|NCT03835481|466930173|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
129718858|NCT03835481|466930174|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
129718859|NCT03835481|466930175|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
129718860|NCT03835481|466930176|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
129718861|NCT03835481|466930177|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
129718862|NCT03835481|466930173|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
129718863|NCT03835481|466930174|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
129718864|NCT03835481|466930175|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
129718865|NCT03835481|466930176|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
129718866|NCT03835481|466930177|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
129718867|NCT03835481|466930173|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129718868|NCT03835481|466930174|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129718869|NCT03835481|466930175|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129718870|NCT03835481|466930176|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
129718871|NCT03835481|466930177|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
129718872|NCT03835481|466930173|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
129718873|NCT03835481|466930174|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
129718874|NCT03835481|466930175|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
129718875|NCT03835481|466930176|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
129718876|NCT03835481|466930177|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
129718877|NCT00255723|466930180|FG000|Overall Study|Adverse Event|1|||
129718878|NCT00255723|466930181|FG001|Overall Study|Adverse Event|1|||
129718879|NCT00255723|466930180|FG000|Overall Study|Death|0|||
129718880|NCT00255723|466930181|FG001|Overall Study|Death|1|||
129718881|NCT00255723|466930180|FG000|Overall Study|Response Data Not Available|1|||
129718882|NCT00255723|466930181|FG001|Overall Study|Response Data Not Available|0|||
129718883|NCT00191945|466930182|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
129718884|NCT00191945|466930183|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
129718885|NCT00191945|466930182|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
129718886|NCT00191945|466930183|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
129718887|NCT00191945|466930182|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
129718888|NCT00191945|466930183|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
129718889|NCT00191945|466930182|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
129718890|NCT00191945|466930183|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
129718891|NCT01169701|466930197|FG000|Overall Study|Lost to Follow-up|1|||
129718892|NCT01169701|466930198|FG001|Overall Study|Lost to Follow-up|1|||
129718893|NCT01169701|466930197|FG000|Overall Study|Withdrawal by Subject|1|||
129718894|NCT01169701|466930198|FG001|Overall Study|Withdrawal by Subject|3|||
129718895|NCT01169701|466930197|FG000|Overall Study|Adverse Event|1|||
129718896|NCT01169701|466930198|FG001|Overall Study|Adverse Event|2|||
129718897|NCT01169701|466930197|FG000|Overall Study|Exclusion criteria|2|||
129718898|NCT01169701|466930198|FG001|Overall Study|Exclusion criteria|0|||
129718899|NCT01169701|466930197|FG000|Overall Study|Death|0|||
129718900|NCT01169701|466930198|FG001|Overall Study|Death|1|||
129718901|NCT01169701|466930197|FG000|Overall Study|Administrative problems|0|||
129718902|NCT01169701|466930198|FG001|Overall Study|Administrative problems|1|||
129718903|NCT01169701|466930197|FG000|Overall Study|Serious adverse event|0|||
129718904|NCT01169701|466930198|FG001|Overall Study|Serious adverse event|1|||
129718905|NCT01169701|466930197|FG000|Overall Study|Sponsor decision|0|||
129718906|NCT01169701|466930198|FG001|Overall Study|Sponsor decision|1|||
129718907|NCT00564902|466930203|FG000|Overall Study|Withdrawal by Subject|0|||
129718908|NCT00564902|466930204|FG001|Overall Study|Withdrawal by Subject|3|||
129718909|NCT00564902|466930205|FG002|Overall Study|Withdrawal by Subject|4|||
129718910|NCT00564902|466930203|FG000|Overall Study|Death|1|||
129718911|NCT00564902|466930204|FG001|Overall Study|Death|1|||
129718912|NCT00564902|466930205|FG002|Overall Study|Death|0|||
129718913|NCT03583359|466930208|FG000|Overall Study|Withdrawal by Subject|15|||
129718914|NCT03583359|466930209|FG001|Overall Study|Withdrawal by Subject|6|||
129718915|NCT03583359|466930208|FG000|Overall Study|Lost to Follow-up|12|||
129718916|NCT03583359|466930209|FG001|Overall Study|Lost to Follow-up|3|||
129718917|NCT03583359|466930208|FG000|Overall Study|Adverse Event|0|||
129718918|NCT03583359|466930209|FG001|Overall Study|Adverse Event|1|||
129718919|NCT03583359|466930208|FG000|Overall Study|Protocol Violation|0|||
129718920|NCT03583359|466930209|FG001|Overall Study|Protocol Violation|1|||
129718921|NCT03583359|466930208|FG000|Overall Study|Other|2|||
129718922|NCT03583359|466930209|FG001|Overall Study|Other|1|||
129718923|NCT00375505|466930210|FG000|Overall Study|Adverse Event|1|||
129718924|NCT00375505|466930211|FG001|Overall Study|Adverse Event|2|||
129718925|NCT01831466|466930212|FG000|Overall Study|Protocol Violation|1|||
129718926|NCT01831466|466930213|FG001|Overall Study|Protocol Violation|1|||
129718927|NCT01831466|466930214|FG002|Overall Study|Protocol Violation|2|||
129718928|NCT01831466|466930215|FG003|Overall Study|Protocol Violation|0|||
129718929|NCT01831466|466930216|FG004|Overall Study|Protocol Violation|0|||
129718930|NCT01831466|466930217|FG005|Overall Study|Protocol Violation|1|||
129718931|NCT01831466|466930218|FG006|Overall Study|Protocol Violation|0|||
129718932|NCT01831466|466930219|FG007|Overall Study|Protocol Violation|0|||
129718933|NCT01831466|466930220|FG008|Overall Study|Protocol Violation|0|||
129718934|NCT01831466|466930221|FG009|Overall Study|Protocol Violation|0|||
129718935|NCT01831466|466930222|FG010|Overall Study|Protocol Violation|0|||
129718936|NCT01831466|466930223|FG011|Overall Study|Protocol Violation|0|||
129718937|NCT01831466|466930212|FG000|Overall Study|Other|2|||
129718938|NCT01831466|466930213|FG001|Overall Study|Other|3|||
129718939|NCT01831466|466930214|FG002|Overall Study|Other|2|||
129718940|NCT01831466|466930215|FG003|Overall Study|Other|2|||
129718941|NCT01831466|466930216|FG004|Overall Study|Other|2|||
129718942|NCT01831466|466930217|FG005|Overall Study|Other|1|||
129718943|NCT01831466|466930218|FG006|Overall Study|Other|0|||
129718944|NCT01831466|466930219|FG007|Overall Study|Other|0|||
129718945|NCT01831466|466930220|FG008|Overall Study|Other|0|||
129718946|NCT01831466|466930221|FG009|Overall Study|Other|0|||
129718947|NCT01831466|466930222|FG010|Overall Study|Other|0|||
129718948|NCT01831466|466930223|FG011|Overall Study|Other|0|||
129718949|NCT01831466|466930212|FG000|Overall Study|Non-compliance with study treatment|2|||
129718950|NCT01831466|466930213|FG001|Overall Study|Non-compliance with study treatment|1|||
129718951|NCT01831466|466930214|FG002|Overall Study|Non-compliance with study treatment|1|||
129718952|NCT01831466|466930215|FG003|Overall Study|Non-compliance with study treatment|0|||
129718953|NCT01831466|466930216|FG004|Overall Study|Non-compliance with study treatment|0|||
129718954|NCT01831466|466930217|FG005|Overall Study|Non-compliance with study treatment|1|||
129803275|NCT02149875|467247555|FG001|Overall Study|Physician Decision|2|||
129803276|NCT02149875|467247556|FG002|Overall Study|Physician Decision|2|||
129803277|NCT01385371|467247557|FG000|Overall Study|Adverse Event|54|||
129803278|NCT01385371|467247558|FG001|Overall Study|Adverse Event|19|||
129803279|NCT01385371|467247557|FG000|Overall Study|Lost to Follow-up|16|||
129803280|NCT01385371|467247558|FG001|Overall Study|Lost to Follow-up|16|||
129803281|NCT01385371|467247557|FG000|Overall Study|Withdrawal by Subject|52|||
129803282|NCT01385371|467247558|FG001|Overall Study|Withdrawal by Subject|39|||
129803283|NCT01385371|467247557|FG000|Overall Study|Protocol Violation|25|||
129803284|NCT01385371|467247558|FG001|Overall Study|Protocol Violation|21|||
129803285|NCT01385371|467247557|FG000|Overall Study|Administrative|2|||
129444358|NCT02315898|465927303|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
129718955|NCT01831466|466930218|FG006|Overall Study|Non-compliance with study treatment|0|||
129803286|NCT01385371|467247558|FG001|Overall Study|Administrative|2|||
129444359|NCT02315898|465927304|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
129718956|NCT01831466|466930219|FG007|Overall Study|Non-compliance with study treatment|0|||
129718957|NCT01831466|466930220|FG008|Overall Study|Non-compliance with study treatment|0|||
129718958|NCT01831466|466930221|FG009|Overall Study|Non-compliance with study treatment|0|||
129718959|NCT01831466|466930222|FG010|Overall Study|Non-compliance with study treatment|0|||
129718960|NCT01831466|466930223|FG011|Overall Study|Non-compliance with study treatment|0|||
129718961|NCT01831466|466930212|FG000|Overall Study|Death|0|||
129718962|NCT01831466|466930213|FG001|Overall Study|Death|1|||
129718963|NCT01831466|466930214|FG002|Overall Study|Death|0|||
129718964|NCT01831466|466930215|FG003|Overall Study|Death|0|||
129718965|NCT01831466|466930216|FG004|Overall Study|Death|0|||
129718966|NCT01831466|466930217|FG005|Overall Study|Death|0|||
129718967|NCT01831466|466930218|FG006|Overall Study|Death|0|||
129718968|NCT01831466|466930219|FG007|Overall Study|Death|0|||
129718969|NCT01831466|466930220|FG008|Overall Study|Death|0|||
129718970|NCT01831466|466930221|FG009|Overall Study|Death|0|||
129803287|NCT02478372|467247559|FG000|Overall Study|Protocol Violation|12|||
129803288|NCT02478372|467247560|FG001|Overall Study|Protocol Violation|8|||
129803289|NCT02478372|467247559|FG000|Overall Study|Lost to Follow-up|1|||
129803290|NCT02478372|467247560|FG001|Overall Study|Lost to Follow-up|4|||
129803291|NCT02478372|467247559|FG000|Overall Study|Death|0|||
129803292|NCT02478372|467247560|FG001|Overall Study|Death|2|||
129803293|NCT02955797|467247563|FG000|Overall Study|Protocol Violation|1|||
129444360|NCT02315898|465927305|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
129444361|NCT02445755|465927306|FG000|Overall Study|Withdrawal by Subject|2|||
129444362|NCT02445755|465927306|FG000|Overall Study|Protocol Violation|6|||
129444363|NCT02445755|465927306|FG000|Overall Study|Screen Failure|5|||
129444364|NCT03239483|465927307|FG000|Overall Study|Lost to Follow-up|1|||
129444365|NCT03239483|465927308|FG001|Overall Study|Lost to Follow-up|0|||
129444366|NCT03239483|465927307|FG000|Overall Study|Withdrawal by Subject|1|||
129444367|NCT03239483|465927308|FG001|Overall Study|Withdrawal by Subject|0|||
129444368|NCT05352048|465927309|FG000|Overall Study|Lost to Follow-up|1|||
129444369|NCT05352048|465927309|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
129444370|NCT01296035|465927324|FG000|Overall Study|Withdrawal by Subject|1|||
129718971|NCT01831466|466930222|FG010|Overall Study|Death|0|||
129718972|NCT01831466|466930223|FG011|Overall Study|Death|0|||
129718973|NCT01831466|466930212|FG000|Overall Study|Withdrawal by Subject|6|||
129718974|NCT01831466|466930213|FG001|Overall Study|Withdrawal by Subject|3|||
129718975|NCT01831466|466930214|FG002|Overall Study|Withdrawal by Subject|3|||
129718976|NCT01831466|466930215|FG003|Overall Study|Withdrawal by Subject|3|||
129718977|NCT01831466|466930216|FG004|Overall Study|Withdrawal by Subject|3|||
129718978|NCT01831466|466930217|FG005|Overall Study|Withdrawal by Subject|5|||
129718979|NCT01831466|466930218|FG006|Overall Study|Withdrawal by Subject|0|||
129718980|NCT01831466|466930219|FG007|Overall Study|Withdrawal by Subject|0|||
129718981|NCT01831466|466930220|FG008|Overall Study|Withdrawal by Subject|0|||
129718982|NCT01831466|466930221|FG009|Overall Study|Withdrawal by Subject|1|||
129718983|NCT01831466|466930222|FG010|Overall Study|Withdrawal by Subject|0|||
129718984|NCT01831466|466930223|FG011|Overall Study|Withdrawal by Subject|1|||
129718985|NCT01831466|466930212|FG000|Overall Study|Lost to Follow-up|0|||
129718986|NCT01831466|466930213|FG001|Overall Study|Lost to Follow-up|1|||
129718987|NCT01831466|466930214|FG002|Overall Study|Lost to Follow-up|4|||
129718988|NCT01831466|466930215|FG003|Overall Study|Lost to Follow-up|2|||
129718989|NCT01831466|466930216|FG004|Overall Study|Lost to Follow-up|0|||
129718990|NCT01831466|466930217|FG005|Overall Study|Lost to Follow-up|3|||
129718991|NCT01831466|466930218|FG006|Overall Study|Lost to Follow-up|0|||
129718992|NCT01831466|466930219|FG007|Overall Study|Lost to Follow-up|0|||
129718993|NCT01831466|466930220|FG008|Overall Study|Lost to Follow-up|0|||
129718994|NCT01831466|466930221|FG009|Overall Study|Lost to Follow-up|1|||
129718995|NCT01831466|466930222|FG010|Overall Study|Lost to Follow-up|0|||
129718996|NCT01831466|466930223|FG011|Overall Study|Lost to Follow-up|1|||
129718997|NCT01831466|466930212|FG000|Overall Study|Lack of Efficacy|5|||
129718998|NCT01831466|466930213|FG001|Overall Study|Lack of Efficacy|8|||
129718999|NCT01831466|466930214|FG002|Overall Study|Lack of Efficacy|7|||
129719000|NCT01831466|466930215|FG003|Overall Study|Lack of Efficacy|6|||
129719001|NCT01831466|466930216|FG004|Overall Study|Lack of Efficacy|9|||
129803294|NCT02955797|467247564|FG001|Overall Study|Protocol Violation|0|||
129803295|NCT02955797|467247565|FG002|Overall Study|Protocol Violation|0|||
129803296|NCT02955797|467247566|FG003|Overall Study|Protocol Violation|1|||
129803297|NCT02955797|467247563|FG000|Overall Study|Withdrawal by Subject|2|||
129803298|NCT02955797|467247564|FG001|Overall Study|Withdrawal by Subject|2|||
129803299|NCT02955797|467247565|FG002|Overall Study|Withdrawal by Subject|0|||
129803300|NCT02955797|467247566|FG003|Overall Study|Withdrawal by Subject|1|||
129803301|NCT02955797|467247563|FG000|Overall Study|Lost to Follow-up|0|||
129444371|NCT04464265|465927325|FG000|Overall Study|Physician Decision|2|||
129444372|NCT00056862|465927330|FG000|Overall Study|Protocol Violation|1|||
129444373|NCT00056862|465927331|FG001|Overall Study|Protocol Violation|0|||
129444374|NCT02378220|465927332|FG000|Overall Study|Death|6|||
129719002|NCT01831466|466930217|FG005|Overall Study|Lack of Efficacy|8|||
129719003|NCT01831466|466930218|FG006|Overall Study|Lack of Efficacy|1|||
129719004|NCT01831466|466930219|FG007|Overall Study|Lack of Efficacy|1|||
129803302|NCT02955797|467247564|FG001|Overall Study|Lost to Follow-up|1|||
129719005|NCT01831466|466930220|FG008|Overall Study|Lack of Efficacy|2|||
129719006|NCT01831466|466930221|FG009|Overall Study|Lack of Efficacy|2|||
129719007|NCT01831466|466930222|FG010|Overall Study|Lack of Efficacy|2|||
129719008|NCT01831466|466930223|FG011|Overall Study|Lack of Efficacy|0|||
129719009|NCT01831466|466930212|FG000|Overall Study|Adverse Event|0|||
129719010|NCT01831466|466930213|FG001|Overall Study|Adverse Event|0|||
129719011|NCT01831466|466930214|FG002|Overall Study|Adverse Event|4|||
129719012|NCT01831466|466930215|FG003|Overall Study|Adverse Event|6|||
129719013|NCT01831466|466930216|FG004|Overall Study|Adverse Event|3|||
129719014|NCT01831466|466930217|FG005|Overall Study|Adverse Event|7|||
129719015|NCT01831466|466930218|FG006|Overall Study|Adverse Event|0|||
129719016|NCT01831466|466930219|FG007|Overall Study|Adverse Event|1|||
129719017|NCT01831466|466930220|FG008|Overall Study|Adverse Event|1|||
129719018|NCT01831466|466930221|FG009|Overall Study|Adverse Event|1|||
129719019|NCT01831466|466930222|FG010|Overall Study|Adverse Event|0|||
129719020|NCT01831466|466930223|FG011|Overall Study|Adverse Event|2|||
129719021|NCT02470585|466930224|FG000|Overall Study|Death|224|||
129719022|NCT02470585|466930225|FG001|Overall Study|Death|227|||
129719023|NCT02470585|466930226|FG002|Overall Study|Death|199|||
129719024|NCT02470585|466930224|FG000|Overall Study|Withdrew consent|21|||
129719025|NCT02470585|466930225|FG001|Overall Study|Withdrew consent|22|||
129719026|NCT02470585|466930226|FG002|Overall Study|Withdrew consent|31|||
129719027|NCT02470585|466930224|FG000|Overall Study|Lost to Follow-up|8|||
129719028|NCT02470585|466930225|FG001|Overall Study|Lost to Follow-up|15|||
129719029|NCT02470585|466930226|FG002|Overall Study|Lost to Follow-up|13|||
129719030|NCT02470585|466930224|FG000|Overall Study|Sponsor discontinued study|117|||
129719031|NCT02470585|466930225|FG001|Overall Study|Sponsor discontinued study|110|||
129719032|NCT02470585|466930226|FG002|Overall Study|Sponsor discontinued study|122|||
129719033|NCT02470585|466930224|FG000|Overall Study|Other, not specified|5|||
129719034|NCT02470585|466930225|FG001|Overall Study|Other, not specified|7|||
129719035|NCT02470585|466930226|FG002|Overall Study|Other, not specified|14|||
129719036|NCT02470585|466930224|FG000|Overall Study|Missing due to site non-compliance|0|||
129719037|NCT02470585|466930225|FG001|Overall Study|Missing due to site non-compliance|2|||
129719038|NCT02470585|466930226|FG002|Overall Study|Missing due to site non-compliance|3|||
129719039|NCT03497039|466930227|FG000|Overall Study|Withdrawal by Subject|1|||
129719040|NCT03497039|466930228|FG001|Overall Study|Withdrawal by Subject|0|||
129719041|NCT03497039|466930227|FG000|Overall Study|Protocol Violation|0|||
129719042|NCT03497039|466930228|FG001|Overall Study|Protocol Violation|1|||
129719043|NCT02146131|466930229|FG000|Overall Study|Physician Decision|61|||
129719044|NCT02146131|466930230|FG001|Overall Study|Physician Decision|56|||
129719045|NCT00465972|466930233|FG000|Overall Study|Withdrawal by Subject|2|||
129719046|NCT00465972|466930234|FG001|Overall Study|Withdrawal by Subject|1|||
129719047|NCT00861692|466930235|FG000|Overall Study|Death|6|||
129719048|NCT03292640|466930236|FG000|Overall Study|Withdrawal by Subject|17|||
129719049|NCT03292640|466930237|FG001|Overall Study|Withdrawal by Subject|16|||
129719050|NCT03292640|466930236|FG000|Overall Study|Adverse Event|20|||
129719051|NCT03292640|466930237|FG001|Overall Study|Adverse Event|2|||
129719052|NCT03292640|466930236|FG000|Overall Study|Lost to Follow-up|24|||
129719053|NCT03292640|466930237|FG001|Overall Study|Lost to Follow-up|24|||
129803303|NCT02955797|467247565|FG002|Overall Study|Lost to Follow-up|0|||
129803304|NCT02955797|467247566|FG003|Overall Study|Lost to Follow-up|0|||
129803305|NCT00961649|467247568|FG000|Overall Study|Adverse Event|4|||
129719054|NCT02218697|466930238|FG000|Overall Study|Adverse Event|0|||
129803306|NCT00961649|467247569|FG001|Overall Study|Adverse Event|0|||
129803307|NCT00961649|467247570|FG002|Overall Study|Adverse Event|0|||
129803308|NCT00961649|467247571|FG003|Overall Study|Adverse Event|2|||
129803309|NCT00961649|467247568|FG000|Overall Study|Inadequate control of IOP|0|||
129803310|NCT00961649|467247569|FG001|Overall Study|Inadequate control of IOP|0|||
129803311|NCT00961649|467247570|FG002|Overall Study|Inadequate control of IOP|0|||
129803312|NCT00961649|467247571|FG003|Overall Study|Inadequate control of IOP|1|||
129719055|NCT02218697|466930239|FG001|Overall Study|Adverse Event|2|||
129719056|NCT02218697|466930238|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
129803313|NCT00961649|467247568|FG000|Overall Study|Patient has travel plans during holidays|0|||
129719057|NCT02218697|466930239|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
129719058|NCT02218697|466930238|FG000|Overall Study|Withdrawal by Subject|2|||
129719059|NCT02218697|466930239|FG001|Overall Study|Withdrawal by Subject|3|||
129719060|NCT04380753|466930240|FG000|Overall Study|Participants continuing study|4|||
129719061|NCT04380753|466930240|FG000|Overall Study|Death|2|||
129719062|NCT03306433|466930243|FG000|Overall Study|Lost to Follow-up|3|||
129719063|NCT03306433|466930243|FG000|Overall Study|Patient did not have teeth extracted|1|||
129803314|NCT00961649|467247569|FG001|Overall Study|Patient has travel plans during holidays|0|||
129891514|NCT01561079|467561154|FG000|Overall Study|Physician Decision|17|||
129891515|NCT01561079|467561154|FG000|Overall Study|Withdrawal by Subject|59|||
129891516|NCT01561079|467561154|FG000|Overall Study|Protocol Violation|2|||
129891517|NCT00664521|467561163|FG000|Overall Study|Adverse Event|4|||
129803315|NCT00961649|467247570|FG002|Overall Study|Patient has travel plans during holidays|1|||
129803316|NCT00961649|467247571|FG003|Overall Study|Patient has travel plans during holidays|0|||
129803317|NCT00961649|467247568|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
129803318|NCT00961649|467247569|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
129803319|NCT00961649|467247570|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
129803320|NCT00961649|467247571|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
129803321|NCT00961649|467247568|FG000|Overall Study|Study terminated by sponsor|4|||
129803322|NCT00961649|467247569|FG001|Overall Study|Study terminated by sponsor|4|||
129803323|NCT00961649|467247570|FG002|Overall Study|Study terminated by sponsor|4|||
129803324|NCT00961649|467247571|FG003|Overall Study|Study terminated by sponsor|1|||
129803325|NCT02711345|467247572|FG000|Overall Study|Adverse Event|0|||
129803326|NCT02711345|467247573|FG001|Overall Study|Adverse Event|0|||
129803327|NCT02711345|467247574|FG002|Overall Study|Adverse Event|0|||
129803328|NCT02711345|467247575|FG003|Overall Study|Adverse Event|1|||
129803329|NCT02711345|467247576|FG004|Overall Study|Adverse Event|1|||
129803330|NCT02711345|467247577|FG005|Overall Study|Adverse Event|2|||
129803331|NCT02711345|467247578|FG006|Overall Study|Adverse Event|1|||
129803332|NCT02711345|467247579|FG007|Overall Study|Adverse Event|0|||
129803333|NCT02711345|467247580|FG008|Overall Study|Adverse Event|0|||
129803334|NCT02711345|467247581|FG009|Overall Study|Adverse Event|2|||
129803335|NCT02711345|467247572|FG000|Overall Study|Physician Decision|0|||
129803336|NCT02711345|467247573|FG001|Overall Study|Physician Decision|0|||
129803337|NCT02711345|467247574|FG002|Overall Study|Physician Decision|1|||
129803338|NCT02711345|467247575|FG003|Overall Study|Physician Decision|0|||
129803339|NCT02711345|467247576|FG004|Overall Study|Physician Decision|0|||
129803340|NCT02711345|467247577|FG005|Overall Study|Physician Decision|0|||
129803341|NCT02711345|467247578|FG006|Overall Study|Physician Decision|0|||
129803342|NCT02711345|467247579|FG007|Overall Study|Physician Decision|0|||
129803343|NCT02711345|467247580|FG008|Overall Study|Physician Decision|1|||
129803344|NCT02711345|467247581|FG009|Overall Study|Physician Decision|0|||
129803345|NCT02711345|467247572|FG000|Overall Study|Progressive disease|1|||
129803346|NCT02711345|467247573|FG001|Overall Study|Progressive disease|3|||
129803347|NCT02711345|467247574|FG002|Overall Study|Progressive disease|5|||
129803348|NCT02711345|467247575|FG003|Overall Study|Progressive disease|3|||
129803349|NCT02711345|467247576|FG004|Overall Study|Progressive disease|7|||
129803350|NCT02711345|467247577|FG005|Overall Study|Progressive disease|2|||
129803351|NCT02711345|467247578|FG006|Overall Study|Progressive disease|8|||
129803352|NCT02711345|467247579|FG007|Overall Study|Progressive disease|4|||
129803353|NCT02711345|467247580|FG008|Overall Study|Progressive disease|5|||
129803354|NCT02711345|467247581|FG009|Overall Study|Progressive disease|6|||
129719064|NCT03306433|466930243|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
129719065|NCT02120781|466932022|FG000|Overall Study|Physician Decision|2|||
129719066|NCT02120781|466932023|FG001|Overall Study|Physician Decision|0|||
129719067|NCT02120781|466932022|FG000|Overall Study|Completion not documented|2|||
129719068|NCT02120781|466932023|FG001|Overall Study|Completion not documented|1|||
129719069|NCT00654745|466932026|FG000|Overall Study|Adverse Event|12|||
129719070|NCT00654745|466932026|FG000|Overall Study|Lost to Follow-up|7|||
129719071|NCT00654745|466932026|FG000|Overall Study|Protocol Violation|11|||
129719072|NCT00654745|466932026|FG000|Overall Study|Withdrawal by Subject|10|||
129719073|NCT00654745|466932026|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
129719074|NCT00984165|466932027|FG000|Overall Study|Death on study|2|||
129719075|NCT00984165|466932028|FG001|Overall Study|Death on study|0|||
129719076|NCT00984165|466932029|FG002|Overall Study|Death on study|0|||
129719077|NCT00984165|466932030|FG003|Overall Study|Death on study|0|||
129719078|NCT00984165|466932027|FG000|Overall Study|Disease progression on study|5|||
129719079|NCT00984165|466932028|FG001|Overall Study|Disease progression on study|1|||
129719080|NCT00984165|466932029|FG002|Overall Study|Disease progression on study|0|||
129719081|NCT00984165|466932030|FG003|Overall Study|Disease progression on study|0|||
129719082|NCT00984165|466932027|FG000|Overall Study|Death of recipient|0|||
129803355|NCT02711345|467247572|FG000|Overall Study|Subject/guardian decision|0|||
129719083|NCT00984165|466932028|FG001|Overall Study|Death of recipient|0|||
129803356|NCT02711345|467247573|FG001|Overall Study|Subject/guardian decision|0|||
129803357|NCT02711345|467247574|FG002|Overall Study|Subject/guardian decision|0|||
129891518|NCT00664521|467561164|FG001|Overall Study|Adverse Event|1|||
129891519|NCT00664521|467561163|FG000|Overall Study|Lost to Follow-up|1|||
129719084|NCT00984165|466932029|FG002|Overall Study|Death of recipient|0|||
129719085|NCT00984165|466932030|FG003|Overall Study|Death of recipient|1|||
129719086|NCT00984165|466932027|FG000|Overall Study|New protocol|0|||
129719087|NCT00984165|466932028|FG001|Overall Study|New protocol|0|||
129719088|NCT00984165|466932029|FG002|Overall Study|New protocol|0|||
129719089|NCT00984165|466932030|FG003|Overall Study|New protocol|1|||
129719090|NCT00984165|466932027|FG000|Overall Study|P+/donor pair removed from protocol|0|||
129719091|NCT00984165|466932028|FG001|Overall Study|P+/donor pair removed from protocol|0|||
129719092|NCT00984165|466932029|FG002|Overall Study|P+/donor pair removed from protocol|0|||
129719093|NCT00984165|466932030|FG003|Overall Study|P+/donor pair removed from protocol|1|||
129719094|NCT00984165|466932027|FG000|Overall Study|removed with a pair recipient|0|||
129719095|NCT00984165|466932028|FG001|Overall Study|removed with a pair recipient|0|||
129719096|NCT00984165|466932029|FG002|Overall Study|removed with a pair recipient|0|||
129719097|NCT00984165|466932030|FG003|Overall Study|removed with a pair recipient|1|||
129719098|NCT00466947|466932031|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
129719099|NCT00466947|466932032|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
129719100|NCT00466947|466932031|FG000|Study End Analysis Period|Adverse Event|35|||
129719101|NCT00466947|466932032|FG001|Study End Analysis Period|Adverse Event|43|||
129719102|NCT00466947|466932031|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
129719103|NCT00466947|466932032|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
129719104|NCT00466947|466932031|FG000|Study End Analysis Period|Physician Decision|29|||
129719105|NCT00466947|466932032|FG001|Study End Analysis Period|Physician Decision|29|||
129719106|NCT00466947|466932031|FG000|Study End Analysis Period|Protocol Violation|9|||
129719107|NCT00466947|466932032|FG001|Study End Analysis Period|Protocol Violation|17|||
129719108|NCT00466947|466932031|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
129719109|NCT00466947|466932032|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
129719110|NCT00466947|466932031|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
129719111|NCT00466947|466932032|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
129719112|NCT00466947|466932031|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
129719113|NCT00466947|466932032|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
129803358|NCT02711345|467247575|FG003|Overall Study|Subject/guardian decision|0|||
129803359|NCT02711345|467247576|FG004|Overall Study|Subject/guardian decision|0|||
129803360|NCT02711345|467247577|FG005|Overall Study|Subject/guardian decision|2|||
129803361|NCT02711345|467247578|FG006|Overall Study|Subject/guardian decision|3|||
129803362|NCT02711345|467247579|FG007|Overall Study|Subject/guardian decision|1|||
129803363|NCT02711345|467247580|FG008|Overall Study|Subject/guardian decision|0|||
129803364|NCT02711345|467247581|FG009|Overall Study|Subject/guardian decision|4|||
129803365|NCT02711345|467247572|FG000|Overall Study|Death|1|||
129803366|NCT02711345|467247573|FG001|Overall Study|Death|0|||
129803367|NCT02711345|467247574|FG002|Overall Study|Death|0|||
129803368|NCT02711345|467247575|FG003|Overall Study|Death|0|||
129803369|NCT02711345|467247576|FG004|Overall Study|Death|0|||
129803370|NCT02711345|467247577|FG005|Overall Study|Death|0|||
129803371|NCT02711345|467247578|FG006|Overall Study|Death|0|||
129803372|NCT02711345|467247579|FG007|Overall Study|Death|1|||
129803373|NCT02711345|467247580|FG008|Overall Study|Death|0|||
129803374|NCT02711345|467247581|FG009|Overall Study|Death|0|||
129803375|NCT01558739|467247584|FG000|Overall Study|Adverse Event|7|||
129803376|NCT01558739|467247584|FG000|Overall Study|Withdrawal by Subject|2|||
129803377|NCT01558739|467247584|FG000|Overall Study|Death|3|||
129803378|NCT01558739|467247584|FG000|Overall Study|Disease Progression|4|||
129803379|NCT01558739|467247584|FG000|Overall Study|Protocol Violation|1|||
129803380|NCT00108433|467249722|FG000|Overall Study|Lack of Efficacy|1|||
129803381|NCT00108433|467249723|FG001|Overall Study|Lack of Efficacy|2|||
129803382|NCT00108433|467249722|FG000|Overall Study|Death|3|||
129803383|NCT00108433|467249723|FG001|Overall Study|Death|0|||
129803384|NCT00108433|467249722|FG000|Overall Study|Adverse Event|3|||
129803385|NCT00108433|467249723|FG001|Overall Study|Adverse Event|1|||
129803386|NCT00108433|467249722|FG000|Overall Study|Other|14|||
129803387|NCT00108433|467249723|FG001|Overall Study|Other|14|||
129803388|NCT00734474|467249731|FG000|Overall Study|Entry Criteria Not Met|0|||
129803389|NCT00734474|467249732|FG001|Overall Study|Entry Criteria Not Met|0|||
129803390|NCT00734474|467249733|FG002|Overall Study|Entry Criteria Not Met|5|||
129803391|NCT00734474|467249734|FG003|Overall Study|Entry Criteria Not Met|0|||
129803392|NCT00734474|467249735|FG004|Overall Study|Entry Criteria Not Met|3|||
129803393|NCT00734474|467249736|FG005|Overall Study|Entry Criteria Not Met|1|||
129803394|NCT00734474|467249737|FG006|Overall Study|Entry Criteria Not Met|0|||
129803395|NCT00734474|467249738|FG007|Overall Study|Entry Criteria Not Met|1|||
129803396|NCT00734474|467249739|FG008|Overall Study|Entry Criteria Not Met|1|||
129803397|NCT00734474|467249731|FG000|Overall Study|Lost to Follow-up|1|||
129803398|NCT00734474|467249732|FG001|Overall Study|Lost to Follow-up|0|||
129803399|NCT00734474|467249733|FG002|Overall Study|Lost to Follow-up|13|||
129719114|NCT00466947|466932031|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
129803400|NCT00734474|467249734|FG003|Overall Study|Lost to Follow-up|0|||
129803401|NCT00734474|467249735|FG004|Overall Study|Lost to Follow-up|11|||
129803402|NCT00734474|467249736|FG005|Overall Study|Lost to Follow-up|1|||
129719115|NCT00466947|466932032|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
129719116|NCT01995526|466932033|FG000|Overall Study|Physician Decision|1|||
129719117|NCT02229825|466932039|FG000|Overall Study|Personal Reasons|0|||
129719118|NCT02229825|466932040|FG001|Overall Study|Personal Reasons|1|||
129719119|NCT02229825|466932039|FG000|Overall Study|Refused continuing medication|7|||
129719120|NCT02229825|466932040|FG001|Overall Study|Refused continuing medication|6|||
129719121|NCT02229825|466932039|FG000|Overall Study|Lost to Follow-up|1|||
129719122|NCT02229825|466932040|FG001|Overall Study|Lost to Follow-up|2|||
129719123|NCT02229825|466932039|FG000|Overall Study|Protocol Violation|1|||
129719124|NCT02229825|466932040|FG001|Overall Study|Protocol Violation|1|||
129719125|NCT02229825|466932039|FG000|Overall Study|Lack of Efficacy|4|||
129719126|NCT02229825|466932040|FG001|Overall Study|Lack of Efficacy|10|||
129719127|NCT02229825|466932039|FG000|Overall Study|Adverse Event|11|||
129719128|NCT02229825|466932040|FG001|Overall Study|Adverse Event|9|||
129719129|NCT02229825|466932039|FG000|Overall Study|Not treated|0|||
129719130|NCT02229825|466932040|FG001|Overall Study|Not treated|1|||
129719131|NCT00104416|466932041|FG000|Double-Blind Phase|Adverse Event|2|||
129719132|NCT00104416|466932042|FG001|Double-Blind Phase|Adverse Event|1|||
129719133|NCT00104416|466932043|FG002|Double-Blind Phase|Adverse Event|0|||
129719134|NCT00104416|466932044|FG003|Double-Blind Phase|Adverse Event|0|||
129719135|NCT00104416|466932045|FG004|Double-Blind Phase|Adverse Event|0|||
129719136|NCT00104416|466932041|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129719137|NCT00104416|466932042|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129719138|NCT00104416|466932043|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129719139|NCT00104416|466932044|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129719140|NCT00104416|466932045|FG004|Double-Blind Phase|Lost to Follow-up|0|||
129719141|NCT00104416|466932041|FG000|Double-Blind Phase|Protocol Violation|0|||
129719142|NCT00104416|466932042|FG001|Double-Blind Phase|Protocol Violation|1|||
129719143|NCT00104416|466932043|FG002|Double-Blind Phase|Protocol Violation|0|||
129719144|NCT00104416|466932044|FG003|Double-Blind Phase|Protocol Violation|0|||
129719145|NCT00104416|466932045|FG004|Double-Blind Phase|Protocol Violation|0|||
129719146|NCT00104416|466932041|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
129719147|NCT00104416|466932042|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
129719148|NCT00104416|466932043|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129719149|NCT00104416|466932044|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129803403|NCT00734474|467249737|FG006|Overall Study|Lost to Follow-up|0|||
129803404|NCT00734474|467249738|FG007|Overall Study|Lost to Follow-up|9|||
129803405|NCT00734474|467249739|FG008|Overall Study|Lost to Follow-up|4|||
129803406|NCT00734474|467249731|FG000|Overall Study|Withdrawal by Subject|2|||
129803407|NCT00734474|467249732|FG001|Overall Study|Withdrawal by Subject|1|||
129803408|NCT00734474|467249733|FG002|Overall Study|Withdrawal by Subject|18|||
129803409|NCT00734474|467249734|FG003|Overall Study|Withdrawal by Subject|0|||
129803410|NCT00734474|467249735|FG004|Overall Study|Withdrawal by Subject|24|||
129803411|NCT00734474|467249736|FG005|Overall Study|Withdrawal by Subject|2|||
129803412|NCT00734474|467249737|FG006|Overall Study|Withdrawal by Subject|0|||
129803413|NCT00734474|467249738|FG007|Overall Study|Withdrawal by Subject|36|||
129803414|NCT00734474|467249739|FG008|Overall Study|Withdrawal by Subject|21|||
129803415|NCT00734474|467249731|FG000|Overall Study|Physician Decision|0|||
129803416|NCT00734474|467249732|FG001|Overall Study|Physician Decision|0|||
129803417|NCT00734474|467249733|FG002|Overall Study|Physician Decision|4|||
129803418|NCT00734474|467249734|FG003|Overall Study|Physician Decision|1|||
129803419|NCT00734474|467249735|FG004|Overall Study|Physician Decision|11|||
129803420|NCT00734474|467249736|FG005|Overall Study|Physician Decision|0|||
129803421|NCT00734474|467249737|FG006|Overall Study|Physician Decision|0|||
129803422|NCT00734474|467249738|FG007|Overall Study|Physician Decision|9|||
129803423|NCT00734474|467249739|FG008|Overall Study|Physician Decision|9|||
129803424|NCT00734474|467249731|FG000|Overall Study|Adverse Event|4|||
129803425|NCT00734474|467249732|FG001|Overall Study|Adverse Event|4|||
129803426|NCT00734474|467249733|FG002|Overall Study|Adverse Event|63|||
129803427|NCT00734474|467249734|FG003|Overall Study|Adverse Event|1|||
129803428|NCT00734474|467249735|FG004|Overall Study|Adverse Event|64|||
129803429|NCT00734474|467249736|FG005|Overall Study|Adverse Event|0|||
129719150|NCT00104416|466932045|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129719151|NCT00104416|466932041|FG000|Double-Blind Phase|Pregnancy|1|||
129719152|NCT00104416|466932042|FG001|Double-Blind Phase|Pregnancy|0|||
129803430|NCT00734474|467249737|FG006|Overall Study|Adverse Event|1|||
129803431|NCT00734474|467249738|FG007|Overall Study|Adverse Event|65|||
129803432|NCT00734474|467249739|FG008|Overall Study|Adverse Event|39|||
129803433|NCT00734474|467249731|FG000|Overall Study|Protocol Violation|0|||
129803434|NCT00734474|467249732|FG001|Overall Study|Protocol Violation|0|||
129803435|NCT00734474|467249733|FG002|Overall Study|Protocol Violation|4|||
129803436|NCT00734474|467249734|FG003|Overall Study|Protocol Violation|0|||
129803437|NCT00734474|467249735|FG004|Overall Study|Protocol Violation|3|||
129803438|NCT00734474|467249736|FG005|Overall Study|Protocol Violation|0|||
129719153|NCT00104416|466932043|FG002|Double-Blind Phase|Pregnancy|0|||
129719154|NCT00104416|466932044|FG003|Double-Blind Phase|Pregnancy|0|||
129719155|NCT00104416|466932045|FG004|Double-Blind Phase|Pregnancy|0|||
129719156|NCT00104416|466932041|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
129803439|NCT00734474|467249737|FG006|Overall Study|Protocol Violation|0|||
129719157|NCT00104416|466932042|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
129719158|NCT00104416|466932043|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
129719159|NCT00104416|466932044|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
129719160|NCT00104416|466932045|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
129719161|NCT00104416|466932041|FG000|Continuation Phase|Adverse Event|0|||
129719162|NCT00104416|466932042|FG001|Continuation Phase|Adverse Event|0|||
129719163|NCT00104416|466932043|FG002|Continuation Phase|Adverse Event|2|||
129719164|NCT00104416|466932044|FG003|Continuation Phase|Adverse Event|0|||
129719165|NCT00104416|466932045|FG004|Continuation Phase|Adverse Event|2|||
129719166|NCT00104416|466932041|FG000|Continuation Phase|Lost to Follow-up|0|||
129719167|NCT00104416|466932042|FG001|Continuation Phase|Lost to Follow-up|0|||
129719168|NCT00104416|466932043|FG002|Continuation Phase|Lost to Follow-up|1|||
129719169|NCT00104416|466932044|FG003|Continuation Phase|Lost to Follow-up|0|||
129719170|NCT00104416|466932045|FG004|Continuation Phase|Lost to Follow-up|1|||
129719171|NCT00104416|466932041|FG000|Continuation Phase|Withdrawal by Subject|0|||
129719172|NCT00104416|466932042|FG001|Continuation Phase|Withdrawal by Subject|0|||
129719173|NCT00104416|466932043|FG002|Continuation Phase|Withdrawal by Subject|2|||
129719174|NCT00104416|466932044|FG003|Continuation Phase|Withdrawal by Subject|1|||
129719175|NCT00104416|466932045|FG004|Continuation Phase|Withdrawal by Subject|1|||
129719176|NCT00104416|466932041|FG000|Continuation Phase|Pregnancy|0|||
129719177|NCT00104416|466932042|FG001|Continuation Phase|Pregnancy|0|||
129719178|NCT00104416|466932043|FG002|Continuation Phase|Pregnancy|1|||
129719179|NCT00104416|466932044|FG003|Continuation Phase|Pregnancy|1|||
129719180|NCT00104416|466932045|FG004|Continuation Phase|Pregnancy|0|||
129719181|NCT00104416|466932041|FG000|Continuation Phase|Non-compliance|0|||
129719182|NCT00104416|466932042|FG001|Continuation Phase|Non-compliance|0|||
129719183|NCT00104416|466932043|FG002|Continuation Phase|Non-compliance|0|||
129719184|NCT00104416|466932044|FG003|Continuation Phase|Non-compliance|0|||
129719185|NCT00104416|466932045|FG004|Continuation Phase|Non-compliance|1|||
129719186|NCT01309997|466932046|FG000|Overall Study|Adverse Event|1|||
129719187|NCT01309997|466932047|FG001|Overall Study|Adverse Event|0|||
129719188|NCT01309997|466932046|FG000|Overall Study|Death|1|||
129719189|NCT01309997|466932047|FG001|Overall Study|Death|3|||
129719190|NCT01309997|466932046|FG000|Overall Study|Lack of Efficacy|2|||
129719191|NCT01309997|466932047|FG001|Overall Study|Lack of Efficacy|2|||
129719192|NCT01309997|466932046|FG000|Overall Study|Withdrawal by Subject|1|||
129719193|NCT01309997|466932047|FG001|Overall Study|Withdrawal by Subject|1|||
129719194|NCT03462641|466932050|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
129719195|NCT03462641|466932051|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
129719196|NCT03462641|466932050|FG000|Visit 2|Withdrawal by Subject|0|||
129719197|NCT03462641|466932051|FG001|Visit 2|Withdrawal by Subject|1|||
129719198|NCT02096952|466932055|FG000|Overall Study|Adverse Event|1|||
129719199|NCT02684617|466932056|FG000|Overall Study|Adverse Event|1|||
129719200|NCT02684617|466932057|FG001|Overall Study|Adverse Event|0|||
129719201|NCT02684617|466932058|FG002|Overall Study|Adverse Event|1|||
129719202|NCT02684617|466932056|FG000|Overall Study|Death|8|||
129803440|NCT00734474|467249738|FG007|Overall Study|Protocol Violation|3|||
129803441|NCT00734474|467249739|FG008|Overall Study|Protocol Violation|1|||
129803442|NCT00734474|467249731|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
129803443|NCT00734474|467249732|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
129803444|NCT00734474|467249733|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803445|NCT00734474|467249734|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
129803446|NCT00734474|467249735|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803447|NCT00734474|467249736|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
129803448|NCT00734474|467249737|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
129803449|NCT00734474|467249738|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803450|NCT00734474|467249739|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
129803451|NCT00734474|467249731|FG000|Overall Study|Sponsor Decision|0|||
129803452|NCT00734474|467249732|FG001|Overall Study|Sponsor Decision|0|||
129803453|NCT00734474|467249733|FG002|Overall Study|Sponsor Decision|0|||
129444375|NCT02378220|465927333|FG001|Overall Study|Death|1|||
129719203|NCT02684617|466932057|FG001|Overall Study|Death|16|||
129719204|NCT02684617|466932058|FG002|Overall Study|Death|28|||
129719205|NCT02684617|466932056|FG000|Overall Study|Withdrawal by Subject|2|||
129719206|NCT02684617|466932057|FG001|Overall Study|Withdrawal by Subject|0|||
129719207|NCT02684617|466932058|FG002|Overall Study|Withdrawal by Subject|4|||
129719208|NCT02684617|466932056|FG000|Overall Study|Screen Failure|1|||
129719209|NCT02684617|466932057|FG001|Overall Study|Screen Failure|0|||
129719210|NCT02684617|466932058|FG002|Overall Study|Screen Failure|2|||
129719211|NCT02684617|466932056|FG000|Overall Study|Study Terminated by Sponsor|6|||
129719212|NCT02684617|466932057|FG001|Overall Study|Study Terminated by Sponsor|1|||
129719213|NCT02684617|466932058|FG002|Overall Study|Study Terminated by Sponsor|5|||
129719214|NCT04482439|466932067|FG000|Overall Study|Lost to Follow-up|1|||
129719215|NCT04482439|466932067|FG000|Overall Study|Unrelated illness|1|||
129719216|NCT02318368|466932068|FG000|Overall Study|Withdrawal by Subject|2|||
129719217|NCT02318368|466932069|FG001|Overall Study|Withdrawal by Subject|0|||
129719218|NCT02318368|466932068|FG000|Overall Study|Study terminated by the sponsor|5|||
129719219|NCT02318368|466932069|FG001|Overall Study|Study terminated by the sponsor|2|||
129719220|NCT02318368|466932068|FG000|Overall Study|Death|0|||
129719221|NCT02318368|466932069|FG001|Overall Study|Death|1|||
129719222|NCT02201329|466932070|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
129719223|NCT02201329|466932070|FG000|Overall Study|Withdrawal by Subject|2|||
129719224|NCT01945996|466932071|FG000|Overall Study|Lost to Follow-up|3|||
129719225|NCT01945996|466932072|FG001|Overall Study|Lost to Follow-up|5|||
129719226|NCT01066104|466932073|FG000|Overall Study|Adverse Event|1|||
129719227|NCT01066104|466932074|FG001|Overall Study|Adverse Event|1|||
129719228|NCT01066104|466932073|FG000|Overall Study|Protocol Violation|1|||
129719229|NCT01066104|466932074|FG001|Overall Study|Protocol Violation|0|||
129719230|NCT04660552|466932075|FG000|Overall Study|Withdrawal by Subject|3|||
129719231|NCT04660552|466932076|FG001|Overall Study|Withdrawal by Subject|1|||
129719232|NCT02091362|466932084|FG000|Period 1|Protocol Violation|1|||
129719233|NCT02091362|466932085|FG001|Period 1|Protocol Violation|0|||
129719234|NCT02091362|466932084|FG000|Period 1|Withdrawal by Subject|2|||
129719235|NCT02091362|466932085|FG001|Period 1|Withdrawal by Subject|3|||
129719236|NCT02091362|466932084|FG000|Period 1|Lost to Follow-up|0|||
129719237|NCT02091362|466932085|FG001|Period 1|Lost to Follow-up|1|||
129719238|NCT02091362|466932084|FG000|Period 1|Adverse Event|2|||
129719239|NCT02091362|466932085|FG001|Period 1|Adverse Event|0|||
129719240|NCT02091362|466932084|FG000|Wash-out|Lost to Follow-up|1|||
129719241|NCT02091362|466932085|FG001|Wash-out|Lost to Follow-up|1|||
129719242|NCT02091362|466932084|FG000|Wash-out|Withdrawal by Subject|0|||
129719243|NCT02091362|466932085|FG001|Wash-out|Withdrawal by Subject|2|||
129719244|NCT02091362|466932084|FG000|Period 2|Adverse Event|1|||
129719245|NCT02091362|466932085|FG001|Period 2|Adverse Event|0|||
129719246|NCT02091362|466932084|FG000|Period 2|Lost to Follow-up|0|||
129719247|NCT02091362|466932085|FG001|Period 2|Lost to Follow-up|1|||
129719248|NCT02091362|466932084|FG000|Period 2|Withdrawal by Subject|1|||
129719249|NCT02091362|466932085|FG001|Period 2|Withdrawal by Subject|1|||
129719250|NCT00690430|466932086|FG000|Core Phase|Abnormal Laboratory value|0|||
129719251|NCT00690430|466932087|FG001|Core Phase|Abnormal Laboratory value|1|||
129719252|NCT00690430|466932088|FG002|Core Phase|Abnormal Laboratory value|0|||
129719253|NCT00690430|466932086|FG000|Core Phase|Adverse Event|5|||
129719254|NCT00690430|466932087|FG001|Core Phase|Adverse Event|1|||
129719255|NCT00690430|466932088|FG002|Core Phase|Adverse Event|0|||
129719256|NCT00690430|466932086|FG000|Core Phase|Death|0|||
129719257|NCT00690430|466932087|FG001|Core Phase|Death|2|||
129719258|NCT00690430|466932088|FG002|Core Phase|Death|0|||
129719259|NCT00690430|466932086|FG000|Core Phase|Protocol Violation|1|||
129719260|NCT00690430|466932087|FG001|Core Phase|Protocol Violation|0|||
129719261|NCT00690430|466932088|FG002|Core Phase|Protocol Violation|0|||
129719262|NCT00690430|466932086|FG000|Core Phase|Withdrawal by Subject|3|||
129719263|NCT00690430|466932087|FG001|Core Phase|Withdrawal by Subject|3|||
129719264|NCT00690430|466932088|FG002|Core Phase|Withdrawal by Subject|0|||
129719265|NCT00690430|466932086|FG000|Core Phase|Subject no longer requires study drug|1|||
129719266|NCT00690430|466932087|FG001|Core Phase|Subject no longer requires study drug|0|||
129719267|NCT00690430|466932088|FG002|Core Phase|Subject no longer requires study drug|0|||
129719268|NCT00690430|466932086|FG000|Core Phase|Lack of Efficacy|8|||
129719269|NCT00690430|466932087|FG001|Core Phase|Lack of Efficacy|10|||
129719270|NCT00690430|466932088|FG002|Core Phase|Lack of Efficacy|0|||
129719271|NCT00690430|466932086|FG000|Core Phase|Administrative Problems|0|||
129719272|NCT00690430|466932087|FG001|Core Phase|Administrative Problems|1|||
129719273|NCT00690430|466932088|FG002|Core Phase|Administrative Problems|0|||
129719274|NCT00690430|466932086|FG000|Core Phase|Early Termination|0|||
129719275|NCT00690430|466932087|FG001|Core Phase|Early Termination|5|||
129719276|NCT00690430|466932088|FG002|Core Phase|Early Termination|0|||
129719277|NCT00690430|466932086|FG000|Extension Phase|Lack of Efficacy|3|||
129719278|NCT00690430|466932087|FG001|Extension Phase|Lack of Efficacy|1|||
129719279|NCT00690430|466932088|FG002|Extension Phase|Lack of Efficacy|4|||
129719280|NCT00690430|466932086|FG000|Extension Phase|Abnormal Lab Values|1|||
129803454|NCT00734474|467249734|FG003|Overall Study|Sponsor Decision|0|||
129803455|NCT00734474|467249735|FG004|Overall Study|Sponsor Decision|2|||
129803456|NCT00734474|467249736|FG005|Overall Study|Sponsor Decision|0|||
129803457|NCT00734474|467249737|FG006|Overall Study|Sponsor Decision|0|||
129803458|NCT00734474|467249738|FG007|Overall Study|Sponsor Decision|0|||
129719281|NCT00690430|466932087|FG001|Extension Phase|Abnormal Lab Values|0|||
129719282|NCT00690430|466932088|FG002|Extension Phase|Abnormal Lab Values|0|||
129719283|NCT00690430|466932086|FG000|Extension Phase|Abnormal test procedure results|1|||
129719284|NCT00690430|466932087|FG001|Extension Phase|Abnormal test procedure results|0|||
129719285|NCT00690430|466932088|FG002|Extension Phase|Abnormal test procedure results|0|||
129719286|NCT00690430|466932086|FG000|Extension Phase|Administrative Problems|0|||
129719287|NCT00690430|466932087|FG001|Extension Phase|Administrative Problems|1|||
129719288|NCT00690430|466932088|FG002|Extension Phase|Administrative Problems|1|||
129719289|NCT00690430|466932086|FG000|Extension Phase|Adverse Event|2|||
129719290|NCT00690430|466932087|FG001|Extension Phase|Adverse Event|1|||
129803459|NCT00734474|467249739|FG008|Overall Study|Sponsor Decision|0|||
129891520|NCT00664521|467561164|FG001|Overall Study|Lost to Follow-up|0|||
129891521|NCT00664521|467561163|FG000|Overall Study|Other|1|||
129891522|NCT00664521|467561164|FG001|Overall Study|Other|0|||
129891523|NCT02459964|467561165|FG000|Overall Study|Withdrawal by Subject|0|||
129891524|NCT02459964|467561166|FG001|Overall Study|Withdrawal by Subject|0|||
129891525|NCT02459964|467561167|FG002|Overall Study|Withdrawal by Subject|1|||
129891526|NCT02459964|467561165|FG000|Overall Study|Abnormal EKG changes|0|||
129891527|NCT02459964|467561166|FG001|Overall Study|Abnormal EKG changes|0|||
129891528|NCT02459964|467561167|FG002|Overall Study|Abnormal EKG changes|1|||
129891529|NCT00367237|467561168|FG000|Overall Study|Adverse Event|7|||
129891530|NCT00367237|467561169|FG001|Overall Study|Adverse Event|2|||
129891531|NCT00367237|467561168|FG000|Overall Study|Lost to Follow-up|1|||
129891532|NCT00367237|467561169|FG001|Overall Study|Lost to Follow-up|0|||
129891533|NCT00367237|467561168|FG000|Overall Study|Withdrawal by Subject|0|||
129891534|NCT00367237|467561169|FG001|Overall Study|Withdrawal by Subject|4|||
129891535|NCT00367237|467561168|FG000|Overall Study|Protocol Violation|2|||
129891536|NCT00367237|467561169|FG001|Overall Study|Protocol Violation|5|||
129891537|NCT00550732|467561170|FG000|Overall Study|Death|4|||
129891538|NCT00550732|467561170|FG000|Overall Study|Withdrawal by Subject|2|||
129891539|NCT00550732|467561170|FG000|Overall Study|Physician Decision|2|||
129891540|NCT00550732|467561170|FG000|Overall Study|Lost to Follow-up|1|||
129891541|NCT00550732|467561170|FG000|Overall Study|Palliative care|1|||
129891542|NCT00550732|467561170|FG000|Overall Study|Adverse Event|1|||
129891543|NCT02800928|467561177|FG000|Overall Study|Withdrawal by Subject|1|||
129891544|NCT02800928|467561178|FG001|Overall Study|Withdrawal by Subject|1|||
129891545|NCT02800928|467561177|FG000|Overall Study|Protocol Violation|1|||
129719291|NCT00690430|466932088|FG002|Extension Phase|Adverse Event|2|||
129719292|NCT00690430|466932086|FG000|Extension Phase|Death|1|||
129719293|NCT00690430|466932087|FG001|Extension Phase|Death|1|||
129719294|NCT00690430|466932088|FG002|Extension Phase|Death|1|||
129719295|NCT00690430|466932086|FG000|Extension Phase|Withdrawal by Subject|0|||
129719296|NCT00690430|466932087|FG001|Extension Phase|Withdrawal by Subject|0|||
129719297|NCT00690430|466932088|FG002|Extension Phase|Withdrawal by Subject|2|||
129719298|NCT00690430|466932086|FG000|Extension Phase|Early Termination|10|||
129719299|NCT00690430|466932087|FG001|Extension Phase|Early Termination|1|||
129719300|NCT00690430|466932088|FG002|Extension Phase|Early Termination|3|||
129719301|NCT02125838|466932097|FG000|Overall Study|Lost to Follow-up|4|||
129719302|NCT02125838|466932098|FG001|Overall Study|Lost to Follow-up|4|||
129719303|NCT00787839|466932099|FG000|Overall Study|Failure to have the OGTT was most common|404|||
129719304|NCT01970241|466932104|FG000|Overall Study|Withdrawal by Subject|2|||
129719305|NCT01970241|466932105|FG001|Overall Study|Withdrawal by Subject|0|||
129719306|NCT01970241|466932104|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
129719307|NCT01970241|466932105|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
129719308|NCT01001767|466932108|FG000|Overall Study|no baseline study performed|1|||
129719309|NCT01001767|466932109|FG001|Overall Study|no baseline study performed|0|||
129719310|NCT01001767|466932108|FG000|Overall Study|Protocol Violation|1|||
129719311|NCT01001767|466932109|FG001|Overall Study|Protocol Violation|0|||
129719312|NCT01001767|466932108|FG000|Overall Study|Lost to Follow-up|1|||
129719313|NCT01001767|466932109|FG001|Overall Study|Lost to Follow-up|0|||
129719314|NCT01001767|466932108|FG000|Overall Study|Physician Decision|1|||
129719315|NCT01001767|466932109|FG001|Overall Study|Physician Decision|0|||
129719316|NCT01667133|466932111|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
129719317|NCT01667133|466932112|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
129719318|NCT01667133|466932113|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
129719319|NCT01667133|466932114|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
129719320|NCT01667133|466932115|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
129719321|NCT01667133|466932116|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
129891546|NCT02800928|467561178|FG001|Overall Study|Protocol Violation|1|||
129891547|NCT04004208|467561186|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129891548|NCT04004208|467561187|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129891549|NCT04004208|467561186|FG000|Overall Study|Death|3|||
129891550|NCT04004208|467561187|FG001|Overall Study|Death|0|||
129891551|NCT04004208|467561186|FG000|Overall Study|COVID-19 pandemic|1|||
129891552|NCT04004208|467561187|FG001|Overall Study|COVID-19 pandemic|0|||
129891553|NCT04004208|467561186|FG000|Overall Study|Physician Decision|1|||
129891554|NCT04004208|467561187|FG001|Overall Study|Physician Decision|0|||
129891555|NCT04004208|467561186|FG000|Overall Study|Adverse Event|1|||
129891556|NCT04004208|467561187|FG001|Overall Study|Adverse Event|1|||
129891557|NCT00570661|467561195|FG000|Overall Study|Disease worsening|5|||
129891558|NCT00570661|467561195|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
129891559|NCT00570661|467561195|FG000|Overall Study|Adverse Event|1|||
129891560|NCT01734382|467561196|FG000|Part 1|Adverse Event|2|||
129891561|NCT01734382|467561197|FG001|Part 1|Adverse Event|0|||
129891562|NCT01734382|467561198|FG002|Part 1|Adverse Event|0|||
129891563|NCT01734382|467561196|FG000|Part 2|Adverse Event|0|||
129891564|NCT01734382|467561197|FG001|Part 2|Adverse Event|0|||
129891565|NCT01734382|467561198|FG002|Part 2|Adverse Event|1|||
129891566|NCT01734382|467561196|FG000|Part 2|Lack of Efficacy|0|||
129891567|NCT01734382|467561197|FG001|Part 2|Lack of Efficacy|1|||
129719322|NCT01667133|466932117|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
129719323|NCT01667133|466932118|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
129719324|NCT01667133|466932119|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
129719325|NCT01667133|466932120|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
129719326|NCT01667133|466932121|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
129719327|NCT01667133|466932122|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
129719328|NCT01667133|466932111|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719329|NCT01667133|466932112|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719330|NCT01667133|466932113|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
129719331|NCT01667133|466932114|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719332|NCT01667133|466932115|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719333|NCT01667133|466932116|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719334|NCT01667133|466932117|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719335|NCT01667133|466932118|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719336|NCT01667133|466932119|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719337|NCT01667133|466932120|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719338|NCT01667133|466932121|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719339|NCT01667133|466932122|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
129719340|NCT01667133|466932111|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
129719341|NCT01667133|466932112|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
129719342|NCT01667133|466932113|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
129719343|NCT01667133|466932114|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
129719344|NCT01667133|466932115|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
129719345|NCT01667133|466932116|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
129719346|NCT01667133|466932117|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
129719347|NCT01667133|466932118|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
129719348|NCT01667133|466932119|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
129719349|NCT01667133|466932120|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
129719350|NCT01667133|466932121|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
129719351|NCT01667133|466932122|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
129719352|NCT01667133|466932111|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719353|NCT01667133|466932112|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719354|NCT01667133|466932113|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719355|NCT01667133|466932114|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
129719356|NCT01667133|466932115|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719357|NCT01667133|466932116|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719358|NCT01667133|466932117|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719359|NCT01667133|466932118|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719360|NCT01667133|466932119|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719361|NCT01667133|466932120|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719362|NCT01667133|466932121|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719363|NCT01667133|466932122|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
129719364|NCT01667133|466932111|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
129719365|NCT01667133|466932112|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
129719366|NCT01667133|466932113|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
129719367|NCT01667133|466932114|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
129719368|NCT01667133|466932115|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
129719369|NCT01667133|466932116|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
129719370|NCT01667133|466932117|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
129719371|NCT01667133|466932118|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
129719372|NCT01667133|466932119|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
129719373|NCT01667133|466932120|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
129719374|NCT01667133|466932121|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
129719375|NCT01667133|466932122|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
129719376|NCT01667133|466932111|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719377|NCT01667133|466932112|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719378|NCT01667133|466932113|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719379|NCT01667133|466932114|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719380|NCT01667133|466932115|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719381|NCT01667133|466932116|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719382|NCT01667133|466932117|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719383|NCT01667133|466932118|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719384|NCT01667133|466932119|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719385|NCT01667133|466932120|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
129719386|NCT01667133|466932121|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719387|NCT01667133|466932122|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
129719388|NCT01667133|466932111|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
129719389|NCT01667133|466932112|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
129719390|NCT01667133|466932113|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
129719391|NCT01667133|466932114|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
129719392|NCT01667133|466932115|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
129719393|NCT01667133|466932116|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
129719394|NCT01667133|466932117|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
129719395|NCT01667133|466932118|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
129719396|NCT01667133|466932119|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
129719397|NCT01667133|466932120|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
129719398|NCT01667133|466932121|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
129719399|NCT01667133|466932122|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
129719400|NCT01667133|466932111|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719401|NCT01667133|466932112|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719402|NCT01667133|466932113|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719403|NCT01667133|466932114|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719404|NCT01667133|466932115|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719405|NCT01667133|466932116|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719406|NCT01667133|466932117|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719407|NCT01667133|466932118|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719408|NCT01667133|466932119|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719409|NCT01667133|466932120|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
129719410|NCT01667133|466932121|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719411|NCT01667133|466932122|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
129719412|NCT01667133|466932111|FG000|Phase 2: Dose-expansion|Death|0|||
129719413|NCT01667133|466932112|FG001|Phase 2: Dose-expansion|Death|0|||
129719414|NCT01667133|466932113|FG002|Phase 2: Dose-expansion|Death|0|||
129719415|NCT01667133|466932114|FG003|Phase 2: Dose-expansion|Death|0|||
129719416|NCT01667133|466932115|FG004|Phase 2: Dose-expansion|Death|0|||
129719417|NCT01667133|466932116|FG005|Phase 2: Dose-expansion|Death|0|||
129719418|NCT01667133|466932117|FG006|Phase 2: Dose-expansion|Death|0|||
129719419|NCT01667133|466932118|FG007|Phase 2: Dose-expansion|Death|0|||
129719420|NCT01667133|466932119|FG008|Phase 2: Dose-expansion|Death|0|||
129719421|NCT01667133|466932120|FG009|Phase 2: Dose-expansion|Death|1|||
129719422|NCT01667133|466932121|FG010|Phase 2: Dose-expansion|Death|0|||
129719423|NCT01667133|466932122|FG011|Phase 2: Dose-expansion|Death|0|||
129719424|NCT01667133|466932111|FG000|Phase 2: Dose-expansion|Other|0|||
129719425|NCT01667133|466932112|FG001|Phase 2: Dose-expansion|Other|0|||
129719426|NCT01667133|466932113|FG002|Phase 2: Dose-expansion|Other|0|||
129719427|NCT01667133|466932114|FG003|Phase 2: Dose-expansion|Other|0|||
129719428|NCT01667133|466932115|FG004|Phase 2: Dose-expansion|Other|0|||
129719429|NCT01667133|466932116|FG005|Phase 2: Dose-expansion|Other|0|||
129719430|NCT01667133|466932117|FG006|Phase 2: Dose-expansion|Other|0|||
129719431|NCT01667133|466932118|FG007|Phase 2: Dose-expansion|Other|0|||
129719432|NCT01667133|466932119|FG008|Phase 2: Dose-expansion|Other|0|||
129719433|NCT01667133|466932120|FG009|Phase 2: Dose-expansion|Other|0|||
129719434|NCT01667133|466932121|FG010|Phase 2: Dose-expansion|Other|0|||
129719435|NCT01667133|466932122|FG011|Phase 2: Dose-expansion|Other|1|||
129719436|NCT00289289|466932127|FG000|Overall Study|Withdrawal by Subject|5|||
129719437|NCT00289289|466932128|FG001|Overall Study|Withdrawal by Subject|3|||
129719438|NCT00289289|466932129|FG002|Overall Study|Withdrawal by Subject|15|||
129719439|NCT00289289|466932127|FG000|Overall Study|Lost to Follow-up|1|||
129719440|NCT00289289|466932128|FG001|Overall Study|Lost to Follow-up|0|||
129719441|NCT00289289|466932129|FG002|Overall Study|Lost to Follow-up|1|||
129719442|NCT00289289|466932127|FG000|Overall Study|Death|4|||
129719443|NCT00289289|466932128|FG001|Overall Study|Death|2|||
129719444|NCT00289289|466932129|FG002|Overall Study|Death|5|||
129719445|NCT00289289|466932127|FG000|Overall Study|No implant attempted|0|||
129719446|NCT00289289|466932128|FG001|Overall Study|No implant attempted|0|||
129719447|NCT00289289|466932129|FG002|Overall Study|No implant attempted|1|||
129719448|NCT00289289|466932127|FG000|Overall Study|Physician Decision|1|||
129719449|NCT00289289|466932128|FG001|Overall Study|Physician Decision|0|||
129719450|NCT00289289|466932129|FG002|Overall Study|Physician Decision|6|||
129719451|NCT00289289|466932127|FG000|Overall Study|Non-study device implanted|2|||
129719452|NCT00289289|466932128|FG001|Overall Study|Non-study device implanted|1|||
129719453|NCT00289289|466932129|FG002|Overall Study|Non-study device implanted|3|||
129719454|NCT00289289|466932127|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
129803460|NCT00734474|467249731|FG000|Overall Study|Death|0|||
129803461|NCT00734474|467249732|FG001|Overall Study|Death|0|||
129803462|NCT00734474|467249733|FG002|Overall Study|Death|1|||
129803463|NCT00734474|467249734|FG003|Overall Study|Death|0|||
129803464|NCT00734474|467249735|FG004|Overall Study|Death|0|||
129803465|NCT00734474|467249736|FG005|Overall Study|Death|0|||
129803466|NCT00734474|467249737|FG006|Overall Study|Death|0|||
129803467|NCT00734474|467249738|FG007|Overall Study|Death|2|||
129803468|NCT00734474|467249739|FG008|Overall Study|Death|1|||
129803469|NCT00734474|467249731|FG000|Overall Study|Lack of Efficacy|0|||
129803470|NCT00734474|467249732|FG001|Overall Study|Lack of Efficacy|0|||
129803471|NCT00734474|467249733|FG002|Overall Study|Lack of Efficacy|4|||
129803472|NCT00734474|467249734|FG003|Overall Study|Lack of Efficacy|0|||
129803473|NCT00734474|467249735|FG004|Overall Study|Lack of Efficacy|0|||
129803474|NCT00734474|467249736|FG005|Overall Study|Lack of Efficacy|0|||
129803475|NCT00734474|467249737|FG006|Overall Study|Lack of Efficacy|0|||
129803476|NCT00734474|467249738|FG007|Overall Study|Lack of Efficacy|4|||
129803477|NCT00734474|467249739|FG008|Overall Study|Lack of Efficacy|6|||
129803478|NCT02570074|467249748|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
129803479|NCT02570074|467249749|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
129803480|NCT02497612|467249750|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
129803481|NCT02497612|467249751|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
129803482|NCT02497612|467249752|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
129803483|NCT02497612|467249753|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
129803484|NCT02497612|467249750|FG000|Overall Study|Participant's request|2|||
129719455|NCT00289289|466932128|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
129719456|NCT00289289|466932129|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
129719457|NCT00289289|466932127|FG000|Overall Study|Other Exit Reason|6|||
129719458|NCT00289289|466932128|FG001|Overall Study|Other Exit Reason|4|||
129719459|NCT00289289|466932129|FG002|Overall Study|Other Exit Reason|12|||
129719460|NCT02567799|466932130|FG000|Concurrent Chemoradiotherapy|Death|1|||
129719461|NCT02567799|466932131|FG001|Concurrent Chemoradiotherapy|Death|0|||
129719462|NCT02567799|466932132|FG002|Concurrent Chemoradiotherapy|Death|0|||
129719463|NCT02567799|466932130|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
129719464|NCT02567799|466932131|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
129719465|NCT02567799|466932132|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
129719466|NCT02567799|466932130|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
129719467|NCT02567799|466932131|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
129719468|NCT02567799|466932132|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
129719469|NCT02567799|466932130|FG000|Follow-up|Death|1|||
129719470|NCT02567799|466932131|FG001|Follow-up|Death|0|||
129719471|NCT02567799|466932132|FG002|Follow-up|Death|1|||
129719472|NCT02567799|466932130|FG000|Follow-up|Progressive Disease|1|||
129719473|NCT02567799|466932131|FG001|Follow-up|Progressive Disease|1|||
129719474|NCT02567799|466932132|FG002|Follow-up|Progressive Disease|3|||
129719475|NCT00349349|466932134|FG000|Overall Study|Adverse Event|5|||
129719476|NCT00349349|466932135|FG001|Overall Study|Adverse Event|6|||
129719477|NCT00349349|466932136|FG002|Overall Study|Adverse Event|2|||
129719478|NCT00349349|466932134|FG000|Overall Study|Withdrawal by Subject|5|||
129719479|NCT00349349|466932135|FG001|Overall Study|Withdrawal by Subject|2|||
129719480|NCT00349349|466932136|FG002|Overall Study|Withdrawal by Subject|1|||
129719481|NCT00349349|466932134|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
129719482|NCT00349349|466932135|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
129719483|NCT00349349|466932136|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
129719484|NCT00349349|466932134|FG000|Overall Study|Death|13|||
129719485|NCT00349349|466932135|FG001|Overall Study|Death|10|||
129719486|NCT00349349|466932136|FG002|Overall Study|Death|1|||
129803485|NCT02497612|467249751|FG001|Overall Study|Participant's request|3|||
129803486|NCT02497612|467249752|FG002|Overall Study|Participant's request|4|||
129444376|NCT00578786|465927334|FG000|Overall Study|Adverse Event|27|||
129719487|NCT00349349|466932134|FG000|Overall Study|Other Treatment Selected|2|||
129719488|NCT00349349|466932135|FG001|Overall Study|Other Treatment Selected|0|||
129719489|NCT00349349|466932136|FG002|Overall Study|Other Treatment Selected|0|||
129803487|NCT02497612|467249753|FG003|Overall Study|Participant's request|1|||
129803488|NCT02497612|467249750|FG000|Overall Study|Investigator's judgement|1|||
129803489|NCT02497612|467249751|FG001|Overall Study|Investigator's judgement|0|||
129803490|NCT02497612|467249752|FG002|Overall Study|Investigator's judgement|0|||
129444377|NCT00578786|465927335|FG001|Overall Study|Adverse Event|37|||
129719490|NCT00349349|466932134|FG000|Overall Study|Participant Reduced General Condition|0|||
129719491|NCT00349349|466932135|FG001|Overall Study|Participant Reduced General Condition|1|||
129719492|NCT00349349|466932136|FG002|Overall Study|Participant Reduced General Condition|0|||
129719493|NCT00349349|466932134|FG000|Overall Study|Physician Decision|1|||
129444378|NCT00578786|465927336|FG002|Overall Study|Adverse Event|17|||
129803491|NCT02497612|467249753|FG003|Overall Study|Investigator's judgement|2|||
129803492|NCT02497612|467249750|FG000|Overall Study|Adverse Event|3|||
129803493|NCT02497612|467249751|FG001|Overall Study|Adverse Event|1|||
129803494|NCT02497612|467249752|FG002|Overall Study|Adverse Event|4|||
129803495|NCT02497612|467249753|FG003|Overall Study|Adverse Event|1|||
129803496|NCT02497612|467249750|FG000|Overall Study|Lost to Follow-up|1|||
129803497|NCT02497612|467249751|FG001|Overall Study|Lost to Follow-up|1|||
129719494|NCT00349349|466932135|FG001|Overall Study|Physician Decision|2|||
129719495|NCT00349349|466932136|FG002|Overall Study|Physician Decision|1|||
129719496|NCT00349349|466932134|FG000|Overall Study|No Response|0|||
129719497|NCT00349349|466932135|FG001|Overall Study|No Response|3|||
129719498|NCT00349349|466932136|FG002|Overall Study|No Response|0|||
129719499|NCT00349349|466932134|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
129719500|NCT00349349|466932135|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
129719501|NCT00349349|466932136|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
129719502|NCT01854775|466932141|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
129719503|NCT01854775|466932142|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
129719504|NCT01854775|466932143|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
129719505|NCT01854775|466932141|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
129719506|NCT01854775|466932142|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
129719507|NCT01854775|466932143|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
129719508|NCT01854775|466932141|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
129719509|NCT01854775|466932142|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
129719510|NCT01854775|466932143|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
129719511|NCT01854775|466932141|FG000|Extension Phase|Pregnancy|3|||
129719512|NCT01854775|466932142|FG001|Extension Phase|Pregnancy|0|||
129719513|NCT01854775|466932143|FG002|Extension Phase|Pregnancy|0|||
129719514|NCT01854775|466932141|FG000|Extension Phase|Investigator's Discretion|1|||
129719515|NCT01854775|466932142|FG001|Extension Phase|Investigator's Discretion|0|||
129719516|NCT01854775|466932143|FG002|Extension Phase|Investigator's Discretion|0|||
129719517|NCT01854775|466932141|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
129719518|NCT01854775|466932142|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
129719519|NCT01854775|466932143|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
129719520|NCT01854775|466932141|FG000|Extension Phase|Lost to Follow-up|2|||
129719521|NCT01854775|466932142|FG001|Extension Phase|Lost to Follow-up|0|||
129719522|NCT01854775|466932143|FG002|Extension Phase|Lost to Follow-up|0|||
129719523|NCT01854775|466932141|FG000|Extension Phase|Still on Study|32|||
129719524|NCT01854775|466932142|FG001|Extension Phase|Still on Study|47|||
129719525|NCT01854775|466932143|FG002|Extension Phase|Still on Study|18|||
129719526|NCT05111002|466932144|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
129719527|NCT05111002|466932145|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
129719528|NCT05111002|466932144|FG000|Secondary Outcome|Lost to Follow-up|1|||
129719529|NCT05111002|466932145|FG001|Secondary Outcome|Lost to Follow-up|0|||
129719530|NCT04776720|466932148|FG000|Overall Study|COVID Related|4|||
129719531|NCT04776720|466932149|FG001|Overall Study|COVID Related|2|||
129719532|NCT04776720|466932148|FG000|Overall Study|Adverse Event|2|||
129719533|NCT04776720|466932149|FG001|Overall Study|Adverse Event|0|||
129719534|NCT04776720|466932148|FG000|Overall Study|Serious Adverse Event|0|||
129719535|NCT04776720|466932149|FG001|Overall Study|Serious Adverse Event|1|||
129719536|NCT04776720|466932148|FG000|Overall Study|Too Busy|3|||
129719537|NCT04776720|466932149|FG001|Overall Study|Too Busy|1|||
129719538|NCT04776720|466932148|FG000|Overall Study|Lost to Follow-up|1|||
129719539|NCT04776720|466932149|FG001|Overall Study|Lost to Follow-up|2|||
129719540|NCT04776720|466932148|FG000|Overall Study|Family|2|||
129719541|NCT04776720|466932149|FG001|Overall Study|Family|2|||
129719542|NCT04776720|466932148|FG000|Overall Study|No remote technology access|0|||
129719543|NCT04776720|466932149|FG001|Overall Study|No remote technology access|1|||
129719544|NCT04776720|466932148|FG000|Overall Study|Withdrawal by Subject|1|||
129719545|NCT04776720|466932149|FG001|Overall Study|Withdrawal by Subject|0|||
129719546|NCT04776720|466932148|FG000|Overall Study|Cannot tolerate intervention|1|||
129719547|NCT04776720|466932149|FG001|Overall Study|Cannot tolerate intervention|0|||
129719548|NCT04776720|466932148|FG000|Overall Study|Incomplete outcome data|6|||
129719549|NCT04776720|466932149|FG001|Overall Study|Incomplete outcome data|1|||
129719550|NCT05356910|466932150|FG000|Overall Study|Lost to Follow-up|10|||
129719551|NCT05356910|466932151|FG001|Overall Study|Lost to Follow-up|19|||
129719552|NCT05356910|466932152|FG002|Overall Study|Lost to Follow-up|0|||
129719553|NCT05356910|466932153|FG003|Overall Study|Lost to Follow-up|0|||
129719554|NCT05356910|466932150|FG000|Overall Study|Withdrawal by Subject|4|||
129719555|NCT05356910|466932151|FG001|Overall Study|Withdrawal by Subject|2|||
129719556|NCT05356910|466932152|FG002|Overall Study|Withdrawal by Subject|0|||
129719557|NCT05356910|466932153|FG003|Overall Study|Withdrawal by Subject|0|||
129719558|NCT03122145|466932155|FG000|Overall Study|Concurrent respiratory disease|3|||
129719559|NCT03122145|466932156|FG001|Overall Study|Concurrent respiratory disease|0|||
129803498|NCT02497612|467249752|FG002|Overall Study|Lost to Follow-up|0|||
129803499|NCT02497612|467249753|FG003|Overall Study|Lost to Follow-up|1|||
129719560|NCT01597908|466932157|FG000|Randomized Phase|Death|217|||
129719561|NCT01597908|466932158|FG001|Randomized Phase|Death|238|||
129719562|NCT01597908|466932159|FG002|Randomized Phase|Death|0|||
129719563|NCT01597908|466932157|FG000|Randomized Phase|Sponsor Decision|93|||
129719564|NCT01597908|466932158|FG001|Randomized Phase|Sponsor Decision|39|||
129719565|NCT01597908|466932159|FG002|Randomized Phase|Sponsor Decision|0|||
129719566|NCT01597908|466932157|FG000|Randomized Phase|Lost to Follow-up|9|||
129719567|NCT01597908|466932158|FG001|Randomized Phase|Lost to Follow-up|16|||
129719568|NCT01597908|466932159|FG002|Randomized Phase|Lost to Follow-up|0|||
129719569|NCT01597908|466932157|FG000|Randomized Phase|Physician Decision|6|||
129719570|NCT01597908|466932158|FG001|Randomized Phase|Physician Decision|3|||
129719571|NCT01597908|466932159|FG002|Randomized Phase|Physician Decision|0|||
129719572|NCT01597908|466932157|FG000|Randomized Phase|Withdrawal by Subject|26|||
129719573|NCT01597908|466932158|FG001|Randomized Phase|Withdrawal by Subject|22|||
129719574|NCT01597908|466932159|FG002|Randomized Phase|Withdrawal by Subject|0|||
129719575|NCT01597908|466932157|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
129719576|NCT01597908|466932158|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
129719577|NCT01597908|466932159|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
129719578|NCT01597908|466932157|FG000|Crossover Phase|Death|0|||
129719579|NCT01597908|466932158|FG001|Crossover Phase|Death|0|||
129719580|NCT01597908|466932159|FG002|Crossover Phase|Death|11|||
129719581|NCT01597908|466932157|FG000|Crossover Phase|Withdrawal by Subject|0|||
129719582|NCT01597908|466932158|FG001|Crossover Phase|Withdrawal by Subject|0|||
129719583|NCT01597908|466932159|FG002|Crossover Phase|Withdrawal by Subject|3|||
129719584|NCT01597908|466932157|FG000|Crossover Phase|Sponsor Decision|0|||
129719585|NCT01597908|466932158|FG001|Crossover Phase|Sponsor Decision|0|||
129719586|NCT01597908|466932159|FG002|Crossover Phase|Sponsor Decision|20|||
129719587|NCT00837161|466932160|FG000|Overall Study|refused hysterectomy|2|||
129719588|NCT01659996|466932163|FG000|Overall Study|Protocol Violation|3|||
129719589|NCT01659996|466932164|FG001|Overall Study|Protocol Violation|3|||
129803500|NCT02497612|467249750|FG000|Overall Study|Other unspecified|1|||
129803501|NCT02497612|467249751|FG001|Overall Study|Other unspecified|1|||
129803502|NCT02497612|467249752|FG002|Overall Study|Other unspecified|2|||
129803503|NCT02497612|467249753|FG003|Overall Study|Other unspecified|0|||
129803504|NCT02497612|467249750|FG000|Overall Study|Not eligible|1|||
129803505|NCT02497612|467249751|FG001|Overall Study|Not eligible|0|||
129719590|NCT01659996|466932165|FG002|Overall Study|Protocol Violation|3|||
129719591|NCT01659996|466932163|FG000|Overall Study|Lost to Follow-up|1|||
129719592|NCT01659996|466932164|FG001|Overall Study|Lost to Follow-up|3|||
129719593|NCT01659996|466932165|FG002|Overall Study|Lost to Follow-up|2|||
129719594|NCT01659996|466932163|FG000|Overall Study|Adverse Event|0|||
129719595|NCT01659996|466932164|FG001|Overall Study|Adverse Event|0|||
129719596|NCT01659996|466932165|FG002|Overall Study|Adverse Event|1|||
129719597|NCT01659996|466932163|FG000|Overall Study|Withdrawal by Subject|4|||
129719598|NCT01659996|466932164|FG001|Overall Study|Withdrawal by Subject|1|||
129719599|NCT01659996|466932165|FG002|Overall Study|Withdrawal by Subject|5|||
129719600|NCT02709577|466932166|FG000|Overall Study|non-accommodating anatomy|0|||
129719601|NCT02709577|466932167|FG001|Overall Study|non-accommodating anatomy|1|||
129719602|NCT02709577|466932168|FG002|Overall Study|non-accommodating anatomy|0|||
129719603|NCT02709577|466932169|FG003|Overall Study|non-accommodating anatomy|0|||
129719604|NCT02709577|466932166|FG000|Overall Study|procedural complication|0|||
129719605|NCT02709577|466932167|FG001|Overall Study|procedural complication|1|||
129719606|NCT02709577|466932168|FG002|Overall Study|procedural complication|0|||
129891568|NCT01734382|467561198|FG002|Part 2|Lack of Efficacy|1|||
129891569|NCT01734382|467561196|FG000|Part 2|Other|0|||
129891570|NCT01734382|467561197|FG001|Part 2|Other|0|||
129891571|NCT01734382|467561198|FG002|Part 2|Other|1|||
129719607|NCT02709577|466932169|FG003|Overall Study|procedural complication|0|||
129719608|NCT02709577|466932166|FG000|Overall Study|Withdrawal by Subject|2|||
129719609|NCT02709577|466932167|FG001|Overall Study|Withdrawal by Subject|3|||
129803506|NCT02497612|467249752|FG002|Overall Study|Not eligible|0|||
129803507|NCT02497612|467249753|FG003|Overall Study|Not eligible|1|||
129803508|NCT02651467|467249754|FG000|Overall Study|Withdrawal by Subject|0|||
129719610|NCT02709577|466932168|FG002|Overall Study|Withdrawal by Subject|2|||
129719611|NCT02709577|466932169|FG003|Overall Study|Withdrawal by Subject|0|||
129719612|NCT00451958|466932172|FG000|CS21A (NCT00451958)|Adverse Event|21|||
129719613|NCT00451958|466932173|FG001|CS21A (NCT00451958)|Adverse Event|34|||
129803509|NCT02651467|467249755|FG001|Overall Study|Withdrawal by Subject|0|||
129719614|NCT00451958|466932174|FG002|CS21A (NCT00451958)|Adverse Event|14|||
129719615|NCT00451958|466932175|FG003|CS21A (NCT00451958)|Adverse Event|17|||
129891572|NCT01734382|467561196|FG000|Part 2|Physician Decision|0|||
129719616|NCT00451958|466932176|FG004|CS21A (NCT00451958)|Adverse Event|0|||
129719617|NCT00451958|466932172|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
129803510|NCT02651467|467249756|FG002|Overall Study|Withdrawal by Subject|2|||
129891573|NCT01734382|467561197|FG001|Part 2|Physician Decision|0|||
129891574|NCT01734382|467561198|FG002|Part 2|Physician Decision|3|||
129719618|NCT00451958|466932173|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
129719619|NCT00451958|466932174|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
129719620|NCT00451958|466932175|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
129719621|NCT00451958|466932176|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
129719622|NCT00451958|466932172|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
129719623|NCT00451958|466932173|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
129891575|NCT01734382|467561196|FG000|Part 2|Protocol Violation|0|||
129719624|NCT00451958|466932174|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
129719625|NCT00451958|466932175|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
129719626|NCT00451958|466932176|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
129719627|NCT00451958|466932172|FG000|CS21A (NCT00451958)|Physician Decision|2|||
129719628|NCT00451958|466932173|FG001|CS21A (NCT00451958)|Physician Decision|4|||
129719629|NCT00451958|466932174|FG002|CS21A (NCT00451958)|Physician Decision|4|||
129719630|NCT00451958|466932175|FG003|CS21A (NCT00451958)|Physician Decision|4|||
129719631|NCT00451958|466932176|FG004|CS21A (NCT00451958)|Physician Decision|0|||
129719632|NCT00451958|466932172|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
129719633|NCT00451958|466932173|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
129719634|NCT00451958|466932174|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
129719635|NCT00451958|466932175|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
129719636|NCT00451958|466932176|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
129719637|NCT00451958|466932172|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
129719638|NCT00451958|466932173|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
129719639|NCT00451958|466932174|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
129719640|NCT00451958|466932175|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
129719641|NCT00451958|466932176|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
129719642|NCT03108521|466932177|FG000|Overall Study|Lost to Follow-up|3|||
129719643|NCT03108521|466932178|FG001|Overall Study|Lost to Follow-up|0|||
129719644|NCT03108521|466932177|FG000|Overall Study|Lack of Efficacy|2|||
129719645|NCT03108521|466932178|FG001|Overall Study|Lack of Efficacy|0|||
129719646|NCT03108521|466932177|FG000|Overall Study|Physician Decision|4|||
129719647|NCT03108521|466932178|FG001|Overall Study|Physician Decision|0|||
129719648|NCT03108521|466932177|FG000|Overall Study|Adverse Event|3|||
129719649|NCT03108521|466932178|FG001|Overall Study|Adverse Event|0|||
129719650|NCT06899737|466932183|FG000|Overall Study|Lost to Follow-up|19|||
129719651|NCT06899737|466932184|FG001|Overall Study|Lost to Follow-up|7|||
129719652|NCT03281629|466932186|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
129719653|NCT03281629|466932187|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
129719654|NCT03281629|466932186|FG000|Overall Study|Death|0|||
129719655|NCT03281629|466932187|FG001|Overall Study|Death|1|||
129719656|NCT03281629|466932186|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
129719657|NCT03281629|466932187|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
129719658|NCT02175277|466932189|FG000|Overall Study|Protocol-specified Criteria|1|||
129719659|NCT00375674|466932194|FG000|Overall Study|Other|26|||
129719660|NCT00375674|466932195|FG001|Overall Study|Other|18|||
129719661|NCT00375674|466932194|FG000|Overall Study|Death|67|||
129719662|NCT00375674|466932195|FG001|Overall Study|Death|76|||
129719663|NCT00375674|466932194|FG000|Overall Study|Participants refused further follow-up|31|||
129719664|NCT00375674|466932195|FG001|Overall Study|Participants refused further follow-up|30|||
129719665|NCT00375674|466932194|FG000|Overall Study|Lost to Follow-up|17|||
129719666|NCT00375674|466932195|FG001|Overall Study|Lost to Follow-up|15|||
129719667|NCT00375674|466932194|FG000|Overall Study|Enrolled but not treated|3|||
129719668|NCT00375674|466932195|FG001|Overall Study|Enrolled but not treated|2|||
129719669|NCT03744910|466934624|FG000|Overall Study|Withdrew Consent|1|||
129719670|NCT03744910|466934625|FG001|Overall Study|Withdrew Consent|8|||
129719671|NCT03744910|466934624|FG000|Overall Study|Physician Decision|5|||
129719672|NCT03744910|466934625|FG001|Overall Study|Physician Decision|4|||
129719673|NCT03744910|466934624|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
129719674|NCT03744910|466934625|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
129719675|NCT03744910|466934624|FG000|Overall Study|Lost to Follow-up|0|||
129719676|NCT03744910|466934625|FG001|Overall Study|Lost to Follow-up|1|||
129719677|NCT03744910|466934624|FG000|Overall Study|Other-unspecified|4|||
129719678|NCT03744910|466934625|FG001|Overall Study|Other-unspecified|1|||
129719679|NCT00064259|466934626|FG000|Overall Study|Adverse Event|1|||
129719680|NCT00064259|466934627|FG001|Overall Study|Adverse Event|0|||
129719681|NCT00064259|466934628|FG002|Overall Study|Adverse Event|0|||
129719682|NCT00064259|466934629|FG003|Overall Study|Adverse Event|1|||
129719683|NCT01132651|466934632|FG000|Overall Study|Lost to Follow-up|1|||
129719684|NCT01132651|466934633|FG001|Overall Study|Lost to Follow-up|1|||
129719685|NCT00948857|466934634|FG000|Overall Study|Lost to Follow-up|1|||
129719686|NCT00948857|466934635|FG001|Overall Study|Lost to Follow-up|0|||
129719687|NCT03430843|466934638|FG000|Overall Study|Death|233|||
129719688|NCT03430843|466934639|FG001|Overall Study|Death|233|||
129719689|NCT03430843|466934638|FG000|Overall Study|Sponsor Decision|17|||
129803511|NCT02651467|467249754|FG000|Overall Study|Other (Not specified)|1|||
129719690|NCT03430843|466934639|FG001|Overall Study|Sponsor Decision|6|||
129719691|NCT03430843|466934638|FG000|Overall Study|Withdrawal by Subject|5|||
129719692|NCT03430843|466934639|FG001|Overall Study|Withdrawal by Subject|14|||
129719693|NCT03430843|466934638|FG000|Overall Study|Lost to Follow-up|1|||
129719694|NCT03430843|466934639|FG001|Overall Study|Lost to Follow-up|3|||
129719695|NCT01905943|466934646|FG000|Overall Study|Withdrawal of consent|90|||
129719696|NCT01905943|466934646|FG000|Overall Study|Lost to Follow-up|16|||
129719697|NCT01905943|466934646|FG000|Overall Study|Investigator discretion|7|||
129719698|NCT01905943|466934646|FG000|Overall Study|Death|186|||
129719699|NCT01905943|466934646|FG000|Overall Study|Adverse Event|3|||
129719700|NCT01905943|466934646|FG000|Overall Study|Other|12|||
129719701|NCT02574078|466934647|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719702|NCT02574078|466934648|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719703|NCT02574078|466934649|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719704|NCT02574078|466934650|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719705|NCT02574078|466934651|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719706|NCT02574078|466934652|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129719707|NCT02574078|466934653|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
129719708|NCT02574078|466934654|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719709|NCT02574078|466934655|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129719710|NCT02574078|466934656|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719711|NCT02574078|466934657|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719712|NCT02574078|466934658|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719713|NCT02574078|466934659|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129719714|NCT02574078|466934647|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
129719715|NCT02574078|466934648|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129719716|NCT02574078|466934649|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
129719717|NCT02574078|466934650|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
129719718|NCT02574078|466934651|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
129719719|NCT02574078|466934652|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
129719720|NCT02574078|466934653|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
129719721|NCT02574078|466934654|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
129719722|NCT02574078|466934655|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
129719723|NCT02574078|466934656|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
129719724|NCT02574078|466934657|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
129719725|NCT02574078|466934658|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
129719726|NCT02574078|466934659|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
129719727|NCT02574078|466934647|FG000|Pre-Treatment Period|Other reasons|0|||
129719728|NCT02574078|466934648|FG001|Pre-Treatment Period|Other reasons|0|||
129719729|NCT02574078|466934649|FG002|Pre-Treatment Period|Other reasons|0|||
129719730|NCT02574078|466934650|FG003|Pre-Treatment Period|Other reasons|0|||
129719731|NCT02574078|466934651|FG004|Pre-Treatment Period|Other reasons|0|||
129719732|NCT02574078|466934652|FG005|Pre-Treatment Period|Other reasons|0|||
129719733|NCT02574078|466934653|FG006|Pre-Treatment Period|Other reasons|2|||
129803512|NCT02651467|467249755|FG001|Overall Study|Other (Not specified)|0|||
129803513|NCT02651467|467249756|FG002|Overall Study|Other (Not specified)|2|||
129444379|NCT00578786|465927334|FG000|Overall Study|Lack of Efficacy|2|||
129719734|NCT02574078|466934654|FG007|Pre-Treatment Period|Other reasons|0|||
129719735|NCT02574078|466934655|FG008|Pre-Treatment Period|Other reasons|0|||
129719736|NCT02574078|466934656|FG009|Pre-Treatment Period|Other reasons|0|||
129719737|NCT02574078|466934657|FG010|Pre-Treatment Period|Other reasons|2|||
129719738|NCT02574078|466934658|FG011|Pre-Treatment Period|Other reasons|0|||
129719739|NCT02574078|466934659|FG012|Pre-Treatment Period|Other reasons|0|||
129719740|NCT02574078|466934647|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
129719741|NCT02574078|466934648|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
129719742|NCT02574078|466934649|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
129719743|NCT02574078|466934650|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
129719744|NCT02574078|466934651|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
129719745|NCT02574078|466934652|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
129719746|NCT02574078|466934653|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
129719747|NCT02574078|466934654|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
129719748|NCT02574078|466934655|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
129719749|NCT02574078|466934656|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
129719750|NCT02574078|466934657|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
129719751|NCT02574078|466934658|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
129719752|NCT02574078|466934659|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
129719753|NCT02574078|466934647|FG000|Treatment Period|Disease progression|6|||
129719754|NCT02574078|466934648|FG001|Treatment Period|Disease progression|4|||
129719755|NCT02574078|466934649|FG002|Treatment Period|Disease progression|7|||
129719756|NCT02574078|466934650|FG003|Treatment Period|Disease progression|18|||
129719757|NCT02574078|466934651|FG004|Treatment Period|Disease progression|16|||
129719758|NCT02574078|466934652|FG005|Treatment Period|Disease progression|26|||
129719759|NCT02574078|466934653|FG006|Treatment Period|Disease progression|5|||
129719760|NCT02574078|466934654|FG007|Treatment Period|Disease progression|9|||
129719761|NCT02574078|466934655|FG008|Treatment Period|Disease progression|8|||
129719762|NCT02574078|466934656|FG009|Treatment Period|Disease progression|5|||
129719763|NCT02574078|466934657|FG010|Treatment Period|Disease progression|20|||
129719764|NCT02574078|466934658|FG011|Treatment Period|Disease progression|29|||
129719765|NCT02574078|466934659|FG012|Treatment Period|Disease progression|2|||
129719766|NCT02574078|466934647|FG000|Treatment Period|Study drug toxicity|1|||
129719767|NCT02574078|466934648|FG001|Treatment Period|Study drug toxicity|1|||
129719768|NCT02574078|466934649|FG002|Treatment Period|Study drug toxicity|0|||
129719769|NCT02574078|466934650|FG003|Treatment Period|Study drug toxicity|5|||
129719770|NCT02574078|466934651|FG004|Treatment Period|Study drug toxicity|3|||
129719771|NCT02574078|466934652|FG005|Treatment Period|Study drug toxicity|1|||
129719772|NCT02574078|466934653|FG006|Treatment Period|Study drug toxicity|2|||
129719773|NCT02574078|466934654|FG007|Treatment Period|Study drug toxicity|0|||
129719774|NCT02574078|466934655|FG008|Treatment Period|Study drug toxicity|2|||
129719775|NCT02574078|466934656|FG009|Treatment Period|Study drug toxicity|1|||
129719776|NCT02574078|466934657|FG010|Treatment Period|Study drug toxicity|16|||
129719777|NCT02574078|466934658|FG011|Treatment Period|Study drug toxicity|2|||
129719778|NCT02574078|466934659|FG012|Treatment Period|Study drug toxicity|4|||
129719779|NCT02574078|466934647|FG000|Treatment Period|Death|2|||
129803514|NCT00004635|467249757|FG000|Period One|refused|2|||
129803515|NCT00004635|467249758|FG001|Period One|refused|1|||
129803516|NCT00004635|467249757|FG000|Period One|Withdrawal by Subject|1|||
129803517|NCT00004635|467249758|FG001|Period One|Withdrawal by Subject|1|||
129803518|NCT00004635|467249757|FG000|Period One|Protocol Violation|1|||
129803519|NCT00004635|467249758|FG001|Period One|Protocol Violation|0|||
129803520|NCT00004635|467249757|FG000|Period One|PSA did not go <5 ng/mL|1|||
129803521|NCT00004635|467249758|FG001|Period One|PSA did not go <5 ng/mL|0|||
129803522|NCT00004635|467249757|FG000|Period One|second malignancy|1|||
129803523|NCT00004635|467249758|FG001|Period One|second malignancy|0|||
129803524|NCT00004635|467249757|FG000|Period One|progressed|0|||
129803525|NCT00004635|467249758|FG001|Period One|progressed|2|||
129803526|NCT00004635|467249757|FG000|Period One|health problem|0|||
129803527|NCT00004635|467249758|FG001|Period One|health problem|1|||
129719780|NCT02574078|466934648|FG001|Treatment Period|Death|0|||
129719781|NCT02574078|466934649|FG002|Treatment Period|Death|0|||
129719782|NCT02574078|466934650|FG003|Treatment Period|Death|0|||
129719783|NCT02574078|466934651|FG004|Treatment Period|Death|1|||
129719784|NCT02574078|466934652|FG005|Treatment Period|Death|1|||
129719785|NCT02574078|466934653|FG006|Treatment Period|Death|1|||
129719786|NCT02574078|466934654|FG007|Treatment Period|Death|1|||
129719787|NCT02574078|466934655|FG008|Treatment Period|Death|7|||
129719788|NCT02574078|466934656|FG009|Treatment Period|Death|1|||
129719789|NCT02574078|466934657|FG010|Treatment Period|Death|0|||
129719790|NCT02574078|466934658|FG011|Treatment Period|Death|2|||
129719791|NCT02574078|466934659|FG012|Treatment Period|Death|1|||
129719792|NCT02574078|466934647|FG000|Treatment Period|Adverse event unrelated to drug|0|||
129719793|NCT02574078|466934648|FG001|Treatment Period|Adverse event unrelated to drug|0|||
129719794|NCT02574078|466934649|FG002|Treatment Period|Adverse event unrelated to drug|1|||
129719795|NCT02574078|466934650|FG003|Treatment Period|Adverse event unrelated to drug|0|||
129719796|NCT02574078|466934651|FG004|Treatment Period|Adverse event unrelated to drug|2|||
129719797|NCT02574078|466934652|FG005|Treatment Period|Adverse event unrelated to drug|3|||
129719798|NCT02574078|466934653|FG006|Treatment Period|Adverse event unrelated to drug|0|||
129719799|NCT02574078|466934654|FG007|Treatment Period|Adverse event unrelated to drug|0|||
129719800|NCT02574078|466934655|FG008|Treatment Period|Adverse event unrelated to drug|1|||
129719801|NCT02574078|466934656|FG009|Treatment Period|Adverse event unrelated to drug|2|||
129719802|NCT02574078|466934657|FG010|Treatment Period|Adverse event unrelated to drug|4|||
129719803|NCT02574078|466934658|FG011|Treatment Period|Adverse event unrelated to drug|1|||
129719804|NCT02574078|466934659|FG012|Treatment Period|Adverse event unrelated to drug|0|||
129719805|NCT02574078|466934647|FG000|Treatment Period|Administrative reason by Sponsor|0|||
129719806|NCT02574078|466934648|FG001|Treatment Period|Administrative reason by Sponsor|1|||
129719807|NCT02574078|466934649|FG002|Treatment Period|Administrative reason by Sponsor|0|||
129719808|NCT02574078|466934650|FG003|Treatment Period|Administrative reason by Sponsor|0|||
129719809|NCT02574078|466934651|FG004|Treatment Period|Administrative reason by Sponsor|0|||
129719810|NCT02574078|466934652|FG005|Treatment Period|Administrative reason by Sponsor|0|||
129719811|NCT02574078|466934653|FG006|Treatment Period|Administrative reason by Sponsor|1|||
129719812|NCT02574078|466934654|FG007|Treatment Period|Administrative reason by Sponsor|0|||
129719813|NCT02574078|466934655|FG008|Treatment Period|Administrative reason by Sponsor|0|||
129719814|NCT02574078|466934656|FG009|Treatment Period|Administrative reason by Sponsor|0|||
129719815|NCT02574078|466934657|FG010|Treatment Period|Administrative reason by Sponsor|0|||
129719816|NCT02574078|466934658|FG011|Treatment Period|Administrative reason by Sponsor|0|||
129719817|NCT02574078|466934659|FG012|Treatment Period|Administrative reason by Sponsor|3|||
129719818|NCT02574078|466934647|FG000|Treatment Period|Other reasons|1|||
129719819|NCT02574078|466934648|FG001|Treatment Period|Other reasons|0|||
129719820|NCT02574078|466934649|FG002|Treatment Period|Other reasons|1|||
129719821|NCT02574078|466934650|FG003|Treatment Period|Other reasons|3|||
129719822|NCT02574078|466934651|FG004|Treatment Period|Other reasons|3|||
129719823|NCT02574078|466934652|FG005|Treatment Period|Other reasons|1|||
129719824|NCT02574078|466934653|FG006|Treatment Period|Other reasons|2|||
129719825|NCT02574078|466934654|FG007|Treatment Period|Other reasons|1|||
129719826|NCT02574078|466934655|FG008|Treatment Period|Other reasons|3|||
129719827|NCT02574078|466934656|FG009|Treatment Period|Other reasons|1|||
129719828|NCT02574078|466934657|FG010|Treatment Period|Other reasons|1|||
129719829|NCT02574078|466934658|FG011|Treatment Period|Other reasons|3|||
129719830|NCT02574078|466934659|FG012|Treatment Period|Other reasons|1|||
129719831|NCT02574078|466934647|FG000|Treatment Period|Participant request to stop drug|0|||
129719832|NCT02574078|466934648|FG001|Treatment Period|Participant request to stop drug|0|||
129719833|NCT02574078|466934649|FG002|Treatment Period|Participant request to stop drug|0|||
129719834|NCT02574078|466934650|FG003|Treatment Period|Participant request to stop drug|2|||
129719835|NCT02574078|466934651|FG004|Treatment Period|Participant request to stop drug|4|||
129719836|NCT02574078|466934652|FG005|Treatment Period|Participant request to stop drug|0|||
129719837|NCT02574078|466934653|FG006|Treatment Period|Participant request to stop drug|1|||
129719838|NCT02574078|466934654|FG007|Treatment Period|Participant request to stop drug|0|||
129719839|NCT02574078|466934655|FG008|Treatment Period|Participant request to stop drug|3|||
129719840|NCT02574078|466934656|FG009|Treatment Period|Participant request to stop drug|2|||
129719841|NCT02574078|466934657|FG010|Treatment Period|Participant request to stop drug|2|||
129719842|NCT02574078|466934658|FG011|Treatment Period|Participant request to stop drug|4|||
129719843|NCT02574078|466934659|FG012|Treatment Period|Participant request to stop drug|1|||
129719844|NCT02574078|466934647|FG000|Treatment Period|Participant withdrew consent|0|||
129719845|NCT02574078|466934648|FG001|Treatment Period|Participant withdrew consent|0|||
129719846|NCT02574078|466934649|FG002|Treatment Period|Participant withdrew consent|0|||
129719847|NCT02574078|466934650|FG003|Treatment Period|Participant withdrew consent|0|||
129719848|NCT02574078|466934651|FG004|Treatment Period|Participant withdrew consent|1|||
129719849|NCT02574078|466934652|FG005|Treatment Period|Participant withdrew consent|1|||
129719850|NCT02574078|466934653|FG006|Treatment Period|Participant withdrew consent|0|||
129719851|NCT02574078|466934654|FG007|Treatment Period|Participant withdrew consent|1|||
129719852|NCT02574078|466934655|FG008|Treatment Period|Participant withdrew consent|0|||
129719853|NCT02574078|466934656|FG009|Treatment Period|Participant withdrew consent|2|||
129719854|NCT02574078|466934657|FG010|Treatment Period|Participant withdrew consent|1|||
129719855|NCT02574078|466934658|FG011|Treatment Period|Participant withdrew consent|4|||
129719856|NCT02574078|466934659|FG012|Treatment Period|Participant withdrew consent|1|||
129719857|NCT02574078|466934647|FG000|Treatment Period|Participant no longer meets criteria|0|||
129891576|NCT01734382|467561197|FG001|Part 2|Protocol Violation|1|||
129719858|NCT02574078|466934648|FG001|Treatment Period|Participant no longer meets criteria|0|||
129719859|NCT02574078|466934649|FG002|Treatment Period|Participant no longer meets criteria|0|||
129719860|NCT02574078|466934650|FG003|Treatment Period|Participant no longer meets criteria|0|||
129719861|NCT02574078|466934651|FG004|Treatment Period|Participant no longer meets criteria|1|||
129719862|NCT02574078|466934652|FG005|Treatment Period|Participant no longer meets criteria|0|||
129719863|NCT02574078|466934653|FG006|Treatment Period|Participant no longer meets criteria|0|||
129719864|NCT02574078|466934654|FG007|Treatment Period|Participant no longer meets criteria|0|||
129719865|NCT02574078|466934655|FG008|Treatment Period|Participant no longer meets criteria|0|||
129719866|NCT02574078|466934656|FG009|Treatment Period|Participant no longer meets criteria|1|||
129719867|NCT02574078|466934657|FG010|Treatment Period|Participant no longer meets criteria|1|||
129719868|NCT02574078|466934658|FG011|Treatment Period|Participant no longer meets criteria|1|||
129719869|NCT02574078|466934659|FG012|Treatment Period|Participant no longer meets criteria|0|||
129719870|NCT02574078|466934647|FG000|Treatment Period|Lost to Follow-up|0|||
129719871|NCT02574078|466934648|FG001|Treatment Period|Lost to Follow-up|0|||
129719872|NCT02574078|466934649|FG002|Treatment Period|Lost to Follow-up|0|||
129719873|NCT02574078|466934650|FG003|Treatment Period|Lost to Follow-up|0|||
129719874|NCT02574078|466934651|FG004|Treatment Period|Lost to Follow-up|0|||
129719875|NCT02574078|466934652|FG005|Treatment Period|Lost to Follow-up|0|||
129719876|NCT02574078|466934653|FG006|Treatment Period|Lost to Follow-up|0|||
129719877|NCT02574078|466934654|FG007|Treatment Period|Lost to Follow-up|0|||
129719878|NCT02574078|466934655|FG008|Treatment Period|Lost to Follow-up|0|||
129719879|NCT02574078|466934656|FG009|Treatment Period|Lost to Follow-up|1|||
129719880|NCT02574078|466934657|FG010|Treatment Period|Lost to Follow-up|0|||
129719881|NCT02574078|466934658|FG011|Treatment Period|Lost to Follow-up|1|||
129719882|NCT02574078|466934659|FG012|Treatment Period|Lost to Follow-up|0|||
129719883|NCT02574078|466934647|FG000|Treatment Period|Maximum clinical benefit|0|||
129719884|NCT02574078|466934648|FG001|Treatment Period|Maximum clinical benefit|0|||
129719885|NCT02574078|466934649|FG002|Treatment Period|Maximum clinical benefit|0|||
129719886|NCT02574078|466934650|FG003|Treatment Period|Maximum clinical benefit|0|||
129719887|NCT02574078|466934651|FG004|Treatment Period|Maximum clinical benefit|0|||
129719888|NCT02574078|466934652|FG005|Treatment Period|Maximum clinical benefit|0|||
129719889|NCT02574078|466934653|FG006|Treatment Period|Maximum clinical benefit|0|||
129719890|NCT02574078|466934654|FG007|Treatment Period|Maximum clinical benefit|0|||
129719891|NCT02574078|466934655|FG008|Treatment Period|Maximum clinical benefit|0|||
129719892|NCT02574078|466934656|FG009|Treatment Period|Maximum clinical benefit|1|||
129719893|NCT02574078|466934657|FG010|Treatment Period|Maximum clinical benefit|0|||
129719894|NCT02574078|466934658|FG011|Treatment Period|Maximum clinical benefit|0|||
129719895|NCT02574078|466934659|FG012|Treatment Period|Maximum clinical benefit|0|||
129719896|NCT03037476|466934660|FG000|Overall Study|Lost to Follow-up|63|||
129719897|NCT03037476|466934661|FG001|Overall Study|Lost to Follow-up|46|||
129719898|NCT01498692|466934669|FG000|Overall Study|Death|4|||
129719899|NCT01498692|466934669|FG000|Overall Study|Withdrawal by Subject|1|||
129719900|NCT01498692|466934669|FG000|Overall Study|Missed 12-month visit|3|||
129719901|NCT00590122|466934670|FG000|Overall Study|swallowed oral dissolving dose|1|||
129719902|NCT00590122|466934671|FG001|Overall Study|swallowed oral dissolving dose|0|||
129719903|NCT01208324|466934672|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
129719904|NCT01208324|466934673|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
129719905|NCT01208324|466934674|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
129719906|NCT01208324|466934675|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
129719907|NCT02707965|466934676|FG000|Overall Study|Withdrawal by Subject|0|||
129719908|NCT02707965|466934677|FG001|Overall Study|Withdrawal by Subject|0|||
129719909|NCT02707965|466934678|FG002|Overall Study|Withdrawal by Subject|1|||
129719910|NCT02707965|466934679|FG003|Overall Study|Withdrawal by Subject|0|||
129719911|NCT02707965|466934680|FG004|Overall Study|Withdrawal by Subject|0|||
129719912|NCT02707965|466934681|FG005|Overall Study|Withdrawal by Subject|0|||
129719913|NCT02707965|466934682|FG006|Overall Study|Withdrawal by Subject|0|||
129719914|NCT02707965|466934683|FG007|Overall Study|Withdrawal by Subject|2|||
129719915|NCT02707965|466934684|FG008|Overall Study|Withdrawal by Subject|0|||
129719916|NCT02707965|466934685|FG009|Overall Study|Withdrawal by Subject|0|||
129719917|NCT02707965|466934686|FG010|Overall Study|Withdrawal by Subject|0|||
129719918|NCT02707965|466934687|FG011|Overall Study|Withdrawal by Subject|0|||
129719919|NCT02707965|466934688|FG012|Overall Study|Withdrawal by Subject|0|||
129719920|NCT02707965|466934689|FG013|Overall Study|Withdrawal by Subject|0|||
129719921|NCT02707965|466934690|FG014|Overall Study|Withdrawal by Subject|0|||
129719922|NCT02707965|466934691|FG015|Overall Study|Withdrawal by Subject|0|||
129719923|NCT02707965|466934676|FG000|Overall Study|PI decisions|0|||
129719924|NCT02707965|466934677|FG001|Overall Study|PI decisions|0|||
129719925|NCT02707965|466934678|FG002|Overall Study|PI decisions|0|||
129719926|NCT02707965|466934679|FG003|Overall Study|PI decisions|0|||
129719927|NCT02707965|466934680|FG004|Overall Study|PI decisions|0|||
129719928|NCT02707965|466934681|FG005|Overall Study|PI decisions|0|||
129719929|NCT02707965|466934682|FG006|Overall Study|PI decisions|0|||
129719930|NCT02707965|466934683|FG007|Overall Study|PI decisions|0|||
129444380|NCT00578786|465927335|FG001|Overall Study|Lack of Efficacy|5|||
129719931|NCT02707965|466934684|FG008|Overall Study|PI decisions|0|||
129719932|NCT02707965|466934685|FG009|Overall Study|PI decisions|0|||
129444381|NCT00578786|465927336|FG002|Overall Study|Lack of Efficacy|2|||
129719933|NCT02707965|466934686|FG010|Overall Study|PI decisions|0|||
129719934|NCT02707965|466934687|FG011|Overall Study|PI decisions|0|||
129719935|NCT02707965|466934688|FG012|Overall Study|PI decisions|0|||
129719936|NCT02707965|466934689|FG013|Overall Study|PI decisions|0|||
129719937|NCT02707965|466934690|FG014|Overall Study|PI decisions|2|||
129719938|NCT02707965|466934691|FG015|Overall Study|PI decisions|0|||
129719939|NCT02707965|466934676|FG000|Overall Study|Protocol deviation|1|||
129719940|NCT02707965|466934677|FG001|Overall Study|Protocol deviation|1|||
129719941|NCT02707965|466934678|FG002|Overall Study|Protocol deviation|0|||
129719942|NCT02707965|466934679|FG003|Overall Study|Protocol deviation|0|||
129719943|NCT02707965|466934680|FG004|Overall Study|Protocol deviation|0|||
129719944|NCT02707965|466934681|FG005|Overall Study|Protocol deviation|0|||
129719945|NCT02707965|466934682|FG006|Overall Study|Protocol deviation|0|||
129719946|NCT02707965|466934683|FG007|Overall Study|Protocol deviation|1|||
129719947|NCT02707965|466934684|FG008|Overall Study|Protocol deviation|0|||
129719948|NCT02707965|466934685|FG009|Overall Study|Protocol deviation|0|||
129719949|NCT02707965|466934686|FG010|Overall Study|Protocol deviation|0|||
129719950|NCT02707965|466934687|FG011|Overall Study|Protocol deviation|0|||
129719951|NCT02707965|466934688|FG012|Overall Study|Protocol deviation|0|||
129719952|NCT02707965|466934689|FG013|Overall Study|Protocol deviation|0|||
129719953|NCT02707965|466934690|FG014|Overall Study|Protocol deviation|0|||
129719954|NCT02707965|466934691|FG015|Overall Study|Protocol deviation|0|||
129719955|NCT00249808|466934692|FG000|Overall Study|Other|27|||
129719956|NCT00249808|466934692|FG000|Overall Study|Protocol Violation|3|||
129719957|NCT00249808|466934692|FG000|Overall Study|Lost to Follow-up|8|||
129719958|NCT00249808|466934692|FG000|Overall Study|Adverse Event|81|||
129719959|NCT00249808|466934692|FG000|Overall Study|Lack of Efficacy|52|||
129719960|NCT00249808|466934692|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
129719961|NCT02789345|466934693|FG000|Overall Study|Adverse Event|0|||
129719962|NCT02789345|466934694|FG001|Overall Study|Adverse Event|0|||
129719963|NCT02789345|466934695|FG002|Overall Study|Adverse Event|1|||
129719964|NCT02789345|466934693|FG000|Overall Study|Death|0|||
129719965|NCT02789345|466934694|FG001|Overall Study|Death|0|||
129719966|NCT02789345|466934695|FG002|Overall Study|Death|1|||
129719967|NCT02789345|466934693|FG000|Overall Study|Physician Decision|2|||
129719968|NCT02789345|466934694|FG001|Overall Study|Physician Decision|0|||
129719969|NCT02789345|466934695|FG002|Overall Study|Physician Decision|1|||
129719970|NCT02789345|466934693|FG000|Overall Study|Progressive Disease|1|||
129719971|NCT02789345|466934694|FG001|Overall Study|Progressive Disease|3|||
129719972|NCT02789345|466934695|FG002|Overall Study|Progressive Disease|14|||
129719973|NCT00135330|466934697|FG000|Overall Study|Adverse Event|2|||
129719974|NCT00135330|466934698|FG001|Overall Study|Adverse Event|5|||
129719975|NCT00135330|466934699|FG002|Overall Study|Adverse Event|1|||
129719976|NCT00135330|466934697|FG000|Overall Study|Lost to Follow-up|0|||
129719977|NCT00135330|466934698|FG001|Overall Study|Lost to Follow-up|2|||
129719978|NCT00135330|466934699|FG002|Overall Study|Lost to Follow-up|3|||
129719979|NCT00135330|466934697|FG000|Overall Study|Physician Decision|1|||
129719980|NCT00135330|466934698|FG001|Overall Study|Physician Decision|1|||
129719981|NCT00135330|466934699|FG002|Overall Study|Physician Decision|0|||
129719982|NCT00135330|466934697|FG000|Overall Study|Protocol Violation|4|||
129719983|NCT00135330|466934698|FG001|Overall Study|Protocol Violation|3|||
129719984|NCT00135330|466934699|FG002|Overall Study|Protocol Violation|3|||
129719985|NCT00135330|466934697|FG000|Overall Study|Patient Decision|5|||
129719986|NCT00135330|466934698|FG001|Overall Study|Patient Decision|1|||
129719987|NCT00135330|466934699|FG002|Overall Study|Patient Decision|4|||
129719988|NCT00135330|466934697|FG000|Overall Study|Sponsor Decision|0|||
129719989|NCT00135330|466934698|FG001|Overall Study|Sponsor Decision|1|||
129719990|NCT00135330|466934699|FG002|Overall Study|Sponsor Decision|0|||
129719991|NCT00372619|466934700|FG000|Overall Study|Ineligible|0|||
129719992|NCT00372619|466934701|FG001|Overall Study|Ineligible|0|||
129719993|NCT00372619|466934702|FG002|Overall Study|Ineligible|0|||
129719994|NCT00372619|466934703|FG003|Overall Study|Ineligible|0|||
129719995|NCT00372619|466934704|FG004|Overall Study|Ineligible|0|||
129719996|NCT00372619|466934705|FG005|Overall Study|Ineligible|2|||
129719997|NCT00372619|466934706|FG006|Overall Study|Ineligible|0|||
129719998|NCT00372619|466934700|FG000|Overall Study|Inevaluable|0|||
129719999|NCT00372619|466934701|FG001|Overall Study|Inevaluable|0|||
129720000|NCT00372619|466934702|FG002|Overall Study|Inevaluable|0|||
129720001|NCT00372619|466934703|FG003|Overall Study|Inevaluable|0|||
129720002|NCT00372619|466934704|FG004|Overall Study|Inevaluable|0|||
129720003|NCT00372619|466934705|FG005|Overall Study|Inevaluable|1|||
129803528|NCT00004635|467249757|FG000|Period One|discrepancy in data entry|0|||
129803529|NCT00004635|467249758|FG001|Period One|discrepancy in data entry|1|||
129803530|NCT00004635|467249757|FG000|Period Two|progression|2|||
129803531|NCT00004635|467249758|FG001|Period Two|progression|3|||
129720004|NCT00372619|466934706|FG006|Overall Study|Inevaluable|0|||
129720005|NCT00066222|466934707|FG000|Overall Study|No protocol treatment received|1|||
129720006|NCT01524224|466934714|FG000|Overall Study|Progressive Disease|1|||
129720007|NCT01524224|466934715|FG001|Overall Study|Progressive Disease|0|||
129720008|NCT01524224|466934716|FG002|Overall Study|Progressive Disease|2|||
129720009|NCT01524224|466934717|FG003|Overall Study|Progressive Disease|1|||
129720010|NCT01524224|466934718|FG004|Overall Study|Progressive Disease|2|||
129720011|NCT01524224|466934719|FG005|Overall Study|Progressive Disease|1|||
129720012|NCT01524224|466934720|FG006|Overall Study|Progressive Disease|1|||
129720013|NCT01524224|466934721|FG007|Overall Study|Progressive Disease|5|||
129720014|NCT01524224|466934714|FG000|Overall Study|Withdrawal by Subject|2|||
129720015|NCT01524224|466934715|FG001|Overall Study|Withdrawal by Subject|0|||
129720016|NCT01524224|466934716|FG002|Overall Study|Withdrawal by Subject|0|||
129720017|NCT01524224|466934717|FG003|Overall Study|Withdrawal by Subject|0|||
129720018|NCT01524224|466934718|FG004|Overall Study|Withdrawal by Subject|0|||
129720019|NCT01524224|466934719|FG005|Overall Study|Withdrawal by Subject|0|||
129720020|NCT01524224|466934720|FG006|Overall Study|Withdrawal by Subject|2|||
129891577|NCT01734382|467561198|FG002|Part 2|Protocol Violation|0|||
129891578|NCT01734382|467561196|FG000|Part 2|Withdrawal by Subject|0|||
129891579|NCT01734382|467561197|FG001|Part 2|Withdrawal by Subject|0|||
129891580|NCT01734382|467561198|FG002|Part 2|Withdrawal by Subject|1|||
129891581|NCT01052662|467561201|FG000|Overall Study|Lost to Follow-up|15|||
129891582|NCT01052662|467561202|FG001|Overall Study|Lost to Follow-up|13|||
129891583|NCT01052662|467561203|FG002|Overall Study|Lost to Follow-up|18|||
129891584|NCT01052662|467561201|FG000|Overall Study|Withdrawal by Subject|3|||
129891585|NCT01052662|467561202|FG001|Overall Study|Withdrawal by Subject|2|||
129720021|NCT01524224|466934721|FG007|Overall Study|Withdrawal by Subject|0|||
129720022|NCT01524224|466934714|FG000|Overall Study|Adverse Event|0|||
129720023|NCT01524224|466934715|FG001|Overall Study|Adverse Event|1|||
129720024|NCT01524224|466934716|FG002|Overall Study|Adverse Event|0|||
129720025|NCT01524224|466934717|FG003|Overall Study|Adverse Event|0|||
129720026|NCT01524224|466934718|FG004|Overall Study|Adverse Event|0|||
129720027|NCT01524224|466934719|FG005|Overall Study|Adverse Event|1|||
129720028|NCT01524224|466934720|FG006|Overall Study|Adverse Event|0|||
129891586|NCT01052662|467561203|FG002|Overall Study|Withdrawal by Subject|1|||
129891587|NCT01052662|467561201|FG000|Overall Study|Pharmacy issue|1|||
129720029|NCT01524224|466934721|FG007|Overall Study|Adverse Event|0|||
129720030|NCT01524224|466934714|FG000|Overall Study|Physician Decision|0|||
129720031|NCT01524224|466934715|FG001|Overall Study|Physician Decision|0|||
129720032|NCT01524224|466934716|FG002|Overall Study|Physician Decision|0|||
129720033|NCT01524224|466934717|FG003|Overall Study|Physician Decision|1|||
129720034|NCT01524224|466934718|FG004|Overall Study|Physician Decision|1|||
129720035|NCT01524224|466934719|FG005|Overall Study|Physician Decision|0|||
129720036|NCT01524224|466934720|FG006|Overall Study|Physician Decision|0|||
129720037|NCT01524224|466934721|FG007|Overall Study|Physician Decision|1|||
129720038|NCT01524224|466934714|FG000|Overall Study|Sponsor Decision|0|||
129720039|NCT01524224|466934715|FG001|Overall Study|Sponsor Decision|0|||
129720040|NCT01524224|466934716|FG002|Overall Study|Sponsor Decision|0|||
129720041|NCT01524224|466934717|FG003|Overall Study|Sponsor Decision|0|||
129720042|NCT01524224|466934718|FG004|Overall Study|Sponsor Decision|1|||
129720043|NCT01524224|466934719|FG005|Overall Study|Sponsor Decision|0|||
129720044|NCT01524224|466934720|FG006|Overall Study|Sponsor Decision|0|||
129720045|NCT01524224|466934721|FG007|Overall Study|Sponsor Decision|0|||
129720046|NCT00615719|466934723|FG000|Overall Study|Physician Decision|5|||
129720047|NCT03517371|466934724|FG000|Overall Study|Adverse Event|8|||
129720048|NCT03517371|466934725|FG001|Overall Study|Adverse Event|9|||
129720049|NCT03517371|466934724|FG000|Overall Study|Lost to Follow-up|1|||
129720050|NCT03517371|466934725|FG001|Overall Study|Lost to Follow-up|2|||
129720051|NCT03517371|466934724|FG000|Overall Study|Withdrawal by Subject|4|||
129720052|NCT03517371|466934725|FG001|Overall Study|Withdrawal by Subject|4|||
129720053|NCT03517371|466934724|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
129720054|NCT03517371|466934725|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
129720055|NCT03517371|466934724|FG000|Overall Study|COVID restrictions|2|||
129720056|NCT03517371|466934725|FG001|Overall Study|COVID restrictions|0|||
129720057|NCT03517371|466934724|FG000|Overall Study|Receiving DBS Surgery|0|||
129720058|NCT03517371|466934725|FG001|Overall Study|Receiving DBS Surgery|1|||
129720059|NCT05420961|466934726|FG000|Overall Study|Withdrawal by Subject|2|||
129720060|NCT05420961|466934727|FG001|Overall Study|Withdrawal by Subject|1|||
129720061|NCT05420961|466934728|FG002|Overall Study|Withdrawal by Subject|1|||
129720062|NCT05420961|466934729|FG003|Overall Study|Withdrawal by Subject|0|||
129720063|NCT05420961|466934730|FG004|Overall Study|Withdrawal by Subject|0|||
129720064|NCT05420961|466934726|FG000|Overall Study|Lost to Follow-up|0|||
129720065|NCT05420961|466934727|FG001|Overall Study|Lost to Follow-up|0|||
129720066|NCT05420961|466934728|FG002|Overall Study|Lost to Follow-up|1|||
129720067|NCT05420961|466934729|FG003|Overall Study|Lost to Follow-up|0|||
129720068|NCT05420961|466934730|FG004|Overall Study|Lost to Follow-up|0|||
129720069|NCT05420961|466934726|FG000|Overall Study|Randomized by mistake without study treatment|0|||
129720070|NCT05420961|466934727|FG001|Overall Study|Randomized by mistake without study treatment|0|||
129720071|NCT05420961|466934728|FG002|Overall Study|Randomized by mistake without study treatment|1|||
129720072|NCT05420961|466934729|FG003|Overall Study|Randomized by mistake without study treatment|0|||
129720073|NCT05420961|466934730|FG004|Overall Study|Randomized by mistake without study treatment|1|||
129720074|NCT04283656|466934731|FG000|Overall Study|Adverse Event|1|||
129720075|NCT04283656|466934732|FG001|Overall Study|Adverse Event|0|||
129720076|NCT04283656|466934731|FG000|Overall Study|Lost to Follow-up|0|||
129720077|NCT04283656|466934732|FG001|Overall Study|Lost to Follow-up|1|||
129720078|NCT00935493|466934737|FG000|Overall Study|Lost to Follow-up|1|||
129720079|NCT00935493|466934738|FG001|Overall Study|Lost to Follow-up|1|||
129720080|NCT00935493|466934739|FG002|Overall Study|Lost to Follow-up|1|||
129720081|NCT00935493|466934737|FG000|Overall Study|Treatment Discontinued|0|||
129720082|NCT00935493|466934738|FG001|Overall Study|Treatment Discontinued|1|||
129720083|NCT00935493|466934739|FG002|Overall Study|Treatment Discontinued|0|||
129720084|NCT01555073|466934740|FG000|Overall Study|Lost to Follow-up|1|||
129891588|NCT01052662|467561202|FG001|Overall Study|Pharmacy issue|3|||
129891589|NCT01052662|467561203|FG002|Overall Study|Pharmacy issue|3|||
129803532|NCT00004635|467249757|FG000|Period Two|Adverse Event|1|||
129803533|NCT00004635|467249758|FG001|Period Two|Adverse Event|0|||
129803534|NCT00004635|467249757|FG000|Period Two|refused|0|||
129803535|NCT00004635|467249758|FG001|Period Two|refused|2|||
129803536|NCT00004635|467249757|FG000|Period Two|health problem|1|||
129803537|NCT00004635|467249758|FG001|Period Two|health problem|1|||
129803538|NCT00004635|467249757|FG000|Period Two|travel issues|0|||
129720085|NCT01555073|466934741|FG001|Overall Study|Lost to Follow-up|2|||
129720086|NCT01555073|466934742|FG002|Overall Study|Lost to Follow-up|0|||
129720087|NCT01555073|466934743|FG003|Overall Study|Lost to Follow-up|5|||
129720088|NCT02565147|466934747|FG000|Overall Study|Withdrawal by Subject|5|||
129720089|NCT02565147|466934748|FG001|Overall Study|Withdrawal by Subject|1|||
129720090|NCT02565147|466934747|FG000|Overall Study|Lost to Follow-up|0|||
129720091|NCT02565147|466934748|FG001|Overall Study|Lost to Follow-up|1|||
129720092|NCT02565147|466934747|FG000|Overall Study|Death|1|||
129720093|NCT02565147|466934748|FG001|Overall Study|Death|1|||
129720094|NCT00335738|466934749|FG000|Overall Study|Physician Decision|6|||
129720095|NCT00335738|466934750|FG001|Overall Study|Physician Decision|0|||
129720096|NCT00335738|466934749|FG000|Overall Study|Withdrawal by Subject|2|||
129720097|NCT00335738|466934750|FG001|Overall Study|Withdrawal by Subject|0|||
129720098|NCT00335738|466934749|FG000|Overall Study|Ineligible|3|||
129720099|NCT00335738|466934750|FG001|Overall Study|Ineligible|4|||
129720100|NCT00992056|466934757|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
129720101|NCT00992056|466934758|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
129720102|NCT00992056|466934757|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
129720103|NCT00992056|466934758|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
129720104|NCT00902850|466934759|FG000|Overall Study|Physician Decision|2|||
129720105|NCT00902850|466934760|FG001|Overall Study|Physician Decision|2|||
129720106|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
129720107|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
129720108|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
129720109|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129720110|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129720111|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129720112|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129720113|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
129720114|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129720115|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129720116|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129720117|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129720118|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129720119|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
129720120|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
129720121|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
129803539|NCT00004635|467249758|FG001|Period Two|travel issues|1|||
129803540|NCT00004635|467249757|FG000|Period Two|secondary malignancy|1|||
129803541|NCT00004635|467249758|FG001|Period Two|secondary malignancy|1|||
129720122|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
129720123|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129720124|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129803542|NCT00004635|467249757|FG000|Period Two|Lost to Follow-up|1|||
129803543|NCT00004635|467249758|FG001|Period Two|Lost to Follow-up|0|||
129720125|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129720126|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129720127|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
129720128|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
129720129|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129720130|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129720131|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129720132|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129720133|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129720134|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
129720135|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129720136|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129720137|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129720138|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129720139|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129720140|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
129720141|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129720142|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
129720143|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129720144|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129720145|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129720146|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129720147|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129720148|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
129720149|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
129720150|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
129720151|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129720152|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129720153|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129720154|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129720155|NCT03745638|466934761|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
129720156|NCT03745638|466934762|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
129720157|NCT03745638|466934763|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129720158|NCT03745638|466934764|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129720159|NCT03745638|466934765|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129720160|NCT03745638|466934766|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129720161|NCT03745638|466934767|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
129720162|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129720163|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129720164|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129720165|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129720166|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129720167|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
129720168|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
129720169|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129720170|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129720171|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129720172|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
129720173|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129720174|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129720175|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
129720176|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129720177|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129720178|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129720179|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
129720180|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
129720181|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
129720182|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
129720183|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129720184|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129720185|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129720186|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129803544|NCT00004635|467249757|FG000|Period Two|discrepancy in data entry|0|||
129891590|NCT01052662|467561201|FG000|Overall Study|Adverse Event|1|||
129803545|NCT00004635|467249758|FG001|Period Two|discrepancy in data entry|1|||
129803546|NCT02024529|467249759|FG000|Overall Study|Withdrawal by Subject|11|||
129803547|NCT02024529|467249760|FG001|Overall Study|Withdrawal by Subject|21|||
129803548|NCT02024529|467249759|FG000|Overall Study|Lost to Follow-up|2|||
129803549|NCT02024529|467249760|FG001|Overall Study|Lost to Follow-up|4|||
129803550|NCT00354614|467249761|FG000|Overall Study|Lack of Efficacy|28|||
129803551|NCT01890746|467249762|FG000|Overall Study|Death|39|||
129803552|NCT01890746|467249763|FG001|Overall Study|Death|30|||
129803553|NCT01890746|467249762|FG000|Overall Study|Adverse Event|1|||
129803554|NCT01890746|467249763|FG001|Overall Study|Adverse Event|0|||
129803555|NCT01890746|467249762|FG000|Overall Study|Lost to Follow-up|4|||
129803556|NCT01890746|467249763|FG001|Overall Study|Lost to Follow-up|1|||
129803557|NCT01890746|467249762|FG000|Overall Study|Physician Decision|3|||
129803558|NCT01890746|467249763|FG001|Overall Study|Physician Decision|2|||
129803559|NCT01890746|467249762|FG000|Overall Study|Withdrawal by Subject|5|||
129803560|NCT01890746|467249763|FG001|Overall Study|Withdrawal by Subject|8|||
129803561|NCT02642029|467249764|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
129803562|NCT02642029|467249765|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803563|NCT02642029|467249766|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803564|NCT02642029|467249767|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803565|NCT02642029|467249768|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129720187|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
129720188|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
129720189|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129720190|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129720191|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129720192|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129720193|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129720194|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129720195|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
129720196|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129720197|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129720198|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129720199|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129720200|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
129720201|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
129720202|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
129720203|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
129720204|NCT03745638|466934761|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129720205|NCT03745638|466934762|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129720206|NCT03745638|466934763|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129720207|NCT03745638|466934764|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129720208|NCT03745638|466934765|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
129720209|NCT03745638|466934766|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
129720210|NCT03745638|466934767|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
129720211|NCT04470050|466934768|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129720212|NCT04470050|466934769|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129720213|NCT04470050|466934770|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129720214|NCT04470050|466934771|FG003|Double-blind Treatment Phase|Adverse Event|1|||
129720215|NCT04470050|466934772|FG004|Double-blind Treatment Phase|Adverse Event|0|||
129720216|NCT04470050|466934773|FG005|Double-blind Treatment Phase|Adverse Event|0|||
129720217|NCT04470050|466934774|FG006|Double-blind Treatment Phase|Adverse Event|0|||
129720218|NCT04470050|466934768|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129720219|NCT04470050|466934769|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
129720220|NCT04470050|466934770|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
129720221|NCT04470050|466934771|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
129720222|NCT04470050|466934772|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
129720223|NCT04470050|466934773|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
129720224|NCT04470050|466934774|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
129720225|NCT04470050|466934768|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
129720226|NCT04470050|466934769|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
129803566|NCT02642029|467249769|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
129803567|NCT02642029|467249764|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803568|NCT02642029|467249765|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
129720227|NCT04470050|466934770|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
129803569|NCT02642029|467249766|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803570|NCT02642029|467249767|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803571|NCT02642029|467249768|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129803572|NCT02642029|467249769|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
129720228|NCT04470050|466934771|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
129720229|NCT04470050|466934772|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
129720230|NCT04470050|466934773|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
129720231|NCT04470050|466934774|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
129720232|NCT03604172|466934776|FG000|Overall Study|Lost to Follow-up|1|||
129720233|NCT03604172|466934777|FG001|Overall Study|Lost to Follow-up|2|||
129720234|NCT02676895|466934778|FG000|Overall Study|Administrative reason|1|||
129720235|NCT02676895|466934779|FG001|Overall Study|Administrative reason|0|||
129720236|NCT02676895|466934780|FG002|Overall Study|Administrative reason|0|||
129720237|NCT02676895|466934778|FG000|Overall Study|Protocol Violation|1|||
129720238|NCT02676895|466934779|FG001|Overall Study|Protocol Violation|0|||
129720239|NCT02676895|466934780|FG002|Overall Study|Protocol Violation|0|||
129720240|NCT02676895|466934778|FG000|Overall Study|Adverse Event|0|||
129720241|NCT02676895|466934779|FG001|Overall Study|Adverse Event|3|||
129720242|NCT02676895|466934780|FG002|Overall Study|Adverse Event|1|||
129720243|NCT02676895|466934778|FG000|Overall Study|Lost to Follow-up|0|||
129720244|NCT02676895|466934779|FG001|Overall Study|Lost to Follow-up|0|||
129720245|NCT02676895|466934780|FG002|Overall Study|Lost to Follow-up|1|||
129720246|NCT02676895|466934778|FG000|Overall Study|Withdrawal by Subject|0|||
129720247|NCT02676895|466934779|FG001|Overall Study|Withdrawal by Subject|0|||
129720248|NCT02676895|466934780|FG002|Overall Study|Withdrawal by Subject|1|||
129720249|NCT00976716|466934786|FG000|Overall Study|Adverse Event|1|||
129720250|NCT03028129|466934789|FG000|Overall Study|Adverse Event|13|||
129720251|NCT03028129|466934790|FG001|Overall Study|Adverse Event|2|||
129720252|NCT03028129|466934789|FG000|Overall Study|Lost to Follow-up|50|||
129720253|NCT03028129|466934790|FG001|Overall Study|Lost to Follow-up|38|||
129720254|NCT03028129|466934789|FG000|Overall Study|Physician Decision|0|||
129720255|NCT03028129|466934790|FG001|Overall Study|Physician Decision|1|||
129720256|NCT03028129|466934789|FG000|Overall Study|Protocol Violation|1|||
129720257|NCT03028129|466934790|FG001|Overall Study|Protocol Violation|1|||
129720258|NCT03028129|466934789|FG000|Overall Study|Withdrawal by Subject|62|||
129720259|NCT03028129|466934790|FG001|Overall Study|Withdrawal by Subject|45|||
129720260|NCT04222699|466934794|FG000|Overall Study|Lost to Follow-up|2|||
129720261|NCT00923351|466934795|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
129720262|NCT00923351|466934796|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
129720263|NCT00923351|466934797|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
129720264|NCT01536561|466934802|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
129720265|NCT01536561|466934802|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
129720266|NCT01536561|466934802|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
129720267|NCT01536561|466934802|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
129720268|NCT01536561|466934802|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
129720269|NCT01536561|466934802|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
129803573|NCT02642029|467249764|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803574|NCT02642029|467249765|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803575|NCT02642029|467249766|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803576|NCT02642029|467249767|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803577|NCT02642029|467249768|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
129803578|NCT02642029|467249769|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
129803579|NCT02642029|467249764|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
129803580|NCT02642029|467249765|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
129803581|NCT02642029|467249766|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
129803582|NCT02642029|467249767|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
129803583|NCT02642029|467249768|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
129803584|NCT02642029|467249769|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
129803585|NCT02642029|467249764|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
129803586|NCT02642029|467249765|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803587|NCT02642029|467249766|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803588|NCT02642029|467249767|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803589|NCT02642029|467249768|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803590|NCT02642029|467249769|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
129803591|NCT02642029|467249764|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
129803592|NCT02642029|467249765|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803593|NCT02642029|467249766|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803594|NCT02642029|467249767|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129720270|NCT00972517|466934805|FG000|Overall Study|Adverse Event|0|||
129720271|NCT00972517|466934806|FG001|Overall Study|Adverse Event|0|||
129720272|NCT00972517|466934807|FG002|Overall Study|Adverse Event|0|||
129720273|NCT00972517|466934808|FG003|Overall Study|Adverse Event|1|||
129720274|NCT00972517|466934809|FG004|Overall Study|Adverse Event|0|||
129720275|NCT00972517|466934810|FG005|Overall Study|Adverse Event|0|||
129720276|NCT00972517|466934805|FG000|Overall Study|Withdrawal by Subject|0|||
129720277|NCT00972517|466934806|FG001|Overall Study|Withdrawal by Subject|1|||
129720278|NCT00972517|466934807|FG002|Overall Study|Withdrawal by Subject|0|||
129720279|NCT00972517|466934808|FG003|Overall Study|Withdrawal by Subject|2|||
129720280|NCT00972517|466934809|FG004|Overall Study|Withdrawal by Subject|1|||
129720281|NCT00972517|466934810|FG005|Overall Study|Withdrawal by Subject|0|||
129720282|NCT00984594|466934811|FG000|Overall Study|Lost to Follow-up|1|||
129720283|NCT00984594|466934812|FG001|Overall Study|Lost to Follow-up|0|||
129720284|NCT00984594|466934811|FG000|Overall Study|Withdrawal by Subject|0|||
129720285|NCT00984594|466934812|FG001|Overall Study|Withdrawal by Subject|1|||
129720286|NCT00851890|466934813|FG000|Overall Study|Lost to Follow-up|0|||
129720287|NCT00851890|466934814|FG001|Overall Study|Lost to Follow-up|1|||
129720288|NCT00851890|466934815|FG002|Overall Study|Lost to Follow-up|0|||
129720289|NCT00851890|466934816|FG003|Overall Study|Lost to Follow-up|1|||
129720290|NCT03135431|466934817|FG000|Overall Study|Study Surgeon not available|2|||
129720291|NCT03135431|466934818|FG001|Overall Study|Study Surgeon not available|0|||
129720292|NCT00281099|466934821|FG000|Overall Study|Death|46|||
129720293|NCT00281099|466934822|FG001|Overall Study|Death|57|||
129720294|NCT00281099|466934821|FG000|Overall Study|Lost to Follow-up|10|||
129720295|NCT00281099|466934822|FG001|Overall Study|Lost to Follow-up|19|||
129720296|NCT00281099|466934821|FG000|Overall Study|Withdrawal by Subject|65|||
129720297|NCT00281099|466934822|FG001|Overall Study|Withdrawal by Subject|70|||
129720298|NCT00281099|466934821|FG000|Overall Study|Physician Decision|79|||
129720299|NCT00281099|466934822|FG001|Overall Study|Physician Decision|72|||
129720300|NCT00281099|466934821|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
129720301|NCT00281099|466934822|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
129720302|NCT01059864|466934827|FG000|Open-Label Run-In Phase|Adverse Event|7|||
129720303|NCT01059864|466934828|FG001|Open-Label Run-In Phase|Adverse Event|0|||
129720304|NCT01059864|466934829|FG002|Open-Label Run-In Phase|Adverse Event|0|||
129720305|NCT01059864|466934827|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
129720306|NCT01059864|466934828|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
129720307|NCT01059864|466934829|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
129720308|NCT01059864|466934827|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
129720309|NCT01059864|466934828|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
129720310|NCT01059864|466934829|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
129720311|NCT01059864|466934827|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
129720312|NCT01059864|466934828|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
129720313|NCT01059864|466934829|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
129720314|NCT01059864|466934827|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
129720315|NCT01059864|466934828|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
129720316|NCT01059864|466934829|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
129720317|NCT01059864|466934827|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129720318|NCT01059864|466934828|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
129720319|NCT01059864|466934829|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
129720320|NCT00962741|466936843|FG000|Overall Study|Failed to return|3|||
129720321|NCT00962741|466936843|FG000|Overall Study|Lost to Follow-up|2|||
129720322|NCT00962741|466936843|FG000|Overall Study|Withdrawal by Subject|1|||
129720323|NCT00962741|466936843|FG000|Overall Study|Lack of Efficacy|1|||
129720324|NCT00962741|466936843|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
129720325|NCT01814878|466936844|FG000|Overall Study|Adverse Event|16|||
129720326|NCT01814878|466936845|FG001|Overall Study|Adverse Event|5|||
129720327|NCT01814878|466936844|FG000|Overall Study|Withdrawal by Subject|20|||
129720328|NCT01814878|466936845|FG001|Overall Study|Withdrawal by Subject|16|||
129720329|NCT01814878|466936844|FG000|Overall Study|Protocol Violation|5|||
129720330|NCT01814878|466936845|FG001|Overall Study|Protocol Violation|5|||
129720331|NCT01814878|466936844|FG000|Overall Study|Physician Decision|3|||
129720332|NCT01814878|466936845|FG001|Overall Study|Physician Decision|1|||
129720333|NCT01814878|466936844|FG000|Overall Study|Screening failure (drop-out)|0|||
129720334|NCT01814878|466936845|FG001|Overall Study|Screening failure (drop-out)|3|||
129720335|NCT01814878|466936844|FG000|Overall Study|Other|2|||
129720336|NCT01814878|466936845|FG001|Overall Study|Other|0|||
129720337|NCT03645421|466936846|FG000|Overall Study|Adverse Event|0|||
129720338|NCT03645421|466936847|FG001|Overall Study|Adverse Event|0|||
129720339|NCT03645421|466936848|FG002|Overall Study|Adverse Event|4|||
129720340|NCT03645421|466936849|FG003|Overall Study|Adverse Event|1|||
129720341|NCT03645421|466936846|FG000|Overall Study|Withdrawal by patient|0|||
129720342|NCT03645421|466936847|FG001|Overall Study|Withdrawal by patient|0|||
129720343|NCT03645421|466936848|FG002|Overall Study|Withdrawal by patient|0|||
129720344|NCT03645421|466936849|FG003|Overall Study|Withdrawal by patient|3|||
129720345|NCT03645421|466936846|FG000|Overall Study|Study specific withdrawal criteria|0|||
129720346|NCT03645421|466936847|FG001|Overall Study|Study specific withdrawal criteria|0|||
129720347|NCT03645421|466936848|FG002|Overall Study|Study specific withdrawal criteria|1|||
129720348|NCT03645421|466936849|FG003|Overall Study|Study specific withdrawal criteria|0|||
129720349|NCT00748618|466936852|FG000|Overall Study|Adverse Event|1|||
129720350|NCT00748618|466936853|FG001|Overall Study|Adverse Event|0|||
129720351|NCT02854436|466936857|FG000|Overall Study|Adverse Event|1|||
129720352|NCT02854436|466936857|FG000|Overall Study|Death|208|||
129720353|NCT02854436|466936857|FG000|Overall Study|Lost to Follow-up|5|||
129720354|NCT02854436|466936857|FG000|Overall Study|Withdrawal by Subject|24|||
129720355|NCT02854436|466936857|FG000|Overall Study|Other|45|||
129720356|NCT02854436|466936857|FG000|Overall Study|Physician Decision|6|||
129720357|NCT01977729|466936859|FG000|Overall Study|Study terminated|1|||
129720358|NCT01268046|466936860|FG000|Overall Study|Withdrawal by Subject|1|||
129720359|NCT01268046|466936861|FG001|Overall Study|Withdrawal by Subject|0|||
129720360|NCT01268046|466936862|FG002|Overall Study|Withdrawal by Subject|0|||
129720361|NCT01268046|466936863|FG003|Overall Study|Withdrawal by Subject|1|||
129720362|NCT01268046|466936860|FG000|Overall Study|Lost to Follow-up|0|||
129720363|NCT01268046|466936861|FG001|Overall Study|Lost to Follow-up|0|||
129720364|NCT01268046|466936862|FG002|Overall Study|Lost to Follow-up|1|||
129720365|NCT01268046|466936863|FG003|Overall Study|Lost to Follow-up|0|||
129720366|NCT02253433|466936864|FG000|Overall Study|Unable to Contact|9|||
129720367|NCT02253433|466936865|FG001|Overall Study|Unable to Contact|16|||
129720368|NCT02253433|466936864|FG000|Overall Study|Death|1|||
129720369|NCT02253433|466936865|FG001|Overall Study|Death|1|||
129720370|NCT02253433|466936864|FG000|Overall Study|No Longer Interested|3|||
129720371|NCT02253433|466936865|FG001|Overall Study|No Longer Interested|15|||
129720372|NCT02253433|466936864|FG000|Overall Study|Out of Study Area|2|||
129720373|NCT02253433|466936865|FG001|Overall Study|Out of Study Area|7|||
129720374|NCT02253433|466936864|FG000|Overall Study|Uncomfortable with home visitors|0|||
129720375|NCT02253433|466936865|FG001|Overall Study|Uncomfortable with home visitors|3|||
129720376|NCT02253433|466936864|FG000|Overall Study|Unstable Housing/Homeless|0|||
129720377|NCT02253433|466936865|FG001|Overall Study|Unstable Housing/Homeless|7|||
129720378|NCT02253433|466936864|FG000|Overall Study|Too Busy|0|||
129720379|NCT02253433|466936865|FG001|Overall Study|Too Busy|4|||
129720380|NCT02253433|466936864|FG000|Overall Study|Medical or Other Concerns|1|||
129720381|NCT02253433|466936865|FG001|Overall Study|Medical or Other Concerns|2|||
129720382|NCT02836717|466936868|FG000|Test Phase|Lack of Efficacy|14|||
129720383|NCT02836717|466936869|FG001|Test Phase|Lack of Efficacy|8|||
129720384|NCT02836717|466936870|FG002|Test Phase|Lack of Efficacy|0|||
129720385|NCT02836717|466936868|FG000|Study Phase|Adverse Event|2|||
129720386|NCT02836717|466936869|FG001|Study Phase|Adverse Event|0|||
129720387|NCT02836717|466936870|FG002|Study Phase|Adverse Event|0|||
129720388|NCT02836717|466936868|FG000|Study Phase|Lack of Efficacy|8|||
129720389|NCT02836717|466936869|FG001|Study Phase|Lack of Efficacy|6|||
129720390|NCT02836717|466936870|FG002|Study Phase|Lack of Efficacy|1|||
129720391|NCT02836717|466936868|FG000|Study Phase|Withdrawal by Subject|1|||
129720392|NCT02836717|466936869|FG001|Study Phase|Withdrawal by Subject|0|||
129720393|NCT02836717|466936870|FG002|Study Phase|Withdrawal by Subject|0|||
129720394|NCT02836717|466936868|FG000|Study Phase|Death|1|||
129720395|NCT02836717|466936869|FG001|Study Phase|Death|0|||
129720396|NCT02836717|466936870|FG002|Study Phase|Death|0|||
129720397|NCT02836717|466936868|FG000|Study Phase|abdominal surgeries|2|||
129720398|NCT02836717|466936869|FG001|Study Phase|abdominal surgeries|1|||
129720399|NCT02836717|466936870|FG002|Study Phase|abdominal surgeries|0|||
129720400|NCT00224120|466936871|FG000|Overall Study|Adverse Event|10|||
129720401|NCT00224120|466936872|FG001|Overall Study|Adverse Event|4|||
129720402|NCT00224120|466936871|FG000|Overall Study|Protocol Violation|1|||
129720403|NCT00224120|466936872|FG001|Overall Study|Protocol Violation|0|||
129720404|NCT00224120|466936871|FG000|Overall Study|Withdrawal by Subject|5|||
129720405|NCT00224120|466936872|FG001|Overall Study|Withdrawal by Subject|10|||
129720406|NCT00224120|466936871|FG000|Overall Study|Lack of Efficacy|0|||
129720407|NCT00224120|466936872|FG001|Overall Study|Lack of Efficacy|2|||
129720408|NCT00224120|466936871|FG000|Overall Study|Lost to Follow-up|2|||
129720409|NCT00224120|466936872|FG001|Overall Study|Lost to Follow-up|3|||
129720410|NCT00224120|466936871|FG000|Overall Study|Other|4|||
129720411|NCT00224120|466936872|FG001|Overall Study|Other|5|||
129720412|NCT00438360|466936873|FG000|Overall Study|Adverse Event|6|||
129720413|NCT00438360|466936874|FG001|Overall Study|Adverse Event|1|||
129720414|NCT00438360|466936873|FG000|Overall Study|Lack of Efficacy|42|||
129720415|NCT00438360|466936874|FG001|Overall Study|Lack of Efficacy|27|||
129720416|NCT00438360|466936873|FG000|Overall Study|Other|24|||
129720417|NCT00438360|466936874|FG001|Overall Study|Other|15|||
129720418|NCT00282087|466936875|FG000|Overall Study|Death|1|||
129720419|NCT01147250|466936880|FG000|Overall Study|Lost to Follow-up|14|||
129720420|NCT01147250|466936881|FG001|Overall Study|Lost to Follow-up|11|||
129720421|NCT01147250|466936880|FG000|Overall Study|Withdrawal by Subject|83|||
129720422|NCT01147250|466936881|FG001|Overall Study|Withdrawal by Subject|88|||
129720423|NCT01147250|466936880|FG000|Overall Study|Site termination by sponsor|13|||
129720424|NCT01147250|466936881|FG001|Overall Study|Site termination by sponsor|5|||
129720425|NCT01147250|466936880|FG000|Overall Study|Other than specified|0|||
129720426|NCT01147250|466936881|FG001|Overall Study|Other than specified|1|||
129720427|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129720428|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
129720429|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129720430|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129720431|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129720432|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
129720433|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
129720434|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
129720435|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129720436|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129720437|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129720438|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129720439|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
129720440|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
129720441|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129720442|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129720443|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129720444|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129720445|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
129720446|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
129720447|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129720448|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129720449|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129720450|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
129720451|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129720452|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
129720453|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129720454|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129720455|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129720456|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129720457|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
129720458|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
129720459|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129720460|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129720461|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129720462|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
129720463|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129720464|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
129720465|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129720466|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129720467|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129720468|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
129720469|NCT03985943|466936884|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129720470|NCT03985943|466936885|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
129720471|NCT03985943|466936886|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129720472|NCT03985943|466936887|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129720473|NCT03985943|466936888|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129720474|NCT03985943|466936889|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
129720475|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129720476|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129720477|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
129720478|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
129720479|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
129720480|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
129803595|NCT02642029|467249768|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803596|NCT02642029|467249769|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
129803597|NCT01134731|467249771|FG000|Overall Study|Adverse Event|3|||
129803598|NCT01134731|467249772|FG001|Overall Study|Adverse Event|2|||
129803599|NCT01134731|467249773|FG002|Overall Study|Adverse Event|1|||
129803600|NCT01134731|467249771|FG000|Overall Study|Physician Decision|2|||
129803601|NCT01134731|467249772|FG001|Overall Study|Physician Decision|2|||
129803602|NCT01134731|467249773|FG002|Overall Study|Physician Decision|2|||
129803603|NCT01134731|467249771|FG000|Overall Study|Lack of Efficacy|0|||
129803604|NCT01134731|467249772|FG001|Overall Study|Lack of Efficacy|0|||
129803605|NCT01134731|467249773|FG002|Overall Study|Lack of Efficacy|1|||
129720481|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129720482|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129720483|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
129720484|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
129720485|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
129720486|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
129720487|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
129720488|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
129720489|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
129720490|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
129720491|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
129720492|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
129720493|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129720494|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129720495|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129720496|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129720497|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129720498|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129720499|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129720500|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129720501|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
129720502|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129720503|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
129720504|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
129720505|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
129720506|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
129720507|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
129720508|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
129720509|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
129720510|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
129720511|NCT03985943|466936884|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
129720512|NCT03985943|466936885|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
129720513|NCT03985943|466936886|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
129720514|NCT03985943|466936887|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
129720515|NCT03985943|466936888|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
129720516|NCT03985943|466936889|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
129720517|NCT00338286|466936890|FG000|Overall Study|Withdrawal by Subject|50|||
129720518|NCT00338286|466936891|FG001|Overall Study|Withdrawal by Subject|54|||
129720519|NCT00338286|466936890|FG000|Overall Study|Lost to Follow-up|80|||
129720520|NCT00338286|466936891|FG001|Overall Study|Lost to Follow-up|66|||
129720521|NCT00338286|466936890|FG000|Overall Study|Other|103|||
129720522|NCT00338286|466936891|FG001|Overall Study|Other|93|||
129720523|NCT00022763|466936895|FG000|Overall Study|Adverse Event|1|||
129720524|NCT00022763|466936896|FG001|Overall Study|Adverse Event|2|||
129720525|NCT00022763|466936895|FG000|Overall Study|Injection Site Reactions|0|||
129720526|NCT00022763|466936896|FG001|Overall Study|Injection Site Reactions|2|||
129720527|NCT00022763|466936895|FG000|Overall Study|Death|0|||
129720528|NCT00022763|466936896|FG001|Overall Study|Death|1|||
129720529|NCT00022763|466936895|FG000|Overall Study|Lost to Follow-up|0|||
129720530|NCT00022763|466936896|FG001|Overall Study|Lost to Follow-up|3|||
129720531|NCT00022763|466936895|FG000|Overall Study|Withdrawal by Subject|4|||
129720532|NCT00022763|466936896|FG001|Overall Study|Withdrawal by Subject|7|||
129720533|NCT00022763|466936895|FG000|Overall Study|Insufficient Therapy|1|||
129720534|NCT00022763|466936896|FG001|Overall Study|Insufficient Therapy|0|||
129720535|NCT00022763|466936895|FG000|Overall Study|Admin|3|||
129720536|NCT00022763|466936896|FG001|Overall Study|Admin|2|||
129803606|NCT01134731|467249771|FG000|Overall Study|Withdrawal by Subject|3|||
129720537|NCT00716482|466936897|FG000|Overall Study|Lost to Follow-up|6|||
129720538|NCT00716482|466936897|FG000|Overall Study|Inadequate acquisition or analysis|50|||
129720539|NCT00716482|466936897|FG000|Overall Study|no pathology obtained|10|||
129720540|NCT00716482|466936897|FG000|Overall Study|technical/machine error|28|||
129720541|NCT00716482|466936897|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
129720542|NCT03248531|466936898|FG000|Overall Study|Adverse Event|0|||
129803607|NCT01134731|467249772|FG001|Overall Study|Withdrawal by Subject|3|||
129803608|NCT01134731|467249773|FG002|Overall Study|Withdrawal by Subject|1|||
129720543|NCT03248531|466936899|FG001|Overall Study|Adverse Event|0|||
129720544|NCT03248531|466936900|FG002|Overall Study|Adverse Event|1|||
129720545|NCT03248531|466936898|FG000|Overall Study|Lost to Follow-up|1|||
129803609|NCT01134731|467249771|FG000|Overall Study|Lost to Follow-up|5|||
129803610|NCT01134731|467249772|FG001|Overall Study|Lost to Follow-up|4|||
129720546|NCT03248531|466936899|FG001|Overall Study|Lost to Follow-up|0|||
129720547|NCT03248531|466936900|FG002|Overall Study|Lost to Follow-up|5|||
129720548|NCT03248531|466936898|FG000|Overall Study|Withdrawal by Subject|3|||
129720549|NCT03248531|466936899|FG001|Overall Study|Withdrawal by Subject|3|||
129720550|NCT03248531|466936900|FG002|Overall Study|Withdrawal by Subject|2|||
129720551|NCT03248531|466936898|FG000|Overall Study|Sponsor Request|0|||
129720552|NCT03248531|466936899|FG001|Overall Study|Sponsor Request|2|||
129720553|NCT03248531|466936900|FG002|Overall Study|Sponsor Request|0|||
129720554|NCT04075513|466936901|FG000|Overall Study|Withdrawal by Subject|2|||
129720555|NCT04075513|466936902|FG001|Overall Study|Withdrawal by Subject|2|||
129720556|NCT04075513|466936901|FG000|Overall Study|Lack of Efficacy|1|||
129720557|NCT04075513|466936902|FG001|Overall Study|Lack of Efficacy|0|||
129720558|NCT04075513|466936901|FG000|Overall Study|Lost to Follow-up|4|||
129720559|NCT04075513|466936902|FG001|Overall Study|Lost to Follow-up|2|||
129720560|NCT04075513|466936901|FG000|Overall Study|Switch to insulin pump|1|||
129720561|NCT04075513|466936902|FG001|Overall Study|Switch to insulin pump|0|||
129720562|NCT03748706|466936904|FG000|Overall Study|Lost to Follow-up|1|||
129720563|NCT04153981|466936907|FG000|Overall Study|Death|1|||
129720564|NCT04153981|466936907|FG000|Overall Study|Withdrawal by Subject|24|||
129720565|NCT04153981|466936907|FG000|Overall Study|Lost to Follow-up|1|||
129720566|NCT04153981|466936907|FG000|Overall Study|Physician Decision|1|||
129720567|NCT04153981|466936907|FG000|Overall Study|Due to Unavailable Glucometer|1|||
129720568|NCT04153981|466936907|FG000|Overall Study|Covid 19|52|||
129720569|NCT04153981|466936907|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
129720570|NCT04153981|466936907|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
129720571|NCT01355679|466936908|FG000|Overall Study|benign tumor types found at biopsy|2|||
129720572|NCT03490292|466936909|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
129720573|NCT03490292|466936910|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
129720574|NCT03490292|466936909|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
129720575|NCT03490292|466936910|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
129720576|NCT03490292|466936909|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
129720577|NCT03490292|466936910|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
129720578|NCT03490292|466936909|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
129720579|NCT03490292|466936910|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
129720580|NCT03490292|466936909|FG000|1 Year Follow Up Post Last Dose|Death|1|||
129720581|NCT03490292|466936910|FG001|1 Year Follow Up Post Last Dose|Death|1|||
129720582|NCT00964002|466936913|FG000|Overall Study|Protocol Violation|8|||
129720583|NCT00904670|466936914|FG000|Open Label Phase|Withdrawal by Subject|2|||
129720584|NCT00904670|466936915|FG001|Open Label Phase|Withdrawal by Subject|0|||
129720585|NCT00904670|466936914|FG000|Open Label Phase|Adverse Event|2|||
129720586|NCT00904670|466936915|FG001|Open Label Phase|Adverse Event|0|||
129720587|NCT00904670|466936914|FG000|Open Label Phase|Lack of Efficacy|1|||
129720588|NCT00904670|466936915|FG001|Open Label Phase|Lack of Efficacy|0|||
129720589|NCT00904670|466936914|FG000|Open Label Phase|Lost to Follow-up|1|||
129720590|NCT00904670|466936915|FG001|Open Label Phase|Lost to Follow-up|0|||
129720591|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
129720592|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
129720593|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
129720594|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
129720595|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Death|58|||
129720596|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Death|65|||
129720597|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Adverse Event|28|||
129720598|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Adverse Event|40|||
129720599|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Disease Progression|22|||
129720600|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Disease Progression|35|||
129720601|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Other|25|||
129720602|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Other|33|||
129720603|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
129720604|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
129803611|NCT01134731|467249773|FG002|Overall Study|Lost to Follow-up|3|||
129803612|NCT00676338|467249774|FG000|Overall Study|Adverse Event|6|||
129444382|NCT00578786|465927334|FG000|Overall Study|Early Escape from Prior Study|2|||
129720605|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Noncompliance|8|||
129720606|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Noncompliance|8|||
129720607|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
129720608|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
129720609|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
129720610|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
129720611|NCT00286091|466936924|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
129720612|NCT00286091|466936925|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
129720613|NCT00286091|466936924|FG000|Open-label Treatment Phase|Physician Decision|24|||
129720614|NCT00286091|466936925|FG001|Open-label Treatment Phase|Physician Decision|21|||
129720615|NCT00286091|466936924|FG000|Open-label Treatment Phase|Adverse Event|5|||
129720616|NCT00286091|466936925|FG001|Open-label Treatment Phase|Adverse Event|16|||
129720617|NCT00286091|466936924|FG000|Open-label Treatment Phase|Other|11|||
129720618|NCT00286091|466936925|FG001|Open-label Treatment Phase|Other|11|||
129720619|NCT00286091|466936924|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
129720620|NCT00286091|466936925|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
129720621|NCT00286091|466936924|FG000|Open-label Treatment Phase|Death|10|||
129720622|NCT00286091|466936925|FG001|Open-label Treatment Phase|Death|7|||
129720623|NCT00286091|466936924|FG000|Open-label Treatment Phase|Disease Progression|9|||
129720624|NCT00286091|466936925|FG001|Open-label Treatment Phase|Disease Progression|3|||
129720625|NCT00286091|466936924|FG000|Open-label Treatment Phase|Noncompliance|3|||
129720626|NCT00286091|466936925|FG001|Open-label Treatment Phase|Noncompliance|1|||
129720627|NCT00286091|466936924|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
129720628|NCT00286091|466936925|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
129720629|NCT00286091|466936924|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
129720630|NCT00286091|466936925|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
129720631|NCT00286091|466936924|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
129720632|NCT00286091|466936925|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
129720633|NCT02936869|466936926|FG000|Overall Study|Lost to Follow-up|1|||
129720634|NCT02936869|466936927|FG001|Overall Study|Lost to Follow-up|3|||
129720635|NCT02936869|466936926|FG000|Overall Study|Death|0|||
129720636|NCT02936869|466936927|FG001|Overall Study|Death|1|||
129720637|NCT02936869|466936926|FG000|Overall Study|Legal Case|0|||
129720638|NCT02936869|466936927|FG001|Overall Study|Legal Case|1|||
129720639|NCT02936869|466936926|FG000|Overall Study|Protocol Violation|1|||
129720640|NCT02936869|466936927|FG001|Overall Study|Protocol Violation|0|||
129720641|NCT04004221|466936928|FG000|Overall Study|Death|89|||
129720642|NCT04004221|466936928|FG000|Overall Study|Withdrawal by Subject|5|||
129720643|NCT04004221|466936928|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
129720644|NCT04004221|466936928|FG000|Overall Study|Sponsor Decision|9|||
129720645|NCT04004221|466936928|FG000|Overall Study|Participant refused to enter LTE|1|||
129720646|NCT03423238|466936929|FG000|Overall Study|Lost to Follow-up|1|||
129720647|NCT03423238|466936930|FG001|Overall Study|Lost to Follow-up|0|||
129720648|NCT03423238|466936929|FG000|Overall Study|Withdrawal by Subject|1|||
129720649|NCT03423238|466936930|FG001|Overall Study|Withdrawal by Subject|0|||
129720650|NCT02036580|466936931|FG000|Overall Study|Withdrawal by Subject|0|||
129720651|NCT02036580|466936932|FG001|Overall Study|Withdrawal by Subject|1|||
129720652|NCT02036580|466936933|FG002|Overall Study|Withdrawal by Subject|0|||
129720653|NCT02036580|466936931|FG000|Overall Study|Adverse Event|1|||
129720654|NCT02036580|466936932|FG001|Overall Study|Adverse Event|0|||
129720655|NCT02036580|466936933|FG002|Overall Study|Adverse Event|0|||
129720656|NCT00506454|466936934|FG000|Overall Study|Withdrawal by Subject|1|||
129720657|NCT00506454|466936935|FG001|Overall Study|Withdrawal by Subject|1|||
129720658|NCT02584452|466936938|FG000|Overall Study|Physician Decision|1|||
129720659|NCT02584452|466936939|FG001|Overall Study|Physician Decision|1|||
129720660|NCT02584452|466936938|FG000|Overall Study|Lost to Follow-up|1|||
129720661|NCT02584452|466936939|FG001|Overall Study|Lost to Follow-up|1|||
129720662|NCT02689206|466936940|FG000|Overall Study|Adverse Event|0|||
129720663|NCT02689206|466936941|FG001|Overall Study|Adverse Event|0|||
129720664|NCT02689206|466936942|FG002|Overall Study|Adverse Event|1|||
129720665|NCT02689206|466936943|FG003|Overall Study|Adverse Event|0|||
129720666|NCT02689206|466936944|FG004|Overall Study|Adverse Event|2|||
129720667|NCT02689206|466936940|FG000|Overall Study|Protocol Violation|1|||
129720668|NCT02689206|466936941|FG001|Overall Study|Protocol Violation|0|||
129720669|NCT02689206|466936942|FG002|Overall Study|Protocol Violation|0|||
129720670|NCT02689206|466936943|FG003|Overall Study|Protocol Violation|1|||
129720671|NCT02689206|466936944|FG004|Overall Study|Protocol Violation|2|||
129720672|NCT02689206|466936940|FG000|Overall Study|Other: Reached stopping criteria|0|||
129720673|NCT02689206|466936941|FG001|Overall Study|Other: Reached stopping criteria|1|||
129720674|NCT02689206|466936942|FG002|Overall Study|Other: Reached stopping criteria|2|||
129720675|NCT02689206|466936943|FG003|Overall Study|Other: Reached stopping criteria|3|||
129803613|NCT00676338|467249775|FG001|Overall Study|Adverse Event|6|||
129803614|NCT00676338|467249776|FG002|Overall Study|Adverse Event|5|||
129720676|NCT02689206|466936944|FG004|Overall Study|Other: Reached stopping criteria|4|||
129720677|NCT02689206|466936940|FG000|Overall Study|Physician Decision|1|||
129720678|NCT02689206|466936941|FG001|Overall Study|Physician Decision|0|||
129720679|NCT02689206|466936942|FG002|Overall Study|Physician Decision|0|||
129720680|NCT02689206|466936943|FG003|Overall Study|Physician Decision|0|||
129720681|NCT02689206|466936944|FG004|Overall Study|Physician Decision|0|||
129720682|NCT02689206|466936940|FG000|Overall Study|Withdrawal by Subject|1|||
129720683|NCT02689206|466936941|FG001|Overall Study|Withdrawal by Subject|0|||
129720684|NCT02689206|466936942|FG002|Overall Study|Withdrawal by Subject|1|||
129720685|NCT02689206|466936943|FG003|Overall Study|Withdrawal by Subject|0|||
129720686|NCT02689206|466936944|FG004|Overall Study|Withdrawal by Subject|0|||
129720687|NCT01558596|466936945|FG000|Overall Study|Withdrawal by Subject|1|||
129720688|NCT01558596|466936946|FG001|Overall Study|Withdrawal by Subject|0|||
129803615|NCT00676338|467249777|FG003|Overall Study|Adverse Event|1|||
129720689|NCT01558596|466936945|FG000|Overall Study|surgery elsewhere or cancelled|1|||
129720690|NCT01558596|466936946|FG001|Overall Study|surgery elsewhere or cancelled|1|||
129720691|NCT01558596|466936945|FG000|Overall Study|Protocol Violation|1|||
129720692|NCT01558596|466936946|FG001|Overall Study|Protocol Violation|0|||
129720693|NCT01479764|466936950|FG000|Randomized|Adverse Event|1|||
129720694|NCT01479764|466936951|FG001|Randomized|Adverse Event|1|||
129720695|NCT01479764|466936950|FG000|Randomized|Withdrawal by Subject|1|||
129720696|NCT01479764|466936951|FG001|Randomized|Withdrawal by Subject|0|||
129720697|NCT01479764|466936950|FG000|Treated|Lost to Follow-up|0|||
129720698|NCT01479764|466936951|FG001|Treated|Lost to Follow-up|2|||
129720699|NCT00260832|466936953|FG000|Overall Study|Adverse Event|26|||
129720700|NCT00260832|466936954|FG001|Overall Study|Adverse Event|19|||
129720701|NCT00260832|466936953|FG000|Overall Study|Progression|116|||
129720702|NCT00260832|466936954|FG001|Overall Study|Progression|96|||
129720703|NCT00260832|466936953|FG000|Overall Study|Withdrawal by Subject|15|||
129720704|NCT00260832|466936954|FG001|Overall Study|Withdrawal by Subject|17|||
129720705|NCT00260832|466936953|FG000|Overall Study|Physician Decision|15|||
129720706|NCT00260832|466936954|FG001|Overall Study|Physician Decision|9|||
129720707|NCT00260832|466936953|FG000|Overall Study|Death|43|||
129720708|NCT00260832|466936954|FG001|Overall Study|Death|62|||
129720709|NCT00260832|466936953|FG000|Overall Study|Other|10|||
129720710|NCT00260832|466936954|FG001|Overall Study|Other|7|||
129720711|NCT00260832|466936953|FG000|Overall Study|Protocol Violation|3|||
129720712|NCT00260832|466936954|FG001|Overall Study|Protocol Violation|1|||
129720713|NCT03098433|466936957|FG000|Overall Study|Withdrawal by Subject|10|||
129720714|NCT01104545|466936958|FG000|Overall Study|Adverse Event|0|||
129720715|NCT01104545|466936959|FG001|Overall Study|Adverse Event|1|||
129720716|NCT01104545|466936960|FG002|Overall Study|Adverse Event|2|||
129720717|NCT03585764|466936963|FG000|Overall Study|Death|3|||
129720718|NCT03585764|466936964|FG001|Overall Study|Death|2|||
129720719|NCT03585764|466936965|FG002|Overall Study|Death|3|||
129720720|NCT03585764|466936966|FG003|Overall Study|Death|0|||
129720721|NCT03585764|466936963|FG000|Overall Study|Lost to Follow-up|0|||
129720722|NCT03585764|466936964|FG001|Overall Study|Lost to Follow-up|1|||
129720723|NCT03585764|466936965|FG002|Overall Study|Lost to Follow-up|0|||
129720724|NCT03585764|466936966|FG003|Overall Study|Lost to Follow-up|0|||
129720725|NCT03585764|466936963|FG000|Overall Study|Physician Decision|0|||
129720726|NCT03585764|466936964|FG001|Overall Study|Physician Decision|0|||
129720727|NCT03585764|466936965|FG002|Overall Study|Physician Decision|2|||
129720728|NCT03585764|466936966|FG003|Overall Study|Physician Decision|0|||
129720729|NCT03640507|466936967|FG000|Overall Study|Withdrawal by Subject|0|||
129720730|NCT03640507|466936968|FG001|Overall Study|Withdrawal by Subject|0|||
129720731|NCT03640507|466936969|FG002|Overall Study|Withdrawal by Subject|1|||
129720732|NCT02993822|466936970|FG000|Overall Study|Lack of Efficacy|1|||
129720733|NCT02993822|466936971|FG001|Overall Study|Lack of Efficacy|1|||
129720734|NCT02993822|466936972|FG002|Overall Study|Lack of Efficacy|0|||
129720735|NCT02993822|466936973|FG003|Overall Study|Lack of Efficacy|0|||
129720736|NCT02993822|466936970|FG000|Overall Study|Protocol Violation|1|||
129720737|NCT02993822|466936971|FG001|Overall Study|Protocol Violation|0|||
129720738|NCT02993822|466936972|FG002|Overall Study|Protocol Violation|0|||
129720739|NCT02993822|466936973|FG003|Overall Study|Protocol Violation|0|||
129720740|NCT02993822|466936970|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
129720741|NCT02993822|466936971|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
129720742|NCT02993822|466936972|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
129720743|NCT02993822|466936973|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
129720744|NCT02993822|466936970|FG000|Overall Study|Adverse Event|3|||
129720745|NCT02993822|466936971|FG001|Overall Study|Adverse Event|1|||
129720746|NCT02993822|466936972|FG002|Overall Study|Adverse Event|7|||
129720747|NCT02993822|466936973|FG003|Overall Study|Adverse Event|0|||
129803616|NCT00676338|467249774|FG000|Overall Study|Lost to Follow-up|4|||
129803617|NCT00676338|467249775|FG001|Overall Study|Lost to Follow-up|1|||
129803618|NCT00676338|467249776|FG002|Overall Study|Lost to Follow-up|3|||
129803619|NCT00676338|467249777|FG003|Overall Study|Lost to Follow-up|4|||
129720748|NCT02993822|466936970|FG000|Overall Study|Withdrawal by Subject|4|||
129720749|NCT02993822|466936971|FG001|Overall Study|Withdrawal by Subject|2|||
129720750|NCT02993822|466936972|FG002|Overall Study|Withdrawal by Subject|2|||
129720751|NCT02993822|466936973|FG003|Overall Study|Withdrawal by Subject|3|||
129720752|NCT02993822|466936970|FG000|Overall Study|Lost to Follow-up|1|||
129803620|NCT00676338|467249774|FG000|Overall Study|Physician Decision|3|||
129803621|NCT00676338|467249775|FG001|Overall Study|Physician Decision|3|||
129720753|NCT02993822|466936971|FG001|Overall Study|Lost to Follow-up|0|||
129720754|NCT02993822|466936972|FG002|Overall Study|Lost to Follow-up|1|||
129720755|NCT02993822|466936973|FG003|Overall Study|Lost to Follow-up|0|||
129720756|NCT01221753|466936974|FG000|Overall Study|Adverse Event|1|||
129720757|NCT01939977|466936978|FG000|Overall Study|Adverse Event|4|||
129803622|NCT00676338|467249776|FG002|Overall Study|Physician Decision|2|||
129720758|NCT01939977|466936979|FG001|Overall Study|Adverse Event|3|||
129720759|NCT01939977|466936978|FG000|Overall Study|Lack of Efficacy|3|||
129720760|NCT01939977|466936979|FG001|Overall Study|Lack of Efficacy|0|||
129720761|NCT01939977|466936978|FG000|Overall Study|Physician Decision|1|||
129720762|NCT01939977|466936979|FG001|Overall Study|Physician Decision|1|||
129720763|NCT01939977|466936978|FG000|Overall Study|Withdrawal by Subject|0|||
129720764|NCT01939977|466936979|FG001|Overall Study|Withdrawal by Subject|2|||
129720765|NCT01939977|466936978|FG000|Overall Study|Did not meet inclusion criteria|1|||
129720766|NCT01939977|466936979|FG001|Overall Study|Did not meet inclusion criteria|0|||
129720767|NCT01939977|466936978|FG000|Overall Study|Did not receive study medication|0|||
129720768|NCT01939977|466936979|FG001|Overall Study|Did not receive study medication|1|||
129720769|NCT04552288|466936983|FG000|Overall Study|Death|3|||
129720770|NCT04552288|466936983|FG000|Overall Study|Lost to Follow-up|6|||
129720771|NCT04552288|466936983|FG000|Overall Study|Physician Decision|3|||
129720772|NCT04552288|466936983|FG000|Overall Study|Protocol Violation|9|||
129720773|NCT04552288|466936983|FG000|Overall Study|Withdrawal by Subject|6|||
129720774|NCT04552288|466936983|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
129720775|NCT05285644|466936984|FG000|Overall Study|Adverse Event|3|||
129720776|NCT05285644|466936985|FG001|Overall Study|Adverse Event|3|||
129720777|NCT05285644|466936984|FG000|Overall Study|Withdrawal of Consent|2|||
129720778|NCT05285644|466936985|FG001|Overall Study|Withdrawal of Consent|5|||
129720779|NCT05285644|466936984|FG000|Overall Study|Noncompliance|0|||
129720780|NCT05285644|466936985|FG001|Overall Study|Noncompliance|4|||
129720781|NCT05285644|466936984|FG000|Overall Study|Lost to Follow-up|4|||
129720782|NCT05285644|466936985|FG001|Overall Study|Lost to Follow-up|6|||
129720783|NCT05285644|466936984|FG000|Overall Study|Disallowed Concurrent Medication|1|||
129720784|NCT05285644|466936985|FG001|Overall Study|Disallowed Concurrent Medication|1|||
129720785|NCT05285644|466936984|FG000|Overall Study|Investigator Decision|2|||
129720786|NCT05285644|466936985|FG001|Overall Study|Investigator Decision|0|||
129720787|NCT05285644|466936984|FG000|Overall Study|Protocol Deviation|1|||
129720788|NCT05285644|466936985|FG001|Overall Study|Protocol Deviation|0|||
129720789|NCT05285644|466936984|FG000|Overall Study|As specified in the Clinical Study Report|7|||
129720790|NCT05285644|466936985|FG001|Overall Study|As specified in the Clinical Study Report|3|||
129720791|NCT04532294|466936986|FG000|Overall Study|Withdrawal by Subject|0|||
129720792|NCT04532294|466936987|FG001|Overall Study|Withdrawal by Subject|0|||
129720793|NCT04532294|466936988|FG002|Overall Study|Withdrawal by Subject|1|||
129720794|NCT04532294|466936986|FG000|Overall Study|Participants Not Dosed|0|||
129720795|NCT04532294|466936987|FG001|Overall Study|Participants Not Dosed|0|||
129720796|NCT04532294|466936988|FG002|Overall Study|Participants Not Dosed|2|||
129720797|NCT04295759|466936989|FG000|Overall Study|Lack of Efficacy|9|||
129720798|NCT04295759|466936989|FG000|Overall Study|Death|1|||
129720799|NCT04295759|466936989|FG000|Overall Study|Withdrawal by Subject|2|||
129720800|NCT04295759|466936989|FG000|Overall Study|Deemed ineligible|1|||
129720801|NCT01696981|466936990|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
129720802|NCT01696981|466936991|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
129720803|NCT01696981|466936990|FG000|Overall Study|Died Before Randomization|3|||
129720804|NCT01696981|466936991|FG001|Overall Study|Died Before Randomization|8|||
129720805|NCT01696981|466936990|FG000|Overall Study|Died Before ASU (Control)|278|||
129720806|NCT01696981|466936991|FG001|Overall Study|Died Before ASU (Control)|0|||
129720807|NCT01696981|466936990|FG000|Overall Study|Refused ASU (Control)|920|||
129720808|NCT01696981|466936991|FG001|Overall Study|Refused ASU (Control)|0|||
129720809|NCT01696981|466936990|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
129720810|NCT01696981|466936991|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
129720811|NCT02798315|466936992|FG000|Overall Study|Failure to return|1|||
129720812|NCT03335150|466936994|FG000|Overall Study|Withdrawal by Subject|10|||
129720813|NCT03335150|466936995|FG001|Overall Study|Withdrawal by Subject|4|||
129720814|NCT03335150|466936994|FG000|Overall Study|Adverse Event|0|||
129720815|NCT03335150|466936995|FG001|Overall Study|Adverse Event|1|||
129720816|NCT02097719|466936996|FG000|Overall Study|Subject Withdrew Consent|1|||
129720817|NCT02097719|466936997|FG001|Overall Study|Subject Withdrew Consent|0|||
129720818|NCT02097719|466936996|FG000|Overall Study|Lost to Follow-up|0|||
129720819|NCT02097719|466936997|FG001|Overall Study|Lost to Follow-up|1|||
129720820|NCT02097719|466936996|FG000|Overall Study|Adverse Event|2|||
129720821|NCT02097719|466936997|FG001|Overall Study|Adverse Event|0|||
129720822|NCT04601532|466936998|FG000|Overall Study|Lost to Follow-up|1|||
129720823|NCT04601532|466936999|FG001|Overall Study|Lost to Follow-up|2|||
129720824|NCT04601532|466936998|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
129720825|NCT04601532|466936999|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
129720826|NCT02744612|466938989|FG000|Overall Study|Withdrawal by Subject|0|||
129720827|NCT02744612|466938990|FG001|Overall Study|Withdrawal by Subject|2|||
129720828|NCT02712983|466938992|FG000|Treatment Phase|Adverse Event|3|||
129720829|NCT02712983|466938993|FG001|Treatment Phase|Adverse Event|1|||
129720830|NCT02712983|466938994|FG002|Treatment Phase|Adverse Event|1|||
129720831|NCT02712983|466938995|FG003|Treatment Phase|Adverse Event|4|||
129720832|NCT02712983|466938996|FG004|Treatment Phase|Adverse Event|3|||
129720833|NCT02712983|466938997|FG005|Treatment Phase|Adverse Event|0|||
129720834|NCT02712983|466938998|FG006|Treatment Phase|Adverse Event|6|||
129720835|NCT02712983|466938999|FG007|Treatment Phase|Adverse Event|6|||
129720836|NCT02712983|466939000|FG008|Treatment Phase|Adverse Event|1|||
129720837|NCT02712983|466938992|FG000|Treatment Phase|Protocol Deviation|0|||
129720838|NCT02712983|466938993|FG001|Treatment Phase|Protocol Deviation|0|||
129720839|NCT02712983|466938994|FG002|Treatment Phase|Protocol Deviation|0|||
129720840|NCT02712983|466938995|FG003|Treatment Phase|Protocol Deviation|2|||
129720841|NCT02712983|466938996|FG004|Treatment Phase|Protocol Deviation|0|||
129720842|NCT02712983|466938997|FG005|Treatment Phase|Protocol Deviation|0|||
129720843|NCT02712983|466938998|FG006|Treatment Phase|Protocol Deviation|1|||
129720844|NCT02712983|466938999|FG007|Treatment Phase|Protocol Deviation|0|||
129720845|NCT02712983|466939000|FG008|Treatment Phase|Protocol Deviation|0|||
129720846|NCT02712983|466938992|FG000|Treatment Phase|Technical Problems|0|||
129720847|NCT02712983|466938993|FG001|Treatment Phase|Technical Problems|0|||
129720848|NCT02712983|466938994|FG002|Treatment Phase|Technical Problems|0|||
129720849|NCT02712983|466938995|FG003|Treatment Phase|Technical Problems|0|||
129720850|NCT02712983|466938996|FG004|Treatment Phase|Technical Problems|0|||
129720851|NCT02712983|466938997|FG005|Treatment Phase|Technical Problems|0|||
129720852|NCT02712983|466938998|FG006|Treatment Phase|Technical Problems|1|||
129720853|NCT02712983|466938999|FG007|Treatment Phase|Technical Problems|0|||
129720854|NCT02712983|466939000|FG008|Treatment Phase|Technical Problems|0|||
129720855|NCT02712983|466938992|FG000|Treatment Phase|Physician Decision|0|||
129720856|NCT02712983|466938993|FG001|Treatment Phase|Physician Decision|0|||
129720857|NCT02712983|466938994|FG002|Treatment Phase|Physician Decision|0|||
129720858|NCT02712983|466938995|FG003|Treatment Phase|Physician Decision|0|||
129720859|NCT02712983|466938996|FG004|Treatment Phase|Physician Decision|0|||
129720860|NCT02712983|466938997|FG005|Treatment Phase|Physician Decision|0|||
129720861|NCT02712983|466938998|FG006|Treatment Phase|Physician Decision|0|||
129720862|NCT02712983|466938999|FG007|Treatment Phase|Physician Decision|1|||
129720863|NCT02712983|466939000|FG008|Treatment Phase|Physician Decision|1|||
129720864|NCT02712983|466938992|FG000|Treatment Phase|Subject Decision|2|||
129720865|NCT02712983|466938993|FG001|Treatment Phase|Subject Decision|0|||
129720866|NCT02712983|466938994|FG002|Treatment Phase|Subject Decision|0|||
129720867|NCT02712983|466938995|FG003|Treatment Phase|Subject Decision|2|||
129720868|NCT02712983|466938996|FG004|Treatment Phase|Subject Decision|1|||
129720869|NCT02712983|466938997|FG005|Treatment Phase|Subject Decision|0|||
129720870|NCT02712983|466938998|FG006|Treatment Phase|Subject Decision|1|||
129720871|NCT02712983|466938999|FG007|Treatment Phase|Subject Decision|2|||
129720872|NCT02712983|466939000|FG008|Treatment Phase|Subject Decision|0|||
129720873|NCT02712983|466938992|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129720874|NCT02712983|466938993|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
129720875|NCT02712983|466938994|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129720876|NCT02712983|466938995|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129720877|NCT02712983|466938996|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129720878|NCT02712983|466938997|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129720879|NCT02712983|466938998|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
129720880|NCT02712983|466938999|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
129720881|NCT02712983|466939000|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129720882|NCT02712983|466938992|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720883|NCT02712983|466938993|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720884|NCT02712983|466938994|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720885|NCT02712983|466938995|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
129720886|NCT02712983|466938996|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720887|NCT02712983|466938997|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720888|NCT02712983|466938998|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720889|NCT02712983|466938999|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720890|NCT02712983|466939000|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
129720891|NCT02712983|466938992|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129720892|NCT02712983|466938993|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129720893|NCT02712983|466938994|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129720894|NCT02712983|466938995|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129720895|NCT02712983|466938996|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
129720896|NCT02712983|466938997|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
129720897|NCT02712983|466938998|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
129720898|NCT02712983|466938999|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
129720899|NCT02712983|466939000|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
129720900|NCT01945216|466939001|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
129720901|NCT01945216|466939001|FG000|Overall Study|Protocol Violation|42|||
129720902|NCT01945216|466939001|FG000|Overall Study|CRF not assured by investigators|5|||
129720903|NCT05360966|466939005|FG000|Overall Study|Adverse Event|5|||
129720904|NCT05360966|466939006|FG001|Overall Study|Adverse Event|5|||
129720905|NCT05360966|466939005|FG000|Overall Study|Withdrawal of Consent|5|||
129720906|NCT05360966|466939006|FG001|Overall Study|Withdrawal of Consent|3|||
129720907|NCT05360966|466939005|FG000|Overall Study|Noncompliance|2|||
129720908|NCT05360966|466939006|FG001|Overall Study|Noncompliance|1|||
129720909|NCT05360966|466939005|FG000|Overall Study|Lost to Follow-up|2|||
129720910|NCT05360966|466939006|FG001|Overall Study|Lost to Follow-up|3|||
129803623|NCT00676338|467249777|FG003|Overall Study|Physician Decision|3|||
129803624|NCT00676338|467249774|FG000|Overall Study|Protocol Violation|5|||
129803625|NCT00676338|467249775|FG001|Overall Study|Protocol Violation|9|||
129803626|NCT00676338|467249776|FG002|Overall Study|Protocol Violation|2|||
129720911|NCT05360966|466939005|FG000|Overall Study|Protocol Deviation|2|||
129720912|NCT05360966|466939006|FG001|Overall Study|Protocol Deviation|1|||
129720913|NCT05360966|466939005|FG000|Overall Study|As specified in the Clinical Study Report|1|||
129720914|NCT05360966|466939006|FG001|Overall Study|As specified in the Clinical Study Report|3|||
129720915|NCT05396014|466939007|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
129720916|NCT05396014|466939008|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720917|NCT05396014|466939009|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720918|NCT05396014|466939010|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720919|NCT05396014|466939011|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720920|NCT05396014|466939012|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720921|NCT05396014|466939013|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720922|NCT05396014|466939014|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720923|NCT05396014|466939015|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720924|NCT05396014|466939016|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720925|NCT05396014|466939017|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720926|NCT05396014|466939018|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720927|NCT05396014|466939019|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720928|NCT05396014|466939020|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
129720929|NCT05396014|466939021|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720930|NCT05396014|466939022|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720931|NCT05396014|466939023|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720932|NCT05396014|466939024|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720933|NCT05396014|466939025|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720934|NCT05396014|466939026|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720935|NCT05396014|466939027|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720936|NCT05396014|466939028|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720937|NCT05396014|466939029|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720938|NCT05396014|466939030|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720939|NCT05396014|466939031|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720940|NCT05396014|466939032|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720941|NCT05396014|466939033|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
129720942|NCT05396014|466939034|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720943|NCT05396014|466939035|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720944|NCT05396014|466939036|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720945|NCT05396014|466939037|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720946|NCT05396014|466939038|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720947|NCT05396014|466939039|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720948|NCT05396014|466939040|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720949|NCT05396014|466939041|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720950|NCT05396014|466939042|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720951|NCT05396014|466939043|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720952|NCT05396014|466939044|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720953|NCT05396014|466939045|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720954|NCT05396014|466939046|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
129720955|NCT05396014|466939047|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720956|NCT05396014|466939048|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720957|NCT05396014|466939049|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
129720958|NCT05396014|466939007|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
129720959|NCT05396014|466939008|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720960|NCT05396014|466939009|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720961|NCT05396014|466939010|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720962|NCT05396014|466939011|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720963|NCT05396014|466939012|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720964|NCT05396014|466939013|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720965|NCT05396014|466939014|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720966|NCT05396014|466939015|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720967|NCT05396014|466939016|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720968|NCT05396014|466939017|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129803627|NCT00676338|467249777|FG003|Overall Study|Protocol Violation|5|||
129803628|NCT00676338|467249774|FG000|Overall Study|Withdrawal by Subject|17|||
129803629|NCT00676338|467249775|FG001|Overall Study|Withdrawal by Subject|9|||
129803630|NCT00676338|467249776|FG002|Overall Study|Withdrawal by Subject|12|||
129891591|NCT01052662|467561202|FG001|Overall Study|Adverse Event|1|||
129720969|NCT05396014|466939018|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720970|NCT05396014|466939019|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720971|NCT05396014|466939020|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
129720972|NCT05396014|466939021|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720973|NCT05396014|466939022|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720974|NCT05396014|466939023|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720975|NCT05396014|466939024|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720976|NCT05396014|466939025|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720977|NCT05396014|466939026|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720978|NCT05396014|466939027|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720979|NCT05396014|466939028|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720980|NCT05396014|466939029|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720981|NCT05396014|466939030|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720982|NCT05396014|466939031|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720983|NCT05396014|466939032|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720984|NCT05396014|466939033|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
129720985|NCT05396014|466939034|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720986|NCT05396014|466939035|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720987|NCT05396014|466939036|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720988|NCT05396014|466939037|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720989|NCT05396014|466939038|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720990|NCT05396014|466939039|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720991|NCT05396014|466939040|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720992|NCT05396014|466939041|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720993|NCT05396014|466939042|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720994|NCT05396014|466939043|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720995|NCT05396014|466939044|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720996|NCT05396014|466939045|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720997|NCT05396014|466939046|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
129720998|NCT05396014|466939047|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129720999|NCT05396014|466939048|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129721000|NCT05396014|466939049|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
129721001|NCT05396014|466939007|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
129721002|NCT05396014|466939008|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721003|NCT05396014|466939009|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721004|NCT05396014|466939010|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721005|NCT05396014|466939011|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721006|NCT05396014|466939012|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721007|NCT05396014|466939013|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721008|NCT05396014|466939014|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721009|NCT05396014|466939015|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721010|NCT05396014|466939016|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721011|NCT05396014|466939017|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721012|NCT05396014|466939018|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721013|NCT05396014|466939019|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721014|NCT05396014|466939020|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
129721015|NCT05396014|466939021|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721016|NCT05396014|466939022|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721017|NCT05396014|466939023|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721018|NCT05396014|466939024|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721019|NCT05396014|466939025|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721020|NCT05396014|466939026|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721021|NCT05396014|466939027|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721022|NCT05396014|466939028|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721023|NCT05396014|466939029|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721024|NCT05396014|466939030|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721025|NCT05396014|466939031|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721026|NCT05396014|466939032|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721027|NCT05396014|466939033|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
129721028|NCT05396014|466939034|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721029|NCT05396014|466939035|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721030|NCT05396014|466939036|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721031|NCT05396014|466939037|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721032|NCT05396014|466939038|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721033|NCT05396014|466939039|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721034|NCT05396014|466939040|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721035|NCT05396014|466939041|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721036|NCT05396014|466939042|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721037|NCT05396014|466939043|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721038|NCT05396014|466939044|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721039|NCT05396014|466939045|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721040|NCT05396014|466939046|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
129721041|NCT05396014|466939047|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721042|NCT05396014|466939048|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129803631|NCT00676338|467249777|FG003|Overall Study|Withdrawal by Subject|6|||
129803632|NCT00676338|467249774|FG000|Overall Study|Entry Criteria Not Met|0|||
129803633|NCT00676338|467249775|FG001|Overall Study|Entry Criteria Not Met|2|||
129803634|NCT00676338|467249776|FG002|Overall Study|Entry Criteria Not Met|1|||
129803635|NCT00676338|467249777|FG003|Overall Study|Entry Criteria Not Met|1|||
129803636|NCT00676338|467249774|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
129803637|NCT00676338|467249775|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
129803638|NCT00676338|467249776|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
129803639|NCT00676338|467249777|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
129803640|NCT02122458|467249778|FG000|Overall Study|Withdrawal by Subject|0|||
129803641|NCT02122458|467249779|FG001|Overall Study|Withdrawal by Subject|0|||
129803642|NCT02122458|467249780|FG002|Overall Study|Withdrawal by Subject|0|||
129803643|NCT02122458|467249781|FG003|Overall Study|Withdrawal by Subject|4|||
129803644|NCT02122458|467249782|FG004|Overall Study|Withdrawal by Subject|4|||
129803645|NCT02122458|467249783|FG005|Overall Study|Withdrawal by Subject|4|||
129803646|NCT02122458|467249784|FG006|Overall Study|Withdrawal by Subject|0|||
129721043|NCT05396014|466939049|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
129721044|NCT05396014|466939007|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721045|NCT05396014|466939008|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721046|NCT05396014|466939009|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721047|NCT05396014|466939010|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721048|NCT05396014|466939011|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721049|NCT05396014|466939012|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721050|NCT05396014|466939013|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721051|NCT05396014|466939014|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721052|NCT05396014|466939015|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721053|NCT05396014|466939016|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721054|NCT05396014|466939017|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721055|NCT05396014|466939018|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721056|NCT05396014|466939019|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721057|NCT05396014|466939020|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721058|NCT05396014|466939021|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721059|NCT05396014|466939022|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721060|NCT05396014|466939023|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721061|NCT05396014|466939024|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721062|NCT05396014|466939025|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721063|NCT05396014|466939026|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721064|NCT05396014|466939027|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721065|NCT05396014|466939028|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721066|NCT05396014|466939029|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721067|NCT05396014|466939030|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721068|NCT05396014|466939031|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721069|NCT05396014|466939032|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721070|NCT05396014|466939033|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
129721071|NCT05396014|466939034|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721072|NCT05396014|466939035|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721073|NCT05396014|466939036|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721074|NCT05396014|466939037|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721075|NCT05396014|466939038|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721076|NCT05396014|466939039|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721077|NCT05396014|466939040|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721078|NCT05396014|466939041|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721079|NCT05396014|466939042|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721080|NCT05396014|466939043|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721081|NCT05396014|466939044|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721082|NCT05396014|466939045|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129803647|NCT02122458|467249778|FG000|Overall Study|Lost to Follow-up|1|||
129803648|NCT02122458|467249779|FG001|Overall Study|Lost to Follow-up|3|||
129803649|NCT02122458|467249780|FG002|Overall Study|Lost to Follow-up|0|||
129803650|NCT02122458|467249781|FG003|Overall Study|Lost to Follow-up|7|||
129803651|NCT02122458|467249782|FG004|Overall Study|Lost to Follow-up|5|||
129803652|NCT02122458|467249783|FG005|Overall Study|Lost to Follow-up|15|||
129803653|NCT02122458|467249784|FG006|Overall Study|Lost to Follow-up|1|||
129721083|NCT05396014|466939046|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
129721084|NCT05396014|466939047|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721085|NCT05396014|466939048|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721086|NCT05396014|466939049|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
129721087|NCT05396014|466939007|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721088|NCT05396014|466939008|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721089|NCT05396014|466939009|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721090|NCT05396014|466939010|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721091|NCT05396014|466939011|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721092|NCT05396014|466939012|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721093|NCT05396014|466939013|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721094|NCT05396014|466939014|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721095|NCT05396014|466939015|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721096|NCT05396014|466939016|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721097|NCT05396014|466939017|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721098|NCT05396014|466939018|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721099|NCT05396014|466939019|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721100|NCT05396014|466939020|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721101|NCT05396014|466939021|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721102|NCT05396014|466939022|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721103|NCT05396014|466939023|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721104|NCT05396014|466939024|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721105|NCT05396014|466939025|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721106|NCT05396014|466939026|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721107|NCT05396014|466939027|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721108|NCT05396014|466939028|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721109|NCT05396014|466939029|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721110|NCT05396014|466939030|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721111|NCT05396014|466939031|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721112|NCT05396014|466939032|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721113|NCT05396014|466939033|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
129721114|NCT05396014|466939034|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721115|NCT05396014|466939035|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721116|NCT05396014|466939036|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721117|NCT05396014|466939037|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721118|NCT05396014|466939038|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721119|NCT05396014|466939039|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721120|NCT05396014|466939040|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721121|NCT05396014|466939041|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721122|NCT05396014|466939042|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721123|NCT05396014|466939043|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721124|NCT05396014|466939044|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721125|NCT05396014|466939045|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721126|NCT05396014|466939046|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721127|NCT05396014|466939047|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721128|NCT05396014|466939048|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721129|NCT05396014|466939049|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
129721130|NCT05396014|466939007|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721131|NCT05396014|466939008|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721132|NCT05396014|466939009|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721133|NCT05396014|466939010|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721134|NCT05396014|466939011|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721135|NCT05396014|466939012|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721136|NCT05396014|466939013|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721137|NCT05396014|466939014|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721138|NCT05396014|466939015|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721139|NCT05396014|466939016|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721140|NCT05396014|466939017|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721141|NCT05396014|466939018|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721142|NCT05396014|466939019|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721143|NCT05396014|466939020|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
129721144|NCT05396014|466939021|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721145|NCT05396014|466939022|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721146|NCT05396014|466939023|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721147|NCT05396014|466939024|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721148|NCT05396014|466939025|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721149|NCT05396014|466939026|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721150|NCT05396014|466939027|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721151|NCT05396014|466939028|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721152|NCT05396014|466939029|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721153|NCT05396014|466939030|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721154|NCT05396014|466939031|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721155|NCT05396014|466939032|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721156|NCT05396014|466939033|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721157|NCT05396014|466939034|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721158|NCT05396014|466939035|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721159|NCT05396014|466939036|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721160|NCT05396014|466939037|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721161|NCT05396014|466939038|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721162|NCT05396014|466939039|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721163|NCT05396014|466939040|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721164|NCT05396014|466939041|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721165|NCT05396014|466939042|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721166|NCT05396014|466939043|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721167|NCT05396014|466939044|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721168|NCT05396014|466939045|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721169|NCT05396014|466939046|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721170|NCT05396014|466939047|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721171|NCT05396014|466939048|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721172|NCT05396014|466939049|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
129721173|NCT05396014|466939007|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
129721174|NCT05396014|466939008|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721175|NCT05396014|466939009|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721176|NCT05396014|466939010|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721177|NCT05396014|466939011|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721178|NCT05396014|466939012|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721179|NCT05396014|466939013|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721180|NCT05396014|466939014|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721181|NCT05396014|466939015|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721182|NCT05396014|466939016|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721183|NCT05396014|466939017|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721184|NCT05396014|466939018|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721185|NCT05396014|466939019|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721186|NCT05396014|466939020|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
129721187|NCT05396014|466939021|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721188|NCT05396014|466939022|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721189|NCT05396014|466939023|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721190|NCT05396014|466939024|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721191|NCT05396014|466939025|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721192|NCT05396014|466939026|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721193|NCT05396014|466939027|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721194|NCT05396014|466939028|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721195|NCT05396014|466939029|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721196|NCT05396014|466939030|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721197|NCT05396014|466939031|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721198|NCT05396014|466939032|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721199|NCT05396014|466939033|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721200|NCT05396014|466939034|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721201|NCT05396014|466939035|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721202|NCT05396014|466939036|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721203|NCT05396014|466939037|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721204|NCT05396014|466939038|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721205|NCT05396014|466939039|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721206|NCT05396014|466939040|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129803654|NCT02122458|467249778|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
129803655|NCT02122458|467249779|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
129891592|NCT01052662|467561203|FG002|Overall Study|Adverse Event|0|||
129721207|NCT05396014|466939041|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721208|NCT05396014|466939042|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721209|NCT05396014|466939043|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721210|NCT05396014|466939044|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721211|NCT05396014|466939045|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721212|NCT05396014|466939046|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
129721213|NCT05396014|466939047|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721214|NCT05396014|466939048|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721215|NCT05396014|466939049|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
129721216|NCT05396014|466939007|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
129721217|NCT05396014|466939008|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721218|NCT05396014|466939009|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721219|NCT05396014|466939010|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721220|NCT05396014|466939011|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721221|NCT05396014|466939012|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721222|NCT05396014|466939013|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721223|NCT05396014|466939014|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721224|NCT05396014|466939015|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721225|NCT05396014|466939016|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721226|NCT05396014|466939017|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721227|NCT05396014|466939018|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721228|NCT05396014|466939019|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721229|NCT05396014|466939020|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721230|NCT05396014|466939021|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721231|NCT05396014|466939022|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721232|NCT05396014|466939023|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721233|NCT05396014|466939024|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721234|NCT05396014|466939025|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721235|NCT05396014|466939026|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721236|NCT05396014|466939027|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721237|NCT05396014|466939028|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721238|NCT05396014|466939029|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721239|NCT05396014|466939030|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721240|NCT05396014|466939031|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721241|NCT05396014|466939032|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721242|NCT05396014|466939033|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
129721243|NCT05396014|466939034|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721244|NCT05396014|466939035|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721245|NCT05396014|466939036|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721246|NCT05396014|466939037|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721247|NCT05396014|466939038|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721248|NCT05396014|466939039|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721249|NCT05396014|466939040|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721250|NCT05396014|466939041|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721251|NCT05396014|466939042|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721252|NCT05396014|466939043|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721253|NCT05396014|466939044|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721254|NCT05396014|466939045|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721255|NCT05396014|466939046|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721256|NCT05396014|466939047|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721257|NCT05396014|466939048|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721258|NCT05396014|466939049|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
129721259|NCT05396014|466939007|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721260|NCT05396014|466939008|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721261|NCT05396014|466939009|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721262|NCT05396014|466939010|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721263|NCT05396014|466939011|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721264|NCT05396014|466939012|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721265|NCT05396014|466939013|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721266|NCT05396014|466939014|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721267|NCT05396014|466939015|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721268|NCT05396014|466939016|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129444383|NCT00578786|465927335|FG001|Overall Study|Early Escape from Prior Study|1|||
129721269|NCT05396014|466939017|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721270|NCT05396014|466939018|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129891593|NCT01052662|467561201|FG000|Overall Study|Legal Problem|2|||
129721271|NCT05396014|466939019|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721272|NCT05396014|466939020|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
129721273|NCT05396014|466939021|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721274|NCT05396014|466939022|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721275|NCT05396014|466939023|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721276|NCT05396014|466939024|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721277|NCT05396014|466939025|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721278|NCT05396014|466939026|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721279|NCT05396014|466939027|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721280|NCT05396014|466939028|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721281|NCT05396014|466939029|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721282|NCT05396014|466939030|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721283|NCT05396014|466939031|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721284|NCT05396014|466939032|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721285|NCT05396014|466939033|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721286|NCT05396014|466939034|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721287|NCT05396014|466939035|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721288|NCT05396014|466939036|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721289|NCT05396014|466939037|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721290|NCT05396014|466939038|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721291|NCT05396014|466939039|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721292|NCT05396014|466939040|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721293|NCT05396014|466939041|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721294|NCT05396014|466939042|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721295|NCT05396014|466939043|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721296|NCT05396014|466939044|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721297|NCT05396014|466939045|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721298|NCT05396014|466939046|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721299|NCT05396014|466939047|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721300|NCT05396014|466939048|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721301|NCT05396014|466939049|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
129721302|NCT05396014|466939007|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721303|NCT05396014|466939008|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721304|NCT05396014|466939009|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721305|NCT05396014|466939010|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129721306|NCT05396014|466939011|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721307|NCT05396014|466939012|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721308|NCT05396014|466939013|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721309|NCT05396014|466939014|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721310|NCT05396014|466939015|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129721311|NCT05396014|466939016|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721312|NCT05396014|466939017|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721313|NCT05396014|466939018|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721314|NCT05396014|466939019|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721315|NCT05396014|466939020|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721316|NCT05396014|466939021|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721317|NCT05396014|466939022|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721318|NCT05396014|466939023|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721319|NCT05396014|466939024|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721320|NCT05396014|466939025|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721321|NCT05396014|466939026|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721322|NCT05396014|466939027|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721323|NCT05396014|466939028|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721324|NCT05396014|466939029|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721325|NCT05396014|466939030|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721326|NCT05396014|466939031|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721327|NCT05396014|466939032|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129721328|NCT05396014|466939033|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721329|NCT05396014|466939034|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721330|NCT05396014|466939035|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721331|NCT05396014|466939036|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129803656|NCT02122458|467249780|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803657|NCT02122458|467249781|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803658|NCT02122458|467249782|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
129444384|NCT00578786|465927336|FG002|Overall Study|Early Escape from Prior Study|2|||
129803659|NCT02122458|467249783|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803660|NCT02122458|467249784|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
129803661|NCT02122458|467249778|FG000|Overall Study|Adverse Event|1|||
129803662|NCT02122458|467249779|FG001|Overall Study|Adverse Event|0|||
129803663|NCT02122458|467249780|FG002|Overall Study|Adverse Event|0|||
129803664|NCT02122458|467249781|FG003|Overall Study|Adverse Event|0|||
129803665|NCT02122458|467249782|FG004|Overall Study|Adverse Event|0|||
129803666|NCT02122458|467249783|FG005|Overall Study|Adverse Event|0|||
129803667|NCT02122458|467249784|FG006|Overall Study|Adverse Event|0|||
129803668|NCT02122458|467249778|FG000|Overall Study|Experimental Error|0|||
129803669|NCT02122458|467249779|FG001|Overall Study|Experimental Error|0|||
129803670|NCT02122458|467249780|FG002|Overall Study|Experimental Error|0|||
129803671|NCT02122458|467249781|FG003|Overall Study|Experimental Error|0|||
129803672|NCT02122458|467249782|FG004|Overall Study|Experimental Error|3|||
129803673|NCT02122458|467249783|FG005|Overall Study|Experimental Error|0|||
129803674|NCT02122458|467249784|FG006|Overall Study|Experimental Error|0|||
129803675|NCT02122458|467249778|FG000|Overall Study|Deployed or Moved|0|||
129803676|NCT02122458|467249779|FG001|Overall Study|Deployed or Moved|0|||
129803677|NCT02122458|467249780|FG002|Overall Study|Deployed or Moved|0|||
129803678|NCT02122458|467249781|FG003|Overall Study|Deployed or Moved|0|||
129803679|NCT02122458|467249782|FG004|Overall Study|Deployed or Moved|1|||
129803680|NCT02122458|467249783|FG005|Overall Study|Deployed or Moved|0|||
129803681|NCT02122458|467249784|FG006|Overall Study|Deployed or Moved|0|||
129803682|NCT02122458|467249778|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
129803683|NCT02122458|467249779|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
129803684|NCT02122458|467249780|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
129803685|NCT02122458|467249781|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
129803686|NCT02122458|467249782|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
129803687|NCT02122458|467249783|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
129803688|NCT02122458|467249784|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
129803689|NCT02122458|467249778|FG000|Overall Study|Noncompliance|0|||
129803690|NCT02122458|467249779|FG001|Overall Study|Noncompliance|1|||
129803691|NCT02122458|467249780|FG002|Overall Study|Noncompliance|0|||
129803692|NCT02122458|467249781|FG003|Overall Study|Noncompliance|0|||
129803693|NCT02122458|467249782|FG004|Overall Study|Noncompliance|0|||
129803694|NCT02122458|467249783|FG005|Overall Study|Noncompliance|0|||
129803695|NCT02122458|467249784|FG006|Overall Study|Noncompliance|0|||
129721332|NCT05396014|466939037|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721333|NCT05396014|466939038|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721334|NCT05396014|466939039|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721335|NCT05396014|466939040|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721336|NCT05396014|466939041|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721337|NCT05396014|466939042|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721338|NCT05396014|466939043|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721339|NCT05396014|466939044|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721340|NCT05396014|466939045|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721341|NCT05396014|466939046|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
129721342|NCT05396014|466939047|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
129721343|NCT05396014|466939048|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
129721344|NCT05396014|466939049|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
129721345|NCT05396014|466939007|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721346|NCT05396014|466939008|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721347|NCT05396014|466939009|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721348|NCT05396014|466939010|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721349|NCT05396014|466939011|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721350|NCT05396014|466939012|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721351|NCT05396014|466939013|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721352|NCT05396014|466939014|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721353|NCT05396014|466939015|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
129721354|NCT05396014|466939016|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721355|NCT05396014|466939017|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721356|NCT05396014|466939018|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721357|NCT05396014|466939019|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721358|NCT05396014|466939020|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721359|NCT05396014|466939021|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129803696|NCT00412542|467249785|FG000|Overall Study|Withdrawal by Subject|0|||
129803697|NCT00412542|467249786|FG001|Overall Study|Withdrawal by Subject|2|||
129803698|NCT00412542|467249785|FG000|Overall Study|Not Eligible|0|||
129721360|NCT05396014|466939022|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129803699|NCT00412542|467249786|FG001|Overall Study|Not Eligible|1|||
129803700|NCT03161093|467249787|FG000|Overall Study|Protocol Violation|11|||
129803701|NCT03161093|467249788|FG001|Overall Study|Protocol Violation|14|||
129721361|NCT05396014|466939023|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721362|NCT05396014|466939024|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721363|NCT05396014|466939025|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721364|NCT05396014|466939026|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721365|NCT05396014|466939027|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721366|NCT05396014|466939028|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721367|NCT05396014|466939029|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
129721368|NCT05396014|466939030|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721369|NCT05396014|466939031|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721370|NCT05396014|466939032|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721371|NCT05396014|466939033|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721372|NCT05396014|466939034|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721373|NCT05396014|466939035|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721374|NCT05396014|466939036|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721375|NCT05396014|466939037|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721376|NCT05396014|466939038|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721377|NCT05396014|466939039|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721378|NCT05396014|466939040|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721379|NCT05396014|466939041|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129891594|NCT01052662|467561202|FG001|Overall Study|Legal Problem|0|||
129891595|NCT01052662|467561203|FG002|Overall Study|Legal Problem|0|||
129891596|NCT01052662|467561201|FG000|Overall Study|Administrative|0|||
129891597|NCT01052662|467561202|FG001|Overall Study|Administrative|3|||
129891598|NCT01052662|467561203|FG002|Overall Study|Administrative|0|||
129891599|NCT00087490|467561204|FG000|Overall Study|Death|6|||
129891600|NCT00087490|467561205|FG001|Overall Study|Death|4|||
129891601|NCT00087490|467561204|FG000|Overall Study|Adverse Event|3|||
129891602|NCT00087490|467561205|FG001|Overall Study|Adverse Event|8|||
129891603|NCT00087490|467561204|FG000|Overall Study|Lack of Efficacy|0|||
129891604|NCT00087490|467561205|FG001|Overall Study|Lack of Efficacy|2|||
129891605|NCT00087490|467561204|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
129891606|NCT00087490|467561205|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
129891607|NCT00087490|467561204|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
129891608|NCT00087490|467561205|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
129891609|NCT00087490|467561204|FG000|Overall Study|Randomized but not treated|7|||
129891610|NCT00087490|467561205|FG001|Overall Study|Randomized but not treated|18|||
129891611|NCT02034435|467561206|FG000|Overall Study|Withdrawal by Subject|1|||
129891612|NCT02034435|467561207|FG001|Overall Study|Withdrawal by Subject|0|||
129891613|NCT02034435|467561208|FG002|Overall Study|Withdrawal by Subject|0|||
129891614|NCT02034435|467561209|FG003|Overall Study|Withdrawal by Subject|0|||
129891615|NCT02034435|467561206|FG000|Overall Study|Illness|0|||
129891616|NCT02034435|467561207|FG001|Overall Study|Illness|2|||
129891617|NCT02034435|467561208|FG002|Overall Study|Illness|0|||
129891618|NCT02034435|467561209|FG003|Overall Study|Illness|0|||
129891619|NCT02034435|467561206|FG000|Overall Study|Inadequate IV access|1|||
129891620|NCT02034435|467561207|FG001|Overall Study|Inadequate IV access|0|||
129721380|NCT05396014|466939042|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
129721381|NCT05396014|466939043|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721382|NCT05396014|466939044|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721383|NCT05396014|466939045|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721384|NCT05396014|466939046|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
129721385|NCT05396014|466939047|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721386|NCT05396014|466939048|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
129721387|NCT05396014|466939049|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
129721388|NCT05396014|466939007|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721389|NCT05396014|466939008|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721390|NCT05396014|466939009|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721391|NCT05396014|466939010|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721392|NCT05396014|466939011|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721393|NCT05396014|466939012|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721394|NCT05396014|466939013|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129891621|NCT02034435|467561208|FG002|Overall Study|Inadequate IV access|0|||
129891622|NCT02034435|467561209|FG003|Overall Study|Inadequate IV access|1|||
129891623|NCT00630539|467561210|FG000|Overall Study|Adverse Event|1|||
129891624|NCT00630539|467561211|FG001|Overall Study|Adverse Event|3|||
129891625|NCT00630539|467561212|FG002|Overall Study|Adverse Event|1|||
129891626|NCT00630539|467561213|FG003|Overall Study|Adverse Event|2|||
129891627|NCT00630539|467561210|FG000|Overall Study|Withdrawal by Subject|0|||
129721395|NCT05396014|466939014|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721396|NCT05396014|466939015|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721397|NCT05396014|466939016|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721398|NCT05396014|466939017|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721399|NCT05396014|466939018|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721400|NCT05396014|466939019|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721401|NCT05396014|466939020|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129721402|NCT05396014|466939021|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721403|NCT05396014|466939022|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721404|NCT05396014|466939023|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721405|NCT05396014|466939024|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721406|NCT05396014|466939025|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721407|NCT05396014|466939026|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721408|NCT05396014|466939027|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721409|NCT05396014|466939028|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721410|NCT05396014|466939029|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721411|NCT05396014|466939030|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721412|NCT05396014|466939031|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721413|NCT05396014|466939032|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721414|NCT05396014|466939033|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129721415|NCT05396014|466939034|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721416|NCT05396014|466939035|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721417|NCT05396014|466939036|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721418|NCT05396014|466939037|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721419|NCT05396014|466939038|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721420|NCT05396014|466939039|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721421|NCT05396014|466939040|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721422|NCT05396014|466939041|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129721423|NCT05396014|466939042|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721424|NCT05396014|466939043|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721425|NCT05396014|466939044|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721426|NCT05396014|466939045|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721427|NCT05396014|466939046|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721428|NCT05396014|466939047|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721429|NCT05396014|466939048|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
129721430|NCT05396014|466939049|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
129721431|NCT05396014|466939007|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721432|NCT05396014|466939008|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721433|NCT05396014|466939009|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721434|NCT05396014|466939010|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721435|NCT05396014|466939011|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721436|NCT05396014|466939012|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721437|NCT05396014|466939013|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721438|NCT05396014|466939014|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721439|NCT05396014|466939015|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721440|NCT05396014|466939016|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721441|NCT05396014|466939017|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721442|NCT05396014|466939018|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721443|NCT05396014|466939019|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721444|NCT05396014|466939020|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721445|NCT05396014|466939021|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721446|NCT05396014|466939022|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721447|NCT05396014|466939023|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721448|NCT05396014|466939024|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721449|NCT05396014|466939025|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721450|NCT05396014|466939026|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721451|NCT05396014|466939027|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721452|NCT05396014|466939028|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721453|NCT05396014|466939029|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721454|NCT05396014|466939030|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721455|NCT05396014|466939031|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721456|NCT05396014|466939032|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721457|NCT05396014|466939033|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
129721458|NCT05396014|466939034|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721459|NCT05396014|466939035|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721460|NCT05396014|466939036|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721461|NCT05396014|466939037|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721462|NCT05396014|466939038|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721463|NCT05396014|466939039|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721464|NCT05396014|466939040|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721465|NCT05396014|466939041|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721466|NCT05396014|466939042|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721467|NCT05396014|466939043|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721468|NCT05396014|466939044|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721469|NCT05396014|466939045|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721470|NCT05396014|466939046|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721471|NCT05396014|466939047|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721472|NCT05396014|466939048|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721473|NCT05396014|466939049|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
129721474|NCT03062280|466939050|FG000|Overall Study|Adverse Event|1|||
129721475|NCT03062280|466939050|FG000|Overall Study|Death|1|||
129803702|NCT03161093|467249789|FG002|Overall Study|Protocol Violation|6|||
129803703|NCT03161093|467249790|FG003|Overall Study|Protocol Violation|13|||
129803704|NCT03161093|467249791|FG004|Overall Study|Protocol Violation|1|||
129803705|NCT03161093|467249792|FG005|Overall Study|Protocol Violation|0|||
129803706|NCT03161093|467249787|FG000|Overall Study|Adverse Event|5|||
129803707|NCT03161093|467249788|FG001|Overall Study|Adverse Event|21|||
129803708|NCT03161093|467249789|FG002|Overall Study|Adverse Event|16|||
129721476|NCT03062280|466939050|FG000|Overall Study|Fertility Treatment|2|||
129721477|NCT03062280|466939050|FG000|Overall Study|Physician Decision|2|||
129721478|NCT03062280|466939050|FG000|Overall Study|Pregnancy|5|||
129721479|NCT03062280|466939050|FG000|Overall Study|Withdrawal by Subject|11|||
129721480|NCT04299308|466939052|FG000|Overall Study|Withdrawal by Subject|1|||
129721481|NCT04299308|466939053|FG001|Overall Study|Withdrawal by Subject|0|||
129721482|NCT04299308|466939052|FG000|Overall Study|issue with PET image (1)|1|||
129721483|NCT04299308|466939053|FG001|Overall Study|issue with PET image (1)|0|||
129721484|NCT05258890|466939054|FG000|Overall Study|Patient withdrawal|6|||
129721485|NCT05258890|466939055|FG001|Overall Study|Patient withdrawal|7|||
129721486|NCT05258890|466939054|FG000|Overall Study|Patient lost to follow-up|10|||
129721487|NCT05258890|466939055|FG001|Overall Study|Patient lost to follow-up|3|||
129721488|NCT05258890|466939054|FG000|Overall Study|Social network member withdrawal|1|||
129721489|NCT05258890|466939055|FG001|Overall Study|Social network member withdrawal|0|||
129721490|NCT05258890|466939054|FG000|Overall Study|Social network member lost to follow-up|5|||
129721491|NCT05258890|466939055|FG001|Overall Study|Social network member lost to follow-up|0|||
129721492|NCT04493424|466939056|FG000|Overall Study|Termination of the trial by the sponsor|89|||
129721493|NCT04493424|466939056|FG000|Overall Study|Withdrawal by Subject|9|||
129721494|NCT04493424|466939056|FG000|Overall Study|Lost to Follow-up|2|||
129721495|NCT04493424|466939056|FG000|Overall Study|Lack of Efficacy|3|||
129721496|NCT04493424|466939056|FG000|Overall Study|Adverse Event|5|||
129721497|NCT00516893|466939059|FG000|Overall Study|Lost to Follow-up|4|||
129721498|NCT00516893|466939059|FG000|Overall Study|Adverse Event|3|||
129721499|NCT00516893|466939059|FG000|Overall Study|Withdrawal by Subject|2|||
129721500|NCT00516893|466939059|FG000|Overall Study|Noncompliance|2|||
129721501|NCT00516893|466939059|FG000|Overall Study|Death|1|||
129721502|NCT00516893|466939059|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
129721503|NCT00516893|466939059|FG000|Overall Study|Relocated|1|||
129721504|NCT00516893|466939059|FG000|Overall Study|Pregnancy|1|||
129721505|NCT00516893|466939059|FG000|Overall Study|Received Medication From Another Study|1|||
129721506|NCT05935878|466939065|FG000|Overall Study|Death|1|||
129721507|NCT05935878|466939066|FG001|Overall Study|Death|2|||
129721508|NCT05935878|466939065|FG000|Overall Study|Withdrawal by Subject|5|||
129721509|NCT05935878|466939066|FG001|Overall Study|Withdrawal by Subject|5|||
129721510|NCT05935878|466939065|FG000|Overall Study|Revision of implant|1|||
129721511|NCT05935878|466939066|FG001|Overall Study|Revision of implant|1|||
129721512|NCT05935878|466939065|FG000|Overall Study|Mobile bearing dislocation|0|||
129721513|NCT05935878|466939066|FG001|Overall Study|Mobile bearing dislocation|1|||
129721514|NCT05924165|466939067|FG000|Overall Study|Physician Decision|2|||
129721515|NCT05924165|466939068|FG001|Overall Study|Physician Decision|3|||
129721516|NCT05959447|466939069|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
129721517|NCT05959447|466939070|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
129721518|NCT05959447|466939069|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
129721519|NCT05959447|466939070|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
129721520|NCT05959447|466939069|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
129721521|NCT05959447|466939070|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
129721522|NCT05959447|466939069|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
129721523|NCT05959447|466939070|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
129721524|NCT00301262|466939071|FG000|Double Blind Phase (DB)|Adverse Event|1|||
129721525|NCT00301262|466939072|FG001|Double Blind Phase (DB)|Adverse Event|0|||
129721526|NCT00301262|466939071|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
129721527|NCT00301262|466939072|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
129721528|NCT00301262|466939071|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
129721529|NCT00301262|466939072|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
129721530|NCT00301262|466939071|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
129721531|NCT00301262|466939072|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
129721532|NCT00301262|466939071|FG000|Double Blind Phase (DB)|Other|1|||
129721533|NCT00301262|466939072|FG001|Double Blind Phase (DB)|Other|4|||
129721534|NCT00301262|466939071|FG000|Open Label Phase (OL)|Adverse Event|1|||
129721535|NCT00301262|466939072|FG001|Open Label Phase (OL)|Adverse Event|0|||
129721536|NCT00301262|466939071|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
129721537|NCT00301262|466939072|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
129721538|NCT00301262|466939071|FG000|Open Label Phase (OL)|Other|2|||
129721539|NCT00301262|466939072|FG001|Open Label Phase (OL)|Other|0|||
129721540|NCT00368745|466939073|FG000|Double-blind Treatment Period|Adverse Event|6|||
129721541|NCT00368745|466939074|FG001|Double-blind Treatment Period|Adverse Event|6|||
129721542|NCT00368745|466939073|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
129721543|NCT00368745|466939074|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
129721544|NCT00368745|466939073|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
129721545|NCT00368745|466939074|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129721546|NCT00368745|466939073|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
129721547|NCT00368745|466939074|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
129721548|NCT00368745|466939073|FG000|Double-blind Treatment Period|Other|7|||
129721549|NCT00368745|466939074|FG001|Double-blind Treatment Period|Other|6|||
129721550|NCT01436656|466939075|FG000|Dose Escalation|Death|1|||
129721551|NCT01436656|466939076|FG001|Dose Escalation|Death|3|||
129721552|NCT01436656|466939077|FG002|Dose Escalation|Death|1|||
129721553|NCT01436656|466939078|FG003|Dose Escalation|Death|0|||
129721554|NCT01436656|466939079|FG004|Dose Escalation|Death|2|||
129721555|NCT01436656|466939080|FG005|Dose Escalation|Death|1|||
129721556|NCT01436656|466939081|FG006|Dose Escalation|Death|1|||
129721557|NCT01436656|466939082|FG007|Dose Escalation|Death|1|||
129721558|NCT01436656|466939083|FG008|Dose Escalation|Death|1|||
129721559|NCT01436656|466939084|FG009|Dose Escalation|Death|0|||
129721560|NCT01436656|466939085|FG010|Dose Escalation|Death|0|||
129721561|NCT01436656|466939086|FG011|Dose Escalation|Death|0|||
129721562|NCT01436656|466939087|FG012|Dose Escalation|Death|0|||
129721563|NCT01436656|466939088|FG013|Dose Escalation|Death|0|||
129721564|NCT01436656|466939089|FG014|Dose Escalation|Death|0|||
129721565|NCT01436656|466939090|FG015|Dose Escalation|Death|0|||
129721566|NCT01436656|466939091|FG016|Dose Escalation|Death|0|||
129721567|NCT01436656|466939092|FG017|Dose Escalation|Death|0|||
129721568|NCT01436656|466939075|FG000|Dose Escalation|Protocol Violation|0|||
129721569|NCT01436656|466939076|FG001|Dose Escalation|Protocol Violation|0|||
129721570|NCT01436656|466939077|FG002|Dose Escalation|Protocol Violation|0|||
129721571|NCT01436656|466939078|FG003|Dose Escalation|Protocol Violation|0|||
129721572|NCT01436656|466939079|FG004|Dose Escalation|Protocol Violation|0|||
129721573|NCT01436656|466939080|FG005|Dose Escalation|Protocol Violation|1|||
129721574|NCT01436656|466939081|FG006|Dose Escalation|Protocol Violation|0|||
129721575|NCT01436656|466939082|FG007|Dose Escalation|Protocol Violation|0|||
129721576|NCT01436656|466939083|FG008|Dose Escalation|Protocol Violation|0|||
129721577|NCT01436656|466939084|FG009|Dose Escalation|Protocol Violation|0|||
129721578|NCT01436656|466939085|FG010|Dose Escalation|Protocol Violation|0|||
129721579|NCT01436656|466939086|FG011|Dose Escalation|Protocol Violation|0|||
129721580|NCT01436656|466939087|FG012|Dose Escalation|Protocol Violation|0|||
129721581|NCT01436656|466939088|FG013|Dose Escalation|Protocol Violation|0|||
129803709|NCT03161093|467249790|FG003|Overall Study|Adverse Event|35|||
129721582|NCT01436656|466939089|FG014|Dose Escalation|Protocol Violation|0|||
129721583|NCT01436656|466939090|FG015|Dose Escalation|Protocol Violation|0|||
129721584|NCT01436656|466939091|FG016|Dose Escalation|Protocol Violation|0|||
129803710|NCT03161093|467249791|FG004|Overall Study|Adverse Event|2|||
129803711|NCT03161093|467249792|FG005|Overall Study|Adverse Event|1|||
129803712|NCT03161093|467249787|FG000|Overall Study|Lack of Efficacy|9|||
129721585|NCT01436656|466939092|FG017|Dose Escalation|Protocol Violation|0|||
129721586|NCT01436656|466939075|FG000|Dose Escalation|Withdrawal by Subject|0|||
129721587|NCT01436656|466939076|FG001|Dose Escalation|Withdrawal by Subject|0|||
129721588|NCT01436656|466939077|FG002|Dose Escalation|Withdrawal by Subject|0|||
129803713|NCT03161093|467249788|FG001|Overall Study|Lack of Efficacy|13|||
129721589|NCT01436656|466939078|FG003|Dose Escalation|Withdrawal by Subject|0|||
129721590|NCT01436656|466939079|FG004|Dose Escalation|Withdrawal by Subject|1|||
129721591|NCT01436656|466939080|FG005|Dose Escalation|Withdrawal by Subject|0|||
129721592|NCT01436656|466939081|FG006|Dose Escalation|Withdrawal by Subject|0|||
129721593|NCT01436656|466939082|FG007|Dose Escalation|Withdrawal by Subject|2|||
129721594|NCT01436656|466939083|FG008|Dose Escalation|Withdrawal by Subject|0|||
129721595|NCT01436656|466939084|FG009|Dose Escalation|Withdrawal by Subject|1|||
129721596|NCT01436656|466939085|FG010|Dose Escalation|Withdrawal by Subject|1|||
129721597|NCT01436656|466939086|FG011|Dose Escalation|Withdrawal by Subject|0|||
129721598|NCT01436656|466939087|FG012|Dose Escalation|Withdrawal by Subject|0|||
129721599|NCT01436656|466939088|FG013|Dose Escalation|Withdrawal by Subject|0|||
129803714|NCT03161093|467249789|FG002|Overall Study|Lack of Efficacy|9|||
129721600|NCT01436656|466939089|FG014|Dose Escalation|Withdrawal by Subject|0|||
129721601|NCT01436656|466939090|FG015|Dose Escalation|Withdrawal by Subject|0|||
129721602|NCT01436656|466939091|FG016|Dose Escalation|Withdrawal by Subject|0|||
129721603|NCT01436656|466939092|FG017|Dose Escalation|Withdrawal by Subject|0|||
129721604|NCT01436656|466939075|FG000|Dose Escalation|Administrative problems|0|||
129721605|NCT01436656|466939076|FG001|Dose Escalation|Administrative problems|1|||
129721606|NCT01436656|466939077|FG002|Dose Escalation|Administrative problems|0|||
129721607|NCT01436656|466939078|FG003|Dose Escalation|Administrative problems|0|||
129721608|NCT01436656|466939079|FG004|Dose Escalation|Administrative problems|0|||
129721609|NCT01436656|466939080|FG005|Dose Escalation|Administrative problems|0|||
129721610|NCT01436656|466939081|FG006|Dose Escalation|Administrative problems|0|||
129721611|NCT01436656|466939082|FG007|Dose Escalation|Administrative problems|0|||
129721612|NCT01436656|466939083|FG008|Dose Escalation|Administrative problems|0|||
129721613|NCT01436656|466939084|FG009|Dose Escalation|Administrative problems|0|||
129721614|NCT01436656|466939085|FG010|Dose Escalation|Administrative problems|0|||
129721615|NCT01436656|466939086|FG011|Dose Escalation|Administrative problems|0|||
129721616|NCT01436656|466939087|FG012|Dose Escalation|Administrative problems|0|||
129721617|NCT01436656|466939088|FG013|Dose Escalation|Administrative problems|0|||
129721618|NCT01436656|466939089|FG014|Dose Escalation|Administrative problems|0|||
129721619|NCT01436656|466939090|FG015|Dose Escalation|Administrative problems|0|||
129721620|NCT01436656|466939091|FG016|Dose Escalation|Administrative problems|0|||
129721621|NCT01436656|466939092|FG017|Dose Escalation|Administrative problems|0|||
129721622|NCT01436656|466939075|FG000|Dose Escalation|Lost to Follow-up|1|||
129721623|NCT01436656|466939076|FG001|Dose Escalation|Lost to Follow-up|0|||
129721624|NCT01436656|466939077|FG002|Dose Escalation|Lost to Follow-up|0|||
129721625|NCT01436656|466939078|FG003|Dose Escalation|Lost to Follow-up|0|||
129803715|NCT03161093|467249790|FG003|Overall Study|Lack of Efficacy|24|||
129803716|NCT03161093|467249791|FG004|Overall Study|Lack of Efficacy|4|||
129803717|NCT03161093|467249792|FG005|Overall Study|Lack of Efficacy|1|||
129803718|NCT03161093|467249787|FG000|Overall Study|Physician Decision|0|||
129803719|NCT03161093|467249788|FG001|Overall Study|Physician Decision|1|||
129803720|NCT03161093|467249789|FG002|Overall Study|Physician Decision|0|||
129721626|NCT01436656|466939079|FG004|Dose Escalation|Lost to Follow-up|1|||
129721627|NCT01436656|466939080|FG005|Dose Escalation|Lost to Follow-up|0|||
129721628|NCT01436656|466939081|FG006|Dose Escalation|Lost to Follow-up|0|||
129721629|NCT01436656|466939082|FG007|Dose Escalation|Lost to Follow-up|0|||
129721630|NCT01436656|466939083|FG008|Dose Escalation|Lost to Follow-up|0|||
129721631|NCT01436656|466939084|FG009|Dose Escalation|Lost to Follow-up|0|||
129721632|NCT01436656|466939085|FG010|Dose Escalation|Lost to Follow-up|0|||
129721633|NCT01436656|466939086|FG011|Dose Escalation|Lost to Follow-up|0|||
129721634|NCT01436656|466939087|FG012|Dose Escalation|Lost to Follow-up|0|||
129721635|NCT01436656|466939088|FG013|Dose Escalation|Lost to Follow-up|0|||
129721636|NCT01436656|466939089|FG014|Dose Escalation|Lost to Follow-up|0|||
129721637|NCT01436656|466939090|FG015|Dose Escalation|Lost to Follow-up|0|||
129721638|NCT01436656|466939091|FG016|Dose Escalation|Lost to Follow-up|0|||
129721639|NCT01436656|466939092|FG017|Dose Escalation|Lost to Follow-up|0|||
129721640|NCT01436656|466939075|FG000|Dose Escalation|New anti-cancer therapy|1|||
129721641|NCT01436656|466939076|FG001|Dose Escalation|New anti-cancer therapy|0|||
129721642|NCT01436656|466939077|FG002|Dose Escalation|New anti-cancer therapy|0|||
129721643|NCT01436656|466939078|FG003|Dose Escalation|New anti-cancer therapy|0|||
129721644|NCT01436656|466939079|FG004|Dose Escalation|New anti-cancer therapy|0|||
129721645|NCT01436656|466939080|FG005|Dose Escalation|New anti-cancer therapy|0|||
129721646|NCT01436656|466939081|FG006|Dose Escalation|New anti-cancer therapy|0|||
129721647|NCT01436656|466939082|FG007|Dose Escalation|New anti-cancer therapy|0|||
129721648|NCT01436656|466939083|FG008|Dose Escalation|New anti-cancer therapy|1|||
129721649|NCT01436656|466939084|FG009|Dose Escalation|New anti-cancer therapy|1|||
129721650|NCT01436656|466939085|FG010|Dose Escalation|New anti-cancer therapy|0|||
129721651|NCT01436656|466939086|FG011|Dose Escalation|New anti-cancer therapy|0|||
129721652|NCT01436656|466939087|FG012|Dose Escalation|New anti-cancer therapy|0|||
129721653|NCT01436656|466939088|FG013|Dose Escalation|New anti-cancer therapy|0|||
129721654|NCT01436656|466939089|FG014|Dose Escalation|New anti-cancer therapy|0|||
129803721|NCT03161093|467249790|FG003|Overall Study|Physician Decision|2|||
129803722|NCT03161093|467249791|FG004|Overall Study|Physician Decision|17|||
129803723|NCT03161093|467249792|FG005|Overall Study|Physician Decision|15|||
129803724|NCT03161093|467249787|FG000|Overall Study|Withdrawal by Subject|24|||
129803725|NCT03161093|467249788|FG001|Overall Study|Withdrawal by Subject|73|||
129803726|NCT03161093|467249789|FG002|Overall Study|Withdrawal by Subject|44|||
129803727|NCT03161093|467249790|FG003|Overall Study|Withdrawal by Subject|97|||
129721655|NCT01436656|466939090|FG015|Dose Escalation|New anti-cancer therapy|0|||
129721656|NCT01436656|466939091|FG016|Dose Escalation|New anti-cancer therapy|0|||
129721657|NCT01436656|466939092|FG017|Dose Escalation|New anti-cancer therapy|0|||
129721658|NCT01436656|466939075|FG000|Dose Expansion|Adverse Event|0|||
129721659|NCT01436656|466939076|FG001|Dose Expansion|Adverse Event|0|||
129721660|NCT01436656|466939077|FG002|Dose Expansion|Adverse Event|0|||
129721661|NCT01436656|466939078|FG003|Dose Expansion|Adverse Event|0|||
129721662|NCT01436656|466939079|FG004|Dose Expansion|Adverse Event|0|||
129721663|NCT01436656|466939080|FG005|Dose Expansion|Adverse Event|0|||
129721664|NCT01436656|466939081|FG006|Dose Expansion|Adverse Event|0|||
129803728|NCT03161093|467249791|FG004|Overall Study|Withdrawal by Subject|11|||
129721665|NCT01436656|466939082|FG007|Dose Expansion|Adverse Event|0|||
129721666|NCT01436656|466939083|FG008|Dose Expansion|Adverse Event|0|||
129721667|NCT01436656|466939084|FG009|Dose Expansion|Adverse Event|0|||
129721668|NCT01436656|466939085|FG010|Dose Expansion|Adverse Event|0|||
129721669|NCT01436656|466939086|FG011|Dose Expansion|Adverse Event|1|||
129721670|NCT01436656|466939087|FG012|Dose Expansion|Adverse Event|0|||
129721671|NCT01436656|466939088|FG013|Dose Expansion|Adverse Event|0|||
129721672|NCT01436656|466939089|FG014|Dose Expansion|Adverse Event|0|||
129721673|NCT01436656|466939090|FG015|Dose Expansion|Adverse Event|0|||
129721674|NCT01436656|466939091|FG016|Dose Expansion|Adverse Event|0|||
129721675|NCT01436656|466939092|FG017|Dose Expansion|Adverse Event|0|||
129721676|NCT01436656|466939075|FG000|Dose Expansion|Withdrawal by Subject|0|||
129721677|NCT01436656|466939076|FG001|Dose Expansion|Withdrawal by Subject|0|||
129721678|NCT01436656|466939077|FG002|Dose Expansion|Withdrawal by Subject|0|||
129721679|NCT01436656|466939078|FG003|Dose Expansion|Withdrawal by Subject|0|||
129721680|NCT01436656|466939079|FG004|Dose Expansion|Withdrawal by Subject|0|||
129721681|NCT01436656|466939080|FG005|Dose Expansion|Withdrawal by Subject|0|||
129721682|NCT01436656|466939081|FG006|Dose Expansion|Withdrawal by Subject|0|||
129721683|NCT01436656|466939082|FG007|Dose Expansion|Withdrawal by Subject|0|||
129721684|NCT01436656|466939083|FG008|Dose Expansion|Withdrawal by Subject|0|||
129721685|NCT01436656|466939084|FG009|Dose Expansion|Withdrawal by Subject|0|||
129721686|NCT01436656|466939085|FG010|Dose Expansion|Withdrawal by Subject|0|||
129721687|NCT01436656|466939086|FG011|Dose Expansion|Withdrawal by Subject|1|||
129721688|NCT01436656|466939087|FG012|Dose Expansion|Withdrawal by Subject|3|||
129721689|NCT01436656|466939088|FG013|Dose Expansion|Withdrawal by Subject|1|||
129721690|NCT01436656|466939089|FG014|Dose Expansion|Withdrawal by Subject|2|||
129721691|NCT01436656|466939090|FG015|Dose Expansion|Withdrawal by Subject|0|||
129721692|NCT01436656|466939091|FG016|Dose Expansion|Withdrawal by Subject|1|||
129721693|NCT01436656|466939092|FG017|Dose Expansion|Withdrawal by Subject|1|||
129721694|NCT01436656|466939075|FG000|Dose Expansion|Death|0|||
129721695|NCT01436656|466939076|FG001|Dose Expansion|Death|0|||
129721696|NCT01436656|466939077|FG002|Dose Expansion|Death|0|||
129721697|NCT01436656|466939078|FG003|Dose Expansion|Death|0|||
129721698|NCT01436656|466939079|FG004|Dose Expansion|Death|0|||
129721699|NCT01436656|466939080|FG005|Dose Expansion|Death|0|||
129721700|NCT01436656|466939081|FG006|Dose Expansion|Death|0|||
129721701|NCT01436656|466939082|FG007|Dose Expansion|Death|0|||
129721702|NCT01436656|466939083|FG008|Dose Expansion|Death|0|||
129721703|NCT01436656|466939084|FG009|Dose Expansion|Death|0|||
129721704|NCT01436656|466939085|FG010|Dose Expansion|Death|0|||
129721705|NCT01436656|466939086|FG011|Dose Expansion|Death|0|||
129721706|NCT01436656|466939087|FG012|Dose Expansion|Death|1|||
129721707|NCT01436656|466939088|FG013|Dose Expansion|Death|0|||
129721708|NCT01436656|466939089|FG014|Dose Expansion|Death|3|||
129721709|NCT01436656|466939090|FG015|Dose Expansion|Death|0|||
129721710|NCT01436656|466939091|FG016|Dose Expansion|Death|3|||
129721711|NCT01436656|466939092|FG017|Dose Expansion|Death|3|||
129721712|NCT01436656|466939075|FG000|Dose Expansion|Lost to Follow-up|0|||
129721713|NCT01436656|466939076|FG001|Dose Expansion|Lost to Follow-up|0|||
129721714|NCT01436656|466939077|FG002|Dose Expansion|Lost to Follow-up|0|||
129721715|NCT01436656|466939078|FG003|Dose Expansion|Lost to Follow-up|0|||
129721716|NCT01436656|466939079|FG004|Dose Expansion|Lost to Follow-up|0|||
129721717|NCT01436656|466939080|FG005|Dose Expansion|Lost to Follow-up|0|||
129721718|NCT01436656|466939081|FG006|Dose Expansion|Lost to Follow-up|0|||
129721719|NCT01436656|466939082|FG007|Dose Expansion|Lost to Follow-up|0|||
129721720|NCT01436656|466939083|FG008|Dose Expansion|Lost to Follow-up|0|||
129721721|NCT01436656|466939084|FG009|Dose Expansion|Lost to Follow-up|0|||
129721722|NCT01436656|466939085|FG010|Dose Expansion|Lost to Follow-up|0|||
129721723|NCT01436656|466939086|FG011|Dose Expansion|Lost to Follow-up|0|||
129721724|NCT01436656|466939087|FG012|Dose Expansion|Lost to Follow-up|0|||
129721725|NCT01436656|466939088|FG013|Dose Expansion|Lost to Follow-up|0|||
129721726|NCT01436656|466939089|FG014|Dose Expansion|Lost to Follow-up|0|||
129721727|NCT01436656|466939090|FG015|Dose Expansion|Lost to Follow-up|0|||
129721728|NCT01436656|466939091|FG016|Dose Expansion|Lost to Follow-up|0|||
129721729|NCT01436656|466939092|FG017|Dose Expansion|Lost to Follow-up|3|||
129721730|NCT01436656|466939075|FG000|Dose Expansion|Disease progression|0|||
129721731|NCT01436656|466939076|FG001|Dose Expansion|Disease progression|0|||
129721732|NCT01436656|466939077|FG002|Dose Expansion|Disease progression|0|||
129721733|NCT01436656|466939078|FG003|Dose Expansion|Disease progression|0|||
129721734|NCT01436656|466939079|FG004|Dose Expansion|Disease progression|0|||
129721735|NCT01436656|466939080|FG005|Dose Expansion|Disease progression|0|||
129721736|NCT01436656|466939081|FG006|Dose Expansion|Disease progression|0|||
129721737|NCT01436656|466939082|FG007|Dose Expansion|Disease progression|0|||
129721738|NCT01436656|466939083|FG008|Dose Expansion|Disease progression|0|||
129721739|NCT01436656|466939084|FG009|Dose Expansion|Disease progression|0|||
129721740|NCT01436656|466939085|FG010|Dose Expansion|Disease progression|0|||
129721741|NCT01436656|466939086|FG011|Dose Expansion|Disease progression|3|||
129721742|NCT01436656|466939087|FG012|Dose Expansion|Disease progression|1|||
129721743|NCT01436656|466939088|FG013|Dose Expansion|Disease progression|0|||
129721744|NCT01436656|466939089|FG014|Dose Expansion|Disease progression|1|||
129721745|NCT01436656|466939090|FG015|Dose Expansion|Disease progression|0|||
129721746|NCT01436656|466939091|FG016|Dose Expansion|Disease progression|0|||
129721747|NCT01436656|466939092|FG017|Dose Expansion|Disease progression|1|||
129721748|NCT01436656|466939075|FG000|Dose Expansion|New cancer therapy|0|||
129721749|NCT01436656|466939076|FG001|Dose Expansion|New cancer therapy|0|||
129721750|NCT01436656|466939077|FG002|Dose Expansion|New cancer therapy|0|||
129721751|NCT01436656|466939078|FG003|Dose Expansion|New cancer therapy|0|||
129721752|NCT01436656|466939079|FG004|Dose Expansion|New cancer therapy|0|||
129721753|NCT01436656|466939080|FG005|Dose Expansion|New cancer therapy|0|||
129721754|NCT01436656|466939081|FG006|Dose Expansion|New cancer therapy|0|||
129721755|NCT01436656|466939082|FG007|Dose Expansion|New cancer therapy|0|||
129721756|NCT01436656|466939083|FG008|Dose Expansion|New cancer therapy|0|||
129721757|NCT01436656|466939084|FG009|Dose Expansion|New cancer therapy|0|||
129721758|NCT01436656|466939085|FG010|Dose Expansion|New cancer therapy|0|||
129721759|NCT01436656|466939086|FG011|Dose Expansion|New cancer therapy|1|||
129721760|NCT01436656|466939087|FG012|Dose Expansion|New cancer therapy|1|||
129721761|NCT01436656|466939088|FG013|Dose Expansion|New cancer therapy|0|||
129721762|NCT01436656|466939089|FG014|Dose Expansion|New cancer therapy|2|||
129721763|NCT01436656|466939090|FG015|Dose Expansion|New cancer therapy|0|||
129721764|NCT01436656|466939091|FG016|Dose Expansion|New cancer therapy|0|||
129721765|NCT01436656|466939092|FG017|Dose Expansion|New cancer therapy|0|||
129721766|NCT04729972|466939093|FG000|Overall Study|Adverse Event|1|||
129721767|NCT00576628|466939095|FG000|Overall Study|Adverse Event|11|||
129721768|NCT00576628|466939095|FG000|Overall Study|Death|2|||
129721769|NCT00576628|466939095|FG000|Overall Study|Failure to return|1|||
129721770|NCT00576628|466939095|FG000|Overall Study|Refused Treatment|8|||
129721771|NCT00576628|466939095|FG000|Overall Study|Pregnancy|1|||
129721772|NCT00576628|466939095|FG000|Overall Study|RBC transfusion|1|||
129721773|NCT00576628|466939095|FG000|Overall Study|Progression of Kidney Disease|1|||
129721774|NCT00576628|466939095|FG000|Overall Study|Progression of Renal Failure|1|||
129721775|NCT00576628|466939095|FG000|Overall Study|The patient move into other town|1|||
129721776|NCT00576628|466939095|FG000|Overall Study|Transplantation|1|||
129721777|NCT00576628|466939095|FG000|Overall Study|Dialysis|15|||
129721778|NCT03206970|466939096|FG000|Overall Study|Death|21|||
129721779|NCT03206970|466939096|FG000|Overall Study|Withdrawal by Subject|13|||
129721780|NCT03206970|466939096|FG000|Overall Study|Lost to Follow-up|3|||
129721781|NCT03206970|466939096|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
129721782|NCT02516982|466939097|FG000|Overall Study|Called in to antenatal appointment|32|||
129721783|NCT02516982|466939098|FG001|Overall Study|Called in to antenatal appointment|35|||
129721784|NCT02516982|466939099|FG002|Overall Study|Called in to antenatal appointment|0|||
129721785|NCT02516982|466939100|FG003|Overall Study|Called in to antenatal appointment|0|||
129721786|NCT02516982|466939097|FG000|Overall Study|Withdrawal by Subject|0|||
129721787|NCT02516982|466939098|FG001|Overall Study|Withdrawal by Subject|0|||
129721788|NCT02516982|466939099|FG002|Overall Study|Withdrawal by Subject|1|||
129721789|NCT02516982|466939100|FG003|Overall Study|Withdrawal by Subject|2|||
129721790|NCT02516982|466939097|FG000|Overall Study|Protocol Violation|0|||
129721791|NCT02516982|466939098|FG001|Overall Study|Protocol Violation|0|||
129721792|NCT02516982|466939099|FG002|Overall Study|Protocol Violation|1|||
129721793|NCT02516982|466939100|FG003|Overall Study|Protocol Violation|1|||
129721794|NCT02516982|466939097|FG000|Overall Study|Did not install the app|0|||
129721795|NCT02516982|466939098|FG001|Overall Study|Did not install the app|0|||
129721796|NCT02516982|466939099|FG002|Overall Study|Did not install the app|46|||
129721797|NCT02516982|466939100|FG003|Overall Study|Did not install the app|47|||
129721798|NCT01804049|466939108|FG000|Overall Study|Adverse Event|2|||
129721799|NCT01804049|466939109|FG001|Overall Study|Adverse Event|10|||
129721800|NCT01804049|466939108|FG000|Overall Study|Lost to Follow-up|2|||
129721801|NCT01804049|466939109|FG001|Overall Study|Lost to Follow-up|1|||
129721802|NCT01804049|466939108|FG000|Overall Study|Decreased interest/personal|4|||
129721803|NCT01804049|466939109|FG001|Overall Study|Decreased interest/personal|5|||
129721804|NCT01804049|466939108|FG000|Overall Study|Other health concerns|2|||
129721805|NCT01804049|466939109|FG001|Overall Study|Other health concerns|7|||
129721806|NCT01804049|466939108|FG000|Overall Study|Moved out of area|0|||
129721807|NCT01804049|466939109|FG001|Overall Study|Moved out of area|7|||
129721808|NCT01804049|466939108|FG000|Overall Study|other MD recommended|1|||
129721809|NCT01804049|466939109|FG001|Overall Study|other MD recommended|1|||
129721810|NCT01804049|466939108|FG000|Overall Study|Enrollment in dual studies|0|||
129721811|NCT01804049|466939109|FG001|Overall Study|Enrollment in dual studies|1|||
129721812|NCT03249909|466939111|FG000|Overall Study|Withdrawal by Subject|3|||
129721813|NCT03249909|466939112|FG001|Overall Study|Withdrawal by Subject|0|||
129721814|NCT03249909|466939113|FG002|Overall Study|Withdrawal by Subject|0|||
129721815|NCT03249909|466939111|FG000|Overall Study|Adverse Event|3|||
129721816|NCT03249909|466939112|FG001|Overall Study|Adverse Event|0|||
129721817|NCT03249909|466939113|FG002|Overall Study|Adverse Event|0|||
129721818|NCT03249909|466939111|FG000|Overall Study|Lost to Follow-up|0|||
129721819|NCT03249909|466939112|FG001|Overall Study|Lost to Follow-up|1|||
129721820|NCT03249909|466939113|FG002|Overall Study|Lost to Follow-up|0|||
129721821|NCT05286658|466939114|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
129721822|NCT05286658|466939114|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
129721823|NCT01035463|466939115|FG000|Overall Study|Adverse Event|0|||
129721824|NCT01035463|466939116|FG001|Overall Study|Adverse Event|0|||
129721825|NCT01035463|466939117|FG002|Overall Study|Adverse Event|4|||
129721826|NCT01035463|466939118|FG003|Overall Study|Adverse Event|1|||
129721827|NCT01035463|466939119|FG004|Overall Study|Adverse Event|5|||
129721828|NCT01035463|466939120|FG005|Overall Study|Adverse Event|7|||
129721829|NCT01035463|466939115|FG000|Overall Study|Withdrawal by Subject|0|||
129721830|NCT01035463|466939116|FG001|Overall Study|Withdrawal by Subject|2|||
129721831|NCT01035463|466939117|FG002|Overall Study|Withdrawal by Subject|1|||
129721832|NCT01035463|466939118|FG003|Overall Study|Withdrawal by Subject|0|||
129721833|NCT01035463|466939119|FG004|Overall Study|Withdrawal by Subject|1|||
129721834|NCT01035463|466939120|FG005|Overall Study|Withdrawal by Subject|4|||
129721835|NCT01035463|466939115|FG000|Overall Study|Disease progression|0|||
129721836|NCT01035463|466939116|FG001|Overall Study|Disease progression|0|||
129721837|NCT01035463|466939117|FG002|Overall Study|Disease progression|0|||
129721838|NCT01035463|466939118|FG003|Overall Study|Disease progression|0|||
129721839|NCT01035463|466939119|FG004|Overall Study|Disease progression|0|||
129721840|NCT01035463|466939120|FG005|Overall Study|Disease progression|3|||
129721841|NCT01035463|466939115|FG000|Overall Study|Other Malignancy|0|||
129721842|NCT01035463|466939116|FG001|Overall Study|Other Malignancy|0|||
129721843|NCT01035463|466939117|FG002|Overall Study|Other Malignancy|0|||
129721844|NCT01035463|466939118|FG003|Overall Study|Other Malignancy|0|||
129721845|NCT01035463|466939119|FG004|Overall Study|Other Malignancy|0|||
129721846|NCT01035463|466939120|FG005|Overall Study|Other Malignancy|2|||
129721847|NCT01035463|466939115|FG000|Overall Study|Other|0|||
129721848|NCT01035463|466939116|FG001|Overall Study|Other|0|||
129721849|NCT01035463|466939117|FG002|Overall Study|Other|0|||
129721850|NCT01035463|466939118|FG003|Overall Study|Other|1|||
129721851|NCT01035463|466939119|FG004|Overall Study|Other|0|||
129721852|NCT01035463|466939120|FG005|Overall Study|Other|2|||
129721853|NCT01092780|466939121|FG000|Washout Period 1|Adverse Event|0|||
129721854|NCT01092780|466939122|FG001|Washout Period 1|Adverse Event|1|||
129721855|NCT01092780|466939123|FG002|Washout Period 1|Adverse Event|0|||
129721856|NCT01092780|466939124|FG003|Washout Period 1|Adverse Event|0|||
129721857|NCT01092780|466939121|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
129721858|NCT01092780|466939122|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
129721859|NCT01092780|466939123|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
129721860|NCT01092780|466939124|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
129721861|NCT01092780|466939121|FG000|Washout Period 2|Adverse Event|0|||
129721862|NCT01092780|466939122|FG001|Washout Period 2|Adverse Event|1|||
129721863|NCT01092780|466939123|FG002|Washout Period 2|Adverse Event|1|||
129721864|NCT01092780|466939124|FG003|Washout Period 2|Adverse Event|0|||
129721865|NCT00851552|466939134|FG000|Overall Study|Death|2|||
129721866|NCT00851552|466939134|FG000|Overall Study|Adverse Event|1|||
129721867|NCT00851552|466939134|FG000|Overall Study|Disease Progression|4|||
129721868|NCT01270880|466939136|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
129721869|NCT00182078|466939137|FG000|Overall Study|Withdrawal by Subject|1|||
129721870|NCT00182078|466939138|FG001|Overall Study|Withdrawal by Subject|0|||
129721871|NCT01606176|466939139|FG000|Overall Study|Adverse Event|2|||
129721872|NCT01606176|466939140|FG001|Overall Study|Adverse Event|3|||
129721873|NCT01606176|466939139|FG000|Overall Study|Disease progression|1|||
129721874|NCT01606176|466939140|FG001|Overall Study|Disease progression|0|||
129721875|NCT01606176|466939139|FG000|Overall Study|Withdrawal by Subject|1|||
129721876|NCT01606176|466939140|FG001|Overall Study|Withdrawal by Subject|0|||
129721877|NCT01076205|466939142|FG000|Overall Study|Adverse Drug Reaction|299|||
129721878|NCT01076205|466939142|FG000|Overall Study|Lack of Effectiveness|1423|||
129721879|NCT01076205|466939142|FG000|Overall Study|Other Reason|1075|||
129721880|NCT01076205|466939142|FG000|Overall Study|Unknown Reason|71|||
129721881|NCT01076205|466939142|FG000|Overall Study|Lost to Follow-up|3151|||
129721882|NCT01832493|466939143|FG000|Overall Study|Physician Decision|2|||
129721883|NCT01832493|466939143|FG000|Overall Study|Protocol Violation|4|||
129803729|NCT03161093|467249792|FG005|Overall Study|Withdrawal by Subject|10|||
129803730|NCT03161093|467249787|FG000|Overall Study|Lost to Follow-up|3|||
129721884|NCT01832493|466939143|FG000|Overall Study|Unable to place LV lead|2|||
129721885|NCT01732510|466939144|FG000|Overall Study|Adverse Event|0|||
129721886|NCT01732510|466939145|FG001|Overall Study|Adverse Event|1|||
129721887|NCT01732510|466939146|FG002|Overall Study|Adverse Event|1|||
129721888|NCT01732510|466939147|FG003|Overall Study|Adverse Event|0|||
129803731|NCT03161093|467249788|FG001|Overall Study|Lost to Follow-up|12|||
129803732|NCT03161093|467249789|FG002|Overall Study|Lost to Follow-up|4|||
129803733|NCT03161093|467249790|FG003|Overall Study|Lost to Follow-up|7|||
129721889|NCT01732510|466939148|FG004|Overall Study|Adverse Event|0|||
129721890|NCT01732510|466939149|FG005|Overall Study|Adverse Event|0|||
129721891|NCT01732510|466939150|FG006|Overall Study|Adverse Event|1|||
129721892|NCT01732510|466939144|FG000|Overall Study|Protocol Violation|0|||
129721893|NCT01732510|466939145|FG001|Overall Study|Protocol Violation|0|||
129721894|NCT01732510|466939146|FG002|Overall Study|Protocol Violation|0|||
129721895|NCT01732510|466939147|FG003|Overall Study|Protocol Violation|1|||
129721896|NCT01732510|466939148|FG004|Overall Study|Protocol Violation|0|||
129721897|NCT01732510|466939149|FG005|Overall Study|Protocol Violation|0|||
129721898|NCT01732510|466939150|FG006|Overall Study|Protocol Violation|0|||
129721899|NCT01732510|466939144|FG000|Overall Study|Withdrawal by Subject|1|||
129721900|NCT01732510|466939145|FG001|Overall Study|Withdrawal by Subject|3|||
129721901|NCT01732510|466939146|FG002|Overall Study|Withdrawal by Subject|2|||
129721902|NCT01732510|466939147|FG003|Overall Study|Withdrawal by Subject|1|||
129721903|NCT01732510|466939148|FG004|Overall Study|Withdrawal by Subject|5|||
129721904|NCT01732510|466939149|FG005|Overall Study|Withdrawal by Subject|0|||
129721905|NCT01732510|466939150|FG006|Overall Study|Withdrawal by Subject|1|||
129721906|NCT01732510|466939144|FG000|Overall Study|Lost to Follow-up|0|||
129721907|NCT01732510|466939145|FG001|Overall Study|Lost to Follow-up|0|||
129721908|NCT01732510|466939146|FG002|Overall Study|Lost to Follow-up|1|||
129721909|NCT01732510|466939147|FG003|Overall Study|Lost to Follow-up|1|||
129721910|NCT01732510|466939148|FG004|Overall Study|Lost to Follow-up|0|||
129721911|NCT01732510|466939149|FG005|Overall Study|Lost to Follow-up|1|||
129721912|NCT01732510|466939150|FG006|Overall Study|Lost to Follow-up|0|||
129721913|NCT01732510|466939144|FG000|Overall Study|Physician Decision|0|||
129721914|NCT01732510|466939145|FG001|Overall Study|Physician Decision|1|||
129721915|NCT01732510|466939146|FG002|Overall Study|Physician Decision|0|||
129721916|NCT01732510|466939147|FG003|Overall Study|Physician Decision|0|||
129721917|NCT01732510|466939148|FG004|Overall Study|Physician Decision|0|||
129721918|NCT01732510|466939149|FG005|Overall Study|Physician Decision|0|||
129721919|NCT01732510|466939150|FG006|Overall Study|Physician Decision|0|||
129721920|NCT01732510|466939144|FG000|Overall Study|Pregnancy|0|||
129721921|NCT01732510|466939145|FG001|Overall Study|Pregnancy|0|||
129721922|NCT01732510|466939146|FG002|Overall Study|Pregnancy|0|||
129721923|NCT01732510|466939147|FG003|Overall Study|Pregnancy|1|||
129721924|NCT01732510|466939148|FG004|Overall Study|Pregnancy|0|||
129721925|NCT01732510|466939149|FG005|Overall Study|Pregnancy|0|||
129721926|NCT01732510|466939150|FG006|Overall Study|Pregnancy|0|||
129721927|NCT01732510|466939144|FG000|Overall Study|Study Terminated By Sponsor|0|||
129721928|NCT01732510|466939145|FG001|Overall Study|Study Terminated By Sponsor|0|||
129721929|NCT01732510|466939146|FG002|Overall Study|Study Terminated By Sponsor|0|||
129721930|NCT01732510|466939147|FG003|Overall Study|Study Terminated By Sponsor|1|||
129721931|NCT01732510|466939148|FG004|Overall Study|Study Terminated By Sponsor|0|||
129721932|NCT01732510|466939149|FG005|Overall Study|Study Terminated By Sponsor|12|||
129721933|NCT01732510|466939150|FG006|Overall Study|Study Terminated By Sponsor|6|||
129721934|NCT01262560|466939154|FG000|Overall Study|Protocol Violation|0|||
129721935|NCT01262560|466939155|FG001|Overall Study|Protocol Violation|1|||
129721936|NCT01262560|466939156|FG002|Overall Study|Protocol Violation|2|||
129721937|NCT03213938|466939157|FG000|Overall Study|Lost to Follow-up|4|||
129721938|NCT03213938|466939158|FG001|Overall Study|Lost to Follow-up|3|||
129721939|NCT03213938|466939157|FG000|Overall Study|Lack of Efficacy|1|||
129721940|NCT03213938|466939158|FG001|Overall Study|Lack of Efficacy|0|||
129721941|NCT03213938|466939157|FG000|Overall Study|Decline to participate|5|||
129721942|NCT03213938|466939158|FG001|Overall Study|Decline to participate|4|||
129721943|NCT03213938|466939157|FG000|Overall Study|Without reason|4|||
129721944|NCT03213938|466939158|FG001|Overall Study|Without reason|5|||
129721945|NCT04238481|466939159|FG000|Overall Study|Miscellaneous|0|||
129721946|NCT04238481|466939160|FG001|Overall Study|Miscellaneous|1|||
129721947|NCT04238481|466939161|FG002|Overall Study|Miscellaneous|0|||
129721948|NCT04238481|466939162|FG003|Overall Study|Miscellaneous|0|||
129721949|NCT00673231|466939163|FG000|Overall Study|Withdrawal by Subject|14|||
129721950|NCT00673231|466939164|FG001|Overall Study|Withdrawal by Subject|10|||
129721951|NCT00673231|466939165|FG002|Overall Study|Withdrawal by Subject|8|||
129721952|NCT00673231|466939166|FG003|Overall Study|Withdrawal by Subject|6|||
129721953|NCT00673231|466939163|FG000|Overall Study|Adverse Event|6|||
129721954|NCT00673231|466939164|FG001|Overall Study|Adverse Event|5|||
129721955|NCT00673231|466939165|FG002|Overall Study|Adverse Event|9|||
129721956|NCT00673231|466939166|FG003|Overall Study|Adverse Event|6|||
129721957|NCT00673231|466939163|FG000|Overall Study|Lost to Follow-up|1|||
129721958|NCT00673231|466939164|FG001|Overall Study|Lost to Follow-up|2|||
129721959|NCT00673231|466939165|FG002|Overall Study|Lost to Follow-up|1|||
129721960|NCT00673231|466939166|FG003|Overall Study|Lost to Follow-up|2|||
129721961|NCT00673231|466939163|FG000|Overall Study|Death|0|||
129721962|NCT00673231|466939164|FG001|Overall Study|Death|0|||
129721963|NCT00673231|466939165|FG002|Overall Study|Death|1|||
129721964|NCT00673231|466939166|FG003|Overall Study|Death|0|||
129721965|NCT00673231|466939163|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
129721966|NCT00673231|466939164|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
129721967|NCT00673231|466939165|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
129721968|NCT00673231|466939166|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
129721969|NCT02952313|466939167|FG000|Primary Endpoint|Lost to Follow-up|4|||
129721970|NCT02952313|466939167|FG000|Primary Endpoint|Withdrawal by Subject|1|||
129721971|NCT02952313|466939167|FG000|Primary Endpoint|Lack of Efficacy|1|||
129721972|NCT02952313|466939167|FG000|Primary Endpoint|Missed visit|1|||
129721973|NCT02952313|466939167|FG000|Long-term Follow-up|Lost to Follow-up|12|||
129803734|NCT03161093|467249791|FG004|Overall Study|Lost to Follow-up|8|||
129803735|NCT03161093|467249792|FG005|Overall Study|Lost to Follow-up|13|||
129803736|NCT03161093|467249787|FG000|Overall Study|Death|3|||
129803737|NCT03161093|467249788|FG001|Overall Study|Death|9|||
129803738|NCT03161093|467249789|FG002|Overall Study|Death|7|||
129803739|NCT03161093|467249790|FG003|Overall Study|Death|9|||
129803740|NCT03161093|467249791|FG004|Overall Study|Death|0|||
129721974|NCT02952313|466939167|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
129721975|NCT02952313|466939167|FG000|Long-term Follow-up|Lack of Efficacy|6|||
129721976|NCT02952313|466939167|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
129721977|NCT02952313|466939167|FG000|Long-term Follow-up|Physician Decision|1|||
129721978|NCT02952313|466939167|FG000|Long-term Follow-up|Death|1|||
129721979|NCT03594747|466939168|FG000|Overall Study|Death|78|||
129721980|NCT03594747|466939169|FG001|Overall Study|Death|86|||
129721981|NCT03594747|466939170|FG002|Overall Study|Death|87|||
129721982|NCT03594747|466939168|FG000|Overall Study|Withdrawal by Subject|5|||
129721983|NCT03594747|466939169|FG001|Overall Study|Withdrawal by Subject|2|||
129721984|NCT03594747|466939170|FG002|Overall Study|Withdrawal by Subject|11|||
129721985|NCT03594747|466939168|FG000|Overall Study|Lost to Follow-up|4|||
129721986|NCT03594747|466939169|FG001|Overall Study|Lost to Follow-up|1|||
129721987|NCT03594747|466939170|FG002|Overall Study|Lost to Follow-up|1|||
129721988|NCT03594747|466939168|FG000|Overall Study|Physician Decision|0|||
129721989|NCT03594747|466939169|FG001|Overall Study|Physician Decision|1|||
129721990|NCT03594747|466939170|FG002|Overall Study|Physician Decision|0|||
129721991|NCT03594747|466939168|FG000|Overall Study|Sponsor decision|23|||
129721992|NCT03594747|466939169|FG001|Overall Study|Sponsor decision|17|||
129721993|NCT03594747|466939170|FG002|Overall Study|Sponsor decision|16|||
129721994|NCT03594747|466939168|FG000|Overall Study|Did not meet inclusion criteria|0|||
129721995|NCT03594747|466939169|FG001|Overall Study|Did not meet inclusion criteria|0|||
129721996|NCT03594747|466939170|FG002|Overall Study|Did not meet inclusion criteria|1|||
129721997|NCT03594747|466939168|FG000|Overall Study|Transfer to long term extension study|10|||
129721998|NCT03594747|466939169|FG001|Overall Study|Transfer to long term extension study|12|||
129721999|NCT03594747|466939170|FG002|Overall Study|Transfer to long term extension study|5|||
129722000|NCT02095873|466939171|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129722001|NCT02095873|466939172|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129722002|NCT02095873|466939171|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
129722003|NCT02095873|466939172|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
129722004|NCT02095873|466939171|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
129722005|NCT02095873|466939172|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
129722006|NCT02015481|466939175|FG000|Overall Study|Death|1|||
129722007|NCT02485639|466939176|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
129722008|NCT02485639|466939176|FG000|Overall Study|Early termination|4|||
129722009|NCT02485639|466939176|FG000|Overall Study|Withdrawal by Subject|4|||
129722010|NCT02566785|466939177|FG000|Overall Study|Lost to Follow-up|0|||
129722011|NCT02566785|466939178|FG001|Overall Study|Lost to Follow-up|2|||
129722012|NCT02566785|466939177|FG000|Overall Study|Worsening condition|1|||
129722013|NCT02566785|466939178|FG001|Overall Study|Worsening condition|1|||
129722014|NCT03823287|466939181|FG000|Overall Study|Withdrawal by Subject|25|||
129722015|NCT03823287|466939182|FG001|Overall Study|Withdrawal by Subject|17|||
129722016|NCT03823287|466939181|FG000|Overall Study|Death|13|||
129722017|NCT03823287|466939182|FG001|Overall Study|Death|7|||
129722018|NCT03823287|466939181|FG000|Overall Study|Lost to Follow-up|7|||
129722019|NCT03823287|466939182|FG001|Overall Study|Lost to Follow-up|8|||
129722020|NCT03823287|466939181|FG000|Overall Study|Adverse Event|6|||
129722021|NCT03823287|466939182|FG001|Overall Study|Adverse Event|8|||
129722022|NCT03823287|466939181|FG000|Overall Study|Physician Decision|5|||
129722023|NCT03823287|466939182|FG001|Overall Study|Physician Decision|2|||
129722024|NCT03823287|466939181|FG000|Overall Study|Lack of Efficacy|2|||
129722025|NCT03823287|466939182|FG001|Overall Study|Lack of Efficacy|0|||
129722026|NCT03823287|466939181|FG000|Overall Study|Other|2|||
129722027|NCT03823287|466939182|FG001|Overall Study|Other|4|||
129722028|NCT01170273|466939184|FG000|Overall Study|Lost to Follow-up|6|||
129722029|NCT01170273|466939185|FG001|Overall Study|Lost to Follow-up|8|||
129722030|NCT01170273|466939184|FG000|Overall Study|Protocol Violation|1|||
129722031|NCT01170273|466939185|FG001|Overall Study|Protocol Violation|0|||
129722032|NCT01170273|466939184|FG000|Overall Study|Death|1|||
129722033|NCT01170273|466939185|FG001|Overall Study|Death|0|||
129722034|NCT01170273|466939184|FG000|Overall Study|Adverse Event|0|||
129803741|NCT03161093|467249792|FG005|Overall Study|Death|0|||
129722035|NCT01170273|466939185|FG001|Overall Study|Adverse Event|1|||
129722036|NCT00334737|466939186|FG000|Hospital Phase|Death|1|||
129722037|NCT00334737|466939187|FG001|Hospital Phase|Death|2|||
129722038|NCT00334737|466939188|FG002|Hospital Phase|Death|3|||
129722039|NCT00334737|466939186|FG000|Hospital Phase|Withdrawal by Subject|0|||
129722040|NCT00334737|466939187|FG001|Hospital Phase|Withdrawal by Subject|0|||
129722041|NCT00334737|466939188|FG002|Hospital Phase|Withdrawal by Subject|1|||
129803742|NCT03161093|467249787|FG000|Overall Study|Unknown - Not reported|0|||
129722042|NCT00334737|466939186|FG000|Hospital Phase|Did not receive study drug|1|||
129722043|NCT00334737|466939187|FG001|Hospital Phase|Did not receive study drug|0|||
129722044|NCT00334737|466939188|FG002|Hospital Phase|Did not receive study drug|0|||
129722045|NCT00334737|466939186|FG000|Follow up Phase|Lost to Follow-up|5|||
129722046|NCT00334737|466939187|FG001|Follow up Phase|Lost to Follow-up|3|||
129722047|NCT00334737|466939188|FG002|Follow up Phase|Lost to Follow-up|6|||
129722048|NCT00583752|466939189|FG000|Overall Study|Lost to Follow-up|5|||
129722049|NCT00583752|466939190|FG001|Overall Study|Lost to Follow-up|5|||
129722050|NCT02316353|466939191|FG000|Overall Study|Pregnancy|1|||
129722051|NCT02316353|466939192|FG001|Overall Study|Pregnancy|3|||
129722052|NCT02316353|466939191|FG000|Overall Study|Adverse Event|1|||
129722053|NCT02316353|466939192|FG001|Overall Study|Adverse Event|3|||
129722054|NCT02316353|466939191|FG000|Overall Study|Withdrawal by Subject|6|||
129722055|NCT02316353|466939192|FG001|Overall Study|Withdrawal by Subject|2|||
129722056|NCT02147197|466939193|FG000|Overall Study|Adverse Event|1|||
129722057|NCT02147197|466939194|FG001|Overall Study|Adverse Event|0|||
129722058|NCT02147197|466939195|FG002|Overall Study|Adverse Event|0|||
129722059|NCT02147197|466939193|FG000|Overall Study|Withdrawal of Consent|4|||
129722060|NCT02147197|466939194|FG001|Overall Study|Withdrawal of Consent|3|||
129722061|NCT02147197|466939195|FG002|Overall Study|Withdrawal of Consent|2|||
129722062|NCT02147197|466939193|FG000|Overall Study|Lost to Follow-up|2|||
129722063|NCT02147197|466939194|FG001|Overall Study|Lost to Follow-up|3|||
129722064|NCT02147197|466939195|FG002|Overall Study|Lost to Follow-up|1|||
129722065|NCT02147197|466939193|FG000|Overall Study|Protocol Violation|1|||
129722066|NCT02147197|466939194|FG001|Overall Study|Protocol Violation|0|||
129722067|NCT02147197|466939195|FG002|Overall Study|Protocol Violation|3|||
129722068|NCT02147197|466939193|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129722069|NCT02147197|466939194|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129722070|NCT02147197|466939195|FG002|Overall Study|Other Miscellaneous Reasons|3|||
129722071|NCT03522246|466940992|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
129722072|NCT03522246|466940993|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
129722073|NCT03522246|466940994|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
129722074|NCT03522246|466940995|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
129722075|NCT03522246|466940996|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
129722076|NCT04683029|466940997|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
129444385|NCT00578786|465927334|FG000|Overall Study|Withdrawal by Subject|7|||
129444386|NCT00578786|465927335|FG001|Overall Study|Withdrawal by Subject|8|||
129444387|NCT00578786|465927336|FG002|Overall Study|Withdrawal by Subject|5|||
129722077|NCT04683029|466940998|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
129722078|NCT04683029|466940999|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
129722079|NCT04683029|466941000|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
129722080|NCT04683029|466940997|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
129722081|NCT04683029|466940998|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
129722082|NCT04683029|466940999|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
129722083|NCT04683029|466941000|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
129722084|NCT04683029|466940997|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
129722085|NCT04683029|466940998|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
129722086|NCT04683029|466940999|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
129722087|NCT04683029|466941000|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
129722088|NCT00814580|466941001|FG000|Overall Study|Adverse Event|6|||
129722089|NCT00814580|466941002|FG001|Overall Study|Adverse Event|15|||
129722090|NCT00814580|466941001|FG000|Overall Study|Lack of Efficacy|18|||
129722091|NCT00814580|466941002|FG001|Overall Study|Lack of Efficacy|25|||
129722092|NCT00814580|466941001|FG000|Overall Study|Protocol Violation|2|||
129722093|NCT00814580|466941002|FG001|Overall Study|Protocol Violation|0|||
129722094|NCT00814580|466941001|FG000|Overall Study|Withdrawal by Subject|2|||
129722095|NCT00814580|466941002|FG001|Overall Study|Withdrawal by Subject|2|||
129722096|NCT00814580|466941001|FG000|Overall Study|Other|1|||
129722097|NCT00814580|466941002|FG001|Overall Study|Other|3|||
129722098|NCT00814580|466941001|FG000|Overall Study|Did Not Take Drug|2|||
129722099|NCT00814580|466941002|FG001|Overall Study|Did Not Take Drug|2|||
129722100|NCT02482428|466941003|FG000|Overall Study|Lost to Follow-up|4|||
129722101|NCT02482428|466941004|FG001|Overall Study|Lost to Follow-up|9|||
129722102|NCT02482428|466941005|FG002|Overall Study|Lost to Follow-up|1|||
129722103|NCT02482428|466941006|FG003|Overall Study|Lost to Follow-up|2|||
129722104|NCT02482428|466941007|FG004|Overall Study|Lost to Follow-up|4|||
129722105|NCT02482428|466941003|FG000|Overall Study|Physician Decision|0|||
129722106|NCT02482428|466941004|FG001|Overall Study|Physician Decision|0|||
129722107|NCT02482428|466941005|FG002|Overall Study|Physician Decision|0|||
129722108|NCT02482428|466941006|FG003|Overall Study|Physician Decision|0|||
129722109|NCT02482428|466941007|FG004|Overall Study|Physician Decision|1|||
129722110|NCT02482428|466941003|FG000|Overall Study|protocol deviation|1|||
129722111|NCT02482428|466941004|FG001|Overall Study|protocol deviation|1|||
129722112|NCT02482428|466941005|FG002|Overall Study|protocol deviation|0|||
129722113|NCT02482428|466941006|FG003|Overall Study|protocol deviation|0|||
129722114|NCT02482428|466941007|FG004|Overall Study|protocol deviation|0|||
129722115|NCT02482428|466941003|FG000|Overall Study|subject/guardian decision|4|||
129722116|NCT02482428|466941004|FG001|Overall Study|subject/guardian decision|2|||
129722117|NCT02482428|466941005|FG002|Overall Study|subject/guardian decision|0|||
129722118|NCT02482428|466941006|FG003|Overall Study|subject/guardian decision|0|||
129722119|NCT02482428|466941007|FG004|Overall Study|subject/guardian decision|2|||
129722120|NCT00459875|466941010|FG000|Overall Study|Ineligible participant|1|||
129722121|NCT00459875|466941010|FG000|Overall Study|Adverse Event|2|||
129722122|NCT01406938|466941013|FG000|Induction Period|Subject/guardian decision|6|||
129722123|NCT01406938|466941014|FG001|Induction Period|Subject/guardian decision|8|||
129722124|NCT01406938|466941015|FG002|Induction Period|Subject/guardian decision|0|||
129722125|NCT01406938|466941016|FG003|Induction Period|Subject/guardian decision|0|||
129722126|NCT01406938|466941017|FG004|Induction Period|Subject/guardian decision|0|||
129722127|NCT01406938|466941018|FG005|Induction Period|Subject/guardian decision|0|||
129722128|NCT01406938|466941013|FG000|Induction Period|Protocol deviation|1|||
129722129|NCT01406938|466941014|FG001|Induction Period|Protocol deviation|0|||
129722130|NCT01406938|466941015|FG002|Induction Period|Protocol deviation|0|||
129722131|NCT01406938|466941016|FG003|Induction Period|Protocol deviation|0|||
129722132|NCT01406938|466941017|FG004|Induction Period|Protocol deviation|0|||
129722133|NCT01406938|466941018|FG005|Induction Period|Protocol deviation|0|||
129722134|NCT01406938|466941013|FG000|Induction Period|Adverse Event|8|||
129722135|NCT01406938|466941014|FG001|Induction Period|Adverse Event|9|||
129722136|NCT01406938|466941015|FG002|Induction Period|Adverse Event|0|||
129722137|NCT01406938|466941016|FG003|Induction Period|Adverse Event|0|||
129722138|NCT01406938|466941017|FG004|Induction Period|Adverse Event|0|||
129722139|NCT01406938|466941018|FG005|Induction Period|Adverse Event|0|||
129722140|NCT01406938|466941013|FG000|Induction Period|Lack of Efficacy|1|||
129722141|NCT01406938|466941014|FG001|Induction Period|Lack of Efficacy|0|||
129803743|NCT03161093|467249788|FG001|Overall Study|Unknown - Not reported|1|||
129803744|NCT03161093|467249789|FG002|Overall Study|Unknown - Not reported|0|||
129803745|NCT03161093|467249790|FG003|Overall Study|Unknown - Not reported|0|||
129803746|NCT03161093|467249791|FG004|Overall Study|Unknown - Not reported|0|||
129803747|NCT03161093|467249792|FG005|Overall Study|Unknown - Not reported|1|||
129803748|NCT01031706|467249793|FG000|Overall Study|Adverse Event|1|||
129803749|NCT01031706|467249794|FG001|Overall Study|Adverse Event|0|||
129803750|NCT01031706|467249793|FG000|Overall Study|Withdrawal by Subject|1|||
129803751|NCT01031706|467249794|FG001|Overall Study|Withdrawal by Subject|1|||
129803752|NCT02124161|467249795|FG000|Overall Study|Other unspecified|0|||
129803753|NCT02124161|467249796|FG001|Overall Study|Other unspecified|1|||
129803754|NCT02124161|467249795|FG000|Overall Study|Death|1|||
129803755|NCT02124161|467249796|FG001|Overall Study|Death|0|||
129803756|NCT02124161|467249795|FG000|Overall Study|Protocol Violation|2|||
129803757|NCT02124161|467249796|FG001|Overall Study|Protocol Violation|1|||
129803758|NCT02124161|467249795|FG000|Overall Study|Withdrawal by Subject|1|||
129803759|NCT02124161|467249796|FG001|Overall Study|Withdrawal by Subject|2|||
129803760|NCT02124161|467249795|FG000|Overall Study|Adverse Event|2|||
129803761|NCT02124161|467249796|FG001|Overall Study|Adverse Event|0|||
129803762|NCT02124161|467249795|FG000|Overall Study|Does not meet entrance criteria|2|||
129803763|NCT02124161|467249796|FG001|Overall Study|Does not meet entrance criteria|3|||
129803764|NCT02124161|467249795|FG000|Overall Study|No longer meets eligibility criteria|5|||
129803765|NCT02124161|467249796|FG001|Overall Study|No longer meets eligibility criteria|4|||
129803766|NCT02124161|467249795|FG000|Overall Study|Lost to Follow-up|3|||
129803767|NCT02124161|467249796|FG001|Overall Study|Lost to Follow-up|4|||
129803768|NCT02517866|467249797|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129803769|NCT02517866|467249798|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129803770|NCT02517866|467249799|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129803771|NCT02517866|467249797|FG000|Overall Study|Significant Protocol Deviation|4|||
129803772|NCT02517866|467249798|FG001|Overall Study|Significant Protocol Deviation|1|||
129803773|NCT02517866|467249799|FG002|Overall Study|Significant Protocol Deviation|0|||
129803774|NCT02517866|467249797|FG000|Overall Study|Lost to Follow-up|1|||
129803775|NCT02517866|467249798|FG001|Overall Study|Lost to Follow-up|0|||
129803776|NCT02517866|467249799|FG002|Overall Study|Lost to Follow-up|0|||
129803777|NCT02517866|467249797|FG000|Overall Study|Voluntary Withdrawal|2|||
129803778|NCT02517866|467249798|FG001|Overall Study|Voluntary Withdrawal|2|||
129803779|NCT02517866|467249799|FG002|Overall Study|Voluntary Withdrawal|0|||
129803780|NCT02517866|467249797|FG000|Overall Study|Investigator Decision|2|||
129803781|NCT02517866|467249798|FG001|Overall Study|Investigator Decision|1|||
129803782|NCT02517866|467249799|FG002|Overall Study|Investigator Decision|0|||
129803783|NCT02517866|467249797|FG000|Overall Study|Reason not specified|2|||
129803784|NCT02517866|467249798|FG001|Overall Study|Reason not specified|0|||
129803785|NCT02517866|467249799|FG002|Overall Study|Reason not specified|0|||
129803786|NCT01147640|467249801|FG000|Overall Study|Adverse Event|2|||
129803787|NCT01147640|467249802|FG001|Overall Study|Adverse Event|0|||
129803788|NCT01147640|467249801|FG000|Overall Study|Physician Decision|1|||
129803789|NCT01147640|467249802|FG001|Overall Study|Physician Decision|0|||
129803790|NCT01147640|467249801|FG000|Overall Study|Withdrawal by Subject|1|||
129722142|NCT01406938|466941015|FG002|Induction Period|Lack of Efficacy|0|||
129722143|NCT01406938|466941016|FG003|Induction Period|Lack of Efficacy|0|||
129722144|NCT01406938|466941017|FG004|Induction Period|Lack of Efficacy|0|||
129722145|NCT01406938|466941018|FG005|Induction Period|Lack of Efficacy|0|||
129722146|NCT01406938|466941013|FG000|Induction Period|Lost to Follow-up|2|||
129722147|NCT01406938|466941014|FG001|Induction Period|Lost to Follow-up|3|||
129722148|NCT01406938|466941015|FG002|Induction Period|Lost to Follow-up|0|||
129722149|NCT01406938|466941016|FG003|Induction Period|Lost to Follow-up|0|||
129722150|NCT01406938|466941017|FG004|Induction Period|Lost to Follow-up|0|||
129722151|NCT01406938|466941018|FG005|Induction Period|Lost to Follow-up|0|||
129722152|NCT01406938|466941013|FG000|Maintenance Period|Adverse Event|0|||
129722153|NCT01406938|466941014|FG001|Maintenance Period|Adverse Event|0|||
129722154|NCT01406938|466941015|FG002|Maintenance Period|Adverse Event|2|||
129722155|NCT01406938|466941016|FG003|Maintenance Period|Adverse Event|8|||
129722156|NCT01406938|466941017|FG004|Maintenance Period|Adverse Event|4|||
129722157|NCT01406938|466941018|FG005|Maintenance Period|Adverse Event|2|||
129722158|NCT01406938|466941013|FG000|Maintenance Period|Death|0|||
129722159|NCT01406938|466941014|FG001|Maintenance Period|Death|0|||
129722160|NCT01406938|466941015|FG002|Maintenance Period|Death|0|||
129722161|NCT01406938|466941016|FG003|Maintenance Period|Death|0|||
129722162|NCT01406938|466941017|FG004|Maintenance Period|Death|1|||
129722163|NCT01406938|466941018|FG005|Maintenance Period|Death|0|||
129722164|NCT01406938|466941013|FG000|Maintenance Period|Subject/guardian decision|0|||
129722165|NCT01406938|466941014|FG001|Maintenance Period|Subject/guardian decision|0|||
129722166|NCT01406938|466941015|FG002|Maintenance Period|Subject/guardian decision|11|||
129722167|NCT01406938|466941016|FG003|Maintenance Period|Subject/guardian decision|7|||
129722168|NCT01406938|466941017|FG004|Maintenance Period|Subject/guardian decision|10|||
129722169|NCT01406938|466941018|FG005|Maintenance Period|Subject/guardian decision|7|||
129722170|NCT01406938|466941013|FG000|Maintenance Period|Protocol Violation|0|||
129722171|NCT01406938|466941014|FG001|Maintenance Period|Protocol Violation|0|||
129722172|NCT01406938|466941015|FG002|Maintenance Period|Protocol Violation|2|||
129722173|NCT01406938|466941016|FG003|Maintenance Period|Protocol Violation|2|||
129722174|NCT01406938|466941017|FG004|Maintenance Period|Protocol Violation|2|||
129722175|NCT01406938|466941018|FG005|Maintenance Period|Protocol Violation|2|||
129722176|NCT01406938|466941013|FG000|Maintenance Period|Pregnancy|0|||
129722177|NCT01406938|466941014|FG001|Maintenance Period|Pregnancy|0|||
129722178|NCT01406938|466941015|FG002|Maintenance Period|Pregnancy|0|||
129722179|NCT01406938|466941016|FG003|Maintenance Period|Pregnancy|0|||
129722180|NCT01406938|466941017|FG004|Maintenance Period|Pregnancy|1|||
129722181|NCT01406938|466941018|FG005|Maintenance Period|Pregnancy|0|||
129722182|NCT01406938|466941013|FG000|Maintenance Period|Lost to Follow-up|0|||
129722183|NCT01406938|466941014|FG001|Maintenance Period|Lost to Follow-up|0|||
129722184|NCT01406938|466941015|FG002|Maintenance Period|Lost to Follow-up|0|||
129803791|NCT01147640|467249802|FG001|Overall Study|Withdrawal by Subject|0|||
129803792|NCT01147640|467249801|FG000|Overall Study|Lost to Follow-up|0|||
129803793|NCT01147640|467249802|FG001|Overall Study|Lost to Follow-up|1|||
129803794|NCT01147640|467249801|FG000|Overall Study|Didn't meet eligibility criteria|1|||
129803795|NCT01147640|467249802|FG001|Overall Study|Didn't meet eligibility criteria|0|||
129803796|NCT01797731|467249804|FG000|Overall Study|Didn't have proper radiographs required|3|||
129803797|NCT01797731|467249805|FG001|Overall Study|Didn't have proper radiographs required|3|||
129803798|NCT00091442|467249807|FG000|Overall Study|Progressive Disease|220|||
129803799|NCT00091442|467249808|FG001|Overall Study|Progressive Disease|189|||
129803800|NCT00091442|467249807|FG000|Overall Study|Physician Decision|61|||
129803801|NCT00091442|467249808|FG001|Overall Study|Physician Decision|58|||
129803802|NCT00091442|467249807|FG000|Overall Study|Withdrawal by Subject|38|||
129803803|NCT00091442|467249808|FG001|Overall Study|Withdrawal by Subject|46|||
129803804|NCT00091442|467249807|FG000|Overall Study|Adverse Event|29|||
129803805|NCT00091442|467249808|FG001|Overall Study|Adverse Event|48|||
129803806|NCT00091442|467249807|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
129803807|NCT00091442|467249808|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
129803808|NCT00091442|467249807|FG000|Overall Study|Death|9|||
129803809|NCT00091442|467249808|FG001|Overall Study|Death|7|||
129803810|NCT00091442|467249807|FG000|Overall Study|Lost to Follow-up|1|||
129803811|NCT00091442|467249808|FG001|Overall Study|Lost to Follow-up|3|||
129803812|NCT00091442|467249807|FG000|Overall Study|Other|2|||
129722185|NCT01406938|466941016|FG003|Maintenance Period|Lost to Follow-up|0|||
129722186|NCT01406938|466941017|FG004|Maintenance Period|Lost to Follow-up|4|||
129722187|NCT01406938|466941018|FG005|Maintenance Period|Lost to Follow-up|0|||
129722188|NCT01406938|466941013|FG000|Maintenance Period|Lack of Efficacy|0|||
129722189|NCT01406938|466941014|FG001|Maintenance Period|Lack of Efficacy|0|||
129722190|NCT01406938|466941015|FG002|Maintenance Period|Lack of Efficacy|2|||
129722191|NCT01406938|466941016|FG003|Maintenance Period|Lack of Efficacy|1|||
129722192|NCT01406938|466941017|FG004|Maintenance Period|Lack of Efficacy|3|||
129722193|NCT01406938|466941018|FG005|Maintenance Period|Lack of Efficacy|5|||
129722194|NCT01406938|466941013|FG000|Follow up|Lack of Efficacy|3|||
129722195|NCT01406938|466941014|FG001|Follow up|Lack of Efficacy|2|||
129722196|NCT01406938|466941015|FG002|Follow up|Lack of Efficacy|1|||
129803813|NCT00091442|467249808|FG001|Overall Study|Other|6|||
129722197|NCT01406938|466941016|FG003|Follow up|Lack of Efficacy|0|||
129722198|NCT01406938|466941017|FG004|Follow up|Lack of Efficacy|0|||
129722199|NCT01406938|466941018|FG005|Follow up|Lack of Efficacy|0|||
129722200|NCT01406938|466941013|FG000|Follow up|Patient/guardian decision|4|||
129722201|NCT01406938|466941014|FG001|Follow up|Patient/guardian decision|2|||
129722202|NCT01406938|466941015|FG002|Follow up|Patient/guardian decision|4|||
129722203|NCT01406938|466941016|FG003|Follow up|Patient/guardian decision|2|||
129722204|NCT01406938|466941017|FG004|Follow up|Patient/guardian decision|4|||
129722205|NCT01406938|466941018|FG005|Follow up|Patient/guardian decision|1|||
129722206|NCT01406938|466941013|FG000|Follow up|Protocol Violation|0|||
129722207|NCT01406938|466941014|FG001|Follow up|Protocol Violation|0|||
129722208|NCT01406938|466941015|FG002|Follow up|Protocol Violation|1|||
129722209|NCT01406938|466941016|FG003|Follow up|Protocol Violation|0|||
129722210|NCT01406938|466941017|FG004|Follow up|Protocol Violation|0|||
129722211|NCT01406938|466941018|FG005|Follow up|Protocol Violation|0|||
129722212|NCT01406938|466941013|FG000|Follow up|Physician Decision|0|||
129722213|NCT01406938|466941014|FG001|Follow up|Physician Decision|0|||
129722214|NCT01406938|466941015|FG002|Follow up|Physician Decision|2|||
129722215|NCT01406938|466941016|FG003|Follow up|Physician Decision|0|||
129722216|NCT01406938|466941017|FG004|Follow up|Physician Decision|3|||
129722217|NCT01406938|466941018|FG005|Follow up|Physician Decision|1|||
129722218|NCT01406938|466941013|FG000|Follow up|Lost to Follow-up|1|||
129722219|NCT01406938|466941014|FG001|Follow up|Lost to Follow-up|1|||
129722220|NCT01406938|466941015|FG002|Follow up|Lost to Follow-up|0|||
129722221|NCT01406938|466941016|FG003|Follow up|Lost to Follow-up|1|||
129722222|NCT01406938|466941017|FG004|Follow up|Lost to Follow-up|2|||
129722223|NCT01406938|466941018|FG005|Follow up|Lost to Follow-up|1|||
129722224|NCT01951586|466941026|FG000|Overall Study|Death|61|||
129722225|NCT01951586|466941027|FG001|Overall Study|Death|120|||
129722226|NCT01951586|466941026|FG000|Overall Study|Withdrawal by Subject|8|||
129722227|NCT01951586|466941027|FG001|Overall Study|Withdrawal by Subject|17|||
129722228|NCT01951586|466941026|FG000|Overall Study|Lost to Follow-up|0|||
129722229|NCT01951586|466941027|FG001|Overall Study|Lost to Follow-up|1|||
129722230|NCT01951586|466941026|FG000|Overall Study|Sponsor Decision|9|||
129722231|NCT01951586|466941027|FG001|Overall Study|Sponsor Decision|10|||
129722232|NCT00878254|466941029|FG000|Overall Study|Physician Decision|1|||
129722233|NCT00878254|466941029|FG000|Overall Study|Death|1|||
129722234|NCT00878254|466941029|FG000|Overall Study|Withdrawal by Subject|1|||
129722235|NCT04560816|466941031|FG000|Overall Study|Withdrawal by Subject|1|||
129722236|NCT04560816|466941032|FG001|Overall Study|Withdrawal by Subject|1|||
129722237|NCT04560816|466941033|FG002|Overall Study|Withdrawal by Subject|1|||
129722238|NCT04560816|466941034|FG003|Overall Study|Withdrawal by Subject|0|||
129722239|NCT04560816|466941035|FG004|Overall Study|Withdrawal by Subject|3|||
129722240|NCT04560816|466941036|FG005|Overall Study|Withdrawal by Subject|0|||
129722241|NCT04560816|466941031|FG000|Overall Study|Lost to Follow-up|1|||
129722242|NCT04560816|466941032|FG001|Overall Study|Lost to Follow-up|0|||
129722243|NCT04560816|466941033|FG002|Overall Study|Lost to Follow-up|0|||
129722244|NCT04560816|466941034|FG003|Overall Study|Lost to Follow-up|0|||
129722245|NCT04560816|466941035|FG004|Overall Study|Lost to Follow-up|0|||
129722246|NCT04560816|466941036|FG005|Overall Study|Lost to Follow-up|0|||
129722247|NCT04560816|466941031|FG000|Overall Study|Protocol Violation|1|||
129722248|NCT04560816|466941032|FG001|Overall Study|Protocol Violation|0|||
129722249|NCT04560816|466941033|FG002|Overall Study|Protocol Violation|0|||
129722250|NCT04560816|466941034|FG003|Overall Study|Protocol Violation|0|||
129722251|NCT04560816|466941035|FG004|Overall Study|Protocol Violation|0|||
129722252|NCT04560816|466941036|FG005|Overall Study|Protocol Violation|0|||
129722253|NCT02277691|466941037|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
129722254|NCT02277691|466941037|FG000|Overall Study|Voluntary Withdrawal|7|||
129722255|NCT02277691|466941037|FG000|Overall Study|Lack of Efficacy|5|||
129722256|NCT02277691|466941037|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
129803814|NCT05095454|467249813|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
129722257|NCT00441142|466941039|FG000|Overall Study|Adverse Event|2|||
129722258|NCT00441142|466941040|FG001|Overall Study|Adverse Event|3|||
129722259|NCT00441142|466941041|FG002|Overall Study|Adverse Event|3|||
129722260|NCT00441142|466941042|FG003|Overall Study|Adverse Event|22|||
129722261|NCT00441142|466941039|FG000|Overall Study|Lack of Efficacy|3|||
129722262|NCT00441142|466941040|FG001|Overall Study|Lack of Efficacy|3|||
129891628|NCT00630539|467561211|FG001|Overall Study|Withdrawal by Subject|1|||
129722263|NCT00441142|466941041|FG002|Overall Study|Lack of Efficacy|17|||
129722264|NCT00441142|466941042|FG003|Overall Study|Lack of Efficacy|32|||
129722265|NCT00441142|466941039|FG000|Overall Study|Withdrawal by Subject|0|||
129722266|NCT00441142|466941040|FG001|Overall Study|Withdrawal by Subject|0|||
129722267|NCT00441142|466941041|FG002|Overall Study|Withdrawal by Subject|2|||
129722268|NCT00441142|466941042|FG003|Overall Study|Withdrawal by Subject|10|||
129722269|NCT00441142|466941039|FG000|Overall Study|Patient still receiving active study tx|1|||
129722270|NCT00441142|466941040|FG001|Overall Study|Patient still receiving active study tx|0|||
129722271|NCT00441142|466941041|FG002|Overall Study|Patient still receiving active study tx|0|||
129444388|NCT00578786|465927334|FG000|Overall Study|Protocol Violation|0|||
129444389|NCT00578786|465927335|FG001|Overall Study|Protocol Violation|3|||
129444390|NCT00578786|465927336|FG002|Overall Study|Protocol Violation|1|||
129444391|NCT00578786|465927334|FG000|Overall Study|Physician Decision|1|||
129722272|NCT00441142|466941042|FG003|Overall Study|Patient still receiving active study tx|2|||
129722273|NCT00441142|466941039|FG000|Overall Study|Physician Decision|0|||
129722274|NCT00441142|466941040|FG001|Overall Study|Physician Decision|1|||
129722275|NCT00441142|466941041|FG002|Overall Study|Physician Decision|0|||
129722276|NCT00441142|466941042|FG003|Overall Study|Physician Decision|1|||
129722277|NCT00441142|466941039|FG000|Overall Study|Death|0|||
129722278|NCT00441142|466941040|FG001|Overall Study|Death|0|||
129722279|NCT00441142|466941041|FG002|Overall Study|Death|0|||
129722280|NCT00441142|466941042|FG003|Overall Study|Death|1|||
129722281|NCT04952597|466941043|FG000|Overall Study|Death|12|||
129722282|NCT04952597|466941044|FG001|Overall Study|Death|13|||
129722283|NCT04952597|466941045|FG002|Overall Study|Death|14|||
129722284|NCT04952597|466941043|FG000|Overall Study|Withdrawal by Subject|1|||
129722285|NCT04952597|466941044|FG001|Overall Study|Withdrawal by Subject|0|||
129444392|NCT00578786|465927335|FG001|Overall Study|Physician Decision|0|||
129722286|NCT04952597|466941045|FG002|Overall Study|Withdrawal by Subject|3|||
129722287|NCT04952597|466941043|FG000|Overall Study|Lost to Follow-up|0|||
129722288|NCT04952597|466941044|FG001|Overall Study|Lost to Follow-up|1|||
129722289|NCT04952597|466941045|FG002|Overall Study|Lost to Follow-up|1|||
129722290|NCT01265563|466941046|FG000|Overall Study|Withdrawal by Subject|0|||
129722291|NCT01265563|466941047|FG001|Overall Study|Withdrawal by Subject|1|||
129722292|NCT01265563|466941048|FG002|Overall Study|Withdrawal by Subject|1|||
129722293|NCT01265563|466941049|FG003|Overall Study|Withdrawal by Subject|0|||
129722294|NCT01265563|466941050|FG004|Overall Study|Withdrawal by Subject|2|||
129722295|NCT04908865|466941055|FG000|Overall Study|Adverse Event|2|||
129722296|NCT04908865|466941055|FG000|Overall Study|Lack of Efficacy|5|||
129722297|NCT04908865|466941055|FG000|Overall Study|Lost to Follow-up|1|||
129722298|NCT02141399|466941056|FG000|Overall Study|Adverse Event|158|||
129722299|NCT02141399|466941056|FG000|Overall Study|Lack of Efficacy|62|||
129722300|NCT02141399|466941056|FG000|Overall Study|Lost to Follow-up|151|||
129722301|NCT02141399|466941056|FG000|Overall Study|Non-compliance with study drug|18|||
129722302|NCT02141399|466941056|FG000|Overall Study|Other|45|||
129722303|NCT02141399|466941056|FG000|Overall Study|Physician Decision|17|||
129722304|NCT02141399|466941056|FG000|Overall Study|Pregnancy|3|||
129722305|NCT02141399|466941056|FG000|Overall Study|Protocol Violation|38|||
129722306|NCT02141399|466941056|FG000|Overall Study|Withdrawal by Subject|238|||
129722307|NCT02141399|466941056|FG000|Overall Study|Failure to meet eligibility criteria|14|||
129722308|NCT05730335|466941059|FG000|Overall Study|Lost to Follow-up|8|||
129722309|NCT05730335|466941059|FG000|Overall Study|Withdrawal by Subject|6|||
129722310|NCT01296711|466941060|FG000|Overall Study|Adverse Event|3|||
129722311|NCT01296711|466941061|FG001|Overall Study|Adverse Event|1|||
129722312|NCT01296711|466941062|FG002|Overall Study|Adverse Event|4|||
129722313|NCT01296711|466941063|FG003|Overall Study|Adverse Event|3|||
129722314|NCT01296711|466941064|FG004|Overall Study|Adverse Event|1|||
129722315|NCT01296711|466941065|FG005|Overall Study|Adverse Event|6|||
129722316|NCT01296711|466941066|FG006|Overall Study|Adverse Event|11|||
129722317|NCT01296711|466941067|FG007|Overall Study|Adverse Event|3|||
129722318|NCT01296711|466941060|FG000|Overall Study|Lack of Efficacy|1|||
129722319|NCT01296711|466941061|FG001|Overall Study|Lack of Efficacy|4|||
129722320|NCT01296711|466941062|FG002|Overall Study|Lack of Efficacy|1|||
129722321|NCT01296711|466941063|FG003|Overall Study|Lack of Efficacy|1|||
129722322|NCT01296711|466941064|FG004|Overall Study|Lack of Efficacy|1|||
129722323|NCT01296711|466941065|FG005|Overall Study|Lack of Efficacy|0|||
129722324|NCT01296711|466941066|FG006|Overall Study|Lack of Efficacy|2|||
129722325|NCT01296711|466941067|FG007|Overall Study|Lack of Efficacy|3|||
129722326|NCT01296711|466941060|FG000|Overall Study|Lost to Follow-up|0|||
129722327|NCT01296711|466941061|FG001|Overall Study|Lost to Follow-up|0|||
129722328|NCT01296711|466941062|FG002|Overall Study|Lost to Follow-up|1|||
129722329|NCT01296711|466941063|FG003|Overall Study|Lost to Follow-up|1|||
129722330|NCT01296711|466941064|FG004|Overall Study|Lost to Follow-up|2|||
129722331|NCT01296711|466941065|FG005|Overall Study|Lost to Follow-up|0|||
129722332|NCT01296711|466941066|FG006|Overall Study|Lost to Follow-up|4|||
129722333|NCT01296711|466941067|FG007|Overall Study|Lost to Follow-up|2|||
129722334|NCT01296711|466941060|FG000|Overall Study|Protocol Violation|0|||
129722335|NCT01296711|466941061|FG001|Overall Study|Protocol Violation|0|||
129722336|NCT01296711|466941062|FG002|Overall Study|Protocol Violation|0|||
129722337|NCT01296711|466941063|FG003|Overall Study|Protocol Violation|1|||
129722338|NCT01296711|466941064|FG004|Overall Study|Protocol Violation|1|||
129722339|NCT01296711|466941065|FG005|Overall Study|Protocol Violation|0|||
129722340|NCT01296711|466941066|FG006|Overall Study|Protocol Violation|0|||
129722341|NCT01296711|466941067|FG007|Overall Study|Protocol Violation|0|||
129722342|NCT01296711|466941060|FG000|Overall Study|Withdrawal by Subject|4|||
129722343|NCT01296711|466941061|FG001|Overall Study|Withdrawal by Subject|2|||
129722344|NCT01296711|466941062|FG002|Overall Study|Withdrawal by Subject|2|||
129722345|NCT01296711|466941063|FG003|Overall Study|Withdrawal by Subject|1|||
129722346|NCT01296711|466941064|FG004|Overall Study|Withdrawal by Subject|1|||
129722347|NCT01296711|466941065|FG005|Overall Study|Withdrawal by Subject|1|||
129722348|NCT01296711|466941066|FG006|Overall Study|Withdrawal by Subject|2|||
129722349|NCT01296711|466941067|FG007|Overall Study|Withdrawal by Subject|1|||
129722350|NCT01296711|466941060|FG000|Overall Study|Study termination|8|||
129722351|NCT01296711|466941061|FG001|Overall Study|Study termination|1|||
129722352|NCT01296711|466941062|FG002|Overall Study|Study termination|5|||
129722353|NCT01296711|466941063|FG003|Overall Study|Study termination|4|||
129722354|NCT01296711|466941064|FG004|Overall Study|Study termination|4|||
129722355|NCT01296711|466941065|FG005|Overall Study|Study termination|4|||
129722356|NCT01296711|466941066|FG006|Overall Study|Study termination|8|||
129722357|NCT01296711|466941067|FG007|Overall Study|Study termination|10|||
129722358|NCT01296711|466941060|FG000|Overall Study|Continued elevated liver enzymes|0|||
129722359|NCT01296711|466941061|FG001|Overall Study|Continued elevated liver enzymes|0|||
129722360|NCT01296711|466941062|FG002|Overall Study|Continued elevated liver enzymes|0|||
129722361|NCT01296711|466941063|FG003|Overall Study|Continued elevated liver enzymes|1|||
129722362|NCT01296711|466941064|FG004|Overall Study|Continued elevated liver enzymes|0|||
129722363|NCT01296711|466941065|FG005|Overall Study|Continued elevated liver enzymes|0|||
129722364|NCT01296711|466941066|FG006|Overall Study|Continued elevated liver enzymes|0|||
129722365|NCT01296711|466941067|FG007|Overall Study|Continued elevated liver enzymes|0|||
129803815|NCT05095454|467249814|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
129803816|NCT03342963|467249815|FG000|Overall Study|Adverse Event|1|||
129803817|NCT03342963|467249816|FG001|Overall Study|Adverse Event|2|||
129803818|NCT03342963|467249817|FG002|Overall Study|Adverse Event|0|||
129803819|NCT03342963|467249818|FG003|Overall Study|Adverse Event|0|||
129803820|NCT03342963|467249815|FG000|Overall Study|Withdrawal by Subject|1|||
129803821|NCT03342963|467249816|FG001|Overall Study|Withdrawal by Subject|0|||
129803822|NCT03342963|467249817|FG002|Overall Study|Withdrawal by Subject|0|||
129803823|NCT03342963|467249818|FG003|Overall Study|Withdrawal by Subject|0|||
129803824|NCT03605212|467249819|FG000|Treatment Period|Adverse Event|1|||
129803825|NCT03605212|467249820|FG001|Treatment Period|Adverse Event|0|||
129803826|NCT03605212|467249821|FG002|Treatment Period|Adverse Event|0|||
129803827|NCT03605212|467249822|FG003|Treatment Period|Adverse Event|0|||
129803828|NCT03605212|467249823|FG004|Treatment Period|Adverse Event|0|||
129803829|NCT03605212|467249819|FG000|Treatment Period|Physician Decision|0|||
129722366|NCT01296711|466941060|FG000|Overall Study|Methotrexate discontinued|0|||
129722367|NCT01296711|466941061|FG001|Overall Study|Methotrexate discontinued|0|||
129722368|NCT01296711|466941062|FG002|Overall Study|Methotrexate discontinued|0|||
129722369|NCT01296711|466941063|FG003|Overall Study|Methotrexate discontinued|1|||
129722370|NCT01296711|466941064|FG004|Overall Study|Methotrexate discontinued|0|||
129722371|NCT01296711|466941065|FG005|Overall Study|Methotrexate discontinued|0|||
129722372|NCT01296711|466941066|FG006|Overall Study|Methotrexate discontinued|0|||
129722373|NCT01296711|466941067|FG007|Overall Study|Methotrexate discontinued|0|||
129803830|NCT03605212|467249820|FG001|Treatment Period|Physician Decision|0|||
129803831|NCT03605212|467249821|FG002|Treatment Period|Physician Decision|0|||
129891629|NCT00630539|467561212|FG002|Overall Study|Withdrawal by Subject|0|||
129722374|NCT01296711|466941060|FG000|Overall Study|Investigator discretion|0|||
129722375|NCT01296711|466941061|FG001|Overall Study|Investigator discretion|0|||
129722376|NCT01296711|466941062|FG002|Overall Study|Investigator discretion|0|||
129722377|NCT01296711|466941063|FG003|Overall Study|Investigator discretion|0|||
129722378|NCT01296711|466941064|FG004|Overall Study|Investigator discretion|0|||
129722379|NCT01296711|466941065|FG005|Overall Study|Investigator discretion|0|||
129722380|NCT01296711|466941066|FG006|Overall Study|Investigator discretion|1|||
129722381|NCT01296711|466941067|FG007|Overall Study|Investigator discretion|0|||
129722382|NCT01296711|466941060|FG000|Overall Study|Other|0|||
129803832|NCT03605212|467249822|FG003|Treatment Period|Physician Decision|0|||
129803833|NCT03605212|467249823|FG004|Treatment Period|Physician Decision|1|||
129803834|NCT01756053|467249824|FG000|Period 1 (10 Days)|Protocol Violation|1|||
129803835|NCT01756053|467249825|FG001|Period 1 (10 Days)|Protocol Violation|1|||
129722383|NCT01296711|466941061|FG001|Overall Study|Other|0|||
129722384|NCT01296711|466941062|FG002|Overall Study|Other|0|||
129722385|NCT01296711|466941063|FG003|Overall Study|Other|0|||
129722386|NCT01296711|466941064|FG004|Overall Study|Other|0|||
129722387|NCT01296711|466941065|FG005|Overall Study|Other|0|||
129722388|NCT01296711|466941066|FG006|Overall Study|Other|1|||
129722389|NCT01296711|466941067|FG007|Overall Study|Other|0|||
129722390|NCT01296711|466941060|FG000|Overall Study|Required restricted steroid injections|0|||
129722391|NCT01296711|466941061|FG001|Overall Study|Required restricted steroid injections|0|||
129722392|NCT01296711|466941062|FG002|Overall Study|Required restricted steroid injections|0|||
129722393|NCT01296711|466941063|FG003|Overall Study|Required restricted steroid injections|0|||
129722394|NCT01296711|466941064|FG004|Overall Study|Required restricted steroid injections|0|||
129722395|NCT01296711|466941065|FG005|Overall Study|Required restricted steroid injections|0|||
129722396|NCT01296711|466941066|FG006|Overall Study|Required restricted steroid injections|1|||
129722397|NCT01296711|466941067|FG007|Overall Study|Required restricted steroid injections|0|||
129722398|NCT01296711|466941060|FG000|Overall Study|Ongoing missed appointments|0|||
129722399|NCT01296711|466941061|FG001|Overall Study|Ongoing missed appointments|0|||
129722400|NCT01296711|466941062|FG002|Overall Study|Ongoing missed appointments|0|||
129722401|NCT01296711|466941063|FG003|Overall Study|Ongoing missed appointments|0|||
129722402|NCT01296711|466941064|FG004|Overall Study|Ongoing missed appointments|0|||
129722403|NCT01296711|466941065|FG005|Overall Study|Ongoing missed appointments|0|||
129722404|NCT01296711|466941066|FG006|Overall Study|Ongoing missed appointments|1|||
129722405|NCT01296711|466941067|FG007|Overall Study|Ongoing missed appointments|0|||
129722406|NCT01296711|466941060|FG000|Overall Study|Failure to comply with visits|0|||
129722407|NCT01296711|466941061|FG001|Overall Study|Failure to comply with visits|0|||
129722408|NCT01296711|466941062|FG002|Overall Study|Failure to comply with visits|0|||
129722409|NCT01296711|466941063|FG003|Overall Study|Failure to comply with visits|0|||
129722410|NCT01296711|466941064|FG004|Overall Study|Failure to comply with visits|0|||
129722411|NCT01296711|466941065|FG005|Overall Study|Failure to comply with visits|0|||
129722412|NCT01296711|466941066|FG006|Overall Study|Failure to comply with visits|0|||
129722413|NCT01296711|466941067|FG007|Overall Study|Failure to comply with visits|1|||
129722414|NCT01296711|466941060|FG000|Overall Study|Patient decision due to transport|0|||
129722415|NCT01296711|466941061|FG001|Overall Study|Patient decision due to transport|0|||
129722416|NCT01296711|466941062|FG002|Overall Study|Patient decision due to transport|0|||
129722417|NCT01296711|466941063|FG003|Overall Study|Patient decision due to transport|0|||
129722418|NCT01296711|466941064|FG004|Overall Study|Patient decision due to transport|0|||
129722419|NCT01296711|466941065|FG005|Overall Study|Patient decision due to transport|0|||
129722420|NCT01296711|466941066|FG006|Overall Study|Patient decision due to transport|0|||
129722421|NCT01296711|466941067|FG007|Overall Study|Patient decision due to transport|1|||
129722422|NCT05411822|466941073|FG000|Overall Study|Withdrawal by Subject|2|||
129722423|NCT05411822|466941074|FG001|Overall Study|Withdrawal by Subject|1|||
129722424|NCT01864148|466941076|FG000|Overall Study|Other|2|||
129722425|NCT01864148|466941077|FG001|Overall Study|Other|1|||
129722426|NCT01864148|466941078|FG002|Overall Study|Other|1|||
129722427|NCT01864148|466941079|FG003|Overall Study|Other|3|||
129722428|NCT01864148|466941080|FG004|Overall Study|Other|1|||
129722429|NCT01864148|466941076|FG000|Overall Study|Death|0|||
129722430|NCT01864148|466941077|FG001|Overall Study|Death|0|||
129891630|NCT00630539|467561213|FG003|Overall Study|Withdrawal by Subject|1|||
129891631|NCT01700530|467561214|FG000|Overall Study|Withdrawal by Subject|0|||
129891632|NCT01700530|467561215|FG001|Overall Study|Withdrawal by Subject|3|||
129722431|NCT01864148|466941078|FG002|Overall Study|Death|0|||
129722432|NCT01864148|466941079|FG003|Overall Study|Death|1|||
129722433|NCT01864148|466941080|FG004|Overall Study|Death|0|||
129722434|NCT01864148|466941076|FG000|Overall Study|Investigator Decision|5|||
129722435|NCT01864148|466941077|FG001|Overall Study|Investigator Decision|0|||
129722436|NCT01864148|466941078|FG002|Overall Study|Investigator Decision|0|||
129722437|NCT01864148|466941079|FG003|Overall Study|Investigator Decision|4|||
129722438|NCT01864148|466941080|FG004|Overall Study|Investigator Decision|6|||
129722439|NCT01864148|466941076|FG000|Overall Study|Withdrawal by Subject|9|||
129722440|NCT01864148|466941077|FG001|Overall Study|Withdrawal by Subject|2|||
129722441|NCT01864148|466941078|FG002|Overall Study|Withdrawal by Subject|6|||
129722442|NCT01864148|466941079|FG003|Overall Study|Withdrawal by Subject|8|||
129722443|NCT01864148|466941080|FG004|Overall Study|Withdrawal by Subject|8|||
129722444|NCT01864148|466941076|FG000|Overall Study|Lost to Follow-up|0|||
129722445|NCT01864148|466941077|FG001|Overall Study|Lost to Follow-up|0|||
129722446|NCT01864148|466941078|FG002|Overall Study|Lost to Follow-up|0|||
129722447|NCT01864148|466941079|FG003|Overall Study|Lost to Follow-up|2|||
129722448|NCT01864148|466941080|FG004|Overall Study|Lost to Follow-up|1|||
129722449|NCT01864148|466941076|FG000|Overall Study|Adverse Event|4|||
129722450|NCT01864148|466941077|FG001|Overall Study|Adverse Event|2|||
129722451|NCT01864148|466941078|FG002|Overall Study|Adverse Event|4|||
129722452|NCT01864148|466941079|FG003|Overall Study|Adverse Event|7|||
129891633|NCT01700530|467561216|FG002|Overall Study|Withdrawal by Subject|1|||
129722453|NCT01864148|466941080|FG004|Overall Study|Adverse Event|7|||
129722454|NCT01864148|466941076|FG000|Overall Study|Not Dosed|0|||
129722455|NCT01864148|466941077|FG001|Overall Study|Not Dosed|0|||
129722456|NCT01864148|466941078|FG002|Overall Study|Not Dosed|0|||
129722457|NCT01864148|466941079|FG003|Overall Study|Not Dosed|1|||
129722458|NCT01864148|466941080|FG004|Overall Study|Not Dosed|0|||
129722459|NCT02027311|466941081|FG000|Overall Study|Protocol Violation|3|||
129722460|NCT02027311|466941082|FG001|Overall Study|Protocol Violation|2|||
129722461|NCT02466425|466941085|FG000|Overall Study|Adverse Event|3|||
129722462|NCT02466425|466941086|FG001|Overall Study|Adverse Event|11|||
129722463|NCT02466425|466941085|FG000|Overall Study|Lack of Efficacy|4|||
129722464|NCT02466425|466941086|FG001|Overall Study|Lack of Efficacy|1|||
129722465|NCT02466425|466941085|FG000|Overall Study|Lost to Follow-up|3|||
129722466|NCT02466425|466941086|FG001|Overall Study|Lost to Follow-up|0|||
129722467|NCT02466425|466941085|FG000|Overall Study|Protocol Violation|1|||
129722468|NCT02466425|466941086|FG001|Overall Study|Protocol Violation|0|||
129722469|NCT02466425|466941085|FG000|Overall Study|Withdrawal by Subject|0|||
129722470|NCT02466425|466941086|FG001|Overall Study|Withdrawal by Subject|1|||
129722471|NCT02466425|466941085|FG000|Overall Study|Other|1|||
129722472|NCT02466425|466941086|FG001|Overall Study|Other|3|||
129722473|NCT02466425|466941085|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129722474|NCT02466425|466941086|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129722475|NCT01721486|466941091|FG000|Overall Study|Protocol Violation|1|||
129722476|NCT01721486|466941092|FG001|Overall Study|Protocol Violation|0|||
129722477|NCT01721486|466941091|FG000|Overall Study|Physician Decision|0|||
129722478|NCT01721486|466941092|FG001|Overall Study|Physician Decision|1|||
129722479|NCT00582712|466941093|FG000|Overall Study|Adverse Event|1|||
129722480|NCT00582712|466941093|FG000|Overall Study|Lack of Efficacy|1|||
129722481|NCT00582712|466941093|FG000|Overall Study|Withdrawal by Subject|1|||
129722482|NCT00582712|466941093|FG000|Overall Study|Complicating disease requiring treatment|1|||
129722483|NCT01901289|466941095|FG000|Overall Study|Death|32|||
129722484|NCT01901289|466941095|FG000|Overall Study|Lost to Follow-up|16|||
129722485|NCT01901289|466941095|FG000|Overall Study|Withdrawal by Subject|35|||
129722486|NCT01901289|466941095|FG000|Overall Study|Other type of endpoint met|2|||
129722487|NCT01813058|466941096|FG000|Overall Study|Withdrawal by Subject|5|||
129722488|NCT01813058|466941097|FG001|Overall Study|Withdrawal by Subject|4|||
129722489|NCT00395486|466941098|FG000|Overall Study|Adverse Event|1|||
129722490|NCT00395486|466941099|FG001|Overall Study|Adverse Event|2|||
129722491|NCT00395486|466941098|FG000|Overall Study|Withdrawal by Subject|5|||
129722492|NCT00395486|466941099|FG001|Overall Study|Withdrawal by Subject|2|||
129722493|NCT00395486|466941098|FG000|Overall Study|Lost to Follow-up|0|||
129722494|NCT00395486|466941099|FG001|Overall Study|Lost to Follow-up|1|||
129722495|NCT00361231|466941104|FG000|Overall Study|Physician Decision|3|||
129722496|NCT00361231|466941104|FG000|Overall Study|Symptomatic deterioration|5|||
129722497|NCT00361231|466941104|FG000|Overall Study|Radiographic disease progression|16|||
129722498|NCT00361231|466941104|FG000|Overall Study|Withdrawal by Subject|4|||
129722499|NCT00361231|466941104|FG000|Overall Study|Adverse Event|6|||
129722500|NCT01814397|466941107|FG000|Overall Study|Adverse Event|7|||
129722501|NCT01814397|466941107|FG000|Overall Study|Withdrawal by Subject|7|||
129722502|NCT00313144|466941108|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
129722503|NCT00313144|466941108|FG000|Overall Study|Death|7|||
129722504|NCT00313144|466941108|FG000|Overall Study|Lost to Follow-up|5|||
129722505|NCT00313144|466941108|FG000|Overall Study|Withdrawal by Subject|4|||
129722506|NCT00313144|466941108|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
129803836|NCT01756053|467249824|FG000|Period 2 (10 Days)|Protocol Violation|0|||
129803837|NCT01756053|467249825|FG001|Period 2 (10 Days)|Protocol Violation|2|||
129803838|NCT00285818|467249826|FG000|Overall Study|Withdrawal by Subject|3|||
129803839|NCT00285818|467249827|FG001|Overall Study|Withdrawal by Subject|2|||
129722507|NCT00313144|466941108|FG000|Overall Study|Physician Decision|4|||
129722508|NCT00313144|466941108|FG000|Overall Study|Adverse event - transient|5|||
129722509|NCT00313144|466941108|FG000|Overall Study|Liver transplant|1|||
129722510|NCT00313144|466941108|FG000|Overall Study|Insurance (homecare provider) change|1|||
129722511|NCT00313144|466941108|FG000|Overall Study|Change to different product|1|||
129722512|NCT00313144|466941108|FG000|Overall Study|Due to termination of the study|66|||
129803840|NCT00285818|467249826|FG000|Overall Study|Lost to Follow-up|1|||
129803841|NCT00285818|467249827|FG001|Overall Study|Lost to Follow-up|0|||
129803842|NCT04041375|467249828|FG000|Intervention Phase|Withdrawal by Subject|2|||
129803843|NCT04041375|467249829|FG001|Intervention Phase|Withdrawal by Subject|2|||
129722513|NCT01932372|466941122|FG000|Overall Study|Not meeting eligibility criteria|33|||
129722514|NCT01932372|466941123|FG001|Overall Study|Not meeting eligibility criteria|179|||
129722515|NCT01917929|466941124|FG000|Overall Study|Death|8|||
129722516|NCT01917929|466941124|FG000|Overall Study|Lost to Follow-up|19|||
129722517|NCT01917929|466941124|FG000|Overall Study|Withdrawal by Subject|33|||
129722518|NCT01917929|466941124|FG000|Overall Study|Adverse Event|6|||
129722519|NCT01917929|466941124|FG000|Overall Study|Investigative Site Terminated|35|||
129722520|NCT01917929|466941124|FG000|Overall Study|Censored because study device not implanted|6|||
129722521|NCT01917929|466941124|FG000|Overall Study|Censored because surgery not performed|3|||
129803844|NCT04041375|467249828|FG000|Follow-up Phase|Death|2|||
129722522|NCT01917929|466941124|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
129722523|NCT01917929|466941124|FG000|Overall Study|Sponsor terminated study|175|||
129722524|NCT03028415|466941125|FG000|Overall Study|Lost to Follow-up|6|||
129722525|NCT03028415|466941126|FG001|Overall Study|Lost to Follow-up|3|||
129722526|NCT03028415|466941125|FG000|Overall Study|Withdrawal by Subject|1|||
129722527|NCT03028415|466941126|FG001|Overall Study|Withdrawal by Subject|0|||
129722528|NCT03028415|466941125|FG000|Overall Study|Discontinued due to COVID-19|1|||
129722529|NCT03028415|466941126|FG001|Overall Study|Discontinued due to COVID-19|0|||
129722530|NCT02907216|466941127|FG000|Overall Study|No benefit to be obtained by continuing|0|||
129722531|NCT02907216|466941128|FG001|Overall Study|No benefit to be obtained by continuing|1|||
129722532|NCT02907216|466941127|FG000|Overall Study|Withdrawal by Subject|1|||
129722533|NCT02907216|466941128|FG001|Overall Study|Withdrawal by Subject|0|||
129722534|NCT02241733|466941131|FG000|Overall Study|Lost to Follow-up|9|||
129722535|NCT02241733|466941132|FG001|Overall Study|Lost to Follow-up|4|||
129722536|NCT02241733|466941131|FG000|Overall Study|Physician Decision|6|||
129722537|NCT02241733|466941132|FG001|Overall Study|Physician Decision|2|||
129722538|NCT02241733|466941131|FG000|Overall Study|Withdrawal by Subject|0|||
129722539|NCT02241733|466941132|FG001|Overall Study|Withdrawal by Subject|2|||
129722540|NCT02241733|466941131|FG000|Overall Study|Death|0|||
129722541|NCT02241733|466941132|FG001|Overall Study|Death|2|||
129722542|NCT00792740|466941143|FG000|Overall Study|Disease Worsening|3|||
129722543|NCT00792740|466941144|FG001|Overall Study|Disease Worsening|2|||
129722544|NCT00792740|466941143|FG000|Overall Study|Personal Reason|1|||
129722545|NCT00792740|466941144|FG001|Overall Study|Personal Reason|0|||
129722546|NCT00792740|466941143|FG000|Overall Study|Adverse Event|1|||
129722547|NCT00792740|466941144|FG001|Overall Study|Adverse Event|3|||
129722548|NCT00792740|466941143|FG000|Overall Study|Patient's withdrawal of consent|0|||
129722549|NCT00792740|466941144|FG001|Overall Study|Patient's withdrawal of consent|1|||
129722550|NCT00792740|466941143|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
129722551|NCT00792740|466941144|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
129722552|NCT00792740|466941143|FG000|Overall Study|Other reasons|0|||
129722553|NCT00792740|466941144|FG001|Overall Study|Other reasons|1|||
129722554|NCT01063062|466941145|FG000|Overall Study|Patient withdrew consent|0|||
129722555|NCT01063062|466941146|FG001|Overall Study|Patient withdrew consent|1|||
129722556|NCT01063062|466941145|FG000|Overall Study|Adverse Event|2|||
129722557|NCT01063062|466941146|FG001|Overall Study|Adverse Event|4|||
129722558|NCT01063062|466941145|FG000|Overall Study|Protocol Violation|5|||
129722559|NCT01063062|466941146|FG001|Overall Study|Protocol Violation|4|||
129722560|NCT01063062|466941145|FG000|Overall Study|Investigator's request|1|||
129722561|NCT01063062|466941146|FG001|Overall Study|Investigator's request|0|||
129722562|NCT01063062|466941145|FG000|Overall Study|Lost to Follow-up|0|||
129722563|NCT01063062|466941146|FG001|Overall Study|Lost to Follow-up|2|||
129722564|NCT01063062|466941145|FG000|Overall Study|Miscellaneous reason|0|||
129722565|NCT01063062|466941146|FG001|Overall Study|Miscellaneous reason|1|||
129722566|NCT00703846|466941149|FG000|Overall Study|Adverse Event|8|||
129722567|NCT00703846|466941149|FG000|Overall Study|Lost to Follow-up|55|||
129722568|NCT00703846|466941149|FG000|Overall Study|Lack of Efficacy|15|||
129722569|NCT00703846|466941149|FG000|Overall Study|Noncompliance with Study Treatment|2|||
129722570|NCT00703846|466941149|FG000|Overall Study|Withdrawal by Subject|40|||
129722571|NCT00703846|466941149|FG000|Overall Study|Death|1|||
129722572|NCT00703846|466941149|FG000|Overall Study|Other|14|||
129803845|NCT04041375|467249829|FG001|Follow-up Phase|Death|0|||
129803846|NCT04041375|467249828|FG000|Follow-up Phase|Lost to Follow-up|2|||
129803847|NCT04041375|467249829|FG001|Follow-up Phase|Lost to Follow-up|1|||
129803848|NCT04041375|467249828|FG000|Follow-up Phase|Too ill|3|||
129803849|NCT04041375|467249829|FG001|Follow-up Phase|Too ill|0|||
129803850|NCT04043728|467249834|FG000|Overall Study|Lost to Follow-up|1|||
129722573|NCT00703846|466941149|FG000|Overall Study|Did Not Receive Study Drug|2|||
129722574|NCT02597452|466941150|FG000|Overall Study|testing incomplete|30|||
129803851|NCT04043728|467249835|FG001|Overall Study|Lost to Follow-up|2|||
129722575|NCT04621240|466941157|FG000|Overall Study|Withdrawal by Subject|36|||
129722576|NCT03206918|466941158|FG000|Overall Study|Death|11|||
129722577|NCT03206918|466941158|FG000|Overall Study|Withdrawal by Subject|5|||
129722578|NCT03206918|466941158|FG000|Overall Study|Study terminated by sponsor|12|||
129722579|NCT03206918|466941158|FG000|Overall Study|Lost to Follow-up|3|||
129722580|NCT03206918|466941158|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
129722581|NCT02954406|466942333|FG000|Overall Study|Adverse Event|0|||
129722582|NCT02954406|466942334|FG001|Overall Study|Adverse Event|1|||
129722583|NCT02954406|466942335|FG002|Overall Study|Adverse Event|0|||
129722584|NCT02954406|466942336|FG003|Overall Study|Adverse Event|0|||
129722585|NCT02954406|466942337|FG004|Overall Study|Adverse Event|1|||
129722586|NCT02954406|466942338|FG005|Overall Study|Adverse Event|0|||
129722587|NCT02954406|466942339|FG006|Overall Study|Adverse Event|0|||
129722588|NCT02954406|466942340|FG007|Overall Study|Adverse Event|0|||
129722589|NCT02954406|466942341|FG008|Overall Study|Adverse Event|1|||
129803852|NCT04043728|467249836|FG002|Overall Study|Lost to Follow-up|0|||
129803853|NCT01033851|467249837|FG000|Overall Study|Withdrawal by Subject|3|||
129722590|NCT02954406|466942342|FG009|Overall Study|Adverse Event|1|||
129722591|NCT02954406|466942343|FG010|Overall Study|Adverse Event|0|||
129722592|NCT02954406|466942333|FG000|Overall Study|Progressive Disease|3|||
129722593|NCT02954406|466942334|FG001|Overall Study|Progressive Disease|4|||
129722594|NCT02954406|466942335|FG002|Overall Study|Progressive Disease|3|||
129722595|NCT02954406|466942336|FG003|Overall Study|Progressive Disease|4|||
129722596|NCT02954406|466942337|FG004|Overall Study|Progressive Disease|3|||
129722597|NCT02954406|466942338|FG005|Overall Study|Progressive Disease|3|||
129722598|NCT02954406|466942339|FG006|Overall Study|Progressive Disease|2|||
129722599|NCT02954406|466942340|FG007|Overall Study|Progressive Disease|2|||
129722600|NCT02954406|466942341|FG008|Overall Study|Progressive Disease|1|||
129722601|NCT02954406|466942342|FG009|Overall Study|Progressive Disease|1|||
129722602|NCT02954406|466942343|FG010|Overall Study|Progressive Disease|0|||
129722603|NCT02954406|466942333|FG000|Overall Study|Symptomatic Deterioration|0|||
129722604|NCT02954406|466942334|FG001|Overall Study|Symptomatic Deterioration|1|||
129722605|NCT02954406|466942335|FG002|Overall Study|Symptomatic Deterioration|0|||
129722606|NCT02954406|466942336|FG003|Overall Study|Symptomatic Deterioration|0|||
129722607|NCT02954406|466942337|FG004|Overall Study|Symptomatic Deterioration|0|||
129722608|NCT02954406|466942338|FG005|Overall Study|Symptomatic Deterioration|0|||
129722609|NCT02954406|466942339|FG006|Overall Study|Symptomatic Deterioration|0|||
129722610|NCT02954406|466942340|FG007|Overall Study|Symptomatic Deterioration|0|||
129722611|NCT02954406|466942341|FG008|Overall Study|Symptomatic Deterioration|0|||
129722612|NCT02954406|466942342|FG009|Overall Study|Symptomatic Deterioration|0|||
129722613|NCT02954406|466942343|FG010|Overall Study|Symptomatic Deterioration|0|||
129722614|NCT02954406|466942333|FG000|Overall Study|Death|0|||
129722615|NCT02954406|466942334|FG001|Overall Study|Death|0|||
129722616|NCT02954406|466942335|FG002|Overall Study|Death|0|||
129722617|NCT02954406|466942336|FG003|Overall Study|Death|0|||
129722618|NCT02954406|466942337|FG004|Overall Study|Death|1|||
129722619|NCT02954406|466942338|FG005|Overall Study|Death|0|||
129722620|NCT02954406|466942339|FG006|Overall Study|Death|0|||
129722621|NCT02954406|466942340|FG007|Overall Study|Death|0|||
129722622|NCT02954406|466942341|FG008|Overall Study|Death|1|||
129722623|NCT02954406|466942342|FG009|Overall Study|Death|1|||
129722624|NCT02954406|466942343|FG010|Overall Study|Death|0|||
129722625|NCT02954406|466942333|FG000|Overall Study|Reason Not Specified|0|||
129722626|NCT02954406|466942334|FG001|Overall Study|Reason Not Specified|0|||
129722627|NCT02954406|466942335|FG002|Overall Study|Reason Not Specified|3|||
129722628|NCT02954406|466942336|FG003|Overall Study|Reason Not Specified|2|||
129722629|NCT02954406|466942337|FG004|Overall Study|Reason Not Specified|2|||
129722630|NCT02954406|466942338|FG005|Overall Study|Reason Not Specified|0|||
129722631|NCT02954406|466942339|FG006|Overall Study|Reason Not Specified|1|||
129722632|NCT02954406|466942340|FG007|Overall Study|Reason Not Specified|0|||
129722633|NCT02954406|466942341|FG008|Overall Study|Reason Not Specified|1|||
129722634|NCT02954406|466942342|FG009|Overall Study|Reason Not Specified|0|||
129722635|NCT02954406|466942343|FG010|Overall Study|Reason Not Specified|0|||
129722636|NCT00782171|466942344|FG000|Overall Study|Lost to Follow-up|2|||
129722637|NCT00782171|466942345|FG001|Overall Study|Lost to Follow-up|2|||
129722638|NCT00782171|466942344|FG000|Overall Study|Withdrawal by Subject|2|||
129722639|NCT00782171|466942345|FG001|Overall Study|Withdrawal by Subject|1|||
129722640|NCT00782171|466942344|FG000|Overall Study|complications|3|||
129722641|NCT00782171|466942345|FG001|Overall Study|complications|1|||
129722642|NCT00782171|466942344|FG000|Overall Study|others|7|||
129722643|NCT00782171|466942345|FG001|Overall Study|others|9|||
129722644|NCT00782171|466942344|FG000|Overall Study|not eligible|8|||
129722645|NCT00782171|466942345|FG001|Overall Study|not eligible|6|||
129722646|NCT04075292|466942350|FG000|Overall Study|Withdrawal by Subject|1|||
129722647|NCT04075292|466942351|FG001|Overall Study|Withdrawal by Subject|9|||
129722648|NCT04075292|466942350|FG000|Overall Study|Death|2|||
129722649|NCT04075292|466942351|FG001|Overall Study|Death|5|||
129722650|NCT04075292|466942350|FG000|Overall Study|Remained on study at time of DCO|74|||
129722651|NCT04075292|466942351|FG001|Overall Study|Remained on study at time of DCO|64|||
129722652|NCT04308239|466942352|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
129722653|NCT04308239|466942353|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
129803854|NCT01033851|467249838|FG001|Overall Study|Withdrawal by Subject|7|||
129803855|NCT02349542|467249839|FG000|Overall Study|Withdrawal by Subject|5|||
129722654|NCT04308239|466942352|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
129722655|NCT04308239|466942353|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
129722656|NCT04308239|466942352|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
129722657|NCT04308239|466942353|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
129722658|NCT04308239|466942352|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
129722659|NCT04308239|466942353|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
129722660|NCT01443364|466942354|FG000|Overall Study|Lack of Efficacy|14|||
129722661|NCT01443364|466942354|FG000|Overall Study|Lost to Follow-up|3|||
129722662|NCT01443364|466942354|FG000|Overall Study|Withdrawal by Subject|5|||
129803856|NCT02919696|467249842|FG000|Overall Study|Adverse Event|1|||
129891634|NCT02223182|467561223|FG000|Double-Blind Period|Adverse Event|0|||
129722663|NCT01443364|466942354|FG000|Overall Study|Other Reason|4|||
129722664|NCT01443364|466942354|FG000|Overall Study|SAE, non-fatal|6|||
129722665|NCT01443364|466942354|FG000|Overall Study|AE, non-serious non-fatal|8|||
129722666|NCT01443364|466942354|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129722667|NCT00559845|466942357|FG000|Overall Study|Withdrew Consent|1|||
129722668|NCT00559845|466942357|FG000|Overall Study|Disease Progression|1|||
129722669|NCT00559845|466942357|FG000|Overall Study|Adverse Event|3|||
129722670|NCT00559845|466942357|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
129722671|NCT00559845|466942357|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
129722672|NCT03367403|466942360|FG000|Overall Study|Adverse Event|20|||
129722673|NCT03367403|466942361|FG001|Overall Study|Adverse Event|6|||
129722674|NCT03367403|466942362|FG002|Overall Study|Adverse Event|2|||
129722675|NCT03367403|466942360|FG000|Overall Study|Withdrawal by Subject|12|||
129722676|NCT03367403|466942361|FG001|Overall Study|Withdrawal by Subject|13|||
129722677|NCT03367403|466942362|FG002|Overall Study|Withdrawal by Subject|1|||
129722678|NCT03367403|466942360|FG000|Overall Study|Death|1|||
129722679|NCT03367403|466942361|FG001|Overall Study|Death|2|||
129722680|NCT03367403|466942362|FG002|Overall Study|Death|0|||
129722681|NCT03367403|466942360|FG000|Overall Study|Physician Decision|0|||
129722682|NCT03367403|466942361|FG001|Overall Study|Physician Decision|1|||
129722683|NCT03367403|466942362|FG002|Overall Study|Physician Decision|0|||
129722684|NCT03367403|466942360|FG000|Overall Study|Protocol Violation|1|||
129722685|NCT03367403|466942361|FG001|Overall Study|Protocol Violation|1|||
129722686|NCT03367403|466942362|FG002|Overall Study|Protocol Violation|0|||
129722687|NCT03367403|466942360|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
129722688|NCT03367403|466942361|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
129722689|NCT03367403|466942362|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
129722690|NCT03367403|466942360|FG000|Overall Study|COVID-19|3|||
129722691|NCT03367403|466942361|FG001|Overall Study|COVID-19|6|||
129722692|NCT03367403|466942362|FG002|Overall Study|COVID-19|0|||
129722693|NCT03367403|466942360|FG000|Overall Study|Abuse of Alcohol Intake|0|||
129722694|NCT03367403|466942361|FG001|Overall Study|Abuse of Alcohol Intake|1|||
129722695|NCT03367403|466942362|FG002|Overall Study|Abuse of Alcohol Intake|0|||
129722696|NCT03367403|466942360|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
129722697|NCT03367403|466942361|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
129722698|NCT03367403|466942362|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
129722699|NCT00194077|466942363|FG000|Overall Study|Lack of Efficacy|22|||
129803857|NCT02919696|467249843|FG001|Overall Study|Adverse Event|2|||
129803858|NCT02919696|467249842|FG000|Overall Study|Withdrawal by Subject|2|||
129803859|NCT02919696|467249843|FG001|Overall Study|Withdrawal by Subject|1|||
129803860|NCT02919696|467249842|FG000|Overall Study|Sponsor Decision|1|||
129803861|NCT02919696|467249843|FG001|Overall Study|Sponsor Decision|1|||
129803862|NCT02919696|467249842|FG000|Overall Study|Never Treated|0|||
129803863|NCT02919696|467249843|FG001|Overall Study|Never Treated|1|||
129803864|NCT04308304|467249844|FG000|Overall Study|Withdrawal by Subject|4|||
129803865|NCT04308304|467249845|FG001|Overall Study|Withdrawal by Subject|0|||
129803866|NCT04308304|467249844|FG000|Overall Study|Protocol Violation|1|||
129803867|NCT04308304|467249845|FG001|Overall Study|Protocol Violation|0|||
129803868|NCT00945555|467249846|FG000|Overall Study|Referred to another hospital|5|||
129803869|NCT00945555|467249846|FG000|Overall Study|Worsening condition, intensive care unit|1|||
129803870|NCT00945555|467249846|FG000|Overall Study|Withdrawal by Subject|2|||
129803871|NCT00945555|467249846|FG000|Overall Study|Participant continued treatment at home|1|||
129803872|NCT00945555|467249846|FG000|Overall Study|Death|18|||
129803873|NCT00945555|467249846|FG000|Overall Study|Other|1|||
129803874|NCT00484094|467249847|FG000|Overall Study|Discontinued|39|||
129803875|NCT00484094|467249847|FG000|Overall Study|Other|3|||
129803876|NCT01414608|467249848|FG000|Overall Study|Ineligible|5|||
129803877|NCT01414608|467249849|FG001|Overall Study|Ineligible|2|||
129803878|NCT01686828|467249850|FG000|Overall Study|Physician Decision|1|||
129722700|NCT00194077|466942364|FG001|Overall Study|Lack of Efficacy|29|||
129722701|NCT00194077|466942363|FG000|Overall Study|Study nonadherence|1|||
129722702|NCT00194077|466942364|FG001|Overall Study|Study nonadherence|0|||
129722703|NCT00194077|466942363|FG000|Overall Study|Withdrawal by Subject|1|||
129803879|NCT01686828|467249851|FG001|Overall Study|Physician Decision|0|||
129722704|NCT00194077|466942364|FG001|Overall Study|Withdrawal by Subject|1|||
129722705|NCT03470194|466942367|FG000|Overall Study|Lost to Follow-up|11|||
129722706|NCT03470194|466942368|FG001|Overall Study|Lost to Follow-up|17|||
129722707|NCT03286543|466942369|FG000|Consented|Screen failure before randomization|2|||
129722708|NCT03286543|466942370|FG001|Consented|Screen failure before randomization|0|||
129722709|NCT03286543|466942371|FG002|Consented|Screen failure before randomization|0|||
129722710|NCT03286543|466942369|FG000|Consented|Screen failure before enrollment|4|||
129803880|NCT01686828|467249852|FG002|Overall Study|Physician Decision|0|||
129803881|NCT01686828|467249853|FG003|Overall Study|Physician Decision|0|||
129803882|NCT01686828|467249850|FG000|Overall Study|New Job|0|||
129803883|NCT01686828|467249851|FG001|Overall Study|New Job|1|||
129803884|NCT01686828|467249852|FG002|Overall Study|New Job|0|||
129722711|NCT03286543|466942370|FG001|Consented|Screen failure before enrollment|0|||
129722712|NCT03286543|466942371|FG002|Consented|Screen failure before enrollment|0|||
129722713|NCT03286543|466942369|FG000|Consented|TKA cancelled after enrollment|1|||
129722714|NCT03286543|466942370|FG001|Consented|TKA cancelled after enrollment|0|||
129722715|NCT03286543|466942371|FG002|Consented|TKA cancelled after enrollment|0|||
129722716|NCT03286543|466942369|FG000|Consented|Withdrawn from study|12|||
129722717|NCT03286543|466942370|FG001|Consented|Withdrawn from study|0|||
129722718|NCT03286543|466942371|FG002|Consented|Withdrawn from study|0|||
129722719|NCT03286543|466942369|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
129722720|NCT03286543|466942370|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
129722721|NCT03286543|466942371|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
129722722|NCT03286543|466942369|FG000|Study Enrollment|Withdrawn from study|0|||
129722723|NCT03286543|466942370|FG001|Study Enrollment|Withdrawn from study|6|||
129722724|NCT03286543|466942371|FG002|Study Enrollment|Withdrawn from study|6|||
129722725|NCT01822899|466942372|FG000|Overall Study|Adverse Event|6|||
129722726|NCT01822899|466942373|FG001|Overall Study|Adverse Event|5|||
129722727|NCT01822899|466942372|FG000|Overall Study|Lack of Efficacy|6|||
129722728|NCT01822899|466942373|FG001|Overall Study|Lack of Efficacy|3|||
129722729|NCT01822899|466942372|FG000|Overall Study|Protocol Violation|6|||
129722730|NCT01822899|466942373|FG001|Overall Study|Protocol Violation|3|||
129722731|NCT01822899|466942372|FG000|Overall Study|Lost to Follow-up|1|||
129722732|NCT01822899|466942373|FG001|Overall Study|Lost to Follow-up|0|||
129722733|NCT01822899|466942372|FG000|Overall Study|Withdrawal by Subject|5|||
129722734|NCT01822899|466942373|FG001|Overall Study|Withdrawal by Subject|7|||
129722735|NCT05332392|466942374|FG000|Overall Study|Did not meet inclusion criteria|25|||
129722736|NCT05332392|466942374|FG000|Overall Study|Principal Investigator's decision|17|||
129722737|NCT05332392|466942374|FG000|Overall Study|Adverse Event|1|||
129722738|NCT05332392|466942374|FG000|Overall Study|Subject's decision|1|||
129722739|NCT00759876|466942378|FG000|Overall Study|Sponsor terminated study early|36|||
129722740|NCT03636893|466942379|FG000|Overall Study|Death|0|||
129722741|NCT03636893|466942380|FG001|Overall Study|Death|1|||
129722742|NCT03636893|466942379|FG000|Overall Study|Protocol Violation|0|||
129722743|NCT03636893|466942380|FG001|Overall Study|Protocol Violation|3|||
129722744|NCT03636893|466942379|FG000|Overall Study|Withdrawal by Subject|1|||
129722745|NCT03636893|466942380|FG001|Overall Study|Withdrawal by Subject|2|||
129722746|NCT03636893|466942379|FG000|Overall Study|Refusal to surgery|4|||
129722747|NCT03636893|466942380|FG001|Overall Study|Refusal to surgery|3|||
129722748|NCT03636893|466942379|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
129722749|NCT03636893|466942380|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
129722750|NCT03636893|466942379|FG000|Overall Study|Adverse Event|1|||
129722751|NCT03636893|466942380|FG001|Overall Study|Adverse Event|1|||
129722752|NCT00758069|466942381|FG000|Overall Study|Lack of Efficacy|0|||
129722753|NCT00758069|466942382|FG001|Overall Study|Lack of Efficacy|0|||
129722754|NCT00758069|466942383|FG002|Overall Study|Lack of Efficacy|1|||
129722755|NCT00758069|466942381|FG000|Overall Study|Incorrect Study Drug|1|||
129722756|NCT00758069|466942382|FG001|Overall Study|Incorrect Study Drug|0|||
129722757|NCT00758069|466942383|FG002|Overall Study|Incorrect Study Drug|0|||
129722758|NCT03818607|466942385|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
129722759|NCT03818607|466942386|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
129722760|NCT03818607|466942385|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
129722761|NCT03818607|466942386|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
129722762|NCT03818607|466942385|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
129722763|NCT03818607|466942386|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
129722764|NCT00588237|466942387|FG000|Overall Study|Evaluable for toxicity only|3|||
129722765|NCT00588237|466942387|FG000|Overall Study|Patien not treated|1|||
129722766|NCT05059301|466942388|FG000|Overall Study|Adverse Event|0|||
129722767|NCT05059301|466942389|FG001|Overall Study|Adverse Event|2|||
129722768|NCT05059301|466942390|FG002|Overall Study|Adverse Event|2|||
129722769|NCT05059301|466942388|FG000|Overall Study|Lost to Follow-up|2|||
129722770|NCT05059301|466942389|FG001|Overall Study|Lost to Follow-up|3|||
129722771|NCT05059301|466942390|FG002|Overall Study|Lost to Follow-up|3|||
129722772|NCT01164891|466942394|FG000|Overall Study|Disease Progression|5|||
129722773|NCT01164891|466942394|FG000|Overall Study|Adverse Event|1|||
129722774|NCT00606034|466942397|FG000|Overall Study|incarceration|1|||
129722775|NCT01126268|466942400|FG000|Overall Study|Adverse Event|1|||
129722776|NCT01988662|466942401|FG000|Overall Study|Subject/guardian decision|1|||
129722777|NCT01988662|466942402|FG001|Overall Study|Subject/guardian decision|1|||
129722778|NCT01988662|466942401|FG000|Overall Study|Adverse Event|3|||
129722779|NCT01988662|466942402|FG001|Overall Study|Adverse Event|1|||
129722780|NCT00842153|466942406|FG000|Overall Study|Adverse Event|0|||
129722781|NCT00842153|466942407|FG001|Overall Study|Adverse Event|1|||
129722782|NCT00842153|466942406|FG000|Overall Study|Lost to Follow-up|1|||
129722783|NCT00842153|466942407|FG001|Overall Study|Lost to Follow-up|2|||
129722784|NCT00002540|466942408|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
129722785|NCT00002540|466942409|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
129803885|NCT01686828|467249853|FG003|Overall Study|New Job|0|||
129722786|NCT00002540|466942408|FG000|Overall Study|Died Before Randomization|2|||
129722787|NCT00002540|466942409|FG001|Overall Study|Died Before Randomization|6|||
129722788|NCT00002540|466942408|FG000|Overall Study|Died Before ASU (Control)|202|||
129722789|NCT00002540|466942409|FG001|Overall Study|Died Before ASU (Control)|0|||
129722790|NCT00002540|466942408|FG000|Overall Study|Refused ASU (Control)|597|||
129722791|NCT00002540|466942409|FG001|Overall Study|Refused ASU (Control)|0|||
129722792|NCT00002540|466942408|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
129722793|NCT00002540|466942409|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
129722794|NCT05312697|466942410|FG000|Overall Study|Sponsor Terminated Trial|2|||
129722795|NCT04445519|466942411|FG000|Overall Study|Due to adaptive design|3|||
129722796|NCT04445519|466942412|FG001|Overall Study|Due to adaptive design|0|||
129722797|NCT04445519|466942413|FG002|Overall Study|Due to adaptive design|0|||
129722798|NCT04445519|466942411|FG000|Overall Study|Lost to Follow-up|0|||
129722799|NCT04445519|466942412|FG001|Overall Study|Lost to Follow-up|1|||
129722800|NCT04445519|466942413|FG002|Overall Study|Lost to Follow-up|4|||
129722801|NCT04445519|466942411|FG000|Overall Study|Sponsor or IRB Decision|0|||
129722802|NCT04445519|466942412|FG001|Overall Study|Sponsor or IRB Decision|1|||
129722803|NCT04445519|466942413|FG002|Overall Study|Sponsor or IRB Decision|2|||
129722804|NCT04445519|466942411|FG000|Overall Study|Withdrawal by Subject|0|||
129722805|NCT04445519|466942412|FG001|Overall Study|Withdrawal by Subject|3|||
129722806|NCT04445519|466942413|FG002|Overall Study|Withdrawal by Subject|3|||
129891635|NCT02223182|467561224|FG001|Double-Blind Period|Adverse Event|2|||
129891636|NCT02223182|467561225|FG002|Double-Blind Period|Adverse Event|1|||
129722807|NCT04445519|466942411|FG000|Overall Study|Adverse Event|0|||
129722808|NCT04445519|466942412|FG001|Overall Study|Adverse Event|8|||
129722809|NCT04445519|466942413|FG002|Overall Study|Adverse Event|6|||
129722810|NCT04445519|466942411|FG000|Overall Study|Other Reason|0|||
129722811|NCT04445519|466942412|FG001|Overall Study|Other Reason|1|||
129722812|NCT04445519|466942413|FG002|Overall Study|Other Reason|1|||
129722813|NCT04445519|466942411|FG000|Overall Study|Protocol Violation|0|||
129722814|NCT04445519|466942412|FG001|Overall Study|Protocol Violation|0|||
129722815|NCT04445519|466942413|FG002|Overall Study|Protocol Violation|1|||
129722816|NCT01345929|466942414|FG000|Overall Study|Withdrawal by Subject|9|||
129722817|NCT01345929|466942415|FG001|Overall Study|Withdrawal by Subject|8|||
129722818|NCT01345929|466942414|FG000|Overall Study|Lost to Follow-up|9|||
129722819|NCT01345929|466942415|FG001|Overall Study|Lost to Follow-up|9|||
129722820|NCT01345929|466942414|FG000|Overall Study|Adverse Event|0|||
129722821|NCT01345929|466942415|FG001|Overall Study|Adverse Event|1|||
129722822|NCT01345929|466942414|FG000|Overall Study|Didn't meet eligibility criteria|2|||
129722823|NCT01345929|466942415|FG001|Overall Study|Didn't meet eligibility criteria|0|||
129722824|NCT01345929|466942414|FG000|Overall Study|40,000 CFU/ML|1|||
129722825|NCT01345929|466942415|FG001|Overall Study|40,000 CFU/ML|0|||
129722826|NCT01345929|466942414|FG000|Overall Study|Patient withdrawal|0|||
129722827|NCT01345929|466942415|FG001|Overall Study|Patient withdrawal|1|||
129722828|NCT02151903|466942416|FG000|Overall Study|Withdrawal by Subject|1|||
129722829|NCT02151903|466942417|FG001|Overall Study|Withdrawal by Subject|0|||
129722830|NCT02151903|466942416|FG000|Overall Study|Progressive disease|2|||
129722831|NCT02151903|466942417|FG001|Overall Study|Progressive disease|1|||
129722832|NCT03768089|466942418|FG000|Part A|Lost to Follow-up|0|||
129722833|NCT03768089|466942419|FG001|Part A|Lost to Follow-up|0|||
129722834|NCT03768089|466942420|FG002|Part A|Lost to Follow-up|0|||
129722835|NCT03768089|466942421|FG003|Part A|Lost to Follow-up|0|||
129722836|NCT03768089|466942422|FG004|Part A|Lost to Follow-up|1|||
129722837|NCT03768089|466942423|FG005|Part A|Lost to Follow-up|0|||
129722838|NCT03768089|466942424|FG006|Part A|Lost to Follow-up|0|||
129722839|NCT03768089|466942425|FG007|Part A|Lost to Follow-up|0|||
129722840|NCT03768089|466942426|FG008|Part A|Lost to Follow-up|0|||
129722841|NCT03768089|466942427|FG009|Part A|Lost to Follow-up|0|||
129722842|NCT03768089|466942428|FG010|Part A|Lost to Follow-up|0|||
129722843|NCT03768089|466942429|FG011|Part A|Lost to Follow-up|0|||
129722844|NCT03768089|466942430|FG012|Part A|Lost to Follow-up|0|||
129722845|NCT03768089|466942431|FG013|Part A|Lost to Follow-up|0|||
129722846|NCT03768089|466942432|FG014|Part A|Lost to Follow-up|0|||
129722847|NCT03768089|466942433|FG015|Part A|Lost to Follow-up|0|||
129722848|NCT03768089|466942434|FG016|Part A|Lost to Follow-up|0|||
129722849|NCT03768089|466942435|FG017|Part A|Lost to Follow-up|0|||
129722850|NCT03768089|466942418|FG000|Part C|Randomized, Never Dosed|0|||
129891637|NCT02223182|467561226|FG003|Double-Blind Period|Adverse Event|0|||
129722851|NCT03768089|466942419|FG001|Part C|Randomized, Never Dosed|0|||
129722852|NCT03768089|466942420|FG002|Part C|Randomized, Never Dosed|0|||
129722853|NCT03768089|466942421|FG003|Part C|Randomized, Never Dosed|0|||
129722854|NCT03768089|466942422|FG004|Part C|Randomized, Never Dosed|0|||
129722855|NCT03768089|466942423|FG005|Part C|Randomized, Never Dosed|0|||
129722856|NCT03768089|466942424|FG006|Part C|Randomized, Never Dosed|0|||
129722857|NCT03768089|466942425|FG007|Part C|Randomized, Never Dosed|0|||
129722858|NCT03768089|466942426|FG008|Part C|Randomized, Never Dosed|0|||
129722859|NCT03768089|466942427|FG009|Part C|Randomized, Never Dosed|0|||
129722860|NCT03768089|466942428|FG010|Part C|Randomized, Never Dosed|0|||
129722861|NCT03768089|466942429|FG011|Part C|Randomized, Never Dosed|0|||
129722862|NCT03768089|466942430|FG012|Part C|Randomized, Never Dosed|0|||
129722863|NCT03768089|466942431|FG013|Part C|Randomized, Never Dosed|0|||
129722864|NCT03768089|466942432|FG014|Part C|Randomized, Never Dosed|1|||
129722865|NCT03768089|466942433|FG015|Part C|Randomized, Never Dosed|0|||
129722866|NCT03768089|466942434|FG016|Part C|Randomized, Never Dosed|0|||
129722867|NCT03768089|466942435|FG017|Part C|Randomized, Never Dosed|0|||
129722868|NCT05141175|466942440|FG000|Overall Study|Withdrawal by Subject|1|||
129722869|NCT00177294|466942441|FG000|Overall Study|Withdrawal by Subject|7|||
129722870|NCT00177294|466942442|FG001|Overall Study|Withdrawal by Subject|5|||
129722871|NCT02443116|466942443|FG000|Part 1|Adverse Event|2|||
129722872|NCT02443116|466942444|FG001|Part 1|Adverse Event|3|||
129722873|NCT02443116|466942445|FG002|Part 1|Adverse Event|0|||
129722874|NCT02443116|466942446|FG003|Part 1|Adverse Event|0|||
129722875|NCT02443116|466942447|FG004|Part 1|Adverse Event|0|||
129722876|NCT02443116|466942448|FG005|Part 1|Adverse Event|0|||
129722877|NCT02443116|466942449|FG006|Part 1|Adverse Event|0|||
129722878|NCT02443116|466942450|FG007|Part 1|Adverse Event|0|||
129722879|NCT02443116|466942451|FG008|Part 1|Adverse Event|0|||
129722880|NCT02443116|466942443|FG000|Part 1|Withdrew informed consent|0|||
129722881|NCT02443116|466942444|FG001|Part 1|Withdrew informed consent|1|||
129722882|NCT02443116|466942445|FG002|Part 1|Withdrew informed consent|0|||
129722883|NCT02443116|466942446|FG003|Part 1|Withdrew informed consent|0|||
129722884|NCT02443116|466942447|FG004|Part 1|Withdrew informed consent|0|||
129722885|NCT02443116|466942448|FG005|Part 1|Withdrew informed consent|0|||
129722886|NCT02443116|466942449|FG006|Part 1|Withdrew informed consent|0|||
129722887|NCT02443116|466942450|FG007|Part 1|Withdrew informed consent|0|||
129722888|NCT02443116|466942451|FG008|Part 1|Withdrew informed consent|0|||
129722889|NCT02443116|466942443|FG000|Part 1|Lost to Follow-up|0|||
129722890|NCT02443116|466942444|FG001|Part 1|Lost to Follow-up|0|||
129722891|NCT02443116|466942445|FG002|Part 1|Lost to Follow-up|2|||
129722892|NCT02443116|466942446|FG003|Part 1|Lost to Follow-up|0|||
129722893|NCT02443116|466942447|FG004|Part 1|Lost to Follow-up|0|||
129722894|NCT02443116|466942448|FG005|Part 1|Lost to Follow-up|0|||
129722895|NCT02443116|466942449|FG006|Part 1|Lost to Follow-up|0|||
129722896|NCT02443116|466942450|FG007|Part 1|Lost to Follow-up|0|||
129722897|NCT02443116|466942451|FG008|Part 1|Lost to Follow-up|0|||
129722898|NCT02443116|466942443|FG000|Part 1|Participant moved out of state|0|||
129722899|NCT02443116|466942444|FG001|Part 1|Participant moved out of state|0|||
129722900|NCT02443116|466942445|FG002|Part 1|Participant moved out of state|1|||
129722901|NCT02443116|466942446|FG003|Part 1|Participant moved out of state|0|||
129722902|NCT02443116|466942447|FG004|Part 1|Participant moved out of state|0|||
129722903|NCT02443116|466942448|FG005|Part 1|Participant moved out of state|0|||
129722904|NCT02443116|466942449|FG006|Part 1|Participant moved out of state|0|||
129722905|NCT02443116|466942450|FG007|Part 1|Participant moved out of state|0|||
129722906|NCT02443116|466942451|FG008|Part 1|Participant moved out of state|0|||
129722907|NCT02443116|466942443|FG000|Part 1|Participant enrolled in another clinical trial|0|||
129722908|NCT02443116|466942444|FG001|Part 1|Participant enrolled in another clinical trial|0|||
129722909|NCT02443116|466942445|FG002|Part 1|Participant enrolled in another clinical trial|1|||
129722910|NCT02443116|466942446|FG003|Part 1|Participant enrolled in another clinical trial|0|||
129722911|NCT02443116|466942447|FG004|Part 1|Participant enrolled in another clinical trial|0|||
129722912|NCT02443116|466942448|FG005|Part 1|Participant enrolled in another clinical trial|0|||
129722913|NCT02443116|466942449|FG006|Part 1|Participant enrolled in another clinical trial|0|||
129722914|NCT02443116|466942450|FG007|Part 1|Participant enrolled in another clinical trial|0|||
129722915|NCT02443116|466942451|FG008|Part 1|Participant enrolled in another clinical trial|0|||
129722916|NCT02443116|466942443|FG000|Part 2|Adverse Event|0|||
129722917|NCT02443116|466942444|FG001|Part 2|Adverse Event|0|||
129722918|NCT02443116|466942445|FG002|Part 2|Adverse Event|0|||
129722919|NCT02443116|466942446|FG003|Part 2|Adverse Event|0|||
129722920|NCT02443116|466942447|FG004|Part 2|Adverse Event|1|||
129722921|NCT02443116|466942448|FG005|Part 2|Adverse Event|1|||
129722922|NCT02443116|466942449|FG006|Part 2|Adverse Event|2|||
129722923|NCT02443116|466942450|FG007|Part 2|Adverse Event|0|||
129722924|NCT02443116|466942451|FG008|Part 2|Adverse Event|0|||
129722925|NCT02443116|466942443|FG000|Part 2|Withdrew informed consent|0|||
129722926|NCT02443116|466942444|FG001|Part 2|Withdrew informed consent|0|||
129722927|NCT02443116|466942445|FG002|Part 2|Withdrew informed consent|0|||
129722928|NCT02443116|466942446|FG003|Part 2|Withdrew informed consent|0|||
129722929|NCT02443116|466942447|FG004|Part 2|Withdrew informed consent|0|||
129722930|NCT02443116|466942448|FG005|Part 2|Withdrew informed consent|1|||
129722931|NCT02443116|466942449|FG006|Part 2|Withdrew informed consent|1|||
129722932|NCT02443116|466942450|FG007|Part 2|Withdrew informed consent|0|||
129722933|NCT02443116|466942451|FG008|Part 2|Withdrew informed consent|0|||
129722934|NCT02443116|466942443|FG000|Part 2|Inability to comply with protocol|0|||
129722935|NCT02443116|466942444|FG001|Part 2|Inability to comply with protocol|0|||
129722936|NCT02443116|466942445|FG002|Part 2|Inability to comply with protocol|0|||
129722937|NCT02443116|466942446|FG003|Part 2|Inability to comply with protocol|1|||
129722938|NCT02443116|466942447|FG004|Part 2|Inability to comply with protocol|0|||
129722939|NCT02443116|466942448|FG005|Part 2|Inability to comply with protocol|0|||
129722940|NCT02443116|466942449|FG006|Part 2|Inability to comply with protocol|0|||
129722941|NCT02443116|466942450|FG007|Part 2|Inability to comply with protocol|0|||
129722942|NCT02443116|466942451|FG008|Part 2|Inability to comply with protocol|0|||
129722943|NCT02443116|466942443|FG000|Part 2|Lost to Follow-up|0|||
129722944|NCT02443116|466942444|FG001|Part 2|Lost to Follow-up|0|||
129722945|NCT02443116|466942445|FG002|Part 2|Lost to Follow-up|0|||
129722946|NCT02443116|466942446|FG003|Part 2|Lost to Follow-up|1|||
129722947|NCT02443116|466942447|FG004|Part 2|Lost to Follow-up|0|||
129722948|NCT02443116|466942448|FG005|Part 2|Lost to Follow-up|0|||
129722949|NCT02443116|466942449|FG006|Part 2|Lost to Follow-up|0|||
129803886|NCT01686828|467249850|FG000|Overall Study|Weight Loss|0|||
129803887|NCT01686828|467249851|FG001|Overall Study|Weight Loss|0|||
129803888|NCT01686828|467249852|FG002|Overall Study|Weight Loss|1|||
129803889|NCT01686828|467249853|FG003|Overall Study|Weight Loss|0|||
129803890|NCT04176705|467249856|FG000|Overall Study|Withdrawal by Subject|4|||
129803891|NCT04176705|467249857|FG001|Overall Study|Withdrawal by Subject|4|||
129803892|NCT04176705|467249856|FG000|Overall Study|Death|1|||
129803893|NCT04176705|467249857|FG001|Overall Study|Death|1|||
129803894|NCT04176705|467249856|FG000|Overall Study|Lost to Follow-up|3|||
129803895|NCT04176705|467249857|FG001|Overall Study|Lost to Follow-up|3|||
129803896|NCT01193842|467249859|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803897|NCT01193842|467249860|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
129803898|NCT01193842|467249861|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803899|NCT01193842|467249862|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803900|NCT01193842|467249863|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
129803901|NCT01193842|467249859|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
129803902|NCT01193842|467249860|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803903|NCT01193842|467249861|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803904|NCT01193842|467249862|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803905|NCT01193842|467249863|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
129803906|NCT01193842|467249859|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803907|NCT01193842|467249860|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803908|NCT01193842|467249861|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
129803909|NCT01193842|467249862|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803910|NCT01193842|467249863|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
129803911|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Death|0|||
129803912|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Death|0|||
129803913|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Death|0|||
129803914|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Death|1|||
129803915|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Death|1|||
129803916|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Adverse Event|0|||
129803917|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Adverse Event|0|||
129803918|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Adverse Event|0|||
129803919|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Adverse Event|5|||
129803920|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Adverse Event|3|||
129803921|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
129803922|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
129803923|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
129803924|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
129803925|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
129803926|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Ineligible|0|||
129803927|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Ineligible|0|||
129803928|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Ineligible|0|||
129803929|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Ineligible|0|||
129803930|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Ineligible|1|||
129803931|NCT01193842|467249859|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
129803932|NCT01193842|467249860|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
129722950|NCT02443116|466942450|FG007|Part 2|Lost to Follow-up|0|||
129722951|NCT02443116|466942451|FG008|Part 2|Lost to Follow-up|0|||
129803933|NCT01193842|467249861|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
129803934|NCT01193842|467249862|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
129803935|NCT01193842|467249863|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
129891638|NCT02223182|467561223|FG000|Double-Blind Period|Withdrawal by Subject|1|||
129722952|NCT02443116|466942443|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722953|NCT02443116|466942444|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129803936|NCT03698331|467249864|FG000|Overall Study|Adverse Event|2|||
129803937|NCT03698331|467249865|FG001|Overall Study|Adverse Event|3|||
129803938|NCT03698331|467249864|FG000|Overall Study|Withdrawal by Subject|1|||
129803939|NCT03698331|467249865|FG001|Overall Study|Withdrawal by Subject|1|||
129803940|NCT03698331|467249864|FG000|Overall Study|Lost to Follow-up|0|||
129803941|NCT03698331|467249865|FG001|Overall Study|Lost to Follow-up|2|||
129803942|NCT03698331|467249864|FG000|Overall Study|Non-compliance with study drug|1|||
129803943|NCT03698331|467249865|FG001|Overall Study|Non-compliance with study drug|0|||
129803944|NCT01467583|467249866|FG000|Overall Study|Death|1|||
129803945|NCT01467583|467249867|FG001|Overall Study|Death|1|||
129803946|NCT01467583|467249868|FG002|Overall Study|Death|0|||
129803947|NCT01467583|467249866|FG000|Overall Study|Withdrawal by Subject|1|||
129803948|NCT01467583|467249867|FG001|Overall Study|Withdrawal by Subject|0|||
129803949|NCT01467583|467249868|FG002|Overall Study|Withdrawal by Subject|0|||
129803950|NCT01467583|467249866|FG000|Overall Study|Protocol Violation|0|||
129803951|NCT01467583|467249867|FG001|Overall Study|Protocol Violation|0|||
129803952|NCT01467583|467249868|FG002|Overall Study|Protocol Violation|2|||
129803953|NCT02130024|467249869|FG000|Overall Study|Adverse Event|10|||
129722954|NCT02443116|466942445|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722955|NCT02443116|466942446|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722956|NCT02443116|466942447|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722957|NCT02443116|466942448|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
129722958|NCT02443116|466942449|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722959|NCT02443116|466942450|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722960|NCT02443116|466942451|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
129722961|NCT02443116|466942443|FG000|Part 3|Adverse Event|0|||
129722962|NCT02443116|466942444|FG001|Part 3|Adverse Event|0|||
129722963|NCT02443116|466942445|FG002|Part 3|Adverse Event|0|||
129722964|NCT02443116|466942446|FG003|Part 3|Adverse Event|0|||
129722965|NCT02443116|466942447|FG004|Part 3|Adverse Event|0|||
129722966|NCT02443116|466942448|FG005|Part 3|Adverse Event|0|||
129722967|NCT02443116|466942449|FG006|Part 3|Adverse Event|0|||
129722968|NCT02443116|466942450|FG007|Part 3|Adverse Event|0|||
129722969|NCT02443116|466942451|FG008|Part 3|Adverse Event|1|||
129722970|NCT02443116|466942443|FG000|Part 3|Withdrew informed consent|0|||
129722971|NCT02443116|466942444|FG001|Part 3|Withdrew informed consent|0|||
129722972|NCT02443116|466942445|FG002|Part 3|Withdrew informed consent|0|||
129722973|NCT02443116|466942446|FG003|Part 3|Withdrew informed consent|0|||
129722974|NCT02443116|466942447|FG004|Part 3|Withdrew informed consent|0|||
129722975|NCT02443116|466942448|FG005|Part 3|Withdrew informed consent|0|||
129722976|NCT02443116|466942449|FG006|Part 3|Withdrew informed consent|0|||
129722977|NCT02443116|466942450|FG007|Part 3|Withdrew informed consent|3|||
129722978|NCT02443116|466942451|FG008|Part 3|Withdrew informed consent|2|||
129722979|NCT02443116|466942443|FG000|Part 3|Lost to Follow-up|0|||
129722980|NCT02443116|466942444|FG001|Part 3|Lost to Follow-up|0|||
129722981|NCT02443116|466942445|FG002|Part 3|Lost to Follow-up|0|||
129722982|NCT02443116|466942446|FG003|Part 3|Lost to Follow-up|0|||
129722983|NCT02443116|466942447|FG004|Part 3|Lost to Follow-up|0|||
129722984|NCT02443116|466942448|FG005|Part 3|Lost to Follow-up|0|||
129722985|NCT02443116|466942449|FG006|Part 3|Lost to Follow-up|0|||
129722986|NCT02443116|466942450|FG007|Part 3|Lost to Follow-up|1|||
129722987|NCT02443116|466942451|FG008|Part 3|Lost to Follow-up|2|||
129722988|NCT03100539|466944131|FG000|Overall Study|Lost to Follow-up|60|||
129722989|NCT03100539|466944132|FG001|Overall Study|Lost to Follow-up|54|||
129722990|NCT03100539|466944133|FG002|Overall Study|Lost to Follow-up|17|||
129722991|NCT03100539|466944131|FG000|Overall Study|Uncollected|8|||
129722992|NCT03100539|466944132|FG001|Overall Study|Uncollected|8|||
129722993|NCT03100539|466944133|FG002|Overall Study|Uncollected|0|||
129722994|NCT03100539|466944131|FG000|Overall Study|Ally Health|0|||
129722995|NCT03100539|466944132|FG001|Overall Study|Ally Health|0|||
129722996|NCT03100539|466944133|FG002|Overall Study|Ally Health|3|||
129722997|NCT03100539|466944131|FG000|Overall Study|Disinterest|0|||
129722998|NCT03100539|466944132|FG001|Overall Study|Disinterest|0|||
129722999|NCT03100539|466944133|FG002|Overall Study|Disinterest|22|||
129723000|NCT03100539|466944131|FG000|Overall Study|Veteran Health|0|||
129723001|NCT03100539|466944132|FG001|Overall Study|Veteran Health|0|||
129723002|NCT03100539|466944133|FG002|Overall Study|Veteran Health|8|||
129723003|NCT03100539|466944131|FG000|Overall Study|Moved|0|||
129803954|NCT02130024|467249870|FG001|Overall Study|Adverse Event|11|||
129803955|NCT02130024|467249869|FG000|Overall Study|Death|2|||
129803956|NCT02130024|467249870|FG001|Overall Study|Death|2|||
129723004|NCT03100539|466944132|FG001|Overall Study|Moved|0|||
129723005|NCT03100539|466944133|FG002|Overall Study|Moved|1|||
129723006|NCT03100539|466944131|FG000|Overall Study|Scheduling Conflicts|0|||
129723007|NCT03100539|466944132|FG001|Overall Study|Scheduling Conflicts|0|||
129723008|NCT03100539|466944133|FG002|Overall Study|Scheduling Conflicts|12|||
129723009|NCT00809835|466944136|FG000|Overall Study|Lost to Follow-up|7|||
129723010|NCT00809835|466944137|FG001|Overall Study|Lost to Follow-up|6|||
129723011|NCT00809835|466944138|FG002|Overall Study|Lost to Follow-up|10|||
129723012|NCT00809835|466944139|FG003|Overall Study|Lost to Follow-up|2|||
129723013|NCT00809835|466944136|FG000|Overall Study|Withdrawal by Subject|1|||
129803957|NCT02130024|467249869|FG000|Overall Study|Lost to Follow-up|1|||
129723014|NCT00809835|466944137|FG001|Overall Study|Withdrawal by Subject|1|||
129803958|NCT02130024|467249870|FG001|Overall Study|Lost to Follow-up|1|||
129803959|NCT02130024|467249869|FG000|Overall Study|Physician Decision|1|||
129723015|NCT00809835|466944138|FG002|Overall Study|Withdrawal by Subject|1|||
129723016|NCT00809835|466944139|FG003|Overall Study|Withdrawal by Subject|0|||
129723017|NCT05659719|466944140|FG000|Overall Study|At sponsor's request|0|||
129723018|NCT05659719|466944141|FG001|Overall Study|At sponsor's request|0|||
129723019|NCT05659719|466944142|FG002|Overall Study|At sponsor's request|0|||
129723020|NCT05659719|466944143|FG003|Overall Study|At sponsor's request|95|||
129723021|NCT05659719|466944140|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
129723022|NCT05659719|466944141|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
129723023|NCT05659719|466944142|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
129723024|NCT05659719|466944143|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
129723025|NCT05659719|466944140|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
129723026|NCT05659719|466944141|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
129723027|NCT05659719|466944142|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
129723028|NCT05659719|466944143|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
129723029|NCT05659719|466944140|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
129723030|NCT05659719|466944141|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
129723031|NCT05659719|466944142|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
129723032|NCT05659719|466944143|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
129723033|NCT05659719|466944140|FG000|Overall Study|Lost to Follow-up|0|||
129723034|NCT05659719|466944141|FG001|Overall Study|Lost to Follow-up|0|||
129723035|NCT05659719|466944142|FG002|Overall Study|Lost to Follow-up|0|||
129723036|NCT05659719|466944143|FG003|Overall Study|Lost to Follow-up|2|||
129723037|NCT05659719|466944140|FG000|Overall Study|Moved to another observational study|0|||
129723038|NCT05659719|466944141|FG001|Overall Study|Moved to another observational study|0|||
129723039|NCT05659719|466944142|FG002|Overall Study|Moved to another observational study|0|||
129723040|NCT05659719|466944143|FG003|Overall Study|Moved to another observational study|1|||
129723041|NCT05659719|466944140|FG000|Overall Study|The child was enrolled in an interventional study|0|||
129723042|NCT05659719|466944141|FG001|Overall Study|The child was enrolled in an interventional study|0|||
129723043|NCT05659719|466944142|FG002|Overall Study|The child was enrolled in an interventional study|0|||
129723044|NCT05659719|466944143|FG003|Overall Study|The child was enrolled in an interventional study|55|||
129723045|NCT05659719|466944140|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
129723046|NCT05659719|466944141|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
129723047|NCT05659719|466944142|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
129723048|NCT05659719|466944143|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
129723049|NCT05659719|466944140|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
129723050|NCT05659719|466944141|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
129723051|NCT05659719|466944142|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
129723052|NCT05659719|466944143|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
129723053|NCT01681186|466944144|FG000|Washout Period From Second Intervention|Adverse Event|0|||
129723054|NCT01681186|466944145|FG001|Washout Period From Second Intervention|Adverse Event|0|||
129723055|NCT01681186|466944146|FG002|Washout Period From Second Intervention|Adverse Event|0|||
129723056|NCT01681186|466944147|FG003|Washout Period From Second Intervention|Adverse Event|0|||
129723057|NCT01681186|466944148|FG004|Washout Period From Second Intervention|Adverse Event|0|||
129723058|NCT01681186|466944149|FG005|Washout Period From Second Intervention|Adverse Event|0|||
129723059|NCT01681186|466944150|FG006|Washout Period From Second Intervention|Adverse Event|1|||
129723060|NCT01681186|466944151|FG007|Washout Period From Second Intervention|Adverse Event|0|||
129723061|NCT01681186|466944144|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
129723062|NCT01681186|466944145|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
129723063|NCT01681186|466944146|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
129723064|NCT01681186|466944147|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
129723065|NCT01681186|466944148|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
129723066|NCT01681186|466944149|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
129723067|NCT01681186|466944150|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
129723068|NCT01681186|466944151|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
129723069|NCT01681186|466944144|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723070|NCT01681186|466944145|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723071|NCT01681186|466944146|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723072|NCT01681186|466944147|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723073|NCT01681186|466944148|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723074|NCT01681186|466944149|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723075|NCT01681186|466944150|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
129723076|NCT01681186|466944151|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
129723077|NCT01681186|466944144|FG000|Fourth Intervention|Protocol Violation|0|||
129723078|NCT01681186|466944145|FG001|Fourth Intervention|Protocol Violation|0|||
129723079|NCT01681186|466944146|FG002|Fourth Intervention|Protocol Violation|0|||
129723080|NCT01681186|466944147|FG003|Fourth Intervention|Protocol Violation|0|||
129723081|NCT01681186|466944148|FG004|Fourth Intervention|Protocol Violation|0|||
129723082|NCT01681186|466944149|FG005|Fourth Intervention|Protocol Violation|0|||
129723083|NCT01681186|466944150|FG006|Fourth Intervention|Protocol Violation|0|||
129723084|NCT01681186|466944151|FG007|Fourth Intervention|Protocol Violation|1|||
129723085|NCT05160415|466944152|FG000|Overall Study|Withdrawal by Subject|3|||
129723086|NCT02582814|466944153|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129723087|NCT02582814|466944154|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129723088|NCT02582814|466944153|FG000|Overall Study|Withdrawal by Subject|4|||
129723089|NCT02582814|466944154|FG001|Overall Study|Withdrawal by Subject|3|||
129723090|NCT02582814|466944153|FG000|Overall Study|Adverse Event|4|||
129723091|NCT02582814|466944154|FG001|Overall Study|Adverse Event|4|||
129723092|NCT03530995|466944155|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
129723093|NCT03530995|466944156|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
129723094|NCT03530995|466944155|FG000|Part 1 Period 3|Protocol Violation|1|||
129723095|NCT03530995|466944156|FG001|Part 1 Period 3|Protocol Violation|0|||
129723096|NCT03530995|466944155|FG000|Part 1 Period 4|Physician Decision|1|||
129723097|NCT03530995|466944156|FG001|Part 1 Period 4|Physician Decision|0|||
129723098|NCT03530995|466944155|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
129723099|NCT03530995|466944156|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
129723100|NCT01986231|466944160|FG000|Overall Study|Adverse Event|1|||
129723101|NCT00623233|466944161|FG000|Overall Study|Adverse Event|10|||
129723102|NCT00623233|466944161|FG000|Overall Study|Physician Decision|10|||
129723103|NCT00623233|466944161|FG000|Overall Study|Lost to Follow-up|1|||
129723104|NCT00623233|466944161|FG000|Overall Study|Withdrawal by Subject|3|||
129723105|NCT01751906|466944162|FG000|Overall Study|Lost to Follow-up|151|||
129723106|NCT01751906|466944163|FG001|Overall Study|Lost to Follow-up|68|||
129723107|NCT01751906|466944162|FG000|Overall Study|Withdrawal by Subject|22|||
129723108|NCT01751906|466944163|FG001|Overall Study|Withdrawal by Subject|18|||
129723109|NCT01751906|466944162|FG000|Overall Study|Physician Decision|5|||
129723110|NCT01751906|466944163|FG001|Overall Study|Physician Decision|2|||
129723111|NCT01751906|466944162|FG000|Overall Study|Death|84|||
129723112|NCT01751906|466944163|FG001|Overall Study|Death|43|||
129723113|NCT01751906|466944162|FG000|Overall Study|Denied on premises for follow-up by law|1|||
129723114|NCT01751906|466944163|FG001|Overall Study|Denied on premises for follow-up by law|0|||
129723115|NCT01110330|466944164|FG000|Overall Study|Adverse Event|0|||
129723116|NCT01110330|466944165|FG001|Overall Study|Adverse Event|4|||
129803960|NCT02130024|467249870|FG001|Overall Study|Physician Decision|3|||
129803961|NCT02130024|467249869|FG000|Overall Study|Protocol Deviation|4|||
129723117|NCT01110330|466944166|FG002|Overall Study|Adverse Event|3|||
129723118|NCT01110330|466944164|FG000|Overall Study|Lack of Efficacy|3|||
129723119|NCT01110330|466944165|FG001|Overall Study|Lack of Efficacy|1|||
129723120|NCT01110330|466944166|FG002|Overall Study|Lack of Efficacy|1|||
129723121|NCT01110330|466944164|FG000|Overall Study|Lost to Follow-up|9|||
129723122|NCT01110330|466944165|FG001|Overall Study|Lost to Follow-up|10|||
129723123|NCT01110330|466944166|FG002|Overall Study|Lost to Follow-up|15|||
129723124|NCT01110330|466944164|FG000|Overall Study|Physician Decision|0|||
129723125|NCT01110330|466944165|FG001|Overall Study|Physician Decision|1|||
129723126|NCT01110330|466944166|FG002|Overall Study|Physician Decision|0|||
129723127|NCT01110330|466944164|FG000|Overall Study|Protocol Violation|2|||
129723128|NCT01110330|466944165|FG001|Overall Study|Protocol Violation|0|||
129723129|NCT01110330|466944166|FG002|Overall Study|Protocol Violation|4|||
129723130|NCT01110330|466944164|FG000|Overall Study|Withdrawal by Subject|0|||
129723131|NCT01110330|466944165|FG001|Overall Study|Withdrawal by Subject|6|||
129723132|NCT01110330|466944166|FG002|Overall Study|Withdrawal by Subject|2|||
129723133|NCT01110330|466944164|FG000|Overall Study|Other|1|||
129723134|NCT01110330|466944165|FG001|Overall Study|Other|1|||
129723135|NCT01110330|466944166|FG002|Overall Study|Other|1|||
129723136|NCT02557100|466944167|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
129723137|NCT02557100|466944168|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
129723138|NCT02557100|466944169|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
129723139|NCT02557100|466944167|FG000|Single Blind Treatment Period|Death|0|||
129723140|NCT02557100|466944168|FG001|Single Blind Treatment Period|Death|1|||
129723141|NCT02557100|466944169|FG002|Single Blind Treatment Period|Death|0|||
129723142|NCT02557100|466944167|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
129723143|NCT02557100|466944168|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
129723144|NCT02557100|466944169|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
129723145|NCT02557100|466944167|FG000|Single Blind Treatment Period|Adverse Event|0|||
129723146|NCT02557100|466944168|FG001|Single Blind Treatment Period|Adverse Event|1|||
129723147|NCT02557100|466944169|FG002|Single Blind Treatment Period|Adverse Event|0|||
129723148|NCT02557100|466944167|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
129723149|NCT02557100|466944168|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
129723150|NCT02557100|466944169|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
129723151|NCT02557100|466944167|FG000|Cumulative Abatacept Period|Other Reasons|0|||
129723152|NCT02557100|466944168|FG001|Cumulative Abatacept Period|Other Reasons|0|||
129723153|NCT02557100|466944169|FG002|Cumulative Abatacept Period|Other Reasons|1|||
129723154|NCT02557100|466944167|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
129723155|NCT02557100|466944168|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
129723156|NCT02557100|466944169|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
129723157|NCT02557100|466944167|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
129723158|NCT02557100|466944168|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
129723159|NCT02557100|466944169|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
129723160|NCT04644276|466944171|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
129723161|NCT04644276|466944172|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
129723162|NCT04644276|466944173|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
129723163|NCT01667224|466944177|FG000|Overall Study|Withdrawal by Subject|3|||
129723164|NCT01667224|466944178|FG001|Overall Study|Withdrawal by Subject|1|||
129723165|NCT01667224|466944177|FG000|Overall Study|Protocol Violation|1|||
129723166|NCT01667224|466944178|FG001|Overall Study|Protocol Violation|1|||
129723167|NCT02314156|466944184|FG000|Overall Study|Adverse Event|1|||
129723168|NCT02314156|466944185|FG001|Overall Study|Adverse Event|0|||
129723169|NCT02314156|466944184|FG000|Overall Study|Withdrawal by Subject|1|||
129723170|NCT02314156|466944185|FG001|Overall Study|Withdrawal by Subject|0|||
129723171|NCT02752633|466944186|FG000|Overall Study|Withdrawal by Subject|1|||
129723172|NCT02846389|466944187|FG000|Overall Study|Withdrawal by Subject|1|||
129723173|NCT02846389|466944188|FG001|Overall Study|Withdrawal by Subject|1|||
129723174|NCT00433966|466944191|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
129723175|NCT00433966|466944192|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
129723176|NCT00433966|466944193|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
129723177|NCT00433966|466944194|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
129723178|NCT00433966|466944191|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
129723179|NCT00433966|466944192|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
129723180|NCT00433966|466944193|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
129723181|NCT00433966|466944194|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
129723182|NCT00433966|466944191|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
129723183|NCT00433966|466944192|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
129723184|NCT00433966|466944193|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
129723185|NCT00433966|466944194|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
129723186|NCT00433966|466944191|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
129723187|NCT00433966|466944192|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
129723188|NCT00433966|466944193|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
129723189|NCT00433966|466944194|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
129723190|NCT00433966|466944191|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
129723191|NCT00433966|466944192|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
129723192|NCT00433966|466944193|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
129723193|NCT00433966|466944194|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
129723194|NCT00853242|466944196|FG000|Overall Study|Adverse Event|0|||
129723195|NCT00853242|466944197|FG001|Overall Study|Adverse Event|1|||
129723196|NCT00853242|466944198|FG002|Overall Study|Adverse Event|1|||
129723197|NCT00853242|466944199|FG003|Overall Study|Adverse Event|0|||
129723198|NCT00853242|466944200|FG004|Overall Study|Adverse Event|3|||
129723199|NCT00853242|466944201|FG005|Overall Study|Adverse Event|1|||
129723200|NCT00853242|466944202|FG006|Overall Study|Adverse Event|1|||
129723201|NCT00853242|466944196|FG000|Overall Study|Noncompliant|0|||
129723202|NCT00853242|466944197|FG001|Overall Study|Noncompliant|0|||
129723203|NCT00853242|466944198|FG002|Overall Study|Noncompliant|0|||
129723204|NCT00853242|466944199|FG003|Overall Study|Noncompliant|0|||
129723205|NCT00853242|466944200|FG004|Overall Study|Noncompliant|1|||
129723206|NCT00853242|466944201|FG005|Overall Study|Noncompliant|0|||
129723207|NCT00853242|466944202|FG006|Overall Study|Noncompliant|0|||
129723208|NCT00853242|466944196|FG000|Overall Study|Withdrawal by Subject|1|||
129723209|NCT00853242|466944197|FG001|Overall Study|Withdrawal by Subject|2|||
129723210|NCT00853242|466944198|FG002|Overall Study|Withdrawal by Subject|0|||
129723211|NCT00853242|466944199|FG003|Overall Study|Withdrawal by Subject|4|||
129723212|NCT00853242|466944200|FG004|Overall Study|Withdrawal by Subject|0|||
129723213|NCT00853242|466944201|FG005|Overall Study|Withdrawal by Subject|0|||
129723214|NCT00853242|466944202|FG006|Overall Study|Withdrawal by Subject|2|||
129723215|NCT00853242|466944196|FG000|Overall Study|Other|2|||
129723216|NCT00853242|466944197|FG001|Overall Study|Other|0|||
129723217|NCT00853242|466944198|FG002|Overall Study|Other|2|||
129723218|NCT00853242|466944199|FG003|Overall Study|Other|0|||
129723219|NCT00853242|466944200|FG004|Overall Study|Other|0|||
129723220|NCT00853242|466944201|FG005|Overall Study|Other|1|||
129723221|NCT00853242|466944202|FG006|Overall Study|Other|2|||
129723222|NCT03497975|466944203|FG000|Overall Study|Withdrew Consent|34|||
129723223|NCT03497975|466944204|FG001|Overall Study|Withdrew Consent|35|||
129723224|NCT03497975|466944203|FG000|Overall Study|Lost to Follow-up|7|||
129723225|NCT03497975|466944204|FG001|Overall Study|Lost to Follow-up|7|||
129723226|NCT03497975|466944203|FG000|Overall Study|Physician Decision|4|||
129723227|NCT03497975|466944204|FG001|Overall Study|Physician Decision|5|||
129723228|NCT03497975|466944203|FG000|Overall Study|Discontinued|42|||
129723229|NCT03497975|466944204|FG001|Overall Study|Discontinued|39|||
129723230|NCT03497975|466944203|FG000|Overall Study|Reason Not Specified|15|||
129723231|NCT03497975|466944204|FG001|Overall Study|Reason Not Specified|14|||
129723232|NCT04026009|466944205|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129723233|NCT04026009|466944206|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129723234|NCT04026009|466944207|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129723235|NCT04026009|466944208|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129444393|NCT00578786|465927336|FG002|Overall Study|Physician Decision|1|||
129723236|NCT04026009|466944209|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129723237|NCT04026009|466944205|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
129723238|NCT04026009|466944206|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
129723239|NCT04026009|466944207|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
129444394|NCT00578786|465927334|FG000|Overall Study|Sponsor Decision|0|||
129723240|NCT04026009|466944208|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
129723241|NCT04026009|466944209|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
129723242|NCT01500252|466944213|FG000|Overall Study|Death|4|||
129723243|NCT01500252|466944214|FG001|Overall Study|Death|2|||
129723244|NCT01500252|466944213|FG000|Overall Study|Lost to Follow-up|5|||
129723245|NCT01500252|466944214|FG001|Overall Study|Lost to Follow-up|4|||
129723246|NCT05319600|466944216|FG000|Overall Study|Withdrawal by Subject|1|||
129723247|NCT05319600|466944217|FG001|Overall Study|Withdrawal by Subject|0|||
129723248|NCT05319600|466944216|FG000|Overall Study|Lost to Follow-up|0|||
129723249|NCT05319600|466944217|FG001|Overall Study|Lost to Follow-up|4|||
129723250|NCT02120300|466944221|FG000|Overall Study|Enrolled but Never Treated|2|||
129723251|NCT02120300|466944222|FG001|Overall Study|Enrolled but Never Treated|0|||
129723252|NCT02120300|466944223|FG002|Overall Study|Enrolled but Never Treated|0|||
129723253|NCT02120300|466944224|FG003|Overall Study|Enrolled but Never Treated|0|||
129723254|NCT02120300|466944221|FG000|Overall Study|Lack of Efficacy|0|||
129723255|NCT02120300|466944222|FG001|Overall Study|Lack of Efficacy|0|||
129723256|NCT02120300|466944223|FG002|Overall Study|Lack of Efficacy|0|||
129723257|NCT02120300|466944224|FG003|Overall Study|Lack of Efficacy|1|||
129723258|NCT02120300|466944221|FG000|Overall Study|Lost to Follow-up|1|||
129723259|NCT02120300|466944222|FG001|Overall Study|Lost to Follow-up|0|||
129723260|NCT02120300|466944223|FG002|Overall Study|Lost to Follow-up|0|||
129723261|NCT02120300|466944224|FG003|Overall Study|Lost to Follow-up|0|||
129723262|NCT02059499|466944233|FG000|Upto Week 20|Lost to Follow-up|2|||
129723263|NCT02059499|466944234|FG001|Upto Week 20|Lost to Follow-up|6|||
129723264|NCT02059499|466944235|FG002|Upto Week 20|Lost to Follow-up|0|||
129723265|NCT02059499|466944233|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
129723266|NCT02059499|466944234|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
129723267|NCT02059499|466944235|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
129723268|NCT02059499|466944233|FG000|Upto Week 20|Withdrawal by Subject|1|||
129723269|NCT02059499|466944234|FG001|Upto Week 20|Withdrawal by Subject|1|||
129723270|NCT02059499|466944235|FG002|Upto Week 20|Withdrawal by Subject|0|||
129723271|NCT02059499|466944233|FG000|Upto Week 20|No treatment per protocol criteria|0|||
129723272|NCT02059499|466944234|FG001|Upto Week 20|No treatment per protocol criteria|0|||
129723273|NCT02059499|466944235|FG002|Upto Week 20|No treatment per protocol criteria|5|||
129723274|NCT02059499|466944233|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
129723275|NCT02059499|466944234|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
129723276|NCT02059499|466944235|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
129723277|NCT02059499|466944233|FG000|Post-week 20|Lost to Follow-up|0|||
129723278|NCT02059499|466944234|FG001|Post-week 20|Lost to Follow-up|2|||
129723279|NCT02059499|466944235|FG002|Post-week 20|Lost to Follow-up|0|||
129723280|NCT02059499|466944233|FG000|Post-week 20|Withdrawal by Subject|0|||
129723281|NCT02059499|466944234|FG001|Post-week 20|Withdrawal by Subject|1|||
129723282|NCT02059499|466944235|FG002|Post-week 20|Withdrawal by Subject|0|||
129723283|NCT02059499|466944233|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
129723284|NCT02059499|466944234|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
129723285|NCT02059499|466944235|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
129803962|NCT02130024|467249870|FG001|Overall Study|Protocol Deviation|0|||
129803963|NCT02130024|467249869|FG000|Overall Study|Site Administration Problems|1|||
129803964|NCT02130024|467249870|FG001|Overall Study|Site Administration Problems|0|||
129803965|NCT02130024|467249869|FG000|Overall Study|Subject Withdrew Consent|6|||
129803966|NCT02130024|467249870|FG001|Overall Study|Subject Withdrew Consent|14|||
129803967|NCT05274165|467249871|FG000|Overall Study|Withdrawal by Subject|3|||
129803968|NCT05274165|467249872|FG001|Overall Study|Withdrawal by Subject|3|||
129803969|NCT02484690|467249873|FG000|Overall Study|Adverse Event|1|||
129803970|NCT02484690|467249874|FG001|Overall Study|Adverse Event|3|||
129803971|NCT02484690|467249875|FG002|Overall Study|Adverse Event|0|||
129803972|NCT02484690|467249876|FG003|Overall Study|Adverse Event|0|||
129803973|NCT02484690|467249877|FG004|Overall Study|Adverse Event|5|||
129803974|NCT02484690|467249873|FG000|Overall Study|Death|0|||
129803975|NCT02484690|467249874|FG001|Overall Study|Death|0|||
129803976|NCT02484690|467249875|FG002|Overall Study|Death|0|||
129803977|NCT02484690|467249876|FG003|Overall Study|Death|0|||
129803978|NCT02484690|467249877|FG004|Overall Study|Death|1|||
129803979|NCT02484690|467249873|FG000|Overall Study|Withdrawal by Subject|1|||
129803980|NCT02484690|467249874|FG001|Overall Study|Withdrawal by Subject|3|||
129803981|NCT02484690|467249875|FG002|Overall Study|Withdrawal by Subject|1|||
129723286|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
129723287|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129723288|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129723289|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129723290|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129803982|NCT02484690|467249876|FG003|Overall Study|Withdrawal by Subject|2|||
129803983|NCT02484690|467249877|FG004|Overall Study|Withdrawal by Subject|0|||
129803984|NCT02484690|467249873|FG000|Overall Study|Physician Decision|2|||
129444395|NCT00578786|465927335|FG001|Overall Study|Sponsor Decision|0|||
129723291|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
129723292|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
129723293|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
129723294|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129723295|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129723296|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129723297|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
129723298|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
129723299|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
129723300|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129723301|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129723302|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129723303|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
129723304|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
129723305|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
129723306|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129723307|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129723308|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129723309|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
129723310|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
129723311|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
129723312|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129723313|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129723314|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129723315|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
129723316|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
129723317|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129723318|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129723319|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129723320|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129723321|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
129723322|NCT03989349|466944236|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
129723323|NCT03989349|466944237|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
129723324|NCT03989349|466944238|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129723325|NCT03989349|466944239|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129723326|NCT03989349|466944240|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129723327|NCT03989349|466944241|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
129723328|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129723329|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129723330|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
129723331|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
129723332|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
129723333|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
129723334|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129723335|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129723336|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
129723337|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
129723338|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
129723339|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
129803985|NCT02484690|467249874|FG001|Overall Study|Physician Decision|0|||
129803986|NCT02484690|467249875|FG002|Overall Study|Physician Decision|1|||
129723340|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129723341|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129723342|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
129723343|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
129723344|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
129723345|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
129723346|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129723347|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129723348|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129723349|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129723350|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
129723351|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129723352|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129723353|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129723354|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129723355|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129723356|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129723357|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129723358|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
129723359|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
129723360|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
129723361|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
129723362|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
129723363|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
129723364|NCT03989349|466944236|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
129723365|NCT03989349|466944237|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
129723366|NCT03989349|466944238|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
129723367|NCT03989349|466944239|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
129723368|NCT03989349|466944240|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
129723369|NCT03989349|466944241|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
129723370|NCT01352221|466944242|FG000|Double-blind Phase|Adverse Event|6|||
129723371|NCT01352221|466944243|FG001|Double-blind Phase|Adverse Event|4|||
129723372|NCT01352221|466944244|FG002|Double-blind Phase|Adverse Event|0|||
129723373|NCT01352221|466944245|FG003|Double-blind Phase|Adverse Event|0|||
129723374|NCT01352221|466944242|FG000|Double-blind Phase|Withdrawal by Subject|3|||
129723375|NCT01352221|466944243|FG001|Double-blind Phase|Withdrawal by Subject|5|||
129723376|NCT01352221|466944244|FG002|Double-blind Phase|Withdrawal by Subject|0|||
129723377|NCT01352221|466944245|FG003|Double-blind Phase|Withdrawal by Subject|0|||
129723378|NCT01352221|466944242|FG000|Double-blind Phase|Lost to Follow-up|0|||
129723379|NCT01352221|466944243|FG001|Double-blind Phase|Lost to Follow-up|1|||
129723380|NCT01352221|466944244|FG002|Double-blind Phase|Lost to Follow-up|0|||
129723381|NCT01352221|466944245|FG003|Double-blind Phase|Lost to Follow-up|0|||
129723382|NCT01352221|466944242|FG000|Double-blind Phase|Protocol Violation|0|||
129723383|NCT01352221|466944243|FG001|Double-blind Phase|Protocol Violation|1|||
129723384|NCT01352221|466944244|FG002|Double-blind Phase|Protocol Violation|0|||
129723385|NCT01352221|466944245|FG003|Double-blind Phase|Protocol Violation|0|||
129723386|NCT01352221|466944242|FG000|Open-label Phase|Physician Decision|0|||
129723387|NCT01352221|466944243|FG001|Open-label Phase|Physician Decision|0|||
129723388|NCT01352221|466944244|FG002|Open-label Phase|Physician Decision|2|||
129723389|NCT01352221|466944245|FG003|Open-label Phase|Physician Decision|1|||
129723390|NCT01352221|466944242|FG000|Open-label Phase|Pregnancy|0|||
129723391|NCT01352221|466944243|FG001|Open-label Phase|Pregnancy|0|||
129723392|NCT01352221|466944244|FG002|Open-label Phase|Pregnancy|1|||
129723393|NCT01352221|466944245|FG003|Open-label Phase|Pregnancy|0|||
129723394|NCT01352221|466944242|FG000|Open-label Phase|Adverse Event|0|||
129723395|NCT01352221|466944243|FG001|Open-label Phase|Adverse Event|0|||
129723396|NCT01352221|466944244|FG002|Open-label Phase|Adverse Event|8|||
129723397|NCT01352221|466944245|FG003|Open-label Phase|Adverse Event|4|||
129803987|NCT02484690|467249876|FG003|Overall Study|Physician Decision|0|||
129723398|NCT01352221|466944242|FG000|Open-label Phase|Withdrawal by Subject|0|||
129723399|NCT01352221|466944243|FG001|Open-label Phase|Withdrawal by Subject|0|||
129723400|NCT01352221|466944244|FG002|Open-label Phase|Withdrawal by Subject|1|||
129723401|NCT01352221|466944245|FG003|Open-label Phase|Withdrawal by Subject|6|||
129723402|NCT01352221|466944242|FG000|Open-label Phase|Worsening of IBD|0|||
129723403|NCT01352221|466944243|FG001|Open-label Phase|Worsening of IBD|0|||
129723404|NCT01352221|466944244|FG002|Open-label Phase|Worsening of IBD|1|||
129723405|NCT01352221|466944245|FG003|Open-label Phase|Worsening of IBD|0|||
129723406|NCT02016716|466944246|FG000|Overall Study|Withdrawal by Subject|5|||
129723407|NCT02016716|466944247|FG001|Overall Study|Withdrawal by Subject|5|||
129723408|NCT02016716|466944248|FG002|Overall Study|Withdrawal by Subject|5|||
129723409|NCT02016716|466944246|FG000|Overall Study|Protocol-specified Criteria|0|||
129723410|NCT02016716|466944247|FG001|Overall Study|Protocol-specified Criteria|1|||
129723411|NCT02016716|466944248|FG002|Overall Study|Protocol-specified Criteria|0|||
129723412|NCT02016716|466944246|FG000|Overall Study|Lost to Follow-up|1|||
129723413|NCT02016716|466944247|FG001|Overall Study|Lost to Follow-up|2|||
129723414|NCT02016716|466944248|FG002|Overall Study|Lost to Follow-up|1|||
129723415|NCT02248649|466944249|FG000|Overall Study|Death|7|||
129723416|NCT02248649|466944250|FG001|Overall Study|Death|11|||
129723417|NCT02248649|466944249|FG000|Overall Study|Lost to Follow-up|14|||
129723418|NCT02248649|466944250|FG001|Overall Study|Lost to Follow-up|10|||
129723419|NCT01439971|466944251|FG000|Overall Study|Required number in cohort dosed|0|||
129723420|NCT01439971|466944252|FG001|Overall Study|Required number in cohort dosed|1|||
129723421|NCT01439971|466944253|FG002|Overall Study|Required number in cohort dosed|2|||
129723422|NCT01439971|466944254|FG003|Overall Study|Required number in cohort dosed|0|||
129723423|NCT01439971|466944255|FG004|Overall Study|Required number in cohort dosed|1|||
129723424|NCT03479541|466944260|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
129723425|NCT03479541|466944261|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
129723426|NCT03479541|466944262|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
129723427|NCT03479541|466944263|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
129723428|NCT03479541|466944260|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
129723429|NCT03479541|466944261|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
129723430|NCT03479541|466944262|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
129723431|NCT03479541|466944263|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
129723432|NCT03479541|466944260|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
129723433|NCT03479541|466944261|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
129723434|NCT03479541|466944262|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
129723435|NCT03479541|466944263|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
129723436|NCT03479541|466944260|FG000|Home Monitoring|Lost to Follow-up|0|||
129723437|NCT03479541|466944261|FG001|Home Monitoring|Lost to Follow-up|0|||
129723438|NCT03479541|466944262|FG002|Home Monitoring|Lost to Follow-up|8|||
129723439|NCT03479541|466944263|FG003|Home Monitoring|Lost to Follow-up|12|||
129723440|NCT03479541|466944260|FG000|Home Monitoring|Withdrawal by Subject|0|||
129723441|NCT03479541|466944261|FG001|Home Monitoring|Withdrawal by Subject|0|||
129723442|NCT03479541|466944262|FG002|Home Monitoring|Withdrawal by Subject|17|||
129723443|NCT03479541|466944263|FG003|Home Monitoring|Withdrawal by Subject|30|||
129723444|NCT03479541|466944260|FG000|Home Monitoring|Early Termination - PI Decision|0|||
129723445|NCT03479541|466944261|FG001|Home Monitoring|Early Termination - PI Decision|0|||
129723446|NCT03479541|466944262|FG002|Home Monitoring|Early Termination - PI Decision|4|||
129723447|NCT03479541|466944263|FG003|Home Monitoring|Early Termination - PI Decision|6|||
129723448|NCT00661726|466944264|FG000|Overall Study|Adverse Event|1|||
129723449|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
129723450|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
129723451|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
129723452|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
129723453|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
129723454|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
129723455|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
129723456|NCT01673854|466944265|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
129723457|NCT01673854|466944265|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
129723458|NCT01673854|466944265|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
129723459|NCT01673854|466944265|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
129723460|NCT01673854|466944265|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
129723461|NCT00107900|466944268|FG000|Overall Study|Adverse Event|3|||
129723462|NCT00107900|466944269|FG001|Overall Study|Adverse Event|2|||
129723463|NCT00107900|466944270|FG002|Overall Study|Adverse Event|10|||
129723464|NCT00107900|466944271|FG003|Overall Study|Adverse Event|3|||
129723465|NCT00107900|466944272|FG004|Overall Study|Adverse Event|5|||
129723466|NCT00107900|466944273|FG005|Overall Study|Adverse Event|3|||
129723467|NCT00107900|466944268|FG000|Overall Study|Death|0|||
129723468|NCT00107900|466944269|FG001|Overall Study|Death|0|||
129723469|NCT00107900|466944270|FG002|Overall Study|Death|0|||
129723470|NCT00107900|466944271|FG003|Overall Study|Death|0|||
129723471|NCT00107900|466944272|FG004|Overall Study|Death|1|||
129723472|NCT00107900|466944273|FG005|Overall Study|Death|0|||
129723473|NCT00107900|466944268|FG000|Overall Study|Lost to Follow-up|4|||
129723474|NCT00107900|466944269|FG001|Overall Study|Lost to Follow-up|1|||
129723475|NCT00107900|466944270|FG002|Overall Study|Lost to Follow-up|3|||
129723476|NCT00107900|466944271|FG003|Overall Study|Lost to Follow-up|2|||
129723477|NCT00107900|466944272|FG004|Overall Study|Lost to Follow-up|5|||
129723478|NCT00107900|466944273|FG005|Overall Study|Lost to Follow-up|5|||
129723479|NCT00107900|466944268|FG000|Overall Study|Protocol Violation|1|||
129723480|NCT00107900|466944269|FG001|Overall Study|Protocol Violation|0|||
129723481|NCT00107900|466944270|FG002|Overall Study|Protocol Violation|5|||
129723482|NCT00107900|466944271|FG003|Overall Study|Protocol Violation|5|||
129723483|NCT00107900|466944272|FG004|Overall Study|Protocol Violation|7|||
129723484|NCT00107900|466944273|FG005|Overall Study|Protocol Violation|0|||
129723485|NCT00107900|466944268|FG000|Overall Study|Withdrawal by Subject|1|||
129723486|NCT00107900|466944269|FG001|Overall Study|Withdrawal by Subject|0|||
129723487|NCT00107900|466944270|FG002|Overall Study|Withdrawal by Subject|5|||
129723488|NCT00107900|466944271|FG003|Overall Study|Withdrawal by Subject|0|||
129723489|NCT00107900|466944272|FG004|Overall Study|Withdrawal by Subject|1|||
129723490|NCT00107900|466944273|FG005|Overall Study|Withdrawal by Subject|1|||
129723491|NCT00107900|466944268|FG000|Overall Study|Administrative Reasons|1|||
129723492|NCT00107900|466944269|FG001|Overall Study|Administrative Reasons|0|||
129723493|NCT00107900|466944270|FG002|Overall Study|Administrative Reasons|2|||
129723494|NCT00107900|466944271|FG003|Overall Study|Administrative Reasons|2|||
129723495|NCT00107900|466944272|FG004|Overall Study|Administrative Reasons|2|||
129723496|NCT00107900|466944273|FG005|Overall Study|Administrative Reasons|0|||
129723497|NCT00830375|466944277|FG000|Overall Study|Lost to Follow-up|1|||
129723498|NCT01700959|466944278|FG000|Overall Study|Adverse Event|0|||
129723499|NCT01700959|466944279|FG001|Overall Study|Adverse Event|1|||
129723500|NCT01700959|466944280|FG002|Overall Study|Adverse Event|1|||
129723501|NCT01700959|466944281|FG003|Overall Study|Adverse Event|2|||
129723502|NCT01700959|466944282|FG004|Overall Study|Adverse Event|0|||
129723503|NCT01700959|466944283|FG005|Overall Study|Adverse Event|2|||
129723504|NCT01700959|466944278|FG000|Overall Study|Withdrawal by Subject|15|||
129723505|NCT01700959|466944279|FG001|Overall Study|Withdrawal by Subject|9|||
129723506|NCT01700959|466944280|FG002|Overall Study|Withdrawal by Subject|12|||
129723507|NCT01700959|466944281|FG003|Overall Study|Withdrawal by Subject|11|||
129723508|NCT01700959|466944282|FG004|Overall Study|Withdrawal by Subject|8|||
129723509|NCT01700959|466944283|FG005|Overall Study|Withdrawal by Subject|12|||
129723510|NCT01700959|466944278|FG000|Overall Study|Ineligible|2|||
129723511|NCT01700959|466944279|FG001|Overall Study|Ineligible|1|||
129723512|NCT01700959|466944280|FG002|Overall Study|Ineligible|2|||
129723513|NCT01700959|466944281|FG003|Overall Study|Ineligible|0|||
129723514|NCT01700959|466944282|FG004|Overall Study|Ineligible|0|||
129723515|NCT01700959|466944283|FG005|Overall Study|Ineligible|1|||
129723516|NCT01700959|466944278|FG000|Overall Study|Noncompliant|9|||
129723517|NCT01700959|466944279|FG001|Overall Study|Noncompliant|9|||
129723518|NCT01700959|466944280|FG002|Overall Study|Noncompliant|17|||
129723519|NCT01700959|466944281|FG003|Overall Study|Noncompliant|18|||
129723520|NCT01700959|466944282|FG004|Overall Study|Noncompliant|15|||
129723521|NCT01700959|466944283|FG005|Overall Study|Noncompliant|9|||
129723522|NCT01700959|466944278|FG000|Overall Study|Side effects|1|||
129723523|NCT01700959|466944279|FG001|Overall Study|Side effects|4|||
129723524|NCT01700959|466944280|FG002|Overall Study|Side effects|8|||
129723525|NCT01700959|466944281|FG003|Overall Study|Side effects|4|||
129723526|NCT01700959|466944282|FG004|Overall Study|Side effects|4|||
129723527|NCT01700959|466944283|FG005|Overall Study|Side effects|1|||
129723528|NCT00875485|466947055|FG000|Challenge Dose Epoch|Pregnancy|1|||
129723529|NCT00875485|466947056|FG001|Challenge Dose Epoch|Pregnancy|0|||
129723530|NCT01271010|466947057|FG000|Overall Study|Reason not specified|11|||
129723531|NCT01271010|466947057|FG000|Overall Study|Start of new CLL therapy|1|||
129723532|NCT01271010|466947057|FG000|Overall Study|Protocol Violation|1|||
129723533|NCT01271010|466947057|FG000|Overall Study|Death|2|||
129803988|NCT02484690|467249877|FG004|Overall Study|Physician Decision|0|||
129803989|NCT02484690|467249873|FG000|Overall Study|Lost to Follow-up|0|||
129803990|NCT02484690|467249874|FG001|Overall Study|Lost to Follow-up|0|||
129723534|NCT01271010|466947057|FG000|Overall Study|Progression and relapse of disease|1|||
129723535|NCT01271010|466947057|FG000|Overall Study|Withdrawal by Subject|18|||
129723536|NCT01271010|466947057|FG000|Overall Study|Disease progression|27|||
129723537|NCT01631747|466947058|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
129723538|NCT01631747|466947059|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
129723539|NCT01631747|466947058|FG000|Live Birth|Pregnancy Termination|1|||
129723540|NCT01631747|466947059|FG001|Live Birth|Pregnancy Termination|0|||
129723541|NCT01631747|466947058|FG000|Live Birth|MIscarriage|2|||
129723542|NCT01631747|466947059|FG001|Live Birth|MIscarriage|0|||
129723543|NCT01631747|466947058|FG000|Live Birth|Stillbirth|1|||
129803991|NCT02484690|467249875|FG002|Overall Study|Lost to Follow-up|1|||
129723544|NCT01631747|466947059|FG001|Live Birth|Stillbirth|1|||
129803992|NCT02484690|467249876|FG003|Overall Study|Lost to Follow-up|0|||
129723545|NCT01631747|466947058|FG000|One Year Infant Outcomes|Patient Refused|13|||
129723546|NCT01631747|466947059|FG001|One Year Infant Outcomes|Patient Refused|9|||
129723547|NCT01456195|466947060|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129723548|NCT01456195|466947061|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
129723549|NCT01456195|466947062|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129723550|NCT01456195|466947060|FG000|Overall Study|Lost to Follow-up|3|||
129723551|NCT01456195|466947061|FG001|Overall Study|Lost to Follow-up|1|||
129723552|NCT01456195|466947062|FG002|Overall Study|Lost to Follow-up|3|||
129723553|NCT01456195|466947060|FG000|Overall Study|Voluntary Withdrawal|5|||
129723554|NCT01456195|466947061|FG001|Overall Study|Voluntary Withdrawal|3|||
129723555|NCT01456195|466947062|FG002|Overall Study|Voluntary Withdrawal|7|||
129723556|NCT01456195|466947060|FG000|Overall Study|Lack of Efficacy|0|||
129723557|NCT01456195|466947061|FG001|Overall Study|Lack of Efficacy|1|||
129723558|NCT01456195|466947062|FG002|Overall Study|Lack of Efficacy|0|||
129723559|NCT01456195|466947060|FG000|Overall Study|Other Reasons|2|||
129723560|NCT01456195|466947061|FG001|Overall Study|Other Reasons|1|||
129723561|NCT01456195|466947062|FG002|Overall Study|Other Reasons|3|||
129723562|NCT04848220|466947065|FG000|Overall Study|Unable to proceed to study procedure|0|||
129723563|NCT04848220|466947066|FG001|Overall Study|Unable to proceed to study procedure|1|||
129723564|NCT04848220|466947067|FG002|Overall Study|Unable to proceed to study procedure|0|||
129723565|NCT04848220|466947065|FG000|Overall Study|Fractional flow not significant|0|||
129723566|NCT04848220|466947066|FG001|Overall Study|Fractional flow not significant|1|||
129723567|NCT04848220|466947067|FG002|Overall Study|Fractional flow not significant|0|||
129723568|NCT02923830|466947068|FG000|Overall Study|Physician Decision|13|||
129723569|NCT02923830|466947069|FG001|Overall Study|Physician Decision|15|||
129723570|NCT00510718|466947070|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
129723571|NCT00510718|466947071|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
129723572|NCT00510718|466947070|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
129723573|NCT00510718|466947071|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
129723574|NCT00510718|466947070|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
129723575|NCT00510718|466947071|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
129723576|NCT00510718|466947070|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
129723577|NCT00510718|466947071|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
129723578|NCT00510718|466947070|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
129723579|NCT00510718|466947071|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
129723580|NCT00510718|466947070|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
129723581|NCT00510718|466947071|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
129723582|NCT02150057|466947080|FG000|Overall Study|Lost to Follow-up|6|||
129723583|NCT02150057|466947081|FG001|Overall Study|Lost to Follow-up|4|||
129723584|NCT00489424|466947082|FG000|Overall Study|Adverse Event|3|||
129723585|NCT00489424|466947083|FG001|Overall Study|Adverse Event|3|||
129723586|NCT00489424|466947084|FG002|Overall Study|Adverse Event|4|||
129723587|NCT00489424|466947082|FG000|Overall Study|Lack of Efficacy|1|||
129723588|NCT00489424|466947083|FG001|Overall Study|Lack of Efficacy|0|||
129723589|NCT00489424|466947084|FG002|Overall Study|Lack of Efficacy|0|||
129723590|NCT00489424|466947082|FG000|Overall Study|Administrative problems|0|||
129723591|NCT00489424|466947083|FG001|Overall Study|Administrative problems|2|||
129723592|NCT00489424|466947084|FG002|Overall Study|Administrative problems|1|||
129723593|NCT00394251|466947085|FG000|Overall Study|Adverse Event|7|||
129723594|NCT00394251|466947086|FG001|Overall Study|Adverse Event|5|||
129723595|NCT00394251|466947085|FG000|Overall Study|Unacceptable Toxicity|20|||
129723596|NCT00394251|466947086|FG001|Overall Study|Unacceptable Toxicity|18|||
129723597|NCT00394251|466947085|FG000|Overall Study|Physician Decision|1|||
129723598|NCT00394251|466947086|FG001|Overall Study|Physician Decision|1|||
129723599|NCT00394251|466947085|FG000|Overall Study|Protocol Violation|0|||
129723600|NCT00394251|466947086|FG001|Overall Study|Protocol Violation|1|||
129723601|NCT00394251|466947085|FG000|Overall Study|Withdrawal by Subject|7|||
129723602|NCT00394251|466947086|FG001|Overall Study|Withdrawal by Subject|11|||
129723603|NCT00394251|466947085|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
129723604|NCT00394251|466947086|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
129723605|NCT05791565|466947087|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
129803993|NCT02484690|467249877|FG004|Overall Study|Lost to Follow-up|0|||
129803994|NCT04916769|467249881|FG000|Period 1|Physician Decision|0|||
129723606|NCT05791565|466947088|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
129723607|NCT01558115|466947089|FG000|Overall Study|Withdrawal by Subject|3|||
129723608|NCT01558115|466947089|FG000|Overall Study|Study closed due to poor enrollment|4|||
129723609|NCT01696994|466947090|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
129723610|NCT01696994|466947091|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
129723611|NCT01696994|466947090|FG000|Overall Study|Died Before Randomization|1|||
129723612|NCT01696994|466947091|FG001|Overall Study|Died Before Randomization|2|||
129723613|NCT01696994|466947090|FG000|Overall Study|Died Before ASU (Control)|73|||
129723614|NCT01696994|466947091|FG001|Overall Study|Died Before ASU (Control)|0|||
129723615|NCT01696994|466947090|FG000|Overall Study|No Ovaries at Baseline|4807|||
129803995|NCT04916769|467249882|FG001|Period 1|Physician Decision|0|||
129723616|NCT01696994|466947091|FG001|Overall Study|No Ovaries at Baseline|4851|||
129723617|NCT01696994|466947090|FG000|Overall Study|Refused ASU (Control)|311|||
129723618|NCT01696994|466947091|FG001|Overall Study|Refused ASU (Control)|0|||
129723619|NCT01696994|466947090|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
129723620|NCT01696994|466947091|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
129723621|NCT02388165|466947092|FG000|Overall Study|Study terminated by sponsor|5|||
129723622|NCT02388165|466947093|FG001|Overall Study|Study terminated by sponsor|5|||
129723623|NCT02388165|466947092|FG000|Overall Study|Other|11|||
129723624|NCT02388165|466947093|FG001|Overall Study|Other|13|||
129723625|NCT02388165|466947092|FG000|Overall Study|No longer meet eligibility criteria|40|||
129723626|NCT02388165|466947093|FG001|Overall Study|No longer meet eligibility criteria|43|||
129723627|NCT02388165|466947092|FG000|Overall Study|Withdrawal of consent|31|||
129723628|NCT02388165|466947093|FG001|Overall Study|Withdrawal of consent|32|||
129723629|NCT02388165|466947092|FG000|Overall Study|Lost to Follow-up|19|||
129723630|NCT02388165|466947093|FG001|Overall Study|Lost to Follow-up|20|||
129723631|NCT02388165|466947092|FG000|Overall Study|Death|13|||
129723632|NCT02388165|466947093|FG001|Overall Study|Death|10|||
129723633|NCT02388165|466947092|FG000|Overall Study|Adverse Event|3|||
129723634|NCT02388165|466947093|FG001|Overall Study|Adverse Event|5|||
129723635|NCT02388165|466947092|FG000|Overall Study|Did not meet entrance criteria|5|||
129723636|NCT02388165|466947093|FG001|Overall Study|Did not meet entrance criteria|2|||
129723637|NCT00705250|466947094|FG000|Overall Study|Withdrawal by Subject|1|||
129723638|NCT00705250|466947094|FG000|Overall Study|Patient died in car accident|1|||
129723639|NCT00880269|466947095|FG000|Overall Study|Protocol Violation|1|||
129723640|NCT00880269|466947096|FG001|Overall Study|Protocol Violation|0|||
129723641|NCT00880269|466947095|FG000|Overall Study|Disease Progression|13|||
129723642|NCT00880269|466947096|FG001|Overall Study|Disease Progression|11|||
129723643|NCT00880269|466947095|FG000|Overall Study|New Cancer Therapy|1|||
129723644|NCT00880269|466947096|FG001|Overall Study|New Cancer Therapy|0|||
129723645|NCT00880269|466947095|FG000|Overall Study|Death|4|||
129723646|NCT00880269|466947096|FG001|Overall Study|Death|2|||
129723647|NCT00880269|466947095|FG000|Overall Study|Lost to Follow-up|0|||
129723648|NCT00880269|466947096|FG001|Overall Study|Lost to Follow-up|1|||
129723649|NCT00880269|466947095|FG000|Overall Study|Withdrawal by Subject|3|||
129723650|NCT00880269|466947096|FG001|Overall Study|Withdrawal by Subject|4|||
129723651|NCT00880269|466947095|FG000|Overall Study|Adverse Event|10|||
129723652|NCT00880269|466947096|FG001|Overall Study|Adverse Event|9|||
129723653|NCT01576146|466947097|FG000|Extension Period 1|Adverse Event|2|||
129723654|NCT01576146|466947097|FG000|Extension Period 1|Death|2|||
129723655|NCT01576146|466947097|FG000|Extension Period 1|Physician Decision|2|||
129803996|NCT04916769|467249883|FG002|Period 1|Physician Decision|0|||
129444396|NCT00578786|465927336|FG002|Overall Study|Sponsor Decision|1|||
129723656|NCT01576146|466947097|FG000|Extension Period 1|Withdrawal by Subject|1|||
129723657|NCT01576146|466947097|FG000|Extension Period 1|Lost to Follow-up|1|||
129723658|NCT01576146|466947097|FG000|Extension Period 1|Parathyroidectomy|1|||
129723659|NCT01576146|466947097|FG000|Extension Period 1|Renal Transplant|1|||
129723660|NCT01576146|466947097|FG000|Extension Period 2|Sponsor Decision|13|||
129723661|NCT01576146|466947097|FG000|Extension Period 2|Death|1|||
129723662|NCT01576146|466947097|FG000|Extension Period 2|Adverse Event|1|||
129723663|NCT01576146|466947097|FG000|Extension Period 2|Renal Transplant|1|||
129803997|NCT04916769|467249884|FG003|Period 1|Physician Decision|0|||
129723664|NCT01576146|466947097|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
129723665|NCT00316225|466947098|FG000|Overall Study|Adverse Event|2|||
129723666|NCT00316225|466947098|FG000|Overall Study|Physician Decision|3|||
129723667|NCT00316225|466947098|FG000|Overall Study|Progressive Disease|15|||
129723668|NCT00316225|466947098|FG000|Overall Study|Withdrawal by Subject|3|||
129723669|NCT00316225|466947098|FG000|Overall Study|Death|2|||
129723670|NCT01811485|466947099|FG000|Overall Study|Adverse Event|1|||
129723671|NCT01811485|466947100|FG001|Overall Study|Adverse Event|3|||
129723672|NCT01811485|466947101|FG002|Overall Study|Adverse Event|2|||
129723673|NCT01811485|466947099|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129723674|NCT01811485|466947100|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129723675|NCT01811485|466947101|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
129723676|NCT01811485|466947099|FG000|Overall Study|Administrative problems|1|||
129723677|NCT01811485|466947100|FG001|Overall Study|Administrative problems|0|||
129723678|NCT01811485|466947101|FG002|Overall Study|Administrative problems|0|||
129723679|NCT01811485|466947099|FG000|Overall Study|Protocol Deviation|0|||
129723680|NCT01811485|466947100|FG001|Overall Study|Protocol Deviation|1|||
129723681|NCT01811485|466947101|FG002|Overall Study|Protocol Deviation|0|||
129723682|NCT01545934|466947102|FG000|Overall Study|Withdrawal by Subject|4|||
129723683|NCT01545934|466947103|FG001|Overall Study|Withdrawal by Subject|3|||
129723684|NCT01545934|466947102|FG000|Overall Study|Lost to Follow-up|1|||
129723685|NCT01545934|466947103|FG001|Overall Study|Lost to Follow-up|0|||
129723686|NCT03654404|466947104|FG000|Overall Study|Death|1|||
129723687|NCT03654404|466947104|FG000|Overall Study|Lost to Follow-up|2|||
129723688|NCT03654404|466947104|FG000|Overall Study|Withdrawal by Subject|5|||
129723689|NCT02003638|466947107|FG000|Overall Study|Withdrawal by Subject|1|||
129723690|NCT02003638|466947108|FG001|Overall Study|Withdrawal by Subject|0|||
129723691|NCT03215758|466947114|FG000|Overall Study|Technical Problems|1|||
129723692|NCT03215758|466947115|FG001|Overall Study|Technical Problems|0|||
129723693|NCT03215758|466947114|FG000|Overall Study|Protocol deviation|0|||
129723694|NCT03215758|466947115|FG001|Overall Study|Protocol deviation|1|||
129723695|NCT03215758|466947114|FG000|Overall Study|Physician Decision|0|||
129723696|NCT03215758|466947115|FG001|Overall Study|Physician Decision|1|||
129723697|NCT03215758|466947114|FG000|Overall Study|Death|0|||
129723698|NCT03215758|466947115|FG001|Overall Study|Death|1|||
129723699|NCT03215758|466947114|FG000|Overall Study|Adverse Event|1|||
129723700|NCT03215758|466947115|FG001|Overall Study|Adverse Event|2|||
129723701|NCT03215758|466947114|FG000|Overall Study|Subject/Guardian Decision|3|||
129723702|NCT03215758|466947115|FG001|Overall Study|Subject/Guardian Decision|3|||
129723703|NCT04115748|466947116|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
129723704|NCT04115748|466947117|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
129723705|NCT04115748|466947118|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
129723706|NCT04115748|466947119|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
129723707|NCT04115748|466947120|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129723708|NCT04115748|466947121|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129723709|NCT04115748|466947122|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129723710|NCT04115748|466947123|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129723711|NCT04115748|466947124|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129723712|NCT04115748|466947125|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
129723713|NCT04115748|466947116|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723714|NCT04115748|466947117|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723715|NCT04115748|466947118|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723716|NCT04115748|466947119|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
129723717|NCT04115748|466947120|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723718|NCT04115748|466947121|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723719|NCT04115748|466947122|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723720|NCT04115748|466947123|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723721|NCT04115748|466947124|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723722|NCT04115748|466947125|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
129723723|NCT04115748|466947116|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129723724|NCT04115748|466947117|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129723725|NCT04115748|466947118|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129723726|NCT04115748|466947119|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
129723727|NCT04115748|466947120|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
129723728|NCT04115748|466947121|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
129723729|NCT04115748|466947122|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
129723730|NCT04115748|466947123|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
129723731|NCT04115748|466947124|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
129723732|NCT04115748|466947125|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
129723733|NCT04115748|466947116|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723734|NCT04115748|466947117|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723735|NCT04115748|466947118|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723736|NCT04115748|466947119|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723737|NCT04115748|466947120|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723738|NCT04115748|466947121|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723739|NCT04115748|466947122|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723740|NCT04115748|466947123|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723741|NCT04115748|466947124|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
129723742|NCT04115748|466947125|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
129723743|NCT00713349|466947126|FG000|Overall Study|Protocol Violation|1|||
129723744|NCT03764631|466947127|FG000|Overall Study|Personal Reasons|3|||
129723745|NCT03764631|466947128|FG001|Overall Study|Personal Reasons|2|||
129723746|NCT03764631|466947127|FG000|Overall Study|Switching Therapy|3|||
129723747|NCT03764631|466947128|FG001|Overall Study|Switching Therapy|3|||
129723748|NCT03764631|466947127|FG000|Overall Study|Adverse Event|0|||
129723749|NCT03764631|466947128|FG001|Overall Study|Adverse Event|1|||
129723750|NCT03764631|466947127|FG000|Overall Study|Lost to Follow-up|33|||
129723751|NCT03764631|466947128|FG001|Overall Study|Lost to Follow-up|41|||
129723752|NCT03764631|466947127|FG000|Overall Study|No data as study site was closed|2|||
129723753|NCT03764631|466947128|FG001|Overall Study|No data as study site was closed|6|||
129723754|NCT01200407|466947129|FG000|Overall Study|Lost to Follow-up|56|||
129723755|NCT01200407|466947129|FG000|Overall Study|Adverse Event|3|||
129723756|NCT01200407|466947129|FG000|Overall Study|Withdrawal by Subject|4|||
129723757|NCT01200407|466947129|FG000|Overall Study|Other|19|||
129723758|NCT03299881|466947130|FG000|Overall Study|Study Termination|17|||
129723759|NCT03299881|466947131|FG001|Overall Study|Study Termination|13|||
129723760|NCT01257230|466947134|FG000|Overall Study|Not Treated|0|||
129723761|NCT01257230|466947135|FG001|Overall Study|Not Treated|0|||
129723762|NCT01257230|466947136|FG002|Overall Study|Not Treated|1|||
129723763|NCT01257230|466947134|FG000|Overall Study|Adverse Event|2|||
129723764|NCT01257230|466947135|FG001|Overall Study|Adverse Event|0|||
129723765|NCT01257230|466947136|FG002|Overall Study|Adverse Event|0|||
129723766|NCT01257230|466947134|FG000|Overall Study|Lack of Efficacy|0|||
129723767|NCT01257230|466947135|FG001|Overall Study|Lack of Efficacy|1|||
129723768|NCT01257230|466947136|FG002|Overall Study|Lack of Efficacy|0|||
129723769|NCT01257230|466947134|FG000|Overall Study|Protocol Violation|3|||
129723770|NCT01257230|466947135|FG001|Overall Study|Protocol Violation|0|||
129723771|NCT01257230|466947136|FG002|Overall Study|Protocol Violation|1|||
129723772|NCT01257230|466947134|FG000|Overall Study|Withdrawal by Subject|0|||
129723773|NCT01257230|466947135|FG001|Overall Study|Withdrawal by Subject|4|||
129723774|NCT01257230|466947136|FG002|Overall Study|Withdrawal by Subject|1|||
129723775|NCT01257230|466947134|FG000|Overall Study|Other reason not defined above|1|||
129723776|NCT01257230|466947135|FG001|Overall Study|Other reason not defined above|5|||
129723777|NCT01257230|466947136|FG002|Overall Study|Other reason not defined above|3|||
129723778|NCT01205061|466947139|FG000|Overall Study|Adverse Event|4|||
129723779|NCT01205061|466947139|FG000|Overall Study|Withdrawal by Subject|11|||
129723780|NCT01205061|466947139|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
129723781|NCT01205061|466947139|FG000|Overall Study|Lost to Follow-up|9|||
129723782|NCT01205061|466947139|FG000|Overall Study|Other|1|||
129723783|NCT00765037|466947140|FG000|Overall Study|Lost to Follow-up|5|||
129723784|NCT00765037|466947140|FG000|Overall Study|Adverse Event|1|||
129723785|NCT03070171|466947147|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
129723786|NCT03070171|466947148|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
129723787|NCT03070171|466947147|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
129723788|NCT03070171|466947148|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
129723789|NCT01471028|466947152|FG000|VTI-208|Adverse Event|39|||
129723790|NCT01471028|466947153|FG001|VTI-208|Adverse Event|41|||
129723791|NCT01471028|466947152|FG000|VTI-208|Withdrawal by Subject|0|||
129723792|NCT01471028|466947153|FG001|VTI-208|Withdrawal by Subject|2|||
129723793|NCT01471028|466947152|FG000|VTI-208|Lost to Follow-up|1|||
129723794|NCT01471028|466947153|FG001|VTI-208|Lost to Follow-up|1|||
129723795|NCT01471028|466947152|FG000|VTI-208E|Death|7|||
129723796|NCT01471028|466947153|FG001|VTI-208E|Death|10|||
129723797|NCT01471028|466947152|FG000|VTI-208E|Withdrawal by Subject|1|||
129723798|NCT01471028|466947153|FG001|VTI-208E|Withdrawal by Subject|0|||
129723799|NCT01471028|466947152|FG000|VTI-208E|Lost to Follow-up|0|||
129723800|NCT01471028|466947153|FG001|VTI-208E|Lost to Follow-up|2|||
129723801|NCT00610857|466947155|FG000|Overall Study|Not evaluable for response|2|||
129723802|NCT01626118|466947156|FG000|Overall Study|Lack of Efficacy|1|||
129723803|NCT01626118|466947157|FG001|Overall Study|Lack of Efficacy|0|||
129723804|NCT01626118|466947158|FG002|Overall Study|Lack of Efficacy|1|||
129723805|NCT01626118|466947159|FG003|Overall Study|Lack of Efficacy|3|||
129723806|NCT01626118|466947156|FG000|Overall Study|Lost to Follow-up|1|||
129723807|NCT01626118|466947157|FG001|Overall Study|Lost to Follow-up|0|||
129723808|NCT01626118|466947158|FG002|Overall Study|Lost to Follow-up|0|||
129723809|NCT01626118|466947159|FG003|Overall Study|Lost to Follow-up|0|||
129723810|NCT01626118|466947156|FG000|Overall Study|Adverse Event|0|||
129723811|NCT01626118|466947157|FG001|Overall Study|Adverse Event|1|||
129723812|NCT01626118|466947158|FG002|Overall Study|Adverse Event|1|||
129723813|NCT01626118|466947159|FG003|Overall Study|Adverse Event|0|||
129723814|NCT01626118|466947156|FG000|Overall Study|Investigator Decision|0|||
129723815|NCT01626118|466947157|FG001|Overall Study|Investigator Decision|1|||
129723816|NCT01626118|466947158|FG002|Overall Study|Investigator Decision|0|||
129723817|NCT01626118|466947159|FG003|Overall Study|Investigator Decision|0|||
129723818|NCT04826094|466947160|FG000|Overall Study|Lost to Follow-up|2|||
129723819|NCT04826094|466947161|FG001|Overall Study|Lost to Follow-up|1|||
129723820|NCT04826094|466947162|FG002|Overall Study|Lost to Follow-up|0|||
129723821|NCT04826094|466947163|FG003|Overall Study|Lost to Follow-up|0|||
129723822|NCT04826094|466947164|FG004|Overall Study|Lost to Follow-up|1|||
129723823|NCT04826094|466947165|FG005|Overall Study|Lost to Follow-up|3|||
129723824|NCT04826094|466947166|FG006|Overall Study|Lost to Follow-up|1|||
129723825|NCT04826094|466947167|FG007|Overall Study|Lost to Follow-up|1|||
129723826|NCT04826094|466947160|FG000|Overall Study|Participant withdrew consent|1|||
129723827|NCT04826094|466947161|FG001|Overall Study|Participant withdrew consent|0|||
129723828|NCT04826094|466947162|FG002|Overall Study|Participant withdrew consent|0|||
129723829|NCT04826094|466947163|FG003|Overall Study|Participant withdrew consent|1|||
129723830|NCT04826094|466947164|FG004|Overall Study|Participant withdrew consent|1|||
129723831|NCT04826094|466947165|FG005|Overall Study|Participant withdrew consent|1|||
129891639|NCT02223182|467561224|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129891640|NCT02223182|467561225|FG002|Double-Blind Period|Withdrawal by Subject|1|||
129723832|NCT04826094|466947166|FG006|Overall Study|Participant withdrew consent|0|||
129723833|NCT04826094|466947167|FG007|Overall Study|Participant withdrew consent|1|||
129723834|NCT04826094|466947160|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
129723835|NCT04826094|466947161|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
129723836|NCT04826094|466947162|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
129891641|NCT02223182|467561226|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129723837|NCT04826094|466947163|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
129723838|NCT04826094|466947164|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
129723839|NCT04826094|466947165|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
129723840|NCT04826094|466947166|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
129891642|NCT02223182|467561223|FG000|Double-Blind Period|Lost to Follow-up|0|||
129723841|NCT04826094|466947167|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
129723842|NCT04826094|466947160|FG000|Overall Study|Withdrawn by Investigator|0|||
129723843|NCT04826094|466947161|FG001|Overall Study|Withdrawn by Investigator|0|||
129723844|NCT04826094|466947162|FG002|Overall Study|Withdrawn by Investigator|0|||
129723845|NCT04826094|466947163|FG003|Overall Study|Withdrawn by Investigator|0|||
129723846|NCT04826094|466947164|FG004|Overall Study|Withdrawn by Investigator|0|||
129723847|NCT04826094|466947165|FG005|Overall Study|Withdrawn by Investigator|1|||
129723848|NCT04826094|466947166|FG006|Overall Study|Withdrawn by Investigator|0|||
129723849|NCT04826094|466947167|FG007|Overall Study|Withdrawn by Investigator|1|||
129723850|NCT04826094|466947160|FG000|Overall Study|Other: Moved from area|1|||
129723851|NCT04826094|466947161|FG001|Overall Study|Other: Moved from area|1|||
129723852|NCT04826094|466947162|FG002|Overall Study|Other: Moved from area|1|||
129723853|NCT04826094|466947163|FG003|Overall Study|Other: Moved from area|0|||
129723854|NCT04826094|466947164|FG004|Overall Study|Other: Moved from area|0|||
129723855|NCT04826094|466947165|FG005|Overall Study|Other: Moved from area|0|||
129723856|NCT04826094|466947166|FG006|Overall Study|Other: Moved from area|0|||
129723857|NCT04826094|466947167|FG007|Overall Study|Other: Moved from area|0|||
129723858|NCT04826094|466947160|FG000|Overall Study|Other: Declined|0|||
129723859|NCT04826094|466947161|FG001|Overall Study|Other: Declined|0|||
129723860|NCT04826094|466947162|FG002|Overall Study|Other: Declined|0|||
129723861|NCT04826094|466947163|FG003|Overall Study|Other: Declined|0|||
129723862|NCT04826094|466947164|FG004|Overall Study|Other: Declined|1|||
129723863|NCT04826094|466947165|FG005|Overall Study|Other: Declined|0|||
129723864|NCT04826094|466947166|FG006|Overall Study|Other: Declined|0|||
129723865|NCT04826094|466947167|FG007|Overall Study|Other: Declined|0|||
129723866|NCT04826094|466947160|FG000|Overall Study|Other: Vaccine not administered|0|||
129723867|NCT04826094|466947161|FG001|Overall Study|Other: Vaccine not administered|0|||
129723868|NCT04826094|466947162|FG002|Overall Study|Other: Vaccine not administered|1|||
129723869|NCT04826094|466947163|FG003|Overall Study|Other: Vaccine not administered|0|||
129723870|NCT04826094|466947164|FG004|Overall Study|Other: Vaccine not administered|0|||
129723871|NCT04826094|466947165|FG005|Overall Study|Other: Vaccine not administered|1|||
129723872|NCT04826094|466947166|FG006|Overall Study|Other: Vaccine not administered|1|||
129891643|NCT02223182|467561224|FG001|Double-Blind Period|Lost to Follow-up|1|||
129891644|NCT02223182|467561225|FG002|Double-Blind Period|Lost to Follow-up|0|||
129891645|NCT02223182|467561226|FG003|Double-Blind Period|Lost to Follow-up|0|||
129891646|NCT02223182|467561223|FG000|Double-Blind Period|Non Compliance|0|||
129891647|NCT02223182|467561224|FG001|Double-Blind Period|Non Compliance|0|||
129891648|NCT02223182|467561225|FG002|Double-Blind Period|Non Compliance|0|||
129723873|NCT04826094|466947167|FG007|Overall Study|Other: Vaccine not administered|3|||
129723874|NCT00700882|466947170|FG000|Overall Study|Never received treatment|6|||
129723875|NCT00700882|466947170|FG000|Overall Study|Ineligible|2|||
129723876|NCT00700882|466947170|FG000|Overall Study|No KIT mutation|51|||
129723877|NCT04154293|466947174|FG000|Overall Study|Withdrawal by Subject|2|||
129723878|NCT04154293|466947175|FG001|Overall Study|Withdrawal by Subject|3|||
129723879|NCT04154293|466947176|FG002|Overall Study|Withdrawal by Subject|1|||
129723880|NCT04154293|466947174|FG000|Overall Study|Physician Decision|0|||
129723881|NCT04154293|466947175|FG001|Overall Study|Physician Decision|0|||
129723882|NCT04154293|466947176|FG002|Overall Study|Physician Decision|1|||
129723883|NCT04731298|466947177|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
129723884|NCT04731298|466947178|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
129723885|NCT01208961|466947179|FG000|High-Fat Period III|Protocol Violation|1|||
129723886|NCT01208961|466947180|FG001|High-Fat Period III|Protocol Violation|0|||
129723887|NCT03403361|466947181|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
129723888|NCT02152371|466947182|FG000|Overall Study|Adverse Event|6|||
129723889|NCT02152371|466947183|FG001|Overall Study|Adverse Event|2|||
129723890|NCT02152371|466947182|FG000|Overall Study|Withdrawal by Subject|3|||
129723891|NCT02152371|466947183|FG001|Overall Study|Withdrawal by Subject|7|||
129723892|NCT02152371|466947182|FG000|Overall Study|Protocol Violation|2|||
129723893|NCT02152371|466947183|FG001|Overall Study|Protocol Violation|3|||
129723894|NCT02152371|466947182|FG000|Overall Study|Lost to Follow-up|1|||
129723895|NCT02152371|466947183|FG001|Overall Study|Lost to Follow-up|0|||
129723896|NCT02152371|466947182|FG000|Overall Study|Lack of Efficacy|0|||
129723897|NCT02152371|466947183|FG001|Overall Study|Lack of Efficacy|1|||
129723898|NCT02152371|466947182|FG000|Overall Study|Physician Decision|0|||
129723899|NCT02152371|466947183|FG001|Overall Study|Physician Decision|2|||
129723900|NCT02152371|466947182|FG000|Overall Study|Reason Not Given|0|||
129723901|NCT02152371|466947183|FG001|Overall Study|Reason Not Given|1|||
129723902|NCT04382586|466947189|FG000|Overall Study|Death|3|||
129723903|NCT04382586|466947190|FG001|Overall Study|Death|4|||
129891649|NCT02223182|467561226|FG003|Double-Blind Period|Non Compliance|1|||
129723904|NCT04382586|466947189|FG000|Overall Study|Lost to Follow-up|11|||
129723905|NCT04382586|466947190|FG001|Overall Study|Lost to Follow-up|8|||
129891650|NCT02223182|467561223|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
129723906|NCT04382586|466947189|FG000|Overall Study|Withdrawal by Subject|3|||
129723907|NCT04382586|466947190|FG001|Overall Study|Withdrawal by Subject|1|||
129723908|NCT04382586|466947189|FG000|Overall Study|Physician Decision|0|||
129723909|NCT04382586|466947190|FG001|Overall Study|Physician Decision|3|||
129723910|NCT06099223|466947196|FG000|Overall Study|Preoperative surveys missed|0|||
129723911|NCT06099223|466947197|FG001|Overall Study|Preoperative surveys missed|1|||
129723912|NCT00079391|466947198|FG000|Overall Study|Withdrawal by Subject|1|||
129723913|NCT02628600|466947202|FG000|Overall Study|Death|2|||
129723914|NCT02628600|466947203|FG001|Overall Study|Death|1|||
129723915|NCT02628600|466947202|FG000|Overall Study|Adverse Event|3|||
129723916|NCT02628600|466947203|FG001|Overall Study|Adverse Event|20|||
129723917|NCT02628600|466947202|FG000|Overall Study|Protocol Violation|0|||
129723918|NCT02628600|466947203|FG001|Overall Study|Protocol Violation|1|||
129723919|NCT02628600|466947202|FG000|Overall Study|Lack of Efficacy|2|||
129723920|NCT02628600|466947203|FG001|Overall Study|Lack of Efficacy|0|||
129723921|NCT02628600|466947202|FG000|Overall Study|Withdrawal by Subject|13|||
129723922|NCT02628600|466947203|FG001|Overall Study|Withdrawal by Subject|8|||
129723923|NCT02628600|466947202|FG000|Overall Study|Lost to Follow-up|1|||
129723924|NCT02628600|466947203|FG001|Overall Study|Lost to Follow-up|0|||
129723925|NCT02628600|466947202|FG000|Overall Study|Physician Decision|2|||
129723926|NCT02628600|466947203|FG001|Overall Study|Physician Decision|2|||
129723927|NCT02628600|466947202|FG000|Overall Study|Other not specified|1|||
129723928|NCT02628600|466947203|FG001|Overall Study|Other not specified|0|||
129723929|NCT01221623|466947204|FG000|Overall Study|Withdrawal by Subject|19|||
129723930|NCT01221623|466947205|FG001|Overall Study|Withdrawal by Subject|8|||
129723931|NCT01221623|466947204|FG000|Overall Study|Lost to Follow-up|7|||
129723932|NCT01221623|466947205|FG001|Overall Study|Lost to Follow-up|1|||
129723933|NCT01221623|466947204|FG000|Overall Study|Adverse Event|6|||
129723934|NCT01221623|466947205|FG001|Overall Study|Adverse Event|3|||
129723935|NCT01221623|466947204|FG000|Overall Study|Death|1|||
129723936|NCT01221623|466947205|FG001|Overall Study|Death|0|||
129723937|NCT01221623|466947204|FG000|Overall Study|Other|5|||
129723938|NCT01221623|466947205|FG001|Overall Study|Other|2|||
129723939|NCT02644096|466947206|FG000|Overall Study|Withdrawal by Subject|28|||
129723940|NCT02644096|466947207|FG001|Overall Study|Withdrawal by Subject|25|||
129723941|NCT02461290|466947208|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
129723942|NCT02461290|466947208|FG000|Overall Study|Lost to Follow-up|3|||
129723943|NCT00526656|466947209|FG000|Overall Study|Death|1|||
129723944|NCT00526656|466947209|FG000|Overall Study|Refused surgery|1|||
129723945|NCT02109432|466949433|FG000|Overall Study|Withdrawal by Subject|1|||
129723946|NCT02908685|466949434|FG000|Part 1 OLE|Withdrawal by Subject|0|||
129723947|NCT02908685|466949435|FG001|Part 1 OLE|Withdrawal by Subject|0|||
129723948|NCT02908685|466949436|FG002|Part 1 OLE|Withdrawal by Subject|0|||
129723949|NCT02908685|466949437|FG003|Part 1 OLE|Withdrawal by Subject|0|||
129723950|NCT02908685|466949438|FG004|Part 1 OLE|Withdrawal by Subject|0|||
129723951|NCT02908685|466949439|FG005|Part 1 OLE|Withdrawal by Subject|0|||
129723952|NCT02908685|466949440|FG006|Part 1 OLE|Withdrawal by Subject|0|||
129723953|NCT02908685|466949441|FG007|Part 1 OLE|Withdrawal by Subject|0|||
129723954|NCT02908685|466949442|FG008|Part 1 OLE|Withdrawal by Subject|0|||
129723955|NCT02908685|466949443|FG009|Part 1 OLE|Withdrawal by Subject|0|||
129723956|NCT02908685|466949444|FG010|Part 1 OLE|Withdrawal by Subject|2|||
129723957|NCT02908685|466949445|FG011|Part 1 OLE|Withdrawal by Subject|1|||
129803998|NCT04916769|467249885|FG004|Period 1|Physician Decision|0|||
129723958|NCT02908685|466949446|FG012|Part 1 OLE|Withdrawal by Subject|0|||
129723959|NCT02908685|466949447|FG013|Part 1 OLE|Withdrawal by Subject|0|||
129803999|NCT04916769|467249886|FG005|Period 1|Physician Decision|1|||
129723960|NCT02908685|466949434|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723961|NCT02908685|466949435|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723962|NCT02908685|466949436|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723963|NCT02908685|466949437|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723964|NCT02908685|466949438|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723965|NCT02908685|466949439|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723966|NCT02908685|466949440|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723967|NCT02908685|466949441|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723968|NCT02908685|466949442|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723969|NCT02908685|466949443|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723970|NCT02908685|466949444|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723971|NCT02908685|466949445|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
129723972|NCT02908685|466949446|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
129723973|NCT02908685|466949447|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
129723974|NCT02908685|466949434|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723975|NCT02908685|466949435|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723976|NCT02908685|466949436|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723977|NCT02908685|466949437|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723978|NCT02908685|466949438|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723979|NCT02908685|466949439|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723980|NCT02908685|466949440|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723981|NCT02908685|466949441|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723982|NCT02908685|466949442|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723983|NCT02908685|466949443|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723984|NCT02908685|466949444|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723985|NCT02908685|466949445|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723986|NCT02908685|466949446|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
129723987|NCT02908685|466949447|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
129723988|NCT02908685|466949434|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723989|NCT02908685|466949435|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723990|NCT02908685|466949436|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723991|NCT02908685|466949437|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723992|NCT02908685|466949438|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723993|NCT02908685|466949439|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723994|NCT02908685|466949440|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723995|NCT02908685|466949441|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723996|NCT02908685|466949442|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723997|NCT02908685|466949443|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723998|NCT02908685|466949444|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129723999|NCT02908685|466949445|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129804000|NCT04916769|467249881|FG000|Period 2|Physician Decision|0|||
129804001|NCT04916769|467249882|FG001|Period 2|Physician Decision|1|||
129804002|NCT04916769|467249883|FG002|Period 2|Physician Decision|0|||
129804003|NCT04916769|467249884|FG003|Period 2|Physician Decision|0|||
129804004|NCT04916769|467249885|FG004|Period 2|Physician Decision|0|||
129804005|NCT04916769|467249886|FG005|Period 2|Physician Decision|0|||
129804006|NCT03672643|467249899|FG000|Overall Study|Adverse Event|3|||
129804007|NCT03672643|467249899|FG000|Overall Study|Death|2|||
129804008|NCT03672643|467249899|FG000|Overall Study|Withdrawal by Subject|1|||
129804009|NCT03672643|467249899|FG000|Overall Study|Progressive disease|11|||
129804010|NCT03672643|467249899|FG000|Overall Study|Global deterioration of health status|1|||
129804011|NCT03672643|467249899|FG000|Overall Study|Refused further treatment|7|||
129804012|NCT03672643|467249899|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
129804013|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
129804014|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804015|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804016|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804017|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804018|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804019|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
129804020|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
129804021|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804022|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804023|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804024|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804025|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129444397|NCT00578786|465927334|FG000|Overall Study|Lost to Follow-up|0|||
129444398|NCT00578786|465927335|FG001|Overall Study|Lost to Follow-up|4|||
129444399|NCT00578786|465927336|FG002|Overall Study|Lost to Follow-up|0|||
129444400|NCT00578786|465927334|FG000|Overall Study|Pregnancy|0|||
129724000|NCT02908685|466949446|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
129804026|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
129804027|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
129804028|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804029|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804030|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804031|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804032|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804033|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
129804034|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
129804035|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804036|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804037|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804038|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804039|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804040|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
129804041|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
129804042|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804043|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804044|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129891651|NCT02223182|467561224|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
129891652|NCT02223182|467561225|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
129891653|NCT02223182|467561226|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
129891654|NCT02223182|467561223|FG000|Open-Label 500 Period|Adverse Event|1|||
129891655|NCT02223182|467561224|FG001|Open-Label 500 Period|Adverse Event|0|||
129891656|NCT02223182|467561225|FG002|Open-Label 500 Period|Adverse Event|2|||
129891657|NCT02223182|467561226|FG003|Open-Label 500 Period|Adverse Event|1|||
129891658|NCT02223182|467561223|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
129724001|NCT02908685|466949447|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
129724002|NCT02908685|466949434|FG000|Part 2 OLE: > Month 24|Death|0|||
129724003|NCT02908685|466949435|FG001|Part 2 OLE: > Month 24|Death|0|||
129724004|NCT02908685|466949436|FG002|Part 2 OLE: > Month 24|Death|0|||
129724005|NCT02908685|466949437|FG003|Part 2 OLE: > Month 24|Death|0|||
129724006|NCT02908685|466949438|FG004|Part 2 OLE: > Month 24|Death|0|||
129724007|NCT02908685|466949439|FG005|Part 2 OLE: > Month 24|Death|0|||
129724008|NCT02908685|466949440|FG006|Part 2 OLE: > Month 24|Death|0|||
129724009|NCT02908685|466949441|FG007|Part 2 OLE: > Month 24|Death|0|||
129724010|NCT02908685|466949442|FG008|Part 2 OLE: > Month 24|Death|0|||
129724011|NCT02908685|466949443|FG009|Part 2 OLE: > Month 24|Death|0|||
129724012|NCT02908685|466949444|FG010|Part 2 OLE: > Month 24|Death|0|||
129724013|NCT02908685|466949445|FG011|Part 2 OLE: > Month 24|Death|0|||
129724014|NCT02908685|466949446|FG012|Part 2 OLE: > Month 24|Death|1|||
129724015|NCT02908685|466949447|FG013|Part 2 OLE: > Month 24|Death|0|||
129724016|NCT02908685|466949434|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
129724017|NCT02908685|466949435|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
129724018|NCT02908685|466949436|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
129724019|NCT02908685|466949437|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
129724020|NCT02908685|466949438|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
129724021|NCT02908685|466949439|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
129724022|NCT02908685|466949440|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
129724023|NCT02908685|466949441|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
129724024|NCT02908685|466949442|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
129724025|NCT02908685|466949443|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
129724026|NCT02908685|466949444|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
129724027|NCT02908685|466949445|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
129724028|NCT02908685|466949446|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
129724029|NCT02908685|466949447|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
129724030|NCT02908685|466949434|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724031|NCT02908685|466949435|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724032|NCT02908685|466949436|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724033|NCT02908685|466949437|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724034|NCT02908685|466949438|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129444401|NCT00578786|465927335|FG001|Overall Study|Pregnancy|1|||
129724035|NCT02908685|466949439|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724036|NCT02908685|466949440|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724037|NCT02908685|466949441|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724038|NCT02908685|466949442|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724039|NCT02908685|466949443|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724040|NCT02908685|466949444|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724041|NCT02908685|466949445|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
129724042|NCT02908685|466949446|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
129724043|NCT02908685|466949447|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
129724044|NCT01691014|466949449|FG000|Overall Study|Premature Termination|1|||
129724045|NCT01691014|466949450|FG001|Overall Study|Premature Termination|6|||
129724046|NCT01691014|466949451|FG002|Overall Study|Premature Termination|0|||
129724047|NCT01691014|466949452|FG003|Overall Study|Premature Termination|3|||
129724048|NCT01691014|466949449|FG000|Overall Study|Other|0|||
129724049|NCT01691014|466949450|FG001|Overall Study|Other|0|||
129724050|NCT01691014|466949451|FG002|Overall Study|Other|2|||
129724051|NCT01691014|466949452|FG003|Overall Study|Other|0|||
129724052|NCT01691014|466949449|FG000|Overall Study|Withdrawal by Subject|0|||
129724053|NCT01691014|466949450|FG001|Overall Study|Withdrawal by Subject|1|||
129724054|NCT01691014|466949451|FG002|Overall Study|Withdrawal by Subject|1|||
129724055|NCT01691014|466949452|FG003|Overall Study|Withdrawal by Subject|1|||
129724056|NCT01691014|466949449|FG000|Overall Study|Adverse Event|0|||
129724057|NCT01691014|466949450|FG001|Overall Study|Adverse Event|5|||
129724058|NCT01691014|466949451|FG002|Overall Study|Adverse Event|1|||
129724059|NCT01691014|466949452|FG003|Overall Study|Adverse Event|1|||
129724060|NCT01691014|466949449|FG000|Overall Study|Lack of Efficacy|2|||
129724061|NCT01691014|466949450|FG001|Overall Study|Lack of Efficacy|3|||
129724062|NCT01691014|466949451|FG002|Overall Study|Lack of Efficacy|7|||
129724063|NCT01691014|466949452|FG003|Overall Study|Lack of Efficacy|0|||
129724064|NCT02370537|466949453|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
129724065|NCT02370537|466949454|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
129724066|NCT02370537|466949455|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
129724067|NCT02370537|466949453|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
129724068|NCT02370537|466949454|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
129804045|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804046|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804047|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
129804048|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
129804049|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804050|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804051|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804052|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804053|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129804054|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
129724069|NCT02370537|466949455|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
129724070|NCT02370537|466949453|FG000|Part B|Not randomised to receive treatment|1|||
129724071|NCT02370537|466949454|FG001|Part B|Not randomised to receive treatment|2|||
129724072|NCT02370537|466949455|FG002|Part B|Not randomised to receive treatment|259|||
129724073|NCT02370537|466949453|FG000|Part B|Withdrawal by Subject|0|||
129724074|NCT02370537|466949454|FG001|Part B|Withdrawal by Subject|1|||
129724075|NCT02370537|466949455|FG002|Part B|Withdrawal by Subject|0|||
129724076|NCT05897242|466949456|FG000|Overall Study|Lost to Follow-up|6|||
129724077|NCT05897242|466949457|FG001|Overall Study|Lost to Follow-up|1|||
129724078|NCT05897242|466949456|FG000|Overall Study|Incomplete|1|||
129724079|NCT05897242|466949457|FG001|Overall Study|Incomplete|0|||
129724080|NCT05897242|466949456|FG000|Overall Study|Withdrawal by Subject|1|||
129724081|NCT05897242|466949457|FG001|Overall Study|Withdrawal by Subject|0|||
129724082|NCT04439539|466949461|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
129724083|NCT04439539|466949462|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
129724084|NCT04439539|466949463|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
129724085|NCT04439539|466949461|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
129724086|NCT04439539|466949462|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
129724087|NCT04439539|466949463|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
129724088|NCT04439539|466949461|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
129724089|NCT04439539|466949462|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
129724090|NCT04439539|466949463|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
129724091|NCT02920528|466949464|FG000|Overall Study|Incomplete Data|1|||
129724092|NCT02920528|466949465|FG001|Overall Study|Incomplete Data|1|||
129724093|NCT02920528|466949466|FG002|Overall Study|Incomplete Data|1|||
129724094|NCT02920528|466949464|FG000|Overall Study|Adverse Event|0|||
129724095|NCT02920528|466949465|FG001|Overall Study|Adverse Event|0|||
129724096|NCT02920528|466949466|FG002|Overall Study|Adverse Event|3|||
129724097|NCT02920528|466949464|FG000|Overall Study|Did not meet inclusion criteria|2|||
129724098|NCT02920528|466949465|FG001|Overall Study|Did not meet inclusion criteria|0|||
129724099|NCT02920528|466949466|FG002|Overall Study|Did not meet inclusion criteria|1|||
129724100|NCT02547038|466949467|FG000|Overall Study|Lost to Follow-up|3|||
129724101|NCT02547038|466949468|FG001|Overall Study|Lost to Follow-up|2|||
129724102|NCT01340625|466949469|FG000|First Intervention|Adverse Event|1|||
129724103|NCT01340625|466949470|FG001|First Intervention|Adverse Event|0|||
129724104|NCT01340625|466949469|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
129724105|NCT01340625|466949470|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
129724106|NCT00066703|466949471|FG000|Overall Study|Adverse Event|80|||
129724107|NCT00066703|466949472|FG001|Overall Study|Adverse Event|111|||
129724108|NCT00066703|466949471|FG000|Overall Study|Death|3|||
129724109|NCT00066703|466949472|FG001|Overall Study|Death|0|||
129724110|NCT00066703|466949471|FG000|Overall Study|Lack of Efficacy|114|||
129724111|NCT00066703|466949472|FG001|Overall Study|Lack of Efficacy|69|||
129724112|NCT00066703|466949471|FG000|Overall Study|Lost to Follow-up|31|||
129724113|NCT00066703|466949472|FG001|Overall Study|Lost to Follow-up|28|||
129724114|NCT00066703|466949471|FG000|Overall Study|Withdrawal by Subject|38|||
129724115|NCT00066703|466949472|FG001|Overall Study|Withdrawal by Subject|63|||
129724116|NCT00066703|466949471|FG000|Overall Study|Treatment ongoing|346|||
129724117|NCT00066703|466949472|FG001|Overall Study|Treatment ongoing|311|||
129724118|NCT01696968|466949473|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
129724119|NCT01696968|466949474|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
129724120|NCT01696968|466949473|FG000|Overall Study|Died Before Randomization|3|||
129724121|NCT01696968|466949474|FG001|Overall Study|Died Before Randomization|8|||
129724122|NCT01696968|466949473|FG000|Overall Study|Died Before ASU (Control)|278|||
129724123|NCT01696968|466949474|FG001|Overall Study|Died Before ASU (Control)|0|||
129724124|NCT01696968|466949473|FG000|Overall Study|Refused ASU (Control)|920|||
129724125|NCT01696968|466949474|FG001|Overall Study|Refused ASU (Control)|0|||
129724126|NCT01696968|466949473|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
129724127|NCT01696968|466949474|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
129724128|NCT01519791|466949489|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
129724129|NCT01519791|466949490|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
129724130|NCT01519791|466949489|FG000|Overall Study|Protocol Violation|6|||
129724131|NCT01519791|466949490|FG001|Overall Study|Protocol Violation|19|||
129724132|NCT01519791|466949489|FG000|Overall Study|Other Reason|87|||
129724133|NCT01519791|466949490|FG001|Overall Study|Other Reason|222|||
129724134|NCT01519791|466949489|FG000|Overall Study|subjects randomized in error|2|||
129724135|NCT01519791|466949490|FG001|Overall Study|subjects randomized in error|0|||
129724136|NCT01519791|466949489|FG000|Overall Study|Lack of Efficacy|16|||
129724137|NCT01519791|466949490|FG001|Overall Study|Lack of Efficacy|20|||
129724138|NCT01519791|466949489|FG000|Overall Study|SAE, non-fatal|6|||
129724139|NCT01519791|466949490|FG001|Overall Study|SAE, non-fatal|22|||
129724140|NCT01519791|466949489|FG000|Overall Study|AE, serious fatal|0|||
129724141|NCT01519791|466949490|FG001|Overall Study|AE, serious fatal|1|||
129724142|NCT01519791|466949489|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
129444402|NCT00578786|465927336|FG002|Overall Study|Pregnancy|0|||
129444403|NCT00578786|465927334|FG000|Overall Study|Not Otherwise Specified|0|||
129724143|NCT01519791|466949490|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
129724144|NCT01519791|466949489|FG000|Overall Study|AE, non-serious non-fatal|12|||
129724145|NCT01519791|466949490|FG001|Overall Study|AE, non-serious non-fatal|31|||
129724146|NCT01519791|466949489|FG000|Overall Study|Withdrawal by Subject|15|||
129724147|NCT01519791|466949490|FG001|Overall Study|Withdrawal by Subject|37|||
129724148|NCT01519791|466949489|FG000|Overall Study|Lost to Follow-up|6|||
129724149|NCT01519791|466949490|FG001|Overall Study|Lost to Follow-up|14|||
129444404|NCT00578786|465927335|FG001|Overall Study|Not Otherwise Specified|4|||
129724150|NCT01289353|466949506|FG000|Overall Study|Lost to Follow-up|2|||
129724151|NCT01549886|466949507|FG000|Overall Study|Sponsor's decision|2|||
129724152|NCT01549886|466949508|FG001|Overall Study|Sponsor's decision|3|||
129724153|NCT06004895|466949509|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
129724154|NCT06004895|466949509|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
129724155|NCT01450696|466949510|FG000|Overall Study|Never Treated|1|||
129724156|NCT01450696|466949511|FG001|Overall Study|Never Treated|1|||
129724157|NCT01450696|466949510|FG000|Overall Study|Death|77|||
129444405|NCT00578786|465927336|FG002|Overall Study|Not Otherwise Specified|1|||
129444406|NCT00578786|465927334|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
129724158|NCT01450696|466949511|FG001|Overall Study|Death|84|||
129724159|NCT01450696|466949510|FG000|Overall Study|Lost to Follow-up|3|||
129724160|NCT01450696|466949511|FG001|Overall Study|Lost to Follow-up|3|||
129724161|NCT01450696|466949510|FG000|Overall Study|Non-Compliance|1|||
129724162|NCT01450696|466949511|FG001|Overall Study|Non-Compliance|0|||
129724163|NCT01450696|466949510|FG000|Overall Study|Withdrawal by Subject|13|||
129724164|NCT01450696|466949511|FG001|Overall Study|Withdrawal by Subject|2|||
129724165|NCT01450696|466949510|FG000|Overall Study|Study Terminated by Sponsor|53|||
129724166|NCT01450696|466949511|FG001|Overall Study|Study Terminated by Sponsor|58|||
129724167|NCT00967694|466949512|FG000|Overall Study|Withdrawal by Subject|6|||
129724168|NCT01843673|466949513|FG000|Overall Study|Lack of Efficacy|2|||
129724169|NCT01843673|466949513|FG000|Overall Study|Withdrawal by Subject|4|||
129724170|NCT02321319|466949514|FG000|Overall Study|Product discontinued|5|||
129724171|NCT02249091|466949515|FG000|Overall Study|Lack of Efficacy|8|||
129724172|NCT02249091|466949516|FG001|Overall Study|Lack of Efficacy|3|||
129724173|NCT02249091|466949515|FG000|Overall Study|Physician Decision|4|||
129724174|NCT02249091|466949516|FG001|Overall Study|Physician Decision|1|||
129724175|NCT02249091|466949515|FG000|Overall Study|Withdrawal by Subject|2|||
129724176|NCT02249091|466949516|FG001|Overall Study|Withdrawal by Subject|2|||
129724177|NCT02249091|466949515|FG000|Overall Study|Death|3|||
129724178|NCT02249091|466949516|FG001|Overall Study|Death|4|||
129724179|NCT02249091|466949515|FG000|Overall Study|Adverse Event|1|||
129724180|NCT02249091|466949516|FG001|Overall Study|Adverse Event|0|||
129724181|NCT02249091|466949515|FG000|Overall Study|Stable disease with following SCT|0|||
129724182|NCT02249091|466949516|FG001|Overall Study|Stable disease with following SCT|1|||
129724183|NCT02249091|466949515|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
129724184|NCT02249091|466949516|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
129724185|NCT02249091|466949515|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
129724186|NCT02249091|466949516|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
129724187|NCT02249091|466949515|FG000|Overall Study|Refractory AML|1|||
129724188|NCT02249091|466949516|FG001|Overall Study|Refractory AML|1|||
129724189|NCT02957747|466949517|FG000|Overall Study|Withdrawal by Subject|0|||
129724190|NCT02957747|466949518|FG001|Overall Study|Withdrawal by Subject|3|||
129724191|NCT02957747|466949517|FG000|Overall Study|Lost to Follow-up|10|||
129724192|NCT02957747|466949518|FG001|Overall Study|Lost to Follow-up|5|||
129724193|NCT00632827|466949519|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
129724194|NCT00632827|466949519|FG000|Overall Study|Death|2|||
129724195|NCT00632827|466949519|FG000|Overall Study|Adverse Event|5|||
129724196|NCT00632827|466949519|FG000|Overall Study|Lost to Follow-up|1|||
129724197|NCT03931382|466949522|FG000|Overall Study|Equipment malfunction|2|||
129724198|NCT03931382|466949523|FG001|Overall Study|Equipment malfunction|0|||
129724199|NCT03931382|466949524|FG002|Overall Study|Equipment malfunction|2|||
129724200|NCT03931382|466949522|FG000|Overall Study|Withdrawal by Subject|0|||
129724201|NCT03931382|466949523|FG001|Overall Study|Withdrawal by Subject|1|||
129724202|NCT03931382|466949524|FG002|Overall Study|Withdrawal by Subject|0|||
129724203|NCT00778375|466949530|FG000|Overall Study|Ineligible|3|||
129724204|NCT00939029|466949531|FG000|Overall Study|Withdrawal by Subject|3|||
129724205|NCT00939029|466949532|FG001|Overall Study|Withdrawal by Subject|7|||
129724206|NCT00939029|466949531|FG000|Overall Study|Lost to Follow-up|3|||
129724207|NCT00939029|466949532|FG001|Overall Study|Lost to Follow-up|4|||
129724208|NCT00939029|466949531|FG000|Overall Study|Adverse Event|0|||
129724209|NCT00939029|466949532|FG001|Overall Study|Adverse Event|1|||
129724210|NCT01421303|466949533|FG000|Overall Study|Lost to Follow-up|13|||
129724211|NCT01421303|466949533|FG000|Overall Study|Non compliance with study procedure|1|||
129724212|NCT01421303|466949533|FG000|Overall Study|Other|7|||
129724213|NCT01421303|466949533|FG000|Overall Study|Withdrawal by Subject|1|||
129724214|NCT06003777|466949534|FG000|Period 1|Adverse Event|0|||
129724215|NCT06003777|466949535|FG001|Period 1|Adverse Event|0|||
129724216|NCT06003777|466949536|FG002|Period 1|Adverse Event|1|||
129724217|NCT06003777|466949537|FG003|Period 1|Adverse Event|0|||
129724218|NCT06003777|466949538|FG004|Period 1|Adverse Event|0|||
129724219|NCT06003777|466949539|FG005|Period 1|Adverse Event|0|||
129724220|NCT06003777|466949540|FG006|Period 1|Adverse Event|0|||
129724221|NCT06003777|466949541|FG007|Period 1|Adverse Event|0|||
129724222|NCT06003777|466949542|FG008|Period 1|Adverse Event|0|||
129724223|NCT06003777|466949543|FG009|Period 1|Adverse Event|0|||
129724224|NCT06003777|466949544|FG010|Period 1|Adverse Event|0|||
129724225|NCT06003777|466949545|FG011|Period 1|Adverse Event|0|||
129724226|NCT06003777|466949534|FG000|Period 1|Withdrawal by Subject|0|||
129724227|NCT06003777|466949535|FG001|Period 1|Withdrawal by Subject|0|||
129724228|NCT06003777|466949536|FG002|Period 1|Withdrawal by Subject|0|||
129724229|NCT06003777|466949537|FG003|Period 1|Withdrawal by Subject|0|||
129724230|NCT06003777|466949538|FG004|Period 1|Withdrawal by Subject|1|||
129724231|NCT06003777|466949539|FG005|Period 1|Withdrawal by Subject|0|||
129724232|NCT06003777|466949540|FG006|Period 1|Withdrawal by Subject|0|||
129724233|NCT06003777|466949541|FG007|Period 1|Withdrawal by Subject|0|||
129724234|NCT06003777|466949542|FG008|Period 1|Withdrawal by Subject|0|||
129724235|NCT06003777|466949543|FG009|Period 1|Withdrawal by Subject|0|||
129724236|NCT06003777|466949544|FG010|Period 1|Withdrawal by Subject|0|||
129724237|NCT06003777|466949545|FG011|Period 1|Withdrawal by Subject|0|||
129724238|NCT06003777|466949534|FG000|Period 2|Withdrawal by Subject|0|||
129724239|NCT06003777|466949535|FG001|Period 2|Withdrawal by Subject|0|||
129724240|NCT06003777|466949536|FG002|Period 2|Withdrawal by Subject|0|||
129724241|NCT06003777|466949537|FG003|Period 2|Withdrawal by Subject|0|||
129724242|NCT06003777|466949538|FG004|Period 2|Withdrawal by Subject|0|||
129724243|NCT06003777|466949539|FG005|Period 2|Withdrawal by Subject|0|||
129724244|NCT06003777|466949540|FG006|Period 2|Withdrawal by Subject|0|||
129724245|NCT06003777|466949541|FG007|Period 2|Withdrawal by Subject|0|||
129724246|NCT06003777|466949542|FG008|Period 2|Withdrawal by Subject|1|||
129724247|NCT06003777|466949543|FG009|Period 2|Withdrawal by Subject|0|||
129724248|NCT06003777|466949544|FG010|Period 2|Withdrawal by Subject|0|||
129724249|NCT06003777|466949545|FG011|Period 2|Withdrawal by Subject|0|||
129724250|NCT06003777|466949534|FG000|Period 3|Adverse Event|0|||
129724251|NCT06003777|466949535|FG001|Period 3|Adverse Event|0|||
129724252|NCT06003777|466949536|FG002|Period 3|Adverse Event|0|||
129724253|NCT06003777|466949537|FG003|Period 3|Adverse Event|0|||
129724254|NCT06003777|466949538|FG004|Period 3|Adverse Event|0|||
129724255|NCT06003777|466949539|FG005|Period 3|Adverse Event|0|||
129724256|NCT06003777|466949540|FG006|Period 3|Adverse Event|1|||
129724257|NCT06003777|466949541|FG007|Period 3|Adverse Event|0|||
129724258|NCT06003777|466949542|FG008|Period 3|Adverse Event|0|||
129724259|NCT06003777|466949543|FG009|Period 3|Adverse Event|0|||
129724260|NCT06003777|466949544|FG010|Period 3|Adverse Event|0|||
129724261|NCT06003777|466949545|FG011|Period 3|Adverse Event|0|||
129724262|NCT06003777|466949534|FG000|Period 4|No longer met eligibility criteria|0|||
129724263|NCT06003777|466949535|FG001|Period 4|No longer met eligibility criteria|0|||
129724264|NCT06003777|466949536|FG002|Period 4|No longer met eligibility criteria|1|||
129724265|NCT06003777|466949537|FG003|Period 4|No longer met eligibility criteria|0|||
129724266|NCT06003777|466949538|FG004|Period 4|No longer met eligibility criteria|0|||
129724267|NCT06003777|466949539|FG005|Period 4|No longer met eligibility criteria|0|||
129724268|NCT06003777|466949540|FG006|Period 4|No longer met eligibility criteria|0|||
129724269|NCT06003777|466949541|FG007|Period 4|No longer met eligibility criteria|0|||
129724270|NCT06003777|466949542|FG008|Period 4|No longer met eligibility criteria|0|||
129724271|NCT06003777|466949543|FG009|Period 4|No longer met eligibility criteria|0|||
129724272|NCT06003777|466949544|FG010|Period 4|No longer met eligibility criteria|0|||
129724273|NCT06003777|466949545|FG011|Period 4|No longer met eligibility criteria|0|||
129724274|NCT06003777|466949534|FG000|Period 4|Withdrawal by Subject|0|||
129724275|NCT06003777|466949535|FG001|Period 4|Withdrawal by Subject|1|||
129724276|NCT06003777|466949536|FG002|Period 4|Withdrawal by Subject|0|||
129724277|NCT06003777|466949537|FG003|Period 4|Withdrawal by Subject|0|||
129724278|NCT06003777|466949538|FG004|Period 4|Withdrawal by Subject|0|||
129724279|NCT06003777|466949539|FG005|Period 4|Withdrawal by Subject|0|||
129724280|NCT06003777|466949540|FG006|Period 4|Withdrawal by Subject|0|||
129724281|NCT06003777|466949541|FG007|Period 4|Withdrawal by Subject|0|||
129724282|NCT06003777|466949542|FG008|Period 4|Withdrawal by Subject|0|||
129724283|NCT06003777|466949543|FG009|Period 4|Withdrawal by Subject|0|||
129724284|NCT06003777|466949544|FG010|Period 4|Withdrawal by Subject|0|||
129724285|NCT06003777|466949545|FG011|Period 4|Withdrawal by Subject|0|||
129724286|NCT04154605|466949548|FG000|Overall Study|Procedure Canceled|1|||
129724287|NCT04154605|466949549|FG001|Overall Study|Procedure Canceled|1|||
129724288|NCT04154605|466949548|FG000|Overall Study|Missed follow up|1|||
129724289|NCT04154605|466949549|FG001|Overall Study|Missed follow up|1|||
129724290|NCT04154605|466949548|FG000|Overall Study|Withdrawal by Subject|1|||
129724291|NCT04154605|466949549|FG001|Overall Study|Withdrawal by Subject|0|||
129724292|NCT00675441|466949550|FG000|Overall Study|Withdrawal by Subject|2|||
129724293|NCT00675441|466949550|FG000|Overall Study|Death|1|||
129724294|NCT00344318|466949554|FG000|Overall Study|Adverse Event|0|||
129724295|NCT00344318|466949555|FG001|Overall Study|Adverse Event|3|||
129724296|NCT00344318|466949556|FG002|Overall Study|Adverse Event|0|||
129724297|NCT00344318|466949557|FG003|Overall Study|Adverse Event|1|||
129724298|NCT00344318|466949554|FG000|Overall Study|Withdrawal by Subject|2|||
129724299|NCT00344318|466949555|FG001|Overall Study|Withdrawal by Subject|2|||
129724300|NCT00344318|466949556|FG002|Overall Study|Withdrawal by Subject|0|||
129724301|NCT00344318|466949557|FG003|Overall Study|Withdrawal by Subject|2|||
129724302|NCT00344318|466949554|FG000|Overall Study|Lost to Follow-up|2|||
129724303|NCT00344318|466949555|FG001|Overall Study|Lost to Follow-up|0|||
129724304|NCT00344318|466949556|FG002|Overall Study|Lost to Follow-up|1|||
129724305|NCT00344318|466949557|FG003|Overall Study|Lost to Follow-up|0|||
129724306|NCT01923363|466949558|FG000|Overall Study|Protocol Violation|1|||
129724307|NCT00656058|466949559|FG000|Overall Study|Withdrawal by Subject|2|||
129891659|NCT02223182|467561224|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
129891660|NCT02223182|467561225|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
129891661|NCT02223182|467561226|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
129891662|NCT02223182|467561223|FG000|Open-Label 500 Period|Physician Decision|0|||
129891663|NCT02223182|467561224|FG001|Open-Label 500 Period|Physician Decision|0|||
129891664|NCT02223182|467561225|FG002|Open-Label 500 Period|Physician Decision|0|||
129891665|NCT02223182|467561226|FG003|Open-Label 500 Period|Physician Decision|1|||
129891666|NCT02223182|467561223|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
129891667|NCT02223182|467561224|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
129891668|NCT02223182|467561225|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
129891669|NCT02223182|467561226|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
129891670|NCT02223182|467561223|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
129891671|NCT02223182|467561224|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
129891672|NCT02223182|467561225|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
129891673|NCT02223182|467561226|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
129891674|NCT02223182|467561223|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
129891675|NCT02223182|467561224|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
129891676|NCT02223182|467561225|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
129891677|NCT02223182|467561226|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
129891678|NCT02223182|467561223|FG000|Open-Label 300 Period|Non Compliance|0|||
129891679|NCT02223182|467561224|FG001|Open-Label 300 Period|Non Compliance|2|||
129891680|NCT02223182|467561225|FG002|Open-Label 300 Period|Non Compliance|1|||
129891681|NCT02223182|467561226|FG003|Open-Label 300 Period|Non Compliance|0|||
129891682|NCT03714022|467561227|FG000|Overall Study|Adverse Event|1|||
129891683|NCT03714022|467561228|FG001|Overall Study|Adverse Event|0|||
129891684|NCT03714022|467561227|FG000|Overall Study|Consent withdrawal|0|||
129891685|NCT03714022|467561228|FG001|Overall Study|Consent withdrawal|1|||
129891686|NCT03714022|467561227|FG000|Overall Study|Lost to Follow-up|3|||
129724308|NCT00656058|466949559|FG000|Overall Study|Withdrawal by Subject|4|||
129724309|NCT06359028|466949560|FG000|Overall Study|Adverse Event|1|||
129724310|NCT06359028|466949561|FG001|Overall Study|Adverse Event|0|||
129724311|NCT06359028|466949560|FG000|Overall Study|Withdrawal by Subject|1|||
129724312|NCT06359028|466949561|FG001|Overall Study|Withdrawal by Subject|0|||
129724313|NCT03515551|466949562|FG000|Overall Study|Death|4|||
129724314|NCT03515551|466949563|FG001|Overall Study|Death|1|||
129724315|NCT03515551|466949564|FG002|Overall Study|Death|2|||
129724316|NCT03515551|466949565|FG003|Overall Study|Death|2|||
129724317|NCT03515551|466949566|FG004|Overall Study|Death|2|||
129724318|NCT03515551|466949567|FG005|Overall Study|Death|4|||
129724319|NCT03515551|466949568|FG006|Overall Study|Death|1|||
129724320|NCT03515551|466949562|FG000|Overall Study|Lost to Follow-up|0|||
129724321|NCT03515551|466949563|FG001|Overall Study|Lost to Follow-up|0|||
129724322|NCT03515551|466949564|FG002|Overall Study|Lost to Follow-up|1|||
129724323|NCT03515551|466949565|FG003|Overall Study|Lost to Follow-up|0|||
129724324|NCT03515551|466949566|FG004|Overall Study|Lost to Follow-up|0|||
129724325|NCT03515551|466949567|FG005|Overall Study|Lost to Follow-up|0|||
129724326|NCT03515551|466949568|FG006|Overall Study|Lost to Follow-up|0|||
129724327|NCT03515551|466949562|FG000|Overall Study|Withdrawal by Subject|0|||
129724328|NCT03515551|466949563|FG001|Overall Study|Withdrawal by Subject|1|||
129724329|NCT03515551|466949564|FG002|Overall Study|Withdrawal by Subject|0|||
129724330|NCT03515551|466949565|FG003|Overall Study|Withdrawal by Subject|0|||
129724331|NCT03515551|466949566|FG004|Overall Study|Withdrawal by Subject|0|||
129724332|NCT03515551|466949567|FG005|Overall Study|Withdrawal by Subject|0|||
129724333|NCT03515551|466949568|FG006|Overall Study|Withdrawal by Subject|1|||
129724334|NCT03515551|466949562|FG000|Overall Study|Study ended by sponsor|0|||
129724335|NCT03515551|466949563|FG001|Overall Study|Study ended by sponsor|0|||
129891687|NCT03714022|467561228|FG001|Overall Study|Lost to Follow-up|2|||
129724336|NCT03515551|466949564|FG002|Overall Study|Study ended by sponsor|2|||
129724337|NCT03515551|466949565|FG003|Overall Study|Study ended by sponsor|1|||
129891688|NCT03289455|467561237|FG000|Overall Study|Death|1|||
129724338|NCT03515551|466949566|FG004|Overall Study|Study ended by sponsor|3|||
129891689|NCT03289455|467561238|FG001|Overall Study|Death|0|||
129891690|NCT03289455|467561239|FG002|Overall Study|Death|0|||
129891691|NCT03289455|467561237|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
129891692|NCT03289455|467561238|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
129891693|NCT03289455|467561239|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
129891694|NCT03289455|467561237|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
129724339|NCT03515551|466949567|FG005|Overall Study|Study ended by sponsor|0|||
129724340|NCT03515551|466949568|FG006|Overall Study|Study ended by sponsor|3|||
129724341|NCT03515551|466949562|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129724342|NCT03515551|466949563|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
129724343|NCT03515551|466949564|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129724344|NCT03515551|466949565|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129724345|NCT03515551|466949566|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129724346|NCT03515551|466949567|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129724347|NCT03515551|466949568|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
129724348|NCT00920387|466949569|FG000|Stage 1|Adverse Event|1|||
129724349|NCT00920387|466949570|FG001|Stage 1|Adverse Event|0|||
129724350|NCT00920387|466949571|FG002|Stage 1|Adverse Event|0|||
129724351|NCT02265536|466949572|FG000|Overall Study|Adverse Event|1|||
129724352|NCT02265536|466949573|FG001|Overall Study|Adverse Event|0|||
129724353|NCT02265536|466949574|FG002|Overall Study|Adverse Event|0|||
129724354|NCT02265536|466949575|FG003|Overall Study|Adverse Event|0|||
129724355|NCT02265536|466949576|FG004|Overall Study|Adverse Event|1|||
129724356|NCT02265536|466949577|FG005|Overall Study|Adverse Event|0|||
129724357|NCT02265536|466949572|FG000|Overall Study|Physician Decision|0|||
129724358|NCT02265536|466949573|FG001|Overall Study|Physician Decision|0|||
129724359|NCT02265536|466949574|FG002|Overall Study|Physician Decision|0|||
129724360|NCT02265536|466949575|FG003|Overall Study|Physician Decision|0|||
129724361|NCT02265536|466949576|FG004|Overall Study|Physician Decision|2|||
129724362|NCT02265536|466949577|FG005|Overall Study|Physician Decision|0|||
129724363|NCT02265536|466949572|FG000|Overall Study|Withdrawal by Subject|0|||
129724364|NCT02265536|466949573|FG001|Overall Study|Withdrawal by Subject|3|||
129724365|NCT02265536|466949574|FG002|Overall Study|Withdrawal by Subject|0|||
129724366|NCT02265536|466949575|FG003|Overall Study|Withdrawal by Subject|0|||
129724367|NCT02265536|466949576|FG004|Overall Study|Withdrawal by Subject|0|||
129724368|NCT02265536|466949577|FG005|Overall Study|Withdrawal by Subject|0|||
129724369|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
129724370|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
129724371|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
129724372|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
129724373|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
129724374|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
129724375|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
129724376|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
129724377|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
129724378|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
129724379|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
129724380|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
129724381|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
129724382|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
129724383|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
129724384|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
129724385|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
129724386|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
129724387|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
129724388|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
129724389|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
129724390|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
129724391|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
129724392|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
129724393|NCT01866111|466949578|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
129724394|NCT01866111|466949579|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
129724395|NCT01866111|466949580|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
129724396|NCT01866111|466949581|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
129724397|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
129724398|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
129724399|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
129724400|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
129724401|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
129724402|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
129724403|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
129891695|NCT03289455|467561238|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
129724404|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
129724405|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
129724406|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
129724407|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
129724408|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
129724409|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
129724410|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
129724411|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
129724412|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
129724413|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Death|1|||
129724414|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Death|1|||
129724415|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Death|3|||
129724416|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Death|2|||
129724417|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
129724418|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
129724419|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
129724420|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
129724421|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
129724422|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
129724423|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
129724424|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
129724425|NCT01866111|466949578|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
129724426|NCT01866111|466949579|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
129724427|NCT01866111|466949580|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
129724428|NCT01866111|466949581|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
129724429|NCT05596734|466949582|FG000|Substudy A|Withdrawal by Subject|1|||
129724430|NCT05596734|466949583|FG001|Substudy A|Withdrawal by Subject|0|||
129724431|NCT05596734|466949584|FG002|Substudy A|Withdrawal by Subject|0|||
129724432|NCT05596734|466949585|FG003|Substudy A|Withdrawal by Subject|0|||
129724433|NCT05596734|466949586|FG004|Substudy A|Withdrawal by Subject|0|||
129724434|NCT05596734|466949587|FG005|Substudy A|Withdrawal by Subject|0|||
129724435|NCT05596734|466949588|FG006|Substudy A|Withdrawal by Subject|1|||
129724436|NCT05596734|466949589|FG007|Substudy A|Withdrawal by Subject|0|||
129724437|NCT05596734|466949590|FG008|Substudy A|Withdrawal by Subject|0|||
129724438|NCT05596734|466949591|FG009|Substudy A|Withdrawal by Subject|0|||
129724439|NCT05596734|466949592|FG010|Substudy A|Withdrawal by Subject|0|||
129724440|NCT05596734|466949593|FG011|Substudy A|Withdrawal by Subject|0|||
129724441|NCT05596734|466949594|FG012|Substudy A|Withdrawal by Subject|0|||
129724442|NCT05596734|466949595|FG013|Substudy A|Withdrawal by Subject|0|||
129724443|NCT05596734|466949596|FG014|Substudy A|Withdrawal by Subject|0|||
129724444|NCT05596734|466949597|FG015|Substudy A|Withdrawal by Subject|0|||
129724445|NCT05596734|466949598|FG016|Substudy A|Withdrawal by Subject|0|||
129724446|NCT05596734|466949599|FG017|Substudy A|Withdrawal by Subject|0|||
129724447|NCT05596734|466949600|FG018|Substudy A|Withdrawal by Subject|0|||
129724448|NCT05596734|466949601|FG019|Substudy A|Withdrawal by Subject|0|||
129724449|NCT05596734|466949602|FG020|Substudy A|Withdrawal by Subject|0|||
129724450|NCT05596734|466949603|FG021|Substudy A|Withdrawal by Subject|0|||
129724451|NCT05596734|466949604|FG022|Substudy A|Withdrawal by Subject|0|||
129724452|NCT05596734|466949605|FG023|Substudy A|Withdrawal by Subject|0|||
129724453|NCT05596734|466949582|FG000|Substudy A|Lost to Follow-up|1|||
129724454|NCT05596734|466949583|FG001|Substudy A|Lost to Follow-up|0|||
129724455|NCT05596734|466949584|FG002|Substudy A|Lost to Follow-up|1|||
129724456|NCT05596734|466949585|FG003|Substudy A|Lost to Follow-up|0|||
129724457|NCT05596734|466949586|FG004|Substudy A|Lost to Follow-up|0|||
129724458|NCT05596734|466949587|FG005|Substudy A|Lost to Follow-up|0|||
129724459|NCT05596734|466949588|FG006|Substudy A|Lost to Follow-up|0|||
129724460|NCT05596734|466949589|FG007|Substudy A|Lost to Follow-up|0|||
129724461|NCT05596734|466949590|FG008|Substudy A|Lost to Follow-up|0|||
129724462|NCT05596734|466949591|FG009|Substudy A|Lost to Follow-up|0|||
129724463|NCT05596734|466949592|FG010|Substudy A|Lost to Follow-up|0|||
129724464|NCT05596734|466949593|FG011|Substudy A|Lost to Follow-up|0|||
129724465|NCT05596734|466949594|FG012|Substudy A|Lost to Follow-up|0|||
129724466|NCT05596734|466949595|FG013|Substudy A|Lost to Follow-up|0|||
129724467|NCT05596734|466949596|FG014|Substudy A|Lost to Follow-up|0|||
129724468|NCT05596734|466949597|FG015|Substudy A|Lost to Follow-up|0|||
129724469|NCT05596734|466949598|FG016|Substudy A|Lost to Follow-up|0|||
129724470|NCT05596734|466949599|FG017|Substudy A|Lost to Follow-up|0|||
129724471|NCT05596734|466949600|FG018|Substudy A|Lost to Follow-up|0|||
129724472|NCT05596734|466949601|FG019|Substudy A|Lost to Follow-up|0|||
129724473|NCT05596734|466949602|FG020|Substudy A|Lost to Follow-up|0|||
129724474|NCT05596734|466949603|FG021|Substudy A|Lost to Follow-up|0|||
129724475|NCT05596734|466949604|FG022|Substudy A|Lost to Follow-up|0|||
129724476|NCT05596734|466949605|FG023|Substudy A|Lost to Follow-up|0|||
129724477|NCT05596734|466949582|FG000|Substudy B|Withdrawal by Subject|0|||
129724478|NCT05596734|466949583|FG001|Substudy B|Withdrawal by Subject|0|||
129724479|NCT05596734|466949584|FG002|Substudy B|Withdrawal by Subject|0|||
129724480|NCT05596734|466949585|FG003|Substudy B|Withdrawal by Subject|0|||
129724481|NCT05596734|466949586|FG004|Substudy B|Withdrawal by Subject|0|||
129724482|NCT05596734|466949587|FG005|Substudy B|Withdrawal by Subject|0|||
129724483|NCT05596734|466949588|FG006|Substudy B|Withdrawal by Subject|0|||
129724484|NCT05596734|466949589|FG007|Substudy B|Withdrawal by Subject|0|||
129724485|NCT05596734|466949590|FG008|Substudy B|Withdrawal by Subject|0|||
129724486|NCT05596734|466949591|FG009|Substudy B|Withdrawal by Subject|0|||
129724487|NCT05596734|466949592|FG010|Substudy B|Withdrawal by Subject|0|||
129724488|NCT05596734|466949593|FG011|Substudy B|Withdrawal by Subject|0|||
129724489|NCT05596734|466949594|FG012|Substudy B|Withdrawal by Subject|1|||
129724490|NCT05596734|466949595|FG013|Substudy B|Withdrawal by Subject|0|||
129724491|NCT05596734|466949596|FG014|Substudy B|Withdrawal by Subject|1|||
129724492|NCT05596734|466949597|FG015|Substudy B|Withdrawal by Subject|2|||
129724493|NCT05596734|466949598|FG016|Substudy B|Withdrawal by Subject|2|||
129724494|NCT05596734|466949599|FG017|Substudy B|Withdrawal by Subject|1|||
129724495|NCT05596734|466949600|FG018|Substudy B|Withdrawal by Subject|2|||
129724496|NCT05596734|466949601|FG019|Substudy B|Withdrawal by Subject|0|||
129724497|NCT05596734|466949602|FG020|Substudy B|Withdrawal by Subject|0|||
129724498|NCT05596734|466949603|FG021|Substudy B|Withdrawal by Subject|0|||
129724499|NCT05596734|466949604|FG022|Substudy B|Withdrawal by Subject|0|||
129724500|NCT05596734|466949605|FG023|Substudy B|Withdrawal by Subject|1|||
129724501|NCT05596734|466949582|FG000|Substudy B|Physician Decision|0|||
129724502|NCT05596734|466949583|FG001|Substudy B|Physician Decision|0|||
129724503|NCT05596734|466949584|FG002|Substudy B|Physician Decision|0|||
129724504|NCT05596734|466949585|FG003|Substudy B|Physician Decision|0|||
129724505|NCT05596734|466949586|FG004|Substudy B|Physician Decision|0|||
129724506|NCT05596734|466949587|FG005|Substudy B|Physician Decision|0|||
129724507|NCT05596734|466949588|FG006|Substudy B|Physician Decision|0|||
129724508|NCT05596734|466949589|FG007|Substudy B|Physician Decision|0|||
129724509|NCT05596734|466949590|FG008|Substudy B|Physician Decision|0|||
129724510|NCT05596734|466949591|FG009|Substudy B|Physician Decision|0|||
129724511|NCT05596734|466949592|FG010|Substudy B|Physician Decision|0|||
129724512|NCT05596734|466949593|FG011|Substudy B|Physician Decision|0|||
129724513|NCT05596734|466949594|FG012|Substudy B|Physician Decision|0|||
129724514|NCT05596734|466949595|FG013|Substudy B|Physician Decision|0|||
129724515|NCT05596734|466949596|FG014|Substudy B|Physician Decision|0|||
129724516|NCT05596734|466949597|FG015|Substudy B|Physician Decision|1|||
129724517|NCT05596734|466949598|FG016|Substudy B|Physician Decision|0|||
129724518|NCT05596734|466949599|FG017|Substudy B|Physician Decision|0|||
129724519|NCT05596734|466949600|FG018|Substudy B|Physician Decision|0|||
129724520|NCT05596734|466949601|FG019|Substudy B|Physician Decision|0|||
129724521|NCT05596734|466949602|FG020|Substudy B|Physician Decision|0|||
129724522|NCT05596734|466949603|FG021|Substudy B|Physician Decision|0|||
129724523|NCT05596734|466949604|FG022|Substudy B|Physician Decision|0|||
129724524|NCT05596734|466949605|FG023|Substudy B|Physician Decision|0|||
129724525|NCT05596734|466949582|FG000|Substudy B|Lost to Follow-up|0|||
129724526|NCT05596734|466949583|FG001|Substudy B|Lost to Follow-up|0|||
129724527|NCT05596734|466949584|FG002|Substudy B|Lost to Follow-up|0|||
129724528|NCT05596734|466949585|FG003|Substudy B|Lost to Follow-up|0|||
129724529|NCT05596734|466949586|FG004|Substudy B|Lost to Follow-up|0|||
129724530|NCT05596734|466949587|FG005|Substudy B|Lost to Follow-up|0|||
129724531|NCT05596734|466949588|FG006|Substudy B|Lost to Follow-up|0|||
129724532|NCT05596734|466949589|FG007|Substudy B|Lost to Follow-up|0|||
129724533|NCT05596734|466949590|FG008|Substudy B|Lost to Follow-up|0|||
129724534|NCT05596734|466949591|FG009|Substudy B|Lost to Follow-up|0|||
129724535|NCT05596734|466949592|FG010|Substudy B|Lost to Follow-up|0|||
129724536|NCT05596734|466949593|FG011|Substudy B|Lost to Follow-up|0|||
129724537|NCT05596734|466949594|FG012|Substudy B|Lost to Follow-up|1|||
129724538|NCT05596734|466949595|FG013|Substudy B|Lost to Follow-up|0|||
129724539|NCT05596734|466949596|FG014|Substudy B|Lost to Follow-up|1|||
129724540|NCT05596734|466949597|FG015|Substudy B|Lost to Follow-up|1|||
129724541|NCT05596734|466949598|FG016|Substudy B|Lost to Follow-up|0|||
129724542|NCT05596734|466949599|FG017|Substudy B|Lost to Follow-up|0|||
129724543|NCT05596734|466949600|FG018|Substudy B|Lost to Follow-up|0|||
129724544|NCT05596734|466949601|FG019|Substudy B|Lost to Follow-up|0|||
129724545|NCT05596734|466949602|FG020|Substudy B|Lost to Follow-up|0|||
129724546|NCT05596734|466949603|FG021|Substudy B|Lost to Follow-up|0|||
129724547|NCT05596734|466949604|FG022|Substudy B|Lost to Follow-up|0|||
129724548|NCT05596734|466949605|FG023|Substudy B|Lost to Follow-up|0|||
129724549|NCT04113018|466949606|FG000|Overall Study|Death|2|||
129724550|NCT04113018|466949606|FG000|Overall Study|Lost to Follow-up|1|||
129724551|NCT04113018|466949606|FG000|Overall Study|Still On Study (on study treatment)|24|||
129724552|NCT04113018|466949606|FG000|Overall Study|Still On Study (in follow up)|12|||
129724553|NCT05005013|466949607|FG000|Overall Study|Withdrawal by Subject|5|||
129724554|NCT05005013|466949608|FG001|Overall Study|Withdrawal by Subject|1|||
129724555|NCT05005013|466949607|FG000|Overall Study|Lost to Follow-up|3|||
129724556|NCT05005013|466949608|FG001|Overall Study|Lost to Follow-up|1|||
129724557|NCT05005013|466949607|FG000|Overall Study|Ineligibility|1|||
129724558|NCT05005013|466949608|FG001|Overall Study|Ineligibility|1|||
129724559|NCT01802580|466949609|FG000|Overall Study|Physician Decision|1|||
129724560|NCT01802580|466949610|FG001|Overall Study|Physician Decision|0|||
129724561|NCT01802580|466949609|FG000|Overall Study|Protocol Violation|2|||
129724562|NCT01802580|466949610|FG001|Overall Study|Protocol Violation|0|||
129724563|NCT01802580|466949609|FG000|Overall Study|Withdrawal by Subject|5|||
129724564|NCT01802580|466949610|FG001|Overall Study|Withdrawal by Subject|6|||
129724565|NCT01802580|466949609|FG000|Overall Study|Other|1|||
129724566|NCT01802580|466949610|FG001|Overall Study|Other|3|||
129724567|NCT01802580|466949609|FG000|Overall Study|Lack of Efficacy|0|||
129724568|NCT01802580|466949610|FG001|Overall Study|Lack of Efficacy|2|||
129724569|NCT02791516|466949615|FG000|Overall Study|Withdrawal by Subject|1|||
129724570|NCT02791516|466949616|FG001|Overall Study|Withdrawal by Subject|1|||
129724571|NCT00211757|466949618|FG000|Overall Study|Withdrawal by Subject|1|||
129724572|NCT00211757|466949619|FG001|Overall Study|Withdrawal by Subject|1|||
129724573|NCT00211757|466949618|FG000|Overall Study|Lack of Efficacy|0|||
129724574|NCT00211757|466949619|FG001|Overall Study|Lack of Efficacy|1|||
129724575|NCT00322452|466949620|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129724576|NCT00322452|466949621|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129724577|NCT00322452|466949620|FG000|Overall Study|Lost to Follow-up|5|||
129724578|NCT00322452|466949621|FG001|Overall Study|Lost to Follow-up|2|||
129724579|NCT00322452|466949620|FG000|Overall Study|Withdrawal by Subject|19|||
129724580|NCT00322452|466949621|FG001|Overall Study|Withdrawal by Subject|46|||
129724581|NCT00322452|466949620|FG000|Overall Study|Death|223|||
129724582|NCT00322452|466949621|FG001|Overall Study|Death|227|||
129724583|NCT04091581|466949622|FG000|Overall Study|Lost to Follow-up|0|||
129724584|NCT04091581|466949623|FG001|Overall Study|Lost to Follow-up|1|||
129724585|NCT03372551|466951390|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
129724586|NCT03372551|466951391|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
129724587|NCT03727646|466951392|FG000|Overall Study|Adverse Event|1|||
129724588|NCT03727646|466951393|FG001|Overall Study|Adverse Event|0|||
129724589|NCT00327015|466951396|FG000|Overall Study|Lack of Efficacy|18|||
129724590|NCT00327015|466951397|FG001|Overall Study|Lack of Efficacy|18|||
129724591|NCT00327015|466951398|FG002|Overall Study|Lack of Efficacy|35|||
129724592|NCT00327015|466951399|FG003|Overall Study|Lack of Efficacy|29|||
129724593|NCT00327015|466951396|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
129724594|NCT00327015|466951397|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
129724595|NCT00327015|466951398|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
129724596|NCT00327015|466951399|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
129724597|NCT00327015|466951396|FG000|Overall Study|Lost to Follow-up|22|||
129724598|NCT00327015|466951397|FG001|Overall Study|Lost to Follow-up|23|||
129724599|NCT00327015|466951398|FG002|Overall Study|Lost to Follow-up|29|||
129724600|NCT00327015|466951399|FG003|Overall Study|Lost to Follow-up|22|||
129724601|NCT00327015|466951396|FG000|Overall Study|Adverse Event|14|||
129724602|NCT00327015|466951397|FG001|Overall Study|Adverse Event|10|||
129724603|NCT00327015|466951398|FG002|Overall Study|Adverse Event|14|||
129724604|NCT00327015|466951399|FG003|Overall Study|Adverse Event|14|||
129724605|NCT00327015|466951396|FG000|Overall Study|Subject no longer meets study criteria|4|||
129724606|NCT00327015|466951397|FG001|Overall Study|Subject no longer meets study criteria|2|||
129724607|NCT00327015|466951398|FG002|Overall Study|Subject no longer meets study criteria|8|||
129724608|NCT00327015|466951399|FG003|Overall Study|Subject no longer meets study criteria|7|||
129724609|NCT00327015|466951396|FG000|Overall Study|Poor/Noncompliance|11|||
129724610|NCT00327015|466951397|FG001|Overall Study|Poor/Noncompliance|8|||
129724611|NCT00327015|466951398|FG002|Overall Study|Poor/Noncompliance|4|||
129724612|NCT00327015|466951399|FG003|Overall Study|Poor/Noncompliance|5|||
129724613|NCT00327015|466951396|FG000|Overall Study|Physician Decision|0|||
129724614|NCT00327015|466951397|FG001|Overall Study|Physician Decision|1|||
129724615|NCT00327015|466951398|FG002|Overall Study|Physician Decision|3|||
129724616|NCT00327015|466951399|FG003|Overall Study|Physician Decision|2|||
129724617|NCT00327015|466951396|FG000|Overall Study|Death|1|||
129724618|NCT00327015|466951397|FG001|Overall Study|Death|2|||
129724619|NCT00327015|466951398|FG002|Overall Study|Death|2|||
129724620|NCT00327015|466951399|FG003|Overall Study|Death|3|||
129724621|NCT00327015|466951396|FG000|Overall Study|Pregnancy|0|||
129724622|NCT00327015|466951397|FG001|Overall Study|Pregnancy|2|||
129724623|NCT00327015|466951398|FG002|Overall Study|Pregnancy|1|||
129724624|NCT00327015|466951399|FG003|Overall Study|Pregnancy|1|||
129724625|NCT00327015|466951396|FG000|Overall Study|Administrative Reason by Sponsor|1|||
129724626|NCT00327015|466951397|FG001|Overall Study|Administrative Reason by Sponsor|2|||
129724627|NCT00327015|466951398|FG002|Overall Study|Administrative Reason by Sponsor|2|||
129724628|NCT00327015|466951399|FG003|Overall Study|Administrative Reason by Sponsor|1|||
129724629|NCT00837265|466951400|FG000|Pilot Phase|Withdrawal by Subject|0|||
129724630|NCT00837265|466951401|FG001|Pilot Phase|Withdrawal by Subject|2|||
129724631|NCT00837265|466951402|FG002|Pilot Phase|Withdrawal by Subject|3|||
129724632|NCT00837265|466951403|FG003|Pilot Phase|Withdrawal by Subject|2|||
129724633|NCT00837265|466951404|FG004|Pilot Phase|Withdrawal by Subject|0|||
129724634|NCT00837265|466951405|FG005|Pilot Phase|Withdrawal by Subject|0|||
129724635|NCT00837265|466951406|FG006|Pilot Phase|Withdrawal by Subject|0|||
129724636|NCT00837265|466951400|FG000|Pilot Phase|Decision of the investigator|2|||
129724637|NCT00837265|466951401|FG001|Pilot Phase|Decision of the investigator|1|||
129724638|NCT00837265|466951402|FG002|Pilot Phase|Decision of the investigator|0|||
129724639|NCT00837265|466951403|FG003|Pilot Phase|Decision of the investigator|0|||
129724640|NCT00837265|466951404|FG004|Pilot Phase|Decision of the investigator|0|||
129724641|NCT00837265|466951405|FG005|Pilot Phase|Decision of the investigator|0|||
129724642|NCT00837265|466951406|FG006|Pilot Phase|Decision of the investigator|0|||
129724643|NCT00837265|466951400|FG000|Pilot Phase|Adverse Event|1|||
129724644|NCT00837265|466951401|FG001|Pilot Phase|Adverse Event|0|||
129724645|NCT00837265|466951402|FG002|Pilot Phase|Adverse Event|0|||
129724646|NCT00837265|466951403|FG003|Pilot Phase|Adverse Event|0|||
129724647|NCT00837265|466951404|FG004|Pilot Phase|Adverse Event|0|||
129724648|NCT00837265|466951405|FG005|Pilot Phase|Adverse Event|0|||
129724649|NCT00837265|466951406|FG006|Pilot Phase|Adverse Event|0|||
129724650|NCT00837265|466951400|FG000|Pilot Phase|Disease progression|0|||
129724651|NCT00837265|466951401|FG001|Pilot Phase|Disease progression|0|||
129724652|NCT00837265|466951402|FG002|Pilot Phase|Disease progression|0|||
129724653|NCT00837265|466951403|FG003|Pilot Phase|Disease progression|1|||
129724654|NCT00837265|466951404|FG004|Pilot Phase|Disease progression|0|||
129724655|NCT00837265|466951405|FG005|Pilot Phase|Disease progression|0|||
129724656|NCT00837265|466951406|FG006|Pilot Phase|Disease progression|0|||
129724657|NCT00837265|466951400|FG000|Pilot Phase|Participant left the city|0|||
129724658|NCT00837265|466951401|FG001|Pilot Phase|Participant left the city|0|||
129724659|NCT00837265|466951402|FG002|Pilot Phase|Participant left the city|0|||
129724660|NCT00837265|466951403|FG003|Pilot Phase|Participant left the city|1|||
129724661|NCT00837265|466951404|FG004|Pilot Phase|Participant left the city|0|||
129724662|NCT00837265|466951405|FG005|Pilot Phase|Participant left the city|0|||
129724663|NCT00837265|466951406|FG006|Pilot Phase|Participant left the city|0|||
129724664|NCT00837265|466951400|FG000|Main Phase|Withdrawal by Subject|0|||
129724665|NCT00837265|466951401|FG001|Main Phase|Withdrawal by Subject|0|||
129724666|NCT00837265|466951402|FG002|Main Phase|Withdrawal by Subject|0|||
129724667|NCT00837265|466951403|FG003|Main Phase|Withdrawal by Subject|0|||
129724668|NCT00837265|466951404|FG004|Main Phase|Withdrawal by Subject|4|||
129724669|NCT00837265|466951405|FG005|Main Phase|Withdrawal by Subject|2|||
129724670|NCT00837265|466951406|FG006|Main Phase|Withdrawal by Subject|1|||
129724671|NCT00837265|466951400|FG000|Main Phase|Decision of the investigator|0|||
129724672|NCT00837265|466951401|FG001|Main Phase|Decision of the investigator|0|||
129724673|NCT00837265|466951402|FG002|Main Phase|Decision of the investigator|0|||
129724674|NCT00837265|466951403|FG003|Main Phase|Decision of the investigator|0|||
129724675|NCT00837265|466951404|FG004|Main Phase|Decision of the investigator|0|||
129724676|NCT00837265|466951405|FG005|Main Phase|Decision of the investigator|2|||
129724677|NCT00837265|466951406|FG006|Main Phase|Decision of the investigator|1|||
129724678|NCT00837265|466951400|FG000|Main Phase|Adverse Event|0|||
129724679|NCT00837265|466951401|FG001|Main Phase|Adverse Event|0|||
129724680|NCT00837265|466951402|FG002|Main Phase|Adverse Event|0|||
129724681|NCT00837265|466951403|FG003|Main Phase|Adverse Event|0|||
129724682|NCT00837265|466951404|FG004|Main Phase|Adverse Event|0|||
129724683|NCT00837265|466951405|FG005|Main Phase|Adverse Event|1|||
129724684|NCT00837265|466951406|FG006|Main Phase|Adverse Event|0|||
129724685|NCT00837265|466951400|FG000|Main Phase|Death|0|||
129724686|NCT00837265|466951401|FG001|Main Phase|Death|0|||
129724687|NCT00837265|466951402|FG002|Main Phase|Death|0|||
129724688|NCT00837265|466951403|FG003|Main Phase|Death|0|||
129724689|NCT00837265|466951404|FG004|Main Phase|Death|2|||
129724690|NCT00837265|466951405|FG005|Main Phase|Death|0|||
129724691|NCT00837265|466951406|FG006|Main Phase|Death|1|||
129724692|NCT00837265|466951400|FG000|Main Phase|Lost to Follow-up|0|||
129724693|NCT00837265|466951401|FG001|Main Phase|Lost to Follow-up|0|||
129724694|NCT00837265|466951402|FG002|Main Phase|Lost to Follow-up|0|||
129724695|NCT00837265|466951403|FG003|Main Phase|Lost to Follow-up|0|||
129724696|NCT00837265|466951404|FG004|Main Phase|Lost to Follow-up|1|||
129724697|NCT00837265|466951405|FG005|Main Phase|Lost to Follow-up|0|||
129724698|NCT00837265|466951406|FG006|Main Phase|Lost to Follow-up|0|||
129724699|NCT00837265|466951400|FG000|Main Phase|Principal investigator resignation|0|||
129724700|NCT00837265|466951401|FG001|Main Phase|Principal investigator resignation|0|||
129724701|NCT00837265|466951402|FG002|Main Phase|Principal investigator resignation|0|||
129724702|NCT00837265|466951403|FG003|Main Phase|Principal investigator resignation|0|||
129724703|NCT00837265|466951404|FG004|Main Phase|Principal investigator resignation|2|||
129724704|NCT00837265|466951405|FG005|Main Phase|Principal investigator resignation|0|||
129724705|NCT00837265|466951406|FG006|Main Phase|Principal investigator resignation|0|||
129724706|NCT00837265|466951400|FG000|Main Phase|Participant's personal reason|0|||
129724707|NCT00837265|466951401|FG001|Main Phase|Participant's personal reason|0|||
129724708|NCT00837265|466951402|FG002|Main Phase|Participant's personal reason|0|||
129724709|NCT00837265|466951403|FG003|Main Phase|Participant's personal reason|0|||
129724710|NCT00837265|466951404|FG004|Main Phase|Participant's personal reason|1|||
129724711|NCT00837265|466951405|FG005|Main Phase|Participant's personal reason|0|||
129724712|NCT00837265|466951406|FG006|Main Phase|Participant's personal reason|0|||
129724713|NCT00473668|466951409|FG000|Overall Study|Withdrawal by Subject|0|||
129804055|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
129804056|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804057|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804058|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129724714|NCT00473668|466951410|FG001|Overall Study|Withdrawal by Subject|2|||
129724715|NCT00473668|466951411|FG002|Overall Study|Withdrawal by Subject|0|||
129724716|NCT00473668|466951409|FG000|Overall Study|Migrated/moved from study area|3|||
129724717|NCT00473668|466951410|FG001|Overall Study|Migrated/moved from study area|2|||
129724718|NCT00473668|466951411|FG002|Overall Study|Migrated/moved from study area|0|||
129724719|NCT00473668|466951409|FG000|Overall Study|Lost to Follow-up|0|||
129724720|NCT00473668|466951410|FG001|Overall Study|Lost to Follow-up|4|||
129724721|NCT00473668|466951411|FG002|Overall Study|Lost to Follow-up|6|||
129724722|NCT00473668|466951409|FG000|Overall Study|Other|2|||
129724723|NCT00473668|466951410|FG001|Overall Study|Other|3|||
129724724|NCT00473668|466951411|FG002|Overall Study|Other|4|||
129724725|NCT02226562|466951412|FG000|Overall Study|Lost to Follow-up|0|||
129724726|NCT02226562|466951413|FG001|Overall Study|Lost to Follow-up|1|||
129724727|NCT01474772|466951415|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
129724728|NCT01474772|466951416|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
129724729|NCT01474772|466951415|FG000|Period 1|AE not Related to Study Drug|1|||
129724730|NCT01474772|466951416|FG001|Period 1|AE not Related to Study Drug|0|||
129724731|NCT01474772|466951415|FG000|Period 1|Withdrawal by Subject|3|||
129724732|NCT01474772|466951416|FG001|Period 1|Withdrawal by Subject|1|||
129724733|NCT01474772|466951415|FG000|Period 1|Lost to Follow-up|1|||
129724734|NCT01474772|466951416|FG001|Period 1|Lost to Follow-up|0|||
129724735|NCT01474772|466951415|FG000|Period 1|Reason not Specified|1|||
129724736|NCT01474772|466951416|FG001|Period 1|Reason not Specified|1|||
129724737|NCT01474772|466951415|FG000|Washout|AE not Related to Study Drug|2|||
129724738|NCT01474772|466951416|FG001|Washout|AE not Related to Study Drug|0|||
129724739|NCT01474772|466951415|FG000|Washout|Withdrawal by Subject|1|||
129724740|NCT01474772|466951416|FG001|Washout|Withdrawal by Subject|0|||
129724741|NCT01474772|466951415|FG000|Washout|Lost to Follow-up|0|||
129724742|NCT01474772|466951416|FG001|Washout|Lost to Follow-up|1|||
129724743|NCT01474772|466951415|FG000|Washout|Reason not Specified|0|||
129724744|NCT01474772|466951416|FG001|Washout|Reason not Specified|1|||
129724745|NCT01474772|466951415|FG000|Period 2|Death|0|||
129724746|NCT01474772|466951416|FG001|Period 2|Death|1|||
129724747|NCT01474772|466951415|FG000|Period 2|AE Related to Study Drug|0|||
129724748|NCT01474772|466951416|FG001|Period 2|AE Related to Study Drug|1|||
129724749|NCT01474772|466951415|FG000|Period 2|AE not Related to Study Drug|4|||
129724750|NCT01474772|466951416|FG001|Period 2|AE not Related to Study Drug|1|||
129724751|NCT01474772|466951415|FG000|Period 2|Lack of Efficacy|1|||
129724752|NCT01474772|466951416|FG001|Period 2|Lack of Efficacy|0|||
129724753|NCT01474772|466951415|FG000|Period 2|Withdrawal by Subject|3|||
129724754|NCT01474772|466951416|FG001|Period 2|Withdrawal by Subject|4|||
129724755|NCT01474772|466951415|FG000|Period 2|Lost to Follow-up|1|||
129724756|NCT01474772|466951416|FG001|Period 2|Lost to Follow-up|1|||
129724757|NCT01474772|466951415|FG000|Period 2|Reason not Specified|0|||
129724758|NCT01474772|466951416|FG001|Period 2|Reason not Specified|2|||
129724759|NCT01474772|466951415|FG000|Follow-up|AE not Related to Study Drug|0|||
129724760|NCT01474772|466951416|FG001|Follow-up|AE not Related to Study Drug|1|||
129724761|NCT00223808|466951417|FG000|Overall Study|<5 hrs therapy before discharge|3|||
129724762|NCT00223808|466951418|FG001|Overall Study|<5 hrs therapy before discharge|5|||
129724763|NCT00223808|466951419|FG002|Overall Study|<5 hrs therapy before discharge|5|||
129724764|NCT03195660|466951420|FG000|Overall Study|The study was terminated|2|||
129724765|NCT05260073|466951422|FG000|Overall Study|Physician Decision|1|||
129724766|NCT05260073|466951422|FG000|Overall Study|Withdrawal by Subject|6|||
129724767|NCT05260073|466951422|FG000|Overall Study|Lost to Follow-up|14|||
129724768|NCT03458910|466951423|FG000|Overall Study|Withdrawal by Subject|7|||
129724769|NCT03458910|466951424|FG001|Overall Study|Withdrawal by Subject|8|||
129724770|NCT03458910|466951425|FG002|Overall Study|Withdrawal by Subject|6|||
129724771|NCT03458910|466951426|FG003|Overall Study|Withdrawal by Subject|4|||
129724772|NCT03458910|466951423|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
129724773|NCT03458910|466951424|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
129724774|NCT03458910|466951425|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
129724775|NCT03458910|466951426|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
129724776|NCT04484649|466951427|FG000|Overall Study|Lost to Follow-up|2|||
129724777|NCT04484649|466951428|FG001|Overall Study|Lost to Follow-up|1|||
129724778|NCT04484649|466951427|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
129724779|NCT04484649|466951428|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
129724780|NCT00152477|466951433|FG000|Chemotherapy Period|Adverse Event|9|||
129724781|NCT00152477|466951434|FG001|Chemotherapy Period|Adverse Event|4|||
129724782|NCT00152477|466951435|FG002|Chemotherapy Period|Adverse Event|5|||
129724783|NCT00152477|466951433|FG000|Chemotherapy Period|Death|1|||
129724784|NCT00152477|466951434|FG001|Chemotherapy Period|Death|3|||
129724785|NCT00152477|466951435|FG002|Chemotherapy Period|Death|3|||
129724786|NCT00152477|466951433|FG000|Chemotherapy Period|Lack of Efficacy|4|||
129724787|NCT00152477|466951434|FG001|Chemotherapy Period|Lack of Efficacy|5|||
129724788|NCT00152477|466951435|FG002|Chemotherapy Period|Lack of Efficacy|6|||
129724789|NCT00152477|466951433|FG000|Chemotherapy Period|Lost to Follow-up|1|||
129724790|NCT00152477|466951434|FG001|Chemotherapy Period|Lost to Follow-up|0|||
129724791|NCT00152477|466951435|FG002|Chemotherapy Period|Lost to Follow-up|1|||
129724792|NCT00152477|466951433|FG000|Chemotherapy Period|Protocol Violation|1|||
129724793|NCT00152477|466951434|FG001|Chemotherapy Period|Protocol Violation|1|||
129724794|NCT00152477|466951435|FG002|Chemotherapy Period|Protocol Violation|0|||
129724795|NCT00152477|466951433|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
129724796|NCT00152477|466951434|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
129724797|NCT00152477|466951435|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
129724798|NCT00152477|466951433|FG000|Chemotherapy Period|Progression of Disease|6|||
129724799|NCT00152477|466951434|FG001|Chemotherapy Period|Progression of Disease|8|||
129724800|NCT00152477|466951435|FG002|Chemotherapy Period|Progression of Disease|4|||
129724801|NCT00152477|466951433|FG000|Chemotherapy Period|Investigator decision|0|||
129724802|NCT00152477|466951434|FG001|Chemotherapy Period|Investigator decision|0|||
129724803|NCT00152477|466951435|FG002|Chemotherapy Period|Investigator decision|1|||
129724804|NCT00152477|466951433|FG000|Chemotherapy Period|Patient condition worsened|1|||
129724805|NCT00152477|466951434|FG001|Chemotherapy Period|Patient condition worsened|0|||
129724806|NCT00152477|466951435|FG002|Chemotherapy Period|Patient condition worsened|0|||
129724807|NCT00152477|466951433|FG000|Monotherapy Period|Adverse Event|1|||
129724808|NCT00152477|466951434|FG001|Monotherapy Period|Adverse Event|0|||
129724809|NCT00152477|466951435|FG002|Monotherapy Period|Adverse Event|5|||
129724810|NCT00152477|466951433|FG000|Monotherapy Period|Death|2|||
129724811|NCT00152477|466951434|FG001|Monotherapy Period|Death|0|||
129724812|NCT00152477|466951435|FG002|Monotherapy Period|Death|1|||
129724813|NCT00152477|466951433|FG000|Monotherapy Period|Lack of Efficacy|7|||
129724814|NCT00152477|466951434|FG001|Monotherapy Period|Lack of Efficacy|16|||
129724815|NCT00152477|466951435|FG002|Monotherapy Period|Lack of Efficacy|10|||
129724816|NCT00152477|466951433|FG000|Monotherapy Period|Protocol Violation|0|||
129724817|NCT00152477|466951434|FG001|Monotherapy Period|Protocol Violation|1|||
129724818|NCT00152477|466951435|FG002|Monotherapy Period|Protocol Violation|0|||
129724819|NCT00152477|466951433|FG000|Monotherapy Period|Withdrawal by Subject|0|||
129724820|NCT00152477|466951434|FG001|Monotherapy Period|Withdrawal by Subject|0|||
129724821|NCT00152477|466951435|FG002|Monotherapy Period|Withdrawal by Subject|4|||
129724822|NCT00152477|466951433|FG000|Monotherapy Period|Progression of Disease|5|||
129724823|NCT00152477|466951434|FG001|Monotherapy Period|Progression of Disease|11|||
129724824|NCT00152477|466951435|FG002|Monotherapy Period|Progression of Disease|12|||
129724825|NCT00152477|466951433|FG000|Monotherapy Period|Patient decision|0|||
129724826|NCT00152477|466951434|FG001|Monotherapy Period|Patient decision|1|||
129724827|NCT00152477|466951435|FG002|Monotherapy Period|Patient decision|1|||
129724828|NCT00152477|466951433|FG000|Monotherapy Period|Study personel decision|0|||
129724829|NCT00152477|466951434|FG001|Monotherapy Period|Study personel decision|0|||
129724830|NCT00152477|466951435|FG002|Monotherapy Period|Study personel decision|1|||
129724831|NCT02570152|466951436|FG000|Overall Study|Protocol Violation|2|||
129724832|NCT02570152|466951436|FG000|Overall Study|Migrated/moved from study area|13|||
129724833|NCT00923975|466951438|FG000|Overall Study|Did not meet inclusion criteria|1|||
129724834|NCT01328535|466951439|FG000|Overall Study|Ineligible|1|||
129724835|NCT01005316|466951440|FG000|Overall Study|Adverse Event|0|||
129724836|NCT01005316|466951441|FG001|Overall Study|Adverse Event|0|||
129724837|NCT01005316|466951442|FG002|Overall Study|Adverse Event|0|||
129724838|NCT01005316|466951443|FG003|Overall Study|Adverse Event|1|||
129724839|NCT01005316|466951440|FG000|Overall Study|Death|20|||
129724840|NCT01005316|466951441|FG001|Overall Study|Death|5|||
129724841|NCT01005316|466951442|FG002|Overall Study|Death|1|||
129724842|NCT01005316|466951443|FG003|Overall Study|Death|15|||
129724843|NCT01005316|466951440|FG000|Overall Study|Study Termination|5|||
129724844|NCT01005316|466951441|FG001|Overall Study|Study Termination|63|||
129724845|NCT01005316|466951442|FG002|Overall Study|Study Termination|9|||
129724846|NCT01005316|466951443|FG003|Overall Study|Study Termination|85|||
129724847|NCT01005316|466951440|FG000|Overall Study|Lost to Follow-up|1|||
129724848|NCT01005316|466951441|FG001|Overall Study|Lost to Follow-up|3|||
129724849|NCT01005316|466951442|FG002|Overall Study|Lost to Follow-up|0|||
129724850|NCT01005316|466951443|FG003|Overall Study|Lost to Follow-up|2|||
129724851|NCT01005316|466951440|FG000|Overall Study|Physician Decision|6|||
129724852|NCT01005316|466951441|FG001|Overall Study|Physician Decision|0|||
129724853|NCT01005316|466951442|FG002|Overall Study|Physician Decision|0|||
129724854|NCT01005316|466951443|FG003|Overall Study|Physician Decision|0|||
129724855|NCT01005316|466951440|FG000|Overall Study|Sponsor Decision|6|||
129724856|NCT01005316|466951441|FG001|Overall Study|Sponsor Decision|3|||
129724857|NCT01005316|466951442|FG002|Overall Study|Sponsor Decision|0|||
129724858|NCT01005316|466951443|FG003|Overall Study|Sponsor Decision|0|||
129724859|NCT01005316|466951440|FG000|Overall Study|Withdrawal by Subject|1|||
129724860|NCT01005316|466951441|FG001|Overall Study|Withdrawal by Subject|1|||
129724861|NCT01005316|466951442|FG002|Overall Study|Withdrawal by Subject|0|||
129724862|NCT01005316|466951443|FG003|Overall Study|Withdrawal by Subject|2|||
129724863|NCT01005316|466951440|FG000|Overall Study|Consented to Another Study|2|||
129724864|NCT01005316|466951441|FG001|Overall Study|Consented to Another Study|0|||
129724865|NCT01005316|466951442|FG002|Overall Study|Consented to Another Study|0|||
129724866|NCT01005316|466951443|FG003|Overall Study|Consented to Another Study|0|||
129724867|NCT01005316|466951440|FG000|Overall Study|Delisted|8|||
129724868|NCT01005316|466951441|FG001|Overall Study|Delisted|0|||
129724869|NCT01005316|466951442|FG002|Overall Study|Delisted|0|||
129724870|NCT01005316|466951443|FG003|Overall Study|Delisted|0|||
129724871|NCT01005316|466951440|FG000|Overall Study|Transferred Care|1|||
129724872|NCT01005316|466951441|FG001|Overall Study|Transferred Care|0|||
129724873|NCT01005316|466951442|FG002|Overall Study|Transferred Care|1|||
129724874|NCT01005316|466951443|FG003|Overall Study|Transferred Care|3|||
129724875|NCT01005316|466951440|FG000|Overall Study|Retransplanted|0|||
129724876|NCT01005316|466951441|FG001|Overall Study|Retransplanted|1|||
129724877|NCT01005316|466951442|FG002|Overall Study|Retransplanted|0|||
129724878|NCT01005316|466951443|FG003|Overall Study|Retransplanted|0|||
129724879|NCT00960011|466951444|FG000|Overall Study|Death|5|||
129724880|NCT00960011|466951445|FG001|Overall Study|Death|0|||
129724881|NCT00960011|466951444|FG000|Overall Study|Lost to Follow-up|6|||
129724882|NCT00960011|466951445|FG001|Overall Study|Lost to Follow-up|2|||
129724883|NCT04417218|466951446|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
129724884|NCT04417218|466951447|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
129724885|NCT01734395|466951450|FG000|Overall Study|Other|65|||
129724886|NCT01734395|466951450|FG000|Overall Study|Lost to Follow-up|287|||
129724887|NCT01734395|466951450|FG000|Overall Study|Lack of Efficacy|5|||
129724888|NCT01734395|466951450|FG000|Overall Study|Adverse Event|40|||
129724889|NCT01734395|466951450|FG000|Overall Study|Withdrawal by Subject|10|||
129724890|NCT01734395|466951450|FG000|Overall Study|Missing the reasons for not completed|3|||
129724891|NCT01032291|466951451|FG000|Safety Lead-in|Adverse Event|1|||
129724892|NCT01032291|466951452|FG001|Safety Lead-in|Adverse Event|0|||
129724893|NCT01032291|466951453|FG002|Safety Lead-in|Adverse Event|0|||
129724894|NCT01032291|466951451|FG000|Safety Lead-in|Death|1|||
129724895|NCT01032291|466951452|FG001|Safety Lead-in|Death|0|||
129724896|NCT01032291|466951453|FG002|Safety Lead-in|Death|0|||
129724897|NCT01032291|466951451|FG000|Proof of Concept|Adverse Event|0|||
129724898|NCT01032291|466951452|FG001|Proof of Concept|Adverse Event|5|||
129724899|NCT01032291|466951453|FG002|Proof of Concept|Adverse Event|1|||
129724900|NCT01032291|466951451|FG000|Proof of Concept|Death|0|||
129724901|NCT01032291|466951452|FG001|Proof of Concept|Death|1|||
129724902|NCT01032291|466951453|FG002|Proof of Concept|Death|2|||
129724903|NCT01032291|466951451|FG000|Proof of Concept|Lack of Efficacy|0|||
129724904|NCT01032291|466951452|FG001|Proof of Concept|Lack of Efficacy|1|||
129724905|NCT01032291|466951453|FG002|Proof of Concept|Lack of Efficacy|0|||
129724906|NCT01032291|466951451|FG000|Proof of Concept|Never Received Study Drug|0|||
129724907|NCT01032291|466951452|FG001|Proof of Concept|Never Received Study Drug|1|||
129724908|NCT01032291|466951453|FG002|Proof of Concept|Never Received Study Drug|0|||
129724909|NCT00313313|466951454|FG000|Overall Study|Lack of Efficacy|14|||
129724910|NCT00313313|466951455|FG001|Overall Study|Lack of Efficacy|9|||
129724911|NCT00313313|466951456|FG002|Overall Study|Lack of Efficacy|20|||
129724912|NCT00313313|466951454|FG000|Overall Study|Withdrawal of consent by subject|18|||
129724913|NCT00313313|466951455|FG001|Overall Study|Withdrawal of consent by subject|17|||
129724914|NCT00313313|466951456|FG002|Overall Study|Withdrawal of consent by subject|31|||
129724915|NCT00313313|466951454|FG000|Overall Study|Lost to Follow-up|10|||
129724916|NCT00313313|466951455|FG001|Overall Study|Lost to Follow-up|7|||
129724917|NCT00313313|466951456|FG002|Overall Study|Lost to Follow-up|9|||
129724918|NCT00313313|466951454|FG000|Overall Study|Adverse Event|15|||
129724919|NCT00313313|466951455|FG001|Overall Study|Adverse Event|16|||
129724920|NCT00313313|466951456|FG002|Overall Study|Adverse Event|12|||
129724921|NCT00313313|466951454|FG000|Overall Study|Physician Decision|2|||
129891696|NCT03289455|467561239|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
129724922|NCT00313313|466951455|FG001|Overall Study|Physician Decision|6|||
129724923|NCT00313313|466951456|FG002|Overall Study|Physician Decision|4|||
129724924|NCT00313313|466951454|FG000|Overall Study|Poor/Noncompliance|3|||
129724925|NCT00313313|466951455|FG001|Overall Study|Poor/Noncompliance|6|||
129724926|NCT00313313|466951456|FG002|Overall Study|Poor/Noncompliance|2|||
129724927|NCT00313313|466951454|FG000|Overall Study|Pregnancy|1|||
129724928|NCT00313313|466951455|FG001|Overall Study|Pregnancy|2|||
129724929|NCT00313313|466951456|FG002|Overall Study|Pregnancy|0|||
129724930|NCT00313313|466951454|FG000|Overall Study|Death|0|||
129724931|NCT00313313|466951455|FG001|Overall Study|Death|0|||
129724932|NCT00313313|466951456|FG002|Overall Study|Death|2|||
129724933|NCT00313313|466951454|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129724934|NCT00313313|466951455|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
129724935|NCT00313313|466951456|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
129724936|NCT00758264|466951457|FG000|Active Phase|Withdrawal by Subject|0|||
129724937|NCT00758264|466951458|FG001|Active Phase|Withdrawal by Subject|0|||
129724938|NCT00758264|466951459|FG002|Active Phase|Withdrawal by Subject|1|||
129724939|NCT00758264|466951457|FG000|Active Phase|Lost to Follow-up|1|||
129724940|NCT00758264|466951458|FG001|Active Phase|Lost to Follow-up|0|||
129724941|NCT00758264|466951459|FG002|Active Phase|Lost to Follow-up|0|||
129724942|NCT00758264|466951457|FG000|Active Phase|Other|0|||
129724943|NCT00758264|466951458|FG001|Active Phase|Other|0|||
129724944|NCT00758264|466951459|FG002|Active Phase|Other|4|||
129724945|NCT03425006|466951460|FG000|Overall Study|Withdrawal by Subject|1|||
129724946|NCT03425006|466951460|FG000|Overall Study|Physician Decision|1|||
129724947|NCT03425006|466951460|FG000|Overall Study|Death|1|||
129724948|NCT01177553|466951461|FG000|Overall Study|babies not yet 6 months of age|1|||
129724949|NCT01177553|466951462|FG001|Overall Study|babies not yet 6 months of age|0|||
129724950|NCT00695955|466951469|FG000|Cohort 1|Adverse Event|26|||
129724951|NCT00695955|466951469|FG000|Cohort 1|Protocol Violation|2|||
129724952|NCT00695955|466951469|FG000|Cohort 1|Lost to Follow-up|30|||
129724953|NCT00695955|466951469|FG000|Cohort 1|Withdrawal by Subject|25|||
129724954|NCT00695955|466951469|FG000|Cohort 1|Lack of Efficacy|3|||
129724955|NCT00695955|466951469|FG000|Cohort 1|Other|16|||
129724956|NCT00695955|466951469|FG000|Cohort 2|Adverse Event|24|||
129724957|NCT00695955|466951469|FG000|Cohort 2|Protocol Violation|5|||
129724958|NCT00695955|466951469|FG000|Cohort 2|Lost to Follow-up|38|||
129724959|NCT00695955|466951469|FG000|Cohort 2|Withdrawal by Subject|28|||
129724960|NCT00695955|466951469|FG000|Cohort 2|Lack of Efficacy|4|||
129724961|NCT00695955|466951469|FG000|Cohort 2|Other|5|||
129724962|NCT00888329|466951470|FG000|Overall Study|Physician Decision|6|||
129724963|NCT00888329|466951471|FG001|Overall Study|Physician Decision|9|||
129724964|NCT01106651|466951473|FG000|Overall Study|Adverse Event|17|||
129724965|NCT01106651|466951474|FG001|Overall Study|Adverse Event|9|||
129724966|NCT01106651|466951475|FG002|Overall Study|Adverse Event|23|||
129724967|NCT01106651|466951473|FG000|Overall Study|Lost to Follow-up|8|||
129724968|NCT01106651|466951474|FG001|Overall Study|Lost to Follow-up|2|||
129724969|NCT01106651|466951475|FG002|Overall Study|Lost to Follow-up|6|||
129804059|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804060|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804061|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
129804062|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
129804063|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804064|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804065|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804066|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804067|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804068|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
129804069|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
129804070|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804071|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804072|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804073|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129891697|NCT03289455|467561237|FG000|Overall Study|Progressive disease|3|||
129891698|NCT03289455|467561238|FG001|Overall Study|Progressive disease|4|||
129724970|NCT01106651|466951473|FG000|Overall Study|Physician Decision|4|||
129724971|NCT01106651|466951474|FG001|Overall Study|Physician Decision|3|||
129724972|NCT01106651|466951475|FG002|Overall Study|Physician Decision|1|||
129724973|NCT01106651|466951473|FG000|Overall Study|Protocol Violation|1|||
129444407|NCT00578786|465927335|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
129724974|NCT01106651|466951474|FG001|Overall Study|Protocol Violation|2|||
129724975|NCT01106651|466951475|FG002|Overall Study|Protocol Violation|1|||
129724976|NCT01106651|466951473|FG000|Overall Study|Withdrawal by Subject|14|||
129724977|NCT01106651|466951474|FG001|Overall Study|Withdrawal by Subject|7|||
129724978|NCT01106651|466951475|FG002|Overall Study|Withdrawal by Subject|4|||
129724979|NCT01106651|466951473|FG000|Overall Study|Noncompliance with study drug|1|||
129724980|NCT01106651|466951474|FG001|Overall Study|Noncompliance with study drug|0|||
129724981|NCT01106651|466951475|FG002|Overall Study|Noncompliance with study drug|2|||
129724982|NCT01106651|466951473|FG000|Overall Study|Other|34|||
129724983|NCT01106651|466951474|FG001|Overall Study|Other|31|||
129724984|NCT01106651|466951475|FG002|Overall Study|Other|21|||
129724985|NCT01106651|466951473|FG000|Overall Study|Death|0|||
129724986|NCT01106651|466951474|FG001|Overall Study|Death|3|||
129724987|NCT01106651|466951475|FG002|Overall Study|Death|0|||
129724988|NCT04590404|466951476|FG000|Overall Study|Death|16|||
129724989|NCT04590404|466951477|FG001|Overall Study|Death|17|||
129724990|NCT04590404|466951476|FG000|Overall Study|Withdrawal by Subject|7|||
129724991|NCT04590404|466951477|FG001|Overall Study|Withdrawal by Subject|2|||
129724992|NCT01581021|466951479|FG000|Overall Study|Lost to Follow-up|4|||
129724993|NCT01581021|466951480|FG001|Overall Study|Lost to Follow-up|6|||
129724994|NCT01581021|466951479|FG000|Overall Study|More than 2 hooks in thoracic|3|||
129724995|NCT01581021|466951480|FG001|Overall Study|More than 2 hooks in thoracic|0|||
129724996|NCT01581021|466951479|FG000|Overall Study|Neuromuscular|2|||
129724997|NCT01581021|466951480|FG001|Overall Study|Neuromuscular|1|||
129724998|NCT01581021|466951479|FG000|Overall Study|Not Randomized|1|||
129724999|NCT01581021|466951480|FG001|Overall Study|Not Randomized|2|||
129725000|NCT01581021|466951479|FG000|Overall Study|Lenke 6 Classification|0|||
129725001|NCT01581021|466951480|FG001|Overall Study|Lenke 6 Classification|1|||
129725002|NCT01581021|466951479|FG000|Overall Study|Lack of Efficacy|0|||
129725003|NCT01581021|466951480|FG001|Overall Study|Lack of Efficacy|1|||
129725004|NCT00054327|466951483|FG000|Overall Study|Engraftment failure|1|||
129725005|NCT00054327|466951484|FG001|Overall Study|Engraftment failure|0|||
129725006|NCT00054327|466951485|FG002|Overall Study|Engraftment failure|0|||
129725007|NCT00054327|466951486|FG003|Overall Study|Engraftment failure|0|||
129725008|NCT00054327|466951487|FG004|Overall Study|Engraftment failure|0|||
129725009|NCT00054327|466951488|FG005|Overall Study|Engraftment failure|0|||
129725010|NCT00290771|466951497|FG000|Overall Study|Disease progression|95|||
129725011|NCT00290771|466951498|FG001|Overall Study|Disease progression|73|||
129725012|NCT00290771|466951497|FG000|Overall Study|Death|11|||
129725013|NCT00290771|466951498|FG001|Overall Study|Death|10|||
129725014|NCT00290771|466951497|FG000|Overall Study|Adverse Event|12|||
129725015|NCT00290771|466951498|FG001|Overall Study|Adverse Event|6|||
129725016|NCT00290771|466951497|FG000|Overall Study|Withdrawal by Subject|5|||
129725017|NCT00290771|466951498|FG001|Overall Study|Withdrawal by Subject|6|||
129725018|NCT00290771|466951497|FG000|Overall Study|Administrative problems|2|||
129725019|NCT00290771|466951498|FG001|Overall Study|Administrative problems|1|||
129725020|NCT00290771|466951497|FG000|Overall Study|Protocol Violation|2|||
129725021|NCT00290771|466951498|FG001|Overall Study|Protocol Violation|0|||
129725022|NCT00290771|466951497|FG000|Overall Study|Lost to Follow-up|0|||
129725023|NCT00290771|466951498|FG001|Overall Study|Lost to Follow-up|1|||
129725024|NCT00244933|466951501|FG000|Overall Study|Not response evaluable|2|||
129725025|NCT02487654|466951504|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
129725026|NCT02487654|466951505|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
129725027|NCT02487654|466951504|FG000|Overall Study|Withdrawal by Subject|3|||
129725028|NCT02487654|466951505|FG001|Overall Study|Withdrawal by Subject|7|||
129725029|NCT02247011|466951506|FG000|Overall Study|Poor quality of radiological results|125|||
129725030|NCT00616018|466951507|FG000|Overall Study|Protocol Violation|3|||
129725031|NCT04700540|466951508|FG000|Overall Study|Withdrawal by Subject|12|||
129725032|NCT04700540|466951509|FG001|Overall Study|Withdrawal by Subject|8|||
129725033|NCT04700540|466951508|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
129725034|NCT04700540|466951509|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
129725035|NCT02602275|466951528|FG000|Day 1|Physician Decision|0|||
129725036|NCT02602275|466951529|FG001|Day 1|Physician Decision|1|||
129725037|NCT01108731|466951532|FG000|Overall Study|Withdrawal by Subject|1|||
129725038|NCT01108731|466951533|FG001|Overall Study|Withdrawal by Subject|1|||
129725039|NCT01108731|466951532|FG000|Overall Study|Adverse Event|3|||
129725040|NCT01108731|466951533|FG001|Overall Study|Adverse Event|3|||
129725041|NCT03802630|466951534|FG000|Overall Study|Study terminated by sponsor|130|||
129725042|NCT03802630|466951535|FG001|Overall Study|Study terminated by sponsor|134|||
129725043|NCT03802630|466951534|FG000|Overall Study|Subject decision|16|||
129725044|NCT03802630|466951535|FG001|Overall Study|Subject decision|9|||
129725045|NCT03802630|466951534|FG000|Overall Study|Adverse Event|3|||
129725046|NCT03802630|466951535|FG001|Overall Study|Adverse Event|1|||
129725047|NCT03802630|466951534|FG000|Overall Study|Lost to Follow-up|2|||
129725048|NCT03802630|466951535|FG001|Overall Study|Lost to Follow-up|2|||
129725049|NCT03802630|466951534|FG000|Overall Study|Physician Decision|2|||
129725050|NCT03802630|466951535|FG001|Overall Study|Physician Decision|0|||
129725051|NCT03802630|466951534|FG000|Overall Study|Death|0|||
129725052|NCT03802630|466951535|FG001|Overall Study|Death|2|||
129725053|NCT00157196|466951536|FG000|Overall Study|Ongoing at data cut-off|9|||
129725054|NCT04210245|466951537|FG000|Overall Study|Adverse Event|0|||
129725055|NCT04210245|466951538|FG001|Overall Study|Adverse Event|3|||
129725056|NCT04210245|466951539|FG002|Overall Study|Adverse Event|6|||
129725057|NCT04210245|466951540|FG003|Overall Study|Adverse Event|0|||
129725058|NCT04210245|466951537|FG000|Overall Study|Withdrawal by Subject|0|||
129725059|NCT04210245|466951538|FG001|Overall Study|Withdrawal by Subject|1|||
129725060|NCT04210245|466951539|FG002|Overall Study|Withdrawal by Subject|4|||
129725061|NCT04210245|466951540|FG003|Overall Study|Withdrawal by Subject|4|||
129725062|NCT04210245|466951537|FG000|Overall Study|Lost to Follow-up|0|||
129725063|NCT04210245|466951538|FG001|Overall Study|Lost to Follow-up|1|||
129725064|NCT04210245|466951539|FG002|Overall Study|Lost to Follow-up|1|||
129725065|NCT04210245|466951540|FG003|Overall Study|Lost to Follow-up|1|||
129725066|NCT04210245|466951537|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
129725067|NCT04210245|466951538|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
129725068|NCT04210245|466951539|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
129725069|NCT04210245|466951540|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
129725070|NCT01892722|466951541|FG000|Overall Study|Protocol deviation|0|||
129725071|NCT01892722|466951542|FG001|Overall Study|Protocol deviation|1|||
129725072|NCT01892722|466951541|FG000|Overall Study|Administrative problems|0|||
129725073|NCT01892722|466951542|FG001|Overall Study|Administrative problems|1|||
129725074|NCT01892722|466951541|FG000|Overall Study|Patient/guardian decision|0|||
129725075|NCT01892722|466951542|FG001|Overall Study|Patient/guardian decision|2|||
129725076|NCT01892722|466951541|FG000|Overall Study|Physician Decision|1|||
129725077|NCT01892722|466951542|FG001|Overall Study|Physician Decision|2|||
129725078|NCT01892722|466951541|FG000|Overall Study|Adverse Event|3|||
129725079|NCT01892722|466951542|FG001|Overall Study|Adverse Event|2|||
129725080|NCT01892722|466951541|FG000|Overall Study|Lack of Efficacy|0|||
129725081|NCT01892722|466951542|FG001|Overall Study|Lack of Efficacy|7|||
129725082|NCT01892722|466951541|FG000|Overall Study|Withdrawal by Subject|3|||
129725083|NCT01892722|466951542|FG001|Overall Study|Withdrawal by Subject|5|||
129725084|NCT01252186|466951545|FG000|Overall Study|Adverse Event|9|||
129725085|NCT01252186|466951546|FG001|Overall Study|Adverse Event|6|||
129725086|NCT01252186|466951547|FG002|Overall Study|Adverse Event|8|||
129725087|NCT01252186|466951545|FG000|Overall Study|Withdrawal by Subject|2|||
129725088|NCT01252186|466951546|FG001|Overall Study|Withdrawal by Subject|5|||
129725089|NCT01252186|466951547|FG002|Overall Study|Withdrawal by Subject|2|||
129725090|NCT01252186|466951545|FG000|Overall Study|Physician Decision|0|||
129725091|NCT01252186|466951546|FG001|Overall Study|Physician Decision|0|||
129725092|NCT01252186|466951547|FG002|Overall Study|Physician Decision|1|||
129725093|NCT01252186|466951545|FG000|Overall Study|Non-compliance|0|||
129725094|NCT01252186|466951546|FG001|Overall Study|Non-compliance|3|||
129725095|NCT01252186|466951547|FG002|Overall Study|Non-compliance|4|||
129725096|NCT01252186|466951545|FG000|Overall Study|Protocol Violation|0|||
129725097|NCT01252186|466951546|FG001|Overall Study|Protocol Violation|0|||
129725098|NCT01252186|466951547|FG002|Overall Study|Protocol Violation|1|||
129725099|NCT01252186|466951545|FG000|Overall Study|Pregnancy|2|||
129725100|NCT01252186|466951546|FG001|Overall Study|Pregnancy|2|||
129725101|NCT01252186|466951547|FG002|Overall Study|Pregnancy|0|||
129725102|NCT01252186|466951545|FG000|Overall Study|Sponsor Request|2|||
129725103|NCT01252186|466951546|FG001|Overall Study|Sponsor Request|1|||
129725104|NCT01252186|466951547|FG002|Overall Study|Sponsor Request|0|||
129725105|NCT01252186|466951545|FG000|Overall Study|Lost to Follow-up|10|||
129725106|NCT01252186|466951546|FG001|Overall Study|Lost to Follow-up|10|||
129725107|NCT01252186|466951547|FG002|Overall Study|Lost to Follow-up|11|||
129725108|NCT01252186|466951545|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
129725109|NCT01252186|466951546|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
129725110|NCT01252186|466951547|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
129725111|NCT02524275|466951548|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
129804074|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129804075|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
129891699|NCT03289455|467561239|FG002|Overall Study|Progressive disease|5|||
129725112|NCT04283994|466951549|FG000|Overall Study|Death|11|||
129725113|NCT04283994|466951550|FG001|Overall Study|Death|20|||
129725114|NCT04283994|466951551|FG002|Overall Study|Death|11|||
129725115|NCT04283994|466951552|FG003|Overall Study|Death|0|||
129725116|NCT04283994|466951553|FG004|Overall Study|Death|0|||
129725117|NCT04283994|466951554|FG005|Overall Study|Death|0|||
129725118|NCT04283994|466951555|FG006|Overall Study|Death|0|||
129725119|NCT04283994|466951549|FG000|Overall Study|Withdrawal by Subject|16|||
129725120|NCT04283994|466951550|FG001|Overall Study|Withdrawal by Subject|4|||
129725121|NCT04283994|466951551|FG002|Overall Study|Withdrawal by Subject|6|||
129725122|NCT04283994|466951552|FG003|Overall Study|Withdrawal by Subject|1|||
129725123|NCT04283994|466951553|FG004|Overall Study|Withdrawal by Subject|0|||
129725124|NCT04283994|466951554|FG005|Overall Study|Withdrawal by Subject|1|||
129725125|NCT04283994|466951555|FG006|Overall Study|Withdrawal by Subject|0|||
129725126|NCT01795495|466951558|FG000|Overall Study|Protocol Violation|1|||
129725127|NCT01795495|466951559|FG001|Overall Study|Protocol Violation|0|||
129725128|NCT01795495|466951560|FG002|Overall Study|Protocol Violation|1|||
129725129|NCT01795495|466951558|FG000|Overall Study|Physician Decision|0|||
129725130|NCT01795495|466951559|FG001|Overall Study|Physician Decision|0|||
129725131|NCT01795495|466951560|FG002|Overall Study|Physician Decision|1|||
129725132|NCT01331837|466951561|FG000|Overall Study|Death|30|||
129725133|NCT01331837|466951562|FG001|Overall Study|Death|34|||
129725134|NCT01331837|466951561|FG000|Overall Study|Lost to Follow-up|3|||
129725135|NCT01331837|466951562|FG001|Overall Study|Lost to Follow-up|1|||
129725136|NCT01331837|466951561|FG000|Overall Study|Info not recorded|10|||
129725137|NCT01331837|466951562|FG001|Overall Study|Info not recorded|16|||
129725138|NCT01331837|466951561|FG000|Overall Study|Withdrawal by Subject|13|||
129725139|NCT01331837|466951562|FG001|Overall Study|Withdrawal by Subject|16|||
129725140|NCT03724981|466953190|FG000|First Device|Protocol Violation|1|||
129725141|NCT03724981|466953191|FG001|First Device|Protocol Violation|1|||
129725142|NCT00197145|466953192|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
129725143|NCT00197145|466953193|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
129725144|NCT00197145|466953192|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
129725145|NCT00197145|466953193|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
129725146|NCT00197145|466953192|FG000|Period 1: Randomized Treatment Phase|Other|2|||
129725147|NCT00197145|466953193|FG001|Period 1: Randomized Treatment Phase|Other|2|||
129725148|NCT00197145|466953192|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
129725149|NCT00197145|466953193|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
129725150|NCT00197145|466953192|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
129725151|NCT00197145|466953193|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
129725152|NCT00197145|466953192|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
129725153|NCT00197145|466953193|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
129725154|NCT00197145|466953192|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
129725155|NCT00197145|466953193|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
129725156|NCT00197145|466953192|FG000|Period 2 : Open Label Phase|Other|1|||
129725157|NCT00197145|466953193|FG001|Period 2 : Open Label Phase|Other|0|||
129725158|NCT02578680|466953196|FG000|Overall Study|Death|329|||
129725159|NCT02578680|466953197|FG001|Overall Study|Death|181|||
129725160|NCT02578680|466953196|FG000|Overall Study|Lost to Follow-up|3|||
129725161|NCT02578680|466953197|FG001|Overall Study|Lost to Follow-up|1|||
129725162|NCT02578680|466953196|FG000|Overall Study|Physician Decision|0|||
129725163|NCT02578680|466953197|FG001|Overall Study|Physician Decision|1|||
129725164|NCT02578680|466953196|FG000|Overall Study|Protocol Violation|1|||
129725165|NCT02578680|466953197|FG001|Overall Study|Protocol Violation|1|||
129725166|NCT02578680|466953196|FG000|Overall Study|Sponsor Decision|64|||
129725167|NCT02578680|466953197|FG001|Overall Study|Sponsor Decision|13|||
129725168|NCT02578680|466953196|FG000|Overall Study|Withdrawal by Subject|13|||
129725169|NCT02578680|466953197|FG001|Overall Study|Withdrawal by Subject|9|||
129725170|NCT03596047|466953198|FG000|Overall Study|Withdrawal by Subject|7|||
129725171|NCT03596047|466953199|FG001|Overall Study|Withdrawal by Subject|4|||
129725172|NCT03596047|466953198|FG000|Overall Study|Lost to Follow-up|0|||
129725173|NCT03596047|466953199|FG001|Overall Study|Lost to Follow-up|2|||
129725174|NCT02290691|466953200|FG000|Overall Study|Noncompliance|0|||
129804076|NCT04526509|467249900|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
129804077|NCT04526509|467249901|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804078|NCT04526509|467249902|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804079|NCT04526509|467249903|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804080|NCT04526509|467249904|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129891700|NCT00114959|467561240|FG000|Overall Study|Lack of Efficacy|6|||
129725175|NCT02290691|466953201|FG001|Overall Study|Noncompliance|1|||
129725176|NCT02290691|466953200|FG000|Overall Study|Withdrawal by Subject|1|||
129725177|NCT02290691|466953201|FG001|Overall Study|Withdrawal by Subject|1|||
129725178|NCT02290691|466953200|FG000|Overall Study|Lost to Follow-up|7|||
129725179|NCT02290691|466953201|FG001|Overall Study|Lost to Follow-up|7|||
129725180|NCT00734604|466953206|FG000|Overall Study|Adverse Event|0|||
129725181|NCT00734604|466953207|FG001|Overall Study|Adverse Event|2|||
129725182|NCT00734604|466953208|FG002|Overall Study|Adverse Event|0|||
129725183|NCT00734604|466953209|FG003|Overall Study|Adverse Event|2|||
129725184|NCT00734604|466953210|FG004|Overall Study|Adverse Event|1|||
129725185|NCT00734604|466953211|FG005|Overall Study|Adverse Event|1|||
129725186|NCT00734604|466953206|FG000|Overall Study|Serious Adverse Event|1|||
129725187|NCT00734604|466953207|FG001|Overall Study|Serious Adverse Event|0|||
129725188|NCT00734604|466953208|FG002|Overall Study|Serious Adverse Event|1|||
129725189|NCT00734604|466953209|FG003|Overall Study|Serious Adverse Event|2|||
129725190|NCT00734604|466953210|FG004|Overall Study|Serious Adverse Event|0|||
129725191|NCT00734604|466953211|FG005|Overall Study|Serious Adverse Event|1|||
129725192|NCT00734604|466953206|FG000|Overall Study|Lost to Follow-up|1|||
129725193|NCT00734604|466953207|FG001|Overall Study|Lost to Follow-up|2|||
129725194|NCT00734604|466953208|FG002|Overall Study|Lost to Follow-up|2|||
129725195|NCT00734604|466953209|FG003|Overall Study|Lost to Follow-up|4|||
129725196|NCT00734604|466953210|FG004|Overall Study|Lost to Follow-up|2|||
129725197|NCT00734604|466953211|FG005|Overall Study|Lost to Follow-up|3|||
129725198|NCT00734604|466953206|FG000|Overall Study|Physician Decision|0|||
129725199|NCT00734604|466953207|FG001|Overall Study|Physician Decision|1|||
129725200|NCT00734604|466953208|FG002|Overall Study|Physician Decision|1|||
129725201|NCT00734604|466953209|FG003|Overall Study|Physician Decision|0|||
129725202|NCT00734604|466953210|FG004|Overall Study|Physician Decision|0|||
129725203|NCT00734604|466953211|FG005|Overall Study|Physician Decision|0|||
129725204|NCT00734604|466953206|FG000|Overall Study|Protocol Violation|0|||
129725205|NCT00734604|466953207|FG001|Overall Study|Protocol Violation|2|||
129725206|NCT00734604|466953208|FG002|Overall Study|Protocol Violation|0|||
129725207|NCT00734604|466953209|FG003|Overall Study|Protocol Violation|0|||
129725208|NCT00734604|466953210|FG004|Overall Study|Protocol Violation|1|||
129725209|NCT00734604|466953211|FG005|Overall Study|Protocol Violation|0|||
129725210|NCT00734604|466953206|FG000|Overall Study|Sponsor Decision|1|||
129725211|NCT00734604|466953207|FG001|Overall Study|Sponsor Decision|2|||
129725212|NCT00734604|466953208|FG002|Overall Study|Sponsor Decision|1|||
129725213|NCT00734604|466953209|FG003|Overall Study|Sponsor Decision|0|||
129725214|NCT00734604|466953210|FG004|Overall Study|Sponsor Decision|2|||
129725215|NCT00734604|466953211|FG005|Overall Study|Sponsor Decision|0|||
129725216|NCT00734604|466953206|FG000|Overall Study|Withdrawal by Subject|0|||
129725217|NCT00734604|466953207|FG001|Overall Study|Withdrawal by Subject|2|||
129725218|NCT00734604|466953208|FG002|Overall Study|Withdrawal by Subject|0|||
129725219|NCT00734604|466953209|FG003|Overall Study|Withdrawal by Subject|1|||
129725220|NCT00734604|466953210|FG004|Overall Study|Withdrawal by Subject|2|||
129725221|NCT00734604|466953211|FG005|Overall Study|Withdrawal by Subject|1|||
129725222|NCT00734604|466953206|FG000|Overall Study|Lack of Efficacy|0|||
129725223|NCT00734604|466953207|FG001|Overall Study|Lack of Efficacy|1|||
129725224|NCT00734604|466953208|FG002|Overall Study|Lack of Efficacy|1|||
129725225|NCT00734604|466953209|FG003|Overall Study|Lack of Efficacy|0|||
129725226|NCT00734604|466953210|FG004|Overall Study|Lack of Efficacy|0|||
129725227|NCT00734604|466953211|FG005|Overall Study|Lack of Efficacy|0|||
129725228|NCT02589665|466953212|FG000|Induction Period|Did not receive drug|0|||
129725229|NCT02589665|466953213|FG001|Induction Period|Did not receive drug|0|||
129725230|NCT02589665|466953214|FG002|Induction Period|Did not receive drug|0|||
129725231|NCT02589665|466953215|FG003|Induction Period|Did not receive drug|1|||
129725232|NCT02589665|466953216|FG004|Induction Period|Did not receive drug|0|||
129725233|NCT02589665|466953217|FG005|Induction Period|Did not receive drug|0|||
129725234|NCT02589665|466953218|FG006|Induction Period|Did not receive drug|0|||
129725235|NCT02589665|466953219|FG007|Induction Period|Did not receive drug|0|||
129725236|NCT02589665|466953220|FG008|Induction Period|Did not receive drug|0|||
129725237|NCT02589665|466953221|FG009|Induction Period|Did not receive drug|0|||
129725238|NCT02589665|466953212|FG000|Induction Period|Adverse Event|3|||
129725239|NCT02589665|466953213|FG001|Induction Period|Adverse Event|0|||
129725240|NCT02589665|466953214|FG002|Induction Period|Adverse Event|2|||
129725241|NCT02589665|466953215|FG003|Induction Period|Adverse Event|2|||
129725242|NCT02589665|466953216|FG004|Induction Period|Adverse Event|0|||
129725243|NCT02589665|466953217|FG005|Induction Period|Adverse Event|0|||
129804081|NCT04526509|467249905|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129725244|NCT02589665|466953218|FG006|Induction Period|Adverse Event|0|||
129725245|NCT02589665|466953219|FG007|Induction Period|Adverse Event|0|||
129725246|NCT02589665|466953220|FG008|Induction Period|Adverse Event|0|||
129725247|NCT02589665|466953221|FG009|Induction Period|Adverse Event|0|||
129725248|NCT02589665|466953212|FG000|Induction Period|Withdrawal by Subject|0|||
129804082|NCT04526509|467249906|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
129804083|NCT04526509|467249900|FG000|Enrolled|Study Terminated by Sponsor|0|||
129804084|NCT04526509|467249901|FG001|Enrolled|Study Terminated by Sponsor|0|||
129725249|NCT02589665|466953213|FG001|Induction Period|Withdrawal by Subject|1|||
129725250|NCT02589665|466953214|FG002|Induction Period|Withdrawal by Subject|0|||
129725251|NCT02589665|466953215|FG003|Induction Period|Withdrawal by Subject|1|||
129804085|NCT04526509|467249902|FG002|Enrolled|Study Terminated by Sponsor|0|||
129725252|NCT02589665|466953216|FG004|Induction Period|Withdrawal by Subject|0|||
129725253|NCT02589665|466953217|FG005|Induction Period|Withdrawal by Subject|0|||
129725254|NCT02589665|466953218|FG006|Induction Period|Withdrawal by Subject|0|||
129725255|NCT02589665|466953219|FG007|Induction Period|Withdrawal by Subject|0|||
129725256|NCT02589665|466953220|FG008|Induction Period|Withdrawal by Subject|0|||
129725257|NCT02589665|466953221|FG009|Induction Period|Withdrawal by Subject|0|||
129725258|NCT02589665|466953212|FG000|Induction Period|Protocol Violation|0|||
129725259|NCT02589665|466953213|FG001|Induction Period|Protocol Violation|1|||
129725260|NCT02589665|466953214|FG002|Induction Period|Protocol Violation|0|||
129725261|NCT02589665|466953215|FG003|Induction Period|Protocol Violation|0|||
129725262|NCT02589665|466953216|FG004|Induction Period|Protocol Violation|0|||
129725263|NCT02589665|466953217|FG005|Induction Period|Protocol Violation|0|||
129725264|NCT02589665|466953218|FG006|Induction Period|Protocol Violation|0|||
129725265|NCT02589665|466953219|FG007|Induction Period|Protocol Violation|0|||
129725266|NCT02589665|466953220|FG008|Induction Period|Protocol Violation|0|||
129725267|NCT02589665|466953221|FG009|Induction Period|Protocol Violation|0|||
129725268|NCT02589665|466953212|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725269|NCT02589665|466953213|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725270|NCT02589665|466953214|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725271|NCT02589665|466953215|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725272|NCT02589665|466953216|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
129725273|NCT02589665|466953217|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
129725274|NCT02589665|466953218|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
129725275|NCT02589665|466953219|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725276|NCT02589665|466953220|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725277|NCT02589665|466953221|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725278|NCT02589665|466953212|FG000|Maintenance Period|Withdrawal by Subject|0|||
129725279|NCT02589665|466953213|FG001|Maintenance Period|Withdrawal by Subject|0|||
129725280|NCT02589665|466953214|FG002|Maintenance Period|Withdrawal by Subject|0|||
129725281|NCT02589665|466953215|FG003|Maintenance Period|Withdrawal by Subject|0|||
129725282|NCT02589665|466953216|FG004|Maintenance Period|Withdrawal by Subject|4|||
129725283|NCT02589665|466953217|FG005|Maintenance Period|Withdrawal by Subject|2|||
129725284|NCT02589665|466953218|FG006|Maintenance Period|Withdrawal by Subject|4|||
129725285|NCT02589665|466953219|FG007|Maintenance Period|Withdrawal by Subject|0|||
129725286|NCT02589665|466953220|FG008|Maintenance Period|Withdrawal by Subject|0|||
129725287|NCT02589665|466953221|FG009|Maintenance Period|Withdrawal by Subject|0|||
129725288|NCT02589665|466953212|FG000|Maintenance Period|Lack of Efficacy|0|||
129725289|NCT02589665|466953213|FG001|Maintenance Period|Lack of Efficacy|0|||
129725290|NCT02589665|466953214|FG002|Maintenance Period|Lack of Efficacy|0|||
129725291|NCT02589665|466953215|FG003|Maintenance Period|Lack of Efficacy|0|||
129725292|NCT02589665|466953216|FG004|Maintenance Period|Lack of Efficacy|2|||
129725293|NCT02589665|466953217|FG005|Maintenance Period|Lack of Efficacy|1|||
129725294|NCT02589665|466953218|FG006|Maintenance Period|Lack of Efficacy|0|||
129725295|NCT02589665|466953219|FG007|Maintenance Period|Lack of Efficacy|0|||
129725296|NCT02589665|466953220|FG008|Maintenance Period|Lack of Efficacy|0|||
129725297|NCT02589665|466953221|FG009|Maintenance Period|Lack of Efficacy|0|||
129725298|NCT02589665|466953212|FG000|Maintenance Period|Adverse Event|0|||
129725299|NCT02589665|466953213|FG001|Maintenance Period|Adverse Event|0|||
129725300|NCT02589665|466953214|FG002|Maintenance Period|Adverse Event|0|||
129725301|NCT02589665|466953215|FG003|Maintenance Period|Adverse Event|0|||
129725302|NCT02589665|466953216|FG004|Maintenance Period|Adverse Event|0|||
129725303|NCT02589665|466953217|FG005|Maintenance Period|Adverse Event|0|||
129725304|NCT02589665|466953218|FG006|Maintenance Period|Adverse Event|2|||
129725305|NCT02589665|466953219|FG007|Maintenance Period|Adverse Event|0|||
129725306|NCT02589665|466953220|FG008|Maintenance Period|Adverse Event|0|||
129725307|NCT02589665|466953221|FG009|Maintenance Period|Adverse Event|0|||
129725308|NCT02589665|466953212|FG000|Maintenance Period|Lost to Follow-up|0|||
129725309|NCT02589665|466953213|FG001|Maintenance Period|Lost to Follow-up|0|||
129725310|NCT02589665|466953214|FG002|Maintenance Period|Lost to Follow-up|0|||
129725311|NCT02589665|466953215|FG003|Maintenance Period|Lost to Follow-up|0|||
129725312|NCT02589665|466953216|FG004|Maintenance Period|Lost to Follow-up|0|||
129725313|NCT02589665|466953217|FG005|Maintenance Period|Lost to Follow-up|1|||
129725314|NCT02589665|466953218|FG006|Maintenance Period|Lost to Follow-up|0|||
129725315|NCT02589665|466953219|FG007|Maintenance Period|Lost to Follow-up|0|||
129725316|NCT02589665|466953220|FG008|Maintenance Period|Lost to Follow-up|0|||
129725317|NCT02589665|466953221|FG009|Maintenance Period|Lost to Follow-up|0|||
129725318|NCT02589665|466953212|FG000|Maintenance Period|Physician Decision|0|||
129725319|NCT02589665|466953213|FG001|Maintenance Period|Physician Decision|0|||
129725320|NCT02589665|466953214|FG002|Maintenance Period|Physician Decision|0|||
129891701|NCT00114959|467561240|FG000|Overall Study|Physician Decision|1|||
129444408|NCT00578786|465927336|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
129725321|NCT02589665|466953215|FG003|Maintenance Period|Physician Decision|0|||
129725322|NCT02589665|466953216|FG004|Maintenance Period|Physician Decision|0|||
129725323|NCT02589665|466953217|FG005|Maintenance Period|Physician Decision|1|||
129725324|NCT02589665|466953218|FG006|Maintenance Period|Physician Decision|0|||
129725325|NCT02589665|466953219|FG007|Maintenance Period|Physician Decision|0|||
129725326|NCT02589665|466953220|FG008|Maintenance Period|Physician Decision|0|||
129891702|NCT00114959|467561240|FG000|Overall Study|Death|1|||
129891703|NCT01007552|467561246|FG000|Overall Study|Withdrawal by Subject|1|||
129725327|NCT02589665|466953221|FG009|Maintenance Period|Physician Decision|0|||
129725328|NCT02589665|466953212|FG000|Maintenance Period|Reason Not Collected|0|||
129725329|NCT02589665|466953213|FG001|Maintenance Period|Reason Not Collected|0|||
129725330|NCT02589665|466953214|FG002|Maintenance Period|Reason Not Collected|0|||
129725331|NCT02589665|466953215|FG003|Maintenance Period|Reason Not Collected|0|||
129725332|NCT02589665|466953216|FG004|Maintenance Period|Reason Not Collected|0|||
129725333|NCT02589665|466953217|FG005|Maintenance Period|Reason Not Collected|1|||
129725334|NCT02589665|466953218|FG006|Maintenance Period|Reason Not Collected|1|||
129725335|NCT02589665|466953219|FG007|Maintenance Period|Reason Not Collected|0|||
129725336|NCT02589665|466953220|FG008|Maintenance Period|Reason Not Collected|0|||
129725337|NCT02589665|466953221|FG009|Maintenance Period|Reason Not Collected|0|||
129725338|NCT02589665|466953212|FG000|Induction Extension Period|Adverse Event|0|||
129725339|NCT02589665|466953213|FG001|Induction Extension Period|Adverse Event|0|||
129725340|NCT02589665|466953214|FG002|Induction Extension Period|Adverse Event|0|||
129725341|NCT02589665|466953215|FG003|Induction Extension Period|Adverse Event|0|||
129725342|NCT02589665|466953216|FG004|Induction Extension Period|Adverse Event|0|||
129725343|NCT02589665|466953217|FG005|Induction Extension Period|Adverse Event|0|||
129725344|NCT02589665|466953218|FG006|Induction Extension Period|Adverse Event|0|||
129725345|NCT02589665|466953219|FG007|Induction Extension Period|Adverse Event|0|||
129725346|NCT02589665|466953220|FG008|Induction Extension Period|Adverse Event|4|||
129725347|NCT02589665|466953221|FG009|Induction Extension Period|Adverse Event|0|||
129725348|NCT02589665|466953212|FG000|Induction Extension Period|Lack of Efficacy|0|||
129725349|NCT02589665|466953213|FG001|Induction Extension Period|Lack of Efficacy|0|||
129725350|NCT02589665|466953214|FG002|Induction Extension Period|Lack of Efficacy|0|||
129725351|NCT02589665|466953215|FG003|Induction Extension Period|Lack of Efficacy|0|||
129725352|NCT02589665|466953216|FG004|Induction Extension Period|Lack of Efficacy|0|||
129725353|NCT02589665|466953217|FG005|Induction Extension Period|Lack of Efficacy|0|||
129725354|NCT02589665|466953218|FG006|Induction Extension Period|Lack of Efficacy|0|||
129725355|NCT02589665|466953219|FG007|Induction Extension Period|Lack of Efficacy|0|||
129725356|NCT02589665|466953220|FG008|Induction Extension Period|Lack of Efficacy|3|||
129725357|NCT02589665|466953221|FG009|Induction Extension Period|Lack of Efficacy|0|||
129725358|NCT02589665|466953212|FG000|Induction Extension Period|Withdrawal by Subject|0|||
129725359|NCT02589665|466953213|FG001|Induction Extension Period|Withdrawal by Subject|0|||
129725360|NCT02589665|466953214|FG002|Induction Extension Period|Withdrawal by Subject|0|||
129725361|NCT02589665|466953215|FG003|Induction Extension Period|Withdrawal by Subject|0|||
129725362|NCT02589665|466953216|FG004|Induction Extension Period|Withdrawal by Subject|0|||
129725363|NCT02589665|466953217|FG005|Induction Extension Period|Withdrawal by Subject|0|||
129725364|NCT02589665|466953218|FG006|Induction Extension Period|Withdrawal by Subject|0|||
129725365|NCT02589665|466953219|FG007|Induction Extension Period|Withdrawal by Subject|2|||
129725366|NCT02589665|466953220|FG008|Induction Extension Period|Withdrawal by Subject|3|||
129725367|NCT02589665|466953221|FG009|Induction Extension Period|Withdrawal by Subject|0|||
129725368|NCT02589665|466953212|FG000|Induction Extension Period|Physician Decision|0|||
129725369|NCT02589665|466953213|FG001|Induction Extension Period|Physician Decision|0|||
129725370|NCT02589665|466953214|FG002|Induction Extension Period|Physician Decision|0|||
129725371|NCT02589665|466953215|FG003|Induction Extension Period|Physician Decision|0|||
129725372|NCT02589665|466953216|FG004|Induction Extension Period|Physician Decision|0|||
129725373|NCT02589665|466953217|FG005|Induction Extension Period|Physician Decision|0|||
129725374|NCT02589665|466953218|FG006|Induction Extension Period|Physician Decision|0|||
129725375|NCT02589665|466953219|FG007|Induction Extension Period|Physician Decision|0|||
129725376|NCT02589665|466953220|FG008|Induction Extension Period|Physician Decision|1|||
129725377|NCT02589665|466953221|FG009|Induction Extension Period|Physician Decision|0|||
129725378|NCT02589665|466953212|FG000|Induction Extension Period|Reason Not Collected|0|||
129725379|NCT02589665|466953213|FG001|Induction Extension Period|Reason Not Collected|0|||
129725380|NCT02589665|466953214|FG002|Induction Extension Period|Reason Not Collected|0|||
129725381|NCT02589665|466953215|FG003|Induction Extension Period|Reason Not Collected|0|||
129725382|NCT02589665|466953216|FG004|Induction Extension Period|Reason Not Collected|0|||
129725383|NCT02589665|466953217|FG005|Induction Extension Period|Reason Not Collected|0|||
129891704|NCT00432159|467563032|FG000|Overall Study|Death|0|||
129725384|NCT02589665|466953218|FG006|Induction Extension Period|Reason Not Collected|0|||
129725385|NCT02589665|466953219|FG007|Induction Extension Period|Reason Not Collected|0|||
129725386|NCT02589665|466953220|FG008|Induction Extension Period|Reason Not Collected|1|||
129725387|NCT02589665|466953221|FG009|Induction Extension Period|Reason Not Collected|0|||
129725388|NCT02589665|466953212|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725389|NCT02589665|466953213|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725390|NCT02589665|466953214|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129891705|NCT00432159|467563033|FG001|Overall Study|Death|1|||
129891706|NCT00432159|467563034|FG002|Overall Study|Death|0|||
129891707|NCT00432159|467563035|FG003|Overall Study|Death|0|||
129725391|NCT02589665|466953215|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725392|NCT02589665|466953216|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725393|NCT02589665|466953217|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725394|NCT02589665|466953218|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725395|NCT02589665|466953219|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725396|NCT02589665|466953220|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
129725397|NCT02589665|466953221|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
129725398|NCT02589665|466953212|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
129725399|NCT02589665|466953213|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
129725400|NCT02589665|466953214|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
129725401|NCT02589665|466953215|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
129725402|NCT02589665|466953216|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
129725403|NCT02589665|466953217|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
129725404|NCT02589665|466953218|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
129725405|NCT02589665|466953219|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
129725406|NCT02589665|466953220|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
129725407|NCT02589665|466953221|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
129725408|NCT02589665|466953212|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
129725409|NCT02589665|466953213|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
129725410|NCT02589665|466953214|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
129725411|NCT02589665|466953215|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
129725412|NCT02589665|466953216|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
129725413|NCT02589665|466953217|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
129725414|NCT02589665|466953218|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
129725415|NCT02589665|466953219|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
129725416|NCT02589665|466953220|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
129725417|NCT02589665|466953221|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
129725418|NCT02589665|466953212|FG000|Maintenance Extension Period|Adverse Event|0|||
129725419|NCT02589665|466953213|FG001|Maintenance Extension Period|Adverse Event|0|||
129725420|NCT02589665|466953214|FG002|Maintenance Extension Period|Adverse Event|0|||
129725421|NCT02589665|466953215|FG003|Maintenance Extension Period|Adverse Event|0|||
129725422|NCT02589665|466953216|FG004|Maintenance Extension Period|Adverse Event|0|||
129725423|NCT02589665|466953217|FG005|Maintenance Extension Period|Adverse Event|0|||
129725424|NCT02589665|466953218|FG006|Maintenance Extension Period|Adverse Event|0|||
129725425|NCT02589665|466953219|FG007|Maintenance Extension Period|Adverse Event|0|||
129725426|NCT02589665|466953220|FG008|Maintenance Extension Period|Adverse Event|0|||
129725427|NCT02589665|466953221|FG009|Maintenance Extension Period|Adverse Event|2|||
129725428|NCT02589665|466953212|FG000|Maintenance Extension Period|Non-responder|0|||
129725429|NCT02589665|466953213|FG001|Maintenance Extension Period|Non-responder|0|||
129725430|NCT02589665|466953214|FG002|Maintenance Extension Period|Non-responder|0|||
129725431|NCT02589665|466953215|FG003|Maintenance Extension Period|Non-responder|0|||
129725432|NCT02589665|466953216|FG004|Maintenance Extension Period|Non-responder|0|||
129725433|NCT02589665|466953217|FG005|Maintenance Extension Period|Non-responder|0|||
129725434|NCT02589665|466953218|FG006|Maintenance Extension Period|Non-responder|0|||
129725435|NCT02589665|466953219|FG007|Maintenance Extension Period|Non-responder|0|||
129725436|NCT02589665|466953220|FG008|Maintenance Extension Period|Non-responder|0|||
129725437|NCT02589665|466953221|FG009|Maintenance Extension Period|Non-responder|1|||
129725438|NCT00978380|466953222|FG000|Overall Study|Protocol Violation|2|||
129725439|NCT00978380|466953222|FG000|Overall Study|Withdrawal criteria|9|||
129725440|NCT00978380|466953222|FG000|Overall Study|Unclassified|8|||
129725441|NCT01681069|466953230|FG000|Overall Study|Withdrawal by Subject|4|||
129725442|NCT01681069|466953231|FG001|Overall Study|Withdrawal by Subject|5|||
129725443|NCT01681069|466953230|FG000|Overall Study|Protocol Violation|1|||
129725444|NCT01681069|466953231|FG001|Overall Study|Protocol Violation|1|||
129725445|NCT01681069|466953230|FG000|Overall Study|Adverse Event|0|||
129725446|NCT01681069|466953231|FG001|Overall Study|Adverse Event|1|||
129725447|NCT03883165|466953232|FG000|Overall Study|Withdrawal by Subject|4|||
129725448|NCT03883165|466953233|FG001|Overall Study|Withdrawal by Subject|3|||
129725449|NCT00245050|466953237|FG000|Overall Study|Adverse Event|3|||
129725450|NCT00245050|466953238|FG001|Overall Study|Adverse Event|2|||
129725451|NCT00425698|466953239|FG000|Overall Study|Adverse Event|3|||
129725452|NCT00425698|466953240|FG001|Overall Study|Adverse Event|1|||
129725453|NCT00425698|466953239|FG000|Overall Study|Withdrawal by Subject|0|||
129725454|NCT00425698|466953240|FG001|Overall Study|Withdrawal by Subject|1|||
129725455|NCT03275246|466953247|FG000|Overall Study|Protocol Violation|5|||
129804086|NCT04526509|467249903|FG003|Enrolled|Study Terminated by Sponsor|0|||
129804087|NCT04526509|467249904|FG004|Enrolled|Study Terminated by Sponsor|0|||
129804088|NCT04526509|467249905|FG005|Enrolled|Study Terminated by Sponsor|0|||
129804089|NCT04526509|467249906|FG006|Enrolled|Study Terminated by Sponsor|1|||
129804090|NCT04526509|467249900|FG000|Enrolled|Death prior to lymphodepletion|0|||
129804091|NCT04526509|467249901|FG001|Enrolled|Death prior to lymphodepletion|0|||
129804092|NCT04526509|467249902|FG002|Enrolled|Death prior to lymphodepletion|0|||
129804093|NCT04526509|467249903|FG003|Enrolled|Death prior to lymphodepletion|1|||
129804094|NCT04526509|467249904|FG004|Enrolled|Death prior to lymphodepletion|0|||
129725456|NCT03275246|466953247|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
129725457|NCT02516098|466953256|FG000|Period 1|Protocol Violation|1|||
129725458|NCT02516098|466953257|FG001|Period 1|Protocol Violation|0|||
129725459|NCT02516098|466953256|FG000|Washout After Period 1|Adverse Event|0|||
129725460|NCT02516098|466953257|FG001|Washout After Period 1|Adverse Event|1|||
129725461|NCT02516098|466953256|FG000|Period 2|Withdrawal by Subject|0|||
129725462|NCT02516098|466953257|FG001|Period 2|Withdrawal by Subject|1|||
129725463|NCT00873041|466953258|FG000|Core Study|Adverse Event|2|||
129725464|NCT00873041|466953259|FG001|Core Study|Adverse Event|3|||
129725465|NCT00873041|466953260|FG002|Core Study|Adverse Event|1|||
129725466|NCT00873041|466953258|FG000|Core Study|Withdrawal by Subject|1|||
129725467|NCT00873041|466953259|FG001|Core Study|Withdrawal by Subject|2|||
129725468|NCT00873041|466953260|FG002|Core Study|Withdrawal by Subject|2|||
129725469|NCT00873041|466953258|FG000|Core Study|Lost to Follow-up|3|||
129725470|NCT00873041|466953259|FG001|Core Study|Lost to Follow-up|1|||
129725471|NCT00873041|466953260|FG002|Core Study|Lost to Follow-up|0|||
129725472|NCT00873041|466953258|FG000|Core Study|Abnormal laboratory value|0|||
129725473|NCT00873041|466953259|FG001|Core Study|Abnormal laboratory value|0|||
129725474|NCT00873041|466953260|FG002|Core Study|Abnormal laboratory value|1|||
129725475|NCT00873041|466953258|FG000|Core Study|Protocol deviation|1|||
129725476|NCT00873041|466953259|FG001|Core Study|Protocol deviation|0|||
129725477|NCT00873041|466953260|FG002|Core Study|Protocol deviation|1|||
129725478|NCT00873041|466953258|FG000|Extension Study|Adverse Event|1|||
129725479|NCT00873041|466953259|FG001|Extension Study|Adverse Event|0|||
129725480|NCT00873041|466953260|FG002|Extension Study|Adverse Event|1|||
129725481|NCT00873041|466953258|FG000|Extension Study|Administrative reasons|0|||
129725482|NCT00873041|466953259|FG001|Extension Study|Administrative reasons|0|||
129725483|NCT00873041|466953260|FG002|Extension Study|Administrative reasons|1|||
129725484|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
129725485|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
129725486|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
129725487|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
129725488|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129725489|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
129725490|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
129725491|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
129725492|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
129725493|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
129725494|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
129725495|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
129725496|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
129725497|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
129725498|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
129725499|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
129725500|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
129725501|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725502|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129444409|NCT00866723|465927337|FG000|Overall Study|Withdrawal by Subject|1|||
129444410|NCT00866723|465927337|FG000|Overall Study|Disease Progression|4|||
129444411|NCT00323297|465927338|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
129725503|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725504|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725505|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725506|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725507|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725508|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129891708|NCT00432159|467563036|FG004|Overall Study|Death|0|||
129725509|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725510|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725511|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725512|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725513|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129725514|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
129725515|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
129725516|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
129891709|NCT00432159|467563032|FG000|Overall Study|Failure|9|||
129725517|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
129725518|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
129725519|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
129725520|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
129725521|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
129725522|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
129725523|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
129725524|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
129725525|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
129725526|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
129725527|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
129725528|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
129725529|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
129725530|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
129725531|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
129725532|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
129725533|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
129725534|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
129725535|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
129725536|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
129725537|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
129725538|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
129725539|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
129725540|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
129725541|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
129725542|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
129725543|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
129725544|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
129725545|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
129725546|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
129725547|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
129725548|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725549|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725550|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725551|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725552|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725553|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725554|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725555|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725556|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725557|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725558|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129725559|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
129725560|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
129725561|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
129725562|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
129725563|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725564|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725565|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725566|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725567|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725568|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725569|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725570|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725571|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725572|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725573|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
129725574|NCT03831191|466953261|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725575|NCT03831191|466953262|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725576|NCT03831191|466953263|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725577|NCT03831191|466953264|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
129725578|NCT03831191|466953265|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725579|NCT03831191|466953266|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725580|NCT03831191|466953267|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725581|NCT03831191|466953268|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725582|NCT03831191|466953269|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725583|NCT03831191|466953270|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725584|NCT03831191|466953271|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725585|NCT03831191|466953272|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725586|NCT03831191|466953273|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725587|NCT03831191|466953274|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725588|NCT03831191|466953275|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
129725589|NCT03831191|466953261|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129725590|NCT03831191|466953262|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129725591|NCT03831191|466953263|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129725592|NCT03831191|466953264|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
129725593|NCT03831191|466953265|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
129725594|NCT03831191|466953266|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
129725595|NCT03831191|466953267|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
129725596|NCT03831191|466953268|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
129725597|NCT03831191|466953269|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
129725598|NCT03831191|466953270|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
129725599|NCT03831191|466953271|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
129725600|NCT03831191|466953272|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
129725601|NCT03831191|466953273|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
129725602|NCT03831191|466953274|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
129725603|NCT03831191|466953275|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
129725604|NCT03831191|466953261|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725605|NCT03831191|466953262|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725606|NCT03831191|466953263|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725607|NCT03831191|466953264|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725608|NCT03831191|466953265|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725609|NCT03831191|466953266|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725610|NCT03831191|466953267|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725611|NCT03831191|466953268|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725612|NCT03831191|466953269|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725613|NCT03831191|466953270|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725614|NCT03831191|466953271|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725615|NCT03831191|466953272|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725616|NCT03831191|466953273|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725617|NCT03831191|466953274|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129725618|NCT03831191|466953275|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129725619|NCT03831191|466953261|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725620|NCT03831191|466953262|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725621|NCT03831191|466953263|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725622|NCT03831191|466953264|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725623|NCT03831191|466953265|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725624|NCT03831191|466953266|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725625|NCT03831191|466953267|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725626|NCT03831191|466953268|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725627|NCT03831191|466953269|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725628|NCT03831191|466953270|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725629|NCT03831191|466953271|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725630|NCT03831191|466953272|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725631|NCT03831191|466953273|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725632|NCT03831191|466953274|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129725633|NCT03831191|466953275|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
129725634|NCT02300558|466953276|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
129725635|NCT02300558|466953276|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
129725636|NCT02300558|466953276|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
129725637|NCT02300558|466953276|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
129725638|NCT01054560|466953279|FG000|Overall Study|Death|10|||
129725639|NCT01054560|466953280|FG001|Overall Study|Death|21|||
129725640|NCT01054560|466953279|FG000|Overall Study|Lost to Follow-up|2|||
129725641|NCT01054560|466953280|FG001|Overall Study|Lost to Follow-up|5|||
129725642|NCT01054560|466953279|FG000|Overall Study|Withdrawal by Subject|0|||
129725643|NCT01054560|466953280|FG001|Overall Study|Withdrawal by Subject|2|||
129804095|NCT04526509|467249905|FG005|Enrolled|Death prior to lymphodepletion|0|||
129804096|NCT04526509|467249906|FG006|Enrolled|Death prior to lymphodepletion|0|||
129804097|NCT04526509|467249900|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804098|NCT04526509|467249901|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129725644|NCT01054560|466953279|FG000|Overall Study|Physician Decision|1|||
129725645|NCT01054560|466953280|FG001|Overall Study|Physician Decision|0|||
129804099|NCT04526509|467249902|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804100|NCT04526509|467249903|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
129804101|NCT04526509|467249904|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129804102|NCT04526509|467249905|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129725646|NCT02135029|466953284|FG000|Overall Study|Adverse Event|2|||
129725647|NCT02135029|466953285|FG001|Overall Study|Adverse Event|2|||
129725648|NCT02135029|466953286|FG002|Overall Study|Adverse Event|2|||
129725649|NCT02135029|466953284|FG000|Overall Study|Lost to Follow-up|0|||
129725650|NCT02135029|466953285|FG001|Overall Study|Lost to Follow-up|1|||
129725651|NCT02135029|466953286|FG002|Overall Study|Lost to Follow-up|0|||
129725652|NCT02135029|466953284|FG000|Overall Study|Withdrawal by Subject|2|||
129725653|NCT02135029|466953285|FG001|Overall Study|Withdrawal by Subject|0|||
129725654|NCT02135029|466953286|FG002|Overall Study|Withdrawal by Subject|1|||
129725655|NCT02135029|466953284|FG000|Overall Study|Other|0|||
129725656|NCT02135029|466953285|FG001|Overall Study|Other|1|||
129725657|NCT02135029|466953286|FG002|Overall Study|Other|0|||
129725658|NCT02135029|466953284|FG000|Overall Study|Death|0|||
129725659|NCT02135029|466953285|FG001|Overall Study|Death|1|||
129725660|NCT02135029|466953286|FG002|Overall Study|Death|0|||
129725661|NCT00712725|466953287|FG000|Overall Study|Adverse Event|1|||
129725662|NCT00712725|466953288|FG001|Overall Study|Adverse Event|0|||
129725663|NCT00712725|466953289|FG002|Overall Study|Adverse Event|0|||
129725664|NCT00712725|466953290|FG003|Overall Study|Adverse Event|1|||
129725665|NCT00712725|466953291|FG004|Overall Study|Adverse Event|0|||
129725666|NCT00712725|466953292|FG005|Overall Study|Adverse Event|0|||
129725667|NCT00712725|466953293|FG006|Overall Study|Adverse Event|0|||
129725668|NCT00712725|466953294|FG007|Overall Study|Adverse Event|0|||
129725669|NCT00712725|466953287|FG000|Overall Study|Lost to Follow-up|3|||
129725670|NCT00712725|466953288|FG001|Overall Study|Lost to Follow-up|2|||
129725671|NCT00712725|466953289|FG002|Overall Study|Lost to Follow-up|1|||
129725672|NCT00712725|466953290|FG003|Overall Study|Lost to Follow-up|1|||
129725673|NCT00712725|466953291|FG004|Overall Study|Lost to Follow-up|2|||
129725674|NCT00712725|466953292|FG005|Overall Study|Lost to Follow-up|2|||
129725675|NCT00712725|466953293|FG006|Overall Study|Lost to Follow-up|3|||
129725676|NCT00712725|466953294|FG007|Overall Study|Lost to Follow-up|1|||
129725677|NCT00712725|466953287|FG000|Overall Study|Physician Decision|2|||
129725678|NCT00712725|466953288|FG001|Overall Study|Physician Decision|0|||
129725679|NCT00712725|466953289|FG002|Overall Study|Physician Decision|0|||
129725680|NCT00712725|466953290|FG003|Overall Study|Physician Decision|0|||
129725681|NCT00712725|466953291|FG004|Overall Study|Physician Decision|1|||
129725682|NCT00712725|466953292|FG005|Overall Study|Physician Decision|0|||
129725683|NCT00712725|466953293|FG006|Overall Study|Physician Decision|2|||
129725684|NCT00712725|466953294|FG007|Overall Study|Physician Decision|0|||
129725685|NCT00712725|466953287|FG000|Overall Study|Pregnancy|0|||
129725686|NCT00712725|466953288|FG001|Overall Study|Pregnancy|1|||
129725687|NCT00712725|466953289|FG002|Overall Study|Pregnancy|0|||
129725688|NCT00712725|466953290|FG003|Overall Study|Pregnancy|0|||
129725689|NCT00712725|466953291|FG004|Overall Study|Pregnancy|1|||
129725690|NCT00712725|466953292|FG005|Overall Study|Pregnancy|0|||
129725691|NCT00712725|466953293|FG006|Overall Study|Pregnancy|2|||
129725692|NCT00712725|466953294|FG007|Overall Study|Pregnancy|0|||
129725693|NCT00712725|466953287|FG000|Overall Study|Protocol Violation|2|||
129725694|NCT00712725|466953288|FG001|Overall Study|Protocol Violation|0|||
129725695|NCT00712725|466953289|FG002|Overall Study|Protocol Violation|1|||
129725696|NCT00712725|466953290|FG003|Overall Study|Protocol Violation|3|||
129725697|NCT00712725|466953291|FG004|Overall Study|Protocol Violation|2|||
129725698|NCT00712725|466953292|FG005|Overall Study|Protocol Violation|0|||
129725699|NCT00712725|466953293|FG006|Overall Study|Protocol Violation|1|||
129725700|NCT00712725|466953294|FG007|Overall Study|Protocol Violation|1|||
129725701|NCT00712725|466953287|FG000|Overall Study|Withdrawal by Subject|2|||
129725702|NCT00712725|466953288|FG001|Overall Study|Withdrawal by Subject|1|||
129725703|NCT00712725|466953289|FG002|Overall Study|Withdrawal by Subject|1|||
129725704|NCT00712725|466953290|FG003|Overall Study|Withdrawal by Subject|2|||
129725705|NCT00712725|466953291|FG004|Overall Study|Withdrawal by Subject|1|||
129725706|NCT00712725|466953292|FG005|Overall Study|Withdrawal by Subject|1|||
129725707|NCT00712725|466953293|FG006|Overall Study|Withdrawal by Subject|1|||
129725708|NCT00712725|466953294|FG007|Overall Study|Withdrawal by Subject|2|||
129725709|NCT00712725|466953287|FG000|Overall Study|Lack of Qualifying Event|16|||
129725710|NCT00712725|466953288|FG001|Overall Study|Lack of Qualifying Event|2|||
129725711|NCT00712725|466953289|FG002|Overall Study|Lack of Qualifying Event|6|||
129725712|NCT00712725|466953290|FG003|Overall Study|Lack of Qualifying Event|8|||
129725713|NCT00712725|466953291|FG004|Overall Study|Lack of Qualifying Event|11|||
129725714|NCT00712725|466953292|FG005|Overall Study|Lack of Qualifying Event|13|||
129725715|NCT00712725|466953293|FG006|Overall Study|Lack of Qualifying Event|11|||
129725716|NCT00712725|466953294|FG007|Overall Study|Lack of Qualifying Event|6|||
129725717|NCT00712725|466953287|FG000|Overall Study|Protocol Specified Criteria|3|||
129725718|NCT00712725|466953288|FG001|Overall Study|Protocol Specified Criteria|0|||
129725719|NCT00712725|466953289|FG002|Overall Study|Protocol Specified Criteria|1|||
129725720|NCT00712725|466953290|FG003|Overall Study|Protocol Specified Criteria|2|||
129725721|NCT00712725|466953291|FG004|Overall Study|Protocol Specified Criteria|1|||
129725722|NCT00712725|466953292|FG005|Overall Study|Protocol Specified Criteria|0|||
129725723|NCT00712725|466953293|FG006|Overall Study|Protocol Specified Criteria|2|||
129725724|NCT00712725|466953294|FG007|Overall Study|Protocol Specified Criteria|1|||
129725725|NCT03466099|466953295|FG000|Overall Study|Adverse Event|1|||
129725726|NCT03466099|466953296|FG001|Overall Study|Adverse Event|1|||
129725727|NCT03466099|466953297|FG002|Overall Study|Adverse Event|1|||
129725728|NCT03466099|466953295|FG000|Overall Study|Withdrawal by Subject|2|||
129725729|NCT03466099|466953296|FG001|Overall Study|Withdrawal by Subject|3|||
129725730|NCT03466099|466953297|FG002|Overall Study|Withdrawal by Subject|1|||
129725731|NCT03466099|466953295|FG000|Overall Study|Use of rescue medication|8|||
129725732|NCT03466099|466953296|FG001|Overall Study|Use of rescue medication|9|||
129725733|NCT03466099|466953297|FG002|Overall Study|Use of rescue medication|13|||
129725734|NCT03466099|466953295|FG000|Overall Study|Rescued without meeting criteria|4|||
129725735|NCT03466099|466953296|FG001|Overall Study|Rescued without meeting criteria|1|||
129725736|NCT03466099|466953297|FG002|Overall Study|Rescued without meeting criteria|1|||
129725737|NCT03466099|466953295|FG000|Overall Study|Subject compliance|2|||
129725738|NCT03466099|466953296|FG001|Overall Study|Subject compliance|0|||
129725739|NCT03466099|466953297|FG002|Overall Study|Subject compliance|0|||
129725740|NCT03466099|466953295|FG000|Overall Study|Worsening disease|0|||
129725741|NCT03466099|466953296|FG001|Overall Study|Worsening disease|0|||
129725742|NCT03466099|466953297|FG002|Overall Study|Worsening disease|1|||
129725743|NCT00613327|466953300|FG000|Overall Study|Adverse Event|38|||
129725744|NCT00613327|466953300|FG000|Overall Study|Lost to Follow-up|8|||
129725745|NCT00613327|466953300|FG000|Overall Study|Withdrawal by Subject|6|||
129725746|NCT00613327|466953300|FG000|Overall Study|Protocol Violation|2|||
129725747|NCT00613327|466953300|FG000|Overall Study|Other|47|||
129725748|NCT03832322|466953303|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
129725749|NCT03832322|466953304|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
129725750|NCT03718884|466953305|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
129725751|NCT03718884|466953306|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
129725752|NCT03718884|466953305|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
129725753|NCT03718884|466953306|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
129725754|NCT00404755|466953307|FG000|Phase I (Bupropion)|Adverse Event|3|||
129725755|NCT00404755|466953307|FG000|Phase I (Bupropion)|Other|1|||
129725756|NCT00404755|466953307|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
129725757|NCT00350870|466953308|FG000|Overall Study|Withdrawal by Subject|21|||
129725758|NCT00350870|466953309|FG001|Overall Study|Withdrawal by Subject|17|||
129725759|NCT00350870|466953310|FG002|Overall Study|Withdrawal by Subject|15|||
129725760|NCT00350870|466953311|FG003|Overall Study|Withdrawal by Subject|14|||
129725761|NCT00350870|466953308|FG000|Overall Study|Physician Decision|1|||
129725762|NCT00350870|466953309|FG001|Overall Study|Physician Decision|0|||
129725763|NCT00350870|466953310|FG002|Overall Study|Physician Decision|1|||
129725764|NCT00350870|466953311|FG003|Overall Study|Physician Decision|1|||
129725765|NCT00349921|466953312|FG000|First Spinal Injection|Physician Decision|1|||
129725766|NCT00349921|466953313|FG001|First Spinal Injection|Physician Decision|0|||
129725767|NCT00349921|466953314|FG002|First Spinal Injection|Physician Decision|0|||
129725768|NCT00349921|466953315|FG003|First Spinal Injection|Physician Decision|0|||
129725769|NCT00349921|466953312|FG000|First Spinal Injection|Adverse Event|0|||
129725770|NCT00349921|466953313|FG001|First Spinal Injection|Adverse Event|0|||
129725771|NCT00349921|466953314|FG002|First Spinal Injection|Adverse Event|1|||
129725772|NCT00349921|466953315|FG003|First Spinal Injection|Adverse Event|0|||
129725773|NCT03194568|466953316|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
129725774|NCT01453205|466953317|FG000|Overall Study|Lost to Follow-up|3|||
129725775|NCT01453205|466953318|FG001|Overall Study|Lost to Follow-up|0|||
129725776|NCT01453205|466953319|FG002|Overall Study|Lost to Follow-up|1|||
129725777|NCT01453205|466953317|FG000|Overall Study|Withdrawal by Subject|8|||
129725778|NCT01453205|466953318|FG001|Overall Study|Withdrawal by Subject|3|||
129725779|NCT01453205|466953319|FG002|Overall Study|Withdrawal by Subject|0|||
129725780|NCT01453205|466953317|FG000|Overall Study|Death|24|||
129725781|NCT01453205|466953318|FG001|Overall Study|Death|22|||
129725782|NCT01453205|466953319|FG002|Overall Study|Death|18|||
129725783|NCT01453205|466953317|FG000|Overall Study|Other|45|||
129725784|NCT01453205|466953318|FG001|Overall Study|Other|27|||
129725785|NCT01453205|466953319|FG002|Overall Study|Other|35|||
129725786|NCT03763656|466953327|FG000|Overall Study|Physician Decision|1|||
129725787|NCT03763656|466953327|FG000|Overall Study|Protocol Violation|1|||
129725788|NCT03763656|466953327|FG000|Overall Study|Withdrawal by Subject|7|||
129725789|NCT00487942|466953328|FG000|Overall Study|Adverse Event|1|||
129725790|NCT00487942|466953329|FG001|Overall Study|Adverse Event|1|||
129725791|NCT00487942|466953330|FG002|Overall Study|Adverse Event|1|||
129725792|NCT00487942|466953331|FG003|Overall Study|Adverse Event|1|||
129725793|NCT00487942|466953328|FG000|Overall Study|Lost to Follow-up|1|||
129725794|NCT00487942|466953329|FG001|Overall Study|Lost to Follow-up|0|||
129725795|NCT00487942|466953330|FG002|Overall Study|Lost to Follow-up|0|||
129725796|NCT00487942|466953331|FG003|Overall Study|Lost to Follow-up|1|||
129725797|NCT00487942|466953328|FG000|Overall Study|Protocol Violation|1|||
129725798|NCT00487942|466953329|FG001|Overall Study|Protocol Violation|1|||
129725799|NCT00487942|466953330|FG002|Overall Study|Protocol Violation|0|||
129725800|NCT00487942|466953331|FG003|Overall Study|Protocol Violation|0|||
129725801|NCT00487942|466953328|FG000|Overall Study|Withdrawal by Subject|0|||
129725802|NCT00487942|466953329|FG001|Overall Study|Withdrawal by Subject|1|||
129725803|NCT00487942|466953330|FG002|Overall Study|Withdrawal by Subject|2|||
129725804|NCT00487942|466953331|FG003|Overall Study|Withdrawal by Subject|0|||
129725805|NCT00082368|466953332|FG000|Overall Study|Not treated-pt had poor IV access|1|||
129725806|NCT03319953|466953335|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
129725807|NCT03319953|466953336|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
129725808|NCT03319953|466953337|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
129725809|NCT03319953|466953338|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
129725810|NCT03319953|466953335|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
129725811|NCT03319953|466953336|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
129725812|NCT03319953|466953337|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
129725813|NCT03319953|466953338|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
129725814|NCT00790868|466955273|FG000|Overall Study|Withdrawal by Subject|4|||
129725815|NCT00790868|466955274|FG001|Overall Study|Withdrawal by Subject|5|||
129725816|NCT00790868|466955273|FG000|Overall Study|Lost to Follow-up|2|||
129725817|NCT00790868|466955274|FG001|Overall Study|Lost to Follow-up|12|||
129725818|NCT01380535|466955275|FG000|Overall Study|Adverse Event|3|||
129725819|NCT01380535|466955276|FG001|Overall Study|Adverse Event|3|||
129725820|NCT01380535|466955275|FG000|Overall Study|Death|3|||
129725821|NCT01380535|466955276|FG001|Overall Study|Death|0|||
129725822|NCT01380535|466955275|FG000|Overall Study|Study site closed|0|||
129725823|NCT01380535|466955276|FG001|Overall Study|Study site closed|5|||
129725824|NCT01380535|466955275|FG000|Overall Study|Withdrawal by Subject|1|||
129725825|NCT01380535|466955276|FG001|Overall Study|Withdrawal by Subject|2|||
129725826|NCT01380535|466955275|FG000|Overall Study|Protocol Violation|0|||
129725827|NCT01380535|466955276|FG001|Overall Study|Protocol Violation|2|||
129725828|NCT01380535|466955275|FG000|Overall Study|Lack of Efficacy|0|||
129725829|NCT01380535|466955276|FG001|Overall Study|Lack of Efficacy|3|||
129725830|NCT04753658|466955282|FG000|Overall Study|Progressive disease|7|||
129725831|NCT04753658|466955282|FG000|Overall Study|Other|7|||
129725832|NCT04753658|466955282|FG000|Overall Study|Adverse Event|1|||
129725833|NCT00306293|466955283|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
129725834|NCT00306293|466955284|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
129725835|NCT00306293|466955283|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
129725836|NCT00306293|466955284|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
129725837|NCT00306293|466955283|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
129725838|NCT00306293|466955284|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
129725839|NCT00306293|466955283|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
129725840|NCT00306293|466955284|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
129725841|NCT00306293|466955283|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
129725842|NCT00306293|466955284|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
129725843|NCT00306293|466955283|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
129725844|NCT00306293|466955284|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
129725845|NCT00306293|466955283|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
129725846|NCT00306293|466955284|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
129725847|NCT00306293|466955283|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
129725848|NCT00306293|466955284|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
129725849|NCT00218634|466955285|FG000|Overall Study|Lost to Follow-up|8|||
129725850|NCT00218634|466955286|FG001|Overall Study|Lost to Follow-up|15|||
129725851|NCT05243745|466955287|FG000|Overall Study|Withdrawal by Subject|0|||
129725852|NCT05243745|466955288|FG001|Overall Study|Withdrawal by Subject|0|||
129725853|NCT05243745|466955289|FG002|Overall Study|Withdrawal by Subject|0|||
129725854|NCT05243745|466955290|FG003|Overall Study|Withdrawal by Subject|1|||
129725855|NCT05243745|466955287|FG000|Overall Study|Unable to Attend Visit 6|0|||
129725856|NCT05243745|466955288|FG001|Overall Study|Unable to Attend Visit 6|0|||
129725857|NCT05243745|466955289|FG002|Overall Study|Unable to Attend Visit 6|1|||
129725858|NCT05243745|466955290|FG003|Overall Study|Unable to Attend Visit 6|0|||
129725859|NCT00420004|466955302|FG000|Overall Study|Adverse Event|4|||
129725860|NCT00420004|466955303|FG001|Overall Study|Adverse Event|1|||
129725861|NCT00420004|466955304|FG002|Overall Study|Adverse Event|1|||
129725862|NCT00420004|466955302|FG000|Overall Study|Lack of Efficacy|5|||
129725863|NCT00420004|466955303|FG001|Overall Study|Lack of Efficacy|4|||
129725864|NCT00420004|466955304|FG002|Overall Study|Lack of Efficacy|1|||
129725865|NCT00420004|466955302|FG000|Overall Study|Lost to Follow-up|31|||
129444412|NCT00323297|465927339|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
129725866|NCT00420004|466955303|FG001|Overall Study|Lost to Follow-up|12|||
129725867|NCT00420004|466955304|FG002|Overall Study|Lost to Follow-up|10|||
129725868|NCT00420004|466955302|FG000|Overall Study|Entry Criteria Not Met|0|||
129725869|NCT00420004|466955303|FG001|Overall Study|Entry Criteria Not Met|1|||
129725870|NCT00420004|466955304|FG002|Overall Study|Entry Criteria Not Met|0|||
129444413|NCT00323297|465927338|FG000|Part A (Double Blind Randomized)|Death|0|||
129725871|NCT00420004|466955302|FG000|Overall Study|Physician Decision|14|||
129725872|NCT00420004|466955303|FG001|Overall Study|Physician Decision|4|||
129804103|NCT04526509|467249906|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
129725873|NCT00420004|466955304|FG002|Overall Study|Physician Decision|2|||
129725874|NCT00420004|466955302|FG000|Overall Study|Protocol Violation|5|||
129725875|NCT00420004|466955303|FG001|Overall Study|Protocol Violation|4|||
129725876|NCT00420004|466955304|FG002|Overall Study|Protocol Violation|3|||
129725877|NCT00420004|466955302|FG000|Overall Study|Withdrawal by Subject|67|||
129725878|NCT00420004|466955303|FG001|Overall Study|Withdrawal by Subject|42|||
129725879|NCT00420004|466955304|FG002|Overall Study|Withdrawal by Subject|14|||
129725880|NCT00420004|466955302|FG000|Overall Study|Sponsor Decision|3|||
129725881|NCT00420004|466955303|FG001|Overall Study|Sponsor Decision|3|||
129725882|NCT00420004|466955304|FG002|Overall Study|Sponsor Decision|1|||
129725883|NCT00591149|466955305|FG000|Overall Study|Adverse Event|4|||
129725884|NCT00591149|466955305|FG000|Overall Study|Withdrawal by Subject|1|||
129725885|NCT00470093|466955306|FG000|Overall Study|Adverse Event|2|||
129725886|NCT00664560|466955307|FG000|Overall Study|Adverse Event|19|||
129725887|NCT00664560|466955308|FG001|Overall Study|Adverse Event|16|||
129725888|NCT00664560|466955309|FG002|Overall Study|Adverse Event|7|||
129725889|NCT00664560|466955307|FG000|Overall Study|Withdrawal by Subject|9|||
129725890|NCT00664560|466955308|FG001|Overall Study|Withdrawal by Subject|13|||
129725891|NCT00664560|466955309|FG002|Overall Study|Withdrawal by Subject|7|||
129725892|NCT00664560|466955307|FG000|Overall Study|Lost to Follow-up|0|||
129725893|NCT00664560|466955308|FG001|Overall Study|Lost to Follow-up|2|||
129725894|NCT00664560|466955309|FG002|Overall Study|Lost to Follow-up|0|||
129725895|NCT00664560|466955307|FG000|Overall Study|Other|11|||
129725896|NCT00664560|466955308|FG001|Overall Study|Other|4|||
129725897|NCT00664560|466955309|FG002|Overall Study|Other|5|||
129725898|NCT02456636|466955310|FG000|Overall Study|Death|0|||
129725899|NCT02456636|466955311|FG001|Overall Study|Death|3|||
129725900|NCT02456636|466955312|FG002|Overall Study|Death|0|||
129725901|NCT02456636|466955310|FG000|Overall Study|Pregnancy|1|||
129725902|NCT02456636|466955311|FG001|Overall Study|Pregnancy|3|||
129725903|NCT02456636|466955312|FG002|Overall Study|Pregnancy|5|||
129725904|NCT02456636|466955310|FG000|Overall Study|Physician Decision|4|||
129725905|NCT02456636|466955311|FG001|Overall Study|Physician Decision|5|||
129725906|NCT02456636|466955312|FG002|Overall Study|Physician Decision|4|||
129725907|NCT02456636|466955310|FG000|Overall Study|Withdrawal by Subject|13|||
129725908|NCT02456636|466955311|FG001|Overall Study|Withdrawal by Subject|14|||
129725909|NCT02456636|466955312|FG002|Overall Study|Withdrawal by Subject|16|||
129725910|NCT02456636|466955310|FG000|Overall Study|Lost to Follow-up|50|||
129725911|NCT02456636|466955311|FG001|Overall Study|Lost to Follow-up|44|||
129725912|NCT02456636|466955312|FG002|Overall Study|Lost to Follow-up|50|||
129725913|NCT03350035|466955313|FG000|Overall Study|Lack of Efficacy|2|||
129725914|NCT03350035|466955314|FG001|Overall Study|Lack of Efficacy|0|||
129725915|NCT03350035|466955315|FG002|Overall Study|Lack of Efficacy|0|||
129725916|NCT03350035|466955313|FG000|Overall Study|Subject discharged to hospice|0|||
129725917|NCT03350035|466955314|FG001|Overall Study|Subject discharged to hospice|0|||
129725918|NCT03350035|466955315|FG002|Overall Study|Subject discharged to hospice|1|||
129725919|NCT01610557|466955316|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129725920|NCT01610557|466955317|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
129725921|NCT01610557|466955318|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129725922|NCT01610557|466955319|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129725923|NCT01610557|466955320|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
129725924|NCT01610557|466955316|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129725925|NCT01610557|466955317|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129725926|NCT01610557|466955318|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129725927|NCT01610557|466955319|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
129725928|NCT01610557|466955320|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
129804104|NCT04526509|467249900|FG000|Enrolled|Physician Decision|0|||
129804105|NCT04526509|467249901|FG001|Enrolled|Physician Decision|1|||
129444414|NCT00323297|465927339|FG001|Part A (Double Blind Randomized)|Death|1|||
129444415|NCT00323297|465927338|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
129444416|NCT00323297|465927339|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
129444417|NCT00323297|465927338|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
129444418|NCT00323297|465927339|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
129444419|NCT00323297|465927338|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
129725929|NCT02039219|466955321|FG000|Treatment|Withdrawal by Subject|1|||
129725930|NCT02039219|466955322|FG001|Treatment|Withdrawal by Subject|0|||
129725931|NCT02039219|466955321|FG000|Treatment|Adverse Event|0|||
129725932|NCT02039219|466955322|FG001|Treatment|Adverse Event|1|||
129725933|NCT02039219|466955321|FG000|Treatment|Physician Decision|1|||
129725934|NCT02039219|466955322|FG001|Treatment|Physician Decision|0|||
129725935|NCT02039219|466955321|FG000|Treatment|Lost to Follow-up|0|||
129725936|NCT02039219|466955322|FG001|Treatment|Lost to Follow-up|1|||
129725937|NCT02039219|466955321|FG000|Treatment|Protocol Violation|1|||
129725938|NCT02039219|466955322|FG001|Treatment|Protocol Violation|0|||
129725939|NCT02039219|466955321|FG000|Treatment|Death|1|||
129725940|NCT02039219|466955322|FG001|Treatment|Death|0|||
129725941|NCT02039219|466955321|FG000|Follow up|Adverse Event|0|||
129804106|NCT04526509|467249902|FG002|Enrolled|Physician Decision|0|||
129804107|NCT04526509|467249903|FG003|Enrolled|Physician Decision|0|||
129804108|NCT04526509|467249904|FG004|Enrolled|Physician Decision|0|||
129804109|NCT04526509|467249905|FG005|Enrolled|Physician Decision|0|||
129804110|NCT04526509|467249906|FG006|Enrolled|Physician Decision|0|||
129804111|NCT04340193|467249908|FG000|Overall Study|Other reason|0|||
129804112|NCT04340193|467249909|FG001|Overall Study|Other reason|0|||
129804113|NCT04340193|467249910|FG002|Overall Study|Other reason|1|||
129804114|NCT04340193|467249908|FG000|Overall Study|Disease recurrence|0|||
129804115|NCT04340193|467249909|FG001|Overall Study|Disease recurrence|1|||
129804116|NCT04340193|467249910|FG002|Overall Study|Disease recurrence|0|||
129804117|NCT04340193|467249908|FG000|Overall Study|Study drug toxicity|1|||
129804118|NCT04340193|467249909|FG001|Overall Study|Study drug toxicity|0|||
129804119|NCT04340193|467249910|FG002|Overall Study|Study drug toxicity|0|||
129804120|NCT04340193|467249908|FG000|Overall Study|Disease progression|1|||
129804121|NCT04340193|467249909|FG001|Overall Study|Disease progression|2|||
129804122|NCT04340193|467249910|FG002|Overall Study|Disease progression|3|||
129804123|NCT04340193|467249908|FG000|Overall Study|Administrative reasons by sponsor|0|||
129804124|NCT04340193|467249909|FG001|Overall Study|Administrative reasons by sponsor|1|||
129804125|NCT04340193|467249910|FG002|Overall Study|Administrative reasons by sponsor|0|||
129804126|NCT04340193|467249908|FG000|Overall Study|Adverse Event|1|||
129804127|NCT04340193|467249909|FG001|Overall Study|Adverse Event|1|||
129804128|NCT04340193|467249910|FG002|Overall Study|Adverse Event|0|||
129804129|NCT01386008|467249911|FG000|Overall Study|exited w/o incident /study discontinued|17|||
129804130|NCT01386008|467249911|FG000|Overall Study|Adverse Event|3|||
129804131|NCT04449861|467249912|FG000|Overall Study|Withdrawal by Subject|4|||
129804132|NCT04449861|467249912|FG000|Overall Study|Lost to Follow-up|5|||
129804133|NCT04449861|467249912|FG000|Overall Study|Death|112|||
129444420|NCT00323297|465927339|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
129725942|NCT02039219|466955322|FG001|Follow up|Adverse Event|1|||
129725943|NCT02974855|466955323|FG000|Overall Study|Adverse Event|0|||
129725944|NCT02974855|466955324|FG001|Overall Study|Adverse Event|1|||
129725945|NCT02974855|466955325|FG002|Overall Study|Adverse Event|0|||
129725946|NCT02974855|466955326|FG003|Overall Study|Adverse Event|1|||
129725947|NCT03576066|466955327|FG000|Overall Study|Noncompliance with study drug|0|||
129725948|NCT03576066|466955328|FG001|Overall Study|Noncompliance with study drug|1|||
129725949|NCT00129701|466955329|FG000|Overall Study|Withdrawal by Subject|33|||
129725950|NCT02750345|466955330|FG000|Intervention 1|Adverse Event|0|||
129725951|NCT02750345|466955331|FG001|Intervention 1|Adverse Event|0|||
129725952|NCT02750345|466955332|FG002|Intervention 1|Adverse Event|0|||
129725953|NCT02750345|466955333|FG003|Intervention 1|Adverse Event|0|||
129725954|NCT02750345|466955334|FG004|Intervention 1|Adverse Event|1|||
129725955|NCT02750345|466955335|FG005|Intervention 1|Adverse Event|0|||
129725956|NCT00006164|466955336|FG000|Overall Study|Withdrew or lost to follow-up|70|||
129725957|NCT00006164|466955337|FG001|Overall Study|Withdrew or lost to follow-up|81|||
129725958|NCT00633074|466955340|FG000|Overall Study|Adverse Event|1|||
129725959|NCT00633074|466955341|FG001|Overall Study|Adverse Event|0|||
129725960|NCT00365105|466955342|FG000|Overall Study|Protocol Violation|5|||
129725961|NCT00365105|466955343|FG001|Overall Study|Protocol Violation|8|||
129725962|NCT00608023|466955344|FG000|Overall Study|Withdrawal by Subject|8|||
129444421|NCT00323297|465927338|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
129444422|NCT00323297|465927339|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
129444423|NCT00323297|465927338|FG000|Part B (Open-label)|Death|0|||
129444424|NCT00323297|465927339|FG001|Part B (Open-label)|Death|1|||
129444425|NCT00323297|465927338|FG000|Part B (Open-label)|Reason unspecified|0|||
129444426|NCT00323297|465927339|FG001|Part B (Open-label)|Reason unspecified|1|||
129444427|NCT00323297|465927338|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
129725963|NCT00608023|466955345|FG001|Overall Study|Withdrawal by Subject|10|||
129725964|NCT00608023|466955346|FG002|Overall Study|Withdrawal by Subject|7|||
129725965|NCT00608023|466955344|FG000|Overall Study|Adverse Event|1|||
129725966|NCT00608023|466955345|FG001|Overall Study|Adverse Event|4|||
129725967|NCT00608023|466955346|FG002|Overall Study|Adverse Event|5|||
129725968|NCT00608023|466955344|FG000|Overall Study|Lost to Follow-up|2|||
129725969|NCT00608023|466955345|FG001|Overall Study|Lost to Follow-up|2|||
129725970|NCT00608023|466955346|FG002|Overall Study|Lost to Follow-up|1|||
129725971|NCT00608023|466955344|FG000|Overall Study|Protocol Violation|1|||
129725972|NCT00608023|466955345|FG001|Overall Study|Protocol Violation|3|||
129725973|NCT00608023|466955346|FG002|Overall Study|Protocol Violation|1|||
129725974|NCT00608023|466955344|FG000|Overall Study|Unknown reason|0|||
129725975|NCT00608023|466955345|FG001|Overall Study|Unknown reason|3|||
129725976|NCT00608023|466955346|FG002|Overall Study|Unknown reason|0|||
129725977|NCT06422364|466955347|FG000|Overall Study|Withdrawn due to study closure|0|||
129804134|NCT00976677|467249913|FG000|Overall Study|Adverse Event|1|||
129804135|NCT00976677|467249914|FG001|Overall Study|Adverse Event|0|||
129804136|NCT00976677|467249913|FG000|Overall Study|Withdrawal by Subject|0|||
129804137|NCT00976677|467249914|FG001|Overall Study|Withdrawal by Subject|2|||
129804138|NCT00976677|467249913|FG000|Overall Study|Disease progression|1|||
129444428|NCT00323297|465927339|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
129804139|NCT00976677|467249914|FG001|Overall Study|Disease progression|1|||
129725978|NCT06422364|466955348|FG001|Overall Study|Withdrawn due to study closure|2|||
129725979|NCT01463696|466955353|FG000|Overall Study|Adverse Event|0|||
129725980|NCT01463696|466955354|FG001|Overall Study|Adverse Event|1|||
129725981|NCT01463696|466955355|FG002|Overall Study|Adverse Event|0|||
129725982|NCT01463696|466955356|FG003|Overall Study|Adverse Event|2|||
129725983|NCT01463696|466955357|FG004|Overall Study|Adverse Event|0|||
129725984|NCT01463696|466955358|FG005|Overall Study|Adverse Event|1|||
129725985|NCT01463696|466955359|FG006|Overall Study|Adverse Event|3|||
129725986|NCT01463696|466955360|FG007|Overall Study|Adverse Event|2|||
129725987|NCT01463696|466955353|FG000|Overall Study|Lost to Follow-up|0|||
129725988|NCT01463696|466955354|FG001|Overall Study|Lost to Follow-up|0|||
129725989|NCT01463696|466955355|FG002|Overall Study|Lost to Follow-up|1|||
129725990|NCT01463696|466955356|FG003|Overall Study|Lost to Follow-up|0|||
129725991|NCT01463696|466955357|FG004|Overall Study|Lost to Follow-up|0|||
129725992|NCT01463696|466955358|FG005|Overall Study|Lost to Follow-up|0|||
129725993|NCT01463696|466955359|FG006|Overall Study|Lost to Follow-up|0|||
129725994|NCT01463696|466955360|FG007|Overall Study|Lost to Follow-up|0|||
129725995|NCT01463696|466955353|FG000|Overall Study|Progressive Disease|0|||
129725996|NCT01463696|466955354|FG001|Overall Study|Progressive Disease|1|||
129725997|NCT01463696|466955355|FG002|Overall Study|Progressive Disease|0|||
129725998|NCT01463696|466955356|FG003|Overall Study|Progressive Disease|1|||
129725999|NCT01463696|466955357|FG004|Overall Study|Progressive Disease|0|||
129726000|NCT01463696|466955358|FG005|Overall Study|Progressive Disease|1|||
129726001|NCT01463696|466955359|FG006|Overall Study|Progressive Disease|4|||
129726002|NCT01463696|466955360|FG007|Overall Study|Progressive Disease|2|||
129726003|NCT01463696|466955353|FG000|Overall Study|Withdrawal by Subject|0|||
129726004|NCT01463696|466955354|FG001|Overall Study|Withdrawal by Subject|0|||
129726005|NCT01463696|466955355|FG002|Overall Study|Withdrawal by Subject|0|||
129726006|NCT01463696|466955356|FG003|Overall Study|Withdrawal by Subject|1|||
129726007|NCT01463696|466955357|FG004|Overall Study|Withdrawal by Subject|1|||
129726008|NCT01463696|466955358|FG005|Overall Study|Withdrawal by Subject|1|||
129726009|NCT01463696|466955359|FG006|Overall Study|Withdrawal by Subject|2|||
129726010|NCT01463696|466955360|FG007|Overall Study|Withdrawal by Subject|0|||
129726011|NCT01463696|466955353|FG000|Overall Study|Not Treated|0|||
129726012|NCT01463696|466955354|FG001|Overall Study|Not Treated|0|||
129726013|NCT01463696|466955355|FG002|Overall Study|Not Treated|0|||
129726014|NCT01463696|466955356|FG003|Overall Study|Not Treated|0|||
129726015|NCT01463696|466955357|FG004|Overall Study|Not Treated|0|||
129726016|NCT01463696|466955358|FG005|Overall Study|Not Treated|0|||
129726017|NCT01463696|466955359|FG006|Overall Study|Not Treated|1|||
129726018|NCT01463696|466955360|FG007|Overall Study|Not Treated|0|||
129726019|NCT03905265|466955362|FG000|Overall Study|Withdrawal by Subject|1|||
129726020|NCT03905265|466955363|FG001|Overall Study|Withdrawal by Subject|1|||
129726021|NCT03905265|466955364|FG002|Overall Study|Withdrawal by Subject|0|||
129726022|NCT03905265|466955365|FG003|Overall Study|Withdrawal by Subject|0|||
129726023|NCT01973387|466955369|FG000|Overall Study|Adverse Event|14|||
129726024|NCT01973387|466955370|FG001|Overall Study|Adverse Event|4|||
129726025|NCT01973387|466955369|FG000|Overall Study|Withdrawal by Subject|7|||
129726026|NCT01973387|466955370|FG001|Overall Study|Withdrawal by Subject|4|||
129726027|NCT01973387|466955369|FG000|Overall Study|Study terminated by sponsor|63|||
129726028|NCT01973387|466955370|FG001|Overall Study|Study terminated by sponsor|0|||
129726029|NCT01973387|466955369|FG000|Overall Study|Progressive disease or relapse|16|||
129726030|NCT01973387|466955370|FG001|Overall Study|Progressive disease or relapse|5|||
129726031|NCT01973387|466955369|FG000|Overall Study|Death|4|||
129726032|NCT01973387|466955370|FG001|Overall Study|Death|3|||
129726033|NCT01973387|466955369|FG000|Overall Study|Randomized, not treated|2|||
129726034|NCT01973387|466955370|FG001|Overall Study|Randomized, not treated|2|||
129726035|NCT03888235|466955379|FG000|Overall Study|Lost to Follow-up|1|||
129726036|NCT03888235|466955380|FG001|Overall Study|Lost to Follow-up|1|||
129726037|NCT03888235|466955381|FG002|Overall Study|Lost to Follow-up|0|||
129726038|NCT03525600|466955386|FG000|Overall Study|Adverse Event|9|||
129726039|NCT03525600|466955387|FG001|Overall Study|Adverse Event|6|||
129726040|NCT03525600|466955388|FG002|Overall Study|Adverse Event|5|||
129726041|NCT03525600|466955389|FG003|Overall Study|Adverse Event|3|||
129804140|NCT00976677|467249913|FG000|Overall Study|Trial unblinded|2|||
129444429|NCT00323297|465927338|FG000|Part B (Open-label)|Lack of Efficacy|3|||
129726042|NCT03525600|466955386|FG000|Overall Study|Lost to Follow-up|2|||
129726043|NCT03525600|466955387|FG001|Overall Study|Lost to Follow-up|4|||
129726044|NCT03525600|466955388|FG002|Overall Study|Lost to Follow-up|4|||
129726045|NCT03525600|466955389|FG003|Overall Study|Lost to Follow-up|0|||
129726046|NCT03525600|466955386|FG000|Overall Study|Physician Decision|1|||
129726047|NCT03525600|466955387|FG001|Overall Study|Physician Decision|0|||
129726048|NCT03525600|466955388|FG002|Overall Study|Physician Decision|2|||
129726049|NCT03525600|466955389|FG003|Overall Study|Physician Decision|0|||
129726050|NCT03525600|466955386|FG000|Overall Study|Consent withdrawal|36|||
129726051|NCT03525600|466955387|FG001|Overall Study|Consent withdrawal|20|||
129726052|NCT03525600|466955388|FG002|Overall Study|Consent withdrawal|6|||
129726053|NCT03525600|466955389|FG003|Overall Study|Consent withdrawal|13|||
129726054|NCT03525600|466955386|FG000|Overall Study|Death|7|||
129891710|NCT00432159|467563033|FG001|Overall Study|Failure|5|||
129891711|NCT00432159|467563034|FG002|Overall Study|Failure|3|||
129891712|NCT00432159|467563035|FG003|Overall Study|Failure|2|||
129891713|NCT00432159|467563036|FG004|Overall Study|Failure|3|||
129891714|NCT00432159|467563032|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
129444430|NCT00323297|465927339|FG001|Part B (Open-label)|Lack of Efficacy|1|||
129726055|NCT03525600|466955387|FG001|Overall Study|Death|6|||
129726056|NCT03525600|466955388|FG002|Overall Study|Death|4|||
129726057|NCT03525600|466955389|FG003|Overall Study|Death|3|||
129726058|NCT03525600|466955386|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
129726059|NCT03525600|466955387|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
129726060|NCT03525600|466955388|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
129726061|NCT03525600|466955389|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
129726062|NCT03525600|466955386|FG000|Overall Study|Other|0|||
129726063|NCT03525600|466955387|FG001|Overall Study|Other|1|||
129726064|NCT03525600|466955388|FG002|Overall Study|Other|0|||
129726065|NCT03525600|466955389|FG003|Overall Study|Other|0|||
129726066|NCT03703817|466955399|FG000|Overall Study|Not meeting eligibility criteria|7|||
129726067|NCT03703817|466955400|FG001|Overall Study|Not meeting eligibility criteria|4|||
129726068|NCT05248997|466955404|FG000|Overall Study|Lost to Follow-up|1|||
129726069|NCT05248997|466955405|FG001|Overall Study|Lost to Follow-up|1|||
129726070|NCT05248997|466955404|FG000|Overall Study|Randomized but not treated|32|||
129726071|NCT05248997|466955405|FG001|Overall Study|Randomized but not treated|25|||
129726072|NCT04262882|466955407|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
129726073|NCT04262882|466955408|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
129726074|NCT04262882|466955407|FG000|Overall Study|Lost to Follow-up|1|||
129726075|NCT04262882|466955408|FG001|Overall Study|Lost to Follow-up|0|||
129891715|NCT00432159|467563033|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
129891716|NCT00432159|467563034|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
129891717|NCT00432159|467563035|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
129444431|NCT00323297|465927338|FG000|Part B (Open-label)|Adverse Event|5|||
129726076|NCT01301066|466955409|FG000|Overall Study|Lost to Follow-up|5|||
129726077|NCT01301066|466955410|FG001|Overall Study|Lost to Follow-up|11|||
129726078|NCT01301066|466955409|FG000|Overall Study|Protocol Violation|8|||
129726079|NCT01301066|466955410|FG001|Overall Study|Protocol Violation|7|||
129726080|NCT01301066|466955409|FG000|Overall Study|Withdrawal by Subject|4|||
129726081|NCT01301066|466955410|FG001|Overall Study|Withdrawal by Subject|9|||
129726082|NCT01301066|466955409|FG000|Overall Study|Adverse Event|6|||
129726083|NCT01301066|466955410|FG001|Overall Study|Adverse Event|6|||
129726084|NCT01301066|466955409|FG000|Overall Study|Sponsor Decision|2|||
129726085|NCT01301066|466955410|FG001|Overall Study|Sponsor Decision|1|||
129726086|NCT01301066|466955409|FG000|Overall Study|Physician Decision|0|||
129726087|NCT01301066|466955410|FG001|Overall Study|Physician Decision|1|||
129726088|NCT01301066|466955409|FG000|Overall Study|Other|2|||
129726089|NCT01301066|466955410|FG001|Overall Study|Other|0|||
129726090|NCT03268954|466955415|FG000|Overall Study|Ongoing|23|||
129726091|NCT03268954|466955416|FG001|Overall Study|Ongoing|31|||
129726092|NCT03268954|466955415|FG000|Overall Study|Adverse Event|53|||
129726093|NCT03268954|466955416|FG001|Overall Study|Adverse Event|62|||
129726094|NCT03268954|466955415|FG000|Overall Study|Withdrawal by Subject|25|||
129726095|NCT03268954|466955416|FG001|Overall Study|Withdrawal by Subject|16|||
129726096|NCT03268954|466955415|FG000|Overall Study|Progressive Disease|61|||
129726097|NCT03268954|466955416|FG001|Overall Study|Progressive Disease|48|||
129726098|NCT03268954|466955415|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
129726099|NCT03268954|466955416|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
129726100|NCT03268954|466955415|FG000|Overall Study|Reason not Specified|40|||
129726101|NCT03268954|466955416|FG001|Overall Study|Reason not Specified|40|||
129726102|NCT03255967|466955417|FG000|Overall Study|Adverse Event|26|||
129726103|NCT03255967|466955418|FG001|Overall Study|Adverse Event|30|||
129726104|NCT03255967|466955417|FG000|Overall Study|Withdrawal by Subject|6|||
129726105|NCT03255967|466955418|FG001|Overall Study|Withdrawal by Subject|6|||
129726106|NCT03255967|466955417|FG000|Overall Study|Schedule conflict|6|||
129726107|NCT03255967|466955418|FG001|Overall Study|Schedule conflict|4|||
129726108|NCT03255967|466955417|FG000|Overall Study|POA did not sign consent form|2|||
129726109|NCT03255967|466955418|FG001|Overall Study|POA did not sign consent form|0|||
129726110|NCT00778258|466955419|FG000|Overall Study|Adverse Event|1|||
129726111|NCT00778258|466955420|FG001|Overall Study|Adverse Event|0|||
129726112|NCT00778258|466955421|FG002|Overall Study|Adverse Event|0|||
129726113|NCT00778258|466955422|FG003|Overall Study|Adverse Event|0|||
129726114|NCT00778258|466955423|FG004|Overall Study|Adverse Event|0|||
129726115|NCT00778258|466955424|FG005|Overall Study|Adverse Event|1|||
129726116|NCT00778258|466955425|FG006|Overall Study|Adverse Event|0|||
129726117|NCT00778258|466955426|FG007|Overall Study|Adverse Event|0|||
129726118|NCT00778258|466955427|FG008|Overall Study|Adverse Event|0|||
129726119|NCT00778258|466955419|FG000|Overall Study|Lost to Follow-up|0|||
129726120|NCT00778258|466955420|FG001|Overall Study|Lost to Follow-up|0|||
129726121|NCT00778258|466955421|FG002|Overall Study|Lost to Follow-up|2|||
129726122|NCT00778258|466955422|FG003|Overall Study|Lost to Follow-up|0|||
129726123|NCT00778258|466955423|FG004|Overall Study|Lost to Follow-up|0|||
129726124|NCT00778258|466955424|FG005|Overall Study|Lost to Follow-up|3|||
129726125|NCT00778258|466955425|FG006|Overall Study|Lost to Follow-up|2|||
129726126|NCT00778258|466955426|FG007|Overall Study|Lost to Follow-up|2|||
129726127|NCT00778258|466955427|FG008|Overall Study|Lost to Follow-up|0|||
129726128|NCT00778258|466955419|FG000|Overall Study|Withdrawal by Subject|6|||
129726129|NCT00778258|466955420|FG001|Overall Study|Withdrawal by Subject|2|||
129726130|NCT00778258|466955421|FG002|Overall Study|Withdrawal by Subject|8|||
129726131|NCT00778258|466955422|FG003|Overall Study|Withdrawal by Subject|2|||
129726132|NCT00778258|466955423|FG004|Overall Study|Withdrawal by Subject|0|||
129726133|NCT00778258|466955424|FG005|Overall Study|Withdrawal by Subject|6|||
129726134|NCT00778258|466955425|FG006|Overall Study|Withdrawal by Subject|12|||
129726135|NCT00778258|466955426|FG007|Overall Study|Withdrawal by Subject|12|||
129726136|NCT00778258|466955427|FG008|Overall Study|Withdrawal by Subject|4|||
129726137|NCT00778258|466955419|FG000|Overall Study|New Contraindication|0|||
129726138|NCT00778258|466955420|FG001|Overall Study|New Contraindication|0|||
129726139|NCT00778258|466955421|FG002|Overall Study|New Contraindication|0|||
129726140|NCT00778258|466955422|FG003|Overall Study|New Contraindication|0|||
129726141|NCT00778258|466955423|FG004|Overall Study|New Contraindication|0|||
129726142|NCT00778258|466955424|FG005|Overall Study|New Contraindication|0|||
129726143|NCT00778258|466955425|FG006|Overall Study|New Contraindication|0|||
129726144|NCT00778258|466955426|FG007|Overall Study|New Contraindication|1|||
129726145|NCT00778258|466955427|FG008|Overall Study|New Contraindication|0|||
129726146|NCT00778258|466955419|FG000|Overall Study|Non-compliance|0|||
129726147|NCT00778258|466955420|FG001|Overall Study|Non-compliance|0|||
129726148|NCT00778258|466955421|FG002|Overall Study|Non-compliance|0|||
129726149|NCT00778258|466955422|FG003|Overall Study|Non-compliance|1|||
129726150|NCT00778258|466955423|FG004|Overall Study|Non-compliance|0|||
129726151|NCT00778258|466955424|FG005|Overall Study|Non-compliance|0|||
129726152|NCT00778258|466955425|FG006|Overall Study|Non-compliance|0|||
129726153|NCT00778258|466955426|FG007|Overall Study|Non-compliance|0|||
129726154|NCT00778258|466955427|FG008|Overall Study|Non-compliance|0|||
129726155|NCT00778258|466955419|FG000|Overall Study|Other|0|||
129726156|NCT00778258|466955420|FG001|Overall Study|Other|0|||
129726157|NCT00778258|466955421|FG002|Overall Study|Other|0|||
129726158|NCT00778258|466955422|FG003|Overall Study|Other|0|||
129726159|NCT00778258|466955423|FG004|Overall Study|Other|0|||
129726160|NCT00778258|466955424|FG005|Overall Study|Other|0|||
129726161|NCT00778258|466955425|FG006|Overall Study|Other|1|||
129726162|NCT00778258|466955426|FG007|Overall Study|Other|0|||
129726163|NCT00778258|466955427|FG008|Overall Study|Other|0|||
129726164|NCT01202188|466955431|FG000|Overall Study|Protocol deviation|14|||
129726165|NCT01202188|466955432|FG001|Overall Study|Protocol deviation|8|||
129726166|NCT01202188|466955433|FG002|Overall Study|Protocol deviation|12|||
129726167|NCT01202188|466955434|FG003|Overall Study|Protocol deviation|10|||
129726168|NCT01202188|466955435|FG004|Overall Study|Protocol deviation|11|||
129726169|NCT01202188|466955431|FG000|Overall Study|Subject withdrew consent|12|||
129726170|NCT01202188|466955432|FG001|Overall Study|Subject withdrew consent|13|||
129726171|NCT01202188|466955433|FG002|Overall Study|Subject withdrew consent|22|||
129726172|NCT01202188|466955434|FG003|Overall Study|Subject withdrew consent|11|||
129726173|NCT01202188|466955435|FG004|Overall Study|Subject withdrew consent|13|||
129726174|NCT01202188|466955431|FG000|Overall Study|Adverse Event|5|||
129726175|NCT01202188|466955432|FG001|Overall Study|Adverse Event|23|||
129726176|NCT01202188|466955433|FG002|Overall Study|Adverse Event|13|||
129726177|NCT01202188|466955434|FG003|Overall Study|Adverse Event|10|||
129726178|NCT01202188|466955435|FG004|Overall Study|Adverse Event|10|||
129726179|NCT01202188|466955431|FG000|Overall Study|Administrative problems|3|||
129726180|NCT01202188|466955432|FG001|Overall Study|Administrative problems|2|||
129726181|NCT01202188|466955433|FG002|Overall Study|Administrative problems|1|||
129726182|NCT01202188|466955434|FG003|Overall Study|Administrative problems|1|||
129726183|NCT01202188|466955435|FG004|Overall Study|Administrative problems|2|||
129726184|NCT01202188|466955431|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129726185|NCT01202188|466955432|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129726186|NCT01202188|466955433|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129726187|NCT01202188|466955434|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
129726188|NCT01202188|466955435|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
129726189|NCT01202188|466955431|FG000|Overall Study|Lost to Follow-up|1|||
129726190|NCT01202188|466955432|FG001|Overall Study|Lost to Follow-up|1|||
129726191|NCT01202188|466955433|FG002|Overall Study|Lost to Follow-up|0|||
129726192|NCT01202188|466955434|FG003|Overall Study|Lost to Follow-up|4|||
129726193|NCT01202188|466955435|FG004|Overall Study|Lost to Follow-up|1|||
129726194|NCT01202188|466955431|FG000|Overall Study|Death|1|||
129726195|NCT01202188|466955432|FG001|Overall Study|Death|1|||
129726196|NCT01202188|466955433|FG002|Overall Study|Death|1|||
129726197|NCT01202188|466955434|FG003|Overall Study|Death|1|||
129726198|NCT01202188|466955435|FG004|Overall Study|Death|0|||
129726199|NCT01202188|466955431|FG000|Overall Study|Abnormal test procedure result (s)|0|||
129726200|NCT01202188|466955432|FG001|Overall Study|Abnormal test procedure result (s)|0|||
129726201|NCT01202188|466955433|FG002|Overall Study|Abnormal test procedure result (s)|2|||
129726202|NCT01202188|466955434|FG003|Overall Study|Abnormal test procedure result (s)|0|||
129726203|NCT01202188|466955435|FG004|Overall Study|Abnormal test procedure result (s)|0|||
129726204|NCT02640625|466957148|FG000|Overall Study|Adverse Event|1|||
129726205|NCT00511433|466957149|FG000|Overall Study|Adverse Event|5|||
129726206|NCT00511433|466957150|FG001|Overall Study|Adverse Event|0|||
129726207|NCT00511433|466957149|FG000|Overall Study|Other Reason|1|||
129726208|NCT00511433|466957150|FG001|Overall Study|Other Reason|1|||
129726209|NCT01740089|466957151|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
129726210|NCT01740089|466957152|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
129726211|NCT01740089|466957153|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
129726212|NCT01740089|466957151|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
129726213|NCT01740089|466957152|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
129726214|NCT01740089|466957153|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
129726215|NCT01740089|466957151|FG000|After 12 Weeks|Lack of Efficacy|3|||
129726216|NCT01740089|466957152|FG001|After 12 Weeks|Lack of Efficacy|1|||
129726217|NCT01740089|466957153|FG002|After 12 Weeks|Lack of Efficacy|4|||
129726218|NCT01740089|466957151|FG000|After 12 Weeks|Adverse Event|2|||
129726219|NCT01740089|466957152|FG001|After 12 Weeks|Adverse Event|0|||
129726220|NCT01740089|466957153|FG002|After 12 Weeks|Adverse Event|5|||
129726221|NCT01740089|466957151|FG000|After 12 Weeks|Protocol Violation|1|||
129726222|NCT01740089|466957152|FG001|After 12 Weeks|Protocol Violation|1|||
129726223|NCT01740089|466957153|FG002|After 12 Weeks|Protocol Violation|1|||
129726224|NCT01740089|466957151|FG000|After 12 Weeks|Withdrawal by Subject|1|||
129726225|NCT01740089|466957152|FG001|After 12 Weeks|Withdrawal by Subject|1|||
129726226|NCT01740089|466957153|FG002|After 12 Weeks|Withdrawal by Subject|1|||
129726227|NCT01579565|466957156|FG000|Randomized|Adverse Event|1|||
129726228|NCT01579565|466957157|FG001|Randomized|Adverse Event|3|||
129726229|NCT01579565|466957156|FG000|Randomized|Withdrawal by Subject|3|||
129726230|NCT01579565|466957157|FG001|Randomized|Withdrawal by Subject|0|||
129726231|NCT01579565|466957156|FG000|Randomized|inadequate preoperative pupil dilation|0|||
129726232|NCT01579565|466957157|FG001|Randomized|inadequate preoperative pupil dilation|1|||
129726233|NCT01579565|466957156|FG000|Randomized|prohibited preoperative eating|1|||
129726234|NCT01579565|466957157|FG001|Randomized|prohibited preoperative eating|0|||
129726235|NCT01579565|466957156|FG000|Randomized|prohibited preoperative medication|0|||
129726236|NCT01579565|466957157|FG001|Randomized|prohibited preoperative medication|1|||
129726237|NCT01579565|466957156|FG000|Treated|Physician Decision|0|||
129726238|NCT01579565|466957157|FG001|Treated|Physician Decision|1|||
129726239|NCT01579565|466957156|FG000|Treated|Lost to Follow-up|2|||
129726240|NCT01579565|466957157|FG001|Treated|Lost to Follow-up|1|||
129726241|NCT01579565|466957156|FG000|Treated|declined to return for final visit|0|||
129726242|NCT01579565|466957157|FG001|Treated|declined to return for final visit|1|||
129726243|NCT02867813|466957158|FG000|Overall Study|Withdrawal by Subject|57|||
129726244|NCT02867813|466957159|FG001|Overall Study|Withdrawal by Subject|56|||
129726245|NCT02867813|466957158|FG000|Overall Study|Decision by Sponsor|7|||
129726246|NCT02867813|466957159|FG001|Overall Study|Decision by Sponsor|7|||
129726247|NCT02867813|466957158|FG000|Overall Study|Lost to Follow-up|91|||
129726248|NCT02867813|466957159|FG001|Overall Study|Lost to Follow-up|78|||
129726249|NCT02867813|466957158|FG000|Overall Study|Missing|2|||
129726250|NCT02867813|466957159|FG001|Overall Study|Missing|1|||
129726251|NCT02867813|466957158|FG000|Overall Study|Death|294|||
129726252|NCT02867813|466957159|FG001|Overall Study|Death|268|||
129726253|NCT01463111|466957166|FG000|Overall Study|Withdrawal by Subject|2|||
129726254|NCT01463111|466957166|FG000|Overall Study|Lost to Follow-up|5|||
129726255|NCT01463111|466957166|FG000|Overall Study|Physician Decision|2|||
129726256|NCT03285958|466957167|FG000|Overall Study|Lost to Follow-up|1|||
129726257|NCT03285958|466957168|FG001|Overall Study|Lost to Follow-up|1|||
129726258|NCT03285958|466957167|FG000|Overall Study|Withdrawal by Subject|1|||
129726259|NCT03285958|466957168|FG001|Overall Study|Withdrawal by Subject|0|||
129726260|NCT03285958|466957167|FG000|Overall Study|Not able to attend required orientation|3|||
129726261|NCT03285958|466957168|FG001|Overall Study|Not able to attend required orientation|0|||
129726262|NCT03116828|466957171|FG000|Overall Study|Adverse Event|1|||
129726263|NCT03116828|466957172|FG001|Overall Study|Adverse Event|10|||
129726264|NCT03116828|466957171|FG000|Overall Study|Withdrawal by Subject|4|||
129726265|NCT03116828|466957172|FG001|Overall Study|Withdrawal by Subject|8|||
129726266|NCT03116828|466957171|FG000|Overall Study|OTHER|3|||
129726267|NCT03116828|466957172|FG001|Overall Study|OTHER|3|||
129726268|NCT00882583|466957173|FG000|Overall Study|Physician Decision|1|||
129726269|NCT00882583|466957174|FG001|Overall Study|Physician Decision|0|||
129726270|NCT00882583|466957173|FG000|Overall Study|Adverse Event|0|||
129726271|NCT00882583|466957174|FG001|Overall Study|Adverse Event|1|||
129726272|NCT00176488|466957191|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
129726273|NCT01044745|466957192|FG000|Overall Study|Ineiligible|2|||
129726274|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Adverse Event|76|||
129726275|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Adverse Event|0|||
129726276|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Adverse Event|0|||
129726277|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Death|3|||
129726278|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Death|0|||
129726279|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Death|0|||
129726280|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
129726281|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
129726282|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
129726283|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Physician Decision|9|||
129726284|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Physician Decision|0|||
129726285|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Physician Decision|0|||
129726286|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
129726287|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
129726288|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
129726289|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Disease progression|45|||
129726290|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Disease progression|0|||
129726291|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Disease progression|0|||
129726292|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
129726293|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
129726294|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
129726295|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
129726296|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
129726297|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
129726298|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
129726299|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
129726300|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
129726301|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
129804141|NCT00976677|467249914|FG001|Overall Study|Trial unblinded|2|||
129726302|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
129726303|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
129726304|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
129726305|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
129726306|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
129726307|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
129726308|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
129726309|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
129726310|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
129726311|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
129726312|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
129726313|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
129726314|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
129726315|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
129726316|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
129726317|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
129726318|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
129726319|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Promotor request|1|||
129726320|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Promotor request|0|||
129726321|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Promotor request|0|||
129726322|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
129726323|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
129726324|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
129726325|NCT01461928|466957197|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
129726326|NCT01461928|466957198|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
129726327|NCT01461928|466957199|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
129726328|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Death|3|||
129726329|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Death|0|||
129726330|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Death|0|||
129726331|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
129726332|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
129726333|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
129726334|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
129726335|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
129726336|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
129726337|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Diseases progression|91|||
129726338|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Diseases progression|0|||
129726339|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Diseases progression|0|||
129726340|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Adverse Event|70|||
129726341|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Adverse Event|0|||
129726342|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Adverse Event|0|||
129726343|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Physician Decision|9|||
129726344|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Physician Decision|0|||
129726345|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Physician Decision|0|||
129726346|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
129726347|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
129726348|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
129726349|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
129726350|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
129726351|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
129726352|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
129726353|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
129726354|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
129726355|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Not compliant|1|||
129726356|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Not compliant|0|||
129726357|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Not compliant|0|||
129726358|NCT01461928|466957197|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
129726359|NCT01461928|466957198|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
129726360|NCT01461928|466957199|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
129726361|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Adverse Event|0|||
129726362|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Adverse Event|2|||
129726363|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Adverse Event|0|||
129726364|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Death|0|||
129726365|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Death|10|||
129726366|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Death|8|||
129726367|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Physician Decision|0|||
129726368|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Physician Decision|0|||
129726369|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Physician Decision|4|||
129726370|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
129726371|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
129726372|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
129726373|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Moved to another town|0|||
129726374|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Moved to another town|1|||
129726375|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Moved to another town|0|||
129726376|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Disease progression|0|||
129726377|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Disease progression|0|||
129726378|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Disease progression|3|||
129726379|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
129726380|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
129726381|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
129726382|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
129726383|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
129726384|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
129726385|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
129726386|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
129726387|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
129726388|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
129726389|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
129726390|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
129726391|NCT01461928|466957197|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
129726392|NCT01461928|466957198|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
129726393|NCT01461928|466957199|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
129726394|NCT01159171|466957200|FG000|Overall Study|Adverse Event|11|||
129726395|NCT01159171|466957200|FG000|Overall Study|Progression of Disease|28|||
129726396|NCT01159171|466957200|FG000|Overall Study|Protocol Violation|1|||
129726397|NCT01159171|466957200|FG000|Overall Study|Need for Surgery|5|||
129726398|NCT01159171|466957200|FG000|Overall Study|Medical Decision|4|||
129726399|NCT01159171|466957200|FG000|Overall Study|Death|1|||
129726400|NCT02242435|466957211|FG000|Overall Study|Lost to Follow-up|3|||
129726401|NCT02242435|466957212|FG001|Overall Study|Lost to Follow-up|4|||
129726402|NCT02242435|466957211|FG000|Overall Study|Adverse Event|3|||
129726403|NCT02242435|466957212|FG001|Overall Study|Adverse Event|2|||
129726404|NCT02242435|466957211|FG000|Overall Study|Withdrawal by Subject|13|||
129726405|NCT02242435|466957212|FG001|Overall Study|Withdrawal by Subject|8|||
129726406|NCT02242435|466957211|FG000|Overall Study|Death|0|||
129726407|NCT02242435|466957212|FG001|Overall Study|Death|1|||
129726408|NCT02242435|466957211|FG000|Overall Study|Protocol Violation|1|||
129726409|NCT02242435|466957212|FG001|Overall Study|Protocol Violation|0|||
129726410|NCT02242435|466957211|FG000|Overall Study|Physician Decision|0|||
129726411|NCT02242435|466957212|FG001|Overall Study|Physician Decision|1|||
129726412|NCT03895086|466957213|FG000|Overall Study|Early termination study|1|||
129726413|NCT03895086|466957214|FG001|Overall Study|Early termination study|0|||
129726414|NCT01089413|466957218|FG000|Overall Study|Lost to Follow-up|1|||
129726415|NCT01089413|466957218|FG000|Overall Study|Progressive Disease|93|||
129726416|NCT01089413|466957218|FG000|Overall Study|Participant Withdrew Consent|1|||
129726417|NCT01089413|466957218|FG000|Overall Study|Unacceptable Toxicity|12|||
129726418|NCT01089413|466957218|FG000|Overall Study|Death|10|||
129726419|NCT01089413|466957218|FG000|Overall Study|Metastasectomy|13|||
129726420|NCT01089413|466957218|FG000|Overall Study|Other|71|||
129726421|NCT02513485|466957222|FG000|Overall Study|Adverse Event|1|||
129726422|NCT02513485|466957223|FG001|Overall Study|Adverse Event|0|||
129726423|NCT02526524|466957231|FG000|Overall Study|Withdrawal by Subject|3|||
129726424|NCT02526524|466957232|FG001|Overall Study|Withdrawal by Subject|3|||
129726425|NCT02526524|466957233|FG002|Overall Study|Withdrawal by Subject|6|||
129726426|NCT02526524|466957234|FG003|Overall Study|Withdrawal by Subject|1|||
129726427|NCT02526524|466957235|FG004|Overall Study|Withdrawal by Subject|9|||
129726428|NCT02526524|466957236|FG005|Overall Study|Withdrawal by Subject|5|||
129726429|NCT02526524|466957231|FG000|Overall Study|Adverse Event|3|||
129726430|NCT02526524|466957232|FG001|Overall Study|Adverse Event|2|||
129726431|NCT02526524|466957233|FG002|Overall Study|Adverse Event|4|||
129726432|NCT02526524|466957234|FG003|Overall Study|Adverse Event|2|||
129726433|NCT02526524|466957235|FG004|Overall Study|Adverse Event|6|||
129726434|NCT02526524|466957236|FG005|Overall Study|Adverse Event|8|||
129726435|NCT02526524|466957231|FG000|Overall Study|Lost to Follow-up|2|||
129726436|NCT02526524|466957232|FG001|Overall Study|Lost to Follow-up|3|||
129726437|NCT02526524|466957233|FG002|Overall Study|Lost to Follow-up|8|||
129726438|NCT02526524|466957234|FG003|Overall Study|Lost to Follow-up|1|||
129726439|NCT02526524|466957235|FG004|Overall Study|Lost to Follow-up|2|||
129726440|NCT02526524|466957236|FG005|Overall Study|Lost to Follow-up|5|||
129726441|NCT02526524|466957231|FG000|Overall Study|Protocol Violation|3|||
129726442|NCT02526524|466957232|FG001|Overall Study|Protocol Violation|1|||
129726443|NCT02526524|466957233|FG002|Overall Study|Protocol Violation|5|||
129726444|NCT02526524|466957234|FG003|Overall Study|Protocol Violation|3|||
129726445|NCT02526524|466957235|FG004|Overall Study|Protocol Violation|4|||
129726446|NCT02526524|466957236|FG005|Overall Study|Protocol Violation|3|||
129726447|NCT02526524|466957231|FG000|Overall Study|Loss of Glucose Control|0|||
129726448|NCT02526524|466957232|FG001|Overall Study|Loss of Glucose Control|0|||
129726449|NCT02526524|466957233|FG002|Overall Study|Loss of Glucose Control|3|||
129726450|NCT02526524|466957234|FG003|Overall Study|Loss of Glucose Control|0|||
129726451|NCT02526524|466957235|FG004|Overall Study|Loss of Glucose Control|2|||
129726452|NCT02526524|466957236|FG005|Overall Study|Loss of Glucose Control|0|||
129726453|NCT02526524|466957231|FG000|Overall Study|Physician Decision|0|||
129726454|NCT02526524|466957232|FG001|Overall Study|Physician Decision|0|||
129726455|NCT02526524|466957233|FG002|Overall Study|Physician Decision|0|||
129726456|NCT02526524|466957234|FG003|Overall Study|Physician Decision|0|||
129726457|NCT02526524|466957235|FG004|Overall Study|Physician Decision|1|||
129726458|NCT02526524|466957236|FG005|Overall Study|Physician Decision|0|||
129726459|NCT02526524|466957231|FG000|Overall Study|Sponsor Decision|1|||
129726460|NCT02526524|466957232|FG001|Overall Study|Sponsor Decision|0|||
129726461|NCT02526524|466957233|FG002|Overall Study|Sponsor Decision|0|||
129726462|NCT02526524|466957234|FG003|Overall Study|Sponsor Decision|0|||
129726463|NCT02526524|466957235|FG004|Overall Study|Sponsor Decision|0|||
129726464|NCT02526524|466957236|FG005|Overall Study|Sponsor Decision|0|||
129726465|NCT05312632|466957239|FG000|Overall Study|Adverse Event|12|||
129726466|NCT05312632|466957239|FG000|Overall Study|Withdrawal by Subject|10|||
129726467|NCT05312632|466957239|FG000|Overall Study|Lack of Efficacy|4|||
129726468|NCT05312632|466957239|FG000|Overall Study|Non-compliance with study procedures|9|||
129726469|NCT05312632|466957239|FG000|Overall Study|Other|4|||
129726470|NCT02379221|466957240|FG000|Overall Study|Lost to Follow-up|1|||
129726471|NCT00519376|466957241|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726472|NCT00519376|466957242|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726473|NCT00519376|466957243|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726474|NCT00519376|466957244|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726475|NCT00519376|466957245|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726476|NCT00519376|466957246|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726477|NCT00519376|466957247|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726478|NCT00519376|466957248|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726479|NCT00519376|466957249|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726480|NCT00519376|466957250|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726481|NCT00519376|466957251|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726482|NCT00519376|466957252|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726483|NCT00519376|466957253|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
129726484|NCT00519376|466957254|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726485|NCT00519376|466957255|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726486|NCT00519376|466957256|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
129726487|NCT00519376|466957241|FG000|Treatment Period 4|Lost to Follow-up|0|||
129726488|NCT00519376|466957242|FG001|Treatment Period 4|Lost to Follow-up|0|||
129726489|NCT00519376|466957243|FG002|Treatment Period 4|Lost to Follow-up|1|||
129726490|NCT00519376|466957244|FG003|Treatment Period 4|Lost to Follow-up|0|||
129726491|NCT00519376|466957245|FG004|Treatment Period 4|Lost to Follow-up|0|||
129726492|NCT00519376|466957246|FG005|Treatment Period 4|Lost to Follow-up|0|||
129726493|NCT00519376|466957247|FG006|Treatment Period 4|Lost to Follow-up|0|||
129726494|NCT00519376|466957248|FG007|Treatment Period 4|Lost to Follow-up|0|||
129726495|NCT00519376|466957249|FG008|Treatment Period 4|Lost to Follow-up|0|||
129726496|NCT00519376|466957250|FG009|Treatment Period 4|Lost to Follow-up|0|||
129726497|NCT00519376|466957251|FG010|Treatment Period 4|Lost to Follow-up|0|||
129726498|NCT00519376|466957252|FG011|Treatment Period 4|Lost to Follow-up|0|||
129726499|NCT00519376|466957253|FG012|Treatment Period 4|Lost to Follow-up|0|||
129726500|NCT00519376|466957254|FG013|Treatment Period 4|Lost to Follow-up|0|||
129726501|NCT00519376|466957255|FG014|Treatment Period 4|Lost to Follow-up|0|||
129726502|NCT00519376|466957256|FG015|Treatment Period 4|Lost to Follow-up|0|||
129726503|NCT02650128|466957259|FG000|Overall Study|Death|2|||
129726504|NCT01801436|466957273|FG000|Overall Study|Withdrawal by Subject|3|||
129726505|NCT01801436|466957273|FG000|Overall Study|Adverse Event|2|||
129726506|NCT01801436|466957273|FG000|Overall Study|Progressive disease|4|||
129726507|NCT01885208|466957274|FG000|Overall Study|Unclassified|32|||
129726508|NCT01885208|466957275|FG001|Overall Study|Unclassified|38|||
129726509|NCT01498575|466957276|FG000|Overall Sample|Withdrawal by Subject|60|||
129726510|NCT01498575|466957277|FG001|Overall Sample|Withdrawal by Subject|14|||
129726511|NCT01498575|466957276|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
129726512|NCT01498575|466957277|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
129726513|NCT01498575|466957276|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
129726514|NCT01498575|466957277|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
129726515|NCT01126437|466957283|FG000|Overall Study|Not treated|11|||
129726516|NCT01126437|466957284|FG001|Overall Study|Not treated|18|||
129726517|NCT01126437|466957285|FG002|Overall Study|Not treated|19|||
129726518|NCT01126437|466957283|FG000|Overall Study|Sites with data irregularities/fraud|6|||
129726519|NCT01126437|466957284|FG001|Overall Study|Sites with data irregularities/fraud|6|||
129726520|NCT01126437|466957285|FG002|Overall Study|Sites with data irregularities/fraud|7|||
129726521|NCT01126437|466957283|FG000|Overall Study|Adverse Event|602|||
129726522|NCT01126437|466957284|FG001|Overall Study|Adverse Event|606|||
129726523|NCT01126437|466957285|FG002|Overall Study|Adverse Event|635|||
129726524|NCT01126437|466957283|FG000|Overall Study|Lack of Efficacy|65|||
129726525|NCT01126437|466957284|FG001|Overall Study|Lack of Efficacy|60|||
129726526|NCT01126437|466957285|FG002|Overall Study|Lack of Efficacy|59|||
129726527|NCT01126437|466957283|FG000|Overall Study|Protocol Violation|64|||
129444432|NCT00323297|465927339|FG001|Part B (Open-label)|Adverse Event|5|||
129444433|NCT00323297|465927338|FG000|Part B (Open-label)|Protocol Violation|0|||
129726528|NCT01126437|466957284|FG001|Overall Study|Protocol Violation|66|||
129726529|NCT01126437|466957285|FG002|Overall Study|Protocol Violation|41|||
129726530|NCT01126437|466957283|FG000|Overall Study|Lost to Follow-up|52|||
129726531|NCT01126437|466957284|FG001|Overall Study|Lost to Follow-up|63|||
129726532|NCT01126437|466957285|FG002|Overall Study|Lost to Follow-up|55|||
129726533|NCT01126437|466957283|FG000|Overall Study|Withdrawal by Subject|331|||
129726534|NCT01126437|466957284|FG001|Overall Study|Withdrawal by Subject|335|||
129726535|NCT01126437|466957285|FG002|Overall Study|Withdrawal by Subject|319|||
129726536|NCT01126437|466957283|FG000|Overall Study|Other reason not specified|210|||
129726537|NCT01126437|466957284|FG001|Overall Study|Other reason not specified|176|||
129726538|NCT01126437|466957285|FG002|Overall Study|Other reason not specified|178|||
129444434|NCT00323297|465927339|FG001|Part B (Open-label)|Protocol Violation|1|||
129726539|NCT01972308|466957292|FG000|Overall Study|Withdrawal by Subject|0|||
129726540|NCT01972308|466957293|FG001|Overall Study|Withdrawal by Subject|1|||
129726541|NCT01972308|466957292|FG000|Overall Study|Lost to Follow-up|4|||
129726542|NCT01972308|466957293|FG001|Overall Study|Lost to Follow-up|6|||
129726543|NCT01972308|466957292|FG000|Overall Study|Death|4|||
129726544|NCT01972308|466957293|FG001|Overall Study|Death|1|||
129726545|NCT01846663|466957294|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
129726546|NCT01846663|466957295|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
129726547|NCT01846663|466957294|FG000|Overall Study|Withdrawal by Subject|1|||
129726548|NCT01846663|466957295|FG001|Overall Study|Withdrawal by Subject|0|||
129726549|NCT01846663|466957294|FG000|Overall Study|Adverse Event|1|||
129726550|NCT01846663|466957295|FG001|Overall Study|Adverse Event|2|||
129726551|NCT01562314|466957300|FG000|Overall Study|Adverse Event|10|||
129726552|NCT01562314|466957301|FG001|Overall Study|Adverse Event|5|||
129726553|NCT01562314|466957300|FG000|Overall Study|Met Withdrawal Criteria|3|||
129726554|NCT01562314|466957301|FG001|Overall Study|Met Withdrawal Criteria|2|||
129726555|NCT01562314|466957300|FG000|Overall Study|Withdrawal by Subject|0|||
129726556|NCT01562314|466957301|FG001|Overall Study|Withdrawal by Subject|1|||
129726557|NCT02851797|466957302|FG000|Overall Study|Withdrawal by Subject|4|||
129726558|NCT02851797|466957303|FG001|Overall Study|Withdrawal by Subject|2|||
129726559|NCT02851797|466957302|FG000|Overall Study|Adverse Event|3|||
129726560|NCT02851797|466957303|FG001|Overall Study|Adverse Event|0|||
129726561|NCT03655054|466957304|FG000|Overall Study|Lost to Follow-up|1|||
129726562|NCT00813865|466957308|FG000|Overall Study|Failure to Respond|3|||
129726563|NCT00813865|466957308|FG000|Overall Study|Lost to Follow-up|3|||
129726564|NCT00813865|466957308|FG000|Overall Study|Withdrawal by Subject|1|||
129726565|NCT02256384|466957313|FG000|Overall Study|Withdrawal by Subject|12|||
129726566|NCT02256384|466957313|FG000|Overall Study|Equipment not capturing data|2|||
129726567|NCT00543803|466957323|FG000|Overall Study|Adverse Event|14|||
129726568|NCT00543803|466957323|FG000|Overall Study|Lack of Efficacy|22|||
129726569|NCT00543803|466957323|FG000|Overall Study|Lost to Follow-up|20|||
129726570|NCT00543803|466957323|FG000|Overall Study|Other|86|||
129726571|NCT04295681|466957327|FG000|Overall Study|Eligibility error|1|||
129726572|NCT04295681|466957328|FG001|Overall Study|Eligibility error|3|||
129726573|NCT00780143|466957335|FG000|Overall Study|Progressive disease|1|||
129726574|NCT00780143|466957335|FG000|Overall Study|Toxicity|1|||
129726575|NCT00780143|466957335|FG000|Overall Study|Adverse Event|1|||
129726576|NCT02438384|466957336|FG000|Overall Study|Lost to Follow-up|8|||
129726577|NCT02438384|466957337|FG001|Overall Study|Lost to Follow-up|6|||
129726578|NCT02438384|466957338|FG002|Overall Study|Lost to Follow-up|4|||
129726579|NCT03315793|466957339|FG000|Overall Study|Adverse Event|4|||
129726580|NCT03315793|466957340|FG001|Overall Study|Adverse Event|2|||
129726581|NCT03315793|466957339|FG000|Overall Study|Protocol Deviation|1|||
129726582|NCT03315793|466957340|FG001|Overall Study|Protocol Deviation|0|||
129726583|NCT03315793|466957339|FG000|Overall Study|Difficult for regular visit|0|||
129726584|NCT03315793|466957340|FG001|Overall Study|Difficult for regular visit|1|||
129726585|NCT01952665|466959276|FG000|Overall Study|Physician Decision|3|||
129726586|NCT01952665|466959277|FG001|Overall Study|Physician Decision|2|||
129726587|NCT01952665|466959276|FG000|Overall Study|Lost to Follow-up|1|||
129726588|NCT01952665|466959277|FG001|Overall Study|Lost to Follow-up|2|||
129726589|NCT01952665|466959276|FG000|Overall Study|Adverse Event|2|||
129726590|NCT01952665|466959277|FG001|Overall Study|Adverse Event|1|||
129726591|NCT01952665|466959276|FG000|Overall Study|Protocol Violation|0|||
129726592|NCT01952665|466959277|FG001|Overall Study|Protocol Violation|1|||
129726593|NCT01537081|466959278|FG000|Overall Study|Adverse Event|5|||
129726594|NCT01537081|466959279|FG001|Overall Study|Adverse Event|2|||
129726595|NCT01537081|466959280|FG002|Overall Study|Adverse Event|2|||
129726596|NCT01537081|466959278|FG000|Overall Study|Lack of Efficacy|2|||
129726597|NCT01537081|466959279|FG001|Overall Study|Lack of Efficacy|1|||
129726598|NCT01537081|466959280|FG002|Overall Study|Lack of Efficacy|0|||
129726599|NCT01537081|466959278|FG000|Overall Study|Lost to Follow-up|17|||
129726600|NCT01537081|466959279|FG001|Overall Study|Lost to Follow-up|15|||
129726601|NCT01537081|466959280|FG002|Overall Study|Lost to Follow-up|9|||
129726602|NCT01537081|466959278|FG000|Overall Study|Protocol Violation|3|||
129726603|NCT01537081|466959279|FG001|Overall Study|Protocol Violation|2|||
129726604|NCT01537081|466959280|FG002|Overall Study|Protocol Violation|2|||
129726605|NCT01537081|466959278|FG000|Overall Study|Withdrawal by Subject|6|||
129726606|NCT01537081|466959279|FG001|Overall Study|Withdrawal by Subject|11|||
129891718|NCT00432159|467563036|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
129726607|NCT01537081|466959280|FG002|Overall Study|Withdrawal by Subject|3|||
129726608|NCT01537081|466959278|FG000|Overall Study|Physician Decision|5|||
129726609|NCT01537081|466959279|FG001|Overall Study|Physician Decision|6|||
129726610|NCT01537081|466959280|FG002|Overall Study|Physician Decision|0|||
129726611|NCT01537081|466959278|FG000|Overall Study|Sponsor decision|0|||
129726612|NCT01537081|466959279|FG001|Overall Study|Sponsor decision|1|||
129726613|NCT01537081|466959280|FG002|Overall Study|Sponsor decision|0|||
129726614|NCT01537081|466959278|FG000|Overall Study|Assigned but never dosed|1|||
129726615|NCT01537081|466959279|FG001|Overall Study|Assigned but never dosed|0|||
129726616|NCT01537081|466959280|FG002|Overall Study|Assigned but never dosed|0|||
129726617|NCT02596958|466959283|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
129726618|NCT02596958|466959283|FG000|Overall Study|Cancer Progression|441|||
129726619|NCT02596958|466959283|FG000|Overall Study|Death From Cancer|112|||
129726620|NCT02596958|466959283|FG000|Overall Study|Death From Other Cause|33|||
129726621|NCT02596958|466959283|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
129726622|NCT02596958|466959283|FG000|Overall Study|Administrative Reasons/Other|231|||
129726623|NCT02596958|466959283|FG000|Overall Study|Lost to Follow-up|33|||
129726624|NCT02596958|466959283|FG000|Overall Study|Missing|32|||
129726625|NCT02596958|466959283|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
129726626|NCT01559259|466959284|FG000|Overall Study|Withdrawal by Subject|0|||
129726627|NCT01559259|466959285|FG001|Overall Study|Withdrawal by Subject|0|||
129726628|NCT01559259|466959286|FG002|Overall Study|Withdrawal by Subject|0|||
129726629|NCT01559259|466959287|FG003|Overall Study|Withdrawal by Subject|1|||
129726630|NCT01559259|466959288|FG004|Overall Study|Withdrawal by Subject|0|||
129726631|NCT01559259|466959284|FG000|Overall Study|Adverse Event|0|||
129726632|NCT01559259|466959285|FG001|Overall Study|Adverse Event|1|||
129726633|NCT01559259|466959286|FG002|Overall Study|Adverse Event|1|||
129726634|NCT01559259|466959287|FG003|Overall Study|Adverse Event|0|||
129726635|NCT01559259|466959288|FG004|Overall Study|Adverse Event|0|||
129726636|NCT00185380|466959290|FG000|Overall Study|Adverse Event|41|||
129726637|NCT00185380|466959291|FG001|Overall Study|Adverse Event|43|||
129726638|NCT00185380|466959292|FG002|Overall Study|Adverse Event|48|||
129726639|NCT00185380|466959290|FG000|Overall Study|Lost to Follow-up|0|||
129726640|NCT00185380|466959291|FG001|Overall Study|Lost to Follow-up|4|||
129726641|NCT00185380|466959292|FG002|Overall Study|Lost to Follow-up|3|||
129726642|NCT00185380|466959290|FG000|Overall Study|Pregnancy|1|||
129726643|NCT00185380|466959291|FG001|Overall Study|Pregnancy|4|||
129726644|NCT00185380|466959292|FG002|Overall Study|Pregnancy|0|||
129726645|NCT00185380|466959290|FG000|Overall Study|Protocol Violation|2|||
129726646|NCT00185380|466959291|FG001|Overall Study|Protocol Violation|2|||
129726647|NCT00185380|466959292|FG002|Overall Study|Protocol Violation|1|||
129726648|NCT00185380|466959290|FG000|Overall Study|Withdrawal by Subject|1|||
129726649|NCT00185380|466959291|FG001|Overall Study|Withdrawal by Subject|2|||
129726650|NCT00185380|466959292|FG002|Overall Study|Withdrawal by Subject|0|||
129726651|NCT00185380|466959290|FG000|Overall Study|Failed insertion|1|||
129726652|NCT00185380|466959291|FG001|Overall Study|Failed insertion|1|||
129726653|NCT00185380|466959292|FG002|Overall Study|Failed insertion|2|||
129726654|NCT00185380|466959290|FG000|Overall Study|Planned pregnancy|9|||
129726655|NCT00185380|466959291|FG001|Overall Study|Planned pregnancy|12|||
129726656|NCT00185380|466959292|FG002|Overall Study|Planned pregnancy|12|||
129726657|NCT00185380|466959290|FG000|Overall Study|No need for contraception|3|||
129726658|NCT00185380|466959291|FG001|Overall Study|No need for contraception|3|||
129726659|NCT00185380|466959292|FG002|Overall Study|No need for contraception|3|||
129726660|NCT00185380|466959290|FG000|Overall Study|Could not attend visits|2|||
129726661|NCT00185380|466959291|FG001|Overall Study|Could not attend visits|0|||
129726662|NCT00185380|466959292|FG002|Overall Study|Could not attend visits|4|||
129726663|NCT00185380|466959290|FG000|Overall Study|personal reason|6|||
129726664|NCT00185380|466959291|FG001|Overall Study|personal reason|1|||
129726665|NCT00185380|466959292|FG002|Overall Study|personal reason|1|||
129726666|NCT02199314|466959293|FG000|Overall Study|Withdrawal by Subject|6|||
129726667|NCT02199314|466959293|FG000|Overall Study|Physician Decision|10|||
129726668|NCT03842969|466959294|FG000|Overall Study|Participant declined follow-up visit|0|||
129726669|NCT03842969|466959295|FG001|Overall Study|Participant declined follow-up visit|1|||
129726670|NCT03842969|466959296|FG002|Overall Study|Participant declined follow-up visit|0|||
129726671|NCT03842969|466959294|FG000|Overall Study|Sponsor's decision|12|||
129726672|NCT03842969|466959295|FG001|Overall Study|Sponsor's decision|99|||
129726673|NCT03842969|466959296|FG002|Overall Study|Sponsor's decision|61|||
129726674|NCT03842969|466959294|FG000|Overall Study|Pregnancy|0|||
129726675|NCT03842969|466959295|FG001|Overall Study|Pregnancy|0|||
129726676|NCT03842969|466959296|FG002|Overall Study|Pregnancy|1|||
129726677|NCT03842969|466959294|FG000|Overall Study|Death|1|||
129726678|NCT03842969|466959295|FG001|Overall Study|Death|0|||
129726679|NCT03842969|466959296|FG002|Overall Study|Death|1|||
129726680|NCT03842969|466959294|FG000|Overall Study|Withdrawal by Subject|3|||
129726681|NCT03842969|466959295|FG001|Overall Study|Withdrawal by Subject|30|||
129804142|NCT00976677|467249913|FG000|Overall Study|Unknown/Missing|1|||
129804143|NCT00976677|467249914|FG001|Overall Study|Unknown/Missing|0|||
129804144|NCT03507400|467249915|FG000|Overall Study|discontinued|5|||
129804145|NCT03507400|467249916|FG001|Overall Study|discontinued|1|||
129804146|NCT03507400|467249915|FG000|Overall Study|Lost to Follow-up|8|||
129804147|NCT03507400|467249916|FG001|Overall Study|Lost to Follow-up|6|||
129804148|NCT03507400|467249915|FG000|Overall Study|Protocol Violation|0|||
129804149|NCT03507400|467249916|FG001|Overall Study|Protocol Violation|1|||
129804150|NCT01555983|467249917|FG000|Overall Study|Withdrawal by Subject|1|||
129804151|NCT01555983|467249918|FG001|Overall Study|Withdrawal by Subject|0|||
129804152|NCT01555983|467249919|FG002|Overall Study|Withdrawal by Subject|0|||
129804153|NCT01555983|467249920|FG003|Overall Study|Withdrawal by Subject|0|||
129726682|NCT03842969|466959296|FG002|Overall Study|Withdrawal by Subject|18|||
129726683|NCT03842969|466959294|FG000|Overall Study|Protocol Violation|1|||
129726684|NCT03842969|466959295|FG001|Overall Study|Protocol Violation|1|||
129726685|NCT03842969|466959296|FG002|Overall Study|Protocol Violation|0|||
129726686|NCT03842969|466959294|FG000|Overall Study|Physician Decision|0|||
129726687|NCT03842969|466959295|FG001|Overall Study|Physician Decision|3|||
129726688|NCT03842969|466959296|FG002|Overall Study|Physician Decision|0|||
129726689|NCT03842969|466959294|FG000|Overall Study|Lost to Follow-up|0|||
129726690|NCT03842969|466959295|FG001|Overall Study|Lost to Follow-up|2|||
129726691|NCT03842969|466959296|FG002|Overall Study|Lost to Follow-up|0|||
129726692|NCT03842969|466959294|FG000|Overall Study|Adverse Event|0|||
129726693|NCT03842969|466959295|FG001|Overall Study|Adverse Event|2|||
129726694|NCT03842969|466959296|FG002|Overall Study|Adverse Event|0|||
129726695|NCT01892436|466959297|FG000|Overall Study|Withdrawal by Subject|8|||
129726696|NCT01892436|466959298|FG001|Overall Study|Withdrawal by Subject|15|||
129726697|NCT01892436|466959299|FG002|Overall Study|Withdrawal by Subject|4|||
129726698|NCT01892436|466959300|FG003|Overall Study|Withdrawal by Subject|4|||
129726699|NCT01892436|466959297|FG000|Overall Study|Death|1|||
129726700|NCT01892436|466959298|FG001|Overall Study|Death|1|||
129726701|NCT01892436|466959299|FG002|Overall Study|Death|0|||
129726702|NCT01892436|466959300|FG003|Overall Study|Death|0|||
129726703|NCT01892436|466959297|FG000|Overall Study|Physician Decision|2|||
129726704|NCT01892436|466959298|FG001|Overall Study|Physician Decision|1|||
129726705|NCT01892436|466959299|FG002|Overall Study|Physician Decision|0|||
129726706|NCT01892436|466959300|FG003|Overall Study|Physician Decision|1|||
129726707|NCT01892436|466959297|FG000|Overall Study|Pregnancy|0|||
129726708|NCT01892436|466959298|FG001|Overall Study|Pregnancy|2|||
129726709|NCT01892436|466959299|FG002|Overall Study|Pregnancy|1|||
129726710|NCT01892436|466959300|FG003|Overall Study|Pregnancy|0|||
129726711|NCT01892436|466959297|FG000|Overall Study|Technical problems|2|||
129726712|NCT01892436|466959298|FG001|Overall Study|Technical problems|1|||
129726713|NCT01892436|466959299|FG002|Overall Study|Technical problems|1|||
129726714|NCT01892436|466959300|FG003|Overall Study|Technical problems|1|||
129726715|NCT01892436|466959297|FG000|Overall Study|Lack of Efficacy|1|||
129726716|NCT01892436|466959298|FG001|Overall Study|Lack of Efficacy|2|||
129726717|NCT01892436|466959299|FG002|Overall Study|Lack of Efficacy|2|||
129726718|NCT01892436|466959300|FG003|Overall Study|Lack of Efficacy|2|||
129726719|NCT01892436|466959297|FG000|Overall Study|Lost to Follow-up|1|||
129726720|NCT01892436|466959298|FG001|Overall Study|Lost to Follow-up|1|||
129726721|NCT01892436|466959299|FG002|Overall Study|Lost to Follow-up|1|||
129726722|NCT01892436|466959300|FG003|Overall Study|Lost to Follow-up|3|||
129726723|NCT01892436|466959297|FG000|Overall Study|non-compliance with treatment|1|||
129726724|NCT01892436|466959298|FG001|Overall Study|non-compliance with treatment|0|||
129726725|NCT01892436|466959299|FG002|Overall Study|non-compliance with treatment|0|||
129726726|NCT01892436|466959300|FG003|Overall Study|non-compliance with treatment|0|||
129726727|NCT01892436|466959297|FG000|Overall Study|Adverse Event|7|||
129726728|NCT01892436|466959298|FG001|Overall Study|Adverse Event|6|||
129726729|NCT01892436|466959299|FG002|Overall Study|Adverse Event|2|||
129726730|NCT01892436|466959300|FG003|Overall Study|Adverse Event|3|||
129726731|NCT00733291|466959302|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
129726732|NCT00733291|466959303|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
129726733|NCT00733291|466959304|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
129726734|NCT00733291|466959305|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
129726735|NCT02759107|466959307|FG000|Overall Study|Adverse Event|0|||
129726736|NCT02759107|466959308|FG001|Overall Study|Adverse Event|0|||
129726737|NCT02759107|466959309|FG002|Overall Study|Adverse Event|0|||
129726738|NCT02759107|466959310|FG003|Overall Study|Adverse Event|0|||
129726739|NCT02759107|466959311|FG004|Overall Study|Adverse Event|0|||
129726740|NCT02759107|466959312|FG005|Overall Study|Adverse Event|0|||
129726741|NCT02759107|466959313|FG006|Overall Study|Adverse Event|0|||
129726742|NCT02759107|466959314|FG007|Overall Study|Adverse Event|0|||
129444435|NCT01251120|465927341|FG000|Overall Study|Lack of Efficacy|0|||
129726743|NCT02759107|466959315|FG008|Overall Study|Adverse Event|0|||
129726744|NCT02759107|466959316|FG009|Overall Study|Adverse Event|0|||
129726745|NCT02759107|466959317|FG010|Overall Study|Adverse Event|0|||
129726746|NCT02759107|466959318|FG011|Overall Study|Adverse Event|0|||
129726747|NCT02759107|466959319|FG012|Overall Study|Adverse Event|2|||
129726748|NCT02759107|466959320|FG013|Overall Study|Adverse Event|0|||
129726749|NCT02759107|466959321|FG014|Overall Study|Adverse Event|0|||
129726750|NCT02759107|466959322|FG015|Overall Study|Adverse Event|1|||
129726751|NCT02759107|466959323|FG016|Overall Study|Adverse Event|0|||
129726752|NCT02759107|466959324|FG017|Overall Study|Adverse Event|2|||
129726753|NCT02759107|466959307|FG000|Overall Study|Scheduling Conflict|0|||
129726754|NCT02759107|466959308|FG001|Overall Study|Scheduling Conflict|0|||
129726755|NCT02759107|466959309|FG002|Overall Study|Scheduling Conflict|0|||
129726756|NCT02759107|466959310|FG003|Overall Study|Scheduling Conflict|0|||
129726757|NCT02759107|466959311|FG004|Overall Study|Scheduling Conflict|0|||
129726758|NCT02759107|466959312|FG005|Overall Study|Scheduling Conflict|0|||
129726759|NCT02759107|466959313|FG006|Overall Study|Scheduling Conflict|0|||
129726760|NCT02759107|466959314|FG007|Overall Study|Scheduling Conflict|0|||
129444436|NCT01251120|465927342|FG001|Overall Study|Lack of Efficacy|1|||
129444437|NCT01822522|465927343|FG000|Overall Study|Adverse Event|1|||
129444438|NCT01822522|465927344|FG001|Overall Study|Adverse Event|1|||
129444439|NCT01822522|465927345|FG002|Overall Study|Adverse Event|1|||
129444440|NCT01822522|465927346|FG003|Overall Study|Adverse Event|0|||
129726761|NCT02759107|466959315|FG008|Overall Study|Scheduling Conflict|0|||
129726762|NCT02759107|466959316|FG009|Overall Study|Scheduling Conflict|1|||
129726763|NCT02759107|466959317|FG010|Overall Study|Scheduling Conflict|0|||
129726764|NCT02759107|466959318|FG011|Overall Study|Scheduling Conflict|0|||
129726765|NCT02759107|466959319|FG012|Overall Study|Scheduling Conflict|0|||
129726766|NCT02759107|466959320|FG013|Overall Study|Scheduling Conflict|0|||
129726767|NCT02759107|466959321|FG014|Overall Study|Scheduling Conflict|0|||
129726768|NCT02759107|466959322|FG015|Overall Study|Scheduling Conflict|0|||
129726769|NCT02759107|466959323|FG016|Overall Study|Scheduling Conflict|0|||
129726770|NCT02759107|466959324|FG017|Overall Study|Scheduling Conflict|0|||
129726771|NCT02019108|466959327|FG000|Overall Study|Lost to Follow-up|5|||
129726772|NCT02019108|466959328|FG001|Overall Study|Lost to Follow-up|7|||
129726773|NCT04569136|466959334|FG000|Overall Study|Lost to Follow-up|2|||
129726774|NCT04569136|466959335|FG001|Overall Study|Lost to Follow-up|0|||
129726775|NCT04569136|466959336|FG002|Overall Study|Lost to Follow-up|1|||
129726776|NCT01466660|466959341|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
129726777|NCT01466660|466959342|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
129726778|NCT01466660|466959341|FG000|Overall Study|Worsening of underlying cancer disease|5|||
129726779|NCT01466660|466959342|FG001|Overall Study|Worsening of underlying cancer disease|2|||
129726780|NCT01466660|466959341|FG000|Overall Study|Other adverse event|19|||
129726781|NCT01466660|466959342|FG001|Overall Study|Other adverse event|18|||
129726782|NCT01466660|466959341|FG000|Overall Study|Protocol Violation|2|||
129726783|NCT01466660|466959342|FG001|Overall Study|Protocol Violation|1|||
129726784|NCT01466660|466959341|FG000|Overall Study|Refused continuation of trial medication|4|||
129726785|NCT01466660|466959342|FG001|Overall Study|Refused continuation of trial medication|3|||
129726786|NCT01466660|466959341|FG000|Overall Study|Other reason not defined above|10|||
129726787|NCT01466660|466959342|FG001|Overall Study|Other reason not defined above|8|||
129726788|NCT00191724|466959343|FG000|Overall Study|Adverse Event|0|||
129726789|NCT00191724|466959344|FG001|Overall Study|Adverse Event|0|||
129726790|NCT00191724|466959345|FG002|Overall Study|Adverse Event|1|||
129726791|NCT00191724|466959346|FG003|Overall Study|Adverse Event|0|||
129726792|NCT00191724|466959347|FG004|Overall Study|Adverse Event|0|||
129726793|NCT00191724|466959343|FG000|Overall Study|Lost to Follow-up|1|||
129726794|NCT00191724|466959344|FG001|Overall Study|Lost to Follow-up|1|||
129726795|NCT00191724|466959345|FG002|Overall Study|Lost to Follow-up|0|||
129726796|NCT00191724|466959346|FG003|Overall Study|Lost to Follow-up|2|||
129726797|NCT00191724|466959347|FG004|Overall Study|Lost to Follow-up|3|||
129726798|NCT00191724|466959343|FG000|Overall Study|Withdrawal by Subject|0|||
129726799|NCT00191724|466959344|FG001|Overall Study|Withdrawal by Subject|0|||
129726800|NCT00191724|466959345|FG002|Overall Study|Withdrawal by Subject|0|||
129726801|NCT00191724|466959346|FG003|Overall Study|Withdrawal by Subject|1|||
129726802|NCT00191724|466959347|FG004|Overall Study|Withdrawal by Subject|0|||
129726803|NCT02301546|466959350|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
129726804|NCT02301546|466959351|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
129726805|NCT02301546|466959350|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
129726806|NCT02301546|466959351|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
129726807|NCT02301546|466959350|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
129726808|NCT02301546|466959351|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
129804154|NCT01555983|467249921|FG004|Overall Study|Withdrawal by Subject|1|||
129804155|NCT01555983|467249922|FG005|Overall Study|Withdrawal by Subject|1|||
129804156|NCT04806503|467251433|FG000|Overall Study|Lost to Follow-up|0|||
129804157|NCT04806503|467251434|FG001|Overall Study|Lost to Follow-up|0|||
129804158|NCT04806503|467251435|FG002|Overall Study|Lost to Follow-up|1|||
129804159|NCT04806503|467251436|FG003|Overall Study|Lost to Follow-up|0|||
129804160|NCT04806503|467251437|FG004|Overall Study|Lost to Follow-up|0|||
129444441|NCT01822522|465927347|FG004|Overall Study|Adverse Event|0|||
129444442|NCT01822522|465927348|FG005|Overall Study|Adverse Event|1|||
129726809|NCT02301546|466959350|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
129726810|NCT02301546|466959351|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
129726811|NCT02301546|466959350|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
129726812|NCT02301546|466959351|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
129726813|NCT02301546|466959350|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
129726814|NCT02301546|466959351|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
129726815|NCT02301546|466959350|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
129726816|NCT02301546|466959351|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
129804161|NCT04806503|467251433|FG000|Overall Study|Withdrawal by Subject|1|||
129726817|NCT04085458|466959356|FG000|Overall Study|Other|1|||
129726818|NCT04085458|466959356|FG000|Overall Study|Withdrawal by Subject|2|||
129726819|NCT04085458|466959356|FG000|Overall Study|Adverse Event|2|||
129726820|NCT02447250|466959357|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
129726821|NCT02447250|466959357|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
129726822|NCT02447250|466959357|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
129726823|NCT03632993|466959358|FG000|Overall Study|Withdrawal by Subject|1|||
129726824|NCT03632993|466959359|FG001|Overall Study|Withdrawal by Subject|0|||
129726825|NCT03632993|466959360|FG002|Overall Study|Withdrawal by Subject|0|||
129726826|NCT03632993|466959361|FG003|Overall Study|Withdrawal by Subject|0|||
129726827|NCT03632993|466959362|FG004|Overall Study|Withdrawal by Subject|0|||
129726828|NCT03632993|466959363|FG005|Overall Study|Withdrawal by Subject|0|||
129726829|NCT03632993|466959364|FG006|Overall Study|Withdrawal by Subject|0|||
129726830|NCT03632993|466959365|FG007|Overall Study|Withdrawal by Subject|0|||
129726831|NCT03632993|466959366|FG008|Overall Study|Withdrawal by Subject|0|||
129726832|NCT03632993|466959367|FG009|Overall Study|Withdrawal by Subject|1|||
129726833|NCT03632993|466959358|FG000|Overall Study|Protocol Non-compliance|0|||
129726834|NCT03632993|466959359|FG001|Overall Study|Protocol Non-compliance|1|||
129726835|NCT03632993|466959360|FG002|Overall Study|Protocol Non-compliance|0|||
129726836|NCT03632993|466959361|FG003|Overall Study|Protocol Non-compliance|0|||
129726837|NCT03632993|466959362|FG004|Overall Study|Protocol Non-compliance|0|||
129726838|NCT03632993|466959363|FG005|Overall Study|Protocol Non-compliance|0|||
129726839|NCT03632993|466959364|FG006|Overall Study|Protocol Non-compliance|0|||
129726840|NCT03632993|466959365|FG007|Overall Study|Protocol Non-compliance|0|||
129726841|NCT03632993|466959366|FG008|Overall Study|Protocol Non-compliance|0|||
129726842|NCT03632993|466959367|FG009|Overall Study|Protocol Non-compliance|0|||
129726843|NCT03632993|466959358|FG000|Overall Study|Lost to Follow-up|0|||
129726844|NCT03632993|466959359|FG001|Overall Study|Lost to Follow-up|0|||
129726845|NCT03632993|466959360|FG002|Overall Study|Lost to Follow-up|0|||
129726846|NCT03632993|466959361|FG003|Overall Study|Lost to Follow-up|0|||
129726847|NCT03632993|466959362|FG004|Overall Study|Lost to Follow-up|0|||
129726848|NCT03632993|466959363|FG005|Overall Study|Lost to Follow-up|1|||
129726849|NCT03632993|466959364|FG006|Overall Study|Lost to Follow-up|0|||
129726850|NCT03632993|466959365|FG007|Overall Study|Lost to Follow-up|1|||
129726851|NCT03632993|466959366|FG008|Overall Study|Lost to Follow-up|0|||
129726852|NCT03632993|466959367|FG009|Overall Study|Lost to Follow-up|0|||
129726853|NCT03632993|466959358|FG000|Overall Study|Adverse Event|0|||
129726854|NCT03632993|466959359|FG001|Overall Study|Adverse Event|0|||
129726855|NCT03632993|466959360|FG002|Overall Study|Adverse Event|0|||
129726856|NCT03632993|466959361|FG003|Overall Study|Adverse Event|0|||
129726857|NCT03632993|466959362|FG004|Overall Study|Adverse Event|0|||
129726858|NCT03632993|466959363|FG005|Overall Study|Adverse Event|1|||
129726859|NCT03632993|466959364|FG006|Overall Study|Adverse Event|0|||
129726860|NCT03632993|466959365|FG007|Overall Study|Adverse Event|1|||
129726861|NCT03632993|466959366|FG008|Overall Study|Adverse Event|0|||
129726862|NCT03632993|466959367|FG009|Overall Study|Adverse Event|0|||
129726863|NCT03224507|466959368|FG000|Overall Study|Death|3|||
129726864|NCT03224507|466959369|FG001|Overall Study|Death|0|||
129726865|NCT03224507|466959368|FG000|Overall Study|Lack of Efficacy|6|||
129726866|NCT03224507|466959369|FG001|Overall Study|Lack of Efficacy|0|||
129726867|NCT03224507|466959368|FG000|Overall Study|Withdrawal by Subject|6|||
129726868|NCT03224507|466959369|FG001|Overall Study|Withdrawal by Subject|0|||
129726869|NCT00075946|466959372|FG000|Overall Study|Path ineligible: undetermined histology|0|||
129726870|NCT00075946|466959373|FG001|Overall Study|Path ineligible: undetermined histology|0|||
129726871|NCT00075946|466959374|FG002|Overall Study|Path ineligible: undetermined histology|0|||
129726872|NCT00075946|466959375|FG003|Overall Study|Path ineligible: undetermined histology|0|||
129726873|NCT00075946|466959376|FG004|Overall Study|Path ineligible: undetermined histology|6|||
129726874|NCT00075946|466959372|FG000|Overall Study|Did not achieve response after induction|0|||
129726875|NCT00075946|466959373|FG001|Overall Study|Did not achieve response after induction|0|||
129726876|NCT00075946|466959374|FG002|Overall Study|Did not achieve response after induction|0|||
129726877|NCT00075946|466959375|FG003|Overall Study|Did not achieve response after induction|0|||
129726878|NCT00075946|466959376|FG004|Overall Study|Did not achieve response after induction|182|||
129726879|NCT00075946|466959372|FG000|Overall Study|Incorrectly randomized (no response)|5|||
129726880|NCT00075946|466959373|FG001|Overall Study|Incorrectly randomized (no response)|5|||
129726881|NCT00075946|466959374|FG002|Overall Study|Incorrectly randomized (no response)|5|||
129726882|NCT00075946|466959375|FG003|Overall Study|Incorrectly randomized (no response)|1|||
129891719|NCT01929993|467563037|FG000|Overall Study|Protocol Violation|4|||
129726883|NCT00075946|466959376|FG004|Overall Study|Incorrectly randomized (no response)|0|||
129726884|NCT00075946|466959372|FG000|Overall Study|Adverse Event|2|||
129726885|NCT00075946|466959373|FG001|Overall Study|Adverse Event|10|||
129726886|NCT00075946|466959374|FG002|Overall Study|Adverse Event|0|||
129726887|NCT00075946|466959375|FG003|Overall Study|Adverse Event|2|||
129726888|NCT00075946|466959376|FG004|Overall Study|Adverse Event|0|||
129726889|NCT00075946|466959372|FG000|Overall Study|Death|0|||
129726890|NCT00075946|466959373|FG001|Overall Study|Death|1|||
129726891|NCT00075946|466959374|FG002|Overall Study|Death|0|||
129726892|NCT00075946|466959375|FG003|Overall Study|Death|0|||
129726893|NCT00075946|466959376|FG004|Overall Study|Death|0|||
129726894|NCT00075946|466959372|FG000|Overall Study|Withdrawal by Subject|23|||
129726895|NCT00075946|466959373|FG001|Overall Study|Withdrawal by Subject|58|||
129726896|NCT00075946|466959374|FG002|Overall Study|Withdrawal by Subject|4|||
129726897|NCT00075946|466959375|FG003|Overall Study|Withdrawal by Subject|9|||
129726898|NCT00075946|466959376|FG004|Overall Study|Withdrawal by Subject|0|||
129726899|NCT00075946|466959372|FG000|Overall Study|Alternative therapy|16|||
129726900|NCT00075946|466959373|FG001|Overall Study|Alternative therapy|2|||
129726901|NCT00075946|466959374|FG002|Overall Study|Alternative therapy|5|||
129726902|NCT00075946|466959375|FG003|Overall Study|Alternative therapy|0|||
129726903|NCT00075946|466959376|FG004|Overall Study|Alternative therapy|0|||
129726904|NCT00075946|466959372|FG000|Overall Study|Other complicating disease|7|||
129726905|NCT00075946|466959373|FG001|Overall Study|Other complicating disease|13|||
129726906|NCT00075946|466959374|FG002|Overall Study|Other complicating disease|1|||
129726907|NCT00075946|466959375|FG003|Overall Study|Other complicating disease|4|||
129726908|NCT00075946|466959376|FG004|Overall Study|Other complicating disease|0|||
129726909|NCT00075946|466959372|FG000|Overall Study|No response to retreatment|23|||
129726910|NCT00075946|466959373|FG001|Overall Study|No response to retreatment|0|||
129726911|NCT00075946|466959374|FG002|Overall Study|No response to retreatment|2|||
129726912|NCT00075946|466959375|FG003|Overall Study|No response to retreatment|0|||
129726913|NCT00075946|466959376|FG004|Overall Study|No response to retreatment|0|||
129726914|NCT00075946|466959372|FG000|Overall Study|Time to progression less than 6 months|15|||
129726915|NCT00075946|466959373|FG001|Overall Study|Time to progression less than 6 months|30|||
129726916|NCT00075946|466959374|FG002|Overall Study|Time to progression less than 6 months|8|||
129726917|NCT00075946|466959375|FG003|Overall Study|Time to progression less than 6 months|3|||
129726918|NCT00075946|466959376|FG004|Overall Study|Time to progression less than 6 months|0|||
129726919|NCT00075946|466959372|FG000|Overall Study|Other|57|||
129726920|NCT00075946|466959373|FG001|Overall Study|Other|32|||
129726921|NCT00075946|466959374|FG002|Overall Study|Other|3|||
129726922|NCT00075946|466959375|FG003|Overall Study|Other|11|||
129726923|NCT00075946|466959376|FG004|Overall Study|Other|0|||
129726924|NCT01229254|466959378|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
129726925|NCT01229254|466959379|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
129726926|NCT01229254|466959380|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
129726927|NCT01229254|466959378|FG000|Overall Study|Adverse Event|4|||
129726928|NCT01229254|466959379|FG001|Overall Study|Adverse Event|5|||
129726929|NCT01229254|466959380|FG002|Overall Study|Adverse Event|3|||
129726930|NCT01229254|466959378|FG000|Overall Study|Lost to Follow-up|3|||
129726931|NCT01229254|466959379|FG001|Overall Study|Lost to Follow-up|0|||
129726932|NCT01229254|466959380|FG002|Overall Study|Lost to Follow-up|1|||
129726933|NCT01229254|466959378|FG000|Overall Study|Physician Decision|0|||
129726934|NCT01229254|466959379|FG001|Overall Study|Physician Decision|3|||
129726935|NCT01229254|466959380|FG002|Overall Study|Physician Decision|0|||
129726936|NCT01229254|466959378|FG000|Overall Study|Protocol Violation|4|||
129726937|NCT01229254|466959379|FG001|Overall Study|Protocol Violation|6|||
129726938|NCT01229254|466959380|FG002|Overall Study|Protocol Violation|5|||
129726939|NCT01229254|466959378|FG000|Overall Study|Withdrawal by Subject|1|||
129726940|NCT01229254|466959379|FG001|Overall Study|Withdrawal by Subject|0|||
129726941|NCT01229254|466959380|FG002|Overall Study|Withdrawal by Subject|1|||
129726942|NCT01229254|466959378|FG000|Overall Study|Non-compliance with Study Drug|0|||
129726943|NCT01229254|466959379|FG001|Overall Study|Non-compliance with Study Drug|1|||
129726944|NCT01229254|466959380|FG002|Overall Study|Non-compliance with Study Drug|1|||
129726945|NCT02231892|466959382|FG000|Overall Study|Lost to Follow-up|1|||
129726946|NCT02231892|466959383|FG001|Overall Study|Lost to Follow-up|0|||
129726947|NCT02231892|466959384|FG002|Overall Study|Lost to Follow-up|3|||
129726948|NCT02231892|466959382|FG000|Overall Study|Withdrawal by Subject|4|||
129726949|NCT02231892|466959383|FG001|Overall Study|Withdrawal by Subject|3|||
129726950|NCT02231892|466959384|FG002|Overall Study|Withdrawal by Subject|15|||
129726951|NCT02231892|466959382|FG000|Overall Study|Physician Decision|0|||
129726952|NCT02231892|466959383|FG001|Overall Study|Physician Decision|2|||
129726953|NCT02231892|466959384|FG002|Overall Study|Physician Decision|4|||
129726954|NCT02231892|466959382|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
129726955|NCT02231892|466959383|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
129726956|NCT02231892|466959384|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
129804162|NCT04806503|467251434|FG001|Overall Study|Withdrawal by Subject|0|||
129804163|NCT04806503|467251435|FG002|Overall Study|Withdrawal by Subject|1|||
129726957|NCT02231892|466959382|FG000|Overall Study|Participant motor threshold was >83%|0|||
129726958|NCT02231892|466959383|FG001|Overall Study|Participant motor threshold was >83%|0|||
129726959|NCT02231892|466959384|FG002|Overall Study|Participant motor threshold was >83%|9|||
129804164|NCT04806503|467251436|FG003|Overall Study|Withdrawal by Subject|1|||
129726960|NCT02231892|466959382|FG000|Overall Study|Could not find motor threshold|2|||
129726961|NCT02231892|466959383|FG001|Overall Study|Could not find motor threshold|0|||
129726962|NCT02231892|466959384|FG002|Overall Study|Could not find motor threshold|1|||
129726963|NCT02231892|466959382|FG000|Overall Study|Could not find reliable motor hotspot|0|||
129726964|NCT02231892|466959383|FG001|Overall Study|Could not find reliable motor hotspot|0|||
129726965|NCT02231892|466959384|FG002|Overall Study|Could not find reliable motor hotspot|1|||
129726966|NCT02680041|466959386|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
129726967|NCT02680041|466959386|FG000|Overall Study|Lost to Follow-up|2|||
129726968|NCT02186652|466959387|FG000|Overall Study|Lost to Follow-up|2|||
129726969|NCT02186652|466959388|FG001|Overall Study|Lost to Follow-up|0|||
129726970|NCT00744978|466959392|FG000|Period 1|Lost to Follow-up|1|||
129726971|NCT00744978|466959393|FG001|Period 1|Lost to Follow-up|0|||
129726972|NCT00744978|466959392|FG000|Period 1|Withdrawal by Subject|0|||
129726973|NCT00744978|466959393|FG001|Period 1|Withdrawal by Subject|2|||
129726974|NCT00744978|466959392|FG000|Period 1|Other|0|||
129726975|NCT00744978|466959393|FG001|Period 1|Other|2|||
129726976|NCT00744978|466959392|FG000|Period 1|Adverse Event|4|||
129726977|NCT00744978|466959393|FG001|Period 1|Adverse Event|0|||
129726978|NCT00744978|466959392|FG000|Period 1|Randomized but not Treated|1|||
129726979|NCT00744978|466959393|FG001|Period 1|Randomized but not Treated|1|||
129726980|NCT00744978|466959392|FG000|Period 2|Adverse Event|0|||
129726981|NCT00744978|466959393|FG001|Period 2|Adverse Event|1|||
129726982|NCT00515294|466959394|FG000|Overall Study|Lost to Follow-up|3|||
129726983|NCT00515294|466959395|FG001|Overall Study|Lost to Follow-up|2|||
129726984|NCT00515294|466959396|FG002|Overall Study|Lost to Follow-up|3|||
129726985|NCT00515294|466959397|FG003|Overall Study|Lost to Follow-up|1|||
129726986|NCT00515294|466959394|FG000|Overall Study|Driver simulator problems|1|||
129726987|NCT00515294|466959395|FG001|Overall Study|Driver simulator problems|1|||
129726988|NCT00515294|466959396|FG002|Overall Study|Driver simulator problems|1|||
129726989|NCT00515294|466959397|FG003|Overall Study|Driver simulator problems|3|||
129726990|NCT00515294|466959394|FG000|Overall Study|Caffeine amount inaccurate|5|||
129726991|NCT00515294|466959395|FG001|Overall Study|Caffeine amount inaccurate|0|||
129726992|NCT00515294|466959396|FG002|Overall Study|Caffeine amount inaccurate|7|||
129726993|NCT00515294|466959397|FG003|Overall Study|Caffeine amount inaccurate|0|||
129726994|NCT03943550|466959404|FG000|Overall Study|Adverse Event|0|||
129726995|NCT03943550|466959405|FG001|Overall Study|Adverse Event|0|||
129726996|NCT03943550|466959406|FG002|Overall Study|Adverse Event|1|||
129726997|NCT03943550|466959404|FG000|Overall Study|Lost to Follow-up|0|||
129726998|NCT03943550|466959405|FG001|Overall Study|Lost to Follow-up|0|||
129726999|NCT03943550|466959406|FG002|Overall Study|Lost to Follow-up|1|||
129727000|NCT03943550|466959404|FG000|Overall Study|Progressive Disease|0|||
129727001|NCT03943550|466959405|FG001|Overall Study|Progressive Disease|0|||
129727002|NCT03943550|466959406|FG002|Overall Study|Progressive Disease|2|||
129727003|NCT03943550|466959404|FG000|Overall Study|Participant Moved Out of the Country|0|||
129727004|NCT03943550|466959405|FG001|Overall Study|Participant Moved Out of the Country|1|||
129727005|NCT03943550|466959406|FG002|Overall Study|Participant Moved Out of the Country|0|||
129727006|NCT03359785|466959407|FG000|Overall Study|Protocol Violation|0|||
129727007|NCT03359785|466959408|FG001|Overall Study|Protocol Violation|1|||
129727008|NCT03359785|466959409|FG002|Overall Study|Protocol Violation|0|||
129727009|NCT03359785|466959410|FG003|Overall Study|Protocol Violation|0|||
129727010|NCT03359785|466959407|FG000|Overall Study|Early study termination due to study pause|0|||
129727011|NCT03359785|466959408|FG001|Overall Study|Early study termination due to study pause|0|||
129727012|NCT03359785|466959409|FG002|Overall Study|Early study termination due to study pause|2|||
129727013|NCT03359785|466959410|FG003|Overall Study|Early study termination due to study pause|0|||
129727014|NCT03359785|466959407|FG000|Overall Study|Withdrawal by Subject|2|||
129727015|NCT03359785|466959408|FG001|Overall Study|Withdrawal by Subject|2|||
129727016|NCT03359785|466959409|FG002|Overall Study|Withdrawal by Subject|0|||
129727017|NCT03359785|466959410|FG003|Overall Study|Withdrawal by Subject|0|||
129727018|NCT02099344|466959416|FG000|Overall Study|Physician Decision|1|||
129727019|NCT02099344|466959417|FG001|Overall Study|Physician Decision|0|||
129727020|NCT02839720|466959418|FG000|Overall Study|Adverse Event|2|||
129727021|NCT02839720|466959418|FG000|Overall Study|Non-compliance|2|||
129727022|NCT02839720|466959418|FG000|Overall Study|Intercurrent Illness|1|||
129727023|NCT02839720|466959418|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
129727024|NCT02649218|466959419|FG000|Overall Study|Adverse Event|8|||
129727025|NCT02649218|466959419|FG000|Overall Study|Lack of Efficacy|8|||
129727026|NCT02649218|466959419|FG000|Overall Study|Pregnancy|3|||
129727027|NCT02649218|466959419|FG000|Overall Study|Protocol Violation|3|||
129727028|NCT02649218|466959419|FG000|Overall Study|Physician Decision|1|||
129727029|NCT02649218|466959419|FG000|Overall Study|Withdrawal by Subject|2|||
129727030|NCT00503581|466959420|FG000|Overall Study|Study closed|3|||
129727031|NCT00503581|466959421|FG001|Overall Study|Study closed|4|||
129727032|NCT00503581|466959422|FG002|Overall Study|Study closed|2|||
129727033|NCT06107803|466959429|FG000|Overall Study|Adverse Event|1|||
129727034|NCT06107803|466959429|FG000|Overall Study|Withdrawal by Subject|2|||
129727035|NCT06107803|466959429|FG000|Overall Study|Protocol Violation|1|||
129727036|NCT04730635|466959431|FG000|Overall Study|Lost to Follow-up|1|||
129727037|NCT04730635|466959432|FG001|Overall Study|Lost to Follow-up|0|||
129727038|NCT04730635|466959431|FG000|Overall Study|Withdrawal by Subject|0|||
129727039|NCT04730635|466959432|FG001|Overall Study|Withdrawal by Subject|1|||
129727040|NCT01096368|466959433|FG000|Overall Study|Death|0|||
129727041|NCT01096368|466959434|FG001|Overall Study|Death|1|||
129727042|NCT01096368|466959435|FG002|Overall Study|Death|0|||
129727043|NCT01096368|466959436|FG003|Overall Study|Death|0|||
129727044|NCT01096368|466959437|FG004|Overall Study|Death|0|||
129727045|NCT01096368|466959433|FG000|Overall Study|Physician Decision|0|||
129727046|NCT01096368|466959434|FG001|Overall Study|Physician Decision|13|||
129727047|NCT01096368|466959435|FG002|Overall Study|Physician Decision|2|||
129727048|NCT01096368|466959436|FG003|Overall Study|Physician Decision|4|||
129727049|NCT01096368|466959437|FG004|Overall Study|Physician Decision|6|||
129727050|NCT01096368|466959433|FG000|Overall Study|Withdrawal by Subject|0|||
129727051|NCT01096368|466959434|FG001|Overall Study|Withdrawal by Subject|52|||
129727052|NCT01096368|466959435|FG002|Overall Study|Withdrawal by Subject|0|||
129727053|NCT01096368|466959436|FG003|Overall Study|Withdrawal by Subject|10|||
129727054|NCT01096368|466959437|FG004|Overall Study|Withdrawal by Subject|14|||
129727055|NCT01096368|466959433|FG000|Overall Study|Ineligible|0|||
129727056|NCT01096368|466959434|FG001|Overall Study|Ineligible|3|||
129727057|NCT01096368|466959435|FG002|Overall Study|Ineligible|2|||
129727058|NCT01096368|466959436|FG003|Overall Study|Ineligible|0|||
129727059|NCT01096368|466959437|FG004|Overall Study|Ineligible|25|||
129727060|NCT01096368|466959433|FG000|Overall Study|Did not start treatment|0|||
129727061|NCT01096368|466959434|FG001|Overall Study|Did not start treatment|4|||
129727062|NCT01096368|466959435|FG002|Overall Study|Did not start treatment|4|||
129727063|NCT01096368|466959436|FG003|Overall Study|Did not start treatment|0|||
129727064|NCT01096368|466959437|FG004|Overall Study|Did not start treatment|0|||
129727065|NCT01096368|466959433|FG000|Overall Study|Progressive disease|0|||
129727066|NCT01096368|466959434|FG001|Overall Study|Progressive disease|6|||
129727067|NCT01096368|466959435|FG002|Overall Study|Progressive disease|0|||
129727068|NCT01096368|466959436|FG003|Overall Study|Progressive disease|10|||
129727069|NCT01096368|466959437|FG004|Overall Study|Progressive disease|3|||
129727070|NCT01096368|466959433|FG000|Overall Study|Other|0|||
129727071|NCT01096368|466959434|FG001|Overall Study|Other|0|||
129727072|NCT01096368|466959435|FG002|Overall Study|Other|1|||
129727073|NCT01096368|466959436|FG003|Overall Study|Other|0|||
129727074|NCT01096368|466959437|FG004|Overall Study|Other|0|||
129727075|NCT01096368|466959433|FG000|Overall Study|Treated with institutional review|0|||
129727076|NCT01096368|466959434|FG001|Overall Study|Treated with institutional review|0|||
129727077|NCT01096368|466959435|FG002|Overall Study|Treated with institutional review|0|||
129727078|NCT01096368|466959436|FG003|Overall Study|Treated with institutional review|0|||
129727079|NCT01096368|466959437|FG004|Overall Study|Treated with institutional review|1|||
129727080|NCT03070223|466959438|FG000|Overall Study|Lost to Follow-up|34|||
129727081|NCT03070223|466959439|FG001|Overall Study|Lost to Follow-up|27|||
129727082|NCT03070223|466959438|FG000|Overall Study|Withdrawal by Subject|12|||
129727083|NCT03070223|466959439|FG001|Overall Study|Withdrawal by Subject|22|||
129727084|NCT03070223|466959438|FG000|Overall Study|Protocol Violation|0|||
129727085|NCT03070223|466959439|FG001|Overall Study|Protocol Violation|1|||
129727086|NCT04934800|466959440|FG000|Overall Study|Other|1|||
129727087|NCT04934800|466959440|FG000|Overall Study|Withdrawal by Subject|5|||
129727088|NCT04934800|466959440|FG000|Overall Study|Lack of Efficacy|1|||
129727089|NCT04934800|466959440|FG000|Overall Study|Adverse Event|9|||
129727090|NCT04934800|466959440|FG000|Overall Study|Lost to Follow-up|5|||
129727091|NCT04934800|466959440|FG000|Overall Study|Enrolled but not treated|1|||
129727092|NCT00516906|466959441|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
129727093|NCT00516906|466959442|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
129727094|NCT01974206|466959445|FG000|Overall Study|Did Not Take Study Drug|0|||
129727095|NCT01974206|466959446|FG001|Overall Study|Did Not Take Study Drug|1|||
129727096|NCT01974206|466959445|FG000|Overall Study|Physician Decision|1|||
129727097|NCT01974206|466959446|FG001|Overall Study|Physician Decision|0|||
129727098|NCT01974206|466959445|FG000|Overall Study|Withdrawal by Subject|3|||
129727099|NCT01974206|466959446|FG001|Overall Study|Withdrawal by Subject|0|||
129727100|NCT01974206|466959445|FG000|Overall Study|Lost to Follow-up|1|||
129727101|NCT01974206|466959446|FG001|Overall Study|Lost to Follow-up|0|||
129727102|NCT01974206|466959445|FG000|Overall Study|Death|1|||
129727103|NCT01974206|466959446|FG001|Overall Study|Death|0|||
129727104|NCT02118766|466959451|FG000|Overall Study|Adverse Event|7|||
129727105|NCT02118766|466959452|FG001|Overall Study|Adverse Event|2|||
129727106|NCT02118766|466959451|FG000|Overall Study|Withdrawal by Subject|3|||
129727107|NCT02118766|466959452|FG001|Overall Study|Withdrawal by Subject|6|||
129727108|NCT02118766|466959451|FG000|Overall Study|Lost to Follow-up|5|||
129727109|NCT02118766|466959452|FG001|Overall Study|Lost to Follow-up|4|||
129727110|NCT02118766|466959451|FG000|Overall Study|Withdrawal by parent/guardian|12|||
129727111|NCT02118766|466959452|FG001|Overall Study|Withdrawal by parent/guardian|18|||
129727112|NCT02118766|466959451|FG000|Overall Study|Other|3|||
129727113|NCT02118766|466959452|FG001|Overall Study|Other|1|||
129727114|NCT03219034|466959456|FG000|Overall Study|Lost to Follow-up|9|||
129727115|NCT03219034|466959457|FG001|Overall Study|Lost to Follow-up|13|||
129804165|NCT04806503|467251437|FG004|Overall Study|Withdrawal by Subject|1|||
129804166|NCT04806503|467251433|FG000|Overall Study|Adverse Event|1|||
129891720|NCT01929993|467563038|FG001|Overall Study|Protocol Violation|6|||
129891721|NCT01929993|467563037|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
129891722|NCT01929993|467563038|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
129891723|NCT01852162|467563039|FG000|Overall Study|Adverse Event|1|||
129891724|NCT01852162|467563040|FG001|Overall Study|Adverse Event|0|||
129891725|NCT01852162|467563039|FG000|Overall Study|Withdrawal by Subject|3|||
129891726|NCT01852162|467563040|FG001|Overall Study|Withdrawal by Subject|1|||
129891727|NCT03660943|467563041|FG000|Overall Study|Adverse Event|5|||
129891728|NCT03660943|467563042|FG001|Overall Study|Adverse Event|3|||
129891729|NCT03660943|467563041|FG000|Overall Study|Death|0|||
129891730|NCT03660943|467563042|FG001|Overall Study|Death|2|||
129891731|NCT03660943|467563041|FG000|Overall Study|Lost to Follow-up|7|||
129891732|NCT03660943|467563042|FG001|Overall Study|Lost to Follow-up|3|||
129891733|NCT03660943|467563041|FG000|Overall Study|Protocol Violation|3|||
129891734|NCT03660943|467563042|FG001|Overall Study|Protocol Violation|5|||
129891735|NCT03660943|467563041|FG000|Overall Study|Withdrawal by Subject|8|||
129891736|NCT03660943|467563042|FG001|Overall Study|Withdrawal by Subject|15|||
129891737|NCT03660943|467563041|FG000|Overall Study|Lack of Efficacy|9|||
129891738|NCT03660943|467563042|FG001|Overall Study|Lack of Efficacy|12|||
129891739|NCT03660943|467563041|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
129891740|NCT03660943|467563042|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
129891741|NCT02892409|467563046|FG000|Overall Study|Adverse Event|1|||
129891742|NCT02892409|467563047|FG001|Overall Study|Adverse Event|0|||
129891743|NCT02892409|467563046|FG000|Overall Study|Withdrawal by Subject|2|||
129891744|NCT02892409|467563047|FG001|Overall Study|Withdrawal by Subject|1|||
129891745|NCT05305040|467563048|FG000|Overall Study|Not Dosed|37|||
129891746|NCT05305040|467563049|FG001|Overall Study|Not Dosed|37|||
129891747|NCT05305040|467563048|FG000|Overall Study|Study Closure|34|||
129891748|NCT05305040|467563049|FG001|Overall Study|Study Closure|46|||
129891749|NCT05305040|467563048|FG000|Overall Study|Death|14|||
129891750|NCT05305040|467563049|FG001|Overall Study|Death|13|||
129891751|NCT05305040|467563048|FG000|Overall Study|Withdrawal by Subject|15|||
129891752|NCT05305040|467563049|FG001|Overall Study|Withdrawal by Subject|10|||
129891753|NCT05305040|467563048|FG000|Overall Study|Other|13|||
129891754|NCT05305040|467563049|FG001|Overall Study|Other|10|||
129891755|NCT05305040|467563048|FG000|Overall Study|Primary Malignancy Relapse|3|||
129891756|NCT05305040|467563049|FG001|Overall Study|Primary Malignancy Relapse|4|||
129891757|NCT05305040|467563048|FG000|Overall Study|Adverse Event|3|||
129891758|NCT05305040|467563049|FG001|Overall Study|Adverse Event|3|||
129891759|NCT05305040|467563048|FG000|Overall Study|Lost to Follow-up|2|||
129891760|NCT05305040|467563049|FG001|Overall Study|Lost to Follow-up|1|||
129891761|NCT05305040|467563048|FG000|Overall Study|Graft versus host disease|2|||
129891762|NCT05305040|467563049|FG001|Overall Study|Graft versus host disease|0|||
129891763|NCT05305040|467563048|FG000|Overall Study|Investigator's Decision|1|||
129891764|NCT05305040|467563049|FG001|Overall Study|Investigator's Decision|1|||
129891765|NCT05305040|467563048|FG000|Overall Study|COVID-19 Reasons|1|||
129891766|NCT05305040|467563049|FG001|Overall Study|COVID-19 Reasons|0|||
129891767|NCT02123966|467563052|FG000|Overall Study|Intercurrent Illness|1|||
129891768|NCT01033643|467563053|FG000|Overall Study|Withdrew Consent|0|||
129891769|NCT01033643|467563054|FG001|Overall Study|Withdrew Consent|3|||
129891770|NCT01033643|467563055|FG002|Overall Study|Withdrew Consent|0|||
129891771|NCT01033643|467563056|FG003|Overall Study|Withdrew Consent|0|||
129891772|NCT01033643|467563057|FG004|Overall Study|Withdrew Consent|0|||
129891773|NCT01033643|467563058|FG005|Overall Study|Withdrew Consent|1|||
129891774|NCT00465361|467563059|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
129891775|NCT02652130|467563060|FG000|Overall Study|Death|1|||
129727116|NCT03219034|466959456|FG000|Overall Study|Additional dental work needed|1|||
129727117|NCT03219034|466959457|FG001|Overall Study|Additional dental work needed|0|||
129727118|NCT03219034|466959456|FG000|Overall Study|UPPP Surgery|1|||
129727119|NCT03219034|466959457|FG001|Overall Study|UPPP Surgery|0|||
129727120|NCT03219034|466959456|FG000|Overall Study|Dental sensitivity|0|||
129891776|NCT00751790|467563067|FG000|Overall Study|Lost to Follow-up|1|||
129891777|NCT00751790|467563067|FG000|Overall Study|Death|3|||
129891778|NCT00751790|467563067|FG000|Overall Study|Withdrawal by Subject|1|||
129891779|NCT04337489|467563068|FG000|Overall Study|Withdrawal by Subject|1|||
129891780|NCT01113463|467563073|FG000|Overall Study|Physician Decision|5|||
129891781|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
129891782|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
129891783|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
129891784|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
129891785|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
129727121|NCT03219034|466959457|FG001|Overall Study|Dental sensitivity|1|||
129891786|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
129891787|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
129891788|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
129891789|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
129891790|NCT01237678|467563074|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
129891791|NCT01237678|467563075|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
129891792|NCT01237678|467563076|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
129891793|NCT01237678|467563074|FG000|Phase II|Adverse Event|0|||
129891794|NCT01237678|467563075|FG001|Phase II|Adverse Event|39|||
129891795|NCT01237678|467563076|FG002|Phase II|Adverse Event|9|||
129891796|NCT01237678|467563074|FG000|Phase II|Death|0|||
129891797|NCT01237678|467563075|FG001|Phase II|Death|0|||
129891798|NCT01237678|467563076|FG002|Phase II|Death|2|||
129891799|NCT01237678|467563074|FG000|Phase II|Lack of Efficacy|0|||
129891800|NCT01237678|467563075|FG001|Phase II|Lack of Efficacy|25|||
129891801|NCT01237678|467563076|FG002|Phase II|Lack of Efficacy|3|||
129891802|NCT01237678|467563074|FG000|Phase II|Withdrawal by Subject|0|||
129891803|NCT01237678|467563075|FG001|Phase II|Withdrawal by Subject|1|||
129891804|NCT01237678|467563076|FG002|Phase II|Withdrawal by Subject|5|||
129891805|NCT01237678|467563074|FG000|Phase II|Completed Cycles 4-6|0|||
129891806|NCT01237678|467563075|FG001|Phase II|Completed Cycles 4-6|11|||
129891807|NCT01237678|467563076|FG002|Phase II|Completed Cycles 4-6|21|||
129891808|NCT01237678|467563074|FG000|Phase II|Sponsor Decision/Study Closed|0|||
129891809|NCT01237678|467563075|FG001|Phase II|Sponsor Decision/Study Closed|18|||
129891810|NCT01237678|467563076|FG002|Phase II|Sponsor Decision/Study Closed|7|||
129891811|NCT01237678|467563074|FG000|Phase II|Randomized but were not treated|0|||
129891812|NCT01237678|467563075|FG001|Phase II|Randomized but were not treated|4|||
129891813|NCT01237678|467563076|FG002|Phase II|Randomized but were not treated|3|||
129891814|NCT03023332|467563077|FG000|Overall Study|Withdrawal by Subject|10|||
129891815|NCT03023332|467563078|FG001|Overall Study|Withdrawal by Subject|5|||
129891816|NCT03023332|467563079|FG002|Overall Study|Withdrawal by Subject|4|||
129891817|NCT03023332|467563080|FG003|Overall Study|Withdrawal by Subject|7|||
129891818|NCT03023332|467563077|FG000|Overall Study|Lost to Follow-up|13|||
129891819|NCT03023332|467563078|FG001|Overall Study|Lost to Follow-up|16|||
129891820|NCT03023332|467563079|FG002|Overall Study|Lost to Follow-up|8|||
129891821|NCT03023332|467563080|FG003|Overall Study|Lost to Follow-up|13|||
129891822|NCT03023332|467563077|FG000|Overall Study|Death|1|||
129891823|NCT03023332|467563078|FG001|Overall Study|Death|0|||
129891824|NCT03023332|467563079|FG002|Overall Study|Death|0|||
129891825|NCT03023332|467563080|FG003|Overall Study|Death|0|||
129891826|NCT01818700|467563081|FG000|Overall Study|Adverse Event|67|||
129891827|NCT01818700|467563081|FG000|Overall Study|Lack of Efficacy|2|||
129891828|NCT01818700|467563081|FG000|Overall Study|Lost to Follow-up|5|||
129891829|NCT01818700|467563081|FG000|Overall Study|Withdrawal by Subject|27|||
129891830|NCT01818700|467563081|FG000|Overall Study|Protocol Violation|2|||
129891831|NCT01818700|467563081|FG000|Overall Study|Other|1|||
129891832|NCT02412761|467563082|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129891833|NCT02412761|467563083|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129891834|NCT02412761|467563084|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129891835|NCT02412761|467563085|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129891836|NCT02412761|467563086|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129891837|NCT02412761|467563087|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129891838|NCT01657682|467563088|FG000|Overall Study|Lost to Follow-up|1|||
129891839|NCT01657682|467563089|FG001|Overall Study|Lost to Follow-up|0|||
129891840|NCT01657682|467563090|FG002|Overall Study|Lost to Follow-up|0|||
129891841|NCT01657682|467563088|FG000|Overall Study|Withdrawal by Subject|0|||
129891842|NCT01657682|467563089|FG001|Overall Study|Withdrawal by Subject|1|||
129891843|NCT01657682|467563090|FG002|Overall Study|Withdrawal by Subject|1|||
129891844|NCT01657682|467563088|FG000|Overall Study|Adverse Event|0|||
129891845|NCT01657682|467563089|FG001|Overall Study|Adverse Event|1|||
129891846|NCT01657682|467563090|FG002|Overall Study|Adverse Event|0|||
129727122|NCT03219034|466959456|FG000|Overall Study|Death in family|0|||
129727123|NCT03219034|466959457|FG001|Overall Study|Death in family|1|||
129727124|NCT02438683|466959458|FG000|Overall Study|Adverse Event|1|||
129891847|NCT01719861|467563091|FG000|Cycle 1|Death|4|||
129891848|NCT01719861|467563091|FG000|Cycle 2|Death|1|||
129891849|NCT04833855|467563097|FG000|Overall Study|Decision by sponsor|0|||
129891850|NCT04833855|467563098|FG001|Overall Study|Decision by sponsor|1|||
129891851|NCT04833855|467563099|FG002|Overall Study|Decision by sponsor|0|||
129891852|NCT04833855|467563100|FG003|Overall Study|Decision by sponsor|0|||
129891853|NCT04833855|467563097|FG000|Overall Study|Withdrawal by Subject|4|||
129727125|NCT02438683|466959459|FG001|Overall Study|Adverse Event|0|||
129727126|NCT02438683|466959460|FG002|Overall Study|Adverse Event|0|||
129727127|NCT02438683|466959461|FG003|Overall Study|Adverse Event|0|||
129727128|NCT02438683|466959462|FG004|Overall Study|Adverse Event|0|||
129727129|NCT02438683|466959463|FG005|Overall Study|Adverse Event|0|||
129727130|NCT04669262|466959474|FG000|Overall Study|Withdrawal by Subject|0|||
129727131|NCT04669262|466959475|FG001|Overall Study|Withdrawal by Subject|0|||
129727132|NCT04669262|466959476|FG002|Overall Study|Withdrawal by Subject|0|||
129727133|NCT04669262|466959477|FG003|Overall Study|Withdrawal by Subject|1|||
129727134|NCT04669262|466959474|FG000|Overall Study|Randomized but Not Treated|0|||
129727135|NCT04669262|466959475|FG001|Overall Study|Randomized but Not Treated|1|||
129727136|NCT04669262|466959476|FG002|Overall Study|Randomized but Not Treated|0|||
129727137|NCT04669262|466959477|FG003|Overall Study|Randomized but Not Treated|0|||
129727138|NCT01638013|466959478|FG000|Overall Study|Adverse Event|36|||
129727139|NCT01638013|466959479|FG001|Overall Study|Adverse Event|29|||
129727140|NCT01638013|466959480|FG002|Overall Study|Adverse Event|48|||
129727141|NCT01638013|466959478|FG000|Overall Study|Lack of Efficacy|39|||
129727142|NCT01638013|466959479|FG001|Overall Study|Lack of Efficacy|11|||
129804167|NCT04806503|467251434|FG001|Overall Study|Adverse Event|1|||
129804168|NCT04806503|467251435|FG002|Overall Study|Adverse Event|0|||
129804169|NCT04806503|467251436|FG003|Overall Study|Adverse Event|1|||
129804170|NCT04806503|467251437|FG004|Overall Study|Adverse Event|0|||
129804171|NCT03589469|467251438|FG000|Overall Study|Withdrawal by Subject|8|||
129804172|NCT03589469|467251438|FG000|Overall Study|Physician Decision|20|||
129804173|NCT03589469|467251438|FG000|Overall Study|Death|97|||
129804174|NCT03589469|467251438|FG000|Overall Study|Lost to Follow-up|8|||
129804175|NCT03589469|467251438|FG000|Overall Study|Miscellaneous|1|||
129804176|NCT02008318|467251440|FG000|Overall Study|Adverse Event|4|||
129804177|NCT02008318|467251441|FG001|Overall Study|Adverse Event|0|||
129804178|NCT02008318|467251440|FG000|Overall Study|Physician Decision|2|||
129804179|NCT02008318|467251441|FG001|Overall Study|Physician Decision|0|||
129804180|NCT02008318|467251440|FG000|Overall Study|Progressive Disease|2|||
129804181|NCT02008318|467251441|FG001|Overall Study|Progressive Disease|0|||
129804182|NCT02008318|467251440|FG000|Overall Study|Protocol Violation|1|||
129804183|NCT02008318|467251441|FG001|Overall Study|Protocol Violation|1|||
129804184|NCT02008318|467251440|FG000|Overall Study|Withdrawal by Subject|3|||
129804185|NCT02008318|467251441|FG001|Overall Study|Withdrawal by Subject|0|||
129804186|NCT00371826|467251448|FG000|Core Phase (12 Months)|Adverse Event|15|||
129804187|NCT00371826|467251449|FG001|Core Phase (12 Months)|Adverse Event|4|||
129804188|NCT00371826|467251450|FG002|Core Phase (12 Months)|Adverse Event|9|||
129804189|NCT00371826|467251448|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
129804190|NCT00371826|467251449|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
129804191|NCT00371826|467251450|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
129804192|NCT00371826|467251448|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
129804193|NCT00371826|467251449|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
129804194|NCT00371826|467251450|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
129804195|NCT00371826|467251448|FG000|Core Phase (12 Months)|Protocol Violation|1|||
129804196|NCT00371826|467251449|FG001|Core Phase (12 Months)|Protocol Violation|0|||
129804197|NCT00371826|467251450|FG002|Core Phase (12 Months)|Protocol Violation|1|||
129804198|NCT00371826|467251448|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
129804199|NCT00371826|467251449|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
129804200|NCT00371826|467251450|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
129804201|NCT00371826|467251448|FG000|Core Phase (12 Months)|Administrative problems|1|||
129804202|NCT00371826|467251449|FG001|Core Phase (12 Months)|Administrative problems|0|||
129804203|NCT00371826|467251450|FG002|Core Phase (12 Months)|Administrative problems|8|||
129804204|NCT00371826|467251448|FG000|Core Phase (12 Months)|Graft Loss|0|||
129804205|NCT00371826|467251449|FG001|Core Phase (12 Months)|Graft Loss|1|||
129804206|NCT00371826|467251450|FG002|Core Phase (12 Months)|Graft Loss|0|||
129804207|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Adverse Event|4|||
129804208|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Adverse Event|5|||
129804209|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Adverse Event|0|||
129804210|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
129804211|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
129804212|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
129804213|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
129804214|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
129804215|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
129804216|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
129727143|NCT01638013|466959480|FG002|Overall Study|Lack of Efficacy|14|||
129727144|NCT01638013|466959478|FG000|Overall Study|Protocol Violation|10|||
129727145|NCT01638013|466959479|FG001|Overall Study|Protocol Violation|7|||
129727146|NCT01638013|466959480|FG002|Overall Study|Protocol Violation|11|||
129727147|NCT01638013|466959478|FG000|Overall Study|Met discontinuation criteria|4|||
129727148|NCT01638013|466959479|FG001|Overall Study|Met discontinuation criteria|0|||
129727149|NCT01638013|466959480|FG002|Overall Study|Met discontinuation criteria|7|||
129727150|NCT01638013|466959478|FG000|Overall Study|Subject Lost to Follow up|1|||
129727151|NCT01638013|466959479|FG001|Overall Study|Subject Lost to Follow up|0|||
129727152|NCT01638013|466959480|FG002|Overall Study|Subject Lost to Follow up|1|||
129727153|NCT01638013|466959478|FG000|Overall Study|Miscellaneous|25|||
129727154|NCT01638013|466959479|FG001|Overall Study|Miscellaneous|19|||
129727155|NCT01638013|466959480|FG002|Overall Study|Miscellaneous|23|||
129727156|NCT01638013|466959478|FG000|Overall Study|Withdrawal of Consent|16|||
129727157|NCT01638013|466959479|FG001|Overall Study|Withdrawal of Consent|12|||
129727158|NCT01638013|466959480|FG002|Overall Study|Withdrawal of Consent|16|||
129727159|NCT01638013|466959478|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
129727160|NCT01638013|466959479|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
129727161|NCT01638013|466959480|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
129727162|NCT03559517|466959483|FG000|Overall Study|Withdrawal by Subject|1|||
129727163|NCT03559517|466959484|FG001|Overall Study|Withdrawal by Subject|0|||
129727164|NCT03559517|466959485|FG002|Overall Study|Withdrawal by Subject|0|||
129727165|NCT01846299|466959486|FG000|Overall Study|Physician Decision|4|||
129727166|NCT01846299|466959487|FG001|Overall Study|Physician Decision|2|||
129727167|NCT01846299|466959486|FG000|Overall Study|Protocol deviation|1|||
129727168|NCT01846299|466959487|FG001|Overall Study|Protocol deviation|0|||
129727169|NCT01846299|466959486|FG000|Overall Study|Death|1|||
129727170|NCT01846299|466959487|FG001|Overall Study|Death|2|||
129727171|NCT01846299|466959486|FG000|Overall Study|Lost to Follow-up|3|||
129727172|NCT01846299|466959487|FG001|Overall Study|Lost to Follow-up|0|||
129727173|NCT01846299|466959486|FG000|Overall Study|Withdrawal by Subject|1|||
129727174|NCT01846299|466959487|FG001|Overall Study|Withdrawal by Subject|6|||
129727175|NCT01846299|466959486|FG000|Overall Study|Adverse Event|2|||
129727176|NCT01846299|466959487|FG001|Overall Study|Adverse Event|0|||
129727177|NCT02013206|466961341|FG000|Overall Study|Progressive disease (PD)|14|||
129727178|NCT02013206|466961342|FG001|Overall Study|Progressive disease (PD)|17|||
129727179|NCT02013206|466961341|FG000|Overall Study|Symptomatic deterioration|3|||
129727180|NCT02013206|466961342|FG001|Overall Study|Symptomatic deterioration|1|||
129727181|NCT02013206|466961341|FG000|Overall Study|Adverse Event|1|||
129727182|NCT02013206|466961342|FG001|Overall Study|Adverse Event|0|||
129727183|NCT02013206|466961341|FG000|Overall Study|Patient refusal|2|||
129727184|NCT02013206|466961342|FG001|Overall Study|Patient refusal|0|||
129727185|NCT02013206|466961341|FG000|Overall Study|Patient non-compliance|1|||
129727186|NCT02013206|466961342|FG001|Overall Study|Patient non-compliance|0|||
129727187|NCT02013206|466961341|FG000|Overall Study|Death|1|||
129727188|NCT02013206|466961342|FG001|Overall Study|Death|2|||
129727189|NCT02013206|466961341|FG000|Overall Study|Other reasons off treatment|5|||
129727190|NCT02013206|466961342|FG001|Overall Study|Other reasons off treatment|2|||
129727191|NCT02791191|466961343|FG000|Overall Study|Adverse Event|2|||
129727192|NCT02791191|466961344|FG001|Overall Study|Adverse Event|4|||
129727193|NCT02791191|466961345|FG002|Overall Study|Adverse Event|5|||
129727194|NCT02791191|466961343|FG000|Overall Study|Lack of Efficacy|0|||
129727195|NCT02791191|466961344|FG001|Overall Study|Lack of Efficacy|1|||
129727196|NCT02791191|466961345|FG002|Overall Study|Lack of Efficacy|0|||
129727197|NCT02791191|466961343|FG000|Overall Study|Study Drug Non-Compliance|0|||
129727198|NCT02791191|466961344|FG001|Overall Study|Study Drug Non-Compliance|2|||
129727199|NCT02791191|466961345|FG002|Overall Study|Study Drug Non-Compliance|0|||
129727200|NCT02791191|466961343|FG000|Overall Study|Site Closed by Sponsor|1|||
129727201|NCT02791191|466961344|FG001|Overall Study|Site Closed by Sponsor|1|||
129727202|NCT02791191|466961345|FG002|Overall Study|Site Closed by Sponsor|3|||
129727203|NCT02791191|466961343|FG000|Overall Study|Progressive Disease|1|||
129727204|NCT02791191|466961344|FG001|Overall Study|Progressive Disease|0|||
129727205|NCT02791191|466961345|FG002|Overall Study|Progressive Disease|0|||
129727206|NCT02791191|466961343|FG000|Overall Study|Study Terminated by Sponsor|29|||
129727207|NCT02791191|466961344|FG001|Overall Study|Study Terminated by Sponsor|101|||
129444443|NCT01822522|465927343|FG000|Overall Study|Death|3|||
129804217|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
129727208|NCT02791191|466961345|FG002|Overall Study|Study Terminated by Sponsor|109|||
129727209|NCT02791191|466961343|FG000|Overall Study|Withdrawal by Subject|3|||
129727210|NCT02791191|466961344|FG001|Overall Study|Withdrawal by Subject|1|||
129727211|NCT02791191|466961345|FG002|Overall Study|Withdrawal by Subject|3|||
129727212|NCT02791191|466961343|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
129727213|NCT02791191|466961344|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
129727214|NCT02791191|466961345|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
129727215|NCT01448824|466961346|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129804218|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
129804219|NCT00371826|467251448|FG000|Extension Phase (24 Months)|Administrative problems|0|||
129727216|NCT01448824|466961347|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129727217|NCT01448824|466961348|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129727218|NCT01448824|466961349|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129727219|NCT01448824|466961350|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129727220|NCT01448824|466961351|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129727221|NCT01448824|466961352|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
129727222|NCT01448824|466961353|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
129727223|NCT01448824|466961346|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129727224|NCT01448824|466961347|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129727225|NCT01448824|466961348|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129727226|NCT01448824|466961349|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
129727227|NCT01448824|466961350|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
129727228|NCT01448824|466961351|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
129727229|NCT01448824|466961352|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129727230|NCT01448824|466961353|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
129727231|NCT01448824|466961346|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129727232|NCT01448824|466961347|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129891854|NCT04833855|467563098|FG001|Overall Study|Withdrawal by Subject|1|||
129891855|NCT04833855|467563099|FG002|Overall Study|Withdrawal by Subject|3|||
129891856|NCT04833855|467563100|FG003|Overall Study|Withdrawal by Subject|1|||
129891857|NCT04833855|467563097|FG000|Overall Study|Lost to Follow-up|1|||
129727233|NCT01448824|466961348|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129727234|NCT01448824|466961349|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129727235|NCT01448824|466961350|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129891858|NCT04833855|467563098|FG001|Overall Study|Lost to Follow-up|0|||
129891859|NCT04833855|467563099|FG002|Overall Study|Lost to Follow-up|2|||
129891860|NCT04833855|467563100|FG003|Overall Study|Lost to Follow-up|2|||
129727236|NCT01448824|466961351|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
129727237|NCT01448824|466961352|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129727238|NCT01448824|466961353|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
129727239|NCT01448824|466961346|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
129727240|NCT01448824|466961347|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
129727241|NCT01448824|466961348|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
129727242|NCT01448824|466961349|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
129727243|NCT01448824|466961350|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
129727244|NCT01448824|466961351|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
129727245|NCT01448824|466961352|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
129727246|NCT01448824|466961353|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
129727247|NCT01448824|466961346|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727248|NCT01448824|466961347|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727249|NCT01448824|466961348|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727250|NCT01448824|466961349|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727251|NCT01448824|466961350|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727252|NCT01448824|466961351|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727253|NCT01448824|466961352|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
129727254|NCT01448824|466961353|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
129727255|NCT01448824|466961346|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727256|NCT01448824|466961347|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727257|NCT01448824|466961348|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727258|NCT01448824|466961349|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727259|NCT01448824|466961350|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727260|NCT01448824|466961351|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727261|NCT01448824|466961352|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
129727262|NCT01448824|466961353|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
129727263|NCT01448824|466961346|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727264|NCT01448824|466961347|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727265|NCT01448824|466961348|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727266|NCT01448824|466961349|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727267|NCT01448824|466961350|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727268|NCT01448824|466961351|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727269|NCT01448824|466961352|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
129727270|NCT01448824|466961353|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
129727271|NCT01448824|466961346|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129727272|NCT01448824|466961347|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129891861|NCT04833855|467563097|FG000|Overall Study|Protocol specified criteria|0|||
129444444|NCT01822522|465927344|FG001|Overall Study|Death|0|||
129891862|NCT04833855|467563098|FG001|Overall Study|Protocol specified criteria|0|||
129891863|NCT04833855|467563099|FG002|Overall Study|Protocol specified criteria|2|||
129891864|NCT04833855|467563100|FG003|Overall Study|Protocol specified criteria|1|||
129891865|NCT03682536|467563102|FG000|Randomization|Withdrawal by Subject|0|||
129891866|NCT03682536|467563103|FG001|Randomization|Withdrawal by Subject|2|||
129891867|NCT03682536|467563102|FG000|Treatment|Other Reasons|8|||
129891868|NCT03682536|467563103|FG001|Treatment|Other Reasons|7|||
129891869|NCT03682536|467563102|FG000|Treatment|Physician Decision|5|||
129891870|NCT03682536|467563103|FG001|Treatment|Physician Decision|5|||
129891871|NCT03682536|467563102|FG000|Treatment|Protocol Violation|1|||
129891872|NCT03682536|467563103|FG001|Treatment|Protocol Violation|0|||
129891873|NCT03682536|467563102|FG000|Treatment|Study Terminated by Sponsor|1|||
129891874|NCT03682536|467563103|FG001|Treatment|Study Terminated by Sponsor|2|||
129891875|NCT03682536|467563102|FG000|Treatment|Lost to Follow-up|0|||
129891876|NCT03682536|467563103|FG001|Treatment|Lost to Follow-up|1|||
129891877|NCT03682536|467563102|FG000|Treatment|Withdrawal by Subject|16|||
129891878|NCT03682536|467563103|FG001|Treatment|Withdrawal by Subject|18|||
129891879|NCT03682536|467563102|FG000|Treatment|Lack of Efficacy|41|||
129891880|NCT03682536|467563103|FG001|Treatment|Lack of Efficacy|68|||
129891881|NCT03682536|467563102|FG000|Treatment|Disease Progression|9|||
129891882|NCT03682536|467563103|FG001|Treatment|Disease Progression|7|||
129891883|NCT03682536|467563102|FG000|Treatment|Adverse Event|9|||
129891884|NCT03682536|467563103|FG001|Treatment|Adverse Event|5|||
129891885|NCT03682536|467563102|FG000|Treatment|Death|14|||
129891886|NCT03682536|467563103|FG001|Treatment|Death|13|||
129891887|NCT03008122|467563104|FG000|Overall Study|Physician Decision|3|||
129891888|NCT03008122|467563105|FG001|Overall Study|Physician Decision|2|||
129891889|NCT03008122|467563106|FG002|Overall Study|Physician Decision|0|||
129891890|NCT03008122|467563104|FG000|Overall Study|Withdrawal by Subject|1|||
129891891|NCT03008122|467563105|FG001|Overall Study|Withdrawal by Subject|3|||
129727273|NCT01448824|466961348|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129727274|NCT01448824|466961349|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129891892|NCT03008122|467563106|FG002|Overall Study|Withdrawal by Subject|0|||
129891893|NCT03008122|467563104|FG000|Overall Study|Lost to Follow-up|4|||
129891894|NCT03008122|467563105|FG001|Overall Study|Lost to Follow-up|8|||
129891895|NCT03008122|467563106|FG002|Overall Study|Lost to Follow-up|3|||
129891896|NCT03008122|467563104|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
129891897|NCT03008122|467563105|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129891898|NCT03008122|467563106|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129891899|NCT03008122|467563104|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
129727275|NCT01448824|466961350|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129727276|NCT01448824|466961351|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129727277|NCT01448824|466961352|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
129727278|NCT01448824|466961353|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
129727279|NCT01995669|466961356|FG000|Overall Study|Progression|2|||
129727280|NCT01995669|466961357|FG001|Overall Study|Progression|1|||
129727281|NCT01995669|466961358|FG002|Overall Study|Progression|1|||
129727282|NCT01995669|466961359|FG003|Overall Study|Progression|13|||
129727283|NCT01995669|466961356|FG000|Overall Study|Adverse Event|0|||
129727284|NCT01995669|466961357|FG001|Overall Study|Adverse Event|0|||
129727285|NCT01995669|466961358|FG002|Overall Study|Adverse Event|0|||
129727286|NCT01995669|466961359|FG003|Overall Study|Adverse Event|3|||
129727287|NCT01995669|466961356|FG000|Overall Study|Death|0|||
129727288|NCT01995669|466961357|FG001|Overall Study|Death|0|||
129727289|NCT01995669|466961358|FG002|Overall Study|Death|0|||
129727290|NCT01995669|466961359|FG003|Overall Study|Death|6|||
129727291|NCT01995669|466961356|FG000|Overall Study|Withdrawal by Subject|0|||
129727292|NCT01995669|466961357|FG001|Overall Study|Withdrawal by Subject|0|||
129727293|NCT01995669|466961358|FG002|Overall Study|Withdrawal by Subject|0|||
129727294|NCT01995669|466961359|FG003|Overall Study|Withdrawal by Subject|6|||
129727295|NCT01995669|466961356|FG000|Overall Study|Insurance Expired|0|||
129727296|NCT01995669|466961357|FG001|Overall Study|Insurance Expired|0|||
129891900|NCT03008122|467563105|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
129891901|NCT03008122|467563106|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
129891902|NCT03008122|467563104|FG000|Overall Study|Death|0|||
129891903|NCT03008122|467563105|FG001|Overall Study|Death|0|||
129727297|NCT01995669|466961358|FG002|Overall Study|Insurance Expired|0|||
129891904|NCT03008122|467563106|FG002|Overall Study|Death|1|||
129891905|NCT02338609|467563107|FG000|Overall Study|Physician Decision|1|||
129891906|NCT02338609|467563107|FG000|Overall Study|Death|1|||
129727298|NCT01995669|466961359|FG003|Overall Study|Insurance Expired|1|||
129727299|NCT05425732|466961360|FG000|Overall Study|Death|4|||
129727300|NCT05425732|466961361|FG001|Overall Study|Death|2|||
129727301|NCT05425732|466961362|FG002|Overall Study|Death|0|||
129727302|NCT05425732|466961363|FG003|Overall Study|Death|0|||
129727303|NCT05425732|466961360|FG000|Overall Study|Lost to Follow-up|10|||
129727304|NCT05425732|466961361|FG001|Overall Study|Lost to Follow-up|15|||
129727305|NCT05425732|466961362|FG002|Overall Study|Lost to Follow-up|5|||
129727306|NCT05425732|466961363|FG003|Overall Study|Lost to Follow-up|3|||
129727307|NCT05425732|466961360|FG000|Overall Study|Physician Decision|0|||
129727308|NCT05425732|466961361|FG001|Overall Study|Physician Decision|2|||
129727309|NCT05425732|466961362|FG002|Overall Study|Physician Decision|0|||
129727310|NCT05425732|466961363|FG003|Overall Study|Physician Decision|0|||
129727311|NCT05425732|466961360|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129727312|NCT05425732|466961361|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
129727313|NCT05425732|466961362|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129727314|NCT05425732|466961363|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129727315|NCT05425732|466961360|FG000|Overall Study|Withdrawal by Subject|4|||
129727316|NCT05425732|466961361|FG001|Overall Study|Withdrawal by Subject|8|||
129727317|NCT05425732|466961362|FG002|Overall Study|Withdrawal by Subject|1|||
129727318|NCT05425732|466961363|FG003|Overall Study|Withdrawal by Subject|1|||
129727319|NCT05425732|466961360|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
129727320|NCT05425732|466961361|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
129727321|NCT05425732|466961362|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
129727322|NCT05425732|466961363|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
129727323|NCT02998203|466961364|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
129727324|NCT02998203|466961365|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
129727325|NCT02998203|466961364|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
129727326|NCT02998203|466961365|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
129727327|NCT04187144|466961366|FG000|Overall Study|Lost to Follow-up|12|||
129727328|NCT04187144|466961367|FG001|Overall Study|Lost to Follow-up|11|||
129727329|NCT04187144|466961366|FG000|Overall Study|Withdrawal by Subject|20|||
129727330|NCT04187144|466961367|FG001|Overall Study|Withdrawal by Subject|18|||
129727331|NCT04187144|466961366|FG000|Overall Study|Adverse Event|19|||
129727332|NCT04187144|466961367|FG001|Overall Study|Adverse Event|4|||
129727333|NCT04187144|466961366|FG000|Overall Study|Physician Decision|5|||
129727334|NCT04187144|466961367|FG001|Overall Study|Physician Decision|3|||
129727335|NCT04187144|466961366|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
129727336|NCT04187144|466961367|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
129727337|NCT04187144|466961366|FG000|Overall Study|Protocol Deviation|1|||
129727338|NCT04187144|466961367|FG001|Overall Study|Protocol Deviation|4|||
129727339|NCT02650804|466961368|FG000|Overall Study|Adverse Event|3|||
129727340|NCT02650804|466961369|FG001|Overall Study|Adverse Event|2|||
129727341|NCT02650804|466961368|FG000|Overall Study|Death|1|||
129727342|NCT02650804|466961369|FG001|Overall Study|Death|2|||
129727343|NCT02650804|466961368|FG000|Overall Study|Progressive Disease|7|||
129727344|NCT02650804|466961369|FG001|Overall Study|Progressive Disease|10|||
129727345|NCT02650804|466961368|FG000|Overall Study|Physician Decision|0|||
129727346|NCT02650804|466961369|FG001|Overall Study|Physician Decision|2|||
129727347|NCT02650804|466961368|FG000|Overall Study|Withdrawal by Subject|1|||
129727348|NCT02650804|466961369|FG001|Overall Study|Withdrawal by Subject|4|||
129727349|NCT02650804|466961368|FG000|Overall Study|Symptomatic deterioration|5|||
129727350|NCT02650804|466961369|FG001|Overall Study|Symptomatic deterioration|7|||
129727351|NCT02650804|466961368|FG000|Overall Study|Protocol Violation|0|||
129727352|NCT02650804|466961369|FG001|Overall Study|Protocol Violation|1|||
129727353|NCT02743949|466961370|FG000|Overall Study|Adverse Event|0|||
129727354|NCT02743949|466961371|FG001|Overall Study|Adverse Event|0|||
129727355|NCT02743949|466961372|FG002|Overall Study|Adverse Event|2|||
129727356|NCT02743949|466961370|FG000|Overall Study|Significant Protocol Deviation|2|||
129727357|NCT02743949|466961371|FG001|Overall Study|Significant Protocol Deviation|0|||
129727358|NCT02743949|466961372|FG002|Overall Study|Significant Protocol Deviation|1|||
129727359|NCT02743949|466961370|FG000|Overall Study|Voluntary Withdrawal|2|||
129727360|NCT02743949|466961371|FG001|Overall Study|Voluntary Withdrawal|1|||
129727361|NCT02743949|466961372|FG002|Overall Study|Voluntary Withdrawal|0|||
129727362|NCT03389555|466961373|FG000|Overall Study|Protocol Violation|1|||
129891907|NCT02234310|467563110|FG000|Overall Study|Physician Decision|1|||
129891908|NCT02234310|467563110|FG000|Overall Study|Adverse Event|1|||
129727363|NCT03389555|466961374|FG001|Overall Study|Protocol Violation|3|||
129727364|NCT03389555|466961373|FG000|Overall Study|Death|1|||
129727365|NCT03389555|466961374|FG001|Overall Study|Death|0|||
129727366|NCT00920218|466961375|FG000|Overall Study|Serious Adverse Event|2|||
129727367|NCT00920218|466961376|FG001|Overall Study|Serious Adverse Event|0|||
129727368|NCT00920218|466961377|FG002|Overall Study|Serious Adverse Event|2|||
129727369|NCT00920218|466961378|FG003|Overall Study|Serious Adverse Event|1|||
129727370|NCT00920218|466961375|FG000|Overall Study|Withdrawal by Subject|0|||
129727371|NCT00920218|466961376|FG001|Overall Study|Withdrawal by Subject|3|||
129727372|NCT00920218|466961377|FG002|Overall Study|Withdrawal by Subject|2|||
129727373|NCT00920218|466961378|FG003|Overall Study|Withdrawal by Subject|0|||
129727374|NCT00920218|466961375|FG000|Overall Study|Migrated/moved from study area|0|||
129891909|NCT02234310|467563110|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
129891910|NCT02234310|467563110|FG000|Overall Study|Withdrawal by Subject|2|||
129891911|NCT02322775|467563114|FG000|Overall Study|Adverse Event|1|||
129891912|NCT02322775|467563115|FG001|Overall Study|Adverse Event|0|||
129727375|NCT00920218|466961376|FG001|Overall Study|Migrated/moved from study area|0|||
129727376|NCT00920218|466961377|FG002|Overall Study|Migrated/moved from study area|1|||
129727377|NCT00920218|466961378|FG003|Overall Study|Migrated/moved from study area|0|||
129727378|NCT00920218|466961375|FG000|Overall Study|Lost to Follow-up|0|||
129727379|NCT00920218|466961376|FG001|Overall Study|Lost to Follow-up|1|||
129727380|NCT00920218|466961377|FG002|Overall Study|Lost to Follow-up|0|||
129727381|NCT00920218|466961378|FG003|Overall Study|Lost to Follow-up|3|||
129727382|NCT00920218|466961375|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
129727383|NCT00920218|466961376|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
129727384|NCT00920218|466961377|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
129727385|NCT00920218|466961378|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
129727386|NCT00920218|466961375|FG000|Overall Study|Other|0|||
129727387|NCT00920218|466961376|FG001|Overall Study|Other|0|||
129727388|NCT00920218|466961377|FG002|Overall Study|Other|1|||
129727389|NCT00920218|466961378|FG003|Overall Study|Other|0|||
129727390|NCT01007435|466961379|FG000|Overall Study|Adverse Event|16|||
129727391|NCT01007435|466961380|FG001|Overall Study|Adverse Event|25|||
129727392|NCT01007435|466961381|FG002|Overall Study|Adverse Event|47|||
129727393|NCT01007435|466961382|FG003|Overall Study|Adverse Event|31|||
129727394|NCT01007435|466961379|FG000|Overall Study|Death|2|||
129727395|NCT01007435|466961380|FG001|Overall Study|Death|4|||
129727396|NCT01007435|466961381|FG002|Overall Study|Death|2|||
129727397|NCT01007435|466961382|FG003|Overall Study|Death|1|||
129727398|NCT01007435|466961379|FG000|Overall Study|Insufficient Therapeutic Response|21|||
129727399|NCT01007435|466961380|FG001|Overall Study|Insufficient Therapeutic Response|7|||
129727400|NCT01007435|466961381|FG002|Overall Study|Insufficient Therapeutic Response|2|||
129727401|NCT01007435|466961382|FG003|Overall Study|Insufficient Therapeutic Response|9|||
129727402|NCT01007435|466961379|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
129727403|NCT01007435|466961380|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
129727404|NCT01007435|466961381|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
129727405|NCT01007435|466961382|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
129727406|NCT01007435|466961379|FG000|Overall Study|Other Protocol Violation|2|||
129727407|NCT01007435|466961380|FG001|Overall Study|Other Protocol Violation|0|||
129727408|NCT01007435|466961381|FG002|Overall Study|Other Protocol Violation|1|||
129727409|NCT01007435|466961382|FG003|Overall Study|Other Protocol Violation|0|||
129727410|NCT01007435|466961379|FG000|Overall Study|Refused Treatment|13|||
129727411|NCT01007435|466961380|FG001|Overall Study|Refused Treatment|13|||
129727412|NCT01007435|466961381|FG002|Overall Study|Refused Treatment|5|||
129727413|NCT01007435|466961382|FG003|Overall Study|Refused Treatment|8|||
129727414|NCT01007435|466961379|FG000|Overall Study|Failure to Return|5|||
129727415|NCT01007435|466961380|FG001|Overall Study|Failure to Return|4|||
129727416|NCT01007435|466961381|FG002|Overall Study|Failure to Return|3|||
129727417|NCT01007435|466961382|FG003|Overall Study|Failure to Return|6|||
129727418|NCT01007435|466961379|FG000|Overall Study|Reason not Specified|1|||
129727419|NCT01007435|466961380|FG001|Overall Study|Reason not Specified|1|||
129727420|NCT01007435|466961381|FG002|Overall Study|Reason not Specified|2|||
129727421|NCT01007435|466961382|FG003|Overall Study|Reason not Specified|1|||
129727422|NCT01345591|466961385|FG000|Overall Study|Lost to Follow-up|1|||
129727423|NCT00847665|466961392|FG000|Overall Study|Withdrawal by Subject|1|||
129727424|NCT00847665|466961393|FG001|Overall Study|Withdrawal by Subject|0|||
129727425|NCT03077438|466961394|FG000|Overall Study|Protocol Violation|3|||
129727426|NCT03077438|466961395|FG001|Overall Study|Protocol Violation|5|||
129727427|NCT03077438|466961394|FG000|Overall Study|Withdrawal by Subject|3|||
129727428|NCT03077438|466961395|FG001|Overall Study|Withdrawal by Subject|6|||
129727429|NCT03077438|466961394|FG000|Overall Study|Lost to Follow-up|6|||
129727430|NCT03077438|466961395|FG001|Overall Study|Lost to Follow-up|3|||
129727431|NCT00624585|466961396|FG000|Overall Study|Death|3|||
129727432|NCT00624585|466961396|FG000|Overall Study|Disease Progression|6|||
129891913|NCT02322775|467563114|FG000|Overall Study|Lost to Follow-up|0|||
129891914|NCT02322775|467563115|FG001|Overall Study|Lost to Follow-up|1|||
129727433|NCT00624585|466961396|FG000|Overall Study|Adverse Event|3|||
129727434|NCT01190475|466961397|FG000|Overall Study|Withdrawal by Subject|0|||
129727435|NCT01190475|466961398|FG001|Overall Study|Withdrawal by Subject|0|||
129727436|NCT01190475|466961399|FG002|Overall Study|Withdrawal by Subject|1|||
129727437|NCT00676520|466961403|FG000|Overall Study|Withdrawal by Subject|163|||
129727438|NCT00676520|466961403|FG000|Overall Study|Lost to Follow-up|162|||
129727439|NCT00676520|466961403|FG000|Overall Study|Death|159|||
129727440|NCT00676520|466961403|FG000|Overall Study|Physician Decision|20|||
129727441|NCT00676520|466961403|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
129727442|NCT00676520|466961403|FG000|Overall Study|Other Reason|18|||
129727443|NCT01425359|466961404|FG000|Overall Study|Randomized but Not Treated|2|||
129891915|NCT02322775|467563114|FG000|Overall Study|Protocol Violation|1|||
129891916|NCT02322775|467563115|FG001|Overall Study|Protocol Violation|0|||
129891917|NCT02322775|467563114|FG000|Overall Study|Withdrawal by Subject|3|||
129891918|NCT02322775|467563115|FG001|Overall Study|Withdrawal by Subject|4|||
129891919|NCT02322775|467563114|FG000|Overall Study|Not willing to perform all FU visits|0|||
129891920|NCT02322775|467563115|FG001|Overall Study|Not willing to perform all FU visits|1|||
129891921|NCT04482855|467563116|FG000|Overall Study|Lost to Follow-up|1|||
129891922|NCT04482855|467563117|FG001|Overall Study|Lost to Follow-up|0|||
129891923|NCT04482855|467563116|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
129891924|NCT04482855|467563117|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
129891925|NCT04482855|467563116|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
129891926|NCT04482855|467563117|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
129891927|NCT03212365|467563123|FG000|Overall Study|Discharged prior to Xa level|12|||
129891928|NCT03212365|467563124|FG001|Overall Study|Discharged prior to Xa level|8|||
129891929|NCT03212365|467563123|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
129727444|NCT01425359|466961405|FG001|Overall Study|Randomized but Not Treated|3|||
129727445|NCT01425359|466961404|FG000|Overall Study|Adverse Event|9|||
129727446|NCT01425359|466961405|FG001|Overall Study|Adverse Event|8|||
129727447|NCT01425359|466961404|FG000|Overall Study|Revascularization|0|||
129727448|NCT01425359|466961405|FG001|Overall Study|Revascularization|1|||
129727449|NCT01425359|466961404|FG000|Overall Study|Death|0|||
129727450|NCT01425359|466961405|FG001|Overall Study|Death|1|||
129727451|NCT01425359|466961404|FG000|Overall Study|Unsatisfactory Response|1|||
129727452|NCT01425359|466961405|FG001|Overall Study|Unsatisfactory Response|0|||
129727453|NCT01425359|466961404|FG000|Overall Study|Protocol Violation|1|||
129727454|NCT01425359|466961405|FG001|Overall Study|Protocol Violation|2|||
129727455|NCT01425359|466961404|FG000|Overall Study|Subject Withdrew Consent|1|||
129727456|NCT01425359|466961405|FG001|Overall Study|Subject Withdrew Consent|2|||
129727457|NCT01425359|466961404|FG000|Overall Study|Investigator's Discretion|2|||
129727458|NCT01425359|466961405|FG001|Overall Study|Investigator's Discretion|0|||
129727459|NCT01425359|466961404|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
129727460|NCT01425359|466961405|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
129727461|NCT03172325|466961416|FG000|Overall Study|Adverse Event|2|||
129727462|NCT03172325|466961417|FG001|Overall Study|Adverse Event|3|||
129727463|NCT03172325|466961416|FG000|Overall Study|Positive PPD|1|||
129727464|NCT03172325|466961417|FG001|Overall Study|Positive PPD|0|||
129727465|NCT03172325|466961416|FG000|Overall Study|Poor Compliance|1|||
129727466|NCT03172325|466961417|FG001|Overall Study|Poor Compliance|1|||
129727467|NCT03305419|466961423|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727468|NCT03305419|466961424|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
129727469|NCT03305419|466961425|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727470|NCT03305419|466961426|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727471|NCT03305419|466961427|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727472|NCT03305419|466961428|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727473|NCT03305419|466961429|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727474|NCT03305419|466961430|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
129727475|NCT03305419|466961423|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
129727476|NCT03305419|466961424|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727477|NCT03305419|466961425|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727478|NCT03305419|466961426|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727479|NCT03305419|466961427|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727480|NCT03305419|466961428|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727481|NCT03305419|466961429|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727482|NCT03305419|466961430|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
129727483|NCT03305419|466961423|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
129727484|NCT03305419|466961424|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727485|NCT03305419|466961425|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727486|NCT03305419|466961426|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727487|NCT03305419|466961427|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727488|NCT03305419|466961428|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727489|NCT03305419|466961429|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727490|NCT03305419|466961430|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
129727491|NCT03305419|466961423|FG000|Part B (14 Days)|Adverse Event|0|||
129727492|NCT03305419|466961424|FG001|Part B (14 Days)|Adverse Event|0|||
129727493|NCT03305419|466961425|FG002|Part B (14 Days)|Adverse Event|0|||
129727494|NCT03305419|466961426|FG003|Part B (14 Days)|Adverse Event|0|||
129727495|NCT03305419|466961427|FG004|Part B (14 Days)|Adverse Event|1|||
129727496|NCT03305419|466961428|FG005|Part B (14 Days)|Adverse Event|2|||
129727497|NCT03305419|466961429|FG006|Part B (14 Days)|Adverse Event|4|||
129727498|NCT03305419|466961430|FG007|Part B (14 Days)|Adverse Event|0|||
129727499|NCT03305419|466961423|FG000|Part B (14 Days)|Physician Decision|0|||
129727500|NCT03305419|466961424|FG001|Part B (14 Days)|Physician Decision|0|||
129727501|NCT03305419|466961425|FG002|Part B (14 Days)|Physician Decision|0|||
129727502|NCT03305419|466961426|FG003|Part B (14 Days)|Physician Decision|0|||
129727503|NCT03305419|466961427|FG004|Part B (14 Days)|Physician Decision|2|||
129727504|NCT03305419|466961428|FG005|Part B (14 Days)|Physician Decision|8|||
129727505|NCT03305419|466961429|FG006|Part B (14 Days)|Physician Decision|1|||
129727506|NCT03305419|466961430|FG007|Part B (14 Days)|Physician Decision|0|||
129727507|NCT00889603|466961432|FG000|Overall Study|Adverse Event|7|||
129727508|NCT00889603|466961432|FG000|Overall Study|Death|3|||
129727509|NCT00889603|466961432|FG000|Overall Study|Lost to Follow-up|19|||
129727510|NCT00889603|466961432|FG000|Overall Study|No longer willing to participant in stud|4|||
129727511|NCT00889603|466961432|FG000|Overall Study|Other|4|||
129727512|NCT01895543|466961433|FG000|Overall Study|Withdrawal by Subject|43|||
129727513|NCT01895543|466961433|FG000|Overall Study|Lost to Follow-up|25|||
129727514|NCT01895543|466961433|FG000|Overall Study|Adverse Event|28|||
129727515|NCT01895543|466961433|FG000|Overall Study|Subject's substantial non-compliance|6|||
129727516|NCT01895543|466961433|FG000|Overall Study|Protocol Violation|1|||
129727517|NCT01895543|466961433|FG000|Overall Study|Physician Decision|2|||
129727518|NCT01895543|466961433|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
129727519|NCT04659174|466961438|FG000|Overall Study|Sponsor decision to discontinue study|0|||
129727520|NCT04659174|466961439|FG001|Overall Study|Sponsor decision to discontinue study|2|||
129727521|NCT04659174|466961438|FG000|Overall Study|Lost to Follow-up|9|||
129727522|NCT04659174|466961439|FG001|Overall Study|Lost to Follow-up|11|||
129727523|NCT04659174|466961438|FG000|Overall Study|Adverse Event|8|||
129727524|NCT04659174|466961439|FG001|Overall Study|Adverse Event|5|||
129727525|NCT04659174|466961438|FG000|Overall Study|Withdrawal by Subject|17|||
129727526|NCT04659174|466961439|FG001|Overall Study|Withdrawal by Subject|33|||
129727527|NCT04659174|466961438|FG000|Overall Study|Progressive disease|0|||
129727528|NCT04659174|466961439|FG001|Overall Study|Progressive disease|2|||
129727529|NCT04659174|466961438|FG000|Overall Study|Other reasons|0|||
129727530|NCT04659174|466961439|FG001|Overall Study|Other reasons|2|||
129727531|NCT04659174|466961438|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
129727532|NCT04659174|466961439|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
129727533|NCT04659174|466961438|FG000|Overall Study|Alcohol or illegal drug use|0|||
129727534|NCT04659174|466961439|FG001|Overall Study|Alcohol or illegal drug use|3|||
129727535|NCT04659174|466961438|FG000|Overall Study|Violation of entry criteria|1|||
129727536|NCT04659174|466961439|FG001|Overall Study|Violation of entry criteria|0|||
129727537|NCT04659174|466961438|FG000|Overall Study|Death|0|||
129727538|NCT04659174|466961439|FG001|Overall Study|Death|1|||
129727539|NCT05129449|466961440|FG000|Overall Study|Protocol Violation|1|||
129727540|NCT03650803|466961442|FG000|Overall Study|Lost to Follow-up|6|||
129727541|NCT02901054|466961443|FG000|Overall Study|Physician Decision|1|||
129727542|NCT02901054|466961443|FG000|Overall Study|Withdrawal by Subject|3|||
129727543|NCT01534260|466961444|FG000|Overall Study|Adverse Event|1|||
129727544|NCT01534260|466961445|FG001|Overall Study|Adverse Event|8|||
129727545|NCT01534260|466961444|FG000|Overall Study|Death|2|||
129727546|NCT01534260|466961445|FG001|Overall Study|Death|0|||
129727547|NCT01534260|466961444|FG000|Overall Study|Lack of Efficacy|1|||
129727548|NCT01534260|466961445|FG001|Overall Study|Lack of Efficacy|1|||
129727549|NCT01534260|466961444|FG000|Overall Study|Withdrawal by Subject|1|||
129727550|NCT01534260|466961445|FG001|Overall Study|Withdrawal by Subject|3|||
129727551|NCT01534260|466961444|FG000|Overall Study|Disease Progression|8|||
129727552|NCT01534260|466961445|FG001|Overall Study|Disease Progression|6|||
129727553|NCT01534260|466961444|FG000|Overall Study|Physician Decision|3|||
129727554|NCT01534260|466961445|FG001|Overall Study|Physician Decision|1|||
129727555|NCT01534260|466961444|FG000|Overall Study|No treatment, per protocol|0|||
129727556|NCT01534260|466961445|FG001|Overall Study|No treatment, per protocol|1|||
129727557|NCT01818258|466961448|FG000|Overall Study|Death|3|||
129727558|NCT01818258|466961449|FG001|Overall Study|Death|0|||
129727559|NCT01818258|466961448|FG000|Overall Study|Withdrawal by Subject|0|||
129727560|NCT01818258|466961449|FG001|Overall Study|Withdrawal by Subject|1|||
129727561|NCT01818258|466961448|FG000|Overall Study|Lost to Follow-up|0|||
129727562|NCT01818258|466961449|FG001|Overall Study|Lost to Follow-up|1|||
129727563|NCT01818258|466961448|FG000|Overall Study|Unable to Travel to Clinic|0|||
129727564|NCT01818258|466961449|FG001|Overall Study|Unable to Travel to Clinic|1|||
129727565|NCT01639339|466961454|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
129727566|NCT01639339|466961455|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
129727567|NCT01639339|466961454|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
129727568|NCT01639339|466961455|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
129727569|NCT01639339|466961454|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
129727570|NCT01639339|466961455|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
129727571|NCT01639339|466961454|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
129727572|NCT01639339|466961455|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
129727573|NCT01639339|466961454|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
129727574|NCT01639339|466961455|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
129727575|NCT01639339|466961454|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
129727576|NCT01639339|466961455|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
129727577|NCT01639339|466961454|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
129727578|NCT01639339|466961455|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
129727579|NCT01639339|466961454|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
129727580|NCT01639339|466961455|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
129727581|NCT01639339|466961454|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
129727582|NCT01639339|466961455|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
129727583|NCT01639339|466961454|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
129727584|NCT01639339|466961455|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
129727585|NCT05145322|466961459|FG000|Overall Study|Lost to Follow-up|4|||
129727586|NCT05145322|466961460|FG001|Overall Study|Lost to Follow-up|5|||
129727587|NCT03022097|466961461|FG000|Overall Study|Adverse Event|3|||
129727588|NCT03022097|466961462|FG001|Overall Study|Adverse Event|4|||
129727589|NCT03022097|466961463|FG002|Overall Study|Adverse Event|1|||
129727590|NCT03022097|466961464|FG003|Overall Study|Adverse Event|3|||
129727591|NCT03022097|466961461|FG000|Overall Study|Progressive Disease|2|||
129727592|NCT03022097|466961462|FG001|Overall Study|Progressive Disease|0|||
129727593|NCT03022097|466961463|FG002|Overall Study|Progressive Disease|5|||
129727594|NCT03022097|466961464|FG003|Overall Study|Progressive Disease|2|||
129727595|NCT03022097|466961461|FG000|Overall Study|Lack of Efficacy|0|||
129727596|NCT03022097|466961462|FG001|Overall Study|Lack of Efficacy|0|||
129727597|NCT03022097|466961463|FG002|Overall Study|Lack of Efficacy|3|||
129727598|NCT03022097|466961464|FG003|Overall Study|Lack of Efficacy|3|||
129727599|NCT03022097|466961461|FG000|Overall Study|Protocol Violation|1|||
129727600|NCT03022097|466961462|FG001|Overall Study|Protocol Violation|0|||
129727601|NCT03022097|466961463|FG002|Overall Study|Protocol Violation|1|||
129727602|NCT03022097|466961464|FG003|Overall Study|Protocol Violation|0|||
129727603|NCT03022097|466961461|FG000|Overall Study|Withdrawal by Subject|11|||
129727604|NCT03022097|466961462|FG001|Overall Study|Withdrawal by Subject|13|||
129727605|NCT03022097|466961463|FG002|Overall Study|Withdrawal by Subject|15|||
129727606|NCT03022097|466961464|FG003|Overall Study|Withdrawal by Subject|21|||
129727607|NCT03022097|466961461|FG000|Overall Study|Lost to Follow-up|0|||
129727608|NCT03022097|466961462|FG001|Overall Study|Lost to Follow-up|0|||
129727609|NCT03022097|466961463|FG002|Overall Study|Lost to Follow-up|1|||
129727610|NCT03022097|466961464|FG003|Overall Study|Lost to Follow-up|1|||
129727611|NCT03022097|466961461|FG000|Overall Study|Other|4|||
129727612|NCT03022097|466961462|FG001|Overall Study|Other|1|||
129727613|NCT03022097|466961463|FG002|Overall Study|Other|6|||
129727614|NCT03022097|466961464|FG003|Overall Study|Other|4|||
129727615|NCT03022097|466961461|FG000|Overall Study|Due to COVID-19 pandemic|0|||
129727616|NCT03022097|466961462|FG001|Overall Study|Due to COVID-19 pandemic|1|||
129727617|NCT03022097|466961463|FG002|Overall Study|Due to COVID-19 pandemic|0|||
129727618|NCT03022097|466961464|FG003|Overall Study|Due to COVID-19 pandemic|0|||
129727619|NCT01349322|466961467|FG000|Overall Study|Protocol Violation|45|||
129444445|NCT01822522|465927345|FG002|Overall Study|Death|2|||
129727620|NCT01349322|466961468|FG001|Overall Study|Protocol Violation|47|||
129727621|NCT05593913|466961473|FG000|Overall Study|Insufficient image quality|39|||
129727622|NCT04470908|466961474|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
129727623|NCT04376684|466961475|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
129727624|NCT04376684|466961476|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
129727625|NCT04376684|466961477|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
129727626|NCT04376684|466961478|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
129727627|NCT04376684|466961475|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
129727628|NCT04376684|466961476|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
129727629|NCT04376684|466961477|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
129727630|NCT04376684|466961478|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
129727631|NCT04376684|466961475|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
129727632|NCT04376684|466961476|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
129727633|NCT04376684|466961477|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
129727634|NCT04376684|466961478|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
129727635|NCT04376684|466961475|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
129727636|NCT04376684|466961476|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
129727637|NCT04376684|466961477|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
129727638|NCT04376684|466961478|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
129727639|NCT04376684|466961475|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
129727640|NCT04376684|466961476|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
129727641|NCT04376684|466961477|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
129727642|NCT04376684|466961478|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
129727643|NCT04376684|466961475|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
129727644|NCT04376684|466961476|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
129727645|NCT04376684|466961477|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
129727646|NCT04376684|466961478|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
129727647|NCT04376684|466961475|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
129727648|NCT04376684|466961476|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
129727649|NCT04376684|466961477|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
129727650|NCT04376684|466961478|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
129727651|NCT02136680|466961485|FG000|Overall Study|No Longer Interested|1|||
129727652|NCT02136680|466961486|FG001|Overall Study|No Longer Interested|1|||
129727653|NCT02136680|466961485|FG000|Overall Study|No longer receiving care at clinic|3|||
129727654|NCT02136680|466961486|FG001|Overall Study|No longer receiving care at clinic|5|||
129727655|NCT02136680|466961485|FG000|Overall Study|Moved away|5|||
129727656|NCT02136680|466961486|FG001|Overall Study|Moved away|4|||
129727657|NCT02136680|466961485|FG000|Overall Study|Unable to schedule|17|||
129727658|NCT02136680|466961486|FG001|Overall Study|Unable to schedule|16|||
129727659|NCT02136680|466961485|FG000|Overall Study|Study ended before interview due|6|||
129727660|NCT02136680|466961486|FG001|Overall Study|Study ended before interview due|3|||
129727661|NCT05151445|466961487|FG000|Overall Study|Withdrawal by Subject|3|||
129727662|NCT01457014|466961488|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
129727663|NCT01457014|466961489|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
129727664|NCT01457014|466961490|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
129727665|NCT01457014|466961491|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
129727666|NCT01457014|466961488|FG000|First Night|Withdrawal by Subject|3|||
129727667|NCT01457014|466961489|FG001|First Night|Withdrawal by Subject|0|||
129727668|NCT01457014|466961490|FG002|First Night|Withdrawal by Subject|0|||
129727669|NCT01457014|466961491|FG003|First Night|Withdrawal by Subject|0|||
129727670|NCT05463744|466961492|FG000|Treatment Period|Withdrawal by Subject|19|||
129727671|NCT05463744|466961493|FG001|Treatment Period|Withdrawal by Subject|16|||
129727672|NCT05463744|466961492|FG000|Treatment Period|Adverse Event|4|||
129727673|NCT05463744|466961493|FG001|Treatment Period|Adverse Event|4|||
129727674|NCT05463744|466961492|FG000|Treatment Period|Pregnancy|0|||
129727675|NCT05463744|466961493|FG001|Treatment Period|Pregnancy|3|||
129727676|NCT05463744|466961492|FG000|Treatment Period|Lost to Follow-up|1|||
129727677|NCT05463744|466961493|FG001|Treatment Period|Lost to Follow-up|3|||
129727678|NCT05463744|466961492|FG000|Treatment Period|Inadvertent enrollment|2|||
129727679|NCT05463744|466961493|FG001|Treatment Period|Inadvertent enrollment|1|||
129727680|NCT05463744|466961492|FG000|Treatment Period|Death|0|||
129727681|NCT05463744|466961493|FG001|Treatment Period|Death|1|||
129727682|NCT05463744|466961492|FG000|Treatment Period|Non-compliance with Study Drug|1|||
129727683|NCT05463744|466961493|FG001|Treatment Period|Non-compliance with Study Drug|0|||
129727684|NCT05463744|466961492|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
129727685|NCT05463744|466961493|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
129727686|NCT05463744|466961492|FG000|Treatment Period|Physician Decision|0|||
129727687|NCT05463744|466961493|FG001|Treatment Period|Physician Decision|1|||
129727688|NCT05463744|466961492|FG000|Follow-Up Period|Withdrawal by Subject|3|||
129804220|NCT00371826|467251449|FG001|Extension Phase (24 Months)|Administrative problems|0|||
129804221|NCT00371826|467251450|FG002|Extension Phase (24 Months)|Administrative problems|2|||
129804222|NCT00385762|467251451|FG000|Overall Study|Adverse Event|1|||
129804223|NCT00385762|467251451|FG000|Overall Study|Lost to Follow-up|1|||
129727689|NCT05463744|466961493|FG001|Follow-Up Period|Withdrawal by Subject|1|||
129804224|NCT00231842|467251452|FG000|Overall Study|Withdrawal by Subject|3|||
129727690|NCT05463744|466961492|FG000|Follow-Up Period|Lost to Follow-up|1|||
129727691|NCT05463744|466961493|FG001|Follow-Up Period|Lost to Follow-up|1|||
129727692|NCT01330628|466961495|FG000|Overall Study|Death|2|||
129727693|NCT01330628|466961496|FG001|Overall Study|Death|3|||
129727694|NCT01330628|466961495|FG000|Overall Study|Lost to Follow-up|5|||
129727695|NCT01330628|466961496|FG001|Overall Study|Lost to Follow-up|6|||
129727696|NCT01330628|466961495|FG000|Overall Study|Adverse Event|44|||
129727697|NCT01330628|466961496|FG001|Overall Study|Adverse Event|25|||
129727698|NCT01330628|466961495|FG000|Overall Study|Withdrawn|18|||
129727699|NCT01330628|466961496|FG001|Overall Study|Withdrawn|6|||
129727700|NCT01330628|466961495|FG000|Overall Study|Didn't receive study treatment|1|||
129727701|NCT01330628|466961496|FG001|Overall Study|Didn't receive study treatment|0|||
129727702|NCT01357161|466961497|FG000|Part 1 (Open Label Run-in)|Death|5|||
129727703|NCT01357161|466961498|FG001|Part 1 (Open Label Run-in)|Death|0|||
129727704|NCT01357161|466961499|FG002|Part 1 (Open Label Run-in)|Death|0|||
129727705|NCT01357161|466961497|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
129727706|NCT01357161|466961498|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
129727707|NCT01357161|466961499|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
129727708|NCT01357161|466961497|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
129727709|NCT01357161|466961498|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
129727710|NCT01357161|466961499|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
129727711|NCT01357161|466961497|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
129727712|NCT01357161|466961498|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
129727713|NCT01357161|466961499|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
129727714|NCT01357161|466961497|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
129727715|NCT01357161|466961498|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
129727716|NCT01357161|466961499|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
129727717|NCT01357161|466961497|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
129727718|NCT01357161|466961498|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
129727719|NCT01357161|466961499|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
129727720|NCT01357161|466961497|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
129727721|NCT01357161|466961498|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
129727722|NCT01357161|466961499|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
129727723|NCT01357161|466961497|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
129727724|NCT01357161|466961498|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
129727725|NCT01357161|466961499|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
129727726|NCT01357161|466961497|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
129727727|NCT01357161|466961498|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
129727728|NCT01357161|466961499|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
129727729|NCT01357161|466961497|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
129727730|NCT01357161|466961498|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
129727731|NCT01357161|466961499|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
129727732|NCT01357161|466961497|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
129727733|NCT01357161|466961498|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
129727734|NCT01357161|466961499|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
129727735|NCT02825420|466961501|FG000|Overall Study|Death|30|||
129727736|NCT02825420|466961502|FG001|Overall Study|Death|12|||
129727737|NCT02825420|466961501|FG000|Overall Study|Progressive disease|6|||
129727738|NCT02825420|466961502|FG001|Overall Study|Progressive disease|1|||
129727739|NCT02825420|466961501|FG000|Overall Study|Lost to Follow-up|2|||
129727740|NCT02825420|466961502|FG001|Overall Study|Lost to Follow-up|2|||
129727741|NCT02825420|466961501|FG000|Overall Study|Withdrawal by Subject|1|||
129727742|NCT02825420|466961502|FG001|Overall Study|Withdrawal by Subject|1|||
129727743|NCT02825420|466961501|FG000|Overall Study|Protocol amendment not signed|1|||
129727744|NCT02825420|466961502|FG001|Overall Study|Protocol amendment not signed|1|||
129727745|NCT02825420|466961501|FG000|Overall Study|Physician Decision|1|||
129727746|NCT02825420|466961502|FG001|Overall Study|Physician Decision|0|||
129727747|NCT02825420|466961501|FG000|Overall Study|Did not receive PLD|2|||
129727748|NCT02825420|466961502|FG001|Overall Study|Did not receive PLD|0|||
129727749|NCT04027049|466961503|FG000|Overall Study|Withdrawn by family|1|||
129727750|NCT04027049|466961504|FG001|Overall Study|Withdrawn by family|0|||
129727751|NCT04027049|466961503|FG000|Overall Study|Participant safety|1|||
129727752|NCT04027049|466961504|FG001|Overall Study|Participant safety|0|||
129727753|NCT02264665|466963212|FG000|Overall Study|Other|0|||
129727754|NCT02264665|466963213|FG001|Overall Study|Other|0|||
129727755|NCT02264665|466963214|FG002|Overall Study|Other|3|||
129727756|NCT02264665|466963215|FG003|Overall Study|Other|0|||
129727757|NCT02264665|466963216|FG004|Overall Study|Other|0|||
129727758|NCT02264665|466963217|FG005|Overall Study|Other|0|||
129727759|NCT02264665|466963218|FG006|Overall Study|Other|0|||
129727760|NCT02264665|466963212|FG000|Overall Study|Death|9|||
129727761|NCT02264665|466963213|FG001|Overall Study|Death|8|||
129727762|NCT02264665|466963214|FG002|Overall Study|Death|13|||
129727763|NCT02264665|466963215|FG003|Overall Study|Death|5|||
129727764|NCT02264665|466963216|FG004|Overall Study|Death|0|||
129727765|NCT02264665|466963217|FG005|Overall Study|Death|0|||
129727766|NCT02264665|466963218|FG006|Overall Study|Death|1|||
129727767|NCT02264665|466963212|FG000|Overall Study|Lost to Follow-up|1|||
129727768|NCT02264665|466963213|FG001|Overall Study|Lost to Follow-up|0|||
129727769|NCT02264665|466963214|FG002|Overall Study|Lost to Follow-up|2|||
129727770|NCT02264665|466963215|FG003|Overall Study|Lost to Follow-up|1|||
129727771|NCT02264665|466963216|FG004|Overall Study|Lost to Follow-up|0|||
129727772|NCT02264665|466963217|FG005|Overall Study|Lost to Follow-up|0|||
129727773|NCT02264665|466963218|FG006|Overall Study|Lost to Follow-up|0|||
129727774|NCT02264665|466963212|FG000|Overall Study|Participant decision|0|||
129727775|NCT02264665|466963213|FG001|Overall Study|Participant decision|0|||
129727776|NCT02264665|466963214|FG002|Overall Study|Participant decision|0|||
129727777|NCT02264665|466963215|FG003|Overall Study|Participant decision|1|||
129727778|NCT02264665|466963216|FG004|Overall Study|Participant decision|0|||
129727779|NCT02264665|466963217|FG005|Overall Study|Participant decision|0|||
129727780|NCT02264665|466963218|FG006|Overall Study|Participant decision|0|||
129727781|NCT02264665|466963212|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
129727782|NCT02264665|466963213|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
129727783|NCT02264665|466963214|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
129727784|NCT02264665|466963215|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
129727785|NCT02264665|466963216|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
129727786|NCT02264665|466963217|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
129727787|NCT02264665|466963218|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
129727788|NCT02264665|466963212|FG000|Overall Study|Data Missing|0|||
129727789|NCT02264665|466963213|FG001|Overall Study|Data Missing|0|||
129727790|NCT02264665|466963214|FG002|Overall Study|Data Missing|1|||
129727791|NCT02264665|466963215|FG003|Overall Study|Data Missing|0|||
129727792|NCT02264665|466963216|FG004|Overall Study|Data Missing|0|||
129727793|NCT02264665|466963217|FG005|Overall Study|Data Missing|0|||
129727794|NCT02264665|466963218|FG006|Overall Study|Data Missing|0|||
129727795|NCT00789581|466963224|FG000|AC Therapy|Adverse Event|2|||
129727796|NCT00789581|466963225|FG001|AC Therapy|Adverse Event|3|||
129727797|NCT00789581|466963224|FG000|AC Therapy|Withdrawal by Subject|4|||
129727798|NCT00789581|466963225|FG001|AC Therapy|Withdrawal by Subject|7|||
129727799|NCT00789581|466963224|FG000|AC Therapy|Disease recurrence|3|||
129727800|NCT00789581|466963225|FG001|AC Therapy|Disease recurrence|1|||
129727801|NCT00789581|466963224|FG000|AC Therapy|Intercurrent Illness|1|||
129727802|NCT00789581|466963225|FG001|AC Therapy|Intercurrent Illness|0|||
129727803|NCT00789581|466963224|FG000|AC Therapy|Never Treated|1|||
129727804|NCT00789581|466963225|FG001|AC Therapy|Never Treated|4|||
129727805|NCT00789581|466963224|FG000|AC Therapy|Other|0|||
129727806|NCT00789581|466963225|FG001|AC Therapy|Other|2|||
129727807|NCT00789581|466963224|FG000|Adjuvant Therapy|Never treated|2|||
129727808|NCT00789581|466963225|FG001|Adjuvant Therapy|Never treated|2|||
129727809|NCT00789581|466963224|FG000|Adjuvant Therapy|Adverse Event|20|||
129727810|NCT00789581|466963225|FG001|Adjuvant Therapy|Adverse Event|44|||
129727811|NCT00789581|466963224|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
129727812|NCT00789581|466963225|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
129727813|NCT00789581|466963224|FG000|Adjuvant Therapy|Disease recurrence|2|||
129727814|NCT00789581|466963225|FG001|Adjuvant Therapy|Disease recurrence|1|||
129727815|NCT00789581|466963224|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
129727816|NCT00789581|466963225|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
129727817|NCT00789581|466963224|FG000|Adjuvant Therapy|Protocol Violation|1|||
129727818|NCT00789581|466963225|FG001|Adjuvant Therapy|Protocol Violation|1|||
129727819|NCT00789581|466963224|FG000|Adjuvant Therapy|Other|0|||
129727820|NCT00789581|466963225|FG001|Adjuvant Therapy|Other|1|||
129727821|NCT01468207|466963226|FG000|Treatment Period 1|Adverse Event|1|||
129727822|NCT01468207|466963227|FG001|Treatment Period 1|Adverse Event|0|||
129727823|NCT01468207|466963228|FG002|Treatment Period 1|Adverse Event|0|||
129727824|NCT01468207|466963229|FG003|Treatment Period 1|Adverse Event|0|||
129727825|NCT01468207|466963230|FG004|Treatment Period 1|Adverse Event|0|||
129727826|NCT01468207|466963231|FG005|Treatment Period 1|Adverse Event|0|||
129727827|NCT01468207|466963226|FG000|Treatment Period 1|Protocol Violation|1|||
129727828|NCT01468207|466963227|FG001|Treatment Period 1|Protocol Violation|1|||
129727829|NCT01468207|466963228|FG002|Treatment Period 1|Protocol Violation|0|||
129727830|NCT01468207|466963229|FG003|Treatment Period 1|Protocol Violation|0|||
129727831|NCT01468207|466963230|FG004|Treatment Period 1|Protocol Violation|0|||
129727832|NCT01468207|466963231|FG005|Treatment Period 1|Protocol Violation|0|||
129727833|NCT01468207|466963226|FG000|Treatment Period 1|Withdrawal by Subject|5|||
129727834|NCT01468207|466963227|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129891930|NCT03212365|467563124|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
129891931|NCT03212365|467563123|FG000|Overall Study|Refused study medication|3|||
129891932|NCT03212365|467563124|FG001|Overall Study|Refused study medication|0|||
129891933|NCT03212365|467563123|FG000|Overall Study|Initiated heparin infusion on floor|1|||
129727835|NCT01468207|466963228|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129727836|NCT01468207|466963229|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129727837|NCT01468207|466963230|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129727838|NCT01468207|466963231|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129727839|NCT01468207|466963226|FG000|Treatment Period 1|Lost to Follow-up|2|||
129727840|NCT01468207|466963227|FG001|Treatment Period 1|Lost to Follow-up|1|||
129727841|NCT01468207|466963228|FG002|Treatment Period 1|Lost to Follow-up|0|||
129727842|NCT01468207|466963229|FG003|Treatment Period 1|Lost to Follow-up|0|||
129727843|NCT01468207|466963230|FG004|Treatment Period 1|Lost to Follow-up|0|||
129727844|NCT01468207|466963231|FG005|Treatment Period 1|Lost to Follow-up|0|||
129727845|NCT01468207|466963226|FG000|Treatment Period 1|Other|0|||
129727846|NCT01468207|466963227|FG001|Treatment Period 1|Other|2|||
129727847|NCT01468207|466963228|FG002|Treatment Period 1|Other|0|||
129727848|NCT01468207|466963229|FG003|Treatment Period 1|Other|0|||
129727849|NCT01468207|466963230|FG004|Treatment Period 1|Other|0|||
129727850|NCT01468207|466963231|FG005|Treatment Period 1|Other|0|||
129727851|NCT01468207|466963226|FG000|Treatment Period 2|Adverse Event|0|||
129727852|NCT01468207|466963227|FG001|Treatment Period 2|Adverse Event|0|||
129727853|NCT01468207|466963228|FG002|Treatment Period 2|Adverse Event|6|||
129727854|NCT01468207|466963229|FG003|Treatment Period 2|Adverse Event|1|||
129727855|NCT01468207|466963230|FG004|Treatment Period 2|Adverse Event|2|||
129727856|NCT01468207|466963231|FG005|Treatment Period 2|Adverse Event|1|||
129727857|NCT01468207|466963226|FG000|Treatment Period 2|Lack of Efficacy|0|||
129727858|NCT01468207|466963227|FG001|Treatment Period 2|Lack of Efficacy|0|||
129727859|NCT01468207|466963228|FG002|Treatment Period 2|Lack of Efficacy|1|||
129727860|NCT01468207|466963229|FG003|Treatment Period 2|Lack of Efficacy|1|||
129727861|NCT01468207|466963230|FG004|Treatment Period 2|Lack of Efficacy|0|||
129727862|NCT01468207|466963231|FG005|Treatment Period 2|Lack of Efficacy|2|||
129727863|NCT01468207|466963226|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129727864|NCT01468207|466963227|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129727865|NCT01468207|466963228|FG002|Treatment Period 2|Withdrawal by Subject|5|||
129727866|NCT01468207|466963229|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129727867|NCT01468207|466963230|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129727868|NCT01468207|466963231|FG005|Treatment Period 2|Withdrawal by Subject|2|||
129727869|NCT01468207|466963226|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
129727870|NCT01468207|466963227|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
129727871|NCT01468207|466963228|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
129727872|NCT01468207|466963229|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
129727873|NCT01468207|466963230|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
129727874|NCT01468207|466963231|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
129727875|NCT01468207|466963226|FG000|Treatment Period 2|Lost to Follow-up|0|||
129727876|NCT01468207|466963227|FG001|Treatment Period 2|Lost to Follow-up|0|||
129727877|NCT01468207|466963228|FG002|Treatment Period 2|Lost to Follow-up|5|||
129727878|NCT01468207|466963229|FG003|Treatment Period 2|Lost to Follow-up|1|||
129727879|NCT01468207|466963230|FG004|Treatment Period 2|Lost to Follow-up|0|||
129727880|NCT01468207|466963231|FG005|Treatment Period 2|Lost to Follow-up|0|||
129727881|NCT01468207|466963226|FG000|Treatment Period 2|Other|0|||
129727882|NCT01468207|466963227|FG001|Treatment Period 2|Other|0|||
129727883|NCT01468207|466963228|FG002|Treatment Period 2|Other|5|||
129727884|NCT01468207|466963229|FG003|Treatment Period 2|Other|1|||
129727885|NCT01468207|466963230|FG004|Treatment Period 2|Other|1|||
129727886|NCT01468207|466963231|FG005|Treatment Period 2|Other|2|||
129727887|NCT00539513|466963234|FG000|Overall Study|Withdrawal by Subject|2|||
129727888|NCT00539513|466963235|FG001|Overall Study|Withdrawal by Subject|1|||
129727889|NCT00539513|466963234|FG000|Overall Study|Lost to Follow-up|0|||
129727890|NCT00539513|466963235|FG001|Overall Study|Lost to Follow-up|1|||
129727891|NCT01328041|466963236|FG000|Overall Study|Adverse Event|7|||
129727892|NCT01328041|466963236|FG000|Overall Study|Lack of Efficacy|27|||
129727893|NCT01328041|466963236|FG000|Overall Study|Protocol Violation|7|||
129727894|NCT01328041|466963236|FG000|Overall Study|Lost to Follow-up|7|||
129727895|NCT01328041|466963236|FG000|Overall Study|Physician Decision|2|||
129727896|NCT01328041|466963236|FG000|Overall Study|Withdrawal by Subject|7|||
129727897|NCT02688088|466963240|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129727898|NCT02688088|466963241|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
129727899|NCT02688088|466963242|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129727900|NCT02688088|466963243|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129727901|NCT02688088|466963244|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
129891934|NCT03212365|467563124|FG001|Overall Study|Initiated heparin infusion on floor|1|||
129727902|NCT02688088|466963240|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129727903|NCT02688088|466963241|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
129727904|NCT02688088|466963242|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129727905|NCT02688088|466963243|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129727906|NCT02688088|466963244|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
129727907|NCT02688088|466963240|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129727908|NCT02688088|466963241|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
129727909|NCT02688088|466963242|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129727910|NCT02688088|466963243|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129727911|NCT02688088|466963244|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
129727912|NCT02688088|466963240|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129727913|NCT02688088|466963241|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
129727914|NCT02688088|466963242|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129727915|NCT02688088|466963243|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129727916|NCT02688088|466963244|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
129727917|NCT02688088|466963240|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129727918|NCT02688088|466963241|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129727919|NCT02688088|466963242|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
129727920|NCT02688088|466963243|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129727921|NCT02688088|466963244|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
129727922|NCT02688088|466963240|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129727923|NCT02688088|466963241|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129727924|NCT02688088|466963242|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
129727925|NCT02688088|466963243|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129727926|NCT02688088|466963244|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
129727927|NCT02688088|466963240|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129727928|NCT02688088|466963241|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129727929|NCT02688088|466963242|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129727930|NCT02688088|466963243|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
129727931|NCT02688088|466963244|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
129727932|NCT02688088|466963240|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129727933|NCT02688088|466963241|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129727934|NCT02688088|466963242|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129727935|NCT02688088|466963243|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
129727936|NCT02688088|466963244|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
129727937|NCT02688088|466963240|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129727938|NCT02688088|466963241|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129727939|NCT02688088|466963242|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129727940|NCT02688088|466963243|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
129727941|NCT02688088|466963244|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
129727942|NCT04021524|466963247|FG000|Overall Study|Change in surgical intervention|0|||
129727943|NCT04021524|466963248|FG001|Overall Study|Change in surgical intervention|1|||
129727944|NCT05275010|466963249|FG000|Overall Study|Reason Not Specified|4|||
129727945|NCT05275010|466963250|FG001|Overall Study|Reason Not Specified|1|||
129727946|NCT05275010|466963249|FG000|Overall Study|Withdrawal by Subject|1|||
129727947|NCT05275010|466963250|FG001|Overall Study|Withdrawal by Subject|0|||
129727948|NCT05275010|466963249|FG000|Overall Study|Lost to Follow-up|0|||
129727949|NCT05275010|466963250|FG001|Overall Study|Lost to Follow-up|1|||
129727950|NCT00730041|466963251|FG000|Overall Study|Lost to Follow-up|0|||
129727951|NCT00730041|466963252|FG001|Overall Study|Lost to Follow-up|2|||
129727952|NCT05526781|466963253|FG000|Overall Study|Lost to Follow-up|1|||
129727953|NCT01921218|466963254|FG000|Overall Study|Death|2|||
129727954|NCT01921218|466963255|FG001|Overall Study|Death|1|||
129727955|NCT01921218|466963254|FG000|Overall Study|Withdrawal by Subject|0|||
129727956|NCT01921218|466963255|FG001|Overall Study|Withdrawal by Subject|2|||
129727957|NCT01921218|466963254|FG000|Overall Study|Kidney transplant|1|||
129727958|NCT01921218|466963255|FG001|Overall Study|Kidney transplant|1|||
129727959|NCT02449889|466963256|FG000|Overall Study|Adverse Event|1|||
129727960|NCT02449889|466963257|FG001|Overall Study|Adverse Event|2|||
129727961|NCT02449889|466963258|FG002|Overall Study|Adverse Event|0|||
129727962|NCT02449889|466963256|FG000|Overall Study|Protocol Violation|0|||
129727963|NCT02449889|466963257|FG001|Overall Study|Protocol Violation|4|||
129727964|NCT02449889|466963258|FG002|Overall Study|Protocol Violation|1|||
129727965|NCT03327220|466963259|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
129727966|NCT03327220|466963260|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
129727967|NCT03327220|466963259|FG000|Overall Study|Investigator Decision|2|||
129727968|NCT03327220|466963260|FG001|Overall Study|Investigator Decision|0|||
129727969|NCT03327220|466963259|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
129727970|NCT03327220|466963260|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
129727971|NCT03327220|466963259|FG000|Overall Study|Fungal infection|1|||
129727972|NCT03327220|466963260|FG001|Overall Study|Fungal infection|0|||
129727973|NCT03327220|466963259|FG000|Overall Study|Discharged to Rehabilitation|0|||
129891935|NCT03212365|467563123|FG000|Overall Study|Unexpected return to OR|1|||
129891936|NCT03212365|467563124|FG001|Overall Study|Unexpected return to OR|1|||
129891937|NCT03212365|467563123|FG000|Overall Study|Medication distribution error|1|||
129891938|NCT03212365|467563124|FG001|Overall Study|Medication distribution error|0|||
129891939|NCT03212365|467563123|FG000|Overall Study|Required epidural placement|1|||
129891940|NCT03212365|467563124|FG001|Overall Study|Required epidural placement|0|||
129891941|NCT03212365|467563123|FG000|Overall Study|Withdrawal by Subject|0|||
129891942|NCT03212365|467563124|FG001|Overall Study|Withdrawal by Subject|1|||
129891943|NCT03212365|467563123|FG000|Overall Study|developed acute renal failure|0|||
129891944|NCT03212365|467563124|FG001|Overall Study|developed acute renal failure|1|||
129891945|NCT02507219|467563125|FG000|Overall Study|Physician Decision|1|||
129891946|NCT02507219|467563126|FG001|Overall Study|Physician Decision|0|||
129891947|NCT02507219|467563127|FG002|Overall Study|Physician Decision|0|||
129891948|NCT02507219|467563128|FG003|Overall Study|Physician Decision|0|||
129891949|NCT02507219|467563129|FG004|Overall Study|Physician Decision|0|||
129891950|NCT02507219|467563130|FG005|Overall Study|Physician Decision|0|||
129891951|NCT02507219|467563125|FG000|Overall Study|Withdrawal by Subject|0|||
129891952|NCT02507219|467563126|FG001|Overall Study|Withdrawal by Subject|0|||
129891953|NCT02507219|467563127|FG002|Overall Study|Withdrawal by Subject|0|||
129727974|NCT03327220|466963260|FG001|Overall Study|Discharged to Rehabilitation|1|||
129727975|NCT03327220|466963259|FG000|Overall Study|Missing|1|||
129727976|NCT03327220|466963260|FG001|Overall Study|Missing|0|||
129727977|NCT00368836|466963263|FG000|Phase II|Screen Failure|1|||
129727978|NCT00368836|466963263|FG000|Phase II|Withdrawal by Subject|1|||
129727979|NCT00368836|466963263|FG000|Phase II|unable to collect blood and/or breath|17|||
129727980|NCT00368836|466963263|FG000|Phase II|Protocol Violation|2|||
129727981|NCT01082874|466963264|FG000|Overall Study|Lost to Follow-up|10|||
129727982|NCT01082874|466963265|FG001|Overall Study|Lost to Follow-up|10|||
129727983|NCT01082874|466963266|FG002|Overall Study|Lost to Follow-up|6|||
129727984|NCT01082874|466963267|FG003|Overall Study|Lost to Follow-up|10|||
129727985|NCT01082874|466963264|FG000|Overall Study|Withdrawal by Subject|1|||
129727986|NCT01082874|466963265|FG001|Overall Study|Withdrawal by Subject|2|||
129727987|NCT01082874|466963266|FG002|Overall Study|Withdrawal by Subject|5|||
129727988|NCT01082874|466963267|FG003|Overall Study|Withdrawal by Subject|3|||
129891954|NCT02507219|467563128|FG003|Overall Study|Withdrawal by Subject|0|||
129891955|NCT02507219|467563129|FG004|Overall Study|Withdrawal by Subject|1|||
129727989|NCT00090142|466963269|FG000|Treatment Period I|Lost to Follow-up|1|||
129727990|NCT00090142|466963270|FG001|Treatment Period I|Lost to Follow-up|2|||
129727991|NCT00090142|466963269|FG000|Treatment Period I|Protocol Violation|2|||
129727992|NCT00090142|466963270|FG001|Treatment Period I|Protocol Violation|0|||
129727993|NCT00090142|466963269|FG000|Treatment Period I|Withdrawal by Subject|2|||
129727994|NCT00090142|466963270|FG001|Treatment Period I|Withdrawal by Subject|0|||
129727995|NCT00090142|466963269|FG000|Treatment Period I|Other|0|||
129727996|NCT00090142|466963270|FG001|Treatment Period I|Other|1|||
129727997|NCT00090142|466963269|FG000|Treatment Period II|Other|1|||
129727998|NCT00090142|466963270|FG001|Treatment Period II|Other|0|||
129727999|NCT02442310|466963271|FG000|Overall Study|Adverse Event|2|||
129728000|NCT02442310|466963271|FG000|Overall Study|Withdrawal by Subject|1|||
129728001|NCT00688324|466963272|FG000|Overall Study|Withdrawal by Subject|2|||
129728002|NCT00688324|466963272|FG000|Overall Study|Physician Decision|5|||
129728003|NCT00688324|466963272|FG000|Overall Study|Lost to Follow-up|1|||
129728004|NCT00006046|466963273|FG000|Overall Study|Adverse Event|3|||
129728005|NCT00006046|466963274|FG001|Overall Study|Adverse Event|0|||
129728006|NCT00006046|466963275|FG002|Overall Study|Adverse Event|0|||
129728007|NCT00006046|466963276|FG003|Overall Study|Adverse Event|0|||
129728008|NCT00006046|466963277|FG004|Overall Study|Adverse Event|0|||
129728009|NCT00006046|466963273|FG000|Overall Study|Disease Progression|2|||
129728010|NCT00006046|466963274|FG001|Overall Study|Disease Progression|0|||
129728011|NCT00006046|466963275|FG002|Overall Study|Disease Progression|0|||
129728012|NCT00006046|466963276|FG003|Overall Study|Disease Progression|0|||
129728013|NCT00006046|466963277|FG004|Overall Study|Disease Progression|0|||
129728014|NCT03176472|466963278|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
129891956|NCT02507219|467563130|FG005|Overall Study|Withdrawal by Subject|0|||
129891957|NCT05174065|467563135|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
129728015|NCT03176472|466963279|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
129728016|NCT03176472|466963278|FG000|Double Blind Treatment Period|Adverse Event|0|||
129728017|NCT03176472|466963279|FG001|Double Blind Treatment Period|Adverse Event|5|||
129891958|NCT05174065|467563136|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
129891959|NCT05174065|467563137|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
129891960|NCT05174065|467563135|FG000|Placebo-controlled Period|Other|0|||
129891961|NCT05174065|467563136|FG001|Placebo-controlled Period|Other|1|||
129891962|NCT05174065|467563137|FG002|Placebo-controlled Period|Other|0|||
129728018|NCT03176472|466963278|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
129728019|NCT03176472|466963279|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129728020|NCT03176472|466963278|FG000|Double Blind Treatment Period|Physician Decision|0|||
129728021|NCT03176472|466963279|FG001|Double Blind Treatment Period|Physician Decision|1|||
129728022|NCT03176472|466963278|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129728023|NCT03176472|466963279|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129728024|NCT03176472|466963278|FG000|Double Blind Treatment Period|Not Provided|1|||
129728025|NCT03176472|466963279|FG001|Double Blind Treatment Period|Not Provided|0|||
129728026|NCT03176472|466963278|FG000|Open Label Extension|Withdrawal by Subject|3|||
129728027|NCT03176472|466963279|FG001|Open Label Extension|Withdrawal by Subject|4|||
129728028|NCT03176472|466963278|FG000|Open Label Extension|Adverse Event|2|||
129728029|NCT03176472|466963279|FG001|Open Label Extension|Adverse Event|4|||
129728030|NCT03176472|466963278|FG000|Open Label Extension|Lost to Follow-up|1|||
129728031|NCT03176472|466963279|FG001|Open Label Extension|Lost to Follow-up|2|||
129728032|NCT03176472|466963278|FG000|Open Label Extension|Protocol Violation|0|||
129728033|NCT03176472|466963279|FG001|Open Label Extension|Protocol Violation|1|||
129728034|NCT03176472|466963278|FG000|Open Label Extension|Not Provided|2|||
129728035|NCT03176472|466963279|FG001|Open Label Extension|Not Provided|1|||
129728036|NCT00596154|466963280|FG000|Overall Study|Not Evaluable|2|||
129728037|NCT00642369|466963281|FG000|Overall Study|Adverse Event|2|||
129728038|NCT00642369|466963282|FG001|Overall Study|Adverse Event|3|||
129728039|NCT00642369|466963281|FG000|Overall Study|Withdrawal by Subject|1|||
129728040|NCT00642369|466963282|FG001|Overall Study|Withdrawal by Subject|0|||
129728041|NCT00642369|466963281|FG000|Overall Study|misdiagnosis|0|||
129728042|NCT00642369|466963282|FG001|Overall Study|misdiagnosis|1|||
129728043|NCT00642369|466963281|FG000|Overall Study|Lack of Efficacy|2|||
129728044|NCT00642369|466963282|FG001|Overall Study|Lack of Efficacy|2|||
129728045|NCT00585546|466963289|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
129728046|NCT00585546|466963289|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
129728047|NCT04154345|466963290|FG000|Overall Study|Covid-19 pandemic|4|||
129728048|NCT03622112|466963292|FG000|Overall Study|Withdrawal by Subject|6|||
129728049|NCT03622112|466963293|FG001|Overall Study|Withdrawal by Subject|2|||
129728050|NCT03622112|466963294|FG002|Overall Study|Withdrawal by Subject|4|||
129728051|NCT03622112|466963295|FG003|Overall Study|Withdrawal by Subject|2|||
129728052|NCT03622112|466963296|FG004|Overall Study|Withdrawal by Subject|1|||
129728053|NCT03622112|466963297|FG005|Overall Study|Withdrawal by Subject|2|||
129728054|NCT03622112|466963298|FG006|Overall Study|Withdrawal by Subject|2|||
129728055|NCT03622112|466963292|FG000|Overall Study|Death|0|||
129728056|NCT03622112|466963293|FG001|Overall Study|Death|0|||
129728057|NCT03622112|466963294|FG002|Overall Study|Death|0|||
129728058|NCT03622112|466963295|FG003|Overall Study|Death|1|||
129728059|NCT03622112|466963296|FG004|Overall Study|Death|0|||
129728060|NCT03622112|466963297|FG005|Overall Study|Death|0|||
129728061|NCT03622112|466963298|FG006|Overall Study|Death|0|||
129728062|NCT03622112|466963292|FG000|Overall Study|Lost to Follow-up|1|||
129728063|NCT03622112|466963293|FG001|Overall Study|Lost to Follow-up|1|||
129728064|NCT03622112|466963294|FG002|Overall Study|Lost to Follow-up|0|||
129728065|NCT03622112|466963295|FG003|Overall Study|Lost to Follow-up|0|||
129728066|NCT03622112|466963296|FG004|Overall Study|Lost to Follow-up|0|||
129728067|NCT03622112|466963297|FG005|Overall Study|Lost to Follow-up|0|||
129728068|NCT03622112|466963298|FG006|Overall Study|Lost to Follow-up|0|||
129728069|NCT03622112|466963292|FG000|Overall Study|Study-specific withdrawal criteria|10|||
129728070|NCT03622112|466963293|FG001|Overall Study|Study-specific withdrawal criteria|8|||
129728071|NCT03622112|466963294|FG002|Overall Study|Study-specific withdrawal criteria|7|||
129728072|NCT03622112|466963295|FG003|Overall Study|Study-specific withdrawal criteria|6|||
129728073|NCT03622112|466963296|FG004|Overall Study|Study-specific withdrawal criteria|4|||
129728074|NCT03622112|466963297|FG005|Overall Study|Study-specific withdrawal criteria|18|||
129728075|NCT03622112|466963298|FG006|Overall Study|Study-specific withdrawal criteria|4|||
129728076|NCT03622112|466963292|FG000|Overall Study|Protocol Violation|2|||
129728077|NCT03622112|466963293|FG001|Overall Study|Protocol Violation|0|||
129728078|NCT03622112|466963294|FG002|Overall Study|Protocol Violation|1|||
129728079|NCT03622112|466963295|FG003|Overall Study|Protocol Violation|1|||
129728080|NCT03622112|466963296|FG004|Overall Study|Protocol Violation|0|||
129728081|NCT03622112|466963297|FG005|Overall Study|Protocol Violation|0|||
129728082|NCT03622112|466963298|FG006|Overall Study|Protocol Violation|0|||
129728083|NCT03622112|466963292|FG000|Overall Study|Adverse Event|6|||
129728084|NCT03622112|466963293|FG001|Overall Study|Adverse Event|8|||
129728085|NCT03622112|466963294|FG002|Overall Study|Adverse Event|4|||
129728086|NCT03622112|466963295|FG003|Overall Study|Adverse Event|11|||
129728087|NCT03622112|466963296|FG004|Overall Study|Adverse Event|4|||
129728088|NCT03622112|466963297|FG005|Overall Study|Adverse Event|20|||
129728089|NCT03622112|466963298|FG006|Overall Study|Adverse Event|2|||
129728090|NCT03622112|466963292|FG000|Overall Study|Reason not specified|0|||
129728091|NCT03622112|466963293|FG001|Overall Study|Reason not specified|1|||
129728092|NCT03622112|466963294|FG002|Overall Study|Reason not specified|0|||
129728093|NCT03622112|466963295|FG003|Overall Study|Reason not specified|1|||
129728094|NCT03622112|466963296|FG004|Overall Study|Reason not specified|1|||
129728095|NCT03622112|466963297|FG005|Overall Study|Reason not specified|2|||
129728096|NCT03622112|466963298|FG006|Overall Study|Reason not specified|1|||
129728097|NCT01694121|466963300|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
129728098|NCT01694121|466963301|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
129728099|NCT00521599|466963302|FG000|Overall Study|Adverse Event|5|||
129891963|NCT05174065|467563135|FG000|Placebo-controlled Period|Adverse Event|1|||
129891964|NCT05174065|467563136|FG001|Placebo-controlled Period|Adverse Event|1|||
129891965|NCT05174065|467563137|FG002|Placebo-controlled Period|Adverse Event|0|||
129891966|NCT05174065|467563135|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
129891967|NCT05174065|467563136|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
129891968|NCT05174065|467563137|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
129891969|NCT05174065|467563135|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
129891970|NCT05174065|467563136|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
129891971|NCT05174065|467563137|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
129891972|NCT05174065|467563135|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
129891973|NCT05174065|467563136|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
129891974|NCT05174065|467563137|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
129891975|NCT01342887|467563143|FG000|Overall Study|Death|2|||
129891976|NCT00209274|467563144|FG000|Overall Study|Missed visit|3|||
129891977|NCT00209274|467563145|FG001|Overall Study|Missed visit|2|||
129891978|NCT00209274|467563144|FG000|Overall Study|Death|32|||
129891979|NCT00209274|467563145|FG001|Overall Study|Death|15|||
129891980|NCT00209274|467563144|FG000|Overall Study|Withdrawal by Subject|30|||
129891981|NCT00209274|467563145|FG001|Overall Study|Withdrawal by Subject|15|||
129891982|NCT00209274|467563144|FG000|Overall Study|Randomized not treated (RNT)|6|||
129891983|NCT00209274|467563145|FG001|Overall Study|Randomized not treated (RNT)|15|||
129891984|NCT02753530|467563146|FG000|Overall Study|Adverse Event|7|||
129891985|NCT02753530|467563147|FG001|Overall Study|Adverse Event|1|||
129891986|NCT02753530|467563146|FG000|Overall Study|Death|0|||
129891987|NCT02753530|467563147|FG001|Overall Study|Death|1|||
129891988|NCT02753530|467563146|FG000|Overall Study|Physician Decision|0|||
129891989|NCT02753530|467563147|FG001|Overall Study|Physician Decision|1|||
129891990|NCT02753530|467563146|FG000|Overall Study|Protocol Violation|1|||
129891991|NCT02753530|467563147|FG001|Overall Study|Protocol Violation|0|||
129891992|NCT02753530|467563146|FG000|Overall Study|Withdrawal by Subject|4|||
129891993|NCT02753530|467563147|FG001|Overall Study|Withdrawal by Subject|3|||
129891994|NCT00429793|467563156|FG000|Overall Study|Improper pre-protocol treatment|3|||
129891995|NCT00429793|467563156|FG000|Overall Study|Required test not done|1|||
129891996|NCT00429793|467563156|FG000|Overall Study|Never treated|1|||
129891997|NCT00429793|467563156|FG000|Overall Study|Non-measurable|1|||
129891998|NCT00097370|467563157|FG000|Stage 1|Adverse Event|3|||
129891999|NCT00097370|467563157|FG000|Stage 1|Withdrawal by Subject|1|||
129892000|NCT00097370|467563157|FG000|Stage 1|Lack of Efficacy|2|||
129892001|NCT00097370|467563157|FG000|Stage 2|Adverse Event|5|||
129892002|NCT00097370|467563157|FG000|Stage 2|Withdrawal by Subject|1|||
129892003|NCT00097370|467563157|FG000|Stage 2|Lack of Efficacy|3|||
129892004|NCT00097370|467563157|FG000|Stage 2|Pregnancy|1|||
129892005|NCT00097370|467563157|FG000|Stage 2|Sponsor Terminated Study|2|||
129892006|NCT00097370|467563157|FG000|Stage 2|Lost to Follow-up|1|||
129892007|NCT00097370|467563157|FG000|Stage 3|Adverse Event|2|||
129892008|NCT00097370|467563157|FG000|Stage 3|Withdrawal by Subject|3|||
129892009|NCT00097370|467563157|FG000|Stage 3|Lack of Efficacy|1|||
129892010|NCT00097370|467563157|FG000|Stage 3|Sponsor Terminated Study|52|||
129892011|NCT00097370|467563157|FG000|Stage 3|Lost to Follow-up|1|||
129892012|NCT02419755|467563158|FG000|Overall Study|Death|1|||
129892013|NCT02419755|467563159|FG001|Overall Study|Death|3|||
129892014|NCT02419755|467563158|FG000|Overall Study|Relapse|0|||
129892015|NCT02419755|467563159|FG001|Overall Study|Relapse|1|||
129892016|NCT02419755|467563158|FG000|Overall Study|Ineligible|1|||
129728100|NCT00521599|466963303|FG001|Overall Study|Adverse Event|7|||
129728101|NCT00521599|466963304|FG002|Overall Study|Adverse Event|6|||
129728102|NCT00521599|466963302|FG000|Overall Study|Treatment Failure|8|||
129728103|NCT00521599|466963303|FG001|Overall Study|Treatment Failure|9|||
129728104|NCT00521599|466963304|FG002|Overall Study|Treatment Failure|22|||
129728105|NCT00521599|466963302|FG000|Overall Study|Lost to Follow-up|2|||
129892017|NCT02419755|467563159|FG001|Overall Study|Ineligible|0|||
129892018|NCT02419755|467563158|FG000|Overall Study|Withdrawal by Subject|1|||
129892019|NCT02419755|467563159|FG001|Overall Study|Withdrawal by Subject|0|||
129892020|NCT02337361|467563161|FG000|3-month Follow-up|Lost to Follow-up|19|||
129892021|NCT02337361|467563162|FG001|3-month Follow-up|Lost to Follow-up|14|||
129444446|NCT01822522|465927346|FG003|Overall Study|Death|0|||
129892022|NCT02337361|467563161|FG000|6-month Follow-up|Lost to Follow-up|2|||
129892023|NCT02337361|467563162|FG001|6-month Follow-up|Lost to Follow-up|4|||
129892024|NCT02427646|467563163|FG000|Overall Study|Lack of Efficacy|2|||
129892025|NCT02427646|467563164|FG001|Overall Study|Lack of Efficacy|3|||
129892026|NCT02427646|467563163|FG000|Overall Study|Physician Decision|1|||
129892027|NCT02427646|467563164|FG001|Overall Study|Physician Decision|4|||
129728106|NCT00521599|466963303|FG001|Overall Study|Lost to Follow-up|1|||
129728107|NCT00521599|466963304|FG002|Overall Study|Lost to Follow-up|2|||
129728108|NCT00521599|466963302|FG000|Overall Study|Withdrawal by Subject|3|||
129728109|NCT00521599|466963303|FG001|Overall Study|Withdrawal by Subject|5|||
129728110|NCT00521599|466963304|FG002|Overall Study|Withdrawal by Subject|1|||
129728111|NCT00521599|466963302|FG000|Overall Study|Withdrawal by subject treatment related|3|||
129728112|NCT00521599|466963303|FG001|Overall Study|Withdrawal by subject treatment related|1|||
129728113|NCT00521599|466963304|FG002|Overall Study|Withdrawal by subject treatment related|2|||
129728114|NCT00521599|466963302|FG000|Overall Study|Protocol Violation|2|||
129728115|NCT00521599|466963303|FG001|Overall Study|Protocol Violation|4|||
129728116|NCT00521599|466963304|FG002|Overall Study|Protocol Violation|2|||
129728117|NCT00521599|466963302|FG000|Overall Study|Did not meet protocol eligibility|2|||
129728118|NCT00521599|466963303|FG001|Overall Study|Did not meet protocol eligibility|2|||
129728119|NCT00521599|466963304|FG002|Overall Study|Did not meet protocol eligibility|1|||
129728120|NCT00866047|466963305|FG000|Treatment Period|Progressive disease|13|||
129728121|NCT00866047|466963305|FG000|Treatment Period|Adverse Event|16|||
129728122|NCT00866047|466963305|FG000|Treatment Period|Physician Decision|14|||
129728123|NCT00866047|466963305|FG000|Treatment Period|Withdrawal by Subject|5|||
129728124|NCT00866047|466963305|FG000|Follow-up Period|Lost to Follow-up|5|||
129728125|NCT02928029|466963306|FG000|Overall Study|Withdrawal by Subject|0|||
129728126|NCT02928029|466963307|FG001|Overall Study|Withdrawal by Subject|1|||
129728127|NCT02928029|466963306|FG000|Overall Study|Radiological progression|1|||
129728128|NCT02928029|466963307|FG001|Overall Study|Radiological progression|0|||
129728129|NCT02928029|466963306|FG000|Overall Study|Clinical progression|1|||
129728130|NCT02928029|466963307|FG001|Overall Study|Clinical progression|2|||
129728131|NCT02928029|466963306|FG000|Overall Study|AE not related to clinical progression|1|||
129728132|NCT02928029|466963307|FG001|Overall Study|AE not related to clinical progression|1|||
129728133|NCT01610713|466963308|FG000|Overall Study|Adverse Event|3|||
129728134|NCT01610713|466963309|FG001|Overall Study|Adverse Event|0|||
129728135|NCT01610713|466963308|FG000|Overall Study|Lack of Efficacy|1|||
129728136|NCT01610713|466963309|FG001|Overall Study|Lack of Efficacy|0|||
129728137|NCT01610713|466963308|FG000|Overall Study|low mood and poor motivation|1|||
129728138|NCT01610713|466963309|FG001|Overall Study|low mood and poor motivation|0|||
129728139|NCT01610713|466963308|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
129728140|NCT01610713|466963309|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
129728141|NCT01610713|466963308|FG000|Overall Study|Lost to Follow-up|0|||
129728142|NCT01610713|466963309|FG001|Overall Study|Lost to Follow-up|1|||
129728143|NCT03770728|466963313|FG000|Overall Study|Adverse Event|1|||
129728144|NCT03770728|466963314|FG001|Overall Study|Adverse Event|0|||
129728145|NCT03770728|466963315|FG002|Overall Study|Adverse Event|1|||
129728146|NCT03770728|466963316|FG003|Overall Study|Adverse Event|0|||
129728147|NCT03770728|466963313|FG000|Overall Study|Poor compliance to protocol|0|||
129728148|NCT03770728|466963314|FG001|Overall Study|Poor compliance to protocol|0|||
129728149|NCT03770728|466963315|FG002|Overall Study|Poor compliance to protocol|1|||
129728150|NCT03770728|466963316|FG003|Overall Study|Poor compliance to protocol|0|||
129728151|NCT03770728|466963313|FG000|Overall Study|Withdrawal by Subject|13|||
129728152|NCT03770728|466963314|FG001|Overall Study|Withdrawal by Subject|8|||
129728153|NCT03770728|466963315|FG002|Overall Study|Withdrawal by Subject|9|||
129728154|NCT03770728|466963316|FG003|Overall Study|Withdrawal by Subject|13|||
129728155|NCT03770728|466963313|FG000|Overall Study|Other than specified|24|||
129728156|NCT03770728|466963314|FG001|Overall Study|Other than specified|23|||
129728157|NCT03770728|466963315|FG002|Overall Study|Other than specified|21|||
129728158|NCT03770728|466963316|FG003|Overall Study|Other than specified|22|||
129728159|NCT00503776|466963317|FG000|Overall Study|Withdrawal by Subject|1|||
129728160|NCT00503776|466963318|FG001|Overall Study|Withdrawal by Subject|0|||
129728161|NCT00503776|466963319|FG002|Overall Study|Withdrawal by Subject|1|||
129728162|NCT00503776|466963320|FG003|Overall Study|Withdrawal by Subject|1|||
129728163|NCT00503776|466963317|FG000|Overall Study|Physician Decision|0|||
129728164|NCT00503776|466963318|FG001|Overall Study|Physician Decision|0|||
129728165|NCT00503776|466963319|FG002|Overall Study|Physician Decision|1|||
129892028|NCT02427646|467563163|FG000|Overall Study|Protocol Violation|3|||
129728166|NCT00503776|466963320|FG003|Overall Study|Physician Decision|1|||
129892029|NCT02427646|467563164|FG001|Overall Study|Protocol Violation|3|||
129728167|NCT02778555|466963321|FG000|Overall Study|Withdrawal by Subject|55|||
129728168|NCT02778555|466963322|FG001|Overall Study|Withdrawal by Subject|32|||
129728169|NCT02778555|466963323|FG002|Overall Study|Withdrawal by Subject|107|||
129728170|NCT02379988|466963324|FG000|Overall Study|Not eligible|1|||
129728171|NCT05427539|466963327|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129728172|NCT05427539|466963328|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129728173|NCT05427539|466963327|FG000|Period 1|Withdrawal by Subject|1|||
129728174|NCT05427539|466963328|FG001|Period 1|Withdrawal by Subject|0|||
129728175|NCT00223977|466963331|FG000|Overall Study|Adverse Event|7|||
129728176|NCT00223977|466963332|FG001|Overall Study|Adverse Event|10|||
129728177|NCT00223977|466963333|FG002|Overall Study|Adverse Event|0|||
129728178|NCT00223977|466963331|FG000|Overall Study|Protocol Violation|0|||
129728179|NCT00223977|466963332|FG001|Overall Study|Protocol Violation|0|||
129728180|NCT00223977|466963333|FG002|Overall Study|Protocol Violation|1|||
129728181|NCT00223977|466963331|FG000|Overall Study|Withdrawal by Subject|1|||
129728182|NCT00223977|466963332|FG001|Overall Study|Withdrawal by Subject|1|||
129728183|NCT00223977|466963333|FG002|Overall Study|Withdrawal by Subject|2|||
129728184|NCT00223977|466963331|FG000|Overall Study|Other|1|||
129728185|NCT00223977|466963332|FG001|Overall Study|Other|0|||
129728186|NCT00223977|466963333|FG002|Overall Study|Other|0|||
129728187|NCT00934947|466963334|FG000|Overall Study|Adverse Event|0|||
129728188|NCT00934947|466963335|FG001|Overall Study|Adverse Event|2|||
129728189|NCT01451931|466963341|FG000|Overall Study|Lost to Follow-up|17|||
129728190|NCT01451931|466963342|FG001|Overall Study|Lost to Follow-up|36|||
129728191|NCT01451931|466963343|FG002|Overall Study|Lost to Follow-up|21|||
129728192|NCT01451931|466963341|FG000|Overall Study|Withdrawal by Subject|16|||
129728193|NCT01451931|466963342|FG001|Overall Study|Withdrawal by Subject|22|||
129728194|NCT01451931|466963343|FG002|Overall Study|Withdrawal by Subject|22|||
129728195|NCT02979093|466963346|FG000|First Scan Session|Scanning data problems|1|||
129728196|NCT02979093|466963347|FG001|First Scan Session|Scanning data problems|2|||
129728197|NCT02979093|466963348|FG002|First Scan Session|Scanning data problems|2|||
129728198|NCT02979093|466963349|FG003|First Scan Session|Scanning data problems|0|||
129728199|NCT02979093|466963346|FG000|Second Scan Session|Scanning data problems|3|||
129728200|NCT02979093|466963347|FG001|Second Scan Session|Scanning data problems|0|||
129728201|NCT02979093|466963348|FG002|Second Scan Session|Scanning data problems|1|||
129728202|NCT02979093|466963349|FG003|Second Scan Session|Scanning data problems|3|||
129728203|NCT03099174|466963350|FG000|Overall Study|Withdrawal by Subject|0|||
129728204|NCT03099174|466963351|FG001|Overall Study|Withdrawal by Subject|0|||
129728205|NCT03099174|466963352|FG002|Overall Study|Withdrawal by Subject|1|||
129728206|NCT03099174|466963353|FG003|Overall Study|Withdrawal by Subject|0|||
129728207|NCT03099174|466963354|FG004|Overall Study|Withdrawal by Subject|2|||
129728208|NCT03099174|466963355|FG005|Overall Study|Withdrawal by Subject|2|||
129728209|NCT03099174|466963356|FG006|Overall Study|Withdrawal by Subject|1|||
129728210|NCT03099174|466963357|FG007|Overall Study|Withdrawal by Subject|4|||
129728211|NCT03099174|466963350|FG000|Overall Study|Adverse Event|0|||
129728212|NCT03099174|466963351|FG001|Overall Study|Adverse Event|1|||
129728213|NCT03099174|466963352|FG002|Overall Study|Adverse Event|1|||
129728214|NCT03099174|466963353|FG003|Overall Study|Adverse Event|2|||
129728215|NCT03099174|466963354|FG004|Overall Study|Adverse Event|5|||
129728216|NCT03099174|466963355|FG005|Overall Study|Adverse Event|3|||
129728217|NCT03099174|466963356|FG006|Overall Study|Adverse Event|6|||
129728218|NCT03099174|466963357|FG007|Overall Study|Adverse Event|4|||
129728219|NCT03099174|466963350|FG000|Overall Study|Other than listed|6|||
129728220|NCT03099174|466963351|FG001|Overall Study|Other than listed|6|||
129728221|NCT03099174|466963352|FG002|Overall Study|Other than listed|5|||
129728222|NCT03099174|466963353|FG003|Overall Study|Other than listed|6|||
129728223|NCT03099174|466963354|FG004|Overall Study|Other than listed|19|||
129728224|NCT03099174|466963355|FG005|Overall Study|Other than listed|10|||
129728225|NCT03099174|466963356|FG006|Overall Study|Other than listed|26|||
129728226|NCT03099174|466963357|FG007|Overall Study|Other than listed|23|||
129728227|NCT02378298|466963358|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
129728228|NCT02378298|466963359|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
129728229|NCT02378298|466963360|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
129728230|NCT02378298|466963358|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
129728231|NCT02378298|466963359|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
129728232|NCT02378298|466963360|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
129728233|NCT02378298|466963358|FG000|Surveillance (19-68 Weeks)|Death|1|||
129728234|NCT02378298|466963359|FG001|Surveillance (19-68 Weeks)|Death|0|||
129728235|NCT02378298|466963360|FG002|Surveillance (19-68 Weeks)|Death|0|||
129728236|NCT04173260|466963361|FG000|Overall Study|Early termination|4|||
129444447|NCT01822522|465927347|FG004|Overall Study|Death|0|||
129444448|NCT01822522|465927348|FG005|Overall Study|Death|0|||
129728237|NCT02308163|466963362|FG000|Overall Study|Not fulfill eligible criteria|1|||
129728238|NCT02308163|466963363|FG001|Overall Study|Not fulfill eligible criteria|2|||
129728239|NCT02308163|466963364|FG002|Overall Study|Not fulfill eligible criteria|0|||
129728240|NCT02308163|466963365|FG003|Overall Study|Not fulfill eligible criteria|1|||
129728241|NCT02308163|466963366|FG004|Overall Study|Not fulfill eligible criteria|1|||
129728242|NCT02308163|466963362|FG000|Overall Study|Adverse Event|9|||
129728243|NCT02308163|466963363|FG001|Overall Study|Adverse Event|5|||
129728244|NCT02308163|466963364|FG002|Overall Study|Adverse Event|2|||
129728245|NCT02308163|466963365|FG003|Overall Study|Adverse Event|2|||
129728246|NCT02308163|466963366|FG004|Overall Study|Adverse Event|11|||
129444449|NCT01822522|465927343|FG000|Overall Study|Lost to Follow-up|0|||
129728247|NCT02308163|466963362|FG000|Overall Study|Lack of Efficacy|11|||
129728248|NCT02308163|466963363|FG001|Overall Study|Lack of Efficacy|3|||
129728249|NCT02308163|466963364|FG002|Overall Study|Lack of Efficacy|8|||
129728250|NCT02308163|466963365|FG003|Overall Study|Lack of Efficacy|4|||
129728251|NCT02308163|466963366|FG004|Overall Study|Lack of Efficacy|6|||
129728252|NCT02308163|466963362|FG000|Overall Study|Withdrawal of consent|2|||
129728253|NCT02308163|466963363|FG001|Overall Study|Withdrawal of consent|3|||
129728254|NCT02308163|466963364|FG002|Overall Study|Withdrawal of consent|0|||
129728255|NCT02308163|466963365|FG003|Overall Study|Withdrawal of consent|2|||
129728256|NCT02308163|466963366|FG004|Overall Study|Withdrawal of consent|6|||
129728257|NCT02308163|466963362|FG000|Overall Study|Protocol Violation|3|||
129728258|NCT02308163|466963363|FG001|Overall Study|Protocol Violation|3|||
129728259|NCT02308163|466963364|FG002|Overall Study|Protocol Violation|3|||
129728260|NCT02308163|466963365|FG003|Overall Study|Protocol Violation|2|||
129728261|NCT02308163|466963366|FG004|Overall Study|Protocol Violation|5|||
129728262|NCT02308163|466963362|FG000|Overall Study|Lab data met discontinuation criteria|3|||
129728263|NCT02308163|466963363|FG001|Overall Study|Lab data met discontinuation criteria|0|||
129728264|NCT02308163|466963364|FG002|Overall Study|Lab data met discontinuation criteria|0|||
129728265|NCT02308163|466963365|FG003|Overall Study|Lab data met discontinuation criteria|2|||
129728266|NCT02308163|466963366|FG004|Overall Study|Lab data met discontinuation criteria|0|||
129728267|NCT02308163|466963362|FG000|Overall Study|Miscellaneous|2|||
129728268|NCT02308163|466963363|FG001|Overall Study|Miscellaneous|2|||
129728269|NCT02308163|466963364|FG002|Overall Study|Miscellaneous|1|||
129728270|NCT02308163|466963365|FG003|Overall Study|Miscellaneous|0|||
129728271|NCT02308163|466963366|FG004|Overall Study|Miscellaneous|5|||
129728272|NCT02684058|466963367|FG000|Treatment Period|Progressive disease|4|||
129728273|NCT02684058|466963368|FG001|Treatment Period|Progressive disease|10|||
129728274|NCT02684058|466963369|FG002|Treatment Period|Progressive disease|19|||
129728275|NCT02684058|466963367|FG000|Treatment Period|Adverse Event|3|||
129728276|NCT02684058|466963368|FG001|Treatment Period|Adverse Event|8|||
129728277|NCT02684058|466963369|FG002|Treatment Period|Adverse Event|1|||
129728278|NCT02684058|466963367|FG000|Treatment Period|Physician Decision|5|||
129728279|NCT02684058|466963368|FG001|Treatment Period|Physician Decision|1|||
129728280|NCT02684058|466963369|FG002|Treatment Period|Physician Decision|2|||
129728281|NCT02684058|466963367|FG000|Treatment Period|New therapy for study indication|1|||
129728282|NCT02684058|466963368|FG001|Treatment Period|New therapy for study indication|0|||
129728283|NCT02684058|466963369|FG002|Treatment Period|New therapy for study indication|0|||
129728284|NCT02684058|466963367|FG000|Treatment Period|Protocol deviation|0|||
129728285|NCT02684058|466963368|FG001|Treatment Period|Protocol deviation|1|||
129728286|NCT02684058|466963369|FG002|Treatment Period|Protocol deviation|0|||
129728287|NCT02684058|466963367|FG000|Treatment Period|Subject/guardian decision|4|||
129728288|NCT02684058|466963368|FG001|Treatment Period|Subject/guardian decision|3|||
129728289|NCT02684058|466963369|FG002|Treatment Period|Subject/guardian decision|0|||
129728290|NCT02684058|466963367|FG000|Treatment Period|Death|0|||
129728291|NCT02684058|466963368|FG001|Treatment Period|Death|0|||
129728292|NCT02684058|466963369|FG002|Treatment Period|Death|2|||
129728293|NCT02684058|466963367|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129728294|NCT02684058|466963368|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129728295|NCT02684058|466963369|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129728296|NCT02684058|466963367|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
129728297|NCT02684058|466963368|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129728298|NCT02684058|466963369|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
129728299|NCT02684058|466963367|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129728300|NCT02684058|466963368|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
129728301|NCT02684058|466963369|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
129728302|NCT02684058|466963367|FG000|Post-treatment Efficacy Follow-up|Death|0|||
129728303|NCT02684058|466963368|FG001|Post-treatment Efficacy Follow-up|Death|0|||
129728304|NCT02684058|466963369|FG002|Post-treatment Efficacy Follow-up|Death|3|||
129728305|NCT02684058|466963367|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
129728306|NCT02684058|466963368|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
129728307|NCT02684058|466963369|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
129728308|NCT02684058|466963367|FG000|Post-treatment Survival Follow-up|Death|0|||
129728309|NCT02684058|466963368|FG001|Post-treatment Survival Follow-up|Death|0|||
129728310|NCT02684058|466963369|FG002|Post-treatment Survival Follow-up|Death|7|||
129728311|NCT02684058|466963367|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
129728312|NCT02684058|466963368|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
129728313|NCT02684058|466963369|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
129728314|NCT02684058|466963367|FG000|Crossover Treatment Period|Progressive disease|0|||
129728315|NCT02684058|466963368|FG001|Crossover Treatment Period|Progressive disease|1|||
129728316|NCT02684058|466963369|FG002|Crossover Treatment Period|Progressive disease|0|||
129728317|NCT01730339|466964790|FG000|Overall Study|Withdrawal by Subject|3|||
129728318|NCT01730339|466964791|FG001|Overall Study|Withdrawal by Subject|2|||
129728319|NCT01730339|466964790|FG000|Overall Study|Lost to Follow-up|1|||
129728320|NCT01730339|466964791|FG001|Overall Study|Lost to Follow-up|1|||
129728321|NCT01730339|466964790|FG000|Overall Study|Un-specified|1|||
129728322|NCT01730339|466964791|FG001|Overall Study|Un-specified|0|||
129728323|NCT03095027|466964792|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
129728324|NCT03095027|466964793|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
129728325|NCT04143217|466964794|FG000|Overall Study|Withdrawal by Subject|42|||
129728326|NCT04143217|466964794|FG000|Overall Study|Adverse Event|29|||
129728327|NCT04143217|466964794|FG000|Overall Study|Lost to Follow-up|29|||
129728328|NCT04143217|466964794|FG000|Overall Study|Lack of Efficacy|15|||
129728329|NCT04143217|466964794|FG000|Overall Study|Physician Decision|1|||
129728330|NCT04143217|466964794|FG000|Overall Study|Non-Compliance With Study Drug|6|||
129728331|NCT04143217|466964794|FG000|Overall Study|Other, Multiple Categories|11|||
129728332|NCT01962987|466964797|FG000|Overall Study|Adverse Event|4|||
129728333|NCT01962987|466964798|FG001|Overall Study|Adverse Event|4|||
129728334|NCT01962987|466964799|FG002|Overall Study|Adverse Event|0|||
129728335|NCT01962987|466964797|FG000|Overall Study|Lost to Follow-up|0|||
129728336|NCT01962987|466964798|FG001|Overall Study|Lost to Follow-up|0|||
129728337|NCT01962987|466964799|FG002|Overall Study|Lost to Follow-up|1|||
129728338|NCT01962987|466964797|FG000|Overall Study|Non compliance with dosing requirements|4|||
129728339|NCT01962987|466964798|FG001|Overall Study|Non compliance with dosing requirements|2|||
129728340|NCT01962987|466964799|FG002|Overall Study|Non compliance with dosing requirements|0|||
129728341|NCT01962987|466964797|FG000|Overall Study|Miscellaneous|1|||
129728342|NCT01962987|466964798|FG001|Overall Study|Miscellaneous|9|||
129728343|NCT01962987|466964799|FG002|Overall Study|Miscellaneous|2|||
129728344|NCT01962987|466964797|FG000|Overall Study|Restricted medication|5|||
129728345|NCT01962987|466964798|FG001|Overall Study|Restricted medication|1|||
129728346|NCT01962987|466964799|FG002|Overall Study|Restricted medication|1|||
129728347|NCT01962987|466964797|FG000|Overall Study|Serious Adverse Event|1|||
129728348|NCT01962987|466964798|FG001|Overall Study|Serious Adverse Event|0|||
129728349|NCT01962987|466964799|FG002|Overall Study|Serious Adverse Event|0|||
129728350|NCT01962987|466964797|FG000|Overall Study|Withdrawal by Subject|11|||
129728351|NCT01962987|466964798|FG001|Overall Study|Withdrawal by Subject|10|||
129728352|NCT01962987|466964799|FG002|Overall Study|Withdrawal by Subject|6|||
129728353|NCT01962987|466964797|FG000|Overall Study|Randomized in Error|4|||
129728354|NCT01962987|466964798|FG001|Overall Study|Randomized in Error|2|||
129728355|NCT01962987|466964799|FG002|Overall Study|Randomized in Error|2|||
129728356|NCT00347438|466964802|FG000|Overall Study|Withdrawal by Subject|1|||
129728357|NCT00347438|466964802|FG000|Overall Study|Physician Decision|1|||
129728358|NCT00322023|466964803|FG000|Overall Study|various|0|||
129728359|NCT00322023|466964804|FG001|Overall Study|various|2|||
129728360|NCT00322023|466964805|FG002|Overall Study|various|6|||
129728361|NCT00523705|466964806|FG000|Overall Study|No time for study.|0|||
129728362|NCT00523705|466964807|FG001|Overall Study|No time for study.|1|||
129728363|NCT00693017|466964808|FG000|Overall Study|Sponsor Decision|2|||
129728364|NCT00693017|466964809|FG001|Overall Study|Sponsor Decision|1|||
129728365|NCT00693017|466964808|FG000|Overall Study|Death|0|||
129728366|NCT00693017|466964809|FG001|Overall Study|Death|1|||
129728367|NCT00113399|466964821|FG000|Overall Study|Death|1|||
129728368|NCT00113399|466964822|FG001|Overall Study|Death|1|||
129728369|NCT00113399|466964821|FG000|Overall Study|Withdrawal by Subject|1|||
129728370|NCT00113399|466964822|FG001|Overall Study|Withdrawal by Subject|2|||
129728371|NCT00113399|466964821|FG000|Overall Study|Complete Response|0|||
129728372|NCT00113399|466964822|FG001|Overall Study|Complete Response|1|||
129728373|NCT00113399|466964821|FG000|Overall Study|Other|0|||
129728374|NCT00113399|466964822|FG001|Overall Study|Other|1|||
129728375|NCT01779856|466964824|FG000|Overall Study|Withdrawal by Subject|15|||
129728376|NCT01779856|466964824|FG000|Overall Study|Death|3|||
129728377|NCT01779856|466964824|FG000|Overall Study|Physician Decision|1|||
129728378|NCT01779856|466964824|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
129728379|NCT01779856|466964824|FG000|Overall Study|Delays in scheduling implant|1|||
129728380|NCT01779856|466964824|FG000|Overall Study|Subject ineligible for Implant|2|||
129728381|NCT01535599|466964826|FG000|Overall Study|Adverse Event|6|||
129728382|NCT01535599|466964827|FG001|Overall Study|Adverse Event|15|||
129728383|NCT01535599|466964826|FG000|Overall Study|Lost to Follow-up|3|||
129728384|NCT01535599|466964827|FG001|Overall Study|Lost to Follow-up|4|||
129728385|NCT01535599|466964826|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
129728386|NCT01535599|466964827|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
129728387|NCT01535599|466964826|FG000|Overall Study|Treatment Failure|33|||
129728388|NCT01535599|466964827|FG001|Overall Study|Treatment Failure|66|||
129728389|NCT01535599|466964826|FG000|Overall Study|BL Culture + for Group A Strep|0|||
129728390|NCT01535599|466964827|FG001|Overall Study|BL Culture + for Group A Strep|1|||
129728391|NCT01535599|466964826|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
129728392|NCT01535599|466964827|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
129728393|NCT01535599|466964826|FG000|Overall Study|Randomized in Error|2|||
129728394|NCT01535599|466964827|FG001|Overall Study|Randomized in Error|4|||
129728395|NCT01535599|466964826|FG000|Overall Study|Did not use product|1|||
129728396|NCT01535599|466964827|FG001|Overall Study|Did not use product|0|||
129728397|NCT01535599|466964826|FG000|Overall Study|Other|1|||
129728398|NCT01535599|466964827|FG001|Overall Study|Other|0|||
129728399|NCT01535599|466964826|FG000|Overall Study|Stopped medication|0|||
129728400|NCT01535599|466964827|FG001|Overall Study|Stopped medication|1|||
129728401|NCT01535599|466964826|FG000|Overall Study|Noncompliance|0|||
129728402|NCT01535599|466964827|FG001|Overall Study|Noncompliance|1|||
129728403|NCT04043234|466964828|FG000|Overall Study|Lost to Follow-up|1|||
129728404|NCT04043234|466964828|FG000|Overall Study|Withdrawal by Subject|1|||
129728405|NCT01165320|466964829|FG000|Overall Study|Clinical adverse experience|2|||
129728406|NCT01165320|466964830|FG001|Overall Study|Clinical adverse experience|1|||
129728407|NCT01165320|466964831|FG002|Overall Study|Clinical adverse experience|0|||
129728408|NCT01165320|466964829|FG000|Overall Study|Laboratory adverse experience|1|||
129728409|NCT01165320|466964830|FG001|Overall Study|Laboratory adverse experience|0|||
129728410|NCT01165320|466964831|FG002|Overall Study|Laboratory adverse experience|0|||
129728411|NCT01165320|466964829|FG000|Overall Study|Lack of Efficacy|0|||
129728412|NCT01165320|466964830|FG001|Overall Study|Lack of Efficacy|2|||
129728413|NCT01165320|466964831|FG002|Overall Study|Lack of Efficacy|0|||
129728414|NCT01165320|466964829|FG000|Overall Study|Reason unknown|0|||
129728415|NCT01165320|466964830|FG001|Overall Study|Reason unknown|1|||
129728416|NCT01165320|466964831|FG002|Overall Study|Reason unknown|0|||
129728417|NCT00385944|466964832|FG000|1st Maintenance Dose Period|Physician Decision|1|||
129728418|NCT00385944|466964833|FG001|1st Maintenance Dose Period|Physician Decision|0|||
129728419|NCT00385944|466964834|FG002|1st Maintenance Dose Period|Physician Decision|0|||
129728420|NCT00385944|466964832|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
129728421|NCT00385944|466964833|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
129728422|NCT00385944|466964834|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
129728423|NCT00385944|466964832|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
129728424|NCT00385944|466964833|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
129728425|NCT00385944|466964834|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
129728426|NCT00385944|466964832|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
129728427|NCT00385944|466964833|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
129728428|NCT00385944|466964834|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
129728429|NCT00590824|466964838|FG000|Overall Study|Disease could not be resected|0|||
129728430|NCT00590824|466964839|FG001|Overall Study|Disease could not be resected|2|||
129728431|NCT00590824|466964840|FG002|Overall Study|Disease could not be resected|1|||
129728432|NCT00590824|466964841|FG003|Overall Study|Disease could not be resected|0|||
129728433|NCT00590824|466964838|FG000|Overall Study|Adverse Event|0|||
129728434|NCT00590824|466964839|FG001|Overall Study|Adverse Event|0|||
129728435|NCT00590824|466964840|FG002|Overall Study|Adverse Event|0|||
129728436|NCT00590824|466964841|FG003|Overall Study|Adverse Event|1|||
129728437|NCT01155466|466964842|FG000|Overall Study|Adverse Event|13|||
129728438|NCT01155466|466964843|FG001|Overall Study|Adverse Event|15|||
129728439|NCT01155466|466964844|FG002|Overall Study|Adverse Event|6|||
129728440|NCT01155466|466964845|FG003|Overall Study|Adverse Event|17|||
129728441|NCT01155466|466964846|FG004|Overall Study|Adverse Event|18|||
129728442|NCT01155466|466964842|FG000|Overall Study|Lost to Follow-up|0|||
129728443|NCT01155466|466964843|FG001|Overall Study|Lost to Follow-up|0|||
129728444|NCT01155466|466964844|FG002|Overall Study|Lost to Follow-up|0|||
129728445|NCT01155466|466964845|FG003|Overall Study|Lost to Follow-up|0|||
129728446|NCT01155466|466964846|FG004|Overall Study|Lost to Follow-up|2|||
129728447|NCT01155466|466964842|FG000|Overall Study|Withdrawal by Subject|7|||
129728448|NCT01155466|466964843|FG001|Overall Study|Withdrawal by Subject|5|||
129728449|NCT01155466|466964844|FG002|Overall Study|Withdrawal by Subject|9|||
129728450|NCT01155466|466964845|FG003|Overall Study|Withdrawal by Subject|4|||
129728451|NCT01155466|466964846|FG004|Overall Study|Withdrawal by Subject|4|||
129728452|NCT01155466|466964842|FG000|Overall Study|Protocol Violation|0|||
129728453|NCT01155466|466964843|FG001|Overall Study|Protocol Violation|0|||
129728454|NCT01155466|466964844|FG002|Overall Study|Protocol Violation|2|||
129728455|NCT01155466|466964845|FG003|Overall Study|Protocol Violation|0|||
129728456|NCT01155466|466964846|FG004|Overall Study|Protocol Violation|1|||
129728457|NCT01155466|466964842|FG000|Overall Study|Administrative|0|||
129728458|NCT01155466|466964843|FG001|Overall Study|Administrative|3|||
129728459|NCT01155466|466964844|FG002|Overall Study|Administrative|0|||
129728460|NCT01155466|466964845|FG003|Overall Study|Administrative|0|||
129728461|NCT01155466|466964846|FG004|Overall Study|Administrative|0|||
129728462|NCT01155466|466964842|FG000|Overall Study|Randomized not treated|2|||
129728463|NCT01155466|466964843|FG001|Overall Study|Randomized not treated|2|||
129728464|NCT01155466|466964844|FG002|Overall Study|Randomized not treated|3|||
129728465|NCT01155466|466964845|FG003|Overall Study|Randomized not treated|0|||
129728466|NCT01155466|466964846|FG004|Overall Study|Randomized not treated|2|||
129728467|NCT02210689|466964847|FG000|Overall Study|Withdrawal by Subject|7|||
129728468|NCT02210689|466964848|FG001|Overall Study|Withdrawal by Subject|4|||
129728469|NCT02210689|466964849|FG002|Overall Study|Withdrawal by Subject|2|||
129728470|NCT02210689|466964847|FG000|Overall Study|Adverse Event|0|||
129728471|NCT02210689|466964848|FG001|Overall Study|Adverse Event|1|||
129728472|NCT02210689|466964849|FG002|Overall Study|Adverse Event|0|||
129728473|NCT02210689|466964847|FG000|Overall Study|Protocol Violation|1|||
129728474|NCT02210689|466964848|FG001|Overall Study|Protocol Violation|0|||
129728475|NCT02210689|466964849|FG002|Overall Study|Protocol Violation|0|||
129728476|NCT02210689|466964847|FG000|Overall Study|Lost to Follow-up|11|||
129728477|NCT02210689|466964848|FG001|Overall Study|Lost to Follow-up|9|||
129728478|NCT02210689|466964849|FG002|Overall Study|Lost to Follow-up|5|||
129728479|NCT02210689|466964847|FG000|Overall Study|Pregnancy|0|||
129728480|NCT02210689|466964848|FG001|Overall Study|Pregnancy|1|||
129728481|NCT02210689|466964849|FG002|Overall Study|Pregnancy|0|||
129728482|NCT02210689|466964847|FG000|Overall Study|Lack of Efficacy|0|||
129728483|NCT02210689|466964848|FG001|Overall Study|Lack of Efficacy|1|||
129728484|NCT02210689|466964849|FG002|Overall Study|Lack of Efficacy|5|||
129728485|NCT02210689|466964847|FG000|Overall Study|Prohibited medication|2|||
129728486|NCT02210689|466964848|FG001|Overall Study|Prohibited medication|8|||
129728487|NCT02210689|466964849|FG002|Overall Study|Prohibited medication|1|||
129728488|NCT02210689|466964847|FG000|Overall Study|Negative Nugent score at baseline|6|||
129728489|NCT02210689|466964848|FG001|Overall Study|Negative Nugent score at baseline|2|||
129728490|NCT02210689|466964849|FG002|Overall Study|Negative Nugent score at baseline|2|||
129728491|NCT02210689|466964847|FG000|Overall Study|Other|25|||
129728492|NCT02210689|466964848|FG001|Overall Study|Other|21|||
129728493|NCT02210689|466964849|FG002|Overall Study|Other|8|||
129728494|NCT00791479|466964855|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129728495|NCT00791479|466964856|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129444450|NCT01822522|465927344|FG001|Overall Study|Lost to Follow-up|0|||
129444451|NCT01822522|465927345|FG002|Overall Study|Lost to Follow-up|1|||
129444452|NCT01822522|465927346|FG003|Overall Study|Lost to Follow-up|1|||
129444453|NCT01822522|465927347|FG004|Overall Study|Lost to Follow-up|0|||
129444454|NCT01822522|465927348|FG005|Overall Study|Lost to Follow-up|1|||
129728496|NCT00791479|466964857|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129728497|NCT00791479|466964858|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129728498|NCT00791479|466964859|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
129728499|NCT00791479|466964860|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
129728500|NCT00791479|466964855|FG000|Overall Study|Adverse Event|0|||
129728501|NCT00791479|466964856|FG001|Overall Study|Adverse Event|1|||
129728502|NCT00791479|466964857|FG002|Overall Study|Adverse Event|0|||
129728503|NCT00791479|466964858|FG003|Overall Study|Adverse Event|2|||
129728504|NCT00791479|466964859|FG004|Overall Study|Adverse Event|0|||
129728505|NCT00791479|466964860|FG005|Overall Study|Adverse Event|1|||
129728506|NCT00791479|466964855|FG000|Overall Study|Lost to Follow-up|0|||
129728507|NCT00791479|466964856|FG001|Overall Study|Lost to Follow-up|1|||
129728508|NCT00791479|466964857|FG002|Overall Study|Lost to Follow-up|0|||
129728509|NCT00791479|466964858|FG003|Overall Study|Lost to Follow-up|0|||
129728510|NCT00791479|466964859|FG004|Overall Study|Lost to Follow-up|0|||
129728511|NCT00791479|466964860|FG005|Overall Study|Lost to Follow-up|1|||
129728512|NCT00791479|466964855|FG000|Overall Study|Protocol Violation|2|||
129728513|NCT00791479|466964856|FG001|Overall Study|Protocol Violation|1|||
129728514|NCT00791479|466964857|FG002|Overall Study|Protocol Violation|0|||
129728515|NCT00791479|466964858|FG003|Overall Study|Protocol Violation|1|||
129728516|NCT00791479|466964859|FG004|Overall Study|Protocol Violation|0|||
129728517|NCT00791479|466964860|FG005|Overall Study|Protocol Violation|0|||
129728518|NCT00791479|466964855|FG000|Overall Study|Withdrawal by Subject|0|||
129728519|NCT00791479|466964856|FG001|Overall Study|Withdrawal by Subject|0|||
129728520|NCT00791479|466964857|FG002|Overall Study|Withdrawal by Subject|0|||
129728521|NCT00791479|466964858|FG003|Overall Study|Withdrawal by Subject|1|||
129728522|NCT00791479|466964859|FG004|Overall Study|Withdrawal by Subject|0|||
129728523|NCT00791479|466964860|FG005|Overall Study|Withdrawal by Subject|1|||
129728524|NCT01778049|466964861|FG000|Open Label Treatment Period|Adverse Event|5|||
129728525|NCT01778049|466964862|FG001|Open Label Treatment Period|Adverse Event|15|||
129444455|NCT01822522|465927343|FG000|Overall Study|Withdrawal by Subject|0|||
129728526|NCT01778049|466964863|FG002|Open Label Treatment Period|Adverse Event|0|||
129444456|NCT01822522|465927344|FG001|Overall Study|Withdrawal by Subject|0|||
129728527|NCT01778049|466964864|FG003|Open Label Treatment Period|Adverse Event|0|||
129728528|NCT01778049|466964865|FG004|Open Label Treatment Period|Adverse Event|0|||
129728529|NCT01778049|466964866|FG005|Open Label Treatment Period|Adverse Event|0|||
129728530|NCT01778049|466964861|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
129728531|NCT01778049|466964862|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
129728532|NCT01778049|466964863|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
129728533|NCT01778049|466964864|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
129728534|NCT01778049|466964865|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
129728535|NCT01778049|466964866|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
129728536|NCT01778049|466964861|FG000|Open Label Treatment Period|Protocol Violation|5|||
129728537|NCT01778049|466964862|FG001|Open Label Treatment Period|Protocol Violation|5|||
129728538|NCT01778049|466964863|FG002|Open Label Treatment Period|Protocol Violation|0|||
129728539|NCT01778049|466964864|FG003|Open Label Treatment Period|Protocol Violation|0|||
129728540|NCT01778049|466964865|FG004|Open Label Treatment Period|Protocol Violation|0|||
129728541|NCT01778049|466964866|FG005|Open Label Treatment Period|Protocol Violation|0|||
129728542|NCT01778049|466964861|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
129728543|NCT01778049|466964862|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
129728544|NCT01778049|466964863|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
129728545|NCT01778049|466964864|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
129728546|NCT01778049|466964865|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
129728547|NCT01778049|466964866|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
129728548|NCT01778049|466964861|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
129728549|NCT01778049|466964862|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
129728550|NCT01778049|466964863|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
129728551|NCT01778049|466964864|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
129728552|NCT01778049|466964865|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
129728553|NCT01778049|466964866|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
129728554|NCT01778049|466964861|FG000|Open Label Treatment Period|Not treated|2|||
129728555|NCT01778049|466964862|FG001|Open Label Treatment Period|Not treated|1|||
129728556|NCT01778049|466964863|FG002|Open Label Treatment Period|Not treated|0|||
129728557|NCT01778049|466964864|FG003|Open Label Treatment Period|Not treated|0|||
129728558|NCT01778049|466964865|FG004|Open Label Treatment Period|Not treated|0|||
129728559|NCT01778049|466964866|FG005|Open Label Treatment Period|Not treated|0|||
129728560|NCT01778049|466964861|FG000|Open Label Treatment Period|Other reason not defined above|77|||
129728561|NCT01778049|466964862|FG001|Open Label Treatment Period|Other reason not defined above|94|||
129728562|NCT01778049|466964863|FG002|Open Label Treatment Period|Other reason not defined above|0|||
129728563|NCT01778049|466964864|FG003|Open Label Treatment Period|Other reason not defined above|0|||
129728564|NCT01778049|466964865|FG004|Open Label Treatment Period|Other reason not defined above|0|||
129728565|NCT01778049|466964866|FG005|Open Label Treatment Period|Other reason not defined above|0|||
129728566|NCT01778049|466964861|FG000|Double Blind Treatment Period|Adverse Event|0|||
129728567|NCT01778049|466964862|FG001|Double Blind Treatment Period|Adverse Event|0|||
129728568|NCT01778049|466964863|FG002|Double Blind Treatment Period|Adverse Event|4|||
129728569|NCT01778049|466964864|FG003|Double Blind Treatment Period|Adverse Event|5|||
129728570|NCT01778049|466964865|FG004|Double Blind Treatment Period|Adverse Event|3|||
129728571|NCT01778049|466964866|FG005|Double Blind Treatment Period|Adverse Event|2|||
129728572|NCT01778049|466964861|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
129728573|NCT01778049|466964862|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
129728574|NCT01778049|466964863|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
129728575|NCT01778049|466964864|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
129728576|NCT01778049|466964865|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
129728577|NCT01778049|466964866|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
129728578|NCT01778049|466964861|FG000|Double Blind Treatment Period|Protocol Violation|0|||
129728579|NCT01778049|466964862|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129728580|NCT01778049|466964863|FG002|Double Blind Treatment Period|Protocol Violation|2|||
129728581|NCT01778049|466964864|FG003|Double Blind Treatment Period|Protocol Violation|0|||
129728582|NCT01778049|466964865|FG004|Double Blind Treatment Period|Protocol Violation|0|||
129728583|NCT01778049|466964866|FG005|Double Blind Treatment Period|Protocol Violation|0|||
129728584|NCT01778049|466964861|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
129728585|NCT01778049|466964862|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129728586|NCT01778049|466964863|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
129728587|NCT01778049|466964864|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
129728588|NCT01778049|466964865|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
129728589|NCT01778049|466964866|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
129728590|NCT01778049|466964861|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
129728591|NCT01778049|466964862|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
129728592|NCT01778049|466964863|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
129728593|NCT01778049|466964864|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
129728594|NCT01778049|466964865|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
129728595|NCT01778049|466964866|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
129728596|NCT01778049|466964861|FG000|Double Blind Treatment Period|Not treated|0|||
129728597|NCT01778049|466964862|FG001|Double Blind Treatment Period|Not treated|0|||
129728598|NCT01778049|466964863|FG002|Double Blind Treatment Period|Not treated|0|||
129728599|NCT01778049|466964864|FG003|Double Blind Treatment Period|Not treated|2|||
129728600|NCT01778049|466964865|FG004|Double Blind Treatment Period|Not treated|2|||
129728601|NCT01778049|466964866|FG005|Double Blind Treatment Period|Not treated|0|||
129728602|NCT01778049|466964861|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
129728603|NCT01778049|466964862|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
129728604|NCT01778049|466964863|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
129728605|NCT01778049|466964864|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
129728606|NCT01778049|466964865|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
129728607|NCT01778049|466964866|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
129728608|NCT03773133|466964867|FG000|Overall Study|Screen Failure|8|||
129728609|NCT00107315|466964872|FG000|Overall Study|Disease Progression|9|||
129728610|NCT00107315|466964872|FG000|Overall Study|Adverse Event|4|||
129728611|NCT00107315|466964872|FG000|Overall Study|Withdrawal by Subject|2|||
129728612|NCT02509039|466964875|FG000|Overall Study|Adverse Event|0|||
129728613|NCT02509039|466964876|FG001|Overall Study|Adverse Event|1|||
129728614|NCT02509039|466964877|FG002|Overall Study|Adverse Event|1|||
129728615|NCT02509039|466964878|FG003|Overall Study|Adverse Event|1|||
129728616|NCT02509039|466964875|FG000|Overall Study|Withdrawal by Subject|0|||
129728617|NCT02509039|466964876|FG001|Overall Study|Withdrawal by Subject|0|||
129728618|NCT02509039|466964877|FG002|Overall Study|Withdrawal by Subject|1|||
129728619|NCT02509039|466964878|FG003|Overall Study|Withdrawal by Subject|0|||
129728620|NCT02509039|466964875|FG000|Overall Study|Progressive disease|2|||
129728621|NCT02509039|466964876|FG001|Overall Study|Progressive disease|2|||
129728622|NCT02509039|466964877|FG002|Overall Study|Progressive disease|1|||
129728623|NCT02509039|466964878|FG003|Overall Study|Progressive disease|5|||
129728624|NCT02509039|466964875|FG000|Overall Study|Study terminated by Sponsor|1|||
129728625|NCT02509039|466964876|FG001|Overall Study|Study terminated by Sponsor|0|||
129728626|NCT02509039|466964877|FG002|Overall Study|Study terminated by Sponsor|0|||
129728627|NCT02509039|466964878|FG003|Overall Study|Study terminated by Sponsor|0|||
129728628|NCT00543296|466964879|FG000|Overall Study|Physician Decision|7|||
129728629|NCT03136497|466964880|FG000|Overall Study|Screen Failure|1|||
129728630|NCT03136497|466964881|FG001|Overall Study|Screen Failure|0|||
129728631|NCT03136497|466964882|FG002|Overall Study|Screen Failure|0|||
129728632|NCT00557310|466964883|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
129728633|NCT00557310|466964883|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
129728634|NCT00557310|466964883|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
129728635|NCT00557310|466964883|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
129728636|NCT00557310|466964883|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
129728637|NCT00557310|466964883|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
129728638|NCT03276026|466964886|FG000|Overall Study|Protocol Violation|1|||
129892030|NCT02427646|467563163|FG000|Overall Study|Bothersome hand weakness|2|||
129892031|NCT02427646|467563164|FG001|Overall Study|Bothersome hand weakness|4|||
129892032|NCT01641861|467563165|FG000|Overall Study|Lost to Follow-up|21|||
129892033|NCT01641861|467563166|FG001|Overall Study|Lost to Follow-up|16|||
129892034|NCT01641861|467563165|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
129892035|NCT01641861|467563166|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
129892036|NCT01641861|467563165|FG000|Overall Study|Died due to drowning|0|||
129892037|NCT01641861|467563166|FG001|Overall Study|Died due to drowning|1|||
129892038|NCT01101542|467563167|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
129728639|NCT03276026|466964887|FG001|Overall Study|Protocol Violation|0|||
129728640|NCT04049266|466964891|FG000|Overall Study|Adverse Event|16|||
129728641|NCT04049266|466964892|FG001|Overall Study|Adverse Event|9|||
129728642|NCT04049266|466964891|FG000|Overall Study|Non-compliance with study drug|0|||
129892039|NCT01101542|467563167|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
129892040|NCT01101542|467563167|FG000|Year 4 Surveillance Period|Other|287|||
129892041|NCT01101542|467563167|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
129892042|NCT01101542|467563167|FG000|Year 5 Surveillance Period|Pregnancy|1|||
129892043|NCT01101542|467563167|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
129892044|NCT01101542|467563167|FG000|Year 6 Surveillance Period|Pregnancy|1|||
129892045|NCT01101542|467563167|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
129892046|NCT00901485|467563168|FG000|Overall Study|Lack of Efficacy|0|||
129728643|NCT04049266|466964892|FG001|Overall Study|Non-compliance with study drug|3|||
129728644|NCT04049266|466964891|FG000|Overall Study|Withdrawal by Subject|6|||
129728645|NCT04049266|466964892|FG001|Overall Study|Withdrawal by Subject|10|||
129728646|NCT04049266|466964891|FG000|Overall Study|Lost to Follow-up|2|||
129728647|NCT04049266|466964892|FG001|Overall Study|Lost to Follow-up|2|||
129728648|NCT04049266|466964891|FG000|Overall Study|Progressive disease|11|||
129728649|NCT04049266|466964892|FG001|Overall Study|Progressive disease|2|||
129728650|NCT04049266|466964891|FG000|Overall Study|Physician Decision|1|||
129728651|NCT04049266|466964892|FG001|Overall Study|Physician Decision|0|||
129728652|NCT04049266|466964891|FG000|Overall Study|Patient moved out of state|1|||
129728653|NCT04049266|466964892|FG001|Overall Study|Patient moved out of state|0|||
129728654|NCT01703208|466964893|FG000|Overall Study|Death|61|||
129728655|NCT01703208|466964894|FG001|Overall Study|Death|48|||
129728656|NCT01703208|466964893|FG000|Overall Study|Lack of Efficacy|1|||
129728657|NCT01703208|466964894|FG001|Overall Study|Lack of Efficacy|2|||
129728658|NCT01703208|466964893|FG000|Overall Study|Lost to Follow-up|68|||
129728659|NCT01703208|466964894|FG001|Overall Study|Lost to Follow-up|62|||
129728660|NCT01703208|466964893|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129728661|NCT01703208|466964894|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129728662|NCT01703208|466964893|FG000|Overall Study|Excluded Medication|1|||
129728663|NCT01703208|466964894|FG001|Overall Study|Excluded Medication|2|||
129728664|NCT01703208|466964893|FG000|Overall Study|Site Discontinued Study Participation|23|||
129728665|NCT01703208|466964894|FG001|Overall Study|Site Discontinued Study Participation|27|||
129728666|NCT01703208|466964893|FG000|Overall Study|Physician Decision|11|||
129728667|NCT01703208|466964894|FG001|Overall Study|Physician Decision|13|||
129728668|NCT01703208|466964893|FG000|Overall Study|Progressive disease|2|||
129728669|NCT01703208|466964894|FG001|Overall Study|Progressive disease|2|||
129728670|NCT01703208|466964893|FG000|Overall Study|Protocol Violation|1|||
129728671|NCT01703208|466964894|FG001|Overall Study|Protocol Violation|1|||
129728672|NCT01703208|466964893|FG000|Overall Study|Study Terminated by Sponsor|1710|||
129728673|NCT01703208|466964894|FG001|Overall Study|Study Terminated by Sponsor|1716|||
129728674|NCT01703208|466964893|FG000|Overall Study|Withdrawal by Subject|205|||
129728675|NCT01703208|466964894|FG001|Overall Study|Withdrawal by Subject|209|||
129728676|NCT01703208|466964893|FG000|Overall Study|Adverse Event|14|||
129728677|NCT01703208|466964894|FG001|Overall Study|Adverse Event|19|||
129728678|NCT01703208|466964893|FG000|Overall Study|Technical Problems|0|||
129728679|NCT01703208|466964894|FG001|Overall Study|Technical Problems|1|||
129728680|NCT01703208|466964893|FG000|Overall Study|Protocol Deviation|2|||
129728681|NCT01703208|466964894|FG001|Overall Study|Protocol Deviation|0|||
129728682|NCT00367744|466964898|FG000|Overall Study|Lost to Follow-up|4|||
129728683|NCT00367744|466964899|FG001|Overall Study|Lost to Follow-up|5|||
129728684|NCT04003207|466964903|FG000|Overall Study|Protocol Violation|1|||
129728685|NCT03941964|466964906|FG000|Overall Study|Adverse Event|1|||
129728686|NCT03941964|466964907|FG001|Overall Study|Adverse Event|8|||
129728687|NCT03941964|466964906|FG000|Overall Study|Progressive disease|7|||
129728688|NCT03941964|466964907|FG001|Overall Study|Progressive disease|3|||
129728689|NCT03941964|466964906|FG000|Overall Study|Lack of Efficacy|0|||
129728690|NCT03941964|466964907|FG001|Overall Study|Lack of Efficacy|1|||
129728691|NCT03941964|466964906|FG000|Overall Study|Death|3|||
129728692|NCT03941964|466964907|FG001|Overall Study|Death|1|||
129728693|NCT03941964|466964906|FG000|Overall Study|Withdrew consent|1|||
129728694|NCT03941964|466964907|FG001|Overall Study|Withdrew consent|3|||
129728695|NCT03941964|466964906|FG000|Overall Study|Physician Decision|9|||
129728696|NCT03941964|466964907|FG001|Overall Study|Physician Decision|2|||
129728697|NCT03941964|466964906|FG000|Overall Study|Other, not specified|2|||
129728698|NCT03941964|466964907|FG001|Overall Study|Other, not specified|1|||
129728699|NCT02298179|466964908|FG000|Overall Study|Lost to Follow-up|0|||
129728700|NCT02298179|466964909|FG001|Overall Study|Lost to Follow-up|0|||
129728701|NCT02298179|466964910|FG002|Overall Study|Lost to Follow-up|1|||
129728702|NCT02298179|466964911|FG003|Overall Study|Lost to Follow-up|0|||
129728703|NCT02298179|466964912|FG004|Overall Study|Lost to Follow-up|0|||
129728704|NCT02298179|466964913|FG005|Overall Study|Lost to Follow-up|0|||
129728705|NCT02298179|466964914|FG006|Overall Study|Lost to Follow-up|0|||
129728706|NCT02298179|466964915|FG007|Overall Study|Lost to Follow-up|1|||
129728707|NCT02298179|466964916|FG008|Overall Study|Lost to Follow-up|0|||
129728708|NCT02298179|466964917|FG009|Overall Study|Lost to Follow-up|0|||
129728709|NCT02298179|466964918|FG010|Overall Study|Lost to Follow-up|0|||
129728710|NCT02298179|466964919|FG011|Overall Study|Lost to Follow-up|0|||
129728711|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
129728712|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
129728713|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Death|0|||
129728714|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Death|0|||
129728715|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
129728716|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
129728717|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
129728718|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
129728719|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
129728720|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
129728721|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
129728722|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
129728723|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
129728724|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
129728725|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
129728726|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
129728727|NCT00433160|466964926|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
129728728|NCT00433160|466964927|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
129728729|NCT00433160|466964926|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
129728730|NCT00433160|466964927|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
129728731|NCT00433160|466964926|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
129728732|NCT00433160|466964927|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
129728733|NCT00433160|466964926|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
129728734|NCT00433160|466964927|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
129728735|NCT00433160|466964926|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
129728736|NCT00433160|466964927|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
129728737|NCT00433160|466964926|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
129728738|NCT00433160|466964927|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
129728739|NCT00433160|466964926|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
129728740|NCT00433160|466964927|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
129728741|NCT00433160|466964926|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
129728742|NCT00433160|466964927|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
129728743|NCT02226198|466966779|FG000|Lead-in Phase|Protocol Violation|1|||
129728744|NCT02226198|466966780|FG001|Lead-in Phase|Protocol Violation|0|||
129728745|NCT02226198|466966781|FG002|Lead-in Phase|Protocol Violation|0|||
129728746|NCT02226198|466966779|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
129728747|NCT02226198|466966780|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
129728748|NCT02226198|466966781|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
129728749|NCT01440517|466966783|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
129728750|NCT01288612|466966785|FG000|Overall Study|Unable to contact|11|||
129728751|NCT01288612|466966786|FG001|Overall Study|Unable to contact|16|||
129728752|NCT01288612|466966787|FG002|Overall Study|Unable to contact|20|||
129728753|NCT01288612|466966785|FG000|Overall Study|Declined|78|||
129728754|NCT01288612|466966786|FG001|Overall Study|Declined|63|||
129728755|NCT01288612|466966787|FG002|Overall Study|Declined|62|||
129728756|NCT01288612|466966785|FG000|Overall Study|Unable to intubate|0|||
129728757|NCT01288612|466966786|FG001|Overall Study|Unable to intubate|3|||
129728758|NCT01288612|466966787|FG002|Overall Study|Unable to intubate|0|||
129728759|NCT05599451|466966788|FG000|Overall Study|Not randomized|11|||
129728760|NCT05599451|466966789|FG001|Overall Study|Not randomized|0|||
129728761|NCT05599451|466966790|FG002|Overall Study|Not randomized|0|||
129728762|NCT05599451|466966791|FG003|Overall Study|Not randomized|0|||
129728763|NCT05599451|466966792|FG004|Overall Study|Not randomized|0|||
129728764|NCT05599451|466966788|FG000|Overall Study|Physician Decision|0|||
129728765|NCT05599451|466966789|FG001|Overall Study|Physician Decision|0|||
129728766|NCT05599451|466966790|FG002|Overall Study|Physician Decision|0|||
129728767|NCT05599451|466966791|FG003|Overall Study|Physician Decision|1|||
129728768|NCT05599451|466966792|FG004|Overall Study|Physician Decision|0|||
129728769|NCT00496483|466966793|FG000|Overall Study|Not dosed|9|||
129728770|NCT00496483|466966793|FG000|Overall Study|Adverse Event|2|||
129728771|NCT00496483|466966793|FG000|Overall Study|Lack of Efficacy|1|||
129728772|NCT00983515|466966795|FG000|Ritonavir Alone|liver panel out of range|6|||
129728773|NCT00983515|466966795|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
129728774|NCT01145352|466966804|FG000|Overall Study|Found to have been registered twice|6|||
129728775|NCT01145352|466966804|FG000|Overall Study|Treated before marketing approval|4|||
129728776|NCT01145352|466966804|FG000|Overall Study|Syringe formulation was used|1|||
129728777|NCT01967823|466966805|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
129728778|NCT05289271|466966811|FG000|Overall Study|Mistakenly allocated, untreated|1|||
129728779|NCT05289271|466966812|FG001|Overall Study|Mistakenly allocated, untreated|0|||
129728780|NCT01257568|466966814|FG000|Overall Study|Lost to Follow-up|2|||
129728781|NCT01257568|466966814|FG000|Overall Study|Withdrawal by Subject|6|||
129728782|NCT01257568|466966814|FG000|Overall Study|Terminated|1|||
129728783|NCT01257568|466966814|FG000|Overall Study|Component Revision|24|||
129728784|NCT03392883|466966815|FG000|Overall Study|Lost to Follow-up|122|||
129728785|NCT03392883|466966816|FG001|Overall Study|Lost to Follow-up|13|||
129728786|NCT03392883|466966817|FG002|Overall Study|Lost to Follow-up|9|||
129728787|NCT03392883|466966815|FG000|Overall Study|Death|4|||
129728788|NCT03392883|466966816|FG001|Overall Study|Death|0|||
129728789|NCT03392883|466966817|FG002|Overall Study|Death|0|||
129728790|NCT03392883|466966815|FG000|Overall Study|Lack of Efficacy|29|||
129728791|NCT03392883|466966816|FG001|Overall Study|Lack of Efficacy|0|||
129728792|NCT03392883|466966817|FG002|Overall Study|Lack of Efficacy|0|||
129728793|NCT03392883|466966815|FG000|Overall Study|Withdrawal by Subject|180|||
129728794|NCT03392883|466966816|FG001|Overall Study|Withdrawal by Subject|0|||
129728795|NCT03392883|466966817|FG002|Overall Study|Withdrawal by Subject|0|||
129728796|NCT03392883|466966815|FG000|Overall Study|Adverse Event|1|||
129728797|NCT03392883|466966816|FG001|Overall Study|Adverse Event|0|||
129728798|NCT03392883|466966817|FG002|Overall Study|Adverse Event|0|||
129728799|NCT00132691|466966824|FG000|Overall Study|Lost to Follow-up|5|||
129728800|NCT00132691|466966825|FG001|Overall Study|Lost to Follow-up|8|||
129728801|NCT00132691|466966824|FG000|Overall Study|Missed 2-year visit|4|||
129728802|NCT00132691|466966825|FG001|Overall Study|Missed 2-year visit|4|||
129728803|NCT00132691|466966824|FG000|Overall Study|Death|2|||
129728804|NCT00132691|466966825|FG001|Overall Study|Death|0|||
129728805|NCT01739933|466966829|FG000|Overall Study|Death|89|||
129728806|NCT01739933|466966830|FG001|Overall Study|Death|86|||
129728807|NCT01739933|466966829|FG000|Overall Study|Withdrawal by Subject|10|||
129728808|NCT01739933|466966830|FG001|Overall Study|Withdrawal by Subject|8|||
129728809|NCT01739933|466966829|FG000|Overall Study|Lost to Follow-up|3|||
129728810|NCT01739933|466966830|FG001|Overall Study|Lost to Follow-up|10|||
129728811|NCT01739933|466966829|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
129728812|NCT01739933|466966830|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
129728813|NCT04098367|466966831|FG000|Overall Study|Adverse Event|0|||
129728814|NCT04098367|466966832|FG001|Overall Study|Adverse Event|0|||
129728815|NCT04098367|466966833|FG002|Overall Study|Adverse Event|1|||
129728816|NCT04098367|466966831|FG000|Overall Study|Lost to Follow-up|1|||
129728817|NCT04098367|466966832|FG001|Overall Study|Lost to Follow-up|5|||
129728818|NCT04098367|466966833|FG002|Overall Study|Lost to Follow-up|2|||
129728819|NCT04098367|466966831|FG000|Overall Study|Withdrawal by Subject|0|||
129728820|NCT04098367|466966832|FG001|Overall Study|Withdrawal by Subject|0|||
129728821|NCT04098367|466966833|FG002|Overall Study|Withdrawal by Subject|1|||
129728822|NCT04098367|466966831|FG000|Overall Study|Sick . Could not attend visit|1|||
129728823|NCT04098367|466966832|FG001|Overall Study|Sick . Could not attend visit|0|||
129728824|NCT04098367|466966833|FG002|Overall Study|Sick . Could not attend visit|0|||
129728825|NCT01231321|466966839|FG000|Overall Study|Adverse Event|3|||
129728826|NCT01231321|466966839|FG000|Overall Study|Lack of Efficacy|2|||
129728827|NCT00908115|466966840|FG000|Overall Study|Other|14|||
129728828|NCT01728077|466966841|FG000|Overall Study|Lack of Efficacy|3|||
129728829|NCT01728077|466966842|FG001|Overall Study|Lack of Efficacy|1|||
129728830|NCT01728077|466966841|FG000|Overall Study|Lost to Follow-up|1|||
129728831|NCT01728077|466966842|FG001|Overall Study|Lost to Follow-up|0|||
129728832|NCT01728077|466966841|FG000|Overall Study|Subject choice|2|||
129728833|NCT01728077|466966842|FG001|Overall Study|Subject choice|3|||
129728834|NCT01728077|466966841|FG000|Overall Study|Death|0|||
129728835|NCT01728077|466966842|FG001|Overall Study|Death|1|||
129728836|NCT01728077|466966841|FG000|Overall Study|Patient moving|1|||
129728837|NCT01728077|466966842|FG001|Overall Study|Patient moving|0|||
129728838|NCT01728077|466966841|FG000|Overall Study|Non compliance|1|||
129728839|NCT01728077|466966842|FG001|Overall Study|Non compliance|0|||
129728840|NCT00396136|466966848|FG000|Overall Study|Death|43|||
129728841|NCT00396136|466966848|FG000|Overall Study|Withdrawal by Subject|59|||
129728842|NCT00396136|466966848|FG000|Overall Study|Lost to Follow-up|15|||
129728843|NCT00396136|466966848|FG000|Overall Study|Study device explanted|8|||
129728844|NCT03960580|466966849|FG000|Overall Study|Adverse Event|2|||
129728845|NCT03960580|466966850|FG001|Overall Study|Adverse Event|1|||
129728846|NCT03960580|466966851|FG002|Overall Study|Adverse Event|1|||
129728847|NCT03960580|466966849|FG000|Overall Study|Lost to Follow-up|1|||
129728848|NCT03960580|466966850|FG001|Overall Study|Lost to Follow-up|0|||
129728849|NCT03960580|466966851|FG002|Overall Study|Lost to Follow-up|0|||
129728850|NCT03960580|466966849|FG000|Overall Study|Lack of Efficacy|2|||
129728851|NCT03960580|466966850|FG001|Overall Study|Lack of Efficacy|1|||
129728852|NCT03960580|466966851|FG002|Overall Study|Lack of Efficacy|0|||
129728853|NCT03960580|466966849|FG000|Overall Study|Protocol Violation|0|||
129728854|NCT03960580|466966850|FG001|Overall Study|Protocol Violation|0|||
129728855|NCT03960580|466966851|FG002|Overall Study|Protocol Violation|1|||
129728856|NCT03960580|466966849|FG000|Overall Study|Withdrawal by Subject|1|||
129728857|NCT03960580|466966850|FG001|Overall Study|Withdrawal by Subject|1|||
129728858|NCT03960580|466966851|FG002|Overall Study|Withdrawal by Subject|1|||
129728859|NCT03960580|466966849|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
129728860|NCT03960580|466966850|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
129728861|NCT03960580|466966851|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
129728862|NCT02359045|466966856|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
129728863|NCT02359045|466966857|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129728864|NCT02359045|466966856|FG000|Overall Study|Lost to Follow-up|1|||
129728865|NCT02359045|466966857|FG001|Overall Study|Lost to Follow-up|1|||
129728866|NCT02359045|466966856|FG000|Overall Study|Adverse Event|0|||
129728867|NCT02359045|466966857|FG001|Overall Study|Adverse Event|1|||
129728868|NCT01271712|466966863|FG000|Double Blind Treatment|Death|2|||
129728869|NCT01271712|466966864|FG001|Double Blind Treatment|Death|0|||
129728870|NCT01271712|466966863|FG000|Double Blind Treatment|Lack of Efficacy|1|||
129728871|NCT01271712|466966864|FG001|Double Blind Treatment|Lack of Efficacy|0|||
129728872|NCT01271712|466966863|FG000|Double Blind Treatment|Adverse Event|9|||
129728873|NCT01271712|466966864|FG001|Double Blind Treatment|Adverse Event|4|||
129728874|NCT01271712|466966863|FG000|Double Blind Treatment|Progressive disease|23|||
129728875|NCT01271712|466966864|FG001|Double Blind Treatment|Progressive disease|3|||
129728876|NCT01271712|466966863|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
129728877|NCT01271712|466966864|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
129728878|NCT01271712|466966863|FG000|Double Blind Treatment|Non compliance with study drug|2|||
129728879|NCT01271712|466966864|FG001|Double Blind Treatment|Non compliance with study drug|0|||
129728880|NCT01271712|466966863|FG000|Double Blind Treatment|receive no study drug|1|||
129728881|NCT01271712|466966864|FG001|Double Blind Treatment|receive no study drug|0|||
129728882|NCT01271712|466966863|FG000|Open Label Treatment|Death|6|||
129728883|NCT01271712|466966864|FG001|Open Label Treatment|Death|5|||
129728884|NCT01271712|466966863|FG000|Open Label Treatment|Withdrawal by Subject|6|||
129728885|NCT01271712|466966864|FG001|Open Label Treatment|Withdrawal by Subject|11|||
129728886|NCT01271712|466966863|FG000|Open Label Treatment|Physician Decision|2|||
129728887|NCT01271712|466966864|FG001|Open Label Treatment|Physician Decision|0|||
129728888|NCT01271712|466966863|FG000|Open Label Treatment|Adverse Event|14|||
129728889|NCT01271712|466966864|FG001|Open Label Treatment|Adverse Event|8|||
129728890|NCT01271712|466966863|FG000|Open Label Treatment|Progressive disease|59|||
129728891|NCT01271712|466966864|FG001|Open Label Treatment|Progressive disease|32|||
129728892|NCT01271712|466966863|FG000|Open Label Treatment|transferred to rollover study|1|||
129892047|NCT00901485|467563169|FG001|Overall Study|Lack of Efficacy|2|||
129728893|NCT01271712|466966864|FG001|Open Label Treatment|transferred to rollover study|0|||
129728894|NCT01271712|466966863|FG000|Open Label Treatment|Non-compliance with study drug|1|||
129728895|NCT01271712|466966864|FG001|Open Label Treatment|Non-compliance with study drug|0|||
129728896|NCT01271712|466966863|FG000|Open Label Treatment|Protocol Violation|0|||
129728897|NCT01271712|466966864|FG001|Open Label Treatment|Protocol Violation|1|||
129728898|NCT01271712|466966863|FG000|Open Label Treatment|Switching to other therapy|2|||
129728899|NCT01271712|466966864|FG001|Open Label Treatment|Switching to other therapy|1|||
129728900|NCT01271712|466966863|FG000|Safety Follow-up|Death|11|||
129728901|NCT01271712|466966864|FG001|Safety Follow-up|Death|7|||
129728902|NCT01271712|466966863|FG000|Safety Follow-up|Withdrawal by Subject|4|||
129728903|NCT01271712|466966864|FG001|Safety Follow-up|Withdrawal by Subject|2|||
129728904|NCT01271712|466966863|FG000|Safety Follow-up|Protocol Violation|1|||
129728905|NCT01271712|466966864|FG001|Safety Follow-up|Protocol Violation|1|||
129728906|NCT01271712|466966863|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
129728907|NCT01271712|466966864|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
129728908|NCT01271712|466966863|FG000|Safety Follow-up|No follow-up|1|||
129728909|NCT01271712|466966864|FG001|Safety Follow-up|No follow-up|1|||
129728910|NCT01271712|466966863|FG000|Safety Follow-up|Progressive disease|1|||
129728911|NCT01271712|466966864|FG001|Safety Follow-up|Progressive disease|0|||
129728912|NCT01271712|466966863|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
129728913|NCT01271712|466966864|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
129728914|NCT00096226|466966867|FG000|Overall Study|Ineligible|2|||
129728915|NCT00096226|466966867|FG000|Overall Study|Protocol treatment not started|1|||
129728916|NCT01666119|466966868|FG000|Overall Study|Adverse Event|6|||
129728917|NCT01666119|466966868|FG000|Overall Study|Withdrawal by Subject|16|||
129728918|NCT01666119|466966868|FG000|Overall Study|Lost to Follow-up|7|||
129728919|NCT01666119|466966868|FG000|Overall Study|non compliance with study medication, pa|18|||
129728920|NCT01666119|466966868|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
129728921|NCT05479097|466966874|FG000|Overall Study|Withdrawal by Subject|2|||
129728922|NCT03894969|466966880|FG000|Overall Study|Adverse Event|0|||
129728923|NCT03894969|466966881|FG001|Overall Study|Adverse Event|2|||
129728924|NCT03894969|466966882|FG002|Overall Study|Adverse Event|0|||
129728925|NCT03894969|466966883|FG003|Overall Study|Adverse Event|1|||
129728926|NCT03894969|466966884|FG004|Overall Study|Adverse Event|2|||
129728927|NCT03894969|466966880|FG000|Overall Study|Lost to Follow-up|3|||
129728928|NCT03894969|466966881|FG001|Overall Study|Lost to Follow-up|1|||
129728929|NCT03894969|466966882|FG002|Overall Study|Lost to Follow-up|1|||
129728930|NCT03894969|466966883|FG003|Overall Study|Lost to Follow-up|0|||
129728931|NCT03894969|466966884|FG004|Overall Study|Lost to Follow-up|0|||
129728932|NCT03894969|466966880|FG000|Overall Study|Withdrawal by Subject|2|||
129728933|NCT03894969|466966881|FG001|Overall Study|Withdrawal by Subject|1|||
129728934|NCT03894969|466966882|FG002|Overall Study|Withdrawal by Subject|3|||
129728935|NCT03894969|466966883|FG003|Overall Study|Withdrawal by Subject|4|||
129728936|NCT03894969|466966884|FG004|Overall Study|Withdrawal by Subject|8|||
129728937|NCT03894969|466966880|FG000|Overall Study|Other|0|||
129728938|NCT03894969|466966881|FG001|Overall Study|Other|0|||
129728939|NCT03894969|466966882|FG002|Overall Study|Other|0|||
129728940|NCT03894969|466966883|FG003|Overall Study|Other|0|||
129728941|NCT03894969|466966884|FG004|Overall Study|Other|3|||
129728942|NCT03894969|466966880|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
129728943|NCT03894969|466966881|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
129728944|NCT03894969|466966882|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
129728945|NCT03894969|466966883|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
129728946|NCT03894969|466966884|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
129728947|NCT03894969|466966880|FG000|Overall Study|Solicited Adverse Event|0|||
129728948|NCT03894969|466966881|FG001|Overall Study|Solicited Adverse Event|1|||
129728949|NCT03894969|466966882|FG002|Overall Study|Solicited Adverse Event|0|||
129728950|NCT03894969|466966883|FG003|Overall Study|Solicited Adverse Event|0|||
129728951|NCT03894969|466966884|FG004|Overall Study|Solicited Adverse Event|0|||
129728952|NCT00468676|466966885|FG000|Overall Study|Lost to Follow-up|14|||
129728953|NCT00468676|466966886|FG001|Overall Study|Lost to Follow-up|11|||
129728954|NCT00468676|466966885|FG000|Overall Study|Death|2|||
129728955|NCT00468676|466966886|FG001|Overall Study|Death|1|||
129728956|NCT00118846|466966893|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
129728957|NCT00118846|466966894|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
129728958|NCT00118846|466966893|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
129728959|NCT00118846|466966894|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
129728960|NCT00118846|466966893|FG000|Overall Study|Physician Decision|1|||
129728961|NCT00118846|466966894|FG001|Overall Study|Physician Decision|0|||
129728962|NCT00118846|466966893|FG000|Overall Study|Medical condition|2|||
129728963|NCT00118846|466966894|FG001|Overall Study|Medical condition|2|||
129728964|NCT00118846|466966893|FG000|Overall Study|Lost to Follow-up|0|||
129728965|NCT00118846|466966894|FG001|Overall Study|Lost to Follow-up|2|||
129728966|NCT00118846|466966893|FG000|Overall Study|Personal reason|4|||
129728967|NCT00118846|466966894|FG001|Overall Study|Personal reason|5|||
129728968|NCT00443053|466966896|FG000|Overall Study|Adverse Event|2|||
129728969|NCT00443053|466966897|FG001|Overall Study|Adverse Event|1|||
129728970|NCT00443053|466966896|FG000|Overall Study|Withdrawal by Subject|9|||
129728971|NCT00443053|466966897|FG001|Overall Study|Withdrawal by Subject|18|||
129728972|NCT00443053|466966896|FG000|Overall Study|Lost to Follow-up|4|||
129728973|NCT00443053|466966897|FG001|Overall Study|Lost to Follow-up|5|||
129728974|NCT00443053|466966896|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129728975|NCT00443053|466966897|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
129728976|NCT00443053|466966896|FG000|Overall Study|Noncompliance|2|||
129728977|NCT00443053|466966897|FG001|Overall Study|Noncompliance|1|||
129728978|NCT00443053|466966896|FG000|Overall Study|Other|3|||
129728979|NCT00443053|466966897|FG001|Overall Study|Other|4|||
129728980|NCT00443053|466966896|FG000|Overall Study|Physician Decision|0|||
129728981|NCT00443053|466966897|FG001|Overall Study|Physician Decision|4|||
129728982|NCT00541866|466966898|FG000|Overall Study|Adverse Event|3|||
129728983|NCT00541866|466966899|FG001|Overall Study|Adverse Event|0|||
129892048|NCT00901485|467563168|FG000|Overall Study|Withdrawal by Subject|1|||
129892049|NCT00901485|467563169|FG001|Overall Study|Withdrawal by Subject|2|||
129892050|NCT01256476|467565302|FG000|Overall Study|Adverse Event|2|||
129892051|NCT01256476|467565303|FG001|Overall Study|Adverse Event|1|||
129892052|NCT01256476|467565302|FG000|Overall Study|Withdrawal by Subject|2|||
129892053|NCT01256476|467565303|FG001|Overall Study|Withdrawal by Subject|1|||
129892054|NCT01256476|467565302|FG000|Overall Study|Lost to Follow-up|1|||
129892055|NCT01256476|467565303|FG001|Overall Study|Lost to Follow-up|2|||
129892056|NCT01256476|467565302|FG000|Overall Study|Persistent ALT or AST elevation|1|||
129892057|NCT01256476|467565303|FG001|Overall Study|Persistent ALT or AST elevation|0|||
129892058|NCT01256476|467565302|FG000|Overall Study|Physician Decision|0|||
129892059|NCT01256476|467565303|FG001|Overall Study|Physician Decision|1|||
129892060|NCT01256476|467565302|FG000|Overall Study|Subject non-compliance|0|||
129892061|NCT01256476|467565303|FG001|Overall Study|Subject non-compliance|1|||
129892062|NCT01256476|467565302|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
129892063|NCT01256476|467565303|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
129892064|NCT00163215|467565304|FG000|Overall Study|Lack of Efficacy|3|||
129892065|NCT00163215|467565304|FG000|Overall Study|Withdrawal by Subject|5|||
129892066|NCT00163215|467565304|FG000|Overall Study|Other|7|||
129892067|NCT05406791|467565309|FG000|Overall Study|Lost to Follow-up|13|||
129892068|NCT05406791|467565310|FG001|Overall Study|Lost to Follow-up|10|||
129892069|NCT01789203|467565311|FG000|Overall Study|Adverse Event|2|||
129892070|NCT01789203|467565312|FG001|Overall Study|Adverse Event|2|||
129728984|NCT00541866|466966900|FG002|Overall Study|Adverse Event|0|||
129728985|NCT00541866|466966901|FG003|Overall Study|Adverse Event|0|||
129728986|NCT00541866|466966902|FG004|Overall Study|Adverse Event|0|||
129728987|NCT00541866|466966898|FG000|Overall Study|Death|1|||
129892071|NCT01789203|467565311|FG000|Overall Study|Withdrawal by Subject|1|||
129892072|NCT01789203|467565312|FG001|Overall Study|Withdrawal by Subject|0|||
129892073|NCT01789203|467565311|FG000|Overall Study|Death|1|||
129728988|NCT00541866|466966899|FG001|Overall Study|Death|0|||
129728989|NCT00541866|466966900|FG002|Overall Study|Death|0|||
129728990|NCT00541866|466966901|FG003|Overall Study|Death|0|||
129728991|NCT00541866|466966902|FG004|Overall Study|Death|0|||
129728992|NCT00541866|466966898|FG000|Overall Study|Lack of Efficacy|19|||
129728993|NCT00541866|466966899|FG001|Overall Study|Lack of Efficacy|15|||
129728994|NCT00541866|466966900|FG002|Overall Study|Lack of Efficacy|10|||
129728995|NCT00541866|466966901|FG003|Overall Study|Lack of Efficacy|12|||
129728996|NCT00541866|466966902|FG004|Overall Study|Lack of Efficacy|14|||
129728997|NCT00541866|466966898|FG000|Overall Study|Not Reported or Other|11|||
129728998|NCT00541866|466966899|FG001|Overall Study|Not Reported or Other|3|||
129728999|NCT00541866|466966900|FG002|Overall Study|Not Reported or Other|3|||
129729000|NCT00541866|466966901|FG003|Overall Study|Not Reported or Other|3|||
129729001|NCT00541866|466966902|FG004|Overall Study|Not Reported or Other|1|||
129729002|NCT00541866|466966898|FG000|Overall Study|Physician Decision|0|||
129729003|NCT00541866|466966899|FG001|Overall Study|Physician Decision|0|||
129729004|NCT00541866|466966900|FG002|Overall Study|Physician Decision|2|||
129729005|NCT00541866|466966901|FG003|Overall Study|Physician Decision|1|||
129729006|NCT00541866|466966902|FG004|Overall Study|Physician Decision|0|||
129729007|NCT01327053|466966903|FG000|Overall Study|Adverse Event|23|||
129729008|NCT01327053|466966904|FG001|Overall Study|Adverse Event|57|||
129729009|NCT01327053|466966903|FG000|Overall Study|Patient/guardian decision|11|||
129729010|NCT01327053|466966904|FG001|Overall Study|Patient/guardian decision|35|||
129729011|NCT01327053|466966903|FG000|Overall Study|Physician Decision|10|||
129729012|NCT01327053|466966904|FG001|Overall Study|Physician Decision|14|||
129729013|NCT01327053|466966903|FG000|Overall Study|Death|1|||
129729014|NCT01327053|466966904|FG001|Overall Study|Death|5|||
129729015|NCT01327053|466966903|FG000|Overall Study|Lost to Follow-up|2|||
129729016|NCT01327053|466966904|FG001|Overall Study|Lost to Follow-up|4|||
129729017|NCT01327053|466966903|FG000|Overall Study|Non-compliance with study treatment|0|||
129729018|NCT01327053|466966904|FG001|Overall Study|Non-compliance with study treatment|5|||
129729019|NCT01327053|466966903|FG000|Overall Study|Study terminated by Sponsor|1|||
129729020|NCT01327053|466966904|FG001|Overall Study|Study terminated by Sponsor|3|||
129892074|NCT01789203|467565312|FG001|Overall Study|Death|0|||
129892075|NCT01789203|467565311|FG000|Overall Study|Protocol Violation|2|||
129892076|NCT01789203|467565312|FG001|Overall Study|Protocol Violation|1|||
129729021|NCT01327053|466966903|FG000|Overall Study|Progressive disease|31|||
129729022|NCT01327053|466966904|FG001|Overall Study|Progressive disease|26|||
129729023|NCT01327053|466966903|FG000|Overall Study|Protocol Violation|0|||
129729024|NCT01327053|466966904|FG001|Overall Study|Protocol Violation|1|||
129729025|NCT01327053|466966903|FG000|Overall Study|Untreated|0|||
129729026|NCT01327053|466966904|FG001|Overall Study|Untreated|1|||
129892077|NCT01789203|467565311|FG000|Overall Study|Other|1|||
129892078|NCT01789203|467565312|FG001|Overall Study|Other|1|||
129892079|NCT01789203|467565311|FG000|Overall Study|patient non-adherent|2|||
129892080|NCT01789203|467565312|FG001|Overall Study|patient non-adherent|0|||
129892081|NCT00354029|467565315|FG000|Overall Study|Protocol Violation|4|||
129892082|NCT00354029|467565316|FG001|Overall Study|Protocol Violation|2|||
129892083|NCT00826280|467565317|FG000|Overall Study|Randomized but drug not received|1|||
129892084|NCT00826280|467565318|FG001|Overall Study|Randomized but drug not received|0|||
129892085|NCT00826280|467565319|FG002|Overall Study|Randomized but drug not received|1|||
129892086|NCT00826280|467565317|FG000|Overall Study|Adverse Event|1|||
129892087|NCT00826280|467565318|FG001|Overall Study|Adverse Event|3|||
129892088|NCT00826280|467565319|FG002|Overall Study|Adverse Event|0|||
129892089|NCT00826280|467565317|FG000|Overall Study|Lost to Follow-up|0|||
129892090|NCT00826280|467565318|FG001|Overall Study|Lost to Follow-up|1|||
129892091|NCT00826280|467565319|FG002|Overall Study|Lost to Follow-up|0|||
129892092|NCT00826280|467565317|FG000|Overall Study|Sponsor discontinued subject or study|1|||
129892093|NCT00826280|467565318|FG001|Overall Study|Sponsor discontinued subject or study|0|||
129892094|NCT00826280|467565319|FG002|Overall Study|Sponsor discontinued subject or study|0|||
129892095|NCT00826280|467565317|FG000|Overall Study|Reversible ischemic defect not present|43|||
129892096|NCT00826280|467565318|FG001|Overall Study|Reversible ischemic defect not present|40|||
129892097|NCT00826280|467565319|FG002|Overall Study|Reversible ischemic defect not present|44|||
129892098|NCT00826280|467565317|FG000|Overall Study|Interpretation Failure|1|||
129892099|NCT00826280|467565318|FG001|Overall Study|Interpretation Failure|0|||
129892100|NCT00826280|467565319|FG002|Overall Study|Interpretation Failure|0|||
129892101|NCT00826280|467565317|FG000|Overall Study|Machine Failure|1|||
129892102|NCT00826280|467565318|FG001|Overall Study|Machine Failure|1|||
129892103|NCT00826280|467565319|FG002|Overall Study|Machine Failure|0|||
129892104|NCT00826280|467565317|FG000|Overall Study|One or more non-interpretable scan|0|||
129892105|NCT00826280|467565318|FG001|Overall Study|One or more non-interpretable scan|1|||
129892106|NCT00826280|467565319|FG002|Overall Study|One or more non-interpretable scan|1|||
129892107|NCT03201757|467565320|FG000|Overall Study|Withdrawal by Subject|133|||
129892108|NCT03201757|467565320|FG000|Overall Study|Adverse Event|44|||
129892109|NCT03201757|467565320|FG000|Overall Study|Lost to Follow-up|37|||
129892110|NCT03201757|467565320|FG000|Overall Study|Pregnancy|2|||
129892111|NCT03201757|467565320|FG000|Overall Study|Lack of Efficacy|1|||
129892112|NCT03201757|467565320|FG000|Overall Study|Protocol Violation|20|||
129892113|NCT03201757|467565320|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
129892114|NCT03201757|467565320|FG000|Overall Study|Not Yet Determined|5|||
129892115|NCT03201757|467565320|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
129892116|NCT03201757|467565320|FG000|Overall Study|Other|20|||
129892117|NCT02297503|467565321|FG000|Overall Study|Withdrawal by Subject|1|||
129892118|NCT02297503|467565322|FG001|Overall Study|Withdrawal by Subject|1|||
129892119|NCT02297503|467565321|FG000|Overall Study|Protocol Violation|1|||
129892120|NCT02297503|467565322|FG001|Overall Study|Protocol Violation|0|||
129892121|NCT02297503|467565321|FG000|Overall Study|Pregnancy|0|||
129892122|NCT02297503|467565322|FG001|Overall Study|Pregnancy|1|||
129892123|NCT02297503|467565321|FG000|Overall Study|Lost to Follow-up|0|||
129892124|NCT02297503|467565322|FG001|Overall Study|Lost to Follow-up|1|||
129892125|NCT02297503|467565321|FG000|Overall Study|Medical reason|0|||
129892126|NCT02297503|467565322|FG001|Overall Study|Medical reason|1|||
129892127|NCT02788656|467565324|FG000|Overall Study|Withdrawal by Subject|1|||
129892128|NCT02788656|467565325|FG001|Overall Study|Withdrawal by Subject|0|||
129892129|NCT02263885|467565326|FG000|Overall Study|Withdrawal by Subject|7|||
129892130|NCT02263885|467565326|FG000|Overall Study|Alternative Treatment|3|||
129892131|NCT01403987|467565334|FG000|Overall Study|Residents forgot their secret PIN|18|||
129892132|NCT01403987|467565335|FG001|Overall Study|Residents forgot their secret PIN|17|||
129892133|NCT01403987|467565336|FG002|Overall Study|Residents forgot their secret PIN|18|||
129892134|NCT00180674|467565338|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
129892135|NCT00180674|467565338|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
129892136|NCT01106976|467565339|FG000|Overall Study|Lost to Follow-up|8|||
129892137|NCT03836664|467565343|FG000|Overall Study|Didn't complete forms and lost drug|3|||
129892138|NCT03836664|467565344|FG001|Overall Study|Didn't complete forms and lost drug|3|||
129892139|NCT01427907|467565345|FG000|Overall Study|Withdrawal by Subject|3|||
129892140|NCT01427907|467565346|FG001|Overall Study|Withdrawal by Subject|4|||
129892141|NCT02179918|467565347|FG000|Overall Study|Death|0|||
129892142|NCT02179918|467565348|FG001|Overall Study|Death|0|||
129892143|NCT02179918|467565349|FG002|Overall Study|Death|0|||
129892144|NCT02179918|467565350|FG003|Overall Study|Death|1|||
129892145|NCT02179918|467565351|FG004|Overall Study|Death|0|||
129892146|NCT02179918|467565347|FG000|Overall Study|Lost to Follow-up|0|||
129892147|NCT02179918|467565348|FG001|Overall Study|Lost to Follow-up|0|||
129892148|NCT02179918|467565349|FG002|Overall Study|Lost to Follow-up|1|||
129892149|NCT02179918|467565350|FG003|Overall Study|Lost to Follow-up|0|||
129729027|NCT01574157|466966905|FG000|Overall Study|Withdrawal by Subject|4|||
129892150|NCT02179918|467565351|FG004|Overall Study|Lost to Follow-up|0|||
129892151|NCT02179918|467565347|FG000|Overall Study|Progressive Disease|4|||
129892152|NCT02179918|467565348|FG001|Overall Study|Progressive Disease|1|||
129892153|NCT02179918|467565349|FG002|Overall Study|Progressive Disease|1|||
129729028|NCT01574157|466966906|FG001|Overall Study|Withdrawal by Subject|5|||
129729029|NCT01574157|466966905|FG000|Overall Study|Lost to Follow-up|0|||
129729030|NCT01574157|466966906|FG001|Overall Study|Lost to Follow-up|3|||
129729031|NCT00721578|466966907|FG000|Overall Study|Death|1|||
129729032|NCT00721578|466966908|FG001|Overall Study|Death|1|||
129729033|NCT00721578|466966907|FG000|Overall Study|Withdrawal by Subject|1|||
129729034|NCT00721578|466966908|FG001|Overall Study|Withdrawal by Subject|1|||
129729035|NCT01944098|466966909|FG000|Overall Study|Physician Decision|1|||
129729036|NCT01944098|466966910|FG001|Overall Study|Physician Decision|0|||
129729037|NCT05032690|466966911|FG000|Period 1|Adverse Event|0|||
129729038|NCT05032690|466966912|FG001|Period 1|Adverse Event|1|||
129729039|NCT05032690|466966913|FG002|Period 1|Adverse Event|0|||
129729040|NCT05032690|466966914|FG003|Period 1|Adverse Event|0|||
129729041|NCT05032690|466966911|FG000|Period 1|Withdrawal by Subject|1|||
129729042|NCT05032690|466966912|FG001|Period 1|Withdrawal by Subject|0|||
129729043|NCT05032690|466966913|FG002|Period 1|Withdrawal by Subject|0|||
129729044|NCT05032690|466966914|FG003|Period 1|Withdrawal by Subject|0|||
129729045|NCT05032690|466966911|FG000|Period 1|No longer meets eligibility criteria|0|||
129729046|NCT05032690|466966912|FG001|Period 1|No longer meets eligibility criteria|1|||
129729047|NCT05032690|466966913|FG002|Period 1|No longer meets eligibility criteria|0|||
129729048|NCT05032690|466966914|FG003|Period 1|No longer meets eligibility criteria|0|||
129729049|NCT05032690|466966911|FG000|Period 2|Adverse Event|1|||
129729050|NCT05032690|466966912|FG001|Period 2|Adverse Event|0|||
129729051|NCT05032690|466966913|FG002|Period 2|Adverse Event|0|||
129729052|NCT05032690|466966914|FG003|Period 2|Adverse Event|0|||
129729053|NCT05032690|466966911|FG000|Period 2|Withdrawal by Subject|0|||
129729054|NCT05032690|466966912|FG001|Period 2|Withdrawal by Subject|1|||
129729055|NCT05032690|466966913|FG002|Period 2|Withdrawal by Subject|0|||
129729056|NCT05032690|466966914|FG003|Period 2|Withdrawal by Subject|0|||
129729057|NCT05032690|466966911|FG000|Period 2|No longer meets eligibility criteria|0|||
129729058|NCT05032690|466966912|FG001|Period 2|No longer meets eligibility criteria|1|||
129729059|NCT05032690|466966913|FG002|Period 2|No longer meets eligibility criteria|0|||
129729060|NCT05032690|466966914|FG003|Period 2|No longer meets eligibility criteria|0|||
129729061|NCT05032690|466966911|FG000|Period 3|Adverse Event|0|||
129729062|NCT05032690|466966912|FG001|Period 3|Adverse Event|1|||
129729063|NCT05032690|466966913|FG002|Period 3|Adverse Event|0|||
129729064|NCT05032690|466966914|FG003|Period 3|Adverse Event|0|||
129729065|NCT00350272|466966915|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
129729066|NCT00350272|466966916|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
129729067|NCT00350272|466966915|FG000|Blinded 12-Week Treatment|Death|1|||
129729068|NCT00350272|466966916|FG001|Blinded 12-Week Treatment|Death|0|||
129729069|NCT00350272|466966915|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
129729070|NCT00350272|466966916|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
129729071|NCT00350272|466966915|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
129729072|NCT00350272|466966916|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
129729073|NCT00350272|466966915|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
129729074|NCT00350272|466966916|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
129729075|NCT00350272|466966915|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
129729076|NCT00350272|466966916|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
129729077|NCT00350272|466966915|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
129729078|NCT00350272|466966916|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
129729079|NCT00350272|466966915|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
129729080|NCT00350272|466966916|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
129729081|NCT00350272|466966915|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
129729082|NCT00350272|466966916|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
129729083|NCT00350272|466966915|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
129729084|NCT00350272|466966916|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
129729085|NCT00350272|466966915|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
129729086|NCT00350272|466966916|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
129729087|NCT02910401|466966917|FG000|Overall Study|Study closure Study closure|0|||
129729088|NCT02910401|466966918|FG001|Overall Study|Study closure Study closure|0|||
129729089|NCT02910401|466966919|FG002|Overall Study|Study closure Study closure|2|||
129729090|NCT02910401|466966917|FG000|Overall Study|Physician Decision|1|||
129729091|NCT02910401|466966918|FG001|Overall Study|Physician Decision|0|||
129729092|NCT02910401|466966919|FG002|Overall Study|Physician Decision|0|||
129729093|NCT03300024|466966920|FG000|Overall Study|Physician Decision|4|||
129729094|NCT03300024|466966921|FG001|Overall Study|Physician Decision|6|||
129729095|NCT03222973|466966922|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
129729096|NCT03222973|466966923|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
129729097|NCT03222973|466966924|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
129729098|NCT03222973|466966925|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
129729099|NCT03222973|466966922|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
129729100|NCT03222973|466966923|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
129729101|NCT03222973|466966924|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
129729102|NCT03222973|466966925|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
129729103|NCT03222973|466966922|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
129729104|NCT03222973|466966923|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
129729105|NCT03222973|466966924|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
129729106|NCT03222973|466966925|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
129729107|NCT03222973|466966922|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
129729108|NCT03222973|466966923|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
129729109|NCT03222973|466966924|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
129729110|NCT03222973|466966925|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
129729111|NCT03222973|466966922|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
129729112|NCT03222973|466966923|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
129729113|NCT03222973|466966924|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
129729114|NCT03222973|466966925|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
129729115|NCT03222973|466966922|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
129729116|NCT03222973|466966923|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
129729117|NCT03222973|466966924|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
129729118|NCT03222973|466966925|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
129729119|NCT03222973|466966922|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
129729120|NCT03222973|466966923|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
129729121|NCT03222973|466966924|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
129729122|NCT03222973|466966925|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
129729123|NCT03222973|466966922|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
129729124|NCT03222973|466966923|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
129729125|NCT03222973|466966924|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
129729126|NCT03222973|466966925|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
129729127|NCT03222973|466966922|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
129729128|NCT03222973|466966923|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
129729129|NCT03222973|466966924|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
129729130|NCT03222973|466966925|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
129729131|NCT03222973|466966922|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
129729132|NCT03222973|466966923|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
129729133|NCT03222973|466966924|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
129729134|NCT03222973|466966925|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
129729135|NCT03222973|466966922|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
129729136|NCT03222973|466966923|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
129729137|NCT03222973|466966924|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
129729138|NCT03222973|466966925|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
129729139|NCT03222973|466966922|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
129729140|NCT03222973|466966923|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
129729141|NCT03222973|466966924|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
129729142|NCT03222973|466966925|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
129729143|NCT02080481|466966926|FG000|Overall Study|Never received a block.|1|||
129729144|NCT02080481|466966927|FG001|Overall Study|Never received a block.|0|||
129729145|NCT00840060|466968647|FG000|Overall Study|Withdrawal by Subject|1|||
129729146|NCT00840060|466968648|FG001|Overall Study|Withdrawal by Subject|0|||
129729147|NCT00840060|466968647|FG000|Overall Study|Change in emotional/behavioral status|0|||
129729148|NCT00840060|466968648|FG001|Overall Study|Change in emotional/behavioral status|1|||
129729149|NCT00871923|466968649|FG000|Overall Study|Death|1|||
129729150|NCT00871923|466968649|FG000|Overall Study|Withdrawal by Subject|1|||
129729151|NCT01263015|466968654|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
129729152|NCT01263015|466968655|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
129729153|NCT01263015|466968654|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
129729154|NCT01263015|466968655|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
129729155|NCT01263015|466968654|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
129729156|NCT01263015|466968655|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
129729157|NCT01263015|466968654|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
129729158|NCT01263015|466968655|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
129729159|NCT01263015|466968654|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
129729160|NCT01263015|466968655|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
129729161|NCT01263015|466968654|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
129729162|NCT01263015|466968655|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
129729163|NCT01263015|466968654|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
129729164|NCT01263015|466968655|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
129729165|NCT01263015|466968654|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
129729166|NCT01263015|466968655|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
129729167|NCT01263015|466968654|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
129729168|NCT01263015|466968655|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
129729169|NCT01263015|466968654|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
129729170|NCT01263015|466968655|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
129729171|NCT01263015|466968654|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
129729172|NCT01263015|466968655|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
129729173|NCT01263015|466968654|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
129729174|NCT01263015|466968655|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
129729175|NCT02723006|466968656|FG000|Overall Study|Withdrawal by Subject|0|||
129729176|NCT02723006|466968657|FG001|Overall Study|Withdrawal by Subject|1|||
129729177|NCT02723006|466968658|FG002|Overall Study|Withdrawal by Subject|1|||
129729178|NCT02723006|466968656|FG000|Overall Study|Study Terminated by Sponsor|1|||
129729179|NCT02723006|466968657|FG001|Overall Study|Study Terminated by Sponsor|6|||
129729180|NCT02723006|466968658|FG002|Overall Study|Study Terminated by Sponsor|6|||
129729181|NCT00303446|466968659|FG000|Overall Study|Withdrawal by Subject|2|||
129892154|NCT02179918|467565350|FG003|Overall Study|Progressive Disease|2|||
129892155|NCT02179918|467565351|FG004|Overall Study|Progressive Disease|6|||
129892156|NCT02179918|467565347|FG000|Overall Study|Other|0|||
129892157|NCT02179918|467565348|FG001|Overall Study|Other|1|||
129892158|NCT02179918|467565349|FG002|Overall Study|Other|0|||
129892159|NCT02179918|467565350|FG003|Overall Study|Other|0|||
129892160|NCT02179918|467565351|FG004|Overall Study|Other|1|||
129892161|NCT02179918|467565347|FG000|Overall Study|Subject refused further follow-up|0|||
129892162|NCT02179918|467565348|FG001|Overall Study|Subject refused further follow-up|1|||
129892163|NCT02179918|467565349|FG002|Overall Study|Subject refused further follow-up|0|||
129892164|NCT02179918|467565350|FG003|Overall Study|Subject refused further follow-up|0|||
129729182|NCT00303446|466968660|FG001|Overall Study|Withdrawal by Subject|2|||
129729183|NCT00303446|466968659|FG000|Overall Study|Death|0|||
129729184|NCT00303446|466968660|FG001|Overall Study|Death|1|||
129729185|NCT00303446|466968659|FG000|Overall Study|Physician Decision|0|||
129729186|NCT00303446|466968660|FG001|Overall Study|Physician Decision|1|||
129729187|NCT04258995|466968661|FG000|Overall Study|Lost to Follow-up|1|||
129729188|NCT04258995|466968662|FG001|Overall Study|Lost to Follow-up|1|||
129729189|NCT00642174|466968664|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
129729190|NCT00642174|466968665|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
129729191|NCT00896363|466968666|FG000|Overall Study|Adverse Event|3|||
129729192|NCT00896363|466968667|FG001|Overall Study|Adverse Event|4|||
129729193|NCT00896363|466968668|FG002|Overall Study|Adverse Event|2|||
129729194|NCT00896363|466968666|FG000|Overall Study|Lack of Efficacy|0|||
129729195|NCT00896363|466968667|FG001|Overall Study|Lack of Efficacy|2|||
129729196|NCT00896363|466968668|FG002|Overall Study|Lack of Efficacy|1|||
129729197|NCT00896363|466968666|FG000|Overall Study|Withdrawal by Subject|3|||
129892165|NCT02179918|467565351|FG004|Overall Study|Subject refused further follow-up|1|||
129892166|NCT00972543|467565356|FG000|Overall Study|Adverse Event|1|||
129892167|NCT00972543|467565357|FG001|Overall Study|Adverse Event|0|||
129892168|NCT00972543|467565356|FG000|Overall Study|Early study termination by sponsor|4|||
129892169|NCT00972543|467565357|FG001|Overall Study|Early study termination by sponsor|1|||
129892170|NCT04537949|467565360|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
129892171|NCT04537949|467565361|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
129892172|NCT04537949|467565362|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
129892173|NCT04537949|467565363|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
129729198|NCT00896363|466968667|FG001|Overall Study|Withdrawal by Subject|5|||
129729199|NCT00896363|466968668|FG002|Overall Study|Withdrawal by Subject|5|||
129729200|NCT00316693|466968673|FG000|Overall Study|Adverse Event|6|||
129729201|NCT00316693|466968674|FG001|Overall Study|Adverse Event|1|||
129729202|NCT00316693|466968673|FG000|Overall Study|Protocol Violation|1|||
129729203|NCT00316693|466968674|FG001|Overall Study|Protocol Violation|0|||
129729204|NCT00316693|466968673|FG000|Overall Study|Withdrawal by Subject|6|||
129729205|NCT00316693|466968674|FG001|Overall Study|Withdrawal by Subject|6|||
129729206|NCT00316693|466968673|FG000|Overall Study|Lost to Follow-up|26|||
129729207|NCT00316693|466968674|FG001|Overall Study|Lost to Follow-up|34|||
129729208|NCT00316693|466968673|FG000|Overall Study|Other|38|||
129729209|NCT00316693|466968674|FG001|Overall Study|Other|44|||
129729210|NCT03002818|466968677|FG000|Overall Study|Decision of the investigator|1|||
129729211|NCT00711113|466968679|FG000|Overall Study|Lost to Follow-up|9|||
129729212|NCT00711113|466968679|FG000|Overall Study|Implant lost|2|||
129729213|NCT01606787|466968686|FG000|Overall Study|Withdrawal by Subject|4|||
129729214|NCT01606787|466968687|FG001|Overall Study|Withdrawal by Subject|5|||
129729215|NCT01606787|466968686|FG000|Overall Study|Surgery canceled|0|||
129892174|NCT04537949|467565364|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
129892175|NCT04537949|467565365|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
129892176|NCT04537949|467565366|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
129729216|NCT01606787|466968687|FG001|Overall Study|Surgery canceled|2|||
129729217|NCT04225676|466968688|FG000|Overall Study|Physician Decision|1|||
129729218|NCT04225676|466968688|FG000|Overall Study|Lack of Efficacy|1|||
129729219|NCT04225676|466968688|FG000|Overall Study|Study terminated by sponsor|3|||
129729220|NCT03245736|466968689|FG000|Overall Study|Adverse Event|1|||
129729221|NCT03245736|466968689|FG000|Overall Study|Progressive Disease|4|||
129729222|NCT00354107|466968695|FG000|Overall Study|Adverse Event|2|||
129729223|NCT00354107|466968695|FG000|Overall Study|Physician Decision|2|||
129729224|NCT00354107|466968695|FG000|Overall Study|Withdrawal by Subject|1|||
129729225|NCT01685801|466968698|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
129729226|NCT01685801|466968699|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
129729227|NCT01685801|466968700|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
129729228|NCT01685801|466968701|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
129729229|NCT01685801|466968698|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
129729230|NCT01685801|466968699|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
129729231|NCT01685801|466968700|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
129729232|NCT01685801|466968701|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
129444457|NCT01822522|465927345|FG002|Overall Study|Withdrawal by Subject|0|||
129729233|NCT04686084|466968702|FG000|Overall Study|Lost to Follow-up|1|||
129729234|NCT03447314|466968706|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
129729235|NCT03447314|466968707|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
129729236|NCT03447314|466968708|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
129729237|NCT03447314|466968709|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
129729238|NCT03447314|466968710|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
129729239|NCT03447314|466968711|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
129729240|NCT03447314|466968712|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
129729241|NCT03447314|466968713|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729242|NCT03447314|466968714|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729243|NCT03447314|466968715|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729244|NCT03447314|466968716|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
129729245|NCT03447314|466968717|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
129892177|NCT04537949|467565367|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
129729246|NCT03447314|466968718|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729247|NCT03447314|466968719|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729248|NCT03447314|466968720|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729249|NCT03447314|466968721|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729250|NCT03447314|466968722|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729251|NCT03447314|466968723|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
129729252|NCT03447314|466968706|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129729253|NCT03447314|466968707|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729254|NCT03447314|466968708|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129729255|NCT03447314|466968709|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729256|NCT03447314|466968710|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729257|NCT03447314|466968711|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129729258|NCT03447314|466968712|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
129729259|NCT03447314|466968713|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729260|NCT03447314|466968714|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729261|NCT03447314|466968715|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729262|NCT03447314|466968716|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729263|NCT03447314|466968717|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729264|NCT03447314|466968718|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129444458|NCT01822522|465927346|FG003|Overall Study|Withdrawal by Subject|1|||
129444459|NCT01822522|465927347|FG004|Overall Study|Withdrawal by Subject|0|||
129729265|NCT03447314|466968719|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129892178|NCT04537949|467565360|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
129444460|NCT01822522|465927348|FG005|Overall Study|Withdrawal by Subject|0|||
129444461|NCT01822522|465927343|FG000|Overall Study|Lack of Efficacy|0|||
129892179|NCT04537949|467565361|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
129892180|NCT04537949|467565362|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
129892181|NCT04537949|467565363|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
129892182|NCT04537949|467565364|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
129892183|NCT04537949|467565365|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
129892184|NCT04537949|467565366|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
129892185|NCT04537949|467565367|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
129892186|NCT04537949|467565360|FG000|Follow-up Phase|Lost to Follow-up|0|||
129892187|NCT04537949|467565361|FG001|Follow-up Phase|Lost to Follow-up|3|||
129892188|NCT04537949|467565362|FG002|Follow-up Phase|Lost to Follow-up|0|||
129892189|NCT04537949|467565363|FG003|Follow-up Phase|Lost to Follow-up|0|||
129892190|NCT04537949|467565364|FG004|Follow-up Phase|Lost to Follow-up|0|||
129892191|NCT04537949|467565365|FG005|Follow-up Phase|Lost to Follow-up|0|||
129892192|NCT04537949|467565366|FG006|Follow-up Phase|Lost to Follow-up|0|||
129892193|NCT04537949|467565367|FG007|Follow-up Phase|Lost to Follow-up|0|||
129892194|NCT04537949|467565360|FG000|Follow-up Phase|personal reasons|0|||
129892195|NCT04537949|467565361|FG001|Follow-up Phase|personal reasons|0|||
129892196|NCT04537949|467565362|FG002|Follow-up Phase|personal reasons|0|||
129892197|NCT04537949|467565363|FG003|Follow-up Phase|personal reasons|1|||
129892198|NCT04537949|467565364|FG004|Follow-up Phase|personal reasons|1|||
129892199|NCT04537949|467565365|FG005|Follow-up Phase|personal reasons|0|||
129892200|NCT04537949|467565366|FG006|Follow-up Phase|personal reasons|0|||
129892201|NCT04537949|467565367|FG007|Follow-up Phase|personal reasons|0|||
129729266|NCT03447314|466968720|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729267|NCT03447314|466968721|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729268|NCT03447314|466968722|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729269|NCT03447314|466968723|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
129729270|NCT03447314|466968706|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729271|NCT03447314|466968707|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729272|NCT03447314|466968708|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
129729273|NCT03447314|466968709|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729274|NCT03447314|466968710|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729275|NCT03447314|466968711|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729276|NCT03447314|466968712|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729277|NCT03447314|466968713|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729278|NCT03447314|466968714|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729279|NCT03447314|466968715|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729280|NCT03447314|466968716|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729281|NCT03447314|466968717|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729282|NCT03447314|466968718|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729283|NCT03447314|466968719|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129892202|NCT04537949|467565360|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129892203|NCT04537949|467565361|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129892204|NCT04537949|467565362|FG002|Follow-up Phase|Withdrawal by Subject|0|||
129892205|NCT04537949|467565363|FG003|Follow-up Phase|Withdrawal by Subject|0|||
129892206|NCT04537949|467565364|FG004|Follow-up Phase|Withdrawal by Subject|1|||
129892207|NCT04537949|467565365|FG005|Follow-up Phase|Withdrawal by Subject|0|||
129892208|NCT04537949|467565366|FG006|Follow-up Phase|Withdrawal by Subject|0|||
129892209|NCT04537949|467565367|FG007|Follow-up Phase|Withdrawal by Subject|0|||
129892210|NCT04003974|467565369|FG000|Overall Study|Missing|1|||
129892211|NCT04003974|467565370|FG001|Overall Study|Missing|0|||
129892212|NCT04003974|467565369|FG000|Overall Study|Withdrawal by Subject|0|||
129892213|NCT04003974|467565370|FG001|Overall Study|Withdrawal by Subject|2|||
129892214|NCT04296942|467565371|FG000|Overall Study|Study closure by sponsor|1|||
129892215|NCT04296942|467565372|FG001|Overall Study|Study closure by sponsor|0|||
129892216|NCT04296942|467565373|FG002|Overall Study|Study closure by sponsor|0|||
129892217|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
129892218|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
129444462|NCT01822522|465927344|FG001|Overall Study|Lack of Efficacy|0|||
129444463|NCT01822522|465927345|FG002|Overall Study|Lack of Efficacy|0|||
129729284|NCT03447314|466968720|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129892219|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
129892220|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
129892221|NCT00335153|467565374|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
129892222|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
129892223|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
129892224|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
129892225|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
129892226|NCT00335153|467565374|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
129892227|NCT02478359|467565375|FG000|Overall Study|Disenrolled from health plan|106|||
129892228|NCT02478359|467565376|FG001|Overall Study|Disenrolled from health plan|65|||
129892229|NCT00372528|467565377|FG000|Overall Study|Lack of Efficacy|1|||
129892230|NCT00372528|467565377|FG000|Overall Study|Adverse Event|1|||
129892231|NCT00372528|467565377|FG000|Overall Study|Study Terminated by Sponsor|18|||
129892232|NCT00372528|467565377|FG000|Overall Study|Other|1|||
129892233|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
129892234|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
129892235|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
129892236|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
129892237|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
129892238|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
129892239|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
129892240|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
129892241|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
129892242|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
129892243|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
129892244|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
129892245|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
129892246|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
129892247|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
129892248|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
129892249|NCT02240680|467565378|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
129892250|NCT02240680|467565379|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
129892251|NCT02240680|467565380|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
129892252|NCT02240680|467565381|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
129892253|NCT02240680|467565378|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
129892254|NCT02240680|467565379|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
129892255|NCT02240680|467565380|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
129892256|NCT02240680|467565381|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
129892257|NCT02240680|467565378|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
129892258|NCT02240680|467565379|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
129892259|NCT02240680|467565380|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
129892260|NCT02240680|467565381|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
129892261|NCT02240680|467565378|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
129892262|NCT02240680|467565379|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
129892263|NCT02240680|467565380|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
129892264|NCT02240680|467565381|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
129892265|NCT00562965|467565382|FG000|Overall Study|Withdrawal by Subject|0|||
129892266|NCT00562965|467565383|FG001|Overall Study|Withdrawal by Subject|1|||
129892267|NCT00562965|467565382|FG000|Overall Study|Death|2|||
129892268|NCT00562965|467565383|FG001|Overall Study|Death|4|||
129892269|NCT00562965|467565382|FG000|Overall Study|Lost to Follow-up|1|||
129892270|NCT00562965|467565383|FG001|Overall Study|Lost to Follow-up|0|||
129892271|NCT00562965|467565382|FG000|Overall Study|Other|0|||
129892272|NCT00562965|467565383|FG001|Overall Study|Other|1|||
129892273|NCT00965484|467565387|FG000|Overall Study|Protocol Violation|1|||
129892274|NCT00965484|467565387|FG000|Overall Study|Withdrawal by Subject|1|||
129892275|NCT00848211|467565388|FG000|Overall Study|Protocol Violation|0|||
129892276|NCT00848211|467565389|FG001|Overall Study|Protocol Violation|1|||
129892277|NCT00848211|467565390|FG002|Overall Study|Protocol Violation|1|||
129892278|NCT00848211|467565391|FG003|Overall Study|Protocol Violation|0|||
129892279|NCT00848211|467565388|FG000|Overall Study|Adverse Event|0|||
129892280|NCT00848211|467565389|FG001|Overall Study|Adverse Event|0|||
129892281|NCT00848211|467565390|FG002|Overall Study|Adverse Event|0|||
129892282|NCT00848211|467565391|FG003|Overall Study|Adverse Event|0|||
129892283|NCT01124617|467565392|FG000|Overall Study|Adverse Event|5|||
129892284|NCT01124617|467565393|FG001|Overall Study|Adverse Event|2|||
129892285|NCT01124617|467565392|FG000|Overall Study|Lack of Efficacy|2|||
129892286|NCT01124617|467565393|FG001|Overall Study|Lack of Efficacy|1|||
129892287|NCT01124617|467565392|FG000|Overall Study|Protocol Violation|1|||
129892288|NCT01124617|467565393|FG001|Overall Study|Protocol Violation|1|||
129892289|NCT01124617|467565392|FG000|Overall Study|Withdrawal by Subject|9|||
129892290|NCT01124617|467565393|FG001|Overall Study|Withdrawal by Subject|1|||
129892291|NCT01124617|467565392|FG000|Overall Study|Other|2|||
129892292|NCT01124617|467565393|FG001|Overall Study|Other|1|||
129892293|NCT00945477|467565394|FG000|Overall Study|Adverse Event|3|||
129892294|NCT00945477|467565394|FG000|Overall Study|Lack of Efficacy|2|||
129892295|NCT00945477|467565394|FG000|Overall Study|Withdrawal by Subject|1|||
129892296|NCT00619151|467565395|FG000|Overall Study|Study terminated prior to followup|1|||
129892297|NCT00619151|467565396|FG001|Overall Study|Study terminated prior to followup|0|||
129892298|NCT02825043|467565397|FG000|Overall Study|Lost to Follow-up|4|||
129892299|NCT03582137|467565400|FG000|Overall Study|Adverse Event|1|||
129892300|NCT03582137|467565401|FG001|Overall Study|Adverse Event|0|||
129892301|NCT01982760|467565402|FG000|Overall Study|Physician Decision|1|||
129892302|NCT01982760|467565403|FG001|Overall Study|Physician Decision|0|||
129892303|NCT03704298|467565405|FG000|Overall Study|Death|3|||
129892304|NCT03704298|467565406|FG001|Overall Study|Death|1|||
129729285|NCT03447314|466968721|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729286|NCT03447314|466968722|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729287|NCT03447314|466968723|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
129729288|NCT03447314|466968706|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729289|NCT03447314|466968707|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729290|NCT03447314|466968708|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
129729291|NCT03447314|466968709|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729292|NCT03447314|466968710|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729293|NCT03447314|466968711|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729294|NCT03447314|466968712|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729295|NCT03447314|466968713|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729296|NCT03447314|466968714|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729297|NCT03447314|466968715|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729298|NCT03447314|466968716|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729299|NCT03447314|466968717|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729300|NCT03447314|466968718|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729301|NCT03447314|466968719|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729302|NCT03447314|466968720|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729303|NCT03447314|466968721|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729304|NCT03447314|466968722|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729305|NCT03447314|466968723|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
129729306|NCT03447314|466968706|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729307|NCT03447314|466968707|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729308|NCT03447314|466968708|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729309|NCT03447314|466968709|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729310|NCT03447314|466968710|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729311|NCT03447314|466968711|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729312|NCT03447314|466968712|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729313|NCT03447314|466968713|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729314|NCT03447314|466968714|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729315|NCT03447314|466968715|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729316|NCT03447314|466968716|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
129729317|NCT03447314|466968717|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729318|NCT03447314|466968718|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729319|NCT03447314|466968719|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729320|NCT03447314|466968720|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729321|NCT03447314|466968721|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729322|NCT03447314|466968722|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729323|NCT03447314|466968723|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
129729324|NCT03447314|466968706|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729325|NCT03447314|466968707|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729326|NCT03447314|466968708|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729327|NCT03447314|466968709|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
129729328|NCT03447314|466968710|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729329|NCT03447314|466968711|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
129729330|NCT03447314|466968712|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729331|NCT03447314|466968713|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729332|NCT03447314|466968714|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729333|NCT03447314|466968715|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729334|NCT03447314|466968716|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729335|NCT03447314|466968717|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729336|NCT03447314|466968718|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729337|NCT03447314|466968719|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729338|NCT03447314|466968720|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729339|NCT03447314|466968721|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729340|NCT03447314|466968722|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729341|NCT03447314|466968723|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
129729342|NCT04600076|466968724|FG000|Overall Study|Lost to Follow-up|3|||
129729343|NCT02891681|466968725|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
129729344|NCT02891681|466968726|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
129729345|NCT02891681|466968727|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
129729346|NCT02891681|466968725|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
129729347|NCT02891681|466968726|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
129729348|NCT02891681|466968727|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
129729349|NCT02891681|466968725|FG000|Overall Study|Taken off study after first imaging appointment|1|||
129729350|NCT02891681|466968726|FG001|Overall Study|Taken off study after first imaging appointment|0|||
129729351|NCT02891681|466968727|FG002|Overall Study|Taken off study after first imaging appointment|0|||
129729352|NCT00957944|466968731|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
129729353|NCT00957944|466968732|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
129729354|NCT01482169|466968733|FG000|Overall Study|Physician Decision|2|||
129729355|NCT00522418|466968734|FG000|Overall Study|Local IRB Consent Violation|5|||
129729356|NCT00522418|466968735|FG001|Overall Study|Local IRB Consent Violation|5|||
129729357|NCT00522418|466968734|FG000|Overall Study|Early Study Termination|46|||
129729358|NCT00522418|466968735|FG001|Overall Study|Early Study Termination|47|||
129729359|NCT00522418|466968734|FG000|Overall Study|Noncompliance|2|||
129729360|NCT00522418|466968735|FG001|Overall Study|Noncompliance|2|||
129729361|NCT00522418|466968734|FG000|Overall Study|Reason Not Specified|3|||
129729362|NCT00522418|466968735|FG001|Overall Study|Reason Not Specified|1|||
129729363|NCT00522418|466968734|FG000|Overall Study|Consent Withdraw|1|||
129729364|NCT00522418|466968735|FG001|Overall Study|Consent Withdraw|2|||
129729365|NCT00522418|466968734|FG000|Overall Study|Lack of Efficacy|0|||
129729366|NCT00522418|466968735|FG001|Overall Study|Lack of Efficacy|1|||
129729367|NCT00578877|466968738|FG000|Overall Study|Lost to Follow-up|8|||
129729368|NCT00578877|466968739|FG001|Overall Study|Lost to Follow-up|10|||
129729369|NCT00578877|466968738|FG000|Overall Study|early discontinue|61|||
129729370|NCT00578877|466968739|FG001|Overall Study|early discontinue|101|||
129892305|NCT03704298|467565407|FG002|Overall Study|Death|1|||
129892306|NCT03704298|467565408|FG003|Overall Study|Death|0|||
129892307|NCT03704298|467565405|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
129892308|NCT03704298|467565406|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
129892309|NCT03704298|467565407|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
129892310|NCT03704298|467565408|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
129892311|NCT03704298|467565405|FG000|Overall Study|Withdrawal by Subject|1|||
129892312|NCT03704298|467565406|FG001|Overall Study|Withdrawal by Subject|0|||
129892313|NCT03704298|467565407|FG002|Overall Study|Withdrawal by Subject|0|||
129729371|NCT00578877|466968738|FG000|Overall Study|did not provide follow-up data|12|||
129729372|NCT00578877|466968739|FG001|Overall Study|did not provide follow-up data|17|||
129729373|NCT02437409|466968744|FG000|Overall Study|Withdrawal by Subject|3|||
129729374|NCT02437409|466968744|FG000|Overall Study|Screening failure|12|||
129729375|NCT00737568|466968747|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
129729376|NCT00737568|466968748|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
129729377|NCT00737568|466968747|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
129729378|NCT00737568|466968748|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
129729379|NCT00737568|466968747|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
129729380|NCT00737568|466968748|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
129729381|NCT00737568|466968747|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
129729382|NCT00737568|466968748|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
129729383|NCT00737568|466968747|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
129729384|NCT00737568|466968748|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
129729385|NCT00737568|466968747|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
129729386|NCT00737568|466968748|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
129729387|NCT00737568|466968747|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
129729388|NCT00737568|466968748|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
129729389|NCT00737568|466968747|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
129729390|NCT00737568|466968748|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
129892314|NCT03704298|467565408|FG003|Overall Study|Withdrawal by Subject|0|||
129892315|NCT03704298|467565405|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
129892316|NCT03704298|467565406|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
129892317|NCT03704298|467565407|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
129892318|NCT03704298|467565408|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
129892319|NCT02303574|467565411|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892320|NCT02303574|467565412|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892321|NCT02303574|467565413|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
129892322|NCT02303574|467565414|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892323|NCT02303574|467565415|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129729391|NCT00737568|466968747|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
129729392|NCT00737568|466968748|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
129729393|NCT00855933|466968749|FG000|Overall Study|Withdrawal by Subject|0|||
129729394|NCT00855933|466968750|FG001|Overall Study|Withdrawal by Subject|1|||
129729395|NCT00951080|466968751|FG000|Overall Study|Adverse Event|3|||
129729396|NCT00951080|466968752|FG001|Overall Study|Adverse Event|3|||
129729397|NCT00951080|466968751|FG000|Overall Study|Lost to Follow-up|0|||
129729398|NCT00951080|466968752|FG001|Overall Study|Lost to Follow-up|1|||
129729399|NCT00951080|466968751|FG000|Overall Study|Physician Decision|4|||
129729400|NCT00951080|466968752|FG001|Overall Study|Physician Decision|1|||
129729401|NCT00951080|466968751|FG000|Overall Study|Other|19|||
129729402|NCT00951080|466968752|FG001|Overall Study|Other|22|||
129729403|NCT01960998|466968753|FG000|Overall Study|Lost to Follow-up|3|||
129729404|NCT01960998|466968754|FG001|Overall Study|Lost to Follow-up|7|||
129729405|NCT01960998|466968753|FG000|Overall Study|Death|0|||
129729406|NCT01960998|466968754|FG001|Overall Study|Death|1|||
129729407|NCT01960998|466968753|FG000|Overall Study|Withdrawal by Subject|8|||
129729408|NCT01960998|466968754|FG001|Overall Study|Withdrawal by Subject|2|||
129729409|NCT01960998|466968753|FG000|Overall Study|lost computer access|0|||
129729410|NCT01960998|466968754|FG001|Overall Study|lost computer access|1|||
129729411|NCT00759356|466968755|FG000|Overall Study|Adverse Event|0|||
129729412|NCT00759356|466968756|FG001|Overall Study|Adverse Event|1|||
129729413|NCT00759356|466968755|FG000|Overall Study|Withdrawal by Subject|0|||
129729414|NCT00759356|466968756|FG001|Overall Study|Withdrawal by Subject|2|||
129729415|NCT00759356|466968755|FG000|Overall Study|Subject was unable to return|1|||
129729416|NCT00759356|466968756|FG001|Overall Study|Subject was unable to return|0|||
129729417|NCT01713283|466968760|FG000|Overall Study|Lack of Efficacy|10|||
129729418|NCT01713283|466968761|FG001|Overall Study|Lack of Efficacy|2|||
129729419|NCT01713283|466968760|FG000|Overall Study|Lost to Follow-up|1|||
129729420|NCT01713283|466968761|FG001|Overall Study|Lost to Follow-up|1|||
129729421|NCT01904149|466968767|FG000|Overall Study|Adverse Event|3|||
129729422|NCT01904149|466968768|FG001|Overall Study|Adverse Event|4|||
129729423|NCT01904149|466968769|FG002|Overall Study|Adverse Event|0|||
129729424|NCT01904149|466968770|FG003|Overall Study|Adverse Event|1|||
129729425|NCT01904149|466968771|FG004|Overall Study|Adverse Event|1|||
129729426|NCT01904149|466968772|FG005|Overall Study|Adverse Event|2|||
129729427|NCT01904149|466968767|FG000|Overall Study|Lack of Efficacy|0|||
129729428|NCT01904149|466968768|FG001|Overall Study|Lack of Efficacy|3|||
129729429|NCT01904149|466968769|FG002|Overall Study|Lack of Efficacy|1|||
129729430|NCT01904149|466968770|FG003|Overall Study|Lack of Efficacy|3|||
129729431|NCT01904149|466968771|FG004|Overall Study|Lack of Efficacy|3|||
129729432|NCT01904149|466968772|FG005|Overall Study|Lack of Efficacy|1|||
129729433|NCT01904149|466968767|FG000|Overall Study|Withdrawal by Subject|1|||
129729434|NCT01904149|466968768|FG001|Overall Study|Withdrawal by Subject|3|||
129729435|NCT01904149|466968769|FG002|Overall Study|Withdrawal by Subject|1|||
129729436|NCT01904149|466968770|FG003|Overall Study|Withdrawal by Subject|0|||
129729437|NCT01904149|466968771|FG004|Overall Study|Withdrawal by Subject|1|||
129729438|NCT01904149|466968772|FG005|Overall Study|Withdrawal by Subject|0|||
129729439|NCT01904149|466968767|FG000|Overall Study|Protocol Violation|0|||
129729440|NCT01904149|466968768|FG001|Overall Study|Protocol Violation|1|||
129729441|NCT01904149|466968769|FG002|Overall Study|Protocol Violation|0|||
129729442|NCT01904149|466968770|FG003|Overall Study|Protocol Violation|0|||
129729443|NCT01904149|466968771|FG004|Overall Study|Protocol Violation|0|||
129729444|NCT01904149|466968772|FG005|Overall Study|Protocol Violation|0|||
129729445|NCT01904149|466968767|FG000|Overall Study|non compliance with study drug|1|||
129729446|NCT01904149|466968768|FG001|Overall Study|non compliance with study drug|0|||
129729447|NCT01904149|466968769|FG002|Overall Study|non compliance with study drug|0|||
129729448|NCT01904149|466968770|FG003|Overall Study|non compliance with study drug|0|||
129729449|NCT01904149|466968771|FG004|Overall Study|non compliance with study drug|0|||
129729450|NCT01904149|466968772|FG005|Overall Study|non compliance with study drug|0|||
129729451|NCT00812006|466968773|FG000|Overall Study|Lost to Follow-up|0|||
129729452|NCT00812006|466968774|FG001|Overall Study|Lost to Follow-up|0|||
129729453|NCT00812006|466968775|FG002|Overall Study|Lost to Follow-up|2|||
129729454|NCT00812006|466968773|FG000|Overall Study|Physician Decision|0|||
129729455|NCT00812006|466968774|FG001|Overall Study|Physician Decision|0|||
129729456|NCT00812006|466968775|FG002|Overall Study|Physician Decision|1|||
129729457|NCT00812006|466968773|FG000|Overall Study|Withdrawal by Subject|2|||
129729458|NCT00812006|466968774|FG001|Overall Study|Withdrawal by Subject|1|||
129729459|NCT00812006|466968775|FG002|Overall Study|Withdrawal by Subject|1|||
129729460|NCT00812006|466968773|FG000|Overall Study|Lack of Qualifying Event|4|||
129729461|NCT00812006|466968774|FG001|Overall Study|Lack of Qualifying Event|2|||
129729462|NCT00812006|466968775|FG002|Overall Study|Lack of Qualifying Event|2|||
129729463|NCT00235391|466968776|FG000|Overall Study|Adverse Event|4|||
129729464|NCT00235391|466968777|FG001|Overall Study|Adverse Event|5|||
129729465|NCT00235391|466968778|FG002|Overall Study|Adverse Event|10|||
129729466|NCT00235391|466968779|FG003|Overall Study|Adverse Event|72|||
129729467|NCT00235391|466968780|FG004|Overall Study|Adverse Event|5|||
129729468|NCT00235391|466968781|FG005|Overall Study|Adverse Event|2|||
129729469|NCT00235391|466968776|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129729470|NCT00235391|466968777|FG001|Overall Study|Abnormal laboratory value(s)|5|||
129729471|NCT00235391|466968778|FG002|Overall Study|Abnormal laboratory value(s)|4|||
129729472|NCT00235391|466968779|FG003|Overall Study|Abnormal laboratory value(s)|27|||
129729473|NCT00235391|466968780|FG004|Overall Study|Abnormal laboratory value(s)|1|||
129729474|NCT00235391|466968781|FG005|Overall Study|Abnormal laboratory value(s)|2|||
129729475|NCT00235391|466968776|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129729476|NCT00235391|466968777|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129729477|NCT00235391|466968778|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129729478|NCT00235391|466968779|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
129729479|NCT00235391|466968780|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
129729480|NCT00235391|466968781|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
129729481|NCT00235391|466968776|FG000|Overall Study|Condition no longer requires treatment|3|||
129729482|NCT00235391|466968777|FG001|Overall Study|Condition no longer requires treatment|0|||
129729483|NCT00235391|466968778|FG002|Overall Study|Condition no longer requires treatment|0|||
129729484|NCT00235391|466968779|FG003|Overall Study|Condition no longer requires treatment|11|||
129729485|NCT00235391|466968780|FG004|Overall Study|Condition no longer requires treatment|1|||
129729486|NCT00235391|466968781|FG005|Overall Study|Condition no longer requires treatment|0|||
129729487|NCT00235391|466968776|FG000|Overall Study|Protocol deviation|0|||
129729488|NCT00235391|466968777|FG001|Overall Study|Protocol deviation|0|||
129729489|NCT00235391|466968778|FG002|Overall Study|Protocol deviation|1|||
129729490|NCT00235391|466968779|FG003|Overall Study|Protocol deviation|11|||
129729491|NCT00235391|466968780|FG004|Overall Study|Protocol deviation|0|||
129729492|NCT00235391|466968781|FG005|Overall Study|Protocol deviation|0|||
129729493|NCT00235391|466968776|FG000|Overall Study|Withdrawal by Subject|2|||
129729494|NCT00235391|466968777|FG001|Overall Study|Withdrawal by Subject|3|||
129729495|NCT00235391|466968778|FG002|Overall Study|Withdrawal by Subject|3|||
129729496|NCT00235391|466968779|FG003|Overall Study|Withdrawal by Subject|61|||
129729497|NCT00235391|466968780|FG004|Overall Study|Withdrawal by Subject|5|||
129729498|NCT00235391|466968781|FG005|Overall Study|Withdrawal by Subject|0|||
129729499|NCT00235391|466968776|FG000|Overall Study|Lost to Follow-up|0|||
129729500|NCT00235391|466968777|FG001|Overall Study|Lost to Follow-up|3|||
129729501|NCT00235391|466968778|FG002|Overall Study|Lost to Follow-up|3|||
129729502|NCT00235391|466968779|FG003|Overall Study|Lost to Follow-up|16|||
129729503|NCT00235391|466968780|FG004|Overall Study|Lost to Follow-up|0|||
129729504|NCT00235391|466968781|FG005|Overall Study|Lost to Follow-up|0|||
129729505|NCT00235391|466968776|FG000|Overall Study|Administrative problems|0|||
129729506|NCT00235391|466968777|FG001|Overall Study|Administrative problems|0|||
129729507|NCT00235391|466968778|FG002|Overall Study|Administrative problems|0|||
129729508|NCT00235391|466968779|FG003|Overall Study|Administrative problems|1|||
129729509|NCT00235391|466968780|FG004|Overall Study|Administrative problems|0|||
129729510|NCT00235391|466968781|FG005|Overall Study|Administrative problems|0|||
129729511|NCT00235391|466968776|FG000|Overall Study|Death|0|||
129729512|NCT00235391|466968777|FG001|Overall Study|Death|0|||
129729513|NCT00235391|466968778|FG002|Overall Study|Death|1|||
129729514|NCT00235391|466968779|FG003|Overall Study|Death|4|||
129729515|NCT00235391|466968780|FG004|Overall Study|Death|0|||
129729516|NCT00235391|466968781|FG005|Overall Study|Death|0|||
129729517|NCT00098748|466968785|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
129729518|NCT00098748|466968786|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
129729519|NCT00098748|466968787|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
129729520|NCT00098748|466968785|FG000|Received Study Treatment|Death|2|||
129729521|NCT00098748|466968786|FG001|Received Study Treatment|Death|1|||
129729522|NCT00098748|466968787|FG002|Received Study Treatment|Death|2|||
129729523|NCT00098748|466968785|FG000|Received Study Treatment|Adverse Event|1|||
129729524|NCT00098748|466968786|FG001|Received Study Treatment|Adverse Event|2|||
129729525|NCT00098748|466968787|FG002|Received Study Treatment|Adverse Event|5|||
129729526|NCT00098748|466968785|FG000|Received Study Treatment|Lack of Efficacy|40|||
129729527|NCT00098748|466968786|FG001|Received Study Treatment|Lack of Efficacy|27|||
129729528|NCT00098748|466968787|FG002|Received Study Treatment|Lack of Efficacy|27|||
129729529|NCT00098748|466968785|FG000|Received Study Treatment|Other|2|||
129729530|NCT00098748|466968786|FG001|Received Study Treatment|Other|2|||
129729531|NCT00098748|466968787|FG002|Received Study Treatment|Other|6|||
129729532|NCT00098748|466968785|FG000|Received Study Treatment|Subject defaulted|3|||
129729533|NCT00098748|466968786|FG001|Received Study Treatment|Subject defaulted|4|||
129729534|NCT00098748|466968787|FG002|Received Study Treatment|Subject defaulted|4|||
129729535|NCT00098748|466968785|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
129729536|NCT00098748|466968786|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
129729537|NCT00098748|466968787|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
129729538|NCT00098748|466968785|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
129729539|NCT00098748|466968786|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
129729540|NCT00098748|466968787|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
129729541|NCT00098748|466968785|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
129729542|NCT00098748|466968786|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
129729543|NCT00098748|466968787|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
129729544|NCT00098748|466968785|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
129729545|NCT00098748|466968786|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
129729546|NCT00098748|466968787|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
129729547|NCT00098748|466968785|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
129729548|NCT00098748|466968786|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
129729549|NCT00098748|466968787|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
129729550|NCT00570037|466968788|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
129729551|NCT00570037|466968789|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
129729552|NCT01081301|466968792|FG000|Overall Study|Bereaved|3|||
129729553|NCT01081301|466968792|FG000|Overall Study|Too busy|5|||
129729554|NCT01081301|466968792|FG000|Overall Study|Patient too ill|2|||
129729555|NCT01081301|466968792|FG000|Overall Study|Lost to Follow-up|4|||
129729556|NCT03551665|466968793|FG000|Overall Study|Lost to Follow-up|11|||
129729557|NCT03551665|466968794|FG001|Overall Study|Lost to Follow-up|2|||
129729558|NCT00413894|466970724|FG000|Overall Study|Withdrawal by Subject|10|||
129729559|NCT00413894|466970724|FG000|Overall Study|Administrative Reasons|1|||
129729560|NCT00413894|466970724|FG000|Overall Study|Hb <10 grams/deciliter|12|||
129729561|NCT00413894|466970724|FG000|Overall Study|Adverse Event|28|||
129729562|NCT00413894|466970724|FG000|Overall Study|Protocol Violation|11|||
129729563|NCT00413894|466970724|FG000|Overall Study|Other|18|||
129729564|NCT01942161|466970725|FG000|Overall Study|Adverse Event|1|||
129729565|NCT01942161|466970726|FG001|Overall Study|Adverse Event|2|||
129729566|NCT01942161|466970727|FG002|Overall Study|Adverse Event|5|||
129729567|NCT01942161|466970725|FG000|Overall Study|Physician Decision|3|||
129729568|NCT01942161|466970726|FG001|Overall Study|Physician Decision|1|||
129729569|NCT01942161|466970727|FG002|Overall Study|Physician Decision|0|||
129729570|NCT01942161|466970725|FG000|Overall Study|Protocol Violation|1|||
129729571|NCT01942161|466970726|FG001|Overall Study|Protocol Violation|0|||
129729572|NCT01942161|466970727|FG002|Overall Study|Protocol Violation|0|||
129729573|NCT01942161|466970725|FG000|Overall Study|Withdrawal by Subject|3|||
129729574|NCT01942161|466970726|FG001|Overall Study|Withdrawal by Subject|3|||
129729575|NCT01942161|466970727|FG002|Overall Study|Withdrawal by Subject|1|||
129729576|NCT02251717|466970731|FG000|Overall Study|Adverse Event|0|||
129729577|NCT02251717|466970732|FG001|Overall Study|Adverse Event|1|||
129729578|NCT02251717|466970731|FG000|Overall Study|Withdrew Consent|1|||
129729579|NCT02251717|466970732|FG001|Overall Study|Withdrew Consent|0|||
129729580|NCT03356977|466970733|FG000|Overall Study|Lost to Follow-up|3|||
129729581|NCT03356977|466970733|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129729582|NCT00445939|466970737|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
129729583|NCT00445939|466970738|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
129729584|NCT00445939|466970739|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
129729585|NCT00445939|466970740|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
129729586|NCT00445939|466970737|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
129729587|NCT00445939|466970738|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
129729588|NCT00445939|466970739|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
129729589|NCT00445939|466970740|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
129729590|NCT00378599|466970744|FG000|Overall Study|Adverse Event|38|||
129729591|NCT00378599|466970744|FG000|Overall Study|Protocol Violation|2|||
129729592|NCT00378599|466970744|FG000|Overall Study|Treatment failure|7|||
129729593|NCT00378599|466970744|FG000|Overall Study|Withdrawal by Subject|5|||
129729594|NCT00489736|466970745|FG000|Overall Study|Lack of Efficacy|53|||
129729595|NCT00489736|466970746|FG001|Overall Study|Lack of Efficacy|14|||
129729596|NCT00489736|466970745|FG000|Overall Study|Adverse Event|32|||
129729597|NCT00489736|466970746|FG001|Overall Study|Adverse Event|45|||
129729598|NCT00489736|466970745|FG000|Overall Study|Poor compliance|6|||
129444464|NCT01822522|465927346|FG003|Overall Study|Lack of Efficacy|0|||
129729599|NCT00489736|466970746|FG001|Overall Study|Poor compliance|2|||
129729600|NCT00489736|466970745|FG000|Overall Study|Not coded/ Not pre-specified|5|||
129729601|NCT00489736|466970746|FG001|Overall Study|Not coded/ Not pre-specified|8|||
129729602|NCT03812185|466970750|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
129729603|NCT02576535|466970753|FG000|Overall Study|Withdrawal by Subject|2|||
129729604|NCT01529515|466970756|FG000|TRANSITION PHASE|Adverse Event|16|||
129729605|NCT01529515|466970757|FG001|TRANSITION PHASE|Adverse Event|0|||
129729606|NCT01529515|466970758|FG002|TRANSITION PHASE|Adverse Event|0|||
129729607|NCT01529515|466970759|FG003|TRANSITION PHASE|Adverse Event|0|||
129729608|NCT01529515|466970756|FG000|TRANSITION PHASE|Death|1|||
129729609|NCT01529515|466970757|FG001|TRANSITION PHASE|Death|0|||
129729610|NCT01529515|466970758|FG002|TRANSITION PHASE|Death|0|||
129729611|NCT01529515|466970759|FG003|TRANSITION PHASE|Death|0|||
129729612|NCT01529515|466970756|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
129729613|NCT01529515|466970757|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
129729614|NCT01529515|466970758|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
129729615|NCT01529515|466970759|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
129729616|NCT01529515|466970756|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
129729617|NCT01529515|466970757|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
129729618|NCT01529515|466970758|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
129729619|NCT01529515|466970759|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
129729620|NCT01529515|466970756|FG000|TRANSITION PHASE|Protocol Violation|4|||
129729621|NCT01529515|466970757|FG001|TRANSITION PHASE|Protocol Violation|0|||
129729622|NCT01529515|466970758|FG002|TRANSITION PHASE|Protocol Violation|0|||
129729623|NCT01529515|466970759|FG003|TRANSITION PHASE|Protocol Violation|0|||
129729624|NCT01529515|466970756|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
129729625|NCT01529515|466970757|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
129729626|NCT01529515|466970758|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
129729627|NCT01529515|466970759|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
129729628|NCT01529515|466970756|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
129729629|NCT01529515|466970757|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
129729630|NCT01529515|466970758|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
129729631|NCT01529515|466970759|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
129729632|NCT01529515|466970756|FG000|TRANSITION PHASE|Other|9|||
129729633|NCT01529515|466970757|FG001|TRANSITION PHASE|Other|0|||
129729634|NCT01529515|466970758|FG002|TRANSITION PHASE|Other|0|||
129729635|NCT01529515|466970759|FG003|TRANSITION PHASE|Other|0|||
129729636|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Adverse Event|0|||
129729637|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Adverse Event|10|||
129729638|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Adverse Event|0|||
129729639|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Adverse Event|0|||
129729640|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
129729641|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
129729642|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
129729643|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
129729644|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
129729645|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
129729646|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
129729647|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
129729648|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
129729649|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
129729650|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
129729651|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
129729652|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
129729653|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
129729654|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
129729655|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
129729656|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
129729657|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
129729658|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
129729659|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
129729660|NCT01529515|466970756|FG000|MAINTENANCE PHASE|Other|0|||
129729661|NCT01529515|466970757|FG001|MAINTENANCE PHASE|Other|10|||
129729662|NCT01529515|466970758|FG002|MAINTENANCE PHASE|Other|0|||
129729663|NCT01529515|466970759|FG003|MAINTENANCE PHASE|Other|0|||
129729664|NCT01529515|466970756|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
129729665|NCT01529515|466970757|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
129729666|NCT01529515|466970758|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
129729667|NCT01529515|466970759|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
129729668|NCT01529515|466970756|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
129729669|NCT01529515|466970757|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
129729670|NCT01529515|466970758|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
129729671|NCT01529515|466970759|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
129729672|NCT01529515|466970756|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
129444465|NCT01822522|465927347|FG004|Overall Study|Lack of Efficacy|0|||
129729673|NCT01529515|466970757|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
129729674|NCT01529515|466970758|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
129729675|NCT01529515|466970759|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
129729676|NCT01529515|466970756|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
129729677|NCT01529515|466970757|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
129729678|NCT01529515|466970758|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
129729679|NCT01529515|466970759|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
129729680|NCT01529515|466970756|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
129729681|NCT01529515|466970757|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
129729682|NCT01529515|466970758|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
129729683|NCT01529515|466970759|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
129729684|NCT01529515|466970756|FG000|DOUBLE BLIND PHASE|Other|0|||
129729685|NCT01529515|466970757|FG001|DOUBLE BLIND PHASE|Other|0|||
129729686|NCT01529515|466970758|FG002|DOUBLE BLIND PHASE|Other|9|||
129729687|NCT01529515|466970759|FG003|DOUBLE BLIND PHASE|Other|2|||
129729688|NCT03334851|466970761|FG000|Overall Study|Other|0|||
129729689|NCT03334851|466970762|FG001|Overall Study|Other|0|||
129729690|NCT03334851|466970763|FG002|Overall Study|Other|0|||
129729691|NCT03334851|466970764|FG003|Overall Study|Other|0|||
129729692|NCT03334851|466970765|FG004|Overall Study|Other|0|||
129729693|NCT03334851|466970766|FG005|Overall Study|Other|0|||
129729694|NCT03334851|466970767|FG006|Overall Study|Other|0|||
129729695|NCT03334851|466970768|FG007|Overall Study|Other|1|||
129729696|NCT03334851|466970769|FG008|Overall Study|Other|0|||
129729697|NCT03334851|466970770|FG009|Overall Study|Other|0|||
129729698|NCT03334851|466970771|FG010|Overall Study|Other|0|||
129729699|NCT03334851|466970772|FG011|Overall Study|Other|0|||
129729700|NCT03334851|466970773|FG012|Overall Study|Other|0|||
129729701|NCT03334851|466970761|FG000|Overall Study|Adverse Event|0|||
129729702|NCT03334851|466970762|FG001|Overall Study|Adverse Event|0|||
129729703|NCT03334851|466970763|FG002|Overall Study|Adverse Event|0|||
129729704|NCT03334851|466970764|FG003|Overall Study|Adverse Event|0|||
129729705|NCT03334851|466970765|FG004|Overall Study|Adverse Event|0|||
129729706|NCT03334851|466970766|FG005|Overall Study|Adverse Event|0|||
129729707|NCT03334851|466970767|FG006|Overall Study|Adverse Event|0|||
129729708|NCT03334851|466970768|FG007|Overall Study|Adverse Event|1|||
129729709|NCT03334851|466970769|FG008|Overall Study|Adverse Event|0|||
129729710|NCT03334851|466970770|FG009|Overall Study|Adverse Event|0|||
129729711|NCT03334851|466970771|FG010|Overall Study|Adverse Event|0|||
129729712|NCT03334851|466970772|FG011|Overall Study|Adverse Event|0|||
129729713|NCT03334851|466970773|FG012|Overall Study|Adverse Event|0|||
129729714|NCT03334851|466970761|FG000|Overall Study|Withdrawal by Subject|0|||
129729715|NCT03334851|466970762|FG001|Overall Study|Withdrawal by Subject|0|||
129729716|NCT03334851|466970763|FG002|Overall Study|Withdrawal by Subject|0|||
129729717|NCT03334851|466970764|FG003|Overall Study|Withdrawal by Subject|0|||
129729718|NCT03334851|466970765|FG004|Overall Study|Withdrawal by Subject|0|||
129729719|NCT03334851|466970766|FG005|Overall Study|Withdrawal by Subject|0|||
129729720|NCT03334851|466970767|FG006|Overall Study|Withdrawal by Subject|0|||
129729721|NCT03334851|466970768|FG007|Overall Study|Withdrawal by Subject|0|||
129729722|NCT03334851|466970769|FG008|Overall Study|Withdrawal by Subject|0|||
129729723|NCT03334851|466970770|FG009|Overall Study|Withdrawal by Subject|0|||
129729724|NCT03334851|466970771|FG010|Overall Study|Withdrawal by Subject|1|||
129729725|NCT03334851|466970772|FG011|Overall Study|Withdrawal by Subject|0|||
129729726|NCT03334851|466970773|FG012|Overall Study|Withdrawal by Subject|1|||
129729727|NCT03334851|466970761|FG000|Overall Study|Lost to Follow-up|0|||
129729728|NCT03334851|466970762|FG001|Overall Study|Lost to Follow-up|0|||
129729729|NCT03334851|466970763|FG002|Overall Study|Lost to Follow-up|0|||
129729730|NCT03334851|466970764|FG003|Overall Study|Lost to Follow-up|0|||
129729731|NCT03334851|466970765|FG004|Overall Study|Lost to Follow-up|0|||
129729732|NCT03334851|466970766|FG005|Overall Study|Lost to Follow-up|0|||
129729733|NCT03334851|466970767|FG006|Overall Study|Lost to Follow-up|0|||
129729734|NCT03334851|466970768|FG007|Overall Study|Lost to Follow-up|0|||
129729735|NCT03334851|466970769|FG008|Overall Study|Lost to Follow-up|0|||
129729736|NCT03334851|466970770|FG009|Overall Study|Lost to Follow-up|0|||
129729737|NCT03334851|466970771|FG010|Overall Study|Lost to Follow-up|2|||
129729738|NCT03334851|466970772|FG011|Overall Study|Lost to Follow-up|1|||
129729739|NCT03334851|466970773|FG012|Overall Study|Lost to Follow-up|0|||
129729740|NCT03920293|466970774|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
129729741|NCT03920293|466970775|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
129729742|NCT03920293|466970774|FG000|Randomized-Controlled Period|Physician Decision|1|||
129729743|NCT03920293|466970775|FG001|Randomized-Controlled Period|Physician Decision|2|||
129729744|NCT03920293|466970774|FG000|Randomized-Controlled Period|Adverse Event|0|||
129729745|NCT03920293|466970775|FG001|Randomized-Controlled Period|Adverse Event|2|||
129729746|NCT03920293|466970774|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
129729747|NCT03920293|466970775|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
129729748|NCT03920293|466970774|FG000|Randomized-Controlled Period|Death|2|||
129729749|NCT03920293|466970775|FG001|Randomized-Controlled Period|Death|0|||
129729750|NCT03920293|466970774|FG000|Randomized-Controlled Period|Protocol Violation|1|||
129729751|NCT03920293|466970775|FG001|Randomized-Controlled Period|Protocol Violation|0|||
129729752|NCT03920293|466970774|FG000|Randomized-Controlled Period|Noncompliance|1|||
129729753|NCT03920293|466970775|FG001|Randomized-Controlled Period|Noncompliance|0|||
129729754|NCT03920293|466970774|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
129729755|NCT03920293|466970775|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
129729756|NCT03920293|466970774|FG000|Open- Label Extension Period|Death|3|||
129729757|NCT03920293|466970775|FG001|Open- Label Extension Period|Death|3|||
129729758|NCT03920293|466970774|FG000|Open- Label Extension Period|Physician Decision|5|||
129729759|NCT03920293|466970775|FG001|Open- Label Extension Period|Physician Decision|3|||
129729760|NCT03920293|466970774|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
129729761|NCT03920293|466970775|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
129729762|NCT01691885|466970777|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
129729763|NCT01691885|466970778|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
129729764|NCT01691885|466970777|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
129729765|NCT01691885|466970778|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
129729766|NCT03555981|466970779|FG000|Overall Study|Lost to Follow-up|0|||
129729767|NCT03555981|466970780|FG001|Overall Study|Lost to Follow-up|2|||
129729768|NCT03272828|466970783|FG000|Overall Study|Lost to Follow-up|7|||
129729769|NCT03272828|466970784|FG001|Overall Study|Lost to Follow-up|7|||
129729770|NCT03272828|466970783|FG000|Overall Study|Withdrawal by Subject|2|||
129729771|NCT03272828|466970784|FG001|Overall Study|Withdrawal by Subject|0|||
129729772|NCT03272828|466970783|FG000|Overall Study|Deceased|1|||
129729773|NCT03272828|466970784|FG001|Overall Study|Deceased|1|||
129729774|NCT03272828|466970783|FG000|Overall Study|Failed implant|1|||
129729775|NCT03272828|466970784|FG001|Overall Study|Failed implant|2|||
129729776|NCT03575065|466970788|FG000|Overall Study|Death|31|||
129729777|NCT03575065|466970789|FG001|Overall Study|Death|12|||
129729778|NCT03575065|466970788|FG000|Overall Study|Sponsor's Decision|28|||
129729779|NCT03575065|466970789|FG001|Overall Study|Sponsor's Decision|13|||
129729780|NCT03575065|466970788|FG000|Overall Study|Withdrawal by Subject|2|||
129729781|NCT03575065|466970789|FG001|Overall Study|Withdrawal by Subject|1|||
129729782|NCT03575065|466970788|FG000|Overall Study|Lost to Follow-up|1|||
129729783|NCT03575065|466970789|FG001|Overall Study|Lost to Follow-up|0|||
129729784|NCT02323126|466970794|FG000|Overall Study|Patient / guardian decision|0|||
129729785|NCT02323126|466970795|FG001|Overall Study|Patient / guardian decision|1|||
129729786|NCT02323126|466970796|FG002|Overall Study|Patient / guardian decision|2|||
129729787|NCT02323126|466970794|FG000|Overall Study|Progressive disease|14|||
129729788|NCT02323126|466970795|FG001|Overall Study|Progressive disease|8|||
129729789|NCT02323126|466970796|FG002|Overall Study|Progressive disease|14|||
129729790|NCT02323126|466970794|FG000|Overall Study|Physician Decision|0|||
129729791|NCT02323126|466970795|FG001|Overall Study|Physician Decision|1|||
129729792|NCT02323126|466970796|FG002|Overall Study|Physician Decision|3|||
129729793|NCT02323126|466970794|FG000|Overall Study|Death|1|||
129729794|NCT02323126|466970795|FG001|Overall Study|Death|1|||
129729795|NCT02323126|466970796|FG002|Overall Study|Death|4|||
129729796|NCT02323126|466970794|FG000|Overall Study|Adverse Event|3|||
129729797|NCT02323126|466970795|FG001|Overall Study|Adverse Event|5|||
129729798|NCT02323126|466970796|FG002|Overall Study|Adverse Event|7|||
129729799|NCT03350256|466970797|FG000|Overall Study|Inclusion/exclusion violation|4|||
129729800|NCT03350256|466970797|FG000|Overall Study|Recommended for other therapies|2|||
129729801|NCT03350256|466970797|FG000|Overall Study|Protocol Violation|3|||
129729802|NCT03350256|466970797|FG000|Overall Study|Non compliance|2|||
129729803|NCT03350256|466970797|FG000|Overall Study|Denial by insurance|1|||
129729804|NCT03350256|466970797|FG000|Overall Study|Adverse Event|2|||
129729805|NCT03350256|466970797|FG000|Overall Study|Trial failure|12|||
129729806|NCT03350256|466970797|FG000|Overall Study|Did not proceed to permanent implant|3|||
129729807|NCT03350256|466970797|FG000|Overall Study|Withdrawal by Subject|3|||
129729808|NCT03350256|466970797|FG000|Overall Study|Subject moving out of state|1|||
129729809|NCT03350256|466970797|FG000|Overall Study|Lost to Follow-up|1|||
129729810|NCT03350256|466970797|FG000|Overall Study|Lack of Efficacy|2|||
129729811|NCT02324205|466970798|FG000|Overall Study|Withdrawal by Subject|37|||
129729812|NCT03664674|466970806|FG000|Overall Study|Adverse Event|1|||
129729813|NCT03664674|466970807|FG001|Overall Study|Adverse Event|1|||
129729814|NCT03664674|466970806|FG000|Overall Study|Physician Decision|0|||
129729815|NCT03664674|466970807|FG001|Overall Study|Physician Decision|1|||
129729816|NCT03664674|466970806|FG000|Overall Study|Withdrawal by Subject|2|||
129729817|NCT03664674|466970807|FG001|Overall Study|Withdrawal by Subject|0|||
129729818|NCT02174523|466970808|FG000|Overall Study|Withdrawal by Subject|1|||
129729819|NCT02174523|466970809|FG001|Overall Study|Withdrawal by Subject|0|||
129729820|NCT00856206|466970810|FG000|Overall Study|Protocol Violation|6|||
129729821|NCT00856206|466970811|FG001|Overall Study|Protocol Violation|18|||
129729822|NCT00856206|466970810|FG000|Overall Study|Adverse Event|10|||
129729823|NCT00856206|466970811|FG001|Overall Study|Adverse Event|46|||
129729824|NCT00856206|466970810|FG000|Overall Study|Lack of Efficacy|1|||
129729825|NCT00856206|466970811|FG001|Overall Study|Lack of Efficacy|2|||
129729826|NCT00856206|466970810|FG000|Overall Study|Withdrawal by Subject|15|||
129729827|NCT00856206|466970811|FG001|Overall Study|Withdrawal by Subject|36|||
129729828|NCT00856206|466970810|FG000|Overall Study|Lost to Follow-up|13|||
129729829|NCT00856206|466970811|FG001|Overall Study|Lost to Follow-up|39|||
129729830|NCT00856206|466970810|FG000|Overall Study|Death|2|||
129729831|NCT00856206|466970811|FG001|Overall Study|Death|2|||
129729832|NCT00856206|466970810|FG000|Overall Study|Decision by the Sponsor|4|||
129729833|NCT00856206|466970811|FG001|Overall Study|Decision by the Sponsor|8|||
129729834|NCT00856206|466970810|FG000|Overall Study|Other than specified above|3|||
129729835|NCT00856206|466970811|FG001|Overall Study|Other than specified above|10|||
129729836|NCT02780856|466970816|FG000|Overall Study|Lost to Follow-up|1|||
129729837|NCT00230282|466970818|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
129729838|NCT00230282|466970818|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
129729839|NCT00230282|466970818|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
129729840|NCT00230282|466970818|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
129729841|NCT03006458|466970821|FG000|First Intervention|Unsatisfied Vision|0|||
129729842|NCT03006458|466970822|FG001|First Intervention|Unsatisfied Vision|3|||
129729843|NCT01468233|466970828|FG000|Treatment Period 1|Adverse Event|5|||
129729844|NCT01468233|466970829|FG001|Treatment Period 1|Adverse Event|3|||
129729845|NCT01468233|466970830|FG002|Treatment Period 1|Adverse Event|0|||
129729846|NCT01468233|466970831|FG003|Treatment Period 1|Adverse Event|0|||
129729847|NCT01468233|466970832|FG004|Treatment Period 1|Adverse Event|0|||
129729848|NCT01468233|466970833|FG005|Treatment Period 1|Adverse Event|0|||
129729849|NCT01468233|466970828|FG000|Treatment Period 1|Withdrawal by Subject|3|||
129729850|NCT01468233|466970829|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129729851|NCT01468233|466970830|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129729852|NCT01468233|466970831|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129729853|NCT01468233|466970832|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129729854|NCT01468233|466970833|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129729855|NCT01468233|466970828|FG000|Treatment Period 1|Lost to Follow-up|3|||
129729856|NCT01468233|466970829|FG001|Treatment Period 1|Lost to Follow-up|0|||
129729857|NCT01468233|466970830|FG002|Treatment Period 1|Lost to Follow-up|0|||
129729858|NCT01468233|466970831|FG003|Treatment Period 1|Lost to Follow-up|0|||
129729859|NCT01468233|466970832|FG004|Treatment Period 1|Lost to Follow-up|0|||
129729860|NCT01468233|466970833|FG005|Treatment Period 1|Lost to Follow-up|0|||
129729861|NCT01468233|466970828|FG000|Treatment Period 1|Other|1|||
129729862|NCT01468233|466970829|FG001|Treatment Period 1|Other|1|||
129729863|NCT01468233|466970830|FG002|Treatment Period 1|Other|0|||
129729864|NCT01468233|466970831|FG003|Treatment Period 1|Other|0|||
129729865|NCT01468233|466970832|FG004|Treatment Period 1|Other|0|||
129729866|NCT01468233|466970833|FG005|Treatment Period 1|Other|0|||
129729867|NCT01468233|466970828|FG000|Treatment Period 2|Adverse Event|0|||
129729868|NCT01468233|466970829|FG001|Treatment Period 2|Adverse Event|0|||
129729869|NCT01468233|466970830|FG002|Treatment Period 2|Adverse Event|3|||
129729870|NCT01468233|466970831|FG003|Treatment Period 2|Adverse Event|0|||
129729871|NCT01468233|466970832|FG004|Treatment Period 2|Adverse Event|2|||
129729872|NCT01468233|466970833|FG005|Treatment Period 2|Adverse Event|1|||
129729873|NCT01468233|466970828|FG000|Treatment Period 2|Lack of Efficacy|0|||
129729874|NCT01468233|466970829|FG001|Treatment Period 2|Lack of Efficacy|0|||
129729875|NCT01468233|466970830|FG002|Treatment Period 2|Lack of Efficacy|9|||
129729876|NCT01468233|466970831|FG003|Treatment Period 2|Lack of Efficacy|2|||
129729877|NCT01468233|466970832|FG004|Treatment Period 2|Lack of Efficacy|0|||
129729878|NCT01468233|466970833|FG005|Treatment Period 2|Lack of Efficacy|1|||
129729879|NCT01468233|466970828|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129729880|NCT01468233|466970829|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129729881|NCT01468233|466970830|FG002|Treatment Period 2|Withdrawal by Subject|9|||
129729882|NCT01468233|466970831|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129729883|NCT01468233|466970832|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129729884|NCT01468233|466970833|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129729885|NCT01468233|466970828|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
129729886|NCT01468233|466970829|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
129729887|NCT01468233|466970830|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
129729888|NCT01468233|466970831|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
129729889|NCT01468233|466970832|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
129729890|NCT01468233|466970833|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
129729891|NCT01468233|466970828|FG000|Treatment Period 2|Lost to Follow-up|0|||
129729892|NCT01468233|466970829|FG001|Treatment Period 2|Lost to Follow-up|0|||
129729893|NCT01468233|466970830|FG002|Treatment Period 2|Lost to Follow-up|3|||
129444466|NCT01822522|465927348|FG005|Overall Study|Lack of Efficacy|2|||
129729894|NCT01468233|466970831|FG003|Treatment Period 2|Lost to Follow-up|0|||
129729895|NCT01468233|466970832|FG004|Treatment Period 2|Lost to Follow-up|2|||
129892324|NCT02303574|467565416|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892325|NCT02303574|467565417|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129729896|NCT01468233|466970833|FG005|Treatment Period 2|Lost to Follow-up|0|||
129729897|NCT01468233|466970828|FG000|Treatment Period 2|Other|0|||
129729898|NCT01468233|466970829|FG001|Treatment Period 2|Other|0|||
129729899|NCT01468233|466970830|FG002|Treatment Period 2|Other|3|||
129729900|NCT01468233|466970831|FG003|Treatment Period 2|Other|0|||
129729901|NCT01468233|466970832|FG004|Treatment Period 2|Other|1|||
129729902|NCT01468233|466970833|FG005|Treatment Period 2|Other|0|||
129729903|NCT00457821|466970841|FG000|Part 2|Withdrawal by Subject|0|||
129729904|NCT00457821|466970842|FG001|Part 2|Withdrawal by Subject|0|||
129729905|NCT00457821|466970843|FG002|Part 2|Withdrawal by Subject|0|||
129729906|NCT00457821|466970844|FG003|Part 2|Withdrawal by Subject|0|||
129729907|NCT00457821|466970845|FG004|Part 2|Withdrawal by Subject|0|||
129729908|NCT00457821|466970846|FG005|Part 2|Withdrawal by Subject|0|||
129729909|NCT00457821|466970847|FG006|Part 2|Withdrawal by Subject|0|||
129729910|NCT00457821|466970848|FG007|Part 2|Withdrawal by Subject|1|||
129729911|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
129729912|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
129729913|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
129729914|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
129729915|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
129729916|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
129729917|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
129729918|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
129729919|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
129729920|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
129729921|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
129729922|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
129729923|NCT01632241|466970849|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
129729924|NCT01632241|466970850|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
129729925|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
129729926|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
129729927|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
129729928|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
129729929|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
129729930|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
129729931|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
129729932|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
129729933|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
129729934|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
129729935|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
129729936|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
129729937|NCT01632241|466970849|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
129729938|NCT01632241|466970850|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
129729939|NCT02851407|466970860|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129729940|NCT02851407|466970861|FG001|Overall Study|Withdrawal by parent/guardian|7|||
129729941|NCT02851407|466970860|FG000|Overall Study|Protocol deviation|0|||
129729942|NCT02851407|466970861|FG001|Overall Study|Protocol deviation|1|||
129729943|NCT02851407|466970860|FG000|Overall Study|Transferred to another hospital to continue|1|||
129729944|NCT02851407|466970861|FG001|Overall Study|Transferred to another hospital to continue|0|||
129729945|NCT02851407|466970860|FG000|Overall Study|Other Death|30|||
129729946|NCT02851407|466970861|FG001|Overall Study|Other Death|20|||
129729947|NCT02851407|466970860|FG000|Overall Study|Adverse event, serious fatal|6|||
129729948|NCT02851407|466970861|FG001|Overall Study|Adverse event, serious fatal|8|||
129729949|NCT02851407|466970860|FG000|Overall Study|Consent withdrawn by participant|5|||
129729950|NCT02851407|466970861|FG001|Overall Study|Consent withdrawn by participant|3|||
129729951|NCT02851407|466970860|FG000|Overall Study|Screen failure|2|||
129729952|NCT02851407|466970861|FG001|Overall Study|Screen failure|1|||
129729953|NCT02851407|466970860|FG000|Overall Study|Disease relapse|9|||
129729954|NCT02851407|466970861|FG001|Overall Study|Disease relapse|6|||
129729955|NCT02851407|466970860|FG000|Overall Study|Physician Decision|7|||
129729956|NCT02851407|466970861|FG001|Overall Study|Physician Decision|6|||
129729957|NCT02851407|466970860|FG000|Overall Study|Transferred to hospital closer to home|0|||
129729958|NCT02851407|466970861|FG001|Overall Study|Transferred to hospital closer to home|1|||
129729959|NCT02851407|466970860|FG000|Overall Study|Enrolled in an investigational study|0|||
129729960|NCT02851407|466970861|FG001|Overall Study|Enrolled in an investigational study|1|||
129729961|NCT02851407|466970860|FG000|Overall Study|Early recovery|1|||
129729962|NCT02851407|466970861|FG001|Overall Study|Early recovery|0|||
129892326|NCT02303574|467565418|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129729963|NCT02851407|466970860|FG000|Overall Study|Adverse event, non-fatal|7|||
129892327|NCT02303574|467565419|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129892328|NCT02303574|467565420|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
129729964|NCT02851407|466970861|FG001|Overall Study|Adverse event, non-fatal|5|||
129729965|NCT02851407|466970860|FG000|Overall Study|Lost to Follow-up|0|||
129729966|NCT02851407|466970861|FG001|Overall Study|Lost to Follow-up|2|||
129729967|NCT02403635|466970862|FG000|Overall Study|Not eligible|9|||
129729968|NCT00835640|466970863|FG000|Second Intervention|Protocol Violation|1|||
129729969|NCT00835640|466970864|FG001|Second Intervention|Protocol Violation|0|||
129729970|NCT00068250|466970865|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
129729971|NCT00068250|466970866|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
129729972|NCT00068250|466970867|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
129729973|NCT00068250|466970868|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
129729974|NCT03349645|466970869|FG000|Overall Study|Sponsor Terminated Study|75|||
129729975|NCT03349645|466970869|FG000|Overall Study|Withdrawal by Subject|4|||
129729976|NCT03349645|466970869|FG000|Overall Study|Protocol Violation|1|||
129729977|NCT03349645|466970869|FG000|Overall Study|Other|2|||
129729978|NCT00580034|466970872|FG000|Overall Study|Toxicity|10|||
129729979|NCT00580034|466970873|FG001|Overall Study|Toxicity|0|||
129729980|NCT01939002|466970874|FG000|Overall Study|Adverse Event|13|||
129729981|NCT01939002|466970875|FG001|Overall Study|Adverse Event|13|||
129729982|NCT01939002|466970874|FG000|Overall Study|Withdrawal by Subject|5|||
129729983|NCT01939002|466970875|FG001|Overall Study|Withdrawal by Subject|3|||
129729984|NCT01939002|466970874|FG000|Overall Study|Other|1|||
129729985|NCT01939002|466970875|FG001|Overall Study|Other|2|||
129729986|NCT03372460|466970879|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
129729987|NCT03372460|466970880|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
129729988|NCT02499900|466970881|FG000|Core Study Period|Other|1|||
129729989|NCT02499900|466970882|FG001|Core Study Period|Other|4|||
129729990|NCT02499900|466970881|FG000|Core Study Period|Lost to Follow-up|1|||
129729991|NCT02499900|466970882|FG001|Core Study Period|Lost to Follow-up|2|||
129729992|NCT02499900|466970881|FG000|Core Study Period|Per sponsor request|0|||
129729993|NCT02499900|466970882|FG001|Core Study Period|Per sponsor request|1|||
129729994|NCT02499900|466970881|FG000|Core Study Period|Pregnancy|1|||
129729995|NCT02499900|466970882|FG001|Core Study Period|Pregnancy|0|||
129729996|NCT02499900|466970881|FG000|Core Study Period|Protocol Violation|3|||
129729997|NCT02499900|466970882|FG001|Core Study Period|Protocol Violation|0|||
129729998|NCT02499900|466970881|FG000|Core Study Period|Withdrawal by Subject|11|||
129729999|NCT02499900|466970882|FG001|Core Study Period|Withdrawal by Subject|10|||
129730000|NCT02499900|466970881|FG000|Core Study Period|Adverse Event|18|||
129730001|NCT02499900|466970882|FG001|Core Study Period|Adverse Event|14|||
129730002|NCT02499900|466970881|FG000|Core Study Period|Death|0|||
129730003|NCT02499900|466970882|FG001|Core Study Period|Death|1|||
129730004|NCT02499900|466970881|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
129730005|NCT02499900|466970882|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
129730006|NCT02499900|466970881|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
129730007|NCT02499900|466970882|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
129730008|NCT02499900|466970881|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
129730009|NCT02499900|466970882|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
129730010|NCT02499900|466970881|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
129730011|NCT02499900|466970882|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
129730012|NCT02499900|466970881|FG000|Extension Study Period|Adverse Event|2|||
129730013|NCT02499900|466970882|FG001|Extension Study Period|Adverse Event|4|||
129730014|NCT02499900|466970881|FG000|Extension Study Period|Withdrawal by Subject|5|||
129730015|NCT02499900|466970882|FG001|Extension Study Period|Withdrawal by Subject|2|||
129730016|NCT02499900|466970881|FG000|Extension Study Period|Physician Decision|2|||
129730017|NCT02499900|466970882|FG001|Extension Study Period|Physician Decision|5|||
129730018|NCT02499900|466970881|FG000|Extension Study Period|Pregnancy|1|||
129730019|NCT02499900|466970882|FG001|Extension Study Period|Pregnancy|2|||
129730020|NCT02499900|466970881|FG000|Extension Study Period|Lost to Follow-up|2|||
129730021|NCT02499900|466970882|FG001|Extension Study Period|Lost to Follow-up|5|||
129730022|NCT02499900|466970881|FG000|Extension Study Period|Other|0|||
129730023|NCT02499900|466970882|FG001|Extension Study Period|Other|2|||
129730024|NCT02439450|466970884|FG000|Overall Study|Adverse Event|4|||
129730025|NCT02439450|466970885|FG001|Overall Study|Adverse Event|1|||
129730026|NCT02439450|466970886|FG002|Overall Study|Adverse Event|0|||
129730027|NCT02439450|466970887|FG003|Overall Study|Adverse Event|0|||
129730028|NCT02439450|466970884|FG000|Overall Study|Withdrawal by Subject|1|||
129730029|NCT02439450|466970885|FG001|Overall Study|Withdrawal by Subject|2|||
129730030|NCT02439450|466970886|FG002|Overall Study|Withdrawal by Subject|0|||
129730031|NCT02439450|466970887|FG003|Overall Study|Withdrawal by Subject|0|||
129730032|NCT02439450|466970884|FG000|Overall Study|Death|3|||
129730033|NCT02439450|466970885|FG001|Overall Study|Death|0|||
129730034|NCT02439450|466970886|FG002|Overall Study|Death|0|||
129730035|NCT02439450|466970887|FG003|Overall Study|Death|1|||
129730036|NCT02439450|466970884|FG000|Overall Study|Progressive Disease|18|||
129730037|NCT02439450|466970885|FG001|Overall Study|Progressive Disease|41|||
129730038|NCT02439450|466970886|FG002|Overall Study|Progressive Disease|2|||
129730039|NCT02439450|466970887|FG003|Overall Study|Progressive Disease|3|||
129730040|NCT01170065|466970892|FG000|Overall Study|Adverse Event|17|||
129730041|NCT01170065|466970893|FG001|Overall Study|Adverse Event|50|||
129730042|NCT01170065|466970894|FG002|Overall Study|Adverse Event|10|||
129730043|NCT01170065|466970892|FG000|Overall Study|Lost to Follow-up|1|||
129730044|NCT01170065|466970893|FG001|Overall Study|Lost to Follow-up|4|||
129730045|NCT01170065|466970894|FG002|Overall Study|Lost to Follow-up|1|||
129730046|NCT01170065|466970892|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
129730047|NCT01170065|466970893|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
129730048|NCT01170065|466970894|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
129730049|NCT01170065|466970892|FG000|Overall Study|Reason other than specified|3|||
129730050|NCT01170065|466970893|FG001|Overall Study|Reason other than specified|8|||
129730051|NCT01170065|466970894|FG002|Overall Study|Reason other than specified|3|||
129730052|NCT01170065|466970892|FG000|Overall Study|Ongoing after planned observation time|5|||
129730053|NCT01170065|466970893|FG001|Overall Study|Ongoing after planned observation time|26|||
129730054|NCT01170065|466970894|FG002|Overall Study|Ongoing after planned observation time|10|||
129730055|NCT00428220|466972858|FG000|Overall Study|Participant died|8|||
129730056|NCT00428220|466972858|FG000|Overall Study|Global deterioration of health status|7|||
129892329|NCT02303574|467565411|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892330|NCT02303574|467565412|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892331|NCT02303574|467565413|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892332|NCT02303574|467565414|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129730057|NCT00428220|466972858|FG000|Overall Study|Lost to Follow-up|4|||
129730058|NCT00428220|466972858|FG000|Overall Study|Objective progression or relapse|123|||
129730059|NCT00428220|466972858|FG000|Overall Study|Participant refused continued treatment|7|||
129730060|NCT00428220|466972858|FG000|Overall Study|Adverse Event|51|||
129730061|NCT00428220|466972858|FG000|Overall Study|Other|23|||
129730062|NCT00549900|466972860|FG000|Overall Study|Adverse Event|1|||
129730063|NCT02982018|466972861|FG000|Overall Study|Incorrect Lens Dispensed|1|||
129730064|NCT02982018|466972862|FG001|Overall Study|Incorrect Lens Dispensed|0|||
129730065|NCT02982018|466972861|FG000|Overall Study|Protocol Violation|1|||
129730066|NCT02982018|466972862|FG001|Overall Study|Protocol Violation|1|||
129730067|NCT02982018|466972861|FG000|Overall Study|Adverse Event|1|||
129730068|NCT02982018|466972862|FG001|Overall Study|Adverse Event|1|||
129730069|NCT02982018|466972861|FG000|Overall Study|Lens Discomfort|2|||
129892333|NCT02303574|467565415|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129730070|NCT02982018|466972862|FG001|Overall Study|Lens Discomfort|0|||
129730071|NCT02982018|466972861|FG000|Overall Study|Withdrawal by Subject|0|||
129730072|NCT02982018|466972862|FG001|Overall Study|Withdrawal by Subject|1|||
129730073|NCT03283098|466972863|FG000|Overall Study|Withdrawal by Subject|0|||
129444467|NCT02558231|465927349|FG000|Overall Study|Death|4|||
129730074|NCT03283098|466972864|FG001|Overall Study|Withdrawal by Subject|1|||
129730075|NCT00798317|466972865|FG000|Overall Study|Physician Decision|0|||
129730076|NCT00798317|466972866|FG001|Overall Study|Physician Decision|1|||
129730077|NCT00798317|466972865|FG000|Overall Study|Withdrawal by Subject|5|||
129730078|NCT00798317|466972866|FG001|Overall Study|Withdrawal by Subject|4|||
129730079|NCT00798317|466972865|FG000|Overall Study|Lost to Follow-up|2|||
129730080|NCT00798317|466972866|FG001|Overall Study|Lost to Follow-up|2|||
129730081|NCT00798317|466972865|FG000|Overall Study|Adverse Event|2|||
129730082|NCT00798317|466972866|FG001|Overall Study|Adverse Event|0|||
129730083|NCT00798317|466972865|FG000|Overall Study|Death|1|||
129730084|NCT00798317|466972866|FG001|Overall Study|Death|0|||
129730085|NCT00416715|466972867|FG000|Overall Study|Not evaluable for joint aches|7|||
129730086|NCT00416715|466972867|FG000|Overall Study|Vitamin D levels not evaluable|8|||
129730087|NCT02545517|466972878|FG000|Overall Study|Death|2|||
129730088|NCT02545517|466972879|FG001|Overall Study|Death|2|||
129730089|NCT02545517|466972880|FG002|Overall Study|Death|1|||
129730090|NCT02545517|466972878|FG000|Overall Study|Lost to Follow-up|14|||
129730091|NCT02545517|466972879|FG001|Overall Study|Lost to Follow-up|13|||
129730092|NCT02545517|466972880|FG002|Overall Study|Lost to Follow-up|17|||
129730093|NCT02545517|466972878|FG000|Overall Study|Protocol Violation|0|||
129730094|NCT02545517|466972879|FG001|Overall Study|Protocol Violation|1|||
129730095|NCT02545517|466972880|FG002|Overall Study|Protocol Violation|1|||
129730096|NCT02545517|466972878|FG000|Overall Study|Withdrawal by Subject|5|||
129730097|NCT02545517|466972879|FG001|Overall Study|Withdrawal by Subject|8|||
129730098|NCT02545517|466972880|FG002|Overall Study|Withdrawal by Subject|9|||
129730099|NCT02545517|466972878|FG000|Overall Study|Administrative reason|5|||
129730100|NCT02545517|466972879|FG001|Overall Study|Administrative reason|6|||
129730101|NCT02545517|466972880|FG002|Overall Study|Administrative reason|10|||
129730102|NCT02545517|466972878|FG000|Overall Study|Other|2|||
129730103|NCT02545517|466972879|FG001|Overall Study|Other|4|||
129730104|NCT02545517|466972880|FG002|Overall Study|Other|3|||
129730105|NCT01069861|466972881|FG000|Overall Study|Death|1|||
129730106|NCT01069861|466972881|FG000|Overall Study|Adverse Event|1|||
129730107|NCT01069861|466972881|FG000|Overall Study|Did not meet entrance criteria|1|||
129730108|NCT04035564|466972882|FG000|Overall Study|Protocol Violation|1|||
129730109|NCT04035564|466972883|FG001|Overall Study|Protocol Violation|2|||
129730110|NCT04035564|466972882|FG000|Overall Study|No laboratory available|2|||
129730111|NCT04035564|466972883|FG001|Overall Study|No laboratory available|2|||
129730112|NCT04035564|466972882|FG000|Overall Study|Guardian declined consent|1|||
129730113|NCT04035564|466972883|FG001|Overall Study|Guardian declined consent|2|||
129730114|NCT00996281|466972885|FG000|Overall Study|Adverse Event|75|||
129730115|NCT00996281|466972886|FG001|Overall Study|Adverse Event|37|||
129730116|NCT00996281|466972885|FG000|Overall Study|Major Protocol Deviation|6|||
129730117|NCT00996281|466972886|FG001|Overall Study|Major Protocol Deviation|7|||
129730118|NCT00996281|466972885|FG000|Overall Study|Lost to Follow-up|14|||
129730119|NCT00996281|466972886|FG001|Overall Study|Lost to Follow-up|16|||
129730120|NCT00996281|466972885|FG000|Overall Study|Withdrawal by Subject|31|||
129730121|NCT00996281|466972886|FG001|Overall Study|Withdrawal by Subject|20|||
129730122|NCT00996281|466972885|FG000|Overall Study|Lack of Efficacy|0|||
129730123|NCT00996281|466972886|FG001|Overall Study|Lack of Efficacy|2|||
129730124|NCT00996281|466972885|FG000|Overall Study|Other|5|||
129730125|NCT00996281|466972886|FG001|Overall Study|Other|7|||
129730126|NCT02754141|466972887|FG000|Overall Study|Disease progression|11|||
129730127|NCT02754141|466972888|FG001|Overall Study|Disease progression|7|||
129730128|NCT02754141|466972889|FG002|Overall Study|Disease progression|8|||
129730129|NCT02754141|466972890|FG003|Overall Study|Disease progression|5|||
129730130|NCT02754141|466972891|FG004|Overall Study|Disease progression|7|||
129730131|NCT02754141|466972892|FG005|Overall Study|Disease progression|7|||
129730132|NCT02754141|466972893|FG006|Overall Study|Disease progression|7|||
129730133|NCT02754141|466972894|FG007|Overall Study|Disease progression|6|||
129730134|NCT02754141|466972895|FG008|Overall Study|Disease progression|11|||
129730135|NCT02754141|466972896|FG009|Overall Study|Disease progression|16|||
129730136|NCT02754141|466972897|FG010|Overall Study|Disease progression|18|||
129730137|NCT02754141|466972898|FG011|Overall Study|Disease progression|13|||
129730138|NCT02754141|466972899|FG012|Overall Study|Disease progression|10|||
129730139|NCT02754141|466972900|FG013|Overall Study|Disease progression|12|||
129730140|NCT02754141|466972901|FG014|Overall Study|Disease progression|12|||
129892334|NCT02303574|467565416|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129444468|NCT02558231|465927350|FG001|Overall Study|Death|12|||
129444469|NCT02558231|465927349|FG000|Overall Study|Lost to Follow-up|7|||
129730141|NCT02754141|466972902|FG015|Overall Study|Disease progression|14|||
129730142|NCT02754141|466972903|FG016|Overall Study|Disease progression|0|||
129730143|NCT02754141|466972904|FG017|Overall Study|Disease progression|1|||
129730144|NCT02754141|466972887|FG000|Overall Study|Study drug toxicity|1|||
129730145|NCT02754141|466972888|FG001|Overall Study|Study drug toxicity|1|||
129730146|NCT02754141|466972889|FG002|Overall Study|Study drug toxicity|0|||
129730147|NCT02754141|466972890|FG003|Overall Study|Study drug toxicity|0|||
129730148|NCT02754141|466972891|FG004|Overall Study|Study drug toxicity|0|||
129730149|NCT02754141|466972892|FG005|Overall Study|Study drug toxicity|0|||
129730150|NCT02754141|466972893|FG006|Overall Study|Study drug toxicity|0|||
129730151|NCT02754141|466972894|FG007|Overall Study|Study drug toxicity|0|||
129730152|NCT02754141|466972895|FG008|Overall Study|Study drug toxicity|0|||
129730153|NCT02754141|466972896|FG009|Overall Study|Study drug toxicity|0|||
129730154|NCT02754141|466972897|FG010|Overall Study|Study drug toxicity|2|||
129730155|NCT02754141|466972898|FG011|Overall Study|Study drug toxicity|1|||
129730156|NCT02754141|466972899|FG012|Overall Study|Study drug toxicity|1|||
129730157|NCT02754141|466972900|FG013|Overall Study|Study drug toxicity|0|||
129730158|NCT02754141|466972901|FG014|Overall Study|Study drug toxicity|0|||
129730159|NCT02754141|466972902|FG015|Overall Study|Study drug toxicity|0|||
129730160|NCT02754141|466972903|FG016|Overall Study|Study drug toxicity|0|||
129730161|NCT02754141|466972904|FG017|Overall Study|Study drug toxicity|0|||
129730162|NCT02754141|466972887|FG000|Overall Study|AE unrelated to study drug|1|||
129730163|NCT02754141|466972888|FG001|Overall Study|AE unrelated to study drug|1|||
129892335|NCT02303574|467565417|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892336|NCT02303574|467565418|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
129892337|NCT02303574|467565419|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892338|NCT02303574|467565420|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
129892339|NCT00859014|467565421|FG000|Overall Study|Death|4|||
129892340|NCT00859014|467565421|FG000|Overall Study|Lost to Follow-up|1|||
129892341|NCT04796935|467565422|FG000|Overall Study|Withdrawal by Subject|0|||
129892342|NCT04796935|467565423|FG001|Overall Study|Withdrawal by Subject|1|||
129892343|NCT04796935|467565422|FG000|Overall Study|Physician Decision|0|||
129892344|NCT04796935|467565423|FG001|Overall Study|Physician Decision|1|||
129892345|NCT04796935|467565422|FG000|Overall Study|Device not available|1|||
129892346|NCT04796935|467565423|FG001|Overall Study|Device not available|0|||
129892347|NCT04796935|467565422|FG000|Overall Study|Trained provider not available|1|||
129892348|NCT04796935|467565423|FG001|Overall Study|Trained provider not available|0|||
129892349|NCT00783718|467565424|FG000|Induction Phase|Adverse Event|4|||
129892350|NCT00783718|467565425|FG001|Induction Phase|Adverse Event|0|||
129892351|NCT00783718|467565426|FG002|Induction Phase|Adverse Event|7|||
129892352|NCT00783718|467565427|FG003|Induction Phase|Adverse Event|0|||
129892353|NCT00783718|467565428|FG004|Induction Phase|Adverse Event|0|||
129892354|NCT00783718|467565429|FG005|Induction Phase|Adverse Event|0|||
129892355|NCT00783718|467565430|FG006|Induction Phase|Adverse Event|0|||
129892356|NCT00783718|467565424|FG000|Induction Phase|Protocol Violation|1|||
129892357|NCT00783718|467565425|FG001|Induction Phase|Protocol Violation|1|||
129892358|NCT00783718|467565426|FG002|Induction Phase|Protocol Violation|6|||
129892359|NCT00783718|467565427|FG003|Induction Phase|Protocol Violation|0|||
129730164|NCT02754141|466972889|FG002|Overall Study|AE unrelated to study drug|0|||
129730165|NCT02754141|466972890|FG003|Overall Study|AE unrelated to study drug|1|||
129730166|NCT02754141|466972891|FG004|Overall Study|AE unrelated to study drug|3|||
129730167|NCT02754141|466972892|FG005|Overall Study|AE unrelated to study drug|2|||
129730168|NCT02754141|466972893|FG006|Overall Study|AE unrelated to study drug|1|||
129730169|NCT02754141|466972894|FG007|Overall Study|AE unrelated to study drug|0|||
129730170|NCT02754141|466972895|FG008|Overall Study|AE unrelated to study drug|0|||
129730171|NCT02754141|466972896|FG009|Overall Study|AE unrelated to study drug|0|||
129730172|NCT02754141|466972897|FG010|Overall Study|AE unrelated to study drug|0|||
129730173|NCT02754141|466972898|FG011|Overall Study|AE unrelated to study drug|0|||
129730174|NCT02754141|466972899|FG012|Overall Study|AE unrelated to study drug|0|||
129730175|NCT02754141|466972900|FG013|Overall Study|AE unrelated to study drug|0|||
129730176|NCT02754141|466972901|FG014|Overall Study|AE unrelated to study drug|0|||
129730177|NCT02754141|466972902|FG015|Overall Study|AE unrelated to study drug|0|||
129730178|NCT02754141|466972903|FG016|Overall Study|AE unrelated to study drug|0|||
129730179|NCT02754141|466972904|FG017|Overall Study|AE unrelated to study drug|0|||
129730180|NCT02754141|466972887|FG000|Overall Study|Request to discontinue|0|||
129730181|NCT02754141|466972888|FG001|Overall Study|Request to discontinue|0|||
129730182|NCT02754141|466972889|FG002|Overall Study|Request to discontinue|0|||
129730183|NCT02754141|466972890|FG003|Overall Study|Request to discontinue|0|||
129730184|NCT02754141|466972891|FG004|Overall Study|Request to discontinue|0|||
129730185|NCT02754141|466972892|FG005|Overall Study|Request to discontinue|0|||
129892360|NCT00783718|467565428|FG004|Induction Phase|Protocol Violation|0|||
129892361|NCT00783718|467565429|FG005|Induction Phase|Protocol Violation|0|||
129892362|NCT00783718|467565430|FG006|Induction Phase|Protocol Violation|0|||
129730186|NCT02754141|466972893|FG006|Overall Study|Request to discontinue|0|||
129730187|NCT02754141|466972894|FG007|Overall Study|Request to discontinue|0|||
129730188|NCT02754141|466972895|FG008|Overall Study|Request to discontinue|1|||
129730189|NCT02754141|466972896|FG009|Overall Study|Request to discontinue|0|||
129730190|NCT02754141|466972897|FG010|Overall Study|Request to discontinue|0|||
129730191|NCT02754141|466972898|FG011|Overall Study|Request to discontinue|0|||
129730192|NCT02754141|466972899|FG012|Overall Study|Request to discontinue|0|||
129730193|NCT02754141|466972900|FG013|Overall Study|Request to discontinue|1|||
129892363|NCT00783718|467565424|FG000|Induction Phase|Lack of Efficacy|5|||
129892364|NCT00783718|467565425|FG001|Induction Phase|Lack of Efficacy|2|||
129892365|NCT00783718|467565426|FG002|Induction Phase|Lack of Efficacy|14|||
129892366|NCT00783718|467565427|FG003|Induction Phase|Lack of Efficacy|0|||
129892367|NCT00783718|467565428|FG004|Induction Phase|Lack of Efficacy|0|||
129730194|NCT02754141|466972901|FG014|Overall Study|Request to discontinue|1|||
129730195|NCT02754141|466972902|FG015|Overall Study|Request to discontinue|0|||
129730196|NCT02754141|466972903|FG016|Overall Study|Request to discontinue|0|||
129730197|NCT02754141|466972904|FG017|Overall Study|Request to discontinue|0|||
129730198|NCT02754141|466972887|FG000|Overall Study|Withdrew consent|0|||
129730199|NCT02754141|466972888|FG001|Overall Study|Withdrew consent|0|||
129730200|NCT02754141|466972889|FG002|Overall Study|Withdrew consent|0|||
129730201|NCT02754141|466972890|FG003|Overall Study|Withdrew consent|0|||
129730202|NCT02754141|466972891|FG004|Overall Study|Withdrew consent|0|||
129730203|NCT02754141|466972892|FG005|Overall Study|Withdrew consent|0|||
129730204|NCT02754141|466972893|FG006|Overall Study|Withdrew consent|0|||
129730205|NCT02754141|466972894|FG007|Overall Study|Withdrew consent|0|||
129730206|NCT02754141|466972895|FG008|Overall Study|Withdrew consent|0|||
129730207|NCT02754141|466972896|FG009|Overall Study|Withdrew consent|1|||
129730208|NCT02754141|466972897|FG010|Overall Study|Withdrew consent|0|||
129730209|NCT02754141|466972898|FG011|Overall Study|Withdrew consent|0|||
129730210|NCT02754141|466972899|FG012|Overall Study|Withdrew consent|0|||
129730211|NCT02754141|466972900|FG013|Overall Study|Withdrew consent|0|||
129730212|NCT02754141|466972901|FG014|Overall Study|Withdrew consent|0|||
129730213|NCT02754141|466972902|FG015|Overall Study|Withdrew consent|0|||
129730214|NCT02754141|466972903|FG016|Overall Study|Withdrew consent|0|||
129730215|NCT02754141|466972904|FG017|Overall Study|Withdrew consent|0|||
129730216|NCT02754141|466972887|FG000|Overall Study|Maximum clinical benefit|0|||
129730217|NCT02754141|466972888|FG001|Overall Study|Maximum clinical benefit|0|||
129730218|NCT02754141|466972889|FG002|Overall Study|Maximum clinical benefit|0|||
129730219|NCT02754141|466972890|FG003|Overall Study|Maximum clinical benefit|1|||
129730220|NCT02754141|466972891|FG004|Overall Study|Maximum clinical benefit|0|||
129730221|NCT02754141|466972892|FG005|Overall Study|Maximum clinical benefit|0|||
129730222|NCT02754141|466972893|FG006|Overall Study|Maximum clinical benefit|0|||
129730223|NCT02754141|466972894|FG007|Overall Study|Maximum clinical benefit|0|||
129730224|NCT02754141|466972895|FG008|Overall Study|Maximum clinical benefit|0|||
129730225|NCT02754141|466972896|FG009|Overall Study|Maximum clinical benefit|0|||
129730226|NCT02754141|466972897|FG010|Overall Study|Maximum clinical benefit|0|||
129730227|NCT02754141|466972898|FG011|Overall Study|Maximum clinical benefit|0|||
129730228|NCT02754141|466972899|FG012|Overall Study|Maximum clinical benefit|0|||
129730229|NCT02754141|466972900|FG013|Overall Study|Maximum clinical benefit|0|||
129730230|NCT02754141|466972901|FG014|Overall Study|Maximum clinical benefit|0|||
129730231|NCT02754141|466972902|FG015|Overall Study|Maximum clinical benefit|0|||
129730232|NCT02754141|466972903|FG016|Overall Study|Maximum clinical benefit|0|||
129730233|NCT02754141|466972904|FG017|Overall Study|Maximum clinical benefit|0|||
129730234|NCT02754141|466972887|FG000|Overall Study|No longer meets study criteria|0|||
129730235|NCT02754141|466972888|FG001|Overall Study|No longer meets study criteria|0|||
129730236|NCT02754141|466972889|FG002|Overall Study|No longer meets study criteria|0|||
129730237|NCT02754141|466972890|FG003|Overall Study|No longer meets study criteria|1|||
129730238|NCT02754141|466972891|FG004|Overall Study|No longer meets study criteria|0|||
129730239|NCT02754141|466972892|FG005|Overall Study|No longer meets study criteria|0|||
129730240|NCT02754141|466972893|FG006|Overall Study|No longer meets study criteria|0|||
129730241|NCT02754141|466972894|FG007|Overall Study|No longer meets study criteria|0|||
129730242|NCT02754141|466972895|FG008|Overall Study|No longer meets study criteria|0|||
129730243|NCT02754141|466972896|FG009|Overall Study|No longer meets study criteria|0|||
129730244|NCT02754141|466972897|FG010|Overall Study|No longer meets study criteria|0|||
129730245|NCT02754141|466972898|FG011|Overall Study|No longer meets study criteria|0|||
129730246|NCT02754141|466972899|FG012|Overall Study|No longer meets study criteria|0|||
129730247|NCT02754141|466972900|FG013|Overall Study|No longer meets study criteria|0|||
129730248|NCT02754141|466972901|FG014|Overall Study|No longer meets study criteria|0|||
129730249|NCT02754141|466972902|FG015|Overall Study|No longer meets study criteria|0|||
129730250|NCT02754141|466972903|FG016|Overall Study|No longer meets study criteria|0|||
129730251|NCT02754141|466972904|FG017|Overall Study|No longer meets study criteria|0|||
129730252|NCT02754141|466972887|FG000|Overall Study|Other reasons|0|||
129730253|NCT02754141|466972888|FG001|Overall Study|Other reasons|0|||
129730254|NCT02754141|466972889|FG002|Overall Study|Other reasons|0|||
129730255|NCT02754141|466972890|FG003|Overall Study|Other reasons|0|||
129730256|NCT02754141|466972891|FG004|Overall Study|Other reasons|0|||
129730257|NCT02754141|466972892|FG005|Overall Study|Other reasons|0|||
129730258|NCT02754141|466972893|FG006|Overall Study|Other reasons|0|||
129730259|NCT02754141|466972894|FG007|Overall Study|Other reasons|1|||
129730260|NCT02754141|466972895|FG008|Overall Study|Other reasons|0|||
129730261|NCT02754141|466972896|FG009|Overall Study|Other reasons|0|||
129730262|NCT02754141|466972897|FG010|Overall Study|Other reasons|0|||
129730263|NCT02754141|466972898|FG011|Overall Study|Other reasons|0|||
129730264|NCT02754141|466972899|FG012|Overall Study|Other reasons|2|||
129730265|NCT02754141|466972900|FG013|Overall Study|Other reasons|0|||
129730266|NCT02754141|466972901|FG014|Overall Study|Other reasons|0|||
129730267|NCT02754141|466972902|FG015|Overall Study|Other reasons|0|||
129730268|NCT02754141|466972903|FG016|Overall Study|Other reasons|0|||
129730269|NCT02754141|466972904|FG017|Overall Study|Other reasons|0|||
129892368|NCT00783718|467565429|FG005|Induction Phase|Lack of Efficacy|0|||
129730270|NCT02754141|466972887|FG000|Overall Study|Completed treatment as per protocol|0|||
129730271|NCT02754141|466972888|FG001|Overall Study|Completed treatment as per protocol|1|||
129730272|NCT02754141|466972889|FG002|Overall Study|Completed treatment as per protocol|0|||
129730273|NCT02754141|466972890|FG003|Overall Study|Completed treatment as per protocol|0|||
129730274|NCT02754141|466972891|FG004|Overall Study|Completed treatment as per protocol|0|||
129730275|NCT02754141|466972892|FG005|Overall Study|Completed treatment as per protocol|0|||
129730276|NCT02754141|466972893|FG006|Overall Study|Completed treatment as per protocol|0|||
129730277|NCT02754141|466972894|FG007|Overall Study|Completed treatment as per protocol|0|||
129730278|NCT02754141|466972895|FG008|Overall Study|Completed treatment as per protocol|0|||
129730279|NCT02754141|466972896|FG009|Overall Study|Completed treatment as per protocol|0|||
129730280|NCT02754141|466972897|FG010|Overall Study|Completed treatment as per protocol|0|||
129730281|NCT02754141|466972898|FG011|Overall Study|Completed treatment as per protocol|0|||
129730282|NCT02754141|466972899|FG012|Overall Study|Completed treatment as per protocol|1|||
129730283|NCT02754141|466972900|FG013|Overall Study|Completed treatment as per protocol|0|||
129730284|NCT02754141|466972901|FG014|Overall Study|Completed treatment as per protocol|0|||
129730285|NCT02754141|466972902|FG015|Overall Study|Completed treatment as per protocol|0|||
129730286|NCT02754141|466972903|FG016|Overall Study|Completed treatment as per protocol|0|||
129730287|NCT02754141|466972904|FG017|Overall Study|Completed treatment as per protocol|0|||
129730288|NCT02754141|466972887|FG000|Overall Study|Not completing monotherapy|0|||
129730289|NCT02754141|466972888|FG001|Overall Study|Not completing monotherapy|0|||
129730290|NCT02754141|466972889|FG002|Overall Study|Not completing monotherapy|0|||
129730291|NCT02754141|466972890|FG003|Overall Study|Not completing monotherapy|0|||
129730292|NCT02754141|466972891|FG004|Overall Study|Not completing monotherapy|0|||
129730293|NCT02754141|466972892|FG005|Overall Study|Not completing monotherapy|0|||
129730294|NCT02754141|466972893|FG006|Overall Study|Not completing monotherapy|0|||
129730295|NCT02754141|466972894|FG007|Overall Study|Not completing monotherapy|0|||
129730296|NCT02754141|466972895|FG008|Overall Study|Not completing monotherapy|0|||
129730297|NCT02754141|466972896|FG009|Overall Study|Not completing monotherapy|0|||
129730298|NCT02754141|466972897|FG010|Overall Study|Not completing monotherapy|0|||
129730299|NCT02754141|466972898|FG011|Overall Study|Not completing monotherapy|0|||
129730300|NCT02754141|466972899|FG012|Overall Study|Not completing monotherapy|0|||
129730301|NCT02754141|466972900|FG013|Overall Study|Not completing monotherapy|1|||
129730302|NCT02754141|466972901|FG014|Overall Study|Not completing monotherapy|0|||
129730303|NCT02754141|466972902|FG015|Overall Study|Not completing monotherapy|0|||
129730304|NCT02754141|466972903|FG016|Overall Study|Not completing monotherapy|0|||
129730305|NCT02754141|466972904|FG017|Overall Study|Not completing monotherapy|0|||
129730306|NCT03361189|466972905|FG000|Overall Study|Received heart transplant|1|||
129730307|NCT03361189|466972906|FG001|Overall Study|Received heart transplant|0|||
129730308|NCT03361189|466972905|FG000|Overall Study|Pacemake replacement|0|||
129730309|NCT03361189|466972906|FG001|Overall Study|Pacemake replacement|1|||
129730310|NCT03505788|466972907|FG000|Overall Study|Lost to Follow-up|2|||
129730311|NCT03505788|466972908|FG001|Overall Study|Lost to Follow-up|1|||
129730312|NCT03505788|466972907|FG000|Overall Study|Withdrawal by Subject|1|||
129730313|NCT03505788|466972908|FG001|Overall Study|Withdrawal by Subject|3|||
129730314|NCT03505788|466972907|FG000|Overall Study|Physician Decision|0|||
129730315|NCT03505788|466972908|FG001|Overall Study|Physician Decision|1|||
129730316|NCT03344549|466972909|FG000|Overall Study|Withdrawal by Subject|3|||
129730317|NCT03344549|466972910|FG001|Overall Study|Withdrawal by Subject|2|||
129730318|NCT03344549|466972909|FG000|Overall Study|Dialysis|2|||
129730319|NCT03344549|466972910|FG001|Overall Study|Dialysis|0|||
129730320|NCT03344549|466972909|FG000|Overall Study|Cancer|1|||
129730321|NCT03344549|466972910|FG001|Overall Study|Cancer|0|||
129730322|NCT03344549|466972909|FG000|Overall Study|Lack of electronic device|1|||
129730323|NCT03344549|466972910|FG001|Overall Study|Lack of electronic device|0|||
129730324|NCT03344549|466972909|FG000|Overall Study|Transportation difficulty|0|||
129730325|NCT03344549|466972910|FG001|Overall Study|Transportation difficulty|13|||
129730326|NCT03333252|466972911|FG000|Overall Study|Adverse Event|10|||
129730327|NCT03333252|466972912|FG001|Overall Study|Adverse Event|6|||
129730328|NCT03333252|466972913|FG002|Overall Study|Adverse Event|5|||
129730329|NCT03333252|466972914|FG003|Overall Study|Adverse Event|2|||
129730330|NCT03333252|466972911|FG000|Overall Study|Death|1|||
129730331|NCT03333252|466972912|FG001|Overall Study|Death|3|||
129730332|NCT03333252|466972913|FG002|Overall Study|Death|0|||
129730333|NCT03333252|466972914|FG003|Overall Study|Death|0|||
129730334|NCT03333252|466972911|FG000|Overall Study|Lack of Efficacy|8|||
129730335|NCT03333252|466972912|FG001|Overall Study|Lack of Efficacy|4|||
129730336|NCT03333252|466972913|FG002|Overall Study|Lack of Efficacy|0|||
129730337|NCT03333252|466972914|FG003|Overall Study|Lack of Efficacy|7|||
129730338|NCT03333252|466972911|FG000|Overall Study|Lost to Follow-up|0|||
129730339|NCT03333252|466972912|FG001|Overall Study|Lost to Follow-up|5|||
129730340|NCT03333252|466972913|FG002|Overall Study|Lost to Follow-up|9|||
129730341|NCT03333252|466972914|FG003|Overall Study|Lost to Follow-up|3|||
129730342|NCT03333252|466972911|FG000|Overall Study|Withdrawal by Subject|14|||
129730343|NCT03333252|466972912|FG001|Overall Study|Withdrawal by Subject|24|||
129730344|NCT03333252|466972913|FG002|Overall Study|Withdrawal by Subject|11|||
129730345|NCT03333252|466972914|FG003|Overall Study|Withdrawal by Subject|17|||
129730346|NCT00666588|466972918|FG000|Overall Study|ineligible|2|||
129730347|NCT00666588|466972919|FG001|Overall Study|ineligible|0|||
129730348|NCT00666588|466972920|FG002|Overall Study|ineligible|0|||
129730349|NCT00666588|466972921|FG003|Overall Study|ineligible|2|||
129730350|NCT00666588|466972918|FG000|Overall Study|inevaluable|2|||
129730351|NCT00666588|466972919|FG001|Overall Study|inevaluable|0|||
129730352|NCT00666588|466972920|FG002|Overall Study|inevaluable|0|||
129730353|NCT00666588|466972921|FG003|Overall Study|inevaluable|0|||
129730354|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
129730355|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
129730356|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
129730357|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
129730358|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
129730359|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
129730360|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
129730361|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
129730362|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
129730363|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
129730364|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Other|1|||
129730365|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Other|1|||
129730366|NCT02075047|466972926|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
129730367|NCT02075047|466972927|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
129730368|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
129730369|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
129730370|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
129730371|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
129730372|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
129730373|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
129730374|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
129730375|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
129730376|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
129730377|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
129730378|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Other|1|||
129730379|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Other|2|||
129730380|NCT02075047|466972926|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
129730381|NCT02075047|466972927|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
129730382|NCT01007123|466972928|FG000|Overall Study|Adverse Event|3|||
129730383|NCT01007123|466972929|FG001|Overall Study|Adverse Event|4|||
129730384|NCT01007123|466972930|FG002|Overall Study|Adverse Event|7|||
129730385|NCT01007123|466972931|FG003|Overall Study|Adverse Event|1|||
129730386|NCT01007123|466972928|FG000|Overall Study|Lack of Efficacy|1|||
129730387|NCT01007123|466972929|FG001|Overall Study|Lack of Efficacy|0|||
129730388|NCT01007123|466972930|FG002|Overall Study|Lack of Efficacy|1|||
129730389|NCT01007123|466972931|FG003|Overall Study|Lack of Efficacy|4|||
129730390|NCT01007123|466972928|FG000|Overall Study|Protocol Violation|1|||
129730391|NCT01007123|466972929|FG001|Overall Study|Protocol Violation|1|||
129730392|NCT01007123|466972930|FG002|Overall Study|Protocol Violation|2|||
129730393|NCT01007123|466972931|FG003|Overall Study|Protocol Violation|1|||
129730394|NCT01007123|466972928|FG000|Overall Study|Withdrawal by Subject|1|||
129730395|NCT01007123|466972929|FG001|Overall Study|Withdrawal by Subject|0|||
129730396|NCT01007123|466972930|FG002|Overall Study|Withdrawal by Subject|1|||
129730397|NCT01007123|466972931|FG003|Overall Study|Withdrawal by Subject|0|||
129730398|NCT01007123|466972928|FG000|Overall Study|Lost to Follow-up|0|||
129730399|NCT01007123|466972929|FG001|Overall Study|Lost to Follow-up|1|||
129730400|NCT01007123|466972930|FG002|Overall Study|Lost to Follow-up|0|||
129730401|NCT01007123|466972931|FG003|Overall Study|Lost to Follow-up|0|||
129730402|NCT04195438|466972938|FG000|Overall Study|Withdrawal by Subject|1|||
129730403|NCT01774097|466972939|FG000|Overall Study|Withdrawal by Subject|1|||
129730404|NCT01774097|466972940|FG001|Overall Study|Withdrawal by Subject|1|||
129730405|NCT01774097|466972939|FG000|Overall Study|Adverse Event|1|||
129730406|NCT01774097|466972940|FG001|Overall Study|Adverse Event|1|||
129730407|NCT00613925|466972941|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
129730408|NCT00613925|466972942|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
129730409|NCT01920568|466972949|FG000|Overall Study|Adverse Event|27|||
129730410|NCT01920568|466972950|FG001|Overall Study|Adverse Event|8|||
129730411|NCT01920568|466972949|FG000|Overall Study|Protocol Violation|5|||
129730412|NCT01920568|466972950|FG001|Overall Study|Protocol Violation|3|||
129730413|NCT01920568|466972949|FG000|Overall Study|Lost to Follow-up|2|||
129730414|NCT01920568|466972950|FG001|Overall Study|Lost to Follow-up|2|||
129730415|NCT01920568|466972949|FG000|Overall Study|Physician Decision|13|||
129730416|NCT01920568|466972950|FG001|Overall Study|Physician Decision|4|||
129730417|NCT01920568|466972949|FG000|Overall Study|Withdrawal by Subject|79|||
129730418|NCT01920568|466972950|FG001|Overall Study|Withdrawal by Subject|55|||
129730419|NCT01920568|466972949|FG000|Overall Study|Death due to disease progression|25|||
129730420|NCT01920568|466972950|FG001|Overall Study|Death due to disease progression|12|||
129730421|NCT00252694|466972952|FG000|Overall Study|Withdrawal by Subject|83|||
129730422|NCT00252694|466972953|FG001|Overall Study|Withdrawal by Subject|91|||
129730423|NCT00252694|466972952|FG000|Overall Study|Death|36|||
129730424|NCT00252694|466972953|FG001|Overall Study|Death|34|||
129730425|NCT00252694|466972952|FG000|Overall Study|Mostly Lost to Follow Up|8|||
129730426|NCT00252694|466972953|FG001|Overall Study|Mostly Lost to Follow Up|13|||
129730427|NCT00252694|466972952|FG000|Overall Study|Patient Moving|17|||
129730428|NCT00252694|466972953|FG001|Overall Study|Patient Moving|16|||
129730429|NCT00794365|466972954|FG000|Overall Study|Lost to Follow-up|38|||
129730430|NCT00794365|466972954|FG000|Overall Study|Other|17|||
129730431|NCT00794365|466972954|FG000|Overall Study|Poor Compliance|11|||
129730432|NCT00794365|466972954|FG000|Overall Study|Adverse Event|10|||
129730433|NCT00794365|466972954|FG000|Overall Study|Lack of Efficacy|3|||
129730434|NCT04584346|466972955|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
129730435|NCT04584346|466972956|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
129730436|NCT04239222|466972957|FG000|Baseline|Withdrawal by Subject|0|||
129730437|NCT04239222|466972958|FG001|Baseline|Withdrawal by Subject|0|||
129730438|NCT04239222|466972959|FG002|Baseline|Withdrawal by Subject|1|||
129730439|NCT04239222|466972960|FG003|Baseline|Withdrawal by Subject|1|||
129730440|NCT04239222|466972957|FG000|First Foot Assignment|Withdrawal by Subject|0|||
129730441|NCT04239222|466972958|FG001|First Foot Assignment|Withdrawal by Subject|0|||
129730442|NCT04239222|466972959|FG002|First Foot Assignment|Withdrawal by Subject|1|||
129730443|NCT04239222|466972960|FG003|First Foot Assignment|Withdrawal by Subject|0|||
129730444|NCT04239222|466972957|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
129730445|NCT04239222|466972958|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
129730446|NCT04239222|466972959|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
129730447|NCT04239222|466972960|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
129730448|NCT02701777|466972964|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
129730449|NCT02701777|466972965|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
129730450|NCT02701777|466972966|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
129730451|NCT02701777|466972967|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
129730452|NCT02701777|466972964|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
129730453|NCT02701777|466972965|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
129730454|NCT02701777|466972966|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
129730455|NCT02701777|466972967|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
129730456|NCT00075725|466972968|FG000|Overall Study|Adverse Event|6|||
129730457|NCT00075725|466972969|FG001|Overall Study|Adverse Event|6|||
129730458|NCT00075725|466972970|FG002|Overall Study|Adverse Event|20|||
129730459|NCT00075725|466972971|FG003|Overall Study|Adverse Event|8|||
129730460|NCT00075725|466972972|FG004|Overall Study|Adverse Event|4|||
129730461|NCT00075725|466972973|FG005|Overall Study|Adverse Event|38|||
129730462|NCT00075725|466972974|FG006|Overall Study|Adverse Event|3|||
129730463|NCT00075725|466972975|FG007|Overall Study|Adverse Event|51|||
129730464|NCT00075725|466972976|FG008|Overall Study|Adverse Event|15|||
129730465|NCT00075725|466972977|FG009|Overall Study|Adverse Event|4|||
129730466|NCT00075725|466972978|FG010|Overall Study|Adverse Event|2|||
129730467|NCT00075725|466972979|FG011|Overall Study|Adverse Event|2|||
129730468|NCT00075725|466972968|FG000|Overall Study|Death|3|||
129730469|NCT00075725|466972969|FG001|Overall Study|Death|5|||
129730470|NCT00075725|466972970|FG002|Overall Study|Death|10|||
129730471|NCT00075725|466972971|FG003|Overall Study|Death|2|||
129730472|NCT00075725|466972972|FG004|Overall Study|Death|3|||
129730473|NCT00075725|466972973|FG005|Overall Study|Death|25|||
129730474|NCT00075725|466972974|FG006|Overall Study|Death|4|||
129730475|NCT00075725|466972975|FG007|Overall Study|Death|22|||
129730476|NCT00075725|466972976|FG008|Overall Study|Death|14|||
129730477|NCT00075725|466972977|FG009|Overall Study|Death|4|||
129730478|NCT00075725|466972978|FG010|Overall Study|Death|3|||
129730479|NCT00075725|466972979|FG011|Overall Study|Death|0|||
129730480|NCT00075725|466972968|FG000|Overall Study|Lost to Follow-up|1|||
129730481|NCT00075725|466972969|FG001|Overall Study|Lost to Follow-up|1|||
129730482|NCT00075725|466972970|FG002|Overall Study|Lost to Follow-up|4|||
129730483|NCT00075725|466972971|FG003|Overall Study|Lost to Follow-up|1|||
129730484|NCT00075725|466972972|FG004|Overall Study|Lost to Follow-up|0|||
129730485|NCT00075725|466972973|FG005|Overall Study|Lost to Follow-up|13|||
129730486|NCT00075725|466972974|FG006|Overall Study|Lost to Follow-up|2|||
129730487|NCT00075725|466972975|FG007|Overall Study|Lost to Follow-up|4|||
129730488|NCT00075725|466972976|FG008|Overall Study|Lost to Follow-up|1|||
129730489|NCT00075725|466972977|FG009|Overall Study|Lost to Follow-up|0|||
129730490|NCT00075725|466972978|FG010|Overall Study|Lost to Follow-up|0|||
129730491|NCT00075725|466972979|FG011|Overall Study|Lost to Follow-up|0|||
129730492|NCT00075725|466972968|FG000|Overall Study|Physician Decision|2|||
129730493|NCT00075725|466972969|FG001|Overall Study|Physician Decision|6|||
129730494|NCT00075725|466972970|FG002|Overall Study|Physician Decision|5|||
129730495|NCT00075725|466972971|FG003|Overall Study|Physician Decision|8|||
129730496|NCT00075725|466972972|FG004|Overall Study|Physician Decision|4|||
129730497|NCT00075725|466972973|FG005|Overall Study|Physician Decision|19|||
129730498|NCT00075725|466972974|FG006|Overall Study|Physician Decision|3|||
129730499|NCT00075725|466972975|FG007|Overall Study|Physician Decision|17|||
129730500|NCT00075725|466972976|FG008|Overall Study|Physician Decision|5|||
129730501|NCT00075725|466972977|FG009|Overall Study|Physician Decision|0|||
129730502|NCT00075725|466972978|FG010|Overall Study|Physician Decision|1|||
129730503|NCT00075725|466972979|FG011|Overall Study|Physician Decision|0|||
129730504|NCT00075725|466972968|FG000|Overall Study|Pregnancy|0|||
129730505|NCT00075725|466972969|FG001|Overall Study|Pregnancy|0|||
129730506|NCT00075725|466972970|FG002|Overall Study|Pregnancy|0|||
129730507|NCT00075725|466972971|FG003|Overall Study|Pregnancy|0|||
129730508|NCT00075725|466972972|FG004|Overall Study|Pregnancy|0|||
129730509|NCT00075725|466972973|FG005|Overall Study|Pregnancy|1|||
129730510|NCT00075725|466972974|FG006|Overall Study|Pregnancy|0|||
129730511|NCT00075725|466972975|FG007|Overall Study|Pregnancy|1|||
129730512|NCT00075725|466972976|FG008|Overall Study|Pregnancy|0|||
129730513|NCT00075725|466972977|FG009|Overall Study|Pregnancy|0|||
129730514|NCT00075725|466972978|FG010|Overall Study|Pregnancy|0|||
129730515|NCT00075725|466972979|FG011|Overall Study|Pregnancy|0|||
129730516|NCT00075725|466972968|FG000|Overall Study|Protocol Violation|1|||
129730517|NCT00075725|466972969|FG001|Overall Study|Protocol Violation|1|||
129730518|NCT00075725|466972970|FG002|Overall Study|Protocol Violation|0|||
129730519|NCT00075725|466972971|FG003|Overall Study|Protocol Violation|3|||
129730520|NCT00075725|466972972|FG004|Overall Study|Protocol Violation|3|||
129730521|NCT00075725|466972973|FG005|Overall Study|Protocol Violation|2|||
129730522|NCT00075725|466972974|FG006|Overall Study|Protocol Violation|1|||
129730523|NCT00075725|466972975|FG007|Overall Study|Protocol Violation|2|||
129730524|NCT00075725|466972976|FG008|Overall Study|Protocol Violation|3|||
129730525|NCT00075725|466972977|FG009|Overall Study|Protocol Violation|0|||
129730526|NCT00075725|466972978|FG010|Overall Study|Protocol Violation|0|||
129730527|NCT00075725|466972979|FG011|Overall Study|Protocol Violation|1|||
129730528|NCT00075725|466972968|FG000|Overall Study|Withdrawal by Subject|12|||
129730529|NCT00075725|466972969|FG001|Overall Study|Withdrawal by Subject|3|||
129730530|NCT00075725|466972970|FG002|Overall Study|Withdrawal by Subject|6|||
129730531|NCT00075725|466972971|FG003|Overall Study|Withdrawal by Subject|10|||
129730532|NCT00075725|466972972|FG004|Overall Study|Withdrawal by Subject|6|||
129730533|NCT00075725|466972973|FG005|Overall Study|Withdrawal by Subject|27|||
129730534|NCT00075725|466972974|FG006|Overall Study|Withdrawal by Subject|7|||
129730535|NCT00075725|466972975|FG007|Overall Study|Withdrawal by Subject|31|||
129730536|NCT00075725|466972976|FG008|Overall Study|Withdrawal by Subject|10|||
129730537|NCT00075725|466972977|FG009|Overall Study|Withdrawal by Subject|2|||
129730538|NCT00075725|466972978|FG010|Overall Study|Withdrawal by Subject|0|||
129730539|NCT00075725|466972979|FG011|Overall Study|Withdrawal by Subject|0|||
129730540|NCT00075725|466972968|FG000|Overall Study|Disease Progression, all other reasons|17|||
129730541|NCT00075725|466972969|FG001|Overall Study|Disease Progression, all other reasons|5|||
129730542|NCT00075725|466972970|FG002|Overall Study|Disease Progression, all other reasons|33|||
129730543|NCT00075725|466972971|FG003|Overall Study|Disease Progression, all other reasons|6|||
129730544|NCT00075725|466972972|FG004|Overall Study|Disease Progression, all other reasons|21|||
129730545|NCT00075725|466972973|FG005|Overall Study|Disease Progression, all other reasons|59|||
129730546|NCT00075725|466972974|FG006|Overall Study|Disease Progression, all other reasons|20|||
129730547|NCT00075725|466972975|FG007|Overall Study|Disease Progression, all other reasons|46|||
129730548|NCT00075725|466972976|FG008|Overall Study|Disease Progression, all other reasons|21|||
129730549|NCT00075725|466972977|FG009|Overall Study|Disease Progression, all other reasons|4|||
129730550|NCT00075725|466972978|FG010|Overall Study|Disease Progression, all other reasons|0|||
129730551|NCT00075725|466972979|FG011|Overall Study|Disease Progression, all other reasons|5|||
129730552|NCT00075725|466972968|FG000|Overall Study|Patient off treatment|0|||
129730553|NCT00075725|466972969|FG001|Overall Study|Patient off treatment|0|||
129730554|NCT00075725|466972970|FG002|Overall Study|Patient off treatment|1|||
129730555|NCT00075725|466972971|FG003|Overall Study|Patient off treatment|2|||
129730556|NCT00075725|466972972|FG004|Overall Study|Patient off treatment|1|||
129730557|NCT00075725|466972973|FG005|Overall Study|Patient off treatment|0|||
129730558|NCT00075725|466972974|FG006|Overall Study|Patient off treatment|0|||
129730559|NCT00075725|466972975|FG007|Overall Study|Patient off treatment|2|||
129730560|NCT00075725|466972976|FG008|Overall Study|Patient off treatment|1|||
129730561|NCT00075725|466972977|FG009|Overall Study|Patient off treatment|0|||
129730562|NCT00075725|466972978|FG010|Overall Study|Patient off treatment|0|||
129730563|NCT00075725|466972979|FG011|Overall Study|Patient off treatment|0|||
129730564|NCT00075725|466972968|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
129730565|NCT00075725|466972969|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
129730566|NCT00075725|466972970|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
129730567|NCT00075725|466972971|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
129730568|NCT00075725|466972972|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
129730569|NCT00075725|466972973|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
129730570|NCT00075725|466972974|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
129444470|NCT02558231|465927350|FG001|Overall Study|Lost to Follow-up|4|||
129730571|NCT00075725|466972975|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
129730572|NCT00075725|466972976|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
129730573|NCT00075725|466972977|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
129730574|NCT00075725|466972978|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
129730575|NCT00075725|466972979|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
129730576|NCT00075725|466972968|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
129730577|NCT00075725|466972969|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
129730578|NCT00075725|466972970|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
129730579|NCT00075725|466972971|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
129730580|NCT00075725|466972972|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
129730581|NCT00075725|466972973|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
129730582|NCT00075725|466972974|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
129730583|NCT00075725|466972975|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
129730584|NCT00075725|466972976|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
129730585|NCT00075725|466972977|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
129730586|NCT00075725|466972978|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
129730587|NCT00075725|466972979|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
129730588|NCT00075725|466972968|FG000|Overall Study|Pt non compliant with therapy|2|||
129730589|NCT00075725|466972969|FG001|Overall Study|Pt non compliant with therapy|1|||
129730590|NCT00075725|466972970|FG002|Overall Study|Pt non compliant with therapy|1|||
129730591|NCT00075725|466972971|FG003|Overall Study|Pt non compliant with therapy|0|||
129730592|NCT00075725|466972972|FG004|Overall Study|Pt non compliant with therapy|2|||
129730593|NCT00075725|466972973|FG005|Overall Study|Pt non compliant with therapy|14|||
129730594|NCT00075725|466972974|FG006|Overall Study|Pt non compliant with therapy|2|||
129730595|NCT00075725|466972975|FG007|Overall Study|Pt non compliant with therapy|5|||
129730596|NCT00075725|466972976|FG008|Overall Study|Pt non compliant with therapy|3|||
129730597|NCT00075725|466972977|FG009|Overall Study|Pt non compliant with therapy|0|||
129730598|NCT00075725|466972978|FG010|Overall Study|Pt non compliant with therapy|0|||
129730599|NCT00075725|466972979|FG011|Overall Study|Pt non compliant with therapy|0|||
129730600|NCT00075725|466972968|FG000|Overall Study|Pt age out of range for treatment|0|||
129730601|NCT00075725|466972969|FG001|Overall Study|Pt age out of range for treatment|1|||
129730602|NCT00075725|466972970|FG002|Overall Study|Pt age out of range for treatment|0|||
129730603|NCT00075725|466972971|FG003|Overall Study|Pt age out of range for treatment|0|||
129730604|NCT00075725|466972972|FG004|Overall Study|Pt age out of range for treatment|0|||
129730605|NCT00075725|466972973|FG005|Overall Study|Pt age out of range for treatment|1|||
129730606|NCT00075725|466972974|FG006|Overall Study|Pt age out of range for treatment|0|||
129730607|NCT00075725|466972975|FG007|Overall Study|Pt age out of range for treatment|1|||
129730608|NCT00075725|466972976|FG008|Overall Study|Pt age out of range for treatment|0|||
129730609|NCT00075725|466972977|FG009|Overall Study|Pt age out of range for treatment|0|||
129730610|NCT00075725|466972978|FG010|Overall Study|Pt age out of range for treatment|0|||
129730611|NCT00075725|466972979|FG011|Overall Study|Pt age out of range for treatment|0|||
129730612|NCT00075725|466972968|FG000|Overall Study|Insurance issues|0|||
129730613|NCT00075725|466972969|FG001|Overall Study|Insurance issues|1|||
129730614|NCT00075725|466972970|FG002|Overall Study|Insurance issues|0|||
129730615|NCT00075725|466972971|FG003|Overall Study|Insurance issues|1|||
129730616|NCT00075725|466972972|FG004|Overall Study|Insurance issues|1|||
129730617|NCT00075725|466972973|FG005|Overall Study|Insurance issues|1|||
129730618|NCT00075725|466972974|FG006|Overall Study|Insurance issues|0|||
129730619|NCT00075725|466972975|FG007|Overall Study|Insurance issues|1|||
129730620|NCT00075725|466972976|FG008|Overall Study|Insurance issues|0|||
129730621|NCT00075725|466972977|FG009|Overall Study|Insurance issues|0|||
129730622|NCT00075725|466972978|FG010|Overall Study|Insurance issues|0|||
129730623|NCT00075725|466972979|FG011|Overall Study|Insurance issues|0|||
129730624|NCT00075725|466972968|FG000|Overall Study|MRD positive after extended ind|0|||
129730625|NCT00075725|466972969|FG001|Overall Study|MRD positive after extended ind|1|||
129730626|NCT00075725|466972970|FG002|Overall Study|MRD positive after extended ind|1|||
129730627|NCT00075725|466972971|FG003|Overall Study|MRD positive after extended ind|0|||
129730628|NCT00075725|466972972|FG004|Overall Study|MRD positive after extended ind|1|||
129730629|NCT00075725|466972973|FG005|Overall Study|MRD positive after extended ind|2|||
129730630|NCT00075725|466972974|FG006|Overall Study|MRD positive after extended ind|0|||
129730631|NCT00075725|466972975|FG007|Overall Study|MRD positive after extended ind|1|||
129730632|NCT00075725|466972976|FG008|Overall Study|MRD positive after extended ind|0|||
129730633|NCT00075725|466972977|FG009|Overall Study|MRD positive after extended ind|0|||
129730634|NCT00075725|466972978|FG010|Overall Study|MRD positive after extended ind|0|||
129730635|NCT00075725|466972979|FG011|Overall Study|MRD positive after extended ind|0|||
129730636|NCT00075725|466972968|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
129730637|NCT00075725|466972969|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
129730638|NCT00075725|466972970|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
129730639|NCT00075725|466972971|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
129730640|NCT00075725|466972972|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
129730641|NCT00075725|466972973|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
129730642|NCT00075725|466972974|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
129730643|NCT00075725|466972975|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
129730644|NCT00075725|466972976|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
129730645|NCT00075725|466972977|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
129730646|NCT00075725|466972978|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
129730647|NCT00075725|466972979|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
129730648|NCT00075725|466972968|FG000|Overall Study|Inevaluable|1|||
129730649|NCT00075725|466972969|FG001|Overall Study|Inevaluable|1|||
129730650|NCT00075725|466972970|FG002|Overall Study|Inevaluable|4|||
129730651|NCT00075725|466972971|FG003|Overall Study|Inevaluable|2|||
129730652|NCT00075725|466972972|FG004|Overall Study|Inevaluable|2|||
129730653|NCT00075725|466972973|FG005|Overall Study|Inevaluable|9|||
129730654|NCT00075725|466972974|FG006|Overall Study|Inevaluable|1|||
129730655|NCT00075725|466972975|FG007|Overall Study|Inevaluable|11|||
129730656|NCT00075725|466972976|FG008|Overall Study|Inevaluable|2|||
129730657|NCT00075725|466972977|FG009|Overall Study|Inevaluable|0|||
129730658|NCT00075725|466972978|FG010|Overall Study|Inevaluable|1|||
129730659|NCT00075725|466972979|FG011|Overall Study|Inevaluable|0|||
129730660|NCT00075725|466972968|FG000|Overall Study|Other|4|||
129730661|NCT00075725|466972969|FG001|Overall Study|Other|2|||
129730662|NCT00075725|466972970|FG002|Overall Study|Other|1|||
129730663|NCT00075725|466972971|FG003|Overall Study|Other|1|||
129730664|NCT00075725|466972972|FG004|Overall Study|Other|1|||
129730665|NCT00075725|466972973|FG005|Overall Study|Other|4|||
129730666|NCT00075725|466972974|FG006|Overall Study|Other|2|||
129730667|NCT00075725|466972975|FG007|Overall Study|Other|9|||
129730668|NCT00075725|466972976|FG008|Overall Study|Other|2|||
129730669|NCT00075725|466972977|FG009|Overall Study|Other|1|||
129730670|NCT00075725|466972978|FG010|Overall Study|Other|0|||
129730671|NCT00075725|466972979|FG011|Overall Study|Other|3|||
129730672|NCT00075725|466972968|FG000|Overall Study|Pt trying to find a BM donor|0|||
129730673|NCT00075725|466972969|FG001|Overall Study|Pt trying to find a BM donor|1|||
129730674|NCT00075725|466972970|FG002|Overall Study|Pt trying to find a BM donor|0|||
129730675|NCT00075725|466972971|FG003|Overall Study|Pt trying to find a BM donor|0|||
129730676|NCT00075725|466972972|FG004|Overall Study|Pt trying to find a BM donor|0|||
129730677|NCT00075725|466972973|FG005|Overall Study|Pt trying to find a BM donor|0|||
129730678|NCT00075725|466972974|FG006|Overall Study|Pt trying to find a BM donor|0|||
129730679|NCT00075725|466972975|FG007|Overall Study|Pt trying to find a BM donor|0|||
129730680|NCT00075725|466972976|FG008|Overall Study|Pt trying to find a BM donor|0|||
129730681|NCT00075725|466972977|FG009|Overall Study|Pt trying to find a BM donor|0|||
129730682|NCT00075725|466972978|FG010|Overall Study|Pt trying to find a BM donor|0|||
129730683|NCT00075725|466972979|FG011|Overall Study|Pt trying to find a BM donor|0|||
129730684|NCT00075725|466972968|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
129730685|NCT00075725|466972969|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
129730686|NCT00075725|466972970|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
129730687|NCT00075725|466972971|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
129730688|NCT00075725|466972972|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
129730689|NCT00075725|466972973|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
129730690|NCT00075725|466972974|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
129730691|NCT00075725|466972975|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
129730692|NCT00075725|466972976|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
129730693|NCT00075725|466972977|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
129730694|NCT00075725|466972978|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
129730695|NCT00075725|466972979|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
129730696|NCT00075725|466972968|FG000|Overall Study|Unsuccessful institutional transfer|0|||
129730697|NCT00075725|466972969|FG001|Overall Study|Unsuccessful institutional transfer|0|||
129730698|NCT00075725|466972970|FG002|Overall Study|Unsuccessful institutional transfer|2|||
129730699|NCT00075725|466972971|FG003|Overall Study|Unsuccessful institutional transfer|0|||
129730700|NCT00075725|466972972|FG004|Overall Study|Unsuccessful institutional transfer|0|||
129730701|NCT00075725|466972973|FG005|Overall Study|Unsuccessful institutional transfer|0|||
129730702|NCT00075725|466972974|FG006|Overall Study|Unsuccessful institutional transfer|0|||
129730703|NCT00075725|466972975|FG007|Overall Study|Unsuccessful institutional transfer|0|||
129730704|NCT00075725|466972976|FG008|Overall Study|Unsuccessful institutional transfer|0|||
129730705|NCT00075725|466972977|FG009|Overall Study|Unsuccessful institutional transfer|1|||
129730706|NCT00075725|466972978|FG010|Overall Study|Unsuccessful institutional transfer|0|||
129730707|NCT00075725|466972979|FG011|Overall Study|Unsuccessful institutional transfer|0|||
129730708|NCT00075725|466972968|FG000|Overall Study|specimen(s) not submitted|0|||
129730709|NCT00075725|466972969|FG001|Overall Study|specimen(s) not submitted|0|||
129730710|NCT00075725|466972970|FG002|Overall Study|specimen(s) not submitted|2|||
129730711|NCT00075725|466972971|FG003|Overall Study|specimen(s) not submitted|0|||
129730712|NCT00075725|466972972|FG004|Overall Study|specimen(s) not submitted|0|||
129730713|NCT00075725|466972973|FG005|Overall Study|specimen(s) not submitted|0|||
129730714|NCT00075725|466972974|FG006|Overall Study|specimen(s) not submitted|0|||
129730715|NCT00075725|466972975|FG007|Overall Study|specimen(s) not submitted|0|||
129730716|NCT00075725|466972976|FG008|Overall Study|specimen(s) not submitted|0|||
129730717|NCT00075725|466972977|FG009|Overall Study|specimen(s) not submitted|0|||
129730718|NCT00075725|466972978|FG010|Overall Study|specimen(s) not submitted|0|||
129730719|NCT00075725|466972979|FG011|Overall Study|specimen(s) not submitted|0|||
129730720|NCT00075725|466972968|FG000|Overall Study|Pt went to transplant|0|||
129730721|NCT00075725|466972969|FG001|Overall Study|Pt went to transplant|0|||
129730722|NCT00075725|466972970|FG002|Overall Study|Pt went to transplant|0|||
129892369|NCT00783718|467565430|FG006|Induction Phase|Lack of Efficacy|0|||
129730723|NCT00075725|466972971|FG003|Overall Study|Pt went to transplant|1|||
129730724|NCT00075725|466972972|FG004|Overall Study|Pt went to transplant|0|||
129730725|NCT00075725|466972973|FG005|Overall Study|Pt went to transplant|1|||
129730726|NCT00075725|466972974|FG006|Overall Study|Pt went to transplant|0|||
129730727|NCT00075725|466972975|FG007|Overall Study|Pt went to transplant|0|||
129730728|NCT00075725|466972976|FG008|Overall Study|Pt went to transplant|0|||
129730729|NCT00075725|466972977|FG009|Overall Study|Pt went to transplant|0|||
129730730|NCT00075725|466972978|FG010|Overall Study|Pt went to transplant|0|||
129730731|NCT00075725|466972979|FG011|Overall Study|Pt went to transplant|0|||
129730732|NCT00075725|466972968|FG000|Overall Study|Pt received additional steroids|0|||
129730733|NCT00075725|466972969|FG001|Overall Study|Pt received additional steroids|0|||
129730734|NCT00075725|466972970|FG002|Overall Study|Pt received additional steroids|0|||
129730735|NCT00075725|466972971|FG003|Overall Study|Pt received additional steroids|1|||
129730736|NCT00075725|466972972|FG004|Overall Study|Pt received additional steroids|0|||
129730737|NCT00075725|466972973|FG005|Overall Study|Pt received additional steroids|0|||
129730738|NCT00075725|466972974|FG006|Overall Study|Pt received additional steroids|0|||
129730739|NCT00075725|466972975|FG007|Overall Study|Pt received additional steroids|0|||
129730740|NCT00075725|466972976|FG008|Overall Study|Pt received additional steroids|0|||
129730741|NCT00075725|466972977|FG009|Overall Study|Pt received additional steroids|0|||
129730742|NCT00075725|466972978|FG010|Overall Study|Pt received additional steroids|0|||
129730743|NCT00075725|466972979|FG011|Overall Study|Pt received additional steroids|0|||
129730744|NCT00075725|466972968|FG000|Overall Study|Pt relocated|0|||
129730745|NCT00075725|466972969|FG001|Overall Study|Pt relocated|0|||
129730746|NCT00075725|466972970|FG002|Overall Study|Pt relocated|0|||
129730747|NCT00075725|466972971|FG003|Overall Study|Pt relocated|2|||
129730748|NCT00075725|466972972|FG004|Overall Study|Pt relocated|0|||
129730749|NCT00075725|466972973|FG005|Overall Study|Pt relocated|1|||
129730750|NCT00075725|466972974|FG006|Overall Study|Pt relocated|1|||
129730751|NCT00075725|466972975|FG007|Overall Study|Pt relocated|2|||
129730752|NCT00075725|466972976|FG008|Overall Study|Pt relocated|1|||
129730753|NCT00075725|466972977|FG009|Overall Study|Pt relocated|0|||
129730754|NCT00075725|466972978|FG010|Overall Study|Pt relocated|0|||
129730755|NCT00075725|466972979|FG011|Overall Study|Pt relocated|0|||
129730756|NCT00075725|466972968|FG000|Overall Study|Institution Terminated|0|||
129730757|NCT00075725|466972969|FG001|Overall Study|Institution Terminated|0|||
129730758|NCT00075725|466972970|FG002|Overall Study|Institution Terminated|0|||
129730759|NCT00075725|466972971|FG003|Overall Study|Institution Terminated|0|||
129730760|NCT00075725|466972972|FG004|Overall Study|Institution Terminated|1|||
129730761|NCT00075725|466972973|FG005|Overall Study|Institution Terminated|0|||
129730762|NCT00075725|466972974|FG006|Overall Study|Institution Terminated|0|||
129730763|NCT00075725|466972975|FG007|Overall Study|Institution Terminated|3|||
129730764|NCT00075725|466972976|FG008|Overall Study|Institution Terminated|0|||
129730765|NCT00075725|466972977|FG009|Overall Study|Institution Terminated|0|||
129730766|NCT00075725|466972978|FG010|Overall Study|Institution Terminated|0|||
129730767|NCT00075725|466972979|FG011|Overall Study|Institution Terminated|0|||
129730768|NCT00075725|466972968|FG000|Overall Study|Study Closure|1|||
129730769|NCT00075725|466972969|FG001|Overall Study|Study Closure|0|||
129730770|NCT00075725|466972970|FG002|Overall Study|Study Closure|0|||
129730771|NCT00075725|466972971|FG003|Overall Study|Study Closure|0|||
129730772|NCT00075725|466972972|FG004|Overall Study|Study Closure|1|||
129730773|NCT00075725|466972973|FG005|Overall Study|Study Closure|3|||
129730774|NCT00075725|466972974|FG006|Overall Study|Study Closure|0|||
129730775|NCT00075725|466972975|FG007|Overall Study|Study Closure|1|||
129730776|NCT00075725|466972976|FG008|Overall Study|Study Closure|0|||
129730777|NCT00075725|466972977|FG009|Overall Study|Study Closure|0|||
129730778|NCT00075725|466972978|FG010|Overall Study|Study Closure|0|||
129730779|NCT00075725|466972979|FG011|Overall Study|Study Closure|0|||
129730780|NCT00075725|466972968|FG000|Overall Study|Other complications|0|||
129730781|NCT00075725|466972969|FG001|Overall Study|Other complications|0|||
129730782|NCT00075725|466972970|FG002|Overall Study|Other complications|0|||
129730783|NCT00075725|466972971|FG003|Overall Study|Other complications|0|||
129730784|NCT00075725|466972972|FG004|Overall Study|Other complications|0|||
129730785|NCT00075725|466972973|FG005|Overall Study|Other complications|1|||
129730786|NCT00075725|466972974|FG006|Overall Study|Other complications|0|||
129730787|NCT00075725|466972975|FG007|Overall Study|Other complications|0|||
129730788|NCT00075725|466972976|FG008|Overall Study|Other complications|0|||
129730789|NCT00075725|466972977|FG009|Overall Study|Other complications|0|||
129730790|NCT00075725|466972978|FG010|Overall Study|Other complications|0|||
129730791|NCT00075725|466972979|FG011|Overall Study|Other complications|0|||
129730792|NCT00075725|466972968|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
129730793|NCT00075725|466972969|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
129730794|NCT00075725|466972970|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
129730795|NCT00075725|466972971|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
129730796|NCT00075725|466972972|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
129730797|NCT00075725|466972973|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
129730798|NCT00075725|466972974|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
129730799|NCT00075725|466972975|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
129730800|NCT00075725|466972976|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
129730801|NCT00075725|466972977|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
129730802|NCT00075725|466972978|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
129730803|NCT00075725|466972979|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
129730804|NCT00075725|466972968|FG000|Overall Study|Pt incarcerated|0|||
129730805|NCT00075725|466972969|FG001|Overall Study|Pt incarcerated|0|||
129730806|NCT00075725|466972970|FG002|Overall Study|Pt incarcerated|0|||
129730807|NCT00075725|466972971|FG003|Overall Study|Pt incarcerated|0|||
129730808|NCT00075725|466972972|FG004|Overall Study|Pt incarcerated|0|||
129730809|NCT00075725|466972973|FG005|Overall Study|Pt incarcerated|0|||
129730810|NCT00075725|466972974|FG006|Overall Study|Pt incarcerated|0|||
129730811|NCT00075725|466972975|FG007|Overall Study|Pt incarcerated|1|||
129730812|NCT00075725|466972976|FG008|Overall Study|Pt incarcerated|0|||
129730813|NCT00075725|466972977|FG009|Overall Study|Pt incarcerated|0|||
129730814|NCT00075725|466972978|FG010|Overall Study|Pt incarcerated|0|||
129730815|NCT00075725|466972979|FG011|Overall Study|Pt incarcerated|0|||
129730816|NCT02240368|466972980|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
129730817|NCT02240368|466972981|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
129730818|NCT02240368|466972982|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
129730819|NCT02240368|466972980|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
129730820|NCT02240368|466972981|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
129730821|NCT02240368|466972982|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
129730822|NCT03385265|466972988|FG000|Overall Study|Withdrawal by Subject|5|||
129730823|NCT03385265|466972989|FG001|Overall Study|Withdrawal by Subject|2|||
129730824|NCT03385265|466972990|FG002|Overall Study|Withdrawal by Subject|5|||
129730825|NCT03385265|466972991|FG003|Overall Study|Withdrawal by Subject|2|||
129730826|NCT02752958|466972994|FG000|Overall Study|Adverse Event|3|||
129730827|NCT02752958|466972994|FG000|Overall Study|Lost to Follow-up|1|||
129730828|NCT02752958|466972994|FG000|Overall Study|Protocol Violation|1|||
129730829|NCT02752958|466972994|FG000|Overall Study|Withdrawal by Subject|2|||
129730830|NCT02752958|466972994|FG000|Overall Study|Other (Reason not specified)|2|||
129730831|NCT00853125|466972995|FG000|Overall Study|Study participant's donor was CMV +|1|||
129730832|NCT03746600|466972997|FG000|Overall Study|Withdrawal by Subject|3|||
129730833|NCT03746600|466972998|FG001|Overall Study|Withdrawal by Subject|3|||
129730834|NCT03746600|466972997|FG000|Overall Study|dismissed from study|1|||
129730835|NCT03746600|466972998|FG001|Overall Study|dismissed from study|0|||
129730836|NCT03746600|466972997|FG000|Overall Study|Lost to Follow-up|1|||
129730837|NCT03746600|466972998|FG001|Overall Study|Lost to Follow-up|0|||
129730838|NCT03023826|466972999|FG000|Period 1|Withdrawal by Subject|0|||
129730839|NCT03023826|466973000|FG001|Period 1|Withdrawal by Subject|0|||
129730840|NCT03023826|466973001|FG002|Period 1|Withdrawal by Subject|0|||
129730841|NCT03023826|466973002|FG003|Period 1|Withdrawal by Subject|0|||
129730842|NCT03023826|466973003|FG004|Period 1|Withdrawal by Subject|1|||
129730843|NCT03023826|466973004|FG005|Period 1|Withdrawal by Subject|0|||
129730844|NCT02182440|466973005|FG000|Overall Study|Adverse Event|0|||
129730845|NCT02182440|466973006|FG001|Overall Study|Adverse Event|1|||
129730846|NCT02182440|466973007|FG002|Overall Study|Adverse Event|0|||
129730847|NCT02182440|466973008|FG003|Overall Study|Adverse Event|0|||
129730848|NCT02182440|466973005|FG000|Overall Study|Death|31|||
129730849|NCT02182440|466973006|FG001|Overall Study|Death|8|||
129730850|NCT02182440|466973007|FG002|Overall Study|Death|5|||
129730851|NCT02182440|466973008|FG003|Overall Study|Death|16|||
129730852|NCT02182440|466973005|FG000|Overall Study|Protocol Violation|0|||
129730853|NCT02182440|466973006|FG001|Overall Study|Protocol Violation|1|||
129730854|NCT02182440|466973007|FG002|Overall Study|Protocol Violation|0|||
129730855|NCT02182440|466973008|FG003|Overall Study|Protocol Violation|0|||
129730856|NCT02182440|466973005|FG000|Overall Study|Physician Decision|1|||
129730857|NCT02182440|466973006|FG001|Overall Study|Physician Decision|0|||
129730858|NCT02182440|466973007|FG002|Overall Study|Physician Decision|0|||
129730859|NCT02182440|466973008|FG003|Overall Study|Physician Decision|0|||
129730860|NCT02182440|466973005|FG000|Overall Study|Withdrawal by Subject|1|||
129730861|NCT02182440|466973006|FG001|Overall Study|Withdrawal by Subject|1|||
129730862|NCT02182440|466973007|FG002|Overall Study|Withdrawal by Subject|3|||
129730863|NCT02182440|466973008|FG003|Overall Study|Withdrawal by Subject|4|||
129730864|NCT02182440|466973005|FG000|Overall Study|different, e.g adm other hospital|12|||
129730865|NCT02182440|466973006|FG001|Overall Study|different, e.g adm other hospital|3|||
129730866|NCT02182440|466973007|FG002|Overall Study|different, e.g adm other hospital|3|||
129730867|NCT02182440|466973008|FG003|Overall Study|different, e.g adm other hospital|10|||
129730868|NCT00072293|466973009|FG000|Overall Study|Lost to Follow-up|1|||
129730869|NCT00072293|466973010|FG001|Overall Study|Lost to Follow-up|1|||
129730870|NCT00072293|466973009|FG000|Overall Study|Withdrawal by Subject|0|||
129730871|NCT00072293|466973010|FG001|Overall Study|Withdrawal by Subject|1|||
129730872|NCT01444027|466973016|FG000|Overall Study|Withdrawal by Subject|4|||
129730873|NCT01444027|466973017|FG001|Overall Study|Withdrawal by Subject|10|||
129730874|NCT01444027|466973018|FG002|Overall Study|Withdrawal by Subject|24|||
129892370|NCT00783718|467565424|FG000|Induction Phase|Withdrawal by Subject|3|||
129892371|NCT00783718|467565425|FG001|Induction Phase|Withdrawal by Subject|4|||
129892372|NCT00783718|467565426|FG002|Induction Phase|Withdrawal by Subject|8|||
129892373|NCT00783718|467565427|FG003|Induction Phase|Withdrawal by Subject|0|||
129892374|NCT00783718|467565428|FG004|Induction Phase|Withdrawal by Subject|0|||
129892375|NCT00783718|467565429|FG005|Induction Phase|Withdrawal by Subject|0|||
129892376|NCT00783718|467565430|FG006|Induction Phase|Withdrawal by Subject|0|||
129892377|NCT00783718|467565424|FG000|Induction Phase|Lost to Follow-up|1|||
129892378|NCT00783718|467565425|FG001|Induction Phase|Lost to Follow-up|0|||
129892379|NCT00783718|467565426|FG002|Induction Phase|Lost to Follow-up|1|||
129892380|NCT00783718|467565427|FG003|Induction Phase|Lost to Follow-up|0|||
129892381|NCT00783718|467565428|FG004|Induction Phase|Lost to Follow-up|0|||
129892382|NCT00783718|467565429|FG005|Induction Phase|Lost to Follow-up|0|||
129892383|NCT00783718|467565430|FG006|Induction Phase|Lost to Follow-up|0|||
129892384|NCT00783718|467565424|FG000|Maintenance Phase|Adverse Event|12|||
129892385|NCT00783718|467565425|FG001|Maintenance Phase|Adverse Event|0|||
129892386|NCT00783718|467565426|FG002|Maintenance Phase|Adverse Event|0|||
129892387|NCT00783718|467565427|FG003|Maintenance Phase|Adverse Event|15|||
129892388|NCT00783718|467565428|FG004|Maintenance Phase|Adverse Event|7|||
129892389|NCT00783718|467565429|FG005|Maintenance Phase|Adverse Event|6|||
129892390|NCT00783718|467565430|FG006|Maintenance Phase|Adverse Event|16|||
129892391|NCT00783718|467565424|FG000|Maintenance Phase|Protocol Violation|1|||
129892392|NCT00783718|467565425|FG001|Maintenance Phase|Protocol Violation|0|||
129892393|NCT00783718|467565426|FG002|Maintenance Phase|Protocol Violation|0|||
129892394|NCT00783718|467565427|FG003|Maintenance Phase|Protocol Violation|0|||
129892395|NCT00783718|467565428|FG004|Maintenance Phase|Protocol Violation|0|||
129892396|NCT00783718|467565429|FG005|Maintenance Phase|Protocol Violation|0|||
129892397|NCT00783718|467565430|FG006|Maintenance Phase|Protocol Violation|2|||
129892398|NCT00783718|467565424|FG000|Maintenance Phase|Lack of Efficacy|83|||
129892399|NCT00783718|467565425|FG001|Maintenance Phase|Lack of Efficacy|0|||
129892400|NCT00783718|467565426|FG002|Maintenance Phase|Lack of Efficacy|0|||
129892401|NCT00783718|467565427|FG003|Maintenance Phase|Lack of Efficacy|61|||
129892402|NCT00783718|467565428|FG004|Maintenance Phase|Lack of Efficacy|31|||
129892403|NCT00783718|467565429|FG005|Maintenance Phase|Lack of Efficacy|33|||
129892404|NCT00783718|467565430|FG006|Maintenance Phase|Lack of Efficacy|155|||
129892405|NCT00783718|467565424|FG000|Maintenance Phase|Withdrawal by Subject|6|||
129892406|NCT00783718|467565425|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129892407|NCT00783718|467565426|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129892408|NCT00783718|467565427|FG003|Maintenance Phase|Withdrawal by Subject|2|||
129892409|NCT00783718|467565428|FG004|Maintenance Phase|Withdrawal by Subject|5|||
129892410|NCT00783718|467565429|FG005|Maintenance Phase|Withdrawal by Subject|2|||
129892411|NCT00783718|467565430|FG006|Maintenance Phase|Withdrawal by Subject|20|||
129892412|NCT00783718|467565424|FG000|Maintenance Phase|Lost to Follow-up|3|||
129730875|NCT01444027|466973016|FG000|Overall Study|Lost to Follow-up|26|||
129730876|NCT01444027|466973017|FG001|Overall Study|Lost to Follow-up|20|||
129730877|NCT01444027|466973018|FG002|Overall Study|Lost to Follow-up|14|||
129730878|NCT01416441|466973020|FG000|Overall Study|Lost to Follow-up|5|||
129730879|NCT01416441|466973020|FG000|Overall Study|Adverse Event|6|||
129730880|NCT01416441|466973020|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
129730881|NCT01416441|466973020|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
129730882|NCT01416441|466973020|FG000|Overall Study|Investigator Withdrew Subject|2|||
129730883|NCT01416441|466973020|FG000|Overall Study|Subject Withdrew Consent|12|||
129892413|NCT00783718|467565425|FG001|Maintenance Phase|Lost to Follow-up|0|||
129892414|NCT00783718|467565426|FG002|Maintenance Phase|Lost to Follow-up|0|||
129730884|NCT01416441|466973020|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
129892415|NCT00783718|467565427|FG003|Maintenance Phase|Lost to Follow-up|0|||
129892416|NCT00783718|467565428|FG004|Maintenance Phase|Lost to Follow-up|2|||
129892417|NCT00783718|467565429|FG005|Maintenance Phase|Lost to Follow-up|0|||
129892418|NCT00783718|467565430|FG006|Maintenance Phase|Lost to Follow-up|2|||
129892419|NCT01027871|467565432|FG000|Overall Study|Physician Decision|1|||
129892420|NCT01027871|467565433|FG001|Overall Study|Physician Decision|5|||
129892421|NCT01027871|467565434|FG002|Overall Study|Physician Decision|0|||
129892422|NCT01027871|467565432|FG000|Overall Study|Protocol Violation|0|||
129892423|NCT01027871|467565433|FG001|Overall Study|Protocol Violation|2|||
129892424|NCT01027871|467565434|FG002|Overall Study|Protocol Violation|2|||
129730885|NCT02653495|466973025|FG000|Overall Study|Lost to Follow-up|2|||
129892425|NCT01027871|467565432|FG000|Overall Study|Withdrawal by Subject|1|||
129892426|NCT01027871|467565433|FG001|Overall Study|Withdrawal by Subject|2|||
129892427|NCT01027871|467565434|FG002|Overall Study|Withdrawal by Subject|2|||
129892428|NCT01027871|467565432|FG000|Overall Study|Adverse Event|0|||
129730886|NCT02653495|466973026|FG001|Overall Study|Lost to Follow-up|0|||
129730887|NCT02653495|466973025|FG000|Overall Study|Screening Failure|10|||
129730888|NCT02653495|466973026|FG001|Overall Study|Screening Failure|0|||
129730889|NCT00953680|466973027|FG000|Period 1|Withdrawal by Subject|0|||
129730890|NCT00953680|466973028|FG001|Period 1|Withdrawal by Subject|1|||
129730891|NCT01360398|466973029|FG000|Overall Study|Withdrawal by Subject|14|||
129730892|NCT01360398|466973029|FG000|Overall Study|Other|7|||
129730893|NCT01360398|466973029|FG000|Overall Study|Migrated/moved from study area|1|||
129730894|NCT00737711|466973030|FG000|Overall Study|Adverse Event|2|||
129730895|NCT00737711|466973030|FG000|Overall Study|Death|8|||
129730896|NCT00737711|466973030|FG000|Overall Study|Failure to return|4|||
129730897|NCT00737711|466973030|FG000|Overall Study|Protocol Violation|1|||
129730898|NCT00737711|466973030|FG000|Overall Study|Withdrawal by Subject|5|||
129730899|NCT00737711|466973030|FG000|Overall Study|Blood transfusion|6|||
129730900|NCT00737711|466973030|FG000|Overall Study|Other|5|||
129730901|NCT01514240|466974817|FG000|Overall Study|Adverse Event|4|||
129730902|NCT01514240|466974818|FG001|Overall Study|Adverse Event|4|||
129730903|NCT01514240|466974817|FG000|Overall Study|Subject Decision|2|||
129730904|NCT01514240|466974818|FG001|Overall Study|Subject Decision|7|||
129730905|NCT01103063|466974819|FG000|Overall Study|Adverse Event|3|||
129730906|NCT01103063|466974820|FG001|Overall Study|Adverse Event|1|||
129730907|NCT01103063|466974819|FG000|Overall Study|Lost to Follow-up|68|||
129730908|NCT01103063|466974820|FG001|Overall Study|Lost to Follow-up|51|||
129730909|NCT01103063|466974819|FG000|Overall Study|Withdrawal by Subject|60|||
129730910|NCT01103063|466974820|FG001|Overall Study|Withdrawal by Subject|15|||
129730911|NCT01103063|466974819|FG000|Overall Study|Other|16|||
129730912|NCT01103063|466974820|FG001|Overall Study|Other|11|||
129730913|NCT01103063|466974819|FG000|Overall Study|Protocol Violation|1|||
129730914|NCT01103063|466974820|FG001|Overall Study|Protocol Violation|0|||
129730915|NCT01103063|466974819|FG000|Overall Study|Study terminated by Sponsor|326|||
129730916|NCT01103063|466974820|FG001|Overall Study|Study terminated by Sponsor|342|||
129730917|NCT01103063|466974819|FG000|Overall Study|Death|3|||
129730918|NCT01103063|466974820|FG001|Overall Study|Death|1|||
129730919|NCT01187446|466974823|FG000|Overall Study|Patient started non-protocol therapy|0|||
129730920|NCT01187446|466974824|FG001|Overall Study|Patient started non-protocol therapy|1|||
129730921|NCT00149994|466974825|FG000|Overall Study|Administrative problems:|1|||
129730922|NCT00149994|466974826|FG001|Overall Study|Administrative problems:|0|||
129730923|NCT00149994|466974825|FG000|Overall Study|Protocol Violation|0|||
129730924|NCT00149994|466974826|FG001|Overall Study|Protocol Violation|1|||
129730925|NCT01342965|466974827|FG000|Overall Study|Death|58|||
129730926|NCT01342965|466974828|FG001|Overall Study|Death|57|||
129730927|NCT01342965|466974827|FG000|Overall Study|Lost to Follow-up|5|||
129730928|NCT01342965|466974828|FG001|Overall Study|Lost to Follow-up|3|||
129730929|NCT01342965|466974827|FG000|Overall Study|Other Reasons- Unspecified|44|||
129730930|NCT01342965|466974828|FG001|Overall Study|Other Reasons- Unspecified|38|||
129730931|NCT01342965|466974827|FG000|Overall Study|Withdrawal by Subject|2|||
129730932|NCT01342965|466974828|FG001|Overall Study|Withdrawal by Subject|9|||
129730933|NCT03538444|466974839|FG000|Overall Study|opioid withdrawal|1|||
129730934|NCT03538444|466974840|FG001|Overall Study|opioid withdrawal|0|||
129730935|NCT04422561|466974843|FG000|Overall Study|Lost to Follow-up|25|||
129730936|NCT04422561|466974844|FG001|Overall Study|Lost to Follow-up|11|||
129730937|NCT03640052|466974845|FG000|Overall Study|Lost to Follow-up|0|||
129730938|NCT03640052|466974846|FG001|Overall Study|Lost to Follow-up|1|||
129730939|NCT03640052|466974847|FG002|Overall Study|Lost to Follow-up|0|||
129730940|NCT03640052|466974848|FG003|Overall Study|Lost to Follow-up|0|||
129730941|NCT03640052|466974849|FG004|Overall Study|Lost to Follow-up|0|||
129730942|NCT00790647|466974856|FG000|Overall Study|Adverse Event|1|||
129730943|NCT04926831|466974857|FG000|Overall Study|Withdrawal by Subject|2|||
129730944|NCT04926831|466974857|FG000|Overall Study|Adverse Event|2|||
129730945|NCT03549871|466974862|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
129730946|NCT03549871|466974863|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
129730947|NCT03549871|466974862|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
129730948|NCT03549871|466974863|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
129730949|NCT03549871|466974862|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
129730950|NCT03549871|466974863|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
129730951|NCT03549871|466974862|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
129730952|NCT03549871|466974863|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
129730953|NCT03549871|466974862|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
129730954|NCT03549871|466974863|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
129730955|NCT03549871|466974862|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
129730956|NCT03549871|466974863|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
129730957|NCT03549871|466974862|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
129730958|NCT03549871|466974863|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
129730959|NCT03549871|466974862|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
129730960|NCT03549871|466974863|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
129730961|NCT03549871|466974862|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
129730962|NCT03549871|466974863|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
129730963|NCT03549871|466974862|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
129730964|NCT03549871|466974863|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
129730965|NCT03549871|466974862|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
129730966|NCT03549871|466974863|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
129730967|NCT01133626|466974865|FG000|Overall Study|Adverse Event|0|||
129892429|NCT01027871|467565433|FG001|Overall Study|Adverse Event|2|||
129892430|NCT01027871|467565434|FG002|Overall Study|Adverse Event|2|||
129892431|NCT01027871|467565432|FG000|Overall Study|Sponsor Decision|0|||
129892432|NCT01027871|467565433|FG001|Overall Study|Sponsor Decision|2|||
129892433|NCT01027871|467565434|FG002|Overall Study|Sponsor Decision|0|||
129892434|NCT01027871|467565432|FG000|Overall Study|Discontinued Prior to Treatment|0|||
129892435|NCT01027871|467565433|FG001|Overall Study|Discontinued Prior to Treatment|0|||
129730968|NCT01133626|466974866|FG001|Overall Study|Adverse Event|1|||
129730969|NCT01133626|466974867|FG002|Overall Study|Adverse Event|0|||
129730970|NCT01133626|466974865|FG000|Overall Study|Withdrawal by Subject|1|||
129730971|NCT01133626|466974866|FG001|Overall Study|Withdrawal by Subject|2|||
129730972|NCT01133626|466974867|FG002|Overall Study|Withdrawal by Subject|2|||
129730973|NCT01133626|466974865|FG000|Overall Study|Other|0|||
129730974|NCT01133626|466974866|FG001|Overall Study|Other|2|||
129730975|NCT01133626|466974867|FG002|Overall Study|Other|0|||
129730976|NCT03298984|466974870|FG000|Overall Study|Physician Decision|1|||
129730977|NCT03298984|466974871|FG001|Overall Study|Physician Decision|0|||
129730978|NCT03298984|466974872|FG002|Overall Study|Physician Decision|0|||
129892436|NCT01027871|467565434|FG002|Overall Study|Discontinued Prior to Treatment|1|||
129892437|NCT04159896|467565440|FG000|Overall Study|Lack of Efficacy|7|||
129730979|NCT03298984|466974873|FG003|Overall Study|Physician Decision|6|||
129730980|NCT03298984|466974870|FG000|Overall Study|Lack of Efficacy|0|||
129892438|NCT04159896|467565440|FG000|Overall Study|Withdrawal by Subject|1|||
129892439|NCT04159896|467565440|FG000|Overall Study|Adverse Event|1|||
129892440|NCT04159896|467565440|FG000|Overall Study|A transient ischaemic attack|1|||
129892441|NCT02084082|467565441|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
129892442|NCT02084082|467565442|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
129892443|NCT02084082|467565443|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
129892444|NCT02084082|467565444|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
129892445|NCT02084082|467565441|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129892446|NCT02084082|467565442|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129892447|NCT02084082|467565443|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
129892448|NCT02084082|467565444|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
129892449|NCT05705167|467565445|FG000|Overall Study|Randomised but not Treated|0|||
129892450|NCT05705167|467565446|FG001|Overall Study|Randomised but not Treated|2|||
129892451|NCT05705167|467565447|FG002|Overall Study|Randomised but not Treated|0|||
129892452|NCT05705167|467565448|FG003|Overall Study|Randomised but not Treated|7|||
129892453|NCT05705167|467565449|FG004|Overall Study|Randomised but not Treated|0|||
129892454|NCT05705167|467565450|FG005|Overall Study|Randomised but not Treated|0|||
129892455|NCT05705167|467565451|FG006|Overall Study|Randomised but not Treated|0|||
129892456|NCT05705167|467565445|FG000|Overall Study|Death|0|||
129892457|NCT05705167|467565446|FG001|Overall Study|Death|0|||
129892458|NCT05705167|467565447|FG002|Overall Study|Death|3|||
129892459|NCT05705167|467565448|FG003|Overall Study|Death|0|||
129892460|NCT05705167|467565449|FG004|Overall Study|Death|1|||
129892461|NCT05705167|467565450|FG005|Overall Study|Death|1|||
129892462|NCT05705167|467565451|FG006|Overall Study|Death|1|||
129892463|NCT05705167|467565445|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892464|NCT05705167|467565446|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129730981|NCT03298984|466974871|FG001|Overall Study|Lack of Efficacy|1|||
129892465|NCT05705167|467565447|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
129730982|NCT03298984|466974872|FG002|Overall Study|Lack of Efficacy|1|||
129730983|NCT03298984|466974873|FG003|Overall Study|Lack of Efficacy|4|||
129730984|NCT03298984|466974870|FG000|Overall Study|Relapsed disease (following remission)|0|||
129730985|NCT03298984|466974871|FG001|Overall Study|Relapsed disease (following remission)|0|||
129892466|NCT05705167|467565448|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
129892467|NCT05705167|467565449|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892468|NCT05705167|467565450|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
129892469|NCT05705167|467565451|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
129892470|NCT04736056|467565452|FG000|Overall Study|Death|0|||
129892471|NCT04736056|467565453|FG001|Overall Study|Death|0|||
129892472|NCT04736056|467565454|FG002|Overall Study|Death|0|||
129730986|NCT03298984|466974872|FG002|Overall Study|Relapsed disease (following remission)|1|||
129730987|NCT03298984|466974873|FG003|Overall Study|Relapsed disease (following remission)|1|||
129730988|NCT03298984|466974870|FG000|Overall Study|Adverse Event|0|||
129730989|NCT03298984|466974871|FG001|Overall Study|Adverse Event|0|||
129730990|NCT03298984|466974872|FG002|Overall Study|Adverse Event|0|||
129730991|NCT03298984|466974873|FG003|Overall Study|Adverse Event|1|||
129730992|NCT03298984|466974870|FG000|Overall Study|Death|0|||
129730993|NCT03298984|466974871|FG001|Overall Study|Death|0|||
129730994|NCT03298984|466974872|FG002|Overall Study|Death|0|||
129730995|NCT03298984|466974873|FG003|Overall Study|Death|2|||
129730996|NCT03298984|466974870|FG000|Overall Study|Insurance Company Decision|0|||
129730997|NCT03298984|466974871|FG001|Overall Study|Insurance Company Decision|0|||
129730998|NCT03298984|466974872|FG002|Overall Study|Insurance Company Decision|0|||
129730999|NCT03298984|466974873|FG003|Overall Study|Insurance Company Decision|1|||
129731000|NCT00294645|466974874|FG000|Overall Study|Death|10|||
129731001|NCT00294645|466974875|FG001|Overall Study|Death|18|||
129731002|NCT00294645|466974874|FG000|Overall Study|Lost to Follow-up|1|||
129731003|NCT00294645|466974875|FG001|Overall Study|Lost to Follow-up|10|||
129731004|NCT00294645|466974874|FG000|Overall Study|Withdrawal by Subject|18|||
129731005|NCT00294645|466974875|FG001|Overall Study|Withdrawal by Subject|34|||
129731006|NCT00294645|466974874|FG000|Overall Study|Physician Decision|15|||
129731007|NCT00294645|466974875|FG001|Overall Study|Physician Decision|20|||
129731008|NCT00294645|466974874|FG000|Overall Study|Other|4|||
129731009|NCT00294645|466974875|FG001|Overall Study|Other|10|||
129731010|NCT03263923|466974876|FG000|Overall Study|Withdrawal by Subject|10|||
129731011|NCT03263923|466974877|FG001|Overall Study|Withdrawal by Subject|8|||
129731012|NCT03263923|466974876|FG000|Overall Study|Lost to Follow-up|15|||
129731013|NCT03263923|466974877|FG001|Overall Study|Lost to Follow-up|13|||
129731014|NCT03305081|466974884|FG000|Overall Study|Lost to Follow-up|10|||
129731015|NCT03305081|466974885|FG001|Overall Study|Lost to Follow-up|15|||
129731016|NCT00772369|466974892|FG000|Overall Study|Did not return record release form|1|||
129731017|NCT01774253|466974893|FG000|Overall Study|Lack of Efficacy|4|||
129731018|NCT01774253|466974893|FG000|Overall Study|Physician Decision|2|||
129731019|NCT01774253|466974893|FG000|Overall Study|Withdrawal by Subject|2|||
129731020|NCT01774253|466974893|FG000|Overall Study|Death|1|||
129731021|NCT00554619|466974894|FG000|Overall Study|Adverse Event|1|||
129731022|NCT00554619|466974894|FG000|Overall Study|Physician Decision|1|||
129731023|NCT00554619|466974894|FG000|Overall Study|Liver Function Test Abnormality|1|||
129731024|NCT01571284|466974897|FG000|Overall Study|Participant's decision|84|||
129731025|NCT01571284|466974897|FG000|Overall Study|Lost to Follow-up|3|||
129731026|NCT01571284|466974897|FG000|Overall Study|Enrolled but not treated|2|||
129731027|NCT01571284|466974897|FG000|Overall Study|Other than specified above|80|||
129731028|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Death|1|||
129731029|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Death|1|||
129731030|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Death|0|||
129731031|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Death|0|||
129731032|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Death|1|||
129731033|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Death|0|||
129731034|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Death|0|||
129731035|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Death|0|||
129731036|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Death|0|||
129731037|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Death|0|||
129731038|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
129731039|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
129731040|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
129731041|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
129731042|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
129731043|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
129731044|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
129731045|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
129731046|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
129731047|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
129731048|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731049|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731050|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731051|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731052|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
129731053|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731054|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731055|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731056|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731057|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
129731058|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
129731059|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731060|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731061|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731062|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731063|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129892473|NCT04736056|467565455|FG003|Overall Study|Death|1|||
129892474|NCT04736056|467565452|FG000|Overall Study|Lost to Follow-up|1|||
129892475|NCT04736056|467565453|FG001|Overall Study|Lost to Follow-up|0|||
129892476|NCT04736056|467565454|FG002|Overall Study|Lost to Follow-up|1|||
129892477|NCT04736056|467565455|FG003|Overall Study|Lost to Follow-up|1|||
129892478|NCT04736056|467565452|FG000|Overall Study|Withdrawal by Subject|2|||
129892479|NCT04736056|467565453|FG001|Overall Study|Withdrawal by Subject|0|||
129892480|NCT04736056|467565454|FG002|Overall Study|Withdrawal by Subject|0|||
129892481|NCT04736056|467565455|FG003|Overall Study|Withdrawal by Subject|0|||
129892482|NCT04736056|467565452|FG000|Overall Study|Physician Decision|1|||
129892483|NCT04736056|467565453|FG001|Overall Study|Physician Decision|0|||
129892484|NCT04736056|467565454|FG002|Overall Study|Physician Decision|1|||
129892485|NCT04736056|467565455|FG003|Overall Study|Physician Decision|0|||
129892486|NCT02099539|467565460|FG000|Overall Study|Progressive Disease|3|||
129892487|NCT02099539|467565461|FG001|Overall Study|Progressive Disease|2|||
129892488|NCT02099539|467565462|FG002|Overall Study|Progressive Disease|2|||
129892489|NCT02099539|467565463|FG003|Overall Study|Progressive Disease|1|||
129892490|NCT02099539|467565464|FG004|Overall Study|Progressive Disease|4|||
129892491|NCT02099539|467565465|FG005|Overall Study|Progressive Disease|2|||
129892492|NCT02099539|467565466|FG006|Overall Study|Progressive Disease|0|||
129892493|NCT02099539|467565460|FG000|Overall Study|Adverse Event|0|||
129892494|NCT02099539|467565461|FG001|Overall Study|Adverse Event|0|||
129892495|NCT02099539|467565462|FG002|Overall Study|Adverse Event|1|||
129892496|NCT02099539|467565463|FG003|Overall Study|Adverse Event|1|||
129892497|NCT02099539|467565464|FG004|Overall Study|Adverse Event|0|||
129892498|NCT02099539|467565465|FG005|Overall Study|Adverse Event|0|||
129892499|NCT02099539|467565466|FG006|Overall Study|Adverse Event|0|||
129892500|NCT02099539|467565460|FG000|Overall Study|Physician Decision|0|||
129892501|NCT02099539|467565461|FG001|Overall Study|Physician Decision|0|||
129892502|NCT02099539|467565462|FG002|Overall Study|Physician Decision|0|||
129892503|NCT02099539|467565463|FG003|Overall Study|Physician Decision|0|||
129892504|NCT02099539|467565464|FG004|Overall Study|Physician Decision|0|||
129892505|NCT02099539|467565465|FG005|Overall Study|Physician Decision|1|||
129892506|NCT02099539|467565466|FG006|Overall Study|Physician Decision|0|||
129892507|NCT03251378|467565470|FG000|Overall Study|Death|3|||
129731064|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731065|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731066|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731067|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
129731068|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
129731069|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731070|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731071|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
129731072|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
129731073|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731074|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731075|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731076|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731077|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
129731078|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
129731079|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731080|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731081|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
129731082|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731083|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129892508|NCT03251378|467565471|FG001|Overall Study|Death|2|||
129892509|NCT03251378|467565472|FG002|Overall Study|Death|3|||
129892510|NCT03251378|467565473|FG003|Overall Study|Death|30|||
129892511|NCT03251378|467565474|FG004|Overall Study|Death|24|||
129892512|NCT03251378|467565475|FG005|Overall Study|Death|12|||
129892513|NCT03251378|467565476|FG006|Overall Study|Death|12|||
129892514|NCT03251378|467565470|FG000|Overall Study|Lost to Follow-up|0|||
129892515|NCT03251378|467565471|FG001|Overall Study|Lost to Follow-up|0|||
129892516|NCT03251378|467565472|FG002|Overall Study|Lost to Follow-up|1|||
129892517|NCT03251378|467565473|FG003|Overall Study|Lost to Follow-up|3|||
129444471|NCT02558231|465927349|FG000|Overall Study|Withdrawal by Subject|7|||
129731084|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731085|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731086|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731087|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
129731088|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
129731089|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
129731090|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
129731091|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
129731092|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
129731093|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129731094|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129731095|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129731096|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129731097|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
129731098|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
129731099|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
129731100|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
129731101|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731102|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
129731103|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731104|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731105|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731106|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731107|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731108|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
129731109|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731110|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731111|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
129731112|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
129731113|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731114|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731115|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731116|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731117|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
129731118|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731119|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731120|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731121|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731122|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731123|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731124|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731125|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731126|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731127|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731128|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731129|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731130|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
129731131|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731132|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
129731133|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731134|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129804225|NCT00231842|467251452|FG000|Overall Study|Did not complete the last 3 cycle|8|||
129731135|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731136|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731137|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731138|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
129731139|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
129731140|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
129731141|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
129731142|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
129731143|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129731144|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129731145|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129731146|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129731147|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
129731148|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731149|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731150|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731151|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
129731152|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
129731153|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731154|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731155|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731156|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731157|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731158|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129731159|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731160|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129731161|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129731162|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129731163|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731164|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731165|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731166|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731167|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731168|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
129731169|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731170|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731171|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731172|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
129731173|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731174|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731175|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731176|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731177|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
129731178|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731179|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731180|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731181|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731182|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
129731183|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731184|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731185|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731186|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731187|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129892518|NCT03251378|467565474|FG004|Overall Study|Lost to Follow-up|0|||
129892519|NCT03251378|467565475|FG005|Overall Study|Lost to Follow-up|0|||
129892520|NCT03251378|467565476|FG006|Overall Study|Lost to Follow-up|0|||
129892521|NCT03251378|467565470|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
129892522|NCT03251378|467565471|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
129892523|NCT03251378|467565472|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
129892524|NCT03251378|467565473|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
129892525|NCT03251378|467565474|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
129892526|NCT03251378|467565475|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
129892527|NCT03251378|467565476|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
129892528|NCT03251378|467565470|FG000|Overall Study|Progressive disease|2|||
129892529|NCT03251378|467565471|FG001|Overall Study|Progressive disease|0|||
129892530|NCT03251378|467565472|FG002|Overall Study|Progressive disease|0|||
129892531|NCT03251378|467565473|FG003|Overall Study|Progressive disease|1|||
129892532|NCT03251378|467565474|FG004|Overall Study|Progressive disease|0|||
129892533|NCT03251378|467565475|FG005|Overall Study|Progressive disease|0|||
129731188|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731189|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
129731190|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731191|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731192|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
129731193|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731194|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731195|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731196|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731197|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
129731198|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
129731199|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731200|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731201|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731202|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
129731203|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731204|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731205|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731206|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731207|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
129731208|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
129731209|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731210|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
129731211|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731212|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
129731213|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731214|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731215|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731216|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731217|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
129731218|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Other|5|||
129731219|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Other|1|||
129731220|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Other|0|||
129731221|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Other|3|||
129731222|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Other|0|||
129731223|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Other|0|||
129731224|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Other|0|||
129731225|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Other|0|||
129731226|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Other|0|||
129731227|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Other|0|||
129892534|NCT03251378|467565476|FG006|Overall Study|Progressive disease|0|||
129731228|NCT03352557|466974898|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731229|NCT03352557|466974899|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731230|NCT03352557|466974900|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731231|NCT03352557|466974901|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731232|NCT03352557|466974902|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
129731233|NCT03352557|466974903|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
129892535|NCT03251378|467565470|FG000|Overall Study|Physician Decision|0|||
129731234|NCT03352557|466974904|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731235|NCT03352557|466974905|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731236|NCT03352557|466974906|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731237|NCT03352557|466974907|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
129731238|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Death|0|||
129731239|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Death|0|||
129731240|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Death|0|||
129731241|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Death|0|||
129731242|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Death|0|||
129731243|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Death|1|||
129731244|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Death|0|||
129731245|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Death|1|||
129731246|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Death|1|||
129731247|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Death|1|||
129731248|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731249|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731250|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731251|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731252|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731253|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
129731254|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731255|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129892536|NCT03251378|467565471|FG001|Overall Study|Physician Decision|2|||
129892537|NCT03251378|467565472|FG002|Overall Study|Physician Decision|0|||
129731256|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731257|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
129731258|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731259|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731260|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731261|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731262|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731263|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731264|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731265|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731266|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
129731267|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
129731268|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129731269|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129731270|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129731271|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129731272|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
129731273|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
129731274|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
129731275|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
129731276|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
129731277|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
129731278|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731279|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731280|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731281|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731282|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731283|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
129731284|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
129731285|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
129731286|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
129731287|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
129731288|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129892538|NCT03251378|467565473|FG003|Overall Study|Physician Decision|0|||
129892539|NCT03251378|467565474|FG004|Overall Study|Physician Decision|0|||
129892540|NCT03251378|467565475|FG005|Overall Study|Physician Decision|0|||
129892541|NCT03251378|467565476|FG006|Overall Study|Physician Decision|0|||
129892542|NCT03251378|467565470|FG000|Overall Study|Other|2|||
129892543|NCT03251378|467565471|FG001|Overall Study|Other|3|||
129892544|NCT03251378|467565472|FG002|Overall Study|Other|2|||
129892545|NCT03251378|467565473|FG003|Overall Study|Other|0|||
129444472|NCT02558231|465927350|FG001|Overall Study|Withdrawal by Subject|4|||
129444473|NCT02558231|465927349|FG000|Overall Study|Physician Decision|7|||
129444474|NCT02558231|465927350|FG001|Overall Study|Physician Decision|5|||
129731289|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731290|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731291|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731292|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731293|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731294|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731295|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731296|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
129731297|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
129731298|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129731299|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129731300|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129731301|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129731302|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129731303|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
129731304|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
129731305|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
129731306|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
129731307|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
129731308|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731309|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731310|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731311|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731312|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731313|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731314|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731315|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
129731316|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
129731317|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
129731318|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731319|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731320|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731321|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731322|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731323|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731324|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731325|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
129731326|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731327|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
129731328|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731329|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731330|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731331|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731332|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731333|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731334|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731335|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
129731336|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731337|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
129731338|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731339|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731340|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129444475|NCT02558231|465927349|FG000|Overall Study|Sponsor Decision|0|||
129444476|NCT02558231|465927350|FG001|Overall Study|Sponsor Decision|1|||
129444477|NCT01006265|465927351|FG000|Overall Study|Lost to Follow-up|1|||
129444478|NCT01006265|465927352|FG001|Overall Study|Lost to Follow-up|0|||
129444479|NCT01006265|465927353|FG002|Overall Study|Lost to Follow-up|1|||
129444480|NCT01006265|465927354|FG003|Overall Study|Lost to Follow-up|0|||
129444481|NCT01006265|465927351|FG000|Overall Study|Withdrawal by Subject|4|||
129444482|NCT01006265|465927352|FG001|Overall Study|Withdrawal by Subject|7|||
129731341|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731342|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731343|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731344|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731345|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
129731346|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
129731347|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
129731348|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731349|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731350|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731351|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731352|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731353|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
129731354|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731355|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731356|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
129731357|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
129731358|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731359|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731360|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731361|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731362|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731363|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731364|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731365|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731366|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
129731367|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
129731368|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731369|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731370|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731371|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731372|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731373|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731374|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731375|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
129731376|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
129731377|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
129731378|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731379|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731380|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731381|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731382|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731383|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731384|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731385|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
129731386|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
129731387|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
129731388|NCT03352557|466974898|FG000|LTE Period: Week 80 to Week 173|Other|0|||
129731389|NCT03352557|466974899|FG001|LTE Period: Week 80 to Week 173|Other|0|||
129731390|NCT03352557|466974900|FG002|LTE Period: Week 80 to Week 173|Other|0|||
129731391|NCT03352557|466974901|FG003|LTE Period: Week 80 to Week 173|Other|0|||
129731392|NCT03352557|466974902|FG004|LTE Period: Week 80 to Week 173|Other|0|||
129731393|NCT03352557|466974903|FG005|LTE Period: Week 80 to Week 173|Other|0|||
129731394|NCT03352557|466974904|FG006|LTE Period: Week 80 to Week 173|Other|0|||
129731395|NCT03352557|466974905|FG007|LTE Period: Week 80 to Week 173|Other|1|||
129444483|NCT01006265|465927353|FG002|Overall Study|Withdrawal by Subject|5|||
129444484|NCT01006265|465927354|FG003|Overall Study|Withdrawal by Subject|5|||
129444485|NCT01006265|465927351|FG000|Overall Study|Administrative reason|1|||
129731396|NCT03352557|466974906|FG008|LTE Period: Week 80 to Week 173|Other|0|||
129731397|NCT03352557|466974907|FG009|LTE Period: Week 80 to Week 173|Other|0|||
129731398|NCT04065074|466974908|FG000|Overall Study|Adverse Event|1|||
129731399|NCT04065074|466974908|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
129731400|NCT00871117|466974909|FG000|Overall Study|Lost to Follow-up|5|||
129731401|NCT00871117|466974910|FG001|Overall Study|Lost to Follow-up|6|||
129731402|NCT00871117|466974909|FG000|Overall Study|Other|0|||
129731403|NCT00871117|466974910|FG001|Overall Study|Other|4|||
129731404|NCT00916058|466974911|FG000|Phase 1|Screen Failure|0|||
129731405|NCT00916058|466974912|FG001|Phase 1|Screen Failure|0|||
129731406|NCT00916058|466974913|FG002|Phase 1|Screen Failure|0|||
129731407|NCT00916058|466974914|FG003|Phase 1|Screen Failure|0|||
129731408|NCT00916058|466974915|FG004|Phase 1|Screen Failure|0|||
129731409|NCT00916058|466974916|FG005|Phase 1|Screen Failure|1|||
129731410|NCT00916058|466974917|FG006|Phase 1|Screen Failure|0|||
129731411|NCT00916058|466974911|FG000|Phase 2|Screen Failure|0|||
129731412|NCT00916058|466974912|FG001|Phase 2|Screen Failure|0|||
129731413|NCT00916058|466974913|FG002|Phase 2|Screen Failure|0|||
129731414|NCT00916058|466974914|FG003|Phase 2|Screen Failure|0|||
129731415|NCT00916058|466974915|FG004|Phase 2|Screen Failure|0|||
129731416|NCT00916058|466974916|FG005|Phase 2|Screen Failure|0|||
129731417|NCT00916058|466974917|FG006|Phase 2|Screen Failure|3|||
129731418|NCT01767493|466974918|FG000|Overall Study|screen failures|3|||
129731419|NCT03444766|466974919|FG000|Overall Study|Other Reasons|2|||
129731420|NCT03444766|466974919|FG000|Overall Study|Participant Withdrew Consent|5|||
129731421|NCT03444766|466974919|FG000|Overall Study|Lost to Follow-up|2|||
129731422|NCT03444766|466974919|FG000|Overall Study|Death|2|||
129731423|NCT03444766|466974919|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
129731424|NCT03444766|466974919|FG000|Overall Study|Disease Progression|49|||
129731425|NCT00977938|466974924|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
129731426|NCT00977938|466974925|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
129731427|NCT00977938|466974926|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
129731428|NCT00977938|466974927|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
129731429|NCT00977938|466974924|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
129731430|NCT00977938|466974925|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
129731431|NCT00977938|466974926|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
129731432|NCT00977938|466974927|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
129731433|NCT00977938|466974924|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
129731434|NCT00977938|466974925|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
129731435|NCT00977938|466974926|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
129731436|NCT00977938|466974927|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
129731437|NCT00977938|466974924|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
129731438|NCT00977938|466974925|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
129731439|NCT00977938|466974926|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
129731440|NCT00977938|466974927|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
129731441|NCT00977938|466974924|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
129731442|NCT00977938|466974925|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
129731443|NCT00977938|466974926|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
129731444|NCT00977938|466974927|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
129731445|NCT00977938|466974924|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
129731446|NCT00977938|466974925|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
129731447|NCT00977938|466974926|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
129731448|NCT00977938|466974927|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
129731449|NCT02142283|466974930|FG000|Overall Study|Death|20|||
129731450|NCT02142283|466974931|FG001|Overall Study|Death|18|||
129731451|NCT02142283|466974930|FG000|Overall Study|Withdrawal by Subject|1|||
129731452|NCT02142283|466974931|FG001|Overall Study|Withdrawal by Subject|3|||
129731453|NCT02460783|466974932|FG000|Overall Study|Withdrawal by Subject|1|||
129731454|NCT02460783|466974933|FG001|Overall Study|Withdrawal by Subject|3|||
129731455|NCT02460783|466974932|FG000|Overall Study|Lost to Follow-up|1|||
129731456|NCT02460783|466974933|FG001|Overall Study|Lost to Follow-up|1|||
129731457|NCT01646645|466974934|FG000|Overall Study|No Treated|1|||
129731458|NCT01646645|466974934|FG000|Overall Study|Inevaluable Donor|29|||
129731459|NCT02374814|466974940|FG000|Overall Study|Lost to Follow-up|1|||
129731460|NCT02374814|466974941|FG001|Overall Study|Lost to Follow-up|1|||
129731461|NCT02374814|466974942|FG002|Overall Study|Lost to Follow-up|0|||
129731462|NCT02374814|466974943|FG003|Overall Study|Lost to Follow-up|1|||
129731463|NCT02374814|466974944|FG004|Overall Study|Lost to Follow-up|0|||
129731464|NCT02374814|466974945|FG005|Overall Study|Lost to Follow-up|0|||
129731465|NCT02374814|466974940|FG000|Overall Study|Withdrawal by Subject|0|||
129731466|NCT02374814|466974941|FG001|Overall Study|Withdrawal by Subject|0|||
129731467|NCT02374814|466974942|FG002|Overall Study|Withdrawal by Subject|1|||
129731468|NCT02374814|466974943|FG003|Overall Study|Withdrawal by Subject|1|||
129731469|NCT02374814|466974944|FG004|Overall Study|Withdrawal by Subject|0|||
129731470|NCT02374814|466974945|FG005|Overall Study|Withdrawal by Subject|0|||
129731471|NCT00884039|466974949|FG000|Overall Study|Withdrawal by Subject|0|||
129731472|NCT00884039|466974950|FG001|Overall Study|Withdrawal by Subject|1|||
129731473|NCT00884039|466974949|FG000|Overall Study|Lack of Efficacy|2|||
129731474|NCT00884039|466974950|FG001|Overall Study|Lack of Efficacy|0|||
129731475|NCT00717522|466974951|FG000|Overall Study|Disease Progression|5|||
129731476|NCT00717522|466974951|FG000|Overall Study|Adverse Event|1|||
129731477|NCT00717522|466974951|FG000|Overall Study|Death|1|||
129731478|NCT01166958|466974954|FG000|Overall Study|Withdrawal by Subject|1|||
129731479|NCT01166958|466974955|FG001|Overall Study|Withdrawal by Subject|0|||
129731480|NCT04209114|466974956|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
129731481|NCT04209114|466974957|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
129731482|NCT04209114|466974958|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
129731483|NCT04209114|466974956|FG000|Pre-Treatment Phase|Other reasons|0|||
129731484|NCT04209114|466974957|FG001|Pre-Treatment Phase|Other reasons|0|||
129731485|NCT04209114|466974958|FG002|Pre-Treatment Phase|Other reasons|1|||
129731486|NCT04209114|466974956|FG000|Pre-Treatment Phase|Death|0|||
129731487|NCT04209114|466974957|FG001|Pre-Treatment Phase|Death|0|||
129731488|NCT04209114|466974958|FG002|Pre-Treatment Phase|Death|1|||
129731489|NCT04209114|466974956|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
129731490|NCT04209114|466974957|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
129731491|NCT04209114|466974958|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
129731492|NCT04209114|466974956|FG000|Treatment Phase|Other reasons|5|||
129731493|NCT04209114|466974957|FG001|Treatment Phase|Other reasons|3|||
129731494|NCT04209114|466974958|FG002|Treatment Phase|Other reasons|0|||
129731495|NCT04209114|466974956|FG000|Treatment Phase|Lost to Follow-up|1|||
129731496|NCT04209114|466974957|FG001|Treatment Phase|Lost to Follow-up|0|||
129731497|NCT04209114|466974958|FG002|Treatment Phase|Lost to Follow-up|0|||
129731498|NCT04209114|466974956|FG000|Treatment Phase|Participant withdrew consent|1|||
129731499|NCT04209114|466974957|FG001|Treatment Phase|Participant withdrew consent|0|||
129731500|NCT04209114|466974958|FG002|Treatment Phase|Participant withdrew consent|0|||
129731501|NCT04209114|466974956|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
129731502|NCT04209114|466974957|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
129731503|NCT04209114|466974958|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
129731504|NCT04209114|466974956|FG000|Treatment Phase|Death|4|||
129731505|NCT04209114|466974957|FG001|Treatment Phase|Death|1|||
129731506|NCT04209114|466974958|FG002|Treatment Phase|Death|0|||
129731507|NCT04209114|466974956|FG000|Treatment Phase|Study drug toxicity|4|||
129731508|NCT04209114|466974957|FG001|Treatment Phase|Study drug toxicity|6|||
129731509|NCT04209114|466974958|FG002|Treatment Phase|Study drug toxicity|0|||
129731510|NCT04209114|466974956|FG000|Treatment Phase|Disease progression|6|||
129731511|NCT04209114|466974957|FG001|Treatment Phase|Disease progression|9|||
129731512|NCT04209114|466974958|FG002|Treatment Phase|Disease progression|0|||
129731513|NCT00624819|466974961|FG000|Follow-up Period: Year 4|Parents decision|0|||
129731514|NCT00624819|466974962|FG001|Follow-up Period: Year 4|Parents decision|0|||
129731515|NCT00624819|466974963|FG002|Follow-up Period: Year 4|Parents decision|1|||
129731516|NCT00624819|466974964|FG003|Follow-up Period: Year 4|Parents decision|0|||
129731517|NCT00624819|466974961|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
129731518|NCT00624819|466974962|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
129731519|NCT00624819|466974963|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
129731520|NCT00624819|466974964|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
129731521|NCT00405964|466974969|FG000|Overall Study|Treatment Failure|17|||
129731522|NCT00405964|466974970|FG001|Overall Study|Treatment Failure|45|||
129731523|NCT00405964|466974969|FG000|Overall Study|Adverse Event|7|||
129731524|NCT00405964|466974970|FG001|Overall Study|Adverse Event|16|||
129731525|NCT00405964|466974969|FG000|Overall Study|Lost to Follow-up|5|||
129731526|NCT00405964|466974970|FG001|Overall Study|Lost to Follow-up|5|||
129731527|NCT00405964|466974969|FG000|Overall Study|Withdrawal by Subject|19|||
129731528|NCT00405964|466974970|FG001|Overall Study|Withdrawal by Subject|23|||
129731529|NCT00405964|466974969|FG000|Overall Study|Protocol Violation|11|||
129731530|NCT00405964|466974970|FG001|Overall Study|Protocol Violation|6|||
129731531|NCT02981407|466974976|FG000|Overall Study|Withdrawal by Subject|2|||
129731532|NCT02981407|466974977|FG001|Overall Study|Withdrawal by Subject|0|||
129731533|NCT00624780|466974981|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
129731534|NCT00624780|466974982|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
129731535|NCT00624780|466974983|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
129731536|NCT00624780|466974984|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
129731537|NCT00624780|466974985|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
129731538|NCT00624780|466974986|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
129731539|NCT00624780|466974981|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
129731540|NCT00624780|466974982|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
129731541|NCT00624780|466974983|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
129731542|NCT00624780|466974984|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
129731543|NCT00624780|466974985|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
129731544|NCT00624780|466974986|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
129731545|NCT00624780|466974981|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
129731546|NCT00624780|466974982|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
129731547|NCT00624780|466974983|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
129731548|NCT00624780|466974984|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
129731549|NCT00624780|466974985|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
129731550|NCT00624780|466974986|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
129731551|NCT00624780|466974981|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
129731552|NCT00624780|466974982|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
129731553|NCT00624780|466974983|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
129731554|NCT00624780|466974984|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
129731555|NCT00624780|466974985|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
129731556|NCT00624780|466974986|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
129731557|NCT00624780|466974981|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
129731558|NCT00624780|466974982|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
129731559|NCT00624780|466974983|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
129731560|NCT00624780|466974984|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
129731561|NCT00624780|466974985|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
129731562|NCT00624780|466974986|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
129731563|NCT00624780|466974981|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
129731564|NCT00624780|466974982|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
129731565|NCT00624780|466974983|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
129731566|NCT00624780|466974984|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
129731567|NCT00624780|466974985|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
129731568|NCT00624780|466974986|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
129731569|NCT00624780|466974981|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
129731570|NCT00624780|466974982|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
129731571|NCT00624780|466974983|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
129731572|NCT00624780|466974984|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
129731573|NCT00624780|466974985|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
129731574|NCT00624780|466974986|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
129731575|NCT00624780|466974981|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129731576|NCT00624780|466974982|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
129731577|NCT00624780|466974983|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129731578|NCT00624780|466974984|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
129731579|NCT00624780|466974985|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129731580|NCT00624780|466974986|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
129731581|NCT00624780|466974981|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
129731582|NCT00624780|466974982|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
129731583|NCT00624780|466974983|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
129731584|NCT00624780|466974984|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
129731585|NCT00624780|466974985|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
129731586|NCT00624780|466974986|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
129731587|NCT00624780|466974981|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
129731588|NCT00624780|466974982|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
129731589|NCT00624780|466974983|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
129731590|NCT00624780|466974984|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
129731591|NCT00624780|466974985|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
129731592|NCT00624780|466974986|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
129731593|NCT00624780|466974981|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
129731594|NCT00624780|466974982|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
129731595|NCT00624780|466974983|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
129731596|NCT00624780|466974984|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
129731597|NCT00624780|466974985|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
129731598|NCT00624780|466974986|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
129731599|NCT00624780|466974981|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
129731600|NCT00624780|466974982|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129731601|NCT00624780|466974983|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129731602|NCT00624780|466974984|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129731603|NCT00624780|466974985|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129731604|NCT00624780|466974986|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
129731605|NCT00624780|466974981|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129731606|NCT00624780|466974982|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129731607|NCT00624780|466974983|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
129731608|NCT00624780|466974984|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129731609|NCT00624780|466974985|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129731610|NCT00624780|466974986|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
129731611|NCT00624780|466974981|FG000|Follow-up (Week 26)|Death|0|||
129731612|NCT00624780|466974982|FG001|Follow-up (Week 26)|Death|0|||
129731613|NCT00624780|466974983|FG002|Follow-up (Week 26)|Death|1|||
129731614|NCT00624780|466974984|FG003|Follow-up (Week 26)|Death|0|||
129731615|NCT00624780|466974985|FG004|Follow-up (Week 26)|Death|0|||
129731616|NCT00624780|466974986|FG005|Follow-up (Week 26)|Death|0|||
129731617|NCT00624780|466974981|FG000|Follow-up (Week 26)|Adverse Event|0|||
129731618|NCT00624780|466974982|FG001|Follow-up (Week 26)|Adverse Event|0|||
129731619|NCT00624780|466974983|FG002|Follow-up (Week 26)|Adverse Event|0|||
129731620|NCT00624780|466974984|FG003|Follow-up (Week 26)|Adverse Event|0|||
129731621|NCT00624780|466974985|FG004|Follow-up (Week 26)|Adverse Event|1|||
129731622|NCT00624780|466974986|FG005|Follow-up (Week 26)|Adverse Event|0|||
129731623|NCT00624780|466974981|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
129731624|NCT00624780|466974982|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
129731625|NCT00624780|466974983|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
129804226|NCT00573183|467251453|FG000|Overall Study|Lost to Follow-up|52|||
129804227|NCT00573183|467251454|FG001|Overall Study|Lost to Follow-up|50|||
129804228|NCT00573183|467251453|FG000|Overall Study|Withdrawal by Subject|8|||
129804229|NCT00573183|467251454|FG001|Overall Study|Withdrawal by Subject|2|||
129804230|NCT00573183|467251453|FG000|Overall Study|Death|0|||
129804231|NCT00573183|467251454|FG001|Overall Study|Death|1|||
129892546|NCT03251378|467565474|FG004|Overall Study|Other|1|||
129892547|NCT03251378|467565475|FG005|Overall Study|Other|1|||
129892548|NCT03251378|467565476|FG006|Overall Study|Other|1|||
129892549|NCT03251378|467565470|FG000|Overall Study|Other|0|||
129804232|NCT00573183|467251453|FG000|Overall Study|Adverse Event|2|||
129804233|NCT00573183|467251454|FG001|Overall Study|Adverse Event|0|||
129804234|NCT00573183|467251453|FG000|Overall Study|Incarceration|5|||
129804235|NCT00573183|467251454|FG001|Overall Study|Incarceration|8|||
129804236|NCT00573183|467251453|FG000|Overall Study|Other|5|||
129804237|NCT00573183|467251454|FG001|Overall Study|Other|2|||
129804238|NCT02422303|467251457|FG000|Overall Study|Lost to Follow-up|1|||
129804239|NCT02422303|467251458|FG001|Overall Study|Lost to Follow-up|1|||
129804240|NCT03270644|467251465|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
129804241|NCT03270644|467251465|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
129892550|NCT03251378|467565471|FG001|Overall Study|Other|0|||
129731626|NCT00624780|466974984|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
129804242|NCT00902668|467251466|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
129892551|NCT03251378|467565472|FG002|Overall Study|Other|0|||
129892552|NCT03251378|467565473|FG003|Overall Study|Other|4|||
129892553|NCT03251378|467565474|FG004|Overall Study|Other|13|||
129892554|NCT03251378|467565475|FG005|Overall Study|Other|0|||
129892555|NCT03251378|467565476|FG006|Overall Study|Other|0|||
129892556|NCT04060680|467565478|FG000|Overall Study|Unsuccessful implant|17|||
129892557|NCT04060680|467565479|FG001|Overall Study|Unsuccessful implant|2|||
129892558|NCT04060680|467565478|FG000|Overall Study|Adverse Event|3|||
129892559|NCT04060680|467565479|FG001|Overall Study|Adverse Event|0|||
129892560|NCT04060680|467565478|FG000|Overall Study|Death|2|||
129892561|NCT04060680|467565479|FG001|Overall Study|Death|0|||
129892562|NCT04060680|467565478|FG000|Overall Study|Study product no longer in use|1|||
129892563|NCT04060680|467565479|FG001|Overall Study|Study product no longer in use|0|||
129892564|NCT04060680|467565478|FG000|Overall Study|Withdrawal by Subject|1|||
129892565|NCT04060680|467565479|FG001|Overall Study|Withdrawal by Subject|0|||
129892566|NCT02956967|467565480|FG000|Overall Study|Adverse Event|3|||
129892567|NCT02956967|467565480|FG000|Overall Study|Reason non-related to neutropenia|10|||
129892568|NCT02956967|467565480|FG000|Overall Study|Lost to Follow-up|5|||
129892569|NCT02956967|467565480|FG000|Overall Study|Missing|1|||
129892570|NCT02956967|467565480|FG000|Overall Study|Termination of Nivestim administration|29|||
129892571|NCT04739423|467565481|FG000|Overall Study|Protocol Violation|0|||
129892572|NCT04739423|467565482|FG001|Overall Study|Protocol Violation|1|||
129892573|NCT04739423|467565483|FG002|Overall Study|Protocol Violation|0|||
129892574|NCT04739423|467565484|FG003|Overall Study|Protocol Violation|0|||
129892575|NCT04739423|467565485|FG004|Overall Study|Protocol Violation|0|||
129892576|NCT04739423|467565486|FG005|Overall Study|Protocol Violation|0|||
129892577|NCT04739423|467565481|FG000|Overall Study|Adverse Event|0|||
129892578|NCT04739423|467565482|FG001|Overall Study|Adverse Event|0|||
129892579|NCT04739423|467565483|FG002|Overall Study|Adverse Event|1|||
129892580|NCT04739423|467565484|FG003|Overall Study|Adverse Event|0|||
129892581|NCT04739423|467565485|FG004|Overall Study|Adverse Event|1|||
129892582|NCT04739423|467565486|FG005|Overall Study|Adverse Event|0|||
129892583|NCT04739423|467565481|FG000|Overall Study|Withdrawal by Subject|0|||
129892584|NCT04739423|467565482|FG001|Overall Study|Withdrawal by Subject|0|||
129892585|NCT04739423|467565483|FG002|Overall Study|Withdrawal by Subject|0|||
129892586|NCT04739423|467565484|FG003|Overall Study|Withdrawal by Subject|0|||
129892587|NCT04739423|467565485|FG004|Overall Study|Withdrawal by Subject|0|||
129731627|NCT00624780|466974985|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
129731628|NCT00624780|466974986|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
129444486|NCT01006265|465927352|FG001|Overall Study|Administrative reason|2|||
129731629|NCT00624780|466974981|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
129731630|NCT00624780|466974982|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
129731631|NCT00624780|466974983|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
129731632|NCT00624780|466974984|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
129731633|NCT00624780|466974985|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
129731634|NCT00624780|466974986|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
129731635|NCT00624780|466974981|FG000|Follow-up (Week 26)|Other|1|||
129731636|NCT00624780|466974982|FG001|Follow-up (Week 26)|Other|1|||
129892588|NCT04739423|467565486|FG005|Overall Study|Withdrawal by Subject|1|||
129731637|NCT00624780|466974983|FG002|Follow-up (Week 26)|Other|0|||
129731638|NCT00624780|466974984|FG003|Follow-up (Week 26)|Other|0|||
129731639|NCT00624780|466974985|FG004|Follow-up (Week 26)|Other|0|||
129892589|NCT00819234|467565490|FG000|Overall Study|Withdrawal by Subject|8|||
129731640|NCT00624780|466974986|FG005|Follow-up (Week 26)|Other|0|||
129892590|NCT00819234|467565491|FG001|Overall Study|Withdrawal by Subject|13|||
129892591|NCT00819234|467565492|FG002|Overall Study|Withdrawal by Subject|6|||
129892592|NCT00819234|467565493|FG003|Overall Study|Withdrawal by Subject|3|||
129892593|NCT00819234|467565494|FG004|Overall Study|Withdrawal by Subject|0|||
129892594|NCT00819234|467565495|FG005|Overall Study|Withdrawal by Subject|4|||
129892595|NCT00819234|467565496|FG006|Overall Study|Withdrawal by Subject|4|||
129892596|NCT00819234|467565497|FG007|Overall Study|Withdrawal by Subject|8|||
129892597|NCT00819234|467565498|FG008|Overall Study|Withdrawal by Subject|5|||
129731641|NCT00496197|466977272|FG000|Overall Study|Discontinued study due to death|43|||
129731642|NCT00496197|466977272|FG000|Overall Study|Adverse Event|13|||
129731643|NCT00496197|466977272|FG000|Overall Study|Does not meet entrance criteria|5|||
129731644|NCT00496197|466977272|FG000|Overall Study|Insufficient clinical response|3|||
129731645|NCT00496197|466977272|FG000|Overall Study|Insufficient bacteriological response|10|||
129731646|NCT00496197|466977272|FG000|Overall Study|Lost to Follow-up|11|||
129731647|NCT00496197|466977272|FG000|Overall Study|Withdrawal by Subject|11|||
129731648|NCT00496197|466977272|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
129731649|NCT00496197|466977272|FG000|Overall Study|Other|14|||
129731650|NCT00496197|466977272|FG000|Overall Study|Protocol Violation|8|||
129731651|NCT01779869|466977273|FG000|Overall Study|Physician Decision|2|||
129731652|NCT00027378|466977274|FG000|Overall Study|Physician Decision|0|||
129731653|NCT00027378|466977275|FG001|Overall Study|Physician Decision|3|||
129731654|NCT05605691|466977276|FG000|Overall Study|Lost to Follow-up|1|||
129731655|NCT02098369|466977277|FG000|Overall Study|Withdrawal by Subject|1|||
129731656|NCT02098369|466977278|FG001|Overall Study|Withdrawal by Subject|5|||
129731657|NCT02098369|466977279|FG002|Overall Study|Withdrawal by Subject|0|||
129731658|NCT02098369|466977277|FG000|Overall Study|Lost to Follow-up|5|||
129731659|NCT02098369|466977278|FG001|Overall Study|Lost to Follow-up|1|||
129731660|NCT02098369|466977279|FG002|Overall Study|Lost to Follow-up|3|||
129731661|NCT02098369|466977277|FG000|Overall Study|Death|1|||
129731662|NCT02098369|466977278|FG001|Overall Study|Death|1|||
129731663|NCT02098369|466977279|FG002|Overall Study|Death|1|||
129731664|NCT02098369|466977277|FG000|Overall Study|Other|0|||
129731665|NCT02098369|466977278|FG001|Overall Study|Other|2|||
129731666|NCT02098369|466977279|FG002|Overall Study|Other|1|||
129731667|NCT02927925|466977293|FG000|Overall Study|Death|16|||
129731668|NCT02927925|466977293|FG000|Overall Study|Physician Decision|1|||
129731669|NCT02927925|466977293|FG000|Overall Study|Withdrawal by Subject|11|||
129731670|NCT02927925|466977293|FG000|Overall Study|Other|3|||
129731671|NCT02927925|466977293|FG000|Overall Study|Disease progression at clinical cutoff|1|||
129731672|NCT02229214|466977294|FG000|Overall Study|Adverse Event|2|||
129731673|NCT02229214|466977295|FG001|Overall Study|Adverse Event|0|||
129731674|NCT02229214|466977294|FG000|Overall Study|Withdrawal by Subject|4|||
129731675|NCT02229214|466977295|FG001|Overall Study|Withdrawal by Subject|0|||
129731676|NCT00246025|466977296|FG000|Overall Study|Adverse Event|7|||
129731677|NCT00246025|466977297|FG001|Overall Study|Adverse Event|9|||
129731678|NCT00246025|466977298|FG002|Overall Study|Adverse Event|9|||
129731679|NCT00246025|466977299|FG003|Overall Study|Adverse Event|10|||
129731680|NCT00246025|466977296|FG000|Overall Study|Withdrawal by Subject|3|||
129731681|NCT00246025|466977297|FG001|Overall Study|Withdrawal by Subject|0|||
129731682|NCT00246025|466977298|FG002|Overall Study|Withdrawal by Subject|1|||
129731683|NCT00246025|466977299|FG003|Overall Study|Withdrawal by Subject|2|||
129731684|NCT00246025|466977296|FG000|Overall Study|unsuitable medical history was found|0|||
129731685|NCT00246025|466977297|FG001|Overall Study|unsuitable medical history was found|0|||
129731686|NCT00246025|466977298|FG002|Overall Study|unsuitable medical history was found|0|||
129731687|NCT00246025|466977299|FG003|Overall Study|unsuitable medical history was found|1|||
129731688|NCT01238835|466977302|FG000|Overall Study|Death|124|||
129731689|NCT01238835|466977302|FG000|Overall Study|Withdrawal by Subject|9|||
129731690|NCT01238835|466977302|FG000|Overall Study|Lost to Follow-up|1|||
129731691|NCT01238835|466977302|FG000|Overall Study|Site early discontinuation|2|||
129731692|NCT00907803|466977304|FG000|Overall Study|Withdrawal of consent - long commute|1|||
129731693|NCT00907803|466977305|FG001|Overall Study|Withdrawal of consent - long commute|0|||
129731694|NCT00907803|466977306|FG002|Overall Study|Withdrawal of consent - long commute|0|||
129731695|NCT00907803|466977304|FG000|Overall Study|Adverse Event|2|||
129731696|NCT00907803|466977305|FG001|Overall Study|Adverse Event|0|||
129731697|NCT00907803|466977306|FG002|Overall Study|Adverse Event|0|||
129731698|NCT00907803|466977304|FG000|Overall Study|Withdrawal by Subject|0|||
129731699|NCT00907803|466977305|FG001|Overall Study|Withdrawal by Subject|1|||
129731700|NCT00907803|466977306|FG002|Overall Study|Withdrawal by Subject|0|||
129731701|NCT00907803|466977304|FG000|Overall Study|Lost to Follow-up|0|||
129731702|NCT00907803|466977305|FG001|Overall Study|Lost to Follow-up|1|||
129731703|NCT00907803|466977306|FG002|Overall Study|Lost to Follow-up|0|||
129731704|NCT00907803|466977304|FG000|Overall Study|Protocol Violation|0|||
129731705|NCT00907803|466977305|FG001|Overall Study|Protocol Violation|1|||
129731706|NCT00907803|466977306|FG002|Overall Study|Protocol Violation|0|||
129731707|NCT03510468|466977307|FG000|Overall Study|Lost to Follow-up|1|||
129731708|NCT03510468|466977307|FG000|Overall Study|Adverse Event|5|||
129731709|NCT03510468|466977307|FG000|Overall Study|Physician Decision|1|||
129731710|NCT03510468|466977307|FG000|Overall Study|non-compliant with treatment|2|||
129731711|NCT03510468|466977307|FG000|Overall Study|Missed visit|1|||
129892598|NCT00819234|467565499|FG009|Overall Study|Withdrawal by Subject|3|||
129892599|NCT00819234|467565490|FG000|Overall Study|Adverse Event|0|||
129892600|NCT00819234|467565491|FG001|Overall Study|Adverse Event|0|||
129892601|NCT00819234|467565492|FG002|Overall Study|Adverse Event|1|||
129892602|NCT00819234|467565493|FG003|Overall Study|Adverse Event|0|||
129892603|NCT00819234|467565494|FG004|Overall Study|Adverse Event|0|||
129892604|NCT00819234|467565495|FG005|Overall Study|Adverse Event|2|||
129892605|NCT00819234|467565496|FG006|Overall Study|Adverse Event|0|||
129731712|NCT04612842|466977308|FG000|Overall Study|Lost to Follow-up|20|||
129731713|NCT04612842|466977309|FG001|Overall Study|Lost to Follow-up|11|||
129731714|NCT04612842|466977308|FG000|Overall Study|Withdrawal by Subject|26|||
129731715|NCT04612842|466977309|FG001|Overall Study|Withdrawal by Subject|15|||
129731716|NCT04612842|466977308|FG000|Overall Study|Death|2|||
129731717|NCT04612842|466977309|FG001|Overall Study|Death|2|||
129731718|NCT05426031|466977310|FG000|Overall Study|Circulatory Arrest|3|||
129731719|NCT05426031|466977311|FG001|Overall Study|Circulatory Arrest|2|||
129731720|NCT02419131|466977312|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
129731721|NCT02419131|466977313|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
129731722|NCT02419131|466977314|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
129731723|NCT02419131|466977312|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
129731724|NCT02419131|466977313|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
129731725|NCT02419131|466977314|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
129731726|NCT04677660|466977315|FG000|Overall Study|Lost to Follow-up|0|||
129731727|NCT04677660|466977316|FG001|Overall Study|Lost to Follow-up|2|||
129731728|NCT04677660|466977315|FG000|Overall Study|Withdrawal by Subject|0|||
129731729|NCT04677660|466977316|FG001|Overall Study|Withdrawal by Subject|1|||
129731730|NCT04677660|466977315|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
129731731|NCT04677660|466977316|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
129731732|NCT02437305|466977320|FG000|Overall Study|Lost to Follow-up|18|||
129731733|NCT02437305|466977321|FG001|Overall Study|Lost to Follow-up|12|||
129731734|NCT01560637|466977338|FG000|Overall Study|Adverse Event|63|||
129731735|NCT01560637|466977338|FG000|Overall Study|Death|69|||
129731736|NCT01560637|466977338|FG000|Overall Study|Lost to Follow-up|8|||
129731737|NCT01560637|466977338|FG000|Overall Study|Protocol Violation|8|||
129731738|NCT01560637|466977338|FG000|Overall Study|Withdrawal by Subject|24|||
129731739|NCT01560637|466977338|FG000|Overall Study|Progressive Disease|20|||
129731740|NCT01560637|466977338|FG000|Overall Study|Other Reason Not Specified|6|||
129731741|NCT00413920|466977339|FG000|Overall Study|Adverse Event|9|||
129731742|NCT00413920|466977340|FG001|Overall Study|Adverse Event|11|||
129731743|NCT00413920|466977339|FG000|Overall Study|Lack of Efficacy|11|||
129892606|NCT00819234|467565497|FG007|Overall Study|Adverse Event|0|||
129892607|NCT00819234|467565498|FG008|Overall Study|Adverse Event|0|||
129892608|NCT00819234|467565499|FG009|Overall Study|Adverse Event|0|||
129731744|NCT00413920|466977340|FG001|Overall Study|Lack of Efficacy|9|||
129731745|NCT00413920|466977339|FG000|Overall Study|Death|3|||
129731746|NCT00413920|466977340|FG001|Overall Study|Death|5|||
129731747|NCT00413920|466977339|FG000|Overall Study|Graft Loss|5|||
129731748|NCT00413920|466977340|FG001|Overall Study|Graft Loss|3|||
129731749|NCT01071200|466977341|FG000|Overall Study|Lack of ovarian response|1|||
129731750|NCT01071200|466977342|FG001|Overall Study|Lack of ovarian response|1|||
129731751|NCT01071200|466977341|FG000|Overall Study|No fertilization|4|||
129731752|NCT01071200|466977342|FG001|Overall Study|No fertilization|0|||
129731753|NCT01071200|466977341|FG000|Overall Study|No oocytes retrieved|1|||
129731754|NCT01071200|466977342|FG001|Overall Study|No oocytes retrieved|1|||
129731755|NCT01071200|466977341|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
129731756|NCT01071200|466977342|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
129731757|NCT01071200|466977341|FG000|Overall Study|No viable embryos|0|||
129731758|NCT01071200|466977342|FG001|Overall Study|No viable embryos|1|||
129731759|NCT03730961|466977343|FG000|Overall Study|Adverse Event|0|||
129731760|NCT03730961|466977344|FG001|Overall Study|Adverse Event|1|||
129731761|NCT01185964|466977350|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
129731762|NCT01185964|466977351|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
129731763|NCT01185964|466977352|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
129731764|NCT01185964|466977353|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
129731765|NCT01185964|466977350|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
129731766|NCT01185964|466977351|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
129731767|NCT01185964|466977352|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
129731768|NCT01185964|466977353|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
129731769|NCT01185964|466977350|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
129731770|NCT01185964|466977351|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
129731771|NCT01185964|466977352|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
129731772|NCT01185964|466977353|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
129731773|NCT01185964|466977350|FG000|Phase 1b and Phase 2|Adverse Event|1|||
129731774|NCT01185964|466977351|FG001|Phase 1b and Phase 2|Adverse Event|0|||
129892609|NCT00819234|467565490|FG000|Overall Study|Physician Decision|0|||
129731775|NCT01185964|466977352|FG002|Phase 1b and Phase 2|Adverse Event|2|||
129731776|NCT01185964|466977353|FG003|Phase 1b and Phase 2|Adverse Event|0|||
129731777|NCT01185964|466977350|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
129731778|NCT01185964|466977351|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
129731779|NCT01185964|466977352|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
129731780|NCT01185964|466977353|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
129731781|NCT01185964|466977350|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
129731782|NCT01185964|466977351|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
129731783|NCT01185964|466977352|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
129731784|NCT01185964|466977353|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
129731785|NCT01185964|466977350|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
129731786|NCT01185964|466977351|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
129731787|NCT01185964|466977352|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
129731788|NCT01185964|466977353|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
129731789|NCT01185964|466977350|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
129731790|NCT01185964|466977351|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
129731791|NCT01185964|466977352|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
129731792|NCT01185964|466977353|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
129731793|NCT01920893|466977354|FG000|Overall Study|Adverse Event|5|||
129731794|NCT01920893|466977355|FG001|Overall Study|Adverse Event|2|||
129731795|NCT01920893|466977354|FG000|Overall Study|Lack of Efficacy|2|||
129731796|NCT01920893|466977355|FG001|Overall Study|Lack of Efficacy|0|||
129731797|NCT03762616|466977356|FG000|Overall Study|Protocol Violation|2|||
129731798|NCT04465877|466977358|FG000|Overall Study|Noncompliant with study requirements|0|||
129731799|NCT04465877|466977359|FG001|Overall Study|Noncompliant with study requirements|0|||
129731800|NCT04465877|466977360|FG002|Overall Study|Noncompliant with study requirements|1|||
129731801|NCT04465877|466977361|FG003|Overall Study|Noncompliant with study requirements|0|||
129731802|NCT02323204|466977364|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
129731803|NCT02323204|466977365|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
129731804|NCT02323204|466977366|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
129731805|NCT02323204|466977367|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
129731806|NCT02323204|466977364|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
129731807|NCT02323204|466977365|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
129731808|NCT02323204|466977366|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
129731809|NCT02323204|466977367|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
129731810|NCT02323204|466977364|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
129731811|NCT02323204|466977365|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
129731812|NCT02323204|466977366|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
129731813|NCT02323204|466977367|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
129731814|NCT02323204|466977364|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
129731815|NCT02323204|466977365|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
129731816|NCT02323204|466977366|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
129731817|NCT02323204|466977367|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
129731818|NCT02323204|466977364|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
129731819|NCT02323204|466977365|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
129731820|NCT02323204|466977366|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
129731821|NCT02323204|466977367|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
129731822|NCT02323204|466977364|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
129731823|NCT02323204|466977365|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
129731824|NCT02323204|466977366|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
129731825|NCT02323204|466977367|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
129731826|NCT02323204|466977364|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129731827|NCT02323204|466977365|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
129731828|NCT02323204|466977366|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129731829|NCT02323204|466977367|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
129731830|NCT02323204|466977364|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
129731831|NCT02323204|466977365|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
129731832|NCT02323204|466977366|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
129731833|NCT02323204|466977367|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
129731834|NCT02323204|466977364|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129731835|NCT02323204|466977365|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
129731836|NCT02323204|466977366|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
129731837|NCT02323204|466977367|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
129731838|NCT03440918|466977373|FG000|Overall Study|Protocol Violation|0|||
129731839|NCT03440918|466977374|FG001|Overall Study|Protocol Violation|16|||
129731840|NCT01396265|466977386|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
129731841|NCT04962230|466977387|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
129731842|NCT04962230|466977387|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
129731843|NCT03576755|466977388|FG000|Overall Study|Withdrawal by Subject|1|||
129731844|NCT03576755|466977389|FG001|Overall Study|Withdrawal by Subject|0|||
129731845|NCT03576755|466977390|FG002|Overall Study|Withdrawal by Subject|0|||
129731846|NCT03576755|466977391|FG003|Overall Study|Withdrawal by Subject|0|||
129731847|NCT03958656|466977392|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
129731848|NCT03958656|466977393|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
129731849|NCT03958656|466977394|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
129731850|NCT03958656|466977395|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
129731851|NCT03958656|466977392|FG000|Overall Study|No longer meets eligibility criteria|0|||
129444487|NCT01006265|465927353|FG002|Overall Study|Administrative reason|3|||
129731852|NCT03958656|466977393|FG001|Overall Study|No longer meets eligibility criteria|0|||
129731853|NCT03958656|466977394|FG002|Overall Study|No longer meets eligibility criteria|1|||
129731854|NCT03958656|466977395|FG003|Overall Study|No longer meets eligibility criteria|0|||
129731855|NCT03958656|466977392|FG000|Overall Study|Started anti-cancer treatment|0|||
129731856|NCT03958656|466977393|FG001|Overall Study|Started anti-cancer treatment|0|||
129731857|NCT03958656|466977394|FG002|Overall Study|Started anti-cancer treatment|1|||
129731858|NCT03958656|466977395|FG003|Overall Study|Started anti-cancer treatment|0|||
129444488|NCT01006265|465927354|FG003|Overall Study|Administrative reason|0|||
129731859|NCT03831880|466977398|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
129731860|NCT03831880|466977399|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
129731861|NCT03831880|466977398|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
129731862|NCT03831880|466977399|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
129731863|NCT03158012|466977402|FG000|Overall Study|Withdrawal by Subject|0|||
129731864|NCT03158012|466977403|FG001|Overall Study|Withdrawal by Subject|1|||
129731865|NCT04346108|466977404|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
129731866|NCT04346108|466977405|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
129892610|NCT00819234|467565491|FG001|Overall Study|Physician Decision|0|||
129892611|NCT00819234|467565492|FG002|Overall Study|Physician Decision|0|||
129731867|NCT04346108|466977406|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
129731868|NCT04346108|466977404|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
129731869|NCT04346108|466977405|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
129731870|NCT04346108|466977406|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
129731871|NCT01598753|466977407|FG000|Overall Study|Adverse Event|1|||
129731872|NCT01598753|466977408|FG001|Overall Study|Adverse Event|9|||
129731873|NCT01598753|466977409|FG002|Overall Study|Adverse Event|1|||
129731874|NCT01598753|466977410|FG003|Overall Study|Adverse Event|7|||
129731875|NCT01598753|466977407|FG000|Overall Study|Lost to Follow-up|4|||
129731876|NCT01598753|466977408|FG001|Overall Study|Lost to Follow-up|3|||
129731877|NCT01598753|466977409|FG002|Overall Study|Lost to Follow-up|7|||
129731878|NCT01598753|466977410|FG003|Overall Study|Lost to Follow-up|5|||
129731879|NCT01598753|466977407|FG000|Overall Study|Physician Decision|0|||
129731880|NCT01598753|466977408|FG001|Overall Study|Physician Decision|1|||
129731881|NCT01598753|466977409|FG002|Overall Study|Physician Decision|0|||
129731882|NCT01598753|466977410|FG003|Overall Study|Physician Decision|2|||
129731883|NCT01598753|466977407|FG000|Overall Study|Withdrawal by Subject|7|||
129731884|NCT01598753|466977408|FG001|Overall Study|Withdrawal by Subject|2|||
129731885|NCT01598753|466977409|FG002|Overall Study|Withdrawal by Subject|0|||
129731886|NCT01598753|466977410|FG003|Overall Study|Withdrawal by Subject|1|||
129731887|NCT02788201|466977411|FG000|Overall Study|Death|1|||
129731888|NCT02788201|466977412|FG001|Overall Study|Death|1|||
129731889|NCT02788201|466977413|FG002|Overall Study|Death|1|||
129731890|NCT02788201|466977414|FG003|Overall Study|Death|1|||
129731891|NCT02788201|466977415|FG004|Overall Study|Death|0|||
129731892|NCT02788201|466977416|FG005|Overall Study|Death|1|||
129731893|NCT02788201|466977411|FG000|Overall Study|Ineligible|0|||
129731894|NCT02788201|466977412|FG001|Overall Study|Ineligible|0|||
129731895|NCT02788201|466977413|FG002|Overall Study|Ineligible|0|||
129731896|NCT02788201|466977414|FG003|Overall Study|Ineligible|0|||
129731897|NCT02788201|466977415|FG004|Overall Study|Ineligible|0|||
129731898|NCT02788201|466977416|FG005|Overall Study|Ineligible|1|||
129731899|NCT02788201|466977411|FG000|Overall Study|Withdrawal by Subject|0|||
129731900|NCT02788201|466977412|FG001|Overall Study|Withdrawal by Subject|0|||
129731901|NCT02788201|466977413|FG002|Overall Study|Withdrawal by Subject|0|||
129731902|NCT02788201|466977414|FG003|Overall Study|Withdrawal by Subject|0|||
129731903|NCT02788201|466977415|FG004|Overall Study|Withdrawal by Subject|0|||
129731904|NCT02788201|466977416|FG005|Overall Study|Withdrawal by Subject|1|||
129731905|NCT01852825|466977417|FG000|Overall Study|Withdrawal by Subject|2|||
129731906|NCT01852825|466977418|FG001|Overall Study|Withdrawal by Subject|0|||
129731907|NCT01852825|466977419|FG002|Overall Study|Withdrawal by Subject|0|||
129731908|NCT02275117|466977422|FG000|Overall Study|Adverse Event|0|||
129731909|NCT02275117|466977423|FG001|Overall Study|Adverse Event|0|||
129731910|NCT02275117|466977424|FG002|Overall Study|Adverse Event|0|||
129731911|NCT02275117|466977425|FG003|Overall Study|Adverse Event|0|||
129731912|NCT02275117|466977426|FG004|Overall Study|Adverse Event|1|||
129731913|NCT02275117|466977422|FG000|Overall Study|Lack of Efficacy|6|||
129731914|NCT02275117|466977423|FG001|Overall Study|Lack of Efficacy|7|||
129731915|NCT02275117|466977424|FG002|Overall Study|Lack of Efficacy|5|||
129731916|NCT02275117|466977425|FG003|Overall Study|Lack of Efficacy|2|||
129731917|NCT02275117|466977426|FG004|Overall Study|Lack of Efficacy|10|||
129731918|NCT02275117|466977422|FG000|Overall Study|Lost to Follow-up|11|||
129731919|NCT02275117|466977423|FG001|Overall Study|Lost to Follow-up|16|||
129731920|NCT02275117|466977424|FG002|Overall Study|Lost to Follow-up|15|||
129731921|NCT02275117|466977425|FG003|Overall Study|Lost to Follow-up|16|||
129731922|NCT02275117|466977426|FG004|Overall Study|Lost to Follow-up|8|||
129731923|NCT02275117|466977422|FG000|Overall Study|Physician Decision|0|||
129731924|NCT02275117|466977423|FG001|Overall Study|Physician Decision|1|||
129731925|NCT02275117|466977424|FG002|Overall Study|Physician Decision|1|||
129731926|NCT02275117|466977425|FG003|Overall Study|Physician Decision|0|||
129731927|NCT02275117|466977426|FG004|Overall Study|Physician Decision|1|||
129731928|NCT02275117|466977422|FG000|Overall Study|Protocol Violation|1|||
129731929|NCT02275117|466977423|FG001|Overall Study|Protocol Violation|0|||
129731930|NCT02275117|466977424|FG002|Overall Study|Protocol Violation|1|||
129731931|NCT02275117|466977425|FG003|Overall Study|Protocol Violation|1|||
129731932|NCT02275117|466977426|FG004|Overall Study|Protocol Violation|0|||
129731933|NCT02275117|466977422|FG000|Overall Study|Withdrawal by Subject|6|||
129731934|NCT02275117|466977423|FG001|Overall Study|Withdrawal by Subject|4|||
129731935|NCT02275117|466977424|FG002|Overall Study|Withdrawal by Subject|7|||
129731936|NCT02275117|466977425|FG003|Overall Study|Withdrawal by Subject|3|||
129731937|NCT02275117|466977426|FG004|Overall Study|Withdrawal by Subject|3|||
129731938|NCT02275117|466977422|FG000|Overall Study|Terminated by Sponsor|4|||
129731939|NCT02275117|466977423|FG001|Overall Study|Terminated by Sponsor|4|||
129731940|NCT02275117|466977424|FG002|Overall Study|Terminated by Sponsor|4|||
129731941|NCT02275117|466977425|FG003|Overall Study|Terminated by Sponsor|6|||
129731942|NCT02275117|466977426|FG004|Overall Study|Terminated by Sponsor|4|||
129731943|NCT02275117|466977422|FG000|Overall Study|Worsening of Study Indication|0|||
129731944|NCT02275117|466977423|FG001|Overall Study|Worsening of Study Indication|1|||
129731945|NCT02275117|466977424|FG002|Overall Study|Worsening of Study Indication|2|||
129731946|NCT02275117|466977425|FG003|Overall Study|Worsening of Study Indication|0|||
129731947|NCT02275117|466977426|FG004|Overall Study|Worsening of Study Indication|0|||
129731948|NCT02275117|466977422|FG000|Overall Study|Study Burden|5|||
129731949|NCT02275117|466977423|FG001|Overall Study|Study Burden|4|||
129731950|NCT02275117|466977424|FG002|Overall Study|Study Burden|7|||
129731951|NCT02275117|466977425|FG003|Overall Study|Study Burden|5|||
129731952|NCT02275117|466977426|FG004|Overall Study|Study Burden|7|||
129731953|NCT02275117|466977422|FG000|Overall Study|Other|1|||
129731954|NCT02275117|466977423|FG001|Overall Study|Other|0|||
129731955|NCT02275117|466977424|FG002|Overall Study|Other|0|||
129731956|NCT02275117|466977425|FG003|Overall Study|Other|0|||
129731957|NCT02275117|466977426|FG004|Overall Study|Other|2|||
129731958|NCT04508751|466977430|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
129731959|NCT04508751|466977431|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
129731960|NCT04508751|466977432|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
129731961|NCT00724854|466977433|FG000|Overall Study|Lack of Efficacy|187|||
129731962|NCT00724854|466977434|FG001|Overall Study|Lack of Efficacy|13|||
129731963|NCT00724854|466977433|FG000|Overall Study|Lost to Follow-up|87|||
129731964|NCT00724854|466977434|FG001|Overall Study|Lost to Follow-up|10|||
129731965|NCT00724854|466977433|FG000|Overall Study|Adverse Event|62|||
129731966|NCT00724854|466977434|FG001|Overall Study|Adverse Event|4|||
129731967|NCT00724854|466977433|FG000|Overall Study|Other|42|||
129731968|NCT00724854|466977434|FG001|Overall Study|Other|3|||
129731969|NCT00724854|466977433|FG000|Overall Study|Death|11|||
129731970|NCT00724854|466977434|FG001|Overall Study|Death|0|||
129731971|NCT00724854|466977433|FG000|Overall Study|Change of treatment|7|||
129731972|NCT00724854|466977434|FG001|Overall Study|Change of treatment|0|||
129731973|NCT00724854|466977433|FG000|Overall Study|Withdrawal by Subject|5|||
129731974|NCT00724854|466977434|FG001|Overall Study|Withdrawal by Subject|0|||
129731975|NCT00724854|466977433|FG000|Overall Study|Adverse event + lack of efficacy|2|||
129731976|NCT00724854|466977434|FG001|Overall Study|Adverse event + lack of efficacy|1|||
129731977|NCT01865812|466977435|FG000|Primary Treatment Phase|Adverse Event|2|||
129731978|NCT01865812|466977436|FG001|Primary Treatment Phase|Adverse Event|0|||
129731979|NCT01865812|466977435|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
129731980|NCT01865812|466977436|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
129731981|NCT01865812|466977435|FG000|Long-term Safety Extension Phase|Pruritus|0|||
129731982|NCT01865812|466977436|FG001|Long-term Safety Extension Phase|Pruritus|3|||
129731983|NCT01865812|466977435|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
129731984|NCT01865812|466977436|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
129731985|NCT01865812|466977435|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
129731986|NCT01865812|466977436|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
129731987|NCT01338610|466977437|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
129731988|NCT01338610|466977438|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
129731989|NCT01338610|466977439|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
129731990|NCT01338610|466977437|FG000|Overall Study|Protocol Violation|1|||
129731991|NCT01338610|466977438|FG001|Overall Study|Protocol Violation|0|||
129731992|NCT01338610|466977439|FG002|Overall Study|Protocol Violation|1|||
129731993|NCT01338610|466977437|FG000|Overall Study|Adverse Event|3|||
129731994|NCT01338610|466977438|FG001|Overall Study|Adverse Event|0|||
129731995|NCT01338610|466977439|FG002|Overall Study|Adverse Event|0|||
129731996|NCT02046226|466977440|FG000|Overall Study|Lost to Follow-up|7|||
129731997|NCT01095653|466977441|FG000|Overall Study|Lack of Efficacy|3|||
129731998|NCT01095653|466977442|FG001|Overall Study|Lack of Efficacy|0|||
129731999|NCT01095653|466977443|FG002|Overall Study|Lack of Efficacy|0|||
129732000|NCT01095653|466977441|FG000|Overall Study|Adverse Event|1|||
129732001|NCT01095653|466977442|FG001|Overall Study|Adverse Event|4|||
129732002|NCT01095653|466977443|FG002|Overall Study|Adverse Event|4|||
129732003|NCT01095653|466977441|FG000|Overall Study|Lost to Follow-up|1|||
129732004|NCT01095653|466977442|FG001|Overall Study|Lost to Follow-up|0|||
129732005|NCT01095653|466977443|FG002|Overall Study|Lost to Follow-up|4|||
129732006|NCT01095653|466977441|FG000|Overall Study|Withdrawal by Subject|4|||
129732007|NCT01095653|466977442|FG001|Overall Study|Withdrawal by Subject|5|||
129732008|NCT01095653|466977443|FG002|Overall Study|Withdrawal by Subject|3|||
129732009|NCT01095653|466977441|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
129732010|NCT01095653|466977442|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
129732011|NCT01095653|466977443|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
129732012|NCT02692040|466977444|FG000|Overall Study|Protocol Violation|0|||
129732013|NCT02692040|466977445|FG001|Overall Study|Protocol Violation|0|||
129732014|NCT02692040|466977446|FG002|Overall Study|Protocol Violation|0|||
129732015|NCT02692040|466977447|FG003|Overall Study|Protocol Violation|0|||
129732016|NCT02692040|466977448|FG004|Overall Study|Protocol Violation|0|||
129732017|NCT02692040|466977449|FG005|Overall Study|Protocol Violation|0|||
129732018|NCT02692040|466977450|FG006|Overall Study|Protocol Violation|0|||
129732019|NCT02692040|466977451|FG007|Overall Study|Protocol Violation|0|||
129732020|NCT02692040|466977452|FG008|Overall Study|Protocol Violation|0|||
129732021|NCT02692040|466977453|FG009|Overall Study|Protocol Violation|0|||
129732022|NCT02692040|466977454|FG010|Overall Study|Protocol Violation|0|||
129732023|NCT02692040|466977455|FG011|Overall Study|Protocol Violation|0|||
129732024|NCT02692040|466977456|FG012|Overall Study|Protocol Violation|1|||
129732025|NCT02692040|466977457|FG013|Overall Study|Protocol Violation|0|||
129732026|NCT02692040|466977458|FG014|Overall Study|Protocol Violation|0|||
129732027|NCT02692040|466977459|FG015|Overall Study|Protocol Violation|0|||
129732028|NCT02692040|466977460|FG016|Overall Study|Protocol Violation|0|||
129732029|NCT02692040|466977444|FG000|Overall Study|Adverse Event|0|||
129732030|NCT02692040|466977445|FG001|Overall Study|Adverse Event|0|||
129732031|NCT02692040|466977446|FG002|Overall Study|Adverse Event|0|||
129732032|NCT02692040|466977447|FG003|Overall Study|Adverse Event|0|||
129732033|NCT02692040|466977448|FG004|Overall Study|Adverse Event|0|||
129732034|NCT02692040|466977449|FG005|Overall Study|Adverse Event|0|||
129732035|NCT02692040|466977450|FG006|Overall Study|Adverse Event|0|||
129732036|NCT02692040|466977451|FG007|Overall Study|Adverse Event|0|||
129732037|NCT02692040|466977452|FG008|Overall Study|Adverse Event|0|||
129732038|NCT02692040|466977453|FG009|Overall Study|Adverse Event|0|||
129732039|NCT02692040|466977454|FG010|Overall Study|Adverse Event|0|||
129732040|NCT02692040|466977455|FG011|Overall Study|Adverse Event|0|||
129732041|NCT02692040|466977456|FG012|Overall Study|Adverse Event|0|||
129732042|NCT02692040|466977457|FG013|Overall Study|Adverse Event|3|||
129732043|NCT02692040|466977458|FG014|Overall Study|Adverse Event|1|||
129732044|NCT02692040|466977459|FG015|Overall Study|Adverse Event|1|||
129732045|NCT02692040|466977460|FG016|Overall Study|Adverse Event|0|||
129732046|NCT00171925|466977461|FG000|Overall Study|Adverse Event|10|||
129732047|NCT00171925|466977462|FG001|Overall Study|Adverse Event|6|||
129732048|NCT00171925|466977461|FG000|Overall Study|Protocol Violation|1|||
129732049|NCT00171925|466977462|FG001|Overall Study|Protocol Violation|1|||
129732050|NCT00171925|466977461|FG000|Overall Study|Withdrawal by Subject|6|||
129732051|NCT00171925|466977462|FG001|Overall Study|Withdrawal by Subject|9|||
129732052|NCT00171925|466977461|FG000|Overall Study|Lost to Follow-up|2|||
129732053|NCT00171925|466977462|FG001|Overall Study|Lost to Follow-up|2|||
129732054|NCT00171925|466977461|FG000|Overall Study|Administrative problems|10|||
129732055|NCT00171925|466977462|FG001|Overall Study|Administrative problems|11|||
129732056|NCT00171925|466977461|FG000|Overall Study|Death|1|||
129732057|NCT00171925|466977462|FG001|Overall Study|Death|2|||
129732058|NCT02826421|466977470|FG000|Overall Study|Adverse Event|1|||
129732059|NCT02826421|466977471|FG001|Overall Study|Adverse Event|0|||
129732060|NCT02826421|466977472|FG002|Overall Study|Adverse Event|0|||
129732061|NCT02826421|466977473|FG003|Overall Study|Adverse Event|1|||
129732062|NCT02826421|466977470|FG000|Overall Study|Withdrawal by Subject|1|||
129732063|NCT02826421|466977471|FG001|Overall Study|Withdrawal by Subject|3|||
129732064|NCT02826421|466977472|FG002|Overall Study|Withdrawal by Subject|1|||
129732065|NCT02826421|466977473|FG003|Overall Study|Withdrawal by Subject|1|||
129732066|NCT02826421|466977470|FG000|Overall Study|Reason not given|1|||
129732067|NCT02826421|466977471|FG001|Overall Study|Reason not given|0|||
129732068|NCT02826421|466977472|FG002|Overall Study|Reason not given|1|||
129732069|NCT02826421|466977473|FG003|Overall Study|Reason not given|0|||
129732070|NCT02210221|466977478|FG000|Overall Study|Lack of Efficacy|7|||
129732071|NCT02210221|466977478|FG000|Overall Study|Withdrawal by Subject|43|||
129732072|NCT02141490|466977479|FG000|Overall Study|Screening failures|4|||
129732073|NCT02141490|466977480|FG001|Overall Study|Screening failures|0|||
129732074|NCT02141490|466977481|FG002|Overall Study|Screening failures|0|||
129732075|NCT00355342|466977486|FG000|Overall Study|Adverse Event|13|||
129732076|NCT00355342|466977487|FG001|Overall Study|Adverse Event|15|||
129732077|NCT00355342|466977486|FG000|Overall Study|Lost to Follow-up|4|||
129732078|NCT00355342|466977487|FG001|Overall Study|Lost to Follow-up|2|||
129732079|NCT00355342|466977486|FG000|Overall Study|Withdrawal by Subject|14|||
129732080|NCT00355342|466977487|FG001|Overall Study|Withdrawal by Subject|11|||
129732081|NCT00355342|466977486|FG000|Overall Study|Sponsor terminated study|2|||
129732082|NCT00355342|466977487|FG001|Overall Study|Sponsor terminated study|2|||
129732083|NCT00355342|466977486|FG000|Overall Study|Overcompliant-PI discretion|1|||
129732084|NCT00355342|466977487|FG001|Overall Study|Overcompliant-PI discretion|0|||
129732085|NCT00355342|466977486|FG000|Overall Study|Use of prohibited medication|1|||
129732086|NCT00355342|466977487|FG001|Overall Study|Use of prohibited medication|0|||
129732087|NCT00355342|466977486|FG000|Overall Study|COPD exacerbation|1|||
129892612|NCT00819234|467565493|FG003|Overall Study|Physician Decision|1|||
129892613|NCT00819234|467565494|FG004|Overall Study|Physician Decision|0|||
129732088|NCT00355342|466977487|FG001|Overall Study|COPD exacerbation|1|||
129732089|NCT00355342|466977486|FG000|Overall Study|Dispensed wrong study drug kit|1|||
129732090|NCT00355342|466977487|FG001|Overall Study|Dispensed wrong study drug kit|0|||
129732091|NCT00355342|466977486|FG000|Overall Study|Non-compliance with Dexa scans|1|||
129732092|NCT00355342|466977487|FG001|Overall Study|Non-compliance with Dexa scans|0|||
129732093|NCT00355342|466977486|FG000|Overall Study|Withdrawal by participant and physician|1|||
129732094|NCT00355342|466977487|FG001|Overall Study|Withdrawal by participant and physician|0|||
129732095|NCT00355342|466977486|FG000|Overall Study|Participant relocated|0|||
129732096|NCT00355342|466977487|FG001|Overall Study|Participant relocated|1|||
129732097|NCT00355342|466977486|FG000|Overall Study|Participant discontinued study drug|0|||
129732098|NCT00355342|466977487|FG001|Overall Study|Participant discontinued study drug|1|||
129732099|NCT00355342|466977486|FG000|Overall Study|Study management|0|||
129732100|NCT00355342|466977487|FG001|Overall Study|Study management|1|||
129732101|NCT00355342|466977486|FG000|Overall Study|Protocol Violation|0|||
129732102|NCT00355342|466977487|FG001|Overall Study|Protocol Violation|1|||
129732103|NCT00355342|466977486|FG000|Overall Study|Use of protocol excluded medication|0|||
129732104|NCT00355342|466977487|FG001|Overall Study|Use of protocol excluded medication|1|||
129732105|NCT00434759|466977488|FG000|Overall Study|Lack of Efficacy|5|||
129732106|NCT00434759|466977489|FG001|Overall Study|Lack of Efficacy|4|||
129732107|NCT00434759|466977488|FG000|Overall Study|Withdrawal by Subject|17|||
129732108|NCT00434759|466977489|FG001|Overall Study|Withdrawal by Subject|1|||
129732109|NCT00434759|466977488|FG000|Overall Study|family affairs|2|||
129732110|NCT00434759|466977489|FG001|Overall Study|family affairs|0|||
129732111|NCT00969761|466977493|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129732112|NCT00969761|466977494|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732113|NCT00969761|466977495|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732114|NCT00969761|466977496|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129732115|NCT00969761|466977497|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732116|NCT00969761|466977498|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732117|NCT00969761|466977499|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732118|NCT00969761|466977500|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732119|NCT00969761|466977501|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129732120|NCT00969761|466977502|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
129732121|NCT00969761|466977503|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129732122|NCT00969761|466977504|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
129892614|NCT00819234|467565495|FG005|Overall Study|Physician Decision|0|||
129892615|NCT00819234|467565496|FG006|Overall Study|Physician Decision|0|||
129892616|NCT00819234|467565497|FG007|Overall Study|Physician Decision|0|||
129892617|NCT00819234|467565498|FG008|Overall Study|Physician Decision|0|||
129892618|NCT00819234|467565499|FG009|Overall Study|Physician Decision|2|||
129892619|NCT00819234|467565490|FG000|Overall Study|Protocol Violation|0|||
129892620|NCT00819234|467565491|FG001|Overall Study|Protocol Violation|0|||
129892621|NCT00819234|467565492|FG002|Overall Study|Protocol Violation|1|||
129892622|NCT00819234|467565493|FG003|Overall Study|Protocol Violation|0|||
129892623|NCT00819234|467565494|FG004|Overall Study|Protocol Violation|0|||
129892624|NCT00819234|467565495|FG005|Overall Study|Protocol Violation|0|||
129892625|NCT00819234|467565496|FG006|Overall Study|Protocol Violation|0|||
129892626|NCT00819234|467565497|FG007|Overall Study|Protocol Violation|0|||
129892627|NCT00819234|467565498|FG008|Overall Study|Protocol Violation|0|||
129892628|NCT00819234|467565499|FG009|Overall Study|Protocol Violation|0|||
129892629|NCT00819234|467565490|FG000|Overall Study|Lost to Follow-up|2|||
129892630|NCT00819234|467565491|FG001|Overall Study|Lost to Follow-up|2|||
129892631|NCT00819234|467565492|FG002|Overall Study|Lost to Follow-up|0|||
129892632|NCT00819234|467565493|FG003|Overall Study|Lost to Follow-up|2|||
129892633|NCT00819234|467565494|FG004|Overall Study|Lost to Follow-up|1|||
129892634|NCT00819234|467565495|FG005|Overall Study|Lost to Follow-up|1|||
129892635|NCT00819234|467565496|FG006|Overall Study|Lost to Follow-up|1|||
129892636|NCT00819234|467565497|FG007|Overall Study|Lost to Follow-up|1|||
129892637|NCT00819234|467565498|FG008|Overall Study|Lost to Follow-up|1|||
129892638|NCT00819234|467565499|FG009|Overall Study|Lost to Follow-up|2|||
129892639|NCT04091672|467567618|FG000|Overall Study|Death|6|||
129732123|NCT00969761|466977493|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732124|NCT00969761|466977494|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732125|NCT00969761|466977495|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
129732126|NCT00969761|466977496|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732127|NCT00969761|466977497|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732128|NCT00969761|466977498|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732129|NCT00969761|466977499|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732130|NCT00969761|466977500|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129892640|NCT04091672|467567619|FG001|Overall Study|Death|6|||
129892641|NCT04091672|467567618|FG000|Overall Study|Lost to Follow-up|7|||
129892642|NCT04091672|467567619|FG001|Overall Study|Lost to Follow-up|7|||
129892643|NCT04091672|467567618|FG000|Overall Study|Withdrawal by Subject|3|||
129892644|NCT04091672|467567619|FG001|Overall Study|Withdrawal by Subject|3|||
129892645|NCT04091672|467567618|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
129892646|NCT04091672|467567619|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
129892647|NCT05296629|467567620|FG000|Overall Study|Withdrawal by Subject|3|||
129892648|NCT05296629|467567621|FG001|Overall Study|Withdrawal by Subject|10|||
129732131|NCT00969761|466977501|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732132|NCT00969761|466977502|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732133|NCT00969761|466977503|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732134|NCT00969761|466977504|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
129732135|NCT00969761|466977493|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732136|NCT00969761|466977494|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732137|NCT00969761|466977495|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
129732138|NCT00969761|466977496|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732139|NCT00969761|466977497|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732140|NCT00969761|466977498|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732141|NCT00969761|466977499|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732142|NCT00969761|466977500|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732143|NCT00969761|466977501|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732144|NCT00969761|466977502|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732145|NCT00969761|466977503|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732146|NCT00969761|466977504|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
129732147|NCT00969761|466977493|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732148|NCT00969761|466977494|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732149|NCT00969761|466977495|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732150|NCT00969761|466977496|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732151|NCT00969761|466977497|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732152|NCT00969761|466977498|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732153|NCT00969761|466977499|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732154|NCT00969761|466977500|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732155|NCT00969761|466977501|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
129732156|NCT00969761|466977502|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732157|NCT00969761|466977503|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732158|NCT00969761|466977504|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
129732159|NCT00969761|466977493|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
129732160|NCT00969761|466977494|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129732161|NCT00969761|466977495|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
129732162|NCT00969761|466977496|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129732163|NCT00969761|466977497|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
129732164|NCT00969761|466977498|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129732165|NCT00969761|466977499|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129732166|NCT00969761|466977500|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
129732167|NCT00969761|466977501|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
129732168|NCT00969761|466977502|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
129732169|NCT00969761|466977503|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129732170|NCT00969761|466977504|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
129732171|NCT00969761|466977493|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732172|NCT00969761|466977494|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732173|NCT00969761|466977495|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732174|NCT00969761|466977496|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
129732175|NCT00969761|466977497|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
129732176|NCT00969761|466977498|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732177|NCT00969761|466977499|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732178|NCT00969761|466977500|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732179|NCT00969761|466977501|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
129732180|NCT00969761|466977502|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732181|NCT00969761|466977503|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732182|NCT00969761|466977504|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
129732183|NCT04030247|466980223|FG000|Overall Study|Withdrawal by Subject|4|||
129732184|NCT04030247|466980223|FG000|Overall Study|Lost to Follow-up|13|||
129732185|NCT00509093|466980224|FG000|Overall Study|Adverse Event|10|||
129732186|NCT00509093|466980224|FG000|Overall Study|Disease Progression|9|||
129732187|NCT00509093|466980224|FG000|Overall Study|Transformed into MDS|1|||
129732188|NCT00509093|466980224|FG000|Overall Study|Withdrawal by Subject|3|||
129732189|NCT00509093|466980224|FG000|Overall Study|Physician Decision|1|||
129732190|NCT03187834|466980225|FG000|Overall Study|Lost to Follow-up|0|||
129732191|NCT03187834|466980226|FG001|Overall Study|Lost to Follow-up|1|||
129732192|NCT03187834|466980227|FG002|Overall Study|Lost to Follow-up|2|||
129732193|NCT03187834|466980228|FG003|Overall Study|Lost to Follow-up|2|||
129732194|NCT03187834|466980225|FG000|Overall Study|Had invalid anthropometric measurements|5|||
129732195|NCT03187834|466980226|FG001|Overall Study|Had invalid anthropometric measurements|3|||
129732196|NCT03187834|466980227|FG002|Overall Study|Had invalid anthropometric measurements|4|||
129732197|NCT03187834|466980228|FG003|Overall Study|Had invalid anthropometric measurements|2|||
129732198|NCT00823212|466980229|FG000|Overall Study|Death|8|||
129732199|NCT00823212|466980230|FG001|Overall Study|Death|10|||
129732200|NCT00823212|466980229|FG000|Overall Study|Withdrawal by Subject|6|||
129732201|NCT00823212|466980230|FG001|Overall Study|Withdrawal by Subject|1|||
129732202|NCT00823212|466980229|FG000|Overall Study|Incarcerated|0|||
129732203|NCT00823212|466980230|FG001|Overall Study|Incarcerated|1|||
129732204|NCT00823212|466980229|FG000|Overall Study|Missed 12-month visit|21|||
129732205|NCT00823212|466980230|FG001|Overall Study|Missed 12-month visit|21|||
129732206|NCT01344538|466980231|FG000|Overall Study|Adverse Event|1|||
129732207|NCT01344538|466980232|FG001|Overall Study|Adverse Event|1|||
129732208|NCT01344538|466980231|FG000|Overall Study|Lost to Follow-up|1|||
129732209|NCT01344538|466980232|FG001|Overall Study|Lost to Follow-up|0|||
129732210|NCT01655381|466980233|FG000|Overall Study|Investigator Decision|1|||
129732211|NCT01655381|466980233|FG000|Overall Study|Moved to Another City|1|||
129732212|NCT01655381|466980233|FG000|Overall Study|Insufficient Treatment Response|1|||
129732213|NCT00320255|466980234|FG000|Overall Study|Lack of Efficacy|1|||
129732214|NCT00320255|466980235|FG001|Overall Study|Lack of Efficacy|0|||
129732215|NCT00320255|466980236|FG002|Overall Study|Lack of Efficacy|0|||
129732216|NCT00320255|466980237|FG003|Overall Study|Lack of Efficacy|0|||
129732217|NCT00320255|466980238|FG004|Overall Study|Lack of Efficacy|0|||
129732218|NCT00320255|466980239|FG005|Overall Study|Lack of Efficacy|0|||
129732219|NCT00320255|466980234|FG000|Overall Study|Adverse Event|5|||
129732220|NCT00320255|466980235|FG001|Overall Study|Adverse Event|2|||
129732221|NCT00320255|466980236|FG002|Overall Study|Adverse Event|3|||
129732222|NCT00320255|466980237|FG003|Overall Study|Adverse Event|2|||
129732223|NCT00320255|466980238|FG004|Overall Study|Adverse Event|0|||
129732224|NCT00320255|466980239|FG005|Overall Study|Adverse Event|0|||
129732225|NCT00320255|466980234|FG000|Overall Study|Withdrawal by Subject|1|||
129732226|NCT00320255|466980235|FG001|Overall Study|Withdrawal by Subject|2|||
129732227|NCT00320255|466980236|FG002|Overall Study|Withdrawal by Subject|2|||
129892649|NCT05296629|467567622|FG002|Overall Study|Withdrawal by Subject|4|||
129892650|NCT05296629|467567620|FG000|Overall Study|Lost to Follow-up|2|||
129892651|NCT05296629|467567621|FG001|Overall Study|Lost to Follow-up|7|||
129732228|NCT00320255|466980237|FG003|Overall Study|Withdrawal by Subject|4|||
129732229|NCT00320255|466980238|FG004|Overall Study|Withdrawal by Subject|0|||
129732230|NCT00320255|466980239|FG005|Overall Study|Withdrawal by Subject|0|||
129732231|NCT00320255|466980234|FG000|Overall Study|Poor compliance/noncompliance|1|||
129732232|NCT00320255|466980235|FG001|Overall Study|Poor compliance/noncompliance|1|||
129732233|NCT00320255|466980236|FG002|Overall Study|Poor compliance/noncompliance|0|||
129732234|NCT00320255|466980237|FG003|Overall Study|Poor compliance/noncompliance|1|||
129732235|NCT00320255|466980238|FG004|Overall Study|Poor compliance/noncompliance|0|||
129732236|NCT00320255|466980239|FG005|Overall Study|Poor compliance/noncompliance|0|||
129732237|NCT00320255|466980234|FG000|Overall Study|No longer meets study criteria|0|||
129732238|NCT00320255|466980235|FG001|Overall Study|No longer meets study criteria|0|||
129732239|NCT00320255|466980236|FG002|Overall Study|No longer meets study criteria|0|||
129732240|NCT00320255|466980237|FG003|Overall Study|No longer meets study criteria|1|||
129444489|NCT04233164|465927355|FG000|Overall Study|Unable to obtain specimen|0|||
129892652|NCT05296629|467567622|FG002|Overall Study|Lost to Follow-up|1|||
129732241|NCT00320255|466980238|FG004|Overall Study|No longer meets study criteria|0|||
129732242|NCT00320255|466980239|FG005|Overall Study|No longer meets study criteria|0|||
129732243|NCT00320255|466980234|FG000|Overall Study|Other|3|||
129732244|NCT00320255|466980235|FG001|Overall Study|Other|2|||
129732245|NCT00320255|466980236|FG002|Overall Study|Other|1|||
129892653|NCT05296629|467567620|FG000|Overall Study|Adverse Event|0|||
129732246|NCT00320255|466980237|FG003|Overall Study|Other|0|||
129732247|NCT00320255|466980238|FG004|Overall Study|Other|0|||
129732248|NCT00320255|466980239|FG005|Overall Study|Other|0|||
129732249|NCT04979897|466980241|FG000|Overall Study|Death|1|||
129732250|NCT04979897|466980242|FG001|Overall Study|Death|8|||
129732251|NCT04979897|466980241|FG000|Overall Study|Lost to Follow-up|111|||
129732252|NCT04979897|466980242|FG001|Overall Study|Lost to Follow-up|56|||
129732253|NCT04979897|466980241|FG000|Overall Study|Withdrawal by Subject|7|||
129732254|NCT04979897|466980242|FG001|Overall Study|Withdrawal by Subject|2|||
129732255|NCT03405935|466980243|FG000|Overall Study|Adverse Event|3|||
129732256|NCT03405935|466980243|FG000|Overall Study|Death|2|||
129732257|NCT03405935|466980243|FG000|Overall Study|Withdrawal by Subject|1|||
129732258|NCT03405935|466980243|FG000|Overall Study|Lost to Follow-up|2|||
129732259|NCT02781792|466980250|FG000|Overall Study|Adverse Event|1|||
129732260|NCT02781792|466980251|FG001|Overall Study|Adverse Event|2|||
129732261|NCT02781792|466980250|FG000|Overall Study|Withdrawal by Subject|3|||
129732262|NCT02781792|466980251|FG001|Overall Study|Withdrawal by Subject|1|||
129732263|NCT02781792|466980250|FG000|Overall Study|Lack of Efficacy|1|||
129732264|NCT02781792|466980251|FG001|Overall Study|Lack of Efficacy|1|||
129732265|NCT02781792|466980250|FG000|Overall Study|Hospice|0|||
129732266|NCT02781792|466980251|FG001|Overall Study|Hospice|1|||
129732267|NCT01703117|466980252|FG000|Overall Study|Adverse Event|4|||
129732268|NCT01703117|466980253|FG001|Overall Study|Adverse Event|3|||
129732269|NCT01703117|466980252|FG000|Overall Study|Withdrawal by Subject|0|||
129732270|NCT01703117|466980253|FG001|Overall Study|Withdrawal by Subject|1|||
129732271|NCT00683917|466980255|FG000|Overall Study|Study prematurely terminated|10|||
129732272|NCT01170598|466980262|FG000|Overall Study|Withdrawal by Subject|1|||
129732273|NCT01170598|466980262|FG000|Overall Study|Death|3|||
129732274|NCT01170598|466980262|FG000|Overall Study|Lost to Follow-up|1|||
129732275|NCT01170598|466980262|FG000|Overall Study|Refused|1|||
129732276|NCT00937404|466980273|FG000|Overall Study|Protocol Violation|1|||
129732277|NCT00937404|466980273|FG000|Overall Study|Withdrawal by Subject|1|||
129732278|NCT04644237|466980274|FG000|Overall Study|Death|3|||
129732279|NCT04644237|466980275|FG001|Overall Study|Death|2|||
129732280|NCT04644237|466980274|FG000|Overall Study|Adverse Event|15|||
129732281|NCT04644237|466980275|FG001|Overall Study|Adverse Event|12|||
129732282|NCT04644237|466980274|FG000|Overall Study|Progressive Disease|47|||
129732283|NCT04644237|466980275|FG001|Overall Study|Progressive Disease|19|||
129732284|NCT04644237|466980274|FG000|Overall Study|Clinical Progression|4|||
129732285|NCT04644237|466980275|FG001|Overall Study|Clinical Progression|1|||
129732286|NCT04644237|466980274|FG000|Overall Study|Withdrawal by Subject|1|||
129732287|NCT04644237|466980275|FG001|Overall Study|Withdrawal by Subject|2|||
129732288|NCT04644237|466980274|FG000|Overall Study|Physician Decision|3|||
129732289|NCT04644237|466980275|FG001|Overall Study|Physician Decision|0|||
129732290|NCT04644237|466980274|FG000|Overall Study|Other|1|||
129732291|NCT04644237|466980275|FG001|Overall Study|Other|0|||
129732292|NCT04644237|466980274|FG000|Overall Study|Randomized but not Treated|1|||
129732293|NCT04644237|466980275|FG001|Overall Study|Randomized but not Treated|0|||
129732294|NCT00090233|466980276|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
129732295|NCT00090233|466980277|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
129732296|NCT00090233|466980276|FG000|Overall Study|Adverse Event|214|||
129732297|NCT00090233|466980277|FG001|Overall Study|Adverse Event|198|||
129732298|NCT00090233|466980276|FG000|Overall Study|Lost to Follow-up|68|||
129732299|NCT00090233|466980277|FG001|Overall Study|Lost to Follow-up|95|||
129444490|NCT04233164|465927356|FG001|Overall Study|Unable to obtain specimen|1|||
129444491|NCT00708175|465927357|FG000|Overall Study|Adverse Event|4|||
129444492|NCT00708175|465927358|FG001|Overall Study|Adverse Event|5|||
129444493|NCT00708175|465927357|FG000|Overall Study|Protocol Violation|2|||
129444494|NCT00708175|465927358|FG001|Overall Study|Protocol Violation|3|||
129444495|NCT00708175|465927357|FG000|Overall Study|Lost to Follow-up|5|||
129444496|NCT00708175|465927358|FG001|Overall Study|Lost to Follow-up|3|||
129444497|NCT00708175|465927357|FG000|Overall Study|Withdrawal by Subject|5|||
129444498|NCT00708175|465927358|FG001|Overall Study|Withdrawal by Subject|7|||
129444499|NCT00708175|465927357|FG000|Overall Study|BMD loss >7%|2|||
129444500|NCT00708175|465927358|FG001|Overall Study|BMD loss >7%|3|||
129732300|NCT00090233|466980276|FG000|Overall Study|Protocol Violation|960|||
129732301|NCT00090233|466980277|FG001|Overall Study|Protocol Violation|1022|||
129732302|NCT00090233|466980276|FG000|Overall Study|Withdrawal by Subject|182|||
129732303|NCT00090233|466980277|FG001|Overall Study|Withdrawal by Subject|211|||
129732304|NCT00090233|466980276|FG000|Overall Study|Moved|203|||
129444501|NCT04435782|465927364|FG000|Overall Study|Study terminated by sponsor|4|||
129444502|NCT03672461|465927365|FG000|Overall Study|COVID Related|4|||
129444503|NCT03672461|465927366|FG001|Overall Study|COVID Related|2|||
129732305|NCT00090233|466980277|FG001|Overall Study|Moved|189|||
129732306|NCT00090233|466980276|FG000|Overall Study|Other|1211|||
129732307|NCT00090233|466980277|FG001|Overall Study|Other|1160|||
129732308|NCT00090233|466980276|FG000|Overall Study|Data not available at data cut-off point|1552|||
129732309|NCT00090233|466980277|FG001|Overall Study|Data not available at data cut-off point|1563|||
129732310|NCT04863248|466980278|FG000|Overall Study|Sponsor Terminated|4|||
129732311|NCT04863248|466980279|FG001|Overall Study|Sponsor Terminated|1|||
129732312|NCT04863248|466980278|FG000|Overall Study|Death|0|||
129732313|NCT04863248|466980279|FG001|Overall Study|Death|1|||
129732314|NCT04863248|466980278|FG000|Overall Study|Withdrawal by Subject|0|||
129732315|NCT04863248|466980279|FG001|Overall Study|Withdrawal by Subject|1|||
129732316|NCT02536300|466980280|FG000|Overall Study|Investigator's Discretion|17|||
129732317|NCT02536300|466980281|FG001|Overall Study|Investigator's Discretion|11|||
129732318|NCT02536300|466980282|FG002|Overall Study|Investigator's Discretion|2|||
129732319|NCT02536300|466980280|FG000|Overall Study|Progressive Disease|11|||
129732320|NCT02536300|466980281|FG001|Overall Study|Progressive Disease|7|||
129732321|NCT02536300|466980282|FG002|Overall Study|Progressive Disease|6|||
129732322|NCT02536300|466980280|FG000|Overall Study|Study Terminated by Sponsor|6|||
129732323|NCT02536300|466980281|FG001|Overall Study|Study Terminated by Sponsor|4|||
129732324|NCT02536300|466980282|FG002|Overall Study|Study Terminated by Sponsor|7|||
129732325|NCT02536300|466980280|FG000|Overall Study|Death|7|||
129732326|NCT02536300|466980281|FG001|Overall Study|Death|0|||
129732327|NCT02536300|466980282|FG002|Overall Study|Death|5|||
129732328|NCT02536300|466980280|FG000|Overall Study|Withdrew Consent|4|||
129732329|NCT02536300|466980281|FG001|Overall Study|Withdrew Consent|2|||
129732330|NCT02536300|466980282|FG002|Overall Study|Withdrew Consent|0|||
129732331|NCT02536300|466980280|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
129732332|NCT02536300|466980281|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
129732333|NCT02536300|466980282|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
129732334|NCT02536300|466980280|FG000|Overall Study|Enrolled but Never Treated|0|||
129732335|NCT02536300|466980281|FG001|Overall Study|Enrolled but Never Treated|0|||
129732336|NCT02536300|466980282|FG002|Overall Study|Enrolled but Never Treated|1|||
129732337|NCT02536300|466980280|FG000|Overall Study|Non-compliance With Study Drug|1|||
129732338|NCT02536300|466980281|FG001|Overall Study|Non-compliance With Study Drug|0|||
129732339|NCT02536300|466980282|FG002|Overall Study|Non-compliance With Study Drug|0|||
129732340|NCT02536300|466980280|FG000|Overall Study|Protocol Violation|0|||
129732341|NCT02536300|466980281|FG001|Overall Study|Protocol Violation|1|||
129732342|NCT02536300|466980282|FG002|Overall Study|Protocol Violation|0|||
129804243|NCT03643575|467251469|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
129804244|NCT03643575|467251470|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
129804245|NCT03643575|467251471|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
129804246|NCT03643575|467251472|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
129804247|NCT03643575|467251473|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
129804248|NCT03643575|467251474|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
129804249|NCT03643575|467251469|FG000|Washout: 7 Days|Adverse Event|1|||
129804250|NCT03643575|467251470|FG001|Washout: 7 Days|Adverse Event|0|||
129804251|NCT03643575|467251471|FG002|Washout: 7 Days|Adverse Event|0|||
129804252|NCT03643575|467251472|FG003|Washout: 7 Days|Adverse Event|0|||
129804253|NCT03643575|467251473|FG004|Washout: 7 Days|Adverse Event|0|||
129804254|NCT03643575|467251474|FG005|Washout: 7 Days|Adverse Event|0|||
129804255|NCT03643575|467251469|FG000|Washout: 7 Days|Non compliance check in|0|||
129804256|NCT03643575|467251470|FG001|Washout: 7 Days|Non compliance check in|1|||
129804257|NCT03643575|467251471|FG002|Washout: 7 Days|Non compliance check in|0|||
129804258|NCT03643575|467251472|FG003|Washout: 7 Days|Non compliance check in|0|||
129804259|NCT03643575|467251473|FG004|Washout: 7 Days|Non compliance check in|0|||
129804260|NCT03643575|467251474|FG005|Washout: 7 Days|Non compliance check in|0|||
129804261|NCT01189604|467251475|FG000|Overall Study|Impossible to visit|0|||
129804262|NCT01189604|467251476|FG001|Overall Study|Impossible to visit|0|||
129804263|NCT01189604|467251477|FG002|Overall Study|Impossible to visit|0|||
129804264|NCT01189604|467251478|FG003|Overall Study|Impossible to visit|0|||
129804265|NCT01189604|467251479|FG004|Overall Study|Impossible to visit|0|||
129804266|NCT01189604|467251480|FG005|Overall Study|Impossible to visit|1|||
129804267|NCT01189604|467251481|FG006|Overall Study|Impossible to visit|0|||
129804268|NCT01189604|467251475|FG000|Overall Study|Adverse Event|0|||
129804269|NCT01189604|467251476|FG001|Overall Study|Adverse Event|1|||
129804270|NCT01189604|467251477|FG002|Overall Study|Adverse Event|0|||
129804271|NCT01189604|467251478|FG003|Overall Study|Adverse Event|0|||
129804272|NCT01189604|467251479|FG004|Overall Study|Adverse Event|2|||
129804273|NCT01189604|467251480|FG005|Overall Study|Adverse Event|0|||
129804274|NCT01189604|467251481|FG006|Overall Study|Adverse Event|1|||
129804275|NCT01189604|467251475|FG000|Overall Study|Withdrawal by Subject|1|||
129804276|NCT01189604|467251476|FG001|Overall Study|Withdrawal by Subject|0|||
129804277|NCT01189604|467251477|FG002|Overall Study|Withdrawal by Subject|0|||
129804278|NCT01189604|467251478|FG003|Overall Study|Withdrawal by Subject|0|||
129804279|NCT01189604|467251479|FG004|Overall Study|Withdrawal by Subject|0|||
129804280|NCT01189604|467251480|FG005|Overall Study|Withdrawal by Subject|0|||
129804281|NCT01189604|467251481|FG006|Overall Study|Withdrawal by Subject|0|||
129804282|NCT00986830|467251484|FG000|Overall Study|Death|1|||
129804283|NCT00986830|467251484|FG000|Overall Study|Lost to Follow-up|1|||
129804284|NCT00986830|467251484|FG000|Overall Study|Lack of Efficacy|1|||
129804285|NCT00986830|467251484|FG000|Overall Study|Unable to access sinus with device|5|||
129804286|NCT01332331|467251486|FG000|Overall Study|Lost to Follow-up|0|||
129804287|NCT01332331|467251487|FG001|Overall Study|Lost to Follow-up|1|||
129732343|NCT01691105|466980289|FG000|1 Month Follow-up|Lost to Follow-up|41|||
129732344|NCT01691105|466980290|FG001|1 Month Follow-up|Lost to Follow-up|38|||
129732345|NCT01691105|466980289|FG000|1 Month Follow-up|Death|2|||
129732346|NCT01691105|466980290|FG001|1 Month Follow-up|Death|3|||
129732347|NCT01691105|466980289|FG000|6 Month Follow-up|Lost to Follow-up|39|||
129732348|NCT01691105|466980290|FG001|6 Month Follow-up|Lost to Follow-up|58|||
129732349|NCT01691105|466980289|FG000|6 Month Follow-up|Death|13|||
129732350|NCT01691105|466980290|FG001|6 Month Follow-up|Death|13|||
129732351|NCT01691105|466980289|FG000|12 Month Follow-up|Lost to Follow-up|50|||
129732352|NCT01691105|466980290|FG001|12 Month Follow-up|Lost to Follow-up|71|||
129732353|NCT01691105|466980289|FG000|12 Month Follow-up|Death|22|||
129732354|NCT01691105|466980290|FG001|12 Month Follow-up|Death|30|||
129732355|NCT01691105|466980289|FG000|12 Month Biochemical Verification|Death|22|||
129732356|NCT01691105|466980290|FG001|12 Month Biochemical Verification|Death|30|||
129732357|NCT01691105|466980289|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
129732358|NCT01691105|466980290|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
129732359|NCT01691105|466980289|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
129732360|NCT01691105|466980290|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
129732361|NCT02233738|466980291|FG000|Overall Study|Lost to Follow-up|5|||
129732362|NCT02233738|466980292|FG001|Overall Study|Lost to Follow-up|12|||
129732363|NCT02233738|466980291|FG000|Overall Study|Death|0|||
129732364|NCT02233738|466980292|FG001|Overall Study|Death|1|||
129732365|NCT02233738|466980291|FG000|Overall Study|Withdrawal by Subject|0|||
129732366|NCT02233738|466980292|FG001|Overall Study|Withdrawal by Subject|1|||
129732367|NCT02233738|466980291|FG000|Overall Study|Did not return after Baseline|3|||
129732368|NCT02233738|466980292|FG001|Overall Study|Did not return after Baseline|2|||
129732369|NCT00096174|466980296|FG000|Overall Study|Lack of Efficacy|9|||
129732370|NCT00096174|466980296|FG000|Overall Study|Adverse Event|15|||
129732371|NCT00096174|466980296|FG000|Overall Study|Death|6|||
129732372|NCT00096174|466980296|FG000|Overall Study|Withdrawal by Subject|15|||
129732373|NCT00096174|466980296|FG000|Overall Study|Not started protocol therapy|3|||
129732374|NCT00096174|466980296|FG000|Overall Study|Ineligible|6|||
129732375|NCT00096174|466980296|FG000|Overall Study|other reason|8|||
129732376|NCT00445848|466980297|FG000|Overall Study|Adverse Event|14|||
129732377|NCT00445848|466980297|FG000|Overall Study|Withdrawal by Subject|4|||
129732378|NCT00445848|466980297|FG000|Overall Study|Progression|62|||
129732379|NCT00445848|466980297|FG000|Overall Study|Other-Not protocol specified|5|||
129732380|NCT04706273|466980298|FG000|Overall Study|Withdrawal by Subject|27|||
129732381|NCT04706273|466980298|FG000|Overall Study|Physician Decision|1|||
129732382|NCT04706273|466980298|FG000|Overall Study|Lost to Follow-up|42|||
129732383|NCT04706273|466980298|FG000|Overall Study|Death|85|||
129732384|NCT04706273|466980298|FG000|Overall Study|Amputation that removes study device|2|||
129732385|NCT04706273|466980298|FG000|Overall Study|Surgical bypass|3|||
129732386|NCT04706273|466980298|FG000|Overall Study|Changing hospital|23|||
129732387|NCT04706273|466980298|FG000|Overall Study|Unable to attend hospital|2|||
129732388|NCT03199053|466980301|FG000|ST Period|Withdrawal by Subject|2|||
129732389|NCT03199053|466980302|FG001|ST Period|Withdrawal by Subject|4|||
129732390|NCT03199053|466980303|FG002|ST Period|Withdrawal by Subject|6|||
129732391|NCT03199053|466980301|FG000|ST Period|Withdrawal by parent/guardian|1|||
129732392|NCT03199053|466980302|FG001|ST Period|Withdrawal by parent/guardian|1|||
129732393|NCT03199053|466980303|FG002|ST Period|Withdrawal by parent/guardian|1|||
129732394|NCT03199053|466980301|FG000|ST Period|Lost to Follow-up|2|||
129732395|NCT03199053|466980302|FG001|ST Period|Lost to Follow-up|0|||
129732396|NCT03199053|466980303|FG002|ST Period|Lost to Follow-up|1|||
129732397|NCT03199053|466980301|FG000|LT Period|Withdrawal by Subject|1|||
129732398|NCT03199053|466980302|FG001|LT Period|Withdrawal by Subject|3|||
129732399|NCT03199053|466980303|FG002|LT Period|Withdrawal by Subject|3|||
129732400|NCT03199053|466980301|FG000|LT Period|Withdrawal by parent/guardian|0|||
129732401|NCT03199053|466980302|FG001|LT Period|Withdrawal by parent/guardian|0|||
129732402|NCT03199053|466980303|FG002|LT Period|Withdrawal by parent/guardian|1|||
129732403|NCT03199053|466980301|FG000|LT Period|Lost to Follow-up|0|||
129732404|NCT03199053|466980302|FG001|LT Period|Lost to Follow-up|1|||
129732405|NCT03199053|466980303|FG002|LT Period|Lost to Follow-up|1|||
129732406|NCT03199053|466980301|FG000|LT Period|Miscellaneous|0|||
129732407|NCT03199053|466980302|FG001|LT Period|Miscellaneous|0|||
129732408|NCT03199053|466980303|FG002|LT Period|Miscellaneous|2|||
129732409|NCT03199053|466980301|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
129732410|NCT03199053|466980302|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
129732411|NCT03199053|466980303|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
129732412|NCT03199053|466980301|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
129732413|NCT03199053|466980302|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
129732414|NCT03199053|466980303|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
129732415|NCT03199053|466980301|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
129732416|NCT03199053|466980302|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
129732417|NCT03199053|466980303|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
129732418|NCT03199053|466980301|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
129732419|NCT03199053|466980302|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
129732420|NCT03199053|466980303|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
129732421|NCT02509052|466980306|FG000|Overall Study|Non compliance|0|||
129732422|NCT02509052|466980307|FG001|Overall Study|Non compliance|0|||
129732423|NCT02509052|466980308|FG002|Overall Study|Non compliance|1|||
129732424|NCT01824823|466980309|FG000|Overall Study|Lack of Efficacy|1|||
129732425|NCT01824823|466980310|FG001|Overall Study|Lack of Efficacy|1|||
129732426|NCT01824823|466980309|FG000|Overall Study|Off-treatment reason not submitted|1|||
129732427|NCT01824823|466980310|FG001|Overall Study|Off-treatment reason not submitted|0|||
129732428|NCT03362931|466980313|FG000|Overall Study|Adverse Event|1|||
129732429|NCT03362931|466980313|FG000|Overall Study|Death|2|||
129732430|NCT01323270|466980314|FG000|Overall Study|Withdrawal by Subject|19|||
129732431|NCT01323270|466980315|FG001|Overall Study|Withdrawal by Subject|10|||
129732432|NCT01323270|466980314|FG000|Overall Study|Protocol Violation|9|||
129732433|NCT01323270|466980315|FG001|Overall Study|Protocol Violation|7|||
129732434|NCT01323270|466980314|FG000|Overall Study|Lost to Follow-up|4|||
129732435|NCT01323270|466980315|FG001|Overall Study|Lost to Follow-up|6|||
129732436|NCT01323270|466980314|FG000|Overall Study|Adverse Event|8|||
129732437|NCT01323270|466980315|FG001|Overall Study|Adverse Event|0|||
129732438|NCT01323270|466980314|FG000|Overall Study|Other|0|||
129732439|NCT01323270|466980315|FG001|Overall Study|Other|3|||
129732440|NCT01323270|466980314|FG000|Overall Study|Physician Decision|0|||
129732441|NCT01323270|466980315|FG001|Overall Study|Physician Decision|2|||
129732442|NCT01323270|466980314|FG000|Overall Study|Not eligible|1|||
129732443|NCT01323270|466980315|FG001|Overall Study|Not eligible|1|||
129732444|NCT01323270|466980314|FG000|Overall Study|Death|1|||
129732445|NCT01323270|466980315|FG001|Overall Study|Death|0|||
129732446|NCT01323270|466980314|FG000|Overall Study|Randomized, but not vaccinated|1|||
129732447|NCT01323270|466980315|FG001|Overall Study|Randomized, but not vaccinated|0|||
129732448|NCT03761394|466980317|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
129732449|NCT03761394|466980318|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
129732450|NCT03761394|466980319|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
129732451|NCT03761394|466980320|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
129732452|NCT03761394|466980317|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
129732453|NCT03761394|466980318|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
129732454|NCT03761394|466980319|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
129732455|NCT03761394|466980320|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
129732456|NCT03761394|466980317|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
129732457|NCT03761394|466980318|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
129732458|NCT03761394|466980319|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
129732459|NCT03761394|466980320|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
129732460|NCT03761394|466980317|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
129732461|NCT03761394|466980318|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
129732462|NCT03761394|466980319|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
129732463|NCT03761394|466980320|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
129732464|NCT01080768|466980329|FG000|Overall Study|Protocol Deviation|2|||
129732465|NCT01080768|466980330|FG001|Overall Study|Protocol Deviation|1|||
129732466|NCT00931723|466980336|FG000|Overall Study|Withdrawal by Subject|11|||
129732467|NCT00931723|466980337|FG001|Overall Study|Withdrawal by Subject|13|||
129732468|NCT00931723|466980336|FG000|Overall Study|Adverse Event|6|||
129732469|NCT00931723|466980337|FG001|Overall Study|Adverse Event|13|||
129732470|NCT00931723|466980336|FG000|Overall Study|Lithium found in blood|0|||
129732471|NCT00931723|466980337|FG001|Overall Study|Lithium found in blood|1|||
129732472|NCT00931723|466980336|FG000|Overall Study|Condition under investigation worsened|1|||
129732473|NCT00931723|466980337|FG001|Overall Study|Condition under investigation worsened|2|||
129732474|NCT00931723|466980336|FG000|Overall Study|Lost to Follow-up|1|||
129732475|NCT00931723|466980337|FG001|Overall Study|Lost to Follow-up|2|||
129732476|NCT00931723|466980336|FG000|Overall Study|Study-specific discontinuation criteria|1|||
129732477|NCT00931723|466980337|FG001|Overall Study|Study-specific discontinuation criteria|1|||
129732478|NCT00931723|466980336|FG000|Overall Study|Severe non-compliance to protocol|2|||
129732479|NCT00931723|466980337|FG001|Overall Study|Severe non-compliance to protocol|0|||
129732480|NCT00931723|466980336|FG000|Overall Study|Safety reasons|0|||
129732481|NCT00931723|466980337|FG001|Overall Study|Safety reasons|1|||
129732482|NCT00931723|466980336|FG000|Overall Study|Took prohibited concomitant medication|0|||
129732483|NCT00931723|466980337|FG001|Overall Study|Took prohibited concomitant medication|1|||
129732484|NCT00931723|466980336|FG000|Overall Study|Lack or insufficient theraputic response|2|||
129732485|NCT00931723|466980337|FG001|Overall Study|Lack or insufficient theraputic response|5|||
129732486|NCT00931723|466980336|FG000|Overall Study|Sponsor decision|1|||
129732487|NCT00931723|466980337|FG001|Overall Study|Sponsor decision|0|||
129732488|NCT00931723|466980336|FG000|Overall Study|Late hospital discharge|1|||
129732489|NCT00931723|466980337|FG001|Overall Study|Late hospital discharge|0|||
129892654|NCT05296629|467567621|FG001|Overall Study|Adverse Event|4|||
129732490|NCT03054350|466980338|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
129732491|NCT03054350|466980339|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
129732492|NCT03054350|466980340|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
129732493|NCT03054350|466980341|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
129732494|NCT03054350|466980342|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
129732495|NCT03054350|466980343|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
129444504|NCT03672461|465927365|FG000|Overall Study|Adverse Event|2|||
129444505|NCT03672461|465927366|FG001|Overall Study|Adverse Event|0|||
129444506|NCT03672461|465927365|FG000|Overall Study|Serious Adverse Event|0|||
129444507|NCT03672461|465927366|FG001|Overall Study|Serious Adverse Event|1|||
129732496|NCT03054350|466980338|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129732497|NCT03054350|466980339|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129732498|NCT03054350|466980340|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
129732499|NCT03054350|466980341|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129444508|NCT03672461|465927365|FG000|Overall Study|Too Busy|3|||
129732500|NCT03054350|466980342|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129732501|NCT03054350|466980343|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
129732502|NCT03054350|466980338|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
129732503|NCT03054350|466980339|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129732504|NCT03054350|466980340|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129732505|NCT03054350|466980341|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
129732506|NCT03054350|466980342|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129732507|NCT03054350|466980343|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
129732508|NCT03054350|466980338|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129732509|NCT03054350|466980339|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129732510|NCT03054350|466980340|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
129732511|NCT03054350|466980341|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129732512|NCT03054350|466980342|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129732513|NCT03054350|466980343|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
129732514|NCT01643850|466980344|FG000|Overall Study|Withdrawal by Subject|0|||
129732515|NCT01643850|466980345|FG001|Overall Study|Withdrawal by Subject|0|||
129732516|NCT01643850|466980346|FG002|Overall Study|Withdrawal by Subject|0|||
129732517|NCT01643850|466980347|FG003|Overall Study|Withdrawal by Subject|0|||
129732518|NCT01643850|466980348|FG004|Overall Study|Withdrawal by Subject|1|||
129732519|NCT01643850|466980349|FG005|Overall Study|Withdrawal by Subject|0|||
129732520|NCT01643850|466980350|FG006|Overall Study|Withdrawal by Subject|0|||
129732521|NCT01643850|466980351|FG007|Overall Study|Withdrawal by Subject|0|||
129732522|NCT01643850|466980352|FG008|Overall Study|Withdrawal by Subject|0|||
129732523|NCT01643850|466980344|FG000|Overall Study|Lost to Follow-up|0|||
129732524|NCT01643850|466980345|FG001|Overall Study|Lost to Follow-up|0|||
129732525|NCT01643850|466980346|FG002|Overall Study|Lost to Follow-up|0|||
129732526|NCT01643850|466980347|FG003|Overall Study|Lost to Follow-up|0|||
129732527|NCT01643850|466980348|FG004|Overall Study|Lost to Follow-up|0|||
129732528|NCT01643850|466980349|FG005|Overall Study|Lost to Follow-up|0|||
129732529|NCT01643850|466980350|FG006|Overall Study|Lost to Follow-up|1|||
129732530|NCT01643850|466980351|FG007|Overall Study|Lost to Follow-up|0|||
129732531|NCT01643850|466980352|FG008|Overall Study|Lost to Follow-up|1|||
129732532|NCT01643850|466980344|FG000|Overall Study|Adverse Event|0|||
129732533|NCT01643850|466980345|FG001|Overall Study|Adverse Event|0|||
129732534|NCT01643850|466980346|FG002|Overall Study|Adverse Event|0|||
129732535|NCT01643850|466980347|FG003|Overall Study|Adverse Event|0|||
129732536|NCT01643850|466980348|FG004|Overall Study|Adverse Event|1|||
129732537|NCT01643850|466980349|FG005|Overall Study|Adverse Event|0|||
129732538|NCT01643850|466980350|FG006|Overall Study|Adverse Event|0|||
129892655|NCT05296629|467567622|FG002|Overall Study|Adverse Event|2|||
129892656|NCT05296629|467567620|FG000|Overall Study|Protocol Violation|0|||
129892657|NCT05296629|467567621|FG001|Overall Study|Protocol Violation|2|||
129892658|NCT05296629|467567622|FG002|Overall Study|Protocol Violation|0|||
129892659|NCT02268396|467567626|FG000|Overall Study|Adverse Event|3|||
129892660|NCT02268396|467567626|FG000|Overall Study|Administrative|2|||
129892661|NCT02268396|467567626|FG000|Overall Study|Withdrawal by Subject|1|||
129892662|NCT02268396|467567626|FG000|Overall Study|Lost to Follow-up|2|||
129892663|NCT02268396|467567626|FG000|Overall Study|Protocol-Specified Criteria|2|||
129892664|NCT02268396|467567626|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
129732539|NCT01643850|466980351|FG007|Overall Study|Adverse Event|0|||
129732540|NCT01643850|466980352|FG008|Overall Study|Adverse Event|0|||
129732541|NCT01643850|466980344|FG000|Overall Study|Administrative Problems|0|||
129892665|NCT00231179|467567629|FG000|Overall Study|Lost to Follow-up|21|||
129892666|NCT00231179|467567630|FG001|Overall Study|Lost to Follow-up|21|||
129892667|NCT00231179|467567629|FG000|Overall Study|Withdrawal by Subject|3|||
129892668|NCT00231179|467567630|FG001|Overall Study|Withdrawal by Subject|3|||
129892669|NCT02401529|467567631|FG000|Overall Study|Lost to Follow-up|2|||
129892670|NCT02401529|467567632|FG001|Overall Study|Lost to Follow-up|1|||
129892671|NCT02401529|467567631|FG000|Overall Study|Physician Decision|2|||
129732542|NCT01643850|466980345|FG001|Overall Study|Administrative Problems|0|||
129732543|NCT01643850|466980346|FG002|Overall Study|Administrative Problems|1|||
129732544|NCT01643850|466980347|FG003|Overall Study|Administrative Problems|0|||
129892672|NCT02401529|467567632|FG001|Overall Study|Physician Decision|6|||
129892673|NCT02401529|467567631|FG000|Overall Study|Protocol Violation|5|||
129732545|NCT01643850|466980348|FG004|Overall Study|Administrative Problems|1|||
129892674|NCT02401529|467567632|FG001|Overall Study|Protocol Violation|0|||
129732546|NCT01643850|466980349|FG005|Overall Study|Administrative Problems|0|||
129732547|NCT01643850|466980350|FG006|Overall Study|Administrative Problems|0|||
129892675|NCT02491411|467567635|FG000|Overall Study|Physician Decision|4|||
129892676|NCT04034238|467567636|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
129892677|NCT04034238|467567637|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129732548|NCT01643850|466980351|FG007|Overall Study|Administrative Problems|0|||
129892678|NCT04034238|467567638|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129892679|NCT04034238|467567639|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129732549|NCT01643850|466980352|FG008|Overall Study|Administrative Problems|0|||
129732550|NCT01133405|466980355|FG000|Period 1|Withdrawal by Subject|0|||
129732551|NCT01133405|466980356|FG001|Period 1|Withdrawal by Subject|1|||
129732552|NCT01133405|466980357|FG002|Period 1|Withdrawal by Subject|0|||
129732553|NCT01133405|466980358|FG003|Period 1|Withdrawal by Subject|1|||
129732554|NCT01133405|466980359|FG004|Period 1|Withdrawal by Subject|0|||
129732555|NCT01133405|466980360|FG005|Period 1|Withdrawal by Subject|1|||
129732556|NCT01133405|466980361|FG006|Period 1|Withdrawal by Subject|0|||
129732557|NCT01133405|466980362|FG007|Period 1|Withdrawal by Subject|0|||
129732558|NCT01133405|466980363|FG008|Period 1|Withdrawal by Subject|0|||
129732559|NCT01133405|466980364|FG009|Period 1|Withdrawal by Subject|0|||
129732560|NCT01133405|466980355|FG000|Period 1|Physician Decision|0|||
129732561|NCT01133405|466980356|FG001|Period 1|Physician Decision|0|||
129732562|NCT01133405|466980357|FG002|Period 1|Physician Decision|0|||
129732563|NCT01133405|466980358|FG003|Period 1|Physician Decision|1|||
129732564|NCT01133405|466980359|FG004|Period 1|Physician Decision|0|||
129732565|NCT01133405|466980360|FG005|Period 1|Physician Decision|0|||
129732566|NCT01133405|466980361|FG006|Period 1|Physician Decision|0|||
129732567|NCT01133405|466980362|FG007|Period 1|Physician Decision|0|||
129732568|NCT01133405|466980363|FG008|Period 1|Physician Decision|0|||
129732569|NCT01133405|466980364|FG009|Period 1|Physician Decision|0|||
129732570|NCT01133405|466980355|FG000|Period 1|Discontinued after randomization|1|||
129732571|NCT01133405|466980356|FG001|Period 1|Discontinued after randomization|0|||
129732572|NCT01133405|466980357|FG002|Period 1|Discontinued after randomization|0|||
129732573|NCT01133405|466980358|FG003|Period 1|Discontinued after randomization|0|||
129732574|NCT01133405|466980359|FG004|Period 1|Discontinued after randomization|0|||
129732575|NCT01133405|466980360|FG005|Period 1|Discontinued after randomization|0|||
129732576|NCT01133405|466980361|FG006|Period 1|Discontinued after randomization|1|||
129732577|NCT01133405|466980362|FG007|Period 1|Discontinued after randomization|0|||
129732578|NCT01133405|466980363|FG008|Period 1|Discontinued after randomization|0|||
129732579|NCT01133405|466980364|FG009|Period 1|Discontinued after randomization|0|||
129732580|NCT01133405|466980355|FG000|Period 1|Received drug only in period 2|0|||
129732581|NCT01133405|466980356|FG001|Period 1|Received drug only in period 2|1|||
129732582|NCT01133405|466980357|FG002|Period 1|Received drug only in period 2|0|||
129732583|NCT01133405|466980358|FG003|Period 1|Received drug only in period 2|2|||
129732584|NCT01133405|466980359|FG004|Period 1|Received drug only in period 2|0|||
129732585|NCT01133405|466980360|FG005|Period 1|Received drug only in period 2|1|||
129732586|NCT01133405|466980361|FG006|Period 1|Received drug only in period 2|0|||
129732587|NCT01133405|466980362|FG007|Period 1|Received drug only in period 2|0|||
129732588|NCT01133405|466980363|FG008|Period 1|Received drug only in period 2|0|||
129732589|NCT01133405|466980364|FG009|Period 1|Received drug only in period 2|0|||
129732590|NCT01133405|466980355|FG000|Period 1|Received drug only in period 3|0|||
129732591|NCT01133405|466980356|FG001|Period 1|Received drug only in period 3|1|||
129732592|NCT01133405|466980357|FG002|Period 1|Received drug only in period 3|1|||
129732593|NCT01133405|466980358|FG003|Period 1|Received drug only in period 3|0|||
129732594|NCT01133405|466980359|FG004|Period 1|Received drug only in period 3|0|||
129732595|NCT01133405|466980360|FG005|Period 1|Received drug only in period 3|0|||
129732596|NCT01133405|466980361|FG006|Period 1|Received drug only in period 3|0|||
129732597|NCT01133405|466980362|FG007|Period 1|Received drug only in period 3|0|||
129732598|NCT01133405|466980363|FG008|Period 1|Received drug only in period 3|0|||
129732599|NCT01133405|466980364|FG009|Period 1|Received drug only in period 3|0|||
129732600|NCT01133405|466980355|FG000|Period 2|Adverse Event|0|||
129732601|NCT01133405|466980356|FG001|Period 2|Adverse Event|0|||
129732602|NCT01133405|466980357|FG002|Period 2|Adverse Event|1|||
129732603|NCT01133405|466980358|FG003|Period 2|Adverse Event|0|||
129732604|NCT01133405|466980359|FG004|Period 2|Adverse Event|0|||
129732605|NCT01133405|466980360|FG005|Period 2|Adverse Event|0|||
129732606|NCT01133405|466980361|FG006|Period 2|Adverse Event|0|||
129732607|NCT01133405|466980362|FG007|Period 2|Adverse Event|0|||
129732608|NCT01133405|466980363|FG008|Period 2|Adverse Event|0|||
129732609|NCT01133405|466980364|FG009|Period 2|Adverse Event|0|||
129732610|NCT01133405|466980355|FG000|Period 2|Withdrawal by Subject|0|||
129732611|NCT01133405|466980356|FG001|Period 2|Withdrawal by Subject|0|||
129732612|NCT01133405|466980357|FG002|Period 2|Withdrawal by Subject|0|||
129732613|NCT01133405|466980358|FG003|Period 2|Withdrawal by Subject|1|||
129732614|NCT01133405|466980359|FG004|Period 2|Withdrawal by Subject|0|||
129732615|NCT01133405|466980360|FG005|Period 2|Withdrawal by Subject|1|||
129732616|NCT01133405|466980361|FG006|Period 2|Withdrawal by Subject|0|||
129732617|NCT01133405|466980362|FG007|Period 2|Withdrawal by Subject|0|||
129732618|NCT01133405|466980363|FG008|Period 2|Withdrawal by Subject|0|||
129732619|NCT01133405|466980364|FG009|Period 2|Withdrawal by Subject|0|||
129732620|NCT01133405|466980355|FG000|Period 2|Entry Criteria Not Met|0|||
129732621|NCT01133405|466980356|FG001|Period 2|Entry Criteria Not Met|1|||
129732622|NCT01133405|466980357|FG002|Period 2|Entry Criteria Not Met|0|||
129732623|NCT01133405|466980358|FG003|Period 2|Entry Criteria Not Met|0|||
129732624|NCT01133405|466980359|FG004|Period 2|Entry Criteria Not Met|0|||
129732625|NCT01133405|466980360|FG005|Period 2|Entry Criteria Not Met|0|||
129732626|NCT01133405|466980361|FG006|Period 2|Entry Criteria Not Met|0|||
129732627|NCT01133405|466980362|FG007|Period 2|Entry Criteria Not Met|0|||
129732628|NCT01133405|466980363|FG008|Period 2|Entry Criteria Not Met|0|||
129732629|NCT01133405|466980364|FG009|Period 2|Entry Criteria Not Met|0|||
129732630|NCT01133405|466980355|FG000|Period 2|Physician Decision|0|||
129732631|NCT01133405|466980356|FG001|Period 2|Physician Decision|0|||
129732632|NCT01133405|466980357|FG002|Period 2|Physician Decision|0|||
129732633|NCT01133405|466980358|FG003|Period 2|Physician Decision|0|||
129732634|NCT01133405|466980359|FG004|Period 2|Physician Decision|0|||
129732635|NCT01133405|466980360|FG005|Period 2|Physician Decision|1|||
129732636|NCT01133405|466980361|FG006|Period 2|Physician Decision|0|||
129732637|NCT01133405|466980362|FG007|Period 2|Physician Decision|0|||
129732638|NCT01133405|466980363|FG008|Period 2|Physician Decision|0|||
129732639|NCT01133405|466980364|FG009|Period 2|Physician Decision|0|||
129732640|NCT03242772|466980365|FG000|Overall Study|Lost to Follow-up|2|||
129732641|NCT03242772|466980366|FG001|Overall Study|Lost to Follow-up|0|||
129732642|NCT03242772|466980365|FG000|Overall Study|Physician Decision|0|||
129732643|NCT03242772|466980366|FG001|Overall Study|Physician Decision|1|||
129732644|NCT03242772|466980365|FG000|Overall Study|Withdrawal by Subject|1|||
129732645|NCT03242772|466980366|FG001|Overall Study|Withdrawal by Subject|0|||
129732646|NCT00089986|466980367|FG000|Overall Study|Adverse Event|6|||
129732647|NCT00089986|466980368|FG001|Overall Study|Adverse Event|9|||
129732648|NCT00089986|466980369|FG002|Overall Study|Adverse Event|6|||
129732649|NCT00089986|466980367|FG000|Overall Study|Lost to Follow-up|3|||
129732650|NCT00089986|466980368|FG001|Overall Study|Lost to Follow-up|1|||
129732651|NCT00089986|466980369|FG002|Overall Study|Lost to Follow-up|1|||
129732652|NCT00089986|466980367|FG000|Overall Study|Protocol Violation|0|||
129732653|NCT00089986|466980368|FG001|Overall Study|Protocol Violation|1|||
129732654|NCT00089986|466980369|FG002|Overall Study|Protocol Violation|0|||
129732655|NCT00089986|466980367|FG000|Overall Study|Patient transferred to another hospital|2|||
129732656|NCT00089986|466980368|FG001|Overall Study|Patient transferred to another hospital|1|||
129892680|NCT04034238|467567636|FG000|Dose Escalation Phase|Screen failures|0|||
129892681|NCT04034238|467567637|FG001|Dose Escalation Phase|Screen failures|0|||
129732657|NCT00089986|466980369|FG002|Overall Study|Patient transferred to another hospital|0|||
129732658|NCT00089986|466980367|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
129732659|NCT00089986|466980368|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
129732660|NCT00089986|466980369|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
129732661|NCT00089986|466980367|FG000|Overall Study|Hemohlobin stopping rule|0|||
129732662|NCT00089986|466980368|FG001|Overall Study|Hemohlobin stopping rule|1|||
129732663|NCT00089986|466980369|FG002|Overall Study|Hemohlobin stopping rule|0|||
129732664|NCT00089986|466980367|FG000|Overall Study|Investigator decision to withdrew|0|||
129732665|NCT00089986|466980368|FG001|Overall Study|Investigator decision to withdrew|1|||
129732666|NCT00089986|466980369|FG002|Overall Study|Investigator decision to withdrew|0|||
129732667|NCT00089986|466980367|FG000|Overall Study|Enrollment in another study|0|||
129732668|NCT00089986|466980368|FG001|Overall Study|Enrollment in another study|1|||
129732669|NCT00089986|466980369|FG002|Overall Study|Enrollment in another study|0|||
129732670|NCT00089986|466980367|FG000|Overall Study|Family decision|0|||
129732671|NCT00089986|466980368|FG001|Overall Study|Family decision|1|||
129732672|NCT00089986|466980369|FG002|Overall Study|Family decision|0|||
129732673|NCT00089986|466980367|FG000|Overall Study|Do not resuscitate (DNR)|0|||
129732674|NCT00089986|466980368|FG001|Overall Study|Do not resuscitate (DNR)|0|||
129732675|NCT00089986|466980369|FG002|Overall Study|Do not resuscitate (DNR)|1|||
129732676|NCT00089986|466980367|FG000|Overall Study|Withdrawal by Subject|3|||
129732677|NCT00089986|466980368|FG001|Overall Study|Withdrawal by Subject|6|||
129732678|NCT00089986|466980369|FG002|Overall Study|Withdrawal by Subject|2|||
129732679|NCT02334683|466980376|FG000|First 12 Week Period|Lost to Follow-up|1|||
129732680|NCT02334683|466980377|FG001|First 12 Week Period|Lost to Follow-up|0|||
129732681|NCT02334683|466980376|FG000|Second 12 Week Period|Adverse Event|0|||
129732682|NCT02334683|466980377|FG001|Second 12 Week Period|Adverse Event|1|||
129732683|NCT01062841|466980378|FG000|Overall Study|Indwelling Device Removed|41|||
129732684|NCT01062841|466980379|FG001|Overall Study|Indwelling Device Removed|48|||
129732685|NCT01062841|466980378|FG000|Overall Study|Death|3|||
129732686|NCT01062841|466980379|FG001|Overall Study|Death|5|||
129732687|NCT01062841|466980378|FG000|Overall Study|Withdrawal by Subject|2|||
129732688|NCT01062841|466980379|FG001|Overall Study|Withdrawal by Subject|0|||
129732689|NCT01062841|466980378|FG000|Overall Study|Withdrawal by Study|3|||
129732690|NCT01062841|466980379|FG001|Overall Study|Withdrawal by Study|0|||
129732691|NCT01218100|466980380|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
129732692|NCT01218100|466980381|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
129732693|NCT01218100|466980382|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
129732694|NCT01218100|466980383|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
129732695|NCT01218100|466980380|FG000|Overall Study|Adverse Event|4|||
129732696|NCT01218100|466980381|FG001|Overall Study|Adverse Event|6|||
129732697|NCT01218100|466980382|FG002|Overall Study|Adverse Event|6|||
129732698|NCT01218100|466980383|FG003|Overall Study|Adverse Event|7|||
129732699|NCT01218100|466980380|FG000|Overall Study|Lack of Efficacy|9|||
129732700|NCT01218100|466980381|FG001|Overall Study|Lack of Efficacy|6|||
129732701|NCT01218100|466980382|FG002|Overall Study|Lack of Efficacy|5|||
129732702|NCT01218100|466980383|FG003|Overall Study|Lack of Efficacy|12|||
129732703|NCT01218100|466980380|FG000|Overall Study|Protocol Violation|0|||
129732704|NCT01218100|466980381|FG001|Overall Study|Protocol Violation|0|||
129732705|NCT01218100|466980382|FG002|Overall Study|Protocol Violation|1|||
129732706|NCT01218100|466980383|FG003|Overall Study|Protocol Violation|1|||
129732707|NCT01218100|466980380|FG000|Overall Study|Withdrawal by Subject|5|||
129732708|NCT01218100|466980381|FG001|Overall Study|Withdrawal by Subject|2|||
129732709|NCT01218100|466980382|FG002|Overall Study|Withdrawal by Subject|6|||
129732710|NCT01218100|466980383|FG003|Overall Study|Withdrawal by Subject|7|||
129732711|NCT01218100|466980380|FG000|Overall Study|Lost to Follow-up|3|||
129892682|NCT04034238|467567638|FG002|Dose Escalation Phase|Screen failures|0|||
129892683|NCT04034238|467567639|FG003|Dose Escalation Phase|Screen failures|2|||
129892684|NCT04034238|467567636|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
129892685|NCT04034238|467567637|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
129892686|NCT04034238|467567638|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
129892687|NCT04034238|467567639|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
129892688|NCT04034238|467567636|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
129892689|NCT04034238|467567637|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
129892690|NCT04034238|467567638|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
129892691|NCT04034238|467567639|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
129892692|NCT01939158|467567640|FG000|Overall Study|Adverse Event|1|||
129892693|NCT01939158|467567641|FG001|Overall Study|Adverse Event|0|||
129892694|NCT01939158|467567642|FG002|Overall Study|Adverse Event|0|||
129892695|NCT01939158|467567643|FG003|Overall Study|Adverse Event|0|||
129892696|NCT01939158|467567640|FG000|Overall Study|Withdrawal by Subject|22|||
129892697|NCT01939158|467567641|FG001|Overall Study|Withdrawal by Subject|25|||
129892698|NCT01939158|467567642|FG002|Overall Study|Withdrawal by Subject|15|||
129892699|NCT01939158|467567643|FG003|Overall Study|Withdrawal by Subject|17|||
129892700|NCT01939158|467567640|FG000|Overall Study|Migrated/moved from study area|5|||
129892701|NCT01939158|467567641|FG001|Overall Study|Migrated/moved from study area|7|||
129892702|NCT01939158|467567642|FG002|Overall Study|Migrated/moved from study area|3|||
129892703|NCT01939158|467567643|FG003|Overall Study|Migrated/moved from study area|6|||
129892704|NCT01939158|467567640|FG000|Overall Study|Lost to Follow-up|18|||
129892705|NCT01939158|467567641|FG001|Overall Study|Lost to Follow-up|17|||
129892706|NCT01939158|467567642|FG002|Overall Study|Lost to Follow-up|17|||
129892707|NCT01939158|467567643|FG003|Overall Study|Lost to Follow-up|17|||
129892708|NCT01939158|467567640|FG000|Overall Study|Death|0|||
129892709|NCT01939158|467567641|FG001|Overall Study|Death|0|||
129892710|NCT01939158|467567642|FG002|Overall Study|Death|1|||
129892711|NCT01939158|467567643|FG003|Overall Study|Death|1|||
129892712|NCT01939158|467567640|FG000|Overall Study|No longer meets eligibility criteria|0|||
129892713|NCT01939158|467567641|FG001|Overall Study|No longer meets eligibility criteria|0|||
129892714|NCT01939158|467567642|FG002|Overall Study|No longer meets eligibility criteria|1|||
129892715|NCT01939158|467567643|FG003|Overall Study|No longer meets eligibility criteria|0|||
129892716|NCT01939158|467567640|FG000|Overall Study|Other|1|||
129892717|NCT01939158|467567641|FG001|Overall Study|Other|3|||
129892718|NCT01939158|467567642|FG002|Overall Study|Other|4|||
129892719|NCT01939158|467567643|FG003|Overall Study|Other|3|||
129892720|NCT02065245|467567646|FG000|Infusion 1|Lost to Follow-up|0|||
129892721|NCT02065245|467567647|FG001|Infusion 1|Lost to Follow-up|0|||
129892722|NCT02065245|467567648|FG002|Infusion 1|Lost to Follow-up|0|||
129892723|NCT02065245|467567649|FG003|Infusion 1|Lost to Follow-up|0|||
129892724|NCT02065245|467567650|FG004|Infusion 1|Lost to Follow-up|0|||
129892725|NCT02065245|467567651|FG005|Infusion 1|Lost to Follow-up|0|||
129892726|NCT02065245|467567652|FG006|Infusion 1|Lost to Follow-up|1|||
129892727|NCT02065245|467567646|FG000|Infusion 1|Death|0|||
129892728|NCT02065245|467567647|FG001|Infusion 1|Death|0|||
129892729|NCT02065245|467567648|FG002|Infusion 1|Death|1|||
129892730|NCT02065245|467567649|FG003|Infusion 1|Death|0|||
129892731|NCT02065245|467567650|FG004|Infusion 1|Death|1|||
129892732|NCT02065245|467567651|FG005|Infusion 1|Death|0|||
129892733|NCT02065245|467567652|FG006|Infusion 1|Death|0|||
129732712|NCT01218100|466980381|FG001|Overall Study|Lost to Follow-up|8|||
129732713|NCT01218100|466980382|FG002|Overall Study|Lost to Follow-up|2|||
129732714|NCT01218100|466980383|FG003|Overall Study|Lost to Follow-up|1|||
129732715|NCT01218100|466980380|FG000|Overall Study|Other Reason|2|||
129892734|NCT02065245|467567646|FG000|Infusion 2|Death|0|||
129892735|NCT02065245|467567647|FG001|Infusion 2|Death|0|||
129892736|NCT02065245|467567648|FG002|Infusion 2|Death|0|||
129732716|NCT01218100|466980381|FG001|Overall Study|Other Reason|2|||
129732717|NCT01218100|466980382|FG002|Overall Study|Other Reason|6|||
129892737|NCT02065245|467567649|FG003|Infusion 2|Death|0|||
129892738|NCT02065245|467567650|FG004|Infusion 2|Death|0|||
129732718|NCT01218100|466980383|FG003|Overall Study|Other Reason|4|||
129732719|NCT02434354|466980390|FG000|Overall Study|screen fail|3|||
129732720|NCT02446418|466980391|FG000|Overall Study|Adverse Event|4|||
129732721|NCT02446418|466980392|FG001|Overall Study|Adverse Event|8|||
129732722|NCT02446418|466980391|FG000|Overall Study|Physician Decision|5|||
129732723|NCT02446418|466980392|FG001|Overall Study|Physician Decision|1|||
129732724|NCT02446418|466980391|FG000|Overall Study|Withdrawal by Subject|3|||
129732725|NCT02446418|466980392|FG001|Overall Study|Withdrawal by Subject|3|||
129732726|NCT02446418|466980391|FG000|Overall Study|Lost to Follow-up|2|||
129732727|NCT02446418|466980392|FG001|Overall Study|Lost to Follow-up|2|||
129732728|NCT02446418|466980391|FG000|Overall Study|Protocol Violation|1|||
129732729|NCT02446418|466980392|FG001|Overall Study|Protocol Violation|2|||
129732730|NCT02446418|466980391|FG000|Overall Study|Lack of Efficacy|2|||
129732731|NCT02446418|466980392|FG001|Overall Study|Lack of Efficacy|0|||
129732732|NCT02446418|466980391|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
129732733|NCT02446418|466980392|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
129732734|NCT02014480|466980395|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129732735|NCT02014480|466980396|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129732736|NCT02014480|466980397|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129732737|NCT02014480|466980398|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129732738|NCT02014480|466980399|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129732739|NCT02014480|466980400|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129732740|NCT02014480|466980395|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129732741|NCT02014480|466980396|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129732742|NCT02014480|466980397|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129732743|NCT02014480|466980398|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
129732744|NCT02014480|466980399|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129732745|NCT02014480|466980400|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129732746|NCT02014480|466980395|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129732747|NCT02014480|466980396|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129732748|NCT02014480|466980397|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
129732749|NCT02014480|466980398|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129732750|NCT02014480|466980399|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129732751|NCT02014480|466980400|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
129732752|NCT02014480|466980395|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129732753|NCT02014480|466980396|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129732754|NCT02014480|466980397|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
129732755|NCT02014480|466980398|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129732756|NCT02014480|466980399|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129732757|NCT02014480|466980400|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129732758|NCT02014480|466980395|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129732759|NCT02014480|466980396|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
129732760|NCT02014480|466980397|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129732761|NCT02014480|466980398|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129732762|NCT02014480|466980399|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129732763|NCT02014480|466980400|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
129732764|NCT02014480|466980395|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
129732765|NCT02014480|466980396|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
129732766|NCT02014480|466980397|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
129732767|NCT02014480|466980398|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
129732768|NCT02014480|466980399|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
129732769|NCT02014480|466980400|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
129732770|NCT02014480|466980395|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129732771|NCT02014480|466980396|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129732772|NCT02014480|466980397|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129732773|NCT02014480|466980398|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129732774|NCT02014480|466980399|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129732775|NCT02014480|466980400|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
129732776|NCT01414205|466980401|FG000|Overall Study|Death|5|||
129732777|NCT01414205|466980402|FG001|Overall Study|Death|1|||
129732778|NCT01414205|466980401|FG000|Overall Study|Lost to Follow-up|1|||
129732779|NCT01414205|466980402|FG001|Overall Study|Lost to Follow-up|4|||
129732780|NCT01414205|466980401|FG000|Overall Study|Physician Decision|0|||
129732781|NCT01414205|466980402|FG001|Overall Study|Physician Decision|1|||
129732782|NCT01414205|466980401|FG000|Overall Study|Randomized but not Treated|1|||
129732783|NCT01414205|466980402|FG001|Overall Study|Randomized but not Treated|1|||
129732784|NCT02305849|466980408|FG000|Overall Study|Adverse Event|10|||
129732785|NCT02305849|466980409|FG001|Overall Study|Adverse Event|12|||
129732786|NCT02305849|466980410|FG002|Overall Study|Adverse Event|7|||
129732787|NCT02305849|466980411|FG003|Overall Study|Adverse Event|3|||
129732788|NCT02305849|466980408|FG000|Overall Study|Lack of Efficacy|10|||
129732789|NCT02305849|466980409|FG001|Overall Study|Lack of Efficacy|6|||
129732790|NCT02305849|466980410|FG002|Overall Study|Lack of Efficacy|3|||
129892739|NCT02065245|467567651|FG005|Infusion 2|Death|0|||
129892740|NCT02065245|467567652|FG006|Infusion 2|Death|1|||
129892741|NCT02065245|467567646|FG000|Infusion 3|Lost to Follow-up|1|||
129892742|NCT02065245|467567647|FG001|Infusion 3|Lost to Follow-up|1|||
129892743|NCT02065245|467567648|FG002|Infusion 3|Lost to Follow-up|0|||
129892744|NCT02065245|467567649|FG003|Infusion 3|Lost to Follow-up|0|||
129892745|NCT02065245|467567650|FG004|Infusion 3|Lost to Follow-up|0|||
129892746|NCT02065245|467567651|FG005|Infusion 3|Lost to Follow-up|0|||
129892747|NCT02065245|467567652|FG006|Infusion 3|Lost to Follow-up|0|||
129892748|NCT01518257|467567653|FG000|Overall Study|Lost to Follow-up|1|||
129892749|NCT01518257|467567654|FG001|Overall Study|Lost to Follow-up|0|||
129892750|NCT01518257|467567653|FG000|Overall Study|Other Miscellaneous Reason|1|||
129892751|NCT01518257|467567654|FG001|Overall Study|Other Miscellaneous Reason|0|||
129892752|NCT01304706|467567655|FG000|Overall Study|Adverse Event|2|||
129892753|NCT01304706|467567655|FG000|Overall Study|Lack of Efficacy|1|||
129892754|NCT01304706|467567655|FG000|Overall Study|Death|3|||
129892755|NCT01304706|467567655|FG000|Overall Study|Withdrawal by Subject|3|||
129892756|NCT01304706|467567655|FG000|Overall Study|Lost to Follow-up|7|||
129892757|NCT01304706|467567655|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
129892758|NCT00924664|467567656|FG000|Overall Study|Adverse Event|23|||
129892759|NCT00924664|467567657|FG001|Overall Study|Adverse Event|39|||
129892760|NCT00924664|467567656|FG000|Overall Study|Lack of Efficacy|10|||
129892761|NCT00924664|467567657|FG001|Overall Study|Lack of Efficacy|15|||
129892762|NCT00924664|467567656|FG000|Overall Study|Lost to Follow-up|10|||
129892763|NCT00924664|467567657|FG001|Overall Study|Lost to Follow-up|12|||
129892764|NCT00924664|467567656|FG000|Overall Study|Withdrawal by Subject|47|||
129892765|NCT00924664|467567657|FG001|Overall Study|Withdrawal by Subject|71|||
129892766|NCT00924664|467567656|FG000|Overall Study|Protocol Violation|2|||
129892767|NCT00924664|467567657|FG001|Overall Study|Protocol Violation|5|||
129892768|NCT00924664|467567656|FG000|Overall Study|Pregnancy|1|||
129892769|NCT00924664|467567657|FG001|Overall Study|Pregnancy|1|||
129892770|NCT00924664|467567656|FG000|Overall Study|Death|0|||
129892771|NCT00924664|467567657|FG001|Overall Study|Death|2|||
129892772|NCT00924664|467567656|FG000|Overall Study|Study terminated by sponsor|199|||
129892773|NCT00924664|467567657|FG001|Overall Study|Study terminated by sponsor|330|||
129892774|NCT00924664|467567656|FG000|Overall Study|Other|29|||
129892775|NCT00924664|467567657|FG001|Overall Study|Other|52|||
129892776|NCT00924664|467567656|FG000|Overall Study|Randomized but not Treated|1|||
129804288|NCT01332331|467251486|FG000|Overall Study|Adverse Event|1|||
129804289|NCT01332331|467251487|FG001|Overall Study|Adverse Event|1|||
129804290|NCT01332331|467251486|FG000|Overall Study|Physician Decision|1|||
129804291|NCT01332331|467251487|FG001|Overall Study|Physician Decision|0|||
129804292|NCT00538291|467251488|FG000|Overall Study|Adverse Event|2|||
129804293|NCT00538291|467251488|FG000|Overall Study|Withdrawal by Subject|1|||
129804294|NCT00591344|467251489|FG000|Overall Study|Transportation issues|1|||
129804295|NCT00591344|467251490|FG001|Overall Study|Transportation issues|0|||
129804296|NCT00591344|467251489|FG000|Overall Study|Moved out of state|1|||
129804297|NCT00591344|467251490|FG001|Overall Study|Moved out of state|0|||
129804298|NCT00591344|467251489|FG000|Overall Study|Medical complications|1|||
129804299|NCT00591344|467251490|FG001|Overall Study|Medical complications|3|||
129804300|NCT00591344|467251489|FG000|Overall Study|Underwent DBS|2|||
129804301|NCT00591344|467251490|FG001|Overall Study|Underwent DBS|2|||
129804302|NCT00591344|467251489|FG000|Overall Study|Death|0|||
129804303|NCT00591344|467251490|FG001|Overall Study|Death|1|||
129804304|NCT00591344|467251489|FG000|Overall Study|Lost to Follow-up|0|||
129804305|NCT00591344|467251490|FG001|Overall Study|Lost to Follow-up|1|||
129804306|NCT00591344|467251489|FG000|Overall Study|Did not want to come off medication|0|||
129804307|NCT00591344|467251490|FG001|Overall Study|Did not want to come off medication|1|||
129804308|NCT01672736|467251497|FG000|Overall Study|Available drug expired on 31 May 16|3|||
129892777|NCT00924664|467567657|FG001|Overall Study|Randomized but not Treated|0|||
129892778|NCT03158948|467567658|FG000|Overall Study|Death|1|||
129892779|NCT03158948|467567659|FG001|Overall Study|Death|1|||
129892780|NCT03158948|467567660|FG002|Overall Study|Death|3|||
129804309|NCT01262573|467251498|FG000|Overall Study|Withdrawal by Subject|0|||
129804310|NCT01262573|467251499|FG001|Overall Study|Withdrawal by Subject|1|||
129892781|NCT03158948|467567661|FG003|Overall Study|Death|2|||
129804311|NCT03800173|467251506|FG000|Overall Study|Lost to Follow-up|0|||
129804312|NCT03800173|467251507|FG001|Overall Study|Lost to Follow-up|0|||
129804313|NCT03800173|467251508|FG002|Overall Study|Lost to Follow-up|0|||
129804314|NCT03800173|467251509|FG003|Overall Study|Lost to Follow-up|0|||
129804315|NCT03800173|467251510|FG004|Overall Study|Lost to Follow-up|1|||
129804316|NCT00936611|467251511|FG000|Overall Study|Progressive Disease|3|||
129892782|NCT03158948|467567658|FG000|Overall Study|Physician Decision|0|||
129892783|NCT03158948|467567659|FG001|Overall Study|Physician Decision|0|||
129892784|NCT03158948|467567660|FG002|Overall Study|Physician Decision|0|||
129892785|NCT03158948|467567661|FG003|Overall Study|Physician Decision|1|||
129892786|NCT01876043|467567662|FG000|Overall Study|Death|1|||
129892787|NCT01876043|467567662|FG000|Overall Study|Withdrawal by Subject|1|||
129892788|NCT00079937|467567663|FG000|Overall Study|Adverse Event|2|||
129892789|NCT00079937|467567664|FG001|Overall Study|Adverse Event|1|||
129732791|NCT02305849|466980411|FG003|Overall Study|Lack of Efficacy|9|||
129732792|NCT02305849|466980408|FG000|Overall Study|Withdrawal by Subject|2|||
129732793|NCT02305849|466980409|FG001|Overall Study|Withdrawal by Subject|2|||
129732794|NCT02305849|466980410|FG002|Overall Study|Withdrawal by Subject|1|||
129732795|NCT02305849|466980411|FG003|Overall Study|Withdrawal by Subject|4|||
129732796|NCT02305849|466980408|FG000|Overall Study|Lost to Follow-up|0|||
129732797|NCT02305849|466980409|FG001|Overall Study|Lost to Follow-up|2|||
129732798|NCT02305849|466980410|FG002|Overall Study|Lost to Follow-up|0|||
129732799|NCT02305849|466980411|FG003|Overall Study|Lost to Follow-up|0|||
129732800|NCT02305849|466980408|FG000|Overall Study|Protocol Violation|3|||
129732801|NCT02305849|466980409|FG001|Overall Study|Protocol Violation|2|||
129732802|NCT02305849|466980410|FG002|Overall Study|Protocol Violation|1|||
129732803|NCT02305849|466980411|FG003|Overall Study|Protocol Violation|1|||
129732804|NCT02305849|466980408|FG000|Overall Study|Lab data met discontinuation criteria|0|||
129732805|NCT02305849|466980409|FG001|Overall Study|Lab data met discontinuation criteria|1|||
129732806|NCT02305849|466980410|FG002|Overall Study|Lab data met discontinuation criteria|2|||
129732807|NCT02305849|466980411|FG003|Overall Study|Lab data met discontinuation criteria|1|||
129732808|NCT02305849|466980408|FG000|Overall Study|Miscellaneous|1|||
129732809|NCT02305849|466980409|FG001|Overall Study|Miscellaneous|2|||
129732810|NCT02305849|466980410|FG002|Overall Study|Miscellaneous|4|||
129732811|NCT02305849|466980411|FG003|Overall Study|Miscellaneous|1|||
129732812|NCT02305849|466980408|FG000|Overall Study|Not fulfill eligibility criteria|1|||
129732813|NCT02305849|466980409|FG001|Overall Study|Not fulfill eligibility criteria|1|||
129732814|NCT02305849|466980410|FG002|Overall Study|Not fulfill eligibility criteria|0|||
129732815|NCT02305849|466980411|FG003|Overall Study|Not fulfill eligibility criteria|0|||
129732816|NCT00495521|466980417|FG000|Overall Study|Physician Decision|0|||
129732817|NCT00495521|466980418|FG001|Overall Study|Physician Decision|1|||
129732818|NCT01300819|466980419|FG000|Overall Study|Adverse Event|9|||
129732819|NCT01300819|466980420|FG001|Overall Study|Adverse Event|27|||
129732820|NCT01300819|466980419|FG000|Overall Study|Lack of Efficacy|2|||
129732821|NCT01300819|466980420|FG001|Overall Study|Lack of Efficacy|1|||
129732822|NCT01300819|466980419|FG000|Overall Study|Withdrawal by Subject|10|||
129732823|NCT01300819|466980420|FG001|Overall Study|Withdrawal by Subject|12|||
129732824|NCT01300819|466980419|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
129732825|NCT01300819|466980420|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
129732826|NCT01300819|466980419|FG000|Overall Study|Refusal to down titrate study drug|0|||
129732827|NCT01300819|466980420|FG001|Overall Study|Refusal to down titrate study drug|1|||
129732828|NCT01300819|466980419|FG000|Overall Study|Administrative reason|0|||
129732829|NCT01300819|466980420|FG001|Overall Study|Administrative reason|1|||
129732830|NCT01300819|466980419|FG000|Overall Study|Safety follow up not done by mistake|0|||
129732831|NCT01300819|466980420|FG001|Overall Study|Safety follow up not done by mistake|1|||
129732832|NCT01300819|466980419|FG000|Overall Study|Follow up call was not done|1|||
129732833|NCT01300819|466980420|FG001|Overall Study|Follow up call was not done|0|||
129732834|NCT01319721|466980421|FG000|Overall Study|Lost to Follow-up|1|||
129732835|NCT01319721|466980422|FG001|Overall Study|Lost to Follow-up|6|||
129732836|NCT00461305|466980424|FG000|Treatment|Adverse Event|26|||
129732837|NCT00461305|466980425|FG001|Treatment|Adverse Event|3|||
129732838|NCT00461305|466980424|FG000|Treatment|Lost to Follow-up|4|||
129732839|NCT00461305|466980425|FG001|Treatment|Lost to Follow-up|2|||
129732840|NCT00461305|466980424|FG000|Treatment|Protocol Violation|13|||
129732841|NCT00461305|466980425|FG001|Treatment|Protocol Violation|2|||
129732842|NCT00461305|466980424|FG000|Treatment|Withdrawal by Subject|48|||
129732843|NCT00461305|466980425|FG001|Treatment|Withdrawal by Subject|2|||
129804317|NCT00936611|467251511|FG000|Overall Study|New Systemic Therapy|22|||
129804318|NCT00936611|467251511|FG000|Overall Study|Lost to Follow-up|1|||
129804319|NCT00936611|467251511|FG000|Overall Study|Withdrawal by Subject|2|||
129804320|NCT00936611|467251511|FG000|Overall Study|Still on Follow-up|1|||
129804321|NCT00936611|467251511|FG000|Overall Study|Still on Active Therapy|7|||
129732844|NCT00461305|466980424|FG000|Treatment|Never dispensed|5|||
129732845|NCT00461305|466980425|FG001|Treatment|Never dispensed|0|||
129732846|NCT00461305|466980424|FG000|Treatment|Study drug not taken|1|||
129732847|NCT00461305|466980425|FG001|Treatment|Study drug not taken|0|||
129732848|NCT00461305|466980424|FG000|Treatment|Partially missing diary|2|||
129732849|NCT00461305|466980425|FG001|Treatment|Partially missing diary|0|||
129804322|NCT00936611|467251511|FG000|Overall Study|Ineligible for Study Drug|3|||
129732850|NCT00461305|466980424|FG000|Treatment|Other (missing drug etc)|2|||
129732851|NCT00461305|466980425|FG001|Treatment|Other (missing drug etc)|0|||
129732852|NCT00461305|466980424|FG000|Continued Treatment|Adverse Event|26|||
129732853|NCT00461305|466980425|FG001|Continued Treatment|Adverse Event|0|||
129732854|NCT00461305|466980424|FG000|Continued Treatment|Lost to Follow-up|4|||
129732855|NCT00461305|466980425|FG001|Continued Treatment|Lost to Follow-up|0|||
129804323|NCT02507973|467251512|FG000|Overall Study|Adverse Event|1|||
129732856|NCT00461305|466980424|FG000|Continued Treatment|Protocol Violation|13|||
129804324|NCT02081183|467251514|FG000|Overall Study|Lost to Follow-up|0|||
129732857|NCT00461305|466980425|FG001|Continued Treatment|Protocol Violation|0|||
129732858|NCT00461305|466980424|FG000|Continued Treatment|Withdrawal by Subject|48|||
129732859|NCT00461305|466980425|FG001|Continued Treatment|Withdrawal by Subject|0|||
129444509|NCT03672461|465927366|FG001|Overall Study|Too Busy|1|||
129732860|NCT00461305|466980424|FG000|Continued Treatment|Partially missing diary|2|||
129732861|NCT00461305|466980425|FG001|Continued Treatment|Partially missing diary|0|||
129732862|NCT00461305|466980424|FG000|Continued Treatment|Other (missing drug etc)|2|||
129444510|NCT03672461|465927365|FG000|Overall Study|Lost to Follow-up|1|||
129444511|NCT03672461|465927366|FG001|Overall Study|Lost to Follow-up|2|||
129444512|NCT03672461|465927365|FG000|Overall Study|Family|2|||
129444513|NCT03672461|465927366|FG001|Overall Study|Family|2|||
129444514|NCT03672461|465927365|FG000|Overall Study|No remote technology access|0|||
129444515|NCT03672461|465927366|FG001|Overall Study|No remote technology access|1|||
129444516|NCT03672461|465927365|FG000|Overall Study|Withdrawal by Subject|1|||
129444517|NCT03672461|465927366|FG001|Overall Study|Withdrawal by Subject|0|||
129444518|NCT03672461|465927365|FG000|Overall Study|Cannot tolerate intervention|1|||
129444519|NCT03672461|465927366|FG001|Overall Study|Cannot tolerate intervention|0|||
129444520|NCT03672461|465927365|FG000|Overall Study|Incomplete outcome data|6|||
129444521|NCT03672461|465927366|FG001|Overall Study|Incomplete outcome data|1|||
129444522|NCT07052682|465927367|FG000|Overall Study|Withdrawal by Subject|4|||
129732863|NCT00461305|466980425|FG001|Continued Treatment|Other (missing drug etc)|0|||
129732864|NCT00787930|466980430|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
129732865|NCT01896271|466980431|FG000|Overall Study|Physician Decision|10|||
129732866|NCT02091284|466982537|FG000|Overall Study|Withdrawal by Subject|2|||
129732867|NCT02091284|466982538|FG001|Overall Study|Withdrawal by Subject|1|||
129732868|NCT02091284|466982537|FG000|Overall Study|unreliable data|1|||
129732869|NCT02091284|466982538|FG001|Overall Study|unreliable data|0|||
129732870|NCT03383783|466982539|FG000|Overall Study|Withdrawal by Subject|2|||
129732871|NCT01340937|466982540|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
129732872|NCT01340937|466982541|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
129732873|NCT01340937|466982542|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
129732874|NCT01340937|466982543|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
129732875|NCT01340937|466982540|FG000|Period 1: Infant Series|Adverse Event|0|||
129732876|NCT01340937|466982541|FG001|Period 1: Infant Series|Adverse Event|1|||
129732877|NCT01340937|466982542|FG002|Period 1: Infant Series|Adverse Event|4|||
129732878|NCT01340937|466982543|FG003|Period 1: Infant Series|Adverse Event|0|||
129732879|NCT01340937|466982540|FG000|Period 1: Infant Series|Death|2|||
129732880|NCT01340937|466982541|FG001|Period 1: Infant Series|Death|0|||
129732881|NCT01340937|466982542|FG002|Period 1: Infant Series|Death|2|||
129732882|NCT01340937|466982543|FG003|Period 1: Infant Series|Death|0|||
129804325|NCT02081183|467251515|FG001|Overall Study|Lost to Follow-up|1|||
129804326|NCT02081183|467251514|FG000|Overall Study|Protocol Violation|1|||
129804327|NCT02081183|467251515|FG001|Overall Study|Protocol Violation|0|||
129804328|NCT02081183|467251514|FG000|Overall Study|Other|3|||
129804329|NCT02081183|467251515|FG001|Overall Study|Other|3|||
129804330|NCT00910273|467251520|FG000|Overall Study|Lack of Efficacy|6|||
129804331|NCT00910273|467251521|FG001|Overall Study|Lack of Efficacy|9|||
129804332|NCT00910273|467251520|FG000|Overall Study|Adverse Event|1|||
129804333|NCT00910273|467251521|FG001|Overall Study|Adverse Event|1|||
129804334|NCT00910273|467251520|FG000|Overall Study|Withdrawal by Subject|1|||
129804335|NCT00910273|467251521|FG001|Overall Study|Withdrawal by Subject|0|||
129804336|NCT00910273|467251520|FG000|Overall Study|Discontinuation of study by sponsor|8|||
129804337|NCT00910273|467251521|FG001|Overall Study|Discontinuation of study by sponsor|2|||
129804338|NCT00910273|467251520|FG000|Overall Study|Protocol Violation|1|||
129804339|NCT00910273|467251521|FG001|Overall Study|Protocol Violation|0|||
129892790|NCT00079937|467567663|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129892791|NCT00079937|467567664|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129892792|NCT00079937|467567663|FG000|Overall Study|Subject no longer requires study drug|3|||
129892793|NCT00079937|467567664|FG001|Overall Study|Subject no longer requires study drug|0|||
129892794|NCT00079937|467567663|FG000|Overall Study|Protocol Violation|8|||
129444523|NCT04667247|465927368|FG000|Overall Study|Withdrawal by Subject|0|||
129444524|NCT04667247|465927369|FG001|Overall Study|Withdrawal by Subject|1|||
129444525|NCT00385203|465929364|FG000|Overall Study|Adverse Event|5|||
129444526|NCT00385203|465929365|FG001|Overall Study|Adverse Event|4|||
129444527|NCT00385203|465929364|FG000|Overall Study|Death|1|||
129444528|NCT00385203|465929365|FG001|Overall Study|Death|0|||
129444529|NCT00385203|465929364|FG000|Overall Study|Condition under investigation worsened|18|||
129732883|NCT01340937|466982540|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
129804340|NCT00910273|467251520|FG000|Overall Study|Lost to Follow-up|1|||
129732884|NCT01340937|466982541|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
129732885|NCT01340937|466982542|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
129732886|NCT01340937|466982543|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
129732887|NCT01340937|466982540|FG000|Period 1: Infant Series|Physician Decision|2|||
129732888|NCT01340937|466982541|FG001|Period 1: Infant Series|Physician Decision|3|||
129732889|NCT01340937|466982542|FG002|Period 1: Infant Series|Physician Decision|1|||
129732890|NCT01340937|466982543|FG003|Period 1: Infant Series|Physician Decision|0|||
129732891|NCT01340937|466982540|FG000|Period 1: Infant Series|Protocol Violation|1|||
129732892|NCT01340937|466982541|FG001|Period 1: Infant Series|Protocol Violation|4|||
129804341|NCT00910273|467251521|FG001|Overall Study|Lost to Follow-up|1|||
129804342|NCT01011738|467251522|FG000|Overall Study|Death|12|||
129804343|NCT01011738|467251523|FG001|Overall Study|Death|3|||
129804344|NCT01011738|467251524|FG002|Overall Study|Death|0|||
129804345|NCT01011738|467251522|FG000|Overall Study|Unknown reasons|312|||
129804346|NCT01011738|467251523|FG001|Overall Study|Unknown reasons|291|||
129804347|NCT01011738|467251524|FG002|Overall Study|Unknown reasons|17|||
129804348|NCT03841448|467251525|FG000|Double-blind Treatment (DBT) Period|Death|1|||
129804349|NCT03841448|467251526|FG001|Double-blind Treatment (DBT) Period|Death|1|||
129804350|NCT03841448|467251527|FG002|Double-blind Treatment (DBT) Period|Death|0|||
129804351|NCT03841448|467251528|FG003|Double-blind Treatment (DBT) Period|Death|0|||
129804352|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
129804353|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
129804354|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
129804355|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
129804356|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Death|0|||
129804357|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Death|0|||
129804358|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Death|0|||
129804359|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Death|1|||
129804360|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
129804361|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
129732893|NCT01340937|466982542|FG002|Period 1: Infant Series|Protocol Violation|4|||
129732894|NCT01340937|466982543|FG003|Period 1: Infant Series|Protocol Violation|3|||
129732895|NCT01340937|466982540|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
129732896|NCT01340937|466982541|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
129732897|NCT01340937|466982542|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
129732898|NCT01340937|466982543|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
129732899|NCT01340937|466982540|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
129732900|NCT01340937|466982541|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
129732901|NCT01340937|466982542|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
129732902|NCT01340937|466982543|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
129732903|NCT01340937|466982540|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
129732904|NCT01340937|466982541|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
129732905|NCT01340937|466982542|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
129732906|NCT01340937|466982543|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
129732907|NCT01340937|466982540|FG000|Period 2: Interim Period|Adverse Event|1|||
129732908|NCT01340937|466982541|FG001|Period 2: Interim Period|Adverse Event|0|||
129732909|NCT01340937|466982542|FG002|Period 2: Interim Period|Adverse Event|1|||
129732910|NCT01340937|466982543|FG003|Period 2: Interim Period|Adverse Event|0|||
129732911|NCT01340937|466982540|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
129732912|NCT01340937|466982541|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
129732913|NCT01340937|466982542|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
129732914|NCT01340937|466982543|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
129732915|NCT01340937|466982540|FG000|Period 2: Interim Period|Physician Decision|0|||
129732916|NCT01340937|466982541|FG001|Period 2: Interim Period|Physician Decision|1|||
129732917|NCT01340937|466982542|FG002|Period 2: Interim Period|Physician Decision|1|||
129732918|NCT01340937|466982543|FG003|Period 2: Interim Period|Physician Decision|0|||
129732919|NCT01340937|466982540|FG000|Period 2: Interim Period|Protocol Violation|5|||
129732920|NCT01340937|466982541|FG001|Period 2: Interim Period|Protocol Violation|3|||
129732921|NCT01340937|466982542|FG002|Period 2: Interim Period|Protocol Violation|6|||
129732922|NCT01340937|466982543|FG003|Period 2: Interim Period|Protocol Violation|3|||
129732923|NCT01340937|466982540|FG000|Period 2: Interim Period|Technical problems|4|||
129732924|NCT01340937|466982541|FG001|Period 2: Interim Period|Technical problems|4|||
129732925|NCT01340937|466982542|FG002|Period 2: Interim Period|Technical problems|6|||
129732926|NCT01340937|466982543|FG003|Period 2: Interim Period|Technical problems|3|||
129732927|NCT01340937|466982540|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
129732928|NCT01340937|466982541|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
129892795|NCT00079937|467567664|FG001|Overall Study|Protocol Violation|6|||
129732929|NCT01340937|466982542|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
129732930|NCT01340937|466982543|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
129732931|NCT01340937|466982540|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
129732932|NCT01340937|466982541|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
129892796|NCT00079937|467567663|FG000|Overall Study|Withdrawal by Subject|21|||
129892797|NCT00079937|467567664|FG001|Overall Study|Withdrawal by Subject|7|||
129892798|NCT00079937|467567663|FG000|Overall Study|Lost to Follow-up|12|||
129892799|NCT00079937|467567664|FG001|Overall Study|Lost to Follow-up|5|||
129892800|NCT00079937|467567663|FG000|Overall Study|Administrative problems|22|||
129892801|NCT00079937|467567664|FG001|Overall Study|Administrative problems|11|||
129892802|NCT01616563|467567665|FG000|Overall Study|Lost to Follow-up|40|||
129892803|NCT02206685|467567666|FG000|Overall Study|Surgery cancelled/changed|2|||
129892804|NCT02206685|467567667|FG001|Overall Study|Surgery cancelled/changed|3|||
129892805|NCT02206685|467567666|FG000|Overall Study|Withdrawal by Subject|1|||
129892806|NCT02206685|467567667|FG001|Overall Study|Withdrawal by Subject|2|||
129892807|NCT02206685|467567666|FG000|Overall Study|Protocol Violation|2|||
129892808|NCT02206685|467567667|FG001|Overall Study|Protocol Violation|2|||
129892809|NCT01195675|467567671|FG000|Overall Study|Adverse Event|1|||
129892810|NCT01195675|467567671|FG000|Overall Study|Withdrawal by Subject|2|||
129892811|NCT01106287|467567672|FG000|Overall Study|Adverse Event|1|||
129892812|NCT01106287|467567673|FG001|Overall Study|Adverse Event|0|||
129892813|NCT01106287|467567674|FG002|Overall Study|Adverse Event|0|||
129892814|NCT01106287|467567675|FG003|Overall Study|Adverse Event|0|||
129892815|NCT00072475|467567676|FG000|Overall Study|Adverse Event|44|||
129892816|NCT00072475|467567676|FG000|Overall Study|Death|3|||
129892817|NCT00072475|467567676|FG000|Overall Study|Withdrawal by Subject|46|||
129892818|NCT00072475|467567676|FG000|Overall Study|Patient/Investigator Decision|4|||
129892819|NCT04730947|467567677|FG000|Overall Study|Withdrawal by Subject|0|||
129892820|NCT04730947|467567678|FG001|Overall Study|Withdrawal by Subject|1|||
129892821|NCT00940017|467567679|FG000|Overall Study|did not meet entrance criteria|3|||
129892822|NCT00940017|467567679|FG000|Overall Study|Adverse Event|1|||
129892823|NCT01450943|467567680|FG000|Overall Study|Screen failure, loss to follow-up|2|||
129892824|NCT01450943|467567681|FG001|Overall Study|Screen failure, loss to follow-up|7|||
129444530|NCT00385203|465929365|FG001|Overall Study|Condition under investigation worsened|3|||
129444531|NCT00385203|465929364|FG000|Overall Study|Incorrect enrollment|2|||
129444532|NCT00385203|465929365|FG001|Overall Study|Incorrect enrollment|0|||
129444533|NCT00404066|465929366|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
129444534|NCT00404066|465929366|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
129444535|NCT00698451|465929373|FG000|Overall Study|Adverse Event|22|||
129444536|NCT00698451|465929373|FG000|Overall Study|Physician Decision|2|||
129444537|NCT00698451|465929373|FG000|Overall Study|Protocol Violation|6|||
129444538|NCT00698451|465929373|FG000|Overall Study|Withdrawal by Subject|6|||
129444539|NCT00698451|465929373|FG000|Overall Study|Disease progression|3|||
129444540|NCT02224599|465929374|FG000|Overall Study|Physician Decision|1|||
129444541|NCT02224599|465929374|FG000|Overall Study|Progression of Disease|1|||
129444542|NCT00733304|465929375|FG000|Overall Study|Adverse Event|3|||
129444543|NCT00733304|465929376|FG001|Overall Study|Adverse Event|0|||
129444544|NCT00733304|465929377|FG002|Overall Study|Adverse Event|0|||
129444545|NCT00733304|465929375|FG000|Overall Study|Lack of Efficacy|0|||
129444546|NCT00733304|465929376|FG001|Overall Study|Lack of Efficacy|0|||
129444547|NCT00733304|465929377|FG002|Overall Study|Lack of Efficacy|2|||
129444548|NCT00733304|465929375|FG000|Overall Study|Lost to Follow-up|0|||
129444549|NCT00733304|465929376|FG001|Overall Study|Lost to Follow-up|1|||
129444550|NCT00733304|465929377|FG002|Overall Study|Lost to Follow-up|0|||
129444551|NCT00733304|465929375|FG000|Overall Study|Physician Decision|3|||
129444552|NCT00733304|465929376|FG001|Overall Study|Physician Decision|1|||
129804362|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
129804363|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
129804364|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
129804365|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
129804366|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
129804367|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
129804368|NCT03841448|467251525|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
129804369|NCT03841448|467251526|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
129804370|NCT03841448|467251527|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
129804371|NCT03841448|467251528|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
129444553|NCT00733304|465929377|FG002|Overall Study|Physician Decision|3|||
129732933|NCT01340937|466982542|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
129732934|NCT01340937|466982543|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
129732935|NCT01340937|466982540|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129804372|NCT00543543|467251529|FG000|Base Study|Adverse Event|1|||
129804373|NCT00543543|467251530|FG001|Base Study|Adverse Event|11|||
129804374|NCT00543543|467251531|FG002|Base Study|Adverse Event|0|||
129892825|NCT01450943|467567682|FG002|Overall Study|Screen failure, loss to follow-up|6|||
129892826|NCT01097655|467567685|FG000|Overall Study|Withdrawal by Subject|1|||
129892827|NCT01097655|467567685|FG000|Overall Study|Subject Documented Twice|1|||
129444554|NCT00733304|465929375|FG000|Overall Study|Withdrawal by Subject|1|||
129444555|NCT00733304|465929376|FG001|Overall Study|Withdrawal by Subject|1|||
129444556|NCT00733304|465929377|FG002|Overall Study|Withdrawal by Subject|0|||
129444557|NCT03155373|465929378|FG000|Overall Study|No longer required surgery|1|||
129444558|NCT03155373|465929378|FG000|Overall Study|Protocol Violation|1|||
129444559|NCT03155373|465929378|FG000|Overall Study|Death|2|||
129732936|NCT01340937|466982541|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129732937|NCT01340937|466982542|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
129732938|NCT01340937|466982543|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
129732939|NCT01340937|466982540|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
129732940|NCT01340937|466982541|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
129732941|NCT01340937|466982542|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
129732942|NCT01340937|466982543|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
129732943|NCT02119156|466982544|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
129732944|NCT02119156|466982545|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
129732945|NCT02119156|466982546|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
129732946|NCT02119156|466982544|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
129732947|NCT02119156|466982545|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
129732948|NCT02119156|466982546|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
129732949|NCT02119156|466982544|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
129732950|NCT02119156|466982545|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
129732951|NCT02119156|466982546|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
129732952|NCT02119156|466982544|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
129732953|NCT02119156|466982545|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
129732954|NCT02119156|466982546|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
129732955|NCT02119156|466982544|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
129732956|NCT02119156|466982545|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
129444560|NCT03155373|465929378|FG000|Overall Study|Withdrawal by Subject|3|||
129444561|NCT00596934|465929381|FG000|Overall Study|Protocol Violation|1|||
129444562|NCT00596934|465929381|FG000|Overall Study|Withdrawal by Subject|1|||
129444563|NCT01214187|465929382|FG000|Overall Study|Adverse Event|6|||
129444564|NCT01214187|465929383|FG001|Overall Study|Adverse Event|2|||
129732957|NCT02119156|466982546|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
129732958|NCT02469415|466982547|FG000|Overall Study|Withdrawal by Subject|1|||
129732959|NCT02469415|466982547|FG000|Overall Study|Investigational agent placed on hold|2|||
129732960|NCT00350623|466982550|FG000|Overall Study|Lost to Follow-up|8|||
129804375|NCT00543543|467251532|FG003|Base Study|Adverse Event|5|||
129804376|NCT00543543|467251529|FG000|Base Study|Lost to Follow-up|12|||
129804377|NCT00543543|467251530|FG001|Base Study|Lost to Follow-up|749|||
129804378|NCT00543543|467251531|FG002|Base Study|Lost to Follow-up|9|||
129804379|NCT00543543|467251532|FG003|Base Study|Lost to Follow-up|701|||
129804380|NCT00543543|467251529|FG000|Base Study|Physician Decision|0|||
129804381|NCT00543543|467251530|FG001|Base Study|Physician Decision|4|||
129804382|NCT00543543|467251531|FG002|Base Study|Physician Decision|0|||
129732961|NCT00350623|466982551|FG001|Overall Study|Lost to Follow-up|3|||
129732962|NCT00350623|466982552|FG002|Overall Study|Lost to Follow-up|4|||
129732963|NCT00350623|466982550|FG000|Overall Study|Withdrawal by Subject|0|||
129732964|NCT00350623|466982551|FG001|Overall Study|Withdrawal by Subject|1|||
129732965|NCT00350623|466982552|FG002|Overall Study|Withdrawal by Subject|1|||
129732966|NCT00350623|466982550|FG000|Overall Study|patient traveling outside the country|0|||
129732967|NCT00350623|466982551|FG001|Overall Study|patient traveling outside the country|0|||
129732968|NCT00350623|466982552|FG002|Overall Study|patient traveling outside the country|1|||
129732969|NCT02685748|466982553|FG000|Overall Study|Withdrawal by Subject|3|||
129732970|NCT02685748|466982554|FG001|Overall Study|Withdrawal by Subject|2|||
129732971|NCT04126564|466982555|FG000|Overall Study|Withdrawal by Subject|0|||
129732972|NCT04126564|466982556|FG001|Overall Study|Withdrawal by Subject|2|||
129732973|NCT04126564|466982555|FG000|Overall Study|Lost to Follow-up|0|||
129732974|NCT04126564|466982556|FG001|Overall Study|Lost to Follow-up|1|||
129732975|NCT03500172|466982557|FG000|Period 1: Baseline Randomization|Death|0|||
129732976|NCT03500172|466982558|FG001|Period 1: Baseline Randomization|Death|0|||
129732977|NCT03500172|466982559|FG002|Period 1: Baseline Randomization|Death|0|||
129732978|NCT03500172|466982560|FG003|Period 1: Baseline Randomization|Death|0|||
129732979|NCT03500172|466982561|FG004|Period 1: Baseline Randomization|Death|0|||
129732980|NCT03500172|466982562|FG005|Period 1: Baseline Randomization|Death|0|||
129732981|NCT03500172|466982563|FG006|Period 1: Baseline Randomization|Death|0|||
129804383|NCT00543543|467251532|FG003|Base Study|Physician Decision|7|||
129444565|NCT01214187|465929382|FG000|Overall Study|Death|1|||
129892828|NCT01097655|467567685|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
129892829|NCT01345292|467567686|FG000|Overall Study|Withdrawal by Subject|2|||
129892830|NCT01345292|467567687|FG001|Overall Study|Withdrawal by Subject|0|||
129892831|NCT01345292|467567688|FG002|Overall Study|Withdrawal by Subject|1|||
129892832|NCT03303105|467567690|FG000|Overall Study|Adverse Event|0|||
129892833|NCT03303105|467567691|FG001|Overall Study|Adverse Event|2|||
129892834|NCT03303105|467567690|FG000|Overall Study|Lack of Efficacy|1|||
129892835|NCT03303105|467567691|FG001|Overall Study|Lack of Efficacy|0|||
129892836|NCT03303105|467567690|FG000|Overall Study|Protocol Violation|1|||
129892837|NCT03303105|467567691|FG001|Overall Study|Protocol Violation|0|||
129892838|NCT03303105|467567690|FG000|Overall Study|Withdrawal by Subject|0|||
129892839|NCT03303105|467567691|FG001|Overall Study|Withdrawal by Subject|2|||
129892840|NCT04822298|467567692|FG000|Overall Study|Death|3|||
129892841|NCT00852475|467567701|FG000|Overall Study|Lost to Follow-up|3|||
129892842|NCT00852475|467567702|FG001|Overall Study|Lost to Follow-up|4|||
129892843|NCT00515086|467567703|FG000|Overall Study|Adverse Event|1|||
129732982|NCT03500172|466982564|FG007|Period 1: Baseline Randomization|Death|0|||
129732983|NCT03500172|466982565|FG008|Period 1: Baseline Randomization|Death|0|||
129732984|NCT03500172|466982566|FG009|Period 1: Baseline Randomization|Death|2|||
129732985|NCT03500172|466982567|FG010|Period 1: Baseline Randomization|Death|0|||
129732986|NCT03500172|466982557|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
129732987|NCT03500172|466982558|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
129732988|NCT03500172|466982559|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
129732989|NCT03500172|466982560|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
129732990|NCT03500172|466982561|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
129732991|NCT03500172|466982562|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
129732992|NCT03500172|466982563|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
129732993|NCT03500172|466982564|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
129732994|NCT03500172|466982565|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
129732995|NCT03500172|466982566|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
129732996|NCT03500172|466982567|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
129732997|NCT03500172|466982557|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
129732998|NCT03500172|466982558|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
129732999|NCT03500172|466982559|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
129733000|NCT03500172|466982560|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
129733001|NCT03500172|466982561|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
129733002|NCT03500172|466982562|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
129733003|NCT03500172|466982563|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
129733004|NCT03500172|466982564|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
129733005|NCT03500172|466982565|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
129733006|NCT03500172|466982566|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
129733007|NCT03500172|466982567|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
129733008|NCT03500172|466982557|FG000|Period 2: Re-Randomization|Death|0|||
129733009|NCT03500172|466982558|FG001|Period 2: Re-Randomization|Death|0|||
129733010|NCT03500172|466982559|FG002|Period 2: Re-Randomization|Death|0|||
129733011|NCT03500172|466982560|FG003|Period 2: Re-Randomization|Death|4|||
129733012|NCT03500172|466982561|FG004|Period 2: Re-Randomization|Death|2|||
129733013|NCT03500172|466982562|FG005|Period 2: Re-Randomization|Death|0|||
129733014|NCT03500172|466982563|FG006|Period 2: Re-Randomization|Death|5|||
129733015|NCT03500172|466982564|FG007|Period 2: Re-Randomization|Death|2|||
129733016|NCT03500172|466982565|FG008|Period 2: Re-Randomization|Death|0|||
129733017|NCT03500172|466982566|FG009|Period 2: Re-Randomization|Death|0|||
129733018|NCT03500172|466982567|FG010|Period 2: Re-Randomization|Death|0|||
129733019|NCT01974752|466982570|FG000|Overall Study|Death|33|||
129892844|NCT00515086|467567704|FG001|Overall Study|Adverse Event|1|||
129892845|NCT00515086|467567705|FG002|Overall Study|Adverse Event|2|||
129892846|NCT00515086|467567706|FG003|Overall Study|Adverse Event|3|||
129892847|NCT00515086|467567703|FG000|Overall Study|Administrative|1|||
129892848|NCT00515086|467567704|FG001|Overall Study|Administrative|1|||
129892849|NCT00515086|467567705|FG002|Overall Study|Administrative|0|||
129892850|NCT00515086|467567706|FG003|Overall Study|Administrative|0|||
129892851|NCT00515086|467567703|FG000|Overall Study|Withdrawal by Subject|1|||
129733020|NCT01974752|466982571|FG001|Overall Study|Death|11|||
129733021|NCT01974752|466982570|FG000|Overall Study|Lost to Follow-up|2|||
129733022|NCT01974752|466982571|FG001|Overall Study|Lost to Follow-up|0|||
129733023|NCT01974752|466982570|FG000|Overall Study|Withdrawal by Subject|2|||
129733024|NCT01974752|466982571|FG001|Overall Study|Withdrawal by Subject|3|||
129733025|NCT01974752|466982570|FG000|Overall Study|Other Eligibility Criteria|0|||
129733026|NCT01974752|466982571|FG001|Overall Study|Other Eligibility Criteria|1|||
129733027|NCT02435680|466982573|FG000|Overall Study|Physician Decision|3|||
129733028|NCT02435680|466982574|FG001|Overall Study|Physician Decision|0|||
129733029|NCT02435680|466982575|FG002|Overall Study|Physician Decision|0|||
129892852|NCT00515086|467567704|FG001|Overall Study|Withdrawal by Subject|0|||
129892853|NCT00515086|467567705|FG002|Overall Study|Withdrawal by Subject|0|||
129733030|NCT02435680|466982573|FG000|Overall Study|subject / guardian decision|0|||
129804384|NCT00543543|467251529|FG000|Base Study|Protocol Violation|0|||
129804385|NCT00543543|467251530|FG001|Base Study|Protocol Violation|6|||
129804386|NCT00543543|467251531|FG002|Base Study|Protocol Violation|0|||
129804387|NCT00543543|467251532|FG003|Base Study|Protocol Violation|6|||
129804388|NCT00543543|467251529|FG000|Base Study|Withdrawal by Subject|7|||
129804389|NCT00543543|467251530|FG001|Base Study|Withdrawal by Subject|482|||
129804390|NCT00543543|467251531|FG002|Base Study|Withdrawal by Subject|5|||
129804391|NCT00543543|467251532|FG003|Base Study|Withdrawal by Subject|503|||
129804392|NCT00543543|467251529|FG000|Extension Study|Adverse Event|0|||
129804393|NCT00543543|467251530|FG001|Extension Study|Adverse Event|0|||
129804394|NCT00543543|467251531|FG002|Extension Study|Adverse Event|0|||
129804395|NCT00543543|467251532|FG003|Extension Study|Adverse Event|5|||
129892854|NCT00515086|467567706|FG003|Overall Study|Withdrawal by Subject|1|||
129892855|NCT00515086|467567703|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
129804396|NCT00543543|467251529|FG000|Extension Study|Lost to Follow-up|0|||
129804397|NCT00543543|467251530|FG001|Extension Study|Lost to Follow-up|0|||
129804398|NCT00543543|467251531|FG002|Extension Study|Lost to Follow-up|0|||
129892856|NCT00515086|467567704|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129804399|NCT00543543|467251532|FG003|Extension Study|Lost to Follow-up|77|||
129804400|NCT00543543|467251529|FG000|Extension Study|Physician Decision|0|||
129733031|NCT02435680|466982574|FG001|Overall Study|subject / guardian decision|3|||
129733032|NCT02435680|466982575|FG002|Overall Study|subject / guardian decision|2|||
129733033|NCT02435680|466982573|FG000|Overall Study|Adverse Event|8|||
129733034|NCT02435680|466982574|FG001|Overall Study|Adverse Event|3|||
129733035|NCT02435680|466982575|FG002|Overall Study|Adverse Event|2|||
129733036|NCT02435680|466982573|FG000|Overall Study|progressive disease|10|||
129733037|NCT02435680|466982574|FG001|Overall Study|progressive disease|7|||
129733038|NCT02435680|466982575|FG002|Overall Study|progressive disease|11|||
129733039|NCT02435680|466982573|FG000|Overall Study|not treated|0|||
129733040|NCT02435680|466982574|FG001|Overall Study|not treated|0|||
129733041|NCT02435680|466982575|FG002|Overall Study|not treated|1|||
129444566|NCT01214187|465929383|FG001|Overall Study|Death|1|||
129733042|NCT00330928|466982578|FG000|Overall Study|Lost to Follow-up|6|||
129733043|NCT00330928|466982578|FG000|Overall Study|Physician Decision|9|||
129733044|NCT00330928|466982578|FG000|Overall Study|Death|1|||
129733045|NCT00330928|466982578|FG000|Overall Study|IVUS could not be performed.|1|||
129733046|NCT03028480|466982579|FG000|Overall Study|No revisit after the first prescription date|2|||
129444567|NCT01214187|465929382|FG000|Overall Study|Withdrawal by Subject|0|||
129444568|NCT01214187|465929383|FG001|Overall Study|Withdrawal by Subject|3|||
129444569|NCT02308007|465929387|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
129444570|NCT02308007|465929388|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
129444571|NCT02308007|465929389|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
129444572|NCT02308007|465929387|FG000|Overall Study|Positive for STD at Baseline|7|||
129444573|NCT02308007|465929388|FG001|Overall Study|Positive for STD at Baseline|11|||
129444574|NCT02308007|465929389|FG002|Overall Study|Positive for STD at Baseline|7|||
129444575|NCT02308007|465929387|FG000|Overall Study|Lost to Follow-up|3|||
129444576|NCT02308007|465929388|FG001|Overall Study|Lost to Follow-up|0|||
129444577|NCT02308007|465929389|FG002|Overall Study|Lost to Follow-up|1|||
129444578|NCT03678103|465929390|FG000|Overall Study|Withdrawn prior to completion|4|||
129444579|NCT01241552|465929395|FG000|Overall Study|Lack of Efficacy|1|||
129444580|NCT01241552|465929396|FG001|Overall Study|Lack of Efficacy|0|||
129444581|NCT01241552|465929397|FG002|Overall Study|Lack of Efficacy|0|||
129444582|NCT01241552|465929398|FG003|Overall Study|Lack of Efficacy|0|||
129444583|NCT01241552|465929395|FG000|Overall Study|Death|26|||
129444584|NCT01241552|465929396|FG001|Overall Study|Death|30|||
129444585|NCT01241552|465929397|FG002|Overall Study|Death|20|||
129444586|NCT01241552|465929398|FG003|Overall Study|Death|25|||
129444587|NCT01241552|465929395|FG000|Overall Study|Adverse Event|1|||
129444588|NCT01241552|465929396|FG001|Overall Study|Adverse Event|1|||
129444589|NCT01241552|465929397|FG002|Overall Study|Adverse Event|0|||
129444590|NCT01241552|465929398|FG003|Overall Study|Adverse Event|0|||
129444591|NCT01241552|465929395|FG000|Overall Study|Technical Problems|2|||
129444592|NCT01241552|465929396|FG001|Overall Study|Technical Problems|0|||
129444593|NCT01241552|465929397|FG002|Overall Study|Technical Problems|2|||
129444594|NCT01241552|465929398|FG003|Overall Study|Technical Problems|2|||
129444595|NCT01241552|465929395|FG000|Overall Study|Progressive Disease|0|||
129444596|NCT01241552|465929396|FG001|Overall Study|Progressive Disease|0|||
129444597|NCT01241552|465929397|FG002|Overall Study|Progressive Disease|1|||
129444598|NCT01241552|465929398|FG003|Overall Study|Progressive Disease|2|||
129444599|NCT01241552|465929395|FG000|Overall Study|Protocol Violation|0|||
129444600|NCT01241552|465929396|FG001|Overall Study|Protocol Violation|2|||
129444601|NCT01241552|465929397|FG002|Overall Study|Protocol Violation|6|||
129444602|NCT01241552|465929398|FG003|Overall Study|Protocol Violation|1|||
129444603|NCT01241552|465929395|FG000|Overall Study|Withdrawal by Subject|7|||
129444604|NCT01241552|465929396|FG001|Overall Study|Withdrawal by Subject|15|||
129444605|NCT01241552|465929397|FG002|Overall Study|Withdrawal by Subject|14|||
129444606|NCT01241552|465929398|FG003|Overall Study|Withdrawal by Subject|15|||
129444607|NCT01241552|465929395|FG000|Overall Study|Physician Decision|2|||
129444608|NCT01241552|465929396|FG001|Overall Study|Physician Decision|4|||
129444609|NCT01241552|465929397|FG002|Overall Study|Physician Decision|2|||
129444610|NCT01241552|465929398|FG003|Overall Study|Physician Decision|3|||
129444611|NCT01241552|465929395|FG000|Overall Study|Lost to Follow-up|2|||
129444612|NCT01241552|465929396|FG001|Overall Study|Lost to Follow-up|11|||
129444613|NCT01241552|465929397|FG002|Overall Study|Lost to Follow-up|15|||
129444614|NCT01241552|465929398|FG003|Overall Study|Lost to Follow-up|16|||
129444615|NCT00528567|465929399|FG000|Overall Study|Death|4|||
129444616|NCT00528567|465929400|FG001|Overall Study|Death|5|||
129733047|NCT03028480|466982579|FG000|Overall Study|Did not use the drug|1|||
129733048|NCT03028480|466982579|FG000|Overall Study|Violation of the enrollment deadline|10|||
129733049|NCT03028480|466982579|FG000|Overall Study|Case report forms were not collected|21|||
129733050|NCT02279719|466982582|FG000|Overall Study|Patients randomized but never treated|0|||
129733051|NCT02279719|466982583|FG001|Overall Study|Patients randomized but never treated|0|||
129733052|NCT02279719|466982584|FG002|Overall Study|Patients randomized but never treated|0|||
129733053|NCT02279719|466982585|FG003|Overall Study|Patients randomized but never treated|0|||
129733054|NCT02279719|466982586|FG004|Overall Study|Patients randomized but never treated|3|||
129733055|NCT02279719|466982587|FG005|Overall Study|Patients randomized but never treated|0|||
129733056|NCT02279719|466982588|FG006|Overall Study|Patients randomized but never treated|3|||
129733057|NCT03541187|466982589|FG000|Overall Study|Lost to Follow-up|2|||
129733058|NCT03541187|466982590|FG001|Overall Study|Lost to Follow-up|6|||
129733059|NCT03541187|466982589|FG000|Overall Study|Pregnancy|0|||
129733060|NCT03541187|466982590|FG001|Overall Study|Pregnancy|1|||
129733061|NCT03541187|466982589|FG000|Overall Study|Withdrawal by Subject|6|||
129804401|NCT00543543|467251530|FG001|Extension Study|Physician Decision|0|||
129804402|NCT00543543|467251531|FG002|Extension Study|Physician Decision|0|||
129804403|NCT00543543|467251532|FG003|Extension Study|Physician Decision|7|||
129444617|NCT00528567|465929399|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
129444618|NCT00528567|465929400|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
129733062|NCT03541187|466982590|FG001|Overall Study|Withdrawal by Subject|2|||
129444619|NCT00528567|465929399|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
129444620|NCT00528567|465929400|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
129444621|NCT00528567|465929399|FG000|Overall Study|Violation Criteria at Entry|3|||
129444622|NCT00528567|465929400|FG001|Overall Study|Violation Criteria at Entry|17|||
129733063|NCT03541187|466982589|FG000|Overall Study|Moved out of town|1|||
129444623|NCT00528567|465929399|FG000|Overall Study|Withdrew Consent|59|||
129444624|NCT00528567|465929400|FG001|Overall Study|Withdrew Consent|55|||
129444625|NCT00528567|465929399|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
129444626|NCT00528567|465929400|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
129444627|NCT00528567|465929399|FG000|Overall Study|Failure to Return|1|||
129444628|NCT00528567|465929400|FG001|Overall Study|Failure to Return|4|||
129444629|NCT00528567|465929399|FG000|Overall Study|Other Protocol Violation|5|||
129444630|NCT00528567|465929400|FG001|Overall Study|Other Protocol Violation|21|||
129444631|NCT00528567|465929399|FG000|Overall Study|Administrative/Other|22|||
129444632|NCT00528567|465929400|FG001|Overall Study|Administrative/Other|75|||
129804404|NCT00543543|467251529|FG000|Extension Study|Pregnancy|0|||
129804405|NCT00543543|467251530|FG001|Extension Study|Pregnancy|0|||
129804406|NCT00543543|467251531|FG002|Extension Study|Pregnancy|0|||
129804407|NCT00543543|467251532|FG003|Extension Study|Pregnancy|6|||
129804408|NCT00543543|467251529|FG000|Extension Study|Protocol Violation|0|||
129804409|NCT00543543|467251530|FG001|Extension Study|Protocol Violation|0|||
129804410|NCT00543543|467251531|FG002|Extension Study|Protocol Violation|0|||
129804411|NCT00543543|467251532|FG003|Extension Study|Protocol Violation|11|||
129804412|NCT00543543|467251529|FG000|Extension Study|Withdrawal by Subject|0|||
129804413|NCT00543543|467251530|FG001|Extension Study|Withdrawal by Subject|0|||
129444633|NCT00631189|465929403|FG000|Initial Phase|Protocol Violation|347|||
129444634|NCT00631189|465929404|FG001|Initial Phase|Protocol Violation|0|||
129804414|NCT00543543|467251531|FG002|Extension Study|Withdrawal by Subject|0|||
129804415|NCT00543543|467251532|FG003|Extension Study|Withdrawal by Subject|120|||
129444635|NCT00631189|465929405|FG002|Initial Phase|Protocol Violation|0|||
129804416|NCT01163266|467251533|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
129733064|NCT03541187|466982590|FG001|Overall Study|Moved out of town|0|||
129733065|NCT03541187|466982589|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
129733066|NCT03541187|466982590|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
129733067|NCT03541187|466982589|FG000|Overall Study|Did not meet randomization criteria|1|||
129733068|NCT03541187|466982590|FG001|Overall Study|Did not meet randomization criteria|1|||
129733069|NCT03541187|466982589|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
129733070|NCT03541187|466982590|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
129733071|NCT03541187|466982589|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
129733072|NCT03541187|466982590|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
129733073|NCT01369680|466982591|FG000|Overall Study|Lost to Follow-up|0|||
129733074|NCT01369680|466982592|FG001|Overall Study|Lost to Follow-up|0|||
129733075|NCT01369680|466982593|FG002|Overall Study|Lost to Follow-up|1|||
129733076|NCT01369680|466982594|FG003|Overall Study|Lost to Follow-up|2|||
129733077|NCT00585221|466982597|FG000|Overall Study|Protocol Violation|8|||
129733078|NCT01118520|466982602|FG000|Overall Study|AAA repair|9|||
129733079|NCT01118520|466982603|FG001|Overall Study|AAA repair|7|||
129733080|NCT01118520|466982604|FG002|Overall Study|AAA repair|9|||
129733081|NCT01118520|466982602|FG000|Overall Study|Adverse Event|3|||
129733082|NCT01118520|466982603|FG001|Overall Study|Adverse Event|3|||
129733083|NCT01118520|466982604|FG002|Overall Study|Adverse Event|3|||
129733084|NCT01118520|466982602|FG000|Overall Study|Withdrawal by Subject|8|||
129733085|NCT01118520|466982603|FG001|Overall Study|Withdrawal by Subject|13|||
129733086|NCT01118520|466982604|FG002|Overall Study|Withdrawal by Subject|8|||
129733087|NCT01089023|466982605|FG000|Overall Study|Lost to Follow-up|3|||
129733088|NCT01089023|466982605|FG000|Overall Study|Adverse Event|1|||
129733089|NCT01089023|466982605|FG000|Overall Study|Withdrawal by Subject|1|||
129733090|NCT01089023|466982605|FG000|Overall Study|Protocol Violation|1|||
129733091|NCT01089023|466982605|FG000|Overall Study|Lack of Efficacy|1|||
129733092|NCT03421743|466982608|FG000|Overall Study|Lack of Efficacy|1|||
129733093|NCT03421743|466982609|FG001|Overall Study|Lack of Efficacy|0|||
129733094|NCT03421743|466982608|FG000|Overall Study|Adverse Event|2|||
129733095|NCT03421743|466982609|FG001|Overall Study|Adverse Event|1|||
129733096|NCT03421743|466982608|FG000|Overall Study|Withdrawal by Subject|0|||
129733097|NCT03421743|466982609|FG001|Overall Study|Withdrawal by Subject|1|||
129733098|NCT01166373|466982610|FG000|Overall Study|Lost to Follow-up|3|||
129733099|NCT01166373|466982611|FG001|Overall Study|Lost to Follow-up|2|||
129733100|NCT01166373|466982612|FG002|Overall Study|Lost to Follow-up|2|||
129733101|NCT01166373|466982613|FG003|Overall Study|Lost to Follow-up|2|||
129733102|NCT01166373|466982610|FG000|Overall Study|Withdrawal by Subject|1|||
129733103|NCT01166373|466982611|FG001|Overall Study|Withdrawal by Subject|2|||
129733104|NCT01166373|466982612|FG002|Overall Study|Withdrawal by Subject|2|||
129733105|NCT01166373|466982613|FG003|Overall Study|Withdrawal by Subject|3|||
129733106|NCT01166373|466982610|FG000|Overall Study|Physician Decision|1|||
129733107|NCT01166373|466982611|FG001|Overall Study|Physician Decision|0|||
129733108|NCT01166373|466982612|FG002|Overall Study|Physician Decision|0|||
129733109|NCT01166373|466982613|FG003|Overall Study|Physician Decision|0|||
129733110|NCT01819129|466982614|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
129733111|NCT01819129|466982615|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
129733112|NCT01819129|466982614|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
129733113|NCT01819129|466982615|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
129733114|NCT01819129|466982614|FG000|Overall Study|Other, Subject moved out of the country|0|||
129733115|NCT01819129|466982615|FG001|Overall Study|Other, Subject moved out of the country|1|||
129733116|NCT01819129|466982614|FG000|Overall Study|Withdrawal by Subject|15|||
129733117|NCT01819129|466982615|FG001|Overall Study|Withdrawal by Subject|15|||
129733118|NCT01819129|466982614|FG000|Overall Study|Lost to Follow-up|5|||
129733119|NCT01819129|466982615|FG001|Overall Study|Lost to Follow-up|2|||
129733120|NCT01819129|466982614|FG000|Overall Study|Lack of Efficacy|0|||
129733121|NCT01819129|466982615|FG001|Overall Study|Lack of Efficacy|1|||
129733122|NCT01819129|466982614|FG000|Overall Study|Adverse Event|1|||
129733123|NCT01819129|466982615|FG001|Overall Study|Adverse Event|4|||
129733124|NCT01819129|466982614|FG000|Overall Study|Death|1|||
129733125|NCT01819129|466982615|FG001|Overall Study|Death|1|||
129733126|NCT01819129|466982614|FG000|Overall Study|Withdrawal Criteria|20|||
129733127|NCT01819129|466982615|FG001|Overall Study|Withdrawal Criteria|15|||
129733128|NCT02836873|466982625|FG000|Overall Study|Protocol Violation|0|||
129733129|NCT02836873|466982626|FG001|Overall Study|Protocol Violation|1|||
129733130|NCT02836873|466982625|FG000|Overall Study|Adverse Event|1|||
129733131|NCT02836873|466982626|FG001|Overall Study|Adverse Event|4|||
129733132|NCT02836873|466982625|FG000|Overall Study|Withdrawal by Subject|2|||
129733133|NCT02836873|466982626|FG001|Overall Study|Withdrawal by Subject|2|||
129733134|NCT02836873|466982625|FG000|Overall Study|Lost to Follow-up|1|||
129892857|NCT00515086|467567705|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
129733135|NCT02836873|466982626|FG001|Overall Study|Lost to Follow-up|3|||
129733136|NCT02836873|466982625|FG000|Overall Study|Physician Decision|0|||
129733137|NCT02836873|466982626|FG001|Overall Study|Physician Decision|1|||
129733138|NCT02836873|466982625|FG000|Overall Study|Other|1|||
129733139|NCT02836873|466982626|FG001|Overall Study|Other|0|||
129733140|NCT00694096|466982627|FG000|Overall Study|Withdrawal by Subject|5|||
129733141|NCT02914548|466982630|FG000|Overall Study|Adverse Event|15|||
129733142|NCT02914548|466982631|FG001|Overall Study|Adverse Event|7|||
129733143|NCT02914548|466982632|FG002|Overall Study|Adverse Event|15|||
129733144|NCT02914548|466982630|FG000|Overall Study|Physician Decision|2|||
129733145|NCT02914548|466982631|FG001|Overall Study|Physician Decision|2|||
129733146|NCT02914548|466982632|FG002|Overall Study|Physician Decision|0|||
129733147|NCT02914548|466982630|FG000|Overall Study|Protocol Violation|1|||
129733148|NCT02914548|466982631|FG001|Overall Study|Protocol Violation|0|||
129733149|NCT02914548|466982632|FG002|Overall Study|Protocol Violation|0|||
129733150|NCT02914548|466982630|FG000|Overall Study|Withdrawal by Subject|3|||
129733151|NCT02914548|466982631|FG001|Overall Study|Withdrawal by Subject|4|||
129733152|NCT02914548|466982632|FG002|Overall Study|Withdrawal by Subject|4|||
129733153|NCT02914548|466982630|FG000|Overall Study|>40% of body surface area|0|||
129733154|NCT02914548|466982631|FG001|Overall Study|>40% of body surface area|1|||
129733155|NCT02914548|466982632|FG002|Overall Study|>40% of body surface area|1|||
129733156|NCT02214225|466982633|FG000|Overall Study|Lost to Follow-up|46|||
129733157|NCT02214225|466982634|FG001|Overall Study|Lost to Follow-up|18|||
129733158|NCT02214225|466982635|FG002|Overall Study|Lost to Follow-up|18|||
129733159|NCT02214225|466982633|FG000|Overall Study|Withdrawal by Subject|2|||
129733160|NCT02214225|466982634|FG001|Overall Study|Withdrawal by Subject|0|||
129733161|NCT02214225|466982635|FG002|Overall Study|Withdrawal by Subject|2|||
129733162|NCT02214225|466982633|FG000|Overall Study|Death|5|||
129804417|NCT01163266|467251534|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
129804418|NCT01163266|467251535|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
129804419|NCT01163266|467251533|FG000|Overall Study|Lack of Efficacy|1|||
129804420|NCT01163266|467251534|FG001|Overall Study|Lack of Efficacy|3|||
129804421|NCT01163266|467251535|FG002|Overall Study|Lack of Efficacy|1|||
129804422|NCT01163266|467251533|FG000|Overall Study|Noncompliance with Study Drug|0|||
129804423|NCT01163266|467251534|FG001|Overall Study|Noncompliance with Study Drug|2|||
129804424|NCT01163266|467251535|FG002|Overall Study|Noncompliance with Study Drug|0|||
129733163|NCT02214225|466982634|FG001|Overall Study|Death|0|||
129733164|NCT02214225|466982635|FG002|Overall Study|Death|1|||
129733165|NCT02214225|466982633|FG000|Overall Study|randomized in error, not vaccinated|2|||
129733166|NCT02214225|466982634|FG001|Overall Study|randomized in error, not vaccinated|1|||
129733167|NCT02214225|466982635|FG002|Overall Study|randomized in error, not vaccinated|1|||
129733168|NCT03754582|466982636|FG000|Treatment Phase|Adverse Event|0|||
129733169|NCT03754582|466982637|FG001|Treatment Phase|Adverse Event|1|||
129733170|NCT03754582|466982638|FG002|Treatment Phase|Adverse Event|0|||
129733171|NCT03754582|466982636|FG000|Follow-up Phase|Other|0|||
129733172|NCT03754582|466982637|FG001|Follow-up Phase|Other|0|||
129733173|NCT03754582|466982638|FG002|Follow-up Phase|Other|1|||
129733174|NCT02680574|466982639|FG000|Overall Study|Death|137|||
129733175|NCT02680574|466982640|FG001|Overall Study|Death|137|||
129733176|NCT02680574|466982639|FG000|Overall Study|Withdrawal by Subject|17|||
129733177|NCT02680574|466982640|FG001|Overall Study|Withdrawal by Subject|9|||
129733178|NCT02680574|466982639|FG000|Overall Study|Lost to Follow-up|4|||
129733179|NCT02680574|466982640|FG001|Overall Study|Lost to Follow-up|6|||
129733180|NCT02847858|466982641|FG000|Overall Study|Lost to Follow-up|401|||
129733181|NCT02847858|466982642|FG001|Overall Study|Lost to Follow-up|269|||
129733182|NCT00681564|466982645|FG000|Overall Study|Lost to Follow-up|6|||
129733183|NCT00681564|466982646|FG001|Overall Study|Lost to Follow-up|6|||
129733184|NCT00681564|466982645|FG000|Overall Study|Withdrawal by Subject|0|||
129733185|NCT00681564|466982646|FG001|Overall Study|Withdrawal by Subject|1|||
129733186|NCT00681564|466982645|FG000|Overall Study|Death|0|||
129733187|NCT00681564|466982646|FG001|Overall Study|Death|1|||
129733188|NCT01009346|466982649|FG000|Overall Study|Adverse Event|4|||
129733189|NCT01253265|466982651|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
129733190|NCT01253265|466982652|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
129733191|NCT01253265|466982653|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
129733192|NCT01253265|466982654|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
129733193|NCT01253265|466982655|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
129733194|NCT01253265|466982651|FG000|Overall Study|Withdrawal by Subject|0|||
129733195|NCT01253265|466982652|FG001|Overall Study|Withdrawal by Subject|0|||
129733196|NCT01253265|466982653|FG002|Overall Study|Withdrawal by Subject|0|||
129733197|NCT01253265|466982654|FG003|Overall Study|Withdrawal by Subject|0|||
129804425|NCT01163266|467251533|FG000|Overall Study|Protocol Deviations|2|||
129804426|NCT01163266|467251534|FG001|Overall Study|Protocol Deviations|2|||
129733198|NCT01253265|466982655|FG004|Overall Study|Withdrawal by Subject|1|||
129733199|NCT00541099|466982656|FG000|Overall Study|Ineligible|3|||
129733200|NCT00066469|466982658|FG000|Overall Study|Death|3|||
129733201|NCT00066469|466982658|FG000|Overall Study|Lack of Efficacy|9|||
129733202|NCT00066469|466982658|FG000|Overall Study|Lost to Follow-up|1|||
129804427|NCT01163266|467251535|FG002|Overall Study|Protocol Deviations|5|||
129733203|NCT00066469|466982658|FG000|Overall Study|Physician Decision|1|||
129733204|NCT00066469|466982658|FG000|Overall Study|Withdrawal by Subject|1|||
129733205|NCT00066469|466982658|FG000|Overall Study|ineligible|1|||
129733206|NCT03271047|466982659|FG000|Phase 1b: Dose Finding Period|Death|8|||
129733207|NCT03271047|466982660|FG001|Phase 1b: Dose Finding Period|Death|8|||
129733208|NCT03271047|466982661|FG002|Phase 1b: Dose Finding Period|Death|0|||
129733209|NCT03271047|466982662|FG003|Phase 1b: Dose Finding Period|Death|0|||
129733210|NCT03271047|466982659|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
129733211|NCT03271047|466982660|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
129733212|NCT03271047|466982661|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
129804428|NCT01163266|467251533|FG000|Overall Study|Withdrawal of Consent|5|||
129804429|NCT01163266|467251534|FG001|Overall Study|Withdrawal of Consent|7|||
129804430|NCT01163266|467251535|FG002|Overall Study|Withdrawal of Consent|3|||
129804431|NCT01163266|467251533|FG000|Overall Study|Lost to Follow-up|7|||
129733213|NCT03271047|466982662|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
129733214|NCT03271047|466982659|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
129733215|NCT03271047|466982660|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
129733216|NCT03271047|466982661|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
129733217|NCT03271047|466982662|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
129733218|NCT03271047|466982659|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
129733219|NCT03271047|466982660|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
129733220|NCT03271047|466982661|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
129733221|NCT03271047|466982662|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
129733222|NCT03271047|466982659|FG000|Randomized Phase 2 Period|Other|0|||
129804432|NCT01163266|467251534|FG001|Overall Study|Lost to Follow-up|7|||
129804433|NCT01163266|467251535|FG002|Overall Study|Lost to Follow-up|10|||
129804434|NCT01163266|467251533|FG000|Overall Study|Other|1|||
129804435|NCT01163266|467251534|FG001|Overall Study|Other|1|||
129733223|NCT03271047|466982660|FG001|Randomized Phase 2 Period|Other|0|||
129804436|NCT01163266|467251535|FG002|Overall Study|Other|2|||
129804437|NCT02586064|467251536|FG000|Overall Study|Other Obligations|6|||
129804438|NCT02586064|467251537|FG001|Overall Study|Other Obligations|6|||
129733224|NCT03271047|466982661|FG002|Randomized Phase 2 Period|Other|0|||
129733225|NCT03271047|466982662|FG003|Randomized Phase 2 Period|Other|1|||
129733226|NCT03271047|466982659|FG000|Randomized Phase 2 Period|Death|0|||
129733227|NCT03271047|466982660|FG001|Randomized Phase 2 Period|Death|0|||
129733228|NCT03271047|466982661|FG002|Randomized Phase 2 Period|Death|20|||
129733229|NCT03271047|466982662|FG003|Randomized Phase 2 Period|Death|21|||
129733230|NCT03271047|466982659|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
129733231|NCT03271047|466982660|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
129733232|NCT03271047|466982661|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
129733233|NCT03271047|466982662|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
129733234|NCT03271047|466982659|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
129733235|NCT03271047|466982660|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
129733236|NCT03271047|466982661|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
129733237|NCT03271047|466982662|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
129733238|NCT03271047|466982659|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
129733239|NCT03271047|466982660|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
129733240|NCT03271047|466982661|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
129733241|NCT03271047|466982662|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
129733242|NCT00711802|466982663|FG000|Overall Study|Not treated (no further detail)|2|||
129733243|NCT00711802|466982664|FG001|Overall Study|Not treated (no further detail)|1|||
129733244|NCT00711802|466982665|FG002|Overall Study|Not treated (no further detail)|2|||
129733245|NCT00711802|466982666|FG003|Overall Study|Not treated (no further detail)|0|||
129733246|NCT00711802|466982667|FG004|Overall Study|Not treated (no further detail)|2|||
129733247|NCT00711802|466982668|FG005|Overall Study|Not treated (no further detail)|0|||
129733248|NCT00711802|466982669|FG006|Overall Study|Not treated (no further detail)|0|||
129733249|NCT00711802|466982670|FG007|Overall Study|Not treated (no further detail)|0|||
129733250|NCT00711802|466982663|FG000|Overall Study|Adverse Event|0|||
129733251|NCT00711802|466982664|FG001|Overall Study|Adverse Event|0|||
129733252|NCT00711802|466982665|FG002|Overall Study|Adverse Event|0|||
129733253|NCT00711802|466982666|FG003|Overall Study|Adverse Event|0|||
129733254|NCT00711802|466982667|FG004|Overall Study|Adverse Event|1|||
129733255|NCT00711802|466982668|FG005|Overall Study|Adverse Event|1|||
129733256|NCT00711802|466982669|FG006|Overall Study|Adverse Event|0|||
129733257|NCT00711802|466982670|FG007|Overall Study|Adverse Event|0|||
129733258|NCT00711802|466982663|FG000|Overall Study|Microbiological failure|0|||
129733259|NCT00711802|466982664|FG001|Overall Study|Microbiological failure|1|||
129733260|NCT00711802|466982665|FG002|Overall Study|Microbiological failure|0|||
129733261|NCT00711802|466982666|FG003|Overall Study|Microbiological failure|0|||
129733262|NCT00711802|466982667|FG004|Overall Study|Microbiological failure|0|||
129733263|NCT00711802|466982668|FG005|Overall Study|Microbiological failure|1|||
129733264|NCT00711802|466982669|FG006|Overall Study|Microbiological failure|0|||
129733265|NCT00711802|466982670|FG007|Overall Study|Microbiological failure|0|||
129733266|NCT00711802|466982663|FG000|Overall Study|Protocol Violation|0|||
129733267|NCT00711802|466982664|FG001|Overall Study|Protocol Violation|0|||
129733268|NCT00711802|466982665|FG002|Overall Study|Protocol Violation|0|||
129733269|NCT00711802|466982666|FG003|Overall Study|Protocol Violation|1|||
129733270|NCT00711802|466982667|FG004|Overall Study|Protocol Violation|0|||
129733271|NCT00711802|466982668|FG005|Overall Study|Protocol Violation|0|||
129733272|NCT00711802|466982669|FG006|Overall Study|Protocol Violation|0|||
129733273|NCT00711802|466982670|FG007|Overall Study|Protocol Violation|0|||
129733274|NCT00711802|466982663|FG000|Overall Study|Physician Decision|0|||
129733275|NCT00711802|466982664|FG001|Overall Study|Physician Decision|2|||
129733276|NCT00711802|466982665|FG002|Overall Study|Physician Decision|0|||
129733277|NCT00711802|466982666|FG003|Overall Study|Physician Decision|0|||
129733278|NCT00711802|466982667|FG004|Overall Study|Physician Decision|0|||
129733279|NCT00711802|466982668|FG005|Overall Study|Physician Decision|0|||
129733280|NCT00711802|466982669|FG006|Overall Study|Physician Decision|0|||
129733281|NCT00711802|466982670|FG007|Overall Study|Physician Decision|0|||
129733282|NCT00711802|466982663|FG000|Overall Study|Withdrawal by Subject|0|||
129733283|NCT00711802|466982664|FG001|Overall Study|Withdrawal by Subject|1|||
129733284|NCT00711802|466982665|FG002|Overall Study|Withdrawal by Subject|0|||
129733285|NCT00711802|466982666|FG003|Overall Study|Withdrawal by Subject|1|||
129804439|NCT02586064|467251536|FG000|Overall Study|Other|3|||
129804440|NCT02586064|467251537|FG001|Overall Study|Other|7|||
129804441|NCT02586064|467251536|FG000|Overall Study|Never Started|3|||
129733286|NCT00711802|466982667|FG004|Overall Study|Withdrawal by Subject|0|||
129733287|NCT00711802|466982668|FG005|Overall Study|Withdrawal by Subject|0|||
129733288|NCT00711802|466982669|FG006|Overall Study|Withdrawal by Subject|0|||
129733289|NCT00711802|466982670|FG007|Overall Study|Withdrawal by Subject|0|||
129733290|NCT00711802|466982663|FG000|Overall Study|Lost to Follow-up|0|||
129733291|NCT00711802|466982664|FG001|Overall Study|Lost to Follow-up|0|||
129733292|NCT00711802|466982665|FG002|Overall Study|Lost to Follow-up|3|||
129733293|NCT00711802|466982666|FG003|Overall Study|Lost to Follow-up|1|||
129733294|NCT00711802|466982667|FG004|Overall Study|Lost to Follow-up|10|||
129733295|NCT00711802|466982668|FG005|Overall Study|Lost to Follow-up|6|||
129733296|NCT00711802|466982669|FG006|Overall Study|Lost to Follow-up|4|||
129444636|NCT00631189|465929406|FG003|Initial Phase|Protocol Violation|0|||
129444637|NCT00631189|465929403|FG000|Initial Phase|Withdrawal by Subject|4|||
129444638|NCT00631189|465929404|FG001|Initial Phase|Withdrawal by Subject|0|||
129444639|NCT00631189|465929405|FG002|Initial Phase|Withdrawal by Subject|0|||
129444640|NCT00631189|465929406|FG003|Initial Phase|Withdrawal by Subject|0|||
129444641|NCT00631189|465929403|FG000|Treatment Phase|Withdrawal by Subject|0|||
129444642|NCT00631189|465929404|FG001|Treatment Phase|Withdrawal by Subject|2|||
129444643|NCT00631189|465929405|FG002|Treatment Phase|Withdrawal by Subject|1|||
129444644|NCT00631189|465929406|FG003|Treatment Phase|Withdrawal by Subject|1|||
129444645|NCT00631189|465929403|FG000|Treatment Phase|Protocol Violation|0|||
129444646|NCT00631189|465929404|FG001|Treatment Phase|Protocol Violation|1|||
129444647|NCT00631189|465929405|FG002|Treatment Phase|Protocol Violation|6|||
129444648|NCT00631189|465929406|FG003|Treatment Phase|Protocol Violation|2|||
129444649|NCT00631189|465929403|FG000|Treatment Phase|Adverse Event|0|||
129444650|NCT00631189|465929404|FG001|Treatment Phase|Adverse Event|3|||
129444651|NCT00631189|465929405|FG002|Treatment Phase|Adverse Event|2|||
129444652|NCT00631189|465929406|FG003|Treatment Phase|Adverse Event|4|||
129444653|NCT00631189|465929403|FG000|Treatment Phase|Lost to Follow-up|0|||
129444654|NCT00631189|465929404|FG001|Treatment Phase|Lost to Follow-up|1|||
129444655|NCT00631189|465929405|FG002|Treatment Phase|Lost to Follow-up|0|||
129444656|NCT00631189|465929406|FG003|Treatment Phase|Lost to Follow-up|0|||
129444657|NCT00631189|465929403|FG000|Treatment Phase|Pregnancy|0|||
129444658|NCT00631189|465929404|FG001|Treatment Phase|Pregnancy|0|||
129444659|NCT00631189|465929405|FG002|Treatment Phase|Pregnancy|1|||
129444660|NCT00631189|465929406|FG003|Treatment Phase|Pregnancy|0|||
129444661|NCT00631189|465929403|FG000|Treatment Phase|patient did not take pravastatin|0|||
129444662|NCT00631189|465929404|FG001|Treatment Phase|patient did not take pravastatin|0|||
129444663|NCT00631189|465929405|FG002|Treatment Phase|patient did not take pravastatin|1|||
129444664|NCT00631189|465929406|FG003|Treatment Phase|patient did not take pravastatin|0|||
129444665|NCT00974090|465929407|FG000|Period 1: Double Blind Period|Adverse Event|2|||
129444666|NCT00974090|465929408|FG001|Period 1: Double Blind Period|Adverse Event|1|||
129444667|NCT00974090|465929407|FG000|Period 1: Double Blind Period|Physician Decision|1|||
129444668|NCT00974090|465929408|FG001|Period 1: Double Blind Period|Physician Decision|0|||
129444669|NCT00974090|465929407|FG000|Period 2: Open-label Period|Adverse Event|4|||
129444670|NCT00974090|465929408|FG001|Period 2: Open-label Period|Adverse Event|6|||
129444671|NCT00974090|465929407|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
129444672|NCT00974090|465929408|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
129444673|NCT00974090|465929407|FG000|Period 2: Open-label Period|Physician Decision|0|||
129444674|NCT00974090|465929408|FG001|Period 2: Open-label Period|Physician Decision|3|||
129444675|NCT00974090|465929407|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
129444676|NCT00974090|465929408|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
129444677|NCT03189862|465929409|FG000|Overall Study|Withdrawal by Subject|1|||
129444678|NCT03189862|465929410|FG001|Overall Study|Withdrawal by Subject|0|||
129444679|NCT03189862|465929409|FG000|Overall Study|Lost to Follow-up|54|||
129444680|NCT03189862|465929410|FG001|Overall Study|Lost to Follow-up|62|||
129444681|NCT01829360|465929411|FG000|Overall Study|Protocol Violation|0|||
129444682|NCT01829360|465929412|FG001|Overall Study|Protocol Violation|0|||
129444683|NCT01829360|465929413|FG002|Overall Study|Protocol Violation|1|||
129444684|NCT01829360|465929414|FG003|Overall Study|Protocol Violation|0|||
129444685|NCT03838198|465929419|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
129444686|NCT03838198|465929420|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
129444687|NCT03838198|465929421|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
129444688|NCT03838198|465929422|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
129444689|NCT03838198|465929419|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
129444690|NCT03838198|465929420|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
129444691|NCT03838198|465929421|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
129444692|NCT03838198|465929422|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
129444693|NCT01271803|465929423|FG000|Overall Study|Progressive disease|0|||
129444694|NCT01271803|465929424|FG001|Overall Study|Progressive disease|0|||
129444695|NCT01271803|465929425|FG002|Overall Study|Progressive disease|2|||
129733297|NCT00711802|466982670|FG007|Overall Study|Lost to Follow-up|2|||
129733298|NCT00711802|466982663|FG000|Overall Study|Reason not reported|0|||
129733299|NCT00711802|466982664|FG001|Overall Study|Reason not reported|1|||
129733300|NCT00711802|466982665|FG002|Overall Study|Reason not reported|1|||
129733301|NCT00711802|466982666|FG003|Overall Study|Reason not reported|0|||
129733302|NCT00711802|466982667|FG004|Overall Study|Reason not reported|1|||
129733303|NCT00711802|466982668|FG005|Overall Study|Reason not reported|0|||
129733304|NCT00711802|466982669|FG006|Overall Study|Reason not reported|1|||
129733305|NCT00711802|466982670|FG007|Overall Study|Reason not reported|0|||
129444696|NCT01271803|465929423|FG000|Overall Study|Death|53|||
129733306|NCT02410824|466982671|FG000|First Intervention (One Week)|Headache|0|||
129733307|NCT02410824|466982672|FG001|First Intervention (One Week)|Headache|1|||
129733308|NCT02436408|466982673|FG000|Overall Study|Death|1|||
129733309|NCT00392808|466982674|FG000|Overall Study|Lost to Follow-up|3|||
129733310|NCT00392808|466982675|FG001|Overall Study|Lost to Follow-up|2|||
129733311|NCT00392808|466982676|FG002|Overall Study|Lost to Follow-up|1|||
129733312|NCT00392808|466982677|FG003|Overall Study|Lost to Follow-up|2|||
129733313|NCT00392808|466982674|FG000|Overall Study|Unable to withdraw blood|3|||
129733314|NCT00392808|466982675|FG001|Overall Study|Unable to withdraw blood|1|||
129733315|NCT00392808|466982676|FG002|Overall Study|Unable to withdraw blood|1|||
129733316|NCT00392808|466982677|FG003|Overall Study|Unable to withdraw blood|2|||
129733317|NCT02649855|466982678|FG000|Overall Study|Refused further treatment|2|||
129733318|NCT02649855|466982679|FG001|Overall Study|Refused further treatment|1|||
129733319|NCT02649855|466982680|FG002|Overall Study|Refused further treatment|1|||
129733320|NCT02649855|466982678|FG000|Overall Study|Withdrew consent|0|||
129733321|NCT02649855|466982679|FG001|Overall Study|Withdrew consent|1|||
129733322|NCT02649855|466982680|FG002|Overall Study|Withdrew consent|0|||
129733323|NCT02649855|466982678|FG000|Overall Study|Switched to alternative treatment|0|||
129733324|NCT02649855|466982679|FG001|Overall Study|Switched to alternative treatment|1|||
129733325|NCT02649855|466982680|FG002|Overall Study|Switched to alternative treatment|1|||
129733326|NCT02649855|466982678|FG000|Overall Study|Principal investigator discretion|0|||
129733327|NCT02649855|466982679|FG001|Overall Study|Principal investigator discretion|1|||
129733328|NCT02649855|466982680|FG002|Overall Study|Principal investigator discretion|1|||
129733329|NCT02649855|466982678|FG000|Overall Study|No treatment, per protocol|1|||
129733330|NCT02649855|466982679|FG001|Overall Study|No treatment, per protocol|0|||
129733331|NCT02649855|466982680|FG002|Overall Study|No treatment, per protocol|0|||
129733332|NCT02649855|466982678|FG000|Overall Study|Initiate new treatment|1|||
129733333|NCT02649855|466982679|FG001|Overall Study|Initiate new treatment|0|||
129733334|NCT02649855|466982680|FG002|Overall Study|Initiate new treatment|0|||
129444697|NCT01271803|465929424|FG001|Overall Study|Death|34|||
129733335|NCT02782325|466982681|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
129733336|NCT02782325|466982682|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
129733337|NCT02782325|466982683|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
129733338|NCT02782325|466982681|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
129733339|NCT02782325|466982682|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
129733340|NCT02782325|466982683|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
129733341|NCT02818036|466982689|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
129733342|NCT02818036|466982690|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
129733343|NCT02818036|466982689|FG000|Overall Study|Withdrawal by Subject|1|||
129733344|NCT02818036|466982690|FG001|Overall Study|Withdrawal by Subject|0|||
129733345|NCT01038713|466982691|FG000|Overall Study|Patient to hospice|1|||
129733346|NCT01038713|466982692|FG001|Overall Study|Patient to hospice|1|||
129733347|NCT01038713|466982693|FG002|Overall Study|Patient to hospice|1|||
129733348|NCT01038713|466982691|FG000|Overall Study|Lost to Follow-up|3|||
129733349|NCT01038713|466982692|FG001|Overall Study|Lost to Follow-up|0|||
129733350|NCT01038713|466982693|FG002|Overall Study|Lost to Follow-up|0|||
129733351|NCT01038713|466982691|FG000|Overall Study|Neuroendocrine Tumor|0|||
129733352|NCT01038713|466982692|FG001|Overall Study|Neuroendocrine Tumor|1|||
129733353|NCT01038713|466982693|FG002|Overall Study|Neuroendocrine Tumor|0|||
129733354|NCT01038713|466982691|FG000|Overall Study|died from PEP|0|||
129733355|NCT01038713|466982692|FG001|Overall Study|died from PEP|1|||
129733356|NCT01038713|466982693|FG002|Overall Study|died from PEP|0|||
129733357|NCT01038713|466982691|FG000|Overall Study|Autoimmune Pancreatitis|1|||
129733358|NCT01038713|466982692|FG001|Overall Study|Autoimmune Pancreatitis|0|||
129733359|NCT01038713|466982693|FG002|Overall Study|Autoimmune Pancreatitis|0|||
129733360|NCT01154283|466982694|FG000|0-6 Weeks|Withdrawal by Subject|7|||
129733361|NCT01154283|466982695|FG001|0-6 Weeks|Withdrawal by Subject|2|||
129733362|NCT01154283|466982694|FG000|0-6 Weeks|Death|0|||
129733363|NCT01154283|466982695|FG001|0-6 Weeks|Death|1|||
129733364|NCT01154283|466982694|FG000|7-12 Weeks|Death|1|||
129733365|NCT01154283|466982695|FG001|7-12 Weeks|Death|0|||
129733366|NCT01154283|466982694|FG000|7-12 Weeks|Withdrawal by Subject|0|||
129733367|NCT01154283|466982695|FG001|7-12 Weeks|Withdrawal by Subject|1|||
129733368|NCT03777917|466982696|FG000|Overall Study|Withdrawal by Subject|1|||
129733369|NCT03777917|466982697|FG001|Overall Study|Withdrawal by Subject|0|||
129733370|NCT03777917|466982696|FG000|Overall Study|Physician Decision|1|||
129733371|NCT03777917|466982697|FG001|Overall Study|Physician Decision|0|||
129733372|NCT03777917|466982696|FG000|Overall Study|Lost to Follow-up|6|||
129733373|NCT03777917|466982697|FG001|Overall Study|Lost to Follow-up|2|||
129733374|NCT03777917|466982696|FG000|Overall Study|Other|1|||
129733375|NCT03777917|466982697|FG001|Overall Study|Other|0|||
129733376|NCT00042432|466982698|FG000|Overall Study|Adverse Event|4|||
129733377|NCT00042432|466982699|FG001|Overall Study|Adverse Event|1|||
129733378|NCT00042432|466982698|FG000|Overall Study|Withdrawal by Subject|1|||
129733379|NCT00042432|466982699|FG001|Overall Study|Withdrawal by Subject|3|||
129733380|NCT00042432|466982698|FG000|Overall Study|Death|0|||
129733381|NCT00042432|466982699|FG001|Overall Study|Death|2|||
129733382|NCT00042432|466982698|FG000|Overall Study|Ineligibility determined|1|||
129733383|NCT00042432|466982699|FG001|Overall Study|Ineligibility determined|0|||
129733384|NCT00042432|466982698|FG000|Overall Study|Initiation of maintenance dialysis|1|||
129733385|NCT00042432|466982699|FG001|Overall Study|Initiation of maintenance dialysis|1|||
129733386|NCT00042432|466982698|FG000|Overall Study|Other|2|||
129733387|NCT00042432|466982699|FG001|Overall Study|Other|0|||
129733388|NCT00657150|466982700|FG000|Overall Study|Adverse Event|19|||
129733389|NCT00657150|466982701|FG001|Overall Study|Adverse Event|10|||
129733390|NCT00657150|466982700|FG000|Overall Study|Non-compliant with protocol|5|||
129804442|NCT02586064|467251537|FG001|Overall Study|Never Started|3|||
129804443|NCT02586064|467251536|FG000|Overall Study|Lost Interest|1|||
129804444|NCT02586064|467251537|FG001|Overall Study|Lost Interest|4|||
129804445|NCT02586064|467251536|FG000|Overall Study|Miscellaneous Life Issues|0|||
129804446|NCT02586064|467251537|FG001|Overall Study|Miscellaneous Life Issues|5|||
129804447|NCT02586064|467251536|FG000|Overall Study|Infrequent Attendance|2|||
129804448|NCT02586064|467251537|FG001|Overall Study|Infrequent Attendance|1|||
129733391|NCT00657150|466982701|FG001|Overall Study|Non-compliant with protocol|9|||
129733392|NCT00657150|466982700|FG000|Overall Study|Lost to Follow-up|2|||
129733393|NCT00657150|466982701|FG001|Overall Study|Lost to Follow-up|0|||
129733394|NCT00657150|466982700|FG000|Overall Study|Withdrawal by Subject|51|||
129733395|NCT00657150|466982701|FG001|Overall Study|Withdrawal by Subject|36|||
129733396|NCT00657150|466982700|FG000|Overall Study|Other|38|||
129733397|NCT00657150|466982701|FG001|Overall Study|Other|38|||
129733398|NCT00657150|466982700|FG000|Treatment|Adverse Event|60|||
129733399|NCT00657150|466982701|FG001|Treatment|Adverse Event|53|||
129733400|NCT00657150|466982700|FG000|Treatment|Non-compliant with protocol|10|||
129733401|NCT00657150|466982701|FG001|Treatment|Non-compliant with protocol|9|||
129733402|NCT00657150|466982700|FG000|Treatment|Lost to Follow-up|1|||
129733403|NCT00657150|466982701|FG001|Treatment|Lost to Follow-up|0|||
129733404|NCT00657150|466982700|FG000|Treatment|Withdrawal by Subject|23|||
129733405|NCT00657150|466982701|FG001|Treatment|Withdrawal by Subject|20|||
129733406|NCT00657150|466982700|FG000|Treatment|Other|13|||
129804449|NCT02586064|467251536|FG000|Overall Study|Timed Out|2|||
129804450|NCT02586064|467251537|FG001|Overall Study|Timed Out|0|||
129804451|NCT02586064|467251536|FG000|Overall Study|AUD relapse|0|||
129804452|NCT02586064|467251537|FG001|Overall Study|AUD relapse|2|||
129804453|NCT02586064|467251536|FG000|Overall Study|Legal Issue|1|||
129804454|NCT02586064|467251537|FG001|Overall Study|Legal Issue|0|||
129804455|NCT03181893|467251538|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804456|NCT03181893|467251539|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
129804457|NCT03181893|467251540|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129733407|NCT00657150|466982701|FG001|Treatment|Other|15|||
129733408|NCT02966795|466982702|FG000|Overall Study|Patient Left the Country|0|||
129733409|NCT02966795|466982703|FG001|Overall Study|Patient Left the Country|1|||
129733410|NCT00432744|466982704|FG000|Months 0-6|Withdrawal by Subject|4|||
129733411|NCT00432744|466982705|FG001|Months 0-6|Withdrawal by Subject|4|||
129733412|NCT00432744|466982704|FG000|Months 0-6|Too disabled to score|1|||
129733413|NCT00432744|466982705|FG001|Months 0-6|Too disabled to score|0|||
129733414|NCT00432744|466982704|FG000|Months 7 - 12|Withdrawal by Subject|1|||
129733415|NCT00432744|466982705|FG001|Months 7 - 12|Withdrawal by Subject|0|||
129733416|NCT00432744|466982704|FG000|Months 7 - 12|Too disabled to score|0|||
129733417|NCT00432744|466982705|FG001|Months 7 - 12|Too disabled to score|1|||
129733418|NCT00468845|466982717|FG000|Overall Study|Adverse Event|9|||
129733419|NCT00468845|466982718|FG001|Overall Study|Adverse Event|14|||
129733420|NCT00468845|466982719|FG002|Overall Study|Adverse Event|11|||
129733421|NCT00468845|466982717|FG000|Overall Study|Lost to Follow-up|2|||
129733422|NCT00468845|466982718|FG001|Overall Study|Lost to Follow-up|1|||
129733423|NCT00468845|466982719|FG002|Overall Study|Lost to Follow-up|2|||
129804458|NCT03181893|467251541|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804459|NCT03181893|467251542|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804460|NCT03181893|467251543|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804461|NCT03181893|467251544|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129733424|NCT00468845|466982717|FG000|Overall Study|Other|4|||
129733425|NCT00468845|466982718|FG001|Overall Study|Other|9|||
129733426|NCT00468845|466982719|FG002|Overall Study|Other|5|||
129733427|NCT00468845|466982717|FG000|Overall Study|No longer willing to participate|5|||
129733428|NCT00468845|466982718|FG001|Overall Study|No longer willing to participate|6|||
129804462|NCT03181893|467251545|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804463|NCT03181893|467251546|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804464|NCT03181893|467251547|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804465|NCT03181893|467251548|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
129804466|NCT03181893|467251538|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
129804467|NCT03181893|467251539|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
129804468|NCT03181893|467251540|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804469|NCT03181893|467251541|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129444698|NCT01271803|465929425|FG002|Overall Study|Death|0|||
129733429|NCT00468845|466982719|FG002|Overall Study|No longer willing to participate|10|||
129733430|NCT00468845|466982717|FG000|Overall Study|Randomized, not treated|1|||
129733431|NCT00468845|466982718|FG001|Overall Study|Randomized, not treated|4|||
129733432|NCT00468845|466982719|FG002|Overall Study|Randomized, not treated|2|||
129733433|NCT02761694|466982724|FG000|Overall Study|Lack of Efficacy|0|||
129733434|NCT02761694|466982725|FG001|Overall Study|Lack of Efficacy|0|||
129733435|NCT02761694|466982726|FG002|Overall Study|Lack of Efficacy|0|||
129733436|NCT02761694|466982727|FG003|Overall Study|Lack of Efficacy|0|||
129733437|NCT02761694|466982728|FG004|Overall Study|Lack of Efficacy|0|||
129733438|NCT02761694|466982729|FG005|Overall Study|Lack of Efficacy|0|||
129733439|NCT02761694|466982730|FG006|Overall Study|Lack of Efficacy|6|||
129733440|NCT02761694|466982731|FG007|Overall Study|Lack of Efficacy|0|||
129733441|NCT02761694|466982732|FG008|Overall Study|Lack of Efficacy|0|||
129733442|NCT02761694|466982733|FG009|Overall Study|Lack of Efficacy|1|||
129733443|NCT02761694|466982734|FG010|Overall Study|Lack of Efficacy|1|||
129733444|NCT02761694|466982735|FG011|Overall Study|Lack of Efficacy|4|||
129733445|NCT02761694|466982724|FG000|Overall Study|Death|0|||
129733446|NCT02761694|466982725|FG001|Overall Study|Death|0|||
129733447|NCT02761694|466982726|FG002|Overall Study|Death|0|||
129733448|NCT02761694|466982727|FG003|Overall Study|Death|0|||
129733449|NCT02761694|466982728|FG004|Overall Study|Death|0|||
129733450|NCT02761694|466982729|FG005|Overall Study|Death|0|||
129733451|NCT02761694|466982730|FG006|Overall Study|Death|2|||
129733452|NCT02761694|466982731|FG007|Overall Study|Death|0|||
129733453|NCT02761694|466982732|FG008|Overall Study|Death|2|||
129733454|NCT02761694|466982733|FG009|Overall Study|Death|2|||
129733455|NCT02761694|466982734|FG010|Overall Study|Death|1|||
129733456|NCT02761694|466982735|FG011|Overall Study|Death|0|||
129733457|NCT02761694|466982724|FG000|Overall Study|Physician Decision|0|||
129733458|NCT02761694|466982725|FG001|Overall Study|Physician Decision|0|||
129733459|NCT02761694|466982726|FG002|Overall Study|Physician Decision|0|||
129733460|NCT02761694|466982727|FG003|Overall Study|Physician Decision|0|||
129733461|NCT02761694|466982728|FG004|Overall Study|Physician Decision|0|||
129733462|NCT02761694|466982729|FG005|Overall Study|Physician Decision|0|||
129733463|NCT02761694|466982730|FG006|Overall Study|Physician Decision|1|||
129733464|NCT02761694|466982731|FG007|Overall Study|Physician Decision|0|||
129733465|NCT02761694|466982732|FG008|Overall Study|Physician Decision|0|||
129804470|NCT03181893|467251542|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129733466|NCT02761694|466982733|FG009|Overall Study|Physician Decision|0|||
129733467|NCT02761694|466982734|FG010|Overall Study|Physician Decision|0|||
129733468|NCT02761694|466982735|FG011|Overall Study|Physician Decision|0|||
129733469|NCT02761694|466982724|FG000|Overall Study|Withdrawal by Subject|0|||
129733470|NCT02761694|466982725|FG001|Overall Study|Withdrawal by Subject|0|||
129733471|NCT02761694|466982726|FG002|Overall Study|Withdrawal by Subject|0|||
129733472|NCT02761694|466982727|FG003|Overall Study|Withdrawal by Subject|1|||
129733473|NCT02761694|466982728|FG004|Overall Study|Withdrawal by Subject|0|||
129733474|NCT02761694|466982729|FG005|Overall Study|Withdrawal by Subject|0|||
129733475|NCT02761694|466982730|FG006|Overall Study|Withdrawal by Subject|4|||
129733476|NCT02761694|466982731|FG007|Overall Study|Withdrawal by Subject|0|||
129733477|NCT02761694|466982732|FG008|Overall Study|Withdrawal by Subject|2|||
129733478|NCT02761694|466982733|FG009|Overall Study|Withdrawal by Subject|1|||
129733479|NCT02761694|466982734|FG010|Overall Study|Withdrawal by Subject|0|||
129733480|NCT02761694|466982735|FG011|Overall Study|Withdrawal by Subject|0|||
129733481|NCT02761694|466982724|FG000|Overall Study|Lost to Follow-up|0|||
129733482|NCT02761694|466982725|FG001|Overall Study|Lost to Follow-up|0|||
129733483|NCT02761694|466982726|FG002|Overall Study|Lost to Follow-up|0|||
129733484|NCT02761694|466982727|FG003|Overall Study|Lost to Follow-up|0|||
129733485|NCT02761694|466982728|FG004|Overall Study|Lost to Follow-up|0|||
129733486|NCT02761694|466982729|FG005|Overall Study|Lost to Follow-up|0|||
129733487|NCT02761694|466982730|FG006|Overall Study|Lost to Follow-up|1|||
129733488|NCT02761694|466982731|FG007|Overall Study|Lost to Follow-up|0|||
129733489|NCT02761694|466982732|FG008|Overall Study|Lost to Follow-up|0|||
129733490|NCT02761694|466982733|FG009|Overall Study|Lost to Follow-up|0|||
129733491|NCT02761694|466982734|FG010|Overall Study|Lost to Follow-up|0|||
129733492|NCT02761694|466982735|FG011|Overall Study|Lost to Follow-up|1|||
129733493|NCT02761694|466982724|FG000|Overall Study|Adverse Event|0|||
129733494|NCT02761694|466982725|FG001|Overall Study|Adverse Event|0|||
129733495|NCT02761694|466982726|FG002|Overall Study|Adverse Event|0|||
129733496|NCT02761694|466982727|FG003|Overall Study|Adverse Event|0|||
129733497|NCT02761694|466982728|FG004|Overall Study|Adverse Event|0|||
129733498|NCT02761694|466982729|FG005|Overall Study|Adverse Event|0|||
129733499|NCT02761694|466982730|FG006|Overall Study|Adverse Event|1|||
129733500|NCT02761694|466982731|FG007|Overall Study|Adverse Event|0|||
129733501|NCT02761694|466982732|FG008|Overall Study|Adverse Event|1|||
129733502|NCT02761694|466982733|FG009|Overall Study|Adverse Event|0|||
129733503|NCT02761694|466982734|FG010|Overall Study|Adverse Event|0|||
129733504|NCT02761694|466982735|FG011|Overall Study|Adverse Event|1|||
129733505|NCT02761694|466982724|FG000|Overall Study|Other|4|||
129733506|NCT02761694|466982725|FG001|Overall Study|Other|4|||
129733507|NCT02761694|466982726|FG002|Overall Study|Other|1|||
129733508|NCT02761694|466982727|FG003|Overall Study|Other|2|||
129733509|NCT02761694|466982728|FG004|Overall Study|Other|3|||
129733510|NCT02761694|466982729|FG005|Overall Study|Other|3|||
129733511|NCT02761694|466982730|FG006|Overall Study|Other|18|||
129733512|NCT02761694|466982731|FG007|Overall Study|Other|8|||
129733513|NCT02761694|466982732|FG008|Overall Study|Other|0|||
129733514|NCT02761694|466982733|FG009|Overall Study|Other|1|||
129733515|NCT02761694|466982734|FG010|Overall Study|Other|1|||
129733516|NCT02761694|466982735|FG011|Overall Study|Other|0|||
129733517|NCT02395055|466982736|FG000|Overall Study|Withdrawal by Subject|7|||
129733518|NCT02395055|466982737|FG001|Overall Study|Withdrawal by Subject|3|||
129733519|NCT03959982|466984705|FG000|Overall Study|Withdrawal by Subject|1|||
129733520|NCT03959982|466984706|FG001|Overall Study|Withdrawal by Subject|0|||
129733521|NCT03959982|466984705|FG000|Overall Study|Physician Decision|2|||
129733522|NCT03959982|466984706|FG001|Overall Study|Physician Decision|0|||
129733523|NCT03959982|466984705|FG000|Overall Study|Lost to Follow-up|1|||
129733524|NCT03959982|466984706|FG001|Overall Study|Lost to Follow-up|0|||
129733525|NCT00758589|466984707|FG000|Overall Study|Adverse Event|3|||
129733526|NCT00758589|466984708|FG001|Overall Study|Adverse Event|2|||
129733527|NCT00758589|466984709|FG002|Overall Study|Adverse Event|5|||
129733528|NCT00758589|466984710|FG003|Overall Study|Adverse Event|4|||
129733529|NCT00758589|466984707|FG000|Overall Study|Withdrawal by Subject|0|||
129444699|NCT01271803|465929423|FG000|Overall Study|Withdrawal by Subject|1|||
129444700|NCT01271803|465929424|FG001|Overall Study|Withdrawal by Subject|5|||
129444701|NCT01271803|465929425|FG002|Overall Study|Withdrawal by Subject|0|||
129892858|NCT00515086|467567706|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129892859|NCT00515086|467567703|FG000|Overall Study|Lost to Follow-up|1|||
129892860|NCT00515086|467567704|FG001|Overall Study|Lost to Follow-up|0|||
129892861|NCT00515086|467567705|FG002|Overall Study|Lost to Follow-up|0|||
129444702|NCT01271803|465929423|FG000|Overall Study|Lost to Follow-up|1|||
129733530|NCT00758589|466984708|FG001|Overall Study|Withdrawal by Subject|1|||
129733531|NCT00758589|466984709|FG002|Overall Study|Withdrawal by Subject|1|||
129733532|NCT00758589|466984710|FG003|Overall Study|Withdrawal by Subject|1|||
129733533|NCT00758589|466984707|FG000|Overall Study|Palm stopped to work|0|||
129733534|NCT00758589|466984708|FG001|Overall Study|Palm stopped to work|0|||
129733535|NCT00758589|466984709|FG002|Overall Study|Palm stopped to work|0|||
129733536|NCT00758589|466984710|FG003|Overall Study|Palm stopped to work|1|||
129733537|NCT05320393|466984711|FG000|Overall Study|Withdrawal by Subject|1|||
129733538|NCT05320393|466984712|FG001|Overall Study|Withdrawal by Subject|0|||
129733539|NCT05320393|466984713|FG002|Overall Study|Withdrawal by Subject|2|||
129733540|NCT05320393|466984711|FG000|Overall Study|Lost to Follow-up|1|||
129733541|NCT05320393|466984712|FG001|Overall Study|Lost to Follow-up|2|||
129733542|NCT05320393|466984713|FG002|Overall Study|Lost to Follow-up|1|||
129733543|NCT05320393|466984711|FG000|Overall Study|Moved; too much driving|0|||
129733544|NCT05320393|466984712|FG001|Overall Study|Moved; too much driving|0|||
129733545|NCT05320393|466984713|FG002|Overall Study|Moved; too much driving|2|||
129733546|NCT05320393|466984711|FG000|Overall Study|Did not receive treatment|0|||
129733547|NCT05320393|466984712|FG001|Overall Study|Did not receive treatment|0|||
129733548|NCT05320393|466984713|FG002|Overall Study|Did not receive treatment|1|||
129733549|NCT03559699|466984717|FG000|Overall Study|Withdrawal by Subject|6|||
129733550|NCT03559699|466984717|FG000|Overall Study|Lost to Follow-up|1|||
129733551|NCT05438602|466984722|FG000|Treatment (15 Days)|Adverse Event|2|||
129733552|NCT05438602|466984723|FG001|Treatment (15 Days)|Adverse Event|1|||
129733553|NCT05438602|466984724|FG002|Treatment (15 Days)|Adverse Event|3|||
129733554|NCT05438602|466984722|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
129733555|NCT05438602|466984723|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
129733556|NCT05438602|466984724|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
129733557|NCT05438602|466984722|FG000|Treatment (15 Days)|Other|0|||
129733558|NCT05438602|466984723|FG001|Treatment (15 Days)|Other|0|||
129733559|NCT05438602|466984724|FG002|Treatment (15 Days)|Other|1|||
129733560|NCT05438602|466984722|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
129733561|NCT05438602|466984723|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
129733562|NCT05438602|466984724|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
129733563|NCT05438602|466984722|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
129733564|NCT05438602|466984723|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
129733565|NCT05438602|466984724|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
129733566|NCT05438602|466984722|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
129733567|NCT05438602|466984723|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
129733568|NCT05438602|466984724|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
129733569|NCT05438602|466984722|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
129733570|NCT05438602|466984723|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
129733571|NCT05438602|466984724|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
129733572|NCT05438602|466984722|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
129733573|NCT05438602|466984723|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
129733574|NCT05438602|466984724|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
129733575|NCT05438602|466984722|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
129733576|NCT05438602|466984723|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
129733577|NCT05438602|466984724|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
129733578|NCT05438602|466984722|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
129733579|NCT05438602|466984723|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
129892862|NCT00515086|467567706|FG003|Overall Study|Lost to Follow-up|0|||
129892863|NCT00515086|467567703|FG000|Overall Study|Study drug no longer required|0|||
129444703|NCT01271803|465929424|FG001|Overall Study|Lost to Follow-up|0|||
129444704|NCT01271803|465929425|FG002|Overall Study|Lost to Follow-up|0|||
129733580|NCT05438602|466984724|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
129733581|NCT01930890|466984725|FG000|Overall Study|Study Termination|14|||
129733582|NCT01930890|466984726|FG001|Overall Study|Study Termination|28|||
129733583|NCT01930890|466984727|FG002|Overall Study|Study Termination|13|||
129733584|NCT01930890|466984728|FG003|Overall Study|Study Termination|25|||
129733585|NCT01930890|466984725|FG000|Overall Study|Death|0|||
129733586|NCT01930890|466984726|FG001|Overall Study|Death|0|||
129733587|NCT01930890|466984727|FG002|Overall Study|Death|0|||
129733588|NCT01930890|466984728|FG003|Overall Study|Death|1|||
129733589|NCT01930890|466984725|FG000|Overall Study|Investigator Decision|0|||
129733590|NCT01930890|466984726|FG001|Overall Study|Investigator Decision|1|||
129733591|NCT01930890|466984727|FG002|Overall Study|Investigator Decision|0|||
129733592|NCT01930890|466984728|FG003|Overall Study|Investigator Decision|0|||
129733593|NCT01930890|466984725|FG000|Overall Study|Consent Withdrawn|0|||
129733594|NCT01930890|466984726|FG001|Overall Study|Consent Withdrawn|3|||
129733595|NCT01930890|466984727|FG002|Overall Study|Consent Withdrawn|0|||
129733596|NCT01930890|466984728|FG003|Overall Study|Consent Withdrawn|1|||
129733597|NCT01930890|466984725|FG000|Overall Study|Adverse Event|0|||
129733598|NCT01930890|466984726|FG001|Overall Study|Adverse Event|1|||
129733599|NCT01930890|466984727|FG002|Overall Study|Adverse Event|0|||
129733600|NCT01930890|466984728|FG003|Overall Study|Adverse Event|0|||
129733601|NCT01278407|466984729|FG000|Confirmatory Phase|Adverse Event|5|||
129733602|NCT01278407|466984730|FG001|Confirmatory Phase|Adverse Event|10|||
129733603|NCT01278407|466984731|FG002|Confirmatory Phase|Adverse Event|1|||
129733604|NCT01278407|466984732|FG003|Confirmatory Phase|Adverse Event|0|||
129733605|NCT01278407|466984733|FG004|Confirmatory Phase|Adverse Event|0|||
129733606|NCT01278407|466984729|FG000|Confirmatory Phase|Participant's Choice|3|||
129733607|NCT01278407|466984730|FG001|Confirmatory Phase|Participant's Choice|5|||
129733608|NCT01278407|466984731|FG002|Confirmatory Phase|Participant's Choice|3|||
129733609|NCT01278407|466984732|FG003|Confirmatory Phase|Participant's Choice|0|||
129733610|NCT01278407|466984733|FG004|Confirmatory Phase|Participant's Choice|0|||
129733611|NCT01278407|466984729|FG000|Confirmatory Phase|Other|1|||
129733612|NCT01278407|466984730|FG001|Confirmatory Phase|Other|1|||
129733613|NCT01278407|466984731|FG002|Confirmatory Phase|Other|2|||
129733614|NCT01278407|466984732|FG003|Confirmatory Phase|Other|0|||
129733615|NCT01278407|466984733|FG004|Confirmatory Phase|Other|0|||
129733616|NCT01278407|466984729|FG000|Extension Phase|Adverse Event|0|||
129733617|NCT01278407|466984730|FG001|Extension Phase|Adverse Event|0|||
129733618|NCT01278407|466984731|FG002|Extension Phase|Adverse Event|0|||
129733619|NCT01278407|466984732|FG003|Extension Phase|Adverse Event|7|||
129733620|NCT01278407|466984733|FG004|Extension Phase|Adverse Event|16|||
129733621|NCT01278407|466984729|FG000|Extension Phase|Participant's Choice|0|||
129733622|NCT01278407|466984730|FG001|Extension Phase|Participant's Choice|0|||
129733623|NCT01278407|466984731|FG002|Extension Phase|Participant's Choice|0|||
129733624|NCT01278407|466984732|FG003|Extension Phase|Participant's Choice|4|||
129733625|NCT01278407|466984733|FG004|Extension Phase|Participant's Choice|11|||
129733626|NCT01278407|466984729|FG000|Extension Phase|Other|0|||
129733627|NCT01278407|466984730|FG001|Extension Phase|Other|0|||
129733628|NCT01278407|466984731|FG002|Extension Phase|Other|0|||
129733629|NCT01278407|466984732|FG003|Extension Phase|Other|1|||
129733630|NCT01278407|466984733|FG004|Extension Phase|Other|3|||
129444705|NCT02178553|465929431|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
129733631|NCT02534935|466984734|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
129733632|NCT02534935|466984735|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
129733633|NCT02534935|466984736|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
129733634|NCT02534935|466984734|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
129733635|NCT02534935|466984735|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
129733636|NCT02534935|466984736|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
129733637|NCT02534935|466984734|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
129733638|NCT02534935|466984735|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
129892864|NCT00515086|467567704|FG001|Overall Study|Study drug no longer required|1|||
129892865|NCT00515086|467567705|FG002|Overall Study|Study drug no longer required|0|||
129892866|NCT00515086|467567706|FG003|Overall Study|Study drug no longer required|0|||
129892867|NCT00515086|467567703|FG000|Overall Study|Death|2|||
129892868|NCT00515086|467567704|FG001|Overall Study|Death|0|||
129892869|NCT00515086|467567705|FG002|Overall Study|Death|0|||
129892870|NCT00515086|467567706|FG003|Overall Study|Death|0|||
129892871|NCT02028884|467567707|FG000|Double-blind Period|Adverse Event|5|||
129892872|NCT02028884|467567708|FG001|Double-blind Period|Adverse Event|3|||
129892873|NCT02028884|467567709|FG002|Double-blind Period|Adverse Event|0|||
129892874|NCT02028884|467567707|FG000|Double-blind Period|Eligibility Violation|1|||
129892875|NCT02028884|467567708|FG001|Double-blind Period|Eligibility Violation|0|||
129892876|NCT02028884|467567709|FG002|Double-blind Period|Eligibility Violation|0|||
129892877|NCT02028884|467567707|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
129892878|NCT02028884|467567708|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
129892879|NCT02028884|467567709|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
129892880|NCT02028884|467567707|FG000|Double-blind Period|Withdrawal by Subject|2|||
129892881|NCT02028884|467567708|FG001|Double-blind Period|Withdrawal by Subject|0|||
129892882|NCT02028884|467567709|FG002|Double-blind Period|Withdrawal by Subject|0|||
129892883|NCT02028884|467567707|FG000|Open-label Extension Period|Adverse Event|3|||
129892884|NCT02028884|467567708|FG001|Open-label Extension Period|Adverse Event|1|||
129892885|NCT02028884|467567709|FG002|Open-label Extension Period|Adverse Event|0|||
129892886|NCT02028884|467567707|FG000|Open-label Extension Period|Lack of Efficacy|3|||
129892887|NCT02028884|467567708|FG001|Open-label Extension Period|Lack of Efficacy|0|||
129892888|NCT02028884|467567709|FG002|Open-label Extension Period|Lack of Efficacy|0|||
129892889|NCT02028884|467567707|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
129892890|NCT02028884|467567708|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
129892891|NCT02028884|467567709|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
129892892|NCT02028884|467567707|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129892893|NCT02028884|467567708|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
129892894|NCT02028884|467567709|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
129892895|NCT02028884|467567707|FG000|Open-label Extension Period|Switched to another treatment option|3|||
129892896|NCT02028884|467567708|FG001|Open-label Extension Period|Switched to another treatment option|0|||
129892897|NCT02028884|467567709|FG002|Open-label Extension Period|Switched to another treatment option|0|||
129892898|NCT02373813|467567710|FG000|Run-In Period|Other, Not Specified|5|||
129892899|NCT02373813|467567711|FG001|Run-In Period|Other, Not Specified|0|||
129892900|NCT02373813|467567712|FG002|Run-In Period|Other, Not Specified|0|||
129892901|NCT02373813|467567713|FG003|Run-In Period|Other, Not Specified|0|||
129892902|NCT02373813|467567710|FG000|Run-In Period|Withdrawal by Subject|16|||
129892903|NCT02373813|467567711|FG001|Run-In Period|Withdrawal by Subject|0|||
129892904|NCT02373813|467567712|FG002|Run-In Period|Withdrawal by Subject|0|||
129892905|NCT02373813|467567713|FG003|Run-In Period|Withdrawal by Subject|0|||
129892906|NCT02373813|467567710|FG000|Run-In Period|Decision by Sponsor|11|||
129892907|NCT02373813|467567711|FG001|Run-In Period|Decision by Sponsor|0|||
129892908|NCT02373813|467567712|FG002|Run-In Period|Decision by Sponsor|0|||
129892909|NCT02373813|467567713|FG003|Run-In Period|Decision by Sponsor|0|||
129892910|NCT02373813|467567710|FG000|Run-In Period|Protocol Violation|75|||
129892911|NCT02373813|467567711|FG001|Run-In Period|Protocol Violation|0|||
129892912|NCT02373813|467567712|FG002|Run-In Period|Protocol Violation|0|||
129892913|NCT02373813|467567713|FG003|Run-In Period|Protocol Violation|0|||
129892914|NCT02373813|467567710|FG000|Run-In Period|Lost to Follow-up|2|||
129892915|NCT02373813|467567711|FG001|Run-In Period|Lost to Follow-up|0|||
129892916|NCT02373813|467567712|FG002|Run-In Period|Lost to Follow-up|0|||
129892917|NCT02373813|467567713|FG003|Run-In Period|Lost to Follow-up|0|||
129892918|NCT02373813|467567710|FG000|Run-In Period|Adverse Event|3|||
129892919|NCT02373813|467567711|FG001|Run-In Period|Adverse Event|0|||
129892920|NCT02373813|467567712|FG002|Run-In Period|Adverse Event|0|||
129892921|NCT02373813|467567713|FG003|Run-In Period|Adverse Event|0|||
129892922|NCT02373813|467567710|FG000|Run-In Period|Noncompliance|1|||
129733639|NCT02534935|466984736|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
129733640|NCT02534935|466984734|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
129733641|NCT02534935|466984735|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
129733642|NCT02534935|466984736|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
129892923|NCT02373813|467567711|FG001|Run-In Period|Noncompliance|0|||
129892924|NCT02373813|467567712|FG002|Run-In Period|Noncompliance|0|||
129892925|NCT02373813|467567713|FG003|Run-In Period|Noncompliance|0|||
129892926|NCT02373813|467567710|FG000|Run-In Period|Ineligibility Determined|3|||
129892927|NCT02373813|467567711|FG001|Run-In Period|Ineligibility Determined|0|||
129892928|NCT02373813|467567712|FG002|Run-In Period|Ineligibility Determined|0|||
129892929|NCT02373813|467567713|FG003|Run-In Period|Ineligibility Determined|0|||
129892930|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
129892931|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
129892932|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
129804471|NCT03181893|467251543|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804472|NCT03181893|467251544|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129733643|NCT02534935|466984734|FG000|Stage 1: 24 Months|Adverse Event|0|||
129733644|NCT02534935|466984735|FG001|Stage 1: 24 Months|Adverse Event|2|||
129733645|NCT02534935|466984736|FG002|Stage 1: 24 Months|Adverse Event|0|||
129804473|NCT03181893|467251545|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804474|NCT03181893|467251546|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804475|NCT03181893|467251547|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804476|NCT03181893|467251548|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
129804477|NCT03181893|467251538|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804478|NCT03181893|467251539|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804479|NCT03181893|467251540|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804480|NCT03181893|467251541|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804481|NCT03181893|467251542|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804482|NCT03181893|467251543|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804483|NCT03181893|467251544|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804484|NCT03181893|467251545|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
129804485|NCT03181893|467251546|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
129804486|NCT03181893|467251547|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804487|NCT03181893|467251548|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
129804488|NCT03181893|467251538|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804489|NCT03181893|467251539|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804490|NCT03181893|467251540|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804491|NCT03181893|467251541|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804492|NCT03181893|467251542|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804493|NCT03181893|467251543|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804494|NCT03181893|467251544|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804495|NCT03181893|467251545|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804496|NCT03181893|467251546|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129804497|NCT03181893|467251547|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
129804498|NCT03181893|467251548|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
129733646|NCT02534935|466984734|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
129733647|NCT02534935|466984735|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
129733648|NCT02534935|466984736|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
129733649|NCT02534935|466984734|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
129733650|NCT02534935|466984735|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
129733651|NCT02534935|466984736|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
129733652|NCT01460719|466984737|FG000|Overall Study|Adverse Event|1|||
129733653|NCT01460719|466984737|FG000|Overall Study|Withdrawal by Subject|1|||
129733654|NCT02838901|466984741|FG000|Overall Study|Withdrawal by Subject|1|||
129733655|NCT02838901|466984742|FG001|Overall Study|Withdrawal by Subject|1|||
129733656|NCT02838901|466984741|FG000|Overall Study|Lost to Follow-up|1|||
129733657|NCT02838901|466984742|FG001|Overall Study|Lost to Follow-up|1|||
129733658|NCT00076336|466984743|FG000|Overall Study|Death|13|||
129733659|NCT00076336|466984744|FG001|Overall Study|Death|17|||
129733660|NCT00076336|466984743|FG000|Overall Study|Adverse Event|4|||
129733661|NCT00076336|466984744|FG001|Overall Study|Adverse Event|4|||
129733662|NCT00076336|466984743|FG000|Overall Study|Lost to Follow-up|4|||
129733663|NCT00076336|466984744|FG001|Overall Study|Lost to Follow-up|4|||
129733664|NCT00076336|466984743|FG000|Overall Study|Non-Compliance|2|||
129733665|NCT00076336|466984744|FG001|Overall Study|Non-Compliance|0|||
129733666|NCT00076336|466984743|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
129733667|NCT00076336|466984744|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
129733668|NCT00076336|466984743|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
129733669|NCT00076336|466984744|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
129733670|NCT00076336|466984743|FG000|Overall Study|Liver Transplantation|3|||
129733671|NCT00076336|466984744|FG001|Overall Study|Liver Transplantation|3|||
129804499|NCT03181893|467251538|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129733672|NCT00076336|466984743|FG000|Overall Study|Virologic Breakthrough|14|||
129733673|NCT00076336|466984744|FG001|Overall Study|Virologic Breakthrough|16|||
129733674|NCT00076336|466984743|FG000|Overall Study|Treatment failure|4|||
129733675|NCT00076336|466984744|FG001|Overall Study|Treatment failure|5|||
129733676|NCT01224821|466984749|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
129733677|NCT01224821|466984749|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
129733678|NCT01224821|466984749|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
129733679|NCT01224821|466984749|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
129733680|NCT01224821|466984749|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
129733681|NCT01224821|466984749|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
129733682|NCT01224821|466984749|FG000|Long-Term Follow-Up|Death|2|||
129733683|NCT01224821|466984749|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
129733684|NCT00623545|466984750|FG000|Overall Study|Adverse Event|6|||
129733685|NCT00623545|466984750|FG000|Overall Study|Withdrawal by Subject|4|||
129733686|NCT02585830|466984757|FG000|Overall Study|Withdrawal by Subject|3|||
129733687|NCT03276052|466984761|FG000|Overall Study|Withdrawal by Subject|5|||
129733688|NCT03276052|466984761|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
129804500|NCT03181893|467251539|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804501|NCT03181893|467251540|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804502|NCT03181893|467251541|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804503|NCT03181893|467251542|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804504|NCT03181893|467251543|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804505|NCT03181893|467251544|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804506|NCT03181893|467251545|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804507|NCT03181893|467251546|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804508|NCT03181893|467251547|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
129804509|NCT03181893|467251548|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
129733689|NCT00435162|466984763|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
129733690|NCT00435162|466984764|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
129733691|NCT00435162|466984765|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
129733692|NCT00435162|466984766|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
129733693|NCT00435162|466984767|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
129733694|NCT00435162|466984768|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
129733695|NCT01765426|466984771|FG000|Overall Study|Lost to Follow-up|0|||
129733696|NCT01765426|466984772|FG001|Overall Study|Lost to Follow-up|1|||
129733697|NCT01765426|466984773|FG002|Overall Study|Lost to Follow-up|0|||
129733698|NCT01765426|466984774|FG003|Overall Study|Lost to Follow-up|0|||
129733699|NCT01510184|466984775|FG000|Overall Study|Sponsor discretion|28|||
129733700|NCT01510184|466984776|FG001|Overall Study|Sponsor discretion|28|||
129733701|NCT01510184|466984775|FG000|Overall Study|Death|1|||
129733702|NCT01510184|466984776|FG001|Overall Study|Death|2|||
129733703|NCT01510184|466984775|FG000|Overall Study|Withdrawal by Subject|1|||
129733704|NCT01510184|466984776|FG001|Overall Study|Withdrawal by Subject|4|||
129733705|NCT01510184|466984775|FG000|Overall Study|Other|0|||
129733706|NCT01510184|466984776|FG001|Overall Study|Other|1|||
129733707|NCT01484834|466984787|FG000|Overall Study|Lost to Follow-up|5|||
129733708|NCT01484834|466984788|FG001|Overall Study|Lost to Follow-up|8|||
129733709|NCT01484834|466984789|FG002|Overall Study|Lost to Follow-up|1|||
129733710|NCT01484834|466984790|FG003|Overall Study|Lost to Follow-up|4|||
129733711|NCT00747344|466984791|FG000|Controlled Period|Adverse Event|3|||
129733712|NCT00747344|466984792|FG001|Controlled Period|Adverse Event|0|||
129733713|NCT00747344|466984793|FG002|Controlled Period|Adverse Event|0|||
129733714|NCT00747344|466984794|FG003|Controlled Period|Adverse Event|0|||
129733715|NCT00747344|466984791|FG000|Controlled Period|Lack of Efficacy|2|||
129733716|NCT00747344|466984792|FG001|Controlled Period|Lack of Efficacy|1|||
129733717|NCT00747344|466984793|FG002|Controlled Period|Lack of Efficacy|0|||
129733718|NCT00747344|466984794|FG003|Controlled Period|Lack of Efficacy|0|||
129733719|NCT00747344|466984791|FG000|Controlled Period|Other|0|||
129733720|NCT00747344|466984792|FG001|Controlled Period|Other|3|||
129733721|NCT00747344|466984793|FG002|Controlled Period|Other|0|||
129733722|NCT00747344|466984794|FG003|Controlled Period|Other|0|||
129733723|NCT00747344|466984791|FG000|After Controlled Period|Adverse Event|0|||
129733724|NCT00747344|466984792|FG001|After Controlled Period|Adverse Event|0|||
129733725|NCT00747344|466984793|FG002|After Controlled Period|Adverse Event|0|||
129804510|NCT00968864|467251550|FG000|Overall Study|Protocol exception/ not evaluable|1|||
129804511|NCT04815031|467251551|FG000|Overall Study|No adverse event information (missing information)|33|||
129804512|NCT00586625|467251552|FG000|Overall Study|Adverse Event|6|||
129733726|NCT00747344|466984794|FG003|After Controlled Period|Adverse Event|1|||
129733727|NCT00765882|466984795|FG000|Overall Study|Adverse Event|10|||
129733728|NCT00765882|466984796|FG001|Overall Study|Adverse Event|21|||
129733729|NCT00765882|466984797|FG002|Overall Study|Adverse Event|20|||
129733730|NCT00765882|466984795|FG000|Overall Study|Lack of Efficacy|4|||
129733731|NCT00765882|466984796|FG001|Overall Study|Lack of Efficacy|0|||
129733732|NCT00765882|466984797|FG002|Overall Study|Lack of Efficacy|1|||
129733733|NCT00765882|466984795|FG000|Overall Study|Protocol Violation|4|||
129733734|NCT00765882|466984796|FG001|Overall Study|Protocol Violation|3|||
129733735|NCT00765882|466984797|FG002|Overall Study|Protocol Violation|1|||
129733736|NCT00765882|466984795|FG000|Overall Study|Withdrawal by Subject|2|||
129733737|NCT00765882|466984796|FG001|Overall Study|Withdrawal by Subject|6|||
129733738|NCT00765882|466984797|FG002|Overall Study|Withdrawal by Subject|6|||
129733739|NCT00765882|466984795|FG000|Overall Study|Lost to Follow-up|1|||
129733740|NCT00765882|466984796|FG001|Overall Study|Lost to Follow-up|9|||
129733741|NCT00765882|466984797|FG002|Overall Study|Lost to Follow-up|6|||
129733742|NCT00765882|466984795|FG000|Overall Study|Other Reason|3|||
129733743|NCT00765882|466984796|FG001|Overall Study|Other Reason|1|||
129733744|NCT00765882|466984797|FG002|Overall Study|Other Reason|2|||
129733745|NCT02231762|466984798|FG000|Combination Phase|Adverse Event|10|||
129733746|NCT02231762|466984799|FG001|Combination Phase|Adverse Event|0|||
129733747|NCT02231762|466984800|FG002|Combination Phase|Adverse Event|0|||
129733748|NCT02231762|466984801|FG003|Combination Phase|Adverse Event|0|||
129733749|NCT02231762|466984798|FG000|Combination Phase|Withdrawal by Subject|2|||
129733750|NCT02231762|466984799|FG001|Combination Phase|Withdrawal by Subject|0|||
129733751|NCT02231762|466984800|FG002|Combination Phase|Withdrawal by Subject|0|||
129733752|NCT02231762|466984801|FG003|Combination Phase|Withdrawal by Subject|0|||
129733753|NCT02231762|466984798|FG000|Combination Phase|Disease Progression|6|||
129733754|NCT02231762|466984799|FG001|Combination Phase|Disease Progression|0|||
129733755|NCT02231762|466984800|FG002|Combination Phase|Disease Progression|0|||
129733756|NCT02231762|466984801|FG003|Combination Phase|Disease Progression|0|||
129733757|NCT02231762|466984798|FG000|Combination Phase|Did not meet inclusion criteria|1|||
129733758|NCT02231762|466984799|FG001|Combination Phase|Did not meet inclusion criteria|0|||
129733759|NCT02231762|466984800|FG002|Combination Phase|Did not meet inclusion criteria|0|||
129733760|NCT02231762|466984801|FG003|Combination Phase|Did not meet inclusion criteria|0|||
129733761|NCT02231762|466984798|FG000|Combination Phase|Protocol Violation|1|||
129733762|NCT02231762|466984799|FG001|Combination Phase|Protocol Violation|0|||
129733763|NCT02231762|466984800|FG002|Combination Phase|Protocol Violation|0|||
129733764|NCT02231762|466984801|FG003|Combination Phase|Protocol Violation|0|||
129733765|NCT02231762|466984798|FG000|Maintenance Phase|Disease progression|0|||
129733766|NCT02231762|466984799|FG001|Maintenance Phase|Disease progression|3|||
129733767|NCT02231762|466984800|FG002|Maintenance Phase|Disease progression|4|||
129733768|NCT02231762|466984801|FG003|Maintenance Phase|Disease progression|3|||
129733769|NCT02231762|466984798|FG000|Maintenance Phase|Adverse Event|0|||
129733770|NCT02231762|466984799|FG001|Maintenance Phase|Adverse Event|0|||
129733771|NCT02231762|466984800|FG002|Maintenance Phase|Adverse Event|1|||
129733772|NCT02231762|466984801|FG003|Maintenance Phase|Adverse Event|2|||
129733773|NCT01799239|466984802|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
129733774|NCT01799239|466984803|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
129733775|NCT01799239|466984802|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
129733776|NCT01799239|466984803|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
129733777|NCT01799239|466984802|FG000|Period 1 (7 Days)|Protocol Violation|0|||
129733778|NCT01799239|466984803|FG001|Period 1 (7 Days)|Protocol Violation|1|||
129733779|NCT01799239|466984802|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
129733780|NCT01799239|466984803|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
129733781|NCT01799239|466984802|FG000|Period 2 (7 Days)|Protocol Violation|1|||
129733782|NCT01799239|466984803|FG001|Period 2 (7 Days)|Protocol Violation|0|||
129733783|NCT01286987|466984807|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
129733784|NCT01286987|466984808|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
129733785|NCT01286987|466984809|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
129733786|NCT01286987|466984810|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
129733787|NCT01286987|466984811|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
129733788|NCT01286987|466984812|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
129733789|NCT01286987|466984813|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
129733790|NCT01286987|466984814|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
129733791|NCT01286987|466984815|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
129733792|NCT01286987|466984816|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
129733793|NCT01286987|466984817|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
129733794|NCT01286987|466984818|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
129733795|NCT01286987|466984819|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
129733796|NCT01286987|466984820|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
129733797|NCT01286987|466984821|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
129733798|NCT01286987|466984807|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
129733799|NCT01286987|466984808|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
129733800|NCT01286987|466984809|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
129733801|NCT01286987|466984810|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
129733802|NCT01286987|466984811|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
129733803|NCT01286987|466984812|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
129733804|NCT01286987|466984813|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
129733805|NCT01286987|466984814|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
129733806|NCT01286987|466984815|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
129733807|NCT01286987|466984816|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
129733808|NCT01286987|466984817|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
129733809|NCT01286987|466984818|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
129733810|NCT01286987|466984819|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
129733811|NCT01286987|466984820|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
129733812|NCT01286987|466984821|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
129733813|NCT01286987|466984807|FG000|Part 1: Dose Escalation|Physician Decision|0|||
129733814|NCT01286987|466984808|FG001|Part 1: Dose Escalation|Physician Decision|0|||
129733815|NCT01286987|466984809|FG002|Part 1: Dose Escalation|Physician Decision|0|||
129733816|NCT01286987|466984810|FG003|Part 1: Dose Escalation|Physician Decision|0|||
129733817|NCT01286987|466984811|FG004|Part 1: Dose Escalation|Physician Decision|1|||
129733818|NCT01286987|466984812|FG005|Part 1: Dose Escalation|Physician Decision|0|||
129733819|NCT01286987|466984813|FG006|Part 1: Dose Escalation|Physician Decision|0|||
129733820|NCT01286987|466984814|FG007|Part 1: Dose Escalation|Physician Decision|0|||
129733821|NCT01286987|466984815|FG008|Part 1: Dose Escalation|Physician Decision|0|||
129733822|NCT01286987|466984816|FG009|Part 1: Dose Escalation|Physician Decision|0|||
129733823|NCT01286987|466984817|FG010|Part 1: Dose Escalation|Physician Decision|0|||
129733824|NCT01286987|466984818|FG011|Part 1: Dose Escalation|Physician Decision|0|||
129733825|NCT01286987|466984819|FG012|Part 1: Dose Escalation|Physician Decision|0|||
129733826|NCT01286987|466984820|FG013|Part 1: Dose Escalation|Physician Decision|0|||
129733827|NCT01286987|466984821|FG014|Part 1: Dose Escalation|Physician Decision|0|||
129733828|NCT01286987|466984807|FG000|Part 2: Dose Expansion|Death|0|||
129733829|NCT01286987|466984808|FG001|Part 2: Dose Expansion|Death|0|||
129733830|NCT01286987|466984809|FG002|Part 2: Dose Expansion|Death|0|||
129733831|NCT01286987|466984810|FG003|Part 2: Dose Expansion|Death|0|||
129733832|NCT01286987|466984811|FG004|Part 2: Dose Expansion|Death|0|||
129733833|NCT01286987|466984812|FG005|Part 2: Dose Expansion|Death|0|||
129733834|NCT01286987|466984813|FG006|Part 2: Dose Expansion|Death|0|||
129733835|NCT01286987|466984814|FG007|Part 2: Dose Expansion|Death|0|||
129733836|NCT01286987|466984815|FG008|Part 2: Dose Expansion|Death|0|||
129733837|NCT01286987|466984816|FG009|Part 2: Dose Expansion|Death|0|||
129733838|NCT01286987|466984817|FG010|Part 2: Dose Expansion|Death|0|||
129733839|NCT01286987|466984818|FG011|Part 2: Dose Expansion|Death|0|||
129733840|NCT01286987|466984819|FG012|Part 2: Dose Expansion|Death|1|||
129733841|NCT01286987|466984820|FG013|Part 2: Dose Expansion|Death|1|||
129733842|NCT01286987|466984821|FG014|Part 2: Dose Expansion|Death|0|||
129733843|NCT01286987|466984807|FG000|Part 2: Dose Expansion|Physician Decision|0|||
129733844|NCT01286987|466984808|FG001|Part 2: Dose Expansion|Physician Decision|0|||
129733845|NCT01286987|466984809|FG002|Part 2: Dose Expansion|Physician Decision|0|||
129733846|NCT01286987|466984810|FG003|Part 2: Dose Expansion|Physician Decision|0|||
129733847|NCT01286987|466984811|FG004|Part 2: Dose Expansion|Physician Decision|0|||
129733848|NCT01286987|466984812|FG005|Part 2: Dose Expansion|Physician Decision|0|||
129733849|NCT01286987|466984813|FG006|Part 2: Dose Expansion|Physician Decision|0|||
129733850|NCT01286987|466984814|FG007|Part 2: Dose Expansion|Physician Decision|0|||
129733851|NCT01286987|466984815|FG008|Part 2: Dose Expansion|Physician Decision|0|||
129733852|NCT01286987|466984816|FG009|Part 2: Dose Expansion|Physician Decision|0|||
129733853|NCT01286987|466984817|FG010|Part 2: Dose Expansion|Physician Decision|1|||
129733854|NCT01286987|466984818|FG011|Part 2: Dose Expansion|Physician Decision|1|||
129733855|NCT01286987|466984819|FG012|Part 2: Dose Expansion|Physician Decision|0|||
129733856|NCT01286987|466984820|FG013|Part 2: Dose Expansion|Physician Decision|1|||
129733857|NCT01286987|466984821|FG014|Part 2: Dose Expansion|Physician Decision|0|||
129733858|NCT01286987|466984807|FG000|Part 2: Dose Expansion|Other|0|||
129733859|NCT01286987|466984808|FG001|Part 2: Dose Expansion|Other|0|||
129733860|NCT01286987|466984809|FG002|Part 2: Dose Expansion|Other|0|||
129733861|NCT01286987|466984810|FG003|Part 2: Dose Expansion|Other|0|||
129733862|NCT01286987|466984811|FG004|Part 2: Dose Expansion|Other|0|||
129733863|NCT01286987|466984812|FG005|Part 2: Dose Expansion|Other|0|||
129733864|NCT01286987|466984813|FG006|Part 2: Dose Expansion|Other|0|||
129804513|NCT00586625|467251553|FG001|Overall Study|Adverse Event|6|||
129804514|NCT00586625|467251552|FG000|Overall Study|Protocol Violation|3|||
129804515|NCT00586625|467251553|FG001|Overall Study|Protocol Violation|0|||
129733865|NCT01286987|466984814|FG007|Part 2: Dose Expansion|Other|0|||
129733866|NCT01286987|466984815|FG008|Part 2: Dose Expansion|Other|0|||
129733867|NCT01286987|466984816|FG009|Part 2: Dose Expansion|Other|0|||
129804516|NCT00586625|467251552|FG000|Overall Study|Withdrawal by Subject|32|||
129804517|NCT00586625|467251553|FG001|Overall Study|Withdrawal by Subject|10|||
129804518|NCT00586625|467251552|FG000|Overall Study|Subject non-compliance|0|||
129733868|NCT01286987|466984817|FG010|Part 2: Dose Expansion|Other|0|||
129733869|NCT01286987|466984818|FG011|Part 2: Dose Expansion|Other|0|||
129733870|NCT01286987|466984819|FG012|Part 2: Dose Expansion|Other|0|||
129733871|NCT01286987|466984820|FG013|Part 2: Dose Expansion|Other|1|||
129733872|NCT01286987|466984821|FG014|Part 2: Dose Expansion|Other|0|||
129733873|NCT01286987|466984807|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
129733874|NCT01286987|466984808|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
129733875|NCT01286987|466984809|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
129733876|NCT01286987|466984810|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
129733877|NCT01286987|466984811|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
129733878|NCT01286987|466984812|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
129733879|NCT01286987|466984813|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
129733880|NCT01286987|466984814|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
129733881|NCT01286987|466984815|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
129733882|NCT01286987|466984816|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
129733883|NCT01286987|466984817|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
129733884|NCT01286987|466984818|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
129733885|NCT01286987|466984819|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
129733886|NCT01286987|466984820|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
129733887|NCT01286987|466984821|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
129733888|NCT01286987|466984807|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
129733889|NCT01286987|466984808|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
129733890|NCT01286987|466984809|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
129733891|NCT01286987|466984810|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
129733892|NCT01286987|466984811|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
129733893|NCT01286987|466984812|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
129733894|NCT01286987|466984813|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
129733895|NCT01286987|466984814|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
129733896|NCT01286987|466984815|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
129733897|NCT01286987|466984816|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
129733898|NCT01286987|466984817|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
129733899|NCT01286987|466984818|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
129733900|NCT01286987|466984819|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
129733901|NCT01286987|466984820|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
129733902|NCT01286987|466984821|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
129733903|NCT01286987|466984807|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733904|NCT01286987|466984808|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733905|NCT01286987|466984809|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733906|NCT01286987|466984810|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733907|NCT01286987|466984811|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733908|NCT01286987|466984812|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733909|NCT01286987|466984813|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733910|NCT01286987|466984814|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733911|NCT01286987|466984815|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733912|NCT01286987|466984816|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733913|NCT01286987|466984817|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
129733914|NCT01286987|466984818|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733915|NCT01286987|466984819|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733916|NCT01286987|466984820|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733917|NCT01286987|466984821|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129733918|NCT02594098|466984822|FG000|Overall Study|Lack of Efficacy|17|||
129804519|NCT00586625|467251553|FG001|Overall Study|Subject non-compliance|1|||
129804520|NCT00586625|467251552|FG000|Overall Study|Subject unable to return for visit|2|||
129804521|NCT00586625|467251553|FG001|Overall Study|Subject unable to return for visit|0|||
129804522|NCT02728596|467251554|FG000|Overall Study|Refusal unrelated to adverse event|3|||
129804523|NCT02728596|467251555|FG001|Overall Study|Refusal unrelated to adverse event|6|||
129804524|NCT02728596|467251556|FG002|Overall Study|Refusal unrelated to adverse event|7|||
129804525|NCT02728596|467251557|FG003|Overall Study|Refusal unrelated to adverse event|7|||
129804526|NCT02728596|467251554|FG000|Overall Study|Death|44|||
129804527|NCT02728596|467251555|FG001|Overall Study|Death|42|||
129804528|NCT02728596|467251556|FG002|Overall Study|Death|123|||
129804529|NCT02728596|467251557|FG003|Overall Study|Death|68|||
129804530|NCT04032652|467251564|FG000|Overall Study|The study was terminated and the PI has|1|||
129804531|NCT04032652|467251565|FG001|Overall Study|The study was terminated and the PI has|1|||
129804532|NCT00165984|467251566|FG000|Overall Study|Death|15|||
129804533|NCT03945266|467251567|FG000|Overall Study|Withdrawal by Subject|1|||
129804534|NCT03945266|467251568|FG001|Overall Study|Withdrawal by Subject|0|||
129804535|NCT03945266|467251567|FG000|Overall Study|Miscarriage|0|||
129804536|NCT03945266|467251568|FG001|Overall Study|Miscarriage|2|||
129804537|NCT03945266|467251567|FG000|Overall Study|Lost to Follow-up|1|||
129804538|NCT03945266|467251568|FG001|Overall Study|Lost to Follow-up|0|||
129804539|NCT01736124|467251569|FG000|Post-intervention Assessment|Death|2|||
129892933|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
129892934|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129733919|NCT02594098|466984823|FG001|Overall Study|Lack of Efficacy|6|||
129804540|NCT01736124|467251570|FG001|Post-intervention Assessment|Death|2|||
129804541|NCT01736124|467251569|FG000|Post-intervention Assessment|lost computer access|1|||
129804542|NCT01736124|467251570|FG001|Post-intervention Assessment|lost computer access|1|||
129804543|NCT01736124|467251569|FG000|Post-intervention Assessment|Moved away|3|||
129804544|NCT01736124|467251570|FG001|Post-intervention Assessment|Moved away|1|||
129804545|NCT01736124|467251569|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
129733920|NCT02594098|466984822|FG000|Overall Study|Withdrawal by Subject|1|||
129733921|NCT02594098|466984823|FG001|Overall Study|Withdrawal by Subject|3|||
129733922|NCT02594098|466984822|FG000|Overall Study|Terminated participation|6|||
129733923|NCT02594098|466984823|FG001|Overall Study|Terminated participation|2|||
129733924|NCT02594098|466984822|FG000|Overall Study|Seek alternative treatment|2|||
129733925|NCT02594098|466984823|FG001|Overall Study|Seek alternative treatment|1|||
129733926|NCT02594098|466984822|FG000|Overall Study|Other|0|||
129733927|NCT02594098|466984823|FG001|Overall Study|Other|1|||
129733928|NCT00033540|466984824|FG000|Overall Study|Adverse Event|14|||
129733929|NCT00033540|466984824|FG000|Overall Study|Death|1|||
129892935|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
129892936|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
129892937|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
129892938|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129733930|NCT00033540|466984824|FG000|Overall Study|Progression|26|||
129733931|NCT00033540|466984824|FG000|Overall Study|Withdrawal by Subject|6|||
129733932|NCT00033540|466984824|FG000|Overall Study|Other|5|||
129733933|NCT00033540|466984824|FG000|Overall Study|Ineligible|3|||
129733934|NCT00033540|466984824|FG000|Overall Study|Never received treatment|2|||
129733935|NCT03366103|466984825|FG000|Overall Study|Disease Progression|3|||
129733936|NCT03366103|466984826|FG001|Overall Study|Disease Progression|1|||
129733937|NCT03366103|466984827|FG002|Overall Study|Disease Progression|0|||
129733938|NCT03366103|466984825|FG000|Overall Study|Adverse Event|0|||
129733939|NCT03366103|466984826|FG001|Overall Study|Adverse Event|1|||
129733940|NCT03366103|466984827|FG002|Overall Study|Adverse Event|0|||
129733941|NCT01036529|466984828|FG000|Overall Study|Adverse Event|0|||
129733942|NCT01036529|466984829|FG001|Overall Study|Adverse Event|1|||
129733943|NCT01036529|466984828|FG000|Overall Study|Lost to Follow-up|0|||
129733944|NCT01036529|466984829|FG001|Overall Study|Lost to Follow-up|1|||
129733945|NCT01036529|466984828|FG000|Overall Study|Physician Decision|1|||
129733946|NCT01036529|466984829|FG001|Overall Study|Physician Decision|0|||
129733947|NCT01036529|466984828|FG000|Overall Study|Withdrawal by Subject|1|||
129733948|NCT01036529|466984829|FG001|Overall Study|Withdrawal by Subject|1|||
129733949|NCT01036529|466984828|FG000|Overall Study|Sponsor study termination|11|||
129733950|NCT01036529|466984829|FG001|Overall Study|Sponsor study termination|12|||
129733951|NCT01853072|466984830|FG000|Overall Study|Adverse event prior to treatment|0|||
129733952|NCT01853072|466984831|FG001|Overall Study|Adverse event prior to treatment|1|||
129733953|NCT01853072|466984830|FG000|Overall Study|Adverse Event|0|||
129733954|NCT01853072|466984831|FG001|Overall Study|Adverse Event|3|||
129733955|NCT01853072|466984830|FG000|Overall Study|Death|1|||
129733956|NCT01853072|466984831|FG001|Overall Study|Death|4|||
129733957|NCT01853072|466984830|FG000|Overall Study|Lost to Follow-up|0|||
129733958|NCT01853072|466984831|FG001|Overall Study|Lost to Follow-up|3|||
129733959|NCT01853072|466984830|FG000|Overall Study|Non-compliance with study drug|0|||
129733960|NCT01853072|466984831|FG001|Overall Study|Non-compliance with study drug|1|||
129733961|NCT01853072|466984830|FG000|Overall Study|Physician Decision|1|||
129733962|NCT01853072|466984831|FG001|Overall Study|Physician Decision|1|||
129733963|NCT01853072|466984830|FG000|Overall Study|Withdrawal by Subject|1|||
129733964|NCT01853072|466984831|FG001|Overall Study|Withdrawal by Subject|2|||
129733965|NCT01853072|466984830|FG000|Overall Study|Reason not specified|9|||
129733966|NCT01853072|466984831|FG001|Overall Study|Reason not specified|6|||
129733967|NCT01816906|466984832|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
129733968|NCT01816906|466984833|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
129733969|NCT01816906|466984832|FG000|Six Months|Lost to Follow-up|14|||
129733970|NCT01816906|466984833|FG001|Six Months|Lost to Follow-up|16|||
129733971|NCT01816906|466984832|FG000|12 Months|Adverse Event|2|||
129733972|NCT01816906|466984833|FG001|12 Months|Adverse Event|2|||
129733973|NCT01816906|466984832|FG000|12 Months|Death|0|||
129733974|NCT01816906|466984833|FG001|12 Months|Death|2|||
129733975|NCT01816906|466984832|FG000|12 Months|Lost to Follow-up|2|||
129733976|NCT01816906|466984833|FG001|12 Months|Lost to Follow-up|1|||
129733977|NCT01527383|466984834|FG000|Overall Study|Adverse Event|5|||
129733978|NCT01527383|466984835|FG001|Overall Study|Adverse Event|0|||
129733979|NCT01527383|466984834|FG000|Overall Study|Lost to Follow-up|3|||
129733980|NCT01527383|466984835|FG001|Overall Study|Lost to Follow-up|0|||
129733981|NCT01527383|466984834|FG000|Overall Study|Physician Decision|2|||
129733982|NCT01527383|466984835|FG001|Overall Study|Physician Decision|0|||
129733983|NCT01527383|466984834|FG000|Overall Study|Pregnancy|1|||
129733984|NCT01527383|466984835|FG001|Overall Study|Pregnancy|0|||
129733985|NCT01527383|466984834|FG000|Overall Study|Protocol Violation|1|||
129733986|NCT01527383|466984835|FG001|Overall Study|Protocol Violation|0|||
129733987|NCT01527383|466984834|FG000|Overall Study|Screen failure|1|||
129733988|NCT01527383|466984835|FG001|Overall Study|Screen failure|0|||
129733989|NCT01527383|466984834|FG000|Overall Study|Participant moved|0|||
129733990|NCT01527383|466984835|FG001|Overall Study|Participant moved|1|||
129733991|NCT01527383|466984834|FG000|Overall Study|Withdrawal by Subject|2|||
129733992|NCT01527383|466984835|FG001|Overall Study|Withdrawal by Subject|3|||
129733993|NCT00746733|466984836|FG000|Second Intervention|Adverse Event|1|||
129733994|NCT00746733|466984837|FG001|Second Intervention|Adverse Event|0|||
129804546|NCT01736124|467251570|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
129804547|NCT01736124|467251569|FG000|Post-intervention Assessment|Illness|3|||
129804548|NCT01736124|467251570|FG001|Post-intervention Assessment|Illness|2|||
129804549|NCT01736124|467251569|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
129804550|NCT01736124|467251570|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
129804551|NCT01736124|467251569|FG000|Post-intervention Assessment|Temporarily away|3|||
129804552|NCT01736124|467251570|FG001|Post-intervention Assessment|Temporarily away|1|||
129804553|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
129804554|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
129804555|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
129804556|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
129804557|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
129804558|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
129804559|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
129804560|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
129804561|NCT01736124|467251569|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
129444706|NCT02178553|465929432|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
129444707|NCT02178553|465929431|FG000|Overall Study|Physician Decision|0|||
129804562|NCT01736124|467251570|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
129804563|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
129804564|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
129804565|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
129804566|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
129804567|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
129804568|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
129804569|NCT01736124|467251569|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
129804570|NCT01736124|467251570|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
129804571|NCT03553927|467251571|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
129804572|NCT03553927|467251572|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
129804573|NCT03553927|467251571|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
129804574|NCT03553927|467251572|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
129444708|NCT02178553|465929432|FG001|Overall Study|Physician Decision|4|||
129444709|NCT02178553|465929431|FG000|Overall Study|Technical problem with injection|1|||
129444710|NCT02178553|465929432|FG001|Overall Study|Technical problem with injection|3|||
129444711|NCT02187809|465929433|FG000|Overall Study|The study was terminated|3|||
129444712|NCT05085665|465929434|FG000|Overall Study|Physician Decision|2|||
129444713|NCT01641809|465929435|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
129444714|NCT01641809|465929436|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
129444715|NCT01641809|465929437|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
129444716|NCT01641809|465929438|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
129444717|NCT01641809|465929435|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
129444718|NCT01641809|465929436|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
129444719|NCT01641809|465929437|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
129444720|NCT01641809|465929438|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
129444721|NCT01641809|465929435|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
129444722|NCT01641809|465929436|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
129444723|NCT01641809|465929437|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
129444724|NCT01641809|465929438|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
129444725|NCT01641809|465929435|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
129444726|NCT01641809|465929436|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
129444727|NCT01641809|465929437|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
129444728|NCT01641809|465929438|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
129804575|NCT02423772|467251573|FG000|Overall Study|Lost to Follow-up|3|||
129804576|NCT02423772|467251574|FG001|Overall Study|Lost to Follow-up|3|||
129804577|NCT02423772|467251573|FG000|Overall Study|Did not begin intervention|2|||
129804578|NCT02423772|467251574|FG001|Overall Study|Did not begin intervention|5|||
129804579|NCT03360747|467251581|FG000|Overall Study|Voluntary Withdrawal|1|||
129804580|NCT01759511|467251582|FG000|Overall Study|Adverse Event|4|||
129804581|NCT01759511|467251582|FG000|Overall Study|Death|2|||
129733995|NCT00746733|466984836|FG000|Third Intervention|Withdrawal by Subject|1|||
129733996|NCT00746733|466984837|FG001|Third Intervention|Withdrawal by Subject|1|||
129733997|NCT03412604|466984838|FG000|Overall Study|Withdrawal by Subject|1|||
129733998|NCT01287221|466984840|FG000|Overall Study|Lack of Perceived Benefit|1|||
129733999|NCT01287221|466984841|FG001|Overall Study|Lack of Perceived Benefit|1|||
129734000|NCT01287221|466984840|FG000|Overall Study|Adverse Event|3|||
129734001|NCT01287221|466984841|FG001|Overall Study|Adverse Event|3|||
129734002|NCT01287221|466984840|FG000|Overall Study|Withdrawal by Subject|0|||
129734003|NCT01287221|466984841|FG001|Overall Study|Withdrawal by Subject|1|||
129734004|NCT00930969|466984842|FG000|Overall Study|Death|5|||
129734005|NCT00930969|466984842|FG000|Overall Study|Lost to Follow-up|1|||
129734006|NCT00930969|466984842|FG000|Overall Study|Physician Decision|13|||
129734007|NCT00930969|466984842|FG000|Overall Study|Withdrawal by Subject|19|||
129734008|NCT00787137|466984844|FG000|Overall Study|Study Termination|0|||
129734009|NCT00787137|466984845|FG001|Overall Study|Study Termination|0|||
129734010|NCT00787137|466984846|FG002|Overall Study|Study Termination|1|||
129734011|NCT02513823|466984848|FG000|Overall Study|Lost to Follow-up|4|||
129734012|NCT02513823|466984848|FG000|Overall Study|Physician Decision|1|||
129734013|NCT02743780|466984853|FG000|Part 3 (7 Days)|Adverse Event|0|||
129734014|NCT02743780|466984854|FG001|Part 3 (7 Days)|Adverse Event|0|||
129734015|NCT02743780|466984855|FG002|Part 3 (7 Days)|Adverse Event|1|||
129734016|NCT02743780|466984856|FG003|Part 3 (7 Days)|Adverse Event|0|||
129734017|NCT02743780|466984857|FG004|Part 3 (7 Days)|Adverse Event|0|||
129734018|NCT01294462|466984858|FG000|Overall Study|Lost to Follow-up|1|||
129734019|NCT01294462|466984859|FG001|Overall Study|Lost to Follow-up|0|||
129734020|NCT01294462|466984858|FG000|Overall Study|Withdrawal by Subject|65|||
129734021|NCT01294462|466984859|FG001|Overall Study|Withdrawal by Subject|63|||
129734022|NCT04342689|466984867|FG000|Overall Study|Withdrawal by Subject|32|||
129734023|NCT04342689|466984868|FG001|Overall Study|Withdrawal by Subject|33|||
129734024|NCT04342689|466984867|FG000|Overall Study|Lost to Follow-up|10|||
129734025|NCT04342689|466984868|FG001|Overall Study|Lost to Follow-up|12|||
129734026|NCT01460407|466984871|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
129734027|NCT01460407|466984872|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
129734028|NCT04070326|466984873|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
129734029|NCT04070326|466984874|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
129734030|NCT01367704|466984878|FG000|Overall Study|Lost to Follow-up|47|||
129734031|NCT01367704|466984879|FG001|Overall Study|Lost to Follow-up|161|||
129734032|NCT00526110|466984880|FG000|Overall Study|Adverse Event|2|||
129734033|NCT00526110|466984881|FG001|Overall Study|Adverse Event|9|||
129734034|NCT00526110|466984880|FG000|Overall Study|Disease Progression|0|||
129734035|NCT00526110|466984881|FG001|Overall Study|Disease Progression|19|||
129734036|NCT00526110|466984880|FG000|Overall Study|Maximal Response|0|||
129734037|NCT00526110|466984881|FG001|Overall Study|Maximal Response|6|||
129734038|NCT00526110|466984880|FG000|Overall Study|Withdrawal by Subject|0|||
129734039|NCT00526110|466984881|FG001|Overall Study|Withdrawal by Subject|2|||
129734040|NCT00526110|466984880|FG000|Overall Study|Poor Tolerance|0|||
129734041|NCT00526110|466984881|FG001|Overall Study|Poor Tolerance|5|||
129734042|NCT01400243|466984882|FG000|Overall Study|Protocol Violation|8|||
129734043|NCT01400243|466984883|FG001|Overall Study|Protocol Violation|11|||
129734044|NCT02193087|466984885|FG000|Overall Study|Adverse Event|2|||
129734045|NCT02193087|466984886|FG001|Overall Study|Adverse Event|0|||
129734046|NCT02193087|466984887|FG002|Overall Study|Adverse Event|0|||
129734047|NCT02193087|466984888|FG003|Overall Study|Adverse Event|11|||
129734048|NCT02193087|466984885|FG000|Overall Study|Lost to Follow-up|14|||
129804582|NCT01759511|467251582|FG000|Overall Study|Lack of Efficacy|2|||
129804583|NCT01759511|467251582|FG000|Overall Study|Physician Decision|1|||
129804584|NCT01759511|467251582|FG000|Overall Study|Progressive Disease|5|||
129804585|NCT01759511|467251582|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
129804586|NCT01759511|467251582|FG000|Overall Study|Study Terminated by Sponsor|13|||
129804587|NCT01759511|467251582|FG000|Overall Study|Withdrawal by Subject|3|||
129804588|NCT03693300|467252990|FG000|Overall Study|Withdrawal by Subject|6|||
129804589|NCT03693300|467252991|FG001|Overall Study|Withdrawal by Subject|0|||
129804590|NCT03693300|467252990|FG000|Overall Study|Death|50|||
129804591|NCT03693300|467252991|FG001|Overall Study|Death|2|||
129804592|NCT03693300|467252990|FG000|Overall Study|Lost to Follow-up|2|||
129734049|NCT02193087|466984886|FG001|Overall Study|Lost to Follow-up|6|||
129734050|NCT02193087|466984887|FG002|Overall Study|Lost to Follow-up|4|||
129734051|NCT02193087|466984888|FG003|Overall Study|Lost to Follow-up|37|||
129734052|NCT02193087|466984885|FG000|Overall Study|Protocol Violation|2|||
129734053|NCT02193087|466984886|FG001|Overall Study|Protocol Violation|0|||
129734054|NCT02193087|466984887|FG002|Overall Study|Protocol Violation|1|||
129734055|NCT02193087|466984888|FG003|Overall Study|Protocol Violation|2|||
129734056|NCT02193087|466984885|FG000|Overall Study|Withdrawal by Subject|10|||
129734057|NCT02193087|466984886|FG001|Overall Study|Withdrawal by Subject|3|||
129734058|NCT02193087|466984887|FG002|Overall Study|Withdrawal by Subject|1|||
129734059|NCT02193087|466984888|FG003|Overall Study|Withdrawal by Subject|19|||
129734060|NCT02193087|466984885|FG000|Overall Study|Other Reason Not Specified|7|||
129734061|NCT02193087|466984886|FG001|Overall Study|Other Reason Not Specified|2|||
129734062|NCT02193087|466984887|FG002|Overall Study|Other Reason Not Specified|1|||
129734063|NCT02193087|466984888|FG003|Overall Study|Other Reason Not Specified|9|||
129734064|NCT02193087|466984885|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
129734065|NCT02193087|466984886|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
129734066|NCT02193087|466984887|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
129734067|NCT02193087|466984888|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
129734068|NCT04096820|466984889|FG000|Overall Study|Did not return for intervention|2|||
129734069|NCT04096820|466984889|FG000|Overall Study|Death|1|||
129734070|NCT00475865|466984890|FG000|Overall Study|Adverse Event|0|||
129734071|NCT00475865|466984891|FG001|Overall Study|Adverse Event|3|||
129734072|NCT00475865|466984892|FG002|Overall Study|Adverse Event|4|||
129734073|NCT00475865|466984890|FG000|Overall Study|Lack of Efficacy|1|||
129734074|NCT00475865|466984891|FG001|Overall Study|Lack of Efficacy|0|||
129734075|NCT00475865|466984892|FG002|Overall Study|Lack of Efficacy|0|||
129734076|NCT00475865|466984890|FG000|Overall Study|Progressive disease|0|||
129734077|NCT00475865|466984891|FG001|Overall Study|Progressive disease|1|||
129734078|NCT00475865|466984892|FG002|Overall Study|Progressive disease|2|||
129734079|NCT00475865|466984890|FG000|Overall Study|Participant did not wish to continue|1|||
129734080|NCT00475865|466984891|FG001|Overall Study|Participant did not wish to continue|0|||
129734081|NCT00475865|466984892|FG002|Overall Study|Participant did not wish to continue|0|||
129734082|NCT00475865|466984890|FG000|Overall Study|Other than above|0|||
129734083|NCT00475865|466984891|FG001|Overall Study|Other than above|1|||
129734084|NCT00475865|466984892|FG002|Overall Study|Other than above|0|||
129734085|NCT00946322|466984895|FG000|Pre-treatment|participant failure to follow up|1|||
129734086|NCT00946322|466984895|FG000|Post-treatment|participant failure to follow up|2|||
129734087|NCT01453946|466984896|FG000|Overall Study|Did not receive drug for the taper phase|1|||
129734088|NCT01453946|466984896|FG000|Overall Study|Protocol Violation|2|||
129734089|NCT01453946|466984896|FG000|Overall Study|Lack of Efficacy|3|||
129734090|NCT01453946|466984896|FG000|Overall Study|Adverse Event|3|||
129734091|NCT00846040|466984897|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
129734092|NCT00846040|466984898|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
129734093|NCT00846040|466984899|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
129734094|NCT00846040|466984897|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
129734095|NCT00846040|466984898|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
129734096|NCT00846040|466984899|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
129734097|NCT02279498|466984902|FG000|Overall Study|Adverse Event|3|||
129734098|NCT02279498|466984903|FG001|Overall Study|Adverse Event|0|||
129734099|NCT02279498|466984902|FG000|Overall Study|Lack of Efficacy|4|||
129734100|NCT02279498|466984903|FG001|Overall Study|Lack of Efficacy|0|||
129734101|NCT02279498|466984902|FG000|Overall Study|Lost to Follow-up|0|||
129734102|NCT02279498|466984903|FG001|Overall Study|Lost to Follow-up|1|||
129734103|NCT02279498|466984902|FG000|Overall Study|Withdrawal by Subject|9|||
129734104|NCT02279498|466984903|FG001|Overall Study|Withdrawal by Subject|2|||
129734105|NCT02279498|466984902|FG000|Overall Study|Undefined|2|||
129734106|NCT02279498|466984903|FG001|Overall Study|Undefined|1|||
129734107|NCT01048866|466984904|FG000|Overall Study|Adverse Event|1|||
129734108|NCT01048866|466984905|FG001|Overall Study|Adverse Event|0|||
129804593|NCT03693300|467252991|FG001|Overall Study|Lost to Follow-up|0|||
129804594|NCT02206048|467252992|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
129804595|NCT04195906|467252995|FG000|Part 1|Adverse Event|3|||
129804596|NCT04195906|467252996|FG001|Part 1|Adverse Event|7|||
129804597|NCT04195906|467252995|FG000|Part 1|Withdrawal by Subject|0|||
129804598|NCT04195906|467252996|FG001|Part 1|Withdrawal by Subject|1|||
129804599|NCT04195906|467252995|FG000|Part 2|Adverse Event|1|||
129804600|NCT04195906|467252996|FG001|Part 2|Adverse Event|1|||
129804601|NCT04195906|467252995|FG000|Part 2|Withdrawal by Subject|0|||
129734109|NCT01048866|466984904|FG000|Overall Study|Protocol Violation|1|||
129734110|NCT01048866|466984905|FG001|Overall Study|Protocol Violation|0|||
129734111|NCT01048866|466984904|FG000|Overall Study|Physician Decision|1|||
129734112|NCT01048866|466984905|FG001|Overall Study|Physician Decision|0|||
129734113|NCT01048866|466984904|FG000|Overall Study|Withdrawal by Subject|0|||
129734114|NCT01048866|466984905|FG001|Overall Study|Withdrawal by Subject|2|||
129734115|NCT01048866|466984904|FG000|Overall Study|Lost to Follow-up|0|||
129734116|NCT01048866|466984905|FG001|Overall Study|Lost to Follow-up|2|||
129734117|NCT01048866|466984904|FG000|Overall Study|Other|1|||
129734118|NCT01048866|466984905|FG001|Overall Study|Other|1|||
129734119|NCT04068519|466984906|FG000|Dose Verification|Death|15|||
129734120|NCT04068519|466984906|FG000|Dose Verification|Withdrawal by Subject|1|||
129804602|NCT04195906|467252996|FG001|Part 2|Withdrawal by Subject|3|||
129804603|NCT04195906|467252995|FG000|Part 2|Other|1|||
129734121|NCT04068519|466984906|FG000|Pharmacokinetic Sub-study|Death|35|||
129734122|NCT04068519|466984906|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
129734123|NCT04068519|466984906|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
129734124|NCT04068519|466984906|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
129734125|NCT04068519|466984906|FG000|Indication Expansion|Death|152|||
129734126|NCT04068519|466984906|FG000|Indication Expansion|Withdrawal by Subject|10|||
129804604|NCT04195906|467252996|FG001|Part 2|Other|3|||
129804605|NCT00428792|467252997|FG000|Overall Study|Lack of Efficacy|1|||
129734127|NCT04068519|466984906|FG000|Indication Expansion|Lost to Follow-up|7|||
129804606|NCT00428792|467252998|FG001|Overall Study|Lack of Efficacy|3|||
129804607|NCT00428792|467252997|FG000|Overall Study|Lost to Follow-up|0|||
129804608|NCT00428792|467252998|FG001|Overall Study|Lost to Follow-up|1|||
129804609|NCT00639678|467252999|FG000|Overall Study|Withdrawal by Subject|3|||
129804610|NCT00639678|467253000|FG001|Overall Study|Withdrawal by Subject|0|||
129804611|NCT00639678|467253001|FG002|Overall Study|Withdrawal by Subject|4|||
129804612|NCT00639678|467253002|FG003|Overall Study|Withdrawal by Subject|0|||
129804613|NCT00639678|467252999|FG000|Overall Study|Lost to Follow-up|1|||
129804614|NCT00639678|467253000|FG001|Overall Study|Lost to Follow-up|0|||
129804615|NCT00639678|467253001|FG002|Overall Study|Lost to Follow-up|6|||
129804616|NCT00639678|467253002|FG003|Overall Study|Lost to Follow-up|0|||
129804617|NCT00639678|467252999|FG000|Overall Study|Adverse Event|0|||
129804618|NCT00639678|467253000|FG001|Overall Study|Adverse Event|1|||
129804619|NCT00639678|467253001|FG002|Overall Study|Adverse Event|0|||
129804620|NCT00639678|467253002|FG003|Overall Study|Adverse Event|0|||
129804621|NCT00639678|467252999|FG000|Overall Study|Lack of Compliance|0|||
129804622|NCT00639678|467253000|FG001|Overall Study|Lack of Compliance|0|||
129804623|NCT00639678|467253001|FG002|Overall Study|Lack of Compliance|1|||
129804624|NCT00639678|467253002|FG003|Overall Study|Lack of Compliance|0|||
129804625|NCT01926015|467253003|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129804626|NCT01926015|467253004|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129804627|NCT01926015|467253003|FG000|Overall Study|Randomized not treated|2|||
129804628|NCT01926015|467253004|FG001|Overall Study|Randomized not treated|0|||
129804629|NCT01364649|467253005|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
129804630|NCT01364649|467253006|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
129804631|NCT01364649|467253005|FG000|Overall Study|Lack of Efficacy|6|||
129804632|NCT01364649|467253006|FG001|Overall Study|Lack of Efficacy|0|||
129804633|NCT01364649|467253005|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
129804634|NCT01364649|467253006|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
129804635|NCT01364649|467253005|FG000|Overall Study|Protocol Deviations|4|||
129804636|NCT01364649|467253006|FG001|Overall Study|Protocol Deviations|8|||
129804637|NCT01364649|467253005|FG000|Overall Study|Withdrawal of Consent|9|||
129804638|NCT01364649|467253006|FG001|Overall Study|Withdrawal of Consent|7|||
129804639|NCT01364649|467253005|FG000|Overall Study|Lost to Follow-up|12|||
129804640|NCT01364649|467253006|FG001|Overall Study|Lost to Follow-up|13|||
129804641|NCT01364649|467253005|FG000|Overall Study|Other|4|||
129804642|NCT01364649|467253006|FG001|Overall Study|Other|1|||
129804643|NCT00615108|467253024|FG000|Overall Study|Adverse Event|122|||
129804644|NCT00615108|467253024|FG000|Overall Study|Other|370|||
129804645|NCT00615108|467253024|FG000|Overall Study|Lost to Follow-up|15|||
129804646|NCT01914757|467253025|FG000|Overall Study|Severe non-compliance to protocol|3|||
129804647|NCT01914757|467253026|FG001|Overall Study|Severe non-compliance to protocol|1|||
129804648|NCT01914757|467253027|FG002|Overall Study|Severe non-compliance to protocol|2|||
129804649|NCT01914757|467253025|FG000|Overall Study|Lost to Follow-up|5|||
129804650|NCT01914757|467253026|FG001|Overall Study|Lost to Follow-up|8|||
129804651|NCT01914757|467253027|FG002|Overall Study|Lost to Follow-up|6|||
129804652|NCT01914757|467253025|FG000|Overall Study|Withdrawal by Subject|15|||
129804653|NCT01914757|467253026|FG001|Overall Study|Withdrawal by Subject|27|||
129804654|NCT01914757|467253027|FG002|Overall Study|Withdrawal by Subject|19|||
129804655|NCT01914757|467253025|FG000|Overall Study|Death|2|||
129804656|NCT01914757|467253026|FG001|Overall Study|Death|2|||
129804657|NCT01914757|467253027|FG002|Overall Study|Death|1|||
129804658|NCT01914757|467253025|FG000|Overall Study|Adverse Event|4|||
129804659|NCT01914757|467253026|FG001|Overall Study|Adverse Event|3|||
129804660|NCT01914757|467253027|FG002|Overall Study|Adverse Event|4|||
129804661|NCT01914757|467253025|FG000|Overall Study|Study specific withdrawal criteria|0|||
129804662|NCT01914757|467253026|FG001|Overall Study|Study specific withdrawal criteria|1|||
129804663|NCT01914757|467253027|FG002|Overall Study|Study specific withdrawal criteria|0|||
129804664|NCT01914757|467253025|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129804665|NCT01914757|467253026|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129804666|NCT01914757|467253027|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
129804667|NCT01914757|467253025|FG000|Overall Study|Other reasons|5|||
129804668|NCT01914757|467253026|FG001|Overall Study|Other reasons|9|||
129804669|NCT01914757|467253027|FG002|Overall Study|Other reasons|4|||
129804670|NCT01426438|467253034|FG000|Overall Study|Lost to Follow-up|1|||
129804671|NCT01426438|467253035|FG001|Overall Study|Lost to Follow-up|3|||
129804672|NCT01426438|467253034|FG000|Overall Study|Off study Treatment|9|||
129804673|NCT01426438|467253035|FG001|Overall Study|Off study Treatment|3|||
129804674|NCT01426438|467253034|FG000|Overall Study|Poor scan quality|3|||
129804675|NCT01426438|467253035|FG001|Overall Study|Poor scan quality|2|||
129804676|NCT01426438|467253034|FG000|Overall Study|Missed Scan|2|||
129804677|NCT01426438|467253035|FG001|Overall Study|Missed Scan|2|||
129804678|NCT02833350|467253036|FG000|Overall Study|Adverse Event|0|||
129804679|NCT02833350|467253037|FG001|Overall Study|Adverse Event|3|||
129804680|NCT02833350|467253038|FG002|Overall Study|Adverse Event|4|||
129804681|NCT02833350|467253039|FG003|Overall Study|Adverse Event|4|||
129804682|NCT02833350|467253040|FG004|Overall Study|Adverse Event|1|||
129804683|NCT02833350|467253041|FG005|Overall Study|Adverse Event|0|||
129804684|NCT02833350|467253042|FG006|Overall Study|Adverse Event|1|||
129804685|NCT02833350|467253036|FG000|Overall Study|Death|0|||
129734128|NCT04431713|466986385|FG000|Overall Study|Withdrawal by Subject|2|||
129734129|NCT04431713|466986386|FG001|Overall Study|Withdrawal by Subject|0|||
129734130|NCT04431713|466986385|FG000|Overall Study|Death|2|||
129734131|NCT04431713|466986386|FG001|Overall Study|Death|2|||
129734132|NCT02285114|466986388|FG000|Main Phase|Investigator's Discretion|0|||
129734133|NCT02285114|466986389|FG001|Main Phase|Investigator's Discretion|2|||
129734134|NCT02285114|466986390|FG002|Main Phase|Investigator's Discretion|0|||
129734135|NCT02285114|466986391|FG003|Main Phase|Investigator's Discretion|0|||
129734136|NCT02285114|466986392|FG004|Main Phase|Investigator's Discretion|0|||
129734137|NCT02285114|466986393|FG005|Main Phase|Investigator's Discretion|0|||
129734138|NCT02285114|466986388|FG000|Main Phase|Enrolled but Never Treated|1|||
129734139|NCT02285114|466986389|FG001|Main Phase|Enrolled but Never Treated|0|||
129734140|NCT02285114|466986390|FG002|Main Phase|Enrolled but Never Treated|0|||
129734141|NCT02285114|466986391|FG003|Main Phase|Enrolled but Never Treated|0|||
129734142|NCT02285114|466986392|FG004|Main Phase|Enrolled but Never Treated|0|||
129734143|NCT02285114|466986393|FG005|Main Phase|Enrolled but Never Treated|0|||
129734144|NCT02285114|466986388|FG000|Main Phase|Withdrew Consent|0|||
129734145|NCT02285114|466986389|FG001|Main Phase|Withdrew Consent|0|||
129734146|NCT02285114|466986390|FG002|Main Phase|Withdrew Consent|1|||
129734147|NCT02285114|466986391|FG003|Main Phase|Withdrew Consent|0|||
129734148|NCT02285114|466986392|FG004|Main Phase|Withdrew Consent|0|||
129734149|NCT02285114|466986393|FG005|Main Phase|Withdrew Consent|0|||
129734150|NCT02285114|466986388|FG000|Extension Phase|Investigator's Discretion|0|||
129734151|NCT02285114|466986389|FG001|Extension Phase|Investigator's Discretion|0|||
129734152|NCT02285114|466986390|FG002|Extension Phase|Investigator's Discretion|0|||
129734153|NCT02285114|466986391|FG003|Extension Phase|Investigator's Discretion|14|||
129734154|NCT02285114|466986392|FG004|Extension Phase|Investigator's Discretion|1|||
129734155|NCT02285114|466986393|FG005|Extension Phase|Investigator's Discretion|0|||
129734156|NCT02285114|466986388|FG000|Extension Phase|Lost to Follow-up|0|||
129734157|NCT02285114|466986389|FG001|Extension Phase|Lost to Follow-up|0|||
129734158|NCT02285114|466986390|FG002|Extension Phase|Lost to Follow-up|0|||
129734159|NCT02285114|466986391|FG003|Extension Phase|Lost to Follow-up|1|||
129734160|NCT02285114|466986392|FG004|Extension Phase|Lost to Follow-up|1|||
129734161|NCT02285114|466986393|FG005|Extension Phase|Lost to Follow-up|0|||
129734162|NCT02285114|466986388|FG000|Extension Phase|Non-compliance with Study Drug|0|||
129734163|NCT02285114|466986389|FG001|Extension Phase|Non-compliance with Study Drug|0|||
129734164|NCT02285114|466986390|FG002|Extension Phase|Non-compliance with Study Drug|0|||
129734165|NCT02285114|466986391|FG003|Extension Phase|Non-compliance with Study Drug|2|||
129734166|NCT02285114|466986392|FG004|Extension Phase|Non-compliance with Study Drug|0|||
129734167|NCT02285114|466986393|FG005|Extension Phase|Non-compliance with Study Drug|0|||
129734168|NCT02285114|466986388|FG000|Extension Phase|Pregnancy|0|||
129734169|NCT02285114|466986389|FG001|Extension Phase|Pregnancy|0|||
129734170|NCT02285114|466986390|FG002|Extension Phase|Pregnancy|0|||
129734171|NCT02285114|466986391|FG003|Extension Phase|Pregnancy|1|||
129734172|NCT02285114|466986392|FG004|Extension Phase|Pregnancy|0|||
129734173|NCT02285114|466986393|FG005|Extension Phase|Pregnancy|0|||
129734174|NCT01156389|466986399|FG000|Overall Study|Elevated liver enzymes|4|||
129734175|NCT01156389|466986400|FG001|Overall Study|Elevated liver enzymes|0|||
129734176|NCT01156389|466986399|FG000|Overall Study|Vomiting|0|||
129734177|NCT01156389|466986400|FG001|Overall Study|Vomiting|1|||
129734178|NCT04599166|466986407|FG000|Overall Study|Technological failure connecting to study app|80|||
129734179|NCT01777542|466986408|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
129734180|NCT01777542|466986409|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
129734181|NCT00953524|466986411|FG000|Overall Study|Adverse Event|2|||
129734182|NCT00953524|466986412|FG001|Overall Study|Adverse Event|0|||
129734183|NCT00953524|466986413|FG002|Overall Study|Adverse Event|1|||
129734184|NCT00953524|466986414|FG003|Overall Study|Adverse Event|2|||
129734185|NCT00953524|466986411|FG000|Overall Study|Protocol Violation|18|||
129734186|NCT00953524|466986412|FG001|Overall Study|Protocol Violation|10|||
129734187|NCT00953524|466986413|FG002|Overall Study|Protocol Violation|11|||
129734188|NCT00953524|466986414|FG003|Overall Study|Protocol Violation|6|||
129804686|NCT02833350|467253037|FG001|Overall Study|Death|0|||
129804687|NCT02833350|467253038|FG002|Overall Study|Death|1|||
129734189|NCT00953524|466986411|FG000|Overall Study|Lost to Follow-up|0|||
129734190|NCT00953524|466986412|FG001|Overall Study|Lost to Follow-up|1|||
129734191|NCT00953524|466986413|FG002|Overall Study|Lost to Follow-up|1|||
129734192|NCT00953524|466986414|FG003|Overall Study|Lost to Follow-up|0|||
129734193|NCT00953524|466986411|FG000|Overall Study|Withdrawal by Subject|2|||
129734194|NCT00953524|466986412|FG001|Overall Study|Withdrawal by Subject|4|||
129734195|NCT00953524|466986413|FG002|Overall Study|Withdrawal by Subject|1|||
129734196|NCT00953524|466986414|FG003|Overall Study|Withdrawal by Subject|0|||
129734197|NCT00869050|466986422|FG000|Overall Study|Screen Failure|3|||
129734198|NCT03554772|466986426|FG000|Overall Study|Lost to Follow-up|0|||
129734199|NCT03554772|466986427|FG001|Overall Study|Lost to Follow-up|0|||
129734200|NCT03554772|466986428|FG002|Overall Study|Lost to Follow-up|0|||
129734201|NCT03554772|466986429|FG003|Overall Study|Lost to Follow-up|2|||
129734202|NCT05136898|466986431|FG000|Overall Study|Adverse Event|2|||
129734203|NCT01145053|466986432|FG000|Overall Study|Adverse Event|22|||
129734204|NCT01145053|466986432|FG000|Overall Study|Lost to Follow-up|28|||
129734205|NCT01145053|466986432|FG000|Overall Study|Withdrawal by Subject|25|||
129734206|NCT01145053|466986432|FG000|Overall Study|Other|18|||
129734207|NCT01994863|466986433|FG000|Period 1|Adverse Event|4|||
129734208|NCT01994863|466986434|FG001|Period 1|Adverse Event|0|||
129734209|NCT01994863|466986433|FG000|Period 1|Withdrawal by Subject|1|||
129734210|NCT01994863|466986434|FG001|Period 1|Withdrawal by Subject|0|||
129734211|NCT01994863|466986433|FG000|Period 1|Trial stopped by sponsor|1|||
129734212|NCT01994863|466986434|FG001|Period 1|Trial stopped by sponsor|3|||
129734213|NCT01994863|466986433|FG000|Period 1|Lack of Efficacy|1|||
129804688|NCT02833350|467253039|FG003|Overall Study|Death|0|||
129804689|NCT02833350|467253040|FG004|Overall Study|Death|0|||
129804690|NCT02833350|467253041|FG005|Overall Study|Death|0|||
129804691|NCT02833350|467253042|FG006|Overall Study|Death|0|||
129804692|NCT02833350|467253036|FG000|Overall Study|Lack of Efficacy|0|||
129804693|NCT02833350|467253037|FG001|Overall Study|Lack of Efficacy|2|||
129804694|NCT02833350|467253038|FG002|Overall Study|Lack of Efficacy|1|||
129804695|NCT02833350|467253039|FG003|Overall Study|Lack of Efficacy|4|||
129804696|NCT02833350|467253040|FG004|Overall Study|Lack of Efficacy|0|||
129804697|NCT02833350|467253041|FG005|Overall Study|Lack of Efficacy|1|||
129804698|NCT02833350|467253042|FG006|Overall Study|Lack of Efficacy|1|||
129804699|NCT02833350|467253036|FG000|Overall Study|Lost to Follow-up|0|||
129804700|NCT02833350|467253037|FG001|Overall Study|Lost to Follow-up|1|||
129804701|NCT02833350|467253038|FG002|Overall Study|Lost to Follow-up|0|||
129804702|NCT02833350|467253039|FG003|Overall Study|Lost to Follow-up|0|||
129804703|NCT02833350|467253040|FG004|Overall Study|Lost to Follow-up|0|||
129804704|NCT02833350|467253041|FG005|Overall Study|Lost to Follow-up|0|||
129804705|NCT02833350|467253042|FG006|Overall Study|Lost to Follow-up|1|||
129804706|NCT02833350|467253036|FG000|Overall Study|Withdrawal by Subject|3|||
129804707|NCT02833350|467253037|FG001|Overall Study|Withdrawal by Subject|3|||
129804708|NCT02833350|467253038|FG002|Overall Study|Withdrawal by Subject|2|||
129804709|NCT02833350|467253039|FG003|Overall Study|Withdrawal by Subject|0|||
129804710|NCT02833350|467253040|FG004|Overall Study|Withdrawal by Subject|2|||
129804711|NCT02833350|467253041|FG005|Overall Study|Withdrawal by Subject|0|||
129734214|NCT01994863|466986434|FG001|Period 1|Lack of Efficacy|0|||
129734215|NCT01994863|466986433|FG000|Period 2|Adverse Event|0|||
129804712|NCT02833350|467253042|FG006|Overall Study|Withdrawal by Subject|2|||
129804713|NCT01500031|467253045|FG000|Overall Study|Death|1|||
129804714|NCT01500031|467253045|FG000|Overall Study|Withdrawal by Subject|4|||
129734216|NCT01994863|466986434|FG001|Period 2|Adverse Event|1|||
129804715|NCT01604408|467253046|FG000|Treatment Period 1|Protocol Violation|0|||
129804716|NCT01604408|467253047|FG001|Treatment Period 1|Protocol Violation|1|||
129734217|NCT01994863|466986433|FG000|Period 2|Lack of Efficacy|0|||
129734218|NCT01994863|466986434|FG001|Period 2|Lack of Efficacy|2|||
129734219|NCT01994863|466986433|FG000|Period 2|Withdrawal by Subject|1|||
129734220|NCT01994863|466986434|FG001|Period 2|Withdrawal by Subject|1|||
129734221|NCT03060512|466986435|FG000|Overall Study|Adverse Event|4|||
129734222|NCT03060512|466986436|FG001|Overall Study|Adverse Event|6|||
129734223|NCT03060512|466986435|FG000|Overall Study|Lost to Follow-up|1|||
129734224|NCT03060512|466986436|FG001|Overall Study|Lost to Follow-up|1|||
129734225|NCT03060512|466986435|FG000|Overall Study|Withdrawal by Subject|1|||
129804717|NCT01604408|467253046|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129734226|NCT03060512|466986436|FG001|Overall Study|Withdrawal by Subject|0|||
129734227|NCT03060512|466986435|FG000|Overall Study|Non-compliance with study medication|1|||
129734228|NCT03060512|466986436|FG001|Overall Study|Non-compliance with study medication|2|||
129734229|NCT03946124|466986437|FG000|Overall Study|Withdrawal by Subject|19|||
129734230|NCT00241631|466986439|FG000|Run in (2 Weeks)|Physician Decision|3|||
129734231|NCT00241631|466986440|FG001|Run in (2 Weeks)|Physician Decision|3|||
129734232|NCT00241631|466986439|FG000|Phase 1 (4 Weeks)|sore throat|1|||
129734233|NCT00241631|466986440|FG001|Phase 1 (4 Weeks)|sore throat|0|||
129734234|NCT00241631|466986439|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
129734235|NCT00241631|466986440|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
129734236|NCT00241631|466986439|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
129734237|NCT00241631|466986440|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
129734238|NCT00241631|466986439|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
129734239|NCT00241631|466986440|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
129734240|NCT03220581|466986442|FG000|Overall Study|Withdrawal by Subject|0|||
129734241|NCT03220581|466986443|FG001|Overall Study|Withdrawal by Subject|1|||
129734242|NCT03220581|466986442|FG000|Overall Study|Lost to Follow-up|3|||
129734243|NCT03220581|466986443|FG001|Overall Study|Lost to Follow-up|6|||
129734244|NCT00919867|466986444|FG000|First Intervention|Withdrawal by Subject|0|||
129734245|NCT00919867|466986445|FG001|First Intervention|Withdrawal by Subject|0|||
129734246|NCT00919867|466986446|FG002|First Intervention|Withdrawal by Subject|1|||
129734247|NCT00919867|466986447|FG003|First Intervention|Withdrawal by Subject|0|||
129734248|NCT00919867|466986448|FG004|First Intervention|Withdrawal by Subject|0|||
129734249|NCT00919867|466986449|FG005|First Intervention|Withdrawal by Subject|0|||
129734250|NCT00919867|466986444|FG000|First Intervention|Physician Decision|0|||
129734251|NCT00919867|466986445|FG001|First Intervention|Physician Decision|0|||
129734252|NCT00919867|466986446|FG002|First Intervention|Physician Decision|0|||
129734253|NCT00919867|466986447|FG003|First Intervention|Physician Decision|0|||
129734254|NCT00919867|466986448|FG004|First Intervention|Physician Decision|0|||
129734255|NCT00919867|466986449|FG005|First Intervention|Physician Decision|1|||
129734256|NCT01561755|466986455|FG000|Overall Study|Lost to Follow-up|0|||
129734257|NCT01561755|466986456|FG001|Overall Study|Lost to Follow-up|1|||
129734258|NCT02813668|466986458|FG000|Overall Study|Death|4|||
129734259|NCT02813668|466986458|FG000|Overall Study|Lost to Follow-up|509|||
129734260|NCT02813668|466986458|FG000|Overall Study|Withdrawal by Subject|148|||
129734261|NCT02813668|466986458|FG000|Overall Study|No longer at worksite|85|||
129734262|NCT02813668|466986458|FG000|Overall Study|Medical reasons not related to the study|4|||
129734263|NCT04662073|466986459|FG000|Overall Study|Withdrawal by Subject|1|||
129734264|NCT04662073|466986460|FG001|Overall Study|Withdrawal by Subject|0|||
129734265|NCT02185014|466986461|FG000|Overall Study|Adverse Event|18|||
129734266|NCT02185014|466986461|FG000|Overall Study|Withdrew Consent|8|||
129734267|NCT02185014|466986461|FG000|Overall Study|Lost to Follow-up|4|||
129734268|NCT02185014|466986461|FG000|Overall Study|Lack of Efficacy|14|||
129734269|NCT02185014|466986461|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
129734270|NCT02185014|466986461|FG000|Overall Study|Subject Noncompliance|1|||
129734271|NCT02185014|466986461|FG000|Overall Study|Other|4|||
129734272|NCT02370641|466986466|FG000|Overall Study|dropped study|4|||
129734273|NCT02370641|466986467|FG001|Overall Study|dropped study|2|||
129734274|NCT02133664|466986471|FG000|Overall Study|Lost to Follow-up|2|||
129734275|NCT02133664|466986472|FG001|Overall Study|Lost to Follow-up|1|||
129734276|NCT02133664|466986471|FG000|Overall Study|Adverse Event|3|||
129734277|NCT02133664|466986472|FG001|Overall Study|Adverse Event|6|||
129734278|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
129734279|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
129734280|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
129734281|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
129734282|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
129734283|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
129734284|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
129734285|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
129734286|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
129734287|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
129734288|NCT03906656|466986475|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
129734289|NCT03906656|466986476|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
129804718|NCT01604408|467253047|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129804719|NCT01604408|467253046|FG000|Treatment Period 2|Protocol Violation|1|||
129734290|NCT03906656|466986475|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
129734291|NCT03906656|466986476|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
129734292|NCT03906656|466986475|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
129734293|NCT03906656|466986476|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
129734294|NCT03906656|466986475|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
129734295|NCT03906656|466986476|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
129734296|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
129804720|NCT01604408|467253047|FG001|Treatment Period 2|Protocol Violation|0|||
129734297|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
129734298|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
129734299|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
129734300|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
129734301|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
129734302|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
129734303|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
129734304|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
129734305|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
129734306|NCT03906656|466986475|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
129734307|NCT03906656|466986476|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
129734308|NCT03906656|466986475|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
129734309|NCT03906656|466986476|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
129734310|NCT03906656|466986475|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
129734311|NCT03906656|466986476|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
129734312|NCT03906656|466986475|FG000|Home Use 2 (3 Months)|Death|2|||
129734313|NCT03906656|466986476|FG001|Home Use 2 (3 Months)|Death|0|||
129734314|NCT03906656|466986475|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
129734315|NCT03906656|466986476|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
129734316|NCT03906656|466986475|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
129734317|NCT03906656|466986476|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
129734318|NCT01945775|466986477|FG000|Overall Study|Death|214|||
129734319|NCT01945775|466986478|FG001|Overall Study|Death|98|||
129734320|NCT01945775|466986477|FG000|Overall Study|Lost to Follow-up|12|||
129734321|NCT01945775|466986478|FG001|Overall Study|Lost to Follow-up|7|||
129734322|NCT01945775|466986477|FG000|Overall Study|Withdrawal by Subject|11|||
129734323|NCT01945775|466986478|FG001|Overall Study|Withdrawal by Subject|21|||
129734324|NCT01945775|466986477|FG000|Overall Study|Other|50|||
129734325|NCT01945775|466986478|FG001|Overall Study|Other|18|||
129734326|NCT02876328|466986479|FG000|Overall Study|Death|2|||
129734327|NCT02876328|466986480|FG001|Overall Study|Death|1|||
129734328|NCT02876328|466986481|FG002|Overall Study|Death|3|||
129734329|NCT02876328|466986482|FG003|Overall Study|Death|0|||
129734330|NCT02876328|466986483|FG004|Overall Study|Death|0|||
129734331|NCT02876328|466986484|FG005|Overall Study|Death|0|||
129734332|NCT02876328|466986485|FG006|Overall Study|Death|1|||
129734333|NCT02876328|466986486|FG007|Overall Study|Death|3|||
129734334|NCT02876328|466986487|FG008|Overall Study|Death|0|||
129734335|NCT02876328|466986488|FG009|Overall Study|Death|1|||
129734336|NCT02876328|466986489|FG010|Overall Study|Death|1|||
129734337|NCT02876328|466986490|FG011|Overall Study|Death|0|||
129734338|NCT02876328|466986491|FG012|Overall Study|Death|0|||
129734339|NCT02876328|466986492|FG013|Overall Study|Death|0|||
129734340|NCT02876328|466986493|FG014|Overall Study|Death|0|||
129734341|NCT02876328|466986494|FG015|Overall Study|Death|0|||
129734342|NCT02876328|466986495|FG016|Overall Study|Death|1|||
129734343|NCT02876328|466986496|FG017|Overall Study|Death|1|||
129734344|NCT02876328|466986497|FG018|Overall Study|Death|0|||
129734345|NCT02876328|466986498|FG019|Overall Study|Death|0|||
129734346|NCT02876328|466986499|FG020|Overall Study|Death|0|||
129734347|NCT02876328|466986500|FG021|Overall Study|Death|1|||
129734348|NCT02876328|466986501|FG022|Overall Study|Death|0|||
129734349|NCT02876328|466986502|FG023|Overall Study|Death|0|||
129734350|NCT02876328|466986479|FG000|Overall Study|Withdrawal by Subject|0|||
129734351|NCT02876328|466986480|FG001|Overall Study|Withdrawal by Subject|2|||
129734352|NCT02876328|466986481|FG002|Overall Study|Withdrawal by Subject|3|||
129734353|NCT02876328|466986482|FG003|Overall Study|Withdrawal by Subject|3|||
129734354|NCT02876328|466986483|FG004|Overall Study|Withdrawal by Subject|0|||
129734355|NCT02876328|466986484|FG005|Overall Study|Withdrawal by Subject|1|||
129734356|NCT02876328|466986485|FG006|Overall Study|Withdrawal by Subject|0|||
129734357|NCT02876328|466986486|FG007|Overall Study|Withdrawal by Subject|1|||
129734358|NCT02876328|466986487|FG008|Overall Study|Withdrawal by Subject|1|||
129734359|NCT02876328|466986488|FG009|Overall Study|Withdrawal by Subject|2|||
129734360|NCT02876328|466986489|FG010|Overall Study|Withdrawal by Subject|0|||
129734361|NCT02876328|466986490|FG011|Overall Study|Withdrawal by Subject|0|||
129734362|NCT02876328|466986491|FG012|Overall Study|Withdrawal by Subject|0|||
129734363|NCT02876328|466986492|FG013|Overall Study|Withdrawal by Subject|0|||
129734364|NCT02876328|466986493|FG014|Overall Study|Withdrawal by Subject|0|||
129892939|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
129444729|NCT01641809|465929435|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
129734365|NCT02876328|466986494|FG015|Overall Study|Withdrawal by Subject|0|||
129734366|NCT02876328|466986495|FG016|Overall Study|Withdrawal by Subject|1|||
129734367|NCT02876328|466986496|FG017|Overall Study|Withdrawal by Subject|3|||
129734368|NCT02876328|466986497|FG018|Overall Study|Withdrawal by Subject|0|||
129734369|NCT02876328|466986498|FG019|Overall Study|Withdrawal by Subject|0|||
129734370|NCT02876328|466986499|FG020|Overall Study|Withdrawal by Subject|1|||
129892940|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
129734371|NCT02876328|466986500|FG021|Overall Study|Withdrawal by Subject|0|||
129734372|NCT02876328|466986501|FG022|Overall Study|Withdrawal by Subject|0|||
129734373|NCT02876328|466986502|FG023|Overall Study|Withdrawal by Subject|0|||
129734374|NCT02876328|466986479|FG000|Overall Study|Missed 12 Month Visit|15|||
129734375|NCT02876328|466986480|FG001|Overall Study|Missed 12 Month Visit|10|||
129734376|NCT02876328|466986481|FG002|Overall Study|Missed 12 Month Visit|11|||
129734377|NCT02876328|466986482|FG003|Overall Study|Missed 12 Month Visit|6|||
129734378|NCT02876328|466986483|FG004|Overall Study|Missed 12 Month Visit|10|||
129734379|NCT02876328|466986484|FG005|Overall Study|Missed 12 Month Visit|14|||
129734380|NCT02876328|466986485|FG006|Overall Study|Missed 12 Month Visit|3|||
129734381|NCT02876328|466986486|FG007|Overall Study|Missed 12 Month Visit|8|||
129734382|NCT02876328|466986487|FG008|Overall Study|Missed 12 Month Visit|9|||
129734383|NCT02876328|466986488|FG009|Overall Study|Missed 12 Month Visit|5|||
129734384|NCT02876328|466986489|FG010|Overall Study|Missed 12 Month Visit|4|||
129734385|NCT02876328|466986490|FG011|Overall Study|Missed 12 Month Visit|1|||
129734386|NCT02876328|466986491|FG012|Overall Study|Missed 12 Month Visit|5|||
129734387|NCT02876328|466986492|FG013|Overall Study|Missed 12 Month Visit|4|||
129734388|NCT02876328|466986493|FG014|Overall Study|Missed 12 Month Visit|4|||
129734389|NCT02876328|466986494|FG015|Overall Study|Missed 12 Month Visit|4|||
129734390|NCT02876328|466986495|FG016|Overall Study|Missed 12 Month Visit|3|||
129734391|NCT02876328|466986496|FG017|Overall Study|Missed 12 Month Visit|6|||
129734392|NCT02876328|466986497|FG018|Overall Study|Missed 12 Month Visit|2|||
129734393|NCT02876328|466986498|FG019|Overall Study|Missed 12 Month Visit|2|||
129734394|NCT02876328|466986499|FG020|Overall Study|Missed 12 Month Visit|11|||
129734395|NCT02876328|466986500|FG021|Overall Study|Missed 12 Month Visit|7|||
129734396|NCT02876328|466986501|FG022|Overall Study|Missed 12 Month Visit|1|||
129734397|NCT02876328|466986502|FG023|Overall Study|Missed 12 Month Visit|0|||
129734398|NCT03515941|466986505|FG000|Overall Study|Adverse Event|1|||
129734399|NCT03515941|466986506|FG001|Overall Study|Adverse Event|0|||
129734400|NCT00334282|466986509|FG000|Overall Study|Lost to Follow-up|11|||
129734401|NCT00334282|466986510|FG001|Overall Study|Lost to Follow-up|5|||
129734402|NCT00334282|466986509|FG000|Overall Study|Withdrawal by Subject|17|||
129734403|NCT00334282|466986510|FG001|Overall Study|Withdrawal by Subject|3|||
129734404|NCT00334282|466986509|FG000|Overall Study|Death|194|||
129734405|NCT00334282|466986510|FG001|Overall Study|Death|100|||
129734406|NCT02759315|466986511|FG000|Overall Study|Adverse Event|0|||
129804721|NCT01604408|467253046|FG000|Treatment Period 2|Adverse Event|0|||
129804722|NCT01604408|467253047|FG001|Treatment Period 2|Adverse Event|1|||
129804723|NCT01604408|467253046|FG000|Treatment Period 3|Protocol Violation|1|||
129804724|NCT01604408|467253047|FG001|Treatment Period 3|Protocol Violation|1|||
129804725|NCT01604408|467253046|FG000|Treatment Period 3|Adverse Event|0|||
129444730|NCT01641809|465929436|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
129734407|NCT02759315|466986512|FG001|Overall Study|Adverse Event|0|||
129734408|NCT02759315|466986513|FG002|Overall Study|Adverse Event|0|||
129804726|NCT01604408|467253047|FG001|Treatment Period 3|Adverse Event|3|||
129804727|NCT01604408|467253046|FG000|Treatment Period 3|Withdrawal by Subject|3|||
129804728|NCT01604408|467253047|FG001|Treatment Period 3|Withdrawal by Subject|1|||
129804729|NCT01604408|467253046|FG000|Treatment Period 3|Sponsor Decision|1|||
129804730|NCT01604408|467253047|FG001|Treatment Period 3|Sponsor Decision|0|||
129804731|NCT01604408|467253046|FG000|Treatment Period 4|Death|1|||
129804732|NCT01604408|467253047|FG001|Treatment Period 4|Death|0|||
129804733|NCT01604408|467253046|FG000|Treatment Period 4|Withdrawal by Subject|2|||
129804734|NCT01604408|467253047|FG001|Treatment Period 4|Withdrawal by Subject|1|||
129804735|NCT01604408|467253046|FG000|Treatment Period 4|Adverse Event|0|||
129804736|NCT01604408|467253047|FG001|Treatment Period 4|Adverse Event|1|||
129734409|NCT02759315|466986514|FG003|Overall Study|Adverse Event|1|||
129734410|NCT02759315|466986515|FG004|Overall Study|Adverse Event|0|||
129734411|NCT02759315|466986511|FG000|Overall Study|Death|0|||
129734412|NCT02759315|466986512|FG001|Overall Study|Death|0|||
129734413|NCT02759315|466986513|FG002|Overall Study|Death|1|||
129734414|NCT02759315|466986514|FG003|Overall Study|Death|0|||
129734415|NCT02759315|466986515|FG004|Overall Study|Death|0|||
129892941|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
129734416|NCT02759315|466986511|FG000|Overall Study|Lost to Follow-up|2|||
129892942|NCT02373813|467567710|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129734417|NCT02759315|466986512|FG001|Overall Study|Lost to Follow-up|0|||
129804737|NCT01604408|467253046|FG000|Treatment Period 5|Adverse Event|4|||
129804738|NCT01604408|467253047|FG001|Treatment Period 5|Adverse Event|0|||
129804739|NCT01604408|467253046|FG000|Treatment Period 6|Lost to Follow-up|0|||
129734418|NCT02759315|466986513|FG002|Overall Study|Lost to Follow-up|4|||
129734419|NCT02759315|466986514|FG003|Overall Study|Lost to Follow-up|0|||
129734420|NCT02759315|466986515|FG004|Overall Study|Lost to Follow-up|0|||
129734421|NCT02759315|466986511|FG000|Overall Study|Protocol Violation|0|||
129734422|NCT02759315|466986512|FG001|Overall Study|Protocol Violation|1|||
129734423|NCT02759315|466986513|FG002|Overall Study|Protocol Violation|0|||
129734424|NCT02759315|466986514|FG003|Overall Study|Protocol Violation|0|||
129734425|NCT02759315|466986515|FG004|Overall Study|Protocol Violation|0|||
129734426|NCT02759315|466986511|FG000|Overall Study|Study terminated prior to completion|2|||
129734427|NCT02759315|466986512|FG001|Overall Study|Study terminated prior to completion|0|||
129734428|NCT02759315|466986513|FG002|Overall Study|Study terminated prior to completion|5|||
129734429|NCT02759315|466986514|FG003|Overall Study|Study terminated prior to completion|0|||
129734430|NCT02759315|466986515|FG004|Overall Study|Study terminated prior to completion|1|||
129734431|NCT03464422|466986522|FG000|Overall Study|Lost to Follow-up|2|||
129734432|NCT03464422|466986522|FG000|Overall Study|Withdrawal by Subject|2|||
129734433|NCT01628367|466986530|FG000|Overall Study|Adverse Event|1|||
129734434|NCT01628367|466986531|FG001|Overall Study|Adverse Event|0|||
129734435|NCT03353922|466986532|FG000|Overall Study|Withdrawal by Subject|1|||
129734436|NCT03353922|466986533|FG001|Overall Study|Withdrawal by Subject|0|||
129734437|NCT03353922|466986534|FG002|Overall Study|Withdrawal by Subject|1|||
129734438|NCT03353922|466986535|FG003|Overall Study|Withdrawal by Subject|1|||
129734439|NCT03353922|466986536|FG004|Overall Study|Withdrawal by Subject|0|||
129734440|NCT03353922|466986537|FG005|Overall Study|Withdrawal by Subject|0|||
129734441|NCT03353922|466986532|FG000|Overall Study|Adverse Event|0|||
129734442|NCT03353922|466986533|FG001|Overall Study|Adverse Event|1|||
129734443|NCT03353922|466986534|FG002|Overall Study|Adverse Event|0|||
129734444|NCT03353922|466986535|FG003|Overall Study|Adverse Event|0|||
129734445|NCT03353922|466986536|FG004|Overall Study|Adverse Event|0|||
129734446|NCT03353922|466986537|FG005|Overall Study|Adverse Event|0|||
129734447|NCT00740714|466986538|FG000|Overall Study|Withdrawal by Subject|17|||
129734448|NCT00740714|466986539|FG001|Overall Study|Withdrawal by Subject|19|||
129734449|NCT00740714|466986540|FG002|Overall Study|Withdrawal by Subject|29|||
129734450|NCT03688555|466986541|FG000|Treatment Period|Adverse Event|0|||
129734451|NCT03688555|466986542|FG001|Treatment Period|Adverse Event|0|||
129734452|NCT03688555|466986543|FG002|Treatment Period|Adverse Event|1|||
129734453|NCT00886119|466986544|FG000|Period 1|Did not meet inclusion criteria|1|||
129734454|NCT00886119|466986545|FG001|Period 1|Did not meet inclusion criteria|0|||
129734455|NCT00259298|466986550|FG000|Overall Study|Withdrawal by Subject|1|||
129734456|NCT00259298|466986550|FG000|Overall Study|Physician Decision|2|||
129734457|NCT00645528|466986551|FG000|Overall Study|Did not show up for Visit 2|7|||
129734458|NCT01140568|466986552|FG000|Overall Study|disease progression|31|||
129734459|NCT01140568|466986552|FG000|Overall Study|Withdrawal by Subject|1|||
129734460|NCT01140568|466986552|FG000|Overall Study|Screen Fail|4|||
129734461|NCT03618628|466986553|FG000|Overall Study|Death|1|||
129734462|NCT03618628|466986553|FG000|Overall Study|Lost to Follow-up|1|||
129734463|NCT01741532|466986555|FG000|Overall Study|Adverse Event|4|||
129734464|NCT01741532|466986556|FG001|Overall Study|Adverse Event|0|||
129734465|NCT01741532|466986555|FG000|Overall Study|Withdrawal by Subject|1|||
129734466|NCT01741532|466986556|FG001|Overall Study|Withdrawal by Subject|1|||
129734467|NCT01741532|466986555|FG000|Overall Study|Protocol Violation|0|||
129734468|NCT01741532|466986556|FG001|Overall Study|Protocol Violation|1|||
129734469|NCT01741532|466986555|FG000|Overall Study|Worsening of the disease|3|||
129734470|NCT01741532|466986556|FG001|Overall Study|Worsening of the disease|1|||
129734471|NCT01741532|466986555|FG000|Overall Study|Sponsor decision|1|||
129734472|NCT01741532|466986556|FG001|Overall Study|Sponsor decision|0|||
129734473|NCT01741532|466986555|FG000|Overall Study|Medical event|1|||
129734474|NCT01741532|466986556|FG001|Overall Study|Medical event|0|||
129734475|NCT02153346|466986559|FG000|Overall Study|Lost to Follow-up|11|||
129734476|NCT03158272|466986563|FG000|Overall Study|Disease progression|3|||
129734477|NCT03158272|466986564|FG001|Overall Study|Disease progression|3|||
129734478|NCT03158272|466986565|FG002|Overall Study|Disease progression|4|||
129734479|NCT03158272|466986566|FG003|Overall Study|Disease progression|6|||
129734480|NCT03158272|466986563|FG000|Overall Study|Death|0|||
129734481|NCT03158272|466986564|FG001|Overall Study|Death|0|||
129734482|NCT03158272|466986565|FG002|Overall Study|Death|1|||
129734483|NCT03158272|466986566|FG003|Overall Study|Death|0|||
129734484|NCT03158272|466986563|FG000|Overall Study|Other reasons|0|||
129734485|NCT03158272|466986564|FG001|Overall Study|Other reasons|0|||
129734486|NCT03158272|466986565|FG002|Overall Study|Other reasons|1|||
129734487|NCT03158272|466986566|FG003|Overall Study|Other reasons|0|||
129734488|NCT03158272|466986563|FG000|Overall Study|Adverse event unrelated to the drug|0|||
129734489|NCT03158272|466986564|FG001|Overall Study|Adverse event unrelated to the drug|1|||
129444731|NCT01641809|465929437|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
129734490|NCT03158272|466986565|FG002|Overall Study|Adverse event unrelated to the drug|0|||
129804740|NCT01604408|467253047|FG001|Treatment Period 6|Lost to Follow-up|1|||
129804741|NCT01604408|467253046|FG000|Treatment Period 6|Adverse Event|2|||
129804742|NCT01604408|467253047|FG001|Treatment Period 6|Adverse Event|0|||
129804743|NCT01604408|467253046|FG000|Treatment Period 6|Sponsor decision|0|||
129804744|NCT01604408|467253047|FG001|Treatment Period 6|Sponsor decision|1|||
129804745|NCT01604408|467253046|FG000|Observation Period|Adverse Event|1|||
129804746|NCT01604408|467253047|FG001|Observation Period|Adverse Event|1|||
129804747|NCT01604408|467253046|FG000|Observation Period|Withdrawal by Subject|0|||
129804748|NCT01604408|467253047|FG001|Observation Period|Withdrawal by Subject|2|||
129804749|NCT00917501|467253048|FG000|Overall Study|Lost to Follow-up|4|||
129804750|NCT00917501|467253049|FG001|Overall Study|Lost to Follow-up|1|||
129804751|NCT00917501|467253048|FG000|Overall Study|Withdrawal by Subject|3|||
129804752|NCT00917501|467253049|FG001|Overall Study|Withdrawal by Subject|1|||
129804753|NCT00917501|467253048|FG000|Overall Study|Lack of Efficacy|1|||
129804754|NCT00917501|467253049|FG001|Overall Study|Lack of Efficacy|2|||
129804755|NCT00917501|467253048|FG000|Overall Study|trouble swollowing capsules|0|||
129804756|NCT00917501|467253049|FG001|Overall Study|trouble swollowing capsules|1|||
129804757|NCT00808483|467253050|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
129804758|NCT00808483|467253051|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
129804759|NCT00808483|467253050|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
129804760|NCT00808483|467253051|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
129804761|NCT00808483|467253050|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
129804762|NCT00808483|467253051|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
129804763|NCT04553679|467253052|FG000|Overall Study|Withdrawal by Subject|2|||
129804764|NCT04553679|467253053|FG001|Overall Study|Withdrawal by Subject|0|||
129804765|NCT04553679|467253052|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
129804766|NCT04553679|467253053|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
129804767|NCT02357979|467253054|FG000|Overall Study|Lost to Follow-up|5|||
129444732|NCT01641809|465929438|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
129734491|NCT03158272|466986566|FG003|Overall Study|Adverse event unrelated to the drug|0|||
129734492|NCT01822535|466986567|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
129734493|NCT01822535|466986568|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
129734494|NCT01822535|466986567|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
129734495|NCT01822535|466986568|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
129734496|NCT01822535|466986567|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
129734497|NCT01822535|466986568|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
129734498|NCT02278614|466986571|FG000|Overall Study|Withdrawal by Subject|3|||
129734499|NCT02278614|466986572|FG001|Overall Study|Withdrawal by Subject|5|||
129734500|NCT02278614|466986571|FG000|Overall Study|Adverse Event|1|||
129734501|NCT02278614|466986572|FG001|Overall Study|Adverse Event|0|||
129734502|NCT02278614|466986571|FG000|Overall Study|left eye was not eligible|1|||
129734503|NCT02278614|466986572|FG001|Overall Study|left eye was not eligible|0|||
129734504|NCT03582813|466986573|FG000|Overall Study|Lost to Follow-up|18|||
129734505|NCT03582813|466986574|FG001|Overall Study|Lost to Follow-up|21|||
129734506|NCT03582813|466986573|FG000|Overall Study|Withdrawal by Subject|1|||
129734507|NCT03582813|466986574|FG001|Overall Study|Withdrawal by Subject|0|||
129734508|NCT02366767|466986577|FG000|Overall Study|left for home after 1 day at camp|1|||
129734509|NCT02366767|466986578|FG001|Overall Study|left for home after 1 day at camp|0|||
129734510|NCT02558400|466986581|FG000|Overall Study|Adverse Event|47|||
129734511|NCT02558400|466986582|FG001|Overall Study|Adverse Event|53|||
129734512|NCT02558400|466986583|FG002|Overall Study|Adverse Event|4|||
129734513|NCT02558400|466986581|FG000|Overall Study|Withdrawal by Subject|13|||
129734514|NCT02558400|466986582|FG001|Overall Study|Withdrawal by Subject|9|||
129734515|NCT02558400|466986583|FG002|Overall Study|Withdrawal by Subject|8|||
129734516|NCT02558400|466986581|FG000|Overall Study|Non-Compliant|0|||
129734517|NCT02558400|466986582|FG001|Overall Study|Non-Compliant|1|||
129734518|NCT02558400|466986583|FG002|Overall Study|Non-Compliant|3|||
129734519|NCT02558400|466986581|FG000|Overall Study|Lost to Follow-up|5|||
129734520|NCT02558400|466986582|FG001|Overall Study|Lost to Follow-up|5|||
129734521|NCT02558400|466986583|FG002|Overall Study|Lost to Follow-up|4|||
129734522|NCT02558400|466986581|FG000|Overall Study|Lack of Efficacy|0|||
129734523|NCT02558400|466986582|FG001|Overall Study|Lack of Efficacy|13|||
129734524|NCT02558400|466986583|FG002|Overall Study|Lack of Efficacy|1|||
129804768|NCT02357979|467253055|FG001|Overall Study|Lost to Follow-up|5|||
129804769|NCT03945214|467253056|FG000|Overall Study|Lost to Follow-up|3|||
129444733|NCT01641809|465929435|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
129734525|NCT02558400|466986581|FG000|Overall Study|Disallowed Concurrent Medication|6|||
129734526|NCT02558400|466986582|FG001|Overall Study|Disallowed Concurrent Medication|7|||
129804770|NCT03945214|467253057|FG001|Overall Study|Lost to Follow-up|4|||
129804771|NCT03945214|467253058|FG002|Overall Study|Lost to Follow-up|7|||
129804772|NCT03945214|467253059|FG003|Overall Study|Lost to Follow-up|4|||
129804773|NCT00074984|467253063|FG000|Overall Study|Death|1|||
129734527|NCT02558400|466986583|FG002|Overall Study|Disallowed Concurrent Medication|5|||
129734528|NCT02558400|466986581|FG000|Overall Study|Physician Decision|2|||
129734529|NCT02558400|466986582|FG001|Overall Study|Physician Decision|2|||
129734530|NCT02558400|466986583|FG002|Overall Study|Physician Decision|0|||
129734531|NCT02558400|466986581|FG000|Overall Study|Protocol Violation|6|||
129734532|NCT02558400|466986582|FG001|Overall Study|Protocol Violation|3|||
129734533|NCT02558400|466986583|FG002|Overall Study|Protocol Violation|8|||
129734534|NCT02558400|466986581|FG000|Overall Study|Death|0|||
129734535|NCT02558400|466986582|FG001|Overall Study|Death|1|||
129734536|NCT02558400|466986583|FG002|Overall Study|Death|0|||
129734537|NCT02558400|466986581|FG000|Overall Study|Ineligible for the study|0|||
129734538|NCT02558400|466986582|FG001|Overall Study|Ineligible for the study|2|||
129734539|NCT02558400|466986583|FG002|Overall Study|Ineligible for the study|0|||
129734540|NCT02230683|466986584|FG000|Overall Study|Adverse Event|1|||
129734541|NCT00260065|466986585|FG000|Overall Study|Progressive Disease|22|||
129734542|NCT00260065|466986585|FG000|Overall Study|Adverse Event|17|||
129734543|NCT00260065|466986585|FG000|Overall Study|Death|13|||
129734544|NCT00260065|466986585|FG000|Overall Study|Withdrawal by Subject|13|||
129734545|NCT00260065|466986585|FG000|Overall Study|Physician Decision|19|||
129734546|NCT00260065|466986585|FG000|Overall Study|Not otherwise specified|8|||
129734547|NCT00260065|466986585|FG000|Overall Study|Medication Noncompliance|1|||
129734548|NCT03654885|466988080|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
129734549|NCT03654885|466988081|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
129734550|NCT03654885|466988080|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
129734551|NCT03654885|466988081|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
129734552|NCT03654885|466988080|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
129734553|NCT03654885|466988081|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
129734554|NCT03654885|466988080|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
129734555|NCT03654885|466988081|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
129734556|NCT03654885|466988080|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
129734557|NCT03654885|466988081|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
129734558|NCT03654885|466988080|FG000|Overall Study|Adverse Event in Study Eye|3|||
129734559|NCT03654885|466988081|FG001|Overall Study|Adverse Event in Study Eye|0|||
129734560|NCT03654885|466988080|FG000|Overall Study|Consent Withdrawn|1|||
129734561|NCT03654885|466988081|FG001|Overall Study|Consent Withdrawn|0|||
129734562|NCT03654885|466988080|FG000|Overall Study|Death|3|||
129734563|NCT03654885|466988081|FG001|Overall Study|Death|1|||
129734564|NCT03654885|466988080|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
129734565|NCT03654885|466988081|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
129734566|NCT03654885|466988080|FG000|Overall Study|Lost to Follow-up|3|||
129734567|NCT03654885|466988081|FG001|Overall Study|Lost to Follow-up|3|||
129734568|NCT05275582|466988082|FG000|Overall Study|Lost to Follow-up|1|||
129734569|NCT05275582|466988083|FG001|Overall Study|Lost to Follow-up|0|||
129734570|NCT05275582|466988082|FG000|Overall Study|Withdrawal by Subject|0|||
129734571|NCT05275582|466988083|FG001|Overall Study|Withdrawal by Subject|2|||
129734572|NCT05275582|466988082|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
129734573|NCT05275582|466988083|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
129734574|NCT05275582|466988082|FG000|Overall Study|Death|1|||
129734575|NCT05275582|466988083|FG001|Overall Study|Death|0|||
129734576|NCT05275582|466988082|FG000|Overall Study|Protocol Violation|1|||
129734577|NCT05275582|466988083|FG001|Overall Study|Protocol Violation|0|||
129734578|NCT00031460|466988086|FG000|Overall Study|Lost to Follow-up|0|||
129734579|NCT00031460|466988087|FG001|Overall Study|Lost to Follow-up|1|||
129734580|NCT00031460|466988086|FG000|Overall Study|Withdrawal by Subject|1|||
129734581|NCT00031460|466988087|FG001|Overall Study|Withdrawal by Subject|1|||
129734582|NCT00031460|466988086|FG000|Overall Study|Non-Compliant|1|||
129734583|NCT00031460|466988087|FG001|Overall Study|Non-Compliant|1|||
129734584|NCT00031460|466988086|FG000|Overall Study|Death|0|||
129734585|NCT00031460|466988087|FG001|Overall Study|Death|1|||
129734586|NCT00031460|466988086|FG000|Overall Study|Reactivation of Disease|5|||
129734587|NCT00031460|466988087|FG001|Overall Study|Reactivation of Disease|9|||
129734588|NCT00031460|466988086|FG000|Overall Study|Disruption of blinded drug supply|2|||
129734589|NCT00031460|466988087|FG001|Overall Study|Disruption of blinded drug supply|0|||
129734590|NCT00031460|466988086|FG000|Overall Study|Confirmed unevaluable|0|||
129734591|NCT00031460|466988087|FG001|Overall Study|Confirmed unevaluable|1|||
129734592|NCT02210832|466988088|FG000|Overall Study|Pregnancy termination .|3|||
129804774|NCT00074984|467253064|FG001|Overall Study|Death|2|||
129804775|NCT00074984|467253063|FG000|Overall Study|Withdrawal by Subject|2|||
129734593|NCT02210832|466988089|FG001|Overall Study|Pregnancy termination .|4|||
129734594|NCT02210832|466988090|FG002|Overall Study|Pregnancy termination .|1|||
129734595|NCT02210832|466988088|FG000|Overall Study|Lost to Follow-up|26|||
129734596|NCT02210832|466988089|FG001|Overall Study|Lost to Follow-up|32|||
129804776|NCT00074984|467253064|FG001|Overall Study|Withdrawal by Subject|3|||
129734597|NCT02210832|466988090|FG002|Overall Study|Lost to Follow-up|17|||
129734598|NCT02080260|466988092|FG000|Overall Study|Death|18|||
129734599|NCT02080260|466988092|FG000|Overall Study|Withdrawal by Subject|1|||
129734600|NCT00471887|466988098|FG000|Overall Study|Adverse Event|9|||
129734601|NCT01030874|466988111|FG000|Overall Study|Withdrawal by Subject|1|||
129734602|NCT01030874|466988112|FG001|Overall Study|Withdrawal by Subject|0|||
129734603|NCT01030874|466988111|FG000|Overall Study|Discharged in first 2 weeks|17|||
129734604|NCT01030874|466988112|FG001|Overall Study|Discharged in first 2 weeks|16|||
129734605|NCT04639219|466988113|FG000|Overall Study|Withdrawal by Subject|8|||
129734606|NCT04639219|466988113|FG000|Overall Study|Lost to Follow-up|6|||
129734607|NCT04639219|466988113|FG000|Overall Study|Death|55|||
129734608|NCT01998893|466988114|FG000|Overall Study|Adverse Event|2|||
129734609|NCT01998893|466988114|FG000|Overall Study|Death|1|||
129734610|NCT01998893|466988114|FG000|Overall Study|Lost to Follow-up|8|||
129734611|NCT01998893|466988114|FG000|Overall Study|Physician Decision|2|||
129734612|NCT01998893|466988114|FG000|Overall Study|Protocol Violation|2|||
129734613|NCT01998893|466988114|FG000|Overall Study|Withdrawal by Subject|1|||
129734614|NCT01998893|466988114|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
129734615|NCT03784846|466988115|FG000|Pre-COVID Study|Lost to Follow-up|3|||
129734616|NCT03784846|466988116|FG001|Pre-COVID Study|Lost to Follow-up|3|||
129734617|NCT03784846|466988117|FG002|Pre-COVID Study|Lost to Follow-up|2|||
129734618|NCT03784846|466988115|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
129734619|NCT03784846|466988116|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
129734620|NCT03784846|466988117|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
129734621|NCT03784846|466988115|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
129734622|NCT03784846|466988116|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
129734623|NCT03784846|466988117|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
129734624|NCT03784846|466988115|FG000|Post-COVID Study|Lost to Follow-up|3|||
129734625|NCT03784846|466988116|FG001|Post-COVID Study|Lost to Follow-up|5|||
129734626|NCT03784846|466988117|FG002|Post-COVID Study|Lost to Follow-up|1|||
129734627|NCT03784846|466988115|FG000|Post-COVID Study|Withdrawal by Subject|1|||
129734628|NCT03784846|466988116|FG001|Post-COVID Study|Withdrawal by Subject|2|||
129734629|NCT03784846|466988117|FG002|Post-COVID Study|Withdrawal by Subject|0|||
129734630|NCT00867087|466988118|FG000|Overall Study|Other|1|||
129734631|NCT00867087|466988118|FG000|Overall Study|Withdrawal by Subject|4|||
129734632|NCT00867087|466988118|FG000|Overall Study|Death|37|||
129734633|NCT03883113|466988120|FG000|Overall Study|Physician Decision|4|||
129734634|NCT03883113|466988121|FG001|Overall Study|Physician Decision|2|||
129734635|NCT03883113|466988120|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
129734636|NCT03883113|466988121|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
129734637|NCT03883113|466988120|FG000|Overall Study|Pregnancy|1|||
129734638|NCT03883113|466988121|FG001|Overall Study|Pregnancy|0|||
129734639|NCT03883113|466988120|FG000|Overall Study|Adverse Event|0|||
129734640|NCT03883113|466988121|FG001|Overall Study|Adverse Event|1|||
129734641|NCT03883113|466988120|FG000|Overall Study|Withdrawal by Subject|1|||
129734642|NCT03883113|466988121|FG001|Overall Study|Withdrawal by Subject|2|||
129734643|NCT03883113|466988120|FG000|Overall Study|Lost to Follow-up|1|||
129734644|NCT03883113|466988121|FG001|Overall Study|Lost to Follow-up|0|||
129734645|NCT01457950|466988122|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
129734646|NCT01457950|466988123|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
129734647|NCT01457950|466988124|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
129734648|NCT01457950|466988125|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
129734649|NCT01457950|466988122|FG000|Double-Blind Phase|Protocol Violation|2|||
129734650|NCT01457950|466988123|FG001|Double-Blind Phase|Protocol Violation|1|||
129734651|NCT01457950|466988124|FG002|Double-Blind Phase|Protocol Violation|0|||
129734652|NCT01457950|466988125|FG003|Double-Blind Phase|Protocol Violation|0|||
129734653|NCT01457950|466988122|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
129734654|NCT01457950|466988123|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
129734655|NCT01457950|466988124|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129734656|NCT01457950|466988125|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129734657|NCT01457950|466988122|FG000|Open-Label Phase|Adverse Event|0|||
129734658|NCT01457950|466988123|FG001|Open-Label Phase|Adverse Event|0|||
129734659|NCT01457950|466988124|FG002|Open-Label Phase|Adverse Event|0|||
129734660|NCT01457950|466988125|FG003|Open-Label Phase|Adverse Event|1|||
129734661|NCT01457950|466988122|FG000|Open-Label Phase|Protocol Violation|0|||
129734662|NCT01457950|466988123|FG001|Open-Label Phase|Protocol Violation|0|||
129734663|NCT01457950|466988124|FG002|Open-Label Phase|Protocol Violation|0|||
129734664|NCT01457950|466988125|FG003|Open-Label Phase|Protocol Violation|1|||
129734665|NCT01457950|466988122|FG000|Open-Label Phase|Withdrawal by Subject|0|||
129734666|NCT01457950|466988123|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129734667|NCT01457950|466988124|FG002|Open-Label Phase|Withdrawal by Subject|2|||
129734668|NCT01457950|466988125|FG003|Open-Label Phase|Withdrawal by Subject|0|||
129734669|NCT00054691|466988126|FG000|Overall Study|Unmeasurable Disease|2|||
129734670|NCT00054691|466988126|FG000|Overall Study|Noncompliant|1|||
129734671|NCT02498067|466988127|FG000|Overall Study|Lost to Follow-up|22|||
129734672|NCT02498067|466988127|FG000|Overall Study|Did not meet inclusion criteria|11|||
129734673|NCT01371643|466988132|FG000|Overall Study|Withdrawal by Subject|3|||
129734674|NCT01371643|466988133|FG001|Overall Study|Withdrawal by Subject|0|||
129734675|NCT03249935|466988134|FG000|Overall Study|Discharged from facility early|36|||
129734676|NCT03249935|466988134|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
129734677|NCT03249935|466988134|FG000|Overall Study|Protocol Violation|5|||
129734678|NCT03593681|466988135|FG000|Overall Study|Inadequate sample collected|12|||
129734679|NCT03593681|466988135|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
129734680|NCT03593681|466988135|FG000|Overall Study|Protocol Violation|3|||
129734681|NCT03593681|466988135|FG000|Overall Study|Withdrawal by Subject|3|||
129734682|NCT03593681|466988135|FG000|Overall Study|Procedure not attempted|3|||
129734683|NCT03593681|466988135|FG000|Overall Study|Adverse Event|2|||
129734684|NCT03593681|466988135|FG000|Overall Study|Physician Decision|1|||
129734685|NCT03987932|466988139|FG000|Overall Study|Lost to Follow-up|2|||
129734686|NCT03987932|466988140|FG001|Overall Study|Lost to Follow-up|1|||
129734687|NCT03987932|466988141|FG002|Overall Study|Lost to Follow-up|1|||
129734688|NCT03987932|466988139|FG000|Overall Study|Non-study related elective surgery|0|||
129734689|NCT03987932|466988140|FG001|Overall Study|Non-study related elective surgery|0|||
129734690|NCT03987932|466988141|FG002|Overall Study|Non-study related elective surgery|1|||
129734691|NCT01669421|466988145|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
129734692|NCT01669421|466988145|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
129734693|NCT00810901|466988149|FG000|Overall Study|Lost to Follow-up|88|||
129734694|NCT00810901|466988150|FG001|Overall Study|Lost to Follow-up|58|||
129734695|NCT00343915|466988157|FG000|Primary Study|Withdrawal by Subject|1|||
129734696|NCT00343915|466988158|FG001|Primary Study|Withdrawal by Subject|0|||
129734697|NCT00343915|466988157|FG000|Primary Study|Lost to Follow-up|2|||
129734698|NCT00343915|466988158|FG001|Primary Study|Lost to Follow-up|3|||
129734699|NCT00343915|466988157|FG000|Primary Study|Other|1|||
129734700|NCT00343915|466988158|FG001|Primary Study|Other|0|||
129734701|NCT00882908|466988159|FG000|Overall Study|Adverse Event|0|||
129734702|NCT00882908|466988160|FG001|Overall Study|Adverse Event|0|||
129734703|NCT00882908|466988161|FG002|Overall Study|Adverse Event|1|||
129734704|NCT00882908|466988162|FG003|Overall Study|Adverse Event|0|||
129734705|NCT00882908|466988163|FG004|Overall Study|Adverse Event|1|||
129734706|NCT00882908|466988159|FG000|Overall Study|Lost to Follow-up|3|||
129734707|NCT00882908|466988160|FG001|Overall Study|Lost to Follow-up|5|||
129734708|NCT00882908|466988161|FG002|Overall Study|Lost to Follow-up|3|||
129734709|NCT00882908|466988162|FG003|Overall Study|Lost to Follow-up|1|||
129734710|NCT00882908|466988163|FG004|Overall Study|Lost to Follow-up|2|||
129734711|NCT00882908|466988159|FG000|Overall Study|Protocol Violation|0|||
129734712|NCT00882908|466988160|FG001|Overall Study|Protocol Violation|1|||
129734713|NCT00882908|466988161|FG002|Overall Study|Protocol Violation|0|||
129734714|NCT00882908|466988162|FG003|Overall Study|Protocol Violation|0|||
129734715|NCT00882908|466988163|FG004|Overall Study|Protocol Violation|0|||
129734716|NCT00882908|466988159|FG000|Overall Study|Withdrawal by Subject|0|||
129734717|NCT00882908|466988160|FG001|Overall Study|Withdrawal by Subject|0|||
129734718|NCT00882908|466988161|FG002|Overall Study|Withdrawal by Subject|3|||
129734719|NCT00882908|466988162|FG003|Overall Study|Withdrawal by Subject|5|||
129734720|NCT00882908|466988163|FG004|Overall Study|Withdrawal by Subject|2|||
129734721|NCT00882908|466988159|FG000|Overall Study|Subject reached a virologic endpoint|0|||
129734722|NCT00882908|466988160|FG001|Overall Study|Subject reached a virologic endpoint|0|||
129734723|NCT00882908|466988161|FG002|Overall Study|Subject reached a virologic endpoint|0|||
129734724|NCT00882908|466988162|FG003|Overall Study|Subject reached a virologic endpoint|0|||
129734725|NCT00882908|466988163|FG004|Overall Study|Subject reached a virologic endpoint|1|||
129804777|NCT00074984|467253063|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
129804778|NCT00074984|467253064|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
129734726|NCT00882908|466988159|FG000|Overall Study|Study terminated in error|0|||
129734727|NCT00882908|466988160|FG001|Overall Study|Study terminated in error|0|||
129734728|NCT00882908|466988161|FG002|Overall Study|Study terminated in error|0|||
129734729|NCT00882908|466988162|FG003|Overall Study|Study terminated in error|1|||
129804779|NCT01772160|467253068|FG000|Overall Study|Death|3|||
129734730|NCT00882908|466988163|FG004|Overall Study|Study terminated in error|0|||
129734731|NCT05291936|466988164|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
129734732|NCT05291936|466988165|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
129734733|NCT05291936|466988164|FG000|Period 1|Withdrew Consent during study|1|||
129734734|NCT05291936|466988165|FG001|Period 1|Withdrew Consent during study|0|||
129734735|NCT05291936|466988164|FG000|Period 2|Adverse Event|0|||
129734736|NCT05291936|466988165|FG001|Period 2|Adverse Event|1|||
129734737|NCT05291936|466988164|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
129734738|NCT05291936|466988165|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129734739|NCT00581828|466988166|FG000|Overall Study|Protocol Violation|1|||
129734740|NCT02370095|466988167|FG000|Overall Study|Withdrawal by Subject|0|||
129734741|NCT02370095|466988168|FG001|Overall Study|Withdrawal by Subject|1|||
129734742|NCT01667562|466988169|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
129734743|NCT01667562|466988170|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
129734744|NCT01667562|466988169|FG000|Erlotinib Phase|Lost to Follow-up|0|||
129734745|NCT01667562|466988170|FG001|Erlotinib Phase|Lost to Follow-up|1|||
129734746|NCT01667562|466988169|FG000|Erlotinib Phase|Adverse Event|0|||
129734747|NCT01667562|466988170|FG001|Erlotinib Phase|Adverse Event|1|||
129734748|NCT01667562|466988169|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
129734749|NCT01667562|466988170|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
129734750|NCT02130986|466988174|FG000|Overall Study|Withdrawal by Subject|4|||
129734751|NCT02130986|466988175|FG001|Overall Study|Withdrawal by Subject|4|||
129734752|NCT02130986|466988174|FG000|Overall Study|Lost to Follow-up|151|||
129734753|NCT02130986|466988175|FG001|Overall Study|Lost to Follow-up|160|||
129734754|NCT01129882|466988176|FG000|Overall Study|Adverse Event|39|||
129734755|NCT01129882|466988176|FG000|Overall Study|Death|6|||
129734756|NCT01129882|466988176|FG000|Overall Study|Lack of Efficacy|5|||
129734757|NCT01129882|466988176|FG000|Overall Study|Lost to Follow-up|13|||
129734758|NCT01129882|466988176|FG000|Overall Study|Physician Decision|27|||
129734759|NCT01129882|466988176|FG000|Overall Study|Protocol Deviation|3|||
129734760|NCT01129882|466988176|FG000|Overall Study|Withdrawal Criteria Met|19|||
129734761|NCT01129882|466988176|FG000|Overall Study|Trial Termination by Sponsor|6|||
129734762|NCT01129882|466988176|FG000|Overall Study|Withdrawal by Subject|160|||
129734763|NCT05590000|466988177|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
129734764|NCT00762996|466988178|FG000|Period One|Protocol Violation|0|||
129734765|NCT00762996|466988179|FG001|Period One|Protocol Violation|0|||
129734766|NCT00762996|466988180|FG002|Period One|Protocol Violation|1|||
129734767|NCT00762996|466988181|FG003|Period One|Protocol Violation|0|||
129734768|NCT00762996|466988178|FG000|Period One|ineligible|0|||
129734769|NCT00762996|466988179|FG001|Period One|ineligible|0|||
129734770|NCT00762996|466988180|FG002|Period One|ineligible|1|||
129734771|NCT00762996|466988181|FG003|Period One|ineligible|1|||
129734772|NCT00762996|466988178|FG000|Period One|Adverse Event|0|||
129734773|NCT00762996|466988179|FG001|Period One|Adverse Event|0|||
129734774|NCT00762996|466988180|FG002|Period One|Adverse Event|1|||
129734775|NCT00762996|466988181|FG003|Period One|Adverse Event|0|||
129734776|NCT00762996|466988178|FG000|Period One|Withdrawal by Subject|0|||
129734777|NCT00762996|466988179|FG001|Period One|Withdrawal by Subject|0|||
129734778|NCT00762996|466988180|FG002|Period One|Withdrawal by Subject|1|||
129734779|NCT00762996|466988181|FG003|Period One|Withdrawal by Subject|0|||
129734780|NCT00536874|466988182|FG000|Overall Study|Adverse Event|1|||
129734781|NCT00536874|466988182|FG000|Overall Study|Death|2|||
129734782|NCT00536874|466988182|FG000|Overall Study|Withdrawal by Subject|1|||
129734783|NCT02689076|466988184|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
129734784|NCT02689076|466988185|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
129734785|NCT02689076|466988186|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
129734786|NCT02689076|466988184|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
129734787|NCT02689076|466988185|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
129734788|NCT02689076|466988186|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
129734789|NCT02689076|466988184|FG000|Overall Study|Did not have an HIE match|2|||
129734790|NCT02689076|466988185|FG001|Overall Study|Did not have an HIE match|0|||
129734791|NCT02689076|466988186|FG002|Overall Study|Did not have an HIE match|0|||
129734792|NCT02689076|466988184|FG000|Overall Study|Death during non-VA encounter|2|||
129734793|NCT02689076|466988185|FG001|Overall Study|Death during non-VA encounter|5|||
129734794|NCT02689076|466988186|FG002|Overall Study|Death during non-VA encounter|0|||
129734795|NCT02689076|466988184|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
129734796|NCT02689076|466988185|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
129734797|NCT02689076|466988186|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
129734798|NCT02689076|466988184|FG000|Overall Study|Participant no longer active in VA system|1|||
129734799|NCT02689076|466988185|FG001|Overall Study|Participant no longer active in VA system|0|||
129734800|NCT02689076|466988186|FG002|Overall Study|Participant no longer active in VA system|0|||
129734801|NCT02689076|466988184|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
129804780|NCT01772160|467253068|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
129804781|NCT01772160|467253068|FG000|Overall Study|Consent withdrawal|3|||
129804782|NCT01772160|467253068|FG000|Overall Study|Migrated / moved from the study area|4|||
129804783|NCT01772160|467253068|FG000|Overall Study|Lost to Follow-up|30|||
129734802|NCT02689076|466988185|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
129734803|NCT02689076|466988186|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
129734804|NCT02084238|466988187|FG000|Overall Study|Lost to Follow-up|2|||
129734805|NCT01304329|466988188|FG000|Third Intervention (3 Days)|Adverse Event|0|||
129734806|NCT01304329|466988189|FG001|Third Intervention (3 Days)|Adverse Event|1|||
129734807|NCT01304329|466988190|FG002|Third Intervention (3 Days)|Adverse Event|0|||
129734808|NCT01304329|466988191|FG003|Third Intervention (3 Days)|Adverse Event|0|||
129734809|NCT01304329|466988192|FG004|Third Intervention (3 Days)|Adverse Event|0|||
129734810|NCT01304329|466988193|FG005|Third Intervention (3 Days)|Adverse Event|0|||
129734811|NCT00993499|466988200|FG000|Run-in Period (8 Days)|Adverse Event|0|||
129734812|NCT00993499|466988201|FG001|Run-in Period (8 Days)|Adverse Event|1|||
129734813|NCT00993499|466988202|FG002|Run-in Period (8 Days)|Adverse Event|0|||
129734814|NCT00993499|466988203|FG003|Run-in Period (8 Days)|Adverse Event|0|||
129734815|NCT00993499|466988204|FG004|Run-in Period (8 Days)|Adverse Event|0|||
129734816|NCT00993499|466988205|FG005|Run-in Period (8 Days)|Adverse Event|0|||
129734817|NCT00993499|466988200|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
129734818|NCT00993499|466988201|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129734819|NCT00993499|466988202|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129734820|NCT00993499|466988203|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129734821|NCT00993499|466988204|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129734822|NCT00993499|466988205|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
129734823|NCT00993499|466988200|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
129734824|NCT00993499|466988201|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
129734825|NCT00993499|466988202|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
129734826|NCT00993499|466988203|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
129734827|NCT00993499|466988204|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
129734828|NCT00993499|466988205|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
129734829|NCT00993499|466988200|FG000|Run-in Period (8 Days)|Progressive disease|0|||
129734830|NCT00993499|466988201|FG001|Run-in Period (8 Days)|Progressive disease|1|||
129734831|NCT00993499|466988202|FG002|Run-in Period (8 Days)|Progressive disease|1|||
129734832|NCT00993499|466988203|FG003|Run-in Period (8 Days)|Progressive disease|0|||
129734833|NCT00993499|466988204|FG004|Run-in Period (8 Days)|Progressive disease|0|||
129734834|NCT00993499|466988205|FG005|Run-in Period (8 Days)|Progressive disease|0|||
129734835|NCT00993499|466988200|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
129734836|NCT00993499|466988201|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
129734837|NCT00993499|466988202|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
129734838|NCT00993499|466988203|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
129734839|NCT00993499|466988204|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
129734840|NCT00993499|466988205|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
129734841|NCT00993499|466988200|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
129734842|NCT00993499|466988201|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
129734843|NCT00993499|466988202|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129734844|NCT00993499|466988203|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129734845|NCT00993499|466988204|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129734846|NCT00993499|466988205|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
129734847|NCT00993499|466988200|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129734848|NCT00993499|466988201|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129734849|NCT00993499|466988202|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
129734850|NCT00993499|466988203|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
129734851|NCT00993499|466988204|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129734852|NCT00993499|466988205|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
129734853|NCT00993499|466988200|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129734854|NCT00993499|466988201|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129734855|NCT00993499|466988202|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
129734856|NCT00993499|466988203|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129734857|NCT00993499|466988204|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129734858|NCT00993499|466988205|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
129734859|NCT00993499|466988200|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129734860|NCT00993499|466988201|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
129734861|NCT00993499|466988202|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129734862|NCT00993499|466988203|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129734863|NCT00993499|466988204|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129734864|NCT00993499|466988205|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
129734865|NCT00993499|466988200|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
129734866|NCT00993499|466988201|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
129804784|NCT01772160|467253068|FG000|Overall Study|Other|5|||
129892943|NCT02373813|467567711|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
129892944|NCT02373813|467567712|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
129892945|NCT02373813|467567713|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
129892946|NCT02403674|467567716|FG000|Base Study|Death|1|||
129892947|NCT02403674|467567717|FG001|Base Study|Death|4|||
129892948|NCT02403674|467567716|FG000|Base Study|Adverse Event|11|||
129892949|NCT02403674|467567717|FG001|Base Study|Adverse Event|26|||
129892950|NCT02403674|467567716|FG000|Base Study|Lack of Efficacy|31|||
129892951|NCT02403674|467567717|FG001|Base Study|Lack of Efficacy|23|||
129892952|NCT02403674|467567716|FG000|Base Study|Lost to Follow-up|6|||
129892953|NCT02403674|467567717|FG001|Base Study|Lost to Follow-up|8|||
129892954|NCT02403674|467567716|FG000|Base Study|Withdrawal by Subject|10|||
129892955|NCT02403674|467567717|FG001|Base Study|Withdrawal by Subject|17|||
129892956|NCT02403674|467567716|FG000|Base Study|Physician Decision|2|||
129892957|NCT02403674|467567717|FG001|Base Study|Physician Decision|2|||
129892958|NCT02403674|467567716|FG000|Base Study|Pregnancy|2|||
129892959|NCT02403674|467567717|FG001|Base Study|Pregnancy|2|||
129892960|NCT02403674|467567716|FG000|Base Study|Protocol Violation|8|||
129892961|NCT02403674|467567717|FG001|Base Study|Protocol Violation|4|||
129892962|NCT02403674|467567716|FG000|Base Study|Non-Compliance with study drug|1|||
129892963|NCT02403674|467567717|FG001|Base Study|Non-Compliance with study drug|4|||
129892964|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
129892965|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
129892966|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
129892967|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
129892968|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
129892969|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
129892970|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
129734867|NCT00993499|466988202|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
129734868|NCT00993499|466988203|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
129734869|NCT00993499|466988204|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
129734870|NCT00993499|466988205|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
129734871|NCT00993499|466988200|FG000|Discontinued After Starting Course 3|DLT|1|||
129734872|NCT00993499|466988201|FG001|Discontinued After Starting Course 3|DLT|0|||
129734873|NCT00993499|466988202|FG002|Discontinued After Starting Course 3|DLT|2|||
129734874|NCT00993499|466988203|FG003|Discontinued After Starting Course 3|DLT|1|||
129734875|NCT00993499|466988204|FG004|Discontinued After Starting Course 3|DLT|0|||
129734876|NCT00993499|466988205|FG005|Discontinued After Starting Course 3|DLT|0|||
129734877|NCT00993499|466988200|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
129734878|NCT00993499|466988201|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
129734879|NCT00993499|466988202|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
129734880|NCT00993499|466988203|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
129734881|NCT00993499|466988204|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
129734882|NCT00993499|466988205|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
129734883|NCT01406015|466988214|FG000|Overall Study|Withdrawal by Subject|3|||
129734884|NCT01406015|466988215|FG001|Overall Study|Withdrawal by Subject|3|||
129734885|NCT00844805|466988216|FG000|Treatment Phase|Adverse Event|5|||
129734886|NCT00844805|466988217|FG001|Treatment Phase|Adverse Event|1|||
129734887|NCT00844805|466988218|FG002|Treatment Phase|Adverse Event|0|||
129734888|NCT00844805|466988219|FG003|Treatment Phase|Adverse Event|0|||
129734889|NCT00844805|466988216|FG000|Treatment Phase|Withdrawal by Subject|3|||
129734890|NCT00844805|466988217|FG001|Treatment Phase|Withdrawal by Subject|4|||
129734891|NCT00844805|466988218|FG002|Treatment Phase|Withdrawal by Subject|0|||
129734892|NCT00844805|466988219|FG003|Treatment Phase|Withdrawal by Subject|0|||
129734893|NCT00844805|466988216|FG000|Treatment Phase|Noncompliance With Protocol|1|||
129734894|NCT00844805|466988217|FG001|Treatment Phase|Noncompliance With Protocol|0|||
129734895|NCT00844805|466988218|FG002|Treatment Phase|Noncompliance With Protocol|0|||
129734896|NCT00844805|466988219|FG003|Treatment Phase|Noncompliance With Protocol|0|||
129734897|NCT00844805|466988216|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
129734898|NCT00844805|466988217|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
129734899|NCT00844805|466988218|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
129892971|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
129892972|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
129734900|NCT00844805|466988219|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
129734901|NCT00844805|466988216|FG000|Follow-Up Phase|Adverse Event|0|||
129892973|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
129892974|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
129734902|NCT00844805|466988217|FG001|Follow-Up Phase|Adverse Event|0|||
129734903|NCT00844805|466988218|FG002|Follow-Up Phase|Adverse Event|1|||
129892975|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
129804785|NCT01522248|467253069|FG000|Overall Study|Lost to Follow-up|1|||
129804786|NCT01522248|467253070|FG001|Overall Study|Lost to Follow-up|0|||
129804787|NCT00694707|467253075|FG000|Overall Study|Did Not Receive Treatment|0|||
129804788|NCT00694707|467253076|FG001|Overall Study|Did Not Receive Treatment|0|||
129804789|NCT00694707|467253077|FG002|Overall Study|Did Not Receive Treatment|1|||
129804790|NCT00694707|467253078|FG003|Overall Study|Did Not Receive Treatment|1|||
129804791|NCT00694707|467253079|FG004|Overall Study|Did Not Receive Treatment|1|||
129804792|NCT00694707|467253075|FG000|Overall Study|Adverse Event|22|||
129804793|NCT00694707|467253076|FG001|Overall Study|Adverse Event|14|||
129804794|NCT00694707|467253077|FG002|Overall Study|Adverse Event|8|||
129804795|NCT00694707|467253078|FG003|Overall Study|Adverse Event|12|||
129804796|NCT00694707|467253079|FG004|Overall Study|Adverse Event|13|||
129804797|NCT00694707|467253075|FG000|Overall Study|Insufficient Therapeutic Response|33|||
129734904|NCT00844805|466988219|FG003|Follow-Up Phase|Adverse Event|0|||
129734905|NCT00844805|466988216|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
129734906|NCT00844805|466988217|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
129734907|NCT00844805|466988218|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
129734908|NCT00844805|466988219|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
129734909|NCT00844805|466988216|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
129734910|NCT00844805|466988217|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
129734911|NCT00844805|466988218|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
129734912|NCT00844805|466988219|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
129734913|NCT00844805|466988216|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
129734914|NCT00844805|466988217|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
129734915|NCT00844805|466988218|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
129734916|NCT00844805|466988219|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
129734917|NCT00844805|466988216|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
129734918|NCT00844805|466988217|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
129734919|NCT00844805|466988218|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
129734920|NCT00844805|466988219|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
129734921|NCT01352741|466988220|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
129734922|NCT01352741|466988221|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
129734923|NCT01352741|466988220|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
129734924|NCT01352741|466988221|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
129734925|NCT01352741|466988220|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
129734926|NCT01352741|466988221|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
129734927|NCT01352741|466988220|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
129734928|NCT01352741|466988221|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
129734929|NCT01352741|466988220|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
129734930|NCT01352741|466988221|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
129734931|NCT01352741|466988220|FG000|Open-label Tapentadol Titration Period|Other|4|||
129734932|NCT01352741|466988221|FG001|Open-label Tapentadol Titration Period|Other|0|||
129734933|NCT01352741|466988220|FG000|Double-blind Comparative Period|Protocol Violation|2|||
129734934|NCT01352741|466988221|FG001|Double-blind Comparative Period|Protocol Violation|0|||
129734935|NCT01352741|466988220|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
129734936|NCT01352741|466988221|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
129734937|NCT01352741|466988220|FG000|Double-blind Comparative Period|Adverse Event|16|||
129734938|NCT01352741|466988221|FG001|Double-blind Comparative Period|Adverse Event|17|||
129734939|NCT01352741|466988220|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
129734940|NCT01352741|466988221|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
129734941|NCT01352741|466988220|FG000|Double-blind Comparative Period|Death|0|||
129734942|NCT01352741|466988221|FG001|Double-blind Comparative Period|Death|1|||
129734943|NCT01352741|466988220|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
129804798|NCT00694707|467253076|FG001|Overall Study|Insufficient Therapeutic Response|18|||
129804799|NCT00694707|467253077|FG002|Overall Study|Insufficient Therapeutic Response|17|||
129804800|NCT00694707|467253078|FG003|Overall Study|Insufficient Therapeutic Response|15|||
129804801|NCT00694707|467253079|FG004|Overall Study|Insufficient Therapeutic Response|10|||
129804802|NCT00694707|467253075|FG000|Overall Study|Protocol Violation|1|||
129804803|NCT00694707|467253076|FG001|Overall Study|Protocol Violation|2|||
129734944|NCT01352741|466988221|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
129734945|NCT01352741|466988220|FG000|Double-blind Comparative Period|Other|1|||
129734946|NCT01352741|466988221|FG001|Double-blind Comparative Period|Other|2|||
129734947|NCT01352741|466988220|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
129734948|NCT01352741|466988221|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
129444734|NCT01641809|465929436|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
129734949|NCT01352741|466988220|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
129734950|NCT01352741|466988221|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
129804804|NCT00694707|467253077|FG002|Overall Study|Protocol Violation|1|||
129804805|NCT00694707|467253078|FG003|Overall Study|Protocol Violation|3|||
129804806|NCT00694707|467253079|FG004|Overall Study|Protocol Violation|1|||
129804807|NCT00694707|467253075|FG000|Overall Study|Withdrawal of Consent|14|||
129734951|NCT01352741|466988220|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
129734952|NCT01352741|466988221|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
129734953|NCT01352741|466988220|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
129734954|NCT01352741|466988221|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
129734955|NCT01886690|466988223|FG000|Overall Study|Protocol Violation|0|||
129734956|NCT01886690|466988224|FG001|Overall Study|Protocol Violation|1|||
129734957|NCT01886690|466988223|FG000|Overall Study|Personal Reasons|0|||
129734958|NCT01886690|466988224|FG001|Overall Study|Personal Reasons|1|||
129734959|NCT01510145|466988225|FG000|Overall Study|Adverse Event|6|||
129734960|NCT01510145|466988225|FG000|Overall Study|Lost to Follow-up|5|||
129734961|NCT01510145|466988225|FG000|Overall Study|Withdrawal by Subject|6|||
129734962|NCT01510145|466988225|FG000|Overall Study|Relative reported subject withdrew|1|||
129734963|NCT03081858|466990090|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
129734964|NCT03081858|466990091|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
129734965|NCT03081858|466990092|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
129734966|NCT03081858|466990093|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
129734967|NCT00262847|466990096|FG000|Overall Study|Disease Progression|309|||
129734968|NCT00262847|466990097|FG001|Overall Study|Disease Progression|274|||
129734969|NCT00262847|466990098|FG002|Overall Study|Disease Progression|195|||
129734970|NCT00262847|466990096|FG000|Overall Study|Patient Refusal|41|||
129734971|NCT00262847|466990097|FG001|Overall Study|Patient Refusal|52|||
129734972|NCT00262847|466990098|FG002|Overall Study|Patient Refusal|47|||
129734973|NCT00262847|466990096|FG000|Overall Study|Adverse Event|74|||
129734974|NCT00262847|466990097|FG001|Overall Study|Adverse Event|88|||
129734975|NCT00262847|466990098|FG002|Overall Study|Adverse Event|108|||
129734976|NCT00262847|466990096|FG000|Overall Study|Death|8|||
129734977|NCT00262847|466990097|FG001|Overall Study|Death|8|||
129734978|NCT00262847|466990098|FG002|Overall Study|Death|11|||
129734979|NCT00262847|466990096|FG000|Overall Study|Concomitant disease|3|||
129734980|NCT00262847|466990097|FG001|Overall Study|Concomitant disease|2|||
129734981|NCT00262847|466990098|FG002|Overall Study|Concomitant disease|4|||
129734982|NCT00262847|466990096|FG000|Overall Study|Other Reasons|79|||
129734983|NCT00262847|466990097|FG001|Overall Study|Other Reasons|88|||
129734984|NCT00262847|466990098|FG002|Overall Study|Other Reasons|27|||
129734985|NCT00262847|466990096|FG000|Overall Study|Did not receive study treatment|4|||
129804808|NCT00694707|467253076|FG001|Overall Study|Withdrawal of Consent|18|||
129804809|NCT00694707|467253077|FG002|Overall Study|Withdrawal of Consent|22|||
129804810|NCT00694707|467253078|FG003|Overall Study|Withdrawal of Consent|16|||
129804811|NCT00694707|467253079|FG004|Overall Study|Withdrawal of Consent|15|||
129804812|NCT00694707|467253075|FG000|Overall Study|Lost to Follow-up|0|||
129804813|NCT00694707|467253076|FG001|Overall Study|Lost to Follow-up|1|||
129804814|NCT00694707|467253077|FG002|Overall Study|Lost to Follow-up|2|||
129804815|NCT00694707|467253078|FG003|Overall Study|Lost to Follow-up|0|||
129804816|NCT00694707|467253079|FG004|Overall Study|Lost to Follow-up|0|||
129804817|NCT00694707|467253075|FG000|Overall Study|Jeopardizing Parole Status|1|||
129804818|NCT00694707|467253076|FG001|Overall Study|Jeopardizing Parole Status|0|||
129804819|NCT00694707|467253077|FG002|Overall Study|Jeopardizing Parole Status|0|||
129804820|NCT00694707|467253078|FG003|Overall Study|Jeopardizing Parole Status|0|||
129804821|NCT00694707|467253079|FG004|Overall Study|Jeopardizing Parole Status|0|||
129804822|NCT00694707|467253075|FG000|Overall Study|Death in the Family|1|||
129804823|NCT00694707|467253076|FG001|Overall Study|Death in the Family|0|||
129804824|NCT00694707|467253077|FG002|Overall Study|Death in the Family|0|||
129804825|NCT00694707|467253078|FG003|Overall Study|Death in the Family|0|||
129804826|NCT00694707|467253079|FG004|Overall Study|Death in the Family|0|||
129804827|NCT00694707|467253075|FG000|Overall Study|Arrest by Police|0|||
129804828|NCT00694707|467253076|FG001|Overall Study|Arrest by Police|1|||
129804829|NCT00694707|467253077|FG002|Overall Study|Arrest by Police|0|||
129804830|NCT00694707|467253078|FG003|Overall Study|Arrest by Police|0|||
129804831|NCT00694707|467253079|FG004|Overall Study|Arrest by Police|0|||
129804832|NCT00694707|467253075|FG000|Overall Study|Administrative Reasons|0|||
129804833|NCT00694707|467253076|FG001|Overall Study|Administrative Reasons|1|||
129804834|NCT00694707|467253077|FG002|Overall Study|Administrative Reasons|0|||
129804835|NCT00694707|467253078|FG003|Overall Study|Administrative Reasons|2|||
129804836|NCT00694707|467253079|FG004|Overall Study|Administrative Reasons|0|||
129734986|NCT00262847|466990097|FG001|Overall Study|Did not receive study treatment|1|||
129804837|NCT00694707|467253075|FG000|Overall Study|Notification of Past Head Injury|0|||
129804838|NCT00694707|467253076|FG001|Overall Study|Notification of Past Head Injury|0|||
129804839|NCT00694707|467253077|FG002|Overall Study|Notification of Past Head Injury|0|||
129804840|NCT00694707|467253078|FG003|Overall Study|Notification of Past Head Injury|1|||
129804841|NCT00694707|467253079|FG004|Overall Study|Notification of Past Head Injury|0|||
129804842|NCT01904058|467253084|FG000|Overall Study|Adverse Event|2|||
129734987|NCT00262847|466990098|FG002|Overall Study|Did not receive study treatment|4|||
129734988|NCT03966885|466990099|FG000|Overall Study|Death|1|||
129734989|NCT03966885|466990100|FG001|Overall Study|Death|0|||
129734990|NCT03966885|466990099|FG000|Overall Study|Lost to Follow-up|1|||
129734991|NCT03966885|466990100|FG001|Overall Study|Lost to Follow-up|2|||
129734992|NCT03966885|466990099|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
129734993|NCT03966885|466990100|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
129734994|NCT03966885|466990099|FG000|Overall Study|Moved from study area.|0|||
129734995|NCT03966885|466990100|FG001|Overall Study|Moved from study area.|2|||
129734996|NCT03710876|466990115|FG000|Overall Study|Death|0|||
129734997|NCT03710876|466990116|FG001|Overall Study|Death|2|||
129734998|NCT03710876|466990115|FG000|Overall Study|Withdrawal by Subject|0|||
129734999|NCT03710876|466990116|FG001|Overall Study|Withdrawal by Subject|2|||
129735000|NCT00289198|466990125|FG000|Overall Study|Adverse Event|0|||
129735001|NCT00289198|466990126|FG001|Overall Study|Adverse Event|2|||
129735002|NCT00289198|466990125|FG000|Overall Study|Protocol Violation|2|||
129735003|NCT00289198|466990126|FG001|Overall Study|Protocol Violation|1|||
129735004|NCT00289198|466990125|FG000|Overall Study|Withdrawal by Subject|4|||
129735005|NCT00289198|466990126|FG001|Overall Study|Withdrawal by Subject|1|||
129892976|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Death|1|||
129892977|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Death|0|||
129892978|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
129735006|NCT00289198|466990125|FG000|Overall Study|Lack of Efficacy|2|||
129735007|NCT00289198|466990126|FG001|Overall Study|Lack of Efficacy|0|||
129735008|NCT00289198|466990125|FG000|Overall Study|Other: Low compliance|0|||
129735009|NCT00289198|466990126|FG001|Overall Study|Other: Low compliance|1|||
129735010|NCT00289198|466990125|FG000|Overall Study|Other: Physician's decision|0|||
129735011|NCT00289198|466990126|FG001|Overall Study|Other: Physician's decision|1|||
129735012|NCT00289198|466990125|FG000|Overall Study|Other: Unable to attend on schedule|2|||
129735013|NCT00289198|466990126|FG001|Overall Study|Other: Unable to attend on schedule|1|||
129735014|NCT00289198|466990125|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
129735015|NCT00289198|466990126|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
129735016|NCT00289198|466990125|FG000|Overall Study|Other: Impossible to come on visit|0|||
129735017|NCT00289198|466990126|FG001|Overall Study|Other: Impossible to come on visit|1|||
129735018|NCT01176565|466990127|FG000|Overall Study|Lost to Follow-up|12|||
129735019|NCT01176565|466990128|FG001|Overall Study|Lost to Follow-up|16|||
129735020|NCT01176565|466990127|FG000|Overall Study|Withdrawal by Subject|7|||
129735021|NCT01176565|466990128|FG001|Overall Study|Withdrawal by Subject|1|||
129735022|NCT01176565|466990127|FG000|Overall Study|Not Analyzed (any other reason)|1|||
129735023|NCT01176565|466990128|FG001|Overall Study|Not Analyzed (any other reason)|2|||
129735024|NCT03602885|466990129|FG000|Overall Study|Lost to Follow-up|3|||
129735025|NCT03602885|466990130|FG001|Overall Study|Lost to Follow-up|0|||
129735026|NCT03106415|466990136|FG000|Phase 1|Withdrawal by Subject|1|||
129735027|NCT03106415|466990137|FG001|Phase 1|Withdrawal by Subject|0|||
129735028|NCT03106415|466990138|FG002|Phase 1|Withdrawal by Subject|0|||
129735029|NCT03106415|466990136|FG000|Phase 1|Adverse Event|1|||
129735030|NCT03106415|466990137|FG001|Phase 1|Adverse Event|1|||
129735031|NCT03106415|466990138|FG002|Phase 1|Adverse Event|0|||
129735032|NCT03106415|466990136|FG000|Phase 1|Protocol Violation|0|||
129735033|NCT03106415|466990137|FG001|Phase 1|Protocol Violation|1|||
129735034|NCT03106415|466990138|FG002|Phase 1|Protocol Violation|0|||
129735035|NCT00293709|466990139|FG000|Overall Study|Other|47|||
129735036|NCT02088073|466990140|FG000|Acute Phase|Withdrawal by Subject|5|||
129735037|NCT02088073|466990141|FG001|Acute Phase|Withdrawal by Subject|0|||
129735038|NCT02088073|466990142|FG002|Acute Phase|Withdrawal by Subject|0|||
129735039|NCT02088073|466990143|FG003|Acute Phase|Withdrawal by Subject|0|||
129735040|NCT02088073|466990144|FG004|Acute Phase|Withdrawal by Subject|0|||
129735041|NCT02088073|466990140|FG000|Acute Phase|Hyperkalemia|2|||
129735042|NCT02088073|466990141|FG001|Acute Phase|Hyperkalemia|0|||
129735043|NCT02088073|466990142|FG002|Acute Phase|Hyperkalemia|0|||
129735044|NCT02088073|466990143|FG003|Acute Phase|Hyperkalemia|0|||
129735045|NCT02088073|466990144|FG004|Acute Phase|Hyperkalemia|0|||
129735046|NCT02088073|466990140|FG000|Maintanance Phase|Withdrawal by Subject|0|||
129735047|NCT02088073|466990141|FG001|Maintanance Phase|Withdrawal by Subject|2|||
129735048|NCT02088073|466990142|FG002|Maintanance Phase|Withdrawal by Subject|0|||
129735049|NCT02088073|466990143|FG003|Maintanance Phase|Withdrawal by Subject|0|||
129735050|NCT02088073|466990144|FG004|Maintanance Phase|Withdrawal by Subject|0|||
129735051|NCT02088073|466990140|FG000|Maintanance Phase|Adverse Event|0|||
129735052|NCT02088073|466990141|FG001|Maintanance Phase|Adverse Event|0|||
129735053|NCT02088073|466990142|FG002|Maintanance Phase|Adverse Event|3|||
129735054|NCT02088073|466990143|FG003|Maintanance Phase|Adverse Event|0|||
129735055|NCT02088073|466990144|FG004|Maintanance Phase|Adverse Event|1|||
129735056|NCT02088073|466990140|FG000|Maintanance Phase|Physician Decision|0|||
129735057|NCT02088073|466990141|FG001|Maintanance Phase|Physician Decision|0|||
129735058|NCT02088073|466990142|FG002|Maintanance Phase|Physician Decision|0|||
129735059|NCT02088073|466990143|FG003|Maintanance Phase|Physician Decision|0|||
129735060|NCT02088073|466990144|FG004|Maintanance Phase|Physician Decision|1|||
129735061|NCT02088073|466990140|FG000|Maintanance Phase|Sponsor's decision|0|||
129735062|NCT02088073|466990141|FG001|Maintanance Phase|Sponsor's decision|2|||
129735063|NCT02088073|466990142|FG002|Maintanance Phase|Sponsor's decision|0|||
129735064|NCT02088073|466990143|FG003|Maintanance Phase|Sponsor's decision|2|||
129735065|NCT02088073|466990144|FG004|Maintanance Phase|Sponsor's decision|1|||
129735066|NCT02088073|466990140|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
129735067|NCT02088073|466990141|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
129735068|NCT02088073|466990142|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
129735069|NCT02088073|466990143|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
129735070|NCT02088073|466990144|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
129735071|NCT02088073|466990140|FG000|Maintanance Phase|Miscellaneous|0|||
129735072|NCT02088073|466990141|FG001|Maintanance Phase|Miscellaneous|2|||
129735073|NCT02088073|466990142|FG002|Maintanance Phase|Miscellaneous|1|||
129735074|NCT02088073|466990143|FG003|Maintanance Phase|Miscellaneous|2|||
129735075|NCT02088073|466990144|FG004|Maintanance Phase|Miscellaneous|1|||
129735076|NCT02088073|466990140|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
129735077|NCT02088073|466990141|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
129735078|NCT02088073|466990142|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
129735079|NCT02088073|466990143|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
129735080|NCT02088073|466990144|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
129735081|NCT02088073|466990140|FG000|Maintanance Phase|Subject compliance|0|||
129735082|NCT02088073|466990141|FG001|Maintanance Phase|Subject compliance|1|||
129735083|NCT02088073|466990142|FG002|Maintanance Phase|Subject compliance|0|||
129735084|NCT02088073|466990143|FG003|Maintanance Phase|Subject compliance|0|||
129735085|NCT02088073|466990144|FG004|Maintanance Phase|Subject compliance|0|||
129735086|NCT01804582|466990145|FG000|Overall Study|Lost to Follow-up|47|||
129735087|NCT01804582|466990146|FG001|Overall Study|Lost to Follow-up|56|||
129735088|NCT01804582|466990145|FG000|Overall Study|Physician Decision|2|||
129735089|NCT01804582|466990146|FG001|Overall Study|Physician Decision|0|||
129735090|NCT02046174|466990147|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
129735091|NCT02046174|466990148|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
129735092|NCT02118597|466990149|FG000|Overall Study|Sponsor terminated the study|14|||
129735093|NCT02118597|466990149|FG000|Overall Study|Serious Adverse Event|1|||
129735094|NCT02118597|466990149|FG000|Overall Study|Investigator's decision|1|||
129735095|NCT01891344|466990150|FG000|Overall Study|Ongoing|6|||
129735096|NCT01891344|466990151|FG001|Overall Study|Ongoing|2|||
129735097|NCT01891344|466990152|FG002|Overall Study|Ongoing|0|||
129735098|NCT01891344|466990153|FG003|Overall Study|Ongoing|1|||
129735099|NCT01891344|466990154|FG004|Overall Study|Ongoing|4|||
129735100|NCT01891344|466990155|FG005|Overall Study|Ongoing|1|||
129735101|NCT01891344|466990156|FG006|Overall Study|Ongoing|0|||
129735102|NCT01891344|466990157|FG007|Overall Study|Ongoing|0|||
129735103|NCT00186537|466990161|FG000|Overall Study|Withdrawal by Subject|4|||
129735104|NCT00186537|466990162|FG001|Overall Study|Withdrawal by Subject|0|||
129735105|NCT00186537|466990163|FG002|Overall Study|Withdrawal by Subject|3|||
129735106|NCT00186537|466990161|FG000|Overall Study|ALT > 1.5 x ULN|3|||
129735107|NCT00186537|466990162|FG001|Overall Study|ALT > 1.5 x ULN|0|||
129735108|NCT00186537|466990163|FG002|Overall Study|ALT > 1.5 x ULN|0|||
129735109|NCT03294135|466990164|FG000|Overall Study|Serious Adverse Event|1|||
129735110|NCT03294135|466990165|FG001|Overall Study|Serious Adverse Event|0|||
129804843|NCT01904058|467253085|FG001|Overall Study|Adverse Event|0|||
129804844|NCT01904058|467253086|FG002|Overall Study|Adverse Event|0|||
129804845|NCT01904058|467253087|FG003|Overall Study|Adverse Event|0|||
129804846|NCT01904058|467253084|FG000|Overall Study|Withdrawal by Subject|1|||
129804847|NCT01904058|467253085|FG001|Overall Study|Withdrawal by Subject|0|||
129804848|NCT01904058|467253086|FG002|Overall Study|Withdrawal by Subject|1|||
129804849|NCT01904058|467253087|FG003|Overall Study|Withdrawal by Subject|0|||
129804850|NCT01904058|467253084|FG000|Overall Study|Pregnancy|0|||
129804851|NCT01904058|467253085|FG001|Overall Study|Pregnancy|0|||
129804852|NCT01904058|467253086|FG002|Overall Study|Pregnancy|0|||
129804853|NCT01904058|467253087|FG003|Overall Study|Pregnancy|1|||
129735111|NCT03294135|466990166|FG002|Overall Study|Serious Adverse Event|0|||
129804854|NCT03096483|467253088|FG000|Overall Study|Withdrawal by site|1|||
129804855|NCT02046733|467253090|FG000|Overall Study|never initiated 'treatment visits'|6|||
129804856|NCT02046733|467253091|FG001|Overall Study|never initiated 'treatment visits'|0|||
129804857|NCT00199875|467253096|FG000|Overall Study|Withdrawal by Subject|0|||
129804858|NCT00199875|467253097|FG001|Overall Study|Withdrawal by Subject|0|||
129804859|NCT00199875|467253098|FG002|Overall Study|Withdrawal by Subject|0|||
129804860|NCT00199875|467253099|FG003|Overall Study|Withdrawal by Subject|0|||
129804861|NCT00199875|467253100|FG004|Overall Study|Withdrawal by Subject|1|||
129804862|NCT01024231|467253101|FG000|Overall Study|Other Reasons|1|||
129804863|NCT01024231|467253102|FG001|Overall Study|Other Reasons|2|||
129804864|NCT01024231|467253103|FG002|Overall Study|Other Reasons|0|||
129804865|NCT01024231|467253104|FG003|Overall Study|Other Reasons|0|||
129804866|NCT01024231|467253105|FG004|Overall Study|Other Reasons|2|||
129804867|NCT01024231|467253106|FG005|Overall Study|Other Reasons|0|||
129804868|NCT01024231|467253107|FG006|Overall Study|Other Reasons|1|||
129735112|NCT03294135|466990164|FG000|Overall Study|Lost to Follow-up|1|||
129735113|NCT03294135|466990165|FG001|Overall Study|Lost to Follow-up|0|||
129735114|NCT03294135|466990166|FG002|Overall Study|Lost to Follow-up|1|||
129735115|NCT03294135|466990164|FG000|Overall Study|Withdrawal by Subject|0|||
129735116|NCT03294135|466990165|FG001|Overall Study|Withdrawal by Subject|0|||
129735117|NCT03294135|466990166|FG002|Overall Study|Withdrawal by Subject|1|||
129735118|NCT03294135|466990164|FG000|Overall Study|Other|2|||
129735119|NCT03294135|466990165|FG001|Overall Study|Other|0|||
129735120|NCT03294135|466990166|FG002|Overall Study|Other|0|||
129735121|NCT02763254|466990167|FG000|Overall Study|Adverse Event|1|||
129735122|NCT03684304|466990168|FG000|Overall Study|Lost to Follow-up|19|||
129735123|NCT03684304|466990169|FG001|Overall Study|Lost to Follow-up|17|||
129735124|NCT01143051|466990170|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
129735125|NCT01143051|466990171|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
129735126|NCT01143051|466990172|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
129735127|NCT01143051|466990173|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
129735128|NCT01143051|466990174|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
129735129|NCT01143051|466990175|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
129735130|NCT01143051|466990170|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
129735131|NCT01143051|466990171|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
129735132|NCT01143051|466990172|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
129735133|NCT01143051|466990173|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
129735134|NCT01143051|466990174|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
129735135|NCT01143051|466990175|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
129735136|NCT03351114|466990176|FG000|Overall Study|Withdrawal by Subject|1|||
129735137|NCT01665430|466990180|FG000|Overall Study|Adverse Event|1|||
129735138|NCT01665430|466990180|FG000|Overall Study|Withdrawal by Subject|6|||
129735139|NCT01665430|466990180|FG000|Overall Study|Other Unspecified|2|||
129735140|NCT02310230|466990181|FG000|Overall Study|Physician Decision|1|||
129735141|NCT02310230|466990182|FG001|Overall Study|Physician Decision|3|||
129735142|NCT02310230|466990181|FG000|Overall Study|monitor baseline taken after induction|2|||
129735143|NCT02310230|466990182|FG001|Overall Study|monitor baseline taken after induction|7|||
129735144|NCT02310230|466990181|FG000|Overall Study|Poor signal quality|5|||
129735145|NCT02310230|466990182|FG001|Overall Study|Poor signal quality|8|||
129735146|NCT02310230|466990181|FG000|Overall Study|Case cancelled|1|||
129735147|NCT02310230|466990182|FG001|Overall Study|Case cancelled|0|||
129735148|NCT01605227|466990183|FG000|Overall Study|Did not receive study treatment|2|||
129735149|NCT01605227|466990184|FG001|Overall Study|Did not receive study treatment|3|||
129735150|NCT01605227|466990183|FG000|Overall Study|Adverse Event|228|||
129735151|NCT01605227|466990184|FG001|Overall Study|Adverse Event|42|||
129735152|NCT01605227|466990183|FG000|Overall Study|Progressive Disease|132|||
129735153|NCT01605227|466990184|FG001|Overall Study|Progressive Disease|128|||
129735154|NCT01605227|466990183|FG000|Overall Study|Clinical Deterioration|227|||
129735155|NCT01605227|466990184|FG001|Overall Study|Clinical Deterioration|133|||
129735156|NCT01605227|466990183|FG000|Overall Study|Lost to Follow-up|1|||
129735157|NCT01605227|466990184|FG001|Overall Study|Lost to Follow-up|0|||
129735158|NCT01605227|466990183|FG000|Overall Study|Protocol Violation|1|||
129735159|NCT01605227|466990184|FG001|Overall Study|Protocol Violation|0|||
129735160|NCT01605227|466990183|FG000|Overall Study|Physician Decision|9|||
129735161|NCT01605227|466990184|FG001|Overall Study|Physician Decision|7|||
129735162|NCT01605227|466990183|FG000|Overall Study|Withdrawal by Subject|18|||
129735163|NCT01605227|466990184|FG001|Overall Study|Withdrawal by Subject|14|||
129735164|NCT01605227|466990183|FG000|Overall Study|Sponsor Decision|2|||
129735165|NCT01605227|466990184|FG001|Overall Study|Sponsor Decision|0|||
129735166|NCT01605227|466990183|FG000|Overall Study|Started New Therapy|1|||
129735167|NCT01605227|466990184|FG001|Overall Study|Started New Therapy|0|||
129735168|NCT01605227|466990183|FG000|Overall Study|Subject Decision|0|||
129735169|NCT01605227|466990184|FG001|Overall Study|Subject Decision|1|||
129735170|NCT01605227|466990183|FG000|Overall Study|Dose Held >6 weeks|0|||
129735171|NCT01605227|466990184|FG001|Overall Study|Dose Held >6 weeks|1|||
129735172|NCT02961790|466990185|FG000|Overall Study|Canceled|4|||
129735173|NCT02961790|466990186|FG001|Overall Study|Canceled|5|||
129735174|NCT02961790|466990187|FG002|Overall Study|Canceled|1|||
129735175|NCT02961790|466990188|FG003|Overall Study|Canceled|4|||
129735176|NCT02961790|466990185|FG000|Overall Study|without baseline data|4|||
129735177|NCT02961790|466990186|FG001|Overall Study|without baseline data|0|||
129735178|NCT02961790|466990187|FG002|Overall Study|without baseline data|1|||
129735179|NCT02961790|466990188|FG003|Overall Study|without baseline data|0|||
129735180|NCT02961790|466990185|FG000|Overall Study|without post baseline data|7|||
129735181|NCT02961790|466990186|FG001|Overall Study|without post baseline data|6|||
129735182|NCT02961790|466990187|FG002|Overall Study|without post baseline data|4|||
129735183|NCT02961790|466990188|FG003|Overall Study|without post baseline data|1|||
129735184|NCT02078102|466990189|FG000|Overall Study|Adverse Event|1|||
129804869|NCT01024231|467253101|FG000|Overall Study|Maximum Clinical Benefit|1|||
129735185|NCT02078102|466990190|FG001|Overall Study|Adverse Event|0|||
129735186|NCT02078102|466990189|FG000|Overall Study|Withdrawal by Subject|1|||
129735187|NCT02078102|466990190|FG001|Overall Study|Withdrawal by Subject|0|||
129735188|NCT02078102|466990189|FG000|Overall Study|Physician Decision|0|||
129735189|NCT02078102|466990190|FG001|Overall Study|Physician Decision|1|||
129735190|NCT03093974|466990195|FG000|Overall Study|Withdrawal by Subject|32|||
129735191|NCT03093974|466990196|FG001|Overall Study|Withdrawal by Subject|27|||
129735192|NCT03093974|466990195|FG000|Overall Study|Adverse Event|17|||
129735193|NCT03093974|466990196|FG001|Overall Study|Adverse Event|24|||
129735194|NCT03093974|466990195|FG000|Overall Study|Death|0|||
129735195|NCT03093974|466990196|FG001|Overall Study|Death|1|||
129735196|NCT03093974|466990195|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129735197|NCT03093974|466990196|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129735198|NCT03093974|466990195|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
129735199|NCT03093974|466990196|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
129735200|NCT03093974|466990195|FG000|Overall Study|Lost to Follow-up|0|||
129735201|NCT03093974|466990196|FG001|Overall Study|Lost to Follow-up|1|||
129735202|NCT03093974|466990195|FG000|Overall Study|Other|1|||
129735203|NCT03093974|466990196|FG001|Overall Study|Other|2|||
129735204|NCT01866423|466990197|FG000|Overall Study|Lack of Efficacy|3|||
129735205|NCT01866423|466990197|FG000|Overall Study|Sponsor Decision|1|||
129735206|NCT01813721|466990198|FG000|Overall Study|Ineligibility determined|63|||
129735207|NCT01813721|466990198|FG000|Overall Study|Withdrawal by Subject|1|||
129735208|NCT02387164|466990199|FG000|Overall Study|Lost to Follow-up|2|||
129735209|NCT02387164|466990200|FG001|Overall Study|Lost to Follow-up|0|||
129735210|NCT02387164|466990199|FG000|Overall Study|Diagnosed|1|||
129735211|NCT02387164|466990200|FG001|Overall Study|Diagnosed|2|||
129735212|NCT01479595|466990203|FG000|Overall Study|Protocol deviation|0|||
129735213|NCT01479595|466990204|FG001|Overall Study|Protocol deviation|1|||
129735214|NCT01479595|466990203|FG000|Overall Study|Adverse Event|2|||
129735215|NCT01479595|466990204|FG001|Overall Study|Adverse Event|1|||
129735216|NCT02255565|466990206|FG000|Overall Study|Withdrawal by Subject|0|||
129735217|NCT02255565|466990207|FG001|Overall Study|Withdrawal by Subject|1|||
129735218|NCT02255565|466990208|FG002|Overall Study|Withdrawal by Subject|0|||
129735219|NCT02120365|466990209|FG000|Overall Study|Withdrawal by Subject|0|||
129735220|NCT02120365|466990210|FG001|Overall Study|Withdrawal by Subject|0|||
129735221|NCT02120365|466990211|FG002|Overall Study|Withdrawal by Subject|2|||
129804870|NCT01024231|467253102|FG001|Overall Study|Maximum Clinical Benefit|2|||
129804871|NCT01024231|467253103|FG002|Overall Study|Maximum Clinical Benefit|0|||
129804872|NCT01024231|467253104|FG003|Overall Study|Maximum Clinical Benefit|1|||
129804873|NCT01024231|467253105|FG004|Overall Study|Maximum Clinical Benefit|1|||
129804874|NCT01024231|467253106|FG005|Overall Study|Maximum Clinical Benefit|0|||
129804875|NCT01024231|467253107|FG006|Overall Study|Maximum Clinical Benefit|0|||
129804876|NCT01024231|467253101|FG000|Overall Study|Disease Progression|3|||
129804877|NCT01024231|467253102|FG001|Overall Study|Disease Progression|1|||
129804878|NCT01024231|467253103|FG002|Overall Study|Disease Progression|3|||
129804879|NCT01024231|467253104|FG003|Overall Study|Disease Progression|0|||
129804880|NCT01024231|467253105|FG004|Overall Study|Disease Progression|4|||
129804881|NCT01024231|467253106|FG005|Overall Study|Disease Progression|11|||
129804882|NCT01024231|467253107|FG006|Overall Study|Disease Progression|6|||
129804883|NCT01024231|467253101|FG000|Overall Study|AE unrelated to Study Drug|0|||
129804884|NCT01024231|467253102|FG001|Overall Study|AE unrelated to Study Drug|1|||
129804885|NCT01024231|467253103|FG002|Overall Study|AE unrelated to Study Drug|0|||
129804886|NCT01024231|467253104|FG003|Overall Study|AE unrelated to Study Drug|0|||
129804887|NCT01024231|467253105|FG004|Overall Study|AE unrelated to Study Drug|0|||
129804888|NCT01024231|467253106|FG005|Overall Study|AE unrelated to Study Drug|0|||
129804889|NCT01024231|467253107|FG006|Overall Study|AE unrelated to Study Drug|0|||
129804890|NCT01024231|467253101|FG000|Overall Study|No longer meets criteria|0|||
129804891|NCT01024231|467253102|FG001|Overall Study|No longer meets criteria|0|||
129735222|NCT02120365|466990212|FG003|Overall Study|Withdrawal by Subject|4|||
129735223|NCT02120365|466990213|FG004|Overall Study|Withdrawal by Subject|0|||
129804892|NCT01024231|467253103|FG002|Overall Study|No longer meets criteria|0|||
129804893|NCT01024231|467253104|FG003|Overall Study|No longer meets criteria|0|||
129804894|NCT01024231|467253105|FG004|Overall Study|No longer meets criteria|1|||
129804895|NCT01024231|467253106|FG005|Overall Study|No longer meets criteria|0|||
129804896|NCT01024231|467253107|FG006|Overall Study|No longer meets criteria|1|||
129804897|NCT01024231|467253101|FG000|Overall Study|Study Drug Toxicity|1|||
129804898|NCT01024231|467253102|FG001|Overall Study|Study Drug Toxicity|6|||
129804899|NCT01024231|467253103|FG002|Overall Study|Study Drug Toxicity|6|||
129804900|NCT01024231|467253104|FG003|Overall Study|Study Drug Toxicity|4|||
129735224|NCT02120365|466990214|FG005|Overall Study|Withdrawal by Subject|2|||
129735225|NCT01719003|466990217|FG000|Overall Study|Non compliant with protocol|1|||
129735226|NCT01719003|466990218|FG001|Overall Study|Non compliant with protocol|1|||
129735227|NCT01719003|466990219|FG002|Overall Study|Non compliant with protocol|0|||
129735228|NCT01719003|466990220|FG003|Overall Study|Non compliant with protocol|1|||
129804901|NCT01024231|467253105|FG004|Overall Study|Study Drug Toxicity|2|||
129804902|NCT01024231|467253106|FG005|Overall Study|Study Drug Toxicity|0|||
129804903|NCT01024231|467253107|FG006|Overall Study|Study Drug Toxicity|7|||
129804904|NCT01024231|467253101|FG000|Overall Study|Death|6|||
129804905|NCT01024231|467253102|FG001|Overall Study|Death|2|||
129735229|NCT01719003|466990221|FG004|Overall Study|Non compliant with protocol|2|||
129735230|NCT01719003|466990222|FG005|Overall Study|Non compliant with protocol|1|||
129735231|NCT01719003|466990223|FG006|Overall Study|Non compliant with protocol|2|||
129735232|NCT01719003|466990224|FG007|Overall Study|Non compliant with protocol|3|||
129735233|NCT01719003|466990225|FG008|Overall Study|Non compliant with protocol|0|||
129735234|NCT01719003|466990217|FG000|Overall Study|Adverse Event|6|||
129735235|NCT01719003|466990218|FG001|Overall Study|Adverse Event|5|||
129735236|NCT01719003|466990219|FG002|Overall Study|Adverse Event|4|||
129735237|NCT01719003|466990220|FG003|Overall Study|Adverse Event|3|||
129735238|NCT01719003|466990221|FG004|Overall Study|Adverse Event|4|||
129735239|NCT01719003|466990222|FG005|Overall Study|Adverse Event|3|||
129735240|NCT01719003|466990223|FG006|Overall Study|Adverse Event|6|||
129735241|NCT01719003|466990224|FG007|Overall Study|Adverse Event|5|||
129735242|NCT01719003|466990225|FG008|Overall Study|Adverse Event|0|||
129735243|NCT01719003|466990217|FG000|Overall Study|Lost to Follow-up|0|||
129735244|NCT01719003|466990218|FG001|Overall Study|Lost to Follow-up|6|||
129735245|NCT01719003|466990219|FG002|Overall Study|Lost to Follow-up|7|||
129735246|NCT01719003|466990220|FG003|Overall Study|Lost to Follow-up|2|||
129735247|NCT01719003|466990221|FG004|Overall Study|Lost to Follow-up|3|||
129735248|NCT01719003|466990222|FG005|Overall Study|Lost to Follow-up|4|||
129735249|NCT01719003|466990223|FG006|Overall Study|Lost to Follow-up|3|||
129735250|NCT01719003|466990224|FG007|Overall Study|Lost to Follow-up|2|||
129735251|NCT01719003|466990225|FG008|Overall Study|Lost to Follow-up|2|||
129735252|NCT01719003|466990217|FG000|Overall Study|Refusal to continue, not due to AE|2|||
129735253|NCT01719003|466990218|FG001|Overall Study|Refusal to continue, not due to AE|5|||
129735254|NCT01719003|466990219|FG002|Overall Study|Refusal to continue, not due to AE|4|||
129735255|NCT01719003|466990220|FG003|Overall Study|Refusal to continue, not due to AE|4|||
129735256|NCT01719003|466990221|FG004|Overall Study|Refusal to continue, not due to AE|4|||
129735257|NCT01719003|466990222|FG005|Overall Study|Refusal to continue, not due to AE|3|||
129735258|NCT01719003|466990223|FG006|Overall Study|Refusal to continue, not due to AE|8|||
129735259|NCT01719003|466990224|FG007|Overall Study|Refusal to continue, not due to AE|7|||
129735260|NCT01719003|466990225|FG008|Overall Study|Refusal to continue, not due to AE|1|||
129735261|NCT01719003|466990217|FG000|Overall Study|Reason other than those specified|0|||
129735262|NCT01719003|466990218|FG001|Overall Study|Reason other than those specified|0|||
129735263|NCT01719003|466990219|FG002|Overall Study|Reason other than those specified|2|||
129735264|NCT01719003|466990220|FG003|Overall Study|Reason other than those specified|3|||
129804906|NCT01024231|467253103|FG002|Overall Study|Death|1|||
129804907|NCT01024231|467253104|FG003|Overall Study|Death|0|||
129804908|NCT01024231|467253105|FG004|Overall Study|Death|4|||
129804909|NCT01024231|467253106|FG005|Overall Study|Death|3|||
129804910|NCT01024231|467253107|FG006|Overall Study|Death|5|||
129804911|NCT01024231|467253101|FG000|Overall Study|Lost to Follow-up|0|||
129804912|NCT01024231|467253102|FG001|Overall Study|Lost to Follow-up|0|||
129804913|NCT01024231|467253103|FG002|Overall Study|Lost to Follow-up|0|||
129804914|NCT01024231|467253104|FG003|Overall Study|Lost to Follow-up|0|||
129804915|NCT01024231|467253105|FG004|Overall Study|Lost to Follow-up|0|||
129804916|NCT01024231|467253106|FG005|Overall Study|Lost to Follow-up|0|||
129804917|NCT01024231|467253107|FG006|Overall Study|Lost to Follow-up|1|||
129804918|NCT01024231|467253101|FG000|Overall Study|Withdrew Consent|0|||
129804919|NCT01024231|467253102|FG001|Overall Study|Withdrew Consent|1|||
129804920|NCT01024231|467253103|FG002|Overall Study|Withdrew Consent|0|||
129804921|NCT01024231|467253104|FG003|Overall Study|Withdrew Consent|0|||
129804922|NCT01024231|467253105|FG004|Overall Study|Withdrew Consent|0|||
129804923|NCT01024231|467253106|FG005|Overall Study|Withdrew Consent|0|||
129804924|NCT01024231|467253107|FG006|Overall Study|Withdrew Consent|0|||
129804925|NCT01024231|467253101|FG000|Overall Study|Continuing on Treatment|0|||
129804926|NCT01024231|467253102|FG001|Overall Study|Continuing on Treatment|0|||
129804927|NCT01024231|467253103|FG002|Overall Study|Continuing on Treatment|0|||
129804928|NCT01024231|467253104|FG003|Overall Study|Continuing on Treatment|0|||
129804929|NCT01024231|467253105|FG004|Overall Study|Continuing on Treatment|3|||
129804930|NCT01024231|467253106|FG005|Overall Study|Continuing on Treatment|2|||
129804931|NCT01024231|467253107|FG006|Overall Study|Continuing on Treatment|0|||
129804932|NCT01013350|467253108|FG000|Overall Study|Lost to Follow-up|15|||
129735265|NCT01719003|466990221|FG004|Overall Study|Reason other than those specified|4|||
129735266|NCT01719003|466990222|FG005|Overall Study|Reason other than those specified|1|||
129735267|NCT01719003|466990223|FG006|Overall Study|Reason other than those specified|0|||
129735268|NCT01719003|466990224|FG007|Overall Study|Reason other than those specified|3|||
129735269|NCT01719003|466990225|FG008|Overall Study|Reason other than those specified|1|||
129735270|NCT01719003|466990217|FG000|Overall Study|Lack of Efficacy|0|||
129804933|NCT01013350|467253109|FG001|Overall Study|Lost to Follow-up|95|||
129804934|NCT01013350|467253108|FG000|Overall Study|Adverse Event|0|||
129804935|NCT01013350|467253109|FG001|Overall Study|Adverse Event|1|||
129804936|NCT01013350|467253108|FG000|Overall Study|Physician Decision|4|||
129804937|NCT01013350|467253109|FG001|Overall Study|Physician Decision|20|||
129804938|NCT01013350|467253108|FG000|Overall Study|Withdrawal by Subject|15|||
129804939|NCT01013350|467253109|FG001|Overall Study|Withdrawal by Subject|38|||
129804940|NCT01013350|467253108|FG000|Overall Study|Death|3|||
129804941|NCT01013350|467253109|FG001|Overall Study|Death|5|||
129735271|NCT01719003|466990218|FG001|Overall Study|Lack of Efficacy|0|||
129735272|NCT01719003|466990219|FG002|Overall Study|Lack of Efficacy|0|||
129735273|NCT01719003|466990220|FG003|Overall Study|Lack of Efficacy|0|||
129735274|NCT01719003|466990221|FG004|Overall Study|Lack of Efficacy|0|||
129735275|NCT01719003|466990222|FG005|Overall Study|Lack of Efficacy|0|||
129735276|NCT01719003|466990223|FG006|Overall Study|Lack of Efficacy|1|||
129735277|NCT01719003|466990224|FG007|Overall Study|Lack of Efficacy|0|||
129735278|NCT01719003|466990225|FG008|Overall Study|Lack of Efficacy|0|||
129735279|NCT00900146|466990226|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
129735280|NCT00900146|466990227|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
129735281|NCT00900146|466990228|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
129735282|NCT00900146|466990229|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
129735283|NCT00900146|466990230|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
129735284|NCT00900146|466990226|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
129735285|NCT00900146|466990227|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
129735286|NCT00900146|466990228|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
129735287|NCT00900146|466990229|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
129735288|NCT00900146|466990230|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
129735289|NCT00900146|466990226|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
129735290|NCT00900146|466990227|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129735291|NCT00900146|466990228|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129735292|NCT00900146|466990229|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129735293|NCT00900146|466990230|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
129735294|NCT00900146|466990226|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
129735295|NCT00900146|466990227|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
129735296|NCT00900146|466990228|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
129735297|NCT00900146|466990229|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
129735298|NCT00900146|466990230|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
129735299|NCT00900146|466990226|FG000|Intermediate: Period III|Lost to Follow-up|2|||
129735300|NCT00900146|466990227|FG001|Intermediate: Period III|Lost to Follow-up|0|||
129735301|NCT00900146|466990228|FG002|Intermediate: Period III|Lost to Follow-up|0|||
129735302|NCT00900146|466990229|FG003|Intermediate: Period III|Lost to Follow-up|0|||
129735303|NCT00900146|466990230|FG004|Intermediate: Period III|Lost to Follow-up|1|||
129735304|NCT00900146|466990226|FG000|Intermediate: Period III|Administrative problems|85|||
129735305|NCT00900146|466990227|FG001|Intermediate: Period III|Administrative problems|92|||
129735306|NCT00900146|466990228|FG002|Intermediate: Period III|Administrative problems|84|||
129735307|NCT00900146|466990229|FG003|Intermediate: Period III|Administrative problems|90|||
129735308|NCT00900146|466990230|FG004|Intermediate: Period III|Administrative problems|163|||
129735309|NCT01028716|466990235|FG000|Overall Study|Physician Decision|1|||
129804942|NCT01013350|467253108|FG000|Overall Study|Participant entered interventional study|0|||
129804943|NCT01013350|467253109|FG001|Overall Study|Participant entered interventional study|8|||
129804944|NCT01013350|467253108|FG000|Overall Study|Other|1|||
129804945|NCT01013350|467253109|FG001|Overall Study|Other|25|||
129804946|NCT02435147|467253111|FG000|Overall Study|non-evaluable DXA scan|11|||
129804947|NCT04128371|467253114|FG000|Overall Study|Lack of Efficacy|1|||
129804948|NCT01346969|467253115|FG000|Overall Study|Withdrawal by Subject|0|||
129804949|NCT01346969|467253116|FG001|Overall Study|Withdrawal by Subject|0|||
129804950|NCT01346969|467253117|FG002|Overall Study|Withdrawal by Subject|1|||
129804951|NCT01346969|467253118|FG003|Overall Study|Withdrawal by Subject|0|||
129804952|NCT01346969|467253115|FG000|Overall Study|Lost to Follow-up|1|||
129804953|NCT01346969|467253116|FG001|Overall Study|Lost to Follow-up|0|||
129804954|NCT01346969|467253117|FG002|Overall Study|Lost to Follow-up|2|||
129804955|NCT01346969|467253118|FG003|Overall Study|Lost to Follow-up|0|||
129804956|NCT01346969|467253115|FG000|Overall Study|Physician Decision|0|||
129804957|NCT01346969|467253116|FG001|Overall Study|Physician Decision|0|||
129804958|NCT01346969|467253117|FG002|Overall Study|Physician Decision|0|||
129804959|NCT01346969|467253118|FG003|Overall Study|Physician Decision|1|||
129804960|NCT01346969|467253115|FG000|Overall Study|Randomized but not treated|1|||
129804961|NCT01346969|467253116|FG001|Overall Study|Randomized but not treated|0|||
129804962|NCT01346969|467253117|FG002|Overall Study|Randomized but not treated|0|||
129804963|NCT01346969|467253118|FG003|Overall Study|Randomized but not treated|0|||
129804964|NCT05736224|467253122|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
129735310|NCT01143896|466990240|FG000|Overall Study|Did not complete Baseline Interview|5|||
129804965|NCT02557295|467253123|FG000|Overall Study|Withdrawal by Subject|9|||
129804966|NCT02557295|467253124|FG001|Overall Study|Withdrawal by Subject|2|||
129804967|NCT02557295|467253125|FG002|Overall Study|Withdrawal by Subject|4|||
129804968|NCT02557295|467253126|FG003|Overall Study|Withdrawal by Subject|0|||
129804969|NCT02557295|467253127|FG004|Overall Study|Withdrawal by Subject|0|||
129735311|NCT01143896|466990241|FG001|Overall Study|Did not complete Baseline Interview|4|||
129735312|NCT01143896|466990240|FG000|Overall Study|Lost to Follow-up|18|||
129735313|NCT01143896|466990241|FG001|Overall Study|Lost to Follow-up|13|||
129735314|NCT01143896|466990240|FG000|Overall Study|Withdrawal by Subject|13|||
129735315|NCT01143896|466990241|FG001|Overall Study|Withdrawal by Subject|5|||
129735316|NCT01143896|466990240|FG000|Overall Study|Death|6|||
129735317|NCT01143896|466990241|FG001|Overall Study|Death|3|||
129735318|NCT00320372|466990242|FG000|Overall Study|Physician Decision|4|||
129735319|NCT00320372|466990243|FG001|Overall Study|Physician Decision|7|||
129735320|NCT00320372|466990242|FG000|Overall Study|Death|7|||
129735321|NCT00320372|466990243|FG001|Overall Study|Death|8|||
129735322|NCT00320372|466990242|FG000|Overall Study|Withdrawal by Subject|55|||
129735323|NCT00320372|466990243|FG001|Overall Study|Withdrawal by Subject|37|||
129735324|NCT00320372|466990242|FG000|Overall Study|Non-Compliance|40|||
129735325|NCT00320372|466990243|FG001|Overall Study|Non-Compliance|39|||
129735326|NCT00320372|466990242|FG000|Overall Study|Did not Meet (I/E)|3|||
129735327|NCT00320372|466990243|FG001|Overall Study|Did not Meet (I/E)|1|||
129735328|NCT00320372|466990242|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
129735329|NCT00320372|466990243|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
129735330|NCT02068118|466990245|FG000|18-month Comparative Study Period|Death|90|||
129735331|NCT02068118|466990246|FG001|18-month Comparative Study Period|Death|97|||
129735332|NCT02068118|466990245|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
129735333|NCT02068118|466990246|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
129735334|NCT02068118|466990245|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
129735335|NCT02068118|466990246|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
129735336|NCT02068118|466990245|FG000|18-month Comparative Study Period|Heart transplant|9|||
129735337|NCT02068118|466990246|FG001|18-month Comparative Study Period|Heart transplant|15|||
129735338|NCT02068118|466990245|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
129735339|NCT02068118|466990246|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
129735340|NCT02068118|466990245|FG000|18-month Comparative Study Period|Hemiplegia|0|||
129735341|NCT02068118|466990246|FG001|18-month Comparative Study Period|Hemiplegia|1|||
129735342|NCT02068118|466990245|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
129735343|NCT02068118|466990246|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
129735344|NCT02068118|466990245|FG000|18-month Comparative Study Period|Move|0|||
129735345|NCT02068118|466990246|FG001|18-month Comparative Study Period|Move|1|||
129735346|NCT02068118|466990245|FG000|18-month Comparative Study Period|Hearing loss|0|||
129735347|NCT02068118|466990246|FG001|18-month Comparative Study Period|Hearing loss|1|||
129735348|NCT02068118|466990245|FG000|Extension Period|Death|0|||
129735349|NCT02068118|466990246|FG001|Extension Period|Death|2|||
129735350|NCT02068118|466990245|FG000|Extension Period|Withdrawal by Subject|1|||
129735351|NCT02068118|466990246|FG001|Extension Period|Withdrawal by Subject|0|||
129735352|NCT02068118|466990245|FG000|Extension Period|Heart transplant|1|||
129735353|NCT02068118|466990246|FG001|Extension Period|Heart transplant|0|||
129735354|NCT02068118|466990245|FG000|Extension Period|Wrong device use|0|||
129735355|NCT02068118|466990246|FG001|Extension Period|Wrong device use|1|||
129735356|NCT00283868|466990247|FG000|Overall Study|Lost to Follow-up|7|||
129735357|NCT00283868|466990248|FG001|Overall Study|Lost to Follow-up|8|||
129735358|NCT01996592|466990250|FG000|Overall Study|no response to text/no diary entry|32|||
129735359|NCT01996592|466990250|FG000|Overall Study|change in surgical date|4|||
129735360|NCT01996592|466990250|FG000|Overall Study|Withdrawal by Subject|5|||
129735361|NCT01996592|466990250|FG000|Overall Study|change in mode of delivery|4|||
129735362|NCT00394901|466990251|FG000|Baseline Phase|Protocol Violation|0|||
129735363|NCT00394901|466990252|FG001|Baseline Phase|Protocol Violation|0|||
129735364|NCT00394901|466990253|FG002|Baseline Phase|Protocol Violation|1|||
129735365|NCT00394901|466990254|FG003|Baseline Phase|Protocol Violation|0|||
129735366|NCT00394901|466990251|FG000|Double-blind Phase|Adverse Event|5|||
129735367|NCT00394901|466990252|FG001|Double-blind Phase|Adverse Event|7|||
129735368|NCT00394901|466990253|FG002|Double-blind Phase|Adverse Event|16|||
129735369|NCT00394901|466990254|FG003|Double-blind Phase|Adverse Event|20|||
129735370|NCT00394901|466990251|FG000|Double-blind Phase|Lack of Efficacy|6|||
129735371|NCT00394901|466990252|FG001|Double-blind Phase|Lack of Efficacy|4|||
129735372|NCT00394901|466990253|FG002|Double-blind Phase|Lack of Efficacy|1|||
129735373|NCT00394901|466990254|FG003|Double-blind Phase|Lack of Efficacy|3|||
129735374|NCT00394901|466990251|FG000|Double-blind Phase|Withdrawal by Subject|2|||
129735375|NCT00394901|466990252|FG001|Double-blind Phase|Withdrawal by Subject|0|||
129735376|NCT00394901|466990253|FG002|Double-blind Phase|Withdrawal by Subject|0|||
129735377|NCT00394901|466990254|FG003|Double-blind Phase|Withdrawal by Subject|0|||
129735378|NCT00394901|466990251|FG000|Double-blind Phase|Lost to Follow-up|0|||
129444735|NCT01641809|465929437|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
129444736|NCT01641809|465929438|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
129735379|NCT00394901|466990252|FG001|Double-blind Phase|Lost to Follow-up|0|||
129735380|NCT00394901|466990253|FG002|Double-blind Phase|Lost to Follow-up|0|||
129735381|NCT00394901|466990254|FG003|Double-blind Phase|Lost to Follow-up|1|||
129735382|NCT00394901|466990251|FG000|Double-blind Phase|Protocol Violation|0|||
129735383|NCT00394901|466990252|FG001|Double-blind Phase|Protocol Violation|0|||
129735384|NCT00394901|466990253|FG002|Double-blind Phase|Protocol Violation|0|||
129735385|NCT00394901|466990254|FG003|Double-blind Phase|Protocol Violation|1|||
129735386|NCT00394901|466990251|FG000|Double-blind Phase|Death|1|||
129735387|NCT00394901|466990252|FG001|Double-blind Phase|Death|0|||
129735388|NCT00394901|466990253|FG002|Double-blind Phase|Death|0|||
129735389|NCT00394901|466990254|FG003|Double-blind Phase|Death|0|||
129735390|NCT00394901|466990251|FG000|Double-blind Phase|Subject's Personal Reason|1|||
129735391|NCT00394901|466990252|FG001|Double-blind Phase|Subject's Personal Reason|0|||
129735392|NCT00394901|466990253|FG002|Double-blind Phase|Subject's Personal Reason|0|||
129735393|NCT00394901|466990254|FG003|Double-blind Phase|Subject's Personal Reason|1|||
129735394|NCT00394901|466990251|FG000|Double-blind Phase|Lack of Compliance|0|||
129735395|NCT00394901|466990252|FG001|Double-blind Phase|Lack of Compliance|3|||
129735396|NCT00394901|466990253|FG002|Double-blind Phase|Lack of Compliance|0|||
129735397|NCT00394901|466990254|FG003|Double-blind Phase|Lack of Compliance|0|||
129735398|NCT00394901|466990251|FG000|Double-blind Phase|Entry into another study was found|0|||
129735399|NCT00394901|466990252|FG001|Double-blind Phase|Entry into another study was found|0|||
129735400|NCT00394901|466990253|FG002|Double-blind Phase|Entry into another study was found|1|||
129735401|NCT00394901|466990254|FG003|Double-blind Phase|Entry into another study was found|0|||
129735402|NCT00394901|466990251|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
129735403|NCT00394901|466990252|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
129735404|NCT00394901|466990253|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
129735405|NCT00394901|466990254|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
129735406|NCT05028517|466990255|FG000|Overall Study|Lost to Follow-up|13|||
129735407|NCT05028517|466990256|FG001|Overall Study|Lost to Follow-up|20|||
129735408|NCT05028517|466990257|FG002|Overall Study|Lost to Follow-up|12|||
129735409|NCT05028517|466990255|FG000|Overall Study|Withdrawal by Subject|0|||
129735410|NCT05028517|466990256|FG001|Overall Study|Withdrawal by Subject|0|||
129735411|NCT05028517|466990257|FG002|Overall Study|Withdrawal by Subject|1|||
129735412|NCT02256267|466990258|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
129735413|NCT02256267|466990258|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
129735414|NCT02360293|466990261|FG000|Overall Study|Lost to Follow-up|73|||
129735415|NCT02360293|466990262|FG001|Overall Study|Lost to Follow-up|95|||
129735416|NCT02360293|466990261|FG000|Overall Study|Withdrawal by Subject|2|||
129735417|NCT02360293|466990262|FG001|Overall Study|Withdrawal by Subject|1|||
129735418|NCT02360293|466990261|FG000|Overall Study|Excluded|1|||
129735419|NCT02360293|466990262|FG001|Overall Study|Excluded|0|||
129735420|NCT04316741|466990263|FG000|Baseline Enrollment|Lost to Follow-up|1|||
129735421|NCT04316741|466990264|FG001|Baseline Enrollment|Lost to Follow-up|1|||
129735422|NCT04316741|466990263|FG000|Immediate Post-Test|Lost to Follow-up|5|||
129735423|NCT04316741|466990264|FG001|Immediate Post-Test|Lost to Follow-up|1|||
129735424|NCT04316741|466990263|FG000|1-month Post-test|Lost to Follow-up|7|||
129735425|NCT04316741|466990264|FG001|1-month Post-test|Lost to Follow-up|2|||
129735426|NCT04316741|466990263|FG000|3-month Follow-up|Lost to Follow-up|10|||
129735427|NCT04316741|466990264|FG001|3-month Follow-up|Lost to Follow-up|2|||
129735428|NCT01498185|466990266|FG000|Overall Study|Adverse Event|0|||
129735429|NCT01498185|466990267|FG001|Overall Study|Adverse Event|0|||
129735430|NCT01498185|466990268|FG002|Overall Study|Adverse Event|0|||
129735431|NCT01498185|466990269|FG003|Overall Study|Adverse Event|1|||
129735432|NCT01498185|466990270|FG004|Overall Study|Adverse Event|0|||
129735433|NCT01498185|466990266|FG000|Overall Study|Withdrawal by Subject|1|||
129735434|NCT01498185|466990267|FG001|Overall Study|Withdrawal by Subject|1|||
129735435|NCT01498185|466990268|FG002|Overall Study|Withdrawal by Subject|0|||
129735436|NCT01498185|466990269|FG003|Overall Study|Withdrawal by Subject|2|||
129735437|NCT01498185|466990270|FG004|Overall Study|Withdrawal by Subject|1|||
129735438|NCT01498185|466990266|FG000|Overall Study|No longer met criteria, etc|0|||
129735439|NCT01498185|466990267|FG001|Overall Study|No longer met criteria, etc|0|||
129735440|NCT01498185|466990268|FG002|Overall Study|No longer met criteria, etc|0|||
129735441|NCT01498185|466990269|FG003|Overall Study|No longer met criteria, etc|0|||
129735442|NCT01498185|466990270|FG004|Overall Study|No longer met criteria, etc|2|||
129735443|NCT01827332|466990271|FG000|Overall Study|Lost to Follow-up|2|||
129735444|NCT01827332|466990272|FG001|Overall Study|Lost to Follow-up|1|||
129735445|NCT02725593|466990273|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
129735446|NCT02725593|466990274|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
129735447|NCT02725593|466990273|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
129735448|NCT02725593|466990274|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
129735449|NCT02725593|466990273|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
129735450|NCT02725593|466990274|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
129735451|NCT02725593|466990273|FG000|Long Term Extension|Withdrawal by Subject|1|||
129735452|NCT02725593|466990274|FG001|Long Term Extension|Withdrawal by Subject|3|||
129735453|NCT00387647|466991886|FG000|Overall Study|Death|18|||
129735454|NCT01309269|466991889|FG000|Overall Study|Adverse Event|56|||
129735455|NCT01309269|466991889|FG000|Overall Study|Withdrawal by Subject|25|||
129735456|NCT01309269|466991889|FG000|Overall Study|Lack of Acceptance|15|||
129735457|NCT01309269|466991889|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
129735458|NCT01309269|466991889|FG000|Overall Study|Kidney Transplant|25|||
129735459|NCT01309269|466991889|FG000|Overall Study|Administrative Problems|141|||
129735460|NCT01309269|466991889|FG000|Overall Study|Other|256|||
129735461|NCT01309269|466991889|FG000|Overall Study|Other|1|||
129735462|NCT01309269|466991889|FG000|Overall Study|Study Completion Data Not Recorded|95|||
129735463|NCT01309269|466991889|FG000|Overall Study|Enrolled but not Treated|107|||
129735464|NCT03131596|466991892|FG000|Overall Study|Protocol Violation|3|||
129735465|NCT03131596|466991893|FG001|Overall Study|Protocol Violation|3|||
129735466|NCT03131596|466991892|FG000|Overall Study|Lost to Follow-up|3|||
129735467|NCT03131596|466991893|FG001|Overall Study|Lost to Follow-up|0|||
129735468|NCT05013424|466991896|FG000|Overall Study|Lost to Follow-up|1|||
129735469|NCT05013424|466991897|FG001|Overall Study|Lost to Follow-up|1|||
129735470|NCT05013424|466991898|FG002|Overall Study|Lost to Follow-up|1|||
129735471|NCT05013424|466991896|FG000|Overall Study|Withdrawal by Subject|0|||
129735472|NCT05013424|466991897|FG001|Overall Study|Withdrawal by Subject|1|||
129735473|NCT05013424|466991898|FG002|Overall Study|Withdrawal by Subject|0|||
129735474|NCT04411420|466991899|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
129735475|NCT04411420|466991900|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
129735476|NCT04411420|466991899|FG000|Survey Subset|Lost to Follow-up|134|||
129735477|NCT04411420|466991900|FG001|Survey Subset|Lost to Follow-up|120|||
129735478|NCT03899064|466991901|FG000|Overall Study|Lost to Follow-up|1|||
129735479|NCT03899064|466991901|FG000|Overall Study|Protocol Violation|2|||
129735480|NCT03899064|466991901|FG000|Overall Study|Withdrawal by Subject|2|||
129735481|NCT03899064|466991901|FG000|Overall Study|Other|2|||
129735482|NCT03769311|466991904|FG000|Overall Study|Withdrawal by Subject|1|||
129735483|NCT01596335|466991905|FG000|Overall Study|exacerbation of primary disease|5|||
129735484|NCT01596335|466991906|FG001|Overall Study|exacerbation of primary disease|9|||
129735485|NCT03627065|466991907|FG000|Overall Study|Study Terminated by sponsor|1|||
129735486|NCT03627065|466991907|FG000|Overall Study|Withdrawal by Subject|2|||
129735487|NCT04524455|466991908|FG000|Overall Study|Death|3|||
129735488|NCT04524455|466991909|FG001|Overall Study|Death|3|||
129735489|NCT04524455|466991908|FG000|Overall Study|Decision by Sponsor|0|||
129735490|NCT04524455|466991909|FG001|Overall Study|Decision by Sponsor|2|||
129735491|NCT04524455|466991908|FG000|Overall Study|Withdrawal of Consent From Study|1|||
129735492|NCT04524455|466991909|FG001|Overall Study|Withdrawal of Consent From Study|0|||
129735493|NCT04524455|466991908|FG000|Overall Study|Lost to Follow-up|0|||
129735494|NCT04524455|466991909|FG001|Overall Study|Lost to Follow-up|1|||
129735495|NCT01062061|466991914|FG000|Overall Study|Enrolled more than once|2|||
129735496|NCT01062061|466991914|FG000|Overall Study|Investigated before study start|13|||
129735497|NCT01062061|466991914|FG000|Overall Study|Outside chief indications|10|||
129735498|NCT01062061|466991914|FG000|Overall Study|Failed to meet inclusion criteria|2|||
129735499|NCT00524589|466991915|FG000|Overall Study|Withdrawal by Subject|2|||
129735500|NCT00524589|466991915|FG000|Overall Study|Disease Progression|16|||
129735501|NCT00098722|466991916|FG000|Double Blind Phase|Adverse Event|7|||
129735502|NCT00098722|466991917|FG001|Double Blind Phase|Adverse Event|7|||
129735503|NCT00098722|466991918|FG002|Double Blind Phase|Adverse Event|3|||
129804970|NCT02557295|467253128|FG005|Overall Study|Withdrawal by Subject|0|||
129804971|NCT02557295|467253129|FG006|Overall Study|Withdrawal by Subject|15|||
129735504|NCT00098722|466991919|FG003|Double Blind Phase|Adverse Event|0|||
129735505|NCT00098722|466991920|FG004|Double Blind Phase|Adverse Event|0|||
129735506|NCT00098722|466991921|FG005|Double Blind Phase|Adverse Event|0|||
129735507|NCT00098722|466991922|FG006|Double Blind Phase|Adverse Event|0|||
129735508|NCT00098722|466991916|FG000|Double Blind Phase|Death|2|||
129735509|NCT00098722|466991917|FG001|Double Blind Phase|Death|5|||
129735510|NCT00098722|466991918|FG002|Double Blind Phase|Death|0|||
129735511|NCT00098722|466991919|FG003|Double Blind Phase|Death|0|||
129735512|NCT00098722|466991920|FG004|Double Blind Phase|Death|0|||
129735513|NCT00098722|466991921|FG005|Double Blind Phase|Death|0|||
129735514|NCT00098722|466991922|FG006|Double Blind Phase|Death|0|||
129735515|NCT00098722|466991916|FG000|Double Blind Phase|Lack of Efficacy|21|||
129735516|NCT00098722|466991917|FG001|Double Blind Phase|Lack of Efficacy|23|||
129735517|NCT00098722|466991918|FG002|Double Blind Phase|Lack of Efficacy|15|||
129735518|NCT00098722|466991919|FG003|Double Blind Phase|Lack of Efficacy|0|||
129735519|NCT00098722|466991920|FG004|Double Blind Phase|Lack of Efficacy|0|||
129735520|NCT00098722|466991921|FG005|Double Blind Phase|Lack of Efficacy|0|||
129735521|NCT00098722|466991922|FG006|Double Blind Phase|Lack of Efficacy|0|||
129735522|NCT00098722|466991916|FG000|Double Blind Phase|Participant defaulted|16|||
129735523|NCT00098722|466991917|FG001|Double Blind Phase|Participant defaulted|11|||
129735524|NCT00098722|466991918|FG002|Double Blind Phase|Participant defaulted|9|||
129735525|NCT00098722|466991919|FG003|Double Blind Phase|Participant defaulted|0|||
129735526|NCT00098722|466991920|FG004|Double Blind Phase|Participant defaulted|0|||
129735527|NCT00098722|466991921|FG005|Double Blind Phase|Participant defaulted|0|||
129735528|NCT00098722|466991922|FG006|Double Blind Phase|Participant defaulted|0|||
129735529|NCT00098722|466991916|FG000|Double Blind Phase|Pregnancy|1|||
129735530|NCT00098722|466991917|FG001|Double Blind Phase|Pregnancy|0|||
129735531|NCT00098722|466991918|FG002|Double Blind Phase|Pregnancy|0|||
129735532|NCT00098722|466991919|FG003|Double Blind Phase|Pregnancy|0|||
129735533|NCT00098722|466991920|FG004|Double Blind Phase|Pregnancy|0|||
129735534|NCT00098722|466991921|FG005|Double Blind Phase|Pregnancy|0|||
129735535|NCT00098722|466991922|FG006|Double Blind Phase|Pregnancy|0|||
129735536|NCT00098722|466991916|FG000|Double Blind Phase|Randomized, not treated|4|||
129735537|NCT00098722|466991917|FG001|Double Blind Phase|Randomized, not treated|3|||
129735538|NCT00098722|466991918|FG002|Double Blind Phase|Randomized, not treated|3|||
129735539|NCT00098722|466991919|FG003|Double Blind Phase|Randomized, not treated|0|||
129735540|NCT00098722|466991920|FG004|Double Blind Phase|Randomized, not treated|0|||
129735541|NCT00098722|466991921|FG005|Double Blind Phase|Randomized, not treated|0|||
129735542|NCT00098722|466991922|FG006|Double Blind Phase|Randomized, not treated|0|||
129735543|NCT00098722|466991916|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
129735544|NCT00098722|466991917|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
129735545|NCT00098722|466991918|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
129735546|NCT00098722|466991919|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
129735547|NCT00098722|466991920|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
129735548|NCT00098722|466991921|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
129735549|NCT00098722|466991922|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
129735550|NCT00098722|466991916|FG000|Double Blind Phase|Other|7|||
129735551|NCT00098722|466991917|FG001|Double Blind Phase|Other|8|||
129735552|NCT00098722|466991918|FG002|Double Blind Phase|Other|7|||
129735553|NCT00098722|466991919|FG003|Double Blind Phase|Other|0|||
129735554|NCT00098722|466991920|FG004|Double Blind Phase|Other|0|||
129735555|NCT00098722|466991921|FG005|Double Blind Phase|Other|0|||
129735556|NCT00098722|466991922|FG006|Double Blind Phase|Other|0|||
129735557|NCT00098722|466991916|FG000|Open Label Phase|Adverse Event|0|||
129735558|NCT00098722|466991917|FG001|Open Label Phase|Adverse Event|0|||
129735559|NCT00098722|466991918|FG002|Open Label Phase|Adverse Event|0|||
129735560|NCT00098722|466991919|FG003|Open Label Phase|Adverse Event|5|||
129735561|NCT00098722|466991920|FG004|Open Label Phase|Adverse Event|0|||
129735562|NCT00098722|466991921|FG005|Open Label Phase|Adverse Event|0|||
129735563|NCT00098722|466991922|FG006|Open Label Phase|Adverse Event|0|||
129735564|NCT00098722|466991916|FG000|Open Label Phase|Death|0|||
129804972|NCT02557295|467253130|FG007|Overall Study|Withdrawal by Subject|1|||
129804973|NCT02557295|467253131|FG008|Overall Study|Withdrawal by Subject|3|||
129804974|NCT02557295|467253123|FG000|Overall Study|Disease Progression|0|||
129804975|NCT02557295|467253124|FG001|Overall Study|Disease Progression|0|||
129804976|NCT02557295|467253125|FG002|Overall Study|Disease Progression|0|||
129804977|NCT02557295|467253126|FG003|Overall Study|Disease Progression|0|||
129804978|NCT02557295|467253127|FG004|Overall Study|Disease Progression|0|||
129804979|NCT02557295|467253128|FG005|Overall Study|Disease Progression|0|||
129804980|NCT02557295|467253129|FG006|Overall Study|Disease Progression|1|||
129804981|NCT02557295|467253130|FG007|Overall Study|Disease Progression|0|||
129804982|NCT02557295|467253131|FG008|Overall Study|Disease Progression|0|||
129735565|NCT00098722|466991917|FG001|Open Label Phase|Death|0|||
129735566|NCT00098722|466991918|FG002|Open Label Phase|Death|0|||
129735567|NCT00098722|466991919|FG003|Open Label Phase|Death|2|||
129804983|NCT02557295|467253123|FG000|Overall Study|Lack of Efficacy|24|||
129735568|NCT00098722|466991920|FG004|Open Label Phase|Death|0|||
129735569|NCT00098722|466991921|FG005|Open Label Phase|Death|0|||
129735570|NCT00098722|466991922|FG006|Open Label Phase|Death|0|||
129735571|NCT00098722|466991916|FG000|Open Label Phase|Lack of Efficacy|0|||
129735572|NCT00098722|466991917|FG001|Open Label Phase|Lack of Efficacy|0|||
129735573|NCT00098722|466991918|FG002|Open Label Phase|Lack of Efficacy|0|||
129735574|NCT00098722|466991919|FG003|Open Label Phase|Lack of Efficacy|8|||
129735575|NCT00098722|466991920|FG004|Open Label Phase|Lack of Efficacy|0|||
129735576|NCT00098722|466991921|FG005|Open Label Phase|Lack of Efficacy|0|||
129735577|NCT00098722|466991922|FG006|Open Label Phase|Lack of Efficacy|0|||
129804984|NCT02557295|467253124|FG001|Overall Study|Lack of Efficacy|1|||
129804985|NCT02557295|467253125|FG002|Overall Study|Lack of Efficacy|3|||
129804986|NCT02557295|467253126|FG003|Overall Study|Lack of Efficacy|0|||
129804987|NCT02557295|467253127|FG004|Overall Study|Lack of Efficacy|0|||
129735578|NCT00098722|466991916|FG000|Open Label Phase|Pregnancy|0|||
129735579|NCT00098722|466991917|FG001|Open Label Phase|Pregnancy|0|||
129735580|NCT00098722|466991918|FG002|Open Label Phase|Pregnancy|0|||
129735581|NCT00098722|466991919|FG003|Open Label Phase|Pregnancy|1|||
129735582|NCT00098722|466991920|FG004|Open Label Phase|Pregnancy|0|||
129735583|NCT00098722|466991921|FG005|Open Label Phase|Pregnancy|0|||
129735584|NCT00098722|466991922|FG006|Open Label Phase|Pregnancy|0|||
129735585|NCT00098722|466991916|FG000|Open Label Phase|Participant defaulted|0|||
129735586|NCT00098722|466991917|FG001|Open Label Phase|Participant defaulted|0|||
129735587|NCT00098722|466991918|FG002|Open Label Phase|Participant defaulted|0|||
129735588|NCT00098722|466991919|FG003|Open Label Phase|Participant defaulted|18|||
129735589|NCT00098722|466991920|FG004|Open Label Phase|Participant defaulted|0|||
129735590|NCT00098722|466991921|FG005|Open Label Phase|Participant defaulted|0|||
129735591|NCT00098722|466991922|FG006|Open Label Phase|Participant defaulted|0|||
129735592|NCT00098722|466991916|FG000|Open Label Phase|Ongoing at cut-off date|0|||
129735593|NCT00098722|466991917|FG001|Open Label Phase|Ongoing at cut-off date|0|||
129735594|NCT00098722|466991918|FG002|Open Label Phase|Ongoing at cut-off date|0|||
129735595|NCT00098722|466991919|FG003|Open Label Phase|Ongoing at cut-off date|220|||
129735596|NCT00098722|466991920|FG004|Open Label Phase|Ongoing at cut-off date|50|||
129735597|NCT00098722|466991921|FG005|Open Label Phase|Ongoing at cut-off date|0|||
129735598|NCT00098722|466991922|FG006|Open Label Phase|Ongoing at cut-off date|0|||
129735599|NCT00098722|466991916|FG000|Open Label Phase|Other|0|||
129735600|NCT00098722|466991917|FG001|Open Label Phase|Other|0|||
129735601|NCT00098722|466991918|FG002|Open Label Phase|Other|0|||
129735602|NCT00098722|466991919|FG003|Open Label Phase|Other|18|||
129735603|NCT00098722|466991920|FG004|Open Label Phase|Other|0|||
129735604|NCT00098722|466991921|FG005|Open Label Phase|Other|0|||
129735605|NCT00098722|466991922|FG006|Open Label Phase|Other|0|||
129735606|NCT00098722|466991916|FG000|Observation Phase|Death|0|||
129735607|NCT00098722|466991917|FG001|Observation Phase|Death|0|||
129735608|NCT00098722|466991918|FG002|Observation Phase|Death|0|||
129735609|NCT00098722|466991919|FG003|Observation Phase|Death|0|||
129735610|NCT00098722|466991920|FG004|Observation Phase|Death|0|||
129735611|NCT00098722|466991921|FG005|Observation Phase|Death|5|||
129735612|NCT00098722|466991922|FG006|Observation Phase|Death|3|||
129735613|NCT00098722|466991916|FG000|Observation Phase|Lack of Efficacy|0|||
129735614|NCT00098722|466991917|FG001|Observation Phase|Lack of Efficacy|0|||
129735615|NCT00098722|466991918|FG002|Observation Phase|Lack of Efficacy|0|||
129735616|NCT00098722|466991919|FG003|Observation Phase|Lack of Efficacy|0|||
129735617|NCT00098722|466991920|FG004|Observation Phase|Lack of Efficacy|0|||
129735618|NCT00098722|466991921|FG005|Observation Phase|Lack of Efficacy|2|||
129735619|NCT00098722|466991922|FG006|Observation Phase|Lack of Efficacy|0|||
129735620|NCT00098722|466991916|FG000|Observation Phase|Participant defaulted|0|||
129735621|NCT00098722|466991917|FG001|Observation Phase|Participant defaulted|0|||
129735622|NCT00098722|466991918|FG002|Observation Phase|Participant defaulted|0|||
129735623|NCT00098722|466991919|FG003|Observation Phase|Participant defaulted|0|||
129735624|NCT00098722|466991920|FG004|Observation Phase|Participant defaulted|0|||
129735625|NCT00098722|466991921|FG005|Observation Phase|Participant defaulted|17|||
129735626|NCT00098722|466991922|FG006|Observation Phase|Participant defaulted|4|||
129735627|NCT00098722|466991916|FG000|Observation Phase|Other|0|||
129735628|NCT00098722|466991917|FG001|Observation Phase|Other|0|||
129735629|NCT00098722|466991918|FG002|Observation Phase|Other|0|||
129735630|NCT00098722|466991919|FG003|Observation Phase|Other|0|||
129735631|NCT00098722|466991920|FG004|Observation Phase|Other|0|||
129735632|NCT00098722|466991921|FG005|Observation Phase|Other|21|||
129735633|NCT00098722|466991922|FG006|Observation Phase|Other|10|||
129735634|NCT02351349|466991923|FG000|Overall Study|Withdrawal by Subject|2|||
129735635|NCT02351349|466991924|FG001|Overall Study|Withdrawal by Subject|3|||
129735636|NCT00440310|466991925|FG000|Overall Study|Lost to Follow-up|4|||
129735637|NCT00440310|466991926|FG001|Overall Study|Lost to Follow-up|5|||
129735638|NCT00440310|466991925|FG000|Overall Study|Protocol Violation|0|||
129735639|NCT00440310|466991926|FG001|Overall Study|Protocol Violation|1|||
129735640|NCT00440310|466991925|FG000|Overall Study|Withdrawal by Subject|15|||
129735641|NCT00440310|466991926|FG001|Overall Study|Withdrawal by Subject|14|||
129735642|NCT00440310|466991925|FG000|Overall Study|No Reply at EOS|7|||
129735643|NCT00440310|466991926|FG001|Overall Study|No Reply at EOS|7|||
129735644|NCT00440310|466991925|FG000|Overall Study|Other|1|||
129735645|NCT00440310|466991926|FG001|Overall Study|Other|0|||
129735646|NCT00440310|466991925|FG000|Overall Study|Status Unknown|1|||
129735647|NCT00440310|466991926|FG001|Overall Study|Status Unknown|3|||
129735648|NCT01519674|466991933|FG000|Overall Study|Adverse Event|3|||
129735649|NCT01519674|466991934|FG001|Overall Study|Adverse Event|3|||
129735650|NCT01519674|466991935|FG002|Overall Study|Adverse Event|0|||
129735651|NCT01519674|466991933|FG000|Overall Study|Lack of Efficacy|1|||
129735652|NCT01519674|466991934|FG001|Overall Study|Lack of Efficacy|1|||
129735653|NCT01519674|466991935|FG002|Overall Study|Lack of Efficacy|1|||
129735654|NCT01519674|466991933|FG000|Overall Study|Protocol Violation|0|||
129735655|NCT01519674|466991934|FG001|Overall Study|Protocol Violation|3|||
129735656|NCT01519674|466991935|FG002|Overall Study|Protocol Violation|1|||
129735657|NCT01519674|466991933|FG000|Overall Study|Withdrawal Criteria|7|||
129735658|NCT01519674|466991934|FG001|Overall Study|Withdrawal Criteria|2|||
129735659|NCT01519674|466991935|FG002|Overall Study|Withdrawal Criteria|7|||
129735660|NCT01519674|466991933|FG000|Overall Study|Unsclassified|10|||
129735661|NCT01519674|466991934|FG001|Overall Study|Unsclassified|4|||
129735662|NCT01519674|466991935|FG002|Overall Study|Unsclassified|3|||
129735663|NCT01610596|466991936|FG000|Overall Study|Lost to Follow-up|0|||
129735664|NCT01610596|466991937|FG001|Overall Study|Lost to Follow-up|1|||
129735665|NCT00799591|466991938|FG000|Overall Study|De-escalation of doses|20|||
129735666|NCT00799591|466991938|FG000|Overall Study|Death|14|||
129735667|NCT00799591|466991938|FG000|Overall Study|Technical failure|12|||
129735668|NCT00799591|466991938|FG000|Overall Study|Resistant germ|11|||
129735669|NCT00799591|466991938|FG000|Overall Study|New infection|4|||
129735670|NCT00799591|466991938|FG000|Overall Study|Resistance germ and technical failure|2|||
129735671|NCT00799591|466991938|FG000|Overall Study|Persistance of fever undetermined origin|1|||
129735672|NCT00799591|466991938|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
129735673|NCT00799591|466991938|FG000|Overall Study|Infectious origin not probable|1|||
129735674|NCT02317809|466991939|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
129735675|NCT02317809|466991940|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
129735676|NCT02317809|466991939|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
129735677|NCT02317809|466991940|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
129735678|NCT02969590|466991943|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
129735679|NCT02969590|466991944|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
129735680|NCT02969590|466991945|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
129735681|NCT02590562|466991950|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
129735682|NCT00598078|466991956|FG000|Period 2 (Day 2)|Adverse Event|1|||
129735683|NCT00598078|466991957|FG001|Period 2 (Day 2)|Adverse Event|0|||
129735684|NCT02699450|466991961|FG000|Overall Study|Death|2|||
129735685|NCT02699450|466991962|FG001|Overall Study|Death|1|||
129735686|NCT02699450|466991963|FG002|Overall Study|Death|2|||
129735687|NCT02699450|466991961|FG000|Overall Study|Met Criteria for Study Exit|0|||
129735688|NCT02699450|466991962|FG001|Overall Study|Met Criteria for Study Exit|0|||
129735689|NCT02699450|466991963|FG002|Overall Study|Met Criteria for Study Exit|1|||
129735690|NCT02699450|466991961|FG000|Overall Study|Protocol Violation|4|||
129735691|NCT02699450|466991962|FG001|Overall Study|Protocol Violation|3|||
129735692|NCT02699450|466991963|FG002|Overall Study|Protocol Violation|5|||
129735693|NCT02699450|466991961|FG000|Overall Study|Lost to Follow-up|3|||
129735694|NCT02699450|466991962|FG001|Overall Study|Lost to Follow-up|0|||
129735695|NCT02699450|466991963|FG002|Overall Study|Lost to Follow-up|5|||
129735696|NCT02699450|466991961|FG000|Overall Study|Physician Decision|2|||
129735697|NCT02699450|466991962|FG001|Overall Study|Physician Decision|0|||
129735698|NCT02699450|466991963|FG002|Overall Study|Physician Decision|0|||
129735699|NCT02699450|466991961|FG000|Overall Study|Withdrawal by Subject|3|||
129735700|NCT02699450|466991962|FG001|Overall Study|Withdrawal by Subject|1|||
129735701|NCT02699450|466991963|FG002|Overall Study|Withdrawal by Subject|2|||
129735702|NCT02699450|466991961|FG000|Overall Study|Adverse Event|1|||
129735703|NCT02699450|466991962|FG001|Overall Study|Adverse Event|0|||
129735704|NCT02699450|466991963|FG002|Overall Study|Adverse Event|0|||
129735705|NCT01133275|466991966|FG000|Overall Study|Withdrawal by Subject|1|||
129735706|NCT01133275|466991966|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
129735707|NCT00700102|466991967|FG000|Overall Study|Died|394|||
129735708|NCT00700102|466991968|FG001|Overall Study|Died|385|||
129735709|NCT00700102|466991967|FG000|Overall Study|Lost to Follow-up|8|||
129735710|NCT00700102|466991968|FG001|Overall Study|Lost to Follow-up|10|||
129735711|NCT02525939|466991969|FG000|Overall Study|Lost to Follow-up|27|||
129735712|NCT02525939|466991970|FG001|Overall Study|Lost to Follow-up|24|||
129735713|NCT02525939|466991969|FG000|Overall Study|Physician Decision|0|||
129735714|NCT02525939|466991970|FG001|Overall Study|Physician Decision|1|||
129735715|NCT02525939|466991969|FG000|Overall Study|Withdrawal by Subject|24|||
129735716|NCT02525939|466991970|FG001|Overall Study|Withdrawal by Subject|39|||
129735717|NCT02525939|466991969|FG000|Overall Study|Death|180|||
129735718|NCT02525939|466991970|FG001|Overall Study|Death|179|||
129735719|NCT01635764|466991971|FG000|Overall Study|Adverse Event|46|||
129735720|NCT01635764|466991971|FG000|Overall Study|Lack of Efficacy|76|||
129735721|NCT01635764|466991971|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
129735722|NCT01635764|466991971|FG000|Overall Study|Protocol Deviation|1|||
129735723|NCT01635764|466991971|FG000|Overall Study|Withdrew Consent|67|||
129735724|NCT01635764|466991971|FG000|Overall Study|Lost to Follow-up|53|||
129735725|NCT01635764|466991971|FG000|Overall Study|Other|28|||
129735726|NCT01174004|466991972|FG000|Overall Study|Adverse Event|2|||
129735727|NCT01174004|466991973|FG001|Overall Study|Adverse Event|10|||
129735728|NCT01174004|466991972|FG000|Overall Study|Withdrawal by Subject|2|||
129735729|NCT01174004|466991973|FG001|Overall Study|Withdrawal by Subject|3|||
129735730|NCT01174004|466991972|FG000|Overall Study|At Discretion of Sponsor|2|||
129735731|NCT01174004|466991973|FG001|Overall Study|At Discretion of Sponsor|2|||
129735732|NCT01174004|466991972|FG000|Overall Study|Protocol Violation|0|||
129735733|NCT01174004|466991973|FG001|Overall Study|Protocol Violation|1|||
129735734|NCT01174004|466991972|FG000|Overall Study|Physician Decision|1|||
129735735|NCT01174004|466991973|FG001|Overall Study|Physician Decision|0|||
129735736|NCT00849875|466991976|FG000|Overall Study|Death|28|||
129735737|NCT00849875|466991976|FG000|Overall Study|Ongoing (unknown completion status)|11|||
129735738|NCT00849875|466991976|FG000|Overall Study|Others|6|||
129735739|NCT00849875|466991976|FG000|Overall Study|Lost to Follow-up|2|||
129735740|NCT00086502|466991977|FG000|Overall Study|Adverse Event|11|||
129735741|NCT00086502|466991978|FG001|Overall Study|Adverse Event|2|||
129735742|NCT00086502|466991977|FG000|Overall Study|Lack of Efficacy|0|||
129735743|NCT00086502|466991978|FG001|Overall Study|Lack of Efficacy|2|||
129735744|NCT00086502|466991977|FG000|Overall Study|Lost to Follow-up|3|||
129735745|NCT00086502|466991978|FG001|Overall Study|Lost to Follow-up|1|||
129735746|NCT00086502|466991977|FG000|Overall Study|Physician Decision|1|||
129735747|NCT00086502|466991978|FG001|Overall Study|Physician Decision|1|||
129735748|NCT00086502|466991977|FG000|Overall Study|Pregnancy|0|||
129735749|NCT00086502|466991978|FG001|Overall Study|Pregnancy|1|||
129735750|NCT00086502|466991977|FG000|Overall Study|Protocol Violation|3|||
129735751|NCT00086502|466991978|FG001|Overall Study|Protocol Violation|3|||
129735752|NCT00086502|466991977|FG000|Overall Study|Withdrawal by Subject|5|||
129735753|NCT00086502|466991978|FG001|Overall Study|Withdrawal by Subject|6|||
129735754|NCT00086502|466991977|FG000|Overall Study|Patient Moved|1|||
129735755|NCT00086502|466991978|FG001|Overall Study|Patient Moved|1|||
129735756|NCT00086502|466991977|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
129735757|NCT00086502|466991978|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
129735758|NCT00086502|466991977|FG000|Overall Study|Patient Accidentally Unblinded|1|||
129735759|NCT00086502|466991978|FG001|Overall Study|Patient Accidentally Unblinded|0|||
129735760|NCT01515475|466991984|FG000|Overall Study|Lost to Follow-up|20|||
129735761|NCT01515475|466991985|FG001|Overall Study|Lost to Follow-up|15|||
129735762|NCT01515475|466991986|FG002|Overall Study|Lost to Follow-up|12|||
129735763|NCT01515475|466991987|FG003|Overall Study|Lost to Follow-up|12|||
129735764|NCT01420627|466991988|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
129735765|NCT00837876|466991989|FG000|Overall Study|Death|2|||
129735766|NCT00837876|466991989|FG000|Overall Study|Adverse Event|7|||
129735767|NCT00837876|466991989|FG000|Overall Study|Physician Decision|1|||
129735768|NCT00837876|466991989|FG000|Overall Study|Withdrawal by Subject|3|||
129735769|NCT00837876|466991989|FG000|Overall Study|disease progression|24|||
129735770|NCT00453973|466991990|FG000|Overall Study|Adverse Event|4|||
129735771|NCT00453973|466991991|FG001|Overall Study|Adverse Event|9|||
129735772|NCT00453973|466991990|FG000|Overall Study|Withdrawal by Subject|7|||
129735773|NCT00453973|466991991|FG001|Overall Study|Withdrawal by Subject|6|||
129735774|NCT00453973|466991990|FG000|Overall Study|PI Decision|0|||
129735775|NCT00453973|466991991|FG001|Overall Study|PI Decision|2|||
129735776|NCT00453973|466991990|FG000|Overall Study|Relocation|1|||
129735777|NCT00453973|466991991|FG001|Overall Study|Relocation|0|||
129735778|NCT00453973|466991990|FG000|Overall Study|Renal transplant|1|||
129735779|NCT00453973|466991991|FG001|Overall Study|Renal transplant|1|||
129735780|NCT00453973|466991990|FG000|Overall Study|Site closed by sponsor|3|||
129735781|NCT00453973|466991991|FG001|Overall Study|Site closed by sponsor|0|||
129735782|NCT00453973|466991990|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
129735783|NCT00453973|466991991|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
129735784|NCT00276094|466991992|FG000|Overall Study|Adverse Event|15|||
129735785|NCT00276094|466991993|FG001|Overall Study|Adverse Event|13|||
129735786|NCT00276094|466991994|FG002|Overall Study|Adverse Event|11|||
129804988|NCT02557295|467253128|FG005|Overall Study|Lack of Efficacy|0|||
129804989|NCT02557295|467253129|FG006|Overall Study|Lack of Efficacy|12|||
129804990|NCT02557295|467253130|FG007|Overall Study|Lack of Efficacy|1|||
129735787|NCT00276094|466991992|FG000|Overall Study|Withdrawal by Subject|14|||
129735788|NCT00276094|466991993|FG001|Overall Study|Withdrawal by Subject|14|||
129735789|NCT00276094|466991994|FG002|Overall Study|Withdrawal by Subject|12|||
129735790|NCT00276094|466991992|FG000|Overall Study|Protocol Violation|16|||
129735791|NCT00276094|466991993|FG001|Overall Study|Protocol Violation|7|||
129735792|NCT00276094|466991994|FG002|Overall Study|Protocol Violation|10|||
129735793|NCT00276094|466991992|FG000|Overall Study|Lost to Follow-up|8|||
129735794|NCT00276094|466991993|FG001|Overall Study|Lost to Follow-up|6|||
129735795|NCT00276094|466991994|FG002|Overall Study|Lost to Follow-up|4|||
129735796|NCT00276094|466991992|FG000|Overall Study|Other-Subject moved out of country|1|||
129735797|NCT00276094|466991993|FG001|Overall Study|Other-Subject moved out of country|0|||
129735798|NCT00276094|466991994|FG002|Overall Study|Other-Subject moved out of country|0|||
129804991|NCT02557295|467253131|FG008|Overall Study|Lack of Efficacy|0|||
129804992|NCT02557295|467253123|FG000|Overall Study|Adverse Event|16|||
129735799|NCT00276094|466991992|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
129735800|NCT00276094|466991993|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
129735801|NCT00276094|466991994|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
129735802|NCT00276094|466991992|FG000|Overall Study|Other-Lack of efficacy|1|||
129735803|NCT00276094|466991993|FG001|Overall Study|Other-Lack of efficacy|0|||
129735804|NCT00276094|466991994|FG002|Overall Study|Other-Lack of efficacy|0|||
129735805|NCT00276094|466991992|FG000|Overall Study|Other-Refused follow-up visit|1|||
129735806|NCT00276094|466991993|FG001|Overall Study|Other-Refused follow-up visit|0|||
129735807|NCT00276094|466991994|FG002|Overall Study|Other-Refused follow-up visit|0|||
129735808|NCT00276094|466991992|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
129735809|NCT00276094|466991993|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
129735810|NCT00276094|466991994|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
129735811|NCT00276094|466991992|FG000|Overall Study|Other-Relocation|0|||
129735812|NCT00276094|466991993|FG001|Overall Study|Other-Relocation|1|||
129735813|NCT00276094|466991994|FG002|Overall Study|Other-Relocation|0|||
129735814|NCT00276094|466991992|FG000|Overall Study|Other-Study medication lost|0|||
129735815|NCT00276094|466991993|FG001|Overall Study|Other-Study medication lost|0|||
129735816|NCT00276094|466991994|FG002|Overall Study|Other-Study medication lost|1|||
129735817|NCT02075632|466991999|FG000|Overall Study|Adverse Event|1|||
129735818|NCT02075632|466992000|FG001|Overall Study|Adverse Event|1|||
129735819|NCT02075632|466991999|FG000|Overall Study|Lost to Follow-up|0|||
129735820|NCT02075632|466992000|FG001|Overall Study|Lost to Follow-up|3|||
129735821|NCT02075632|466991999|FG000|Overall Study|Withdrawal by Subject|0|||
129735822|NCT02075632|466992000|FG001|Overall Study|Withdrawal by Subject|1|||
129735823|NCT01969500|466992010|FG000|Overall Study|Death|0|||
129735824|NCT01969500|466992011|FG001|Overall Study|Death|1|||
129735825|NCT01969500|466992010|FG000|Overall Study|extended hospitalization|1|||
129735826|NCT01969500|466992011|FG001|Overall Study|extended hospitalization|1|||
129735827|NCT01873729|466992012|FG000|Overall Study|Withdrawal by Subject|1|||
129735828|NCT02463032|466992013|FG000|Overall Study|Lack of Efficacy|61|||
129735829|NCT02463032|466992014|FG001|Overall Study|Lack of Efficacy|50|||
129735830|NCT02463032|466992013|FG000|Overall Study|Death|8|||
129735831|NCT02463032|466992014|FG001|Overall Study|Death|8|||
129735832|NCT02463032|466992013|FG000|Overall Study|Adverse Event|2|||
129735833|NCT02463032|466992014|FG001|Overall Study|Adverse Event|6|||
129735834|NCT01066780|466992015|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
129735835|NCT01066780|466992016|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
129735836|NCT00613080|466992017|FG000|Overall Study|Ineligible / no protocol treatment|11|||
129735837|NCT03757130|466992018|FG000|Overall Study|Lost to Follow-up|0|||
129735838|NCT03757130|466992019|FG001|Overall Study|Lost to Follow-up|0|||
129735839|NCT03757130|466992020|FG002|Overall Study|Lost to Follow-up|0|||
129735840|NCT03757130|466992021|FG003|Overall Study|Lost to Follow-up|1|||
129735841|NCT03757130|466992022|FG004|Overall Study|Lost to Follow-up|0|||
129735842|NCT03757130|466992023|FG005|Overall Study|Lost to Follow-up|0|||
129735843|NCT03757130|466992024|FG006|Overall Study|Lost to Follow-up|0|||
129735844|NCT03757130|466992025|FG007|Overall Study|Lost to Follow-up|1|||
129735845|NCT03757130|466992018|FG000|Overall Study|Withdrawal by Subject|0|||
129735846|NCT03757130|466992019|FG001|Overall Study|Withdrawal by Subject|0|||
129735847|NCT03757130|466992020|FG002|Overall Study|Withdrawal by Subject|0|||
129735848|NCT03757130|466992021|FG003|Overall Study|Withdrawal by Subject|0|||
129735849|NCT03757130|466992022|FG004|Overall Study|Withdrawal by Subject|0|||
129735850|NCT03757130|466992023|FG005|Overall Study|Withdrawal by Subject|0|||
129735851|NCT03757130|466992024|FG006|Overall Study|Withdrawal by Subject|1|||
129735852|NCT03757130|466992025|FG007|Overall Study|Withdrawal by Subject|0|||
129735853|NCT02226549|466992026|FG000|Overall Study|Randomized but Never Treated|1|||
129735854|NCT02226549|466992027|FG001|Overall Study|Randomized but Never Treated|0|||
129735855|NCT02226549|466992026|FG000|Overall Study|Lost to Follow-up|0|||
129735856|NCT02226549|466992027|FG001|Overall Study|Lost to Follow-up|1|||
129735857|NCT02726880|466992029|FG000|Overall Study|Withdrawal by Subject|2|||
129735858|NCT02726880|466992030|FG001|Overall Study|Withdrawal by Subject|0|||
129735859|NCT02726880|466992029|FG000|Overall Study|Lost to Follow-up|1|||
129735860|NCT02726880|466992030|FG001|Overall Study|Lost to Follow-up|3|||
129735861|NCT02312219|466992031|FG000|Overall Study|Withdrawal by Subject|1|||
129735862|NCT02312219|466992032|FG001|Overall Study|Withdrawal by Subject|2|||
129735863|NCT02312219|466992031|FG000|Overall Study|could not schedule imaging in time|0|||
129735864|NCT02312219|466992032|FG001|Overall Study|could not schedule imaging in time|2|||
129735865|NCT02312219|466992031|FG000|Overall Study|Other|0|||
129735866|NCT02312219|466992032|FG001|Overall Study|Other|1|||
129735867|NCT02312219|466992031|FG000|Overall Study|Not randomized. Ineligible|0|||
129735868|NCT02312219|466992032|FG001|Overall Study|Not randomized. Ineligible|1|||
129735869|NCT01269385|466992033|FG000|Overall Study|Adverse Event|1|||
129735870|NCT01269385|466992034|FG001|Overall Study|Adverse Event|1|||
129892979|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
129735871|NCT01269385|466992035|FG002|Overall Study|Adverse Event|0|||
129735872|NCT01269385|466992036|FG003|Overall Study|Adverse Event|0|||
129735873|NCT00546260|466992037|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
129735874|NCT00546260|466992038|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
129735875|NCT03759041|466992039|FG000|Overall Study|Withdrawal by Subject|4|||
129735876|NCT03759041|466992040|FG001|Overall Study|Withdrawal by Subject|10|||
129735877|NCT03759041|466992041|FG002|Overall Study|Withdrawal by Subject|10|||
129735878|NCT03759041|466992039|FG000|Overall Study|Adverse Event|1|||
129735879|NCT03759041|466992040|FG001|Overall Study|Adverse Event|3|||
129735880|NCT03759041|466992041|FG002|Overall Study|Adverse Event|4|||
129735881|NCT03759041|466992039|FG000|Overall Study|Lack of Efficacy|0|||
129735882|NCT03759041|466992040|FG001|Overall Study|Lack of Efficacy|0|||
129735883|NCT03759041|466992041|FG002|Overall Study|Lack of Efficacy|1|||
129735884|NCT03759041|466992039|FG000|Overall Study|Study Terminated by Sponsor|15|||
129735885|NCT03759041|466992040|FG001|Overall Study|Study Terminated by Sponsor|16|||
129735886|NCT03759041|466992041|FG002|Overall Study|Study Terminated by Sponsor|10|||
129735887|NCT03759041|466992039|FG000|Overall Study|Other reason for discontinuation|0|||
129735888|NCT03759041|466992040|FG001|Overall Study|Other reason for discontinuation|2|||
129735889|NCT03759041|466992041|FG002|Overall Study|Other reason for discontinuation|1|||
129735890|NCT03759041|466992039|FG000|Overall Study|Lost to Follow-up|7|||
129735891|NCT03759041|466992040|FG001|Overall Study|Lost to Follow-up|2|||
129735892|NCT03759041|466992041|FG002|Overall Study|Lost to Follow-up|2|||
129735893|NCT03759041|466992039|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
129735894|NCT03759041|466992040|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
129735895|NCT03759041|466992041|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
129735896|NCT04384107|466992042|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
129735897|NCT04384107|466992043|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129735898|NCT04384107|466992042|FG000|Overall Study|Lost to Follow-up|1|||
129735899|NCT04384107|466992043|FG001|Overall Study|Lost to Follow-up|0|||
129735900|NCT00276614|466992044|FG000|Overall Study|Progression of disease under study|3|||
129735901|NCT01522404|466992047|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
129735902|NCT01522404|466992048|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
129735903|NCT01522404|466992047|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
129735904|NCT01522404|466992048|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
129735905|NCT01522404|466992047|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
129735906|NCT01522404|466992048|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
129735907|NCT01591863|466992053|FG000|Overall Study|Adverse Event|3|||
129735908|NCT01591863|466992053|FG000|Overall Study|Withdrawal by Subject|1|||
129735909|NCT01591863|466992053|FG000|Overall Study|recurrence|9|||
129735910|NCT01591863|466992053|FG000|Overall Study|Lack of Efficacy|1|||
129735911|NCT00664326|466993411|FG000|Overall Study|Adverse Event|14|||
129735912|NCT00664326|466993411|FG000|Overall Study|Noncompliance with study medication|3|||
129735913|NCT00664326|466993411|FG000|Overall Study|Withdrawal by Subject|1|||
129804993|NCT02557295|467253124|FG001|Overall Study|Adverse Event|2|||
129804994|NCT02557295|467253125|FG002|Overall Study|Adverse Event|3|||
129804995|NCT02557295|467253126|FG003|Overall Study|Adverse Event|0|||
129735914|NCT00664326|466993411|FG000|Overall Study|Physician Decision|1|||
129735915|NCT00664326|466993411|FG000|Overall Study|Other Reasons|3|||
129735916|NCT00664326|466993411|FG000|Overall Study|Death|2|||
129735917|NCT00664326|466993411|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
129735918|NCT01266317|466993412|FG000|Overall Study|Withdrawal by Subject|2|||
129735919|NCT00490776|466993413|FG000|Overall Study|Withdrawal by Subject|1|||
129735920|NCT00490776|466993413|FG000|Overall Study|Administrative Problems|1|||
129735921|NCT00490776|466993413|FG000|Overall Study|Death|1|||
129735922|NCT00490776|466993413|FG000|Overall Study|New Cancer Therapy|1|||
129735923|NCT00490776|466993413|FG000|Overall Study|Disease Progression|5|||
129735924|NCT00046930|466993421|FG000|Overall Study|Ineligible|12|||
129735925|NCT00046930|466993422|FG001|Overall Study|Ineligible|4|||
129735926|NCT04912895|466993423|FG000|Overall Study|Unable to provide specimen|2|||
129735927|NCT04912895|466993424|FG001|Overall Study|Unable to provide specimen|0|||
129735928|NCT04912895|466993425|FG002|Overall Study|Unable to provide specimen|0|||
129735929|NCT00520013|466993426|FG000|Overall Study|Withdrawal by Subject|0|||
129735930|NCT00520013|466993427|FG001|Overall Study|Withdrawal by Subject|0|||
129735931|NCT00520013|466993428|FG002|Overall Study|Withdrawal by Subject|1|||
129735932|NCT00520013|466993426|FG000|Overall Study|Adverse Event|2|||
129735933|NCT00520013|466993427|FG001|Overall Study|Adverse Event|10|||
129735934|NCT00520013|466993428|FG002|Overall Study|Adverse Event|7|||
129735935|NCT00520013|466993426|FG000|Overall Study|Progressive Disease|7|||
129735936|NCT00520013|466993427|FG001|Overall Study|Progressive Disease|3|||
129804996|NCT02557295|467253127|FG004|Overall Study|Adverse Event|0|||
129735937|NCT00520013|466993428|FG002|Overall Study|Progressive Disease|0|||
129735938|NCT00520013|466993426|FG000|Overall Study|Clinical Progression|3|||
129735939|NCT00520013|466993427|FG001|Overall Study|Clinical Progression|1|||
129804997|NCT02557295|467253128|FG005|Overall Study|Adverse Event|0|||
129804998|NCT02557295|467253129|FG006|Overall Study|Adverse Event|2|||
129804999|NCT02557295|467253130|FG007|Overall Study|Adverse Event|1|||
129735940|NCT00520013|466993428|FG002|Overall Study|Clinical Progression|0|||
129735941|NCT00520013|466993426|FG000|Overall Study|Death|0|||
129735942|NCT00520013|466993427|FG001|Overall Study|Death|1|||
129735943|NCT00520013|466993428|FG002|Overall Study|Death|0|||
129735944|NCT00520013|466993426|FG000|Overall Study|Physician Decision|0|||
129735945|NCT00520013|466993427|FG001|Overall Study|Physician Decision|0|||
129735946|NCT00520013|466993428|FG002|Overall Study|Physician Decision|3|||
129735947|NCT02677844|466993429|FG000|Period 3|Withdrawal by Subject|0|||
129735948|NCT02677844|466993430|FG001|Period 3|Withdrawal by Subject|0|||
129735949|NCT02677844|466993431|FG002|Period 3|Withdrawal by Subject|0|||
129735950|NCT02677844|466993432|FG003|Period 3|Withdrawal by Subject|1|||
129735951|NCT02677844|466993433|FG004|Period 3|Withdrawal by Subject|0|||
129735952|NCT02677844|466993434|FG005|Period 3|Withdrawal by Subject|0|||
129735953|NCT02677844|466993435|FG006|Period 3|Withdrawal by Subject|0|||
129735954|NCT01149486|466993436|FG000|First Intervention|Adverse Event|0|||
129735955|NCT01149486|466993437|FG001|First Intervention|Adverse Event|1|||
129735956|NCT01135914|466993440|FG000|Overall Study|Withdrawal by Subject|1|||
129735957|NCT01135914|466993441|FG001|Overall Study|Withdrawal by Subject|3|||
129735958|NCT01135914|466993442|FG002|Overall Study|Withdrawal by Subject|6|||
129735959|NCT01135914|466993440|FG000|Overall Study|Lost to Follow-up|1|||
129735960|NCT01135914|466993441|FG001|Overall Study|Lost to Follow-up|0|||
129735961|NCT01135914|466993442|FG002|Overall Study|Lost to Follow-up|1|||
129735962|NCT01135914|466993440|FG000|Overall Study|Protocol Violation|0|||
129735963|NCT01135914|466993441|FG001|Overall Study|Protocol Violation|0|||
129735964|NCT01135914|466993442|FG002|Overall Study|Protocol Violation|3|||
129735965|NCT01135914|466993440|FG000|Overall Study|Lack of Efficacy|2|||
129735966|NCT01135914|466993441|FG001|Overall Study|Lack of Efficacy|1|||
129735967|NCT01135914|466993442|FG002|Overall Study|Lack of Efficacy|10|||
129735968|NCT01135914|466993440|FG000|Overall Study|Adverse Event|0|||
129735969|NCT01135914|466993441|FG001|Overall Study|Adverse Event|1|||
129735970|NCT01135914|466993442|FG002|Overall Study|Adverse Event|2|||
129735971|NCT03532932|466993444|FG000|Overall Study|Protocol Deviation|33|||
129735972|NCT03532932|466993445|FG001|Overall Study|Protocol Deviation|31|||
129735973|NCT03532932|466993444|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
129735974|NCT03532932|466993445|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
129735975|NCT03532932|466993444|FG000|Overall Study|Withdrawal by Subject|2|||
129735976|NCT03532932|466993445|FG001|Overall Study|Withdrawal by Subject|0|||
129735977|NCT03532932|466993444|FG000|Overall Study|Lost to Follow-up|15|||
129735978|NCT03532932|466993445|FG001|Overall Study|Lost to Follow-up|9|||
129735979|NCT03532932|466993444|FG000|Overall Study|Adverse Event|4|||
129735980|NCT03532932|466993445|FG001|Overall Study|Adverse Event|3|||
129735981|NCT03532932|466993444|FG000|Overall Study|Death|0|||
129735982|NCT03532932|466993445|FG001|Overall Study|Death|2|||
129735983|NCT03532932|466993444|FG000|Overall Study|Other|11|||
129735984|NCT03532932|466993445|FG001|Overall Study|Other|16|||
129735985|NCT01344629|466993450|FG000|Crossover Period 2|Withdrawal by Subject|0|||
129735986|NCT01344629|466993451|FG001|Crossover Period 2|Withdrawal by Subject|1|||
129735987|NCT00693472|466993453|FG000|Part 1|Adverse Event|1|||
129735988|NCT00693472|466993454|FG001|Part 1|Adverse Event|1|||
129735989|NCT00693472|466993455|FG002|Part 1|Adverse Event|0|||
129735990|NCT00693472|466993456|FG003|Part 1|Adverse Event|0|||
129735991|NCT00693472|466993453|FG000|Part 1|Lost to Follow-up|0|||
129735992|NCT00693472|466993454|FG001|Part 1|Lost to Follow-up|1|||
129735993|NCT00693472|466993455|FG002|Part 1|Lost to Follow-up|0|||
129735994|NCT00693472|466993456|FG003|Part 1|Lost to Follow-up|0|||
129735995|NCT00693472|466993453|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
129735996|NCT00693472|466993454|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
129735997|NCT00693472|466993455|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
129735998|NCT00693472|466993456|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
129735999|NCT00693472|466993453|FG000|Part 2|Adverse Event|0|||
129736000|NCT00693472|466993454|FG001|Part 2|Adverse Event|0|||
129736001|NCT00693472|466993455|FG002|Part 2|Adverse Event|1|||
129736002|NCT00693472|466993456|FG003|Part 2|Adverse Event|0|||
129736003|NCT00693472|466993453|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
129736004|NCT00693472|466993454|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
129736005|NCT00693472|466993455|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
129736006|NCT00693472|466993456|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
129736007|NCT04063787|466993457|FG000|Overall Study|Inadequate Doppler data|4|||
129736008|NCT04063787|466993457|FG000|Overall Study|Lost to Follow-up|2|||
129736009|NCT04063787|466993457|FG000|Overall Study|Death|3|||
129736010|NCT05545644|466993458|FG000|Overall Study|Lost to Follow-up|4|||
129736011|NCT05545644|466993459|FG001|Overall Study|Lost to Follow-up|3|||
129736012|NCT00554099|466993462|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
129736013|NCT00554099|466993463|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
129736014|NCT00554099|466993464|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
129805000|NCT02557295|467253131|FG008|Overall Study|Adverse Event|1|||
129736015|NCT00554099|466993462|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
129736016|NCT00554099|466993463|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
129736017|NCT00554099|466993464|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
129736018|NCT00554099|466993462|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129736019|NCT00554099|466993463|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129736020|NCT00554099|466993464|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
129736021|NCT00554099|466993462|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
129736022|NCT00554099|466993463|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
129736023|NCT00554099|466993464|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
129736024|NCT00554099|466993462|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
129736025|NCT00554099|466993463|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
129736026|NCT00554099|466993464|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
129736027|NCT00554099|466993462|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129736028|NCT00554099|466993463|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
129736029|NCT00554099|466993464|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129736030|NCT00554099|466993462|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
129736031|NCT00554099|466993463|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
129736032|NCT00554099|466993464|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
129736033|NCT00554099|466993462|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
129736034|NCT00554099|466993463|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
129736035|NCT00554099|466993464|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
129736036|NCT00554099|466993462|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
129736037|NCT00554099|466993463|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
129736038|NCT00554099|466993464|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
129736039|NCT03002623|466993465|FG000|Overall Study|Lost to Follow-up|1|||
129736040|NCT03002623|466993466|FG001|Overall Study|Lost to Follow-up|0|||
129736041|NCT03002623|466993465|FG000|Overall Study|Physician Decision|1|||
129736042|NCT03002623|466993466|FG001|Overall Study|Physician Decision|1|||
129736043|NCT00493636|466993468|FG000|Overall Study|Withdrawal by Subject|1|||
129736044|NCT00493636|466993469|FG001|Overall Study|Withdrawal by Subject|0|||
129736045|NCT00493636|466993468|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
129736046|NCT00493636|466993469|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
129736047|NCT00493636|466993468|FG000|Overall Study|Mis-randomization|1|||
129736048|NCT00493636|466993469|FG001|Overall Study|Mis-randomization|1|||
129736049|NCT00612508|466993476|FG000|Overall Study|Withdrawal by Subject|3|||
129736050|NCT00612508|466993477|FG001|Overall Study|Withdrawal by Subject|4|||
129736051|NCT02012686|466993478|FG000|Overall Study|muscle contraction|0|||
129736052|NCT02012686|466993479|FG001|Overall Study|muscle contraction|1|||
129736053|NCT02012686|466993478|FG000|Overall Study|electrocardiography monitoring noise|0|||
129736054|NCT02012686|466993479|FG001|Overall Study|electrocardiography monitoring noise|1|||
129736055|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
129736056|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
129736057|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
129736058|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
129736059|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
129736060|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
129736061|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
129736062|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
129736063|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
129736064|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
129736065|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
129736066|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
129805001|NCT02557295|467253123|FG000|Overall Study|Lost to Follow-up|4|||
129805002|NCT02557295|467253124|FG001|Overall Study|Lost to Follow-up|0|||
129805003|NCT02557295|467253125|FG002|Overall Study|Lost to Follow-up|0|||
129805004|NCT02557295|467253126|FG003|Overall Study|Lost to Follow-up|0|||
129444737|NCT01641809|465929435|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
129892980|NCT02403674|467567716|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
129892981|NCT02403674|467567717|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
129892982|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
129892983|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
129892984|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
129892985|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
129892986|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
129892987|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
129892988|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
129892989|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
129892990|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
129892991|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
129892992|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Death|2|||
129892993|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Death|2|||
129892994|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
129892995|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
129892996|NCT02403674|467567716|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
129892997|NCT02403674|467567717|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
129892998|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
129892999|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
129893000|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
129893001|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
129893002|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
129893003|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
129736067|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
129736068|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
129736069|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
129736070|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
129736071|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
129736072|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
129736073|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
129736074|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
129736075|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
129736076|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
129736077|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
129736078|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
129736079|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
129736080|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
129736081|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
129893004|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
129893005|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
129736082|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
129736083|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
129736084|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
129736085|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
129736086|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
129736087|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
129736088|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
129736089|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
129736090|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
129736091|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
129736092|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
129736093|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
129736094|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
129805005|NCT02557295|467253127|FG004|Overall Study|Lost to Follow-up|0|||
129805006|NCT02557295|467253128|FG005|Overall Study|Lost to Follow-up|0|||
129805007|NCT02557295|467253129|FG006|Overall Study|Lost to Follow-up|9|||
129805008|NCT02557295|467253130|FG007|Overall Study|Lost to Follow-up|0|||
129805009|NCT02557295|467253131|FG008|Overall Study|Lost to Follow-up|0|||
129805010|NCT02557295|467253123|FG000|Overall Study|Study Close|54|||
129805011|NCT02557295|467253124|FG001|Overall Study|Study Close|3|||
129805012|NCT02557295|467253125|FG002|Overall Study|Study Close|5|||
129805013|NCT02557295|467253126|FG003|Overall Study|Study Close|3|||
129805014|NCT02557295|467253127|FG004|Overall Study|Study Close|0|||
129805015|NCT02557295|467253128|FG005|Overall Study|Study Close|0|||
129736095|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
129736096|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
129736097|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
129736098|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
129736099|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
129736100|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
129736101|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
129805016|NCT02557295|467253129|FG006|Overall Study|Study Close|37|||
129805017|NCT02557295|467253130|FG007|Overall Study|Study Close|3|||
129805018|NCT02557295|467253131|FG008|Overall Study|Study Close|19|||
129805019|NCT02557295|467253123|FG000|Overall Study|except for study close|4|||
129805020|NCT02557295|467253124|FG001|Overall Study|except for study close|0|||
129805021|NCT02557295|467253125|FG002|Overall Study|except for study close|0|||
129805022|NCT02557295|467253126|FG003|Overall Study|except for study close|0|||
129805023|NCT02557295|467253127|FG004|Overall Study|except for study close|0|||
129805024|NCT02557295|467253128|FG005|Overall Study|except for study close|0|||
129805025|NCT02557295|467253129|FG006|Overall Study|except for study close|5|||
129805026|NCT02557295|467253130|FG007|Overall Study|except for study close|1|||
129805027|NCT02557295|467253131|FG008|Overall Study|except for study close|0|||
129805028|NCT03673046|467254919|FG000|Overall Study|Adverse Event|1|||
129805029|NCT03673046|467254920|FG001|Overall Study|Adverse Event|1|||
129805030|NCT03673046|467254919|FG000|Overall Study|Withdrawal by Subject|8|||
129805031|NCT03673046|467254920|FG001|Overall Study|Withdrawal by Subject|2|||
129805032|NCT03817879|467254921|FG000|Overall Study|Drop out|5|||
129805033|NCT03817879|467254922|FG001|Overall Study|Drop out|12|||
129805034|NCT03817879|467254921|FG000|Overall Study|Withdrawal by Subject|0|||
129805035|NCT03817879|467254922|FG001|Overall Study|Withdrawal by Subject|1|||
129805036|NCT01896050|467254923|FG000|Overall Study|Adverse Event|37|||
129805037|NCT01896050|467254924|FG001|Overall Study|Adverse Event|2|||
129805038|NCT01896050|467254923|FG000|Overall Study|Death|1|||
129805039|NCT01896050|467254924|FG001|Overall Study|Death|0|||
129805040|NCT00392015|467254925|FG000|Overall Study|Lost to Follow-up|2|||
129805041|NCT00392015|467254926|FG001|Overall Study|Lost to Follow-up|0|||
129805042|NCT00392015|467254927|FG002|Overall Study|Lost to Follow-up|2|||
129805043|NCT00392015|467254928|FG003|Overall Study|Lost to Follow-up|1|||
129805044|NCT00392015|467254929|FG004|Overall Study|Lost to Follow-up|1|||
129893006|NCT02403674|467567716|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
129893007|NCT02403674|467567717|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
129893008|NCT01254305|467567719|FG000|Overall Study|Adverse Event|6|||
129893009|NCT01254305|467567720|FG001|Overall Study|Adverse Event|3|||
129736102|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
129736103|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
129736104|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
129736105|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
129805045|NCT00392015|467254930|FG005|Overall Study|Lost to Follow-up|0|||
129805046|NCT00392015|467254925|FG000|Overall Study|Withdrawal by Subject|0|||
129893010|NCT01254305|467567721|FG002|Overall Study|Adverse Event|2|||
129893011|NCT01254305|467567719|FG000|Overall Study|Lack of Efficacy|1|||
129893012|NCT01254305|467567720|FG001|Overall Study|Lack of Efficacy|0|||
129893013|NCT01254305|467567721|FG002|Overall Study|Lack of Efficacy|1|||
129893014|NCT01254305|467567719|FG000|Overall Study|Protocol Violation|1|||
129893015|NCT01254305|467567720|FG001|Overall Study|Protocol Violation|7|||
129893016|NCT01254305|467567721|FG002|Overall Study|Protocol Violation|3|||
129893017|NCT01254305|467567719|FG000|Overall Study|Withdrawal by Subject|4|||
129893018|NCT01254305|467567720|FG001|Overall Study|Withdrawal by Subject|2|||
129893019|NCT01254305|467567721|FG002|Overall Study|Withdrawal by Subject|4|||
129893020|NCT01254305|467567719|FG000|Overall Study|Lost to Follow-up|10|||
129893021|NCT01254305|467567720|FG001|Overall Study|Lost to Follow-up|6|||
129893022|NCT01254305|467567721|FG002|Overall Study|Lost to Follow-up|5|||
129893023|NCT01254305|467567719|FG000|Overall Study|Other Reasons|0|||
129893024|NCT01254305|467567720|FG001|Overall Study|Other Reasons|0|||
129893025|NCT01254305|467567721|FG002|Overall Study|Other Reasons|2|||
129805047|NCT00392015|467254926|FG001|Overall Study|Withdrawal by Subject|0|||
129805048|NCT00392015|467254927|FG002|Overall Study|Withdrawal by Subject|2|||
129893026|NCT03738241|467567725|FG000|Overall Study|Withdrawal by Subject|0|||
129893027|NCT03738241|467567726|FG001|Overall Study|Withdrawal by Subject|0|||
129805049|NCT00392015|467254928|FG003|Overall Study|Withdrawal by Subject|0|||
129805050|NCT00392015|467254929|FG004|Overall Study|Withdrawal by Subject|0|||
129805051|NCT00392015|467254930|FG005|Overall Study|Withdrawal by Subject|0|||
129805052|NCT00392015|467254925|FG000|Overall Study|Adverse Event|0|||
129805053|NCT00392015|467254926|FG001|Overall Study|Adverse Event|0|||
129805054|NCT00392015|467254927|FG002|Overall Study|Adverse Event|0|||
129805055|NCT00392015|467254928|FG003|Overall Study|Adverse Event|0|||
129805056|NCT00392015|467254929|FG004|Overall Study|Adverse Event|1|||
129736106|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
129736107|NCT02008357|466993480|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
129736108|NCT02008357|466993481|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
129736109|NCT02008357|466993480|FG000|Open-label Extension Period|Adverse Event|8|||
129736110|NCT02008357|466993481|FG001|Open-label Extension Period|Adverse Event|7|||
129736111|NCT02008357|466993480|FG000|Open-label Extension Period|Death|7|||
129736112|NCT02008357|466993481|FG001|Open-label Extension Period|Death|4|||
129736113|NCT02008357|466993480|FG000|Open-label Extension Period|Lack of Efficacy|9|||
129736114|NCT02008357|466993481|FG001|Open-label Extension Period|Lack of Efficacy|5|||
129736115|NCT02008357|466993480|FG000|Open-label Extension Period|Lost to Follow-up|2|||
129736116|NCT02008357|466993481|FG001|Open-label Extension Period|Lost to Follow-up|2|||
129736117|NCT02008357|466993480|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
129736118|NCT02008357|466993481|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
129736119|NCT02008357|466993480|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
129736120|NCT02008357|466993481|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
129736121|NCT02008357|466993480|FG000|Open-label Extension Period|Safety Risk|2|||
129736122|NCT02008357|466993481|FG001|Open-label Extension Period|Safety Risk|1|||
129736123|NCT02008357|466993480|FG000|Open-label Extension Period|Non-Compliance|0|||
129736124|NCT02008357|466993481|FG001|Open-label Extension Period|Non-Compliance|1|||
129736125|NCT02008357|466993480|FG000|Open-label Extension Period|Investigator Recommendation|0|||
129736126|NCT02008357|466993481|FG001|Open-label Extension Period|Investigator Recommendation|1|||
129736127|NCT02008357|466993480|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
129736128|NCT02008357|466993481|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
129736129|NCT02008357|466993480|FG000|Open-label Extension Period|Coordinating Center Request|2|||
129736130|NCT02008357|466993481|FG001|Open-label Extension Period|Coordinating Center Request|4|||
129736131|NCT02008357|466993480|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
129736132|NCT02008357|466993481|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
129736133|NCT02008357|466993480|FG000|Open-label Extension Period|Study Ended|20|||
129736134|NCT02008357|466993481|FG001|Open-label Extension Period|Study Ended|25|||
129736135|NCT02008357|466993480|FG000|Open-label Extension Period|Personal Reasons|0|||
129736136|NCT02008357|466993481|FG001|Open-label Extension Period|Personal Reasons|1|||
129736137|NCT02008357|466993480|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
129736138|NCT02008357|466993481|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
129736139|NCT02008357|466993480|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
129736140|NCT02008357|466993481|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
129736141|NCT02008357|466993480|FG000|Open-label Extension Period|Other|2|||
129736142|NCT02008357|466993481|FG001|Open-label Extension Period|Other|0|||
129736143|NCT01442064|466993482|FG000|Overall Study|Adverse Event|2|||
129736144|NCT01442064|466993483|FG001|Overall Study|Adverse Event|2|||
129736145|NCT01442064|466993484|FG002|Overall Study|Adverse Event|2|||
129736146|NCT01442064|466993485|FG003|Overall Study|Adverse Event|1|||
129736147|NCT01442064|466993486|FG004|Overall Study|Adverse Event|2|||
129736148|NCT01442064|466993487|FG005|Overall Study|Adverse Event|0|||
129736149|NCT01442064|466993482|FG000|Overall Study|Death|0|||
129736150|NCT01442064|466993483|FG001|Overall Study|Death|1|||
129736151|NCT01442064|466993484|FG002|Overall Study|Death|3|||
129736152|NCT01442064|466993485|FG003|Overall Study|Death|3|||
129736153|NCT01442064|466993486|FG004|Overall Study|Death|1|||
129736154|NCT01442064|466993487|FG005|Overall Study|Death|3|||
129736155|NCT01442064|466993482|FG000|Overall Study|Lost to Follow-up|5|||
129736156|NCT01442064|466993483|FG001|Overall Study|Lost to Follow-up|5|||
129736157|NCT01442064|466993484|FG002|Overall Study|Lost to Follow-up|1|||
129736158|NCT01442064|466993485|FG003|Overall Study|Lost to Follow-up|1|||
129736159|NCT01442064|466993486|FG004|Overall Study|Lost to Follow-up|3|||
129736160|NCT01442064|466993487|FG005|Overall Study|Lost to Follow-up|3|||
129736161|NCT01442064|466993482|FG000|Overall Study|Physician Decision|1|||
129736162|NCT01442064|466993483|FG001|Overall Study|Physician Decision|1|||
129736163|NCT01442064|466993484|FG002|Overall Study|Physician Decision|2|||
129736164|NCT01442064|466993485|FG003|Overall Study|Physician Decision|3|||
129736165|NCT01442064|466993486|FG004|Overall Study|Physician Decision|3|||
129736166|NCT01442064|466993487|FG005|Overall Study|Physician Decision|1|||
129736167|NCT01442064|466993482|FG000|Overall Study|Withdrawal by Subject|6|||
129736168|NCT01442064|466993483|FG001|Overall Study|Withdrawal by Subject|3|||
129736169|NCT01442064|466993484|FG002|Overall Study|Withdrawal by Subject|2|||
129736170|NCT01442064|466993485|FG003|Overall Study|Withdrawal by Subject|2|||
129736171|NCT01442064|466993486|FG004|Overall Study|Withdrawal by Subject|2|||
129736172|NCT01442064|466993487|FG005|Overall Study|Withdrawal by Subject|1|||
129736173|NCT01442064|466993482|FG000|Overall Study|Sponsor decision|82|||
129736174|NCT01442064|466993483|FG001|Overall Study|Sponsor decision|88|||
129736175|NCT01442064|466993484|FG002|Overall Study|Sponsor decision|92|||
129736176|NCT01442064|466993485|FG003|Overall Study|Sponsor decision|88|||
129736177|NCT01442064|466993486|FG004|Overall Study|Sponsor decision|95|||
129736178|NCT01442064|466993487|FG005|Overall Study|Sponsor decision|87|||
129736179|NCT01442064|466993482|FG000|Overall Study|Subject non-compliance|0|||
129736180|NCT01442064|466993483|FG001|Overall Study|Subject non-compliance|0|||
129736181|NCT01442064|466993484|FG002|Overall Study|Subject non-compliance|0|||
129736182|NCT01442064|466993485|FG003|Overall Study|Subject non-compliance|0|||
129736183|NCT01442064|466993486|FG004|Overall Study|Subject non-compliance|0|||
129736184|NCT01442064|466993487|FG005|Overall Study|Subject non-compliance|2|||
129736185|NCT01442064|466993482|FG000|Overall Study|Condition mandated other intervention|1|||
129736186|NCT01442064|466993483|FG001|Overall Study|Condition mandated other intervention|1|||
129736187|NCT01442064|466993484|FG002|Overall Study|Condition mandated other intervention|2|||
129736188|NCT01442064|466993485|FG003|Overall Study|Condition mandated other intervention|0|||
129736189|NCT01442064|466993486|FG004|Overall Study|Condition mandated other intervention|0|||
129736190|NCT01442064|466993487|FG005|Overall Study|Condition mandated other intervention|2|||
129736191|NCT03553498|466993490|FG000|Overall Study|Missing primary outcome|1|||
129736192|NCT03553498|466993491|FG001|Overall Study|Missing primary outcome|2|||
129736193|NCT04941807|466993492|FG000|Overall Study|Lost to Follow-up|1|||
129736194|NCT04941807|466993493|FG001|Overall Study|Lost to Follow-up|1|||
129736195|NCT01100567|466993494|FG000|Overall Study|Withdrawal by Subject|5|||
129736196|NCT01100567|466993495|FG001|Overall Study|Withdrawal by Subject|8|||
129736197|NCT01100567|466993494|FG000|Overall Study|Early Hospital Discharge|6|||
129736198|NCT01100567|466993495|FG001|Overall Study|Early Hospital Discharge|4|||
129805057|NCT00392015|467254930|FG005|Overall Study|Adverse Event|0|||
129805058|NCT00392015|467254925|FG000|Overall Study|Previous trial recipient|0|||
129805059|NCT00392015|467254926|FG001|Overall Study|Previous trial recipient|0|||
129805060|NCT00392015|467254927|FG002|Overall Study|Previous trial recipient|0|||
129805061|NCT00392015|467254928|FG003|Overall Study|Previous trial recipient|0|||
129805062|NCT00392015|467254929|FG004|Overall Study|Previous trial recipient|1|||
129805063|NCT00392015|467254930|FG005|Overall Study|Previous trial recipient|0|||
129736199|NCT01100567|466993494|FG000|Overall Study|Lost to Follow-up|1|||
129736200|NCT01100567|466993495|FG001|Overall Study|Lost to Follow-up|2|||
129736201|NCT01100567|466993494|FG000|Overall Study|Physician Decision|0|||
129736202|NCT01100567|466993495|FG001|Overall Study|Physician Decision|1|||
129736203|NCT01100567|466993494|FG000|Overall Study|Deemed ineligible after consent|0|||
129736204|NCT01100567|466993495|FG001|Overall Study|Deemed ineligible after consent|1|||
129736205|NCT02741570|466993496|FG000|Pre-Treatment Period|Other reasons|0|||
129736206|NCT02741570|466993497|FG001|Pre-Treatment Period|Other reasons|3|||
129805064|NCT02925923|467254934|FG000|Overall Study|blood samples hemolyzed|0|||
129893028|NCT03738241|467567727|FG002|Overall Study|Withdrawal by Subject|0|||
129893029|NCT03738241|467567728|FG003|Overall Study|Withdrawal by Subject|0|||
129893030|NCT03738241|467567729|FG004|Overall Study|Withdrawal by Subject|0|||
129893031|NCT03738241|467567730|FG005|Overall Study|Withdrawal by Subject|0|||
129893032|NCT03738241|467567731|FG006|Overall Study|Withdrawal by Subject|0|||
129893033|NCT03738241|467567732|FG007|Overall Study|Withdrawal by Subject|0|||
129893034|NCT03738241|467567733|FG008|Overall Study|Withdrawal by Subject|0|||
129736207|NCT02741570|466993496|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
129893035|NCT03738241|467567734|FG009|Overall Study|Withdrawal by Subject|1|||
129893036|NCT03738241|467567725|FG000|Overall Study|Physician Decision|0|||
129893037|NCT03738241|467567726|FG001|Overall Study|Physician Decision|0|||
129893038|NCT03738241|467567727|FG002|Overall Study|Physician Decision|0|||
129893039|NCT03738241|467567728|FG003|Overall Study|Physician Decision|0|||
129736208|NCT02741570|466993497|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
129736209|NCT02741570|466993496|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
129736210|NCT02741570|466993497|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
129736211|NCT02741570|466993496|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
129736212|NCT02741570|466993497|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
129736213|NCT02741570|466993496|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
129736214|NCT02741570|466993497|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
129736215|NCT02741570|466993496|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
129736216|NCT02741570|466993497|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
129736217|NCT02741570|466993496|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
129736218|NCT02741570|466993497|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129736219|NCT02741570|466993496|FG000|Pre-Treatment Period|Death|0|||
129736220|NCT02741570|466993497|FG001|Pre-Treatment Period|Death|1|||
129736221|NCT02741570|466993496|FG000|Pre-Treatment Period|Disease progression|0|||
129736222|NCT02741570|466993497|FG001|Pre-Treatment Period|Disease progression|1|||
129893040|NCT03738241|467567729|FG004|Overall Study|Physician Decision|0|||
129893041|NCT03738241|467567730|FG005|Overall Study|Physician Decision|0|||
129893042|NCT03738241|467567731|FG006|Overall Study|Physician Decision|0|||
129893043|NCT03738241|467567732|FG007|Overall Study|Physician Decision|0|||
129893044|NCT03738241|467567733|FG008|Overall Study|Physician Decision|1|||
129893045|NCT03738241|467567734|FG009|Overall Study|Physician Decision|0|||
129893046|NCT03738241|467567725|FG000|Overall Study|Adverse Event|1|||
129893047|NCT03738241|467567726|FG001|Overall Study|Adverse Event|0|||
129893048|NCT03738241|467567727|FG002|Overall Study|Adverse Event|0|||
129893049|NCT03738241|467567728|FG003|Overall Study|Adverse Event|0|||
129893050|NCT03738241|467567729|FG004|Overall Study|Adverse Event|0|||
129893051|NCT03738241|467567730|FG005|Overall Study|Adverse Event|0|||
129893052|NCT03738241|467567731|FG006|Overall Study|Adverse Event|0|||
129893053|NCT03738241|467567732|FG007|Overall Study|Adverse Event|0|||
129893054|NCT03738241|467567733|FG008|Overall Study|Adverse Event|0|||
129893055|NCT03738241|467567734|FG009|Overall Study|Adverse Event|0|||
129893056|NCT03169361|467567735|FG000|Overall Study|Protocol Violation|32|||
129893057|NCT00088465|467567736|FG000|Overall Study|Withdrawal by Subject|290|||
129893058|NCT00088465|467567736|FG000|Overall Study|Adverse Event|77|||
129893059|NCT00088465|467567736|FG000|Overall Study|Lost to Follow-up|57|||
129893060|NCT00088465|467567736|FG000|Overall Study|Physician Decision|45|||
129736223|NCT02741570|466993496|FG000|Treatment Period|Other reasons|47|||
129736224|NCT02741570|466993497|FG001|Treatment Period|Other reasons|12|||
129736225|NCT02741570|466993496|FG000|Treatment Period|Poor/non-compliance|0|||
129736226|NCT02741570|466993497|FG001|Treatment Period|Poor/non-compliance|2|||
129736227|NCT02741570|466993496|FG000|Treatment Period|Maximum clinical benefit|4|||
129736228|NCT02741570|466993497|FG001|Treatment Period|Maximum clinical benefit|6|||
129736229|NCT02741570|466993496|FG000|Treatment Period|Lost to Follow-up|1|||
129736230|NCT02741570|466993497|FG001|Treatment Period|Lost to Follow-up|3|||
129736231|NCT02741570|466993496|FG000|Treatment Period|Participant withdrew consent|9|||
129736232|NCT02741570|466993497|FG001|Treatment Period|Participant withdrew consent|13|||
129736233|NCT02741570|466993496|FG000|Treatment Period|Participant request to discontinue treatment|8|||
129736234|NCT02741570|466993497|FG001|Treatment Period|Participant request to discontinue treatment|23|||
129736235|NCT02741570|466993496|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
129736236|NCT02741570|466993497|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
129736237|NCT02741570|466993496|FG000|Treatment Period|Death|9|||
129893061|NCT00088465|467567736|FG000|Overall Study|Sponsor Decision|37|||
129893062|NCT00088465|467567736|FG000|Overall Study|Lack of Efficacy|27|||
129893063|NCT00088465|467567736|FG000|Overall Study|Protocol Violation|17|||
129893064|NCT00088465|467567736|FG000|Overall Study|Death|11|||
129736238|NCT02741570|466993497|FG001|Treatment Period|Death|7|||
129893065|NCT00495469|467567737|FG000|Overall Study|Adverse Event|0|||
129893066|NCT00495469|467567738|FG001|Overall Study|Adverse Event|1|||
129893067|NCT00495469|467567739|FG002|Overall Study|Adverse Event|3|||
129893068|NCT00495469|467567740|FG003|Overall Study|Adverse Event|0|||
129736239|NCT02741570|466993496|FG000|Treatment Period|Study drug toxicity|55|||
129736240|NCT02741570|466993497|FG001|Treatment Period|Study drug toxicity|47|||
129736241|NCT02741570|466993496|FG000|Treatment Period|Disease progression|294|||
129736242|NCT02741570|466993497|FG001|Treatment Period|Disease progression|301|||
129736243|NCT02741570|466993496|FG000|Treatment Period|Administrative reason by sponsor|0|||
129736244|NCT02741570|466993497|FG001|Treatment Period|Administrative reason by sponsor|1|||
129736245|NCT00160199|466993500|FG000|Overall Study|Adverse Event|5|||
129736246|NCT00160199|466993501|FG001|Overall Study|Adverse Event|14|||
129736247|NCT00160199|466993500|FG000|Overall Study|Lack of Efficacy|0|||
129736248|NCT00160199|466993501|FG001|Overall Study|Lack of Efficacy|1|||
129736249|NCT00160199|466993500|FG000|Overall Study|Lost to Follow-up|7|||
129736250|NCT00160199|466993501|FG001|Overall Study|Lost to Follow-up|7|||
129736251|NCT00160199|466993500|FG000|Overall Study|Withdrawal by Subject|4|||
129736252|NCT00160199|466993501|FG001|Overall Study|Withdrawal by Subject|6|||
129736253|NCT00160199|466993500|FG000|Overall Study|Administrative|0|||
129736254|NCT00160199|466993501|FG001|Overall Study|Administrative|1|||
129736255|NCT00160199|466993500|FG000|Overall Study|Protocol Violation|8|||
129736256|NCT00160199|466993501|FG001|Overall Study|Protocol Violation|8|||
129736257|NCT03352453|466993504|FG000|Overall Study|Miscellaneous Reasons|1|||
129736258|NCT03352453|466993505|FG001|Overall Study|Miscellaneous Reasons|2|||
129736259|NCT03352453|466993504|FG000|Overall Study|Lack of Efficacy|1|||
129736260|NCT03352453|466993505|FG001|Overall Study|Lack of Efficacy|0|||
129736261|NCT03352453|466993504|FG000|Overall Study|Withdrawal by Subject|8|||
129736262|NCT03352453|466993505|FG001|Overall Study|Withdrawal by Subject|14|||
129736263|NCT03352453|466993504|FG000|Overall Study|Study Terminated by Sponsor|2|||
129736264|NCT03352453|466993505|FG001|Overall Study|Study Terminated by Sponsor|1|||
129736265|NCT03352453|466993504|FG000|Overall Study|Protocol Deviation|1|||
129736266|NCT03352453|466993505|FG001|Overall Study|Protocol Deviation|0|||
129736267|NCT03352453|466993504|FG000|Overall Study|Lost to Follow-up|7|||
129736268|NCT03352453|466993505|FG001|Overall Study|Lost to Follow-up|6|||
129736269|NCT03352453|466993504|FG000|Overall Study|Adverse Event|2|||
129736270|NCT03352453|466993505|FG001|Overall Study|Adverse Event|9|||
129736271|NCT01241760|466993508|FG000|Overall Study|Adverse Event|1|||
129736272|NCT01241760|466993509|FG001|Overall Study|Adverse Event|0|||
129736273|NCT01241760|466993508|FG000|Overall Study|Lost to Follow-up|18|||
129736274|NCT01241760|466993509|FG001|Overall Study|Lost to Follow-up|22|||
129736275|NCT01241760|466993508|FG000|Overall Study|Withdrawal by Subject|13|||
129736276|NCT01241760|466993509|FG001|Overall Study|Withdrawal by Subject|13|||
129736277|NCT01241760|466993508|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
129736278|NCT01241760|466993509|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
129736279|NCT01241760|466993508|FG000|Overall Study|Other|1|||
129736280|NCT01241760|466993509|FG001|Overall Study|Other|1|||
129736281|NCT00514020|466993510|FG000|Overall Study|Adverse Event|6|||
129736282|NCT00514020|466993510|FG000|Overall Study|Withdrawal by Subject|3|||
129736283|NCT00514020|466993510|FG000|Overall Study|Physician Decision|1|||
129736284|NCT00514020|466993510|FG000|Overall Study|disease progression|9|||
129736285|NCT00514020|466993510|FG000|Overall Study|other complicating disease|2|||
129736286|NCT00514020|466993510|FG000|Overall Study|patient went to radiation treatment|1|||
129736287|NCT00514020|466993510|FG000|Overall Study|"patients moved to the no tx group"|6|||
129736288|NCT03089944|466993511|FG000|Overall Study|Lost to Follow-up|8|||
129736289|NCT03089944|466993511|FG000|Overall Study|Withdrew Consent|2|||
129736290|NCT03089944|466993511|FG000|Overall Study|Adverse Event|1|||
129736291|NCT03089944|466993511|FG000|Overall Study|Other|1|||
129736292|NCT03780959|466993516|FG000|Part 1|Adverse Event|1|||
129736293|NCT03780959|466993517|FG001|Part 1|Adverse Event|0|||
129805065|NCT02925923|467254935|FG001|Overall Study|blood samples hemolyzed|2|||
129805066|NCT00866788|467254936|FG000|Overall Study|Adverse Event|0|||
129805067|NCT00866788|467254937|FG001|Overall Study|Adverse Event|2|||
129805068|NCT00866788|467254938|FG002|Overall Study|Adverse Event|0|||
129736294|NCT03780959|466993518|FG002|Part 1|Adverse Event|0|||
129736295|NCT03780959|466993516|FG000|Part 1|Withdrawal by Subject|1|||
129736296|NCT03780959|466993517|FG001|Part 1|Withdrawal by Subject|0|||
129736297|NCT03780959|466993518|FG002|Part 1|Withdrawal by Subject|0|||
129736298|NCT03780959|466993516|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
129736299|NCT03780959|466993517|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
129736300|NCT03780959|466993518|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
129805069|NCT00866788|467254939|FG003|Overall Study|Adverse Event|1|||
129805070|NCT00866788|467254936|FG000|Overall Study|Lost to Follow-up|1|||
129805071|NCT00866788|467254937|FG001|Overall Study|Lost to Follow-up|1|||
129736301|NCT03780959|466993516|FG000|Part 1|Response Status|2|||
129736302|NCT03780959|466993517|FG001|Part 1|Response Status|0|||
129736303|NCT03780959|466993518|FG002|Part 1|Response Status|0|||
129736304|NCT03780959|466993516|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
129736305|NCT03780959|466993517|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
129736306|NCT03780959|466993518|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
129736307|NCT03780959|466993516|FG000|Part 2|Response Status|0|||
129736308|NCT03780959|466993517|FG001|Part 2|Response Status|18|||
129805072|NCT00866788|467254938|FG002|Overall Study|Lost to Follow-up|0|||
129805073|NCT00866788|467254939|FG003|Overall Study|Lost to Follow-up|2|||
129893069|NCT00495469|467567741|FG004|Overall Study|Adverse Event|1|||
129893070|NCT00495469|467567742|FG005|Overall Study|Adverse Event|1|||
129893071|NCT00495469|467567743|FG006|Overall Study|Adverse Event|1|||
129893072|NCT00495469|467567737|FG000|Overall Study|Lost to Follow-up|1|||
129736309|NCT03780959|466993518|FG002|Part 2|Response Status|6|||
129736310|NCT01636713|466993519|FG000|Overall Study|Adverse Event|16|||
129736311|NCT01636713|466993520|FG001|Overall Study|Adverse Event|16|||
129736312|NCT01636713|466993521|FG002|Overall Study|Adverse Event|7|||
129736313|NCT01636713|466993519|FG000|Overall Study|Lack of Efficacy|6|||
129736314|NCT01636713|466993520|FG001|Overall Study|Lack of Efficacy|6|||
129736315|NCT01636713|466993521|FG002|Overall Study|Lack of Efficacy|2|||
129736316|NCT01636713|466993519|FG000|Overall Study|Protocol Violation|3|||
129736317|NCT01636713|466993520|FG001|Overall Study|Protocol Violation|0|||
129736318|NCT01636713|466993521|FG002|Overall Study|Protocol Violation|1|||
129736319|NCT01636713|466993519|FG000|Overall Study|Lost to Follow-up|0|||
129736320|NCT01636713|466993520|FG001|Overall Study|Lost to Follow-up|0|||
129736321|NCT01636713|466993521|FG002|Overall Study|Lost to Follow-up|1|||
129736322|NCT01636713|466993519|FG000|Overall Study|Withdrawal by Subject|5|||
129736323|NCT01636713|466993520|FG001|Overall Study|Withdrawal by Subject|4|||
129736324|NCT01636713|466993521|FG002|Overall Study|Withdrawal by Subject|8|||
129736325|NCT01636713|466993519|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
129736326|NCT01636713|466993520|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
129736327|NCT01636713|466993521|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
129736328|NCT03689244|466993522|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
129736329|NCT03689244|466993523|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
129736330|NCT03689244|466993524|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
129736331|NCT03689244|466993525|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
129736332|NCT03689244|466993522|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
129736333|NCT03689244|466993523|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
129736334|NCT03689244|466993524|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
129736335|NCT03689244|466993525|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
129736336|NCT03689244|466993522|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
129736337|NCT03689244|466993523|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
129736338|NCT03689244|466993524|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
129736339|NCT03689244|466993525|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
129736340|NCT03689244|466993522|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
129736341|NCT03689244|466993523|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
129736342|NCT03689244|466993524|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
129736343|NCT03689244|466993525|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
129736344|NCT03689244|466993522|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
129736345|NCT03689244|466993523|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
129736346|NCT03689244|466993524|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
129736347|NCT03689244|466993525|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
129736348|NCT03689244|466993522|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
129736349|NCT03689244|466993523|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
129736350|NCT03689244|466993524|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
129736351|NCT03689244|466993525|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
129736352|NCT03689244|466993522|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
129736353|NCT03689244|466993523|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
129736354|NCT03689244|466993524|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
129736355|NCT03689244|466993525|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
129736356|NCT03689244|466993522|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
129736357|NCT03689244|466993523|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
129736358|NCT03689244|466993524|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
129736359|NCT03689244|466993525|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
129736360|NCT03697993|466993536|FG000|Overall Study|Became Ineligible after Enrollment|1|||
129736361|NCT03697993|466993537|FG001|Overall Study|Became Ineligible after Enrollment|3|||
129736362|NCT03697993|466993536|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
129736363|NCT03697993|466993537|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
129736364|NCT03697993|466993536|FG000|Overall Study|Lost to Follow-up|3|||
129736365|NCT03697993|466993537|FG001|Overall Study|Lost to Follow-up|0|||
129736366|NCT03697993|466993536|FG000|Overall Study|Physician Decision|4|||
129736367|NCT03697993|466993537|FG001|Overall Study|Physician Decision|0|||
129736368|NCT03697993|466993536|FG000|Overall Study|Initial Urine Culture Negative|0|||
129736369|NCT03697993|466993537|FG001|Overall Study|Initial Urine Culture Negative|1|||
129736370|NCT01565564|466993538|FG000|Overall Study|Lost to Follow-up|5|||
129736371|NCT01565564|466993539|FG001|Overall Study|Lost to Follow-up|1|||
129736372|NCT02698371|466993540|FG000|All Participants Flow|Lost to Follow-up|3|||
129736373|NCT02698371|466993540|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
129736374|NCT02698371|466993540|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
129893073|NCT00495469|467567738|FG001|Overall Study|Lost to Follow-up|1|||
129736375|NCT02698371|466993540|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
129736376|NCT02698371|466993540|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
129736377|NCT02698371|466993540|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
129736378|NCT02698371|466993540|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
129736379|NCT00459537|466993545|FG000|Overall Study|Adverse Event|1|||
129736380|NCT00459537|466993546|FG001|Overall Study|Adverse Event|6|||
129736381|NCT00459537|466993545|FG000|Overall Study|Lack of Efficacy|10|||
129736382|NCT00459537|466993546|FG001|Overall Study|Lack of Efficacy|11|||
129736383|NCT00459537|466993545|FG000|Overall Study|Withdrawal by Subject|20|||
129736384|NCT00459537|466993546|FG001|Overall Study|Withdrawal by Subject|26|||
129736385|NCT00459537|466993545|FG000|Overall Study|Lost to Follow-up|27|||
129736386|NCT00459537|466993546|FG001|Overall Study|Lost to Follow-up|30|||
129736387|NCT00459537|466993545|FG000|Overall Study|Administrative problems|3|||
129736388|NCT00459537|466993546|FG001|Overall Study|Administrative problems|0|||
129736389|NCT00459537|466993545|FG000|Overall Study|Protocol Violation|4|||
129736390|NCT00459537|466993546|FG001|Overall Study|Protocol Violation|3|||
129736391|NCT00459537|466993545|FG000|Overall Study|Missing|1|||
129736392|NCT00459537|466993546|FG001|Overall Study|Missing|0|||
129736393|NCT01999218|466993547|FG000|Overall Study|Hyperglycemia|18|||
129736394|NCT01999218|466993548|FG001|Overall Study|Hyperglycemia|17|||
129736395|NCT01999218|466993549|FG002|Overall Study|Hyperglycemia|17|||
129736396|NCT01999218|466993547|FG000|Overall Study|Lack of Efficacy|1|||
129736397|NCT01999218|466993548|FG001|Overall Study|Lack of Efficacy|0|||
129736398|NCT01999218|466993549|FG002|Overall Study|Lack of Efficacy|1|||
129736399|NCT01999218|466993547|FG000|Overall Study|Lost to Follow-up|22|||
129736400|NCT01999218|466993548|FG001|Overall Study|Lost to Follow-up|17|||
129736401|NCT01999218|466993549|FG002|Overall Study|Lost to Follow-up|18|||
129736402|NCT01999218|466993547|FG000|Overall Study|Non-Compliance With Study Drug|6|||
129736403|NCT01999218|466993548|FG001|Overall Study|Non-Compliance With Study Drug|4|||
129736404|NCT01999218|466993549|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129736405|NCT01999218|466993547|FG000|Overall Study|Physician Decision|1|||
129736406|NCT01999218|466993548|FG001|Overall Study|Physician Decision|4|||
129736407|NCT01999218|466993549|FG002|Overall Study|Physician Decision|6|||
129736408|NCT01999218|466993547|FG000|Overall Study|Protocol Violation|4|||
129736409|NCT01999218|466993548|FG001|Overall Study|Protocol Violation|5|||
129736410|NCT01999218|466993549|FG002|Overall Study|Protocol Violation|4|||
129736411|NCT01999218|466993547|FG000|Overall Study|Screen failure|0|||
129736412|NCT01999218|466993548|FG001|Overall Study|Screen failure|1|||
129736413|NCT01999218|466993549|FG002|Overall Study|Screen failure|0|||
129736414|NCT01999218|466993547|FG000|Overall Study|Study Terminated By Sponsor|7|||
129736415|NCT01999218|466993548|FG001|Overall Study|Study Terminated By Sponsor|5|||
129736416|NCT01999218|466993549|FG002|Overall Study|Study Terminated By Sponsor|12|||
129736417|NCT01999218|466993547|FG000|Overall Study|Participant moves|2|||
129736418|NCT01999218|466993548|FG001|Overall Study|Participant moves|5|||
129736419|NCT01999218|466993549|FG002|Overall Study|Participant moves|3|||
129736420|NCT01999218|466993547|FG000|Overall Study|Withdrawal by Subject|28|||
129736421|NCT01999218|466993548|FG001|Overall Study|Withdrawal by Subject|29|||
129736422|NCT01999218|466993549|FG002|Overall Study|Withdrawal by Subject|34|||
129736423|NCT01999218|466993547|FG000|Overall Study|Creatinine/eGFR|0|||
129736424|NCT01999218|466993548|FG001|Overall Study|Creatinine/eGFR|0|||
129736425|NCT01999218|466993549|FG002|Overall Study|Creatinine/eGFR|1|||
129736426|NCT01999218|466993547|FG000|Overall Study|Death|7|||
129736427|NCT01999218|466993548|FG001|Overall Study|Death|1|||
129736428|NCT01999218|466993549|FG002|Overall Study|Death|2|||
129736429|NCT01999218|466993547|FG000|Overall Study|Excluded Medication|1|||
129736430|NCT01999218|466993548|FG001|Overall Study|Excluded Medication|1|||
129736431|NCT01999218|466993549|FG002|Overall Study|Excluded Medication|2|||
129736432|NCT01999218|466993547|FG000|Overall Study|Adverse Event|9|||
129736433|NCT01999218|466993548|FG001|Overall Study|Adverse Event|7|||
129736434|NCT01999218|466993549|FG002|Overall Study|Adverse Event|7|||
129736435|NCT01999218|466993547|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
129736436|NCT01999218|466993548|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
129736437|NCT01999218|466993549|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
129805074|NCT00866788|467254936|FG000|Overall Study|Withdrawal by Subject|2|||
129805075|NCT00866788|467254937|FG001|Overall Study|Withdrawal by Subject|1|||
129805076|NCT00866788|467254938|FG002|Overall Study|Withdrawal by Subject|0|||
129736438|NCT02032407|466995023|FG000|Overall Study|Lost to Follow-up|2|||
129736439|NCT02032407|466995023|FG000|Overall Study|Pregnancy|1|||
129736440|NCT02032407|466995023|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129736441|NCT02191605|466995024|FG000|Overall Study|Lost to Follow-up|9|||
129736442|NCT02191605|466995025|FG001|Overall Study|Lost to Follow-up|4|||
129736443|NCT02191605|466995026|FG002|Overall Study|Lost to Follow-up|7|||
129736444|NCT02191605|466995027|FG003|Overall Study|Lost to Follow-up|3|||
129736445|NCT02191605|466995028|FG004|Overall Study|Lost to Follow-up|4|||
129736446|NCT03647267|466995032|FG000|Overall Study|Lost to Follow-up|1|||
129736447|NCT03647267|466995033|FG001|Overall Study|Lost to Follow-up|0|||
129893074|NCT00495469|467567739|FG002|Overall Study|Lost to Follow-up|3|||
129736448|NCT01350115|466995034|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
129736449|NCT01350115|466995035|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
129736450|NCT01350115|466995034|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
129736451|NCT01350115|466995035|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
129736452|NCT01350115|466995034|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
129736453|NCT01350115|466995035|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
129736454|NCT05079477|466995036|FG000|Overall Study|Lost to Follow-up|2|||
129805077|NCT00866788|467254939|FG003|Overall Study|Withdrawal by Subject|1|||
129736455|NCT05079477|466995037|FG001|Overall Study|Lost to Follow-up|0|||
129736456|NCT05079477|466995036|FG000|Overall Study|Withdrawal by Subject|1|||
129736457|NCT05079477|466995037|FG001|Overall Study|Withdrawal by Subject|0|||
129736458|NCT05079477|466995036|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
129736459|NCT05079477|466995037|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
129736460|NCT05079477|466995036|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
129736461|NCT05079477|466995037|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
129736462|NCT00734071|466995038|FG000|Overall Study|Adverse Event|4|||
129736463|NCT00734071|466995039|FG001|Overall Study|Adverse Event|3|||
129736464|NCT00734071|466995038|FG000|Overall Study|Lack of Efficacy|3|||
129736465|NCT00734071|466995039|FG001|Overall Study|Lack of Efficacy|1|||
129805078|NCT00866788|467254936|FG000|Overall Study|Pregnancy|0|||
129805079|NCT00866788|467254937|FG001|Overall Study|Pregnancy|1|||
129805080|NCT00866788|467254938|FG002|Overall Study|Pregnancy|0|||
129805081|NCT00866788|467254939|FG003|Overall Study|Pregnancy|0|||
129805082|NCT00866788|467254936|FG000|Overall Study|Disease progression|3|||
129805083|NCT00866788|467254937|FG001|Overall Study|Disease progression|1|||
129805084|NCT00866788|467254938|FG002|Overall Study|Disease progression|1|||
129805085|NCT00866788|467254939|FG003|Overall Study|Disease progression|0|||
129805086|NCT00866788|467254936|FG000|Overall Study|Physician Decision|0|||
129805087|NCT00866788|467254937|FG001|Overall Study|Physician Decision|0|||
129805088|NCT00866788|467254938|FG002|Overall Study|Physician Decision|1|||
129805089|NCT00866788|467254939|FG003|Overall Study|Physician Decision|1|||
129805090|NCT02742441|467254940|FG000|Overall Study|Lost to Follow-up|4|||
129805091|NCT02742441|467254941|FG001|Overall Study|Lost to Follow-up|4|||
129805092|NCT02742441|467254940|FG000|Overall Study|Withdrawal by Subject|2|||
129805093|NCT02742441|467254941|FG001|Overall Study|Withdrawal by Subject|2|||
129805094|NCT02742441|467254940|FG000|Overall Study|Adverse Event|0|||
129805095|NCT02742441|467254941|FG001|Overall Study|Adverse Event|2|||
129805096|NCT02202837|467254942|FG000|Overall Study|Enbrel treatment discontinued|36|||
129805097|NCT02202837|467254943|FG001|Overall Study|Enbrel treatment discontinued|4|||
129805098|NCT02202837|467254942|FG000|Overall Study|Other|10|||
129805099|NCT02202837|467254943|FG001|Overall Study|Other|0|||
129805100|NCT02202837|467254942|FG000|Overall Study|Lost to Follow-up|7|||
129805101|NCT02202837|467254943|FG001|Overall Study|Lost to Follow-up|1|||
129805102|NCT02281773|467254944|FG000|Overall Study|Adverse Event|6|||
129805103|NCT02281773|467254945|FG001|Overall Study|Adverse Event|1|||
129805104|NCT02281773|467254946|FG002|Overall Study|Adverse Event|4|||
129805105|NCT02281773|467254947|FG003|Overall Study|Adverse Event|8|||
129805106|NCT02281773|467254948|FG004|Overall Study|Adverse Event|9|||
129805107|NCT02281773|467254944|FG000|Overall Study|Protocol Violation|1|||
129805108|NCT02281773|467254945|FG001|Overall Study|Protocol Violation|0|||
129805109|NCT02281773|467254946|FG002|Overall Study|Protocol Violation|0|||
129805110|NCT02281773|467254947|FG003|Overall Study|Protocol Violation|2|||
129805111|NCT02281773|467254948|FG004|Overall Study|Protocol Violation|2|||
129805112|NCT02281773|467254944|FG000|Overall Study|Lost to Follow-up|2|||
129805113|NCT02281773|467254945|FG001|Overall Study|Lost to Follow-up|2|||
129805114|NCT02281773|467254946|FG002|Overall Study|Lost to Follow-up|6|||
129805115|NCT02281773|467254947|FG003|Overall Study|Lost to Follow-up|2|||
129805116|NCT02281773|467254948|FG004|Overall Study|Lost to Follow-up|10|||
129805117|NCT02281773|467254944|FG000|Overall Study|Withdrawal by Subject|2|||
129805118|NCT02281773|467254945|FG001|Overall Study|Withdrawal by Subject|8|||
129805119|NCT02281773|467254946|FG002|Overall Study|Withdrawal by Subject|6|||
129805120|NCT02281773|467254947|FG003|Overall Study|Withdrawal by Subject|6|||
129805121|NCT02281773|467254948|FG004|Overall Study|Withdrawal by Subject|8|||
129805122|NCT02281773|467254944|FG000|Overall Study|Other Reason|0|||
129805123|NCT02281773|467254945|FG001|Overall Study|Other Reason|4|||
129805124|NCT02281773|467254946|FG002|Overall Study|Other Reason|2|||
129805125|NCT02281773|467254947|FG003|Overall Study|Other Reason|3|||
129805126|NCT02281773|467254948|FG004|Overall Study|Other Reason|1|||
129805127|NCT02104752|467254949|FG000|Overall Study|Withdrawal by Subject|1|||
129805128|NCT02104752|467254950|FG001|Overall Study|Withdrawal by Subject|0|||
129805129|NCT02104752|467254949|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
129805130|NCT02104752|467254950|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
129805131|NCT05439941|467254951|FG000|Overall Study|Lack of Efficacy|8|||
129805132|NCT05439941|467254952|FG001|Overall Study|Lack of Efficacy|5|||
129805133|NCT05439941|467254953|FG002|Overall Study|Lack of Efficacy|3|||
129805134|NCT05439941|467254951|FG000|Overall Study|Treatment Failure|0|||
129893075|NCT00495469|467567740|FG003|Overall Study|Lost to Follow-up|1|||
129444738|NCT01641809|465929436|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
129736466|NCT00734071|466995038|FG000|Overall Study|Noncompliance|2|||
129736467|NCT00734071|466995039|FG001|Overall Study|Noncompliance|2|||
129736468|NCT00734071|466995038|FG000|Overall Study|Protocol Deviations|3|||
129736469|NCT00734071|466995039|FG001|Overall Study|Protocol Deviations|4|||
129736470|NCT00734071|466995038|FG000|Overall Study|Voluntary Withdrawal|9|||
129736471|NCT00734071|466995039|FG001|Overall Study|Voluntary Withdrawal|7|||
129736472|NCT00734071|466995038|FG000|Overall Study|Lost to Follow-up|16|||
129736473|NCT00734071|466995039|FG001|Overall Study|Lost to Follow-up|8|||
129736474|NCT00734071|466995038|FG000|Overall Study|Other|1|||
129736475|NCT00734071|466995039|FG001|Overall Study|Other|2|||
129736476|NCT00240110|466995043|FG000|Overall Study|Lost to Follow-up|6|||
129736477|NCT00240110|466995044|FG001|Overall Study|Lost to Follow-up|7|||
129736478|NCT00583791|466995045|FG000|Overall Study|Other|67|||
129736479|NCT00583791|466995045|FG000|Overall Study|Death|6|||
129736480|NCT03323736|466995046|FG000|Overall Study|Screen Failure|14|||
129736481|NCT03323736|466995047|FG001|Overall Study|Screen Failure|9|||
129736482|NCT03323736|466995048|FG002|Overall Study|Screen Failure|1|||
129736483|NCT03323736|466995046|FG000|Overall Study|Withdrawal Before Treatment|3|||
129736484|NCT03323736|466995047|FG001|Overall Study|Withdrawal Before Treatment|1|||
129736485|NCT03323736|466995048|FG002|Overall Study|Withdrawal Before Treatment|1|||
129736486|NCT03323736|466995046|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
129736487|NCT03323736|466995047|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
129736488|NCT03323736|466995048|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
129805135|NCT05439941|467254952|FG001|Overall Study|Treatment Failure|1|||
129805136|NCT05439941|467254953|FG002|Overall Study|Treatment Failure|0|||
129805137|NCT05439941|467254951|FG000|Overall Study|Adverse Event|1|||
129805138|NCT05439941|467254952|FG001|Overall Study|Adverse Event|3|||
129805139|NCT05439941|467254953|FG002|Overall Study|Adverse Event|0|||
129805140|NCT05439941|467254951|FG000|Overall Study|Adverse Event - Parent Study|1|||
129805141|NCT05439941|467254952|FG001|Overall Study|Adverse Event - Parent Study|0|||
129805142|NCT05439941|467254953|FG002|Overall Study|Adverse Event - Parent Study|0|||
129805143|NCT05439941|467254951|FG000|Overall Study|Pregnancy|1|||
129805144|NCT05439941|467254952|FG001|Overall Study|Pregnancy|0|||
129805145|NCT05439941|467254953|FG002|Overall Study|Pregnancy|0|||
129805146|NCT05439941|467254951|FG000|Overall Study|Withdrawal by Subject|9|||
129805147|NCT05439941|467254952|FG001|Overall Study|Withdrawal by Subject|6|||
129805148|NCT05439941|467254953|FG002|Overall Study|Withdrawal by Subject|10|||
129805149|NCT05439941|467254951|FG000|Overall Study|Non-Compliance|1|||
129805150|NCT05439941|467254952|FG001|Overall Study|Non-Compliance|1|||
129805151|NCT05439941|467254953|FG002|Overall Study|Non-Compliance|1|||
129805152|NCT05439941|467254951|FG000|Overall Study|Lost to Follow-up|2|||
129805153|NCT05439941|467254952|FG001|Overall Study|Lost to Follow-up|2|||
129805154|NCT05439941|467254953|FG002|Overall Study|Lost to Follow-up|0|||
129805155|NCT05439941|467254951|FG000|Overall Study|Physician Decision|1|||
129805156|NCT05439941|467254952|FG001|Overall Study|Physician Decision|0|||
129805157|NCT05439941|467254953|FG002|Overall Study|Physician Decision|0|||
129805158|NCT05439941|467254951|FG000|Overall Study|Trial Termination by Sponsor|78|||
129805159|NCT05439941|467254952|FG001|Overall Study|Trial Termination by Sponsor|83|||
129805160|NCT05439941|467254953|FG002|Overall Study|Trial Termination by Sponsor|65|||
129805161|NCT05439941|467254951|FG000|Overall Study|Other than Reasons Listed|2|||
129805162|NCT05439941|467254952|FG001|Overall Study|Other than Reasons Listed|1|||
129805163|NCT05439941|467254953|FG002|Overall Study|Other than Reasons Listed|0|||
129805164|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
129805165|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
129805166|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
129805167|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
129805168|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
129805169|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
129805170|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
129805171|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
129805172|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
129805173|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
129805174|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
129805175|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
129805176|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
129805177|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
129805178|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
129805179|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
129805180|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
129805181|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
129805182|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
129805183|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
129805184|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
129736489|NCT02654236|466995052|FG000|Overall Study|Withdrawal by Subject|0|||
129736490|NCT02654236|466995053|FG001|Overall Study|Withdrawal by Subject|0|||
129736491|NCT02654236|466995054|FG002|Overall Study|Withdrawal by Subject|2|||
129736492|NCT03204890|466995055|FG000|Overall Study|Withdrawal by Subject|1|||
129736493|NCT01549873|466995056|FG000|Overall Study|Physician Decision|0|||
129736494|NCT01549873|466995057|FG001|Overall Study|Physician Decision|1|||
129736495|NCT01688739|466995061|FG000|Overall Study|Administrative Decision|1|||
129736496|NCT01688739|466995062|FG001|Overall Study|Administrative Decision|0|||
129736497|NCT01688739|466995063|FG002|Overall Study|Administrative Decision|0|||
129736498|NCT01688739|466995064|FG003|Overall Study|Administrative Decision|0|||
129736499|NCT01688739|466995065|FG004|Overall Study|Administrative Decision|0|||
129736500|NCT01688739|466995066|FG005|Overall Study|Administrative Decision|0|||
129736501|NCT01688739|466995067|FG006|Overall Study|Administrative Decision|0|||
129736502|NCT01688739|466995068|FG007|Overall Study|Administrative Decision|0|||
129736503|NCT01688739|466995069|FG008|Overall Study|Administrative Decision|0|||
129736504|NCT01688739|466995070|FG009|Overall Study|Administrative Decision|0|||
129736505|NCT02559414|466995072|FG000|Overall Study|Lost to Follow-up|0|||
129736506|NCT02559414|466995073|FG001|Overall Study|Lost to Follow-up|1|||
129736507|NCT02559414|466995074|FG002|Overall Study|Lost to Follow-up|0|||
129736508|NCT02559414|466995072|FG000|Overall Study|Withdrawal by Subject|1|||
129736509|NCT02559414|466995073|FG001|Overall Study|Withdrawal by Subject|0|||
129736510|NCT02559414|466995074|FG002|Overall Study|Withdrawal by Subject|1|||
129736511|NCT02559414|466995072|FG000|Overall Study|Other|0|||
129736512|NCT02559414|466995073|FG001|Overall Study|Other|1|||
129736513|NCT02559414|466995074|FG002|Overall Study|Other|1|||
129736514|NCT03369431|466995075|FG000|Overall Study|Lost to Follow-up|1|||
129736515|NCT03369431|466995076|FG001|Overall Study|Lost to Follow-up|3|||
129736516|NCT03369431|466995075|FG000|Overall Study|Withdrawal by Subject|2|||
129736517|NCT03369431|466995076|FG001|Overall Study|Withdrawal by Subject|3|||
129736518|NCT03369431|466995075|FG000|Overall Study|Protocol Violation|1|||
129736519|NCT03369431|466995076|FG001|Overall Study|Protocol Violation|1|||
129736520|NCT01113580|466995081|FG000|Overall Study|Protocol Violation|1|||
129736521|NCT01113580|466995082|FG001|Overall Study|Protocol Violation|0|||
129736522|NCT02785458|466995090|FG000|1 Month|Withdrawal by Subject|2|||
129736523|NCT02785458|466995091|FG001|1 Month|Withdrawal by Subject|1|||
129736524|NCT02785458|466995090|FG000|1 Month|Lost to Follow-up|38|||
129736525|NCT02785458|466995091|FG001|1 Month|Lost to Follow-up|31|||
129736526|NCT02785458|466995090|FG000|1 Month|Deemed Ineligible|1|||
129736527|NCT02785458|466995091|FG001|1 Month|Deemed Ineligible|0|||
129736528|NCT02785458|466995090|FG000|1 Month|Completed Evaluation by Baseline|42|||
129736529|NCT02785458|466995091|FG001|1 Month|Completed Evaluation by Baseline|39|||
129736530|NCT02785458|466995090|FG000|1 Month|Partial Interview|0|||
129736531|NCT02785458|466995091|FG001|1 Month|Partial Interview|4|||
129736532|NCT02785458|466995090|FG000|3 Months|Withdrawal by Subject|3|||
129736533|NCT02785458|466995091|FG001|3 Months|Withdrawal by Subject|1|||
129736534|NCT02785458|466995090|FG000|3 Months|Lost to Follow-up|25|||
129736535|NCT02785458|466995091|FG001|3 Months|Lost to Follow-up|21|||
129736536|NCT02785458|466995090|FG000|3 Months|Completed Evaluation at 1 Month|100|||
129736537|NCT02785458|466995091|FG001|3 Months|Completed Evaluation at 1 Month|89|||
129736538|NCT00824005|466995093|FG000|Overall Study|Death|0|||
129736539|NCT00824005|466995094|FG001|Overall Study|Death|1|||
129736540|NCT00824005|466995093|FG000|Overall Study|Lost to Follow-up|0|||
129736541|NCT00824005|466995094|FG001|Overall Study|Lost to Follow-up|1|||
129736542|NCT03458702|466995095|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
129736543|NCT03458702|466995096|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
129736544|NCT03458702|466995095|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
129736545|NCT03458702|466995096|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
129736546|NCT01390779|466995097|FG000|Overall Study|Physician Decision|1|||
129736547|NCT01874275|466995098|FG000|Overall Study|Lost to Follow-up|1|||
129736548|NCT01874275|466995099|FG001|Overall Study|Lost to Follow-up|0|||
129736549|NCT01697462|466995100|FG000|Overall Study|Disease Progression|1|||
129736550|NCT01697462|466995100|FG000|Overall Study|Adverse Event|6|||
129736551|NCT01697462|466995100|FG000|Overall Study|Lost to Follow-up|21|||
129736552|NCT01697462|466995100|FG000|Overall Study|Withdrawal by Subject|12|||
129736553|NCT01697462|466995100|FG000|Overall Study|Investigator Decision|21|||
129736554|NCT01697462|466995100|FG000|Overall Study|Death|1|||
129736555|NCT01697462|466995100|FG000|Overall Study|Other|10|||
129736556|NCT01697462|466995100|FG000|Overall Study|Missing|5|||
129736557|NCT00168103|466995101|FG000|Overall Study|Withdrawal by Subject|1|||
129736558|NCT00168103|466995102|FG001|Overall Study|Withdrawal by Subject|2|||
129736559|NCT00168103|466995103|FG002|Overall Study|Withdrawal by Subject|1|||
129736560|NCT00168103|466995104|FG003|Overall Study|Withdrawal by Subject|0|||
129736561|NCT00168103|466995101|FG000|Overall Study|Lost to Follow-up|1|||
129736562|NCT00168103|466995102|FG001|Overall Study|Lost to Follow-up|3|||
129736563|NCT00168103|466995103|FG002|Overall Study|Lost to Follow-up|0|||
129736564|NCT00168103|466995104|FG003|Overall Study|Lost to Follow-up|0|||
129736565|NCT00989235|466995105|FG000|Overall Study|Death|0|||
129736566|NCT00989235|466995106|FG001|Overall Study|Death|1|||
129805185|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
129805186|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
129805187|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
129805188|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
129805189|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
129805190|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
129805191|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
129805192|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
129805193|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
129805194|NCT00313300|467254954|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
129805195|NCT00313300|467254955|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129805196|NCT00313300|467254956|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129805197|NCT00313300|467254957|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129893076|NCT00495469|467567741|FG004|Overall Study|Lost to Follow-up|0|||
129893077|NCT00495469|467567742|FG005|Overall Study|Lost to Follow-up|0|||
129893078|NCT00495469|467567743|FG006|Overall Study|Lost to Follow-up|0|||
129893079|NCT00495469|467567737|FG000|Overall Study|Protocol Violation|0|||
129893080|NCT00495469|467567738|FG001|Overall Study|Protocol Violation|0|||
129893081|NCT00495469|467567739|FG002|Overall Study|Protocol Violation|0|||
129893082|NCT00495469|467567740|FG003|Overall Study|Protocol Violation|0|||
129893083|NCT00495469|467567741|FG004|Overall Study|Protocol Violation|1|||
129893084|NCT00495469|467567742|FG005|Overall Study|Protocol Violation|2|||
129893085|NCT00495469|467567743|FG006|Overall Study|Protocol Violation|0|||
129736567|NCT00989235|466995105|FG000|Overall Study|Adverse Event|0|||
129736568|NCT00989235|466995106|FG001|Overall Study|Adverse Event|1|||
129736569|NCT00989235|466995105|FG000|Overall Study|Lack of Efficacy|1|||
129736570|NCT00989235|466995106|FG001|Overall Study|Lack of Efficacy|0|||
129736571|NCT00989235|466995105|FG000|Overall Study|Withdrawal of Consent|1|||
129736572|NCT00989235|466995106|FG001|Overall Study|Withdrawal of Consent|1|||
129736573|NCT00989235|466995105|FG000|Overall Study|Desire to Become Pregnant|1|||
129736574|NCT00989235|466995106|FG001|Overall Study|Desire to Become Pregnant|0|||
129736575|NCT00989235|466995105|FG000|Overall Study|Randomized by Mistake|0|||
129893086|NCT00495469|467567737|FG000|Overall Study|Withdrawal by Subject|5|||
129893087|NCT00495469|467567738|FG001|Overall Study|Withdrawal by Subject|3|||
129893088|NCT00495469|467567739|FG002|Overall Study|Withdrawal by Subject|1|||
129893089|NCT00495469|467567740|FG003|Overall Study|Withdrawal by Subject|3|||
129893090|NCT00495469|467567741|FG004|Overall Study|Withdrawal by Subject|3|||
129893091|NCT00495469|467567742|FG005|Overall Study|Withdrawal by Subject|2|||
129893092|NCT00495469|467567743|FG006|Overall Study|Withdrawal by Subject|3|||
129893093|NCT00495469|467567737|FG000|Overall Study|Lack of Efficacy|0|||
129893094|NCT00495469|467567738|FG001|Overall Study|Lack of Efficacy|0|||
129893095|NCT00495469|467567739|FG002|Overall Study|Lack of Efficacy|0|||
129893096|NCT00495469|467567740|FG003|Overall Study|Lack of Efficacy|0|||
129893097|NCT00495469|467567741|FG004|Overall Study|Lack of Efficacy|0|||
129893098|NCT00495469|467567742|FG005|Overall Study|Lack of Efficacy|0|||
129893099|NCT00495469|467567743|FG006|Overall Study|Lack of Efficacy|1|||
129893100|NCT00495469|467567737|FG000|Overall Study|Liver function test abnormality|0|||
129893101|NCT00495469|467567738|FG001|Overall Study|Liver function test abnormality|1|||
129893102|NCT00495469|467567739|FG002|Overall Study|Liver function test abnormality|0|||
129736576|NCT00989235|466995106|FG001|Overall Study|Randomized by Mistake|2|||
129736577|NCT00989235|466995105|FG000|Overall Study|Lost to Follow-up|0|||
129736578|NCT00989235|466995106|FG001|Overall Study|Lost to Follow-up|1|||
129805198|NCT00313300|467254958|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
129805199|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
129805200|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
129893103|NCT00495469|467567740|FG003|Overall Study|Liver function test abnormality|0|||
129893104|NCT00495469|467567741|FG004|Overall Study|Liver function test abnormality|0|||
129736579|NCT00545532|466995107|FG000|Overall Study|Withdrawal by Subject|1|||
129805201|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
129736580|NCT00545532|466995108|FG001|Overall Study|Withdrawal by Subject|3|||
129805202|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
129893105|NCT00495469|467567742|FG005|Overall Study|Liver function test abnormality|0|||
129893106|NCT00495469|467567743|FG006|Overall Study|Liver function test abnormality|0|||
129736581|NCT00545532|466995107|FG000|Overall Study|Lost to Follow-up|5|||
129736582|NCT00545532|466995108|FG001|Overall Study|Lost to Follow-up|6|||
129736583|NCT00545532|466995107|FG000|Overall Study|Death|0|||
129736584|NCT00545532|466995108|FG001|Overall Study|Death|1|||
129736585|NCT03630302|466995109|FG000|Surgery|hardware issue prevented LFP recordings|1|||
129736586|NCT03630302|466995109|FG000|3 Month Visit|Adverse Event|2|||
129736587|NCT03630302|466995109|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
129736588|NCT00931801|466995112|FG000|Overall Study|Adverse Event|0|||
129736589|NCT00931801|466995113|FG001|Overall Study|Adverse Event|0|||
129736590|NCT00931801|466995114|FG002|Overall Study|Adverse Event|1|||
129736591|NCT00931801|466995112|FG000|Overall Study|Lost to Follow-up|0|||
129736592|NCT00931801|466995113|FG001|Overall Study|Lost to Follow-up|1|||
129736593|NCT00931801|466995114|FG002|Overall Study|Lost to Follow-up|0|||
129736594|NCT00931801|466995112|FG000|Overall Study|Withdrawal by Subject|1|||
129736595|NCT00931801|466995113|FG001|Overall Study|Withdrawal by Subject|0|||
129736596|NCT00931801|466995114|FG002|Overall Study|Withdrawal by Subject|0|||
129736597|NCT00931801|466995112|FG000|Overall Study|Confirmed Virologic Failure|0|||
129736598|NCT00931801|466995113|FG001|Overall Study|Confirmed Virologic Failure|0|||
129736599|NCT00931801|466995114|FG002|Overall Study|Confirmed Virologic Failure|3|||
129736600|NCT00933244|466995115|FG000|Overall Study|Withdrawal by Subject|5|||
129736601|NCT00933244|466995116|FG001|Overall Study|Withdrawal by Subject|1|||
129736602|NCT00933244|466995117|FG002|Overall Study|Withdrawal by Subject|3|||
129736603|NCT02266875|466995118|FG000|Overall Study|Withdrawal by Subject|9|||
129736604|NCT02266875|466995119|FG001|Overall Study|Withdrawal by Subject|0|||
129736605|NCT02266875|466995118|FG000|Overall Study|Lost to Follow-up|2|||
129736606|NCT02266875|466995119|FG001|Overall Study|Lost to Follow-up|0|||
129736607|NCT00875056|466995123|FG000|Overall Study|Adverse Event|6|||
129736608|NCT00875056|466995124|FG001|Overall Study|Adverse Event|1|||
129736609|NCT00875056|466995125|FG002|Overall Study|Adverse Event|2|||
129736610|NCT00875056|466995123|FG000|Overall Study|Progressive Disease|14|||
129736611|NCT00875056|466995124|FG001|Overall Study|Progressive Disease|8|||
129736612|NCT00875056|466995125|FG002|Overall Study|Progressive Disease|3|||
129736613|NCT00875056|466995123|FG000|Overall Study|Withdrawal by Subject|3|||
129736614|NCT00875056|466995124|FG001|Overall Study|Withdrawal by Subject|0|||
129736615|NCT00875056|466995125|FG002|Overall Study|Withdrawal by Subject|1|||
129736616|NCT00391391|466995128|FG000|Overall Study|Adverse Event|0|||
129736617|NCT00391391|466995129|FG001|Overall Study|Adverse Event|0|||
129736618|NCT00391391|466995130|FG002|Overall Study|Adverse Event|0|||
129736619|NCT00391391|466995131|FG003|Overall Study|Adverse Event|1|||
129736620|NCT00391391|466995128|FG000|Overall Study|Lost to Follow-up|1|||
129736621|NCT00391391|466995129|FG001|Overall Study|Lost to Follow-up|3|||
129736622|NCT00391391|466995130|FG002|Overall Study|Lost to Follow-up|7|||
129736623|NCT00391391|466995131|FG003|Overall Study|Lost to Follow-up|4|||
129736624|NCT00391391|466995128|FG000|Overall Study|Protocol Violation|2|||
129736625|NCT00391391|466995129|FG001|Overall Study|Protocol Violation|3|||
129736626|NCT00391391|466995130|FG002|Overall Study|Protocol Violation|6|||
129736627|NCT00391391|466995131|FG003|Overall Study|Protocol Violation|7|||
129736628|NCT00391391|466995128|FG000|Overall Study|Withdrawal by Subject|6|||
129736629|NCT00391391|466995129|FG001|Overall Study|Withdrawal by Subject|4|||
129736630|NCT00391391|466995130|FG002|Overall Study|Withdrawal by Subject|10|||
129736631|NCT00391391|466995131|FG003|Overall Study|Withdrawal by Subject|7|||
129736632|NCT01920152|466995132|FG000|Overall Study|Withdrawal by Subject|1|||
129736633|NCT01920152|466995133|FG001|Overall Study|Withdrawal by Subject|2|||
129736634|NCT04375397|466995136|FG000|Overall Study|Death|1|||
129736635|NCT04375397|466995137|FG001|Overall Study|Death|1|||
129736636|NCT04375397|466995136|FG000|Overall Study|Withdrew consent|2|||
129736637|NCT04375397|466995137|FG001|Overall Study|Withdrew consent|0|||
129736638|NCT04375397|466995136|FG000|Overall Study|Lost to Follow-up|6|||
129736639|NCT04375397|466995137|FG001|Overall Study|Lost to Follow-up|4|||
129736640|NCT04375397|466995136|FG000|Overall Study|Other, not specified|0|||
129736641|NCT04375397|466995137|FG001|Overall Study|Other, not specified|1|||
129736642|NCT00610441|466995141|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
129736643|NCT00610441|466995142|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
129736644|NCT00610441|466995143|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
129736645|NCT00610441|466995144|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
129736646|NCT00610441|466995141|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129736647|NCT00610441|466995142|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129736648|NCT00610441|466995143|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
129736649|NCT00610441|466995144|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
129736650|NCT00610441|466995141|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
129736651|NCT00610441|466995142|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
129893107|NCT00495469|467567737|FG000|Overall Study|ST depression at randomisation in ECG|0|||
129893108|NCT00495469|467567738|FG001|Overall Study|ST depression at randomisation in ECG|1|||
129893109|NCT00495469|467567739|FG002|Overall Study|ST depression at randomisation in ECG|0|||
129893110|NCT00495469|467567740|FG003|Overall Study|ST depression at randomisation in ECG|0|||
129893111|NCT00495469|467567741|FG004|Overall Study|ST depression at randomisation in ECG|0|||
129893112|NCT00495469|467567742|FG005|Overall Study|ST depression at randomisation in ECG|0|||
129893113|NCT00495469|467567743|FG006|Overall Study|ST depression at randomisation in ECG|0|||
129893114|NCT00448864|467567746|FG000|Overall Study|Death|1|||
129893115|NCT00448864|467567747|FG001|Overall Study|Death|0|||
129893116|NCT00448864|467567748|FG002|Overall Study|Death|0|||
129893117|NCT00448864|467567746|FG000|Overall Study|Lost to Follow-up|3|||
129736652|NCT00610441|466995143|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
129736653|NCT00610441|466995144|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
129736654|NCT00610441|466995141|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
129736655|NCT00610441|466995142|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
129736656|NCT00610441|466995143|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
129736657|NCT00610441|466995144|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
129736658|NCT00610441|466995141|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
129736659|NCT00610441|466995142|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
129736660|NCT00610441|466995143|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
129736661|NCT00610441|466995144|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
129736662|NCT00610441|466995141|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129736663|NCT00610441|466995142|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
129736664|NCT00610441|466995143|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129736665|NCT00610441|466995144|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
129736666|NCT00610441|466995141|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
129736667|NCT00610441|466995142|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
129736668|NCT00610441|466995143|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
129736669|NCT00610441|466995144|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
129736670|NCT00610441|466995141|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
129736671|NCT00610441|466995142|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
129736672|NCT00610441|466995143|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
129736673|NCT00610441|466995144|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
129736674|NCT00610441|466995141|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
129736675|NCT00610441|466995142|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
129736676|NCT00610441|466995143|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
129736677|NCT00610441|466995144|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
129736678|NCT01995552|466995145|FG000|Overall Study|Protocol Violation|1|||
129736679|NCT01995552|466995145|FG000|Overall Study|Lack of Efficacy|15|||
129736680|NCT01995552|466995145|FG000|Overall Study|Death|1|||
129736681|NCT01011933|466995147|FG000|Overall Study|Wrong cell type|1|||
129736682|NCT01011933|466995147|FG000|Overall Study|Improper pre-protocol Rx|1|||
129736683|NCT01011933|466995147|FG000|Overall Study|Inadequate pathology|1|||
129736684|NCT01011933|466995147|FG000|Overall Study|Never treated|1|||
129736685|NCT01439074|466995148|FG000|Overall Study|Lost to Follow-up|3|||
129736686|NCT01439074|466995149|FG001|Overall Study|Lost to Follow-up|4|||
129736687|NCT01439074|466995148|FG000|Overall Study|Subject shedding|1|||
129736688|NCT01439074|466995149|FG001|Overall Study|Subject shedding|0|||
129736689|NCT01439074|466995148|FG000|Overall Study|Withdrawal by Subject|1|||
129736690|NCT01439074|466995149|FG001|Overall Study|Withdrawal by Subject|5|||
129736691|NCT01439074|466995148|FG000|Overall Study|Other|4|||
129805203|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
129805204|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
129805205|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
129805206|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
129805207|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
129805208|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
129805209|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
129805210|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
129805211|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
129805212|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
129805213|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
129805214|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
129805215|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
129805216|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
129805217|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
129805218|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
129805219|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
129805220|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
129805221|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
129805222|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
129893118|NCT00448864|467567747|FG001|Overall Study|Lost to Follow-up|1|||
129893119|NCT00448864|467567748|FG002|Overall Study|Lost to Follow-up|0|||
129893120|NCT00448864|467567746|FG000|Overall Study|Physician Decision|1|||
129893121|NCT00448864|467567747|FG001|Overall Study|Physician Decision|0|||
129893122|NCT00448864|467567748|FG002|Overall Study|Physician Decision|1|||
129893123|NCT00448864|467567746|FG000|Overall Study|Withdrawal by Subject|0|||
129893124|NCT00448864|467567747|FG001|Overall Study|Withdrawal by Subject|2|||
129893125|NCT00448864|467567748|FG002|Overall Study|Withdrawal by Subject|0|||
129893126|NCT00448864|467567746|FG000|Overall Study|Protocol Violation|0|||
129893127|NCT00448864|467567747|FG001|Overall Study|Protocol Violation|2|||
129893128|NCT00448864|467567748|FG002|Overall Study|Protocol Violation|0|||
129893129|NCT03606460|467567751|FG000|Overall Study|Lost to Follow-up|1|||
129893130|NCT03606460|467567752|FG001|Overall Study|Lost to Follow-up|8|||
129893131|NCT04170023|467567753|FG000|LTE Period|Withdrawal by Subject|1|||
129893132|NCT04170023|467567754|FG001|LTE Period|Withdrawal by Subject|0|||
129893133|NCT04170023|467567755|FG002|LTE Period|Withdrawal by Subject|0|||
129893134|NCT04170023|467567753|FG000|LTE Period|Study Termination|11|||
129893135|NCT04170023|467567754|FG001|LTE Period|Study Termination|11|||
129893136|NCT04170023|467567755|FG002|LTE Period|Study Termination|5|||
129893137|NCT01414166|467567764|FG000|Overall Study|Adverse Event|10|||
129893138|NCT01414166|467567765|FG001|Overall Study|Adverse Event|2|||
129893139|NCT01414166|467567764|FG000|Overall Study|Lost to Follow-up|4|||
129893140|NCT01414166|467567765|FG001|Overall Study|Lost to Follow-up|1|||
129893141|NCT01414166|467567764|FG000|Overall Study|Non-compliance with study drug|2|||
129893142|NCT01414166|467567765|FG001|Overall Study|Non-compliance with study drug|0|||
129893143|NCT01414166|467567764|FG000|Overall Study|Physician Decision|2|||
129893144|NCT01414166|467567765|FG001|Overall Study|Physician Decision|0|||
129893145|NCT01414166|467567764|FG000|Overall Study|Protocol Violation|2|||
129893146|NCT01414166|467567765|FG001|Overall Study|Protocol Violation|0|||
129893147|NCT01414166|467567764|FG000|Overall Study|Study terminated by Sponsor|68|||
129893148|NCT01414166|467567765|FG001|Overall Study|Study terminated by Sponsor|75|||
129893149|NCT01414166|467567764|FG000|Overall Study|Withdrawal by Subject|3|||
129893150|NCT01414166|467567765|FG001|Overall Study|Withdrawal by Subject|5|||
129893151|NCT03782727|467567766|FG000|Overall Study|Lost to Follow-up|32|||
129893152|NCT01823341|467567769|FG000|Overall Study|Failed run-in|7|||
129893153|NCT01823341|467567769|FG000|Overall Study|Withdrawal by Subject|7|||
129893154|NCT01823341|467567769|FG000|Overall Study|Adverse Event|1|||
129893155|NCT00924560|467567770|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
129893156|NCT00924560|467567771|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
129893157|NCT00924560|467567772|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
129893158|NCT00924560|467567770|FG000|Overall Study|Non Compliance with the Protocol|20|||
129893159|NCT00924560|467567771|FG001|Overall Study|Non Compliance with the Protocol|15|||
129893160|NCT00924560|467567772|FG002|Overall Study|Non Compliance with the Protocol|4|||
129893161|NCT00924560|467567770|FG000|Overall Study|Physician Decision|2|||
129893162|NCT00924560|467567771|FG001|Overall Study|Physician Decision|3|||
129893163|NCT00924560|467567772|FG002|Overall Study|Physician Decision|4|||
129893164|NCT00924560|467567770|FG000|Overall Study|Withdrawal by Subject|50|||
129893165|NCT00924560|467567771|FG001|Overall Study|Withdrawal by Subject|44|||
129893166|NCT00924560|467567772|FG002|Overall Study|Withdrawal by Subject|18|||
129893167|NCT00924560|467567770|FG000|Overall Study|Adverse Event|39|||
129893168|NCT00924560|467567771|FG001|Overall Study|Adverse Event|33|||
129893169|NCT00924560|467567772|FG002|Overall Study|Adverse Event|0|||
129893170|NCT00924560|467567770|FG000|Overall Study|Pregnancy|5|||
129893171|NCT00924560|467567771|FG001|Overall Study|Pregnancy|7|||
129893172|NCT00924560|467567772|FG002|Overall Study|Pregnancy|1|||
129893173|NCT00924560|467567770|FG000|Overall Study|Lost to Follow-up|78|||
129893174|NCT00924560|467567771|FG001|Overall Study|Lost to Follow-up|94|||
129893175|NCT00924560|467567772|FG002|Overall Study|Lost to Follow-up|45|||
129893176|NCT00924560|467567770|FG000|Overall Study|Miscellaneous Reasons|13|||
129893177|NCT00924560|467567771|FG001|Overall Study|Miscellaneous Reasons|10|||
129893178|NCT00924560|467567772|FG002|Overall Study|Miscellaneous Reasons|10|||
129893179|NCT02696226|467567774|FG000|Overall Study|Study terminated - lack of enrollment|1|||
129893180|NCT02696226|467567775|FG001|Overall Study|Study terminated - lack of enrollment|0|||
129893181|NCT02696226|467567776|FG002|Overall Study|Study terminated - lack of enrollment|2|||
129444739|NCT01641809|465929437|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
129444740|NCT01641809|465929438|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
129893182|NCT02696226|467567777|FG003|Overall Study|Study terminated - lack of enrollment|0|||
129444741|NCT01641809|465929435|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
129444742|NCT01641809|465929436|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
129736692|NCT01439074|466995149|FG001|Overall Study|Other|4|||
129893183|NCT02909101|467567785|FG000|Overall Study|Lost to Follow-up|1|||
129893184|NCT02909101|467567786|FG001|Overall Study|Lost to Follow-up|1|||
129893185|NCT03073005|467567787|FG000|Overall Study|Death|6|||
129893186|NCT03073005|467567788|FG001|Overall Study|Death|0|||
129893187|NCT03073005|467567789|FG002|Overall Study|Death|7|||
129893188|NCT03073005|467567790|FG003|Overall Study|Death|0|||
129893189|NCT03073005|467567787|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
129805223|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
129805224|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
129805225|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
129805226|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
129805227|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
129805228|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
129805229|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
129805230|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
129736693|NCT02639338|466995150|FG000|Overall Study|Lost to Follow-up|2|||
129736694|NCT02639338|466995151|FG001|Overall Study|Lost to Follow-up|2|||
129736695|NCT02639338|466995150|FG000|Overall Study|Withdrew Consent|1|||
129736696|NCT02639338|466995151|FG001|Overall Study|Withdrew Consent|2|||
129736697|NCT02639338|466995150|FG000|Overall Study|Death|1|||
129736698|NCT02639338|466995151|FG001|Overall Study|Death|0|||
129736699|NCT02639338|466995150|FG000|Overall Study|Randomized but Not Treated|0|||
129736700|NCT02639338|466995151|FG001|Overall Study|Randomized but Not Treated|1|||
129736701|NCT00787202|466995152|FG000|Overall Study|Adverse Event|3|||
129736702|NCT00787202|466995153|FG001|Overall Study|Adverse Event|2|||
129736703|NCT00787202|466995154|FG002|Overall Study|Adverse Event|0|||
129736704|NCT00787202|466995155|FG003|Overall Study|Adverse Event|0|||
129736705|NCT00787202|466995156|FG004|Overall Study|Adverse Event|2|||
129736706|NCT00787202|466995152|FG000|Overall Study|Lack of Efficacy|5|||
129736707|NCT00787202|466995153|FG001|Overall Study|Lack of Efficacy|6|||
129736708|NCT00787202|466995154|FG002|Overall Study|Lack of Efficacy|5|||
129736709|NCT00787202|466995155|FG003|Overall Study|Lack of Efficacy|2|||
129736710|NCT00787202|466995156|FG004|Overall Study|Lack of Efficacy|1|||
129736711|NCT00787202|466995152|FG000|Overall Study|Lost to Follow-up|1|||
129736712|NCT00787202|466995153|FG001|Overall Study|Lost to Follow-up|0|||
129736713|NCT00787202|466995154|FG002|Overall Study|Lost to Follow-up|0|||
129736714|NCT00787202|466995155|FG003|Overall Study|Lost to Follow-up|0|||
129736715|NCT00787202|466995156|FG004|Overall Study|Lost to Follow-up|0|||
129736716|NCT00787202|466995152|FG000|Overall Study|Withdrawal by Subject|2|||
129736717|NCT00787202|466995153|FG001|Overall Study|Withdrawal by Subject|2|||
129736718|NCT00787202|466995154|FG002|Overall Study|Withdrawal by Subject|2|||
129736719|NCT00787202|466995155|FG003|Overall Study|Withdrawal by Subject|0|||
129736720|NCT00787202|466995156|FG004|Overall Study|Withdrawal by Subject|0|||
129736721|NCT00787202|466995152|FG000|Overall Study|Protocol Violation|2|||
129736722|NCT00787202|466995153|FG001|Overall Study|Protocol Violation|1|||
129736723|NCT00787202|466995154|FG002|Overall Study|Protocol Violation|0|||
129736724|NCT00787202|466995155|FG003|Overall Study|Protocol Violation|0|||
129736725|NCT00787202|466995156|FG004|Overall Study|Protocol Violation|1|||
129736726|NCT00787202|466995152|FG000|Overall Study|Randomized, not treated|1|||
129736727|NCT00787202|466995153|FG001|Overall Study|Randomized, not treated|0|||
129736728|NCT00787202|466995154|FG002|Overall Study|Randomized, not treated|0|||
129736729|NCT00787202|466995155|FG003|Overall Study|Randomized, not treated|0|||
129736730|NCT00787202|466995156|FG004|Overall Study|Randomized, not treated|0|||
129736731|NCT02525094|466995163|FG000|Overall Study|Lost to Follow-up|2|||
129736732|NCT02525094|466995164|FG001|Overall Study|Lost to Follow-up|1|||
129736733|NCT02525094|466995163|FG000|Overall Study|Withdrawal by Subject|5|||
129736734|NCT02525094|466995164|FG001|Overall Study|Withdrawal by Subject|6|||
129736735|NCT02525094|466995163|FG000|Overall Study|Not Treated|1|||
129805231|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
129805232|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
129736736|NCT02525094|466995164|FG001|Overall Study|Not Treated|1|||
129736737|NCT01751776|466995169|FG000|Overall Study|Adverse Event|0|||
129736738|NCT01751776|466995170|FG001|Overall Study|Adverse Event|0|||
129736739|NCT01751776|466995171|FG002|Overall Study|Adverse Event|0|||
129736740|NCT01751776|466995172|FG003|Overall Study|Adverse Event|0|||
129736741|NCT01751776|466995173|FG004|Overall Study|Adverse Event|0|||
129736742|NCT01751776|466995174|FG005|Overall Study|Adverse Event|0|||
129736743|NCT01751776|466995175|FG006|Overall Study|Adverse Event|4|||
129736744|NCT01751776|466995176|FG007|Overall Study|Adverse Event|2|||
129736745|NCT01751776|466995169|FG000|Overall Study|Consent withdrawn|0|||
129736746|NCT01751776|466995170|FG001|Overall Study|Consent withdrawn|0|||
129736747|NCT01751776|466995171|FG002|Overall Study|Consent withdrawn|0|||
129736748|NCT01751776|466995172|FG003|Overall Study|Consent withdrawn|0|||
129736749|NCT01751776|466995173|FG004|Overall Study|Consent withdrawn|0|||
129736750|NCT01751776|466995174|FG005|Overall Study|Consent withdrawn|0|||
129736751|NCT01751776|466995175|FG006|Overall Study|Consent withdrawn|0|||
129736752|NCT01751776|466995176|FG007|Overall Study|Consent withdrawn|1|||
129736753|NCT01751776|466995169|FG000|Overall Study|Other reason not specified above|0|||
129736754|NCT01751776|466995170|FG001|Overall Study|Other reason not specified above|0|||
129736755|NCT01751776|466995171|FG002|Overall Study|Other reason not specified above|0|||
129736756|NCT01751776|466995172|FG003|Overall Study|Other reason not specified above|0|||
129736757|NCT01751776|466995173|FG004|Overall Study|Other reason not specified above|0|||
129736758|NCT01751776|466995174|FG005|Overall Study|Other reason not specified above|0|||
129736759|NCT01751776|466995175|FG006|Overall Study|Other reason not specified above|0|||
129736760|NCT01751776|466995176|FG007|Overall Study|Other reason not specified above|1|||
129736761|NCT00831701|466995179|FG000|Overall Study|Withdrawal by Subject|2|||
129736762|NCT00831701|466995180|FG001|Overall Study|Withdrawal by Subject|0|||
129736763|NCT00831701|466995179|FG000|Overall Study|Stone expulsion before first medication|2|||
129736764|NCT00831701|466995180|FG001|Overall Study|Stone expulsion before first medication|2|||
129736765|NCT00831701|466995179|FG000|Overall Study|Lost to Follow-up|1|||
129736766|NCT00831701|466995180|FG001|Overall Study|Lost to Follow-up|3|||
129736767|NCT02290938|466995181|FG000|Overall Study|Lost to Follow-up|14|||
129736768|NCT02290938|466995182|FG001|Overall Study|Lost to Follow-up|43|||
129736769|NCT03159104|466995183|FG000|Overall Study|Violation of inclusion criteria|1|||
129736770|NCT03159104|466995184|FG001|Overall Study|Violation of inclusion criteria|2|||
129736771|NCT00456599|466995185|FG000|Overall Study|Non-compliance|1|||
129736772|NCT00456599|466995185|FG000|Overall Study|Withdrawal by Subject|2|||
129736773|NCT00151372|466996663|FG000|Overall Study|Death|12|||
129736774|NCT00151372|466996664|FG001|Overall Study|Death|11|||
129736775|NCT00151372|466996663|FG000|Overall Study|Lost to Follow-up|5|||
129736776|NCT00151372|466996664|FG001|Overall Study|Lost to Follow-up|5|||
129736777|NCT00151372|466996663|FG000|Overall Study|Too sick medically to continue|5|||
129736778|NCT00151372|466996664|FG001|Overall Study|Too sick medically to continue|6|||
129736779|NCT00151372|466996663|FG000|Overall Study|Withdrawal by Subject|7|||
129736780|NCT00151372|466996664|FG001|Overall Study|Withdrawal by Subject|7|||
129736781|NCT04271475|466996670|FG000|DB Period: Day 1 up to EODBT|Death|1|||
129736782|NCT04271475|466996671|FG001|DB Period: Day 1 up to EODBT|Death|0|||
129736783|NCT04271475|466996672|FG002|DB Period: Day 1 up to EODBT|Death|0|||
129736784|NCT04271475|466996673|FG003|DB Period: Day 1 up to EODBT|Death|0|||
129736785|NCT04271475|466996670|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
129736786|NCT04271475|466996671|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
129736787|NCT04271475|466996672|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
129736788|NCT04271475|466996673|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
129736789|NCT04271475|466996670|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
129736790|NCT04271475|466996671|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
129736791|NCT04271475|466996672|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
129736792|NCT04271475|466996673|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
129736793|NCT04271475|466996670|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
129736794|NCT04271475|466996671|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
129736795|NCT04271475|466996672|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
129736796|NCT04271475|466996673|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
129736797|NCT04271475|466996670|FG000|DB Period: Day 1 up to EODBT|Other|8|||
129736798|NCT04271475|466996671|FG001|DB Period: Day 1 up to EODBT|Other|5|||
129736799|NCT04271475|466996672|FG002|DB Period: Day 1 up to EODBT|Other|0|||
129736800|NCT04271475|466996673|FG003|DB Period: Day 1 up to EODBT|Other|0|||
129736801|NCT04271475|466996670|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
129736802|NCT04271475|466996671|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
129736803|NCT04271475|466996672|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
129736804|NCT04271475|466996673|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
129736805|NCT04271475|466996670|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
129736806|NCT04271475|466996671|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
129736807|NCT04271475|466996672|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
129736808|NCT04271475|466996673|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
129736809|NCT00159913|466996675|FG000|Overall Study|Adverse Event|1|||
129736810|NCT00159913|466996676|FG001|Overall Study|Adverse Event|0|||
129736811|NCT00159913|466996677|FG002|Overall Study|Adverse Event|1|||
129736812|NCT00159913|466996678|FG003|Overall Study|Adverse Event|0|||
129736813|NCT00159913|466996675|FG000|Overall Study|Withdrawal by Subject|0|||
129736814|NCT00159913|466996676|FG001|Overall Study|Withdrawal by Subject|0|||
129736815|NCT00159913|466996677|FG002|Overall Study|Withdrawal by Subject|0|||
129736816|NCT00159913|466996678|FG003|Overall Study|Withdrawal by Subject|1|||
129736817|NCT00159913|466996675|FG000|Overall Study|Lost to Follow-up|0|||
129736818|NCT00159913|466996676|FG001|Overall Study|Lost to Follow-up|0|||
129736819|NCT00159913|466996677|FG002|Overall Study|Lost to Follow-up|0|||
129736820|NCT00159913|466996678|FG003|Overall Study|Lost to Follow-up|1|||
129736821|NCT00159913|466996675|FG000|Overall Study|Protocol Violation|1|||
129736822|NCT00159913|466996676|FG001|Overall Study|Protocol Violation|0|||
129736823|NCT00159913|466996677|FG002|Overall Study|Protocol Violation|1|||
129736824|NCT00159913|466996678|FG003|Overall Study|Protocol Violation|0|||
129736825|NCT01318070|466996683|FG000|Overall Study|Adverse Event|1|||
129736826|NCT01318070|466996684|FG001|Overall Study|Adverse Event|1|||
129736827|NCT01318070|466996685|FG002|Overall Study|Adverse Event|5|||
129736828|NCT01318070|466996683|FG000|Overall Study|Withdrawal by Subject|0|||
129736829|NCT01318070|466996684|FG001|Overall Study|Withdrawal by Subject|1|||
129736830|NCT01318070|466996685|FG002|Overall Study|Withdrawal by Subject|1|||
129736831|NCT01318070|466996683|FG000|Overall Study|Lack of Efficacy|0|||
129736832|NCT01318070|466996684|FG001|Overall Study|Lack of Efficacy|0|||
129736833|NCT01318070|466996685|FG002|Overall Study|Lack of Efficacy|1|||
129736834|NCT01318070|466996683|FG000|Overall Study|Principal Investigator Discretion|1|||
129736835|NCT01318070|466996684|FG001|Overall Study|Principal Investigator Discretion|0|||
129736836|NCT01318070|466996685|FG002|Overall Study|Principal Investigator Discretion|0|||
129736837|NCT02956850|466996686|FG000|Overall Study|Withdrawal by Subject|0|||
129736838|NCT02956850|466996687|FG001|Overall Study|Withdrawal by Subject|0|||
129736839|NCT02956850|466996688|FG002|Overall Study|Withdrawal by Subject|0|||
129736840|NCT02956850|466996689|FG003|Overall Study|Withdrawal by Subject|0|||
129736841|NCT02956850|466996690|FG004|Overall Study|Withdrawal by Subject|0|||
129736842|NCT02956850|466996691|FG005|Overall Study|Withdrawal by Subject|0|||
129736843|NCT02956850|466996692|FG006|Overall Study|Withdrawal by Subject|0|||
129736844|NCT02956850|466996693|FG007|Overall Study|Withdrawal by Subject|0|||
129736845|NCT02956850|466996694|FG008|Overall Study|Withdrawal by Subject|0|||
129736846|NCT02956850|466996695|FG009|Overall Study|Withdrawal by Subject|0|||
129736847|NCT02956850|466996696|FG010|Overall Study|Withdrawal by Subject|0|||
129736848|NCT02956850|466996697|FG011|Overall Study|Withdrawal by Subject|0|||
129736849|NCT02956850|466996698|FG012|Overall Study|Withdrawal by Subject|0|||
129736850|NCT02956850|466996699|FG013|Overall Study|Withdrawal by Subject|0|||
129736851|NCT02956850|466996700|FG014|Overall Study|Withdrawal by Subject|0|||
129736852|NCT02956850|466996701|FG015|Overall Study|Withdrawal by Subject|0|||
129736853|NCT02956850|466996702|FG016|Overall Study|Withdrawal by Subject|0|||
129736854|NCT02956850|466996703|FG017|Overall Study|Withdrawal by Subject|1|||
129736855|NCT01287195|466996708|FG000|Overall Study|Withdrawal by Subject|2|||
129736856|NCT00870194|466996712|FG000|Overall Study|Adverse Event|10|||
129736857|NCT00870194|466996713|FG001|Overall Study|Adverse Event|5|||
129736858|NCT00870194|466996712|FG000|Overall Study|Lack of Efficacy|0|||
129736859|NCT00870194|466996713|FG001|Overall Study|Lack of Efficacy|1|||
129736860|NCT00870194|466996712|FG000|Overall Study|Lost to Follow-up|2|||
129736861|NCT00870194|466996713|FG001|Overall Study|Lost to Follow-up|0|||
129736862|NCT00870194|466996712|FG000|Overall Study|Physician Decision|3|||
129736863|NCT00870194|466996713|FG001|Overall Study|Physician Decision|1|||
129736864|NCT00870194|466996712|FG000|Overall Study|Protocol Violation|3|||
129736865|NCT00870194|466996713|FG001|Overall Study|Protocol Violation|3|||
129736866|NCT00870194|466996712|FG000|Overall Study|Entry Criteria Not Met|1|||
129736867|NCT00870194|466996713|FG001|Overall Study|Entry Criteria Not Met|2|||
129736868|NCT00870194|466996712|FG000|Overall Study|Subject Decision|7|||
129736869|NCT00870194|466996713|FG001|Overall Study|Subject Decision|2|||
129736870|NCT02322190|466996714|FG000|Overall Study|Death on study|1|||
129736871|NCT02322190|466996715|FG001|Overall Study|Death on study|0|||
129805233|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
129736872|NCT01685983|466996719|FG000|Overall Study|Adverse Event|7|||
129736873|NCT01685983|466996719|FG000|Overall Study|Death|1|||
129805234|NCT00313300|467254954|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
129805235|NCT00313300|467254955|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805236|NCT00313300|467254956|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805237|NCT00313300|467254957|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805238|NCT00313300|467254958|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
129805239|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
129805240|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
129805241|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
129805242|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
129805243|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
129893190|NCT03073005|467567788|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
129893191|NCT03073005|467567789|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
129893192|NCT03073005|467567790|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
129893193|NCT03073005|467567787|FG000|Overall Study|Lost to Follow-up|2|||
129893194|NCT03073005|467567788|FG001|Overall Study|Lost to Follow-up|2|||
129893195|NCT03073005|467567789|FG002|Overall Study|Lost to Follow-up|1|||
129893196|NCT03073005|467567790|FG003|Overall Study|Lost to Follow-up|2|||
129736874|NCT01685983|466996719|FG000|Overall Study|Withdrawal by Subject|19|||
129736875|NCT01685983|466996719|FG000|Overall Study|Protocol Violation|2|||
129736876|NCT01685983|466996719|FG000|Overall Study|Physician Decision|13|||
129736877|NCT01685983|466996719|FG000|Overall Study|Other|7|||
129736878|NCT01685983|466996719|FG000|Overall Study|Progressive Disease|32|||
129736879|NCT01685983|466996719|FG000|Overall Study|Noncompliance with Study Drug|1|||
129736880|NCT01443130|466996720|FG000|Overall Study|Lost to Follow-up|44|||
129736881|NCT01443130|466996721|FG001|Overall Study|Lost to Follow-up|42|||
129736882|NCT01443130|466996722|FG002|Overall Study|Lost to Follow-up|50|||
129736883|NCT01443130|466996723|FG003|Overall Study|Lost to Follow-up|23|||
129736884|NCT01443130|466996724|FG004|Overall Study|Lost to Follow-up|25|||
129736885|NCT01443130|466996725|FG005|Overall Study|Lost to Follow-up|21|||
129736886|NCT01443130|466996720|FG000|Overall Study|Death|0|||
129736887|NCT01443130|466996721|FG001|Overall Study|Death|1|||
129736888|NCT01443130|466996722|FG002|Overall Study|Death|0|||
129736889|NCT01443130|466996723|FG003|Overall Study|Death|7|||
129736890|NCT01443130|466996724|FG004|Overall Study|Death|10|||
129736891|NCT01443130|466996725|FG005|Overall Study|Death|8|||
129736892|NCT01443130|466996720|FG000|Overall Study|Adverse Event|2|||
129736893|NCT01443130|466996721|FG001|Overall Study|Adverse Event|1|||
129736894|NCT01443130|466996722|FG002|Overall Study|Adverse Event|1|||
129736895|NCT01443130|466996723|FG003|Overall Study|Adverse Event|0|||
129736896|NCT01443130|466996724|FG004|Overall Study|Adverse Event|0|||
129736897|NCT01443130|466996725|FG005|Overall Study|Adverse Event|0|||
129736898|NCT01443130|466996720|FG000|Overall Study|Protocol Violation|2|||
129736899|NCT01443130|466996721|FG001|Overall Study|Protocol Violation|1|||
129736900|NCT01443130|466996722|FG002|Overall Study|Protocol Violation|3|||
129736901|NCT01443130|466996723|FG003|Overall Study|Protocol Violation|2|||
129736902|NCT01443130|466996724|FG004|Overall Study|Protocol Violation|2|||
129736903|NCT01443130|466996725|FG005|Overall Study|Protocol Violation|3|||
129736904|NCT01443130|466996720|FG000|Overall Study|Withdrawal by Subject|15|||
129736905|NCT01443130|466996721|FG001|Overall Study|Withdrawal by Subject|14|||
129736906|NCT01443130|466996722|FG002|Overall Study|Withdrawal by Subject|12|||
129736907|NCT01443130|466996723|FG003|Overall Study|Withdrawal by Subject|7|||
129736908|NCT01443130|466996724|FG004|Overall Study|Withdrawal by Subject|7|||
129736909|NCT01443130|466996725|FG005|Overall Study|Withdrawal by Subject|2|||
129736910|NCT01443130|466996720|FG000|Overall Study|Death of Subject's Infant|5|||
129736911|NCT01443130|466996721|FG001|Overall Study|Death of Subject's Infant|10|||
129736912|NCT01443130|466996722|FG002|Overall Study|Death of Subject's Infant|11|||
129736913|NCT01443130|466996723|FG003|Overall Study|Death of Subject's Infant|0|||
129736914|NCT01443130|466996724|FG004|Overall Study|Death of Subject's Infant|0|||
129736915|NCT01443130|466996725|FG005|Overall Study|Death of Subject's Infant|0|||
129736916|NCT01167907|466996727|FG000|Overall Study|Protocol Violation|1|||
129736917|NCT01167907|466996728|FG001|Overall Study|Protocol Violation|0|||
129736918|NCT01167907|466996727|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
129736919|NCT01167907|466996728|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
129736920|NCT03461406|466996729|FG000|Overall Study|Death|1|||
129736921|NCT03461406|466996730|FG001|Overall Study|Death|2|||
129736922|NCT03461406|466996729|FG000|Overall Study|Consent Withdrawn by Participant|0|||
129736923|NCT03461406|466996730|FG001|Overall Study|Consent Withdrawn by Participant|1|||
129736924|NCT03461406|466996729|FG000|Overall Study|Screen Failure|3|||
129736925|NCT03461406|466996730|FG001|Overall Study|Screen Failure|1|||
129736926|NCT03461406|466996729|FG000|Overall Study|Reason not Specified|1|||
129736927|NCT03461406|466996730|FG001|Overall Study|Reason not Specified|3|||
129736928|NCT03461406|466996729|FG000|Overall Study|Lost to Follow-up|3|||
129736929|NCT03461406|466996730|FG001|Overall Study|Lost to Follow-up|0|||
129736930|NCT03077698|466996731|FG000|Progestin Monotherapy|Stable Disease|8|||
129736931|NCT03077698|466996732|FG001|Progestin Monotherapy|Stable Disease|0|||
129736932|NCT03077698|466996731|FG000|Progestin Monotherapy|Adverse Event|1|||
129736933|NCT03077698|466996732|FG001|Progestin Monotherapy|Adverse Event|0|||
129736934|NCT03077698|466996731|FG000|Progestin Monotherapy|Death|1|||
129893197|NCT03073005|467567787|FG000|Overall Study|Withdrawal by Subject|0|||
129736935|NCT03077698|466996732|FG001|Progestin Monotherapy|Death|0|||
129736936|NCT03077698|466996731|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
129736937|NCT03077698|466996732|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
129736938|NCT03077698|466996731|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
129736939|NCT03077698|466996732|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
129736940|NCT03077698|466996731|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
129736941|NCT03077698|466996732|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
129736942|NCT03077698|466996731|FG000|Safety Follow Up|Withdrawal by Subject|2|||
129736943|NCT03077698|466996732|FG001|Safety Follow Up|Withdrawal by Subject|1|||
129736944|NCT03077698|466996731|FG000|Safety Follow Up|Transfer of care to hospice|1|||
129736945|NCT03077698|466996732|FG001|Safety Follow Up|Transfer of care to hospice|0|||
129736946|NCT00973102|466996737|FG000|Overall Study|Protocol Violation|1|||
129736947|NCT00973102|466996738|FG001|Overall Study|Protocol Violation|0|||
129736948|NCT00973102|466996737|FG000|Overall Study|Prisoner|0|||
129736949|NCT00973102|466996738|FG001|Overall Study|Prisoner|1|||
129736950|NCT01710527|466996741|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
129736951|NCT01710527|466996742|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
129736952|NCT02635347|466996745|FG000|Overall Study|Failed screening|20|||
129736953|NCT02635347|466996746|FG001|Overall Study|Failed screening|7|||
129736954|NCT02124772|466996748|FG000|Overall Study|Lack of Efficacy|2|||
129736955|NCT02124772|466996749|FG001|Overall Study|Lack of Efficacy|0|||
129736956|NCT02124772|466996750|FG002|Overall Study|Lack of Efficacy|0|||
129736957|NCT02124772|466996751|FG003|Overall Study|Lack of Efficacy|1|||
129736958|NCT02124772|466996752|FG004|Overall Study|Lack of Efficacy|2|||
129736959|NCT02124772|466996753|FG005|Overall Study|Lack of Efficacy|3|||
129736960|NCT02124772|466996754|FG006|Overall Study|Lack of Efficacy|0|||
129736961|NCT02124772|466996755|FG007|Overall Study|Lack of Efficacy|2|||
129736962|NCT02124772|466996756|FG008|Overall Study|Lack of Efficacy|0|||
129736963|NCT02124772|466996757|FG009|Overall Study|Lack of Efficacy|1|||
129736964|NCT02124772|466996758|FG010|Overall Study|Lack of Efficacy|0|||
129736965|NCT02124772|466996759|FG011|Overall Study|Lack of Efficacy|0|||
129736966|NCT02124772|466996760|FG012|Overall Study|Lack of Efficacy|1|||
129736967|NCT02124772|466996748|FG000|Overall Study|Adverse Event|1|||
129736968|NCT02124772|466996749|FG001|Overall Study|Adverse Event|4|||
129736969|NCT02124772|466996750|FG002|Overall Study|Adverse Event|1|||
129736970|NCT02124772|466996751|FG003|Overall Study|Adverse Event|5|||
129736971|NCT02124772|466996752|FG004|Overall Study|Adverse Event|2|||
129736972|NCT02124772|466996753|FG005|Overall Study|Adverse Event|1|||
129736973|NCT02124772|466996754|FG006|Overall Study|Adverse Event|1|||
129736974|NCT02124772|466996755|FG007|Overall Study|Adverse Event|5|||
129736975|NCT02124772|466996756|FG008|Overall Study|Adverse Event|0|||
129736976|NCT02124772|466996757|FG009|Overall Study|Adverse Event|3|||
129736977|NCT02124772|466996758|FG010|Overall Study|Adverse Event|1|||
129736978|NCT02124772|466996759|FG011|Overall Study|Adverse Event|3|||
129736979|NCT02124772|466996760|FG012|Overall Study|Adverse Event|1|||
129736980|NCT02124772|466996748|FG000|Overall Study|Withdrawal consent|0|||
129736981|NCT02124772|466996749|FG001|Overall Study|Withdrawal consent|1|||
129736982|NCT02124772|466996750|FG002|Overall Study|Withdrawal consent|1|||
129736983|NCT02124772|466996751|FG003|Overall Study|Withdrawal consent|1|||
129736984|NCT02124772|466996752|FG004|Overall Study|Withdrawal consent|0|||
129736985|NCT02124772|466996753|FG005|Overall Study|Withdrawal consent|1|||
129736986|NCT02124772|466996754|FG006|Overall Study|Withdrawal consent|1|||
129444743|NCT01641809|465929437|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
129444744|NCT01641809|465929438|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
129444745|NCT01641809|465929435|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
129444746|NCT01641809|465929436|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
129444747|NCT01641809|465929437|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
129444748|NCT01641809|465929438|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
129444749|NCT01641809|465929435|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
129444750|NCT01641809|465929436|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
129444751|NCT01641809|465929437|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
129444752|NCT01641809|465929438|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
129444753|NCT01641809|465929435|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
129444754|NCT01641809|465929436|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
129444755|NCT01641809|465929437|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
129444756|NCT01641809|465929438|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
129444757|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
129736987|NCT02124772|466996755|FG007|Overall Study|Withdrawal consent|0|||
129736988|NCT02124772|466996756|FG008|Overall Study|Withdrawal consent|0|||
129736989|NCT02124772|466996757|FG009|Overall Study|Withdrawal consent|1|||
129736990|NCT02124772|466996758|FG010|Overall Study|Withdrawal consent|0|||
129805244|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
129805245|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
129805246|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
129444758|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
129444759|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
129736991|NCT02124772|466996759|FG011|Overall Study|Withdrawal consent|1|||
129736992|NCT02124772|466996760|FG012|Overall Study|Withdrawal consent|0|||
129736993|NCT02124772|466996748|FG000|Overall Study|Investigator discretion|0|||
129736994|NCT02124772|466996749|FG001|Overall Study|Investigator discretion|2|||
129736995|NCT02124772|466996750|FG002|Overall Study|Investigator discretion|2|||
129736996|NCT02124772|466996751|FG003|Overall Study|Investigator discretion|1|||
129736997|NCT02124772|466996752|FG004|Overall Study|Investigator discretion|1|||
129805247|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
129805248|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
129805249|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
129805250|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
129805251|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
129805252|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
129805253|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
129805254|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
129805255|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805256|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805257|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805258|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
129805259|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
129805260|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
129805261|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
129805262|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
129805263|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
129805264|NCT00313300|467254954|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
129805265|NCT00313300|467254955|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
129805266|NCT00313300|467254956|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
129805267|NCT00313300|467254957|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
129805268|NCT00313300|467254958|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
129805269|NCT02336373|467254959|FG000|Overall Study|Protocol closed early|4|||
129805270|NCT02336373|467254959|FG000|Overall Study|Physician Decision|14|||
129805271|NCT00850343|467254960|FG000|Overall Study|Withdrawal by Subject|11|||
129805272|NCT00850343|467254961|FG001|Overall Study|Withdrawal by Subject|0|||
129805273|NCT00850343|467254962|FG002|Overall Study|Withdrawal by Subject|3|||
129805274|NCT00850343|467254963|FG003|Overall Study|Withdrawal by Subject|2|||
129805275|NCT00850343|467254960|FG000|Overall Study|Adverse Event|15|||
129805276|NCT00850343|467254961|FG001|Overall Study|Adverse Event|2|||
129805277|NCT00850343|467254962|FG002|Overall Study|Adverse Event|6|||
129805278|NCT00850343|467254963|FG003|Overall Study|Adverse Event|6|||
129805279|NCT00850343|467254960|FG000|Overall Study|Pregnancy|0|||
129805280|NCT00850343|467254961|FG001|Overall Study|Pregnancy|0|||
129805281|NCT00850343|467254962|FG002|Overall Study|Pregnancy|0|||
129805282|NCT00850343|467254963|FG003|Overall Study|Pregnancy|1|||
129805283|NCT00850343|467254960|FG000|Overall Study|Lack of Efficacy|17|||
129805284|NCT00850343|467254961|FG001|Overall Study|Lack of Efficacy|0|||
129805285|NCT00850343|467254962|FG002|Overall Study|Lack of Efficacy|3|||
129805286|NCT00850343|467254963|FG003|Overall Study|Lack of Efficacy|2|||
129805287|NCT00850343|467254960|FG000|Overall Study|Non-compliance with Study Procedures|1|||
129805288|NCT00850343|467254961|FG001|Overall Study|Non-compliance with Study Procedures|0|||
129805289|NCT00850343|467254962|FG002|Overall Study|Non-compliance with Study Procedures|1|||
129805290|NCT00850343|467254963|FG003|Overall Study|Non-compliance with Study Procedures|1|||
129805291|NCT00850343|467254960|FG000|Overall Study|Physician Decision|2|||
129805292|NCT00850343|467254961|FG001|Overall Study|Physician Decision|1|||
129805293|NCT00850343|467254962|FG002|Overall Study|Physician Decision|1|||
129805294|NCT00850343|467254963|FG003|Overall Study|Physician Decision|1|||
129805295|NCT02764333|467254966|FG000|Overall Study|Ineligible|1|||
129805296|NCT01788046|467254980|FG000|Overall Study|Withdrawal by Subject|12|||
129805297|NCT01788046|467254981|FG001|Overall Study|Withdrawal by Subject|12|||
129805298|NCT01788046|467254980|FG000|Overall Study|Lost to Follow-up|12|||
129805299|NCT01788046|467254981|FG001|Overall Study|Lost to Follow-up|19|||
129805300|NCT01788046|467254980|FG000|Overall Study|Death|7|||
129805301|NCT01788046|467254981|FG001|Overall Study|Death|5|||
129805302|NCT01788046|467254980|FG000|Overall Study|Protocol Specified Criteria|25|||
129805303|NCT01788046|467254981|FG001|Overall Study|Protocol Specified Criteria|1|||
129805304|NCT01856907|467254984|FG000|Overall Study|Pregnancy|0|||
129805305|NCT01856907|467254985|FG001|Overall Study|Pregnancy|1|||
129805306|NCT01856907|467254986|FG002|Overall Study|Pregnancy|0|||
129805307|NCT01856907|467254984|FG000|Overall Study|Pregnancy|0|||
129805308|NCT01856907|467254985|FG001|Overall Study|Pregnancy|1|||
129805309|NCT01856907|467254986|FG002|Overall Study|Pregnancy|0|||
129805310|NCT01856907|467254984|FG000|Overall Study|Withdrawal by Subject|0|||
129805311|NCT01856907|467254985|FG001|Overall Study|Withdrawal by Subject|1|||
129805312|NCT01856907|467254986|FG002|Overall Study|Withdrawal by Subject|0|||
129893198|NCT03073005|467567788|FG001|Overall Study|Withdrawal by Subject|4|||
129893199|NCT03073005|467567789|FG002|Overall Study|Withdrawal by Subject|4|||
129893200|NCT03073005|467567790|FG003|Overall Study|Withdrawal by Subject|4|||
129893201|NCT01290094|467567791|FG000|Overall Study|Withdrawal by Subject|1|||
129893202|NCT01290094|467567791|FG000|Overall Study|Lost to Follow-up|5|||
129893203|NCT00093795|467569676|FG000|Overall Study|No follow up data|20|||
129893204|NCT00093795|467569677|FG001|Overall Study|No follow up data|16|||
129893205|NCT00093795|467569678|FG002|Overall Study|No follow up data|17|||
129893206|NCT02949271|467569681|FG000|Overall Study|Lack of Efficacy|5|||
129893207|NCT02949271|467569682|FG001|Overall Study|Lack of Efficacy|4|||
129893208|NCT02949271|467569681|FG000|Overall Study|Lost to Follow-up|3|||
129893209|NCT02949271|467569682|FG001|Overall Study|Lost to Follow-up|6|||
129893210|NCT02949271|467569681|FG000|Overall Study|Physician Decision|5|||
129893211|NCT02949271|467569682|FG001|Overall Study|Physician Decision|5|||
129736998|NCT02124772|466996753|FG005|Overall Study|Investigator discretion|0|||
129736999|NCT02124772|466996754|FG006|Overall Study|Investigator discretion|1|||
129737000|NCT02124772|466996755|FG007|Overall Study|Investigator discretion|0|||
129737001|NCT02124772|466996756|FG008|Overall Study|Investigator discretion|0|||
129737002|NCT02124772|466996757|FG009|Overall Study|Investigator discretion|1|||
129737003|NCT02124772|466996758|FG010|Overall Study|Investigator discretion|0|||
129737004|NCT02124772|466996759|FG011|Overall Study|Investigator discretion|1|||
129737005|NCT02124772|466996760|FG012|Overall Study|Investigator discretion|0|||
129737006|NCT02124772|466996748|FG000|Overall Study|Progressive disease|0|||
129737007|NCT02124772|466996749|FG001|Overall Study|Progressive disease|0|||
129737008|NCT02124772|466996750|FG002|Overall Study|Progressive disease|0|||
129737009|NCT02124772|466996751|FG003|Overall Study|Progressive disease|0|||
129737010|NCT02124772|466996752|FG004|Overall Study|Progressive disease|0|||
129893212|NCT02949271|467569681|FG000|Overall Study|Protocol Violation|6|||
129893213|NCT02949271|467569682|FG001|Overall Study|Protocol Violation|3|||
129893214|NCT02949271|467569681|FG000|Overall Study|Withdrawal by Subject|1|||
129893215|NCT02949271|467569682|FG001|Overall Study|Withdrawal by Subject|0|||
129893216|NCT02949271|467569681|FG000|Overall Study|Delivered prior to intervention|7|||
129893217|NCT02949271|467569682|FG001|Overall Study|Delivered prior to intervention|9|||
129893218|NCT02949271|467569681|FG000|Overall Study|Outside the window for cervical dilation|2|||
129893219|NCT02949271|467569682|FG001|Overall Study|Outside the window for cervical dilation|3|||
129893220|NCT05458102|467569683|FG000|Overall Study|Withdrew consent|2|||
129893221|NCT05458102|467569684|FG001|Overall Study|Withdrew consent|0|||
129893222|NCT05458102|467569683|FG000|Overall Study|Adverse Event|1|||
129893223|NCT05458102|467569684|FG001|Overall Study|Adverse Event|0|||
129893224|NCT05458102|467569683|FG000|Overall Study|Enrolled but never treated|1|||
129893225|NCT05458102|467569684|FG001|Overall Study|Enrolled but never treated|0|||
129893226|NCT05458102|467569683|FG000|Overall Study|Protocol Violation|1|||
129893227|NCT05458102|467569684|FG001|Overall Study|Protocol Violation|0|||
129893228|NCT00723294|467569685|FG000|Overall Study|Lobular histology|2|||
129893229|NCT00723294|467569685|FG000|Overall Study|>25% intraductal component|1|||
129893230|NCT00723294|467569685|FG000|Overall Study|No MRI tumor enhancement|1|||
129893231|NCT00723294|467569685|FG000|Overall Study|1.0-Tesla MRI|1|||
129893232|NCT00723294|467569685|FG000|Overall Study|No cryoabalation|2|||
129893233|NCT00723294|467569685|FG000|Overall Study|Did not undergo surgery|1|||
129893234|NCT00723294|467569685|FG000|Overall Study|Treated prior to registration|1|||
129893235|NCT00723294|467569685|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
129893236|NCT00723294|467569685|FG000|Overall Study|Benign lesion|1|||
129893237|NCT00723294|467569685|FG000|Overall Study|Withdrawal by Subject|1|||
129893238|NCT00723294|467569685|FG000|Overall Study|No treatment due to probe failure|1|||
129893239|NCT02703532|467569689|FG000|Overall Study|Withdrawal by Subject|0|||
129893240|NCT02703532|467569690|FG001|Overall Study|Withdrawal by Subject|1|||
129893241|NCT02703532|467569691|FG002|Overall Study|Withdrawal by Subject|0|||
129893242|NCT02703532|467569692|FG003|Overall Study|Withdrawal by Subject|1|||
129893243|NCT02703532|467569689|FG000|Overall Study|Lost to Follow-up|2|||
129893244|NCT02703532|467569690|FG001|Overall Study|Lost to Follow-up|0|||
129893245|NCT02703532|467569691|FG002|Overall Study|Lost to Follow-up|2|||
129893246|NCT02703532|467569692|FG003|Overall Study|Lost to Follow-up|0|||
129893247|NCT02271594|467569695|FG000|Overall Study|Study closed; recruiting failure|19|||
129893248|NCT02271594|467569696|FG001|Overall Study|Study closed; recruiting failure|12|||
129893249|NCT04454567|467569698|FG000|Overall Study|Study Terminated by Sponsor|1|||
129893250|NCT04454567|467569699|FG001|Overall Study|Study Terminated by Sponsor|1|||
129893251|NCT01175707|467569704|FG000|Overall Study|Adverse Event|4|||
129893252|NCT01175707|467569705|FG001|Overall Study|Adverse Event|6|||
129893253|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
129893254|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129893255|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
129893256|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
129893257|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
129893258|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
129893259|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
129893260|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
129893261|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
129893262|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
129893263|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
129893264|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
129893265|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
129893266|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
129893267|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129893268|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129893269|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
129737011|NCT02124772|466996753|FG005|Overall Study|Progressive disease|0|||
129737012|NCT02124772|466996754|FG006|Overall Study|Progressive disease|1|||
129737013|NCT02124772|466996755|FG007|Overall Study|Progressive disease|1|||
129737014|NCT02124772|466996756|FG008|Overall Study|Progressive disease|0|||
129893270|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
129893271|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129737015|NCT02124772|466996757|FG009|Overall Study|Progressive disease|0|||
129737016|NCT02124772|466996758|FG010|Overall Study|Progressive disease|0|||
129737017|NCT02124772|466996759|FG011|Overall Study|Progressive disease|0|||
129737018|NCT02124772|466996760|FG012|Overall Study|Progressive disease|0|||
129737019|NCT02124772|466996748|FG000|Overall Study|Other|0|||
129737020|NCT02124772|466996749|FG001|Overall Study|Other|7|||
129737021|NCT02124772|466996750|FG002|Overall Study|Other|2|||
129737022|NCT02124772|466996751|FG003|Overall Study|Other|5|||
129737023|NCT02124772|466996752|FG004|Overall Study|Other|4|||
129737024|NCT02124772|466996753|FG005|Overall Study|Other|3|||
129737025|NCT02124772|466996754|FG006|Overall Study|Other|4|||
129893272|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893273|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893274|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893275|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
129893276|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129893277|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893278|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893279|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129737026|NCT02124772|466996755|FG007|Overall Study|Other|1|||
129737027|NCT02124772|466996756|FG008|Overall Study|Other|1|||
129737028|NCT02124772|466996757|FG009|Overall Study|Other|1|||
129737029|NCT02124772|466996758|FG010|Overall Study|Other|1|||
129737030|NCT02124772|466996759|FG011|Overall Study|Other|1|||
129737031|NCT02124772|466996760|FG012|Overall Study|Other|0|||
129737032|NCT00780273|466996761|FG000|Overall Study|Death|1|||
129737033|NCT00780273|466996761|FG000|Overall Study|Lost to Follow-up|1|||
129737034|NCT01688921|466996762|FG000|Overall Study|Lost to Follow-up|7|||
129737035|NCT01688921|466996763|FG001|Overall Study|Lost to Follow-up|13|||
129737036|NCT01688921|466996762|FG000|Overall Study|Physician Decision|6|||
129737037|NCT01688921|466996763|FG001|Overall Study|Physician Decision|1|||
129737038|NCT01688921|466996762|FG000|Overall Study|Protocol Violation|0|||
129737039|NCT01688921|466996763|FG001|Overall Study|Protocol Violation|1|||
129737040|NCT01688921|466996762|FG000|Overall Study|informed consent|3|||
129737041|NCT01688921|466996763|FG001|Overall Study|informed consent|0|||
129737042|NCT02358044|466996764|FG000|Overall Study|Adverse Event|0|||
129737043|NCT02358044|466996765|FG001|Overall Study|Adverse Event|1|||
129737044|NCT02358044|466996764|FG000|Overall Study|Lost to Follow-up|2|||
129737045|NCT02358044|466996765|FG001|Overall Study|Lost to Follow-up|1|||
129737046|NCT02358044|466996764|FG000|Overall Study|Physician Decision|0|||
129737047|NCT02358044|466996765|FG001|Overall Study|Physician Decision|1|||
129805313|NCT03626168|467254989|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129805314|NCT03626168|467254990|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129805315|NCT03626168|467254989|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
129805316|NCT03626168|467254990|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
129805317|NCT03626168|467254989|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129805318|NCT03626168|467254990|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
129805319|NCT00850070|467254991|FG000|Overall Study|Lack of Efficacy|1|||
129805320|NCT00850070|467254992|FG001|Overall Study|Lack of Efficacy|1|||
129805321|NCT00850070|467254991|FG000|Overall Study|Adverse Event|2|||
129805322|NCT00850070|467254992|FG001|Overall Study|Adverse Event|0|||
129805323|NCT05047770|467254993|FG000|Overall Study|Withdrawal by Subject|15|||
129805324|NCT05047770|467254994|FG001|Overall Study|Withdrawal by Subject|10|||
129805325|NCT05047770|467254995|FG002|Overall Study|Withdrawal by Subject|6|||
129805326|NCT05047770|467254996|FG003|Overall Study|Withdrawal by Subject|12|||
129805327|NCT05047770|467254993|FG000|Overall Study|Lost to Follow-up|7|||
129805328|NCT05047770|467254994|FG001|Overall Study|Lost to Follow-up|5|||
129805329|NCT05047770|467254995|FG002|Overall Study|Lost to Follow-up|12|||
129805330|NCT05047770|467254996|FG003|Overall Study|Lost to Follow-up|13|||
129805331|NCT05047770|467254993|FG000|Overall Study|Other|1|||
129805332|NCT05047770|467254994|FG001|Overall Study|Other|0|||
129805333|NCT05047770|467254995|FG002|Overall Study|Other|1|||
129805334|NCT05047770|467254996|FG003|Overall Study|Other|0|||
129805335|NCT01268150|467255006|FG000|Treatment Phase|Progression of disease|18|||
129805336|NCT01268150|467255006|FG000|Treatment Phase|Adverse Event|3|||
129805337|NCT01268150|467255006|FG000|Treatment Phase|Withdrawal by Subject|3|||
129805338|NCT01268150|467255006|FG000|Treatment Phase|Other|4|||
129805339|NCT01268150|467255006|FG000|Extension Phase|Adverse Event|3|||
129805340|NCT01268150|467255006|FG000|Extension Phase|Disease progression|18|||
129805341|NCT01268150|467255006|FG000|Extension Phase|Other|6|||
129805342|NCT00395733|467255007|FG000|Period 2|Withdrawal by Subject|1|||
129805343|NCT00395733|467255008|FG001|Period 2|Withdrawal by Subject|2|||
129805344|NCT00395733|467255007|FG000|Period 2|Protocol Violation|0|||
129805345|NCT00395733|467255008|FG001|Period 2|Protocol Violation|1|||
129805346|NCT00395733|467255007|FG000|Period 2|Adverse Event|0|||
129805347|NCT00395733|467255008|FG001|Period 2|Adverse Event|2|||
129805348|NCT00395733|467255007|FG000|Period 2|Technical problems|1|||
129893280|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893281|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129737048|NCT02358044|466996764|FG000|Overall Study|Withdrawal by Subject|0|||
129737049|NCT02358044|466996765|FG001|Overall Study|Withdrawal by Subject|4|||
129737050|NCT01739803|466996768|FG000|Overall Study|Lost to Follow-up|9|||
129737051|NCT01739803|466996769|FG001|Overall Study|Lost to Follow-up|6|||
129805349|NCT00395733|467255008|FG001|Period 2|Technical problems|0|||
129805350|NCT03725852|467255009|FG000|Overall Study|Death|1|||
129805351|NCT03725852|467255010|FG001|Overall Study|Death|0|||
129805352|NCT03725852|467255009|FG000|Overall Study|Withdrawal by Subject|1|||
129805353|NCT03725852|467255010|FG001|Overall Study|Withdrawal by Subject|0|||
129805354|NCT03725852|467255009|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
129805355|NCT03725852|467255010|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
129805356|NCT04738734|467255013|FG000|Overall Study|Withdrawal by Subject|2|||
129805357|NCT04738734|467255014|FG001|Overall Study|Withdrawal by Subject|4|||
129737052|NCT00969436|466996771|FG000|Overall Study|Protocol Violation|1|||
129737053|NCT00969436|466996772|FG001|Overall Study|Protocol Violation|3|||
129805358|NCT04738734|467255013|FG000|Overall Study|Lost to Follow-up|5|||
129737054|NCT00969436|466996773|FG002|Overall Study|Protocol Violation|0|||
129737055|NCT00969436|466996771|FG000|Overall Study|Migrated/moved from study area|12|||
129737056|NCT00969436|466996772|FG001|Overall Study|Migrated/moved from study area|10|||
129737057|NCT00969436|466996773|FG002|Overall Study|Migrated/moved from study area|2|||
129737058|NCT00969436|466996771|FG000|Overall Study|Father - serious health problem|0|||
129737059|NCT00969436|466996772|FG001|Overall Study|Father - serious health problem|0|||
129737060|NCT00969436|466996773|FG002|Overall Study|Father - serious health problem|1|||
129737061|NCT00969436|466996771|FG000|Overall Study|Parents personal problem|0|||
129737062|NCT00969436|466996772|FG001|Overall Study|Parents personal problem|0|||
129737063|NCT00969436|466996773|FG002|Overall Study|Parents personal problem|1|||
129737064|NCT00969436|466996771|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
129737065|NCT00969436|466996772|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
129737066|NCT00969436|466996773|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
129737067|NCT00969436|466996771|FG000|Overall Study|Withdrawal by Subject|3|||
129737068|NCT00969436|466996772|FG001|Overall Study|Withdrawal by Subject|0|||
129737069|NCT00969436|466996773|FG002|Overall Study|Withdrawal by Subject|2|||
129737070|NCT00969436|466996771|FG000|Overall Study|Lost to Follow-up|8|||
129737071|NCT00969436|466996772|FG001|Overall Study|Lost to Follow-up|8|||
129737072|NCT00969436|466996773|FG002|Overall Study|Lost to Follow-up|5|||
129737073|NCT03474081|466996780|FG000|Overall Study|Adverse Event|6|||
129737074|NCT03474081|466996781|FG001|Overall Study|Adverse Event|3|||
129737075|NCT03474081|466996780|FG000|Overall Study|Lost to Follow-up|2|||
129737076|NCT03474081|466996781|FG001|Overall Study|Lost to Follow-up|1|||
129737077|NCT03474081|466996780|FG000|Overall Study|Physician Decision|3|||
129737078|NCT03474081|466996781|FG001|Overall Study|Physician Decision|2|||
129737079|NCT03474081|466996780|FG000|Overall Study|Withdrawal by Subject|5|||
129737080|NCT03474081|466996781|FG001|Overall Study|Withdrawal by Subject|7|||
129737081|NCT03474081|466996780|FG000|Overall Study|Investigator site closed|1|||
129737082|NCT03474081|466996781|FG001|Overall Study|Investigator site closed|0|||
129737083|NCT02210091|466996782|FG000|Overall Study|Physician Decision|0|||
129737084|NCT02210091|466996783|FG001|Overall Study|Physician Decision|1|||
129737085|NCT02210091|466996782|FG000|Overall Study|Withdrawal by Sponsor|0|||
129737086|NCT02210091|466996783|FG001|Overall Study|Withdrawal by Sponsor|1|||
129737087|NCT01831817|466996784|FG000|Overall Study|Lost to Follow-up|1|||
129737088|NCT01831817|466996785|FG001|Overall Study|Lost to Follow-up|0|||
129737089|NCT01831817|466996786|FG002|Overall Study|Lost to Follow-up|0|||
129737090|NCT01831817|466996787|FG003|Overall Study|Lost to Follow-up|0|||
129737091|NCT01831817|466996784|FG000|Overall Study|Withdrawl of Consent|3|||
129737092|NCT01831817|466996785|FG001|Overall Study|Withdrawl of Consent|0|||
129737093|NCT01831817|466996786|FG002|Overall Study|Withdrawl of Consent|0|||
129737094|NCT01831817|466996787|FG003|Overall Study|Withdrawl of Consent|0|||
129737095|NCT02198235|466996789|FG000|Overall Study|Lost to Follow-up|3|||
129737096|NCT02198235|466996790|FG001|Overall Study|Lost to Follow-up|2|||
129737097|NCT02198235|466996791|FG002|Overall Study|Lost to Follow-up|2|||
129737098|NCT04573881|466996794|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
129737099|NCT00541346|466998470|FG000|Follow-up|Adverse Event|1|||
129737100|NCT04732949|466998471|FG000|Overall Study|Withdrawal by Subject|23|||
129737101|NCT04732949|466998472|FG001|Overall Study|Withdrawal by Subject|27|||
129737102|NCT04732949|466998471|FG000|Overall Study|Protocol Violation|0|||
129737103|NCT04732949|466998472|FG001|Overall Study|Protocol Violation|1|||
129737104|NCT04732949|466998471|FG000|Overall Study|Non-compliance|0|||
129737105|NCT04732949|466998472|FG001|Overall Study|Non-compliance|2|||
129737106|NCT04732949|466998471|FG000|Overall Study|Physician Decision|2|||
129737107|NCT04732949|466998472|FG001|Overall Study|Physician Decision|1|||
129737108|NCT04732949|466998471|FG000|Overall Study|Serious adverse event (Fatal)|16|||
129737109|NCT04732949|466998472|FG001|Overall Study|Serious adverse event (Fatal)|18|||
129737110|NCT04732949|466998471|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
129737111|NCT04732949|466998472|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
129737112|NCT04732949|466998471|FG000|Overall Study|Non-serious adverse event|1|||
129737113|NCT04732949|466998472|FG001|Overall Study|Non-serious adverse event|3|||
129737114|NCT04732949|466998471|FG000|Overall Study|Lost to Follow-up|26|||
129737115|NCT04732949|466998472|FG001|Overall Study|Lost to Follow-up|27|||
129737116|NCT04732949|466998471|FG000|Overall Study|Other|6|||
129737117|NCT04732949|466998472|FG001|Overall Study|Other|3|||
129737118|NCT02853435|466998473|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129737119|NCT02853435|466998474|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129737120|NCT02853435|466998475|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129737121|NCT02853435|466998476|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129893282|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129893283|NCT01323660|467569707|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
129893284|NCT01323660|467569708|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129893285|NCT01323660|467569709|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129893286|NCT01323660|467569710|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129893287|NCT01323660|467569711|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
129893288|NCT01323660|467569712|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129737122|NCT02853435|466998477|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
129737123|NCT02853435|466998478|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
129737124|NCT03747120|466998479|FG000|Overall Study|treatment related toxicity|3|||
129737125|NCT03747120|466998480|FG001|Overall Study|treatment related toxicity|0|||
129737126|NCT03747120|466998481|FG002|Overall Study|treatment related toxicity|0|||
129737127|NCT03747120|466998479|FG000|Overall Study|Withdrawal by Subject|0|||
129737128|NCT03747120|466998480|FG001|Overall Study|Withdrawal by Subject|1|||
129737129|NCT03747120|466998481|FG002|Overall Study|Withdrawal by Subject|2|||
129737130|NCT00996801|466998482|FG000|Overall Study|Adverse Event|6|||
129737131|NCT00996801|466998483|FG001|Overall Study|Adverse Event|4|||
129737132|NCT00996801|466998484|FG002|Overall Study|Adverse Event|12|||
129737133|NCT00996801|466998485|FG003|Overall Study|Adverse Event|17|||
129737134|NCT00996801|466998486|FG004|Overall Study|Adverse Event|31|||
129737135|NCT00996801|466998487|FG005|Overall Study|Adverse Event|3|||
129737136|NCT00996801|466998482|FG000|Overall Study|Lack of Efficacy|3|||
129737137|NCT00996801|466998483|FG001|Overall Study|Lack of Efficacy|0|||
129737138|NCT00996801|466998484|FG002|Overall Study|Lack of Efficacy|1|||
129737139|NCT00996801|466998485|FG003|Overall Study|Lack of Efficacy|3|||
129737140|NCT00996801|466998486|FG004|Overall Study|Lack of Efficacy|0|||
129737141|NCT00996801|466998487|FG005|Overall Study|Lack of Efficacy|1|||
129737142|NCT00996801|466998482|FG000|Overall Study|Lost to Follow-up|0|||
129737143|NCT00996801|466998483|FG001|Overall Study|Lost to Follow-up|0|||
129737144|NCT00996801|466998484|FG002|Overall Study|Lost to Follow-up|0|||
129737145|NCT00996801|466998485|FG003|Overall Study|Lost to Follow-up|3|||
129737146|NCT00996801|466998486|FG004|Overall Study|Lost to Follow-up|3|||
129737147|NCT00996801|466998487|FG005|Overall Study|Lost to Follow-up|2|||
129737148|NCT00996801|466998482|FG000|Overall Study|Physician Decision|0|||
129737149|NCT00996801|466998483|FG001|Overall Study|Physician Decision|0|||
129737150|NCT00996801|466998484|FG002|Overall Study|Physician Decision|0|||
129737151|NCT00996801|466998485|FG003|Overall Study|Physician Decision|1|||
129737152|NCT00996801|466998486|FG004|Overall Study|Physician Decision|0|||
129737153|NCT00996801|466998487|FG005|Overall Study|Physician Decision|0|||
129737154|NCT00996801|466998482|FG000|Overall Study|Progressive Disease|0|||
129737155|NCT00996801|466998483|FG001|Overall Study|Progressive Disease|1|||
129737156|NCT00996801|466998484|FG002|Overall Study|Progressive Disease|0|||
129737157|NCT00996801|466998485|FG003|Overall Study|Progressive Disease|0|||
129737158|NCT00996801|466998486|FG004|Overall Study|Progressive Disease|0|||
129737159|NCT00996801|466998487|FG005|Overall Study|Progressive Disease|0|||
129737160|NCT00996801|466998482|FG000|Overall Study|Protocol Violation|3|||
129737161|NCT00996801|466998483|FG001|Overall Study|Protocol Violation|4|||
129737162|NCT00996801|466998484|FG002|Overall Study|Protocol Violation|1|||
129737163|NCT00996801|466998485|FG003|Overall Study|Protocol Violation|2|||
129737164|NCT00996801|466998486|FG004|Overall Study|Protocol Violation|3|||
129737165|NCT00996801|466998487|FG005|Overall Study|Protocol Violation|4|||
129737166|NCT00996801|466998482|FG000|Overall Study|Study Terminated by Sponsor|0|||
129737167|NCT00996801|466998483|FG001|Overall Study|Study Terminated by Sponsor|1|||
129737168|NCT00996801|466998484|FG002|Overall Study|Study Terminated by Sponsor|0|||
129737169|NCT00996801|466998485|FG003|Overall Study|Study Terminated by Sponsor|0|||
129737170|NCT00996801|466998486|FG004|Overall Study|Study Terminated by Sponsor|46|||
129737171|NCT00996801|466998487|FG005|Overall Study|Study Terminated by Sponsor|0|||
129737172|NCT00996801|466998482|FG000|Overall Study|Withdrawal by Subject|8|||
129737173|NCT00996801|466998483|FG001|Overall Study|Withdrawal by Subject|6|||
129737174|NCT00996801|466998484|FG002|Overall Study|Withdrawal by Subject|9|||
129737175|NCT00996801|466998485|FG003|Overall Study|Withdrawal by Subject|5|||
129737176|NCT00996801|466998486|FG004|Overall Study|Withdrawal by Subject|5|||
129737177|NCT00996801|466998487|FG005|Overall Study|Withdrawal by Subject|9|||
129737178|NCT02804750|466998488|FG000|Period 1|Adverse Event|0|||
129737179|NCT02804750|466998489|FG001|Period 1|Adverse Event|2|||
129737180|NCT02804750|466998488|FG000|Period 1|Withdrawal by Subject|0|||
129737181|NCT02804750|466998489|FG001|Period 1|Withdrawal by Subject|1|||
129737182|NCT02804750|466998488|FG000|Period 2|Adverse Event|1|||
129737183|NCT02804750|466998489|FG001|Period 2|Adverse Event|0|||
129737184|NCT02804750|466998488|FG000|Period 3|Adverse Event|0|||
129737185|NCT02804750|466998489|FG001|Period 3|Adverse Event|2|||
129893289|NCT01323660|467569707|FG000|Washout Period (14 Days)|Adverse Event|0|||
129893290|NCT01323660|467569708|FG001|Washout Period (14 Days)|Adverse Event|0|||
129737186|NCT02804750|466998488|FG000|Period 4|Adverse Event|0|||
129737187|NCT02804750|466998489|FG001|Period 4|Adverse Event|5|||
129737188|NCT01657760|466998493|FG000|Overall Study|Withdrawal by Subject|0|||
129737189|NCT01657760|466998494|FG001|Overall Study|Withdrawal by Subject|0|||
129737190|NCT01657760|466998495|FG002|Overall Study|Withdrawal by Subject|0|||
129737191|NCT01657760|466998496|FG003|Overall Study|Withdrawal by Subject|1|||
129893291|NCT01323660|467569709|FG002|Washout Period (14 Days)|Adverse Event|0|||
129893292|NCT01323660|467569710|FG003|Washout Period (14 Days)|Adverse Event|0|||
129893293|NCT01323660|467569711|FG004|Washout Period (14 Days)|Adverse Event|1|||
129893294|NCT01323660|467569712|FG005|Washout Period (14 Days)|Adverse Event|0|||
129893295|NCT01323660|467569707|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
129893296|NCT01323660|467569708|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
129893297|NCT01323660|467569709|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
129737192|NCT01657760|466998493|FG000|Overall Study|Physician Decision|1|||
129737193|NCT01657760|466998494|FG001|Overall Study|Physician Decision|1|||
129737194|NCT01657760|466998495|FG002|Overall Study|Physician Decision|1|||
129737195|NCT01657760|466998496|FG003|Overall Study|Physician Decision|2|||
129737196|NCT00940485|466998501|FG000|Overall Study|HBeAb positive at Baseline|3|||
129737197|NCT00940485|466998502|FG001|Overall Study|HBeAb positive at Baseline|2|||
129737198|NCT00940485|466998501|FG000|Overall Study|Lost to Follow-up|2|||
129737199|NCT00940485|466998502|FG001|Overall Study|Lost to Follow-up|3|||
129737200|NCT00940485|466998501|FG000|Overall Study|Adverse Event|8|||
129737201|NCT00940485|466998502|FG001|Overall Study|Adverse Event|0|||
129737202|NCT00940485|466998501|FG000|Overall Study|Withdrawal by Subject|1|||
129737203|NCT00940485|466998502|FG001|Overall Study|Withdrawal by Subject|1|||
129737204|NCT00940485|466998501|FG000|Overall Study|Others|1|||
129737205|NCT00940485|466998502|FG001|Overall Study|Others|1|||
129737206|NCT06250738|466998508|FG000|Overall Study|Lost to Follow-up|1|||
129737207|NCT02936284|466998510|FG000|Overall Study|Withdrawal by Subject|3|||
129737208|NCT02936284|466998511|FG001|Overall Study|Withdrawal by Subject|1|||
129737209|NCT02936284|466998510|FG000|Overall Study|Lost to Follow-up|7|||
129737210|NCT02936284|466998511|FG001|Overall Study|Lost to Follow-up|8|||
129737211|NCT01068249|466998514|FG000|Overall Study|Death|1|||
129737212|NCT01068249|466998514|FG000|Overall Study|Withdrawal by Subject|3|||
129737213|NCT03921554|466998517|FG000|Overall Study|Adverse Event|2|||
129737214|NCT03921554|466998517|FG000|Overall Study|Withdrawal by Subject|1|||
129737215|NCT03921554|466998517|FG000|Overall Study|Death|3|||
129737216|NCT01146652|466998522|FG000|Overall Study|Adverse Event|506|||
129737217|NCT01146652|466998523|FG001|Overall Study|Adverse Event|15|||
129737218|NCT01146652|466998522|FG000|Overall Study|Lack of Efficacy|91|||
129737219|NCT01146652|466998523|FG001|Overall Study|Lack of Efficacy|7|||
129737220|NCT01146652|466998522|FG000|Overall Study|Poor compliance to protocol|38|||
129737221|NCT01146652|466998523|FG001|Overall Study|Poor compliance to protocol|1|||
129805359|NCT04738734|467255014|FG001|Overall Study|Lost to Follow-up|2|||
129805360|NCT04738734|467255013|FG000|Overall Study|Physician Decision|0|||
129805361|NCT04738734|467255014|FG001|Overall Study|Physician Decision|1|||
129805362|NCT04738734|467255013|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
129805363|NCT04738734|467255014|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
129805364|NCT01297920|467255017|FG000|Overall Study|Adverse Event|42|||
129805365|NCT01297920|467255018|FG001|Overall Study|Adverse Event|10|||
129805366|NCT01297920|467255019|FG002|Overall Study|Adverse Event|38|||
129805367|NCT01297920|467255017|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
129805368|NCT01297920|467255018|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
129805369|NCT01297920|467255019|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
129737222|NCT01146652|466998522|FG000|Overall Study|Other unspecified reasons|314|||
129737223|NCT01146652|466998523|FG001|Overall Study|Other unspecified reasons|22|||
129737224|NCT01146652|466998522|FG000|Overall Study|Enrolled but not treated|2|||
129737225|NCT01146652|466998523|FG001|Overall Study|Enrolled but not treated|0|||
129805370|NCT01297920|467255017|FG000|Overall Study|Noncompliance|1|||
129805371|NCT01297920|467255018|FG001|Overall Study|Noncompliance|0|||
129893298|NCT01323660|467569710|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
129893299|NCT01323660|467569711|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
129893300|NCT01323660|467569712|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
129893301|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129893302|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129893303|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129893304|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129893305|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
129893306|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
129893307|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
129893308|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129893309|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
129893310|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
129893311|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129893312|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
129893313|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893314|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893315|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893316|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129893317|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
129737226|NCT03455829|466998527|FG000|Overall Study|Death|2|||
129737227|NCT03455829|466998528|FG001|Overall Study|Death|3|||
129737228|NCT03455829|466998529|FG002|Overall Study|Death|2|||
129737229|NCT03455829|466998530|FG003|Overall Study|Death|4|||
129737230|NCT03455829|466998531|FG004|Overall Study|Death|2|||
129737231|NCT03455829|466998527|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
129737232|NCT03455829|466998528|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
129737233|NCT03455829|466998529|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
129737234|NCT03455829|466998530|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
129737235|NCT03455829|466998531|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
129737236|NCT03455829|466998527|FG000|Overall Study|Disease progression|0|||
129737237|NCT03455829|466998528|FG001|Overall Study|Disease progression|0|||
129737238|NCT03455829|466998529|FG002|Overall Study|Disease progression|0|||
129737239|NCT03455829|466998530|FG003|Overall Study|Disease progression|1|||
129737240|NCT03455829|466998531|FG004|Overall Study|Disease progression|1|||
129737241|NCT00096018|466998539|FG000|Overall Study|Became Ineligible (not treated)|0|||
129737242|NCT00096018|466998540|FG001|Overall Study|Became Ineligible (not treated)|3|||
129737243|NCT00096018|466998539|FG000|Overall Study|Miscellaneous (not treated)|0|||
129737244|NCT00096018|466998540|FG001|Overall Study|Miscellaneous (not treated)|2|||
129737245|NCT00096018|466998539|FG000|Overall Study|Adverse Event|0|||
129737246|NCT00096018|466998540|FG001|Overall Study|Adverse Event|5|||
129893318|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
129893319|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129893320|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129893321|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129737247|NCT00096018|466998539|FG000|Overall Study|Death|0|||
129737248|NCT00096018|466998540|FG001|Overall Study|Death|1|||
129737249|NCT00096018|466998539|FG000|Overall Study|Withdrawal by Subject|0|||
129737250|NCT00096018|466998540|FG001|Overall Study|Withdrawal by Subject|2|||
129737251|NCT00096018|466998539|FG000|Overall Study|Miscellaneous|2|||
129737252|NCT00096018|466998540|FG001|Overall Study|Miscellaneous|1|||
129737253|NCT03689712|466998541|FG000|Overall Study|Adverse Event|1|||
129737254|NCT03689712|466998542|FG001|Overall Study|Adverse Event|0|||
129737255|NCT03689712|466998541|FG000|Overall Study|Death|20|||
129737256|NCT03689712|466998542|FG001|Overall Study|Death|10|||
129737257|NCT03689712|466998541|FG000|Overall Study|Lost to Follow-up|6|||
129737258|NCT03689712|466998542|FG001|Overall Study|Lost to Follow-up|6|||
129737259|NCT03689712|466998541|FG000|Overall Study|Other|1|||
129737260|NCT03689712|466998542|FG001|Overall Study|Other|0|||
129805372|NCT01297920|467255019|FG002|Overall Study|Noncompliance|0|||
129805373|NCT01297920|467255017|FG000|Overall Study|Protocol Violation|1|||
129805374|NCT01297920|467255018|FG001|Overall Study|Protocol Violation|3|||
129805375|NCT01297920|467255019|FG002|Overall Study|Protocol Violation|0|||
129805376|NCT01297920|467255017|FG000|Overall Study|Inadequate Control of IOP|7|||
129805377|NCT01297920|467255018|FG001|Overall Study|Inadequate Control of IOP|9|||
129805378|NCT01297920|467255019|FG002|Overall Study|Inadequate Control of IOP|17|||
129805379|NCT01297920|467255017|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
129805380|NCT01297920|467255018|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
129805381|NCT01297920|467255019|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
129805382|NCT00474760|467255020|FG000|Overall Study|Death|0|||
129805383|NCT00474760|467255021|FG001|Overall Study|Death|0|||
129805384|NCT00474760|467255022|FG002|Overall Study|Death|0|||
129805385|NCT00474760|467255023|FG003|Overall Study|Death|0|||
129805386|NCT00474760|467255024|FG004|Overall Study|Death|2|||
129805387|NCT00474760|467255025|FG005|Overall Study|Death|0|||
129805388|NCT00474760|467255026|FG006|Overall Study|Death|0|||
129805389|NCT00474760|467255020|FG000|Overall Study|Adverse Event|0|||
129805390|NCT00474760|467255021|FG001|Overall Study|Adverse Event|0|||
129805391|NCT00474760|467255022|FG002|Overall Study|Adverse Event|0|||
129805392|NCT00474760|467255023|FG003|Overall Study|Adverse Event|0|||
129805393|NCT00474760|467255024|FG004|Overall Study|Adverse Event|1|||
129805394|NCT00474760|467255025|FG005|Overall Study|Adverse Event|7|||
129805395|NCT00474760|467255026|FG006|Overall Study|Adverse Event|0|||
129805396|NCT00474760|467255020|FG000|Overall Study|Laboratory abnormality|0|||
129805397|NCT00474760|467255021|FG001|Overall Study|Laboratory abnormality|0|||
129805398|NCT00474760|467255022|FG002|Overall Study|Laboratory abnormality|0|||
129805399|NCT00474760|467255023|FG003|Overall Study|Laboratory abnormality|0|||
129805400|NCT00474760|467255024|FG004|Overall Study|Laboratory abnormality|0|||
129805401|NCT00474760|467255025|FG005|Overall Study|Laboratory abnormality|1|||
129737261|NCT03689712|466998541|FG000|Overall Study|Patient Non-Compliance|0|||
129737262|NCT03689712|466998542|FG001|Overall Study|Patient Non-Compliance|1|||
129737263|NCT03689712|466998541|FG000|Overall Study|Withdrawal by Subject|20|||
129737264|NCT03689712|466998542|FG001|Overall Study|Withdrawal by Subject|4|||
129737265|NCT03689712|466998541|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
129737266|NCT03689712|466998542|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
129737267|NCT03689712|466998541|FG000|Overall Study|Randomized but not Treated|13|||
129737268|NCT03689712|466998542|FG001|Overall Study|Randomized but not Treated|7|||
129737269|NCT03689712|466998541|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
129737270|NCT03689712|466998542|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
129737271|NCT00689793|466998543|FG000|Overall Study|Lost to Follow-up|4|||
129737272|NCT00689793|466998544|FG001|Overall Study|Lost to Follow-up|5|||
129805402|NCT00474760|467255026|FG006|Overall Study|Laboratory abnormality|0|||
129805403|NCT00474760|467255020|FG000|Overall Study|Withdrawal by Subject|0|||
129805404|NCT00474760|467255021|FG001|Overall Study|Withdrawal by Subject|0|||
129805405|NCT00474760|467255022|FG002|Overall Study|Withdrawal by Subject|0|||
129805406|NCT00474760|467255023|FG003|Overall Study|Withdrawal by Subject|1|||
129805407|NCT00474760|467255024|FG004|Overall Study|Withdrawal by Subject|0|||
129805408|NCT00474760|467255025|FG005|Overall Study|Withdrawal by Subject|1|||
129737273|NCT03968159|466998545|FG000|Overall Study|Adverse Event|4|||
129737274|NCT03968159|466998546|FG001|Overall Study|Adverse Event|4|||
129737275|NCT03968159|466998545|FG000|Overall Study|Lost to Follow-up|1|||
129805409|NCT00474760|467255026|FG006|Overall Study|Withdrawal by Subject|1|||
129805410|NCT00474760|467255020|FG000|Overall Study|Other|0|||
129805411|NCT00474760|467255021|FG001|Overall Study|Other|1|||
129805412|NCT00474760|467255022|FG002|Overall Study|Other|0|||
129805413|NCT00474760|467255023|FG003|Overall Study|Other|0|||
129805414|NCT00474760|467255024|FG004|Overall Study|Other|1|||
129737276|NCT03968159|466998546|FG001|Overall Study|Lost to Follow-up|1|||
129737277|NCT03968159|466998545|FG000|Overall Study|Use of prohibited medication|0|||
129737278|NCT03968159|466998546|FG001|Overall Study|Use of prohibited medication|1|||
129737279|NCT03968159|466998545|FG000|Overall Study|Protocol Violation|2|||
129805415|NCT00474760|467255025|FG005|Overall Study|Other|0|||
129805416|NCT00474760|467255026|FG006|Overall Study|Other|0|||
129805417|NCT00474760|467255020|FG000|Overall Study|Progressive disease|3|||
129805418|NCT00474760|467255021|FG001|Overall Study|Progressive disease|2|||
129805419|NCT00474760|467255022|FG002|Overall Study|Progressive disease|3|||
129805420|NCT00474760|467255023|FG003|Overall Study|Progressive disease|2|||
129805421|NCT00474760|467255024|FG004|Overall Study|Progressive disease|8|||
129805422|NCT00474760|467255025|FG005|Overall Study|Progressive disease|20|||
129805423|NCT00474760|467255026|FG006|Overall Study|Progressive disease|7|||
129805424|NCT00474760|467255020|FG000|Overall Study|Terminated by sponsor|0|||
129805425|NCT00474760|467255021|FG001|Overall Study|Terminated by sponsor|0|||
129805426|NCT00474760|467255022|FG002|Overall Study|Terminated by sponsor|0|||
129805427|NCT00474760|467255023|FG003|Overall Study|Terminated by sponsor|0|||
129805428|NCT00474760|467255024|FG004|Overall Study|Terminated by sponsor|0|||
129805429|NCT00474760|467255025|FG005|Overall Study|Terminated by sponsor|0|||
129805430|NCT00474760|467255026|FG006|Overall Study|Terminated by sponsor|2|||
129805431|NCT00331422|467255027|FG000|Overall Study|Did not receive entire study regimen|5|||
129805432|NCT02345226|467255028|FG000|Double-Blind Phase|Adverse Event|5|||
129805433|NCT02345226|467255029|FG001|Double-Blind Phase|Adverse Event|6|||
129805434|NCT02345226|467255028|FG000|Double-Blind Phase|Death|3|||
129805435|NCT02345226|467255029|FG001|Double-Blind Phase|Death|0|||
129805436|NCT02345226|467255028|FG000|Double-Blind Phase|Pregnancy|0|||
129805437|NCT02345226|467255029|FG001|Double-Blind Phase|Pregnancy|1|||
129805438|NCT02345226|467255028|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129805439|NCT02345226|467255029|FG001|Double-Blind Phase|Lack of Efficacy|0|||
129805440|NCT02345226|467255028|FG000|Double-Blind Phase|Investigator's Discretion|4|||
129805441|NCT02345226|467255029|FG001|Double-Blind Phase|Investigator's Discretion|3|||
129805442|NCT02345226|467255028|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
129805443|NCT02345226|467255029|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
129805444|NCT02345226|467255028|FG000|Double-Blind Phase|Withdrew Consent|41|||
129805445|NCT02345226|467255029|FG001|Double-Blind Phase|Withdrew Consent|39|||
129805446|NCT02345226|467255028|FG000|Double-Blind Phase|Lost to Follow-up|12|||
129805447|NCT02345226|467255029|FG001|Double-Blind Phase|Lost to Follow-up|16|||
129737280|NCT03968159|466998546|FG001|Overall Study|Protocol Violation|2|||
129805448|NCT02345226|467255028|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
129805449|NCT02345226|467255029|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
129805450|NCT02345226|467255028|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129805451|NCT02345226|467255029|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
129893322|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129737281|NCT03968159|466998545|FG000|Overall Study|Withdrawal by Subject|4|||
129737282|NCT03968159|466998546|FG001|Overall Study|Withdrawal by Subject|6|||
129737283|NCT03968159|466998545|FG000|Overall Study|Lack of Efficacy|0|||
129737284|NCT03968159|466998546|FG001|Overall Study|Lack of Efficacy|1|||
129737285|NCT03968159|466998545|FG000|Overall Study|Not further specified|2|||
129737286|NCT03968159|466998546|FG001|Overall Study|Not further specified|0|||
129737287|NCT03283150|466998547|FG000|Overall Study|Withdrawal by Subject|6|||
129737288|NCT03283150|466998548|FG001|Overall Study|Withdrawal by Subject|0|||
129737289|NCT03283150|466998549|FG002|Overall Study|Withdrawal by Subject|0|||
129737290|NCT00864851|466998550|FG000|Overall Study|Withdrawal by Subject|0|||
129737291|NCT00864851|466998551|FG001|Overall Study|Withdrawal by Subject|1|||
129737292|NCT00864851|466998552|FG002|Overall Study|Withdrawal by Subject|0|||
129737293|NCT00864851|466998550|FG000|Overall Study|Physician Decision|1|||
129737294|NCT00864851|466998551|FG001|Overall Study|Physician Decision|0|||
129805452|NCT01710046|467255032|FG000|Overall Study|Lost to Follow-up|1|||
129805453|NCT01710046|467255033|FG001|Overall Study|Lost to Follow-up|0|||
129805454|NCT02282358|467255036|FG000|Overall Study|Nonevaluable|1|||
129893323|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
129893324|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
129893325|NCT01323660|467569707|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129893326|NCT01323660|467569708|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129893327|NCT01323660|467569709|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129893328|NCT01323660|467569710|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129893329|NCT01323660|467569711|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
129893330|NCT01323660|467569712|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129893331|NCT00278564|467569717|FG000|Overall Study|Lack of Efficacy|4|||
129893332|NCT00051311|467569718|FG000|Overall Study|Starting new study|0|||
129893333|NCT00051311|467569719|FG001|Overall Study|Starting new study|1|||
129893334|NCT00051311|467569718|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
129893335|NCT00051311|467569719|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
129893336|NCT00051311|467569718|FG000|Overall Study|Death of recipient|8|||
129737295|NCT00864851|466998552|FG002|Overall Study|Physician Decision|0|||
129737296|NCT00864851|466998550|FG000|Overall Study|Death|1|||
129737297|NCT00864851|466998551|FG001|Overall Study|Death|0|||
129805455|NCT01786148|467255037|FG000|Overall Study|Lost to Follow-up|21|||
129805456|NCT01786148|467255038|FG001|Overall Study|Lost to Follow-up|13|||
129805457|NCT01786148|467255037|FG000|Overall Study|Death|0|||
129444760|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
129444761|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
129444762|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
129737298|NCT00864851|466998552|FG002|Overall Study|Death|0|||
129737299|NCT00864851|466998550|FG000|Overall Study|Patient uncooperative|1|||
129737300|NCT00864851|466998551|FG001|Overall Study|Patient uncooperative|0|||
129737301|NCT00864851|466998552|FG002|Overall Study|Patient uncooperative|0|||
129737302|NCT01842581|466998556|FG000|Overall Study|Adverse Event|6|||
129737303|NCT01842581|466998557|FG001|Overall Study|Adverse Event|4|||
129737304|NCT01842581|466998556|FG000|Overall Study|HE breakthrough|26|||
129737305|NCT01842581|466998557|FG001|Overall Study|HE breakthrough|13|||
129737306|NCT01842581|466998556|FG000|Overall Study|Liver transplant|2|||
129737307|NCT01842581|466998557|FG001|Overall Study|Liver transplant|0|||
129737308|NCT01842581|466998556|FG000|Overall Study|Lost to Follow-up|2|||
129737309|NCT01842581|466998557|FG001|Overall Study|Lost to Follow-up|5|||
129737310|NCT01842581|466998556|FG000|Overall Study|Withdrawal by Subject|5|||
129737311|NCT01842581|466998557|FG001|Overall Study|Withdrawal by Subject|7|||
129805458|NCT01786148|467255038|FG001|Overall Study|Death|1|||
129805459|NCT01786148|467255037|FG000|Overall Study|Withdrawal by Subject|0|||
129737312|NCT01842581|466998556|FG000|Overall Study|Other than specified|3|||
129737313|NCT01842581|466998557|FG001|Overall Study|Other than specified|1|||
129737314|NCT00353873|466998558|FG000|Overall Study|Protocol Violation|1|||
129737315|NCT00353873|466998559|FG001|Overall Study|Protocol Violation|2|||
129737316|NCT00353873|466998558|FG000|Overall Study|Exacerbation|1|||
129737317|NCT00353873|466998559|FG001|Overall Study|Exacerbation|0|||
129737318|NCT00353873|466998558|FG000|Overall Study|Adverse Event|1|||
129444763|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
129737319|NCT00353873|466998559|FG001|Overall Study|Adverse Event|0|||
129737320|NCT00353873|466998558|FG000|Overall Study|Physician Decision|2|||
129737321|NCT00353873|466998559|FG001|Overall Study|Physician Decision|0|||
129737322|NCT00353873|466998558|FG000|Overall Study|Withdrawal by Subject|1|||
129737323|NCT00353873|466998559|FG001|Overall Study|Withdrawal by Subject|1|||
129737324|NCT02717130|466998560|FG000|Overall Study|Withdrawal by Subject|1|||
129737325|NCT02717130|466998560|FG000|Overall Study|Adverse Event|1|||
129737326|NCT02717130|466998560|FG000|Overall Study|Physician Decision|1|||
129737327|NCT02717130|466998560|FG000|Overall Study|Study Closure|4|||
129737328|NCT00106691|466998561|FG000|Overall Study|Adverse Event|60|||
129737329|NCT00106691|466998562|FG001|Overall Study|Adverse Event|64|||
129737330|NCT00106691|466998561|FG000|Overall Study|Lost to Follow-up|23|||
129737331|NCT00106691|466998562|FG001|Overall Study|Lost to Follow-up|18|||
129737332|NCT00106691|466998561|FG000|Overall Study|Physician Decision|18|||
129737333|NCT00106691|466998562|FG001|Overall Study|Physician Decision|21|||
129737334|NCT00106691|466998561|FG000|Overall Study|Protocol Violation|13|||
129737335|NCT00106691|466998562|FG001|Overall Study|Protocol Violation|18|||
129737336|NCT00106691|466998561|FG000|Overall Study|Withdrawal by Subject|75|||
129737337|NCT00106691|466998562|FG001|Overall Study|Withdrawal by Subject|70|||
129737338|NCT00106691|466998561|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
129737339|NCT00106691|466998562|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
129737340|NCT00106691|466998561|FG000|Overall Study|QTc>480|3|||
129737341|NCT00106691|466998562|FG001|Overall Study|QTc>480|1|||
129737342|NCT00106691|466998561|FG000|Overall Study|mililtary deployment|2|||
129737343|NCT00106691|466998562|FG001|Overall Study|mililtary deployment|0|||
129737344|NCT00106691|466998561|FG000|Overall Study|Study Site Closing/PI Moved|1|||
129737345|NCT00106691|466998562|FG001|Overall Study|Study Site Closing/PI Moved|2|||
129737346|NCT00106691|466998561|FG000|Overall Study|Cardiologist recommendation|1|||
129737347|NCT00106691|466998562|FG001|Overall Study|Cardiologist recommendation|0|||
129737348|NCT00106691|466998561|FG000|Overall Study|Pt. moved to another state|1|||
129737349|NCT00106691|466998562|FG001|Overall Study|Pt. moved to another state|0|||
129737350|NCT00106691|466998561|FG000|Overall Study|Taking exclusionary avodart|1|||
129737351|NCT00106691|466998562|FG001|Overall Study|Taking exclusionary avodart|0|||
129737352|NCT00106691|466998561|FG000|Overall Study|Not able to discontinue plavix|0|||
129737353|NCT00106691|466998562|FG001|Overall Study|Not able to discontinue plavix|1|||
129737354|NCT00530920|466998563|FG000|Overall Study|Randomized but not treated|0|||
129737355|NCT00530920|466998564|FG001|Overall Study|Randomized but not treated|2|||
129737356|NCT00530920|466998565|FG002|Overall Study|Randomized but not treated|0|||
129737357|NCT00530920|466998563|FG000|Overall Study|Adverse Event|0|||
129737358|NCT00530920|466998564|FG001|Overall Study|Adverse Event|0|||
129737359|NCT00530920|466998565|FG002|Overall Study|Adverse Event|3|||
129805460|NCT01786148|467255038|FG001|Overall Study|Withdrawal by Subject|7|||
129805461|NCT01786148|467255037|FG000|Overall Study|Incarceration|1|||
129805462|NCT01786148|467255038|FG001|Overall Study|Incarceration|1|||
129805463|NCT01811225|467255047|FG000|Treatment Period 1|Adverse Event|2|||
129737360|NCT00530920|466998563|FG000|Overall Study|Withdrawal by Subject|0|||
129737361|NCT00530920|466998564|FG001|Overall Study|Withdrawal by Subject|0|||
129805464|NCT01811225|467255048|FG001|Treatment Period 1|Adverse Event|3|||
129737362|NCT00530920|466998565|FG002|Overall Study|Withdrawal by Subject|1|||
129737363|NCT04957758|466998567|FG000|Overall Study|Adverse Event|1|||
129737364|NCT04957758|466998568|FG001|Overall Study|Adverse Event|0|||
129737365|NCT04957758|466998567|FG000|Overall Study|Lost to Follow-up|0|||
129737366|NCT04957758|466998568|FG001|Overall Study|Lost to Follow-up|2|||
129737367|NCT04957758|466998567|FG000|Overall Study|Withdrawal by Subject|4|||
129805465|NCT01811225|467255047|FG000|Treatment Period 1|Lost to Follow-up|12|||
129737368|NCT04957758|466998568|FG001|Overall Study|Withdrawal by Subject|2|||
129805466|NCT01811225|467255048|FG001|Treatment Period 1|Lost to Follow-up|8|||
129805467|NCT01811225|467255047|FG000|Treatment Period 1|transporation|1|||
129805468|NCT01811225|467255048|FG001|Treatment Period 1|transporation|0|||
129805469|NCT01811225|467255047|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
129805470|NCT01811225|467255048|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
129805471|NCT01811225|467255047|FG000|Treatment Period 2|Lost to Follow-up|1|||
129805472|NCT01811225|467255048|FG001|Treatment Period 2|Lost to Follow-up|2|||
129805473|NCT01811225|467255047|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
129805474|NCT01811225|467255048|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
129805475|NCT03896165|467255049|FG000|Overall Study|Withdrawal by Subject|2|||
129805476|NCT02158975|467255050|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
129805477|NCT03000569|467255051|FG000|Overall Study|Withdrawal by Subject|1|||
129805478|NCT03000569|467255052|FG001|Overall Study|Withdrawal by Subject|0|||
129805479|NCT04122534|467255053|FG000|Overall Study|Lost to Follow-up|4|||
129805480|NCT00397215|467255066|FG000|Month 0 (Day 0)|Adverse Event|0|||
129805481|NCT00397215|467255067|FG001|Month 0 (Day 0)|Adverse Event|1|||
129805482|NCT00397215|467255068|FG002|Month 0 (Day 0)|Adverse Event|0|||
129805483|NCT00397215|467255069|FG003|Month 0 (Day 0)|Adverse Event|0|||
129805484|NCT00397215|467255066|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
129805485|NCT00397215|467255067|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
129805486|NCT00397215|467255068|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
129805487|NCT00397215|467255069|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
129805488|NCT00397215|467255066|FG000|Month 0 (Day 0)|Other|4|||
129805489|NCT00397215|467255067|FG001|Month 0 (Day 0)|Other|1|||
129805490|NCT00397215|467255068|FG002|Month 0 (Day 0)|Other|3|||
129805491|NCT00397215|467255069|FG003|Month 0 (Day 0)|Other|3|||
129805492|NCT00397215|467255066|FG000|Month 6 (Day 180)|Adverse Event|0|||
129805493|NCT00397215|467255067|FG001|Month 6 (Day 180)|Adverse Event|3|||
129444764|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
129444765|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
129444766|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
129444767|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
129444768|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
129444769|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
129444770|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
129444771|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
129444772|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
129444773|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
129444774|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
129444775|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
129444776|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
129444777|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
129444778|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
129444779|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
129444780|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
129444781|NCT01641809|465929435|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
129444782|NCT01641809|465929436|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
129805494|NCT00397215|467255068|FG002|Month 6 (Day 180)|Adverse Event|2|||
129805495|NCT00397215|467255069|FG003|Month 6 (Day 180)|Adverse Event|0|||
129805496|NCT00397215|467255066|FG000|Month 6 (Day 180)|Other|2|||
129805497|NCT00397215|467255067|FG001|Month 6 (Day 180)|Other|0|||
129805498|NCT00397215|467255068|FG002|Month 6 (Day 180)|Other|3|||
129805499|NCT00397215|467255069|FG003|Month 6 (Day 180)|Other|0|||
129805500|NCT02128932|467255070|FG000|Overall Study|Withdrawal by Subject|11|||
129737369|NCT04957758|466998567|FG000|Overall Study|Protocol Violation|0|||
129737370|NCT04957758|466998568|FG001|Overall Study|Protocol Violation|1|||
129737371|NCT00707746|466998569|FG000|Treatment Period|Adverse Event|2|||
129737372|NCT00707746|466998570|FG001|Treatment Period|Adverse Event|4|||
129737373|NCT00707746|466998569|FG000|Treatment Period|Ineligibility|0|||
129737374|NCT00707746|466998570|FG001|Treatment Period|Ineligibility|1|||
129737375|NCT00685373|466998574|FG000|Overall Study|Adverse Event|3|||
129737376|NCT00685373|466998574|FG000|Overall Study|Withdrawal by Subject|5|||
129737377|NCT00685373|466998574|FG000|Overall Study|Lack of Efficacy|3|||
129737378|NCT00685373|466998574|FG000|Overall Study|Condition no longer requires study drug|1|||
129737379|NCT00685373|466998574|FG000|Overall Study|Lost to Follow-up|2|||
129805501|NCT02128932|467255071|FG001|Overall Study|Withdrawal by Subject|7|||
129737380|NCT00685373|466998574|FG000|Overall Study|Protocol Violation|1|||
129737381|NCT02642965|466998576|FG000|Overall Study|Lack of Efficacy|4|||
129737382|NCT02642965|466998576|FG000|Overall Study|Physician Decision|9|||
129805502|NCT02128932|467255072|FG002|Overall Study|Withdrawal by Subject|8|||
129805503|NCT02128932|467255070|FG000|Overall Study|Death|2|||
129805504|NCT02128932|467255071|FG001|Overall Study|Death|0|||
129805505|NCT02128932|467255072|FG002|Overall Study|Death|2|||
129805506|NCT02128932|467255070|FG000|Overall Study|Lost to Follow-up|2|||
129444783|NCT01641809|465929437|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
129737383|NCT03099148|466998579|FG000|Wash-out|scheduling conflict|0|||
129805507|NCT02128932|467255071|FG001|Overall Study|Lost to Follow-up|1|||
129805508|NCT02128932|467255072|FG002|Overall Study|Lost to Follow-up|1|||
129805509|NCT02128932|467255070|FG000|Overall Study|No reason for withdrawal|12|||
129805510|NCT02128932|467255071|FG001|Overall Study|No reason for withdrawal|11|||
129805511|NCT02128932|467255072|FG002|Overall Study|No reason for withdrawal|7|||
129805512|NCT01361568|467255073|FG000|Overall Study|Adverse Event|0|||
129805513|NCT01361568|467255074|FG001|Overall Study|Adverse Event|0|||
129805514|NCT01361568|467255075|FG002|Overall Study|Adverse Event|0|||
129805515|NCT01361568|467255076|FG003|Overall Study|Adverse Event|0|||
129805516|NCT01361568|467255077|FG004|Overall Study|Adverse Event|1|||
129805517|NCT01361568|467255078|FG005|Overall Study|Adverse Event|0|||
129805518|NCT01361568|467255073|FG000|Overall Study|Physician Decision|0|||
129805519|NCT01361568|467255074|FG001|Overall Study|Physician Decision|0|||
129893337|NCT00051311|467569719|FG001|Overall Study|Death of recipient|8|||
129805520|NCT01361568|467255075|FG002|Overall Study|Physician Decision|0|||
129805521|NCT01361568|467255076|FG003|Overall Study|Physician Decision|0|||
129805522|NCT01361568|467255077|FG004|Overall Study|Physician Decision|0|||
129805523|NCT01361568|467255078|FG005|Overall Study|Physician Decision|1|||
129805524|NCT01361568|467255073|FG000|Overall Study|Withdrawal by Subject|2|||
129805525|NCT01361568|467255074|FG001|Overall Study|Withdrawal by Subject|1|||
129805526|NCT01361568|467255075|FG002|Overall Study|Withdrawal by Subject|0|||
129805527|NCT01361568|467255076|FG003|Overall Study|Withdrawal by Subject|0|||
129805528|NCT01361568|467255077|FG004|Overall Study|Withdrawal by Subject|0|||
129805529|NCT01361568|467255078|FG005|Overall Study|Withdrawal by Subject|1|||
129805530|NCT00657358|467255083|FG000|Overall Study|Lack of Efficacy|6|||
129805531|NCT02959983|467255084|FG000|Overall Study|Protocol Violation|0|||
129805532|NCT02959983|467255085|FG001|Overall Study|Protocol Violation|1|||
129805533|NCT02959983|467255084|FG000|Overall Study|Lack of Efficacy|0|||
129805534|NCT02959983|467255085|FG001|Overall Study|Lack of Efficacy|1|||
129805535|NCT02959983|467255084|FG000|Overall Study|Lost to Follow-up|12|||
129805536|NCT02959983|467255085|FG001|Overall Study|Lost to Follow-up|9|||
129805537|NCT02959983|467255084|FG000|Overall Study|Other|1|||
129805538|NCT02959983|467255085|FG001|Overall Study|Other|1|||
129805539|NCT02959983|467255084|FG000|Overall Study|Physician Decision|1|||
129805540|NCT02959983|467255085|FG001|Overall Study|Physician Decision|0|||
129805541|NCT02959983|467255084|FG000|Overall Study|Adverse Event|5|||
129805542|NCT02959983|467255085|FG001|Overall Study|Adverse Event|1|||
129805543|NCT02959983|467255084|FG000|Overall Study|Withdrawal by Subject|7|||
129805544|NCT02959983|467255085|FG001|Overall Study|Withdrawal by Subject|12|||
129805545|NCT01254630|467255086|FG000|Overall Study|Adverse Event|36|||
129805546|NCT01254630|467255087|FG001|Overall Study|Adverse Event|15|||
129805547|NCT01254630|467255088|FG002|Overall Study|Adverse Event|40|||
129805548|NCT01254630|467255089|FG003|Overall Study|Adverse Event|8|||
129805549|NCT01254630|467255086|FG000|Overall Study|Death|461|||
129805550|NCT01254630|467255087|FG001|Overall Study|Death|151|||
129805551|NCT01254630|467255088|FG002|Overall Study|Death|478|||
129805552|NCT01254630|467255089|FG003|Overall Study|Death|139|||
129805553|NCT01254630|467255086|FG000|Overall Study|Lost to Follow-up|80|||
129805554|NCT01254630|467255087|FG001|Overall Study|Lost to Follow-up|26|||
129805555|NCT01254630|467255088|FG002|Overall Study|Lost to Follow-up|89|||
129805556|NCT01254630|467255089|FG003|Overall Study|Lost to Follow-up|32|||
129805557|NCT01254630|467255086|FG000|Overall Study|Physician Decision|24|||
129805558|NCT01254630|467255087|FG001|Overall Study|Physician Decision|8|||
129805559|NCT01254630|467255088|FG002|Overall Study|Physician Decision|16|||
129805560|NCT01254630|467255089|FG003|Overall Study|Physician Decision|7|||
129805561|NCT01254630|467255086|FG000|Overall Study|Withdrawal by Subject|201|||
129805562|NCT01254630|467255087|FG001|Overall Study|Withdrawal by Subject|94|||
129805563|NCT01254630|467255088|FG002|Overall Study|Withdrawal by Subject|188|||
129805564|NCT01254630|467255089|FG003|Overall Study|Withdrawal by Subject|89|||
129805565|NCT01254630|467255086|FG000|Overall Study|Study terminated by sponsor|0|||
129805566|NCT01254630|467255087|FG001|Overall Study|Study terminated by sponsor|994|||
129805567|NCT01254630|467255088|FG002|Overall Study|Study terminated by sponsor|0|||
129805568|NCT01254630|467255089|FG003|Overall Study|Study terminated by sponsor|1010|||
129805569|NCT01254630|467255086|FG000|Overall Study|Status not recorded|0|||
129805570|NCT01254630|467255087|FG001|Overall Study|Status not recorded|0|||
129805571|NCT01254630|467255088|FG002|Overall Study|Status not recorded|1|||
129805572|NCT01254630|467255089|FG003|Overall Study|Status not recorded|0|||
129805573|NCT02180724|467256724|FG000|Overall Study|Death|26|||
129805574|NCT02180724|467256725|FG001|Overall Study|Death|1|||
129805575|NCT02180724|467256724|FG000|Overall Study|Lost to Follow-up|3|||
129893338|NCT00051311|467569718|FG000|Overall Study|Recipient taken off study|4|||
129805576|NCT02180724|467256725|FG001|Overall Study|Lost to Follow-up|1|||
129805577|NCT02180724|467256724|FG000|Overall Study|Withdrawal by Subject|4|||
129805578|NCT02180724|467256725|FG001|Overall Study|Withdrawal by Subject|2|||
129805579|NCT02180724|467256724|FG000|Overall Study|PI Decision|5|||
129805580|NCT02180724|467256725|FG001|Overall Study|PI Decision|2|||
129805581|NCT02180724|467256724|FG000|Overall Study|Study terminated by sponsor|54|||
129805582|NCT02180724|467256725|FG001|Overall Study|Study terminated by sponsor|8|||
129805583|NCT01824342|467256731|FG000|Overall Study|Withdrawal by Subject|0|||
129805584|NCT01824342|467256732|FG001|Overall Study|Withdrawal by Subject|3|||
129805585|NCT01824342|467256731|FG000|Overall Study|Adverse Event|1|||
129893339|NCT00051311|467569719|FG001|Overall Study|Recipient taken off study|4|||
129893340|NCT03566680|467569730|FG000|Overall Study|Pregnancy|1|||
129893341|NCT03566680|467569730|FG000|Overall Study|Lost to Follow-up|13|||
129893342|NCT03566680|467569730|FG000|Overall Study|Withdrawal by Subject|3|||
129893343|NCT01687270|467569731|FG000|Overall Study|Lack of Efficacy|11|||
129893344|NCT01687270|467569731|FG000|Overall Study|Lost to Follow-up|1|||
129893345|NCT00958009|467569733|FG000|Overall Study|Adverse Event|1|||
129893346|NCT00958009|467569733|FG000|Overall Study|Subject found device difficult to use|1|||
129893347|NCT00558753|467569734|FG000|Overall Study|Lost to Follow-up|5|||
129893348|NCT00558753|467569735|FG001|Overall Study|Lost to Follow-up|7|||
129893349|NCT00578227|467569738|FG000|Overall Study|Lost to Follow-up|0|||
129737384|NCT03099148|466998580|FG001|Wash-out|scheduling conflict|1|||
129737385|NCT03099148|466998581|FG002|Wash-out|scheduling conflict|0|||
129737386|NCT03099148|466998582|FG003|Wash-out|scheduling conflict|0|||
129737387|NCT03099148|466998579|FG000|Wash-out|Adverse Event|0|||
129737388|NCT03099148|466998580|FG001|Wash-out|Adverse Event|1|||
129737389|NCT03099148|466998581|FG002|Wash-out|Adverse Event|0|||
129737390|NCT03099148|466998582|FG003|Wash-out|Adverse Event|0|||
129737391|NCT00966719|466998583|FG000|Overall Study|Lost to Follow-up|6|||
129737392|NCT00966719|466998584|FG001|Overall Study|Lost to Follow-up|11|||
129737393|NCT01703065|466998585|FG000|Overall Study|Lack of Efficacy|1|||
129737394|NCT01703065|466998586|FG001|Overall Study|Lack of Efficacy|0|||
129737395|NCT01439126|466998587|FG000|Overall Study|Adverse Event|2|||
129737396|NCT01439126|466998588|FG001|Overall Study|Adverse Event|0|||
129737397|NCT01439126|466998587|FG000|Overall Study|Withdrawal by Subject|5|||
129737398|NCT01439126|466998588|FG001|Overall Study|Withdrawal by Subject|21|||
129737399|NCT01439126|466998587|FG000|Overall Study|Protocol Violation|6|||
129737400|NCT01439126|466998588|FG001|Overall Study|Protocol Violation|4|||
129737401|NCT01439126|466998587|FG000|Overall Study|Lost to Follow-up|6|||
129737402|NCT01439126|466998588|FG001|Overall Study|Lost to Follow-up|3|||
129737403|NCT01439126|466998587|FG000|Overall Study|Other-Use of prohibited treatment|0|||
129737404|NCT01439126|466998588|FG001|Overall Study|Other-Use of prohibited treatment|2|||
129737405|NCT01439126|466998587|FG000|Overall Study|Other-Miscellaneous|12|||
129737406|NCT01439126|466998588|FG001|Overall Study|Other-Miscellaneous|12|||
129737407|NCT01617447|466998589|FG000|Overall Study|Adverse Event|0|||
129737408|NCT01617447|466998590|FG001|Overall Study|Adverse Event|1|||
129737409|NCT01617447|466998589|FG000|Overall Study|Physician Decision|0|||
129893350|NCT00578227|467569739|FG001|Overall Study|Lost to Follow-up|1|||
129893351|NCT00578227|467569740|FG002|Overall Study|Lost to Follow-up|1|||
129737410|NCT01617447|466998590|FG001|Overall Study|Physician Decision|2|||
129737411|NCT02713529|466998592|FG000|Overall Study|Withdrawal by Subject|3|||
129737412|NCT02713529|466998593|FG001|Overall Study|Withdrawal by Subject|1|||
129737413|NCT02713529|466998594|FG002|Overall Study|Withdrawal by Subject|4|||
129737414|NCT02713529|466998595|FG003|Overall Study|Withdrawal by Subject|2|||
129737415|NCT02713529|466998596|FG004|Overall Study|Withdrawal by Subject|0|||
129737416|NCT02713529|466998597|FG005|Overall Study|Withdrawal by Subject|1|||
129737417|NCT02713529|466998598|FG006|Overall Study|Withdrawal by Subject|1|||
129737418|NCT02713529|466998592|FG000|Overall Study|Lost to Follow-up|1|||
129737419|NCT02713529|466998593|FG001|Overall Study|Lost to Follow-up|0|||
129737420|NCT02713529|466998594|FG002|Overall Study|Lost to Follow-up|1|||
129737421|NCT02713529|466998595|FG003|Overall Study|Lost to Follow-up|0|||
129737422|NCT02713529|466998596|FG004|Overall Study|Lost to Follow-up|0|||
129737423|NCT02713529|466998597|FG005|Overall Study|Lost to Follow-up|0|||
129737424|NCT02713529|466998598|FG006|Overall Study|Lost to Follow-up|0|||
129737425|NCT02713529|466998592|FG000|Overall Study|Death|3|||
129737426|NCT02713529|466998593|FG001|Overall Study|Death|3|||
129737427|NCT02713529|466998594|FG002|Overall Study|Death|26|||
129737428|NCT02713529|466998595|FG003|Overall Study|Death|27|||
129737429|NCT02713529|466998596|FG004|Overall Study|Death|3|||
129737430|NCT02713529|466998597|FG005|Overall Study|Death|13|||
129737431|NCT02713529|466998598|FG006|Overall Study|Death|3|||
129737432|NCT02827500|466998599|FG000|Overall Study|Death|7|||
129737433|NCT02827500|466998600|FG001|Overall Study|Death|3|||
129737434|NCT02827500|466998599|FG000|Overall Study|Lost to Follow-up|1|||
129737435|NCT02827500|466998600|FG001|Overall Study|Lost to Follow-up|1|||
129737436|NCT02827500|466998599|FG000|Overall Study|Withdrawal by Subject|3|||
129737437|NCT02827500|466998600|FG001|Overall Study|Withdrawal by Subject|1|||
129737438|NCT02827500|466998599|FG000|Overall Study|Missing primary endpoint data|3|||
129737439|NCT02827500|466998600|FG001|Overall Study|Missing primary endpoint data|1|||
129737440|NCT02827500|466998599|FG000|Overall Study|Other|5|||
129737441|NCT02827500|466998600|FG001|Overall Study|Other|1|||
129737442|NCT02308488|466998601|FG000|Overall Study|Withdrawal by Subject|2|||
129737443|NCT02242981|466998602|FG000|Overall Study|Withdrawal by Subject|1|||
129737444|NCT02644356|466998608|FG000|Overall Study|Withdrawal by Subject|2|||
129737445|NCT00897390|466998610|FG000|Overall Study|Adverse Event|2|||
129737446|NCT00897390|466998610|FG000|Overall Study|No Longer Met Study Criteria|1|||
129737447|NCT00897390|466998610|FG000|Overall Study|Personal Reasons|1|||
129737448|NCT00897390|466998610|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
129737449|NCT02564978|466998612|FG000|Overall Study|Adverse Event|8|||
129737450|NCT02564978|466998612|FG000|Overall Study|Death|1|||
129737451|NCT02564978|466998612|FG000|Overall Study|Lost to Follow-up|1|||
129737452|NCT02564978|466998612|FG000|Overall Study|Withdrawal by Subject|15|||
129737453|NCT02564978|466998612|FG000|Overall Study|Early Study Closure|2|||
129737454|NCT02564978|466998612|FG000|Overall Study|Other Reason|5|||
129737455|NCT00203021|467000217|FG000|Overall Study|Death|4|||
129737456|NCT00203021|467000218|FG001|Overall Study|Death|1|||
129737457|NCT00203021|467000217|FG000|Overall Study|Adverse Event|10|||
129737458|NCT00203021|467000218|FG001|Overall Study|Adverse Event|5|||
129737459|NCT00203021|467000217|FG000|Overall Study|Withdrawal by Subject|45|||
129737460|NCT00203021|467000218|FG001|Overall Study|Withdrawal by Subject|48|||
129737461|NCT00203021|467000217|FG000|Overall Study|Lost to Follow-up|9|||
129737462|NCT00203021|467000218|FG001|Overall Study|Lost to Follow-up|7|||
129737463|NCT00203021|467000217|FG000|Overall Study|Other than specified|11|||
129737464|NCT00203021|467000218|FG001|Overall Study|Other than specified|16|||
129737465|NCT05160766|467000219|FG000|Overall Study|Adverse Event|0|||
129737466|NCT05160766|467000220|FG001|Overall Study|Adverse Event|1|||
129737467|NCT05160766|467000221|FG002|Overall Study|Adverse Event|0|||
129737468|NCT05160766|467000222|FG003|Overall Study|Adverse Event|0|||
129737469|NCT05160766|467000219|FG000|Overall Study|COVID-19 infection|0|||
129737470|NCT05160766|467000220|FG001|Overall Study|COVID-19 infection|1|||
129737471|NCT05160766|467000221|FG002|Overall Study|COVID-19 infection|0|||
129737472|NCT05160766|467000222|FG003|Overall Study|COVID-19 infection|0|||
129737473|NCT05160766|467000219|FG000|Overall Study|travel time|1|||
129737474|NCT05160766|467000220|FG001|Overall Study|travel time|0|||
129737475|NCT05160766|467000221|FG002|Overall Study|travel time|0|||
129737476|NCT05160766|467000222|FG003|Overall Study|travel time|1|||
129737477|NCT05160766|467000219|FG000|Overall Study|Withdrawal by Subject|3|||
129737478|NCT05160766|467000220|FG001|Overall Study|Withdrawal by Subject|5|||
129737479|NCT05160766|467000221|FG002|Overall Study|Withdrawal by Subject|4|||
129737480|NCT05160766|467000222|FG003|Overall Study|Withdrawal by Subject|2|||
129737481|NCT05160766|467000219|FG000|Overall Study|Death|0|||
129737482|NCT05160766|467000220|FG001|Overall Study|Death|0|||
129737483|NCT05160766|467000221|FG002|Overall Study|Death|2|||
129737484|NCT05160766|467000222|FG003|Overall Study|Death|5|||
129737485|NCT05160766|467000219|FG000|Overall Study|Lost to Follow-up|0|||
129737486|NCT05160766|467000220|FG001|Overall Study|Lost to Follow-up|0|||
129737487|NCT05160766|467000221|FG002|Overall Study|Lost to Follow-up|1|||
129737488|NCT05160766|467000222|FG003|Overall Study|Lost to Follow-up|2|||
129737489|NCT05160766|467000219|FG000|Overall Study|No show|0|||
129737490|NCT05160766|467000220|FG001|Overall Study|No show|0|||
129737491|NCT05160766|467000221|FG002|Overall Study|No show|1|||
129737492|NCT05160766|467000222|FG003|Overall Study|No show|1|||
129737493|NCT05160766|467000219|FG000|Overall Study|Physician Decision|0|||
129737494|NCT05160766|467000220|FG001|Overall Study|Physician Decision|0|||
129737495|NCT05160766|467000221|FG002|Overall Study|Physician Decision|0|||
129737496|NCT05160766|467000222|FG003|Overall Study|Physician Decision|1|||
129737497|NCT05160766|467000219|FG000|Overall Study|Protocol Violation|0|||
129737498|NCT05160766|467000220|FG001|Overall Study|Protocol Violation|0|||
129737499|NCT05160766|467000221|FG002|Overall Study|Protocol Violation|1|||
129805586|NCT01824342|467256732|FG001|Overall Study|Adverse Event|1|||
129805587|NCT01824342|467256731|FG000|Overall Study|Disease Progression|1|||
129805588|NCT01824342|467256732|FG001|Overall Study|Disease Progression|1|||
129805589|NCT01824342|467256731|FG000|Overall Study|Physician Decision|5|||
129805590|NCT01824342|467256732|FG001|Overall Study|Physician Decision|0|||
129805591|NCT01824342|467256731|FG000|Overall Study|Death|2|||
129805592|NCT01824342|467256732|FG001|Overall Study|Death|0|||
129805593|NCT01313858|467256737|FG000|Overall Study|Premature Treatment Termination|251|||
129805594|NCT01313858|467256738|FG001|Overall Study|Premature Treatment Termination|219|||
129805595|NCT01313858|467256739|FG002|Overall Study|Premature Treatment Termination|191|||
129805596|NCT01313858|467256737|FG000|Overall Study|Lost to Follow-up|35|||
129805597|NCT01313858|467256738|FG001|Overall Study|Lost to Follow-up|51|||
129805598|NCT01313858|467256739|FG002|Overall Study|Lost to Follow-up|47|||
129805599|NCT02899299|467256740|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
129737500|NCT05160766|467000222|FG003|Overall Study|Protocol Violation|0|||
129737501|NCT04284813|467000232|FG000|Overall Study|Withdrawal by Subject|1|||
129805600|NCT02899299|467256741|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
129444784|NCT01641809|465929438|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
129805601|NCT02899299|467256740|FG000|Pre-treatment|Participant withdrew consent|1|||
129805602|NCT02899299|467256741|FG001|Pre-treatment|Participant withdrew consent|11|||
129805603|NCT02899299|467256740|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
129737502|NCT00431951|467000233|FG000|Overall Study|Inability to follow study procedures|1|||
129737503|NCT00431951|467000234|FG001|Overall Study|Inability to follow study procedures|0|||
129737504|NCT00431951|467000235|FG002|Overall Study|Inability to follow study procedures|1|||
129737505|NCT00431951|467000236|FG003|Overall Study|Inability to follow study procedures|2|||
129737506|NCT00431951|467000233|FG000|Overall Study|Lost to Follow-up|0|||
129737507|NCT00431951|467000234|FG001|Overall Study|Lost to Follow-up|1|||
129737508|NCT00431951|467000235|FG002|Overall Study|Lost to Follow-up|0|||
129444785|NCT00778622|465929439|FG000|Overall Study|Adverse Event|5|||
129444786|NCT00778622|465929440|FG001|Overall Study|Adverse Event|4|||
129444787|NCT00778622|465929441|FG002|Overall Study|Adverse Event|7|||
129444788|NCT00778622|465929439|FG000|Overall Study|Withdrawal by Subject|4|||
129444789|NCT00778622|465929440|FG001|Overall Study|Withdrawal by Subject|5|||
129444790|NCT00778622|465929441|FG002|Overall Study|Withdrawal by Subject|5|||
129444791|NCT00778622|465929439|FG000|Overall Study|Lost to Follow-up|3|||
129444792|NCT00778622|465929440|FG001|Overall Study|Lost to Follow-up|3|||
129444793|NCT00778622|465929441|FG002|Overall Study|Lost to Follow-up|2|||
129444794|NCT00778622|465929439|FG000|Overall Study|Protocol Violation|0|||
129444795|NCT00778622|465929440|FG001|Overall Study|Protocol Violation|3|||
129444796|NCT00778622|465929441|FG002|Overall Study|Protocol Violation|0|||
129444797|NCT00778622|465929439|FG000|Overall Study|Lack of Efficacy|2|||
129444798|NCT00778622|465929440|FG001|Overall Study|Lack of Efficacy|0|||
129444799|NCT00778622|465929441|FG002|Overall Study|Lack of Efficacy|0|||
129444800|NCT00778622|465929439|FG000|Overall Study|immigration|1|||
129444801|NCT00778622|465929440|FG001|Overall Study|immigration|0|||
129444802|NCT00778622|465929441|FG002|Overall Study|immigration|0|||
129444803|NCT00778622|465929439|FG000|Overall Study|Other|1|||
129444804|NCT00778622|465929440|FG001|Overall Study|Other|0|||
129444805|NCT00778622|465929441|FG002|Overall Study|Other|1|||
129444806|NCT00890929|465929442|FG000|Overall Study|Death before treatment|2|||
129444807|NCT00890929|465929442|FG000|Overall Study|Withdrawal by Subject|3|||
129444808|NCT00890929|465929442|FG000|Overall Study|Physician Decision|1|||
129444809|NCT01840605|465929445|FG000|Overall Study|Adverse Event|0|||
129444810|NCT01840605|465929446|FG001|Overall Study|Adverse Event|1|||
129444811|NCT01840605|465929445|FG000|Overall Study|Physician Decision|2|||
129444812|NCT01840605|465929446|FG001|Overall Study|Physician Decision|1|||
129444813|NCT03065023|465929447|FG000|Overall Study|Progressive Disease|0|||
129444814|NCT03065023|465929448|FG001|Overall Study|Progressive Disease|1|||
129444815|NCT03065023|465929449|FG002|Overall Study|Progressive Disease|0|||
129444816|NCT03065023|465929450|FG003|Overall Study|Progressive Disease|0|||
129444817|NCT03065023|465929451|FG004|Overall Study|Progressive Disease|0|||
129444818|NCT03065023|465929447|FG000|Overall Study|Death|2|||
129444819|NCT03065023|465929448|FG001|Overall Study|Death|0|||
129444820|NCT03065023|465929449|FG002|Overall Study|Death|1|||
129444821|NCT03065023|465929450|FG003|Overall Study|Death|1|||
129444822|NCT03065023|465929451|FG004|Overall Study|Death|0|||
129444823|NCT03065023|465929447|FG000|Overall Study|Lost to Follow-up|0|||
129444824|NCT03065023|465929448|FG001|Overall Study|Lost to Follow-up|1|||
129737509|NCT00431951|467000236|FG003|Overall Study|Lost to Follow-up|0|||
129737510|NCT00431951|467000233|FG000|Overall Study|Withdrawal by Subject|0|||
129737511|NCT00431951|467000234|FG001|Overall Study|Withdrawal by Subject|1|||
129737512|NCT00431951|467000235|FG002|Overall Study|Withdrawal by Subject|0|||
129737513|NCT00431951|467000236|FG003|Overall Study|Withdrawal by Subject|0|||
129737514|NCT00431951|467000233|FG000|Overall Study|Adverse Event|0|||
129737515|NCT00431951|467000234|FG001|Overall Study|Adverse Event|0|||
129737516|NCT00431951|467000235|FG002|Overall Study|Adverse Event|1|||
129737517|NCT00431951|467000236|FG003|Overall Study|Adverse Event|0|||
129737518|NCT01146288|467000237|FG000|First Intervention(1 Day)|Adverse Event|0|||
129737519|NCT01146288|467000238|FG001|First Intervention(1 Day)|Adverse Event|1|||
129737520|NCT00385723|467000239|FG000|Overall Study|Lost to Follow-up|1|||
129444825|NCT03065023|465929449|FG002|Overall Study|Lost to Follow-up|0|||
129444826|NCT03065023|465929450|FG003|Overall Study|Lost to Follow-up|0|||
129444827|NCT03065023|465929451|FG004|Overall Study|Lost to Follow-up|0|||
129444828|NCT03065023|465929447|FG000|Overall Study|Participant Decision|0|||
129444829|NCT03065023|465929448|FG001|Overall Study|Participant Decision|0|||
129737521|NCT00385723|467000240|FG001|Overall Study|Lost to Follow-up|1|||
129737522|NCT00385723|467000241|FG002|Overall Study|Lost to Follow-up|0|||
129737523|NCT00385723|467000239|FG000|Overall Study|Withdrawal by Subject|1|||
129737524|NCT00385723|467000240|FG001|Overall Study|Withdrawal by Subject|0|||
129893352|NCT00578227|467569738|FG000|Overall Study|Withdrawal by Subject|5|||
129893353|NCT00578227|467569739|FG001|Overall Study|Withdrawal by Subject|1|||
129444830|NCT03065023|465929449|FG002|Overall Study|Participant Decision|0|||
129444831|NCT03065023|465929450|FG003|Overall Study|Participant Decision|1|||
129444832|NCT03065023|465929451|FG004|Overall Study|Participant Decision|0|||
129444833|NCT03065023|465929447|FG000|Overall Study|Withdrawal by Subject|0|||
129444834|NCT03065023|465929448|FG001|Overall Study|Withdrawal by Subject|0|||
129444835|NCT03065023|465929449|FG002|Overall Study|Withdrawal by Subject|0|||
129444836|NCT03065023|465929450|FG003|Overall Study|Withdrawal by Subject|1|||
129444837|NCT03065023|465929451|FG004|Overall Study|Withdrawal by Subject|0|||
129444838|NCT04029961|465929452|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
129444839|NCT04029961|465929453|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
129444840|NCT04029961|465929452|FG000|Overall Study|Change in Treatment Course|0|||
129737525|NCT00385723|467000241|FG002|Overall Study|Withdrawal by Subject|2|||
129737526|NCT01100528|467000244|FG000|Overall Study|Death|1|||
129737527|NCT01100528|467000244|FG000|Overall Study|Withdrawal by Subject|2|||
129444841|NCT04029961|465929453|FG001|Overall Study|Change in Treatment Course|1|||
129805604|NCT02899299|467256741|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
129805605|NCT02899299|467256740|FG000|Pre-treatment|Not reported|0|||
129805606|NCT02899299|467256741|FG001|Pre-treatment|Not reported|1|||
129805607|NCT02899299|467256740|FG000|Treatment|Disease Progression|182|||
129805608|NCT02899299|467256741|FG001|Treatment|Disease Progression|43|||
129805609|NCT02899299|467256740|FG000|Treatment|Study Drug Toxicity|60|||
129805610|NCT02899299|467256741|FG001|Treatment|Study Drug Toxicity|24|||
129805611|NCT02899299|467256740|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
129737528|NCT01299571|467000249|FG000|Overall Study|Protocol Violation|107|||
129737529|NCT00708734|467000252|FG000|Overall Study|scheduling conflict|2|||
129737530|NCT00708734|467000252|FG000|Overall Study|moved|1|||
129737531|NCT00708734|467000252|FG000|Overall Study|leg injury|1|||
129737532|NCT00708734|467000252|FG000|Overall Study|knee replacement|1|||
129737533|NCT00708734|467000252|FG000|Overall Study|vertigo|1|||
129737534|NCT00708734|467000252|FG000|Overall Study|leg fracture|1|||
129737535|NCT02006069|467000254|FG000|Overall Study|MPP other programming|239|||
129737536|NCT02006069|467000255|FG001|Overall Study|MPP other programming|0|||
129737537|NCT02006069|467000254|FG000|Overall Study|RV only pacing|0|||
129737538|NCT02006069|467000255|FG001|Overall Study|RV only pacing|3|||
129737539|NCT02066129|467000256|FG000|Overall Study|Lost to Follow-up|13|||
129737540|NCT02066129|467000257|FG001|Overall Study|Lost to Follow-up|12|||
129805612|NCT02899299|467256741|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
129805613|NCT02899299|467256740|FG000|Treatment|Participant request to discontinue Study treatment|4|||
129805614|NCT02899299|467256741|FG001|Treatment|Participant request to discontinue Study treatment|10|||
129805615|NCT02899299|467256740|FG000|Treatment|Participant withdrew consent|6|||
129805616|NCT02899299|467256741|FG001|Treatment|Participant withdrew consent|3|||
129805617|NCT02899299|467256740|FG000|Treatment|Lost to Follow-up|0|||
129805618|NCT02899299|467256741|FG001|Treatment|Lost to Follow-up|2|||
129805619|NCT02899299|467256740|FG000|Treatment|Maximum Clinical Benefit|11|||
129805620|NCT02899299|467256741|FG001|Treatment|Maximum Clinical Benefit|2|||
129805621|NCT02899299|467256740|FG000|Treatment|Poor/Non-compliance|1|||
129805622|NCT02899299|467256741|FG001|Treatment|Poor/Non-compliance|0|||
129805623|NCT02899299|467256740|FG000|Treatment|Participant no longer meets Study criteria|4|||
129805624|NCT02899299|467256741|FG001|Treatment|Participant no longer meets Study criteria|0|||
129805625|NCT02899299|467256740|FG000|Treatment|Administrative reason by Sponsor|2|||
129805626|NCT02899299|467256741|FG001|Treatment|Administrative reason by Sponsor|0|||
129805627|NCT02899299|467256740|FG000|Treatment|Other reasons|12|||
129805628|NCT02899299|467256741|FG001|Treatment|Other reasons|2|||
129805629|NCT02899299|467256740|FG000|Treatment|Not reported|7|||
129805630|NCT02899299|467256741|FG001|Treatment|Not reported|0|||
129805631|NCT02468232|467256752|FG000|Core Part of Study|Adverse Event|0|||
129805632|NCT02468232|467256753|FG001|Core Part of Study|Adverse Event|1|||
129805633|NCT02468232|467256754|FG002|Core Part of Study|Adverse Event|0|||
129805634|NCT02468232|467256755|FG003|Core Part of Study|Adverse Event|0|||
129805635|NCT02468232|467256752|FG000|Core Part of Study|Death|20|||
129805636|NCT02468232|467256753|FG001|Core Part of Study|Death|17|||
129805637|NCT02468232|467256754|FG002|Core Part of Study|Death|0|||
129805638|NCT02468232|467256755|FG003|Core Part of Study|Death|0|||
129805639|NCT02468232|467256752|FG000|Core Part of Study|Technical Problems|1|||
129805640|NCT02468232|467256753|FG001|Core Part of Study|Technical Problems|1|||
129805641|NCT02468232|467256754|FG002|Core Part of Study|Technical Problems|0|||
129805642|NCT02468232|467256755|FG003|Core Part of Study|Technical Problems|0|||
129805643|NCT02468232|467256752|FG000|OLE Part of Study|Adverse Event|0|||
129805644|NCT02468232|467256753|FG001|OLE Part of Study|Adverse Event|0|||
129805645|NCT02468232|467256754|FG002|OLE Part of Study|Adverse Event|4|||
129805646|NCT02468232|467256755|FG003|OLE Part of Study|Adverse Event|5|||
129805647|NCT02468232|467256752|FG000|OLE Part of Study|Death|0|||
129805648|NCT02468232|467256753|FG001|OLE Part of Study|Death|0|||
129805649|NCT02468232|467256754|FG002|OLE Part of Study|Death|4|||
129805650|NCT02468232|467256755|FG003|OLE Part of Study|Death|2|||
129805651|NCT02468232|467256752|FG000|OLE Part of Study|Physician Decision|0|||
129805652|NCT02468232|467256753|FG001|OLE Part of Study|Physician Decision|0|||
129805653|NCT02468232|467256754|FG002|OLE Part of Study|Physician Decision|4|||
129805654|NCT02468232|467256755|FG003|OLE Part of Study|Physician Decision|0|||
129805655|NCT02468232|467256752|FG000|OLE Part of Study|Subject/Guardian decision|0|||
129737541|NCT02066129|467000256|FG000|Overall Study|Withdrawal by Subject|7|||
129737542|NCT02066129|467000257|FG001|Overall Study|Withdrawal by Subject|10|||
129737543|NCT02066129|467000256|FG000|Overall Study|Lack of Efficacy|8|||
129805656|NCT02468232|467256753|FG001|OLE Part of Study|Subject/Guardian decision|0|||
129805657|NCT02468232|467256754|FG002|OLE Part of Study|Subject/Guardian decision|2|||
129805658|NCT02468232|467256755|FG003|OLE Part of Study|Subject/Guardian decision|5|||
129805659|NCT00506662|467256756|FG000|Overall Study|Adverse Event|0|||
129805660|NCT00506662|467256757|FG001|Overall Study|Adverse Event|2|||
129737544|NCT02066129|467000257|FG001|Overall Study|Lack of Efficacy|10|||
129805661|NCT00506662|467256756|FG000|Overall Study|Lack of Efficacy|1|||
129805662|NCT00506662|467256757|FG001|Overall Study|Lack of Efficacy|0|||
129805663|NCT00506662|467256756|FG000|Overall Study|Protocol Violation|2|||
129805664|NCT00506662|467256757|FG001|Overall Study|Protocol Violation|4|||
129805665|NCT00506662|467256756|FG000|Overall Study|Trial terminated|10|||
129805666|NCT00506662|467256757|FG001|Overall Study|Trial terminated|16|||
129737545|NCT02066129|467000256|FG000|Overall Study|Physician Decision|1|||
129737546|NCT02066129|467000257|FG001|Overall Study|Physician Decision|1|||
129737547|NCT00316888|467000261|FG000|Overall Study|Adverse Event|4|||
129737548|NCT00316888|467000262|FG001|Overall Study|Adverse Event|5|||
129737549|NCT00316888|467000261|FG000|Overall Study|Withdrawal by Subject|2|||
129737550|NCT00316888|467000262|FG001|Overall Study|Withdrawal by Subject|2|||
129737551|NCT00316888|467000261|FG000|Overall Study|Not start protocol therapy|0|||
129737552|NCT00316888|467000262|FG001|Overall Study|Not start protocol therapy|1|||
129737553|NCT00857948|467000263|FG000|Overall Study|Withdrawal by Subject|2|||
129737554|NCT00857948|467000264|FG001|Overall Study|Withdrawal by Subject|0|||
129737555|NCT00857948|467000265|FG002|Overall Study|Withdrawal by Subject|0|||
129737556|NCT00857948|467000266|FG003|Overall Study|Withdrawal by Subject|0|||
129737557|NCT00857948|467000263|FG000|Overall Study|Protocol Violation|1|||
129737558|NCT00857948|467000264|FG001|Overall Study|Protocol Violation|0|||
129737559|NCT00857948|467000265|FG002|Overall Study|Protocol Violation|1|||
129737560|NCT00857948|467000266|FG003|Overall Study|Protocol Violation|0|||
129737561|NCT00815191|467000267|FG000|Overall Study|Protocol Violation|1|||
129737562|NCT00815191|467000268|FG001|Overall Study|Protocol Violation|1|||
129737563|NCT01814670|467000271|FG000|Overall Study|Protocol Violation|12|||
129737564|NCT03443427|467000272|FG000|Overall Study|Adverse Event|2|||
129737565|NCT03443427|467000273|FG001|Overall Study|Adverse Event|3|||
129737566|NCT03443427|467000272|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
129737567|NCT03443427|467000273|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129893354|NCT00578227|467569740|FG002|Overall Study|Withdrawal by Subject|3|||
129893355|NCT00577629|467569741|FG000|Treatment Period|Death|1|||
129893356|NCT00577629|467569741|FG000|Long Term Follow-Up|Death|15|||
129893357|NCT00577629|467569741|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
129893358|NCT00577629|467569741|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
129893359|NCT00577629|467569741|FG000|Long Term Follow-Up|Physician Decision|1|||
129893360|NCT01605136|467569742|FG000|Study Period|Withdrawal by Subject|2|||
129893361|NCT01605136|467569743|FG001|Study Period|Withdrawal by Subject|0|||
129893362|NCT01605136|467569742|FG000|Study Period|Physician Decision|1|||
129893363|NCT01605136|467569743|FG001|Study Period|Physician Decision|1|||
129893364|NCT01605136|467569742|FG000|Study Period|Lost to Follow-up|0|||
129893365|NCT01605136|467569743|FG001|Study Period|Lost to Follow-up|2|||
129737568|NCT03443427|467000272|FG000|Overall Study|Other|4|||
129737569|NCT03443427|467000273|FG001|Overall Study|Other|6|||
129737570|NCT02576860|467000274|FG000|Overall Study|Adverse Event|6|||
129893366|NCT01605136|467569742|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
129737571|NCT02576860|467000275|FG001|Overall Study|Adverse Event|6|||
129805667|NCT00506662|467256756|FG000|Overall Study|Not recorded|4|||
129737572|NCT02576860|467000274|FG000|Overall Study|Lost to Follow-up|5|||
129737573|NCT02576860|467000275|FG001|Overall Study|Lost to Follow-up|7|||
129737574|NCT02576860|467000274|FG000|Overall Study|Physician Decision|0|||
129737575|NCT02576860|467000275|FG001|Overall Study|Physician Decision|1|||
129737576|NCT02576860|467000274|FG000|Overall Study|Protocol Violation|0|||
129737577|NCT02576860|467000275|FG001|Overall Study|Protocol Violation|2|||
129737578|NCT02576860|467000274|FG000|Overall Study|Withdrawal by Subject|13|||
129737579|NCT02576860|467000275|FG001|Overall Study|Withdrawal by Subject|8|||
129737580|NCT02576860|467000274|FG000|Overall Study|Disallowed medication|1|||
129737581|NCT02576860|467000275|FG001|Overall Study|Disallowed medication|0|||
129737582|NCT01541917|467000276|FG000|Overall Study|Lost to Follow-up|2|||
129737583|NCT01541917|467000277|FG001|Overall Study|Lost to Follow-up|2|||
129737584|NCT01541917|467000276|FG000|Overall Study|Withdrawal by Subject|13|||
129737585|NCT01541917|467000277|FG001|Overall Study|Withdrawal by Subject|7|||
129737586|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
129737587|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
129737588|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
129737589|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
129737590|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
129737591|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
129737592|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
129737593|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
129737594|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
129737595|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
129737596|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
129737597|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
129737598|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
129737599|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
129737600|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
129737601|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
129737602|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
129737603|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
129737604|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
129737605|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
129737606|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
129737607|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
129737608|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
129737609|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
129737610|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
129737611|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
129737612|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
129737613|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
129737614|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
129737615|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
129737616|NCT00121641|467000278|FG000|24-week Short-term Treatment Period|Other Reason|1|||
129805668|NCT00506662|467256757|FG001|Overall Study|Not recorded|6|||
129805669|NCT00246753|467256758|FG000|Overall Study|Withdrawal by Subject|2|||
129805670|NCT00246753|467256758|FG000|Overall Study|Physician Decision|2|||
129805671|NCT00246753|467256758|FG000|Overall Study|Adverse Event|2|||
129805672|NCT00246753|467256758|FG000|Overall Study|Unacceptable toxicity|2|||
129805673|NCT00617851|467256762|FG000|Overall Study|Death|0|||
129805674|NCT00617851|467256763|FG001|Overall Study|Death|0|||
129805675|NCT00617851|467256764|FG002|Overall Study|Death|0|||
129805676|NCT00617851|467256765|FG003|Overall Study|Death|1|||
129805677|NCT00617851|467256762|FG000|Overall Study|Withdrawal by Subject|14|||
129805678|NCT00617851|467256763|FG001|Overall Study|Withdrawal by Subject|7|||
129737617|NCT00121641|467000279|FG001|24-week Short-term Treatment Period|Other Reason|0|||
129737618|NCT00121641|467000280|FG002|24-week Short-term Treatment Period|Other Reason|0|||
129737619|NCT00121641|467000281|FG003|24-week Short-term Treatment Period|Other Reason|0|||
129737620|NCT00121641|467000282|FG004|24-week Short-term Treatment Period|Other Reason|0|||
129805679|NCT00617851|467256764|FG002|Overall Study|Withdrawal by Subject|12|||
129805680|NCT00617851|467256765|FG003|Overall Study|Withdrawal by Subject|4|||
129737621|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
129737622|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
129805681|NCT00617851|467256762|FG000|Overall Study|Lost to Follow-up|27|||
129805682|NCT00617851|467256763|FG001|Overall Study|Lost to Follow-up|29|||
129805683|NCT00617851|467256764|FG002|Overall Study|Lost to Follow-up|31|||
129737623|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
129737624|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
129737625|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
129737626|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
129737627|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
129737628|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
129737629|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
129737630|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
129737631|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
129737632|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
129737633|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
129737634|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
129737635|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
129737636|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
129737637|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
129737638|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
129737639|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
129737640|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
129737641|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
129737642|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
129737643|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
129737644|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
129737645|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
129737646|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
129737647|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
129737648|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
129737649|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
129737650|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
129737651|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
129737652|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
129737653|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
129737654|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
129737655|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
129737656|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
129737657|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
129737658|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
129737659|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
129737660|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
129737661|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Death|0|||
129737662|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Death|0|||
129737663|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Death|0|||
129737664|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Death|1|||
129737665|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Death|0|||
129737666|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Missing|0|||
129737667|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Missing|0|||
129737668|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Missing|1|||
129737669|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Missing|0|||
129737670|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Missing|0|||
129737671|NCT00121641|467000278|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
129737672|NCT00121641|467000279|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
129737673|NCT00121641|467000280|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
129737674|NCT00121641|467000281|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
129737675|NCT00121641|467000282|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
129737676|NCT00094107|467000289|FG000|Overall Study|Lack of Efficacy|23|||
129737677|NCT00094107|467000289|FG000|Overall Study|Death|5|||
129737678|NCT00094107|467000289|FG000|Overall Study|Adverse Event|3|||
129737679|NCT00094107|467000289|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
129737680|NCT00525824|467000292|FG000|Overall Study|Adverse Event|7|||
129737681|NCT00525824|467000293|FG001|Overall Study|Adverse Event|11|||
129737682|NCT00525824|467000294|FG002|Overall Study|Adverse Event|6|||
129737683|NCT00525824|467000295|FG003|Overall Study|Adverse Event|7|||
129737684|NCT00525824|467000292|FG000|Overall Study|Withdrawal by Subject|5|||
129737685|NCT00525824|467000293|FG001|Overall Study|Withdrawal by Subject|9|||
129737686|NCT00525824|467000294|FG002|Overall Study|Withdrawal by Subject|3|||
129737687|NCT00525824|467000295|FG003|Overall Study|Withdrawal by Subject|4|||
129737688|NCT00525824|467000292|FG000|Overall Study|Lost to Follow-up|4|||
129737689|NCT00525824|467000293|FG001|Overall Study|Lost to Follow-up|2|||
129737690|NCT00525824|467000294|FG002|Overall Study|Lost to Follow-up|4|||
129737691|NCT00525824|467000295|FG003|Overall Study|Lost to Follow-up|0|||
129737692|NCT00525824|467000292|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
129737693|NCT00525824|467000293|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
129737694|NCT00525824|467000294|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
129737695|NCT00525824|467000295|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
129737696|NCT00525824|467000292|FG000|Overall Study|Severe non-compliance|0|||
129737697|NCT00525824|467000293|FG001|Overall Study|Severe non-compliance|1|||
129737698|NCT00525824|467000294|FG002|Overall Study|Severe non-compliance|1|||
129737699|NCT00525824|467000295|FG003|Overall Study|Severe non-compliance|1|||
129737700|NCT00525824|467000292|FG000|Overall Study|Safety reasons|1|||
129737701|NCT00525824|467000293|FG001|Overall Study|Safety reasons|0|||
129737702|NCT00525824|467000294|FG002|Overall Study|Safety reasons|1|||
129737703|NCT00525824|467000295|FG003|Overall Study|Safety reasons|0|||
129737704|NCT00525824|467000292|FG000|Overall Study|Other|1|||
129737705|NCT00525824|467000293|FG001|Overall Study|Other|3|||
129737706|NCT00525824|467000294|FG002|Overall Study|Other|3|||
129737707|NCT00525824|467000295|FG003|Overall Study|Other|1|||
129737708|NCT00806442|467000299|FG000|Overall Study|Lost to Follow-up|3|||
129737709|NCT00806442|467000300|FG001|Overall Study|Lost to Follow-up|2|||
129737710|NCT00806442|467000299|FG000|Overall Study|Withdrawal by Subject|1|||
129737711|NCT00806442|467000300|FG001|Overall Study|Withdrawal by Subject|5|||
129737712|NCT01264770|467000316|FG000|Overall Study|Not reported|0|||
129737713|NCT01264770|467000317|FG001|Overall Study|Not reported|0|||
129737714|NCT01264770|467000318|FG002|Overall Study|Not reported|1|||
129737715|NCT01264770|467000319|FG003|Overall Study|Not reported|0|||
129737716|NCT01264770|467000320|FG004|Overall Study|Not reported|0|||
129737717|NCT01264770|467000321|FG005|Overall Study|Not reported|0|||
129737718|NCT01264770|467000316|FG000|Overall Study|e.g., change in circumstances|8|||
129737719|NCT01264770|467000317|FG001|Overall Study|e.g., change in circumstances|3|||
129737720|NCT01264770|467000318|FG002|Overall Study|e.g., change in circumstances|3|||
129737721|NCT01264770|467000319|FG003|Overall Study|e.g., change in circumstances|3|||
129737722|NCT01264770|467000320|FG004|Overall Study|e.g., change in circumstances|4|||
129805684|NCT00617851|467256765|FG003|Overall Study|Lost to Follow-up|19|||
129805685|NCT00617851|467256762|FG000|Overall Study|Inappropriate Enrollment|5|||
129805686|NCT00617851|467256763|FG001|Overall Study|Inappropriate Enrollment|4|||
129805687|NCT00617851|467256764|FG002|Overall Study|Inappropriate Enrollment|1|||
129805688|NCT00617851|467256765|FG003|Overall Study|Inappropriate Enrollment|1|||
129805689|NCT00617851|467256762|FG000|Overall Study|Unable to classify|1|||
129805690|NCT00617851|467256763|FG001|Overall Study|Unable to classify|0|||
129805691|NCT00617851|467256764|FG002|Overall Study|Unable to classify|1|||
129805692|NCT00617851|467256765|FG003|Overall Study|Unable to classify|0|||
129805693|NCT01200524|467256766|FG000|Overall Study|Withdrawal by Subject|1|||
129805694|NCT01200524|467256767|FG001|Overall Study|Withdrawal by Subject|1|||
129805695|NCT01200524|467256768|FG002|Overall Study|Withdrawal by Subject|3|||
129737723|NCT01264770|467000321|FG005|Overall Study|e.g., change in circumstances|4|||
129737724|NCT01264770|467000316|FG000|Overall Study|Severe non-compliance to protocol|0|||
129737725|NCT01264770|467000317|FG001|Overall Study|Severe non-compliance to protocol|0|||
129737726|NCT01264770|467000318|FG002|Overall Study|Severe non-compliance to protocol|1|||
129737727|NCT01264770|467000319|FG003|Overall Study|Severe non-compliance to protocol|1|||
129737728|NCT01264770|467000320|FG004|Overall Study|Severe non-compliance to protocol|0|||
129737729|NCT01264770|467000321|FG005|Overall Study|Severe non-compliance to protocol|0|||
129737730|NCT01264770|467000316|FG000|Overall Study|Lack of therapeutic response|1|||
129805696|NCT01200524|467256766|FG000|Overall Study|Adverse Event|1|||
129805697|NCT01200524|467256767|FG001|Overall Study|Adverse Event|0|||
129737731|NCT01264770|467000317|FG001|Overall Study|Lack of therapeutic response|0|||
129737732|NCT01264770|467000318|FG002|Overall Study|Lack of therapeutic response|2|||
129737733|NCT01264770|467000319|FG003|Overall Study|Lack of therapeutic response|1|||
129737734|NCT01264770|467000320|FG004|Overall Study|Lack of therapeutic response|1|||
129737735|NCT01264770|467000321|FG005|Overall Study|Lack of therapeutic response|0|||
129893367|NCT01605136|467569743|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
129893368|NCT01072929|467569744|FG000|Overall Study|Adverse Event|8|||
129893369|NCT01072929|467569745|FG001|Overall Study|Adverse Event|11|||
129893370|NCT01072929|467569746|FG002|Overall Study|Adverse Event|2|||
129893371|NCT01072929|467569744|FG000|Overall Study|Lack of Efficacy|7|||
129893372|NCT01072929|467569745|FG001|Overall Study|Lack of Efficacy|4|||
129893373|NCT01072929|467569746|FG002|Overall Study|Lack of Efficacy|0|||
129893374|NCT01072929|467569744|FG000|Overall Study|Withdrawal by Subject|7|||
129893375|NCT01072929|467569745|FG001|Overall Study|Withdrawal by Subject|15|||
129893376|NCT01072929|467569746|FG002|Overall Study|Withdrawal by Subject|3|||
129893377|NCT01072929|467569744|FG000|Overall Study|Protocol Violation|13|||
129893378|NCT01072929|467569745|FG001|Overall Study|Protocol Violation|11|||
129893379|NCT01072929|467569746|FG002|Overall Study|Protocol Violation|2|||
129893380|NCT01072929|467569744|FG000|Overall Study|Lost to Follow-up|8|||
129893381|NCT01072929|467569745|FG001|Overall Study|Lost to Follow-up|4|||
129893382|NCT01072929|467569746|FG002|Overall Study|Lost to Follow-up|1|||
129893383|NCT01072929|467569744|FG000|Overall Study|Noncompliance with study medication|0|||
129893384|NCT01072929|467569745|FG001|Overall Study|Noncompliance with study medication|3|||
129893385|NCT01072929|467569746|FG002|Overall Study|Noncompliance with study medication|0|||
129893386|NCT01072929|467569744|FG000|Overall Study|Noncompliance with study procedures|1|||
129893387|NCT01072929|467569745|FG001|Overall Study|Noncompliance with study procedures|0|||
129893388|NCT01072929|467569746|FG002|Overall Study|Noncompliance with study procedures|1|||
129893389|NCT01072929|467569744|FG000|Overall Study|Other|0|||
129893390|NCT01072929|467569745|FG001|Overall Study|Other|3|||
129893391|NCT01072929|467569746|FG002|Overall Study|Other|0|||
129893392|NCT04824131|467569747|FG000|CAB LA Oral Phase|Adverse Event|1|||
129893393|NCT04824131|467569747|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
129893394|NCT04824131|467569747|FG000|Step 3|Withdrawal by Subject|2|||
129893395|NCT05489224|467569748|FG000|Treatment Period I|Withdrawal by Subject|6|||
129893396|NCT05489224|467569749|FG001|Treatment Period I|Withdrawal by Subject|5|||
129893397|NCT05489224|467569750|FG002|Treatment Period I|Withdrawal by Subject|0|||
129893398|NCT05489224|467569748|FG000|Treatment Period I|Adverse Event|3|||
129893399|NCT05489224|467569749|FG001|Treatment Period I|Adverse Event|11|||
129893400|NCT05489224|467569750|FG002|Treatment Period I|Adverse Event|0|||
129893401|NCT05489224|467569748|FG000|Treatment Period I|Lost to Follow-up|0|||
129893402|NCT05489224|467569749|FG001|Treatment Period I|Lost to Follow-up|1|||
129893403|NCT05489224|467569750|FG002|Treatment Period I|Lost to Follow-up|0|||
129893404|NCT05489224|467569748|FG000|Treatment Period I|Physician Decision|0|||
129893405|NCT05489224|467569749|FG001|Treatment Period I|Physician Decision|1|||
129893406|NCT05489224|467569750|FG002|Treatment Period I|Physician Decision|0|||
129893407|NCT05489224|467569748|FG000|Treatment Period II up to Week 32|Ongoing|222|||
129893408|NCT05489224|467569749|FG001|Treatment Period II up to Week 32|Ongoing|107|||
129893409|NCT05489224|467569750|FG002|Treatment Period II up to Week 32|Ongoing|107|||
129893410|NCT05489224|467569748|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
129893411|NCT05489224|467569749|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
129737736|NCT01264770|467000316|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
129893412|NCT05489224|467569750|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
129893413|NCT05489224|467569748|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
129893414|NCT05489224|467569749|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
129893415|NCT05489224|467569750|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
129893416|NCT04887285|467569752|FG000|Overall Study|Lost to Follow-up|0|||
129893417|NCT04887285|467569753|FG001|Overall Study|Lost to Follow-up|2|||
129893418|NCT04887285|467569754|FG002|Overall Study|Lost to Follow-up|3|||
129893419|NCT04640571|467569755|FG000|Overall Study|Withdrawal by Subject|0|||
129893420|NCT04640571|467569756|FG001|Overall Study|Withdrawal by Subject|0|||
129893421|NCT04640571|467569757|FG002|Overall Study|Withdrawal by Subject|0|||
129893422|NCT04640571|467569758|FG003|Overall Study|Withdrawal by Subject|0|||
129893423|NCT04640571|467569759|FG004|Overall Study|Withdrawal by Subject|0|||
129893424|NCT04640571|467569760|FG005|Overall Study|Withdrawal by Subject|2|||
129893425|NCT01723774|467569766|FG000|Neoadjuvant|Ki67 > 10%|4|||
129893426|NCT01723774|467569767|FG001|Neoadjuvant|Ki67 > 10%|0|||
129893427|NCT01723774|467569768|FG002|Neoadjuvant|Ki67 > 10%|10|||
129893428|NCT01723774|467569769|FG003|Neoadjuvant|Ki67 > 10%|0|||
129893429|NCT01723774|467569766|FG000|Neoadjuvant|Withdrawal by Subject|3|||
129893430|NCT01723774|467569767|FG001|Neoadjuvant|Withdrawal by Subject|1|||
129893431|NCT01723774|467569768|FG002|Neoadjuvant|Withdrawal by Subject|0|||
129893432|NCT01723774|467569769|FG003|Neoadjuvant|Withdrawal by Subject|0|||
129893433|NCT01723774|467569766|FG000|Neoadjuvant|Disease progression|0|||
129893434|NCT01723774|467569767|FG001|Neoadjuvant|Disease progression|1|||
129893435|NCT01723774|467569768|FG002|Neoadjuvant|Disease progression|1|||
129893436|NCT01723774|467569769|FG003|Neoadjuvant|Disease progression|0|||
129893437|NCT01723774|467569766|FG000|Neoadjuvant|Adverse Event|0|||
129893438|NCT01723774|467569767|FG001|Neoadjuvant|Adverse Event|1|||
129893439|NCT01723774|467569768|FG002|Neoadjuvant|Adverse Event|2|||
129893440|NCT01723774|467569769|FG003|Neoadjuvant|Adverse Event|0|||
129893441|NCT01723774|467569766|FG000|Neoadjuvant|High estradiol|0|||
129893442|NCT01723774|467569767|FG001|Neoadjuvant|High estradiol|1|||
129805698|NCT01200524|467256768|FG002|Overall Study|Adverse Event|0|||
129805699|NCT01200524|467256766|FG000|Overall Study|Non availability of study nurse|0|||
129805700|NCT01200524|467256767|FG001|Overall Study|Non availability of study nurse|0|||
129805701|NCT01200524|467256768|FG002|Overall Study|Non availability of study nurse|1|||
129805702|NCT01303861|467256769|FG000|Overall Study|Lost to Follow-up|34|||
129805703|NCT01303861|467256770|FG001|Overall Study|Lost to Follow-up|14|||
129805704|NCT01303861|467256771|FG002|Overall Study|Lost to Follow-up|27|||
129805705|NCT01303861|467256772|FG003|Overall Study|Lost to Follow-up|31|||
129805706|NCT01303861|467256769|FG000|Overall Study|Lack of Efficacy|3|||
129805707|NCT01303861|467256770|FG001|Overall Study|Lack of Efficacy|2|||
129805708|NCT01303861|467256771|FG002|Overall Study|Lack of Efficacy|1|||
129805709|NCT01303861|467256772|FG003|Overall Study|Lack of Efficacy|0|||
129805710|NCT01303861|467256769|FG000|Overall Study|Withdrawal by Subject|16|||
129805711|NCT01303861|467256770|FG001|Overall Study|Withdrawal by Subject|8|||
129805712|NCT01303861|467256771|FG002|Overall Study|Withdrawal by Subject|8|||
129805713|NCT01303861|467256772|FG003|Overall Study|Withdrawal by Subject|23|||
129805714|NCT01303861|467256769|FG000|Overall Study|Adverse Event|4|||
129805715|NCT01303861|467256770|FG001|Overall Study|Adverse Event|1|||
129805716|NCT01303861|467256771|FG002|Overall Study|Adverse Event|0|||
129805717|NCT01303861|467256772|FG003|Overall Study|Adverse Event|5|||
129805718|NCT01303861|467256769|FG000|Overall Study|Pregnancy|1|||
129805719|NCT01303861|467256770|FG001|Overall Study|Pregnancy|0|||
129805720|NCT01303861|467256771|FG002|Overall Study|Pregnancy|0|||
129805721|NCT01303861|467256772|FG003|Overall Study|Pregnancy|0|||
129805722|NCT02476201|467256775|FG000|Overall Study|Unable to program MPP|9|||
129805723|NCT02476201|467256775|FG000|Overall Study|Study echo not performed|5|||
129805724|NCT02476201|467256775|FG000|Overall Study|Adverse Event|4|||
129805725|NCT02476201|467256775|FG000|Overall Study|Death|2|||
129805726|NCT02476201|467256775|FG000|Overall Study|Lost to Follow-up|2|||
129805727|NCT02476201|467256775|FG000|Overall Study|MPP programmed to OFF|2|||
129805728|NCT02476201|467256775|FG000|Overall Study|Withdrawal by Subject|1|||
129805729|NCT02476201|467256775|FG000|Overall Study|Unsuccessful implant|1|||
129805730|NCT02248701|467256781|FG000|Overall Study|Withdrawal by Subject|2|||
129805731|NCT02248701|467256782|FG001|Overall Study|Withdrawal by Subject|1|||
129805732|NCT02248701|467256781|FG000|Overall Study|Physician Decision|0|||
129805733|NCT02248701|467256782|FG001|Overall Study|Physician Decision|1|||
129805734|NCT02248701|467256781|FG000|Overall Study|Adverse Event|1|||
129805735|NCT02248701|467256782|FG001|Overall Study|Adverse Event|0|||
129805736|NCT02248701|467256781|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
129805737|NCT02248701|467256782|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
129805738|NCT00845858|467256783|FG000|Overall Study|Withdrawal by Subject|5|||
129805739|NCT00845858|467256784|FG001|Overall Study|Withdrawal by Subject|1|||
129805740|NCT00845858|467256785|FG002|Overall Study|Withdrawal by Subject|1|||
129805741|NCT00845858|467256783|FG000|Overall Study|Adverse Event|3|||
129805742|NCT00845858|467256784|FG001|Overall Study|Adverse Event|8|||
129805743|NCT00845858|467256785|FG002|Overall Study|Adverse Event|4|||
129805744|NCT00845858|467256783|FG000|Overall Study|Protocol Violation|0|||
129805745|NCT00845858|467256784|FG001|Overall Study|Protocol Violation|0|||
129805746|NCT00845858|467256785|FG002|Overall Study|Protocol Violation|1|||
129805747|NCT00845858|467256783|FG000|Overall Study|not eligible|0|||
129444842|NCT03427125|465929454|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
129444843|NCT03427125|465929455|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
129444844|NCT03427125|465929456|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
129444845|NCT05975840|465929457|FG000|Overall Study|Other|1|||
129444846|NCT05975840|465929458|FG001|Overall Study|Other|0|||
129444847|NCT05975840|465929459|FG002|Overall Study|Other|0|||
129444848|NCT05975840|465929460|FG003|Overall Study|Other|0|||
129444849|NCT05975840|465929461|FG004|Overall Study|Other|1|||
129444850|NCT05975840|465929462|FG005|Overall Study|Other|0|||
129444851|NCT05975840|465929463|FG006|Overall Study|Other|0|||
129444852|NCT05975840|465929464|FG007|Overall Study|Other|0|||
129444853|NCT05975840|465929457|FG000|Overall Study|Lost to Follow-up|3|||
129444854|NCT05975840|465929458|FG001|Overall Study|Lost to Follow-up|6|||
129444855|NCT05975840|465929459|FG002|Overall Study|Lost to Follow-up|3|||
129444856|NCT05975840|465929460|FG003|Overall Study|Lost to Follow-up|1|||
129444857|NCT05975840|465929461|FG004|Overall Study|Lost to Follow-up|4|||
129444858|NCT05975840|465929462|FG005|Overall Study|Lost to Follow-up|1|||
129444859|NCT05975840|465929463|FG006|Overall Study|Lost to Follow-up|2|||
129444860|NCT05975840|465929464|FG007|Overall Study|Lost to Follow-up|4|||
129444861|NCT05975840|465929457|FG000|Overall Study|Migrated/moved from the study area|1|||
129444862|NCT05975840|465929458|FG001|Overall Study|Migrated/moved from the study area|0|||
129444863|NCT05975840|465929459|FG002|Overall Study|Migrated/moved from the study area|0|||
129444864|NCT05975840|465929460|FG003|Overall Study|Migrated/moved from the study area|0|||
129444865|NCT05975840|465929461|FG004|Overall Study|Migrated/moved from the study area|0|||
129805748|NCT00845858|467256784|FG001|Overall Study|not eligible|3|||
129805749|NCT00845858|467256785|FG002|Overall Study|not eligible|2|||
129805750|NCT00880542|467256786|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
129805751|NCT00880542|467256786|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
129805752|NCT00880542|467256786|FG000|REP: Surgical Resection|progressive disease|1|||
129444866|NCT05975840|465929462|FG005|Overall Study|Migrated/moved from the study area|0|||
129444867|NCT05975840|465929463|FG006|Overall Study|Migrated/moved from the study area|0|||
129444868|NCT05975840|465929464|FG007|Overall Study|Migrated/moved from the study area|0|||
129444869|NCT05975840|465929457|FG000|Overall Study|Withdrawal by Subject|0|||
129444870|NCT05975840|465929458|FG001|Overall Study|Withdrawal by Subject|5|||
129444871|NCT05975840|465929459|FG002|Overall Study|Withdrawal by Subject|2|||
129444872|NCT05975840|465929460|FG003|Overall Study|Withdrawal by Subject|2|||
129444873|NCT05975840|465929461|FG004|Overall Study|Withdrawal by Subject|0|||
129444874|NCT05975840|465929462|FG005|Overall Study|Withdrawal by Subject|2|||
129444875|NCT05975840|465929463|FG006|Overall Study|Withdrawal by Subject|2|||
129444876|NCT05975840|465929464|FG007|Overall Study|Withdrawal by Subject|1|||
129444877|NCT05975840|465929457|FG000|Overall Study|Protocol Violation|0|||
129444878|NCT05975840|465929458|FG001|Overall Study|Protocol Violation|1|||
129444879|NCT05975840|465929459|FG002|Overall Study|Protocol Violation|0|||
129444880|NCT05975840|465929460|FG003|Overall Study|Protocol Violation|0|||
129444881|NCT05975840|465929461|FG004|Overall Study|Protocol Violation|0|||
129444882|NCT05975840|465929462|FG005|Overall Study|Protocol Violation|0|||
129444883|NCT05975840|465929463|FG006|Overall Study|Protocol Violation|0|||
129444884|NCT05975840|465929464|FG007|Overall Study|Protocol Violation|0|||
129444885|NCT05975840|465929457|FG000|Overall Study|Adverse Event|0|||
129444886|NCT05975840|465929458|FG001|Overall Study|Adverse Event|0|||
129444887|NCT05975840|465929459|FG002|Overall Study|Adverse Event|0|||
129444888|NCT05975840|465929460|FG003|Overall Study|Adverse Event|1|||
129444889|NCT05975840|465929461|FG004|Overall Study|Adverse Event|0|||
129444890|NCT05975840|465929462|FG005|Overall Study|Adverse Event|0|||
129444891|NCT05975840|465929463|FG006|Overall Study|Adverse Event|0|||
129444892|NCT05975840|465929464|FG007|Overall Study|Adverse Event|0|||
129737737|NCT01264770|467000317|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
129737738|NCT01264770|467000318|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
129737739|NCT01264770|467000319|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
129737740|NCT01264770|467000320|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
129737741|NCT01264770|467000321|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
129737742|NCT01264770|467000316|FG000|Overall Study|Lost to Follow-up|0|||
129737743|NCT01264770|467000317|FG001|Overall Study|Lost to Follow-up|0|||
129737744|NCT01264770|467000318|FG002|Overall Study|Lost to Follow-up|1|||
129805753|NCT04289623|467256787|FG000|Wave 1 Emails|Email was not delivered|268|||
129805754|NCT04289623|467256788|FG001|Wave 1 Emails|Email was not delivered|257|||
129805755|NCT04289623|467256789|FG002|Wave 1 Emails|Email was not delivered|0|||
129444893|NCT05975840|465929457|FG000|Overall Study|Death|0|||
129444894|NCT05975840|465929458|FG001|Overall Study|Death|1|||
129444895|NCT05975840|465929459|FG002|Overall Study|Death|0|||
129444896|NCT05975840|465929460|FG003|Overall Study|Death|0|||
129737745|NCT01264770|467000319|FG003|Overall Study|Lost to Follow-up|1|||
129805756|NCT04289623|467256790|FG003|Wave 1 Emails|Email was not delivered|0|||
129805757|NCT04289623|467256791|FG004|Wave 1 Emails|Email was not delivered|0|||
129444897|NCT05975840|465929461|FG004|Overall Study|Death|0|||
129444898|NCT05975840|465929462|FG005|Overall Study|Death|0|||
129444899|NCT05975840|465929463|FG006|Overall Study|Death|0|||
129737746|NCT01264770|467000320|FG004|Overall Study|Lost to Follow-up|0|||
129737747|NCT01264770|467000321|FG005|Overall Study|Lost to Follow-up|0|||
129737748|NCT01264770|467000316|FG000|Overall Study|Adverse Event|7|||
129737749|NCT01264770|467000317|FG001|Overall Study|Adverse Event|7|||
129737750|NCT01264770|467000318|FG002|Overall Study|Adverse Event|8|||
129737751|NCT01264770|467000319|FG003|Overall Study|Adverse Event|0|||
129737752|NCT01264770|467000320|FG004|Overall Study|Adverse Event|2|||
129737753|NCT01264770|467000321|FG005|Overall Study|Adverse Event|1|||
129737754|NCT02356887|467000325|FG000|Overall Study|poor compliance|2|||
129737755|NCT01490294|467000326|FG000|Overall Study|Prematurely discontinuation|4|||
129737756|NCT01490294|467000327|FG001|Overall Study|Prematurely discontinuation|0|||
129737757|NCT01490294|467000328|FG002|Overall Study|Prematurely discontinuation|1|||
129737758|NCT01490294|467000329|FG003|Overall Study|Prematurely discontinuation|1|||
129737759|NCT01490294|467000326|FG000|Overall Study|Adverse Event|1|||
129737760|NCT01490294|467000327|FG001|Overall Study|Adverse Event|0|||
129737761|NCT01490294|467000328|FG002|Overall Study|Adverse Event|0|||
129737762|NCT01490294|467000329|FG003|Overall Study|Adverse Event|0|||
129737763|NCT00160654|467000336|FG000|Overall Study|Adverse Event|14|||
129444900|NCT05975840|465929464|FG007|Overall Study|Death|1|||
129444901|NCT04014361|465929467|FG000|Period 2|Physician Decision|0|||
129737764|NCT00160654|467000336|FG000|Overall Study|Lack of Efficacy|4|||
129737765|NCT00160654|467000336|FG000|Overall Study|Lost to Follow-up|2|||
129737766|NCT00160654|467000336|FG000|Overall Study|Intake of expired drug|7|||
129737767|NCT00160654|467000336|FG000|Overall Study|Psychological trauma|1|||
129737768|NCT00160654|467000336|FG000|Overall Study|Sponsor decision|1|||
129737769|NCT00160654|467000336|FG000|Overall Study|Patient met exclusion criteria|1|||
129737770|NCT00160654|467000336|FG000|Overall Study|Patient decision|1|||
129737771|NCT00160654|467000336|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
129737772|NCT00160654|467000336|FG000|Overall Study|Met exclusion criteria|1|||
129737773|NCT02404649|467000337|FG000|Overall Study|Adverse Event|1|||
129737774|NCT02404649|467000338|FG001|Overall Study|Adverse Event|2|||
129737775|NCT00330668|467000342|FG000|BID Dosing Period|Adverse Event|1|||
129737776|NCT00330668|467000342|FG000|BID Dosing Period|Lost to Follow-up|7|||
129737777|NCT00330668|467000342|FG000|BID Dosing Period|Non-Compliance|5|||
129737778|NCT00330668|467000342|FG000|BID Dosing Period|Withdrawal by Subject|19|||
129737779|NCT00330668|467000342|FG000|BID Dosing Period|Sponsor's decision|1|||
129737780|NCT00330668|467000342|FG000|BID Dosing Period|Other|3|||
129737781|NCT00330668|467000342|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
129737782|NCT00330668|467000342|FG000|QD Dosing Period|Other|1|||
129737783|NCT00330668|467000342|FG000|QD Dosing Period|Withdrawal by Subject|1|||
129737784|NCT00330668|467000342|FG000|QD Dosing Period|Lost to Follow-up|2|||
129737785|NCT01839656|467000343|FG000|Overall Study|Withdrawal by Subject|1|||
129737786|NCT01839656|467000344|FG001|Overall Study|Withdrawal by Subject|1|||
129737787|NCT01839656|467000343|FG000|Overall Study|Adverse event, serious fatal|1|||
129737788|NCT01839656|467000344|FG001|Overall Study|Adverse event, serious fatal|4|||
129737789|NCT01839656|467000343|FG000|Overall Study|Early study closure|0|||
129737790|NCT01839656|467000344|FG001|Overall Study|Early study closure|11|||
129737791|NCT01839656|467000343|FG000|Overall Study|Adverse Event|1|||
129737792|NCT01839656|467000344|FG001|Overall Study|Adverse Event|0|||
129737793|NCT02535416|467000354|FG000|Overall Study|Family bereavement overseas|1|||
129737794|NCT02535416|467000355|FG001|Overall Study|Family bereavement overseas|0|||
129737795|NCT02535416|467000356|FG002|Overall Study|Family bereavement overseas|0|||
129737796|NCT02535416|467000357|FG003|Overall Study|Family bereavement overseas|0|||
129737797|NCT02535416|467000358|FG004|Overall Study|Family bereavement overseas|0|||
129737798|NCT02535416|467000359|FG005|Overall Study|Family bereavement overseas|0|||
129737799|NCT02535416|467000360|FG006|Overall Study|Family bereavement overseas|0|||
129737800|NCT02535416|467000361|FG007|Overall Study|Family bereavement overseas|0|||
129737801|NCT02535416|467000362|FG008|Overall Study|Family bereavement overseas|0|||
129805758|NCT04289623|467256792|FG005|Wave 1 Emails|Email was not delivered|0|||
129805759|NCT03758443|467256793|FG000|Induction Period|Adverse Event|2|||
129805760|NCT03758443|467256794|FG001|Induction Period|Adverse Event|4|||
129805761|NCT03758443|467256795|FG002|Induction Period|Adverse Event|2|||
129805762|NCT03758443|467256796|FG003|Induction Period|Adverse Event|3|||
129805763|NCT03758443|467256793|FG000|Induction Period|Physician Decision|1|||
129805764|NCT03758443|467256794|FG001|Induction Period|Physician Decision|1|||
129805765|NCT03758443|467256795|FG002|Induction Period|Physician Decision|3|||
129805766|NCT03758443|467256796|FG003|Induction Period|Physician Decision|0|||
129805767|NCT03758443|467256793|FG000|Induction Period|Protocol Violation|0|||
129737802|NCT02739321|467000365|FG000|Overall Study|Lack of Efficacy|1|||
129737803|NCT02739321|467000366|FG001|Overall Study|Lack of Efficacy|1|||
129737804|NCT02739321|467000365|FG000|Overall Study|Lost to Follow-up|1|||
129737805|NCT02739321|467000366|FG001|Overall Study|Lost to Follow-up|1|||
129737806|NCT02739321|467000365|FG000|Overall Study|Withdrawal by Subject|1|||
129737807|NCT02739321|467000366|FG001|Overall Study|Withdrawal by Subject|2|||
129737808|NCT01711866|467000367|FG000|Overall Study|Noncompliant|3|||
129805768|NCT03758443|467256794|FG001|Induction Period|Protocol Violation|0|||
129805769|NCT03758443|467256795|FG002|Induction Period|Protocol Violation|0|||
129444902|NCT04014361|465929468|FG001|Period 2|Physician Decision|0|||
129444903|NCT04014361|465929469|FG002|Period 2|Physician Decision|0|||
129444904|NCT04014361|465929470|FG003|Period 2|Physician Decision|1|||
129444905|NCT04014361|465929471|FG004|Period 2|Physician Decision|0|||
129444906|NCT04014361|465929472|FG005|Period 2|Physician Decision|0|||
129444907|NCT04014361|465929473|FG006|Period 2|Physician Decision|0|||
129444908|NCT04014361|465929474|FG007|Period 2|Physician Decision|0|||
129444909|NCT02593786|465929476|FG000|Overall Study|Disease progression|12|||
129444910|NCT02593786|465929477|FG001|Overall Study|Disease progression|16|||
129444911|NCT02593786|465929478|FG002|Overall Study|Disease progression|10|||
129444912|NCT02593786|465929479|FG003|Overall Study|Disease progression|7|||
129444913|NCT02593786|465929476|FG000|Overall Study|Study drug toxicity|1|||
129444914|NCT02593786|465929477|FG001|Overall Study|Study drug toxicity|0|||
129444915|NCT02593786|465929478|FG002|Overall Study|Study drug toxicity|0|||
129444916|NCT02593786|465929479|FG003|Overall Study|Study drug toxicity|0|||
129444917|NCT02593786|465929476|FG000|Overall Study|Adverse event unrelated to study drug|1|||
129444918|NCT02593786|465929477|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129444919|NCT02593786|465929478|FG002|Overall Study|Adverse event unrelated to study drug|1|||
129444920|NCT02593786|465929479|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129444921|NCT02593786|465929476|FG000|Overall Study|Participant request to discontinue study therapy|0|||
129444922|NCT02593786|465929477|FG001|Overall Study|Participant request to discontinue study therapy|2|||
129444923|NCT02593786|465929478|FG002|Overall Study|Participant request to discontinue study therapy|0|||
129444924|NCT02593786|465929479|FG003|Overall Study|Participant request to discontinue study therapy|0|||
129444925|NCT02593786|465929476|FG000|Overall Study|Other reasons|1|||
129444926|NCT02593786|465929477|FG001|Overall Study|Other reasons|1|||
129444927|NCT02593786|465929478|FG002|Overall Study|Other reasons|0|||
129444928|NCT02593786|465929479|FG003|Overall Study|Other reasons|5|||
129444929|NCT01130051|465929480|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
129444930|NCT01130051|465929481|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
129444931|NCT01130051|465929480|FG000|Washout Period of 14 Days|Protocol Violation|1|||
129444932|NCT01130051|465929481|FG001|Washout Period of 14 Days|Protocol Violation|1|||
129444933|NCT04252287|465929485|FG000|Overall Study|Death|5|||
129444934|NCT04252287|465929486|FG001|Overall Study|Death|3|||
129444935|NCT04252287|465929485|FG000|Overall Study|Lost to Follow-up|4|||
129444936|NCT04252287|465929486|FG001|Overall Study|Lost to Follow-up|6|||
129444937|NCT04252287|465929485|FG000|Overall Study|Withdrawal by Subject|19|||
129805770|NCT03758443|467256796|FG003|Induction Period|Protocol Violation|1|||
129805771|NCT03758443|467256793|FG000|Induction Period|Withdrawal by Subject|3|||
129805772|NCT03758443|467256794|FG001|Induction Period|Withdrawal by Subject|2|||
129805773|NCT03758443|467256795|FG002|Induction Period|Withdrawal by Subject|2|||
129805774|NCT03758443|467256796|FG003|Induction Period|Withdrawal by Subject|4|||
129805775|NCT03758443|467256793|FG000|Extended Induction Period|Adverse Event|1|||
129805776|NCT03758443|467256794|FG001|Extended Induction Period|Adverse Event|1|||
129805777|NCT03758443|467256795|FG002|Extended Induction Period|Adverse Event|0|||
129444938|NCT04252287|465929486|FG001|Overall Study|Withdrawal by Subject|16|||
129444939|NCT04252287|465929485|FG000|Overall Study|Protocol Violation|3|||
129444940|NCT04252287|465929486|FG001|Overall Study|Protocol Violation|4|||
129444941|NCT00835120|465929492|FG000|Overall Study|Lack of Efficacy|1|||
129444942|NCT00835120|465929492|FG000|Overall Study|Lost to Follow-up|3|||
129444943|NCT00835120|465929492|FG000|Overall Study|Adverse Event|2|||
129444944|NCT00835120|465929492|FG000|Overall Study|Withdrawal by Subject|2|||
129444945|NCT01298518|465929494|FG000|Overall Study|Withdrawal by Subject|0|||
129444946|NCT01298518|465929495|FG001|Overall Study|Withdrawal by Subject|0|||
129444947|NCT01298518|465929496|FG002|Overall Study|Withdrawal by Subject|1|||
129444948|NCT02273726|465929497|FG000|Overall Study|Death|70|||
129444949|NCT02273726|465929498|FG001|Overall Study|Death|62|||
129444950|NCT02273726|465929497|FG000|Overall Study|Withdrawal by Subject|41|||
129444951|NCT02273726|465929498|FG001|Overall Study|Withdrawal by Subject|29|||
129444952|NCT02273726|465929497|FG000|Overall Study|Kidney transplant|31|||
129444953|NCT02273726|465929498|FG001|Overall Study|Kidney transplant|39|||
129444954|NCT02273726|465929497|FG000|Overall Study|Physician Decision|30|||
129444955|NCT02273726|465929498|FG001|Overall Study|Physician Decision|15|||
129805778|NCT03758443|467256796|FG003|Extended Induction Period|Adverse Event|1|||
129805779|NCT03758443|467256793|FG000|Extended Induction Period|Lost to Follow-up|1|||
129805780|NCT03758443|467256794|FG001|Extended Induction Period|Lost to Follow-up|0|||
129805781|NCT03758443|467256795|FG002|Extended Induction Period|Lost to Follow-up|0|||
129444956|NCT02273726|465929497|FG000|Overall Study|Adverse Event|27|||
129444957|NCT02273726|465929498|FG001|Overall Study|Adverse Event|9|||
129444958|NCT02273726|465929497|FG000|Overall Study|Lost to Follow-up|6|||
129444959|NCT02273726|465929498|FG001|Overall Study|Lost to Follow-up|3|||
129444960|NCT02273726|465929497|FG000|Overall Study|Lack of Efficacy|6|||
129444961|NCT02273726|465929498|FG001|Overall Study|Lack of Efficacy|1|||
129444962|NCT02273726|465929497|FG000|Overall Study|Protocol Violation|4|||
129444963|NCT02273726|465929498|FG001|Overall Study|Protocol Violation|0|||
129444964|NCT02273726|465929497|FG000|Overall Study|Other than specified|28|||
129444965|NCT02273726|465929498|FG001|Overall Study|Other than specified|30|||
129444966|NCT03610165|465929499|FG000|Overall Study|Device didn't work|0|||
129444967|NCT03610165|465929500|FG001|Overall Study|Device didn't work|1|||
129737809|NCT01711866|467000367|FG000|Overall Study|Withdrawal by Subject|3|||
129737810|NCT01711866|467000367|FG000|Overall Study|Adverse Event|2|||
129737811|NCT00958217|467000371|FG000|Overall Study|Death|2|||
129737812|NCT00958217|467000372|FG001|Overall Study|Death|1|||
129737813|NCT00958217|467000371|FG000|Overall Study|Withdrawal by Subject|4|||
129737814|NCT00958217|467000372|FG001|Overall Study|Withdrawal by Subject|3|||
129737815|NCT00958217|467000371|FG000|Overall Study|Lost to Follow-up|17|||
129737816|NCT00958217|467000372|FG001|Overall Study|Lost to Follow-up|19|||
129737817|NCT00958217|467000371|FG000|Overall Study|Moved out of area|1|||
129737818|NCT00958217|467000372|FG001|Overall Study|Moved out of area|1|||
129737819|NCT00958217|467000371|FG000|Overall Study|Inpatient hospitalization|0|||
129737820|NCT00958217|467000372|FG001|Overall Study|Inpatient hospitalization|1|||
129737821|NCT01825941|467001997|FG000|Overall Study|Lost to Follow-up|4|||
129737822|NCT01825941|467001998|FG001|Overall Study|Lost to Follow-up|1|||
129737823|NCT00528996|467001999|FG000|Overall Study|Other reasons than listing|6|||
129737824|NCT00528996|467002000|FG001|Overall Study|Other reasons than listing|7|||
129737825|NCT00528996|467002001|FG002|Overall Study|Other reasons than listing|14|||
129737826|NCT00528996|467002002|FG003|Overall Study|Other reasons than listing|11|||
129737827|NCT00528996|467002003|FG004|Overall Study|Other reasons than listing|5|||
129737828|NCT00528996|467001999|FG000|Overall Study|Refused continue medication|16|||
129737829|NCT00528996|467002000|FG001|Overall Study|Refused continue medication|0|||
129737830|NCT00528996|467002001|FG002|Overall Study|Refused continue medication|3|||
129737831|NCT00528996|467002002|FG003|Overall Study|Refused continue medication|3|||
129737832|NCT00528996|467002003|FG004|Overall Study|Refused continue medication|6|||
129737833|NCT00528996|467001999|FG000|Overall Study|Lost to Follow-up|2|||
129737834|NCT00528996|467002000|FG001|Overall Study|Lost to Follow-up|0|||
129737835|NCT00528996|467002001|FG002|Overall Study|Lost to Follow-up|4|||
129737836|NCT00528996|467002002|FG003|Overall Study|Lost to Follow-up|1|||
129737837|NCT00528996|467002003|FG004|Overall Study|Lost to Follow-up|3|||
129737838|NCT00528996|467001999|FG000|Overall Study|Protocol Violation|1|||
129737839|NCT00528996|467002000|FG001|Overall Study|Protocol Violation|2|||
129737840|NCT00528996|467002001|FG002|Overall Study|Protocol Violation|3|||
129737841|NCT00528996|467002002|FG003|Overall Study|Protocol Violation|3|||
129737842|NCT00528996|467002003|FG004|Overall Study|Protocol Violation|2|||
129737843|NCT00528996|467001999|FG000|Overall Study|Lack of Efficacy|7|||
129737844|NCT00528996|467002000|FG001|Overall Study|Lack of Efficacy|2|||
129737845|NCT00528996|467002001|FG002|Overall Study|Lack of Efficacy|1|||
129737846|NCT00528996|467002002|FG003|Overall Study|Lack of Efficacy|3|||
129737847|NCT00528996|467002003|FG004|Overall Study|Lack of Efficacy|3|||
129737848|NCT00528996|467001999|FG000|Overall Study|Adverse Event|32|||
129737849|NCT00528996|467002000|FG001|Overall Study|Adverse Event|13|||
129737850|NCT00528996|467002001|FG002|Overall Study|Adverse Event|18|||
129737851|NCT00528996|467002002|FG003|Overall Study|Adverse Event|29|||
129737852|NCT00528996|467002003|FG004|Overall Study|Adverse Event|18|||
129737853|NCT05565937|467002005|FG000|Overall Study|Adverse Event|0|||
129737854|NCT05565937|467002006|FG001|Overall Study|Adverse Event|1|||
129737855|NCT05565937|467002005|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
129737856|NCT05565937|467002006|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
129737857|NCT05565937|467002005|FG000|Overall Study|Lost to Follow-up|2|||
129737858|NCT05565937|467002006|FG001|Overall Study|Lost to Follow-up|0|||
129737859|NCT05565937|467002005|FG000|Overall Study|Pregnancy|0|||
129737860|NCT05565937|467002006|FG001|Overall Study|Pregnancy|2|||
129737861|NCT05565937|467002005|FG000|Overall Study|Anisometropia|0|||
129737862|NCT05565937|467002006|FG001|Overall Study|Anisometropia|1|||
129737863|NCT04544683|467002007|FG000|Overall Study|Lost to Follow-up|2|||
129737864|NCT04544683|467002007|FG000|Overall Study|Underwent cervical spine surgery|6|||
129737865|NCT04938037|467002010|FG000|Overall Study|Lost to Follow-up|4|||
129737866|NCT04938037|467002011|FG001|Overall Study|Lost to Follow-up|3|||
129737867|NCT02943915|467002014|FG000|Overall Study|Withdrawal by Subject|2|||
129737868|NCT02943915|467002015|FG001|Overall Study|Withdrawal by Subject|1|||
129737869|NCT02943915|467002016|FG002|Overall Study|Withdrawal by Subject|0|||
129737870|NCT02943915|467002017|FG003|Overall Study|Withdrawal by Subject|0|||
129737871|NCT02943915|467002014|FG000|Overall Study|Lost to Follow-up|3|||
129737872|NCT02943915|467002015|FG001|Overall Study|Lost to Follow-up|1|||
129737873|NCT02943915|467002016|FG002|Overall Study|Lost to Follow-up|0|||
129737874|NCT02943915|467002017|FG003|Overall Study|Lost to Follow-up|0|||
129737875|NCT02943915|467002014|FG000|Overall Study|excluded|0|||
129737876|NCT02943915|467002015|FG001|Overall Study|excluded|1|||
129737877|NCT02943915|467002016|FG002|Overall Study|excluded|0|||
129737878|NCT02943915|467002017|FG003|Overall Study|excluded|0|||
129737879|NCT00004445|467002020|FG000|Overall Study|Physician Decision|2|||
129737880|NCT00004445|467002020|FG000|Overall Study|Withdrawal by Subject|1|||
129737881|NCT02753127|467002030|FG000|Overall Study|Lost to Follow-up|13|||
129737882|NCT02753127|467002031|FG001|Overall Study|Lost to Follow-up|11|||
129805782|NCT03758443|467256796|FG003|Extended Induction Period|Lost to Follow-up|0|||
129805783|NCT03758443|467256793|FG000|Extended Induction Period|Physician Decision|2|||
129805784|NCT03758443|467256794|FG001|Extended Induction Period|Physician Decision|1|||
129805785|NCT03758443|467256795|FG002|Extended Induction Period|Physician Decision|2|||
129805786|NCT03758443|467256796|FG003|Extended Induction Period|Physician Decision|2|||
129805787|NCT03758443|467256793|FG000|Extended Induction Period|Protocol Violation|0|||
129893443|NCT01723774|467569768|FG002|Neoadjuvant|High estradiol|0|||
129737883|NCT02753127|467002030|FG000|Overall Study|Withdrawal by Subject|37|||
129737884|NCT02753127|467002031|FG001|Overall Study|Withdrawal by Subject|47|||
129737885|NCT02753127|467002030|FG000|Overall Study|Other|3|||
129737886|NCT02753127|467002031|FG001|Overall Study|Other|8|||
129737887|NCT02753127|467002030|FG000|Overall Study|Hospice|0|||
129737888|NCT02753127|467002031|FG001|Overall Study|Hospice|2|||
129737889|NCT01818284|467002035|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
129737890|NCT01818284|467002036|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
129805788|NCT03758443|467256794|FG001|Extended Induction Period|Protocol Violation|0|||
129805789|NCT03758443|467256795|FG002|Extended Induction Period|Protocol Violation|0|||
129805790|NCT03758443|467256796|FG003|Extended Induction Period|Protocol Violation|1|||
129805791|NCT03758443|467256793|FG000|Extended Induction Period|Withdrawal by Subject|8|||
129805792|NCT03758443|467256794|FG001|Extended Induction Period|Withdrawal by Subject|1|||
129805793|NCT03758443|467256795|FG002|Extended Induction Period|Withdrawal by Subject|7|||
129805794|NCT03758443|467256796|FG003|Extended Induction Period|Withdrawal by Subject|3|||
129805795|NCT03758443|467256793|FG000|Extended Induction Period|Miscellaneous|1|||
129805796|NCT03758443|467256794|FG001|Extended Induction Period|Miscellaneous|0|||
129805797|NCT03758443|467256795|FG002|Extended Induction Period|Miscellaneous|0|||
129805798|NCT03758443|467256796|FG003|Extended Induction Period|Miscellaneous|0|||
129805799|NCT03758443|467256793|FG000|Maintenance Period|Adverse Event|1|||
129805800|NCT03758443|467256794|FG001|Maintenance Period|Adverse Event|2|||
129805801|NCT03758443|467256795|FG002|Maintenance Period|Adverse Event|0|||
129805802|NCT03758443|467256796|FG003|Maintenance Period|Adverse Event|0|||
129805803|NCT03758443|467256793|FG000|Maintenance Period|Lost to Follow-up|0|||
129805804|NCT03758443|467256794|FG001|Maintenance Period|Lost to Follow-up|0|||
129805805|NCT03758443|467256795|FG002|Maintenance Period|Lost to Follow-up|0|||
129805806|NCT03758443|467256796|FG003|Maintenance Period|Lost to Follow-up|1|||
129805807|NCT03758443|467256793|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
129805808|NCT03758443|467256794|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
129805809|NCT03758443|467256795|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
129805810|NCT03758443|467256796|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
129805811|NCT03758443|467256793|FG000|Maintenance Period|Protocol Violation|0|||
129805812|NCT03758443|467256794|FG001|Maintenance Period|Protocol Violation|1|||
129805813|NCT03758443|467256795|FG002|Maintenance Period|Protocol Violation|0|||
129805814|NCT03758443|467256796|FG003|Maintenance Period|Protocol Violation|0|||
129805815|NCT03758443|467256793|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
129805816|NCT03758443|467256794|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
129805817|NCT03758443|467256795|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
129805818|NCT03758443|467256796|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
129805819|NCT03758443|467256793|FG000|Maintenance Period|Withdrawal by Subject|1|||
129805820|NCT03758443|467256794|FG001|Maintenance Period|Withdrawal by Subject|0|||
129805821|NCT03758443|467256795|FG002|Maintenance Period|Withdrawal by Subject|1|||
129805822|NCT03758443|467256796|FG003|Maintenance Period|Withdrawal by Subject|1|||
129805823|NCT03758443|467256793|FG000|Maintenance Period|Miscellaneous|0|||
129805824|NCT03758443|467256794|FG001|Maintenance Period|Miscellaneous|0|||
129805825|NCT03758443|467256795|FG002|Maintenance Period|Miscellaneous|1|||
129805826|NCT03758443|467256796|FG003|Maintenance Period|Miscellaneous|0|||
129805827|NCT03080454|467256797|FG000|Baseline|Adverse Event|2|||
129805828|NCT03080454|467256797|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
129805829|NCT03080454|467256797|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
129805830|NCT01436396|467256798|FG000|Overall Study|Protocol Violation|7|||
129805831|NCT01436396|467256799|FG001|Overall Study|Protocol Violation|5|||
129805832|NCT01436396|467256798|FG000|Overall Study|Adverse Event|1|||
129805833|NCT01436396|467256799|FG001|Overall Study|Adverse Event|2|||
129805834|NCT01436396|467256798|FG000|Overall Study|Withdrawal by Subject|19|||
129805835|NCT01436396|467256799|FG001|Overall Study|Withdrawal by Subject|29|||
129805836|NCT01436396|467256798|FG000|Overall Study|Serious adverse event|2|||
129805837|NCT01436396|467256799|FG001|Overall Study|Serious adverse event|3|||
129805838|NCT01436396|467256798|FG000|Overall Study|Lost to Follow-up|3|||
129805839|NCT01436396|467256799|FG001|Overall Study|Lost to Follow-up|3|||
129805840|NCT00216476|467256800|FG000|Overall Study|Withdrawal by Subject|59|||
129805841|NCT00216476|467256801|FG001|Overall Study|Withdrawal by Subject|72|||
129805842|NCT00216476|467256802|FG002|Overall Study|Withdrawal by Subject|9|||
129805843|NCT00216476|467256800|FG000|Overall Study|Lost to Follow-up|10|||
129805844|NCT00216476|467256801|FG001|Overall Study|Lost to Follow-up|9|||
129805845|NCT00216476|467256802|FG002|Overall Study|Lost to Follow-up|1|||
129805846|NCT00216476|467256800|FG000|Overall Study|Adverse Event|6|||
129805847|NCT00216476|467256801|FG001|Overall Study|Adverse Event|10|||
129805848|NCT00216476|467256802|FG002|Overall Study|Adverse Event|1|||
129805849|NCT00216476|467256800|FG000|Overall Study|Lack of Efficacy|4|||
129805850|NCT00216476|467256801|FG001|Overall Study|Lack of Efficacy|3|||
129805851|NCT00216476|467256802|FG002|Overall Study|Lack of Efficacy|0|||
129805852|NCT00216476|467256800|FG000|Overall Study|Death|2|||
129805853|NCT00216476|467256801|FG001|Overall Study|Death|0|||
129805854|NCT00216476|467256802|FG002|Overall Study|Death|0|||
129805855|NCT00216476|467256800|FG000|Overall Study|Pregnancy|0|||
129805856|NCT00216476|467256801|FG001|Overall Study|Pregnancy|1|||
129805857|NCT00216476|467256802|FG002|Overall Study|Pregnancy|1|||
129805858|NCT00216476|467256800|FG000|Overall Study|Other|0|||
129805859|NCT00216476|467256801|FG001|Overall Study|Other|0|||
129805860|NCT00216476|467256802|FG002|Overall Study|Other|1|||
129805861|NCT00216476|467256800|FG000|Overall Study|Refuses Injection|11|||
129805862|NCT00216476|467256801|FG001|Overall Study|Refuses Injection|0|||
129805863|NCT00216476|467256802|FG002|Overall Study|Refuses Injection|0|||
129805864|NCT00216476|467256800|FG000|Overall Study|No Further Need for Treatment|3|||
129444968|NCT00671554|465929501|FG000|Overall Study|Disease progression|3|||
129444969|NCT02129205|465929502|FG000|Overall Study|Withdrawal by Subject|0|||
129444970|NCT02129205|465929503|FG001|Overall Study|Withdrawal by Subject|0|||
129444971|NCT02129205|465929504|FG002|Overall Study|Withdrawal by Subject|0|||
129444972|NCT02129205|465929505|FG003|Overall Study|Withdrawal by Subject|0|||
129444973|NCT02129205|465929506|FG004|Overall Study|Withdrawal by Subject|1|||
129444974|NCT02129205|465929507|FG005|Overall Study|Withdrawal by Subject|1|||
129444975|NCT02129205|465929508|FG006|Overall Study|Withdrawal by Subject|1|||
129444976|NCT02129205|465929509|FG007|Overall Study|Withdrawal by Subject|0|||
129444977|NCT02129205|465929510|FG008|Overall Study|Withdrawal by Subject|1|||
129444978|NCT02129205|465929511|FG009|Overall Study|Withdrawal by Subject|0|||
129444979|NCT02129205|465929502|FG000|Overall Study|Other|1|||
129444980|NCT02129205|465929503|FG001|Overall Study|Other|0|||
129444981|NCT02129205|465929504|FG002|Overall Study|Other|0|||
129444982|NCT02129205|465929505|FG003|Overall Study|Other|0|||
129444983|NCT02129205|465929506|FG004|Overall Study|Other|2|||
129444984|NCT02129205|465929507|FG005|Overall Study|Other|3|||
129444985|NCT02129205|465929508|FG006|Overall Study|Other|3|||
129444986|NCT02129205|465929509|FG007|Overall Study|Other|2|||
129444987|NCT02129205|465929510|FG008|Overall Study|Other|1|||
129444988|NCT02129205|465929511|FG009|Overall Study|Other|0|||
129444989|NCT02877927|465929512|FG000|Overall Study|Adverse Event|1|||
129444990|NCT02877927|465929513|FG001|Overall Study|Adverse Event|0|||
129444991|NCT02877927|465929512|FG000|Overall Study|Lost to Follow-up|37|||
129444992|NCT02877927|465929513|FG001|Overall Study|Lost to Follow-up|38|||
129444993|NCT02877927|465929512|FG000|Overall Study|Withdrawal by Subject|11|||
129444994|NCT02877927|465929513|FG001|Overall Study|Withdrawal by Subject|12|||
129444995|NCT02877927|465929512|FG000|Overall Study|Physician Decision|0|||
129444996|NCT02877927|465929513|FG001|Overall Study|Physician Decision|1|||
129444997|NCT02877927|465929512|FG000|Overall Study|Missed EOT/PTE Visit|5|||
129444998|NCT02877927|465929513|FG001|Overall Study|Missed EOT/PTE Visit|6|||
129444999|NCT01810016|465929514|FG000|Overall Study|Progressive disease|1|||
129445000|NCT01810016|465929515|FG001|Overall Study|Progressive disease|1|||
129445001|NCT01810016|465929516|FG002|Overall Study|Progressive disease|0|||
129445002|NCT01810016|465929514|FG000|Overall Study|Death|0|||
129445003|NCT01810016|465929515|FG001|Overall Study|Death|0|||
129445004|NCT01810016|465929516|FG002|Overall Study|Death|1|||
129445005|NCT06950879|465929524|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
129445006|NCT01444651|465931133|FG000|Overall Study|Adverse Event|3|||
129445007|NCT01444651|465931134|FG001|Overall Study|Adverse Event|2|||
129445008|NCT01444651|465931133|FG000|Overall Study|Lost to Follow-up|5|||
129445009|NCT01444651|465931134|FG001|Overall Study|Lost to Follow-up|5|||
129445010|NCT01444651|465931133|FG000|Overall Study|Non-fasting|2|||
129445011|NCT01444651|465931134|FG001|Overall Study|Non-fasting|1|||
129445012|NCT01444651|465931133|FG000|Overall Study|Missing data|1|||
129737891|NCT01818284|467002035|FG000|Overall Study|Death|0|||
129893444|NCT01723774|467569769|FG003|Neoadjuvant|High estradiol|0|||
129737892|NCT01818284|467002036|FG001|Overall Study|Death|2|||
129737893|NCT03681678|467002037|FG000|Overall Study|Lost to Follow-up|20|||
129737894|NCT04619004|467002038|FG000|Overall Study|Death|114|||
129737895|NCT04619004|467002039|FG001|Overall Study|Death|28|||
129737896|NCT04619004|467002038|FG000|Overall Study|Lost to Follow-up|1|||
129737897|NCT04619004|467002039|FG001|Overall Study|Lost to Follow-up|1|||
129737898|NCT04619004|467002038|FG000|Overall Study|Withdrawal by Subject|24|||
129737899|NCT04619004|467002039|FG001|Overall Study|Withdrawal by Subject|7|||
129737900|NCT04619004|467002038|FG000|Overall Study|Other - Not specified|0|||
129737901|NCT04619004|467002039|FG001|Overall Study|Other - Not specified|1|||
129737902|NCT01114360|467002041|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
129737903|NCT01114360|467002042|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
129737904|NCT03007745|467002043|FG000|Overall Study|Sleep test negative for OSA|53|||
129737905|NCT03007745|467002044|FG001|Overall Study|Sleep test negative for OSA|49|||
129737906|NCT03007745|467002043|FG000|Overall Study|Physician Decision|6|||
129737907|NCT03007745|467002044|FG001|Overall Study|Physician Decision|9|||
129737908|NCT03007745|467002043|FG000|Overall Study|Withdrawal by Subject|38|||
129737909|NCT03007745|467002044|FG001|Overall Study|Withdrawal by Subject|16|||
129737910|NCT03007745|467002043|FG000|Overall Study|Lost to Follow-up|19|||
129737911|NCT03007745|467002044|FG001|Overall Study|Lost to Follow-up|25|||
129445013|NCT01444651|465931134|FG001|Overall Study|Missing data|1|||
129445014|NCT01436071|465931135|FG000|Overall Study|Adverse Event|1|||
129445015|NCT01436071|465931136|FG001|Overall Study|Adverse Event|0|||
129445016|NCT01436071|465931135|FG000|Overall Study|Lack of Efficacy|16|||
129445017|NCT01436071|465931136|FG001|Overall Study|Lack of Efficacy|7|||
129445018|NCT01436071|465931135|FG000|Overall Study|Protocol Violation|0|||
129445019|NCT01436071|465931136|FG001|Overall Study|Protocol Violation|1|||
129445020|NCT01436071|465931135|FG000|Overall Study|Lost to Follow-up|3|||
129445021|NCT01436071|465931136|FG001|Overall Study|Lost to Follow-up|1|||
129445022|NCT01436071|465931135|FG000|Overall Study|Physician Decision|1|||
129445023|NCT01436071|465931136|FG001|Overall Study|Physician Decision|0|||
129445024|NCT01436071|465931135|FG000|Overall Study|Withdrawal by Subject|2|||
129445025|NCT01436071|465931136|FG001|Overall Study|Withdrawal by Subject|2|||
129805865|NCT00216476|467256801|FG001|Overall Study|No Further Need for Treatment|4|||
129805866|NCT00216476|467256802|FG002|Overall Study|No Further Need for Treatment|1|||
129805867|NCT00216476|467256800|FG000|Overall Study|Non-compliance|0|||
129805868|NCT00216476|467256801|FG001|Overall Study|Non-compliance|4|||
129805869|NCT00216476|467256802|FG002|Overall Study|Non-compliance|1|||
129805870|NCT00216476|467256800|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
129805871|NCT00216476|467256801|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
129805872|NCT00216476|467256802|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
129805873|NCT00216476|467256800|FG000|Overall Study|Administrative Reasons|1|||
129805874|NCT00216476|467256801|FG001|Overall Study|Administrative Reasons|1|||
129805875|NCT00216476|467256802|FG002|Overall Study|Administrative Reasons|0|||
129805876|NCT00216476|467256800|FG000|Overall Study|Protocol Deviation|5|||
129805877|NCT00216476|467256801|FG001|Overall Study|Protocol Deviation|1|||
129805878|NCT00216476|467256802|FG002|Overall Study|Protocol Deviation|0|||
129805879|NCT00216476|467256800|FG000|Overall Study|Patient Moved|2|||
129805880|NCT00216476|467256801|FG001|Overall Study|Patient Moved|2|||
129805881|NCT00216476|467256802|FG002|Overall Study|Patient Moved|0|||
129805882|NCT02191137|467256803|FG000|Treatment|Death|4|||
129805883|NCT02191137|467256803|FG000|Treatment|Withdrawal by Subject|3|||
129805884|NCT02191137|467256803|FG000|Treatment|Adverse Event|2|||
129805885|NCT02191137|467256803|FG000|Treatment|Other|1|||
129805886|NCT02191137|467256803|FG000|Follow-up|Lost to Follow-up|2|||
129805887|NCT02191137|467256803|FG000|Follow-up|Ongoing/unknown|2|||
129805888|NCT02191137|467256803|FG000|Follow-up|Adverse Event|1|||
129805889|NCT00696800|467256804|FG000|Overall Study|Adverse Event|16|||
129805890|NCT00696800|467256805|FG001|Overall Study|Adverse Event|3|||
129805891|NCT00696800|467256804|FG000|Overall Study|Insufficient compliance with medication|2|||
129805892|NCT00696800|467256805|FG001|Overall Study|Insufficient compliance with medication|1|||
129445026|NCT01436071|465931135|FG000|Overall Study|Did Not Receive Trial Medication|3|||
129445027|NCT01436071|465931136|FG001|Overall Study|Did Not Receive Trial Medication|3|||
129445028|NCT02462928|465931140|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
129445029|NCT02462928|465931141|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
129445030|NCT02462928|465931142|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
129445031|NCT02462928|465931140|FG000|Overall Study|Adverse Event|47|||
129445032|NCT02462928|465931141|FG001|Overall Study|Adverse Event|51|||
129445033|NCT02462928|465931142|FG002|Overall Study|Adverse Event|25|||
129445034|NCT02462928|465931140|FG000|Overall Study|Lack of Efficacy|3|||
129445035|NCT02462928|465931141|FG001|Overall Study|Lack of Efficacy|8|||
129805893|NCT00696800|467256804|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
129805894|NCT00696800|467256805|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
129805895|NCT00696800|467256804|FG000|Overall Study|Insufficient ovarian response|4|||
129805896|NCT00696800|467256805|FG001|Overall Study|Insufficient ovarian response|1|||
129805897|NCT00696800|467256804|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
129805898|NCT00696800|467256805|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
129805899|NCT00696800|467256804|FG000|Overall Study|Too high ovarian response|6|||
129805900|NCT00696800|467256805|FG001|Overall Study|Too high ovarian response|1|||
129805901|NCT00696800|467256804|FG000|Overall Study|No/too few/bad quality oocytes|4|||
129805902|NCT00696800|467256805|FG001|Overall Study|No/too few/bad quality oocytes|3|||
129805903|NCT00696800|467256804|FG000|Overall Study|No/abnormal fertilization|11|||
129805904|NCT00696800|467256805|FG001|Overall Study|No/abnormal fertilization|13|||
129805905|NCT00696800|467256804|FG000|Overall Study|No/too few/bad quality embryos|24|||
129805906|NCT00696800|467256805|FG001|Overall Study|No/too few/bad quality embryos|18|||
129805907|NCT00696800|467256804|FG000|Overall Study|Other Reasons|5|||
129805908|NCT00696800|467256805|FG001|Overall Study|Other Reasons|3|||
129805909|NCT00696800|467256804|FG000|Overall Study|Not treated|1|||
129805910|NCT00696800|467256805|FG001|Overall Study|Not treated|2|||
129805911|NCT02853344|467256810|FG000|Overall Study|Lost to Follow-up|1|||
129805912|NCT02853344|467256811|FG001|Overall Study|Lost to Follow-up|1|||
129805913|NCT02853344|467256810|FG000|Overall Study|Withdrawal by Subject|2|||
129805914|NCT02853344|467256811|FG001|Overall Study|Withdrawal by Subject|4|||
129805915|NCT02853344|467256810|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
129805916|NCT02853344|467256811|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
129805917|NCT02853344|467256810|FG000|Overall Study|Death|70|||
129805918|NCT02853344|467256811|FG001|Overall Study|Death|112|||
129805919|NCT02913612|467256812|FG000|Overall Study|Lost to Follow-up|6|||
129805920|NCT02913612|467256813|FG001|Overall Study|Lost to Follow-up|5|||
129805921|NCT02913612|467256814|FG002|Overall Study|Lost to Follow-up|2|||
129805922|NCT02913612|467256815|FG003|Overall Study|Lost to Follow-up|0|||
129805923|NCT02913612|467256812|FG000|Overall Study|Physician Decision|1|||
129805924|NCT02913612|467256813|FG001|Overall Study|Physician Decision|4|||
129805925|NCT02913612|467256814|FG002|Overall Study|Physician Decision|1|||
129805926|NCT02913612|467256815|FG003|Overall Study|Physician Decision|0|||
129805927|NCT02913612|467256812|FG000|Overall Study|Withdrawal by Subject|2|||
129805928|NCT02913612|467256813|FG001|Overall Study|Withdrawal by Subject|4|||
129805929|NCT02913612|467256814|FG002|Overall Study|Withdrawal by Subject|0|||
129805930|NCT02913612|467256815|FG003|Overall Study|Withdrawal by Subject|0|||
129805931|NCT02913612|467256812|FG000|Overall Study|Hemangioma resolved|1|||
129805932|NCT02913612|467256813|FG001|Overall Study|Hemangioma resolved|0|||
129805933|NCT02913612|467256814|FG002|Overall Study|Hemangioma resolved|0|||
129805934|NCT02913612|467256815|FG003|Overall Study|Hemangioma resolved|0|||
129805935|NCT02913612|467256812|FG000|Overall Study|Local IRB decision|1|||
129805936|NCT02913612|467256813|FG001|Overall Study|Local IRB decision|0|||
129805937|NCT02913612|467256814|FG002|Overall Study|Local IRB decision|0|||
129805938|NCT02913612|467256815|FG003|Overall Study|Local IRB decision|0|||
129805939|NCT02913612|467256812|FG000|Overall Study|Study drug non-compliance|1|||
129805940|NCT02913612|467256813|FG001|Overall Study|Study drug non-compliance|1|||
129445036|NCT02462928|465931142|FG002|Overall Study|Lack of Efficacy|3|||
129445037|NCT02462928|465931140|FG000|Overall Study|Lost to Follow-up|4|||
129805941|NCT02913612|467256814|FG002|Overall Study|Study drug non-compliance|0|||
129805942|NCT02913612|467256815|FG003|Overall Study|Study drug non-compliance|0|||
129805943|NCT02913612|467256812|FG000|Overall Study|Insurance issues|0|||
129805944|NCT02913612|467256813|FG001|Overall Study|Insurance issues|1|||
129805945|NCT02913612|467256814|FG002|Overall Study|Insurance issues|0|||
129805946|NCT02913612|467256815|FG003|Overall Study|Insurance issues|0|||
129805947|NCT02913612|467256812|FG000|Overall Study|Needed to treat second hemangioma|0|||
129805948|NCT02913612|467256813|FG001|Overall Study|Needed to treat second hemangioma|1|||
129805949|NCT02913612|467256814|FG002|Overall Study|Needed to treat second hemangioma|0|||
129805950|NCT02913612|467256815|FG003|Overall Study|Needed to treat second hemangioma|0|||
129893445|NCT04319094|467569773|FG000|Baseline|Lost to Follow-up|4|||
129445038|NCT02462928|465931141|FG001|Overall Study|Lost to Follow-up|4|||
129805951|NCT02913612|467256812|FG000|Overall Study|Study completion criteria not met|0|||
129805952|NCT02913612|467256813|FG001|Overall Study|Study completion criteria not met|1|||
129805953|NCT02913612|467256814|FG002|Overall Study|Study completion criteria not met|0|||
129805954|NCT02913612|467256815|FG003|Overall Study|Study completion criteria not met|0|||
129805955|NCT02913612|467256812|FG000|Overall Study|Ineligible|0|||
129805956|NCT02913612|467256813|FG001|Overall Study|Ineligible|1|||
129805957|NCT02913612|467256814|FG002|Overall Study|Ineligible|0|||
129805958|NCT02913612|467256815|FG003|Overall Study|Ineligible|0|||
129805959|NCT00973674|467256818|FG000|Overall Study|Protocol Violation|2|||
129805960|NCT00973674|467256819|FG001|Overall Study|Protocol Violation|0|||
129805961|NCT00071396|467256820|FG000|Overall Study|Withdrawal by Subject|1|||
129805962|NCT00071396|467256820|FG000|Overall Study|Physician Decision|2|||
129805963|NCT00116428|467256821|FG000|Overall Study|Withdrawal by Subject|2|||
129445039|NCT02462928|465931142|FG002|Overall Study|Lost to Follow-up|1|||
129805964|NCT00116428|467256822|FG001|Overall Study|Withdrawal by Subject|5|||
129445040|NCT02462928|465931140|FG000|Overall Study|Withdrawal by Patient|31|||
129445041|NCT02462928|465931141|FG001|Overall Study|Withdrawal by Patient|21|||
129445042|NCT02462928|465931142|FG002|Overall Study|Withdrawal by Patient|21|||
129445043|NCT02462928|465931140|FG000|Overall Study|Protocol Violation|0|||
129893446|NCT04319094|467569774|FG001|Baseline|Lost to Follow-up|5|||
129893447|NCT04319094|467569773|FG000|Baseline|Protocol Violation|0|||
129893448|NCT04319094|467569774|FG001|Baseline|Protocol Violation|3|||
129893449|NCT04319094|467569773|FG000|Baseline|Withdrawal by Subject|2|||
129445044|NCT02462928|465931141|FG001|Overall Study|Protocol Violation|1|||
129445045|NCT02462928|465931142|FG002|Overall Study|Protocol Violation|0|||
129445046|NCT02462928|465931140|FG000|Overall Study|Reason not Specified|4|||
129445047|NCT02462928|465931141|FG001|Overall Study|Reason not Specified|6|||
129445048|NCT02462928|465931142|FG002|Overall Study|Reason not Specified|5|||
129445049|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
129445050|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
129445051|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
129445052|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
129445053|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
129445054|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
129445055|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
129737912|NCT03007745|467002043|FG000|Overall Study|Unable to login to website|17|||
129737913|NCT03007745|467002044|FG001|Overall Study|Unable to login to website|4|||
129737914|NCT01300351|467002045|FG000|Overall Study|Did not receive treatment|2|||
129737915|NCT01300351|467002046|FG001|Overall Study|Did not receive treatment|0|||
129737916|NCT01300351|467002045|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
129737917|NCT01300351|467002046|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
129737918|NCT01300351|467002045|FG000|Overall Study|Lost to Follow-up|0|||
129737919|NCT01300351|467002046|FG001|Overall Study|Lost to Follow-up|1|||
129737920|NCT01300351|467002045|FG000|Overall Study|Adverse Event|0|||
129737921|NCT01300351|467002046|FG001|Overall Study|Adverse Event|4|||
129737922|NCT01300351|467002045|FG000|Overall Study|Withdrawal by Subject|7|||
129737923|NCT01300351|467002046|FG001|Overall Study|Withdrawal by Subject|10|||
129737924|NCT05824936|467002050|FG000|Overall Study|Lost to Follow-up|1|||
129737925|NCT00673881|467002051|FG000|Overall Study|Withdrawal by Subject|1|||
129737926|NCT00413010|467002052|FG000|Overall Study|Adverse Event|8|||
129737927|NCT00413010|467002053|FG001|Overall Study|Adverse Event|4|||
129737928|NCT00413010|467002052|FG000|Overall Study|Laboratory abnormality|0|||
129737929|NCT00413010|467002053|FG001|Overall Study|Laboratory abnormality|2|||
129737930|NCT00413010|467002052|FG000|Overall Study|Lack of Efficacy|0|||
129737931|NCT00413010|467002053|FG001|Overall Study|Lack of Efficacy|3|||
129737932|NCT00413010|467002052|FG000|Overall Study|Lost to Follow-up|3|||
129737933|NCT00413010|467002053|FG001|Overall Study|Lost to Follow-up|0|||
129737934|NCT00413010|467002052|FG000|Overall Study|Withdrawal by Subject|7|||
129737935|NCT00413010|467002053|FG001|Overall Study|Withdrawal by Subject|2|||
129737936|NCT00413010|467002052|FG000|Overall Study|Due to termination of the study|54|||
129737937|NCT00413010|467002053|FG001|Overall Study|Due to termination of the study|52|||
129737938|NCT01533922|467002054|FG000|Overall Study|Adverse Event|5|||
129737939|NCT01533922|467002055|FG001|Overall Study|Adverse Event|8|||
129737940|NCT01533922|467002056|FG002|Overall Study|Adverse Event|6|||
129737941|NCT01533922|467002057|FG003|Overall Study|Adverse Event|3|||
129737942|NCT01533922|467002058|FG004|Overall Study|Adverse Event|4|||
129737943|NCT01533922|467002054|FG000|Overall Study|Lack of Efficacy|0|||
129737944|NCT01533922|467002055|FG001|Overall Study|Lack of Efficacy|0|||
129737945|NCT01533922|467002056|FG002|Overall Study|Lack of Efficacy|1|||
129737946|NCT01533922|467002057|FG003|Overall Study|Lack of Efficacy|0|||
129737947|NCT01533922|467002058|FG004|Overall Study|Lack of Efficacy|0|||
129737948|NCT01533922|467002054|FG000|Overall Study|Protocol Violation|0|||
129737949|NCT01533922|467002055|FG001|Overall Study|Protocol Violation|3|||
129893450|NCT04319094|467569774|FG001|Baseline|Withdrawal by Subject|1|||
129445056|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
129737950|NCT01533922|467002056|FG002|Overall Study|Protocol Violation|0|||
129737951|NCT01533922|467002057|FG003|Overall Study|Protocol Violation|0|||
129737952|NCT01533922|467002058|FG004|Overall Study|Protocol Violation|1|||
129737953|NCT01533922|467002054|FG000|Overall Study|Withdrawal by Subject|3|||
129737954|NCT01533922|467002055|FG001|Overall Study|Withdrawal by Subject|1|||
129737955|NCT01533922|467002056|FG002|Overall Study|Withdrawal by Subject|2|||
129737956|NCT01533922|467002057|FG003|Overall Study|Withdrawal by Subject|2|||
129737957|NCT01533922|467002058|FG004|Overall Study|Withdrawal by Subject|1|||
129737958|NCT01533922|467002054|FG000|Overall Study|Other reason not defined above|2|||
129737959|NCT01533922|467002055|FG001|Overall Study|Other reason not defined above|0|||
129737960|NCT01533922|467002056|FG002|Overall Study|Other reason not defined above|1|||
129737961|NCT01533922|467002057|FG003|Overall Study|Other reason not defined above|0|||
129737962|NCT01533922|467002058|FG004|Overall Study|Other reason not defined above|0|||
129737963|NCT02634606|467002061|FG000|Overall Study|unable to obtain the drug at start|13|||
129893451|NCT04319094|467569773|FG000|Post-Intervention|Death|0|||
129893452|NCT04319094|467569774|FG001|Post-Intervention|Death|1|||
129893453|NCT04319094|467569773|FG000|Post-Intervention|Lost to Follow-up|4|||
129893454|NCT04319094|467569774|FG001|Post-Intervention|Lost to Follow-up|4|||
129893455|NCT04319094|467569773|FG000|Post-Intervention|Withdrawal by Subject|8|||
129893456|NCT04319094|467569774|FG001|Post-Intervention|Withdrawal by Subject|5|||
129893457|NCT04319094|467569773|FG000|Post-Intervention|Incomplete Data Collection|1|||
129893458|NCT04319094|467569774|FG001|Post-Intervention|Incomplete Data Collection|3|||
129893459|NCT04319094|467569773|FG000|3-month|Death|1|||
129737964|NCT01267175|467002062|FG000|Overall Study|Withdrawal by Subject|1|||
129737965|NCT01267175|467002062|FG000|Overall Study|Lost to Follow-up|1|||
129737966|NCT00286221|467002065|FG000|Overall Study|Protocol Violation|2|||
129737967|NCT00286221|467002066|FG001|Overall Study|Protocol Violation|1|||
129737968|NCT00286221|467002067|FG002|Overall Study|Protocol Violation|6|||
129737969|NCT00286221|467002068|FG003|Overall Study|Protocol Violation|4|||
129737970|NCT00286221|467002065|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
129737971|NCT00286221|467002066|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
129737972|NCT00286221|467002067|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
129737973|NCT00286221|467002068|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
129737974|NCT00286221|467002065|FG000|Overall Study|Inability to trigger PCA|2|||
129737975|NCT00286221|467002066|FG001|Overall Study|Inability to trigger PCA|0|||
129737976|NCT00286221|467002067|FG002|Overall Study|Inability to trigger PCA|0|||
129805965|NCT00116428|467256821|FG000|Overall Study|Did not meet inclusion criteria|1|||
129805966|NCT00116428|467256822|FG001|Overall Study|Did not meet inclusion criteria|0|||
129805967|NCT03452228|467256823|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129893460|NCT04319094|467569774|FG001|3-month|Death|0|||
129893461|NCT04319094|467569773|FG000|3-month|Lost to Follow-up|2|||
129893462|NCT04319094|467569774|FG001|3-month|Lost to Follow-up|2|||
129893463|NCT04319094|467569773|FG000|3-month|Withdrawal by Subject|0|||
129893464|NCT04319094|467569774|FG001|3-month|Withdrawal by Subject|3|||
129893465|NCT04319094|467569773|FG000|3-month|Incomplete data collection|9|||
129893466|NCT04319094|467569774|FG001|3-month|Incomplete data collection|7|||
129893467|NCT04319094|467569773|FG000|6-month|Lost to Follow-up|1|||
129893468|NCT04319094|467569774|FG001|6-month|Lost to Follow-up|1|||
129893469|NCT04319094|467569773|FG000|6-month|Withdrawal by Subject|0|||
129893470|NCT04319094|467569774|FG001|6-month|Withdrawal by Subject|3|||
129893471|NCT04319094|467569773|FG000|6-month|Incomplete data collection|14|||
129805968|NCT03452228|467256824|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
129805969|NCT03452228|467256825|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
129805970|NCT03452228|467256823|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129805971|NCT03452228|467256824|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129805972|NCT03452228|467256825|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129805973|NCT03452228|467256823|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
129805974|NCT03452228|467256824|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
129805975|NCT03452228|467256825|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
129805976|NCT03452228|467256823|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129805977|NCT03452228|467256824|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129805978|NCT03452228|467256825|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
129805979|NCT02713204|467256826|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
129805980|NCT02713204|467256827|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805981|NCT02713204|467256828|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
129805982|NCT02713204|467256829|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805983|NCT02713204|467256830|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805984|NCT02713204|467256831|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805985|NCT02713204|467256832|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805986|NCT02713204|467256833|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
129805987|NCT02713204|467256826|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805988|NCT02713204|467256827|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805989|NCT02713204|467256828|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
129805990|NCT02713204|467256829|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805991|NCT02713204|467256830|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805992|NCT02713204|467256831|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129893472|NCT04319094|467569774|FG001|6-month|Incomplete data collection|9|||
129893473|NCT04319094|467569773|FG000|9-month|Lost to Follow-up|8|||
129893474|NCT04319094|467569774|FG001|9-month|Lost to Follow-up|4|||
129893475|NCT04319094|467569773|FG000|9-month|Withdrawal by Subject|0|||
129737977|NCT00286221|467002068|FG003|Overall Study|Inability to trigger PCA|0|||
129737978|NCT00286221|467002065|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
129737979|NCT00286221|467002066|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
129805993|NCT02713204|467256832|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129893476|NCT04319094|467569774|FG001|9-month|Withdrawal by Subject|1|||
129893477|NCT04319094|467569773|FG000|9-month|Incomplete data collection|8|||
129893478|NCT04319094|467569774|FG001|9-month|Incomplete data collection|5|||
129893479|NCT04319094|467569773|FG000|12-month|Lost to Follow-up|11|||
129737980|NCT00286221|467002067|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
129737981|NCT00286221|467002068|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
129737982|NCT02553538|467002070|FG000|Overall Study|Could Not Reach by Telephone|133|||
129737983|NCT02553538|467002071|FG001|Overall Study|Could Not Reach by Telephone|0|||
129737984|NCT02553538|467002070|FG000|Overall Study|Died or Left Network|54|||
129737985|NCT02553538|467002071|FG001|Overall Study|Died or Left Network|56|||
129737986|NCT02690649|467002072|FG000|Overall Study|Withdrawal by Subject|1|||
129737987|NCT02690649|467002073|FG001|Overall Study|Withdrawal by Subject|1|||
129737988|NCT02690649|467002072|FG000|Overall Study|Protocol Violation|0|||
129737989|NCT02690649|467002073|FG001|Overall Study|Protocol Violation|3|||
129737990|NCT02276547|467002074|FG000|Overall Study|Death|2|||
129737991|NCT02276547|467002074|FG000|Overall Study|Explant|2|||
129737992|NCT01754194|467002075|FG000|Overall Study|Lost to Follow-up|39|||
129737993|NCT01754194|467002076|FG001|Overall Study|Lost to Follow-up|14|||
129737994|NCT01754194|467002075|FG000|Overall Study|Withdrawal by Subject|4|||
129737995|NCT01754194|467002076|FG001|Overall Study|Withdrawal by Subject|5|||
129737996|NCT01754194|467002075|FG000|Overall Study|Other|9|||
129737997|NCT01754194|467002076|FG001|Overall Study|Other|8|||
129737998|NCT00907296|467002077|FG000|Overall Study|Ineligibility Determined|1|||
129737999|NCT00907296|467002078|FG001|Overall Study|Ineligibility Determined|0|||
129738000|NCT00907296|467002079|FG002|Overall Study|Ineligibility Determined|0|||
129738001|NCT00907296|467002080|FG003|Overall Study|Ineligibility Determined|1|||
129738002|NCT00907296|467002081|FG004|Overall Study|Ineligibility Determined|0|||
129738003|NCT00907296|467002082|FG005|Overall Study|Ineligibility Determined|0|||
129738004|NCT00907296|467002083|FG006|Overall Study|Ineligibility Determined|0|||
129738005|NCT00907296|467002084|FG007|Overall Study|Ineligibility Determined|1|||
129738006|NCT00907296|467002085|FG008|Overall Study|Ineligibility Determined|0|||
129893480|NCT04319094|467569774|FG001|12-month|Lost to Follow-up|8|||
129738007|NCT00907296|467002086|FG009|Overall Study|Ineligibility Determined|0|||
129738008|NCT00907296|467002077|FG000|Overall Study|Protocol Deviation|0|||
129738009|NCT00907296|467002078|FG001|Overall Study|Protocol Deviation|1|||
129738010|NCT00907296|467002079|FG002|Overall Study|Protocol Deviation|0|||
129738011|NCT00907296|467002080|FG003|Overall Study|Protocol Deviation|0|||
129738012|NCT00907296|467002081|FG004|Overall Study|Protocol Deviation|0|||
129738013|NCT00907296|467002082|FG005|Overall Study|Protocol Deviation|0|||
129738014|NCT00907296|467002083|FG006|Overall Study|Protocol Deviation|0|||
129738015|NCT00907296|467002084|FG007|Overall Study|Protocol Deviation|0|||
129738016|NCT00907296|467002085|FG008|Overall Study|Protocol Deviation|0|||
129738017|NCT00907296|467002086|FG009|Overall Study|Protocol Deviation|0|||
129805994|NCT02713204|467256833|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129805995|NCT02713204|467256826|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129805996|NCT02713204|467256827|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
129805997|NCT02713204|467256828|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129805998|NCT02713204|467256829|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129805999|NCT02713204|467256830|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806000|NCT02713204|467256831|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806001|NCT02713204|467256832|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806002|NCT02713204|467256833|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129806003|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Adverse Event|1|||
129806004|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Adverse Event|0|||
129806005|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Adverse Event|0|||
129806006|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Adverse Event|1|||
129806007|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Adverse Event|1|||
129806008|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Adverse Event|0|||
129806009|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Adverse Event|2|||
129806010|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Adverse Event|1|||
129806011|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Death|0|||
129806012|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Death|0|||
129806013|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Death|0|||
129806014|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Death|1|||
129806015|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Death|0|||
129806016|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Death|1|||
129806017|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Death|0|||
129806018|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Death|3|||
129806019|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806020|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806021|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806022|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
129806023|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806024|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806025|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806026|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
129806027|NCT02713204|467256826|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
129806028|NCT02713204|467256827|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
129806029|NCT02713204|467256828|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
129806030|NCT02713204|467256829|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
129806031|NCT02713204|467256830|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
129806032|NCT02713204|467256831|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
129806033|NCT02713204|467256832|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
129806034|NCT02713204|467256833|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
129806035|NCT00669396|467256834|FG000|Overall Study|Lost to Follow-up|10|||
129806036|NCT00669396|467256835|FG001|Overall Study|Lost to Follow-up|12|||
129806037|NCT04251273|467256836|FG000|Overall Study|Lost to Follow-up|331|||
129806038|NCT04251273|467256837|FG001|Overall Study|Lost to Follow-up|290|||
129806039|NCT04402060|467256838|FG000|Overall Study|Death|1|||
129806040|NCT04402060|467256839|FG001|Overall Study|Death|12|||
129806041|NCT04402060|467256840|FG002|Overall Study|Death|7|||
129806042|NCT04402060|467256838|FG000|Overall Study|Adverse Event|0|||
129806043|NCT04402060|467256839|FG001|Overall Study|Adverse Event|0|||
129806044|NCT04402060|467256840|FG002|Overall Study|Adverse Event|1|||
129806045|NCT04402060|467256838|FG000|Overall Study|Withdrawal by Subject|0|||
129806046|NCT04402060|467256839|FG001|Overall Study|Withdrawal by Subject|1|||
129806047|NCT04402060|467256840|FG002|Overall Study|Withdrawal by Subject|2|||
129806048|NCT04402060|467256838|FG000|Overall Study|Sponsor Request|0|||
129806049|NCT04402060|467256839|FG001|Overall Study|Sponsor Request|2|||
129806050|NCT04402060|467256840|FG002|Overall Study|Sponsor Request|0|||
129806051|NCT04402060|467256838|FG000|Overall Study|Physician Decision|0|||
129806052|NCT04402060|467256839|FG001|Overall Study|Physician Decision|0|||
129806053|NCT04402060|467256840|FG002|Overall Study|Physician Decision|1|||
129806054|NCT04402060|467256838|FG000|Overall Study|Other|0|||
129806055|NCT04402060|467256839|FG001|Overall Study|Other|1|||
129806056|NCT04402060|467256840|FG002|Overall Study|Other|0|||
129806057|NCT00810693|467256843|FG000|Treatment Period|Adverse Event|8|||
129806058|NCT00810693|467256844|FG001|Treatment Period|Adverse Event|1|||
129806059|NCT00810693|467256845|FG002|Treatment Period|Adverse Event|7|||
129806060|NCT00810693|467256843|FG000|Treatment Period|Death|0|||
129806061|NCT00810693|467256844|FG001|Treatment Period|Death|1|||
129806062|NCT00810693|467256845|FG002|Treatment Period|Death|2|||
129806063|NCT00810693|467256843|FG000|Treatment Period|Lack of Efficacy|0|||
129806064|NCT00810693|467256844|FG001|Treatment Period|Lack of Efficacy|0|||
129806065|NCT00810693|467256845|FG002|Treatment Period|Lack of Efficacy|1|||
129806066|NCT00810693|467256843|FG000|Treatment Period|Lost to Follow-up|1|||
129806067|NCT00810693|467256844|FG001|Treatment Period|Lost to Follow-up|0|||
129806068|NCT00810693|467256845|FG002|Treatment Period|Lost to Follow-up|0|||
129806069|NCT00810693|467256843|FG000|Treatment Period|Non-compliance|1|||
129806070|NCT00810693|467256844|FG001|Treatment Period|Non-compliance|0|||
129738018|NCT00907296|467002077|FG000|Overall Study|Noncompliance|1|||
129738019|NCT00907296|467002078|FG001|Overall Study|Noncompliance|1|||
129738020|NCT00907296|467002079|FG002|Overall Study|Noncompliance|1|||
129738021|NCT00907296|467002080|FG003|Overall Study|Noncompliance|0|||
129738022|NCT00907296|467002081|FG004|Overall Study|Noncompliance|0|||
129738023|NCT00907296|467002082|FG005|Overall Study|Noncompliance|1|||
129738024|NCT00907296|467002083|FG006|Overall Study|Noncompliance|0|||
129738025|NCT00907296|467002084|FG007|Overall Study|Noncompliance|2|||
129738026|NCT00907296|467002085|FG008|Overall Study|Noncompliance|0|||
129738027|NCT00907296|467002086|FG009|Overall Study|Noncompliance|0|||
129738028|NCT00907296|467002077|FG000|Overall Study|Adverse Event|2|||
129738029|NCT00907296|467002078|FG001|Overall Study|Adverse Event|0|||
129738030|NCT00907296|467002079|FG002|Overall Study|Adverse Event|0|||
129738031|NCT00907296|467002080|FG003|Overall Study|Adverse Event|0|||
129738032|NCT00907296|467002081|FG004|Overall Study|Adverse Event|0|||
129738033|NCT00907296|467002082|FG005|Overall Study|Adverse Event|0|||
129738034|NCT00907296|467002083|FG006|Overall Study|Adverse Event|1|||
129738035|NCT00907296|467002084|FG007|Overall Study|Adverse Event|0|||
129738036|NCT00907296|467002085|FG008|Overall Study|Adverse Event|0|||
129738037|NCT00907296|467002086|FG009|Overall Study|Adverse Event|1|||
129738038|NCT00907296|467002077|FG000|Overall Study|Withdrawal by Subject|7|||
129806071|NCT00810693|467256845|FG002|Treatment Period|Non-compliance|0|||
129806072|NCT00810693|467256843|FG000|Treatment Period|Protocol Violation|1|||
129806073|NCT00810693|467256844|FG001|Treatment Period|Protocol Violation|2|||
129806074|NCT00810693|467256845|FG002|Treatment Period|Protocol Violation|2|||
129806075|NCT00810693|467256843|FG000|Treatment Period|Withdrawal by Subject|6|||
129806076|NCT00810693|467256844|FG001|Treatment Period|Withdrawal by Subject|2|||
129806077|NCT00810693|467256845|FG002|Treatment Period|Withdrawal by Subject|3|||
129806078|NCT00810693|467256843|FG000|Treatment Period|Not treated|0|||
129806079|NCT00810693|467256844|FG001|Treatment Period|Not treated|1|||
129806080|NCT00810693|467256845|FG002|Treatment Period|Not treated|1|||
129806081|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Adverse Event|3|||
129806082|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Adverse Event|1|||
129806083|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Adverse Event|1|||
129806084|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Death|2|||
129806085|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Death|0|||
129806086|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Death|1|||
129806087|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
129806088|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
129806089|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
129806090|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
129806091|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
129806092|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
129806093|NCT00810693|467256843|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
129806094|NCT00810693|467256844|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
129806095|NCT00810693|467256845|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
129806096|NCT03212690|467256846|FG000|Overall Study|Protocol Violation|1|||
129806097|NCT03386474|467256856|FG000|Overall Study|Death|1|||
129806098|NCT03386474|467256857|FG001|Overall Study|Death|0|||
129806099|NCT03386474|467256856|FG000|Overall Study|Adverse Event|0|||
129806100|NCT03386474|467256857|FG001|Overall Study|Adverse Event|1|||
129806101|NCT02155881|467256858|FG000|Overall Study|Withdrawal by Subject|0|||
129806102|NCT02155881|467256859|FG001|Overall Study|Withdrawal by Subject|2|||
129806103|NCT02155881|467256858|FG000|Overall Study|Inappropriately randomized|2|||
129806104|NCT02155881|467256859|FG001|Overall Study|Inappropriately randomized|2|||
129806105|NCT04357782|467256860|FG000|Overall Study|Discharged from hospital|1|||
129806106|NCT04357782|467256861|FG001|Overall Study|Discharged from hospital|0|||
129806107|NCT04357782|467256860|FG000|Overall Study|Death|0|||
129806108|NCT04357782|467256861|FG001|Overall Study|Death|2|||
129806109|NCT03780543|467256862|FG000|Overall Study|Adverse Event|1|||
129806110|NCT03780543|467256863|FG001|Overall Study|Adverse Event|0|||
129806111|NCT03780543|467256864|FG002|Overall Study|Adverse Event|2|||
129806112|NCT03780543|467256862|FG000|Overall Study|Lost to Follow-up|2|||
129806113|NCT03780543|467256863|FG001|Overall Study|Lost to Follow-up|0|||
129806114|NCT03780543|467256864|FG002|Overall Study|Lost to Follow-up|1|||
129738039|NCT00907296|467002078|FG001|Overall Study|Withdrawal by Subject|2|||
129738040|NCT00907296|467002079|FG002|Overall Study|Withdrawal by Subject|1|||
129738041|NCT00907296|467002080|FG003|Overall Study|Withdrawal by Subject|1|||
129738042|NCT00907296|467002081|FG004|Overall Study|Withdrawal by Subject|1|||
129738043|NCT00907296|467002082|FG005|Overall Study|Withdrawal by Subject|5|||
129738044|NCT00907296|467002083|FG006|Overall Study|Withdrawal by Subject|3|||
129738045|NCT00907296|467002084|FG007|Overall Study|Withdrawal by Subject|2|||
129738046|NCT00907296|467002085|FG008|Overall Study|Withdrawal by Subject|4|||
129738047|NCT00907296|467002086|FG009|Overall Study|Withdrawal by Subject|2|||
129738048|NCT00907296|467002077|FG000|Overall Study|Lost to Follow-up|9|||
129738049|NCT00907296|467002078|FG001|Overall Study|Lost to Follow-up|1|||
129738050|NCT00907296|467002079|FG002|Overall Study|Lost to Follow-up|0|||
129738051|NCT00907296|467002080|FG003|Overall Study|Lost to Follow-up|2|||
129806115|NCT03780543|467256862|FG000|Overall Study|Study terminated by Sponsor|8|||
129806116|NCT03780543|467256863|FG001|Overall Study|Study terminated by Sponsor|7|||
129806117|NCT03780543|467256864|FG002|Overall Study|Study terminated by Sponsor|13|||
129806118|NCT03780543|467256862|FG000|Overall Study|Withdrawal by Subject|1|||
129806119|NCT03780543|467256863|FG001|Overall Study|Withdrawal by Subject|8|||
129806120|NCT03780543|467256864|FG002|Overall Study|Withdrawal by Subject|1|||
129806121|NCT03780543|467256862|FG000|Overall Study|Noncompliance with study drug|1|||
129806122|NCT03780543|467256863|FG001|Overall Study|Noncompliance with study drug|0|||
129806123|NCT03780543|467256864|FG002|Overall Study|Noncompliance with study drug|0|||
129806124|NCT00066729|467256865|FG000|Overall Study|Lost to Follow-up|1|||
129806125|NCT00066729|467256865|FG000|Overall Study|Disease progression|1|||
129806126|NCT00287365|467256868|FG000|Overall Study|sample not acquired|13|||
129806127|NCT02298023|467256871|FG000|Overall Study|Withdrawal by Subject|1|||
129738052|NCT00907296|467002081|FG004|Overall Study|Lost to Follow-up|0|||
129738053|NCT00907296|467002082|FG005|Overall Study|Lost to Follow-up|3|||
129738054|NCT00907296|467002083|FG006|Overall Study|Lost to Follow-up|2|||
129806128|NCT02298023|467256872|FG001|Overall Study|Withdrawal by Subject|0|||
129893481|NCT02487446|467569778|FG000|Period 1|Physician Decision|0|||
129893482|NCT02487446|467569779|FG001|Period 1|Physician Decision|1|||
129893483|NCT02487446|467569778|FG000|Period 1|Lack of Efficacy|1|||
129738055|NCT00907296|467002084|FG007|Overall Study|Lost to Follow-up|2|||
129738056|NCT00907296|467002085|FG008|Overall Study|Lost to Follow-up|0|||
129738057|NCT00907296|467002086|FG009|Overall Study|Lost to Follow-up|4|||
129738058|NCT00357656|467002090|FG000|Overall Study|Other, No surgery performed|0|||
129738059|NCT00357656|467002091|FG001|Overall Study|Other, No surgery performed|3|||
129738060|NCT02573246|467002092|FG000|Overall Study|Lost to Follow-up|2|||
129738061|NCT02573246|467002093|FG001|Overall Study|Lost to Follow-up|0|||
129738062|NCT02573246|467002094|FG002|Overall Study|Lost to Follow-up|0|||
129738063|NCT02573246|467002095|FG003|Overall Study|Lost to Follow-up|0|||
129738064|NCT02573246|467002096|FG004|Overall Study|Lost to Follow-up|1|||
129738065|NCT02573246|467002092|FG000|Overall Study|Withdrawal by Subject|0|||
129738066|NCT02573246|467002093|FG001|Overall Study|Withdrawal by Subject|0|||
129738067|NCT02573246|467002094|FG002|Overall Study|Withdrawal by Subject|0|||
129738068|NCT02573246|467002095|FG003|Overall Study|Withdrawal by Subject|0|||
129738069|NCT02573246|467002096|FG004|Overall Study|Withdrawal by Subject|1|||
129738070|NCT02573246|467002092|FG000|Overall Study|Physician Decision|1|||
129738071|NCT02573246|467002093|FG001|Overall Study|Physician Decision|1|||
129738072|NCT02573246|467002094|FG002|Overall Study|Physician Decision|3|||
129738073|NCT02573246|467002095|FG003|Overall Study|Physician Decision|2|||
129738074|NCT02573246|467002096|FG004|Overall Study|Physician Decision|2|||
129738075|NCT01219933|467002097|FG000|Overall Study|Adverse Event|8|||
129738076|NCT01219933|467002097|FG000|Overall Study|No LDA reached|5|||
129738077|NCT01219933|467002097|FG000|Overall Study|No LDA maintained|7|||
129738078|NCT01219933|467002097|FG000|Overall Study|Lost to Follow-up|3|||
129738079|NCT01219933|467002097|FG000|Overall Study|GC free|1|||
129738080|NCT01219933|467002097|FG000|Overall Study|Withdrawal by Subject|5|||
129738081|NCT01219933|467002097|FG000|Overall Study|Protocol Violation|8|||
129738082|NCT01219933|467002097|FG000|Overall Study|Lack of Efficacy|1|||
129738083|NCT03149003|467002098|FG000|Overall Study|Randomized but not treated|0|||
129738084|NCT03149003|467002099|FG001|Overall Study|Randomized but not treated|1|||
129738085|NCT03149003|467002100|FG002|Overall Study|Randomized but not treated|18|||
129738086|NCT02900170|467002102|FG000|Overall Study|Lost to Follow-up|8|||
129738087|NCT01565941|467002103|FG000|Overall Study|Withdrawn by parent/guardian|3|||
129738088|NCT01565941|467002104|FG001|Overall Study|Withdrawn by parent/guardian|2|||
129738089|NCT01565941|467002103|FG000|Overall Study|Randomized; did not receive intevention|8|||
129738090|NCT01565941|467002104|FG001|Overall Study|Randomized; did not receive intevention|2|||
129738091|NCT03262116|467002105|FG000|Overall Study|Physician Decision|0|||
129738092|NCT03262116|467002106|FG001|Overall Study|Physician Decision|2|||
129738093|NCT03262116|467002107|FG002|Overall Study|Physician Decision|1|||
129738094|NCT03262116|467002108|FG003|Overall Study|Physician Decision|1|||
129738095|NCT03262116|467002109|FG004|Overall Study|Physician Decision|1|||
129738096|NCT03262116|467002110|FG005|Overall Study|Physician Decision|2|||
129738097|NCT02365285|467002111|FG000|Overall Study|Physician Decision|0|||
129738098|NCT02365285|467002112|FG001|Overall Study|Physician Decision|1|||
129738099|NCT02365285|467002113|FG002|Overall Study|Physician Decision|1|||
129738100|NCT02365285|467002114|FG003|Overall Study|Physician Decision|0|||
129738101|NCT02365285|467002111|FG000|Overall Study|Adverse Event|0|||
129738102|NCT02365285|467002112|FG001|Overall Study|Adverse Event|0|||
129738103|NCT02365285|467002113|FG002|Overall Study|Adverse Event|0|||
129738104|NCT02365285|467002114|FG003|Overall Study|Adverse Event|2|||
129738105|NCT02608450|467002117|FG000|Overall Study|Lost to Follow-up|39|||
129738106|NCT02608450|467002118|FG001|Overall Study|Lost to Follow-up|32|||
129738107|NCT02608450|467002117|FG000|Overall Study|Withdrawal by Subject|21|||
129738108|NCT02608450|467002118|FG001|Overall Study|Withdrawal by Subject|15|||
129738109|NCT02608450|467002117|FG000|Overall Study|Adverse Event|3|||
129738110|NCT02608450|467002118|FG001|Overall Study|Adverse Event|6|||
129738111|NCT02608450|467002117|FG000|Overall Study|Withdrawal by parent|2|||
129893484|NCT02487446|467569779|FG001|Period 1|Lack of Efficacy|0|||
129738112|NCT02608450|467002118|FG001|Overall Study|Withdrawal by parent|3|||
129738113|NCT02608450|467002117|FG000|Overall Study|Lack of Efficacy|0|||
129738114|NCT02608450|467002118|FG001|Overall Study|Lack of Efficacy|3|||
129738115|NCT02608450|467002117|FG000|Overall Study|Noncompliance with study drug|0|||
129738116|NCT02608450|467002118|FG001|Overall Study|Noncompliance with study drug|2|||
129738117|NCT02608450|467002117|FG000|Overall Study|Physician Decision|0|||
129738118|NCT02608450|467002118|FG001|Overall Study|Physician Decision|1|||
129738119|NCT02608450|467002117|FG000|Overall Study|Pregnancy|0|||
129738120|NCT02608450|467002118|FG001|Overall Study|Pregnancy|1|||
129738121|NCT02608450|467002117|FG000|Overall Study|Progressive disease|1|||
129738122|NCT02608450|467002118|FG001|Overall Study|Progressive disease|0|||
129738123|NCT02608450|467002117|FG000|Overall Study|Multiple reasons|0|||
129738124|NCT02608450|467002118|FG001|Overall Study|Multiple reasons|2|||
129738125|NCT00249613|467002121|FG000|12 Month Follow-up|Death|1|||
129738126|NCT00249613|467002122|FG001|12 Month Follow-up|Death|1|||
129738127|NCT00249613|467002121|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
129738128|NCT00249613|467002122|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
129893485|NCT02487446|467569778|FG000|Period 1|Protocol deviation|3|||
129738129|NCT00249613|467002121|FG000|12 Month Follow-up|Lost to Follow-up|10|||
129738130|NCT00249613|467002122|FG001|12 Month Follow-up|Lost to Follow-up|8|||
129738131|NCT00424190|467002127|FG000|Overall Study|Withdrew consent|3|||
129738132|NCT00424190|467002128|FG001|Overall Study|Withdrew consent|4|||
129738133|NCT00424190|467002127|FG000|Overall Study|Death|3|||
129738134|NCT00424190|467002128|FG001|Overall Study|Death|0|||
129738135|NCT00424190|467002127|FG000|Overall Study|Noncompliance|1|||
129738136|NCT00424190|467002128|FG001|Overall Study|Noncompliance|2|||
129738137|NCT00424190|467002127|FG000|Overall Study|Request of sponsor or investigator|0|||
129738138|NCT00424190|467002128|FG001|Overall Study|Request of sponsor or investigator|2|||
129738139|NCT00424190|467002127|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
129738140|NCT00424190|467002128|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
129738141|NCT00424190|467002127|FG000|Overall Study|Other|15|||
129738142|NCT00424190|467002128|FG001|Overall Study|Other|21|||
129738143|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
129738144|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
129738145|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
129738146|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
129738147|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
129738148|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
129738149|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
129738150|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
129738151|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
129738152|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
129738153|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
129738154|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
129738155|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
129738156|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
129738157|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
129738158|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
129738159|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
129738160|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
129738161|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
129738162|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
129738163|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
129738164|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
129738165|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
129738166|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
129738167|NCT01672866|467002129|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
129738168|NCT01672866|467002130|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
129738169|NCT01672866|467002131|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
129806129|NCT02298023|467256873|FG002|Overall Study|Withdrawal by Subject|0|||
129806130|NCT01967173|467256874|FG000|Overall Study|Lost to Follow-up|5|||
129806131|NCT01967173|467256875|FG001|Overall Study|Lost to Follow-up|3|||
129806132|NCT01967173|467256876|FG002|Overall Study|Lost to Follow-up|2|||
129806133|NCT01967173|467256877|FG003|Overall Study|Lost to Follow-up|4|||
129806134|NCT01967173|467256878|FG004|Overall Study|Lost to Follow-up|8|||
129806135|NCT01967173|467256879|FG005|Overall Study|Lost to Follow-up|12|||
129806136|NCT01967173|467256880|FG006|Overall Study|Lost to Follow-up|6|||
129806137|NCT01967173|467256881|FG007|Overall Study|Lost to Follow-up|8|||
129806138|NCT01967173|467256874|FG000|Overall Study|Physician Decision|2|||
129806139|NCT01967173|467256875|FG001|Overall Study|Physician Decision|0|||
129806140|NCT01967173|467256876|FG002|Overall Study|Physician Decision|2|||
129806141|NCT01967173|467256877|FG003|Overall Study|Physician Decision|1|||
129806142|NCT01967173|467256878|FG004|Overall Study|Physician Decision|1|||
129806143|NCT01967173|467256879|FG005|Overall Study|Physician Decision|1|||
129738170|NCT01672866|467002129|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
129738171|NCT01672866|467002130|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
129738172|NCT01672866|467002131|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
129738173|NCT01672866|467002129|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
129738174|NCT01672866|467002130|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
129738175|NCT01672866|467002131|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
129738176|NCT01672866|467002129|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
129738177|NCT01672866|467002130|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
129738178|NCT01672866|467002131|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
129738179|NCT01672866|467002129|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
129738180|NCT01672866|467002130|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
129738181|NCT01672866|467002131|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
129738182|NCT01378429|467002134|FG000|Overall Study|Noncompliance with study drug|1|||
129738183|NCT01378429|467002135|FG001|Overall Study|Noncompliance with study drug|0|||
129738184|NCT02241187|467002136|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
129738185|NCT00199888|467002137|FG000|Overall Study|Lost to Follow-up|1|||
129738186|NCT05219669|467002138|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
129738187|NCT05219669|467002139|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
129738188|NCT05219669|467002140|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
129738189|NCT05219669|467002141|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
129738190|NCT05219669|467002142|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
129738191|NCT05219669|467002143|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
129738192|NCT02544373|467002145|FG000|Overall Study|Lost to Follow-up|5|||
129738193|NCT02544373|467002146|FG001|Overall Study|Lost to Follow-up|3|||
129738194|NCT02544373|467002145|FG000|Overall Study|Withdrawal by Subject|8|||
129738195|NCT02544373|467002146|FG001|Overall Study|Withdrawal by Subject|2|||
129738196|NCT02621073|467002147|FG000|Overall Study|Lost to Follow-up|0|||
129738197|NCT02621073|467002148|FG001|Overall Study|Lost to Follow-up|1|||
129738198|NCT02621073|467002147|FG000|Overall Study|Physician Decision|3|||
129738199|NCT02621073|467002148|FG001|Overall Study|Physician Decision|2|||
129738200|NCT01595581|467002149|FG000|Overall Study|Withdrawal by Subject|1|||
129738201|NCT01595581|467002150|FG001|Overall Study|Withdrawal by Subject|0|||
129738202|NCT01440881|467002151|FG000|Overall Study|Death|0|||
129738203|NCT01440881|467002152|FG001|Overall Study|Death|1|||
129738204|NCT02383433|467002155|FG000|Overall Study|Disease progression|2|||
129738205|NCT02920957|467002156|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
129738206|NCT02920957|467002157|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
129738207|NCT02920957|467002156|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
129738208|NCT02920957|467002157|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
129738209|NCT02920957|467002156|FG000|First Intervention : 1 Month|Adverse Event|1|||
129738210|NCT02920957|467002157|FG001|First Intervention : 1 Month|Adverse Event|0|||
129738211|NCT02920957|467002156|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
129738212|NCT02920957|467002157|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
129738213|NCT01345682|467002163|FG000|Overall Study|Progressive disease per RECIST|226|||
129738214|NCT01345682|467002164|FG001|Overall Study|Progressive disease per RECIST|93|||
129738215|NCT01345682|467002163|FG000|Overall Study|Worsening of underlying cancer disease|23|||
129738216|NCT01345682|467002164|FG001|Overall Study|Worsening of underlying cancer disease|12|||
129738217|NCT01345682|467002163|FG000|Overall Study|Adverse Event|51|||
129738218|NCT01345682|467002164|FG001|Overall Study|Adverse Event|41|||
129738219|NCT01345682|467002163|FG000|Overall Study|Non-compliance with protocol|0|||
129738220|NCT01345682|467002164|FG001|Overall Study|Non-compliance with protocol|1|||
129738221|NCT01345682|467002163|FG000|Overall Study|Lost to Follow-up|0|||
129738222|NCT01345682|467002164|FG001|Overall Study|Lost to Follow-up|1|||
129738223|NCT01345682|467002163|FG000|Overall Study|Refused to continue trial medication|16|||
129738224|NCT01345682|467002164|FG001|Overall Study|Refused to continue trial medication|9|||
129738225|NCT01345682|467002163|FG000|Overall Study|Not treated|2|||
129738226|NCT01345682|467002164|FG001|Overall Study|Not treated|1|||
129738227|NCT01345682|467002163|FG000|Overall Study|Reason other than those specified above|4|||
129738228|NCT01345682|467002164|FG001|Overall Study|Reason other than those specified above|3|||
129738229|NCT01075984|467002169|FG000|Treatment Phase|Adverse Event|0|||
129738230|NCT01075984|467002170|FG001|Treatment Phase|Adverse Event|1|||
129738231|NCT01075984|467002171|FG002|Treatment Phase|Adverse Event|3|||
129738232|NCT01075984|467002172|FG003|Treatment Phase|Adverse Event|7|||
129738233|NCT01075984|467002173|FG004|Treatment Phase|Adverse Event|35|||
129738234|NCT01075984|467002169|FG000|Treatment Phase|Protocol Violation|0|||
129738235|NCT01075984|467002170|FG001|Treatment Phase|Protocol Violation|0|||
129738236|NCT01075984|467002171|FG002|Treatment Phase|Protocol Violation|1|||
129893486|NCT02487446|467569779|FG001|Period 1|Protocol deviation|2|||
129893487|NCT02487446|467569778|FG000|Period 1|Lost to Follow-up|2|||
129893488|NCT02487446|467569779|FG001|Period 1|Lost to Follow-up|0|||
129893489|NCT02487446|467569778|FG000|Period 1|Withdrawal by Subject|2|||
129893490|NCT02487446|467569779|FG001|Period 1|Withdrawal by Subject|0|||
129893491|NCT02487446|467569778|FG000|Period 1|Adverse Event|5|||
129893492|NCT02487446|467569779|FG001|Period 1|Adverse Event|5|||
129893493|NCT02487446|467569778|FG000|Washout|Lost to Follow-up|0|||
129893494|NCT02487446|467569779|FG001|Washout|Lost to Follow-up|2|||
129893495|NCT02487446|467569778|FG000|Washout|Withdrawal by Subject|1|||
129893496|NCT02487446|467569779|FG001|Washout|Withdrawal by Subject|4|||
129893497|NCT02487446|467569778|FG000|Washout|Adverse Event|2|||
129738237|NCT01075984|467002172|FG003|Treatment Phase|Protocol Violation|0|||
129893498|NCT02487446|467569779|FG001|Washout|Adverse Event|2|||
129893499|NCT02487446|467569778|FG000|Period 2|Protocol deviation|0|||
129893500|NCT02487446|467569779|FG001|Period 2|Protocol deviation|1|||
129893501|NCT02487446|467569778|FG000|Period 2|Lost to Follow-up|1|||
129893502|NCT02487446|467569779|FG001|Period 2|Lost to Follow-up|1|||
129893503|NCT02487446|467569778|FG000|Period 2|Withdrawal by Subject|1|||
129893504|NCT02487446|467569779|FG001|Period 2|Withdrawal by Subject|1|||
129893505|NCT02487446|467569778|FG000|Period 2|Adverse Event|6|||
129893506|NCT02487446|467569779|FG001|Period 2|Adverse Event|2|||
129893507|NCT01822821|467569780|FG000|Overall Study|Eligible surgery cancelled|1|||
129893508|NCT01822821|467569781|FG001|Overall Study|Eligible surgery cancelled|1|||
129893509|NCT01822821|467569780|FG000|Overall Study|Other reasons|1|||
129893510|NCT01822821|467569781|FG001|Overall Study|Other reasons|0|||
129893511|NCT05780047|467569782|FG000|Overall Study|Did not submit baseline urine test kit|226|||
129893512|NCT05780047|467569782|FG000|Overall Study|Lost to Follow-up|34|||
129893513|NCT05780047|467569782|FG000|Overall Study|Did not submit second urine test kit|124|||
129893514|NCT00764868|467569785|FG000|Overall Study|Adverse Event|18|||
129893515|NCT00764868|467569785|FG000|Overall Study|Withdrawal by Subject|31|||
129893516|NCT00764868|467569785|FG000|Overall Study|Non-compliance|16|||
129893517|NCT00764868|467569785|FG000|Overall Study|Lost to Follow-up|25|||
129893518|NCT00764868|467569785|FG000|Overall Study|Lack of Efficacy|5|||
129893519|NCT00764868|467569785|FG000|Overall Study|Subject moved|7|||
129893520|NCT00764868|467569785|FG000|Overall Study|Pregnancy|3|||
129893521|NCT00764868|467569785|FG000|Overall Study|Prohibited medication|1|||
129893522|NCT00764868|467569785|FG000|Overall Study|Out of town|1|||
129893523|NCT00764868|467569785|FG000|Overall Study|Misuse and compliance of study drug|1|||
129893524|NCT00764868|467569785|FG000|Overall Study|Subject sent to boarding school|1|||
129893525|NCT00764868|467569785|FG000|Overall Study|Met an exclusion criteria|1|||
129893526|NCT00764868|467569785|FG000|Overall Study|Positive drug screen|2|||
129893527|NCT00764868|467569785|FG000|Overall Study|Sponsor requested withdrawal|1|||
129893528|NCT04438785|467569790|FG000|Overall Study|change of weight, give up intervention|2|||
129738238|NCT01075984|467002173|FG004|Treatment Phase|Protocol Violation|3|||
129738239|NCT01075984|467002169|FG000|Treatment Phase|Withdrawal by Subject|0|||
129738240|NCT01075984|467002170|FG001|Treatment Phase|Withdrawal by Subject|0|||
129738241|NCT01075984|467002171|FG002|Treatment Phase|Withdrawal by Subject|2|||
129738242|NCT01075984|467002172|FG003|Treatment Phase|Withdrawal by Subject|0|||
129738243|NCT01075984|467002173|FG004|Treatment Phase|Withdrawal by Subject|15|||
129738244|NCT01075984|467002169|FG000|Treatment Phase|Treatment Failure|0|||
129738245|NCT01075984|467002170|FG001|Treatment Phase|Treatment Failure|0|||
129738246|NCT01075984|467002171|FG002|Treatment Phase|Treatment Failure|1|||
129738247|NCT01075984|467002172|FG003|Treatment Phase|Treatment Failure|0|||
129738248|NCT01075984|467002173|FG004|Treatment Phase|Treatment Failure|5|||
129738249|NCT01075984|467002169|FG000|Treatment Phase|Progression of disease|0|||
129738250|NCT01075984|467002170|FG001|Treatment Phase|Progression of disease|0|||
129738251|NCT01075984|467002171|FG002|Treatment Phase|Progression of disease|0|||
129738252|NCT01075984|467002172|FG003|Treatment Phase|Progression of disease|0|||
129738253|NCT01075984|467002173|FG004|Treatment Phase|Progression of disease|2|||
129738254|NCT01075984|467002169|FG000|Follow-up Phase|Protocol Violation|0|||
129738255|NCT01075984|467002170|FG001|Follow-up Phase|Protocol Violation|0|||
129738256|NCT01075984|467002171|FG002|Follow-up Phase|Protocol Violation|1|||
129738257|NCT01075984|467002172|FG003|Follow-up Phase|Protocol Violation|0|||
129738258|NCT01075984|467002173|FG004|Follow-up Phase|Protocol Violation|3|||
129738259|NCT01075984|467002169|FG000|Follow-up Phase|Adverse Event|0|||
129738260|NCT01075984|467002170|FG001|Follow-up Phase|Adverse Event|0|||
129738261|NCT01075984|467002171|FG002|Follow-up Phase|Adverse Event|0|||
129738262|NCT01075984|467002172|FG003|Follow-up Phase|Adverse Event|2|||
129738263|NCT01075984|467002173|FG004|Follow-up Phase|Adverse Event|27|||
129738264|NCT01075984|467002169|FG000|Follow-up Phase|Administrative|0|||
129738265|NCT01075984|467002170|FG001|Follow-up Phase|Administrative|0|||
129738266|NCT01075984|467002171|FG002|Follow-up Phase|Administrative|0|||
129738267|NCT01075984|467002172|FG003|Follow-up Phase|Administrative|0|||
129738268|NCT01075984|467002173|FG004|Follow-up Phase|Administrative|1|||
129738269|NCT01075984|467002169|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129738270|NCT01075984|467002170|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129738271|NCT01075984|467002171|FG002|Follow-up Phase|Withdrawal by Subject|0|||
129738272|NCT01075984|467002172|FG003|Follow-up Phase|Withdrawal by Subject|0|||
129738273|NCT01075984|467002173|FG004|Follow-up Phase|Withdrawal by Subject|10|||
129738274|NCT01075984|467002169|FG000|Follow-up Phase|Progression of disease|0|||
129806144|NCT01967173|467256880|FG006|Overall Study|Physician Decision|1|||
129806145|NCT01967173|467256881|FG007|Overall Study|Physician Decision|0|||
129806146|NCT01967173|467256874|FG000|Overall Study|Lack of Efficacy|2|||
129806147|NCT01967173|467256875|FG001|Overall Study|Lack of Efficacy|0|||
129806148|NCT01967173|467256876|FG002|Overall Study|Lack of Efficacy|2|||
129806149|NCT01967173|467256877|FG003|Overall Study|Lack of Efficacy|2|||
129806150|NCT01967173|467256878|FG004|Overall Study|Lack of Efficacy|0|||
129806151|NCT01967173|467256879|FG005|Overall Study|Lack of Efficacy|1|||
129806152|NCT01967173|467256880|FG006|Overall Study|Lack of Efficacy|0|||
129806153|NCT01967173|467256881|FG007|Overall Study|Lack of Efficacy|2|||
129806154|NCT01967173|467256874|FG000|Overall Study|Pregnancy|0|||
129806155|NCT01967173|467256875|FG001|Overall Study|Pregnancy|0|||
129806156|NCT01967173|467256876|FG002|Overall Study|Pregnancy|0|||
129806157|NCT01967173|467256877|FG003|Overall Study|Pregnancy|0|||
129806158|NCT01967173|467256878|FG004|Overall Study|Pregnancy|0|||
129806159|NCT01967173|467256879|FG005|Overall Study|Pregnancy|0|||
129806160|NCT01967173|467256880|FG006|Overall Study|Pregnancy|1|||
129806161|NCT01967173|467256881|FG007|Overall Study|Pregnancy|1|||
129806162|NCT01967173|467256874|FG000|Overall Study|Adverse Event|0|||
129806163|NCT01967173|467256875|FG001|Overall Study|Adverse Event|0|||
129806164|NCT01967173|467256876|FG002|Overall Study|Adverse Event|0|||
129806165|NCT01967173|467256877|FG003|Overall Study|Adverse Event|0|||
129806166|NCT01967173|467256878|FG004|Overall Study|Adverse Event|0|||
129806167|NCT01967173|467256879|FG005|Overall Study|Adverse Event|0|||
129806168|NCT01967173|467256880|FG006|Overall Study|Adverse Event|0|||
129806169|NCT01967173|467256881|FG007|Overall Study|Adverse Event|1|||
129806170|NCT01967173|467256874|FG000|Overall Study|Withdrawal by Subject|15|||
129806171|NCT01967173|467256875|FG001|Overall Study|Withdrawal by Subject|14|||
129806172|NCT01967173|467256876|FG002|Overall Study|Withdrawal by Subject|10|||
129806173|NCT01967173|467256877|FG003|Overall Study|Withdrawal by Subject|7|||
129806174|NCT01967173|467256878|FG004|Overall Study|Withdrawal by Subject|8|||
129806175|NCT01967173|467256879|FG005|Overall Study|Withdrawal by Subject|9|||
129806176|NCT01967173|467256880|FG006|Overall Study|Withdrawal by Subject|10|||
129806177|NCT01967173|467256881|FG007|Overall Study|Withdrawal by Subject|12|||
129806178|NCT02020577|467256882|FG000|Overall Study|Progressive disease|3|||
129806179|NCT02020577|467256883|FG001|Overall Study|Progressive disease|38|||
129806180|NCT02020577|467256882|FG000|Overall Study|Other AE or clinical progression|0|||
129806181|NCT02020577|467256883|FG001|Overall Study|Other AE or clinical progression|15|||
129806182|NCT02020577|467256882|FG000|Overall Study|Withdrawal by Subject|0|||
129806183|NCT02020577|467256883|FG001|Overall Study|Withdrawal by Subject|1|||
129806184|NCT02020577|467256882|FG000|Overall Study|Other than stated above|0|||
129806185|NCT02020577|467256883|FG001|Overall Study|Other than stated above|1|||
129806186|NCT00241358|467256884|FG000|Overall Study|Determined to be not ineligible|0|||
129806187|NCT00241358|467256885|FG001|Overall Study|Determined to be not ineligible|1|||
129806188|NCT00241358|467256886|FG002|Overall Study|Determined to be not ineligible|1|||
129806189|NCT02663908|467256887|FG000|Overall Study|Withdrawal by Subject|8|||
129806190|NCT02663908|467256888|FG001|Overall Study|Withdrawal by Subject|5|||
129806191|NCT02663908|467256887|FG000|Overall Study|Lost to Follow-up|1|||
129806192|NCT02663908|467256888|FG001|Overall Study|Lost to Follow-up|5|||
129806193|NCT02663908|467256887|FG000|Overall Study|Adverse Event|13|||
129445057|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
129445058|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
129445059|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
129445060|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
129445061|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
129445062|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
129445063|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
129445064|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
129445065|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
129445066|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
129445067|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Early termination|0|||
129445068|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Early termination|0|||
129445069|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Early termination|34|||
129445070|NCT01493557|465931143|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
129445071|NCT01493557|465931144|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
129445072|NCT01493557|465931145|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
129445073|NCT01493557|465931143|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
129445074|NCT01493557|465931144|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
129445075|NCT01493557|465931145|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
129445076|NCT01493557|465931143|FG000|Randomized to Management Strategies|Other adverse event|8|||
129445077|NCT01493557|465931144|FG001|Randomized to Management Strategies|Other adverse event|5|||
129445078|NCT01493557|465931145|FG002|Randomized to Management Strategies|Other adverse event|0|||
129445079|NCT01493557|465931143|FG000|Randomized to Management Strategies|Protocol Violation|3|||
129445080|NCT01493557|465931144|FG001|Randomized to Management Strategies|Protocol Violation|0|||
129445081|NCT01493557|465931145|FG002|Randomized to Management Strategies|Protocol Violation|0|||
129445082|NCT01493557|465931143|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
129445083|NCT01493557|465931144|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
129445084|NCT01493557|465931145|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
129445085|NCT01493557|465931143|FG000|Randomized to Management Strategies|Other than stated above|1|||
129445086|NCT01493557|465931144|FG001|Randomized to Management Strategies|Other than stated above|3|||
129445087|NCT01493557|465931145|FG002|Randomized to Management Strategies|Other than stated above|0|||
129445088|NCT01493557|465931143|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
129445089|NCT01493557|465931144|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
129445090|NCT01493557|465931145|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
129445091|NCT01493557|465931143|FG000|Adding the Second Strategy|Other adverse event|1|||
129445092|NCT01493557|465931144|FG001|Adding the Second Strategy|Other adverse event|2|||
129445093|NCT01493557|465931145|FG002|Adding the Second Strategy|Other adverse event|0|||
129445094|NCT01493557|465931143|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
129445095|NCT01493557|465931144|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
129445096|NCT01493557|465931145|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
129445097|NCT01890148|465931160|FG000|Overall Study|Adverse Event|1|||
129445098|NCT01215175|465931161|FG000|Overall Study|Lost to Follow-up|0|||
129445099|NCT01215175|465931162|FG001|Overall Study|Lost to Follow-up|1|||
129445100|NCT01215175|465931163|FG002|Overall Study|Lost to Follow-up|0|||
129445101|NCT01215175|465931164|FG003|Overall Study|Lost to Follow-up|1|||
129445102|NCT01215175|465931165|FG004|Overall Study|Lost to Follow-up|0|||
129445103|NCT01678209|465931166|FG000|Overall Study|could not scan twice|1|||
129445104|NCT01678209|465931167|FG001|Overall Study|could not scan twice|1|||
129445105|NCT01678209|465931168|FG002|Overall Study|could not scan twice|1|||
129445106|NCT01678209|465931166|FG000|Overall Study|scheduling conflicts|0|||
129445107|NCT01678209|465931167|FG001|Overall Study|scheduling conflicts|0|||
129445108|NCT01678209|465931168|FG002|Overall Study|scheduling conflicts|1|||
129445109|NCT01678209|465931166|FG000|Overall Study|screen fail|16|||
129445110|NCT01678209|465931167|FG001|Overall Study|screen fail|17|||
129445111|NCT01678209|465931168|FG002|Overall Study|screen fail|16|||
129445112|NCT00702845|465931169|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
129445113|NCT00702845|465931170|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
129445114|NCT00702845|465931169|FG000|Overall Study|Too high ovarian response|5|||
129445115|NCT00702845|465931170|FG001|Overall Study|Too high ovarian response|1|||
129445116|NCT00702845|465931169|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
129445117|NCT00702845|465931170|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
129445118|NCT00702845|465931169|FG000|Overall Study|Insufficient ovarian response|1|||
129445119|NCT00702845|465931170|FG001|Overall Study|Insufficient ovarian response|0|||
129445120|NCT00702845|465931169|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
129445121|NCT00702845|465931170|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
129445122|NCT00702845|465931169|FG000|Overall Study|No or abnormal fertilization|4|||
129445123|NCT00702845|465931170|FG001|Overall Study|No or abnormal fertilization|2|||
129445124|NCT00702845|465931169|FG000|Overall Study|Patient's decision|2|||
129445125|NCT00702845|465931170|FG001|Overall Study|Patient's decision|1|||
129445126|NCT00702845|465931169|FG000|Overall Study|Not randomized|0|||
129445127|NCT00702845|465931170|FG001|Overall Study|Not randomized|1|||
129445128|NCT02973425|465931174|FG000|Overall Study|Lost to Follow-up|49|||
129445129|NCT02973425|465931175|FG001|Overall Study|Lost to Follow-up|53|||
129445130|NCT03876171|465931176|FG000|Overall Study|Withdrawal by Subject|3|||
129445131|NCT03876171|465931177|FG001|Overall Study|Withdrawal by Subject|3|||
129445132|NCT03876171|465931176|FG000|Overall Study|Re-arrest|0|||
129738275|NCT01075984|467002170|FG001|Follow-up Phase|Progression of disease|0|||
129738276|NCT01075984|467002171|FG002|Follow-up Phase|Progression of disease|0|||
129738277|NCT01075984|467002172|FG003|Follow-up Phase|Progression of disease|0|||
129738278|NCT01075984|467002173|FG004|Follow-up Phase|Progression of disease|2|||
129738279|NCT01075984|467002169|FG000|Follow-up Phase|Treatment failure|0|||
129445133|NCT03876171|465931177|FG001|Overall Study|Re-arrest|4|||
129445134|NCT03503513|465931178|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
129738280|NCT01075984|467002170|FG001|Follow-up Phase|Treatment failure|0|||
129738281|NCT01075984|467002171|FG002|Follow-up Phase|Treatment failure|0|||
129738282|NCT01075984|467002172|FG003|Follow-up Phase|Treatment failure|0|||
129738283|NCT01075984|467002173|FG004|Follow-up Phase|Treatment failure|4|||
129738284|NCT02440789|467002174|FG000|Overall Study|Withdrawal by Subject|3|||
129738285|NCT02440789|467002174|FG000|Overall Study|Not willing to adhere to reqs|1|||
129738286|NCT03684694|467002177|FG000|Phase 1|Withdrawal by Subject|1|||
129738287|NCT03684694|467002178|FG001|Phase 1|Withdrawal by Subject|0|||
129738288|NCT03684694|467002179|FG002|Phase 1|Withdrawal by Subject|0|||
129738289|NCT03684694|467002180|FG003|Phase 1|Withdrawal by Subject|0|||
129738290|NCT03684694|467002181|FG004|Phase 1|Withdrawal by Subject|0|||
129738291|NCT03684694|467002182|FG005|Phase 1|Withdrawal by Subject|0|||
129738292|NCT03684694|467002177|FG000|Phase 1|Investigator/Sponsor Decision|12|||
129738293|NCT03684694|467002178|FG001|Phase 1|Investigator/Sponsor Decision|2|||
129806194|NCT02663908|467256888|FG001|Overall Study|Adverse Event|11|||
129445135|NCT03503513|465931178|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
129738294|NCT03684694|467002179|FG002|Phase 1|Investigator/Sponsor Decision|1|||
129738295|NCT03684694|467002180|FG003|Phase 1|Investigator/Sponsor Decision|0|||
129738296|NCT03684694|467002181|FG004|Phase 1|Investigator/Sponsor Decision|0|||
129893529|NCT04438785|467569791|FG001|Overall Study|change of weight, give up intervention|10|||
129893530|NCT04011033|467569792|FG000|Overall Study|Physician Decision|2|||
129445136|NCT03503513|465931178|FG000|Overall Study|Physician Decision|3|||
129445137|NCT03503513|465931178|FG000|Overall Study|Withdrawal by Subject|2|||
129445138|NCT03503513|465931178|FG000|Overall Study|Lost to Follow-up|1|||
129445139|NCT00929656|465931183|FG000|Overall Study|Lost to Follow-up|0|||
129445140|NCT00929656|465931184|FG001|Overall Study|Lost to Follow-up|1|||
129445141|NCT00607880|465931185|FG000|Overall Study|Unable to place port due to occlusion|1|||
129738297|NCT03684694|467002182|FG005|Phase 1|Investigator/Sponsor Decision|0|||
129738298|NCT03684694|467002177|FG000|Phase 1|Death|24|||
129738299|NCT03684694|467002178|FG001|Phase 1|Death|0|||
129445142|NCT00607880|465931186|FG001|Overall Study|Unable to place port due to occlusion|0|||
129445143|NCT01170039|465931187|FG000|Overall Study|Withdrawal by Subject|5|||
129445144|NCT01170039|465931188|FG001|Overall Study|Withdrawal by Subject|3|||
129445145|NCT01170039|465931187|FG000|Overall Study|Lack of funding, drug not available|3|||
129445146|NCT01170039|465931188|FG001|Overall Study|Lack of funding, drug not available|3|||
129445147|NCT00908583|465931189|FG000|Phase 1|Withdrawal by Subject|1|||
129445148|NCT00908583|465931189|FG000|Phase 1|Adverse Event|4|||
129445149|NCT00908583|465931189|FG000|Phase 2|Physician Decision|1|||
129445150|NCT00908583|465931189|FG000|Phase 2|Adverse Event|1|||
129445151|NCT00908583|465931189|FG000|Phase 3|Adverse Event|2|||
129445152|NCT00908583|465931189|FG000|Phase 4|Adverse Event|1|||
129445153|NCT00908583|465931189|FG000|Phase 4|Physician Decision|1|||
129445154|NCT00908583|465931189|FG000|Phase 5|Adverse Event|3|||
129445155|NCT00860951|465931190|FG000|Overall Study|Withdrawal by Subject|2|||
129445156|NCT00860951|465931190|FG000|Overall Study|Lost to Follow-up|5|||
129445157|NCT00727649|465931191|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
129445158|NCT00727649|465931192|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
129445159|NCT00727649|465931191|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
129445160|NCT00727649|465931192|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
129445161|NCT00727649|465931191|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
129445162|NCT00727649|465931192|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
129445163|NCT00727649|465931191|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
129445164|NCT00727649|465931192|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
129445165|NCT00727649|465931191|FG000|Second Intervention (4-weeks)|Death|1|||
129445166|NCT00727649|465931192|FG001|Second Intervention (4-weeks)|Death|0|||
129445167|NCT00727649|465931191|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
129445168|NCT00727649|465931192|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
129445169|NCT00727649|465931191|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
129445170|NCT00727649|465931192|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
129445171|NCT03823404|465931194|FG000|Overall Study|Lost to Follow-up|1|||
129445172|NCT03823404|465931195|FG001|Overall Study|Lost to Follow-up|2|||
129445173|NCT03823404|465931196|FG002|Overall Study|Lost to Follow-up|3|||
129445174|NCT03823404|465931194|FG000|Overall Study|Protocol Violation|2|||
129445175|NCT03823404|465931195|FG001|Overall Study|Protocol Violation|0|||
129445176|NCT03823404|465931196|FG002|Overall Study|Protocol Violation|2|||
129445177|NCT03823404|465931194|FG000|Overall Study|Adverse Event|35|||
129445178|NCT03823404|465931195|FG001|Overall Study|Adverse Event|38|||
129738300|NCT03684694|467002179|FG002|Phase 1|Death|3|||
129738301|NCT03684694|467002180|FG003|Phase 1|Death|0|||
129738302|NCT03684694|467002181|FG004|Phase 1|Death|0|||
129738303|NCT03684694|467002182|FG005|Phase 1|Death|0|||
129806195|NCT02663908|467256887|FG000|Overall Study|Protocol Violation|1|||
129806196|NCT02663908|467256888|FG001|Overall Study|Protocol Violation|2|||
129806197|NCT02663908|467256887|FG000|Overall Study|Lack of therapeutic response|2|||
129806198|NCT02663908|467256888|FG001|Overall Study|Lack of therapeutic response|0|||
129806199|NCT02663908|467256887|FG000|Overall Study|COVID-19|1|||
129806200|NCT02663908|467256888|FG001|Overall Study|COVID-19|0|||
129806201|NCT02663908|467256887|FG000|Overall Study|Site closed|1|||
129806202|NCT02663908|467256888|FG001|Overall Study|Site closed|0|||
129806203|NCT02663908|467256887|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
129806204|NCT02663908|467256888|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
129806205|NCT02663908|467256887|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
129806206|NCT02663908|467256888|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
129806207|NCT02663908|467256887|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
129893531|NCT04011033|467569793|FG001|Overall Study|Physician Decision|3|||
129445179|NCT03823404|465931196|FG002|Overall Study|Adverse Event|8|||
129445180|NCT03823404|465931194|FG000|Overall Study|Withdrawal by Subject|38|||
129445181|NCT03823404|465931195|FG001|Overall Study|Withdrawal by Subject|40|||
129445182|NCT03823404|465931196|FG002|Overall Study|Withdrawal by Subject|35|||
129445183|NCT03823404|465931194|FG000|Overall Study|Death|4|||
129445184|NCT03823404|465931195|FG001|Overall Study|Death|0|||
129445185|NCT03823404|465931196|FG002|Overall Study|Death|0|||
129445186|NCT03823404|465931194|FG000|Overall Study|Other: Various reasons provided|5|||
129738304|NCT03684694|467002177|FG000|Phase 1|Lost to Follow-up|0|||
129445187|NCT03823404|465931195|FG001|Overall Study|Other: Various reasons provided|5|||
129738305|NCT03684694|467002178|FG001|Phase 1|Lost to Follow-up|0|||
129738306|NCT03684694|467002179|FG002|Phase 1|Lost to Follow-up|1|||
129738307|NCT03684694|467002180|FG003|Phase 1|Lost to Follow-up|0|||
129738308|NCT03684694|467002181|FG004|Phase 1|Lost to Follow-up|0|||
129738309|NCT03684694|467002182|FG005|Phase 1|Lost to Follow-up|0|||
129738310|NCT03684694|467002177|FG000|Phase 1|Miscellaneous|0|||
129738311|NCT03684694|467002178|FG001|Phase 1|Miscellaneous|1|||
129738312|NCT03684694|467002179|FG002|Phase 1|Miscellaneous|0|||
129738313|NCT03684694|467002180|FG003|Phase 1|Miscellaneous|0|||
129738314|NCT03684694|467002181|FG004|Phase 1|Miscellaneous|0|||
129806208|NCT02663908|467256888|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
129806209|NCT02663908|467256887|FG000|Overall Study|Death|1|||
129806210|NCT02663908|467256888|FG001|Overall Study|Death|0|||
129806211|NCT02663908|467256887|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
129806212|NCT02663908|467256888|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
129806213|NCT02663908|467256887|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
129893532|NCT04011033|467569792|FG000|Overall Study|Withdrawal by Subject|1|||
129738315|NCT03684694|467002182|FG005|Phase 1|Miscellaneous|0|||
129738316|NCT03684694|467002177|FG000|Phase 2|Withdrawal by Subject|0|||
129738317|NCT03684694|467002178|FG001|Phase 2|Withdrawal by Subject|0|||
129738318|NCT03684694|467002179|FG002|Phase 2|Withdrawal by Subject|0|||
129738319|NCT03684694|467002180|FG003|Phase 2|Withdrawal by Subject|0|||
129445188|NCT03823404|465931196|FG002|Overall Study|Other: Various reasons provided|6|||
129445189|NCT03383289|465931199|FG000|Overall Study|Death|83|||
129445190|NCT03383289|465931200|FG001|Overall Study|Death|78|||
129445191|NCT03383289|465931199|FG000|Overall Study|discharge from facility|84|||
129445192|NCT03383289|465931200|FG001|Overall Study|discharge from facility|84|||
129445193|NCT03383289|465931199|FG000|Overall Study|Withdrawal by Subject|4|||
129445194|NCT03383289|465931200|FG001|Overall Study|Withdrawal by Subject|1|||
129445195|NCT00832117|465931201|FG000|Overall Study|Death|1|||
129445196|NCT00832117|465931201|FG000|Overall Study|Disease Progression|11|||
129445197|NCT01524133|465931204|FG000|Treatment Phase|Withdrawal by Subject|13|||
129445198|NCT01524133|465931205|FG001|Treatment Phase|Withdrawal by Subject|28|||
129445199|NCT01524133|465931206|FG002|Treatment Phase|Withdrawal by Subject|31|||
129445200|NCT01524133|465931204|FG000|Treatment Phase|Physician Decision|6|||
129445201|NCT01524133|465931205|FG001|Treatment Phase|Physician Decision|3|||
129445202|NCT01524133|465931206|FG002|Treatment Phase|Physician Decision|3|||
129445203|NCT01524133|465931204|FG000|Treatment Phase|Lost to Follow-up|0|||
129445204|NCT01524133|465931205|FG001|Treatment Phase|Lost to Follow-up|1|||
129445205|NCT01524133|465931206|FG002|Treatment Phase|Lost to Follow-up|2|||
129445206|NCT01524133|465931204|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
129445207|NCT01524133|465931205|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
129738320|NCT03684694|467002181|FG004|Phase 2|Withdrawal by Subject|0|||
129738321|NCT03684694|467002182|FG005|Phase 2|Withdrawal by Subject|1|||
129738322|NCT03684694|467002177|FG000|Phase 2|Investigator/Sponsor Decision|0|||
129738323|NCT03684694|467002178|FG001|Phase 2|Investigator/Sponsor Decision|0|||
129738324|NCT03684694|467002179|FG002|Phase 2|Investigator/Sponsor Decision|0|||
129738325|NCT03684694|467002180|FG003|Phase 2|Investigator/Sponsor Decision|17|||
129738326|NCT03684694|467002181|FG004|Phase 2|Investigator/Sponsor Decision|16|||
129738327|NCT03684694|467002182|FG005|Phase 2|Investigator/Sponsor Decision|6|||
129738328|NCT03684694|467002177|FG000|Phase 2|Death|0|||
129738329|NCT03684694|467002178|FG001|Phase 2|Death|0|||
129738330|NCT03684694|467002179|FG002|Phase 2|Death|0|||
129738331|NCT03684694|467002180|FG003|Phase 2|Death|28|||
129738332|NCT03684694|467002181|FG004|Phase 2|Death|14|||
129738333|NCT03684694|467002182|FG005|Phase 2|Death|3|||
129738334|NCT03684694|467002177|FG000|Phase 2|Lost to Follow-up|0|||
129738335|NCT03684694|467002178|FG001|Phase 2|Lost to Follow-up|0|||
129738336|NCT03684694|467002179|FG002|Phase 2|Lost to Follow-up|0|||
129738337|NCT03684694|467002180|FG003|Phase 2|Lost to Follow-up|1|||
129738338|NCT03684694|467002181|FG004|Phase 2|Lost to Follow-up|0|||
129738339|NCT03684694|467002182|FG005|Phase 2|Lost to Follow-up|0|||
129738340|NCT03684694|467002177|FG000|Phase 2|Miscellaneous|0|||
129738341|NCT03684694|467002178|FG001|Phase 2|Miscellaneous|0|||
129738342|NCT03684694|467002179|FG002|Phase 2|Miscellaneous|0|||
129738343|NCT03684694|467002180|FG003|Phase 2|Miscellaneous|3|||
129738344|NCT03684694|467002181|FG004|Phase 2|Miscellaneous|0|||
129738345|NCT03684694|467002182|FG005|Phase 2|Miscellaneous|0|||
129738346|NCT03172130|467003559|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
129738347|NCT03172130|467003560|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
129738348|NCT02831933|467003564|FG000|Overall Study|Physician Decision|11|||
129738349|NCT05065190|467003570|FG000|Overall Study|Other than listed|2|||
129738350|NCT05065190|467003571|FG001|Overall Study|Other than listed|12|||
129738351|NCT05065190|467003570|FG000|Overall Study|Lack of Efficacy|4|||
129738352|NCT05065190|467003571|FG001|Overall Study|Lack of Efficacy|0|||
129738353|NCT05065190|467003570|FG000|Overall Study|Adverse Event|1|||
129738354|NCT05065190|467003571|FG001|Overall Study|Adverse Event|10|||
129738355|NCT01073930|467003579|FG000|Overall Study|Withdrawal by Subject|3|||
129738356|NCT01073930|467003580|FG001|Overall Study|Withdrawal by Subject|2|||
129738357|NCT01073930|467003579|FG000|Overall Study|Lost to Follow-up|0|||
129738358|NCT01073930|467003580|FG001|Overall Study|Lost to Follow-up|1|||
129445208|NCT01524133|465931206|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
129445209|NCT01524133|465931204|FG000|Overall Study 52 Weeks|Physician Decision|1|||
129445210|NCT01524133|465931205|FG001|Overall Study 52 Weeks|Physician Decision|0|||
129445211|NCT01524133|465931206|FG002|Overall Study 52 Weeks|Physician Decision|2|||
129445212|NCT01524133|465931204|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
129445213|NCT01524133|465931205|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
129445214|NCT01524133|465931206|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
129445215|NCT00059839|465931207|FG000|Overall Study|Death|1|||
129738359|NCT01073930|467003579|FG000|Overall Study|Adverse Event|0|||
129738360|NCT01073930|467003580|FG001|Overall Study|Adverse Event|1|||
129738361|NCT01073930|467003579|FG000|Overall Study|Noncompliance with study drug|0|||
129738362|NCT01073930|467003580|FG001|Overall Study|Noncompliance with study drug|1|||
129738363|NCT01073930|467003579|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
129738364|NCT01073930|467003580|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
129738365|NCT01022424|467003581|FG000|Overall Study|Adverse Event|1|||
129738366|NCT01022424|467003581|FG000|Overall Study|Physician Decision|1|||
129738367|NCT01022424|467003581|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
129738368|NCT02783170|467003584|FG000|Overall Study|Randomized but not Vaccinated|1|||
129738369|NCT02783170|467003585|FG001|Overall Study|Randomized but not Vaccinated|0|||
129738370|NCT03320330|467003586|FG000|Overall Study|Lack of Efficacy|5|||
129445216|NCT00059839|465931208|FG001|Overall Study|Death|1|||
129445217|NCT00059839|465931207|FG000|Overall Study|Lack of Efficacy|6|||
129738371|NCT03320330|467003587|FG001|Overall Study|Lack of Efficacy|5|||
129738372|NCT03320330|467003588|FG002|Overall Study|Lack of Efficacy|14|||
129738373|NCT03320330|467003586|FG000|Overall Study|Physician Decision|1|||
129738374|NCT03320330|467003587|FG001|Overall Study|Physician Decision|0|||
129738375|NCT03320330|467003588|FG002|Overall Study|Physician Decision|0|||
129738376|NCT01806064|467003589|FG000|Overall Study|Randomized Not Enrolled|0|||
129738377|NCT01806064|467003590|FG001|Overall Study|Randomized Not Enrolled|0|||
129738378|NCT01806064|467003591|FG002|Overall Study|Randomized Not Enrolled|0|||
129738379|NCT01806064|467003592|FG003|Overall Study|Randomized Not Enrolled|1|||
129738380|NCT01806064|467003593|FG004|Overall Study|Randomized Not Enrolled|2|||
129738381|NCT01282294|467003596|FG000|Overall Study|Lost to Follow-up|14|||
129738382|NCT01282294|467003596|FG000|Overall Study|Screening failure|1|||
129738383|NCT01282294|467003596|FG000|Overall Study|Adverse Event|1|||
129738384|NCT01282294|467003596|FG000|Overall Study|Patient non-compliance|2|||
129738385|NCT01282294|467003596|FG000|Overall Study|Physician Decision|1|||
129738386|NCT04692077|467003597|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
129738387|NCT03826342|467003598|FG000|Overall Study|Withdrawal by Subject|8|||
129738388|NCT03826342|467003599|FG001|Overall Study|Withdrawal by Subject|1|||
129738389|NCT03826342|467003598|FG000|Overall Study|Lost to Follow-up|7|||
129738390|NCT03826342|467003599|FG001|Overall Study|Lost to Follow-up|7|||
129738391|NCT03826342|467003598|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
129738392|NCT03826342|467003599|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
129738393|NCT02046070|467003603|FG000|Overall Study|Progressive Disease|18|||
129738394|NCT02046070|467003604|FG001|Overall Study|Progressive Disease|11|||
129738395|NCT02046070|467003605|FG002|Overall Study|Progressive Disease|40|||
129738396|NCT02046070|467003603|FG000|Overall Study|Adverse Event|8|||
129738397|NCT02046070|467003604|FG001|Overall Study|Adverse Event|10|||
129738398|NCT02046070|467003605|FG002|Overall Study|Adverse Event|17|||
129738399|NCT02046070|467003603|FG000|Overall Study|Withdrawal by Subject|1|||
129738400|NCT02046070|467003604|FG001|Overall Study|Withdrawal by Subject|2|||
129738401|NCT02046070|467003605|FG002|Overall Study|Withdrawal by Subject|6|||
129738402|NCT02046070|467003603|FG000|Overall Study|Study Terminated by Sponsor|1|||
129738403|NCT02046070|467003604|FG001|Overall Study|Study Terminated by Sponsor|1|||
129738404|NCT02046070|467003605|FG002|Overall Study|Study Terminated by Sponsor|1|||
129738405|NCT02046070|467003603|FG000|Overall Study|Reason not Specified|4|||
129738406|NCT02046070|467003604|FG001|Overall Study|Reason not Specified|4|||
129738407|NCT02046070|467003605|FG002|Overall Study|Reason not Specified|6|||
129738408|NCT04030962|467003606|FG000|Stage 2|Adverse Event|0|||
129738409|NCT04030962|467003607|FG001|Stage 2|Adverse Event|0|||
129738410|NCT04030962|467003608|FG002|Stage 2|Adverse Event|0|||
129738411|NCT04030962|467003609|FG003|Stage 2|Adverse Event|0|||
129738412|NCT04030962|467003610|FG004|Stage 2|Adverse Event|0|||
129738413|NCT04030962|467003611|FG005|Stage 2|Adverse Event|0|||
129738414|NCT04030962|467003612|FG006|Stage 2|Adverse Event|0|||
129738415|NCT04030962|467003613|FG007|Stage 2|Adverse Event|0|||
129738416|NCT04030962|467003614|FG008|Stage 2|Adverse Event|1|||
129738417|NCT04030962|467003615|FG009|Stage 2|Adverse Event|0|||
129738418|NCT04030962|467003616|FG010|Stage 2|Adverse Event|1|||
129738419|NCT04030962|467003617|FG011|Stage 2|Adverse Event|1|||
129738420|NCT04030962|467003618|FG012|Stage 2|Adverse Event|1|||
129738421|NCT04030962|467003606|FG000|Stage 2|Withdrawal by Subject|0|||
129738422|NCT04030962|467003607|FG001|Stage 2|Withdrawal by Subject|0|||
129738423|NCT04030962|467003608|FG002|Stage 2|Withdrawal by Subject|0|||
129738424|NCT04030962|467003609|FG003|Stage 2|Withdrawal by Subject|0|||
129738425|NCT04030962|467003610|FG004|Stage 2|Withdrawal by Subject|0|||
129738426|NCT04030962|467003611|FG005|Stage 2|Withdrawal by Subject|0|||
129738427|NCT04030962|467003612|FG006|Stage 2|Withdrawal by Subject|0|||
129738428|NCT04030962|467003613|FG007|Stage 2|Withdrawal by Subject|0|||
129738429|NCT04030962|467003614|FG008|Stage 2|Withdrawal by Subject|1|||
129738430|NCT04030962|467003615|FG009|Stage 2|Withdrawal by Subject|0|||
129738431|NCT04030962|467003616|FG010|Stage 2|Withdrawal by Subject|0|||
129738432|NCT04030962|467003617|FG011|Stage 2|Withdrawal by Subject|2|||
129738433|NCT04030962|467003618|FG012|Stage 2|Withdrawal by Subject|1|||
129738434|NCT04030962|467003606|FG000|Stage 2|Lost to Follow-up|0|||
129738435|NCT04030962|467003607|FG001|Stage 2|Lost to Follow-up|0|||
129738436|NCT04030962|467003608|FG002|Stage 2|Lost to Follow-up|0|||
129738437|NCT04030962|467003609|FG003|Stage 2|Lost to Follow-up|0|||
129738438|NCT04030962|467003610|FG004|Stage 2|Lost to Follow-up|0|||
129738439|NCT04030962|467003611|FG005|Stage 2|Lost to Follow-up|0|||
129738440|NCT04030962|467003612|FG006|Stage 2|Lost to Follow-up|0|||
129738441|NCT04030962|467003613|FG007|Stage 2|Lost to Follow-up|0|||
129738442|NCT04030962|467003614|FG008|Stage 2|Lost to Follow-up|1|||
129738443|NCT04030962|467003615|FG009|Stage 2|Lost to Follow-up|0|||
129738444|NCT04030962|467003616|FG010|Stage 2|Lost to Follow-up|0|||
129738445|NCT04030962|467003617|FG011|Stage 2|Lost to Follow-up|0|||
129738446|NCT04030962|467003618|FG012|Stage 2|Lost to Follow-up|0|||
129738447|NCT04030962|467003606|FG000|Stage 2|Technical Problems|0|||
129738448|NCT04030962|467003607|FG001|Stage 2|Technical Problems|0|||
129738449|NCT04030962|467003608|FG002|Stage 2|Technical Problems|0|||
129738450|NCT04030962|467003609|FG003|Stage 2|Technical Problems|0|||
129738451|NCT04030962|467003610|FG004|Stage 2|Technical Problems|0|||
129738452|NCT04030962|467003611|FG005|Stage 2|Technical Problems|0|||
129738453|NCT04030962|467003612|FG006|Stage 2|Technical Problems|0|||
129738454|NCT04030962|467003613|FG007|Stage 2|Technical Problems|0|||
129738455|NCT04030962|467003614|FG008|Stage 2|Technical Problems|0|||
129738456|NCT04030962|467003615|FG009|Stage 2|Technical Problems|0|||
129738457|NCT04030962|467003616|FG010|Stage 2|Technical Problems|0|||
129738458|NCT04030962|467003617|FG011|Stage 2|Technical Problems|1|||
129738459|NCT04030962|467003618|FG012|Stage 2|Technical Problems|0|||
129738460|NCT05601102|467003621|FG000|Overall Study|Death|1|||
129738461|NCT05601102|467003622|FG001|Overall Study|Death|2|||
129738462|NCT05601102|467003621|FG000|Overall Study|Withdrawal by Subject|1|||
129738463|NCT05601102|467003622|FG001|Overall Study|Withdrawal by Subject|1|||
129738464|NCT05601102|467003621|FG000|Overall Study|Lost to Follow-up|0|||
129738465|NCT05601102|467003622|FG001|Overall Study|Lost to Follow-up|2|||
129738466|NCT05288166|467003623|FG000|Overall Study|Adverse Event|1|||
129738467|NCT05288166|467003624|FG001|Overall Study|Adverse Event|0|||
129738468|NCT05288166|467003623|FG000|Overall Study|Lost to Follow-up|2|||
129738469|NCT05288166|467003624|FG001|Overall Study|Lost to Follow-up|0|||
129738470|NCT05288166|467003623|FG000|Overall Study|Physician Decision|0|||
129738471|NCT05288166|467003624|FG001|Overall Study|Physician Decision|2|||
129738472|NCT05288166|467003623|FG000|Overall Study|Screen Failure|1|||
129738473|NCT05288166|467003624|FG001|Overall Study|Screen Failure|1|||
129738474|NCT05288166|467003623|FG000|Overall Study|Withdrawal by Subject|4|||
129738475|NCT05288166|467003624|FG001|Overall Study|Withdrawal by Subject|2|||
129738476|NCT05288166|467003623|FG000|Overall Study|On Study Treatment|408|||
129738477|NCT05288166|467003624|FG001|Overall Study|On Study Treatment|418|||
129738478|NCT02981524|467003626|FG000|Overall Study|Progressive Disease|14|||
129738479|NCT02981524|467003626|FG000|Overall Study|Death (unrelated)|1|||
129738480|NCT02981524|467003626|FG000|Overall Study|Treatment Related Toxicity|1|||
129738481|NCT02981524|467003626|FG000|Overall Study|Withdrawal by Subject|1|||
129738482|NCT00895661|467003630|FG000|Overall Study|Death|1|||
129738483|NCT00895661|467003630|FG000|Overall Study|reason unknown|2|||
129738484|NCT04094584|467003631|FG000|Overall Study|No interest in study|88|||
129738485|NCT04094584|467003631|FG000|Overall Study|Unwilling to undergo screening tests|36|||
129738486|NCT04094584|467003631|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
129738487|NCT04094584|467003631|FG000|Overall Study|Opioid use|7|||
129738488|NCT04094584|467003631|FG000|Overall Study|Need for major surgery in study period|4|||
129738489|NCT04094584|467003631|FG000|Overall Study|eligible but declined enrollment|4|||
129738490|NCT04094584|467003631|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
129738491|NCT04094584|467003631|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
129738492|NCT04094584|467003631|FG000|Overall Study|Lost to Follow-up|3|||
129738493|NCT04094584|467003631|FG000|Overall Study|Withdrawal by Subject|2|||
129738494|NCT00791557|467003632|FG000|Overall Study|Adverse Event|1|||
129738495|NCT03344640|467003633|FG000|Overall Study|Adverse Event|1|||
129738496|NCT03344640|467003634|FG001|Overall Study|Adverse Event|0|||
129738497|NCT03344640|467003633|FG000|Overall Study|Physician Decision|1|||
129738498|NCT03344640|467003634|FG001|Overall Study|Physician Decision|1|||
129738499|NCT03344640|467003633|FG000|Overall Study|Withdrawal by Subject|1|||
129738500|NCT03344640|467003634|FG001|Overall Study|Withdrawal by Subject|2|||
129738501|NCT03344640|467003633|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
129738502|NCT03344640|467003634|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
129738503|NCT01902888|467003635|FG000|Overall Study|Study Terminated|3|||
129738504|NCT00582738|467003636|FG000|Overall Study|Administrative Problems|7|||
129738505|NCT00582738|467003637|FG001|Overall Study|Administrative Problems|8|||
129738506|NCT00582738|467003636|FG000|Overall Study|Adverse Event|0|||
129738507|NCT00582738|467003637|FG001|Overall Study|Adverse Event|5|||
129738508|NCT00582738|467003636|FG000|Overall Study|Graft Lost|0|||
129738509|NCT00582738|467003637|FG001|Overall Study|Graft Lost|1|||
129738510|NCT00582738|467003636|FG000|Overall Study|Other|1|||
129738511|NCT00582738|467003637|FG001|Overall Study|Other|0|||
129738512|NCT00582738|467003636|FG000|Overall Study|Protocol Violation|1|||
129806214|NCT02663908|467256888|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
129806215|NCT03308786|467256889|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
129806216|NCT06238362|467256893|FG000|Overall Study|Insufficient total sleep time|1|||
129806217|NCT06238362|467256894|FG001|Overall Study|Insufficient total sleep time|0|||
129806218|NCT06238362|467256893|FG000|Overall Study|Inadequate signal quality|1|||
129738513|NCT00582738|467003637|FG001|Overall Study|Protocol Violation|1|||
129738514|NCT00582738|467003636|FG000|Overall Study|Withdrawal by Subject|0|||
129738515|NCT00582738|467003637|FG001|Overall Study|Withdrawal by Subject|3|||
129738516|NCT00652899|467003638|FG000|Overall Study|Death|1|||
129738517|NCT00652899|467003638|FG000|Overall Study|Treating physician decision|1|||
129738518|NCT04135859|467003640|FG000|Overall Study|Withdrawal by Subject|1|||
129738519|NCT04135859|467003641|FG001|Overall Study|Withdrawal by Subject|0|||
129445218|NCT00059839|465931208|FG001|Overall Study|Lack of Efficacy|5|||
129445219|NCT00059839|465931207|FG000|Overall Study|Lost to Follow-up|2|||
129738520|NCT04135859|467003640|FG000|Overall Study|Withdrawal due to screening failure|1|||
129445220|NCT00059839|465931208|FG001|Overall Study|Lost to Follow-up|0|||
129738521|NCT04135859|467003641|FG001|Overall Study|Withdrawal due to screening failure|2|||
129445221|NCT00059839|465931207|FG000|Overall Study|Physician Decision|1|||
129445222|NCT00059839|465931208|FG001|Overall Study|Physician Decision|2|||
129445223|NCT00059839|465931207|FG000|Overall Study|Withdrawal by Subject|1|||
129445224|NCT00059839|465931208|FG001|Overall Study|Withdrawal by Subject|6|||
129445225|NCT00059839|465931207|FG000|Overall Study|Ineligible|1|||
129445226|NCT00059839|465931208|FG001|Overall Study|Ineligible|3|||
129445227|NCT03842163|465931209|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
129445228|NCT03842163|465931209|FG000|Overall Study|Scintigraphy was not performed|44|||
129445229|NCT03829241|465931210|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
129445230|NCT03829241|465931211|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
129445231|NCT03829241|465931210|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
129445232|NCT03829241|465931211|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
129445233|NCT03829241|465931210|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
129445234|NCT03829241|465931211|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
129445235|NCT03829241|465931210|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
129738522|NCT04135859|467003640|FG000|Overall Study|Did not complete stress test|3|||
129738523|NCT04135859|467003641|FG001|Overall Study|Did not complete stress test|3|||
129738524|NCT04135859|467003640|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
129738525|NCT04135859|467003641|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
129738526|NCT00551291|467003642|FG000|Overall Study|Physician Decision|1|||
129738527|NCT01943552|467003643|FG000|Overall Study|Adverse Event|3|||
129738528|NCT01943552|467003644|FG001|Overall Study|Adverse Event|2|||
129738529|NCT01943552|467003643|FG000|Overall Study|Withdrawal by Subject|6|||
129738530|NCT01943552|467003644|FG001|Overall Study|Withdrawal by Subject|6|||
129738531|NCT01943552|467003643|FG000|Overall Study|Other Reasons|16|||
129738532|NCT01943552|467003644|FG001|Overall Study|Other Reasons|17|||
129738533|NCT01600053|467003645|FG000|Overall Study|Adverse Event|2|||
129738534|NCT01600053|467003645|FG000|Overall Study|trial will not meet the interim endpoint|9|||
129738535|NCT04047420|467003646|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
129738536|NCT04047420|467003646|FG000|Washout Period|Refused Participation|2|||
129738537|NCT02636946|467003648|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
129738538|NCT02636946|467003649|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
129738539|NCT02636946|467003648|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
129738540|NCT02636946|467003649|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
129738541|NCT02636946|467003648|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
129738542|NCT02636946|467003649|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
129738543|NCT02636946|467003648|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
129738544|NCT02636946|467003649|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
129738545|NCT02636946|467003648|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
129738546|NCT02636946|467003649|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
129738547|NCT02636946|467003648|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
129738548|NCT02636946|467003649|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
129445236|NCT03829241|465931211|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
129738549|NCT00477269|467003650|FG000|Core Study|Adverse Event|6|||
129738550|NCT00477269|467003651|FG001|Core Study|Adverse Event|4|||
129738551|NCT00477269|467003652|FG002|Core Study|Adverse Event|0|||
129738552|NCT00477269|467003650|FG000|Core Study|Death|3|||
129738553|NCT00477269|467003651|FG001|Core Study|Death|3|||
129738554|NCT00477269|467003652|FG002|Core Study|Death|0|||
129738555|NCT00477269|467003650|FG000|Core Study|Withdrawn Consent|0|||
129738556|NCT00477269|467003651|FG001|Core Study|Withdrawn Consent|1|||
129738557|NCT00477269|467003652|FG002|Core Study|Withdrawn Consent|0|||
129738558|NCT00477269|467003650|FG000|Open Label Extension|Adverse Event|0|||
129738559|NCT00477269|467003651|FG001|Open Label Extension|Adverse Event|0|||
129738560|NCT00477269|467003652|FG002|Open Label Extension|Adverse Event|4|||
129738561|NCT00477269|467003650|FG000|Open Label Extension|Abnormal laboratory values|0|||
129738562|NCT00477269|467003651|FG001|Open Label Extension|Abnormal laboratory values|0|||
129738563|NCT00477269|467003652|FG002|Open Label Extension|Abnormal laboratory values|1|||
129738564|NCT00477269|467003650|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
129738565|NCT00477269|467003651|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
129738566|NCT00477269|467003652|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
129738567|NCT00477269|467003650|FG000|Open Label Extension|Adminiatrative problems|0|||
129445237|NCT03829241|465931210|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
129738568|NCT00477269|467003651|FG001|Open Label Extension|Adminiatrative problems|0|||
129738569|NCT00477269|467003652|FG002|Open Label Extension|Adminiatrative problems|2|||
129738570|NCT00477269|467003650|FG000|Open Label Extension|Death|0|||
129738571|NCT00477269|467003651|FG001|Open Label Extension|Death|0|||
129738572|NCT00477269|467003652|FG002|Open Label Extension|Death|4|||
129738573|NCT01792518|467003655|FG000|Overall Study|Adverse Event|3|||
129893533|NCT04011033|467569793|FG001|Overall Study|Withdrawal by Subject|0|||
129445238|NCT03829241|465931211|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
129738574|NCT01792518|467003656|FG001|Overall Study|Adverse Event|4|||
129738575|NCT01792518|467003655|FG000|Overall Study|Protocol Violation|0|||
129738576|NCT01792518|467003656|FG001|Overall Study|Protocol Violation|1|||
129738577|NCT01792518|467003655|FG000|Overall Study|Lost to Follow-up|3|||
129738578|NCT01792518|467003656|FG001|Overall Study|Lost to Follow-up|1|||
129738579|NCT01792518|467003655|FG000|Overall Study|Withdrawal by Subject|2|||
129738580|NCT01792518|467003656|FG001|Overall Study|Withdrawal by Subject|0|||
129738581|NCT01792518|467003655|FG000|Overall Study|Other Reason|0|||
129738582|NCT01792518|467003656|FG001|Overall Study|Other Reason|1|||
129738583|NCT00351273|467003690|FG000|Overall Study|Lost to Follow-up|1|||
129738584|NCT00351273|467003691|FG001|Overall Study|Lost to Follow-up|2|||
129738585|NCT00351273|467003692|FG002|Overall Study|Lost to Follow-up|5|||
129738586|NCT01977690|467003693|FG000|Overall Study|Withdrawal by Subject|0|||
129738587|NCT01977690|467003694|FG001|Overall Study|Withdrawal by Subject|4|||
129738588|NCT03442296|467003700|FG000|3 Month Follow-up|Death|3|||
129738589|NCT03442296|467003701|FG001|3 Month Follow-up|Death|1|||
129738590|NCT03442296|467003700|FG000|3 Month Follow-up|Lost to Follow-up|1|||
129738591|NCT03442296|467003701|FG001|3 Month Follow-up|Lost to Follow-up|1|||
129738592|NCT03442296|467003700|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
129738593|NCT03442296|467003701|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
129738594|NCT03442296|467003700|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
129738595|NCT03442296|467003701|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
129738596|NCT03442296|467003700|FG000|12 Month Follow-up|Incomplete measurement|1|||
129738597|NCT03442296|467003701|FG001|12 Month Follow-up|Incomplete measurement|1|||
129738598|NCT00447122|467003703|FG000|Overall Study|worsening medical condition -came off|0|||
129738599|NCT00447122|467003704|FG001|Overall Study|worsening medical condition -came off|1|||
129738600|NCT00447122|467003705|FG002|Overall Study|worsening medical condition -came off|0|||
129738601|NCT00447122|467003706|FG003|Overall Study|worsening medical condition -came off|0|||
129738602|NCT01174173|467003709|FG000|Overall Study|drug-drug interaction|1|||
129738603|NCT02769962|467004899|FG000|Overall Study|Physician Decision|0|||
129738604|NCT02769962|467004900|FG001|Overall Study|Physician Decision|0|||
129738605|NCT02769962|467004901|FG002|Overall Study|Physician Decision|0|||
129738606|NCT02769962|467004902|FG003|Overall Study|Physician Decision|0|||
129738607|NCT02769962|467004903|FG004|Overall Study|Physician Decision|0|||
129738608|NCT02769962|467004904|FG005|Overall Study|Physician Decision|1|||
129738609|NCT02769962|467004905|FG006|Overall Study|Physician Decision|0|||
129738610|NCT02769962|467004906|FG007|Overall Study|Physician Decision|1|||
129738611|NCT02769962|467004899|FG000|Overall Study|Refused further treatment|0|||
129738612|NCT02769962|467004900|FG001|Overall Study|Refused further treatment|0|||
129738613|NCT02769962|467004901|FG002|Overall Study|Refused further treatment|0|||
129738614|NCT02769962|467004902|FG003|Overall Study|Refused further treatment|0|||
129738615|NCT02769962|467004903|FG004|Overall Study|Refused further treatment|0|||
129738616|NCT02769962|467004904|FG005|Overall Study|Refused further treatment|1|||
129738617|NCT02769962|467004905|FG006|Overall Study|Refused further treatment|1|||
129738618|NCT02769962|467004906|FG007|Overall Study|Refused further treatment|0|||
129738619|NCT01266590|467004907|FG000|Overall Study|Adverse Event|3|||
129738620|NCT01266590|467004907|FG000|Overall Study|Lost to Follow-up|1|||
129738621|NCT01266590|467004907|FG000|Overall Study|Withdrawal by Subject|1|||
129738622|NCT01266590|467004907|FG000|Overall Study|Physician Decision|1|||
129738623|NCT00720343|467004910|FG000|Overall Study|Lost to Follow-up|1|||
129738624|NCT00720343|467004911|FG001|Overall Study|Lost to Follow-up|0|||
129738625|NCT00720343|467004910|FG000|Overall Study|Protocol Violation|0|||
129738626|NCT00720343|467004911|FG001|Overall Study|Protocol Violation|2|||
129738627|NCT02008773|467004912|FG000|Overall Study|Adverse Event|3|||
129738628|NCT02008773|467004913|FG001|Overall Study|Adverse Event|3|||
129738629|NCT02008773|467004914|FG002|Overall Study|Adverse Event|1|||
129738630|NCT02008773|467004915|FG003|Overall Study|Adverse Event|2|||
129738631|NCT02008773|467004912|FG000|Overall Study|Medication Non-compliance|2|||
129806219|NCT06238362|467256894|FG001|Overall Study|Inadequate signal quality|0|||
129806220|NCT05136690|467256895|FG000|Period 1|Withdrawal by Subject|0|||
129806221|NCT05136690|467256896|FG001|Period 1|Withdrawal by Subject|1|||
129806222|NCT05136690|467256895|FG000|Period 2|Lost to Follow-up|0|||
129806223|NCT05136690|467256896|FG001|Period 2|Lost to Follow-up|3|||
129806224|NCT05136690|467256895|FG000|Period 2|Withdrawal by Subject|0|||
129806225|NCT05136690|467256896|FG001|Period 2|Withdrawal by Subject|1|||
129806226|NCT01863953|467258369|FG000|Overall Study|Adverse Event|0|||
129806227|NCT01863953|467258370|FG001|Overall Study|Adverse Event|0|||
129738632|NCT02008773|467004913|FG001|Overall Study|Medication Non-compliance|1|||
129738633|NCT02008773|467004914|FG002|Overall Study|Medication Non-compliance|3|||
129738634|NCT02008773|467004915|FG003|Overall Study|Medication Non-compliance|2|||
129738635|NCT02008773|467004912|FG000|Overall Study|Withdrawal by Subject|8|||
129738636|NCT02008773|467004913|FG001|Overall Study|Withdrawal by Subject|4|||
129738637|NCT02008773|467004914|FG002|Overall Study|Withdrawal by Subject|7|||
129738638|NCT02008773|467004915|FG003|Overall Study|Withdrawal by Subject|6|||
129806228|NCT01863953|467258371|FG002|Overall Study|Adverse Event|1|||
129806229|NCT01626456|467258377|FG000|Overall Study|Withdrawal by Subject|21|||
129806230|NCT01626456|467258378|FG001|Overall Study|Withdrawal by Subject|46|||
129738639|NCT02008773|467004912|FG000|Overall Study|Lost to Follow-up|0|||
129738640|NCT02008773|467004913|FG001|Overall Study|Lost to Follow-up|1|||
129738641|NCT02008773|467004914|FG002|Overall Study|Lost to Follow-up|3|||
129738642|NCT02008773|467004915|FG003|Overall Study|Lost to Follow-up|2|||
129738643|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
129738644|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
129738645|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
129738646|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
129738647|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
129738648|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
129738649|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
129738650|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
129738651|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
129738652|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
129738653|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
129738654|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
129738655|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
129738656|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
129738657|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
129738658|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
129738659|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
129738660|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
129738661|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
129738662|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
129738663|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
129738664|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
129738665|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
129738666|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
129738667|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
129738668|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
129738669|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
129738670|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
129738671|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
129738672|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129738673|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129738674|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
129738675|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
129738676|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
129738677|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
129738678|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
129445239|NCT03829241|465931210|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
129738679|NCT02198794|467004916|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
129738680|NCT02198794|467004917|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
129445240|NCT03829241|465931211|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
129738681|NCT02198794|467004918|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
129738682|NCT02198794|467004919|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
129738683|NCT02198794|467004916|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
129738684|NCT02198794|467004917|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
129738685|NCT02198794|467004918|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
129738686|NCT02198794|467004919|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
129738687|NCT02198794|467004916|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
129738688|NCT02198794|467004917|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
129738689|NCT02198794|467004918|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
129738690|NCT02198794|467004919|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
129738691|NCT02198794|467004916|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129738692|NCT02198794|467004917|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129738693|NCT02198794|467004918|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
129738694|NCT02198794|467004919|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
129738695|NCT02198794|467004916|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
129738696|NCT02198794|467004917|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
129738697|NCT02198794|467004918|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
129738698|NCT02198794|467004919|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
129738699|NCT02198794|467004916|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
129738700|NCT02198794|467004917|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
129738701|NCT02198794|467004918|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
129738702|NCT02198794|467004919|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
129738703|NCT01918332|467004920|FG000|Overall Study|Adverse Event|0|||
129738704|NCT01918332|467004921|FG001|Overall Study|Adverse Event|0|||
129738705|NCT01918332|467004922|FG002|Overall Study|Adverse Event|0|||
129738706|NCT01918332|467004923|FG003|Overall Study|Adverse Event|1|||
129738707|NCT01918332|467004920|FG000|Overall Study|Withdrawal by Subject|2|||
129738708|NCT01918332|467004921|FG001|Overall Study|Withdrawal by Subject|3|||
129738709|NCT01918332|467004922|FG002|Overall Study|Withdrawal by Subject|2|||
129738710|NCT01918332|467004923|FG003|Overall Study|Withdrawal by Subject|3|||
129738711|NCT01918332|467004920|FG000|Overall Study|Protocol Violation|6|||
129738712|NCT01918332|467004921|FG001|Overall Study|Protocol Violation|2|||
129738713|NCT01918332|467004922|FG002|Overall Study|Protocol Violation|6|||
129738714|NCT01918332|467004923|FG003|Overall Study|Protocol Violation|3|||
129738715|NCT01918332|467004920|FG000|Overall Study|lipid result by central lab did not meet|0|||
129738716|NCT01918332|467004921|FG001|Overall Study|lipid result by central lab did not meet|0|||
129738717|NCT01918332|467004922|FG002|Overall Study|lipid result by central lab did not meet|1|||
129738718|NCT01918332|467004923|FG003|Overall Study|lipid result by central lab did not meet|0|||
129738719|NCT02408523|467004924|FG000|Overall Study|Adverse Event|4|||
129738720|NCT02408523|467004925|FG001|Overall Study|Adverse Event|10|||
129738721|NCT02408523|467004924|FG000|Overall Study|Lack of Efficacy|0|||
129738722|NCT02408523|467004925|FG001|Overall Study|Lack of Efficacy|1|||
129738723|NCT02408523|467004924|FG000|Overall Study|Protocol Violation|1|||
129738724|NCT02408523|467004925|FG001|Overall Study|Protocol Violation|2|||
129738725|NCT02408523|467004924|FG000|Overall Study|Lost to Follow-up|2|||
129738726|NCT02408523|467004925|FG001|Overall Study|Lost to Follow-up|3|||
129738727|NCT02408523|467004924|FG000|Overall Study|Withdrawal by Subject|3|||
129738728|NCT02408523|467004925|FG001|Overall Study|Withdrawal by Subject|1|||
129738729|NCT02408523|467004924|FG000|Overall Study|Sponsor request|1|||
129738730|NCT02408523|467004925|FG001|Overall Study|Sponsor request|0|||
129738731|NCT02408523|467004924|FG000|Overall Study|Did not satisfy extension conditions|0|||
129738732|NCT02408523|467004925|FG001|Overall Study|Did not satisfy extension conditions|1|||
129738733|NCT00701805|467004926|FG000|Overall Study|Withdrawal by Subject|3|||
129738734|NCT00701805|467004927|FG001|Overall Study|Withdrawal by Subject|1|||
129738735|NCT00701805|467004928|FG002|Overall Study|Withdrawal by Subject|4|||
129738736|NCT00701805|467004929|FG003|Overall Study|Withdrawal by Subject|3|||
129738737|NCT00701805|467004926|FG000|Overall Study|Adverse Event|0|||
129738738|NCT00701805|467004927|FG001|Overall Study|Adverse Event|1|||
129738739|NCT00701805|467004928|FG002|Overall Study|Adverse Event|1|||
129738740|NCT00701805|467004929|FG003|Overall Study|Adverse Event|0|||
129738741|NCT00701805|467004926|FG000|Overall Study|Missed 7 consecutive doses|0|||
129738742|NCT00701805|467004927|FG001|Overall Study|Missed 7 consecutive doses|1|||
129738743|NCT00701805|467004928|FG002|Overall Study|Missed 7 consecutive doses|0|||
129893534|NCT02027935|467569794|FG000|Overall Study|Death|1|||
129738744|NCT00701805|467004929|FG003|Overall Study|Missed 7 consecutive doses|0|||
129806231|NCT01626456|467258377|FG000|Overall Study|Adverse Event|2|||
129806232|NCT01626456|467258378|FG001|Overall Study|Adverse Event|27|||
129806233|NCT01626456|467258377|FG000|Overall Study|Lost to Follow-up|2|||
129806234|NCT01626456|467258378|FG001|Overall Study|Lost to Follow-up|27|||
129806235|NCT01626456|467258377|FG000|Overall Study|Lack of Efficacy|6|||
129806236|NCT01626456|467258378|FG001|Overall Study|Lack of Efficacy|7|||
129738745|NCT00701805|467004926|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
129738746|NCT00701805|467004927|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
129738747|NCT00701805|467004928|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
129738748|NCT00701805|467004929|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
129738749|NCT00701805|467004926|FG000|Overall Study|Physician decision, change of therapy|0|||
129738750|NCT00701805|467004927|FG001|Overall Study|Physician decision, change of therapy|0|||
129738751|NCT00701805|467004928|FG002|Overall Study|Physician decision, change of therapy|0|||
129738752|NCT00701805|467004929|FG003|Overall Study|Physician decision, change of therapy|1|||
129738753|NCT00701805|467004926|FG000|Overall Study|Difficult to travel to dialysis site|0|||
129738754|NCT00701805|467004927|FG001|Overall Study|Difficult to travel to dialysis site|0|||
129738755|NCT00701805|467004928|FG002|Overall Study|Difficult to travel to dialysis site|1|||
129738756|NCT00701805|467004929|FG003|Overall Study|Difficult to travel to dialysis site|0|||
129738757|NCT00701805|467004926|FG000|Overall Study|Resumption criteria were not met|0|||
129738758|NCT00701805|467004927|FG001|Overall Study|Resumption criteria were not met|1|||
129738759|NCT00701805|467004928|FG002|Overall Study|Resumption criteria were not met|0|||
129738760|NCT00701805|467004929|FG003|Overall Study|Resumption criteria were not met|0|||
129738761|NCT02252965|467004933|FG000|Overall Study|Adverse Event|9|||
129738762|NCT02252965|467004934|FG001|Overall Study|Adverse Event|14|||
129738763|NCT02252965|467004933|FG000|Overall Study|Lost to Follow-up|16|||
129738764|NCT02252965|467004934|FG001|Overall Study|Lost to Follow-up|8|||
129738765|NCT02252965|467004933|FG000|Overall Study|Protocol Violation|4|||
129738766|NCT02252965|467004934|FG001|Overall Study|Protocol Violation|5|||
129738767|NCT02252965|467004933|FG000|Overall Study|Lack of Efficacy|0|||
129738768|NCT02252965|467004934|FG001|Overall Study|Lack of Efficacy|2|||
129738769|NCT02252965|467004933|FG000|Overall Study|Withdrawal by Subject|7|||
129738770|NCT02252965|467004934|FG001|Overall Study|Withdrawal by Subject|9|||
129738771|NCT02252965|467004933|FG000|Overall Study|Other|4|||
129738772|NCT02252965|467004934|FG001|Overall Study|Other|5|||
129738773|NCT04256512|467004935|FG000|Overall Study|Withdrawal by Subject|1|||
129738774|NCT04435600|467004943|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738775|NCT04435600|467004944|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738776|NCT04435600|467004945|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
129738777|NCT04435600|467004946|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738778|NCT04435600|467004947|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738779|NCT04435600|467004948|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738780|NCT04435600|467004949|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738781|NCT04435600|467004950|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738782|NCT04435600|467004951|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738783|NCT04435600|467004952|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
129738784|NCT04435600|467004943|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738785|NCT04435600|467004944|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738786|NCT04435600|467004945|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738787|NCT04435600|467004946|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738788|NCT04435600|467004947|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738789|NCT04435600|467004948|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738790|NCT04435600|467004949|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738791|NCT04435600|467004950|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738792|NCT04435600|467004951|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
129738793|NCT04435600|467004952|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
129738794|NCT04435600|467004943|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738795|NCT04435600|467004944|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738796|NCT04435600|467004945|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738797|NCT04435600|467004946|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738798|NCT04435600|467004947|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738799|NCT04435600|467004948|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738800|NCT04435600|467004949|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738801|NCT04435600|467004950|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129738802|NCT04435600|467004951|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
129806237|NCT01626456|467258377|FG000|Overall Study|Physician Decision|1|||
129806238|NCT01626456|467258378|FG001|Overall Study|Physician Decision|4|||
129806239|NCT01626456|467258377|FG000|Overall Study|Protocol Violation|1|||
129806240|NCT01626456|467258378|FG001|Overall Study|Protocol Violation|1|||
129806241|NCT01626456|467258377|FG000|Overall Study|Site Closure|2|||
129806242|NCT01626456|467258378|FG001|Overall Study|Site Closure|3|||
129806243|NCT01626456|467258377|FG000|Overall Study|Incarceration|0|||
129806244|NCT01626456|467258378|FG001|Overall Study|Incarceration|2|||
129738803|NCT04435600|467004952|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
129738804|NCT04435600|467004943|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738805|NCT04435600|467004944|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738806|NCT04435600|467004945|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738807|NCT04435600|467004946|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738808|NCT04435600|467004947|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738809|NCT04435600|467004948|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
129806245|NCT04015336|467258379|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
129806246|NCT01868503|467258383|FG000|Overall Study|Withdrawal by Subject|1|||
129806247|NCT01868503|467258383|FG000|Overall Study|Protocol Violation|1|||
129806248|NCT03650556|467258384|FG000|Overall Study|Death|2|||
129806249|NCT03650556|467258384|FG000|Overall Study|Withdrawal by Subject|20|||
129806250|NCT03650556|467258384|FG000|Overall Study|Physician Decision|2|||
129806251|NCT03650556|467258384|FG000|Overall Study|Lost to Follow-up|8|||
129806252|NCT03650556|467258384|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
129806253|NCT03650556|467258384|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
129806254|NCT00691301|467258385|FG000|Overall Study|Adverse Event|10|||
129806255|NCT00691301|467258385|FG000|Overall Study|Death|2|||
129806256|NCT00691301|467258385|FG000|Overall Study|Lack of Efficacy|32|||
129806257|NCT00691301|467258385|FG000|Overall Study|Withdrawal by Subject|4|||
129806258|NCT00691301|467258385|FG000|Overall Study|Concurrent illness|2|||
129806259|NCT00691301|467258385|FG000|Overall Study|other reason|3|||
129806260|NCT00691301|467258385|FG000|Overall Study|Did not initiate study treatment|1|||
129806261|NCT01823146|467258386|FG000|Overall Study|Withdrawal by Subject|0|||
129806262|NCT01823146|467258387|FG001|Overall Study|Withdrawal by Subject|1|||
129806263|NCT01823146|467258386|FG000|Overall Study|Lost to Follow-up|2|||
129806264|NCT01823146|467258387|FG001|Overall Study|Lost to Follow-up|1|||
129806265|NCT00463580|467258388|FG000|Overall Study|Lost to Follow-up|1|||
129806266|NCT00463580|467258389|FG001|Overall Study|Lost to Follow-up|0|||
129806267|NCT00463580|467258388|FG000|Overall Study|Schedule conflict|2|||
129806268|NCT00463580|467258389|FG001|Overall Study|Schedule conflict|0|||
129806269|NCT00463580|467258388|FG000|Overall Study|Medical/psychiatric complications|0|||
129806270|NCT00463580|467258389|FG001|Overall Study|Medical/psychiatric complications|2|||
129806271|NCT03917459|467258390|FG000|Overall Study|Adverse Event|1|||
129806272|NCT03917459|467258391|FG001|Overall Study|Adverse Event|0|||
129806273|NCT03917459|467258390|FG000|Overall Study|Withdrawal by Subject|0|||
129806274|NCT03917459|467258391|FG001|Overall Study|Withdrawal by Subject|1|||
129806275|NCT00491764|467258392|FG000|Overall Study|Adverse Event|1|||
129806276|NCT00491764|467258393|FG001|Overall Study|Adverse Event|2|||
129806277|NCT00491764|467258394|FG002|Overall Study|Adverse Event|4|||
129806278|NCT00491764|467258395|FG003|Overall Study|Adverse Event|4|||
129806279|NCT00491764|467258396|FG004|Overall Study|Adverse Event|0|||
129806280|NCT00491764|467258397|FG005|Overall Study|Adverse Event|1|||
129806281|NCT00491764|467258392|FG000|Overall Study|Lost to Follow-up|0|||
129806282|NCT00491764|467258393|FG001|Overall Study|Lost to Follow-up|1|||
129806283|NCT00491764|467258394|FG002|Overall Study|Lost to Follow-up|0|||
129806284|NCT00491764|467258395|FG003|Overall Study|Lost to Follow-up|1|||
129806285|NCT00491764|467258396|FG004|Overall Study|Lost to Follow-up|0|||
129806286|NCT00491764|467258397|FG005|Overall Study|Lost to Follow-up|3|||
129806287|NCT00491764|467258392|FG000|Overall Study|Withdrawal by Subject|2|||
129806288|NCT00491764|467258393|FG001|Overall Study|Withdrawal by Subject|3|||
129806289|NCT00491764|467258394|FG002|Overall Study|Withdrawal by Subject|1|||
129806290|NCT00491764|467258395|FG003|Overall Study|Withdrawal by Subject|2|||
129806291|NCT00491764|467258396|FG004|Overall Study|Withdrawal by Subject|2|||
129806292|NCT00491764|467258397|FG005|Overall Study|Withdrawal by Subject|4|||
129806293|NCT00491764|467258392|FG000|Overall Study|Non Compliance with the Protocol|1|||
129806294|NCT00491764|467258393|FG001|Overall Study|Non Compliance with the Protocol|0|||
129806295|NCT00491764|467258394|FG002|Overall Study|Non Compliance with the Protocol|0|||
129806296|NCT00491764|467258395|FG003|Overall Study|Non Compliance with the Protocol|0|||
129806297|NCT00491764|467258396|FG004|Overall Study|Non Compliance with the Protocol|0|||
129738810|NCT04435600|467004949|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738811|NCT04435600|467004950|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
129806298|NCT00491764|467258397|FG005|Overall Study|Non Compliance with the Protocol|0|||
129806299|NCT00491764|467258392|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
129806300|NCT00491764|467258393|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
129806301|NCT00491764|467258394|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
129806302|NCT00491764|467258395|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
129806303|NCT00491764|467258396|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
129806304|NCT00491764|467258397|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
129806305|NCT00491764|467258392|FG000|Overall Study|Administrative|1|||
129806306|NCT00491764|467258393|FG001|Overall Study|Administrative|0|||
129806307|NCT00491764|467258394|FG002|Overall Study|Administrative|2|||
129806308|NCT00491764|467258395|FG003|Overall Study|Administrative|1|||
129806309|NCT00491764|467258396|FG004|Overall Study|Administrative|0|||
129806310|NCT00491764|467258397|FG005|Overall Study|Administrative|0|||
129806311|NCT00697788|467258400|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806312|NCT00697788|467258401|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
129806313|NCT00697788|467258402|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806314|NCT00697788|467258403|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806315|NCT00697788|467258404|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806316|NCT00697788|467258405|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806317|NCT00697788|467258406|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806318|NCT00697788|467258407|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
129806319|NCT00697788|467258400|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806320|NCT00697788|467258401|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806321|NCT00697788|467258402|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806322|NCT00697788|467258403|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806323|NCT00697788|467258404|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
129806324|NCT00697788|467258405|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806325|NCT00697788|467258406|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806326|NCT00697788|467258407|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
129806327|NCT00075218|467258416|FG000|Double-Blind Treatment|Adverse Event|23|||
129806328|NCT00075218|467258417|FG001|Double-Blind Treatment|Adverse Event|4|||
129806329|NCT00075218|467258418|FG002|Double-Blind Treatment|Adverse Event|0|||
129806330|NCT00075218|467258416|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
129806331|NCT00075218|467258417|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
129806332|NCT00075218|467258418|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
129806333|NCT00075218|467258416|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
129806334|NCT00075218|467258417|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
129806335|NCT00075218|467258418|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
129806336|NCT00075218|467258416|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
129806337|NCT00075218|467258417|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
129806338|NCT00075218|467258418|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
129806339|NCT00075218|467258416|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
129806340|NCT00075218|467258417|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
129806341|NCT00075218|467258418|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
129806342|NCT00075218|467258416|FG000|Double-Blind Treatment|No study medication taken|2|||
129806343|NCT00075218|467258417|FG001|Double-Blind Treatment|No study medication taken|0|||
129806344|NCT00075218|467258418|FG002|Double-Blind Treatment|No study medication taken|0|||
129806345|NCT00075218|467258416|FG000|Open-Label Treatment|Lack of Efficacy|0|||
129806346|NCT00075218|467258417|FG001|Open-Label Treatment|Lack of Efficacy|0|||
129806347|NCT00075218|467258418|FG002|Open-Label Treatment|Lack of Efficacy|174|||
129806348|NCT00075218|467258416|FG000|Open-Label Treatment|Adverse Event|0|||
129806349|NCT00075218|467258417|FG001|Open-Label Treatment|Adverse Event|0|||
129806350|NCT00075218|467258418|FG002|Open-Label Treatment|Adverse Event|51|||
129806351|NCT00075218|467258416|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
129806352|NCT00075218|467258417|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129806353|NCT00075218|467258418|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
129893535|NCT02027935|467569794|FG000|Overall Study|Lack of Efficacy|5|||
129893536|NCT02027935|467569794|FG000|Overall Study|Study Closure|1|||
129738812|NCT04435600|467004951|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
129738813|NCT04435600|467004952|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
129738814|NCT02797184|467004954|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
129738815|NCT02797184|467004955|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
129738816|NCT05149313|467004956|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
129738817|NCT05149313|467004957|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
129738818|NCT05149313|467004958|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
129738819|NCT05149313|467004959|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
129738820|NCT05149313|467004956|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
129738821|NCT05149313|467004957|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
129738822|NCT05149313|467004958|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
129738823|NCT05149313|467004959|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
129738824|NCT05149313|467004956|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
129738825|NCT05149313|467004957|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
129738826|NCT05149313|467004958|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
129738827|NCT05149313|467004959|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
129806354|NCT00075218|467258416|FG000|Open-Label Treatment|Decision of Sponsor|0|||
129806355|NCT00075218|467258417|FG001|Open-Label Treatment|Decision of Sponsor|0|||
129806356|NCT00075218|467258418|FG002|Open-Label Treatment|Decision of Sponsor|8|||
129806357|NCT00075218|467258416|FG000|Open-Label Treatment|Protocol Violation|0|||
129806358|NCT00075218|467258417|FG001|Open-Label Treatment|Protocol Violation|0|||
129893537|NCT00689104|467569795|FG000|Overall Study|Eligibility criterion not met|5|||
129738828|NCT05149313|467004956|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
129738829|NCT05149313|467004957|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
129738830|NCT05149313|467004958|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
129738831|NCT05149313|467004959|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
129738832|NCT05149313|467004956|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
129738833|NCT05149313|467004957|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
129738834|NCT05149313|467004958|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
129738835|NCT05149313|467004959|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
129738836|NCT05149313|467004956|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
129738837|NCT05149313|467004957|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
129738838|NCT05149313|467004958|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
129738839|NCT05149313|467004959|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
129738840|NCT05149313|467004956|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
129738841|NCT05149313|467004957|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
129738842|NCT05149313|467004958|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
129738843|NCT05149313|467004959|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
129738844|NCT05149313|467004956|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129738845|NCT05149313|467004957|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129738846|NCT05149313|467004958|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
129738847|NCT05149313|467004959|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
129738848|NCT05149313|467004956|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129738849|NCT05149313|467004957|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129738850|NCT05149313|467004958|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
129738851|NCT05149313|467004959|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
129738852|NCT05149313|467004956|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129738853|NCT05149313|467004957|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129738854|NCT05149313|467004958|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
129738855|NCT05149313|467004959|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129738856|NCT05149313|467004956|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
129738857|NCT05149313|467004957|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
129738858|NCT05149313|467004958|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
129738859|NCT05149313|467004959|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
129738860|NCT03199391|467004964|FG000|Overall Study|Death|1|||
129738861|NCT03199391|467004964|FG000|Overall Study|Lost to Follow-up|3|||
129738862|NCT03199391|467004964|FG000|Overall Study|Adverse Event|2|||
129738863|NCT03199391|467004964|FG000|Overall Study|Withdrawal by Subject|10|||
129738864|NCT01867086|467004965|FG000|Overall Study|Disease Progression|1|||
129738865|NCT00483041|467004967|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
129738866|NCT00483041|467004968|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
129738867|NCT02258529|467004970|FG000|Overall Study|Study Terminated by Sponsor|9|||
129738868|NCT02258529|467004970|FG000|Overall Study|Adverse Event|1|||
129738869|NCT00443781|467004971|FG000|Overall Study|Lost to Follow-up|10|||
129738870|NCT00443781|467004971|FG000|Overall Study|Physician Decision|2|||
129738871|NCT00443781|467004971|FG000|Overall Study|Protocol Violation|1|||
129738872|NCT00443781|467004971|FG000|Overall Study|Withdrawal by Subject|6|||
129738873|NCT00443781|467004971|FG000|Overall Study|Unable to comply with study follow up|2|||
129738874|NCT00443781|467004971|FG000|Overall Study|Investigator terminated participation|1|||
129738875|NCT00443781|467004971|FG000|Overall Study|Insurance not covered|2|||
129738876|NCT00443781|467004971|FG000|Overall Study|PD/FAD not done|1|||
129738877|NCT02066415|467004972|FG000|Overall Study|Decision by Sponsor|5|||
129738878|NCT02066415|467004973|FG001|Overall Study|Decision by Sponsor|4|||
129738879|NCT02066415|467004974|FG002|Overall Study|Decision by Sponsor|2|||
129738880|NCT02066415|467004972|FG000|Overall Study|Withdrawal by Subject|9|||
129738881|NCT02066415|467004973|FG001|Overall Study|Withdrawal by Subject|1|||
129738882|NCT02066415|467004974|FG002|Overall Study|Withdrawal by Subject|4|||
129738883|NCT02066415|467004972|FG000|Overall Study|Lost to Follow-up|7|||
129738884|NCT02066415|467004973|FG001|Overall Study|Lost to Follow-up|2|||
129738885|NCT02066415|467004974|FG002|Overall Study|Lost to Follow-up|2|||
129738886|NCT05432167|467004978|FG000|Overall Study|Adverse Event|0|||
129738887|NCT05432167|467004979|FG001|Overall Study|Adverse Event|2|||
129738888|NCT05432167|467004980|FG002|Overall Study|Adverse Event|1|||
129738889|NCT05432167|467004978|FG000|Overall Study|Lost to Follow-up|3|||
129738890|NCT05432167|467004979|FG001|Overall Study|Lost to Follow-up|3|||
129738891|NCT05432167|467004980|FG002|Overall Study|Lost to Follow-up|2|||
129738892|NCT05432167|467004978|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
129738893|NCT05432167|467004979|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
129738894|NCT05432167|467004980|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
129738895|NCT05432167|467004978|FG000|Overall Study|Physician Decision|1|||
129738896|NCT05432167|467004979|FG001|Overall Study|Physician Decision|0|||
129738897|NCT05432167|467004980|FG002|Overall Study|Physician Decision|0|||
129738898|NCT05432167|467004978|FG000|Overall Study|Withdrawal by Subject|7|||
129738899|NCT05432167|467004979|FG001|Overall Study|Withdrawal by Subject|4|||
129806359|NCT00075218|467258418|FG002|Open-Label Treatment|Protocol Violation|1|||
129738900|NCT05432167|467004980|FG002|Overall Study|Withdrawal by Subject|11|||
129738901|NCT05432167|467004978|FG000|Overall Study|Other|0|||
129738902|NCT05432167|467004979|FG001|Overall Study|Other|0|||
129738903|NCT05432167|467004980|FG002|Overall Study|Other|1|||
129738904|NCT02616393|467004988|FG000|Overall Study|Death|5|||
129738905|NCT02616393|467004989|FG001|Overall Study|Death|12|||
129738906|NCT02616393|467004990|FG002|Overall Study|Death|1|||
129738907|NCT02616393|467004988|FG000|Overall Study|Termination by Sponsor|4|||
129738908|NCT02616393|467004989|FG001|Overall Study|Termination by Sponsor|5|||
129738909|NCT02616393|467004990|FG002|Overall Study|Termination by Sponsor|2|||
129738910|NCT02616393|467004988|FG000|Overall Study|Other|3|||
129738911|NCT02616393|467004989|FG001|Overall Study|Other|0|||
129738912|NCT02616393|467004990|FG002|Overall Study|Other|0|||
129738913|NCT02616393|467004988|FG000|Overall Study|Withdrawal by Subject|1|||
129738914|NCT02616393|467004989|FG001|Overall Study|Withdrawal by Subject|1|||
129738915|NCT02616393|467004990|FG002|Overall Study|Withdrawal by Subject|0|||
129738916|NCT02616393|467004988|FG000|Overall Study|Lost to Follow-up|0|||
129738917|NCT02616393|467004989|FG001|Overall Study|Lost to Follow-up|2|||
129738918|NCT02616393|467004990|FG002|Overall Study|Lost to Follow-up|0|||
129738919|NCT02758301|467004992|FG000|Overall Study|Death|12|||
129738920|NCT02758301|467004993|FG001|Overall Study|Death|0|||
129806360|NCT00075218|467258416|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
129445241|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
129806361|NCT00075218|467258417|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
129806362|NCT00075218|467258418|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
129806363|NCT03840174|467258419|FG000|Overall Study|Withdrawal by Subject|1|||
129738921|NCT02758301|467004992|FG000|Overall Study|Physician Decision|10|||
129738922|NCT02758301|467004993|FG001|Overall Study|Physician Decision|1|||
129738923|NCT02758301|467004992|FG000|Overall Study|Withdrawal by Subject|5|||
129738924|NCT02758301|467004993|FG001|Overall Study|Withdrawal by Subject|6|||
129738925|NCT02758301|467004992|FG000|Overall Study|Lost to Follow-up|7|||
129738926|NCT02758301|467004993|FG001|Overall Study|Lost to Follow-up|0|||
129738927|NCT02758301|467004992|FG000|Overall Study|Protocol Violation|0|||
129738928|NCT02758301|467004993|FG001|Overall Study|Protocol Violation|1|||
129738929|NCT00364533|467004994|FG000|Overall Study|Adverse Event|8|||
129738930|NCT00364533|467004995|FG001|Overall Study|Adverse Event|7|||
129738931|NCT00364533|467004996|FG002|Overall Study|Adverse Event|15|||
129738932|NCT00364533|467004997|FG003|Overall Study|Adverse Event|5|||
129738933|NCT00364533|467004998|FG004|Overall Study|Adverse Event|2|||
129738934|NCT00364533|467004994|FG000|Overall Study|Withdrawal by Subject|4|||
129738935|NCT00364533|467004995|FG001|Overall Study|Withdrawal by Subject|8|||
129738936|NCT00364533|467004996|FG002|Overall Study|Withdrawal by Subject|6|||
129738937|NCT00364533|467004997|FG003|Overall Study|Withdrawal by Subject|6|||
129738938|NCT00364533|467004998|FG004|Overall Study|Withdrawal by Subject|6|||
129738939|NCT00364533|467004994|FG000|Overall Study|Lack of Efficacy|22|||
129738940|NCT00364533|467004995|FG001|Overall Study|Lack of Efficacy|22|||
129738941|NCT00364533|467004996|FG002|Overall Study|Lack of Efficacy|21|||
129738942|NCT00364533|467004997|FG003|Overall Study|Lack of Efficacy|17|||
129738943|NCT00364533|467004998|FG004|Overall Study|Lack of Efficacy|42|||
129738944|NCT00364533|467004994|FG000|Overall Study|Subject discharged from hospital|4|||
129738945|NCT00364533|467004995|FG001|Overall Study|Subject discharged from hospital|1|||
129738946|NCT00364533|467004996|FG002|Overall Study|Subject discharged from hospital|2|||
129738947|NCT00364533|467004997|FG003|Overall Study|Subject discharged from hospital|3|||
129738948|NCT00364533|467004998|FG004|Overall Study|Subject discharged from hospital|1|||
129738949|NCT00364533|467004994|FG000|Overall Study|Variations in drug compliance|2|||
129738950|NCT00364533|467004995|FG001|Overall Study|Variations in drug compliance|1|||
129738951|NCT00364533|467004996|FG002|Overall Study|Variations in drug compliance|1|||
129738952|NCT00364533|467004997|FG003|Overall Study|Variations in drug compliance|0|||
129738953|NCT00364533|467004998|FG004|Overall Study|Variations in drug compliance|0|||
129738954|NCT00364533|467004994|FG000|Overall Study|Non-compliance|1|||
129738955|NCT00364533|467004995|FG001|Overall Study|Non-compliance|0|||
129738956|NCT00364533|467004996|FG002|Overall Study|Non-compliance|0|||
129738957|NCT00364533|467004997|FG003|Overall Study|Non-compliance|0|||
129738958|NCT00364533|467004998|FG004|Overall Study|Non-compliance|0|||
129738959|NCT00364533|467004994|FG000|Overall Study|Protocol Violation|1|||
129738960|NCT00364533|467004995|FG001|Overall Study|Protocol Violation|1|||
129738961|NCT00364533|467004996|FG002|Overall Study|Protocol Violation|0|||
129738962|NCT00364533|467004997|FG003|Overall Study|Protocol Violation|0|||
129738963|NCT00364533|467004998|FG004|Overall Study|Protocol Violation|0|||
129738964|NCT02445573|467004999|FG000|Overall Study|Withdrawal by Subject|1|||
129738965|NCT02445573|467005000|FG001|Overall Study|Withdrawal by Subject|1|||
129738966|NCT02445573|467004999|FG000|Overall Study|Lost to Follow-up|0|||
129738967|NCT02445573|467005000|FG001|Overall Study|Lost to Follow-up|1|||
129738968|NCT02855944|467005001|FG000|Period 1: Treatment|Ongoing|14|||
129738969|NCT02855944|467005002|FG001|Period 1: Treatment|Ongoing|0|||
129738970|NCT02855944|467005001|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
129738971|NCT02855944|467005002|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
129738972|NCT02855944|467005001|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
129738973|NCT02855944|467005002|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
129738974|NCT03242018|467005011|FG000|Overall Study|Adverse Event|7|||
129738975|NCT03242018|467005012|FG001|Overall Study|Adverse Event|7|||
129738976|NCT03242018|467005013|FG002|Overall Study|Adverse Event|6|||
129738977|NCT03242018|467005011|FG000|Overall Study|Lost to Follow-up|2|||
129738978|NCT03242018|467005012|FG001|Overall Study|Lost to Follow-up|2|||
129738979|NCT03242018|467005013|FG002|Overall Study|Lost to Follow-up|2|||
129738980|NCT03242018|467005011|FG000|Overall Study|At the Participant's Own Request|5|||
129738981|NCT03242018|467005012|FG001|Overall Study|At the Participant's Own Request|1|||
129738982|NCT03242018|467005013|FG002|Overall Study|At the Participant's Own Request|4|||
129806364|NCT03840174|467258420|FG001|Overall Study|Withdrawal by Subject|0|||
129806365|NCT03840174|467258421|FG002|Overall Study|Withdrawal by Subject|0|||
129738983|NCT03242018|467005011|FG000|Overall Study|Reason Not Specified|3|||
129738984|NCT03242018|467005012|FG001|Overall Study|Reason Not Specified|4|||
129738985|NCT03242018|467005013|FG002|Overall Study|Reason Not Specified|1|||
129738986|NCT03242018|467005011|FG000|Overall Study|Study Terminated by Sponsor|1|||
129738987|NCT03242018|467005012|FG001|Overall Study|Study Terminated by Sponsor|0|||
129738988|NCT03242018|467005013|FG002|Overall Study|Study Terminated by Sponsor|1|||
129738989|NCT01283542|467005015|FG000|Main Phase|Acute or progressive vision loss|1|||
129806366|NCT03840174|467258422|FG003|Overall Study|Withdrawal by Subject|0|||
129738990|NCT01283542|467005015|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
129738991|NCT01283542|467005015|FG000|Main Phase|abnormal laboratory values|5|||
129738992|NCT01283542|467005015|FG000|Extension Phase|Physician Decision|1|||
129738993|NCT01283542|467005015|FG000|Extension Phase|Adverse Event|1|||
129806367|NCT00131508|467258423|FG000|Overall Study|Disease progression|0|||
129738994|NCT01283542|467005015|FG000|Extension Phase|Administrative problems|1|||
129738995|NCT00257660|467005016|FG000|Overall Study|Lack of Efficacy|5|||
129738996|NCT00257660|467005017|FG001|Overall Study|Lack of Efficacy|23|||
129738997|NCT00257660|467005016|FG000|Overall Study|Withdrawal by Subject|2|||
129738998|NCT00257660|467005017|FG001|Overall Study|Withdrawal by Subject|0|||
129738999|NCT00257660|467005016|FG000|Overall Study|Lost to Follow-up|1|||
129739000|NCT00257660|467005017|FG001|Overall Study|Lost to Follow-up|0|||
129739001|NCT00257660|467005016|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
129739002|NCT00257660|467005017|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
129739003|NCT00257660|467005016|FG000|Overall Study|No longer wanted to do blood draws|1|||
129739004|NCT00257660|467005017|FG001|Overall Study|No longer wanted to do blood draws|0|||
129739005|NCT02449018|467005022|FG000|Overall Study|Abnormal laboratory value|0|||
129739006|NCT02449018|467005023|FG001|Overall Study|Abnormal laboratory value|1|||
129739007|NCT02449018|467005022|FG000|Overall Study|Administrative problems|1|||
129739008|NCT02449018|467005023|FG001|Overall Study|Administrative problems|0|||
129739009|NCT02449018|467005022|FG000|Overall Study|Adverse Event|5|||
129739010|NCT02449018|467005023|FG001|Overall Study|Adverse Event|1|||
129739011|NCT02449018|467005022|FG000|Overall Study|Protocol deviation|4|||
129739012|NCT02449018|467005023|FG001|Overall Study|Protocol deviation|0|||
129739013|NCT02449018|467005022|FG000|Overall Study|Patient decision|2|||
129739014|NCT02449018|467005023|FG001|Overall Study|Patient decision|0|||
129739015|NCT03995355|467005024|FG000|Overall Study|Adverse Event|1|||
129739016|NCT03995355|467005025|FG001|Overall Study|Adverse Event|0|||
129739017|NCT03995355|467005024|FG000|Overall Study|Withdrawal by Subject|1|||
129739018|NCT03995355|467005025|FG001|Overall Study|Withdrawal by Subject|0|||
129739019|NCT03995355|467005024|FG000|Overall Study|Scheduling Issues|0|||
129739020|NCT03995355|467005025|FG001|Overall Study|Scheduling Issues|1|||
129739021|NCT03426631|467005026|FG000|Overall Study|Lost to Follow-up|0|||
129739022|NCT03426631|467005027|FG001|Overall Study|Lost to Follow-up|1|||
129739023|NCT00654004|467005028|FG000|Overall Study|Lost to Follow-up|1|||
129739024|NCT00654004|467005029|FG001|Overall Study|Lost to Follow-up|0|||
129739025|NCT03134183|467005030|FG000|Overall Study|Withdrawal by Subject|1|||
129739026|NCT03134183|467005031|FG001|Overall Study|Withdrawal by Subject|1|||
129739027|NCT01969721|467005032|FG000|Overall Study|Adverse Event|3|||
129739028|NCT01969721|467005033|FG001|Overall Study|Adverse Event|8|||
129739029|NCT01969721|467005034|FG002|Overall Study|Adverse Event|3|||
129739030|NCT01969721|467005035|FG003|Overall Study|Adverse Event|2|||
129739031|NCT01969721|467005032|FG000|Overall Study|Lack of Efficacy|0|||
129739032|NCT01969721|467005033|FG001|Overall Study|Lack of Efficacy|0|||
129739033|NCT01969721|467005034|FG002|Overall Study|Lack of Efficacy|1|||
129739034|NCT01969721|467005035|FG003|Overall Study|Lack of Efficacy|0|||
129739035|NCT01969721|467005032|FG000|Overall Study|Non compliant with protocol|1|||
129739036|NCT01969721|467005033|FG001|Overall Study|Non compliant with protocol|1|||
129739037|NCT01969721|467005034|FG002|Overall Study|Non compliant with protocol|0|||
129739038|NCT01969721|467005035|FG003|Overall Study|Non compliant with protocol|2|||
129739039|NCT01969721|467005032|FG000|Overall Study|Other not defined above|0|||
129739040|NCT01969721|467005033|FG001|Overall Study|Other not defined above|2|||
129739041|NCT01969721|467005034|FG002|Overall Study|Other not defined above|0|||
129739042|NCT01969721|467005035|FG003|Overall Study|Other not defined above|0|||
129739043|NCT01969721|467005032|FG000|Overall Study|Discontinued during washout periods.|0|||
129739044|NCT01969721|467005033|FG001|Overall Study|Discontinued during washout periods.|1|||
129739045|NCT01969721|467005034|FG002|Overall Study|Discontinued during washout periods.|1|||
129739046|NCT01969721|467005035|FG003|Overall Study|Discontinued during washout periods.|2|||
129739047|NCT00495755|467005036|FG000|Overall Study|Adverse Event|3|||
129739048|NCT02117349|467005037|FG000|Overall Study|Withdrawal by Subject|1|||
129739049|NCT02117349|467005038|FG001|Overall Study|Withdrawal by Subject|0|||
129739050|NCT02117349|467005037|FG000|Overall Study|Lost to Follow-up|1|||
129739051|NCT02117349|467005038|FG001|Overall Study|Lost to Follow-up|1|||
129739052|NCT02117349|467005037|FG000|Overall Study|Death|1|||
129739053|NCT02117349|467005038|FG001|Overall Study|Death|0|||
129739054|NCT01012323|467005039|FG000|Overall Study|Investigator Judgment|1|||
129739055|NCT02265796|467005040|FG000|Overall Study|Death|1|||
129893538|NCT00689104|467569796|FG001|Overall Study|Eligibility criterion not met|8|||
129893539|NCT00689104|467569797|FG002|Overall Study|Eligibility criterion not met|0|||
129445242|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
129739056|NCT02265796|467005041|FG001|Overall Study|Death|0|||
129739057|NCT02265796|467005040|FG000|Overall Study|started on excluded medication|1|||
129739058|NCT02265796|467005041|FG001|Overall Study|started on excluded medication|0|||
129739059|NCT02265796|467005040|FG000|Overall Study|Withdrawal by Subject|1|||
129739060|NCT02265796|467005041|FG001|Overall Study|Withdrawal by Subject|1|||
129739061|NCT03938324|467006437|FG000|Overall Study|Lost to Follow-up|42|||
129739062|NCT03938324|467006438|FG001|Overall Study|Lost to Follow-up|21|||
129739063|NCT03938324|467006437|FG000|Overall Study|Withdrawal by Subject|6|||
129739064|NCT03938324|467006438|FG001|Overall Study|Withdrawal by Subject|1|||
129739065|NCT00837759|467006439|FG000|Overall Study|Protocol Violation|3|||
129739066|NCT00837759|467006439|FG000|Overall Study|Lost to Follow-up|1|||
129739067|NCT02081599|467006440|FG000|Period 1：Double-blind Period|Adverse Event|3|||
129739068|NCT02081599|467006441|FG001|Period 1：Double-blind Period|Adverse Event|0|||
129739069|NCT02081599|467006440|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
129739070|NCT02081599|467006441|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
129739071|NCT02081599|467006440|FG000|Period 1：Double-blind Period|Physician Decision|1|||
129739072|NCT02081599|467006441|FG001|Period 1：Double-blind Period|Physician Decision|0|||
129739073|NCT02081599|467006440|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
129739074|NCT02081599|467006441|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
129739075|NCT02081599|467006440|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
129739076|NCT02081599|467006441|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
129739077|NCT02081599|467006440|FG000|Period 1：Double-blind Period|stopping criteria|1|||
129739078|NCT02081599|467006441|FG001|Period 1：Double-blind Period|stopping criteria|0|||
129739079|NCT02081599|467006440|FG000|Period 2：Open-label Period|Adverse Event|1|||
129739080|NCT02081599|467006441|FG001|Period 2：Open-label Period|Adverse Event|0|||
129739081|NCT02081599|467006440|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
129739082|NCT02081599|467006441|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
129739083|NCT02081599|467006440|FG000|Period 2：Open-label Period|Physician Decision|1|||
129739084|NCT02081599|467006441|FG001|Period 2：Open-label Period|Physician Decision|0|||
129739085|NCT02081599|467006440|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
129739086|NCT02081599|467006441|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
129739087|NCT01286077|467006442|FG000|Overall Study|Adverse Event|2|||
129739088|NCT01286077|467006443|FG001|Overall Study|Adverse Event|0|||
129739089|NCT01286077|467006442|FG000|Overall Study|Death|1|||
129739090|NCT01286077|467006443|FG001|Overall Study|Death|0|||
129739091|NCT01286077|467006442|FG000|Overall Study|Protocol Violation|1|||
129739092|NCT01286077|467006443|FG001|Overall Study|Protocol Violation|1|||
129739093|NCT01286077|467006442|FG000|Overall Study|Withdrawal by Subject|0|||
129739094|NCT01286077|467006443|FG001|Overall Study|Withdrawal by Subject|2|||
129739095|NCT01286077|467006442|FG000|Overall Study|Intercurrent illness|1|||
129739096|NCT01286077|467006443|FG001|Overall Study|Intercurrent illness|0|||
129739097|NCT01286077|467006442|FG000|Overall Study|Non-compliance|1|||
129739098|NCT01286077|467006443|FG001|Overall Study|Non-compliance|0|||
129739099|NCT01286077|467006442|FG000|Overall Study|The subject starts with alternative MMY|0|||
129739100|NCT01286077|467006443|FG001|Overall Study|The subject starts with alternative MMY|3|||
129739101|NCT01286077|467006442|FG000|Overall Study|Patient's decision to stop treatment|3|||
129739102|NCT01286077|467006443|FG001|Overall Study|Patient's decision to stop treatment|0|||
129739103|NCT01286077|467006442|FG000|Overall Study|Progression of disease|0|||
129739104|NCT01286077|467006443|FG001|Overall Study|Progression of disease|1|||
129739105|NCT01286077|467006442|FG000|Overall Study|refill medication not received in time|1|||
129739106|NCT01286077|467006443|FG001|Overall Study|refill medication not received in time|0|||
129739107|NCT05063539|467006444|FG000|Overall Study|Adverse Event|1|||
129739108|NCT05063539|467006445|FG001|Overall Study|Adverse Event|2|||
129739109|NCT05063539|467006446|FG002|Overall Study|Adverse Event|1|||
129739110|NCT05063539|467006444|FG000|Overall Study|Death|0|||
129739111|NCT05063539|467006445|FG001|Overall Study|Death|1|||
129739112|NCT05063539|467006446|FG002|Overall Study|Death|1|||
129739113|NCT05063539|467006444|FG000|Overall Study|Lost to Follow-up|0|||
129739114|NCT05063539|467006445|FG001|Overall Study|Lost to Follow-up|1|||
129739115|NCT05063539|467006446|FG002|Overall Study|Lost to Follow-up|0|||
129739116|NCT05063539|467006444|FG000|Overall Study|Physician Decision|4|||
129739117|NCT05063539|467006445|FG001|Overall Study|Physician Decision|3|||
129739118|NCT05063539|467006446|FG002|Overall Study|Physician Decision|1|||
129739119|NCT05063539|467006444|FG000|Overall Study|Progressive Disease|0|||
129739120|NCT05063539|467006445|FG001|Overall Study|Progressive Disease|2|||
129739121|NCT05063539|467006446|FG002|Overall Study|Progressive Disease|0|||
129739122|NCT05063539|467006444|FG000|Overall Study|Withdrawal by Subject|17|||
129739123|NCT05063539|467006445|FG001|Overall Study|Withdrawal by Subject|26|||
129739124|NCT05063539|467006446|FG002|Overall Study|Withdrawal by Subject|14|||
129739125|NCT05063539|467006444|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
129739126|NCT05063539|467006445|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
129739127|NCT05063539|467006446|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
129739128|NCT05063539|467006444|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
129739129|NCT05063539|467006445|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
129739130|NCT05063539|467006446|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
129739131|NCT05063539|467006444|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
129739132|NCT05063539|467006445|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
129739133|NCT05063539|467006446|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
129739134|NCT05063539|467006444|FG000|Overall Study|Discontinued due to Common Close Design|0|||
129739135|NCT05063539|467006445|FG001|Overall Study|Discontinued due to Common Close Design|1|||
129739136|NCT05063539|467006446|FG002|Overall Study|Discontinued due to Common Close Design|0|||
129739137|NCT05063539|467006444|FG000|Overall Study|Participant not co-operative|0|||
129739138|NCT05063539|467006445|FG001|Overall Study|Participant not co-operative|1|||
129739139|NCT05063539|467006446|FG002|Overall Study|Participant not co-operative|0|||
129739140|NCT05063539|467006444|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
129739141|NCT05063539|467006445|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
129739142|NCT05063539|467006446|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
129739143|NCT05063539|467006444|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
129739144|NCT05063539|467006445|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
129739145|NCT05063539|467006446|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
129739146|NCT01751139|467006447|FG000|Overall Study|Other|135|||
129739147|NCT01751139|467006447|FG000|Overall Study|Sponsor study termination|1609|||
129739148|NCT01751139|467006447|FG000|Overall Study|Lost to Follow-up|240|||
129739149|NCT01751139|467006447|FG000|Overall Study|Withdrawal by Subject|251|||
129739150|NCT01751139|467006447|FG000|Overall Study|Adverse Event|1|||
129739151|NCT01751139|467006447|FG000|Overall Study|Death|31|||
129739152|NCT04736628|467006448|FG000|Overall Study|Not treated|0|||
129739153|NCT04736628|467006449|FG001|Overall Study|Not treated|0|||
129739154|NCT04736628|467006450|FG002|Overall Study|Not treated|0|||
129739155|NCT04736628|467006451|FG003|Overall Study|Not treated|2|||
129739156|NCT04736628|467006448|FG000|Overall Study|Other reason than listed|1|||
129739157|NCT04736628|467006449|FG001|Overall Study|Other reason than listed|2|||
129739158|NCT04736628|467006450|FG002|Overall Study|Other reason than listed|2|||
129739159|NCT04736628|467006451|FG003|Overall Study|Other reason than listed|3|||
129739160|NCT04736628|467006448|FG000|Overall Study|Protocol deviation|0|||
129739161|NCT04736628|467006449|FG001|Overall Study|Protocol deviation|0|||
129739162|NCT04736628|467006450|FG002|Overall Study|Protocol deviation|0|||
129739163|NCT04736628|467006451|FG003|Overall Study|Protocol deviation|1|||
129739164|NCT04736628|467006448|FG000|Overall Study|Burden of study procedures|1|||
129739165|NCT04736628|467006449|FG001|Overall Study|Burden of study procedures|0|||
129739166|NCT04736628|467006450|FG002|Overall Study|Burden of study procedures|0|||
129739167|NCT04736628|467006451|FG003|Overall Study|Burden of study procedures|1|||
129739168|NCT04736628|467006448|FG000|Overall Study|Change of residence|0|||
129739169|NCT04736628|467006449|FG001|Overall Study|Change of residence|1|||
129739170|NCT04736628|467006450|FG002|Overall Study|Change of residence|0|||
129739171|NCT04736628|467006451|FG003|Overall Study|Change of residence|0|||
129739172|NCT04736628|467006448|FG000|Overall Study|Perceived lack of efficacy|1|||
129739173|NCT04736628|467006449|FG001|Overall Study|Perceived lack of efficacy|0|||
129739174|NCT04736628|467006450|FG002|Overall Study|Perceived lack of efficacy|0|||
129739175|NCT04736628|467006451|FG003|Overall Study|Perceived lack of efficacy|1|||
129739176|NCT04736628|467006448|FG000|Overall Study|Adverse Event|3|||
129739177|NCT04736628|467006449|FG001|Overall Study|Adverse Event|2|||
129739178|NCT04736628|467006450|FG002|Overall Study|Adverse Event|4|||
129739179|NCT04736628|467006451|FG003|Overall Study|Adverse Event|3|||
129739180|NCT04279613|467006452|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129739181|NCT04279613|467006453|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129739182|NCT04279613|467006454|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129739183|NCT04279613|467006455|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
129739184|NCT04279613|467006456|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
129739185|NCT04279613|467006452|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129739186|NCT04279613|467006453|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
129739187|NCT04279613|467006454|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129739188|NCT04279613|467006455|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129739189|NCT04279613|467006456|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
129739190|NCT04279613|467006452|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129739191|NCT04279613|467006453|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129739192|NCT04279613|467006454|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
129739193|NCT04279613|467006455|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129739194|NCT04279613|467006456|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
129739195|NCT04279613|467006452|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129739196|NCT04279613|467006453|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129739197|NCT04279613|467006454|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129739198|NCT04279613|467006455|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
129739199|NCT04279613|467006456|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
129739200|NCT04279613|467006452|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129739201|NCT04279613|467006453|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129739202|NCT04279613|467006454|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129739203|NCT04279613|467006455|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
129739204|NCT04279613|467006456|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
129739205|NCT04428151|467006457|FG000|Overall Study|Death|100|||
129739206|NCT04428151|467006458|FG001|Overall Study|Death|86|||
129739207|NCT04428151|467006459|FG002|Overall Study|Death|57|||
129739208|NCT04428151|467006457|FG000|Overall Study|Lost to Follow-up|1|||
129739209|NCT04428151|467006458|FG001|Overall Study|Lost to Follow-up|1|||
129739210|NCT04428151|467006459|FG002|Overall Study|Lost to Follow-up|0|||
129739211|NCT04428151|467006457|FG000|Overall Study|Withdrawal by Subject|2|||
129739212|NCT04428151|467006458|FG001|Overall Study|Withdrawal by Subject|2|||
129739213|NCT04428151|467006459|FG002|Overall Study|Withdrawal by Subject|3|||
129739214|NCT04428151|467006457|FG000|Overall Study|Participant Ongoing in Study|41|||
129739215|NCT04428151|467006458|FG001|Overall Study|Participant Ongoing in Study|53|||
129739216|NCT04428151|467006459|FG002|Overall Study|Participant Ongoing in Study|28|||
129739217|NCT02704689|467006460|FG000|Overall Study|Physician Decision|1|||
129739218|NCT02704689|467006460|FG000|Overall Study|Study device not implanted|2|||
129739219|NCT02212678|467006463|FG000|Overall Study|Adverse Event|1|||
129739220|NCT02337634|467006464|FG000|Overall Study|Protocol Violation|3|||
129739221|NCT02337634|467006465|FG001|Overall Study|Protocol Violation|1|||
129739222|NCT02337634|467006464|FG000|Overall Study|Lost to Follow-up|1|||
129739223|NCT02337634|467006465|FG001|Overall Study|Lost to Follow-up|0|||
129739224|NCT04068610|467006466|FG000|Overall Study|Death|4|||
129739225|NCT04068610|467006467|FG001|Overall Study|Death|8|||
129739226|NCT04068610|467006468|FG002|Overall Study|Death|13|||
129739227|NCT04068610|467006466|FG000|Overall Study|Lost to Follow-up|0|||
129739228|NCT04068610|467006467|FG001|Overall Study|Lost to Follow-up|2|||
129739229|NCT04068610|467006468|FG002|Overall Study|Lost to Follow-up|0|||
129739230|NCT04068610|467006466|FG000|Overall Study|Withdrawal by Subject|0|||
129739231|NCT04068610|467006467|FG001|Overall Study|Withdrawal by Subject|4|||
129739232|NCT04068610|467006468|FG002|Overall Study|Withdrawal by Subject|2|||
129739233|NCT04068610|467006466|FG000|Overall Study|Other|3|||
129739234|NCT04068610|467006467|FG001|Overall Study|Other|12|||
129739235|NCT04068610|467006468|FG002|Overall Study|Other|11|||
129739236|NCT02428205|467006469|FG000|Overall Study|Lack of Efficacy|1|||
129739237|NCT02428205|467006470|FG001|Overall Study|Lack of Efficacy|0|||
129739238|NCT02428205|467006469|FG000|Overall Study|Lost to Follow-up|1|||
129739239|NCT02428205|467006470|FG001|Overall Study|Lost to Follow-up|1|||
129739240|NCT02428205|467006469|FG000|Overall Study|Worse behavior|0|||
129739241|NCT02428205|467006470|FG001|Overall Study|Worse behavior|1|||
129739242|NCT00527319|467006471|FG000|Overall Study|Withdrawal by Subject|5|||
129739243|NCT00527319|467006472|FG001|Overall Study|Withdrawal by Subject|0|||
129739244|NCT00527319|467006473|FG002|Overall Study|Withdrawal by Subject|1|||
129739245|NCT00527319|467006471|FG000|Overall Study|Lost to Follow-up|1|||
129739246|NCT00527319|467006472|FG001|Overall Study|Lost to Follow-up|0|||
129739247|NCT00527319|467006473|FG002|Overall Study|Lost to Follow-up|0|||
129739248|NCT00527319|467006471|FG000|Overall Study|Death|0|||
129739249|NCT00527319|467006472|FG001|Overall Study|Death|3|||
129739250|NCT00527319|467006473|FG002|Overall Study|Death|1|||
129739251|NCT00527319|467006471|FG000|Overall Study|Intercurrent Medical Illness|0|||
129739252|NCT00527319|467006472|FG001|Overall Study|Intercurrent Medical Illness|1|||
129739253|NCT00527319|467006473|FG002|Overall Study|Intercurrent Medical Illness|3|||
129806368|NCT00131508|467258424|FG001|Overall Study|Disease progression|2|||
129806369|NCT00131508|467258423|FG000|Overall Study|Non-Compliance|2|||
129806370|NCT00131508|467258424|FG001|Overall Study|Non-Compliance|4|||
129739254|NCT00527319|467006471|FG000|Overall Study|Adverse Event|0|||
129739255|NCT00527319|467006472|FG001|Overall Study|Adverse Event|0|||
129739256|NCT00527319|467006473|FG002|Overall Study|Adverse Event|1|||
129739257|NCT03344172|467006476|FG000|Overall Study|Received <1 dose of treatment|1|||
129739258|NCT03344172|467006477|FG001|Overall Study|Received <1 dose of treatment|0|||
129739259|NCT00680368|467006480|FG000|Overall Study|not supervised, not eligible|15|||
129806371|NCT00131508|467258423|FG000|Overall Study|Withdrawal by Subject|1|||
129739260|NCT00430937|467006484|FG000|Overall Study|Adverse Event|3|||
129739261|NCT00430937|467006485|FG001|Overall Study|Adverse Event|8|||
129739262|NCT00430937|467006484|FG000|Overall Study|Death|0|||
129739263|NCT00430937|467006485|FG001|Overall Study|Death|1|||
129739264|NCT00430937|467006484|FG000|Overall Study|Lost to Follow-up|6|||
129739265|NCT00430937|467006485|FG001|Overall Study|Lost to Follow-up|6|||
129806372|NCT00131508|467258424|FG001|Overall Study|Withdrawal by Subject|2|||
129806373|NCT05224141|467258426|FG000|Overall Study|Ongoing|75|||
129806374|NCT05224141|467258427|FG001|Overall Study|Ongoing|88|||
129739266|NCT00430937|467006484|FG000|Overall Study|Withdrawal by Subject|5|||
129739267|NCT00430937|467006485|FG001|Overall Study|Withdrawal by Subject|2|||
129739268|NCT00430937|467006484|FG000|Overall Study|Protocol Violation|3|||
129739269|NCT00430937|467006485|FG001|Overall Study|Protocol Violation|2|||
129893540|NCT00689104|467569798|FG003|Overall Study|Eligibility criterion not met|4|||
129893541|NCT00689104|467569795|FG000|Overall Study|Adverse Event|13|||
129893542|NCT00689104|467569796|FG001|Overall Study|Adverse Event|25|||
129893543|NCT00689104|467569797|FG002|Overall Study|Adverse Event|16|||
129739270|NCT00430937|467006484|FG000|Overall Study|Lack of Efficacy|6|||
129739271|NCT00430937|467006485|FG001|Overall Study|Lack of Efficacy|5|||
129739272|NCT00430937|467006484|FG000|Overall Study|Inappropriate enrollment|2|||
129739273|NCT00430937|467006485|FG001|Overall Study|Inappropriate enrollment|1|||
129739274|NCT00430937|467006484|FG000|Overall Study|Administrative reasons|1|||
129739275|NCT00430937|467006485|FG001|Overall Study|Administrative reasons|0|||
129739276|NCT00430937|467006484|FG000|Overall Study|Protocol discontinuation criteria met|1|||
129739277|NCT00430937|467006485|FG001|Overall Study|Protocol discontinuation criteria met|2|||
129739278|NCT00430937|467006484|FG000|Overall Study|Unable to classify|0|||
129739279|NCT00430937|467006485|FG001|Overall Study|Unable to classify|1|||
129739280|NCT02392403|467006488|FG000|Overall Study|Adverse Event|1|||
129739281|NCT02392403|467006488|FG000|Overall Study|Death|1|||
129739282|NCT02392403|467006488|FG000|Overall Study|Withdrawal by Subject|1|||
129739283|NCT00657371|467006492|FG000|Overall Study|Poor bowel preparation|15|||
129739284|NCT00657371|467006492|FG000|Overall Study|Unable to intubate the cecum|5|||
129739285|NCT00657371|467006492|FG000|Overall Study|Protocol Violation|2|||
129739286|NCT00657371|467006492|FG000|Overall Study|Device- related reasons|13|||
129739287|NCT00657371|467006492|FG000|Overall Study|Pre-existing medical condition|4|||
129739288|NCT01639755|467006493|FG000|Overall Study|Study Ongoing|15|||
129739289|NCT01639755|467006493|FG000|Overall Study|Patient had device explantation|4|||
129739290|NCT03629912|467006494|FG000|Overall Study|Lost to Follow-up|19|||
129739291|NCT03629912|467006495|FG001|Overall Study|Lost to Follow-up|7|||
129739292|NCT03629912|467006496|FG002|Overall Study|Lost to Follow-up|5|||
129739293|NCT03629912|467006497|FG003|Overall Study|Lost to Follow-up|1|||
129739294|NCT03629912|467006494|FG000|Overall Study|Withdrawal by Subject|6|||
129739295|NCT03629912|467006495|FG001|Overall Study|Withdrawal by Subject|0|||
129739296|NCT03629912|467006496|FG002|Overall Study|Withdrawal by Subject|1|||
129739297|NCT03629912|467006497|FG003|Overall Study|Withdrawal by Subject|2|||
129739298|NCT03629912|467006494|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
129739299|NCT03629912|467006495|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
129739300|NCT03629912|467006496|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
129739301|NCT03629912|467006497|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
129739302|NCT03629912|467006494|FG000|Overall Study|Death|1|||
129739303|NCT03629912|467006495|FG001|Overall Study|Death|0|||
129739304|NCT03629912|467006496|FG002|Overall Study|Death|0|||
129739305|NCT03629912|467006497|FG003|Overall Study|Death|0|||
129739306|NCT01475162|467006498|FG000|Overall Study|Physician Decision|1|||
129739307|NCT01475162|467006498|FG000|Overall Study|Death|10|||
129739308|NCT01475162|467006498|FG000|Overall Study|Study closed for safety|3|||
129739309|NCT00490022|467006499|FG000|Overall Study|Adverse Event|0|||
129739310|NCT00490022|467006500|FG001|Overall Study|Adverse Event|2|||
129739311|NCT00490022|467006499|FG000|Overall Study|Withdrawal by Subject|1|||
129739312|NCT00490022|467006500|FG001|Overall Study|Withdrawal by Subject|0|||
129739313|NCT00490022|467006499|FG000|Overall Study|Subject failed to disclose concommitant|0|||
129739314|NCT00490022|467006500|FG001|Overall Study|Subject failed to disclose concommitant|1|||
129739315|NCT05059977|467006502|FG000|Overall Study|Withdrawal by Subject|0|||
129739316|NCT05059977|467006503|FG001|Overall Study|Withdrawal by Subject|0|||
129739317|NCT05059977|467006504|FG002|Overall Study|Withdrawal by Subject|1|||
129739318|NCT04405245|467006505|FG000|Overall Study|Adverse Event|0|||
129739319|NCT04405245|467006506|FG001|Overall Study|Adverse Event|1|||
129739320|NCT04405245|467006507|FG002|Overall Study|Adverse Event|0|||
129739321|NCT00576472|467006508|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739322|NCT00576472|467006509|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739323|NCT00576472|467006510|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739324|NCT00576472|467006511|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
129739325|NCT00576472|467006512|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739326|NCT00576472|467006513|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739327|NCT00576472|467006514|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739328|NCT00576472|467006515|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739329|NCT00576472|467006516|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739330|NCT00576472|467006517|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739331|NCT00576472|467006518|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739332|NCT00576472|467006519|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739333|NCT00576472|467006520|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739334|NCT00576472|467006521|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739335|NCT00576472|467006522|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
129739336|NCT00576472|467006508|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
129739337|NCT00576472|467006509|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
129739338|NCT00576472|467006510|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
129739339|NCT00576472|467006511|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
129739340|NCT00576472|467006512|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
129739341|NCT00576472|467006513|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
129739342|NCT00576472|467006514|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
129739343|NCT00576472|467006515|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
129739344|NCT00576472|467006516|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
129739345|NCT00576472|467006517|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
129739346|NCT00576472|467006518|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
129739347|NCT00576472|467006519|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
129739348|NCT00576472|467006520|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
129739349|NCT00576472|467006521|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
129739350|NCT00576472|467006522|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
129739351|NCT00576472|467006508|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739352|NCT00576472|467006509|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739353|NCT00576472|467006510|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739354|NCT00576472|467006511|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
129739355|NCT00576472|467006512|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739356|NCT00576472|467006513|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739357|NCT00576472|467006514|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739358|NCT00576472|467006515|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739359|NCT00576472|467006516|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739360|NCT00576472|467006517|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739361|NCT00576472|467006518|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739362|NCT00576472|467006519|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739363|NCT00576472|467006520|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739364|NCT00576472|467006521|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739365|NCT00576472|467006522|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
129739366|NCT00576472|467006508|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
129739367|NCT00576472|467006509|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
129739368|NCT00576472|467006510|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
129739369|NCT00576472|467006511|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
129739370|NCT00576472|467006512|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
129739371|NCT00576472|467006513|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
129806375|NCT05224141|467258426|FG000|Overall Study|Withdrawal by Subject|2|||
129806376|NCT05224141|467258427|FG001|Overall Study|Withdrawal by Subject|4|||
129806377|NCT05224141|467258426|FG000|Overall Study|Death|153|||
129806378|NCT05224141|467258427|FG001|Overall Study|Death|138|||
129806379|NCT03469934|467258432|FG000|Overall Study|Withdrawal by Subject|0|||
129806380|NCT03469934|467258433|FG001|Overall Study|Withdrawal by Subject|1|||
129806381|NCT04889222|467258435|FG000|Overall Study|Did not meet eligibility criteria|8|||
129806382|NCT04889222|467258435|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
129806383|NCT04889222|467258435|FG000|Overall Study|Did not proceed due to time constraints|5|||
129806384|NCT02639546|467258440|FG000|Overall Study|Death|2|||
129806385|NCT02639546|467258441|FG001|Overall Study|Death|2|||
129806386|NCT02639546|467258442|FG002|Overall Study|Death|1|||
129806387|NCT02639546|467258443|FG003|Overall Study|Death|2|||
129806388|NCT02639546|467258444|FG004|Overall Study|Death|2|||
129806389|NCT02639546|467258445|FG005|Overall Study|Death|2|||
129806390|NCT02639546|467258446|FG006|Overall Study|Death|0|||
129806391|NCT02639546|467258447|FG007|Overall Study|Death|0|||
129806392|NCT02639546|467258440|FG000|Overall Study|Lost to Follow-up|0|||
129806393|NCT02639546|467258441|FG001|Overall Study|Lost to Follow-up|0|||
129806394|NCT02639546|467258442|FG002|Overall Study|Lost to Follow-up|1|||
129806395|NCT02639546|467258443|FG003|Overall Study|Lost to Follow-up|0|||
129806396|NCT02639546|467258444|FG004|Overall Study|Lost to Follow-up|1|||
129806397|NCT02639546|467258445|FG005|Overall Study|Lost to Follow-up|1|||
129806398|NCT02639546|467258446|FG006|Overall Study|Lost to Follow-up|0|||
129806399|NCT02639546|467258447|FG007|Overall Study|Lost to Follow-up|1|||
129806400|NCT02639546|467258440|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
129739372|NCT00576472|467006514|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
129806401|NCT02639546|467258441|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
129806402|NCT02639546|467258442|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
129806403|NCT02639546|467258443|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
129806404|NCT02639546|467258444|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
129806405|NCT02639546|467258445|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
129893544|NCT00689104|467569798|FG003|Overall Study|Adverse Event|24|||
129806406|NCT02639546|467258446|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
129806407|NCT02639546|467258447|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
129806408|NCT02639546|467258440|FG000|Overall Study|Study Terminated By Sponsor|0|||
129806409|NCT02639546|467258441|FG001|Overall Study|Study Terminated By Sponsor|2|||
129806410|NCT02639546|467258442|FG002|Overall Study|Study Terminated By Sponsor|3|||
129806411|NCT02639546|467258443|FG003|Overall Study|Study Terminated By Sponsor|4|||
129806412|NCT02639546|467258444|FG004|Overall Study|Study Terminated By Sponsor|4|||
129806413|NCT02639546|467258445|FG005|Overall Study|Study Terminated By Sponsor|3|||
129806414|NCT02639546|467258446|FG006|Overall Study|Study Terminated By Sponsor|3|||
129806415|NCT02639546|467258447|FG007|Overall Study|Study Terminated By Sponsor|9|||
129806416|NCT02639546|467258440|FG000|Overall Study|Withdrawal by Subject|2|||
129806417|NCT02639546|467258441|FG001|Overall Study|Withdrawal by Subject|2|||
129806418|NCT02639546|467258442|FG002|Overall Study|Withdrawal by Subject|1|||
129806419|NCT02639546|467258443|FG003|Overall Study|Withdrawal by Subject|0|||
129806420|NCT02639546|467258444|FG004|Overall Study|Withdrawal by Subject|0|||
129806421|NCT02639546|467258445|FG005|Overall Study|Withdrawal by Subject|1|||
129806422|NCT02639546|467258446|FG006|Overall Study|Withdrawal by Subject|2|||
129806423|NCT02639546|467258447|FG007|Overall Study|Withdrawal by Subject|1|||
129806424|NCT00113087|467258448|FG000|Overall Study|Death or Transplant|14|||
129806425|NCT00113087|467258449|FG001|Overall Study|Death or Transplant|16|||
129806426|NCT00113087|467258448|FG000|Overall Study|Family or MD withdrew subject|10|||
129806427|NCT00113087|467258449|FG001|Overall Study|Family or MD withdrew subject|5|||
129806428|NCT02215096|467258450|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
129806429|NCT02215096|467258451|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806430|NCT02215096|467258452|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806431|NCT02215096|467258453|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806432|NCT02215096|467258454|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
129806433|NCT02215096|467258450|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806434|NCT02215096|467258451|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806435|NCT02215096|467258452|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806436|NCT02215096|467258453|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
129806437|NCT02215096|467258454|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
129806438|NCT02215096|467258450|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806439|NCT02215096|467258451|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806440|NCT02215096|467258452|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806441|NCT02215096|467258453|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
129806442|NCT02215096|467258454|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
129806443|NCT02215096|467258450|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
129806444|NCT02215096|467258451|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
129806445|NCT02215096|467258452|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
129806446|NCT02215096|467258453|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
129806447|NCT02215096|467258454|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
129806448|NCT02840721|467258455|FG000|Treatment Period|Adverse Event|1|||
129806449|NCT02840721|467258455|FG000|Follow-Up|Lack of Efficacy|1|||
129806450|NCT02840721|467258455|FG000|Follow-Up|Withdrawal by Subject|4|||
129806451|NCT02840721|467258455|FG000|Follow-Up|Withdrawal of Consent|2|||
129806452|NCT00423514|467258457|FG000|Overall Study|Ineligible|1|||
129806453|NCT00423514|467258458|FG001|Overall Study|Ineligible|0|||
129806454|NCT03685123|467258459|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
129806455|NCT03685123|467258460|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
129806456|NCT03685123|467258461|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
129806457|NCT03685123|467258459|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
129806458|NCT03685123|467258460|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
129806459|NCT03685123|467258461|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
129806460|NCT03685123|467258459|FG000|Weight Loss Phase|Lost to Follow-up|1|||
129806461|NCT03685123|467258460|FG001|Weight Loss Phase|Lost to Follow-up|0|||
129806462|NCT03685123|467258461|FG002|Weight Loss Phase|Lost to Follow-up|0|||
129806463|NCT03685123|467258459|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
129806464|NCT03685123|467258460|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
129806465|NCT03685123|467258461|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
129806466|NCT03685123|467258459|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
129806467|NCT03685123|467258460|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
129806468|NCT03685123|467258461|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
129806469|NCT03685123|467258459|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
129806470|NCT03685123|467258460|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
129806471|NCT03685123|467258461|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
129806472|NCT00400764|467258462|FG000|Phase Ib|Adverse Event|1|||
129806473|NCT00400764|467258463|FG001|Phase Ib|Adverse Event|0|||
129806474|NCT00400764|467258464|FG002|Phase Ib|Adverse Event|0|||
129806475|NCT00400764|467258465|FG003|Phase Ib|Adverse Event|0|||
129739373|NCT00576472|467006515|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
129739374|NCT00576472|467006516|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
129739375|NCT00576472|467006517|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
129739376|NCT00576472|467006518|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
129739377|NCT00576472|467006519|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
129739378|NCT00576472|467006520|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
129739379|NCT00576472|467006521|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
129739380|NCT00576472|467006522|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
129739381|NCT00576472|467006508|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739382|NCT00576472|467006509|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739383|NCT00576472|467006510|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739384|NCT00576472|467006511|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
129739385|NCT00576472|467006512|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739386|NCT00576472|467006513|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739387|NCT00576472|467006514|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739388|NCT00576472|467006515|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739389|NCT00576472|467006516|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739390|NCT00576472|467006517|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739391|NCT00576472|467006518|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739392|NCT00576472|467006519|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739393|NCT00576472|467006520|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739394|NCT00576472|467006521|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739395|NCT00576472|467006522|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
129739396|NCT00576472|467006508|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739397|NCT00576472|467006509|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739398|NCT00576472|467006510|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739399|NCT00576472|467006511|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739400|NCT00576472|467006512|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739401|NCT00576472|467006513|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739402|NCT00576472|467006514|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
129739403|NCT00576472|467006515|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739404|NCT00576472|467006516|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739405|NCT00576472|467006517|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739406|NCT00576472|467006518|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739407|NCT00576472|467006519|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739408|NCT00576472|467006520|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739409|NCT00576472|467006521|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
129806476|NCT00400764|467258466|FG004|Phase Ib|Adverse Event|0|||
129806477|NCT00400764|467258462|FG000|Phase Ib|Death|1|||
129806478|NCT00400764|467258463|FG001|Phase Ib|Death|0|||
129806479|NCT00400764|467258464|FG002|Phase Ib|Death|0|||
129806480|NCT00400764|467258465|FG003|Phase Ib|Death|0|||
129806481|NCT00400764|467258466|FG004|Phase Ib|Death|0|||
129806482|NCT00400764|467258462|FG000|Phase Ib|Disease Progression|4|||
129806483|NCT00400764|467258463|FG001|Phase Ib|Disease Progression|4|||
129806484|NCT00400764|467258464|FG002|Phase Ib|Disease Progression|0|||
129806485|NCT00400764|467258465|FG003|Phase Ib|Disease Progression|0|||
129806486|NCT00400764|467258466|FG004|Phase Ib|Disease Progression|0|||
129806487|NCT00400764|467258462|FG000|Phase II|Death|0|||
129806488|NCT00400764|467258463|FG001|Phase II|Death|0|||
129806489|NCT00400764|467258464|FG002|Phase II|Death|1|||
129806490|NCT00400764|467258465|FG003|Phase II|Death|2|||
129806491|NCT00400764|467258466|FG004|Phase II|Death|0|||
129806492|NCT00400764|467258462|FG000|Phase II|Lost to Follow-up|0|||
129806493|NCT00400764|467258463|FG001|Phase II|Lost to Follow-up|0|||
129806494|NCT00400764|467258464|FG002|Phase II|Lost to Follow-up|1|||
129806495|NCT00400764|467258465|FG003|Phase II|Lost to Follow-up|0|||
129806496|NCT00400764|467258466|FG004|Phase II|Lost to Follow-up|0|||
129806497|NCT00400764|467258462|FG000|Phase II|Physician Decision|0|||
129806498|NCT00400764|467258463|FG001|Phase II|Physician Decision|0|||
129806499|NCT00400764|467258464|FG002|Phase II|Physician Decision|1|||
129893545|NCT00689104|467569795|FG000|Overall Study|Lack of Efficacy|5|||
129893546|NCT00689104|467569796|FG001|Overall Study|Lack of Efficacy|6|||
129893547|NCT00689104|467569797|FG002|Overall Study|Lack of Efficacy|2|||
129893548|NCT00689104|467569798|FG003|Overall Study|Lack of Efficacy|3|||
129893549|NCT00689104|467569795|FG000|Overall Study|Withdrawal by Subject|12|||
129893550|NCT00689104|467569796|FG001|Overall Study|Withdrawal by Subject|11|||
129893551|NCT00689104|467569797|FG002|Overall Study|Withdrawal by Subject|18|||
129893552|NCT00689104|467569798|FG003|Overall Study|Withdrawal by Subject|11|||
129893553|NCT00689104|467569795|FG000|Overall Study|Lost to Follow-up|4|||
129893554|NCT00689104|467569796|FG001|Overall Study|Lost to Follow-up|3|||
129893555|NCT00689104|467569797|FG002|Overall Study|Lost to Follow-up|2|||
129893556|NCT00689104|467569798|FG003|Overall Study|Lost to Follow-up|5|||
129893557|NCT00689104|467569795|FG000|Overall Study|Protocol Violation|2|||
129893558|NCT00689104|467569796|FG001|Overall Study|Protocol Violation|3|||
129893559|NCT00689104|467569797|FG002|Overall Study|Protocol Violation|5|||
129893560|NCT00689104|467569798|FG003|Overall Study|Protocol Violation|3|||
129893561|NCT00689104|467569795|FG000|Overall Study|Randomized but never received study drug|2|||
129893562|NCT00689104|467569796|FG001|Overall Study|Randomized but never received study drug|1|||
129893563|NCT00689104|467569797|FG002|Overall Study|Randomized but never received study drug|1|||
129893564|NCT00689104|467569798|FG003|Overall Study|Randomized but never received study drug|0|||
129893565|NCT00689104|467569795|FG000|Overall Study|Physician Decision|1|||
129893566|NCT00689104|467569796|FG001|Overall Study|Physician Decision|0|||
129893567|NCT00689104|467569797|FG002|Overall Study|Physician Decision|0|||
129893568|NCT00689104|467569798|FG003|Overall Study|Physician Decision|0|||
129893569|NCT00689104|467569795|FG000|Overall Study|Non-compliance with study procedures|0|||
129893570|NCT00689104|467569796|FG001|Overall Study|Non-compliance with study procedures|0|||
129893571|NCT00689104|467569797|FG002|Overall Study|Non-compliance with study procedures|1|||
129806500|NCT00400764|467258465|FG003|Phase II|Physician Decision|1|||
129806501|NCT00400764|467258466|FG004|Phase II|Physician Decision|0|||
129806502|NCT00400764|467258462|FG000|Phase II|Sponsor's decision to terminate|0|||
129806503|NCT00400764|467258463|FG001|Phase II|Sponsor's decision to terminate|0|||
129806504|NCT00400764|467258464|FG002|Phase II|Sponsor's decision to terminate|18|||
129806505|NCT00400764|467258465|FG003|Phase II|Sponsor's decision to terminate|22|||
129806506|NCT00400764|467258466|FG004|Phase II|Sponsor's decision to terminate|11|||
129806507|NCT00400764|467258462|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
129806508|NCT00400764|467258463|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
129806509|NCT00400764|467258464|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
129806510|NCT00400764|467258465|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
129806511|NCT00400764|467258466|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
129806512|NCT00400764|467258462|FG000|Phase II|Withdrawal by Subject|0|||
129806513|NCT00400764|467258463|FG001|Phase II|Withdrawal by Subject|0|||
129806514|NCT00400764|467258464|FG002|Phase II|Withdrawal by Subject|1|||
129806515|NCT00400764|467258465|FG003|Phase II|Withdrawal by Subject|1|||
129893572|NCT00689104|467569798|FG003|Overall Study|Non-compliance with study procedures|0|||
129893573|NCT04873817|467569799|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
129893574|NCT04873817|467569799|FG000|Overall Study|Lost to Follow-up|4|||
129893575|NCT04873817|467569799|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
129893576|NCT04873817|467569799|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
129893577|NCT04873817|467569799|FG000|Overall Study|Other Reasons|3|||
129893578|NCT03590743|467569802|FG000|Overall Study|Withdrawal by Subject|0|||
129893579|NCT03590743|467569803|FG001|Overall Study|Withdrawal by Subject|1|||
129893580|NCT00604786|467569804|FG000|Overall Study|Lost to Follow-up|2|||
129893581|NCT00604786|467569805|FG001|Overall Study|Lost to Follow-up|0|||
129893582|NCT01221181|467569806|FG000|Overall Study|Lost to Follow-up|1|||
129893583|NCT02698436|467569807|FG000|Overall Study|Adverse Event|1|||
129893584|NCT02698436|467569808|FG001|Overall Study|Adverse Event|0|||
129893585|NCT02698436|467569807|FG000|Overall Study|Withdrawal by Subject|3|||
129893586|NCT02698436|467569808|FG001|Overall Study|Withdrawal by Subject|3|||
129893587|NCT02698436|467569807|FG000|Overall Study|Lost to Follow-up|2|||
129893588|NCT02698436|467569808|FG001|Overall Study|Lost to Follow-up|4|||
129893589|NCT02698436|467569807|FG000|Overall Study|Non-compliance with study regimen|1|||
129893590|NCT02698436|467569808|FG001|Overall Study|Non-compliance with study regimen|0|||
129893591|NCT01394991|467569809|FG000|Overall Study|Adverse Event|0|||
129893592|NCT01394991|467569810|FG001|Overall Study|Adverse Event|4|||
129893593|NCT01394991|467569809|FG000|Overall Study|Lack of Efficacy|5|||
129806516|NCT00400764|467258466|FG004|Phase II|Withdrawal by Subject|0|||
129806517|NCT02628938|467258467|FG000|Overall Study|Did not attend the follow up recall|2|||
129893594|NCT01394991|467569810|FG001|Overall Study|Lack of Efficacy|7|||
129893595|NCT01394991|467569809|FG000|Overall Study|Lost to Follow-up|6|||
129893596|NCT01394991|467569810|FG001|Overall Study|Lost to Follow-up|8|||
129893597|NCT01394991|467569809|FG000|Overall Study|Physician Decision|1|||
129806518|NCT02628938|467258468|FG001|Overall Study|Did not attend the follow up recall|2|||
129806519|NCT02628938|467258469|FG002|Overall Study|Did not attend the follow up recall|1|||
129806520|NCT02628938|467258467|FG000|Overall Study|Failure to comply with the instructions|3|||
129806521|NCT02628938|467258468|FG001|Overall Study|Failure to comply with the instructions|0|||
129739410|NCT00576472|467006522|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
129739411|NCT00576472|467006508|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
129739412|NCT00576472|467006509|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
129739413|NCT00576472|467006510|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
129739414|NCT00576472|467006511|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
129739415|NCT00576472|467006512|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
129739416|NCT00576472|467006513|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
129739417|NCT00576472|467006514|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
129739418|NCT00576472|467006515|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
129739419|NCT00576472|467006516|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
129739420|NCT00576472|467006517|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
129739421|NCT00576472|467006518|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
129739422|NCT00576472|467006519|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
129739423|NCT00576472|467006520|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
129739424|NCT00576472|467006521|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
129739425|NCT00576472|467006522|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
129739426|NCT00576472|467006508|FG000|MPH Cross Over Phase|Physician Decision|0|||
129739427|NCT00576472|467006509|FG001|MPH Cross Over Phase|Physician Decision|0|||
129739428|NCT00576472|467006510|FG002|MPH Cross Over Phase|Physician Decision|0|||
129739429|NCT00576472|467006511|FG003|MPH Cross Over Phase|Physician Decision|0|||
129739430|NCT00576472|467006512|FG004|MPH Cross Over Phase|Physician Decision|0|||
129739431|NCT00576472|467006513|FG005|MPH Cross Over Phase|Physician Decision|0|||
129739432|NCT00576472|467006514|FG006|MPH Cross Over Phase|Physician Decision|4|||
129739433|NCT00576472|467006515|FG007|MPH Cross Over Phase|Physician Decision|0|||
129739434|NCT00576472|467006516|FG008|MPH Cross Over Phase|Physician Decision|0|||
129739435|NCT00576472|467006517|FG009|MPH Cross Over Phase|Physician Decision|0|||
129739436|NCT00576472|467006518|FG010|MPH Cross Over Phase|Physician Decision|0|||
129739437|NCT00576472|467006519|FG011|MPH Cross Over Phase|Physician Decision|0|||
129739438|NCT00576472|467006520|FG012|MPH Cross Over Phase|Physician Decision|0|||
129445243|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
129445244|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
129445245|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
129445246|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
129445247|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
129445248|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
129445249|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
129445250|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
129445251|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
129445252|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
129739439|NCT00576472|467006521|FG013|MPH Cross Over Phase|Physician Decision|0|||
129739440|NCT00576472|467006522|FG014|MPH Cross Over Phase|Physician Decision|0|||
129739441|NCT00576472|467006508|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739442|NCT00576472|467006509|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739443|NCT00576472|467006510|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739444|NCT00576472|467006511|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739445|NCT00576472|467006512|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739446|NCT00576472|467006513|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739447|NCT00576472|467006514|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739448|NCT00576472|467006515|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739449|NCT00576472|467006516|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
129739450|NCT00576472|467006517|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739451|NCT00576472|467006518|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
129739452|NCT00576472|467006519|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
129739453|NCT00576472|467006520|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739454|NCT00576472|467006521|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739455|NCT00576472|467006522|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
129739456|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739457|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739458|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739459|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739460|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739461|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739462|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739463|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739464|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739465|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739466|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739467|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739468|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739469|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
129739470|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
129739471|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
129739472|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
129739473|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
129739474|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
129739475|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
129739476|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
129739477|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
129739478|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
129739479|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
129739480|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
129739481|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
129739482|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
129739483|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
129739484|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
129739485|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
129739486|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
129739487|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
129739488|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
129739489|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
129739490|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
129739491|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
129739492|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
129739493|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
129739494|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
129806522|NCT02628938|467258469|FG002|Overall Study|Failure to comply with the instructions|3|||
129806523|NCT03113916|467258470|FG000|Overall Study|Withdrawal by Subject|9|||
129806524|NCT03113916|467258471|FG001|Overall Study|Withdrawal by Subject|7|||
129806525|NCT03113916|467258470|FG000|Overall Study|Pregnancy|1|||
129806526|NCT03113916|467258471|FG001|Overall Study|Pregnancy|3|||
129806527|NCT03113916|467258470|FG000|Overall Study|Lost to Follow-up|1|||
129806528|NCT03113916|467258471|FG001|Overall Study|Lost to Follow-up|2|||
129806529|NCT00761631|467258472|FG000|Overall Study|Parent/legal guardian request|8|||
129806530|NCT00761631|467258473|FG001|Overall Study|Parent/legal guardian request|3|||
129806531|NCT00761631|467258474|FG002|Overall Study|Parent/legal guardian request|8|||
129806532|NCT00761631|467258475|FG003|Overall Study|Parent/legal guardian request|0|||
129806533|NCT00761631|467258476|FG004|Overall Study|Parent/legal guardian request|5|||
129806534|NCT00761631|467258477|FG005|Overall Study|Parent/legal guardian request|0|||
129806535|NCT00761631|467258472|FG000|Overall Study|Lost to Follow-up|2|||
129806536|NCT00761631|467258473|FG001|Overall Study|Lost to Follow-up|4|||
129806537|NCT00761631|467258474|FG002|Overall Study|Lost to Follow-up|7|||
129806538|NCT00761631|467258475|FG003|Overall Study|Lost to Follow-up|1|||
129806539|NCT00761631|467258476|FG004|Overall Study|Lost to Follow-up|6|||
129806540|NCT00761631|467258477|FG005|Overall Study|Lost to Follow-up|1|||
129806541|NCT00761631|467258472|FG000|Overall Study|Protocol Violation|2|||
129806542|NCT00761631|467258473|FG001|Overall Study|Protocol Violation|0|||
129806543|NCT00761631|467258474|FG002|Overall Study|Protocol Violation|0|||
129806544|NCT00761631|467258475|FG003|Overall Study|Protocol Violation|1|||
129806545|NCT00761631|467258476|FG004|Overall Study|Protocol Violation|5|||
129806546|NCT00761631|467258477|FG005|Overall Study|Protocol Violation|1|||
129806547|NCT00761631|467258472|FG000|Overall Study|Randomized, not treated|1|||
129806548|NCT00761631|467258473|FG001|Overall Study|Randomized, not treated|0|||
129806549|NCT00761631|467258474|FG002|Overall Study|Randomized, not treated|0|||
129806550|NCT00761631|467258475|FG003|Overall Study|Randomized, not treated|0|||
129806551|NCT00761631|467258476|FG004|Overall Study|Randomized, not treated|0|||
129806552|NCT00761631|467258477|FG005|Overall Study|Randomized, not treated|0|||
129806553|NCT00761631|467258472|FG000|Overall Study|Failed to return|1|||
129806554|NCT00761631|467258473|FG001|Overall Study|Failed to return|0|||
129806555|NCT00761631|467258474|FG002|Overall Study|Failed to return|1|||
129806556|NCT00761631|467258475|FG003|Overall Study|Failed to return|1|||
129806557|NCT00761631|467258476|FG004|Overall Study|Failed to return|5|||
129806558|NCT00761631|467258477|FG005|Overall Study|Failed to return|2|||
129806559|NCT00761631|467258472|FG000|Overall Study|Physician Decision|1|||
129806560|NCT00761631|467258473|FG001|Overall Study|Physician Decision|0|||
129806561|NCT00761631|467258474|FG002|Overall Study|Physician Decision|0|||
129806562|NCT00761631|467258475|FG003|Overall Study|Physician Decision|0|||
129806563|NCT00761631|467258476|FG004|Overall Study|Physician Decision|0|||
129445253|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
129445254|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
129445255|NCT03829241|465931210|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
129445256|NCT03829241|465931211|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
129445257|NCT01132612|465931223|FG000|Overall Study|Death|0|||
129445258|NCT01132612|465931224|FG001|Overall Study|Death|0|||
129445259|NCT01132612|465931225|FG002|Overall Study|Death|1|||
129445260|NCT01132612|465931223|FG000|Overall Study|Protocol deviation|0|||
129445261|NCT01132612|465931224|FG001|Overall Study|Protocol deviation|0|||
129445262|NCT01132612|465931225|FG002|Overall Study|Protocol deviation|3|||
129445263|NCT01132612|465931223|FG000|Overall Study|Lost to Follow-up|2|||
129445264|NCT01132612|465931224|FG001|Overall Study|Lost to Follow-up|2|||
129445265|NCT01132612|465931225|FG002|Overall Study|Lost to Follow-up|7|||
129445266|NCT01132612|465931223|FG000|Overall Study|Adverse Event|5|||
129445267|NCT01132612|465931224|FG001|Overall Study|Adverse Event|2|||
129445268|NCT01132612|465931225|FG002|Overall Study|Adverse Event|15|||
129445269|NCT01132612|465931223|FG000|Overall Study|Withdrawal by Subject|5|||
129445270|NCT01132612|465931224|FG001|Overall Study|Withdrawal by Subject|8|||
129445271|NCT01132612|465931225|FG002|Overall Study|Withdrawal by Subject|19|||
129445272|NCT01132612|465931223|FG000|Overall Study|Administrative problems|5|||
129445273|NCT01132612|465931224|FG001|Overall Study|Administrative problems|1|||
129445274|NCT01132612|465931225|FG002|Overall Study|Administrative problems|52|||
129445275|NCT01132612|465931223|FG000|Overall Study|Lack of Efficacy|23|||
129445276|NCT01132612|465931224|FG001|Overall Study|Lack of Efficacy|22|||
129445277|NCT01132612|465931225|FG002|Overall Study|Lack of Efficacy|73|||
129445278|NCT02252536|465931226|FG000|Overall Study|Lost to Follow-up|5|||
129445279|NCT02252536|465931227|FG001|Overall Study|Lost to Follow-up|3|||
129445280|NCT01438151|465931229|FG000|Overall Study|study terminated|8|||
129445281|NCT01026142|465931237|FG000|Overall Study|Death|136|||
129445282|NCT01026142|465931238|FG001|Overall Study|Death|134|||
129445283|NCT01026142|465931237|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
129445284|NCT01026142|465931238|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
129445285|NCT01862640|465931241|FG000|Overall Study|Adverse Event|4|||
129445286|NCT01862640|465931242|FG001|Overall Study|Adverse Event|10|||
129445287|NCT01862640|465931243|FG002|Overall Study|Adverse Event|6|||
129445288|NCT01862640|465931244|FG003|Overall Study|Adverse Event|8|||
129445289|NCT01862640|465931241|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
129445290|NCT01862640|465931242|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
129445291|NCT01862640|465931243|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
129445292|NCT01862640|465931244|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
129445293|NCT01862640|465931241|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
129445294|NCT01862640|465931242|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
129445295|NCT01862640|465931243|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
129445296|NCT01862640|465931244|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
129445297|NCT01862640|465931241|FG000|Overall Study|Withdrawal by Subject|2|||
129445298|NCT01862640|465931242|FG001|Overall Study|Withdrawal by Subject|4|||
129445299|NCT01862640|465931243|FG002|Overall Study|Withdrawal by Subject|8|||
129445300|NCT01862640|465931244|FG003|Overall Study|Withdrawal by Subject|5|||
129445301|NCT01862640|465931241|FG000|Overall Study|Protocol Deviation|0|||
129445302|NCT01862640|465931242|FG001|Overall Study|Protocol Deviation|0|||
129445303|NCT01862640|465931243|FG002|Overall Study|Protocol Deviation|1|||
129445304|NCT01862640|465931244|FG003|Overall Study|Protocol Deviation|0|||
129445305|NCT05211739|465931245|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
129445306|NCT05211739|465931246|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
129445307|NCT05211739|465931245|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
129445308|NCT05211739|465931246|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
129445309|NCT05211739|465931245|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
129445310|NCT05211739|465931246|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
129445311|NCT05211739|465931245|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
129445312|NCT05211739|465931246|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
129445313|NCT01975428|465931247|FG000|Overall Study|Lost to Follow-up|17|||
129445314|NCT01975428|465931248|FG001|Overall Study|Lost to Follow-up|4|||
129445315|NCT01975428|465931247|FG000|Overall Study|Withdrawal by Subject|3|||
129806564|NCT00761631|467258477|FG005|Overall Study|Physician Decision|0|||
129445316|NCT01975428|465931248|FG001|Overall Study|Withdrawal by Subject|10|||
129445317|NCT00728481|465931249|FG000|Overall Study|Withdrawal by Subject|0|||
129445318|NCT00728481|465931250|FG001|Overall Study|Withdrawal by Subject|1|||
129445319|NCT00728481|465931249|FG000|Overall Study|Adverse Event|0|||
129445320|NCT00728481|465931250|FG001|Overall Study|Adverse Event|1|||
129445321|NCT00728481|465931249|FG000|Overall Study|Study medication non-compliance|0|||
129445322|NCT00728481|465931250|FG001|Overall Study|Study medication non-compliance|2|||
129445323|NCT00728481|465931249|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
129445324|NCT00728481|465931250|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
129806565|NCT00761631|467258472|FG000|Overall Study|Other|0|||
129806566|NCT00761631|467258473|FG001|Overall Study|Other|0|||
129739495|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
129739496|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
129739497|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
129739498|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
129739499|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
129739500|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
129739501|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Side effects|0|||
129739502|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Side effects|0|||
129739503|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Side effects|0|||
129739504|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Side effects|0|||
129739505|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Side effects|0|||
129739506|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Side effects|0|||
129739507|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Side effects|0|||
129739508|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Side effects|0|||
129739509|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Side effects|0|||
129739510|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Side effects|0|||
129806567|NCT00761631|467258474|FG002|Overall Study|Other|0|||
129806568|NCT00761631|467258475|FG003|Overall Study|Other|0|||
129806569|NCT00761631|467258476|FG004|Overall Study|Other|1|||
129806570|NCT00761631|467258477|FG005|Overall Study|Other|1|||
129806571|NCT01441180|467258483|FG000|Overall Study|Lost to Follow-up|1|||
129806572|NCT01441180|467258484|FG001|Overall Study|Lost to Follow-up|1|||
129806573|NCT01441180|467258485|FG002|Overall Study|Lost to Follow-up|1|||
129806574|NCT01441180|467258483|FG000|Overall Study|Discontinued|0|||
129806575|NCT01441180|467258484|FG001|Overall Study|Discontinued|0|||
129806576|NCT01441180|467258485|FG002|Overall Study|Discontinued|2|||
129806577|NCT01402011|467258488|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
129806578|NCT01402011|467258489|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
129806579|NCT01402011|467258490|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
129806580|NCT01402011|467258488|FG000|Active Treatment Period|Withdrawal by Subject|1|||
129806581|NCT01402011|467258489|FG001|Active Treatment Period|Withdrawal by Subject|3|||
129806582|NCT01402011|467258490|FG002|Active Treatment Period|Withdrawal by Subject|0|||
129806583|NCT01402011|467258488|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
129806584|NCT01402011|467258489|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
129806585|NCT01402011|467258490|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
129806586|NCT02569671|467258491|FG000|Overall Study|Lost to Follow-up|2|||
129806587|NCT02569671|467258492|FG001|Overall Study|Lost to Follow-up|1|||
129806588|NCT02569671|467258491|FG000|Overall Study|Withdrawal by Subject|1|||
129806589|NCT02569671|467258492|FG001|Overall Study|Withdrawal by Subject|3|||
129806590|NCT02612129|467258493|FG000|Single Dose Treatment Period|Screening Failure|1|||
129806591|NCT02612129|467258494|FG001|Single Dose Treatment Period|Screening Failure|0|||
129806592|NCT02612129|467258495|FG002|Single Dose Treatment Period|Screening Failure|0|||
129806593|NCT02612129|467258493|FG000|Continuous Treatment Period|Early Escape|0|||
129806594|NCT02612129|467258494|FG001|Continuous Treatment Period|Early Escape|2|||
129806595|NCT02612129|467258495|FG002|Continuous Treatment Period|Early Escape|0|||
129806596|NCT02612129|467258493|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
129806597|NCT02612129|467258494|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
129806598|NCT02612129|467258495|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
129806599|NCT02612129|467258493|FG000|Continuous Treatment Period|Safety Reasons|0|||
129806600|NCT02612129|467258494|FG001|Continuous Treatment Period|Safety Reasons|3|||
129806601|NCT02612129|467258495|FG002|Continuous Treatment Period|Safety Reasons|0|||
129739511|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Side effects|0|||
129739512|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Side effects|0|||
129739513|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Side effects|0|||
129739514|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Side effects|0|||
129739515|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Side effects|8|||
129739516|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739517|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129806602|NCT02612129|467258493|FG000|Continuous Treatment Period|Death|0|||
129806603|NCT02612129|467258494|FG001|Continuous Treatment Period|Death|1|||
129806604|NCT02612129|467258495|FG002|Continuous Treatment Period|Death|0|||
129806605|NCT02612129|467258493|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
129806606|NCT02612129|467258494|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
129806607|NCT02612129|467258495|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
129806608|NCT03487549|467258496|FG000|Overall Study|Protocol Violation|0|||
129806609|NCT03487549|467258497|FG001|Overall Study|Protocol Violation|1|||
129806610|NCT03487549|467258496|FG000|Overall Study|Lost to Follow-up|2|||
129806611|NCT03487549|467258497|FG001|Overall Study|Lost to Follow-up|1|||
129806612|NCT03487549|467258496|FG000|Overall Study|Withdrawal by Subject|2|||
129806613|NCT03487549|467258497|FG001|Overall Study|Withdrawal by Subject|0|||
129806614|NCT01543698|467261028|FG000|Phase 1b|Disease progression|2|||
129806615|NCT01543698|467261029|FG001|Phase 1b|Disease progression|4|||
129445325|NCT00041067|465931251|FG000|Overall Study|Adverse Event|20|||
129445326|NCT00041067|465931251|FG000|Overall Study|Progression|19|||
129445327|NCT00041067|465931251|FG000|Overall Study|Patient refusal|12|||
129445328|NCT00041067|465931251|FG000|Overall Study|Other reasons|23|||
129445329|NCT00041067|465931251|FG000|Overall Study|Ineligible|2|||
129445330|NCT01505010|465931252|FG000|Overall Study|Protocol Violation|0|||
129445331|NCT01505010|465931253|FG001|Overall Study|Protocol Violation|1|||
129445332|NCT01505010|465931252|FG000|Overall Study|Lost to Follow-up|0|||
129445333|NCT01505010|465931253|FG001|Overall Study|Lost to Follow-up|1|||
129445334|NCT04399122|465931261|FG000|Overall Study|Lost to Follow-up|2|||
129445335|NCT04399122|465931262|FG001|Overall Study|Lost to Follow-up|0|||
129806616|NCT01543698|467261030|FG002|Phase 1b|Disease progression|3|||
129806617|NCT01543698|467261031|FG003|Phase 1b|Disease progression|2|||
129806618|NCT01543698|467261032|FG004|Phase 1b|Disease progression|10|||
129806619|NCT01543698|467261033|FG005|Phase 1b|Disease progression|6|||
129806620|NCT01543698|467261034|FG006|Phase 1b|Disease progression|5|||
129806621|NCT01543698|467261035|FG007|Phase 1b|Disease progression|3|||
129806622|NCT01543698|467261036|FG008|Phase 1b|Disease progression|4|||
129806623|NCT01543698|467261037|FG009|Phase 1b|Disease progression|5|||
129806624|NCT01543698|467261038|FG010|Phase 1b|Disease progression|1|||
129806625|NCT01543698|467261039|FG011|Phase 1b|Disease progression|0|||
129806626|NCT01543698|467261040|FG012|Phase 1b|Disease progression|0|||
129806627|NCT01543698|467261041|FG013|Phase 1b|Disease progression|0|||
129806628|NCT01543698|467261042|FG014|Phase 1b|Disease progression|0|||
129806629|NCT01543698|467261028|FG000|Phase 1b|Death|0|||
129806630|NCT01543698|467261029|FG001|Phase 1b|Death|0|||
129806631|NCT01543698|467261030|FG002|Phase 1b|Death|1|||
129806632|NCT01543698|467261031|FG003|Phase 1b|Death|1|||
129806633|NCT01543698|467261032|FG004|Phase 1b|Death|0|||
129806634|NCT01543698|467261033|FG005|Phase 1b|Death|0|||
129806635|NCT01543698|467261034|FG006|Phase 1b|Death|0|||
129806636|NCT01543698|467261035|FG007|Phase 1b|Death|0|||
129806637|NCT01543698|467261036|FG008|Phase 1b|Death|0|||
129806638|NCT01543698|467261037|FG009|Phase 1b|Death|0|||
129806639|NCT01543698|467261038|FG010|Phase 1b|Death|1|||
129806640|NCT01543698|467261039|FG011|Phase 1b|Death|0|||
129806641|NCT01543698|467261040|FG012|Phase 1b|Death|0|||
129806642|NCT01543698|467261041|FG013|Phase 1b|Death|0|||
129806643|NCT01543698|467261042|FG014|Phase 1b|Death|0|||
129806644|NCT01543698|467261028|FG000|Phase 1b|Withdrawal by Subject|0|||
129806645|NCT01543698|467261029|FG001|Phase 1b|Withdrawal by Subject|1|||
129806646|NCT01543698|467261030|FG002|Phase 1b|Withdrawal by Subject|0|||
129806647|NCT01543698|467261031|FG003|Phase 1b|Withdrawal by Subject|1|||
129806648|NCT01543698|467261032|FG004|Phase 1b|Withdrawal by Subject|0|||
129806649|NCT01543698|467261033|FG005|Phase 1b|Withdrawal by Subject|0|||
129806650|NCT01543698|467261034|FG006|Phase 1b|Withdrawal by Subject|1|||
129806651|NCT01543698|467261035|FG007|Phase 1b|Withdrawal by Subject|0|||
129806652|NCT01543698|467261036|FG008|Phase 1b|Withdrawal by Subject|0|||
129806653|NCT01543698|467261037|FG009|Phase 1b|Withdrawal by Subject|0|||
129806654|NCT01543698|467261038|FG010|Phase 1b|Withdrawal by Subject|0|||
129806655|NCT01543698|467261039|FG011|Phase 1b|Withdrawal by Subject|0|||
129806656|NCT01543698|467261040|FG012|Phase 1b|Withdrawal by Subject|0|||
129806657|NCT01543698|467261041|FG013|Phase 1b|Withdrawal by Subject|0|||
129806658|NCT01543698|467261042|FG014|Phase 1b|Withdrawal by Subject|0|||
129806659|NCT01543698|467261028|FG000|Phase 1b|Adverse Event|1|||
129806660|NCT01543698|467261029|FG001|Phase 1b|Adverse Event|0|||
129806661|NCT01543698|467261030|FG002|Phase 1b|Adverse Event|0|||
129806662|NCT01543698|467261031|FG003|Phase 1b|Adverse Event|1|||
129806663|NCT01543698|467261032|FG004|Phase 1b|Adverse Event|2|||
129806664|NCT01543698|467261033|FG005|Phase 1b|Adverse Event|2|||
129806665|NCT01543698|467261034|FG006|Phase 1b|Adverse Event|0|||
129806666|NCT01543698|467261035|FG007|Phase 1b|Adverse Event|0|||
129806667|NCT01543698|467261036|FG008|Phase 1b|Adverse Event|1|||
129806668|NCT01543698|467261037|FG009|Phase 1b|Adverse Event|1|||
129806669|NCT01543698|467261038|FG010|Phase 1b|Adverse Event|2|||
129806670|NCT01543698|467261039|FG011|Phase 1b|Adverse Event|0|||
129445336|NCT04399122|465931261|FG000|Overall Study|Withdrawal by Subject|1|||
129445337|NCT04399122|465931262|FG001|Overall Study|Withdrawal by Subject|0|||
129806671|NCT01543698|467261040|FG012|Phase 1b|Adverse Event|0|||
129445338|NCT02536755|465931265|FG000|Overall Study|Adverse Event|4|||
129445339|NCT02301936|465931266|FG000|Overall Study|Lost to Follow-up|1|||
129445340|NCT02301936|465931267|FG001|Overall Study|Lost to Follow-up|0|||
129806672|NCT01543698|467261041|FG013|Phase 1b|Adverse Event|0|||
129445341|NCT01174238|465931268|FG000|Overall Study|Lost to Follow-up|2|||
129806673|NCT01543698|467261042|FG014|Phase 1b|Adverse Event|0|||
129806674|NCT01543698|467261028|FG000|Phase 1b|Administrative problems|1|||
129806675|NCT01543698|467261029|FG001|Phase 1b|Administrative problems|0|||
129806676|NCT01543698|467261030|FG002|Phase 1b|Administrative problems|0|||
129806677|NCT01543698|467261031|FG003|Phase 1b|Administrative problems|0|||
129806678|NCT01543698|467261032|FG004|Phase 1b|Administrative problems|1|||
129806679|NCT01543698|467261033|FG005|Phase 1b|Administrative problems|0|||
129806680|NCT01543698|467261034|FG006|Phase 1b|Administrative problems|0|||
129806681|NCT01543698|467261035|FG007|Phase 1b|Administrative problems|1|||
129806682|NCT01543698|467261036|FG008|Phase 1b|Administrative problems|0|||
129806683|NCT01543698|467261037|FG009|Phase 1b|Administrative problems|0|||
129893598|NCT01394991|467569810|FG001|Overall Study|Physician Decision|3|||
129893599|NCT01394991|467569809|FG000|Overall Study|Protocol Violation|1|||
129893600|NCT01394991|467569810|FG001|Overall Study|Protocol Violation|1|||
129893601|NCT01394991|467569809|FG000|Overall Study|Withdrawal by Subject|20|||
129893602|NCT01394991|467569810|FG001|Overall Study|Withdrawal by Subject|17|||
129893603|NCT01394991|467569809|FG000|Overall Study|Chemotherapy Termination|10|||
129893604|NCT01394991|467569810|FG001|Overall Study|Chemotherapy Termination|15|||
129893605|NCT01394991|467569809|FG000|Overall Study|Disease Progression|7|||
129893606|NCT01394991|467569810|FG001|Overall Study|Disease Progression|7|||
129893607|NCT01394991|467569809|FG000|Overall Study|Prematurely Termination of Trial|9|||
129893608|NCT01394991|467569810|FG001|Overall Study|Prematurely Termination of Trial|10|||
129893609|NCT04949399|467569815|FG000|Overall Study|Lost to Follow-up|11|||
129893610|NCT04949399|467569816|FG001|Overall Study|Lost to Follow-up|6|||
129893611|NCT04949399|467569815|FG000|Overall Study|Withdrawal by Subject|2|||
129893612|NCT04949399|467569816|FG001|Overall Study|Withdrawal by Subject|3|||
129893613|NCT00814489|467569817|FG000|Overall Study|Other|2|||
129893614|NCT00814489|467569818|FG001|Overall Study|Other|0|||
129893615|NCT00814489|467569819|FG002|Overall Study|Other|1|||
129893616|NCT01712685|467569845|FG000|Overall Study|pt declined to participate before trmt|1|||
129893617|NCT01866917|467569846|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
129893618|NCT01866917|467569847|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
129893619|NCT04610684|467571604|FG000|Study Treatment|Withdrawal by Subject|1|||
129893620|NCT04610684|467571604|FG000|Study Treatment|Disease Progression|2|||
129893621|NCT04610684|467571604|FG000|Follow up|Death|2|||
129893622|NCT04610684|467571604|FG000|Follow up|Withdrawal by Subject|1|||
129893623|NCT01251614|467571608|FG000|Overall Study|Adverse Event|1|||
129893624|NCT01251614|467571609|FG001|Overall Study|Adverse Event|0|||
129893625|NCT01251614|467571610|FG002|Overall Study|Adverse Event|1|||
129893626|NCT01251614|467571608|FG000|Overall Study|Lack of Efficacy|1|||
129893627|NCT01251614|467571609|FG001|Overall Study|Lack of Efficacy|9|||
129893628|NCT01251614|467571610|FG002|Overall Study|Lack of Efficacy|4|||
129893629|NCT01251614|467571608|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
129893630|NCT01251614|467571609|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
129893631|NCT01251614|467571610|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
129893632|NCT01251614|467571608|FG000|Overall Study|Pregnancy|0|||
129893633|NCT01251614|467571609|FG001|Overall Study|Pregnancy|0|||
129893634|NCT01251614|467571610|FG002|Overall Study|Pregnancy|2|||
129893635|NCT01251614|467571608|FG000|Overall Study|Loss of Disease Control|0|||
129893636|NCT01251614|467571609|FG001|Overall Study|Loss of Disease Control|1|||
129893637|NCT01251614|467571610|FG002|Overall Study|Loss of Disease Control|0|||
129893638|NCT01251614|467571608|FG000|Overall Study|Withdrawal by Subject|0|||
129893639|NCT01251614|467571609|FG001|Overall Study|Withdrawal by Subject|2|||
129893640|NCT01251614|467571610|FG002|Overall Study|Withdrawal by Subject|1|||
129893641|NCT01251614|467571608|FG000|Overall Study|Lost to Follow-up|0|||
129893642|NCT01251614|467571609|FG001|Overall Study|Lost to Follow-up|1|||
129893643|NCT01251614|467571610|FG002|Overall Study|Lost to Follow-up|0|||
129893644|NCT02153788|467571611|FG000|Overall Study|Physician Decision|2|||
129893645|NCT02153788|467571612|FG001|Overall Study|Physician Decision|1|||
129893646|NCT01684046|467571616|FG000|Period 1, First 30 Days|Adverse Event|0|||
129893647|NCT01684046|467571617|FG001|Period 1, First 30 Days|Adverse Event|2|||
129893648|NCT04531540|467571620|FG000|Overall Study|Adverse Event|1|||
129893649|NCT04531540|467571620|FG000|Overall Study|Protocol Violation|3|||
129893650|NCT04531540|467571620|FG000|Overall Study|Withdrawal by Subject|4|||
129893651|NCT04531540|467571620|FG000|Overall Study|Found to be Ineligible|1|||
129893652|NCT02688621|467571621|FG000|Overall Study|Pregnancy|1|||
129893653|NCT02688621|467571622|FG001|Overall Study|Pregnancy|3|||
129893654|NCT02688621|467571621|FG000|Overall Study|Lost to Follow-up|38|||
129893655|NCT02688621|467571622|FG001|Overall Study|Lost to Follow-up|15|||
129893656|NCT02688621|467571621|FG000|Overall Study|Withdrawal by Subject|1|||
129893657|NCT02688621|467571622|FG001|Overall Study|Withdrawal by Subject|0|||
129893658|NCT03239210|467571623|FG000|Overall Study|Lost to Follow-up|2|||
129893659|NCT03239210|467571624|FG001|Overall Study|Lost to Follow-up|2|||
129893660|NCT03239210|467571623|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
129893661|NCT03239210|467571624|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
129893662|NCT03239210|467571623|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
129893663|NCT03239210|467571624|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
129893664|NCT01575860|467571625|FG000|Overall Study|Withdrawal by Subject|1|||
129893665|NCT01575860|467571625|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
129893666|NCT01094743|467571627|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
129893667|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
129893668|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
129893669|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
129893670|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
129893671|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
129806684|NCT01543698|467261038|FG010|Phase 1b|Administrative problems|2|||
129806685|NCT01543698|467261039|FG011|Phase 1b|Administrative problems|0|||
129806686|NCT01543698|467261040|FG012|Phase 1b|Administrative problems|0|||
129806687|NCT01543698|467261041|FG013|Phase 1b|Administrative problems|0|||
129806688|NCT01543698|467261042|FG014|Phase 1b|Administrative problems|0|||
129806689|NCT01543698|467261028|FG000|Phase 1b|Protocol Violation|2|||
129806690|NCT01543698|467261029|FG001|Phase 1b|Protocol Violation|0|||
129806691|NCT01543698|467261030|FG002|Phase 1b|Protocol Violation|0|||
129806692|NCT01543698|467261031|FG003|Phase 1b|Protocol Violation|0|||
129806693|NCT01543698|467261032|FG004|Phase 1b|Protocol Violation|0|||
129806694|NCT01543698|467261033|FG005|Phase 1b|Protocol Violation|0|||
129806695|NCT01543698|467261034|FG006|Phase 1b|Protocol Violation|0|||
129806696|NCT01543698|467261035|FG007|Phase 1b|Protocol Violation|0|||
129806697|NCT01543698|467261036|FG008|Phase 1b|Protocol Violation|0|||
129806698|NCT01543698|467261037|FG009|Phase 1b|Protocol Violation|0|||
129806699|NCT01543698|467261038|FG010|Phase 1b|Protocol Violation|0|||
129806700|NCT01543698|467261039|FG011|Phase 1b|Protocol Violation|0|||
129806701|NCT01543698|467261040|FG012|Phase 1b|Protocol Violation|0|||
129806702|NCT01543698|467261041|FG013|Phase 1b|Protocol Violation|0|||
129806703|NCT01543698|467261042|FG014|Phase 1b|Protocol Violation|0|||
129806704|NCT01543698|467261028|FG000|Phase 2|Protocol Violation|0|||
129806705|NCT01543698|467261029|FG001|Phase 2|Protocol Violation|0|||
129806706|NCT01543698|467261030|FG002|Phase 2|Protocol Violation|0|||
129806707|NCT01543698|467261031|FG003|Phase 2|Protocol Violation|0|||
129806708|NCT01543698|467261032|FG004|Phase 2|Protocol Violation|0|||
129806709|NCT01543698|467261033|FG005|Phase 2|Protocol Violation|0|||
129806710|NCT01543698|467261034|FG006|Phase 2|Protocol Violation|0|||
129806711|NCT01543698|467261035|FG007|Phase 2|Protocol Violation|0|||
129806712|NCT01543698|467261036|FG008|Phase 2|Protocol Violation|0|||
129806713|NCT01543698|467261037|FG009|Phase 2|Protocol Violation|0|||
129806714|NCT01543698|467261038|FG010|Phase 2|Protocol Violation|0|||
129806715|NCT01543698|467261039|FG011|Phase 2|Protocol Violation|0|||
129806716|NCT01543698|467261040|FG012|Phase 2|Protocol Violation|1|||
129806717|NCT01543698|467261041|FG013|Phase 2|Protocol Violation|0|||
129806718|NCT01543698|467261042|FG014|Phase 2|Protocol Violation|0|||
129806719|NCT01543698|467261028|FG000|Phase 2|Disease progression|0|||
129806720|NCT01543698|467261029|FG001|Phase 2|Disease progression|0|||
129806721|NCT01543698|467261030|FG002|Phase 2|Disease progression|0|||
129806722|NCT01543698|467261031|FG003|Phase 2|Disease progression|0|||
129806723|NCT01543698|467261032|FG004|Phase 2|Disease progression|0|||
129806724|NCT01543698|467261033|FG005|Phase 2|Disease progression|0|||
129806725|NCT01543698|467261034|FG006|Phase 2|Disease progression|0|||
129806726|NCT01543698|467261035|FG007|Phase 2|Disease progression|0|||
129806727|NCT01543698|467261036|FG008|Phase 2|Disease progression|0|||
129806728|NCT01543698|467261037|FG009|Phase 2|Disease progression|0|||
129806729|NCT01543698|467261038|FG010|Phase 2|Disease progression|0|||
129806730|NCT01543698|467261039|FG011|Phase 2|Disease progression|10|||
129806731|NCT01543698|467261040|FG012|Phase 2|Disease progression|21|||
129806732|NCT01543698|467261041|FG013|Phase 2|Disease progression|30|||
129806733|NCT01543698|467261042|FG014|Phase 2|Disease progression|25|||
129806734|NCT01543698|467261028|FG000|Phase 2|Death|0|||
129806735|NCT01543698|467261029|FG001|Phase 2|Death|0|||
129806736|NCT01543698|467261030|FG002|Phase 2|Death|0|||
129806737|NCT01543698|467261031|FG003|Phase 2|Death|0|||
129806738|NCT01543698|467261032|FG004|Phase 2|Death|0|||
129806739|NCT01543698|467261033|FG005|Phase 2|Death|0|||
129806740|NCT01543698|467261034|FG006|Phase 2|Death|0|||
129806741|NCT01543698|467261035|FG007|Phase 2|Death|0|||
129806742|NCT01543698|467261036|FG008|Phase 2|Death|0|||
129806743|NCT01543698|467261037|FG009|Phase 2|Death|0|||
129806744|NCT01543698|467261038|FG010|Phase 2|Death|0|||
129806745|NCT01543698|467261039|FG011|Phase 2|Death|0|||
129806746|NCT01543698|467261040|FG012|Phase 2|Death|1|||
129806747|NCT01543698|467261041|FG013|Phase 2|Death|1|||
129806748|NCT01543698|467261042|FG014|Phase 2|Death|1|||
129806749|NCT01543698|467261028|FG000|Phase 2|Administrative problems|0|||
129806750|NCT01543698|467261029|FG001|Phase 2|Administrative problems|0|||
129806751|NCT01543698|467261030|FG002|Phase 2|Administrative problems|0|||
129806752|NCT01543698|467261031|FG003|Phase 2|Administrative problems|0|||
129806753|NCT01543698|467261032|FG004|Phase 2|Administrative problems|0|||
129806754|NCT01543698|467261033|FG005|Phase 2|Administrative problems|0|||
129806755|NCT01543698|467261034|FG006|Phase 2|Administrative problems|0|||
129806756|NCT01543698|467261035|FG007|Phase 2|Administrative problems|0|||
129806757|NCT01543698|467261036|FG008|Phase 2|Administrative problems|0|||
129806758|NCT01543698|467261037|FG009|Phase 2|Administrative problems|0|||
129806759|NCT01543698|467261038|FG010|Phase 2|Administrative problems|0|||
129806760|NCT01543698|467261039|FG011|Phase 2|Administrative problems|0|||
129806761|NCT01543698|467261040|FG012|Phase 2|Administrative problems|0|||
129806762|NCT01543698|467261041|FG013|Phase 2|Administrative problems|3|||
129806763|NCT01543698|467261042|FG014|Phase 2|Administrative problems|1|||
129806764|NCT01543698|467261028|FG000|Phase 2|Withdrawal by Subject|0|||
129806765|NCT01543698|467261029|FG001|Phase 2|Withdrawal by Subject|0|||
129806766|NCT01543698|467261030|FG002|Phase 2|Withdrawal by Subject|0|||
129806767|NCT01543698|467261031|FG003|Phase 2|Withdrawal by Subject|0|||
129806768|NCT01543698|467261032|FG004|Phase 2|Withdrawal by Subject|0|||
129806769|NCT01543698|467261033|FG005|Phase 2|Withdrawal by Subject|0|||
129806770|NCT01543698|467261034|FG006|Phase 2|Withdrawal by Subject|0|||
129806771|NCT01543698|467261035|FG007|Phase 2|Withdrawal by Subject|0|||
129806772|NCT01543698|467261036|FG008|Phase 2|Withdrawal by Subject|0|||
129806773|NCT01543698|467261037|FG009|Phase 2|Withdrawal by Subject|0|||
129806774|NCT01543698|467261038|FG010|Phase 2|Withdrawal by Subject|0|||
129806775|NCT01543698|467261039|FG011|Phase 2|Withdrawal by Subject|0|||
129806776|NCT01543698|467261040|FG012|Phase 2|Withdrawal by Subject|0|||
129806777|NCT01543698|467261041|FG013|Phase 2|Withdrawal by Subject|3|||
129806778|NCT01543698|467261042|FG014|Phase 2|Withdrawal by Subject|1|||
129806779|NCT01543698|467261028|FG000|Phase 2|Adverse Event|0|||
129806780|NCT01543698|467261029|FG001|Phase 2|Adverse Event|0|||
129806781|NCT01543698|467261030|FG002|Phase 2|Adverse Event|0|||
129806782|NCT01543698|467261031|FG003|Phase 2|Adverse Event|0|||
129806783|NCT01543698|467261032|FG004|Phase 2|Adverse Event|0|||
129806784|NCT01543698|467261033|FG005|Phase 2|Adverse Event|0|||
129806785|NCT01543698|467261034|FG006|Phase 2|Adverse Event|0|||
129806786|NCT01543698|467261035|FG007|Phase 2|Adverse Event|0|||
129806787|NCT01543698|467261036|FG008|Phase 2|Adverse Event|0|||
129806788|NCT01543698|467261037|FG009|Phase 2|Adverse Event|0|||
129806789|NCT01543698|467261038|FG010|Phase 2|Adverse Event|0|||
129806790|NCT01543698|467261039|FG011|Phase 2|Adverse Event|1|||
129806791|NCT01543698|467261040|FG012|Phase 2|Adverse Event|3|||
129806792|NCT01543698|467261041|FG013|Phase 2|Adverse Event|5|||
129806793|NCT01543698|467261042|FG014|Phase 2|Adverse Event|14|||
129806794|NCT00150709|467261043|FG000|Overall Study|Protocol Violation|7|||
129806795|NCT00150709|467261044|FG001|Overall Study|Protocol Violation|8|||
129806796|NCT00150709|467261045|FG002|Overall Study|Protocol Violation|3|||
129806797|NCT00150709|467261046|FG003|Overall Study|Protocol Violation|1|||
129806798|NCT00150709|467261043|FG000|Overall Study|Adverse Event|8|||
129806799|NCT00150709|467261044|FG001|Overall Study|Adverse Event|2|||
129806800|NCT00150709|467261045|FG002|Overall Study|Adverse Event|2|||
129806801|NCT00150709|467261046|FG003|Overall Study|Adverse Event|3|||
129806802|NCT00150709|467261043|FG000|Overall Study|Lack of Efficacy|6|||
129806803|NCT00150709|467261044|FG001|Overall Study|Lack of Efficacy|11|||
129806804|NCT00150709|467261045|FG002|Overall Study|Lack of Efficacy|9|||
129806805|NCT00150709|467261046|FG003|Overall Study|Lack of Efficacy|0|||
129806806|NCT00150709|467261043|FG000|Overall Study|Withdrawal by Subject|7|||
129806807|NCT00150709|467261044|FG001|Overall Study|Withdrawal by Subject|10|||
129806808|NCT00150709|467261045|FG002|Overall Study|Withdrawal by Subject|5|||
129806809|NCT00150709|467261046|FG003|Overall Study|Withdrawal by Subject|0|||
129806810|NCT00150709|467261043|FG000|Overall Study|Lost to Follow-up|3|||
129806811|NCT00150709|467261044|FG001|Overall Study|Lost to Follow-up|2|||
129806812|NCT00150709|467261045|FG002|Overall Study|Lost to Follow-up|0|||
129806813|NCT00150709|467261046|FG003|Overall Study|Lost to Follow-up|0|||
129806814|NCT00150709|467261043|FG000|Overall Study|Sponsor decision|0|||
129893672|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
129893673|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
129893674|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
129893675|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
129893676|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
129893677|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
129806815|NCT00150709|467261044|FG001|Overall Study|Sponsor decision|0|||
129806816|NCT00150709|467261045|FG002|Overall Study|Sponsor decision|0|||
129806817|NCT00150709|467261046|FG003|Overall Study|Sponsor decision|1|||
129806818|NCT00150709|467261043|FG000|Overall Study|Site/Investigator discontinued the study|5|||
129806819|NCT00150709|467261044|FG001|Overall Study|Site/Investigator discontinued the study|5|||
129806820|NCT00150709|467261045|FG002|Overall Study|Site/Investigator discontinued the study|2|||
129806821|NCT00150709|467261046|FG003|Overall Study|Site/Investigator discontinued the study|0|||
129806822|NCT00150709|467261043|FG000|Overall Study|Decision of parent(s)|1|||
129806823|NCT00150709|467261044|FG001|Overall Study|Decision of parent(s)|2|||
129806824|NCT00150709|467261045|FG002|Overall Study|Decision of parent(s)|0|||
129806825|NCT00150709|467261046|FG003|Overall Study|Decision of parent(s)|0|||
129806826|NCT00150709|467261043|FG000|Overall Study|Decision of parent(s) and investigator|3|||
129806827|NCT00150709|467261044|FG001|Overall Study|Decision of parent(s) and investigator|0|||
129806828|NCT00150709|467261045|FG002|Overall Study|Decision of parent(s) and investigator|0|||
129806829|NCT00150709|467261046|FG003|Overall Study|Decision of parent(s) and investigator|0|||
129806830|NCT00150709|467261043|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
129806831|NCT00150709|467261044|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
129806832|NCT00150709|467261045|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
129806833|NCT00150709|467261046|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
129893678|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
129893679|NCT02851511|467571628|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
129893680|NCT02851511|467571629|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
129893681|NCT02851511|467571630|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
129893682|NCT02851511|467571631|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
129893683|NCT02851511|467571628|FG000|Phase I|Physician Decision|0|||
129893684|NCT02851511|467571629|FG001|Phase I|Physician Decision|0|||
129893685|NCT02851511|467571630|FG002|Phase I|Physician Decision|0|||
129893686|NCT02851511|467571631|FG003|Phase I|Physician Decision|1|||
129893687|NCT02851511|467571628|FG000|Phase I|Withdrawal by Subject|2|||
129893688|NCT02851511|467571629|FG001|Phase I|Withdrawal by Subject|1|||
129893689|NCT02851511|467571630|FG002|Phase I|Withdrawal by Subject|0|||
129893690|NCT02851511|467571631|FG003|Phase I|Withdrawal by Subject|3|||
129893691|NCT02851511|467571628|FG000|Phase II|Physician Decision|18|||
129893692|NCT02851511|467571629|FG001|Phase II|Physician Decision|16|||
129893693|NCT02851511|467571630|FG002|Phase II|Physician Decision|0|||
129893694|NCT02851511|467571631|FG003|Phase II|Physician Decision|0|||
129893695|NCT02851511|467571628|FG000|Phase II|Withdrawal by Subject|18|||
129893696|NCT02851511|467571629|FG001|Phase II|Withdrawal by Subject|16|||
129893697|NCT02851511|467571630|FG002|Phase II|Withdrawal by Subject|0|||
129739518|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739519|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739520|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739521|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739522|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129893698|NCT02851511|467571631|FG003|Phase II|Withdrawal by Subject|0|||
129893699|NCT02851511|467571628|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
129893700|NCT02851511|467571629|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
129893701|NCT02851511|467571630|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
129893702|NCT02851511|467571631|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
129893703|NCT02851511|467571628|FG000|Phase II|Lost to Follow-up|0|||
129893704|NCT02851511|467571629|FG001|Phase II|Lost to Follow-up|1|||
129893705|NCT02851511|467571630|FG002|Phase II|Lost to Follow-up|0|||
129893706|NCT02851511|467571631|FG003|Phase II|Lost to Follow-up|0|||
129893707|NCT00003377|467571632|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
129893708|NCT00003377|467571633|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
129893709|NCT00003377|467571634|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
129893710|NCT00003377|467571635|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
129893711|NCT00003377|467571636|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
129893712|NCT00003377|467571632|FG000|Period II|Ureteral stent complications|0|||
129893713|NCT00003377|467571633|FG001|Period II|Ureteral stent complications|0|||
129893714|NCT00003377|467571634|FG002|Period II|Ureteral stent complications|0|||
129893715|NCT00003377|467571635|FG003|Period II|Ureteral stent complications|0|||
129893716|NCT00003377|467571636|FG004|Period II|Ureteral stent complications|1|||
129893717|NCT02256969|467571638|FG000|Overall Study|Screenfailed or withdrew|2|||
129893718|NCT02256969|467571639|FG001|Overall Study|Screenfailed or withdrew|1|||
129893719|NCT02256969|467571640|FG002|Overall Study|Screenfailed or withdrew|1|||
129893720|NCT00372567|467571641|FG000|Phase 3 Study|Adverse Event|5|||
129893721|NCT00372567|467571642|FG001|Phase 3 Study|Adverse Event|1|||
129893722|NCT00372567|467571643|FG002|Phase 3 Study|Adverse Event|1|||
129893723|NCT00372567|467571641|FG000|Phase 3 Study|Death|1|||
129893724|NCT00372567|467571642|FG001|Phase 3 Study|Death|1|||
129893725|NCT00372567|467571643|FG002|Phase 3 Study|Death|0|||
129893726|NCT00372567|467571641|FG000|Phase 3 Study|Protocol Violation|0|||
129893727|NCT00372567|467571642|FG001|Phase 3 Study|Protocol Violation|0|||
129893728|NCT00372567|467571643|FG002|Phase 3 Study|Protocol Violation|1|||
129893729|NCT00372567|467571641|FG000|Phase 3 Study|Objective progression or relapse|10|||
129893730|NCT00372567|467571642|FG001|Phase 3 Study|Objective progression or relapse|13|||
129893731|NCT00372567|467571643|FG002|Phase 3 Study|Objective progression or relapse|4|||
129893732|NCT00372567|467571641|FG000|Phase 3 Study|Global deterioration of health status|0|||
129893733|NCT00372567|467571642|FG001|Phase 3 Study|Global deterioration of health status|1|||
129893734|NCT00372567|467571643|FG002|Phase 3 Study|Global deterioration of health status|0|||
129893735|NCT00372567|467571641|FG000|Phase 3 Study|Other|2|||
129893736|NCT00372567|467571642|FG001|Phase 3 Study|Other|2|||
129893737|NCT00372567|467571643|FG002|Phase 3 Study|Other|1|||
129893738|NCT00372567|467571641|FG000|Phase 3 Study|study terminated by sponsor|13|||
129893739|NCT00372567|467571642|FG001|Phase 3 Study|study terminated by sponsor|8|||
129893740|NCT00372567|467571643|FG002|Phase 3 Study|study terminated by sponsor|5|||
129893741|NCT02347943|467571644|FG000|Overall Study|Study was cancelled|140|||
129739523|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129893742|NCT02347943|467571645|FG001|Overall Study|Study was cancelled|67|||
129739524|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129893743|NCT02347943|467571646|FG002|Overall Study|Study was cancelled|45|||
129893744|NCT00303303|467571650|FG000|Overall Study|Withdrawal by Subject|0|||
129893745|NCT00303303|467571651|FG001|Overall Study|Withdrawal by Subject|0|||
129893746|NCT00303303|467571652|FG002|Overall Study|Withdrawal by Subject|1|||
129893747|NCT00582790|467571656|FG000|Overall Study|Rapid progression of disease|1|||
129893748|NCT00480441|467571657|FG000|Screening|Not Eligible|37|||
129893749|NCT00480441|467571658|FG001|Screening|Not Eligible|0|||
129893750|NCT00480441|467571659|FG002|Screening|Not Eligible|0|||
129893751|NCT00480441|467571657|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
129893752|NCT00480441|467571658|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
129893753|NCT00480441|467571659|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
129893754|NCT00480441|467571657|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
129893755|NCT00480441|467571658|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
129893756|NCT00480441|467571659|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
129893757|NCT00480441|467571657|FG000|Baseline Functional MRI|physical contraindication|4|||
129893758|NCT00480441|467571658|FG001|Baseline Functional MRI|physical contraindication|0|||
129893759|NCT00480441|467571659|FG002|Baseline Functional MRI|physical contraindication|0|||
129893760|NCT00480441|467571657|FG000|Randomization|Lost to Follow-up|0|||
129893761|NCT00480441|467571658|FG001|Randomization|Lost to Follow-up|7|||
129893762|NCT00480441|467571659|FG002|Randomization|Lost to Follow-up|2|||
129893763|NCT02374957|467571660|FG000|Overall Study|Patient did not complete forms correctly|1|||
129893764|NCT02374957|467571661|FG001|Overall Study|Patient did not complete forms correctly|0|||
129893765|NCT05349084|467571662|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
129893766|NCT01004263|467571674|FG000|Overall Study|Adverse Event|15|||
129893767|NCT01004263|467571674|FG000|Overall Study|Withdrawal by Subject|58|||
129893768|NCT01004263|467571674|FG000|Overall Study|Protocol Violation|10|||
129893769|NCT01004263|467571674|FG000|Overall Study|Lost to Follow-up|64|||
129893770|NCT01004263|467571674|FG000|Overall Study|Lack of Efficacy|13|||
129893771|NCT01004263|467571674|FG000|Overall Study|Pregnancy|2|||
129893772|NCT01004263|467571674|FG000|Overall Study|Physician Decision|15|||
129893773|NCT01004263|467571674|FG000|Overall Study|Lack of Qualifying Event|2|||
129893774|NCT00821236|467571675|FG000|Overall Study|Lost to Follow-up|3|||
129893775|NCT02096003|467571676|FG000|Overall Study|Protocol Violation|0|||
129893776|NCT02096003|467571677|FG001|Overall Study|Protocol Violation|2|||
129893777|NCT02096003|467571676|FG000|Overall Study|additional surgery|2|||
129893778|NCT02096003|467571677|FG001|Overall Study|additional surgery|1|||
129893779|NCT01511250|467571678|FG000|Overall Study|Withdrawal of Consent|1|||
129893780|NCT01511250|467571679|FG001|Overall Study|Withdrawal of Consent|0|||
129893781|NCT01511250|467571680|FG002|Overall Study|Withdrawal of Consent|0|||
129893782|NCT01511250|467571681|FG003|Overall Study|Withdrawal of Consent|0|||
129893783|NCT01511250|467571682|FG004|Overall Study|Withdrawal of Consent|0|||
129893784|NCT01511250|467571683|FG005|Overall Study|Withdrawal of Consent|0|||
129893785|NCT01511250|467571684|FG006|Overall Study|Withdrawal of Consent|0|||
129893786|NCT01511250|467571685|FG007|Overall Study|Withdrawal of Consent|1|||
129893787|NCT01511250|467571686|FG008|Overall Study|Withdrawal of Consent|1|||
129893788|NCT01511250|467571687|FG009|Overall Study|Withdrawal of Consent|0|||
129893789|NCT01511250|467571678|FG000|Overall Study|Sponsor/Investigator Decision|1|||
129893790|NCT01511250|467571679|FG001|Overall Study|Sponsor/Investigator Decision|0|||
129893791|NCT01511250|467571680|FG002|Overall Study|Sponsor/Investigator Decision|0|||
129893792|NCT01511250|467571681|FG003|Overall Study|Sponsor/Investigator Decision|0|||
129893793|NCT01511250|467571682|FG004|Overall Study|Sponsor/Investigator Decision|0|||
129893794|NCT01511250|467571683|FG005|Overall Study|Sponsor/Investigator Decision|0|||
129893795|NCT01511250|467571684|FG006|Overall Study|Sponsor/Investigator Decision|0|||
129893796|NCT01511250|467571685|FG007|Overall Study|Sponsor/Investigator Decision|0|||
129893797|NCT01511250|467571686|FG008|Overall Study|Sponsor/Investigator Decision|0|||
129893798|NCT01511250|467571687|FG009|Overall Study|Sponsor/Investigator Decision|0|||
129893799|NCT01511250|467571678|FG000|Overall Study|Lost to Follow-up|7|||
129893800|NCT01511250|467571679|FG001|Overall Study|Lost to Follow-up|3|||
129893801|NCT01511250|467571680|FG002|Overall Study|Lost to Follow-up|3|||
129893802|NCT01511250|467571681|FG003|Overall Study|Lost to Follow-up|3|||
129893803|NCT01511250|467571682|FG004|Overall Study|Lost to Follow-up|0|||
129893804|NCT01511250|467571683|FG005|Overall Study|Lost to Follow-up|0|||
129445342|NCT01102803|465931270|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
129739525|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739526|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739527|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739528|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739529|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
129739530|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
129739531|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
129739532|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
129739533|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
129893805|NCT01511250|467571684|FG006|Overall Study|Lost to Follow-up|2|||
129893806|NCT01511250|467571685|FG007|Overall Study|Lost to Follow-up|3|||
129893807|NCT01511250|467571686|FG008|Overall Study|Lost to Follow-up|13|||
129893808|NCT01511250|467571687|FG009|Overall Study|Lost to Follow-up|5|||
129893809|NCT01511250|467571678|FG000|Overall Study|Protocol Violation|0|||
129893810|NCT01511250|467571679|FG001|Overall Study|Protocol Violation|2|||
129806834|NCT00150709|467261043|FG000|Overall Study|Investigator decision|1|||
129806835|NCT00150709|467261044|FG001|Overall Study|Investigator decision|0|||
129806836|NCT00150709|467261045|FG002|Overall Study|Investigator decision|0|||
129806837|NCT00150709|467261046|FG003|Overall Study|Investigator decision|1|||
129806838|NCT00150709|467261043|FG000|Overall Study|Subject relocated|2|||
129806839|NCT00150709|467261044|FG001|Overall Study|Subject relocated|2|||
129806840|NCT00150709|467261045|FG002|Overall Study|Subject relocated|1|||
129806841|NCT00150709|467261046|FG003|Overall Study|Subject relocated|0|||
129806842|NCT00150709|467261043|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
129806843|NCT00150709|467261044|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
129806844|NCT00150709|467261045|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
129806845|NCT00150709|467261046|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
129806846|NCT00150709|467261043|FG000|Overall Study|Convenience|0|||
129806847|NCT00150709|467261044|FG001|Overall Study|Convenience|1|||
129806848|NCT00150709|467261045|FG002|Overall Study|Convenience|0|||
129806849|NCT00150709|467261046|FG003|Overall Study|Convenience|0|||
129806850|NCT00150709|467261043|FG000|Overall Study|Subject entered new drug study|0|||
129806851|NCT00150709|467261044|FG001|Overall Study|Subject entered new drug study|1|||
129806852|NCT00150709|467261045|FG002|Overall Study|Subject entered new drug study|0|||
129806853|NCT00150709|467261046|FG003|Overall Study|Subject entered new drug study|0|||
129806854|NCT00150709|467261043|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
129806855|NCT00150709|467261044|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
129806856|NCT00150709|467261045|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
129806857|NCT00150709|467261046|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
129806858|NCT00150709|467261043|FG000|Overall Study|Lack of ease of swallowing|0|||
129806859|NCT00150709|467261044|FG001|Overall Study|Lack of ease of swallowing|1|||
129806860|NCT00150709|467261045|FG002|Overall Study|Lack of ease of swallowing|0|||
129806861|NCT00150709|467261046|FG003|Overall Study|Lack of ease of swallowing|0|||
129806862|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Adverse Event|16|||
129806863|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Adverse Event|17|||
129806864|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Adverse Event|13|||
129806865|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Adverse Event|18|||
129806866|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Adverse Event|0|||
129806867|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Adverse Event|0|||
129806868|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Adverse Event|0|||
129806869|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Adverse Event|0|||
129806870|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
129806871|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
129806872|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
129806873|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
129806874|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806875|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806876|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806877|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
129806878|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
129806879|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
129806880|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
129806881|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
129806882|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
129806883|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
129806884|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
129806885|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
129806886|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
129806887|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
129806888|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
129806889|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
129739534|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
129739535|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
129739536|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
129739537|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
129739538|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
129739539|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
129739540|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
129739541|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
129739542|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
129739543|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
129739544|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
129739545|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
129739546|NCT00576472|467006508|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739547|NCT00576472|467006509|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739548|NCT00576472|467006510|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129806890|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806891|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806892|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
129806893|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
129739549|NCT00576472|467006511|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739550|NCT00576472|467006512|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739551|NCT00576472|467006513|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739552|NCT00576472|467006514|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739553|NCT00576472|467006515|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739554|NCT00576472|467006516|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739555|NCT00576472|467006517|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739556|NCT00576472|467006518|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129806894|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
129806895|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806896|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
129806897|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
129806898|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806899|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806900|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806901|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
129806902|NCT02975336|467261047|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
129806903|NCT02975336|467261048|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
129806904|NCT02975336|467261049|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
129806905|NCT02975336|467261050|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
129806906|NCT02975336|467261051|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
129806907|NCT02975336|467261052|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
129806908|NCT02975336|467261053|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
129806909|NCT02975336|467261054|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
129806910|NCT02975336|467261047|FG000|LTE (104 Weeks)|Adverse Event|0|||
129806911|NCT02975336|467261048|FG001|LTE (104 Weeks)|Adverse Event|0|||
129806912|NCT02975336|467261049|FG002|LTE (104 Weeks)|Adverse Event|0|||
129806913|NCT02975336|467261050|FG003|LTE (104 Weeks)|Adverse Event|0|||
129806914|NCT02975336|467261051|FG004|LTE (104 Weeks)|Adverse Event|7|||
129806915|NCT02975336|467261052|FG005|LTE (104 Weeks)|Adverse Event|4|||
129806916|NCT02975336|467261053|FG006|LTE (104 Weeks)|Adverse Event|2|||
129806917|NCT02975336|467261054|FG007|LTE (104 Weeks)|Adverse Event|0|||
129806918|NCT02975336|467261047|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
129806919|NCT02975336|467261048|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
129806920|NCT02975336|467261049|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
129806921|NCT02975336|467261050|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
129806922|NCT02975336|467261051|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
129806923|NCT02975336|467261052|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
129806924|NCT02975336|467261053|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
129806925|NCT02975336|467261054|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
129806926|NCT02975336|467261047|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
129806927|NCT02975336|467261048|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
129806928|NCT02975336|467261049|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
129806929|NCT02975336|467261050|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
129806930|NCT02975336|467261051|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
129806931|NCT02975336|467261052|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
129806932|NCT02975336|467261053|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
129806933|NCT02975336|467261054|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
129806934|NCT02975336|467261047|FG000|LTE (104 Weeks)|Other|0|||
129806935|NCT02975336|467261048|FG001|LTE (104 Weeks)|Other|0|||
129806936|NCT02975336|467261049|FG002|LTE (104 Weeks)|Other|0|||
129806937|NCT02975336|467261050|FG003|LTE (104 Weeks)|Other|0|||
129806938|NCT02975336|467261051|FG004|LTE (104 Weeks)|Other|55|||
129806939|NCT02975336|467261052|FG005|LTE (104 Weeks)|Other|63|||
129806940|NCT02975336|467261053|FG006|LTE (104 Weeks)|Other|76|||
129806941|NCT02975336|467261054|FG007|LTE (104 Weeks)|Other|72|||
129806942|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
129806943|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
129806944|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
129806945|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
129806946|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
129806947|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
129806948|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
129806949|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
129806950|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
129806951|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129893811|NCT01511250|467571680|FG002|Overall Study|Protocol Violation|1|||
129806952|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806953|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806954|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806955|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806956|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806957|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
129806958|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
129806959|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129893812|NCT01511250|467571681|FG003|Overall Study|Protocol Violation|0|||
129893813|NCT01511250|467571682|FG004|Overall Study|Protocol Violation|0|||
129893814|NCT01511250|467571683|FG005|Overall Study|Protocol Violation|0|||
129893815|NCT01511250|467571684|FG006|Overall Study|Protocol Violation|0|||
129893816|NCT01511250|467571685|FG007|Overall Study|Protocol Violation|0|||
129893817|NCT01511250|467571686|FG008|Overall Study|Protocol Violation|0|||
129893818|NCT01511250|467571687|FG009|Overall Study|Protocol Violation|0|||
129893819|NCT04668144|467571692|FG000|Overall Study|Protocol Violation|0|||
129893820|NCT04668144|467571693|FG001|Overall Study|Protocol Violation|1|||
129893821|NCT04668144|467571694|FG002|Overall Study|Protocol Violation|2|||
129893822|NCT00916006|467571696|FG000|Overall Study|Adverse Event|1|||
129893823|NCT00916006|467571697|FG001|Overall Study|Adverse Event|1|||
129893824|NCT00916006|467571696|FG000|Overall Study|Withdrawal by Subject|2|||
129893825|NCT00916006|467571697|FG001|Overall Study|Withdrawal by Subject|5|||
129893826|NCT00916006|467571696|FG000|Overall Study|Protocol Violation|0|||
129893827|NCT00916006|467571697|FG001|Overall Study|Protocol Violation|1|||
129893828|NCT02929108|467571702|FG000|Overall Study|Hospice patient death|100|||
129893829|NCT02929108|467571703|FG001|Overall Study|Hospice patient death|64|||
129893830|NCT02929108|467571704|FG002|Overall Study|Hospice patient death|28|||
129893831|NCT02929108|467571705|FG003|Overall Study|Hospice patient death|46|||
129893832|NCT02929108|467571706|FG004|Overall Study|Hospice patient death|55|||
129893833|NCT02929108|467571707|FG005|Overall Study|Hospice patient death|28|||
129893834|NCT02929108|467571708|FG006|Overall Study|Hospice patient death|78|||
129893835|NCT00052962|467571709|FG000|Overall Study|Not evaluable|0|||
129893836|NCT00052962|467571710|FG001|Overall Study|Not evaluable|2|||
129893837|NCT00052962|467571709|FG000|Overall Study|Not randomized/not evaluable|1|||
129893838|NCT00052962|467571710|FG001|Overall Study|Not randomized/not evaluable|0|||
129893839|NCT05487703|467571711|FG000|Overall Study|Other|19|||
129893840|NCT05487703|467571711|FG000|Overall Study|Participant not well|5|||
129893841|NCT05487703|467571711|FG000|Overall Study|Insurance Reasons|6|||
129893842|NCT05487703|467571711|FG000|Overall Study|Physician Decision|19|||
129893843|NCT05487703|467571711|FG000|Overall Study|Lack of Efficacy|60|||
129893844|NCT00832780|467571715|FG000|Overall Study|Death|16|||
129893845|NCT00832780|467571715|FG000|Overall Study|Lost to Follow-up|4|||
129893846|NCT00832780|467571715|FG000|Overall Study|no reason given|2|||
129893847|NCT00832780|467571715|FG000|Overall Study|other complicating condition|2|||
129893848|NCT00832780|467571715|FG000|Overall Study|Physician Decision|1|||
129893849|NCT00665561|467571718|FG000|Overall Study|Death recorded on subject summary pages|75|||
129893850|NCT00665561|467571719|FG001|Overall Study|Death recorded on subject summary pages|75|||
129893851|NCT00665561|467571718|FG000|Overall Study|Does not meet entrance criteria|19|||
129893852|NCT00665561|467571719|FG001|Overall Study|Does not meet entrance criteria|21|||
129893853|NCT00665561|467571718|FG000|Overall Study|Lost to Follow-up|203|||
129893854|NCT00665561|467571719|FG001|Overall Study|Lost to Follow-up|264|||
129893855|NCT00665561|467571718|FG000|Overall Study|Withdrawal by Subject|74|||
129893856|NCT00665561|467571719|FG001|Overall Study|Withdrawal by Subject|65|||
129893857|NCT00665561|467571718|FG000|Overall Study|Other|123|||
129893858|NCT00665561|467571719|FG001|Overall Study|Other|108|||
129893859|NCT00665561|467571718|FG000|Overall Study|Site closed|8|||
129893860|NCT00665561|467571719|FG001|Overall Study|Site closed|0|||
129893861|NCT00665561|467571718|FG000|Overall Study|Withdrawn due to pregnancy|0|||
129893862|NCT00665561|467571719|FG001|Overall Study|Withdrawn due to pregnancy|1|||
129893863|NCT01734811|467571727|FG000|Overall Study|Lost to Follow-up|2|||
129893864|NCT01734811|467571728|FG001|Overall Study|Lost to Follow-up|3|||
129893865|NCT01734811|467571727|FG000|Overall Study|Withdrawal by Subject|2|||
129893866|NCT01734811|467571728|FG001|Overall Study|Withdrawal by Subject|0|||
129893867|NCT00062868|467571729|FG000|Dose Level 1|Death|2|||
129893868|NCT00062868|467571730|FG001|Dose Level 1|Death|0|||
129893869|NCT00062868|467571731|FG002|Dose Level 1|Death|0|||
129893870|NCT00062868|467571732|FG003|Dose Level 1|Death|2|||
129893871|NCT00062868|467571733|FG004|Dose Level 1|Death|0|||
129893872|NCT00062868|467571734|FG005|Dose Level 1|Death|0|||
129893873|NCT00062868|467571735|FG006|Dose Level 1|Death|3|||
129893874|NCT00062868|467571736|FG007|Dose Level 1|Death|0|||
129893875|NCT00062868|467571737|FG008|Dose Level 1|Death|0|||
129893876|NCT00062868|467571738|FG009|Dose Level 1|Death|0|||
129893877|NCT00062868|467571739|FG010|Dose Level 1|Death|0|||
129893878|NCT00062868|467571740|FG011|Dose Level 1|Death|0|||
129893879|NCT00062868|467571741|FG012|Dose Level 1|Death|0|||
129893880|NCT00062868|467571742|FG013|Dose Level 1|Death|0|||
129893881|NCT00062868|467571743|FG014|Dose Level 1|Death|0|||
129893882|NCT00062868|467571744|FG015|Dose Level 1|Death|0|||
129893883|NCT00062868|467571745|FG016|Dose Level 1|Death|0|||
129893884|NCT00062868|467571746|FG017|Dose Level 1|Death|0|||
129893885|NCT00062868|467571747|FG018|Dose Level 1|Death|7|||
129893886|NCT00062868|467571748|FG019|Dose Level 1|Death|0|||
129893887|NCT00062868|467571749|FG020|Dose Level 1|Death|1|||
129893888|NCT00062868|467571729|FG000|Dose Level 1|Lost to Follow-up|0|||
129893889|NCT00062868|467571730|FG001|Dose Level 1|Lost to Follow-up|0|||
129893890|NCT00062868|467571731|FG002|Dose Level 1|Lost to Follow-up|0|||
129893891|NCT00062868|467571732|FG003|Dose Level 1|Lost to Follow-up|0|||
129893892|NCT00062868|467571733|FG004|Dose Level 1|Lost to Follow-up|0|||
129893893|NCT00062868|467571734|FG005|Dose Level 1|Lost to Follow-up|0|||
129893894|NCT00062868|467571735|FG006|Dose Level 1|Lost to Follow-up|0|||
129893895|NCT00062868|467571736|FG007|Dose Level 1|Lost to Follow-up|0|||
129893896|NCT00062868|467571737|FG008|Dose Level 1|Lost to Follow-up|0|||
129893897|NCT00062868|467571738|FG009|Dose Level 1|Lost to Follow-up|0|||
129893898|NCT00062868|467571739|FG010|Dose Level 1|Lost to Follow-up|0|||
129893899|NCT00062868|467571740|FG011|Dose Level 1|Lost to Follow-up|0|||
129893900|NCT00062868|467571741|FG012|Dose Level 1|Lost to Follow-up|1|||
129893901|NCT00062868|467571742|FG013|Dose Level 1|Lost to Follow-up|0|||
129893902|NCT00062868|467571743|FG014|Dose Level 1|Lost to Follow-up|0|||
129893903|NCT00062868|467571744|FG015|Dose Level 1|Lost to Follow-up|0|||
129893904|NCT00062868|467571745|FG016|Dose Level 1|Lost to Follow-up|0|||
129893905|NCT00062868|467571746|FG017|Dose Level 1|Lost to Follow-up|0|||
129893906|NCT00062868|467571747|FG018|Dose Level 1|Lost to Follow-up|2|||
129739557|NCT00576472|467006519|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739558|NCT00576472|467006520|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739559|NCT00576472|467006521|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
129739560|NCT00576472|467006522|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
129739561|NCT02391961|467006528|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
129739562|NCT02391961|467006529|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
129739563|NCT02391961|467006528|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129739564|NCT02391961|467006529|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
129739565|NCT02391961|467006528|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129739566|NCT02391961|467006529|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129739567|NCT03263780|467006532|FG000|Overall Study|Withdrawal by Subject|3|||
129739568|NCT03263780|467006532|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
129739569|NCT01504204|467006533|FG000|Overall Study|Lost to Follow-up|1|||
129739570|NCT01504204|467006534|FG001|Overall Study|Lost to Follow-up|1|||
129739571|NCT00903331|467006535|FG000|Overall Study|Death|4|||
129739572|NCT00903331|467006536|FG001|Overall Study|Death|8|||
129893907|NCT00062868|467571748|FG019|Dose Level 1|Lost to Follow-up|0|||
129893908|NCT00062868|467571749|FG020|Dose Level 1|Lost to Follow-up|1|||
129893909|NCT00062868|467571729|FG000|Dose Level 2|Death|0|||
129893910|NCT00062868|467571730|FG001|Dose Level 2|Death|3|||
129893911|NCT00062868|467571731|FG002|Dose Level 2|Death|0|||
129893912|NCT00062868|467571732|FG003|Dose Level 2|Death|0|||
129893913|NCT00062868|467571733|FG004|Dose Level 2|Death|2|||
129893914|NCT00062868|467571734|FG005|Dose Level 2|Death|0|||
129893915|NCT00062868|467571735|FG006|Dose Level 2|Death|0|||
129893916|NCT00062868|467571736|FG007|Dose Level 2|Death|0|||
129893917|NCT00062868|467571737|FG008|Dose Level 2|Death|0|||
129893918|NCT00062868|467571738|FG009|Dose Level 2|Death|0|||
129893919|NCT00062868|467571739|FG010|Dose Level 2|Death|1|||
129893920|NCT00062868|467571740|FG011|Dose Level 2|Death|0|||
129893921|NCT00062868|467571741|FG012|Dose Level 2|Death|0|||
129893922|NCT00062868|467571742|FG013|Dose Level 2|Death|0|||
129893923|NCT00062868|467571743|FG014|Dose Level 2|Death|0|||
129893924|NCT00062868|467571744|FG015|Dose Level 2|Death|0|||
129893925|NCT00062868|467571745|FG016|Dose Level 2|Death|2|||
129893926|NCT00062868|467571746|FG017|Dose Level 2|Death|0|||
129893927|NCT00062868|467571747|FG018|Dose Level 2|Death|0|||
129893928|NCT00062868|467571748|FG019|Dose Level 2|Death|0|||
129893929|NCT00062868|467571749|FG020|Dose Level 2|Death|0|||
129893930|NCT00062868|467571729|FG000|Dose Level 2|Lost to Follow-up|0|||
129893931|NCT00062868|467571730|FG001|Dose Level 2|Lost to Follow-up|0|||
129893932|NCT00062868|467571731|FG002|Dose Level 2|Lost to Follow-up|0|||
129893933|NCT00062868|467571732|FG003|Dose Level 2|Lost to Follow-up|0|||
129893934|NCT00062868|467571733|FG004|Dose Level 2|Lost to Follow-up|0|||
129893935|NCT00062868|467571734|FG005|Dose Level 2|Lost to Follow-up|0|||
129893936|NCT00062868|467571735|FG006|Dose Level 2|Lost to Follow-up|0|||
129893937|NCT00062868|467571736|FG007|Dose Level 2|Lost to Follow-up|0|||
129893938|NCT00062868|467571737|FG008|Dose Level 2|Lost to Follow-up|0|||
129893939|NCT00062868|467571738|FG009|Dose Level 2|Lost to Follow-up|0|||
129893940|NCT00062868|467571739|FG010|Dose Level 2|Lost to Follow-up|0|||
129893941|NCT00062868|467571740|FG011|Dose Level 2|Lost to Follow-up|0|||
129893942|NCT00062868|467571741|FG012|Dose Level 2|Lost to Follow-up|0|||
129445343|NCT01102803|465931271|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
129739573|NCT00903331|467006535|FG000|Overall Study|Withdrawal of consent|1|||
129893943|NCT00062868|467571742|FG013|Dose Level 2|Lost to Follow-up|1|||
129893944|NCT00062868|467571743|FG014|Dose Level 2|Lost to Follow-up|0|||
129893945|NCT00062868|467571744|FG015|Dose Level 2|Lost to Follow-up|0|||
129893946|NCT00062868|467571745|FG016|Dose Level 2|Lost to Follow-up|1|||
129893947|NCT00062868|467571746|FG017|Dose Level 2|Lost to Follow-up|0|||
129739574|NCT00903331|467006536|FG001|Overall Study|Withdrawal of consent|8|||
129739575|NCT00903331|467006535|FG000|Overall Study|Lung transplant|0|||
129893948|NCT00062868|467571747|FG018|Dose Level 2|Lost to Follow-up|0|||
129893949|NCT00062868|467571748|FG019|Dose Level 2|Lost to Follow-up|0|||
129893950|NCT00062868|467571749|FG020|Dose Level 2|Lost to Follow-up|0|||
129893951|NCT00062868|467571729|FG000|Dose Level 3|Death|0|||
129893952|NCT00062868|467571730|FG001|Dose Level 3|Death|0|||
129893953|NCT00062868|467571731|FG002|Dose Level 3|Death|0|||
129806960|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129893954|NCT00062868|467571732|FG003|Dose Level 3|Death|0|||
129806961|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806962|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806963|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129893955|NCT00062868|467571733|FG004|Dose Level 3|Death|0|||
129893956|NCT00062868|467571734|FG005|Dose Level 3|Death|0|||
129893957|NCT00062868|467571735|FG006|Dose Level 3|Death|0|||
129893958|NCT00062868|467571736|FG007|Dose Level 3|Death|0|||
129893959|NCT00062868|467571737|FG008|Dose Level 3|Death|0|||
129893960|NCT00062868|467571738|FG009|Dose Level 3|Death|0|||
129893961|NCT00062868|467571739|FG010|Dose Level 3|Death|0|||
129893962|NCT00062868|467571740|FG011|Dose Level 3|Death|1|||
129893963|NCT00062868|467571741|FG012|Dose Level 3|Death|0|||
129893964|NCT00062868|467571742|FG013|Dose Level 3|Death|0|||
129893965|NCT00062868|467571743|FG014|Dose Level 3|Death|0|||
129893966|NCT00062868|467571744|FG015|Dose Level 3|Death|0|||
129893967|NCT00062868|467571745|FG016|Dose Level 3|Death|0|||
129893968|NCT00062868|467571746|FG017|Dose Level 3|Death|1|||
129893969|NCT00062868|467571747|FG018|Dose Level 3|Death|0|||
129893970|NCT00062868|467571748|FG019|Dose Level 3|Death|0|||
129893971|NCT00062868|467571749|FG020|Dose Level 3|Death|0|||
129893972|NCT00062868|467571729|FG000|Dose Level 3|Lost to Follow-up|0|||
129893973|NCT00062868|467571730|FG001|Dose Level 3|Lost to Follow-up|0|||
129893974|NCT00062868|467571731|FG002|Dose Level 3|Lost to Follow-up|0|||
129893975|NCT00062868|467571732|FG003|Dose Level 3|Lost to Follow-up|0|||
129893976|NCT00062868|467571733|FG004|Dose Level 3|Lost to Follow-up|0|||
129893977|NCT00062868|467571734|FG005|Dose Level 3|Lost to Follow-up|0|||
129893978|NCT00062868|467571735|FG006|Dose Level 3|Lost to Follow-up|0|||
129893979|NCT00062868|467571736|FG007|Dose Level 3|Lost to Follow-up|0|||
129739576|NCT00903331|467006536|FG001|Overall Study|Lung transplant|2|||
129739577|NCT02723175|467006537|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
129739578|NCT02723175|467006538|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
129739579|NCT02723175|467006537|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
129739580|NCT02723175|467006538|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
129739581|NCT03691779|467006548|FG000|Part B (24 Weeks)|Adverse Event|0|||
129739582|NCT03691779|467006549|FG001|Part B (24 Weeks)|Adverse Event|1|||
129739583|NCT03691779|467006548|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
129739584|NCT03691779|467006549|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
129739585|NCT00267150|467006550|FG000|Overall Study|Adverse Event|1|||
129739586|NCT01561963|467006551|FG000|Overall Study|Adverse Event|1|||
129739587|NCT00162266|467006554|FG000|Double-Blind Period|Adverse Event|5|||
129739588|NCT00162266|467006555|FG001|Double-Blind Period|Adverse Event|9|||
129739589|NCT00162266|467006556|FG002|Double-Blind Period|Adverse Event|11|||
129739590|NCT00162266|467006557|FG003|Double-Blind Period|Adverse Event|0|||
129739591|NCT00162266|467006554|FG000|Double-Blind Period|Death|0|||
129739592|NCT00162266|467006555|FG001|Double-Blind Period|Death|1|||
129739593|NCT00162266|467006556|FG002|Double-Blind Period|Death|0|||
129739594|NCT00162266|467006557|FG003|Double-Blind Period|Death|0|||
129739595|NCT00162266|467006554|FG000|Double-Blind Period|Lost to Follow-up|1|||
129739596|NCT00162266|467006555|FG001|Double-Blind Period|Lost to Follow-up|2|||
129806964|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806965|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
129806966|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
129806967|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806968|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806969|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806970|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806971|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806972|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806973|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
129806974|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
129739597|NCT00162266|467006556|FG002|Double-Blind Period|Lost to Follow-up|0|||
129893980|NCT00062868|467571737|FG008|Dose Level 3|Lost to Follow-up|0|||
129893981|NCT00062868|467571738|FG009|Dose Level 3|Lost to Follow-up|0|||
129893982|NCT00062868|467571739|FG010|Dose Level 3|Lost to Follow-up|0|||
129893983|NCT00062868|467571740|FG011|Dose Level 3|Lost to Follow-up|0|||
129893984|NCT00062868|467571741|FG012|Dose Level 3|Lost to Follow-up|0|||
129893985|NCT00062868|467571742|FG013|Dose Level 3|Lost to Follow-up|0|||
129445344|NCT01102803|465931270|FG000|Post to Follow-Up|Lost to Follow-up|1|||
129739598|NCT00162266|467006557|FG003|Double-Blind Period|Lost to Follow-up|0|||
129739599|NCT00162266|467006554|FG000|Double-Blind Period|Other Reason|1|||
129739600|NCT00162266|467006555|FG001|Double-Blind Period|Other Reason|0|||
129739601|NCT00162266|467006556|FG002|Double-Blind Period|Other Reason|1|||
129893986|NCT00062868|467571743|FG014|Dose Level 3|Lost to Follow-up|1|||
129893987|NCT00062868|467571744|FG015|Dose Level 3|Lost to Follow-up|0|||
129893988|NCT00062868|467571745|FG016|Dose Level 3|Lost to Follow-up|0|||
129893989|NCT00062868|467571746|FG017|Dose Level 3|Lost to Follow-up|0|||
129893990|NCT00062868|467571747|FG018|Dose Level 3|Lost to Follow-up|0|||
129893991|NCT00062868|467571748|FG019|Dose Level 3|Lost to Follow-up|0|||
129893992|NCT00062868|467571749|FG020|Dose Level 3|Lost to Follow-up|0|||
129893993|NCT00062868|467571729|FG000|Dose Level 3|Withdrew|0|||
129739602|NCT00162266|467006557|FG003|Double-Blind Period|Other Reason|0|||
129739603|NCT00162266|467006554|FG000|Double-Blind Period|Lack of Efficacy|13|||
129739604|NCT00162266|467006555|FG001|Double-Blind Period|Lack of Efficacy|17|||
129739605|NCT00162266|467006556|FG002|Double-Blind Period|Lack of Efficacy|30|||
129739606|NCT00162266|467006557|FG003|Double-Blind Period|Lack of Efficacy|0|||
129893994|NCT00062868|467571730|FG001|Dose Level 3|Withdrew|0|||
129893995|NCT00062868|467571731|FG002|Dose Level 3|Withdrew|2|||
129893996|NCT00062868|467571732|FG003|Dose Level 3|Withdrew|0|||
129893997|NCT00062868|467571733|FG004|Dose Level 3|Withdrew|0|||
129893998|NCT00062868|467571734|FG005|Dose Level 3|Withdrew|0|||
129893999|NCT00062868|467571735|FG006|Dose Level 3|Withdrew|0|||
129894000|NCT00062868|467571736|FG007|Dose Level 3|Withdrew|0|||
129894001|NCT00062868|467571737|FG008|Dose Level 3|Withdrew|0|||
129894002|NCT00062868|467571738|FG009|Dose Level 3|Withdrew|0|||
129894003|NCT00062868|467571739|FG010|Dose Level 3|Withdrew|0|||
129894004|NCT00062868|467571740|FG011|Dose Level 3|Withdrew|0|||
129894005|NCT00062868|467571741|FG012|Dose Level 3|Withdrew|0|||
129894006|NCT00062868|467571742|FG013|Dose Level 3|Withdrew|0|||
129894007|NCT00062868|467571743|FG014|Dose Level 3|Withdrew|0|||
129894008|NCT00062868|467571744|FG015|Dose Level 3|Withdrew|0|||
129894009|NCT00062868|467571745|FG016|Dose Level 3|Withdrew|0|||
129894010|NCT00062868|467571746|FG017|Dose Level 3|Withdrew|0|||
129894011|NCT00062868|467571747|FG018|Dose Level 3|Withdrew|0|||
129894012|NCT00062868|467571748|FG019|Dose Level 3|Withdrew|0|||
129894013|NCT00062868|467571749|FG020|Dose Level 3|Withdrew|0|||
129894014|NCT00725010|467571752|FG000|Overall Study|Toxicity|9|||
129894015|NCT00725010|467571752|FG000|Overall Study|Tumor Progression|7|||
129894016|NCT00725010|467571752|FG000|Overall Study|Withdrawal by Subject|2|||
129894017|NCT00725010|467571752|FG000|Overall Study|Death|1|||
129894018|NCT00725010|467571752|FG000|Overall Study|Lost to Follow-up|1|||
129894019|NCT00725010|467571752|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
129894020|NCT00725010|467571752|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
129894021|NCT00725010|467571752|FG000|Overall Study|No further documentation|1|||
129894022|NCT00725010|467571752|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
129894023|NCT02414828|467571753|FG000|Overall Study|Lost to Follow-up|0|||
129894024|NCT02414828|467571754|FG001|Overall Study|Lost to Follow-up|1|||
129894025|NCT02414828|467571755|FG002|Overall Study|Lost to Follow-up|1|||
129894026|NCT02414828|467571756|FG003|Overall Study|Lost to Follow-up|2|||
129894027|NCT00670540|467571759|FG000|Overall Study|ineligible|17|||
129894028|NCT00670540|467571759|FG000|Overall Study|not living in France|348|||
129894029|NCT00670540|467571759|FG000|Overall Study|refused to participate|189|||
129894030|NCT00670540|467571759|FG000|Overall Study|controls randomised for no follow up|2770|||
129894031|NCT00670540|467571759|FG000|Overall Study|missing information inclusion criteria|1|||
129894032|NCT01515319|467571760|FG000|Overall Study|Withdrawal by Subject|0|||
129894033|NCT01515319|467571761|FG001|Overall Study|Withdrawal by Subject|0|||
129894034|NCT01515319|467571762|FG002|Overall Study|Withdrawal by Subject|0|||
129894035|NCT01515319|467571763|FG003|Overall Study|Withdrawal by Subject|0|||
129894036|NCT01515319|467571764|FG004|Overall Study|Withdrawal by Subject|0|||
129894037|NCT01515319|467571765|FG005|Overall Study|Withdrawal by Subject|0|||
129894038|NCT01515319|467571766|FG006|Overall Study|Withdrawal by Subject|1|||
129894039|NCT01515319|467571767|FG007|Overall Study|Withdrawal by Subject|0|||
129894040|NCT01515319|467571768|FG008|Overall Study|Withdrawal by Subject|0|||
129894041|NCT01515319|467571769|FG009|Overall Study|Withdrawal by Subject|0|||
129894042|NCT01515319|467571760|FG000|Overall Study|Adverse Event|0|||
129894043|NCT01515319|467571761|FG001|Overall Study|Adverse Event|0|||
129894044|NCT01515319|467571762|FG002|Overall Study|Adverse Event|0|||
129894045|NCT01515319|467571763|FG003|Overall Study|Adverse Event|0|||
129894046|NCT01515319|467571764|FG004|Overall Study|Adverse Event|0|||
129894047|NCT01515319|467571765|FG005|Overall Study|Adverse Event|0|||
129894048|NCT01515319|467571766|FG006|Overall Study|Adverse Event|0|||
129894049|NCT01515319|467571767|FG007|Overall Study|Adverse Event|0|||
129894050|NCT01515319|467571768|FG008|Overall Study|Adverse Event|3|||
129894051|NCT01515319|467571769|FG009|Overall Study|Adverse Event|0|||
129894052|NCT01515319|467571760|FG000|Overall Study|Protocol Violation|0|||
129739607|NCT00162266|467006554|FG000|Double-Blind Period|Withdrawal by Subject|5|||
129894053|NCT01515319|467571761|FG001|Overall Study|Protocol Violation|0|||
129894054|NCT01515319|467571762|FG002|Overall Study|Protocol Violation|0|||
129894055|NCT01515319|467571763|FG003|Overall Study|Protocol Violation|0|||
129894056|NCT01515319|467571764|FG004|Overall Study|Protocol Violation|0|||
129894057|NCT01515319|467571765|FG005|Overall Study|Protocol Violation|0|||
129894058|NCT01515319|467571766|FG006|Overall Study|Protocol Violation|0|||
129739608|NCT00162266|467006555|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129894059|NCT01515319|467571767|FG007|Overall Study|Protocol Violation|0|||
129894060|NCT01515319|467571768|FG008|Overall Study|Protocol Violation|2|||
129894061|NCT01515319|467571769|FG009|Overall Study|Protocol Violation|0|||
129894062|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Adverse Event|5|||
129894063|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Adverse Event|13|||
129739609|NCT00162266|467006556|FG002|Double-Blind Period|Withdrawal by Subject|6|||
129739610|NCT00162266|467006557|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129894064|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Adverse Event|0|||
129894065|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
129894066|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
129739611|NCT00162266|467006554|FG000|Open-Label Period|Death|0|||
129739612|NCT00162266|467006555|FG001|Open-Label Period|Death|0|||
129739613|NCT00162266|467006556|FG002|Open-Label Period|Death|0|||
129739614|NCT00162266|467006557|FG003|Open-Label Period|Death|7|||
129739615|NCT00162266|467006554|FG000|Open-Label Period|Adverse Event|0|||
129739616|NCT00162266|467006555|FG001|Open-Label Period|Adverse Event|0|||
129739617|NCT00162266|467006556|FG002|Open-Label Period|Adverse Event|0|||
129739618|NCT00162266|467006557|FG003|Open-Label Period|Adverse Event|46|||
129739619|NCT00162266|467006554|FG000|Open-Label Period|Lack of Efficacy|0|||
129739620|NCT00162266|467006555|FG001|Open-Label Period|Lack of Efficacy|0|||
129739621|NCT00162266|467006556|FG002|Open-Label Period|Lack of Efficacy|0|||
129445345|NCT01102803|465931271|FG001|Post to Follow-Up|Lost to Follow-up|3|||
129739622|NCT00162266|467006557|FG003|Open-Label Period|Lack of Efficacy|26|||
129739623|NCT00162266|467006554|FG000|Open-Label Period|Lost to Follow-up|0|||
129894067|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
129894068|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
129894069|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
129894070|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
129894071|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
129894072|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
129894073|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
129894074|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
129894075|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
129894076|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
129894077|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
129894078|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
129894079|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
129894080|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Physician Decision|2|||
129894081|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Physician Decision|3|||
129894082|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Physician Decision|0|||
129894083|NCT01449929|467571770|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
129894084|NCT01449929|467571771|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
129894085|NCT01449929|467571772|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
129894086|NCT01449929|467571770|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
129894087|NCT01449929|467571771|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
129894088|NCT01449929|467571772|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
129894089|NCT01449929|467571770|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
129894090|NCT01449929|467571771|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
129894091|NCT01449929|467571772|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
129894092|NCT01449929|467571770|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
129894093|NCT01449929|467571771|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
129894094|NCT01449929|467571772|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
129445346|NCT02684279|465931272|FG000|Overall Study|Adverse Event|87|||
129739624|NCT00162266|467006555|FG001|Open-Label Period|Lost to Follow-up|0|||
129739625|NCT00162266|467006556|FG002|Open-Label Period|Lost to Follow-up|0|||
129739626|NCT00162266|467006557|FG003|Open-Label Period|Lost to Follow-up|3|||
129739627|NCT00162266|467006554|FG000|Open-Label Period|Withdrawal by Subject|0|||
129739628|NCT00162266|467006555|FG001|Open-Label Period|Withdrawal by Subject|0|||
129739629|NCT00162266|467006556|FG002|Open-Label Period|Withdrawal by Subject|0|||
129739630|NCT00162266|467006557|FG003|Open-Label Period|Withdrawal by Subject|31|||
129739631|NCT00162266|467006554|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
129739632|NCT00162266|467006555|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
129739633|NCT00162266|467006556|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
129739634|NCT00162266|467006557|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
129739635|NCT00162266|467006554|FG000|Open-Label Period|Other Reasons|0|||
129739636|NCT00162266|467006555|FG001|Open-Label Period|Other Reasons|0|||
129739637|NCT00162266|467006556|FG002|Open-Label Period|Other Reasons|0|||
129739638|NCT00162266|467006557|FG003|Open-Label Period|Other Reasons|15|||
129739639|NCT02299076|467006558|FG000|Overall Study|Fraudulent Entries|20|||
129739640|NCT02299076|467006559|FG001|Overall Study|Fraudulent Entries|14|||
129739641|NCT04208087|467006560|FG000|Overall Study|Adverse Event|1|||
129739642|NCT04208087|467006561|FG001|Overall Study|Adverse Event|0|||
129739643|NCT04208087|467006562|FG002|Overall Study|Adverse Event|0|||
129739644|NCT04208087|467006563|FG003|Overall Study|Adverse Event|0|||
129739645|NCT04208087|467006564|FG004|Overall Study|Adverse Event|0|||
129739646|NCT04208087|467006560|FG000|Overall Study|Withdrawal by Subject|0|||
129739647|NCT04208087|467006561|FG001|Overall Study|Withdrawal by Subject|0|||
129739648|NCT04208087|467006562|FG002|Overall Study|Withdrawal by Subject|1|||
129739649|NCT04208087|467006563|FG003|Overall Study|Withdrawal by Subject|0|||
129739650|NCT04208087|467006564|FG004|Overall Study|Withdrawal by Subject|0|||
129739651|NCT04208087|467006560|FG000|Overall Study|Other|0|||
129739652|NCT04208087|467006561|FG001|Overall Study|Other|0|||
129739653|NCT04208087|467006562|FG002|Overall Study|Other|0|||
129739654|NCT04208087|467006563|FG003|Overall Study|Other|0|||
129739655|NCT04208087|467006564|FG004|Overall Study|Other|1|||
129739656|NCT02477553|467006566|FG000|Overall Study|Screening up-to-date|12|||
129739657|NCT02477553|467006567|FG001|Overall Study|Screening up-to-date|13|||
129739658|NCT02477553|467006566|FG000|Overall Study|No MD visit|1|||
129739659|NCT02477553|467006567|FG001|Overall Study|No MD visit|1|||
129739660|NCT02477553|467006566|FG000|Overall Study|Workup consistent w/CRC|1|||
129739661|NCT02477553|467006567|FG001|Overall Study|Workup consistent w/CRC|1|||
129739662|NCT02477553|467006566|FG000|Overall Study|Technical issues with intervention|2|||
129739663|NCT02477553|467006567|FG001|Overall Study|Technical issues with intervention|0|||
129739664|NCT02477553|467006566|FG000|Overall Study|Elevated risk for CRC|2|||
129739665|NCT02477553|467006567|FG001|Overall Study|Elevated risk for CRC|2|||
129739666|NCT02477553|467006566|FG000|Overall Study|MD advised against screening|1|||
129739667|NCT02477553|467006567|FG001|Overall Study|MD advised against screening|3|||
129739668|NCT02477553|467006566|FG000|Overall Study|patient deceased|1|||
129739669|NCT02477553|467006567|FG001|Overall Study|patient deceased|0|||
129739670|NCT00637572|467006569|FG000|Overall Study|Adverse Event|1|||
129739671|NCT00637572|467006570|FG001|Overall Study|Adverse Event|2|||
129739672|NCT00637572|467006569|FG000|Overall Study|Death|0|||
129739673|NCT00637572|467006570|FG001|Overall Study|Death|1|||
129739674|NCT00637572|467006569|FG000|Overall Study|Lost to Follow-up|0|||
129739675|NCT00637572|467006570|FG001|Overall Study|Lost to Follow-up|1|||
129739676|NCT00637572|467006569|FG000|Overall Study|Physician Decision|1|||
129739677|NCT00637572|467006570|FG001|Overall Study|Physician Decision|1|||
129739678|NCT00637572|467006569|FG000|Overall Study|Withdrawal by Subject|0|||
129739679|NCT00637572|467006570|FG001|Overall Study|Withdrawal by Subject|2|||
129739680|NCT00637572|467006569|FG000|Overall Study|Illicit Drug Use|1|||
129739681|NCT00637572|467006570|FG001|Overall Study|Illicit Drug Use|0|||
129739682|NCT00896649|467006571|FG000|Overall Study|Physician Decision|1|||
129739683|NCT00896649|467006571|FG000|Overall Study|Pregnancy|1|||
129739684|NCT00896649|467006571|FG000|Overall Study|missing documentation|1|||
129739685|NCT00896649|467006571|FG000|Overall Study|technical difficulties|2|||
129739686|NCT03652675|467006574|FG000|Overall Study|Lost to Follow-up|4|||
129739687|NCT03652675|467006575|FG001|Overall Study|Lost to Follow-up|4|||
129739688|NCT01638559|467006576|FG000|Overall Study|Lost to Follow-up|1|||
129739689|NCT01638559|467006576|FG000|Overall Study|Withdrawal by Subject|1|||
129739690|NCT01638559|467006576|FG000|Overall Study|Subject declined to travel for biopsy|1|||
129739691|NCT00483002|467006579|FG000|Overall Study|Adverse Event|68|||
129739692|NCT00483002|467006579|FG000|Overall Study|Lack of Efficacy|555|||
129739693|NCT00483002|467006579|FG000|Overall Study|Lost to Follow-up|962|||
129739694|NCT00483002|467006579|FG000|Overall Study|Other|2|||
129739695|NCT00483002|467006579|FG000|Overall Study|Other|967|||
129739696|NCT01895309|467006580|FG000|Overall Study|Adverse Event|13|||
129739697|NCT01895309|467006581|FG001|Overall Study|Adverse Event|17|||
129739698|NCT01895309|467006580|FG000|Overall Study|Protocol Violation|1|||
129739699|NCT01895309|467006581|FG001|Overall Study|Protocol Violation|0|||
129739700|NCT01895309|467006580|FG000|Overall Study|Lack of Efficacy|1|||
129739701|NCT01895309|467006581|FG001|Overall Study|Lack of Efficacy|3|||
129739702|NCT01895309|467006580|FG000|Overall Study|Lost to Follow-up|1|||
129739703|NCT01895309|467006581|FG001|Overall Study|Lost to Follow-up|3|||
129739704|NCT01895309|467006580|FG000|Overall Study|Physician Decision|15|||
129894095|NCT01871285|467571773|FG000|First Intervention (1 Day)|Adverse Event|1|||
129894096|NCT01871285|467571774|FG001|First Intervention (1 Day)|Adverse Event|0|||
129894097|NCT01871285|467571775|FG002|First Intervention (1 Day)|Adverse Event|0|||
129894098|NCT01871285|467571776|FG003|First Intervention (1 Day)|Adverse Event|0|||
129894099|NCT01871285|467571773|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
129894100|NCT01871285|467571774|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
129894101|NCT01871285|467571775|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
129894102|NCT01871285|467571776|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
129894103|NCT01959880|467571777|FG000|Overall Study|Withdrawal by Subject|11|||
129894104|NCT01959880|467571778|FG001|Overall Study|Withdrawal by Subject|13|||
129894105|NCT01959880|467571779|FG002|Overall Study|Withdrawal by Subject|8|||
129894106|NCT01959880|467571780|FG003|Overall Study|Withdrawal by Subject|7|||
129894107|NCT01959880|467571777|FG000|Overall Study|Death|1|||
129894108|NCT01959880|467571778|FG001|Overall Study|Death|10|||
129894109|NCT01959880|467571779|FG002|Overall Study|Death|1|||
129894110|NCT01959880|467571780|FG003|Overall Study|Death|2|||
129894111|NCT01959880|467571777|FG000|Overall Study|Lost to Follow-up|95|||
129894112|NCT01959880|467571778|FG001|Overall Study|Lost to Follow-up|18|||
129894113|NCT01959880|467571779|FG002|Overall Study|Lost to Follow-up|15|||
129894114|NCT01959880|467571780|FG003|Overall Study|Lost to Follow-up|8|||
129894115|NCT01959880|467571777|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
129894116|NCT01959880|467571778|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
129894117|NCT01959880|467571779|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
129894118|NCT01959880|467571780|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
129894119|NCT01959880|467571777|FG000|Overall Study|Study completed early-FDA approved|1003|||
129894120|NCT01959880|467571778|FG001|Overall Study|Study completed early-FDA approved|311|||
129894121|NCT01959880|467571779|FG002|Overall Study|Study completed early-FDA approved|179|||
129894122|NCT01959880|467571780|FG003|Overall Study|Study completed early-FDA approved|152|||
129894123|NCT01919619|467571781|FG000|Overall Study|Physician Decision|1|||
129894124|NCT01919619|467571782|FG001|Overall Study|Physician Decision|1|||
129894125|NCT03253653|467571787|FG000|Overall Study|Withdrawal by Subject|4|||
129894126|NCT03253653|467571788|FG001|Overall Study|Withdrawal by Subject|1|||
129894127|NCT03253653|467571787|FG000|Overall Study|Protocol Violation|0|||
129894128|NCT03253653|467571788|FG001|Overall Study|Protocol Violation|5|||
129894129|NCT00662909|467571790|FG000|Overall Study|Adverse Event|17|||
129894130|NCT00662909|467571791|FG001|Overall Study|Adverse Event|18|||
129894131|NCT00662909|467571792|FG002|Overall Study|Adverse Event|19|||
129894132|NCT00662909|467571790|FG000|Overall Study|Lack of Efficacy|9|||
129894133|NCT00662909|467571791|FG001|Overall Study|Lack of Efficacy|1|||
129894134|NCT00662909|467571792|FG002|Overall Study|Lack of Efficacy|5|||
129894135|NCT00662909|467571790|FG000|Overall Study|Withdrawal by Subject|29|||
129894136|NCT00662909|467571791|FG001|Overall Study|Withdrawal by Subject|22|||
129894137|NCT00662909|467571792|FG002|Overall Study|Withdrawal by Subject|16|||
129894138|NCT00662909|467571790|FG000|Overall Study|Lost to Follow-up|2|||
129894139|NCT00662909|467571791|FG001|Overall Study|Lost to Follow-up|9|||
129894140|NCT00662909|467571792|FG002|Overall Study|Lost to Follow-up|3|||
129894141|NCT00662909|467571790|FG000|Overall Study|Protocol Violation|7|||
129894142|NCT00662909|467571791|FG001|Overall Study|Protocol Violation|4|||
129894143|NCT00662909|467571792|FG002|Overall Study|Protocol Violation|5|||
129739705|NCT01895309|467006581|FG001|Overall Study|Physician Decision|10|||
129739706|NCT01895309|467006580|FG000|Overall Study|Withdrawal by Subject|9|||
129739707|NCT01895309|467006581|FG001|Overall Study|Withdrawal by Subject|18|||
129739708|NCT04268745|467006582|FG000|Overall Study|Lost to Follow-up|2|||
129739709|NCT04268745|467006583|FG001|Overall Study|Lost to Follow-up|3|||
129739710|NCT04268745|467006582|FG000|Overall Study|Withdrawal by Subject|4|||
129739711|NCT04268745|467006583|FG001|Overall Study|Withdrawal by Subject|2|||
129739712|NCT04268745|467006582|FG000|Overall Study|Death in the family|1|||
129739713|NCT04268745|467006583|FG001|Overall Study|Death in the family|0|||
129739714|NCT01646203|467008010|FG000|Overall Study|Adverse Event|2|||
129739715|NCT01646203|467008011|FG001|Overall Study|Adverse Event|0|||
129739716|NCT01646203|467008012|FG002|Overall Study|Adverse Event|1|||
129739717|NCT01646203|467008010|FG000|Overall Study|Withdrawal by Subject|0|||
129739718|NCT01646203|467008011|FG001|Overall Study|Withdrawal by Subject|1|||
129739719|NCT01646203|467008012|FG002|Overall Study|Withdrawal by Subject|0|||
129739720|NCT01646203|467008010|FG000|Overall Study|Physician's Decision|0|||
129739721|NCT01646203|467008011|FG001|Overall Study|Physician's Decision|1|||
129739722|NCT01646203|467008012|FG002|Overall Study|Physician's Decision|0|||
129739723|NCT03242252|467008014|FG000|Overall Study|At the Participant's own Request|18|||
129739724|NCT03242252|467008015|FG001|Overall Study|At the Participant's own Request|10|||
129739725|NCT03242252|467008016|FG002|Overall Study|At the Participant's own Request|15|||
129739726|NCT03242252|467008014|FG000|Overall Study|Adverse Event|8|||
129739727|NCT03242252|467008015|FG001|Overall Study|Adverse Event|6|||
129739728|NCT03242252|467008016|FG002|Overall Study|Adverse Event|9|||
129739729|NCT03242252|467008014|FG000|Overall Study|Poor Compliance to Protocol|0|||
129739730|NCT03242252|467008015|FG001|Overall Study|Poor Compliance to Protocol|2|||
129739731|NCT03242252|467008016|FG002|Overall Study|Poor Compliance to Protocol|3|||
129739732|NCT03242252|467008014|FG000|Overall Study|Study Terminated by Sponsor|1|||
129739733|NCT03242252|467008015|FG001|Overall Study|Study Terminated by Sponsor|0|||
129739734|NCT03242252|467008016|FG002|Overall Study|Study Terminated by Sponsor|0|||
129739735|NCT03242252|467008014|FG000|Overall Study|Reason not Specified|4|||
129739736|NCT03242252|467008015|FG001|Overall Study|Reason not Specified|4|||
129739737|NCT03242252|467008016|FG002|Overall Study|Reason not Specified|1|||
129739738|NCT03242252|467008014|FG000|Overall Study|Lost to Follow-up|5|||
129739739|NCT03242252|467008015|FG001|Overall Study|Lost to Follow-up|1|||
129739740|NCT03242252|467008016|FG002|Overall Study|Lost to Follow-up|4|||
129894144|NCT00662909|467571790|FG000|Overall Study|Randomized- never received study drug|1|||
129894145|NCT00662909|467571791|FG001|Overall Study|Randomized- never received study drug|0|||
129894146|NCT00662909|467571792|FG002|Overall Study|Randomized- never received study drug|0|||
129894147|NCT00662909|467571790|FG000|Overall Study|Non-compliance with study procedures|3|||
129894148|NCT00662909|467571791|FG001|Overall Study|Non-compliance with study procedures|3|||
129894149|NCT00662909|467571792|FG002|Overall Study|Non-compliance with study procedures|2|||
129894150|NCT00662909|467571790|FG000|Overall Study|Physician Decision|1|||
129894151|NCT00662909|467571791|FG001|Overall Study|Physician Decision|1|||
129894152|NCT00662909|467571792|FG002|Overall Study|Physician Decision|2|||
129894153|NCT00662909|467571790|FG000|Overall Study|Eligibility criterion not met|0|||
129894154|NCT00662909|467571791|FG001|Overall Study|Eligibility criterion not met|1|||
129894155|NCT00662909|467571792|FG002|Overall Study|Eligibility criterion not met|1|||
129894156|NCT04978363|467573331|FG000|Overall Study|Other medical issues unrelated to the study|0|||
129894157|NCT04978363|467573332|FG001|Overall Study|Other medical issues unrelated to the study|0|||
129894158|NCT04978363|467573333|FG002|Overall Study|Other medical issues unrelated to the study|0|||
129894159|NCT04978363|467573334|FG003|Overall Study|Other medical issues unrelated to the study|0|||
129894160|NCT04978363|467573335|FG004|Overall Study|Other medical issues unrelated to the study|1|||
129894161|NCT04978363|467573336|FG005|Overall Study|Other medical issues unrelated to the study|0|||
129894162|NCT04978363|467573337|FG006|Overall Study|Other medical issues unrelated to the study|0|||
129894163|NCT04978363|467573338|FG007|Overall Study|Other medical issues unrelated to the study|0|||
129894164|NCT04978363|467573339|FG008|Overall Study|Other medical issues unrelated to the study|0|||
129894165|NCT04978363|467573340|FG009|Overall Study|Other medical issues unrelated to the study|0|||
129894166|NCT04978363|467573341|FG010|Overall Study|Other medical issues unrelated to the study|0|||
129894167|NCT04978363|467573331|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
129894168|NCT04978363|467573332|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
129894169|NCT04978363|467573333|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
129894170|NCT04978363|467573334|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
129894171|NCT04978363|467573335|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
129894172|NCT04978363|467573336|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
129894173|NCT04978363|467573337|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
129894174|NCT04978363|467573338|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
129894175|NCT04978363|467573339|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
129894176|NCT04978363|467573340|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
129894177|NCT04978363|467573341|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
129894178|NCT04978363|467573331|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894179|NCT04978363|467573332|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
129894180|NCT04978363|467573333|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894181|NCT04978363|467573334|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894182|NCT04978363|467573335|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894183|NCT04978363|467573336|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894184|NCT04978363|467573337|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894185|NCT04978363|467573338|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894186|NCT04978363|467573339|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894187|NCT04978363|467573340|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894188|NCT04978363|467573341|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
129894189|NCT02790606|467573349|FG000|Overall Study|Death|27|||
129894190|NCT02790606|467573349|FG000|Overall Study|Lost to Follow-up|4|||
129894191|NCT02790606|467573349|FG000|Overall Study|Physician Decision|3|||
129894192|NCT02790606|467573349|FG000|Overall Study|Withdrawal by Subject|1|||
129894193|NCT02735915|467573350|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
129894194|NCT02735915|467573350|FG000|Overall Study|Withdrawal following SAE|2|||
129894195|NCT02735915|467573350|FG000|Overall Study|Withdrawal by Subject|1|||
129894196|NCT05328973|467573351|FG000|Overall Study|Withdrawal by Subject|0|||
129894197|NCT05328973|467573352|FG001|Overall Study|Withdrawal by Subject|1|||
129894198|NCT00946114|467573353|FG000|Overall Study|Death|5|||
129894199|NCT00946114|467573354|FG001|Overall Study|Death|2|||
129894200|NCT00946114|467573353|FG000|Overall Study|Other|1|||
129894201|NCT00946114|467573354|FG001|Overall Study|Other|0|||
129894202|NCT00946114|467573353|FG000|Overall Study|Withdrawal by Subject|2|||
129894203|NCT00946114|467573354|FG001|Overall Study|Withdrawal by Subject|0|||
129894204|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
129894205|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
129894206|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
129894207|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
129894208|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
129894209|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
129979653|NCT00403767|467889418|FG001|Overall Study|Investigator dec./not protocol-related|178|||
129894210|NCT01764386|467573356|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
129894211|NCT01764386|467573357|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
129894212|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
129894213|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
129894214|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
129894215|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
129894216|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
129894217|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
129894218|NCT01764386|467573356|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
129894219|NCT01764386|467573357|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
129894220|NCT00498186|467573358|FG000|Overall Study|Protocol Violation|10|||
129894221|NCT00498186|467573358|FG000|Overall Study|Lack of Efficacy|31|||
129894222|NCT00498186|467573358|FG000|Overall Study|Adverse Event|89|||
129894223|NCT00498186|467573358|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
129894224|NCT00498186|467573358|FG000|Overall Study|Withdrawal by Subject|18|||
129894225|NCT00498186|467573358|FG000|Overall Study|Lost to Follow-up|3|||
129894226|NCT00498186|467573358|FG000|Overall Study|Other|10|||
129894227|NCT03929302|467573359|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
129894228|NCT03929302|467573360|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
129894229|NCT03929302|467573361|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
129894230|NCT03929302|467573359|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
129894231|NCT03929302|467573360|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
129894232|NCT03929302|467573361|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
129894233|NCT03929302|467573359|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
129894234|NCT03929302|467573360|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
129894235|NCT03929302|467573361|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
129894236|NCT02757885|467573362|FG000|Overall Study|Screen Failures|4|||
129894237|NCT00886613|467573363|FG000|Overall Study|Protocol deviation (Part B)|1|||
129894238|NCT00886613|467573364|FG001|Overall Study|Protocol deviation (Part B)|0|||
129894239|NCT00886613|467573365|FG002|Overall Study|Protocol deviation (Part B)|0|||
129894240|NCT00886613|467573363|FG000|Overall Study|Lost to follow-up (Part B)|1|||
129894241|NCT00886613|467573364|FG001|Overall Study|Lost to follow-up (Part B)|0|||
129894242|NCT00886613|467573365|FG002|Overall Study|Lost to follow-up (Part B)|1|||
129894243|NCT00886613|467573363|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
129894244|NCT00886613|467573364|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
129894245|NCT00886613|467573365|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
129894246|NCT00463151|467573374|FG000|Overall Study|Adverse Event|0|||
129894247|NCT00463151|467573375|FG001|Overall Study|Adverse Event|0|||
129894248|NCT00463151|467573376|FG002|Overall Study|Adverse Event|1|||
129894249|NCT00463151|467573377|FG003|Overall Study|Adverse Event|0|||
129894250|NCT00463151|467573374|FG000|Overall Study|Lack of Efficacy|2|||
129894251|NCT00463151|467573375|FG001|Overall Study|Lack of Efficacy|5|||
129894252|NCT00463151|467573376|FG002|Overall Study|Lack of Efficacy|2|||
129894253|NCT00463151|467573377|FG003|Overall Study|Lack of Efficacy|5|||
129894254|NCT00463151|467573374|FG000|Overall Study|Protocol Violation|0|||
129894255|NCT00463151|467573375|FG001|Overall Study|Protocol Violation|0|||
129894256|NCT00463151|467573376|FG002|Overall Study|Protocol Violation|0|||
129894257|NCT00463151|467573377|FG003|Overall Study|Protocol Violation|1|||
129894258|NCT00463151|467573374|FG000|Overall Study|Withdrawal by Subject|0|||
129894259|NCT00463151|467573375|FG001|Overall Study|Withdrawal by Subject|0|||
129894260|NCT00463151|467573376|FG002|Overall Study|Withdrawal by Subject|0|||
129894261|NCT00463151|467573377|FG003|Overall Study|Withdrawal by Subject|1|||
129894262|NCT00293462|467573378|FG000|Overall Study|Withdrawal by Subject|4|||
129894263|NCT00293462|467573379|FG001|Overall Study|Withdrawal by Subject|3|||
129894264|NCT00293462|467573380|FG002|Overall Study|Withdrawal by Subject|8|||
129894265|NCT00293462|467573378|FG000|Overall Study|Death|1|||
129894266|NCT00293462|467573379|FG001|Overall Study|Death|0|||
129894267|NCT00293462|467573380|FG002|Overall Study|Death|0|||
129894268|NCT00293462|467573378|FG000|Overall Study|Lost to Follow-up|0|||
129894269|NCT00293462|467573379|FG001|Overall Study|Lost to Follow-up|1|||
129894270|NCT00293462|467573380|FG002|Overall Study|Lost to Follow-up|0|||
129894271|NCT00293462|467573378|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
129894272|NCT00293462|467573379|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
129894273|NCT00293462|467573380|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
129894274|NCT00293462|467573378|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
129894275|NCT00293462|467573379|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
129894276|NCT00293462|467573380|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
129894277|NCT00293462|467573378|FG000|Overall Study|Refuse Radiation Treatment|1|||
129894278|NCT00293462|467573379|FG001|Overall Study|Refuse Radiation Treatment|0|||
129894279|NCT00293462|467573380|FG002|Overall Study|Refuse Radiation Treatment|0|||
129894280|NCT00293462|467573378|FG000|Overall Study|No Show|0|||
129894281|NCT00293462|467573379|FG001|Overall Study|No Show|0|||
129894282|NCT00293462|467573380|FG002|Overall Study|No Show|1|||
129739741|NCT01659255|467008017|FG000|Overall Study|Adverse Event|0|||
129739742|NCT01659255|467008018|FG001|Overall Study|Adverse Event|0|||
129739743|NCT01659255|467008019|FG002|Overall Study|Adverse Event|0|||
129739744|NCT01659255|467008020|FG003|Overall Study|Adverse Event|0|||
129739745|NCT01659255|467008021|FG004|Overall Study|Adverse Event|0|||
129739746|NCT01659255|467008022|FG005|Overall Study|Adverse Event|1|||
129739747|NCT01659255|467008023|FG006|Overall Study|Adverse Event|1|||
129739748|NCT01659255|467008024|FG007|Overall Study|Adverse Event|0|||
129739749|NCT01659255|467008025|FG008|Overall Study|Adverse Event|0|||
129739750|NCT01659255|467008026|FG009|Overall Study|Adverse Event|1|||
129739751|NCT01659255|467008027|FG010|Overall Study|Adverse Event|0|||
129739752|NCT01659255|467008028|FG011|Overall Study|Adverse Event|1|||
129739753|NCT01659255|467008029|FG012|Overall Study|Adverse Event|0|||
129739754|NCT01659255|467008030|FG013|Overall Study|Adverse Event|2|||
129739755|NCT01659255|467008031|FG014|Overall Study|Adverse Event|0|||
129739756|NCT01659255|467008032|FG015|Overall Study|Adverse Event|1|||
129739757|NCT01659255|467008033|FG016|Overall Study|Adverse Event|0|||
129739758|NCT01659255|467008017|FG000|Overall Study|Death|0|||
129739759|NCT01659255|467008018|FG001|Overall Study|Death|1|||
129739760|NCT01659255|467008019|FG002|Overall Study|Death|0|||
129739761|NCT01659255|467008020|FG003|Overall Study|Death|0|||
129739762|NCT01659255|467008021|FG004|Overall Study|Death|0|||
129806975|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806976|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806977|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806978|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806979|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806980|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806981|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
129806982|NCT00533897|467261057|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
129806983|NCT00533897|467261058|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806984|NCT00533897|467261059|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806985|NCT00533897|467261060|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806986|NCT00533897|467261061|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806987|NCT00533897|467261062|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806988|NCT00533897|467261063|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806989|NCT00533897|467261064|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
129806990|NCT00533897|467261057|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806991|NCT00533897|467261058|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
129806992|NCT00533897|467261059|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
129806993|NCT00533897|467261060|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806994|NCT00533897|467261061|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806995|NCT00533897|467261062|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806996|NCT00533897|467261063|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806997|NCT00533897|467261064|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
129806998|NCT00533897|467261057|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129806999|NCT00533897|467261058|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807000|NCT00533897|467261059|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
129807001|NCT00533897|467261060|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807002|NCT00533897|467261061|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807003|NCT00533897|467261062|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807004|NCT00533897|467261063|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807005|NCT00533897|467261064|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
129807006|NCT00533897|467261057|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807007|NCT00533897|467261058|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807008|NCT00533897|467261059|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807009|NCT00533897|467261060|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807010|NCT00533897|467261061|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807011|NCT00533897|467261062|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
129807012|NCT00533897|467261063|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807013|NCT00533897|467261064|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
129807014|NCT00533897|467261057|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807015|NCT00533897|467261058|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807016|NCT00533897|467261059|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807017|NCT00533897|467261060|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807018|NCT00533897|467261061|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807019|NCT00533897|467261062|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
129979654|NCT00403767|467889417|FG000|Overall Study|Lost to Follow-up|6|||
129979655|NCT00403767|467889418|FG001|Overall Study|Lost to Follow-up|8|||
129894283|NCT00293462|467573378|FG000|Overall Study|Went back to his home country|0|||
129894284|NCT00293462|467573379|FG001|Overall Study|Went back to his home country|0|||
129894285|NCT00293462|467573380|FG002|Overall Study|Went back to his home country|1|||
129894286|NCT00293462|467573378|FG000|Overall Study|Blood clot after chemotherapy|0|||
129894287|NCT00293462|467573379|FG001|Overall Study|Blood clot after chemotherapy|0|||
129894288|NCT00293462|467573380|FG002|Overall Study|Blood clot after chemotherapy|1|||
129894289|NCT00293462|467573378|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
129894290|NCT00293462|467573379|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
129894291|NCT00293462|467573380|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
129894292|NCT00293462|467573378|FG000|Overall Study|Possible Tracheostomy leakage|0|||
129894293|NCT00293462|467573379|FG001|Overall Study|Possible Tracheostomy leakage|1|||
129894294|NCT00293462|467573380|FG002|Overall Study|Possible Tracheostomy leakage|0|||
129894295|NCT00293462|467573378|FG000|Overall Study|Low radiation dose in oral cavity|0|||
129894296|NCT00293462|467573379|FG001|Overall Study|Low radiation dose in oral cavity|1|||
129894297|NCT00293462|467573380|FG002|Overall Study|Low radiation dose in oral cavity|0|||
129894298|NCT00293462|467573378|FG000|Overall Study|Physician Decision|0|||
129894299|NCT00293462|467573379|FG001|Overall Study|Physician Decision|1|||
129894300|NCT00293462|467573380|FG002|Overall Study|Physician Decision|0|||
129894301|NCT00688688|467573381|FG000|Overall Study|Eligibility criterion not met|7|||
129894302|NCT00688688|467573382|FG001|Overall Study|Eligibility criterion not met|7|||
129894303|NCT00688688|467573383|FG002|Overall Study|Eligibility criterion not met|10|||
129894304|NCT00688688|467573381|FG000|Overall Study|Adverse Event|52|||
129894305|NCT00688688|467573382|FG001|Overall Study|Adverse Event|51|||
129894306|NCT00688688|467573383|FG002|Overall Study|Adverse Event|50|||
129894307|NCT00688688|467573381|FG000|Overall Study|Lack of Efficacy|34|||
129894308|NCT00688688|467573382|FG001|Overall Study|Lack of Efficacy|25|||
129894309|NCT00688688|467573383|FG002|Overall Study|Lack of Efficacy|45|||
129894310|NCT00688688|467573381|FG000|Overall Study|Withdrawal by Subject|66|||
129894311|NCT00688688|467573382|FG001|Overall Study|Withdrawal by Subject|75|||
129894312|NCT00688688|467573383|FG002|Overall Study|Withdrawal by Subject|65|||
129894313|NCT00688688|467573381|FG000|Overall Study|Lost to Follow-up|14|||
129894314|NCT00688688|467573382|FG001|Overall Study|Lost to Follow-up|7|||
129894315|NCT00688688|467573383|FG002|Overall Study|Lost to Follow-up|7|||
129894316|NCT00688688|467573381|FG000|Overall Study|Protocol Violation|6|||
129894317|NCT00688688|467573382|FG001|Overall Study|Protocol Violation|9|||
129894318|NCT00688688|467573383|FG002|Overall Study|Protocol Violation|11|||
129894319|NCT00688688|467573381|FG000|Overall Study|Randomized but never received study drug|1|||
129894320|NCT00688688|467573382|FG001|Overall Study|Randomized but never received study drug|0|||
129894321|NCT00688688|467573383|FG002|Overall Study|Randomized but never received study drug|0|||
129894322|NCT00688688|467573381|FG000|Overall Study|Non-compliance with study procedures|5|||
129894323|NCT00688688|467573382|FG001|Overall Study|Non-compliance with study procedures|3|||
129894324|NCT00688688|467573383|FG002|Overall Study|Non-compliance with study procedures|4|||
129894325|NCT00688688|467573381|FG000|Overall Study|Taking exclusionary medications|1|||
129894326|NCT00688688|467573382|FG001|Overall Study|Taking exclusionary medications|0|||
129445347|NCT02684279|465931272|FG000|Overall Study|Lack of Efficacy|4|||
129445348|NCT02684279|465931272|FG000|Overall Study|Lost to Follow-up|61|||
129739763|NCT01659255|467008022|FG005|Overall Study|Death|0|||
129739764|NCT01659255|467008023|FG006|Overall Study|Death|0|||
129739765|NCT01659255|467008024|FG007|Overall Study|Death|1|||
129739766|NCT01659255|467008025|FG008|Overall Study|Death|1|||
129739767|NCT01659255|467008026|FG009|Overall Study|Death|0|||
129739768|NCT01659255|467008027|FG010|Overall Study|Death|0|||
129739769|NCT01659255|467008028|FG011|Overall Study|Death|0|||
129739770|NCT01659255|467008029|FG012|Overall Study|Death|1|||
129739771|NCT01659255|467008030|FG013|Overall Study|Death|1|||
129739772|NCT01659255|467008031|FG014|Overall Study|Death|2|||
129739773|NCT01659255|467008032|FG015|Overall Study|Death|1|||
129739774|NCT01659255|467008033|FG016|Overall Study|Death|0|||
129739775|NCT01659255|467008017|FG000|Overall Study|Progressive Disease|2|||
129739776|NCT01659255|467008018|FG001|Overall Study|Progressive Disease|0|||
129739777|NCT01659255|467008019|FG002|Overall Study|Progressive Disease|0|||
129894327|NCT00688688|467573383|FG002|Overall Study|Taking exclusionary medications|0|||
129894328|NCT00688688|467573381|FG000|Overall Study|Site closure|0|||
129894329|NCT00688688|467573382|FG001|Overall Study|Site closure|1|||
129894330|NCT00688688|467573383|FG002|Overall Study|Site closure|0|||
129894331|NCT00688688|467573381|FG000|Overall Study|Violation of exclusion criterion|0|||
129894332|NCT00688688|467573382|FG001|Overall Study|Violation of exclusion criterion|1|||
129894333|NCT00688688|467573383|FG002|Overall Study|Violation of exclusion criterion|0|||
129894334|NCT03283553|467573386|FG000|Patient Participant Flow|Death|5|||
129894335|NCT03283553|467573387|FG001|Patient Participant Flow|Death|10|||
129894336|NCT03283553|467573386|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
129894337|NCT03283553|467573387|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
129894338|NCT03283553|467573386|FG000|Patient Participant Flow|Lost to Follow-up|1|||
129445349|NCT02684279|465931272|FG000|Overall Study|Protocol Violation|6|||
129739778|NCT01659255|467008020|FG003|Overall Study|Progressive Disease|0|||
129739779|NCT01659255|467008021|FG004|Overall Study|Progressive Disease|0|||
129894339|NCT03283553|467573387|FG001|Patient Participant Flow|Lost to Follow-up|1|||
129894340|NCT03283553|467573386|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
129894341|NCT03283553|467573387|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
129894342|NCT03283553|467573386|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
129894343|NCT03283553|467573387|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
129894344|NCT03283553|467573386|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
129894345|NCT03283553|467573387|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
129894346|NCT03686683|467573388|FG000|Overall Study|Withdrawal by Subject|52|||
129894347|NCT03686683|467573389|FG001|Overall Study|Withdrawal by Subject|32|||
129894348|NCT03686683|467573388|FG000|Overall Study|Lost to Follow-up|23|||
129894349|NCT03686683|467573389|FG001|Overall Study|Lost to Follow-up|19|||
129894350|NCT03686683|467573388|FG000|Overall Study|Adverse Event|1|||
129894351|NCT03686683|467573389|FG001|Overall Study|Adverse Event|0|||
129894352|NCT03686683|467573388|FG000|Overall Study|Death|10|||
129894353|NCT03686683|467573389|FG001|Overall Study|Death|5|||
129894354|NCT03686683|467573388|FG000|Overall Study|Progressive Disease|1|||
129894355|NCT03686683|467573389|FG001|Overall Study|Progressive Disease|1|||
129894356|NCT03686683|467573388|FG000|Overall Study|Noncompliance|1|||
129894357|NCT03686683|467573389|FG001|Overall Study|Noncompliance|0|||
129894358|NCT03686683|467573388|FG000|Overall Study|Physician Decision|1|||
129894359|NCT03686683|467573389|FG001|Overall Study|Physician Decision|1|||
129894360|NCT03686683|467573388|FG000|Overall Study|Screen fail post-randomization|1|||
129894361|NCT03686683|467573389|FG001|Overall Study|Screen fail post-randomization|0|||
129894362|NCT03686683|467573388|FG000|Overall Study|Protocol Violation|3|||
129894363|NCT03686683|467573389|FG001|Overall Study|Protocol Violation|0|||
129894364|NCT03686683|467573388|FG000|Overall Study|No data available|1|||
129894365|NCT03686683|467573389|FG001|Overall Study|No data available|0|||
129894366|NCT03255941|467573390|FG000|Overall Study|Not eligible or refused injection|37|||
129894367|NCT03255941|467573391|FG001|Overall Study|Not eligible or refused injection|44|||
129739780|NCT01659255|467008022|FG005|Overall Study|Progressive Disease|0|||
129739781|NCT01659255|467008023|FG006|Overall Study|Progressive Disease|0|||
129739782|NCT01659255|467008024|FG007|Overall Study|Progressive Disease|1|||
129739783|NCT01659255|467008025|FG008|Overall Study|Progressive Disease|0|||
129739784|NCT01659255|467008026|FG009|Overall Study|Progressive Disease|2|||
129739785|NCT01659255|467008027|FG010|Overall Study|Progressive Disease|2|||
129739786|NCT01659255|467008028|FG011|Overall Study|Progressive Disease|3|||
129739787|NCT01659255|467008029|FG012|Overall Study|Progressive Disease|5|||
129739788|NCT01659255|467008030|FG013|Overall Study|Progressive Disease|13|||
129739789|NCT01659255|467008031|FG014|Overall Study|Progressive Disease|6|||
129739790|NCT01659255|467008032|FG015|Overall Study|Progressive Disease|2|||
129739791|NCT01659255|467008033|FG016|Overall Study|Progressive Disease|3|||
129739792|NCT01659255|467008017|FG000|Overall Study|Withdrew Consent|0|||
129739793|NCT01659255|467008018|FG001|Overall Study|Withdrew Consent|0|||
129739794|NCT01659255|467008019|FG002|Overall Study|Withdrew Consent|0|||
129739795|NCT01659255|467008020|FG003|Overall Study|Withdrew Consent|0|||
129739796|NCT01659255|467008021|FG004|Overall Study|Withdrew Consent|0|||
129739797|NCT01659255|467008022|FG005|Overall Study|Withdrew Consent|0|||
129739798|NCT01659255|467008023|FG006|Overall Study|Withdrew Consent|0|||
129739799|NCT01659255|467008024|FG007|Overall Study|Withdrew Consent|0|||
129739800|NCT01659255|467008025|FG008|Overall Study|Withdrew Consent|0|||
129739801|NCT01659255|467008026|FG009|Overall Study|Withdrew Consent|0|||
129739802|NCT01659255|467008027|FG010|Overall Study|Withdrew Consent|1|||
129739803|NCT01659255|467008028|FG011|Overall Study|Withdrew Consent|0|||
129739804|NCT01659255|467008029|FG012|Overall Study|Withdrew Consent|0|||
129739805|NCT01659255|467008030|FG013|Overall Study|Withdrew Consent|1|||
129739806|NCT01659255|467008031|FG014|Overall Study|Withdrew Consent|0|||
129739807|NCT01659255|467008032|FG015|Overall Study|Withdrew Consent|0|||
129739808|NCT01659255|467008033|FG016|Overall Study|Withdrew Consent|0|||
129739809|NCT01659255|467008017|FG000|Overall Study|Investigator Decision|0|||
129739810|NCT01659255|467008018|FG001|Overall Study|Investigator Decision|0|||
129739811|NCT01659255|467008019|FG002|Overall Study|Investigator Decision|0|||
129739812|NCT01659255|467008020|FG003|Overall Study|Investigator Decision|0|||
129739813|NCT01659255|467008021|FG004|Overall Study|Investigator Decision|0|||
129739814|NCT01659255|467008022|FG005|Overall Study|Investigator Decision|0|||
129739815|NCT01659255|467008023|FG006|Overall Study|Investigator Decision|0|||
129739816|NCT01659255|467008024|FG007|Overall Study|Investigator Decision|0|||
129739817|NCT01659255|467008025|FG008|Overall Study|Investigator Decision|0|||
129739818|NCT01659255|467008026|FG009|Overall Study|Investigator Decision|0|||
129739819|NCT01659255|467008027|FG010|Overall Study|Investigator Decision|0|||
129739820|NCT01659255|467008028|FG011|Overall Study|Investigator Decision|0|||
129739821|NCT01659255|467008029|FG012|Overall Study|Investigator Decision|1|||
129739822|NCT01659255|467008030|FG013|Overall Study|Investigator Decision|1|||
129894368|NCT03255941|467573392|FG002|Overall Study|Not eligible or refused injection|5|||
129739823|NCT01659255|467008031|FG014|Overall Study|Investigator Decision|0|||
129739824|NCT01659255|467008032|FG015|Overall Study|Investigator Decision|0|||
129739825|NCT01659255|467008033|FG016|Overall Study|Investigator Decision|0|||
129894369|NCT03255941|467573393|FG003|Overall Study|Not eligible or refused injection|6|||
129894370|NCT03255941|467573390|FG000|Overall Study|Did not complete exit interview|1|||
129894371|NCT03255941|467573391|FG001|Overall Study|Did not complete exit interview|2|||
129894372|NCT03255941|467573392|FG002|Overall Study|Did not complete exit interview|0|||
129894373|NCT03255941|467573393|FG003|Overall Study|Did not complete exit interview|0|||
129894374|NCT00372060|467573394|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
129894375|NCT00372060|467573395|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
129894376|NCT00372060|467573394|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
129894377|NCT00372060|467573395|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
129894378|NCT00372060|467573394|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
129739826|NCT01659255|467008017|FG000|Overall Study|Sponsor's Decision|0|||
129739827|NCT01659255|467008018|FG001|Overall Study|Sponsor's Decision|0|||
129739828|NCT01659255|467008019|FG002|Overall Study|Sponsor's Decision|0|||
129739829|NCT01659255|467008020|FG003|Overall Study|Sponsor's Decision|0|||
129739830|NCT01659255|467008021|FG004|Overall Study|Sponsor's Decision|0|||
129739831|NCT01659255|467008022|FG005|Overall Study|Sponsor's Decision|0|||
129739832|NCT01659255|467008023|FG006|Overall Study|Sponsor's Decision|1|||
129739833|NCT01659255|467008024|FG007|Overall Study|Sponsor's Decision|0|||
129739834|NCT01659255|467008025|FG008|Overall Study|Sponsor's Decision|0|||
129739835|NCT01659255|467008026|FG009|Overall Study|Sponsor's Decision|0|||
129739836|NCT01659255|467008027|FG010|Overall Study|Sponsor's Decision|0|||
129739837|NCT01659255|467008028|FG011|Overall Study|Sponsor's Decision|0|||
129739838|NCT01659255|467008029|FG012|Overall Study|Sponsor's Decision|0|||
129739839|NCT01659255|467008030|FG013|Overall Study|Sponsor's Decision|0|||
129739840|NCT01659255|467008031|FG014|Overall Study|Sponsor's Decision|0|||
129739841|NCT01659255|467008032|FG015|Overall Study|Sponsor's Decision|0|||
129739842|NCT01659255|467008033|FG016|Overall Study|Sponsor's Decision|0|||
129739843|NCT01659255|467008017|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739844|NCT01659255|467008018|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739845|NCT01659255|467008019|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739846|NCT01659255|467008020|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739847|NCT01659255|467008021|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739848|NCT01659255|467008022|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739849|NCT01659255|467008023|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739850|NCT01659255|467008024|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739851|NCT01659255|467008025|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739852|NCT01659255|467008026|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739853|NCT01659255|467008027|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739854|NCT01659255|467008028|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739855|NCT01659255|467008029|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739856|NCT01659255|467008030|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739857|NCT01659255|467008031|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739858|NCT01659255|467008032|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
129739859|NCT01659255|467008033|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
129739860|NCT01659255|467008017|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
129739861|NCT01659255|467008018|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
129739862|NCT01659255|467008019|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
129739863|NCT01659255|467008020|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
129807020|NCT00533897|467261063|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807021|NCT00533897|467261064|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
129807022|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807023|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807024|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807025|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807026|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807027|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
129807028|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
129807029|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
129807030|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Death|0|||
129807031|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Death|0|||
129807032|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Death|0|||
129807033|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Death|0|||
129807034|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Death|0|||
129739864|NCT01659255|467008021|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
129739865|NCT01659255|467008022|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
129739866|NCT01659255|467008023|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
129739867|NCT01659255|467008024|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
129739868|NCT01659255|467008025|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
129739869|NCT01659255|467008026|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
129739870|NCT01659255|467008027|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
129739871|NCT01659255|467008028|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
129739872|NCT01659255|467008029|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
129739873|NCT01659255|467008030|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
129739874|NCT01659255|467008031|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
129739875|NCT01659255|467008032|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
129739876|NCT01659255|467008033|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
129739877|NCT01116427|467008036|FG000|Core Phase|Adverse Event|0|||
129739878|NCT01116427|467008037|FG001|Core Phase|Adverse Event|1|||
129739879|NCT01116427|467008036|FG000|Core Phase|Lost to Follow-up|1|||
129739880|NCT01116427|467008037|FG001|Core Phase|Lost to Follow-up|0|||
129739881|NCT01116427|467008036|FG000|Core Phase|Withdrawal by Subject|3|||
129739882|NCT01116427|467008037|FG001|Core Phase|Withdrawal by Subject|0|||
129739883|NCT01116427|467008036|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
129739884|NCT01116427|467008037|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
129739885|NCT01116427|467008036|FG000|Extension Phase|Adverse Event|1|||
129739886|NCT01116427|467008037|FG001|Extension Phase|Adverse Event|1|||
129739887|NCT01116427|467008036|FG000|Extension Phase|Lost to Follow-up|2|||
129739888|NCT01116427|467008037|FG001|Extension Phase|Lost to Follow-up|0|||
129739889|NCT01116427|467008036|FG000|Extension Phase|Withdrawal by Subject|5|||
129739890|NCT01116427|467008037|FG001|Extension Phase|Withdrawal by Subject|1|||
129739891|NCT01116427|467008036|FG000|Extension Phase|Not using appropriate birth control|1|||
129739892|NCT01116427|467008037|FG001|Extension Phase|Not using appropriate birth control|0|||
129739893|NCT02989805|467008038|FG000|Overall Study|invalid consent|6|||
129739894|NCT02989805|467008039|FG001|Overall Study|invalid consent|4|||
129739895|NCT02211313|467008040|FG000|Overall Study|Treatment Failure|5|||
129739896|NCT02211313|467008041|FG001|Overall Study|Treatment Failure|2|||
129739897|NCT02211313|467008040|FG000|Overall Study|No Follow up Questionnaires|1|||
129739898|NCT02211313|467008041|FG001|Overall Study|No Follow up Questionnaires|1|||
129739899|NCT03743064|467008042|FG000|Overall Study|Adverse Event|7|||
129807035|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Death|0|||
129807036|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Death|1|||
129807037|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Death|3|||
129807038|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807039|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807040|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807041|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807042|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807043|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
129807044|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
129807045|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
129807046|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807047|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807048|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807049|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807050|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807051|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807052|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
129807053|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
129807054|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Adverse Event|0|||
129807055|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Adverse Event|0|||
129807056|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Adverse Event|0|||
129807057|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Adverse Event|0|||
129807058|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Adverse Event|0|||
129807059|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Adverse Event|0|||
129807060|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Adverse Event|2|||
129739900|NCT03743064|467008043|FG001|Overall Study|Adverse Event|9|||
129739901|NCT03743064|467008042|FG000|Overall Study|Death|25|||
129739902|NCT03743064|467008043|FG001|Overall Study|Death|28|||
129894379|NCT00372060|467573395|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
129894380|NCT00372060|467573394|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
129894381|NCT00372060|467573395|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
129894382|NCT00372060|467573394|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
129894383|NCT00372060|467573395|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
129894384|NCT00372060|467573394|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
129894385|NCT00372060|467573395|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
129894386|NCT01579578|467573396|FG000|Overall Study|Death|4|||
129894387|NCT01579578|467573397|FG001|Overall Study|Death|1|||
129894388|NCT01579578|467573396|FG000|Overall Study|Lost to Follow-up|1|||
129894389|NCT01579578|467573397|FG001|Overall Study|Lost to Follow-up|1|||
129894390|NCT01579578|467573396|FG000|Overall Study|Withdrawal by Subject|2|||
129894391|NCT01579578|467573397|FG001|Overall Study|Withdrawal by Subject|1|||
129894392|NCT01579578|467573396|FG000|Overall Study|Eligibility criteria|3|||
129739903|NCT03743064|467008042|FG000|Overall Study|Lost to Follow-up|3|||
129739904|NCT03743064|467008043|FG001|Overall Study|Lost to Follow-up|6|||
129739905|NCT03743064|467008042|FG000|Overall Study|Withdrawal by Subject|28|||
129739906|NCT03743064|467008043|FG001|Overall Study|Withdrawal by Subject|25|||
129739907|NCT03743064|467008042|FG000|Overall Study|Physician Decision|2|||
129739908|NCT03743064|467008043|FG001|Overall Study|Physician Decision|4|||
129739909|NCT03743064|467008042|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
129739910|NCT03743064|467008043|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
129739911|NCT02771626|467008044|FG000|Overall Study|Adverse Event|1|||
129739912|NCT02771626|467008045|FG001|Overall Study|Adverse Event|5|||
129739913|NCT02771626|467008046|FG002|Overall Study|Adverse Event|3|||
129739914|NCT02771626|467008047|FG003|Overall Study|Adverse Event|0|||
129739915|NCT02771626|467008048|FG004|Overall Study|Adverse Event|1|||
129739916|NCT02771626|467008049|FG005|Overall Study|Adverse Event|1|||
129739917|NCT02771626|467008044|FG000|Overall Study|Radiologic Disease Progression|6|||
129739918|NCT02771626|467008045|FG001|Overall Study|Radiologic Disease Progression|13|||
129739919|NCT02771626|467008046|FG002|Overall Study|Radiologic Disease Progression|10|||
129739920|NCT02771626|467008047|FG003|Overall Study|Radiologic Disease Progression|7|||
129739921|NCT02771626|467008048|FG004|Overall Study|Radiologic Disease Progression|28|||
129739922|NCT02771626|467008049|FG005|Overall Study|Radiologic Disease Progression|15|||
129739923|NCT02771626|467008044|FG000|Overall Study|Symptomatic Deterioration|0|||
129739924|NCT02771626|467008045|FG001|Overall Study|Symptomatic Deterioration|4|||
129739925|NCT02771626|467008046|FG002|Overall Study|Symptomatic Deterioration|2|||
129739926|NCT02771626|467008047|FG003|Overall Study|Symptomatic Deterioration|0|||
129739927|NCT02771626|467008048|FG004|Overall Study|Symptomatic Deterioration|5|||
129739928|NCT02771626|467008049|FG005|Overall Study|Symptomatic Deterioration|2|||
129739929|NCT02771626|467008044|FG000|Overall Study|Participant Request|0|||
129739930|NCT02771626|467008045|FG001|Overall Study|Participant Request|1|||
129739931|NCT02771626|467008046|FG002|Overall Study|Participant Request|0|||
129739932|NCT02771626|467008047|FG003|Overall Study|Participant Request|2|||
129739933|NCT02771626|467008048|FG004|Overall Study|Participant Request|0|||
129739934|NCT02771626|467008049|FG005|Overall Study|Participant Request|1|||
129739935|NCT02771626|467008044|FG000|Overall Study|Investigator Decision|0|||
129739936|NCT02771626|467008045|FG001|Overall Study|Investigator Decision|1|||
129739937|NCT02771626|467008046|FG002|Overall Study|Investigator Decision|0|||
129739938|NCT02771626|467008047|FG003|Overall Study|Investigator Decision|0|||
129739939|NCT02771626|467008048|FG004|Overall Study|Investigator Decision|1|||
129739940|NCT02771626|467008049|FG005|Overall Study|Investigator Decision|0|||
129739941|NCT02771626|467008044|FG000|Overall Study|Study Termination by Sponsor|0|||
129739942|NCT02771626|467008045|FG001|Overall Study|Study Termination by Sponsor|2|||
129739943|NCT02771626|467008046|FG002|Overall Study|Study Termination by Sponsor|1|||
129739944|NCT02771626|467008047|FG003|Overall Study|Study Termination by Sponsor|0|||
129739945|NCT02771626|467008048|FG004|Overall Study|Study Termination by Sponsor|1|||
129739946|NCT02771626|467008049|FG005|Overall Study|Study Termination by Sponsor|0|||
129739947|NCT02771626|467008044|FG000|Overall Study|Informed Consent Withdrawn|0|||
129739948|NCT02771626|467008045|FG001|Overall Study|Informed Consent Withdrawn|0|||
129739949|NCT02771626|467008046|FG002|Overall Study|Informed Consent Withdrawn|1|||
129739950|NCT02771626|467008047|FG003|Overall Study|Informed Consent Withdrawn|0|||
129739951|NCT02771626|467008048|FG004|Overall Study|Informed Consent Withdrawn|1|||
129739952|NCT02771626|467008049|FG005|Overall Study|Informed Consent Withdrawn|1|||
129739953|NCT02771626|467008044|FG000|Overall Study|Other, Not Specified|1|||
129739954|NCT02771626|467008045|FG001|Overall Study|Other, Not Specified|0|||
129739955|NCT02771626|467008046|FG002|Overall Study|Other, Not Specified|0|||
129739956|NCT02771626|467008047|FG003|Overall Study|Other, Not Specified|0|||
129739957|NCT02771626|467008048|FG004|Overall Study|Other, Not Specified|0|||
129739958|NCT02771626|467008049|FG005|Overall Study|Other, Not Specified|1|||
129739959|NCT02648217|467008050|FG000|Overall Study|Adverse Event|0|||
129807061|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Adverse Event|5|||
129807062|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Pregnancy|0|||
129807063|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Pregnancy|0|||
129807064|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Pregnancy|0|||
129807065|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Pregnancy|0|||
129807066|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Pregnancy|0|||
129807067|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Pregnancy|0|||
129807068|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Pregnancy|0|||
129807069|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Pregnancy|2|||
129807070|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807071|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807072|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807073|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807074|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807075|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
129807076|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
129807077|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
129807078|NCT00533897|467261057|FG000|Long Term Extension (LTE)|Other|0|||
129807079|NCT00533897|467261058|FG001|Long Term Extension (LTE)|Other|0|||
129807080|NCT00533897|467261059|FG002|Long Term Extension (LTE)|Other|0|||
129807081|NCT00533897|467261060|FG003|Long Term Extension (LTE)|Other|0|||
129807082|NCT00533897|467261061|FG004|Long Term Extension (LTE)|Other|0|||
129807083|NCT00533897|467261062|FG005|Long Term Extension (LTE)|Other|0|||
129807084|NCT00533897|467261063|FG006|Long Term Extension (LTE)|Other|1|||
129807085|NCT00533897|467261064|FG007|Long Term Extension (LTE)|Other|6|||
129807086|NCT01816074|467261066|FG000|Phase 1|Time commitment issues|0|||
129807087|NCT01816074|467261067|FG001|Phase 1|Time commitment issues|0|||
129807088|NCT01816074|467261068|FG002|Phase 1|Time commitment issues|1|||
129807089|NCT01816074|467261069|FG003|Phase 1|Time commitment issues|0|||
129807090|NCT01816074|467261066|FG000|Phase 2|Time commitment Issues|0|||
129807091|NCT01816074|467261067|FG001|Phase 2|Time commitment Issues|2|||
129807092|NCT01816074|467261068|FG002|Phase 2|Time commitment Issues|0|||
129807093|NCT01816074|467261069|FG003|Phase 2|Time commitment Issues|0|||
129807094|NCT01816074|467261066|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
129807095|NCT01816074|467261067|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
129807096|NCT01816074|467261068|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
129807097|NCT01816074|467261069|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
129807098|NCT01816074|467261066|FG000|Phase 2|Physician Decision|0|||
129807099|NCT01816074|467261067|FG001|Phase 2|Physician Decision|0|||
129807100|NCT01816074|467261068|FG002|Phase 2|Physician Decision|0|||
129807101|NCT01816074|467261069|FG003|Phase 2|Physician Decision|1|||
129807102|NCT01816074|467261066|FG000|Phase 2|Withdrawal by Subject|1|||
129807103|NCT01816074|467261067|FG001|Phase 2|Withdrawal by Subject|0|||
129807104|NCT01816074|467261068|FG002|Phase 2|Withdrawal by Subject|0|||
129807105|NCT01816074|467261069|FG003|Phase 2|Withdrawal by Subject|0|||
129807106|NCT03228433|467261072|FG000|Overall Study|Lost to Follow-up|1|||
129807107|NCT03228433|467261073|FG001|Overall Study|Lost to Follow-up|0|||
129807108|NCT03228433|467261074|FG002|Overall Study|Lost to Follow-up|0|||
129807109|NCT03228433|467261075|FG003|Overall Study|Lost to Follow-up|0|||
129807110|NCT03228433|467261076|FG004|Overall Study|Lost to Follow-up|0|||
129807111|NCT03228433|467261077|FG005|Overall Study|Lost to Follow-up|0|||
129807112|NCT03228433|467261072|FG000|Overall Study|Positive alcohol test|0|||
129807113|NCT03228433|467261073|FG001|Overall Study|Positive alcohol test|0|||
129807114|NCT03228433|467261074|FG002|Overall Study|Positive alcohol test|0|||
129807115|NCT03228433|467261075|FG003|Overall Study|Positive alcohol test|1|||
129807116|NCT03228433|467261076|FG004|Overall Study|Positive alcohol test|0|||
129807117|NCT03228433|467261077|FG005|Overall Study|Positive alcohol test|0|||
129807118|NCT01030536|467261078|FG000|Overall Study|Withdrawal by Subject|0|||
129807119|NCT01030536|467261079|FG001|Overall Study|Withdrawal by Subject|0|||
129894393|NCT01579578|467573397|FG001|Overall Study|Eligibility criteria|9|||
129894394|NCT01579578|467573396|FG000|Overall Study|Ongoing|3|||
129807120|NCT01030536|467261080|FG002|Overall Study|Withdrawal by Subject|1|||
129807121|NCT01030536|467261081|FG003|Overall Study|Withdrawal by Subject|0|||
129807122|NCT01030536|467261082|FG004|Overall Study|Withdrawal by Subject|0|||
129807123|NCT01030536|467261078|FG000|Overall Study|undefined|1|||
129807124|NCT01030536|467261079|FG001|Overall Study|undefined|0|||
129807125|NCT01030536|467261080|FG002|Overall Study|undefined|1|||
129807126|NCT01030536|467261081|FG003|Overall Study|undefined|1|||
129807127|NCT01030536|467261082|FG004|Overall Study|undefined|0|||
129807128|NCT01030536|467261078|FG000|Overall Study|Adverse Event|0|||
129807129|NCT01030536|467261079|FG001|Overall Study|Adverse Event|3|||
129807130|NCT01030536|467261080|FG002|Overall Study|Adverse Event|1|||
129807131|NCT01030536|467261081|FG003|Overall Study|Adverse Event|0|||
129807132|NCT01030536|467261082|FG004|Overall Study|Adverse Event|1|||
129807133|NCT01030536|467261078|FG000|Overall Study|Progressive disease|6|||
129807134|NCT01030536|467261079|FG001|Overall Study|Progressive disease|2|||
129807135|NCT01030536|467261080|FG002|Overall Study|Progressive disease|3|||
129807136|NCT01030536|467261081|FG003|Overall Study|Progressive disease|2|||
129807137|NCT01030536|467261082|FG004|Overall Study|Progressive disease|0|||
129807138|NCT01030536|467261078|FG000|Overall Study|Death|0|||
129807139|NCT01030536|467261079|FG001|Overall Study|Death|1|||
129807140|NCT01030536|467261080|FG002|Overall Study|Death|0|||
129807141|NCT01030536|467261081|FG003|Overall Study|Death|0|||
129807142|NCT01030536|467261082|FG004|Overall Study|Death|0|||
129807143|NCT01419626|467261087|FG000|Overall Study|Protocol Violation|3|||
129807144|NCT01419626|467261088|FG001|Overall Study|Protocol Violation|2|||
129807145|NCT01419626|467261089|FG002|Overall Study|Protocol Violation|2|||
129807146|NCT01419626|467261087|FG000|Overall Study|Withdrawal by Subject|1|||
129807147|NCT01419626|467261088|FG001|Overall Study|Withdrawal by Subject|0|||
129807148|NCT01419626|467261089|FG002|Overall Study|Withdrawal by Subject|0|||
129807149|NCT01419626|467261087|FG000|Overall Study|Lost to Follow-up|0|||
129807150|NCT01419626|467261088|FG001|Overall Study|Lost to Follow-up|1|||
129807151|NCT01419626|467261089|FG002|Overall Study|Lost to Follow-up|1|||
129807152|NCT01365052|467261090|FG000|Overall Study|Adverse Event|4|||
129807153|NCT01365052|467261091|FG001|Overall Study|Adverse Event|4|||
129807154|NCT01146912|467261092|FG000|Overall Study|Already received influenza vaccination|817|||
129807155|NCT01146912|467261093|FG001|Overall Study|Already received influenza vaccination|822|||
129807156|NCT01146912|467261094|FG002|Overall Study|Already received influenza vaccination|13|||
129807157|NCT01146912|467261095|FG003|Overall Study|Already received influenza vaccination|15|||
129807158|NCT01146912|467261096|FG004|Overall Study|Already received influenza vaccination|41|||
129807159|NCT01146912|467261097|FG005|Overall Study|Already received influenza vaccination|61|||
129807160|NCT01146912|467261098|FG006|Overall Study|Already received influenza vaccination|56|||
129807161|NCT01146912|467261099|FG007|Overall Study|Already received influenza vaccination|0|||
129807162|NCT01146912|467261092|FG000|Overall Study|< 14 weeks gestational age|0|||
129807163|NCT01146912|467261093|FG001|Overall Study|< 14 weeks gestational age|0|||
129807164|NCT01146912|467261094|FG002|Overall Study|< 14 weeks gestational age|3|||
129807165|NCT01146912|467261095|FG003|Overall Study|< 14 weeks gestational age|2|||
129807166|NCT01146912|467261096|FG004|Overall Study|< 14 weeks gestational age|0|||
129807167|NCT01146912|467261097|FG005|Overall Study|< 14 weeks gestational age|0|||
129807168|NCT01146912|467261098|FG006|Overall Study|< 14 weeks gestational age|0|||
129807169|NCT01146912|467261099|FG007|Overall Study|< 14 weeks gestational age|0|||
129807170|NCT01146912|467261092|FG000|Overall Study|Duplicate patient|0|||
129807171|NCT01146912|467261093|FG001|Overall Study|Duplicate patient|0|||
129807172|NCT01146912|467261094|FG002|Overall Study|Duplicate patient|1|||
129807173|NCT01146912|467261095|FG003|Overall Study|Duplicate patient|0|||
129807174|NCT01146912|467261096|FG004|Overall Study|Duplicate patient|0|||
129807175|NCT01146912|467261097|FG005|Overall Study|Duplicate patient|0|||
129807176|NCT01146912|467261098|FG006|Overall Study|Duplicate patient|0|||
129807177|NCT01146912|467261099|FG007|Overall Study|Duplicate patient|0|||
129807178|NCT01145625|467261102|FG000|Overall Study|Lost to Follow-up|8|||
129807179|NCT01145625|467261103|FG001|Overall Study|Lost to Follow-up|9|||
129807180|NCT01145625|467261102|FG000|Overall Study|Adverse Event|6|||
129807181|NCT01145625|467261103|FG001|Overall Study|Adverse Event|4|||
129807182|NCT01145625|467261102|FG000|Overall Study|Protocol Violation|3|||
129807183|NCT01145625|467261103|FG001|Overall Study|Protocol Violation|1|||
129807184|NCT01145625|467261102|FG000|Overall Study|Withdrawal by Subject|7|||
129807185|NCT01145625|467261103|FG001|Overall Study|Withdrawal by Subject|16|||
129807186|NCT01145625|467261102|FG000|Overall Study|Pregnancy|0|||
129807187|NCT01145625|467261103|FG001|Overall Study|Pregnancy|1|||
129807188|NCT02202980|467261104|FG000|Overall Study|Lack of Efficacy|1|||
129807189|NCT02202980|467261105|FG001|Overall Study|Lack of Efficacy|0|||
129807190|NCT02202980|467261106|FG002|Overall Study|Lack of Efficacy|7|||
129807191|NCT02202980|467261107|FG003|Overall Study|Lack of Efficacy|0|||
129807192|NCT02202980|467261108|FG004|Overall Study|Lack of Efficacy|3|||
129894395|NCT01579578|467573397|FG001|Overall Study|Ongoing|0|||
129894396|NCT01528709|467573398|FG000|Overall Study|Death|2|||
129894397|NCT01528709|467573399|FG001|Overall Study|Death|0|||
129807193|NCT02202980|467261109|FG005|Overall Study|Lack of Efficacy|1|||
129807194|NCT02202980|467261110|FG006|Overall Study|Lack of Efficacy|11|||
129807195|NCT02202980|467261111|FG007|Overall Study|Lack of Efficacy|2|||
129807196|NCT02202980|467261112|FG008|Overall Study|Lack of Efficacy|2|||
129807197|NCT02202980|467261113|FG009|Overall Study|Lack of Efficacy|0|||
129807198|NCT02202980|467261114|FG010|Overall Study|Lack of Efficacy|0|||
129894398|NCT01528709|467573398|FG000|Overall Study|Withdrawal by Subject|10|||
129807199|NCT02202980|467261115|FG011|Overall Study|Lack of Efficacy|3|||
129807200|NCT02202980|467261116|FG012|Overall Study|Lack of Efficacy|10|||
129807201|NCT02202980|467261117|FG013|Overall Study|Lack of Efficacy|0|||
129807202|NCT02202980|467261104|FG000|Overall Study|Protocol Violation|0|||
129807203|NCT02202980|467261105|FG001|Overall Study|Protocol Violation|0|||
129807204|NCT02202980|467261106|FG002|Overall Study|Protocol Violation|0|||
129807205|NCT02202980|467261107|FG003|Overall Study|Protocol Violation|3|||
129807206|NCT02202980|467261108|FG004|Overall Study|Protocol Violation|3|||
129807207|NCT02202980|467261109|FG005|Overall Study|Protocol Violation|0|||
129807208|NCT02202980|467261110|FG006|Overall Study|Protocol Violation|0|||
129807209|NCT02202980|467261111|FG007|Overall Study|Protocol Violation|0|||
129807210|NCT02202980|467261112|FG008|Overall Study|Protocol Violation|0|||
129807211|NCT02202980|467261113|FG009|Overall Study|Protocol Violation|0|||
129739960|NCT02648217|467008051|FG001|Overall Study|Adverse Event|1|||
129739961|NCT02648217|467008050|FG000|Overall Study|Lost to Follow-up|1|||
129739962|NCT02648217|467008051|FG001|Overall Study|Lost to Follow-up|1|||
129739963|NCT02648217|467008050|FG000|Overall Study|Withdrawal by Subject|4|||
129739964|NCT02648217|467008051|FG001|Overall Study|Withdrawal by Subject|3|||
129739965|NCT02648217|467008050|FG000|Overall Study|Unclassified|5|||
129739966|NCT02648217|467008051|FG001|Overall Study|Unclassified|0|||
129739967|NCT03316950|467008052|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
129739968|NCT03316950|467008053|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
129739969|NCT03316950|467008054|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
129739970|NCT03316950|467008055|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
129739971|NCT03316950|467008052|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
129739972|NCT03316950|467008053|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
129739973|NCT03316950|467008054|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
129739974|NCT03316950|467008055|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
129739975|NCT03316950|467008052|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
129739976|NCT03316950|467008053|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
129739977|NCT03316950|467008054|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
129739978|NCT03316950|467008055|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
129739979|NCT02335424|467008056|FG000|Overall Study|Withdrawal by Subject|19|||
129739980|NCT02335424|467008056|FG000|Overall Study|Adverse Event|25|||
129739981|NCT02335424|467008056|FG000|Overall Study|Death|273|||
129739982|NCT02335424|467008056|FG000|Overall Study|Lost to Follow-up|3|||
129739983|NCT02335424|467008056|FG000|Overall Study|Physician Decision|13|||
129739984|NCT02335424|467008056|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
129739985|NCT02335424|467008056|FG000|Overall Study|Protocol Violation|1|||
129739986|NCT02335424|467008056|FG000|Overall Study|Screen failure|1|||
129739987|NCT02776033|467008059|FG000|Overall Study|Withdrawal by Subject|0|||
129739988|NCT02776033|467008060|FG001|Overall Study|Withdrawal by Subject|0|||
129739989|NCT02776033|467008061|FG002|Overall Study|Withdrawal by Subject|2|||
129739990|NCT02776033|467008059|FG000|Overall Study|Physician Decision|2|||
129739991|NCT02776033|467008060|FG001|Overall Study|Physician Decision|0|||
129739992|NCT02776033|467008061|FG002|Overall Study|Physician Decision|0|||
129739993|NCT02776033|467008059|FG000|Overall Study|Lost to Follow-up|1|||
129739994|NCT02776033|467008060|FG001|Overall Study|Lost to Follow-up|0|||
129739995|NCT02776033|467008061|FG002|Overall Study|Lost to Follow-up|0|||
129739996|NCT02776033|467008059|FG000|Overall Study|Adverse Event|1|||
129739997|NCT02776033|467008060|FG001|Overall Study|Adverse Event|2|||
129739998|NCT02776033|467008061|FG002|Overall Study|Adverse Event|0|||
129739999|NCT02712424|467008062|FG000|Overall Study|Lost to Follow-up|34|||
129740000|NCT02712424|467008063|FG001|Overall Study|Lost to Follow-up|32|||
129740001|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
129740002|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
129740003|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
129740004|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
129740005|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
129807212|NCT02202980|467261114|FG010|Overall Study|Protocol Violation|0|||
129807213|NCT02202980|467261115|FG011|Overall Study|Protocol Violation|0|||
129807214|NCT02202980|467261116|FG012|Overall Study|Protocol Violation|0|||
129807215|NCT02202980|467261117|FG013|Overall Study|Protocol Violation|0|||
129807216|NCT02202980|467261104|FG000|Overall Study|Lost to Follow-up|0|||
129807217|NCT02202980|467261105|FG001|Overall Study|Lost to Follow-up|1|||
129807218|NCT02202980|467261106|FG002|Overall Study|Lost to Follow-up|1|||
129807219|NCT02202980|467261107|FG003|Overall Study|Lost to Follow-up|1|||
129807220|NCT02202980|467261108|FG004|Overall Study|Lost to Follow-up|0|||
129807221|NCT02202980|467261109|FG005|Overall Study|Lost to Follow-up|0|||
129807222|NCT02202980|467261110|FG006|Overall Study|Lost to Follow-up|0|||
129807223|NCT02202980|467261111|FG007|Overall Study|Lost to Follow-up|1|||
129807224|NCT02202980|467261112|FG008|Overall Study|Lost to Follow-up|1|||
129807225|NCT02202980|467261113|FG009|Overall Study|Lost to Follow-up|0|||
129807226|NCT02202980|467261114|FG010|Overall Study|Lost to Follow-up|0|||
129807227|NCT02202980|467261115|FG011|Overall Study|Lost to Follow-up|0|||
129807228|NCT02202980|467261116|FG012|Overall Study|Lost to Follow-up|1|||
129807229|NCT02202980|467261117|FG013|Overall Study|Lost to Follow-up|0|||
129807230|NCT02202980|467261104|FG000|Overall Study|Withdrew Consent|0|||
129807231|NCT02202980|467261105|FG001|Overall Study|Withdrew Consent|1|||
129807232|NCT02202980|467261106|FG002|Overall Study|Withdrew Consent|2|||
129807233|NCT02202980|467261107|FG003|Overall Study|Withdrew Consent|0|||
129807234|NCT02202980|467261108|FG004|Overall Study|Withdrew Consent|0|||
129807235|NCT02202980|467261109|FG005|Overall Study|Withdrew Consent|0|||
129807236|NCT02202980|467261110|FG006|Overall Study|Withdrew Consent|0|||
129740006|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
129740007|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
129807237|NCT02202980|467261111|FG007|Overall Study|Withdrew Consent|0|||
129807238|NCT02202980|467261112|FG008|Overall Study|Withdrew Consent|1|||
129807239|NCT02202980|467261113|FG009|Overall Study|Withdrew Consent|0|||
129894399|NCT01528709|467573399|FG001|Overall Study|Withdrawal by Subject|15|||
129894400|NCT01528709|467573398|FG000|Overall Study|allergy|1|||
129894401|NCT01528709|467573399|FG001|Overall Study|allergy|0|||
129894402|NCT05124899|467573403|FG000|Overall Study|Lost to Follow-up|3|||
129894403|NCT00647348|467573411|FG000|Overall Study|Lost to Follow-up|3|||
129894404|NCT00647348|467573412|FG001|Overall Study|Lost to Follow-up|6|||
129894405|NCT01417000|467573413|FG000|Overall Study|Death|59|||
129894406|NCT01417000|467573414|FG001|Overall Study|Death|28|||
129894407|NCT01417000|467573413|FG000|Overall Study|Lost to Follow-up|1|||
129894408|NCT01417000|467573414|FG001|Overall Study|Lost to Follow-up|0|||
129894409|NCT01417000|467573413|FG000|Overall Study|Study Terminated by Sponsor|1|||
129894410|NCT01417000|467573414|FG001|Overall Study|Study Terminated by Sponsor|1|||
129894411|NCT02397889|467573423|FG000|Overall Study|Physician Decision|1|||
129894412|NCT02397889|467573424|FG001|Overall Study|Physician Decision|0|||
129894413|NCT00797225|467573436|FG000|Weeks 1 to 12|Adverse Event|0|||
129807240|NCT02202980|467261114|FG010|Overall Study|Withdrew Consent|0|||
129807241|NCT02202980|467261115|FG011|Overall Study|Withdrew Consent|0|||
129807242|NCT02202980|467261116|FG012|Overall Study|Withdrew Consent|0|||
129807243|NCT02202980|467261117|FG013|Overall Study|Withdrew Consent|0|||
129807244|NCT02130570|467261121|FG000|Overall Study|Death|3|||
129807245|NCT02130570|467261122|FG001|Overall Study|Death|5|||
129740008|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
129807246|NCT02130570|467261121|FG000|Overall Study|Withdrawal by Subject|6|||
129807247|NCT02130570|467261122|FG001|Overall Study|Withdrawal by Subject|3|||
129807248|NCT02130570|467261121|FG000|Overall Study|Part of practice that discontinued study|0|||
129807249|NCT02130570|467261122|FG001|Overall Study|Part of practice that discontinued study|5|||
129807250|NCT01696695|467261125|FG000|Overall Study|Disease progression|373|||
129807251|NCT01696695|467261125|FG000|Overall Study|Death|29|||
129807252|NCT01696695|467261125|FG000|Overall Study|Adverse Event|74|||
129807253|NCT01696695|467261125|FG000|Overall Study|Withdrawal by Subject|92|||
129807254|NCT01696695|467261125|FG000|Overall Study|Lost to Follow-up|48|||
129807255|NCT01696695|467261125|FG000|Overall Study|Other|74|||
129807256|NCT01696695|467261125|FG000|Overall Study|Major Protocol Violation|192|||
129807257|NCT01180647|467261128|FG000|Overall Study|Lost to Follow-up|5|||
129807258|NCT01180647|467261129|FG001|Overall Study|Lost to Follow-up|6|||
129807259|NCT00386607|467261130|FG000|Core|Adverse Event|40|||
129807260|NCT00386607|467261131|FG001|Core|Adverse Event|0|||
129807261|NCT00386607|467261130|FG000|Core|Abnormal laboratory value(s)|3|||
129807262|NCT00386607|467261131|FG001|Core|Abnormal laboratory value(s)|0|||
129807263|NCT00386607|467261130|FG000|Core|Unsatisfactory therapeutic effect|23|||
129807264|NCT00386607|467261131|FG001|Core|Unsatisfactory therapeutic effect|0|||
129807265|NCT00386607|467261130|FG000|Core|Condition no longer requires study drug|4|||
129807266|NCT00386607|467261131|FG001|Core|Condition no longer requires study drug|0|||
129807267|NCT00386607|467261130|FG000|Core|Patient withdrew consent|15|||
129807268|NCT00386607|467261131|FG001|Core|Patient withdrew consent|0|||
129807269|NCT00386607|467261130|FG000|Core|Lost to Follow-up|23|||
129894414|NCT00797225|467573437|FG001|Weeks 1 to 12|Adverse Event|0|||
129894415|NCT00797225|467573438|FG002|Weeks 1 to 12|Adverse Event|1|||
129894416|NCT00797225|467573439|FG003|Weeks 1 to 12|Adverse Event|0|||
129894417|NCT00797225|467573440|FG004|Weeks 1 to 12|Adverse Event|0|||
129740009|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
129740010|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
129740011|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
129740012|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
129740013|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
129740014|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
129740015|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
129740016|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
129740017|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
129740018|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
129740019|NCT01302054|467008069|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
129807270|NCT00386607|467261131|FG001|Core|Lost to Follow-up|0|||
129807271|NCT00386607|467261130|FG000|Core|Administrative problems|1|||
129807272|NCT00386607|467261131|FG001|Core|Administrative problems|0|||
129807273|NCT00386607|467261130|FG000|Core|Protocol Deviation|6|||
129807274|NCT00386607|467261131|FG001|Core|Protocol Deviation|0|||
129807275|NCT00386607|467261130|FG000|Extension|Adverse Event|0|||
129894418|NCT00797225|467573441|FG005|Weeks 1 to 12|Adverse Event|0|||
129894419|NCT00797225|467573442|FG006|Weeks 1 to 12|Adverse Event|0|||
129894420|NCT00797225|467573443|FG007|Weeks 1 to 12|Adverse Event|0|||
129894421|NCT00797225|467573436|FG000|Weeks 1 to 12|Non-compliance|0|||
129807276|NCT00386607|467261131|FG001|Extension|Adverse Event|6|||
129894422|NCT00797225|467573437|FG001|Weeks 1 to 12|Non-compliance|1|||
129807277|NCT00386607|467261130|FG000|Extension|Abnormal laboratory value(s)|0|||
129807278|NCT00386607|467261131|FG001|Extension|Abnormal laboratory value(s)|1|||
129807279|NCT00386607|467261130|FG000|Extension|Administrative problems|0|||
129894423|NCT00797225|467573438|FG002|Weeks 1 to 12|Non-compliance|0|||
129894424|NCT00797225|467573439|FG003|Weeks 1 to 12|Non-compliance|0|||
129894425|NCT00797225|467573440|FG004|Weeks 1 to 12|Non-compliance|0|||
129894426|NCT00797225|467573441|FG005|Weeks 1 to 12|Non-compliance|0|||
129894427|NCT00797225|467573442|FG006|Weeks 1 to 12|Non-compliance|0|||
129894428|NCT00797225|467573443|FG007|Weeks 1 to 12|Non-compliance|0|||
129894429|NCT00797225|467573436|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
129894430|NCT00797225|467573437|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
129894431|NCT00797225|467573438|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
129894432|NCT00797225|467573439|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
129894433|NCT00797225|467573440|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
129894434|NCT00797225|467573441|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
129894435|NCT00797225|467573442|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
129894436|NCT00797225|467573443|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
129894437|NCT00797225|467573436|FG000|Weeks 1 to 12|Sponsor Decision|1|||
129894438|NCT00797225|467573437|FG001|Weeks 1 to 12|Sponsor Decision|0|||
129894439|NCT00797225|467573438|FG002|Weeks 1 to 12|Sponsor Decision|0|||
129894440|NCT00797225|467573439|FG003|Weeks 1 to 12|Sponsor Decision|0|||
129894441|NCT00797225|467573440|FG004|Weeks 1 to 12|Sponsor Decision|0|||
129894442|NCT00797225|467573441|FG005|Weeks 1 to 12|Sponsor Decision|0|||
129894443|NCT00797225|467573442|FG006|Weeks 1 to 12|Sponsor Decision|0|||
129894444|NCT00797225|467573443|FG007|Weeks 1 to 12|Sponsor Decision|0|||
129894445|NCT00797225|467573436|FG000|Weeks 13 to 24|Non-compliance|0|||
129894446|NCT00797225|467573437|FG001|Weeks 13 to 24|Non-compliance|2|||
129894447|NCT00797225|467573438|FG002|Weeks 13 to 24|Non-compliance|0|||
129894448|NCT00797225|467573439|FG003|Weeks 13 to 24|Non-compliance|0|||
129894449|NCT00797225|467573440|FG004|Weeks 13 to 24|Non-compliance|0|||
129894450|NCT00797225|467573441|FG005|Weeks 13 to 24|Non-compliance|0|||
129894451|NCT00797225|467573442|FG006|Weeks 13 to 24|Non-compliance|0|||
129894452|NCT00797225|467573443|FG007|Weeks 13 to 24|Non-compliance|0|||
129740020|NCT01302054|467008070|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
129740021|NCT01302054|467008071|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
129740022|NCT01302054|467008069|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
129740023|NCT01302054|467008070|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
129740024|NCT01302054|467008071|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
129740025|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129740026|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
129740027|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
129740028|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129740029|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
129740030|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129740031|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129740032|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
129740033|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
129740034|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
129740035|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
129740036|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
129894453|NCT00797225|467573436|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
129894454|NCT00797225|467573437|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
129894455|NCT00797225|467573438|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
129894456|NCT00797225|467573439|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
129894457|NCT00797225|467573440|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
129894458|NCT00797225|467573441|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
129894459|NCT00797225|467573442|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
129894460|NCT00797225|467573443|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
129894461|NCT00797225|467573436|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
129894462|NCT00797225|467573437|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
129894463|NCT00797225|467573438|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
129894464|NCT00797225|467573439|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
129894465|NCT00797225|467573440|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
129894466|NCT00797225|467573441|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
129894467|NCT00797225|467573442|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
129894468|NCT00797225|467573443|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
129894469|NCT00797225|467573436|FG000|Weeks 13 to 24|Adverse Event|0|||
129894470|NCT00797225|467573437|FG001|Weeks 13 to 24|Adverse Event|1|||
129894471|NCT00797225|467573438|FG002|Weeks 13 to 24|Adverse Event|0|||
129894472|NCT00797225|467573439|FG003|Weeks 13 to 24|Adverse Event|0|||
129894473|NCT00797225|467573440|FG004|Weeks 13 to 24|Adverse Event|0|||
129894474|NCT00797225|467573441|FG005|Weeks 13 to 24|Adverse Event|0|||
129894475|NCT00797225|467573442|FG006|Weeks 13 to 24|Adverse Event|1|||
129894476|NCT00797225|467573443|FG007|Weeks 13 to 24|Adverse Event|0|||
129894477|NCT00797225|467573436|FG000|Weeks 13 to 24|Sponsor Decision|0|||
129894478|NCT00797225|467573437|FG001|Weeks 13 to 24|Sponsor Decision|0|||
129740037|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129894479|NCT00797225|467573438|FG002|Weeks 13 to 24|Sponsor Decision|0|||
129894480|NCT00797225|467573439|FG003|Weeks 13 to 24|Sponsor Decision|0|||
129894481|NCT00797225|467573440|FG004|Weeks 13 to 24|Sponsor Decision|0|||
129894482|NCT00797225|467573441|FG005|Weeks 13 to 24|Sponsor Decision|0|||
129894483|NCT00797225|467573442|FG006|Weeks 13 to 24|Sponsor Decision|1|||
129740038|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
129740039|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
129740040|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
129740041|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
129740042|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
129740043|NCT01302054|467008069|FG000|Double-Blind Treatment Phase|Other|0|||
129740044|NCT01302054|467008070|FG001|Double-Blind Treatment Phase|Other|4|||
129740045|NCT01302054|467008071|FG002|Double-Blind Treatment Phase|Other|9|||
129740046|NCT02713867|467008072|FG000|Randomization|Other Reason|2|||
129740047|NCT02713867|467008073|FG001|Randomization|Other Reason|1|||
129740048|NCT02713867|467008072|FG000|Randomization|Participant Withdrew consent|0|||
129740049|NCT02713867|467008073|FG001|Randomization|Participant Withdrew consent|2|||
129740050|NCT02713867|467008072|FG000|Treatment Period|Other Reasons|22|||
129740051|NCT02713867|467008073|FG001|Treatment Period|Other Reasons|28|||
129740052|NCT02713867|467008072|FG000|Treatment Period|Administrative reason by sponsor|21|||
129740053|NCT02713867|467008073|FG001|Treatment Period|Administrative reason by sponsor|16|||
129740054|NCT02713867|467008072|FG000|Treatment Period|No longer meets study criteria|2|||
129740055|NCT02713867|467008073|FG001|Treatment Period|No longer meets study criteria|1|||
129740056|NCT02713867|467008072|FG000|Treatment Period|Poor/Non Compliance|1|||
129740057|NCT02713867|467008073|FG001|Treatment Period|Poor/Non Compliance|0|||
129740058|NCT02713867|467008072|FG000|Treatment Period|Maximum Clinical Benefit|5|||
129740059|NCT02713867|467008073|FG001|Treatment Period|Maximum Clinical Benefit|6|||
129740060|NCT02713867|467008072|FG000|Treatment Period|Withdrew consent|3|||
129740061|NCT02713867|467008073|FG001|Treatment Period|Withdrew consent|6|||
129740062|NCT02713867|467008072|FG000|Treatment Period|Requested to Discontinue|8|||
129740063|NCT02713867|467008073|FG001|Treatment Period|Requested to Discontinue|8|||
129740064|NCT02713867|467008072|FG000|Treatment Period|AE unrelated to Study Drug|11|||
129740065|NCT02713867|467008073|FG001|Treatment Period|AE unrelated to Study Drug|10|||
129740066|NCT02713867|467008072|FG000|Treatment Period|Death|7|||
129740067|NCT02713867|467008073|FG001|Treatment Period|Death|3|||
129740068|NCT02713867|467008072|FG000|Treatment Period|Study Drug Toxicity|16|||
129740069|NCT02713867|467008073|FG001|Treatment Period|Study Drug Toxicity|19|||
129740070|NCT02713867|467008072|FG000|Treatment Period|Disease Progression|82|||
129740071|NCT02713867|467008073|FG001|Treatment Period|Disease Progression|83|||
129740072|NCT02715726|467008077|FG000|Overall Study|Adverse Event|2|||
129740073|NCT02715726|467008078|FG001|Overall Study|Adverse Event|6|||
129740074|NCT02715726|467008077|FG000|Overall Study|Protocol Violation|1|||
129740075|NCT02715726|467008078|FG001|Overall Study|Protocol Violation|0|||
129740076|NCT02715726|467008077|FG000|Overall Study|Death|2|||
129740077|NCT02715726|467008078|FG001|Overall Study|Death|1|||
129740078|NCT02715726|467008077|FG000|Overall Study|Participant moved|1|||
129740079|NCT02715726|467008078|FG001|Overall Study|Participant moved|3|||
129740080|NCT02715726|467008077|FG000|Overall Study|Other than specified above|11|||
129740081|NCT02715726|467008078|FG001|Overall Study|Other than specified above|15|||
129740082|NCT02715726|467008077|FG000|Overall Study|Randomized but not treated|1|||
129740083|NCT02715726|467008078|FG001|Overall Study|Randomized but not treated|2|||
129740084|NCT01177969|467008079|FG000|Overall Study|Protocol Violation|2|||
129740085|NCT01177969|467008080|FG001|Overall Study|Protocol Violation|1|||
129740086|NCT01177969|467008079|FG000|Overall Study|Withdrawal by Subject|1|||
129740087|NCT01177969|467008080|FG001|Overall Study|Withdrawal by Subject|2|||
129740088|NCT03230292|467008081|FG000|Overall Study|Adverse Event|1|||
129740089|NCT03230292|467008081|FG000|Overall Study|Protocol Violation|1|||
129740090|NCT03230292|467008081|FG000|Overall Study|Lost to Follow-up|1|||
129740091|NCT03230292|467008081|FG000|Overall Study|Withdrawal by Subject|3|||
129740092|NCT00635089|467008083|FG000|Overall Study|Adverse Event|7|||
129740093|NCT00635089|467008083|FG000|Overall Study|Lack of Efficacy|28|||
129740094|NCT00635089|467008083|FG000|Overall Study|Protocol Deviation|4|||
129740095|NCT00635089|467008083|FG000|Overall Study|Lost to Follow-up|8|||
129740096|NCT00635089|467008083|FG000|Overall Study|Other|31|||
129740097|NCT02565810|467008084|FG000|Overall Study|Withdrawal by Subject|1|||
129740098|NCT04109976|467008087|FG000|Overall Study|Withdrawal by Subject|1|||
129740099|NCT04109976|467008088|FG001|Overall Study|Withdrawal by Subject|0|||
129740100|NCT00491608|467008089|FG000|Overall Study|Death|2|||
129740101|NCT00491608|467008089|FG000|Overall Study|Withdrawal by Subject|1|||
129740102|NCT00413374|467008090|FG000|Overall Study|Ineligible due to screening criteria.|3|||
129740103|NCT00413374|467008091|FG001|Overall Study|Ineligible due to screening criteria.|0|||
129740104|NCT00413374|467008090|FG000|Overall Study|Adverse Event|1|||
129740105|NCT00413374|467008091|FG001|Overall Study|Adverse Event|0|||
129740106|NCT00413374|467008090|FG000|Overall Study|Lost to Follow-up|1|||
129740107|NCT00413374|467008091|FG001|Overall Study|Lost to Follow-up|0|||
129740108|NCT00413374|467008090|FG000|Overall Study|Surgery|1|||
129740109|NCT00413374|467008091|FG001|Overall Study|Surgery|0|||
129740110|NCT02613169|467008093|FG000|Overall Study|Withdrawal by Subject|4|||
129740111|NCT02613169|467008094|FG001|Overall Study|Withdrawal by Subject|1|||
129740112|NCT02613169|467008093|FG000|Overall Study|Lost to Follow-up|0|||
129740113|NCT02613169|467008094|FG001|Overall Study|Lost to Follow-up|5|||
129740114|NCT02613169|467008093|FG000|Overall Study|HIV|0|||
129807280|NCT00386607|467261131|FG001|Extension|Administrative problems|1|||
129807281|NCT00386607|467261130|FG000|Extension|Lost to Follow-up|0|||
129807282|NCT00386607|467261131|FG001|Extension|Lost to Follow-up|3|||
129807283|NCT00386607|467261130|FG000|Extension|Patient withdrew consent|0|||
129807284|NCT00386607|467261131|FG001|Extension|Patient withdrew consent|5|||
129740115|NCT02613169|467008094|FG001|Overall Study|HIV|2|||
129740116|NCT02613169|467008093|FG000|Overall Study|No TB infection endpoint|14|||
129807285|NCT00386607|467261130|FG000|Extension|Unsatisfactory therapeutic effect|0|||
129807286|NCT00386607|467261131|FG001|Extension|Unsatisfactory therapeutic effect|1|||
129807287|NCT01927627|467261133|FG000|Overall Study|Adverse Event|3|||
129807288|NCT01927627|467261133|FG000|Overall Study|Lack of Efficacy|1|||
129807289|NCT01927627|467261133|FG000|Overall Study|Financial Concerns|1|||
129807290|NCT00467857|467261134|FG000|Overall Study|Adverse Event|1|||
129740117|NCT02613169|467008094|FG001|Overall Study|No TB infection endpoint|9|||
129740118|NCT00343382|467008095|FG000|Overall Study|Adverse Event|2|||
129740119|NCT00343382|467008096|FG001|Overall Study|Adverse Event|10|||
129740120|NCT00343382|467008097|FG002|Overall Study|Adverse Event|7|||
129740121|NCT00343382|467008095|FG000|Overall Study|Withdrawal by Subject|1|||
129740122|NCT00343382|467008096|FG001|Overall Study|Withdrawal by Subject|2|||
129740123|NCT00343382|467008097|FG002|Overall Study|Withdrawal by Subject|6|||
129740124|NCT00343382|467008095|FG000|Overall Study|Other Reason Not Specified|1|||
129740125|NCT00343382|467008096|FG001|Overall Study|Other Reason Not Specified|2|||
129740126|NCT00343382|467008097|FG002|Overall Study|Other Reason Not Specified|4|||
129740127|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
129740128|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
129740129|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
129740130|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
129740131|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
129740132|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
129740133|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129740134|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129740135|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129740136|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129740137|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
129740138|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
129740139|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
129740140|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
129740141|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129740142|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
129740143|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
129740144|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129740145|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129740146|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129740147|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129740148|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
129740149|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129740150|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
129740151|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
129740152|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
129740153|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
129740154|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
129740155|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129740156|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129740157|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129740158|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129740159|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
129740160|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
129740161|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
129740162|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
129740163|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129740164|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
129807291|NCT00467857|467261135|FG001|Overall Study|Adverse Event|0|||
129807292|NCT00467857|467261134|FG000|Overall Study|Withdrew consent|2|||
129807293|NCT00467857|467261135|FG001|Overall Study|Withdrew consent|0|||
129807294|NCT00467857|467261134|FG000|Overall Study|Death|0|||
129807295|NCT00467857|467261135|FG001|Overall Study|Death|1|||
129807296|NCT00467857|467261134|FG000|Overall Study|Discharged from court service|0|||
129807297|NCT00467857|467261135|FG001|Overall Study|Discharged from court service|1|||
129807298|NCT00467857|467261134|FG000|Overall Study|Emergency care required|0|||
129807299|NCT00467857|467261135|FG001|Overall Study|Emergency care required|1|||
129807300|NCT00467857|467261134|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
129740165|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
129740166|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129740167|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129740168|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129740169|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129740170|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
129740171|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740172|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740173|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
129740174|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740175|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740176|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
129740177|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740178|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740179|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740180|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740181|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
129740182|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
129740183|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740184|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740185|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740186|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740187|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740188|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740189|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740190|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740191|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740192|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
129740193|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740194|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740195|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
129740196|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740197|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740198|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740199|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740200|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740201|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740202|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740203|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
129740204|NCT02914561|467008102|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
129740205|NCT02914561|467008103|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129740206|NCT02914561|467008104|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129740207|NCT02914561|467008105|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129740208|NCT02914561|467008106|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129740209|NCT02914561|467008107|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
129740210|NCT02914561|467008108|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129740211|NCT02914561|467008109|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129740212|NCT02914561|467008110|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129740213|NCT02914561|467008111|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129740214|NCT02914561|467008112|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
129740215|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129740216|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129740217|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129807301|NCT00467857|467261135|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
129807302|NCT00467857|467261134|FG000|Overall Study|Discontinuation reason missing|0|||
129807303|NCT00467857|467261135|FG001|Overall Study|Discontinuation reason missing|3|||
129807304|NCT03208127|467261138|FG000|Overall Study|Death|1|||
129807305|NCT00579098|467261139|FG000|Overall Study|Lost to Follow-up|2|||
129807306|NCT00579098|467261140|FG001|Overall Study|Lost to Follow-up|0|||
129807307|NCT00579098|467261139|FG000|Overall Study|Adverse Event|2|||
129807308|NCT00579098|467261140|FG001|Overall Study|Adverse Event|3|||
129807309|NCT00579098|467261139|FG000|Overall Study|Withdrawal by Subject|2|||
129807310|NCT00579098|467261140|FG001|Overall Study|Withdrawal by Subject|3|||
129807311|NCT00579098|467261139|FG000|Overall Study|AF returned after ablation|3|||
129807312|NCT00579098|467261140|FG001|Overall Study|AF returned after ablation|2|||
129807313|NCT02121522|467261145|FG000|Overall Study|Adverse Event|1|||
129894484|NCT00797225|467573443|FG007|Weeks 13 to 24|Sponsor Decision|0|||
129894485|NCT01928940|467573444|FG000|Overall Study|Adverse Event|0|||
129894486|NCT01928940|467573445|FG001|Overall Study|Adverse Event|1|||
129894487|NCT02954055|467573446|FG000|Overall Study|Did not initiate therapy|6|||
129894488|NCT02954055|467573447|FG001|Overall Study|Did not initiate therapy|1|||
129894489|NCT01352507|467573452|FG000|Treatment Period 1|Adverse Event|3|||
129894490|NCT01352507|467573453|FG001|Treatment Period 1|Adverse Event|0|||
129894491|NCT01352507|467573452|FG000|Treatment Period 1|Lost to Follow-up|3|||
129894492|NCT01352507|467573453|FG001|Treatment Period 1|Lost to Follow-up|4|||
129894493|NCT01352507|467573452|FG000|Treatment Period 1|Withdrawal by Subject|7|||
129894494|NCT01352507|467573453|FG001|Treatment Period 1|Withdrawal by Subject|5|||
129894495|NCT01352507|467573452|FG000|Treatment Period 1|Physician Decision|1|||
129894496|NCT01352507|467573453|FG001|Treatment Period 1|Physician Decision|0|||
129894497|NCT01352507|467573452|FG000|Washout Period|Withdrawal by Subject|0|||
129894498|NCT01352507|467573453|FG001|Washout Period|Withdrawal by Subject|1|||
129894499|NCT01352507|467573452|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
129894500|NCT01352507|467573453|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
129894501|NCT01352507|467573452|FG000|Treatment Period 2|Withdrawal by Subject|4|||
129894502|NCT01352507|467573453|FG001|Treatment Period 2|Withdrawal by Subject|3|||
129894503|NCT01352507|467573452|FG000|Treatment Period 2|Lack of Efficacy|1|||
129894504|NCT01352507|467573453|FG001|Treatment Period 2|Lack of Efficacy|0|||
129894505|NCT03686384|467573454|FG000|Overall Study|Lack of Efficacy|4|||
129740218|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129740219|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129740220|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
129740221|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
129740222|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
129740223|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
129740224|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
129740225|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
129740226|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129740227|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129740228|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129740229|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129740230|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129740231|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
129740232|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
129740233|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
129740234|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
129740235|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
129740236|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
129740237|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129740238|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129740239|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129740240|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129740241|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129740242|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
129740243|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
129740244|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
129740245|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
129740246|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
129740247|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
129740248|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740249|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740250|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740251|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740252|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740253|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740254|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
129740255|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740256|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
129740257|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
129740258|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
129740259|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129740260|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129894506|NCT03686384|467573455|FG001|Overall Study|Lack of Efficacy|13|||
129894507|NCT03686384|467573454|FG000|Overall Study|Lost to Follow-up|3|||
129894508|NCT03686384|467573455|FG001|Overall Study|Lost to Follow-up|0|||
129894509|NCT03686384|467573454|FG000|Overall Study|Physician Decision|0|||
129894510|NCT03686384|467573455|FG001|Overall Study|Physician Decision|1|||
129894511|NCT03686384|467573454|FG000|Overall Study|Took prohibited medication|0|||
129894512|NCT03686384|467573455|FG001|Overall Study|Took prohibited medication|1|||
129894513|NCT02820051|467573458|FG000|Overall Study|Lost to Follow-up|7|||
129894514|NCT02820051|467573459|FG001|Overall Study|Lost to Follow-up|4|||
129894515|NCT01222247|467573460|FG000|Overall Study|Lost to Follow-up|2|||
129894516|NCT01222247|467573461|FG001|Overall Study|Lost to Follow-up|2|||
129894517|NCT01767909|467573462|FG000|Overall Study|Withdrawal by Subject|4|||
129894518|NCT01767909|467573463|FG001|Overall Study|Withdrawal by Subject|7|||
129894519|NCT01767909|467573462|FG000|Overall Study|Adverse Event|3|||
129894520|NCT01767909|467573463|FG001|Overall Study|Adverse Event|1|||
129894521|NCT01767909|467573462|FG000|Overall Study|Withdrawal by Study Partner|3|||
129894522|NCT01767909|467573463|FG001|Overall Study|Withdrawal by Study Partner|1|||
129894523|NCT01767909|467573462|FG000|Overall Study|Non-Compliance|2|||
129894524|NCT01767909|467573463|FG001|Overall Study|Non-Compliance|0|||
129894525|NCT01767909|467573462|FG000|Overall Study|Perceived Lack of Efficacy|1|||
129894526|NCT01767909|467573463|FG001|Overall Study|Perceived Lack of Efficacy|0|||
129894527|NCT01767909|467573462|FG000|Overall Study|Investigator Recommendation|0|||
129894528|NCT01767909|467573463|FG001|Overall Study|Investigator Recommendation|1|||
129894529|NCT01767909|467573462|FG000|Overall Study|Lost to Follow-up|0|||
129894530|NCT01767909|467573463|FG001|Overall Study|Lost to Follow-up|1|||
129894531|NCT01767909|467573462|FG000|Overall Study|LP uncessessful|0|||
129894532|NCT01767909|467573463|FG001|Overall Study|LP uncessessful|1|||
129894533|NCT04939428|467573464|FG000|Overall Study|Death|0|||
129894534|NCT04939428|467573465|FG001|Overall Study|Death|1|||
129894535|NCT04939428|467573466|FG002|Overall Study|Death|0|||
129894536|NCT04939428|467573464|FG000|Overall Study|Lost to Follow-up|0|||
129894537|NCT04939428|467573465|FG001|Overall Study|Lost to Follow-up|5|||
129894538|NCT04939428|467573466|FG002|Overall Study|Lost to Follow-up|0|||
129894539|NCT04939428|467573464|FG000|Overall Study|Physician Decision|1|||
129894540|NCT04939428|467573465|FG001|Overall Study|Physician Decision|0|||
129894541|NCT04939428|467573466|FG002|Overall Study|Physician Decision|0|||
129894542|NCT04939428|467573464|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129894543|NCT04939428|467573465|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129894544|NCT04939428|467573466|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129894545|NCT04939428|467573464|FG000|Overall Study|Withdrawal by Subject|10|||
129894546|NCT04939428|467573465|FG001|Overall Study|Withdrawal by Subject|11|||
129894547|NCT04939428|467573466|FG002|Overall Study|Withdrawal by Subject|0|||
129894548|NCT04939428|467573464|FG000|Overall Study|Unkown|6|||
129894549|NCT04939428|467573465|FG001|Overall Study|Unkown|3|||
129894550|NCT04939428|467573466|FG002|Overall Study|Unkown|0|||
129894551|NCT04939428|467573464|FG000|Overall Study|Discotinued per protocol|0|||
129894552|NCT04939428|467573465|FG001|Overall Study|Discotinued per protocol|0|||
129894553|NCT04939428|467573466|FG002|Overall Study|Discotinued per protocol|902|||
129894554|NCT04956692|467573469|FG000|Overall Study|Death|115|||
129894555|NCT04956692|467573470|FG001|Overall Study|Death|47|||
129894556|NCT04956692|467573469|FG000|Overall Study|Lost to Follow-up|0|||
129894557|NCT04956692|467573470|FG001|Overall Study|Lost to Follow-up|1|||
129894558|NCT04956692|467573469|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129894559|NCT04956692|467573470|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129894560|NCT04956692|467573469|FG000|Overall Study|Withdrawal by Subject|5|||
129894561|NCT04956692|467573470|FG001|Overall Study|Withdrawal by Subject|2|||
129894562|NCT04956692|467573469|FG000|Overall Study|Ongoing in Study|236|||
129894563|NCT04956692|467573470|FG001|Overall Study|Ongoing in Study|123|||
129894564|NCT04639947|467573471|FG000|Overall Study|Screen fail|1|||
129894565|NCT04863898|467573474|FG000|Overall Study|Away from study clinic during intervention training period|2|||
129894566|NCT04863898|467573474|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
129894567|NCT04863898|467573474|FG000|Overall Study|Lost to Follow-up|3|||
129894568|NCT04863898|467573474|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
129894569|NCT04863898|467573474|FG000|Overall Study|No longer employed at clinic|3|||
129894570|NCT00614744|467573475|FG000|Overall Study|Lost to Follow-up|5|||
129894571|NCT00614744|467573476|FG001|Overall Study|Lost to Follow-up|4|||
129894572|NCT00614744|467573475|FG000|Overall Study|Incomplete for Behavior Issues|0|||
129894573|NCT00614744|467573476|FG001|Overall Study|Incomplete for Behavior Issues|2|||
129740261|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129740262|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129740263|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129894574|NCT00877851|467573477|FG000|Overall Study|Lost to Follow-up|5|||
129894575|NCT00877851|467573478|FG001|Overall Study|Lost to Follow-up|5|||
129894576|NCT00877851|467573477|FG000|Overall Study|computer problem|3|||
129894577|NCT00877851|467573478|FG001|Overall Study|computer problem|0|||
129894578|NCT00877851|467573477|FG000|Overall Study|no longer interested in participating|1|||
129894579|NCT00877851|467573478|FG001|Overall Study|no longer interested in participating|0|||
129894580|NCT00770211|467573486|FG000|Overall Study|Lost to Follow-up|1|||
129894581|NCT00770211|467573487|FG001|Overall Study|Lost to Follow-up|0|||
129894582|NCT00770211|467573486|FG000|Overall Study|Withdrawal by Subject|0|||
129894583|NCT00770211|467573487|FG001|Overall Study|Withdrawal by Subject|2|||
129894584|NCT03005288|467573491|FG000|Overall Study|Withdrawal by Subject|7|||
129894585|NCT03005288|467573492|FG001|Overall Study|Withdrawal by Subject|5|||
129894586|NCT03005288|467573491|FG000|Overall Study|Lost to Follow-up|0|||
129894587|NCT03005288|467573492|FG001|Overall Study|Lost to Follow-up|1|||
129894588|NCT03005288|467573491|FG000|Overall Study|Adverse Event|5|||
129894589|NCT03005288|467573492|FG001|Overall Study|Adverse Event|0|||
129894590|NCT03005288|467573491|FG000|Overall Study|Protocol deviation|0|||
129894591|NCT03005288|467573492|FG001|Overall Study|Protocol deviation|1|||
129894592|NCT03005288|467573491|FG000|Overall Study|Physician Decision|0|||
129894593|NCT03005288|467573492|FG001|Overall Study|Physician Decision|1|||
129894594|NCT03824236|467573493|FG000|Overall Study|Lost to Follow-up|0|||
129894595|NCT03824236|467573494|FG001|Overall Study|Lost to Follow-up|0|||
129894596|NCT03824236|467573495|FG002|Overall Study|Lost to Follow-up|1|||
129894597|NCT00701311|467573496|FG000|Overall Study|Lack of Efficacy|3|||
129894598|NCT00701311|467573496|FG000|Overall Study|Adverse Event|3|||
129894599|NCT00701311|467573496|FG000|Overall Study|Withdrawal by Subject|2|||
129894600|NCT01140347|467573497|FG000|Overall Study|Lost to Follow-up|5|||
129894601|NCT01140347|467573498|FG001|Overall Study|Lost to Follow-up|6|||
129894602|NCT01140347|467573497|FG000|Overall Study|Withdrawal by Subject|13|||
129894603|NCT01140347|467573498|FG001|Overall Study|Withdrawal by Subject|8|||
129894604|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
129894605|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
129894606|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
129894607|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
129894608|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
129894609|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
129894610|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
129894611|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
129894612|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
129894613|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
129894614|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
129894615|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
129894616|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
129894617|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
129894618|NCT04672460|467575138|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
129894619|NCT04672460|467575139|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
129894620|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
129894621|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
129894622|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
129894623|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
129894624|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
129894625|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
129894626|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
129894627|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
129894628|NCT04672460|467575138|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
129894629|NCT04672460|467575139|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
129894630|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
129894631|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
129894632|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
129894633|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
129894634|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
129894635|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
129894636|NCT04672460|467575138|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
129894637|NCT04672460|467575139|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
129894638|NCT00049517|467575142|FG000|Induction|Disease progression|0|||
129894639|NCT00049517|467575143|FG001|Induction|Disease progression|0|||
129894640|NCT00049517|467575144|FG002|Induction|Disease progression|0|||
129894641|NCT00049517|467575145|FG003|Induction|Disease progression|0|||
129894642|NCT00049517|467575146|FG004|Induction|Disease progression|18|||
129894643|NCT00049517|467575147|FG005|Induction|Disease progression|11|||
129894644|NCT00049517|467575142|FG000|Induction|Adverse Event|0|||
129894645|NCT00049517|467575143|FG001|Induction|Adverse Event|0|||
129894646|NCT00049517|467575144|FG002|Induction|Adverse Event|0|||
129894647|NCT00049517|467575145|FG003|Induction|Adverse Event|0|||
129894648|NCT00049517|467575146|FG004|Induction|Adverse Event|5|||
129894649|NCT00049517|467575147|FG005|Induction|Adverse Event|7|||
129894650|NCT00049517|467575142|FG000|Induction|Death|0|||
129894651|NCT00049517|467575143|FG001|Induction|Death|0|||
129894652|NCT00049517|467575144|FG002|Induction|Death|0|||
129894653|NCT00049517|467575145|FG003|Induction|Death|0|||
129894654|NCT00049517|467575146|FG004|Induction|Death|9|||
129894655|NCT00049517|467575147|FG005|Induction|Death|6|||
129894656|NCT00049517|467575142|FG000|Induction|Withdrawal by Subject|0|||
129894657|NCT00049517|467575143|FG001|Induction|Withdrawal by Subject|0|||
129894658|NCT00049517|467575144|FG002|Induction|Withdrawal by Subject|0|||
129894659|NCT00049517|467575145|FG003|Induction|Withdrawal by Subject|0|||
129894660|NCT00049517|467575146|FG004|Induction|Withdrawal by Subject|1|||
129894661|NCT00049517|467575147|FG005|Induction|Withdrawal by Subject|3|||
129894662|NCT00049517|467575142|FG000|Induction|Alternative therapy|0|||
129894663|NCT00049517|467575143|FG001|Induction|Alternative therapy|0|||
129894664|NCT00049517|467575144|FG002|Induction|Alternative therapy|0|||
129894665|NCT00049517|467575145|FG003|Induction|Alternative therapy|0|||
129894666|NCT00049517|467575146|FG004|Induction|Alternative therapy|2|||
129894667|NCT00049517|467575147|FG005|Induction|Alternative therapy|2|||
129894668|NCT00049517|467575142|FG000|Induction|Other complicating disease|0|||
129894669|NCT00049517|467575143|FG001|Induction|Other complicating disease|0|||
129894670|NCT00049517|467575144|FG002|Induction|Other complicating disease|0|||
129894671|NCT00049517|467575145|FG003|Induction|Other complicating disease|0|||
129894672|NCT00049517|467575146|FG004|Induction|Other complicating disease|3|||
129894673|NCT00049517|467575147|FG005|Induction|Other complicating disease|0|||
129894674|NCT00049517|467575142|FG000|Induction|Reasons not reported|0|||
129894675|NCT00049517|467575143|FG001|Induction|Reasons not reported|0|||
129894676|NCT00049517|467575144|FG002|Induction|Reasons not reported|0|||
129894677|NCT00049517|467575145|FG003|Induction|Reasons not reported|0|||
129894678|NCT00049517|467575146|FG004|Induction|Reasons not reported|22|||
129894679|NCT00049517|467575147|FG005|Induction|Reasons not reported|25|||
129740264|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129740265|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
129740266|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
129740267|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
129740268|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
129740269|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
129740270|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740271|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740272|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740273|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740274|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740275|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740276|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
129740277|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740278|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
129740279|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740280|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
129740281|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740282|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740283|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740284|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740285|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740286|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740287|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129740288|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129807314|NCT00338104|467261148|FG000|Overall Study|Protocol Violation|2|||
129807315|NCT00338104|467261149|FG001|Overall Study|Protocol Violation|1|||
129807316|NCT00338104|467261150|FG002|Overall Study|Protocol Violation|3|||
129807317|NCT00633750|467261151|FG000|Overall Study|Adverse Event|2|||
129807318|NCT00633750|467261151|FG000|Overall Study|Withdrawal by Subject|3|||
129807319|NCT03307785|467261155|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
129807320|NCT03307785|467261156|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
129807321|NCT03307785|467261157|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
129807322|NCT03307785|467261158|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
129807323|NCT03307785|467261159|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
129807324|NCT03307785|467261160|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
129894680|NCT00049517|467575142|FG000|Conditioning/Transplant|Disease progression|14|||
129894681|NCT00049517|467575143|FG001|Conditioning/Transplant|Disease progression|6|||
129894682|NCT00049517|467575144|FG002|Conditioning/Transplant|Disease progression|10|||
129894683|NCT00049517|467575145|FG003|Conditioning/Transplant|Disease progression|6|||
129894684|NCT00049517|467575146|FG004|Conditioning/Transplant|Disease progression|0|||
129894685|NCT00049517|467575147|FG005|Conditioning/Transplant|Disease progression|0|||
129894686|NCT00049517|467575142|FG000|Conditioning/Transplant|Adverse Event|2|||
129894687|NCT00049517|467575143|FG001|Conditioning/Transplant|Adverse Event|1|||
129894688|NCT00049517|467575144|FG002|Conditioning/Transplant|Adverse Event|4|||
129894689|NCT00049517|467575145|FG003|Conditioning/Transplant|Adverse Event|8|||
129894690|NCT00049517|467575146|FG004|Conditioning/Transplant|Adverse Event|0|||
129894691|NCT00049517|467575147|FG005|Conditioning/Transplant|Adverse Event|0|||
129894692|NCT00049517|467575142|FG000|Conditioning/Transplant|Death|1|||
129894693|NCT00049517|467575143|FG001|Conditioning/Transplant|Death|0|||
129894694|NCT00049517|467575144|FG002|Conditioning/Transplant|Death|0|||
129894695|NCT00049517|467575145|FG003|Conditioning/Transplant|Death|2|||
129894696|NCT00049517|467575146|FG004|Conditioning/Transplant|Death|0|||
129894697|NCT00049517|467575147|FG005|Conditioning/Transplant|Death|0|||
129894698|NCT00049517|467575142|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
129894699|NCT00049517|467575143|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
129894700|NCT00049517|467575144|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
129894701|NCT00049517|467575145|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
129894702|NCT00049517|467575146|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
129894703|NCT00049517|467575147|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
129894704|NCT00049517|467575142|FG000|Conditioning/Transplant|Alternative therapy|4|||
129894705|NCT00049517|467575143|FG001|Conditioning/Transplant|Alternative therapy|4|||
129894706|NCT00049517|467575144|FG002|Conditioning/Transplant|Alternative therapy|2|||
129894707|NCT00049517|467575145|FG003|Conditioning/Transplant|Alternative therapy|1|||
129894708|NCT00049517|467575146|FG004|Conditioning/Transplant|Alternative therapy|1|||
129894709|NCT00049517|467575147|FG005|Conditioning/Transplant|Alternative therapy|0|||
129894710|NCT00049517|467575142|FG000|Conditioning/Transplant|Other complicating disease|2|||
129894711|NCT00049517|467575143|FG001|Conditioning/Transplant|Other complicating disease|0|||
129894712|NCT00049517|467575144|FG002|Conditioning/Transplant|Other complicating disease|0|||
129894713|NCT00049517|467575145|FG003|Conditioning/Transplant|Other complicating disease|4|||
129894714|NCT00049517|467575146|FG004|Conditioning/Transplant|Other complicating disease|0|||
129894715|NCT00049517|467575147|FG005|Conditioning/Transplant|Other complicating disease|1|||
129894716|NCT00049517|467575142|FG000|Conditioning/Transplant|Reasons not reported|25|||
129894717|NCT00049517|467575143|FG001|Conditioning/Transplant|Reasons not reported|31|||
129894718|NCT00049517|467575144|FG002|Conditioning/Transplant|Reasons not reported|18|||
129894719|NCT00049517|467575145|FG003|Conditioning/Transplant|Reasons not reported|15|||
129894720|NCT00049517|467575146|FG004|Conditioning/Transplant|Reasons not reported|5|||
129894721|NCT00049517|467575147|FG005|Conditioning/Transplant|Reasons not reported|5|||
129894722|NCT01211665|467575150|FG000|Overall Study|Withdrawal by Subject|1|||
129894723|NCT01211665|467575151|FG001|Overall Study|Withdrawal by Subject|0|||
129894724|NCT01211665|467575150|FG000|Overall Study|Death|1|||
129894725|NCT01211665|467575151|FG001|Overall Study|Death|0|||
129894726|NCT01390857|467575154|FG000|Overall Study|Protocol Violation|2|||
129894727|NCT01390857|467575154|FG000|Overall Study|Lost to Follow-up|1|||
129894728|NCT01390857|467575154|FG000|Overall Study|No Visit after the First Visit|7|||
129894729|NCT01123161|467575155|FG000|Overall Study|Lost to Follow-up|1|||
129894730|NCT01123161|467575156|FG001|Overall Study|Lost to Follow-up|0|||
129894731|NCT01123161|467575155|FG000|Overall Study|Withdrawal by Subject|1|||
129894732|NCT01123161|467575156|FG001|Overall Study|Withdrawal by Subject|0|||
129894733|NCT04541186|467575163|FG000|Main Study|Adverse Event|0|||
129894734|NCT04541186|467575164|FG001|Main Study|Adverse Event|0|||
129894735|NCT04541186|467575165|FG002|Main Study|Adverse Event|4|||
129894736|NCT04541186|467575166|FG003|Main Study|Adverse Event|0|||
129894737|NCT04541186|467575167|FG004|Main Study|Adverse Event|0|||
129894738|NCT04541186|467575163|FG000|Main Study|Investigator Decision|0|||
129894739|NCT04541186|467575164|FG001|Main Study|Investigator Decision|0|||
129894740|NCT04541186|467575165|FG002|Main Study|Investigator Decision|1|||
129894741|NCT04541186|467575166|FG003|Main Study|Investigator Decision|1|||
129894742|NCT04541186|467575167|FG004|Main Study|Investigator Decision|0|||
129894743|NCT04541186|467575163|FG000|Main Study|Withdrawal by Subject|1|||
129894744|NCT04541186|467575164|FG001|Main Study|Withdrawal by Subject|1|||
129894745|NCT04541186|467575165|FG002|Main Study|Withdrawal by Subject|0|||
129894746|NCT04541186|467575166|FG003|Main Study|Withdrawal by Subject|0|||
129894747|NCT04541186|467575167|FG004|Main Study|Withdrawal by Subject|0|||
129894748|NCT04541186|467575163|FG000|Main Study|COVID-19-related Dose Interruption|0|||
129894749|NCT04541186|467575164|FG001|Main Study|COVID-19-related Dose Interruption|0|||
129894750|NCT04541186|467575165|FG002|Main Study|COVID-19-related Dose Interruption|0|||
129894751|NCT04541186|467575166|FG003|Main Study|COVID-19-related Dose Interruption|0|||
129894752|NCT04541186|467575167|FG004|Main Study|COVID-19-related Dose Interruption|1|||
129894753|NCT04541186|467575163|FG000|Main Study|Randomized in Error Not Treated|0|||
129894754|NCT04541186|467575164|FG001|Main Study|Randomized in Error Not Treated|0|||
129894755|NCT04541186|467575165|FG002|Main Study|Randomized in Error Not Treated|1|||
129894756|NCT04541186|467575166|FG003|Main Study|Randomized in Error Not Treated|0|||
129894757|NCT04541186|467575167|FG004|Main Study|Randomized in Error Not Treated|0|||
129894758|NCT04541186|467575163|FG000|Fibrate Expansion Study|Other than Specified|0|||
129894759|NCT04541186|467575164|FG001|Fibrate Expansion Study|Other than Specified|0|||
129894760|NCT04541186|467575165|FG002|Fibrate Expansion Study|Other than Specified|0|||
129894761|NCT04541186|467575166|FG003|Fibrate Expansion Study|Other than Specified|0|||
129894762|NCT04541186|467575167|FG004|Fibrate Expansion Study|Other than Specified|1|||
129894763|NCT00691028|467575168|FG000|Open-label Period|Adverse Event|0|||
129894764|NCT00691028|467575169|FG001|Open-label Period|Adverse Event|0|||
129894765|NCT00691028|467575170|FG002|Open-label Period|Adverse Event|0|||
129894766|NCT00691028|467575171|FG003|Open-label Period|Adverse Event|16|||
129894767|NCT00691028|467575168|FG000|Open-label Period|Withdrawal by Subject|0|||
129894768|NCT00691028|467575169|FG001|Open-label Period|Withdrawal by Subject|0|||
129894769|NCT00691028|467575170|FG002|Open-label Period|Withdrawal by Subject|0|||
129894770|NCT00691028|467575171|FG003|Open-label Period|Withdrawal by Subject|3|||
129894771|NCT00691028|467575168|FG000|Open-label Period|not come to a hospital|0|||
129894772|NCT00691028|467575169|FG001|Open-label Period|not come to a hospital|0|||
129894773|NCT00691028|467575170|FG002|Open-label Period|not come to a hospital|0|||
129894774|NCT00691028|467575171|FG003|Open-label Period|not come to a hospital|1|||
129894775|NCT00691028|467575168|FG000|Double-blind Period|Adverse Event|8|||
129894776|NCT00691028|467575169|FG001|Double-blind Period|Adverse Event|9|||
129894777|NCT00691028|467575170|FG002|Double-blind Period|Adverse Event|6|||
129894778|NCT00691028|467575171|FG003|Double-blind Period|Adverse Event|0|||
129894779|NCT00691028|467575168|FG000|Double-blind Period|Lack of Efficacy|4|||
129894780|NCT00691028|467575169|FG001|Double-blind Period|Lack of Efficacy|3|||
129894781|NCT00691028|467575170|FG002|Double-blind Period|Lack of Efficacy|2|||
129894782|NCT00691028|467575171|FG003|Double-blind Period|Lack of Efficacy|0|||
129894783|NCT00691028|467575168|FG000|Double-blind Period|Withdrawal by Subject|1|||
129894784|NCT00691028|467575169|FG001|Double-blind Period|Withdrawal by Subject|0|||
129894785|NCT00691028|467575170|FG002|Double-blind Period|Withdrawal by Subject|1|||
129894786|NCT00691028|467575171|FG003|Double-blind Period|Withdrawal by Subject|0|||
129894787|NCT00691028|467575168|FG000|Double-blind Period|not come to a hospital.|0|||
129894788|NCT00691028|467575169|FG001|Double-blind Period|not come to a hospital.|1|||
129894789|NCT00691028|467575170|FG002|Double-blind Period|not come to a hospital.|0|||
129894790|NCT00691028|467575171|FG003|Double-blind Period|not come to a hospital.|0|||
129894791|NCT00058058|467575179|FG000|Overall Study|Withdrawal by Subject|4|||
129894792|NCT00058058|467575179|FG000|Overall Study|Ineligible|20|||
129894793|NCT00058058|467575179|FG000|Overall Study|Claustrophobic|5|||
129894794|NCT00058058|467575179|FG000|Overall Study|technical issues|6|||
129894795|NCT00058058|467575179|FG000|Overall Study|Poor positioning, illness,pain|3|||
129894796|NCT03085017|467575180|FG000|Overall Study|Death|0|||
129894797|NCT03085017|467575181|FG001|Overall Study|Death|3|||
129894798|NCT03255018|467575185|FG000|Overall Study|Death on study|0|||
129894799|NCT03255018|467575186|FG001|Overall Study|Death on study|5|||
129894800|NCT03255018|467575185|FG000|Overall Study|Withdrawal by Subject|0|||
129894801|NCT03255018|467575186|FG001|Overall Study|Withdrawal by Subject|2|||
129894802|NCT03681691|467575190|FG000|Overall Study|COVID|1|||
129894803|NCT03681691|467575191|FG001|Overall Study|COVID|0|||
129894804|NCT03681691|467575190|FG000|Overall Study|prolonged bleeding|1|||
129894805|NCT03681691|467575191|FG001|Overall Study|prolonged bleeding|0|||
129894806|NCT03681691|467575190|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
129894807|NCT03681691|467575191|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
129894808|NCT00748969|467575192|FG000|Overall Study|Withdrawal by Subject|1|||
129894809|NCT00748969|467575193|FG001|Overall Study|Withdrawal by Subject|0|||
129894810|NCT00748969|467575192|FG000|Overall Study|Withdrawal by Subject|0|||
129894811|NCT00748969|467575193|FG001|Overall Study|Withdrawal by Subject|1|||
129894812|NCT03613129|467575194|FG000|Pre-treatment Assessment|Protocol Violation|2|||
129894813|NCT03613129|467575195|FG001|Pre-treatment Assessment|Protocol Violation|0|||
129894814|NCT03613129|467575196|FG002|Pre-treatment Assessment|Protocol Violation|0|||
129894815|NCT03613129|467575197|FG003|Pre-treatment Assessment|Protocol Violation|0|||
129894816|NCT03613129|467575198|FG004|Pre-treatment Assessment|Protocol Violation|0|||
129894817|NCT03613129|467575194|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
129894818|NCT03613129|467575195|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894819|NCT03613129|467575196|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894820|NCT03613129|467575197|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894821|NCT03613129|467575198|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
129894822|NCT02334306|467575199|FG000|Double-blind Period|Adverse Event|0|||
129894823|NCT02334306|467575200|FG001|Double-blind Period|Adverse Event|1|||
129894824|NCT02334306|467575199|FG000|Double-blind Period|Withdrawal by Subject|1|||
129894825|NCT02334306|467575200|FG001|Double-blind Period|Withdrawal by Subject|1|||
129894826|NCT00465985|467575201|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
129894827|NCT00465985|467575202|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
129894828|NCT00465985|467575201|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
129894829|NCT00465985|467575202|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
129894830|NCT00465985|467575201|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
129894831|NCT00465985|467575202|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
129894832|NCT00465985|467575201|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
129894833|NCT00465985|467575202|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
129894834|NCT03532178|467575203|FG000|First Period|Withdrawal by Subject|1|||
129894835|NCT03532178|467575204|FG001|First Period|Withdrawal by Subject|3|||
129894836|NCT03532178|467575203|FG000|First Period|technical issues in data collection Technical issues|0|||
129894837|NCT03532178|467575204|FG001|First Period|technical issues in data collection Technical issues|1|||
129894838|NCT03532178|467575203|FG000|Second Period|Withdrawal by Subject|1|||
129894839|NCT03532178|467575204|FG001|Second Period|Withdrawal by Subject|1|||
129894840|NCT03532178|467575203|FG000|Second Period|Technical issues|0|||
129894841|NCT03532178|467575204|FG001|Second Period|Technical issues|1|||
129894842|NCT03302156|467575205|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
129894843|NCT03302156|467575206|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
129894844|NCT03302156|467575207|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
129894845|NCT02390557|467575208|FG000|Wave 2|Survey non-respondent|72|||
129894846|NCT02390557|467575209|FG001|Wave 2|Survey non-respondent|41|||
129894847|NCT02390557|467575210|FG002|Wave 2|Survey non-respondent|23|||
129894848|NCT03278028|467575214|FG000|Overall Study|Lost to Follow-up|1|||
129894849|NCT03278028|467575215|FG001|Overall Study|Lost to Follow-up|0|||
129894850|NCT03278028|467575214|FG000|Overall Study|Withdrawal by Subject|3|||
129894851|NCT03278028|467575215|FG001|Overall Study|Withdrawal by Subject|1|||
129894852|NCT03278028|467575214|FG000|Overall Study|Pregnancy|0|||
129894853|NCT03278028|467575215|FG001|Overall Study|Pregnancy|1|||
129894854|NCT01360840|467575216|FG000|Overall Study|Ongoing at data cut-off|10|||
129894855|NCT01360840|467575217|FG001|Overall Study|Ongoing at data cut-off|10|||
129894856|NCT01360840|467575218|FG002|Overall Study|Ongoing at data cut-off|9|||
129894857|NCT01813422|467575220|FG000|Overall Study|Withdrawal by Subject|14|||
129894858|NCT01813422|467575221|FG001|Overall Study|Withdrawal by Subject|8|||
129894859|NCT01813422|467575220|FG000|Overall Study|Death|2|||
129894860|NCT01813422|467575221|FG001|Overall Study|Death|3|||
129894861|NCT01813422|467575220|FG000|Overall Study|Sponsor Decision|2|||
129894862|NCT01813422|467575221|FG001|Overall Study|Sponsor Decision|1|||
129894863|NCT01813422|467575220|FG000|Overall Study|Lost to Follow-up|2|||
129894864|NCT01813422|467575221|FG001|Overall Study|Lost to Follow-up|4|||
129894865|NCT01653743|467575222|FG000|Overall Study|Withdrawal by Subject|1|||
129894866|NCT01653743|467575223|FG001|Overall Study|Withdrawal by Subject|0|||
129894867|NCT01653743|467575222|FG000|Overall Study|Investigator discretion|3|||
129894868|NCT01653743|467575223|FG001|Overall Study|Investigator discretion|0|||
129894869|NCT04889118|467575224|FG000|Overall Study|Death|33|||
129894870|NCT04889118|467575225|FG001|Overall Study|Death|37|||
129894871|NCT04889118|467575224|FG000|Overall Study|Ongoing in Study|31|||
129894872|NCT04889118|467575225|FG001|Overall Study|Ongoing in Study|30|||
129894873|NCT01582243|467575234|FG000|Overall Study|Withdrawal by Subject|1|||
129894874|NCT01582243|467575234|FG000|Overall Study|Adverse Event|1|||
129894875|NCT01582243|467575234|FG000|Overall Study|Lost to Follow-up|1|||
129894876|NCT01119703|467575235|FG000|Overall Study|Adverse Event|0|||
129894877|NCT01119703|467575236|FG001|Overall Study|Adverse Event|1|||
129894878|NCT03178201|467575237|FG000|Overall Study|Off study|5|||
129894879|NCT01763047|467575238|FG000|Period 1|Test Article Not Available|4|||
129894880|NCT01763047|467575239|FG001|Period 1|Test Article Not Available|1|||
129894881|NCT01763047|467575238|FG000|Period 1|Protocol Violation|4|||
129894882|NCT01763047|467575239|FG001|Period 1|Protocol Violation|4|||
129894883|NCT01763047|467575238|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
129894884|NCT01763047|467575239|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
129894885|NCT01763047|467575238|FG000|Period 1|Adverse Event|0|||
129894886|NCT01763047|467575239|FG001|Period 1|Adverse Event|1|||
129894887|NCT01763047|467575238|FG000|Period 1|Unsatisfactory Visual Response|0|||
129894888|NCT01763047|467575239|FG001|Period 1|Unsatisfactory Visual Response|3|||
129894889|NCT01763047|467575238|FG000|Period 1|Lens Power Not Available|0|||
129894890|NCT01763047|467575239|FG001|Period 1|Lens Power Not Available|1|||
129894891|NCT01763047|467575238|FG000|Period 1|Study Site office Closed|0|||
129894892|NCT01763047|467575239|FG001|Period 1|Study Site office Closed|1|||
129894893|NCT01763047|467575238|FG000|Period 2|Lens Discomfort|1|||
129894894|NCT01763047|467575239|FG001|Period 2|Lens Discomfort|0|||
129894895|NCT01763047|467575238|FG000|Period 2|No longer meets Eligibility Criteria|1|||
129894896|NCT01763047|467575239|FG001|Period 2|No longer meets Eligibility Criteria|0|||
129894897|NCT01763047|467575238|FG000|Period 2|Study Site office Closed|1|||
129894898|NCT01763047|467575239|FG001|Period 2|Study Site office Closed|1|||
129894899|NCT01763047|467575238|FG000|Period 2|Unsatisfactory Visual Response|1|||
129894900|NCT01763047|467575239|FG001|Period 2|Unsatisfactory Visual Response|1|||
129894901|NCT01763047|467575238|FG000|Period 2|Protocol Violation|0|||
129894902|NCT01763047|467575239|FG001|Period 2|Protocol Violation|2|||
129894903|NCT01763047|467575238|FG000|Period 2|Unsatisfactory lens Fitting|0|||
129894904|NCT01763047|467575239|FG001|Period 2|Unsatisfactory lens Fitting|1|||
129894905|NCT02282527|467575243|FG000|Overall Study|Lost to Follow-up|0|||
129894906|NCT02282527|467575244|FG001|Overall Study|Lost to Follow-up|1|||
129894907|NCT02282527|467575243|FG000|Overall Study|Lack of home health aid|1|||
129894908|NCT02282527|467575244|FG001|Overall Study|Lack of home health aid|0|||
129894909|NCT00941031|467575245|FG000|Induction Period|Lack of Efficacy|2|||
129894910|NCT00941031|467575246|FG001|Induction Period|Lack of Efficacy|1|||
129894911|NCT00941031|467575247|FG002|Induction Period|Lack of Efficacy|0|||
129894912|NCT00941031|467575248|FG003|Induction Period|Lack of Efficacy|5|||
129894913|NCT00941031|467575249|FG004|Induction Period|Lack of Efficacy|0|||
129894914|NCT00941031|467575250|FG005|Induction Period|Lack of Efficacy|0|||
129894915|NCT00941031|467575251|FG006|Induction Period|Lack of Efficacy|0|||
129894916|NCT00941031|467575245|FG000|Induction Period|Withdrawal by Subject|1|||
129894917|NCT00941031|467575246|FG001|Induction Period|Withdrawal by Subject|2|||
129894918|NCT00941031|467575247|FG002|Induction Period|Withdrawal by Subject|2|||
129894919|NCT00941031|467575248|FG003|Induction Period|Withdrawal by Subject|2|||
129894920|NCT00941031|467575249|FG004|Induction Period|Withdrawal by Subject|0|||
129894921|NCT00941031|467575250|FG005|Induction Period|Withdrawal by Subject|0|||
129894922|NCT00941031|467575251|FG006|Induction Period|Withdrawal by Subject|0|||
129894923|NCT00941031|467575245|FG000|Induction Period|Adminstative Problems|1|||
129894924|NCT00941031|467575246|FG001|Induction Period|Adminstative Problems|1|||
129894925|NCT00941031|467575247|FG002|Induction Period|Adminstative Problems|1|||
129894926|NCT00941031|467575248|FG003|Induction Period|Adminstative Problems|0|||
129894927|NCT00941031|467575249|FG004|Induction Period|Adminstative Problems|0|||
129894928|NCT00941031|467575250|FG005|Induction Period|Adminstative Problems|0|||
129894929|NCT00941031|467575251|FG006|Induction Period|Adminstative Problems|0|||
129894930|NCT00941031|467575245|FG000|Induction Period|Adverse Event|1|||
129894931|NCT00941031|467575246|FG001|Induction Period|Adverse Event|0|||
129894932|NCT00941031|467575247|FG002|Induction Period|Adverse Event|3|||
129894933|NCT00941031|467575248|FG003|Induction Period|Adverse Event|2|||
129894934|NCT00941031|467575249|FG004|Induction Period|Adverse Event|0|||
129894935|NCT00941031|467575250|FG005|Induction Period|Adverse Event|0|||
129894936|NCT00941031|467575251|FG006|Induction Period|Adverse Event|0|||
129894937|NCT00941031|467575245|FG000|Maintenance Period|Withdrawal by Subject|0|||
129894938|NCT00941031|467575246|FG001|Maintenance Period|Withdrawal by Subject|0|||
129894939|NCT00941031|467575247|FG002|Maintenance Period|Withdrawal by Subject|0|||
129894940|NCT00941031|467575248|FG003|Maintenance Period|Withdrawal by Subject|0|||
129894941|NCT00941031|467575249|FG004|Maintenance Period|Withdrawal by Subject|6|||
129894942|NCT00941031|467575250|FG005|Maintenance Period|Withdrawal by Subject|2|||
129894943|NCT00941031|467575251|FG006|Maintenance Period|Withdrawal by Subject|13|||
129894944|NCT00941031|467575245|FG000|Maintenance Period|Administrative Problems|0|||
129894945|NCT00941031|467575246|FG001|Maintenance Period|Administrative Problems|0|||
129894946|NCT00941031|467575247|FG002|Maintenance Period|Administrative Problems|0|||
129894947|NCT00941031|467575248|FG003|Maintenance Period|Administrative Problems|0|||
129894948|NCT00941031|467575249|FG004|Maintenance Period|Administrative Problems|1|||
129894949|NCT00941031|467575250|FG005|Maintenance Period|Administrative Problems|0|||
129894950|NCT00941031|467575251|FG006|Maintenance Period|Administrative Problems|1|||
129894951|NCT00941031|467575245|FG000|Maintenance Period|Protocol Violation|0|||
129894952|NCT00941031|467575246|FG001|Maintenance Period|Protocol Violation|0|||
129894953|NCT00941031|467575247|FG002|Maintenance Period|Protocol Violation|0|||
129894954|NCT00941031|467575248|FG003|Maintenance Period|Protocol Violation|0|||
129894955|NCT00941031|467575249|FG004|Maintenance Period|Protocol Violation|0|||
129894956|NCT00941031|467575250|FG005|Maintenance Period|Protocol Violation|0|||
129894957|NCT00941031|467575251|FG006|Maintenance Period|Protocol Violation|1|||
129894958|NCT00941031|467575245|FG000|Maintenance Period|Adverse Event|0|||
129894959|NCT00941031|467575246|FG001|Maintenance Period|Adverse Event|0|||
129894960|NCT00941031|467575247|FG002|Maintenance Period|Adverse Event|0|||
129445350|NCT02684279|465931272|FG000|Overall Study|Pregnancy|8|||
129894961|NCT00941031|467575248|FG003|Maintenance Period|Adverse Event|0|||
129894962|NCT00941031|467575249|FG004|Maintenance Period|Adverse Event|0|||
129894963|NCT00941031|467575250|FG005|Maintenance Period|Adverse Event|2|||
129894964|NCT00941031|467575251|FG006|Maintenance Period|Adverse Event|8|||
129894965|NCT00941031|467575245|FG000|Maintenance Period|Lost to Follow-up|0|||
129894966|NCT00941031|467575246|FG001|Maintenance Period|Lost to Follow-up|0|||
129894967|NCT00941031|467575247|FG002|Maintenance Period|Lost to Follow-up|0|||
129894968|NCT00941031|467575248|FG003|Maintenance Period|Lost to Follow-up|0|||
129894969|NCT00941031|467575249|FG004|Maintenance Period|Lost to Follow-up|2|||
129894970|NCT00941031|467575250|FG005|Maintenance Period|Lost to Follow-up|2|||
129894971|NCT00941031|467575251|FG006|Maintenance Period|Lost to Follow-up|7|||
129894972|NCT00941031|467575245|FG000|Maintenance Period|Lack of Efficacy|0|||
129894973|NCT00941031|467575246|FG001|Maintenance Period|Lack of Efficacy|0|||
129894974|NCT00941031|467575247|FG002|Maintenance Period|Lack of Efficacy|0|||
129894975|NCT00941031|467575248|FG003|Maintenance Period|Lack of Efficacy|0|||
129894976|NCT00941031|467575249|FG004|Maintenance Period|Lack of Efficacy|0|||
129894977|NCT00941031|467575250|FG005|Maintenance Period|Lack of Efficacy|0|||
129894978|NCT00941031|467575251|FG006|Maintenance Period|Lack of Efficacy|13|||
129894979|NCT01872611|467575252|FG000|Overall Study|Adverse Event|3|||
129894980|NCT01872611|467575253|FG001|Overall Study|Adverse Event|1|||
129894981|NCT01872611|467575252|FG000|Overall Study|Adverse Event, prior to treatment|0|||
129894982|NCT01872611|467575253|FG001|Overall Study|Adverse Event, prior to treatment|1|||
129894983|NCT01872611|467575252|FG000|Overall Study|Death|0|||
129894984|NCT01872611|467575253|FG001|Overall Study|Death|1|||
129894985|NCT01872611|467575252|FG000|Overall Study|Death, prior to treatment|0|||
129894986|NCT01872611|467575253|FG001|Overall Study|Death, prior to treatment|1|||
129894987|NCT01872611|467575252|FG000|Overall Study|Lost to Follow-up|8|||
129894988|NCT01872611|467575253|FG001|Overall Study|Lost to Follow-up|1|||
129894989|NCT01872611|467575252|FG000|Overall Study|Physician Decision|1|||
129894990|NCT01872611|467575253|FG001|Overall Study|Physician Decision|0|||
129894991|NCT01872611|467575252|FG000|Overall Study|Withdrawal by Subject|6|||
129894992|NCT01872611|467575253|FG001|Overall Study|Withdrawal by Subject|1|||
129894993|NCT01872611|467575252|FG000|Overall Study|Reason not provided|6|||
129894994|NCT01872611|467575253|FG001|Overall Study|Reason not provided|6|||
129894995|NCT03124108|467575254|FG000|Overall Study|Adverse Event|0|||
129894996|NCT03124108|467575255|FG001|Overall Study|Adverse Event|1|||
129894997|NCT03124108|467575256|FG002|Overall Study|Adverse Event|0|||
129894998|NCT00631917|467575257|FG000|Overall Study|Adverse Event|34|||
129894999|NCT00631917|467575258|FG001|Overall Study|Adverse Event|45|||
129895000|NCT00631917|467575257|FG000|Overall Study|Abnormal laboratory value(s)|2|||
129895001|NCT00631917|467575258|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129895002|NCT00631917|467575257|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129895003|NCT00631917|467575258|FG001|Overall Study|Abnormal test procedure result(s)|2|||
129740289|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
129740290|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129895004|NCT00631917|467575257|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
129895005|NCT00631917|467575258|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
129895006|NCT00631917|467575257|FG000|Overall Study|No longer required study drug|0|||
129895007|NCT00631917|467575258|FG001|Overall Study|No longer required study drug|1|||
129895008|NCT00631917|467575257|FG000|Overall Study|Protocol deviation|6|||
129895009|NCT00631917|467575258|FG001|Overall Study|Protocol deviation|5|||
129895010|NCT00631917|467575257|FG000|Overall Study|Subject withdrew consent|25|||
129895011|NCT00631917|467575258|FG001|Overall Study|Subject withdrew consent|33|||
129895012|NCT00631917|467575257|FG000|Overall Study|Lost to Follow-up|7|||
129895013|NCT00631917|467575258|FG001|Overall Study|Lost to Follow-up|7|||
129895014|NCT00631917|467575257|FG000|Overall Study|Administrative problems|2|||
129895015|NCT00631917|467575258|FG001|Overall Study|Administrative problems|0|||
129895016|NCT00631917|467575257|FG000|Overall Study|Death|1|||
129895017|NCT00631917|467575258|FG001|Overall Study|Death|0|||
129895018|NCT05650333|467575259|FG000|Treatment Period (7 Days)|Adverse Event|1|||
129895019|NCT02616263|467575260|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
129895020|NCT02616263|467575261|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
129895021|NCT02616263|467575260|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
129740291|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
129895022|NCT02616263|467575261|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
129895023|NCT02616263|467575260|FG000|6 Month to 1.5 Year|Death|1|||
129895024|NCT02616263|467575261|FG001|6 Month to 1.5 Year|Death|0|||
129895025|NCT02616263|467575260|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
129895026|NCT02616263|467575261|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
129740292|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740293|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740294|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740295|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740296|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740297|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740298|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
129740299|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740300|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129740301|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129895027|NCT02616263|467575260|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
129895028|NCT02616263|467575261|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
129895029|NCT02616263|467575260|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
129895030|NCT02616263|467575261|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
129895031|NCT02939183|467575264|FG000|Overall Study|Death|0|||
129895032|NCT02939183|467575265|FG001|Overall Study|Death|0|||
129895033|NCT02939183|467575266|FG002|Overall Study|Death|1|||
129895034|NCT02939183|467575267|FG003|Overall Study|Death|0|||
129895035|NCT02939183|467575268|FG004|Overall Study|Death|0|||
129895036|NCT02939183|467575269|FG005|Overall Study|Death|2|||
129895037|NCT02939183|467575270|FG006|Overall Study|Death|1|||
129895038|NCT02939183|467575271|FG007|Overall Study|Death|0|||
129895039|NCT02939183|467575272|FG008|Overall Study|Death|0|||
129895040|NCT02939183|467575264|FG000|Overall Study|Sponsor decision|0|||
129895041|NCT02939183|467575265|FG001|Overall Study|Sponsor decision|1|||
129895042|NCT02939183|467575266|FG002|Overall Study|Sponsor decision|0|||
129895043|NCT02939183|467575267|FG003|Overall Study|Sponsor decision|1|||
129895044|NCT02939183|467575268|FG004|Overall Study|Sponsor decision|2|||
129895045|NCT02939183|467575269|FG005|Overall Study|Sponsor decision|0|||
129895046|NCT02939183|467575270|FG006|Overall Study|Sponsor decision|3|||
129895047|NCT02939183|467575271|FG007|Overall Study|Sponsor decision|1|||
129895048|NCT02939183|467575272|FG008|Overall Study|Sponsor decision|4|||
129895049|NCT02939183|467575264|FG000|Overall Study|Withdrawal by Subject|0|||
129895050|NCT02939183|467575265|FG001|Overall Study|Withdrawal by Subject|2|||
129895051|NCT02939183|467575266|FG002|Overall Study|Withdrawal by Subject|0|||
129895052|NCT02939183|467575267|FG003|Overall Study|Withdrawal by Subject|1|||
129895053|NCT02939183|467575268|FG004|Overall Study|Withdrawal by Subject|0|||
129895054|NCT02939183|467575269|FG005|Overall Study|Withdrawal by Subject|0|||
129740302|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
129895055|NCT02939183|467575270|FG006|Overall Study|Withdrawal by Subject|2|||
129895056|NCT02939183|467575271|FG007|Overall Study|Withdrawal by Subject|2|||
129740303|NCT02914561|467008102|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740304|NCT02914561|467008103|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740305|NCT02914561|467008104|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740306|NCT02914561|467008105|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740307|NCT02914561|467008106|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740308|NCT02914561|467008107|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740309|NCT02914561|467008108|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740310|NCT02914561|467008109|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
129740311|NCT02914561|467008110|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
129740312|NCT02914561|467008111|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
129740313|NCT02914561|467008112|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
129740314|NCT01455220|467008115|FG000|Overall Study|screen fail|30|||
129740315|NCT00521222|467008117|FG000|Overall Study|Lost to Follow-up|0|||
129740316|NCT00521222|467008118|FG001|Overall Study|Lost to Follow-up|0|||
129740317|NCT00521222|467008119|FG002|Overall Study|Lost to Follow-up|1|||
129740318|NCT00521222|467008120|FG003|Overall Study|Lost to Follow-up|1|||
129740319|NCT00521222|467008117|FG000|Overall Study|Withdrawal by Subject|0|||
129740320|NCT00521222|467008118|FG001|Overall Study|Withdrawal by Subject|0|||
129895057|NCT02939183|467575272|FG008|Overall Study|Withdrawal by Subject|2|||
129740321|NCT00521222|467008119|FG002|Overall Study|Withdrawal by Subject|2|||
129740322|NCT00521222|467008120|FG003|Overall Study|Withdrawal by Subject|0|||
129740323|NCT00521222|467008117|FG000|Overall Study|Physician Decision|0|||
129740324|NCT00521222|467008118|FG001|Overall Study|Physician Decision|1|||
129740325|NCT00521222|467008119|FG002|Overall Study|Physician Decision|0|||
129740326|NCT00521222|467008120|FG003|Overall Study|Physician Decision|1|||
129740327|NCT03332160|467008121|FG000|Overall Study|Withdrawal by Subject|1|||
129895058|NCT02939183|467575264|FG000|Overall Study|Not treated due to adverse event|0|||
129895059|NCT02939183|467575265|FG001|Overall Study|Not treated due to adverse event|0|||
129895060|NCT02939183|467575266|FG002|Overall Study|Not treated due to adverse event|0|||
129740328|NCT03332160|467008122|FG001|Overall Study|Withdrawal by Subject|1|||
129740329|NCT03332160|467008121|FG000|Overall Study|Adverse Event|0|||
129740330|NCT03332160|467008122|FG001|Overall Study|Adverse Event|1|||
129895061|NCT02939183|467575267|FG003|Overall Study|Not treated due to adverse event|1|||
129807325|NCT03307785|467261161|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
129807326|NCT03307785|467261162|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
129807327|NCT03307785|467261163|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
129807328|NCT03307785|467261164|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
129807329|NCT03307785|467261165|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
129807330|NCT03307785|467261155|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
129807331|NCT03307785|467261156|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
129807332|NCT03307785|467261157|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807333|NCT03307785|467261158|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807334|NCT03307785|467261159|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807335|NCT03307785|467261160|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807336|NCT03307785|467261161|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807337|NCT03307785|467261162|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129740331|NCT03332160|467008121|FG000|Overall Study|Developed Exclusion Criteria|0|||
129740332|NCT03332160|467008122|FG001|Overall Study|Developed Exclusion Criteria|1|||
129740333|NCT03332160|467008121|FG000|Overall Study|Non-adherence to treatment|0|||
129740334|NCT03332160|467008122|FG001|Overall Study|Non-adherence to treatment|2|||
129740335|NCT03869333|467008123|FG000|Overall Study|Lost to Follow-up|1|||
129740336|NCT03869333|467008124|FG001|Overall Study|Lost to Follow-up|0|||
129740337|NCT03869333|467008125|FG002|Overall Study|Lost to Follow-up|0|||
129740338|NCT03869333|467008126|FG003|Overall Study|Lost to Follow-up|0|||
129740339|NCT03869333|467008123|FG000|Overall Study|Pregnancy|1|||
129740340|NCT03869333|467008124|FG001|Overall Study|Pregnancy|0|||
129740341|NCT03869333|467008125|FG002|Overall Study|Pregnancy|0|||
129740342|NCT03869333|467008126|FG003|Overall Study|Pregnancy|0|||
129740343|NCT03869333|467008123|FG000|Overall Study|Physician Decision|0|||
129740344|NCT03869333|467008124|FG001|Overall Study|Physician Decision|1|||
129807338|NCT03307785|467261163|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807339|NCT03307785|467261164|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807340|NCT03307785|467261165|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
129807341|NCT03307785|467261155|FG000|Part A: Up to 28.5 Months|Death|4|||
129807342|NCT03307785|467261156|FG001|Part A: Up to 28.5 Months|Death|4|||
129807343|NCT03307785|467261157|FG002|Part A: Up to 28.5 Months|Death|0|||
129807344|NCT03307785|467261158|FG003|Part A: Up to 28.5 Months|Death|0|||
129807345|NCT03307785|467261159|FG004|Part A: Up to 28.5 Months|Death|0|||
129807346|NCT03307785|467261160|FG005|Part A: Up to 28.5 Months|Death|0|||
129807347|NCT03307785|467261161|FG006|Part A: Up to 28.5 Months|Death|0|||
129807348|NCT03307785|467261162|FG007|Part A: Up to 28.5 Months|Death|0|||
129807349|NCT03307785|467261163|FG008|Part A: Up to 28.5 Months|Death|0|||
129807350|NCT03307785|467261164|FG009|Part A: Up to 28.5 Months|Death|0|||
129807351|NCT03307785|467261165|FG010|Part A: Up to 28.5 Months|Death|0|||
129807352|NCT03307785|467261155|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
129807353|NCT03307785|467261156|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
129807354|NCT03307785|467261157|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
129807355|NCT03307785|467261158|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
129807356|NCT03307785|467261159|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
129807357|NCT03307785|467261160|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
129807358|NCT03307785|467261161|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
129807359|NCT03307785|467261162|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
129807360|NCT03307785|467261163|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
129807361|NCT03307785|467261164|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
129807362|NCT03307785|467261165|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
129807363|NCT03307785|467261155|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807364|NCT03307785|467261156|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807365|NCT03307785|467261157|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
129807366|NCT03307785|467261158|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807367|NCT03307785|467261159|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807368|NCT03307785|467261160|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807369|NCT03307785|467261161|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807370|NCT03307785|467261162|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807371|NCT03307785|467261163|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807372|NCT03307785|467261164|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
129807373|NCT03307785|467261165|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
129895062|NCT02939183|467575268|FG004|Overall Study|Not treated due to adverse event|0|||
129740345|NCT03869333|467008125|FG002|Overall Study|Physician Decision|0|||
129740346|NCT03869333|467008126|FG003|Overall Study|Physician Decision|0|||
129740347|NCT01927055|467008127|FG000|Open-label|Adverse Event|6|||
129740348|NCT01927055|467008128|FG001|Open-label|Adverse Event|0|||
129740349|NCT01927055|467008129|FG002|Open-label|Adverse Event|0|||
129740350|NCT01927055|467008127|FG000|Open-label|Withdrawal by Subject|1|||
129740351|NCT01927055|467008128|FG001|Open-label|Withdrawal by Subject|0|||
129740352|NCT01927055|467008129|FG002|Open-label|Withdrawal by Subject|0|||
129740353|NCT01927055|467008127|FG000|Open-label|Study Stopped|4|||
129740354|NCT01927055|467008128|FG001|Open-label|Study Stopped|0|||
129807374|NCT03307785|467261155|FG000|Part B: Up to Approx. 66 Months|Death|0|||
129807375|NCT03307785|467261156|FG001|Part B: Up to Approx. 66 Months|Death|0|||
129807376|NCT03307785|467261157|FG002|Part B: Up to Approx. 66 Months|Death|7|||
129807377|NCT03307785|467261158|FG003|Part B: Up to Approx. 66 Months|Death|0|||
129807378|NCT03307785|467261159|FG004|Part B: Up to Approx. 66 Months|Death|0|||
129807379|NCT03307785|467261160|FG005|Part B: Up to Approx. 66 Months|Death|0|||
129807380|NCT03307785|467261161|FG006|Part B: Up to Approx. 66 Months|Death|0|||
129807381|NCT03307785|467261162|FG007|Part B: Up to Approx. 66 Months|Death|0|||
129807382|NCT03307785|467261163|FG008|Part B: Up to Approx. 66 Months|Death|0|||
129807383|NCT03307785|467261164|FG009|Part B: Up to Approx. 66 Months|Death|0|||
129807384|NCT03307785|467261165|FG010|Part B: Up to Approx. 66 Months|Death|0|||
129807385|NCT03307785|467261155|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807386|NCT03307785|467261156|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807387|NCT03307785|467261157|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
129807388|NCT03307785|467261158|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807389|NCT03307785|467261159|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807390|NCT03307785|467261160|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807391|NCT03307785|467261161|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807392|NCT03307785|467261162|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807393|NCT03307785|467261163|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807394|NCT03307785|467261164|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807395|NCT03307785|467261165|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
129807396|NCT03307785|467261155|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807397|NCT03307785|467261156|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807398|NCT03307785|467261157|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
129807399|NCT03307785|467261158|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807400|NCT03307785|467261159|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807401|NCT03307785|467261160|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807402|NCT03307785|467261161|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807403|NCT03307785|467261162|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807404|NCT03307785|467261163|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807405|NCT03307785|467261164|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807406|NCT03307785|467261165|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
129807407|NCT03307785|467261155|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807408|NCT03307785|467261156|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807409|NCT03307785|467261157|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
129807410|NCT03307785|467261158|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807411|NCT03307785|467261159|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807412|NCT03307785|467261160|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807413|NCT03307785|467261161|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807414|NCT03307785|467261162|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807415|NCT03307785|467261163|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807416|NCT03307785|467261164|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807417|NCT03307785|467261165|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
129807418|NCT03307785|467261155|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807419|NCT03307785|467261156|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807420|NCT03307785|467261157|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807421|NCT03307785|467261158|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
129807422|NCT03307785|467261159|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
129807423|NCT03307785|467261160|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807424|NCT03307785|467261161|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807425|NCT03307785|467261162|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807426|NCT03307785|467261163|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807427|NCT03307785|467261164|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807428|NCT03307785|467261165|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
129807429|NCT03307785|467261155|FG000|Part C: Up to Approx. 60 Months|Death|0|||
129807430|NCT03307785|467261156|FG001|Part C: Up to Approx. 60 Months|Death|0|||
129807431|NCT03307785|467261157|FG002|Part C: Up to Approx. 60 Months|Death|0|||
129807432|NCT03307785|467261158|FG003|Part C: Up to Approx. 60 Months|Death|2|||
129807433|NCT03307785|467261159|FG004|Part C: Up to Approx. 60 Months|Death|5|||
129807434|NCT03307785|467261160|FG005|Part C: Up to Approx. 60 Months|Death|0|||
129807435|NCT03307785|467261161|FG006|Part C: Up to Approx. 60 Months|Death|0|||
129807436|NCT03307785|467261162|FG007|Part C: Up to Approx. 60 Months|Death|0|||
129807437|NCT03307785|467261163|FG008|Part C: Up to Approx. 60 Months|Death|0|||
129807438|NCT03307785|467261164|FG009|Part C: Up to Approx. 60 Months|Death|0|||
129807439|NCT03307785|467261165|FG010|Part C: Up to Approx. 60 Months|Death|0|||
129807440|NCT03307785|467261155|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129895063|NCT02939183|467575269|FG005|Overall Study|Not treated due to adverse event|0|||
129895064|NCT02939183|467575270|FG006|Overall Study|Not treated due to adverse event|1|||
129895065|NCT02939183|467575271|FG007|Overall Study|Not treated due to adverse event|0|||
129895066|NCT02939183|467575272|FG008|Overall Study|Not treated due to adverse event|0|||
129895067|NCT02696785|467575273|FG000|Blinded Treatment Period|Adverse Event|0|||
129895068|NCT02696785|467575274|FG001|Blinded Treatment Period|Adverse Event|1|||
129895069|NCT02696785|467575275|FG002|Blinded Treatment Period|Adverse Event|3|||
129895070|NCT02696785|467575276|FG003|Blinded Treatment Period|Adverse Event|0|||
129895071|NCT02696785|467575273|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
129895072|NCT02696785|467575274|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
129895073|NCT02696785|467575275|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
129895074|NCT02696785|467575276|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
129895075|NCT02696785|467575273|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
129895076|NCT02696785|467575274|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
129895077|NCT02696785|467575275|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
129895078|NCT02696785|467575276|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
129895079|NCT02696785|467575273|FG000|Blinded Treatment Period|Screen Failure|1|||
129895080|NCT02696785|467575274|FG001|Blinded Treatment Period|Screen Failure|0|||
129895081|NCT02696785|467575275|FG002|Blinded Treatment Period|Screen Failure|0|||
129895082|NCT02696785|467575276|FG003|Blinded Treatment Period|Screen Failure|0|||
129895083|NCT02696785|467575273|FG000|Washout Period|Withdrawal by Subject|0|||
129895084|NCT02696785|467575274|FG001|Washout Period|Withdrawal by Subject|1|||
129895085|NCT02696785|467575275|FG002|Washout Period|Withdrawal by Subject|0|||
129895086|NCT02696785|467575276|FG003|Washout Period|Withdrawal by Subject|0|||
129895087|NCT02696785|467575273|FG000|Washout Period|Lack of Efficacy|0|||
129895088|NCT02696785|467575274|FG001|Washout Period|Lack of Efficacy|1|||
129895089|NCT02696785|467575275|FG002|Washout Period|Lack of Efficacy|0|||
129895090|NCT02696785|467575276|FG003|Washout Period|Lack of Efficacy|0|||
129895091|NCT02696785|467575273|FG000|Extended Treatment Period|Adverse Event|2|||
129895092|NCT02696785|467575274|FG001|Extended Treatment Period|Adverse Event|3|||
129895093|NCT02696785|467575275|FG002|Extended Treatment Period|Adverse Event|2|||
129895094|NCT02696785|467575276|FG003|Extended Treatment Period|Adverse Event|1|||
129895095|NCT02696785|467575273|FG000|Extended Treatment Period|Lack of Efficacy|0|||
129895096|NCT02696785|467575274|FG001|Extended Treatment Period|Lack of Efficacy|1|||
129740355|NCT01927055|467008129|FG002|Open-label|Study Stopped|0|||
129740356|NCT01927055|467008127|FG000|Open-label|Supine Hypertension|4|||
129740357|NCT01927055|467008128|FG001|Open-label|Supine Hypertension|0|||
129895097|NCT02696785|467575275|FG002|Extended Treatment Period|Lack of Efficacy|0|||
129895098|NCT02696785|467575276|FG003|Extended Treatment Period|Lack of Efficacy|0|||
129895099|NCT02696785|467575273|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
129895100|NCT02696785|467575274|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
129895101|NCT02696785|467575275|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
129895102|NCT02696785|467575276|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
129895103|NCT02696785|467575273|FG000|Follow-up Period|Adverse Event|0|||
129895104|NCT02696785|467575274|FG001|Follow-up Period|Adverse Event|0|||
129895105|NCT02696785|467575275|FG002|Follow-up Period|Adverse Event|8|||
129895106|NCT02696785|467575276|FG003|Follow-up Period|Adverse Event|2|||
129895107|NCT02696785|467575273|FG000|Follow-up Period|Lost to Follow-up|0|||
129895108|NCT02696785|467575274|FG001|Follow-up Period|Lost to Follow-up|0|||
129895109|NCT02696785|467575275|FG002|Follow-up Period|Lost to Follow-up|0|||
129895110|NCT02696785|467575276|FG003|Follow-up Period|Lost to Follow-up|1|||
129895111|NCT02696785|467575273|FG000|Follow-up Period|Lack of Efficacy|0|||
129895112|NCT02696785|467575274|FG001|Follow-up Period|Lack of Efficacy|0|||
129895113|NCT02696785|467575275|FG002|Follow-up Period|Lack of Efficacy|0|||
129895114|NCT02696785|467575276|FG003|Follow-up Period|Lack of Efficacy|1|||
129895115|NCT02696785|467575273|FG000|Follow-up Period|Withdrawal by Subject|1|||
129895116|NCT02696785|467575274|FG001|Follow-up Period|Withdrawal by Subject|0|||
129895117|NCT02696785|467575275|FG002|Follow-up Period|Withdrawal by Subject|5|||
129895118|NCT02696785|467575276|FG003|Follow-up Period|Withdrawal by Subject|4|||
129895119|NCT03905135|467575277|FG000|Dose Escalation|Adverse Event|1|||
129895120|NCT03905135|467575278|FG001|Dose Escalation|Adverse Event|1|||
129895121|NCT03905135|467575277|FG000|Dose Escalation|Progressive disease|3|||
129895122|NCT03905135|467575278|FG001|Dose Escalation|Progressive disease|1|||
129895123|NCT03905135|467575277|FG000|Dose Escalation|Intercurrent illness|1|||
129895124|NCT03905135|467575278|FG001|Dose Escalation|Intercurrent illness|0|||
129895125|NCT01740557|467575279|FG000|Overall Study|Ineligible|1|||
129895126|NCT01740557|467575279|FG000|Overall Study|Screen failure|1|||
129740358|NCT01927055|467008129|FG002|Open-label|Supine Hypertension|0|||
129740359|NCT01927055|467008127|FG000|Open-label|Difficulty attending study visits|1|||
129895127|NCT00490555|467575280|FG000|Overall Study|noncompliant with drug administration|0|||
129895128|NCT00490555|467575281|FG001|Overall Study|noncompliant with drug administration|0|||
129895129|NCT00490555|467575282|FG002|Overall Study|noncompliant with drug administration|2|||
129740360|NCT01927055|467008128|FG001|Open-label|Difficulty attending study visits|0|||
129740361|NCT01927055|467008129|FG002|Open-label|Difficulty attending study visits|0|||
129740362|NCT01927055|467008127|FG000|Double-Blind|Adverse Event|0|||
129740363|NCT01927055|467008128|FG001|Double-Blind|Adverse Event|1|||
129740364|NCT01927055|467008129|FG002|Double-Blind|Adverse Event|1|||
129740365|NCT01927055|467008127|FG000|Double-Blind|Protocol Violation|0|||
129740366|NCT01927055|467008128|FG001|Double-Blind|Protocol Violation|0|||
129740367|NCT01927055|467008129|FG002|Double-Blind|Protocol Violation|1|||
129740368|NCT01927055|467008127|FG000|Double-Blind|Withdrawal by Subject|0|||
129740369|NCT01927055|467008128|FG001|Double-Blind|Withdrawal by Subject|2|||
129740370|NCT01927055|467008129|FG002|Double-Blind|Withdrawal by Subject|3|||
129740371|NCT01927055|467008127|FG000|Double-Blind|Study Stopped|0|||
129740372|NCT01927055|467008128|FG001|Double-Blind|Study Stopped|7|||
129740373|NCT01927055|467008129|FG002|Double-Blind|Study Stopped|7|||
129740374|NCT01927055|467008127|FG000|Double-Blind|Supine Hypertension|0|||
129740375|NCT01927055|467008128|FG001|Double-Blind|Supine Hypertension|0|||
129740376|NCT01927055|467008129|FG002|Double-Blind|Supine Hypertension|1|||
129740377|NCT01927055|467008127|FG000|Double-Blind|Extended Vacation|0|||
129740378|NCT01927055|467008128|FG001|Double-Blind|Extended Vacation|1|||
129740379|NCT01927055|467008129|FG002|Double-Blind|Extended Vacation|0|||
129740380|NCT00952614|467008135|FG000|Overall Study|Death|3|||
129740381|NCT00952614|467008135|FG000|Overall Study|Lost to Follow-up|3|||
129740382|NCT00952614|467008135|FG000|Overall Study|other reason|1|||
129740383|NCT04023682|467008136|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
129740384|NCT01291277|467008137|FG000|Overall Study|Death|2|||
129740385|NCT01291277|467008138|FG001|Overall Study|Death|2|||
129740386|NCT01291277|467008137|FG000|Overall Study|Lost to Follow-up|3|||
129740387|NCT01291277|467008138|FG001|Overall Study|Lost to Follow-up|1|||
129740388|NCT02963701|467008139|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
129740389|NCT02963701|467008140|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
129740390|NCT03480009|467008141|FG000|Overall Study|Lost to Follow-up|4|||
129740391|NCT03480009|467008142|FG001|Overall Study|Lost to Follow-up|5|||
129740392|NCT03480009|467008143|FG002|Overall Study|Lost to Follow-up|4|||
129740393|NCT03480009|467008144|FG003|Overall Study|Lost to Follow-up|0|||
129740394|NCT01105377|467008147|FG000|Overall Study|Withdrawal by Subject|0|||
129740395|NCT01105377|467008148|FG001|Overall Study|Withdrawal by Subject|1|||
129740396|NCT01403116|467008154|FG000|Overall Study|Adverse Event|7|||
129807441|NCT03307785|467261156|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807442|NCT03307785|467261157|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807443|NCT03307785|467261158|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
129807444|NCT03307785|467261159|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807445|NCT03307785|467261160|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807446|NCT03307785|467261161|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807447|NCT03307785|467261162|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807448|NCT03307785|467261163|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807449|NCT03307785|467261164|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807450|NCT03307785|467261165|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
129807451|NCT03307785|467261155|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807452|NCT03307785|467261156|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129740397|NCT01403116|467008155|FG001|Overall Study|Adverse Event|4|||
129740398|NCT01403116|467008154|FG000|Overall Study|Lost to Follow-up|7|||
129740399|NCT01403116|467008155|FG001|Overall Study|Lost to Follow-up|5|||
129740400|NCT01403116|467008154|FG000|Overall Study|Withdrawal by Subject|12|||
129740401|NCT01403116|467008155|FG001|Overall Study|Withdrawal by Subject|15|||
129740402|NCT01403116|467008154|FG000|Overall Study|Non-compliance of study drug|3|||
129740403|NCT01403116|467008155|FG001|Overall Study|Non-compliance of study drug|0|||
129740404|NCT01403116|467008154|FG000|Overall Study|Protocol Violation|0|||
129807453|NCT03307785|467261157|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807454|NCT03307785|467261158|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129740405|NCT01403116|467008155|FG001|Overall Study|Protocol Violation|1|||
129740406|NCT01403116|467008154|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
129740407|NCT01403116|467008155|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
129740408|NCT01403116|467008154|FG000|Overall Study|Hct >54%|2|||
129740409|NCT01403116|467008155|FG001|Overall Study|Hct >54%|0|||
129740410|NCT01403116|467008154|FG000|Overall Study|unable to keep appointments|0|||
129740411|NCT01403116|467008155|FG001|Overall Study|unable to keep appointments|2|||
129740412|NCT02540291|467008156|FG000|Overall Study|Death|7|||
129740413|NCT02540291|467008157|FG001|Overall Study|Death|7|||
129895130|NCT00490555|467575283|FG003|Overall Study|noncompliant with drug administration|0|||
129895131|NCT01007149|467575288|FG000|Overall Study|Administrative problems|0|||
129895132|NCT01007149|467575289|FG001|Overall Study|Administrative problems|1|||
129895133|NCT01913340|467575290|FG000|Overall Study|Death|2|||
129895134|NCT01913340|467575291|FG001|Overall Study|Death|5|||
129895135|NCT01913340|467575290|FG000|Overall Study|Lost to Follow-up|1|||
129895136|NCT01913340|467575291|FG001|Overall Study|Lost to Follow-up|1|||
129895137|NCT02320253|467575292|FG000|Overall Study|Withdrawal by Subject|3|||
129895138|NCT02320253|467575293|FG001|Overall Study|Withdrawal by Subject|0|||
129895139|NCT02320253|467575294|FG002|Overall Study|Withdrawal by Subject|0|||
129895140|NCT02320253|467575292|FG000|Overall Study|Lost to Follow-up|2|||
129895141|NCT02320253|467575293|FG001|Overall Study|Lost to Follow-up|2|||
129895142|NCT02320253|467575294|FG002|Overall Study|Lost to Follow-up|1|||
129895143|NCT02320253|467575292|FG000|Overall Study|Death|1|||
129895144|NCT02320253|467575293|FG001|Overall Study|Death|0|||
129895145|NCT02320253|467575294|FG002|Overall Study|Death|1|||
129895146|NCT00603538|467575295|FG000|Overall Study|Adverse Event|0|||
129895147|NCT00603538|467575296|FG001|Overall Study|Adverse Event|4|||
129895148|NCT00603538|467575297|FG002|Overall Study|Adverse Event|2|||
129895149|NCT00603538|467575295|FG000|Overall Study|Objective progression or relapse|3|||
129895150|NCT00603538|467575296|FG001|Overall Study|Objective progression or relapse|0|||
129895151|NCT00603538|467575297|FG002|Overall Study|Objective progression or relapse|0|||
129895152|NCT05750745|467575299|FG000|Overall Study|Adverse Event|1|||
129895153|NCT05750745|467575300|FG001|Overall Study|Adverse Event|0|||
129895154|NCT05750745|467575301|FG002|Overall Study|Adverse Event|0|||
129895155|NCT05750745|467575299|FG000|Overall Study|Protocol Violation|1|||
129895156|NCT05750745|467575300|FG001|Overall Study|Protocol Violation|0|||
129895157|NCT05750745|467575301|FG002|Overall Study|Protocol Violation|0|||
129895158|NCT05750745|467575299|FG000|Overall Study|Withdrawal by Subject|0|||
129895159|NCT05750745|467575300|FG001|Overall Study|Withdrawal by Subject|1|||
129895160|NCT05750745|467575301|FG002|Overall Study|Withdrawal by Subject|0|||
129895161|NCT00359619|467577091|FG000|Overall Study|Adverse Event|0|||
129895162|NCT00359619|467577092|FG001|Overall Study|Adverse Event|0|||
129895163|NCT00359619|467577093|FG002|Overall Study|Adverse Event|1|||
129895164|NCT00359619|467577094|FG003|Overall Study|Adverse Event|0|||
129895165|NCT00359619|467577095|FG004|Overall Study|Adverse Event|0|||
129895166|NCT00359619|467577096|FG005|Overall Study|Adverse Event|0|||
129895167|NCT00359619|467577097|FG006|Overall Study|Adverse Event|1|||
129895168|NCT00359619|467577091|FG000|Overall Study|Withdrawal by Subject|3|||
129895169|NCT00359619|467577092|FG001|Overall Study|Withdrawal by Subject|1|||
129895170|NCT00359619|467577093|FG002|Overall Study|Withdrawal by Subject|4|||
129895171|NCT00359619|467577094|FG003|Overall Study|Withdrawal by Subject|2|||
129895172|NCT00359619|467577095|FG004|Overall Study|Withdrawal by Subject|2|||
129895173|NCT00359619|467577096|FG005|Overall Study|Withdrawal by Subject|0|||
129895174|NCT00359619|467577097|FG006|Overall Study|Withdrawal by Subject|3|||
129895175|NCT00359619|467577091|FG000|Overall Study|Other|1|||
129895176|NCT00359619|467577092|FG001|Overall Study|Other|0|||
129895177|NCT00359619|467577093|FG002|Overall Study|Other|0|||
129895178|NCT00359619|467577094|FG003|Overall Study|Other|0|||
129895179|NCT00359619|467577095|FG004|Overall Study|Other|0|||
129895180|NCT00359619|467577096|FG005|Overall Study|Other|0|||
129895181|NCT00359619|467577097|FG006|Overall Study|Other|0|||
129895182|NCT00359619|467577091|FG000|Overall Study|Lost to Follow-up|4|||
129895183|NCT00359619|467577092|FG001|Overall Study|Lost to Follow-up|4|||
129895184|NCT00359619|467577093|FG002|Overall Study|Lost to Follow-up|2|||
129895185|NCT00359619|467577094|FG003|Overall Study|Lost to Follow-up|1|||
129895186|NCT00359619|467577095|FG004|Overall Study|Lost to Follow-up|1|||
129895187|NCT00359619|467577096|FG005|Overall Study|Lost to Follow-up|5|||
129895188|NCT00359619|467577097|FG006|Overall Study|Lost to Follow-up|0|||
129895189|NCT00256308|467577100|FG000|Overall Study|Death|2|||
129895190|NCT01419717|467577101|FG000|Overall Study|Protocol-specified Criteria|62|||
129895191|NCT01419717|467577101|FG000|Overall Study|Adverse Event|19|||
129895192|NCT01419717|467577101|FG000|Overall Study|Death|17|||
129895193|NCT01419717|467577101|FG000|Overall Study|Withdrawal by Subject|10|||
129740414|NCT02540291|467008158|FG002|Overall Study|Death|5|||
129740415|NCT02540291|467008159|FG003|Overall Study|Death|7|||
129740416|NCT02540291|467008156|FG000|Overall Study|Lost to Follow-up|0|||
129740417|NCT02540291|467008157|FG001|Overall Study|Lost to Follow-up|0|||
129740418|NCT02540291|467008158|FG002|Overall Study|Lost to Follow-up|1|||
129740419|NCT02540291|467008159|FG003|Overall Study|Lost to Follow-up|0|||
129740420|NCT02540291|467008156|FG000|Overall Study|Withdrawal Of Consent|0|||
129740421|NCT02540291|467008157|FG001|Overall Study|Withdrawal Of Consent|1|||
129740422|NCT02540291|467008158|FG002|Overall Study|Withdrawal Of Consent|0|||
129740423|NCT02540291|467008159|FG003|Overall Study|Withdrawal Of Consent|0|||
129895194|NCT01419717|467577101|FG000|Overall Study|Disease Progression|9|||
129740424|NCT02540291|467008156|FG000|Overall Study|Study Terminated By Sponsor|1|||
129740425|NCT02540291|467008157|FG001|Overall Study|Study Terminated By Sponsor|0|||
129740426|NCT02540291|467008158|FG002|Overall Study|Study Terminated By Sponsor|0|||
129740427|NCT02540291|467008159|FG003|Overall Study|Study Terminated By Sponsor|0|||
129740428|NCT02540291|467008156|FG000|Overall Study|Other|0|||
129740429|NCT02540291|467008157|FG001|Overall Study|Other|0|||
129740430|NCT02540291|467008158|FG002|Overall Study|Other|1|||
129740431|NCT02540291|467008159|FG003|Overall Study|Other|0|||
129740432|NCT04046250|467008173|FG000|Overall Study|Death|0|||
129740433|NCT04046250|467008174|FG001|Overall Study|Death|1|||
129740434|NCT04046250|467008173|FG000|Overall Study|Withdrawal by Subject|3|||
129740435|NCT04046250|467008174|FG001|Overall Study|Withdrawal by Subject|3|||
129740436|NCT04576897|467008175|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
129740437|NCT00527332|467008176|FG000|Overall Study|Protocol Violation|4|||
129740438|NCT00527332|467008177|FG001|Overall Study|Protocol Violation|8|||
129740439|NCT00527332|467008176|FG000|Overall Study|Withdrew consent|5|||
129740440|NCT00527332|467008177|FG001|Overall Study|Withdrew consent|1|||
129740441|NCT02666105|467008178|FG000|Overall Study|Death|1|||
129740442|NCT02100969|467009991|FG000|Overall Study|Did not pass screening phase|1|||
129740443|NCT01629953|467009992|FG000|Overall Study|Death|3|||
129740444|NCT01629953|467009993|FG001|Overall Study|Death|1|||
129740445|NCT01629953|467009992|FG000|Overall Study|Lost to Follow-up|10|||
129740446|NCT01629953|467009993|FG001|Overall Study|Lost to Follow-up|14|||
129740447|NCT00707954|467009994|FG000|Overall Study|Physician Decision|0|||
129740448|NCT00707954|467009995|FG001|Overall Study|Physician Decision|0|||
129740449|NCT00707954|467009996|FG002|Overall Study|Physician Decision|0|||
129740450|NCT00707954|467009997|FG003|Overall Study|Physician Decision|0|||
129740451|NCT00707954|467009998|FG004|Overall Study|Physician Decision|1|||
129740452|NCT04037254|467009999|FG000|Overall Study|Protocol Violation|1|||
129740453|NCT04037254|467010000|FG001|Overall Study|Protocol Violation|0|||
129740454|NCT04037254|467010001|FG002|Overall Study|Protocol Violation|0|||
129740455|NCT04037254|467010002|FG003|Overall Study|Protocol Violation|0|||
129740456|NCT04037254|467010003|FG004|Overall Study|Protocol Violation|0|||
129740457|NCT04037254|467009999|FG000|Overall Study|Withdrawal by Subject|0|||
129740458|NCT04037254|467010000|FG001|Overall Study|Withdrawal by Subject|0|||
129740459|NCT04037254|467010001|FG002|Overall Study|Withdrawal by Subject|1|||
129740460|NCT04037254|467010002|FG003|Overall Study|Withdrawal by Subject|0|||
129740461|NCT04037254|467010003|FG004|Overall Study|Withdrawal by Subject|0|||
129740462|NCT04037254|467009999|FG000|Overall Study|Delayed or incomplete treatment|0|||
129740463|NCT04037254|467010000|FG001|Overall Study|Delayed or incomplete treatment|2|||
129740464|NCT04037254|467010001|FG002|Overall Study|Delayed or incomplete treatment|1|||
129740465|NCT04037254|467010002|FG003|Overall Study|Delayed or incomplete treatment|0|||
129740466|NCT04037254|467010003|FG004|Overall Study|Delayed or incomplete treatment|0|||
129740467|NCT01306656|467010004|FG000|Overall Study|Lost to Follow-up|1|||
129740468|NCT01306656|467010005|FG001|Overall Study|Lost to Follow-up|0|||
129740469|NCT02504580|467010006|FG000|Overall Study|Other|1|||
129740470|NCT02504580|467010007|FG001|Overall Study|Other|0|||
129740471|NCT02504580|467010008|FG002|Overall Study|Other|0|||
129740472|NCT02504580|467010009|FG003|Overall Study|Other|2|||
129740473|NCT02504580|467010010|FG004|Overall Study|Other|1|||
129740474|NCT02504580|467010011|FG005|Overall Study|Other|1|||
129740475|NCT02504580|467010012|FG006|Overall Study|Other|1|||
129740476|NCT02504580|467010013|FG007|Overall Study|Other|2|||
129740477|NCT02504580|467010014|FG008|Overall Study|Other|0|||
129740478|NCT02504580|467010015|FG009|Overall Study|Other|0|||
129740479|NCT02504580|467010016|FG010|Overall Study|Other|0|||
129740480|NCT02504580|467010017|FG011|Overall Study|Other|2|||
129740481|NCT02504580|467010006|FG000|Overall Study|Subject refusal to continue|0|||
129740482|NCT02504580|467010007|FG001|Overall Study|Subject refusal to continue|1|||
129740483|NCT02504580|467010008|FG002|Overall Study|Subject refusal to continue|0|||
129740484|NCT02504580|467010009|FG003|Overall Study|Subject refusal to continue|0|||
129740485|NCT02504580|467010010|FG004|Overall Study|Subject refusal to continue|0|||
129740486|NCT02504580|467010011|FG005|Overall Study|Subject refusal to continue|0|||
129740487|NCT02504580|467010012|FG006|Overall Study|Subject refusal to continue|0|||
129807455|NCT03307785|467261159|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
129807456|NCT03307785|467261160|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807457|NCT03307785|467261161|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129740488|NCT02504580|467010013|FG007|Overall Study|Subject refusal to continue|0|||
129740489|NCT02504580|467010014|FG008|Overall Study|Subject refusal to continue|0|||
129740490|NCT02504580|467010015|FG009|Overall Study|Subject refusal to continue|0|||
129740491|NCT02504580|467010016|FG010|Overall Study|Subject refusal to continue|0|||
129740492|NCT02504580|467010017|FG011|Overall Study|Subject refusal to continue|0|||
129740493|NCT00448747|467010019|FG000|Overall Study|collapsed veins|1|||
129740494|NCT00448747|467010020|FG001|Overall Study|collapsed veins|0|||
129740495|NCT04051827|467010026|FG000|Overall Study|Death|1|||
129740496|NCT04051827|467010026|FG000|Overall Study|Withdrawal by Subject|4|||
129740497|NCT04051827|467010026|FG000|Overall Study|Progressive disease|16|||
129740498|NCT04051827|467010026|FG000|Overall Study|Physician Decision|1|||
129740499|NCT04051827|467010026|FG000|Overall Study|Other|4|||
129740500|NCT01424566|467010027|FG000|Single-blind Treatment|Adverse Event|71|||
129740501|NCT01424566|467010028|FG001|Single-blind Treatment|Adverse Event|0|||
129740502|NCT01424566|467010029|FG002|Single-blind Treatment|Adverse Event|0|||
129740503|NCT01424566|467010027|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
129740504|NCT01424566|467010028|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
129740505|NCT01424566|467010029|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
129740506|NCT01424566|467010027|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
129740507|NCT01424566|467010028|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
129895195|NCT01419717|467577101|FG000|Overall Study|Other|4|||
129895196|NCT01419717|467577101|FG000|Overall Study|Lost to Follow-up|2|||
129895197|NCT01419717|467577101|FG000|Overall Study|Administrative Decision|1|||
129895198|NCT01419717|467577101|FG000|Overall Study|Noncompliance|1|||
129895199|NCT02857283|467577102|FG000|First Exposure|Withdrawal by Subject|1|||
129895200|NCT02857283|467577103|FG001|First Exposure|Withdrawal by Subject|0|||
129895201|NCT00587288|467577104|FG000|Overall Study|Adverse Event|0|||
129895202|NCT00587288|467577105|FG001|Overall Study|Adverse Event|1|||
129895203|NCT00587288|467577104|FG000|Overall Study|Lack of Efficacy|2|||
129895204|NCT00587288|467577105|FG001|Overall Study|Lack of Efficacy|8|||
129895205|NCT00587288|467577104|FG000|Overall Study|Protocol Violation|1|||
129895206|NCT00587288|467577105|FG001|Overall Study|Protocol Violation|0|||
129895207|NCT05074498|467577110|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895208|NCT05074498|467577111|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895209|NCT05074498|467577112|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895210|NCT05074498|467577113|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
129895211|NCT05074498|467577114|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895212|NCT05074498|467577115|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
129895213|NCT05074498|467577110|FG000|Part 1 (Upto Day 104)|Other|1|||
129895214|NCT05074498|467577111|FG001|Part 1 (Upto Day 104)|Other|0|||
129895215|NCT05074498|467577112|FG002|Part 1 (Upto Day 104)|Other|0|||
129895216|NCT05074498|467577113|FG003|Part 1 (Upto Day 104)|Other|0|||
129895217|NCT05074498|467577114|FG004|Part 1 (Upto Day 104)|Other|0|||
129895218|NCT05074498|467577115|FG005|Part 1 (Upto Day 104)|Other|0|||
129895219|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895220|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895221|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895222|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895223|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
129895224|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
129895225|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Death|0|||
129895226|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Death|0|||
129895227|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Death|0|||
129895228|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Death|0|||
129895229|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Death|1|||
129895230|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Death|0|||
129895231|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895232|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895233|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895234|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
129895235|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
129895236|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
129895237|NCT05074498|467577110|FG000|Part 2 (Upto Day 104)|Other|0|||
129895238|NCT05074498|467577111|FG001|Part 2 (Upto Day 104)|Other|0|||
129895239|NCT05074498|467577112|FG002|Part 2 (Upto Day 104)|Other|0|||
129895240|NCT05074498|467577113|FG003|Part 2 (Upto Day 104)|Other|0|||
129895241|NCT05074498|467577114|FG004|Part 2 (Upto Day 104)|Other|1|||
129895242|NCT05074498|467577115|FG005|Part 2 (Upto Day 104)|Other|0|||
129895243|NCT01240356|467577116|FG000|Overall Study|Withdrawal by Subject|2|||
129895244|NCT01240356|467577117|FG001|Overall Study|Withdrawal by Subject|0|||
129895245|NCT01240356|467577116|FG000|Overall Study|MRI contraindication|1|||
129895246|NCT01240356|467577117|FG001|Overall Study|MRI contraindication|0|||
129895247|NCT01244984|467577124|FG000|Overall Study|Adverse Event|2|||
129895248|NCT01244984|467577125|FG001|Overall Study|Adverse Event|11|||
129895249|NCT01244984|467577126|FG002|Overall Study|Adverse Event|2|||
129895250|NCT01244984|467577124|FG000|Overall Study|Protocol Violation|1|||
129895251|NCT01244984|467577125|FG001|Overall Study|Protocol Violation|0|||
129895252|NCT01244984|467577126|FG002|Overall Study|Protocol Violation|0|||
129895253|NCT01244984|467577124|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
129740508|NCT01424566|467010029|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
129895254|NCT01244984|467577125|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
129895255|NCT01244984|467577126|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
129895256|NCT01244984|467577124|FG000|Overall Study|Withdrawal by Subject|1|||
129895257|NCT01244984|467577125|FG001|Overall Study|Withdrawal by Subject|2|||
129895258|NCT01244984|467577126|FG002|Overall Study|Withdrawal by Subject|2|||
129895259|NCT02072226|467577128|FG000|Overall Study|Lost to Follow-up|11|||
129895260|NCT02072226|467577129|FG001|Overall Study|Lost to Follow-up|7|||
129895261|NCT02072226|467577128|FG000|Overall Study|Patient Non-compliance|2|||
129895262|NCT02072226|467577129|FG001|Overall Study|Patient Non-compliance|3|||
129807458|NCT03307785|467261162|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807459|NCT03307785|467261163|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807460|NCT03307785|467261164|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807461|NCT03307785|467261165|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
129807462|NCT03307785|467261155|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807463|NCT03307785|467261156|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807464|NCT03307785|467261157|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807465|NCT03307785|467261158|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807466|NCT03307785|467261159|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807467|NCT03307785|467261160|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
129807468|NCT03307785|467261161|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807469|NCT03307785|467261162|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807470|NCT03307785|467261163|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807471|NCT03307785|467261164|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807472|NCT03307785|467261165|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
129807473|NCT03307785|467261155|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
129807474|NCT03307785|467261156|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
129807475|NCT03307785|467261157|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
129807476|NCT03307785|467261158|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
129807477|NCT03307785|467261159|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
129807478|NCT03307785|467261160|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
129807479|NCT03307785|467261161|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
129807480|NCT03307785|467261162|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
129807481|NCT03307785|467261163|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
129807482|NCT03307785|467261164|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
129807483|NCT03307785|467261165|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
129807484|NCT03307785|467261155|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129895263|NCT02072226|467577128|FG000|Overall Study|Death|1|||
129895264|NCT02072226|467577129|FG001|Overall Study|Death|0|||
129895265|NCT02072226|467577128|FG000|Overall Study|Patient Withdrawal of Consent|1|||
129807485|NCT03307785|467261156|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807486|NCT03307785|467261157|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807487|NCT03307785|467261158|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807488|NCT03307785|467261159|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807489|NCT03307785|467261160|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
129807490|NCT03307785|467261161|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807491|NCT03307785|467261162|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807492|NCT03307785|467261163|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807493|NCT03307785|467261164|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807494|NCT03307785|467261165|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
129807495|NCT03307785|467261155|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807496|NCT03307785|467261156|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807497|NCT03307785|467261157|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807498|NCT03307785|467261158|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807499|NCT03307785|467261159|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807500|NCT03307785|467261160|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
129807501|NCT03307785|467261161|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129895266|NCT02072226|467577129|FG001|Overall Study|Patient Withdrawal of Consent|0|||
129895267|NCT02095158|467577137|FG000|Overall Study|Adverse Event|14|||
129895268|NCT02095158|467577137|FG000|Overall Study|Lack of Efficacy|3|||
129895269|NCT02095158|467577137|FG000|Overall Study|Pregnancy|1|||
129895270|NCT02095158|467577137|FG000|Overall Study|Lost to Follow-up|20|||
129895271|NCT02095158|467577137|FG000|Overall Study|Personal Reasons|35|||
129895272|NCT02095158|467577137|FG000|Overall Study|Protocol Violation|1|||
129895273|NCT02095158|467577137|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129895274|NCT03424239|467577143|FG000|Overall Study|Withdrawal by Subject|2|||
129895275|NCT01446003|467577145|FG000|Period 1|Protocol Violation|2|||
129895276|NCT01446003|467577146|FG001|Period 1|Protocol Violation|0|||
129895277|NCT01446003|467577145|FG000|Period 2|Adverse Event|1|||
129895278|NCT01446003|467577146|FG001|Period 2|Adverse Event|0|||
129807502|NCT03307785|467261162|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807503|NCT03307785|467261163|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807504|NCT03307785|467261164|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129895279|NCT00318656|467577147|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
129895280|NCT00318656|467577148|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
129895281|NCT00318656|467577147|FG000|Overall Study|Did not receive any treatment|0|||
129895282|NCT00318656|467577148|FG001|Overall Study|Did not receive any treatment|1|||
129895283|NCT02042443|467577149|FG000|Overall Study|Adverse Event|2|||
129895284|NCT02042443|467577150|FG001|Overall Study|Adverse Event|1|||
129740509|NCT01424566|467010027|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
129740510|NCT01424566|467010028|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
129740511|NCT01424566|467010029|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
129740512|NCT01424566|467010027|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
129740513|NCT01424566|467010028|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
129740514|NCT01424566|467010029|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
129740515|NCT01424566|467010027|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
129740516|NCT01424566|467010028|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
129740517|NCT01424566|467010029|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
129740518|NCT01424566|467010027|FG000|Double-blind Treatment|Adverse Event|0|||
129740519|NCT01424566|467010028|FG001|Double-blind Treatment|Adverse Event|21|||
129740520|NCT01424566|467010029|FG002|Double-blind Treatment|Adverse Event|13|||
129740521|NCT01424566|467010027|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
129740522|NCT01424566|467010028|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
129740523|NCT01424566|467010029|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
129740524|NCT01424566|467010027|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
129740525|NCT01424566|467010028|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
129740526|NCT01424566|467010029|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
129740527|NCT01424566|467010027|FG000|Double-blind Treatment|Lack of Efficacy|0|||
129740528|NCT01424566|467010028|FG001|Double-blind Treatment|Lack of Efficacy|1|||
129807505|NCT03307785|467261165|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
129807506|NCT03307785|467261155|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807507|NCT03307785|467261156|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807508|NCT03307785|467261157|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807509|NCT03307785|467261158|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807510|NCT03307785|467261159|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807511|NCT03307785|467261160|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
129807512|NCT03307785|467261161|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129740529|NCT01424566|467010029|FG002|Double-blind Treatment|Lack of Efficacy|1|||
129740530|NCT03779503|467010034|FG000|First Intervention|Adverse Event|0|||
129740531|NCT03779503|467010035|FG001|First Intervention|Adverse Event|1|||
129740532|NCT03779503|467010034|FG000|First Intervention|Withdrawal by Subject|1|||
129740533|NCT03779503|467010035|FG001|First Intervention|Withdrawal by Subject|0|||
129807513|NCT03307785|467261162|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807514|NCT03307785|467261163|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807515|NCT03307785|467261164|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807516|NCT03307785|467261165|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
129807517|NCT03307785|467261155|FG000|Part E: Up to 4.4 Months|Death|0|||
129807518|NCT03307785|467261156|FG001|Part E: Up to 4.4 Months|Death|0|||
129807519|NCT03307785|467261157|FG002|Part E: Up to 4.4 Months|Death|0|||
129807520|NCT03307785|467261158|FG003|Part E: Up to 4.4 Months|Death|0|||
129807521|NCT03307785|467261159|FG004|Part E: Up to 4.4 Months|Death|0|||
129807522|NCT03307785|467261160|FG005|Part E: Up to 4.4 Months|Death|0|||
129807523|NCT03307785|467261161|FG006|Part E: Up to 4.4 Months|Death|1|||
129807524|NCT03307785|467261162|FG007|Part E: Up to 4.4 Months|Death|0|||
129807525|NCT03307785|467261163|FG008|Part E: Up to 4.4 Months|Death|0|||
129807526|NCT03307785|467261164|FG009|Part E: Up to 4.4 Months|Death|0|||
129807527|NCT03307785|467261165|FG010|Part E: Up to 4.4 Months|Death|0|||
129807528|NCT03307785|467261155|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
129807529|NCT03307785|467261156|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
129807530|NCT03307785|467261157|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
129807531|NCT03307785|467261158|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
129807532|NCT03307785|467261159|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
129807533|NCT03307785|467261160|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
129807534|NCT03307785|467261161|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
129807535|NCT03307785|467261162|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
129807536|NCT03307785|467261163|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
129807537|NCT03307785|467261164|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
129807538|NCT03307785|467261165|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
129807539|NCT03307785|467261155|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
129807540|NCT03307785|467261156|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
129807541|NCT03307785|467261157|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
129807542|NCT03307785|467261158|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
129895285|NCT02042443|467577149|FG000|Overall Study|Withdrawal by Subject|0|||
129895286|NCT02042443|467577150|FG001|Overall Study|Withdrawal by Subject|1|||
129895287|NCT02042443|467577149|FG000|Overall Study|Progression|21|||
129895288|NCT02042443|467577150|FG001|Overall Study|Progression|17|||
129895289|NCT02042443|467577149|FG000|Overall Study|not protocol specified|1|||
129895290|NCT02042443|467577150|FG001|Overall Study|not protocol specified|1|||
129895291|NCT02042443|467577149|FG000|Overall Study|Not eligible/not analyzable|3|||
129895292|NCT02042443|467577150|FG001|Overall Study|Not eligible/not analyzable|6|||
129895293|NCT02784704|467577151|FG000|Overall Study|Adverse Event|4|||
129895294|NCT02784704|467577152|FG001|Overall Study|Adverse Event|2|||
129895295|NCT02784704|467577151|FG000|Overall Study|Lost to Follow-up|6|||
129895296|NCT02784704|467577152|FG001|Overall Study|Lost to Follow-up|4|||
129895297|NCT02784704|467577151|FG000|Overall Study|Withdrawal by Subject|1|||
129895298|NCT02784704|467577152|FG001|Overall Study|Withdrawal by Subject|3|||
129895299|NCT02784704|467577151|FG000|Overall Study|Subject Non Compliance|2|||
129895300|NCT02784704|467577152|FG001|Overall Study|Subject Non Compliance|0|||
129895301|NCT00783692|467577155|FG000|Induction Phase|Adverse Event|7|||
129895302|NCT00783692|467577156|FG001|Induction Phase|Adverse Event|9|||
129740534|NCT00687609|467010036|FG000|Overall Study|Physician Decision|1|||
129740535|NCT00687609|467010036|FG000|Overall Study|Withdrawal by Subject|2|||
129740536|NCT00908037|467010037|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740537|NCT00908037|467010038|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740538|NCT00908037|467010039|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740539|NCT00908037|467010040|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740540|NCT00908037|467010041|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
129740541|NCT00908037|467010042|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740542|NCT00908037|467010043|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
129740543|NCT00908037|467010044|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740544|NCT00908037|467010045|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
129740545|NCT00908037|467010046|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740546|NCT00908037|467010047|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740547|NCT00908037|467010048|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
129740548|NCT00908037|467010037|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740549|NCT00908037|467010038|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740550|NCT00908037|467010039|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740551|NCT00908037|467010040|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740552|NCT00908037|467010041|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
129740553|NCT00908037|467010042|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740554|NCT00908037|467010043|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740555|NCT00908037|467010044|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740556|NCT00908037|467010045|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
129740557|NCT00908037|467010046|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740558|NCT00908037|467010047|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740559|NCT00908037|467010048|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
129740560|NCT00908037|467010037|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740561|NCT00908037|467010038|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740562|NCT00908037|467010039|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740563|NCT00908037|467010040|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
129740564|NCT00908037|467010041|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740565|NCT00908037|467010042|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740566|NCT00908037|467010043|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
129740567|NCT00908037|467010044|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740568|NCT00908037|467010045|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740569|NCT00908037|467010046|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740570|NCT00908037|467010047|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740571|NCT00908037|467010048|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
129740572|NCT00908037|467010037|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740573|NCT00908037|467010038|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740574|NCT00908037|467010039|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740575|NCT00908037|467010040|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740576|NCT00908037|467010041|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740577|NCT00908037|467010042|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740578|NCT00908037|467010043|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740579|NCT00908037|467010044|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740580|NCT00908037|467010045|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129895303|NCT00783692|467577157|FG002|Induction Phase|Adverse Event|24|||
129895304|NCT00783692|467577158|FG003|Induction Phase|Adverse Event|0|||
129895305|NCT00783692|467577159|FG004|Induction Phase|Adverse Event|0|||
129895306|NCT00783692|467577160|FG005|Induction Phase|Adverse Event|0|||
129895307|NCT00783692|467577161|FG006|Induction Phase|Adverse Event|0|||
129895308|NCT00783692|467577155|FG000|Induction Phase|Protocol Violation|0|||
129895309|NCT00783692|467577156|FG001|Induction Phase|Protocol Violation|0|||
129895310|NCT00783692|467577157|FG002|Induction Phase|Protocol Violation|1|||
129895311|NCT00783692|467577158|FG003|Induction Phase|Protocol Violation|0|||
129895312|NCT00783692|467577159|FG004|Induction Phase|Protocol Violation|0|||
129895313|NCT00783692|467577160|FG005|Induction Phase|Protocol Violation|0|||
129895314|NCT00783692|467577161|FG006|Induction Phase|Protocol Violation|0|||
129895315|NCT00783692|467577155|FG000|Induction Phase|Lack of Efficacy|1|||
129895316|NCT00783692|467577156|FG001|Induction Phase|Lack of Efficacy|3|||
129895317|NCT00783692|467577157|FG002|Induction Phase|Lack of Efficacy|28|||
129895318|NCT00783692|467577158|FG003|Induction Phase|Lack of Efficacy|0|||
129895319|NCT00783692|467577159|FG004|Induction Phase|Lack of Efficacy|0|||
129895320|NCT00783692|467577160|FG005|Induction Phase|Lack of Efficacy|0|||
129895321|NCT00783692|467577161|FG006|Induction Phase|Lack of Efficacy|0|||
129895322|NCT00783692|467577155|FG000|Induction Phase|Withdrawal by Subject|3|||
129895323|NCT00783692|467577156|FG001|Induction Phase|Withdrawal by Subject|9|||
129895324|NCT00783692|467577157|FG002|Induction Phase|Withdrawal by Subject|16|||
129895325|NCT00783692|467577158|FG003|Induction Phase|Withdrawal by Subject|0|||
129895326|NCT00783692|467577159|FG004|Induction Phase|Withdrawal by Subject|0|||
129895327|NCT00783692|467577160|FG005|Induction Phase|Withdrawal by Subject|0|||
129895328|NCT00783692|467577161|FG006|Induction Phase|Withdrawal by Subject|0|||
129895329|NCT00783692|467577155|FG000|Induction Phase|Lost to Follow-up|0|||
129895330|NCT00783692|467577156|FG001|Induction Phase|Lost to Follow-up|0|||
129895331|NCT00783692|467577157|FG002|Induction Phase|Lost to Follow-up|3|||
129895332|NCT00783692|467577158|FG003|Induction Phase|Lost to Follow-up|0|||
129895333|NCT00783692|467577159|FG004|Induction Phase|Lost to Follow-up|0|||
129895334|NCT00783692|467577160|FG005|Induction Phase|Lost to Follow-up|0|||
129895335|NCT00783692|467577161|FG006|Induction Phase|Lost to Follow-up|0|||
129895336|NCT00783692|467577155|FG000|Induction Phase|Other|0|||
129895337|NCT00783692|467577156|FG001|Induction Phase|Other|0|||
129895338|NCT00783692|467577157|FG002|Induction Phase|Other|2|||
129895339|NCT00783692|467577158|FG003|Induction Phase|Other|0|||
129895340|NCT00783692|467577159|FG004|Induction Phase|Other|0|||
129895341|NCT00783692|467577160|FG005|Induction Phase|Other|0|||
129895342|NCT00783692|467577161|FG006|Induction Phase|Other|0|||
129895343|NCT00783692|467577155|FG000|Maintenance Phase|Adverse Event|7|||
129895344|NCT00783692|467577156|FG001|Maintenance Phase|Adverse Event|0|||
129895345|NCT00783692|467577157|FG002|Maintenance Phase|Adverse Event|0|||
129895346|NCT00783692|467577158|FG003|Maintenance Phase|Adverse Event|15|||
129895347|NCT00783692|467577159|FG004|Maintenance Phase|Adverse Event|12|||
129895348|NCT00783692|467577160|FG005|Maintenance Phase|Adverse Event|9|||
129895349|NCT00783692|467577161|FG006|Maintenance Phase|Adverse Event|38|||
129895350|NCT00783692|467577155|FG000|Maintenance Phase|Protocol Violation|0|||
129895351|NCT00783692|467577156|FG001|Maintenance Phase|Protocol Violation|0|||
129895352|NCT00783692|467577157|FG002|Maintenance Phase|Protocol Violation|0|||
129895353|NCT00783692|467577158|FG003|Maintenance Phase|Protocol Violation|1|||
129895354|NCT00783692|467577159|FG004|Maintenance Phase|Protocol Violation|2|||
129895355|NCT00783692|467577160|FG005|Maintenance Phase|Protocol Violation|3|||
129895356|NCT00783692|467577161|FG006|Maintenance Phase|Protocol Violation|4|||
129895357|NCT00783692|467577155|FG000|Maintenance Phase|Lack of Efficacy|79|||
129895358|NCT00783692|467577156|FG001|Maintenance Phase|Lack of Efficacy|0|||
129895359|NCT00783692|467577157|FG002|Maintenance Phase|Lack of Efficacy|0|||
129740581|NCT00908037|467010046|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740582|NCT00908037|467010047|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
129740583|NCT00908037|467010048|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
129740584|NCT00908037|467010037|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740585|NCT00908037|467010038|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740586|NCT00908037|467010039|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740587|NCT00908037|467010040|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740588|NCT00908037|467010041|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740589|NCT00908037|467010042|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740590|NCT00908037|467010043|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129895360|NCT00783692|467577158|FG003|Maintenance Phase|Lack of Efficacy|64|||
129895361|NCT00783692|467577159|FG004|Maintenance Phase|Lack of Efficacy|58|||
129895362|NCT00783692|467577160|FG005|Maintenance Phase|Lack of Efficacy|48|||
129895363|NCT00783692|467577161|FG006|Maintenance Phase|Lack of Efficacy|177|||
129895364|NCT00783692|467577155|FG000|Maintenance Phase|Withdrawal by Subject|7|||
129895365|NCT00783692|467577156|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129895366|NCT00783692|467577157|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129895367|NCT00783692|467577158|FG003|Maintenance Phase|Withdrawal by Subject|7|||
129895368|NCT00783692|467577159|FG004|Maintenance Phase|Withdrawal by Subject|6|||
129895369|NCT00783692|467577160|FG005|Maintenance Phase|Withdrawal by Subject|9|||
129895370|NCT00783692|467577161|FG006|Maintenance Phase|Withdrawal by Subject|24|||
129895371|NCT00783692|467577155|FG000|Maintenance Phase|Lost to Follow-up|2|||
129895372|NCT00783692|467577156|FG001|Maintenance Phase|Lost to Follow-up|0|||
129740591|NCT00908037|467010044|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740592|NCT00908037|467010045|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740593|NCT00908037|467010046|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
129740594|NCT00908037|467010047|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
129740595|NCT00908037|467010048|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
129740596|NCT00908037|467010037|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740597|NCT00908037|467010038|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740598|NCT00908037|467010039|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740599|NCT00908037|467010040|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740600|NCT00908037|467010041|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740601|NCT00908037|467010042|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740602|NCT00908037|467010043|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740603|NCT00908037|467010044|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740604|NCT00908037|467010045|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740605|NCT00908037|467010046|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
129740606|NCT00908037|467010047|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740607|NCT00908037|467010048|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
129740608|NCT00908037|467010037|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740609|NCT00908037|467010038|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740610|NCT00908037|467010039|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740611|NCT00908037|467010040|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740612|NCT00908037|467010041|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129807543|NCT03307785|467261159|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
129807544|NCT03307785|467261160|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
129807545|NCT03307785|467261161|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
129807546|NCT03307785|467261162|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
129807547|NCT03307785|467261163|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
129807548|NCT03307785|467261164|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
129807549|NCT03307785|467261165|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
129807550|NCT03666624|467261170|FG000|Overall Study|participant grieving over recent death of parent|1|||
129807551|NCT03666624|467261171|FG001|Overall Study|participant grieving over recent death of parent|0|||
129807552|NCT03021304|467261172|FG000|Overall Study|Lack of Efficacy|1|||
129807553|NCT00569270|467261174|FG000|Period: First Intervention|Protocol Violation|0|||
129807554|NCT00569270|467261175|FG001|Period: First Intervention|Protocol Violation|1|||
129807555|NCT00492531|467261176|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
129807556|NCT00492531|467261177|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
129807557|NCT03822182|467261178|FG000|Overall Study|Protocol Violation|0|||
129807558|NCT03822182|467261179|FG001|Overall Study|Protocol Violation|1|||
129807559|NCT03822182|467261180|FG002|Overall Study|Protocol Violation|1|||
129807560|NCT00810355|467261181|FG000|Overall Study|Lost to Follow-up|13|||
129807561|NCT00810355|467261182|FG001|Overall Study|Lost to Follow-up|17|||
129807562|NCT00810355|467261183|FG002|Overall Study|Lost to Follow-up|11|||
129807563|NCT00810355|467261181|FG000|Overall Study|Withdrawal by Subject|1|||
129807564|NCT00810355|467261182|FG001|Overall Study|Withdrawal by Subject|0|||
129807565|NCT00810355|467261183|FG002|Overall Study|Withdrawal by Subject|0|||
129807566|NCT00843856|467261186|FG000|Overall Study|Lost to Follow-up|1|||
129807567|NCT00843856|467261187|FG001|Overall Study|Lost to Follow-up|2|||
129807568|NCT01758523|467261188|FG000|Overall Study|Adverse Event|2|||
129807569|NCT01758523|467261189|FG001|Overall Study|Adverse Event|1|||
129807570|NCT01758523|467261188|FG000|Overall Study|Lack of Efficacy|4|||
129807571|NCT01758523|467261189|FG001|Overall Study|Lack of Efficacy|2|||
129807572|NCT01758523|467261188|FG000|Overall Study|Lost to Follow-up|3|||
129807573|NCT01758523|467261189|FG001|Overall Study|Lost to Follow-up|4|||
129807574|NCT01758523|467261188|FG000|Overall Study|Withdrawal by Subject|12|||
129740613|NCT00908037|467010042|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740614|NCT00908037|467010043|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740615|NCT00908037|467010044|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740616|NCT00908037|467010045|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740617|NCT00908037|467010046|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129807575|NCT01758523|467261189|FG001|Overall Study|Withdrawal by Subject|7|||
129807576|NCT01893203|467261190|FG000|Overall Study|Withdrawal by Subject|1|||
129807577|NCT00621959|467261191|FG000|Overall Study|Adverse Event|4|||
129807578|NCT00621959|467261192|FG001|Overall Study|Adverse Event|2|||
129807579|NCT00621959|467261191|FG000|Overall Study|Lack of Efficacy|1|||
129807580|NCT00621959|467261192|FG001|Overall Study|Lack of Efficacy|1|||
129807581|NCT00621959|467261191|FG000|Overall Study|Lost to Follow-up|0|||
129807582|NCT00621959|467261192|FG001|Overall Study|Lost to Follow-up|2|||
129807583|NCT00621959|467261191|FG000|Overall Study|Withdrawal by Subject|1|||
129807584|NCT00621959|467261192|FG001|Overall Study|Withdrawal by Subject|1|||
129807585|NCT00621959|467261191|FG000|Overall Study|Other|1|||
129740618|NCT00908037|467010047|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
129740619|NCT00908037|467010048|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
129740620|NCT00908037|467010037|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740621|NCT00908037|467010038|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740622|NCT00908037|467010039|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740623|NCT00908037|467010040|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740624|NCT00908037|467010041|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740625|NCT00908037|467010042|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740626|NCT00908037|467010043|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740627|NCT00908037|467010044|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740628|NCT00908037|467010045|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740629|NCT00908037|467010046|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
129740630|NCT00908037|467010047|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740631|NCT00908037|467010048|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
129740632|NCT00908037|467010037|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740633|NCT00908037|467010038|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740634|NCT00908037|467010039|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740635|NCT00908037|467010040|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740636|NCT00908037|467010041|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740637|NCT00908037|467010042|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740638|NCT00908037|467010043|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740639|NCT00908037|467010044|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740640|NCT00908037|467010045|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740641|NCT00908037|467010046|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740642|NCT00908037|467010047|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
129740643|NCT00908037|467010048|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
129740644|NCT00581360|467010054|FG000|Overall Study|Withdrawal by Subject|1|||
129740645|NCT00552760|467010055|FG000|Overall Study|Adverse Event|3|||
129740646|NCT00552760|467010056|FG001|Overall Study|Adverse Event|5|||
129740647|NCT00552760|467010055|FG000|Overall Study|Relapsed- Depressed Event|10|||
129740648|NCT00552760|467010056|FG001|Overall Study|Relapsed- Depressed Event|16|||
129740649|NCT00552760|467010055|FG000|Overall Study|Relapse- Manic Event|3|||
129740650|NCT00552760|467010056|FG001|Overall Study|Relapse- Manic Event|3|||
129740651|NCT00552760|467010055|FG000|Overall Study|Relapsed- Mixed Event|3|||
129740652|NCT00552760|467010056|FG001|Overall Study|Relapsed- Mixed Event|5|||
129740653|NCT00552760|467010055|FG000|Overall Study|Protocol Violation|0|||
129740654|NCT00552760|467010056|FG001|Overall Study|Protocol Violation|1|||
129740655|NCT00552760|467010055|FG000|Overall Study|Lost to Follow-up|1|||
129740656|NCT00552760|467010056|FG001|Overall Study|Lost to Follow-up|1|||
129740657|NCT00552760|467010055|FG000|Overall Study|Non-compliance|1|||
129740658|NCT00552760|467010056|FG001|Overall Study|Non-compliance|1|||
129740659|NCT00552760|467010055|FG000|Overall Study|Medical Condition|1|||
129740660|NCT00552760|467010056|FG001|Overall Study|Medical Condition|1|||
129740661|NCT00552760|467010055|FG000|Overall Study|Withdrawal by Subject|3|||
129740662|NCT00552760|467010056|FG001|Overall Study|Withdrawal by Subject|0|||
129740663|NCT00552760|467010055|FG000|Overall Study|Medication Change|1|||
129740664|NCT00552760|467010056|FG001|Overall Study|Medication Change|0|||
129740665|NCT00924404|467010059|FG000|Overall Study|Lost to Follow-up|6|||
129740666|NCT00924404|467010060|FG001|Overall Study|Lost to Follow-up|4|||
129740667|NCT03831945|467010061|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
129807586|NCT00621959|467261192|FG001|Overall Study|Other|3|||
129807587|NCT00590135|467261193|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
129807588|NCT04729621|467261194|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
129807589|NCT04729621|467261195|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
129807590|NCT04729621|467261196|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
129740668|NCT03831945|467010062|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
129740669|NCT03831945|467010061|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
129740670|NCT03831945|467010062|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
129740671|NCT03831945|467010061|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
129740672|NCT03831945|467010062|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
129740673|NCT00710385|467010064|FG000|Overall Study|Did not qualify|1|||
129740674|NCT00710385|467010064|FG000|Overall Study|Withdrawal by Subject|1|||
129740675|NCT00710385|467010064|FG000|Overall Study|Undisclosed back pain|1|||
129807591|NCT04729621|467261197|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
129740676|NCT00710385|467010064|FG000|Overall Study|Physician Decision|1|||
129740677|NCT00710385|467010064|FG000|Overall Study|Undisclosed excessive methadone use|1|||
129740678|NCT01985360|467010065|FG000|Overall Study|Withdrawal by Subject|4|||
129740679|NCT01985360|467010066|FG001|Overall Study|Withdrawal by Subject|0|||
129740680|NCT01985360|467010065|FG000|Overall Study|Lost to Follow-up|5|||
129740681|NCT01985360|467010066|FG001|Overall Study|Lost to Follow-up|3|||
129740682|NCT02976103|467010067|FG000|Overall Study|Withdrawal by Subject|1|||
129740683|NCT02976103|467010068|FG001|Overall Study|Withdrawal by Subject|0|||
129740684|NCT02976103|467010067|FG000|Overall Study|Lost to Follow-up|12|||
129740685|NCT02976103|467010068|FG001|Overall Study|Lost to Follow-up|8|||
129740686|NCT04881747|467010071|FG000|Period 2 Washout|Adverse Event|1|||
129740687|NCT04881747|467010072|FG001|Period 2 Washout|Adverse Event|0|||
129740688|NCT04881747|467010073|FG002|Period 2 Washout|Adverse Event|0|||
129740689|NCT04881747|467010074|FG003|Period 2 Washout|Adverse Event|0|||
129740690|NCT04881747|467010075|FG004|Period 2 Washout|Adverse Event|1|||
129740691|NCT04881747|467010076|FG005|Period 2 Washout|Adverse Event|0|||
129740692|NCT04881747|467010071|FG000|Period 2 Washout|Withdrawal by Subject|1|||
129740693|NCT04881747|467010072|FG001|Period 2 Washout|Withdrawal by Subject|0|||
129740694|NCT04881747|467010073|FG002|Period 2 Washout|Withdrawal by Subject|0|||
129740695|NCT04881747|467010074|FG003|Period 2 Washout|Withdrawal by Subject|1|||
129740696|NCT04881747|467010075|FG004|Period 2 Washout|Withdrawal by Subject|0|||
129740697|NCT04881747|467010076|FG005|Period 2 Washout|Withdrawal by Subject|0|||
129740698|NCT04598269|467010079|FG000|Overall Study|Adverse Event|0|||
129740699|NCT04598269|467010080|FG001|Overall Study|Adverse Event|3|||
129740700|NCT04598269|467010079|FG000|Overall Study|Withdrawal by Subject|1|||
129740701|NCT04598269|467010080|FG001|Overall Study|Withdrawal by Subject|4|||
129740702|NCT04598269|467010079|FG000|Overall Study|Lost to Follow-up|1|||
129740703|NCT04598269|467010080|FG001|Overall Study|Lost to Follow-up|0|||
129740704|NCT04598269|467010079|FG000|Overall Study|Not Treated|2|||
129740705|NCT04598269|467010080|FG001|Overall Study|Not Treated|0|||
129740706|NCT02598128|467010085|FG000|Period A: Days -7 to -1|Adverse Event|1|||
129740707|NCT02598128|467010086|FG001|Period A: Days -7 to -1|Adverse Event|0|||
129740708|NCT02598128|467010087|FG002|Period A: Days -7 to -1|Adverse Event|0|||
129740709|NCT02598128|467010088|FG003|Period A: Days -7 to -1|Adverse Event|0|||
129740710|NCT01459913|467010090|FG000|Overall Study|Adverse Event|0|||
129740711|NCT01459913|467010091|FG001|Overall Study|Adverse Event|0|||
129740712|NCT01459913|467010092|FG002|Overall Study|Adverse Event|0|||
129740713|NCT01459913|467010093|FG003|Overall Study|Adverse Event|3|||
129740714|NCT01459913|467010090|FG000|Overall Study|Withdrawal by Subject|4|||
129740715|NCT01459913|467010091|FG001|Overall Study|Withdrawal by Subject|0|||
129740716|NCT01459913|467010092|FG002|Overall Study|Withdrawal by Subject|0|||
129740717|NCT01459913|467010093|FG003|Overall Study|Withdrawal by Subject|5|||
129740718|NCT01459913|467010090|FG000|Overall Study|Lost to Follow-up|7|||
129740719|NCT01459913|467010091|FG001|Overall Study|Lost to Follow-up|4|||
129740720|NCT01459913|467010092|FG002|Overall Study|Lost to Follow-up|1|||
129740721|NCT01459913|467010093|FG003|Overall Study|Lost to Follow-up|8|||
129740722|NCT01459913|467010090|FG000|Overall Study|Death|0|||
129740723|NCT01459913|467010091|FG001|Overall Study|Death|0|||
129740724|NCT01459913|467010092|FG002|Overall Study|Death|0|||
129740725|NCT01459913|467010093|FG003|Overall Study|Death|1|||
129740726|NCT01459913|467010090|FG000|Overall Study|Non- Compliance|0|||
129740727|NCT01459913|467010091|FG001|Overall Study|Non- Compliance|0|||
129740728|NCT01459913|467010092|FG002|Overall Study|Non- Compliance|0|||
129740729|NCT01459913|467010093|FG003|Overall Study|Non- Compliance|3|||
129740730|NCT01459913|467010090|FG000|Overall Study|Physician Decision|0|||
129740731|NCT01459913|467010091|FG001|Overall Study|Physician Decision|1|||
129740732|NCT01459913|467010092|FG002|Overall Study|Physician Decision|0|||
129740733|NCT01459913|467010093|FG003|Overall Study|Physician Decision|0|||
129445351|NCT02684279|465931272|FG000|Overall Study|Withdrawal by Subject|92|||
129740734|NCT01459913|467010090|FG000|Overall Study|Study Terminated by Sponsor|30|||
129740735|NCT01459913|467010091|FG001|Overall Study|Study Terminated by Sponsor|15|||
129740736|NCT01459913|467010092|FG002|Overall Study|Study Terminated by Sponsor|9|||
129740737|NCT01459913|467010093|FG003|Overall Study|Study Terminated by Sponsor|11|||
129740738|NCT01459913|467010090|FG000|Overall Study|Other|0|||
129740739|NCT01459913|467010091|FG001|Overall Study|Other|0|||
129740740|NCT01459913|467010092|FG002|Overall Study|Other|3|||
129740741|NCT01459913|467010093|FG003|Overall Study|Other|1|||
129740742|NCT01459913|467010090|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
129740743|NCT01459913|467010091|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
129740744|NCT01459913|467010092|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
129740745|NCT01459913|467010093|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
129740746|NCT01064687|467010094|FG000|Overall Study|Adverse Event|9|||
129740747|NCT01064687|467010095|FG001|Overall Study|Adverse Event|4|||
129740748|NCT01064687|467010096|FG002|Overall Study|Adverse Event|10|||
129740749|NCT01064687|467010097|FG003|Overall Study|Adverse Event|3|||
129740750|NCT01064687|467010094|FG000|Overall Study|Death|1|||
129740751|NCT01064687|467010095|FG001|Overall Study|Death|1|||
129740752|NCT01064687|467010096|FG002|Overall Study|Death|0|||
129740753|NCT01064687|467010097|FG003|Overall Study|Death|0|||
129979656|NCT00403767|467889417|FG000|Overall Study|Protocol Violation|142|||
129740754|NCT01064687|467010094|FG000|Overall Study|Entry Criteria Not Met|3|||
129740755|NCT01064687|467010095|FG001|Overall Study|Entry Criteria Not Met|0|||
129740756|NCT01064687|467010096|FG002|Overall Study|Entry Criteria Not Met|0|||
129740757|NCT01064687|467010097|FG003|Overall Study|Entry Criteria Not Met|0|||
129740758|NCT01064687|467010094|FG000|Overall Study|Lack of Efficacy|1|||
129740759|NCT01064687|467010095|FG001|Overall Study|Lack of Efficacy|0|||
129740760|NCT01064687|467010096|FG002|Overall Study|Lack of Efficacy|2|||
129740761|NCT01064687|467010097|FG003|Overall Study|Lack of Efficacy|3|||
129740762|NCT01064687|467010094|FG000|Overall Study|Lost to Follow-up|7|||
129740763|NCT01064687|467010095|FG001|Overall Study|Lost to Follow-up|10|||
129740764|NCT01064687|467010096|FG002|Overall Study|Lost to Follow-up|13|||
129740765|NCT01064687|467010097|FG003|Overall Study|Lost to Follow-up|5|||
129740766|NCT01064687|467010094|FG000|Overall Study|Physician Decision|2|||
129740767|NCT01064687|467010095|FG001|Overall Study|Physician Decision|2|||
129740768|NCT01064687|467010096|FG002|Overall Study|Physician Decision|0|||
129740769|NCT01064687|467010097|FG003|Overall Study|Physician Decision|0|||
129740770|NCT01064687|467010094|FG000|Overall Study|Protocol Violation|1|||
129740771|NCT01064687|467010095|FG001|Overall Study|Protocol Violation|1|||
129740772|NCT01064687|467010096|FG002|Overall Study|Protocol Violation|0|||
129740773|NCT01064687|467010097|FG003|Overall Study|Protocol Violation|1|||
129740774|NCT01064687|467010094|FG000|Overall Study|Sponsor Decision|0|||
129740775|NCT01064687|467010095|FG001|Overall Study|Sponsor Decision|0|||
129740776|NCT01064687|467010096|FG002|Overall Study|Sponsor Decision|3|||
129740777|NCT01064687|467010097|FG003|Overall Study|Sponsor Decision|0|||
129740778|NCT01064687|467010094|FG000|Overall Study|Withdrawal by Subject|9|||
129740779|NCT01064687|467010095|FG001|Overall Study|Withdrawal by Subject|7|||
129740780|NCT01064687|467010096|FG002|Overall Study|Withdrawal by Subject|12|||
129740781|NCT01064687|467010097|FG003|Overall Study|Withdrawal by Subject|5|||
129740782|NCT01064687|467010094|FG000|Overall Study|Treatment Noncompliance|1|||
129740783|NCT01064687|467010095|FG001|Overall Study|Treatment Noncompliance|1|||
129740784|NCT01064687|467010096|FG002|Overall Study|Treatment Noncompliance|1|||
129740785|NCT01064687|467010097|FG003|Overall Study|Treatment Noncompliance|0|||
129740786|NCT00619489|467010098|FG000|Overall Study|Adverse Event|0|||
129740787|NCT00619489|467010099|FG001|Overall Study|Adverse Event|7|||
129740788|NCT00619489|467010098|FG000|Overall Study|Withdrawal by Subject|1|||
129740789|NCT00619489|467010099|FG001|Overall Study|Withdrawal by Subject|1|||
129740790|NCT00619489|467010098|FG000|Overall Study|Lack of Efficacy|0|||
129740791|NCT00619489|467010099|FG001|Overall Study|Lack of Efficacy|11|||
129740792|NCT00619489|467010098|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
129740793|NCT00619489|467010099|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
129740794|NCT02966015|467010100|FG000|Inclusion Visit|did not answer questionnaire|8|||
129740795|NCT02966015|467010101|FG001|Inclusion Visit|did not answer questionnaire|3|||
129740796|NCT03040986|467010106|FG000|Overall Study|Hospice|1|||
129740797|NCT03040986|467010107|FG001|Overall Study|Hospice|0|||
129740798|NCT03040986|467010106|FG000|Overall Study|Adverse Event|2|||
129740799|NCT03040986|467010107|FG001|Overall Study|Adverse Event|1|||
129740800|NCT03040986|467010106|FG000|Overall Study|Disease progression on study|3|||
129740801|NCT03040986|467010107|FG001|Overall Study|Disease progression on study|1|||
129740802|NCT01183468|467010112|FG000|Overall Study|Lost to Follow-up|2|||
129740803|NCT01183468|467010113|FG001|Overall Study|Lost to Follow-up|1|||
129740804|NCT01183468|467010114|FG002|Overall Study|Lost to Follow-up|0|||
129740805|NCT01183468|467010115|FG003|Overall Study|Lost to Follow-up|0|||
129740806|NCT01183468|467010112|FG000|Overall Study|Physician Decision|1|||
129740807|NCT01183468|467010113|FG001|Overall Study|Physician Decision|0|||
129740808|NCT01183468|467010114|FG002|Overall Study|Physician Decision|0|||
129740809|NCT01183468|467010115|FG003|Overall Study|Physician Decision|0|||
129740810|NCT01183468|467010112|FG000|Overall Study|Withdrawal by Subject|0|||
129740811|NCT01183468|467010113|FG001|Overall Study|Withdrawal by Subject|1|||
129740812|NCT01183468|467010114|FG002|Overall Study|Withdrawal by Subject|0|||
129740813|NCT01183468|467010115|FG003|Overall Study|Withdrawal by Subject|0|||
129740814|NCT00845065|467010116|FG000|Overall Study|Adverse Event|3|||
129740815|NCT00845065|467010117|FG001|Overall Study|Adverse Event|23|||
129740816|NCT00845065|467010116|FG000|Overall Study|Lack of Efficacy|43|||
129740817|NCT00845065|467010117|FG001|Overall Study|Lack of Efficacy|21|||
129740818|NCT00845065|467010116|FG000|Overall Study|Non-Medical Reasons|1|||
129740819|NCT00845065|467010117|FG001|Overall Study|Non-Medical Reasons|11|||
129740820|NCT01198509|467010118|FG000|Overall Study|Withdrawal by Subject|1|||
129740821|NCT01198509|467010119|FG001|Overall Study|Withdrawal by Subject|0|||
129740822|NCT01198509|467010120|FG002|Overall Study|Withdrawal by Subject|0|||
129740823|NCT01198509|467010121|FG003|Overall Study|Withdrawal by Subject|0|||
129740824|NCT01198509|467010122|FG004|Overall Study|Withdrawal by Subject|0|||
129740825|NCT01198509|467010123|FG005|Overall Study|Withdrawal by Subject|0|||
129740826|NCT00499746|467010124|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
129740827|NCT00499746|467010124|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
129740828|NCT00499746|467010124|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
129740829|NCT00499746|467010124|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
129740830|NCT02273960|467010125|FG000|Short Term Period|Lost to Follow-up|1|||
129807592|NCT04729621|467261198|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
129807593|NCT04729621|467261194|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
129807594|NCT04729621|467261195|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
129807595|NCT04729621|467261196|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
129807596|NCT04729621|467261197|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
129807597|NCT04729621|467261198|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
129807598|NCT04729621|467261194|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
129807599|NCT04729621|467261195|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
129807600|NCT04729621|467261196|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
129807601|NCT04729621|467261197|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
129807602|NCT04729621|467261198|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
129895373|NCT00783692|467577157|FG002|Maintenance Phase|Lost to Follow-up|0|||
129740831|NCT02273960|467010126|FG001|Short Term Period|Lost to Follow-up|0|||
129740832|NCT02273960|467010127|FG002|Short Term Period|Lost to Follow-up|0|||
129740833|NCT02273960|467010128|FG003|Short Term Period|Lost to Follow-up|0|||
129740834|NCT02273960|467010125|FG000|Short Term Period|Lack of Efficacy|0|||
129740835|NCT02273960|467010126|FG001|Short Term Period|Lack of Efficacy|0|||
129740836|NCT02273960|467010127|FG002|Short Term Period|Lack of Efficacy|0|||
129740837|NCT02273960|467010128|FG003|Short Term Period|Lack of Efficacy|1|||
129740838|NCT02273960|467010125|FG000|Short Term Period|ST complete, not entering LTE|4|||
129740839|NCT02273960|467010126|FG001|Short Term Period|ST complete, not entering LTE|6|||
129740840|NCT02273960|467010127|FG002|Short Term Period|ST complete, not entering LTE|4|||
129740841|NCT02273960|467010128|FG003|Short Term Period|ST complete, not entering LTE|5|||
129740842|NCT02273960|467010125|FG000|Long Term Extension|Death|0|||
129740843|NCT02273960|467010126|FG001|Long Term Extension|Death|0|||
129740844|NCT02273960|467010127|FG002|Long Term Extension|Death|0|||
129740845|NCT02273960|467010128|FG003|Long Term Extension|Death|1|||
129740846|NCT00558272|467010129|FG000|Overall Study|Adverse Event|10|||
129740847|NCT00558272|467010130|FG001|Overall Study|Adverse Event|0|||
129740848|NCT00558272|467010129|FG000|Overall Study|Death|1|||
129740849|NCT00558272|467010130|FG001|Overall Study|Death|0|||
129740850|NCT00558272|467010129|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
129740851|NCT00558272|467010130|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
129740852|NCT00558272|467010129|FG000|Overall Study|AZ study team decision|0|||
129740853|NCT00558272|467010130|FG001|Overall Study|AZ study team decision|1|||
129740854|NCT00558272|467010129|FG000|Overall Study|Incorrectly enrolled|1|||
129740855|NCT00558272|467010130|FG001|Overall Study|Incorrectly enrolled|0|||
129740856|NCT00558272|467010129|FG000|Overall Study|Withdrawal by Subject|0|||
129740857|NCT00558272|467010130|FG001|Overall Study|Withdrawal by Subject|1|||
129740858|NCT02745535|467010132|FG000|Overall Study|Death|1|||
129740859|NCT02745535|467010132|FG000|Overall Study|Adverse Event|3|||
129740860|NCT02745535|467010132|FG000|Overall Study|Lost to Follow-up|2|||
129740861|NCT00849108|467010133|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
129740862|NCT00849108|467010134|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
129740863|NCT00849108|467010133|FG000|Cohort 2 Efficacy|Adverse Event|0|||
129740864|NCT00849108|467010134|FG001|Cohort 2 Efficacy|Adverse Event|1|||
129740865|NCT00849108|467010133|FG000|Cohort 2 Efficacy|Other|0|||
129895374|NCT00783692|467577158|FG003|Maintenance Phase|Lost to Follow-up|1|||
129895375|NCT00783692|467577159|FG004|Maintenance Phase|Lost to Follow-up|3|||
129895376|NCT00783692|467577160|FG005|Maintenance Phase|Lost to Follow-up|2|||
129895377|NCT00783692|467577161|FG006|Maintenance Phase|Lost to Follow-up|5|||
129895378|NCT00783692|467577155|FG000|Maintenance Phase|Other|0|||
129895379|NCT00783692|467577156|FG001|Maintenance Phase|Other|0|||
129895380|NCT00783692|467577157|FG002|Maintenance Phase|Other|0|||
129895381|NCT00783692|467577158|FG003|Maintenance Phase|Other|1|||
129895382|NCT00783692|467577159|FG004|Maintenance Phase|Other|0|||
129895383|NCT00783692|467577160|FG005|Maintenance Phase|Other|1|||
129895384|NCT00783692|467577161|FG006|Maintenance Phase|Other|1|||
129895385|NCT00768066|467577164|FG000|Overall Study|Did not receive study product injection.|3|||
129895386|NCT00768066|467577165|FG001|Overall Study|Did not receive study product injection.|3|||
129895387|NCT00768066|467577166|FG002|Overall Study|Did not receive study product injection.|0|||
129895388|NCT04831775|467577167|FG000|Overall Study|Lost to Follow-up|11|||
129895389|NCT04831775|467577168|FG001|Overall Study|Lost to Follow-up|13|||
129895390|NCT05550337|467577171|FG000|Overall Study|Lack of Efficacy|0|||
129740866|NCT00849108|467010134|FG001|Cohort 2 Efficacy|Other|9|||
129895391|NCT05550337|467577172|FG001|Overall Study|Lack of Efficacy|0|||
129895392|NCT05550337|467577173|FG002|Overall Study|Lack of Efficacy|1|||
129895393|NCT05550337|467577171|FG000|Overall Study|Adverse Event|1|||
129740867|NCT01563172|467010135|FG000|Overall Study|Adverse Event|5|||
129740868|NCT01563172|467010135|FG000|Overall Study|Lost to Follow-up|2|||
129740869|NCT01563172|467010135|FG000|Overall Study|Other (Protocol deviation)|5|||
129740870|NCT01563172|467010135|FG000|Overall Study|Other (Not specified)|1|||
129740871|NCT02014584|467010138|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129740872|NCT02014584|467010139|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
129740873|NCT02014584|467010140|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129740874|NCT02014584|467010141|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129740875|NCT02014584|467010142|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129740876|NCT02014584|467010143|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129740877|NCT02014584|467010138|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
129740878|NCT02014584|467010139|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
129740879|NCT02014584|467010140|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129740880|NCT02014584|467010141|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129740881|NCT02014584|467010142|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129740882|NCT02014584|467010143|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129740883|NCT02014584|467010138|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129740884|NCT02014584|467010139|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129740885|NCT02014584|467010140|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
129740886|NCT02014584|467010141|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129740887|NCT02014584|467010142|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129740888|NCT02014584|467010143|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
129740889|NCT02014584|467010138|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129740890|NCT02014584|467010139|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129740891|NCT02014584|467010140|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
129740892|NCT02014584|467010141|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
129740893|NCT02014584|467010142|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129740894|NCT02014584|467010143|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
129740895|NCT02014584|467010138|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129740896|NCT02014584|467010139|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129740897|NCT02014584|467010140|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129740898|NCT02014584|467010141|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129740899|NCT02014584|467010142|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
129740900|NCT02014584|467010143|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
129740901|NCT00772109|467010144|FG000|Overall Study|Serious adverse event|1|||
129740902|NCT00772109|467010145|FG001|Overall Study|Serious adverse event|0|||
129740903|NCT00772109|467010146|FG002|Overall Study|Serious adverse event|1|||
129740904|NCT00772109|467010147|FG003|Overall Study|Serious adverse event|0|||
129807603|NCT04729621|467261194|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129807604|NCT04729621|467261195|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129807605|NCT04729621|467261196|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
129807606|NCT04729621|467261197|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
129807607|NCT04729621|467261198|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
129807608|NCT04729621|467261194|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807609|NCT04729621|467261195|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807610|NCT04729621|467261196|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807611|NCT04729621|467261197|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
129807612|NCT04729621|467261198|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
129807613|NCT04729621|467261194|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
129807614|NCT04729621|467261195|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
129807615|NCT04729621|467261196|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
129807616|NCT04729621|467261197|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
129807617|NCT04729621|467261198|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
129807618|NCT03439657|467261199|FG000|Overall Study|Adverse Event|2|||
129895394|NCT05550337|467577172|FG001|Overall Study|Adverse Event|5|||
129895395|NCT05550337|467577173|FG002|Overall Study|Adverse Event|0|||
129895396|NCT05550337|467577171|FG000|Overall Study|Withdrawal by Subject|8|||
129895397|NCT05550337|467577172|FG001|Overall Study|Withdrawal by Subject|14|||
129807619|NCT03439657|467261200|FG001|Overall Study|Adverse Event|3|||
129807620|NCT03439657|467261199|FG000|Overall Study|Lost to Follow-up|1|||
129807621|NCT03439657|467261200|FG001|Overall Study|Lost to Follow-up|0|||
129807622|NCT03439657|467261199|FG000|Overall Study|Protocol Violation|1|||
129807623|NCT03439657|467261200|FG001|Overall Study|Protocol Violation|1|||
129895398|NCT05550337|467577173|FG002|Overall Study|Withdrawal by Subject|10|||
129807624|NCT03439657|467261199|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
129895399|NCT05550337|467577171|FG000|Overall Study|Pregnancy|0|||
129895400|NCT05550337|467577172|FG001|Overall Study|Pregnancy|0|||
129895401|NCT05550337|467577173|FG002|Overall Study|Pregnancy|1|||
129895402|NCT05550337|467577171|FG000|Overall Study|Protocol Violation|1|||
129895403|NCT05550337|467577172|FG001|Overall Study|Protocol Violation|3|||
129740905|NCT00772109|467010144|FG000|Overall Study|Protocol Violation|5|||
129895404|NCT05550337|467577173|FG002|Overall Study|Protocol Violation|4|||
129895405|NCT05550337|467577171|FG000|Overall Study|Physician Decision|2|||
129895406|NCT05550337|467577172|FG001|Overall Study|Physician Decision|1|||
129895407|NCT05550337|467577173|FG002|Overall Study|Physician Decision|1|||
129895408|NCT05550337|467577171|FG000|Overall Study|Lost to Follow-up|16|||
129895409|NCT05550337|467577172|FG001|Overall Study|Lost to Follow-up|11|||
129895410|NCT05550337|467577173|FG002|Overall Study|Lost to Follow-up|11|||
129895411|NCT03115346|467577175|FG000|Overall Study|Did not have AAA surgery|28|||
129895412|NCT03115346|467577176|FG001|Overall Study|Did not have AAA surgery|15|||
129895413|NCT03115346|467577175|FG000|Overall Study|Death|3|||
129895414|NCT03115346|467577176|FG001|Overall Study|Death|1|||
129895415|NCT03115346|467577175|FG000|Overall Study|Withdrawal by Subject|0|||
129895416|NCT03115346|467577176|FG001|Overall Study|Withdrawal by Subject|3|||
129895417|NCT03115346|467577175|FG000|Overall Study|Lost to Follow-up|0|||
129895418|NCT03115346|467577176|FG001|Overall Study|Lost to Follow-up|3|||
129895419|NCT01737268|467577178|FG000|Overall Study|Adverse Event|6|||
129895420|NCT01737268|467577178|FG000|Overall Study|Worsening of Target Disease|2|||
129895421|NCT01737268|467577178|FG000|Overall Study|In consideration of the patient's safety|1|||
129895422|NCT03499600|467577184|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
129895423|NCT03499600|467577185|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
129895424|NCT01137292|467577186|FG000|Overall Study|Death|30|||
129895425|NCT01137292|467577186|FG000|Overall Study|Adverse Event|3|||
129895426|NCT01137292|467577186|FG000|Overall Study|Lack of Efficacy|13|||
129895427|NCT01137292|467577186|FG000|Overall Study|Lost to Follow-up|1|||
129895428|NCT01137292|467577186|FG000|Overall Study|Other|7|||
129895429|NCT02014558|467577189|FG000|Overall Study|Never Received Study Drug|0|||
129895430|NCT02014558|467577190|FG001|Overall Study|Never Received Study Drug|0|||
129895431|NCT02014558|467577191|FG002|Overall Study|Never Received Study Drug|0|||
129740906|NCT00772109|467010145|FG001|Overall Study|Protocol Violation|8|||
129740907|NCT00772109|467010146|FG002|Overall Study|Protocol Violation|7|||
129740908|NCT00772109|467010147|FG003|Overall Study|Protocol Violation|6|||
129740909|NCT00772109|467010144|FG000|Overall Study|Lost to Follow-up|7|||
129740910|NCT00772109|467010145|FG001|Overall Study|Lost to Follow-up|3|||
129740911|NCT00772109|467010146|FG002|Overall Study|Lost to Follow-up|5|||
129740912|NCT00772109|467010147|FG003|Overall Study|Lost to Follow-up|9|||
129740913|NCT00772109|467010144|FG000|Overall Study|Withdrawal by Subject|8|||
129740914|NCT00772109|467010145|FG001|Overall Study|Withdrawal by Subject|8|||
129740915|NCT00772109|467010146|FG002|Overall Study|Withdrawal by Subject|6|||
129740916|NCT00772109|467010147|FG003|Overall Study|Withdrawal by Subject|16|||
129740917|NCT01624090|467010148|FG000|Overall Study|DLT, taken off therapy|0|||
129740918|NCT01624090|467010149|FG001|Overall Study|DLT, taken off therapy|1|||
129740919|NCT01624090|467010150|FG002|Overall Study|DLT, taken off therapy|0|||
129740920|NCT01624090|467010151|FG003|Overall Study|DLT, taken off therapy|0|||
129740921|NCT01624090|467010148|FG000|Overall Study|Withdrew prior to treatment|0|||
129740922|NCT01624090|467010149|FG001|Overall Study|Withdrew prior to treatment|1|||
129740923|NCT01624090|467010150|FG002|Overall Study|Withdrew prior to treatment|0|||
129740924|NCT01624090|467010151|FG003|Overall Study|Withdrew prior to treatment|0|||
129740925|NCT01624090|467010148|FG000|Overall Study|Died on study|0|||
129740926|NCT01624090|467010149|FG001|Overall Study|Died on study|0|||
129740927|NCT01624090|467010150|FG002|Overall Study|Died on study|2|||
129740928|NCT01624090|467010151|FG003|Overall Study|Died on study|0|||
129740929|NCT01624090|467010148|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
129740930|NCT01624090|467010149|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
129740931|NCT01624090|467010150|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
129740932|NCT01624090|467010151|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
129740933|NCT01624090|467010148|FG000|Overall Study|Dose escalated|0|||
129740934|NCT01624090|467010149|FG001|Overall Study|Dose escalated|0|||
129740935|NCT01624090|467010150|FG002|Overall Study|Dose escalated|3|||
129740936|NCT01624090|467010151|FG003|Overall Study|Dose escalated|0|||
129740937|NCT00752726|467010152|FG000|Overall Study|Lost to Follow-up|2|||
129740938|NCT00752726|467010153|FG001|Overall Study|Lost to Follow-up|1|||
129740939|NCT00752726|467010152|FG000|Overall Study|Adverse Event|3|||
129895432|NCT02014558|467577192|FG003|Overall Study|Never Received Study Drug|0|||
129895433|NCT02014558|467577193|FG004|Overall Study|Never Received Study Drug|1|||
129740940|NCT00752726|467010153|FG001|Overall Study|Adverse Event|0|||
129740941|NCT00752726|467010152|FG000|Overall Study|Withdrawal by Subject|5|||
129740942|NCT00752726|467010153|FG001|Overall Study|Withdrawal by Subject|10|||
129740943|NCT00752726|467010152|FG000|Overall Study|Other Reason|1|||
129740944|NCT00752726|467010153|FG001|Overall Study|Other Reason|2|||
129740945|NCT00042666|467010154|FG000|Overall Study|Adverse Event|2|||
129895434|NCT02014558|467577194|FG005|Overall Study|Never Received Study Drug|0|||
129895435|NCT02014558|467577195|FG006|Overall Study|Never Received Study Drug|1|||
129895436|NCT02014558|467577196|FG007|Overall Study|Never Received Study Drug|0|||
129895437|NCT02014558|467577197|FG008|Overall Study|Never Received Study Drug|2|||
129895438|NCT02014558|467577198|FG009|Overall Study|Never Received Study Drug|0|||
129740946|NCT00042666|467010154|FG000|Overall Study|Death|4|||
129740947|NCT00042666|467010154|FG000|Overall Study|Protocol Violation|1|||
129740948|NCT00042666|467010154|FG000|Overall Study|Participant/Physician Perception|1|||
129740949|NCT00042666|467010154|FG000|Overall Study|Progressive Disease|41|||
129740950|NCT00042666|467010154|FG000|Overall Study|Other|1|||
129740951|NCT00042666|467010154|FG000|Overall Study|Other|4|||
129740952|NCT04232215|467010155|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129740953|NCT04232215|467010156|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129740954|NCT01555125|467010159|FG000|Induction Period|Lost to Follow-up|0|||
129740955|NCT01555125|467010160|FG001|Induction Period|Lost to Follow-up|2|||
129740956|NCT01555125|467010161|FG002|Induction Period|Lost to Follow-up|0|||
129740957|NCT01555125|467010162|FG003|Induction Period|Lost to Follow-up|0|||
129740958|NCT01555125|467010163|FG004|Induction Period|Lost to Follow-up|0|||
129740959|NCT01555125|467010159|FG000|Induction Period|Adverse Event|0|||
129740960|NCT01555125|467010160|FG001|Induction Period|Adverse Event|1|||
129740961|NCT01555125|467010161|FG002|Induction Period|Adverse Event|0|||
129740962|NCT01555125|467010162|FG003|Induction Period|Adverse Event|0|||
129740963|NCT01555125|467010163|FG004|Induction Period|Adverse Event|1|||
129740964|NCT01555125|467010159|FG000|Induction Period|Subject / guardian decision|0|||
129740965|NCT01555125|467010160|FG001|Induction Period|Subject / guardian decision|0|||
129740966|NCT01555125|467010161|FG002|Induction Period|Subject / guardian decision|0|||
129740967|NCT01555125|467010162|FG003|Induction Period|Subject / guardian decision|0|||
129740968|NCT01555125|467010163|FG004|Induction Period|Subject / guardian decision|2|||
129740969|NCT01555125|467010159|FG000|Induction Period|Death|1|||
129895439|NCT02014558|467577199|FG010|Overall Study|Never Received Study Drug|2|||
129895440|NCT02014558|467577200|FG011|Overall Study|Never Received Study Drug|2|||
129740970|NCT01555125|467010160|FG001|Induction Period|Death|0|||
129740971|NCT01555125|467010161|FG002|Induction Period|Death|0|||
129740972|NCT01555125|467010162|FG003|Induction Period|Death|0|||
129740973|NCT01555125|467010163|FG004|Induction Period|Death|0|||
129740974|NCT01555125|467010159|FG000|Maintenance Period|Adverse Event|1|||
129740975|NCT01555125|467010160|FG001|Maintenance Period|Adverse Event|1|||
129740976|NCT01555125|467010161|FG002|Maintenance Period|Adverse Event|0|||
129740977|NCT01555125|467010162|FG003|Maintenance Period|Adverse Event|0|||
129740978|NCT01555125|467010163|FG004|Maintenance Period|Adverse Event|0|||
129740979|NCT01555125|467010159|FG000|Maintenance Period|Subject / guardian decision|1|||
129740980|NCT01555125|467010160|FG001|Maintenance Period|Subject / guardian decision|2|||
129740981|NCT01555125|467010161|FG002|Maintenance Period|Subject / guardian decision|0|||
129740982|NCT01555125|467010162|FG003|Maintenance Period|Subject / guardian decision|0|||
129740983|NCT01555125|467010163|FG004|Maintenance Period|Subject / guardian decision|0|||
129740984|NCT01555125|467010159|FG000|Maintenance Period|Lost to Follow-up|2|||
129740985|NCT01555125|467010160|FG001|Maintenance Period|Lost to Follow-up|0|||
129740986|NCT01555125|467010161|FG002|Maintenance Period|Lost to Follow-up|0|||
129740987|NCT01555125|467010162|FG003|Maintenance Period|Lost to Follow-up|1|||
129740988|NCT01555125|467010163|FG004|Maintenance Period|Lost to Follow-up|0|||
129740989|NCT01555125|467010159|FG000|Maintenance Period|Lack of Efficacy|6|||
129740990|NCT01555125|467010160|FG001|Maintenance Period|Lack of Efficacy|1|||
129740991|NCT01555125|467010161|FG002|Maintenance Period|Lack of Efficacy|3|||
129740992|NCT01555125|467010162|FG003|Maintenance Period|Lack of Efficacy|0|||
129740993|NCT01555125|467010163|FG004|Maintenance Period|Lack of Efficacy|0|||
129740994|NCT01555125|467010159|FG000|Maintenance Period|Physician Decision|0|||
129740995|NCT01555125|467010160|FG001|Maintenance Period|Physician Decision|0|||
129740996|NCT01555125|467010161|FG002|Maintenance Period|Physician Decision|1|||
129740997|NCT01555125|467010162|FG003|Maintenance Period|Physician Decision|0|||
129740998|NCT01555125|467010163|FG004|Maintenance Period|Physician Decision|0|||
129740999|NCT01555125|467010159|FG000|Maintenance Period|Death|0|||
129895441|NCT02014558|467577201|FG012|Overall Study|Never Received Study Drug|0|||
129895442|NCT02014558|467577189|FG000|Overall Study|Adverse Event|0|||
129895443|NCT02014558|467577190|FG001|Overall Study|Adverse Event|0|||
129895444|NCT02014558|467577191|FG002|Overall Study|Adverse Event|0|||
129895445|NCT02014558|467577192|FG003|Overall Study|Adverse Event|0|||
129895446|NCT02014558|467577193|FG004|Overall Study|Adverse Event|1|||
129895447|NCT02014558|467577194|FG005|Overall Study|Adverse Event|0|||
129895448|NCT02014558|467577195|FG006|Overall Study|Adverse Event|0|||
129895449|NCT02014558|467577196|FG007|Overall Study|Adverse Event|0|||
129895450|NCT02014558|467577197|FG008|Overall Study|Adverse Event|2|||
129895451|NCT02014558|467577198|FG009|Overall Study|Adverse Event|2|||
129895452|NCT02014558|467577199|FG010|Overall Study|Adverse Event|5|||
129895453|NCT02014558|467577200|FG011|Overall Study|Adverse Event|21|||
129895454|NCT02014558|467577201|FG012|Overall Study|Adverse Event|3|||
129895455|NCT02014558|467577189|FG000|Overall Study|Death|1|||
129895456|NCT02014558|467577190|FG001|Overall Study|Death|0|||
129895457|NCT02014558|467577191|FG002|Overall Study|Death|0|||
129895458|NCT02014558|467577192|FG003|Overall Study|Death|0|||
129895459|NCT02014558|467577193|FG004|Overall Study|Death|0|||
129895460|NCT02014558|467577194|FG005|Overall Study|Death|0|||
129741000|NCT01555125|467010160|FG001|Maintenance Period|Death|0|||
129895461|NCT02014558|467577195|FG006|Overall Study|Death|1|||
129895462|NCT02014558|467577196|FG007|Overall Study|Death|1|||
129741001|NCT01555125|467010161|FG002|Maintenance Period|Death|0|||
129741002|NCT01555125|467010162|FG003|Maintenance Period|Death|1|||
129741003|NCT01555125|467010163|FG004|Maintenance Period|Death|0|||
129741004|NCT01555125|467010159|FG000|Extension|Adverse Event|1|||
129741005|NCT01555125|467010160|FG001|Extension|Adverse Event|2|||
129741006|NCT01555125|467010161|FG002|Extension|Adverse Event|1|||
129741007|NCT01555125|467010162|FG003|Extension|Adverse Event|1|||
129741008|NCT01555125|467010163|FG004|Extension|Adverse Event|0|||
129741009|NCT01555125|467010159|FG000|Extension|Protocol deviation|1|||
129741010|NCT01555125|467010160|FG001|Extension|Protocol deviation|0|||
129741011|NCT01555125|467010161|FG002|Extension|Protocol deviation|0|||
129741012|NCT01555125|467010162|FG003|Extension|Protocol deviation|0|||
129741013|NCT01555125|467010163|FG004|Extension|Protocol deviation|0|||
129741014|NCT01555125|467010159|FG000|Extension|Lack of Efficacy|7|||
129741015|NCT01555125|467010160|FG001|Extension|Lack of Efficacy|6|||
129741016|NCT01555125|467010161|FG002|Extension|Lack of Efficacy|3|||
129741017|NCT01555125|467010162|FG003|Extension|Lack of Efficacy|0|||
129741018|NCT01555125|467010163|FG004|Extension|Lack of Efficacy|0|||
129741019|NCT01555125|467010159|FG000|Extension|Lost to Follow-up|2|||
129741020|NCT01555125|467010160|FG001|Extension|Lost to Follow-up|1|||
129741021|NCT01555125|467010161|FG002|Extension|Lost to Follow-up|2|||
129741022|NCT01555125|467010162|FG003|Extension|Lost to Follow-up|0|||
129741023|NCT01555125|467010163|FG004|Extension|Lost to Follow-up|0|||
129741024|NCT01555125|467010159|FG000|Extension|Study terminated by sponsor|32|||
129741025|NCT01555125|467010160|FG001|Extension|Study terminated by sponsor|33|||
129741026|NCT01555125|467010161|FG002|Extension|Study terminated by sponsor|16|||
129741027|NCT01555125|467010162|FG003|Extension|Study terminated by sponsor|20|||
129741028|NCT01555125|467010163|FG004|Extension|Study terminated by sponsor|0|||
129741029|NCT01555125|467010159|FG000|Extension|Subject/guardian decision|1|||
129741030|NCT01555125|467010160|FG001|Extension|Subject/guardian decision|9|||
129741031|NCT01555125|467010161|FG002|Extension|Subject/guardian decision|1|||
129741032|NCT01555125|467010162|FG003|Extension|Subject/guardian decision|0|||
129741033|NCT01555125|467010163|FG004|Extension|Subject/guardian decision|0|||
129741034|NCT01555125|467010159|FG000|Extension|Technical Problems|1|||
129741035|NCT01555125|467010160|FG001|Extension|Technical Problems|0|||
129741036|NCT01555125|467010161|FG002|Extension|Technical Problems|0|||
129741037|NCT01555125|467010162|FG003|Extension|Technical Problems|1|||
129741038|NCT01555125|467010163|FG004|Extension|Technical Problems|0|||
129741039|NCT01555125|467010159|FG000|Follow-Up Period|Lost to Follow-up|1|||
129741040|NCT01555125|467010160|FG001|Follow-Up Period|Lost to Follow-up|0|||
129741041|NCT01555125|467010161|FG002|Follow-Up Period|Lost to Follow-up|0|||
129741042|NCT01555125|467010162|FG003|Follow-Up Period|Lost to Follow-up|0|||
129741043|NCT01555125|467010163|FG004|Follow-Up Period|Lost to Follow-up|0|||
129741044|NCT01555125|467010159|FG000|Follow-Up Period|Subject / guardian decision|3|||
129741045|NCT01555125|467010160|FG001|Follow-Up Period|Subject / guardian decision|1|||
129741046|NCT01555125|467010161|FG002|Follow-Up Period|Subject / guardian decision|1|||
129741047|NCT01555125|467010162|FG003|Follow-Up Period|Subject / guardian decision|1|||
129741048|NCT01555125|467010163|FG004|Follow-Up Period|Subject / guardian decision|0|||
129741049|NCT02651220|467010164|FG000|Overall Study|Adverse Event|1|||
129741050|NCT02651220|467010165|FG001|Overall Study|Adverse Event|5|||
129741051|NCT02651220|467010166|FG002|Overall Study|Adverse Event|1|||
129741052|NCT02651220|467010164|FG000|Overall Study|Lost to Follow-up|8|||
129741053|NCT02651220|467010165|FG001|Overall Study|Lost to Follow-up|14|||
129741054|NCT02651220|467010166|FG002|Overall Study|Lost to Follow-up|14|||
129741055|NCT02651220|467010164|FG000|Overall Study|Non-Compliance with Study Drug|4|||
129741056|NCT02651220|467010165|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129741057|NCT02651220|467010166|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129741058|NCT02651220|467010164|FG000|Overall Study|Pregnancy|1|||
129741059|NCT02651220|467010165|FG001|Overall Study|Pregnancy|0|||
129741060|NCT02651220|467010166|FG002|Overall Study|Pregnancy|1|||
129741061|NCT02651220|467010164|FG000|Overall Study|Protocol Violation|0|||
129741062|NCT02651220|467010165|FG001|Overall Study|Protocol Violation|0|||
129741063|NCT02651220|467010166|FG002|Overall Study|Protocol Violation|1|||
129741064|NCT02651220|467010164|FG000|Overall Study|Withdrawal by Subject|5|||
129741065|NCT02651220|467010165|FG001|Overall Study|Withdrawal by Subject|6|||
129741066|NCT02651220|467010166|FG002|Overall Study|Withdrawal by Subject|8|||
129741067|NCT02651220|467010164|FG000|Overall Study|Miscellaneous|4|||
129741068|NCT02651220|467010165|FG001|Overall Study|Miscellaneous|1|||
129741069|NCT02651220|467010166|FG002|Overall Study|Miscellaneous|2|||
129741070|NCT02651220|467010164|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129895463|NCT02014558|467577197|FG008|Overall Study|Death|2|||
129741071|NCT02651220|467010165|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129741072|NCT02651220|467010166|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
129741073|NCT05327361|467010174|FG000|Overall Study|Lost to Follow-up|4|||
129741074|NCT01439373|467010175|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
129741075|NCT01439373|467010176|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
129741076|NCT01439373|467010175|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
129741077|NCT01439373|467010176|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
129741078|NCT01078168|467010181|FG000|Overall Study|Physician Decision|0|||
129741079|NCT01078168|467010182|FG001|Overall Study|Physician Decision|1|||
129741080|NCT01264419|467010184|FG000|Overall Study|Lost to Follow-up|3|||
129741081|NCT00477152|467012640|FG000|Overall Study|Parent withdrew consent|2|||
129741082|NCT00477152|467012640|FG000|Overall Study|Adverse Event|1|||
129741083|NCT02905006|467012641|FG000|Overall Study|Adverse Event|1|||
129741084|NCT02905006|467012642|FG001|Overall Study|Adverse Event|1|||
129741085|NCT02905006|467012643|FG002|Overall Study|Adverse Event|1|||
129741086|NCT02905006|467012644|FG003|Overall Study|Adverse Event|1|||
129741087|NCT02905006|467012645|FG004|Overall Study|Adverse Event|0|||
129741088|NCT02905006|467012646|FG005|Overall Study|Adverse Event|1|||
129741089|NCT02905006|467012641|FG000|Overall Study|Lack of Efficacy|1|||
129741090|NCT02905006|467012642|FG001|Overall Study|Lack of Efficacy|0|||
129741091|NCT02905006|467012643|FG002|Overall Study|Lack of Efficacy|0|||
129741092|NCT02905006|467012644|FG003|Overall Study|Lack of Efficacy|0|||
129741093|NCT02905006|467012645|FG004|Overall Study|Lack of Efficacy|0|||
129741094|NCT02905006|467012646|FG005|Overall Study|Lack of Efficacy|0|||
129741095|NCT02905006|467012641|FG000|Overall Study|Protocol Violation|2|||
129741096|NCT02905006|467012642|FG001|Overall Study|Protocol Violation|0|||
129741097|NCT02905006|467012643|FG002|Overall Study|Protocol Violation|0|||
129741098|NCT02905006|467012644|FG003|Overall Study|Protocol Violation|0|||
129741099|NCT02905006|467012645|FG004|Overall Study|Protocol Violation|0|||
129741100|NCT02905006|467012646|FG005|Overall Study|Protocol Violation|0|||
129741101|NCT02905006|467012641|FG000|Overall Study|Lost to Follow-up|0|||
129741102|NCT02905006|467012642|FG001|Overall Study|Lost to Follow-up|0|||
129741103|NCT02905006|467012643|FG002|Overall Study|Lost to Follow-up|0|||
129741104|NCT02905006|467012644|FG003|Overall Study|Lost to Follow-up|1|||
129741105|NCT02905006|467012645|FG004|Overall Study|Lost to Follow-up|1|||
129741106|NCT02905006|467012646|FG005|Overall Study|Lost to Follow-up|0|||
129741107|NCT02905006|467012641|FG000|Overall Study|Withdrawal by Subject|0|||
129741108|NCT02905006|467012642|FG001|Overall Study|Withdrawal by Subject|0|||
129741109|NCT02905006|467012643|FG002|Overall Study|Withdrawal by Subject|1|||
129741110|NCT02905006|467012644|FG003|Overall Study|Withdrawal by Subject|1|||
129741111|NCT02905006|467012645|FG004|Overall Study|Withdrawal by Subject|0|||
129741112|NCT02905006|467012646|FG005|Overall Study|Withdrawal by Subject|1|||
129741113|NCT02905006|467012641|FG000|Overall Study|Screening exclusion criteria met|1|||
129741114|NCT02905006|467012642|FG001|Overall Study|Screening exclusion criteria met|0|||
129741115|NCT02905006|467012643|FG002|Overall Study|Screening exclusion criteria met|0|||
129741116|NCT02905006|467012644|FG003|Overall Study|Screening exclusion criteria met|0|||
129741117|NCT02905006|467012645|FG004|Overall Study|Screening exclusion criteria met|0|||
129741118|NCT02905006|467012646|FG005|Overall Study|Screening exclusion criteria met|0|||
129741119|NCT02905006|467012641|FG000|Overall Study|Lab withdrawal criterion met|0|||
129741120|NCT02905006|467012642|FG001|Overall Study|Lab withdrawal criterion met|1|||
129741121|NCT02905006|467012643|FG002|Overall Study|Lab withdrawal criterion met|2|||
129741122|NCT02905006|467012644|FG003|Overall Study|Lab withdrawal criterion met|2|||
129741123|NCT02905006|467012645|FG004|Overall Study|Lab withdrawal criterion met|2|||
129741124|NCT02905006|467012646|FG005|Overall Study|Lab withdrawal criterion met|1|||
129741125|NCT02905006|467012641|FG000|Overall Study|Positive for Tuberculosis|0|||
129741126|NCT02905006|467012642|FG001|Overall Study|Positive for Tuberculosis|1|||
129741127|NCT02905006|467012643|FG002|Overall Study|Positive for Tuberculosis|0|||
129741128|NCT02905006|467012644|FG003|Overall Study|Positive for Tuberculosis|0|||
129741129|NCT02905006|467012645|FG004|Overall Study|Positive for Tuberculosis|0|||
129741130|NCT02905006|467012646|FG005|Overall Study|Positive for Tuberculosis|0|||
129741131|NCT02905006|467012641|FG000|Overall Study|Subject positive for Hep B|0|||
129741132|NCT02905006|467012642|FG001|Overall Study|Subject positive for Hep B|0|||
129741133|NCT02905006|467012643|FG002|Overall Study|Subject positive for Hep B|1|||
129741134|NCT02905006|467012644|FG003|Overall Study|Subject positive for Hep B|0|||
129741135|NCT02905006|467012645|FG004|Overall Study|Subject positive for Hep B|0|||
129741136|NCT02905006|467012646|FG005|Overall Study|Subject positive for Hep B|0|||
129741137|NCT02905006|467012641|FG000|Overall Study|Patient moved abroad|0|||
129741138|NCT02905006|467012642|FG001|Overall Study|Patient moved abroad|0|||
129741139|NCT02905006|467012643|FG002|Overall Study|Patient moved abroad|0|||
129741140|NCT02905006|467012644|FG003|Overall Study|Patient moved abroad|1|||
129741141|NCT02905006|467012645|FG004|Overall Study|Patient moved abroad|0|||
129741142|NCT02905006|467012646|FG005|Overall Study|Patient moved abroad|0|||
129741143|NCT02905006|467012641|FG000|Overall Study|Patient randomized by mistake|0|||
129741144|NCT02905006|467012642|FG001|Overall Study|Patient randomized by mistake|0|||
129741145|NCT02905006|467012643|FG002|Overall Study|Patient randomized by mistake|0|||
129741146|NCT02905006|467012644|FG003|Overall Study|Patient randomized by mistake|0|||
129741147|NCT02905006|467012645|FG004|Overall Study|Patient randomized by mistake|0|||
129741148|NCT02905006|467012646|FG005|Overall Study|Patient randomized by mistake|1|||
129741149|NCT02429791|467012647|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
129741150|NCT02429791|467012648|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
129741151|NCT02429791|467012647|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
129741152|NCT02429791|467012648|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
129895464|NCT02014558|467577198|FG009|Overall Study|Death|5|||
129741153|NCT02429791|467012647|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
129741154|NCT02429791|467012648|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
129741155|NCT02429791|467012647|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
129741156|NCT02429791|467012648|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
129741157|NCT02429791|467012647|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
129741158|NCT02429791|467012648|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
129741159|NCT02429791|467012647|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
129741160|NCT02429791|467012648|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
129741161|NCT02429791|467012647|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
129741162|NCT02429791|467012648|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
129741163|NCT02429791|467012647|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
129741164|NCT02429791|467012648|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
129741165|NCT02429791|467012647|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
129741166|NCT02429791|467012648|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
129741167|NCT02429791|467012647|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
129741168|NCT02429791|467012648|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
129741169|NCT02429791|467012647|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
129741170|NCT02429791|467012648|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
129741171|NCT02429791|467012647|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
129741172|NCT02429791|467012648|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
129741173|NCT02429791|467012647|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
129741174|NCT02429791|467012648|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
129741175|NCT02429791|467012647|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
129741176|NCT02429791|467012648|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
129741177|NCT02429791|467012647|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
129741178|NCT02429791|467012648|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
129741179|NCT02429791|467012647|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
129741180|NCT02429791|467012648|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
129741181|NCT02429791|467012647|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
129741182|NCT02429791|467012648|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
129741183|NCT02429791|467012647|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
129741184|NCT02429791|467012648|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
129741185|NCT04201093|467012649|FG000|Overall Study|Adverse Event|6|||
129741186|NCT04201093|467012650|FG001|Overall Study|Adverse Event|29|||
129741187|NCT04201093|467012651|FG002|Overall Study|Adverse Event|35|||
129741188|NCT04201093|467012649|FG000|Overall Study|Death|2|||
129741189|NCT04201093|467012650|FG001|Overall Study|Death|1|||
129741190|NCT04201093|467012651|FG002|Overall Study|Death|0|||
129741191|NCT04201093|467012649|FG000|Overall Study|Lack of Efficacy|5|||
129741192|NCT04201093|467012650|FG001|Overall Study|Lack of Efficacy|1|||
129741193|NCT04201093|467012651|FG002|Overall Study|Lack of Efficacy|2|||
129741194|NCT04201093|467012649|FG000|Overall Study|Lost to Follow-up|0|||
129741195|NCT04201093|467012650|FG001|Overall Study|Lost to Follow-up|0|||
129741196|NCT04201093|467012651|FG002|Overall Study|Lost to Follow-up|1|||
129741197|NCT04201093|467012649|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
129741198|NCT04201093|467012650|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
129741199|NCT04201093|467012651|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
129741200|NCT04201093|467012649|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
129741201|NCT04201093|467012650|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
129741202|NCT04201093|467012651|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
129741203|NCT04201093|467012649|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
129741204|NCT04201093|467012650|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
129741205|NCT04201093|467012651|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
129741206|NCT04201093|467012649|FG000|Overall Study|Physician Decision|1|||
129807625|NCT03439657|467261200|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
129807626|NCT00370071|467261204|FG000|Overall Study|Withdrawal by Subject|2|||
129807627|NCT01999868|467261206|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
129807628|NCT01999868|467261207|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
129807629|NCT01999868|467261208|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
129807630|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
129807631|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
129895465|NCT02014558|467577199|FG010|Overall Study|Death|5|||
129895466|NCT02014558|467577200|FG011|Overall Study|Death|19|||
129807632|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
129807633|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
129807634|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
129807635|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
129895467|NCT02014558|467577201|FG012|Overall Study|Death|2|||
129741207|NCT04201093|467012650|FG001|Overall Study|Physician Decision|0|||
129741208|NCT04201093|467012651|FG002|Overall Study|Physician Decision|0|||
129741209|NCT04201093|467012649|FG000|Overall Study|Protocol Deviation|1|||
129741210|NCT04201093|467012650|FG001|Overall Study|Protocol Deviation|0|||
129741211|NCT04201093|467012651|FG002|Overall Study|Protocol Deviation|0|||
129741212|NCT04201093|467012649|FG000|Overall Study|Site Terminated by Sponsor|5|||
129741213|NCT04201093|467012650|FG001|Overall Study|Site Terminated by Sponsor|3|||
129741214|NCT04201093|467012651|FG002|Overall Study|Site Terminated by Sponsor|1|||
129741215|NCT04201093|467012649|FG000|Overall Study|Withdrawal by Subject|7|||
129741216|NCT04201093|467012650|FG001|Overall Study|Withdrawal by Subject|8|||
129741217|NCT04201093|467012651|FG002|Overall Study|Withdrawal by Subject|15|||
129741218|NCT04201093|467012649|FG000|Overall Study|Other|0|||
129741219|NCT04201093|467012650|FG001|Overall Study|Other|1|||
129741220|NCT04201093|467012651|FG002|Overall Study|Other|2|||
129741221|NCT00881504|467012652|FG000|Overall Study|Withdrawal by Subject|1|||
129741222|NCT00007020|467012653|FG000|Overall Study|Death|16|||
129741223|NCT00007020|467012653|FG000|Overall Study|Lost to Follow-up|13|||
129741224|NCT00007020|467012653|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
129741225|NCT00007020|467012653|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
129741226|NCT00007020|467012653|FG000|Overall Study|Pt cared for by outside physician|4|||
129741227|NCT00007020|467012653|FG000|Overall Study|No evidence of treatment|6|||
129741228|NCT01276223|467012654|FG000|Overall Study|Adverse Event|7|||
129741229|NCT01276223|467012655|FG001|Overall Study|Adverse Event|4|||
129741230|NCT01276223|467012656|FG002|Overall Study|Adverse Event|1|||
129741231|NCT01276223|467012654|FG000|Overall Study|Lost to Follow-up|0|||
129741232|NCT01276223|467012655|FG001|Overall Study|Lost to Follow-up|0|||
129741233|NCT01276223|467012656|FG002|Overall Study|Lost to Follow-up|1|||
129741234|NCT01276223|467012654|FG000|Overall Study|Other|0|||
129741235|NCT01276223|467012655|FG001|Overall Study|Other|0|||
129741236|NCT01276223|467012656|FG002|Overall Study|Other|1|||
129741237|NCT01276223|467012654|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
129741238|NCT01276223|467012655|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
129741239|NCT01276223|467012656|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
129741240|NCT01276223|467012654|FG000|Overall Study|Protocol Violation|1|||
129741241|NCT01276223|467012655|FG001|Overall Study|Protocol Violation|0|||
129741242|NCT01276223|467012656|FG002|Overall Study|Protocol Violation|0|||
129741243|NCT05856227|467012657|FG000|Overall Study|Adverse Event|0|||
129741244|NCT05856227|467012658|FG001|Overall Study|Adverse Event|1|||
129741245|NCT05856227|467012657|FG000|Overall Study|Due to Investigator absence|1|||
129741246|NCT05856227|467012658|FG001|Overall Study|Due to Investigator absence|0|||
129741247|NCT05856227|467012657|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
129741248|NCT05856227|467012658|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
129741249|NCT01571232|467012660|FG000|Overall Study|Lost to Follow-up|0|||
129741250|NCT01571232|467012661|FG001|Overall Study|Lost to Follow-up|1|||
129741251|NCT01571232|467012660|FG000|Overall Study|Withdrawal by Subject|1|||
129741252|NCT01571232|467012661|FG001|Overall Study|Withdrawal by Subject|0|||
129741253|NCT00771615|467012662|FG000|Overall Study|Withdrawal by Subject|0|||
129741254|NCT00771615|467012663|FG001|Overall Study|Withdrawal by Subject|1|||
129741255|NCT00771615|467012664|FG002|Overall Study|Withdrawal by Subject|0|||
129741256|NCT00771615|467012665|FG003|Overall Study|Withdrawal by Subject|0|||
129741257|NCT00771615|467012666|FG004|Overall Study|Withdrawal by Subject|0|||
129741258|NCT00771615|467012667|FG005|Overall Study|Withdrawal by Subject|0|||
129741259|NCT00771615|467012668|FG006|Overall Study|Withdrawal by Subject|0|||
129741260|NCT00771615|467012669|FG007|Overall Study|Withdrawal by Subject|1|||
129741261|NCT00771615|467012670|FG008|Overall Study|Withdrawal by Subject|0|||
129741262|NCT00771615|467012662|FG000|Overall Study|Lost to Follow-up|1|||
129741263|NCT00771615|467012663|FG001|Overall Study|Lost to Follow-up|1|||
129807636|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
129807637|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
129807638|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
129807639|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
129807640|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
129741264|NCT00771615|467012664|FG002|Overall Study|Lost to Follow-up|1|||
129741265|NCT00771615|467012665|FG003|Overall Study|Lost to Follow-up|1|||
129741266|NCT00771615|467012666|FG004|Overall Study|Lost to Follow-up|0|||
129741267|NCT00771615|467012667|FG005|Overall Study|Lost to Follow-up|1|||
129741268|NCT00771615|467012668|FG006|Overall Study|Lost to Follow-up|1|||
129741269|NCT00771615|467012669|FG007|Overall Study|Lost to Follow-up|0|||
129741270|NCT00771615|467012670|FG008|Overall Study|Lost to Follow-up|0|||
129807641|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
129807642|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
129807643|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
129895468|NCT02014558|467577189|FG000|Overall Study|Lack of Efficacy|1|||
129741271|NCT02455076|467012671|FG000|Inpatient|Withdrawal by Subject|1|||
129741272|NCT02455076|467012672|FG001|Inpatient|Withdrawal by Subject|0|||
129741273|NCT02455076|467012673|FG002|Inpatient|Withdrawal by Subject|0|||
129741274|NCT02455076|467012674|FG003|Inpatient|Withdrawal by Subject|0|||
129741275|NCT02455076|467012675|FG004|Inpatient|Withdrawal by Subject|0|||
129741276|NCT02455076|467012671|FG000|Inpatient|Discharged <24 h after admission|0|||
129741277|NCT02455076|467012672|FG001|Inpatient|Discharged <24 h after admission|1|||
129741278|NCT02455076|467012673|FG002|Inpatient|Discharged <24 h after admission|0|||
129895469|NCT02014558|467577190|FG001|Overall Study|Lack of Efficacy|2|||
129741279|NCT02455076|467012674|FG003|Inpatient|Discharged <24 h after admission|0|||
129741280|NCT02455076|467012675|FG004|Inpatient|Discharged <24 h after admission|0|||
129741281|NCT02455076|467012671|FG000|Inpatient|Adverse Event|3|||
129741282|NCT02455076|467012672|FG001|Inpatient|Adverse Event|0|||
129741283|NCT02455076|467012673|FG002|Inpatient|Adverse Event|0|||
129741284|NCT02455076|467012674|FG003|Inpatient|Adverse Event|0|||
129741285|NCT02455076|467012675|FG004|Inpatient|Adverse Event|0|||
129741286|NCT02455076|467012671|FG000|Outpatient|Adverse Event|0|||
129741287|NCT02455076|467012672|FG001|Outpatient|Adverse Event|0|||
129741288|NCT02455076|467012673|FG002|Outpatient|Adverse Event|0|||
129741289|NCT02455076|467012674|FG003|Outpatient|Adverse Event|5|||
129741290|NCT02455076|467012675|FG004|Outpatient|Adverse Event|0|||
129741291|NCT02455076|467012671|FG000|Outpatient|Lost to Follow-up|0|||
129741292|NCT02455076|467012672|FG001|Outpatient|Lost to Follow-up|0|||
129741293|NCT02455076|467012673|FG002|Outpatient|Lost to Follow-up|0|||
129741294|NCT02455076|467012674|FG003|Outpatient|Lost to Follow-up|1|||
129741295|NCT02455076|467012675|FG004|Outpatient|Lost to Follow-up|12|||
129741296|NCT03517969|467012676|FG000|Overall Study|Never started protocol treatment|3|||
129741297|NCT03517969|467012677|FG001|Overall Study|Never started protocol treatment|5|||
129741298|NCT03517969|467012676|FG000|Overall Study|Disease progression|11|||
129741299|NCT03517969|467012677|FG001|Overall Study|Disease progression|16|||
129741300|NCT03517969|467012676|FG000|Overall Study|PSA progression|8|||
129741301|NCT03517969|467012677|FG001|Overall Study|PSA progression|1|||
129741302|NCT03517969|467012676|FG000|Overall Study|Clinical progression|4|||
129741303|NCT03517969|467012677|FG001|Overall Study|Clinical progression|2|||
129741304|NCT03517969|467012676|FG000|Overall Study|Adverse Event|5|||
129741305|NCT03517969|467012677|FG001|Overall Study|Adverse Event|4|||
129741306|NCT03517969|467012676|FG000|Overall Study|Intercurrent illness|1|||
129741307|NCT03517969|467012677|FG001|Overall Study|Intercurrent illness|2|||
129741308|NCT03517969|467012676|FG000|Overall Study|Death|1|||
129807644|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
129807645|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
129807646|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
129807647|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
129807648|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
129807649|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
129807650|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
129807651|NCT01999868|467261206|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
129807652|NCT01999868|467261207|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
129807653|NCT01999868|467261208|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
129807654|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
129807655|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
129807656|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
129807657|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
129807658|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
129807659|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
129807660|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
129807661|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
129807662|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
129807663|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
129807664|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
129895470|NCT02014558|467577191|FG002|Overall Study|Lack of Efficacy|1|||
129895471|NCT02014558|467577192|FG003|Overall Study|Lack of Efficacy|1|||
129895472|NCT02014558|467577193|FG004|Overall Study|Lack of Efficacy|0|||
129895473|NCT02014558|467577194|FG005|Overall Study|Lack of Efficacy|0|||
129895474|NCT02014558|467577195|FG006|Overall Study|Lack of Efficacy|1|||
129895475|NCT02014558|467577196|FG007|Overall Study|Lack of Efficacy|3|||
129895476|NCT02014558|467577197|FG008|Overall Study|Lack of Efficacy|3|||
129895477|NCT02014558|467577198|FG009|Overall Study|Lack of Efficacy|3|||
129741309|NCT03517969|467012677|FG001|Overall Study|Death|1|||
129895478|NCT02014558|467577199|FG010|Overall Study|Lack of Efficacy|16|||
129741310|NCT03517969|467012676|FG000|Overall Study|Withdrawal by Subject|1|||
129741311|NCT03517969|467012677|FG001|Overall Study|Withdrawal by Subject|2|||
129741312|NCT03517969|467012676|FG000|Overall Study|Physician Decision|1|||
129741313|NCT03517969|467012677|FG001|Overall Study|Physician Decision|1|||
129741314|NCT03517969|467012676|FG000|Overall Study|No clinical benefit|1|||
129807665|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
129807666|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
129807667|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
129807668|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
129807669|NCT01999868|467261206|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
129807670|NCT01999868|467261207|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
129807671|NCT01999868|467261208|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
129807672|NCT00289016|467261213|FG000|Overall Study|Disease Progression|29|||
129807673|NCT00289016|467261213|FG000|Overall Study|Death|2|||
129741315|NCT03517969|467012677|FG001|Overall Study|No clinical benefit|0|||
129741316|NCT03517969|467012676|FG000|Overall Study|Delayed treatment for dental treatment|1|||
129741317|NCT03517969|467012677|FG001|Overall Study|Delayed treatment for dental treatment|0|||
129741318|NCT03517969|467012676|FG000|Overall Study|Difficult to maintain appointment|0|||
129741319|NCT03517969|467012677|FG001|Overall Study|Difficult to maintain appointment|1|||
129741320|NCT03517969|467012676|FG000|Overall Study|Protocol Violation|0|||
129741321|NCT03517969|467012677|FG001|Overall Study|Protocol Violation|1|||
129741322|NCT05779007|467012682|FG000|Overall Study|not meeting eligibility criteria|3517|||
129741323|NCT05779007|467012683|FG001|Overall Study|not meeting eligibility criteria|2009|||
129741324|NCT01638546|467012694|FG000|Overall Study|Adverse Event|1|||
129741325|NCT01638546|467012695|FG001|Overall Study|Adverse Event|3|||
129741326|NCT05147662|467012698|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129741327|NCT05147662|467012698|FG000|Overall Study|Assigned to treatment but never treated|1|||
129741328|NCT04676867|467012699|FG000|Overall Study|Screen failure|0|||
129741329|NCT04676867|467012700|FG001|Overall Study|Screen failure|0|||
129741330|NCT04676867|467012701|FG002|Overall Study|Screen failure|6|||
129741331|NCT04676867|467012702|FG003|Overall Study|Screen failure|2|||
129741332|NCT04676867|467012699|FG000|Overall Study|Death|0|||
129741333|NCT04676867|467012700|FG001|Overall Study|Death|0|||
129741334|NCT04676867|467012701|FG002|Overall Study|Death|1|||
129741335|NCT04676867|467012702|FG003|Overall Study|Death|0|||
129741336|NCT04676867|467012699|FG000|Overall Study|Withdrawal by Subject|2|||
129741337|NCT04676867|467012700|FG001|Overall Study|Withdrawal by Subject|2|||
129741338|NCT04676867|467012701|FG002|Overall Study|Withdrawal by Subject|4|||
129741339|NCT04676867|467012702|FG003|Overall Study|Withdrawal by Subject|4|||
129741340|NCT04676867|467012699|FG000|Overall Study|Lost to Follow-up|1|||
129741341|NCT04676867|467012700|FG001|Overall Study|Lost to Follow-up|0|||
129741342|NCT04676867|467012701|FG002|Overall Study|Lost to Follow-up|0|||
129741343|NCT04676867|467012702|FG003|Overall Study|Lost to Follow-up|0|||
129741344|NCT00549770|467012707|FG000|Overall Study|Protocol deviation|1|||
129741345|NCT00549770|467012708|FG001|Overall Study|Protocol deviation|1|||
129741346|NCT00549770|467012709|FG002|Overall Study|Protocol deviation|1|||
129741347|NCT00549770|467012710|FG003|Overall Study|Protocol deviation|2|||
129741348|NCT00549770|467012711|FG004|Overall Study|Protocol deviation|2|||
129741349|NCT00549770|467012712|FG005|Overall Study|Protocol deviation|2|||
129741350|NCT00549770|467012713|FG006|Overall Study|Protocol deviation|1|||
129741351|NCT00549770|467012714|FG007|Overall Study|Protocol deviation|2|||
129741352|NCT00549770|467012707|FG000|Overall Study|Administrative problems|0|||
129741353|NCT00549770|467012708|FG001|Overall Study|Administrative problems|1|||
129741354|NCT00549770|467012709|FG002|Overall Study|Administrative problems|0|||
129741355|NCT00549770|467012710|FG003|Overall Study|Administrative problems|0|||
129741356|NCT00549770|467012711|FG004|Overall Study|Administrative problems|0|||
129741357|NCT00549770|467012712|FG005|Overall Study|Administrative problems|0|||
129741358|NCT00549770|467012713|FG006|Overall Study|Administrative problems|0|||
129741359|NCT00549770|467012714|FG007|Overall Study|Administrative problems|1|||
129741360|NCT00549770|467012707|FG000|Overall Study|Lost to Follow-up|0|||
129741361|NCT00549770|467012708|FG001|Overall Study|Lost to Follow-up|0|||
129741362|NCT00549770|467012709|FG002|Overall Study|Lost to Follow-up|2|||
129741363|NCT00549770|467012710|FG003|Overall Study|Lost to Follow-up|2|||
129741364|NCT00549770|467012711|FG004|Overall Study|Lost to Follow-up|3|||
129741365|NCT00549770|467012712|FG005|Overall Study|Lost to Follow-up|2|||
129741366|NCT00549770|467012713|FG006|Overall Study|Lost to Follow-up|0|||
129741367|NCT00549770|467012714|FG007|Overall Study|Lost to Follow-up|0|||
129741368|NCT00549770|467012707|FG000|Overall Study|Withdrawal by Subject|4|||
129741369|NCT00549770|467012708|FG001|Overall Study|Withdrawal by Subject|6|||
129741370|NCT00549770|467012709|FG002|Overall Study|Withdrawal by Subject|4|||
129741371|NCT00549770|467012710|FG003|Overall Study|Withdrawal by Subject|5|||
129741372|NCT00549770|467012711|FG004|Overall Study|Withdrawal by Subject|6|||
129741373|NCT00549770|467012712|FG005|Overall Study|Withdrawal by Subject|6|||
129895479|NCT02014558|467577200|FG011|Overall Study|Lack of Efficacy|8|||
129741374|NCT00549770|467012713|FG006|Overall Study|Withdrawal by Subject|4|||
129741375|NCT00549770|467012714|FG007|Overall Study|Withdrawal by Subject|9|||
129741376|NCT00549770|467012707|FG000|Overall Study|Lack of Efficacy|1|||
129741377|NCT00549770|467012708|FG001|Overall Study|Lack of Efficacy|0|||
129741378|NCT00549770|467012709|FG002|Overall Study|Lack of Efficacy|2|||
129741379|NCT00549770|467012710|FG003|Overall Study|Lack of Efficacy|3|||
129807674|NCT00289016|467261213|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
129807675|NCT00289016|467261213|FG000|Overall Study|Withdrawal by Subject|2|||
129807676|NCT00289016|467261213|FG000|Overall Study|Adverse Event|1|||
129807677|NCT00289016|467261213|FG000|Overall Study|Other|1|||
129807678|NCT00319501|467261214|FG000|Double-blind Period|Withdrawal by Subject|0|||
129807679|NCT00319501|467261215|FG001|Double-blind Period|Withdrawal by Subject|3|||
129807680|NCT00319501|467261214|FG000|Double-blind Period|Sponsor Request|1|||
129807681|NCT00319501|467261215|FG001|Double-blind Period|Sponsor Request|0|||
129807682|NCT00319501|467261214|FG000|Double-blind Period|Did not receive treatment|42|||
129807683|NCT00319501|467261215|FG001|Double-blind Period|Did not receive treatment|29|||
129807684|NCT00319501|467261214|FG000|Open-label Period|Adverse Event|5|||
129741380|NCT00549770|467012711|FG004|Overall Study|Lack of Efficacy|5|||
129741381|NCT00549770|467012712|FG005|Overall Study|Lack of Efficacy|1|||
129741382|NCT00549770|467012713|FG006|Overall Study|Lack of Efficacy|3|||
129741383|NCT00549770|467012714|FG007|Overall Study|Lack of Efficacy|8|||
129741384|NCT00549770|467012707|FG000|Overall Study|Abnormal test procedure results|0|||
129741385|NCT00549770|467012708|FG001|Overall Study|Abnormal test procedure results|0|||
129741386|NCT00549770|467012709|FG002|Overall Study|Abnormal test procedure results|0|||
129741387|NCT00549770|467012710|FG003|Overall Study|Abnormal test procedure results|2|||
129741388|NCT00549770|467012711|FG004|Overall Study|Abnormal test procedure results|0|||
129741389|NCT00549770|467012712|FG005|Overall Study|Abnormal test procedure results|1|||
129741390|NCT00549770|467012713|FG006|Overall Study|Abnormal test procedure results|1|||
129741391|NCT00549770|467012714|FG007|Overall Study|Abnormal test procedure results|1|||
129741392|NCT00549770|467012707|FG000|Overall Study|Abnormal laboratory values|0|||
129741393|NCT00549770|467012708|FG001|Overall Study|Abnormal laboratory values|0|||
129741394|NCT00549770|467012709|FG002|Overall Study|Abnormal laboratory values|0|||
129741395|NCT00549770|467012710|FG003|Overall Study|Abnormal laboratory values|0|||
129741396|NCT00549770|467012711|FG004|Overall Study|Abnormal laboratory values|0|||
129741397|NCT00549770|467012712|FG005|Overall Study|Abnormal laboratory values|1|||
129741398|NCT00549770|467012713|FG006|Overall Study|Abnormal laboratory values|0|||
129741399|NCT00549770|467012714|FG007|Overall Study|Abnormal laboratory values|0|||
129741400|NCT00549770|467012707|FG000|Overall Study|Adverse Event|1|||
129741401|NCT00549770|467012708|FG001|Overall Study|Adverse Event|3|||
129741402|NCT00549770|467012709|FG002|Overall Study|Adverse Event|1|||
129741403|NCT00549770|467012710|FG003|Overall Study|Adverse Event|2|||
129741404|NCT00549770|467012711|FG004|Overall Study|Adverse Event|1|||
129741405|NCT00549770|467012712|FG005|Overall Study|Adverse Event|0|||
129741406|NCT00549770|467012713|FG006|Overall Study|Adverse Event|5|||
129741407|NCT00549770|467012714|FG007|Overall Study|Adverse Event|4|||
129741408|NCT01079936|467012715|FG000|Phase I: MTD|First Remission Status|2|||
129741409|NCT01079936|467012716|FG001|Phase I: MTD|First Remission Status|0|||
129741410|NCT01079936|467012717|FG002|Phase I: MTD|First Remission Status|0|||
129741411|NCT01079936|467012718|FG003|Phase I: MTD|First Remission Status|0|||
129741412|NCT01079936|467012719|FG004|Phase I: MTD|First Remission Status|0|||
129741413|NCT01079936|467012715|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
129741414|NCT01079936|467012716|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
129741415|NCT01079936|467012717|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
129741416|NCT01079936|467012718|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
129741417|NCT01079936|467012719|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
129741418|NCT01079936|467012715|FG000|Phase II|Adverse Event|0|||
129741419|NCT01079936|467012716|FG001|Phase II|Adverse Event|0|||
129741420|NCT01079936|467012717|FG002|Phase II|Adverse Event|1|||
129741421|NCT01079936|467012718|FG003|Phase II|Adverse Event|0|||
129741422|NCT01079936|467012719|FG004|Phase II|Adverse Event|0|||
129741423|NCT01079936|467012715|FG000|Phase II|Insurance Issue|0|||
129741424|NCT01079936|467012716|FG001|Phase II|Insurance Issue|0|||
129741425|NCT01079936|467012717|FG002|Phase II|Insurance Issue|0|||
129741426|NCT01079936|467012718|FG003|Phase II|Insurance Issue|0|||
129741427|NCT01079936|467012719|FG004|Phase II|Insurance Issue|1|||
129807685|NCT00319501|467261215|FG001|Open-label Period|Adverse Event|0|||
129807686|NCT00319501|467261214|FG000|Open-label Period|Protocol Violation|6|||
129807687|NCT00319501|467261215|FG001|Open-label Period|Protocol Violation|0|||
129807688|NCT00319501|467261214|FG000|Open-label Period|Withdrawal by Subject|38|||
129807689|NCT00319501|467261215|FG001|Open-label Period|Withdrawal by Subject|0|||
129895480|NCT02014558|467577201|FG012|Overall Study|Lack of Efficacy|5|||
129741428|NCT00548717|467012720|FG000|Overall Study|Death|5|||
129741429|NCT00548717|467012721|FG001|Overall Study|Death|2|||
129741430|NCT00548717|467012720|FG000|Overall Study|Relapse|3|||
129741431|NCT00548717|467012721|FG001|Overall Study|Relapse|0|||
129741432|NCT00548717|467012720|FG000|Overall Study|Alternative treatment for GVHD|1|||
129741433|NCT00548717|467012721|FG001|Overall Study|Alternative treatment for GVHD|0|||
129741434|NCT02809053|467012723|FG000|Overall Study|Death|0|||
129741435|NCT02809053|467012724|FG001|Overall Study|Death|1|||
129741436|NCT02809053|467012723|FG000|Overall Study|Lost to Follow-up|3|||
129807690|NCT00319501|467261214|FG000|Open-label Period|Principal Investigator decision|6|||
129807691|NCT00319501|467261215|FG001|Open-label Period|Principal Investigator decision|0|||
129807692|NCT00319501|467261214|FG000|Open-label Period|Sponsor request|12|||
129741437|NCT02809053|467012724|FG001|Overall Study|Lost to Follow-up|1|||
129741438|NCT02809053|467012723|FG000|Overall Study|Withdrawal by Subject|2|||
129741439|NCT02809053|467012724|FG001|Overall Study|Withdrawal by Subject|3|||
129741440|NCT02809053|467012723|FG000|Overall Study|Disease Progression|2|||
129741441|NCT02809053|467012724|FG001|Overall Study|Disease Progression|1|||
129741442|NCT00869401|467012727|FG000|Overall Study|Withdrawal by Subject|0|||
129741443|NCT00869401|467012728|FG001|Overall Study|Withdrawal by Subject|0|||
129741444|NCT00869401|467012729|FG002|Overall Study|Withdrawal by Subject|0|||
129741445|NCT00869401|467012730|FG003|Overall Study|Withdrawal by Subject|5|||
129741446|NCT00869401|467012731|FG004|Overall Study|Withdrawal by Subject|3|||
129741447|NCT01147900|467012732|FG000|At Year 10|Lost to Follow-up|0|||
129741448|NCT01147900|467012733|FG001|At Year 10|Lost to Follow-up|1|||
129741449|NCT01147900|467012734|FG002|At Year 10|Lost to Follow-up|0|||
129741450|NCT01953913|467012735|FG000|Overall Study|Disease Progression|349|||
129741451|NCT01953913|467012735|FG000|Overall Study|Worsening of underlying cancer|22|||
129741452|NCT01953913|467012735|FG000|Overall Study|Adverse Event|20|||
129741453|NCT01953913|467012735|FG000|Overall Study|Protocol Violation|6|||
129741454|NCT01953913|467012735|FG000|Overall Study|Lost to Follow-up|4|||
129741455|NCT01953913|467012735|FG000|Overall Study|Withdrawal by Subject|32|||
129741456|NCT01953913|467012735|FG000|Overall Study|Other than listed|108|||
129741457|NCT01953913|467012735|FG000|Overall Study|Not Treated|1|||
129741458|NCT01732913|467012736|FG000|Overall Study|Study Terminated by Sponsor|105|||
129741459|NCT01732913|467012737|FG001|Overall Study|Study Terminated by Sponsor|55|||
129741460|NCT01732913|467012736|FG000|Overall Study|Withdrawal by Subject|27|||
129741461|NCT01732913|467012737|FG001|Overall Study|Withdrawal by Subject|4|||
129741462|NCT01732913|467012736|FG000|Overall Study|Physician Decision|14|||
129741463|NCT01732913|467012737|FG001|Overall Study|Physician Decision|7|||
129741464|NCT01732913|467012736|FG000|Overall Study|Other|7|||
129741465|NCT01732913|467012737|FG001|Overall Study|Other|1|||
129741466|NCT01732913|467012736|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
129741467|NCT01732913|467012737|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
129741468|NCT00082381|467012738|FG000|Overall Study|Adverse Event|27|||
129741469|NCT00082381|467012739|FG001|Overall Study|Adverse Event|2|||
129741470|NCT00082381|467012738|FG000|Overall Study|Lost to Follow-up|5|||
129741471|NCT00082381|467012739|FG001|Overall Study|Lost to Follow-up|7|||
129741472|NCT00082381|467012738|FG000|Overall Study|Patient Decision|8|||
129741473|NCT00082381|467012739|FG001|Overall Study|Patient Decision|4|||
129741474|NCT00082381|467012738|FG000|Overall Study|Physician Decision|1|||
129741475|NCT00082381|467012739|FG001|Overall Study|Physician Decision|2|||
129741476|NCT00082381|467012738|FG000|Overall Study|Protocol Violation|10|||
129741477|NCT00082381|467012739|FG001|Overall Study|Protocol Violation|11|||
129741478|NCT00082381|467012738|FG000|Overall Study|Loss of Glucose Control|4|||
129741479|NCT00082381|467012739|FG001|Overall Study|Loss of Glucose Control|0|||
129741480|NCT00025155|467012740|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
129741481|NCT00025155|467012740|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
129741482|NCT03022981|467012741|FG000|Overall Study|Adverse Event|0|||
129741483|NCT03022981|467012742|FG001|Overall Study|Adverse Event|1|||
129741484|NCT03022981|467012743|FG002|Overall Study|Adverse Event|0|||
129741485|NCT03022981|467012741|FG000|Overall Study|Investigator's Discretion|0|||
129741486|NCT03022981|467012742|FG001|Overall Study|Investigator's Discretion|1|||
129741487|NCT03022981|467012743|FG002|Overall Study|Investigator's Discretion|2|||
129741488|NCT03022981|467012741|FG000|Overall Study|Lost to Follow-up|6|||
129741489|NCT03022981|467012742|FG001|Overall Study|Lost to Follow-up|2|||
129741490|NCT03022981|467012743|FG002|Overall Study|Lost to Follow-up|1|||
129741491|NCT03022981|467012741|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129741492|NCT03022981|467012742|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129741493|NCT03022981|467012743|FG002|Overall Study|Non-Compliance With Study Drug|2|||
129741494|NCT03022981|467012741|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
129741495|NCT03022981|467012742|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
129741496|NCT03022981|467012743|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
129741497|NCT00444067|467012744|FG000|Overall Study|Lost to Follow-up|0|||
129741498|NCT00444067|467012745|FG001|Overall Study|Lost to Follow-up|1|||
129741499|NCT03178669|467012746|FG000|Overall Study|Adverse Event|4|||
129741500|NCT03178669|467012747|FG001|Overall Study|Adverse Event|1|||
129741501|NCT03178669|467012748|FG002|Overall Study|Adverse Event|4|||
129741502|NCT03178669|467012749|FG003|Overall Study|Adverse Event|2|||
129741503|NCT03178669|467012750|FG004|Overall Study|Adverse Event|2|||
129741504|NCT03178669|467012746|FG000|Overall Study|Lack of Efficacy|0|||
129741505|NCT03178669|467012747|FG001|Overall Study|Lack of Efficacy|0|||
129741506|NCT03178669|467012748|FG002|Overall Study|Lack of Efficacy|2|||
129741507|NCT03178669|467012749|FG003|Overall Study|Lack of Efficacy|0|||
129741508|NCT03178669|467012750|FG004|Overall Study|Lack of Efficacy|1|||
129741509|NCT03178669|467012746|FG000|Overall Study|Physician Decision|0|||
129741510|NCT03178669|467012747|FG001|Overall Study|Physician Decision|0|||
129741511|NCT03178669|467012748|FG002|Overall Study|Physician Decision|0|||
129741512|NCT03178669|467012749|FG003|Overall Study|Physician Decision|0|||
129741513|NCT03178669|467012750|FG004|Overall Study|Physician Decision|1|||
129741514|NCT03178669|467012746|FG000|Overall Study|Withdrawal by Subject|1|||
129741515|NCT03178669|467012747|FG001|Overall Study|Withdrawal by Subject|0|||
129741516|NCT03178669|467012748|FG002|Overall Study|Withdrawal by Subject|1|||
129741517|NCT03178669|467012749|FG003|Overall Study|Withdrawal by Subject|1|||
129741518|NCT03178669|467012750|FG004|Overall Study|Withdrawal by Subject|0|||
129741519|NCT03178669|467012746|FG000|Overall Study|Lost to Follow-up|0|||
129741520|NCT03178669|467012747|FG001|Overall Study|Lost to Follow-up|0|||
129741521|NCT03178669|467012748|FG002|Overall Study|Lost to Follow-up|0|||
129741522|NCT03178669|467012749|FG003|Overall Study|Lost to Follow-up|1|||
129741523|NCT03178669|467012750|FG004|Overall Study|Lost to Follow-up|0|||
129741524|NCT01600092|467012751|FG000|Overall Study|Adverse Event|2|||
129741525|NCT01600092|467012752|FG001|Overall Study|Adverse Event|0|||
129741526|NCT01600092|467012751|FG000|Overall Study|Lost to Follow-up|4|||
129741527|NCT01600092|467012752|FG001|Overall Study|Lost to Follow-up|6|||
129741528|NCT01600092|467012751|FG000|Overall Study|Withdrawal by parent/guardian|8|||
129741529|NCT01600092|467012752|FG001|Overall Study|Withdrawal by parent/guardian|6|||
129741530|NCT01600092|467012751|FG000|Overall Study|Physician Decision|1|||
129741531|NCT01600092|467012752|FG001|Overall Study|Physician Decision|1|||
129741532|NCT01600092|467012751|FG000|Overall Study|Randomized but not vaccinated|3|||
129741533|NCT01600092|467012752|FG001|Overall Study|Randomized but not vaccinated|3|||
129741534|NCT00079677|467012753|FG000|Overall Study|Adverse Event|5|||
129741535|NCT00079677|467012754|FG001|Overall Study|Adverse Event|6|||
129741536|NCT00079677|467012753|FG000|Overall Study|Lack of Efficacy|1|||
129741537|NCT00079677|467012754|FG001|Overall Study|Lack of Efficacy|0|||
129741538|NCT00079677|467012753|FG000|Overall Study|Lost to Follow-up|2|||
129741539|NCT00079677|467012754|FG001|Overall Study|Lost to Follow-up|2|||
129741540|NCT00079677|467012753|FG000|Overall Study|Physician Decision|3|||
129741541|NCT00079677|467012754|FG001|Overall Study|Physician Decision|0|||
129741542|NCT00079677|467012753|FG000|Overall Study|Protocol Violation|2|||
129741543|NCT00079677|467012754|FG001|Overall Study|Protocol Violation|3|||
129741544|NCT00079677|467012753|FG000|Overall Study|Withdrawal by Subject|5|||
129741545|NCT00079677|467012754|FG001|Overall Study|Withdrawal by Subject|3|||
129741546|NCT00079677|467012753|FG000|Overall Study|Miscellaneous|2|||
129741547|NCT00079677|467012754|FG001|Overall Study|Miscellaneous|0|||
129741548|NCT01300455|467012755|FG000|Washout|Withdrawal by Subject|1|||
129741549|NCT01300455|467012756|FG001|Washout|Withdrawal by Subject|0|||
129741550|NCT00084487|467012757|FG000|Overall Study|Death|1|||
129741551|NCT00565136|467012758|FG000|Overall Study|Lost to Follow-up|1|||
129741552|NCT00565136|467012758|FG000|Overall Study|Withdrawal by Subject|1|||
129741553|NCT00565136|467012758|FG000|Overall Study|Protocol Violation|1|||
129741554|NCT02528357|467012759|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741555|NCT02528357|467012760|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
129741556|NCT02528357|467012761|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741557|NCT02528357|467012762|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741558|NCT02528357|467012763|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741559|NCT02528357|467012764|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741560|NCT02528357|467012765|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741561|NCT02528357|467012766|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741562|NCT02528357|467012767|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741563|NCT02528357|467012768|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741564|NCT02528357|467012769|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741565|NCT02528357|467012770|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741566|NCT02528357|467012771|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741567|NCT02528357|467012772|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741568|NCT02528357|467012773|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741569|NCT02528357|467012774|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741570|NCT02528357|467012775|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741571|NCT02528357|467012776|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741572|NCT02528357|467012777|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
129741573|NCT02528357|467012759|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741574|NCT02528357|467012760|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741575|NCT02528357|467012761|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741576|NCT02528357|467012762|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
129741577|NCT02528357|467012763|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741578|NCT02528357|467012764|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
129741579|NCT02528357|467012765|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741580|NCT02528357|467012766|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
129741581|NCT02528357|467012767|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741582|NCT02528357|467012768|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741583|NCT02528357|467012769|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129807693|NCT00319501|467261215|FG001|Open-label Period|Sponsor request|0|||
129807694|NCT00319501|467261214|FG000|Open-label Period|Lost to Follow-up|5|||
129741584|NCT02528357|467012770|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741585|NCT02528357|467012771|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741586|NCT02528357|467012772|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741587|NCT02528357|467012773|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741588|NCT02528357|467012774|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741589|NCT02528357|467012775|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741590|NCT02528357|467012776|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741591|NCT02528357|467012777|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
129741592|NCT02528357|467012759|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741593|NCT02528357|467012760|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741594|NCT02528357|467012761|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
129741595|NCT02528357|467012762|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741596|NCT02528357|467012763|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
129741597|NCT02528357|467012764|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741598|NCT02528357|467012765|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
129741599|NCT02528357|467012766|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
129741600|NCT02528357|467012767|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741601|NCT02528357|467012768|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741602|NCT02528357|467012769|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741603|NCT02528357|467012770|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741604|NCT02528357|467012771|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741605|NCT02528357|467012772|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741606|NCT02528357|467012773|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741607|NCT02528357|467012774|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741608|NCT02528357|467012775|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741609|NCT02528357|467012776|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741610|NCT02528357|467012777|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
129741611|NCT02528357|467012759|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741612|NCT02528357|467012760|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741613|NCT02528357|467012761|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741614|NCT02528357|467012762|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741615|NCT02528357|467012763|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129741616|NCT02528357|467012764|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741617|NCT02528357|467012765|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741618|NCT02528357|467012766|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741619|NCT02528357|467012767|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741620|NCT02528357|467012768|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741621|NCT02528357|467012769|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741622|NCT02528357|467012770|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741623|NCT02528357|467012771|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741624|NCT02528357|467012772|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741625|NCT02528357|467012773|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741626|NCT02528357|467012774|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741627|NCT02528357|467012775|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741628|NCT02528357|467012776|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741629|NCT02528357|467012777|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741630|NCT02528357|467012759|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741631|NCT02528357|467012760|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741632|NCT02528357|467012761|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741633|NCT02528357|467012762|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741634|NCT02528357|467012763|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741635|NCT02528357|467012764|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741636|NCT02528357|467012765|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741637|NCT02528357|467012766|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129807695|NCT00319501|467261215|FG001|Open-label Period|Lost to Follow-up|0|||
129807696|NCT00319501|467261214|FG000|Open-label Period|Did not receive treatment|33|||
129807697|NCT00319501|467261215|FG001|Open-label Period|Did not receive treatment|0|||
129807698|NCT00319501|467261214|FG000|Open-label Period|Other|11|||
129741638|NCT02528357|467012767|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741639|NCT02528357|467012768|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741640|NCT02528357|467012769|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741641|NCT02528357|467012770|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741642|NCT02528357|467012771|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741643|NCT02528357|467012772|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
129741644|NCT02528357|467012773|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
129741645|NCT02528357|467012774|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741646|NCT02528357|467012775|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741647|NCT02528357|467012776|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741648|NCT02528357|467012777|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
129741649|NCT02528357|467012759|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741650|NCT02528357|467012760|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741651|NCT02528357|467012761|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741652|NCT02528357|467012762|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741653|NCT02528357|467012763|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741654|NCT02528357|467012764|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741655|NCT02528357|467012765|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741656|NCT02528357|467012766|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741657|NCT02528357|467012767|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741658|NCT02528357|467012768|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741659|NCT02528357|467012769|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741660|NCT02528357|467012770|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741661|NCT02528357|467012771|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741662|NCT02528357|467012772|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
129741663|NCT02528357|467012773|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741664|NCT02528357|467012774|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741665|NCT02528357|467012775|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741666|NCT02528357|467012776|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741667|NCT02528357|467012777|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
129741668|NCT02528357|467012759|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741669|NCT02528357|467012760|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741670|NCT02528357|467012761|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741671|NCT02528357|467012762|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741672|NCT02528357|467012763|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741673|NCT02528357|467012764|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741674|NCT02528357|467012765|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741675|NCT02528357|467012766|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741676|NCT02528357|467012767|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741677|NCT02528357|467012768|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129807699|NCT00319501|467261215|FG001|Open-label Period|Other|0|||
129807700|NCT00319501|467261214|FG000|Open-label Extension Period|Adverse Event|2|||
129807701|NCT00319501|467261215|FG001|Open-label Extension Period|Adverse Event|0|||
129807702|NCT00319501|467261214|FG000|Open-label Extension Period|Did not receive treatment|18|||
129807703|NCT00319501|467261215|FG001|Open-label Extension Period|Did not receive treatment|0|||
129807704|NCT00319501|467261214|FG000|Open-label Extension Period|Other|1|||
129807705|NCT00319501|467261215|FG001|Open-label Extension Period|Other|0|||
129807706|NCT00319501|467261214|FG000|Open-label Extension Period|Principal investigator decision|2|||
129807707|NCT00319501|467261215|FG001|Open-label Extension Period|Principal investigator decision|0|||
129807708|NCT00319501|467261214|FG000|Open-label Extension Period|Sponsor request|26|||
129807709|NCT00319501|467261215|FG001|Open-label Extension Period|Sponsor request|0|||
129807710|NCT00319501|467261214|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
129807711|NCT00319501|467261215|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129807712|NCT02764697|467261222|FG000|Overall Study|Lack of Efficacy|3|||
129807713|NCT00302107|467261223|FG000|Overall Study|Lost to Follow-up|6|||
129807714|NCT00302107|467261224|FG001|Overall Study|Lost to Follow-up|5|||
129807715|NCT00302107|467261223|FG000|Overall Study|Protocol Violation|1|||
129807716|NCT00302107|467261224|FG001|Overall Study|Protocol Violation|0|||
129807717|NCT00302107|467261223|FG000|Overall Study|Relocation|0|||
129807718|NCT00302107|467261224|FG001|Overall Study|Relocation|1|||
129807719|NCT00302107|467261223|FG000|Overall Study|Withdrawal by Subject|0|||
129807720|NCT00302107|467261224|FG001|Overall Study|Withdrawal by Subject|3|||
129807721|NCT00302107|467261223|FG000|Overall Study|Adverse Event|1|||
129807722|NCT00302107|467261224|FG001|Overall Study|Adverse Event|0|||
129807723|NCT01790932|467261225|FG000|Overall Study|Disease Progression|41|||
129807724|NCT01790932|467261225|FG000|Overall Study|Adverse Event|7|||
129807725|NCT01790932|467261225|FG000|Overall Study|Physician Decision|1|||
129741678|NCT02528357|467012769|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
129807726|NCT01790932|467261225|FG000|Overall Study|Withdrawal by Subject|1|||
129807727|NCT04223973|467261226|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
129807728|NCT04223973|467261227|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
129807729|NCT04223973|467261226|FG000|Overall Study|Adverse Event|4|||
129807730|NCT04223973|467261227|FG001|Overall Study|Adverse Event|0|||
129807731|NCT04223973|467261226|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
129807732|NCT04223973|467261227|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
129807733|NCT04223973|467261226|FG000|Overall Study|Physician Decision|1|||
129807734|NCT04223973|467261227|FG001|Overall Study|Physician Decision|1|||
129807735|NCT04223973|467261226|FG000|Overall Study|Withdrawal by Subject|0|||
129807736|NCT04223973|467261227|FG001|Overall Study|Withdrawal by Subject|1|||
129807737|NCT01757535|467261228|FG000|Overall Study|Disease Relapse|151|||
129807738|NCT01757535|467261229|FG001|Overall Study|Disease Relapse|181|||
129807739|NCT01757535|467261228|FG000|Overall Study|Other Reasons|28|||
129807740|NCT01757535|467261229|FG001|Overall Study|Other Reasons|27|||
129807741|NCT01757535|467261228|FG000|Overall Study|Adverse Event|31|||
129807742|NCT01757535|467261229|FG001|Overall Study|Adverse Event|11|||
129807743|NCT01757535|467261228|FG000|Overall Study|Withdrew Consent|19|||
129807744|NCT01757535|467261229|FG001|Overall Study|Withdrew Consent|13|||
129807745|NCT01757535|467261228|FG000|Overall Study|Physician Decision|7|||
129807746|NCT01757535|467261229|FG001|Overall Study|Physician Decision|0|||
129807747|NCT01757535|467261228|FG000|Overall Study|Death|2|||
129807748|NCT01757535|467261229|FG001|Overall Study|Death|2|||
129807749|NCT00717093|467262520|FG000|Overall Study|Adverse Event|19|||
129807750|NCT00717093|467262521|FG001|Overall Study|Adverse Event|9|||
129807751|NCT00717093|467262520|FG000|Overall Study|Lack of Efficacy|3|||
129807752|NCT00717093|467262521|FG001|Overall Study|Lack of Efficacy|13|||
129807753|NCT00717093|467262520|FG000|Overall Study|Lost to Follow-up|9|||
129807754|NCT00717093|467262521|FG001|Overall Study|Lost to Follow-up|6|||
129807755|NCT00717093|467262520|FG000|Overall Study|Withdrawal by Subject|12|||
129807756|NCT00717093|467262521|FG001|Overall Study|Withdrawal by Subject|19|||
129807757|NCT00717093|467262520|FG000|Overall Study|Other|0|||
129807758|NCT00717093|467262521|FG001|Overall Study|Other|1|||
129807759|NCT00717093|467262520|FG000|Overall Study|Randomized but not treated|1|||
129807760|NCT00717093|467262521|FG001|Overall Study|Randomized but not treated|0|||
129741679|NCT02528357|467012770|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741680|NCT02528357|467012771|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
129741681|NCT02528357|467012772|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
129741682|NCT02528357|467012773|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
129741683|NCT02528357|467012774|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741684|NCT02528357|467012775|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741685|NCT02528357|467012776|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741686|NCT02528357|467012777|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
129741687|NCT02528357|467012759|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741688|NCT02528357|467012760|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741689|NCT02528357|467012761|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741690|NCT02528357|467012762|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741691|NCT02528357|467012763|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741692|NCT02528357|467012764|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741693|NCT02528357|467012765|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741694|NCT02528357|467012766|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741695|NCT02528357|467012767|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129807761|NCT00531934|467262522|FG000|Overall Study|Adverse Event|4|||
129807762|NCT00531934|467262523|FG001|Overall Study|Adverse Event|8|||
129807763|NCT00531934|467262522|FG000|Overall Study|Progression|52|||
129807764|NCT00531934|467262523|FG001|Overall Study|Progression|42|||
129807765|NCT00531934|467262522|FG000|Overall Study|Death|7|||
129807766|NCT00531934|467262523|FG001|Overall Study|Death|10|||
129807767|NCT00531934|467262522|FG000|Overall Study|Withdrawal by Subject|1|||
129807768|NCT00531934|467262523|FG001|Overall Study|Withdrawal by Subject|1|||
129807769|NCT00531934|467262522|FG000|Overall Study|Other|2|||
129807770|NCT00531934|467262523|FG001|Overall Study|Other|2|||
129807771|NCT00217620|467262528|FG000|Overall Study|Adverse Event|2|||
129807772|NCT00217620|467262528|FG000|Overall Study|Progression|31|||
129807773|NCT00217620|467262528|FG000|Overall Study|Not Protocol Specified|4|||
129807774|NCT00217620|467262528|FG000|Overall Study|Ineligible|13|||
129807775|NCT00217620|467262528|FG000|Overall Study|Never received treatment|1|||
129807776|NCT00825682|467262534|FG000|Overall Study|personal reasons/ inconvenience|13|||
129807777|NCT00825682|467262535|FG001|Overall Study|personal reasons/ inconvenience|5|||
129741696|NCT02528357|467012768|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129741697|NCT02528357|467012769|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741698|NCT02528357|467012770|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
129741699|NCT02528357|467012771|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
129741700|NCT02528357|467012772|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129741701|NCT02528357|467012773|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129741702|NCT02528357|467012774|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741703|NCT02528357|467012775|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741704|NCT02528357|467012776|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741705|NCT02528357|467012777|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741706|NCT02528357|467012759|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741707|NCT02528357|467012760|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741708|NCT02528357|467012761|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741709|NCT02528357|467012762|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741710|NCT02528357|467012763|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741711|NCT02528357|467012764|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741712|NCT02528357|467012765|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741713|NCT02528357|467012766|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741714|NCT02528357|467012767|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741715|NCT02528357|467012768|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741716|NCT02528357|467012769|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741717|NCT02528357|467012770|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741718|NCT02528357|467012771|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741719|NCT02528357|467012772|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741720|NCT02528357|467012773|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741721|NCT02528357|467012774|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741722|NCT02528357|467012775|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
129741723|NCT02528357|467012776|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741724|NCT02528357|467012777|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
129741725|NCT02528357|467012759|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741726|NCT02528357|467012760|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741727|NCT02528357|467012761|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741728|NCT02528357|467012762|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741729|NCT02528357|467012763|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741730|NCT02528357|467012764|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741731|NCT02528357|467012765|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741732|NCT02528357|467012766|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741733|NCT02528357|467012767|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741734|NCT02528357|467012768|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741735|NCT02528357|467012769|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741736|NCT02528357|467012770|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741737|NCT02528357|467012771|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741738|NCT02528357|467012772|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741739|NCT02528357|467012773|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741740|NCT02528357|467012774|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
129741741|NCT02528357|467012775|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
129741742|NCT02528357|467012776|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
129741743|NCT02528357|467012777|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
129741744|NCT02438813|467012783|FG000|Overall Study|Patient Decision|59|||
129741745|NCT02438813|467012783|FG000|Overall Study|Patient Lost to Follow-Up|137|||
129741746|NCT02438813|467012783|FG000|Overall Study|Study Ended by Sponsor|80|||
129741747|NCT02438813|467012783|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
129741748|NCT02228096|467012794|FG000|Overall Study|Study terminated by Sponsor|24|||
129741749|NCT02228096|467012794|FG000|Overall Study|Lack of Efficacy|18|||
129741750|NCT02228096|467012794|FG000|Overall Study|Death|12|||
129895481|NCT02014558|467577189|FG000|Overall Study|Lost to Follow-up|0|||
129741751|NCT02228096|467012794|FG000|Overall Study|Physician Decision|3|||
129741752|NCT02228096|467012794|FG000|Overall Study|Subject/guardian decision|2|||
129741753|NCT02228096|467012794|FG000|Overall Study|New therapy for study indication|1|||
129741754|NCT02228096|467012794|FG000|Overall Study|Enrolled, not infused|11|||
129741755|NCT00454649|467012795|FG000|Overall Study|Lack of Efficacy|2|||
129741756|NCT00454649|467012796|FG001|Overall Study|Lack of Efficacy|2|||
129741757|NCT00454649|467012797|FG002|Overall Study|Lack of Efficacy|10|||
129741758|NCT00454649|467012798|FG003|Overall Study|Lack of Efficacy|3|||
129741759|NCT00454649|467012799|FG004|Overall Study|Lack of Efficacy|0|||
129741760|NCT00454649|467012800|FG005|Overall Study|Lack of Efficacy|4|||
129741761|NCT00454649|467012801|FG006|Overall Study|Lack of Efficacy|5|||
129741762|NCT00454649|467012802|FG007|Overall Study|Lack of Efficacy|13|||
129741763|NCT00454649|467012803|FG008|Overall Study|Lack of Efficacy|10|||
129741764|NCT00454649|467012804|FG009|Overall Study|Lack of Efficacy|2|||
129741765|NCT00454649|467012795|FG000|Overall Study|Adverse Event|0|||
129741766|NCT00454649|467012796|FG001|Overall Study|Adverse Event|1|||
129741767|NCT00454649|467012797|FG002|Overall Study|Adverse Event|3|||
129741768|NCT00454649|467012798|FG003|Overall Study|Adverse Event|0|||
129741769|NCT00454649|467012799|FG004|Overall Study|Adverse Event|1|||
129741770|NCT00454649|467012800|FG005|Overall Study|Adverse Event|2|||
129741771|NCT00454649|467012801|FG006|Overall Study|Adverse Event|3|||
129741772|NCT00454649|467012802|FG007|Overall Study|Adverse Event|4|||
129741773|NCT00454649|467012803|FG008|Overall Study|Adverse Event|6|||
129741774|NCT00454649|467012804|FG009|Overall Study|Adverse Event|2|||
129741775|NCT00454649|467012795|FG000|Overall Study|Lost to Follow-up|0|||
129741776|NCT00454649|467012796|FG001|Overall Study|Lost to Follow-up|0|||
129741777|NCT00454649|467012797|FG002|Overall Study|Lost to Follow-up|1|||
129741778|NCT00454649|467012798|FG003|Overall Study|Lost to Follow-up|0|||
129741779|NCT00454649|467012799|FG004|Overall Study|Lost to Follow-up|0|||
129741780|NCT00454649|467012800|FG005|Overall Study|Lost to Follow-up|0|||
129741781|NCT00454649|467012801|FG006|Overall Study|Lost to Follow-up|1|||
129741782|NCT00454649|467012802|FG007|Overall Study|Lost to Follow-up|0|||
129741783|NCT00454649|467012803|FG008|Overall Study|Lost to Follow-up|0|||
129741784|NCT00454649|467012804|FG009|Overall Study|Lost to Follow-up|0|||
129741785|NCT00454649|467012795|FG000|Overall Study|Other|1|||
129741786|NCT00454649|467012796|FG001|Overall Study|Other|1|||
129741787|NCT00454649|467012797|FG002|Overall Study|Other|5|||
129741788|NCT00454649|467012798|FG003|Overall Study|Other|3|||
129741789|NCT00454649|467012799|FG004|Overall Study|Other|0|||
129895482|NCT02014558|467577190|FG001|Overall Study|Lost to Follow-up|0|||
129895483|NCT02014558|467577191|FG002|Overall Study|Lost to Follow-up|0|||
129895484|NCT02014558|467577192|FG003|Overall Study|Lost to Follow-up|0|||
129895485|NCT02014558|467577193|FG004|Overall Study|Lost to Follow-up|0|||
129895486|NCT02014558|467577194|FG005|Overall Study|Lost to Follow-up|0|||
129895487|NCT02014558|467577195|FG006|Overall Study|Lost to Follow-up|0|||
129741790|NCT00454649|467012800|FG005|Overall Study|Other|0|||
129741791|NCT00454649|467012801|FG006|Overall Study|Other|0|||
129741792|NCT00454649|467012802|FG007|Overall Study|Other|0|||
129741793|NCT00454649|467012803|FG008|Overall Study|Other|3|||
129741794|NCT00454649|467012804|FG009|Overall Study|Other|1|||
129741795|NCT00454649|467012795|FG000|Overall Study|Withdrawal by Subject|0|||
129741796|NCT00454649|467012796|FG001|Overall Study|Withdrawal by Subject|0|||
129741797|NCT00454649|467012797|FG002|Overall Study|Withdrawal by Subject|0|||
129741798|NCT00454649|467012798|FG003|Overall Study|Withdrawal by Subject|0|||
129741799|NCT00454649|467012799|FG004|Overall Study|Withdrawal by Subject|0|||
129895488|NCT02014558|467577196|FG007|Overall Study|Lost to Follow-up|0|||
129895489|NCT02014558|467577197|FG008|Overall Study|Lost to Follow-up|0|||
129895490|NCT02014558|467577198|FG009|Overall Study|Lost to Follow-up|0|||
129895491|NCT02014558|467577199|FG010|Overall Study|Lost to Follow-up|1|||
129741800|NCT00454649|467012800|FG005|Overall Study|Withdrawal by Subject|1|||
129741801|NCT00454649|467012801|FG006|Overall Study|Withdrawal by Subject|0|||
129741802|NCT00454649|467012802|FG007|Overall Study|Withdrawal by Subject|2|||
129741803|NCT00454649|467012803|FG008|Overall Study|Withdrawal by Subject|1|||
129895492|NCT02014558|467577200|FG011|Overall Study|Lost to Follow-up|0|||
129741804|NCT00454649|467012804|FG009|Overall Study|Withdrawal by Subject|0|||
129741805|NCT01789606|467012805|FG000|Overall Study|Participant not Purchased the Product|0|||
129741806|NCT01789606|467012806|FG001|Overall Study|Participant not Purchased the Product|20|||
129895493|NCT02014558|467577201|FG012|Overall Study|Lost to Follow-up|0|||
129741807|NCT01789606|467012805|FG000|Overall Study|Withdrawal by Subject|0|||
129741808|NCT01789606|467012806|FG001|Overall Study|Withdrawal by Subject|1|||
129741809|NCT01789606|467012805|FG000|Overall Study|Ineligible|6|||
129741810|NCT01789606|467012806|FG001|Overall Study|Ineligible|2|||
129741811|NCT01789606|467012805|FG000|Overall Study|Administrative Reasons|17|||
129741812|NCT01789606|467012806|FG001|Overall Study|Administrative Reasons|6|||
129741813|NCT01789606|467012805|FG000|Overall Study|No Study Medication Taken|0|||
129895494|NCT02014558|467577189|FG000|Overall Study|Progressive Disease|1|||
129741814|NCT01789606|467012806|FG001|Overall Study|No Study Medication Taken|1|||
129741815|NCT01789606|467012805|FG000|Overall Study|Protocol Violation|0|||
129741816|NCT01789606|467012806|FG001|Overall Study|Protocol Violation|55|||
129741817|NCT01789606|467012805|FG000|Overall Study|Adverse Event|0|||
129741818|NCT01789606|467012806|FG001|Overall Study|Adverse Event|3|||
129741819|NCT01789606|467012805|FG000|Overall Study|Lost to Follow-up|0|||
129741820|NCT01789606|467012806|FG001|Overall Study|Lost to Follow-up|14|||
129741821|NCT01789606|467012805|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
129741822|NCT01789606|467012806|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
129741823|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
129741824|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
129741825|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
129741826|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
129741827|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
129741828|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
129741829|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
129741830|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
129741831|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Death|0|||
129741832|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Death|1|||
129741833|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
129741834|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
129741835|NCT03281304|467012822|FG000|Treatment Phase (up to 42 Months)|Other|0|||
129741836|NCT03281304|467012823|FG001|Treatment Phase (up to 42 Months)|Other|2|||
129741837|NCT03281304|467012822|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
129741838|NCT03281304|467012823|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
129741839|NCT00626405|467012824|FG000|Overall Study|Deemed Ineligible|1|||
129741840|NCT00626405|467012825|FG001|Overall Study|Deemed Ineligible|0|||
129741841|NCT00626405|467012824|FG000|Overall Study|Withdrawal by Subject|0|||
129741842|NCT00626405|467012825|FG001|Overall Study|Withdrawal by Subject|1|||
129741843|NCT03834220|467012826|FG000|Overall Study|Adverse Event|1|||
129741844|NCT03834220|467012827|FG001|Overall Study|Adverse Event|0|||
129741845|NCT03834220|467012828|FG002|Overall Study|Adverse Event|0|||
129741846|NCT03834220|467012826|FG000|Overall Study|Death|8|||
129741847|NCT03834220|467012827|FG001|Overall Study|Death|1|||
129741848|NCT03834220|467012828|FG002|Overall Study|Death|17|||
129741849|NCT03834220|467012826|FG000|Overall Study|Reason not Specified|9|||
129741850|NCT03834220|467012827|FG001|Overall Study|Reason not Specified|0|||
129741851|NCT03834220|467012828|FG002|Overall Study|Reason not Specified|6|||
129741852|NCT03834220|467012826|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
129741853|NCT03834220|467012827|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
129741854|NCT03834220|467012828|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
129741855|NCT03834220|467012826|FG000|Overall Study|Withdrawal of Consent|2|||
129741856|NCT03834220|467012827|FG001|Overall Study|Withdrawal of Consent|2|||
129741857|NCT03834220|467012828|FG002|Overall Study|Withdrawal of Consent|2|||
129741858|NCT02593318|467012829|FG000|Overall Study|Withdrawal by Subject|1|||
129741859|NCT02593318|467012830|FG001|Overall Study|Withdrawal by Subject|1|||
129741860|NCT02720692|467014921|FG000|Overall Study|Withdrawal by Subject|3|||
129741861|NCT02720692|467014922|FG001|Overall Study|Withdrawal by Subject|0|||
129741862|NCT02720692|467014921|FG000|Overall Study|Physician Decision|1|||
129741863|NCT02720692|467014922|FG001|Overall Study|Physician Decision|0|||
129741864|NCT02720692|467014921|FG000|Overall Study|Lost to Follow-up|8|||
129741865|NCT02720692|467014922|FG001|Overall Study|Lost to Follow-up|3|||
129741866|NCT02720692|467014921|FG000|Overall Study|Subject unable to return for visit|1|||
129741867|NCT02720692|467014922|FG001|Overall Study|Subject unable to return for visit|0|||
129741868|NCT05011513|467014923|FG000|Overall Study|Death|0|||
129741869|NCT05011513|467014924|FG001|Overall Study|Death|1|||
129741870|NCT05011513|467014923|FG000|Overall Study|Lost to Follow-up|4|||
129741871|NCT05011513|467014924|FG001|Overall Study|Lost to Follow-up|0|||
129741872|NCT05011513|467014923|FG000|Overall Study|Withdrawal by Subject|18|||
129741873|NCT05011513|467014924|FG001|Overall Study|Withdrawal by Subject|17|||
129741874|NCT05011513|467014923|FG000|Overall Study|Other|4|||
129741875|NCT05011513|467014924|FG001|Overall Study|Other|2|||
129741876|NCT03878758|467014925|FG000|Overall Study|Withdrawal by Subject|1|||
129741877|NCT03878758|467014925|FG000|Overall Study|Protocol defined|2|||
129741878|NCT03878758|467014925|FG000|Overall Study|Improper consent documentation|1|||
129741879|NCT02315560|467014926|FG000|Overall Study|noncompliance by subjects|3|||
129741880|NCT00358436|467014928|FG000|Overall Study|Adverse Event|29|||
129741881|NCT00358436|467014929|FG001|Overall Study|Adverse Event|13|||
129741882|NCT00358436|467014928|FG000|Overall Study|Lack of Efficacy|34|||
129741883|NCT00358436|467014929|FG001|Overall Study|Lack of Efficacy|36|||
129741884|NCT00358436|467014928|FG000|Overall Study|Lost to Follow-up|11|||
129741885|NCT00358436|467014929|FG001|Overall Study|Lost to Follow-up|6|||
129741886|NCT00358436|467014928|FG000|Overall Study|Protocol Violation|8|||
129741887|NCT00358436|467014929|FG001|Overall Study|Protocol Violation|3|||
129741888|NCT00358436|467014928|FG000|Overall Study|Withdrawal by Subject|40|||
129741889|NCT00358436|467014929|FG001|Overall Study|Withdrawal by Subject|17|||
129741890|NCT00358436|467014928|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
129741891|NCT00358436|467014929|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
129741892|NCT00358436|467014928|FG000|Overall Study|COPD exacerbation|22|||
129741893|NCT00358436|467014929|FG001|Overall Study|COPD exacerbation|10|||
129741894|NCT00358436|467014928|FG000|Overall Study|Other|6|||
129741895|NCT00358436|467014929|FG001|Overall Study|Other|1|||
129741896|NCT00652951|467014932|FG000|Booster Phase|Adverse event, non-fatal|0|||
129741897|NCT00652951|467014933|FG001|Booster Phase|Adverse event, non-fatal|1|||
129741898|NCT00652951|467014934|FG002|Booster Phase|Adverse event, non-fatal|0|||
129741899|NCT00652951|467014932|FG000|Booster Phase|Other|1|||
129741900|NCT00652951|467014933|FG001|Booster Phase|Other|0|||
129741901|NCT00652951|467014934|FG002|Booster Phase|Other|0|||
129741902|NCT01206582|467014935|FG000|Overall Study|Withdrew prior to study|1|||
129741903|NCT01206582|467014936|FG001|Overall Study|Withdrew prior to study|0|||
129741904|NCT01206582|467014935|FG000|Overall Study|Discontinued intervention before week 8|1|||
129741905|NCT01206582|467014936|FG001|Overall Study|Discontinued intervention before week 8|2|||
129741906|NCT06359080|467014937|FG000|Overall Study|Withdrawal by Subject|3|||
129741907|NCT00306527|467014940|FG000|Overall Study|Lost to Follow-up|3|||
129741908|NCT00306527|467014941|FG001|Overall Study|Lost to Follow-up|4|||
129741909|NCT00306527|467014942|FG002|Overall Study|Lost to Follow-up|3|||
129741910|NCT00306527|467014943|FG003|Overall Study|Lost to Follow-up|0|||
129741911|NCT00306527|467014940|FG000|Overall Study|Withdrawal by Subject|2|||
129741912|NCT00306527|467014941|FG001|Overall Study|Withdrawal by Subject|3|||
129741913|NCT00306527|467014942|FG002|Overall Study|Withdrawal by Subject|0|||
129741914|NCT00306527|467014943|FG003|Overall Study|Withdrawal by Subject|3|||
129741915|NCT00306527|467014940|FG000|Overall Study|Adverse Event|0|||
129741916|NCT00306527|467014941|FG001|Overall Study|Adverse Event|0|||
129741917|NCT00306527|467014942|FG002|Overall Study|Adverse Event|1|||
129741918|NCT00306527|467014943|FG003|Overall Study|Adverse Event|1|||
129741919|NCT00306527|467014940|FG000|Overall Study|Death|1|||
129741920|NCT00306527|467014941|FG001|Overall Study|Death|0|||
129741921|NCT00306527|467014942|FG002|Overall Study|Death|1|||
129741922|NCT00306527|467014943|FG003|Overall Study|Death|2|||
129741923|NCT00417963|467014959|FG000|Overall Study|Lost to Follow-up|3|||
129741924|NCT00417963|467014959|FG000|Overall Study|Withdrawal by Subject|18|||
129741925|NCT00417963|467014959|FG000|Overall Study|Death|17|||
129741926|NCT00417963|467014959|FG000|Overall Study|Study device could not be deployed|3|||
129741927|NCT01023672|467014960|FG000|Overall Study|Worsening disease|2|||
129741928|NCT01023672|467014960|FG000|Overall Study|Death|1|||
129741929|NCT00387725|467014961|FG000|Overall Study|Adverse Event|0|||
129741930|NCT00387725|467014962|FG001|Overall Study|Adverse Event|0|||
129741931|NCT00387725|467014963|FG002|Overall Study|Adverse Event|0|||
129741932|NCT00387725|467014964|FG003|Overall Study|Adverse Event|1|||
129741933|NCT00387725|467014961|FG000|Overall Study|Protocol Violation|0|||
129741934|NCT00387725|467014962|FG001|Overall Study|Protocol Violation|1|||
129741935|NCT00387725|467014963|FG002|Overall Study|Protocol Violation|0|||
129741936|NCT00387725|467014964|FG003|Overall Study|Protocol Violation|0|||
129741937|NCT00387725|467014961|FG000|Overall Study|Withdrawal by Subject|1|||
129741938|NCT00387725|467014962|FG001|Overall Study|Withdrawal by Subject|0|||
129741939|NCT00387725|467014963|FG002|Overall Study|Withdrawal by Subject|1|||
129741940|NCT00387725|467014964|FG003|Overall Study|Withdrawal by Subject|0|||
129741941|NCT00387725|467014961|FG000|Overall Study|Parent/legal guardian request|0|||
129741942|NCT00387725|467014962|FG001|Overall Study|Parent/legal guardian request|0|||
129741943|NCT00387725|467014963|FG002|Overall Study|Parent/legal guardian request|1|||
129741944|NCT00387725|467014964|FG003|Overall Study|Parent/legal guardian request|1|||
129741945|NCT02017522|467014967|FG000|Overall Study|Withdrawal by Subject|1|||
129741946|NCT02166463|467014968|FG000|Overall Study|Lost to Follow-up|0|||
129741947|NCT02166463|467014969|FG001|Overall Study|Lost to Follow-up|1|||
129741948|NCT02166463|467014968|FG000|Overall Study|Physician Decision|10|||
129741949|NCT02166463|467014969|FG001|Overall Study|Physician Decision|10|||
129741950|NCT02166463|467014968|FG000|Overall Study|Ineligible|11|||
129741951|NCT02166463|467014969|FG001|Overall Study|Ineligible|2|||
129741952|NCT02166463|467014968|FG000|Overall Study|Progressive Disease|9|||
129741953|NCT02166463|467014969|FG001|Overall Study|Progressive Disease|6|||
129741954|NCT02166463|467014968|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
129741955|NCT02166463|467014969|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
129741956|NCT02166463|467014968|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
129741957|NCT02166463|467014969|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
129741958|NCT02166463|467014968|FG000|Overall Study|Refusal of further protocol therapy|5|||
129741959|NCT02166463|467014969|FG001|Overall Study|Refusal of further protocol therapy|6|||
129741960|NCT00859937|467014970|FG000|Overall Study|Protocol Violation|1|||
129741961|NCT00859937|467014971|FG001|Overall Study|Protocol Violation|0|||
129741962|NCT02478164|467014972|FG000|Overall Study|Lack of Efficacy|13|||
129741963|NCT02478164|467014972|FG000|Overall Study|Adverse Event|1|||
129741964|NCT02478164|467014972|FG000|Overall Study|Withdrawal by Subject|1|||
129741965|NCT05194267|467014973|FG000|Overall Study|Withdrawal by Subject|2|||
129741966|NCT00802893|467014974|FG000|Overall Study|study terminated|3|||
129741967|NCT06151288|467014975|FG000|Overall Study|Lost to Follow-up|4|||
129741968|NCT06151288|467014976|FG001|Overall Study|Lost to Follow-up|2|||
129741969|NCT06151288|467014977|FG002|Overall Study|Lost to Follow-up|4|||
129741970|NCT06151288|467014978|FG003|Overall Study|Lost to Follow-up|3|||
129741971|NCT06151288|467014975|FG000|Overall Study|Withdrawal by Subject|4|||
129741972|NCT06151288|467014976|FG001|Overall Study|Withdrawal by Subject|5|||
129741973|NCT06151288|467014977|FG002|Overall Study|Withdrawal by Subject|1|||
129741974|NCT06151288|467014978|FG003|Overall Study|Withdrawal by Subject|1|||
129741975|NCT04588389|467014979|FG000|Overall Study|Issues with anesthesia during surgery|2|||
129741976|NCT04588389|467014980|FG001|Overall Study|Issues with anesthesia during surgery|0|||
129741977|NCT04588389|467014981|FG002|Overall Study|Issues with anesthesia during surgery|0|||
129741978|NCT02911142|467014982|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
129741979|NCT02911142|467014982|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
129741980|NCT02911142|467014982|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
129741981|NCT02911142|467014982|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
129741982|NCT00026312|467014983|FG000|Overall Study|Adverse Event|0|||
129741983|NCT00026312|467014984|FG001|Overall Study|Adverse Event|32|||
129741984|NCT00026312|467014983|FG000|Overall Study|Death|1|||
129741985|NCT00026312|467014984|FG001|Overall Study|Death|7|||
129741986|NCT00026312|467014983|FG000|Overall Study|Lack of Efficacy|19|||
129741987|NCT00026312|467014984|FG001|Overall Study|Lack of Efficacy|114|||
129741988|NCT00026312|467014983|FG000|Overall Study|Lost to Follow-up|0|||
129741989|NCT00026312|467014984|FG001|Overall Study|Lost to Follow-up|5|||
129741990|NCT00026312|467014983|FG000|Overall Study|Physician Decision|1|||
129741991|NCT00026312|467014984|FG001|Overall Study|Physician Decision|37|||
129741992|NCT00026312|467014983|FG000|Overall Study|Protocol Violation|0|||
129741993|NCT00026312|467014984|FG001|Overall Study|Protocol Violation|3|||
129741994|NCT00026312|467014983|FG000|Overall Study|Withdrawal by Subject|1|||
129741995|NCT00026312|467014984|FG001|Overall Study|Withdrawal by Subject|6|||
129741996|NCT00026312|467014983|FG000|Overall Study|Ineligible|4|||
129741997|NCT00026312|467014984|FG001|Overall Study|Ineligible|5|||
129741998|NCT00026312|467014983|FG000|Overall Study|Entry onto another COG study|0|||
129741999|NCT00026312|467014984|FG001|Overall Study|Entry onto another COG study|1|||
129742000|NCT00026312|467014983|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
129742001|NCT00026312|467014984|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
129742002|NCT00231413|467014987|FG000|Overall Study|Non-serious AE|0|||
129742003|NCT00231413|467014988|FG001|Overall Study|Non-serious AE|0|||
129742004|NCT00231413|467014989|FG002|Overall Study|Non-serious AE|1|||
129742005|NCT00231413|467014990|FG003|Overall Study|Non-serious AE|0|||
129742006|NCT00231413|467014991|FG004|Overall Study|Non-serious AE|0|||
129742007|NCT00231413|467014992|FG005|Overall Study|Non-serious AE|0|||
129742008|NCT00231413|467014993|FG006|Overall Study|Non-serious AE|1|||
129742009|NCT00231413|467014987|FG000|Overall Study|Withdrawal by Subject|3|||
129742010|NCT00231413|467014988|FG001|Overall Study|Withdrawal by Subject|1|||
129742011|NCT00231413|467014989|FG002|Overall Study|Withdrawal by Subject|4|||
129742012|NCT00231413|467014990|FG003|Overall Study|Withdrawal by Subject|2|||
129742013|NCT00231413|467014991|FG004|Overall Study|Withdrawal by Subject|2|||
129742014|NCT00231413|467014992|FG005|Overall Study|Withdrawal by Subject|0|||
129742015|NCT00231413|467014993|FG006|Overall Study|Withdrawal by Subject|3|||
129807778|NCT01644565|467262538|FG000|Overall Study|Undisclosed Medical History|1|||
129807779|NCT01644565|467262539|FG001|Overall Study|Undisclosed Medical History|0|||
129807780|NCT01644565|467262540|FG002|Overall Study|Undisclosed Medical History|0|||
129807781|NCT01644565|467262541|FG003|Overall Study|Undisclosed Medical History|0|||
129807782|NCT01644565|467262542|FG004|Overall Study|Undisclosed Medical History|0|||
129807783|NCT01644565|467262543|FG005|Overall Study|Undisclosed Medical History|0|||
129807784|NCT01644565|467262544|FG006|Overall Study|Undisclosed Medical History|0|||
129807785|NCT01644565|467262545|FG007|Overall Study|Undisclosed Medical History|0|||
129807786|NCT01644565|467262546|FG008|Overall Study|Undisclosed Medical History|0|||
129807787|NCT01644565|467262538|FG000|Overall Study|Lost to Follow-up|0|||
129807788|NCT01644565|467262539|FG001|Overall Study|Lost to Follow-up|0|||
129807789|NCT01644565|467262540|FG002|Overall Study|Lost to Follow-up|0|||
129807790|NCT01644565|467262541|FG003|Overall Study|Lost to Follow-up|1|||
129807791|NCT01644565|467262542|FG004|Overall Study|Lost to Follow-up|0|||
129807792|NCT01644565|467262543|FG005|Overall Study|Lost to Follow-up|0|||
129807793|NCT01644565|467262544|FG006|Overall Study|Lost to Follow-up|0|||
129807794|NCT01644565|467262545|FG007|Overall Study|Lost to Follow-up|2|||
129807795|NCT01644565|467262546|FG008|Overall Study|Lost to Follow-up|0|||
129742016|NCT00231413|467014987|FG000|Overall Study|Migrated/moved from study area|0|||
129742017|NCT00231413|467014988|FG001|Overall Study|Migrated/moved from study area|0|||
129742018|NCT00231413|467014989|FG002|Overall Study|Migrated/moved from study area|1|||
129807796|NCT01644565|467262538|FG000|Overall Study|Family emergency|0|||
129742019|NCT00231413|467014990|FG003|Overall Study|Migrated/moved from study area|0|||
129742020|NCT00231413|467014991|FG004|Overall Study|Migrated/moved from study area|0|||
129742021|NCT00231413|467014992|FG005|Overall Study|Migrated/moved from study area|1|||
129742022|NCT00231413|467014993|FG006|Overall Study|Migrated/moved from study area|0|||
129742023|NCT00231413|467014987|FG000|Overall Study|Lost to Follow-up|4|||
129742024|NCT00231413|467014988|FG001|Overall Study|Lost to Follow-up|4|||
129742025|NCT00231413|467014989|FG002|Overall Study|Lost to Follow-up|1|||
129742026|NCT00231413|467014990|FG003|Overall Study|Lost to Follow-up|1|||
129742027|NCT00231413|467014991|FG004|Overall Study|Lost to Follow-up|1|||
129742028|NCT00231413|467014992|FG005|Overall Study|Lost to Follow-up|4|||
129742029|NCT00231413|467014993|FG006|Overall Study|Lost to Follow-up|0|||
129742030|NCT00231413|467014987|FG000|Overall Study|Pregnancy|1|||
129742031|NCT00231413|467014988|FG001|Overall Study|Pregnancy|0|||
129742032|NCT00231413|467014989|FG002|Overall Study|Pregnancy|0|||
129742033|NCT00231413|467014990|FG003|Overall Study|Pregnancy|0|||
129742034|NCT00231413|467014991|FG004|Overall Study|Pregnancy|0|||
129742035|NCT00231413|467014992|FG005|Overall Study|Pregnancy|0|||
129742036|NCT00231413|467014993|FG006|Overall Study|Pregnancy|0|||
129742037|NCT02294734|467014994|FG000|Overall Study|Adverse Event|5|||
129742038|NCT02294734|467014995|FG001|Overall Study|Adverse Event|5|||
129742039|NCT02294734|467014994|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
129742040|NCT02294734|467014995|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
129742041|NCT02294734|467014994|FG000|Overall Study|Lost to Follow-up|2|||
129742042|NCT02294734|467014995|FG001|Overall Study|Lost to Follow-up|0|||
129742043|NCT02294734|467014994|FG000|Overall Study|Physician Decision|2|||
129742044|NCT02294734|467014995|FG001|Overall Study|Physician Decision|1|||
129742045|NCT02294734|467014994|FG000|Overall Study|Withdrawal by Subject|4|||
129742046|NCT02294734|467014995|FG001|Overall Study|Withdrawal by Subject|2|||
129742047|NCT03157583|467014996|FG000|Overall Study|Other (did not meet study criteria)|1|||
129742048|NCT00847015|467014999|FG000|Overall Study|Withdrawal by Subject|1|||
129742049|NCT00847015|467014999|FG000|Overall Study|declined any surgery|1|||
129742050|NCT00847015|467014999|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
129742051|NCT01141478|467015000|FG000|Overall Study|Withdrawal by Subject|1|||
129742052|NCT01141478|467015001|FG001|Overall Study|Withdrawal by Subject|1|||
129742053|NCT03847909|467015011|FG000|Overall Study|Withdrawal by Subject|1|||
129742054|NCT03847909|467015012|FG001|Overall Study|Withdrawal by Subject|1|||
129742055|NCT00975143|467015013|FG000|Overall Study|Adverse Event|19|||
129742056|NCT00975143|467015014|FG001|Overall Study|Adverse Event|15|||
129742057|NCT00975143|467015013|FG000|Overall Study|Withdrawal by Subject|15|||
129742058|NCT00975143|467015014|FG001|Overall Study|Withdrawal by Subject|15|||
129742059|NCT00975143|467015013|FG000|Overall Study|Lost to Follow-up|20|||
129742060|NCT00975143|467015014|FG001|Overall Study|Lost to Follow-up|16|||
129742061|NCT00975143|467015013|FG000|Overall Study|Non-compliance|5|||
129742062|NCT00975143|467015014|FG001|Overall Study|Non-compliance|8|||
129742063|NCT00975143|467015013|FG000|Overall Study|Physician Decision|1|||
129742064|NCT00975143|467015014|FG001|Overall Study|Physician Decision|2|||
129742065|NCT00975143|467015013|FG000|Overall Study|Details not available|10|||
129742066|NCT00975143|467015014|FG001|Overall Study|Details not available|4|||
129742067|NCT01375608|467015015|FG000|Overall Study|Withdrawal by Subject|2|||
129742068|NCT02049138|467015018|FG000|Overall Study|Adverse Event|46|||
129742069|NCT02049138|467015019|FG001|Overall Study|Adverse Event|25|||
129742070|NCT02049138|467015020|FG002|Overall Study|Adverse Event|1|||
129742071|NCT02049138|467015018|FG000|Overall Study|Withdrawal by Subject|57|||
129742072|NCT02049138|467015019|FG001|Overall Study|Withdrawal by Subject|21|||
129742073|NCT02049138|467015020|FG002|Overall Study|Withdrawal by Subject|5|||
129742074|NCT02049138|467015018|FG000|Overall Study|Lost to Follow-up|18|||
129742075|NCT02049138|467015019|FG001|Overall Study|Lost to Follow-up|5|||
129742076|NCT02049138|467015020|FG002|Overall Study|Lost to Follow-up|1|||
129742077|NCT02049138|467015018|FG000|Overall Study|Lack of Efficacy|10|||
129742078|NCT02049138|467015019|FG001|Overall Study|Lack of Efficacy|26|||
129742079|NCT02049138|467015020|FG002|Overall Study|Lack of Efficacy|1|||
129742080|NCT02049138|467015018|FG000|Overall Study|Non-Compliance|15|||
129742081|NCT02049138|467015019|FG001|Overall Study|Non-Compliance|6|||
129742082|NCT02049138|467015020|FG002|Overall Study|Non-Compliance|0|||
129742083|NCT02049138|467015018|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
129742084|NCT02049138|467015019|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
129742085|NCT02049138|467015020|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
129742086|NCT02049138|467015018|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
129742087|NCT02049138|467015019|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129742088|NCT02049138|467015020|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129742089|NCT02049138|467015018|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129742090|NCT02049138|467015019|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
129742091|NCT02049138|467015020|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
129742092|NCT02049138|467015018|FG000|Overall Study|Other|15|||
129742093|NCT02049138|467015019|FG001|Overall Study|Other|13|||
129742094|NCT02049138|467015020|FG002|Overall Study|Other|0|||
129742095|NCT02049138|467015018|FG000|Overall Study|Missing|0|||
129742096|NCT02049138|467015019|FG001|Overall Study|Missing|1|||
129742097|NCT02049138|467015020|FG002|Overall Study|Missing|0|||
129742098|NCT02925741|467015021|FG000|Overall Study|Withdrawal by Subject|11|||
129742099|NCT02925741|467015022|FG001|Overall Study|Withdrawal by Subject|0|||
129742100|NCT05086510|467015023|FG000|Overall Study|Lost to Follow-up|0|||
129742101|NCT05086510|467015024|FG001|Overall Study|Lost to Follow-up|2|||
129742102|NCT05086510|467015023|FG000|Overall Study|Death|0|||
129742103|NCT05086510|467015024|FG001|Overall Study|Death|2|||
129742104|NCT00295932|467015025|FG000|Overall Study|Not Treated|0|||
129742105|NCT00295932|467015026|FG001|Overall Study|Not Treated|0|||
129742106|NCT00295932|467015027|FG002|Overall Study|Not Treated|0|||
129742107|NCT00295932|467015028|FG003|Overall Study|Not Treated|0|||
129742108|NCT00295932|467015029|FG004|Overall Study|Not Treated|0|||
129742109|NCT00295932|467015030|FG005|Overall Study|Not Treated|0|||
129742110|NCT00295932|467015031|FG006|Overall Study|Not Treated|0|||
129742111|NCT00295932|467015032|FG007|Overall Study|Not Treated|0|||
129742112|NCT00295932|467015033|FG008|Overall Study|Not Treated|0|||
129742113|NCT00295932|467015034|FG009|Overall Study|Not Treated|0|||
129742114|NCT00295932|467015035|FG010|Overall Study|Not Treated|1|||
129742115|NCT00109577|467015036|FG000|Overall Study|Withdrawal by Subject|3|||
129742116|NCT00109577|467015037|FG001|Overall Study|Withdrawal by Subject|3|||
129742117|NCT00884832|467015038|FG000|Overall Study|Withdrawal by Subject|0|||
129742118|NCT00884832|467015039|FG001|Overall Study|Withdrawal by Subject|1|||
129742119|NCT03322423|467015040|FG000|Period 1|Subject no longer eligible|0|||
129742120|NCT03322423|467015041|FG001|Period 1|Subject no longer eligible|1|||
129742121|NCT03322423|467015040|FG000|Period 1|Withdrawal by Subject|0|||
129742122|NCT03322423|467015041|FG001|Period 1|Withdrawal by Subject|1|||
129742123|NCT03322423|467015040|FG000|Period 1|Incorrect Lens Dispensed|1|||
129742124|NCT03322423|467015041|FG001|Period 1|Incorrect Lens Dispensed|0|||
129742125|NCT03322423|467015040|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
129742126|NCT03322423|467015041|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
129742127|NCT03322423|467015040|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
129742128|NCT03322423|467015041|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
129742129|NCT03322423|467015040|FG000|Period 2|Protocol Violation|1|||
129742130|NCT03322423|467015041|FG001|Period 2|Protocol Violation|0|||
129742131|NCT03322423|467015040|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
129742132|NCT03322423|467015041|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
129742133|NCT02096263|467015042|FG000|Overall Study|Adverse Event|1|||
129742134|NCT02096263|467015043|FG001|Overall Study|Adverse Event|0|||
129742135|NCT02096263|467015044|FG002|Overall Study|Adverse Event|1|||
129742136|NCT02096263|467015042|FG000|Overall Study|Lost to Follow-up|14|||
129742137|NCT02096263|467015043|FG001|Overall Study|Lost to Follow-up|18|||
129742138|NCT02096263|467015044|FG002|Overall Study|Lost to Follow-up|15|||
129742139|NCT02096263|467015042|FG000|Overall Study|Other|7|||
129742140|NCT02096263|467015043|FG001|Overall Study|Other|9|||
129742141|NCT02096263|467015044|FG002|Overall Study|Other|6|||
129742142|NCT02096263|467015042|FG000|Overall Study|Sponsor study termination|0|||
129742143|NCT02096263|467015043|FG001|Overall Study|Sponsor study termination|0|||
129742144|NCT02096263|467015044|FG002|Overall Study|Sponsor study termination|1|||
129742145|NCT02096263|467015042|FG000|Overall Study|Protocol Violation|7|||
129742146|NCT02096263|467015043|FG001|Overall Study|Protocol Violation|2|||
129742147|NCT02096263|467015044|FG002|Overall Study|Protocol Violation|8|||
129742148|NCT02096263|467015042|FG000|Overall Study|Withdrawal by Subject|5|||
129742149|NCT02096263|467015043|FG001|Overall Study|Withdrawal by Subject|7|||
129742150|NCT02096263|467015044|FG002|Overall Study|Withdrawal by Subject|8|||
129742151|NCT02337725|467015045|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
129742152|NCT02337725|467015046|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
129742153|NCT02337725|467015045|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
129742154|NCT02337725|467015046|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
129742155|NCT02337725|467015045|FG000|Overall Study|Major Protocol Deviation|0|||
129742156|NCT02337725|467015046|FG001|Overall Study|Major Protocol Deviation|1|||
129742157|NCT02337725|467015045|FG000|Overall Study|Voluntary Withdrawal|14|||
129742158|NCT02337725|467015046|FG001|Overall Study|Voluntary Withdrawal|3|||
129742159|NCT02337725|467015045|FG000|Overall Study|Lack of Efficacy|4|||
129742160|NCT02337725|467015046|FG001|Overall Study|Lack of Efficacy|0|||
129742161|NCT00500760|467015054|FG000|Overall Study|Death|32|||
129807797|NCT01644565|467262539|FG001|Overall Study|Family emergency|0|||
129807798|NCT01644565|467262540|FG002|Overall Study|Family emergency|0|||
129807799|NCT01644565|467262541|FG003|Overall Study|Family emergency|0|||
129807800|NCT01644565|467262542|FG004|Overall Study|Family emergency|1|||
129807801|NCT01644565|467262543|FG005|Overall Study|Family emergency|0|||
129807802|NCT01644565|467262544|FG006|Overall Study|Family emergency|0|||
129807803|NCT01644565|467262545|FG007|Overall Study|Family emergency|0|||
129807804|NCT01644565|467262546|FG008|Overall Study|Family emergency|0|||
129807805|NCT01644565|467262538|FG000|Overall Study|Relocation|0|||
129807806|NCT01644565|467262539|FG001|Overall Study|Relocation|0|||
129742162|NCT00500760|467015055|FG001|Overall Study|Death|15|||
129742163|NCT00500760|467015054|FG000|Overall Study|Withdrawal by Subject|5|||
129742164|NCT00500760|467015055|FG001|Overall Study|Withdrawal by Subject|7|||
129807807|NCT01644565|467262540|FG002|Overall Study|Relocation|0|||
129742165|NCT00500760|467015054|FG000|Overall Study|Administrative decision|2|||
129742166|NCT00500760|467015055|FG001|Overall Study|Administrative decision|0|||
129742167|NCT00500760|467015054|FG000|Overall Study|Lost to Follow-up|3|||
129807808|NCT01644565|467262541|FG003|Overall Study|Relocation|0|||
129742168|NCT00500760|467015055|FG001|Overall Study|Lost to Follow-up|0|||
129742169|NCT00500760|467015054|FG000|Overall Study|Other|1|||
129742170|NCT00500760|467015055|FG001|Overall Study|Other|2|||
129742171|NCT02925728|467015060|FG000|Overall Study|Death|3|||
129742172|NCT02925728|467015061|FG001|Overall Study|Death|5|||
129742173|NCT02925728|467015060|FG000|Overall Study|Physician Decision|1|||
129742174|NCT02925728|467015061|FG001|Overall Study|Physician Decision|0|||
129742175|NCT02925728|467015060|FG000|Overall Study|Withdrawal by Subject|1|||
129742176|NCT02925728|467015061|FG001|Overall Study|Withdrawal by Subject|0|||
129742177|NCT05098509|467015062|FG000|Overall Study|Withdrawal by Subject|0|||
129742178|NCT05098509|467015063|FG001|Overall Study|Withdrawal by Subject|0|||
129742179|NCT05098509|467015064|FG002|Overall Study|Withdrawal by Subject|1|||
129742180|NCT05098509|467015065|FG003|Overall Study|Withdrawal by Subject|0|||
129742181|NCT05098509|467015062|FG000|Overall Study|Early study termination|1|||
129742182|NCT05098509|467015063|FG001|Overall Study|Early study termination|1|||
129742183|NCT05098509|467015064|FG002|Overall Study|Early study termination|1|||
129742184|NCT05098509|467015065|FG003|Overall Study|Early study termination|0|||
129742185|NCT04033068|467015066|FG000|Overall Study|Withdrawal by Subject|0|||
129742186|NCT04033068|467015067|FG001|Overall Study|Withdrawal by Subject|0|||
129742187|NCT04033068|467015068|FG002|Overall Study|Withdrawal by Subject|1|||
129742188|NCT04033068|467015069|FG003|Overall Study|Withdrawal by Subject|0|||
129742189|NCT04033068|467015066|FG000|Overall Study|Lost to Follow-up|0|||
129742190|NCT04033068|467015067|FG001|Overall Study|Lost to Follow-up|1|||
129742191|NCT04033068|467015068|FG002|Overall Study|Lost to Follow-up|0|||
129742192|NCT04033068|467015069|FG003|Overall Study|Lost to Follow-up|0|||
129742193|NCT04033068|467015066|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
129742194|NCT04033068|467015067|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
129742195|NCT04033068|467015068|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
129742196|NCT04033068|467015069|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
129742197|NCT02986854|467015071|FG000|Overall Study|Withdrawal by Subject|0|||
129742198|NCT02986854|467015072|FG001|Overall Study|Withdrawal by Subject|1|||
129742199|NCT02986854|467015073|FG002|Overall Study|Withdrawal by Subject|1|||
129742200|NCT02986854|467015071|FG000|Overall Study|Lost to Follow-up|3|||
129742201|NCT02986854|467015072|FG001|Overall Study|Lost to Follow-up|11|||
129742202|NCT02986854|467015073|FG002|Overall Study|Lost to Follow-up|2|||
129742203|NCT00324233|467015076|FG000|First Period|unable to insert catheter|1|||
129742204|NCT00324233|467015077|FG001|First Period|unable to insert catheter|0|||
129742205|NCT00324233|467015076|FG000|Second Period|unable to insert catheter|1|||
129742206|NCT00324233|467015077|FG001|Second Period|unable to insert catheter|1|||
129742207|NCT00324233|467015076|FG000|Second Period|Protocol Violation|4|||
129742208|NCT00324233|467015077|FG001|Second Period|Protocol Violation|6|||
129742209|NCT01972789|467015080|FG000|Overall Study|Adverse Event|11|||
129742210|NCT01972789|467015081|FG001|Overall Study|Adverse Event|4|||
129742211|NCT01972789|467015080|FG000|Overall Study|Subject withdrew consent|14|||
129742212|NCT01972789|467015081|FG001|Overall Study|Subject withdrew consent|12|||
129742213|NCT01972789|467015080|FG000|Overall Study|Lost to Follow-up|4|||
129742214|NCT01972789|467015081|FG001|Overall Study|Lost to Follow-up|7|||
129742215|NCT01972789|467015080|FG000|Overall Study|Death|7|||
129742216|NCT01972789|467015081|FG001|Overall Study|Death|5|||
129742217|NCT01972789|467015080|FG000|Overall Study|Protocol deviation|1|||
129742218|NCT01972789|467015081|FG001|Overall Study|Protocol deviation|0|||
129742219|NCT01972789|467015080|FG000|Overall Study|Physician Decision|3|||
129742220|NCT01972789|467015081|FG001|Overall Study|Physician Decision|2|||
129742221|NCT00086411|467015089|FG000|Overall Study|Lost to Follow-up|11|||
129742222|NCT00086411|467015090|FG001|Overall Study|Lost to Follow-up|11|||
129807809|NCT01644565|467262542|FG004|Overall Study|Relocation|0|||
129807810|NCT01644565|467262543|FG005|Overall Study|Relocation|0|||
129807811|NCT01644565|467262544|FG006|Overall Study|Relocation|0|||
129742223|NCT00086411|467015091|FG002|Overall Study|Lost to Follow-up|13|||
129742224|NCT00086411|467015092|FG003|Overall Study|Lost to Follow-up|12|||
129807812|NCT01644565|467262545|FG007|Overall Study|Relocation|0|||
129742225|NCT00279812|467015093|FG000|Overall Study|Protocol Violation|1|||
129742226|NCT00279812|467015094|FG001|Overall Study|Protocol Violation|1|||
129742227|NCT00279812|467015095|FG002|Overall Study|Protocol Violation|0|||
129742228|NCT00279812|467015096|FG003|Overall Study|Protocol Violation|0|||
129742229|NCT00279812|467015097|FG004|Overall Study|Protocol Violation|1|||
129742230|NCT00279812|467015098|FG005|Overall Study|Protocol Violation|0|||
129742231|NCT00279812|467015093|FG000|Overall Study|Withdrawal by Subject|0|||
129742232|NCT00279812|467015094|FG001|Overall Study|Withdrawal by Subject|4|||
129742233|NCT00279812|467015095|FG002|Overall Study|Withdrawal by Subject|2|||
129742234|NCT00279812|467015096|FG003|Overall Study|Withdrawal by Subject|0|||
129742235|NCT00279812|467015097|FG004|Overall Study|Withdrawal by Subject|0|||
129742236|NCT00279812|467015098|FG005|Overall Study|Withdrawal by Subject|0|||
129742237|NCT00279812|467015093|FG000|Overall Study|Adverse Event|0|||
129742238|NCT00279812|467015094|FG001|Overall Study|Adverse Event|1|||
129742239|NCT00279812|467015095|FG002|Overall Study|Adverse Event|1|||
129807813|NCT01644565|467262546|FG008|Overall Study|Relocation|1|||
129742240|NCT00279812|467015096|FG003|Overall Study|Adverse Event|0|||
129742241|NCT00279812|467015097|FG004|Overall Study|Adverse Event|2|||
129742242|NCT00279812|467015098|FG005|Overall Study|Adverse Event|1|||
129742243|NCT01879072|467015099|FG000|Overall Study|Withdrawal by Subject|121|||
129742244|NCT01879072|467015099|FG000|Overall Study|Not Transplanted|30|||
129742245|NCT02503501|467016891|FG000|Overall Study|Physician Decision|1|||
129742246|NCT02503501|467016892|FG001|Overall Study|Physician Decision|0|||
129742247|NCT02503501|467016891|FG000|Overall Study|Protocol Violation|0|||
129742248|NCT02503501|467016892|FG001|Overall Study|Protocol Violation|1|||
129742249|NCT02503501|467016891|FG000|Overall Study|Withdrawal by Subject|0|||
129742250|NCT02503501|467016892|FG001|Overall Study|Withdrawal by Subject|2|||
129742251|NCT01740401|467016893|FG000|Overall Study|Progression of disease|6|||
129742252|NCT01740401|467016893|FG000|Overall Study|Adverse Event|2|||
129742253|NCT01740401|467016893|FG000|Overall Study|Did not reach primary endpoint|2|||
129742254|NCT02806960|467016894|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129742255|NCT02806960|467016895|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129742256|NCT02806960|467016896|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129742257|NCT02806960|467016897|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
129742258|NCT03667690|467016898|FG000|Overall Study|Adverse Event|0|||
129742259|NCT03667690|467016899|FG001|Overall Study|Adverse Event|3|||
129742260|NCT03667690|467016898|FG000|Overall Study|Death|22|||
129742261|NCT03667690|467016899|FG001|Overall Study|Death|21|||
129742262|NCT03667690|467016898|FG000|Overall Study|Lost to Follow-up|4|||
129742263|NCT03667690|467016899|FG001|Overall Study|Lost to Follow-up|5|||
129742264|NCT03667690|467016898|FG000|Overall Study|Withdrawal by Subject|7|||
129742265|NCT03667690|467016899|FG001|Overall Study|Withdrawal by Subject|8|||
129742266|NCT03667690|467016898|FG000|Overall Study|Subject could not return for additional investigational product|1|||
129742267|NCT03667690|467016899|FG001|Overall Study|Subject could not return for additional investigational product|0|||
129742268|NCT03667690|467016898|FG000|Overall Study|Subject discharged to hospice care|2|||
129742269|NCT03667690|467016899|FG001|Overall Study|Subject discharged to hospice care|0|||
129742270|NCT03667690|467016898|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
129742271|NCT03667690|467016899|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
129742272|NCT03667690|467016898|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
129742273|NCT03667690|467016899|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
129742274|NCT03667690|467016898|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
129742275|NCT03667690|467016899|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
129742276|NCT03667690|467016898|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
129742277|NCT03667690|467016899|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
129742278|NCT03667690|467016898|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
129742279|NCT03667690|467016899|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
129742280|NCT03495102|467016900|FG000|Overall Study|Adverse Event|5|||
129742281|NCT03495102|467016901|FG001|Overall Study|Adverse Event|7|||
129742282|NCT03495102|467016902|FG002|Overall Study|Adverse Event|10|||
129742283|NCT03495102|467016900|FG000|Overall Study|Death|3|||
129742284|NCT03495102|467016901|FG001|Overall Study|Death|4|||
129742285|NCT03495102|467016902|FG002|Overall Study|Death|4|||
129742286|NCT03495102|467016900|FG000|Overall Study|Lost to Follow-up|15|||
129742287|NCT03495102|467016901|FG001|Overall Study|Lost to Follow-up|16|||
129742288|NCT03495102|467016902|FG002|Overall Study|Lost to Follow-up|17|||
129742289|NCT03495102|467016900|FG000|Overall Study|Physician Decision|2|||
129742290|NCT03495102|467016901|FG001|Overall Study|Physician Decision|0|||
129742291|NCT03495102|467016902|FG002|Overall Study|Physician Decision|2|||
129742292|NCT03495102|467016900|FG000|Overall Study|Withdrawal by Subject|25|||
129742293|NCT03495102|467016901|FG001|Overall Study|Withdrawal by Subject|36|||
129742294|NCT03495102|467016902|FG002|Overall Study|Withdrawal by Subject|18|||
129742295|NCT03495102|467016900|FG000|Overall Study|Protocol Violation|1|||
129742296|NCT03495102|467016901|FG001|Overall Study|Protocol Violation|1|||
129742297|NCT03495102|467016902|FG002|Overall Study|Protocol Violation|0|||
129742298|NCT03495102|467016900|FG000|Overall Study|Site Closure|3|||
129742299|NCT03495102|467016901|FG001|Overall Study|Site Closure|1|||
129742300|NCT03495102|467016902|FG002|Overall Study|Site Closure|2|||
129742301|NCT03495102|467016900|FG000|Overall Study|Non-compliance|1|||
129742302|NCT03495102|467016901|FG001|Overall Study|Non-compliance|0|||
129895495|NCT02014558|467577190|FG001|Overall Study|Progressive Disease|0|||
129742303|NCT03495102|467016902|FG002|Overall Study|Non-compliance|0|||
129742304|NCT03495102|467016900|FG000|Overall Study|Participant Duplicated at Another Site|0|||
129742305|NCT03495102|467016901|FG001|Overall Study|Participant Duplicated at Another Site|0|||
129742306|NCT03495102|467016902|FG002|Overall Study|Participant Duplicated at Another Site|1|||
129742307|NCT03495102|467016900|FG000|Overall Study|Primary Care Physician Recommendation|0|||
129742308|NCT03495102|467016901|FG001|Overall Study|Primary Care Physician Recommendation|1|||
129742309|NCT03495102|467016902|FG002|Overall Study|Primary Care Physician Recommendation|0|||
129895496|NCT02014558|467577191|FG002|Overall Study|Progressive Disease|1|||
129742310|NCT03495102|467016900|FG000|Overall Study|Relocated to Another Country|0|||
129742311|NCT03495102|467016901|FG001|Overall Study|Relocated to Another Country|1|||
129742312|NCT03495102|467016902|FG002|Overall Study|Relocated to Another Country|0|||
129742313|NCT03495102|467016900|FG000|Overall Study|Participant was in Rehabilitation|1|||
129742314|NCT03495102|467016901|FG001|Overall Study|Participant was in Rehabilitation|0|||
129742315|NCT03495102|467016902|FG002|Overall Study|Participant was in Rehabilitation|0|||
129742316|NCT01161537|467016904|FG000|Part B|Withdrawal by Subject|2|||
129742317|NCT00321464|467016907|FG000|Overall Study|Death|169|||
129742318|NCT00321464|467016908|FG001|Overall Study|Death|174|||
129742319|NCT00321464|467016907|FG000|Overall Study|Disease progression|124|||
129742320|NCT00321464|467016908|FG001|Overall Study|Disease progression|124|||
129742321|NCT00321464|467016907|FG000|Overall Study|Withdrawal by Subject|117|||
129742322|NCT00321464|467016908|FG001|Overall Study|Withdrawal by Subject|118|||
129742323|NCT00321464|467016907|FG000|Overall Study|Participant request|57|||
129742324|NCT00321464|467016908|FG001|Overall Study|Participant request|61|||
129742325|NCT00321464|467016907|FG000|Overall Study|Adverse Event|43|||
129742326|NCT00321464|467016908|FG001|Overall Study|Adverse Event|28|||
129742327|NCT00321464|467016907|FG000|Overall Study|Physician Decision|15|||
129742328|NCT00321464|467016908|FG001|Overall Study|Physician Decision|14|||
129742329|NCT00321464|467016907|FG000|Overall Study|Noncompliance|4|||
129742330|NCT00321464|467016908|FG001|Overall Study|Noncompliance|10|||
129742331|NCT00321464|467016907|FG000|Overall Study|Lost to Follow-up|7|||
129742332|NCT00321464|467016908|FG001|Overall Study|Lost to Follow-up|8|||
129742333|NCT00321464|467016907|FG000|Overall Study|Protocol deviation|0|||
129742334|NCT00321464|467016908|FG001|Overall Study|Protocol deviation|2|||
129742335|NCT00321464|467016907|FG000|Overall Study|Ineligibility determined|2|||
129742336|NCT00321464|467016908|FG001|Overall Study|Ineligibility determined|1|||
129742337|NCT00321464|467016907|FG000|Overall Study|Other|21|||
129742338|NCT00321464|467016908|FG001|Overall Study|Other|18|||
129742339|NCT04327024|467016909|FG000|Overall Study|Death|1|||
129742340|NCT04327024|467016910|FG001|Overall Study|Death|2|||
129742341|NCT04327024|467016911|FG002|Overall Study|Death|1|||
129742342|NCT04327024|467016909|FG000|Overall Study|Non-compliance with study drug|0|||
129742343|NCT04327024|467016910|FG001|Overall Study|Non-compliance with study drug|1|||
129742344|NCT04327024|467016911|FG002|Overall Study|Non-compliance with study drug|0|||
129742345|NCT04327024|467016909|FG000|Overall Study|Withdrawal by Subject|1|||
129742346|NCT04327024|467016910|FG001|Overall Study|Withdrawal by Subject|1|||
129742347|NCT04327024|467016911|FG002|Overall Study|Withdrawal by Subject|2|||
129742348|NCT01192568|467016913|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
129742349|NCT01192568|467016914|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
129742350|NCT01192568|467016915|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
129742351|NCT01192568|467016916|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
129742352|NCT01192568|467016913|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
129742353|NCT01192568|467016914|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
129742354|NCT01192568|467016915|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
129742355|NCT01192568|467016916|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
129742356|NCT02593825|467016917|FG000|Intervention|Lost to Follow-up|10|||
129742357|NCT02593825|467016918|FG001|Intervention|Lost to Follow-up|12|||
129742358|NCT02522325|467016919|FG000|Overall Study|Adverse Event|0|||
129742359|NCT02522325|467016920|FG001|Overall Study|Adverse Event|1|||
129742360|NCT01209078|467016921|FG000|Overall Study|Adverse Event|5|||
129742361|NCT01209078|467016922|FG001|Overall Study|Adverse Event|0|||
129742362|NCT01209078|467016921|FG000|Overall Study|Lost to Follow-up|4|||
129742363|NCT01209078|467016922|FG001|Overall Study|Lost to Follow-up|0|||
129742364|NCT01209078|467016921|FG000|Overall Study|Physician Decision|5|||
129742365|NCT01209078|467016922|FG001|Overall Study|Physician Decision|2|||
129742366|NCT01209078|467016921|FG000|Overall Study|Withdrawal by Subject|2|||
129742367|NCT01209078|467016922|FG001|Overall Study|Withdrawal by Subject|1|||
129742368|NCT00924508|467016923|FG000|Overall Study|Withdrawal by Subject|3|||
129742369|NCT00511134|467016927|FG000|Overall Study|Withdrawal by Subject|0|||
129742370|NCT00511134|467016928|FG001|Overall Study|Withdrawal by Subject|2|||
129742371|NCT01949090|467016929|FG000|Overall Study|Serious Adverse Event|0|||
129742372|NCT01949090|467016930|FG001|Overall Study|Serious Adverse Event|1|||
129742373|NCT01949090|467016931|FG002|Overall Study|Serious Adverse Event|2|||
129742374|NCT01949090|467016932|FG003|Overall Study|Serious Adverse Event|0|||
129742375|NCT01949090|467016933|FG004|Overall Study|Serious Adverse Event|1|||
129742376|NCT01949090|467016929|FG000|Overall Study|Withdrawal by Subject|2|||
129742377|NCT01949090|467016930|FG001|Overall Study|Withdrawal by Subject|0|||
129742378|NCT01949090|467016931|FG002|Overall Study|Withdrawal by Subject|0|||
129742379|NCT01949090|467016932|FG003|Overall Study|Withdrawal by Subject|0|||
129742380|NCT01949090|467016933|FG004|Overall Study|Withdrawal by Subject|1|||
129742381|NCT01949090|467016929|FG000|Overall Study|Protocol non-compliance|0|||
129742382|NCT01949090|467016930|FG001|Overall Study|Protocol non-compliance|0|||
129742383|NCT01949090|467016931|FG002|Overall Study|Protocol non-compliance|0|||
129742384|NCT01949090|467016932|FG003|Overall Study|Protocol non-compliance|0|||
129742385|NCT01949090|467016933|FG004|Overall Study|Protocol non-compliance|1|||
129742386|NCT01949090|467016929|FG000|Overall Study|Lost to Follow-up|2|||
129742387|NCT01949090|467016930|FG001|Overall Study|Lost to Follow-up|1|||
129742388|NCT01949090|467016931|FG002|Overall Study|Lost to Follow-up|0|||
129742389|NCT01949090|467016932|FG003|Overall Study|Lost to Follow-up|1|||
129742390|NCT01949090|467016933|FG004|Overall Study|Lost to Follow-up|1|||
129742391|NCT03459365|467016934|FG000|Overall Study|Withdrawal by Subject|6|||
129742392|NCT03459365|467016934|FG000|Overall Study|Protocol Violation|8|||
129742393|NCT00785980|467016938|FG000|7 Day Washout Period|Protocol Violation|3|||
129742394|NCT03055013|467016939|FG000|Overall Study|Adverse Event|78|||
129742395|NCT03055013|467016940|FG001|Overall Study|Adverse Event|0|||
129742396|NCT03055013|467016939|FG000|Overall Study|Death|6|||
129742397|NCT03055013|467016940|FG001|Overall Study|Death|0|||
129742398|NCT03055013|467016939|FG000|Overall Study|Disease relapse|33|||
129742399|NCT03055013|467016940|FG001|Overall Study|Disease relapse|0|||
129742400|NCT03055013|467016939|FG000|Overall Study|Withdrawal by Subject|28|||
129742401|NCT03055013|467016940|FG001|Overall Study|Withdrawal by Subject|0|||
129742402|NCT03055013|467016939|FG000|Overall Study|Other complicating disease|5|||
129742403|NCT03055013|467016940|FG001|Overall Study|Other complicating disease|0|||
129742404|NCT03055013|467016939|FG000|Overall Study|Physician Decision|1|||
129742405|NCT03055013|467016940|FG001|Overall Study|Physician Decision|0|||
129742406|NCT03055013|467016939|FG000|Overall Study|Benign mass/non-RCC|4|||
129742407|NCT03055013|467016940|FG001|Overall Study|Benign mass/non-RCC|0|||
129742408|NCT03055013|467016939|FG000|Overall Study|Enrolled in another trial|1|||
129742409|NCT03055013|467016940|FG001|Overall Study|Enrolled in another trial|0|||
129742410|NCT03055013|467016939|FG000|Overall Study|Non-protocol therapy|1|||
129742411|NCT03055013|467016940|FG001|Overall Study|Non-protocol therapy|0|||
129742412|NCT03055013|467016939|FG000|Overall Study|Incompliance|1|||
129742413|NCT03055013|467016940|FG001|Overall Study|Incompliance|0|||
129742414|NCT03055013|467016939|FG000|Overall Study|Insurance issues|1|||
129742415|NCT03055013|467016940|FG001|Overall Study|Insurance issues|0|||
129742416|NCT03055013|467016939|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
129742417|NCT03055013|467016940|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
129742418|NCT03055013|467016939|FG000|Overall Study|Did not receive nivolumab|10|||
129742419|NCT03055013|467016940|FG001|Overall Study|Did not receive nivolumab|0|||
129742420|NCT03055013|467016939|FG000|Overall Study|Did not receive surgery|0|||
129742421|NCT03055013|467016940|FG001|Overall Study|Did not receive surgery|28|||
129742422|NCT00528801|467016941|FG000|Overall Study|Withdrawal by Subject|1|||
129742423|NCT00528801|467016942|FG001|Overall Study|Withdrawal by Subject|1|||
129742424|NCT00528801|467016941|FG000|Overall Study|Protocol Violation|11|||
129742425|NCT00528801|467016942|FG001|Overall Study|Protocol Violation|5|||
129742426|NCT00528801|467016941|FG000|Overall Study|Lost to Follow-up|15|||
129742427|NCT00528801|467016942|FG001|Overall Study|Lost to Follow-up|4|||
129742428|NCT00528801|467016941|FG000|Overall Study|Administrative Reasons|0|||
129742429|NCT00528801|467016942|FG001|Overall Study|Administrative Reasons|1|||
129742430|NCT00344500|467016943|FG000|Overall Study|Adverse Event|6|||
129742431|NCT00344500|467016944|FG001|Overall Study|Adverse Event|2|||
129742432|NCT00344500|467016945|FG002|Overall Study|Adverse Event|0|||
129742433|NCT00344500|467016943|FG000|Overall Study|Lost to Follow-up|5|||
129742434|NCT00344500|467016944|FG001|Overall Study|Lost to Follow-up|13|||
129742435|NCT00344500|467016945|FG002|Overall Study|Lost to Follow-up|1|||
129742436|NCT00344500|467016943|FG000|Overall Study|Withdrawal by Subject|7|||
129742437|NCT00344500|467016944|FG001|Overall Study|Withdrawal by Subject|10|||
129742438|NCT00344500|467016945|FG002|Overall Study|Withdrawal by Subject|0|||
129742439|NCT00344500|467016943|FG000|Overall Study|Protocol Violation|4|||
129742440|NCT00344500|467016944|FG001|Overall Study|Protocol Violation|7|||
129742441|NCT00344500|467016945|FG002|Overall Study|Protocol Violation|1|||
129742442|NCT00344500|467016943|FG000|Overall Study|Not Noted|1|||
129742443|NCT00344500|467016944|FG001|Overall Study|Not Noted|3|||
129742444|NCT00344500|467016945|FG002|Overall Study|Not Noted|0|||
129742445|NCT02207491|467016946|FG000|Overall Study|Adverse Event|20|||
129742446|NCT02207491|467016947|FG001|Overall Study|Adverse Event|4|||
129742447|NCT02207491|467016946|FG000|Overall Study|Withdrawal by Subject|3|||
129742448|NCT02207491|467016947|FG001|Overall Study|Withdrawal by Subject|2|||
129742449|NCT02207491|467016946|FG000|Overall Study|Non-compliant|0|||
129742450|NCT02207491|467016947|FG001|Overall Study|Non-compliant|1|||
129742451|NCT02207491|467016946|FG000|Overall Study|Lost to Follow-up|0|||
129742452|NCT02207491|467016947|FG001|Overall Study|Lost to Follow-up|1|||
129742453|NCT02207491|467016946|FG000|Overall Study|Lack of Efficacy|3|||
129742454|NCT02207491|467016947|FG001|Overall Study|Lack of Efficacy|0|||
129742455|NCT02207491|467016946|FG000|Overall Study|Physician Decision|2|||
129742456|NCT02207491|467016947|FG001|Overall Study|Physician Decision|0|||
129742457|NCT02207491|467016946|FG000|Overall Study|Protocol Violation|3|||
129742458|NCT02207491|467016947|FG001|Overall Study|Protocol Violation|5|||
129742459|NCT00599755|467016948|FG000|Overall Study|Adverse Event|11|||
129742460|NCT00599755|467016948|FG000|Overall Study|Withdrawal by Subject|2|||
129742461|NCT00599755|467016948|FG000|Overall Study|Progression of Disease|3|||
129742462|NCT00599755|467016948|FG000|Overall Study|Other Reason|2|||
129742463|NCT00599755|467016948|FG000|Overall Study|No data available|1|||
129742464|NCT04680975|467016950|FG000|Overall Study|Adverse Event|3|||
129742465|NCT04680975|467016950|FG000|Overall Study|Death|1|||
129742466|NCT04680975|467016950|FG000|Overall Study|Progressive Disease|1|||
129742467|NCT04680975|467016950|FG000|Overall Study|Withdrawal by Subject|1|||
129742468|NCT03909152|467016951|FG000|Overall Study|Adverse Event|14|||
129742469|NCT03909152|467016952|FG001|Overall Study|Adverse Event|5|||
129742470|NCT03909152|467016953|FG002|Overall Study|Adverse Event|1|||
129742471|NCT03909152|467016954|FG003|Overall Study|Adverse Event|14|||
129742472|NCT02615691|467016955|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
129742473|NCT02615691|467016955|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
129742474|NCT02615691|467016955|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
129742475|NCT02615691|467016955|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
129742476|NCT02702414|467016956|FG000|Overall Study|Death|96|||
129742477|NCT02702414|467016957|FG001|Overall Study|Death|42|||
129742478|NCT02702414|467016956|FG000|Overall Study|Lost to Follow-up|0|||
129742479|NCT02702414|467016957|FG001|Overall Study|Lost to Follow-up|1|||
129742480|NCT02702414|467016956|FG000|Overall Study|Withdrawal by Subject|0|||
129742481|NCT02702414|467016957|FG001|Overall Study|Withdrawal by Subject|1|||
129742482|NCT02702414|467016956|FG000|Overall Study|Protocol Violation|1|||
129742483|NCT02702414|467016957|FG001|Overall Study|Protocol Violation|0|||
129742484|NCT02702414|467016956|FG000|Overall Study|Sponsor Decision|8|||
129742485|NCT02702414|467016957|FG001|Overall Study|Sponsor Decision|7|||
129742486|NCT02596230|467016958|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
129742487|NCT02596230|467016959|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
129742488|NCT02596230|467016960|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
129742489|NCT02596230|467016961|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
129742490|NCT02596230|467016962|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
129742491|NCT02596230|467016958|FG000|Objective 2, One Year|Lost to Follow-up|0|||
129742492|NCT02596230|467016959|FG001|Objective 2, One Year|Lost to Follow-up|41|||
129742493|NCT02596230|467016960|FG002|Objective 2, One Year|Lost to Follow-up|41|||
129742494|NCT02596230|467016961|FG003|Objective 2, One Year|Lost to Follow-up|32|||
129742495|NCT02596230|467016962|FG004|Objective 2, One Year|Lost to Follow-up|46|||
129742496|NCT02596230|467016958|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
129742497|NCT02596230|467016959|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
129742498|NCT02596230|467016960|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
129742499|NCT02596230|467016961|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
129742500|NCT02596230|467016962|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
129742501|NCT02596230|467016958|FG000|Objective 2, One Year|Adverse drug reaction|0|||
129742502|NCT02596230|467016959|FG001|Objective 2, One Year|Adverse drug reaction|1|||
129742503|NCT02596230|467016960|FG002|Objective 2, One Year|Adverse drug reaction|0|||
129742504|NCT02596230|467016961|FG003|Objective 2, One Year|Adverse drug reaction|0|||
129742505|NCT02596230|467016962|FG004|Objective 2, One Year|Adverse drug reaction|0|||
129742506|NCT02596230|467016958|FG000|Objective 2, One Year|Death|0|||
129742507|NCT02596230|467016959|FG001|Objective 2, One Year|Death|12|||
129742508|NCT02596230|467016960|FG002|Objective 2, One Year|Death|41|||
129742509|NCT02596230|467016961|FG003|Objective 2, One Year|Death|21|||
129742510|NCT02596230|467016962|FG004|Objective 2, One Year|Death|30|||
129742511|NCT02596230|467016958|FG000|Objective 2, One Year|Other|0|||
129742512|NCT02596230|467016959|FG001|Objective 2, One Year|Other|3|||
129742513|NCT02596230|467016960|FG002|Objective 2, One Year|Other|2|||
129742514|NCT02596230|467016961|FG003|Objective 2, One Year|Other|0|||
129742515|NCT02596230|467016962|FG004|Objective 2, One Year|Other|0|||
129742516|NCT01272869|467016963|FG000|Period 2 (14 Days)|Adverse Event|1|||
129742517|NCT01272869|467016964|FG001|Period 2 (14 Days)|Adverse Event|0|||
129742518|NCT03908476|467016966|FG000|Overall Study|Death|3|||
129742519|NCT03908476|467016967|FG001|Overall Study|Death|0|||
129742520|NCT03908476|467016966|FG000|Overall Study|Lost to Follow-up|3|||
129742521|NCT03908476|467016967|FG001|Overall Study|Lost to Follow-up|1|||
129895497|NCT02014558|467577192|FG003|Overall Study|Progressive Disease|1|||
129895498|NCT02014558|467577193|FG004|Overall Study|Progressive Disease|1|||
129895499|NCT02014558|467577194|FG005|Overall Study|Progressive Disease|2|||
129895500|NCT02014558|467577195|FG006|Overall Study|Progressive Disease|1|||
129895501|NCT02014558|467577196|FG007|Overall Study|Progressive Disease|6|||
129742522|NCT03908476|467016966|FG000|Overall Study|Withdrawal by Subject|7|||
129742523|NCT03908476|467016967|FG001|Overall Study|Withdrawal by Subject|1|||
129742524|NCT03908476|467016966|FG000|Overall Study|Physician Decision|2|||
129742525|NCT03908476|467016967|FG001|Overall Study|Physician Decision|0|||
129895502|NCT02014558|467577197|FG008|Overall Study|Progressive Disease|5|||
129895503|NCT02014558|467577198|FG009|Overall Study|Progressive Disease|6|||
129895504|NCT02014558|467577199|FG010|Overall Study|Progressive Disease|22|||
129742526|NCT03908476|467016966|FG000|Overall Study|System Explanted and not Replaced|4|||
129742527|NCT03908476|467016967|FG001|Overall Study|System Explanted and not Replaced|0|||
129742528|NCT03908476|467016966|FG000|Overall Study|Intrathecal Pump|1|||
129742529|NCT03908476|467016967|FG001|Overall Study|Intrathecal Pump|0|||
129742530|NCT03908476|467016966|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
129742531|NCT03908476|467016967|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
129742532|NCT02868229|467016968|FG000|Overall Study|Adverse Event|1|||
129742533|NCT02868229|467016969|FG001|Overall Study|Adverse Event|0|||
129807814|NCT01550289|467262547|FG000|Overall Study|Protocol Violation|1|||
129742534|NCT02868229|467016970|FG002|Overall Study|Adverse Event|0|||
129742535|NCT02868229|467016971|FG003|Overall Study|Adverse Event|1|||
129742536|NCT02868229|467016968|FG000|Overall Study|Death|0|||
129742537|NCT02868229|467016969|FG001|Overall Study|Death|0|||
129742538|NCT02868229|467016970|FG002|Overall Study|Death|1|||
129742539|NCT02868229|467016971|FG003|Overall Study|Death|1|||
129742540|NCT02868229|467016968|FG000|Overall Study|Missed dose|0|||
129742541|NCT02868229|467016969|FG001|Overall Study|Missed dose|0|||
129742542|NCT02868229|467016970|FG002|Overall Study|Missed dose|0|||
129742543|NCT02868229|467016971|FG003|Overall Study|Missed dose|3|||
129742544|NCT03194438|467016972|FG000|Overall Study|Withdrawal by Subject|2|||
129742545|NCT02250664|467016973|FG000|Overall Study|Lost to Follow-up|18|||
129742546|NCT02250664|467016974|FG001|Overall Study|Lost to Follow-up|28|||
129742547|NCT02250664|467016975|FG002|Overall Study|Lost to Follow-up|33|||
129742548|NCT02250664|467016973|FG000|Overall Study|Personal Reasons|7|||
129742549|NCT02250664|467016974|FG001|Overall Study|Personal Reasons|8|||
129742550|NCT02250664|467016975|FG002|Overall Study|Personal Reasons|14|||
129742551|NCT02250664|467016973|FG000|Overall Study|Adverse Event|6|||
129742552|NCT02250664|467016974|FG001|Overall Study|Adverse Event|3|||
129742553|NCT02250664|467016975|FG002|Overall Study|Adverse Event|8|||
129742554|NCT02250664|467016973|FG000|Overall Study|Incarcerated|2|||
129742555|NCT02250664|467016974|FG001|Overall Study|Incarcerated|1|||
129742556|NCT02250664|467016975|FG002|Overall Study|Incarcerated|2|||
129742557|NCT02250664|467016973|FG000|Overall Study|Withdrawal by Subject|0|||
129742558|NCT02250664|467016974|FG001|Overall Study|Withdrawal by Subject|1|||
129807815|NCT01550289|467262548|FG001|Overall Study|Protocol Violation|0|||
129807816|NCT01550289|467262547|FG000|Overall Study|Lost to Follow-up|1|||
129807817|NCT01550289|467262548|FG001|Overall Study|Lost to Follow-up|1|||
129807818|NCT01550289|467262547|FG000|Overall Study|Withdrawal by Subject|11|||
129807819|NCT01550289|467262548|FG001|Overall Study|Withdrawal by Subject|3|||
129807820|NCT01897454|467262549|FG000|Overall Study|Withdrawal by Subject|1|||
129807821|NCT00094172|467262552|FG000|Overall Study|Adverse Event|0|||
129807822|NCT00094172|467262553|FG001|Overall Study|Adverse Event|1|||
129807823|NCT00094172|467262552|FG000|Overall Study|Lost to Follow-up|2|||
129807824|NCT00094172|467262553|FG001|Overall Study|Lost to Follow-up|0|||
129807825|NCT00094172|467262552|FG000|Overall Study|Protocol Violation|0|||
129895505|NCT02014558|467577200|FG011|Overall Study|Progressive Disease|31|||
129895506|NCT02014558|467577201|FG012|Overall Study|Progressive Disease|6|||
129742559|NCT02250664|467016975|FG002|Overall Study|Withdrawal by Subject|2|||
129742560|NCT02250664|467016973|FG000|Overall Study|Death|0|||
129742561|NCT02250664|467016974|FG001|Overall Study|Death|1|||
129742562|NCT02250664|467016975|FG002|Overall Study|Death|1|||
129742563|NCT02250664|467016973|FG000|Overall Study|Physician Decision|1|||
129742564|NCT02250664|467016974|FG001|Overall Study|Physician Decision|3|||
129742565|NCT02250664|467016975|FG002|Overall Study|Physician Decision|1|||
129742566|NCT02250664|467016973|FG000|Overall Study|Protocol Violation|1|||
129742567|NCT02250664|467016974|FG001|Overall Study|Protocol Violation|0|||
129742568|NCT02250664|467016975|FG002|Overall Study|Protocol Violation|1|||
129742569|NCT02250664|467016973|FG000|Overall Study|Reason unknown|1|||
129742570|NCT02250664|467016974|FG001|Overall Study|Reason unknown|0|||
129742571|NCT02250664|467016975|FG002|Overall Study|Reason unknown|0|||
129742572|NCT00117793|467016976|FG000|Overall Study|Withdrawal by Subject|12|||
129742573|NCT04268173|467016977|FG000|Overall Study|Lost to Follow-up|75|||
129742574|NCT04268173|467016978|FG001|Overall Study|Lost to Follow-up|108|||
129742575|NCT00545103|467016979|FG000|Overall Study|Lack of Efficacy|48|||
129742576|NCT00545103|467016980|FG001|Overall Study|Lack of Efficacy|45|||
129742577|NCT00545103|467016981|FG002|Overall Study|Lack of Efficacy|31|||
129742578|NCT00545103|467016982|FG003|Overall Study|Lack of Efficacy|27|||
129742579|NCT00545103|467016979|FG000|Overall Study|Withdrawal by Subject|6|||
129807826|NCT00094172|467262553|FG001|Overall Study|Protocol Violation|1|||
129895507|NCT02014558|467577189|FG000|Overall Study|Withdrawal by Subject|0|||
129895508|NCT02014558|467577190|FG001|Overall Study|Withdrawal by Subject|0|||
129742580|NCT00545103|467016980|FG001|Overall Study|Withdrawal by Subject|10|||
129742581|NCT00545103|467016981|FG002|Overall Study|Withdrawal by Subject|18|||
129742582|NCT00545103|467016982|FG003|Overall Study|Withdrawal by Subject|22|||
129807827|NCT00094172|467262552|FG000|Overall Study|Withdrawal by Subject|10|||
129807828|NCT00094172|467262553|FG001|Overall Study|Withdrawal by Subject|5|||
129895509|NCT02014558|467577191|FG002|Overall Study|Withdrawal by Subject|0|||
129742583|NCT00545103|467016979|FG000|Overall Study|Adverse Event|11|||
129742584|NCT00545103|467016980|FG001|Overall Study|Adverse Event|12|||
129742585|NCT00545103|467016981|FG002|Overall Study|Adverse Event|17|||
129742586|NCT00545103|467016982|FG003|Overall Study|Adverse Event|10|||
129742587|NCT00545103|467016979|FG000|Overall Study|Lost to Follow-up|4|||
129742588|NCT00545103|467016980|FG001|Overall Study|Lost to Follow-up|6|||
129742589|NCT00545103|467016981|FG002|Overall Study|Lost to Follow-up|3|||
129742590|NCT00545103|467016982|FG003|Overall Study|Lost to Follow-up|4|||
129742591|NCT00545103|467016979|FG000|Overall Study|Protocol Violation|1|||
129742592|NCT00545103|467016980|FG001|Overall Study|Protocol Violation|2|||
129742593|NCT00545103|467016981|FG002|Overall Study|Protocol Violation|3|||
129742594|NCT00545103|467016982|FG003|Overall Study|Protocol Violation|0|||
129742595|NCT00545103|467016979|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
129742596|NCT00545103|467016980|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
129742597|NCT00545103|467016981|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
129742598|NCT00545103|467016982|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
129742599|NCT00545103|467016979|FG000|Overall Study|Difficult to open package|0|||
129742600|NCT00545103|467016980|FG001|Overall Study|Difficult to open package|0|||
129742601|NCT00545103|467016981|FG002|Overall Study|Difficult to open package|0|||
129742602|NCT00545103|467016982|FG003|Overall Study|Difficult to open package|1|||
129742603|NCT00545103|467016979|FG000|Overall Study|Investigational product not taken|1|||
129742604|NCT00545103|467016980|FG001|Overall Study|Investigational product not taken|0|||
129742605|NCT00545103|467016981|FG002|Overall Study|Investigational product not taken|0|||
129742606|NCT00545103|467016982|FG003|Overall Study|Investigational product not taken|1|||
129742607|NCT00545103|467016979|FG000|Overall Study|Wish to start a family|0|||
129742608|NCT00545103|467016980|FG001|Overall Study|Wish to start a family|0|||
129742609|NCT00545103|467016981|FG002|Overall Study|Wish to start a family|0|||
129742610|NCT00545103|467016982|FG003|Overall Study|Wish to start a family|1|||
129742611|NCT00545103|467016979|FG000|Overall Study|Diverticulitis crisis|0|||
129742612|NCT00545103|467016980|FG001|Overall Study|Diverticulitis crisis|0|||
129742613|NCT00545103|467016981|FG002|Overall Study|Diverticulitis crisis|0|||
129742614|NCT00545103|467016982|FG003|Overall Study|Diverticulitis crisis|1|||
129742615|NCT00545103|467016979|FG000|Overall Study|Personal reasons|1|||
129742616|NCT00545103|467016980|FG001|Overall Study|Personal reasons|0|||
129742617|NCT00545103|467016981|FG002|Overall Study|Personal reasons|0|||
129742618|NCT00545103|467016982|FG003|Overall Study|Personal reasons|0|||
129742619|NCT00545103|467016979|FG000|Overall Study|Subject's decision|1|||
129742620|NCT00545103|467016980|FG001|Overall Study|Subject's decision|0|||
129742621|NCT00545103|467016981|FG002|Overall Study|Subject's decision|0|||
129742622|NCT00545103|467016982|FG003|Overall Study|Subject's decision|0|||
129742623|NCT00545103|467016979|FG000|Overall Study|Noncompliance|0|||
129742624|NCT00545103|467016980|FG001|Overall Study|Noncompliance|1|||
129742625|NCT00545103|467016981|FG002|Overall Study|Noncompliance|0|||
129742626|NCT00545103|467016982|FG003|Overall Study|Noncompliance|0|||
129742627|NCT00545103|467016979|FG000|Overall Study|Investigator decision|0|||
129742628|NCT00545103|467016980|FG001|Overall Study|Investigator decision|0|||
129742629|NCT00545103|467016981|FG002|Overall Study|Investigator decision|1|||
129742630|NCT00545103|467016982|FG003|Overall Study|Investigator decision|0|||
129742631|NCT00545103|467016979|FG000|Overall Study|Subject moved|0|||
129742632|NCT00545103|467016980|FG001|Overall Study|Subject moved|1|||
129742633|NCT00545103|467016981|FG002|Overall Study|Subject moved|0|||
129742634|NCT00545103|467016982|FG003|Overall Study|Subject moved|0|||
129742635|NCT00545103|467016979|FG000|Overall Study|Use of prohibited medication|0|||
129742636|NCT00545103|467016980|FG001|Overall Study|Use of prohibited medication|0|||
129742637|NCT00545103|467016981|FG002|Overall Study|Use of prohibited medication|1|||
129742638|NCT00545103|467016982|FG003|Overall Study|Use of prohibited medication|0|||
129742639|NCT00545103|467016979|FG000|Overall Study|Does not want to take study drug anymore|1|||
129742640|NCT00545103|467016980|FG001|Overall Study|Does not want to take study drug anymore|0|||
129742641|NCT00545103|467016981|FG002|Overall Study|Does not want to take study drug anymore|1|||
129807829|NCT00094172|467262552|FG000|Overall Study|Primary endpoint met.|1|||
129807830|NCT00094172|467262553|FG001|Overall Study|Primary endpoint met.|0|||
129807831|NCT00094172|467262552|FG000|Overall Study|Started other MS therapy due to disease|1|||
129807832|NCT00094172|467262553|FG001|Overall Study|Started other MS therapy due to disease|0|||
129807833|NCT01392443|467262558|FG000|Overall Study|Disease progression|30|||
129742642|NCT00545103|467016982|FG003|Overall Study|Does not want to take study drug anymore|0|||
129807834|NCT01392443|467262558|FG000|Overall Study|Adverse Event|24|||
129807835|NCT01392443|467262558|FG000|Overall Study|Death|7|||
129807836|NCT01392443|467262558|FG000|Overall Study|Withdrawal by Subject|5|||
129807837|NCT01392443|467262558|FG000|Overall Study|Lost to Follow-up|1|||
129807838|NCT01392443|467262558|FG000|Overall Study|Protocol Violation|1|||
129807839|NCT01977794|467262559|FG000|Overall Study|Adverse Event|2|||
129742643|NCT00545103|467016979|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
129742644|NCT00545103|467016980|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
129742645|NCT00545103|467016981|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
129742646|NCT00545103|467016982|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
129742647|NCT00545103|467016979|FG000|Overall Study|Death|0|||
129742648|NCT00545103|467016980|FG001|Overall Study|Death|1|||
129742649|NCT00545103|467016981|FG002|Overall Study|Death|0|||
129742650|NCT00545103|467016982|FG003|Overall Study|Death|0|||
129742651|NCT04891107|467016983|FG000|Overall Study|Physician Decision|1|||
129742652|NCT04891107|467016983|FG000|Overall Study|Withdrawal by Subject|1|||
129807840|NCT01977794|467262560|FG001|Overall Study|Adverse Event|2|||
129807841|NCT01977794|467262559|FG000|Overall Study|Lost to Follow-up|2|||
129807842|NCT01977794|467262560|FG001|Overall Study|Lost to Follow-up|1|||
129895510|NCT02014558|467577192|FG003|Overall Study|Withdrawal by Subject|0|||
129807843|NCT01977794|467262559|FG000|Overall Study|Protocol Violation|1|||
129742653|NCT04891107|467016983|FG000|Overall Study|Screen failure after consent|1|||
129742654|NCT01571453|467016984|FG000|Overall Study|Adverse Event|14|||
129742655|NCT01571453|467016985|FG001|Overall Study|Adverse Event|32|||
129742656|NCT01571453|467016984|FG000|Overall Study|Lack of Efficacy|8|||
129742657|NCT01571453|467016985|FG001|Overall Study|Lack of Efficacy|3|||
129742658|NCT01571453|467016984|FG000|Overall Study|Non-compliance|2|||
129742659|NCT01571453|467016985|FG001|Overall Study|Non-compliance|4|||
129742660|NCT01571453|467016984|FG000|Overall Study|Protocol Violation|1|||
129742661|NCT01571453|467016985|FG001|Overall Study|Protocol Violation|5|||
129742662|NCT01571453|467016984|FG000|Overall Study|Withdrawal of consent|5|||
129742663|NCT01571453|467016985|FG001|Overall Study|Withdrawal of consent|13|||
129742664|NCT01571453|467016984|FG000|Overall Study|Lost to Follow-up|4|||
129742665|NCT01571453|467016985|FG001|Overall Study|Lost to Follow-up|2|||
129742666|NCT01571453|467016984|FG000|Overall Study|Administrative or other reason(s)|4|||
129742667|NCT01571453|467016985|FG001|Overall Study|Administrative or other reason(s)|3|||
129742668|NCT02453555|467016986|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
129742669|NCT02453555|467016987|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
129742670|NCT02453555|467016988|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
129742671|NCT02453555|467016989|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
129742672|NCT02453555|467016990|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
129742673|NCT02453555|467016991|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
129742674|NCT02453555|467016986|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
129742675|NCT02453555|467016987|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129742676|NCT02453555|467016988|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129742677|NCT02453555|467016989|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129742678|NCT02453555|467016990|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129742679|NCT02453555|467016991|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
129742680|NCT02453555|467016986|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
129742681|NCT02453555|467016987|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
129742682|NCT02453555|467016988|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129742683|NCT02453555|467016989|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129742684|NCT02453555|467016990|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129742685|NCT02453555|467016991|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129742686|NCT02453555|467016986|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
129742687|NCT02453555|467016987|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
129742688|NCT02453555|467016988|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
129742689|NCT02453555|467016989|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
129742690|NCT02453555|467016990|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
129742691|NCT02453555|467016991|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
129742692|NCT02453555|467016986|FG000|Extension Period|Adverse Event|0|||
129742693|NCT02453555|467016987|FG001|Extension Period|Adverse Event|0|||
129742694|NCT02453555|467016988|FG002|Extension Period|Adverse Event|1|||
129742695|NCT02453555|467016989|FG003|Extension Period|Adverse Event|2|||
129742696|NCT02453555|467016990|FG004|Extension Period|Adverse Event|1|||
129742697|NCT02453555|467016991|FG005|Extension Period|Adverse Event|1|||
129742698|NCT02453555|467016986|FG000|Extension Period|Protocol Violation|0|||
129742699|NCT02453555|467016987|FG001|Extension Period|Protocol Violation|0|||
129742700|NCT02453555|467016988|FG002|Extension Period|Protocol Violation|1|||
129742701|NCT02453555|467016989|FG003|Extension Period|Protocol Violation|0|||
129742702|NCT02453555|467016990|FG004|Extension Period|Protocol Violation|0|||
129742703|NCT02453555|467016991|FG005|Extension Period|Protocol Violation|0|||
129742704|NCT02453555|467016986|FG000|Extension Period|Withdrawal by Subject|0|||
129742705|NCT02453555|467016987|FG001|Extension Period|Withdrawal by Subject|0|||
129742706|NCT02453555|467016988|FG002|Extension Period|Withdrawal by Subject|1|||
129742707|NCT02453555|467016989|FG003|Extension Period|Withdrawal by Subject|0|||
129742708|NCT02453555|467016990|FG004|Extension Period|Withdrawal by Subject|0|||
129742709|NCT02453555|467016991|FG005|Extension Period|Withdrawal by Subject|0|||
129742710|NCT04284774|467016992|FG000|Overall Study|Progressive disease|5|||
129742711|NCT02879578|467016993|FG000|Overall Study|Adverse Event|1|||
129742712|NCT02879578|467016994|FG001|Overall Study|Adverse Event|2|||
129742713|NCT02879578|467016995|FG002|Overall Study|Adverse Event|14|||
129742714|NCT02879578|467016993|FG000|Overall Study|Protocol Violation|0|||
129742715|NCT02879578|467016994|FG001|Overall Study|Protocol Violation|1|||
129742716|NCT02879578|467016995|FG002|Overall Study|Protocol Violation|1|||
129742717|NCT02879578|467016993|FG000|Overall Study|Withdrawal by Subject|8|||
129742718|NCT02879578|467016994|FG001|Overall Study|Withdrawal by Subject|6|||
129742719|NCT02879578|467016995|FG002|Overall Study|Withdrawal by Subject|9|||
129742720|NCT02879578|467016993|FG000|Overall Study|Lost to Follow-up|1|||
129742721|NCT02879578|467016994|FG001|Overall Study|Lost to Follow-up|0|||
129742722|NCT02879578|467016995|FG002|Overall Study|Lost to Follow-up|4|||
129742723|NCT02879578|467016993|FG000|Overall Study|Physician Decision|0|||
129742724|NCT02879578|467016994|FG001|Overall Study|Physician Decision|0|||
129807844|NCT01977794|467262560|FG001|Overall Study|Protocol Violation|0|||
129807845|NCT01977794|467262559|FG000|Overall Study|Death|1|||
129742725|NCT02879578|467016995|FG002|Overall Study|Physician Decision|4|||
129742726|NCT03203291|467017001|FG000|Overall Study|Withdrawal by Subject|1|||
129742727|NCT02039856|467017002|FG000|Overall Study|Death|5|||
129742728|NCT02039856|467017003|FG001|Overall Study|Death|3|||
129742729|NCT02039856|467017002|FG000|Overall Study|Partial survey completion|61|||
129742730|NCT02039856|467017003|FG001|Overall Study|Partial survey completion|26|||
129742731|NCT02039856|467017002|FG000|Overall Study|Lost to Follow-up|388|||
129742732|NCT02039856|467017003|FG001|Overall Study|Lost to Follow-up|206|||
129742733|NCT02039856|467017002|FG000|Overall Study|Withdrawal by Subject|1573|||
129742734|NCT02039856|467017003|FG001|Overall Study|Withdrawal by Subject|618|||
129807846|NCT01977794|467262560|FG001|Overall Study|Death|1|||
129807847|NCT01977794|467262559|FG000|Overall Study|Withdrew consent|2|||
129807848|NCT01977794|467262560|FG001|Overall Study|Withdrew consent|1|||
129807849|NCT01977794|467262559|FG000|Overall Study|Other|0|||
129807850|NCT01977794|467262560|FG001|Overall Study|Other|1|||
129807851|NCT00827502|467262563|FG000|Overall Study|randomized but not treated|11|||
129807852|NCT00827502|467262563|FG000|Overall Study|Adverse Event|1|||
129807853|NCT00827502|467262563|FG000|Overall Study|Lost to Follow-up|4|||
129807854|NCT00827502|467262563|FG000|Overall Study|Withdrawal by Subject|5|||
129807855|NCT02478632|467262564|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
129742735|NCT02409342|467017004|FG000|Overall Study|Death|211|||
129742736|NCT02409342|467017005|FG001|Overall Study|Death|201|||
129742737|NCT02409342|467017004|FG000|Overall Study|Withdrawal by Subject|24|||
129742738|NCT02409342|467017005|FG001|Overall Study|Withdrawal by Subject|17|||
129742739|NCT02409342|467017004|FG000|Overall Study|Study Terminated By Sponsor|48|||
129742740|NCT02409342|467017005|FG001|Overall Study|Study Terminated By Sponsor|59|||
129742741|NCT02409342|467017004|FG000|Overall Study|Lost to Follow-up|3|||
129742742|NCT02409342|467017005|FG001|Overall Study|Lost to Follow-up|5|||
129742743|NCT02409342|467017004|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
129742744|NCT02409342|467017005|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
129742745|NCT02409342|467017004|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
129742746|NCT02409342|467017005|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
129742747|NCT02409342|467017004|FG000|Overall Study|Sponsor Decision|1|||
129742748|NCT02409342|467017005|FG001|Overall Study|Sponsor Decision|0|||
129742749|NCT03908970|467017006|FG000|Overall Study|Adverse Event|7|||
129742750|NCT03908970|467017007|FG001|Overall Study|Adverse Event|21|||
129742751|NCT03908970|467017006|FG000|Overall Study|Physician Decision|1|||
129742752|NCT03908970|467017007|FG001|Overall Study|Physician Decision|4|||
129742753|NCT03908970|467017006|FG000|Overall Study|Withdrawal by Subject|9|||
129742754|NCT03908970|467017007|FG001|Overall Study|Withdrawal by Subject|22|||
129742755|NCT01274429|467017013|FG000|Overall Study|Study closed do to lack of funding|5|||
129742756|NCT03268941|467018789|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129742757|NCT03268941|467018790|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129742758|NCT03268941|467018791|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129742759|NCT03268941|467018792|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
129742760|NCT03268941|467018793|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129742761|NCT03268941|467018794|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129742762|NCT03268941|467018795|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
129742763|NCT03268941|467018789|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
129742764|NCT03268941|467018790|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
129742765|NCT03268941|467018791|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
129742766|NCT03268941|467018792|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
129742767|NCT03268941|467018793|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
129742768|NCT03268941|467018794|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
129742769|NCT03268941|467018795|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
129742770|NCT03268941|467018789|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
129742771|NCT03268941|467018790|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129742772|NCT03268941|467018791|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129742773|NCT03268941|467018792|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129742774|NCT03268941|467018793|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129742775|NCT03268941|467018794|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129807856|NCT02478632|467262565|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
129807857|NCT02478632|467262564|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
129807858|NCT02478632|467262565|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
129807859|NCT02478632|467262564|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
129807860|NCT02478632|467262565|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
129742776|NCT03268941|467018795|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
129742777|NCT03268941|467018789|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
129807861|NCT03019185|467262566|FG000|Overall Study|Lost to Follow-up|3|||
129742778|NCT03268941|467018790|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
129742779|NCT03268941|467018791|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
129807862|NCT03019185|467262567|FG001|Overall Study|Lost to Follow-up|0|||
129742780|NCT03268941|467018792|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
129742781|NCT03268941|467018793|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
129742782|NCT03268941|467018794|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
129742783|NCT03268941|467018795|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
129742784|NCT03268941|467018789|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129742785|NCT03268941|467018790|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129742786|NCT03268941|467018791|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129742787|NCT03268941|467018792|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129742788|NCT03268941|467018793|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129742789|NCT03268941|467018794|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
129742790|NCT03268941|467018795|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
129742791|NCT01216683|467018796|FG000|Induction|Never started treatment|0|||
129742792|NCT01216683|467018797|FG001|Induction|Never started treatment|6|||
129742793|NCT01216683|467018798|FG002|Induction|Never started treatment|3|||
129742794|NCT01216683|467018796|FG000|Induction|Lack of Efficacy|4|||
129742795|NCT01216683|467018797|FG001|Induction|Lack of Efficacy|3|||
129742796|NCT01216683|467018798|FG002|Induction|Lack of Efficacy|7|||
129742797|NCT01216683|467018796|FG000|Induction|Adverse Event|0|||
129742798|NCT01216683|467018797|FG001|Induction|Adverse Event|5|||
129742799|NCT01216683|467018798|FG002|Induction|Adverse Event|5|||
129742800|NCT01216683|467018796|FG000|Induction|Death|0|||
129742801|NCT01216683|467018797|FG001|Induction|Death|0|||
129742802|NCT01216683|467018798|FG002|Induction|Death|2|||
129742803|NCT01216683|467018796|FG000|Induction|Withdrawal by Subject|0|||
129742804|NCT01216683|467018797|FG001|Induction|Withdrawal by Subject|4|||
129742805|NCT01216683|467018798|FG002|Induction|Withdrawal by Subject|2|||
129742806|NCT01216683|467018796|FG000|Induction|Other disease|0|||
129742807|NCT01216683|467018797|FG001|Induction|Other disease|1|||
129742808|NCT01216683|467018798|FG002|Induction|Other disease|2|||
129742809|NCT01216683|467018796|FG000|Continuation|Lack of Efficacy|3|||
129742810|NCT01216683|467018797|FG001|Continuation|Lack of Efficacy|2|||
129742811|NCT01216683|467018798|FG002|Continuation|Lack of Efficacy|7|||
129742812|NCT01216683|467018796|FG000|Continuation|Adverse Event|5|||
129895511|NCT02014558|467577193|FG004|Overall Study|Withdrawal by Subject|1|||
129895512|NCT02014558|467577194|FG005|Overall Study|Withdrawal by Subject|0|||
129895513|NCT02014558|467577195|FG006|Overall Study|Withdrawal by Subject|0|||
129742813|NCT01216683|467018797|FG001|Continuation|Adverse Event|3|||
129742814|NCT01216683|467018798|FG002|Continuation|Adverse Event|16|||
129742815|NCT01216683|467018796|FG000|Continuation|Death|1|||
129742816|NCT01216683|467018797|FG001|Continuation|Death|0|||
129742817|NCT01216683|467018798|FG002|Continuation|Death|2|||
129742818|NCT01216683|467018796|FG000|Continuation|Withdrawal by Subject|4|||
129742819|NCT01216683|467018797|FG001|Continuation|Withdrawal by Subject|5|||
129742820|NCT01216683|467018798|FG002|Continuation|Withdrawal by Subject|9|||
129742821|NCT01216683|467018796|FG000|Continuation|Other diseases|0|||
129742822|NCT01216683|467018797|FG001|Continuation|Other diseases|2|||
129742823|NCT01216683|467018798|FG002|Continuation|Other diseases|1|||
129742824|NCT01216683|467018796|FG000|Continuation|Physician Decision|1|||
129742825|NCT01216683|467018797|FG001|Continuation|Physician Decision|0|||
129742826|NCT01216683|467018798|FG002|Continuation|Physician Decision|1|||
129742827|NCT01216683|467018796|FG000|Continuation|Non-compliance|1|||
129742828|NCT01216683|467018797|FG001|Continuation|Non-compliance|0|||
129742829|NCT01216683|467018798|FG002|Continuation|Non-compliance|1|||
129742830|NCT01216683|467018796|FG000|Continuation|Insurance change|0|||
129895514|NCT02014558|467577196|FG007|Overall Study|Withdrawal by Subject|0|||
129895515|NCT02014558|467577197|FG008|Overall Study|Withdrawal by Subject|0|||
129895516|NCT02014558|467577198|FG009|Overall Study|Withdrawal by Subject|2|||
129895517|NCT02014558|467577199|FG010|Overall Study|Withdrawal by Subject|6|||
129895518|NCT02014558|467577200|FG011|Overall Study|Withdrawal by Subject|10|||
129742831|NCT01216683|467018797|FG001|Continuation|Insurance change|1|||
129742832|NCT01216683|467018798|FG002|Continuation|Insurance change|0|||
129742833|NCT01216683|467018796|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
129742834|NCT01216683|467018797|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
129742835|NCT01216683|467018798|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
129742836|NCT01216683|467018796|FG000|Continuation|Not reported|0|||
129742837|NCT01216683|467018797|FG001|Continuation|Not reported|0|||
129742838|NCT01216683|467018798|FG002|Continuation|Not reported|1|||
129742839|NCT01216683|467018796|FG000|Continuation|Never started treatment|0|||
129742840|NCT01216683|467018797|FG001|Continuation|Never started treatment|1|||
129742841|NCT01216683|467018798|FG002|Continuation|Never started treatment|5|||
129742842|NCT00765063|467018804|FG000|Overall Study|Lack of Efficacy|5|||
129742843|NCT00765063|467018804|FG000|Overall Study|Withdrawal by Subject|1|||
129742844|NCT00765063|467018804|FG000|Overall Study|Other|16|||
129742845|NCT00765063|467018804|FG000|Overall Study|Protocol Violation|6|||
129742846|NCT00765063|467018804|FG000|Overall Study|Adverse Event|4|||
129742847|NCT03614325|467018807|FG000|Overall Study|Withdrawal by Subject|0|||
129742848|NCT03614325|467018808|FG001|Overall Study|Withdrawal by Subject|2|||
129742849|NCT03614325|467018807|FG000|Overall Study|Surgery Cancelled|2|||
129742850|NCT03614325|467018808|FG001|Overall Study|Surgery Cancelled|1|||
129742851|NCT03614325|467018807|FG000|Overall Study|Lost to Follow-up|2|||
129742852|NCT03614325|467018808|FG001|Overall Study|Lost to Follow-up|1|||
129742853|NCT03614325|467018807|FG000|Overall Study|Surgery never scheduled|1|||
129742854|NCT03614325|467018808|FG001|Overall Study|Surgery never scheduled|0|||
129742855|NCT01041287|467018809|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
129742856|NCT01041287|467018810|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
129742857|NCT01041287|467018809|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
129742858|NCT01041287|467018810|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
129742859|NCT02814175|467018811|FG000|Part 1|Adverse Event|2|||
129742860|NCT02814175|467018812|FG001|Part 1|Adverse Event|3|||
129742861|NCT02814175|467018813|FG002|Part 1|Adverse Event|0|||
129742862|NCT02814175|467018814|FG003|Part 1|Adverse Event|0|||
129742863|NCT02814175|467018815|FG004|Part 1|Adverse Event|0|||
129742864|NCT02814175|467018816|FG005|Part 1|Adverse Event|0|||
129742865|NCT02814175|467018811|FG000|Part 1|Withdrawal Consent|8|||
129742866|NCT02814175|467018812|FG001|Part 1|Withdrawal Consent|1|||
129742867|NCT02814175|467018813|FG002|Part 1|Withdrawal Consent|0|||
129742868|NCT02814175|467018814|FG003|Part 1|Withdrawal Consent|0|||
129742869|NCT02814175|467018815|FG004|Part 1|Withdrawal Consent|0|||
129742870|NCT02814175|467018816|FG005|Part 1|Withdrawal Consent|0|||
129742871|NCT02814175|467018811|FG000|Part 1|Lost to Follow-up|1|||
129742872|NCT02814175|467018812|FG001|Part 1|Lost to Follow-up|0|||
129742873|NCT02814175|467018813|FG002|Part 1|Lost to Follow-up|0|||
129742874|NCT02814175|467018814|FG003|Part 1|Lost to Follow-up|0|||
129742875|NCT02814175|467018815|FG004|Part 1|Lost to Follow-up|0|||
129742876|NCT02814175|467018816|FG005|Part 1|Lost to Follow-up|0|||
129742877|NCT02814175|467018811|FG000|Part 1|Lack of Efficacy|1|||
129742878|NCT02814175|467018812|FG001|Part 1|Lack of Efficacy|2|||
129742879|NCT02814175|467018813|FG002|Part 1|Lack of Efficacy|0|||
129742880|NCT02814175|467018814|FG003|Part 1|Lack of Efficacy|0|||
129742881|NCT02814175|467018815|FG004|Part 1|Lack of Efficacy|0|||
129742882|NCT02814175|467018816|FG005|Part 1|Lack of Efficacy|0|||
129742883|NCT02814175|467018811|FG000|Part 2|Adverse Event|0|||
129742884|NCT02814175|467018812|FG001|Part 2|Adverse Event|0|||
129742885|NCT02814175|467018813|FG002|Part 2|Adverse Event|0|||
129742886|NCT02814175|467018814|FG003|Part 2|Adverse Event|1|||
129742887|NCT02814175|467018815|FG004|Part 2|Adverse Event|1|||
129742888|NCT02814175|467018816|FG005|Part 2|Adverse Event|2|||
129742889|NCT02814175|467018811|FG000|Part 2|Withdrawal Consent|0|||
129742890|NCT02814175|467018812|FG001|Part 2|Withdrawal Consent|0|||
129742891|NCT02814175|467018813|FG002|Part 2|Withdrawal Consent|0|||
129742892|NCT02814175|467018814|FG003|Part 2|Withdrawal Consent|2|||
129742893|NCT02814175|467018815|FG004|Part 2|Withdrawal Consent|1|||
129742894|NCT02814175|467018816|FG005|Part 2|Withdrawal Consent|1|||
129742895|NCT02814175|467018811|FG000|Part 2|Lost to Follow-up|0|||
129742896|NCT02814175|467018812|FG001|Part 2|Lost to Follow-up|0|||
129742897|NCT02814175|467018813|FG002|Part 2|Lost to Follow-up|0|||
129742898|NCT02814175|467018814|FG003|Part 2|Lost to Follow-up|1|||
129742899|NCT02814175|467018815|FG004|Part 2|Lost to Follow-up|0|||
129742900|NCT02814175|467018816|FG005|Part 2|Lost to Follow-up|0|||
129742901|NCT02814175|467018811|FG000|Part 2|Lack of Efficacy|0|||
129742902|NCT02814175|467018812|FG001|Part 2|Lack of Efficacy|0|||
129742903|NCT02814175|467018813|FG002|Part 2|Lack of Efficacy|0|||
129742904|NCT02814175|467018814|FG003|Part 2|Lack of Efficacy|0|||
129742905|NCT02814175|467018815|FG004|Part 2|Lack of Efficacy|0|||
129742906|NCT02814175|467018816|FG005|Part 2|Lack of Efficacy|3|||
129742907|NCT01673620|467018822|FG000|Overall Study|Adverse Event|1|||
129742908|NCT01673620|467018823|FG001|Overall Study|Adverse Event|0|||
129807863|NCT03019185|467262568|FG002|Overall Study|Lost to Follow-up|2|||
129807864|NCT03019185|467262566|FG000|Overall Study|Withdrawal by Subject|1|||
129807865|NCT03019185|467262567|FG001|Overall Study|Withdrawal by Subject|1|||
129807866|NCT03019185|467262568|FG002|Overall Study|Withdrawal by Subject|0|||
129807867|NCT03019185|467262566|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
129807868|NCT03019185|467262567|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
129807869|NCT03019185|467262568|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
129807870|NCT03019185|467262566|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
129807871|NCT03019185|467262567|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
129807872|NCT03019185|467262568|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
129742909|NCT01597635|467018824|FG000|Part A|Adverse Event|3|||
129742910|NCT01597635|467018825|FG001|Part A|Adverse Event|0|||
129742911|NCT01597635|467018826|FG002|Part A|Adverse Event|0|||
129742912|NCT01597635|467018824|FG000|Part B|Adverse Event|0|||
129742913|NCT01597635|467018825|FG001|Part B|Adverse Event|0|||
129742914|NCT01597635|467018826|FG002|Part B|Adverse Event|1|||
129742915|NCT01597635|467018824|FG000|Part B|Protocol Violation|0|||
129742916|NCT01597635|467018825|FG001|Part B|Protocol Violation|1|||
129742917|NCT01597635|467018826|FG002|Part B|Protocol Violation|0|||
129742918|NCT01597635|467018824|FG000|Part B|Protocol-defined stopping criteria|0|||
129742919|NCT01597635|467018825|FG001|Part B|Protocol-defined stopping criteria|4|||
129742920|NCT01597635|467018826|FG002|Part B|Protocol-defined stopping criteria|3|||
129742921|NCT01597635|467018824|FG000|Part B|Withdrawal by Subject|0|||
129742922|NCT01597635|467018825|FG001|Part B|Withdrawal by Subject|1|||
129742923|NCT01597635|467018826|FG002|Part B|Withdrawal by Subject|0|||
129742924|NCT00495625|467018827|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
129742925|NCT01912339|467018828|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
129742926|NCT01912339|467018829|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
129742927|NCT01912339|467018830|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
129742928|NCT01912339|467018828|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
129742929|NCT01912339|467018829|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
129742930|NCT01912339|467018830|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
129742931|NCT01912339|467018828|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
129742932|NCT01912339|467018829|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
129742933|NCT01912339|467018830|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
129742934|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
129742935|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
129742936|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
129742937|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
129742938|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
129742939|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
129742940|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
129742941|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
129742942|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
129742943|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
129742944|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
129742945|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
129742946|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
129742947|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
129742948|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
129742949|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
129742950|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
129742951|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
129742952|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
129742953|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
129742954|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
129742955|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
129742956|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
129742957|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
129742958|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
129742959|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
129742960|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
129742961|NCT01912339|467018828|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
129742962|NCT01912339|467018829|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
129742963|NCT01912339|467018830|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
129742964|NCT03464019|467018831|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
129742965|NCT03464019|467018832|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
129742966|NCT03464019|467018833|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
129742967|NCT03464019|467018831|FG000|NODE-301 Part 1|Ablation|0|||
129742968|NCT03464019|467018832|FG001|NODE-301 Part 1|Ablation|0|||
129742969|NCT03464019|467018833|FG002|NODE-301 Part 1|Ablation|16|||
129742970|NCT03464019|467018831|FG000|NODE-301 Part 1|Test Dose Failure|0|||
129742971|NCT03464019|467018832|FG001|NODE-301 Part 1|Test Dose Failure|0|||
129742972|NCT03464019|467018833|FG002|NODE-301 Part 1|Test Dose Failure|8|||
129742973|NCT03464019|467018831|FG000|NODE-301 Part 1|Adverse Event|0|||
129742974|NCT03464019|467018832|FG001|NODE-301 Part 1|Adverse Event|0|||
129742975|NCT03464019|467018833|FG002|NODE-301 Part 1|Adverse Event|5|||
129742976|NCT03464019|467018831|FG000|NODE-301 Part 1|Physician Decision|0|||
129742977|NCT03464019|467018832|FG001|NODE-301 Part 1|Physician Decision|0|||
129742978|NCT03464019|467018833|FG002|NODE-301 Part 1|Physician Decision|4|||
129807873|NCT03355365|467262569|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
129807874|NCT03355365|467262570|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
129807875|NCT03355365|467262569|FG000|Year 1, First Intervention|Protocol Violation|1|||
129807876|NCT03355365|467262570|FG001|Year 1, First Intervention|Protocol Violation|0|||
129807877|NCT03355365|467262569|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
129807878|NCT03355365|467262570|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
129807879|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
129807880|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
129742979|NCT03464019|467018831|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
129742980|NCT03464019|467018832|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
129742981|NCT03464019|467018833|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
129742982|NCT03464019|467018831|FG000|NODE-301 Part 1|Protocol Violation|0|||
129742983|NCT03464019|467018832|FG001|NODE-301 Part 1|Protocol Violation|0|||
129742984|NCT03464019|467018833|FG002|NODE-301 Part 1|Protocol Violation|2|||
129742985|NCT03464019|467018831|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
129445352|NCT02684279|465931272|FG000|Overall Study|non-compliance with study drug|9|||
129742986|NCT03464019|467018832|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
129742987|NCT03464019|467018833|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
129742988|NCT03464019|467018831|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
129742989|NCT03464019|467018832|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
129742990|NCT03464019|467018833|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
129742991|NCT03464019|467018831|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
129742992|NCT03464019|467018832|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
129742993|NCT03464019|467018833|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
129742994|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
129742995|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
129742996|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
129742997|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
129742998|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
129742999|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
129743000|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
129743001|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
129743002|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
129743003|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
129743004|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
129743005|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
129743006|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
129743007|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
129743008|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
129743009|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
129743010|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
129743011|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
129743012|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
129743013|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
129743014|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
129743015|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
129743016|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
129743017|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
129743018|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
129743019|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
129743020|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
129743021|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
129743022|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
129743023|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
129743024|NCT03464019|467018831|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
129743025|NCT03464019|467018832|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
129743026|NCT03464019|467018833|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
129743027|NCT00126776|467018834|FG000|Overall Study|follow up complete on all patients|0|||
129743028|NCT00126776|467018835|FG001|Overall Study|follow up complete on all patients|0|||
129743029|NCT03626545|467018839|FG000|Overall Study|Progressive disease|3|||
129743030|NCT03626545|467018840|FG001|Overall Study|Progressive disease|82|||
129743031|NCT03626545|467018841|FG002|Overall Study|Progressive disease|85|||
129807881|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
129807882|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
129807883|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|severe COVID|0|||
129807884|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|severe COVID|1|||
129807885|NCT03355365|467262569|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
129807886|NCT03355365|467262570|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
129807887|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Adverse Event|3|||
129807888|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Adverse Event|0|||
129807889|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
129807890|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
129807891|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
129807892|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
129807893|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Physician Decision|0|||
129807894|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Physician Decision|2|||
129807895|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
129807896|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
129807897|NCT02110238|467262571|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
129743032|NCT03626545|467018839|FG000|Overall Study|Adverse Event|3|||
129743033|NCT03626545|467018840|FG001|Overall Study|Adverse Event|13|||
129743034|NCT03626545|467018841|FG002|Overall Study|Adverse Event|10|||
129743035|NCT03626545|467018839|FG000|Overall Study|Physician Decision|1|||
129743036|NCT03626545|467018840|FG001|Overall Study|Physician Decision|18|||
129743037|NCT03626545|467018841|FG002|Overall Study|Physician Decision|14|||
129743038|NCT03626545|467018839|FG000|Overall Study|Subject Decision|0|||
129743039|NCT03626545|467018840|FG001|Overall Study|Subject Decision|5|||
129743040|NCT03626545|467018841|FG002|Overall Study|Subject Decision|5|||
129743041|NCT03626545|467018839|FG000|Overall Study|Death|1|||
129743042|NCT03626545|467018840|FG001|Overall Study|Death|1|||
129743043|NCT03626545|467018841|FG002|Overall Study|Death|1|||
129743044|NCT03626545|467018839|FG000|Overall Study|Protocol Deviation|0|||
129743045|NCT03626545|467018840|FG001|Overall Study|Protocol Deviation|1|||
129743046|NCT03626545|467018841|FG002|Overall Study|Protocol Deviation|1|||
129743047|NCT03626545|467018839|FG000|Overall Study|Guardian Decision|0|||
129743048|NCT03626545|467018840|FG001|Overall Study|Guardian Decision|0|||
129743049|NCT03626545|467018841|FG002|Overall Study|Guardian Decision|1|||
129743050|NCT01939366|467018844|FG000|Overall Study|Adverse Event|8|||
129743051|NCT01939366|467018845|FG001|Overall Study|Adverse Event|17|||
129743052|NCT01939366|467018846|FG002|Overall Study|Adverse Event|30|||
129743053|NCT01939366|467018847|FG003|Overall Study|Adverse Event|8|||
129743054|NCT01939366|467018848|FG004|Overall Study|Adverse Event|5|||
129743055|NCT01939366|467018844|FG000|Overall Study|Lack of Efficacy|2|||
129743056|NCT01939366|467018845|FG001|Overall Study|Lack of Efficacy|1|||
129743057|NCT01939366|467018846|FG002|Overall Study|Lack of Efficacy|1|||
129743058|NCT01939366|467018847|FG003|Overall Study|Lack of Efficacy|1|||
129743059|NCT01939366|467018848|FG004|Overall Study|Lack of Efficacy|3|||
129743060|NCT01939366|467018844|FG000|Overall Study|Lost to Follow-up|1|||
129743061|NCT01939366|467018845|FG001|Overall Study|Lost to Follow-up|1|||
129743062|NCT01939366|467018846|FG002|Overall Study|Lost to Follow-up|0|||
129743063|NCT01939366|467018847|FG003|Overall Study|Lost to Follow-up|0|||
129743064|NCT01939366|467018848|FG004|Overall Study|Lost to Follow-up|0|||
129743065|NCT01939366|467018844|FG000|Overall Study|Withdrawal by Subject|1|||
129743066|NCT01939366|467018845|FG001|Overall Study|Withdrawal by Subject|0|||
129743067|NCT01939366|467018846|FG002|Overall Study|Withdrawal by Subject|2|||
129743068|NCT01939366|467018847|FG003|Overall Study|Withdrawal by Subject|2|||
129743069|NCT01939366|467018848|FG004|Overall Study|Withdrawal by Subject|3|||
129743070|NCT01939366|467018844|FG000|Overall Study|Inclusion criteria not met|0|||
129743071|NCT01939366|467018845|FG001|Overall Study|Inclusion criteria not met|1|||
129743072|NCT01939366|467018846|FG002|Overall Study|Inclusion criteria not met|1|||
129743073|NCT01939366|467018847|FG003|Overall Study|Inclusion criteria not met|0|||
129743074|NCT01939366|467018848|FG004|Overall Study|Inclusion criteria not met|1|||
129743075|NCT01939366|467018844|FG000|Overall Study|Other|0|||
129743076|NCT01939366|467018845|FG001|Overall Study|Other|0|||
129743077|NCT01939366|467018846|FG002|Overall Study|Other|2|||
129743078|NCT01939366|467018847|FG003|Overall Study|Other|2|||
129743079|NCT01939366|467018848|FG004|Overall Study|Other|1|||
129743080|NCT01939366|467018844|FG000|Overall Study|Protocol Violation|0|||
129743081|NCT01939366|467018845|FG001|Overall Study|Protocol Violation|0|||
129743082|NCT01939366|467018846|FG002|Overall Study|Protocol Violation|0|||
129743083|NCT01939366|467018847|FG003|Overall Study|Protocol Violation|1|||
129743084|NCT01939366|467018848|FG004|Overall Study|Protocol Violation|0|||
129743085|NCT01939366|467018844|FG000|Overall Study|Sponsor decision|0|||
129743086|NCT01939366|467018845|FG001|Overall Study|Sponsor decision|0|||
129743087|NCT01939366|467018846|FG002|Overall Study|Sponsor decision|0|||
129743088|NCT01939366|467018847|FG003|Overall Study|Sponsor decision|0|||
129743089|NCT01939366|467018848|FG004|Overall Study|Sponsor decision|2|||
129743090|NCT01939366|467018844|FG000|Overall Study|GCP non-compliance at site|2|||
129743091|NCT01939366|467018845|FG001|Overall Study|GCP non-compliance at site|3|||
129743092|NCT01939366|467018846|FG002|Overall Study|GCP non-compliance at site|2|||
129743093|NCT01939366|467018847|FG003|Overall Study|GCP non-compliance at site|3|||
129743094|NCT01939366|467018848|FG004|Overall Study|GCP non-compliance at site|3|||
129743095|NCT02271945|467018853|FG000|Overall Study|Death|3|||
129743096|NCT02271945|467018854|FG001|Overall Study|Death|3|||
129743097|NCT02271945|467018853|FG000|Overall Study|Withdrawal by Subject|1|||
129743098|NCT02271945|467018854|FG001|Overall Study|Withdrawal by Subject|1|||
129743099|NCT02271945|467018853|FG000|Overall Study|Other|1|||
129807898|NCT02110238|467262572|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
129807899|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
129807900|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
129807901|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
129807902|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
129807903|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
129743100|NCT02271945|467018854|FG001|Overall Study|Other|1|||
129743101|NCT00615030|467018855|FG000|Period I|Administrative problem|0|||
129743102|NCT00615030|467018856|FG001|Period I|Administrative problem|0|||
129743103|NCT00615030|467018857|FG002|Period I|Administrative problem|0|||
129743104|NCT00615030|467018858|FG003|Period I|Administrative problem|0|||
129743105|NCT00615030|467018859|FG004|Period I|Administrative problem|1|||
129743106|NCT00615030|467018860|FG005|Period I|Administrative problem|0|||
129743107|NCT00615030|467018861|FG006|Period I|Administrative problem|0|||
129743108|NCT00615030|467018862|FG007|Period I|Administrative problem|0|||
129743109|NCT00615030|467018863|FG008|Period I|Administrative problem|0|||
129743110|NCT00615030|467018864|FG009|Period I|Administrative problem|0|||
129895519|NCT02014558|467577201|FG012|Overall Study|Withdrawal by Subject|0|||
129895520|NCT02014558|467577189|FG000|Overall Study|Miscellaneous|2|||
129895521|NCT02014558|467577190|FG001|Overall Study|Miscellaneous|1|||
129895522|NCT02014558|467577191|FG002|Overall Study|Miscellaneous|1|||
129895523|NCT02014558|467577192|FG003|Overall Study|Miscellaneous|1|||
129895524|NCT02014558|467577193|FG004|Overall Study|Miscellaneous|0|||
129895525|NCT02014558|467577194|FG005|Overall Study|Miscellaneous|1|||
129895526|NCT02014558|467577195|FG006|Overall Study|Miscellaneous|0|||
129895527|NCT02014558|467577196|FG007|Overall Study|Miscellaneous|1|||
129895528|NCT02014558|467577197|FG008|Overall Study|Miscellaneous|1|||
129895529|NCT02014558|467577198|FG009|Overall Study|Miscellaneous|3|||
129895530|NCT02014558|467577199|FG010|Overall Study|Miscellaneous|12|||
129895531|NCT02014558|467577200|FG011|Overall Study|Miscellaneous|11|||
129895532|NCT02014558|467577201|FG012|Overall Study|Miscellaneous|1|||
129895533|NCT04580407|467577202|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
129895534|NCT02068885|467577205|FG000|Overall Study|Withdrew|3|||
129895535|NCT02068885|467577206|FG001|Overall Study|Withdrew|5|||
129895536|NCT02068885|467577207|FG002|Overall Study|Withdrew|8|||
129895537|NCT00828919|467577213|FG000|Overall Study|Death|0|||
129895538|NCT00828919|467577214|FG001|Overall Study|Death|1|||
129895539|NCT00828919|467577215|FG002|Overall Study|Death|2|||
129743111|NCT00615030|467018865|FG010|Period I|Administrative problem|0|||
129743112|NCT00615030|467018866|FG011|Period I|Administrative problem|0|||
129743113|NCT00615030|467018855|FG000|Period I|Protocol deviation|1|||
129743114|NCT00615030|467018856|FG001|Period I|Protocol deviation|0|||
129743115|NCT00615030|467018857|FG002|Period I|Protocol deviation|0|||
129743116|NCT00615030|467018858|FG003|Period I|Protocol deviation|0|||
129743117|NCT00615030|467018859|FG004|Period I|Protocol deviation|0|||
129743118|NCT00615030|467018860|FG005|Period I|Protocol deviation|0|||
129743119|NCT00615030|467018861|FG006|Period I|Protocol deviation|0|||
129743120|NCT00615030|467018862|FG007|Period I|Protocol deviation|0|||
129743121|NCT00615030|467018863|FG008|Period I|Protocol deviation|0|||
129743122|NCT00615030|467018864|FG009|Period I|Protocol deviation|0|||
129743123|NCT00615030|467018865|FG010|Period I|Protocol deviation|0|||
129743124|NCT00615030|467018866|FG011|Period I|Protocol deviation|0|||
129743125|NCT00615030|467018855|FG000|Period I|Subject withdrew consent|0|||
129743126|NCT00615030|467018856|FG001|Period I|Subject withdrew consent|0|||
129743127|NCT00615030|467018857|FG002|Period I|Subject withdrew consent|0|||
129743128|NCT00615030|467018858|FG003|Period I|Subject withdrew consent|0|||
129743129|NCT00615030|467018859|FG004|Period I|Subject withdrew consent|0|||
129743130|NCT00615030|467018860|FG005|Period I|Subject withdrew consent|0|||
129743131|NCT00615030|467018861|FG006|Period I|Subject withdrew consent|0|||
129743132|NCT00615030|467018862|FG007|Period I|Subject withdrew consent|0|||
129743133|NCT00615030|467018863|FG008|Period I|Subject withdrew consent|1|||
129743134|NCT00615030|467018864|FG009|Period I|Subject withdrew consent|0|||
129743135|NCT00615030|467018865|FG010|Period I|Subject withdrew consent|1|||
129743136|NCT00615030|467018866|FG011|Period I|Subject withdrew consent|1|||
129743137|NCT00615030|467018855|FG000|Period I|Abnormal laboratory value(s)|0|||
129743138|NCT00615030|467018856|FG001|Period I|Abnormal laboratory value(s)|0|||
129743139|NCT00615030|467018857|FG002|Period I|Abnormal laboratory value(s)|0|||
129743140|NCT00615030|467018858|FG003|Period I|Abnormal laboratory value(s)|0|||
129743141|NCT00615030|467018859|FG004|Period I|Abnormal laboratory value(s)|0|||
129743142|NCT00615030|467018860|FG005|Period I|Abnormal laboratory value(s)|1|||
129743143|NCT00615030|467018861|FG006|Period I|Abnormal laboratory value(s)|0|||
129743144|NCT00615030|467018862|FG007|Period I|Abnormal laboratory value(s)|0|||
129743145|NCT00615030|467018863|FG008|Period I|Abnormal laboratory value(s)|0|||
129743146|NCT00615030|467018864|FG009|Period I|Abnormal laboratory value(s)|0|||
129743147|NCT00615030|467018865|FG010|Period I|Abnormal laboratory value(s)|0|||
129743148|NCT00615030|467018866|FG011|Period I|Abnormal laboratory value(s)|0|||
129743149|NCT00615030|467018855|FG000|Period II|Adverse Event|0|||
129743150|NCT00615030|467018856|FG001|Period II|Adverse Event|0|||
129895540|NCT00828919|467577216|FG003|Overall Study|Death|0|||
129895541|NCT00828919|467577217|FG004|Overall Study|Death|0|||
129895542|NCT00828919|467577213|FG000|Overall Study|Adverse Event|2|||
129895543|NCT00828919|467577214|FG001|Overall Study|Adverse Event|2|||
129895544|NCT00828919|467577215|FG002|Overall Study|Adverse Event|2|||
129895545|NCT00828919|467577216|FG003|Overall Study|Adverse Event|1|||
129743151|NCT00615030|467018857|FG002|Period II|Adverse Event|1|||
129743152|NCT00615030|467018858|FG003|Period II|Adverse Event|0|||
129743153|NCT00615030|467018859|FG004|Period II|Adverse Event|0|||
129743154|NCT00615030|467018860|FG005|Period II|Adverse Event|0|||
129743155|NCT00615030|467018861|FG006|Period II|Adverse Event|0|||
129743156|NCT00615030|467018862|FG007|Period II|Adverse Event|0|||
129743157|NCT00615030|467018863|FG008|Period II|Adverse Event|1|||
129743158|NCT00615030|467018864|FG009|Period II|Adverse Event|0|||
129743159|NCT00615030|467018865|FG010|Period II|Adverse Event|0|||
129743160|NCT00615030|467018866|FG011|Period II|Adverse Event|0|||
129743161|NCT00615030|467018855|FG000|Period II|Subject withdrew consent|0|||
129743162|NCT00615030|467018856|FG001|Period II|Subject withdrew consent|0|||
129743163|NCT00615030|467018857|FG002|Period II|Subject withdrew consent|0|||
129895546|NCT00828919|467577217|FG004|Overall Study|Adverse Event|3|||
129743164|NCT00615030|467018858|FG003|Period II|Subject withdrew consent|1|||
129743165|NCT00615030|467018859|FG004|Period II|Subject withdrew consent|0|||
129743166|NCT00615030|467018860|FG005|Period II|Subject withdrew consent|0|||
129743167|NCT00615030|467018861|FG006|Period II|Subject withdrew consent|1|||
129743168|NCT00615030|467018862|FG007|Period II|Subject withdrew consent|0|||
129743169|NCT00615030|467018863|FG008|Period II|Subject withdrew consent|0|||
129743170|NCT00615030|467018864|FG009|Period II|Subject withdrew consent|0|||
129743171|NCT00615030|467018865|FG010|Period II|Subject withdrew consent|0|||
129743172|NCT00615030|467018866|FG011|Period II|Subject withdrew consent|0|||
129743173|NCT00615030|467018855|FG000|Period III|Administrative problems|1|||
129743174|NCT00615030|467018856|FG001|Period III|Administrative problems|0|||
129743175|NCT00615030|467018857|FG002|Period III|Administrative problems|0|||
129743176|NCT00615030|467018858|FG003|Period III|Administrative problems|1|||
129743177|NCT00615030|467018859|FG004|Period III|Administrative problems|0|||
129743178|NCT00615030|467018860|FG005|Period III|Administrative problems|0|||
129743179|NCT00615030|467018861|FG006|Period III|Administrative problems|0|||
129743180|NCT00615030|467018862|FG007|Period III|Administrative problems|0|||
129743181|NCT00615030|467018863|FG008|Period III|Administrative problems|0|||
129743182|NCT00615030|467018864|FG009|Period III|Administrative problems|0|||
129743183|NCT00615030|467018865|FG010|Period III|Administrative problems|0|||
129743184|NCT00615030|467018866|FG011|Period III|Administrative problems|0|||
129743185|NCT00151476|467018867|FG000|FAP Identified Subjects|Protocol Violation|0|||
129743186|NCT00151476|467018868|FG001|FAP Identified Subjects|Protocol Violation|1|||
129743187|NCT00151476|467018867|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
129743188|NCT00151476|467018868|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
129743189|NCT00151476|467018867|FG000|FAP Analyzed Subjects|Other study participation|0|||
129743190|NCT00151476|467018868|FG001|FAP Analyzed Subjects|Other study participation|1|||
129743191|NCT03446456|467018869|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
129743192|NCT03446456|467018870|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
129743193|NCT03446456|467018869|FG000|Overall Study|Lost to Follow-up|1|||
129743194|NCT03446456|467018870|FG001|Overall Study|Lost to Follow-up|3|||
129743195|NCT03446456|467018869|FG000|Overall Study|Participant failed the toxicology test|1|||
129743196|NCT03446456|467018870|FG001|Overall Study|Participant failed the toxicology test|0|||
129743197|NCT03446456|467018869|FG000|Overall Study|Break down of the experimental equipment|1|||
129743198|NCT03446456|467018870|FG001|Overall Study|Break down of the experimental equipment|0|||
129743199|NCT04099511|467018877|FG000|Overall Study|Lost to Follow-up|2|||
129743200|NCT04099511|467018878|FG001|Overall Study|Lost to Follow-up|2|||
129743201|NCT04099511|467018877|FG000|Overall Study|Withdrawal by Subject|8|||
129743202|NCT04099511|467018878|FG001|Overall Study|Withdrawal by Subject|4|||
129743203|NCT03002311|467018883|FG000|Overall Study|Lost to Follow-up|13|||
129743204|NCT03002311|467018884|FG001|Overall Study|Lost to Follow-up|26|||
129743205|NCT03002311|467018883|FG000|Overall Study|Referral provider called to schedule app|3|||
129743206|NCT03002311|467018884|FG001|Overall Study|Referral provider called to schedule app|3|||
129743207|NCT03002311|467018883|FG000|Overall Study|Physician Decision|3|||
129743208|NCT03002311|467018884|FG001|Overall Study|Physician Decision|1|||
129743209|NCT00320424|467018885|FG000|Overall Study|Adverse Event|3|||
129743210|NCT00320424|467018885|FG000|Overall Study|Other|3|||
129743211|NCT00658814|467018886|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
129743212|NCT00658814|467018887|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
129743213|NCT00658814|467018886|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
129743214|NCT00658814|467018887|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
129743215|NCT00658814|467018886|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
129743216|NCT00658814|467018887|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
129743217|NCT00658814|467018886|FG000|Remission Induction Chemotherapy|Death|1|||
129743218|NCT00658814|467018887|FG001|Remission Induction Chemotherapy|Death|4|||
129743219|NCT00658814|467018886|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
129743220|NCT00658814|467018887|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
129743221|NCT00658814|467018886|FG000|Remission Induction Chemotherapy|Not eligible|1|||
129743222|NCT00658814|467018887|FG001|Remission Induction Chemotherapy|Not eligible|2|||
129743223|NCT00658814|467018886|FG000|Consolidation Therapy|Not protocol specified|0|||
129743224|NCT00658814|467018887|FG001|Consolidation Therapy|Not protocol specified|1|||
129807904|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
129807905|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
129807906|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
129807907|NCT02110238|467262571|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
129807908|NCT02110238|467262572|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
129807909|NCT01330030|467262581|FG000|Overall Study|Lost to Follow-up|16|||
129807910|NCT01330030|467262582|FG001|Overall Study|Lost to Follow-up|17|||
129807911|NCT01781975|467262598|FG000|Overall Study|Death|1|||
129807912|NCT01781975|467262599|FG001|Overall Study|Death|0|||
129807913|NCT01781975|467262598|FG000|Overall Study|Withdrawal by Subject|1|||
129807914|NCT01781975|467262599|FG001|Overall Study|Withdrawal by Subject|1|||
129807915|NCT02404220|467262601|FG000|Overall Study|Adverse Event|0|||
129807916|NCT02404220|467262602|FG001|Overall Study|Adverse Event|0|||
129807917|NCT02404220|467262603|FG002|Overall Study|Adverse Event|1|||
129807918|NCT02404220|467262604|FG003|Overall Study|Adverse Event|0|||
129807919|NCT02404220|467262601|FG000|Overall Study|Death|5|||
129807920|NCT02404220|467262602|FG001|Overall Study|Death|5|||
129807921|NCT02404220|467262603|FG002|Overall Study|Death|3|||
129807922|NCT02404220|467262604|FG003|Overall Study|Death|8|||
129895547|NCT00828919|467577213|FG000|Overall Study|Objective progression or relapse|4|||
129895548|NCT00828919|467577214|FG001|Overall Study|Objective progression or relapse|4|||
129895549|NCT00828919|467577215|FG002|Overall Study|Objective progression or relapse|11|||
129895550|NCT00828919|467577216|FG003|Overall Study|Objective progression or relapse|0|||
129895551|NCT00828919|467577217|FG004|Overall Study|Objective progression or relapse|5|||
129895552|NCT00828919|467577213|FG000|Overall Study|No longer willing to participate in study|0|||
129895553|NCT00828919|467577214|FG001|Overall Study|No longer willing to participate in study|0|||
129895554|NCT00828919|467577215|FG002|Overall Study|No longer willing to participate in study|2|||
129895555|NCT00828919|467577216|FG003|Overall Study|No longer willing to participate in study|0|||
129895556|NCT00828919|467577217|FG004|Overall Study|No longer willing to participate in study|0|||
129895557|NCT00828919|467577213|FG000|Overall Study|Insufficient Clinical Response|0|||
129895558|NCT00828919|467577214|FG001|Overall Study|Insufficient Clinical Response|1|||
129895559|NCT00828919|467577215|FG002|Overall Study|Insufficient Clinical Response|2|||
129743225|NCT00658814|467018886|FG000|Consolidation Therapy|Not eligible|2|||
129895560|NCT00828919|467577216|FG003|Overall Study|Insufficient Clinical Response|0|||
129895561|NCT00828919|467577217|FG004|Overall Study|Insufficient Clinical Response|0|||
129895562|NCT00828919|467577213|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895563|NCT00828919|467577214|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895564|NCT00828919|467577215|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895565|NCT00828919|467577216|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
129895566|NCT00828919|467577217|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
129895567|NCT00828919|467577213|FG000|Overall Study|Other|1|||
129895568|NCT00828919|467577214|FG001|Overall Study|Other|0|||
129895569|NCT00828919|467577215|FG002|Overall Study|Other|1|||
129895570|NCT00828919|467577216|FG003|Overall Study|Other|1|||
129895571|NCT00828919|467577217|FG004|Overall Study|Other|0|||
129895572|NCT00828919|467577213|FG000|Overall Study|Lost to Follow-up|0|||
129895573|NCT00828919|467577214|FG001|Overall Study|Lost to Follow-up|1|||
129895574|NCT00828919|467577215|FG002|Overall Study|Lost to Follow-up|0|||
129895575|NCT00828919|467577216|FG003|Overall Study|Lost to Follow-up|0|||
129895576|NCT00828919|467577217|FG004|Overall Study|Lost to Follow-up|0|||
129895577|NCT05567159|467577220|FG000|Overall Study|Adverse Event|4|||
129895578|NCT05567159|467577220|FG000|Overall Study|Physician Decision|3|||
129895579|NCT05567159|467577220|FG000|Overall Study|Protocol deviation|1|||
129895580|NCT03015740|467577223|FG000|Overall Study|Adverse Event|1|||
129895581|NCT03015740|467577224|FG001|Overall Study|Adverse Event|0|||
129895582|NCT03015740|467577225|FG002|Overall Study|Adverse Event|0|||
129895583|NCT03015740|467577223|FG000|Overall Study|Death|3|||
129895584|NCT03015740|467577224|FG001|Overall Study|Death|5|||
129445353|NCT02684279|465931272|FG000|Overall Study|non compliance with study visits|2|||
129743226|NCT00658814|467018887|FG001|Consolidation Therapy|Not eligible|2|||
129743227|NCT00658814|467018886|FG000|Maintenance Therapy|Adverse Event|1|||
129743228|NCT00658814|467018887|FG001|Maintenance Therapy|Adverse Event|1|||
129743229|NCT00658814|467018886|FG000|Maintenance Therapy|Not protocol specified|1|||
129743230|NCT00658814|467018887|FG001|Maintenance Therapy|Not protocol specified|0|||
129743231|NCT00658814|467018886|FG000|Maintenance Therapy|Not eligible|1|||
129743232|NCT00658814|467018887|FG001|Maintenance Therapy|Not eligible|0|||
129743233|NCT03270891|467018888|FG000|Overall Study|Lost to Follow-up|3|||
129743234|NCT03270891|467018889|FG001|Overall Study|Lost to Follow-up|6|||
129743235|NCT03270891|467018890|FG002|Overall Study|Lost to Follow-up|0|||
129743236|NCT03270891|467018888|FG000|Overall Study|Withdrawal by Subject|1|||
129743237|NCT03270891|467018889|FG001|Overall Study|Withdrawal by Subject|0|||
129743238|NCT03270891|467018890|FG002|Overall Study|Withdrawal by Subject|0|||
129743239|NCT03270891|467018888|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
129743240|NCT03270891|467018889|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
129743241|NCT03270891|467018890|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
129895585|NCT03015740|467577225|FG002|Overall Study|Death|0|||
129445354|NCT02684279|465931272|FG000|Overall Study|subject to have surgery|1|||
129895586|NCT03015740|467577223|FG000|Overall Study|Withdrawal by Subject|2|||
129895587|NCT03015740|467577224|FG001|Overall Study|Withdrawal by Subject|0|||
129807923|NCT02404220|467262601|FG000|Overall Study|Progressive Disease|0|||
129807924|NCT02404220|467262602|FG001|Overall Study|Progressive Disease|0|||
129807925|NCT02404220|467262603|FG002|Overall Study|Progressive Disease|1|||
129807926|NCT02404220|467262604|FG003|Overall Study|Progressive Disease|1|||
129807927|NCT02404220|467262601|FG000|Overall Study|Study Terminated by Sponsor|0|||
129895588|NCT03015740|467577225|FG002|Overall Study|Withdrawal by Subject|0|||
129895589|NCT02449044|467577226|FG000|Overall Study|Lost to Follow-up|2|||
129895590|NCT02449044|467577226|FG000|Overall Study|Withdrawal by Subject|13|||
129895591|NCT02449044|467577226|FG000|Overall Study|Adverse Event|30|||
129895592|NCT02449044|467577226|FG000|Overall Study|Met Withdrawal Criteria|7|||
129743242|NCT02540668|467018891|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
129743243|NCT02540668|467018892|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
129743244|NCT02883062|467018894|FG000|Overall Study|Withdrawal by Subject|6|||
129743245|NCT02883062|467018895|FG001|Overall Study|Withdrawal by Subject|0|||
129743246|NCT02888743|467018896|FG000|Overall Study|Withdrawal by Subject|1|||
129743247|NCT02888743|467018897|FG001|Overall Study|Withdrawal by Subject|2|||
129743248|NCT02888743|467018898|FG002|Overall Study|Withdrawal by Subject|2|||
129743249|NCT02888743|467018899|FG003|Overall Study|Withdrawal by Subject|0|||
129743250|NCT02888743|467018900|FG004|Overall Study|Withdrawal by Subject|1|||
129743251|NCT02888743|467018896|FG000|Overall Study|Disease progression before treatment|2|||
129743252|NCT02888743|467018897|FG001|Overall Study|Disease progression before treatment|0|||
129743253|NCT02888743|467018898|FG002|Overall Study|Disease progression before treatment|2|||
129743254|NCT02888743|467018899|FG003|Overall Study|Disease progression before treatment|0|||
129743255|NCT02888743|467018900|FG004|Overall Study|Disease progression before treatment|0|||
129743256|NCT02888743|467018896|FG000|Overall Study|Patient ineligible|1|||
129743257|NCT02888743|467018897|FG001|Overall Study|Patient ineligible|2|||
129743258|NCT02888743|467018898|FG002|Overall Study|Patient ineligible|0|||
129743259|NCT02888743|467018899|FG003|Overall Study|Patient ineligible|0|||
129445355|NCT02684279|465931272|FG000|Overall Study|family emergency|1|||
129445356|NCT02684279|465931272|FG000|Overall Study|Site closures|7|||
129445357|NCT02684279|465931272|FG000|Overall Study|Physician Decision|1|||
129445358|NCT02733185|465931273|FG000|Overall Study|Withdrawal by Subject|12|||
129445359|NCT02733185|465931274|FG001|Overall Study|Withdrawal by Subject|10|||
129445360|NCT02733185|465931275|FG002|Overall Study|Withdrawal by Subject|17|||
129445361|NCT02733185|465931276|FG003|Overall Study|Withdrawal by Subject|21|||
129445362|NCT02733185|465931273|FG000|Overall Study|Death|46|||
129895593|NCT02449044|467577226|FG000|Overall Study|Physician Decision|9|||
129895594|NCT02449044|467577226|FG000|Overall Study|Sponsor Discontinued Trial|3|||
129895595|NCT02501811|467577228|FG000|Overall Study|Death|1|||
129445363|NCT02733185|465931274|FG001|Overall Study|Death|34|||
129445364|NCT02733185|465931275|FG002|Overall Study|Death|35|||
129445365|NCT02733185|465931276|FG003|Overall Study|Death|43|||
129445366|NCT02733185|465931273|FG000|Overall Study|Lost to Follow-up|17|||
129445367|NCT02733185|465931274|FG001|Overall Study|Lost to Follow-up|18|||
129445368|NCT02733185|465931275|FG002|Overall Study|Lost to Follow-up|16|||
129445369|NCT02733185|465931276|FG003|Overall Study|Lost to Follow-up|11|||
129445370|NCT01624259|465931277|FG000|Overall Study|Adverse Event|18|||
129445371|NCT01624259|465931278|FG001|Overall Study|Adverse Event|18|||
129445372|NCT01624259|465931277|FG000|Overall Study|Protocol Violation|1|||
129445373|NCT01624259|465931278|FG001|Overall Study|Protocol Violation|2|||
129445374|NCT01624259|465931277|FG000|Overall Study|Withdrawal by Subject|5|||
129445375|NCT01624259|465931278|FG001|Overall Study|Withdrawal by Subject|7|||
129445376|NCT01624259|465931277|FG000|Overall Study|Physician Decision|1|||
129445377|NCT01624259|465931278|FG001|Overall Study|Physician Decision|1|||
129445378|NCT01624259|465931277|FG000|Overall Study|Lost to Follow-up|2|||
129445379|NCT01624259|465931278|FG001|Overall Study|Lost to Follow-up|3|||
129445380|NCT01624259|465931277|FG000|Overall Study|Abnormal laboratory measure|3|||
129445381|NCT01624259|465931278|FG001|Overall Study|Abnormal laboratory measure|0|||
129445382|NCT03828292|465931279|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
129445383|NCT03828292|465931280|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
129445384|NCT03828292|465931281|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
129445385|NCT03828292|465931282|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
129445386|NCT03828292|465931283|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
129445387|NCT03828292|465931284|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
129445388|NCT03828292|465931279|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
129445389|NCT03828292|465931280|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
129445390|NCT03828292|465931281|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
129445391|NCT03828292|465931282|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
129743260|NCT02888743|467018900|FG004|Overall Study|Patient ineligible|0|||
129743261|NCT04816721|467018905|FG000|Overall Study|Withdrawal by Subject|0|||
129743262|NCT04816721|467018906|FG001|Overall Study|Withdrawal by Subject|2|||
129743263|NCT04816721|467018907|FG002|Overall Study|Withdrawal by Subject|0|||
129743264|NCT04816721|467018908|FG003|Overall Study|Withdrawal by Subject|1|||
129743265|NCT04816721|467018909|FG004|Overall Study|Withdrawal by Subject|1|||
129743266|NCT04816721|467018910|FG005|Overall Study|Withdrawal by Subject|0|||
129743267|NCT04816721|467018911|FG006|Overall Study|Withdrawal by Subject|0|||
129743268|NCT04816721|467018912|FG007|Overall Study|Withdrawal by Subject|0|||
129743269|NCT04816721|467018905|FG000|Overall Study|Miscellaneous|0|||
129895596|NCT02501811|467577229|FG001|Overall Study|Death|3|||
129445392|NCT03828292|465931283|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
129743270|NCT04816721|467018906|FG001|Overall Study|Miscellaneous|0|||
129743271|NCT04816721|467018907|FG002|Overall Study|Miscellaneous|0|||
129743272|NCT04816721|467018908|FG003|Overall Study|Miscellaneous|0|||
129743273|NCT04816721|467018909|FG004|Overall Study|Miscellaneous|0|||
129743274|NCT04816721|467018910|FG005|Overall Study|Miscellaneous|1|||
129743275|NCT04816721|467018911|FG006|Overall Study|Miscellaneous|0|||
129743276|NCT04816721|467018912|FG007|Overall Study|Miscellaneous|0|||
129743277|NCT04816721|467018905|FG000|Overall Study|Lost to Follow-up|0|||
129743278|NCT04816721|467018906|FG001|Overall Study|Lost to Follow-up|0|||
129743279|NCT04816721|467018907|FG002|Overall Study|Lost to Follow-up|0|||
129743280|NCT04816721|467018908|FG003|Overall Study|Lost to Follow-up|1|||
129743281|NCT04816721|467018909|FG004|Overall Study|Lost to Follow-up|0|||
129743282|NCT04816721|467018910|FG005|Overall Study|Lost to Follow-up|0|||
129743283|NCT04816721|467018911|FG006|Overall Study|Lost to Follow-up|0|||
129743284|NCT04816721|467018912|FG007|Overall Study|Lost to Follow-up|0|||
129743285|NCT02708485|467018913|FG000|Overall Study|Withdrawal by Subject|3|||
129743286|NCT02708485|467018914|FG001|Overall Study|Withdrawal by Subject|2|||
129743287|NCT03266172|467018915|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
129743288|NCT03266172|467018916|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
129743289|NCT03266172|467018917|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
129743290|NCT03266172|467018915|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
129743291|NCT03266172|467018916|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
129743292|NCT03266172|467018917|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
129743293|NCT03266172|467018915|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
129743294|NCT03266172|467018916|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
129743295|NCT03266172|467018917|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
129743296|NCT03266172|467018915|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
129743297|NCT03266172|467018916|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
129743298|NCT03266172|467018917|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
129743299|NCT03266172|467018915|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129807928|NCT02404220|467262602|FG001|Overall Study|Study Terminated by Sponsor|0|||
129807929|NCT02404220|467262603|FG002|Overall Study|Study Terminated by Sponsor|2|||
129807930|NCT02404220|467262604|FG003|Overall Study|Study Terminated by Sponsor|1|||
129807931|NCT02404220|467262601|FG000|Overall Study|Withdrawal by Subject|0|||
129807932|NCT02404220|467262602|FG001|Overall Study|Withdrawal by Subject|1|||
129807933|NCT02404220|467262603|FG002|Overall Study|Withdrawal by Subject|0|||
129807934|NCT02404220|467262604|FG003|Overall Study|Withdrawal by Subject|0|||
129807935|NCT02404220|467262601|FG000|Overall Study|Enrolled but Never Treated|0|||
129807936|NCT02404220|467262602|FG001|Overall Study|Enrolled but Never Treated|2|||
129807937|NCT02404220|467262603|FG002|Overall Study|Enrolled but Never Treated|0|||
129807938|NCT02404220|467262604|FG003|Overall Study|Enrolled but Never Treated|0|||
129807939|NCT01622231|467262605|FG000|Overall Study|Physician Decision|1|||
129807940|NCT01622231|467262605|FG000|Overall Study|Withdrawal by Subject|1|||
129807941|NCT02905149|467262606|FG000|Overall Study|Lost to Follow-up|2|||
129807942|NCT02905149|467262607|FG001|Overall Study|Lost to Follow-up|0|||
129807943|NCT02329080|467262608|FG000|Overall Study|Adverse Event|1|||
129807944|NCT02329080|467262608|FG000|Overall Study|Death|4|||
129807945|NCT02329080|467262608|FG000|Overall Study|Lack of Efficacy|22|||
129807946|NCT02329080|467262608|FG000|Overall Study|Lost to Follow-up|1|||
129807947|NCT02329080|467262608|FG000|Overall Study|Physician Decision|2|||
129807948|NCT02329080|467262608|FG000|Overall Study|Partial response|4|||
129807949|NCT02329080|467262608|FG000|Overall Study|Complete response|4|||
129807950|NCT01609231|467262615|FG000|Overall Study|Adverse Event|1|||
129807951|NCT01609231|467262616|FG001|Overall Study|Adverse Event|3|||
129807952|NCT01609231|467262615|FG000|Overall Study|Physician Decision|1|||
129807953|NCT01609231|467262616|FG001|Overall Study|Physician Decision|0|||
129807954|NCT01609231|467262615|FG000|Overall Study|Withdrawal by Subject|1|||
129807955|NCT01609231|467262616|FG001|Overall Study|Withdrawal by Subject|0|||
129807956|NCT02846324|467262620|FG000|Overall Study|Other|1|||
129807957|NCT02846324|467262621|FG001|Overall Study|Other|0|||
129807958|NCT02846324|467262622|FG002|Overall Study|Other|0|||
129807959|NCT02846324|467262623|FG003|Overall Study|Other|0|||
129807960|NCT02846324|467262620|FG000|Overall Study|Withdrawal by Subject|1|||
129807961|NCT02846324|467262621|FG001|Overall Study|Withdrawal by Subject|0|||
129807962|NCT02846324|467262622|FG002|Overall Study|Withdrawal by Subject|4|||
129743300|NCT03266172|467018916|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129743301|NCT03266172|467018917|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
129743302|NCT03266172|467018915|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129743303|NCT03266172|467018916|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
129743304|NCT03266172|467018917|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
129807963|NCT02846324|467262623|FG003|Overall Study|Withdrawal by Subject|0|||
129807964|NCT04203797|467262628|FG000|Overall Study|Adverse Event|1|||
129807965|NCT04203797|467262629|FG001|Overall Study|Adverse Event|0|||
129807966|NCT04203797|467262628|FG000|Overall Study|Did not complete End of Study follow-up|1|||
129807967|NCT04203797|467262629|FG001|Overall Study|Did not complete End of Study follow-up|0|||
129807968|NCT00516074|467262630|FG000|Overall Study|Adverse Event|0|||
129743305|NCT01554514|467018920|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
129743306|NCT01554514|467018920|FG000|Overall Study|Physician Decision|1|||
129743307|NCT00290498|467018921|FG000|Overall Study|Death|2|||
129743308|NCT00290498|467018922|FG001|Overall Study|Death|0|||
129743309|NCT00290498|467018921|FG000|Overall Study|Physician Decision|1|||
129743310|NCT00290498|467018922|FG001|Overall Study|Physician Decision|0|||
129743311|NCT00290498|467018921|FG000|Overall Study|Withdrawal by Subject|1|||
129743312|NCT00290498|467018922|FG001|Overall Study|Withdrawal by Subject|0|||
129743313|NCT00290498|467018921|FG000|Overall Study|Ineligible|3|||
129743314|NCT00290498|467018922|FG001|Overall Study|Ineligible|0|||
129743315|NCT00290498|467018921|FG000|Overall Study|Non-Compliance|1|||
129743316|NCT00290498|467018922|FG001|Overall Study|Non-Compliance|0|||
129743317|NCT01716104|467018924|FG000|Overall Study|Do not meet inclusion criteria|6|||
129743318|NCT01716104|467018925|FG001|Overall Study|Do not meet inclusion criteria|7|||
129743319|NCT01753401|467018926|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
129743320|NCT01753401|467018927|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
129743321|NCT01753401|467018928|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
129743322|NCT01753401|467018929|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
129743323|NCT01753401|467018926|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
129743324|NCT01753401|467018927|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
129743325|NCT01753401|467018928|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
129743326|NCT01753401|467018929|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
129743327|NCT01753401|467018926|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
129743328|NCT01753401|467018927|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
129743329|NCT01753401|467018928|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
129743330|NCT01753401|467018929|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
129743331|NCT01753401|467018926|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
129743332|NCT01753401|467018927|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
129743333|NCT01753401|467018928|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
129743334|NCT01753401|467018929|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
129743335|NCT01753401|467018926|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
129743336|NCT01753401|467018927|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
129743337|NCT01753401|467018928|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
129743338|NCT01753401|467018929|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
129743339|NCT01753401|467018926|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
129743340|NCT01753401|467018927|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
129743341|NCT01753401|467018928|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
129743342|NCT01753401|467018929|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
129743343|NCT01753401|467018926|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
129743344|NCT01753401|467018927|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
129743345|NCT01753401|467018928|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
129743346|NCT01753401|467018929|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
129743347|NCT05026853|467018930|FG000|Overall Study|Cancelled appointment|1|||
129743348|NCT05026853|467018931|FG001|Overall Study|Cancelled appointment|0|||
129743349|NCT05026853|467018930|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
129743350|NCT05026853|467018931|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
129743351|NCT05026853|467018930|FG000|Overall Study|Did not complete 12-week survey|16|||
129743352|NCT05026853|467018931|FG001|Overall Study|Did not complete 12-week survey|16|||
129743353|NCT03615066|467018932|FG000|Main Study|Withdrew Consent|0|||
129743354|NCT03615066|467018933|FG001|Main Study|Withdrew Consent|1|||
129743355|NCT03615066|467018934|FG002|Main Study|Withdrew Consent|1|||
129743356|NCT03615066|467018932|FG000|Main Study|Lost to Follow-up|0|||
129743357|NCT03615066|467018933|FG001|Main Study|Lost to Follow-up|0|||
129743358|NCT03615066|467018934|FG002|Main Study|Lost to Follow-up|1|||
129743359|NCT03615066|467018932|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
129743360|NCT03615066|467018933|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
129743361|NCT03615066|467018934|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
129743362|NCT03615066|467018932|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
129743363|NCT03615066|467018933|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
129743364|NCT03615066|467018934|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
129743365|NCT03615066|467018932|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
129743366|NCT03615066|467018933|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
129743367|NCT03615066|467018934|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
129743368|NCT00129961|467018935|FG000|Overall Study|Adverse Event|1|||
129743369|NCT00129961|467018936|FG001|Overall Study|Adverse Event|0|||
129743370|NCT00129961|467018935|FG000|Overall Study|Death|1|||
129743371|NCT00129961|467018936|FG001|Overall Study|Death|1|||
129743372|NCT00129961|467018935|FG000|Overall Study|Withdrawal by Sponsor|14|||
129743373|NCT00129961|467018936|FG001|Overall Study|Withdrawal by Sponsor|20|||
129743374|NCT00129961|467018935|FG000|Overall Study|Physician Decision|1|||
129743375|NCT00129961|467018936|FG001|Overall Study|Physician Decision|0|||
129807969|NCT00516074|467262631|FG001|Overall Study|Adverse Event|1|||
129895597|NCT02501811|467577230|FG002|Overall Study|Death|2|||
129895598|NCT02501811|467577231|FG003|Overall Study|Death|3|||
129895599|NCT02501811|467577228|FG000|Overall Study|Withdrawal by Subject|3|||
129895600|NCT02501811|467577229|FG001|Overall Study|Withdrawal by Subject|3|||
129895601|NCT02501811|467577230|FG002|Overall Study|Withdrawal by Subject|2|||
129895602|NCT02501811|467577231|FG003|Overall Study|Withdrawal by Subject|3|||
129895603|NCT02501811|467577228|FG000|Overall Study|Lost to Follow-up|0|||
129895604|NCT02501811|467577229|FG001|Overall Study|Lost to Follow-up|0|||
129895605|NCT02501811|467577230|FG002|Overall Study|Lost to Follow-up|2|||
129895606|NCT02501811|467577231|FG003|Overall Study|Lost to Follow-up|1|||
129895607|NCT02624778|467578489|FG000|Overall Study|Lost to Follow-up|0|||
129895608|NCT02624778|467578490|FG001|Overall Study|Lost to Follow-up|0|||
129743376|NCT00129961|467018935|FG000|Overall Study|Withdrawal by Subject|2|||
129743377|NCT00129961|467018936|FG001|Overall Study|Withdrawal by Subject|1|||
129743378|NCT00129961|467018935|FG000|Overall Study|Missing Record|0|||
129743379|NCT00129961|467018936|FG001|Overall Study|Missing Record|1|||
129743380|NCT00694304|467018940|FG000|Overall Study|Adverse Event|42|||
129743381|NCT00694304|467018940|FG000|Overall Study|Lack of Efficacy|35|||
129743382|NCT00694304|467018940|FG000|Overall Study|Non-compliance With Study Product|16|||
129743383|NCT00694304|467018940|FG000|Overall Study|Protocol Violation|6|||
129743384|NCT00694304|467018940|FG000|Overall Study|Withdrawal of Consent|61|||
129743385|NCT00694304|467018940|FG000|Overall Study|Lost to Follow-up|15|||
129743386|NCT00694304|467018940|FG000|Overall Study|Administrative or Other Reasons|32|||
129743387|NCT01270256|467018941|FG000|Overall Study|Withdrawal by Subject|1|||
129743388|NCT01270256|467018942|FG001|Overall Study|Withdrawal by Subject|0|||
129743389|NCT04407234|467018951|FG000|Overall Study|Adverse Event|3|||
129743390|NCT04407234|467018952|FG001|Overall Study|Adverse Event|3|||
129743391|NCT00727558|467018953|FG000|Overall Study|Lens issue|0|||
129743392|NCT00727558|467018954|FG001|Overall Study|Lens issue|1|||
129743393|NCT00727558|467018953|FG000|Overall Study|Adverse Event|0|||
129743394|NCT00727558|467018954|FG001|Overall Study|Adverse Event|1|||
129743395|NCT00727558|467018953|FG000|Overall Study|Subject unable to return for follow-up|1|||
129743396|NCT00727558|467018954|FG001|Overall Study|Subject unable to return for follow-up|1|||
129743397|NCT00727558|467018953|FG000|Overall Study|Lost to Follow-up|1|||
129743398|NCT00727558|467018954|FG001|Overall Study|Lost to Follow-up|0|||
129743399|NCT01754493|467020597|FG000|Overall Study|Adverse Event|1|||
129743400|NCT01754493|467020597|FG000|Overall Study|Lost to Follow-up|3|||
129743401|NCT01754493|467020597|FG000|Overall Study|Withdrawal by Subject|1|||
129743402|NCT01754493|467020597|FG000|Overall Study|Moved out of town|1|||
129743403|NCT01754493|467020597|FG000|Overall Study|Scheduling conflict|1|||
129743404|NCT01543776|467020598|FG000|Overall Study|Withdrawal by Subject|2|||
129743405|NCT01543776|467020599|FG001|Overall Study|Withdrawal by Subject|2|||
129743406|NCT00568126|467020600|FG000|Overall Study|Adverse Event|3|||
129743407|NCT00568126|467020601|FG001|Overall Study|Adverse Event|0|||
129743408|NCT00568126|467020600|FG000|Overall Study|Withdrawal by Subject|2|||
129743409|NCT00568126|467020601|FG001|Overall Study|Withdrawal by Subject|3|||
129743410|NCT00568126|467020600|FG000|Overall Study|Lost to Follow-up|4|||
129743411|NCT00568126|467020601|FG001|Overall Study|Lost to Follow-up|3|||
129743412|NCT00568126|467020600|FG000|Overall Study|Lack of Efficacy|0|||
129743413|NCT00568126|467020601|FG001|Overall Study|Lack of Efficacy|1|||
129743414|NCT00568126|467020600|FG000|Overall Study|Physician Decision|2|||
129743415|NCT00568126|467020601|FG001|Overall Study|Physician Decision|2|||
129743416|NCT02421588|467020602|FG000|Overall Study|Non-treatment-related AE|8|||
129743417|NCT02421588|467020603|FG001|Overall Study|Non-treatment-related AE|8|||
129743418|NCT02421588|467020602|FG000|Overall Study|Progressive disease|152|||
129743419|NCT02421588|467020603|FG001|Overall Study|Progressive disease|135|||
129743420|NCT02421588|467020602|FG000|Overall Study|Death|11|||
129743421|NCT02421588|467020603|FG001|Overall Study|Death|3|||
129743422|NCT02421588|467020602|FG000|Overall Study|Physician Decision|8|||
129743423|NCT02421588|467020603|FG001|Overall Study|Physician Decision|17|||
129743424|NCT02421588|467020602|FG000|Overall Study|Other reason not specified|3|||
129743425|NCT02421588|467020603|FG001|Overall Study|Other reason not specified|1|||
129743426|NCT02421588|467020602|FG000|Overall Study|Symptomatic deterioration|13|||
129743427|NCT02421588|467020603|FG001|Overall Study|Symptomatic deterioration|19|||
129743428|NCT02421588|467020602|FG000|Overall Study|Treatment-related AE|10|||
129743429|NCT02421588|467020603|FG001|Overall Study|Treatment-related AE|14|||
129743430|NCT02421588|467020602|FG000|Overall Study|Withdrawal by Subject|14|||
129743431|NCT02421588|467020603|FG001|Overall Study|Withdrawal by Subject|16|||
129743432|NCT02421588|467020602|FG000|Overall Study|Not treated|2|||
129743433|NCT02421588|467020603|FG001|Overall Study|Not treated|8|||
129743434|NCT02649894|467020609|FG000|Overall Study|Adverse Event|1|||
129743435|NCT02649894|467020610|FG001|Overall Study|Adverse Event|0|||
129895609|NCT02624778|467578491|FG002|Overall Study|Lost to Follow-up|1|||
129895610|NCT02624778|467578492|FG003|Overall Study|Lost to Follow-up|0|||
129743436|NCT02649894|467020609|FG000|Overall Study|Physician Decision|0|||
129743437|NCT02649894|467020610|FG001|Overall Study|Physician Decision|1|||
129743438|NCT02649894|467020609|FG000|Overall Study|Withdrawal by Subject|5|||
129895611|NCT02624778|467578493|FG004|Overall Study|Lost to Follow-up|0|||
129743439|NCT02649894|467020610|FG001|Overall Study|Withdrawal by Subject|2|||
129743440|NCT02649894|467020609|FG000|Overall Study|Lost to Follow-up|2|||
129743441|NCT02649894|467020610|FG001|Overall Study|Lost to Follow-up|1|||
129743442|NCT02649894|467020609|FG000|Overall Study|Death|30|||
129743443|NCT02649894|467020610|FG001|Overall Study|Death|7|||
129743444|NCT02649894|467020609|FG000|Overall Study|Other, not specified|6|||
129743445|NCT02649894|467020610|FG001|Overall Study|Other, not specified|0|||
129743446|NCT00719680|467020611|FG000|Overall Study|Adverse Event|1|||
129743447|NCT00719680|467020611|FG000|Overall Study|Lost to Follow-up|1|||
129743448|NCT00719680|467020611|FG000|Overall Study|Withdrawal by Subject|3|||
129743449|NCT04071158|467020612|FG000|Overall Study|Lost to Follow-up|1|||
129743450|NCT04071158|467020613|FG001|Overall Study|Lost to Follow-up|2|||
129743451|NCT04071158|467020614|FG002|Overall Study|Lost to Follow-up|3|||
129743452|NCT04071158|467020615|FG003|Overall Study|Lost to Follow-up|3|||
129743453|NCT04071158|467020616|FG004|Overall Study|Lost to Follow-up|5|||
129743454|NCT04071158|467020612|FG000|Overall Study|Randomized but not treated|2|||
129743455|NCT04071158|467020613|FG001|Overall Study|Randomized but not treated|2|||
129743456|NCT04071158|467020614|FG002|Overall Study|Randomized but not treated|0|||
129743457|NCT04071158|467020615|FG003|Overall Study|Randomized but not treated|0|||
129743458|NCT04071158|467020616|FG004|Overall Study|Randomized but not treated|0|||
129743459|NCT01286740|467020617|FG000|Overall Study|Enrolled but not treated|1|||
129743460|NCT01286740|467020617|FG000|Overall Study|Protocol Violation|1|||
129743461|NCT01110382|467020619|FG000|Overall Study|Withdrawal by Subject|0|||
129743462|NCT01110382|467020620|FG001|Overall Study|Withdrawal by Subject|1|||
129743463|NCT01110382|467020619|FG000|Overall Study|Protocol Violation|0|||
129743464|NCT01110382|467020620|FG001|Overall Study|Protocol Violation|1|||
129743465|NCT05222555|467020621|FG000|Overall Study|Ongoing|2|||
129743466|NCT05222555|467020622|FG001|Overall Study|Ongoing|18|||
129743467|NCT05222555|467020621|FG000|Overall Study|Adverse Event|1|||
129743468|NCT05222555|467020622|FG001|Overall Study|Adverse Event|1|||
129743469|NCT05222555|467020621|FG000|Overall Study|Death|0|||
129743470|NCT05222555|467020622|FG001|Overall Study|Death|6|||
129743471|NCT05222555|467020621|FG000|Overall Study|Withdrawal by Subject|0|||
129743472|NCT05222555|467020622|FG001|Overall Study|Withdrawal by Subject|11|||
129743473|NCT00300365|467020623|FG000|Overall Study|Lost to Follow-up|1|||
129743474|NCT00300365|467020624|FG001|Overall Study|Lost to Follow-up|0|||
129743475|NCT00300365|467020623|FG000|Overall Study|Physician Decision|2|||
129743476|NCT00300365|467020624|FG001|Overall Study|Physician Decision|0|||
129743477|NCT00300365|467020623|FG000|Overall Study|Withdrawal by Subject|1|||
129743478|NCT00300365|467020624|FG001|Overall Study|Withdrawal by Subject|0|||
129743479|NCT00300365|467020623|FG000|Overall Study|Adverse Event|0|||
129743480|NCT00300365|467020624|FG001|Overall Study|Adverse Event|2|||
129743481|NCT01422824|467020625|FG000|Overall Study|Case record form not evaluated|1|||
129743482|NCT01422824|467020625|FG000|Overall Study|Lost to Follow-up|37|||
129743483|NCT00902174|467020626|FG000|Overall Study|Adverse Event|27|||
129743484|NCT00902174|467020627|FG001|Overall Study|Adverse Event|7|||
129743485|NCT00902174|467020626|FG000|Overall Study|Lack of Efficacy|1|||
129743486|NCT00902174|467020627|FG001|Overall Study|Lack of Efficacy|5|||
129743487|NCT00902174|467020626|FG000|Overall Study|Death|2|||
129743488|NCT00902174|467020627|FG001|Overall Study|Death|2|||
129743489|NCT00902174|467020626|FG000|Overall Study|Withdrawal by Subject|2|||
129743490|NCT00902174|467020627|FG001|Overall Study|Withdrawal by Subject|1|||
129743491|NCT00902174|467020626|FG000|Overall Study|Abnormal labs|1|||
129743492|NCT00902174|467020627|FG001|Overall Study|Abnormal labs|1|||
129743493|NCT00902174|467020626|FG000|Overall Study|Protocol Violation|1|||
129743494|NCT00902174|467020627|FG001|Overall Study|Protocol Violation|1|||
129743495|NCT00902174|467020626|FG000|Overall Study|Administration problem|0|||
129743496|NCT00902174|467020627|FG001|Overall Study|Administration problem|1|||
129743497|NCT01581619|467020628|FG000|Overall Study|Withdrawal by Subject|1|||
129743498|NCT01581619|467020628|FG000|Overall Study|Lost to Follow-up|1|||
129743499|NCT03129360|467020631|FG000|Overall Study|Did not meet entry criteria|0|||
129743500|NCT03129360|467020632|FG001|Overall Study|Did not meet entry criteria|2|||
129743501|NCT03129360|467020633|FG002|Overall Study|Did not meet entry criteria|1|||
129743502|NCT03129360|467020631|FG000|Overall Study|Excluded due to motion in scanner|1|||
129743503|NCT03129360|467020632|FG001|Overall Study|Excluded due to motion in scanner|0|||
129743504|NCT03129360|467020633|FG002|Overall Study|Excluded due to motion in scanner|0|||
129743505|NCT03006887|467020634|FG000|Overall Study|Adverse Event|1|||
129743506|NCT03836677|467020635|FG000|Period 1|Adverse Event|0|||
129743507|NCT03836677|467020636|FG001|Period 1|Adverse Event|1|||
129743508|NCT03836677|467020635|FG000|Period 2|Severe non-compliance to protocol|1|||
129743509|NCT03836677|467020636|FG001|Period 2|Severe non-compliance to protocol|0|||
129743510|NCT01353911|467020637|FG000|Overall Study|Lost to Follow-up|2|||
129743511|NCT01353911|467020638|FG001|Overall Study|Lost to Follow-up|6|||
129743512|NCT01353911|467020639|FG002|Overall Study|Lost to Follow-up|4|||
129743513|NCT01353911|467020640|FG003|Overall Study|Lost to Follow-up|0|||
129743514|NCT01353911|467020641|FG004|Overall Study|Lost to Follow-up|4|||
129743515|NCT01353911|467020642|FG005|Overall Study|Lost to Follow-up|4|||
129743516|NCT01353911|467020643|FG006|Overall Study|Lost to Follow-up|3|||
129743517|NCT01353911|467020644|FG007|Overall Study|Lost to Follow-up|6|||
129743518|NCT01353911|467020637|FG000|Overall Study|Withdrawal by Subject|2|||
129743519|NCT01353911|467020638|FG001|Overall Study|Withdrawal by Subject|3|||
129743520|NCT01353911|467020639|FG002|Overall Study|Withdrawal by Subject|4|||
129743521|NCT01353911|467020640|FG003|Overall Study|Withdrawal by Subject|2|||
129743522|NCT01353911|467020641|FG004|Overall Study|Withdrawal by Subject|2|||
129743523|NCT01353911|467020642|FG005|Overall Study|Withdrawal by Subject|3|||
129743524|NCT01353911|467020643|FG006|Overall Study|Withdrawal by Subject|3|||
129743525|NCT01353911|467020644|FG007|Overall Study|Withdrawal by Subject|9|||
129743526|NCT01353911|467020637|FG000|Overall Study|Status Not Recorded|4|||
129743527|NCT01353911|467020638|FG001|Overall Study|Status Not Recorded|0|||
129743528|NCT01353911|467020639|FG002|Overall Study|Status Not Recorded|1|||
129743529|NCT01353911|467020640|FG003|Overall Study|Status Not Recorded|0|||
129743530|NCT01353911|467020641|FG004|Overall Study|Status Not Recorded|0|||
129743531|NCT01353911|467020642|FG005|Overall Study|Status Not Recorded|0|||
129743532|NCT01353911|467020643|FG006|Overall Study|Status Not Recorded|0|||
129743533|NCT01353911|467020644|FG007|Overall Study|Status Not Recorded|0|||
129743534|NCT00462748|467020649|FG000|Overall Study|Adverse Event|7|||
129743535|NCT00462748|467020650|FG001|Overall Study|Adverse Event|5|||
129743536|NCT00462748|467020651|FG002|Overall Study|Adverse Event|9|||
129743537|NCT00462748|467020649|FG000|Overall Study|Protocol Violation|0|||
129743538|NCT00462748|467020650|FG001|Overall Study|Protocol Violation|2|||
129743539|NCT00462748|467020651|FG002|Overall Study|Protocol Violation|1|||
129743540|NCT00462748|467020649|FG000|Overall Study|Withdrew consent|3|||
129743541|NCT00462748|467020650|FG001|Overall Study|Withdrew consent|3|||
129743542|NCT00462748|467020651|FG002|Overall Study|Withdrew consent|0|||
129743543|NCT00462748|467020649|FG000|Overall Study|Lost to Follow-up|1|||
129743544|NCT00462748|467020650|FG001|Overall Study|Lost to Follow-up|1|||
129743545|NCT00462748|467020651|FG002|Overall Study|Lost to Follow-up|1|||
129743546|NCT00462748|467020649|FG000|Overall Study|Discontinued after 41 days Rx|1|||
129743547|NCT00462748|467020650|FG001|Overall Study|Discontinued after 41 days Rx|0|||
129743548|NCT00462748|467020651|FG002|Overall Study|Discontinued after 41 days Rx|0|||
129743549|NCT03233438|467020652|FG000|Overall Study|Lost to Follow-up|4|||
129743550|NCT03233438|467020653|FG001|Overall Study|Lost to Follow-up|9|||
129743551|NCT03233438|467020652|FG000|Overall Study|Withdrawal by Subject|2|||
129743552|NCT03233438|467020653|FG001|Overall Study|Withdrawal by Subject|1|||
129743553|NCT03233438|467020652|FG000|Overall Study|No recording of dalbavancin|0|||
129743554|NCT03233438|467020653|FG001|Overall Study|No recording of dalbavancin|1|||
129743555|NCT03429543|467020654|FG000|Overall Study|Adverse Event|1|||
129743556|NCT03429543|467020655|FG001|Overall Study|Adverse Event|1|||
129743557|NCT03429543|467020656|FG002|Overall Study|Adverse Event|0|||
129743558|NCT03429543|467020657|FG003|Overall Study|Adverse Event|0|||
129743559|NCT03429543|467020658|FG004|Overall Study|Adverse Event|0|||
129743560|NCT03429543|467020659|FG005|Overall Study|Adverse Event|2|||
129743561|NCT03429543|467020660|FG006|Overall Study|Adverse Event|0|||
129743562|NCT03429543|467020654|FG000|Overall Study|Lost to Follow-up|1|||
129743563|NCT03429543|467020655|FG001|Overall Study|Lost to Follow-up|0|||
129743564|NCT03429543|467020656|FG002|Overall Study|Lost to Follow-up|0|||
129743565|NCT03429543|467020657|FG003|Overall Study|Lost to Follow-up|0|||
129743566|NCT03429543|467020658|FG004|Overall Study|Lost to Follow-up|1|||
129743567|NCT03429543|467020659|FG005|Overall Study|Lost to Follow-up|0|||
129743568|NCT03429543|467020660|FG006|Overall Study|Lost to Follow-up|0|||
129743569|NCT03429543|467020654|FG000|Overall Study|Withdrawal by Subject|5|||
129743570|NCT03429543|467020655|FG001|Overall Study|Withdrawal by Subject|0|||
129743571|NCT03429543|467020656|FG002|Overall Study|Withdrawal by Subject|1|||
129743572|NCT03429543|467020657|FG003|Overall Study|Withdrawal by Subject|2|||
129743573|NCT03429543|467020658|FG004|Overall Study|Withdrawal by Subject|6|||
129743574|NCT03429543|467020659|FG005|Overall Study|Withdrawal by Subject|3|||
129743575|NCT03429543|467020660|FG006|Overall Study|Withdrawal by Subject|1|||
129743576|NCT03429543|467020654|FG000|Overall Study|Other reason than listed|0|||
129743577|NCT03429543|467020655|FG001|Overall Study|Other reason than listed|1|||
129743578|NCT03429543|467020656|FG002|Overall Study|Other reason than listed|0|||
129743579|NCT03429543|467020657|FG003|Overall Study|Other reason than listed|0|||
129743580|NCT03429543|467020658|FG004|Overall Study|Other reason than listed|4|||
129743581|NCT03429543|467020659|FG005|Overall Study|Other reason than listed|4|||
129743582|NCT03429543|467020660|FG006|Overall Study|Other reason than listed|0|||
129743583|NCT03429543|467020654|FG000|Overall Study|Not treated|0|||
129743584|NCT03429543|467020655|FG001|Overall Study|Not treated|0|||
129743585|NCT03429543|467020656|FG002|Overall Study|Not treated|0|||
129895612|NCT02624778|467578494|FG005|Overall Study|Lost to Follow-up|0|||
129743586|NCT03429543|467020657|FG003|Overall Study|Not treated|0|||
129743587|NCT03429543|467020658|FG004|Overall Study|Not treated|1|||
129743588|NCT03429543|467020659|FG005|Overall Study|Not treated|0|||
129743589|NCT03429543|467020660|FG006|Overall Study|Not treated|0|||
129743590|NCT01818492|467020661|FG000|Overall Study|Adverse Event|2|||
129743591|NCT01818492|467020661|FG000|Overall Study|Death|3|||
129743592|NCT01818492|467020661|FG000|Overall Study|Withdrawal by Subject|1|||
129743593|NCT01818492|467020661|FG000|Overall Study|Additional therapy when not allowed PP|4|||
129743594|NCT01729208|467020662|FG000|Baseline|Physician Decision|5|||
129743595|NCT01729208|467020663|FG001|Baseline|Physician Decision|4|||
129743596|NCT01729208|467020662|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
129743597|NCT01729208|467020663|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
129743598|NCT01729208|467020662|FG000|12 Months Follow-up|Lost to Follow-up|3|||
129743599|NCT01729208|467020663|FG001|12 Months Follow-up|Lost to Follow-up|3|||
129743600|NCT01729208|467020662|FG000|24 Months Follow-up|Lost to Follow-up|3|||
129743601|NCT01729208|467020663|FG001|24 Months Follow-up|Lost to Follow-up|0|||
129743602|NCT01729208|467020662|FG000|36 Months Follow-up|Physician Decision|1|||
129743603|NCT01729208|467020663|FG001|36 Months Follow-up|Physician Decision|0|||
129743604|NCT01729208|467020662|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
129743605|NCT01729208|467020663|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
129743606|NCT02428413|467020665|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
129743607|NCT02428413|467020666|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
129743608|NCT02428413|467020665|FG000|Overall Study|Protocol Violation|1|||
129743609|NCT02428413|467020666|FG001|Overall Study|Protocol Violation|2|||
129743610|NCT02428413|467020665|FG000|Overall Study|Case Cancelled|2|||
129743611|NCT02428413|467020666|FG001|Overall Study|Case Cancelled|0|||
129743612|NCT02428413|467020665|FG000|Overall Study|Missed Cases|1|||
129743613|NCT02428413|467020666|FG001|Overall Study|Missed Cases|2|||
129743614|NCT02428413|467020665|FG000|Overall Study|Nurse Refusal|1|||
129743615|NCT02428413|467020666|FG001|Overall Study|Nurse Refusal|0|||
129743616|NCT02345330|467020669|FG000|Overall Study|Death|1|||
129743617|NCT02345330|467020669|FG000|Overall Study|Progressive Disease|2|||
129743618|NCT03688100|467020670|FG000|Overall Study|Lost to Follow-up|21|||
129743619|NCT03688100|467020671|FG001|Overall Study|Lost to Follow-up|15|||
129743620|NCT03688100|467020672|FG002|Overall Study|Lost to Follow-up|15|||
129743621|NCT03688100|467020673|FG003|Overall Study|Lost to Follow-up|18|||
129743622|NCT03688100|467020670|FG000|Overall Study|Withdrawal by Subject|19|||
129743623|NCT03688100|467020671|FG001|Overall Study|Withdrawal by Subject|16|||
129743624|NCT03688100|467020672|FG002|Overall Study|Withdrawal by Subject|0|||
129743625|NCT03688100|467020673|FG003|Overall Study|Withdrawal by Subject|0|||
129743626|NCT03688100|467020670|FG000|Overall Study|Death|36|||
129743627|NCT03688100|467020671|FG001|Overall Study|Death|27|||
129743628|NCT03688100|467020672|FG002|Overall Study|Death|0|||
129743629|NCT03688100|467020673|FG003|Overall Study|Death|0|||
129743630|NCT00494507|467020676|FG000|Double-Blind Phase|Adverse Event|2|||
129743631|NCT00494507|467020677|FG001|Double-Blind Phase|Adverse Event|0|||
129743632|NCT00494507|467020678|FG002|Double-Blind Phase|Adverse Event|1|||
129743633|NCT00494507|467020679|FG003|Double-Blind Phase|Adverse Event|0|||
129743634|NCT00494507|467020676|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
129743635|NCT00494507|467020677|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
129743636|NCT00494507|467020678|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129743637|NCT00494507|467020679|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129743638|NCT00494507|467020676|FG000|Double-Blind Phase|Subject Non-compliance|0|||
129743639|NCT00494507|467020677|FG001|Double-Blind Phase|Subject Non-compliance|0|||
129743640|NCT00494507|467020678|FG002|Double-Blind Phase|Subject Non-compliance|1|||
129743641|NCT00494507|467020679|FG003|Double-Blind Phase|Subject Non-compliance|0|||
129743642|NCT00494507|467020676|FG000|Double-Blind Phase|Negative DNA test|0|||
129743643|NCT00494507|467020677|FG001|Double-Blind Phase|Negative DNA test|0|||
129743644|NCT00494507|467020678|FG002|Double-Blind Phase|Negative DNA test|0|||
129743645|NCT00494507|467020679|FG003|Double-Blind Phase|Negative DNA test|1|||
129743646|NCT00494507|467020676|FG000|Open-Label Phase|Adverse Event|0|||
129743647|NCT00494507|467020677|FG001|Open-Label Phase|Adverse Event|1|||
129807970|NCT00516074|467262630|FG000|Overall Study|Subject Decision|4|||
129807971|NCT00516074|467262631|FG001|Overall Study|Subject Decision|2|||
129807972|NCT00516074|467262630|FG000|Overall Study|Loss of Glucose Control|2|||
129807973|NCT00516074|467262631|FG001|Overall Study|Loss of Glucose Control|0|||
129807974|NCT03540030|467262632|FG000|Overall Study|Withdrawal by Subject|2|||
129743648|NCT00494507|467020678|FG002|Open-Label Phase|Adverse Event|5|||
129807975|NCT03540030|467262633|FG001|Overall Study|Withdrawal by Subject|1|||
129807976|NCT03540030|467262632|FG000|Overall Study|screen fail|7|||
129807977|NCT03540030|467262633|FG001|Overall Study|screen fail|1|||
129743649|NCT00494507|467020679|FG003|Open-Label Phase|Adverse Event|3|||
129743650|NCT00494507|467020676|FG000|Open-Label Phase|Worsening Disease|0|||
129743651|NCT00494507|467020677|FG001|Open-Label Phase|Worsening Disease|0|||
129743652|NCT00494507|467020678|FG002|Open-Label Phase|Worsening Disease|0|||
129743653|NCT00494507|467020679|FG003|Open-Label Phase|Worsening Disease|2|||
129743654|NCT02437084|467020681|FG000|Overall Study|Withdrawal by Subject|2|||
129743655|NCT02437084|467020681|FG000|Overall Study|Physician Decision|1|||
129743656|NCT00587847|467020682|FG000|Overall Study|Lack of Efficacy|5|||
129743657|NCT00587847|467020682|FG000|Overall Study|Adverse Event|2|||
129807978|NCT03540030|467262632|FG000|Overall Study|never had surgery after signing consent|9|||
129807979|NCT03540030|467262633|FG001|Overall Study|never had surgery after signing consent|1|||
129807980|NCT00003487|467262635|FG000|Overall Study|Not evaluable|2|||
129807981|NCT03855228|467262637|FG000|Overall Study|Adverse Event|2|||
129807982|NCT03855228|467262638|FG001|Overall Study|Adverse Event|4|||
129743658|NCT03729245|467020683|FG000|Overall Study|Lost to Follow-up|5|||
129743659|NCT03729245|467020684|FG001|Overall Study|Lost to Follow-up|6|||
129743660|NCT03729245|467020683|FG000|Overall Study|Withdrawal by Subject|16|||
129743661|NCT03729245|467020684|FG001|Overall Study|Withdrawal by Subject|19|||
129743662|NCT03729245|467020683|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
129743663|NCT03729245|467020684|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
129743664|NCT04032080|467020685|FG000|Overall Study|Death|6|||
129743665|NCT00989781|467020692|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
129743666|NCT00989781|467020693|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
129743667|NCT00576576|467020696|FG000|Overall Study|Lost to Follow-up|6|||
129743668|NCT00576576|467020696|FG000|Overall Study|Protocol Violation|1|||
129743669|NCT01805037|467020702|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
129743670|NCT01805037|467020703|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
129743671|NCT01805037|467020702|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
129743672|NCT01805037|467020703|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
129743673|NCT01805037|467020702|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
129743674|NCT01805037|467020703|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
129743675|NCT01805037|467020702|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
129743676|NCT01805037|467020703|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
129743677|NCT01805037|467020702|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
129743678|NCT01805037|467020703|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
129743679|NCT01805037|467020702|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
129743680|NCT01805037|467020703|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
129743681|NCT01805037|467020702|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
129743682|NCT01805037|467020703|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
129743683|NCT01805037|467020702|FG000|Follow Up (up to 3 Years)|Death|0|||
129743684|NCT01805037|467020703|FG001|Follow Up (up to 3 Years)|Death|2|||
129743685|NCT01805037|467020702|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
129743686|NCT01805037|467020703|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
129743687|NCT01805037|467020702|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
129743688|NCT01805037|467020703|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
129743689|NCT02177838|467020704|FG000|Overall Study|Withdrawal by Subject|1|||
129743690|NCT02177838|467020704|FG000|Overall Study|Physician Decision|1|||
129743691|NCT02177838|467020704|FG000|Overall Study|Death|1|||
129743692|NCT03517566|467020708|FG000|Overall Study|Adverse Event|5|||
129743693|NCT03517566|467020709|FG001|Overall Study|Adverse Event|2|||
129743694|NCT03517566|467020710|FG002|Overall Study|Adverse Event|2|||
129743695|NCT03517566|467020711|FG003|Overall Study|Adverse Event|8|||
129743696|NCT03517566|467020712|FG004|Overall Study|Adverse Event|7|||
129743697|NCT03517566|467020708|FG000|Overall Study|Lack of Efficacy|3|||
129743698|NCT03517566|467020709|FG001|Overall Study|Lack of Efficacy|2|||
129743699|NCT03517566|467020710|FG002|Overall Study|Lack of Efficacy|1|||
129743700|NCT03517566|467020711|FG003|Overall Study|Lack of Efficacy|1|||
129743701|NCT03517566|467020712|FG004|Overall Study|Lack of Efficacy|4|||
129743702|NCT03517566|467020708|FG000|Overall Study|Lost to Follow-up|3|||
129743703|NCT03517566|467020709|FG001|Overall Study|Lost to Follow-up|1|||
129743704|NCT03517566|467020710|FG002|Overall Study|Lost to Follow-up|1|||
129743705|NCT03517566|467020711|FG003|Overall Study|Lost to Follow-up|1|||
129743706|NCT03517566|467020712|FG004|Overall Study|Lost to Follow-up|0|||
129743707|NCT03517566|467020708|FG000|Overall Study|Physician Decision|1|||
129743708|NCT03517566|467020709|FG001|Overall Study|Physician Decision|1|||
129743709|NCT03517566|467020710|FG002|Overall Study|Physician Decision|0|||
129743710|NCT03517566|467020711|FG003|Overall Study|Physician Decision|1|||
129743711|NCT03517566|467020712|FG004|Overall Study|Physician Decision|0|||
129743712|NCT03517566|467020708|FG000|Overall Study|Pregnancy|0|||
129743713|NCT03517566|467020709|FG001|Overall Study|Pregnancy|1|||
129743714|NCT03517566|467020710|FG002|Overall Study|Pregnancy|0|||
129743715|NCT03517566|467020711|FG003|Overall Study|Pregnancy|0|||
129743716|NCT03517566|467020712|FG004|Overall Study|Pregnancy|0|||
129743717|NCT03517566|467020708|FG000|Overall Study|Protocol Deviation|0|||
129743718|NCT03517566|467020709|FG001|Overall Study|Protocol Deviation|1|||
129743719|NCT03517566|467020710|FG002|Overall Study|Protocol Deviation|0|||
129743720|NCT03517566|467020711|FG003|Overall Study|Protocol Deviation|1|||
129743721|NCT03517566|467020712|FG004|Overall Study|Protocol Deviation|1|||
129743722|NCT03517566|467020708|FG000|Overall Study|Study terminated by Sponsor|11|||
129743723|NCT03517566|467020709|FG001|Overall Study|Study terminated by Sponsor|5|||
129743724|NCT03517566|467020710|FG002|Overall Study|Study terminated by Sponsor|6|||
129743725|NCT03517566|467020711|FG003|Overall Study|Study terminated by Sponsor|14|||
129743726|NCT03517566|467020712|FG004|Overall Study|Study terminated by Sponsor|12|||
129743727|NCT03517566|467020708|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
129743728|NCT03517566|467020709|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
129743729|NCT03517566|467020710|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
129743730|NCT03517566|467020711|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
129743731|NCT03517566|467020712|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
129743732|NCT04566692|467020714|FG000|Overall Study|Adverse Event|2|||
129743733|NCT04566692|467020715|FG001|Overall Study|Adverse Event|0|||
129743734|NCT04566692|467020714|FG000|Overall Study|Withdrawal by Subject|1|||
129743735|NCT04566692|467020715|FG001|Overall Study|Withdrawal by Subject|1|||
129743736|NCT04311463|467020718|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
129743737|NCT04311463|467020719|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
129743738|NCT04311463|467020718|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
129743739|NCT04311463|467020719|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
129743740|NCT04311463|467020718|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
129743741|NCT04311463|467020719|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
129743742|NCT00737633|467020721|FG000|Overall Study|Study terminated by sponsor|44|||
129743743|NCT00737633|467020722|FG001|Overall Study|Study terminated by sponsor|55|||
129743744|NCT00737633|467020721|FG000|Overall Study|Lost to Follow-up|0|||
129743745|NCT00737633|467020722|FG001|Overall Study|Lost to Follow-up|1|||
129743746|NCT00737633|467020721|FG000|Overall Study|protocol non-compliance|0|||
129743747|NCT00737633|467020722|FG001|Overall Study|protocol non-compliance|1|||
129743748|NCT01300260|467020727|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
129743749|NCT01300260|467020728|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
129743750|NCT01300260|467020727|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
129743751|NCT01300260|467020728|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
129743752|NCT01300260|467020727|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
129743753|NCT01300260|467020728|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
129743754|NCT00293020|467020734|FG000|Overall Study|Withdrawal by Subject|34|||
129743755|NCT00293020|467020734|FG000|Overall Study|Adverse Event|30|||
129743756|NCT00293020|467020734|FG000|Overall Study|Death|32|||
129743757|NCT00293020|467020734|FG000|Overall Study|Lack of Efficacy|12|||
129743758|NCT00293020|467020734|FG000|Overall Study|Lost to Follow-up|4|||
129743759|NCT00293020|467020734|FG000|Overall Study|Protocol Violation|6|||
129743760|NCT00293020|467020734|FG000|Overall Study|Physician Decision|21|||
129743761|NCT00293020|467020734|FG000|Overall Study|Other Reason|22|||
129743762|NCT00293020|467020734|FG000|Overall Study|No dose taken|1|||
129743763|NCT01147848|467020735|FG000|Run-in Period|Screen Failure|623|||
129743764|NCT01147848|467020736|FG001|Run-in Period|Screen Failure|0|||
129743765|NCT01147848|467020737|FG002|Run-in Period|Screen Failure|0|||
129743766|NCT01147848|467020735|FG000|Run-in Period|Run-in Failure|135|||
129743767|NCT01147848|467020736|FG001|Run-in Period|Run-in Failure|0|||
129743768|NCT01147848|467020737|FG002|Run-in Period|Run-in Failure|0|||
129743769|NCT01147848|467020735|FG000|Randomized Phase|Adverse Event|0|||
129743770|NCT01147848|467020736|FG001|Randomized Phase|Adverse Event|6|||
129743771|NCT01147848|467020737|FG002|Randomized Phase|Adverse Event|8|||
129743772|NCT01147848|467020735|FG000|Randomized Phase|Lack of Efficacy|0|||
129743773|NCT01147848|467020736|FG001|Randomized Phase|Lack of Efficacy|20|||
129743774|NCT01147848|467020737|FG002|Randomized Phase|Lack of Efficacy|11|||
129743775|NCT01147848|467020735|FG000|Randomized Phase|Protocol Violation|0|||
129743776|NCT01147848|467020736|FG001|Randomized Phase|Protocol Violation|7|||
129743777|NCT01147848|467020737|FG002|Randomized Phase|Protocol Violation|10|||
129743778|NCT01147848|467020735|FG000|Randomized Phase|Lost to Follow-up|0|||
129743779|NCT01147848|467020736|FG001|Randomized Phase|Lost to Follow-up|5|||
129743780|NCT01147848|467020737|FG002|Randomized Phase|Lost to Follow-up|7|||
129743781|NCT01147848|467020735|FG000|Randomized Phase|Physician Decision|0|||
129743782|NCT01147848|467020736|FG001|Randomized Phase|Physician Decision|0|||
129743783|NCT01147848|467020737|FG002|Randomized Phase|Physician Decision|1|||
129743784|NCT01147848|467020735|FG000|Randomized Phase|Withdrawal by Subject|0|||
129743785|NCT01147848|467020736|FG001|Randomized Phase|Withdrawal by Subject|7|||
129743786|NCT01147848|467020737|FG002|Randomized Phase|Withdrawal by Subject|9|||
129743787|NCT02540265|467020739|FG000|Overall Study|Lost to Follow-up|0|||
129743788|NCT02540265|467020740|FG001|Overall Study|Lost to Follow-up|0|||
129743789|NCT02540265|467020741|FG002|Overall Study|Lost to Follow-up|1|||
129743790|NCT03157037|467020744|FG000|Overall Study|Death|1|||
129743791|NCT02102399|467020748|FG000|Overall Study|Withdrawal by Subject|6|||
129743792|NCT02102399|467020749|FG001|Overall Study|Withdrawal by Subject|4|||
129743793|NCT03101085|467020750|FG000|Overall Study|Lost to Follow-up|0|||
129743794|NCT03101085|467020751|FG001|Overall Study|Lost to Follow-up|1|||
129743795|NCT00695864|467020752|FG000|Placebo|Withdrawal by Subject|1|||
129743796|NCT00695864|467020752|FG000|Placebo|Physician Decision|4|||
129743797|NCT00718770|467020753|FG000|Overall Study|Adverse Event|1|||
129743798|NCT00718770|467020753|FG000|Overall Study|Lack of Efficacy|1|||
129743799|NCT00718770|467020753|FG000|Overall Study|Lack of Efficacy|1|||
129743800|NCT00718770|467020753|FG000|Overall Study|Adverse Event|1|||
129743801|NCT00718770|467020753|FG000|Overall Study|Lack of Efficacy|1|||
129743802|NCT00718770|467020753|FG000|Overall Study|Adverse Event|1|||
129743803|NCT00718770|467020753|FG000|Overall Study|Lack of Efficacy|1|||
129743804|NCT00718770|467020753|FG000|Overall Study|Adverse Event|1|||
129743805|NCT01704456|467020754|FG000|Overall Study|Lost to Follow-up|8|||
129743806|NCT01704456|467020755|FG001|Overall Study|Lost to Follow-up|14|||
129743807|NCT00498355|467020756|FG000|Overall Study|Lost to Follow-up|1|||
129743808|NCT04583956|467020757|FG000|Overall Study|Death|9|||
129743809|NCT04583956|467020758|FG001|Overall Study|Death|11|||
129743810|NCT04583956|467020757|FG000|Overall Study|Lost to Follow-up|7|||
129743811|NCT04583956|467020758|FG001|Overall Study|Lost to Follow-up|9|||
129743812|NCT04583956|467020757|FG000|Overall Study|Protocol Violation|2|||
129807983|NCT03855228|467262639|FG002|Overall Study|Adverse Event|4|||
129807984|NCT03855228|467262640|FG003|Overall Study|Adverse Event|8|||
129807985|NCT03855228|467262637|FG000|Overall Study|Treatment Failure|1|||
129807986|NCT03855228|467262638|FG001|Overall Study|Treatment Failure|2|||
129743813|NCT04583956|467020758|FG001|Overall Study|Protocol Violation|0|||
129743814|NCT04583956|467020757|FG000|Overall Study|Withdrawal by Subject|0|||
129743815|NCT04583956|467020758|FG001|Overall Study|Withdrawal by Subject|2|||
129743816|NCT04583956|467020757|FG000|Overall Study|Randomized but not dosed|2|||
129743817|NCT04583956|467020758|FG001|Overall Study|Randomized but not dosed|3|||
129743818|NCT04583956|467020757|FG000|Overall Study|Withdrawal of consent before product administration|1|||
129743819|NCT04583956|467020758|FG001|Overall Study|Withdrawal of consent before product administration|0|||
129743820|NCT04599465|467022331|FG000|Overall Study|Physician Decision|1|||
129743821|NCT04599465|467022331|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
129743822|NCT03416127|467022332|FG000|Overall Study|Withdrawal by Subject|0|||
129743823|NCT03416127|467022333|FG001|Overall Study|Withdrawal by Subject|1|||
129743824|NCT03416127|467022334|FG002|Overall Study|Withdrawal by Subject|1|||
129743825|NCT01971008|467022335|FG000|Overall Study|Protocol Violation|2|||
129743826|NCT01971008|467022336|FG001|Overall Study|Protocol Violation|1|||
129743827|NCT02489942|467022339|FG000|Overall Study|Request by patient|602|||
129743828|NCT02489942|467022339|FG000|Overall Study|Improvement/remission|157|||
129743829|NCT02489942|467022339|FG000|Overall Study|No change/Progressive disease|263|||
129743830|NCT02489942|467022339|FG000|Overall Study|Adverse Event|522|||
129743831|NCT02489942|467022339|FG000|Overall Study|Other personal reasons|1218|||
129743832|NCT02489942|467022339|FG000|Overall Study|Lost to Follow-up|456|||
129743833|NCT02489942|467022339|FG000|Overall Study|Not continuously investigated|7|||
129743834|NCT02489942|467022339|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
129743835|NCT02489942|467022339|FG000|Overall Study|Multiple registration|1|||
129743836|NCT02489942|467022339|FG000|Overall Study|No patient visit after entry|100|||
129743837|NCT02489942|467022339|FG000|Overall Study|No treatment with Jardiance|2|||
129743838|NCT02489942|467022339|FG000|Overall Study|Patient received Jardiance before registration|1|||
129743839|NCT02489942|467022339|FG000|Overall Study|No CRF collected|86|||
129743840|NCT00858208|467022340|FG000|Overall Study|Adverse Event|3|||
129743841|NCT00858208|467022340|FG000|Overall Study|Lost to Follow-up|26|||
129743842|NCT00858208|467022340|FG000|Overall Study|Participant refused|40|||
129743843|NCT00858208|467022340|FG000|Overall Study|Other|10|||
129743844|NCT02702180|467022341|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129743845|NCT02702180|467022342|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129743846|NCT02702180|467022343|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129743847|NCT02702180|467022341|FG000|Double-blind Treatment Period|Adverse Event|0|||
129743848|NCT02702180|467022342|FG001|Double-blind Treatment Period|Adverse Event|0|||
129743849|NCT02702180|467022343|FG002|Double-blind Treatment Period|Adverse Event|1|||
129743850|NCT02702180|467022341|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129743851|NCT02702180|467022342|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129743852|NCT02702180|467022343|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
129743853|NCT02702180|467022341|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129743854|NCT02702180|467022342|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129743855|NCT02702180|467022343|FG002|Double-blind Treatment Period|Protocol Violation|2|||
129743856|NCT02702180|467022341|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129743857|NCT02702180|467022342|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
129807987|NCT03855228|467262639|FG002|Overall Study|Treatment Failure|1|||
129807988|NCT03855228|467262640|FG003|Overall Study|Treatment Failure|8|||
129743858|NCT02702180|467022343|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
129743859|NCT02702180|467022341|FG000|Open-label Treatment Period|Withdrawn in error|0|||
129743860|NCT02702180|467022342|FG001|Open-label Treatment Period|Withdrawn in error|0|||
129743861|NCT02702180|467022343|FG002|Open-label Treatment Period|Withdrawn in error|1|||
129743862|NCT00567359|467022344|FG000|Overall Study|Withdrawal by Subject|1|||
129743863|NCT00679172|467022345|FG000|Overall Study|Non-compliance|1|||
129743864|NCT00679172|467022346|FG001|Overall Study|Non-compliance|1|||
129743865|NCT00679172|467022347|FG002|Overall Study|Non-compliance|0|||
129807989|NCT03855228|467262637|FG000|Overall Study|Lost to Follow-up|0|||
129807990|NCT03855228|467262638|FG001|Overall Study|Lost to Follow-up|0|||
129743866|NCT00679172|467022348|FG003|Overall Study|Non-compliance|1|||
129743867|NCT00679172|467022349|FG004|Overall Study|Non-compliance|0|||
129743868|NCT00679172|467022345|FG000|Overall Study|Other not specified|0|||
129743869|NCT00679172|467022346|FG001|Overall Study|Other not specified|0|||
129743870|NCT00679172|467022347|FG002|Overall Study|Other not specified|1|||
129743871|NCT00679172|467022348|FG003|Overall Study|Other not specified|0|||
129743872|NCT00679172|467022349|FG004|Overall Study|Other not specified|0|||
129895613|NCT02624778|467578495|FG006|Overall Study|Lost to Follow-up|0|||
129743873|NCT00793325|467022350|FG000|Overall Study|Protocol Violation|18|||
129743874|NCT00793325|467022350|FG000|Overall Study|Lost to Follow-up|1|||
129743875|NCT00372697|467022351|FG000|Overall Study|Protocol Violation|1|||
129743876|NCT00372697|467022352|FG001|Overall Study|Protocol Violation|1|||
129807991|NCT03855228|467262639|FG002|Overall Study|Lost to Follow-up|0|||
129807992|NCT03855228|467262640|FG003|Overall Study|Lost to Follow-up|1|||
129743877|NCT01815840|467022353|FG000|Overall Study|Missing|1|||
129743878|NCT01815840|467022354|FG001|Overall Study|Missing|0|||
129743879|NCT01815840|467022353|FG000|Overall Study|Withdrew Consent|31|||
129743880|NCT01815840|467022354|FG001|Overall Study|Withdrew Consent|30|||
129743881|NCT01815840|467022353|FG000|Overall Study|Administrative/Other|1|||
129743882|NCT01815840|467022354|FG001|Overall Study|Administrative/Other|3|||
129743883|NCT01815840|467022353|FG000|Overall Study|Adverse Event|10|||
129743884|NCT01815840|467022354|FG001|Overall Study|Adverse Event|16|||
129743885|NCT01815840|467022353|FG000|Overall Study|Death|2|||
129743886|NCT01815840|467022354|FG001|Overall Study|Death|2|||
129743887|NCT01815840|467022353|FG000|Overall Study|Disease progression|3|||
129743888|NCT01815840|467022354|FG001|Overall Study|Disease progression|2|||
129743889|NCT01815840|467022353|FG000|Overall Study|Investigators Decision|2|||
129743890|NCT01815840|467022354|FG001|Overall Study|Investigators Decision|3|||
129743891|NCT01815840|467022353|FG000|Overall Study|Lost to Follow-up|3|||
129743892|NCT01815840|467022354|FG001|Overall Study|Lost to Follow-up|6|||
129743893|NCT01815840|467022353|FG000|Overall Study|Refused Treatment|5|||
129743894|NCT01815840|467022354|FG001|Overall Study|Refused Treatment|1|||
129743895|NCT01815840|467022353|FG000|Overall Study|Sponsor Termination Treatment|1|||
129743896|NCT01815840|467022354|FG001|Overall Study|Sponsor Termination Treatment|0|||
129743897|NCT03221842|467022356|FG000|Period 1 (Open-label)|Adverse Event|4|||
129743898|NCT03221842|467022357|FG001|Period 1 (Open-label)|Adverse Event|0|||
129743899|NCT03221842|467022356|FG000|Period 1 (Open-label)|Physician Decision|2|||
129743900|NCT03221842|467022357|FG001|Period 1 (Open-label)|Physician Decision|0|||
129743901|NCT03221842|467022356|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
129743902|NCT03221842|467022357|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
129743903|NCT03221842|467022356|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
129743904|NCT03221842|467022357|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
129743905|NCT03221842|467022356|FG000|Period 1 (Open-label)|Other|2|||
129743906|NCT03221842|467022357|FG001|Period 1 (Open-label)|Other|0|||
129743907|NCT03221842|467022356|FG000|Period 2 (Randomized, Blinded)|Death|0|||
129743908|NCT03221842|467022357|FG001|Period 2 (Randomized, Blinded)|Death|1|||
129743909|NCT03221842|467022356|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
129743910|NCT03221842|467022357|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
129743911|NCT00704288|467022358|FG000|Overall Treatment Period|Adverse Event|11|||
129743912|NCT00704288|467022359|FG001|Overall Treatment Period|Adverse Event|8|||
129743913|NCT00704288|467022360|FG002|Overall Treatment Period|Adverse Event|22|||
129743914|NCT00704288|467022358|FG000|Overall Treatment Period|Death|0|||
129743915|NCT00704288|467022359|FG001|Overall Treatment Period|Death|0|||
129743916|NCT00704288|467022360|FG002|Overall Treatment Period|Death|1|||
129743917|NCT00704288|467022358|FG000|Overall Treatment Period|Physician Decision|0|||
129743918|NCT00704288|467022359|FG001|Overall Treatment Period|Physician Decision|2|||
129743919|NCT00704288|467022360|FG002|Overall Treatment Period|Physician Decision|0|||
129743920|NCT00704288|467022358|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
129743921|NCT00704288|467022359|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
129743922|NCT00704288|467022360|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
129743923|NCT00704288|467022358|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
129743924|NCT00704288|467022359|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
129743925|NCT00704288|467022360|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
129743926|NCT00704288|467022358|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
129743927|NCT00704288|467022359|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
129743928|NCT00704288|467022360|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
129743929|NCT00704288|467022358|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
129743930|NCT00704288|467022359|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
129743931|NCT00704288|467022360|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
129743932|NCT00704288|467022358|FG000|Overall Treatment Period|Roll-over to another study|1|||
129743933|NCT00704288|467022359|FG001|Overall Treatment Period|Roll-over to another study|0|||
129743934|NCT00704288|467022360|FG002|Overall Treatment Period|Roll-over to another study|4|||
129743935|NCT00704288|467022358|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
129743936|NCT00704288|467022359|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
129743937|NCT00704288|467022360|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
129743938|NCT00704288|467022358|FG000|Extended Post Treatment Follow Up Period|Death|41|||
129743939|NCT00704288|467022359|FG001|Extended Post Treatment Follow Up Period|Death|50|||
129743940|NCT00704288|467022360|FG002|Extended Post Treatment Follow Up Period|Death|93|||
129743941|NCT00704288|467022358|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
129743942|NCT00704288|467022359|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
129743943|NCT00704288|467022360|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
129743944|NCT00704288|467022358|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
129743945|NCT00704288|467022359|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
129743946|NCT00704288|467022360|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
129743947|NCT00704288|467022358|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
129743948|NCT00704288|467022359|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
129743949|NCT00704288|467022360|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
129743950|NCT04395690|467022361|FG000|Overall Study|Lost to Follow-up|1|||
129743951|NCT04395690|467022362|FG001|Overall Study|Lost to Follow-up|1|||
129743952|NCT03387020|467022364|FG000|Overall Study|Adverse Event|0|||
129743953|NCT03387020|467022365|FG001|Overall Study|Adverse Event|2|||
129743954|NCT03387020|467022366|FG002|Overall Study|Adverse Event|0|||
129743955|NCT03387020|467022364|FG000|Overall Study|Withdrawal by Subject|2|||
129743956|NCT03387020|467022365|FG001|Overall Study|Withdrawal by Subject|0|||
129743957|NCT03387020|467022366|FG002|Overall Study|Withdrawal by Subject|0|||
129743958|NCT00434642|467022367|FG000|Blinded Treatment Phase|Adverse Event|12|||
129743959|NCT00434642|467022368|FG001|Blinded Treatment Phase|Adverse Event|58|||
129743960|NCT00434642|467022367|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
129743961|NCT00434642|467022368|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
129743962|NCT00434642|467022367|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
129743963|NCT00434642|467022368|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
129743964|NCT00434642|467022367|FG000|Blinded Treatment Phase|Physician Decision|19|||
129743965|NCT00434642|467022368|FG001|Blinded Treatment Phase|Physician Decision|27|||
129743966|NCT00434642|467022367|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
129743967|NCT00434642|467022368|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
129743968|NCT00434642|467022367|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
129743969|NCT00434642|467022368|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
129743970|NCT00434642|467022367|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
129743971|NCT00434642|467022368|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
129743972|NCT00434642|467022367|FG000|Open-label Treatment Phase|Adverse Event|0|||
129743973|NCT00434642|467022368|FG001|Open-label Treatment Phase|Adverse Event|5|||
129743974|NCT00434642|467022367|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
129743975|NCT00434642|467022368|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
129743976|NCT04512976|467022373|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129743977|NCT04512976|467022374|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129743978|NCT04512976|467022375|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129743979|NCT04512976|467022376|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129743980|NCT04512976|467022377|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
129743981|NCT04512976|467022378|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
129743982|NCT00527982|467022379|FG000|Overall Study|Physician Decision|1|||
129743983|NCT00527982|467022380|FG001|Overall Study|Physician Decision|0|||
129743984|NCT00753454|467022387|FG000|Overall Study|Adverse Event|4|||
129743985|NCT00753454|467022387|FG000|Overall Study|Lack of Efficacy|1|||
129743986|NCT00753454|467022387|FG000|Overall Study|Lost to Follow-up|3|||
129743987|NCT00753454|467022387|FG000|Overall Study|Withdrawal by Subject|5|||
129743988|NCT00753454|467022387|FG000|Overall Study|Investigator Decision|1|||
129743989|NCT03927144|467022388|FG000|Core Phase|Adverse Event|9|||
129743990|NCT03927144|467022389|FG001|Core Phase|Adverse Event|5|||
129743991|NCT03927144|467022388|FG000|Core Phase|Lost to Follow-up|3|||
129743992|NCT03927144|467022389|FG001|Core Phase|Lost to Follow-up|2|||
129743993|NCT03927144|467022388|FG000|Core Phase|New Therapy for Study Indication|0|||
129807993|NCT03855228|467262637|FG000|Overall Study|Protocol Violation|0|||
129807994|NCT03855228|467262638|FG001|Overall Study|Protocol Violation|1|||
129743994|NCT03927144|467022389|FG001|Core Phase|New Therapy for Study Indication|1|||
129743995|NCT03927144|467022388|FG000|Core Phase|No Longer Clinically Benefiting|4|||
129743996|NCT03927144|467022389|FG001|Core Phase|No Longer Clinically Benefiting|4|||
129743997|NCT03927144|467022388|FG000|Core Phase|Physician Decision|2|||
129743998|NCT03927144|467022389|FG001|Core Phase|Physician Decision|8|||
129743999|NCT03927144|467022388|FG000|Core Phase|Protocol Violation|2|||
129744000|NCT03927144|467022389|FG001|Core Phase|Protocol Violation|2|||
129744001|NCT03927144|467022388|FG000|Core Phase|Withdrawal by Subject|16|||
129744002|NCT03927144|467022389|FG001|Core Phase|Withdrawal by Subject|40|||
129807995|NCT03855228|467262639|FG002|Overall Study|Protocol Violation|2|||
129807996|NCT03855228|467262640|FG003|Overall Study|Protocol Violation|1|||
129807997|NCT03855228|467262637|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
129807998|NCT03855228|467262638|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
129744003|NCT03927144|467022388|FG000|Extension Phase|Adverse Event|2|||
129807999|NCT03855228|467262639|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
129808000|NCT03855228|467262640|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
129744004|NCT03927144|467022389|FG001|Extension Phase|Adverse Event|1|||
129744005|NCT03927144|467022388|FG000|Extension Phase|No longer clinically benefiting|4|||
129744006|NCT03927144|467022389|FG001|Extension Phase|No longer clinically benefiting|5|||
129744007|NCT03927144|467022388|FG000|Extension Phase|Pregnancy|1|||
129744008|NCT03927144|467022389|FG001|Extension Phase|Pregnancy|0|||
129744009|NCT03927144|467022388|FG000|Extension Phase|Protocol Violation|0|||
129744010|NCT03927144|467022389|FG001|Extension Phase|Protocol Violation|1|||
129895614|NCT02624778|467578496|FG007|Overall Study|Lost to Follow-up|0|||
129744011|NCT03927144|467022388|FG000|Extension Phase|Withdrawal by Subject|8|||
129744012|NCT03927144|467022389|FG001|Extension Phase|Withdrawal by Subject|3|||
129744013|NCT04541628|467022392|FG000|Overall Study|Study Terminated|1|||
129744014|NCT04541628|467022393|FG001|Overall Study|Study Terminated|1|||
129744015|NCT04541628|467022394|FG002|Overall Study|Study Terminated|1|||
129744016|NCT05011058|467022398|FG000|Overall Study|Sponsor Decision|2|||
129744017|NCT05011058|467022399|FG001|Overall Study|Sponsor Decision|0|||
129744018|NCT05011058|467022400|FG002|Overall Study|Sponsor Decision|14|||
129744019|NCT05011058|467022401|FG003|Overall Study|Sponsor Decision|0|||
129744020|NCT05011058|467022402|FG004|Overall Study|Sponsor Decision|0|||
129744021|NCT05011058|467022403|FG005|Overall Study|Sponsor Decision|1|||
129744022|NCT05011058|467022404|FG006|Overall Study|Sponsor Decision|0|||
129744023|NCT05011058|467022405|FG007|Overall Study|Sponsor Decision|5|||
129744024|NCT01452919|467022406|FG000|Open-Label Treatment|Adverse Event|5|||
129744025|NCT01452919|467022407|FG001|Open-Label Treatment|Adverse Event|0|||
129744026|NCT01452919|467022408|FG002|Open-Label Treatment|Adverse Event|0|||
129744027|NCT01452919|467022406|FG000|Open-Label Treatment|Lost to Follow-up|4|||
129744028|NCT01452919|467022407|FG001|Open-Label Treatment|Lost to Follow-up|0|||
129744029|NCT01452919|467022408|FG002|Open-Label Treatment|Lost to Follow-up|0|||
129744030|NCT01452919|467022406|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
129744031|NCT01452919|467022407|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
129744032|NCT01452919|467022408|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
129744033|NCT01452919|467022406|FG000|Open-Label Treatment|Protocol Violation|4|||
129744034|NCT01452919|467022407|FG001|Open-Label Treatment|Protocol Violation|0|||
129744035|NCT01452919|467022408|FG002|Open-Label Treatment|Protocol Violation|0|||
129744036|NCT01452919|467022406|FG000|Open-Label Treatment|Sponsor Decision|1|||
129744037|NCT01452919|467022407|FG001|Open-Label Treatment|Sponsor Decision|0|||
129744038|NCT01452919|467022408|FG002|Open-Label Treatment|Sponsor Decision|0|||
129744039|NCT01452919|467022406|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
129744040|NCT01452919|467022407|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129744041|NCT01452919|467022408|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
129744042|NCT01452919|467022406|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
129744043|NCT01452919|467022407|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
129744044|NCT01452919|467022408|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
129744045|NCT01452919|467022406|FG000|Randomization Treatment|Adverse Event|0|||
129744046|NCT01452919|467022407|FG001|Randomization Treatment|Adverse Event|0|||
129744047|NCT01452919|467022408|FG002|Randomization Treatment|Adverse Event|2|||
129744048|NCT01452919|467022406|FG000|Randomization Treatment|Sponsor Decision|0|||
129744049|NCT01452919|467022407|FG001|Randomization Treatment|Sponsor Decision|1|||
129744050|NCT01452919|467022408|FG002|Randomization Treatment|Sponsor Decision|0|||
129744051|NCT01452919|467022406|FG000|Randomization Treatment|Withdrawal by Subject|0|||
129744052|NCT01452919|467022407|FG001|Randomization Treatment|Withdrawal by Subject|1|||
129744053|NCT01452919|467022408|FG002|Randomization Treatment|Withdrawal by Subject|0|||
129744054|NCT01452919|467022406|FG000|Randomization Treatment|Subject is moving or has moved|0|||
129744055|NCT01452919|467022407|FG001|Randomization Treatment|Subject is moving or has moved|1|||
129744056|NCT01452919|467022408|FG002|Randomization Treatment|Subject is moving or has moved|0|||
129744057|NCT01192412|467022409|FG000|Overall Study|Lost to Follow-up|2|||
129744058|NCT01192412|467022410|FG001|Overall Study|Lost to Follow-up|1|||
129744059|NCT01192412|467022409|FG000|Overall Study|Withdrawal by Subject|2|||
129744060|NCT01192412|467022410|FG001|Overall Study|Withdrawal by Subject|1|||
129744061|NCT01359943|467022413|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
129744062|NCT01359943|467022414|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
129744063|NCT01359943|467022415|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
129808001|NCT00913380|467262643|FG000|Clinical Outcomes|Lost to Follow-up|6|||
129808002|NCT00913380|467262644|FG001|Clinical Outcomes|Lost to Follow-up|6|||
129808003|NCT02004522|467262648|FG000|Overall Study|Adverse Event|55|||
129808004|NCT02004522|467262649|FG001|Overall Study|Adverse Event|6|||
129808005|NCT02004522|467262648|FG000|Overall Study|Withdrawal by Subject|13|||
129808006|NCT02004522|467262649|FG001|Overall Study|Withdrawal by Subject|7|||
129808007|NCT02004522|467262648|FG000|Overall Study|Death|12|||
129808008|NCT02004522|467262649|FG001|Overall Study|Death|3|||
129744064|NCT01359943|467022413|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
129744065|NCT01359943|467022414|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
129744066|NCT01359943|467022415|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
129744067|NCT01359943|467022413|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
129744068|NCT01359943|467022414|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
129744069|NCT01359943|467022415|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808009|NCT02004522|467262648|FG000|Overall Study|Physician Decision|3|||
129808010|NCT02004522|467262649|FG001|Overall Study|Physician Decision|4|||
129808011|NCT02004522|467262648|FG000|Overall Study|Protocol Violation|1|||
129808012|NCT02004522|467262649|FG001|Overall Study|Protocol Violation|0|||
129808013|NCT02004522|467262648|FG000|Overall Study|Other is reason listed by PI|4|||
129808014|NCT02004522|467262649|FG001|Overall Study|Other is reason listed by PI|1|||
129808015|NCT02004522|467262648|FG000|Overall Study|Never Dosed|2|||
129808016|NCT02004522|467262649|FG001|Overall Study|Never Dosed|4|||
129744070|NCT01359943|467022413|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
129744071|NCT01359943|467022414|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
129744072|NCT01359943|467022415|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
129744073|NCT01359943|467022413|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
129744074|NCT01359943|467022414|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
129744075|NCT01359943|467022415|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
129744076|NCT01359943|467022413|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
129744077|NCT01359943|467022414|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
129744078|NCT01359943|467022415|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
129744079|NCT01359943|467022413|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
129744080|NCT01359943|467022414|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
129744081|NCT01359943|467022415|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
129744082|NCT01359943|467022413|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
129744083|NCT01359943|467022414|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
129744084|NCT01359943|467022415|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
129744085|NCT01359943|467022413|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
129744086|NCT01359943|467022414|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
129744087|NCT01359943|467022415|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
129744088|NCT01359943|467022413|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
129744089|NCT01359943|467022414|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
129744090|NCT01359943|467022415|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
129744091|NCT01359943|467022413|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
129744092|NCT01359943|467022414|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
129744093|NCT01359943|467022415|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
129744094|NCT01359943|467022413|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
129744095|NCT01359943|467022414|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
129744096|NCT01359943|467022415|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
129744097|NCT01359943|467022413|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
129744098|NCT01359943|467022414|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
129744099|NCT01359943|467022415|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
129744100|NCT01359943|467022413|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
129744101|NCT01359943|467022414|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
129744102|NCT01359943|467022415|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
129744103|NCT01359943|467022413|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
129744104|NCT01359943|467022414|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
129744105|NCT01359943|467022415|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
129744106|NCT00308074|467022419|FG000|Overall Study|Withdrawal by Subject|1|||
129744107|NCT01529034|467022426|FG000|Overall Study|Discontinued prior to study treatment|14|||
129744108|NCT01529034|467022426|FG000|Overall Study|Site closure|62|||
129744109|NCT01529034|467022426|FG000|Overall Study|Study termination|29|||
129744110|NCT01529034|467022426|FG000|Overall Study|Withdrawal by Subject|25|||
129744111|NCT01529034|467022426|FG000|Overall Study|No treated SCs within protocol window|13|||
129744112|NCT01529034|467022426|FG000|Overall Study|Noncompliance|8|||
129744113|NCT01529034|467022426|FG000|Overall Study|Caregiver no longer available|7|||
129744114|NCT01529034|467022426|FG000|Overall Study|Adverse Event|4|||
129744115|NCT01529034|467022426|FG000|Overall Study|Protocol Violation|4|||
129744116|NCT01529034|467022426|FG000|Overall Study|Lack of Efficacy|4|||
129744117|NCT01529034|467022426|FG000|Overall Study|Investigator no longer available|2|||
129744118|NCT01529034|467022426|FG000|Overall Study|Study drug not available|2|||
129744119|NCT03194646|467022429|FG000|Overall Study|Adverse Event|24|||
129744120|NCT03194646|467022430|FG001|Overall Study|Adverse Event|25|||
129744121|NCT03194646|467022431|FG002|Overall Study|Adverse Event|14|||
129744122|NCT03194646|467022432|FG003|Overall Study|Adverse Event|17|||
129744123|NCT03194646|467022429|FG000|Overall Study|Lack of Efficacy|4|||
129744124|NCT03194646|467022430|FG001|Overall Study|Lack of Efficacy|2|||
129744125|NCT03194646|467022431|FG002|Overall Study|Lack of Efficacy|2|||
129744126|NCT03194646|467022432|FG003|Overall Study|Lack of Efficacy|12|||
129808017|NCT02004522|467262648|FG000|Overall Study|Disease Progression|35|||
129808018|NCT02004522|467262649|FG001|Overall Study|Disease Progression|31|||
129808019|NCT02004522|467262648|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
129808020|NCT02004522|467262649|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
129808021|NCT01787331|467262650|FG000|Overall Study|Physician Decision|1|||
129808022|NCT01787331|467262650|FG000|Overall Study|Withdrawal by Subject|1|||
129744127|NCT03194646|467022429|FG000|Overall Study|Lost to Follow-up|30|||
129744128|NCT03194646|467022430|FG001|Overall Study|Lost to Follow-up|22|||
129744129|NCT03194646|467022431|FG002|Overall Study|Lost to Follow-up|12|||
129744130|NCT03194646|467022432|FG003|Overall Study|Lost to Follow-up|35|||
129744131|NCT03194646|467022429|FG000|Overall Study|Non-compliance with study drug|4|||
129744132|NCT03194646|467022430|FG001|Overall Study|Non-compliance with study drug|0|||
129744133|NCT03194646|467022431|FG002|Overall Study|Non-compliance with study drug|1|||
129744134|NCT03194646|467022432|FG003|Overall Study|Non-compliance with study drug|1|||
129744135|NCT03194646|467022429|FG000|Overall Study|Other|89|||
129744136|NCT03194646|467022430|FG001|Overall Study|Other|68|||
129744137|NCT03194646|467022431|FG002|Overall Study|Other|34|||
129744138|NCT03194646|467022432|FG003|Overall Study|Other|31|||
129744139|NCT03194646|467022429|FG000|Overall Study|Physician Decision|7|||
129744140|NCT03194646|467022430|FG001|Overall Study|Physician Decision|9|||
129744141|NCT03194646|467022431|FG002|Overall Study|Physician Decision|5|||
129744142|NCT03194646|467022432|FG003|Overall Study|Physician Decision|4|||
129744143|NCT03194646|467022429|FG000|Overall Study|Pregnancy|4|||
129744144|NCT03194646|467022430|FG001|Overall Study|Pregnancy|5|||
129744145|NCT03194646|467022431|FG002|Overall Study|Pregnancy|1|||
129744146|NCT03194646|467022432|FG003|Overall Study|Pregnancy|2|||
129744147|NCT03194646|467022429|FG000|Overall Study|Protocol Violation|4|||
129744148|NCT03194646|467022430|FG001|Overall Study|Protocol Violation|2|||
129744149|NCT03194646|467022431|FG002|Overall Study|Protocol Violation|1|||
129744150|NCT03194646|467022432|FG003|Overall Study|Protocol Violation|1|||
129744151|NCT03194646|467022429|FG000|Overall Study|Site terminated by sponsor|0|||
129744152|NCT03194646|467022430|FG001|Overall Study|Site terminated by sponsor|0|||
129744153|NCT03194646|467022431|FG002|Overall Study|Site terminated by sponsor|2|||
129744154|NCT03194646|467022432|FG003|Overall Study|Site terminated by sponsor|0|||
129744155|NCT03194646|467022429|FG000|Overall Study|Study terminated by sponsor|62|||
129744156|NCT03194646|467022430|FG001|Overall Study|Study terminated by sponsor|61|||
129744157|NCT03194646|467022431|FG002|Overall Study|Study terminated by sponsor|30|||
129744158|NCT03194646|467022432|FG003|Overall Study|Study terminated by sponsor|34|||
129744159|NCT03194646|467022429|FG000|Overall Study|Withdrawal by Subject|75|||
129744160|NCT03194646|467022430|FG001|Overall Study|Withdrawal by Subject|74|||
129744161|NCT03194646|467022431|FG002|Overall Study|Withdrawal by Subject|36|||
129744162|NCT03194646|467022432|FG003|Overall Study|Withdrawal by Subject|131|||
129744163|NCT03194646|467022429|FG000|Overall Study|Missing|1|||
129744164|NCT03194646|467022430|FG001|Overall Study|Missing|0|||
129744165|NCT03194646|467022431|FG002|Overall Study|Missing|1|||
129744166|NCT03194646|467022432|FG003|Overall Study|Missing|12|||
129744167|NCT02141360|467022434|FG000|Overall Study|Withdrawal by Subject|6|||
129744168|NCT02141360|467022435|FG001|Overall Study|Withdrawal by Subject|0|||
129744169|NCT02141360|467022436|FG002|Overall Study|Withdrawal by Subject|0|||
129744170|NCT02141360|467022434|FG000|Overall Study|Study Terminated before Visit|1|||
129744171|NCT02141360|467022435|FG001|Overall Study|Study Terminated before Visit|0|||
129808023|NCT00667875|467262651|FG000|Overall Study|Adverse Event|0|||
129808024|NCT00667875|467262652|FG001|Overall Study|Adverse Event|2|||
129808025|NCT00667875|467262653|FG002|Overall Study|Adverse Event|6|||
129808026|NCT00667875|467262651|FG000|Overall Study|Withdrawal by Subject|10|||
129808027|NCT00667875|467262652|FG001|Overall Study|Withdrawal by Subject|9|||
129744172|NCT02141360|467022436|FG002|Overall Study|Study Terminated before Visit|0|||
129744173|NCT01178099|467022437|FG000|Overall Study|Physician Decision|0|||
129744174|NCT01178099|467022438|FG001|Overall Study|Physician Decision|1|||
129744175|NCT02516592|467022441|FG000|Overall Study|Patient withdrew consent|5|||
129744176|NCT02516592|467022442|FG001|Overall Study|Patient withdrew consent|2|||
129744177|NCT02516592|467022441|FG000|Overall Study|Protocol deviation|4|||
129744178|NCT02516592|467022442|FG001|Overall Study|Protocol deviation|4|||
129744179|NCT02516592|467022441|FG000|Overall Study|Lost to Follow-up|2|||
129808028|NCT00667875|467262653|FG002|Overall Study|Withdrawal by Subject|7|||
129808029|NCT00450255|467262654|FG000|Overall Study|Prior RFA ablation of liver|1|||
129808030|NCT01696071|467262655|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
129808031|NCT01696071|467262656|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
129808032|NCT00142298|467262659|FG000|Overall Study|Adverse Event|10|||
129808033|NCT00142298|467262660|FG001|Overall Study|Adverse Event|10|||
129808034|NCT00142298|467262661|FG002|Overall Study|Adverse Event|1|||
129808035|NCT00142298|467262662|FG003|Overall Study|Adverse Event|5|||
129808036|NCT00142298|467262663|FG004|Overall Study|Adverse Event|2|||
129808037|NCT00142298|467262664|FG005|Overall Study|Adverse Event|2|||
129808038|NCT00142298|467262665|FG006|Overall Study|Adverse Event|0|||
129808039|NCT00142298|467262666|FG007|Overall Study|Adverse Event|0|||
129808040|NCT00142298|467262667|FG008|Overall Study|Adverse Event|0|||
129808041|NCT00142298|467262668|FG009|Overall Study|Adverse Event|0|||
129808042|NCT00142298|467262659|FG000|Overall Study|Clinical disease progression|1|||
129808043|NCT00142298|467262660|FG001|Overall Study|Clinical disease progression|0|||
129808044|NCT00142298|467262661|FG002|Overall Study|Clinical disease progression|0|||
129808045|NCT00142298|467262662|FG003|Overall Study|Clinical disease progression|0|||
129808046|NCT00142298|467262663|FG004|Overall Study|Clinical disease progression|0|||
129808047|NCT00142298|467262664|FG005|Overall Study|Clinical disease progression|0|||
129808048|NCT00142298|467262665|FG006|Overall Study|Clinical disease progression|0|||
129808049|NCT00142298|467262666|FG007|Overall Study|Clinical disease progression|0|||
129808050|NCT00142298|467262667|FG008|Overall Study|Clinical disease progression|0|||
129808051|NCT00142298|467262668|FG009|Overall Study|Clinical disease progression|0|||
129808052|NCT00142298|467262659|FG000|Overall Study|Death|1|||
129808053|NCT00142298|467262660|FG001|Overall Study|Death|1|||
129808054|NCT00142298|467262661|FG002|Overall Study|Death|1|||
129808055|NCT00142298|467262662|FG003|Overall Study|Death|0|||
129808056|NCT00142298|467262663|FG004|Overall Study|Death|0|||
129895615|NCT02624778|467578497|FG008|Overall Study|Lost to Follow-up|0|||
129744180|NCT02516592|467022442|FG001|Overall Study|Lost to Follow-up|3|||
129744181|NCT02516592|467022441|FG000|Overall Study|Patient/guardian decision|2|||
129744182|NCT02516592|467022442|FG001|Overall Study|Patient/guardian decision|1|||
129744183|NCT02516592|467022441|FG000|Overall Study|Adverse Event|1|||
129744184|NCT02516592|467022442|FG001|Overall Study|Adverse Event|2|||
129744185|NCT02516592|467022441|FG000|Overall Study|Abnormal test procedure result|1|||
129744186|NCT02516592|467022442|FG001|Overall Study|Abnormal test procedure result|0|||
129744187|NCT02516592|467022441|FG000|Overall Study|Death|1|||
129744188|NCT02516592|467022442|FG001|Overall Study|Death|1|||
129744189|NCT02473367|467022443|FG000|Wait 1|Withdrawal by Subject|1|||
129744190|NCT02473367|467022443|FG000|Period 4|Lost to Follow-up|1|||
129744191|NCT00454584|467022445|FG000|Controlled Period|Adverse Event|5|||
129744192|NCT00454584|467022446|FG001|Controlled Period|Adverse Event|2|||
129744193|NCT00454584|467022447|FG002|Controlled Period|Adverse Event|1|||
129744194|NCT00454584|467022448|FG003|Controlled Period|Adverse Event|0|||
129744195|NCT00454584|467022449|FG004|Controlled Period|Adverse Event|0|||
129744196|NCT00454584|467022450|FG005|Controlled Period|Adverse Event|0|||
129744197|NCT00454584|467022445|FG000|Controlled Period|Lost to Follow-up|1|||
129744198|NCT00454584|467022446|FG001|Controlled Period|Lost to Follow-up|2|||
129744199|NCT00454584|467022447|FG002|Controlled Period|Lost to Follow-up|2|||
129744200|NCT00454584|467022448|FG003|Controlled Period|Lost to Follow-up|0|||
129744201|NCT00454584|467022449|FG004|Controlled Period|Lost to Follow-up|0|||
129744202|NCT00454584|467022450|FG005|Controlled Period|Lost to Follow-up|0|||
129744203|NCT00454584|467022445|FG000|Controlled Period|Other|5|||
129744204|NCT00454584|467022446|FG001|Controlled Period|Other|4|||
129744205|NCT00454584|467022447|FG002|Controlled Period|Other|2|||
129744206|NCT00454584|467022448|FG003|Controlled Period|Other|0|||
129744207|NCT00454584|467022449|FG004|Controlled Period|Other|0|||
129744208|NCT00454584|467022450|FG005|Controlled Period|Other|0|||
129744209|NCT00454584|467022445|FG000|After Controlled Period|Adverse Event|0|||
129744210|NCT00454584|467022446|FG001|After Controlled Period|Adverse Event|0|||
129744211|NCT00454584|467022447|FG002|After Controlled Period|Adverse Event|0|||
129744212|NCT00454584|467022448|FG003|After Controlled Period|Adverse Event|9|||
129744213|NCT00454584|467022449|FG004|After Controlled Period|Adverse Event|3|||
129744214|NCT00454584|467022450|FG005|After Controlled Period|Adverse Event|9|||
129744215|NCT00454584|467022445|FG000|After Controlled Period|Lack of Efficacy|0|||
129744216|NCT00454584|467022446|FG001|After Controlled Period|Lack of Efficacy|0|||
129744217|NCT00454584|467022447|FG002|After Controlled Period|Lack of Efficacy|0|||
129744218|NCT00454584|467022448|FG003|After Controlled Period|Lack of Efficacy|1|||
129744219|NCT00454584|467022449|FG004|After Controlled Period|Lack of Efficacy|0|||
129744220|NCT00454584|467022450|FG005|After Controlled Period|Lack of Efficacy|0|||
129744221|NCT00454584|467022445|FG000|After Controlled Period|Lost to Follow-up|0|||
129744222|NCT00454584|467022446|FG001|After Controlled Period|Lost to Follow-up|0|||
129744223|NCT00454584|467022447|FG002|After Controlled Period|Lost to Follow-up|0|||
129744224|NCT00454584|467022448|FG003|After Controlled Period|Lost to Follow-up|2|||
129744225|NCT00454584|467022449|FG004|After Controlled Period|Lost to Follow-up|4|||
129744226|NCT00454584|467022450|FG005|After Controlled Period|Lost to Follow-up|6|||
129744227|NCT00454584|467022445|FG000|After Controlled Period|Other|0|||
129744228|NCT00454584|467022446|FG001|After Controlled Period|Other|0|||
129744229|NCT00454584|467022447|FG002|After Controlled Period|Other|0|||
129744230|NCT00454584|467022448|FG003|After Controlled Period|Other|1|||
129744231|NCT00454584|467022449|FG004|After Controlled Period|Other|0|||
129895616|NCT02624778|467578489|FG000|Overall Study|Withdrawal by Subject|0|||
129895617|NCT02624778|467578490|FG001|Overall Study|Withdrawal by Subject|1|||
129744232|NCT00454584|467022450|FG005|After Controlled Period|Other|0|||
129744233|NCT00454584|467022445|FG000|After Controlled Period|Other|0|||
129744234|NCT00454584|467022446|FG001|After Controlled Period|Other|0|||
129744235|NCT00454584|467022447|FG002|After Controlled Period|Other|0|||
129744236|NCT00454584|467022448|FG003|After Controlled Period|Other|13|||
129744237|NCT00454584|467022449|FG004|After Controlled Period|Other|5|||
129744238|NCT00454584|467022450|FG005|After Controlled Period|Other|17|||
129744239|NCT00454181|467022452|FG000|Overall Study|Adverse Event|1|||
129744240|NCT00454181|467022453|FG001|Overall Study|Adverse Event|1|||
129744241|NCT00454181|467022452|FG000|Overall Study|Lost to Follow-up|11|||
129744242|NCT00454181|467022453|FG001|Overall Study|Lost to Follow-up|1|||
129744243|NCT00454181|467022452|FG000|Overall Study|Protocol Violation|1|||
129744244|NCT00454181|467022453|FG001|Overall Study|Protocol Violation|1|||
129744245|NCT00454181|467022452|FG000|Overall Study|Withdrawal by Subject|2|||
129744246|NCT00454181|467022453|FG001|Overall Study|Withdrawal by Subject|0|||
129744247|NCT03689855|467022465|FG000|Overall Study|Adverse Event|3|||
129744248|NCT03689855|467022465|FG000|Overall Study|Withdrawal by Subject|1|||
129744249|NCT02409719|467022466|FG000|Overall Study|Lost to Follow-up|3|||
129744250|NCT02409719|467022467|FG001|Overall Study|Lost to Follow-up|3|||
129744251|NCT00764673|467022468|FG000|Overall Study|Death|1|||
129744252|NCT00764673|467022468|FG000|Overall Study|Lost to Follow-up|3|||
129744253|NCT00764673|467022468|FG000|Overall Study|Withdrawal by Subject|6|||
129744254|NCT00764673|467022468|FG000|Overall Study|Revision of Device|2|||
129744255|NCT01438177|467022469|FG000|Overall Study|Withdrawal by Subject|1|||
129744256|NCT01438177|467022469|FG000|Overall Study|Initiation of new therapy|1|||
129744257|NCT01727336|467022472|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129744258|NCT01727336|467022473|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
129744259|NCT01727336|467022474|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
129744260|NCT01727336|467022475|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129744261|NCT01727336|467022476|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129744262|NCT01727336|467022477|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
129744263|NCT01727336|467022472|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
129744264|NCT01727336|467022473|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
129744265|NCT01727336|467022474|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
129744266|NCT01727336|467022475|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
129744267|NCT01727336|467022476|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
129744268|NCT01727336|467022477|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
129744269|NCT01727336|467022472|FG000|Part 2 Blinded|Death|0|||
129744270|NCT01727336|467022473|FG001|Part 2 Blinded|Death|0|||
129744271|NCT01727336|467022474|FG002|Part 2 Blinded|Death|0|||
129744272|NCT01727336|467022475|FG003|Part 2 Blinded|Death|0|||
129744273|NCT01727336|467022476|FG004|Part 2 Blinded|Death|20|||
129744274|NCT01727336|467022477|FG005|Part 2 Blinded|Death|16|||
129744275|NCT01727336|467022472|FG000|Part 2 Blinded|Lack of Efficacy|0|||
129744276|NCT01727336|467022473|FG001|Part 2 Blinded|Lack of Efficacy|0|||
129744277|NCT01727336|467022474|FG002|Part 2 Blinded|Lack of Efficacy|0|||
129744278|NCT01727336|467022475|FG003|Part 2 Blinded|Lack of Efficacy|0|||
129744279|NCT01727336|467022476|FG004|Part 2 Blinded|Lack of Efficacy|42|||
129744280|NCT01727336|467022477|FG005|Part 2 Blinded|Lack of Efficacy|44|||
129744281|NCT01727336|467022472|FG000|Part 2 Blinded|Lost to Follow-up|0|||
129744282|NCT01727336|467022473|FG001|Part 2 Blinded|Lost to Follow-up|0|||
129744283|NCT01727336|467022474|FG002|Part 2 Blinded|Lost to Follow-up|0|||
129744284|NCT01727336|467022475|FG003|Part 2 Blinded|Lost to Follow-up|0|||
129744285|NCT01727336|467022476|FG004|Part 2 Blinded|Lost to Follow-up|0|||
129744286|NCT01727336|467022477|FG005|Part 2 Blinded|Lost to Follow-up|1|||
129744287|NCT01727336|467022472|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
129744288|NCT01727336|467022473|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
129744289|NCT01727336|467022474|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
129744290|NCT01727336|467022475|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
129744291|NCT01727336|467022476|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
129744292|NCT01727336|467022477|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
129744293|NCT01727336|467022472|FG000|Part 2 Blinded|use of prohibited medications|0|||
129744294|NCT01727336|467022473|FG001|Part 2 Blinded|use of prohibited medications|0|||
129744295|NCT01727336|467022474|FG002|Part 2 Blinded|use of prohibited medications|0|||
129744296|NCT01727336|467022475|FG003|Part 2 Blinded|use of prohibited medications|0|||
129744297|NCT01727336|467022476|FG004|Part 2 Blinded|use of prohibited medications|1|||
129744298|NCT01727336|467022477|FG005|Part 2 Blinded|use of prohibited medications|3|||
129744299|NCT00619099|467022478|FG000|Overall Study|Progressive Disease|7|||
129744300|NCT00619099|467022479|FG001|Overall Study|Progressive Disease|5|||
129744301|NCT00619099|467022478|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
129744302|NCT00619099|467022479|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
129744303|NCT00619099|467022478|FG000|Overall Study|Adverse Event|4|||
129744304|NCT00619099|467022479|FG001|Overall Study|Adverse Event|3|||
129744305|NCT00619099|467022478|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
129744306|NCT00619099|467022479|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
129744307|NCT00619099|467022478|FG000|Overall Study|Withdrawal by Subject|10|||
129744308|NCT00619099|467022479|FG001|Overall Study|Withdrawal by Subject|2|||
129744309|NCT00619099|467022478|FG000|Overall Study|Physician Decision|9|||
129744310|NCT00619099|467022479|FG001|Overall Study|Physician Decision|6|||
129744311|NCT00129467|467022480|FG000|Received Intervention|Death|1|||
129744312|NCT00129467|467022481|FG001|Received Intervention|Death|1|||
129744313|NCT00129467|467022480|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
129744314|NCT00129467|467022481|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
129744315|NCT00129467|467022480|FG000|Received Intervention|Delirium|2|||
129744316|NCT00129467|467022481|FG001|Received Intervention|Delirium|0|||
129744317|NCT00129467|467022480|FG000|Received Intervention|Withdrawal by Subject|1|||
129808057|NCT00142298|467262664|FG005|Overall Study|Death|6|||
129808058|NCT00142298|467262665|FG006|Overall Study|Death|0|||
129744318|NCT00129467|467022481|FG001|Received Intervention|Withdrawal by Subject|0|||
129744319|NCT00129467|467022480|FG000|Received Intervention|Nausea|1|||
129744320|NCT00129467|467022481|FG001|Received Intervention|Nausea|0|||
129744321|NCT00129467|467022480|FG000|Received Intervention|Intolerance to citalopram|0|||
129744322|NCT00129467|467022481|FG001|Received Intervention|Intolerance to citalopram|1|||
129744323|NCT00129467|467022480|FG000|Received Intervention|Dizzyness, fatigue|0|||
129744324|NCT00129467|467022481|FG001|Received Intervention|Dizzyness, fatigue|1|||
129744325|NCT00129467|467022480|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
129744326|NCT00129467|467022481|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
129744327|NCT00129467|467022480|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
129808059|NCT00142298|467262666|FG007|Overall Study|Death|0|||
129744328|NCT00129467|467022481|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
129744329|NCT01424228|467022487|FG000|Overall Study|Withdrawal by Subject|27|||
129744330|NCT01424228|467022488|FG001|Overall Study|Withdrawal by Subject|11|||
129744331|NCT01424228|467022487|FG000|Overall Study|Adverse Event|10|||
129744332|NCT01424228|467022488|FG001|Overall Study|Adverse Event|14|||
129744333|NCT01424228|467022487|FG000|Overall Study|Sponsor's decision|9|||
129744334|NCT01424228|467022488|FG001|Overall Study|Sponsor's decision|12|||
129744335|NCT01424228|467022487|FG000|Overall Study|Lack of Efficacy|5|||
129744336|NCT01424228|467022488|FG001|Overall Study|Lack of Efficacy|7|||
129744337|NCT01424228|467022487|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
129744338|NCT01424228|467022488|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
129744339|NCT01424228|467022487|FG000|Overall Study|Non-compliance|2|||
129744340|NCT01424228|467022488|FG001|Overall Study|Non-compliance|0|||
129744341|NCT01424228|467022487|FG000|Overall Study|Worsening of symptoms|1|||
129744342|NCT01424228|467022488|FG001|Overall Study|Worsening of symptoms|0|||
129744343|NCT01424228|467022487|FG000|Overall Study|Unplanned journey|0|||
129895618|NCT02624778|467578491|FG002|Overall Study|Withdrawal by Subject|0|||
129895619|NCT02624778|467578492|FG003|Overall Study|Withdrawal by Subject|0|||
129744344|NCT01424228|467022488|FG001|Overall Study|Unplanned journey|1|||
129744345|NCT00671437|467022491|FG000|Overall Study|Progressive disease before C1 week 8|8|||
129744346|NCT00671437|467022491|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
129744347|NCT00671437|467022491|FG000|Overall Study|Adverse Event|3|||
129744348|NCT00671437|467022491|FG000|Overall Study|Ineligible post-hoc|1|||
129744349|NCT03927404|467022493|FG000|Overall Study|Withdrawal by Subject|1|||
129744350|NCT01229449|467022494|FG000|Overall Study|Withdrawal by Subject|0|||
129744351|NCT01229449|467022495|FG001|Overall Study|Withdrawal by Subject|3|||
129744352|NCT01229449|467022496|FG002|Overall Study|Withdrawal by Subject|0|||
129744353|NCT01229449|467022497|FG003|Overall Study|Withdrawal by Subject|1|||
129744354|NCT01229449|467022498|FG004|Overall Study|Withdrawal by Subject|1|||
129744355|NCT01229449|467022494|FG000|Overall Study|Lost to Follow-up|1|||
129744356|NCT01229449|467022495|FG001|Overall Study|Lost to Follow-up|1|||
129744357|NCT01229449|467022496|FG002|Overall Study|Lost to Follow-up|1|||
129744358|NCT01229449|467022497|FG003|Overall Study|Lost to Follow-up|0|||
129744359|NCT01229449|467022498|FG004|Overall Study|Lost to Follow-up|0|||
129744360|NCT01229449|467022494|FG000|Overall Study|Physician Decision|0|||
129744361|NCT01229449|467022495|FG001|Overall Study|Physician Decision|0|||
129744362|NCT01229449|467022496|FG002|Overall Study|Physician Decision|1|||
129744363|NCT01229449|467022497|FG003|Overall Study|Physician Decision|0|||
129744364|NCT01229449|467022498|FG004|Overall Study|Physician Decision|0|||
129744365|NCT00377364|467022499|FG000|Overall Study|Lost to Follow-up|1|||
129744366|NCT00377364|467022500|FG001|Overall Study|Lost to Follow-up|0|||
129744367|NCT00377364|467022499|FG000|Overall Study|Withdrawal by Subject|1|||
129744368|NCT00377364|467022500|FG001|Overall Study|Withdrawal by Subject|0|||
129744369|NCT03180307|467022504|FG000|Overall Study|Lost to Follow-up|2|||
129744370|NCT03180307|467022505|FG001|Overall Study|Lost to Follow-up|0|||
129744371|NCT03180307|467022504|FG000|Overall Study|Death|1|||
129744372|NCT03180307|467022505|FG001|Overall Study|Death|0|||
129744373|NCT03180307|467022504|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
129744374|NCT03180307|467022505|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
129744375|NCT02100475|467025001|FG000|Overall Study|Unclassified|1|||
129744376|NCT02100475|467025002|FG001|Overall Study|Unclassified|2|||
129744377|NCT02100475|467025001|FG000|Overall Study|Withdrawal criteria|1|||
129744378|NCT02100475|467025002|FG001|Overall Study|Withdrawal criteria|0|||
129744379|NCT00649428|467025003|FG000|Overall Study|Adverse Event|2|||
129744380|NCT00649428|467025004|FG001|Overall Study|Adverse Event|2|||
129744381|NCT00649428|467025003|FG000|Overall Study|Withdrawal by Subject|6|||
129744382|NCT00649428|467025004|FG001|Overall Study|Withdrawal by Subject|6|||
129744383|NCT00649428|467025003|FG000|Overall Study|Lost to Follow-up|1|||
129744384|NCT00649428|467025004|FG001|Overall Study|Lost to Follow-up|3|||
129744385|NCT00649428|467025003|FG000|Overall Study|Insufficient manufacturing yield|5|||
129744386|NCT00649428|467025004|FG001|Overall Study|Insufficient manufacturing yield|1|||
129744387|NCT00649428|467025003|FG000|Overall Study|Protocol Violation|6|||
129744388|NCT00649428|467025004|FG001|Overall Study|Protocol Violation|2|||
129744389|NCT00649428|467025003|FG000|Overall Study|Physician Decision|0|||
129744390|NCT00649428|467025004|FG001|Overall Study|Physician Decision|1|||
129744391|NCT00742417|467025005|FG000|Randomized|Withdrawal by legal representative|0|||
129744392|NCT00742417|467025006|FG001|Randomized|Withdrawal by legal representative|1|||
129744393|NCT00742417|467025005|FG000|Randomized|Withdrawal by Subject|1|||
129744394|NCT00742417|467025006|FG001|Randomized|Withdrawal by Subject|0|||
129895620|NCT02624778|467578493|FG004|Overall Study|Withdrawal by Subject|0|||
129744395|NCT00742417|467025005|FG000|Randomized|Physician Decision|1|||
129895621|NCT02624778|467578494|FG005|Overall Study|Withdrawal by Subject|1|||
129895622|NCT02624778|467578495|FG006|Overall Study|Withdrawal by Subject|1|||
129744396|NCT00742417|467025006|FG001|Randomized|Physician Decision|0|||
129744397|NCT00742417|467025005|FG000|Intensive Period|Withdrawal by Subject|1|||
129744398|NCT00742417|467025006|FG001|Intensive Period|Withdrawal by Subject|1|||
129744399|NCT00742417|467025005|FG000|Intensive Period|Adverse Event|2|||
129744400|NCT00742417|467025006|FG001|Intensive Period|Adverse Event|0|||
129744401|NCT04566601|467025007|FG000|Overall Study|Other than listed|13|||
129744402|NCT04566601|467025008|FG001|Overall Study|Other than listed|4|||
129744403|NCT04566601|467025009|FG002|Overall Study|Other than listed|2|||
129744404|NCT04566601|467025010|FG003|Overall Study|Other than listed|1|||
129744405|NCT04566601|467025011|FG004|Overall Study|Other than listed|4|||
129744406|NCT04566601|467025007|FG000|Overall Study|Protocol deviation|3|||
129744407|NCT04566601|467025008|FG001|Overall Study|Protocol deviation|0|||
129744408|NCT04566601|467025009|FG002|Overall Study|Protocol deviation|1|||
129744409|NCT04566601|467025010|FG003|Overall Study|Protocol deviation|1|||
129744410|NCT04566601|467025011|FG004|Overall Study|Protocol deviation|1|||
129744411|NCT04566601|467025007|FG000|Overall Study|Technical problems|0|||
129744412|NCT04566601|467025008|FG001|Overall Study|Technical problems|0|||
129744413|NCT04566601|467025009|FG002|Overall Study|Technical problems|1|||
129744414|NCT04566601|467025010|FG003|Overall Study|Technical problems|0|||
129744415|NCT04566601|467025011|FG004|Overall Study|Technical problems|0|||
129744416|NCT04566601|467025007|FG000|Overall Study|No reason available|3|||
129744417|NCT04566601|467025008|FG001|Overall Study|No reason available|2|||
129744418|NCT04566601|467025009|FG002|Overall Study|No reason available|7|||
129744419|NCT04566601|467025010|FG003|Overall Study|No reason available|1|||
129744420|NCT04566601|467025011|FG004|Overall Study|No reason available|5|||
129744421|NCT04566601|467025007|FG000|Overall Study|Burden of study procedures|3|||
129744422|NCT04566601|467025008|FG001|Overall Study|Burden of study procedures|0|||
129744423|NCT04566601|467025009|FG002|Overall Study|Burden of study procedures|0|||
129744424|NCT04566601|467025010|FG003|Overall Study|Burden of study procedures|3|||
129744425|NCT04566601|467025011|FG004|Overall Study|Burden of study procedures|1|||
129744426|NCT04566601|467025007|FG000|Overall Study|Change of residence|2|||
129744427|NCT04566601|467025008|FG001|Overall Study|Change of residence|2|||
129744428|NCT04566601|467025009|FG002|Overall Study|Change of residence|0|||
129744429|NCT04566601|467025010|FG003|Overall Study|Change of residence|1|||
129744430|NCT04566601|467025011|FG004|Overall Study|Change of residence|2|||
129744431|NCT04566601|467025007|FG000|Overall Study|Perceived lack of efficacy|2|||
129744432|NCT04566601|467025008|FG001|Overall Study|Perceived lack of efficacy|0|||
129744433|NCT04566601|467025009|FG002|Overall Study|Perceived lack of efficacy|1|||
129744434|NCT04566601|467025010|FG003|Overall Study|Perceived lack of efficacy|1|||
129744435|NCT04566601|467025011|FG004|Overall Study|Perceived lack of efficacy|2|||
129744436|NCT04566601|467025007|FG000|Overall Study|Adverse Event|7|||
129744437|NCT04566601|467025008|FG001|Overall Study|Adverse Event|4|||
129744438|NCT04566601|467025009|FG002|Overall Study|Adverse Event|6|||
129744439|NCT04566601|467025010|FG003|Overall Study|Adverse Event|5|||
129744440|NCT04566601|467025011|FG004|Overall Study|Adverse Event|12|||
129744441|NCT01363661|467025013|FG000|Overall Study|Adverse Event|9|||
129744442|NCT01363661|467025014|FG001|Overall Study|Adverse Event|2|||
129744443|NCT01363661|467025013|FG000|Overall Study|Withdrawal by Subject|1|||
129744444|NCT01363661|467025014|FG001|Overall Study|Withdrawal by Subject|1|||
129744445|NCT01363661|467025013|FG000|Overall Study|Protocol Violation|1|||
129744446|NCT01363661|467025014|FG001|Overall Study|Protocol Violation|0|||
129744447|NCT01363661|467025013|FG000|Overall Study|Lost to Follow-up|3|||
129744448|NCT01363661|467025014|FG001|Overall Study|Lost to Follow-up|1|||
129744449|NCT03775512|467025015|FG000|Overall Study|Death|1|||
129744450|NCT03775512|467025016|FG001|Overall Study|Death|1|||
129744451|NCT03775512|467025015|FG000|Overall Study|Withdrawal by Subject|7|||
129808060|NCT00142298|467262667|FG008|Overall Study|Death|0|||
129808061|NCT00142298|467262668|FG009|Overall Study|Death|0|||
129808062|NCT00142298|467262659|FG000|Overall Study|Lack of Efficacy|44|||
129808063|NCT00142298|467262660|FG001|Overall Study|Lack of Efficacy|62|||
129808064|NCT00142298|467262661|FG002|Overall Study|Lack of Efficacy|9|||
129808065|NCT00142298|467262662|FG003|Overall Study|Lack of Efficacy|12|||
129808066|NCT00142298|467262663|FG004|Overall Study|Lack of Efficacy|1|||
129808067|NCT00142298|467262664|FG005|Overall Study|Lack of Efficacy|0|||
129808068|NCT00142298|467262665|FG006|Overall Study|Lack of Efficacy|0|||
129808069|NCT00142298|467262666|FG007|Overall Study|Lack of Efficacy|1|||
129808070|NCT00142298|467262667|FG008|Overall Study|Lack of Efficacy|0|||
129808071|NCT00142298|467262668|FG009|Overall Study|Lack of Efficacy|0|||
129808072|NCT00142298|467262659|FG000|Overall Study|Non-compliance|15|||
129808073|NCT00142298|467262660|FG001|Overall Study|Non-compliance|13|||
129808074|NCT00142298|467262661|FG002|Overall Study|Non-compliance|0|||
129808075|NCT00142298|467262662|FG003|Overall Study|Non-compliance|6|||
129744452|NCT03775512|467025016|FG001|Overall Study|Withdrawal by Subject|4|||
129808076|NCT00142298|467262663|FG004|Overall Study|Non-compliance|1|||
129808077|NCT00142298|467262664|FG005|Overall Study|Non-compliance|0|||
129808078|NCT00142298|467262665|FG006|Overall Study|Non-compliance|0|||
129744453|NCT03775512|467025015|FG000|Overall Study|Lost to Follow-up|5|||
129744454|NCT03775512|467025016|FG001|Overall Study|Lost to Follow-up|5|||
129744455|NCT03775512|467025015|FG000|Overall Study|Excluded before Catheter insertion|14|||
129744456|NCT03775512|467025016|FG001|Overall Study|Excluded before Catheter insertion|5|||
129744457|NCT03775512|467025015|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
129744458|NCT03775512|467025016|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
129808079|NCT00142298|467262666|FG007|Overall Study|Non-compliance|3|||
129744459|NCT03775512|467025015|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
129744460|NCT03775512|467025016|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
129744461|NCT01378325|467025019|FG000|Overall Study|Protocol Violation|0|||
129744462|NCT01378325|467025020|FG001|Overall Study|Protocol Violation|1|||
129744463|NCT00767806|467025021|FG000|Overall Study|Adverse Event|30|||
129744464|NCT00767806|467025022|FG001|Overall Study|Adverse Event|11|||
129744465|NCT00767806|467025021|FG000|Overall Study|Withdrawal by Subject|8|||
129744466|NCT00767806|467025022|FG001|Overall Study|Withdrawal by Subject|13|||
129744467|NCT00767806|467025021|FG000|Overall Study|Protocol Violation|6|||
129744468|NCT00767806|467025022|FG001|Overall Study|Protocol Violation|5|||
129744469|NCT00767806|467025021|FG000|Overall Study|Lack of Efficacy|1|||
129744470|NCT00767806|467025022|FG001|Overall Study|Lack of Efficacy|9|||
129744471|NCT00767806|467025021|FG000|Overall Study|Physician Decision|4|||
129744472|NCT00767806|467025022|FG001|Overall Study|Physician Decision|3|||
129808080|NCT00142298|467262667|FG008|Overall Study|Non-compliance|3|||
129808081|NCT00142298|467262668|FG009|Overall Study|Non-compliance|0|||
129808082|NCT00142298|467262659|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
129808083|NCT00142298|467262660|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
129895623|NCT02624778|467578496|FG007|Overall Study|Withdrawal by Subject|1|||
129895624|NCT02624778|467578497|FG008|Overall Study|Withdrawal by Subject|1|||
129895625|NCT02624778|467578489|FG000|Overall Study|Adverse Event|0|||
129895626|NCT02624778|467578490|FG001|Overall Study|Adverse Event|0|||
129895627|NCT02624778|467578491|FG002|Overall Study|Adverse Event|0|||
129895628|NCT02624778|467578492|FG003|Overall Study|Adverse Event|0|||
129895629|NCT02624778|467578493|FG004|Overall Study|Adverse Event|0|||
129895630|NCT02624778|467578494|FG005|Overall Study|Adverse Event|0|||
129895631|NCT02624778|467578495|FG006|Overall Study|Adverse Event|0|||
129895632|NCT02624778|467578496|FG007|Overall Study|Adverse Event|0|||
129895633|NCT02624778|467578497|FG008|Overall Study|Adverse Event|2|||
129895634|NCT02624778|467578489|FG000|Overall Study|Death|0|||
129895635|NCT02624778|467578490|FG001|Overall Study|Death|0|||
129895636|NCT02624778|467578491|FG002|Overall Study|Death|0|||
129895637|NCT02624778|467578492|FG003|Overall Study|Death|0|||
129895638|NCT02624778|467578493|FG004|Overall Study|Death|0|||
129895639|NCT02624778|467578494|FG005|Overall Study|Death|0|||
129895640|NCT02624778|467578495|FG006|Overall Study|Death|1|||
129895641|NCT02624778|467578496|FG007|Overall Study|Death|0|||
129895642|NCT02624778|467578497|FG008|Overall Study|Death|0|||
129895643|NCT02624778|467578489|FG000|Overall Study|Physician Decision|0|||
129895644|NCT02624778|467578490|FG001|Overall Study|Physician Decision|0|||
129895645|NCT02624778|467578491|FG002|Overall Study|Physician Decision|0|||
129895646|NCT02624778|467578492|FG003|Overall Study|Physician Decision|0|||
129895647|NCT02624778|467578493|FG004|Overall Study|Physician Decision|0|||
129895648|NCT02624778|467578494|FG005|Overall Study|Physician Decision|0|||
129895649|NCT02624778|467578495|FG006|Overall Study|Physician Decision|0|||
129895650|NCT02624778|467578496|FG007|Overall Study|Physician Decision|3|||
129895651|NCT02624778|467578497|FG008|Overall Study|Physician Decision|3|||
129895652|NCT01537133|467578505|FG000|Overall Study|Withdrawal by Subject|2|||
129895653|NCT01537133|467578506|FG001|Overall Study|Withdrawal by Subject|0|||
129895654|NCT01537133|467578507|FG002|Overall Study|Withdrawal by Subject|0|||
129895655|NCT01537133|467578508|FG003|Overall Study|Withdrawal by Subject|0|||
129895656|NCT01537133|467578505|FG000|Overall Study|Lost to Follow-up|1|||
129895657|NCT01537133|467578506|FG001|Overall Study|Lost to Follow-up|0|||
129895658|NCT01537133|467578507|FG002|Overall Study|Lost to Follow-up|0|||
129895659|NCT01537133|467578508|FG003|Overall Study|Lost to Follow-up|0|||
129895660|NCT00531479|467578509|FG000|Overall Study|Death|68|||
129808084|NCT00142298|467262661|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
129808085|NCT00142298|467262662|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
129808086|NCT00142298|467262663|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
129808087|NCT00142298|467262664|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
129808088|NCT00142298|467262665|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
129808089|NCT00142298|467262666|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
129808090|NCT00142298|467262667|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
129895661|NCT00531479|467578510|FG001|Overall Study|Death|71|||
129895662|NCT00531479|467578509|FG000|Overall Study|Lost to Follow-up|0|||
129744473|NCT00767806|467025021|FG000|Overall Study|Lost to Follow-up|1|||
129895663|NCT00531479|467578510|FG001|Overall Study|Lost to Follow-up|2|||
129895664|NCT00531479|467578509|FG000|Overall Study|Other|0|||
129895665|NCT00531479|467578510|FG001|Overall Study|Other|1|||
129895666|NCT00531479|467578509|FG000|Overall Study|Withdrawal by Subject|6|||
129895667|NCT00531479|467578510|FG001|Overall Study|Withdrawal by Subject|6|||
129744474|NCT00767806|467025022|FG001|Overall Study|Lost to Follow-up|4|||
129744475|NCT00767806|467025021|FG000|Overall Study|Entry Criteria Not Met|1|||
129895668|NCT00531479|467578509|FG000|Overall Study|Did not receive treatment|2|||
129895669|NCT00531479|467578510|FG001|Overall Study|Did not receive treatment|3|||
129895670|NCT02501629|467578518|FG000|Overall Study|Death|0|||
129895671|NCT02501629|467578519|FG001|Overall Study|Death|1|||
129895672|NCT02501629|467578518|FG000|Overall Study|Withdrawn from study by sponsor|1|||
129979657|NCT00403767|467889418|FG001|Overall Study|Protocol Violation|124|||
129744476|NCT00767806|467025022|FG001|Overall Study|Entry Criteria Not Met|1|||
129744477|NCT00767806|467025021|FG000|Overall Study|Sponsor Decision|0|||
129744478|NCT00767806|467025022|FG001|Overall Study|Sponsor Decision|1|||
129744479|NCT01272635|467025023|FG000|Overall Study|Lost to Follow-up|31|||
129744480|NCT01272635|467025024|FG001|Overall Study|Lost to Follow-up|20|||
129744481|NCT01272635|467025025|FG002|Overall Study|Lost to Follow-up|31|||
129744482|NCT01272635|467025026|FG003|Overall Study|Lost to Follow-up|23|||
129744483|NCT02397057|467025029|FG000|Overall Study|Withdrawal by Subject|6|||
129744484|NCT02397057|467025030|FG001|Overall Study|Withdrawal by Subject|7|||
129744485|NCT02397057|467025029|FG000|Overall Study|Lost to Follow-up|4|||
129744486|NCT02397057|467025030|FG001|Overall Study|Lost to Follow-up|3|||
129744487|NCT02397057|467025029|FG000|Overall Study|Death|1|||
129744488|NCT02397057|467025030|FG001|Overall Study|Death|0|||
129744489|NCT02397057|467025029|FG000|Overall Study|Adverse Event|0|||
129744490|NCT02397057|467025030|FG001|Overall Study|Adverse Event|1|||
129744491|NCT02397057|467025029|FG000|Overall Study|Physician Decision|0|||
129744492|NCT02397057|467025030|FG001|Overall Study|Physician Decision|1|||
129744493|NCT02397057|467025029|FG000|Overall Study|Subject did not receive study drug|0|||
129744494|NCT02397057|467025030|FG001|Overall Study|Subject did not receive study drug|1|||
129744495|NCT01393639|467025031|FG000|Overall Study|Protocol Violation|0|||
129744496|NCT01393639|467025032|FG001|Overall Study|Protocol Violation|0|||
129744497|NCT01393639|467025033|FG002|Overall Study|Protocol Violation|0|||
129744498|NCT01393639|467025034|FG003|Overall Study|Protocol Violation|1|||
129744499|NCT01393639|467025035|FG004|Overall Study|Protocol Violation|0|||
129744500|NCT01393639|467025036|FG005|Overall Study|Protocol Violation|0|||
129744501|NCT01393639|467025037|FG006|Overall Study|Protocol Violation|0|||
129744502|NCT01393639|467025031|FG000|Overall Study|Other|0|||
129744503|NCT01393639|467025032|FG001|Overall Study|Other|2|||
129744504|NCT01393639|467025033|FG002|Overall Study|Other|0|||
129744505|NCT01393639|467025034|FG003|Overall Study|Other|2|||
129744506|NCT01393639|467025035|FG004|Overall Study|Other|1|||
129744507|NCT01393639|467025036|FG005|Overall Study|Other|0|||
129744508|NCT01393639|467025037|FG006|Overall Study|Other|1|||
129744509|NCT01393639|467025031|FG000|Overall Study|Withdrawal by Subject|1|||
129895673|NCT02501629|467578519|FG001|Overall Study|Withdrawn from study by sponsor|0|||
129895674|NCT02501629|467578518|FG000|Overall Study|Early termination by sponsor|1|||
129895675|NCT02501629|467578519|FG001|Overall Study|Early termination by sponsor|0|||
129895676|NCT02501629|467578518|FG000|Overall Study|Withdrawal by Subject|3|||
129895677|NCT02501629|467578519|FG001|Overall Study|Withdrawal by Subject|5|||
129895678|NCT02501629|467578518|FG000|Overall Study|Subject did not return to site|0|||
129895679|NCT02501629|467578519|FG001|Overall Study|Subject did not return to site|1|||
129895680|NCT00868231|467578522|FG000|Treatment Period 1|Adverse Event|0|||
129895681|NCT00868231|467578523|FG001|Treatment Period 1|Adverse Event|0|||
129895682|NCT00868231|467578524|FG002|Treatment Period 1|Adverse Event|0|||
129445393|NCT03828292|465931284|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
129808091|NCT00142298|467262668|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
129808092|NCT00142298|467262659|FG000|Overall Study|Pregnancy|4|||
129808093|NCT00142298|467262660|FG001|Overall Study|Pregnancy|4|||
129808094|NCT00142298|467262661|FG002|Overall Study|Pregnancy|2|||
129808095|NCT00142298|467262662|FG003|Overall Study|Pregnancy|3|||
129808096|NCT00142298|467262663|FG004|Overall Study|Pregnancy|0|||
129808097|NCT00142298|467262664|FG005|Overall Study|Pregnancy|0|||
129808098|NCT00142298|467262665|FG006|Overall Study|Pregnancy|0|||
129808099|NCT00142298|467262666|FG007|Overall Study|Pregnancy|0|||
129808100|NCT00142298|467262667|FG008|Overall Study|Pregnancy|1|||
129808101|NCT00142298|467262668|FG009|Overall Study|Pregnancy|0|||
129808102|NCT00142298|467262659|FG000|Overall Study|Virologic breakthrough|19|||
129808103|NCT00142298|467262660|FG001|Overall Study|Virologic breakthrough|23|||
129808104|NCT00142298|467262661|FG002|Overall Study|Virologic breakthrough|9|||
129808105|NCT00142298|467262662|FG003|Overall Study|Virologic breakthrough|7|||
129808106|NCT00142298|467262663|FG004|Overall Study|Virologic breakthrough|2|||
129744510|NCT01393639|467025032|FG001|Overall Study|Withdrawal by Subject|1|||
129744511|NCT01393639|467025033|FG002|Overall Study|Withdrawal by Subject|0|||
129744512|NCT01393639|467025034|FG003|Overall Study|Withdrawal by Subject|0|||
129744513|NCT01393639|467025035|FG004|Overall Study|Withdrawal by Subject|0|||
129744514|NCT01393639|467025036|FG005|Overall Study|Withdrawal by Subject|0|||
129744515|NCT01393639|467025037|FG006|Overall Study|Withdrawal by Subject|1|||
129744516|NCT01393639|467025031|FG000|Overall Study|Medication error without associated AE|0|||
129744517|NCT01393639|467025032|FG001|Overall Study|Medication error without associated AE|0|||
129744518|NCT01393639|467025033|FG002|Overall Study|Medication error without associated AE|0|||
129808107|NCT00142298|467262664|FG005|Overall Study|Virologic breakthrough|3|||
129808108|NCT00142298|467262665|FG006|Overall Study|Virologic breakthrough|3|||
129808109|NCT00142298|467262666|FG007|Overall Study|Virologic breakthrough|0|||
129808110|NCT00142298|467262667|FG008|Overall Study|Virologic breakthrough|0|||
129744519|NCT01393639|467025034|FG003|Overall Study|Medication error without associated AE|0|||
129808111|NCT00142298|467262668|FG009|Overall Study|Virologic breakthrough|0|||
129895683|NCT00868231|467578525|FG003|Treatment Period 1|Adverse Event|0|||
129895684|NCT00868231|467578526|FG004|Treatment Period 1|Adverse Event|1|||
129895685|NCT00868231|467578527|FG005|Treatment Period 1|Adverse Event|0|||
129895686|NCT00868231|467578522|FG000|Treatment Period 2|Adverse Event|1|||
129895687|NCT00868231|467578523|FG001|Treatment Period 2|Adverse Event|0|||
129895688|NCT00868231|467578524|FG002|Treatment Period 2|Adverse Event|0|||
129895689|NCT00868231|467578525|FG003|Treatment Period 2|Adverse Event|0|||
129895690|NCT00868231|467578526|FG004|Treatment Period 2|Adverse Event|0|||
129895691|NCT00868231|467578527|FG005|Treatment Period 2|Adverse Event|0|||
129744520|NCT01393639|467025035|FG004|Overall Study|Medication error without associated AE|0|||
129744521|NCT01393639|467025036|FG005|Overall Study|Medication error without associated AE|0|||
129744522|NCT01393639|467025037|FG006|Overall Study|Medication error without associated AE|1|||
129744523|NCT01393639|467025031|FG000|Overall Study|Lost to Follow-up|0|||
129744524|NCT01393639|467025032|FG001|Overall Study|Lost to Follow-up|1|||
129744525|NCT01393639|467025033|FG002|Overall Study|Lost to Follow-up|0|||
129744526|NCT01393639|467025034|FG003|Overall Study|Lost to Follow-up|0|||
129744527|NCT01393639|467025035|FG004|Overall Study|Lost to Follow-up|0|||
129744528|NCT01393639|467025036|FG005|Overall Study|Lost to Follow-up|0|||
129744529|NCT01393639|467025037|FG006|Overall Study|Lost to Follow-up|1|||
129744530|NCT01393639|467025031|FG000|Overall Study|Lack of Efficacy|0|||
129744531|NCT01393639|467025032|FG001|Overall Study|Lack of Efficacy|0|||
129744532|NCT01393639|467025033|FG002|Overall Study|Lack of Efficacy|0|||
129744533|NCT01393639|467025034|FG003|Overall Study|Lack of Efficacy|0|||
129744534|NCT01393639|467025035|FG004|Overall Study|Lack of Efficacy|0|||
129744535|NCT01393639|467025036|FG005|Overall Study|Lack of Efficacy|0|||
129744536|NCT01393639|467025037|FG006|Overall Study|Lack of Efficacy|1|||
129744537|NCT01393639|467025031|FG000|Overall Study|Adverse Event|2|||
129744538|NCT01393639|467025032|FG001|Overall Study|Adverse Event|3|||
129744539|NCT01393639|467025033|FG002|Overall Study|Adverse Event|1|||
129744540|NCT01393639|467025034|FG003|Overall Study|Adverse Event|2|||
129744541|NCT01393639|467025035|FG004|Overall Study|Adverse Event|0|||
129744542|NCT01393639|467025036|FG005|Overall Study|Adverse Event|2|||
129744543|NCT01393639|467025037|FG006|Overall Study|Adverse Event|3|||
129744544|NCT02241343|467025040|FG000|Overall Study|Adverse Event|1|||
129744545|NCT01329939|467025043|FG000|Overall Study|Lost to Follow-up|3|||
129744546|NCT01329939|467025044|FG001|Overall Study|Lost to Follow-up|0|||
129744547|NCT01329939|467025045|FG002|Overall Study|Lost to Follow-up|1|||
129744548|NCT01329939|467025046|FG003|Overall Study|Lost to Follow-up|2|||
129744549|NCT01329939|467025043|FG000|Overall Study|Withdrawal by Subject|0|||
129744550|NCT01329939|467025044|FG001|Overall Study|Withdrawal by Subject|1|||
129744551|NCT01329939|467025045|FG002|Overall Study|Withdrawal by Subject|0|||
129744552|NCT01329939|467025046|FG003|Overall Study|Withdrawal by Subject|0|||
129744553|NCT01329939|467025043|FG000|Overall Study|Adverse Event|0|||
129744554|NCT01329939|467025044|FG001|Overall Study|Adverse Event|0|||
129744555|NCT01329939|467025045|FG002|Overall Study|Adverse Event|0|||
129744556|NCT01329939|467025046|FG003|Overall Study|Adverse Event|3|||
129744557|NCT03722524|467025047|FG000|Overall Study|Protocol Violation|86|||
129744558|NCT03722524|467025047|FG000|Overall Study|Adverse Event|7|||
129744559|NCT03722524|467025047|FG000|Overall Study|Lost to Follow-up|1|||
129744560|NCT03722524|467025047|FG000|Overall Study|Reason is not stated|1|||
129744561|NCT03722524|467025047|FG000|Overall Study|Physician Decision|1|||
129744562|NCT03722524|467025047|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
129744563|NCT02942485|467025048|FG000|Overall Study|Lost to Follow-up|1|||
129744564|NCT02942485|467025049|FG001|Overall Study|Lost to Follow-up|0|||
129744565|NCT04369950|467025051|FG000|Overall Study|Protocol Violation|2|||
129744566|NCT04369950|467025052|FG001|Overall Study|Protocol Violation|2|||
129744567|NCT00989963|467025053|FG000|Overall Study|Adverse Event|1|||
129744568|NCT00989963|467025054|FG001|Overall Study|Adverse Event|1|||
129744569|NCT00989963|467025055|FG002|Overall Study|Adverse Event|1|||
129744570|NCT01240200|467025056|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
129744571|NCT01240200|467025057|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
129744572|NCT00646399|467025060|FG000|Overall Study|Death|63|||
129744573|NCT00646399|467025061|FG001|Overall Study|Death|53|||
129744574|NCT00646399|467025060|FG000|Overall Study|Withdrawal by Subject|9|||
129744575|NCT00646399|467025061|FG001|Overall Study|Withdrawal by Subject|10|||
129744576|NCT00646399|467025060|FG000|Overall Study|Other Reason|11|||
129744577|NCT00646399|467025061|FG001|Overall Study|Other Reason|11|||
129744578|NCT00455143|467025065|FG000|Overall Study|Physician Decision|1|||
129744579|NCT00455143|467025065|FG000|Overall Study|Withdrawal by Subject|1|||
129744580|NCT00455143|467025065|FG000|Overall Study|Staff was not avail to follow patient|2|||
129744581|NCT00455143|467025065|FG000|Overall Study|No longer met Inclusion Criteria|1|||
129744582|NCT00455143|467025065|FG000|Overall Study|Surgical time, staff not available|1|||
129744583|NCT00470418|467025066|FG000|Overall Study|Withdrawal by Subject|1|||
129744584|NCT00470418|467025067|FG001|Overall Study|Withdrawal by Subject|0|||
129744585|NCT02479139|467025068|FG000|Overall Study|Lost to Follow-up|2|||
129744586|NCT02479139|467025069|FG001|Overall Study|Lost to Follow-up|4|||
129744587|NCT02479139|467025070|FG002|Overall Study|Lost to Follow-up|4|||
129744588|NCT02479139|467025071|FG003|Overall Study|Lost to Follow-up|2|||
129895692|NCT00868231|467578522|FG000|Treatment Period 3|Adverse Event|0|||
129895693|NCT00868231|467578523|FG001|Treatment Period 3|Adverse Event|0|||
129744589|NCT02479139|467025072|FG004|Overall Study|Lost to Follow-up|3|||
129744590|NCT02479139|467025073|FG005|Overall Study|Lost to Follow-up|5|||
129744591|NCT02479139|467025068|FG000|Overall Study|Withdrew Consent|5|||
129744592|NCT02479139|467025069|FG001|Overall Study|Withdrew Consent|6|||
129744593|NCT02479139|467025070|FG002|Overall Study|Withdrew Consent|1|||
129744594|NCT02479139|467025071|FG003|Overall Study|Withdrew Consent|4|||
129744595|NCT02479139|467025072|FG004|Overall Study|Withdrew Consent|1|||
129744596|NCT02479139|467025073|FG005|Overall Study|Withdrew Consent|1|||
129744597|NCT02479139|467025068|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129744598|NCT02479139|467025069|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129744599|NCT02479139|467025070|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
129744600|NCT02479139|467025071|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129744601|NCT02479139|467025072|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129744602|NCT02479139|467025073|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
129744603|NCT02479139|467025068|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129744604|NCT02479139|467025069|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129808112|NCT00142298|467262659|FG000|Overall Study|Other- not specified|0|||
129808113|NCT00142298|467262660|FG001|Overall Study|Other- not specified|3|||
129808114|NCT00142298|467262661|FG002|Overall Study|Other- not specified|0|||
129808115|NCT00142298|467262662|FG003|Overall Study|Other- not specified|1|||
129895694|NCT00868231|467578524|FG002|Treatment Period 3|Adverse Event|1|||
129895695|NCT00868231|467578525|FG003|Treatment Period 3|Adverse Event|0|||
129895696|NCT00868231|467578526|FG004|Treatment Period 3|Adverse Event|0|||
129895697|NCT00868231|467578527|FG005|Treatment Period 3|Adverse Event|0|||
129895698|NCT01124162|467578532|FG000|First Intervention|Adverse Event|2|||
129895699|NCT01124162|467578533|FG001|First Intervention|Adverse Event|0|||
129744605|NCT02479139|467025070|FG002|Overall Study|Other Miscellaneous Reasons|1|||
129895700|NCT01124162|467578532|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
129895701|NCT01124162|467578533|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129895702|NCT02680756|467578536|FG000|Overall Study|Adverse Event|10|||
129895703|NCT02680756|467578537|FG001|Overall Study|Adverse Event|2|||
129895704|NCT02680756|467578536|FG000|Overall Study|Lost to Follow-up|7|||
129744606|NCT02479139|467025071|FG003|Overall Study|Other Miscellaneous Reasons|1|||
129744607|NCT02479139|467025072|FG004|Overall Study|Other Miscellaneous Reasons|1|||
129808116|NCT00142298|467262663|FG004|Overall Study|Other- not specified|0|||
129808117|NCT00142298|467262664|FG005|Overall Study|Other- not specified|0|||
129808118|NCT00142298|467262665|FG006|Overall Study|Other- not specified|0|||
129808119|NCT00142298|467262666|FG007|Overall Study|Other- not specified|0|||
129808120|NCT00142298|467262667|FG008|Overall Study|Other- not specified|0|||
129808121|NCT00142298|467262668|FG009|Overall Study|Other- not specified|0|||
129808122|NCT00142298|467262659|FG000|Overall Study|Lost to Follow-up|0|||
129808123|NCT00142298|467262660|FG001|Overall Study|Lost to Follow-up|0|||
129808124|NCT00142298|467262661|FG002|Overall Study|Lost to Follow-up|0|||
129808125|NCT00142298|467262662|FG003|Overall Study|Lost to Follow-up|0|||
129808126|NCT00142298|467262663|FG004|Overall Study|Lost to Follow-up|0|||
129808127|NCT00142298|467262664|FG005|Overall Study|Lost to Follow-up|0|||
129808128|NCT00142298|467262665|FG006|Overall Study|Lost to Follow-up|2|||
129808129|NCT00142298|467262666|FG007|Overall Study|Lost to Follow-up|0|||
129808130|NCT00142298|467262667|FG008|Overall Study|Lost to Follow-up|0|||
129808131|NCT00142298|467262668|FG009|Overall Study|Lost to Follow-up|0|||
129808132|NCT00142298|467262659|FG000|Overall Study|Treatment Failure|0|||
129808133|NCT00142298|467262660|FG001|Overall Study|Treatment Failure|0|||
129808134|NCT00142298|467262661|FG002|Overall Study|Treatment Failure|0|||
129808135|NCT00142298|467262662|FG003|Overall Study|Treatment Failure|0|||
129744608|NCT02479139|467025073|FG005|Overall Study|Other Miscellaneous Reasons|0|||
129744609|NCT00885482|467025074|FG000|Overall Study|Pregnancy|1|||
129744610|NCT00885482|467025074|FG000|Overall Study|Lack of Efficacy|1|||
129895705|NCT02680756|467578537|FG001|Overall Study|Lost to Follow-up|6|||
129895706|NCT02680756|467578536|FG000|Overall Study|Withdrawal by Subject|5|||
129744611|NCT00885482|467025074|FG000|Overall Study|Death|1|||
129744612|NCT00885482|467025074|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
129744613|NCT00084656|467025075|FG000|Overall Study|Other reasons|0|||
129744614|NCT00084656|467025076|FG001|Overall Study|Other reasons|12|||
129808136|NCT00142298|467262663|FG004|Overall Study|Treatment Failure|0|||
129808137|NCT00142298|467262664|FG005|Overall Study|Treatment Failure|2|||
129808138|NCT00142298|467262665|FG006|Overall Study|Treatment Failure|2|||
129808139|NCT00142298|467262666|FG007|Overall Study|Treatment Failure|0|||
129808140|NCT00142298|467262667|FG008|Overall Study|Treatment Failure|0|||
129895707|NCT02680756|467578537|FG001|Overall Study|Withdrawal by Subject|5|||
129895708|NCT02680756|467578536|FG000|Overall Study|Physician Decision|4|||
129744615|NCT00084656|467025077|FG002|Overall Study|Other reasons|11|||
129744616|NCT00084656|467025075|FG000|Overall Study|Withdrawal by Subject|15|||
129744617|NCT00084656|467025076|FG001|Overall Study|Withdrawal by Subject|4|||
129744618|NCT00084656|467025077|FG002|Overall Study|Withdrawal by Subject|4|||
129744619|NCT00084656|467025075|FG000|Overall Study|Disease relapse|0|||
129744620|NCT00084656|467025076|FG001|Overall Study|Disease relapse|9|||
129744621|NCT00084656|467025077|FG002|Overall Study|Disease relapse|10|||
129744622|NCT00084656|467025075|FG000|Overall Study|Disease progression|9|||
129744623|NCT00084656|467025076|FG001|Overall Study|Disease progression|0|||
129744624|NCT00084656|467025077|FG002|Overall Study|Disease progression|0|||
129744625|NCT00084656|467025075|FG000|Overall Study|Lost to Follow-up|1|||
129744626|NCT00084656|467025076|FG001|Overall Study|Lost to Follow-up|0|||
129744627|NCT00084656|467025077|FG002|Overall Study|Lost to Follow-up|1|||
129744628|NCT02772978|467025078|FG000|Overall Study|Withdrawal by Subject|1|||
129744629|NCT02772978|467025079|FG001|Overall Study|Withdrawal by Subject|1|||
129744630|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
129744631|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
129744632|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
129744633|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
129744634|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
129744635|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
129744636|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
129744637|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
129744638|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
129744639|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
129744640|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
129744641|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
129744642|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
129744643|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
129744644|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
129744645|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
129744646|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
129744647|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
129744648|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
129744649|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
129744650|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
129744651|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
129744652|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
129744653|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
129744654|NCT01532869|467025080|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
129744655|NCT01532869|467025081|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
129744656|NCT01532869|467025080|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
129744657|NCT01532869|467025081|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
129744658|NCT01532869|467025080|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
129744659|NCT01532869|467025081|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
129744660|NCT01532869|467025080|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
129744661|NCT01532869|467025081|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
129744662|NCT01532869|467025080|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
129744663|NCT01532869|467025081|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
129744664|NCT01331291|467025082|FG000|Overall Study|Lack of Efficacy|2|||
129744665|NCT01331291|467025083|FG001|Overall Study|Lack of Efficacy|8|||
129744666|NCT01331291|467025082|FG000|Overall Study|Death|0|||
129744667|NCT01331291|467025083|FG001|Overall Study|Death|1|||
129744668|NCT00778895|467025084|FG000|Active Phase|Adverse Event|3|||
129744669|NCT00778895|467025085|FG001|Active Phase|Adverse Event|1|||
129744670|NCT00778895|467025086|FG002|Active Phase|Adverse Event|0|||
129744671|NCT00778895|467025084|FG000|Active Phase|Withdrawal by Subject|1|||
129744672|NCT00778895|467025085|FG001|Active Phase|Withdrawal by Subject|4|||
129744673|NCT00778895|467025086|FG002|Active Phase|Withdrawal by Subject|0|||
129744674|NCT00778895|467025084|FG000|Active Phase|Lost to Follow-up|1|||
129744675|NCT00778895|467025085|FG001|Active Phase|Lost to Follow-up|1|||
129744676|NCT00778895|467025086|FG002|Active Phase|Lost to Follow-up|0|||
129808141|NCT00142298|467262668|FG009|Overall Study|Treatment Failure|0|||
129808142|NCT00300274|467262669|FG000|Overall Study|Withdrawal by Subject|12|||
129744677|NCT00778895|467025084|FG000|Active Phase|Other|2|||
129744678|NCT00778895|467025085|FG001|Active Phase|Other|0|||
129744679|NCT00778895|467025086|FG002|Active Phase|Other|0|||
129744680|NCT00778895|467025084|FG000|ESFU Phase|Adverse Event|2|||
129744681|NCT00778895|467025085|FG001|ESFU Phase|Adverse Event|1|||
129744682|NCT00778895|467025086|FG002|ESFU Phase|Adverse Event|0|||
129744683|NCT00778895|467025084|FG000|ESFU Phase|Withdrawal by Subject|1|||
129744684|NCT00778895|467025085|FG001|ESFU Phase|Withdrawal by Subject|4|||
129744685|NCT00778895|467025086|FG002|ESFU Phase|Withdrawal by Subject|0|||
129744686|NCT00778895|467025084|FG000|ESFU Phase|Lost to Follow-up|6|||
129744687|NCT00778895|467025085|FG001|ESFU Phase|Lost to Follow-up|7|||
129744688|NCT00778895|467025086|FG002|ESFU Phase|Lost to Follow-up|2|||
129744689|NCT00778895|467025084|FG000|ESFU Phase|Other|2|||
129744690|NCT00778895|467025085|FG001|ESFU Phase|Other|0|||
129744691|NCT00778895|467025086|FG002|ESFU Phase|Other|0|||
129744692|NCT02540993|467025088|FG000|Overall Study|Lost to Follow-up|5|||
129744693|NCT02540993|467025089|FG001|Overall Study|Lost to Follow-up|3|||
129744694|NCT02540993|467025088|FG000|Overall Study|Withdrawal by Subject|4|||
129744695|NCT02540993|467025089|FG001|Overall Study|Withdrawal by Subject|6|||
129744696|NCT02540993|467025088|FG000|Overall Study|GCP violations|33|||
129744697|NCT02540993|467025089|FG001|Overall Study|GCP violations|27|||
129744698|NCT00409344|467025090|FG000|Overall Study|no enrollment|0|||
129744699|NCT00409344|467025091|FG001|Overall Study|no enrollment|0|||
129744700|NCT01009086|467025092|FG000|Overall Study|Lack of Efficacy|16|||
129744701|NCT01009086|467025093|FG001|Overall Study|Lack of Efficacy|15|||
129744702|NCT01009086|467025094|FG002|Overall Study|Lack of Efficacy|9|||
129744703|NCT01009086|467025092|FG000|Overall Study|Lost to Follow-up|4|||
129744704|NCT01009086|467025093|FG001|Overall Study|Lost to Follow-up|5|||
129744705|NCT01009086|467025094|FG002|Overall Study|Lost to Follow-up|3|||
129744706|NCT01009086|467025092|FG000|Overall Study|Adverse Event|12|||
129744707|NCT01009086|467025093|FG001|Overall Study|Adverse Event|11|||
129744708|NCT01009086|467025094|FG002|Overall Study|Adverse Event|8|||
129744709|NCT01009086|467025092|FG000|Overall Study|Withdrawal by Subject|9|||
129744710|NCT01009086|467025093|FG001|Overall Study|Withdrawal by Subject|11|||
129744711|NCT01009086|467025094|FG002|Overall Study|Withdrawal by Subject|13|||
129744712|NCT01009086|467025092|FG000|Overall Study|Other|3|||
129744713|NCT01009086|467025093|FG001|Overall Study|Other|5|||
129744714|NCT01009086|467025094|FG002|Overall Study|Other|1|||
129744715|NCT00590577|467025096|FG000|Overall Study|Lack of Efficacy|31|||
129744716|NCT00590577|467025097|FG001|Overall Study|Lack of Efficacy|28|||
129744717|NCT00590577|467025098|FG002|Overall Study|Lack of Efficacy|23|||
129744718|NCT00590577|467025099|FG003|Overall Study|Lack of Efficacy|45|||
129744719|NCT00590577|467025096|FG000|Overall Study|Withdrawal by Subject|23|||
129744720|NCT00590577|467025097|FG001|Overall Study|Withdrawal by Subject|28|||
129744721|NCT00590577|467025098|FG002|Overall Study|Withdrawal by Subject|30|||
129744722|NCT00590577|467025099|FG003|Overall Study|Withdrawal by Subject|26|||
129744723|NCT00590577|467025096|FG000|Overall Study|Adverse Event|10|||
129744724|NCT00590577|467025097|FG001|Overall Study|Adverse Event|10|||
129744725|NCT00590577|467025098|FG002|Overall Study|Adverse Event|13|||
129744726|NCT00590577|467025099|FG003|Overall Study|Adverse Event|11|||
129744727|NCT00590577|467025096|FG000|Overall Study|Lost to Follow-up|12|||
129744728|NCT00590577|467025097|FG001|Overall Study|Lost to Follow-up|6|||
129744729|NCT00590577|467025098|FG002|Overall Study|Lost to Follow-up|6|||
129744730|NCT00590577|467025099|FG003|Overall Study|Lost to Follow-up|9|||
129808143|NCT00300274|467262670|FG001|Overall Study|Withdrawal by Subject|3|||
129808144|NCT00300274|467262671|FG002|Overall Study|Withdrawal by Subject|14|||
129808145|NCT00300274|467262669|FG000|Overall Study|Lost to Follow-up|3|||
129808146|NCT00300274|467262670|FG001|Overall Study|Lost to Follow-up|4|||
129808147|NCT00300274|467262671|FG002|Overall Study|Lost to Follow-up|5|||
129808148|NCT00300274|467262669|FG000|Overall Study|Death|31|||
129808149|NCT00300274|467262670|FG001|Overall Study|Death|20|||
129808150|NCT00300274|467262671|FG002|Overall Study|Death|25|||
129808151|NCT00300274|467262669|FG000|Overall Study|Re-transplant|0|||
129808152|NCT00300274|467262670|FG001|Overall Study|Re-transplant|0|||
129808153|NCT00300274|467262671|FG002|Overall Study|Re-transplant|1|||
129808154|NCT05147428|467262674|FG000|Overall Study|Removed prior to mailing|289|||
129808155|NCT05147428|467262675|FG001|Overall Study|Removed prior to mailing|306|||
129808156|NCT05147428|467262676|FG002|Overall Study|Removed prior to mailing|270|||
129744731|NCT00590577|467025096|FG000|Overall Study|Pregnancy|0|||
129808157|NCT05147428|467262674|FG000|Overall Study|Died or disenrolled during blackout period|239|||
129744732|NCT00590577|467025097|FG001|Overall Study|Pregnancy|1|||
129744733|NCT00590577|467025098|FG002|Overall Study|Pregnancy|0|||
129744734|NCT00590577|467025099|FG003|Overall Study|Pregnancy|0|||
129744735|NCT00590577|467025096|FG000|Overall Study|Various reasons|1|||
129744736|NCT00590577|467025097|FG001|Overall Study|Various reasons|3|||
129744737|NCT00590577|467025098|FG002|Overall Study|Various reasons|1|||
129744738|NCT00590577|467025099|FG003|Overall Study|Various reasons|2|||
129744739|NCT04349033|467025100|FG000|Overall Study|Lost to Follow-up|3|||
129744740|NCT04349033|467025101|FG001|Overall Study|Lost to Follow-up|1|||
129808158|NCT05147428|467262675|FG001|Overall Study|Died or disenrolled during blackout period|278|||
129808159|NCT05147428|467262676|FG002|Overall Study|Died or disenrolled during blackout period|273|||
129744741|NCT04349033|467025102|FG002|Overall Study|Lost to Follow-up|1|||
129744742|NCT03596450|467025109|FG000|Overall Study|Death|9|||
129744743|NCT03596450|467025110|FG001|Overall Study|Death|9|||
129808160|NCT03689530|467263945|FG000|Overall Study|Withdrawal by Subject|53|||
129744744|NCT03596450|467025109|FG000|Overall Study|Protocol Violation|18|||
129808161|NCT03689530|467263946|FG001|Overall Study|Withdrawal by Subject|16|||
129808162|NCT04622306|467263950|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
129744745|NCT03596450|467025110|FG001|Overall Study|Protocol Violation|26|||
129744746|NCT03596450|467025109|FG000|Overall Study|Lost to Follow-up|50|||
129744747|NCT03596450|467025110|FG001|Overall Study|Lost to Follow-up|56|||
129744748|NCT03596450|467025109|FG000|Overall Study|Adverse Event|14|||
129744749|NCT03596450|467025110|FG001|Overall Study|Adverse Event|7|||
129744750|NCT03596450|467025109|FG000|Overall Study|Withdrawal by Subject|38|||
129744751|NCT03596450|467025110|FG001|Overall Study|Withdrawal by Subject|36|||
129744752|NCT03596450|467025109|FG000|Overall Study|Accidentally Randomized|2|||
129744753|NCT03596450|467025110|FG001|Overall Study|Accidentally Randomized|0|||
129744754|NCT03596450|467025109|FG000|Overall Study|Other reasons|48|||
129744755|NCT03596450|467025110|FG001|Overall Study|Other reasons|53|||
129744756|NCT03596450|467025109|FG000|Overall Study|Pregnancy|2|||
129744757|NCT03596450|467025110|FG001|Overall Study|Pregnancy|0|||
129744758|NCT00410605|467025111|FG000|Overall Study|Adverse Event|12|||
129744759|NCT00410605|467025111|FG000|Overall Study|Physician Decision|3|||
129744760|NCT00410605|467025111|FG000|Overall Study|Withdrawal by Subject|5|||
129744761|NCT00410605|467025111|FG000|Overall Study|Started Non-Protocol Therapy|3|||
129744762|NCT00410605|467025111|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
129744763|NCT00410605|467025111|FG000|Overall Study|Transferred to another Institution|1|||
129744764|NCT04058886|467025114|FG000|Overall Study|Withdrawal by Subject|4|||
129744765|NCT04058886|467025114|FG000|Overall Study|Inadequate deafness interpreter service|1|||
129744766|NCT02332291|467025115|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
129744767|NCT02332291|467025116|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
129744768|NCT02332291|467025115|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
129744769|NCT02332291|467025116|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
129744770|NCT02332291|467025115|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
129808163|NCT04622306|467263951|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
129808164|NCT04622306|467263952|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
129808165|NCT04622306|467263953|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
129744771|NCT02332291|467025116|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
129744772|NCT02332291|467025115|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
129744773|NCT02332291|467025116|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
129744774|NCT02332291|467025115|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
129744775|NCT02332291|467025116|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
129744776|NCT02332291|467025115|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
129744777|NCT02332291|467025116|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
129744778|NCT02220712|467025120|FG000|Overall Study|Adverse Event|1|||
129744779|NCT02220712|467025120|FG000|Overall Study|Withdrawal by Subject|2|||
129744780|NCT02220712|467025120|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
129744781|NCT00760838|467025121|FG000|Overall Study|Adverse Event|1|||
129744782|NCT00760838|467025122|FG001|Overall Study|Adverse Event|1|||
129744783|NCT00760838|467025121|FG000|Overall Study|Lack of Efficacy|1|||
129744784|NCT00760838|467025122|FG001|Overall Study|Lack of Efficacy|0|||
129744785|NCT00760838|467025121|FG000|Overall Study|Lost to Follow-up|2|||
129744786|NCT00760838|467025122|FG001|Overall Study|Lost to Follow-up|0|||
129744787|NCT00760838|467025121|FG000|Overall Study|Withdrawal by Subject|1|||
129744788|NCT00760838|467025122|FG001|Overall Study|Withdrawal by Subject|1|||
129744789|NCT03624127|467025123|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
129744790|NCT03624127|467025124|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
129744791|NCT03624127|467025125|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
129744792|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
129744793|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
129744794|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
129744795|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Death|0|||
129744796|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Death|1|||
129895709|NCT02680756|467578537|FG001|Overall Study|Physician Decision|1|||
129895710|NCT02680756|467578536|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
129744797|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Death|0|||
129808166|NCT04622306|467263954|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
129808167|NCT04622306|467263955|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
129808168|NCT04622306|467263950|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808169|NCT04622306|467263951|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808170|NCT04622306|467263952|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
129895711|NCT02680756|467578537|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
129744798|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
129744799|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
129744800|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
129744801|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
129744802|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
129808171|NCT04622306|467263953|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
129895712|NCT02680756|467578536|FG000|Overall Study|Blood transfusion for any reason|0|||
129895713|NCT02680756|467578537|FG001|Overall Study|Blood transfusion for any reason|1|||
129895714|NCT02680756|467578536|FG000|Overall Study|Death|1|||
129895715|NCT02680756|467578537|FG001|Overall Study|Death|0|||
129895716|NCT02680756|467578536|FG000|Overall Study|Protocol Violation|1|||
129895717|NCT02680756|467578537|FG001|Overall Study|Protocol Violation|0|||
129895718|NCT02680756|467578536|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
129895719|NCT02680756|467578537|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
129895720|NCT02680756|467578536|FG000|Overall Study|None of above or not recorded|3|||
129744803|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
129744804|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
129744805|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
129744806|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
129744807|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
129744808|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
129744809|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
129744810|NCT03624127|467025123|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
129744811|NCT03624127|467025124|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
129744812|NCT03624127|467025125|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
129744813|NCT03624127|467025123|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
129744814|NCT03624127|467025124|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
129744815|NCT03624127|467025125|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
129744816|NCT03624127|467025123|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
129744817|NCT03624127|467025124|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
129744818|NCT03624127|467025125|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
129744819|NCT03624127|467025123|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
129744820|NCT03624127|467025124|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
129744821|NCT03624127|467025125|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
129744822|NCT03624127|467025123|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
129744823|NCT03624127|467025124|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
129744824|NCT03624127|467025125|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
129744825|NCT03624127|467025123|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
129744826|NCT03624127|467025124|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
129744827|NCT03624127|467025125|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
129744828|NCT03624127|467025123|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
129744829|NCT03624127|467025124|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
129744830|NCT03624127|467025125|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
129744831|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
129744832|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
129744833|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
129744834|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
129744835|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
129744836|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
129744837|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
129744838|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
129744839|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
129744840|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
129744841|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
129744842|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
129744843|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
129744844|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
129744845|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
129808172|NCT04622306|467263954|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808173|NCT04622306|467263955|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
129808174|NCT00736944|467263956|FG000|Induction|Death|1|||
129808175|NCT00736944|467263956|FG000|Definitive Treatment|Physician Decision|1|||
129808176|NCT01601132|467263957|FG000|Overall Study|Patient withdrew consent|1|||
129808177|NCT01601132|467263957|FG000|Overall Study|Protocol deviation|1|||
129808178|NCT00142935|467263958|FG000|Overall Study|Other reason|1|||
129808179|NCT00142935|467263959|FG001|Overall Study|Other reason|1|||
129808180|NCT00142935|467263960|FG002|Overall Study|Other reason|1|||
129808181|NCT00142935|467263958|FG000|Overall Study|Lost to Follow-up|2|||
129808182|NCT00142935|467263959|FG001|Overall Study|Lost to Follow-up|5|||
129808183|NCT00142935|467263960|FG002|Overall Study|Lost to Follow-up|5|||
129744846|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
129744847|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
129744848|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
129744849|NCT03624127|467025123|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
129744850|NCT03624127|467025124|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
129808184|NCT00142935|467263958|FG000|Overall Study|Death|0|||
129808185|NCT00142935|467263959|FG001|Overall Study|Death|2|||
129808186|NCT00142935|467263960|FG002|Overall Study|Death|1|||
129895721|NCT02680756|467578537|FG001|Overall Study|None of above or not recorded|2|||
129744851|NCT03624127|467025125|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
129744852|NCT02607228|467025126|FG000|Overall Study|Progressive Disease|4|||
129744853|NCT02607228|467025127|FG001|Overall Study|Progressive Disease|3|||
129744854|NCT02607228|467025128|FG002|Overall Study|Progressive Disease|1|||
129744855|NCT02607228|467025129|FG003|Overall Study|Progressive Disease|5|||
129744856|NCT02607228|467025130|FG004|Overall Study|Progressive Disease|4|||
129744857|NCT02607228|467025131|FG005|Overall Study|Progressive Disease|3|||
129895722|NCT01516892|467578539|FG000|Overall Study|Adverse Event|25|||
129895723|NCT01516892|467578539|FG000|Overall Study|Lack of Efficacy|35|||
129895724|NCT01516892|467578539|FG000|Overall Study|Pregnancy|5|||
129895725|NCT01516892|467578539|FG000|Overall Study|Lost to Follow-up|82|||
129895726|NCT01516892|467578539|FG000|Overall Study|Subject Withdrew Consent|92|||
129895727|NCT01516892|467578539|FG000|Overall Study|Protocol Violation|60|||
129895728|NCT01516892|467578539|FG000|Overall Study|Other Miscellaneous Reasons|43|||
129895729|NCT01516892|467578539|FG000|Overall Study|Missing|1|||
129895730|NCT04381494|467578540|FG000|Overall Study|Early termination of trial|19|||
129895731|NCT04381494|467578540|FG000|Overall Study|Investigator's discretion|1|||
129895732|NCT04381494|467578540|FG000|Overall Study|Withdrawal by Subject|9|||
129895733|NCT04381494|467578540|FG000|Overall Study|NSCLC disease progression|4|||
129895734|NCT04381494|467578540|FG000|Overall Study|Device-Related Adverse Event|2|||
129895735|NCT04310579|467578541|FG000|Overall Study|Adverse Event|0|||
129895736|NCT04310579|467578542|FG001|Overall Study|Adverse Event|0|||
129895737|NCT04310579|467578543|FG002|Overall Study|Adverse Event|0|||
129895738|NCT04310579|467578544|FG003|Overall Study|Adverse Event|0|||
129895739|NCT04310579|467578545|FG004|Overall Study|Adverse Event|0|||
129895740|NCT04310579|467578546|FG005|Overall Study|Adverse Event|0|||
129744858|NCT02607228|467025132|FG006|Overall Study|Progressive Disease|1|||
129744859|NCT02607228|467025126|FG000|Overall Study|Adverse Event|1|||
129744860|NCT02607228|467025127|FG001|Overall Study|Adverse Event|0|||
129744861|NCT02607228|467025128|FG002|Overall Study|Adverse Event|1|||
129744862|NCT02607228|467025129|FG003|Overall Study|Adverse Event|0|||
129744863|NCT02607228|467025130|FG004|Overall Study|Adverse Event|1|||
129744864|NCT02607228|467025131|FG005|Overall Study|Adverse Event|1|||
129744865|NCT02607228|467025132|FG006|Overall Study|Adverse Event|1|||
129744866|NCT02607228|467025126|FG000|Overall Study|Investigator's Discretion|0|||
129744867|NCT02607228|467025127|FG001|Overall Study|Investigator's Discretion|0|||
129744868|NCT02607228|467025128|FG002|Overall Study|Investigator's Discretion|1|||
129744869|NCT02607228|467025129|FG003|Overall Study|Investigator's Discretion|0|||
129744870|NCT02607228|467025130|FG004|Overall Study|Investigator's Discretion|0|||
129744871|NCT02607228|467025131|FG005|Overall Study|Investigator's Discretion|1|||
129744872|NCT02607228|467025132|FG006|Overall Study|Investigator's Discretion|0|||
129744873|NCT02607228|467025126|FG000|Overall Study|Withdrew Consent|0|||
129744874|NCT02607228|467025127|FG001|Overall Study|Withdrew Consent|1|||
129744875|NCT02607228|467025128|FG002|Overall Study|Withdrew Consent|0|||
129744876|NCT02607228|467025129|FG003|Overall Study|Withdrew Consent|0|||
129744877|NCT02607228|467025130|FG004|Overall Study|Withdrew Consent|0|||
129744878|NCT02607228|467025131|FG005|Overall Study|Withdrew Consent|1|||
129744879|NCT02607228|467025132|FG006|Overall Study|Withdrew Consent|0|||
129744880|NCT02607228|467025126|FG000|Overall Study|Study Terminated by Sponsor|0|||
129744881|NCT02607228|467025127|FG001|Overall Study|Study Terminated by Sponsor|0|||
129744882|NCT02607228|467025128|FG002|Overall Study|Study Terminated by Sponsor|0|||
129744883|NCT02607228|467025129|FG003|Overall Study|Study Terminated by Sponsor|1|||
129744884|NCT02607228|467025130|FG004|Overall Study|Study Terminated by Sponsor|0|||
129744885|NCT02607228|467025131|FG005|Overall Study|Study Terminated by Sponsor|0|||
129744886|NCT02607228|467025132|FG006|Overall Study|Study Terminated by Sponsor|0|||
129744887|NCT03576716|467025135|FG000|Overall Study|Withdrawal by Subject|0|||
129744888|NCT03576716|467025136|FG001|Overall Study|Withdrawal by Subject|1|||
129744889|NCT00559988|467025137|FG000|Overall Study|Death|147|||
129744890|NCT00559988|467025138|FG001|Overall Study|Death|140|||
129744891|NCT00559988|467025137|FG000|Overall Study|Withdrawal by Subject|152|||
129744892|NCT00559988|467025138|FG001|Overall Study|Withdrawal by Subject|139|||
129744893|NCT00559988|467025137|FG000|Overall Study|Lost to Follow-up|42|||
129744894|NCT00559988|467025138|FG001|Overall Study|Lost to Follow-up|56|||
129895741|NCT04310579|467578547|FG006|Overall Study|Adverse Event|2|||
129895742|NCT04310579|467578548|FG007|Overall Study|Adverse Event|0|||
129744895|NCT00559988|467025137|FG000|Overall Study|ICD device explanted|10|||
129744896|NCT00559988|467025138|FG001|Overall Study|ICD device explanted|17|||
129744897|NCT01455194|467025139|FG000|Overall Study|Screen Failure|20|||
129744898|NCT01455194|467025140|FG001|Overall Study|Screen Failure|0|||
129744899|NCT01455194|467025141|FG002|Overall Study|Screen Failure|0|||
129744900|NCT01455194|467025142|FG003|Overall Study|Screen Failure|0|||
129744901|NCT01455194|467025139|FG000|Overall Study|Randomisation Failure|90|||
129895743|NCT04310579|467578549|FG008|Overall Study|Adverse Event|1|||
129895744|NCT04310579|467578550|FG009|Overall Study|Adverse Event|1|||
129895745|NCT04310579|467578551|FG010|Overall Study|Adverse Event|0|||
129744902|NCT01455194|467025140|FG001|Overall Study|Randomisation Failure|0|||
129744903|NCT01455194|467025141|FG002|Overall Study|Randomisation Failure|0|||
129744904|NCT01455194|467025142|FG003|Overall Study|Randomisation Failure|0|||
129744905|NCT01455194|467025139|FG000|Overall Study|Deterioration in asthma|12|||
129744906|NCT01455194|467025140|FG001|Overall Study|Deterioration in asthma|6|||
129744907|NCT01455194|467025141|FG002|Overall Study|Deterioration in asthma|14|||
129744908|NCT01455194|467025142|FG003|Overall Study|Deterioration in asthma|9|||
129744909|NCT01455194|467025139|FG000|Overall Study|Adverse Event|1|||
129744910|NCT01455194|467025140|FG001|Overall Study|Adverse Event|1|||
129744911|NCT01455194|467025141|FG002|Overall Study|Adverse Event|1|||
129744912|NCT01455194|467025142|FG003|Overall Study|Adverse Event|3|||
129744913|NCT01455194|467025139|FG000|Overall Study|Withdrawal by Subject|21|||
129744914|NCT01455194|467025140|FG001|Overall Study|Withdrawal by Subject|16|||
129744915|NCT01455194|467025141|FG002|Overall Study|Withdrawal by Subject|12|||
129744916|NCT01455194|467025142|FG003|Overall Study|Withdrawal by Subject|9|||
129744917|NCT01455194|467025139|FG000|Overall Study|Lost to Follow-up|2|||
129744918|NCT01455194|467025140|FG001|Overall Study|Lost to Follow-up|0|||
129744919|NCT01455194|467025141|FG002|Overall Study|Lost to Follow-up|1|||
129744920|NCT01455194|467025142|FG003|Overall Study|Lost to Follow-up|1|||
129744921|NCT01455194|467025139|FG000|Overall Study|Pregnancy|0|||
129744922|NCT01455194|467025140|FG001|Overall Study|Pregnancy|1|||
129744923|NCT01455194|467025141|FG002|Overall Study|Pregnancy|1|||
129744924|NCT01455194|467025142|FG003|Overall Study|Pregnancy|0|||
129744925|NCT01455194|467025139|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
129744926|NCT01455194|467025140|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
129744927|NCT01455194|467025141|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
129744928|NCT01455194|467025142|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
129744929|NCT01455194|467025139|FG000|Overall Study|Miscellaneous|4|||
129744930|NCT01455194|467025140|FG001|Overall Study|Miscellaneous|5|||
129744931|NCT01455194|467025141|FG002|Overall Study|Miscellaneous|1|||
129744932|NCT01455194|467025142|FG003|Overall Study|Miscellaneous|4|||
129744933|NCT02249182|467025143|FG000|Treatment Phase|Lost to Follow-up|4|||
129744934|NCT02249182|467025144|FG001|Treatment Phase|Lost to Follow-up|0|||
129744935|NCT02249182|467025145|FG002|Treatment Phase|Lost to Follow-up|0|||
129744936|NCT02249182|467025146|FG003|Treatment Phase|Lost to Follow-up|0|||
129744937|NCT02249182|467025147|FG004|Treatment Phase|Lost to Follow-up|0|||
129744938|NCT04356040|467025150|FG000|Overall Study|Death|2|||
129744939|NCT04356040|467025151|FG001|Overall Study|Death|0|||
129744940|NCT04356040|467025150|FG000|Overall Study|Lost to Follow-up|1|||
129744941|NCT04356040|467025151|FG001|Overall Study|Lost to Follow-up|0|||
129744942|NCT04356040|467025150|FG000|Overall Study|Physician Decision|0|||
129744943|NCT04356040|467025151|FG001|Overall Study|Physician Decision|1|||
129744944|NCT04356040|467025150|FG000|Overall Study|Withdrawal by Subject|13|||
129744945|NCT04356040|467025151|FG001|Overall Study|Withdrawal by Subject|1|||
129744946|NCT04356040|467025150|FG000|Overall Study|Enrollment Pause|10|||
129744947|NCT04356040|467025151|FG001|Overall Study|Enrollment Pause|0|||
129744948|NCT04356040|467025150|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
129744949|NCT04356040|467025151|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
129744950|NCT04356040|467025150|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
129744951|NCT04356040|467025151|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
129744952|NCT04356040|467025150|FG000|Overall Study|PI left institution|3|||
129744953|NCT04356040|467025151|FG001|Overall Study|PI left institution|0|||
129744954|NCT00788710|467025152|FG000|Overall Study|Adverse Event|1|||
129744955|NCT00788710|467025153|FG001|Overall Study|Adverse Event|3|||
129744956|NCT00788710|467025154|FG002|Overall Study|Adverse Event|4|||
129744957|NCT00788710|467025152|FG000|Overall Study|Lack of Efficacy|0|||
129744958|NCT00788710|467025153|FG001|Overall Study|Lack of Efficacy|0|||
129744959|NCT00788710|467025154|FG002|Overall Study|Lack of Efficacy|1|||
129744960|NCT00788710|467025152|FG000|Overall Study|Lost to Follow-up|0|||
129744961|NCT00788710|467025153|FG001|Overall Study|Lost to Follow-up|1|||
129744962|NCT00788710|467025154|FG002|Overall Study|Lost to Follow-up|0|||
129744963|NCT00788710|467025152|FG000|Overall Study|Physician Decision|2|||
129744964|NCT00788710|467025153|FG001|Overall Study|Physician Decision|1|||
129744965|NCT00788710|467025154|FG002|Overall Study|Physician Decision|0|||
129744966|NCT00788710|467025152|FG000|Overall Study|Protocol Violation|0|||
129744967|NCT00788710|467025153|FG001|Overall Study|Protocol Violation|1|||
129744968|NCT00788710|467025154|FG002|Overall Study|Protocol Violation|1|||
129744969|NCT00788710|467025152|FG000|Overall Study|Withdrawal by Subject|2|||
129744970|NCT00788710|467025153|FG001|Overall Study|Withdrawal by Subject|2|||
129744971|NCT00788710|467025154|FG002|Overall Study|Withdrawal by Subject|0|||
129744972|NCT01990859|467025155|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
129744973|NCT01990859|467025155|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
129744974|NCT01717326|467025156|FG000|Overall Study|Death|0|||
129744975|NCT01717326|467025157|FG001|Overall Study|Death|0|||
129744976|NCT01717326|467025158|FG002|Overall Study|Death|0|||
129744977|NCT01717326|467025159|FG003|Overall Study|Death|0|||
129744978|NCT01717326|467025160|FG004|Overall Study|Death|0|||
129744979|NCT01717326|467025161|FG005|Overall Study|Death|0|||
129744980|NCT01717326|467025162|FG006|Overall Study|Death|0|||
129744981|NCT01717326|467025163|FG007|Overall Study|Death|0|||
129744982|NCT01717326|467025164|FG008|Overall Study|Death|0|||
129744983|NCT01717326|467025165|FG009|Overall Study|Death|0|||
129744984|NCT01717326|467025166|FG010|Overall Study|Death|1|||
129744985|NCT01717326|467025167|FG011|Overall Study|Death|0|||
129744986|NCT01717326|467025168|FG012|Overall Study|Death|0|||
129744987|NCT01717326|467025169|FG013|Overall Study|Death|0|||
129744988|NCT01717326|467025170|FG014|Overall Study|Death|0|||
129744989|NCT01717326|467025171|FG015|Overall Study|Death|0|||
129744990|NCT01717326|467025172|FG016|Overall Study|Death|0|||
129744991|NCT01717326|467025173|FG017|Overall Study|Death|0|||
129744992|NCT01717326|467025174|FG018|Overall Study|Death|0|||
129744993|NCT01717326|467025175|FG019|Overall Study|Death|0|||
129744994|NCT01717326|467025156|FG000|Overall Study|Lost to Follow-up|3|||
129744995|NCT01717326|467025157|FG001|Overall Study|Lost to Follow-up|0|||
129744996|NCT01717326|467025158|FG002|Overall Study|Lost to Follow-up|0|||
129744997|NCT01717326|467025159|FG003|Overall Study|Lost to Follow-up|2|||
129744998|NCT01717326|467025160|FG004|Overall Study|Lost to Follow-up|1|||
129744999|NCT01717326|467025161|FG005|Overall Study|Lost to Follow-up|0|||
129745000|NCT01717326|467025162|FG006|Overall Study|Lost to Follow-up|1|||
129745001|NCT01717326|467025163|FG007|Overall Study|Lost to Follow-up|0|||
129745002|NCT01717326|467025164|FG008|Overall Study|Lost to Follow-up|0|||
129745003|NCT01717326|467025165|FG009|Overall Study|Lost to Follow-up|0|||
129745004|NCT01717326|467025166|FG010|Overall Study|Lost to Follow-up|1|||
129745005|NCT01717326|467025167|FG011|Overall Study|Lost to Follow-up|0|||
129745006|NCT01717326|467025168|FG012|Overall Study|Lost to Follow-up|0|||
129745007|NCT01717326|467025169|FG013|Overall Study|Lost to Follow-up|0|||
129745008|NCT01717326|467025170|FG014|Overall Study|Lost to Follow-up|0|||
129745009|NCT01717326|467025171|FG015|Overall Study|Lost to Follow-up|2|||
129745010|NCT01717326|467025172|FG016|Overall Study|Lost to Follow-up|1|||
129745011|NCT01717326|467025173|FG017|Overall Study|Lost to Follow-up|0|||
129745012|NCT01717326|467025174|FG018|Overall Study|Lost to Follow-up|2|||
129745013|NCT01717326|467025175|FG019|Overall Study|Lost to Follow-up|3|||
129745014|NCT01717326|467025156|FG000|Overall Study|Physician Decision|0|||
129745015|NCT01717326|467025157|FG001|Overall Study|Physician Decision|0|||
129745016|NCT01717326|467025158|FG002|Overall Study|Physician Decision|0|||
129745017|NCT01717326|467025159|FG003|Overall Study|Physician Decision|0|||
129745018|NCT01717326|467025160|FG004|Overall Study|Physician Decision|0|||
129745019|NCT01717326|467025161|FG005|Overall Study|Physician Decision|0|||
129745020|NCT01717326|467025162|FG006|Overall Study|Physician Decision|0|||
129745021|NCT01717326|467025163|FG007|Overall Study|Physician Decision|0|||
129745022|NCT01717326|467025164|FG008|Overall Study|Physician Decision|0|||
129745023|NCT01717326|467025165|FG009|Overall Study|Physician Decision|1|||
129745024|NCT01717326|467025166|FG010|Overall Study|Physician Decision|0|||
129745025|NCT01717326|467025167|FG011|Overall Study|Physician Decision|0|||
129745026|NCT01717326|467025168|FG012|Overall Study|Physician Decision|0|||
129745027|NCT01717326|467025169|FG013|Overall Study|Physician Decision|0|||
129745028|NCT01717326|467025170|FG014|Overall Study|Physician Decision|0|||
129745029|NCT01717326|467025171|FG015|Overall Study|Physician Decision|0|||
129745030|NCT01717326|467025172|FG016|Overall Study|Physician Decision|0|||
129745031|NCT01717326|467025173|FG017|Overall Study|Physician Decision|0|||
129745032|NCT01717326|467025174|FG018|Overall Study|Physician Decision|0|||
129745033|NCT01717326|467025175|FG019|Overall Study|Physician Decision|0|||
129745034|NCT01717326|467025156|FG000|Overall Study|Protocol Violation|0|||
129745035|NCT01717326|467025157|FG001|Overall Study|Protocol Violation|0|||
129745036|NCT01717326|467025158|FG002|Overall Study|Protocol Violation|0|||
129745037|NCT01717326|467025159|FG003|Overall Study|Protocol Violation|0|||
129745038|NCT01717326|467025160|FG004|Overall Study|Protocol Violation|1|||
129745039|NCT01717326|467025161|FG005|Overall Study|Protocol Violation|0|||
129745040|NCT01717326|467025162|FG006|Overall Study|Protocol Violation|0|||
129745041|NCT01717326|467025163|FG007|Overall Study|Protocol Violation|0|||
129745042|NCT01717326|467025164|FG008|Overall Study|Protocol Violation|0|||
129745043|NCT01717326|467025165|FG009|Overall Study|Protocol Violation|0|||
129745044|NCT01717326|467025166|FG010|Overall Study|Protocol Violation|0|||
129745045|NCT01717326|467025167|FG011|Overall Study|Protocol Violation|0|||
129745046|NCT01717326|467025168|FG012|Overall Study|Protocol Violation|0|||
129745047|NCT01717326|467025169|FG013|Overall Study|Protocol Violation|0|||
129745048|NCT01717326|467025170|FG014|Overall Study|Protocol Violation|0|||
129745049|NCT01717326|467025171|FG015|Overall Study|Protocol Violation|0|||
129745050|NCT01717326|467025172|FG016|Overall Study|Protocol Violation|0|||
129745051|NCT01717326|467025173|FG017|Overall Study|Protocol Violation|0|||
129745052|NCT01717326|467025174|FG018|Overall Study|Protocol Violation|0|||
129745053|NCT01717326|467025175|FG019|Overall Study|Protocol Violation|0|||
129745054|NCT01717326|467025156|FG000|Overall Study|Withdrawal by Subject|0|||
129745055|NCT01717326|467025157|FG001|Overall Study|Withdrawal by Subject|1|||
129745056|NCT01717326|467025158|FG002|Overall Study|Withdrawal by Subject|0|||
129745057|NCT01717326|467025159|FG003|Overall Study|Withdrawal by Subject|0|||
129745058|NCT01717326|467025160|FG004|Overall Study|Withdrawal by Subject|0|||
129745059|NCT01717326|467025161|FG005|Overall Study|Withdrawal by Subject|0|||
129745060|NCT01717326|467025162|FG006|Overall Study|Withdrawal by Subject|0|||
129745061|NCT01717326|467025163|FG007|Overall Study|Withdrawal by Subject|0|||
129745062|NCT01717326|467025164|FG008|Overall Study|Withdrawal by Subject|0|||
129745063|NCT01717326|467025165|FG009|Overall Study|Withdrawal by Subject|1|||
129745064|NCT01717326|467025166|FG010|Overall Study|Withdrawal by Subject|0|||
129745065|NCT01717326|467025167|FG011|Overall Study|Withdrawal by Subject|0|||
129745066|NCT01717326|467025168|FG012|Overall Study|Withdrawal by Subject|1|||
129745067|NCT01717326|467025169|FG013|Overall Study|Withdrawal by Subject|0|||
129745068|NCT01717326|467025170|FG014|Overall Study|Withdrawal by Subject|0|||
129745069|NCT01717326|467025171|FG015|Overall Study|Withdrawal by Subject|1|||
129745070|NCT01717326|467025172|FG016|Overall Study|Withdrawal by Subject|0|||
129745071|NCT01717326|467025173|FG017|Overall Study|Withdrawal by Subject|0|||
129745072|NCT01717326|467025174|FG018|Overall Study|Withdrawal by Subject|2|||
129745073|NCT01717326|467025175|FG019|Overall Study|Withdrawal by Subject|3|||
129745074|NCT02262754|467025177|FG000|Overall Study|Adverse Event|3|||
129745075|NCT02262754|467025178|FG001|Overall Study|Adverse Event|4|||
129745076|NCT02262754|467025179|FG002|Overall Study|Adverse Event|0|||
129745077|NCT02262754|467025177|FG000|Overall Study|Lack of Efficacy|2|||
129745078|NCT02262754|467025178|FG001|Overall Study|Lack of Efficacy|0|||
129745079|NCT02262754|467025179|FG002|Overall Study|Lack of Efficacy|1|||
129745080|NCT02262754|467025177|FG000|Overall Study|Lost to Follow-up|0|||
129745081|NCT02262754|467025178|FG001|Overall Study|Lost to Follow-up|0|||
129745082|NCT02262754|467025179|FG002|Overall Study|Lost to Follow-up|1|||
129745083|NCT02262754|467025177|FG000|Overall Study|No longer meets eligibility criteria|0|||
129745084|NCT02262754|467025178|FG001|Overall Study|No longer meets eligibility criteria|1|||
129745085|NCT02262754|467025179|FG002|Overall Study|No longer meets eligibility criteria|0|||
129745086|NCT02262754|467025177|FG000|Overall Study|Study terminated by sponsor|5|||
129745087|NCT02262754|467025178|FG001|Overall Study|Study terminated by sponsor|4|||
129745088|NCT02262754|467025179|FG002|Overall Study|Study terminated by sponsor|4|||
129745089|NCT02262754|467025177|FG000|Overall Study|Protocol Violation|1|||
129745090|NCT02262754|467025178|FG001|Overall Study|Protocol Violation|0|||
129745091|NCT02262754|467025179|FG002|Overall Study|Protocol Violation|0|||
129745092|NCT02262754|467025177|FG000|Overall Study|Withdrawal by Subject|1|||
129745093|NCT02262754|467025178|FG001|Overall Study|Withdrawal by Subject|0|||
129745094|NCT02262754|467025179|FG002|Overall Study|Withdrawal by Subject|1|||
129745095|NCT02262754|467025177|FG000|Overall Study|Other|4|||
129745096|NCT02262754|467025178|FG001|Overall Study|Other|0|||
129745097|NCT02262754|467025179|FG002|Overall Study|Other|2|||
129745098|NCT02577016|467025184|FG000|Overall Study|Adverse Event|2|||
129745099|NCT02577016|467025185|FG001|Overall Study|Adverse Event|1|||
129745100|NCT02577016|467025184|FG000|Overall Study|Physician Decision|0|||
129745101|NCT02577016|467025185|FG001|Overall Study|Physician Decision|1|||
129745102|NCT02126839|467025186|FG000|Overall Study|Adverse Event|0|||
129745103|NCT02126839|467025187|FG001|Overall Study|Adverse Event|1|||
129745104|NCT02126839|467025186|FG000|Overall Study|Withdrawal by Subject|1|||
129745105|NCT02126839|467025187|FG001|Overall Study|Withdrawal by Subject|0|||
129745106|NCT02126839|467025186|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129745107|NCT02126839|467025187|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129745108|NCT02126839|467025186|FG000|Overall Study|Protocol Violation|2|||
129745109|NCT02126839|467025187|FG001|Overall Study|Protocol Violation|3|||
129745110|NCT02126839|467025186|FG000|Overall Study|Sponsor request|0|||
129745111|NCT02126839|467025187|FG001|Overall Study|Sponsor request|1|||
129745112|NCT02126839|467025186|FG000|Overall Study|Lost to Follow-up|1|||
129745113|NCT02126839|467025187|FG001|Overall Study|Lost to Follow-up|4|||
129745114|NCT02126839|467025186|FG000|Overall Study|Other|5|||
129745115|NCT02126839|467025187|FG001|Overall Study|Other|5|||
129745116|NCT00812565|467025190|FG000|Overall Study|Did Not Receive Study Medication|1|||
129745117|NCT00812565|467025191|FG001|Overall Study|Did Not Receive Study Medication|1|||
129745118|NCT00812565|467025192|FG002|Overall Study|Did Not Receive Study Medication|0|||
129745119|NCT00812565|467025193|FG003|Overall Study|Did Not Receive Study Medication|0|||
129745120|NCT00812565|467025194|FG004|Overall Study|Did Not Receive Study Medication|0|||
129745121|NCT00812565|467025195|FG005|Overall Study|Did Not Receive Study Medication|0|||
129745122|NCT00812565|467025196|FG006|Overall Study|Did Not Receive Study Medication|0|||
129745123|NCT00812565|467025197|FG007|Overall Study|Did Not Receive Study Medication|0|||
129745124|NCT00812565|467025190|FG000|Overall Study|Adverse Event|0|||
129745125|NCT00812565|467025191|FG001|Overall Study|Adverse Event|0|||
129745126|NCT00812565|467025192|FG002|Overall Study|Adverse Event|0|||
129745127|NCT00812565|467025193|FG003|Overall Study|Adverse Event|2|||
129745128|NCT00812565|467025194|FG004|Overall Study|Adverse Event|0|||
129745129|NCT00812565|467025195|FG005|Overall Study|Adverse Event|0|||
129745130|NCT00812565|467025196|FG006|Overall Study|Adverse Event|0|||
129745131|NCT00812565|467025197|FG007|Overall Study|Adverse Event|1|||
129745132|NCT00812565|467025190|FG000|Overall Study|Did Not Come to Study Visit|1|||
129745133|NCT00812565|467025191|FG001|Overall Study|Did Not Come to Study Visit|0|||
129745134|NCT00812565|467025192|FG002|Overall Study|Did Not Come to Study Visit|0|||
129745135|NCT00812565|467025193|FG003|Overall Study|Did Not Come to Study Visit|0|||
129745136|NCT00812565|467025194|FG004|Overall Study|Did Not Come to Study Visit|0|||
129745137|NCT00812565|467025195|FG005|Overall Study|Did Not Come to Study Visit|0|||
129745138|NCT00812565|467025196|FG006|Overall Study|Did Not Come to Study Visit|0|||
129745139|NCT00812565|467025197|FG007|Overall Study|Did Not Come to Study Visit|0|||
129808187|NCT02980783|467263962|FG000|Overall Study|Lost to Follow-up|1|||
129808188|NCT02589405|467263965|FG000|Overall Study|Adverse Event|3|||
129808189|NCT02589405|467263965|FG000|Overall Study|Withdrawal by Subject|1|||
129808190|NCT04545060|467263968|FG000|Overall Study|Adverse Event|0|||
129808191|NCT04545060|467263969|FG001|Overall Study|Adverse Event|1|||
129808192|NCT04545060|467263968|FG000|Overall Study|Death|0|||
129808193|NCT04545060|467263969|FG001|Overall Study|Death|5|||
129808194|NCT04545060|467263968|FG000|Overall Study|Lost to Follow-up|10|||
129808195|NCT04545060|467263969|FG001|Overall Study|Lost to Follow-up|13|||
129808196|NCT04545060|467263968|FG000|Overall Study|Physician Decision|3|||
129808197|NCT04545060|467263969|FG001|Overall Study|Physician Decision|0|||
129808198|NCT04545060|467263968|FG000|Overall Study|Withdrawal by Subject|17|||
129808199|NCT04545060|467263969|FG001|Overall Study|Withdrawal by Subject|22|||
129808200|NCT00619177|467263972|FG000|Overall Study|Adverse Event|18|||
129808201|NCT00619177|467263972|FG000|Overall Study|Lost to Follow-up|2|||
129808202|NCT00619177|467263972|FG000|Overall Study|Lack of Efficacy|1|||
129808203|NCT00619177|467263972|FG000|Overall Study|Missing termination information|481|||
129808204|NCT00619177|467263972|FG000|Overall Study|Not specified reasons|6|||
129808205|NCT03082261|467263973|FG000|Overall Study|Death|4|||
129808206|NCT03082261|467263973|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
129808207|NCT03082261|467263973|FG000|Overall Study|Insurance denial|1|||
129808208|NCT03082261|467263973|FG000|Overall Study|Peripheral lead added|1|||
129808209|NCT03082261|467263973|FG000|Overall Study|Withdrawal by Subject|40|||
129808210|NCT03082261|467263973|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
129808211|NCT03082261|467263973|FG000|Overall Study|Subject implanted with device other than study device|1|||
129808212|NCT03082261|467263973|FG000|Overall Study|Lost to Follow-up|14|||
129808213|NCT03082261|467263973|FG000|Overall Study|Subject moved to a different state|1|||
129808214|NCT03082261|467263973|FG000|Overall Study|Subject non-compliance|2|||
129808215|NCT03082261|467263973|FG000|Overall Study|Subject participation terminated by investigator|9|||
129745140|NCT00812565|467025190|FG000|Overall Study|Withdrawal of Consent|1|||
129745141|NCT00812565|467025191|FG001|Overall Study|Withdrawal of Consent|0|||
129895746|NCT04310579|467578541|FG000|Overall Study|Withdrawal by Subject|0|||
129895747|NCT04310579|467578542|FG001|Overall Study|Withdrawal by Subject|0|||
129895748|NCT04310579|467578543|FG002|Overall Study|Withdrawal by Subject|0|||
129895749|NCT04310579|467578544|FG003|Overall Study|Withdrawal by Subject|0|||
129745142|NCT00812565|467025192|FG002|Overall Study|Withdrawal of Consent|0|||
129745143|NCT00812565|467025193|FG003|Overall Study|Withdrawal of Consent|0|||
129745144|NCT00812565|467025194|FG004|Overall Study|Withdrawal of Consent|1|||
129745145|NCT00812565|467025195|FG005|Overall Study|Withdrawal of Consent|0|||
129745146|NCT00812565|467025196|FG006|Overall Study|Withdrawal of Consent|0|||
129745147|NCT00812565|467025197|FG007|Overall Study|Withdrawal of Consent|0|||
129745148|NCT00812565|467025190|FG000|Overall Study|Reason Not Specified|0|||
129745149|NCT00812565|467025191|FG001|Overall Study|Reason Not Specified|0|||
129745150|NCT00812565|467025192|FG002|Overall Study|Reason Not Specified|0|||
129745151|NCT00812565|467025193|FG003|Overall Study|Reason Not Specified|0|||
129745152|NCT00812565|467025194|FG004|Overall Study|Reason Not Specified|0|||
129745153|NCT00812565|467025195|FG005|Overall Study|Reason Not Specified|1|||
129745154|NCT00812565|467025196|FG006|Overall Study|Reason Not Specified|0|||
129745155|NCT00812565|467025197|FG007|Overall Study|Reason Not Specified|0|||
129745156|NCT02596945|467025198|FG000|Overall Study|No documentation of study drug dosing|3|||
129745157|NCT02596945|467025198|FG000|Overall Study|Other|32|||
129745158|NCT02596945|467025198|FG000|Overall Study|Change to hemodialysis|15|||
129745159|NCT02596945|467025198|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
129745160|NCT02596945|467025198|FG000|Overall Study|Withdrawal by Subject|1|||
129745161|NCT02596945|467025198|FG000|Overall Study|Missing|1|||
129745162|NCT00422383|467025199|FG000|Overall Study|Adverse Event|5|||
129745163|NCT00422383|467025200|FG001|Overall Study|Adverse Event|3|||
129745164|NCT00422383|467025201|FG002|Overall Study|Adverse Event|1|||
129808216|NCT03082261|467263973|FG000|Overall Study|Subject participation terminated by sponsor|4|||
129808217|NCT03082261|467263973|FG000|Overall Study|System explant|19|||
129808218|NCT03082261|467263973|FG000|Overall Study|Unable to place lead(s)|2|||
129808219|NCT03082261|467263973|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
129808220|NCT01032174|467263978|FG000|Overall Study|Adverse Event|0|||
129808221|NCT01032174|467263979|FG001|Overall Study|Adverse Event|1|||
129745165|NCT00422383|467025202|FG003|Overall Study|Adverse Event|1|||
129745166|NCT00422383|467025203|FG004|Overall Study|Adverse Event|0|||
129808222|NCT00702689|467263980|FG000|Overall Study|Withdrawal by Subject|4|||
129808223|NCT00702689|467263980|FG000|Overall Study|Recurrent malignancy|1|||
129808224|NCT00702689|467263980|FG000|Overall Study|Adverse Event|1|||
129808225|NCT01281137|467263983|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
129808226|NCT01281137|467263984|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
129808227|NCT01281137|467263983|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
129895750|NCT04310579|467578545|FG004|Overall Study|Withdrawal by Subject|0|||
129745167|NCT00422383|467025199|FG000|Overall Study|Lack of Efficacy|4|||
129895751|NCT04310579|467578546|FG005|Overall Study|Withdrawal by Subject|1|||
129745168|NCT00422383|467025200|FG001|Overall Study|Lack of Efficacy|4|||
129745169|NCT00422383|467025201|FG002|Overall Study|Lack of Efficacy|2|||
129745170|NCT00422383|467025202|FG003|Overall Study|Lack of Efficacy|1|||
129745171|NCT00422383|467025203|FG004|Overall Study|Lack of Efficacy|1|||
129745172|NCT00422383|467025199|FG000|Overall Study|Lost to Follow-up|0|||
129745173|NCT00422383|467025200|FG001|Overall Study|Lost to Follow-up|1|||
129745174|NCT00422383|467025201|FG002|Overall Study|Lost to Follow-up|0|||
129745175|NCT00422383|467025202|FG003|Overall Study|Lost to Follow-up|0|||
129745176|NCT00422383|467025203|FG004|Overall Study|Lost to Follow-up|1|||
129745177|NCT00422383|467025199|FG000|Overall Study|Protocol Violation|1|||
129745178|NCT00422383|467025200|FG001|Overall Study|Protocol Violation|1|||
129745179|NCT00422383|467025201|FG002|Overall Study|Protocol Violation|1|||
129745180|NCT00422383|467025202|FG003|Overall Study|Protocol Violation|0|||
129745181|NCT00422383|467025203|FG004|Overall Study|Protocol Violation|0|||
129745182|NCT00422383|467025199|FG000|Overall Study|Withdrawal by Subject|5|||
129745183|NCT00422383|467025200|FG001|Overall Study|Withdrawal by Subject|5|||
129745184|NCT00422383|467025201|FG002|Overall Study|Withdrawal by Subject|0|||
129745185|NCT00422383|467025202|FG003|Overall Study|Withdrawal by Subject|0|||
129745186|NCT00422383|467025203|FG004|Overall Study|Withdrawal by Subject|1|||
129745187|NCT05066165|467026867|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
129745188|NCT05066165|467026868|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
129745189|NCT05066165|467026867|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
129745190|NCT05066165|467026868|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
129745191|NCT03738618|467026869|FG000|Overall Study|Protocol deviation|23|||
129808228|NCT01281137|467263984|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
129808229|NCT01281137|467263983|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
129808230|NCT01281137|467263984|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
129808231|NCT01281137|467263983|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
129808232|NCT01281137|467263984|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
129808233|NCT01281137|467263983|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
129808234|NCT01281137|467263984|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
129808235|NCT02761733|467263987|FG000|Overall Study|Death|3|||
129808236|NCT02761733|467263988|FG001|Overall Study|Death|5|||
129808237|NCT02761733|467263989|FG002|Overall Study|Death|1|||
129808238|NCT02761733|467263990|FG003|Overall Study|Death|1|||
129808239|NCT02761733|467263987|FG000|Overall Study|Lost to Follow-up|6|||
129808240|NCT02761733|467263988|FG001|Overall Study|Lost to Follow-up|7|||
129808241|NCT02761733|467263989|FG002|Overall Study|Lost to Follow-up|0|||
129808242|NCT02761733|467263990|FG003|Overall Study|Lost to Follow-up|3|||
129808243|NCT02761733|467263987|FG000|Overall Study|Physician Decision|4|||
129808244|NCT02761733|467263988|FG001|Overall Study|Physician Decision|0|||
129808245|NCT02761733|467263989|FG002|Overall Study|Physician Decision|0|||
129808246|NCT02761733|467263990|FG003|Overall Study|Physician Decision|0|||
129808247|NCT02761733|467263987|FG000|Overall Study|Withdrawal by Subject|2|||
129808248|NCT02761733|467263988|FG001|Overall Study|Withdrawal by Subject|0|||
129808249|NCT02761733|467263989|FG002|Overall Study|Withdrawal by Subject|0|||
129808250|NCT02761733|467263990|FG003|Overall Study|Withdrawal by Subject|0|||
129808251|NCT02761733|467263987|FG000|Overall Study|Discharged from Study Site|10|||
129808252|NCT02761733|467263988|FG001|Overall Study|Discharged from Study Site|9|||
129808253|NCT02761733|467263989|FG002|Overall Study|Discharged from Study Site|25|||
129808254|NCT02761733|467263990|FG003|Overall Study|Discharged from Study Site|11|||
129808255|NCT02761733|467263987|FG000|Overall Study|Cognitive Impairment|5|||
129808256|NCT02761733|467263988|FG001|Overall Study|Cognitive Impairment|0|||
129808257|NCT02761733|467263989|FG002|Overall Study|Cognitive Impairment|1|||
129808258|NCT02761733|467263990|FG003|Overall Study|Cognitive Impairment|0|||
129808259|NCT01986907|467263993|FG000|Overall Study|Adverse Event|11|||
129808260|NCT01986907|467263993|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
129808261|NCT01986907|467263993|FG000|Overall Study|Protocol Violation|4|||
129808262|NCT01986907|467263993|FG000|Overall Study|Withdrawal by Subject|76|||
129808263|NCT01986907|467263993|FG000|Overall Study|Lost to Follow-up|38|||
129808264|NCT01986907|467263993|FG000|Overall Study|Death|9|||
129808265|NCT04295772|467263997|FG000|Overall Study|Protocol Violation|1|||
129808266|NCT04295772|467263998|FG001|Overall Study|Protocol Violation|0|||
129808267|NCT04295772|467263997|FG000|Overall Study|Ongoing for safety monitoring|14|||
129745192|NCT03738618|467026870|FG001|Overall Study|Protocol deviation|0|||
129808268|NCT04295772|467263998|FG001|Overall Study|Ongoing for safety monitoring|1|||
129745193|NCT03738618|467026869|FG000|Overall Study|Adverse Event|4|||
129745194|NCT03738618|467026870|FG001|Overall Study|Adverse Event|0|||
129745195|NCT03738618|467026869|FG000|Overall Study|Lost to Follow-up|2|||
129745196|NCT03738618|467026870|FG001|Overall Study|Lost to Follow-up|0|||
129745197|NCT03738618|467026869|FG000|Overall Study|Randomization failure|1|||
129808269|NCT04295772|467263997|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
129745198|NCT03738618|467026870|FG001|Overall Study|Randomization failure|0|||
129745199|NCT03738618|467026869|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
129745200|NCT03738618|467026870|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
129745201|NCT03738618|467026869|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
129745202|NCT03738618|467026870|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
129745203|NCT01769196|467026871|FG000|Overall Study|Adverse Event|24|||
129745204|NCT01769196|467026872|FG001|Overall Study|Adverse Event|20|||
129745205|NCT01769196|467026871|FG000|Overall Study|Death|21|||
129745206|NCT01769196|467026872|FG001|Overall Study|Death|26|||
129745207|NCT01769196|467026871|FG000|Overall Study|Investigator Discretion|7|||
129745208|NCT01769196|467026872|FG001|Overall Study|Investigator Discretion|3|||
129745209|NCT01769196|467026871|FG000|Overall Study|Lack of Efficacy|3|||
129745210|NCT01769196|467026872|FG001|Overall Study|Lack of Efficacy|2|||
129745211|NCT01769196|467026871|FG000|Overall Study|Progressive disease|11|||
129745212|NCT01769196|467026872|FG001|Overall Study|Progressive disease|6|||
129745213|NCT01769196|467026871|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
129745214|NCT01769196|467026872|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
129745215|NCT01769196|467026871|FG000|Overall Study|Protocol Violation|0|||
129745216|NCT01769196|467026872|FG001|Overall Study|Protocol Violation|3|||
129745217|NCT01769196|467026871|FG000|Overall Study|Study terminated by sponsor|160|||
129745218|NCT01769196|467026872|FG001|Overall Study|Study terminated by sponsor|161|||
129745219|NCT01769196|467026871|FG000|Overall Study|Participant never dosed with study drug|1|||
129745220|NCT01769196|467026872|FG001|Overall Study|Participant never dosed with study drug|0|||
129745221|NCT01769196|467026871|FG000|Overall Study|Withdrew consent|36|||
129745222|NCT01769196|467026872|FG001|Overall Study|Withdrew consent|40|||
129745223|NCT01450098|467026879|FG000|Period 3|Protocol Violation|0|||
129745224|NCT01450098|467026880|FG001|Period 3|Protocol Violation|1|||
129745225|NCT01450098|467026879|FG000|Period 3|Withdrawal by Subject|0|||
129745226|NCT01450098|467026880|FG001|Period 3|Withdrawal by Subject|2|||
129745227|NCT00655629|467026881|FG000|Overall Study|Adverse Event|4|||
129745228|NCT00655629|467026882|FG001|Overall Study|Adverse Event|1|||
129745229|NCT00655629|467026881|FG000|Overall Study|Lack of Efficacy|2|||
129745230|NCT00655629|467026882|FG001|Overall Study|Lack of Efficacy|12|||
129745231|NCT00655629|467026881|FG000|Overall Study|Lost to Follow-up|4|||
129745232|NCT00655629|467026882|FG001|Overall Study|Lost to Follow-up|3|||
129808270|NCT04295772|467263998|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
129808271|NCT03576495|467264011|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
129808272|NCT03576495|467264012|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
129808273|NCT03608254|467264014|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
129808274|NCT03608254|467264014|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
129808275|NCT00239590|467264016|FG000|Randomized|Lost to Follow-up|0|||
129808276|NCT00239590|467264017|FG001|Randomized|Lost to Follow-up|1|||
129808277|NCT00239590|467264016|FG000|Randomized|Withdrawal by Subject|0|||
129808278|NCT00239590|467264017|FG001|Randomized|Withdrawal by Subject|1|||
129808279|NCT00239590|467264016|FG000|Completed Study Protocol|Adverse Event|1|||
129808280|NCT00239590|467264017|FG001|Completed Study Protocol|Adverse Event|1|||
129808281|NCT00239590|467264016|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
129808282|NCT00239590|467264017|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
129808283|NCT02362269|467264020|FG000|Overall Study|Moved|1|||
129808284|NCT02362269|467264021|FG001|Overall Study|Moved|0|||
129808285|NCT02362269|467264020|FG000|Overall Study|Lost to Follow-up|0|||
129808286|NCT02362269|467264021|FG001|Overall Study|Lost to Follow-up|6|||
129808287|NCT01903031|467264022|FG000|Overall Study|Not Able to Attend Clinic|1|||
129808288|NCT01903031|467264023|FG001|Overall Study|Not Able to Attend Clinic|1|||
129808289|NCT01903031|467264024|FG002|Overall Study|Not Able to Attend Clinic|0|||
129808290|NCT01903031|467264022|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
129745233|NCT00655629|467026881|FG000|Overall Study|Protocol Violation|5|||
129745234|NCT00655629|467026882|FG001|Overall Study|Protocol Violation|3|||
129808291|NCT01903031|467264023|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
129808292|NCT01903031|467264024|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
129808293|NCT01903031|467264022|FG000|Overall Study|Adverse Event|0|||
129895752|NCT04310579|467578547|FG006|Overall Study|Withdrawal by Subject|0|||
129895753|NCT04310579|467578548|FG007|Overall Study|Withdrawal by Subject|0|||
129745235|NCT00655629|467026881|FG000|Overall Study|consent withdrawn|6|||
129745236|NCT00655629|467026882|FG001|Overall Study|consent withdrawn|4|||
129745237|NCT00705367|467026883|FG000|Long-term Extension Period|Adverse Event|2|||
129895754|NCT04310579|467578549|FG008|Overall Study|Withdrawal by Subject|0|||
129808294|NCT01903031|467264023|FG001|Overall Study|Adverse Event|1|||
129808295|NCT01903031|467264024|FG002|Overall Study|Adverse Event|0|||
129808296|NCT01903031|467264022|FG000|Overall Study|Withdrawal by Subject|0|||
129895755|NCT04310579|467578550|FG009|Overall Study|Withdrawal by Subject|0|||
129895756|NCT04310579|467578551|FG010|Overall Study|Withdrawal by Subject|0|||
129745238|NCT00705367|467026884|FG001|Long-term Extension Period|Adverse Event|0|||
129745239|NCT00705367|467026883|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
129745240|NCT00705367|467026884|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
129745241|NCT00705367|467026883|FG000|Long-term Extension Period|Lack of Efficacy|1|||
129745242|NCT00705367|467026884|FG001|Long-term Extension Period|Lack of Efficacy|0|||
129745243|NCT00705367|467026883|FG000|Long-term Extension Period|No longer met study criteria|1|||
129745244|NCT00705367|467026884|FG001|Long-term Extension Period|No longer met study criteria|0|||
129745245|NCT00705367|467026883|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
129745246|NCT00705367|467026884|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
129745247|NCT01832155|467026885|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
129745248|NCT01832155|467026886|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
129745249|NCT01832155|467026885|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
129745250|NCT01832155|467026886|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
129745251|NCT01055314|467026887|FG000|Overall Study|Adverse Event|7|||
129745252|NCT01055314|467026888|FG001|Overall Study|Adverse Event|4|||
129745253|NCT01055314|467026887|FG000|Overall Study|Death|2|||
129745254|NCT01055314|467026888|FG001|Overall Study|Death|1|||
129745255|NCT01055314|467026887|FG000|Overall Study|Lack of Efficacy|11|||
129745256|NCT01055314|467026888|FG001|Overall Study|Lack of Efficacy|19|||
129745257|NCT01055314|467026887|FG000|Overall Study|Physician Decision|10|||
129745258|NCT01055314|467026888|FG001|Overall Study|Physician Decision|5|||
129745259|NCT01055314|467026887|FG000|Overall Study|Withdrawal by Subject|1|||
129745260|NCT01055314|467026888|FG001|Overall Study|Withdrawal by Subject|0|||
129745261|NCT01055314|467026887|FG000|Overall Study|Ineligible|3|||
129745262|NCT01055314|467026888|FG001|Overall Study|Ineligible|5|||
129745263|NCT01055314|467026887|FG000|Overall Study|Refusal of further protocol therapy|10|||
129745264|NCT01055314|467026888|FG001|Overall Study|Refusal of further protocol therapy|4|||
129745265|NCT01055314|467026887|FG000|Overall Study|No treatment|1|||
129745266|NCT01055314|467026888|FG001|Overall Study|No treatment|0|||
129745267|NCT01279616|467026889|FG000|Overall Study|donor could not be located|5|||
129745268|NCT01279616|467026889|FG000|Overall Study|no signs of sickle cell disease|2|||
129745269|NCT02462720|467026890|FG000|Part 2|Withdrawal by Subject|1|||
129745270|NCT02462720|467026891|FG001|Part 2|Withdrawal by Subject|0|||
129745271|NCT02462720|467026890|FG000|Part 2|Protocol Violation|0|||
129745272|NCT02462720|467026891|FG001|Part 2|Protocol Violation|1|||
129745273|NCT00183625|467026894|FG000|Overall Study|Withdrawal by Subject|18|||
129745274|NCT00183625|467026895|FG001|Overall Study|Withdrawal by Subject|18|||
129745275|NCT00183625|467026896|FG002|Overall Study|Withdrawal by Subject|19|||
129745276|NCT00183625|467026897|FG003|Overall Study|Withdrawal by Subject|14|||
129745277|NCT05249569|467026900|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
129745278|NCT02678923|467026901|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
129745279|NCT02678923|467026902|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
129745280|NCT02678923|467026901|FG000|Overall Study|Withdrawal by Subject|3|||
129745281|NCT02678923|467026902|FG001|Overall Study|Withdrawal by Subject|2|||
129745282|NCT02678923|467026901|FG000|Overall Study|Lost to Follow-up|1|||
129745283|NCT02678923|467026902|FG001|Overall Study|Lost to Follow-up|0|||
129745284|NCT02678923|467026901|FG000|Overall Study|Did Not Return for Study Visits|1|||
129745285|NCT02678923|467026902|FG001|Overall Study|Did Not Return for Study Visits|0|||
129745286|NCT00098306|467026905|FG000|Double Blind|Randomized, not treated|9|||
129745287|NCT00098306|467026906|FG001|Double Blind|Randomized, not treated|5|||
129745288|NCT00098306|467026907|FG002|Double Blind|Randomized, not treated|2|||
129745289|NCT00098306|467026908|FG003|Double Blind|Randomized, not treated|0|||
129745290|NCT00098306|467026909|FG004|Double Blind|Randomized, not treated|0|||
129745291|NCT00098306|467026910|FG005|Double Blind|Randomized, not treated|0|||
129745292|NCT00098306|467026911|FG006|Double Blind|Randomized, not treated|0|||
129745293|NCT00098306|467026905|FG000|Double Blind|Ongoing at cut-off date|151|||
129745294|NCT00098306|467026906|FG001|Double Blind|Ongoing at cut-off date|166|||
129745295|NCT00098306|467026907|FG002|Double Blind|Ongoing at cut-off date|72|||
129745296|NCT00098306|467026908|FG003|Double Blind|Ongoing at cut-off date|0|||
129745297|NCT00098306|467026909|FG004|Double Blind|Ongoing at cut-off date|0|||
129745298|NCT00098306|467026910|FG005|Double Blind|Ongoing at cut-off date|0|||
129745299|NCT00098306|467026911|FG006|Double Blind|Ongoing at cut-off date|0|||
129745300|NCT00098306|467026905|FG000|Double Blind|Adverse Event|11|||
129745301|NCT00098306|467026906|FG001|Double Blind|Adverse Event|10|||
129745302|NCT00098306|467026907|FG002|Double Blind|Adverse Event|6|||
129745303|NCT00098306|467026908|FG003|Double Blind|Adverse Event|0|||
129745304|NCT00098306|467026909|FG004|Double Blind|Adverse Event|0|||
129745305|NCT00098306|467026910|FG005|Double Blind|Adverse Event|0|||
129745306|NCT00098306|467026911|FG006|Double Blind|Adverse Event|0|||
129745307|NCT00098306|467026905|FG000|Double Blind|Lack of Efficacy|43|||
129745308|NCT00098306|467026906|FG001|Double Blind|Lack of Efficacy|34|||
129745309|NCT00098306|467026907|FG002|Double Blind|Lack of Efficacy|17|||
129745310|NCT00098306|467026908|FG003|Double Blind|Lack of Efficacy|0|||
129745311|NCT00098306|467026909|FG004|Double Blind|Lack of Efficacy|0|||
129745312|NCT00098306|467026910|FG005|Double Blind|Lack of Efficacy|0|||
129745313|NCT00098306|467026911|FG006|Double Blind|Lack of Efficacy|0|||
129745314|NCT00098306|467026905|FG000|Double Blind|Death|1|||
129745315|NCT00098306|467026906|FG001|Double Blind|Death|4|||
129745316|NCT00098306|467026907|FG002|Double Blind|Death|1|||
129745317|NCT00098306|467026908|FG003|Double Blind|Death|0|||
129745318|NCT00098306|467026909|FG004|Double Blind|Death|0|||
129745319|NCT00098306|467026910|FG005|Double Blind|Death|0|||
129745320|NCT00098306|467026911|FG006|Double Blind|Death|0|||
129745321|NCT00098306|467026905|FG000|Double Blind|Participant defaulted|19|||
129745322|NCT00098306|467026906|FG001|Double Blind|Participant defaulted|18|||
129745323|NCT00098306|467026907|FG002|Double Blind|Participant defaulted|11|||
129745324|NCT00098306|467026908|FG003|Double Blind|Participant defaulted|0|||
129745325|NCT00098306|467026909|FG004|Double Blind|Participant defaulted|0|||
129745326|NCT00098306|467026910|FG005|Double Blind|Participant defaulted|0|||
129745327|NCT00098306|467026911|FG006|Double Blind|Participant defaulted|0|||
129745328|NCT00098306|467026905|FG000|Double Blind|Un-specified|7|||
129745329|NCT00098306|467026906|FG001|Double Blind|Un-specified|3|||
129745330|NCT00098306|467026907|FG002|Double Blind|Un-specified|11|||
129745331|NCT00098306|467026908|FG003|Double Blind|Un-specified|0|||
129745332|NCT00098306|467026909|FG004|Double Blind|Un-specified|0|||
129745333|NCT00098306|467026910|FG005|Double Blind|Un-specified|0|||
129745334|NCT00098306|467026911|FG006|Double Blind|Un-specified|0|||
129745335|NCT00098306|467026905|FG000|Open Label|Lack of Efficacy|0|||
129745336|NCT00098306|467026906|FG001|Open Label|Lack of Efficacy|0|||
129745337|NCT00098306|467026907|FG002|Open Label|Lack of Efficacy|0|||
129745338|NCT00098306|467026908|FG003|Open Label|Lack of Efficacy|13|||
129745339|NCT00098306|467026909|FG004|Open Label|Lack of Efficacy|0|||
129745340|NCT00098306|467026910|FG005|Open Label|Lack of Efficacy|0|||
129745341|NCT00098306|467026911|FG006|Open Label|Lack of Efficacy|0|||
129745342|NCT00098306|467026905|FG000|Open Label|Adverse Event|0|||
129745343|NCT00098306|467026906|FG001|Open Label|Adverse Event|0|||
129745344|NCT00098306|467026907|FG002|Open Label|Adverse Event|0|||
129745345|NCT00098306|467026908|FG003|Open Label|Adverse Event|2|||
129745346|NCT00098306|467026909|FG004|Open Label|Adverse Event|0|||
129745347|NCT00098306|467026910|FG005|Open Label|Adverse Event|0|||
129745348|NCT00098306|467026911|FG006|Open Label|Adverse Event|0|||
129745349|NCT00098306|467026905|FG000|Open Label|Death|0|||
129745350|NCT00098306|467026906|FG001|Open Label|Death|0|||
129745351|NCT00098306|467026907|FG002|Open Label|Death|0|||
129745352|NCT00098306|467026908|FG003|Open Label|Death|4|||
129745353|NCT00098306|467026909|FG004|Open Label|Death|0|||
129745354|NCT00098306|467026910|FG005|Open Label|Death|0|||
129745355|NCT00098306|467026911|FG006|Open Label|Death|0|||
129745356|NCT00098306|467026905|FG000|Open Label|Participant defaulted|0|||
129745357|NCT00098306|467026906|FG001|Open Label|Participant defaulted|0|||
129745358|NCT00098306|467026907|FG002|Open Label|Participant defaulted|0|||
129745359|NCT00098306|467026908|FG003|Open Label|Participant defaulted|24|||
129745360|NCT00098306|467026909|FG004|Open Label|Participant defaulted|0|||
129745361|NCT00098306|467026910|FG005|Open Label|Participant defaulted|0|||
129745362|NCT00098306|467026911|FG006|Open Label|Participant defaulted|0|||
129745363|NCT00098306|467026905|FG000|Open Label|Un-specified|0|||
129745364|NCT00098306|467026906|FG001|Open Label|Un-specified|0|||
129745365|NCT00098306|467026907|FG002|Open Label|Un-specified|0|||
129745366|NCT00098306|467026908|FG003|Open Label|Un-specified|15|||
129745367|NCT00098306|467026909|FG004|Open Label|Un-specified|0|||
129745368|NCT00098306|467026910|FG005|Open Label|Un-specified|0|||
129745369|NCT00098306|467026911|FG006|Open Label|Un-specified|0|||
129745370|NCT00098306|467026905|FG000|Open Label|Ongoing at cut-off date|0|||
129745371|NCT00098306|467026906|FG001|Open Label|Ongoing at cut-off date|0|||
129745372|NCT00098306|467026907|FG002|Open Label|Ongoing at cut-off date|0|||
129745373|NCT00098306|467026908|FG003|Open Label|Ongoing at cut-off date|269|||
129745374|NCT00098306|467026909|FG004|Open Label|Ongoing at cut-off date|62|||
129745375|NCT00098306|467026910|FG005|Open Label|Ongoing at cut-off date|0|||
129745376|NCT00098306|467026911|FG006|Open Label|Ongoing at cut-off date|0|||
129745377|NCT00098306|467026905|FG000|Observational Phase|Death|0|||
129745378|NCT00098306|467026906|FG001|Observational Phase|Death|0|||
129745379|NCT00098306|467026907|FG002|Observational Phase|Death|0|||
129745380|NCT00098306|467026908|FG003|Observational Phase|Death|0|||
129745381|NCT00098306|467026909|FG004|Observational Phase|Death|0|||
129745382|NCT00098306|467026910|FG005|Observational Phase|Death|5|||
129745383|NCT00098306|467026911|FG006|Observational Phase|Death|4|||
129745384|NCT00098306|467026905|FG000|Observational Phase|Participant defaulted|0|||
129745385|NCT00098306|467026906|FG001|Observational Phase|Participant defaulted|0|||
129745386|NCT00098306|467026907|FG002|Observational Phase|Participant defaulted|0|||
129745387|NCT00098306|467026908|FG003|Observational Phase|Participant defaulted|0|||
129745388|NCT00098306|467026909|FG004|Observational Phase|Participant defaulted|0|||
129745389|NCT00098306|467026910|FG005|Observational Phase|Participant defaulted|34|||
129745390|NCT00098306|467026911|FG006|Observational Phase|Participant defaulted|18|||
129745391|NCT00098306|467026905|FG000|Observational Phase|Un-specified|0|||
129745392|NCT00098306|467026906|FG001|Observational Phase|Un-specified|0|||
129745393|NCT00098306|467026907|FG002|Observational Phase|Un-specified|0|||
129745394|NCT00098306|467026908|FG003|Observational Phase|Un-specified|0|||
129745395|NCT00098306|467026909|FG004|Observational Phase|Un-specified|0|||
129745396|NCT00098306|467026910|FG005|Observational Phase|Un-specified|7|||
129745397|NCT00098306|467026911|FG006|Observational Phase|Un-specified|4|||
129745398|NCT01423916|467026912|FG000|Overall Study|Adverse Event|5|||
129745399|NCT01423916|467026913|FG001|Overall Study|Adverse Event|9|||
129745400|NCT01423916|467026914|FG002|Overall Study|Adverse Event|2|||
129745401|NCT01423916|467026912|FG000|Overall Study|Met Withdrawal Criteria|1|||
129745402|NCT01423916|467026913|FG001|Overall Study|Met Withdrawal Criteria|1|||
129745403|NCT01423916|467026914|FG002|Overall Study|Met Withdrawal Criteria|1|||
129745404|NCT01423916|467026912|FG000|Overall Study|Physician Decision|1|||
129745405|NCT01423916|467026913|FG001|Overall Study|Physician Decision|0|||
129745406|NCT01423916|467026914|FG002|Overall Study|Physician Decision|1|||
129745407|NCT01423916|467026912|FG000|Overall Study|Withdrawal by Subject|3|||
129745408|NCT01423916|467026913|FG001|Overall Study|Withdrawal by Subject|10|||
129745409|NCT01423916|467026914|FG002|Overall Study|Withdrawal by Subject|3|||
129745410|NCT01423916|467026912|FG000|Overall Study|Protocol Deviation|1|||
129745411|NCT01423916|467026913|FG001|Overall Study|Protocol Deviation|0|||
129745412|NCT01423916|467026914|FG002|Overall Study|Protocol Deviation|0|||
129745413|NCT01966445|467026919|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129745414|NCT01966445|467026920|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129745415|NCT01966445|467026921|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129745416|NCT01966445|467026922|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
129745417|NCT01966445|467026923|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129745418|NCT01966445|467026924|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
129745419|NCT01966445|467026925|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
129745420|NCT01966445|467026919|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129745421|NCT01966445|467026920|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
129745422|NCT01966445|467026921|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129745423|NCT01966445|467026922|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
129745424|NCT01966445|467026923|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
129745425|NCT01966445|467026924|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129745426|NCT01966445|467026925|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
129745427|NCT01966445|467026919|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129745428|NCT01966445|467026920|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
129745429|NCT01966445|467026921|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
129745430|NCT01966445|467026922|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129745431|NCT01966445|467026923|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
129745432|NCT01966445|467026924|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129745433|NCT01966445|467026925|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
129745434|NCT01966445|467026919|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129745435|NCT01966445|467026920|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129745436|NCT01966445|467026921|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129745437|NCT01966445|467026922|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129745438|NCT01966445|467026923|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129745439|NCT01966445|467026924|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
129745440|NCT01966445|467026925|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
129745441|NCT01966445|467026919|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129745442|NCT01966445|467026920|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129745443|NCT01966445|467026921|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129745444|NCT01966445|467026922|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129745445|NCT01966445|467026923|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129745446|NCT01966445|467026924|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
129745447|NCT01966445|467026925|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
129745448|NCT01374178|467026926|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
129745449|NCT01374178|467026927|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
129745450|NCT01374178|467026926|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
129745451|NCT01374178|467026927|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
129745452|NCT04856904|467026930|FG000|Overall Study|Physician Decision|1|||
129745453|NCT04856904|467026931|FG001|Overall Study|Physician Decision|1|||
129745454|NCT04856904|467026930|FG000|Overall Study|Withdrawal by Subject|13|||
129745455|NCT04856904|467026931|FG001|Overall Study|Withdrawal by Subject|13|||
129745456|NCT04856904|467026930|FG000|Overall Study|Adverse Event|1|||
129745457|NCT04856904|467026931|FG001|Overall Study|Adverse Event|1|||
129745458|NCT04856904|467026930|FG000|Overall Study|Non-compliance with study drug|1|||
129745459|NCT04856904|467026931|FG001|Overall Study|Non-compliance with study drug|1|||
129745460|NCT04856904|467026930|FG000|Overall Study|Lost to Follow-up|4|||
129745461|NCT04856904|467026931|FG001|Overall Study|Lost to Follow-up|4|||
129745462|NCT04856904|467026930|FG000|Overall Study|Withdrawal by Subject|1|||
129745463|NCT04856904|467026931|FG001|Overall Study|Withdrawal by Subject|1|||
129745464|NCT04856904|467026930|FG000|Overall Study|Protocol Violation|1|||
129745465|NCT04856904|467026931|FG001|Overall Study|Protocol Violation|1|||
129745466|NCT00077649|467026932|FG000|Overall Study|Adverse Event|5|||
129745467|NCT00077649|467026933|FG001|Overall Study|Adverse Event|1|||
129745468|NCT00077649|467026934|FG002|Overall Study|Adverse Event|7|||
129745469|NCT00077649|467026935|FG003|Overall Study|Adverse Event|9|||
129745470|NCT00077649|467026932|FG000|Overall Study|Lack of Efficacy|5|||
129745471|NCT00077649|467026933|FG001|Overall Study|Lack of Efficacy|3|||
129745472|NCT00077649|467026934|FG002|Overall Study|Lack of Efficacy|3|||
129745473|NCT00077649|467026935|FG003|Overall Study|Lack of Efficacy|2|||
129745474|NCT00077649|467026932|FG000|Overall Study|Withdrawal by Subject|0|||
129745475|NCT00077649|467026933|FG001|Overall Study|Withdrawal by Subject|1|||
129745476|NCT00077649|467026934|FG002|Overall Study|Withdrawal by Subject|1|||
129745477|NCT00077649|467026935|FG003|Overall Study|Withdrawal by Subject|2|||
129745478|NCT00077649|467026932|FG000|Overall Study|Lost to Follow-up|2|||
129745479|NCT00077649|467026933|FG001|Overall Study|Lost to Follow-up|2|||
129745480|NCT00077649|467026934|FG002|Overall Study|Lost to Follow-up|3|||
129745481|NCT00077649|467026935|FG003|Overall Study|Lost to Follow-up|2|||
129745482|NCT00077649|467026932|FG000|Overall Study|Abnormality of Laboratory Test|1|||
129745483|NCT00077649|467026933|FG001|Overall Study|Abnormality of Laboratory Test|2|||
129745484|NCT00077649|467026934|FG002|Overall Study|Abnormality of Laboratory Test|1|||
129745485|NCT00077649|467026935|FG003|Overall Study|Abnormality of Laboratory Test|2|||
129745486|NCT00077649|467026932|FG000|Overall Study|Randomized but never dosed|1|||
129745487|NCT00077649|467026933|FG001|Overall Study|Randomized but never dosed|0|||
129745488|NCT00077649|467026934|FG002|Overall Study|Randomized but never dosed|0|||
129745489|NCT00077649|467026935|FG003|Overall Study|Randomized but never dosed|0|||
129745490|NCT01641822|467026936|FG000|Run-in Phase|Noncompliance with study drug|1|||
129745491|NCT01641822|467026937|FG001|Run-in Phase|Noncompliance with study drug|0|||
129745492|NCT01641822|467026938|FG002|Run-in Phase|Noncompliance with study drug|0|||
129745493|NCT01641822|467026936|FG000|Run-in Phase|Adverse Event|3|||
129745494|NCT01641822|467026937|FG001|Run-in Phase|Adverse Event|0|||
129745495|NCT01641822|467026938|FG002|Run-in Phase|Adverse Event|0|||
129745496|NCT01641822|467026936|FG000|Run-in Phase|Withdrew consent|1|||
129745497|NCT01641822|467026937|FG001|Run-in Phase|Withdrew consent|0|||
129745498|NCT01641822|467026938|FG002|Run-in Phase|Withdrew consent|0|||
129745499|NCT01641822|467026936|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
129745500|NCT01641822|467026937|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
129745501|NCT01641822|467026938|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
129745502|NCT01641822|467026936|FG000|Comparative Phase|Noncompliance with study drug|0|||
129745503|NCT01641822|467026937|FG001|Comparative Phase|Noncompliance with study drug|1|||
129745504|NCT01641822|467026938|FG002|Comparative Phase|Noncompliance with study drug|0|||
129745505|NCT01641822|467026936|FG000|Comparative Phase|Investigator's discretion|0|||
129745506|NCT01641822|467026937|FG001|Comparative Phase|Investigator's discretion|0|||
129745507|NCT01641822|467026938|FG002|Comparative Phase|Investigator's discretion|1|||
129745508|NCT01641822|467026936|FG000|Comparative Phase|Pregnancy|0|||
129745509|NCT01641822|467026937|FG001|Comparative Phase|Pregnancy|0|||
129745510|NCT01641822|467026938|FG002|Comparative Phase|Pregnancy|1|||
129745511|NCT01641822|467026936|FG000|Comparative Phase|Adverse event, serious fatal|0|||
129745512|NCT01641822|467026937|FG001|Comparative Phase|Adverse event, serious fatal|1|||
129745513|NCT01641822|467026938|FG002|Comparative Phase|Adverse event, serious fatal|0|||
129745514|NCT01641822|467026936|FG000|Comparative Phase|Withdrew consent|0|||
129745515|NCT01641822|467026937|FG001|Comparative Phase|Withdrew consent|3|||
129745516|NCT01641822|467026938|FG002|Comparative Phase|Withdrew consent|7|||
129745517|NCT01641822|467026936|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
129745518|NCT01641822|467026937|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
129745519|NCT01641822|467026938|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
129745520|NCT02421601|467026939|FG000|Overall Study|Adverse Event|4|||
129745521|NCT02421601|467026939|FG000|Overall Study|Lack of Efficacy|5|||
129745522|NCT02421601|467026939|FG000|Overall Study|Physician Decision|1|||
129745523|NCT02421601|467026939|FG000|Overall Study|Withdrawal by Subject|31|||
129745524|NCT02421601|467026939|FG000|Overall Study|Others|41|||
129745525|NCT00599638|467026940|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
129745526|NCT00599638|467026941|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
129745527|NCT00599638|467026942|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
129745528|NCT00599638|467026943|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
129745529|NCT00599638|467026940|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
129745530|NCT00599638|467026941|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
129745531|NCT00599638|467026942|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
129745532|NCT00599638|467026943|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
129745533|NCT00599638|467026940|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
129745534|NCT00599638|467026941|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
129745535|NCT00599638|467026942|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
129745536|NCT00599638|467026943|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
129745537|NCT00599638|467026940|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
129745538|NCT00599638|467026941|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
129745539|NCT00599638|467026942|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
129745540|NCT00599638|467026943|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
129745541|NCT00599638|467026940|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
129745542|NCT00599638|467026941|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
129745543|NCT00599638|467026942|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
129745544|NCT00599638|467026943|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
129745545|NCT00599638|467026940|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
129745546|NCT00599638|467026941|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
129745547|NCT00599638|467026942|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
129745548|NCT00599638|467026943|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
129745549|NCT00599638|467026940|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
129745550|NCT00599638|467026941|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
129745551|NCT00599638|467026942|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
129745552|NCT00599638|467026943|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
129745553|NCT00599638|467026940|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
129745554|NCT00599638|467026941|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
129745555|NCT00599638|467026942|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
129745556|NCT00599638|467026943|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
129745557|NCT00599638|467026940|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
129745558|NCT00599638|467026941|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
129745559|NCT00599638|467026942|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
129745560|NCT00599638|467026943|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
129745561|NCT02895945|467026946|FG000|Overall Study|Physician Decision|2|||
129745562|NCT02895945|467026947|FG001|Overall Study|Physician Decision|1|||
129745563|NCT01026220|467026951|FG000|Induction|Death|1|||
129745564|NCT01026220|467026952|FG001|Induction|Death|0|||
129745565|NCT01026220|467026953|FG002|Induction|Death|0|||
129745566|NCT01026220|467026951|FG000|Induction|Lack of Efficacy|2|||
129745567|NCT01026220|467026952|FG001|Induction|Lack of Efficacy|0|||
129745568|NCT01026220|467026953|FG002|Induction|Lack of Efficacy|0|||
129745569|NCT01026220|467026951|FG000|Induction|Physician Decision|12|||
129745570|NCT01026220|467026952|FG001|Induction|Physician Decision|0|||
129745571|NCT01026220|467026953|FG002|Induction|Physician Decision|0|||
129745572|NCT01026220|467026951|FG000|Induction|Withdrawal by Subject|9|||
129745573|NCT01026220|467026952|FG001|Induction|Withdrawal by Subject|0|||
129745574|NCT01026220|467026953|FG002|Induction|Withdrawal by Subject|0|||
129745575|NCT01026220|467026951|FG000|Induction|Ineligible|1|||
129745576|NCT01026220|467026952|FG001|Induction|Ineligible|0|||
129745577|NCT01026220|467026953|FG002|Induction|Ineligible|0|||
129745578|NCT01026220|467026951|FG000|Consolidation Maintenance|Death|0|||
129745579|NCT01026220|467026952|FG001|Consolidation Maintenance|Death|1|||
129745580|NCT01026220|467026953|FG002|Consolidation Maintenance|Death|0|||
129745581|NCT01026220|467026951|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
129745582|NCT01026220|467026952|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
129745583|NCT01026220|467026953|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
129745584|NCT01026220|467026951|FG000|Consolidation Maintenance|Physician Decision|0|||
129745585|NCT01026220|467026952|FG001|Consolidation Maintenance|Physician Decision|2|||
129745586|NCT01026220|467026953|FG002|Consolidation Maintenance|Physician Decision|7|||
129745587|NCT01026220|467026951|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
129745588|NCT01026220|467026952|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
129808297|NCT01903031|467264023|FG001|Overall Study|Withdrawal by Subject|1|||
129808298|NCT01903031|467264024|FG002|Overall Study|Withdrawal by Subject|1|||
129808299|NCT01903031|467264022|FG000|Overall Study|Protocol Violation|0|||
129745589|NCT01026220|467026953|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
129745590|NCT03550404|467026954|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
129745591|NCT03550404|467026955|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
129745592|NCT03550404|467026956|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
129745593|NCT03550404|467026954|FG000|Phase 2|Vacated position|1|||
129808300|NCT01903031|467264023|FG001|Overall Study|Protocol Violation|0|||
129745594|NCT03550404|467026955|FG001|Phase 2|Vacated position|0|||
129745595|NCT03550404|467026956|FG002|Phase 2|Vacated position|0|||
129745596|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
129745597|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
129745598|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
129745599|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
129745600|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
129745601|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
129745602|NCT01389323|467026958|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
129745603|NCT01389323|467026958|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
129745604|NCT01389323|467026958|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
129745605|NCT01389323|467026958|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
129745606|NCT01389323|467026958|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
129808301|NCT01903031|467264024|FG002|Overall Study|Protocol Violation|2|||
129808302|NCT01903031|467264022|FG000|Overall Study|Lost to Follow-up|0|||
129745607|NCT05096312|467026959|FG000|Overall Study|Lost to Follow-up|2|||
129745608|NCT05096312|467026960|FG001|Overall Study|Lost to Follow-up|4|||
129745609|NCT05096312|467026959|FG000|Overall Study|Adverse Event|1|||
129745610|NCT05096312|467026960|FG001|Overall Study|Adverse Event|0|||
129745611|NCT03135210|467026961|FG000|Overall Study|Death|0|||
129745612|NCT03135210|467026962|FG001|Overall Study|Death|1|||
129745613|NCT00844558|467026964|FG000|Overall Study|Withdrawal by Subject|9|||
129745614|NCT00844558|467026965|FG001|Overall Study|Withdrawal by Subject|2|||
129745615|NCT00844558|467026964|FG000|Overall Study|Death|1|||
129745616|NCT00844558|467026965|FG001|Overall Study|Death|0|||
129745617|NCT00844558|467026964|FG000|Overall Study|Protocol Violation|1|||
129745618|NCT00844558|467026965|FG001|Overall Study|Protocol Violation|1|||
129745619|NCT00844558|467026964|FG000|Overall Study|Lost to Follow-up|0|||
129745620|NCT00844558|467026965|FG001|Overall Study|Lost to Follow-up|1|||
129745621|NCT00844558|467026964|FG000|Overall Study|Physician Decision|1|||
129745622|NCT00844558|467026965|FG001|Overall Study|Physician Decision|0|||
129745623|NCT01894022|467026981|FG000|Overall Study|Death|1|||
129745624|NCT01894022|467026982|FG001|Overall Study|Death|0|||
129745625|NCT01894022|467026981|FG000|Overall Study|Adverse Event, non-fatal|1|||
129745626|NCT01894022|467026982|FG001|Overall Study|Adverse Event, non-fatal|0|||
129745627|NCT01894022|467026981|FG000|Overall Study|Study Closed/terminated|7|||
129745628|NCT01894022|467026982|FG001|Overall Study|Study Closed/terminated|10|||
129745629|NCT04294147|467026991|FG000|Overall Study|Protocol Violation|2|||
129745630|NCT04294147|467026992|FG001|Overall Study|Protocol Violation|0|||
129745631|NCT05392803|467026993|FG000|Overall Study|Lost to Follow-up|0|||
129745632|NCT05392803|467026994|FG001|Overall Study|Lost to Follow-up|2|||
129745633|NCT01887353|467026997|FG000|Overall Study|Study stopped early|4|||
129745634|NCT01887353|467026998|FG001|Overall Study|Study stopped early|3|||
129745635|NCT00699335|467026999|FG000|Overall Study|Combination of multiple reasons|176|||
129745636|NCT00699335|467026999|FG000|Overall Study|Missing data|52|||
129745637|NCT01069705|467027000|FG000|Overall Study|Adverse Event|1|||
129745638|NCT01069705|467027000|FG000|Overall Study|Withdrawal by Subject|2|||
129745639|NCT02999633|467027001|FG000|Overall Study|Adverse Event|2|||
129745640|NCT02999633|467027001|FG000|Overall Study|Progressive disease|12|||
129745641|NCT01545050|467027002|FG000|Overall Study|Lack of Efficacy|0|||
129745642|NCT01545050|467027003|FG001|Overall Study|Lack of Efficacy|0|||
129745643|NCT01545050|467027004|FG002|Overall Study|Lack of Efficacy|0|||
129745644|NCT01545050|467027005|FG003|Overall Study|Lack of Efficacy|3|||
129745645|NCT01545050|467027006|FG004|Overall Study|Lack of Efficacy|2|||
129745646|NCT01545050|467027002|FG000|Overall Study|Adverse Event|1|||
129745647|NCT01545050|467027003|FG001|Overall Study|Adverse Event|1|||
129745648|NCT01545050|467027004|FG002|Overall Study|Adverse Event|2|||
129745649|NCT01545050|467027005|FG003|Overall Study|Adverse Event|2|||
129745650|NCT01545050|467027006|FG004|Overall Study|Adverse Event|0|||
129745651|NCT01545050|467027002|FG000|Overall Study|Discontinued study treatment|1|||
129745652|NCT01545050|467027003|FG001|Overall Study|Discontinued study treatment|0|||
129745653|NCT01545050|467027004|FG002|Overall Study|Discontinued study treatment|0|||
129745654|NCT01545050|467027005|FG003|Overall Study|Discontinued study treatment|0|||
129745655|NCT01545050|467027006|FG004|Overall Study|Discontinued study treatment|0|||
129745656|NCT01545050|467027002|FG000|Overall Study|Withdrawal by Subject|1|||
129745657|NCT01545050|467027003|FG001|Overall Study|Withdrawal by Subject|0|||
129745658|NCT01545050|467027004|FG002|Overall Study|Withdrawal by Subject|0|||
129745659|NCT01545050|467027005|FG003|Overall Study|Withdrawal by Subject|2|||
129745660|NCT01545050|467027006|FG004|Overall Study|Withdrawal by Subject|1|||
129745661|NCT01545050|467027002|FG000|Overall Study|Participant no longer meets study criteria|0|||
129808303|NCT01903031|467264023|FG001|Overall Study|Lost to Follow-up|0|||
129808304|NCT01903031|467264024|FG002|Overall Study|Lost to Follow-up|1|||
129808305|NCT01903031|467264022|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
129808306|NCT01903031|467264023|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
129808307|NCT01903031|467264024|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
129808308|NCT00447005|467264025|FG000|Overall Study|Adverse Event|1|||
129808309|NCT00447005|467264025|FG000|Overall Study|Lack of Efficacy|11|||
129808310|NCT01484275|467264029|FG000|Overall Study|Study terminated by sponsor|28|||
129808311|NCT01484275|467264030|FG001|Overall Study|Study terminated by sponsor|32|||
129745662|NCT01545050|467027003|FG001|Overall Study|Participant no longer meets study criteria|2|||
129745663|NCT01545050|467027004|FG002|Overall Study|Participant no longer meets study criteria|0|||
129745664|NCT01545050|467027005|FG003|Overall Study|Participant no longer meets study criteria|0|||
129745665|NCT01545050|467027006|FG004|Overall Study|Participant no longer meets study criteria|1|||
129745666|NCT01545050|467027002|FG000|Overall Study|Administrative reason by sponsor|4|||
129745667|NCT01545050|467027003|FG001|Overall Study|Administrative reason by sponsor|2|||
129745668|NCT01545050|467027004|FG002|Overall Study|Administrative reason by sponsor|3|||
129745669|NCT01545050|467027005|FG003|Overall Study|Administrative reason by sponsor|5|||
129745670|NCT01545050|467027006|FG004|Overall Study|Administrative reason by sponsor|5|||
129745671|NCT03262441|467027007|FG000|Overall Study|Withdrawal by Subject|1|||
129745672|NCT03235089|467027008|FG000|Overall Study|Lost to Follow-up|1|||
129745673|NCT03235089|467027009|FG001|Overall Study|Lost to Follow-up|1|||
129808312|NCT01484275|467264029|FG000|Overall Study|Other|10|||
129745674|NCT03235089|467027008|FG000|Overall Study|Physician Decision|2|||
129745675|NCT03235089|467027009|FG001|Overall Study|Physician Decision|2|||
129745676|NCT03238924|467027010|FG000|Overall Study|Withdrawal by Subject|2|||
129745677|NCT03238924|467027011|FG001|Overall Study|Withdrawal by Subject|2|||
129745678|NCT04667104|467027014|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
129745679|NCT04667104|467027015|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
129745680|NCT04667104|467027016|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
129745681|NCT02188849|467027017|FG000|Overall Study|Lost to Follow-up|3|||
129745682|NCT02188849|467027018|FG001|Overall Study|Lost to Follow-up|8|||
129745683|NCT01630889|467027019|FG000|Overall Study|Death|2|||
129745684|NCT01630889|467027019|FG000|Overall Study|Withdrawal by Subject|1|||
129745685|NCT01630889|467027019|FG000|Overall Study|Other than Specified|2|||
129745686|NCT01630889|467027019|FG000|Overall Study|Lost to Follow-up|4|||
129745687|NCT01630889|467027019|FG000|Overall Study|Other|1|||
129745688|NCT03208088|467027020|FG000|Period 2|Withdrawal by Subject|0|||
129745689|NCT03208088|467027021|FG001|Period 2|Withdrawal by Subject|0|||
129745690|NCT03208088|467027022|FG002|Period 2|Withdrawal by Subject|0|||
129745691|NCT03208088|467027023|FG003|Period 2|Withdrawal by Subject|0|||
129745692|NCT03208088|467027024|FG004|Period 2|Withdrawal by Subject|0|||
129745693|NCT03208088|467027025|FG005|Period 2|Withdrawal by Subject|0|||
129745694|NCT03208088|467027026|FG006|Period 2|Withdrawal by Subject|0|||
129745695|NCT03208088|467027027|FG007|Period 2|Withdrawal by Subject|0|||
129745696|NCT03208088|467027028|FG008|Period 2|Withdrawal by Subject|1|||
129745697|NCT03208088|467027029|FG009|Period 2|Withdrawal by Subject|0|||
129745698|NCT03208088|467027020|FG000|Period 3|Unsatisfactory Test Article|0|||
129745699|NCT03208088|467027021|FG001|Period 3|Unsatisfactory Test Article|0|||
129745700|NCT03208088|467027022|FG002|Period 3|Unsatisfactory Test Article|0|||
129745701|NCT03208088|467027023|FG003|Period 3|Unsatisfactory Test Article|1|||
129745702|NCT03208088|467027024|FG004|Period 3|Unsatisfactory Test Article|0|||
129745703|NCT03208088|467027025|FG005|Period 3|Unsatisfactory Test Article|0|||
129808313|NCT01484275|467264030|FG001|Overall Study|Other|0|||
129808314|NCT01484275|467264029|FG000|Overall Study|Death|3|||
129808315|NCT01484275|467264030|FG001|Overall Study|Death|4|||
129808316|NCT01484275|467264029|FG000|Overall Study|Withdrawal by Subject|1|||
129808317|NCT01484275|467264030|FG001|Overall Study|Withdrawal by Subject|5|||
129808318|NCT01484275|467264029|FG000|Overall Study|Lost to Follow-up|1|||
129808319|NCT01484275|467264030|FG001|Overall Study|Lost to Follow-up|1|||
129808320|NCT04154930|467264033|FG000|Overall Study|Withdrawal by Subject|15|||
129808321|NCT04154930|467264034|FG001|Overall Study|Withdrawal by Subject|6|||
129808322|NCT04154930|467264033|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
129808323|NCT04154930|467264034|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
129808324|NCT04154930|467264033|FG000|Overall Study|Lost to Follow-up|14|||
129808325|NCT04154930|467264034|FG001|Overall Study|Lost to Follow-up|6|||
129808326|NCT04154930|467264033|FG000|Overall Study|Other|6|||
129808327|NCT04154930|467264034|FG001|Overall Study|Other|0|||
129808328|NCT00722800|467264039|FG000|Overall Study|Withdrawal by Subject|1|||
129808329|NCT00722800|467264040|FG001|Overall Study|Withdrawal by Subject|0|||
129808330|NCT00722800|467264039|FG000|Overall Study|Physician Decision|1|||
129808331|NCT00722800|467264040|FG001|Overall Study|Physician Decision|0|||
129808332|NCT02130297|467264043|FG000|Overall Study|Lost to Follow-up|4|||
129808333|NCT00806351|467264057|FG000|Overall Study|Death|5|||
129808334|NCT00806351|467264058|FG001|Overall Study|Death|4|||
129808335|NCT00508755|467264063|FG000|Overall Study|Withdrawal by Subject|1|||
129808336|NCT04439201|467264069|FG000|Overall Study|Ineligible|2|||
129808337|NCT04439201|467264069|FG000|Overall Study|Never start protocol therapy|1|||
129808338|NCT04439201|467264069|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
129808339|NCT04439201|467264069|FG000|Overall Study|Mutation status not confirmed|4|||
129808340|NCT04439201|467264069|FG000|Overall Study|Adverse Event|1|||
129808341|NCT04439201|467264069|FG000|Overall Study|Death|7|||
129808342|NCT04439201|467264069|FG000|Overall Study|Withdrawal by Subject|2|||
129808343|NCT04439201|467264069|FG000|Overall Study|Disease progression|20|||
129895757|NCT04310579|467578541|FG000|Overall Study|Positive COVID-19 test|0|||
129895758|NCT04310579|467578542|FG001|Overall Study|Positive COVID-19 test|0|||
129808344|NCT04439201|467264069|FG000|Overall Study|Alternative therapy|1|||
129808345|NCT04439201|467264069|FG000|Overall Study|Physician Decision|1|||
129808346|NCT03730012|467264070|FG000|Overall Study|Adverse Event|0|||
129808347|NCT03730012|467264071|FG001|Overall Study|Adverse Event|1|||
129808348|NCT03730012|467264070|FG000|Overall Study|Lack of Efficacy|1|||
129808349|NCT03730012|467264071|FG001|Overall Study|Lack of Efficacy|5|||
129745704|NCT03208088|467027026|FG006|Period 3|Unsatisfactory Test Article|0|||
129745705|NCT03208088|467027027|FG007|Period 3|Unsatisfactory Test Article|0|||
129745706|NCT03208088|467027028|FG008|Period 3|Unsatisfactory Test Article|0|||
129745707|NCT03208088|467027029|FG009|Period 3|Unsatisfactory Test Article|0|||
129745708|NCT03208088|467027020|FG000|Period 4|Unsatisfactory Test Article|0|||
129745709|NCT03208088|467027021|FG001|Period 4|Unsatisfactory Test Article|0|||
129745710|NCT03208088|467027022|FG002|Period 4|Unsatisfactory Test Article|0|||
129745711|NCT03208088|467027023|FG003|Period 4|Unsatisfactory Test Article|1|||
129808350|NCT03730012|467264070|FG000|Overall Study|Withdrawal by Subject|0|||
129745712|NCT03208088|467027024|FG004|Period 4|Unsatisfactory Test Article|0|||
129745713|NCT03208088|467027025|FG005|Period 4|Unsatisfactory Test Article|0|||
129745714|NCT03208088|467027026|FG006|Period 4|Unsatisfactory Test Article|0|||
129745715|NCT03208088|467027027|FG007|Period 4|Unsatisfactory Test Article|0|||
129745716|NCT03208088|467027028|FG008|Period 4|Unsatisfactory Test Article|0|||
129745717|NCT03208088|467027029|FG009|Period 4|Unsatisfactory Test Article|0|||
129745718|NCT00605345|467027030|FG000|Overall Study|Withdrawal by Subject|1|||
129745719|NCT00605345|467027031|FG001|Overall Study|Withdrawal by Subject|0|||
129745720|NCT00605345|467027030|FG000|Overall Study|Adverse Event|0|||
129745721|NCT00605345|467027031|FG001|Overall Study|Adverse Event|1|||
129745722|NCT00605345|467027030|FG000|Overall Study|Protocol Violation|0|||
129745723|NCT00605345|467027031|FG001|Overall Study|Protocol Violation|2|||
129745724|NCT00566254|467027032|FG000|Overall Study|Adverse Event|3|||
129745725|NCT00566254|467027033|FG001|Overall Study|Adverse Event|1|||
129808351|NCT03730012|467264071|FG001|Overall Study|Withdrawal by Subject|1|||
129745726|NCT00566254|467027032|FG000|Overall Study|Protocol Violation|1|||
129745727|NCT00566254|467027033|FG001|Overall Study|Protocol Violation|3|||
129745728|NCT00566254|467027032|FG000|Overall Study|Withdrawal by Subject|1|||
129745729|NCT00566254|467027033|FG001|Overall Study|Withdrawal by Subject|2|||
129745730|NCT00566254|467027032|FG000|Overall Study|Lack of Efficacy|5|||
129745731|NCT00566254|467027033|FG001|Overall Study|Lack of Efficacy|6|||
129745732|NCT00566254|467027032|FG000|Overall Study|Other|0|||
129745733|NCT00566254|467027033|FG001|Overall Study|Other|2|||
129745734|NCT00238238|467027034|FG000|Overall Study|Withdrawal by Subject|0|||
129745735|NCT00238238|467027035|FG001|Overall Study|Withdrawal by Subject|3|||
129745736|NCT00238238|467027036|FG002|Overall Study|Withdrawal by Subject|0|||
129745737|NCT01345669|467027037|FG000|Overall Study|Primary tumour recurrence|53|||
129745738|NCT01345669|467027038|FG001|Overall Study|Primary tumour recurrence|32|||
129745739|NCT01345669|467027037|FG000|Overall Study|Second primary tumour|4|||
129745740|NCT01345669|467027038|FG001|Overall Study|Second primary tumour|3|||
129745741|NCT01345669|467027037|FG000|Overall Study|Adverse Event|63|||
129745742|NCT01345669|467027038|FG001|Overall Study|Adverse Event|9|||
129745743|NCT01345669|467027037|FG000|Overall Study|Protocol Violation|3|||
129745744|NCT01345669|467027038|FG001|Overall Study|Protocol Violation|1|||
129745745|NCT01345669|467027037|FG000|Overall Study|Lost to Follow-up|1|||
129745746|NCT01345669|467027038|FG001|Overall Study|Lost to Follow-up|1|||
129745747|NCT01345669|467027037|FG000|Overall Study|Withdrawal by Subject|52|||
129745748|NCT01345669|467027038|FG001|Overall Study|Withdrawal by Subject|13|||
129745749|NCT01345669|467027037|FG000|Overall Study|Other Reasons|111|||
129745750|NCT01345669|467027038|FG001|Overall Study|Other Reasons|60|||
129745751|NCT01793883|467027039|FG000|Overall Study|Withdrawal by Subject|3|||
129745752|NCT01793883|467027040|FG001|Overall Study|Withdrawal by Subject|7|||
129745753|NCT01793883|467027041|FG002|Overall Study|Withdrawal by Subject|3|||
129745754|NCT01793883|467027039|FG000|Overall Study|Subject noncompliance|0|||
129745755|NCT01793883|467027040|FG001|Overall Study|Subject noncompliance|1|||
129745756|NCT01793883|467027041|FG002|Overall Study|Subject noncompliance|1|||
129745757|NCT01793883|467027039|FG000|Overall Study|Lost to Follow-up|5|||
129745758|NCT01793883|467027040|FG001|Overall Study|Lost to Follow-up|1|||
129745759|NCT01793883|467027041|FG002|Overall Study|Lost to Follow-up|3|||
129745760|NCT01793883|467027039|FG000|Overall Study|Randomized in error|1|||
129808352|NCT03730012|467264070|FG000|Overall Study|Miscellaneous|2|||
129808353|NCT03730012|467264071|FG001|Overall Study|Miscellaneous|1|||
129808354|NCT04680052|467265680|FG000|Overall Study|Ongoing|244|||
129808355|NCT04680052|467265681|FG001|Overall Study|Ongoing|229|||
129808356|NCT04680052|467265682|FG002|Overall Study|Ongoing|39|||
129808357|NCT04680052|467265683|FG003|Overall Study|Ongoing|46|||
129808358|NCT04680052|467265680|FG000|Overall Study|Death|15|||
129808359|NCT04680052|467265681|FG001|Overall Study|Death|22|||
129808360|NCT04680052|467265682|FG002|Overall Study|Death|7|||
129808361|NCT04680052|467265683|FG003|Overall Study|Death|1|||
129808362|NCT04680052|467265680|FG000|Overall Study|Lost to Follow-up|3|||
129745761|NCT01793883|467027040|FG001|Overall Study|Randomized in error|0|||
129745762|NCT01793883|467027041|FG002|Overall Study|Randomized in error|0|||
129745763|NCT01793883|467027039|FG000|Overall Study|Unable to complete spriometry|1|||
129745764|NCT01793883|467027040|FG001|Overall Study|Unable to complete spriometry|0|||
129745765|NCT01793883|467027041|FG002|Overall Study|Unable to complete spriometry|0|||
129745766|NCT01793883|467027039|FG000|Overall Study|Unable to complete measurements|1|||
129745767|NCT01793883|467027040|FG001|Overall Study|Unable to complete measurements|0|||
129745768|NCT01793883|467027041|FG002|Overall Study|Unable to complete measurements|0|||
129745769|NCT01793883|467027039|FG000|Overall Study|Met exclusion criteria|1|||
129745770|NCT01793883|467027040|FG001|Overall Study|Met exclusion criteria|0|||
129745771|NCT01793883|467027041|FG002|Overall Study|Met exclusion criteria|0|||
129745772|NCT01793883|467027039|FG000|Overall Study|Dosing error|0|||
129745773|NCT01793883|467027040|FG001|Overall Study|Dosing error|1|||
129745774|NCT01793883|467027041|FG002|Overall Study|Dosing error|0|||
129745775|NCT01793883|467027039|FG000|Overall Study|Respiratory distress during spirometry|0|||
129745776|NCT01793883|467027040|FG001|Overall Study|Respiratory distress during spirometry|0|||
129808363|NCT04680052|467265681|FG001|Overall Study|Lost to Follow-up|2|||
129808364|NCT04680052|467265682|FG002|Overall Study|Lost to Follow-up|0|||
129808365|NCT04680052|467265683|FG003|Overall Study|Lost to Follow-up|1|||
129808366|NCT04680052|467265680|FG000|Overall Study|Withdrawal by Subject|11|||
129808367|NCT04680052|467265681|FG001|Overall Study|Withdrawal by Subject|19|||
129808368|NCT04680052|467265682|FG002|Overall Study|Withdrawal by Subject|7|||
129808369|NCT04680052|467265683|FG003|Overall Study|Withdrawal by Subject|5|||
129808370|NCT04680052|467265680|FG000|Overall Study|Missing|0|||
129745777|NCT01793883|467027041|FG002|Overall Study|Respiratory distress during spirometry|1|||
129745778|NCT02478255|467027042|FG000|Overall Study|Physician Decision|6|||
129745779|NCT02478255|467027043|FG001|Overall Study|Physician Decision|0|||
129745780|NCT02478255|467027042|FG000|Overall Study|Withdrawal by Subject|2|||
129745781|NCT02478255|467027043|FG001|Overall Study|Withdrawal by Subject|0|||
129745782|NCT01730586|467027044|FG000|Overall Study|Progressive Disease|2|||
129745783|NCT01730586|467027044|FG000|Overall Study|Inadequate Trial|8|||
129745784|NCT01730586|467027044|FG000|Overall Study|Adverse Event|2|||
129745785|NCT01730586|467027044|FG000|Overall Study|Hospice|1|||
129745786|NCT00061633|467027045|FG000|Overall Study|Adverse Event|1|||
129745787|NCT00061633|467027046|FG001|Overall Study|Adverse Event|2|||
129808371|NCT04680052|467265681|FG001|Overall Study|Missing|1|||
129808372|NCT04680052|467265682|FG002|Overall Study|Missing|0|||
129808373|NCT04680052|467265683|FG003|Overall Study|Missing|0|||
129808374|NCT04680052|467265680|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129808375|NCT04680052|467265681|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
129808376|NCT04680052|467265682|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129745788|NCT00061633|467027045|FG000|Overall Study|Withdrawal by Subject|2|||
129745789|NCT00061633|467027046|FG001|Overall Study|Withdrawal by Subject|2|||
129808377|NCT04680052|467265683|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
129808378|NCT04680052|467265680|FG000|Overall Study|Physician Decision|0|||
129808379|NCT04680052|467265681|FG001|Overall Study|Physician Decision|1|||
129808380|NCT04680052|467265682|FG002|Overall Study|Physician Decision|0|||
129808381|NCT04680052|467265683|FG003|Overall Study|Physician Decision|0|||
129808382|NCT03320057|467265684|FG000|Overall Study|Lost to Follow-up|4|||
129808383|NCT03320057|467265685|FG001|Overall Study|Lost to Follow-up|17|||
129808384|NCT03320057|467265684|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
129808385|NCT03320057|467265685|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
129808386|NCT01367002|467265686|FG000|Overall Study|Withdrawal by Subject|1|||
129808387|NCT01367002|467265687|FG001|Overall Study|Withdrawal by Subject|0|||
129808388|NCT01367002|467265686|FG000|Overall Study|Physician Decision|0|||
129808389|NCT01367002|467265687|FG001|Overall Study|Physician Decision|2|||
129808390|NCT06956170|467265688|FG000|Overall Study|Death|2|||
129808391|NCT06956170|467265689|FG001|Overall Study|Death|1|||
129808392|NCT06956170|467265688|FG000|Overall Study|Withdrawal by Subject|1|||
129808393|NCT06956170|467265689|FG001|Overall Study|Withdrawal by Subject|0|||
129808394|NCT06956170|467265688|FG000|Overall Study|Ongoing|7|||
129808395|NCT06956170|467265689|FG001|Overall Study|Ongoing|10|||
129808396|NCT01516437|467265690|FG000|Overall Study|Reason not specified|0|||
129808397|NCT01516437|467265691|FG001|Overall Study|Reason not specified|0|||
129808398|NCT01516437|467265692|FG002|Overall Study|Reason not specified|1|||
129808399|NCT01516437|467265693|FG003|Overall Study|Reason not specified|1|||
129808400|NCT00316719|467265696|FG000|Overall Study|Adverse Event|0|||
129808401|NCT00316719|467265697|FG001|Overall Study|Adverse Event|6|||
129808402|NCT00316719|467265696|FG000|Overall Study|Consent withdrawn|2|||
129808403|NCT00316719|467265697|FG001|Overall Study|Consent withdrawn|0|||
129808404|NCT02400333|467265700|FG000|Overall Study|Withdrawal by Subject|0|||
129808405|NCT02400333|467265701|FG001|Overall Study|Withdrawal by Subject|1|||
129808406|NCT02400333|467265702|FG002|Overall Study|Withdrawal by Subject|0|||
129808407|NCT02400333|467265703|FG003|Overall Study|Withdrawal by Subject|1|||
129808408|NCT02400333|467265700|FG000|Overall Study|Protocol Violation|1|||
129808409|NCT02400333|467265701|FG001|Overall Study|Protocol Violation|0|||
129808410|NCT02400333|467265702|FG002|Overall Study|Protocol Violation|2|||
129808411|NCT02400333|467265703|FG003|Overall Study|Protocol Violation|1|||
129808412|NCT02468674|467265704|FG000|Overall Study|Adverse Event|0|||
129808413|NCT02468674|467265705|FG001|Overall Study|Adverse Event|0|||
129808414|NCT02468674|467265706|FG002|Overall Study|Adverse Event|0|||
129808415|NCT02468674|467265707|FG003|Overall Study|Adverse Event|1|||
129895759|NCT04310579|467578543|FG002|Overall Study|Positive COVID-19 test|0|||
129808416|NCT02468674|467265708|FG004|Overall Study|Adverse Event|0|||
129808417|NCT02468674|467265709|FG005|Overall Study|Adverse Event|1|||
129808418|NCT02468674|467265710|FG006|Overall Study|Adverse Event|0|||
129808419|NCT02468674|467265711|FG007|Overall Study|Adverse Event|0|||
129808420|NCT02468674|467265712|FG008|Overall Study|Adverse Event|0|||
129808421|NCT02468674|467265704|FG000|Overall Study|Lost to Follow-up|1|||
129808422|NCT02468674|467265705|FG001|Overall Study|Lost to Follow-up|0|||
129808423|NCT02468674|467265706|FG002|Overall Study|Lost to Follow-up|0|||
129745790|NCT00061633|467027045|FG000|Overall Study|Lost to Follow-up|1|||
129745791|NCT00061633|467027046|FG001|Overall Study|Lost to Follow-up|4|||
129745792|NCT00061633|467027045|FG000|Overall Study|Other|1|||
129745793|NCT00061633|467027046|FG001|Overall Study|Other|1|||
129745794|NCT00061633|467027045|FG000|Overall Study|Never received study treatment|0|||
129745795|NCT00061633|467027046|FG001|Overall Study|Never received study treatment|2|||
129745796|NCT00842543|467029269|FG000|Overall Study|Withdrawal by Subject|2|||
129745797|NCT00842543|467029270|FG001|Overall Study|Withdrawal by Subject|0|||
129745798|NCT00842543|467029271|FG002|Overall Study|Withdrawal by Subject|3|||
129745799|NCT00842543|467029272|FG003|Overall Study|Withdrawal by Subject|4|||
129745800|NCT01483183|467029277|FG000|Overall Study|Physician Decision|0|||
129745801|NCT01483183|467029278|FG001|Overall Study|Physician Decision|0|||
129745802|NCT01483183|467029279|FG002|Overall Study|Physician Decision|0|||
129745803|NCT01483183|467029280|FG003|Overall Study|Physician Decision|0|||
129745804|NCT01483183|467029281|FG004|Overall Study|Physician Decision|0|||
129745805|NCT01483183|467029282|FG005|Overall Study|Physician Decision|0|||
129745806|NCT01483183|467029283|FG006|Overall Study|Physician Decision|2|||
129745807|NCT01483183|467029284|FG007|Overall Study|Physician Decision|0|||
129745808|NCT01483183|467029285|FG008|Overall Study|Physician Decision|0|||
129745809|NCT01483183|467029286|FG009|Overall Study|Physician Decision|0|||
129745810|NCT01483183|467029277|FG000|Overall Study|Withdrawal by Subject|0|||
129745811|NCT01483183|467029278|FG001|Overall Study|Withdrawal by Subject|0|||
129745812|NCT01483183|467029279|FG002|Overall Study|Withdrawal by Subject|0|||
129745813|NCT01483183|467029280|FG003|Overall Study|Withdrawal by Subject|0|||
129745814|NCT01483183|467029281|FG004|Overall Study|Withdrawal by Subject|0|||
129745815|NCT01483183|467029282|FG005|Overall Study|Withdrawal by Subject|0|||
129745816|NCT01483183|467029283|FG006|Overall Study|Withdrawal by Subject|0|||
129745817|NCT01483183|467029284|FG007|Overall Study|Withdrawal by Subject|0|||
129745818|NCT01483183|467029285|FG008|Overall Study|Withdrawal by Subject|0|||
129745819|NCT01483183|467029286|FG009|Overall Study|Withdrawal by Subject|1|||
129745820|NCT00239928|467029287|FG000|Overall Study|Lack of Efficacy|1|||
129745821|NCT00239928|467029287|FG000|Overall Study|Adverse Event|4|||
129745822|NCT00239928|467029287|FG000|Overall Study|Not need to continue study|3|||
129745823|NCT00239928|467029287|FG000|Overall Study|Withdrawal by Subject|2|||
129745824|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745825|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745826|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
129745827|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
129745828|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
129745829|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745830|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
129745831|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
129808424|NCT02468674|467265707|FG003|Overall Study|Lost to Follow-up|0|||
129808425|NCT02468674|467265708|FG004|Overall Study|Lost to Follow-up|0|||
129808426|NCT02468674|467265709|FG005|Overall Study|Lost to Follow-up|0|||
129808427|NCT02468674|467265710|FG006|Overall Study|Lost to Follow-up|0|||
129808428|NCT02468674|467265711|FG007|Overall Study|Lost to Follow-up|1|||
129808429|NCT02468674|467265712|FG008|Overall Study|Lost to Follow-up|1|||
129808430|NCT02468674|467265704|FG000|Overall Study|Physician Decision|0|||
129808431|NCT02468674|467265705|FG001|Overall Study|Physician Decision|0|||
129808432|NCT02468674|467265706|FG002|Overall Study|Physician Decision|0|||
129808433|NCT02468674|467265707|FG003|Overall Study|Physician Decision|0|||
129808434|NCT02468674|467265708|FG004|Overall Study|Physician Decision|0|||
129895760|NCT04310579|467578544|FG003|Overall Study|Positive COVID-19 test|0|||
129895761|NCT04310579|467578545|FG004|Overall Study|Positive COVID-19 test|0|||
129895762|NCT04310579|467578546|FG005|Overall Study|Positive COVID-19 test|0|||
129895763|NCT04310579|467578547|FG006|Overall Study|Positive COVID-19 test|0|||
129895764|NCT04310579|467578548|FG007|Overall Study|Positive COVID-19 test|0|||
129895765|NCT04310579|467578549|FG008|Overall Study|Positive COVID-19 test|0|||
129895766|NCT04310579|467578550|FG009|Overall Study|Positive COVID-19 test|0|||
129895767|NCT04310579|467578551|FG010|Overall Study|Positive COVID-19 test|1|||
129895768|NCT03635112|467578552|FG000|Overall Study|Adverse Event|5|||
129895769|NCT03635112|467578553|FG001|Overall Study|Adverse Event|9|||
129895770|NCT03635112|467578554|FG002|Overall Study|Adverse Event|14|||
129895771|NCT03635112|467578552|FG000|Overall Study|Lost to Follow-up|1|||
129895772|NCT03635112|467578553|FG001|Overall Study|Lost to Follow-up|0|||
129895773|NCT03635112|467578554|FG002|Overall Study|Lost to Follow-up|1|||
129895774|NCT03635112|467578552|FG000|Overall Study|Physician Decision|5|||
129895775|NCT03635112|467578553|FG001|Overall Study|Physician Decision|7|||
129745832|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
129745833|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745834|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745835|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745836|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
129745837|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
129808435|NCT02468674|467265709|FG005|Overall Study|Physician Decision|0|||
129808436|NCT02468674|467265710|FG006|Overall Study|Physician Decision|1|||
129808437|NCT02468674|467265711|FG007|Overall Study|Physician Decision|0|||
129808438|NCT02468674|467265712|FG008|Overall Study|Physician Decision|0|||
129895776|NCT03635112|467578554|FG002|Overall Study|Physician Decision|5|||
129895777|NCT03635112|467578552|FG000|Overall Study|Protocol Violation|0|||
129895778|NCT03635112|467578553|FG001|Overall Study|Protocol Violation|0|||
129895779|NCT03635112|467578554|FG002|Overall Study|Protocol Violation|1|||
129895780|NCT03635112|467578552|FG000|Overall Study|Study Terminated by Sponsor|11|||
129895781|NCT03635112|467578553|FG001|Overall Study|Study Terminated by Sponsor|17|||
129895782|NCT03635112|467578554|FG002|Overall Study|Study Terminated by Sponsor|21|||
129895783|NCT03635112|467578552|FG000|Overall Study|Withdrawal by Subject|4|||
129895784|NCT03635112|467578553|FG001|Overall Study|Withdrawal by Subject|9|||
129895785|NCT03635112|467578554|FG002|Overall Study|Withdrawal by Subject|7|||
129745838|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
129745839|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
129745840|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
129745841|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
129745842|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
129745843|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
129745844|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
129745845|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
129745846|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129745847|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129745848|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129745849|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
129745850|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745851|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129745852|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129745853|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745854|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745855|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129745856|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
129745857|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745858|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745859|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745860|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745861|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745862|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
129745863|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745864|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129745865|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129745866|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745867|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745868|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745869|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129745870|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745871|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
129745872|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745873|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745874|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745875|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
129745876|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745877|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745878|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745879|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
129745880|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745881|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745882|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745883|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
129895786|NCT03635112|467578552|FG000|Overall Study|Miscellaneous|0|||
129895787|NCT03635112|467578553|FG001|Overall Study|Miscellaneous|0|||
129895788|NCT03635112|467578554|FG002|Overall Study|Miscellaneous|1|||
129895789|NCT03006341|467578556|FG000|Overall Study|Not linked in the EMR|25069|||
129895790|NCT03006341|467578557|FG001|Overall Study|Not linked in the EMR|67505|||
129895791|NCT03006341|467578558|FG002|Overall Study|Not linked in the EMR|30993|||
129745884|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129895792|NCT03006341|467578559|FG003|Overall Study|Not linked in the EMR|10685|||
129745885|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745886|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129895793|NCT02950545|467578562|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895794|NCT02950545|467578563|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895795|NCT02950545|467578564|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129745887|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129808439|NCT02468674|467265704|FG000|Overall Study|Patient/Guardian Decision|0|||
129808440|NCT02468674|467265705|FG001|Overall Study|Patient/Guardian Decision|0|||
129808441|NCT02468674|467265706|FG002|Overall Study|Patient/Guardian Decision|0|||
129808442|NCT02468674|467265707|FG003|Overall Study|Patient/Guardian Decision|0|||
129808443|NCT02468674|467265708|FG004|Overall Study|Patient/Guardian Decision|1|||
129808444|NCT02468674|467265709|FG005|Overall Study|Patient/Guardian Decision|0|||
129895796|NCT02950545|467578565|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895797|NCT02950545|467578566|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
129895798|NCT02950545|467578567|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
129895799|NCT02950545|467578562|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
129895800|NCT02950545|467578563|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
129895801|NCT02950545|467578564|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
129895802|NCT02950545|467578565|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
129895803|NCT02950545|467578566|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
129895804|NCT02950545|467578567|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
129895805|NCT02950545|467578562|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895806|NCT02950545|467578563|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895807|NCT02950545|467578564|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895808|NCT02950545|467578565|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129745888|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
129745889|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745890|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745891|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745892|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
129745893|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745894|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745895|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
129745896|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129895809|NCT02950545|467578566|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
129895810|NCT02950545|467578567|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
129895811|NCT02950545|467578562|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
129895812|NCT02950545|467578563|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895813|NCT02950545|467578564|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895814|NCT02950545|467578565|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895815|NCT02950545|467578566|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895816|NCT02950545|467578567|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
129895817|NCT02950545|467578562|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895818|NCT02950545|467578563|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895819|NCT02950545|467578564|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895820|NCT02950545|467578565|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895821|NCT02950545|467578566|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
129895822|NCT02950545|467578567|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
129895823|NCT03101592|467578568|FG000|Overall Study|participant files could not be located|111|||
129895824|NCT03101592|467578569|FG001|Overall Study|participant files could not be located|170|||
129745897|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745898|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745899|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745900|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745901|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
129745902|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745903|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
129745904|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745905|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745906|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745907|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745908|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745909|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129808445|NCT02468674|467265710|FG006|Overall Study|Patient/Guardian Decision|0|||
129808446|NCT02468674|467265711|FG007|Overall Study|Patient/Guardian Decision|2|||
129808447|NCT02468674|467265712|FG008|Overall Study|Patient/Guardian Decision|1|||
129808448|NCT02468674|467265704|FG000|Overall Study|Protocol Deviation|0|||
129808449|NCT02468674|467265705|FG001|Overall Study|Protocol Deviation|0|||
129895825|NCT03101592|467578570|FG002|Overall Study|participant files could not be located|118|||
129895826|NCT01770860|467578571|FG000|Overall Study|Withdrawal by Subject|4|||
129895827|NCT01770860|467578571|FG000|Overall Study|Lost to Follow-up|1|||
129895828|NCT01770860|467578571|FG000|Overall Study|Administrative decision made by the PI|1|||
129808450|NCT02468674|467265706|FG002|Overall Study|Protocol Deviation|0|||
129895829|NCT03398356|467578574|FG000|Before Treatment|Lost to Follow-up|1|||
129895830|NCT03398356|467578575|FG001|Before Treatment|Lost to Follow-up|2|||
129895831|NCT03398356|467578576|FG002|Before Treatment|Lost to Follow-up|0|||
129745910|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745911|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745912|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745913|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745914|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
129745915|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
129745916|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745917|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745918|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745919|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745920|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745921|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745922|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745923|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745924|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745925|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745926|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745927|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
129745928|NCT03100058|467029289|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745929|NCT03100058|467029290|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745930|NCT03100058|467029291|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745931|NCT03100058|467029292|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745932|NCT03100058|467029293|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745933|NCT03100058|467029294|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129808451|NCT02468674|467265707|FG003|Overall Study|Protocol Deviation|0|||
129808452|NCT02468674|467265708|FG004|Overall Study|Protocol Deviation|0|||
129808453|NCT02468674|467265709|FG005|Overall Study|Protocol Deviation|0|||
129808454|NCT02468674|467265710|FG006|Overall Study|Protocol Deviation|0|||
129808455|NCT02468674|467265711|FG007|Overall Study|Protocol Deviation|1|||
129808456|NCT02468674|467265712|FG008|Overall Study|Protocol Deviation|1|||
129808457|NCT02280304|467265714|FG000|Overall Study|Lost to Follow-up|7|||
129808458|NCT02280304|467265715|FG001|Overall Study|Lost to Follow-up|8|||
129808459|NCT01890473|467265722|FG000|Overall Study|Lost to Follow-up|1|||
129808460|NCT01890473|467265723|FG001|Overall Study|Lost to Follow-up|0|||
129808461|NCT01890473|467265722|FG000|Overall Study|Poor/non-compliance|1|||
129808462|NCT01890473|467265723|FG001|Overall Study|Poor/non-compliance|0|||
129808463|NCT00934089|467265724|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
129808464|NCT00934089|467265725|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
129808465|NCT00934089|467265724|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
129808466|NCT00934089|467265725|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
129808467|NCT00003473|467265726|FG000|Overall Study|Three patients were not evaluable.|3|||
129808468|NCT01546207|467265729|FG000|Overall Study|Death|1|||
129895832|NCT03398356|467578574|FG000|Before Treatment|drug intolerance|2|||
129895833|NCT03398356|467578575|FG001|Before Treatment|drug intolerance|1|||
129895834|NCT03398356|467578576|FG002|Before Treatment|drug intolerance|0|||
129895835|NCT03398356|467578574|FG000|Before Treatment|Withdrawal by Subject|0|||
129895836|NCT03398356|467578575|FG001|Before Treatment|Withdrawal by Subject|5|||
129895837|NCT03398356|467578576|FG002|Before Treatment|Withdrawal by Subject|0|||
129895838|NCT03398356|467578574|FG000|Before Treatment|Physician Decision|0|||
129895839|NCT03398356|467578575|FG001|Before Treatment|Physician Decision|0|||
129895840|NCT03398356|467578576|FG002|Before Treatment|Physician Decision|11|||
129895841|NCT03398356|467578574|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
129895842|NCT03398356|467578575|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
129895843|NCT03398356|467578576|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
129895844|NCT03432533|467578579|FG000|Overall Study|Lost to Follow-up|1|||
129895845|NCT03432533|467578580|FG001|Overall Study|Lost to Follow-up|2|||
129895846|NCT03432533|467578579|FG000|Overall Study|Withdrawal by Subject|14|||
129895847|NCT03432533|467578580|FG001|Overall Study|Withdrawal by Subject|9|||
129895848|NCT01648283|467578581|FG000|Overall Study|Withdrawal by Subject|14|||
129895849|NCT00601640|467578586|FG000|Overall Study|Withdrawal by Subject|3|||
129895850|NCT00601640|467578587|FG001|Overall Study|Withdrawal by Subject|0|||
129745934|NCT03100058|467029295|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
129745935|NCT03100058|467029296|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745936|NCT03100058|467029297|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745937|NCT03100058|467029298|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745938|NCT03100058|467029299|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745939|NCT03100058|467029300|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129808469|NCT00713323|467265730|FG000|Overall Study|Adverse Event|75|||
129808470|NCT00713323|467265730|FG000|Overall Study|Withdrawal by Subject|15|||
129808471|NCT00713323|467265730|FG000|Overall Study|Lost to Follow-up|11|||
129808472|NCT00713323|467265730|FG000|Overall Study|Lack of Efficacy|36|||
129895851|NCT00601640|467578588|FG002|Overall Study|Withdrawal by Subject|7|||
129895852|NCT00601640|467578586|FG000|Overall Study|Death|1|||
129895853|NCT00601640|467578587|FG001|Overall Study|Death|0|||
129895854|NCT00601640|467578588|FG002|Overall Study|Death|0|||
129808473|NCT00713323|467265730|FG000|Overall Study|Low creatine clearance at screening|1|||
129808474|NCT00713323|467265730|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
129808475|NCT00713323|467265730|FG000|Overall Study|Surgery cured allodynic pain|1|||
129808476|NCT00713323|467265730|FG000|Overall Study|Pain free|1|||
129808477|NCT00713323|467265730|FG000|Overall Study|Non-compliance|1|||
129808478|NCT00713323|467265730|FG000|Overall Study|Pain resolved|1|||
129808479|NCT00713323|467265730|FG000|Overall Study|Subject travelling to USA|1|||
129808480|NCT00713323|467265730|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
129808481|NCT00713323|467265730|FG000|Overall Study|Treatment that may interact with Sativex|1|||
129808482|NCT01947582|467265736|FG000|Overall Study|Withdrawal by Subject|1|||
129808483|NCT01826604|467265737|FG000|Overall Study|Lost to Follow-up|8|||
129808484|NCT01826604|467265738|FG001|Overall Study|Lost to Follow-up|9|||
129808485|NCT00491075|467265739|FG000|Overall Study|Withdrawal by Subject|1|||
129808486|NCT00491075|467265739|FG000|Overall Study|Physician Decision|1|||
129808487|NCT01603355|467265740|FG000|Overall Study|Lack of Efficacy|2|||
129808488|NCT05350410|467265744|FG000|Overall Study|Withdrawal by Subject|1|||
129808489|NCT01952145|467265745|FG000|Overall Study|Protocol Violation|2|||
129808490|NCT01952145|467265746|FG001|Overall Study|Protocol Violation|1|||
129808491|NCT01952145|467265745|FG000|Overall Study|Death|0|||
129808492|NCT01952145|467265746|FG001|Overall Study|Death|1|||
129808493|NCT01952145|467265745|FG000|Overall Study|Adverse Event|9|||
129808494|NCT01952145|467265746|FG001|Overall Study|Adverse Event|0|||
129808495|NCT01952145|467265745|FG000|Overall Study|Withdrawal Criteria|16|||
129808496|NCT01952145|467265746|FG001|Overall Study|Withdrawal Criteria|11|||
129808497|NCT01952145|467265745|FG000|Overall Study|Unclassified|1|||
129808498|NCT01952145|467265746|FG001|Overall Study|Unclassified|1|||
129808499|NCT04138810|467265750|FG000|Overall Study|Withdrawal by Subject|0|||
129808500|NCT04138810|467265751|FG001|Overall Study|Withdrawal by Subject|1|||
129808501|NCT04138810|467265750|FG000|Overall Study|Subject cancelled surgery|1|||
129808502|NCT04138810|467265751|FG001|Overall Study|Subject cancelled surgery|0|||
129895855|NCT00601640|467578586|FG000|Overall Study|Adverse Event|0|||
129895856|NCT00601640|467578587|FG001|Overall Study|Adverse Event|4|||
129895857|NCT00601640|467578588|FG002|Overall Study|Adverse Event|2|||
129808503|NCT00753766|467265752|FG000|Overall Study|Physician Decision|1|||
129808504|NCT00753766|467265753|FG001|Overall Study|Physician Decision|0|||
129808505|NCT00839852|467265754|FG000|Overall Study|Adverse Event|10|||
129808506|NCT00839852|467265754|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129808507|NCT00839852|467265754|FG000|Overall Study|Protocol Violation|9|||
129808508|NCT00839852|467265754|FG000|Overall Study|Withdrawal of Consent|16|||
129808509|NCT00839852|467265754|FG000|Overall Study|Lost to Follow-up|7|||
129808510|NCT00839852|467265754|FG000|Overall Study|Lack of Compliance While in Jail|1|||
129808511|NCT00839852|467265754|FG000|Overall Study|Pregnancy|1|||
129808512|NCT00494299|467265755|FG000|Overall Study|Adverse Event|93|||
129808513|NCT00494299|467265756|FG001|Overall Study|Adverse Event|13|||
129895858|NCT00601640|467578586|FG000|Overall Study|intercurrent illness|1|||
129895859|NCT00601640|467578587|FG001|Overall Study|intercurrent illness|0|||
129745940|NCT03100058|467029301|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
129745941|NCT03100058|467029289|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745942|NCT03100058|467029290|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745943|NCT03100058|467029291|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745944|NCT03100058|467029292|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745945|NCT03100058|467029293|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745946|NCT03100058|467029294|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745947|NCT03100058|467029295|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745948|NCT03100058|467029296|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745949|NCT03100058|467029297|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745950|NCT03100058|467029298|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
129745951|NCT03100058|467029299|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
129745952|NCT03100058|467029300|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
129745953|NCT03100058|467029301|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
129745954|NCT03100058|467029289|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745955|NCT03100058|467029290|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129808514|NCT00494299|467265755|FG000|Overall Study|Lost to Follow-up|1|||
129808515|NCT00494299|467265756|FG001|Overall Study|Lost to Follow-up|0|||
129808516|NCT00494299|467265755|FG000|Overall Study|Physician Decision|0|||
129808517|NCT00494299|467265756|FG001|Overall Study|Physician Decision|2|||
129808518|NCT00494299|467265755|FG000|Overall Study|Protocol Violation|1|||
129808519|NCT00494299|467265756|FG001|Overall Study|Protocol Violation|2|||
129808520|NCT00494299|467265755|FG000|Overall Study|Withdrawal by Subject|8|||
129808521|NCT00494299|467265756|FG001|Overall Study|Withdrawal by Subject|3|||
129808522|NCT00494299|467265755|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
129808523|NCT00494299|467265756|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
129895860|NCT00601640|467578588|FG002|Overall Study|intercurrent illness|0|||
129895861|NCT00601640|467578586|FG000|Overall Study|change in eligibility status|0|||
129745956|NCT03100058|467029291|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745957|NCT03100058|467029292|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745958|NCT03100058|467029293|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745959|NCT03100058|467029294|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745960|NCT03100058|467029295|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745961|NCT03100058|467029296|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745962|NCT03100058|467029297|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745963|NCT03100058|467029298|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745964|NCT03100058|467029299|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
129745965|NCT03100058|467029300|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
129745966|NCT03100058|467029301|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
129745967|NCT03100058|467029289|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745968|NCT03100058|467029290|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745969|NCT03100058|467029291|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745970|NCT03100058|467029292|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745971|NCT03100058|467029293|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745972|NCT03100058|467029294|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745973|NCT03100058|467029295|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745974|NCT03100058|467029296|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745975|NCT03100058|467029297|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745976|NCT03100058|467029298|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
129745977|NCT03100058|467029299|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
129745978|NCT03100058|467029300|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
129745979|NCT03100058|467029301|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
129745980|NCT03100058|467029289|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745981|NCT03100058|467029290|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745982|NCT03100058|467029291|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745983|NCT03100058|467029292|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745984|NCT03100058|467029293|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745985|NCT03100058|467029294|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745986|NCT03100058|467029295|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745987|NCT03100058|467029296|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745988|NCT03100058|467029297|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745989|NCT03100058|467029298|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745990|NCT03100058|467029299|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
129745991|NCT03100058|467029300|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745992|NCT03100058|467029301|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
129745993|NCT03100058|467029289|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129745994|NCT03100058|467029290|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129745995|NCT03100058|467029291|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129745996|NCT03100058|467029292|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129745997|NCT03100058|467029293|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129745998|NCT03100058|467029294|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129745999|NCT03100058|467029295|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129746000|NCT03100058|467029296|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129746001|NCT03100058|467029297|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129746002|NCT03100058|467029298|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129746003|NCT03100058|467029299|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129746004|NCT03100058|467029300|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
129746005|NCT03100058|467029301|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
129746006|NCT03100058|467029289|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746007|NCT03100058|467029290|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746008|NCT03100058|467029291|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746009|NCT03100058|467029292|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746010|NCT03100058|467029293|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746011|NCT03100058|467029294|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746012|NCT03100058|467029295|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746013|NCT03100058|467029296|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746014|NCT03100058|467029297|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746015|NCT03100058|467029298|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
129746016|NCT03100058|467029299|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129808524|NCT00494299|467265755|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
129808525|NCT00494299|467265756|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
129808526|NCT00494299|467265755|FG000|Overall Study|Site Closed by Sponsor|6|||
129808527|NCT00494299|467265756|FG001|Overall Study|Site Closed by Sponsor|0|||
129808528|NCT00494299|467265755|FG000|Overall Study|Protocol Driven Decision Point|11|||
129808529|NCT00494299|467265756|FG001|Overall Study|Protocol Driven Decision Point|22|||
129808530|NCT02805972|467265761|FG000|Washout Period|Lost to Follow-up|3|||
129808531|NCT02805972|467265762|FG001|Washout Period|Lost to Follow-up|0|||
129808532|NCT01206166|467265764|FG000|Overall Study|No evaluable data|2|||
129808533|NCT01206166|467265765|FG001|Overall Study|No evaluable data|3|||
129808534|NCT00932126|467265766|FG000|Overall Study|Adverse Event|0|||
129808535|NCT00932126|467265767|FG001|Overall Study|Adverse Event|0|||
129808536|NCT00932126|467265768|FG002|Overall Study|Adverse Event|0|||
129808537|NCT00932126|467265769|FG003|Overall Study|Adverse Event|0|||
129746017|NCT03100058|467029300|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746018|NCT03100058|467029301|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
129746019|NCT00774800|467029303|FG000|Intervention 4|Withdrawal by Subject|1|||
129746020|NCT01331109|467029304|FG000|Overall Study|Adverse Event|6|||
129746021|NCT01331109|467029304|FG000|Overall Study|Lack of Efficacy|2|||
129746022|NCT01331109|467029304|FG000|Overall Study|Protocol Violation|3|||
129746023|NCT01331109|467029304|FG000|Overall Study|Withdrawal by Subject|7|||
129746024|NCT01331109|467029304|FG000|Overall Study|Lost to Follow-up|1|||
129746025|NCT01331109|467029304|FG000|Overall Study|Study Terminated by Sponsor|38|||
129746026|NCT00479856|467029305|FG000|Overall Study|Adverse Event|1|||
129746027|NCT00479856|467029305|FG000|Overall Study|Withdrawal by Subject|1|||
129746028|NCT00479856|467029305|FG000|Overall Study|Physician Decision|1|||
129746029|NCT00661622|467029308|FG000|Overall Study|Protocol Violation|1|||
129746030|NCT00661622|467029309|FG001|Overall Study|Protocol Violation|0|||
129746031|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
129746032|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
129746033|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
129746034|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
129746035|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Death|2|||
129746036|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Death|2|||
129746037|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Death|0|||
129746038|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Death|0|||
129746039|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
129746040|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
129746041|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
129746042|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
129746043|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
129746044|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
129746045|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
129746046|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
129746047|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
129746048|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
129746049|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
129746050|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
129746051|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
129746052|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
129746053|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
129746054|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
129746055|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
129746056|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
129746057|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
129746058|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
129746059|NCT03068754|467029312|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
129746060|NCT03068754|467029313|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
129746061|NCT03068754|467029314|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
129808538|NCT00932126|467265770|FG004|Overall Study|Adverse Event|0|||
129808539|NCT00932126|467265771|FG005|Overall Study|Adverse Event|0|||
129808540|NCT00932126|467265772|FG006|Overall Study|Adverse Event|1|||
129808541|NCT00932126|467265773|FG007|Overall Study|Adverse Event|2|||
129808542|NCT00932126|467265766|FG000|Overall Study|Protocol Violation|0|||
129808543|NCT00932126|467265767|FG001|Overall Study|Protocol Violation|0|||
129808544|NCT00932126|467265768|FG002|Overall Study|Protocol Violation|0|||
129808545|NCT00932126|467265769|FG003|Overall Study|Protocol Violation|0|||
129808546|NCT00932126|467265770|FG004|Overall Study|Protocol Violation|1|||
129808547|NCT00932126|467265771|FG005|Overall Study|Protocol Violation|0|||
129808548|NCT00932126|467265772|FG006|Overall Study|Protocol Violation|0|||
129746062|NCT03068754|467029315|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
129746063|NCT03068754|467029312|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
129746064|NCT03068754|467029313|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
129746065|NCT03068754|467029314|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
129746066|NCT03068754|467029315|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
129808549|NCT00932126|467265773|FG007|Overall Study|Protocol Violation|0|||
129746067|NCT03068754|467029312|FG000|Open Label Extension Period (OLE)|Death|0|||
129746068|NCT03068754|467029313|FG001|Open Label Extension Period (OLE)|Death|0|||
129746069|NCT03068754|467029314|FG002|Open Label Extension Period (OLE)|Death|0|||
129746070|NCT03068754|467029315|FG003|Open Label Extension Period (OLE)|Death|1|||
129746071|NCT03068754|467029312|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
129746072|NCT03068754|467029313|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
129746073|NCT03068754|467029314|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
129746074|NCT03068754|467029315|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
129746075|NCT03068754|467029312|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
129746076|NCT03068754|467029313|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
129746077|NCT03068754|467029314|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
129746078|NCT03068754|467029315|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
129746079|NCT03068754|467029312|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
129746080|NCT03068754|467029313|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
129746081|NCT03068754|467029314|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
129746082|NCT03068754|467029315|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
129746083|NCT03068754|467029312|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
129746084|NCT03068754|467029313|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
129746085|NCT03068754|467029314|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
129746086|NCT03068754|467029315|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
129746087|NCT04496453|467029320|FG000|Overall Study|Lost to Follow-up|6|||
129746088|NCT03997825|467029321|FG000|Overall Study|Death|3|||
129746089|NCT03997825|467029321|FG000|Overall Study|Lost to Follow-up|10|||
129746090|NCT03997825|467029321|FG000|Overall Study|Withdrawal by Subject|3|||
129746091|NCT03997825|467029321|FG000|Overall Study|Refused participation|1|||
129746092|NCT00383162|467029322|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
129746093|NCT00383162|467029323|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
129746094|NCT00383162|467029322|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
129746095|NCT00383162|467029323|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
129746096|NCT00383162|467029322|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
129746097|NCT00383162|467029323|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
129746098|NCT00383162|467029322|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
129746099|NCT00383162|467029323|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
129746100|NCT00383162|467029322|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
129746101|NCT00383162|467029323|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
129746102|NCT00383162|467029322|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
129746103|NCT00383162|467029323|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
129746104|NCT00383162|467029322|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
129746105|NCT00383162|467029323|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
129746106|NCT00383162|467029322|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
129746107|NCT00383162|467029323|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
129746108|NCT00383162|467029322|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
129746109|NCT00383162|467029323|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
129746110|NCT00767819|467029324|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
129746111|NCT00767819|467029325|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
129808550|NCT00932126|467265766|FG000|Overall Study|Withdrawal by Subject|0|||
129808551|NCT00932126|467265767|FG001|Overall Study|Withdrawal by Subject|0|||
129808552|NCT00932126|467265768|FG002|Overall Study|Withdrawal by Subject|1|||
129808553|NCT00932126|467265769|FG003|Overall Study|Withdrawal by Subject|0|||
129808554|NCT00932126|467265770|FG004|Overall Study|Withdrawal by Subject|0|||
129808555|NCT00932126|467265771|FG005|Overall Study|Withdrawal by Subject|0|||
129808556|NCT00932126|467265772|FG006|Overall Study|Withdrawal by Subject|0|||
129808557|NCT00932126|467265773|FG007|Overall Study|Withdrawal by Subject|1|||
129808558|NCT00932126|467265766|FG000|Overall Study|Objective progression or relapse|3|||
129808559|NCT00932126|467265767|FG001|Overall Study|Objective progression or relapse|3|||
129808560|NCT00932126|467265768|FG002|Overall Study|Objective progression or relapse|2|||
129808561|NCT00932126|467265769|FG003|Overall Study|Objective progression or relapse|3|||
129808562|NCT00932126|467265770|FG004|Overall Study|Objective progression or relapse|3|||
129808563|NCT00932126|467265771|FG005|Overall Study|Objective progression or relapse|3|||
129808564|NCT00932126|467265772|FG006|Overall Study|Objective progression or relapse|3|||
129895862|NCT00601640|467578587|FG001|Overall Study|change in eligibility status|1|||
129746112|NCT00767819|467029326|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129895863|NCT00601640|467578588|FG002|Overall Study|change in eligibility status|1|||
129746113|NCT00767819|467029324|FG000|Overall Study|Withdrawal by Subject|1|||
129808565|NCT00932126|467265773|FG007|Overall Study|Objective progression or relapse|5|||
129808566|NCT00932126|467265766|FG000|Overall Study|Other|0|||
129808567|NCT00932126|467265767|FG001|Overall Study|Other|0|||
129808568|NCT00932126|467265768|FG002|Overall Study|Other|0|||
129808569|NCT00932126|467265769|FG003|Overall Study|Other|0|||
129895864|NCT00530777|467578589|FG000|Overall Study|Lost to Follow-up|0|||
129746114|NCT00767819|467029325|FG001|Overall Study|Withdrawal by Subject|1|||
129746115|NCT00767819|467029326|FG002|Overall Study|Withdrawal by Subject|0|||
129746116|NCT00767819|467029324|FG000|Overall Study|Administrative problems|0|||
129746117|NCT00767819|467029325|FG001|Overall Study|Administrative problems|1|||
129746118|NCT00767819|467029326|FG002|Overall Study|Administrative problems|0|||
129746119|NCT00767819|467029324|FG000|Overall Study|Death|2|||
129746120|NCT00767819|467029325|FG001|Overall Study|Death|3|||
129746121|NCT00767819|467029326|FG002|Overall Study|Death|0|||
129746122|NCT00767819|467029324|FG000|Overall Study|Adverse Event|2|||
129746123|NCT00767819|467029325|FG001|Overall Study|Adverse Event|0|||
129746124|NCT00767819|467029326|FG002|Overall Study|Adverse Event|0|||
129746125|NCT00767819|467029324|FG000|Overall Study|Abnormal lab values|1|||
129746126|NCT00767819|467029325|FG001|Overall Study|Abnormal lab values|0|||
129746127|NCT00767819|467029326|FG002|Overall Study|Abnormal lab values|0|||
129746128|NCT00767819|467029324|FG000|Overall Study|Lost to Follow-up|1|||
129746129|NCT00767819|467029325|FG001|Overall Study|Lost to Follow-up|0|||
129746130|NCT00767819|467029326|FG002|Overall Study|Lost to Follow-up|0|||
129746131|NCT02726022|467029328|FG000|Overall Study|Adverse Event|14|||
129746132|NCT02726022|467029328|FG000|Overall Study|Treatment Failure|8|||
129746133|NCT02726022|467029328|FG000|Overall Study|Poor Compliance|13|||
129746134|NCT02726022|467029328|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
129746135|NCT00915551|467029329|FG000|Overall Study|Withdrawal by Subject|0|||
129746136|NCT00915551|467029330|FG001|Overall Study|Withdrawal by Subject|1|||
129746137|NCT00235716|467029331|FG000|Overall Study|Death|26|||
129746138|NCT00235716|467029332|FG001|Overall Study|Death|39|||
129746139|NCT00235716|467029333|FG002|Overall Study|Death|32|||
129746140|NCT00235716|467029334|FG003|Overall Study|Death|31|||
129746141|NCT00235716|467029331|FG000|Overall Study|Withdrawal by Subject|23|||
129746142|NCT00235716|467029332|FG001|Overall Study|Withdrawal by Subject|19|||
129746143|NCT00235716|467029333|FG002|Overall Study|Withdrawal by Subject|17|||
129746144|NCT00235716|467029334|FG003|Overall Study|Withdrawal by Subject|18|||
129746145|NCT00235716|467029331|FG000|Overall Study|Lost to Follow-up|12|||
129746146|NCT00235716|467029332|FG001|Overall Study|Lost to Follow-up|7|||
129746147|NCT00235716|467029333|FG002|Overall Study|Lost to Follow-up|14|||
129746148|NCT00235716|467029334|FG003|Overall Study|Lost to Follow-up|10|||
129746149|NCT00235716|467029331|FG000|Overall Study|Adverse Event|1|||
129746150|NCT00235716|467029332|FG001|Overall Study|Adverse Event|1|||
129746151|NCT00235716|467029333|FG002|Overall Study|Adverse Event|1|||
129746152|NCT00235716|467029334|FG003|Overall Study|Adverse Event|0|||
129746153|NCT00235716|467029331|FG000|Overall Study|Physician Decision|0|||
129746154|NCT00235716|467029332|FG001|Overall Study|Physician Decision|1|||
129746155|NCT00235716|467029333|FG002|Overall Study|Physician Decision|1|||
129746156|NCT00235716|467029334|FG003|Overall Study|Physician Decision|3|||
129746157|NCT04390841|467029335|FG000|Overall Study|Withdrawal by Subject|2|||
129746158|NCT02891382|467029346|FG000|Overall Study|Lost to Follow-up|3|||
129746159|NCT02891382|467029347|FG001|Overall Study|Lost to Follow-up|4|||
129746160|NCT02891382|467029348|FG002|Overall Study|Lost to Follow-up|5|||
129746161|NCT02891382|467029349|FG003|Overall Study|Lost to Follow-up|3|||
129746162|NCT02891382|467029350|FG004|Overall Study|Lost to Follow-up|4|||
129746163|NCT02516228|467029357|FG000|Overall Study|Lost to Follow-up|1|||
129746164|NCT02516228|467029357|FG000|Overall Study|Withdrawal by Subject|1|||
129746165|NCT02516228|467029357|FG000|Overall Study|Physician Decision|1|||
129746166|NCT03916484|467029358|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129746167|NCT03916484|467029359|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
129746168|NCT03916484|467029360|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129746169|NCT03916484|467029361|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
129746170|NCT03916484|467029358|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
129746171|NCT03916484|467029359|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
129746172|NCT03916484|467029360|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
129746173|NCT03916484|467029361|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
129746174|NCT01196416|467029368|FG000|Overall Study|Withdrawal by Subject|2|||
129746175|NCT00504894|467029369|FG000|Overall Study|fMRI technical problems|1|||
129746176|NCT00504894|467029370|FG001|Overall Study|fMRI technical problems|1|||
129895865|NCT00530777|467578590|FG001|Overall Study|Lost to Follow-up|1|||
129895866|NCT00530777|467578589|FG000|Overall Study|Death|1|||
129895867|NCT00530777|467578590|FG001|Overall Study|Death|2|||
129746177|NCT00504894|467029371|FG002|Overall Study|fMRI technical problems|0|||
129746178|NCT00504894|467029369|FG000|Overall Study|Withdrawal by Subject|0|||
129746179|NCT00504894|467029370|FG001|Overall Study|Withdrawal by Subject|1|||
129746180|NCT00504894|467029371|FG002|Overall Study|Withdrawal by Subject|0|||
129746181|NCT00504894|467029369|FG000|Overall Study|Infusion technical problems|0|||
129746182|NCT00504894|467029370|FG001|Overall Study|Infusion technical problems|1|||
129746183|NCT00504894|467029371|FG002|Overall Study|Infusion technical problems|0|||
129895868|NCT00530777|467578589|FG000|Overall Study|Physician Decision|1|||
129746184|NCT00504894|467029369|FG000|Overall Study|poor subject data|2|||
129746185|NCT00504894|467029370|FG001|Overall Study|poor subject data|0|||
129746186|NCT00504894|467029371|FG002|Overall Study|poor subject data|0|||
129746187|NCT05090852|467029372|FG000|Overall Study|Physician Decision|5|||
129808570|NCT00932126|467265770|FG004|Overall Study|Other|1|||
129746188|NCT00148941|467029376|FG000|Overall Study|Lost to Follow-up|17|||
129746189|NCT00148941|467029377|FG001|Overall Study|Lost to Follow-up|24|||
129746190|NCT00148941|467029378|FG002|Overall Study|Lost to Follow-up|18|||
129746191|NCT00148941|467029379|FG003|Overall Study|Lost to Follow-up|22|||
129746192|NCT00148941|467029376|FG000|Overall Study|Withdrawal by Subject|1|||
129746193|NCT00148941|467029377|FG001|Overall Study|Withdrawal by Subject|0|||
129746194|NCT00148941|467029378|FG002|Overall Study|Withdrawal by Subject|1|||
129746195|NCT00148941|467029379|FG003|Overall Study|Withdrawal by Subject|0|||
129746196|NCT00148941|467029376|FG000|Overall Study|Other|0|||
129746197|NCT00148941|467029377|FG001|Overall Study|Other|0|||
129746198|NCT00148941|467029378|FG002|Overall Study|Other|1|||
129746199|NCT00148941|467029379|FG003|Overall Study|Other|2|||
129746200|NCT02673684|467029380|FG000|Overall Study|Study not completed d/t loss of funding|9|||
129746201|NCT02673684|467029381|FG001|Overall Study|Study not completed d/t loss of funding|8|||
129746202|NCT01092663|467029382|FG000|Overall Study|Withdrawal by Subject|3|||
129746203|NCT01092663|467029383|FG001|Overall Study|Withdrawal by Subject|2|||
129746204|NCT01092663|467029382|FG000|Overall Study|Glucose >300mg/dL|1|||
129746205|NCT01092663|467029383|FG001|Overall Study|Glucose >300mg/dL|0|||
129746206|NCT01092663|467029382|FG000|Overall Study|High fasting triglyceride|2|||
129746207|NCT01092663|467029383|FG001|Overall Study|High fasting triglyceride|0|||
129746208|NCT01092663|467029382|FG000|Overall Study|Adverse Event|1|||
129746209|NCT01092663|467029383|FG001|Overall Study|Adverse Event|1|||
129746210|NCT01092663|467029382|FG000|Overall Study|Protocol Violation|0|||
129746211|NCT01092663|467029383|FG001|Overall Study|Protocol Violation|1|||
129746212|NCT03688620|467029384|FG000|Overall Study|Other|0|||
129746213|NCT03688620|467029385|FG001|Overall Study|Other|0|||
129746214|NCT03688620|467029386|FG002|Overall Study|Other|1|||
129746215|NCT03688620|467029384|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
129746216|NCT03688620|467029385|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
129746217|NCT03688620|467029386|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
129746218|NCT03688620|467029384|FG000|Overall Study|Lost to Follow-up|16|||
129746219|NCT03688620|467029385|FG001|Overall Study|Lost to Follow-up|0|||
129746220|NCT03688620|467029386|FG002|Overall Study|Lost to Follow-up|1|||
129746221|NCT03688620|467029384|FG000|Overall Study|Withdrawal by Subject|0|||
129746222|NCT03688620|467029385|FG001|Overall Study|Withdrawal by Subject|0|||
129808571|NCT00932126|467265771|FG005|Overall Study|Other|0|||
129808572|NCT00932126|467265772|FG006|Overall Study|Other|1|||
129808573|NCT00932126|467265773|FG007|Overall Study|Other|2|||
129808574|NCT02716805|467265774|FG000|Overall Study|Progressive disease|2|||
129808575|NCT02716805|467265775|FG001|Overall Study|Progressive disease|0|||
129808576|NCT02716805|467265776|FG002|Overall Study|Progressive disease|0|||
129808577|NCT02716805|467265777|FG003|Overall Study|Progressive disease|0|||
129808578|NCT00066365|467265778|FG000|Overall Study|Adverse Event|1|||
129808579|NCT00066365|467265779|FG001|Overall Study|Adverse Event|0|||
129808580|NCT00066365|467265778|FG000|Overall Study|Lack of Efficacy|15|||
129808581|NCT00066365|467265779|FG001|Overall Study|Lack of Efficacy|12|||
129808582|NCT00066365|467265778|FG000|Overall Study|Physician Decision|1|||
129808583|NCT00066365|467265779|FG001|Overall Study|Physician Decision|0|||
129808584|NCT00066365|467265778|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
129808585|NCT00066365|467265779|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
129808586|NCT00066365|467265778|FG000|Overall Study|Ineligible|4|||
129808587|NCT00066365|467265779|FG001|Overall Study|Ineligible|2|||
129808588|NCT02635776|467265784|FG000|Overall Study|Physician Decision|1|||
129808589|NCT02635776|467265785|FG001|Overall Study|Physician Decision|0|||
129808590|NCT02635776|467265784|FG000|Overall Study|Adverse Event|51|||
129808591|NCT02635776|467265785|FG001|Overall Study|Adverse Event|3|||
129808592|NCT02635776|467265784|FG000|Overall Study|Withdrawal by Subject|41|||
129808593|NCT02635776|467265785|FG001|Overall Study|Withdrawal by Subject|7|||
129808594|NCT02635776|467265784|FG000|Overall Study|Lost to Follow-up|4|||
129746223|NCT03688620|467029386|FG002|Overall Study|Withdrawal by Subject|6|||
129895869|NCT00530777|467578590|FG001|Overall Study|Physician Decision|0|||
129746224|NCT01008904|467029387|FG000|Overall Study|Lost to Follow-up|1|||
129746225|NCT01008904|467029387|FG000|Overall Study|Adverse Event|2|||
129808595|NCT02635776|467265785|FG001|Overall Study|Lost to Follow-up|0|||
129808596|NCT02635776|467265784|FG000|Overall Study|Other reasons|5|||
129808597|NCT02635776|467265785|FG001|Overall Study|Other reasons|1|||
129808598|NCT00788073|467265786|FG000|STX209 Then Placebo|Adverse Event|1|||
129808599|NCT00788073|467265787|FG001|STX209 Then Placebo|Adverse Event|0|||
129808600|NCT00788073|467265786|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
129895870|NCT00530777|467578589|FG000|Overall Study|Withdrawal by Subject|0|||
129746226|NCT01008904|467029387|FG000|Overall Study|unexpected unrelated surgery|1|||
129746227|NCT01183065|467029388|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
129746228|NCT02456857|467029389|FG000|Overall Study|Disease Progression|4|||
129746229|NCT00781859|467029390|FG000|Overall Study|Adverse Event|2|||
129746230|NCT00781859|467029391|FG001|Overall Study|Adverse Event|2|||
129746231|NCT00781859|467029390|FG000|Overall Study|Withdrawal by Subject|8|||
129808601|NCT00788073|467265787|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
129808602|NCT00788073|467265786|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
129746232|NCT00781859|467029391|FG001|Overall Study|Withdrawal by Subject|4|||
129746233|NCT00781859|467029390|FG000|Overall Study|Lost to Follow-up|6|||
129746234|NCT00781859|467029391|FG001|Overall Study|Lost to Follow-up|3|||
129746235|NCT00781859|467029390|FG000|Overall Study|Death|3|||
129746236|NCT00781859|467029391|FG001|Overall Study|Death|0|||
129746237|NCT01983774|467029395|FG000|Overall Study|Lung Transplant|0|||
129746238|NCT01983774|467029396|FG001|Overall Study|Lung Transplant|1|||
129746239|NCT01983774|467029395|FG000|Overall Study|Lost to Follow-up|1|||
129746240|NCT01983774|467029396|FG001|Overall Study|Lost to Follow-up|0|||
129746241|NCT01008449|467029397|FG000|Overall Study|Lost to Follow-up|29|||
129746242|NCT01008449|467029398|FG001|Overall Study|Lost to Follow-up|19|||
129746243|NCT01220180|467029399|FG000|Overall Study|Lost to Follow-up|76|||
129746244|NCT01220180|467029399|FG000|Overall Study|Other|72|||
129746245|NCT01220180|467029399|FG000|Overall Study|Adverse Event|35|||
129746246|NCT01220180|467029399|FG000|Overall Study|Lack of Efficacy|22|||
129746247|NCT01220180|467029399|FG000|Overall Study|Death|1|||
129746248|NCT01220180|467029399|FG000|Overall Study|Randomized but not treated|1|||
129746249|NCT01067469|467029404|FG000|Overall Study|Withdrawal by Subject|0|||
129746250|NCT01067469|467029405|FG001|Overall Study|Withdrawal by Subject|1|||
129746251|NCT01067469|467029404|FG000|Overall Study|Disease Progression|0|||
129746252|NCT01067469|467029405|FG001|Overall Study|Disease Progression|1|||
129746253|NCT01299116|467029408|FG000|Overall Study|Lost to Follow-up|65|||
129746254|NCT01299116|467029409|FG001|Overall Study|Lost to Follow-up|9|||
129746255|NCT01299116|467029410|FG002|Overall Study|Lost to Follow-up|11|||
129746256|NCT01620944|467029412|FG000|Overall Study|Early termination of Study|2|||
129746257|NCT01620944|467029413|FG001|Overall Study|Early termination of Study|1|||
129746258|NCT01123707|467029414|FG000|Overall Study|Lost to Follow-up|3|||
129746259|NCT01123707|467029415|FG001|Overall Study|Lost to Follow-up|1|||
129746260|NCT01123707|467029416|FG002|Overall Study|Lost to Follow-up|3|||
129746261|NCT01123707|467029417|FG003|Overall Study|Lost to Follow-up|2|||
129746262|NCT01123707|467029414|FG000|Overall Study|Adverse Event|5|||
129746263|NCT01123707|467029415|FG001|Overall Study|Adverse Event|7|||
129746264|NCT01123707|467029416|FG002|Overall Study|Adverse Event|5|||
129746265|NCT01123707|467029417|FG003|Overall Study|Adverse Event|3|||
129746266|NCT01123707|467029414|FG000|Overall Study|Sponsor Discontinued Study|30|||
129746267|NCT01123707|467029415|FG001|Overall Study|Sponsor Discontinued Study|24|||
129746268|NCT01123707|467029416|FG002|Overall Study|Sponsor Discontinued Study|25|||
129746269|NCT01123707|467029417|FG003|Overall Study|Sponsor Discontinued Study|40|||
129746270|NCT01123707|467029414|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
129746271|NCT01123707|467029415|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
129746272|NCT01123707|467029416|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
129746273|NCT01123707|467029417|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
129746274|NCT01123707|467029414|FG000|Overall Study|Investigator Withdrew Participant|0|||
129746275|NCT01123707|467029415|FG001|Overall Study|Investigator Withdrew Participant|1|||
129746276|NCT01123707|467029416|FG002|Overall Study|Investigator Withdrew Participant|1|||
129746277|NCT01123707|467029417|FG003|Overall Study|Investigator Withdrew Participant|1|||
129746278|NCT01123707|467029414|FG000|Overall Study|Subject Withdrew Consent|4|||
129746279|NCT01123707|467029415|FG001|Overall Study|Subject Withdrew Consent|5|||
129746280|NCT01123707|467029416|FG002|Overall Study|Subject Withdrew Consent|1|||
129746281|NCT01123707|467029417|FG003|Overall Study|Subject Withdrew Consent|2|||
129746282|NCT01123707|467029414|FG000|Overall Study|Lack of Efficacy|1|||
129746283|NCT01123707|467029415|FG001|Overall Study|Lack of Efficacy|2|||
129746284|NCT01123707|467029416|FG002|Overall Study|Lack of Efficacy|1|||
129746285|NCT01123707|467029417|FG003|Overall Study|Lack of Efficacy|0|||
129746286|NCT01123707|467029414|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
129746287|NCT01123707|467029415|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
129746288|NCT01123707|467029416|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
129746289|NCT01123707|467029417|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
129746290|NCT04378114|467029418|FG000|Overall Study|Withdrawal by Subject|5|||
129746291|NCT01959243|467029423|FG000|Overall Study|Investigator Decision|3|||
129746292|NCT01959243|467029424|FG001|Overall Study|Investigator Decision|0|||
129746293|NCT01959243|467029423|FG000|Overall Study|Adverse Event|5|||
129746294|NCT01959243|467029424|FG001|Overall Study|Adverse Event|2|||
129746295|NCT01959243|467029423|FG000|Overall Study|Administrative reasons|2|||
129746296|NCT01959243|467029424|FG001|Overall Study|Administrative reasons|1|||
129746297|NCT01959243|467029423|FG000|Overall Study|Lost to Follow-up|3|||
129746298|NCT01959243|467029424|FG001|Overall Study|Lost to Follow-up|1|||
129746299|NCT00629798|467029425|FG000|Overall Study|Not Treated|4|||
129746300|NCT02554981|467029426|FG000|Overall Study|Adverse Event|1|||
129746301|NCT02554981|467029426|FG000|Overall Study|Administrative Reasons|1|||
129746302|NCT02554981|467029426|FG000|Overall Study|Other Miscellaneous Reasons|3|||
129746303|NCT01114438|467029427|FG000|Overall Study|Adverse Event|10|||
129746304|NCT01114438|467029427|FG000|Overall Study|concomitant medication|1|||
129746305|NCT01114438|467029427|FG000|Overall Study|Physician Decision|1|||
129746306|NCT01114438|467029427|FG000|Overall Study|Withdrawal by Subject|2|||
129746307|NCT00428844|467029430|FG000|Completed Study Drug Treatment|Adverse Event|2|||
129746308|NCT00428844|467029431|FG001|Completed Study Drug Treatment|Adverse Event|4|||
129746309|NCT00428844|467029432|FG002|Completed Study Drug Treatment|Adverse Event|4|||
129746310|NCT00428844|467029430|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
129746311|NCT00428844|467029431|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
129746312|NCT00428844|467029432|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
129746313|NCT00428844|467029430|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
129746314|NCT00428844|467029431|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
129746315|NCT00428844|467029432|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
129746316|NCT00428844|467029430|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
129746317|NCT00428844|467029431|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
129746318|NCT00428844|467029432|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
129746319|NCT00428844|467029430|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
129746320|NCT00428844|467029431|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
129746321|NCT00428844|467029432|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
129746322|NCT00428844|467029430|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
129746323|NCT00428844|467029431|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
129746324|NCT00428844|467029432|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
129746325|NCT00428844|467029430|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
129746326|NCT00428844|467029431|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
129746327|NCT00428844|467029432|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
129746328|NCT00428844|467029430|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
129746329|NCT00428844|467029431|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
129746330|NCT00428844|467029432|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
129746331|NCT00428844|467029430|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
129746332|NCT00428844|467029431|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
129746333|NCT00428844|467029432|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
129746334|NCT00488826|467029435|FG000|Overall Study|Withdrawal by Subject|40|||
129746335|NCT00488826|467029436|FG001|Overall Study|Withdrawal by Subject|35|||
129746336|NCT00488826|467029437|FG002|Overall Study|Withdrawal by Subject|19|||
129746337|NCT00488826|467029435|FG000|Overall Study|Protocol Violation|0|||
129746338|NCT00488826|467029436|FG001|Overall Study|Protocol Violation|0|||
129746339|NCT00488826|467029437|FG002|Overall Study|Protocol Violation|2|||
129746340|NCT00488826|467029435|FG000|Overall Study|Adverse Event|9|||
129746341|NCT00488826|467029436|FG001|Overall Study|Adverse Event|15|||
129746342|NCT00488826|467029437|FG002|Overall Study|Adverse Event|4|||
129746343|NCT00488826|467029435|FG000|Overall Study|Lost to Follow-up|5|||
129746344|NCT00488826|467029436|FG001|Overall Study|Lost to Follow-up|1|||
129746345|NCT00488826|467029437|FG002|Overall Study|Lost to Follow-up|0|||
129746346|NCT00488826|467029435|FG000|Overall Study|Protocol Deviations|2|||
129746347|NCT00488826|467029436|FG001|Overall Study|Protocol Deviations|1|||
129746348|NCT00488826|467029437|FG002|Overall Study|Protocol Deviations|1|||
129746349|NCT02292706|467029438|FG000|Overall Study|Lost to Follow-up|20|||
129746350|NCT02292706|467029439|FG001|Overall Study|Lost to Follow-up|44|||
129746351|NCT02292706|467029440|FG002|Overall Study|Lost to Follow-up|24|||
129746352|NCT02292706|467029441|FG003|Overall Study|Lost to Follow-up|61|||
129746353|NCT02292706|467029442|FG004|Overall Study|Lost to Follow-up|21|||
129746354|NCT02292706|467029443|FG005|Overall Study|Lost to Follow-up|52|||
129746355|NCT02292706|467029444|FG006|Overall Study|Lost to Follow-up|25|||
129746356|NCT02292706|467029445|FG007|Overall Study|Lost to Follow-up|0|||
129746357|NCT02292706|467029438|FG000|Overall Study|Withdrew consent|15|||
129746358|NCT02292706|467029439|FG001|Overall Study|Withdrew consent|56|||
129746359|NCT02292706|467029440|FG002|Overall Study|Withdrew consent|43|||
129746360|NCT02292706|467029441|FG003|Overall Study|Withdrew consent|36|||
129808603|NCT00788073|467265787|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
129808604|NCT00788073|467265786|FG000|STX209 Then Placebo|unable to return due to travel|0|||
129808605|NCT00788073|467265787|FG001|STX209 Then Placebo|unable to return due to travel|1|||
129808606|NCT00788073|467265786|FG000|Placebo Then STX209|Adverse Event|2|||
129808607|NCT00788073|467265787|FG001|Placebo Then STX209|Adverse Event|0|||
129808608|NCT00788073|467265786|FG000|Placebo Then STX209|Protocol Violation|0|||
129808609|NCT00788073|467265787|FG001|Placebo Then STX209|Protocol Violation|1|||
129808610|NCT02058693|467265790|FG000|Phase 1|Withdrawal by Subject|3|||
129808611|NCT02058693|467265791|FG001|Phase 1|Withdrawal by Subject|2|||
129746361|NCT02292706|467029442|FG004|Overall Study|Withdrew consent|13|||
129746362|NCT02292706|467029443|FG005|Overall Study|Withdrew consent|51|||
129746363|NCT02292706|467029444|FG006|Overall Study|Withdrew consent|20|||
129808612|NCT02058693|467265790|FG000|Phase 1|Adverse Event|0|||
129808613|NCT02058693|467265791|FG001|Phase 1|Adverse Event|1|||
129895871|NCT00530777|467578590|FG001|Overall Study|Withdrawal by Subject|1|||
129895872|NCT00530777|467578589|FG000|Overall Study|Unable to adhere to visit schedule|5|||
129746364|NCT02292706|467029445|FG007|Overall Study|Withdrew consent|0|||
129746365|NCT02292706|467029438|FG000|Overall Study|Death|3|||
129746366|NCT02292706|467029439|FG001|Overall Study|Death|11|||
129746367|NCT02292706|467029440|FG002|Overall Study|Death|16|||
129746368|NCT02292706|467029441|FG003|Overall Study|Death|22|||
129746369|NCT02292706|467029442|FG004|Overall Study|Death|8|||
129746370|NCT02292706|467029443|FG005|Overall Study|Death|17|||
129746371|NCT02292706|467029444|FG006|Overall Study|Death|3|||
129746372|NCT02292706|467029445|FG007|Overall Study|Death|0|||
129746373|NCT02292706|467029438|FG000|Overall Study|Study terminated by sponsor|0|||
129746374|NCT02292706|467029439|FG001|Overall Study|Study terminated by sponsor|9|||
129746375|NCT02292706|467029440|FG002|Overall Study|Study terminated by sponsor|4|||
129746376|NCT02292706|467029441|FG003|Overall Study|Study terminated by sponsor|21|||
129746377|NCT02292706|467029442|FG004|Overall Study|Study terminated by sponsor|11|||
129746378|NCT02292706|467029443|FG005|Overall Study|Study terminated by sponsor|13|||
129746379|NCT02292706|467029444|FG006|Overall Study|Study terminated by sponsor|3|||
129746380|NCT02292706|467029445|FG007|Overall Study|Study terminated by sponsor|0|||
129746381|NCT02292706|467029438|FG000|Overall Study|Investigator's discretion|4|||
129746382|NCT02292706|467029439|FG001|Overall Study|Investigator's discretion|9|||
129746383|NCT02292706|467029440|FG002|Overall Study|Investigator's discretion|7|||
129746384|NCT02292706|467029441|FG003|Overall Study|Investigator's discretion|11|||
129746385|NCT02292706|467029442|FG004|Overall Study|Investigator's discretion|4|||
129746386|NCT02292706|467029443|FG005|Overall Study|Investigator's discretion|10|||
129746387|NCT02292706|467029444|FG006|Overall Study|Investigator's discretion|1|||
129746388|NCT02292706|467029445|FG007|Overall Study|Investigator's discretion|0|||
129746389|NCT02292706|467029438|FG000|Overall Study|Liver transplant|1|||
129746390|NCT02292706|467029439|FG001|Overall Study|Liver transplant|1|||
129746391|NCT02292706|467029440|FG002|Overall Study|Liver transplant|11|||
129746392|NCT02292706|467029441|FG003|Overall Study|Liver transplant|16|||
129746393|NCT02292706|467029442|FG004|Overall Study|Liver transplant|5|||
129746394|NCT02292706|467029443|FG005|Overall Study|Liver transplant|6|||
129746395|NCT02292706|467029444|FG006|Overall Study|Liver transplant|5|||
129746396|NCT02292706|467029445|FG007|Overall Study|Liver transplant|0|||
129746397|NCT02292706|467029438|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
129746398|NCT02292706|467029439|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
129746399|NCT02292706|467029440|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
129746400|NCT02292706|467029441|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
129746401|NCT02292706|467029442|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
129746402|NCT02292706|467029443|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
129746403|NCT02292706|467029444|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
129746404|NCT02292706|467029445|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
129746405|NCT02292706|467029438|FG000|Overall Study|Subject terminated by sponsor|1|||
129746406|NCT02292706|467029439|FG001|Overall Study|Subject terminated by sponsor|0|||
129746407|NCT02292706|467029440|FG002|Overall Study|Subject terminated by sponsor|0|||
129746408|NCT02292706|467029441|FG003|Overall Study|Subject terminated by sponsor|2|||
129746409|NCT02292706|467029442|FG004|Overall Study|Subject terminated by sponsor|1|||
129746410|NCT02292706|467029443|FG005|Overall Study|Subject terminated by sponsor|0|||
129746411|NCT02292706|467029444|FG006|Overall Study|Subject terminated by sponsor|0|||
129746412|NCT02292706|467029445|FG007|Overall Study|Subject terminated by sponsor|0|||
129746413|NCT02292706|467029438|FG000|Overall Study|Missing|0|||
129746414|NCT02292706|467029439|FG001|Overall Study|Missing|0|||
129746415|NCT02292706|467029440|FG002|Overall Study|Missing|1|||
129746416|NCT02292706|467029441|FG003|Overall Study|Missing|1|||
129746417|NCT02292706|467029442|FG004|Overall Study|Missing|0|||
129746418|NCT02292706|467029443|FG005|Overall Study|Missing|1|||
129746419|NCT02292706|467029444|FG006|Overall Study|Missing|0|||
129746420|NCT02292706|467029445|FG007|Overall Study|Missing|0|||
129746421|NCT02292706|467029438|FG000|Overall Study|Virologic relapse or reinfection|1|||
129746422|NCT02292706|467029439|FG001|Overall Study|Virologic relapse or reinfection|0|||
129746423|NCT02292706|467029440|FG002|Overall Study|Virologic relapse or reinfection|0|||
129746424|NCT02292706|467029441|FG003|Overall Study|Virologic relapse or reinfection|1|||
129746425|NCT02292706|467029442|FG004|Overall Study|Virologic relapse or reinfection|0|||
129746426|NCT02292706|467029443|FG005|Overall Study|Virologic relapse or reinfection|1|||
129746427|NCT02292706|467029444|FG006|Overall Study|Virologic relapse or reinfection|0|||
129746428|NCT02292706|467029445|FG007|Overall Study|Virologic relapse or reinfection|0|||
129746429|NCT02725866|467029448|FG000|Overall Study|Failure to return|6|||
129746430|NCT02725866|467029448|FG000|Overall Study|Withdrew consent|3|||
129808614|NCT02058693|467265790|FG000|Phase 1|Lack of Efficacy|1|||
129808615|NCT02058693|467265791|FG001|Phase 1|Lack of Efficacy|0|||
129808616|NCT02058693|467265790|FG000|Phase 1|Physician Decision|1|||
129808617|NCT02058693|467265791|FG001|Phase 1|Physician Decision|1|||
129746431|NCT02725866|467029448|FG000|Overall Study|Insufficient virological response|1|||
129746432|NCT02725866|467029448|FG000|Overall Study|Other, not specified|4|||
129746433|NCT03043651|467029454|FG000|Overall Study|Death|1|||
129746434|NCT03043651|467029454|FG000|Overall Study|Progressive Disease|2|||
129746435|NCT03043651|467029454|FG000|Overall Study|Adverse Event|2|||
129746436|NCT03043651|467029454|FG000|Overall Study|Withdrawal by Subject|4|||
129746437|NCT03043651|467029454|FG000|Overall Study|Study Terminated by Sponsor|39|||
129746438|NCT03597061|467029462|FG000|Overall Study|Lost to Follow-up|1|||
129746439|NCT03597061|467029463|FG001|Overall Study|Lost to Follow-up|0|||
129808618|NCT02058693|467265790|FG000|Phase 2|Withdrawal by Subject|0|||
129808619|NCT02058693|467265791|FG001|Phase 2|Withdrawal by Subject|2|||
129746440|NCT03597061|467029462|FG000|Overall Study|Protocol Violation|0|||
129746441|NCT03597061|467029463|FG001|Overall Study|Protocol Violation|1|||
129746442|NCT00761527|467029464|FG000|Overall Study|Adverse Event|3|||
129746443|NCT00761527|467029464|FG000|Overall Study|Poor Compliance|8|||
129746444|NCT00761527|467029464|FG000|Overall Study|Lost to Follow-up|9|||
129746445|NCT00761527|467029464|FG000|Overall Study|Unknown reason|2|||
129746446|NCT01431963|467029465|FG000|Overall Study|Adverse Event|18|||
129746447|NCT01431963|467029465|FG000|Overall Study|Lack of Efficacy|7|||
129746448|NCT01431963|467029465|FG000|Overall Study|Protocol Violation|1|||
129746449|NCT01431963|467029465|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
129746450|NCT01431963|467029465|FG000|Overall Study|Physician Decision|4|||
129746451|NCT01431963|467029465|FG000|Overall Study|Withdrawal by Subject|3|||
129746452|NCT02921087|467029468|FG000|Overall Study|Withdrawal by Subject|0|||
129746453|NCT02921087|467029469|FG001|Overall Study|Withdrawal by Subject|1|||
129746454|NCT00687531|467029470|FG000|Overall Study|Did not meet protocol eligibility|104|||
129746455|NCT00687531|467029470|FG000|Overall Study|Adverse Event|5|||
129746456|NCT00687531|467029470|FG000|Overall Study|Lost to Follow-up|26|||
129746457|NCT03210961|467031240|FG000|Overall Study|Adverse Event|0|||
129746458|NCT03210961|467031241|FG001|Overall Study|Adverse Event|0|||
129746459|NCT03210961|467031242|FG002|Overall Study|Adverse Event|0|||
129746460|NCT03210961|467031243|FG003|Overall Study|Adverse Event|0|||
129746461|NCT03210961|467031244|FG004|Overall Study|Adverse Event|0|||
129746462|NCT03210961|467031245|FG005|Overall Study|Adverse Event|0|||
129746463|NCT03210961|467031246|FG006|Overall Study|Adverse Event|0|||
129746464|NCT03210961|467031247|FG007|Overall Study|Adverse Event|0|||
129746465|NCT03210961|467031248|FG008|Overall Study|Adverse Event|0|||
129746466|NCT03210961|467031249|FG009|Overall Study|Adverse Event|0|||
129746467|NCT03210961|467031250|FG010|Overall Study|Adverse Event|0|||
129746468|NCT03210961|467031251|FG011|Overall Study|Adverse Event|0|||
129746469|NCT03210961|467031252|FG012|Overall Study|Adverse Event|0|||
129746470|NCT03210961|467031253|FG013|Overall Study|Adverse Event|1|||
129746471|NCT03210961|467031254|FG014|Overall Study|Adverse Event|0|||
129746472|NCT03210961|467031240|FG000|Overall Study|Lost to Follow-up|0|||
129746473|NCT03210961|467031241|FG001|Overall Study|Lost to Follow-up|0|||
129746474|NCT03210961|467031242|FG002|Overall Study|Lost to Follow-up|0|||
129746475|NCT03210961|467031243|FG003|Overall Study|Lost to Follow-up|0|||
129746476|NCT03210961|467031244|FG004|Overall Study|Lost to Follow-up|0|||
129746477|NCT03210961|467031245|FG005|Overall Study|Lost to Follow-up|0|||
129746478|NCT03210961|467031246|FG006|Overall Study|Lost to Follow-up|0|||
129746479|NCT03210961|467031247|FG007|Overall Study|Lost to Follow-up|0|||
129746480|NCT03210961|467031248|FG008|Overall Study|Lost to Follow-up|0|||
129746481|NCT03210961|467031249|FG009|Overall Study|Lost to Follow-up|0|||
129746482|NCT03210961|467031250|FG010|Overall Study|Lost to Follow-up|0|||
129746483|NCT03210961|467031251|FG011|Overall Study|Lost to Follow-up|0|||
129746484|NCT03210961|467031252|FG012|Overall Study|Lost to Follow-up|0|||
129746485|NCT03210961|467031253|FG013|Overall Study|Lost to Follow-up|0|||
129746486|NCT03210961|467031254|FG014|Overall Study|Lost to Follow-up|1|||
129746487|NCT03210961|467031240|FG000|Overall Study|Withdrawal by Subject|0|||
129746488|NCT03210961|467031241|FG001|Overall Study|Withdrawal by Subject|0|||
129746489|NCT03210961|467031242|FG002|Overall Study|Withdrawal by Subject|0|||
129746490|NCT03210961|467031243|FG003|Overall Study|Withdrawal by Subject|0|||
129746491|NCT03210961|467031244|FG004|Overall Study|Withdrawal by Subject|0|||
129746492|NCT03210961|467031245|FG005|Overall Study|Withdrawal by Subject|0|||
129746493|NCT03210961|467031246|FG006|Overall Study|Withdrawal by Subject|0|||
129746494|NCT03210961|467031247|FG007|Overall Study|Withdrawal by Subject|0|||
129746495|NCT03210961|467031248|FG008|Overall Study|Withdrawal by Subject|0|||
129808620|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
129808621|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
129808622|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
129808623|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
129808624|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808625|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808626|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808627|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808628|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808629|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129746496|NCT03210961|467031249|FG009|Overall Study|Withdrawal by Subject|0|||
129746497|NCT03210961|467031250|FG010|Overall Study|Withdrawal by Subject|0|||
129746498|NCT03210961|467031251|FG011|Overall Study|Withdrawal by Subject|0|||
129746499|NCT03210961|467031252|FG012|Overall Study|Withdrawal by Subject|0|||
129746500|NCT03210961|467031253|FG013|Overall Study|Withdrawal by Subject|0|||
129808630|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129808631|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
129746501|NCT03210961|467031254|FG014|Overall Study|Withdrawal by Subject|1|||
129746502|NCT03210961|467031240|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746503|NCT03210961|467031241|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746504|NCT03210961|467031242|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746505|NCT03210961|467031243|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746506|NCT03210961|467031244|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746507|NCT03210961|467031245|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746508|NCT03210961|467031246|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746509|NCT03210961|467031247|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746510|NCT03210961|467031248|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746511|NCT03210961|467031249|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746512|NCT03210961|467031250|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746513|NCT03210961|467031251|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746514|NCT03210961|467031252|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746515|NCT03210961|467031253|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
129746516|NCT03210961|467031254|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
129746517|NCT03210961|467031240|FG000|Overall Study|Other|0|||
129746518|NCT03210961|467031241|FG001|Overall Study|Other|0|||
129746519|NCT03210961|467031242|FG002|Overall Study|Other|0|||
129746520|NCT03210961|467031243|FG003|Overall Study|Other|1|||
129746521|NCT03210961|467031244|FG004|Overall Study|Other|0|||
129746522|NCT03210961|467031245|FG005|Overall Study|Other|0|||
129746523|NCT03210961|467031246|FG006|Overall Study|Other|1|||
129746524|NCT03210961|467031247|FG007|Overall Study|Other|0|||
129746525|NCT03210961|467031248|FG008|Overall Study|Other|0|||
129746526|NCT03210961|467031249|FG009|Overall Study|Other|0|||
129746527|NCT03210961|467031250|FG010|Overall Study|Other|1|||
129746528|NCT03210961|467031251|FG011|Overall Study|Other|0|||
129746529|NCT03210961|467031252|FG012|Overall Study|Other|2|||
129746530|NCT03210961|467031253|FG013|Overall Study|Other|2|||
129746531|NCT03210961|467031254|FG014|Overall Study|Other|0|||
129746532|NCT00602420|467031255|FG000|Overall Study|Death|1|||
129746533|NCT00602420|467031256|FG001|Overall Study|Death|4|||
129746534|NCT00602420|467031255|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
129746535|NCT00602420|467031256|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
129746536|NCT00602420|467031255|FG000|Overall Study|Withdrawal by Subject|18|||
129746537|NCT00602420|467031256|FG001|Overall Study|Withdrawal by Subject|17|||
129746538|NCT00602420|467031255|FG000|Overall Study|Adverse Event|1|||
129746539|NCT00602420|467031256|FG001|Overall Study|Adverse Event|0|||
129746540|NCT00703924|467031265|FG000|Overall Study|Withdrawal by Subject|1|||
129746541|NCT00703924|467031266|FG001|Overall Study|Withdrawal by Subject|1|||
129746542|NCT03077919|467031267|FG000|Overall Study|Lost to Follow-up|4|||
129746543|NCT03077919|467031268|FG001|Overall Study|Lost to Follow-up|1|||
129746544|NCT03592368|467031269|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
129746545|NCT03592368|467031270|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
129746546|NCT03592368|467031271|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
129746547|NCT03592368|467031272|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
129746548|NCT03592368|467031269|FG000|Overall Study|Adverse Event|0|||
129746549|NCT03592368|467031270|FG001|Overall Study|Adverse Event|0|||
129746550|NCT03592368|467031271|FG002|Overall Study|Adverse Event|0|||
129746551|NCT03592368|467031272|FG003|Overall Study|Adverse Event|1|||
129746552|NCT03592368|467031269|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
129746553|NCT03592368|467031270|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
129746554|NCT03592368|467031271|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
129746555|NCT03592368|467031272|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
129746556|NCT03499314|467031273|FG000|Overall Study|Time Commitment|1|||
129746557|NCT03499314|467031274|FG001|Overall Study|Time Commitment|2|||
129746558|NCT03499314|467031273|FG000|Overall Study|Medical issue unrelated to research study|1|||
129746559|NCT03499314|467031274|FG001|Overall Study|Medical issue unrelated to research study|1|||
129746560|NCT01618695|467031276|FG000|Core Phase|Adverse Event|4|||
129746561|NCT01618695|467031277|FG001|Core Phase|Adverse Event|5|||
129746562|NCT01618695|467031278|FG002|Core Phase|Adverse Event|15|||
129746563|NCT01618695|467031279|FG003|Core Phase|Adverse Event|20|||
129808632|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
129808633|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
129808634|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
129808635|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808636|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129746564|NCT01618695|467031276|FG000|Core Phase|Lost to Follow-up|0|||
129746565|NCT01618695|467031277|FG001|Core Phase|Lost to Follow-up|0|||
129746566|NCT01618695|467031278|FG002|Core Phase|Lost to Follow-up|1|||
129808637|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129746567|NCT01618695|467031279|FG003|Core Phase|Lost to Follow-up|0|||
129746568|NCT01618695|467031276|FG000|Core Phase|Withdrawal by Subject|16|||
129746569|NCT01618695|467031277|FG001|Core Phase|Withdrawal by Subject|11|||
129746570|NCT01618695|467031278|FG002|Core Phase|Withdrawal by Subject|9|||
129746571|NCT01618695|467031279|FG003|Core Phase|Withdrawal by Subject|13|||
129808638|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129746572|NCT01618695|467031276|FG000|Core Phase|Pregnancy|2|||
129746573|NCT01618695|467031277|FG001|Core Phase|Pregnancy|0|||
129746574|NCT01618695|467031278|FG002|Core Phase|Pregnancy|0|||
129746575|NCT01618695|467031279|FG003|Core Phase|Pregnancy|0|||
129746576|NCT01618695|467031276|FG000|Core Phase|Lack of Efficacy|1|||
129746577|NCT01618695|467031277|FG001|Core Phase|Lack of Efficacy|2|||
129746578|NCT01618695|467031278|FG002|Core Phase|Lack of Efficacy|1|||
129746579|NCT01618695|467031279|FG003|Core Phase|Lack of Efficacy|1|||
129746580|NCT01618695|467031276|FG000|Core Phase|Other than specified|1|||
129746581|NCT01618695|467031277|FG001|Core Phase|Other than specified|2|||
129746582|NCT01618695|467031278|FG002|Core Phase|Other than specified|2|||
129746583|NCT01618695|467031279|FG003|Core Phase|Other than specified|2|||
129746584|NCT01618695|467031276|FG000|Core Phase|Not treated|1|||
129746585|NCT01618695|467031277|FG001|Core Phase|Not treated|0|||
129746586|NCT01618695|467031278|FG002|Core Phase|Not treated|2|||
129746587|NCT01618695|467031279|FG003|Core Phase|Not treated|0|||
129746588|NCT01618695|467031276|FG000|Extension Phase|Lack of Efficacy|17|||
129746589|NCT01618695|467031277|FG001|Extension Phase|Lack of Efficacy|33|||
129746590|NCT01618695|467031278|FG002|Extension Phase|Lack of Efficacy|26|||
129746591|NCT01618695|467031279|FG003|Extension Phase|Lack of Efficacy|24|||
129746592|NCT01618695|467031276|FG000|Extension Phase|Pregnancy|2|||
129746593|NCT01618695|467031277|FG001|Extension Phase|Pregnancy|0|||
129746594|NCT01618695|467031278|FG002|Extension Phase|Pregnancy|1|||
129746595|NCT01618695|467031279|FG003|Extension Phase|Pregnancy|1|||
129746596|NCT01618695|467031276|FG000|Extension Phase|Withdrawal by Subject|43|||
129746597|NCT01618695|467031277|FG001|Extension Phase|Withdrawal by Subject|48|||
129746598|NCT01618695|467031278|FG002|Extension Phase|Withdrawal by Subject|42|||
129746599|NCT01618695|467031279|FG003|Extension Phase|Withdrawal by Subject|33|||
129746600|NCT01618695|467031276|FG000|Extension Phase|Adverse Event|18|||
129746601|NCT01618695|467031277|FG001|Extension Phase|Adverse Event|16|||
129746602|NCT01618695|467031278|FG002|Extension Phase|Adverse Event|9|||
129746603|NCT01618695|467031279|FG003|Extension Phase|Adverse Event|20|||
129746604|NCT01618695|467031276|FG000|Extension Phase|Lost to Follow-up|2|||
129746605|NCT01618695|467031277|FG001|Extension Phase|Lost to Follow-up|1|||
129746606|NCT01618695|467031278|FG002|Extension Phase|Lost to Follow-up|1|||
129746607|NCT01618695|467031279|FG003|Extension Phase|Lost to Follow-up|1|||
129746608|NCT01618695|467031276|FG000|Extension Phase|Other than specified|13|||
129746609|NCT01618695|467031277|FG001|Extension Phase|Other than specified|18|||
129746610|NCT01618695|467031278|FG002|Extension Phase|Other than specified|13|||
129746611|NCT01618695|467031279|FG003|Extension Phase|Other than specified|18|||
129746612|NCT02454478|467031282|FG000|Overall Study|Incomplete DLT Evaluation|1|||
129746613|NCT02352753|467031285|FG000|6-Month Dosing Period|Decision by sponsor|2|||
129746614|NCT02352753|467031285|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
129746615|NCT02352753|467031285|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
129746616|NCT02352753|467031285|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
129746617|NCT02352753|467031285|FG000|3-Month Dosing Period|Decision by sponsor|14|||
129746618|NCT02352753|467031285|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
129746619|NCT00539305|467031286|FG000|Overall Study|Adverse Event|1|||
129746620|NCT00539305|467031287|FG001|Overall Study|Adverse Event|0|||
129746621|NCT00539305|467031286|FG000|Overall Study|Substance Use|0|||
129746622|NCT00539305|467031287|FG001|Overall Study|Substance Use|1|||
129746623|NCT00539305|467031286|FG000|Overall Study|Withdrawal by Subject|0|||
129746624|NCT00539305|467031287|FG001|Overall Study|Withdrawal by Subject|1|||
129746625|NCT00413036|467031293|FG000|Overall Study|Adverse Event|44|||
129746626|NCT00413036|467031293|FG000|Overall Study|Lack of Efficacy|129|||
129746627|NCT00413036|467031293|FG000|Overall Study|Withdrawal by Subject|7|||
129746628|NCT00413036|467031293|FG000|Overall Study|Death|9|||
129808639|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808640|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808641|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808642|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808643|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
129808644|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
129808645|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
129808646|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808647|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808648|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808649|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808650|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808651|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808652|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808653|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808654|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129746629|NCT00413036|467031293|FG000|Overall Study|Other|26|||
129746630|NCT00413036|467031293|FG000|Overall Study|Missing|2|||
129746631|NCT01369641|467031294|FG000|Overall Study|Withdrawal by Subject|1|||
129746632|NCT02760810|467031302|FG000|Overall Study|Protocol Violation|1|||
129746633|NCT00820222|467031303|FG000|Overall Study|Lost to Follow-up|10|||
129746634|NCT00820222|467031304|FG001|Overall Study|Lost to Follow-up|9|||
129895873|NCT00530777|467578590|FG001|Overall Study|Unable to adhere to visit schedule|1|||
129746635|NCT00820222|467031303|FG000|Overall Study|Withdrawal by Subject|19|||
129746636|NCT00820222|467031304|FG001|Overall Study|Withdrawal by Subject|21|||
129746637|NCT00820222|467031303|FG000|Overall Study|Physician Decision|93|||
129746638|NCT00820222|467031304|FG001|Overall Study|Physician Decision|88|||
129746639|NCT00820222|467031303|FG000|Overall Study|Sponsor Terminated Study|43|||
129746640|NCT00820222|467031304|FG001|Overall Study|Sponsor Terminated Study|65|||
129746641|NCT00820222|467031303|FG000|Overall Study|Unkown|11|||
129746642|NCT00820222|467031304|FG001|Overall Study|Unkown|7|||
129746643|NCT00932165|467031305|FG000|Overall Study|Lost to Follow-up|1|||
129746644|NCT00588094|467031306|FG000|Overall Study|Adverse Event|3|||
129746645|NCT00588094|467031306|FG000|Overall Study|Progression of Disease|2|||
129746646|NCT01336023|467031307|FG000|Week 0 to Week 26|Adverse Event|8|||
129746647|NCT01336023|467031308|FG001|Week 0 to Week 26|Adverse Event|10|||
129746648|NCT01336023|467031309|FG002|Week 0 to Week 26|Adverse Event|24|||
129746649|NCT01336023|467031307|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
129746650|NCT01336023|467031308|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
129746651|NCT01336023|467031309|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
129746652|NCT01336023|467031307|FG000|Week 0 to Week 26|Protocol Violation|1|||
129746653|NCT01336023|467031308|FG001|Week 0 to Week 26|Protocol Violation|2|||
129746654|NCT01336023|467031309|FG002|Week 0 to Week 26|Protocol Violation|0|||
129746655|NCT01336023|467031307|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
129746656|NCT01336023|467031308|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
129746657|NCT01336023|467031309|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
129746658|NCT01336023|467031307|FG000|Week 0 to Week 26|Unclassified|5|||
129746659|NCT01336023|467031308|FG001|Week 0 to Week 26|Unclassified|16|||
129746660|NCT01336023|467031309|FG002|Week 0 to Week 26|Unclassified|9|||
129746661|NCT01336023|467031307|FG000|Week 27 to 52|Adverse Event|1|||
129746662|NCT01336023|467031308|FG001|Week 27 to 52|Adverse Event|5|||
129746663|NCT01336023|467031309|FG002|Week 27 to 52|Adverse Event|2|||
129746664|NCT01336023|467031307|FG000|Week 27 to 52|Protocol Violation|0|||
129746665|NCT01336023|467031308|FG001|Week 27 to 52|Protocol Violation|2|||
129746666|NCT01336023|467031309|FG002|Week 27 to 52|Protocol Violation|1|||
129746667|NCT01336023|467031307|FG000|Week 27 to 52|Withdrawal Criteria|14|||
129746668|NCT01336023|467031308|FG001|Week 27 to 52|Withdrawal Criteria|19|||
129746669|NCT01336023|467031309|FG002|Week 27 to 52|Withdrawal Criteria|16|||
129746670|NCT01336023|467031307|FG000|Week 27 to 52|Unclassified|13|||
129746671|NCT01336023|467031308|FG001|Week 27 to 52|Unclassified|18|||
129746672|NCT01336023|467031309|FG002|Week 27 to 52|Unclassified|9|||
129746673|NCT00666965|467031312|FG000|Overall Study|Adverse Event|0|||
129746674|NCT00666965|467031313|FG001|Overall Study|Adverse Event|2|||
129746675|NCT00666965|467031314|FG002|Overall Study|Adverse Event|1|||
129746676|NCT00666965|467031315|FG003|Overall Study|Adverse Event|9|||
129746677|NCT00666965|467031312|FG000|Overall Study|Lack of Efficacy|1|||
129746678|NCT00666965|467031313|FG001|Overall Study|Lack of Efficacy|1|||
129746679|NCT00666965|467031314|FG002|Overall Study|Lack of Efficacy|0|||
129746680|NCT00666965|467031315|FG003|Overall Study|Lack of Efficacy|0|||
129746681|NCT00666965|467031312|FG000|Overall Study|Protocol Violation|0|||
129746682|NCT00666965|467031313|FG001|Overall Study|Protocol Violation|0|||
129746683|NCT00666965|467031314|FG002|Overall Study|Protocol Violation|0|||
129746684|NCT00666965|467031315|FG003|Overall Study|Protocol Violation|2|||
129746685|NCT00666965|467031312|FG000|Overall Study|Discontinuation criteria|2|||
129746686|NCT00666965|467031313|FG001|Overall Study|Discontinuation criteria|1|||
129746687|NCT00666965|467031314|FG002|Overall Study|Discontinuation criteria|1|||
129746688|NCT00666965|467031315|FG003|Overall Study|Discontinuation criteria|2|||
129746689|NCT00666965|467031312|FG000|Overall Study|Withdrawal by Subject|0|||
129746690|NCT00666965|467031313|FG001|Overall Study|Withdrawal by Subject|0|||
129746691|NCT00666965|467031314|FG002|Overall Study|Withdrawal by Subject|0|||
129746692|NCT00666965|467031315|FG003|Overall Study|Withdrawal by Subject|2|||
129746693|NCT01853878|467031322|FG000|Overall Study|Recurrence|2|||
129746694|NCT01853878|467031323|FG001|Overall Study|Recurrence|0|||
129746695|NCT01853878|467031322|FG000|Overall Study|Adverse Event|2|||
129746696|NCT01853878|467031323|FG001|Overall Study|Adverse Event|0|||
129746697|NCT01853878|467031322|FG000|Overall Study|Withdrawal by Subject|3|||
129746698|NCT01853878|467031323|FG001|Overall Study|Withdrawal by Subject|1|||
129746699|NCT01853878|467031322|FG000|Overall Study|Migrated/moved from the study area|1|||
129746700|NCT01853878|467031323|FG001|Overall Study|Migrated/moved from the study area|0|||
129746701|NCT01853878|467031322|FG000|Overall Study|Other|55|||
129895874|NCT03382821|467578597|FG000|Overall Study|Did not receive allocated intervention.|0|||
129746702|NCT01853878|467031323|FG001|Overall Study|Other|43|||
129746703|NCT01361178|467031324|FG000|Overall Study|Death|13|||
129746704|NCT01361178|467031325|FG001|Overall Study|Death|0|||
129746705|NCT00391625|467031326|FG000|Month 14|Withdrawal by Subject|1|||
129746706|NCT00391625|467031326|FG000|Month 50|Physician Decision|1|||
129746707|NCT03916081|467031329|FG000|Overall Study|Adverse Event|1|||
129746708|NCT03916081|467031330|FG001|Overall Study|Adverse Event|0|||
129746709|NCT03916081|467031331|FG002|Overall Study|Adverse Event|0|||
129746710|NCT03916081|467031329|FG000|Overall Study|Physician Decision|0|||
129746711|NCT03916081|467031330|FG001|Overall Study|Physician Decision|0|||
129746712|NCT03916081|467031331|FG002|Overall Study|Physician Decision|1|||
129746713|NCT03916081|467031329|FG000|Overall Study|Lost to Follow-up|0|||
129746714|NCT03916081|467031330|FG001|Overall Study|Lost to Follow-up|1|||
129746715|NCT03916081|467031331|FG002|Overall Study|Lost to Follow-up|0|||
129746716|NCT03916081|467031329|FG000|Overall Study|Withdrawal by Subject|3|||
129746717|NCT03916081|467031330|FG001|Overall Study|Withdrawal by Subject|0|||
129746718|NCT03916081|467031331|FG002|Overall Study|Withdrawal by Subject|1|||
129746719|NCT03916081|467031329|FG000|Overall Study|Worsening of AD|0|||
129746720|NCT03916081|467031330|FG001|Overall Study|Worsening of AD|0|||
129746721|NCT03916081|467031331|FG002|Overall Study|Worsening of AD|1|||
129746722|NCT03244826|467031332|FG000|Overall Study|Withdrawal by Subject|2|||
129746723|NCT03244826|467031333|FG001|Overall Study|Withdrawal by Subject|0|||
129746724|NCT03244826|467031332|FG000|Overall Study|Transplant delayed or withdrawn|12|||
129746725|NCT03244826|467031333|FG001|Overall Study|Transplant delayed or withdrawn|10|||
129746726|NCT00416455|467031337|FG000|Overall Study|PET / CT not done|3|||
129746727|NCT00416455|467031338|FG001|Overall Study|PET / CT not done|5|||
129746728|NCT00416455|467031337|FG000|Overall Study|PET / CT poor quality|2|||
129746729|NCT00416455|467031338|FG001|Overall Study|PET / CT poor quality|1|||
129746730|NCT00416455|467031337|FG000|Overall Study|Inadequate pathology|11|||
129746731|NCT00416455|467031338|FG001|Overall Study|Inadequate pathology|2|||
129746732|NCT00622388|467031340|FG000|Overall Study|Disease Progression|47|||
129746733|NCT00622388|467031340|FG000|Overall Study|Adverse Event|6|||
129746734|NCT00622388|467031340|FG000|Overall Study|Protocol Violation|3|||
129746735|NCT00622388|467031340|FG000|Overall Study|Participant Refusal|1|||
129746736|NCT00622388|467031340|FG000|Overall Study|Death|3|||
129746737|NCT00622388|467031340|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
129746738|NCT00622388|467031340|FG000|Overall Study|Took Prohibited Medication|2|||
129808655|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
129808656|NCT02925117|467265794|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
129808657|NCT02925117|467265795|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
129808658|NCT02925117|467265796|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
129808659|NCT02925117|467265797|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
129808660|NCT02925117|467265798|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
129808661|NCT02925117|467265799|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
129808662|NCT02925117|467265800|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
129808663|NCT02925117|467265801|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
129895875|NCT03382821|467578598|FG001|Overall Study|Did not receive allocated intervention.|3|||
129895876|NCT00282438|467578599|FG000|Overall Study|Lack of Efficacy|1|||
129895877|NCT00282438|467578600|FG001|Overall Study|Lack of Efficacy|0|||
129895878|NCT00282438|467578599|FG000|Overall Study|Death|0|||
129895879|NCT00282438|467578600|FG001|Overall Study|Death|1|||
129895880|NCT01008748|467578610|FG000|Overall Study|Lost to Follow-up|80|||
129895881|NCT01008748|467578610|FG000|Overall Study|Other|1|||
129895882|NCT02775435|467578611|FG000|Overall Study|Adverse Event|32|||
129895883|NCT02775435|467578612|FG001|Overall Study|Adverse Event|27|||
129895884|NCT02775435|467578611|FG000|Overall Study|Lost to Follow-up|2|||
129895885|NCT02775435|467578612|FG001|Overall Study|Lost to Follow-up|2|||
129895886|NCT02775435|467578611|FG000|Overall Study|Sponsor decision|44|||
129895887|NCT02775435|467578612|FG001|Overall Study|Sponsor decision|19|||
129895888|NCT02775435|467578611|FG000|Overall Study|Withdrawal by Subject|4|||
129895889|NCT02775435|467578612|FG001|Overall Study|Withdrawal by Subject|9|||
129895890|NCT02775435|467578611|FG000|Overall Study|Death|196|||
129895891|NCT02775435|467578612|FG001|Overall Study|Death|224|||
129895892|NCT01268566|467578613|FG000|Overall Study|Lost to Follow-up|1|||
129895893|NCT01268566|467578613|FG000|Overall Study|Withdrawal by Subject|12|||
129895894|NCT01268566|467578613|FG000|Overall Study|Death|30|||
129895895|NCT02138916|467578614|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
129895896|NCT02138916|467578615|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
129895897|NCT02138916|467578616|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
129895898|NCT02138916|467578614|FG000|Overall Study|Death|14|||
129895899|NCT02138916|467578615|FG001|Overall Study|Death|11|||
129895900|NCT02138916|467578616|FG002|Overall Study|Death|12|||
129746739|NCT00622388|467031340|FG000|Overall Study|Withdrew Consent|1|||
129808664|NCT02925117|467265802|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
129895901|NCT02138916|467578614|FG000|Overall Study|Withdrawal by Subject|27|||
129895902|NCT02138916|467578615|FG001|Overall Study|Withdrawal by Subject|31|||
129895903|NCT02138916|467578616|FG002|Overall Study|Withdrawal by Subject|32|||
129895904|NCT02138916|467578614|FG000|Overall Study|Study specific withdrawal criteria|0|||
129895905|NCT02138916|467578615|FG001|Overall Study|Study specific withdrawal criteria|0|||
129895906|NCT02138916|467578616|FG002|Overall Study|Study specific withdrawal criteria|1|||
129895907|NCT02138916|467578614|FG000|Overall Study|incorrect enrolment|1|||
129895908|NCT02138916|467578615|FG001|Overall Study|incorrect enrolment|1|||
129895909|NCT02138916|467578616|FG002|Overall Study|incorrect enrolment|0|||
129746740|NCT00622388|467031340|FG000|Overall Study|Insurance Expired|1|||
129746741|NCT00348309|467031341|FG000|Overall Study|Adverse Event|56|||
129808665|NCT02925117|467265803|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
129808666|NCT02925117|467265804|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
129746742|NCT00348309|467031342|FG001|Overall Study|Adverse Event|28|||
129746743|NCT00348309|467031343|FG002|Overall Study|Adverse Event|63|||
129746744|NCT00348309|467031341|FG000|Overall Study|Lost to Follow-up|6|||
129746745|NCT00348309|467031342|FG001|Overall Study|Lost to Follow-up|7|||
129746746|NCT00348309|467031343|FG002|Overall Study|Lost to Follow-up|4|||
129746747|NCT00348309|467031341|FG000|Overall Study|Protocol Violation|7|||
129746748|NCT00348309|467031342|FG001|Overall Study|Protocol Violation|12|||
129746749|NCT00348309|467031343|FG002|Overall Study|Protocol Violation|7|||
129746750|NCT00348309|467031341|FG000|Overall Study|Withdrawal by Subject|33|||
129746751|NCT00348309|467031342|FG001|Overall Study|Withdrawal by Subject|37|||
129746752|NCT00348309|467031343|FG002|Overall Study|Withdrawal by Subject|40|||
129746753|NCT00348309|467031341|FG000|Overall Study|Non-compliance|8|||
129746754|NCT00348309|467031342|FG001|Overall Study|Non-compliance|6|||
129746755|NCT00348309|467031343|FG002|Overall Study|Non-compliance|8|||
129746756|NCT00348309|467031341|FG000|Overall Study|Death of caregiver|1|||
129746757|NCT00348309|467031342|FG001|Overall Study|Death of caregiver|0|||
129746758|NCT00348309|467031343|FG002|Overall Study|Death of caregiver|1|||
129746759|NCT00348309|467031341|FG000|Overall Study|Lack of insight, dementia|1|||
129746760|NCT00348309|467031342|FG001|Overall Study|Lack of insight, dementia|0|||
129746761|NCT00348309|467031343|FG002|Overall Study|Lack of insight, dementia|0|||
129746762|NCT00348309|467031341|FG000|Overall Study|Wrong bottle allocated|1|||
129746763|NCT00348309|467031342|FG001|Overall Study|Wrong bottle allocated|0|||
129746764|NCT00348309|467031343|FG002|Overall Study|Wrong bottle allocated|0|||
129746765|NCT00348309|467031341|FG000|Overall Study|Caregiver sick|1|||
129746766|NCT00348309|467031342|FG001|Overall Study|Caregiver sick|0|||
129746767|NCT00348309|467031343|FG002|Overall Study|Caregiver sick|0|||
129746768|NCT00348309|467031341|FG000|Overall Study|Use of prohibited medication|5|||
129746769|NCT00348309|467031342|FG001|Overall Study|Use of prohibited medication|2|||
129746770|NCT00348309|467031343|FG002|Overall Study|Use of prohibited medication|2|||
129746771|NCT00348309|467031341|FG000|Overall Study|Caregiver withdrawal|3|||
129746772|NCT00348309|467031342|FG001|Overall Study|Caregiver withdrawal|0|||
129746773|NCT00348309|467031343|FG002|Overall Study|Caregiver withdrawal|7|||
129746774|NCT00348309|467031341|FG000|Overall Study|Unable to complete ET visit|1|||
129746775|NCT00348309|467031342|FG001|Overall Study|Unable to complete ET visit|0|||
129746776|NCT00348309|467031343|FG002|Overall Study|Unable to complete ET visit|0|||
129746777|NCT00348309|467031341|FG000|Overall Study|PI closing medical practice|1|||
129746778|NCT00348309|467031342|FG001|Overall Study|PI closing medical practice|0|||
129746779|NCT00348309|467031343|FG002|Overall Study|PI closing medical practice|0|||
129746780|NCT00348309|467031341|FG000|Overall Study|Principal investigator's decision|1|||
129746781|NCT00348309|467031342|FG001|Overall Study|Principal investigator's decision|0|||
129746782|NCT00348309|467031343|FG002|Overall Study|Principal investigator's decision|0|||
129746783|NCT00348309|467031341|FG000|Overall Study|No disponibility of medication|1|||
129746784|NCT00348309|467031342|FG001|Overall Study|No disponibility of medication|0|||
129746785|NCT00348309|467031343|FG002|Overall Study|No disponibility of medication|0|||
129746786|NCT00348309|467031341|FG000|Overall Study|Worsened neurodegenerative disease|1|||
129746787|NCT00348309|467031342|FG001|Overall Study|Worsened neurodegenerative disease|0|||
129746788|NCT00348309|467031343|FG002|Overall Study|Worsened neurodegenerative disease|0|||
129746789|NCT00348309|467031341|FG000|Overall Study|Cognitive and behaviour worsening|2|||
129746790|NCT00348309|467031342|FG001|Overall Study|Cognitive and behaviour worsening|0|||
129746791|NCT00348309|467031343|FG002|Overall Study|Cognitive and behaviour worsening|0|||
129746792|NCT00348309|467031341|FG000|Overall Study|Worsening of alzheimer|1|||
129746793|NCT00348309|467031342|FG001|Overall Study|Worsening of alzheimer|0|||
129746794|NCT00348309|467031343|FG002|Overall Study|Worsening of alzheimer|1|||
129746795|NCT00348309|467031341|FG000|Overall Study|Did not appear in time for Visit 3|1|||
129746796|NCT00348309|467031342|FG001|Overall Study|Did not appear in time for Visit 3|0|||
129808667|NCT02925117|467265805|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
129808668|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808669|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808670|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808671|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808672|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808673|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
129808674|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808675|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808676|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808677|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
129808678|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
129808679|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
129808680|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808681|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808682|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808683|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808684|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
129808685|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
129808686|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
129895910|NCT02138916|467578614|FG000|Overall Study|Severe non-compliance|1|||
129895911|NCT02138916|467578615|FG001|Overall Study|Severe non-compliance|2|||
129895912|NCT02138916|467578616|FG002|Overall Study|Severe non-compliance|1|||
129895913|NCT02138916|467578614|FG000|Overall Study|Lost to Follow-up|4|||
129895914|NCT02138916|467578615|FG001|Overall Study|Lost to Follow-up|2|||
129895915|NCT02138916|467578616|FG002|Overall Study|Lost to Follow-up|3|||
129895916|NCT02138916|467578614|FG000|Overall Study|Adverse Event|4|||
129895917|NCT02138916|467578615|FG001|Overall Study|Adverse Event|4|||
129895918|NCT02138916|467578616|FG002|Overall Study|Adverse Event|3|||
129895919|NCT04794179|467578617|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
129895920|NCT04794179|467578618|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
129895921|NCT01190176|467578621|FG000|Overall Study|Withdrawal by Subject|1|||
129746797|NCT00348309|467031343|FG002|Overall Study|Did not appear in time for Visit 3|0|||
129746798|NCT00348309|467031341|FG000|Overall Study|Participant died|2|||
129746799|NCT00348309|467031342|FG001|Overall Study|Participant died|1|||
129746800|NCT00348309|467031343|FG002|Overall Study|Participant died|1|||
129746801|NCT00348309|467031341|FG000|Overall Study|Decision of sponsor|1|||
129746802|NCT00348309|467031342|FG001|Overall Study|Decision of sponsor|0|||
129746803|NCT00348309|467031343|FG002|Overall Study|Decision of sponsor|0|||
129746804|NCT00348309|467031341|FG000|Overall Study|Ineffectiveness of treatment|0|||
129746805|NCT00348309|467031342|FG001|Overall Study|Ineffectiveness of treatment|1|||
129746806|NCT00348309|467031343|FG002|Overall Study|Ineffectiveness of treatment|0|||
129746807|NCT00348309|467031341|FG000|Overall Study|A foul of exclusion criteria|0|||
129746808|NCT00348309|467031342|FG001|Overall Study|A foul of exclusion criteria|1|||
129746809|NCT00348309|467031343|FG002|Overall Study|A foul of exclusion criteria|0|||
129746810|NCT00348309|467031341|FG000|Overall Study|Participant was hospitalized|0|||
129746811|NCT00348309|467031342|FG001|Overall Study|Participant was hospitalized|1|||
129746812|NCT00348309|467031343|FG002|Overall Study|Participant was hospitalized|0|||
129746813|NCT00348309|467031341|FG000|Overall Study|Sponsor refuseal|0|||
129746814|NCT00348309|467031342|FG001|Overall Study|Sponsor refuseal|1|||
129746815|NCT00348309|467031343|FG002|Overall Study|Sponsor refuseal|1|||
129746816|NCT00348309|467031341|FG000|Overall Study|Forgot often medication|0|||
129746817|NCT00348309|467031342|FG001|Overall Study|Forgot often medication|1|||
129746818|NCT00348309|467031343|FG002|Overall Study|Forgot often medication|0|||
129746819|NCT00348309|467031341|FG000|Overall Study|Medical Monitor decision|0|||
129746820|NCT00348309|467031342|FG001|Overall Study|Medical Monitor decision|0|||
129746821|NCT00348309|467031343|FG002|Overall Study|Medical Monitor decision|1|||
129746822|NCT00348309|467031341|FG000|Overall Study|Increased dose of Aricept|0|||
129746823|NCT00348309|467031342|FG001|Overall Study|Increased dose of Aricept|0|||
129746824|NCT00348309|467031343|FG002|Overall Study|Increased dose of Aricept|1|||
129746825|NCT00348309|467031341|FG000|Overall Study|Site closure|0|||
129746826|NCT00348309|467031342|FG001|Overall Study|Site closure|0|||
129746827|NCT00348309|467031343|FG002|Overall Study|Site closure|1|||
129746828|NCT00348309|467031341|FG000|Overall Study|Adverse event not attended|0|||
129746829|NCT00348309|467031342|FG001|Overall Study|Adverse event not attended|0|||
129746830|NCT00348309|467031343|FG002|Overall Study|Adverse event not attended|1|||
129746831|NCT00348309|467031341|FG000|Overall Study|ECG abnormal|0|||
129746832|NCT00348309|467031342|FG001|Overall Study|ECG abnormal|0|||
129746833|NCT00348309|467031343|FG002|Overall Study|ECG abnormal|2|||
129746834|NCT00348309|467031341|FG000|Overall Study|Cardiologist recommendations|0|||
129746835|NCT00348309|467031342|FG001|Overall Study|Cardiologist recommendations|0|||
129746836|NCT00348309|467031343|FG002|Overall Study|Cardiologist recommendations|1|||
129746837|NCT00348309|467031341|FG000|Overall Study|HCV career|0|||
129746838|NCT00348309|467031342|FG001|Overall Study|HCV career|0|||
129746839|NCT00348309|467031343|FG002|Overall Study|HCV career|1|||
129746840|NCT00828750|467031344|FG000|Overall Study|Lack of Efficacy|3|||
129746841|NCT00828750|467031344|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
129746842|NCT04079114|467031345|FG000|Overall Study|Study prematuely terminated.|166|||
129746843|NCT01364389|467031346|FG000|Overall Study|Withdrawal by Subject|0|||
129746844|NCT01364389|467031347|FG001|Overall Study|Withdrawal by Subject|1|||
129746845|NCT01364389|467031348|FG002|Overall Study|Withdrawal by Subject|0|||
129746846|NCT01364389|467031346|FG000|Overall Study|Protocol deviation|0|||
129746847|NCT01364389|467031347|FG001|Overall Study|Protocol deviation|0|||
129746848|NCT01364389|467031348|FG002|Overall Study|Protocol deviation|1|||
129895922|NCT01190176|467578621|FG000|Overall Study|Lost to Follow-up|1|||
129746849|NCT01364389|467031346|FG000|Overall Study|Administrative problems|1|||
129746850|NCT01364389|467031347|FG001|Overall Study|Administrative problems|0|||
129746851|NCT01364389|467031348|FG002|Overall Study|Administrative problems|0|||
129746852|NCT01364389|467031346|FG000|Overall Study|Adverse Event|1|||
129808687|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
129808688|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808689|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808690|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808691|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
129808692|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808693|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808694|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808695|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808696|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808697|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
129808698|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808699|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808700|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808701|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808702|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
129808703|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
129808704|NCT02925117|467265794|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
129808705|NCT02925117|467265795|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
129808706|NCT02925117|467265796|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
129808707|NCT02925117|467265797|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
129808708|NCT02925117|467265798|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
129808709|NCT02925117|467265799|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
129808710|NCT02925117|467265800|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
129808711|NCT02925117|467265801|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
129808712|NCT02925117|467265802|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
129808713|NCT02925117|467265803|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
129808714|NCT02925117|467265804|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
129808715|NCT02925117|467265805|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
129808716|NCT00347360|467265810|FG000|Overall Study|Adverse Event|1|||
129808717|NCT00347360|467265811|FG001|Overall Study|Adverse Event|2|||
129746853|NCT01364389|467031347|FG001|Overall Study|Adverse Event|0|||
129746854|NCT01364389|467031348|FG002|Overall Study|Adverse Event|0|||
129746855|NCT01068158|467031349|FG000|Overall Study|Withdrawal by Subject|1|||
129746856|NCT01068158|467031350|FG001|Overall Study|Withdrawal by Subject|2|||
129746857|NCT01068158|467031349|FG000|Overall Study|Lost to Follow-up|7|||
129746858|NCT01068158|467031350|FG001|Overall Study|Lost to Follow-up|0|||
129746859|NCT01068158|467031349|FG000|Overall Study|Protocol Violation|0|||
129746860|NCT01068158|467031350|FG001|Overall Study|Protocol Violation|2|||
129746861|NCT00991406|467031351|FG000|Overall Study|One participant did not respond to FES.|1|||
129746862|NCT01300572|467031352|FG000|Overall Study|HAMA + post dosimetry|1|||
129746863|NCT02160145|467031354|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
129746864|NCT02160145|467031355|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
129746865|NCT02160145|467031356|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
129746866|NCT02160145|467031354|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
129746867|NCT02160145|467031355|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
129746868|NCT02160145|467031356|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
129746869|NCT02160145|467031354|FG000|Randomized Double-blind Period|Subject decision|0|||
129746870|NCT02160145|467031355|FG001|Randomized Double-blind Period|Subject decision|21|||
129746871|NCT02160145|467031356|FG002|Randomized Double-blind Period|Subject decision|20|||
129746872|NCT02160145|467031354|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
129746873|NCT02160145|467031355|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
129746874|NCT02160145|467031356|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
129746875|NCT02160145|467031354|FG000|Randomized Double-blind Period|Physician Decision|0|||
129746876|NCT02160145|467031355|FG001|Randomized Double-blind Period|Physician Decision|7|||
129746877|NCT02160145|467031356|FG002|Randomized Double-blind Period|Physician Decision|5|||
129808718|NCT00347360|467265812|FG002|Overall Study|Adverse Event|0|||
129808719|NCT00347360|467265813|FG003|Overall Study|Adverse Event|4|||
129808720|NCT00347360|467265814|FG004|Overall Study|Adverse Event|1|||
129808721|NCT00347360|467265815|FG005|Overall Study|Adverse Event|2|||
129895923|NCT03697460|467578622|FG000|Overall Study|Withdrawal by Subject|3|||
129808722|NCT00347360|467265816|FG006|Overall Study|Adverse Event|2|||
129895924|NCT00445692|467578624|FG000|Overall Study|Adverse Event|11|||
129746878|NCT00375518|467031357|FG000|Overall Study|Withdrawal by Subject|2|||
129746879|NCT00375518|467031358|FG001|Overall Study|Withdrawal by Subject|10|||
129808723|NCT00347360|467265817|FG007|Overall Study|Adverse Event|0|||
129746880|NCT00375518|467031357|FG000|Overall Study|Patient Not Treated|6|||
129746881|NCT00375518|467031358|FG001|Overall Study|Patient Not Treated|6|||
129746882|NCT00375518|467031357|FG000|Overall Study|Death|0|||
129746883|NCT00375518|467031358|FG001|Overall Study|Death|1|||
129746884|NCT00411632|467031359|FG000|Overall Study|Death|1|||
129746885|NCT01108523|467031360|FG000|Overall Study|Protocol Violation|4|||
129746886|NCT03848949|467031366|FG000|Overall Study|Lost to Follow-up|5|||
129746887|NCT03848949|467031367|FG001|Overall Study|Lost to Follow-up|7|||
129746888|NCT02353728|467031370|FG000|Overall Study|Subject non-compliance|1|||
129746889|NCT02301624|467031371|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
129746890|NCT02301624|467031372|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
129808724|NCT00347360|467265818|FG008|Overall Study|Adverse Event|2|||
129808725|NCT00347360|467265819|FG009|Overall Study|Adverse Event|3|||
129808726|NCT00347360|467265820|FG010|Overall Study|Adverse Event|3|||
129808727|NCT00347360|467265821|FG011|Overall Study|Adverse Event|1|||
129808728|NCT00347360|467265822|FG012|Overall Study|Adverse Event|3|||
129808729|NCT00347360|467265823|FG013|Overall Study|Adverse Event|2|||
129808730|NCT00347360|467265824|FG014|Overall Study|Adverse Event|2|||
129808731|NCT00347360|467265810|FG000|Overall Study|Lost to Follow-up|0|||
129808732|NCT00347360|467265811|FG001|Overall Study|Lost to Follow-up|0|||
129808733|NCT00347360|467265812|FG002|Overall Study|Lost to Follow-up|0|||
129808734|NCT00347360|467265813|FG003|Overall Study|Lost to Follow-up|2|||
129808735|NCT00347360|467265814|FG004|Overall Study|Lost to Follow-up|1|||
129808736|NCT00347360|467265815|FG005|Overall Study|Lost to Follow-up|1|||
129808737|NCT00347360|467265816|FG006|Overall Study|Lost to Follow-up|0|||
129808738|NCT00347360|467265817|FG007|Overall Study|Lost to Follow-up|1|||
129808739|NCT00347360|467265818|FG008|Overall Study|Lost to Follow-up|1|||
129808740|NCT00347360|467265819|FG009|Overall Study|Lost to Follow-up|2|||
129808741|NCT00347360|467265820|FG010|Overall Study|Lost to Follow-up|0|||
129808742|NCT00347360|467265821|FG011|Overall Study|Lost to Follow-up|0|||
129808743|NCT00347360|467265822|FG012|Overall Study|Lost to Follow-up|1|||
129808744|NCT00347360|467265823|FG013|Overall Study|Lost to Follow-up|0|||
129808745|NCT00347360|467265824|FG014|Overall Study|Lost to Follow-up|0|||
129808746|NCT00347360|467265810|FG000|Overall Study|Protocol Violation|2|||
129808747|NCT00347360|467265811|FG001|Overall Study|Protocol Violation|3|||
129808748|NCT00347360|467265812|FG002|Overall Study|Protocol Violation|1|||
129808749|NCT00347360|467265813|FG003|Overall Study|Protocol Violation|2|||
129808750|NCT00347360|467265814|FG004|Overall Study|Protocol Violation|1|||
129808751|NCT00347360|467265815|FG005|Overall Study|Protocol Violation|2|||
129808752|NCT00347360|467265816|FG006|Overall Study|Protocol Violation|0|||
129808753|NCT00347360|467265817|FG007|Overall Study|Protocol Violation|0|||
129808754|NCT00347360|467265818|FG008|Overall Study|Protocol Violation|1|||
129808755|NCT00347360|467265819|FG009|Overall Study|Protocol Violation|2|||
129808756|NCT00347360|467265820|FG010|Overall Study|Protocol Violation|0|||
129808757|NCT00347360|467265821|FG011|Overall Study|Protocol Violation|0|||
129808758|NCT00347360|467265822|FG012|Overall Study|Protocol Violation|0|||
129808759|NCT00347360|467265823|FG013|Overall Study|Protocol Violation|1|||
129808760|NCT00347360|467265824|FG014|Overall Study|Protocol Violation|0|||
129808761|NCT00347360|467265810|FG000|Overall Study|Withdrawal by Subject|0|||
129808762|NCT00347360|467265811|FG001|Overall Study|Withdrawal by Subject|1|||
129808763|NCT00347360|467265812|FG002|Overall Study|Withdrawal by Subject|2|||
129808764|NCT00347360|467265813|FG003|Overall Study|Withdrawal by Subject|4|||
129808765|NCT00347360|467265814|FG004|Overall Study|Withdrawal by Subject|1|||
129808766|NCT00347360|467265815|FG005|Overall Study|Withdrawal by Subject|2|||
129808767|NCT00347360|467265816|FG006|Overall Study|Withdrawal by Subject|1|||
129808768|NCT00347360|467265817|FG007|Overall Study|Withdrawal by Subject|1|||
129808769|NCT00347360|467265818|FG008|Overall Study|Withdrawal by Subject|1|||
129808770|NCT00347360|467265819|FG009|Overall Study|Withdrawal by Subject|1|||
129808771|NCT00347360|467265820|FG010|Overall Study|Withdrawal by Subject|0|||
129808772|NCT00347360|467265821|FG011|Overall Study|Withdrawal by Subject|3|||
129808773|NCT00347360|467265822|FG012|Overall Study|Withdrawal by Subject|4|||
129895925|NCT00445692|467578624|FG000|Overall Study|Lack of Efficacy|5|||
129895926|NCT03425539|467578626|FG000|Overall Study|Randomized but not treated|0|||
129895927|NCT03425539|467578627|FG001|Overall Study|Randomized but not treated|1|||
129895928|NCT03425539|467578626|FG000|Overall Study|Adverse Event|2|||
129895929|NCT03425539|467578627|FG001|Overall Study|Adverse Event|2|||
129808774|NCT00347360|467265823|FG013|Overall Study|Withdrawal by Subject|2|||
129808775|NCT00347360|467265824|FG014|Overall Study|Withdrawal by Subject|1|||
129808776|NCT00347360|467265810|FG000|Overall Study|Lack of Efficacy|1|||
129808777|NCT00347360|467265811|FG001|Overall Study|Lack of Efficacy|1|||
129808778|NCT00347360|467265812|FG002|Overall Study|Lack of Efficacy|3|||
129895930|NCT03425539|467578626|FG000|Overall Study|Withdrawal by Subject|3|||
129746891|NCT02301624|467031371|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
129808779|NCT00347360|467265813|FG003|Overall Study|Lack of Efficacy|1|||
129808780|NCT00347360|467265814|FG004|Overall Study|Lack of Efficacy|0|||
129895931|NCT03425539|467578627|FG001|Overall Study|Withdrawal by Subject|0|||
129746892|NCT02301624|467031372|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
129808781|NCT00347360|467265815|FG005|Overall Study|Lack of Efficacy|1|||
129808782|NCT00347360|467265816|FG006|Overall Study|Lack of Efficacy|0|||
129746893|NCT02301624|467031371|FG000|Open-label Maintenance Phase|Adverse Event|2|||
129746894|NCT02301624|467031372|FG001|Open-label Maintenance Phase|Adverse Event|5|||
129746895|NCT02301624|467031371|FG000|Open-label Maintenance Phase|Physician Decision|3|||
129746896|NCT02301624|467031372|FG001|Open-label Maintenance Phase|Physician Decision|3|||
129746897|NCT02301624|467031371|FG000|Open-label Maintenance Phase|Death|2|||
129746898|NCT02301624|467031372|FG001|Open-label Maintenance Phase|Death|1|||
129746899|NCT02301624|467031371|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
129746900|NCT02301624|467031372|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
129746901|NCT00895310|467031373|FG000|Overall Study|Withdrawal by Subject|1|||
129746902|NCT00619307|467031374|FG000|Overall Study|Adverse Event|0|||
129746903|NCT00619307|467031375|FG001|Overall Study|Adverse Event|1|||
129746904|NCT00619307|467031374|FG000|Overall Study|Lost to Follow-up|0|||
129746905|NCT00619307|467031375|FG001|Overall Study|Lost to Follow-up|1|||
129746906|NCT00619307|467031374|FG000|Overall Study|Protocol Violation|3|||
129746907|NCT00619307|467031375|FG001|Overall Study|Protocol Violation|0|||
129746908|NCT00619307|467031374|FG000|Overall Study|Withdrew consent|1|||
129746909|NCT00619307|467031375|FG001|Overall Study|Withdrew consent|0|||
129746910|NCT00619307|467031374|FG000|Overall Study|Severe migraine|0|||
129746911|NCT00619307|467031375|FG001|Overall Study|Severe migraine|1|||
129746912|NCT00619307|467031374|FG000|Overall Study|MS attack plus steroids|0|||
129746913|NCT00619307|467031375|FG001|Overall Study|MS attack plus steroids|1|||
129746914|NCT00659230|467031376|FG000|Overall Study|Lost to Follow-up|2|||
129746915|NCT00659230|467031377|FG001|Overall Study|Lost to Follow-up|5|||
129746916|NCT00659230|467031376|FG000|Overall Study|Lost source documentation|5|||
129746917|NCT00659230|467031377|FG001|Overall Study|Lost source documentation|4|||
129746918|NCT00659230|467031376|FG000|Overall Study|Did not return post-randomization|2|||
129746919|NCT00659230|467031377|FG001|Overall Study|Did not return post-randomization|3|||
129746920|NCT00547521|467031378|FG000|Short Term Study (4 Months)|Adverse Event|1|||
129746921|NCT00547521|467031379|FG001|Short Term Study (4 Months)|Adverse Event|0|||
129746922|NCT00547521|467031378|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
129746923|NCT00547521|467031379|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
129746924|NCT00547521|467031378|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
129746925|NCT00547521|467031379|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
129746926|NCT00547521|467031378|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
129746927|NCT00547521|467031379|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
129746928|NCT00547521|467031378|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
129746929|NCT00547521|467031379|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
129746930|NCT00547521|467031378|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
129746931|NCT00547521|467031379|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
129746932|NCT00547521|467031378|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
129746933|NCT00547521|467031379|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
129746934|NCT00547521|467031378|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
129746935|NCT00547521|467031379|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
129746936|NCT00547521|467031378|FG000|Long Term Extension (LTE) Study|Other|0|||
129746937|NCT00547521|467031379|FG001|Long Term Extension (LTE) Study|Other|2|||
129746938|NCT00547521|467031378|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
129746939|NCT00547521|467031379|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
129746940|NCT03109184|467033721|FG000|Overall Study|Lost to Follow-up|6|||
129746941|NCT03109184|467033722|FG001|Overall Study|Lost to Follow-up|6|||
129746942|NCT03109184|467033721|FG000|Overall Study|Withdrawal by Subject|1|||
129746943|NCT03109184|467033722|FG001|Overall Study|Withdrawal by Subject|1|||
129746944|NCT01031979|467033725|FG000|Overall Study|Lost to Follow-up|5|||
129746945|NCT01031979|467033726|FG001|Overall Study|Lost to Follow-up|4|||
129746946|NCT03831100|467033728|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
129746947|NCT03831100|467033729|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
129746948|NCT02008227|467033733|FG000|Overall Study|Lost to Follow-up|7|||
129746949|NCT02008227|467033734|FG001|Overall Study|Lost to Follow-up|9|||
129746950|NCT02008227|467033733|FG000|Overall Study|Death|494|||
129746951|NCT02008227|467033734|FG001|Overall Study|Death|485|||
129746952|NCT02008227|467033733|FG000|Overall Study|Withdrawal by Subject|67|||
129746953|NCT02008227|467033734|FG001|Overall Study|Withdrawal by Subject|36|||
129746954|NCT02008227|467033733|FG000|Overall Study|Study Terminated By Sponsor|44|||
129746955|NCT02008227|467033734|FG001|Overall Study|Study Terminated By Sponsor|83|||
129746956|NCT01487265|467033737|FG000|Overall Study|Adverse Event|8|||
129746957|NCT01487265|467033737|FG000|Overall Study|Withdrawal by Subject|5|||
129746958|NCT01487265|467033737|FG000|Overall Study|Disease Progression|21|||
129746959|NCT01487265|467033737|FG000|Overall Study|Death|2|||
129746960|NCT01487265|467033737|FG000|Overall Study|Still on Treatment|1|||
129746961|NCT01959841|467033738|FG000|Overall Study|Adverse Event|1|||
129746962|NCT01959841|467033739|FG001|Overall Study|Adverse Event|3|||
129746963|NCT01959841|467033740|FG002|Overall Study|Adverse Event|2|||
129746964|NCT01959841|467033738|FG000|Overall Study|Lack of Efficacy|5|||
129746965|NCT01959841|467033739|FG001|Overall Study|Lack of Efficacy|0|||
129746966|NCT01959841|467033740|FG002|Overall Study|Lack of Efficacy|0|||
129746967|NCT01959841|467033738|FG000|Overall Study|Lost to Follow-up|1|||
129746968|NCT01959841|467033739|FG001|Overall Study|Lost to Follow-up|1|||
129746969|NCT01959841|467033740|FG002|Overall Study|Lost to Follow-up|0|||
129746970|NCT01959841|467033738|FG000|Overall Study|Physician Decision|0|||
129746971|NCT01959841|467033739|FG001|Overall Study|Physician Decision|2|||
129746972|NCT01959841|467033740|FG002|Overall Study|Physician Decision|3|||
129746973|NCT01959841|467033738|FG000|Overall Study|Protocol Violation|16|||
129746974|NCT01959841|467033739|FG001|Overall Study|Protocol Violation|23|||
129746975|NCT01959841|467033740|FG002|Overall Study|Protocol Violation|16|||
129746976|NCT01959841|467033738|FG000|Overall Study|Withdrawal by Subject|7|||
129746977|NCT01959841|467033739|FG001|Overall Study|Withdrawal by Subject|7|||
129746978|NCT01959841|467033740|FG002|Overall Study|Withdrawal by Subject|5|||
129746979|NCT01959841|467033738|FG000|Overall Study|Clinical laboratory value|2|||
129746980|NCT01959841|467033739|FG001|Overall Study|Clinical laboratory value|6|||
129746981|NCT01959841|467033740|FG002|Overall Study|Clinical laboratory value|6|||
129746982|NCT01959841|467033738|FG000|Overall Study|Platelet count below on day1 or 4|11|||
129746983|NCT01959841|467033739|FG001|Overall Study|Platelet count below on day1 or 4|15|||
129746984|NCT01959841|467033740|FG002|Overall Study|Platelet count below on day1 or 4|11|||
129746985|NCT00780416|467033741|FG000|Overall Study|Physician Decision|3|||
129746986|NCT00780416|467033742|FG001|Overall Study|Physician Decision|3|||
129746987|NCT00780416|467033741|FG000|Overall Study|Protocol Violation|1|||
129746988|NCT00780416|467033742|FG001|Overall Study|Protocol Violation|0|||
129746989|NCT00780416|467033741|FG000|Overall Study|Withdrawal by Subject|8|||
129746990|NCT00780416|467033742|FG001|Overall Study|Withdrawal by Subject|6|||
129746991|NCT00666224|467033743|FG000|Double-Blind|Adverse Event|15|||
129746992|NCT00666224|467033744|FG001|Double-Blind|Adverse Event|5|||
129746993|NCT00666224|467033743|FG000|Double-Blind|Lost to Follow-up|2|||
129746994|NCT00666224|467033744|FG001|Double-Blind|Lost to Follow-up|2|||
129746995|NCT00666224|467033743|FG000|Double-Blind|Withdrawal by Subject|18|||
129746996|NCT00666224|467033744|FG001|Double-Blind|Withdrawal by Subject|14|||
129746997|NCT00666224|467033743|FG000|Double-Blind|Physician Decision|0|||
129746998|NCT00666224|467033744|FG001|Double-Blind|Physician Decision|3|||
129746999|NCT00666224|467033743|FG000|Double-Blind|Sponsor decision|1|||
129747000|NCT00666224|467033744|FG001|Double-Blind|Sponsor decision|0|||
129747001|NCT00666224|467033743|FG000|Double-Blind|Pregnancy|3|||
129747002|NCT00666224|467033744|FG001|Double-Blind|Pregnancy|2|||
129747003|NCT00666224|467033743|FG000|Double-Blind|Noncompliance|1|||
129747004|NCT00666224|467033744|FG001|Double-Blind|Noncompliance|0|||
129747005|NCT00666224|467033743|FG000|Double-Blind|Death|1|||
129747006|NCT00666224|467033744|FG001|Double-Blind|Death|0|||
129747007|NCT00666224|467033743|FG000|Double-Blind|Undefined/Unknown|4|||
129747008|NCT00666224|467033744|FG001|Double-Blind|Undefined/Unknown|1|||
129747009|NCT00666224|467033743|FG000|Open-Label|Adverse Event|8|||
129747010|NCT00666224|467033744|FG001|Open-Label|Adverse Event|43|||
129747011|NCT00666224|467033743|FG000|Open-Label|Lost to Follow-up|4|||
129747012|NCT00666224|467033744|FG001|Open-Label|Lost to Follow-up|5|||
129747013|NCT00666224|467033743|FG000|Open-Label|Withdrawal by Subject|12|||
129747014|NCT00666224|467033744|FG001|Open-Label|Withdrawal by Subject|25|||
129747015|NCT00666224|467033743|FG000|Open-Label|Physician Decision|7|||
129747016|NCT00666224|467033744|FG001|Open-Label|Physician Decision|5|||
129747017|NCT00666224|467033743|FG000|Open-Label|Pregnancy|1|||
129747018|NCT00666224|467033744|FG001|Open-Label|Pregnancy|5|||
129747019|NCT00666224|467033743|FG000|Open-Label|Noncompliance|2|||
129747020|NCT00666224|467033744|FG001|Open-Label|Noncompliance|1|||
129747021|NCT00666224|467033743|FG000|Open-Label|Undefined/Unknown|1|||
129747022|NCT00666224|467033744|FG001|Open-Label|Undefined/Unknown|1|||
129747023|NCT03521141|467033748|FG000|Overall Study|Death|1|||
129895932|NCT03425539|467578626|FG000|Overall Study|Lost to Follow-up|0|||
129895933|NCT03425539|467578627|FG001|Overall Study|Lost to Follow-up|1|||
129747024|NCT03521141|467033749|FG001|Overall Study|Death|0|||
129747025|NCT03521141|467033750|FG002|Overall Study|Death|1|||
129747026|NCT01271725|467033755|FG000|Part A|Progressive disease according to RECIST|8|||
129747027|NCT01271725|467033756|FG001|Part A|Progressive disease according to RECIST|0|||
129747028|NCT01271725|467033755|FG000|Part A|Clinical signs/symptoms of progression|2|||
129747029|NCT01271725|467033756|FG001|Part A|Clinical signs/symptoms of progression|0|||
129747030|NCT01271725|467033755|FG000|Part A|Other Adverse Event|8|||
129747031|NCT01271725|467033756|FG001|Part A|Other Adverse Event|0|||
129747032|NCT01271725|467033755|FG000|Part A|Lost to Follow-up|1|||
129747033|NCT01271725|467033756|FG001|Part A|Lost to Follow-up|0|||
129747034|NCT01271725|467033755|FG000|Part A|Withdrawal by Subject|12|||
129747035|NCT01271725|467033756|FG001|Part A|Withdrawal by Subject|0|||
129747036|NCT01271725|467033755|FG000|Part A|Other than specified|3|||
129747037|NCT01271725|467033756|FG001|Part A|Other than specified|0|||
129747038|NCT01271725|467033755|FG000|Part A|Protocol Violation|1|||
129895934|NCT02040844|467578632|FG000|Overall Study|Adverse Event|0|||
129747039|NCT01271725|467033756|FG001|Part A|Protocol Violation|0|||
129747040|NCT01271725|467033755|FG000|Part B|Other than specified|0|||
129747041|NCT01271725|467033756|FG001|Part B|Other than specified|2|||
129747042|NCT01271725|467033755|FG000|Part B|Clinical signs/symptoms of progression|0|||
129808783|NCT00347360|467265817|FG007|Overall Study|Lack of Efficacy|1|||
129808784|NCT00347360|467265818|FG008|Overall Study|Lack of Efficacy|1|||
129808785|NCT00347360|467265819|FG009|Overall Study|Lack of Efficacy|0|||
129808786|NCT00347360|467265820|FG010|Overall Study|Lack of Efficacy|0|||
129808787|NCT00347360|467265821|FG011|Overall Study|Lack of Efficacy|0|||
129808788|NCT00347360|467265822|FG012|Overall Study|Lack of Efficacy|0|||
129808789|NCT00347360|467265823|FG013|Overall Study|Lack of Efficacy|0|||
129808790|NCT00347360|467265824|FG014|Overall Study|Lack of Efficacy|0|||
129808791|NCT00347360|467265810|FG000|Overall Study|Reason not listed/blank|1|||
129808792|NCT00347360|467265811|FG001|Overall Study|Reason not listed/blank|0|||
129808793|NCT00347360|467265812|FG002|Overall Study|Reason not listed/blank|0|||
129808794|NCT00347360|467265813|FG003|Overall Study|Reason not listed/blank|0|||
129808795|NCT00347360|467265814|FG004|Overall Study|Reason not listed/blank|0|||
129808796|NCT00347360|467265815|FG005|Overall Study|Reason not listed/blank|0|||
129808797|NCT00347360|467265816|FG006|Overall Study|Reason not listed/blank|1|||
129808798|NCT00347360|467265817|FG007|Overall Study|Reason not listed/blank|0|||
129808799|NCT00347360|467265818|FG008|Overall Study|Reason not listed/blank|0|||
129808800|NCT00347360|467265819|FG009|Overall Study|Reason not listed/blank|0|||
129808801|NCT00347360|467265820|FG010|Overall Study|Reason not listed/blank|0|||
129808802|NCT00347360|467265821|FG011|Overall Study|Reason not listed/blank|0|||
129808803|NCT00347360|467265822|FG012|Overall Study|Reason not listed/blank|0|||
129808804|NCT00347360|467265823|FG013|Overall Study|Reason not listed/blank|1|||
129808805|NCT00347360|467265824|FG014|Overall Study|Reason not listed/blank|0|||
129808806|NCT00347360|467265810|FG000|Overall Study|Per sponsors instruction|0|||
129808807|NCT00347360|467265811|FG001|Overall Study|Per sponsors instruction|1|||
129808808|NCT00347360|467265812|FG002|Overall Study|Per sponsors instruction|0|||
129808809|NCT00347360|467265813|FG003|Overall Study|Per sponsors instruction|0|||
129808810|NCT00347360|467265814|FG004|Overall Study|Per sponsors instruction|0|||
129808811|NCT00347360|467265815|FG005|Overall Study|Per sponsors instruction|0|||
129808812|NCT00347360|467265816|FG006|Overall Study|Per sponsors instruction|0|||
129808813|NCT00347360|467265817|FG007|Overall Study|Per sponsors instruction|0|||
129808814|NCT00347360|467265818|FG008|Overall Study|Per sponsors instruction|0|||
129808815|NCT00347360|467265819|FG009|Overall Study|Per sponsors instruction|0|||
129808816|NCT00347360|467265820|FG010|Overall Study|Per sponsors instruction|0|||
129808817|NCT00347360|467265821|FG011|Overall Study|Per sponsors instruction|0|||
129808818|NCT00347360|467265822|FG012|Overall Study|Per sponsors instruction|0|||
129895935|NCT02040844|467578633|FG001|Overall Study|Adverse Event|0|||
129895936|NCT02040844|467578634|FG002|Overall Study|Adverse Event|1|||
129895937|NCT02040844|467578632|FG000|Overall Study|Withdrawal by Subject|16|||
129895938|NCT02040844|467578633|FG001|Overall Study|Withdrawal by Subject|22|||
129895939|NCT02040844|467578634|FG002|Overall Study|Withdrawal by Subject|25|||
129895940|NCT02040844|467578632|FG000|Overall Study|Lost to Follow-up|12|||
129895941|NCT02040844|467578633|FG001|Overall Study|Lost to Follow-up|9|||
129895942|NCT02040844|467578634|FG002|Overall Study|Lost to Follow-up|13|||
129895943|NCT02040844|467578632|FG000|Overall Study|Missing|13|||
129895944|NCT02040844|467578633|FG001|Overall Study|Missing|3|||
129747043|NCT01271725|467033756|FG001|Part B|Clinical signs/symptoms of progression|2|||
129747044|NCT01271725|467033755|FG000|Part B|Other Adverse Event|0|||
129747045|NCT01271725|467033756|FG001|Part B|Other Adverse Event|1|||
129747046|NCT01271725|467033755|FG000|Part B|Protocol Violation|0|||
129747047|NCT01271725|467033756|FG001|Part B|Protocol Violation|1|||
129747048|NCT01271725|467033755|FG000|Part B|Withdrawal by Subject|0|||
129747049|NCT01271725|467033756|FG001|Part B|Withdrawal by Subject|6|||
129747050|NCT01702025|467033757|FG000|Overall Study|Equipment failure|1|||
129747051|NCT01702025|467033758|FG001|Overall Study|Equipment failure|0|||
129747052|NCT01702025|467033759|FG002|Overall Study|Equipment failure|0|||
129895945|NCT02040844|467578634|FG002|Overall Study|Missing|2|||
129747053|NCT01702025|467033760|FG003|Overall Study|Equipment failure|0|||
129747054|NCT01702025|467033757|FG000|Overall Study|Adverse Event|1|||
129747055|NCT01702025|467033758|FG001|Overall Study|Adverse Event|1|||
129747056|NCT01702025|467033759|FG002|Overall Study|Adverse Event|1|||
129808819|NCT00347360|467265823|FG013|Overall Study|Per sponsors instruction|0|||
129808820|NCT00347360|467265824|FG014|Overall Study|Per sponsors instruction|0|||
129895946|NCT02040844|467578632|FG000|Overall Study|Non-specified|8|||
129808821|NCT00347360|467265810|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
129895947|NCT02040844|467578633|FG001|Overall Study|Non-specified|2|||
129747057|NCT01702025|467033760|FG003|Overall Study|Adverse Event|0|||
129808822|NCT00347360|467265811|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
129808823|NCT00347360|467265812|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
129808824|NCT00347360|467265813|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
129808825|NCT00347360|467265814|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
129808826|NCT00347360|467265815|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
129808827|NCT00347360|467265816|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
129895948|NCT02040844|467578634|FG002|Overall Study|Non-specified|5|||
129895949|NCT02040844|467578632|FG000|Overall Study|Concomitant medication|1|||
129895950|NCT02040844|467578633|FG001|Overall Study|Concomitant medication|3|||
129747058|NCT03354273|467033761|FG000|Overall Study|Adverse Event|5|||
129747059|NCT03354273|467033761|FG000|Overall Study|Screen Failure|21|||
129747060|NCT03354273|467033761|FG000|Overall Study|Withdrawal by Subject|34|||
129747061|NCT03354273|467033761|FG000|Overall Study|Technical Problems|30|||
129747062|NCT03354273|467033761|FG000|Overall Study|Lost to Follow-up|4|||
129747063|NCT03354273|467033761|FG000|Overall Study|Investigator Decision|3|||
129747064|NCT03354273|467033761|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
129747065|NCT03354273|467033761|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
129747066|NCT03354273|467033761|FG000|Overall Study|COVID-19 Restrictions|9|||
129747067|NCT03354273|467033761|FG000|Overall Study|Other|5|||
129747068|NCT03229109|467033768|FG000|Overall Study|Withdrawal by Subject|0|||
129747069|NCT03229109|467033769|FG001|Overall Study|Withdrawal by Subject|0|||
129747070|NCT03229109|467033770|FG002|Overall Study|Withdrawal by Subject|0|||
129747071|NCT03229109|467033771|FG003|Overall Study|Withdrawal by Subject|1|||
129747072|NCT04207749|467033772|FG000|Overall Study|Lost to Follow-up|0|||
129747073|NCT04207749|467033773|FG001|Overall Study|Lost to Follow-up|2|||
129747074|NCT04207749|467033772|FG000|Overall Study|Protocol Violation|0|||
129747075|NCT04207749|467033773|FG001|Overall Study|Protocol Violation|1|||
129747076|NCT04207749|467033772|FG000|Overall Study|Withdrawal by Subject|3|||
129747077|NCT04207749|467033773|FG001|Overall Study|Withdrawal by Subject|0|||
129747078|NCT04207749|467033772|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
129747079|NCT04207749|467033773|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
129747080|NCT01835223|467033776|FG000|Overall Study|Adverse Event|1|||
129747081|NCT01835223|467033777|FG001|Overall Study|Adverse Event|0|||
129747082|NCT01835223|467033776|FG000|Overall Study|Withdrawal by Subject|2|||
129747083|NCT01835223|467033777|FG001|Overall Study|Withdrawal by Subject|0|||
129747084|NCT01835223|467033776|FG000|Overall Study|Disease progression|2|||
129747085|NCT01835223|467033777|FG001|Overall Study|Disease progression|1|||
129747086|NCT01835223|467033776|FG000|Overall Study|Became Inelligible|4|||
129747087|NCT01835223|467033777|FG001|Overall Study|Became Inelligible|0|||
129747088|NCT01504841|467033781|FG000|Overall Study|Withdrawal by Subject|1|||
129747089|NCT01504841|467033782|FG001|Overall Study|Withdrawal by Subject|1|||
129747090|NCT01504841|467033783|FG002|Overall Study|Withdrawal by Subject|0|||
129747091|NCT03149055|467033788|FG000|Overall Study|Not treated|4|||
129747092|NCT01610336|467033789|FG000|Overall Study|Progressive Disease|4|||
129747093|NCT01610336|467033790|FG001|Overall Study|Progressive Disease|6|||
129747094|NCT01610336|467033791|FG002|Overall Study|Progressive Disease|6|||
129747095|NCT01610336|467033792|FG003|Overall Study|Progressive Disease|5|||
129747096|NCT01610336|467033793|FG004|Overall Study|Progressive Disease|3|||
129747097|NCT01610336|467033794|FG005|Overall Study|Progressive Disease|10|||
129747098|NCT01610336|467033795|FG006|Overall Study|Progressive Disease|1|||
129747099|NCT01610336|467033796|FG007|Overall Study|Progressive Disease|6|||
129747100|NCT01610336|467033797|FG008|Overall Study|Progressive Disease|6|||
129747101|NCT01610336|467033798|FG009|Overall Study|Progressive Disease|40|||
129747102|NCT01610336|467033799|FG010|Overall Study|Progressive Disease|36|||
129747103|NCT01610336|467033789|FG000|Overall Study|Adverse Event|0|||
129747104|NCT01610336|467033790|FG001|Overall Study|Adverse Event|0|||
129747105|NCT01610336|467033791|FG002|Overall Study|Adverse Event|0|||
129747106|NCT01610336|467033792|FG003|Overall Study|Adverse Event|1|||
129747107|NCT01610336|467033793|FG004|Overall Study|Adverse Event|1|||
129747108|NCT01610336|467033794|FG005|Overall Study|Adverse Event|1|||
129747109|NCT01610336|467033795|FG006|Overall Study|Adverse Event|0|||
129747110|NCT01610336|467033796|FG007|Overall Study|Adverse Event|0|||
129747111|NCT01610336|467033797|FG008|Overall Study|Adverse Event|2|||
129747112|NCT01610336|467033798|FG009|Overall Study|Adverse Event|8|||
129747113|NCT01610336|467033799|FG010|Overall Study|Adverse Event|6|||
129747114|NCT01610336|467033789|FG000|Overall Study|Subject/Guardian decision|1|||
129747115|NCT01610336|467033790|FG001|Overall Study|Subject/Guardian decision|1|||
129747116|NCT01610336|467033791|FG002|Overall Study|Subject/Guardian decision|0|||
129747117|NCT01610336|467033792|FG003|Overall Study|Subject/Guardian decision|1|||
129747118|NCT01610336|467033793|FG004|Overall Study|Subject/Guardian decision|0|||
129747119|NCT01610336|467033794|FG005|Overall Study|Subject/Guardian decision|0|||
129747120|NCT01610336|467033795|FG006|Overall Study|Subject/Guardian decision|0|||
129747121|NCT01610336|467033796|FG007|Overall Study|Subject/Guardian decision|1|||
129747122|NCT01610336|467033797|FG008|Overall Study|Subject/Guardian decision|0|||
129747123|NCT01610336|467033798|FG009|Overall Study|Subject/Guardian decision|2|||
129747124|NCT01610336|467033799|FG010|Overall Study|Subject/Guardian decision|2|||
129747125|NCT01610336|467033789|FG000|Overall Study|Death|0|||
129747126|NCT01610336|467033790|FG001|Overall Study|Death|0|||
129895951|NCT02040844|467578634|FG002|Overall Study|Concomitant medication|1|||
129895952|NCT01560949|467578637|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
129747127|NCT01610336|467033791|FG002|Overall Study|Death|0|||
129895953|NCT01560949|467578637|FG000|Surgery Phase|Physician Decision|3|||
129747128|NCT01610336|467033792|FG003|Overall Study|Death|0|||
129747129|NCT01610336|467033793|FG004|Overall Study|Death|0|||
129747130|NCT01610336|467033794|FG005|Overall Study|Death|1|||
129747131|NCT01610336|467033795|FG006|Overall Study|Death|3|||
129747132|NCT01610336|467033796|FG007|Overall Study|Death|0|||
129747133|NCT01610336|467033797|FG008|Overall Study|Death|0|||
129747134|NCT01610336|467033798|FG009|Overall Study|Death|1|||
129747135|NCT01610336|467033799|FG010|Overall Study|Death|2|||
129747136|NCT01610336|467033789|FG000|Overall Study|Non-Compliance with study treatment|0|||
129747137|NCT01610336|467033790|FG001|Overall Study|Non-Compliance with study treatment|0|||
129747138|NCT01610336|467033791|FG002|Overall Study|Non-Compliance with study treatment|0|||
129747139|NCT01610336|467033792|FG003|Overall Study|Non-Compliance with study treatment|0|||
129747140|NCT01610336|467033793|FG004|Overall Study|Non-Compliance with study treatment|0|||
129747141|NCT01610336|467033794|FG005|Overall Study|Non-Compliance with study treatment|0|||
129747142|NCT01610336|467033795|FG006|Overall Study|Non-Compliance with study treatment|0|||
129747143|NCT01610336|467033796|FG007|Overall Study|Non-Compliance with study treatment|0|||
129747144|NCT01610336|467033797|FG008|Overall Study|Non-Compliance with study treatment|0|||
129747145|NCT01610336|467033798|FG009|Overall Study|Non-Compliance with study treatment|1|||
129747146|NCT01610336|467033799|FG010|Overall Study|Non-Compliance with study treatment|0|||
129747147|NCT01610336|467033789|FG000|Overall Study|Physician Decision|0|||
129747148|NCT01610336|467033790|FG001|Overall Study|Physician Decision|0|||
129747149|NCT01610336|467033791|FG002|Overall Study|Physician Decision|0|||
129747150|NCT01610336|467033792|FG003|Overall Study|Physician Decision|0|||
129747151|NCT01610336|467033793|FG004|Overall Study|Physician Decision|0|||
129747152|NCT01610336|467033794|FG005|Overall Study|Physician Decision|0|||
129747153|NCT01610336|467033795|FG006|Overall Study|Physician Decision|1|||
129747154|NCT01610336|467033796|FG007|Overall Study|Physician Decision|0|||
129747155|NCT01610336|467033797|FG008|Overall Study|Physician Decision|0|||
129747156|NCT01610336|467033798|FG009|Overall Study|Physician Decision|0|||
129747157|NCT01610336|467033799|FG010|Overall Study|Physician Decision|0|||
129747158|NCT01610336|467033789|FG000|Overall Study|Protocol Deviation|0|||
129747159|NCT01610336|467033790|FG001|Overall Study|Protocol Deviation|0|||
129747160|NCT01610336|467033791|FG002|Overall Study|Protocol Deviation|0|||
129747161|NCT01610336|467033792|FG003|Overall Study|Protocol Deviation|0|||
129747162|NCT01610336|467033793|FG004|Overall Study|Protocol Deviation|0|||
129747163|NCT01610336|467033794|FG005|Overall Study|Protocol Deviation|0|||
129747164|NCT01610336|467033795|FG006|Overall Study|Protocol Deviation|0|||
129747165|NCT01610336|467033796|FG007|Overall Study|Protocol Deviation|0|||
129747166|NCT01610336|467033797|FG008|Overall Study|Protocol Deviation|0|||
129747167|NCT01610336|467033798|FG009|Overall Study|Protocol Deviation|1|||
129747168|NCT01610336|467033799|FG010|Overall Study|Protocol Deviation|0|||
129747169|NCT01610336|467033789|FG000|Overall Study|Transfer to another trial|0|||
129747170|NCT01610336|467033790|FG001|Overall Study|Transfer to another trial|0|||
129747171|NCT01610336|467033791|FG002|Overall Study|Transfer to another trial|0|||
129747172|NCT01610336|467033792|FG003|Overall Study|Transfer to another trial|0|||
129747173|NCT01610336|467033793|FG004|Overall Study|Transfer to another trial|0|||
129747174|NCT01610336|467033794|FG005|Overall Study|Transfer to another trial|0|||
129747175|NCT01610336|467033795|FG006|Overall Study|Transfer to another trial|0|||
129747176|NCT01610336|467033796|FG007|Overall Study|Transfer to another trial|0|||
129747177|NCT01610336|467033797|FG008|Overall Study|Transfer to another trial|0|||
129747178|NCT01610336|467033798|FG009|Overall Study|Transfer to another trial|0|||
129747179|NCT01610336|467033799|FG010|Overall Study|Transfer to another trial|1|||
129747180|NCT04440813|467033800|FG000|Overall Study|Lost to Follow-up|5|||
129747181|NCT04440813|467033801|FG001|Overall Study|Lost to Follow-up|5|||
129747182|NCT02629822|467033802|FG000|Base Study|Lost to Follow-up|2|||
129747183|NCT02629822|467033802|FG000|Base Study|Non-Compliance With Study Drug|1|||
129747184|NCT02629822|467033802|FG000|Extension Study|Adverse Event|1|||
129747185|NCT02629822|467033802|FG000|Extension Study|Lost to Follow-up|1|||
129747186|NCT03679624|467033803|FG000|Overall Study|Adverse Event|1|||
129747187|NCT03679624|467033804|FG001|Overall Study|Adverse Event|0|||
129747188|NCT00741013|467033805|FG000|Overall Study|Adverse Event|1|||
129747189|NCT00741013|467033806|FG001|Overall Study|Adverse Event|0|||
129747190|NCT00741013|467033807|FG002|Overall Study|Adverse Event|0|||
129747191|NCT00741013|467033805|FG000|Overall Study|Withdrawal by Subject|0|||
129747192|NCT00741013|467033806|FG001|Overall Study|Withdrawal by Subject|0|||
129747193|NCT00741013|467033807|FG002|Overall Study|Withdrawal by Subject|1|||
129747194|NCT00741013|467033805|FG000|Overall Study|Discovered failed screen after enrolled|0|||
129747195|NCT00741013|467033806|FG001|Overall Study|Discovered failed screen after enrolled|2|||
129747196|NCT00741013|467033807|FG002|Overall Study|Discovered failed screen after enrolled|0|||
129747197|NCT01559675|467033811|FG000|Overall Study|Protocol Violation|1|||
129747198|NCT01559675|467033812|FG001|Overall Study|Protocol Violation|2|||
129747199|NCT01559675|467033811|FG000|Overall Study|2nd operation on same patient excluded|14|||
129747200|NCT01559675|467033812|FG001|Overall Study|2nd operation on same patient excluded|12|||
129747201|NCT00291018|467033813|FG000|Overall Study|Not Consented or Declined PAS|12|||
129747202|NCT00291018|467033814|FG001|Overall Study|Not Consented or Declined PAS|15|||
129747203|NCT00291018|467033815|FG002|Overall Study|Not Consented or Declined PAS|15|||
129747204|NCT00291018|467033813|FG000|Overall Study|Death|3|||
129747205|NCT00291018|467033814|FG001|Overall Study|Death|3|||
129747206|NCT00291018|467033815|FG002|Overall Study|Death|4|||
129747207|NCT00291018|467033813|FG000|Overall Study|Withdrawal by Subject|2|||
129747208|NCT00291018|467033814|FG001|Overall Study|Withdrawal by Subject|8|||
129747209|NCT00291018|467033815|FG002|Overall Study|Withdrawal by Subject|1|||
129747210|NCT00291018|467033813|FG000|Overall Study|Failures|5|||
129808828|NCT00347360|467265817|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
129808829|NCT00347360|467265818|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
129808830|NCT00347360|467265819|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
129808831|NCT00347360|467265820|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
129808832|NCT00347360|467265821|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
129808833|NCT00347360|467265822|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
129808834|NCT00347360|467265823|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
129808835|NCT00347360|467265824|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
129808836|NCT00347360|467265810|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
129808837|NCT00347360|467265811|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
129808838|NCT00347360|467265812|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
129808839|NCT00347360|467265813|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
129808840|NCT00347360|467265814|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
129808841|NCT00347360|467265815|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
129808842|NCT00347360|467265816|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
129808843|NCT00347360|467265817|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
129808844|NCT00347360|467265818|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
129808845|NCT00347360|467265819|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
129808846|NCT00347360|467265820|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
129808847|NCT00347360|467265821|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
129808848|NCT00347360|467265822|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
129808849|NCT00347360|467265823|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
129808850|NCT00347360|467265824|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
129808851|NCT00347360|467265810|FG000|Overall Study|Abnormal lab values|0|||
129747211|NCT00291018|467033814|FG001|Overall Study|Failures|12|||
129747212|NCT00291018|467033815|FG002|Overall Study|Failures|5|||
129747213|NCT00291018|467033813|FG000|Overall Study|Lost to Follow-up|3|||
129747214|NCT00291018|467033814|FG001|Overall Study|Lost to Follow-up|4|||
129747215|NCT00291018|467033815|FG002|Overall Study|Lost to Follow-up|18|||
129747216|NCT01496469|467033816|FG000|Overall Study|Adverse Event|1|||
129747217|NCT01496469|467033817|FG001|Overall Study|Adverse Event|0|||
129747218|NCT01496469|467033816|FG000|Overall Study|Protocol Violation|2|||
129747219|NCT01496469|467033817|FG001|Overall Study|Protocol Violation|0|||
129747220|NCT01496469|467033816|FG000|Overall Study|Lost to Follow-up|1|||
129747221|NCT01496469|467033817|FG001|Overall Study|Lost to Follow-up|1|||
129747222|NCT01496469|467033816|FG000|Overall Study|Withdrawal by Subject|4|||
129747223|NCT01496469|467033817|FG001|Overall Study|Withdrawal by Subject|4|||
129747224|NCT01496469|467033816|FG000|Overall Study|BP exceeds protocol limits|1|||
129747225|NCT01496469|467033817|FG001|Overall Study|BP exceeds protocol limits|2|||
129747226|NCT01496469|467033816|FG000|Overall Study|Other|1|||
129747227|NCT01496469|467033817|FG001|Overall Study|Other|1|||
129747228|NCT00193180|467033818|FG000|Overall Study|Lack of Efficacy|1|||
129747229|NCT00193180|467033818|FG000|Overall Study|Adverse Event|8|||
129747230|NCT00193180|467033818|FG000|Overall Study|Protocol Violation|1|||
129747231|NCT01357551|467033819|FG000|Overall Study|Withdrawal by Subject|6|||
129747232|NCT01357551|467033820|FG001|Overall Study|Withdrawal by Subject|4|||
129747233|NCT01357551|467033819|FG000|Overall Study|Death|0|||
129747234|NCT01357551|467033820|FG001|Overall Study|Death|1|||
129747235|NCT01357551|467033819|FG000|Overall Study|Lost to Follow-up|16|||
129747236|NCT01357551|467033820|FG001|Overall Study|Lost to Follow-up|6|||
129747237|NCT01235234|467033821|FG000|Overall Study|Adverse Event|2|||
129747238|NCT01235234|467033822|FG001|Overall Study|Adverse Event|2|||
129747239|NCT01235234|467033823|FG002|Overall Study|Adverse Event|1|||
129747240|NCT04776317|467033830|FG000|Overall Study|Physician Decision|0|||
129747241|NCT04776317|467033831|FG001|Overall Study|Physician Decision|1|||
129747242|NCT04776317|467033832|FG002|Overall Study|Physician Decision|0|||
129747243|NCT04776317|467033833|FG003|Overall Study|Physician Decision|0|||
129808852|NCT00347360|467265811|FG001|Overall Study|Abnormal lab values|0|||
129808853|NCT00347360|467265812|FG002|Overall Study|Abnormal lab values|0|||
129808854|NCT00347360|467265813|FG003|Overall Study|Abnormal lab values|0|||
129808855|NCT00347360|467265814|FG004|Overall Study|Abnormal lab values|0|||
129808856|NCT00347360|467265815|FG005|Overall Study|Abnormal lab values|0|||
129808857|NCT00347360|467265816|FG006|Overall Study|Abnormal lab values|1|||
129808858|NCT00347360|467265817|FG007|Overall Study|Abnormal lab values|0|||
129808859|NCT00347360|467265818|FG008|Overall Study|Abnormal lab values|0|||
129808860|NCT00347360|467265819|FG009|Overall Study|Abnormal lab values|0|||
129747244|NCT04776317|467033834|FG004|Overall Study|Physician Decision|0|||
129747245|NCT04776317|467033835|FG005|Overall Study|Physician Decision|0|||
129747246|NCT04776317|467033836|FG006|Overall Study|Physician Decision|0|||
129747247|NCT04776317|467033837|FG007|Overall Study|Physician Decision|0|||
129747248|NCT04776317|467033838|FG008|Overall Study|Physician Decision|0|||
129747249|NCT04776317|467033839|FG009|Overall Study|Physician Decision|0|||
129747250|NCT04776317|467033840|FG010|Overall Study|Physician Decision|0|||
129747251|NCT04776317|467033841|FG011|Overall Study|Physician Decision|0|||
129747252|NCT04776317|467033842|FG012|Overall Study|Physician Decision|0|||
129808861|NCT00347360|467265820|FG010|Overall Study|Abnormal lab values|0|||
129808862|NCT00347360|467265821|FG011|Overall Study|Abnormal lab values|0|||
129808863|NCT00347360|467265822|FG012|Overall Study|Abnormal lab values|0|||
129808864|NCT00347360|467265823|FG013|Overall Study|Abnormal lab values|0|||
129808865|NCT00347360|467265824|FG014|Overall Study|Abnormal lab values|0|||
129808866|NCT00347360|467265810|FG000|Overall Study|PI recommended early withdrawal|0|||
129808867|NCT00347360|467265811|FG001|Overall Study|PI recommended early withdrawal|0|||
129808868|NCT00347360|467265812|FG002|Overall Study|PI recommended early withdrawal|0|||
129808869|NCT00347360|467265813|FG003|Overall Study|PI recommended early withdrawal|0|||
129808870|NCT00347360|467265814|FG004|Overall Study|PI recommended early withdrawal|0|||
129808871|NCT00347360|467265815|FG005|Overall Study|PI recommended early withdrawal|0|||
129808872|NCT00347360|467265816|FG006|Overall Study|PI recommended early withdrawal|0|||
129808873|NCT00347360|467265817|FG007|Overall Study|PI recommended early withdrawal|0|||
129808874|NCT00347360|467265818|FG008|Overall Study|PI recommended early withdrawal|0|||
129808875|NCT00347360|467265819|FG009|Overall Study|PI recommended early withdrawal|1|||
129808876|NCT00347360|467265820|FG010|Overall Study|PI recommended early withdrawal|0|||
129808877|NCT00347360|467265821|FG011|Overall Study|PI recommended early withdrawal|0|||
129808878|NCT00347360|467265822|FG012|Overall Study|PI recommended early withdrawal|0|||
129808879|NCT00347360|467265823|FG013|Overall Study|PI recommended early withdrawal|0|||
129808880|NCT00347360|467265824|FG014|Overall Study|PI recommended early withdrawal|0|||
129808881|NCT00347360|467265810|FG000|Overall Study|Did not meet criteria before ABPM|0|||
129808882|NCT00347360|467265811|FG001|Overall Study|Did not meet criteria before ABPM|0|||
129808883|NCT00347360|467265812|FG002|Overall Study|Did not meet criteria before ABPM|0|||
129808884|NCT00347360|467265813|FG003|Overall Study|Did not meet criteria before ABPM|0|||
129808885|NCT00347360|467265814|FG004|Overall Study|Did not meet criteria before ABPM|0|||
129808886|NCT00347360|467265815|FG005|Overall Study|Did not meet criteria before ABPM|0|||
129808887|NCT00347360|467265816|FG006|Overall Study|Did not meet criteria before ABPM|0|||
129808888|NCT00347360|467265817|FG007|Overall Study|Did not meet criteria before ABPM|0|||
129808889|NCT00347360|467265818|FG008|Overall Study|Did not meet criteria before ABPM|0|||
129808890|NCT00347360|467265819|FG009|Overall Study|Did not meet criteria before ABPM|0|||
129808891|NCT00347360|467265820|FG010|Overall Study|Did not meet criteria before ABPM|1|||
129808892|NCT00347360|467265821|FG011|Overall Study|Did not meet criteria before ABPM|0|||
129808893|NCT00347360|467265822|FG012|Overall Study|Did not meet criteria before ABPM|0|||
129808894|NCT00347360|467265823|FG013|Overall Study|Did not meet criteria before ABPM|0|||
129808895|NCT00347360|467265824|FG014|Overall Study|Did not meet criteria before ABPM|0|||
129808896|NCT00347360|467265810|FG000|Overall Study|Randomized in error|0|||
129808897|NCT00347360|467265811|FG001|Overall Study|Randomized in error|0|||
129808898|NCT00347360|467265812|FG002|Overall Study|Randomized in error|0|||
129808899|NCT00347360|467265813|FG003|Overall Study|Randomized in error|0|||
129808900|NCT00347360|467265814|FG004|Overall Study|Randomized in error|0|||
129808901|NCT00347360|467265815|FG005|Overall Study|Randomized in error|0|||
129808902|NCT00347360|467265816|FG006|Overall Study|Randomized in error|0|||
129808903|NCT00347360|467265817|FG007|Overall Study|Randomized in error|0|||
129808904|NCT00347360|467265818|FG008|Overall Study|Randomized in error|0|||
129808905|NCT00347360|467265819|FG009|Overall Study|Randomized in error|0|||
129808906|NCT00347360|467265820|FG010|Overall Study|Randomized in error|0|||
129808907|NCT00347360|467265821|FG011|Overall Study|Randomized in error|1|||
129808908|NCT00347360|467265822|FG012|Overall Study|Randomized in error|0|||
129808909|NCT00347360|467265823|FG013|Overall Study|Randomized in error|0|||
129808910|NCT00347360|467265824|FG014|Overall Study|Randomized in error|0|||
129808911|NCT00347360|467265810|FG000|Overall Study|Failed inclusion criteria #4|0|||
129808912|NCT00347360|467265811|FG001|Overall Study|Failed inclusion criteria #4|0|||
129808913|NCT00347360|467265812|FG002|Overall Study|Failed inclusion criteria #4|0|||
129808914|NCT00347360|467265813|FG003|Overall Study|Failed inclusion criteria #4|0|||
129808915|NCT00347360|467265814|FG004|Overall Study|Failed inclusion criteria #4|0|||
129808916|NCT00347360|467265815|FG005|Overall Study|Failed inclusion criteria #4|0|||
129808917|NCT00347360|467265816|FG006|Overall Study|Failed inclusion criteria #4|0|||
129808918|NCT00347360|467265817|FG007|Overall Study|Failed inclusion criteria #4|0|||
129808919|NCT00347360|467265818|FG008|Overall Study|Failed inclusion criteria #4|0|||
129808920|NCT00347360|467265819|FG009|Overall Study|Failed inclusion criteria #4|0|||
129808921|NCT00347360|467265820|FG010|Overall Study|Failed inclusion criteria #4|0|||
129808922|NCT00347360|467265821|FG011|Overall Study|Failed inclusion criteria #4|1|||
129808923|NCT00347360|467265822|FG012|Overall Study|Failed inclusion criteria #4|0|||
129808924|NCT00347360|467265823|FG013|Overall Study|Failed inclusion criteria #4|0|||
129895954|NCT00681811|467578640|FG000|Overall Study|Adverse Event|1|||
129808925|NCT00347360|467265824|FG014|Overall Study|Failed inclusion criteria #4|0|||
129808926|NCT00347360|467265810|FG000|Overall Study|Prolonged duration between visits|0|||
129808927|NCT00347360|467265811|FG001|Overall Study|Prolonged duration between visits|0|||
129808928|NCT00347360|467265812|FG002|Overall Study|Prolonged duration between visits|0|||
129808929|NCT00347360|467265813|FG003|Overall Study|Prolonged duration between visits|0|||
129808930|NCT00347360|467265814|FG004|Overall Study|Prolonged duration between visits|0|||
129808931|NCT00347360|467265815|FG005|Overall Study|Prolonged duration between visits|0|||
129808932|NCT00347360|467265816|FG006|Overall Study|Prolonged duration between visits|0|||
129747253|NCT04776317|467033843|FG013|Overall Study|Physician Decision|0|||
129747254|NCT04776317|467033844|FG014|Overall Study|Physician Decision|0|||
129747255|NCT04776317|467033830|FG000|Overall Study|Protocol Violation|0|||
129747256|NCT04776317|467033831|FG001|Overall Study|Protocol Violation|0|||
129747257|NCT04776317|467033832|FG002|Overall Study|Protocol Violation|1|||
129747258|NCT04776317|467033833|FG003|Overall Study|Protocol Violation|0|||
129747259|NCT04776317|467033834|FG004|Overall Study|Protocol Violation|0|||
129747260|NCT04776317|467033835|FG005|Overall Study|Protocol Violation|0|||
129747261|NCT04776317|467033836|FG006|Overall Study|Protocol Violation|0|||
129747262|NCT04776317|467033837|FG007|Overall Study|Protocol Violation|0|||
129747263|NCT04776317|467033838|FG008|Overall Study|Protocol Violation|0|||
129747264|NCT04776317|467033839|FG009|Overall Study|Protocol Violation|0|||
129747265|NCT04776317|467033840|FG010|Overall Study|Protocol Violation|0|||
129747266|NCT04776317|467033841|FG011|Overall Study|Protocol Violation|0|||
129747267|NCT04776317|467033842|FG012|Overall Study|Protocol Violation|0|||
129747268|NCT04776317|467033843|FG013|Overall Study|Protocol Violation|0|||
129747269|NCT04776317|467033844|FG014|Overall Study|Protocol Violation|0|||
129747270|NCT04776317|467033830|FG000|Overall Study|Withdrawal by Subject|0|||
129747271|NCT04776317|467033831|FG001|Overall Study|Withdrawal by Subject|0|||
129747272|NCT04776317|467033832|FG002|Overall Study|Withdrawal by Subject|0|||
129747273|NCT04776317|467033833|FG003|Overall Study|Withdrawal by Subject|0|||
129747274|NCT04776317|467033834|FG004|Overall Study|Withdrawal by Subject|1|||
129747275|NCT04776317|467033835|FG005|Overall Study|Withdrawal by Subject|0|||
129747276|NCT04776317|467033836|FG006|Overall Study|Withdrawal by Subject|0|||
129747277|NCT04776317|467033837|FG007|Overall Study|Withdrawal by Subject|0|||
129747278|NCT04776317|467033838|FG008|Overall Study|Withdrawal by Subject|0|||
129747279|NCT04776317|467033839|FG009|Overall Study|Withdrawal by Subject|0|||
129747280|NCT04776317|467033840|FG010|Overall Study|Withdrawal by Subject|0|||
129747281|NCT04776317|467033841|FG011|Overall Study|Withdrawal by Subject|0|||
129747282|NCT04776317|467033842|FG012|Overall Study|Withdrawal by Subject|0|||
129747283|NCT04776317|467033843|FG013|Overall Study|Withdrawal by Subject|0|||
129747284|NCT04776317|467033844|FG014|Overall Study|Withdrawal by Subject|0|||
129747285|NCT04207060|467033845|FG000|Overall Study|Lost to Follow-up|2|||
129747286|NCT04207060|467033846|FG001|Overall Study|Lost to Follow-up|0|||
129747287|NCT02524158|467033847|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
129747288|NCT02524158|467033848|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
129747289|NCT02524158|467033847|FG000|12-weeks Assessment|Lost to Follow-up|18|||
129747290|NCT02524158|467033848|FG001|12-weeks Assessment|Lost to Follow-up|12|||
129747291|NCT02524158|467033847|FG000|6-month Assessment|Withdrawal by Subject|1|||
129747292|NCT02524158|467033848|FG001|6-month Assessment|Withdrawal by Subject|1|||
129747293|NCT02524158|467033847|FG000|6-month Assessment|Lost to Follow-up|21|||
129747294|NCT02524158|467033848|FG001|6-month Assessment|Lost to Follow-up|20|||
129747295|NCT03671304|467033849|FG000|Overall Study|study terminated|7|||
129747296|NCT02718716|467033850|FG000|Overall Study|Lack of Efficacy|1|||
129747297|NCT02718716|467033851|FG001|Overall Study|Lack of Efficacy|0|||
129747298|NCT02718716|467033852|FG002|Overall Study|Lack of Efficacy|0|||
129747299|NCT02718716|467033853|FG003|Overall Study|Lack of Efficacy|0|||
129747300|NCT02718716|467033854|FG004|Overall Study|Lack of Efficacy|0|||
129747301|NCT04869358|467033855|FG000|Overall Study|Wish to have children.|1|||
129747302|NCT04869358|467033856|FG001|Overall Study|Wish to have children.|0|||
129747303|NCT04869358|467033857|FG002|Overall Study|Wish to have children.|0|||
129747304|NCT04869358|467033858|FG003|Overall Study|Wish to have children.|0|||
129747305|NCT04164732|467033859|FG000|Treatment run-in Period|Adverse Event|4|||
129808933|NCT00347360|467265817|FG007|Overall Study|Prolonged duration between visits|0|||
129808934|NCT00347360|467265818|FG008|Overall Study|Prolonged duration between visits|0|||
129808935|NCT00347360|467265819|FG009|Overall Study|Prolonged duration between visits|0|||
129808936|NCT00347360|467265820|FG010|Overall Study|Prolonged duration between visits|0|||
129808937|NCT00347360|467265821|FG011|Overall Study|Prolonged duration between visits|0|||
129808938|NCT00347360|467265822|FG012|Overall Study|Prolonged duration between visits|1|||
129808939|NCT00347360|467265823|FG013|Overall Study|Prolonged duration between visits|0|||
129808940|NCT00347360|467265824|FG014|Overall Study|Prolonged duration between visits|0|||
129808941|NCT00347360|467265810|FG000|Overall Study|Subject left town, ran out of study drug|0|||
129808942|NCT00347360|467265811|FG001|Overall Study|Subject left town, ran out of study drug|0|||
129747306|NCT04164732|467033860|FG001|Treatment run-in Period|Adverse Event|0|||
129747307|NCT04164732|467033861|FG002|Treatment run-in Period|Adverse Event|0|||
129747308|NCT04164732|467033859|FG000|Treatment run-in Period|Physician Decision|1|||
129747309|NCT04164732|467033860|FG001|Treatment run-in Period|Physician Decision|0|||
129808943|NCT00347360|467265812|FG002|Overall Study|Subject left town, ran out of study drug|0|||
129747310|NCT04164732|467033861|FG002|Treatment run-in Period|Physician Decision|0|||
129808944|NCT00347360|467265813|FG003|Overall Study|Subject left town, ran out of study drug|0|||
129808945|NCT00347360|467265814|FG004|Overall Study|Subject left town, ran out of study drug|0|||
129808946|NCT00347360|467265815|FG005|Overall Study|Subject left town, ran out of study drug|0|||
129808947|NCT00347360|467265816|FG006|Overall Study|Subject left town, ran out of study drug|0|||
129808948|NCT00347360|467265817|FG007|Overall Study|Subject left town, ran out of study drug|0|||
129808949|NCT00347360|467265818|FG008|Overall Study|Subject left town, ran out of study drug|0|||
129747311|NCT04164732|467033859|FG000|Treatment run-in Period|Screen Failure|1|||
129747312|NCT04164732|467033860|FG001|Treatment run-in Period|Screen Failure|0|||
129747313|NCT04164732|467033861|FG002|Treatment run-in Period|Screen Failure|0|||
129747314|NCT04164732|467033859|FG000|Randomized Treatment Period|Adverse Event|0|||
129747315|NCT04164732|467033860|FG001|Randomized Treatment Period|Adverse Event|1|||
129747316|NCT04164732|467033861|FG002|Randomized Treatment Period|Adverse Event|0|||
129747317|NCT04164732|467033859|FG000|Randomized Treatment Period|Protocol Deviation|0|||
129747318|NCT04164732|467033860|FG001|Randomized Treatment Period|Protocol Deviation|1|||
129747319|NCT04164732|467033861|FG002|Randomized Treatment Period|Protocol Deviation|1|||
129747320|NCT04164732|467033859|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
129747321|NCT04164732|467033860|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
129747322|NCT04164732|467033861|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
129747323|NCT04302545|467033862|FG000|Overall Study|Lost to Follow-up|3|||
129747324|NCT04302545|467033863|FG001|Overall Study|Lost to Follow-up|4|||
129747325|NCT02690714|467033867|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
129747326|NCT02690714|467033867|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
129747327|NCT02202538|467033868|FG000|Overall Study|Withdrawal by Subject|5|||
129747328|NCT02202538|467033868|FG000|Overall Study|Did not meet all inclusion criteria|2|||
129747329|NCT02202538|467033868|FG000|Overall Study|Investigator Decision|1|||
129747330|NCT01457846|467033869|FG000|Overall Study|Death before treatment|1|||
129747331|NCT01457846|467033870|FG001|Overall Study|Death before treatment|2|||
129747332|NCT01457846|467033869|FG000|Overall Study|Did not receive treatment|0|||
129747333|NCT01457846|467033870|FG001|Overall Study|Did not receive treatment|1|||
129747334|NCT01457846|467033869|FG000|Overall Study|Death|27|||
129747335|NCT01457846|467033870|FG001|Overall Study|Death|16|||
129747336|NCT01457846|467033869|FG000|Overall Study|Unclassified reason for not completed|11|||
129747337|NCT01457846|467033870|FG001|Overall Study|Unclassified reason for not completed|10|||
129747338|NCT01457846|467033869|FG000|Overall Study|Withdrawal by Subject|1|||
129747339|NCT01457846|467033870|FG001|Overall Study|Withdrawal by Subject|1|||
129747340|NCT01457846|467033869|FG000|Overall Study|Lost to Follow-up|1|||
129747341|NCT01457846|467033870|FG001|Overall Study|Lost to Follow-up|0|||
129747342|NCT02161757|467033871|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
129747343|NCT02161757|467033872|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
129747344|NCT02161757|467033873|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
129747345|NCT02161757|467033871|FG000|Treatment Through Study Completion|Adverse Event|1|||
129747346|NCT02161757|467033872|FG001|Treatment Through Study Completion|Adverse Event|1|||
129747347|NCT02161757|467033873|FG002|Treatment Through Study Completion|Adverse Event|0|||
129747348|NCT02161757|467033871|FG000|Treatment Through Study Completion|Protocol Violation|0|||
129747349|NCT02161757|467033872|FG001|Treatment Through Study Completion|Protocol Violation|1|||
129747350|NCT02161757|467033873|FG002|Treatment Through Study Completion|Protocol Violation|2|||
129747351|NCT02161757|467033871|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
129747352|NCT02161757|467033872|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
129747353|NCT02161757|467033873|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
129747354|NCT02161757|467033871|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
129747355|NCT02161757|467033872|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
129747356|NCT02161757|467033873|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
129747357|NCT02161757|467033871|FG000|Treatment Through Study Completion|Other|20|||
129747358|NCT02161757|467033872|FG001|Treatment Through Study Completion|Other|19|||
129747359|NCT02161757|467033873|FG002|Treatment Through Study Completion|Other|12|||
129747360|NCT02161757|467033871|FG000|Treatment Through Study Completion|Death|2|||
129747361|NCT02161757|467033872|FG001|Treatment Through Study Completion|Death|1|||
129747362|NCT02161757|467033873|FG002|Treatment Through Study Completion|Death|1|||
129747363|NCT00465647|467033876|FG000|Overall Study|Administrative|2|||
129747364|NCT00465647|467033877|FG001|Overall Study|Administrative|2|||
129747365|NCT00465647|467033878|FG002|Overall Study|Administrative|3|||
129747366|NCT00465647|467033879|FG003|Overall Study|Administrative|2|||
129747367|NCT00465647|467033876|FG000|Overall Study|Adverse Event|2|||
129747368|NCT00465647|467033877|FG001|Overall Study|Adverse Event|0|||
129747369|NCT00465647|467033878|FG002|Overall Study|Adverse Event|3|||
129747370|NCT00465647|467033879|FG003|Overall Study|Adverse Event|2|||
129747371|NCT00465647|467033876|FG000|Overall Study|Withdrawal by Subject|1|||
129747372|NCT00465647|467033877|FG001|Overall Study|Withdrawal by Subject|2|||
129747373|NCT00465647|467033878|FG002|Overall Study|Withdrawal by Subject|2|||
129747374|NCT00465647|467033879|FG003|Overall Study|Withdrawal by Subject|7|||
129747375|NCT00465647|467033876|FG000|Overall Study|"The other reasons included loss of IV"|8|||
129747376|NCT00465647|467033877|FG001|Overall Study|"The other reasons included loss of IV"|4|||
129747377|NCT00465647|467033878|FG002|Overall Study|"The other reasons included loss of IV"|3|||
129747378|NCT00465647|467033879|FG003|Overall Study|"The other reasons included loss of IV"|2|||
129747379|NCT01240135|467033882|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
129747380|NCT01240135|467033883|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
129747381|NCT01240135|467033882|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
129895955|NCT00681811|467578641|FG001|Overall Study|Adverse Event|1|||
129747382|NCT01240135|467033883|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
129747383|NCT01371305|467033884|FG000|Overall Study|Adverse Event|0|||
129747384|NCT01371305|467033885|FG001|Overall Study|Adverse Event|0|||
129747385|NCT01371305|467033886|FG002|Overall Study|Adverse Event|0|||
129747386|NCT01371305|467033887|FG003|Overall Study|Adverse Event|2|||
129747387|NCT01371305|467033888|FG004|Overall Study|Adverse Event|1|||
129747388|NCT01371305|467033889|FG005|Overall Study|Adverse Event|0|||
129747389|NCT01371305|467033884|FG000|Overall Study|Study terminated by sponsor|0|||
129747390|NCT01371305|467033885|FG001|Overall Study|Study terminated by sponsor|0|||
129747391|NCT01371305|467033886|FG002|Overall Study|Study terminated by sponsor|0|||
129747392|NCT01371305|467033887|FG003|Overall Study|Study terminated by sponsor|0|||
129747393|NCT01371305|467033888|FG004|Overall Study|Study terminated by sponsor|3|||
129747394|NCT01371305|467033889|FG005|Overall Study|Study terminated by sponsor|1|||
129747395|NCT01371305|467033884|FG000|Overall Study|Subject request|0|||
129747396|NCT01371305|467033885|FG001|Overall Study|Subject request|0|||
129747397|NCT01371305|467033886|FG002|Overall Study|Subject request|0|||
129747398|NCT01371305|467033887|FG003|Overall Study|Subject request|0|||
129747399|NCT01371305|467033888|FG004|Overall Study|Subject request|0|||
129747400|NCT01371305|467033889|FG005|Overall Study|Subject request|1|||
129747401|NCT02828020|467033892|FG000|Treatment Period|Adverse Event|3|||
129747402|NCT02828020|467033893|FG001|Treatment Period|Adverse Event|1|||
129747403|NCT02828020|467033894|FG002|Treatment Period|Adverse Event|1|||
129747404|NCT02828020|467033892|FG000|Treatment Period|Withdrawal of Consent|10|||
129747405|NCT02828020|467033893|FG001|Treatment Period|Withdrawal of Consent|14|||
129747406|NCT02828020|467033894|FG002|Treatment Period|Withdrawal of Consent|9|||
129747407|NCT02828020|467033892|FG000|Treatment Period|Lost to Follow-up|21|||
129895956|NCT00681811|467578640|FG000|Overall Study|Withdrawal by Subject|2|||
129895957|NCT00681811|467578641|FG001|Overall Study|Withdrawal by Subject|2|||
129895958|NCT00681811|467578640|FG000|Overall Study|Non-compliance|0|||
129895959|NCT00681811|467578641|FG001|Overall Study|Non-compliance|1|||
129895960|NCT01562743|467578644|FG000|Overall Study|Adverse Event|29|||
129895961|NCT01562743|467578644|FG000|Overall Study|Lack of Efficacy|3|||
129895962|NCT01562743|467578644|FG000|Overall Study|Withdrawal by Subject|13|||
129895963|NCT01562743|467578644|FG000|Overall Study|Protocol Violation|1|||
129747408|NCT02828020|467033893|FG001|Treatment Period|Lost to Follow-up|24|||
129747409|NCT02828020|467033894|FG002|Treatment Period|Lost to Follow-up|18|||
129747410|NCT02828020|467033892|FG000|Treatment Period|Lack of Qualifying Event|44|||
129747411|NCT02828020|467033893|FG001|Treatment Period|Lack of Qualifying Event|53|||
129747412|NCT02828020|467033894|FG002|Treatment Period|Lack of Qualifying Event|43|||
129747413|NCT02828020|467033892|FG000|Treatment Period|Pregnancy|0|||
129747414|NCT02828020|467033893|FG001|Treatment Period|Pregnancy|2|||
129747415|NCT02828020|467033894|FG002|Treatment Period|Pregnancy|0|||
129747416|NCT02828020|467033892|FG000|Treatment Period|Protocol Violation|2|||
129747417|NCT02828020|467033893|FG001|Treatment Period|Protocol Violation|4|||
129747418|NCT02828020|467033894|FG002|Treatment Period|Protocol Violation|7|||
129747419|NCT02828020|467033892|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
129747420|NCT02828020|467033893|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
129747421|NCT02828020|467033894|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
129747422|NCT02828020|467033892|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
129747423|NCT02828020|467033893|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
129747424|NCT02828020|467033894|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
129747425|NCT02828020|467033892|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
129747426|NCT02828020|467033893|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
129747427|NCT02828020|467033894|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
129747428|NCT02828020|467033892|FG000|Safety Follow-up Period|Protocol Violation|0|||
129747429|NCT02828020|467033893|FG001|Safety Follow-up Period|Protocol Violation|2|||
129747430|NCT02828020|467033894|FG002|Safety Follow-up Period|Protocol Violation|1|||
129747431|NCT02828020|467033892|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
129747432|NCT02828020|467033893|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
129747433|NCT02828020|467033894|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
129747434|NCT01138501|467033895|FG000|Overall Study|Protocol Violation|2|||
129747435|NCT01138501|467033895|FG000|Overall Study|Withdrawal by Subject|3|||
129747436|NCT01339897|467033896|FG000|Overall Study|Adverse Event|1|||
129895964|NCT01562743|467578644|FG000|Overall Study|Discontinuation criteria|2|||
129747437|NCT01339897|467033897|FG001|Overall Study|Adverse Event|0|||
129747438|NCT01339897|467033898|FG002|Overall Study|Adverse Event|0|||
129747439|NCT01339897|467033899|FG003|Overall Study|Adverse Event|1|||
129747440|NCT00847197|467033903|FG000|Overall Study|Adverse Event|21|||
129747441|NCT00847197|467033904|FG001|Overall Study|Adverse Event|3|||
129747442|NCT00847197|467033903|FG000|Overall Study|Protocol Violation|0|||
129747443|NCT00847197|467033904|FG001|Overall Study|Protocol Violation|1|||
129747444|NCT00847197|467033903|FG000|Overall Study|Withdrawal by Subject|3|||
129747445|NCT00847197|467033904|FG001|Overall Study|Withdrawal by Subject|1|||
129747446|NCT01894243|467033905|FG000|Overall Study|Adverse Event|0|||
129747447|NCT01894243|467033906|FG001|Overall Study|Adverse Event|1|||
129747448|NCT01894243|467033907|FG002|Overall Study|Adverse Event|2|||
129895965|NCT01562743|467578644|FG000|Overall Study|Lost to Follow-up|2|||
129747449|NCT01894243|467033905|FG000|Overall Study|Death|0|||
129747450|NCT01894243|467033906|FG001|Overall Study|Death|0|||
129747451|NCT01894243|467033907|FG002|Overall Study|Death|3|||
129747452|NCT01894243|467033905|FG000|Overall Study|Lack of Efficacy|3|||
129747453|NCT01894243|467033906|FG001|Overall Study|Lack of Efficacy|3|||
129747454|NCT01894243|467033907|FG002|Overall Study|Lack of Efficacy|1|||
129747455|NCT01894243|467033905|FG000|Overall Study|Condition under investigation worsened|8|||
129747456|NCT01894243|467033906|FG001|Overall Study|Condition under investigation worsened|6|||
129747457|NCT01894243|467033907|FG002|Overall Study|Condition under investigation worsened|2|||
129747458|NCT01894243|467033905|FG000|Overall Study|Subject decision|1|||
129747459|NCT01894243|467033906|FG001|Overall Study|Subject decision|0|||
129747460|NCT01894243|467033907|FG002|Overall Study|Subject decision|0|||
129747461|NCT01894243|467033905|FG000|Overall Study|Other|1|||
129747462|NCT01894243|467033906|FG001|Overall Study|Other|0|||
129747463|NCT01894243|467033907|FG002|Overall Study|Other|0|||
129747464|NCT01743040|467033908|FG000|Overall Study|Death|1|||
129747465|NCT01743040|467033908|FG000|Overall Study|Lost to Follow-up|66|||
129747466|NCT01743040|467033908|FG000|Overall Study|Physician Decision|40|||
129747467|NCT01743040|467033908|FG000|Overall Study|Protocol Violation|1|||
129747468|NCT01743040|467033908|FG000|Overall Study|Withdrawal by Subject|121|||
129747469|NCT00830180|467033912|FG000|Overall Study|Adverse Event|6|||
129747470|NCT00830180|467033912|FG000|Overall Study|Death|11|||
129747471|NCT00830180|467033912|FG000|Overall Study|Insufficient clinical response|1|||
129747472|NCT00830180|467033912|FG000|Overall Study|Withdrawal by Subject|5|||
129747473|NCT00830180|467033912|FG000|Overall Study|Progressive disease|2|||
129747474|NCT00830180|467033912|FG000|Overall Study|Other - Unspecified|1|||
129747475|NCT01832532|467033913|FG000|Overall Study|Withdrawal by Subject|5|||
129747476|NCT01832532|467033914|FG001|Overall Study|Withdrawal by Subject|2|||
129747477|NCT02687581|467033916|FG000|Overall Study|Withdrawal by Subject|1|||
129747478|NCT02687581|467033917|FG001|Overall Study|Withdrawal by Subject|0|||
129747479|NCT02687581|467033918|FG002|Overall Study|Withdrawal by Subject|0|||
129747480|NCT02687581|467033919|FG003|Overall Study|Withdrawal by Subject|1|||
129747481|NCT02687581|467033916|FG000|Overall Study|Lost to Follow-up|2|||
129747482|NCT02687581|467033917|FG001|Overall Study|Lost to Follow-up|2|||
129747483|NCT02687581|467033918|FG002|Overall Study|Lost to Follow-up|0|||
129747484|NCT02687581|467033919|FG003|Overall Study|Lost to Follow-up|0|||
129747485|NCT02687581|467033916|FG000|Overall Study|the device is too small for the patient.|1|||
129747486|NCT02687581|467033917|FG001|Overall Study|the device is too small for the patient.|0|||
129747487|NCT02687581|467033918|FG002|Overall Study|the device is too small for the patient.|0|||
129747488|NCT02687581|467033919|FG003|Overall Study|the device is too small for the patient.|0|||
129747489|NCT01990612|467033922|FG000|Overall Study|Lost to Follow-up|2|||
129747490|NCT01990612|467033923|FG001|Overall Study|Lost to Follow-up|1|||
129747491|NCT01990612|467033922|FG000|Overall Study|Withdrawal by Subject|5|||
129747492|NCT01990612|467033923|FG001|Overall Study|Withdrawal by Subject|2|||
129747493|NCT02974842|467033924|FG000|Overall Study|Withdrawal by Subject|4|||
129747494|NCT02974842|467033924|FG000|Overall Study|Screen failures|4|||
129747495|NCT02467582|467036123|FG000|Allocation|Withdrawal by Subject|1|||
129747496|NCT02467582|467036124|FG001|Allocation|Withdrawal by Subject|0|||
129747497|NCT02467582|467036123|FG000|Follow-up|Death|5|||
129747498|NCT02467582|467036124|FG001|Follow-up|Death|4|||
129747499|NCT02467582|467036123|FG000|Follow-up|Lost to Follow-up|6|||
129747500|NCT02467582|467036124|FG001|Follow-up|Lost to Follow-up|5|||
129747501|NCT02291419|467036125|FG000|Overall Study|Early study termination|1|||
129747502|NCT02291419|467036126|FG001|Overall Study|Early study termination|5|||
129747503|NCT00965575|467036130|FG000|Overall Study|subject unwillingness to swallow study c|1|||
129747504|NCT00965575|467036131|FG001|Overall Study|subject unwillingness to swallow study c|0|||
129747505|NCT03047031|467036140|FG000|Overall Study|Other than listed|1|||
129747506|NCT03047031|467036141|FG001|Overall Study|Other than listed|0|||
129747507|NCT03047031|467036142|FG002|Overall Study|Other than listed|0|||
129747508|NCT03047031|467036140|FG000|Overall Study|Lost to Follow-up|4|||
129747509|NCT03047031|467036141|FG001|Overall Study|Lost to Follow-up|0|||
129747510|NCT03047031|467036142|FG002|Overall Study|Lost to Follow-up|0|||
129747511|NCT03047031|467036140|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
129747512|NCT03047031|467036141|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
129747513|NCT03047031|467036142|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
129747514|NCT03047031|467036140|FG000|Overall Study|Adverse Event|1|||
129747515|NCT03047031|467036141|FG001|Overall Study|Adverse Event|0|||
129747516|NCT03047031|467036142|FG002|Overall Study|Adverse Event|0|||
129747517|NCT03047031|467036140|FG000|Overall Study|Withdrawal by Subject|2|||
129808950|NCT00347360|467265819|FG009|Overall Study|Subject left town, ran out of study drug|0|||
129808951|NCT00347360|467265820|FG010|Overall Study|Subject left town, ran out of study drug|0|||
129808952|NCT00347360|467265821|FG011|Overall Study|Subject left town, ran out of study drug|0|||
129808953|NCT00347360|467265822|FG012|Overall Study|Subject left town, ran out of study drug|0|||
129808954|NCT00347360|467265823|FG013|Overall Study|Subject left town, ran out of study drug|1|||
129747518|NCT03047031|467036141|FG001|Overall Study|Withdrawal by Subject|0|||
129747519|NCT03047031|467036142|FG002|Overall Study|Withdrawal by Subject|0|||
129895966|NCT01562743|467578644|FG000|Overall Study|Physician Decision|2|||
129895967|NCT05349864|467580386|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
129895968|NCT05349864|467580387|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
129895969|NCT02321540|467580391|FG000|Overall Study|Death|0|||
129895970|NCT02321540|467580392|FG001|Overall Study|Death|1|||
129895971|NCT02321540|467580391|FG000|Overall Study|Progression|3|||
129895972|NCT02321540|467580392|FG001|Overall Study|Progression|9|||
129895973|NCT00003656|467580397|FG000|Overall Study|Adverse Event|0|||
129895974|NCT00003656|467580398|FG001|Overall Study|Adverse Event|1|||
129895975|NCT01941316|467580399|FG000|Overall Study|Adverse Event|0|||
129895976|NCT01941316|467580400|FG001|Overall Study|Adverse Event|1|||
129895977|NCT01941316|467580401|FG002|Overall Study|Adverse Event|0|||
129895978|NCT01941316|467580402|FG003|Overall Study|Adverse Event|7|||
129895979|NCT01941316|467580399|FG000|Overall Study|Progressive Disease|3|||
129895980|NCT01941316|467580400|FG001|Overall Study|Progressive Disease|6|||
129895981|NCT01941316|467580401|FG002|Overall Study|Progressive Disease|2|||
129895982|NCT01941316|467580402|FG003|Overall Study|Progressive Disease|29|||
129895983|NCT01941316|467580399|FG000|Overall Study|Withdrawal by Subject|0|||
129895984|NCT01941316|467580400|FG001|Overall Study|Withdrawal by Subject|2|||
129895985|NCT01941316|467580401|FG002|Overall Study|Withdrawal by Subject|1|||
129895986|NCT01941316|467580402|FG003|Overall Study|Withdrawal by Subject|8|||
129895987|NCT01941316|467580399|FG000|Overall Study|Death|0|||
129895988|NCT01941316|467580400|FG001|Overall Study|Death|0|||
129895989|NCT01941316|467580401|FG002|Overall Study|Death|0|||
129895990|NCT01941316|467580402|FG003|Overall Study|Death|3|||
129895991|NCT01941316|467580399|FG000|Overall Study|Physician Decision|0|||
129895992|NCT01941316|467580400|FG001|Overall Study|Physician Decision|0|||
129895993|NCT01941316|467580401|FG002|Overall Study|Physician Decision|0|||
129895994|NCT01941316|467580402|FG003|Overall Study|Physician Decision|3|||
129895995|NCT01941316|467580399|FG000|Overall Study|Protocol Violation|0|||
129895996|NCT01941316|467580400|FG001|Overall Study|Protocol Violation|0|||
129895997|NCT01941316|467580401|FG002|Overall Study|Protocol Violation|0|||
129895998|NCT01941316|467580402|FG003|Overall Study|Protocol Violation|3|||
129895999|NCT01941316|467580399|FG000|Overall Study|Intercurrent illness|0|||
129896000|NCT01941316|467580400|FG001|Overall Study|Intercurrent illness|0|||
129896001|NCT01941316|467580401|FG002|Overall Study|Intercurrent illness|0|||
129896002|NCT01941316|467580402|FG003|Overall Study|Intercurrent illness|1|||
129896003|NCT01941316|467580399|FG000|Overall Study|Other, not specified|0|||
129896004|NCT01941316|467580400|FG001|Overall Study|Other, not specified|0|||
129896005|NCT01941316|467580401|FG002|Overall Study|Other, not specified|0|||
129896006|NCT01941316|467580402|FG003|Overall Study|Other, not specified|1|||
129896007|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
129896008|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
129896009|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
129896010|NCT03537651|467580413|FG000|Part A (Up to 96 Weeks)|Other|1|||
129747520|NCT03047031|467036140|FG000|Overall Study|Change to other medication|2|||
129747521|NCT03047031|467036141|FG001|Overall Study|Change to other medication|0|||
129747522|NCT03047031|467036142|FG002|Overall Study|Change to other medication|0|||
129747523|NCT03047031|467036140|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
129747524|NCT03047031|467036141|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
129747525|NCT03047031|467036142|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
129747526|NCT01959139|467036154|FG000|Phase II|Disease progression|0|||
129747527|NCT01959139|467036155|FG001|Phase II|Disease progression|0|||
129747528|NCT01959139|467036156|FG002|Phase II|Disease progression|26|||
129747529|NCT01959139|467036157|FG003|Phase II|Disease progression|34|||
129747530|NCT01959139|467036154|FG000|Phase II|Adverse Event|0|||
129747531|NCT01959139|467036155|FG001|Phase II|Adverse Event|0|||
129896011|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
129896012|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
129896013|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
129896014|NCT03537651|467580413|FG000|Part B (Up to 192 Weeks)|Other|1|||
129896015|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
129896016|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
129747532|NCT01959139|467036156|FG002|Phase II|Adverse Event|10|||
129747533|NCT01959139|467036157|FG003|Phase II|Adverse Event|11|||
129896017|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
129896018|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Death|3|||
129896019|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Death|0|||
129896020|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Death|0|||
129747534|NCT01959139|467036154|FG000|Phase II|Patient Refusal|0|||
129747535|NCT01959139|467036155|FG001|Phase II|Patient Refusal|0|||
129896021|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
129896022|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129896023|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
129896024|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
129747536|NCT01959139|467036156|FG002|Phase II|Patient Refusal|5|||
129747537|NCT01959139|467036157|FG003|Phase II|Patient Refusal|4|||
129747538|NCT01959139|467036154|FG000|Phase II|Death|0|||
129808955|NCT00347360|467265824|FG014|Overall Study|Subject left town, ran out of study drug|0|||
129808956|NCT00347360|467265810|FG000|Overall Study|Subject refuse to sign updated consent|0|||
129808957|NCT00347360|467265811|FG001|Overall Study|Subject refuse to sign updated consent|0|||
129808958|NCT00347360|467265812|FG002|Overall Study|Subject refuse to sign updated consent|0|||
129808959|NCT00347360|467265813|FG003|Overall Study|Subject refuse to sign updated consent|0|||
129808960|NCT00347360|467265814|FG004|Overall Study|Subject refuse to sign updated consent|0|||
129808961|NCT00347360|467265815|FG005|Overall Study|Subject refuse to sign updated consent|0|||
129808962|NCT00347360|467265816|FG006|Overall Study|Subject refuse to sign updated consent|0|||
129808963|NCT00347360|467265817|FG007|Overall Study|Subject refuse to sign updated consent|0|||
129808964|NCT00347360|467265818|FG008|Overall Study|Subject refuse to sign updated consent|0|||
129808965|NCT00347360|467265819|FG009|Overall Study|Subject refuse to sign updated consent|0|||
129808966|NCT00347360|467265820|FG010|Overall Study|Subject refuse to sign updated consent|0|||
129808967|NCT00347360|467265821|FG011|Overall Study|Subject refuse to sign updated consent|0|||
129808968|NCT00347360|467265822|FG012|Overall Study|Subject refuse to sign updated consent|0|||
129747539|NCT01959139|467036155|FG001|Phase II|Death|0|||
129808969|NCT00347360|467265823|FG013|Overall Study|Subject refuse to sign updated consent|0|||
129808970|NCT00347360|467265824|FG014|Overall Study|Subject refuse to sign updated consent|1|||
129808971|NCT00347360|467265810|FG000|Overall Study|Visits conflicted with new job|0|||
129808972|NCT00347360|467265811|FG001|Overall Study|Visits conflicted with new job|0|||
129808973|NCT00347360|467265812|FG002|Overall Study|Visits conflicted with new job|0|||
129808974|NCT00347360|467265813|FG003|Overall Study|Visits conflicted with new job|0|||
129808975|NCT00347360|467265814|FG004|Overall Study|Visits conflicted with new job|0|||
129808976|NCT00347360|467265815|FG005|Overall Study|Visits conflicted with new job|0|||
129808977|NCT00347360|467265816|FG006|Overall Study|Visits conflicted with new job|1|||
129808978|NCT00347360|467265817|FG007|Overall Study|Visits conflicted with new job|0|||
129808979|NCT00347360|467265818|FG008|Overall Study|Visits conflicted with new job|0|||
129808980|NCT00347360|467265819|FG009|Overall Study|Visits conflicted with new job|0|||
129808981|NCT00347360|467265820|FG010|Overall Study|Visits conflicted with new job|0|||
129808982|NCT00347360|467265821|FG011|Overall Study|Visits conflicted with new job|0|||
129808983|NCT00347360|467265822|FG012|Overall Study|Visits conflicted with new job|0|||
129808984|NCT00347360|467265823|FG013|Overall Study|Visits conflicted with new job|0|||
129808985|NCT00347360|467265824|FG014|Overall Study|Visits conflicted with new job|0|||
129808986|NCT01449539|467265825|FG000|Overall Study|Withdrawal by Subject|3|||
129808987|NCT01449539|467265825|FG000|Overall Study|Toxicity not study related|1|||
129808988|NCT02187744|467265828|FG000|Study|Participant refused further follow-up|1|||
129808989|NCT02187744|467265829|FG001|Study|Participant refused further follow-up|0|||
129808990|NCT02187744|467265828|FG000|Study|Other|2|||
129808991|NCT02187744|467265829|FG001|Study|Other|1|||
129808992|NCT02187744|467265828|FG000|Study|Lost to Follow-up|0|||
129808993|NCT02187744|467265829|FG001|Study|Lost to Follow-up|2|||
129808994|NCT02187744|467265828|FG000|Study|Related adverse event, not serious|0|||
129808995|NCT02187744|467265829|FG001|Study|Related adverse event, not serious|2|||
129808996|NCT02187744|467265828|FG000|Study|Death|1|||
129747540|NCT01959139|467036156|FG002|Phase II|Death|3|||
129747541|NCT01959139|467036157|FG003|Phase II|Death|1|||
129747542|NCT01959139|467036154|FG000|Phase II|Other/Unknown|0|||
129747543|NCT01959139|467036155|FG001|Phase II|Other/Unknown|0|||
129747544|NCT01959139|467036156|FG002|Phase II|Other/Unknown|8|||
129747545|NCT01959139|467036157|FG003|Phase II|Other/Unknown|5|||
129747546|NCT01959139|467036154|FG000|Phase II|On treatment|0|||
129747547|NCT01959139|467036155|FG001|Phase II|On treatment|0|||
129747548|NCT01959139|467036156|FG002|Phase II|On treatment|4|||
129747549|NCT01959139|467036157|FG003|Phase II|On treatment|0|||
129747550|NCT00630344|467036160|FG000|Overall Study|Adverse Event|5|||
129747551|NCT00630344|467036160|FG000|Overall Study|Progressive Disease|19|||
129747552|NCT00630344|467036160|FG000|Overall Study|Physician Decision|9|||
129747553|NCT00630344|467036160|FG000|Overall Study|Withdrawal by Subject|1|||
129747554|NCT00630344|467036160|FG000|Overall Study|Intercurrent Illness|1|||
129747555|NCT00630344|467036160|FG000|Overall Study|Other|1|||
129747556|NCT05362058|467036161|FG000|Treatment Period|Adverse Event|3|||
129747557|NCT05362058|467036162|FG001|Treatment Period|Adverse Event|3|||
129808997|NCT02187744|467265829|FG001|Study|Death|0|||
129808998|NCT02187744|467265828|FG000|Study|Related adverse event, serious non-fatal|0|||
129808999|NCT02187744|467265829|FG001|Study|Related adverse event, serious non-fatal|1|||
129809000|NCT02187744|467265828|FG000|Treatment|Death|1|||
129809001|NCT02187744|467265829|FG001|Treatment|Death|0|||
129747558|NCT05362058|467036161|FG000|Treatment Period|Assigned treatment by mistake|3|||
129809002|NCT02187744|467265828|FG000|Treatment|Related adverse event, serious non-fatal|0|||
129747559|NCT05362058|467036162|FG001|Treatment Period|Assigned treatment by mistake|4|||
129747560|NCT05362058|467036161|FG000|Treatment Period|Death|1|||
129747561|NCT05362058|467036162|FG001|Treatment Period|Death|1|||
129747562|NCT05362058|467036161|FG000|Treatment Period|Lost to Follow-up|6|||
129747563|NCT05362058|467036162|FG001|Treatment Period|Lost to Follow-up|3|||
129747564|NCT05362058|467036161|FG000|Treatment Period|Non-compliance with study drug|0|||
129747565|NCT05362058|467036162|FG001|Treatment Period|Non-compliance with study drug|1|||
129747566|NCT05362058|467036161|FG000|Treatment Period|Physician Decision|1|||
129747567|NCT05362058|467036162|FG001|Treatment Period|Physician Decision|0|||
129747568|NCT05362058|467036161|FG000|Treatment Period|Protocol deviation|1|||
129747569|NCT05362058|467036162|FG001|Treatment Period|Protocol deviation|0|||
129747570|NCT05362058|467036161|FG000|Treatment Period|Withdrawal by Subject|10|||
129747571|NCT05362058|467036162|FG001|Treatment Period|Withdrawal by Subject|11|||
129747572|NCT05362058|467036161|FG000|Follow-Up Period|Death|1|||
129747573|NCT05362058|467036162|FG001|Follow-Up Period|Death|0|||
129747574|NCT05362058|467036161|FG000|Follow-Up Period|Lost to Follow-up|2|||
129747575|NCT05362058|467036162|FG001|Follow-Up Period|Lost to Follow-up|1|||
129747576|NCT05362058|467036161|FG000|Follow-Up Period|Protocol deviation|1|||
129747577|NCT05362058|467036162|FG001|Follow-Up Period|Protocol deviation|1|||
129747578|NCT05362058|467036161|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129747579|NCT05362058|467036162|FG001|Follow-Up Period|Withdrawal by Subject|3|||
129747580|NCT01964963|467036165|FG000|Overall Study|Case Report Forms Uncollected|888|||
129747581|NCT01964963|467036165|FG000|Overall Study|Protocol Deviation|50|||
129747582|NCT01964963|467036165|FG000|Overall Study|Data Reliability was not Assured|5|||
129747583|NCT00930553|467036166|FG000|Overall Study|Adverse Event|1|||
129747584|NCT00930553|467036166|FG000|Overall Study|Lack of Efficacy|7|||
129747585|NCT00930553|467036166|FG000|Overall Study|Physician Decision|39|||
129747586|NCT00930553|467036166|FG000|Overall Study|Protocol Violation|1|||
129747587|NCT00930553|467036166|FG000|Overall Study|Pregnancy|1|||
129747588|NCT00930553|467036166|FG000|Overall Study|Withdrawal by Subject|88|||
129747589|NCT00930553|467036166|FG000|Overall Study|Lost to Follow-up|25|||
129747590|NCT00930553|467036166|FG000|Overall Study|Death|9|||
129747591|NCT00930553|467036166|FG000|Overall Study|Study terminated by sponsor|24|||
129747592|NCT00930553|467036166|FG000|Overall Study|Other than specified above|28|||
129747593|NCT00856544|467036175|FG000|Overall Study|Randomized but not treated|3|||
129747594|NCT00856544|467036176|FG001|Overall Study|Randomized but not treated|0|||
129747595|NCT00856544|467036177|FG002|Overall Study|Randomized but not treated|0|||
129747596|NCT00856544|467036178|FG003|Overall Study|Randomized but not treated|0|||
129747597|NCT00856544|467036175|FG000|Overall Study|Death|0|||
129747598|NCT00856544|467036176|FG001|Overall Study|Death|2|||
129747599|NCT00856544|467036177|FG002|Overall Study|Death|0|||
129747600|NCT00856544|467036178|FG003|Overall Study|Death|0|||
129747601|NCT00856544|467036175|FG000|Overall Study|Adverse Event|20|||
129747602|NCT00856544|467036176|FG001|Overall Study|Adverse Event|29|||
129747603|NCT00856544|467036177|FG002|Overall Study|Adverse Event|2|||
129747604|NCT00856544|467036178|FG003|Overall Study|Adverse Event|3|||
129747605|NCT00856544|467036175|FG000|Overall Study|Lack of Efficacy|16|||
129747606|NCT00856544|467036176|FG001|Overall Study|Lack of Efficacy|12|||
129747607|NCT00856544|467036177|FG002|Overall Study|Lack of Efficacy|3|||
129747608|NCT00856544|467036178|FG003|Overall Study|Lack of Efficacy|3|||
129747609|NCT00856544|467036175|FG000|Overall Study|Other|9|||
129747610|NCT00856544|467036176|FG001|Overall Study|Other|16|||
129747611|NCT00856544|467036177|FG002|Overall Study|Other|1|||
129747612|NCT00856544|467036178|FG003|Overall Study|Other|6|||
129747613|NCT00856544|467036175|FG000|Overall Study|Lost to Follow-up|1|||
129747614|NCT00856544|467036176|FG001|Overall Study|Lost to Follow-up|2|||
129747615|NCT00856544|467036177|FG002|Overall Study|Lost to Follow-up|2|||
129896025|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
129896026|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
129896027|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
129896028|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
129896029|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
129747616|NCT00856544|467036178|FG003|Overall Study|Lost to Follow-up|0|||
129896030|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
129896031|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
129747617|NCT00856544|467036175|FG000|Overall Study|Withdrawal by Subject|8|||
129747618|NCT00856544|467036176|FG001|Overall Study|Withdrawal by Subject|5|||
129747619|NCT00856544|467036177|FG002|Overall Study|Withdrawal by Subject|0|||
129747620|NCT00856544|467036178|FG003|Overall Study|Withdrawal by Subject|1|||
129747621|NCT00787189|467036179|FG000|Overall Study|Lost to Follow-up|2|||
129747622|NCT00787189|467036180|FG001|Overall Study|Lost to Follow-up|2|||
129747623|NCT00286494|467036181|FG000|Overall Study|Hyperglycemic rescue|12|||
129747624|NCT00286494|467036182|FG001|Overall Study|Hyperglycemic rescue|19|||
129747625|NCT00286494|467036183|FG002|Overall Study|Hyperglycemic rescue|18|||
129747626|NCT00286494|467036181|FG000|Overall Study|Withdrawal by Subject|2|||
129747627|NCT00286494|467036182|FG001|Overall Study|Withdrawal by Subject|10|||
129747628|NCT00286494|467036183|FG002|Overall Study|Withdrawal by Subject|9|||
129747629|NCT00286494|467036181|FG000|Overall Study|Adverse Event|3|||
129747630|NCT00286494|467036182|FG001|Overall Study|Adverse Event|8|||
129747631|NCT00286494|467036183|FG002|Overall Study|Adverse Event|6|||
129747632|NCT00286494|467036181|FG000|Overall Study|Physician Decision|5|||
129747633|NCT00286494|467036182|FG001|Overall Study|Physician Decision|5|||
129747634|NCT00286494|467036183|FG002|Overall Study|Physician Decision|1|||
129896032|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
129896033|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
129896034|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
129896035|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
129896036|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Other|1|||
129896037|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Other|0|||
129896038|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Other|0|||
129896039|NCT02403323|467580414|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
129896040|NCT02403323|467580415|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129896041|NCT02403323|467580416|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
129896042|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129896043|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
129896044|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
129896045|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
129896046|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
129896047|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
129896048|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
129896049|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
129896050|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
129896051|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129896052|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
129896053|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
129896054|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
129896055|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
129896056|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
129896057|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
129896058|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
129896059|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
129896060|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
129896061|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
129896062|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
129896063|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
129896064|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
129896065|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
129896066|NCT02403323|467580414|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
129896067|NCT02403323|467580415|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
129896068|NCT02403323|467580416|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
129896069|NCT00197236|467580420|FG000|Overall Study|Adverse Event|1|||
129896070|NCT00197236|467580421|FG001|Overall Study|Adverse Event|0|||
129896071|NCT00197236|467580422|FG002|Overall Study|Adverse Event|1|||
129896072|NCT00197236|467580420|FG000|Overall Study|Lost to Follow-up|5|||
129896073|NCT00197236|467580421|FG001|Overall Study|Lost to Follow-up|14|||
129896074|NCT00197236|467580422|FG002|Overall Study|Lost to Follow-up|6|||
129896075|NCT00197236|467580420|FG000|Overall Study|Protocol Violation|0|||
129896076|NCT00197236|467580421|FG001|Overall Study|Protocol Violation|0|||
129896077|NCT00197236|467580422|FG002|Overall Study|Protocol Violation|1|||
129896078|NCT00197236|467580420|FG000|Overall Study|Withdrawal by Subject|7|||
129896079|NCT00197236|467580421|FG001|Overall Study|Withdrawal by Subject|3|||
129896080|NCT00197236|467580422|FG002|Overall Study|Withdrawal by Subject|11|||
129896081|NCT00197236|467580420|FG000|Overall Study|Study drug/medication expiration|1|||
129896082|NCT00197236|467580421|FG001|Overall Study|Study drug/medication expiration|0|||
129896083|NCT00197236|467580422|FG002|Overall Study|Study drug/medication expiration|3|||
129896084|NCT00197236|467580420|FG000|Overall Study|Returned out of specified time window|0|||
129896085|NCT00197236|467580421|FG001|Overall Study|Returned out of specified time window|0|||
129896086|NCT00197236|467580422|FG002|Overall Study|Returned out of specified time window|1|||
129896087|NCT03885596|467580423|FG000|Overall Study|Withdrawal by Subject|2|||
129896088|NCT03885596|467580424|FG001|Overall Study|Withdrawal by Subject|1|||
129896089|NCT03885596|467580425|FG002|Overall Study|Withdrawal by Subject|0|||
129896090|NCT03885596|467580426|FG003|Overall Study|Withdrawal by Subject|0|||
129896091|NCT03852433|467580427|FG000|Overall Study|Withdrawal of consent|5|||
129747635|NCT00286494|467036181|FG000|Overall Study|Lost to Follow-up|3|||
129747636|NCT00286494|467036182|FG001|Overall Study|Lost to Follow-up|1|||
129747637|NCT00286494|467036183|FG002|Overall Study|Lost to Follow-up|3|||
129896092|NCT03852433|467580428|FG001|Overall Study|Withdrawal of consent|8|||
129896093|NCT03852433|467580429|FG002|Overall Study|Withdrawal of consent|1|||
129896094|NCT03852433|467580430|FG003|Overall Study|Withdrawal of consent|1|||
129896095|NCT03852433|467580427|FG000|Overall Study|Adverse Event|1|||
129747638|NCT00286494|467036181|FG000|Overall Study|Protocol Violation|1|||
129747639|NCT00286494|467036182|FG001|Overall Study|Protocol Violation|1|||
129747640|NCT00286494|467036183|FG002|Overall Study|Protocol Violation|2|||
129747641|NCT00296140|467036184|FG000|Overall Study|Lost to Follow-up|1|||
129747642|NCT00296140|467036185|FG001|Overall Study|Lost to Follow-up|0|||
129747643|NCT00296140|467036184|FG000|Overall Study|Withdrawal by Subject|1|||
129747644|NCT00296140|467036185|FG001|Overall Study|Withdrawal by Subject|0|||
129747645|NCT00296140|467036184|FG000|Overall Study|Discharge to Nursing Home|1|||
129747646|NCT00296140|467036185|FG001|Overall Study|Discharge to Nursing Home|0|||
129747647|NCT01856582|467036189|FG000|Overall Study|Died prior to Boost infusion|1|||
129747648|NCT00596830|467036190|FG000|Overall Study|Death|258|||
129747649|NCT00596830|467036191|FG001|Overall Study|Death|247|||
129747650|NCT00596830|467036190|FG000|Overall Study|Lost to Follow-up|7|||
129747651|NCT00596830|467036191|FG001|Overall Study|Lost to Follow-up|11|||
129747652|NCT00596830|467036190|FG000|Overall Study|Withdrawal by Subject|22|||
129747653|NCT00596830|467036191|FG001|Overall Study|Withdrawal by Subject|12|||
129747654|NCT00596830|467036190|FG000|Overall Study|Study terminated by sponsor|51|||
129747655|NCT00596830|467036191|FG001|Overall Study|Study terminated by sponsor|62|||
129747656|NCT00596830|467036190|FG000|Overall Study|Follow-up was discontinued|1|||
129747657|NCT00596830|467036191|FG001|Overall Study|Follow-up was discontinued|0|||
129747658|NCT00596830|467036190|FG000|Overall Study|Randomized but not treated|3|||
129747659|NCT00596830|467036191|FG001|Overall Study|Randomized but not treated|7|||
129747660|NCT00887926|467036192|FG000|Overall Study|Withdrawal by Subject|0|||
129747661|NCT00887926|467036193|FG001|Overall Study|Withdrawal by Subject|1|||
129747662|NCT00887926|467036194|FG002|Overall Study|Withdrawal by Subject|0|||
129747663|NCT00887926|467036195|FG003|Overall Study|Withdrawal by Subject|0|||
129747664|NCT00880191|467036196|FG000|Overall Study|Refused further treatment|4|||
129747665|NCT00880191|467036197|FG001|Overall Study|Refused further treatment|1|||
129747666|NCT00880191|467036196|FG000|Overall Study|Adverse Event|8|||
129747667|NCT00880191|467036197|FG001|Overall Study|Adverse Event|6|||
129747668|NCT00880191|467036196|FG000|Overall Study|Hospitalization/efficacy|1|||
129747669|NCT00880191|467036197|FG001|Overall Study|Hospitalization/efficacy|1|||
129747670|NCT02097030|467036198|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
129747671|NCT02097030|467036199|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
129747672|NCT02097030|467036198|FG000|First Intervention (3 Days)|Visual Acuity|0|||
129747673|NCT02097030|467036199|FG001|First Intervention (3 Days)|Visual Acuity|1|||
129747674|NCT01919801|467036200|FG000|Overall Study|Withdrawal by Subject|1|||
129747675|NCT01919801|467036201|FG001|Overall Study|Withdrawal by Subject|0|||
129747676|NCT01919801|467036200|FG000|Overall Study|Physician Decision|0|||
129747677|NCT01919801|467036201|FG001|Overall Study|Physician Decision|1|||
129747678|NCT01919801|467036200|FG000|Overall Study|Lost to Follow-up|0|||
129747679|NCT01919801|467036201|FG001|Overall Study|Lost to Follow-up|1|||
129747680|NCT01919801|467036200|FG000|Overall Study|Other|0|||
129747681|NCT01919801|467036201|FG001|Overall Study|Other|1|||
129747682|NCT01843062|467036202|FG000|Overall Study|Protocol Violation|1|||
129747683|NCT01843062|467036203|FG001|Overall Study|Protocol Violation|0|||
129747684|NCT01843062|467036202|FG000|Overall Study|New treatment following progression|2|||
129747685|NCT01843062|467036203|FG001|Overall Study|New treatment following progression|0|||
129747686|NCT01843062|467036202|FG000|Overall Study|Pregnancy|1|||
129747687|NCT01843062|467036203|FG001|Overall Study|Pregnancy|0|||
129747688|NCT01843062|467036202|FG000|Overall Study|Adverse Event|2|||
129747689|NCT01843062|467036203|FG001|Overall Study|Adverse Event|0|||
129747690|NCT01843062|467036202|FG000|Overall Study|Incorrect randomisation|1|||
129747691|NCT01843062|467036203|FG001|Overall Study|Incorrect randomisation|0|||
129747692|NCT01843062|467036202|FG000|Overall Study|Withdrawal by Subject|12|||
129747693|NCT01843062|467036203|FG001|Overall Study|Withdrawal by Subject|3|||
129747694|NCT01843062|467036202|FG000|Overall Study|Death|1|||
129747695|NCT01843062|467036203|FG001|Overall Study|Death|2|||
129747696|NCT01843062|467036202|FG000|Overall Study|Lost to Follow-up|2|||
129747697|NCT01843062|467036203|FG001|Overall Study|Lost to Follow-up|4|||
129747698|NCT01677858|467036204|FG000|Overall Study|Adverse Event|0|||
129747699|NCT01677858|467036205|FG001|Overall Study|Adverse Event|0|||
129747700|NCT01677858|467036206|FG002|Overall Study|Adverse Event|2|||
129747701|NCT01677858|467036207|FG003|Overall Study|Adverse Event|3|||
129747702|NCT01677858|467036208|FG004|Overall Study|Adverse Event|13|||
129747703|NCT01677858|467036204|FG000|Overall Study|Death|0|||
129747704|NCT01677858|467036205|FG001|Overall Study|Death|0|||
129747705|NCT01677858|467036206|FG002|Overall Study|Death|0|||
129747706|NCT01677858|467036207|FG003|Overall Study|Death|0|||
129747707|NCT01677858|467036208|FG004|Overall Study|Death|1|||
129747708|NCT01677858|467036204|FG000|Overall Study|Physician Decision|1|||
129747709|NCT01677858|467036205|FG001|Overall Study|Physician Decision|0|||
129747710|NCT01677858|467036206|FG002|Overall Study|Physician Decision|2|||
129747711|NCT01677858|467036207|FG003|Overall Study|Physician Decision|0|||
129747712|NCT01677858|467036208|FG004|Overall Study|Physician Decision|12|||
129747713|NCT01677858|467036204|FG000|Overall Study|Progressive Disease|2|||
129747714|NCT01677858|467036205|FG001|Overall Study|Progressive Disease|1|||
129747715|NCT01677858|467036206|FG002|Overall Study|Progressive Disease|9|||
129747716|NCT01677858|467036207|FG003|Overall Study|Progressive Disease|3|||
129747717|NCT01677858|467036208|FG004|Overall Study|Progressive Disease|43|||
129747718|NCT01677858|467036204|FG000|Overall Study|Withdrawal by Subject|0|||
129747719|NCT01677858|467036205|FG001|Overall Study|Withdrawal by Subject|1|||
129896096|NCT03852433|467580428|FG001|Overall Study|Adverse Event|1|||
129896097|NCT03852433|467580429|FG002|Overall Study|Adverse Event|1|||
129896098|NCT03852433|467580430|FG003|Overall Study|Adverse Event|1|||
129896099|NCT03852433|467580427|FG000|Overall Study|Lost to Follow-up|0|||
129896100|NCT03852433|467580428|FG001|Overall Study|Lost to Follow-up|1|||
129747720|NCT01677858|467036206|FG002|Overall Study|Withdrawal by Subject|1|||
129747721|NCT01677858|467036207|FG003|Overall Study|Withdrawal by Subject|0|||
129747722|NCT01677858|467036208|FG004|Overall Study|Withdrawal by Subject|15|||
129747723|NCT01677858|467036204|FG000|Overall Study|Lost to Follow-up|0|||
129747724|NCT01677858|467036205|FG001|Overall Study|Lost to Follow-up|0|||
129747725|NCT01677858|467036206|FG002|Overall Study|Lost to Follow-up|0|||
129747726|NCT01677858|467036207|FG003|Overall Study|Lost to Follow-up|0|||
129747727|NCT01677858|467036208|FG004|Overall Study|Lost to Follow-up|1|||
129747728|NCT00773747|467036209|FG000|Overall Study|Lack of Efficacy|112|||
129747729|NCT00773747|467036210|FG001|Overall Study|Lack of Efficacy|144|||
129747730|NCT00773747|467036209|FG000|Overall Study|Physician Decision|26|||
129747731|NCT00773747|467036210|FG001|Overall Study|Physician Decision|18|||
129747732|NCT00773747|467036209|FG000|Overall Study|Lost to Follow-up|0|||
129747733|NCT00773747|467036210|FG001|Overall Study|Lost to Follow-up|1|||
129747734|NCT00773747|467036209|FG000|Overall Study|Protocol Violation|2|||
129747735|NCT00773747|467036210|FG001|Overall Study|Protocol Violation|2|||
129747736|NCT00773747|467036209|FG000|Overall Study|Withdrawal by Subject|89|||
129747737|NCT00773747|467036210|FG001|Overall Study|Withdrawal by Subject|61|||
129747738|NCT00773747|467036209|FG000|Overall Study|Adverse Event|61|||
129747739|NCT00773747|467036210|FG001|Overall Study|Adverse Event|62|||
129747740|NCT00773747|467036209|FG000|Overall Study|Death|5|||
129747741|NCT00773747|467036210|FG001|Overall Study|Death|8|||
129747742|NCT00773747|467036209|FG000|Overall Study|Not Treated|2|||
129747743|NCT00773747|467036210|FG001|Overall Study|Not Treated|0|||
129747744|NCT02669212|467036213|FG000|Overall Study|Lost to Follow-up|1|||
129747745|NCT02669212|467036214|FG001|Overall Study|Lost to Follow-up|0|||
129747746|NCT02669212|467036213|FG000|Overall Study|Medical Condition|3|||
129747747|NCT02669212|467036214|FG001|Overall Study|Medical Condition|4|||
129747748|NCT02669212|467036213|FG000|Overall Study|Withdrawal by Subject|0|||
129747749|NCT02669212|467036214|FG001|Overall Study|Withdrawal by Subject|2|||
129747750|NCT02669212|467036213|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
129747751|NCT02669212|467036214|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
129747752|NCT03549104|467036215|FG000|Overall Study|Withdrawal by Subject|5|||
129747753|NCT03549104|467036216|FG001|Overall Study|Withdrawal by Subject|2|||
129747754|NCT03549104|467036215|FG000|Overall Study|Covid shelter in place|1|||
129747755|NCT03549104|467036216|FG001|Overall Study|Covid shelter in place|2|||
129747756|NCT03078855|467036217|FG000|Overall Study|Lack of Efficacy|62|||
129747757|NCT03078855|467036218|FG001|Overall Study|Lack of Efficacy|31|||
129747758|NCT03078855|467036217|FG000|Overall Study|Death|1|||
129747759|NCT03078855|467036218|FG001|Overall Study|Death|0|||
129747760|NCT03078855|467036217|FG000|Overall Study|Withdrawal by Subject|12|||
129747761|NCT03078855|467036218|FG001|Overall Study|Withdrawal by Subject|6|||
129747762|NCT03078855|467036217|FG000|Overall Study|Physician Decision|3|||
129747763|NCT03078855|467036218|FG001|Overall Study|Physician Decision|2|||
129747764|NCT03078855|467036217|FG000|Overall Study|Second Malignancy|4|||
129747765|NCT03078855|467036218|FG001|Overall Study|Second Malignancy|0|||
129747766|NCT03078855|467036217|FG000|Overall Study|Ineligible|2|||
129747767|NCT03078855|467036218|FG001|Overall Study|Ineligible|0|||
129747768|NCT03078855|467036217|FG000|Overall Study|Withdrew before day 1 treatment|2|||
129747769|NCT03078855|467036218|FG001|Overall Study|Withdrew before day 1 treatment|1|||
129747770|NCT00391027|467036219|FG000|Overall Study|Adverse Event|8|||
129747771|NCT00391027|467036220|FG001|Overall Study|Adverse Event|8|||
129747772|NCT00391027|467036219|FG000|Overall Study|Lack of Efficacy|3|||
129747773|NCT00391027|467036220|FG001|Overall Study|Lack of Efficacy|0|||
129747774|NCT00391027|467036219|FG000|Overall Study|Withdrawal by Subject|10|||
129747775|NCT00391027|467036220|FG001|Overall Study|Withdrawal by Subject|1|||
129747776|NCT00391027|467036219|FG000|Overall Study|Other|4|||
129747777|NCT00391027|467036220|FG001|Overall Study|Other|3|||
129747778|NCT01846741|467036228|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
129747779|NCT01628965|467036229|FG000|Overall Study|Adverse Event|30|||
129747780|NCT01628965|467036229|FG000|Overall Study|Lack of Efficacy|7|||
129747781|NCT01628965|467036229|FG000|Overall Study|Withdrawal by Subject|3|||
129747782|NCT01628965|467036229|FG000|Overall Study|Lost to Follow-up|1|||
129896101|NCT03852433|467580429|FG002|Overall Study|Lost to Follow-up|0|||
129896102|NCT03852433|467580430|FG003|Overall Study|Lost to Follow-up|1|||
129896103|NCT03852433|467580427|FG000|Overall Study|Pregnancy|0|||
129747783|NCT01628965|467036229|FG000|Overall Study|Discontinuation criteria|8|||
129747784|NCT00360568|467036231|FG000|Overall Study|Adverse Event|1|||
129747785|NCT00360568|467036232|FG001|Overall Study|Adverse Event|2|||
129747786|NCT00360568|467036231|FG000|Overall Study|Lack of Efficacy|1|||
129747787|NCT00360568|467036232|FG001|Overall Study|Lack of Efficacy|0|||
129896104|NCT03852433|467580428|FG001|Overall Study|Pregnancy|1|||
129747788|NCT00360568|467036231|FG000|Overall Study|Withdrawal by Subject|0|||
129747789|NCT00360568|467036232|FG001|Overall Study|Withdrawal by Subject|3|||
129747790|NCT04006392|467036233|FG000|Overall Study|Lost to Follow-up|0|||
129747791|NCT04006392|467036234|FG001|Overall Study|Lost to Follow-up|1|||
129747792|NCT03824587|467036235|FG000|Run-in Period|Screen Failure|0|||
129747793|NCT03824587|467036236|FG001|Run-in Period|Screen Failure|275|||
129747794|NCT03824587|467036235|FG000|Treatment Period|Adverse Event|4|||
129747795|NCT03824587|467036236|FG001|Treatment Period|Adverse Event|1|||
129747796|NCT03824587|467036235|FG000|Treatment Period|Withdrawal by Subject|0|||
129747797|NCT03824587|467036236|FG001|Treatment Period|Withdrawal by Subject|1|||
129747798|NCT03824587|467036235|FG000|Treatment Period|Kidney Transplant|1|||
129747799|NCT03824587|467036236|FG001|Treatment Period|Kidney Transplant|1|||
129747800|NCT00986362|467036237|FG000|Overall Study|Death|2|||
129747801|NCT00986362|467036238|FG001|Overall Study|Death|0|||
129747802|NCT00986362|467036237|FG000|Overall Study|Lost to Follow-up|0|||
129747803|NCT00986362|467036238|FG001|Overall Study|Lost to Follow-up|1|||
129747804|NCT02006979|467036239|FG000|Overall Study|Withdrawal by Subject|1|||
129747805|NCT02006979|467036240|FG001|Overall Study|Withdrawal by Subject|1|||
129747806|NCT02006979|467036239|FG000|Overall Study|Protocol Violation|0|||
129747807|NCT02006979|467036240|FG001|Overall Study|Protocol Violation|1|||
129747808|NCT03170193|467036241|FG000|Overall Study|Withdrawal by Subject|0|||
129747809|NCT03170193|467036242|FG001|Overall Study|Withdrawal by Subject|0|||
129747810|NCT03170193|467036243|FG002|Overall Study|Withdrawal by Subject|0|||
129747811|NCT03170193|467036244|FG003|Overall Study|Withdrawal by Subject|1|||
129747812|NCT03170193|467036245|FG004|Overall Study|Withdrawal by Subject|0|||
129747813|NCT03170193|467036246|FG005|Overall Study|Withdrawal by Subject|0|||
129747814|NCT03170193|467036247|FG006|Overall Study|Withdrawal by Subject|0|||
129747815|NCT03170193|467036241|FG000|Overall Study|Lost to Follow-up|1|||
129747816|NCT03170193|467036242|FG001|Overall Study|Lost to Follow-up|1|||
129747817|NCT03170193|467036243|FG002|Overall Study|Lost to Follow-up|0|||
129747818|NCT03170193|467036244|FG003|Overall Study|Lost to Follow-up|0|||
129747819|NCT03170193|467036245|FG004|Overall Study|Lost to Follow-up|0|||
129747820|NCT03170193|467036246|FG005|Overall Study|Lost to Follow-up|0|||
129747821|NCT03170193|467036247|FG006|Overall Study|Lost to Follow-up|0|||
129747822|NCT01368081|467036248|FG000|Overall Study|Adverse Event|4|||
129747823|NCT01368081|467036249|FG001|Overall Study|Adverse Event|4|||
129747824|NCT01368081|467036250|FG002|Overall Study|Adverse Event|3|||
129747825|NCT01368081|467036251|FG003|Overall Study|Adverse Event|2|||
129747826|NCT01368081|467036252|FG004|Overall Study|Adverse Event|2|||
129747827|NCT01368081|467036253|FG005|Overall Study|Adverse Event|5|||
129747828|NCT01368081|467036254|FG006|Overall Study|Adverse Event|6|||
129747829|NCT01368081|467036255|FG007|Overall Study|Adverse Event|2|||
129747830|NCT01368081|467036256|FG008|Overall Study|Adverse Event|3|||
129747831|NCT01368081|467036257|FG009|Overall Study|Adverse Event|5|||
129747832|NCT01368081|467036258|FG010|Overall Study|Adverse Event|6|||
129747833|NCT01368081|467036259|FG011|Overall Study|Adverse Event|1|||
129747834|NCT01368081|467036260|FG012|Overall Study|Adverse Event|3|||
129747835|NCT01368081|467036248|FG000|Overall Study|Lack of Efficacy|0|||
129747836|NCT01368081|467036249|FG001|Overall Study|Lack of Efficacy|1|||
129747837|NCT01368081|467036250|FG002|Overall Study|Lack of Efficacy|0|||
129747838|NCT01368081|467036251|FG003|Overall Study|Lack of Efficacy|1|||
129747839|NCT01368081|467036252|FG004|Overall Study|Lack of Efficacy|0|||
129747840|NCT01368081|467036253|FG005|Overall Study|Lack of Efficacy|0|||
129747841|NCT01368081|467036254|FG006|Overall Study|Lack of Efficacy|0|||
129747842|NCT01368081|467036255|FG007|Overall Study|Lack of Efficacy|2|||
129747843|NCT01368081|467036256|FG008|Overall Study|Lack of Efficacy|0|||
129747844|NCT01368081|467036257|FG009|Overall Study|Lack of Efficacy|0|||
129747845|NCT01368081|467036258|FG010|Overall Study|Lack of Efficacy|0|||
129747846|NCT01368081|467036259|FG011|Overall Study|Lack of Efficacy|0|||
129747847|NCT01368081|467036260|FG012|Overall Study|Lack of Efficacy|0|||
129747848|NCT01368081|467036248|FG000|Overall Study|Protocol Violation|0|||
129896105|NCT03852433|467580429|FG002|Overall Study|Pregnancy|1|||
129896106|NCT03852433|467580430|FG003|Overall Study|Pregnancy|0|||
129896107|NCT03852433|467580427|FG000|Overall Study|Protocol Violation|0|||
129896108|NCT03852433|467580428|FG001|Overall Study|Protocol Violation|0|||
129896109|NCT03852433|467580429|FG002|Overall Study|Protocol Violation|1|||
129896110|NCT03852433|467580430|FG003|Overall Study|Protocol Violation|1|||
129896111|NCT03852433|467580427|FG000|Overall Study|Death|0|||
129896112|NCT03852433|467580428|FG001|Overall Study|Death|0|||
129747849|NCT01368081|467036249|FG001|Overall Study|Protocol Violation|0|||
129896113|NCT03852433|467580429|FG002|Overall Study|Death|1|||
129896114|NCT03852433|467580430|FG003|Overall Study|Death|0|||
129896115|NCT03852433|467580427|FG000|Overall Study|Lack of Efficacy|0|||
129747850|NCT01368081|467036250|FG002|Overall Study|Protocol Violation|0|||
129747851|NCT01368081|467036251|FG003|Overall Study|Protocol Violation|0|||
129747852|NCT01368081|467036252|FG004|Overall Study|Protocol Violation|0|||
129747853|NCT01368081|467036253|FG005|Overall Study|Protocol Violation|1|||
129896116|NCT03852433|467580428|FG001|Overall Study|Lack of Efficacy|1|||
129896117|NCT03852433|467580429|FG002|Overall Study|Lack of Efficacy|0|||
129896118|NCT03852433|467580430|FG003|Overall Study|Lack of Efficacy|0|||
129896119|NCT03852433|467580427|FG000|Overall Study|Non-compliance with study drug|0|||
129747854|NCT01368081|467036254|FG006|Overall Study|Protocol Violation|0|||
129747855|NCT01368081|467036255|FG007|Overall Study|Protocol Violation|1|||
129747856|NCT01368081|467036256|FG008|Overall Study|Protocol Violation|0|||
129896120|NCT03852433|467580428|FG001|Overall Study|Non-compliance with study drug|0|||
129896121|NCT03852433|467580429|FG002|Overall Study|Non-compliance with study drug|0|||
129896122|NCT03852433|467580430|FG003|Overall Study|Non-compliance with study drug|1|||
129896123|NCT03852433|467580427|FG000|Overall Study|Physician Decision|1|||
129896124|NCT03852433|467580428|FG001|Overall Study|Physician Decision|0|||
129896125|NCT03852433|467580429|FG002|Overall Study|Physician Decision|0|||
129896126|NCT03852433|467580430|FG003|Overall Study|Physician Decision|0|||
129896127|NCT03852433|467580427|FG000|Overall Study|Randomized but never treated|1|||
129896128|NCT03852433|467580428|FG001|Overall Study|Randomized but never treated|0|||
129896129|NCT03852433|467580429|FG002|Overall Study|Randomized but never treated|0|||
129896130|NCT03852433|467580430|FG003|Overall Study|Randomized but never treated|0|||
129896131|NCT01076335|467580431|FG000|Overall Study|Withdrawal by Subject|3|||
129896132|NCT01076335|467580431|FG000|Overall Study|Withdrawal without treatment|1|||
129896133|NCT01835899|467580433|FG000|Overall Study|Adverse Event|0|||
129896134|NCT01835899|467580434|FG001|Overall Study|Adverse Event|0|||
129896135|NCT01835899|467580435|FG002|Overall Study|Adverse Event|1|||
129896136|NCT01835899|467580433|FG000|Overall Study|Other than stated above|0|||
129896137|NCT01835899|467580434|FG001|Overall Study|Other than stated above|1|||
129896138|NCT01835899|467580435|FG002|Overall Study|Other than stated above|0|||
129896139|NCT03168438|467580437|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
129896140|NCT03168438|467580438|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
129896141|NCT05015478|467580441|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
129896142|NCT05015478|467580442|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
129896143|NCT05015478|467580443|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
129896144|NCT05015478|467580444|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
129896145|NCT00654238|467580449|FG000|Overall Study|Screen Failures|4|||
129896146|NCT01348087|467580459|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
129896147|NCT01348087|467580459|FG000|Overall Study|Administrative problems|79|||
129896148|NCT01348087|467580459|FG000|Overall Study|protocol deviation|1|||
129896149|NCT01348087|467580459|FG000|Overall Study|Lost to Follow-up|1|||
129896150|NCT01348087|467580459|FG000|Overall Study|Subject withdrew consent|7|||
129896151|NCT01348087|467580459|FG000|Overall Study|Adverse Event|25|||
129896152|NCT00117988|467580462|FG000|Overall Study|Death|3|||
129747857|NCT01368081|467036257|FG009|Overall Study|Protocol Violation|0|||
129747858|NCT01368081|467036258|FG010|Overall Study|Protocol Violation|0|||
129747859|NCT01368081|467036259|FG011|Overall Study|Protocol Violation|0|||
129747860|NCT01368081|467036260|FG012|Overall Study|Protocol Violation|0|||
129747861|NCT01368081|467036248|FG000|Overall Study|Lost to Follow-up|0|||
129747862|NCT01368081|467036249|FG001|Overall Study|Lost to Follow-up|0|||
129747863|NCT01368081|467036250|FG002|Overall Study|Lost to Follow-up|0|||
129747864|NCT01368081|467036251|FG003|Overall Study|Lost to Follow-up|0|||
129747865|NCT01368081|467036252|FG004|Overall Study|Lost to Follow-up|0|||
129747866|NCT01368081|467036253|FG005|Overall Study|Lost to Follow-up|0|||
129747867|NCT01368081|467036254|FG006|Overall Study|Lost to Follow-up|0|||
129747868|NCT01368081|467036255|FG007|Overall Study|Lost to Follow-up|0|||
129747869|NCT01368081|467036256|FG008|Overall Study|Lost to Follow-up|0|||
129747870|NCT01368081|467036257|FG009|Overall Study|Lost to Follow-up|0|||
129747871|NCT01368081|467036258|FG010|Overall Study|Lost to Follow-up|0|||
129747872|NCT01368081|467036259|FG011|Overall Study|Lost to Follow-up|0|||
129747873|NCT01368081|467036260|FG012|Overall Study|Lost to Follow-up|1|||
129747874|NCT01368081|467036248|FG000|Overall Study|Withdrawal by Subject|4|||
129747875|NCT01368081|467036249|FG001|Overall Study|Withdrawal by Subject|4|||
129747876|NCT01368081|467036250|FG002|Overall Study|Withdrawal by Subject|1|||
129747877|NCT01368081|467036251|FG003|Overall Study|Withdrawal by Subject|1|||
129747878|NCT01368081|467036252|FG004|Overall Study|Withdrawal by Subject|0|||
129747879|NCT01368081|467036253|FG005|Overall Study|Withdrawal by Subject|3|||
129747880|NCT01368081|467036254|FG006|Overall Study|Withdrawal by Subject|4|||
129896153|NCT00117988|467580462|FG000|Overall Study|Adverse Event|1|||
129896154|NCT05096884|467580463|FG000|Overall Study|Excluded based on negative tilt table test|4|||
129896155|NCT01096056|467580466|FG000|Overall Study|Lost to Follow-up|0|||
129896156|NCT01096056|467580467|FG001|Overall Study|Lost to Follow-up|1|||
129896157|NCT03781804|467580469|FG000|Overall Study|Adverse Event|2|||
129896158|NCT03781804|467580470|FG001|Overall Study|Adverse Event|2|||
129896159|NCT03781804|467580471|FG002|Overall Study|Adverse Event|3|||
129896160|NCT03781804|467580469|FG000|Overall Study|Lost to Follow-up|1|||
129747881|NCT01368081|467036255|FG007|Overall Study|Withdrawal by Subject|2|||
129747882|NCT01368081|467036256|FG008|Overall Study|Withdrawal by Subject|5|||
129896161|NCT03781804|467580470|FG001|Overall Study|Lost to Follow-up|1|||
129896162|NCT03781804|467580471|FG002|Overall Study|Lost to Follow-up|2|||
129896163|NCT03781804|467580469|FG000|Overall Study|Lack of Efficacy|4|||
129747883|NCT01368081|467036257|FG009|Overall Study|Withdrawal by Subject|4|||
129747884|NCT01368081|467036258|FG010|Overall Study|Withdrawal by Subject|3|||
129747885|NCT01368081|467036259|FG011|Overall Study|Withdrawal by Subject|2|||
129747886|NCT01368081|467036260|FG012|Overall Study|Withdrawal by Subject|0|||
129747887|NCT01368081|467036248|FG000|Overall Study|Other reason not defined above|2|||
129747888|NCT01368081|467036249|FG001|Overall Study|Other reason not defined above|0|||
129747889|NCT01368081|467036250|FG002|Overall Study|Other reason not defined above|0|||
129747890|NCT01368081|467036251|FG003|Overall Study|Other reason not defined above|1|||
129747891|NCT01368081|467036252|FG004|Overall Study|Other reason not defined above|0|||
129747892|NCT01368081|467036253|FG005|Overall Study|Other reason not defined above|1|||
129747893|NCT01368081|467036254|FG006|Overall Study|Other reason not defined above|2|||
129747894|NCT01368081|467036255|FG007|Overall Study|Other reason not defined above|0|||
129747895|NCT01368081|467036256|FG008|Overall Study|Other reason not defined above|0|||
129747896|NCT01368081|467036257|FG009|Overall Study|Other reason not defined above|1|||
129747897|NCT01368081|467036258|FG010|Overall Study|Other reason not defined above|0|||
129747898|NCT01368081|467036259|FG011|Overall Study|Other reason not defined above|0|||
129747899|NCT01368081|467036260|FG012|Overall Study|Other reason not defined above|3|||
129747900|NCT03755661|467036263|FG000|Overall Study|Lost to Follow-up|1|||
129747901|NCT03755661|467036264|FG001|Overall Study|Lost to Follow-up|0|||
129747902|NCT02277119|467036265|FG000|Overall Study|Lack of Efficacy|1|||
129747903|NCT02277119|467036266|FG001|Overall Study|Lack of Efficacy|1|||
129747904|NCT02277119|467036267|FG002|Overall Study|Lack of Efficacy|1|||
129747905|NCT02277119|467036265|FG000|Overall Study|Protocol Violation|2|||
129747906|NCT02277119|467036266|FG001|Overall Study|Protocol Violation|3|||
129747907|NCT02277119|467036267|FG002|Overall Study|Protocol Violation|7|||
129747908|NCT04699461|467036268|FG000|Overall Study|Withdrawal by Subject|1|||
129747909|NCT04699461|467036269|FG001|Overall Study|Withdrawal by Subject|0|||
129747910|NCT04699461|467036268|FG000|Overall Study|Study termination by sponsor|2|||
129747911|NCT04699461|467036269|FG001|Overall Study|Study termination by sponsor|1|||
129747912|NCT04699461|467036268|FG000|Overall Study|Death|1|||
129747913|NCT04699461|467036269|FG001|Overall Study|Death|0|||
129747914|NCT04699461|467036268|FG000|Overall Study|Radiographic progression|0|||
129747915|NCT04699461|467036269|FG001|Overall Study|Radiographic progression|1|||
129747916|NCT03068767|467036270|FG000|Overall Study|Lost to Follow-up|7|||
129747917|NCT03068767|467036271|FG001|Overall Study|Lost to Follow-up|3|||
129747918|NCT03068767|467036270|FG000|Overall Study|Protocol Violation|3|||
129747919|NCT03068767|467036271|FG001|Overall Study|Protocol Violation|0|||
129747920|NCT04167137|467036274|FG000|Overall Study|Disease progression|1|||
129747921|NCT04167137|467036275|FG001|Overall Study|Disease progression|1|||
129747922|NCT04167137|467036276|FG002|Overall Study|Disease progression|3|||
129747923|NCT04167137|467036277|FG003|Overall Study|Disease progression|3|||
129747924|NCT04167137|467036278|FG004|Overall Study|Disease progression|2|||
129747925|NCT04167137|467036279|FG005|Overall Study|Disease progression|3|||
129747926|NCT04167137|467036280|FG006|Overall Study|Disease progression|2|||
129747927|NCT04167137|467036281|FG007|Overall Study|Disease progression|2|||
129747928|NCT04167137|467036274|FG000|Overall Study|Withdrawal by Subject|1|||
129747929|NCT04167137|467036275|FG001|Overall Study|Withdrawal by Subject|0|||
129747930|NCT04167137|467036276|FG002|Overall Study|Withdrawal by Subject|0|||
129747931|NCT04167137|467036277|FG003|Overall Study|Withdrawal by Subject|1|||
129809003|NCT02187744|467265829|FG001|Treatment|Related adverse event, serious non-fatal|1|||
129809004|NCT02187744|467265828|FG000|Treatment|Related adverse event, not serious|0|||
129809005|NCT02187744|467265829|FG001|Treatment|Related adverse event, not serious|2|||
129809006|NCT02187744|467265828|FG000|Treatment|Lost to Follow-up|0|||
129809007|NCT02187744|467265829|FG001|Treatment|Lost to Follow-up|1|||
129809008|NCT02187744|467265828|FG000|Treatment|Other|2|||
129809009|NCT02187744|467265829|FG001|Treatment|Other|0|||
129809010|NCT02187744|467265828|FG000|Treatment|Participant refused continued treatment|1|||
129809011|NCT02187744|467265829|FG001|Treatment|Participant refused continued treatment|1|||
129809012|NCT01972568|467265830|FG000|Overall Study|Other events|3|||
129809013|NCT01972568|467265831|FG001|Overall Study|Other events|0|||
129809014|NCT01972568|467265832|FG002|Overall Study|Other events|0|||
129809015|NCT01972568|467265830|FG000|Overall Study|Lack of Efficacy|0|||
129809016|NCT01972568|467265831|FG001|Overall Study|Lack of Efficacy|1|||
129809017|NCT01972568|467265832|FG002|Overall Study|Lack of Efficacy|2|||
129809018|NCT01972568|467265830|FG000|Overall Study|Protocol Violation|1|||
129809019|NCT01972568|467265831|FG001|Overall Study|Protocol Violation|2|||
129809020|NCT01972568|467265832|FG002|Overall Study|Protocol Violation|2|||
129809021|NCT01972568|467265830|FG000|Overall Study|Withdrawal by Subject|6|||
129809022|NCT01972568|467265831|FG001|Overall Study|Withdrawal by Subject|3|||
129809023|NCT01972568|467265832|FG002|Overall Study|Withdrawal by Subject|7|||
129809024|NCT01972568|467265830|FG000|Overall Study|Lost to Follow-up|1|||
129809025|NCT01972568|467265831|FG001|Overall Study|Lost to Follow-up|0|||
129747932|NCT04167137|467036278|FG004|Overall Study|Withdrawal by Subject|0|||
129747933|NCT04167137|467036279|FG005|Overall Study|Withdrawal by Subject|2|||
129747934|NCT04167137|467036280|FG006|Overall Study|Withdrawal by Subject|1|||
129747935|NCT04167137|467036281|FG007|Overall Study|Withdrawal by Subject|0|||
129747936|NCT04167137|467036274|FG000|Overall Study|Adverse Event|0|||
129747937|NCT04167137|467036275|FG001|Overall Study|Adverse Event|0|||
129747938|NCT04167137|467036276|FG002|Overall Study|Adverse Event|0|||
129747939|NCT04167137|467036277|FG003|Overall Study|Adverse Event|0|||
129747940|NCT04167137|467036278|FG004|Overall Study|Adverse Event|0|||
129747941|NCT04167137|467036279|FG005|Overall Study|Adverse Event|1|||
129747942|NCT04167137|467036280|FG006|Overall Study|Adverse Event|0|||
129747943|NCT04167137|467036281|FG007|Overall Study|Adverse Event|1|||
129747944|NCT04167137|467036274|FG000|Overall Study|Physician Decision|0|||
129747945|NCT04167137|467036275|FG001|Overall Study|Physician Decision|0|||
129747946|NCT04167137|467036276|FG002|Overall Study|Physician Decision|0|||
129747947|NCT04167137|467036277|FG003|Overall Study|Physician Decision|1|||
129896164|NCT03781804|467580470|FG001|Overall Study|Lack of Efficacy|2|||
129896165|NCT03781804|467580471|FG002|Overall Study|Lack of Efficacy|9|||
129896166|NCT03781804|467580469|FG000|Overall Study|Protocol Violation|0|||
129747948|NCT04167137|467036278|FG004|Overall Study|Physician Decision|0|||
129747949|NCT04167137|467036279|FG005|Overall Study|Physician Decision|0|||
129747950|NCT04167137|467036280|FG006|Overall Study|Physician Decision|1|||
129747951|NCT04167137|467036281|FG007|Overall Study|Physician Decision|0|||
129747952|NCT04167137|467036274|FG000|Overall Study|Death|0|||
129747953|NCT04167137|467036275|FG001|Overall Study|Death|1|||
129747954|NCT04167137|467036276|FG002|Overall Study|Death|0|||
129747955|NCT04167137|467036277|FG003|Overall Study|Death|0|||
129747956|NCT04167137|467036278|FG004|Overall Study|Death|0|||
129747957|NCT04167137|467036279|FG005|Overall Study|Death|0|||
129747958|NCT04167137|467036280|FG006|Overall Study|Death|0|||
129747959|NCT04167137|467036281|FG007|Overall Study|Death|0|||
129747960|NCT04167137|467036274|FG000|Overall Study|Study terminated by Sponsor|0|||
129747961|NCT04167137|467036275|FG001|Overall Study|Study terminated by Sponsor|0|||
129747962|NCT04167137|467036276|FG002|Overall Study|Study terminated by Sponsor|0|||
129747963|NCT04167137|467036277|FG003|Overall Study|Study terminated by Sponsor|0|||
129747964|NCT04167137|467036278|FG004|Overall Study|Study terminated by Sponsor|0|||
129747965|NCT04167137|467036279|FG005|Overall Study|Study terminated by Sponsor|0|||
129747966|NCT04167137|467036280|FG006|Overall Study|Study terminated by Sponsor|0|||
129747967|NCT04167137|467036281|FG007|Overall Study|Study terminated by Sponsor|1|||
129747968|NCT01748825|467036284|FG000|Dose Escalation|Refused further treatment|2|||
129747969|NCT01748825|467036285|FG001|Dose Escalation|Refused further treatment|2|||
129747970|NCT01748825|467036286|FG002|Dose Escalation|Refused further treatment|0|||
129747971|NCT01748825|467036287|FG003|Dose Escalation|Refused further treatment|0|||
129747972|NCT01748825|467036288|FG004|Dose Escalation|Refused further treatment|1|||
129747973|NCT01748825|467036289|FG005|Dose Escalation|Refused further treatment|2|||
129747974|NCT01748825|467036290|FG006|Dose Escalation|Refused further treatment|0|||
129747975|NCT01748825|467036291|FG007|Dose Escalation|Refused further treatment|0|||
129747976|NCT01748825|467036292|FG008|Dose Escalation|Refused further treatment|0|||
129747977|NCT01748825|467036293|FG009|Dose Escalation|Refused further treatment|0|||
129747978|NCT01748825|467036284|FG000|Dose Escalation|Switched to alternative treatment|0|||
129747979|NCT01748825|467036285|FG001|Dose Escalation|Switched to alternative treatment|0|||
129747980|NCT01748825|467036286|FG002|Dose Escalation|Switched to alternative treatment|0|||
129747981|NCT01748825|467036287|FG003|Dose Escalation|Switched to alternative treatment|1|||
129747982|NCT01748825|467036288|FG004|Dose Escalation|Switched to alternative treatment|0|||
129747983|NCT01748825|467036289|FG005|Dose Escalation|Switched to alternative treatment|0|||
129747984|NCT01748825|467036290|FG006|Dose Escalation|Switched to alternative treatment|0|||
129747985|NCT01748825|467036291|FG007|Dose Escalation|Switched to alternative treatment|0|||
129747986|NCT01748825|467036292|FG008|Dose Escalation|Switched to alternative treatment|0|||
129747987|NCT01748825|467036293|FG009|Dose Escalation|Switched to alternative treatment|0|||
129747988|NCT01748825|467036284|FG000|Dose Escalation|Adverse Event|0|||
129747989|NCT01748825|467036285|FG001|Dose Escalation|Adverse Event|0|||
129747990|NCT01748825|467036286|FG002|Dose Escalation|Adverse Event|0|||
129747991|NCT01748825|467036287|FG003|Dose Escalation|Adverse Event|0|||
129747992|NCT01748825|467036288|FG004|Dose Escalation|Adverse Event|0|||
129747993|NCT01748825|467036289|FG005|Dose Escalation|Adverse Event|0|||
129747994|NCT01748825|467036290|FG006|Dose Escalation|Adverse Event|1|||
129747995|NCT01748825|467036291|FG007|Dose Escalation|Adverse Event|0|||
129747996|NCT01748825|467036292|FG008|Dose Escalation|Adverse Event|0|||
129747997|NCT01748825|467036293|FG009|Dose Escalation|Adverse Event|0|||
129747998|NCT01748825|467036284|FG000|Dose Expansion|Refused further treatment|0|||
129747999|NCT01748825|467036285|FG001|Dose Expansion|Refused further treatment|0|||
129748000|NCT01748825|467036286|FG002|Dose Expansion|Refused further treatment|0|||
129748001|NCT01748825|467036287|FG003|Dose Expansion|Refused further treatment|0|||
129748002|NCT01748825|467036288|FG004|Dose Expansion|Refused further treatment|0|||
129748003|NCT01748825|467036289|FG005|Dose Expansion|Refused further treatment|0|||
129896167|NCT03781804|467580470|FG001|Overall Study|Protocol Violation|0|||
129896168|NCT03781804|467580471|FG002|Overall Study|Protocol Violation|1|||
129748004|NCT01748825|467036290|FG006|Dose Expansion|Refused further treatment|0|||
129748005|NCT01748825|467036291|FG007|Dose Expansion|Refused further treatment|0|||
129748006|NCT01748825|467036292|FG008|Dose Expansion|Refused further treatment|1|||
129748007|NCT01748825|467036293|FG009|Dose Expansion|Refused further treatment|1|||
129748008|NCT01748825|467036284|FG000|Dose Expansion|Switched to alternative treatment|0|||
129748009|NCT01748825|467036285|FG001|Dose Expansion|Switched to alternative treatment|0|||
129748010|NCT01748825|467036286|FG002|Dose Expansion|Switched to alternative treatment|0|||
129748011|NCT01748825|467036287|FG003|Dose Expansion|Switched to alternative treatment|0|||
129748012|NCT01748825|467036288|FG004|Dose Expansion|Switched to alternative treatment|0|||
129748013|NCT01748825|467036289|FG005|Dose Expansion|Switched to alternative treatment|0|||
129748014|NCT01748825|467036290|FG006|Dose Expansion|Switched to alternative treatment|0|||
129748015|NCT01748825|467036291|FG007|Dose Expansion|Switched to alternative treatment|0|||
129748016|NCT01748825|467036292|FG008|Dose Expansion|Switched to alternative treatment|0|||
129748017|NCT01748825|467036293|FG009|Dose Expansion|Switched to alternative treatment|1|||
129748018|NCT01748825|467036284|FG000|Dose Expansion|Adverse Event|0|||
129748019|NCT01748825|467036285|FG001|Dose Expansion|Adverse Event|0|||
129748020|NCT01748825|467036286|FG002|Dose Expansion|Adverse Event|0|||
129748021|NCT01748825|467036287|FG003|Dose Expansion|Adverse Event|0|||
129748022|NCT01748825|467036288|FG004|Dose Expansion|Adverse Event|0|||
129748023|NCT01748825|467036289|FG005|Dose Expansion|Adverse Event|0|||
129748024|NCT01748825|467036290|FG006|Dose Expansion|Adverse Event|0|||
129748025|NCT01748825|467036291|FG007|Dose Expansion|Adverse Event|0|||
129748026|NCT01748825|467036292|FG008|Dose Expansion|Adverse Event|0|||
129748027|NCT01748825|467036293|FG009|Dose Expansion|Adverse Event|3|||
129748028|NCT01748825|467036284|FG000|Dose Expansion|Physician Decision|0|||
129748029|NCT01748825|467036285|FG001|Dose Expansion|Physician Decision|0|||
129748030|NCT01748825|467036286|FG002|Dose Expansion|Physician Decision|0|||
129748031|NCT01748825|467036287|FG003|Dose Expansion|Physician Decision|0|||
129748032|NCT01748825|467036288|FG004|Dose Expansion|Physician Decision|0|||
129748033|NCT01748825|467036289|FG005|Dose Expansion|Physician Decision|0|||
129748034|NCT01748825|467036290|FG006|Dose Expansion|Physician Decision|0|||
129748035|NCT01748825|467036291|FG007|Dose Expansion|Physician Decision|0|||
129748036|NCT01748825|467036292|FG008|Dose Expansion|Physician Decision|1|||
129748037|NCT01748825|467036293|FG009|Dose Expansion|Physician Decision|0|||
129748038|NCT04412707|467036297|FG000|Cycle 1|Death|0|||
129748039|NCT04412707|467036298|FG001|Cycle 1|Death|3|||
129748040|NCT04412707|467036297|FG000|Cycle 1|Disease progression|1|||
129748041|NCT04412707|467036298|FG001|Cycle 1|Disease progression|2|||
129748042|NCT04412707|467036297|FG000|Cycle 2|Death|0|||
129748043|NCT04412707|467036298|FG001|Cycle 2|Death|1|||
129748044|NCT04412707|467036297|FG000|Cycle 2|Disease progression|3|||
129748045|NCT04412707|467036298|FG001|Cycle 2|Disease progression|0|||
129748046|NCT04412707|467036297|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
129748047|NCT04412707|467036298|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
129748048|NCT04412707|467036297|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
129748049|NCT04412707|467036298|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
129748050|NCT04412707|467036297|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
129748051|NCT04412707|467036298|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
129748052|NCT04412707|467036297|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
129748053|NCT04412707|467036298|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
129748054|NCT01370265|467037615|FG000|First Intervention|Adverse Event|1|||
129748055|NCT01370265|467037616|FG001|First Intervention|Adverse Event|1|||
129748056|NCT01732770|467037618|FG000|Overall Study|Lost to Follow-up|2|||
129748057|NCT01732770|467037619|FG001|Overall Study|Lost to Follow-up|3|||
129748058|NCT01732770|467037618|FG000|Overall Study|Withdrawal by Subject|5|||
129748059|NCT01732770|467037619|FG001|Overall Study|Withdrawal by Subject|3|||
129748060|NCT01732770|467037618|FG000|Overall Study|Decision by Sponsor|2|||
129748061|NCT01732770|467037619|FG001|Overall Study|Decision by Sponsor|2|||
129748062|NCT01732770|467037618|FG000|Overall Study|Death|1|||
129748063|NCT01732770|467037619|FG001|Overall Study|Death|0|||
129748064|NCT00871338|467037623|FG000|Prior to Booster|Withdrawal by Subject|1|||
129748065|NCT00871338|467037624|FG001|Prior to Booster|Withdrawal by Subject|3|||
129748066|NCT00871338|467037623|FG000|Prior to Booster|Lost to Follow-up|1|||
129748067|NCT00871338|467037624|FG001|Prior to Booster|Lost to Follow-up|0|||
129748068|NCT02391363|467037625|FG000|Overall Study|Lost to Follow-up|5|||
129748069|NCT02391363|467037626|FG001|Overall Study|Lost to Follow-up|5|||
129748070|NCT02391363|467037625|FG000|Overall Study|Withdrawal by Subject|6|||
129748071|NCT02391363|467037626|FG001|Overall Study|Withdrawal by Subject|3|||
129748072|NCT04794270|467037627|FG000|Period 1|Non Compliance|1|||
129748073|NCT04794270|467037628|FG001|Period 1|Non Compliance|0|||
129748074|NCT04794270|467037627|FG000|Period 1|Adverse Event|1|||
129748075|NCT04794270|467037628|FG001|Period 1|Adverse Event|0|||
129748076|NCT04794270|467037627|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
129748077|NCT04794270|467037628|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
129748078|NCT00265317|467037631|FG000|Lead-In|Objective progression or relapse|6|||
129748079|NCT00265317|467037632|FG001|Lead-In|Objective progression or relapse|11|||
129748080|NCT00265317|467037633|FG002|Lead-In|Objective progression or relapse|0|||
129748081|NCT00265317|467037634|FG003|Lead-In|Objective progression or relapse|0|||
129445394|NCT03828292|465931279|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129748082|NCT00265317|467037631|FG000|Lead-In|Adverse Event|2|||
129748083|NCT00265317|467037632|FG001|Lead-In|Adverse Event|1|||
129748084|NCT00265317|467037633|FG002|Lead-In|Adverse Event|0|||
129748085|NCT00265317|467037634|FG003|Lead-In|Adverse Event|0|||
129748086|NCT00265317|467037631|FG000|Lead-In|Death|3|||
129748087|NCT00265317|467037632|FG001|Lead-In|Death|5|||
129748088|NCT00265317|467037633|FG002|Lead-In|Death|0|||
129748089|NCT00265317|467037634|FG003|Lead-In|Death|0|||
129748090|NCT00265317|467037631|FG000|Lead-In|Withdrawal/other than adverse event|1|||
129748091|NCT00265317|467037632|FG001|Lead-In|Withdrawal/other than adverse event|0|||
129748092|NCT00265317|467037633|FG002|Lead-In|Withdrawal/other than adverse event|0|||
129748093|NCT00265317|467037634|FG003|Lead-In|Withdrawal/other than adverse event|0|||
129748094|NCT00265317|467037631|FG000|Phase 2|Objective progression or relapse|0|||
129748095|NCT00265317|467037632|FG001|Phase 2|Objective progression or relapse|0|||
129748096|NCT00265317|467037633|FG002|Phase 2|Objective progression or relapse|37|||
129748097|NCT00265317|467037634|FG003|Phase 2|Objective progression or relapse|38|||
129748098|NCT00265317|467037631|FG000|Phase 2|Global deterioration of health status|0|||
129748099|NCT00265317|467037632|FG001|Phase 2|Global deterioration of health status|0|||
129748100|NCT00265317|467037633|FG002|Phase 2|Global deterioration of health status|3|||
129748101|NCT00265317|467037634|FG003|Phase 2|Global deterioration of health status|0|||
129748102|NCT00265317|467037631|FG000|Phase 2|Adverse Event|0|||
129748103|NCT00265317|467037632|FG001|Phase 2|Adverse Event|0|||
129748104|NCT00265317|467037633|FG002|Phase 2|Adverse Event|7|||
129748105|NCT00265317|467037634|FG003|Phase 2|Adverse Event|5|||
129748106|NCT00265317|467037631|FG000|Phase 2|Death|0|||
129748107|NCT00265317|467037632|FG001|Phase 2|Death|0|||
129748108|NCT00265317|467037633|FG002|Phase 2|Death|12|||
129748109|NCT00265317|467037634|FG003|Phase 2|Death|15|||
129748110|NCT00265317|467037631|FG000|Phase 2|Protocol Violation|0|||
129748111|NCT00265317|467037632|FG001|Phase 2|Protocol Violation|0|||
129748112|NCT00265317|467037633|FG002|Phase 2|Protocol Violation|1|||
129748113|NCT00265317|467037634|FG003|Phase 2|Protocol Violation|4|||
129748114|NCT00265317|467037631|FG000|Phase 2|Lost to Follow-up|0|||
129748115|NCT00265317|467037632|FG001|Phase 2|Lost to Follow-up|0|||
129748116|NCT00265317|467037633|FG002|Phase 2|Lost to Follow-up|0|||
129748117|NCT00265317|467037634|FG003|Phase 2|Lost to Follow-up|1|||
129748118|NCT00265317|467037631|FG000|Phase 2|Withdrawal/other than adverse event|0|||
129748119|NCT00265317|467037632|FG001|Phase 2|Withdrawal/other than adverse event|0|||
129748120|NCT00265317|467037633|FG002|Phase 2|Withdrawal/other than adverse event|2|||
129748121|NCT00265317|467037634|FG003|Phase 2|Withdrawal/other than adverse event|1|||
129748122|NCT00265317|467037631|FG000|Phase 2|Study terminated by sponsor|0|||
129748123|NCT00265317|467037632|FG001|Phase 2|Study terminated by sponsor|0|||
129748124|NCT00265317|467037633|FG002|Phase 2|Study terminated by sponsor|1|||
129748125|NCT00265317|467037634|FG003|Phase 2|Study terminated by sponsor|0|||
129748126|NCT00265317|467037631|FG000|Phase 2|Other|0|||
129748127|NCT00265317|467037632|FG001|Phase 2|Other|0|||
129748128|NCT00265317|467037633|FG002|Phase 2|Other|1|||
129748129|NCT00265317|467037634|FG003|Phase 2|Other|1|||
129748130|NCT02510001|467037635|FG000|Overall Study|Early disease progression|0|||
129748131|NCT02510001|467037636|FG001|Overall Study|Early disease progression|0|||
129748132|NCT02510001|467037637|FG002|Overall Study|Early disease progression|0|||
129748133|NCT02510001|467037638|FG003|Overall Study|Early disease progression|1|||
129748134|NCT02510001|467037639|FG004|Overall Study|Early disease progression|1|||
129748135|NCT02510001|467037640|FG005|Overall Study|Early disease progression|1|||
129748136|NCT02510001|467037641|FG006|Overall Study|Early disease progression|0|||
129748137|NCT02510001|467037642|FG007|Overall Study|Early disease progression|0|||
129748138|NCT02510001|467037635|FG000|Overall Study|Adverse Event|0|||
129748139|NCT02510001|467037636|FG001|Overall Study|Adverse Event|0|||
129748140|NCT02510001|467037637|FG002|Overall Study|Adverse Event|0|||
129748141|NCT02510001|467037638|FG003|Overall Study|Adverse Event|1|||
129748142|NCT02510001|467037639|FG004|Overall Study|Adverse Event|2|||
129748143|NCT02510001|467037640|FG005|Overall Study|Adverse Event|1|||
129748144|NCT02510001|467037641|FG006|Overall Study|Adverse Event|2|||
129748145|NCT02510001|467037642|FG007|Overall Study|Adverse Event|5|||
129748146|NCT02510001|467037635|FG000|Overall Study|Physician Decision|0|||
129748147|NCT02510001|467037636|FG001|Overall Study|Physician Decision|0|||
129748148|NCT02510001|467037637|FG002|Overall Study|Physician Decision|0|||
129748149|NCT02510001|467037638|FG003|Overall Study|Physician Decision|0|||
129748150|NCT02510001|467037639|FG004|Overall Study|Physician Decision|1|||
129748151|NCT02510001|467037640|FG005|Overall Study|Physician Decision|0|||
129748152|NCT02510001|467037641|FG006|Overall Study|Physician Decision|0|||
129748153|NCT02510001|467037642|FG007|Overall Study|Physician Decision|0|||
129748154|NCT02510001|467037635|FG000|Overall Study|Withdrawal by Subject|0|||
129748155|NCT02510001|467037636|FG001|Overall Study|Withdrawal by Subject|0|||
129748156|NCT02510001|467037637|FG002|Overall Study|Withdrawal by Subject|0|||
129748157|NCT02510001|467037638|FG003|Overall Study|Withdrawal by Subject|0|||
129748158|NCT02510001|467037639|FG004|Overall Study|Withdrawal by Subject|0|||
129748159|NCT02510001|467037640|FG005|Overall Study|Withdrawal by Subject|0|||
129748160|NCT02510001|467037641|FG006|Overall Study|Withdrawal by Subject|0|||
129748161|NCT02510001|467037642|FG007|Overall Study|Withdrawal by Subject|2|||
129748162|NCT02950480|467037647|FG000|Overall Study|Withdrawal by Subject|1|||
129748163|NCT02950480|467037648|FG001|Overall Study|Withdrawal by Subject|0|||
129748164|NCT00711971|467037651|FG000|Overall Study|Lost to Follow-up|3|||
129748165|NCT00711971|467037652|FG001|Overall Study|Lost to Follow-up|4|||
129748166|NCT00711971|467037653|FG002|Overall Study|Lost to Follow-up|1|||
129748167|NCT02644343|467037654|FG000|Overall Study|Withdrawal by Subject|1|||
129748168|NCT03704688|467037657|FG000|Overall Study|Adverse Event|0|||
129896169|NCT03781804|467580469|FG000|Overall Study|Withdrawal by Subject|0|||
129896170|NCT03781804|467580470|FG001|Overall Study|Withdrawal by Subject|1|||
129896171|NCT03781804|467580471|FG002|Overall Study|Withdrawal by Subject|1|||
129896172|NCT03781804|467580469|FG000|Overall Study|Reason not provided|2|||
129896173|NCT03781804|467580470|FG001|Overall Study|Reason not provided|2|||
129896174|NCT03781804|467580471|FG002|Overall Study|Reason not provided|0|||
129896175|NCT00337818|467580472|FG000|Overall Study|Lost to Follow-up|289|||
129896176|NCT00337818|467580473|FG001|Overall Study|Lost to Follow-up|91|||
129896177|NCT00337818|467580474|FG002|Overall Study|Lost to Follow-up|107|||
129896178|NCT04678830|467580475|FG000|Overall Study|Lack of Efficacy|2|||
129896179|NCT04678830|467580476|FG001|Overall Study|Lack of Efficacy|0|||
129748169|NCT03704688|467037658|FG001|Overall Study|Adverse Event|0|||
129748170|NCT03704688|467037659|FG002|Overall Study|Adverse Event|0|||
129748171|NCT03704688|467037660|FG003|Overall Study|Adverse Event|4|||
129748172|NCT03704688|467037661|FG004|Overall Study|Adverse Event|1|||
129748173|NCT03704688|467037662|FG005|Overall Study|Adverse Event|0|||
129748174|NCT03704688|467037657|FG000|Overall Study|Disease Progression|0|||
129748175|NCT03704688|467037658|FG001|Overall Study|Disease Progression|0|||
129748176|NCT03704688|467037659|FG002|Overall Study|Disease Progression|0|||
129748177|NCT03704688|467037660|FG003|Overall Study|Disease Progression|3|||
129748178|NCT03704688|467037661|FG004|Overall Study|Disease Progression|1|||
129748179|NCT03704688|467037662|FG005|Overall Study|Disease Progression|0|||
129748180|NCT03704688|467037657|FG000|Overall Study|Death|0|||
129748181|NCT03704688|467037658|FG001|Overall Study|Death|0|||
129748182|NCT03704688|467037659|FG002|Overall Study|Death|0|||
129748183|NCT03704688|467037660|FG003|Overall Study|Death|0|||
129748184|NCT03704688|467037661|FG004|Overall Study|Death|3|||
129748185|NCT03704688|467037662|FG005|Overall Study|Death|0|||
129748186|NCT01440816|467037666|FG000|Overall Study|Disease Progression|0|||
129748187|NCT01440816|467037667|FG001|Overall Study|Disease Progression|9|||
129748188|NCT01440816|467037666|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
129748189|NCT01440816|467037667|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
129748190|NCT00847886|467037668|FG000|Overall Study|Adverse Event|0|||
129748191|NCT00847886|467037669|FG001|Overall Study|Adverse Event|1|||
129748192|NCT01687101|467037670|FG000|Overall Study|Lost to Follow-up|7|||
129748193|NCT03920254|467037672|FG000|Overall Study|Adverse Event|1|||
129748194|NCT03920254|467037673|FG001|Overall Study|Adverse Event|0|||
129748195|NCT03920254|467037674|FG002|Overall Study|Adverse Event|0|||
129748196|NCT03920254|467037672|FG000|Overall Study|Physician Decision|0|||
129748197|NCT03920254|467037673|FG001|Overall Study|Physician Decision|1|||
129748198|NCT03920254|467037674|FG002|Overall Study|Physician Decision|2|||
129748199|NCT03920254|467037672|FG000|Overall Study|Study Terminated By Sponsor|12|||
129748200|NCT03920254|467037673|FG001|Overall Study|Study Terminated By Sponsor|17|||
129748201|NCT03920254|467037674|FG002|Overall Study|Study Terminated By Sponsor|12|||
129748202|NCT03920254|467037672|FG000|Overall Study|Withdrawal by Subject|0|||
129748203|NCT03920254|467037673|FG001|Overall Study|Withdrawal by Subject|0|||
129748204|NCT03920254|467037674|FG002|Overall Study|Withdrawal by Subject|1|||
129748205|NCT03250182|467037675|FG000|Overall Study|Withdrawal by Subject|1|||
129748206|NCT05274269|467037676|FG000|Overall Study|Adverse Event|0|||
129748207|NCT05274269|467037677|FG001|Overall Study|Adverse Event|3|||
129748208|NCT05274269|467037676|FG000|Overall Study|Death|0|||
129748209|NCT05274269|467037677|FG001|Overall Study|Death|1|||
129748210|NCT05274269|467037676|FG000|Overall Study|Other|0|||
129748211|NCT05274269|467037677|FG001|Overall Study|Other|2|||
129809026|NCT01972568|467265832|FG002|Overall Study|Lost to Follow-up|0|||
129809027|NCT01972568|467265830|FG000|Overall Study|Adverse Event|5|||
129809028|NCT01972568|467265831|FG001|Overall Study|Adverse Event|6|||
129809029|NCT01972568|467265832|FG002|Overall Study|Adverse Event|5|||
129809030|NCT02572401|467265833|FG000|Overall Study|Lost to Follow-up|5|||
129809031|NCT02572401|467265834|FG001|Overall Study|Lost to Follow-up|8|||
129809032|NCT02572401|467265835|FG002|Overall Study|Lost to Follow-up|9|||
129809033|NCT02572401|467265836|FG003|Overall Study|Lost to Follow-up|9|||
129809034|NCT02572401|467265833|FG000|Overall Study|Death|0|||
129809035|NCT02572401|467265834|FG001|Overall Study|Death|0|||
129809036|NCT02572401|467265835|FG002|Overall Study|Death|0|||
129809037|NCT02572401|467265836|FG003|Overall Study|Death|1|||
129809038|NCT00306189|467265837|FG000|Overall Study|Physician Decision|0|||
129809039|NCT00306189|467265838|FG001|Overall Study|Physician Decision|0|||
129809040|NCT00306189|467265839|FG002|Overall Study|Physician Decision|0|||
129809041|NCT00306189|467265840|FG003|Overall Study|Physician Decision|1|||
129809042|NCT00306189|467265837|FG000|Overall Study|Adverse Event|3|||
129809043|NCT00306189|467265838|FG001|Overall Study|Adverse Event|3|||
129809044|NCT00306189|467265839|FG002|Overall Study|Adverse Event|2|||
129809045|NCT00306189|467265840|FG003|Overall Study|Adverse Event|2|||
129809046|NCT00306189|467265837|FG000|Overall Study|Withdrawal by Subject|4|||
129809047|NCT00306189|467265838|FG001|Overall Study|Withdrawal by Subject|2|||
129809048|NCT00306189|467265839|FG002|Overall Study|Withdrawal by Subject|8|||
129809049|NCT00306189|467265840|FG003|Overall Study|Withdrawal by Subject|1|||
129809050|NCT00306189|467265837|FG000|Overall Study|Ineligibility determined|1|||
129809051|NCT00306189|467265838|FG001|Overall Study|Ineligibility determined|1|||
129748212|NCT05274269|467037676|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129748213|NCT05274269|467037677|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129445395|NCT03828292|465931280|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129748214|NCT01858740|467037681|FG000|Overall Study|Death|4|||
129748215|NCT01068769|467037682|FG000|Overall Study|Ineligible|1|||
129748216|NCT00709618|467037683|FG000|Overall Study|Withdrawal by Subject|4|||
129748217|NCT00709618|467037683|FG000|Overall Study|Lost to Follow-up|1|||
129748218|NCT00709618|467037683|FG000|Overall Study|Study Closed/Terminated|25|||
129748219|NCT04042909|467037684|FG000|Overall Study|Withdrawal by Subject|1|||
129748220|NCT04042909|467037685|FG001|Overall Study|Withdrawal by Subject|0|||
129748221|NCT04042909|467037686|FG002|Overall Study|Withdrawal by Subject|0|||
129748222|NCT04042909|467037684|FG000|Overall Study|duplicate cases|2|||
129748223|NCT04042909|467037685|FG001|Overall Study|duplicate cases|0|||
129748224|NCT04042909|467037686|FG002|Overall Study|duplicate cases|0|||
129748225|NCT04042909|467037684|FG000|Overall Study|technical problem|0|||
129748226|NCT04042909|467037685|FG001|Overall Study|technical problem|1|||
129748227|NCT04042909|467037686|FG002|Overall Study|technical problem|0|||
129748228|NCT00894361|467037689|FG000|Overall Study|deaths and less than 2 years followup|24|||
129748229|NCT00894361|467037690|FG001|Overall Study|deaths and less than 2 years followup|64|||
129748230|NCT04124705|467037699|FG000|Titration Period|Adverse Event|9|||
129748231|NCT04124705|467037700|FG001|Titration Period|Adverse Event|5|||
129748232|NCT04124705|467037699|FG000|Titration Period|Withdrawal by Subject|6|||
129748233|NCT04124705|467037700|FG001|Titration Period|Withdrawal by Subject|3|||
129748234|NCT04124705|467037699|FG000|Titration Period|Lost to Follow-up|0|||
129748235|NCT04124705|467037700|FG001|Titration Period|Lost to Follow-up|1|||
129748236|NCT04124705|467037699|FG000|Titration Period|Death|1|||
129748237|NCT04124705|467037700|FG001|Titration Period|Death|1|||
129748238|NCT04124705|467037699|FG000|Titration Period|Lack of Efficacy|2|||
129748239|NCT04124705|467037700|FG001|Titration Period|Lack of Efficacy|0|||
129748240|NCT04124705|467037699|FG000|Titration Period|Physician Decision|2|||
129748241|NCT04124705|467037700|FG001|Titration Period|Physician Decision|0|||
129748242|NCT04124705|467037699|FG000|Titration Period|Non-compliance with Study Drug|2|||
129748243|NCT04124705|467037700|FG001|Titration Period|Non-compliance with Study Drug|0|||
129748244|NCT04124705|467037699|FG000|Titration Period|Other|4|||
129748245|NCT04124705|467037700|FG001|Titration Period|Other|9|||
129748246|NCT04124705|467037699|FG000|Stabilization Period|Adverse Event|4|||
129748247|NCT04124705|467037700|FG001|Stabilization Period|Adverse Event|2|||
129748248|NCT04124705|467037699|FG000|Stabilization Period|Withdrawal by Subject|1|||
129748249|NCT04124705|467037700|FG001|Stabilization Period|Withdrawal by Subject|1|||
129748250|NCT04124705|467037699|FG000|Stabilization Period|Lost to Follow-up|0|||
129748251|NCT04124705|467037700|FG001|Stabilization Period|Lost to Follow-up|1|||
129748252|NCT04124705|467037699|FG000|Stabilization Period|Lack of Efficacy|4|||
129748253|NCT04124705|467037700|FG001|Stabilization Period|Lack of Efficacy|2|||
129748254|NCT04124705|467037699|FG000|Stabilization Period|Protocol Deviation|0|||
129748255|NCT04124705|467037700|FG001|Stabilization Period|Protocol Deviation|2|||
129748256|NCT04124705|467037699|FG000|Stabilization Period|Other|2|||
129748257|NCT04124705|467037700|FG001|Stabilization Period|Other|2|||
129748258|NCT01636986|467037701|FG000|Overall Study|Withdrawal by Subject|0|||
129748259|NCT01636986|467037702|FG001|Overall Study|Withdrawal by Subject|1|||
129748260|NCT01636986|467037701|FG000|Overall Study|Corneal Staining|0|||
129748261|NCT01636986|467037702|FG001|Overall Study|Corneal Staining|1|||
129748262|NCT01844778|467037709|FG000|Overall Study|Protocol deviation|0|||
129748263|NCT01844778|467037710|FG001|Overall Study|Protocol deviation|1|||
129748264|NCT01844778|467037711|FG002|Overall Study|Protocol deviation|2|||
129748265|NCT01844778|467037709|FG000|Overall Study|Withdrawal by Subject|2|||
129748266|NCT01844778|467037710|FG001|Overall Study|Withdrawal by Subject|0|||
129748267|NCT01844778|467037711|FG002|Overall Study|Withdrawal by Subject|0|||
129748268|NCT01844778|467037709|FG000|Overall Study|Adverse Event|0|||
129809052|NCT00306189|467265839|FG002|Overall Study|Ineligibility determined|1|||
129809053|NCT00306189|467265840|FG003|Overall Study|Ineligibility determined|1|||
129809054|NCT00306189|467265837|FG000|Overall Study|Other|1|||
129809055|NCT00306189|467265838|FG001|Overall Study|Other|0|||
129809056|NCT00306189|467265839|FG002|Overall Study|Other|0|||
129809057|NCT00306189|467265840|FG003|Overall Study|Other|0|||
129809058|NCT00945893|467265841|FG000|Overall Study|Lost to Follow-up|2|||
129748269|NCT01844778|467037710|FG001|Overall Study|Adverse Event|2|||
129748270|NCT01844778|467037711|FG002|Overall Study|Adverse Event|2|||
129748271|NCT01153698|467037713|FG000|Overall Study|Adverse Event|12|||
129748272|NCT01153698|467037713|FG000|Overall Study|Lost to Follow-up|4|||
129809059|NCT00945893|467265842|FG001|Overall Study|Lost to Follow-up|8|||
129809060|NCT00945893|467265841|FG000|Overall Study|Withdrawal of consent|1|||
129809061|NCT00945893|467265842|FG001|Overall Study|Withdrawal of consent|2|||
129809062|NCT01187433|467265843|FG000|Overall Study|Protocol Violation|6|||
129809063|NCT01187433|467265844|FG001|Overall Study|Protocol Violation|2|||
129809064|NCT01187433|467265843|FG000|Overall Study|Withdrawal by Subject|5|||
129809065|NCT01187433|467265844|FG001|Overall Study|Withdrawal by Subject|2|||
129809066|NCT00437983|467265846|FG000|Overall Study|Adverse Event|6|||
129809067|NCT00437983|467265847|FG001|Overall Study|Adverse Event|6|||
129896180|NCT04678830|467580475|FG000|Overall Study|Withdrawal by Subject|0|||
129896181|NCT04678830|467580476|FG001|Overall Study|Withdrawal by Subject|1|||
129896182|NCT03563053|467580479|FG000|Overall Study|Withdrawal by Subject|17|||
129896183|NCT03563053|467580479|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
129896184|NCT03563053|467580479|FG000|Overall Study|Adverse Event|3|||
129896185|NCT03563053|467580479|FG000|Overall Study|Physician Decision|1|||
129896186|NCT03563053|467580479|FG000|Overall Study|study terminated by sponsor|71|||
129896187|NCT01836458|467580480|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
129896188|NCT01836458|467580481|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129896189|NCT01836458|467580482|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
129748273|NCT01153698|467037713|FG000|Overall Study|Withdrawal by Subject|2|||
129748274|NCT01153698|467037713|FG000|Overall Study|Switch to other anticoagulants|4|||
129748275|NCT01153698|467037713|FG000|Overall Study|Other|2|||
129748276|NCT01153698|467037713|FG000|Overall Study|Not treated with Pradaxa|5|||
129748277|NCT01496846|467037714|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
129748278|NCT01496846|467037715|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
129748279|NCT01496846|467037716|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129748280|NCT01496846|467037717|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129748281|NCT01496846|467037718|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129748282|NCT01496846|467037719|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
129748283|NCT01772576|467037720|FG000|Overall Study|Death|15|||
129748284|NCT01772576|467037720|FG000|Overall Study|Protocol Violation|1|||
129748285|NCT01772576|467037720|FG000|Overall Study|Lost to Follow-up|3|||
129748286|NCT01772576|467037720|FG000|Overall Study|Study device not used|3|||
129748287|NCT01772576|467037720|FG000|Overall Study|Adverse Event|6|||
129748288|NCT01772576|467037720|FG000|Overall Study|Withdrawal by Subject|6|||
129748289|NCT04356352|467037727|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
129748290|NCT04356352|467037728|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
129748291|NCT04356352|467037729|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
129748292|NCT04356352|467037727|FG000|Overall Study|Protocol Violation|0|||
129748293|NCT04356352|467037728|FG001|Overall Study|Protocol Violation|3|||
129748294|NCT04356352|467037729|FG002|Overall Study|Protocol Violation|1|||
129748295|NCT00379912|467037734|FG000|Overall Study|Lack of Efficacy|1|||
129748296|NCT00379912|467037735|FG001|Overall Study|Lack of Efficacy|0|||
129748297|NCT00621140|467037736|FG000|Overall Study|Adverse Event|4|||
129748298|NCT00621140|467037737|FG001|Overall Study|Adverse Event|5|||
129748299|NCT00621140|467037736|FG000|Overall Study|Lost to Follow-up|1|||
129748300|NCT00621140|467037737|FG001|Overall Study|Lost to Follow-up|2|||
129748301|NCT00621140|467037736|FG000|Overall Study|Withdrawal by Subject|4|||
129748302|NCT00621140|467037737|FG001|Overall Study|Withdrawal by Subject|6|||
129748303|NCT00621140|467037736|FG000|Overall Study|Other incl. lack of efficacy|6|||
129748304|NCT00621140|467037737|FG001|Overall Study|Other incl. lack of efficacy|5|||
129748305|NCT02873338|467037738|FG000|Overall Study|Adverse Event|0|||
129748306|NCT02873338|467037739|FG001|Overall Study|Adverse Event|2|||
129748307|NCT02873338|467037740|FG002|Overall Study|Adverse Event|1|||
129748308|NCT02873338|467037738|FG000|Overall Study|Death|2|||
129748309|NCT02873338|467037739|FG001|Overall Study|Death|1|||
129748310|NCT02873338|467037740|FG002|Overall Study|Death|1|||
129748311|NCT02873338|467037738|FG000|Overall Study|Withdrawal by Subject|2|||
129748312|NCT02873338|467037739|FG001|Overall Study|Withdrawal by Subject|1|||
129748313|NCT02873338|467037740|FG002|Overall Study|Withdrawal by Subject|3|||
129748314|NCT02873338|467037738|FG000|Overall Study|Lack of Efficacy|0|||
129748315|NCT02873338|467037739|FG001|Overall Study|Lack of Efficacy|2|||
129748316|NCT02873338|467037740|FG002|Overall Study|Lack of Efficacy|0|||
129748317|NCT02873338|467037738|FG000|Overall Study|Other or Missing|14|||
129748318|NCT02873338|467037739|FG001|Overall Study|Other or Missing|15|||
129748319|NCT02873338|467037740|FG002|Overall Study|Other or Missing|13|||
129896190|NCT01836458|467580483|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
129896191|NCT02189863|467580484|FG000|First 2 Weeks|Motion Sickness|4|||
129896192|NCT02189863|467580485|FG001|First 2 Weeks|Motion Sickness|2|||
129896193|NCT03369951|467580487|FG000|Overall Study|Withdrawal by Subject|3|||
129896194|NCT03369951|467580487|FG000|Overall Study|Death|1|||
129896195|NCT03369951|467580487|FG000|Overall Study|Lost to Follow-up|1|||
129748320|NCT03657095|467037741|FG000|Overall Study|Withdrawal by Subject|1|||
129748321|NCT03657095|467037742|FG001|Overall Study|Withdrawal by Subject|1|||
129748322|NCT03657095|467037741|FG000|Overall Study|Adverse Event|0|||
129748323|NCT03657095|467037742|FG001|Overall Study|Adverse Event|3|||
129748324|NCT03657095|467037741|FG000|Overall Study|Study Terminated by Sponsor|58|||
129748325|NCT03657095|467037742|FG001|Overall Study|Study Terminated by Sponsor|49|||
129748326|NCT02980133|467037743|FG000|Overall Study|Other than specified|1|||
129748327|NCT02980133|467037744|FG001|Overall Study|Other than specified|1|||
129748328|NCT02980133|467037745|FG002|Overall Study|Other than specified|2|||
129896196|NCT03369951|467580487|FG000|Overall Study|Protocol Violation|1|||
129896197|NCT03677375|467580491|FG000|Overall Study|Incomplete procedure|8|||
129896198|NCT03677375|467580491|FG000|Overall Study|Adverse Event|3|||
129748329|NCT02980133|467037746|FG003|Overall Study|Other than specified|2|||
129748330|NCT02980133|467037743|FG000|Overall Study|Lost to Follow-up|0|||
129748331|NCT02980133|467037744|FG001|Overall Study|Lost to Follow-up|0|||
129748332|NCT02980133|467037745|FG002|Overall Study|Lost to Follow-up|1|||
129748333|NCT02980133|467037746|FG003|Overall Study|Lost to Follow-up|3|||
129748334|NCT02980133|467037743|FG000|Overall Study|Protocol Violation|0|||
129748335|NCT02980133|467037744|FG001|Overall Study|Protocol Violation|1|||
129748336|NCT02980133|467037745|FG002|Overall Study|Protocol Violation|0|||
129748337|NCT02980133|467037746|FG003|Overall Study|Protocol Violation|0|||
129748338|NCT02980133|467037743|FG000|Overall Study|Withdrawal by parent/guardian|6|||
129748339|NCT02980133|467037744|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129748340|NCT02980133|467037745|FG002|Overall Study|Withdrawal by parent/guardian|3|||
129748341|NCT02980133|467037746|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129748342|NCT02980133|467037743|FG000|Overall Study|Withdrawal by Subject|0|||
129748343|NCT02980133|467037744|FG001|Overall Study|Withdrawal by Subject|0|||
129748344|NCT02980133|467037745|FG002|Overall Study|Withdrawal by Subject|1|||
129748345|NCT02980133|467037746|FG003|Overall Study|Withdrawal by Subject|0|||
129748346|NCT00384332|467037747|FG000|Overall Study|Lost to Follow-up|4|||
129748347|NCT00384332|467037748|FG001|Overall Study|Lost to Follow-up|0|||
129748348|NCT02560012|467037749|FG000|Overall Study|Study Terminated|2|||
129748349|NCT01007838|467037750|FG000|Overall Study|Withdrawal by Subject|1|||
129748350|NCT01007838|467037751|FG001|Overall Study|Withdrawal by Subject|0|||
129748351|NCT01007838|467037752|FG002|Overall Study|Withdrawal by Subject|0|||
129748352|NCT01007838|467037753|FG003|Overall Study|Withdrawal by Subject|0|||
129748353|NCT01007838|467037750|FG000|Overall Study|Physician Decision|1|||
129748354|NCT01007838|467037751|FG001|Overall Study|Physician Decision|0|||
129748355|NCT01007838|467037752|FG002|Overall Study|Physician Decision|0|||
129748356|NCT01007838|467037753|FG003|Overall Study|Physician Decision|0|||
129748357|NCT01007838|467037750|FG000|Overall Study|Started home haemodialysis|1|||
129748358|NCT01007838|467037751|FG001|Overall Study|Started home haemodialysis|0|||
129748359|NCT01007838|467037752|FG002|Overall Study|Started home haemodialysis|0|||
129748360|NCT01007838|467037753|FG003|Overall Study|Started home haemodialysis|0|||
129748361|NCT00852241|467037754|FG000|Overall Study|Physician Decision|18|||
129748362|NCT00118430|467037756|FG000|Overall Study|Withdrawal by Subject|6|||
129748363|NCT00118430|467037757|FG001|Overall Study|Withdrawal by Subject|2|||
129748364|NCT00118430|467037758|FG002|Overall Study|Withdrawal by Subject|0|||
129748365|NCT00118430|467037756|FG000|Overall Study|Lost to Follow-up|15|||
129748366|NCT00118430|467037757|FG001|Overall Study|Lost to Follow-up|22|||
129748367|NCT00118430|467037758|FG002|Overall Study|Lost to Follow-up|28|||
129748368|NCT02147288|467037759|FG000|Overall Study|post-operative hematoma|1|||
129748369|NCT02147288|467037760|FG001|Overall Study|post-operative hematoma|1|||
129748370|NCT02147288|467037761|FG002|Overall Study|post-operative hematoma|0|||
129748371|NCT02147288|467037762|FG003|Overall Study|post-operative hematoma|0|||
129748372|NCT02147288|467037763|FG004|Overall Study|post-operative hematoma|0|||
129748373|NCT02147288|467037764|FG005|Overall Study|post-operative hematoma|0|||
129748374|NCT02147288|467037765|FG006|Overall Study|post-operative hematoma|0|||
129748375|NCT02147288|467037766|FG007|Overall Study|post-operative hematoma|0|||
129748376|NCT02147288|467037767|FG008|Overall Study|post-operative hematoma|0|||
129748377|NCT02147288|467037768|FG009|Overall Study|post-operative hematoma|0|||
129748378|NCT02147288|467037759|FG000|Overall Study|complications from concurrent hernia rep|0|||
129748379|NCT02147288|467037760|FG001|Overall Study|complications from concurrent hernia rep|1|||
129748380|NCT02147288|467037761|FG002|Overall Study|complications from concurrent hernia rep|0|||
129748381|NCT02147288|467037762|FG003|Overall Study|complications from concurrent hernia rep|0|||
129748382|NCT02147288|467037763|FG004|Overall Study|complications from concurrent hernia rep|0|||
129748383|NCT02147288|467037764|FG005|Overall Study|complications from concurrent hernia rep|0|||
129748384|NCT02147288|467037765|FG006|Overall Study|complications from concurrent hernia rep|0|||
129748385|NCT02147288|467037766|FG007|Overall Study|complications from concurrent hernia rep|0|||
129748386|NCT02147288|467037767|FG008|Overall Study|complications from concurrent hernia rep|0|||
129748387|NCT02147288|467037768|FG009|Overall Study|complications from concurrent hernia rep|0|||
129748388|NCT02069392|467037771|FG000|Overall Study|Withdrawal by Subject|4|||
129748389|NCT02069392|467037772|FG001|Overall Study|Withdrawal by Subject|2|||
129748390|NCT00269633|467037773|FG000|Overall Study|Withdrawal by Subject|1|||
129748391|NCT00269633|467037774|FG001|Overall Study|Withdrawal by Subject|0|||
129748392|NCT02927938|467037775|FG000|Overall Study|Death|0|||
129748393|NCT02927938|467037776|FG001|Overall Study|Death|1|||
129748394|NCT02927938|467037777|FG002|Overall Study|Death|0|||
129748395|NCT02927938|467037778|FG003|Overall Study|Death|4|||
129748396|NCT02927938|467037775|FG000|Overall Study|Early Study Termination|1|||
129748397|NCT02927938|467037776|FG001|Overall Study|Early Study Termination|5|||
129748398|NCT02927938|467037777|FG002|Overall Study|Early Study Termination|4|||
129748399|NCT02927938|467037778|FG003|Overall Study|Early Study Termination|3|||
129748400|NCT02476006|467037779|FG000|Overall Study|Death|4|||
129748401|NCT02476006|467037779|FG000|Overall Study|Lack of treatment efficacy|2|||
129748402|NCT02476006|467037779|FG000|Overall Study|Pregnancy|1|||
129748403|NCT02476006|467037779|FG000|Overall Study|Participant did not wish to continue|39|||
129748404|NCT02476006|467037779|FG000|Overall Study|Adverse Event|41|||
129748405|NCT02476006|467037779|FG000|Overall Study|Poor compliance to study protocol|3|||
129748406|NCT02476006|467037779|FG000|Overall Study|Sponsor decision|6|||
129748407|NCT02476006|467037779|FG000|Overall Study|Lost to Follow-up|5|||
129748408|NCT02476006|467037779|FG000|Overall Study|Physician Decision|5|||
129748409|NCT02476006|467037779|FG000|Overall Study|Study ended treatment not available|4|||
129748410|NCT02476006|467037779|FG000|Overall Study|Switched to commercial drug|4|||
129748411|NCT02476006|467037779|FG000|Overall Study|Excluded from study|1|||
129748412|NCT02476006|467037779|FG000|Overall Study|Protocol Violation|1|||
129748413|NCT02476006|467037779|FG000|Overall Study|Enrolled but not treated|4|||
129748414|NCT02611817|467040076|FG000|Open-label Induction Phase|Reason not Specified|9|||
129748415|NCT02611817|467040077|FG001|Open-label Induction Phase|Reason not Specified|0|||
129748416|NCT02611817|467040078|FG002|Open-label Induction Phase|Reason not Specified|0|||
129748417|NCT02611817|467040076|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
129748418|NCT02611817|467040077|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
129748419|NCT02611817|467040078|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
129748420|NCT02611817|467040076|FG000|Open-label Induction Phase|Pregnancy|1|||
129748421|NCT02611817|467040077|FG001|Open-label Induction Phase|Pregnancy|0|||
129748422|NCT02611817|467040078|FG002|Open-label Induction Phase|Pregnancy|0|||
129748423|NCT02611817|467040076|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
129748424|NCT02611817|467040077|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
129748425|NCT02611817|467040078|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
129748426|NCT02611817|467040076|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
129748427|NCT02611817|467040077|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
129748428|NCT02611817|467040078|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
129748429|NCT02611817|467040076|FG000|Open-label Induction Phase|Protocol Violation|5|||
129748430|NCT02611817|467040077|FG001|Open-label Induction Phase|Protocol Violation|0|||
129748431|NCT02611817|467040078|FG002|Open-label Induction Phase|Protocol Violation|0|||
129748432|NCT02611817|467040076|FG000|Open-label Induction Phase|Adverse Event|16|||
129748433|NCT02611817|467040077|FG001|Open-label Induction Phase|Adverse Event|0|||
129748434|NCT02611817|467040078|FG002|Open-label Induction Phase|Adverse Event|0|||
129748435|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
129748436|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
129748437|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
129748438|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
129748439|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
129748440|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
129748441|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
129748442|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
129748443|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
129748444|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
129748445|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
129748446|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
129748447|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
129748448|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
129748449|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
129748450|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
129748451|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
129748452|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
129748453|NCT02611817|467040076|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
129748454|NCT02611817|467040077|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
129748455|NCT02611817|467040078|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
129748456|NCT00931606|467040079|FG000|Overall Study|Death|1|||
129748457|NCT00931606|467040080|FG001|Overall Study|Death|3|||
129748458|NCT00931606|467040081|FG002|Overall Study|Death|2|||
129748459|NCT00931606|467040082|FG003|Overall Study|Death|0|||
129748460|NCT00931606|467040079|FG000|Overall Study|Lost to Follow-up|0|||
129748461|NCT00931606|467040080|FG001|Overall Study|Lost to Follow-up|1|||
129748462|NCT00931606|467040081|FG002|Overall Study|Lost to Follow-up|0|||
129748463|NCT00931606|467040082|FG003|Overall Study|Lost to Follow-up|0|||
129748464|NCT00931606|467040079|FG000|Overall Study|Physician Decision|0|||
129748465|NCT00931606|467040080|FG001|Overall Study|Physician Decision|0|||
129748466|NCT00931606|467040081|FG002|Overall Study|Physician Decision|3|||
129748467|NCT00931606|467040082|FG003|Overall Study|Physician Decision|0|||
129748468|NCT00931606|467040079|FG000|Overall Study|Sponsor Decision|1|||
129748469|NCT00931606|467040080|FG001|Overall Study|Sponsor Decision|4|||
129748470|NCT00931606|467040081|FG002|Overall Study|Sponsor Decision|0|||
129748471|NCT00931606|467040082|FG003|Overall Study|Sponsor Decision|2|||
129748472|NCT00931606|467040079|FG000|Overall Study|Withdrawal by Subject|3|||
129748473|NCT00931606|467040080|FG001|Overall Study|Withdrawal by Subject|1|||
129748474|NCT00931606|467040081|FG002|Overall Study|Withdrawal by Subject|1|||
129748475|NCT00931606|467040082|FG003|Overall Study|Withdrawal by Subject|1|||
129748476|NCT03412812|467040090|FG000|Level 1|Death|3|||
129748477|NCT03412812|467040091|FG001|Level 1|Death|0|||
129748478|NCT03412812|467040090|FG000|Level 1|Adverse Event|0|||
129748479|NCT03412812|467040091|FG001|Level 1|Adverse Event|1|||
129748480|NCT03828617|467040095|FG000|Overall Study|Lost to Follow-up|22|||
129748481|NCT03828617|467040096|FG001|Overall Study|Lost to Follow-up|12|||
129748482|NCT03828617|467040097|FG002|Overall Study|Lost to Follow-up|23|||
129748483|NCT03828617|467040098|FG003|Overall Study|Lost to Follow-up|7|||
129748484|NCT03828617|467040095|FG000|Overall Study|No longer met eligibility criteria|0|||
129748485|NCT03828617|467040096|FG001|Overall Study|No longer met eligibility criteria|1|||
129748486|NCT03828617|467040097|FG002|Overall Study|No longer met eligibility criteria|1|||
129748487|NCT03828617|467040098|FG003|Overall Study|No longer met eligibility criteria|3|||
129748488|NCT03828617|467040095|FG000|Overall Study|Protocol Violation|0|||
129748489|NCT03828617|467040096|FG001|Overall Study|Protocol Violation|2|||
129748490|NCT03828617|467040097|FG002|Overall Study|Protocol Violation|0|||
129748491|NCT03828617|467040098|FG003|Overall Study|Protocol Violation|0|||
129748492|NCT03828617|467040095|FG000|Overall Study|Withdrawal by Subject|2|||
129748493|NCT03828617|467040096|FG001|Overall Study|Withdrawal by Subject|0|||
129748494|NCT03828617|467040097|FG002|Overall Study|Withdrawal by Subject|2|||
129748495|NCT03828617|467040098|FG003|Overall Study|Withdrawal by Subject|0|||
129748496|NCT03826186|467040099|FG000|Overall Study|Protocol Violation|2|||
129748497|NCT03826186|467040100|FG001|Overall Study|Protocol Violation|0|||
129748498|NCT03826186|467040099|FG000|Overall Study|Withdrawal by Subject|1|||
129748499|NCT03826186|467040100|FG001|Overall Study|Withdrawal by Subject|0|||
129748500|NCT00082407|467040103|FG000|Overall Study|Adverse Event|20|||
129748501|NCT00082407|467040104|FG001|Overall Study|Adverse Event|0|||
129748502|NCT00082407|467040103|FG000|Overall Study|Protocol Violation|14|||
129748503|NCT00082407|467040104|FG001|Overall Study|Protocol Violation|12|||
129748504|NCT00082407|467040103|FG000|Overall Study|Patient Decision|13|||
129748505|NCT00082407|467040104|FG001|Overall Study|Patient Decision|6|||
129748506|NCT00082407|467040103|FG000|Overall Study|Physician Decision|5|||
129748507|NCT00082407|467040104|FG001|Overall Study|Physician Decision|3|||
129748508|NCT00082407|467040103|FG000|Overall Study|Loss of Glucose Control|2|||
129748509|NCT00082407|467040104|FG001|Overall Study|Loss of Glucose Control|2|||
129748510|NCT00082407|467040103|FG000|Overall Study|Death|2|||
129748511|NCT00082407|467040104|FG001|Overall Study|Death|1|||
129748512|NCT00082407|467040103|FG000|Overall Study|Lost to Follow-up|0|||
129748513|NCT00082407|467040104|FG001|Overall Study|Lost to Follow-up|3|||
129748514|NCT00891228|467040106|FG000|Overall Study|Adverse Event|0|||
129748515|NCT00891228|467040107|FG001|Overall Study|Adverse Event|2|||
129748516|NCT00891228|467040108|FG002|Overall Study|Adverse Event|3|||
129748517|NCT00891228|467040106|FG000|Overall Study|Withdrawal by Subject|2|||
129748518|NCT00891228|467040107|FG001|Overall Study|Withdrawal by Subject|4|||
129748519|NCT00891228|467040108|FG002|Overall Study|Withdrawal by Subject|5|||
129748520|NCT00891228|467040106|FG000|Overall Study|Protocol Violation|3|||
129748521|NCT00891228|467040107|FG001|Overall Study|Protocol Violation|1|||
129748522|NCT00891228|467040108|FG002|Overall Study|Protocol Violation|2|||
129748523|NCT00891228|467040106|FG000|Overall Study|Physician Decision|2|||
129748524|NCT00891228|467040107|FG001|Overall Study|Physician Decision|1|||
129748525|NCT00891228|467040108|FG002|Overall Study|Physician Decision|0|||
129748526|NCT00891228|467040106|FG000|Overall Study|Lost to Follow-up|4|||
129748527|NCT00891228|467040107|FG001|Overall Study|Lost to Follow-up|4|||
129748528|NCT00891228|467040108|FG002|Overall Study|Lost to Follow-up|5|||
129748529|NCT00891228|467040106|FG000|Overall Study|Pregnancy|0|||
129748530|NCT00891228|467040107|FG001|Overall Study|Pregnancy|1|||
129748531|NCT00891228|467040108|FG002|Overall Study|Pregnancy|0|||
129748532|NCT02688985|467040111|FG000|Overall Study|Adverse Event|1|||
129748533|NCT02688985|467040112|FG001|Overall Study|Adverse Event|2|||
129748534|NCT02688985|467040113|FG002|Overall Study|Adverse Event|2|||
129748535|NCT02688985|467040114|FG003|Overall Study|Adverse Event|0|||
129748536|NCT02688985|467040115|FG004|Overall Study|Adverse Event|0|||
129748537|NCT02688985|467040111|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
129748538|NCT02688985|467040112|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
129748539|NCT02688985|467040113|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
129748540|NCT02688985|467040114|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
129748541|NCT02688985|467040115|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
129748542|NCT02688985|467040111|FG000|Overall Study|Death|0|||
129748543|NCT02688985|467040112|FG001|Overall Study|Death|0|||
129748544|NCT02688985|467040113|FG002|Overall Study|Death|0|||
129748545|NCT02688985|467040114|FG003|Overall Study|Death|0|||
129748546|NCT02688985|467040115|FG004|Overall Study|Death|1|||
129748547|NCT02688985|467040111|FG000|Overall Study|Lack of Efficacy|0|||
129748548|NCT02688985|467040112|FG001|Overall Study|Lack of Efficacy|0|||
129748549|NCT02688985|467040113|FG002|Overall Study|Lack of Efficacy|0|||
129748550|NCT02688985|467040114|FG003|Overall Study|Lack of Efficacy|0|||
129748551|NCT02688985|467040115|FG004|Overall Study|Lack of Efficacy|1|||
129748552|NCT02688985|467040111|FG000|Overall Study|Lost to Follow-up|2|||
129748553|NCT02688985|467040112|FG001|Overall Study|Lost to Follow-up|0|||
129748554|NCT02688985|467040113|FG002|Overall Study|Lost to Follow-up|1|||
129748555|NCT02688985|467040114|FG003|Overall Study|Lost to Follow-up|1|||
129748556|NCT02688985|467040115|FG004|Overall Study|Lost to Follow-up|1|||
129748557|NCT02688985|467040111|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129748558|NCT02688985|467040112|FG001|Overall Study|Non-Compliance With Study Drug|3|||
129748559|NCT02688985|467040113|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129748560|NCT02688985|467040114|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129748561|NCT02688985|467040115|FG004|Overall Study|Non-Compliance With Study Drug|1|||
129748562|NCT02688985|467040111|FG000|Overall Study|Other|3|||
129748563|NCT02688985|467040112|FG001|Overall Study|Other|4|||
129748564|NCT02688985|467040113|FG002|Overall Study|Other|1|||
129748565|NCT02688985|467040114|FG003|Overall Study|Other|0|||
129748566|NCT02688985|467040115|FG004|Overall Study|Other|0|||
129748567|NCT02688985|467040111|FG000|Overall Study|Physician Decision|2|||
129748568|NCT02688985|467040112|FG001|Overall Study|Physician Decision|2|||
129748569|NCT02688985|467040113|FG002|Overall Study|Physician Decision|0|||
129748570|NCT02688985|467040114|FG003|Overall Study|Physician Decision|0|||
129748571|NCT02688985|467040115|FG004|Overall Study|Physician Decision|1|||
129748572|NCT02688985|467040111|FG000|Overall Study|Pregnancy|0|||
129748573|NCT02688985|467040112|FG001|Overall Study|Pregnancy|0|||
129809068|NCT00437983|467265846|FG000|Overall Study|Protocol Violation|2|||
129809069|NCT00437983|467265847|FG001|Overall Study|Protocol Violation|1|||
129809070|NCT00437983|467265846|FG000|Overall Study|Withdrawal by Subject|5|||
129809071|NCT00437983|467265847|FG001|Overall Study|Withdrawal by Subject|6|||
129748574|NCT02688985|467040113|FG002|Overall Study|Pregnancy|2|||
129748575|NCT02688985|467040114|FG003|Overall Study|Pregnancy|1|||
129748576|NCT02688985|467040115|FG004|Overall Study|Pregnancy|0|||
129748577|NCT02688985|467040111|FG000|Overall Study|Study Terminated By Sponsor|0|||
129748578|NCT02688985|467040112|FG001|Overall Study|Study Terminated By Sponsor|0|||
129748579|NCT02688985|467040113|FG002|Overall Study|Study Terminated By Sponsor|0|||
129748580|NCT02688985|467040114|FG003|Overall Study|Study Terminated By Sponsor|1|||
129748581|NCT02688985|467040115|FG004|Overall Study|Study Terminated By Sponsor|0|||
129748582|NCT02688985|467040111|FG000|Overall Study|Withdrawal by Subject|2|||
129748583|NCT02688985|467040112|FG001|Overall Study|Withdrawal by Subject|8|||
129748584|NCT02688985|467040113|FG002|Overall Study|Withdrawal by Subject|7|||
129748585|NCT02688985|467040114|FG003|Overall Study|Withdrawal by Subject|1|||
129748586|NCT02688985|467040115|FG004|Overall Study|Withdrawal by Subject|4|||
129748587|NCT01726582|467040118|FG000|Overall Study|Physician Decision|99|||
129748588|NCT01726582|467040118|FG000|Overall Study|Death|85|||
129748589|NCT01363908|467040119|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
129748590|NCT01363908|467040120|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
129748591|NCT01363908|467040119|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
129748592|NCT01363908|467040120|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
129748593|NCT01363908|467040119|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
129809072|NCT00672646|467265850|FG000|Overall Study|Lost to Follow-up|0|||
129809073|NCT00672646|467265851|FG001|Overall Study|Lost to Follow-up|1|||
129809074|NCT00672646|467265852|FG002|Overall Study|Lost to Follow-up|2|||
129809075|NCT00672646|467265850|FG000|Overall Study|Withdrawal by Subject|0|||
129809076|NCT00672646|467265851|FG001|Overall Study|Withdrawal by Subject|0|||
129809077|NCT00672646|467265852|FG002|Overall Study|Withdrawal by Subject|1|||
129809078|NCT00242216|467265853|FG000|Overall Study|Lost to Follow-up|12|||
129809079|NCT00242216|467265854|FG001|Overall Study|Lost to Follow-up|17|||
129809080|NCT00242216|467265853|FG000|Overall Study|Death|4|||
129809081|NCT00242216|467265854|FG001|Overall Study|Death|2|||
129809082|NCT00242216|467265853|FG000|Overall Study|Lack of Efficacy|1|||
129809083|NCT00242216|467265854|FG001|Overall Study|Lack of Efficacy|2|||
129809084|NCT00242216|467265853|FG000|Overall Study|no medicaiton dispensed|1|||
129809085|NCT00242216|467265854|FG001|Overall Study|no medicaiton dispensed|1|||
129809086|NCT00678080|467265855|FG000|Overall Study|Physician Decision|2|||
129809087|NCT00678080|467265856|FG001|Overall Study|Physician Decision|0|||
129748594|NCT01363908|467040120|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
129748595|NCT01363908|467040119|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
129748596|NCT01363908|467040120|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
129748597|NCT03437577|467040121|FG000|Pre-Randomization|Withdrawal by Subject|0|||
129748598|NCT03437577|467040122|FG001|Pre-Randomization|Withdrawal by Subject|0|||
129748599|NCT03437577|467040123|FG002|Pre-Randomization|Withdrawal by Subject|10|||
129748600|NCT03437577|467040121|FG000|Post-Randomization|Physician Decision|0|||
129748601|NCT03437577|467040122|FG001|Post-Randomization|Physician Decision|2|||
129809088|NCT00678080|467265855|FG000|Overall Study|Lost to Follow-up|1|||
129809089|NCT00678080|467265856|FG001|Overall Study|Lost to Follow-up|0|||
129809090|NCT00678080|467265855|FG000|Overall Study|Withdrawal by Subject|0|||
129809091|NCT00678080|467265856|FG001|Overall Study|Withdrawal by Subject|1|||
129809092|NCT01034631|467267571|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
129809093|NCT01034631|467267572|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
129809094|NCT01034631|467267573|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
129809095|NCT01034631|467267571|FG000|Phase II|Not Evaluable per protocol|0|||
129809096|NCT01034631|467267572|FG001|Phase II|Not Evaluable per protocol|0|||
129809097|NCT01034631|467267573|FG002|Phase II|Not Evaluable per protocol|2|||
129809098|NCT01034631|467267571|FG000|Phase II|Determined Ineligible per protocol|0|||
129809099|NCT01034631|467267572|FG001|Phase II|Determined Ineligible per protocol|1|||
129809100|NCT01034631|467267573|FG002|Phase II|Determined Ineligible per protocol|0|||
129748602|NCT03437577|467040123|FG002|Post-Randomization|Physician Decision|0|||
129748603|NCT00536471|467040124|FG000|Overall Study|Lost to Follow-up|48|||
129748604|NCT00536471|467040125|FG001|Overall Study|Lost to Follow-up|23|||
129748605|NCT00536471|467040126|FG002|Overall Study|Lost to Follow-up|48|||
129748606|NCT00536471|467040127|FG003|Overall Study|Lost to Follow-up|22|||
129748607|NCT00536471|467040124|FG000|Overall Study|Adverse Event|32|||
129748608|NCT00536471|467040125|FG001|Overall Study|Adverse Event|16|||
129748609|NCT00536471|467040126|FG002|Overall Study|Adverse Event|28|||
129748610|NCT00536471|467040127|FG003|Overall Study|Adverse Event|13|||
129748611|NCT00536471|467040124|FG000|Overall Study|Withdrawal by Subject|40|||
129748612|NCT00536471|467040125|FG001|Overall Study|Withdrawal by Subject|24|||
129748613|NCT00536471|467040126|FG002|Overall Study|Withdrawal by Subject|43|||
129748614|NCT00536471|467040127|FG003|Overall Study|Withdrawal by Subject|21|||
129748615|NCT00536471|467040124|FG000|Overall Study|Lack of Efficacy|17|||
129748616|NCT00536471|467040125|FG001|Overall Study|Lack of Efficacy|18|||
129748617|NCT00536471|467040126|FG002|Overall Study|Lack of Efficacy|11|||
129748618|NCT00536471|467040127|FG003|Overall Study|Lack of Efficacy|9|||
129748619|NCT00536471|467040124|FG000|Overall Study|Protocol Violation|8|||
129748620|NCT00536471|467040125|FG001|Overall Study|Protocol Violation|1|||
129748621|NCT00536471|467040126|FG002|Overall Study|Protocol Violation|2|||
129748622|NCT00536471|467040127|FG003|Overall Study|Protocol Violation|3|||
129748623|NCT00536471|467040124|FG000|Overall Study|Physician Decision|11|||
129748624|NCT00536471|467040125|FG001|Overall Study|Physician Decision|1|||
129748625|NCT00536471|467040126|FG002|Overall Study|Physician Decision|3|||
129748626|NCT00536471|467040127|FG003|Overall Study|Physician Decision|2|||
129748627|NCT00536471|467040124|FG000|Overall Study|Death|0|||
129748628|NCT00536471|467040125|FG001|Overall Study|Death|0|||
129748629|NCT00536471|467040126|FG002|Overall Study|Death|1|||
129748630|NCT00536471|467040127|FG003|Overall Study|Death|2|||
129748631|NCT00536471|467040124|FG000|Overall Study|Sponsor Decision|0|||
129748632|NCT00536471|467040125|FG001|Overall Study|Sponsor Decision|1|||
129748633|NCT00536471|467040126|FG002|Overall Study|Sponsor Decision|3|||
129748634|NCT00536471|467040127|FG003|Overall Study|Sponsor Decision|2|||
129748635|NCT00988091|467040137|FG000|Double-blind Period|Withdrawal by Subject|15|||
129748636|NCT00988091|467040138|FG001|Double-blind Period|Withdrawal by Subject|13|||
129748637|NCT00988091|467040137|FG000|Double-blind Period|Lost to Follow-up|12|||
129748638|NCT00988091|467040138|FG001|Double-blind Period|Lost to Follow-up|14|||
129748639|NCT00988091|467040137|FG000|Double-blind Period|Other|8|||
129748640|NCT00988091|467040138|FG001|Double-blind Period|Other|8|||
129748641|NCT00988091|467040137|FG000|Double-blind Period|Adverse Event|6|||
129748642|NCT00988091|467040138|FG001|Double-blind Period|Adverse Event|9|||
129748643|NCT00988091|467040137|FG000|Double-blind Period|Use of exclusionary medication|2|||
129748644|NCT00988091|467040138|FG001|Double-blind Period|Use of exclusionary medication|3|||
129748645|NCT00988091|467040137|FG000|Open-label Period|Adverse Event|4|||
129748646|NCT00988091|467040138|FG001|Open-label Period|Adverse Event|7|||
129748647|NCT00988091|467040137|FG000|Open-label Period|Use of exclusionary medication|1|||
129748648|NCT00988091|467040138|FG001|Open-label Period|Use of exclusionary medication|1|||
129748649|NCT00988091|467040137|FG000|Open-label Period|Protocol Violation|1|||
129748650|NCT00988091|467040138|FG001|Open-label Period|Protocol Violation|1|||
129748651|NCT00988091|467040137|FG000|Open-label Period|Withdrawal by Subject|10|||
129748652|NCT00988091|467040138|FG001|Open-label Period|Withdrawal by Subject|16|||
129748653|NCT00988091|467040137|FG000|Open-label Period|Lost to Follow-up|3|||
129748654|NCT00988091|467040138|FG001|Open-label Period|Lost to Follow-up|5|||
129748655|NCT00988091|467040137|FG000|Open-label Period|Other|2|||
129748656|NCT00988091|467040138|FG001|Open-label Period|Other|3|||
129748657|NCT00994422|467040139|FG000|Overall Study|Lost to Follow-up|7|||
129748658|NCT00994422|467040140|FG001|Overall Study|Lost to Follow-up|1|||
129748659|NCT00836186|467040145|FG000|Overall Study|Blood could not be drawn|1|||
129748660|NCT00532298|467040146|FG000|Overall Study|Adverse Event|1|||
129748661|NCT00532298|467040147|FG001|Overall Study|Adverse Event|0|||
129748662|NCT00532298|467040148|FG002|Overall Study|Adverse Event|0|||
129748663|NCT00532298|467040149|FG003|Overall Study|Adverse Event|0|||
129748664|NCT00532298|467040150|FG004|Overall Study|Adverse Event|1|||
129748665|NCT00532298|467040151|FG005|Overall Study|Adverse Event|1|||
129748666|NCT00532298|467040146|FG000|Overall Study|Lost to Follow-up|1|||
129748667|NCT00532298|467040147|FG001|Overall Study|Lost to Follow-up|1|||
129748668|NCT00532298|467040148|FG002|Overall Study|Lost to Follow-up|1|||
129748669|NCT00532298|467040149|FG003|Overall Study|Lost to Follow-up|0|||
129748670|NCT00532298|467040150|FG004|Overall Study|Lost to Follow-up|0|||
129748671|NCT00532298|467040151|FG005|Overall Study|Lost to Follow-up|1|||
129748672|NCT01973998|467040152|FG000|Overall Study|Death|2|||
129748673|NCT01973998|467040153|FG001|Overall Study|Death|2|||
129748674|NCT02951429|467040160|FG000|Overall Study|Adverse Event|3|||
129748675|NCT02951429|467040161|FG001|Overall Study|Adverse Event|7|||
129748676|NCT02951429|467040160|FG000|Overall Study|Death|28|||
129748677|NCT02951429|467040161|FG001|Overall Study|Death|36|||
129748678|NCT02951429|467040160|FG000|Overall Study|Lack of Efficacy|0|||
129748679|NCT02951429|467040161|FG001|Overall Study|Lack of Efficacy|1|||
129748680|NCT02951429|467040160|FG000|Overall Study|Lost to Follow-up|0|||
129748681|NCT02951429|467040161|FG001|Overall Study|Lost to Follow-up|1|||
129748682|NCT02951429|467040160|FG000|Overall Study|Lung Transplantation|9|||
129748683|NCT02951429|467040161|FG001|Overall Study|Lung Transplantation|6|||
129748684|NCT02951429|467040160|FG000|Overall Study|Other|1|||
129748685|NCT02951429|467040161|FG001|Overall Study|Other|3|||
129748686|NCT02951429|467040160|FG000|Overall Study|Progressive Disease|1|||
129748687|NCT02951429|467040161|FG001|Overall Study|Progressive Disease|1|||
129748688|NCT02951429|467040160|FG000|Overall Study|Withdrawal by Subject|7|||
129748689|NCT02951429|467040161|FG001|Overall Study|Withdrawal by Subject|11|||
129748690|NCT02951429|467040160|FG000|Overall Study|Participant ongoing in the study|23|||
129748691|NCT02951429|467040161|FG001|Overall Study|Participant ongoing in the study|17|||
129748692|NCT01620528|467040162|FG000|Treatment Period|Did Not Receive Study Drug|0|||
129748693|NCT01620528|467040163|FG001|Treatment Period|Did Not Receive Study Drug|0|||
129748694|NCT01620528|467040164|FG002|Treatment Period|Did Not Receive Study Drug|1|||
129748695|NCT01620528|467040162|FG000|Treatment Period|Withdrawal by Subject|35|||
129748696|NCT01620528|467040163|FG001|Treatment Period|Withdrawal by Subject|21|||
129748697|NCT01620528|467040164|FG002|Treatment Period|Withdrawal by Subject|16|||
129748698|NCT01620528|467040162|FG000|Treatment Period|Adverse Event|17|||
129748699|NCT01620528|467040163|FG001|Treatment Period|Adverse Event|13|||
129748700|NCT01620528|467040164|FG002|Treatment Period|Adverse Event|21|||
129748701|NCT01620528|467040162|FG000|Treatment Period|Lost to Follow-up|16|||
129748702|NCT01620528|467040163|FG001|Treatment Period|Lost to Follow-up|8|||
129748703|NCT01620528|467040164|FG002|Treatment Period|Lost to Follow-up|14|||
129748704|NCT01620528|467040162|FG000|Treatment Period|Other|9|||
129748705|NCT01620528|467040163|FG001|Treatment Period|Other|5|||
129748706|NCT01620528|467040164|FG002|Treatment Period|Other|7|||
129748707|NCT01620528|467040162|FG000|Treatment Period|Subject Noncompliant|11|||
129748708|NCT01620528|467040163|FG001|Treatment Period|Subject Noncompliant|2|||
129748709|NCT01620528|467040164|FG002|Treatment Period|Subject Noncompliant|2|||
129748710|NCT01620528|467040162|FG000|Treatment Period|Pregnancy|7|||
129748711|NCT01620528|467040163|FG001|Treatment Period|Pregnancy|2|||
129748712|NCT01620528|467040164|FG002|Treatment Period|Pregnancy|2|||
129748713|NCT01620528|467040162|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
129748714|NCT01620528|467040163|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
129748715|NCT01620528|467040164|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
129748716|NCT01620528|467040162|FG000|Treatment Period|Exclusionary Medication Received|0|||
129748717|NCT01620528|467040163|FG001|Treatment Period|Exclusionary Medication Received|1|||
129748718|NCT01620528|467040164|FG002|Treatment Period|Exclusionary Medication Received|0|||
129748719|NCT01620528|467040162|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
129748720|NCT01620528|467040163|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
129748721|NCT01620528|467040164|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
129748722|NCT01620528|467040162|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129748723|NCT01620528|467040163|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129748724|NCT01620528|467040164|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
129748725|NCT01620528|467040162|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
129748726|NCT01620528|467040163|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
129748727|NCT01620528|467040164|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
129748728|NCT01620528|467040162|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
129748729|NCT01620528|467040163|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
129748730|NCT01620528|467040164|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
129748731|NCT01620528|467040162|FG000|Post-Treatment Follow-Up Period|Other|6|||
129748732|NCT01620528|467040163|FG001|Post-Treatment Follow-Up Period|Other|4|||
129748733|NCT01620528|467040164|FG002|Post-Treatment Follow-Up Period|Other|2|||
129748734|NCT03664765|467040165|FG000|Overall Study|Withdrawal by Subject|4|||
129748735|NCT03664765|467040166|FG001|Overall Study|Withdrawal by Subject|1|||
129748736|NCT03664765|467040165|FG000|Overall Study|Lost to Follow-up|0|||
129748737|NCT03664765|467040166|FG001|Overall Study|Lost to Follow-up|1|||
129748738|NCT01090063|467040167|FG000|Screen|Screen Failed|4|||
129748739|NCT01090063|467040167|FG000|Treatment|Withdrawal by Subject|4|||
129748740|NCT02106403|467040171|FG000|Follow-Up Visit 3|Other Reason|0|||
129748741|NCT02106403|467040172|FG001|Follow-Up Visit 3|Other Reason|0|||
129748742|NCT02106403|467040173|FG002|Follow-Up Visit 3|Other Reason|0|||
129748743|NCT02106403|467040174|FG003|Follow-Up Visit 3|Other Reason|0|||
129748744|NCT02106403|467040175|FG004|Follow-Up Visit 3|Other Reason|0|||
129748745|NCT02106403|467040176|FG005|Follow-Up Visit 3|Other Reason|1|||
129809101|NCT03372096|467267575|FG000|Overall Study|Study Closed|8|||
129809102|NCT00680017|467267576|FG000|Overall Study|Adverse Event|13|||
129809103|NCT00680017|467267577|FG001|Overall Study|Adverse Event|7|||
129809104|NCT00680017|467267576|FG000|Overall Study|Withdrawal by Subject|2|||
129809105|NCT00680017|467267577|FG001|Overall Study|Withdrawal by Subject|5|||
129809106|NCT00680017|467267576|FG000|Overall Study|Lost to Follow-up|2|||
129809107|NCT00680017|467267577|FG001|Overall Study|Lost to Follow-up|0|||
129809108|NCT05074667|467267578|FG000|Overall Study|Death|1|||
129809109|NCT05074667|467267578|FG000|Overall Study|Withdrawal by Subject|4|||
129896199|NCT03677375|467580491|FG000|Overall Study|Physician Decision|1|||
129896200|NCT00561574|467580497|FG000|Overall Study|Adverse Event|21|||
129896201|NCT00561574|467580498|FG001|Overall Study|Adverse Event|24|||
129896202|NCT00561574|467580497|FG000|Overall Study|Lack of Efficacy|11|||
129748746|NCT04038567|467040178|FG000|Overall Study|Lost to Follow-up|6|||
129748747|NCT04038567|467040179|FG001|Overall Study|Lost to Follow-up|4|||
129748748|NCT04038567|467040180|FG002|Overall Study|Lost to Follow-up|5|||
129748749|NCT04038567|467040181|FG003|Overall Study|Lost to Follow-up|4|||
129748750|NCT04038567|467040182|FG004|Overall Study|Lost to Follow-up|6|||
129748751|NCT04038567|467040183|FG005|Overall Study|Lost to Follow-up|4|||
129748752|NCT04038567|467040184|FG006|Overall Study|Lost to Follow-up|4|||
129748753|NCT04038567|467040185|FG007|Overall Study|Lost to Follow-up|1|||
129748754|NCT04038567|467040178|FG000|Overall Study|Withdrawal by Subject|2|||
129748755|NCT04038567|467040179|FG001|Overall Study|Withdrawal by Subject|1|||
129748756|NCT04038567|467040180|FG002|Overall Study|Withdrawal by Subject|1|||
129748757|NCT04038567|467040181|FG003|Overall Study|Withdrawal by Subject|1|||
129748758|NCT04038567|467040182|FG004|Overall Study|Withdrawal by Subject|4|||
129748759|NCT04038567|467040183|FG005|Overall Study|Withdrawal by Subject|1|||
129748760|NCT04038567|467040184|FG006|Overall Study|Withdrawal by Subject|1|||
129748761|NCT04038567|467040185|FG007|Overall Study|Withdrawal by Subject|1|||
129748762|NCT04038567|467040178|FG000|Overall Study|missed survey window|1|||
129748763|NCT04038567|467040179|FG001|Overall Study|missed survey window|2|||
129748764|NCT04038567|467040180|FG002|Overall Study|missed survey window|0|||
129748765|NCT04038567|467040181|FG003|Overall Study|missed survey window|0|||
129748766|NCT04038567|467040182|FG004|Overall Study|missed survey window|1|||
129748767|NCT04038567|467040183|FG005|Overall Study|missed survey window|1|||
129748768|NCT04038567|467040184|FG006|Overall Study|missed survey window|2|||
129748769|NCT04038567|467040185|FG007|Overall Study|missed survey window|2|||
129896203|NCT00561574|467580498|FG001|Overall Study|Lack of Efficacy|21|||
129896204|NCT00561574|467580497|FG000|Overall Study|Withdrawal by Subject|4|||
129896205|NCT00561574|467580498|FG001|Overall Study|Withdrawal by Subject|4|||
129896206|NCT00561574|467580497|FG000|Overall Study|Reason Unrelated to Trial|6|||
129896207|NCT00561574|467580498|FG001|Overall Study|Reason Unrelated to Trial|2|||
129896208|NCT00561574|467580497|FG000|Overall Study|Lost to Follow-up|1|||
129896209|NCT00561574|467580498|FG001|Overall Study|Lost to Follow-up|0|||
129896210|NCT00561574|467580497|FG000|Overall Study|Other|5|||
129896211|NCT00561574|467580498|FG001|Overall Study|Other|7|||
129896212|NCT03971357|467580499|FG000|Overall Study|Lack of Efficacy|0|||
129896213|NCT03971357|467580500|FG001|Overall Study|Lack of Efficacy|1|||
129896214|NCT00630864|467580507|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
129896215|NCT00630864|467580507|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
129896216|NCT00124982|467580508|FG000|Short-term Period|Death|1|||
129748770|NCT04038567|467040178|FG000|Overall Study|technical issues|0|||
129748771|NCT04038567|467040179|FG001|Overall Study|technical issues|0|||
129748772|NCT04038567|467040180|FG002|Overall Study|technical issues|0|||
129896217|NCT00124982|467580509|FG001|Short-term Period|Death|1|||
129896218|NCT00124982|467580510|FG002|Short-term Period|Death|0|||
129896219|NCT00124982|467580508|FG000|Short-term Period|Adverse Event|17|||
129896220|NCT00124982|467580509|FG001|Short-term Period|Adverse Event|22|||
129896221|NCT00124982|467580510|FG002|Short-term Period|Adverse Event|0|||
129896222|NCT00124982|467580508|FG000|Short-term Period|Lack of Efficacy|32|||
129896223|NCT00124982|467580509|FG001|Short-term Period|Lack of Efficacy|73|||
129896224|NCT00124982|467580510|FG002|Short-term Period|Lack of Efficacy|0|||
129896225|NCT00124982|467580508|FG000|Short-term Period|Lost to Follow-up|8|||
129896226|NCT00124982|467580509|FG001|Short-term Period|Lost to Follow-up|5|||
129896227|NCT00124982|467580510|FG002|Short-term Period|Lost to Follow-up|0|||
129896228|NCT00124982|467580508|FG000|Short-term Period|Withdrawal of Consent|7|||
129896229|NCT00124982|467580509|FG001|Short-term Period|Withdrawal of Consent|9|||
129896230|NCT00124982|467580510|FG002|Short-term Period|Withdrawal of Consent|0|||
129896231|NCT00124982|467580508|FG000|Short-term Period|Poor/Non-compliance|3|||
129896232|NCT00124982|467580509|FG001|Short-term Period|Poor/Non-compliance|1|||
129896233|NCT00124982|467580510|FG002|Short-term Period|Poor/Non-compliance|0|||
129896234|NCT00124982|467580508|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
129896235|NCT00124982|467580509|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
129896236|NCT00124982|467580510|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
129896237|NCT00124982|467580508|FG000|Short-term Period|Participant Decision|1|||
129748773|NCT04038567|467040181|FG003|Overall Study|technical issues|0|||
129748774|NCT04038567|467040182|FG004|Overall Study|technical issues|0|||
129748775|NCT04038567|467040183|FG005|Overall Study|technical issues|0|||
129748776|NCT04038567|467040184|FG006|Overall Study|technical issues|1|||
129748777|NCT04038567|467040185|FG007|Overall Study|technical issues|0|||
129748778|NCT04038567|467040178|FG000|Overall Study|Medical issues (i.e., illness)|0|||
129748779|NCT04038567|467040179|FG001|Overall Study|Medical issues (i.e., illness)|1|||
129896238|NCT00124982|467580509|FG001|Short-term Period|Participant Decision|0|||
129896239|NCT00124982|467580510|FG002|Short-term Period|Participant Decision|0|||
129896240|NCT00124982|467580508|FG000|Short-term Period|Participant Chose Own Doctor|0|||
129896241|NCT00124982|467580509|FG001|Short-term Period|Participant Chose Own Doctor|1|||
129809110|NCT05074667|467267578|FG000|Overall Study|Lost to Follow-up|10|||
129809111|NCT05154578|467267581|FG000|Overall Study|Withdrawal by Subject|2|||
129809112|NCT05154578|467267582|FG001|Overall Study|Withdrawal by Subject|3|||
129809113|NCT05154578|467267583|FG002|Overall Study|Withdrawal by Subject|2|||
129809114|NCT05154578|467267584|FG003|Overall Study|Withdrawal by Subject|4|||
129809115|NCT05154578|467267585|FG004|Overall Study|Withdrawal by Subject|0|||
129809116|NCT05154578|467267581|FG000|Overall Study|Lost to Follow-up|0|||
129809117|NCT05154578|467267582|FG001|Overall Study|Lost to Follow-up|1|||
129809118|NCT05154578|467267583|FG002|Overall Study|Lost to Follow-up|0|||
129809119|NCT05154578|467267584|FG003|Overall Study|Lost to Follow-up|3|||
129809120|NCT05154578|467267585|FG004|Overall Study|Lost to Follow-up|0|||
129809121|NCT05154578|467267581|FG000|Overall Study|Adverse Event|0|||
129809122|NCT05154578|467267582|FG001|Overall Study|Adverse Event|0|||
129809123|NCT05154578|467267583|FG002|Overall Study|Adverse Event|0|||
129809124|NCT05154578|467267584|FG003|Overall Study|Adverse Event|1|||
129809125|NCT05154578|467267585|FG004|Overall Study|Adverse Event|0|||
129809126|NCT05154578|467267581|FG000|Overall Study|Relocated to another province|0|||
129809127|NCT05154578|467267582|FG001|Overall Study|Relocated to another province|0|||
129809128|NCT05154578|467267583|FG002|Overall Study|Relocated to another province|1|||
129809129|NCT05154578|467267584|FG003|Overall Study|Relocated to another province|0|||
129809130|NCT05154578|467267585|FG004|Overall Study|Relocated to another province|1|||
129809131|NCT05154578|467267581|FG000|Overall Study|Baby loss|0|||
129809132|NCT05154578|467267582|FG001|Overall Study|Baby loss|1|||
129809133|NCT05154578|467267583|FG002|Overall Study|Baby loss|0|||
129809134|NCT05154578|467267584|FG003|Overall Study|Baby loss|0|||
129809135|NCT05154578|467267585|FG004|Overall Study|Baby loss|0|||
129809136|NCT00864721|467267591|FG000|Overall Study|Patient request|11|||
129809137|NCT00864721|467267591|FG000|Overall Study|Hospitalized|1|||
129809138|NCT00864721|467267591|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
129809139|NCT00864721|467267591|FG000|Overall Study|Adverse Event|21|||
129809140|NCT01705730|467267592|FG000|Overall Study|Lack of Efficacy|1|||
129809141|NCT01705730|467267592|FG000|Overall Study|Adverse Event|3|||
129809142|NCT01705730|467267592|FG000|Overall Study|Lost to Follow-up|1|||
129809143|NCT01705730|467267592|FG000|Overall Study|Reason not Specified|4|||
129809144|NCT01773733|467267593|FG000|Overall Study|Adverse Event|3286|||
129809145|NCT01773733|467267594|FG001|Overall Study|Adverse Event|540|||
129809146|NCT01773733|467267593|FG000|Overall Study|Pregnancy|28|||
129809147|NCT01773733|467267594|FG001|Overall Study|Pregnancy|0|||
129809148|NCT01773733|467267593|FG000|Overall Study|Other different categories of not compl|55415|||
129809149|NCT01773733|467267594|FG001|Overall Study|Other different categories of not compl|7781|||
129809150|NCT00705289|467267595|FG000|Overall Study|Subject or treating physician's choice|131|||
129809151|NCT02601027|467267596|FG000|Registration to Surgery|Withdrawal by Subject|20|||
129809152|NCT02601027|467267597|FG001|Registration to Surgery|Withdrawal by Subject|10|||
129809153|NCT02609828|467267598|FG000|Overall Study|Adverse Event|8|||
129809154|NCT02609828|467267599|FG001|Overall Study|Adverse Event|1|||
129809155|NCT02609828|467267600|FG002|Overall Study|Adverse Event|0|||
129809156|NCT02609828|467267601|FG003|Overall Study|Adverse Event|6|||
129809157|NCT02609828|467267598|FG000|Overall Study|Death|15|||
129809158|NCT02609828|467267599|FG001|Overall Study|Death|1|||
129809159|NCT02609828|467267600|FG002|Overall Study|Death|1|||
129809160|NCT02609828|467267601|FG003|Overall Study|Death|19|||
129809161|NCT02609828|467267598|FG000|Overall Study|Insufficient clinical response|2|||
129809162|NCT02609828|467267599|FG001|Overall Study|Insufficient clinical response|1|||
129809163|NCT02609828|467267600|FG002|Overall Study|Insufficient clinical response|0|||
129809164|NCT02609828|467267601|FG003|Overall Study|Insufficient clinical response|0|||
129809165|NCT02609828|467267598|FG000|Overall Study|Lost to Follow-up|0|||
129809166|NCT02609828|467267599|FG001|Overall Study|Lost to Follow-up|0|||
129809167|NCT02609828|467267600|FG002|Overall Study|Lost to Follow-up|0|||
129809168|NCT02609828|467267601|FG003|Overall Study|Lost to Follow-up|1|||
129809169|NCT02609828|467267598|FG000|Overall Study|Protocol Violation|2|||
129809170|NCT02609828|467267599|FG001|Overall Study|Protocol Violation|0|||
129809171|NCT02609828|467267600|FG002|Overall Study|Protocol Violation|0|||
129809172|NCT02609828|467267601|FG003|Overall Study|Protocol Violation|1|||
129809173|NCT02609828|467267598|FG000|Overall Study|Withdrawal by Subject|12|||
129809174|NCT02609828|467267599|FG001|Overall Study|Withdrawal by Subject|1|||
129809175|NCT02609828|467267600|FG002|Overall Study|Withdrawal by Subject|0|||
129809176|NCT02609828|467267601|FG003|Overall Study|Withdrawal by Subject|10|||
129809177|NCT02609828|467267598|FG000|Overall Study|Other|3|||
129809178|NCT02609828|467267599|FG001|Overall Study|Other|0|||
129809179|NCT02609828|467267600|FG002|Overall Study|Other|0|||
129809180|NCT02609828|467267601|FG003|Overall Study|Other|6|||
129809181|NCT02609828|467267598|FG000|Overall Study|Randomized but not treated|1|||
129809182|NCT02609828|467267599|FG001|Overall Study|Randomized but not treated|0|||
129809183|NCT02609828|467267600|FG002|Overall Study|Randomized but not treated|0|||
129809184|NCT02609828|467267601|FG003|Overall Study|Randomized but not treated|0|||
129809185|NCT03758066|467267602|FG000|Overall Study|Lost to Follow-up|14|||
129809186|NCT00762385|467267605|FG000|First Intervention|Lens Issue|1|||
129809187|NCT00762385|467267606|FG001|First Intervention|Lens Issue|1|||
129809188|NCT00762385|467267605|FG000|First Intervention|Lost to Follow-up|0|||
129809189|NCT00762385|467267606|FG001|First Intervention|Lost to Follow-up|2|||
129809190|NCT00762385|467267605|FG000|First Intervention|Ineligible|1|||
129809191|NCT00762385|467267606|FG001|First Intervention|Ineligible|0|||
129809192|NCT00762385|467267605|FG000|First Intervention|Protocol Violation|0|||
129809193|NCT00762385|467267606|FG001|First Intervention|Protocol Violation|1|||
129809194|NCT00762385|467267605|FG000|Second Intervention|Protocol Violation|3|||
129809195|NCT00762385|467267606|FG001|Second Intervention|Protocol Violation|3|||
129809196|NCT01540838|467267607|FG000|Overall Study|Open nasogastric tube|9|||
129809197|NCT01540838|467267608|FG001|Overall Study|Open nasogastric tube|7|||
129809198|NCT01540838|467267607|FG000|Overall Study|Treatment doses missing|8|||
129809199|NCT01540838|467267608|FG001|Overall Study|Treatment doses missing|12|||
129809200|NCT01540838|467267607|FG000|Overall Study|Additional antibiotic treatment|1|||
129809201|NCT01540838|467267608|FG001|Overall Study|Additional antibiotic treatment|2|||
129809202|NCT01540838|467267607|FG000|Overall Study|Died before treatment initiation|1|||
129809203|NCT01540838|467267608|FG001|Overall Study|Died before treatment initiation|1|||
129809204|NCT01540838|467267607|FG000|Overall Study|Not BM. Other treatment|3|||
129809205|NCT01540838|467267608|FG001|Overall Study|Not BM. Other treatment|1|||
129809206|NCT04891978|467267609|FG000|Baseline|Protocol Violation|2|||
129809207|NCT04891978|467267610|FG001|Baseline|Protocol Violation|1|||
129809208|NCT04891978|467267611|FG002|Baseline|Protocol Violation|0|||
129809209|NCT04891978|467267609|FG000|Baseline|Missing AIRQ|1|||
129809210|NCT04891978|467267610|FG001|Baseline|Missing AIRQ|0|||
129809211|NCT04891978|467267611|FG002|Baseline|Missing AIRQ|0|||
129809212|NCT04891978|467267609|FG000|Baseline|Did not attend a baseline visit|0|||
129809213|NCT04891978|467267610|FG001|Baseline|Did not attend a baseline visit|0|||
129809214|NCT04891978|467267611|FG002|Baseline|Did not attend a baseline visit|9|||
129809215|NCT03641339|467267612|FG000|Overall Study|Physician Decision|1|||
129809216|NCT03641339|467267613|FG001|Overall Study|Physician Decision|0|||
129809217|NCT03641339|467267614|FG002|Overall Study|Physician Decision|0|||
129809218|NCT03641339|467267615|FG003|Overall Study|Physician Decision|0|||
129809219|NCT03641339|467267616|FG004|Overall Study|Physician Decision|0|||
129809220|NCT03641339|467267617|FG005|Overall Study|Physician Decision|0|||
129809221|NCT03641339|467267612|FG000|Overall Study|Withdrawal by Subject|0|||
129809222|NCT03641339|467267613|FG001|Overall Study|Withdrawal by Subject|2|||
129809223|NCT03641339|467267614|FG002|Overall Study|Withdrawal by Subject|0|||
129809224|NCT03641339|467267615|FG003|Overall Study|Withdrawal by Subject|2|||
129809225|NCT03641339|467267616|FG004|Overall Study|Withdrawal by Subject|0|||
129809226|NCT03641339|467267617|FG005|Overall Study|Withdrawal by Subject|1|||
129809227|NCT03863197|467267618|FG000|Overall Study|Lost to Follow-up|2|||
129809228|NCT03863197|467267619|FG001|Overall Study|Lost to Follow-up|3|||
129809229|NCT03863197|467267618|FG000|Overall Study|Withdrawal by Subject|4|||
129809230|NCT03863197|467267619|FG001|Overall Study|Withdrawal by Subject|0|||
129809231|NCT03863197|467267618|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
129809232|NCT03863197|467267619|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
129809233|NCT05338216|467267620|FG000|Overall Study|Withdrawal by Subject|1|||
129809234|NCT05338216|467267621|FG001|Overall Study|Withdrawal by Subject|1|||
129809235|NCT01065597|467267622|FG000|Overall Study|Adverse Event|1|||
129809236|NCT00413244|467267625|FG000|Overall Study|Withdrawal by Subject|10|||
129809237|NCT00413244|467267626|FG001|Overall Study|Withdrawal by Subject|1|||
129809238|NCT00446251|467267627|FG000|Overall Study|On-study Transplants|2|||
129809239|NCT00446251|467267627|FG000|Overall Study|Rituximab Infusion Reaction|2|||
129809240|NCT00446251|467267627|FG000|Overall Study|Lost to Follow-up|1|||
129809241|NCT02264639|467267629|FG000|Overall Study|Death (after completing single-dose phase)|1|||
129809242|NCT02264639|467267630|FG001|Overall Study|Death (after completing single-dose phase)|0|||
129809243|NCT02264639|467267631|FG002|Overall Study|Death (after completing single-dose phase)|0|||
129809244|NCT02264639|467267632|FG003|Overall Study|Death (after completing single-dose phase)|0|||
129809245|NCT02264639|467267633|FG004|Overall Study|Death (after completing single-dose phase)|0|||
129809246|NCT02264639|467267629|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
129809247|NCT02264639|467267630|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129896242|NCT00124982|467580510|FG002|Short-term Period|Participant Chose Own Doctor|0|||
129896243|NCT00124982|467580508|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
129809248|NCT02264639|467267631|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129809249|NCT02264639|467267632|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129809250|NCT02264639|467267633|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
129809251|NCT02264639|467267629|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809252|NCT02264639|467267630|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809253|NCT02264639|467267631|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
129809254|NCT02264639|467267632|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809255|NCT02264639|467267633|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
129809256|NCT02264639|467267629|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129809257|NCT02264639|467267630|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129748780|NCT04038567|467040180|FG002|Overall Study|Medical issues (i.e., illness)|2|||
129748781|NCT04038567|467040181|FG003|Overall Study|Medical issues (i.e., illness)|1|||
129748782|NCT04038567|467040182|FG004|Overall Study|Medical issues (i.e., illness)|1|||
129748783|NCT04038567|467040183|FG005|Overall Study|Medical issues (i.e., illness)|1|||
129748784|NCT04038567|467040184|FG006|Overall Study|Medical issues (i.e., illness)|0|||
129748785|NCT04038567|467040185|FG007|Overall Study|Medical issues (i.e., illness)|0|||
129748786|NCT04038567|467040178|FG000|Overall Study|Death|0|||
129748787|NCT04038567|467040179|FG001|Overall Study|Death|0|||
129748788|NCT04038567|467040180|FG002|Overall Study|Death|0|||
129748789|NCT04038567|467040181|FG003|Overall Study|Death|1|||
129748790|NCT04038567|467040182|FG004|Overall Study|Death|1|||
129748791|NCT04038567|467040183|FG005|Overall Study|Death|0|||
129748792|NCT04038567|467040184|FG006|Overall Study|Death|0|||
129748793|NCT04038567|467040185|FG007|Overall Study|Death|1|||
129748794|NCT01817959|467040191|FG000|Overall Study|Graft loss|1|||
129748795|NCT01817959|467040192|FG001|Overall Study|Graft loss|1|||
129748796|NCT01817959|467040191|FG000|Overall Study|forbidden medication|1|||
129748797|NCT01817959|467040192|FG001|Overall Study|forbidden medication|1|||
129748798|NCT01817959|467040191|FG000|Overall Study|Adverse Event|1|||
129748799|NCT01817959|467040192|FG001|Overall Study|Adverse Event|0|||
129748800|NCT01817959|467040191|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
129748801|NCT01817959|467040192|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
129748802|NCT00923845|467040195|FG000|Induction Therapy|Poor performance status|0|||
129748803|NCT00923845|467040196|FG001|Induction Therapy|Poor performance status|2|||
129748804|NCT01128946|467040200|FG000|Period I|Protocol Violation|0|||
129748805|NCT01128946|467040201|FG001|Period I|Protocol Violation|1|||
129748806|NCT01128946|467040202|FG002|Period I|Protocol Violation|0|||
129748807|NCT01128946|467040203|FG003|Period I|Protocol Violation|0|||
129748808|NCT01128946|467040200|FG000|Period I|Withdrawal by Subject|0|||
129748809|NCT01128946|467040201|FG001|Period I|Withdrawal by Subject|0|||
129748810|NCT01128946|467040202|FG002|Period I|Withdrawal by Subject|1|||
129748811|NCT01128946|467040203|FG003|Period I|Withdrawal by Subject|1|||
129748812|NCT01128946|467040200|FG000|Period II|Protocol Violation|0|||
129748813|NCT01128946|467040201|FG001|Period II|Protocol Violation|1|||
129748814|NCT01128946|467040202|FG002|Period II|Protocol Violation|0|||
129748815|NCT01128946|467040203|FG003|Period II|Protocol Violation|0|||
129748816|NCT01128946|467040200|FG000|Period II|Withdrawal by Subject|0|||
129748817|NCT01128946|467040201|FG001|Period II|Withdrawal by Subject|0|||
129748818|NCT01128946|467040202|FG002|Period II|Withdrawal by Subject|0|||
129748819|NCT01128946|467040203|FG003|Period II|Withdrawal by Subject|1|||
129748820|NCT01128946|467040200|FG000|Period III|Protocol Violation|1|||
129748821|NCT01128946|467040201|FG001|Period III|Protocol Violation|0|||
129748822|NCT01128946|467040202|FG002|Period III|Protocol Violation|0|||
129748823|NCT01128946|467040203|FG003|Period III|Protocol Violation|0|||
129748824|NCT01371734|467040204|FG000|Overall Study|Other|2|||
129748825|NCT01371734|467040205|FG001|Overall Study|Other|1|||
129748826|NCT01371734|467040206|FG002|Overall Study|Other|2|||
129748827|NCT01371734|467040204|FG000|Overall Study|Withdrawal by Subject|3|||
129748828|NCT01371734|467040205|FG001|Overall Study|Withdrawal by Subject|4|||
129748829|NCT01371734|467040206|FG002|Overall Study|Withdrawal by Subject|9|||
129748830|NCT01371734|467040204|FG000|Overall Study|Lost to Follow-up|5|||
129748831|NCT01371734|467040205|FG001|Overall Study|Lost to Follow-up|3|||
129748832|NCT01371734|467040206|FG002|Overall Study|Lost to Follow-up|1|||
129748833|NCT01371734|467040204|FG000|Overall Study|Protocol Violation|3|||
129748834|NCT01371734|467040205|FG001|Overall Study|Protocol Violation|1|||
129748835|NCT01371734|467040206|FG002|Overall Study|Protocol Violation|2|||
129748836|NCT01371734|467040204|FG000|Overall Study|Adverse Event|8|||
129748837|NCT01371734|467040205|FG001|Overall Study|Adverse Event|8|||
129748838|NCT01371734|467040206|FG002|Overall Study|Adverse Event|3|||
129748839|NCT01371734|467040204|FG000|Overall Study|Lack of Efficacy|2|||
129748840|NCT01371734|467040205|FG001|Overall Study|Lack of Efficacy|2|||
129748841|NCT01371734|467040206|FG002|Overall Study|Lack of Efficacy|0|||
129748842|NCT03565237|467040207|FG000|Overall Study|Non-compliance of Investigational Product|1|||
129748843|NCT03565237|467040207|FG000|Overall Study|Physician Decision|1|||
129809258|NCT02264639|467267631|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129809259|NCT02264639|467267632|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
129748844|NCT01140061|467040211|FG000|Part I|Adverse Event|1|||
129748845|NCT01140061|467040212|FG001|Part I|Adverse Event|0|||
129748846|NCT01140061|467040213|FG002|Part I|Adverse Event|0|||
129748847|NCT01140061|467040214|FG003|Part I|Adverse Event|0|||
129748848|NCT01140061|467040215|FG004|Part I|Adverse Event|0|||
129748849|NCT01140061|467040216|FG005|Part I|Adverse Event|0|||
129748850|NCT01140061|467040217|FG006|Part I|Adverse Event|0|||
129748851|NCT01140061|467040218|FG007|Part I|Adverse Event|0|||
129748852|NCT01140061|467040219|FG008|Part I|Adverse Event|0|||
129748853|NCT01140061|467040220|FG009|Part I|Adverse Event|0|||
129748854|NCT01140061|467040211|FG000|Extension|Laboratory Adverse Event|0|||
129748855|NCT01140061|467040212|FG001|Extension|Laboratory Adverse Event|0|||
129748856|NCT01140061|467040213|FG002|Extension|Laboratory Adverse Event|0|||
129896244|NCT00124982|467580509|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
129896245|NCT00124982|467580510|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
129896246|NCT00124982|467580508|FG000|Short-term Period|Participant Had Lymphopenia|1|||
129896247|NCT00124982|467580509|FG001|Short-term Period|Participant Had Lymphopenia|0|||
129896248|NCT00124982|467580510|FG002|Short-term Period|Participant Had Lymphopenia|0|||
129896249|NCT00124982|467580508|FG000|Long-term Period|Death|0|||
129896250|NCT00124982|467580509|FG001|Long-term Period|Death|0|||
129896251|NCT00124982|467580510|FG002|Long-term Period|Death|1|||
129896252|NCT00124982|467580508|FG000|Long-term Period|Adverse Event|0|||
129896253|NCT00124982|467580509|FG001|Long-term Period|Adverse Event|0|||
129896254|NCT00124982|467580510|FG002|Long-term Period|Adverse Event|17|||
129896255|NCT00124982|467580508|FG000|Long-term Period|Lack of Efficacy|0|||
129896256|NCT00124982|467580509|FG001|Long-term Period|Lack of Efficacy|0|||
129896257|NCT00124982|467580510|FG002|Long-term Period|Lack of Efficacy|46|||
129896258|NCT00124982|467580508|FG000|Long-term Period|Lost to Follow-up|0|||
129896259|NCT00124982|467580509|FG001|Long-term Period|Lost to Follow-up|0|||
129809260|NCT02264639|467267633|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
129896260|NCT00124982|467580510|FG002|Long-term Period|Lost to Follow-up|4|||
129896261|NCT00124982|467580508|FG000|Long-term Period|Withdrawal by Subject|0|||
129896262|NCT00124982|467580509|FG001|Long-term Period|Withdrawal by Subject|0|||
129896263|NCT00124982|467580510|FG002|Long-term Period|Withdrawal by Subject|16|||
129896264|NCT00124982|467580508|FG000|Long-term Period|Pregnancy|0|||
129896265|NCT00124982|467580509|FG001|Long-term Period|Pregnancy|0|||
129896266|NCT00124982|467580510|FG002|Long-term Period|Pregnancy|1|||
129896267|NCT00124982|467580508|FG000|Long-term Period|Poor/Non-compliance|0|||
129896268|NCT00124982|467580509|FG001|Long-term Period|Poor/Non-compliance|0|||
129896269|NCT00124982|467580510|FG002|Long-term Period|Poor/Non-compliance|2|||
129896270|NCT00124982|467580508|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
129896271|NCT00124982|467580509|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
129896272|NCT00124982|467580510|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
129896273|NCT00124982|467580508|FG000|Long-term Period|Neurologist Recommendation|0|||
129896274|NCT00124982|467580509|FG001|Long-term Period|Neurologist Recommendation|0|||
129896275|NCT00124982|467580510|FG002|Long-term Period|Neurologist Recommendation|1|||
129896276|NCT00430677|467580511|FG000|Short-term Period|Death|1|||
129896277|NCT00430677|467580512|FG001|Short-term Period|Death|1|||
129896278|NCT00430677|467580513|FG002|Short-term Period|Death|5|||
129896279|NCT00430677|467580511|FG000|Short-term Period|Adverse Event|15|||
129896280|NCT00430677|467580512|FG001|Short-term Period|Adverse Event|13|||
129896281|NCT00430677|467580513|FG002|Short-term Period|Adverse Event|9|||
129896282|NCT00430677|467580511|FG000|Short-term Period|Lack of Efficacy|5|||
129896283|NCT00430677|467580512|FG001|Short-term Period|Lack of Efficacy|6|||
129896284|NCT00430677|467580513|FG002|Short-term Period|Lack of Efficacy|4|||
129896285|NCT00430677|467580511|FG000|Short-term Period|Withdrawal by Subject|1|||
129896286|NCT00430677|467580512|FG001|Short-term Period|Withdrawal by Subject|1|||
129896287|NCT00430677|467580513|FG002|Short-term Period|Withdrawal by Subject|2|||
129896288|NCT00430677|467580511|FG000|Short-term Period|Participant no longer met study criteria|1|||
129896289|NCT00430677|467580512|FG001|Short-term Period|Participant no longer met study criteria|1|||
129896290|NCT00430677|467580513|FG002|Short-term Period|Participant no longer met study criteria|2|||
129896291|NCT00430677|467580511|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
129896292|NCT00430677|467580512|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
129896293|NCT00430677|467580513|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
129896294|NCT00430677|467580511|FG000|Short-term Period|Pregnancy|0|||
129896295|NCT00430677|467580512|FG001|Short-term Period|Pregnancy|2|||
129896296|NCT00430677|467580513|FG002|Short-term Period|Pregnancy|0|||
129896297|NCT00430677|467580511|FG000|Long-term Extension Period|Death|1|||
129896298|NCT00430677|467580512|FG001|Long-term Extension Period|Death|0|||
129896299|NCT00430677|467580513|FG002|Long-term Extension Period|Death|0|||
129896300|NCT00430677|467580511|FG000|Long-term Extension Period|Adverse Event|3|||
129809261|NCT01416272|467267634|FG000|Overall Study|Unacceptable distance visual acuity|2|||
129809262|NCT01416272|467267634|FG000|Overall Study|Lost to Follow-up|1|||
129809263|NCT01416272|467267634|FG000|Overall Study|Study related complaints|1|||
129809264|NCT04545554|467267639|FG000|Overall Study|Withdrawal by Subject|0|||
129809265|NCT04545554|467267640|FG001|Overall Study|Withdrawal by Subject|0|||
129809266|NCT04545554|467267641|FG002|Overall Study|Withdrawal by Subject|0|||
129809267|NCT04545554|467267642|FG003|Overall Study|Withdrawal by Subject|1|||
129809268|NCT04545554|467267643|FG004|Overall Study|Withdrawal by Subject|0|||
129809269|NCT04545554|467267644|FG005|Overall Study|Withdrawal by Subject|0|||
129809270|NCT00660673|467267645|FG000|Overall Study|Adverse Event|84|||
129896301|NCT00430677|467580512|FG001|Long-term Extension Period|Adverse Event|2|||
129896302|NCT00430677|467580513|FG002|Long-term Extension Period|Adverse Event|5|||
129896303|NCT00430677|467580511|FG000|Long-term Extension Period|Lack of Efficacy|5|||
129896304|NCT00430677|467580512|FG001|Long-term Extension Period|Lack of Efficacy|3|||
129809271|NCT00660673|467267645|FG000|Overall Study|Lack of Efficacy|7|||
129809272|NCT00660673|467267645|FG000|Overall Study|Withdrawal by Subject|22|||
129809273|NCT00660673|467267645|FG000|Overall Study|Administrative|2|||
129896305|NCT00430677|467580513|FG002|Long-term Extension Period|Lack of Efficacy|8|||
129896306|NCT00430677|467580511|FG000|Long-term Extension Period|Lost to Follow-up|1|||
129896307|NCT00430677|467580512|FG001|Long-term Extension Period|Lost to Follow-up|1|||
129896308|NCT00430677|467580513|FG002|Long-term Extension Period|Lost to Follow-up|1|||
129896309|NCT00430677|467580511|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
129896310|NCT00430677|467580512|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
129896311|NCT00430677|467580513|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
129896312|NCT00430677|467580511|FG000|Long-term Extension Period|Pregnancy|1|||
129896313|NCT00430677|467580512|FG001|Long-term Extension Period|Pregnancy|1|||
129896314|NCT00430677|467580513|FG002|Long-term Extension Period|Pregnancy|0|||
129896315|NCT00430677|467580511|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
129896316|NCT00430677|467580512|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
129896317|NCT00430677|467580513|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
129896318|NCT00430677|467580511|FG000|Long-term Extension Period|Other|2|||
129896319|NCT00430677|467580512|FG001|Long-term Extension Period|Other|1|||
129896320|NCT00430677|467580513|FG002|Long-term Extension Period|Other|1|||
129748857|NCT01140061|467040214|FG003|Extension|Laboratory Adverse Event|0|||
129748858|NCT01140061|467040215|FG004|Extension|Laboratory Adverse Event|0|||
129748859|NCT01140061|467040216|FG005|Extension|Laboratory Adverse Event|0|||
129896321|NCT00430677|467580511|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
129896322|NCT00430677|467580512|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
129896323|NCT00430677|467580513|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
129896324|NCT01555762|467580516|FG000|Overall Study|No information on Bevacizumab intake|11|||
129896325|NCT01555762|467580516|FG000|Overall Study|Missing start date of infusion|8|||
129896326|NCT01555762|467580516|FG000|Overall Study|75 years old or more ticked No|1|||
129896327|NCT01555762|467580516|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
129896328|NCT01555762|467580516|FG000|Overall Study|Death linked to progression of disease|165|||
129896329|NCT01555762|467580516|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
129896330|NCT01555762|467580516|FG000|Overall Study|Investigator's decision|10|||
129896331|NCT01555762|467580516|FG000|Overall Study|Participant not wishing to continue|5|||
129896332|NCT01555762|467580516|FG000|Overall Study|Missing data|1|||
129896333|NCT01555762|467580516|FG000|Overall Study|Death linked to an adverse event|14|||
129896334|NCT01333514|467580517|FG000|Overall Study|Withdrawal by Subject|1|||
129896335|NCT01333514|467580518|FG001|Overall Study|Withdrawal by Subject|0|||
129896336|NCT00836810|467580521|FG000|Overall Study|New diagnosis|1|||
129896337|NCT00836810|467580522|FG001|Overall Study|New diagnosis|0|||
129896338|NCT03102242|467580523|FG000|Overall Study|Adverse Event|2|||
129896339|NCT00389519|467580524|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
129896340|NCT00389519|467580525|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
129896341|NCT00389519|467580526|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
129896342|NCT00389519|467580527|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
129896343|NCT00389519|467580524|FG000|Placebo Run-In|Withdrawal by Subject|19|||
129896344|NCT00389519|467580525|FG001|Placebo Run-In|Withdrawal by Subject|0|||
129896345|NCT00389519|467580526|FG002|Placebo Run-In|Withdrawal by Subject|0|||
129896346|NCT00389519|467580527|FG003|Placebo Run-In|Withdrawal by Subject|0|||
129896347|NCT00389519|467580524|FG000|Placebo Run-In|Reason not specified|40|||
129896348|NCT00389519|467580525|FG001|Placebo Run-In|Reason not specified|0|||
129896349|NCT00389519|467580526|FG002|Placebo Run-In|Reason not specified|0|||
129896350|NCT00389519|467580527|FG003|Placebo Run-In|Reason not specified|0|||
129896351|NCT00389519|467580524|FG000|Randomized|Did not receive study drug|2|||
129896352|NCT00389519|467580525|FG001|Randomized|Did not receive study drug|0|||
129896353|NCT00389519|467580526|FG002|Randomized|Did not receive study drug|0|||
129896354|NCT00389519|467580527|FG003|Randomized|Did not receive study drug|0|||
129896355|NCT00389519|467580524|FG000|Treated|Adverse Event|1|||
129748860|NCT01140061|467040217|FG006|Extension|Laboratory Adverse Event|0|||
129748861|NCT01140061|467040218|FG007|Extension|Laboratory Adverse Event|0|||
129748862|NCT01140061|467040219|FG008|Extension|Laboratory Adverse Event|0|||
129748863|NCT01140061|467040220|FG009|Extension|Laboratory Adverse Event|1|||
129748864|NCT02669121|467040221|FG000|Overall Study|Adverse Event|4|||
129748865|NCT02669121|467040222|FG001|Overall Study|Adverse Event|5|||
129748866|NCT02669121|467040221|FG000|Overall Study|Lost to Follow-up|15|||
129748867|NCT02669121|467040222|FG001|Overall Study|Lost to Follow-up|27|||
129896356|NCT00389519|467580525|FG001|Treated|Adverse Event|0|||
129896357|NCT00389519|467580526|FG002|Treated|Adverse Event|0|||
129896358|NCT00389519|467580527|FG003|Treated|Adverse Event|2|||
129896359|NCT00389519|467580524|FG000|Treated|Reason not specified|1|||
129896360|NCT00389519|467580525|FG001|Treated|Reason not specified|1|||
129896361|NCT00389519|467580526|FG002|Treated|Reason not specified|0|||
129896362|NCT00389519|467580527|FG003|Treated|Reason not specified|2|||
129748868|NCT02669121|467040221|FG000|Overall Study|Withdrawal by Subject|132|||
129748869|NCT02669121|467040222|FG001|Overall Study|Withdrawal by Subject|140|||
129748870|NCT02669121|467040221|FG000|Overall Study|Pregnancy|0|||
129896363|NCT01311713|467580530|FG000|Overall Study|Death|0|||
129896364|NCT01311713|467580531|FG001|Overall Study|Death|0|||
129748871|NCT02669121|467040222|FG001|Overall Study|Pregnancy|1|||
129748872|NCT02669121|467040221|FG000|Overall Study|Discharged from US Military Active Service|117|||
129748873|NCT02669121|467040222|FG001|Overall Study|Discharged from US Military Active Service|91|||
129748874|NCT02669121|467040221|FG000|Overall Study|Reason not Specified|22|||
129748875|NCT02669121|467040222|FG001|Overall Study|Reason not Specified|18|||
129748876|NCT04384523|467040223|FG000|Overall Study|Lost to Follow-up|0|||
129748877|NCT04384523|467040224|FG001|Overall Study|Lost to Follow-up|0|||
129748878|NCT04384523|467040225|FG002|Overall Study|Lost to Follow-up|0|||
129748879|NCT04384523|467040226|FG003|Overall Study|Lost to Follow-up|0|||
129748880|NCT04384523|467040227|FG004|Overall Study|Lost to Follow-up|0|||
129748881|NCT04384523|467040228|FG005|Overall Study|Lost to Follow-up|1|||
129748882|NCT04384523|467040223|FG000|Overall Study|Protocol Violation|0|||
129748883|NCT04384523|467040224|FG001|Overall Study|Protocol Violation|1|||
129748884|NCT04384523|467040225|FG002|Overall Study|Protocol Violation|0|||
129748885|NCT04384523|467040226|FG003|Overall Study|Protocol Violation|0|||
129748886|NCT04384523|467040227|FG004|Overall Study|Protocol Violation|0|||
129748887|NCT04384523|467040228|FG005|Overall Study|Protocol Violation|0|||
129748888|NCT04384523|467040223|FG000|Overall Study|Withdrawal by Subject|1|||
129748889|NCT04384523|467040224|FG001|Overall Study|Withdrawal by Subject|0|||
129748890|NCT04384523|467040225|FG002|Overall Study|Withdrawal by Subject|0|||
129748891|NCT04384523|467040226|FG003|Overall Study|Withdrawal by Subject|0|||
129748892|NCT04384523|467040227|FG004|Overall Study|Withdrawal by Subject|0|||
129748893|NCT04384523|467040228|FG005|Overall Study|Withdrawal by Subject|0|||
129748894|NCT00835341|467040229|FG000|Overall Study|Lost to Follow-up|3|||
129748895|NCT00835341|467040230|FG001|Overall Study|Lost to Follow-up|12|||
129748896|NCT04405076|467040232|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
129748897|NCT04405076|467040233|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
129748898|NCT04405076|467040234|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
129748899|NCT04405076|467040235|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
129748900|NCT04405076|467040236|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
129748901|NCT04405076|467040237|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
129748902|NCT04405076|467040238|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
129748903|NCT04405076|467040239|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
129748904|NCT04405076|467040240|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
129748905|NCT04405076|467040232|FG000|Part A (Blinded Phase)|Physician Decision|1|||
129748906|NCT04405076|467040233|FG001|Part A (Blinded Phase)|Physician Decision|2|||
129748907|NCT04405076|467040234|FG002|Part A (Blinded Phase)|Physician Decision|0|||
129748908|NCT04405076|467040235|FG003|Part A (Blinded Phase)|Physician Decision|0|||
129748909|NCT04405076|467040236|FG004|Part A (Blinded Phase)|Physician Decision|0|||
129748910|NCT04405076|467040237|FG005|Part A (Blinded Phase)|Physician Decision|0|||
129748911|NCT04405076|467040238|FG006|Part A (Blinded Phase)|Physician Decision|0|||
129748912|NCT04405076|467040239|FG007|Part A (Blinded Phase)|Physician Decision|0|||
129748913|NCT04405076|467040240|FG008|Part A (Blinded Phase)|Physician Decision|0|||
129748914|NCT04405076|467040232|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
129748915|NCT04405076|467040233|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
129748916|NCT04405076|467040234|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
129748917|NCT04405076|467040235|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
129748918|NCT04405076|467040236|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
129748919|NCT04405076|467040237|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
129748920|NCT04405076|467040238|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
129748921|NCT04405076|467040239|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
129748922|NCT04405076|467040240|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
129748923|NCT04405076|467040232|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
129748924|NCT04405076|467040233|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748925|NCT04405076|467040234|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748926|NCT04405076|467040235|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748927|NCT04405076|467040236|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748928|NCT04405076|467040237|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748929|NCT04405076|467040238|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748930|NCT04405076|467040239|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748931|NCT04405076|467040240|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
129748932|NCT04405076|467040232|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
129748933|NCT04405076|467040233|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
129748934|NCT04405076|467040234|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129809274|NCT00660673|467267645|FG000|Overall Study|Protocol Violation|2|||
129809275|NCT05213481|467267647|FG000|Overall Study|Adverse Event|3|||
129748935|NCT04405076|467040235|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129748936|NCT04405076|467040236|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129748937|NCT04405076|467040237|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129748938|NCT04405076|467040238|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129748939|NCT04405076|467040239|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129809276|NCT05213481|467267647|FG000|Overall Study|Lost to Follow-up|1|||
129896365|NCT01311713|467580532|FG002|Overall Study|Death|1|||
129896366|NCT01311713|467580533|FG003|Overall Study|Death|1|||
129896367|NCT01311713|467580534|FG004|Overall Study|Death|0|||
129896368|NCT01311713|467580535|FG005|Overall Study|Death|1|||
129896369|NCT01311713|467580536|FG006|Overall Study|Death|0|||
129896370|NCT01311713|467580530|FG000|Overall Study|Adverse Event|0|||
129896371|NCT01311713|467580531|FG001|Overall Study|Adverse Event|1|||
129896372|NCT01311713|467580532|FG002|Overall Study|Adverse Event|0|||
129896373|NCT01311713|467580533|FG003|Overall Study|Adverse Event|2|||
129896374|NCT01311713|467580534|FG004|Overall Study|Adverse Event|0|||
129896375|NCT01311713|467580535|FG005|Overall Study|Adverse Event|0|||
129896376|NCT01311713|467580536|FG006|Overall Study|Adverse Event|2|||
129896377|NCT01311713|467580530|FG000|Overall Study|Withdrawal by Subject|0|||
129896378|NCT01311713|467580531|FG001|Overall Study|Withdrawal by Subject|1|||
129896379|NCT01311713|467580532|FG002|Overall Study|Withdrawal by Subject|1|||
129896380|NCT01311713|467580533|FG003|Overall Study|Withdrawal by Subject|0|||
129896381|NCT01311713|467580534|FG004|Overall Study|Withdrawal by Subject|0|||
129896382|NCT01311713|467580535|FG005|Overall Study|Withdrawal by Subject|1|||
129896383|NCT01311713|467580536|FG006|Overall Study|Withdrawal by Subject|2|||
129896384|NCT01311713|467580530|FG000|Overall Study|Disease progression|3|||
129896385|NCT01311713|467580531|FG001|Overall Study|Disease progression|4|||
129896386|NCT01311713|467580532|FG002|Overall Study|Disease progression|3|||
129896387|NCT01311713|467580533|FG003|Overall Study|Disease progression|2|||
129896388|NCT01311713|467580534|FG004|Overall Study|Disease progression|4|||
129896389|NCT01311713|467580535|FG005|Overall Study|Disease progression|4|||
129896390|NCT01311713|467580536|FG006|Overall Study|Disease progression|5|||
129896391|NCT01311713|467580530|FG000|Overall Study|Lost to Follow-up|0|||
129896392|NCT01311713|467580531|FG001|Overall Study|Lost to Follow-up|0|||
129896393|NCT01311713|467580532|FG002|Overall Study|Lost to Follow-up|1|||
129896394|NCT01311713|467580533|FG003|Overall Study|Lost to Follow-up|0|||
129896395|NCT01311713|467580534|FG004|Overall Study|Lost to Follow-up|0|||
129896396|NCT01311713|467580535|FG005|Overall Study|Lost to Follow-up|0|||
129896397|NCT01311713|467580536|FG006|Overall Study|Lost to Follow-up|0|||
129896398|NCT01311713|467580530|FG000|Overall Study|Stopped taking study medication|0|||
129896399|NCT01311713|467580531|FG001|Overall Study|Stopped taking study medication|0|||
129896400|NCT01311713|467580532|FG002|Overall Study|Stopped taking study medication|0|||
129896401|NCT01311713|467580533|FG003|Overall Study|Stopped taking study medication|1|||
129896402|NCT01311713|467580534|FG004|Overall Study|Stopped taking study medication|1|||
129896403|NCT01311713|467580535|FG005|Overall Study|Stopped taking study medication|0|||
129896404|NCT01311713|467580536|FG006|Overall Study|Stopped taking study medication|0|||
129896405|NCT01311713|467580530|FG000|Overall Study|Enrolled but not treated|0|||
129896406|NCT01311713|467580531|FG001|Overall Study|Enrolled but not treated|0|||
129896407|NCT01311713|467580532|FG002|Overall Study|Enrolled but not treated|1|||
129896408|NCT01311713|467580533|FG003|Overall Study|Enrolled but not treated|0|||
129896409|NCT01311713|467580534|FG004|Overall Study|Enrolled but not treated|0|||
129896410|NCT01311713|467580535|FG005|Overall Study|Enrolled but not treated|0|||
129896411|NCT01311713|467580536|FG006|Overall Study|Enrolled but not treated|0|||
129896412|NCT01311713|467580530|FG000|Overall Study|Other than specified|0|||
129809277|NCT00415168|467267651|FG000|Overall Study|Death|26|||
129809278|NCT00415168|467267651|FG000|Overall Study|Lost to Follow-up|3|||
129809279|NCT00415168|467267651|FG000|Overall Study|Physician Decision|13|||
129809280|NCT00415168|467267651|FG000|Overall Study|Sponsor Decision|4|||
129809281|NCT00415168|467267651|FG000|Overall Study|Withdrawal by Subject|6|||
129809282|NCT01387789|467267655|FG000|Overall Study|Adverse Event|5|||
129809283|NCT01387789|467267655|FG000|Overall Study|Lack of Efficacy|2|||
129809284|NCT01387789|467267655|FG000|Overall Study|Lost to Follow-up|1|||
129809285|NCT02059408|467267658|FG000|Overall Study|Did not get tested|0|||
129809286|NCT02059408|467267659|FG001|Overall Study|Did not get tested|330|||
129809287|NCT02059408|467267660|FG002|Overall Study|Did not get tested|358|||
129809288|NCT02993757|467267661|FG000|Overall Study|Non compliance with the protocol|155|||
129809289|NCT02993757|467267662|FG001|Overall Study|Non compliance with the protocol|170|||
129809290|NCT02993757|467267661|FG000|Overall Study|Lost to Follow-up|1|||
129896413|NCT01311713|467580531|FG001|Overall Study|Other than specified|1|||
129896414|NCT01311713|467580532|FG002|Overall Study|Other than specified|2|||
129896415|NCT01311713|467580533|FG003|Overall Study|Other than specified|0|||
129896416|NCT01311713|467580534|FG004|Overall Study|Other than specified|0|||
129896417|NCT01311713|467580535|FG005|Overall Study|Other than specified|0|||
129896418|NCT01311713|467580536|FG006|Overall Study|Other than specified|0|||
129896419|NCT00946192|467580537|FG000|Overall Study|Lost to Follow-up|6|||
129896420|NCT00946192|467580538|FG001|Overall Study|Lost to Follow-up|11|||
129748940|NCT04405076|467040240|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
129748941|NCT04405076|467040232|FG000|Part A (Blinded Phase)|Other than Specified|0|||
129748942|NCT04405076|467040233|FG001|Part A (Blinded Phase)|Other than Specified|0|||
129748943|NCT04405076|467040234|FG002|Part A (Blinded Phase)|Other than Specified|3|||
129748944|NCT04405076|467040235|FG003|Part A (Blinded Phase)|Other than Specified|0|||
129748945|NCT04405076|467040236|FG004|Part A (Blinded Phase)|Other than Specified|0|||
129748946|NCT04405076|467040237|FG005|Part A (Blinded Phase)|Other than Specified|0|||
129748947|NCT04405076|467040238|FG006|Part A (Blinded Phase)|Other than Specified|0|||
129748948|NCT04405076|467040239|FG007|Part A (Blinded Phase)|Other than Specified|0|||
129748949|NCT04405076|467040240|FG008|Part A (Blinded Phase)|Other than Specified|0|||
129748950|NCT04405076|467040232|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129748951|NCT04405076|467040233|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129748952|NCT04405076|467040234|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129748953|NCT04405076|467040235|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
129748954|NCT04405076|467040236|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
129748955|NCT04405076|467040237|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
129748956|NCT04405076|467040238|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129748957|NCT04405076|467040239|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129748958|NCT04405076|467040240|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
129748959|NCT04405076|467040232|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748960|NCT04405076|467040233|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748961|NCT04405076|467040234|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748962|NCT04405076|467040235|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748963|NCT04405076|467040236|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
129748964|NCT04405076|467040237|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748965|NCT04405076|467040238|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748966|NCT04405076|467040239|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748967|NCT04405076|467040240|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
129748968|NCT04405076|467040232|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129748969|NCT04405076|467040233|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129748970|NCT04405076|467040234|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129748971|NCT04405076|467040235|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
129748972|NCT04405076|467040236|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
129748973|NCT04405076|467040237|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
129748974|NCT04405076|467040238|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129748975|NCT04405076|467040239|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129748976|NCT04405076|467040240|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
129748977|NCT04405076|467040232|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748978|NCT04405076|467040233|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748979|NCT04405076|467040234|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748980|NCT04405076|467040235|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748981|NCT04405076|467040236|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748982|NCT04405076|467040237|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748983|NCT04405076|467040238|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
129748984|NCT04405076|467040239|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
129748985|NCT04405076|467040240|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
129748986|NCT04405076|467040232|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129896421|NCT00946192|467580539|FG002|Overall Study|Lost to Follow-up|9|||
129748987|NCT04405076|467040233|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748988|NCT04405076|467040234|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748989|NCT04405076|467040235|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748990|NCT04405076|467040236|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748991|NCT04405076|467040237|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748992|NCT04405076|467040238|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
129748993|NCT04405076|467040239|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748994|NCT04405076|467040240|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
129748995|NCT00392990|467040243|FG000|Treatment on Study|Adverse Event|3|||
129748996|NCT00392990|467040244|FG001|Treatment on Study|Adverse Event|1|||
129748997|NCT00392990|467040243|FG000|Follow up for 2 Years|Death|4|||
129748998|NCT00392990|467040244|FG001|Follow up for 2 Years|Death|0|||
129748999|NCT03052816|467040247|FG000|Overall Study|Withdrawal by Subject|1|||
129749000|NCT03052816|467040248|FG001|Overall Study|Withdrawal by Subject|0|||
129749001|NCT03052816|467040247|FG000|Overall Study|Desired opioids|2|||
129749002|NCT03052816|467040248|FG001|Overall Study|Desired opioids|0|||
129749003|NCT00408434|467040249|FG000|Overall Study|Adverse Event|0|||
129749004|NCT00408434|467040250|FG001|Overall Study|Adverse Event|0|||
129749005|NCT00408434|467040251|FG002|Overall Study|Adverse Event|1|||
129749006|NCT00408434|467040252|FG003|Overall Study|Adverse Event|0|||
129749007|NCT00408434|467040253|FG004|Overall Study|Adverse Event|0|||
129749008|NCT00408434|467040254|FG005|Overall Study|Adverse Event|0|||
129749009|NCT00408434|467040255|FG006|Overall Study|Adverse Event|0|||
129749010|NCT00408434|467040249|FG000|Overall Study|Progressive disease|6|||
129749011|NCT00408434|467040250|FG001|Overall Study|Progressive disease|3|||
129749012|NCT00408434|467040251|FG002|Overall Study|Progressive disease|4|||
129749013|NCT00408434|467040252|FG003|Overall Study|Progressive disease|3|||
129749014|NCT00408434|467040253|FG004|Overall Study|Progressive disease|3|||
129749015|NCT00408434|467040254|FG005|Overall Study|Progressive disease|1|||
129749016|NCT00408434|467040255|FG006|Overall Study|Progressive disease|4|||
129749017|NCT00408434|467040249|FG000|Overall Study|Other|0|||
129749018|NCT00408434|467040250|FG001|Overall Study|Other|0|||
129749019|NCT00408434|467040251|FG002|Overall Study|Other|1|||
129749020|NCT00408434|467040252|FG003|Overall Study|Other|0|||
129749021|NCT00408434|467040253|FG004|Overall Study|Other|2|||
129749022|NCT00408434|467040254|FG005|Overall Study|Other|1|||
129749023|NCT00408434|467040255|FG006|Overall Study|Other|0|||
129749024|NCT00408434|467040249|FG000|Overall Study|Terminated by Investigator|0|||
129749025|NCT00408434|467040250|FG001|Overall Study|Terminated by Investigator|0|||
129749026|NCT00408434|467040251|FG002|Overall Study|Terminated by Investigator|0|||
129749027|NCT00408434|467040252|FG003|Overall Study|Terminated by Investigator|0|||
129749028|NCT00408434|467040253|FG004|Overall Study|Terminated by Investigator|1|||
129749029|NCT00408434|467040254|FG005|Overall Study|Terminated by Investigator|1|||
129749030|NCT00408434|467040255|FG006|Overall Study|Terminated by Investigator|0|||
129749031|NCT00588354|467040256|FG000|Baseline to 2 Weeks|Adverse Event|1|||
129749032|NCT00588354|467040257|FG001|Baseline to 2 Weeks|Adverse Event|0|||
129749033|NCT00588354|467040256|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
129749034|NCT00588354|467040257|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
129749035|NCT00588354|467040256|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
129749036|NCT00588354|467040257|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
129749037|NCT04000581|467040258|FG000|Overall Study|Withdrawal by Subject|0|||
129749038|NCT04000581|467040259|FG001|Overall Study|Withdrawal by Subject|1|||
129749039|NCT00895453|467040260|FG000|Overall Study|Lost to Follow-up|25|||
129749040|NCT00895453|467040261|FG001|Overall Study|Lost to Follow-up|25|||
129749041|NCT00895453|467040262|FG002|Overall Study|Lost to Follow-up|23|||
129749042|NCT01736618|467040269|FG000|Overall Study|Death|294|||
129749043|NCT01736618|467040269|FG000|Overall Study|Lost to Follow-up|193|||
129749044|NCT01736618|467040269|FG000|Overall Study|Withdrawal by Subject|54|||
129749045|NCT01736618|467040269|FG000|Overall Study|Subject unable to be followed at study location|223|||
129896422|NCT00946192|467580537|FG000|Overall Study|Withdrawal by Subject|10|||
129749046|NCT01736618|467040269|FG000|Overall Study|Physician Decision|33|||
129749047|NCT01736618|467040269|FG000|Overall Study|Transplant or removal of target organ|19|||
129749048|NCT01736618|467040269|FG000|Overall Study|Change in indication or condition|78|||
129749049|NCT01736618|467040269|FG000|Overall Study|Study device explant|103|||
129749050|NCT01736618|467040269|FG000|Overall Study|Unable to complete implant|2|||
129749051|NCT00400569|467040274|FG000|Overall Study|Death|1|||
129749052|NCT00620113|467040277|FG000|Overall Study|Adverse Event|3|||
129749053|NCT00620113|467040278|FG001|Overall Study|Adverse Event|2|||
129749054|NCT00620113|467040279|FG002|Overall Study|Adverse Event|2|||
129749055|NCT00620113|467040280|FG003|Overall Study|Adverse Event|1|||
129749056|NCT00620113|467040277|FG000|Overall Study|Lack of Efficacy|2|||
129749057|NCT00620113|467040278|FG001|Overall Study|Lack of Efficacy|3|||
129749058|NCT00620113|467040279|FG002|Overall Study|Lack of Efficacy|0|||
129749059|NCT00620113|467040280|FG003|Overall Study|Lack of Efficacy|2|||
129749060|NCT00620113|467040277|FG000|Overall Study|Physician Decision|1|||
129749061|NCT00620113|467040278|FG001|Overall Study|Physician Decision|0|||
129749062|NCT00620113|467040279|FG002|Overall Study|Physician Decision|0|||
129749063|NCT00620113|467040280|FG003|Overall Study|Physician Decision|2|||
129749064|NCT00620113|467040277|FG000|Overall Study|Protocol Violation|2|||
129749065|NCT00620113|467040278|FG001|Overall Study|Protocol Violation|1|||
129749066|NCT00620113|467040279|FG002|Overall Study|Protocol Violation|0|||
129749067|NCT00620113|467040280|FG003|Overall Study|Protocol Violation|0|||
129749068|NCT00620113|467040277|FG000|Overall Study|Withdrawal by Subject|5|||
129749069|NCT00620113|467040278|FG001|Overall Study|Withdrawal by Subject|1|||
129749070|NCT00620113|467040279|FG002|Overall Study|Withdrawal by Subject|3|||
129749071|NCT00620113|467040280|FG003|Overall Study|Withdrawal by Subject|5|||
129749072|NCT02461745|467040285|FG000|Overall Study|Lack of Efficacy|9|||
129749073|NCT02461745|467040286|FG001|Overall Study|Lack of Efficacy|1|||
129749074|NCT02461745|467040285|FG000|Overall Study|Lost to Follow-up|2|||
129749075|NCT02461745|467040286|FG001|Overall Study|Lost to Follow-up|2|||
129749076|NCT02461745|467040285|FG000|Overall Study|Withdrawal by Subject|3|||
129749077|NCT02461745|467040286|FG001|Overall Study|Withdrawal by Subject|1|||
129749078|NCT00211887|467040287|FG000|Overall Study|Adverse Event|8|||
129749079|NCT00211887|467040288|FG001|Overall Study|Adverse Event|4|||
129749080|NCT00211887|467040289|FG002|Overall Study|Adverse Event|6|||
129749081|NCT00211887|467040287|FG000|Overall Study|Death|1|||
129749082|NCT00211887|467040288|FG001|Overall Study|Death|1|||
129749083|NCT00211887|467040289|FG002|Overall Study|Death|1|||
129749084|NCT00211887|467040287|FG000|Overall Study|Lost to Follow-up|28|||
129749085|NCT00211887|467040288|FG001|Overall Study|Lost to Follow-up|13|||
129749086|NCT00211887|467040289|FG002|Overall Study|Lost to Follow-up|9|||
129749087|NCT00211887|467040287|FG000|Overall Study|Non-medical reason|31|||
129749088|NCT00211887|467040288|FG001|Overall Study|Non-medical reason|14|||
129749089|NCT00211887|467040289|FG002|Overall Study|Non-medical reason|8|||
129749090|NCT00211887|467040287|FG000|Overall Study|Other medical reason|15|||
129749091|NCT00211887|467040288|FG001|Overall Study|Other medical reason|11|||
129809291|NCT02993757|467267662|FG001|Overall Study|Lost to Follow-up|0|||
129809292|NCT02993757|467267661|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
129809293|NCT02993757|467267662|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
129809294|NCT00957580|467267665|FG000|Overall Study|Ongoing at data cut-off|0|||
129809295|NCT00957580|467267666|FG001|Overall Study|Ongoing at data cut-off|1|||
129809296|NCT00957580|467267667|FG002|Overall Study|Ongoing at data cut-off|0|||
129809297|NCT00957580|467267665|FG000|Overall Study|Enrolled but not treated|0|||
129809298|NCT00957580|467267666|FG001|Overall Study|Enrolled but not treated|1|||
129809299|NCT00957580|467267667|FG002|Overall Study|Enrolled but not treated|0|||
129809300|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129896423|NCT00946192|467580538|FG001|Overall Study|Withdrawal by Subject|7|||
129896424|NCT00946192|467580539|FG002|Overall Study|Withdrawal by Subject|3|||
129896425|NCT00946192|467580537|FG000|Overall Study|Did not start medication|2|||
129896426|NCT00946192|467580538|FG001|Overall Study|Did not start medication|0|||
129896427|NCT00946192|467580539|FG002|Overall Study|Did not start medication|0|||
129749092|NCT00211887|467040289|FG002|Overall Study|Other medical reason|7|||
129749093|NCT00211887|467040287|FG000|Overall Study|Side effects|19|||
129749094|NCT00211887|467040288|FG001|Overall Study|Side effects|13|||
129809301|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129809302|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129749095|NCT00211887|467040289|FG002|Overall Study|Side effects|5|||
129749096|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Adverse Event|33|||
129749097|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
129749098|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
129749099|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
129749100|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Physician Decision|6|||
129749101|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
129749102|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
129749103|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
129749104|NCT00965419|467040293|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
129749105|NCT00965419|467040293|FG000|Follow-up Phase|Adverse Event|9|||
129749106|NCT00965419|467040293|FG000|Follow-up Phase|Protocol Violation|4|||
129749107|NCT00965419|467040293|FG000|Follow-up Phase|Withdrawal by Subject|8|||
129749108|NCT00965419|467040293|FG000|Follow-up Phase|Physician Decision|4|||
129749109|NCT00965419|467040293|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
129749110|NCT00965419|467040293|FG000|Follow-up Phase|Lack of Efficacy|28|||
129749111|NCT00826618|467041779|FG000|Overall Study|Withdrawal by Subject|1|||
129749112|NCT03712787|467041780|FG000|Overall Study|Adverse Event|2|||
129749113|NCT03712787|467041781|FG001|Overall Study|Adverse Event|3|||
129749114|NCT03712787|467041782|FG002|Overall Study|Adverse Event|0|||
129749115|NCT03712787|467041783|FG003|Overall Study|Adverse Event|4|||
129749116|NCT03712787|467041780|FG000|Overall Study|Withdrawal by Subject|4|||
129749117|NCT03712787|467041781|FG001|Overall Study|Withdrawal by Subject|14|||
129749118|NCT03712787|467041782|FG002|Overall Study|Withdrawal by Subject|12|||
129749119|NCT03712787|467041783|FG003|Overall Study|Withdrawal by Subject|8|||
129749120|NCT03712787|467041780|FG000|Overall Study|Lost to Follow-up|1|||
129749121|NCT03712787|467041781|FG001|Overall Study|Lost to Follow-up|1|||
129749122|NCT03712787|467041782|FG002|Overall Study|Lost to Follow-up|2|||
129749123|NCT03712787|467041783|FG003|Overall Study|Lost to Follow-up|1|||
129749124|NCT03712787|467041780|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129749125|NCT03712787|467041781|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
129749126|NCT03712787|467041782|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
129749127|NCT03712787|467041783|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
129749128|NCT03712787|467041780|FG000|Overall Study|COVID-19 Infection|0|||
129749129|NCT03712787|467041781|FG001|Overall Study|COVID-19 Infection|1|||
129749130|NCT03712787|467041782|FG002|Overall Study|COVID-19 Infection|0|||
129749131|NCT03712787|467041783|FG003|Overall Study|COVID-19 Infection|0|||
129749132|NCT03712787|467041780|FG000|Overall Study|Other, Not Specified|79|||
129749133|NCT03712787|467041781|FG001|Overall Study|Other, Not Specified|77|||
129749134|NCT03712787|467041782|FG002|Overall Study|Other, Not Specified|74|||
129749135|NCT03712787|467041783|FG003|Overall Study|Other, Not Specified|78|||
129749136|NCT00732875|467041784|FG000|Overall Study|Adverse Event|16|||
129749137|NCT00732875|467041784|FG000|Overall Study|Withdrawal by Subject|6|||
129749138|NCT00732875|467041784|FG000|Overall Study|Lack of Efficacy|13|||
129749139|NCT00303485|467041792|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
129749140|NCT00303485|467041793|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
129749141|NCT00303485|467041792|FG000|Overall Study|Failure to return|0|||
129749142|NCT00303485|467041793|FG001|Overall Study|Failure to return|1|||
129749143|NCT00303485|467041792|FG000|Overall Study|Withdrawal by Subject|1|||
129749144|NCT00303485|467041793|FG001|Overall Study|Withdrawal by Subject|0|||
129749145|NCT02219334|467041801|FG000|Overall Study|Withdrawal by Subject|1|||
129749146|NCT02219334|467041802|FG001|Overall Study|Withdrawal by Subject|0|||
129749147|NCT02219334|467041801|FG000|Overall Study|Protocol Violation|7|||
129749148|NCT02219334|467041802|FG001|Overall Study|Protocol Violation|3|||
129749149|NCT02630472|467041805|FG000|Overall Study|Physician Decision|10|||
129749150|NCT02630472|467041806|FG001|Overall Study|Physician Decision|0|||
129749151|NCT04878211|467041807|FG000|Overall Study|Lost to Follow-up|0|||
129749152|NCT04878211|467041808|FG001|Overall Study|Lost to Follow-up|0|||
129749153|NCT04878211|467041809|FG002|Overall Study|Lost to Follow-up|0|||
129749154|NCT04878211|467041810|FG003|Overall Study|Lost to Follow-up|1|||
129749155|NCT04878211|467041811|FG004|Overall Study|Lost to Follow-up|0|||
129749156|NCT04878211|467041812|FG005|Overall Study|Lost to Follow-up|1|||
129749157|NCT04878211|467041807|FG000|Overall Study|Protocol deviation|1|||
129749158|NCT04878211|467041808|FG001|Overall Study|Protocol deviation|0|||
129749159|NCT04878211|467041809|FG002|Overall Study|Protocol deviation|0|||
129749160|NCT04878211|467041810|FG003|Overall Study|Protocol deviation|0|||
129749161|NCT04878211|467041811|FG004|Overall Study|Protocol deviation|0|||
129749162|NCT04878211|467041812|FG005|Overall Study|Protocol deviation|0|||
129749163|NCT04878211|467041807|FG000|Overall Study|Study terminated by sponsor|0|||
129749164|NCT04878211|467041808|FG001|Overall Study|Study terminated by sponsor|0|||
129749165|NCT04878211|467041809|FG002|Overall Study|Study terminated by sponsor|0|||
129749166|NCT04878211|467041810|FG003|Overall Study|Study terminated by sponsor|0|||
129749167|NCT04878211|467041811|FG004|Overall Study|Study terminated by sponsor|9|||
129749168|NCT04878211|467041812|FG005|Overall Study|Study terminated by sponsor|4|||
129749169|NCT04878211|467041807|FG000|Overall Study|Subject decision|0|||
129749170|NCT04878211|467041808|FG001|Overall Study|Subject decision|0|||
129749171|NCT04878211|467041809|FG002|Overall Study|Subject decision|0|||
129749172|NCT04878211|467041810|FG003|Overall Study|Subject decision|0|||
129749173|NCT04878211|467041811|FG004|Overall Study|Subject decision|1|||
129749174|NCT04878211|467041812|FG005|Overall Study|Subject decision|0|||
129749175|NCT04774926|467041813|FG000|Overall Study|Adverse Event|15|||
129749176|NCT04774926|467041813|FG000|Overall Study|Lost to Follow-up|3|||
129749177|NCT04774926|467041813|FG000|Overall Study|Physician Decision|6|||
129749178|NCT04774926|467041813|FG000|Overall Study|Withdrawal by Subject|3|||
129749179|NCT04774926|467041813|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
129749180|NCT02783599|467041814|FG000|Overall Study|Progressive disease|23|||
129749181|NCT02783599|467041814|FG000|Overall Study|Surgical Resection|10|||
129749182|NCT02783599|467041814|FG000|Overall Study|Adverse Event|4|||
129749183|NCT02783599|467041814|FG000|Overall Study|Physician Decision|2|||
129809303|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
129809304|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
129809305|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
129809306|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
129809307|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
129809308|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809309|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
129809310|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809311|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809312|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129749184|NCT02783599|467041814|FG000|Overall Study|Death|1|||
129749185|NCT05173012|467041818|FG000|Overall Study|Adverse Event|2|||
129749186|NCT05173012|467041819|FG001|Overall Study|Adverse Event|3|||
129749187|NCT05173012|467041820|FG002|Overall Study|Adverse Event|4|||
129749188|NCT05173012|467041821|FG003|Overall Study|Adverse Event|13|||
129749189|NCT05173012|467041822|FG004|Overall Study|Adverse Event|0|||
129749190|NCT05173012|467041823|FG005|Overall Study|Adverse Event|0|||
129749191|NCT05173012|467041824|FG006|Overall Study|Adverse Event|2|||
129749192|NCT05173012|467041825|FG007|Overall Study|Adverse Event|4|||
129749193|NCT05173012|467041818|FG000|Overall Study|Lost to Follow-up|0|||
129749194|NCT05173012|467041819|FG001|Overall Study|Lost to Follow-up|0|||
129749195|NCT05173012|467041820|FG002|Overall Study|Lost to Follow-up|0|||
129749196|NCT05173012|467041821|FG003|Overall Study|Lost to Follow-up|1|||
129749197|NCT05173012|467041822|FG004|Overall Study|Lost to Follow-up|0|||
129749198|NCT05173012|467041823|FG005|Overall Study|Lost to Follow-up|0|||
129749199|NCT05173012|467041824|FG006|Overall Study|Lost to Follow-up|0|||
129749200|NCT05173012|467041825|FG007|Overall Study|Lost to Follow-up|0|||
129749201|NCT05173012|467041818|FG000|Overall Study|Withdrawal by Subject|1|||
129749202|NCT05173012|467041819|FG001|Overall Study|Withdrawal by Subject|0|||
129749203|NCT05173012|467041820|FG002|Overall Study|Withdrawal by Subject|1|||
129749204|NCT05173012|467041821|FG003|Overall Study|Withdrawal by Subject|3|||
129749205|NCT05173012|467041822|FG004|Overall Study|Withdrawal by Subject|1|||
129749206|NCT05173012|467041823|FG005|Overall Study|Withdrawal by Subject|0|||
129749207|NCT05173012|467041824|FG006|Overall Study|Withdrawal by Subject|1|||
129749208|NCT05173012|467041825|FG007|Overall Study|Withdrawal by Subject|0|||
129749209|NCT05173012|467041818|FG000|Overall Study|Protocol Deviation|0|||
129749210|NCT05173012|467041819|FG001|Overall Study|Protocol Deviation|0|||
129749211|NCT05173012|467041820|FG002|Overall Study|Protocol Deviation|0|||
129749212|NCT05173012|467041821|FG003|Overall Study|Protocol Deviation|1|||
129749213|NCT05173012|467041822|FG004|Overall Study|Protocol Deviation|0|||
129749214|NCT05173012|467041823|FG005|Overall Study|Protocol Deviation|0|||
129749215|NCT05173012|467041824|FG006|Overall Study|Protocol Deviation|0|||
129809313|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809314|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
129809315|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
129809316|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129896428|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
129896429|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
129896430|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
129749216|NCT05173012|467041825|FG007|Overall Study|Protocol Deviation|0|||
129749217|NCT05173012|467041818|FG000|Overall Study|Other|0|||
129749218|NCT05173012|467041819|FG001|Overall Study|Other|0|||
129749219|NCT05173012|467041820|FG002|Overall Study|Other|0|||
129749220|NCT05173012|467041821|FG003|Overall Study|Other|2|||
129896431|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
129896432|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
129896433|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
129749221|NCT05173012|467041822|FG004|Overall Study|Other|0|||
129749222|NCT05173012|467041823|FG005|Overall Study|Other|0|||
129749223|NCT05173012|467041824|FG006|Overall Study|Other|0|||
129749224|NCT05173012|467041825|FG007|Overall Study|Other|0|||
129749225|NCT02936843|467041826|FG000|Overall Study|Lost to Follow-up|3|||
129749226|NCT02936843|467041827|FG001|Overall Study|Lost to Follow-up|1|||
129749227|NCT02936843|467041826|FG000|Overall Study|Withdrawal by Subject|1|||
129749228|NCT02936843|467041827|FG001|Overall Study|Withdrawal by Subject|1|||
129749229|NCT03668613|467041828|FG000|Overall Study|Adverse Event|1|||
129749230|NCT03668613|467041829|FG001|Overall Study|Adverse Event|2|||
129749231|NCT03668613|467041828|FG000|Overall Study|Lack of Efficacy|5|||
129749232|NCT03668613|467041829|FG001|Overall Study|Lack of Efficacy|1|||
129749233|NCT03668613|467041828|FG000|Overall Study|Pregnancy|0|||
129749234|NCT03668613|467041829|FG001|Overall Study|Pregnancy|2|||
129749235|NCT03668613|467041828|FG000|Overall Study|Protocol Violation|1|||
129749236|NCT03668613|467041829|FG001|Overall Study|Protocol Violation|0|||
129749237|NCT03668613|467041828|FG000|Overall Study|Physician Decision|1|||
129749238|NCT03668613|467041829|FG001|Overall Study|Physician Decision|0|||
129749239|NCT03668613|467041828|FG000|Overall Study|Withdrawal by Subject|2|||
129749240|NCT03668613|467041829|FG001|Overall Study|Withdrawal by Subject|1|||
129749241|NCT03668613|467041828|FG000|Overall Study|Guardian decision|1|||
129749242|NCT03668613|467041829|FG001|Overall Study|Guardian decision|0|||
129749243|NCT01393821|467041830|FG000|Overall Study|Cancel|1|||
129749244|NCT01393821|467041831|FG001|Overall Study|Cancel|1|||
129749245|NCT01393821|467041830|FG000|Overall Study|not evaluable for primary endpoint|4|||
129749246|NCT01393821|467041831|FG001|Overall Study|not evaluable for primary endpoint|2|||
129749247|NCT03386487|467041832|FG000|Overall Study|Lost to Follow-up|5|||
129749248|NCT03386487|467041833|FG001|Overall Study|Lost to Follow-up|6|||
129749249|NCT03386487|467041832|FG000|Overall Study|Withdrawal by Subject|11|||
129749250|NCT03386487|467041833|FG001|Overall Study|Withdrawal by Subject|7|||
129749251|NCT03386487|467041832|FG000|Overall Study|Physician Decision|11|||
129749252|NCT03386487|467041833|FG001|Overall Study|Physician Decision|8|||
129749253|NCT02703324|467041834|FG000|Period Two|Withdrawal by Subject|0|||
129749254|NCT02703324|467041835|FG001|Period Two|Withdrawal by Subject|0|||
129749255|NCT02703324|467041836|FG002|Period Two|Withdrawal by Subject|1|||
129749256|NCT02703324|467041837|FG003|Period Two|Withdrawal by Subject|0|||
129749257|NCT02703324|467041838|FG004|Period Two|Withdrawal by Subject|0|||
129749258|NCT02703324|467041839|FG005|Period Two|Withdrawal by Subject|0|||
129749259|NCT06312592|467041840|FG000|Overall Study|Lost to Follow-up|29|||
129749260|NCT06312592|467041841|FG001|Overall Study|Lost to Follow-up|13|||
129749261|NCT01948063|467041844|FG000|Overall Study|Boston MCI halted research protocol|0|||
129749262|NCT01948063|467041845|FG001|Overall Study|Boston MCI halted research protocol|1|||
129749263|NCT01948063|467041844|FG000|Overall Study|Discovered an enrollment in other study|0|||
129749264|NCT01948063|467041845|FG001|Overall Study|Discovered an enrollment in other study|1|||
129749265|NCT01948063|467041844|FG000|Overall Study|Blood samples were accidentally thawed|1|||
129749266|NCT01948063|467041845|FG001|Overall Study|Blood samples were accidentally thawed|0|||
129749267|NCT01858766|467041846|FG000|Overall Study|Randomized but Never Treated|0|||
129749268|NCT01858766|467041847|FG001|Overall Study|Randomized but Never Treated|0|||
129749269|NCT01858766|467041848|FG002|Overall Study|Randomized but Never Treated|0|||
129749270|NCT01858766|467041849|FG003|Overall Study|Randomized but Never Treated|0|||
129749271|NCT01858766|467041850|FG004|Overall Study|Randomized but Never Treated|0|||
129749272|NCT01858766|467041851|FG005|Overall Study|Randomized but Never Treated|1|||
129809317|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809318|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
129809319|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809320|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809321|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809322|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809323|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809324|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Other|0|||
129809325|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Other|0|||
129809326|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Other|1|||
129809327|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Other|1|||
129809328|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Other|2|||
129809329|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Other|0|||
129809330|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Other|0|||
129809331|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Other|0|||
129809332|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809333|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809334|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809335|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
129749273|NCT01858766|467041852|FG006|Overall Study|Randomized but Never Treated|0|||
129749274|NCT01858766|467041853|FG007|Overall Study|Randomized but Never Treated|0|||
129749275|NCT01858766|467041854|FG008|Overall Study|Randomized but Never Treated|0|||
129749276|NCT01858766|467041855|FG009|Overall Study|Randomized but Never Treated|0|||
129749277|NCT01858766|467041856|FG010|Overall Study|Randomized but Never Treated|0|||
129749278|NCT01858766|467041857|FG011|Overall Study|Randomized but Never Treated|0|||
129809336|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
129809337|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
129809338|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
129749279|NCT01858766|467041858|FG012|Overall Study|Randomized but Never Treated|0|||
129749280|NCT01858766|467041859|FG013|Overall Study|Randomized but Never Treated|0|||
129749281|NCT01858766|467041860|FG014|Overall Study|Randomized but Never Treated|0|||
129749282|NCT01858766|467041861|FG015|Overall Study|Randomized but Never Treated|0|||
129749283|NCT01858766|467041862|FG016|Overall Study|Randomized but Never Treated|0|||
129749284|NCT01858766|467041863|FG017|Overall Study|Randomized but Never Treated|1|||
129749285|NCT01858766|467041864|FG018|Overall Study|Randomized but Never Treated|0|||
129749286|NCT01858766|467041846|FG000|Overall Study|Death|0|||
129749287|NCT01858766|467041847|FG001|Overall Study|Death|0|||
129749288|NCT01858766|467041848|FG002|Overall Study|Death|1|||
129749289|NCT01858766|467041849|FG003|Overall Study|Death|0|||
129749290|NCT01858766|467041850|FG004|Overall Study|Death|0|||
129749291|NCT01858766|467041851|FG005|Overall Study|Death|0|||
129749292|NCT01858766|467041852|FG006|Overall Study|Death|0|||
129749293|NCT01858766|467041853|FG007|Overall Study|Death|0|||
129749294|NCT01858766|467041854|FG008|Overall Study|Death|0|||
129749295|NCT01858766|467041855|FG009|Overall Study|Death|0|||
129749296|NCT01858766|467041856|FG010|Overall Study|Death|0|||
129749297|NCT01858766|467041857|FG011|Overall Study|Death|0|||
129749298|NCT01858766|467041858|FG012|Overall Study|Death|0|||
129749299|NCT01858766|467041859|FG013|Overall Study|Death|0|||
129749300|NCT01858766|467041860|FG014|Overall Study|Death|0|||
129749301|NCT01858766|467041861|FG015|Overall Study|Death|0|||
129749302|NCT01858766|467041862|FG016|Overall Study|Death|0|||
129749303|NCT01858766|467041863|FG017|Overall Study|Death|0|||
129749304|NCT01858766|467041864|FG018|Overall Study|Death|0|||
129749305|NCT01858766|467041846|FG000|Overall Study|Lack of Efficacy|1|||
129749306|NCT01858766|467041847|FG001|Overall Study|Lack of Efficacy|0|||
129749307|NCT01858766|467041848|FG002|Overall Study|Lack of Efficacy|0|||
129749308|NCT01858766|467041849|FG003|Overall Study|Lack of Efficacy|0|||
129749309|NCT01858766|467041850|FG004|Overall Study|Lack of Efficacy|1|||
129749310|NCT01858766|467041851|FG005|Overall Study|Lack of Efficacy|2|||
129749311|NCT01858766|467041852|FG006|Overall Study|Lack of Efficacy|0|||
129749312|NCT01858766|467041853|FG007|Overall Study|Lack of Efficacy|0|||
129749313|NCT01858766|467041854|FG008|Overall Study|Lack of Efficacy|0|||
129749314|NCT01858766|467041855|FG009|Overall Study|Lack of Efficacy|0|||
129749315|NCT01858766|467041856|FG010|Overall Study|Lack of Efficacy|0|||
129749316|NCT01858766|467041857|FG011|Overall Study|Lack of Efficacy|3|||
129749317|NCT01858766|467041858|FG012|Overall Study|Lack of Efficacy|5|||
129749318|NCT01858766|467041859|FG013|Overall Study|Lack of Efficacy|3|||
129749319|NCT01858766|467041860|FG014|Overall Study|Lack of Efficacy|5|||
129749320|NCT01858766|467041861|FG015|Overall Study|Lack of Efficacy|5|||
129749321|NCT01858766|467041862|FG016|Overall Study|Lack of Efficacy|2|||
129749322|NCT01858766|467041863|FG017|Overall Study|Lack of Efficacy|3|||
129749323|NCT01858766|467041864|FG018|Overall Study|Lack of Efficacy|3|||
129749324|NCT01858766|467041846|FG000|Overall Study|Lost to Follow-up|0|||
129749325|NCT01858766|467041847|FG001|Overall Study|Lost to Follow-up|0|||
129749326|NCT01858766|467041848|FG002|Overall Study|Lost to Follow-up|0|||
129749327|NCT01858766|467041849|FG003|Overall Study|Lost to Follow-up|0|||
129749328|NCT01858766|467041850|FG004|Overall Study|Lost to Follow-up|0|||
129749329|NCT01858766|467041851|FG005|Overall Study|Lost to Follow-up|1|||
129749330|NCT01858766|467041852|FG006|Overall Study|Lost to Follow-up|0|||
129749331|NCT01858766|467041853|FG007|Overall Study|Lost to Follow-up|2|||
129749332|NCT01858766|467041854|FG008|Overall Study|Lost to Follow-up|0|||
129749333|NCT01858766|467041855|FG009|Overall Study|Lost to Follow-up|0|||
129749334|NCT01858766|467041856|FG010|Overall Study|Lost to Follow-up|0|||
129749335|NCT01858766|467041857|FG011|Overall Study|Lost to Follow-up|1|||
129749336|NCT01858766|467041858|FG012|Overall Study|Lost to Follow-up|0|||
129749337|NCT01858766|467041859|FG013|Overall Study|Lost to Follow-up|0|||
129749338|NCT01858766|467041860|FG014|Overall Study|Lost to Follow-up|3|||
129749339|NCT01858766|467041861|FG015|Overall Study|Lost to Follow-up|1|||
129809339|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
129445396|NCT03828292|465931281|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129749340|NCT01858766|467041862|FG016|Overall Study|Lost to Follow-up|1|||
129749341|NCT01858766|467041863|FG017|Overall Study|Lost to Follow-up|0|||
129749342|NCT01858766|467041864|FG018|Overall Study|Lost to Follow-up|1|||
129749343|NCT01858766|467041846|FG000|Overall Study|Withdrew Consent|0|||
129749344|NCT01858766|467041847|FG001|Overall Study|Withdrew Consent|0|||
129749345|NCT01858766|467041848|FG002|Overall Study|Withdrew Consent|0|||
129749346|NCT01858766|467041849|FG003|Overall Study|Withdrew Consent|0|||
129749347|NCT01858766|467041850|FG004|Overall Study|Withdrew Consent|0|||
129749348|NCT01858766|467041851|FG005|Overall Study|Withdrew Consent|0|||
129749349|NCT01858766|467041852|FG006|Overall Study|Withdrew Consent|0|||
129749350|NCT01858766|467041853|FG007|Overall Study|Withdrew Consent|0|||
129749351|NCT01858766|467041854|FG008|Overall Study|Withdrew Consent|0|||
129749352|NCT01858766|467041855|FG009|Overall Study|Withdrew Consent|0|||
129749353|NCT01858766|467041856|FG010|Overall Study|Withdrew Consent|0|||
129749354|NCT01858766|467041857|FG011|Overall Study|Withdrew Consent|1|||
129749355|NCT01858766|467041858|FG012|Overall Study|Withdrew Consent|0|||
129749356|NCT01858766|467041859|FG013|Overall Study|Withdrew Consent|0|||
129749357|NCT01858766|467041860|FG014|Overall Study|Withdrew Consent|0|||
129749358|NCT01858766|467041861|FG015|Overall Study|Withdrew Consent|0|||
129749359|NCT01858766|467041862|FG016|Overall Study|Withdrew Consent|0|||
129749360|NCT01858766|467041863|FG017|Overall Study|Withdrew Consent|0|||
129749361|NCT01858766|467041864|FG018|Overall Study|Withdrew Consent|0|||
129749362|NCT03517228|467041867|FG000|Overall Study|Withdrawal by Subject|2|||
129749363|NCT03517228|467041867|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
129749364|NCT03517228|467041867|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
129749365|NCT03517228|467041867|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
129749366|NCT03517228|467041867|FG000|Overall Study|Canceled due to device being updated|1|||
129749367|NCT03517228|467041867|FG000|Overall Study|No V Cares in stock|1|||
129749368|NCT03517228|467041867|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
129749369|NCT03781414|467041878|FG000|Overall Study|Study terminated by sponsor|39|||
129749370|NCT03781414|467041879|FG001|Overall Study|Study terminated by sponsor|34|||
129749371|NCT03781414|467041880|FG002|Overall Study|Study terminated by sponsor|25|||
129749372|NCT03781414|467041878|FG000|Overall Study|Adverse Event|3|||
129749373|NCT03781414|467041879|FG001|Overall Study|Adverse Event|6|||
129749374|NCT03781414|467041880|FG002|Overall Study|Adverse Event|3|||
129749375|NCT03781414|467041878|FG000|Overall Study|Physician Decision|2|||
129749376|NCT03781414|467041879|FG001|Overall Study|Physician Decision|0|||
129749377|NCT03781414|467041880|FG002|Overall Study|Physician Decision|1|||
129749378|NCT03781414|467041878|FG000|Overall Study|Withdrawal by Subject|2|||
129749379|NCT03781414|467041879|FG001|Overall Study|Withdrawal by Subject|3|||
129749380|NCT03781414|467041880|FG002|Overall Study|Withdrawal by Subject|3|||
129749381|NCT03781414|467041878|FG000|Overall Study|Death|1|||
129749382|NCT03781414|467041879|FG001|Overall Study|Death|4|||
129749383|NCT03781414|467041880|FG002|Overall Study|Death|0|||
129749384|NCT03781414|467041878|FG000|Overall Study|Lost to Follow-up|1|||
129749385|NCT03781414|467041879|FG001|Overall Study|Lost to Follow-up|1|||
129749386|NCT03781414|467041880|FG002|Overall Study|Lost to Follow-up|0|||
129749387|NCT04752358|467041884|FG000|Overall Study|Death|2|||
129749388|NCT04752358|467041885|FG001|Overall Study|Death|1|||
129749389|NCT00719355|467041888|FG000|Overall Study|Death|0|||
129749390|NCT00719355|467041889|FG001|Overall Study|Death|1|||
129749391|NCT00719355|467041888|FG000|Overall Study|Medical|14|||
129749392|NCT00719355|467041889|FG001|Overall Study|Medical|5|||
129749393|NCT00719355|467041888|FG000|Overall Study|Compliance|4|||
129749394|NCT00719355|467041889|FG001|Overall Study|Compliance|6|||
129749395|NCT00719355|467041888|FG000|Overall Study|Moved|0|||
129749396|NCT00719355|467041889|FG001|Overall Study|Moved|1|||
129749397|NCT01835158|467041890|FG000|Overall Study|Withdrawal by Subject|1|||
129749398|NCT01835158|467041891|FG001|Overall Study|Withdrawal by Subject|6|||
129749399|NCT03364738|467041892|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
129749400|NCT03364738|467041892|FG000|Overall Study|Withdrawal by Subject|1|||
129749401|NCT03364738|467041892|FG000|Overall Study|Adverse Event|1|||
129749402|NCT03245398|467041897|FG000|Overall Study|Travelled to another island|1|||
129749403|NCT03245398|467041898|FG001|Overall Study|Travelled to another island|0|||
129749404|NCT03422536|467041905|FG000|Randomized|Physician Decision|1|||
129749405|NCT03422536|467041906|FG001|Randomized|Physician Decision|1|||
129749406|NCT03422536|467041905|FG000|Allocation - Received Intervention|Disease progression|19|||
129749407|NCT03422536|467041906|FG001|Allocation - Received Intervention|Disease progression|25|||
129749408|NCT03422536|467041905|FG000|Allocation - Received Intervention|Death|1|||
129749409|NCT03422536|467041906|FG001|Allocation - Received Intervention|Death|3|||
129749410|NCT03422536|467041905|FG000|Allocation - Received Intervention|Adverse Event|1|||
129749411|NCT03422536|467041906|FG001|Allocation - Received Intervention|Adverse Event|0|||
129896434|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
129896435|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
129896436|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Death|1|||
129896437|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Death|0|||
129749412|NCT03422536|467041905|FG000|Allocation - Received Intervention|Physician Decision|1|||
129749413|NCT03422536|467041906|FG001|Allocation - Received Intervention|Physician Decision|1|||
129749414|NCT03422536|467041905|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
129749415|NCT03422536|467041906|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
129749416|NCT03422536|467041905|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
129896438|NCT01080131|467580540|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
129896439|NCT01080131|467580541|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
129749417|NCT03422536|467041906|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
129749418|NCT04531241|467041907|FG000|Period 1|Withdrawal by Subject|2|||
129749419|NCT04531241|467041908|FG001|Period 1|Withdrawal by Subject|0|||
129896440|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
129896441|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
129896442|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
129896443|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
129896444|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
129896445|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
129896446|NCT01080131|467580540|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
129749420|NCT04531241|467041907|FG000|Period 1|Dispesed incorrect lens power|1|||
129749421|NCT04531241|467041908|FG001|Period 1|Dispesed incorrect lens power|0|||
129749422|NCT04531241|467041907|FG000|Period 1|Protocol Violation|1|||
129749423|NCT04531241|467041908|FG001|Period 1|Protocol Violation|0|||
129749424|NCT04531241|467041907|FG000|Period 1|No longer eligible|0|||
129749425|NCT04531241|467041908|FG001|Period 1|No longer eligible|1|||
129749426|NCT04531241|467041907|FG000|Period 1|Lens Discomfort|0|||
129749427|NCT04531241|467041908|FG001|Period 1|Lens Discomfort|1|||
129749428|NCT04531241|467041907|FG000|Period 2|Covid-19 Related|1|||
129749429|NCT04531241|467041908|FG001|Period 2|Covid-19 Related|1|||
129749430|NCT02023996|467041909|FG000|Overall Study|Protocol Violation|6|||
129749431|NCT00395850|467041916|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
129749432|NCT00395850|467041917|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
129749433|NCT00395850|467041918|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
129749434|NCT00395850|467041919|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
129749435|NCT00395850|467041916|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
129749436|NCT00395850|467041917|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
129749437|NCT00395850|467041918|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
129749438|NCT00395850|467041919|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
129749439|NCT00395850|467041916|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
129749440|NCT00395850|467041917|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
129749441|NCT00395850|467041918|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
129749442|NCT00395850|467041919|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
129749443|NCT00395850|467041916|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
129749444|NCT00395850|467041917|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
129749445|NCT00395850|467041918|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
129749446|NCT00395850|467041919|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
129749447|NCT00395850|467041916|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
129749448|NCT00395850|467041917|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
129749449|NCT00395850|467041918|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
129749450|NCT00395850|467041919|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
129896447|NCT01080131|467580541|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
129896448|NCT01080131|467580540|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
129896449|NCT01080131|467580541|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
129896450|NCT01080131|467580540|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
129896451|NCT01080131|467580541|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
129896452|NCT01080131|467580540|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
129896453|NCT01080131|467580541|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
129896454|NCT04155424|467580542|FG000|Overall Study|Other than specified|3|||
129896455|NCT04155424|467580542|FG000|Overall Study|Withdrawal by Subject|1|||
129896456|NCT04155424|467580542|FG000|Overall Study|Adverse Event|1|||
129896457|NCT04159506|467580543|FG000|Overall Study|Lost to Follow-up|2|||
129896458|NCT04159506|467580544|FG001|Overall Study|Lost to Follow-up|5|||
129749451|NCT00395850|467041916|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
129749452|NCT00395850|467041917|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
129749453|NCT00395850|467041918|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
129749454|NCT00395850|467041919|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
129749455|NCT00395850|467041916|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
129749456|NCT00395850|467041917|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
129749457|NCT00395850|467041918|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
129749458|NCT00395850|467041919|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
129749459|NCT00705146|467041925|FG000|Overall Study|Lost to Follow-up|1|||
129749460|NCT00705146|467041926|FG001|Overall Study|Lost to Follow-up|1|||
129749461|NCT00095173|467041929|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
129749462|NCT00095173|467041930|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129749463|NCT00095173|467041931|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129749464|NCT00095173|467041932|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129749465|NCT00095173|467041933|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129749466|NCT00095173|467041934|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
129896459|NCT00797862|467582074|FG000|Overall Study|Adverse Event|86|||
129749467|NCT00095173|467041929|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
129749468|NCT00095173|467041930|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129749469|NCT00095173|467041931|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129749470|NCT00095173|467041932|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129749471|NCT00095173|467041933|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129749472|NCT00095173|467041934|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
129749473|NCT00095173|467041929|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
129749474|NCT00095173|467041930|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129749475|NCT00095173|467041931|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129749476|NCT00095173|467041932|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129749477|NCT00095173|467041933|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129749478|NCT00095173|467041934|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
129749479|NCT00095173|467041929|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
129749480|NCT00095173|467041930|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
129749481|NCT00095173|467041931|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
129749482|NCT00095173|467041932|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
129749483|NCT00095173|467041933|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
129749484|NCT00095173|467041934|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
129749485|NCT00095173|467041929|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129749486|NCT00095173|467041930|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
129749487|NCT00095173|467041931|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
129749488|NCT00095173|467041932|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129749489|NCT00095173|467041933|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129749490|NCT00095173|467041934|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
129749491|NCT00095173|467041929|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129749492|NCT00095173|467041930|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
129749493|NCT00095173|467041931|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129749494|NCT00095173|467041932|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129749495|NCT00095173|467041933|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129749496|NCT00095173|467041934|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
129749497|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Death|0|||
129749498|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Death|0|||
129749499|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Death|0|||
129749500|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Death|0|||
129749501|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Death|0|||
129749502|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Death|1|||
129749503|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
129749504|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
129749505|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
129749506|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
129749507|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
129749508|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
129749509|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
129749510|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
129749511|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
129749512|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
129749513|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
129749514|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
129749515|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
129749516|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
129749517|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
129749518|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
129749519|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
129749520|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
129749521|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129749522|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129749523|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129749524|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
129896460|NCT00797862|467582075|FG001|Overall Study|Adverse Event|44|||
129749525|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
129749526|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
129749527|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129749528|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129749529|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129896461|NCT00797862|467582076|FG002|Overall Study|Adverse Event|58|||
129749530|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
129749531|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
129749532|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
129749533|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129749534|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129749535|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129749536|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
129749537|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
129749538|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
129749539|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
129749540|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
129749541|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
129749542|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
129749543|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
129749544|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
129445397|NCT03828292|465931282|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
129445398|NCT03828292|465931283|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129445399|NCT03828292|465931284|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
129749545|NCT00095173|467041929|FG000|Open-Label Extension Phase (Period C)|Other|0|||
129749546|NCT00095173|467041930|FG001|Open-Label Extension Phase (Period C)|Other|0|||
129749547|NCT00095173|467041931|FG002|Open-Label Extension Phase (Period C)|Other|0|||
129749548|NCT00095173|467041932|FG003|Open-Label Extension Phase (Period C)|Other|4|||
129749549|NCT00095173|467041933|FG004|Open-Label Extension Phase (Period C)|Other|6|||
129749550|NCT00095173|467041934|FG005|Open-Label Extension Phase (Period C)|Other|8|||
129749551|NCT00330681|467041938|FG000|Overall Study|Adverse Event|3|||
129749552|NCT00330681|467041939|FG001|Overall Study|Adverse Event|6|||
129749553|NCT00330681|467041938|FG000|Overall Study|Protocol Violation|0|||
129749554|NCT00330681|467041939|FG001|Overall Study|Protocol Violation|1|||
129749555|NCT00330681|467041938|FG000|Overall Study|Withdrawal by Subject|5|||
129749556|NCT00330681|467041939|FG001|Overall Study|Withdrawal by Subject|5|||
129749557|NCT00330681|467041938|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
129749558|NCT00330681|467041939|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
129749559|NCT04698993|467041940|FG000|Overall Study|PCR results not accessible|2|||
129749560|NCT04698993|467041941|FG001|Overall Study|PCR results not accessible|7|||
129749561|NCT04698993|467041940|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
129749562|NCT04698993|467041941|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
129749563|NCT00527904|467041942|FG000|Overall Study|Adverse Event|45|||
129749564|NCT00527904|467041942|FG000|Overall Study|Withdrawal by Subject|21|||
129749565|NCT00527904|467041942|FG000|Overall Study|Lost to Follow-up|8|||
129749566|NCT00527904|467041942|FG000|Overall Study|misc|22|||
129749567|NCT02578186|467041943|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
129749568|NCT02578186|467041944|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
129749569|NCT02578186|467041943|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
129749570|NCT02578186|467041944|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
129749571|NCT00428389|467041945|FG000|Core Phase|Adverse Event|6|||
129749572|NCT00428389|467041946|FG001|Core Phase|Adverse Event|4|||
129749573|NCT00428389|467041945|FG000|Core Phase|Lack of Efficacy|2|||
129749574|NCT00428389|467041946|FG001|Core Phase|Lack of Efficacy|0|||
129749575|NCT00428389|467041945|FG000|Core Phase|Abnormal test procedure result(s)|0|||
129749576|NCT00428389|467041946|FG001|Core Phase|Abnormal test procedure result(s)|1|||
129749577|NCT00428389|467041945|FG000|Core Phase|Withdrawal by Subject|3|||
129749578|NCT00428389|467041946|FG001|Core Phase|Withdrawal by Subject|4|||
129749579|NCT00428389|467041945|FG000|Core Phase|Protocol deviation|0|||
129749580|NCT00428389|467041946|FG001|Core Phase|Protocol deviation|2|||
129749581|NCT00428389|467041945|FG000|Extension Phase|Adverse Event|17|||
129749582|NCT00428389|467041946|FG001|Extension Phase|Adverse Event|11|||
129749583|NCT00428389|467041945|FG000|Extension Phase|Lack of Efficacy|4|||
129749584|NCT00428389|467041946|FG001|Extension Phase|Lack of Efficacy|3|||
129749585|NCT00428389|467041945|FG000|Extension Phase|Withdrawal by Subject|6|||
129749586|NCT00428389|467041946|FG001|Extension Phase|Withdrawal by Subject|6|||
129749587|NCT00428389|467041945|FG000|Extension Phase|Lost to Follow-up|0|||
129749588|NCT00428389|467041946|FG001|Extension Phase|Lost to Follow-up|3|||
129749589|NCT00428389|467041945|FG000|Extension Phase|Death|1|||
129749590|NCT00428389|467041946|FG001|Extension Phase|Death|0|||
129749591|NCT00428389|467041945|FG000|Extension Phase|Protocol Violation|3|||
129749592|NCT00428389|467041946|FG001|Extension Phase|Protocol Violation|2|||
129749593|NCT00428389|467041945|FG000|Extension Phase|Administrative problems|1|||
129749594|NCT00428389|467041946|FG001|Extension Phase|Administrative problems|1|||
129749595|NCT01534195|467041947|FG000|Overall Study|Withdrawal by Subject|1|||
129749596|NCT01534195|467041948|FG001|Overall Study|Withdrawal by Subject|1|||
129749597|NCT02708355|467041949|FG000|Overall Study|Adverse Event|1|||
129749598|NCT02708355|467041950|FG001|Overall Study|Adverse Event|0|||
129749599|NCT02708355|467041951|FG002|Overall Study|Adverse Event|0|||
129749600|NCT03216746|467041952|FG000|Overall Study|Lost to Follow-up|6|||
129749601|NCT03216746|467041953|FG001|Overall Study|Lost to Follow-up|8|||
129749602|NCT03216746|467041954|FG002|Overall Study|Lost to Follow-up|5|||
129749603|NCT03216746|467041955|FG003|Overall Study|Lost to Follow-up|6|||
129749604|NCT01320202|467041956|FG000|Overall Study|Adverse Event|5|||
129749605|NCT01320202|467041957|FG001|Overall Study|Adverse Event|5|||
129749606|NCT01320202|467041956|FG000|Overall Study|Death|5|||
129749607|NCT01320202|467041957|FG001|Overall Study|Death|3|||
129749608|NCT01320202|467041956|FG000|Overall Study|Lost to Follow-up|1|||
129749609|NCT01320202|467041957|FG001|Overall Study|Lost to Follow-up|0|||
129809340|NCT01090492|467267668|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
129809341|NCT01090492|467267669|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
129809342|NCT01090492|467267670|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
129809343|NCT01090492|467267671|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
129809344|NCT01090492|467267672|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
129809345|NCT01090492|467267673|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
129809346|NCT01090492|467267674|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
129809347|NCT01090492|467267675|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
129809348|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809349|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809350|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809351|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809352|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809353|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
129809354|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809355|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
129809356|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809357|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
129809358|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809359|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809360|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809361|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809362|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809363|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
129809364|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Other|0|||
129809365|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Other|1|||
129809366|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Other|1|||
129809367|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Other|0|||
129809368|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Other|0|||
129809369|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Other|0|||
129809370|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Other|0|||
129809371|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Other|0|||
129809372|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
129809373|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
129809374|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809375|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
129809376|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809377|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809378|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
129809379|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
129809380|NCT01090492|467267668|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809381|NCT01090492|467267669|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129749610|NCT01320202|467041956|FG000|Overall Study|Physician Decision|3|||
129749611|NCT01320202|467041957|FG001|Overall Study|Physician Decision|1|||
129749612|NCT01320202|467041956|FG000|Overall Study|Protocol Violation|2|||
129749613|NCT01320202|467041957|FG001|Overall Study|Protocol Violation|1|||
129749614|NCT01320202|467041956|FG000|Overall Study|Withdrawal by Subject|10|||
129749615|NCT01320202|467041957|FG001|Overall Study|Withdrawal by Subject|3|||
129749616|NCT01320202|467041956|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
129749617|NCT01320202|467041957|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
129749618|NCT01320202|467041956|FG000|Overall Study|kidney transplant|1|||
129749619|NCT01320202|467041957|FG001|Overall Study|kidney transplant|2|||
129749620|NCT01320202|467041956|FG000|Overall Study|blood transfusion|1|||
129749621|NCT01320202|467041957|FG001|Overall Study|blood transfusion|7|||
129749622|NCT01320202|467041956|FG000|Overall Study|moved/changed dialysis|5|||
129749623|NCT01320202|467041957|FG001|Overall Study|moved/changed dialysis|2|||
129749624|NCT01320202|467041956|FG000|Overall Study|sponsor request|2|||
129749625|NCT01320202|467041957|FG001|Overall Study|sponsor request|0|||
129749626|NCT01320202|467041956|FG000|Overall Study|ineligible|3|||
129749627|NCT01320202|467041957|FG001|Overall Study|ineligible|0|||
129749628|NCT01320202|467041956|FG000|Overall Study|regained renal function|1|||
129749629|NCT01320202|467041957|FG001|Overall Study|regained renal function|0|||
129749630|NCT00635882|467041958|FG000|Overall Study|Protocol Violation|1|||
129749631|NCT00635882|467041959|FG001|Overall Study|Protocol Violation|0|||
129749632|NCT00635882|467041960|FG002|Overall Study|Protocol Violation|0|||
129749633|NCT00635882|467041961|FG003|Overall Study|Protocol Violation|0|||
129749634|NCT00635882|467041962|FG004|Overall Study|Protocol Violation|0|||
129749635|NCT00635882|467041963|FG005|Overall Study|Protocol Violation|0|||
129749636|NCT00825812|467041964|FG000|Overall Study|Never entered follow up|0|||
129749637|NCT00825812|467041965|FG001|Overall Study|Never entered follow up|0|||
129749638|NCT00825812|467041966|FG002|Overall Study|Never entered follow up|0|||
129749639|NCT00825812|467041967|FG003|Overall Study|Never entered follow up|1|||
129749640|NCT00825812|467041964|FG000|Overall Study|Adverse Event|0|||
129749641|NCT00825812|467041965|FG001|Overall Study|Adverse Event|0|||
129749642|NCT00825812|467041966|FG002|Overall Study|Adverse Event|0|||
129749643|NCT00825812|467041967|FG003|Overall Study|Adverse Event|1|||
129896462|NCT00797862|467582074|FG000|Overall Study|Abnormal Test Procedure Result|0|||
129896463|NCT00797862|467582075|FG001|Overall Study|Abnormal Test Procedure Result|1|||
129896464|NCT00797862|467582076|FG002|Overall Study|Abnormal Test Procedure Result|1|||
129896465|NCT00797862|467582074|FG000|Overall Study|Lack of Efficacy|1|||
129896466|NCT00797862|467582075|FG001|Overall Study|Lack of Efficacy|7|||
129896467|NCT00797862|467582076|FG002|Overall Study|Lack of Efficacy|6|||
129896468|NCT00797862|467582074|FG000|Overall Study|No longer required study medication|1|||
129896469|NCT00797862|467582075|FG001|Overall Study|No longer required study medication|0|||
129896470|NCT00797862|467582076|FG002|Overall Study|No longer required study medication|0|||
129896471|NCT00797862|467582074|FG000|Overall Study|Withdrawal by Subject|14|||
129896472|NCT00797862|467582075|FG001|Overall Study|Withdrawal by Subject|7|||
129896473|NCT00797862|467582076|FG002|Overall Study|Withdrawal by Subject|7|||
129896474|NCT00797862|467582074|FG000|Overall Study|Lost to Follow-up|11|||
129896475|NCT00797862|467582075|FG001|Overall Study|Lost to Follow-up|0|||
129896476|NCT00797862|467582076|FG002|Overall Study|Lost to Follow-up|5|||
129896477|NCT00797862|467582074|FG000|Overall Study|Administrative Problem|4|||
129896478|NCT00797862|467582075|FG001|Overall Study|Administrative Problem|0|||
129896479|NCT00797862|467582076|FG002|Overall Study|Administrative Problem|0|||
129896480|NCT00797862|467582074|FG000|Overall Study|Protocol Violation|4|||
129896481|NCT00797862|467582075|FG001|Overall Study|Protocol Violation|6|||
129896482|NCT00797862|467582076|FG002|Overall Study|Protocol Violation|8|||
129896483|NCT00797862|467582074|FG000|Overall Study|Mis-randomized|3|||
129896484|NCT00797862|467582075|FG001|Overall Study|Mis-randomized|3|||
129896485|NCT00797862|467582076|FG002|Overall Study|Mis-randomized|1|||
129896486|NCT00409708|467582080|FG000|Treatment|Abnormal test procedure result(s)|1|||
129896487|NCT00409708|467582081|FG001|Treatment|Abnormal test procedure result(s)|0|||
129896488|NCT00409708|467582080|FG000|Treatment|Lack of Efficacy|0|||
129896489|NCT00409708|467582081|FG001|Treatment|Lack of Efficacy|1|||
129896490|NCT00409708|467582080|FG000|Treatment|Protocol Violation|6|||
129896491|NCT00409708|467582081|FG001|Treatment|Protocol Violation|2|||
129896492|NCT00409708|467582080|FG000|Treatment|Withdrawal by Subject|3|||
129896493|NCT00409708|467582081|FG001|Treatment|Withdrawal by Subject|8|||
129749644|NCT00825812|467041964|FG000|Overall Study|Subject withdrew consent|0|||
129749645|NCT00825812|467041965|FG001|Overall Study|Subject withdrew consent|0|||
129896494|NCT00409708|467582080|FG000|Treatment|Lost to Follow-up|0|||
129896495|NCT00409708|467582081|FG001|Treatment|Lost to Follow-up|6|||
129896496|NCT00409708|467582080|FG000|Treatment|Administrative problems|5|||
129749646|NCT00825812|467041966|FG002|Overall Study|Subject withdrew consent|3|||
129749647|NCT00825812|467041967|FG003|Overall Study|Subject withdrew consent|2|||
129749648|NCT00825812|467041964|FG000|Overall Study|Non-compliance with protocol|0|||
129749649|NCT00825812|467041965|FG001|Overall Study|Non-compliance with protocol|0|||
129749650|NCT00825812|467041966|FG002|Overall Study|Non-compliance with protocol|0|||
129749651|NCT00825812|467041967|FG003|Overall Study|Non-compliance with protocol|1|||
129749652|NCT00825812|467041964|FG000|Overall Study|Administrative|0|||
129749653|NCT00825812|467041965|FG001|Overall Study|Administrative|1|||
129749654|NCT00825812|467041966|FG002|Overall Study|Administrative|3|||
129896497|NCT00409708|467582081|FG001|Treatment|Administrative problems|0|||
129896498|NCT00409708|467582080|FG000|Washout|Lack of Efficacy|9|||
129896499|NCT00409708|467582081|FG001|Washout|Lack of Efficacy|1|||
129749655|NCT00825812|467041967|FG003|Overall Study|Administrative|5|||
129749656|NCT01278797|467041970|FG000|Period 1|Adverse Event|0|||
129749657|NCT01278797|467041971|FG001|Period 1|Adverse Event|1|||
129749658|NCT01278797|467041970|FG000|Period 1|Protocol Violation|1|||
129749659|NCT01278797|467041971|FG001|Period 1|Protocol Violation|0|||
129749660|NCT03343626|467044379|FG000|Overall Study|Lost to Follow-up|4|||
129749661|NCT03343626|467044380|FG001|Overall Study|Lost to Follow-up|3|||
129749662|NCT03343626|467044381|FG002|Overall Study|Lost to Follow-up|2|||
129749663|NCT03343626|467044382|FG003|Overall Study|Lost to Follow-up|5|||
129749664|NCT03343626|467044383|FG004|Overall Study|Lost to Follow-up|4|||
129749665|NCT03343626|467044384|FG005|Overall Study|Lost to Follow-up|4|||
129749666|NCT03343626|467044385|FG006|Overall Study|Lost to Follow-up|4|||
129749667|NCT03343626|467044386|FG007|Overall Study|Lost to Follow-up|7|||
129749668|NCT03343626|467044379|FG000|Overall Study|Withdrawal of Consent|2|||
129749669|NCT03343626|467044380|FG001|Overall Study|Withdrawal of Consent|1|||
129749670|NCT03343626|467044381|FG002|Overall Study|Withdrawal of Consent|0|||
129749671|NCT03343626|467044382|FG003|Overall Study|Withdrawal of Consent|3|||
129749672|NCT03343626|467044383|FG004|Overall Study|Withdrawal of Consent|3|||
129749673|NCT03343626|467044384|FG005|Overall Study|Withdrawal of Consent|1|||
129749674|NCT03343626|467044385|FG006|Overall Study|Withdrawal of Consent|1|||
129749675|NCT03343626|467044386|FG007|Overall Study|Withdrawal of Consent|2|||
129749676|NCT03343626|467044379|FG000|Overall Study|Reason not Specified|0|||
129749677|NCT03343626|467044380|FG001|Overall Study|Reason not Specified|1|||
129749678|NCT03343626|467044381|FG002|Overall Study|Reason not Specified|0|||
129749679|NCT03343626|467044382|FG003|Overall Study|Reason not Specified|0|||
129749680|NCT03343626|467044383|FG004|Overall Study|Reason not Specified|0|||
129749681|NCT03343626|467044384|FG005|Overall Study|Reason not Specified|0|||
129749682|NCT03343626|467044385|FG006|Overall Study|Reason not Specified|0|||
129749683|NCT03343626|467044386|FG007|Overall Study|Reason not Specified|1|||
129749684|NCT03343626|467044379|FG000|Overall Study|Data Entry Error|0|||
129749685|NCT03343626|467044380|FG001|Overall Study|Data Entry Error|0|||
129749686|NCT03343626|467044381|FG002|Overall Study|Data Entry Error|0|||
129749687|NCT03343626|467044382|FG003|Overall Study|Data Entry Error|0|||
129749688|NCT03343626|467044383|FG004|Overall Study|Data Entry Error|0|||
129749689|NCT03343626|467044384|FG005|Overall Study|Data Entry Error|0|||
129749690|NCT03343626|467044385|FG006|Overall Study|Data Entry Error|0|||
129749691|NCT03343626|467044386|FG007|Overall Study|Data Entry Error|1|||
129749692|NCT02475278|467044389|FG000|Overall Study|Lost to Follow-up|1|||
129749693|NCT02475278|467044389|FG000|Overall Study|Reason Not Specified|1|||
129749694|NCT01865448|467044390|FG000|Overall Study|Adverse Event|1|||
129749695|NCT01865448|467044391|FG001|Overall Study|Adverse Event|1|||
129749696|NCT01865448|467044390|FG000|Overall Study|Pregnancy|0|||
129749697|NCT01865448|467044391|FG001|Overall Study|Pregnancy|1|||
129749698|NCT01865448|467044390|FG000|Overall Study|dropout unrelated to study|1|||
129749699|NCT01865448|467044391|FG001|Overall Study|dropout unrelated to study|1|||
129749700|NCT05111249|467044395|FG000|Overall Study|Lost to Follow-up|0|||
129749701|NCT05111249|467044396|FG001|Overall Study|Lost to Follow-up|2|||
129749702|NCT05111249|467044395|FG000|Overall Study|Physician Decision|0|||
129749703|NCT05111249|467044396|FG001|Overall Study|Physician Decision|1|||
129749704|NCT05111249|467044395|FG000|Overall Study|Participant decision|1|||
129749705|NCT05111249|467044396|FG001|Overall Study|Participant decision|5|||
129749706|NCT05128578|467044397|FG000|Overall Study|Withdrawal by Subject|9|||
129749707|NCT05128578|467044397|FG000|Overall Study|Lost to Follow-up|5|||
129749708|NCT00872599|467044398|FG000|Second Washout Period|Adverse Event|1|||
129749709|NCT00872599|467044399|FG001|Second Washout Period|Adverse Event|1|||
129749710|NCT00801229|467044402|FG000|Signed Consent|Withdrawal by Subject|2|||
129749711|NCT00801229|467044403|FG001|Signed Consent|Withdrawal by Subject|2|||
129749712|NCT00801229|467044402|FG000|Signed Consent|Found Ineligible|1|||
129749713|NCT00801229|467044403|FG001|Signed Consent|Found Ineligible|1|||
129749714|NCT00801229|467044402|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
129749715|NCT00801229|467044403|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
129749716|NCT00801229|467044402|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
129749717|NCT00801229|467044403|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
129749718|NCT00801229|467044402|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
129749719|NCT00801229|467044403|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
129749720|NCT00801229|467044402|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
129749721|NCT00801229|467044403|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
129749722|NCT00801229|467044402|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
129749723|NCT00801229|467044403|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
129749724|NCT00801229|467044402|FG000|Received Study Drug/Placebo|Adverse Event|1|||
129749725|NCT00801229|467044403|FG001|Received Study Drug/Placebo|Adverse Event|1|||
129749726|NCT02610777|467044404|FG000|Overall Study|Lost to Follow-up|1|||
129749727|NCT02610777|467044405|FG001|Overall Study|Lost to Follow-up|0|||
129749728|NCT02610777|467044404|FG000|Overall Study|Site Terminated by Sponsor|9|||
129749729|NCT02610777|467044405|FG001|Overall Study|Site Terminated by Sponsor|8|||
129749730|NCT02610777|467044404|FG000|Overall Study|Withdrawal by Subject|2|||
129896500|NCT00409708|467582080|FG000|Washout|Protocol Violation|0|||
129749731|NCT02610777|467044405|FG001|Overall Study|Withdrawal by Subject|2|||
129749732|NCT02610777|467044404|FG000|Overall Study|Reason not Specified|0|||
129749733|NCT02610777|467044405|FG001|Overall Study|Reason not Specified|1|||
129749734|NCT02610777|467044404|FG000|Overall Study|Death|50|||
129749735|NCT02610777|467044405|FG001|Overall Study|Death|47|||
129749736|NCT02300259|467044408|FG000|Period 1|Adverse Event|0|||
129749737|NCT02300259|467044409|FG001|Period 1|Adverse Event|0|||
129749738|NCT02300259|467044410|FG002|Period 1|Adverse Event|1|||
129749739|NCT02300259|467044408|FG000|Period 1|Withdrawal by Subject|0|||
129749740|NCT02300259|467044409|FG001|Period 1|Withdrawal by Subject|0|||
129749741|NCT02300259|467044410|FG002|Period 1|Withdrawal by Subject|1|||
129749742|NCT02300259|467044408|FG000|Period 2|Adverse Event|1|||
129749743|NCT02300259|467044409|FG001|Period 2|Adverse Event|0|||
129749744|NCT02300259|467044410|FG002|Period 2|Adverse Event|0|||
129749745|NCT02300259|467044408|FG000|Period 2|Withdrawal by Subject|0|||
129749746|NCT02300259|467044409|FG001|Period 2|Withdrawal by Subject|0|||
129749747|NCT02300259|467044410|FG002|Period 2|Withdrawal by Subject|1|||
129749748|NCT02737475|467044411|FG000|Overall Study|Other reasons|0|||
129749749|NCT02737475|467044412|FG001|Overall Study|Other reasons|0|||
129749750|NCT02737475|467044413|FG002|Overall Study|Other reasons|0|||
129749751|NCT02737475|467044414|FG003|Overall Study|Other reasons|0|||
129749752|NCT02737475|467044415|FG004|Overall Study|Other reasons|1|||
129749753|NCT02737475|467044416|FG005|Overall Study|Other reasons|1|||
129749754|NCT02737475|467044417|FG006|Overall Study|Other reasons|0|||
129749755|NCT02737475|467044418|FG007|Overall Study|Other reasons|0|||
129749756|NCT02737475|467044419|FG008|Overall Study|Other reasons|1|||
129749757|NCT02737475|467044420|FG009|Overall Study|Other reasons|0|||
129749758|NCT02737475|467044421|FG010|Overall Study|Other reasons|1|||
129749759|NCT02737475|467044422|FG011|Overall Study|Other reasons|0|||
129749760|NCT02737475|467044423|FG012|Overall Study|Other reasons|0|||
129749761|NCT02737475|467044424|FG013|Overall Study|Other reasons|0|||
129749762|NCT02737475|467044425|FG014|Overall Study|Other reasons|0|||
129749763|NCT02737475|467044426|FG015|Overall Study|Other reasons|0|||
129749764|NCT02737475|467044427|FG016|Overall Study|Other reasons|0|||
129749765|NCT02737475|467044428|FG017|Overall Study|Other reasons|0|||
129749766|NCT02737475|467044429|FG018|Overall Study|Other reasons|0|||
129749767|NCT02737475|467044430|FG019|Overall Study|Other reasons|0|||
129749768|NCT02737475|467044431|FG020|Overall Study|Other reasons|0|||
129749769|NCT02737475|467044432|FG021|Overall Study|Other reasons|1|||
129749770|NCT02737475|467044433|FG022|Overall Study|Other reasons|0|||
129749771|NCT02737475|467044434|FG023|Overall Study|Other reasons|1|||
129749772|NCT02737475|467044435|FG024|Overall Study|Other reasons|1|||
129749773|NCT02737475|467044436|FG025|Overall Study|Other reasons|1|||
129749774|NCT02737475|467044437|FG026|Overall Study|Other reasons|0|||
129749775|NCT02737475|467044411|FG000|Overall Study|Death|1|||
129749776|NCT02737475|467044412|FG001|Overall Study|Death|0|||
129749777|NCT02737475|467044413|FG002|Overall Study|Death|0|||
129749778|NCT02737475|467044414|FG003|Overall Study|Death|1|||
129749779|NCT02737475|467044415|FG004|Overall Study|Death|0|||
129749780|NCT02737475|467044416|FG005|Overall Study|Death|0|||
129749781|NCT02737475|467044417|FG006|Overall Study|Death|0|||
129749782|NCT02737475|467044418|FG007|Overall Study|Death|2|||
129809382|NCT01090492|467267670|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809383|NCT01090492|467267671|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809384|NCT01090492|467267672|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809385|NCT01090492|467267673|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809386|NCT01090492|467267674|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
129809387|NCT01090492|467267675|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
129809388|NCT03113071|467267676|FG000|Overall Study|Withdrawal by Subject|1|||
129809389|NCT03113071|467267677|FG001|Overall Study|Withdrawal by Subject|0|||
129809390|NCT01602120|467267678|FG000|Overall Study|Adverse Event|3|||
129809391|NCT01602120|467267679|FG001|Overall Study|Adverse Event|6|||
129809392|NCT01602120|467267680|FG002|Overall Study|Adverse Event|0|||
129809393|NCT01602120|467267681|FG003|Overall Study|Adverse Event|2|||
129749783|NCT02737475|467044419|FG008|Overall Study|Death|0|||
129749784|NCT02737475|467044420|FG009|Overall Study|Death|0|||
129749785|NCT02737475|467044421|FG010|Overall Study|Death|0|||
129749786|NCT02737475|467044422|FG011|Overall Study|Death|4|||
129749787|NCT02737475|467044423|FG012|Overall Study|Death|2|||
129749788|NCT02737475|467044424|FG013|Overall Study|Death|2|||
129749789|NCT02737475|467044425|FG014|Overall Study|Death|0|||
129749790|NCT02737475|467044426|FG015|Overall Study|Death|2|||
129749791|NCT02737475|467044427|FG016|Overall Study|Death|2|||
129749792|NCT02737475|467044428|FG017|Overall Study|Death|2|||
129749793|NCT02737475|467044429|FG018|Overall Study|Death|1|||
129749794|NCT02737475|467044430|FG019|Overall Study|Death|0|||
129749795|NCT02737475|467044431|FG020|Overall Study|Death|0|||
129749796|NCT02737475|467044432|FG021|Overall Study|Death|0|||
129749797|NCT02737475|467044433|FG022|Overall Study|Death|0|||
129749798|NCT02737475|467044434|FG023|Overall Study|Death|0|||
129809394|NCT01602120|467267678|FG000|Overall Study|Death|0|||
129809395|NCT01602120|467267679|FG001|Overall Study|Death|4|||
129749799|NCT02737475|467044435|FG024|Overall Study|Death|0|||
129749800|NCT02737475|467044436|FG025|Overall Study|Death|0|||
129749801|NCT02737475|467044437|FG026|Overall Study|Death|0|||
129749802|NCT02737475|467044411|FG000|Overall Study|Participant withdrew consent|0|||
129749803|NCT02737475|467044412|FG001|Overall Study|Participant withdrew consent|0|||
129749804|NCT02737475|467044413|FG002|Overall Study|Participant withdrew consent|0|||
129749805|NCT02737475|467044414|FG003|Overall Study|Participant withdrew consent|0|||
129749806|NCT02737475|467044415|FG004|Overall Study|Participant withdrew consent|0|||
129749807|NCT02737475|467044416|FG005|Overall Study|Participant withdrew consent|2|||
129749808|NCT02737475|467044417|FG006|Overall Study|Participant withdrew consent|0|||
129749809|NCT02737475|467044418|FG007|Overall Study|Participant withdrew consent|0|||
129749810|NCT02737475|467044419|FG008|Overall Study|Participant withdrew consent|0|||
129749811|NCT02737475|467044420|FG009|Overall Study|Participant withdrew consent|0|||
129749812|NCT02737475|467044421|FG010|Overall Study|Participant withdrew consent|0|||
129749813|NCT02737475|467044422|FG011|Overall Study|Participant withdrew consent|0|||
129749814|NCT02737475|467044423|FG012|Overall Study|Participant withdrew consent|0|||
129749815|NCT02737475|467044424|FG013|Overall Study|Participant withdrew consent|0|||
129749816|NCT02737475|467044425|FG014|Overall Study|Participant withdrew consent|1|||
129749817|NCT02737475|467044426|FG015|Overall Study|Participant withdrew consent|0|||
129749818|NCT02737475|467044427|FG016|Overall Study|Participant withdrew consent|0|||
129749819|NCT02737475|467044428|FG017|Overall Study|Participant withdrew consent|2|||
129749820|NCT02737475|467044429|FG018|Overall Study|Participant withdrew consent|1|||
129749821|NCT02737475|467044430|FG019|Overall Study|Participant withdrew consent|0|||
129749822|NCT02737475|467044431|FG020|Overall Study|Participant withdrew consent|2|||
129749823|NCT02737475|467044432|FG021|Overall Study|Participant withdrew consent|0|||
129749824|NCT02737475|467044433|FG022|Overall Study|Participant withdrew consent|0|||
129749825|NCT02737475|467044434|FG023|Overall Study|Participant withdrew consent|0|||
129749826|NCT02737475|467044435|FG024|Overall Study|Participant withdrew consent|0|||
129749827|NCT02737475|467044436|FG025|Overall Study|Participant withdrew consent|0|||
129749828|NCT02737475|467044437|FG026|Overall Study|Participant withdrew consent|0|||
129749829|NCT02737475|467044411|FG000|Overall Study|Lost to Follow-up|0|||
129749830|NCT02737475|467044412|FG001|Overall Study|Lost to Follow-up|0|||
129749831|NCT02737475|467044413|FG002|Overall Study|Lost to Follow-up|0|||
129749832|NCT02737475|467044414|FG003|Overall Study|Lost to Follow-up|0|||
129749833|NCT02737475|467044415|FG004|Overall Study|Lost to Follow-up|0|||
129749834|NCT02737475|467044416|FG005|Overall Study|Lost to Follow-up|0|||
129749835|NCT02737475|467044417|FG006|Overall Study|Lost to Follow-up|0|||
129749836|NCT02737475|467044418|FG007|Overall Study|Lost to Follow-up|0|||
129749837|NCT02737475|467044419|FG008|Overall Study|Lost to Follow-up|0|||
129749838|NCT02737475|467044420|FG009|Overall Study|Lost to Follow-up|0|||
129749839|NCT02737475|467044421|FG010|Overall Study|Lost to Follow-up|0|||
129749840|NCT02737475|467044422|FG011|Overall Study|Lost to Follow-up|0|||
129749841|NCT02737475|467044423|FG012|Overall Study|Lost to Follow-up|0|||
129749842|NCT02737475|467044424|FG013|Overall Study|Lost to Follow-up|0|||
129749843|NCT02737475|467044425|FG014|Overall Study|Lost to Follow-up|0|||
129749844|NCT02737475|467044426|FG015|Overall Study|Lost to Follow-up|1|||
129749845|NCT02737475|467044427|FG016|Overall Study|Lost to Follow-up|0|||
129749846|NCT02737475|467044428|FG017|Overall Study|Lost to Follow-up|0|||
129749847|NCT02737475|467044429|FG018|Overall Study|Lost to Follow-up|0|||
129749848|NCT02737475|467044430|FG019|Overall Study|Lost to Follow-up|0|||
129749849|NCT02737475|467044431|FG020|Overall Study|Lost to Follow-up|0|||
129749850|NCT02737475|467044432|FG021|Overall Study|Lost to Follow-up|0|||
129749851|NCT02737475|467044433|FG022|Overall Study|Lost to Follow-up|0|||
129749852|NCT02737475|467044434|FG023|Overall Study|Lost to Follow-up|0|||
129809396|NCT01602120|467267680|FG002|Overall Study|Death|0|||
129809397|NCT01602120|467267681|FG003|Overall Study|Death|0|||
129809398|NCT01602120|467267678|FG000|Overall Study|Lost to Follow-up|0|||
129749853|NCT02737475|467044435|FG024|Overall Study|Lost to Follow-up|0|||
129749854|NCT02737475|467044436|FG025|Overall Study|Lost to Follow-up|0|||
129749855|NCT02737475|467044437|FG026|Overall Study|Lost to Follow-up|0|||
129749856|NCT02737475|467044411|FG000|Overall Study|Disease Progression|0|||
129749857|NCT02737475|467044412|FG001|Overall Study|Disease Progression|0|||
129749858|NCT02737475|467044413|FG002|Overall Study|Disease Progression|0|||
129749859|NCT02737475|467044414|FG003|Overall Study|Disease Progression|0|||
129749860|NCT02737475|467044415|FG004|Overall Study|Disease Progression|0|||
129749861|NCT02737475|467044416|FG005|Overall Study|Disease Progression|0|||
129749862|NCT02737475|467044417|FG006|Overall Study|Disease Progression|0|||
129749863|NCT02737475|467044418|FG007|Overall Study|Disease Progression|0|||
129749864|NCT02737475|467044419|FG008|Overall Study|Disease Progression|0|||
129749865|NCT02737475|467044420|FG009|Overall Study|Disease Progression|0|||
129749866|NCT02737475|467044421|FG010|Overall Study|Disease Progression|0|||
129749867|NCT02737475|467044422|FG011|Overall Study|Disease Progression|0|||
129749868|NCT02737475|467044423|FG012|Overall Study|Disease Progression|0|||
129749869|NCT02737475|467044424|FG013|Overall Study|Disease Progression|0|||
129749870|NCT02737475|467044425|FG014|Overall Study|Disease Progression|0|||
129809399|NCT01602120|467267679|FG001|Overall Study|Lost to Follow-up|1|||
129749871|NCT02737475|467044426|FG015|Overall Study|Disease Progression|0|||
129749872|NCT02737475|467044427|FG016|Overall Study|Disease Progression|0|||
129749873|NCT02737475|467044428|FG017|Overall Study|Disease Progression|0|||
129749874|NCT02737475|467044429|FG018|Overall Study|Disease Progression|0|||
129749875|NCT02737475|467044430|FG019|Overall Study|Disease Progression|0|||
129749876|NCT02737475|467044431|FG020|Overall Study|Disease Progression|0|||
129749877|NCT02737475|467044432|FG021|Overall Study|Disease Progression|0|||
129749878|NCT02737475|467044433|FG022|Overall Study|Disease Progression|0|||
129749879|NCT02737475|467044434|FG023|Overall Study|Disease Progression|0|||
129749880|NCT02737475|467044435|FG024|Overall Study|Disease Progression|0|||
129749881|NCT02737475|467044436|FG025|Overall Study|Disease Progression|0|||
129749882|NCT02737475|467044437|FG026|Overall Study|Disease Progression|1|||
129749883|NCT03688074|467044438|FG000|Overall Study|Adverse Event|0|||
129749884|NCT03688074|467044439|FG001|Overall Study|Adverse Event|1|||
129749885|NCT03688074|467044438|FG000|Overall Study|Other|1|||
129749886|NCT03688074|467044439|FG001|Overall Study|Other|0|||
129749887|NCT00660179|467044440|FG000|Overall Study|Death|44|||
129749888|NCT00660179|467044441|FG001|Overall Study|Death|47|||
129749889|NCT00660179|467044442|FG002|Overall Study|Death|34|||
129749890|NCT00660179|467044440|FG000|Overall Study|Withdrawal of consent|4|||
129749891|NCT00660179|467044441|FG001|Overall Study|Withdrawal of consent|6|||
129749892|NCT00660179|467044442|FG002|Overall Study|Withdrawal of consent|4|||
129749893|NCT00660179|467044440|FG000|Overall Study|Lost to Follow-up|7|||
129749894|NCT00660179|467044441|FG001|Overall Study|Lost to Follow-up|5|||
129749895|NCT00660179|467044442|FG002|Overall Study|Lost to Follow-up|2|||
129749896|NCT00660179|467044440|FG000|Overall Study|Administrative reason|0|||
129749897|NCT00660179|467044441|FG001|Overall Study|Administrative reason|0|||
129749898|NCT00660179|467044442|FG002|Overall Study|Administrative reason|1|||
129749899|NCT00660179|467044440|FG000|Overall Study|Incorrect randomization|1|||
129749900|NCT00660179|467044441|FG001|Overall Study|Incorrect randomization|0|||
129749901|NCT00660179|467044442|FG002|Overall Study|Incorrect randomization|0|||
129749902|NCT02255461|467044443|FG000|Overall Study|Adverse Event|0|||
129749903|NCT02255461|467044444|FG001|Overall Study|Adverse Event|1|||
129749904|NCT02255461|467044445|FG002|Overall Study|Adverse Event|0|||
129749905|NCT02255461|467044446|FG003|Overall Study|Adverse Event|0|||
129749906|NCT02255461|467044447|FG004|Overall Study|Adverse Event|1|||
129749907|NCT02255461|467044443|FG000|Overall Study|Withdrawal by Subject|0|||
129749908|NCT02255461|467044444|FG001|Overall Study|Withdrawal by Subject|0|||
129749909|NCT02255461|467044445|FG002|Overall Study|Withdrawal by Subject|1|||
129749910|NCT02255461|467044446|FG003|Overall Study|Withdrawal by Subject|0|||
129749911|NCT02255461|467044447|FG004|Overall Study|Withdrawal by Subject|1|||
129749912|NCT02255461|467044443|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
129749913|NCT02255461|467044444|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
129749914|NCT02255461|467044445|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
129749915|NCT02255461|467044446|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
129749916|NCT02255461|467044447|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
129749917|NCT03056339|467044452|FG000|Overall Study|Failed Requirements|0|||
129749918|NCT03056339|467044453|FG001|Overall Study|Failed Requirements|2|||
129749919|NCT03056339|467044454|FG002|Overall Study|Failed Requirements|7|||
129749920|NCT03056339|467044455|FG003|Overall Study|Failed Requirements|1|||
129749921|NCT01128244|467044460|FG000|Overall Study|Adverse Event|1|||
129749922|NCT01128244|467044460|FG000|Overall Study|Scheduling conflict|2|||
129749923|NCT04171219|467044463|FG000|Overall Study|Adverse Event|1|||
129749924|NCT04171219|467044464|FG001|Overall Study|Adverse Event|0|||
129749925|NCT04171219|467044463|FG000|Overall Study|Death|0|||
129749926|NCT04171219|467044464|FG001|Overall Study|Death|1|||
129749927|NCT04171219|467044463|FG000|Overall Study|Lack of Efficacy|9|||
129749928|NCT04171219|467044464|FG001|Overall Study|Lack of Efficacy|13|||
129749929|NCT04171219|467044463|FG000|Overall Study|Withdrawal by Subject|1|||
129749930|NCT04171219|467044464|FG001|Overall Study|Withdrawal by Subject|2|||
129749931|NCT04171219|467044463|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
129749932|NCT04171219|467044464|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
129749933|NCT04171219|467044463|FG000|Overall Study|Clinical PD/Patient choice|1|||
129749934|NCT04171219|467044464|FG001|Overall Study|Clinical PD/Patient choice|0|||
129749935|NCT04171219|467044463|FG000|Overall Study|Toxicity/ Patient choice|1|||
129749936|NCT04171219|467044464|FG001|Overall Study|Toxicity/ Patient choice|0|||
129749937|NCT04809285|467044465|FG000|Phase 1|Lost to Follow-up|6|||
129749938|NCT04809285|467044465|FG000|Phase 1|Protocol Violation|2|||
129749939|NCT04809285|467044465|FG000|Phase 1|Physician Decision|3|||
129749940|NCT04809285|467044465|FG000|Phase 1|Withdrawal by Subject|29|||
129749941|NCT04809285|467044465|FG000|Phase 2|Protocol Violation|3|||
129749942|NCT04809285|467044465|FG000|Phase 2|Withdrawal by Subject|4|||
129749943|NCT03040674|467044469|FG000|Overall Study|Lost to Follow-up|225|||
129749944|NCT03040674|467044469|FG000|Overall Study|Death|23|||
129749945|NCT02206035|467044470|FG000|Overall Study|Physician Decision|10|||
129749946|NCT02206035|467044471|FG001|Overall Study|Physician Decision|0|||
129749947|NCT02206035|467044472|FG002|Overall Study|Physician Decision|175|||
129749948|NCT01934010|467044473|FG000|Overall Study|Adverse Event|1|||
129749949|NCT01934010|467044474|FG001|Overall Study|Adverse Event|1|||
129749950|NCT01934010|467044475|FG002|Overall Study|Adverse Event|0|||
129749951|NCT01934010|467044473|FG000|Overall Study|Withdrawal by Subject|15|||
129749952|NCT01934010|467044474|FG001|Overall Study|Withdrawal by Subject|6|||
129749953|NCT01934010|467044475|FG002|Overall Study|Withdrawal by Subject|2|||
129749954|NCT01934010|467044473|FG000|Overall Study|Lost to Follow-up|7|||
129749955|NCT01934010|467044474|FG001|Overall Study|Lost to Follow-up|4|||
129749956|NCT01934010|467044475|FG002|Overall Study|Lost to Follow-up|0|||
129749957|NCT04303572|467044476|FG000|Overall Study|Study closed due to poor enrollment|1|||
129749958|NCT04929249|467044477|FG000|Overall Study|Adverse Event|2|||
129749959|NCT04929249|467044478|FG001|Overall Study|Adverse Event|1|||
129749960|NCT04929249|467044477|FG000|Overall Study|Death|2|||
129749961|NCT04929249|467044478|FG001|Overall Study|Death|1|||
129749962|NCT04929249|467044477|FG000|Overall Study|Lost to Follow-up|3|||
129749963|NCT04929249|467044478|FG001|Overall Study|Lost to Follow-up|11|||
129749964|NCT04929249|467044477|FG000|Overall Study|Technical problems|0|||
129749965|NCT04929249|467044478|FG001|Overall Study|Technical problems|1|||
129749966|NCT04929249|467044477|FG000|Overall Study|Subject decision|6|||
129749967|NCT04929249|467044478|FG001|Overall Study|Subject decision|8|||
129749968|NCT04929249|467044477|FG000|Overall Study|Withdrew consent|0|||
129749969|NCT04929249|467044478|FG001|Overall Study|Withdrew consent|8|||
129749970|NCT01620762|467044485|FG000|Overall Study|Protocol Violation|1|||
129749971|NCT01620762|467044486|FG001|Overall Study|Protocol Violation|1|||
129749972|NCT01620762|467044487|FG002|Overall Study|Protocol Violation|1|||
129749973|NCT01620762|467044485|FG000|Overall Study|Adverse Event|9|||
129749974|NCT01620762|467044486|FG001|Overall Study|Adverse Event|5|||
129749975|NCT01620762|467044487|FG002|Overall Study|Adverse Event|2|||
129749976|NCT01620762|467044485|FG000|Overall Study|Withdrawal by Subject|23|||
129749977|NCT01620762|467044486|FG001|Overall Study|Withdrawal by Subject|26|||
129749978|NCT01620762|467044487|FG002|Overall Study|Withdrawal by Subject|27|||
129749979|NCT01620762|467044485|FG000|Overall Study|Lost to Follow-up|11|||
129749980|NCT01620762|467044486|FG001|Overall Study|Lost to Follow-up|17|||
129749981|NCT01620762|467044487|FG002|Overall Study|Lost to Follow-up|10|||
129749982|NCT01620762|467044485|FG000|Overall Study|Protocol deviation|1|||
129749983|NCT01620762|467044486|FG001|Overall Study|Protocol deviation|1|||
129749984|NCT01620762|467044487|FG002|Overall Study|Protocol deviation|6|||
129749985|NCT01620762|467044485|FG000|Overall Study|Subject deterioration|0|||
129749986|NCT01620762|467044486|FG001|Overall Study|Subject deterioration|1|||
129749987|NCT01620762|467044487|FG002|Overall Study|Subject deterioration|1|||
129749988|NCT01620762|467044485|FG000|Overall Study|Non-specified|3|||
129809400|NCT01602120|467267680|FG002|Overall Study|Lost to Follow-up|0|||
129809401|NCT01602120|467267681|FG003|Overall Study|Lost to Follow-up|1|||
129809402|NCT01602120|467267678|FG000|Overall Study|Protocol Violation|1|||
129809403|NCT01602120|467267679|FG001|Overall Study|Protocol Violation|1|||
129809404|NCT01602120|467267680|FG002|Overall Study|Protocol Violation|0|||
129749989|NCT01620762|467044486|FG001|Overall Study|Non-specified|6|||
129749990|NCT01620762|467044487|FG002|Overall Study|Non-specified|5|||
129749991|NCT01620762|467044485|FG000|Overall Study|Use of prohibted therapies|0|||
129749992|NCT01620762|467044486|FG001|Overall Study|Use of prohibted therapies|1|||
129749993|NCT01620762|467044487|FG002|Overall Study|Use of prohibted therapies|1|||
129749994|NCT00172042|467044494|FG000|Overall Study|Adverse Event|27|||
129749995|NCT00172042|467044495|FG001|Overall Study|Adverse Event|13|||
129749996|NCT00172042|467044494|FG000|Overall Study|Abnormal laboratory value(s)|5|||
129749997|NCT00172042|467044495|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129749998|NCT00172042|467044494|FG000|Overall Study|Abnormal test procedure(s)|0|||
129749999|NCT00172042|467044495|FG001|Overall Study|Abnormal test procedure(s)|3|||
129750000|NCT00172042|467044494|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
129750001|NCT00172042|467044495|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
129750002|NCT00172042|467044494|FG000|Overall Study|Patient no longer requires study drug|10|||
129750003|NCT00172042|467044495|FG001|Overall Study|Patient no longer requires study drug|8|||
129750004|NCT00172042|467044494|FG000|Overall Study|Protocol Violation|8|||
129750005|NCT00172042|467044495|FG001|Overall Study|Protocol Violation|7|||
129750006|NCT00172042|467044494|FG000|Overall Study|Withdrawal by Subject|37|||
129809405|NCT01602120|467267681|FG003|Overall Study|Protocol Violation|0|||
129750007|NCT00172042|467044495|FG001|Overall Study|Withdrawal by Subject|25|||
129750008|NCT00172042|467044494|FG000|Overall Study|Lost to Follow-up|3|||
129750009|NCT00172042|467044495|FG001|Overall Study|Lost to Follow-up|5|||
129750010|NCT00172042|467044494|FG000|Overall Study|Administrative problems|13|||
129750011|NCT00172042|467044495|FG001|Overall Study|Administrative problems|10|||
129750012|NCT00172042|467044494|FG000|Overall Study|Death|42|||
129750013|NCT00172042|467044495|FG001|Overall Study|Death|42|||
129750014|NCT01771250|467044496|FG000|Period 1|Met exclusion criteria|1|||
129750015|NCT01771250|467044497|FG001|Period 1|Met exclusion criteria|0|||
129750016|NCT00483938|467044498|FG000|Overall Study|Protocol Violation|0|||
129750017|NCT00483938|467044499|FG001|Overall Study|Protocol Violation|0|||
129750018|NCT00483938|467044500|FG002|Overall Study|Protocol Violation|0|||
129750019|NCT00483938|467044501|FG003|Overall Study|Protocol Violation|0|||
129750020|NCT00483938|467044502|FG004|Overall Study|Protocol Violation|0|||
129750021|NCT00483938|467044503|FG005|Overall Study|Protocol Violation|0|||
129750022|NCT00483938|467044504|FG006|Overall Study|Protocol Violation|3|||
129750023|NCT00483938|467044498|FG000|Overall Study|Withdrawal by Subject|1|||
129750024|NCT00483938|467044499|FG001|Overall Study|Withdrawal by Subject|6|||
129750025|NCT00483938|467044500|FG002|Overall Study|Withdrawal by Subject|0|||
129750026|NCT00483938|467044501|FG003|Overall Study|Withdrawal by Subject|0|||
129750027|NCT00483938|467044502|FG004|Overall Study|Withdrawal by Subject|1|||
129750028|NCT00483938|467044503|FG005|Overall Study|Withdrawal by Subject|3|||
129750029|NCT00483938|467044504|FG006|Overall Study|Withdrawal by Subject|2|||
129750030|NCT00483938|467044498|FG000|Overall Study|Lost to Follow-up|1|||
129750031|NCT00483938|467044499|FG001|Overall Study|Lost to Follow-up|2|||
129750032|NCT00483938|467044500|FG002|Overall Study|Lost to Follow-up|0|||
129750033|NCT00483938|467044501|FG003|Overall Study|Lost to Follow-up|2|||
129750034|NCT00483938|467044502|FG004|Overall Study|Lost to Follow-up|1|||
129750035|NCT00483938|467044503|FG005|Overall Study|Lost to Follow-up|1|||
129750036|NCT00483938|467044504|FG006|Overall Study|Lost to Follow-up|3|||
129750037|NCT00483938|467044498|FG000|Overall Study|Death|0|||
129750038|NCT00483938|467044499|FG001|Overall Study|Death|2|||
129750039|NCT00483938|467044500|FG002|Overall Study|Death|0|||
129750040|NCT00483938|467044501|FG003|Overall Study|Death|0|||
129750041|NCT00483938|467044502|FG004|Overall Study|Death|0|||
129750042|NCT00483938|467044503|FG005|Overall Study|Death|0|||
129750043|NCT00483938|467044504|FG006|Overall Study|Death|0|||
129750044|NCT00483938|467044498|FG000|Overall Study|Other|3|||
129750045|NCT00483938|467044499|FG001|Overall Study|Other|9|||
129750046|NCT00483938|467044500|FG002|Overall Study|Other|0|||
129750047|NCT00483938|467044501|FG003|Overall Study|Other|4|||
129750048|NCT00483938|467044502|FG004|Overall Study|Other|0|||
129750049|NCT00483938|467044503|FG005|Overall Study|Other|4|||
129750050|NCT00483938|467044504|FG006|Overall Study|Other|32|||
129750051|NCT02218008|467044505|FG000|Stage 1 (S1)|Adverse Event|6|||
129750052|NCT02218008|467044506|FG001|Stage 1 (S1)|Adverse Event|5|||
129750053|NCT02218008|467044507|FG002|Stage 1 (S1)|Adverse Event|11|||
129750054|NCT02218008|467044508|FG003|Stage 1 (S1)|Adverse Event|0|||
129750055|NCT02218008|467044509|FG004|Stage 1 (S1)|Adverse Event|0|||
129750056|NCT02218008|467044510|FG005|Stage 1 (S1)|Adverse Event|0|||
129750057|NCT02218008|467044505|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
129750058|NCT02218008|467044506|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
129750059|NCT02218008|467044507|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
129750060|NCT02218008|467044508|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
129750061|NCT02218008|467044509|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
129750062|NCT02218008|467044510|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
129750063|NCT02218008|467044505|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
129750064|NCT02218008|467044506|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
129750065|NCT02218008|467044507|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
129750066|NCT02218008|467044508|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
129750067|NCT02218008|467044509|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
129750068|NCT02218008|467044510|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
129750069|NCT02218008|467044505|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
129896501|NCT00409708|467582081|FG001|Washout|Protocol Violation|1|||
129896502|NCT00409708|467582080|FG000|Washout|Withdrawal by Subject|11|||
129896503|NCT00409708|467582081|FG001|Washout|Withdrawal by Subject|5|||
129750070|NCT02218008|467044506|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
129750071|NCT02218008|467044507|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
129750072|NCT02218008|467044508|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
129750073|NCT02218008|467044509|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
129750074|NCT02218008|467044510|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
129750075|NCT02218008|467044505|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
129896504|NCT00409708|467582080|FG000|Washout|Lost to Follow-up|1|||
129750076|NCT02218008|467044506|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
129750077|NCT02218008|467044507|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129750078|NCT02218008|467044508|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129750079|NCT02218008|467044509|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129750080|NCT02218008|467044510|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
129750081|NCT02218008|467044505|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
129750082|NCT02218008|467044506|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
129750083|NCT02218008|467044507|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
129750084|NCT02218008|467044508|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
129750085|NCT02218008|467044509|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
129750086|NCT02218008|467044510|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
129750087|NCT02218008|467044505|FG000|Stage 1 (S1)|Pregnancy|0|||
129750088|NCT02218008|467044506|FG001|Stage 1 (S1)|Pregnancy|0|||
129750089|NCT02218008|467044507|FG002|Stage 1 (S1)|Pregnancy|1|||
129750090|NCT02218008|467044508|FG003|Stage 1 (S1)|Pregnancy|0|||
129750091|NCT02218008|467044509|FG004|Stage 1 (S1)|Pregnancy|0|||
129750092|NCT02218008|467044510|FG005|Stage 1 (S1)|Pregnancy|0|||
129750093|NCT02218008|467044505|FG000|Stage 1 (S1)|Protocol Violation|0|||
129750094|NCT02218008|467044506|FG001|Stage 1 (S1)|Protocol Violation|0|||
129750095|NCT02218008|467044507|FG002|Stage 1 (S1)|Protocol Violation|1|||
129750096|NCT02218008|467044508|FG003|Stage 1 (S1)|Protocol Violation|0|||
129750097|NCT02218008|467044509|FG004|Stage 1 (S1)|Protocol Violation|0|||
129750098|NCT02218008|467044510|FG005|Stage 1 (S1)|Protocol Violation|0|||
129750099|NCT02218008|467044505|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
129750100|NCT02218008|467044506|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129750101|NCT02218008|467044507|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129750102|NCT02218008|467044508|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129750103|NCT02218008|467044509|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129750104|NCT02218008|467044510|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
129750105|NCT02218008|467044505|FG000|Stage 2 (S2)|Adverse Event|0|||
129750106|NCT02218008|467044506|FG001|Stage 2 (S2)|Adverse Event|0|||
129750107|NCT02218008|467044507|FG002|Stage 2 (S2)|Adverse Event|0|||
129750108|NCT02218008|467044508|FG003|Stage 2 (S2)|Adverse Event|2|||
129750109|NCT02218008|467044509|FG004|Stage 2 (S2)|Adverse Event|3|||
129750110|NCT02218008|467044510|FG005|Stage 2 (S2)|Adverse Event|3|||
129750111|NCT02218008|467044505|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
129750112|NCT02218008|467044506|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
129750113|NCT02218008|467044507|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
129750114|NCT02218008|467044508|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
129750115|NCT02218008|467044509|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
129750116|NCT02218008|467044510|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
129750117|NCT02218008|467044505|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
129750118|NCT02218008|467044506|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
129750119|NCT02218008|467044507|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
129750120|NCT02218008|467044508|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
129750121|NCT02218008|467044509|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
129750122|NCT02218008|467044510|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
129750123|NCT02218008|467044505|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129750124|NCT02218008|467044506|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129750125|NCT02218008|467044507|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129750126|NCT02218008|467044508|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
129750127|NCT02218008|467044509|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129750128|NCT02218008|467044510|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
129750129|NCT02218008|467044505|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
129750130|NCT02218008|467044506|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
129750131|NCT02218008|467044507|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
129750132|NCT02218008|467044508|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
129750133|NCT02218008|467044509|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
129750134|NCT02218008|467044510|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
129750135|NCT02038075|467044511|FG000|Overall Study|Withdrawal by Subject|3|||
129750136|NCT02038075|467044512|FG001|Overall Study|Withdrawal by Subject|0|||
129750137|NCT00106353|467044513|FG000|Part 1|Disease progression|3|||
129750138|NCT00106353|467044514|FG001|Part 1|Disease progression|4|||
129750139|NCT00106353|467044515|FG002|Part 1|Disease progression|1|||
129750140|NCT00106353|467044516|FG003|Part 1|Disease progression|3|||
129750141|NCT00106353|467044517|FG004|Part 1|Disease progression|0|||
129750142|NCT00106353|467044518|FG005|Part 1|Disease progression|0|||
129809406|NCT01602120|467267678|FG000|Overall Study|Non-compliance|0|||
129809407|NCT01602120|467267679|FG001|Overall Study|Non-compliance|3|||
129809408|NCT01602120|467267680|FG002|Overall Study|Non-compliance|0|||
129809409|NCT01602120|467267681|FG003|Overall Study|Non-compliance|1|||
129809410|NCT01602120|467267678|FG000|Overall Study|Withdrawal by Subject|8|||
129809411|NCT01602120|467267679|FG001|Overall Study|Withdrawal by Subject|17|||
129750143|NCT00106353|467044519|FG006|Part 1|Disease progression|0|||
129750144|NCT00106353|467044513|FG000|Part 1|Withdrawal by Subject|0|||
129750145|NCT00106353|467044514|FG001|Part 1|Withdrawal by Subject|0|||
129750146|NCT00106353|467044515|FG002|Part 1|Withdrawal by Subject|1|||
129750147|NCT00106353|467044516|FG003|Part 1|Withdrawal by Subject|2|||
129750148|NCT00106353|467044517|FG004|Part 1|Withdrawal by Subject|0|||
129750149|NCT00106353|467044518|FG005|Part 1|Withdrawal by Subject|0|||
129750150|NCT00106353|467044519|FG006|Part 1|Withdrawal by Subject|0|||
129750151|NCT00106353|467044513|FG000|Part 1|Symptomatic deterioration|0|||
129750152|NCT00106353|467044514|FG001|Part 1|Symptomatic deterioration|0|||
129750153|NCT00106353|467044515|FG002|Part 1|Symptomatic deterioration|1|||
129809412|NCT01602120|467267680|FG002|Overall Study|Withdrawal by Subject|0|||
129750154|NCT00106353|467044516|FG003|Part 1|Symptomatic deterioration|0|||
129750155|NCT00106353|467044517|FG004|Part 1|Symptomatic deterioration|0|||
129750156|NCT00106353|467044518|FG005|Part 1|Symptomatic deterioration|0|||
129750157|NCT00106353|467044519|FG006|Part 1|Symptomatic deterioration|0|||
129750158|NCT00106353|467044513|FG000|Part 1|Entered follow-up phase|1|||
129750159|NCT00106353|467044514|FG001|Part 1|Entered follow-up phase|1|||
129750160|NCT00106353|467044515|FG002|Part 1|Entered follow-up phase|0|||
129750161|NCT00106353|467044516|FG003|Part 1|Entered follow-up phase|1|||
129750162|NCT00106353|467044517|FG004|Part 1|Entered follow-up phase|0|||
129750163|NCT00106353|467044518|FG005|Part 1|Entered follow-up phase|0|||
129750164|NCT00106353|467044519|FG006|Part 1|Entered follow-up phase|0|||
129750165|NCT00106353|467044513|FG000|Part 1|Adverse Event|0|||
129750166|NCT00106353|467044514|FG001|Part 1|Adverse Event|0|||
129750167|NCT00106353|467044515|FG002|Part 1|Adverse Event|0|||
129750168|NCT00106353|467044516|FG003|Part 1|Adverse Event|1|||
129750169|NCT00106353|467044517|FG004|Part 1|Adverse Event|0|||
129750170|NCT00106353|467044518|FG005|Part 1|Adverse Event|0|||
129750171|NCT00106353|467044519|FG006|Part 1|Adverse Event|0|||
129750172|NCT00106353|467044513|FG000|Part 2|Disease progression|0|||
129750173|NCT00106353|467044514|FG001|Part 2|Disease progression|0|||
129750174|NCT00106353|467044515|FG002|Part 2|Disease progression|0|||
129750175|NCT00106353|467044516|FG003|Part 2|Disease progression|0|||
129750176|NCT00106353|467044517|FG004|Part 2|Disease progression|8|||
129750177|NCT00106353|467044518|FG005|Part 2|Disease progression|14|||
129750178|NCT00106353|467044519|FG006|Part 2|Disease progression|13|||
129750179|NCT00106353|467044513|FG000|Part 2|Death|0|||
129750180|NCT00106353|467044514|FG001|Part 2|Death|0|||
129750181|NCT00106353|467044515|FG002|Part 2|Death|0|||
129750182|NCT00106353|467044516|FG003|Part 2|Death|0|||
129750183|NCT00106353|467044517|FG004|Part 2|Death|3|||
129750184|NCT00106353|467044518|FG005|Part 2|Death|0|||
129750185|NCT00106353|467044519|FG006|Part 2|Death|1|||
129750186|NCT00106353|467044513|FG000|Part 2|Symptomatic deterioration|0|||
129750187|NCT00106353|467044514|FG001|Part 2|Symptomatic deterioration|0|||
129750188|NCT00106353|467044515|FG002|Part 2|Symptomatic deterioration|0|||
129750189|NCT00106353|467044516|FG003|Part 2|Symptomatic deterioration|0|||
129750190|NCT00106353|467044517|FG004|Part 2|Symptomatic deterioration|3|||
129750191|NCT00106353|467044518|FG005|Part 2|Symptomatic deterioration|0|||
129750192|NCT00106353|467044519|FG006|Part 2|Symptomatic deterioration|0|||
129750193|NCT00106353|467044513|FG000|Part 2|Adverse Event|0|||
129750194|NCT00106353|467044514|FG001|Part 2|Adverse Event|0|||
129750195|NCT00106353|467044515|FG002|Part 2|Adverse Event|0|||
129750196|NCT00106353|467044516|FG003|Part 2|Adverse Event|0|||
129750197|NCT00106353|467044517|FG004|Part 2|Adverse Event|0|||
129750198|NCT00106353|467044518|FG005|Part 2|Adverse Event|2|||
129750199|NCT00106353|467044519|FG006|Part 2|Adverse Event|1|||
129750200|NCT00106353|467044513|FG000|Part 2|Other|0|||
129750201|NCT00106353|467044514|FG001|Part 2|Other|0|||
129750202|NCT00106353|467044515|FG002|Part 2|Other|0|||
129750203|NCT00106353|467044516|FG003|Part 2|Other|0|||
129750204|NCT00106353|467044517|FG004|Part 2|Other|1|||
129750205|NCT00106353|467044518|FG005|Part 2|Other|1|||
129750206|NCT00106353|467044519|FG006|Part 2|Other|1|||
129750207|NCT00106353|467044513|FG000|Part 2|Withdrawal by Subject|0|||
129750208|NCT00106353|467044514|FG001|Part 2|Withdrawal by Subject|0|||
129750209|NCT00106353|467044515|FG002|Part 2|Withdrawal by Subject|0|||
129750210|NCT00106353|467044516|FG003|Part 2|Withdrawal by Subject|0|||
129750211|NCT00106353|467044517|FG004|Part 2|Withdrawal by Subject|1|||
129750212|NCT00106353|467044518|FG005|Part 2|Withdrawal by Subject|0|||
129750213|NCT00106353|467044519|FG006|Part 2|Withdrawal by Subject|0|||
129750214|NCT00106353|467044513|FG000|Part 2|Physician Decision|0|||
129750215|NCT00106353|467044514|FG001|Part 2|Physician Decision|0|||
129750216|NCT00106353|467044515|FG002|Part 2|Physician Decision|0|||
129750217|NCT00106353|467044516|FG003|Part 2|Physician Decision|0|||
129809413|NCT01602120|467267681|FG003|Overall Study|Withdrawal by Subject|3|||
129809414|NCT01602120|467267678|FG000|Overall Study|Study Terminated by Sponsor|12|||
129809415|NCT01602120|467267679|FG001|Overall Study|Study Terminated by Sponsor|24|||
129809416|NCT01602120|467267680|FG002|Overall Study|Study Terminated by Sponsor|17|||
129809417|NCT01602120|467267681|FG003|Overall Study|Study Terminated by Sponsor|44|||
129809418|NCT01602120|467267678|FG000|Overall Study|Physician Decision|2|||
129809419|NCT01602120|467267679|FG001|Overall Study|Physician Decision|3|||
129809420|NCT01602120|467267680|FG002|Overall Study|Physician Decision|0|||
129750218|NCT00106353|467044517|FG004|Part 2|Physician Decision|0|||
129750219|NCT00106353|467044518|FG005|Part 2|Physician Decision|1|||
129750220|NCT00106353|467044519|FG006|Part 2|Physician Decision|0|||
129750221|NCT03477838|467044520|FG000|Overall Study|Lost to Follow-up|14|||
129809421|NCT01602120|467267681|FG003|Overall Study|Physician Decision|0|||
129809422|NCT01602120|467267678|FG000|Overall Study|Unspecified Reason|3|||
129750222|NCT02519595|467044524|FG000|Overall Study|Protocol Violation|8|||
129750223|NCT02519595|467044525|FG001|Overall Study|Protocol Violation|22|||
129750224|NCT02519595|467044526|FG002|Overall Study|Protocol Violation|16|||
129750225|NCT00850538|467044529|FG000|Overall Study|unable/unwilling to complete MRI|13|||
129750226|NCT00850538|467044529|FG000|Overall Study|specimen missed due to scheduling error|14|||
129750227|NCT00850538|467044529|FG000|Overall Study|specimen unusable|7|||
129750228|NCT00850538|467044529|FG000|Overall Study|Withdrawal by Subject|3|||
129750229|NCT00850538|467044529|FG000|Overall Study|radiology error|2|||
129750230|NCT00850538|467044529|FG000|Overall Study|Protocol Violation|2|||
129750231|NCT03188510|467044535|FG000|Overall Study|Inappropriate behavior with site staff|0|||
129750232|NCT03188510|467044536|FG001|Overall Study|Inappropriate behavior with site staff|1|||
129750233|NCT03188510|467044537|FG002|Overall Study|Inappropriate behavior with site staff|0|||
129750234|NCT03052049|467044539|FG000|Overall Study|Withdrawal by Subject|2|||
129750235|NCT00999518|467044543|FG000|Overall Study|Adverse Event|1|||
129750236|NCT00999518|467044544|FG001|Overall Study|Adverse Event|6|||
129750237|NCT00999518|467044545|FG002|Overall Study|Adverse Event|3|||
129750238|NCT00999518|467044546|FG003|Overall Study|Adverse Event|1|||
129750239|NCT00999518|467044547|FG004|Overall Study|Adverse Event|2|||
129750240|NCT00999518|467044543|FG000|Overall Study|Lack of Efficacy|2|||
129750241|NCT00999518|467044544|FG001|Overall Study|Lack of Efficacy|0|||
129750242|NCT00999518|467044545|FG002|Overall Study|Lack of Efficacy|0|||
129750243|NCT00999518|467044546|FG003|Overall Study|Lack of Efficacy|2|||
129750244|NCT00999518|467044547|FG004|Overall Study|Lack of Efficacy|2|||
129750245|NCT00999518|467044543|FG000|Overall Study|Lost to Follow-up|0|||
129750246|NCT00999518|467044544|FG001|Overall Study|Lost to Follow-up|0|||
129750247|NCT00999518|467044545|FG002|Overall Study|Lost to Follow-up|0|||
129750248|NCT00999518|467044546|FG003|Overall Study|Lost to Follow-up|4|||
129750249|NCT00999518|467044547|FG004|Overall Study|Lost to Follow-up|1|||
129750250|NCT00999518|467044543|FG000|Overall Study|Did not meet entrance criteria|0|||
129750251|NCT00999518|467044544|FG001|Overall Study|Did not meet entrance criteria|0|||
129750252|NCT00999518|467044545|FG002|Overall Study|Did not meet entrance criteria|0|||
129750253|NCT00999518|467044546|FG003|Overall Study|Did not meet entrance criteria|0|||
129750254|NCT00999518|467044547|FG004|Overall Study|Did not meet entrance criteria|1|||
129750255|NCT00999518|467044543|FG000|Overall Study|Study terminated by sponsor|10|||
129750256|NCT00999518|467044544|FG001|Overall Study|Study terminated by sponsor|6|||
129750257|NCT00999518|467044545|FG002|Overall Study|Study terminated by sponsor|5|||
129750258|NCT00999518|467044546|FG003|Overall Study|Study terminated by sponsor|5|||
129750259|NCT00999518|467044547|FG004|Overall Study|Study terminated by sponsor|9|||
129750260|NCT00999518|467044543|FG000|Overall Study|Pregnancy|0|||
129750261|NCT00999518|467044544|FG001|Overall Study|Pregnancy|0|||
129750262|NCT00999518|467044545|FG002|Overall Study|Pregnancy|1|||
129750263|NCT00999518|467044546|FG003|Overall Study|Pregnancy|0|||
129750264|NCT00999518|467044547|FG004|Overall Study|Pregnancy|0|||
129750265|NCT00999518|467044543|FG000|Overall Study|Protocol Violation|0|||
129750266|NCT00999518|467044544|FG001|Overall Study|Protocol Violation|1|||
129750267|NCT00999518|467044545|FG002|Overall Study|Protocol Violation|0|||
129750268|NCT00999518|467044546|FG003|Overall Study|Protocol Violation|0|||
129750269|NCT00999518|467044547|FG004|Overall Study|Protocol Violation|2|||
129750270|NCT00999518|467044543|FG000|Overall Study|Withdrawal by Subject|5|||
129750271|NCT00999518|467044544|FG001|Overall Study|Withdrawal by Subject|4|||
129750272|NCT00999518|467044545|FG002|Overall Study|Withdrawal by Subject|10|||
129750273|NCT00999518|467044546|FG003|Overall Study|Withdrawal by Subject|6|||
129750274|NCT00999518|467044547|FG004|Overall Study|Withdrawal by Subject|1|||
129750275|NCT00999518|467044543|FG000|Overall Study|Other|5|||
129750276|NCT00999518|467044544|FG001|Overall Study|Other|7|||
129750277|NCT00999518|467044545|FG002|Overall Study|Other|1|||
129750278|NCT00999518|467044546|FG003|Overall Study|Other|4|||
129750279|NCT00999518|467044547|FG004|Overall Study|Other|5|||
129750280|NCT00999518|467044543|FG000|Overall Study|Randomized but not Treated|1|||
129750281|NCT00999518|467044544|FG001|Overall Study|Randomized but not Treated|1|||
129750282|NCT00999518|467044545|FG002|Overall Study|Randomized but not Treated|2|||
129750283|NCT00999518|467044546|FG003|Overall Study|Randomized but not Treated|0|||
129750284|NCT00999518|467044547|FG004|Overall Study|Randomized but not Treated|1|||
129750285|NCT01088399|467044548|FG000|Overall Study|Adverse Event|211|||
129750286|NCT01088399|467044549|FG001|Overall Study|Adverse Event|16|||
129750287|NCT01088399|467044550|FG002|Overall Study|Adverse Event|0|||
129750288|NCT01088399|467044548|FG000|Overall Study|Death|204|||
129750289|NCT01088399|467044549|FG001|Overall Study|Death|45|||
129750290|NCT01088399|467044550|FG002|Overall Study|Death|0|||
129750291|NCT01088399|467044548|FG000|Overall Study|Lack of Efficacy|298|||
129750292|NCT01088399|467044549|FG001|Overall Study|Lack of Efficacy|7|||
129750293|NCT01088399|467044550|FG002|Overall Study|Lack of Efficacy|5|||
129750294|NCT01088399|467044548|FG000|Overall Study|Lost to Follow-up|1070|||
129750295|NCT01088399|467044549|FG001|Overall Study|Lost to Follow-up|278|||
129750296|NCT01088399|467044550|FG002|Overall Study|Lost to Follow-up|58|||
129750297|NCT01088399|467044548|FG000|Overall Study|Physician Decision|531|||
129750298|NCT01088399|467044549|FG001|Overall Study|Physician Decision|88|||
129750299|NCT01088399|467044550|FG002|Overall Study|Physician Decision|16|||
129750300|NCT01088399|467044548|FG000|Overall Study|Withdrawal by Subject|544|||
129750301|NCT01088399|467044549|FG001|Overall Study|Withdrawal by Subject|195|||
129750302|NCT01088399|467044550|FG002|Overall Study|Withdrawal by Subject|33|||
129750303|NCT01088399|467044548|FG000|Overall Study|Change to or start of somatropin therapy|234|||
129750304|NCT01088399|467044549|FG001|Overall Study|Change to or start of somatropin therapy|17|||
129750305|NCT01088399|467044550|FG002|Overall Study|Change to or start of somatropin therapy|12|||
129750306|NCT01088399|467044548|FG000|Overall Study|Sponsor decision|1573|||
129750307|NCT01088399|467044549|FG001|Overall Study|Sponsor decision|298|||
129750308|NCT01088399|467044550|FG002|Overall Study|Sponsor decision|7|||
129750309|NCT01088399|467044548|FG000|Overall Study|Protocol Violation|10|||
129750310|NCT01088399|467044549|FG001|Overall Study|Protocol Violation|1|||
129750311|NCT01088399|467044550|FG002|Overall Study|Protocol Violation|0|||
129750312|NCT01088399|467044548|FG000|Overall Study|Enrollment criteria not met|48|||
129750313|NCT01088399|467044549|FG001|Overall Study|Enrollment criteria not met|119|||
129750314|NCT01088399|467044550|FG002|Overall Study|Enrollment criteria not met|70|||
129750315|NCT01088399|467044548|FG000|Overall Study|Study summary visit not completed|2398|||
129750316|NCT01088399|467044549|FG001|Overall Study|Study summary visit not completed|283|||
129750317|NCT01088399|467044550|FG002|Overall Study|Study summary visit not completed|80|||
129750318|NCT00782483|467044551|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
129750319|NCT01016600|467046167|FG000|Overall Study|Did not start treatment|1|||
129750320|NCT01016600|467046168|FG001|Overall Study|Did not start treatment|0|||
129750321|NCT01016600|467046169|FG002|Overall Study|Did not start treatment|0|||
129750322|NCT01016600|467046170|FG003|Overall Study|Did not start treatment|0|||
129750323|NCT02679755|467046171|FG000|Overall Study|Death|0|||
129750324|NCT02679755|467046172|FG001|Overall Study|Death|3|||
129750325|NCT02679755|467046171|FG000|Overall Study|Global deterioration of health status|1|||
129750326|NCT02679755|467046172|FG001|Overall Study|Global deterioration of health status|8|||
129750327|NCT02679755|467046171|FG000|Overall Study|Lost to Follow-up|1|||
129750328|NCT02679755|467046172|FG001|Overall Study|Lost to Follow-up|0|||
129750329|NCT02679755|467046171|FG000|Overall Study|Objective progression or relapse|24|||
129750330|NCT02679755|467046172|FG001|Overall Study|Objective progression or relapse|83|||
129750331|NCT02679755|467046171|FG000|Overall Study|Not defined|0|||
129750332|NCT02679755|467046172|FG001|Overall Study|Not defined|2|||
129750333|NCT02679755|467046171|FG000|Overall Study|Withdrawal by participant|6|||
129750334|NCT02679755|467046172|FG001|Overall Study|Withdrawal by participant|3|||
129750335|NCT02679755|467046171|FG000|Overall Study|Adverse Event|1|||
129750336|NCT02679755|467046172|FG001|Overall Study|Adverse Event|4|||
129750337|NCT02679755|467046171|FG000|Overall Study|Adverse events not related to study drug|1|||
129750338|NCT02679755|467046172|FG001|Overall Study|Adverse events not related to study drug|2|||
129750339|NCT02451917|467046175|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
129750340|NCT02451917|467046176|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
129750341|NCT02451917|467046175|FG000|First Intervention (24 Weeks)|Death|0|||
129750342|NCT02451917|467046176|FG001|First Intervention (24 Weeks)|Death|1|||
129750343|NCT02451917|467046175|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
129750344|NCT02451917|467046176|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
129750345|NCT04737278|467046179|FG000|Overall Study|Lost to Follow-up|1|||
129750346|NCT04737278|467046180|FG001|Overall Study|Lost to Follow-up|1|||
129750347|NCT04737278|467046179|FG000|Overall Study|Withdrawal by Subject|1|||
129750348|NCT04737278|467046180|FG001|Overall Study|Withdrawal by Subject|0|||
129750349|NCT04737278|467046179|FG000|Overall Study|Protocol Violation|1|||
129750350|NCT04737278|467046180|FG001|Overall Study|Protocol Violation|1|||
129750351|NCT04737278|467046179|FG000|Overall Study|failure to complete questionnaire|1|||
129750352|NCT04737278|467046180|FG001|Overall Study|failure to complete questionnaire|1|||
129750353|NCT00546000|467046181|FG000|Overall Study|Adverse Event|1|||
129750354|NCT00546000|467046181|FG000|Overall Study|Lost to Follow-up|1|||
129750355|NCT00546000|467046181|FG000|Overall Study|Baseline HPA Axis Supression|2|||
129750356|NCT01504412|467046183|FG000|Overall Study|Adverse Event|1|||
129750357|NCT01504412|467046184|FG001|Overall Study|Adverse Event|8|||
129750358|NCT01504412|467046185|FG002|Overall Study|Adverse Event|1|||
129750359|NCT01504412|467046186|FG003|Overall Study|Adverse Event|7|||
129750360|NCT01504412|467046187|FG004|Overall Study|Adverse Event|10|||
129750361|NCT01504412|467046183|FG000|Overall Study|Withdrawal by Subject|2|||
129750362|NCT01504412|467046184|FG001|Overall Study|Withdrawal by Subject|1|||
129750363|NCT01504412|467046185|FG002|Overall Study|Withdrawal by Subject|1|||
129750364|NCT01504412|467046186|FG003|Overall Study|Withdrawal by Subject|5|||
129750365|NCT01504412|467046187|FG004|Overall Study|Withdrawal by Subject|1|||
129750366|NCT01504412|467046183|FG000|Overall Study|Other|2|||
129750367|NCT01504412|467046184|FG001|Overall Study|Other|1|||
129750368|NCT01504412|467046185|FG002|Overall Study|Other|1|||
129809423|NCT01602120|467267679|FG001|Overall Study|Unspecified Reason|1|||
129750369|NCT01504412|467046186|FG003|Overall Study|Other|6|||
129750370|NCT01504412|467046187|FG004|Overall Study|Other|1|||
129750371|NCT01504412|467046183|FG000|Overall Study|Lost to Follow-up|0|||
129750372|NCT01504412|467046184|FG001|Overall Study|Lost to Follow-up|2|||
129750373|NCT01504412|467046185|FG002|Overall Study|Lost to Follow-up|0|||
129750374|NCT01504412|467046186|FG003|Overall Study|Lost to Follow-up|0|||
129750375|NCT01504412|467046187|FG004|Overall Study|Lost to Follow-up|0|||
129750376|NCT01504412|467046183|FG000|Overall Study|Lack of Efficacy|0|||
129750377|NCT01504412|467046184|FG001|Overall Study|Lack of Efficacy|0|||
129750378|NCT01504412|467046185|FG002|Overall Study|Lack of Efficacy|1|||
129750379|NCT01504412|467046186|FG003|Overall Study|Lack of Efficacy|0|||
129750380|NCT01504412|467046187|FG004|Overall Study|Lack of Efficacy|1|||
129750381|NCT01504412|467046183|FG000|Overall Study|Death|0|||
129750382|NCT01504412|467046184|FG001|Overall Study|Death|0|||
129750383|NCT01504412|467046185|FG002|Overall Study|Death|0|||
129750384|NCT01504412|467046186|FG003|Overall Study|Death|1|||
129896505|NCT00409708|467582081|FG001|Washout|Lost to Follow-up|3|||
129896506|NCT01474538|467582084|FG000|Treatment Period 1|Death|1|||
129896507|NCT01474538|467582085|FG001|Treatment Period 1|Death|0|||
129750385|NCT01504412|467046187|FG004|Overall Study|Death|0|||
129750386|NCT02974257|467046188|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
129750387|NCT02974257|467046189|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
129750388|NCT02974257|467046188|FG000|Overall Study|Clinical indication for thiamine|1|||
129750389|NCT02974257|467046189|FG001|Overall Study|Clinical indication for thiamine|0|||
129750390|NCT02974257|467046188|FG000|Overall Study|Already on thiamine|1|||
129750391|NCT02974257|467046189|FG001|Overall Study|Already on thiamine|0|||
129750392|NCT02974257|467046188|FG000|Overall Study|Extubated prior to study drug|0|||
129809424|NCT01602120|467267680|FG002|Overall Study|Unspecified Reason|0|||
129809425|NCT01602120|467267681|FG003|Overall Study|Unspecified Reason|2|||
129809426|NCT01681472|467267689|FG000|Overall Study|Adverse Event|0|||
129809427|NCT01681472|467267690|FG001|Overall Study|Adverse Event|1|||
129809428|NCT01681472|467267691|FG002|Overall Study|Adverse Event|0|||
129809429|NCT01681472|467267692|FG003|Overall Study|Adverse Event|0|||
129809430|NCT01999179|467267705|FG000|Overall Study|Adverse Event|1|||
129809431|NCT01999179|467267705|FG000|Overall Study|Lost to Follow-up|1|||
129809432|NCT01999179|467267705|FG000|Overall Study|Change in Therapy|3|||
129809433|NCT01999179|467267705|FG000|Overall Study|New catheter|2|||
129809434|NCT03128411|467267709|FG000|Treatment Phase|Adverse Event|21|||
129809435|NCT03128411|467267709|FG000|Treatment Phase|Physician Decision|1|||
129809436|NCT03128411|467267709|FG000|Treatment Phase|Other|2|||
129809437|NCT03128411|467267709|FG000|Long Term Follow-up Phase|Death|2|||
129809438|NCT02900976|467267714|FG000|Overall Study|Adverse Event|0|||
129809439|NCT02900976|467267715|FG001|Overall Study|Adverse Event|1|||
129809440|NCT02900976|467267714|FG000|Overall Study|Physician Decision|0|||
129809441|NCT02900976|467267715|FG001|Overall Study|Physician Decision|2|||
129809442|NCT02900976|467267714|FG000|Overall Study|Progressive disease|0|||
129809443|NCT02900976|467267715|FG001|Overall Study|Progressive disease|6|||
129809444|NCT06934993|467267716|FG000|Overall Study|Withdrawal by Subject|29|||
129809445|NCT06934993|467267716|FG000|Overall Study|elevated postoperative creatinine level|11|||
129809446|NCT06934993|467267716|FG000|Overall Study|Death|3|||
129809447|NCT03128047|467267717|FG000|Overall Study|Withdrawal by Subject|1|||
129809448|NCT00739674|467269309|FG000|Overall Study|Screening failures|19|||
129809449|NCT00739674|467269310|FG001|Overall Study|Screening failures|17|||
129809450|NCT00739674|467269309|FG000|Overall Study|Site 212 removal|19|||
129809451|NCT00739674|467269310|FG001|Overall Study|Site 212 removal|13|||
129809452|NCT00739674|467269309|FG000|Overall Study|No follow-up data|33|||
129896508|NCT01474538|467582084|FG000|Treatment Period 1|Physician Decision|1|||
129896509|NCT01474538|467582085|FG001|Treatment Period 1|Physician Decision|0|||
129809453|NCT00739674|467269310|FG001|Overall Study|No follow-up data|18|||
129809454|NCT00739674|467269309|FG000|Overall Study|Dietician consultation >30 days|1|||
129809455|NCT00739674|467269310|FG001|Overall Study|Dietician consultation >30 days|9|||
129809456|NCT00739674|467269309|FG000|Overall Study|Adverse Event|22|||
129809457|NCT00739674|467269310|FG001|Overall Study|Adverse Event|13|||
129750393|NCT02974257|467046189|FG001|Overall Study|Extubated prior to study drug|1|||
129750394|NCT02974257|467046188|FG000|Overall Study|Death|0|||
129750395|NCT02974257|467046189|FG001|Overall Study|Death|1|||
129750396|NCT01449006|467046194|FG000|Overall Study|Lost to Follow-up|1|||
129750397|NCT01449006|467046195|FG001|Overall Study|Lost to Follow-up|0|||
129750398|NCT01449006|467046194|FG000|Overall Study|Withdrawal by Subject|1|||
129750399|NCT01449006|467046195|FG001|Overall Study|Withdrawal by Subject|0|||
129750400|NCT01449006|467046194|FG000|Overall Study|Protocol Violation|1|||
129750401|NCT01449006|467046195|FG001|Overall Study|Protocol Violation|0|||
129750402|NCT03350815|467046196|FG000|Period 1|Adverse Event|10|||
129750403|NCT03350815|467046197|FG001|Period 1|Adverse Event|0|||
129750404|NCT03350815|467046198|FG002|Period 1|Adverse Event|0|||
129750405|NCT03350815|467046199|FG003|Period 1|Adverse Event|0|||
129750406|NCT03350815|467046196|FG000|Period 1|Technical problems|1|||
129750407|NCT03350815|467046197|FG001|Period 1|Technical problems|0|||
129750408|NCT03350815|467046198|FG002|Period 1|Technical problems|0|||
129750409|NCT03350815|467046199|FG003|Period 1|Technical problems|0|||
129750410|NCT03350815|467046196|FG000|Period 1|Lost to Follow-up|3|||
129750411|NCT03350815|467046197|FG001|Period 1|Lost to Follow-up|0|||
129750412|NCT03350815|467046198|FG002|Period 1|Lost to Follow-up|0|||
129750413|NCT03350815|467046199|FG003|Period 1|Lost to Follow-up|0|||
129750414|NCT03350815|467046196|FG000|Period 1|Physician Decision|1|||
129750415|NCT03350815|467046197|FG001|Period 1|Physician Decision|0|||
129750416|NCT03350815|467046198|FG002|Period 1|Physician Decision|0|||
129750417|NCT03350815|467046199|FG003|Period 1|Physician Decision|0|||
129750418|NCT03350815|467046196|FG000|Period 1|Withdrawal by Subject|8|||
129750419|NCT03350815|467046197|FG001|Period 1|Withdrawal by Subject|0|||
129750420|NCT03350815|467046198|FG002|Period 1|Withdrawal by Subject|0|||
129750421|NCT03350815|467046199|FG003|Period 1|Withdrawal by Subject|0|||
129750422|NCT03350815|467046196|FG000|Period 1|Lack of Efficacy|15|||
129750423|NCT03350815|467046197|FG001|Period 1|Lack of Efficacy|0|||
129750424|NCT03350815|467046198|FG002|Period 1|Lack of Efficacy|0|||
129750425|NCT03350815|467046199|FG003|Period 1|Lack of Efficacy|0|||
129750426|NCT03350815|467046196|FG000|Period 1|Non-compliance with study treatment|2|||
129750427|NCT03350815|467046197|FG001|Period 1|Non-compliance with study treatment|0|||
129809458|NCT00739674|467269309|FG000|Overall Study|Death|1|||
129809459|NCT00739674|467269310|FG001|Overall Study|Death|0|||
129809460|NCT00739674|467269309|FG000|Overall Study|Lack of Efficacy|1|||
129809461|NCT00739674|467269310|FG001|Overall Study|Lack of Efficacy|0|||
129809462|NCT00739674|467269309|FG000|Overall Study|Lost to Follow-up|52|||
129809463|NCT00739674|467269310|FG001|Overall Study|Lost to Follow-up|30|||
129809464|NCT00739674|467269309|FG000|Overall Study|Protocol Violation|5|||
129809465|NCT00739674|467269310|FG001|Overall Study|Protocol Violation|5|||
129809466|NCT00739674|467269309|FG000|Overall Study|Withdrawal by Subject|9|||
129809467|NCT00739674|467269310|FG001|Overall Study|Withdrawal by Subject|9|||
129809468|NCT00739674|467269309|FG000|Overall Study|Reason missing|2|||
129809469|NCT00739674|467269310|FG001|Overall Study|Reason missing|0|||
129809470|NCT00739674|467269309|FG000|Overall Study|Clinic closed|6|||
129809471|NCT00739674|467269310|FG001|Overall Study|Clinic closed|4|||
129809472|NCT00739674|467269309|FG000|Overall Study|Patient moved|3|||
129809473|NCT00739674|467269310|FG001|Overall Study|Patient moved|2|||
129809474|NCT00739674|467269309|FG000|Overall Study|Non compliant|4|||
129809475|NCT00739674|467269310|FG001|Overall Study|Non compliant|0|||
129809476|NCT00739674|467269309|FG000|Overall Study|Unable to attend visit|3|||
129809477|NCT00739674|467269310|FG001|Overall Study|Unable to attend visit|1|||
129809478|NCT00739674|467269309|FG000|Overall Study|Home monitoring off meds|1|||
129809479|NCT00739674|467269310|FG001|Overall Study|Home monitoring off meds|0|||
129809480|NCT00739674|467269309|FG000|Overall Study|Erectile dysfunction|0|||
129750428|NCT03350815|467046198|FG002|Period 1|Non-compliance with study treatment|0|||
129750429|NCT03350815|467046199|FG003|Period 1|Non-compliance with study treatment|0|||
129750430|NCT03350815|467046196|FG000|Period 1|Protocol Violation|3|||
129750431|NCT03350815|467046197|FG001|Period 1|Protocol Violation|0|||
129750432|NCT03350815|467046198|FG002|Period 1|Protocol Violation|0|||
129750433|NCT03350815|467046199|FG003|Period 1|Protocol Violation|0|||
129750434|NCT03350815|467046196|FG000|Period 2|Adverse Event|0|||
129750435|NCT03350815|467046197|FG001|Period 2|Adverse Event|3|||
129750436|NCT03350815|467046198|FG002|Period 2|Adverse Event|5|||
129750437|NCT03350815|467046199|FG003|Period 2|Adverse Event|0|||
129750438|NCT03350815|467046196|FG000|Period 2|Technical problem|0|||
129809481|NCT00739674|467269310|FG001|Overall Study|Erectile dysfunction|1|||
129750439|NCT03350815|467046197|FG001|Period 2|Technical problem|1|||
129750440|NCT03350815|467046198|FG002|Period 2|Technical problem|0|||
129750441|NCT03350815|467046199|FG003|Period 2|Technical problem|0|||
129750442|NCT03350815|467046196|FG000|Period 2|Lost to Follow-up|0|||
129750443|NCT03350815|467046197|FG001|Period 2|Lost to Follow-up|3|||
129809482|NCT01594281|467269311|FG000|Interventional Core Phase|Protocol Deviation|1|||
129809483|NCT01594281|467269312|FG001|Interventional Core Phase|Protocol Deviation|0|||
129809484|NCT01594281|467269313|FG002|Interventional Core Phase|Protocol Deviation|0|||
129809485|NCT01594281|467269311|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
129809486|NCT01594281|467269312|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
129750444|NCT03350815|467046198|FG002|Period 2|Lost to Follow-up|3|||
129750445|NCT03350815|467046199|FG003|Period 2|Lost to Follow-up|0|||
129750446|NCT03350815|467046196|FG000|Period 2|Physician Decision|0|||
129750447|NCT03350815|467046197|FG001|Period 2|Physician Decision|0|||
129750448|NCT03350815|467046198|FG002|Period 2|Physician Decision|1|||
129750449|NCT03350815|467046199|FG003|Period 2|Physician Decision|0|||
129750450|NCT03350815|467046196|FG000|Period 2|Withdrawal by Subject|0|||
129750451|NCT03350815|467046197|FG001|Period 2|Withdrawal by Subject|3|||
129750452|NCT03350815|467046198|FG002|Period 2|Withdrawal by Subject|4|||
129750453|NCT03350815|467046199|FG003|Period 2|Withdrawal by Subject|0|||
129750454|NCT03350815|467046196|FG000|Period 2|Lack of Efficacy|0|||
129750455|NCT03350815|467046197|FG001|Period 2|Lack of Efficacy|6|||
129750456|NCT03350815|467046198|FG002|Period 2|Lack of Efficacy|2|||
129750457|NCT03350815|467046199|FG003|Period 2|Lack of Efficacy|0|||
129750458|NCT03350815|467046196|FG000|Period 2|Protocol Violation|0|||
129750459|NCT03350815|467046197|FG001|Period 2|Protocol Violation|0|||
129750460|NCT03350815|467046198|FG002|Period 2|Protocol Violation|1|||
129750461|NCT03350815|467046199|FG003|Period 2|Protocol Violation|0|||
129750462|NCT03350815|467046196|FG000|Period 2|New therapy for study indication|0|||
129750463|NCT03350815|467046197|FG001|Period 2|New therapy for study indication|0|||
129750464|NCT03350815|467046198|FG002|Period 2|New therapy for study indication|1|||
129750465|NCT03350815|467046199|FG003|Period 2|New therapy for study indication|0|||
129750466|NCT02837029|467046202|FG000|Screening|Failed to meet screening requirements.|7|||
129750467|NCT02837029|467046203|FG001|Screening|Failed to meet screening requirements.|3|||
129750468|NCT02837029|467046204|FG002|Screening|Failed to meet screening requirements.|0|||
129750469|NCT02837029|467046202|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
129750470|NCT02837029|467046203|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
129750471|NCT02837029|467046204|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
129809487|NCT01594281|467269313|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
129809488|NCT01594281|467269311|FG000|Interventional Core Phase|Death|1|||
129809489|NCT01594281|467269312|FG001|Interventional Core Phase|Death|1|||
129809490|NCT01594281|467269313|FG002|Interventional Core Phase|Death|2|||
129809491|NCT01594281|467269311|FG000|Interventional Core Phase|Lost to Follow-up|1|||
129809492|NCT01594281|467269312|FG001|Interventional Core Phase|Lost to Follow-up|4|||
129809493|NCT01594281|467269313|FG002|Interventional Core Phase|Lost to Follow-up|1|||
129809494|NCT01594281|467269311|FG000|Interventional Core Phase|Adverse Event|4|||
129809495|NCT01594281|467269312|FG001|Interventional Core Phase|Adverse Event|4|||
129809496|NCT01594281|467269313|FG002|Interventional Core Phase|Adverse Event|4|||
129809497|NCT01594281|467269311|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
129809498|NCT01594281|467269312|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
129809499|NCT01594281|467269313|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
129809500|NCT01594281|467269311|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
129896510|NCT01474538|467582084|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129750472|NCT02837029|467046202|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
129750473|NCT02837029|467046203|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
129750474|NCT02837029|467046204|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
129750475|NCT02837029|467046202|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
129750476|NCT02837029|467046203|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
129750477|NCT02837029|467046204|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
129750478|NCT02837029|467046202|FG000|Cycle 2 and Beyond|Adverse Event|1|||
129750479|NCT02837029|467046203|FG001|Cycle 2 and Beyond|Adverse Event|0|||
129750480|NCT02837029|467046204|FG002|Cycle 2 and Beyond|Adverse Event|0|||
129750481|NCT02837029|467046202|FG000|2 Year Follow-up|Death|6|||
129750482|NCT02837029|467046203|FG001|2 Year Follow-up|Death|7|||
129750483|NCT02837029|467046204|FG002|2 Year Follow-up|Death|0|||
129750484|NCT00398567|467046205|FG000|Overall Study|Disease Progression|3|||
129750485|NCT00398567|467046206|FG001|Overall Study|Disease Progression|4|||
129750486|NCT00398567|467046207|FG002|Overall Study|Disease Progression|27|||
129750487|NCT00398567|467046205|FG000|Overall Study|Withdrawal by Subject|1|||
129750488|NCT00398567|467046206|FG001|Overall Study|Withdrawal by Subject|0|||
129750489|NCT00398567|467046207|FG002|Overall Study|Withdrawal by Subject|4|||
129750490|NCT00398567|467046205|FG000|Overall Study|Adverse Event|0|||
129750491|NCT00398567|467046206|FG001|Overall Study|Adverse Event|0|||
129750492|NCT00398567|467046207|FG002|Overall Study|Adverse Event|2|||
129750493|NCT00398567|467046205|FG000|Overall Study|Protocol Violation|0|||
129809501|NCT01594281|467269312|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
129896511|NCT01474538|467582085|FG001|Treatment Period 1|Withdrawal by Subject|3|||
129896512|NCT01474538|467582084|FG000|Treatment Period 1|Protocol Violation|0|||
129896513|NCT01474538|467582085|FG001|Treatment Period 1|Protocol Violation|1|||
129750494|NCT00398567|467046206|FG001|Overall Study|Protocol Violation|0|||
129750495|NCT00398567|467046207|FG002|Overall Study|Protocol Violation|1|||
129750496|NCT02034877|467046208|FG000|Overall Study|Lost to Follow-up|0|||
129750497|NCT02034877|467046209|FG001|Overall Study|Lost to Follow-up|3|||
129750498|NCT02034877|467046208|FG000|Overall Study|No Longer Willing to Participate|0|||
129750499|NCT02034877|467046209|FG001|Overall Study|No Longer Willing to Participate|3|||
129750500|NCT03906071|467046212|FG000|Overall Study|Death|180|||
129750501|NCT03906071|467046213|FG001|Overall Study|Death|185|||
129750502|NCT03906071|467046212|FG000|Overall Study|Lost to Follow-up|3|||
129750503|NCT03906071|467046213|FG001|Overall Study|Lost to Follow-up|3|||
129750504|NCT03906071|467046212|FG000|Overall Study|Withdrawal by Subject|15|||
129750505|NCT03906071|467046213|FG001|Overall Study|Withdrawal by Subject|27|||
129750506|NCT03906071|467046212|FG000|Overall Study|Other|2|||
129750507|NCT03906071|467046213|FG001|Overall Study|Other|1|||
129750508|NCT01564732|467046225|FG000|Overall Study|Early termination by the study sponsor|6|||
129750509|NCT01564732|467046226|FG001|Overall Study|Early termination by the study sponsor|5|||
129750510|NCT01979952|467046229|FG000|Overall Study|Adverse Event|4|||
129750511|NCT01979952|467046230|FG001|Overall Study|Adverse Event|5|||
129750512|NCT01979952|467046229|FG000|Overall Study|Protocol Violation|1|||
129750513|NCT01979952|467046230|FG001|Overall Study|Protocol Violation|0|||
129750514|NCT01979952|467046229|FG000|Overall Study|Withdrawal by Subject|2|||
129809502|NCT01594281|467269313|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
129809503|NCT01594281|467269311|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
129809504|NCT01594281|467269312|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
129809505|NCT01594281|467269313|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
129809506|NCT04805541|467269315|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
129809507|NCT00283400|467269319|FG000|Overall Study|Withdrawal by Subject|1|||
129809508|NCT00283400|467269320|FG001|Overall Study|Withdrawal by Subject|1|||
129809509|NCT00283400|467269321|FG002|Overall Study|Withdrawal by Subject|0|||
129809510|NCT00283400|467269322|FG003|Overall Study|Withdrawal by Subject|0|||
129809511|NCT00283400|467269319|FG000|Overall Study|Death|1|||
129809512|NCT00283400|467269320|FG001|Overall Study|Death|0|||
129809513|NCT00283400|467269321|FG002|Overall Study|Death|1|||
129809514|NCT00283400|467269322|FG003|Overall Study|Death|0|||
129809515|NCT01560403|467269323|FG000|Overall Study|Lost to Follow-up|0|||
129809516|NCT01560403|467269324|FG001|Overall Study|Lost to Follow-up|1|||
129809517|NCT03166735|467269325|FG000|Overall Study|Not Treated|1|||
129809518|NCT03166735|467269326|FG001|Overall Study|Not Treated|0|||
129809519|NCT03166735|467269327|FG002|Overall Study|Not Treated|0|||
129809520|NCT03166735|467269328|FG003|Overall Study|Not Treated|0|||
129809521|NCT03166735|467269329|FG004|Overall Study|Not Treated|0|||
129809522|NCT03166735|467269325|FG000|Overall Study|follow-up not completed as planned|0|||
129809523|NCT03166735|467269326|FG001|Overall Study|follow-up not completed as planned|1|||
129809524|NCT03166735|467269327|FG002|Overall Study|follow-up not completed as planned|1|||
129809525|NCT03166735|467269328|FG003|Overall Study|follow-up not completed as planned|0|||
129809526|NCT03166735|467269329|FG004|Overall Study|follow-up not completed as planned|1|||
129809527|NCT03166735|467269325|FG000|Overall Study|Withdrawal by Subject|0|||
129809528|NCT03166735|467269326|FG001|Overall Study|Withdrawal by Subject|0|||
129809529|NCT03166735|467269327|FG002|Overall Study|Withdrawal by Subject|1|||
129809530|NCT03166735|467269328|FG003|Overall Study|Withdrawal by Subject|1|||
129809531|NCT03166735|467269329|FG004|Overall Study|Withdrawal by Subject|2|||
129809532|NCT03166735|467269325|FG000|Overall Study|Lost to Follow-up|0|||
129809533|NCT03166735|467269326|FG001|Overall Study|Lost to Follow-up|2|||
129809534|NCT03166735|467269327|FG002|Overall Study|Lost to Follow-up|1|||
129809535|NCT03166735|467269328|FG003|Overall Study|Lost to Follow-up|0|||
129809536|NCT03166735|467269329|FG004|Overall Study|Lost to Follow-up|1|||
129809537|NCT01020981|467269332|FG000|Overall Study|Did not return mailed survey|74|||
129809538|NCT01020981|467269333|FG001|Overall Study|Did not return mailed survey|58|||
129809539|NCT01020981|467269332|FG000|Overall Study|Survey returned undeliverable|8|||
129809540|NCT01020981|467269333|FG001|Overall Study|Survey returned undeliverable|32|||
129809541|NCT01020981|467269332|FG000|Overall Study|Participant declined to complete survey|2|||
129809542|NCT01020981|467269333|FG001|Overall Study|Participant declined to complete survey|0|||
129809543|NCT00040365|467269336|FG000|Overall Study|Death|1|||
129809544|NCT00040365|467269336|FG000|Overall Study|Progressive disease|7|||
129809545|NCT00040365|467269336|FG000|Overall Study|Lost to Follow-up|3|||
129809546|NCT00541931|467269337|FG000|Overall Study|Adverse Event|1|||
129809547|NCT00541931|467269338|FG001|Overall Study|Adverse Event|0|||
129809548|NCT00541931|467269337|FG000|Overall Study|Lost to Follow-up|3|||
129750515|NCT01979952|467046230|FG001|Overall Study|Withdrawal by Subject|1|||
129750516|NCT01979952|467046229|FG000|Overall Study|Other than specified above|1|||
129750517|NCT01979952|467046230|FG001|Overall Study|Other than specified above|0|||
129750518|NCT05438576|467046231|FG000|Overall Study|Death|1|||
129750519|NCT05438576|467046232|FG001|Overall Study|Death|1|||
129809549|NCT00541931|467269338|FG001|Overall Study|Lost to Follow-up|3|||
129809550|NCT00541931|467269337|FG000|Overall Study|Withdrawal by Subject|1|||
129809551|NCT00541931|467269338|FG001|Overall Study|Withdrawal by Subject|0|||
129750520|NCT05438576|467046231|FG000|Overall Study|Withdrawal by Subject|4|||
129750521|NCT05438576|467046232|FG001|Overall Study|Withdrawal by Subject|2|||
129809552|NCT00541931|467269337|FG000|Overall Study|Transportation Issue|0|||
129809553|NCT00541931|467269338|FG001|Overall Study|Transportation Issue|1|||
129809554|NCT02555683|467269339|FG000|Overall Study|Physician Decision|1|||
129809555|NCT02555683|467269340|FG001|Overall Study|Physician Decision|0|||
129809556|NCT02555683|467269341|FG002|Overall Study|Physician Decision|2|||
129750522|NCT05438576|467046231|FG000|Overall Study|Not Eligible|2|||
129750523|NCT05438576|467046232|FG001|Overall Study|Not Eligible|1|||
129750524|NCT05438576|467046231|FG000|Overall Study|Did not complete baseline testing|22|||
129750525|NCT05438576|467046232|FG001|Overall Study|Did not complete baseline testing|4|||
129750526|NCT01067144|467046238|FG000|Treatment|Did not receive allocated intervention|4|||
129750527|NCT01067144|467046239|FG001|Treatment|Did not receive allocated intervention|7|||
129750528|NCT01067144|467046238|FG000|Follow-up|Lost to Follow-up|22|||
129750529|NCT01067144|467046239|FG001|Follow-up|Lost to Follow-up|12|||
129750530|NCT01067144|467046238|FG000|Follow-up|Censored owing to second surgery|19|||
129750531|NCT01067144|467046239|FG001|Follow-up|Censored owing to second surgery|28|||
129750532|NCT01067144|467046238|FG000|Follow-up|Withdrawal by Subject|18|||
129750533|NCT01067144|467046239|FG001|Follow-up|Withdrawal by Subject|14|||
129809557|NCT02555683|467269339|FG000|Overall Study|Lost to Follow-up|2|||
129809558|NCT02555683|467269340|FG001|Overall Study|Lost to Follow-up|1|||
129809559|NCT02555683|467269341|FG002|Overall Study|Lost to Follow-up|2|||
129809560|NCT02555683|467269339|FG000|Overall Study|Technical Problems|1|||
129809561|NCT02555683|467269340|FG001|Overall Study|Technical Problems|1|||
129809562|NCT02555683|467269341|FG002|Overall Study|Technical Problems|0|||
129809563|NCT02555683|467269339|FG000|Overall Study|Protocol deviation|0|||
129809564|NCT02555683|467269340|FG001|Overall Study|Protocol deviation|1|||
129809565|NCT02555683|467269341|FG002|Overall Study|Protocol deviation|0|||
129809566|NCT02555683|467269339|FG000|Overall Study|Lack of Efficacy|2|||
129809567|NCT02555683|467269340|FG001|Overall Study|Lack of Efficacy|0|||
129809568|NCT02555683|467269341|FG002|Overall Study|Lack of Efficacy|0|||
129809569|NCT02555683|467269339|FG000|Overall Study|Death|0|||
129809570|NCT02555683|467269340|FG001|Overall Study|Death|1|||
129750534|NCT01067144|467046238|FG000|Follow-up|Surgery cancelled|0|||
129750535|NCT01067144|467046239|FG001|Follow-up|Surgery cancelled|1|||
129750536|NCT01067144|467046238|FG000|Follow-up|Death|0|||
129809571|NCT02555683|467269341|FG002|Overall Study|Death|2|||
129809572|NCT02555683|467269339|FG000|Overall Study|Adverse Event|1|||
129809573|NCT02555683|467269340|FG001|Overall Study|Adverse Event|0|||
129896514|NCT01474538|467582084|FG000|Treatment Period 2|Death|1|||
129809574|NCT02555683|467269341|FG002|Overall Study|Adverse Event|1|||
129750537|NCT01067144|467046239|FG001|Follow-up|Death|1|||
129750538|NCT00475709|467046240|FG000|Overall Study|Did not meet eligibility criteria|8|||
129750539|NCT00475709|467046240|FG000|Overall Study|Death|41|||
129750540|NCT00475709|467046240|FG000|Overall Study|Device Explant|6|||
129750541|NCT00475709|467046240|FG000|Overall Study|Lost to Follow-up|21|||
129750542|NCT00555672|467046241|FG000|Overall Study|Death|0|||
129750543|NCT00555672|467046242|FG001|Overall Study|Death|2|||
129750544|NCT00555672|467046241|FG000|Overall Study|Adverse Event|8|||
129750545|NCT00555672|467046242|FG001|Overall Study|Adverse Event|2|||
129750546|NCT00555672|467046241|FG000|Overall Study|Objective progression or relapse|11|||
129750547|NCT00555672|467046242|FG001|Overall Study|Objective progression or relapse|5|||
129750548|NCT00555672|467046241|FG000|Overall Study|Other|3|||
129750549|NCT00555672|467046242|FG001|Overall Study|Other|1|||
129750550|NCT00555672|467046241|FG000|Overall Study|Participant refused|2|||
129750551|NCT00555672|467046242|FG001|Overall Study|Participant refused|0|||
129750552|NCT01415401|467046247|FG000|Overall Study|Adverse Event|5|||
129750553|NCT01415401|467046247|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
129750554|NCT01415401|467046247|FG000|Overall Study|Terminated by Sponsor|1|||
129750555|NCT04765202|467046261|FG000|Overall Study|Lost to Follow-up|1|||
129750556|NCT04765202|467046262|FG001|Overall Study|Lost to Follow-up|1|||
129750557|NCT04765202|467046263|FG002|Overall Study|Lost to Follow-up|2|||
129750558|NCT04765202|467046264|FG003|Overall Study|Lost to Follow-up|2|||
129750559|NCT04765202|467046261|FG000|Overall Study|Physician Decision|0|||
129750560|NCT04765202|467046262|FG001|Overall Study|Physician Decision|0|||
129750561|NCT04765202|467046263|FG002|Overall Study|Physician Decision|1|||
129750562|NCT04765202|467046264|FG003|Overall Study|Physician Decision|1|||
129750563|NCT02305238|467046266|FG000|Overall Study|Death|2|||
129750564|NCT02305238|467046267|FG001|Overall Study|Death|1|||
129750565|NCT02305238|467046268|FG002|Overall Study|Death|0|||
129750566|NCT02305238|467046266|FG000|Overall Study|Progressive disease|4|||
129750567|NCT02305238|467046267|FG001|Overall Study|Progressive disease|4|||
129750568|NCT02305238|467046268|FG002|Overall Study|Progressive disease|0|||
129750569|NCT02305238|467046266|FG000|Overall Study|Logistical difficulties|1|||
129750570|NCT02305238|467046267|FG001|Overall Study|Logistical difficulties|3|||
129750571|NCT02305238|467046268|FG002|Overall Study|Logistical difficulties|0|||
129750572|NCT02305238|467046266|FG000|Overall Study|Protocol Violation|0|||
129750573|NCT02305238|467046267|FG001|Overall Study|Protocol Violation|3|||
129750574|NCT02305238|467046268|FG002|Overall Study|Protocol Violation|0|||
129750575|NCT02305238|467046266|FG000|Overall Study|Physician Decision|2|||
129750576|NCT02305238|467046267|FG001|Overall Study|Physician Decision|1|||
129750577|NCT02305238|467046268|FG002|Overall Study|Physician Decision|0|||
129750578|NCT02305238|467046266|FG000|Overall Study|Adverse Event|4|||
129750579|NCT02305238|467046267|FG001|Overall Study|Adverse Event|2|||
129750580|NCT02305238|467046268|FG002|Overall Study|Adverse Event|0|||
129750581|NCT02305238|467046266|FG000|Overall Study|Withdrawal by Subject|3|||
129750582|NCT02305238|467046267|FG001|Overall Study|Withdrawal by Subject|4|||
129750583|NCT02305238|467046268|FG002|Overall Study|Withdrawal by Subject|0|||
129750584|NCT02305238|467046266|FG000|Overall Study|Randomized failure|0|||
129750585|NCT02305238|467046267|FG001|Overall Study|Randomized failure|0|||
129750586|NCT02305238|467046268|FG002|Overall Study|Randomized failure|8|||
129750587|NCT02305238|467046266|FG000|Overall Study|Required procedure failed|0|||
129750588|NCT02305238|467046267|FG001|Overall Study|Required procedure failed|1|||
129750589|NCT02305238|467046268|FG002|Overall Study|Required procedure failed|0|||
129750590|NCT01019369|467046269|FG000|Overall Study|Lost to Follow-up|10|||
129750591|NCT01019369|467046270|FG001|Overall Study|Lost to Follow-up|6|||
129750592|NCT01019369|467046269|FG000|Overall Study|Withdrawal by Subject|0|||
129750593|NCT01019369|467046270|FG001|Overall Study|Withdrawal by Subject|1|||
129750594|NCT02513472|467046271|FG000|Overall Study|Radiological Disease Progression|45|||
129750595|NCT02513472|467046272|FG001|Overall Study|Radiological Disease Progression|57|||
129750596|NCT02513472|467046271|FG000|Overall Study|Clinical Disease Progression|5|||
129750597|NCT02513472|467046272|FG001|Overall Study|Clinical Disease Progression|13|||
129750598|NCT02513472|467046271|FG000|Overall Study|Adverse Event|8|||
129750599|NCT02513472|467046272|FG001|Overall Study|Adverse Event|11|||
129750600|NCT02513472|467046271|FG000|Overall Study|Withdrawal by Subject|0|||
129750601|NCT02513472|467046272|FG001|Overall Study|Withdrawal by Subject|4|||
129750602|NCT02513472|467046271|FG000|Overall Study|Subject Choice|2|||
129750603|NCT02513472|467046272|FG001|Overall Study|Subject Choice|7|||
129750604|NCT02513472|467046271|FG000|Overall Study|Treatment Completed as per Protocol|3|||
129750605|NCT02513472|467046272|FG001|Overall Study|Treatment Completed as per Protocol|3|||
129750606|NCT02513472|467046271|FG000|Overall Study|Other|3|||
129750607|NCT02513472|467046272|FG001|Overall Study|Other|6|||
129750608|NCT01380834|467046273|FG000|Overall Study|Physician Decision|1|||
129750609|NCT01380834|467046274|FG001|Overall Study|Physician Decision|0|||
129750610|NCT04310566|467046275|FG000|Period 1|Study Termination due to COVID-19|15|||
129750611|NCT04310566|467046276|FG001|Period 1|Study Termination due to COVID-19|17|||
129750612|NCT04310566|467046275|FG000|Period 1|Protocol Violation|0|||
129750613|NCT04310566|467046276|FG001|Period 1|Protocol Violation|1|||
129750614|NCT04310566|467046275|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
129750615|NCT04310566|467046276|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
129750616|NCT04310566|467046275|FG000|Period 1|Lost to Follow-up|1|||
129750617|NCT04310566|467046276|FG001|Period 1|Lost to Follow-up|0|||
129750618|NCT04310566|467046275|FG000|Period 1|Withdrawal by Subject|0|||
129750619|NCT04310566|467046276|FG001|Period 1|Withdrawal by Subject|1|||
129750620|NCT04310566|467046275|FG000|Period 2|Study Termination|7|||
129750621|NCT04310566|467046276|FG001|Period 2|Study Termination|5|||
129750622|NCT04565951|467046277|FG000|Overall Study|Lost to Follow-up|66|||
129750623|NCT04565951|467046278|FG001|Overall Study|Lost to Follow-up|38|||
129750624|NCT04565951|467046277|FG000|Overall Study|Withdrawal by Subject|14|||
129750625|NCT04565951|467046278|FG001|Overall Study|Withdrawal by Subject|7|||
129750626|NCT04565951|467046277|FG000|Overall Study|Death|0|||
129750627|NCT04565951|467046278|FG001|Overall Study|Death|1|||
129750628|NCT00429169|467046287|FG000|Overall Study|Lost to Follow-up|0|||
129750629|NCT00429169|467046288|FG001|Overall Study|Lost to Follow-up|1|||
129750630|NCT00429169|467046287|FG000|Overall Study|Ineligibility discovered after entry|2|||
129750631|NCT00429169|467046288|FG001|Overall Study|Ineligibility discovered after entry|1|||
129750632|NCT01711645|467046289|FG000|Overall Study|Withdrawal by Subject|8|||
129750633|NCT01711645|467046289|FG000|Overall Study|Lost to Follow-up|6|||
129750634|NCT01711645|467046289|FG000|Overall Study|Physician Decision|5|||
129750635|NCT01746173|467046295|FG000|Overall Study|Disease Progression|2|||
129750636|NCT01371552|467046299|FG000|Part 1, First 3 Days|Inconvenience|0|||
129750637|NCT01371552|467046300|FG001|Part 1, First 3 Days|Inconvenience|0|||
129750638|NCT01371552|467046301|FG002|Part 1, First 3 Days|Inconvenience|1|||
129750639|NCT01371552|467046302|FG003|Part 1, First 3 Days|Inconvenience|0|||
129750640|NCT01371552|467046303|FG004|Part 1, First 3 Days|Inconvenience|0|||
129750641|NCT01371552|467046304|FG005|Part 1, First 3 Days|Inconvenience|0|||
129750642|NCT02328027|467046305|FG000|Overall Study|Withdrawal by Subject|0|||
129750643|NCT02328027|467046306|FG001|Overall Study|Withdrawal by Subject|1|||
129750644|NCT03304873|467046307|FG000|Overall Study|Lost to Follow-up|1|||
129750645|NCT03304873|467046308|FG001|Overall Study|Lost to Follow-up|8|||
129750646|NCT03319212|467046309|FG000|Overall Study|Discontinued as moving out of local area|0|||
129750647|NCT03319212|467046310|FG001|Overall Study|Discontinued as moving out of local area|1|||
129750648|NCT03319212|467046309|FG000|Overall Study|Adverse Event|2|||
129750649|NCT03319212|467046310|FG001|Overall Study|Adverse Event|2|||
129750650|NCT03319212|467046309|FG000|Overall Study|Withdrawal by Subject|0|||
129750651|NCT03319212|467046310|FG001|Overall Study|Withdrawal by Subject|1|||
129750652|NCT03319212|467046309|FG000|Overall Study|Lost to Follow-up|0|||
129750653|NCT03319212|467046310|FG001|Overall Study|Lost to Follow-up|1|||
129750654|NCT03319212|467046309|FG000|Overall Study|Physician Decision|1|||
129750655|NCT03319212|467046310|FG001|Overall Study|Physician Decision|0|||
129750656|NCT00250276|467046311|FG000|Overall Study|Serious Adverse Event|0|||
129750657|NCT00250276|467046312|FG001|Overall Study|Serious Adverse Event|0|||
129750658|NCT00250276|467046313|FG002|Overall Study|Serious Adverse Event|1|||
129750659|NCT00250276|467046314|FG003|Overall Study|Serious Adverse Event|0|||
129750660|NCT00250276|467046311|FG000|Overall Study|Non-serious Adverse Event|2|||
129750661|NCT00250276|467046312|FG001|Overall Study|Non-serious Adverse Event|0|||
129750662|NCT00250276|467046313|FG002|Overall Study|Non-serious Adverse Event|0|||
129750663|NCT00250276|467046314|FG003|Overall Study|Non-serious Adverse Event|2|||
129750664|NCT00250276|467046311|FG000|Overall Study|Protocol Violation|0|||
129750665|NCT00250276|467046312|FG001|Overall Study|Protocol Violation|1|||
129750666|NCT00250276|467046313|FG002|Overall Study|Protocol Violation|0|||
129750667|NCT00250276|467046314|FG003|Overall Study|Protocol Violation|0|||
129750668|NCT00250276|467046311|FG000|Overall Study|Withdrawal by Subject|1|||
129750669|NCT00250276|467046312|FG001|Overall Study|Withdrawal by Subject|2|||
129750670|NCT00250276|467046313|FG002|Overall Study|Withdrawal by Subject|3|||
129750671|NCT00250276|467046314|FG003|Overall Study|Withdrawal by Subject|2|||
129750672|NCT00250276|467046311|FG000|Overall Study|Migrated/moved from study area|3|||
129750673|NCT00250276|467046312|FG001|Overall Study|Migrated/moved from study area|0|||
129750674|NCT00250276|467046313|FG002|Overall Study|Migrated/moved from study area|2|||
129750675|NCT00250276|467046314|FG003|Overall Study|Migrated/moved from study area|7|||
129750676|NCT00250276|467046311|FG000|Overall Study|Lost to Follow-up|11|||
129750677|NCT00250276|467046312|FG001|Overall Study|Lost to Follow-up|18|||
129750678|NCT00250276|467046313|FG002|Overall Study|Lost to Follow-up|13|||
129750679|NCT00250276|467046314|FG003|Overall Study|Lost to Follow-up|8|||
129750680|NCT01546688|467046315|FG000|Overall Study|Adverse Event|0|||
129750681|NCT01546688|467046316|FG001|Overall Study|Adverse Event|4|||
129750682|NCT01546688|467046315|FG000|Overall Study|Withdrawal by Subject|2|||
129750683|NCT01546688|467046316|FG001|Overall Study|Withdrawal by Subject|1|||
129750684|NCT01546688|467046315|FG000|Overall Study|Lack of Efficacy|1|||
129750685|NCT01546688|467046316|FG001|Overall Study|Lack of Efficacy|0|||
129750686|NCT01811186|467046317|FG000|Overall Study|Adverse Event|54|||
129750687|NCT01811186|467046318|FG001|Overall Study|Adverse Event|38|||
129750688|NCT01811186|467046317|FG000|Overall Study|Protocol Violation|5|||
129750689|NCT01811186|467046318|FG001|Overall Study|Protocol Violation|6|||
129750690|NCT01811186|467046317|FG000|Overall Study|Withdrawal by Subject|5|||
129750691|NCT01811186|467046318|FG001|Overall Study|Withdrawal by Subject|10|||
129750692|NCT01811186|467046317|FG000|Overall Study|Lack of Efficacy|3|||
129750693|NCT01811186|467046318|FG001|Overall Study|Lack of Efficacy|6|||
129750694|NCT01811186|467046317|FG000|Overall Study|Lost to Follow-up|4|||
129750695|NCT01811186|467046318|FG001|Overall Study|Lost to Follow-up|2|||
129750696|NCT03369236|467046321|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
129750697|NCT03369236|467046322|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
129750698|NCT03369236|467046321|FG000|Open-label Extension Period|Lack of Efficacy|2|||
129750699|NCT03369236|467046322|FG001|Open-label Extension Period|Lack of Efficacy|1|||
129750700|NCT03369236|467046321|FG000|Open-label Extension Period|Adverse Event|0|||
129750701|NCT03369236|467046322|FG001|Open-label Extension Period|Adverse Event|1|||
129809575|NCT02555683|467269339|FG000|Overall Study|Subject/guardian decision|12|||
129809576|NCT02555683|467269340|FG001|Overall Study|Subject/guardian decision|12|||
129809577|NCT02555683|467269341|FG002|Overall Study|Subject/guardian decision|22|||
129809578|NCT02555683|467269339|FG000|Overall Study|Death post Treatment/safety period|0|||
129809579|NCT02555683|467269340|FG001|Overall Study|Death post Treatment/safety period|1|||
129809580|NCT02555683|467269341|FG002|Overall Study|Death post Treatment/safety period|0|||
129809581|NCT01086033|467269344|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
129809582|NCT01086033|467269344|FG000|Overall Study|Lost to Follow-up|86|||
129809583|NCT01086033|467269344|FG000|Overall Study|Adverse Event|42|||
129809584|NCT01086033|467269344|FG000|Overall Study|Withdrawal by Subject|41|||
129809585|NCT01086033|467269344|FG000|Overall Study|Other|14|||
129896515|NCT01474538|467582085|FG001|Treatment Period 2|Death|0|||
129896516|NCT01474538|467582084|FG000|Treatment Period 2|Adverse Event|1|||
129750702|NCT03369236|467046321|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
129750703|NCT03369236|467046322|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
129750704|NCT01153724|467046327|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129750705|NCT01153724|467046327|FG000|Treatment Period 2|Adverse Event|1|||
129750706|NCT01153724|467046327|FG000|Treatment Period 2|Other reason not defined above|1|||
129750707|NCT02508428|467046334|FG000|Overall Study|Death|32|||
129750708|NCT02508428|467046335|FG001|Overall Study|Death|33|||
129750709|NCT02508428|467046334|FG000|Overall Study|Liner revised|3|||
129750710|NCT02508428|467046335|FG001|Overall Study|Liner revised|19|||
129750711|NCT02508428|467046334|FG000|Overall Study|Incomplete follow-up|17|||
129750712|NCT02508428|467046335|FG001|Overall Study|Incomplete follow-up|15|||
129750713|NCT00534976|467046340|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
129750714|NCT00534976|467046341|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
129750715|NCT00534976|467046340|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
129750716|NCT00534976|467046341|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
129750717|NCT00534976|467046340|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
129750718|NCT00534976|467046341|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
129750719|NCT02123576|467046342|FG000|Overall Study|Adverse Event|1|||
129750720|NCT02123576|467046343|FG001|Overall Study|Adverse Event|0|||
129809586|NCT01086033|467269344|FG000|Overall Study|Other|13|||
129809587|NCT01086033|467269344|FG000|Overall Study|AE and Withdrew Consent|5|||
129809588|NCT01086033|467269344|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
129896517|NCT01474538|467582085|FG001|Treatment Period 2|Adverse Event|1|||
129896518|NCT01474538|467582084|FG000|Treatment Period 2|Withdrawal by Subject|2|||
129896519|NCT01474538|467582085|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129750721|NCT00934128|467046344|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
129750722|NCT00934128|467046345|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
129750723|NCT00934128|467046344|FG000|First Intervention (2 Hours)|Adverse Event|4|||
129750724|NCT00934128|467046345|FG001|First Intervention (2 Hours)|Adverse Event|1|||
129750725|NCT00934128|467046344|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
129750726|NCT00934128|467046345|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
129809589|NCT01086033|467269344|FG000|Overall Study|Withdrew consent and Other Reason|4|||
129809590|NCT01086033|467269344|FG000|Overall Study|AE and Lack of Efficacy|4|||
129896520|NCT01474538|467582084|FG000|Treatment Period 2|Sponsor decision|1|||
129896521|NCT01474538|467582085|FG001|Treatment Period 2|Sponsor decision|0|||
129809591|NCT01086033|467269344|FG000|Overall Study|Death|1|||
129809592|NCT01086033|467269344|FG000|Overall Study|AE and Lost to Follow-up|1|||
129750727|NCT00934128|467046344|FG000|Washout Period (1 Hour)|Patient preference|1|||
129750728|NCT00934128|467046345|FG001|Washout Period (1 Hour)|Patient preference|3|||
129750729|NCT00934128|467046344|FG000|Washout Period (1 Hour)|Pain|1|||
129750730|NCT00934128|467046345|FG001|Washout Period (1 Hour)|Pain|0|||
129750731|NCT00934128|467046344|FG000|Washout Period (1 Hour)|Too tired|1|||
129750732|NCT00934128|467046345|FG001|Washout Period (1 Hour)|Too tired|0|||
129750733|NCT00934128|467046344|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
129750734|NCT00934128|467046345|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
129750735|NCT00934128|467046344|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
129750736|NCT00934128|467046345|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
129750737|NCT02834247|467046346|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
129750738|NCT02834247|467046347|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
129750739|NCT02834247|467046348|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
129750740|NCT02834247|467046349|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
129750741|NCT02834247|467046346|FG000|Dose Escalation Phase|Death|5|||
129750742|NCT02834247|467046347|FG001|Dose Escalation Phase|Death|6|||
129750743|NCT02834247|467046348|FG002|Dose Escalation Phase|Death|5|||
129750744|NCT02834247|467046349|FG003|Dose Escalation Phase|Death|0|||
129750745|NCT02834247|467046346|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
129750746|NCT02834247|467046347|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
129750747|NCT02834247|467046348|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
129750748|NCT02834247|467046349|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
129750749|NCT02834247|467046346|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
129750750|NCT02834247|467046347|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
129750751|NCT02834247|467046348|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129750752|NCT02834247|467046349|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129750753|NCT02834247|467046346|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
129750754|NCT02834247|467046347|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
129750755|NCT02834247|467046348|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
129750756|NCT02834247|467046349|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
129750757|NCT02834247|467046346|FG000|Dose Expansion Phase|Death|0|||
129750758|NCT02834247|467046347|FG001|Dose Expansion Phase|Death|0|||
129750759|NCT02834247|467046348|FG002|Dose Expansion Phase|Death|0|||
129750760|NCT02834247|467046349|FG003|Dose Expansion Phase|Death|8|||
129750761|NCT02834247|467046346|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
129750762|NCT02834247|467046347|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
129750763|NCT02834247|467046348|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
129750764|NCT02834247|467046349|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
129750765|NCT02834247|467046346|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
129750766|NCT02834247|467046347|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
129750767|NCT02834247|467046348|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
129750768|NCT02834247|467046349|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
129750769|NCT01946152|467047922|FG000|Overall Study|Adverse Event|1|||
129750770|NCT01946152|467047923|FG001|Overall Study|Adverse Event|0|||
129750771|NCT01946152|467047924|FG002|Overall Study|Adverse Event|0|||
129750772|NCT01946152|467047925|FG003|Overall Study|Adverse Event|0|||
129809593|NCT01086033|467269344|FG000|Overall Study|AE and Other Reason|1|||
129809594|NCT01086033|467269344|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
129809595|NCT04572633|467269345|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
129809596|NCT02924571|467269346|FG000|Overall Study|Lost to Follow-up|1|||
129809597|NCT02924571|467269347|FG001|Overall Study|Lost to Follow-up|1|||
129809598|NCT02924571|467269348|FG002|Overall Study|Lost to Follow-up|0|||
129809599|NCT00434954|467269352|FG000|Overall Study|Adverse Event|17|||
129809600|NCT00434954|467269353|FG001|Overall Study|Adverse Event|2|||
129809601|NCT00434954|467269352|FG000|Overall Study|Entry criteria not met|14|||
129809602|NCT00434954|467269353|FG001|Overall Study|Entry criteria not met|16|||
129809603|NCT00434954|467269352|FG000|Overall Study|Lost to Follow-up|0|||
129809604|NCT00434954|467269353|FG001|Overall Study|Lost to Follow-up|1|||
129750773|NCT01946152|467047922|FG000|Overall Study|Withdrawal by Subject|0|||
129750774|NCT01946152|467047923|FG001|Overall Study|Withdrawal by Subject|2|||
129750775|NCT01946152|467047924|FG002|Overall Study|Withdrawal by Subject|0|||
129750776|NCT01946152|467047925|FG003|Overall Study|Withdrawal by Subject|0|||
129750777|NCT01946152|467047922|FG000|Overall Study|Progression|0|||
129750778|NCT01946152|467047923|FG001|Overall Study|Progression|1|||
129809605|NCT00434954|467269352|FG000|Overall Study|Physician Decision|6|||
129809606|NCT00434954|467269353|FG001|Overall Study|Physician Decision|3|||
129809607|NCT00434954|467269352|FG000|Overall Study|Protocol Violation|36|||
129809608|NCT00434954|467269353|FG001|Overall Study|Protocol Violation|27|||
129809609|NCT00434954|467269352|FG000|Overall Study|Sponsor decision|1|||
129809610|NCT00434954|467269353|FG001|Overall Study|Sponsor decision|0|||
129809611|NCT00434954|467269352|FG000|Overall Study|Subject decision|8|||
129750779|NCT01946152|467047924|FG002|Overall Study|Progression|4|||
129809612|NCT00434954|467269353|FG001|Overall Study|Subject decision|22|||
129809613|NCT00894166|467269354|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
129809614|NCT00894166|467269355|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
129809615|NCT00894166|467269356|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
129750780|NCT01946152|467047925|FG003|Overall Study|Progression|7|||
129750781|NCT01946152|467047922|FG000|Overall Study|Physician Decision|0|||
129750782|NCT01946152|467047923|FG001|Overall Study|Physician Decision|0|||
129750783|NCT01946152|467047924|FG002|Overall Study|Physician Decision|1|||
129750784|NCT01946152|467047925|FG003|Overall Study|Physician Decision|0|||
129750785|NCT01946152|467047922|FG000|Overall Study|Second malignancy|0|||
129750786|NCT01946152|467047923|FG001|Overall Study|Second malignancy|0|||
129750787|NCT01946152|467047924|FG002|Overall Study|Second malignancy|1|||
129750788|NCT01946152|467047925|FG003|Overall Study|Second malignancy|0|||
129750789|NCT01946152|467047922|FG000|Overall Study|Adverse Event|0|||
129750790|NCT01946152|467047923|FG001|Overall Study|Adverse Event|0|||
129750791|NCT01946152|467047924|FG002|Overall Study|Adverse Event|0|||
129750792|NCT01946152|467047925|FG003|Overall Study|Adverse Event|1|||
129750793|NCT00799266|467047932|FG000|Overall Study|Adverse Event|0|||
129750794|NCT00799266|467047933|FG001|Overall Study|Adverse Event|1|||
129750795|NCT00799266|467047932|FG000|Overall Study|Subject withdrew consent|3|||
129750796|NCT00799266|467047933|FG001|Overall Study|Subject withdrew consent|0|||
129750797|NCT01061359|467047935|FG000|Overall Study|Death|32|||
129750798|NCT01061359|467047935|FG000|Overall Study|Lost to Follow-up|1072|||
129750799|NCT01061359|467047935|FG000|Overall Study|Relapse|187|||
129750800|NCT01061359|467047935|FG000|Overall Study|Secondary neoplasm|11|||
129750801|NCT04273893|467047942|FG000|Overall Study|Withdrawal by Subject|0|||
129750802|NCT04273893|467047943|FG001|Overall Study|Withdrawal by Subject|2|||
129750803|NCT04273893|467047942|FG000|Overall Study|Treatment of Disease Progression|0|||
129750804|NCT04273893|467047943|FG001|Overall Study|Treatment of Disease Progression|2|||
129750805|NCT04273893|467047942|FG000|Overall Study|Death|1|||
129750806|NCT04273893|467047943|FG001|Overall Study|Death|2|||
129750807|NCT04273893|467047942|FG000|Overall Study|Lost to Follow-up|0|||
129750808|NCT04273893|467047943|FG001|Overall Study|Lost to Follow-up|2|||
129750809|NCT04273893|467047942|FG000|Overall Study|Physician Decision|1|||
129750810|NCT04273893|467047943|FG001|Overall Study|Physician Decision|0|||
129750811|NCT01036321|467047945|FG000|Overall Study|Ineligible after randomization|0|||
129750812|NCT01036321|467047946|FG001|Overall Study|Ineligible after randomization|1|||
129750813|NCT01036321|467047945|FG000|Overall Study|Withdrawal by Subject|3|||
129750814|NCT01036321|467047946|FG001|Overall Study|Withdrawal by Subject|2|||
129750815|NCT01036321|467047945|FG000|Overall Study|Adverse Event|2|||
129750816|NCT01036321|467047946|FG001|Overall Study|Adverse Event|1|||
129750817|NCT00381693|467047949|FG000|Overall Study|Death|1|||
129750818|NCT00381693|467047949|FG000|Overall Study|Adverse Event|4|||
129750819|NCT00381693|467047949|FG000|Overall Study|Patient Choice|1|||
129750820|NCT00381693|467047949|FG000|Overall Study|Progression|2|||
129750821|NCT02598297|467047950|FG000|Overall Study|Study terminated by Sponsor|21|||
129750822|NCT02598297|467047951|FG001|Overall Study|Study terminated by Sponsor|23|||
129750823|NCT02598297|467047950|FG000|Overall Study|Adverse Event|1|||
129750824|NCT02598297|467047951|FG001|Overall Study|Adverse Event|1|||
129750825|NCT02598297|467047950|FG000|Overall Study|Physician Decision|1|||
129750826|NCT02598297|467047951|FG001|Overall Study|Physician Decision|0|||
129750827|NCT02598297|467047950|FG000|Overall Study|Subject/guardian decision|1|||
129750828|NCT02598297|467047951|FG001|Overall Study|Subject/guardian decision|0|||
129750829|NCT02598297|467047950|FG000|Overall Study|Followed for survival|1|||
129750830|NCT02598297|467047951|FG001|Overall Study|Followed for survival|0|||
129750831|NCT00394706|467047962|FG000|Overall Study|Withdrawal by Subject|2|||
129750832|NCT00394706|467047963|FG001|Overall Study|Withdrawal by Subject|0|||
129750833|NCT00394706|467047964|FG002|Overall Study|Withdrawal by Subject|1|||
129750834|NCT00394706|467047965|FG003|Overall Study|Withdrawal by Subject|0|||
129750835|NCT00394706|467047966|FG004|Overall Study|Withdrawal by Subject|0|||
129750836|NCT00394706|467047967|FG005|Overall Study|Withdrawal by Subject|2|||
129750837|NCT00394706|467047968|FG006|Overall Study|Withdrawal by Subject|1|||
129809616|NCT00894166|467269357|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
129809617|NCT00894166|467269358|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
129809618|NCT00894166|467269359|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
129809619|NCT00894166|467269360|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
129809620|NCT00894166|467269361|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
129809621|NCT00894166|467269354|FG000|Overall Study|Death|0|||
129750838|NCT00394706|467047969|FG007|Overall Study|Withdrawal by Subject|0|||
129750839|NCT00394706|467047962|FG000|Overall Study|Lost to Follow-up|2|||
129750840|NCT00394706|467047963|FG001|Overall Study|Lost to Follow-up|2|||
129809622|NCT00894166|467269355|FG001|Overall Study|Death|0|||
129809623|NCT00894166|467269356|FG002|Overall Study|Death|0|||
129750841|NCT00394706|467047964|FG002|Overall Study|Lost to Follow-up|8|||
129750842|NCT00394706|467047965|FG003|Overall Study|Lost to Follow-up|1|||
129750843|NCT00394706|467047966|FG004|Overall Study|Lost to Follow-up|2|||
129750844|NCT00394706|467047967|FG005|Overall Study|Lost to Follow-up|5|||
129750845|NCT00394706|467047968|FG006|Overall Study|Lost to Follow-up|2|||
129750846|NCT00394706|467047969|FG007|Overall Study|Lost to Follow-up|0|||
129750847|NCT02003534|467047973|FG000|Overall Study|Lost to Follow-up|47|||
129750848|NCT02506192|467047976|FG000|Overall Study|Withdrawal by Subject|1|||
129750849|NCT02506192|467047977|FG001|Overall Study|Withdrawal by Subject|1|||
129750850|NCT05292131|467047980|FG000|Overall Study|Lost to Follow-up|1|||
129750851|NCT05292131|467047981|FG001|Overall Study|Lost to Follow-up|1|||
129750852|NCT05292131|467047980|FG000|Overall Study|Withdrawal by Subject|0|||
129809624|NCT00894166|467269357|FG003|Overall Study|Death|1|||
129809625|NCT00894166|467269358|FG004|Overall Study|Death|0|||
129809626|NCT00894166|467269359|FG005|Overall Study|Death|0|||
129809627|NCT00894166|467269360|FG006|Overall Study|Death|0|||
129809628|NCT00894166|467269361|FG007|Overall Study|Death|0|||
129809629|NCT03750955|467269369|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
129809630|NCT03750955|467269370|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
129809631|NCT03750955|467269369|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
129750853|NCT05292131|467047981|FG001|Overall Study|Withdrawal by Subject|1|||
129750854|NCT06136897|467047982|FG000|Overall Study|Ineligible|3|||
129750855|NCT06136897|467047982|FG000|Overall Study|Mutation status not confirmed|7|||
129750856|NCT06136897|467047982|FG000|Overall Study|Adverse Event|2|||
129750857|NCT06136897|467047982|FG000|Overall Study|Death|1|||
129750858|NCT06136897|467047982|FG000|Overall Study|Disease progression|18|||
129750859|NCT06136897|467047982|FG000|Overall Study|Other complicating disease|1|||
129750860|NCT06136897|467047982|FG000|Overall Study|Withdrawal by Subject|1|||
129750861|NCT06136897|467047982|FG000|Overall Study|Still on treatment|1|||
129750862|NCT06136897|467047982|FG000|Overall Study|Lost to Follow-up|1|||
129750863|NCT03785405|467047983|FG000|Overall Study|Adverse Event|16|||
129750864|NCT03785405|467047984|FG001|Overall Study|Adverse Event|1|||
129750865|NCT03785405|467047983|FG000|Overall Study|Death|6|||
129750866|NCT03785405|467047984|FG001|Overall Study|Death|4|||
129750867|NCT03785405|467047983|FG000|Overall Study|Guardian decision|4|||
129750868|NCT03785405|467047984|FG001|Overall Study|Guardian decision|1|||
129750869|NCT03785405|467047983|FG000|Overall Study|Lost to Follow-up|1|||
129750870|NCT03785405|467047984|FG001|Overall Study|Lost to Follow-up|0|||
129750871|NCT03785405|467047983|FG000|Overall Study|Physician Decision|8|||
129750872|NCT03785405|467047984|FG001|Overall Study|Physician Decision|5|||
129750873|NCT03785405|467047983|FG000|Overall Study|Participant decision|2|||
129750874|NCT03785405|467047984|FG001|Overall Study|Participant decision|0|||
129750875|NCT03785405|467047983|FG000|Overall Study|Other|1|||
129750876|NCT03785405|467047984|FG001|Overall Study|Other|0|||
129750877|NCT03785405|467047983|FG000|Overall Study|No treatment was received|0|||
129750878|NCT03785405|467047984|FG001|Overall Study|No treatment was received|1|||
129750879|NCT03705559|467047985|FG000|Overall Study|COVID Shut down|1|||
129750880|NCT02881762|467047988|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
129750881|NCT02881762|467047989|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129750882|NCT00203424|467047993|FG000|Treatment Period|Withdrawal by Subject|4|||
129750883|NCT00203424|467047993|FG000|Treatment Period|Adverse Event|5|||
129750884|NCT00203424|467047993|FG000|Treatment Period|progressive disease|2|||
129750885|NCT00203424|467047993|FG000|Follow-up Period|Withdrawal by Subject|1|||
129750886|NCT00203424|467047993|FG000|Follow-up Period|progressive disease|4|||
129750887|NCT00203424|467047993|FG000|Follow-up Period|Lost to Follow-up|1|||
129750888|NCT01053988|467047994|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
129750889|NCT01053988|467047995|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129750890|NCT01053988|467047996|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129809632|NCT03750955|467269370|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
129809633|NCT01180985|467269373|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
129809634|NCT01180985|467269374|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
129809635|NCT00129272|467269379|FG000|Overall Study|Lost to Follow-up|12|||
129809636|NCT00129272|467269380|FG001|Overall Study|Lost to Follow-up|11|||
129809637|NCT00129272|467269379|FG000|Overall Study|Withdrawal by Subject|5|||
129809638|NCT00129272|467269380|FG001|Overall Study|Withdrawal by Subject|11|||
129809639|NCT03345914|467269381|FG000|Overall Study|Transition to another study at week 16|80|||
129809640|NCT03345914|467269382|FG001|Overall Study|Transition to another study at week 16|86|||
129750891|NCT01053988|467047997|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129750892|NCT01053988|467047998|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129750893|NCT01053988|467047999|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
129750894|NCT01053988|467047994|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
129750895|NCT01053988|467047995|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129750896|NCT01053988|467047996|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129750897|NCT01053988|467047997|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129750898|NCT01053988|467047998|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129750899|NCT01053988|467047999|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
129750900|NCT01053988|467047994|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
129750901|NCT01053988|467047995|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129750902|NCT01053988|467047996|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129750903|NCT01053988|467047997|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129750904|NCT01053988|467047998|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129750905|NCT01053988|467047999|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
129750906|NCT01053988|467047994|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
129750907|NCT01053988|467047995|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
129750908|NCT01053988|467047996|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
129750909|NCT01053988|467047997|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
129750910|NCT01053988|467047998|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
129750911|NCT01053988|467047999|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
129750912|NCT01053988|467047994|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
129750913|NCT01053988|467047995|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
129750914|NCT01053988|467047996|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
129750915|NCT01053988|467047997|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
129750916|NCT01053988|467047998|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
129750917|NCT01053988|467047999|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
129750918|NCT01053988|467047994|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
129750919|NCT01053988|467047995|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129750920|NCT01053988|467047996|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129750921|NCT01053988|467047997|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129750922|NCT01053988|467047998|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129750923|NCT01053988|467047999|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
129750924|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
129750925|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
129750926|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
129750927|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
129750928|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
129750929|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
129750930|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129750931|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
129750932|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
129750933|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
129750934|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
129750935|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
129750936|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
129750937|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
129750938|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
129750939|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
129750940|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
129750941|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
129750942|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129750943|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
129750944|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129750945|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
129750946|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
129750947|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
129750948|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129750949|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
129750950|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
129750951|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
129750952|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
129750953|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
129750954|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129750955|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
129750956|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129750957|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129750958|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129750959|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
129750960|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129750961|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
129750962|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
129750963|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
129750964|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
129750965|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
129750966|NCT01053988|467047994|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129750967|NCT01053988|467047995|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
129750968|NCT01053988|467047996|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129750969|NCT01053988|467047997|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
129750970|NCT01053988|467047998|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
129750971|NCT01053988|467047999|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129750972|NCT01922271|467048000|FG000|WASHOUT Period|Withdrawal by Subject|1|||
129750973|NCT01922271|467048001|FG001|WASHOUT Period|Withdrawal by Subject|0|||
129750974|NCT01824355|467048002|FG000|Overall Study|Adverse Event|2|||
129750975|NCT01824355|467048002|FG000|Overall Study|unevaluable reference method results per|1|||
129750976|NCT02576795|467048004|FG000|Overall Study|Lost to Follow-up|0|||
129750977|NCT02576795|467048005|FG001|Overall Study|Lost to Follow-up|0|||
129750978|NCT02576795|467048006|FG002|Overall Study|Lost to Follow-up|1|||
129750979|NCT02576795|467048007|FG003|Overall Study|Lost to Follow-up|0|||
129750980|NCT04427072|467048009|FG000|Randomized Treatment Phase|Progressive disease|9|||
129750981|NCT04427072|467048010|FG001|Randomized Treatment Phase|Progressive disease|4|||
129750982|NCT04427072|467048009|FG000|Randomized Treatment Phase|Adverse Event|3|||
129750983|NCT04427072|467048010|FG001|Randomized Treatment Phase|Adverse Event|1|||
129750984|NCT04427072|467048009|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
129750985|NCT04427072|467048010|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
129750986|NCT04427072|467048009|FG000|Randomized Treatment Phase|Death|0|||
129750987|NCT04427072|467048010|FG001|Randomized Treatment Phase|Death|1|||
129750988|NCT04427072|467048009|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
129750989|NCT04427072|467048010|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
129750990|NCT04427072|467048009|FG000|Extension Treatment Phase|Progressive disease|0|||
129750991|NCT04427072|467048010|FG001|Extension Treatment Phase|Progressive disease|5|||
129750992|NCT05232864|467048011|FG000|Overall Study|Adverse Event|0|||
129750993|NCT05232864|467048012|FG001|Overall Study|Adverse Event|1|||
129750994|NCT05232864|467048011|FG000|Overall Study|Study terminated by sponsor|16|||
129750995|NCT05232864|467048012|FG001|Overall Study|Study terminated by sponsor|14|||
129750996|NCT00465452|467048019|FG000|Overall Study|Adverse Event|1|||
129750997|NCT02104947|467048025|FG000|Overall Study|Withdrawal by Subject|10|||
129750998|NCT02104947|467048026|FG001|Overall Study|Withdrawal by Subject|3|||
129750999|NCT02104947|467048025|FG000|Overall Study|Lost to Follow-up|4|||
129751000|NCT02104947|467048026|FG001|Overall Study|Lost to Follow-up|4|||
129751001|NCT02104947|467048025|FG000|Overall Study|Protocol Violation|6|||
129751002|NCT02104947|467048026|FG001|Overall Study|Protocol Violation|8|||
129751003|NCT02104947|467048025|FG000|Overall Study|Adverse Event|57|||
129751004|NCT02104947|467048026|FG001|Overall Study|Adverse Event|38|||
129751005|NCT02104947|467048025|FG000|Overall Study|Other than stated above|2|||
129751006|NCT02104947|467048026|FG001|Overall Study|Other than stated above|3|||
129751007|NCT00145574|467048027|FG000|Double Blind|Adverse Event|0|||
129751008|NCT00145574|467048028|FG001|Double Blind|Adverse Event|3|||
129751009|NCT00145574|467048029|FG002|Double Blind|Adverse Event|1|||
129751010|NCT00145574|467048027|FG000|Double Blind|Withdrawal by Subject|1|||
129751011|NCT00145574|467048028|FG001|Double Blind|Withdrawal by Subject|1|||
129751012|NCT00145574|467048029|FG002|Double Blind|Withdrawal by Subject|1|||
129751013|NCT00145574|467048027|FG000|Double Blind|required restricted medicine|0|||
129751014|NCT00145574|467048028|FG001|Double Blind|required restricted medicine|1|||
129751015|NCT00145574|467048029|FG002|Double Blind|required restricted medicine|0|||
129751016|NCT00145574|467048027|FG000|Open Label Long-term Extension|Adverse Event|0|||
129751017|NCT00145574|467048028|FG001|Open Label Long-term Extension|Adverse Event|0|||
129751018|NCT00145574|467048029|FG002|Open Label Long-term Extension|Adverse Event|5|||
129751019|NCT00145574|467048027|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
129751020|NCT00145574|467048028|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
129751021|NCT00145574|467048029|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
129751022|NCT00145574|467048027|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
129751023|NCT00145574|467048028|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
129751024|NCT00145574|467048029|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
129896522|NCT01474538|467582084|FG000|Treatment Period 2|Physician Decision|0|||
129751025|NCT00145574|467048027|FG000|Open Label Long-term Extension|required restricted medicine|0|||
129751026|NCT00145574|467048028|FG001|Open Label Long-term Extension|required restricted medicine|0|||
129751027|NCT00145574|467048029|FG002|Open Label Long-term Extension|required restricted medicine|1|||
129751028|NCT00858637|467048033|FG000|Active Comparison Phase|Adverse Event|14|||
129751029|NCT00858637|467048034|FG001|Active Comparison Phase|Adverse Event|0|||
129751030|NCT00858637|467048035|FG002|Active Comparison Phase|Adverse Event|0|||
129751031|NCT00858637|467048036|FG003|Active Comparison Phase|Adverse Event|9|||
129751032|NCT00858637|467048037|FG004|Active Comparison Phase|Adverse Event|0|||
129751033|NCT00858637|467048038|FG005|Active Comparison Phase|Adverse Event|0|||
129751034|NCT00858637|467048033|FG000|Active Comparison Phase|Death|1|||
129751035|NCT00858637|467048034|FG001|Active Comparison Phase|Death|0|||
129751036|NCT00858637|467048035|FG002|Active Comparison Phase|Death|0|||
129751037|NCT00858637|467048036|FG003|Active Comparison Phase|Death|1|||
129751038|NCT00858637|467048037|FG004|Active Comparison Phase|Death|0|||
129751039|NCT00858637|467048038|FG005|Active Comparison Phase|Death|0|||
129751040|NCT00858637|467048033|FG000|Active Comparison Phase|Physician Decision|1|||
129751041|NCT00858637|467048034|FG001|Active Comparison Phase|Physician Decision|0|||
129751042|NCT00858637|467048035|FG002|Active Comparison Phase|Physician Decision|0|||
129751043|NCT00858637|467048036|FG003|Active Comparison Phase|Physician Decision|1|||
129751044|NCT00858637|467048037|FG004|Active Comparison Phase|Physician Decision|0|||
129751045|NCT00858637|467048038|FG005|Active Comparison Phase|Physician Decision|0|||
129751046|NCT00858637|467048033|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
129751047|NCT00858637|467048034|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
129751048|NCT00858637|467048035|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
129751049|NCT00858637|467048036|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
129751050|NCT00858637|467048037|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
129751051|NCT00858637|467048038|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
129751052|NCT00858637|467048033|FG000|Active Comparison Phase|Other Reasons|1|||
129751053|NCT00858637|467048034|FG001|Active Comparison Phase|Other Reasons|0|||
129751054|NCT00858637|467048035|FG002|Active Comparison Phase|Other Reasons|0|||
129751055|NCT00858637|467048036|FG003|Active Comparison Phase|Other Reasons|1|||
129751056|NCT00858637|467048037|FG004|Active Comparison Phase|Other Reasons|0|||
129751057|NCT00858637|467048038|FG005|Active Comparison Phase|Other Reasons|0|||
129751058|NCT00858637|467048033|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
129751059|NCT00858637|467048034|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
129751060|NCT00858637|467048035|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
129751061|NCT00858637|467048036|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
129751062|NCT00858637|467048037|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
129751063|NCT00858637|467048038|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
129751064|NCT00858637|467048033|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129751065|NCT00858637|467048034|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129751066|NCT00858637|467048035|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129751067|NCT00858637|467048036|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129751068|NCT00858637|467048037|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
129751069|NCT00858637|467048038|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
129751070|NCT04677504|467048042|FG000|Overall Study|Death|51|||
129751071|NCT04677504|467048043|FG001|Overall Study|Death|49|||
129751072|NCT04677504|467048042|FG000|Overall Study|Progressive Disease|1|||
129751073|NCT04677504|467048043|FG001|Overall Study|Progressive Disease|0|||
129751074|NCT04677504|467048042|FG000|Overall Study|Symptomatic Deterioration|1|||
129751075|NCT04677504|467048043|FG001|Overall Study|Symptomatic Deterioration|0|||
129751076|NCT04677504|467048042|FG000|Overall Study|Withdrawal by Subject|2|||
129751077|NCT04677504|467048043|FG001|Overall Study|Withdrawal by Subject|5|||
129751078|NCT04677504|467048042|FG000|Overall Study|Study Terminated By Sponsor|28|||
129751079|NCT04677504|467048043|FG001|Overall Study|Study Terminated By Sponsor|24|||
129751080|NCT04677504|467048042|FG000|Overall Study|Adverse Event|0|||
129751081|NCT04677504|467048043|FG001|Overall Study|Adverse Event|1|||
129751082|NCT03182907|467048044|FG000|Overall Study|Death|3|||
129751083|NCT03182907|467048045|FG001|Overall Study|Death|0|||
129751084|NCT03182907|467048044|FG000|Overall Study|Protocol Violation|4|||
129751085|NCT03182907|467048045|FG001|Overall Study|Protocol Violation|0|||
129751086|NCT03182907|467048044|FG000|Overall Study|Lost to Follow-up|1|||
129751087|NCT03182907|467048045|FG001|Overall Study|Lost to Follow-up|0|||
129751088|NCT03182907|467048044|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129751089|NCT03182907|467048045|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129751090|NCT04230213|467048055|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
129751091|NCT04230213|467048056|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
129751092|NCT04230213|467048057|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
129751093|NCT04230213|467048055|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
129751094|NCT04230213|467048056|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
129751095|NCT04230213|467048057|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
129751096|NCT04230213|467048055|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
129751097|NCT04230213|467048056|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
129751098|NCT04230213|467048057|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
129751099|NCT04230213|467048055|FG000|TP2: Week 10 to Week 16|Other|0|||
129751100|NCT04230213|467048056|FG001|TP2: Week 10 to Week 16|Other|2|||
129751101|NCT04230213|467048057|FG002|TP2: Week 10 to Week 16|Other|1|||
129751102|NCT04230213|467048055|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
129751103|NCT04230213|467048056|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
129751104|NCT04230213|467048057|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
129751105|NCT04230213|467048055|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
129751106|NCT04230213|467048056|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
129751107|NCT04230213|467048057|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
129751108|NCT04230213|467048055|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
129751109|NCT04230213|467048056|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
129751110|NCT04230213|467048057|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
129751111|NCT04230213|467048055|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
129751112|NCT04230213|467048056|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
129751113|NCT04230213|467048057|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
129751114|NCT04230213|467048055|FG000|TP3: Week 16 to Week 22|Other|0|||
129751115|NCT04230213|467048056|FG001|TP3: Week 16 to Week 22|Other|1|||
129751116|NCT04230213|467048057|FG002|TP3: Week 16 to Week 22|Other|3|||
129751117|NCT04230213|467048055|FG000|TP4: Week 22 to Week 32|Other|0|||
129751118|NCT04230213|467048056|FG001|TP4: Week 22 to Week 32|Other|5|||
129751119|NCT04230213|467048057|FG002|TP4: Week 22 to Week 32|Other|5|||
129751120|NCT04230213|467048055|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
129751121|NCT04230213|467048056|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
129751122|NCT04230213|467048057|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
129751123|NCT04230213|467048055|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
129751124|NCT04230213|467048056|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
129751125|NCT04230213|467048057|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
129751126|NCT04230213|467048055|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
129751127|NCT04230213|467048056|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
129751128|NCT04230213|467048057|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
129751129|NCT04230213|467048055|FG000|Follow up: Week 32 to Week 36|Other|0|||
129751130|NCT04230213|467048056|FG001|Follow up: Week 32 to Week 36|Other|1|||
129751131|NCT04230213|467048057|FG002|Follow up: Week 32 to Week 36|Other|1|||
129751132|NCT01957202|467049891|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751133|NCT01957202|467049892|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
129751134|NCT01957202|467049893|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751135|NCT01957202|467049894|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751136|NCT01957202|467049895|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751137|NCT01957202|467049896|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751138|NCT01957202|467049897|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751139|NCT01957202|467049898|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751140|NCT01957202|467049899|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751141|NCT01957202|467049900|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751142|NCT01957202|467049901|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751143|NCT01957202|467049902|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751144|NCT01957202|467049903|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751145|NCT01957202|467049904|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751146|NCT01957202|467049905|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751147|NCT01957202|467049906|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751148|NCT01957202|467049907|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
129751149|NCT01957202|467049908|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
129751150|NCT01957202|467049891|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751151|NCT01957202|467049892|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751152|NCT01957202|467049893|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751153|NCT01957202|467049894|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751154|NCT01957202|467049895|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751155|NCT01957202|467049896|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751156|NCT01957202|467049897|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751157|NCT01957202|467049898|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751158|NCT01957202|467049899|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751159|NCT01957202|467049900|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751160|NCT01957202|467049901|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751161|NCT01957202|467049902|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751162|NCT01957202|467049903|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751163|NCT01957202|467049904|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751164|NCT01957202|467049905|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751165|NCT01957202|467049906|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751166|NCT01957202|467049907|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
129809641|NCT03345914|467269383|FG002|Overall Study|Transition to another study at week 16|78|||
129809642|NCT03345914|467269381|FG000|Overall Study|Transition to OLE during follow-up|37|||
129751167|NCT01957202|467049908|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
129751168|NCT01456169|467049909|FG000|Overall Study|Adverse Event|1|||
129751169|NCT01456169|467049910|FG001|Overall Study|Adverse Event|2|||
129751170|NCT01456169|467049911|FG002|Overall Study|Adverse Event|7|||
129751171|NCT01456169|467049909|FG000|Overall Study|Major Protocol Deviation|3|||
129751172|NCT01456169|467049910|FG001|Overall Study|Major Protocol Deviation|2|||
129751173|NCT01456169|467049911|FG002|Overall Study|Major Protocol Deviation|3|||
129751174|NCT01456169|467049909|FG000|Overall Study|Voluntary Withdrawal|3|||
129751175|NCT01456169|467049910|FG001|Overall Study|Voluntary Withdrawal|0|||
129751176|NCT01456169|467049911|FG002|Overall Study|Voluntary Withdrawal|2|||
129751177|NCT01456169|467049909|FG000|Overall Study|Lack of Efficacy|2|||
129751178|NCT01456169|467049910|FG001|Overall Study|Lack of Efficacy|0|||
129751179|NCT01456169|467049911|FG002|Overall Study|Lack of Efficacy|0|||
129751180|NCT01456169|467049909|FG000|Overall Study|Other|1|||
129751181|NCT01456169|467049910|FG001|Overall Study|Other|1|||
129751182|NCT01456169|467049911|FG002|Overall Study|Other|0|||
129751183|NCT02342223|467049916|FG000|Overall Study|Lost to Follow-up|1|||
129751184|NCT01200368|467049921|FG000|Infant Series|Adverse Event|2|||
129751185|NCT01200368|467049922|FG001|Infant Series|Adverse Event|2|||
129751186|NCT01200368|467049923|FG002|Infant Series|Adverse Event|3|||
129751187|NCT01200368|467049921|FG000|Infant Series|Withdrawal by Subject|0|||
129751188|NCT01200368|467049922|FG001|Infant Series|Withdrawal by Subject|2|||
129751189|NCT01200368|467049923|FG002|Infant Series|Withdrawal by Subject|2|||
129751190|NCT01200368|467049921|FG000|Infant Series|Did not meet entrance criteria|0|||
129751191|NCT01200368|467049922|FG001|Infant Series|Did not meet entrance criteria|1|||
129751192|NCT01200368|467049923|FG002|Infant Series|Did not meet entrance criteria|0|||
129751193|NCT01200368|467049921|FG000|Infant Series|Randomized, not vaccinated|0|||
129751194|NCT01200368|467049922|FG001|Infant Series|Randomized, not vaccinated|1|||
129751195|NCT01200368|467049923|FG002|Infant Series|Randomized, not vaccinated|1|||
129751196|NCT01200368|467049921|FG000|Infant Series|Other|1|||
129751197|NCT01200368|467049922|FG001|Infant Series|Other|0|||
129751198|NCT01200368|467049923|FG002|Infant Series|Other|0|||
129751199|NCT01200368|467049921|FG000|After Infant Series|Adverse Event|6|||
129751200|NCT01200368|467049922|FG001|After Infant Series|Adverse Event|6|||
129751201|NCT01200368|467049923|FG002|After Infant Series|Adverse Event|3|||
129751202|NCT01200368|467049921|FG000|After Infant Series|Withdrawal by Subject|10|||
129751203|NCT01200368|467049922|FG001|After Infant Series|Withdrawal by Subject|8|||
129751204|NCT01200368|467049923|FG002|After Infant Series|Withdrawal by Subject|4|||
129751205|NCT01200368|467049921|FG000|After Infant Series|Lost to Follow-up|1|||
129751206|NCT01200368|467049922|FG001|After Infant Series|Lost to Follow-up|0|||
129751207|NCT01200368|467049923|FG002|After Infant Series|Lost to Follow-up|0|||
129751208|NCT01200368|467049921|FG000|After Infant Series|Other|1|||
129751209|NCT01200368|467049922|FG001|After Infant Series|Other|2|||
129751210|NCT01200368|467049923|FG002|After Infant Series|Other|2|||
129751211|NCT01200368|467049921|FG000|Toddler Dose|Adverse Event|0|||
129751212|NCT01200368|467049922|FG001|Toddler Dose|Adverse Event|3|||
129751213|NCT01200368|467049923|FG002|Toddler Dose|Adverse Event|1|||
129751214|NCT02221674|467049926|FG000|Overall Study|Lost to Follow-up|1|||
129751215|NCT02221674|467049927|FG001|Overall Study|Lost to Follow-up|0|||
129751216|NCT02221674|467049928|FG002|Overall Study|Lost to Follow-up|0|||
129751217|NCT02557542|467049930|FG000|Overall Study|Poor recruitment|3|||
129751218|NCT02557542|467049931|FG001|Overall Study|Poor recruitment|0|||
129751219|NCT04390880|467049932|FG000|Overall Study|Withdrawal by Subject|1|||
129751220|NCT03724890|467049936|FG000|Overall Study|Death|2|||
129751221|NCT03724890|467049937|FG001|Overall Study|Death|6|||
129751222|NCT03724890|467049938|FG002|Overall Study|Death|3|||
129751223|NCT03724890|467049939|FG003|Overall Study|Death|5|||
129751224|NCT03724890|467049940|FG004|Overall Study|Death|2|||
129751225|NCT03724890|467049941|FG005|Overall Study|Death|0|||
129751226|NCT03724890|467049942|FG006|Overall Study|Death|2|||
129751227|NCT03724890|467049943|FG007|Overall Study|Death|3|||
129751228|NCT03724890|467049944|FG008|Overall Study|Death|4|||
129751229|NCT03724890|467049945|FG009|Overall Study|Death|2|||
129751230|NCT03724890|467049946|FG010|Overall Study|Death|2|||
129751231|NCT03724890|467049936|FG000|Overall Study|Lost to Follow-up|0|||
129751232|NCT03724890|467049937|FG001|Overall Study|Lost to Follow-up|3|||
129751233|NCT03724890|467049938|FG002|Overall Study|Lost to Follow-up|0|||
129751234|NCT03724890|467049939|FG003|Overall Study|Lost to Follow-up|1|||
129751235|NCT03724890|467049940|FG004|Overall Study|Lost to Follow-up|2|||
129751236|NCT03724890|467049941|FG005|Overall Study|Lost to Follow-up|2|||
129751237|NCT03724890|467049942|FG006|Overall Study|Lost to Follow-up|1|||
129751238|NCT03724890|467049943|FG007|Overall Study|Lost to Follow-up|0|||
129751239|NCT03724890|467049944|FG008|Overall Study|Lost to Follow-up|2|||
129751240|NCT03724890|467049945|FG009|Overall Study|Lost to Follow-up|0|||
129751241|NCT03724890|467049946|FG010|Overall Study|Lost to Follow-up|0|||
129751242|NCT03724890|467049936|FG000|Overall Study|Withdrawal by Subject|1|||
129751243|NCT03724890|467049937|FG001|Overall Study|Withdrawal by Subject|2|||
129751244|NCT03724890|467049938|FG002|Overall Study|Withdrawal by Subject|1|||
129751245|NCT03724890|467049939|FG003|Overall Study|Withdrawal by Subject|0|||
129751246|NCT03724890|467049940|FG004|Overall Study|Withdrawal by Subject|0|||
129751247|NCT03724890|467049941|FG005|Overall Study|Withdrawal by Subject|1|||
129751248|NCT03724890|467049942|FG006|Overall Study|Withdrawal by Subject|0|||
129751249|NCT03724890|467049943|FG007|Overall Study|Withdrawal by Subject|0|||
129751250|NCT03724890|467049944|FG008|Overall Study|Withdrawal by Subject|2|||
129751251|NCT03724890|467049945|FG009|Overall Study|Withdrawal by Subject|2|||
129751252|NCT03724890|467049946|FG010|Overall Study|Withdrawal by Subject|1|||
129751253|NCT03724890|467049936|FG000|Overall Study|Other|1|||
129751254|NCT03724890|467049937|FG001|Overall Study|Other|0|||
129751255|NCT03724890|467049938|FG002|Overall Study|Other|0|||
129751256|NCT03724890|467049939|FG003|Overall Study|Other|0|||
129751257|NCT03724890|467049940|FG004|Overall Study|Other|0|||
129751258|NCT03724890|467049941|FG005|Overall Study|Other|0|||
129751259|NCT03724890|467049942|FG006|Overall Study|Other|0|||
129751260|NCT03724890|467049943|FG007|Overall Study|Other|1|||
129751261|NCT03724890|467049944|FG008|Overall Study|Other|1|||
129751262|NCT03724890|467049945|FG009|Overall Study|Other|0|||
129751263|NCT03724890|467049946|FG010|Overall Study|Other|2|||
129751264|NCT02123823|467049949|FG000|Overall Study|Lack of Efficacy|0|||
129751265|NCT02123823|467049950|FG001|Overall Study|Lack of Efficacy|2|||
129751266|NCT02123823|467049951|FG002|Overall Study|Lack of Efficacy|8|||
129751267|NCT02123823|467049952|FG003|Overall Study|Lack of Efficacy|10|||
129751268|NCT02123823|467049949|FG000|Overall Study|Progressive disease|3|||
129751269|NCT02123823|467049950|FG001|Overall Study|Progressive disease|19|||
129751270|NCT02123823|467049951|FG002|Overall Study|Progressive disease|52|||
129751271|NCT02123823|467049952|FG003|Overall Study|Progressive disease|53|||
129751272|NCT02123823|467049949|FG000|Overall Study|Withdrawal by Subject|0|||
129751273|NCT02123823|467049950|FG001|Overall Study|Withdrawal by Subject|0|||
129751274|NCT02123823|467049951|FG002|Overall Study|Withdrawal by Subject|7|||
129751275|NCT02123823|467049952|FG003|Overall Study|Withdrawal by Subject|2|||
129751276|NCT02123823|467049949|FG000|Overall Study|Adverse Event|0|||
129751277|NCT02123823|467049950|FG001|Overall Study|Adverse Event|0|||
129751278|NCT02123823|467049951|FG002|Overall Study|Adverse Event|3|||
129809643|NCT03345914|467269382|FG001|Overall Study|Transition to OLE during follow-up|33|||
129809644|NCT03345914|467269383|FG002|Overall Study|Transition to OLE during follow-up|39|||
129751279|NCT02123823|467049952|FG003|Overall Study|Adverse Event|5|||
129751280|NCT01635855|467049954|FG000|Overall Study|Withdrawal by Subject|4|||
129751281|NCT05870865|467049957|FG000|Randomized|Did not receive study treatment|2|||
129751282|NCT05870865|467049958|FG001|Randomized|Did not receive study treatment|4|||
129751283|NCT05870865|467049959|FG002|Randomized|Did not receive study treatment|4|||
129751284|NCT05870865|467049960|FG003|Randomized|Did not receive study treatment|3|||
129751285|NCT05870865|467049957|FG000|Treatment Period|Adverse Event|1|||
129751286|NCT05870865|467049958|FG001|Treatment Period|Adverse Event|1|||
129809645|NCT03345914|467269381|FG000|Overall Study|Physician Decision|0|||
129809646|NCT03345914|467269382|FG001|Overall Study|Physician Decision|1|||
129809647|NCT03345914|467269383|FG002|Overall Study|Physician Decision|1|||
129809648|NCT03345914|467269381|FG000|Overall Study|Withdrawal by Subject|5|||
129809649|NCT03345914|467269382|FG001|Overall Study|Withdrawal by Subject|1|||
129809650|NCT03345914|467269383|FG002|Overall Study|Withdrawal by Subject|2|||
129809651|NCT03345914|467269381|FG000|Overall Study|Other|1|||
129809652|NCT03345914|467269382|FG001|Overall Study|Other|1|||
129809653|NCT03345914|467269383|FG002|Overall Study|Other|1|||
129809654|NCT03345914|467269381|FG000|Overall Study|Ongoing|0|||
129809655|NCT03345914|467269382|FG001|Overall Study|Ongoing|0|||
129809656|NCT03345914|467269383|FG002|Overall Study|Ongoing|1|||
129809657|NCT00885846|467269389|FG000|Overall Study|Withdrawal by Subject|2|||
129896523|NCT01474538|467582085|FG001|Treatment Period 2|Physician Decision|1|||
129896524|NCT01474538|467582084|FG000|Treatment Period 2|Protocol Violation|1|||
129896525|NCT01474538|467582085|FG001|Treatment Period 2|Protocol Violation|0|||
129896526|NCT01456780|467582086|FG000|Overall Study|Lost to Follow-up|3|||
129896527|NCT01456780|467582087|FG001|Overall Study|Lost to Follow-up|3|||
129896528|NCT01456780|467582088|FG002|Overall Study|Lost to Follow-up|0|||
129896529|NCT03120676|467582091|FG000|Overall Study|Not treated|1|||
129896530|NCT00926393|467582092|FG000|Overall Study|Withdrawal by Subject|1|||
129896531|NCT00926393|467582093|FG001|Overall Study|Withdrawal by Subject|2|||
129896532|NCT00926393|467582092|FG000|Overall Study|Adverse Event|1|||
129896533|NCT00926393|467582093|FG001|Overall Study|Adverse Event|1|||
129896534|NCT02333630|467582094|FG000|Overall Study|Lost to Follow-up|5|||
129896535|NCT02333630|467582095|FG001|Overall Study|Lost to Follow-up|2|||
129896536|NCT00984282|467582096|FG000|Double Blind Treatment|Adverse Event|40|||
129896537|NCT00984282|467582097|FG001|Double Blind Treatment|Adverse Event|6|||
129896538|NCT00984282|467582096|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
129896539|NCT00984282|467582097|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
129751287|NCT05870865|467049959|FG002|Treatment Period|Adverse Event|1|||
129751288|NCT05870865|467049960|FG003|Treatment Period|Adverse Event|1|||
129751289|NCT05870865|467049957|FG000|Treatment Period|Lost to Follow-up|0|||
129751290|NCT05870865|467049958|FG001|Treatment Period|Lost to Follow-up|1|||
129751291|NCT05870865|467049959|FG002|Treatment Period|Lost to Follow-up|2|||
129751292|NCT05870865|467049960|FG003|Treatment Period|Lost to Follow-up|0|||
129751293|NCT05870865|467049957|FG000|Treatment Period|Protocol Violation|0|||
129751294|NCT05870865|467049958|FG001|Treatment Period|Protocol Violation|0|||
129809658|NCT00885846|467269390|FG001|Overall Study|Withdrawal by Subject|5|||
129896540|NCT00984282|467582096|FG000|Double Blind Treatment|Physician Decision|1|||
129896541|NCT00984282|467582097|FG001|Double Blind Treatment|Physician Decision|2|||
129896542|NCT00984282|467582096|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
129751295|NCT05870865|467049959|FG002|Treatment Period|Protocol Violation|0|||
129896543|NCT00984282|467582097|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
129751296|NCT05870865|467049960|FG003|Treatment Period|Protocol Violation|1|||
129809659|NCT00885846|467269391|FG002|Overall Study|Withdrawal by Subject|2|||
129809660|NCT01786668|467269393|FG000|Overall Study|Adverse Event|0|||
129751297|NCT05870865|467049957|FG000|Treatment Period|Withdrawal by Subject|0|||
129751298|NCT05870865|467049958|FG001|Treatment Period|Withdrawal by Subject|1|||
129751299|NCT05870865|467049959|FG002|Treatment Period|Withdrawal by Subject|1|||
129751300|NCT05870865|467049960|FG003|Treatment Period|Withdrawal by Subject|1|||
129751301|NCT03828019|467049964|FG000|Overall Study|Withdrawal by Subject|3|||
129751302|NCT03828019|467049965|FG001|Overall Study|Withdrawal by Subject|8|||
129751303|NCT03828019|467049964|FG000|Overall Study|Lost to Follow-up|1|||
129751304|NCT03828019|467049965|FG001|Overall Study|Lost to Follow-up|6|||
129751305|NCT03828019|467049964|FG000|Overall Study|Incarcerated|1|||
129751306|NCT03828019|467049965|FG001|Overall Study|Incarcerated|0|||
129751307|NCT03828019|467049964|FG000|Overall Study|Adverse Event|0|||
129751308|NCT03828019|467049965|FG001|Overall Study|Adverse Event|1|||
129751309|NCT03400176|467049966|FG000|Dose Escalation|Progressive disease|1|||
129751310|NCT03400176|467049967|FG001|Dose Escalation|Progressive disease|1|||
129751311|NCT03400176|467049968|FG002|Dose Escalation|Progressive disease|0|||
129751312|NCT03400176|467049969|FG003|Dose Escalation|Progressive disease|0|||
129751313|NCT03400176|467049970|FG004|Dose Escalation|Progressive disease|1|||
129751314|NCT03400176|467049966|FG000|Dose Escalation|Patient decision|0|||
129809661|NCT01786668|467269394|FG001|Overall Study|Adverse Event|1|||
129751315|NCT03400176|467049967|FG001|Dose Escalation|Patient decision|0|||
129751316|NCT03400176|467049968|FG002|Dose Escalation|Patient decision|0|||
129751317|NCT03400176|467049969|FG003|Dose Escalation|Patient decision|0|||
129751318|NCT03400176|467049970|FG004|Dose Escalation|Patient decision|1|||
129751319|NCT03400176|467049966|FG000|Dose Expansion|Patient decision|0|||
129751320|NCT03400176|467049967|FG001|Dose Expansion|Patient decision|0|||
129751321|NCT03400176|467049968|FG002|Dose Expansion|Patient decision|0|||
129751322|NCT03400176|467049969|FG003|Dose Expansion|Patient decision|1|||
129751323|NCT03400176|467049970|FG004|Dose Expansion|Patient decision|0|||
129751324|NCT03400176|467049966|FG000|Dose Expansion|Adverse Event|0|||
129751325|NCT03400176|467049967|FG001|Dose Expansion|Adverse Event|0|||
129751326|NCT03400176|467049968|FG002|Dose Expansion|Adverse Event|0|||
129751327|NCT03400176|467049969|FG003|Dose Expansion|Adverse Event|1|||
129751328|NCT03400176|467049970|FG004|Dose Expansion|Adverse Event|0|||
129751329|NCT03400176|467049966|FG000|Dose Expansion|Physician Decision|0|||
129751330|NCT03400176|467049967|FG001|Dose Expansion|Physician Decision|0|||
129751331|NCT03400176|467049968|FG002|Dose Expansion|Physician Decision|0|||
129751332|NCT03400176|467049969|FG003|Dose Expansion|Physician Decision|1|||
129751333|NCT03400176|467049970|FG004|Dose Expansion|Physician Decision|0|||
129751334|NCT03400176|467049966|FG000|Dose Expansion|Progressive disease|0|||
129751335|NCT03400176|467049967|FG001|Dose Expansion|Progressive disease|0|||
129751336|NCT03400176|467049968|FG002|Dose Expansion|Progressive disease|1|||
129751337|NCT03400176|467049969|FG003|Dose Expansion|Progressive disease|1|||
129751338|NCT03400176|467049970|FG004|Dose Expansion|Progressive disease|0|||
129751339|NCT00206440|467049971|FG000|Overall Study|Protocol Violation|1|||
129751340|NCT00206440|467049972|FG001|Overall Study|Protocol Violation|2|||
129751341|NCT00206440|467049971|FG000|Overall Study|Adverse Event|4|||
129751342|NCT00206440|467049972|FG001|Overall Study|Adverse Event|2|||
129751343|NCT01298765|467049973|FG000|Titration Period|Adverse Event|26|||
129751344|NCT01298765|467049973|FG000|Titration Period|Death|1|||
129751345|NCT01298765|467049973|FG000|Titration Period|Lack of Efficacy|21|||
129751346|NCT01298765|467049973|FG000|Titration Period|Lost to Follow-up|9|||
129751347|NCT01298765|467049973|FG000|Titration Period|Physician Decision|1|||
129751348|NCT01298765|467049973|FG000|Titration Period|Withdrawal by Subject|10|||
129751349|NCT01298765|467049973|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
129751350|NCT01298765|467049973|FG000|Long-Term Treatment Period|Adverse Event|19|||
129751351|NCT01298765|467049973|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
129751352|NCT01298765|467049973|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
129751353|NCT01298765|467049973|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
129751354|NCT01298765|467049973|FG000|Long-Term Treatment Period|Physician Decision|1|||
129751355|NCT01298765|467049973|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
129751356|NCT00766051|467049975|FG000|Overall Study|Withdrawal by Subject|2|||
129751357|NCT00766051|467049976|FG001|Overall Study|Withdrawal by Subject|0|||
129751358|NCT03302247|467049979|FG000|Overall Study|the study has closed prematurely|2|||
129751359|NCT03302247|467049979|FG000|Overall Study|Death|1|||
129751360|NCT04090242|467049980|FG000|Overall Study|Withdrawal by Subject|1|||
129751361|NCT04090242|467049981|FG001|Overall Study|Withdrawal by Subject|0|||
129751362|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
129751363|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
129751364|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
129751365|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Death|0|||
129751366|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Death|2|||
129751367|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Death|0|||
129751368|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
129751369|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
129751370|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
129751371|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
129751372|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
129751373|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
129751374|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
129751375|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
129751376|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
129751377|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
129751378|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
129751379|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
129751380|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
129751381|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
129751382|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
129751383|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Recovery|1|||
129751384|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Recovery|0|||
129751385|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Recovery|1|||
129751386|NCT00195663|467049982|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
129751387|NCT00195663|467049983|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
129751388|NCT00195663|467049984|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
129751389|NCT00195663|467049982|FG000|Open-Label Extension Period|Adverse Event|21|||
129751390|NCT00195663|467049983|FG001|Open-Label Extension Period|Adverse Event|32|||
129751391|NCT00195663|467049984|FG002|Open-Label Extension Period|Adverse Event|36|||
129751392|NCT00195663|467049982|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
129751393|NCT00195663|467049983|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
129751394|NCT00195663|467049984|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
129751395|NCT00195663|467049982|FG000|Open-Label Extension Period|Recovery|0|||
129751396|NCT00195663|467049983|FG001|Open-Label Extension Period|Recovery|2|||
129751397|NCT00195663|467049984|FG002|Open-Label Extension Period|Recovery|2|||
129751398|NCT00195663|467049982|FG000|Open-Label Extension Period|Protocol Violation|3|||
129751399|NCT00195663|467049983|FG001|Open-Label Extension Period|Protocol Violation|4|||
129751400|NCT00195663|467049984|FG002|Open-Label Extension Period|Protocol Violation|4|||
129751401|NCT00195663|467049982|FG000|Open-Label Extension Period|Death|2|||
129751402|NCT00195663|467049983|FG001|Open-Label Extension Period|Death|2|||
129751403|NCT00195663|467049984|FG002|Open-Label Extension Period|Death|2|||
129751404|NCT00195663|467049982|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
129751405|NCT00195663|467049983|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
129751406|NCT00195663|467049984|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
129751407|NCT00195663|467049982|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
129751408|NCT00195663|467049983|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
129751409|NCT00195663|467049984|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
129751410|NCT00195663|467049982|FG000|Open-Label Extension Period|Administrative reasons|11|||
129751411|NCT00195663|467049983|FG001|Open-Label Extension Period|Administrative reasons|11|||
129751412|NCT00195663|467049984|FG002|Open-Label Extension Period|Administrative reasons|13|||
129751413|NCT00604695|467049985|FG000|Overall Study|Did not receive first bolus.|0|||
129751414|NCT00604695|467049986|FG001|Overall Study|Did not receive first bolus.|4|||
129751415|NCT03214406|467049987|FG000|Overall Study|did not meet enrollment criteria|9|||
129751416|NCT03214406|467049988|FG001|Overall Study|did not meet enrollment criteria|13|||
129751417|NCT03214406|467049987|FG000|Overall Study|Withdrawal by Subject|1|||
129751418|NCT03214406|467049988|FG001|Overall Study|Withdrawal by Subject|0|||
129751419|NCT03214406|467049987|FG000|Overall Study|Lost to Follow-up|0|||
129751420|NCT03214406|467049988|FG001|Overall Study|Lost to Follow-up|2|||
129751421|NCT01098305|467049991|FG000|Overall Study|Lost to Follow-up|31|||
129751422|NCT01098305|467049992|FG001|Overall Study|Lost to Follow-up|33|||
129751423|NCT01180296|467049997|FG000|Overall Study|Protocol Violation|1|||
129751424|NCT01180296|467049998|FG001|Overall Study|Protocol Violation|2|||
129751425|NCT03364309|467050001|FG000|Induction Period|Adverse Event|4|||
129751426|NCT03364309|467050002|FG001|Induction Period|Adverse Event|0|||
129751427|NCT03364309|467050003|FG002|Induction Period|Adverse Event|1|||
129751428|NCT03364309|467050004|FG003|Induction Period|Adverse Event|0|||
129751429|NCT03364309|467050005|FG004|Induction Period|Adverse Event|0|||
129751430|NCT03364309|467050006|FG005|Induction Period|Adverse Event|0|||
129751431|NCT03364309|467050007|FG006|Induction Period|Adverse Event|0|||
129751432|NCT03364309|467050008|FG007|Induction Period|Adverse Event|0|||
129751433|NCT03364309|467050009|FG008|Induction Period|Adverse Event|0|||
129751434|NCT03364309|467050010|FG009|Induction Period|Adverse Event|0|||
129751435|NCT03364309|467050011|FG010|Induction Period|Adverse Event|0|||
129751436|NCT03364309|467050012|FG011|Induction Period|Adverse Event|0|||
129751437|NCT03364309|467050013|FG012|Induction Period|Adverse Event|0|||
129751438|NCT03364309|467050014|FG013|Induction Period|Adverse Event|0|||
129751439|NCT03364309|467050015|FG014|Induction Period|Adverse Event|0|||
129751440|NCT03364309|467050016|FG015|Induction Period|Adverse Event|0|||
129751441|NCT03364309|467050017|FG016|Induction Period|Adverse Event|0|||
129751442|NCT03364309|467050018|FG017|Induction Period|Adverse Event|0|||
129751443|NCT03364309|467050019|FG018|Induction Period|Adverse Event|0|||
129751444|NCT03364309|467050001|FG000|Induction Period|Withdrawal by Subject|1|||
129751445|NCT03364309|467050002|FG001|Induction Period|Withdrawal by Subject|3|||
129751446|NCT03364309|467050003|FG002|Induction Period|Withdrawal by Subject|0|||
129751447|NCT03364309|467050004|FG003|Induction Period|Withdrawal by Subject|0|||
129751448|NCT03364309|467050005|FG004|Induction Period|Withdrawal by Subject|0|||
129751449|NCT03364309|467050006|FG005|Induction Period|Withdrawal by Subject|0|||
129751450|NCT03364309|467050007|FG006|Induction Period|Withdrawal by Subject|0|||
129751451|NCT03364309|467050008|FG007|Induction Period|Withdrawal by Subject|0|||
129751452|NCT03364309|467050009|FG008|Induction Period|Withdrawal by Subject|0|||
129751453|NCT03364309|467050010|FG009|Induction Period|Withdrawal by Subject|0|||
129751454|NCT03364309|467050011|FG010|Induction Period|Withdrawal by Subject|0|||
129751455|NCT03364309|467050012|FG011|Induction Period|Withdrawal by Subject|0|||
129751456|NCT03364309|467050013|FG012|Induction Period|Withdrawal by Subject|0|||
129751457|NCT03364309|467050014|FG013|Induction Period|Withdrawal by Subject|0|||
129751458|NCT03364309|467050015|FG014|Induction Period|Withdrawal by Subject|0|||
129751459|NCT03364309|467050016|FG015|Induction Period|Withdrawal by Subject|0|||
129751460|NCT03364309|467050017|FG016|Induction Period|Withdrawal by Subject|0|||
129751461|NCT03364309|467050018|FG017|Induction Period|Withdrawal by Subject|0|||
129751462|NCT03364309|467050019|FG018|Induction Period|Withdrawal by Subject|0|||
129751463|NCT03364309|467050001|FG000|Induction Period|Lost to Follow-up|1|||
129751464|NCT03364309|467050002|FG001|Induction Period|Lost to Follow-up|0|||
129751465|NCT03364309|467050003|FG002|Induction Period|Lost to Follow-up|0|||
129751466|NCT03364309|467050004|FG003|Induction Period|Lost to Follow-up|0|||
129751467|NCT03364309|467050005|FG004|Induction Period|Lost to Follow-up|0|||
129751468|NCT03364309|467050006|FG005|Induction Period|Lost to Follow-up|0|||
129751469|NCT03364309|467050007|FG006|Induction Period|Lost to Follow-up|0|||
129751470|NCT03364309|467050008|FG007|Induction Period|Lost to Follow-up|0|||
129751471|NCT03364309|467050009|FG008|Induction Period|Lost to Follow-up|0|||
129751472|NCT03364309|467050010|FG009|Induction Period|Lost to Follow-up|0|||
129751473|NCT03364309|467050011|FG010|Induction Period|Lost to Follow-up|0|||
129751474|NCT03364309|467050012|FG011|Induction Period|Lost to Follow-up|0|||
129751475|NCT03364309|467050013|FG012|Induction Period|Lost to Follow-up|0|||
129751476|NCT03364309|467050014|FG013|Induction Period|Lost to Follow-up|0|||
129751477|NCT03364309|467050015|FG014|Induction Period|Lost to Follow-up|0|||
129751478|NCT03364309|467050016|FG015|Induction Period|Lost to Follow-up|0|||
129751479|NCT03364309|467050017|FG016|Induction Period|Lost to Follow-up|0|||
129751480|NCT03364309|467050018|FG017|Induction Period|Lost to Follow-up|0|||
129751481|NCT03364309|467050019|FG018|Induction Period|Lost to Follow-up|0|||
129751482|NCT03364309|467050001|FG000|Induction Period|Physician Decision|0|||
129751483|NCT03364309|467050002|FG001|Induction Period|Physician Decision|1|||
129751484|NCT03364309|467050003|FG002|Induction Period|Physician Decision|0|||
129751485|NCT03364309|467050004|FG003|Induction Period|Physician Decision|0|||
129751486|NCT03364309|467050005|FG004|Induction Period|Physician Decision|0|||
129751487|NCT03364309|467050006|FG005|Induction Period|Physician Decision|0|||
129751488|NCT03364309|467050007|FG006|Induction Period|Physician Decision|0|||
129751489|NCT03364309|467050008|FG007|Induction Period|Physician Decision|0|||
129751490|NCT03364309|467050009|FG008|Induction Period|Physician Decision|0|||
129751491|NCT03364309|467050010|FG009|Induction Period|Physician Decision|0|||
129751492|NCT03364309|467050011|FG010|Induction Period|Physician Decision|0|||
129751493|NCT03364309|467050012|FG011|Induction Period|Physician Decision|0|||
129751494|NCT03364309|467050013|FG012|Induction Period|Physician Decision|0|||
129751495|NCT03364309|467050014|FG013|Induction Period|Physician Decision|0|||
129751496|NCT03364309|467050015|FG014|Induction Period|Physician Decision|0|||
129751497|NCT03364309|467050016|FG015|Induction Period|Physician Decision|0|||
129751498|NCT03364309|467050017|FG016|Induction Period|Physician Decision|0|||
129751499|NCT03364309|467050018|FG017|Induction Period|Physician Decision|0|||
129751500|NCT03364309|467050019|FG018|Induction Period|Physician Decision|0|||
129751501|NCT03364309|467050001|FG000|Maintenance Period|Withdrawal by Subject|0|||
129751502|NCT03364309|467050002|FG001|Maintenance Period|Withdrawal by Subject|0|||
129751503|NCT03364309|467050003|FG002|Maintenance Period|Withdrawal by Subject|0|||
129809662|NCT01786668|467269395|FG002|Overall Study|Adverse Event|1|||
129809663|NCT01786668|467269396|FG003|Overall Study|Adverse Event|2|||
129751504|NCT03364309|467050004|FG003|Maintenance Period|Withdrawal by Subject|1|||
129751505|NCT03364309|467050005|FG004|Maintenance Period|Withdrawal by Subject|3|||
129751506|NCT03364309|467050006|FG005|Maintenance Period|Withdrawal by Subject|1|||
129751507|NCT03364309|467050007|FG006|Maintenance Period|Withdrawal by Subject|3|||
129751508|NCT03364309|467050008|FG007|Maintenance Period|Withdrawal by Subject|0|||
129751509|NCT03364309|467050009|FG008|Maintenance Period|Withdrawal by Subject|1|||
129751510|NCT03364309|467050010|FG009|Maintenance Period|Withdrawal by Subject|1|||
129751511|NCT03364309|467050011|FG010|Maintenance Period|Withdrawal by Subject|2|||
129751512|NCT03364309|467050012|FG011|Maintenance Period|Withdrawal by Subject|0|||
129751513|NCT03364309|467050013|FG012|Maintenance Period|Withdrawal by Subject|0|||
129751514|NCT03364309|467050014|FG013|Maintenance Period|Withdrawal by Subject|0|||
129751515|NCT03364309|467050015|FG014|Maintenance Period|Withdrawal by Subject|0|||
129751516|NCT03364309|467050016|FG015|Maintenance Period|Withdrawal by Subject|0|||
129751517|NCT03364309|467050017|FG016|Maintenance Period|Withdrawal by Subject|0|||
129751518|NCT03364309|467050018|FG017|Maintenance Period|Withdrawal by Subject|0|||
129751519|NCT03364309|467050019|FG018|Maintenance Period|Withdrawal by Subject|0|||
129751520|NCT03364309|467050001|FG000|Maintenance Period|Adverse Event|0|||
129751521|NCT03364309|467050002|FG001|Maintenance Period|Adverse Event|0|||
129751522|NCT03364309|467050003|FG002|Maintenance Period|Adverse Event|0|||
129751523|NCT03364309|467050004|FG003|Maintenance Period|Adverse Event|0|||
129751524|NCT03364309|467050005|FG004|Maintenance Period|Adverse Event|2|||
129751525|NCT03364309|467050006|FG005|Maintenance Period|Adverse Event|0|||
129751526|NCT03364309|467050007|FG006|Maintenance Period|Adverse Event|3|||
129751527|NCT03364309|467050008|FG007|Maintenance Period|Adverse Event|0|||
129751528|NCT03364309|467050009|FG008|Maintenance Period|Adverse Event|1|||
129751529|NCT03364309|467050010|FG009|Maintenance Period|Adverse Event|0|||
129751530|NCT03364309|467050011|FG010|Maintenance Period|Adverse Event|2|||
129751531|NCT03364309|467050012|FG011|Maintenance Period|Adverse Event|0|||
129751532|NCT03364309|467050013|FG012|Maintenance Period|Adverse Event|0|||
129751533|NCT03364309|467050014|FG013|Maintenance Period|Adverse Event|0|||
129751534|NCT03364309|467050015|FG014|Maintenance Period|Adverse Event|0|||
129751535|NCT03364309|467050016|FG015|Maintenance Period|Adverse Event|0|||
129751536|NCT03364309|467050017|FG016|Maintenance Period|Adverse Event|0|||
129751537|NCT03364309|467050018|FG017|Maintenance Period|Adverse Event|0|||
129751538|NCT03364309|467050019|FG018|Maintenance Period|Adverse Event|0|||
129751539|NCT03364309|467050001|FG000|Maintenance Period|Relapsed|0|||
129751540|NCT03364309|467050002|FG001|Maintenance Period|Relapsed|0|||
129751541|NCT03364309|467050003|FG002|Maintenance Period|Relapsed|0|||
129751542|NCT03364309|467050004|FG003|Maintenance Period|Relapsed|43|||
129751543|NCT03364309|467050005|FG004|Maintenance Period|Relapsed|7|||
129751544|NCT03364309|467050006|FG005|Maintenance Period|Relapsed|45|||
129751545|NCT03364309|467050007|FG006|Maintenance Period|Relapsed|10|||
129751546|NCT03364309|467050008|FG007|Maintenance Period|Relapsed|2|||
129751547|NCT03364309|467050009|FG008|Maintenance Period|Relapsed|0|||
129751548|NCT03364309|467050010|FG009|Maintenance Period|Relapsed|0|||
129751549|NCT03364309|467050011|FG010|Maintenance Period|Relapsed|0|||
129751550|NCT03364309|467050012|FG011|Maintenance Period|Relapsed|0|||
129751551|NCT03364309|467050013|FG012|Maintenance Period|Relapsed|0|||
129751552|NCT03364309|467050014|FG013|Maintenance Period|Relapsed|0|||
129751553|NCT03364309|467050015|FG014|Maintenance Period|Relapsed|0|||
129751554|NCT03364309|467050016|FG015|Maintenance Period|Relapsed|0|||
129751555|NCT03364309|467050017|FG016|Maintenance Period|Relapsed|0|||
129751556|NCT03364309|467050018|FG017|Maintenance Period|Relapsed|0|||
129751557|NCT03364309|467050019|FG018|Maintenance Period|Relapsed|0|||
129751558|NCT03364309|467050001|FG000|Maintenance Period|Lack of Efficacy|0|||
129751559|NCT03364309|467050002|FG001|Maintenance Period|Lack of Efficacy|0|||
129751560|NCT03364309|467050003|FG002|Maintenance Period|Lack of Efficacy|0|||
129751561|NCT03364309|467050004|FG003|Maintenance Period|Lack of Efficacy|0|||
129751562|NCT03364309|467050005|FG004|Maintenance Period|Lack of Efficacy|0|||
129751563|NCT03364309|467050006|FG005|Maintenance Period|Lack of Efficacy|0|||
129751564|NCT03364309|467050007|FG006|Maintenance Period|Lack of Efficacy|0|||
129751565|NCT03364309|467050008|FG007|Maintenance Period|Lack of Efficacy|0|||
129751566|NCT03364309|467050009|FG008|Maintenance Period|Lack of Efficacy|1|||
129751567|NCT03364309|467050010|FG009|Maintenance Period|Lack of Efficacy|3|||
129751568|NCT03364309|467050011|FG010|Maintenance Period|Lack of Efficacy|2|||
129751569|NCT03364309|467050012|FG011|Maintenance Period|Lack of Efficacy|0|||
129751570|NCT03364309|467050013|FG012|Maintenance Period|Lack of Efficacy|0|||
129751571|NCT03364309|467050014|FG013|Maintenance Period|Lack of Efficacy|0|||
129751572|NCT03364309|467050015|FG014|Maintenance Period|Lack of Efficacy|0|||
129751573|NCT03364309|467050016|FG015|Maintenance Period|Lack of Efficacy|0|||
129751574|NCT03364309|467050017|FG016|Maintenance Period|Lack of Efficacy|0|||
129751575|NCT03364309|467050018|FG017|Maintenance Period|Lack of Efficacy|0|||
129751576|NCT03364309|467050019|FG018|Maintenance Period|Lack of Efficacy|0|||
129751577|NCT03364309|467050001|FG000|Maintenance Period|Death|0|||
129751578|NCT03364309|467050002|FG001|Maintenance Period|Death|0|||
129751579|NCT03364309|467050003|FG002|Maintenance Period|Death|0|||
129751580|NCT03364309|467050004|FG003|Maintenance Period|Death|0|||
129751581|NCT03364309|467050005|FG004|Maintenance Period|Death|0|||
129751582|NCT03364309|467050006|FG005|Maintenance Period|Death|0|||
129751583|NCT03364309|467050007|FG006|Maintenance Period|Death|0|||
129751584|NCT03364309|467050008|FG007|Maintenance Period|Death|0|||
129751585|NCT03364309|467050009|FG008|Maintenance Period|Death|1|||
129751586|NCT03364309|467050010|FG009|Maintenance Period|Death|0|||
129751587|NCT03364309|467050011|FG010|Maintenance Period|Death|0|||
129751588|NCT03364309|467050012|FG011|Maintenance Period|Death|0|||
129751589|NCT03364309|467050013|FG012|Maintenance Period|Death|0|||
129751590|NCT03364309|467050014|FG013|Maintenance Period|Death|0|||
129751591|NCT03364309|467050015|FG014|Maintenance Period|Death|0|||
129751592|NCT03364309|467050016|FG015|Maintenance Period|Death|0|||
129751593|NCT03364309|467050017|FG016|Maintenance Period|Death|0|||
129751594|NCT03364309|467050018|FG017|Maintenance Period|Death|0|||
129751595|NCT03364309|467050019|FG018|Maintenance Period|Death|0|||
129751596|NCT03364309|467050001|FG000|Maintenance Period|Lost to Follow-up|0|||
129751597|NCT03364309|467050002|FG001|Maintenance Period|Lost to Follow-up|0|||
129751598|NCT03364309|467050003|FG002|Maintenance Period|Lost to Follow-up|0|||
129751599|NCT03364309|467050004|FG003|Maintenance Period|Lost to Follow-up|0|||
129751600|NCT03364309|467050005|FG004|Maintenance Period|Lost to Follow-up|0|||
129751601|NCT03364309|467050006|FG005|Maintenance Period|Lost to Follow-up|0|||
129751602|NCT03364309|467050007|FG006|Maintenance Period|Lost to Follow-up|0|||
129751603|NCT03364309|467050008|FG007|Maintenance Period|Lost to Follow-up|0|||
129751604|NCT03364309|467050009|FG008|Maintenance Period|Lost to Follow-up|1|||
129751605|NCT03364309|467050010|FG009|Maintenance Period|Lost to Follow-up|0|||
129751606|NCT03364309|467050011|FG010|Maintenance Period|Lost to Follow-up|0|||
129751607|NCT03364309|467050012|FG011|Maintenance Period|Lost to Follow-up|0|||
129751608|NCT03364309|467050013|FG012|Maintenance Period|Lost to Follow-up|0|||
129751609|NCT03364309|467050014|FG013|Maintenance Period|Lost to Follow-up|0|||
129751610|NCT03364309|467050015|FG014|Maintenance Period|Lost to Follow-up|0|||
129751611|NCT03364309|467050016|FG015|Maintenance Period|Lost to Follow-up|0|||
129751612|NCT03364309|467050017|FG016|Maintenance Period|Lost to Follow-up|0|||
129751613|NCT03364309|467050018|FG017|Maintenance Period|Lost to Follow-up|0|||
129751614|NCT03364309|467050019|FG018|Maintenance Period|Lost to Follow-up|0|||
129751615|NCT03364309|467050001|FG000|Maintenance Period|Miscellaneous|0|||
129751616|NCT03364309|467050002|FG001|Maintenance Period|Miscellaneous|0|||
129751617|NCT03364309|467050003|FG002|Maintenance Period|Miscellaneous|0|||
129751618|NCT03364309|467050004|FG003|Maintenance Period|Miscellaneous|0|||
129751619|NCT03364309|467050005|FG004|Maintenance Period|Miscellaneous|0|||
129751620|NCT03364309|467050006|FG005|Maintenance Period|Miscellaneous|0|||
129751621|NCT03364309|467050007|FG006|Maintenance Period|Miscellaneous|0|||
129751622|NCT03364309|467050008|FG007|Maintenance Period|Miscellaneous|0|||
129751623|NCT03364309|467050009|FG008|Maintenance Period|Miscellaneous|1|||
129751624|NCT03364309|467050010|FG009|Maintenance Period|Miscellaneous|0|||
129751625|NCT03364309|467050011|FG010|Maintenance Period|Miscellaneous|0|||
129751626|NCT03364309|467050012|FG011|Maintenance Period|Miscellaneous|0|||
129751627|NCT03364309|467050013|FG012|Maintenance Period|Miscellaneous|0|||
129751628|NCT03364309|467050014|FG013|Maintenance Period|Miscellaneous|0|||
129751629|NCT03364309|467050015|FG014|Maintenance Period|Miscellaneous|0|||
129751630|NCT03364309|467050016|FG015|Maintenance Period|Miscellaneous|0|||
129751631|NCT03364309|467050017|FG016|Maintenance Period|Miscellaneous|0|||
129751632|NCT03364309|467050018|FG017|Maintenance Period|Miscellaneous|0|||
129751633|NCT03364309|467050019|FG018|Maintenance Period|Miscellaneous|0|||
129751634|NCT03364309|467050001|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751635|NCT03364309|467050002|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751636|NCT03364309|467050003|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751637|NCT03364309|467050004|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751638|NCT03364309|467050005|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751639|NCT03364309|467050006|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751640|NCT03364309|467050007|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751641|NCT03364309|467050008|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751642|NCT03364309|467050009|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751643|NCT03364309|467050010|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751644|NCT03364309|467050011|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751645|NCT03364309|467050012|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751646|NCT03364309|467050013|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751647|NCT03364309|467050014|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
129751648|NCT03364309|467050015|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
129751649|NCT03364309|467050016|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
129751650|NCT03364309|467050017|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751651|NCT03364309|467050018|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751652|NCT03364309|467050019|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
129751653|NCT03364309|467050001|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751654|NCT03364309|467050002|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751655|NCT03364309|467050003|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751656|NCT03364309|467050004|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751657|NCT03364309|467050005|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751658|NCT03364309|467050006|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751659|NCT03364309|467050007|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751660|NCT03364309|467050008|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751661|NCT03364309|467050009|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751662|NCT03364309|467050010|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751663|NCT03364309|467050011|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751664|NCT03364309|467050012|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751665|NCT03364309|467050013|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751666|NCT03364309|467050014|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751667|NCT03364309|467050015|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
129751668|NCT03364309|467050016|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751669|NCT03364309|467050017|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751670|NCT03364309|467050018|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751671|NCT03364309|467050019|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
129751672|NCT03364309|467050001|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
129751673|NCT03364309|467050002|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
129751674|NCT03364309|467050003|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
129751675|NCT03364309|467050004|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
129751676|NCT03364309|467050005|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
129751677|NCT03364309|467050006|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
129751678|NCT03364309|467050007|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
129751679|NCT03364309|467050008|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
129751680|NCT03364309|467050009|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
129751681|NCT03364309|467050010|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
129751682|NCT03364309|467050011|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
129751683|NCT03364309|467050012|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
129751684|NCT03364309|467050013|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
129751685|NCT03364309|467050014|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
129751686|NCT03364309|467050015|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
129751687|NCT03364309|467050016|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
129751688|NCT03364309|467050017|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
129751689|NCT03364309|467050018|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
129751690|NCT03364309|467050019|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
129751691|NCT03364309|467050001|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751692|NCT03364309|467050002|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751693|NCT03364309|467050003|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751694|NCT03364309|467050004|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751695|NCT03364309|467050005|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751696|NCT03364309|467050006|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751697|NCT03364309|467050007|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129809664|NCT01786668|467269393|FG000|Overall Study|Withdrawal by Subject|0|||
129809665|NCT01786668|467269394|FG001|Overall Study|Withdrawal by Subject|0|||
129809666|NCT01786668|467269395|FG002|Overall Study|Withdrawal by Subject|3|||
129809667|NCT01786668|467269396|FG003|Overall Study|Withdrawal by Subject|1|||
129809668|NCT01786668|467269393|FG000|Overall Study|Pregnancy|0|||
129809669|NCT01786668|467269394|FG001|Overall Study|Pregnancy|0|||
129809670|NCT01786668|467269395|FG002|Overall Study|Pregnancy|0|||
129809671|NCT01786668|467269396|FG003|Overall Study|Pregnancy|1|||
129809672|NCT01786668|467269393|FG000|Overall Study|Lost to Follow-up|1|||
129896544|NCT00984282|467582096|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
129896545|NCT00984282|467582097|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
129896546|NCT00984282|467582096|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
129896547|NCT00984282|467582097|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
129896548|NCT00984282|467582096|FG000|Double Blind Treatment|Lost to Follow-up|3|||
129896549|NCT00984282|467582097|FG001|Double Blind Treatment|Lost to Follow-up|0|||
129896550|NCT00984282|467582096|FG000|Double Blind Treatment|Death|8|||
129751698|NCT03364309|467050008|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129809673|NCT01786668|467269394|FG001|Overall Study|Lost to Follow-up|0|||
129809674|NCT01786668|467269395|FG002|Overall Study|Lost to Follow-up|1|||
129751699|NCT03364309|467050009|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751700|NCT03364309|467050010|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751701|NCT03364309|467050011|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751702|NCT03364309|467050012|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129809675|NCT01786668|467269396|FG003|Overall Study|Lost to Follow-up|0|||
129809676|NCT03570697|467269397|FG000|Overall Study|Lost to Follow-up|0|||
129896551|NCT00984282|467582097|FG001|Double Blind Treatment|Death|4|||
129896552|NCT00984282|467582096|FG000|Double Blind Treatment|Not treated|0|||
129751703|NCT03364309|467050013|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751704|NCT03364309|467050014|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751705|NCT03364309|467050015|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751706|NCT03364309|467050016|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
129751707|NCT03364309|467050017|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
129751708|NCT03364309|467050018|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
129751709|NCT03364309|467050019|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
129751710|NCT03364309|467050001|FG000|Post-Treatment Followup Period|Adverse Event|0|||
129751711|NCT03364309|467050002|FG001|Post-Treatment Followup Period|Adverse Event|0|||
129751712|NCT03364309|467050003|FG002|Post-Treatment Followup Period|Adverse Event|0|||
129751713|NCT03364309|467050004|FG003|Post-Treatment Followup Period|Adverse Event|0|||
129751714|NCT03364309|467050005|FG004|Post-Treatment Followup Period|Adverse Event|0|||
129751715|NCT03364309|467050006|FG005|Post-Treatment Followup Period|Adverse Event|0|||
129751716|NCT03364309|467050007|FG006|Post-Treatment Followup Period|Adverse Event|0|||
129751717|NCT03364309|467050008|FG007|Post-Treatment Followup Period|Adverse Event|0|||
129751718|NCT03364309|467050009|FG008|Post-Treatment Followup Period|Adverse Event|0|||
129751719|NCT03364309|467050010|FG009|Post-Treatment Followup Period|Adverse Event|0|||
129751720|NCT03364309|467050011|FG010|Post-Treatment Followup Period|Adverse Event|0|||
129751721|NCT03364309|467050012|FG011|Post-Treatment Followup Period|Adverse Event|0|||
129751722|NCT03364309|467050013|FG012|Post-Treatment Followup Period|Adverse Event|0|||
129751723|NCT03364309|467050014|FG013|Post-Treatment Followup Period|Adverse Event|0|||
129751724|NCT03364309|467050015|FG014|Post-Treatment Followup Period|Adverse Event|0|||
129751725|NCT03364309|467050016|FG015|Post-Treatment Followup Period|Adverse Event|0|||
129751726|NCT03364309|467050017|FG016|Post-Treatment Followup Period|Adverse Event|2|||
129751727|NCT03364309|467050018|FG017|Post-Treatment Followup Period|Adverse Event|6|||
129751728|NCT03364309|467050019|FG018|Post-Treatment Followup Period|Adverse Event|1|||
129751729|NCT03364309|467050001|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751730|NCT03364309|467050002|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751731|NCT03364309|467050003|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751732|NCT03364309|467050004|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751733|NCT03364309|467050005|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751734|NCT03364309|467050006|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751735|NCT03364309|467050007|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751736|NCT03364309|467050008|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751737|NCT03364309|467050009|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751738|NCT03364309|467050010|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751739|NCT03364309|467050011|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751740|NCT03364309|467050012|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751741|NCT03364309|467050013|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751742|NCT03364309|467050014|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751743|NCT03364309|467050015|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751744|NCT03364309|467050016|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751745|NCT03364309|467050017|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751746|NCT03364309|467050018|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
129751747|NCT03364309|467050019|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
129751748|NCT03364309|467050001|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
129751749|NCT03364309|467050002|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
129751750|NCT03364309|467050003|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
129751751|NCT03364309|467050004|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
129751752|NCT03364309|467050005|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
129751753|NCT03364309|467050006|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
129751754|NCT03364309|467050007|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
129751755|NCT03364309|467050008|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
129751756|NCT03364309|467050009|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
129896553|NCT00984282|467582097|FG001|Double Blind Treatment|Not treated|1|||
129896554|NCT00984282|467582096|FG000|Double Blind Treatment|Switched to commercial drug|6|||
129896555|NCT00984282|467582097|FG001|Double Blind Treatment|Switched to commercial drug|1|||
129751757|NCT03364309|467050010|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
129751758|NCT03364309|467050011|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
129751759|NCT03364309|467050012|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
129751760|NCT03364309|467050013|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
129751761|NCT03364309|467050014|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
129751762|NCT03364309|467050015|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
129751763|NCT03364309|467050016|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
129751764|NCT03364309|467050017|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
129751765|NCT03364309|467050018|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
129751766|NCT03364309|467050019|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
129751767|NCT00167310|467050020|FG000|Overall Study|Protocol Violation|5|||
129751768|NCT00167310|467050021|FG001|Overall Study|Protocol Violation|3|||
129751769|NCT00167310|467050020|FG000|Overall Study|Withdrawal by Subject|3|||
129751770|NCT00167310|467050021|FG001|Overall Study|Withdrawal by Subject|7|||
129751771|NCT03543137|467050025|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
129751772|NCT03543137|467050026|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
129751773|NCT03543137|467050025|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
129751774|NCT03543137|467050026|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
129751775|NCT03543137|467050025|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
129751776|NCT03543137|467050026|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
129751777|NCT01052077|467050027|FG000|Phase A|Lost to Follow-up|22|||
129751778|NCT01052077|467050028|FG001|Phase A|Lost to Follow-up|0|||
129751779|NCT01052077|467050029|FG002|Phase A|Lost to Follow-up|0|||
129751780|NCT01052077|467050030|FG003|Phase A|Lost to Follow-up|0|||
129751781|NCT01052077|467050027|FG000|Phase A|Adverse Event|32|||
129751782|NCT01052077|467050028|FG001|Phase A|Adverse Event|0|||
129751783|NCT01052077|467050029|FG002|Phase A|Adverse Event|0|||
129751784|NCT01052077|467050030|FG003|Phase A|Adverse Event|0|||
129751785|NCT01052077|467050027|FG000|Phase A|Met Withdrawal Criteria|26|||
129751786|NCT01052077|467050028|FG001|Phase A|Met Withdrawal Criteria|0|||
129751787|NCT01052077|467050029|FG002|Phase A|Met Withdrawal Criteria|0|||
129751788|NCT01052077|467050030|FG003|Phase A|Met Withdrawal Criteria|0|||
129751789|NCT01052077|467050027|FG000|Phase A|Physician Decision|10|||
129751790|NCT01052077|467050028|FG001|Phase A|Physician Decision|0|||
129751791|NCT01052077|467050029|FG002|Phase A|Physician Decision|0|||
129751792|NCT01052077|467050030|FG003|Phase A|Physician Decision|0|||
129751793|NCT01052077|467050027|FG000|Phase A|Withdrawal by Subject|29|||
129751794|NCT01052077|467050028|FG001|Phase A|Withdrawal by Subject|0|||
129751795|NCT01052077|467050029|FG002|Phase A|Withdrawal by Subject|0|||
129751796|NCT01052077|467050030|FG003|Phase A|Withdrawal by Subject|0|||
129751797|NCT01052077|467050027|FG000|Phase A|Protocol Deviation|27|||
129751798|NCT01052077|467050028|FG001|Phase A|Protocol Deviation|0|||
129751799|NCT01052077|467050029|FG002|Phase A|Protocol Deviation|0|||
129751800|NCT01052077|467050030|FG003|Phase A|Protocol Deviation|0|||
129751801|NCT01052077|467050027|FG000|Phase B|Lost to Follow-up|0|||
129751802|NCT01052077|467050028|FG001|Phase B|Lost to Follow-up|2|||
129751803|NCT01052077|467050029|FG002|Phase B|Lost to Follow-up|3|||
129751804|NCT01052077|467050030|FG003|Phase B|Lost to Follow-up|0|||
129751805|NCT01052077|467050027|FG000|Phase B|Adverse Event|0|||
129751806|NCT01052077|467050028|FG001|Phase B|Adverse Event|9|||
129751807|NCT01052077|467050029|FG002|Phase B|Adverse Event|2|||
129751808|NCT01052077|467050030|FG003|Phase B|Adverse Event|0|||
129751809|NCT01052077|467050027|FG000|Phase B|Met Withdrawal Criteria|0|||
129751810|NCT01052077|467050028|FG001|Phase B|Met Withdrawal Criteria|2|||
129751811|NCT01052077|467050029|FG002|Phase B|Met Withdrawal Criteria|1|||
129751812|NCT01052077|467050030|FG003|Phase B|Met Withdrawal Criteria|0|||
129751813|NCT01052077|467050027|FG000|Phase B|Physician Decision|0|||
129751814|NCT01052077|467050028|FG001|Phase B|Physician Decision|1|||
129751815|NCT01052077|467050029|FG002|Phase B|Physician Decision|1|||
129751816|NCT01052077|467050030|FG003|Phase B|Physician Decision|0|||
129751817|NCT01052077|467050027|FG000|Phase B|Withdrawal by Subject|0|||
129751818|NCT01052077|467050028|FG001|Phase B|Withdrawal by Subject|0|||
129751819|NCT01052077|467050029|FG002|Phase B|Withdrawal by Subject|5|||
129809677|NCT03570697|467269398|FG001|Overall Study|Lost to Follow-up|1|||
129809678|NCT03570697|467269397|FG000|Overall Study|Death|2|||
129751820|NCT01052077|467050030|FG003|Phase B|Withdrawal by Subject|0|||
129751821|NCT01052077|467050027|FG000|Phase B|Protocol Deviation|0|||
129809679|NCT03570697|467269398|FG001|Overall Study|Death|0|||
129809680|NCT03570697|467269397|FG000|Overall Study|Withdrawal by Subject|4|||
129751822|NCT01052077|467050028|FG001|Phase B|Protocol Deviation|3|||
129751823|NCT01052077|467050029|FG002|Phase B|Protocol Deviation|4|||
129751824|NCT01052077|467050030|FG003|Phase B|Protocol Deviation|0|||
129751825|NCT01052077|467050027|FG000|Phase B|Lack of Efficacy|0|||
129751826|NCT01052077|467050028|FG001|Phase B|Lack of Efficacy|1|||
129751827|NCT01052077|467050029|FG002|Phase B|Lack of Efficacy|0|||
129751828|NCT01052077|467050030|FG003|Phase B|Lack of Efficacy|0|||
129751829|NCT01052077|467050027|FG000|Phase A+|Lost to Follow-up|0|||
129809681|NCT03570697|467269398|FG001|Overall Study|Withdrawal by Subject|2|||
129751830|NCT01052077|467050028|FG001|Phase A+|Lost to Follow-up|0|||
129751831|NCT01052077|467050029|FG002|Phase A+|Lost to Follow-up|0|||
129751832|NCT01052077|467050030|FG003|Phase A+|Lost to Follow-up|8|||
129751833|NCT01052077|467050027|FG000|Phase A+|Adverse Event|0|||
129751834|NCT01052077|467050028|FG001|Phase A+|Adverse Event|0|||
129809682|NCT01776840|467269399|FG000|Overall Study|Lost to Follow-up|12|||
129751835|NCT01052077|467050029|FG002|Phase A+|Adverse Event|0|||
129751836|NCT01052077|467050030|FG003|Phase A+|Adverse Event|4|||
129751837|NCT01052077|467050027|FG000|Phase A+|Met Withdrawal Criteria|0|||
129751838|NCT01052077|467050028|FG001|Phase A+|Met Withdrawal Criteria|0|||
129751839|NCT01052077|467050029|FG002|Phase A+|Met Withdrawal Criteria|0|||
129751840|NCT01052077|467050030|FG003|Phase A+|Met Withdrawal Criteria|2|||
129751841|NCT01052077|467050027|FG000|Phase A+|Withdrawal by Subject|0|||
129751842|NCT01052077|467050028|FG001|Phase A+|Withdrawal by Subject|0|||
129751843|NCT01052077|467050029|FG002|Phase A+|Withdrawal by Subject|0|||
129751844|NCT01052077|467050030|FG003|Phase A+|Withdrawal by Subject|7|||
129751845|NCT02465203|467050031|FG000|Overall Study|Protocol Violation|1|||
129751846|NCT02465203|467050032|FG001|Overall Study|Protocol Violation|1|||
129751847|NCT02465203|467050033|FG002|Overall Study|Protocol Violation|1|||
129751848|NCT02465203|467050031|FG000|Overall Study|Study terminated by sponsor|50|||
129751849|NCT02465203|467050032|FG001|Overall Study|Study terminated by sponsor|34|||
129751850|NCT02465203|467050033|FG002|Overall Study|Study terminated by sponsor|11|||
129751851|NCT02465203|467050031|FG000|Overall Study|New therapy for study indication|4|||
129751852|NCT02465203|467050032|FG001|Overall Study|New therapy for study indication|0|||
129751853|NCT02465203|467050033|FG002|Overall Study|New therapy for study indication|0|||
129751854|NCT02465203|467050031|FG000|Overall Study|Patient/guardian decision|1|||
129751855|NCT02465203|467050032|FG001|Overall Study|Patient/guardian decision|1|||
129751856|NCT02465203|467050033|FG002|Overall Study|Patient/guardian decision|1|||
129751857|NCT00042991|467050038|FG000|Overall Study|Adverse Event|1|||
129751858|NCT00042991|467050039|FG001|Overall Study|Adverse Event|4|||
129751859|NCT00042991|467050040|FG002|Overall Study|Adverse Event|2|||
129751860|NCT00042991|467050041|FG003|Overall Study|Adverse Event|0|||
129751861|NCT00042991|467050042|FG004|Overall Study|Adverse Event|0|||
129751862|NCT00042991|467050043|FG005|Overall Study|Adverse Event|1|||
129751863|NCT00042991|467050044|FG006|Overall Study|Adverse Event|0|||
129751864|NCT00042991|467050038|FG000|Overall Study|Withdrawal by Subject|0|||
129751865|NCT00042991|467050039|FG001|Overall Study|Withdrawal by Subject|7|||
129751866|NCT00042991|467050040|FG002|Overall Study|Withdrawal by Subject|2|||
129751867|NCT00042991|467050041|FG003|Overall Study|Withdrawal by Subject|0|||
129751868|NCT00042991|467050042|FG004|Overall Study|Withdrawal by Subject|1|||
129751869|NCT00042991|467050043|FG005|Overall Study|Withdrawal by Subject|0|||
129751870|NCT00042991|467050044|FG006|Overall Study|Withdrawal by Subject|0|||
129751871|NCT00042991|467050038|FG000|Overall Study|Disease Progression|5|||
129751872|NCT00042991|467050039|FG001|Overall Study|Disease Progression|29|||
129751873|NCT00042991|467050040|FG002|Overall Study|Disease Progression|2|||
129751874|NCT00042991|467050041|FG003|Overall Study|Disease Progression|2|||
129751875|NCT00042991|467050042|FG004|Overall Study|Disease Progression|1|||
129751876|NCT00042991|467050043|FG005|Overall Study|Disease Progression|4|||
129751877|NCT00042991|467050044|FG006|Overall Study|Disease Progression|2|||
129751878|NCT00042991|467050038|FG000|Overall Study|Alternative Therapy|0|||
129751879|NCT00042991|467050039|FG001|Overall Study|Alternative Therapy|0|||
129751880|NCT00042991|467050040|FG002|Overall Study|Alternative Therapy|0|||
129751881|NCT00042991|467050041|FG003|Overall Study|Alternative Therapy|0|||
129751882|NCT00042991|467050042|FG004|Overall Study|Alternative Therapy|1|||
129751883|NCT00042991|467050043|FG005|Overall Study|Alternative Therapy|0|||
129751884|NCT00042991|467050044|FG006|Overall Study|Alternative Therapy|0|||
129751885|NCT04072887|467050045|FG000|Overall Study|Withdrawal by Subject|3|||
129751886|NCT04072887|467050046|FG001|Overall Study|Withdrawal by Subject|8|||
129751887|NCT04072887|467050047|FG002|Overall Study|Withdrawal by Subject|1|||
129751888|NCT04072887|467050048|FG003|Overall Study|Withdrawal by Subject|3|||
129751889|NCT04072887|467050049|FG004|Overall Study|Withdrawal by Subject|3|||
129751890|NCT04072887|467050050|FG005|Overall Study|Withdrawal by Subject|13|||
129751891|NCT04072887|467050045|FG000|Overall Study|Adverse Event|2|||
129751892|NCT04072887|467050046|FG001|Overall Study|Adverse Event|4|||
129751893|NCT04072887|467050047|FG002|Overall Study|Adverse Event|1|||
129751894|NCT04072887|467050048|FG003|Overall Study|Adverse Event|4|||
129751895|NCT04072887|467050049|FG004|Overall Study|Adverse Event|0|||
129751896|NCT04072887|467050050|FG005|Overall Study|Adverse Event|1|||
129751897|NCT04072887|467050045|FG000|Overall Study|Physician Decision|2|||
129751898|NCT04072887|467050046|FG001|Overall Study|Physician Decision|0|||
129751899|NCT04072887|467050047|FG002|Overall Study|Physician Decision|0|||
129751900|NCT04072887|467050048|FG003|Overall Study|Physician Decision|0|||
129751901|NCT04072887|467050049|FG004|Overall Study|Physician Decision|0|||
129751902|NCT04072887|467050050|FG005|Overall Study|Physician Decision|1|||
129751903|NCT04072887|467050045|FG000|Overall Study|Lost to Follow-up|1|||
129751904|NCT04072887|467050046|FG001|Overall Study|Lost to Follow-up|3|||
129751905|NCT04072887|467050047|FG002|Overall Study|Lost to Follow-up|0|||
129751906|NCT04072887|467050048|FG003|Overall Study|Lost to Follow-up|0|||
129751907|NCT04072887|467050049|FG004|Overall Study|Lost to Follow-up|0|||
129751908|NCT04072887|467050050|FG005|Overall Study|Lost to Follow-up|0|||
129751909|NCT04072887|467050045|FG000|Overall Study|Death|0|||
129751910|NCT04072887|467050046|FG001|Overall Study|Death|2|||
129751911|NCT04072887|467050047|FG002|Overall Study|Death|0|||
129751912|NCT04072887|467050048|FG003|Overall Study|Death|2|||
129751913|NCT04072887|467050049|FG004|Overall Study|Death|3|||
129751914|NCT04072887|467050050|FG005|Overall Study|Death|0|||
129751915|NCT03193736|467050051|FG000|Overall Study|Death|2|||
129751916|NCT03193736|467050051|FG000|Overall Study|Withdrawal by Subject|1|||
129751917|NCT03193736|467050051|FG000|Overall Study|Lost to Follow-up|1|||
129751918|NCT03193736|467050051|FG000|Overall Study|implant not received|1|||
129751919|NCT00423449|467050052|FG000|Overall Study|Clinical Adverse Event|1|||
129751920|NCT00423449|467050053|FG001|Overall Study|Clinical Adverse Event|0|||
129751921|NCT00423449|467050054|FG002|Overall Study|Clinical Adverse Event|1|||
129751922|NCT00423449|467050055|FG003|Overall Study|Clinical Adverse Event|8|||
129751923|NCT00423449|467050056|FG004|Overall Study|Clinical Adverse Event|2|||
129751924|NCT00423449|467050052|FG000|Overall Study|Death|1|||
129751925|NCT00423449|467050053|FG001|Overall Study|Death|0|||
129751926|NCT00423449|467050054|FG002|Overall Study|Death|2|||
129751927|NCT00423449|467050055|FG003|Overall Study|Death|1|||
129751928|NCT00423449|467050056|FG004|Overall Study|Death|1|||
129751929|NCT00423449|467050052|FG000|Overall Study|Progressive Disease|1|||
129751930|NCT00423449|467050053|FG001|Overall Study|Progressive Disease|3|||
129751931|NCT00423449|467050054|FG002|Overall Study|Progressive Disease|8|||
129751932|NCT00423449|467050055|FG003|Overall Study|Progressive Disease|11|||
129751933|NCT00423449|467050056|FG004|Overall Study|Progressive Disease|4|||
129751934|NCT00423449|467050052|FG000|Overall Study|Laboratory Adverse Event|0|||
129751935|NCT00423449|467050053|FG001|Overall Study|Laboratory Adverse Event|1|||
129751936|NCT00423449|467050054|FG002|Overall Study|Laboratory Adverse Event|2|||
129751937|NCT00423449|467050055|FG003|Overall Study|Laboratory Adverse Event|0|||
129751938|NCT00423449|467050056|FG004|Overall Study|Laboratory Adverse Event|0|||
129751939|NCT00423449|467050052|FG000|Overall Study|Other|0|||
129751940|NCT00423449|467050053|FG001|Overall Study|Other|0|||
129751941|NCT00423449|467050054|FG002|Overall Study|Other|0|||
129751942|NCT00423449|467050055|FG003|Overall Study|Other|1|||
129751943|NCT00423449|467050056|FG004|Overall Study|Other|0|||
129751944|NCT00423449|467050052|FG000|Overall Study|Protocol Violation|0|||
129751945|NCT00423449|467050053|FG001|Overall Study|Protocol Violation|0|||
129751946|NCT00423449|467050054|FG002|Overall Study|Protocol Violation|2|||
129751947|NCT00423449|467050055|FG003|Overall Study|Protocol Violation|1|||
129751948|NCT00423449|467050056|FG004|Overall Study|Protocol Violation|0|||
129751949|NCT02697435|467050057|FG000|Overall Study|Withdrawal by Subject|1|||
129751950|NCT02697435|467050058|FG001|Overall Study|Withdrawal by Subject|0|||
129751951|NCT02697435|467050057|FG000|Overall Study|Physician Decision|0|||
129751952|NCT02697435|467050058|FG001|Overall Study|Physician Decision|4|||
129751953|NCT04371666|467050067|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
129751954|NCT04371666|467050068|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
129751955|NCT04371666|467050067|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
129751956|NCT04371666|467050068|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
129751957|NCT04371666|467050067|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
129751958|NCT04371666|467050068|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
129751959|NCT04371666|467050067|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
129751960|NCT04371666|467050068|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
129751961|NCT04371666|467050067|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
129751962|NCT04371666|467050068|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
129751963|NCT04371666|467050067|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
129751964|NCT04371666|467050068|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
129751965|NCT00861471|467050075|FG000|Overall Study|Withdrawal by Subject|1|||
129751966|NCT00861471|467050075|FG000|Overall Study|Adverse Event|2|||
129751967|NCT00861471|467050075|FG000|Overall Study|Lack of Efficacy|3|||
129751968|NCT00861471|467050075|FG000|Overall Study|treatment for lumbar laminectomy|1|||
129751969|NCT00861471|467050075|FG000|Overall Study|Physician Decision|2|||
129751970|NCT01445080|467050076|FG000|Overall Study|Adverse Event|5|||
129751971|NCT01445080|467050077|FG001|Overall Study|Adverse Event|3|||
129751972|NCT01445080|467050078|FG002|Overall Study|Adverse Event|11|||
129751973|NCT01445080|467050079|FG003|Overall Study|Adverse Event|6|||
129809683|NCT01776840|467269400|FG001|Overall Study|Lost to Follow-up|7|||
129809684|NCT01776840|467269399|FG000|Overall Study|Withdrawal by Subject|32|||
129751974|NCT01445080|467050080|FG004|Overall Study|Adverse Event|2|||
129751975|NCT01445080|467050081|FG005|Overall Study|Adverse Event|3|||
129751976|NCT01445080|467050082|FG006|Overall Study|Adverse Event|0|||
129751977|NCT01445080|467050083|FG007|Overall Study|Adverse Event|3|||
129809685|NCT01776840|467269400|FG001|Overall Study|Withdrawal by Subject|48|||
129751978|NCT01445080|467050084|FG008|Overall Study|Adverse Event|10|||
129751979|NCT01445080|467050076|FG000|Overall Study|Physician Decision|0|||
129809686|NCT01776840|467269399|FG000|Overall Study|Sponsor decision|89|||
129809687|NCT01776840|467269400|FG001|Overall Study|Sponsor decision|87|||
129751980|NCT01445080|467050077|FG001|Overall Study|Physician Decision|0|||
129751981|NCT01445080|467050078|FG002|Overall Study|Physician Decision|1|||
129751982|NCT01445080|467050079|FG003|Overall Study|Physician Decision|0|||
129751983|NCT01445080|467050080|FG004|Overall Study|Physician Decision|0|||
129751984|NCT01445080|467050081|FG005|Overall Study|Physician Decision|3|||
129751985|NCT01445080|467050082|FG006|Overall Study|Physician Decision|2|||
129751986|NCT01445080|467050083|FG007|Overall Study|Physician Decision|2|||
129751987|NCT01445080|467050084|FG008|Overall Study|Physician Decision|0|||
129751988|NCT01445080|467050076|FG000|Overall Study|Withdrawal by Subject|1|||
129751989|NCT01445080|467050077|FG001|Overall Study|Withdrawal by Subject|0|||
129751990|NCT01445080|467050078|FG002|Overall Study|Withdrawal by Subject|0|||
129751991|NCT01445080|467050079|FG003|Overall Study|Withdrawal by Subject|1|||
129751992|NCT01445080|467050080|FG004|Overall Study|Withdrawal by Subject|0|||
129751993|NCT01445080|467050081|FG005|Overall Study|Withdrawal by Subject|0|||
129751994|NCT01445080|467050082|FG006|Overall Study|Withdrawal by Subject|0|||
129751995|NCT01445080|467050083|FG007|Overall Study|Withdrawal by Subject|0|||
129751996|NCT01445080|467050084|FG008|Overall Study|Withdrawal by Subject|2|||
129751997|NCT01445080|467050076|FG000|Overall Study|Ineligible/Inevaluable|1|||
129751998|NCT01445080|467050077|FG001|Overall Study|Ineligible/Inevaluable|2|||
129751999|NCT01445080|467050078|FG002|Overall Study|Ineligible/Inevaluable|0|||
129752000|NCT01445080|467050079|FG003|Overall Study|Ineligible/Inevaluable|1|||
129752001|NCT01445080|467050080|FG004|Overall Study|Ineligible/Inevaluable|2|||
129752002|NCT01445080|467050081|FG005|Overall Study|Ineligible/Inevaluable|3|||
129752003|NCT01445080|467050082|FG006|Overall Study|Ineligible/Inevaluable|0|||
129752004|NCT01445080|467050083|FG007|Overall Study|Ineligible/Inevaluable|0|||
129752005|NCT01445080|467050084|FG008|Overall Study|Ineligible/Inevaluable|6|||
129752006|NCT00445770|467050085|FG000|Overall Study|Adverse Event|9|||
129752007|NCT00445770|467050086|FG001|Overall Study|Adverse Event|15|||
129752008|NCT00445770|467050087|FG002|Overall Study|Adverse Event|19|||
129752009|NCT00445770|467050085|FG000|Overall Study|Lack of Efficacy|38|||
129752010|NCT00445770|467050086|FG001|Overall Study|Lack of Efficacy|13|||
129752011|NCT00445770|467050087|FG002|Overall Study|Lack of Efficacy|6|||
129752012|NCT00445770|467050085|FG000|Overall Study|Lost to Follow-up|0|||
129752013|NCT00445770|467050086|FG001|Overall Study|Lost to Follow-up|2|||
129752014|NCT00445770|467050087|FG002|Overall Study|Lost to Follow-up|0|||
129752015|NCT00445770|467050085|FG000|Overall Study|Other|6|||
129752016|NCT00445770|467050086|FG001|Overall Study|Other|5|||
129752017|NCT00445770|467050087|FG002|Overall Study|Other|6|||
129752018|NCT03857542|467050088|FG000|Overall Study|Adverse Event|1|||
129752019|NCT03857542|467050089|FG001|Overall Study|Adverse Event|3|||
129752020|NCT03857542|467050088|FG000|Overall Study|Withdrawal by Subject|2|||
129752021|NCT03857542|467050089|FG001|Overall Study|Withdrawal by Subject|1|||
129752022|NCT03857542|467050088|FG000|Overall Study|Lost to Follow-up|2|||
129752023|NCT03857542|467050089|FG001|Overall Study|Lost to Follow-up|1|||
129752024|NCT03857542|467050088|FG000|Overall Study|Reason not Specified|1|||
129752025|NCT03857542|467050089|FG001|Overall Study|Reason not Specified|0|||
129752026|NCT03058692|467051932|FG000|Overall Study|Lost to Follow-up|2|||
129752027|NCT03058692|467051933|FG001|Overall Study|Lost to Follow-up|1|||
129752028|NCT03058692|467051932|FG000|Overall Study|Withdrawal by Subject|1|||
129752029|NCT03058692|467051933|FG001|Overall Study|Withdrawal by Subject|1|||
129752030|NCT01698814|467051936|FG000|Overall Study|Adverse Event|0|||
129752031|NCT01698814|467051937|FG001|Overall Study|Adverse Event|2|||
129752032|NCT01698814|467051936|FG000|Overall Study|Lost to Follow-up|0|||
129752033|NCT01698814|467051937|FG001|Overall Study|Lost to Follow-up|1|||
129752034|NCT01698814|467051936|FG000|Overall Study|Pregnancy|1|||
129752035|NCT01698814|467051937|FG001|Overall Study|Pregnancy|0|||
129752036|NCT01698814|467051936|FG000|Overall Study|Randomized in error|1|||
129752037|NCT01698814|467051937|FG001|Overall Study|Randomized in error|0|||
129752038|NCT04014062|467051938|FG000|Period I: Dosing|Medical Grounds|4|||
129809688|NCT00493025|467269402|FG000|Overall Study|Physician Decision|19|||
129809689|NCT03068455|467269403|FG000|Pre-treatment Period|Disease progression|0|||
129809690|NCT03068455|467269404|FG001|Pre-treatment Period|Disease progression|1|||
129809691|NCT03068455|467269403|FG000|Pre-treatment Period|Participant withdrew consent|1|||
129752039|NCT04014062|467051939|FG001|Period I: Dosing|Medical Grounds|5|||
129752040|NCT04014062|467051938|FG000|Period I: Dosing|Withdrawal by Subject|3|||
129752041|NCT04014062|467051939|FG001|Period I: Dosing|Withdrawal by Subject|1|||
129752042|NCT03038126|467051941|FG000|Overall Study|Death|1|||
129752043|NCT03038126|467051942|FG001|Overall Study|Death|1|||
129752044|NCT03038126|467051941|FG000|Overall Study|Withdrawal by Subject|5|||
129752045|NCT03038126|467051942|FG001|Overall Study|Withdrawal by Subject|0|||
129752046|NCT03038126|467051941|FG000|Overall Study|Lost to Follow-up|0|||
129752047|NCT03038126|467051942|FG001|Overall Study|Lost to Follow-up|1|||
129752048|NCT03038126|467051941|FG000|Overall Study|Long Term Hospitalization|2|||
129752049|NCT03038126|467051942|FG001|Overall Study|Long Term Hospitalization|0|||
129809692|NCT03068455|467269404|FG001|Pre-treatment Period|Participant withdrew consent|1|||
129752050|NCT03038126|467051941|FG000|Overall Study|Too Ill to Participate|1|||
129752051|NCT03038126|467051942|FG001|Overall Study|Too Ill to Participate|2|||
129752052|NCT01724866|467051943|FG000|Overall Study|Adverse Event|0|||
129809693|NCT03068455|467269403|FG000|Pre-treatment Period|Poor/non-compliance|0|||
129896556|NCT00984282|467582096|FG000|Double Blind Treatment|protocol driven decision point|1|||
129896557|NCT00984282|467582097|FG001|Double Blind Treatment|protocol driven decision point|1|||
129896558|NCT00984282|467582096|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
129896559|NCT00984282|467582097|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
129896560|NCT00984282|467582096|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
129896561|NCT00984282|467582097|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
129896562|NCT00984282|467582096|FG000|Open-label Treatment|Adverse Event|20|||
129896563|NCT00984282|467582097|FG001|Open-label Treatment|Adverse Event|30|||
129896564|NCT00984282|467582096|FG000|Open-label Treatment|Withdrawal by Subject|6|||
129896565|NCT00984282|467582097|FG001|Open-label Treatment|Withdrawal by Subject|21|||
129896566|NCT00984282|467582096|FG000|Open-label Treatment|Death|7|||
129896567|NCT00984282|467582097|FG001|Open-label Treatment|Death|15|||
129896568|NCT00984282|467582096|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
129896569|NCT00984282|467582097|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
129896570|NCT00984282|467582096|FG000|Open-label Treatment|Lost to Follow-up|1|||
129896571|NCT00984282|467582097|FG001|Open-label Treatment|Lost to Follow-up|1|||
129896572|NCT00984282|467582096|FG000|Open-label Treatment|Patient convenience|1|||
129896573|NCT00984282|467582097|FG001|Open-label Treatment|Patient convenience|0|||
129896574|NCT00984282|467582096|FG000|Open-label Treatment|Non-compliant with study medication|1|||
129896575|NCT00984282|467582097|FG001|Open-label Treatment|Non-compliant with study medication|0|||
129896576|NCT00984282|467582096|FG000|Open-label Treatment|Target lesion removed|0|||
129896577|NCT00984282|467582097|FG001|Open-label Treatment|Target lesion removed|1|||
129896578|NCT00984282|467582096|FG000|Open-label Treatment|Protocol driven decision point|1|||
129896579|NCT00984282|467582097|FG001|Open-label Treatment|Protocol driven decision point|1|||
129896580|NCT00984282|467582096|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
129896581|NCT00984282|467582097|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
129896582|NCT00984282|467582096|FG000|Open-label Treatment|Switched to commercial drug|6|||
129896583|NCT00984282|467582097|FG001|Open-label Treatment|Switched to commercial drug|7|||
129896584|NCT00984282|467582096|FG000|Open-label Treatment|Physician Decision|1|||
129896585|NCT00984282|467582097|FG001|Open-label Treatment|Physician Decision|0|||
129896586|NCT00984282|467582096|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
129896587|NCT00984282|467582097|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
129896588|NCT00984282|467582096|FG000|Long Term Follow-up|Death|27|||
129896589|NCT00984282|467582097|FG001|Long Term Follow-up|Death|68|||
129896590|NCT00984282|467582096|FG000|Long Term Follow-up|Lost to Follow-up|3|||
129896591|NCT00984282|467582097|FG001|Long Term Follow-up|Lost to Follow-up|6|||
129896592|NCT00984282|467582096|FG000|Long Term Follow-up|Protocol driven decision point|25|||
129896593|NCT00984282|467582097|FG001|Long Term Follow-up|Protocol driven decision point|26|||
129896594|NCT00984282|467582096|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
129896595|NCT00984282|467582097|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
129896596|NCT00984282|467582096|FG000|Long Term Follow-up|Switched to commercial drug|4|||
129896597|NCT00984282|467582097|FG001|Long Term Follow-up|Switched to commercial drug|2|||
129752053|NCT01724866|467051944|FG001|Overall Study|Adverse Event|0|||
129752054|NCT01724866|467051945|FG002|Overall Study|Adverse Event|1|||
129752055|NCT01724866|467051946|FG003|Overall Study|Adverse Event|1|||
129752056|NCT01724866|467051943|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
129752057|NCT01724866|467051944|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
129752058|NCT01724866|467051945|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
129752059|NCT01724866|467051946|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
129752060|NCT01724866|467051943|FG000|Overall Study|Investigator's Discretion|0|||
129752061|NCT01724866|467051944|FG001|Overall Study|Investigator's Discretion|1|||
129752062|NCT01724866|467051945|FG002|Overall Study|Investigator's Discretion|1|||
129752063|NCT01724866|467051946|FG003|Overall Study|Investigator's Discretion|0|||
129752064|NCT01724866|467051943|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
129896598|NCT00984282|467582096|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
129752065|NCT01724866|467051944|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
129752066|NCT01724866|467051945|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
129752067|NCT01724866|467051946|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
129752068|NCT01724866|467051943|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
129752069|NCT01724866|467051944|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
129752070|NCT01724866|467051945|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
129752071|NCT01724866|467051946|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
129752072|NCT01424501|467051947|FG000|Overall Study|Withdrawal by Subject|1|||
129752073|NCT01424501|467051948|FG001|Overall Study|Withdrawal by Subject|0|||
129896599|NCT00984282|467582097|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
129896600|NCT02223793|467582098|FG000|Overall Study|Lost to Follow-up|10|||
129752074|NCT01424501|467051949|FG002|Overall Study|Withdrawal by Subject|1|||
129752075|NCT01424501|467051950|FG003|Overall Study|Withdrawal by Subject|0|||
129752076|NCT01424501|467051951|FG004|Overall Study|Withdrawal by Subject|0|||
129752077|NCT01424501|467051952|FG005|Overall Study|Withdrawal by Subject|0|||
129752078|NCT01424501|467051947|FG000|Overall Study|Lost to Follow-up|0|||
129752079|NCT01424501|467051948|FG001|Overall Study|Lost to Follow-up|1|||
129752080|NCT01424501|467051949|FG002|Overall Study|Lost to Follow-up|1|||
129752081|NCT01424501|467051950|FG003|Overall Study|Lost to Follow-up|0|||
129752082|NCT01424501|467051951|FG004|Overall Study|Lost to Follow-up|0|||
129752083|NCT01424501|467051952|FG005|Overall Study|Lost to Follow-up|0|||
129752084|NCT01980095|467051953|FG000|Overall Study|Lost to Follow-up|6|||
129752085|NCT01980095|467051954|FG001|Overall Study|Lost to Follow-up|7|||
129896601|NCT02223793|467582099|FG001|Overall Study|Lost to Follow-up|1|||
129896602|NCT02223793|467582100|FG002|Overall Study|Lost to Follow-up|2|||
129896603|NCT02223793|467582098|FG000|Overall Study|Withdrawal by Subject|3|||
129896604|NCT02223793|467582099|FG001|Overall Study|Withdrawal by Subject|2|||
129896605|NCT02223793|467582100|FG002|Overall Study|Withdrawal by Subject|3|||
129752086|NCT01980095|467051953|FG000|Overall Study|Withdrawal by Subject|2|||
129752087|NCT01980095|467051954|FG001|Overall Study|Withdrawal by Subject|3|||
129752088|NCT01980095|467051953|FG000|Overall Study|Poor compliance|5|||
129752089|NCT01980095|467051954|FG001|Overall Study|Poor compliance|0|||
129752090|NCT01980095|467051953|FG000|Overall Study|Safety issue|0|||
129752091|NCT01980095|467051954|FG001|Overall Study|Safety issue|1|||
129752092|NCT01980095|467051953|FG000|Overall Study|Study drug discontinued|1|||
129752093|NCT01980095|467051954|FG001|Overall Study|Study drug discontinued|0|||
129752094|NCT01980095|467051953|FG000|Overall Study|Randomized by mistake|1|||
129752095|NCT01980095|467051954|FG001|Overall Study|Randomized by mistake|0|||
129752096|NCT01362608|467051959|FG000|Overall Study|Protocol Violation|0|||
129752097|NCT01362608|467051960|FG001|Overall Study|Protocol Violation|1|||
129752098|NCT01362608|467051959|FG000|Overall Study|Lost to Follow-up|3|||
129752099|NCT01362608|467051960|FG001|Overall Study|Lost to Follow-up|1|||
129752100|NCT01362608|467051959|FG000|Overall Study|Withdrawal by Subject|1|||
129752101|NCT01362608|467051960|FG001|Overall Study|Withdrawal by Subject|2|||
129752102|NCT01362608|467051959|FG000|Overall Study|Lack of Efficacy|0|||
129752103|NCT01362608|467051960|FG001|Overall Study|Lack of Efficacy|2|||
129752104|NCT01362608|467051959|FG000|Overall Study|Adverse Event|0|||
129752105|NCT01362608|467051960|FG001|Overall Study|Adverse Event|2|||
129752106|NCT04506502|467051968|FG000|Overall Study|Withdrawal by Subject|1|||
129752107|NCT04506502|467051968|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
129752108|NCT03526146|467051970|FG000|Overall Study|Lost to Follow-up|5|||
129752109|NCT03526146|467051970|FG000|Overall Study|Withdrawal by Subject|6|||
129752110|NCT03526146|467051970|FG000|Overall Study|class canceled due to COVID-19|4|||
129752111|NCT01136408|467051973|FG000|Overall Study|Adverse Event|4|||
129752112|NCT01136408|467051974|FG001|Overall Study|Adverse Event|8|||
129752113|NCT01136408|467051975|FG002|Overall Study|Adverse Event|4|||
129752114|NCT01136408|467051973|FG000|Overall Study|Protocol Violation|1|||
129752115|NCT01136408|467051974|FG001|Overall Study|Protocol Violation|1|||
129752116|NCT01136408|467051975|FG002|Overall Study|Protocol Violation|1|||
129752117|NCT02828436|467051976|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
129752118|NCT02828436|467051977|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
129752119|NCT02828436|467051976|FG000|Period 1|Lost to Follow-up|0|||
129752120|NCT02828436|467051977|FG001|Period 1|Lost to Follow-up|1|||
129752121|NCT02828436|467051976|FG000|Period 2|Withdrawal by Subject|4|||
129752122|NCT02828436|467051977|FG001|Period 2|Withdrawal by Subject|0|||
129752123|NCT02828436|467051976|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
129752124|NCT02828436|467051977|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
129752125|NCT02828436|467051976|FG000|Period 2|Lost to Follow-up|1|||
129752126|NCT02828436|467051977|FG001|Period 2|Lost to Follow-up|0|||
129752127|NCT04421482|467051980|FG000|Overall Study|Physician Decision|1|||
129752128|NCT03010319|467051983|FG000|Overall Study|Adverse Event|15|||
129752129|NCT03010319|467051984|FG001|Overall Study|Adverse Event|9|||
129752130|NCT03010319|467051983|FG000|Overall Study|Withdrawal by Subject|1|||
129752131|NCT03010319|467051984|FG001|Overall Study|Withdrawal by Subject|6|||
129752132|NCT03010319|467051983|FG000|Overall Study|Physician Decision|2|||
129752133|NCT03010319|467051984|FG001|Overall Study|Physician Decision|4|||
129752134|NCT03010319|467051983|FG000|Overall Study|Sponsor requested withdrawal|2|||
129752135|NCT03010319|467051984|FG001|Overall Study|Sponsor requested withdrawal|2|||
129752136|NCT03010319|467051983|FG000|Overall Study|Death|1|||
129752137|NCT03010319|467051984|FG001|Overall Study|Death|0|||
129752138|NCT03010319|467051983|FG000|Overall Study|Lost to Follow-up|0|||
129752139|NCT03010319|467051984|FG001|Overall Study|Lost to Follow-up|1|||
129752140|NCT03010319|467051983|FG000|Overall Study|Other Reason|5|||
129752141|NCT03010319|467051984|FG001|Overall Study|Other Reason|7|||
129752142|NCT02128724|467051985|FG000|Overall Study|Death|1|||
129752143|NCT02128724|467051986|FG001|Overall Study|Death|0|||
129752144|NCT02128724|467051987|FG002|Overall Study|Death|0|||
129752145|NCT02128724|467051988|FG003|Overall Study|Death|0|||
129896606|NCT02223793|467582098|FG000|Overall Study|Moved/studycenter unable to participate|4|||
129752146|NCT02128724|467051985|FG000|Overall Study|Adverse Event|0|||
129752147|NCT02128724|467051986|FG001|Overall Study|Adverse Event|1|||
129752148|NCT02128724|467051987|FG002|Overall Study|Adverse Event|0|||
129752149|NCT02128724|467051988|FG003|Overall Study|Adverse Event|0|||
129752150|NCT02128724|467051985|FG000|Overall Study|Physician Decision|0|||
129752151|NCT02128724|467051986|FG001|Overall Study|Physician Decision|0|||
129752152|NCT02128724|467051987|FG002|Overall Study|Physician Decision|0|||
129752153|NCT02128724|467051988|FG003|Overall Study|Physician Decision|2|||
129752154|NCT02128724|467051985|FG000|Overall Study|Withdrawal by Subject|0|||
129752155|NCT02128724|467051986|FG001|Overall Study|Withdrawal by Subject|0|||
129752156|NCT02128724|467051987|FG002|Overall Study|Withdrawal by Subject|0|||
129752157|NCT02128724|467051988|FG003|Overall Study|Withdrawal by Subject|1|||
129752158|NCT03329092|467051989|FG000|Overall Study|Other|2|||
129752159|NCT03329092|467051990|FG001|Overall Study|Other|2|||
129752160|NCT03329092|467051989|FG000|Overall Study|Withdrawal by Subject|16|||
129752161|NCT03329092|467051990|FG001|Overall Study|Withdrawal by Subject|3|||
129752162|NCT03329092|467051989|FG000|Overall Study|Physician Decision|1|||
129752163|NCT03329092|467051990|FG001|Overall Study|Physician Decision|0|||
129752164|NCT03329092|467051989|FG000|Overall Study|Death|17|||
129752165|NCT03329092|467051990|FG001|Overall Study|Death|11|||
129752166|NCT03329092|467051989|FG000|Overall Study|Adverse Event|3|||
129752167|NCT03329092|467051990|FG001|Overall Study|Adverse Event|1|||
129752168|NCT03329092|467051989|FG000|Overall Study|Lost to Follow-up|1|||
129752169|NCT03329092|467051990|FG001|Overall Study|Lost to Follow-up|1|||
129809694|NCT03068455|467269404|FG001|Pre-treatment Period|Poor/non-compliance|1|||
129809695|NCT03068455|467269403|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
129809696|NCT03068455|467269404|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
129809697|NCT03068455|467269403|FG000|Pre-treatment Period|Not reported|2|||
129809698|NCT03068455|467269404|FG001|Pre-treatment Period|Not reported|1|||
129809699|NCT03068455|467269403|FG000|Treatment Period|Disease progression|166|||
129809700|NCT03068455|467269404|FG001|Treatment Period|Disease progression|208|||
129809701|NCT03068455|467269403|FG000|Treatment Period|Study drug toxicity|317|||
129809702|NCT03068455|467269404|FG001|Treatment Period|Study drug toxicity|104|||
129809703|NCT03068455|467269403|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
129809704|NCT03068455|467269404|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
129809705|NCT03068455|467269403|FG000|Treatment Period|Participant request to stop therapy|33|||
129809706|NCT03068455|467269404|FG001|Treatment Period|Participant request to stop therapy|20|||
129809707|NCT03068455|467269403|FG000|Treatment Period|Participant withdrew consent|5|||
129809708|NCT03068455|467269404|FG001|Treatment Period|Participant withdrew consent|10|||
129809709|NCT03068455|467269403|FG000|Treatment Period|Poor/non-compliance|3|||
129809710|NCT03068455|467269404|FG001|Treatment Period|Poor/non-compliance|0|||
129809711|NCT03068455|467269403|FG000|Treatment Period|Participant no longer meets study criteria|1|||
129809712|NCT03068455|467269404|FG001|Treatment Period|Participant no longer meets study criteria|3|||
129809713|NCT03068455|467269403|FG000|Treatment Period|Other reasons|12|||
129809714|NCT03068455|467269404|FG001|Treatment Period|Other reasons|4|||
129809715|NCT03173313|467269408|FG000|Overall Study|Lost to Follow-up|2|||
129809716|NCT03173313|467269409|FG001|Overall Study|Lost to Follow-up|3|||
129809717|NCT03173313|467269408|FG000|Overall Study|Withdrawal by Subject|0|||
129809718|NCT03173313|467269409|FG001|Overall Study|Withdrawal by Subject|1|||
129809719|NCT03173313|467269408|FG000|Overall Study|Death|5|||
129809720|NCT03173313|467269409|FG001|Overall Study|Death|0|||
129809721|NCT03173313|467269408|FG000|Overall Study|Physician Decision|1|||
129809722|NCT03173313|467269409|FG001|Overall Study|Physician Decision|0|||
129809723|NCT03173313|467269408|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
129809724|NCT03173313|467269409|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
129809725|NCT03173313|467269408|FG000|Overall Study|Bone Fracture|1|||
129809726|NCT03173313|467269409|FG001|Overall Study|Bone Fracture|0|||
129809727|NCT01876420|467269410|FG000|Overall Study|Missed 30 day visit|1|||
129809728|NCT04515394|467269414|FG000|Overall Study|Participant did not receive treatment|1|||
129752170|NCT05786508|467051991|FG000|Overall Study|Withdrawal by Subject|2|||
129752171|NCT05786508|467051992|FG001|Overall Study|Withdrawal by Subject|0|||
129752172|NCT04426318|467051993|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
129752173|NCT04426318|467051994|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
129752174|NCT03574779|467051995|FG000|Overall Study|Screening failure|13|||
129752175|NCT03574779|467051996|FG001|Overall Study|Screening failure|83|||
129809729|NCT01042678|467269415|FG000|Overall Study|Physician Decision|1|||
129752176|NCT02588261|467051997|FG000|Overall Study|Study Terminated by Sponsor|157|||
129809730|NCT01042678|467269416|FG001|Overall Study|Physician Decision|0|||
129809731|NCT01042678|467269417|FG002|Overall Study|Physician Decision|0|||
129809732|NCT01042678|467269418|FG003|Overall Study|Physician Decision|0|||
129809733|NCT01042678|467269419|FG004|Overall Study|Physician Decision|0|||
129809734|NCT01042678|467269420|FG005|Overall Study|Physician Decision|0|||
129809735|NCT01058655|467269424|FG000|Overall Study|Withdrawal by Subject|1|||
129809736|NCT01058655|467269425|FG001|Overall Study|Withdrawal by Subject|0|||
129809737|NCT01058655|467269426|FG002|Overall Study|Withdrawal by Subject|3|||
129896607|NCT02223793|467582099|FG001|Overall Study|Moved/studycenter unable to participate|6|||
129896608|NCT02223793|467582100|FG002|Overall Study|Moved/studycenter unable to participate|8|||
129896609|NCT00315055|467582101|FG000|Overall Study|Protocol Violation|2|||
129896610|NCT00315055|467582102|FG001|Overall Study|Protocol Violation|4|||
129896611|NCT00315055|467582101|FG000|Overall Study|Lost to Follow-up|1|||
129896612|NCT00315055|467582102|FG001|Overall Study|Lost to Follow-up|1|||
129752177|NCT02588261|467051998|FG001|Overall Study|Study Terminated by Sponsor|142|||
129752178|NCT02588261|467051997|FG000|Overall Study|Protocol Deviation|1|||
129752179|NCT02588261|467051998|FG001|Overall Study|Protocol Deviation|0|||
129752180|NCT02588261|467051997|FG000|Overall Study|Death|1|||
129752181|NCT02588261|467051998|FG001|Overall Study|Death|2|||
129752182|NCT02588261|467051997|FG000|Overall Study|Withdrawal by Subject|12|||
129752183|NCT02588261|467051998|FG001|Overall Study|Withdrawal by Subject|8|||
129752184|NCT02588261|467051997|FG000|Overall Study|Noncompliance with Study Drug|0|||
129752185|NCT02588261|467051998|FG001|Overall Study|Noncompliance with Study Drug|1|||
129752186|NCT02588261|467051997|FG000|Overall Study|Miscellaneous|5|||
129752187|NCT02588261|467051998|FG001|Overall Study|Miscellaneous|4|||
129752188|NCT02588261|467051997|FG000|Overall Study|Progressive Disease|61|||
129752189|NCT02588261|467051998|FG001|Overall Study|Progressive Disease|82|||
129752190|NCT02588261|467051997|FG000|Overall Study|Adverse Event|29|||
129752191|NCT02588261|467051998|FG001|Overall Study|Adverse Event|24|||
129896613|NCT02359435|467582103|FG000|Overall Study|Lost to Follow-up|4|||
129896614|NCT02359435|467582104|FG001|Overall Study|Lost to Follow-up|4|||
129896615|NCT01289119|467582105|FG000|Overall Study|Adverse Event|2|||
129896616|NCT01289119|467582106|FG001|Overall Study|Adverse Event|1|||
129896617|NCT01289119|467582107|FG002|Overall Study|Adverse Event|0|||
129896618|NCT01289119|467582108|FG003|Overall Study|Adverse Event|2|||
129896619|NCT01289119|467582109|FG004|Overall Study|Adverse Event|1|||
129896620|NCT01289119|467582110|FG005|Overall Study|Adverse Event|0|||
129896621|NCT01289119|467582105|FG000|Overall Study|Major Protocol Deviation|2|||
129896622|NCT01289119|467582106|FG001|Overall Study|Major Protocol Deviation|1|||
129896623|NCT01289119|467582107|FG002|Overall Study|Major Protocol Deviation|3|||
129896624|NCT01289119|467582108|FG003|Overall Study|Major Protocol Deviation|0|||
129896625|NCT01289119|467582109|FG004|Overall Study|Major Protocol Deviation|2|||
129896626|NCT01289119|467582110|FG005|Overall Study|Major Protocol Deviation|1|||
129896627|NCT01289119|467582105|FG000|Overall Study|Lost to Follow-up|0|||
129896628|NCT01289119|467582106|FG001|Overall Study|Lost to Follow-up|3|||
129896629|NCT01289119|467582107|FG002|Overall Study|Lost to Follow-up|0|||
129896630|NCT01289119|467582108|FG003|Overall Study|Lost to Follow-up|0|||
129896631|NCT01289119|467582109|FG004|Overall Study|Lost to Follow-up|0|||
129896632|NCT01289119|467582110|FG005|Overall Study|Lost to Follow-up|1|||
129896633|NCT01289119|467582105|FG000|Overall Study|Withdrawal by Subject|4|||
129896634|NCT01289119|467582106|FG001|Overall Study|Withdrawal by Subject|2|||
129896635|NCT01289119|467582107|FG002|Overall Study|Withdrawal by Subject|4|||
129896636|NCT01289119|467582108|FG003|Overall Study|Withdrawal by Subject|3|||
129896637|NCT01289119|467582109|FG004|Overall Study|Withdrawal by Subject|1|||
129896638|NCT01289119|467582110|FG005|Overall Study|Withdrawal by Subject|1|||
129896639|NCT01289119|467582105|FG000|Overall Study|Pregnancy|0|||
129896640|NCT01289119|467582106|FG001|Overall Study|Pregnancy|1|||
129896641|NCT01289119|467582107|FG002|Overall Study|Pregnancy|0|||
129896642|NCT01289119|467582108|FG003|Overall Study|Pregnancy|0|||
129896643|NCT01289119|467582109|FG004|Overall Study|Pregnancy|0|||
129896644|NCT01289119|467582110|FG005|Overall Study|Pregnancy|0|||
129896645|NCT01289119|467582105|FG000|Overall Study|Lack of Efficacy|0|||
129896646|NCT01289119|467582106|FG001|Overall Study|Lack of Efficacy|1|||
129896647|NCT01289119|467582107|FG002|Overall Study|Lack of Efficacy|1|||
129896648|NCT01289119|467582108|FG003|Overall Study|Lack of Efficacy|1|||
129896649|NCT01289119|467582109|FG004|Overall Study|Lack of Efficacy|1|||
129896650|NCT01289119|467582110|FG005|Overall Study|Lack of Efficacy|1|||
129896651|NCT01289119|467582105|FG000|Overall Study|Other|1|||
129896652|NCT01289119|467582106|FG001|Overall Study|Other|0|||
129896653|NCT01289119|467582107|FG002|Overall Study|Other|1|||
129896654|NCT01289119|467582108|FG003|Overall Study|Other|0|||
129896655|NCT01289119|467582109|FG004|Overall Study|Other|0|||
129896656|NCT01289119|467582110|FG005|Overall Study|Other|0|||
129752192|NCT02588261|467051997|FG000|Overall Study|Lost to Follow-up|1|||
129752193|NCT02588261|467051998|FG001|Overall Study|Lost to Follow-up|0|||
129752194|NCT02287467|467052000|FG000|Overall Study|Protocol Violation|12|||
129752195|NCT02287467|467052001|FG001|Overall Study|Protocol Violation|9|||
129752196|NCT03781778|467052002|FG000|Overall Study|Withdrawal by Subject|2|||
129752197|NCT03781778|467052003|FG001|Overall Study|Withdrawal by Subject|2|||
129896657|NCT01704846|467582111|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129896658|NCT01704846|467582112|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129896659|NCT00530335|467582113|FG000|Overall Study|Adverse Event|3|||
129896660|NCT00530335|467582113|FG000|Overall Study|Protocol Violation|1|||
129896661|NCT00530335|467582113|FG000|Overall Study|Withdrawal by Subject|1|||
129896662|NCT00530335|467582113|FG000|Overall Study|Physician Decision|1|||
129896663|NCT04577183|467582114|FG000|Overall Study|Death|1|||
129896664|NCT04577183|467582114|FG000|Overall Study|Withdrawal by Subject|3|||
129896665|NCT04577183|467582114|FG000|Overall Study|Early termination|2|||
129752198|NCT02652156|467052004|FG000|Overall Study|Physician Decision|1|||
129752199|NCT02652156|467052005|FG001|Overall Study|Physician Decision|0|||
129752200|NCT02652156|467052006|FG002|Overall Study|Physician Decision|0|||
129752201|NCT00108862|467052007|FG000|Overall Study|Death|31|||
129752202|NCT00108862|467052008|FG001|Overall Study|Death|37|||
129752203|NCT00108862|467052007|FG000|Overall Study|Withdrawal by Subject|10|||
129752204|NCT00108862|467052008|FG001|Overall Study|Withdrawal by Subject|6|||
129752205|NCT00108862|467052007|FG000|Overall Study|Lost to Follow-up|27|||
129752206|NCT00108862|467052008|FG001|Overall Study|Lost to Follow-up|19|||
129752207|NCT03534141|467052009|FG000|Overall Study|Enrolled in other clinical trial|1|||
129752208|NCT03534141|467052010|FG001|Overall Study|Enrolled in other clinical trial|0|||
129752209|NCT03534141|467052009|FG000|Overall Study|Liver transplant aborted after randomization|0|||
129752210|NCT03534141|467052010|FG001|Overall Study|Liver transplant aborted after randomization|2|||
129752211|NCT03534141|467052009|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
129752212|NCT03534141|467052010|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
129752213|NCT00517361|467052011|FG000|Overall Study|Death|6|||
129752214|NCT00517361|467052011|FG000|Overall Study|The study was terminated|5|||
129752215|NCT01685697|467052012|FG000|Overall Study|Protocol Violation|3|||
129752216|NCT01685697|467052013|FG001|Overall Study|Protocol Violation|3|||
129752217|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Death|0|||
129752218|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Death|0|||
129752219|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Death|0|||
129752220|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Death|0|||
129752221|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Death|1|||
129752222|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Death|0|||
129752223|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Death|0|||
129752224|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Death|0|||
129752225|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
129752226|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
129752227|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
129752228|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
129752229|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
129752230|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
129752231|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
129752232|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
129752233|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
129752234|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129752235|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129752236|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
129752237|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129752238|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
129752239|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129752240|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
129752241|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
129752242|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
129752243|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
129752244|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
129752245|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
129752246|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
129752247|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
129752248|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
129752249|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
129752250|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
129752251|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
129752252|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
129752253|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
129809738|NCT01058655|467269427|FG003|Overall Study|Withdrawal by Subject|4|||
129809739|NCT01058655|467269424|FG000|Overall Study|Prolonged Treatment Delay|0|||
129809740|NCT01058655|467269425|FG001|Overall Study|Prolonged Treatment Delay|0|||
129809741|NCT01058655|467269426|FG002|Overall Study|Prolonged Treatment Delay|0|||
129809742|NCT01058655|467269427|FG003|Overall Study|Prolonged Treatment Delay|2|||
129752254|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
129752255|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
129752256|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
129752257|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
129752258|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129809743|NCT01058655|467269424|FG000|Overall Study|Symptomatic Deterioration|0|||
129809744|NCT01058655|467269425|FG001|Overall Study|Symptomatic Deterioration|0|||
129809745|NCT01058655|467269426|FG002|Overall Study|Symptomatic Deterioration|0|||
129752259|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129752260|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
129752261|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
129752262|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
129752263|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129752264|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
129752265|NCT00726232|467052014|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
129752266|NCT00726232|467052015|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752267|NCT00726232|467052016|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752268|NCT00726232|467052017|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752269|NCT00726232|467052018|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752270|NCT00726232|467052019|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752271|NCT00726232|467052020|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752272|NCT00726232|467052021|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
129752273|NCT00726232|467052014|FG000|Expansion Phase|Death|0|||
129752274|NCT00726232|467052015|FG001|Expansion Phase|Death|0|||
129752275|NCT00726232|467052016|FG002|Expansion Phase|Death|0|||
129752276|NCT00726232|467052017|FG003|Expansion Phase|Death|0|||
129752277|NCT00726232|467052018|FG004|Expansion Phase|Death|0|||
129752278|NCT00726232|467052019|FG005|Expansion Phase|Death|0|||
129752279|NCT00726232|467052020|FG006|Expansion Phase|Death|0|||
129752280|NCT00726232|467052021|FG007|Expansion Phase|Death|1|||
129752281|NCT00726232|467052014|FG000|Expansion Phase|Adverse Event|0|||
129752282|NCT00726232|467052015|FG001|Expansion Phase|Adverse Event|0|||
129752283|NCT00726232|467052016|FG002|Expansion Phase|Adverse Event|0|||
129752284|NCT00726232|467052017|FG003|Expansion Phase|Adverse Event|0|||
129809746|NCT01058655|467269427|FG003|Overall Study|Symptomatic Deterioration|1|||
129809747|NCT01058655|467269424|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
129809748|NCT01058655|467269425|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
129809749|NCT01058655|467269426|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
129809750|NCT01058655|467269427|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
129809751|NCT01058655|467269424|FG000|Overall Study|Death|0|||
129809752|NCT01058655|467269425|FG001|Overall Study|Death|1|||
129809753|NCT01058655|467269426|FG002|Overall Study|Death|1|||
129809754|NCT01058655|467269427|FG003|Overall Study|Death|0|||
129809755|NCT01058655|467269424|FG000|Overall Study|Disease Progression|1|||
129809756|NCT01058655|467269425|FG001|Overall Study|Disease Progression|2|||
129809757|NCT01058655|467269426|FG002|Overall Study|Disease Progression|4|||
129809758|NCT01058655|467269427|FG003|Overall Study|Disease Progression|24|||
129752285|NCT00726232|467052018|FG004|Expansion Phase|Adverse Event|0|||
129752286|NCT00726232|467052019|FG005|Expansion Phase|Adverse Event|0|||
129752287|NCT00726232|467052020|FG006|Expansion Phase|Adverse Event|6|||
129752288|NCT00726232|467052021|FG007|Expansion Phase|Adverse Event|11|||
129752289|NCT00726232|467052014|FG000|Expansion Phase|Withdrawal by Subject|0|||
129752290|NCT00726232|467052015|FG001|Expansion Phase|Withdrawal by Subject|0|||
129752291|NCT00726232|467052016|FG002|Expansion Phase|Withdrawal by Subject|0|||
129752292|NCT00726232|467052017|FG003|Expansion Phase|Withdrawal by Subject|0|||
129752293|NCT00726232|467052018|FG004|Expansion Phase|Withdrawal by Subject|0|||
129752294|NCT00726232|467052019|FG005|Expansion Phase|Withdrawal by Subject|0|||
129752295|NCT00726232|467052020|FG006|Expansion Phase|Withdrawal by Subject|2|||
129752296|NCT00726232|467052021|FG007|Expansion Phase|Withdrawal by Subject|3|||
129752297|NCT00726232|467052014|FG000|Expansion Phase|Disease progression|0|||
129752298|NCT00726232|467052015|FG001|Expansion Phase|Disease progression|0|||
129809759|NCT01058655|467269424|FG000|Overall Study|Other|0|||
129752299|NCT00726232|467052016|FG002|Expansion Phase|Disease progression|0|||
129809760|NCT01058655|467269425|FG001|Overall Study|Other|0|||
129809761|NCT01058655|467269426|FG002|Overall Study|Other|0|||
129809762|NCT01058655|467269427|FG003|Overall Study|Other|4|||
129809763|NCT04472429|467269428|FG000|Randomized Period|Ongoing|90|||
129809764|NCT04472429|467269429|FG001|Randomized Period|Ongoing|40|||
129809765|NCT04472429|467269430|FG002|Randomized Period|Ongoing|0|||
129809766|NCT04472429|467269428|FG000|Randomized Period|Death|52|||
129809767|NCT04472429|467269429|FG001|Randomized Period|Death|37|||
129809768|NCT04472429|467269430|FG002|Randomized Period|Death|0|||
129752300|NCT00726232|467052017|FG003|Expansion Phase|Disease progression|0|||
129752301|NCT00726232|467052018|FG004|Expansion Phase|Disease progression|0|||
129809769|NCT04472429|467269428|FG000|Randomized Period|Lost to Follow-up|4|||
129896666|NCT00938340|467582118|FG000|Overall Study|Withdrawal by Subject|3|||
129752302|NCT00726232|467052019|FG005|Expansion Phase|Disease progression|0|||
129752303|NCT00726232|467052020|FG006|Expansion Phase|Disease progression|4|||
129752304|NCT00726232|467052021|FG007|Expansion Phase|Disease progression|0|||
129752305|NCT00726232|467052014|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
129809770|NCT04472429|467269429|FG001|Randomized Period|Lost to Follow-up|0|||
129809771|NCT04472429|467269430|FG002|Randomized Period|Lost to Follow-up|0|||
129809772|NCT04472429|467269428|FG000|Randomized Period|Physician Decision|1|||
129809773|NCT04472429|467269429|FG001|Randomized Period|Physician Decision|2|||
129809774|NCT04472429|467269430|FG002|Randomized Period|Physician Decision|0|||
129752306|NCT00726232|467052015|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
129752307|NCT00726232|467052016|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
129752308|NCT00726232|467052017|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
129752309|NCT00726232|467052018|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
129752310|NCT00726232|467052019|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
129752311|NCT00726232|467052020|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
129752312|NCT00726232|467052021|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
129752313|NCT00726232|467052014|FG000|Expansion Phase|Per Investigator: lack of response|0|||
129752314|NCT00726232|467052015|FG001|Expansion Phase|Per Investigator: lack of response|0|||
129752315|NCT00726232|467052016|FG002|Expansion Phase|Per Investigator: lack of response|0|||
129752316|NCT00726232|467052017|FG003|Expansion Phase|Per Investigator: lack of response|0|||
129752317|NCT00726232|467052018|FG004|Expansion Phase|Per Investigator: lack of response|0|||
129752318|NCT00726232|467052019|FG005|Expansion Phase|Per Investigator: lack of response|0|||
129752319|NCT00726232|467052020|FG006|Expansion Phase|Per Investigator: lack of response|1|||
129752320|NCT00726232|467052021|FG007|Expansion Phase|Per Investigator: lack of response|7|||
129752321|NCT00726232|467052014|FG000|Expansion Phase|Unspecified reason|0|||
129752322|NCT00726232|467052015|FG001|Expansion Phase|Unspecified reason|0|||
129752323|NCT00726232|467052016|FG002|Expansion Phase|Unspecified reason|0|||
129752324|NCT00726232|467052017|FG003|Expansion Phase|Unspecified reason|0|||
129752325|NCT00726232|467052018|FG004|Expansion Phase|Unspecified reason|0|||
129752326|NCT00726232|467052019|FG005|Expansion Phase|Unspecified reason|0|||
129752327|NCT00726232|467052020|FG006|Expansion Phase|Unspecified reason|1|||
129752328|NCT00726232|467052021|FG007|Expansion Phase|Unspecified reason|0|||
129752329|NCT00195091|467052022|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
129752330|NCT00245037|467052023|FG000|Overall Study|Death|17|||
129752331|NCT00566852|467052026|FG000|Overall Study|Protocol Violation|22|||
129752332|NCT00566852|467052027|FG001|Overall Study|Protocol Violation|24|||
129752333|NCT00566852|467052026|FG000|Overall Study|Death|95|||
129752334|NCT00566852|467052027|FG001|Overall Study|Death|78|||
129752335|NCT00566852|467052026|FG000|Overall Study|Withdrawal by Subject|30|||
129752336|NCT00566852|467052027|FG001|Overall Study|Withdrawal by Subject|25|||
129752337|NCT00566852|467052026|FG000|Overall Study|Patient refusal|37|||
129752338|NCT00566852|467052027|FG001|Overall Study|Patient refusal|37|||
129752339|NCT00566852|467052026|FG000|Overall Study|Not tested due to disability|6|||
129752340|NCT00566852|467052027|FG001|Overall Study|Not tested due to disability|12|||
129752341|NCT00566852|467052026|FG000|Overall Study|Missing reason not specified|1|||
129752342|NCT00566852|467052027|FG001|Overall Study|Missing reason not specified|2|||
129752343|NCT00566852|467052026|FG000|Overall Study|Missing reason not reported|16|||
129752344|NCT00566852|467052027|FG001|Overall Study|Missing reason not reported|20|||
129752345|NCT04079816|467052028|FG000|Overall Study|Request of Subject|2|||
129752346|NCT04079816|467052028|FG000|Overall Study|Unable to draw samples|1|||
129752347|NCT04137731|467052029|FG000|Overall Study|Surgery Cancellation|1|||
129752348|NCT04137731|467052030|FG001|Overall Study|Surgery Cancellation|2|||
129752349|NCT04137731|467052029|FG000|Overall Study|Withdrawal by Subject|2|||
129752350|NCT04137731|467052030|FG001|Overall Study|Withdrawal by Subject|0|||
129752351|NCT04137731|467052029|FG000|Overall Study|Protocol Violation|0|||
129752352|NCT04137731|467052030|FG001|Overall Study|Protocol Violation|1|||
129752353|NCT00310817|467052031|FG000|Overall Study|AE or Death|3|||
129752354|NCT00310817|467052032|FG001|Overall Study|AE or Death|1|||
129752355|NCT00310817|467052033|FG002|Overall Study|AE or Death|0|||
129752356|NCT00310817|467052034|FG003|Overall Study|AE or Death|0|||
129752357|NCT00310817|467052031|FG000|Overall Study|Withdrawal by Subject|1|||
129752358|NCT00310817|467052032|FG001|Overall Study|Withdrawal by Subject|4|||
129752359|NCT00310817|467052033|FG002|Overall Study|Withdrawal by Subject|6|||
129752360|NCT00310817|467052034|FG003|Overall Study|Withdrawal by Subject|7|||
129752361|NCT00310817|467052031|FG000|Overall Study|Lost to Follow-up|2|||
129752362|NCT00310817|467052032|FG001|Overall Study|Lost to Follow-up|1|||
129752363|NCT00310817|467052033|FG002|Overall Study|Lost to Follow-up|0|||
129752364|NCT00310817|467052034|FG003|Overall Study|Lost to Follow-up|0|||
129809775|NCT04472429|467269428|FG000|Randomized Period|Withdrawal by Subject|6|||
129809776|NCT04472429|467269429|FG001|Randomized Period|Withdrawal by Subject|5|||
129752365|NCT00310817|467052031|FG000|Overall Study|Inappropriate Enrollment|1|||
129752366|NCT00310817|467052032|FG001|Overall Study|Inappropriate Enrollment|0|||
129752367|NCT00310817|467052033|FG002|Overall Study|Inappropriate Enrollment|1|||
129752368|NCT00310817|467052034|FG003|Overall Study|Inappropriate Enrollment|0|||
129752369|NCT00310817|467052031|FG000|Overall Study|Protocol Violation|1|||
129752370|NCT00310817|467052032|FG001|Overall Study|Protocol Violation|1|||
129752371|NCT00310817|467052033|FG002|Overall Study|Protocol Violation|1|||
129752372|NCT00310817|467052034|FG003|Overall Study|Protocol Violation|1|||
129752373|NCT00310817|467052031|FG000|Overall Study|Unable to classify|3|||
129752374|NCT00310817|467052032|FG001|Overall Study|Unable to classify|1|||
129752375|NCT00310817|467052033|FG002|Overall Study|Unable to classify|0|||
129752376|NCT00310817|467052034|FG003|Overall Study|Unable to classify|0|||
129752377|NCT01702246|467052035|FG000|Overall Study|Lost to Follow-up|2|||
129809777|NCT04472429|467269430|FG002|Randomized Period|Withdrawal by Subject|0|||
129752378|NCT01702246|467052035|FG000|Overall Study|Withdrawal by Subject|2|||
129752379|NCT01702246|467052035|FG000|Overall Study|Physician Decision|1|||
129809778|NCT04472429|467269428|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
129809779|NCT04472429|467269429|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
129809780|NCT04472429|467269430|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
129809781|NCT04472429|467269428|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
129752380|NCT01587040|467052036|FG000|Overall Study|Protocol Violation|0|||
129752381|NCT01587040|467052037|FG001|Overall Study|Protocol Violation|0|||
129752382|NCT01587040|467052038|FG002|Overall Study|Protocol Violation|1|||
129752383|NCT01587040|467052039|FG003|Overall Study|Protocol Violation|0|||
129752384|NCT01587040|467052036|FG000|Overall Study|Adverse Event|0|||
129752385|NCT01587040|467052037|FG001|Overall Study|Adverse Event|1|||
129752386|NCT01587040|467052038|FG002|Overall Study|Adverse Event|10|||
129752387|NCT01587040|467052039|FG003|Overall Study|Adverse Event|0|||
129752388|NCT01587040|467052036|FG000|Overall Study|Disease progression|12|||
129752389|NCT01587040|467052037|FG001|Overall Study|Disease progression|1|||
129752390|NCT01587040|467052038|FG002|Overall Study|Disease progression|15|||
129752391|NCT01587040|467052039|FG003|Overall Study|Disease progression|3|||
129752392|NCT01587040|467052036|FG000|Overall Study|Other than specified|5|||
129752393|NCT01587040|467052037|FG001|Overall Study|Other than specified|1|||
129752394|NCT01587040|467052038|FG002|Overall Study|Other than specified|11|||
129752395|NCT01587040|467052039|FG003|Overall Study|Other than specified|1|||
129752396|NCT04607837|467052042|FG000|Overall Study|Adverse Event|8|||
129752397|NCT04607837|467052043|FG001|Overall Study|Adverse Event|2|||
129752398|NCT04607837|467052042|FG000|Overall Study|Withdrawal by Subject|8|||
129752399|NCT04607837|467052043|FG001|Overall Study|Withdrawal by Subject|7|||
129752400|NCT04607837|467052042|FG000|Overall Study|Physician Decision|2|||
129752401|NCT04607837|467052043|FG001|Overall Study|Physician Decision|0|||
129752402|NCT04607837|467052042|FG000|Overall Study|Lack of Efficacy|2|||
129752403|NCT04607837|467052043|FG001|Overall Study|Lack of Efficacy|0|||
129752404|NCT04607837|467052042|FG000|Overall Study|Participant terminated by sponsor|1|||
129752405|NCT04607837|467052043|FG001|Overall Study|Participant terminated by sponsor|0|||
129752406|NCT04607837|467052042|FG000|Overall Study|Disease worsening|36|||
129752407|NCT04607837|467052043|FG001|Overall Study|Disease worsening|36|||
129752408|NCT04607837|467052042|FG000|Overall Study|Other|1|||
129752409|NCT04607837|467052043|FG001|Overall Study|Other|0|||
129752410|NCT04346654|467052044|FG000|Overall Study|Adverse Event|2|||
129752411|NCT04346654|467052045|FG001|Overall Study|Adverse Event|0|||
129752412|NCT04346654|467052044|FG000|Overall Study|Non-response|1|||
129752413|NCT04346654|467052045|FG001|Overall Study|Non-response|1|||
129752414|NCT04346654|467052044|FG000|Overall Study|Withdrawal by Subject|2|||
129752415|NCT04346654|467052045|FG001|Overall Study|Withdrawal by Subject|0|||
129752416|NCT04346654|467052044|FG000|Overall Study|Lost to Follow-up|0|||
129752417|NCT04346654|467052045|FG001|Overall Study|Lost to Follow-up|1|||
129752418|NCT04346654|467052044|FG000|Overall Study|Pregnancy|0|||
129752419|NCT04346654|467052045|FG001|Overall Study|Pregnancy|1|||
129752420|NCT05715242|467052046|FG000|Overall Study|Lost to Follow-up|0|||
129752421|NCT05715242|467052047|FG001|Overall Study|Lost to Follow-up|0|||
129752422|NCT05715242|467052048|FG002|Overall Study|Lost to Follow-up|1|||
129752423|NCT05715242|467052049|FG003|Overall Study|Lost to Follow-up|0|||
129752424|NCT05715242|467052050|FG004|Overall Study|Lost to Follow-up|0|||
129752425|NCT05715242|467052051|FG005|Overall Study|Lost to Follow-up|1|||
129752426|NCT05715242|467052052|FG006|Overall Study|Lost to Follow-up|0|||
129752427|NCT05715242|467052053|FG007|Overall Study|Lost to Follow-up|0|||
129752428|NCT05715242|467052054|FG008|Overall Study|Lost to Follow-up|0|||
129752429|NCT05715242|467052055|FG009|Overall Study|Lost to Follow-up|0|||
129752430|NCT05715242|467052056|FG010|Overall Study|Lost to Follow-up|0|||
129809782|NCT04472429|467269429|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
129809783|NCT04472429|467269430|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
129809784|NCT04472429|467269428|FG000|Open-label Monotherapy Period|Ongoing|0|||
129809785|NCT04472429|467269429|FG001|Open-label Monotherapy Period|Ongoing|0|||
129752431|NCT05715242|467052057|FG011|Overall Study|Lost to Follow-up|0|||
129752432|NCT05715242|467052058|FG012|Overall Study|Lost to Follow-up|0|||
129752433|NCT05715242|467052059|FG013|Overall Study|Lost to Follow-up|0|||
129752434|NCT05715242|467052060|FG014|Overall Study|Lost to Follow-up|0|||
129752435|NCT05715242|467052061|FG015|Overall Study|Lost to Follow-up|0|||
129809786|NCT04472429|467269430|FG002|Open-label Monotherapy Period|Ongoing|32|||
129752436|NCT02915978|467052062|FG000|Overall Study|Adverse Event|2|||
129752437|NCT02915978|467052063|FG001|Overall Study|Adverse Event|1|||
129752438|NCT02915978|467052064|FG002|Overall Study|Adverse Event|0|||
129752439|NCT02343406|467052070|FG000|Overall Study|Progressive disease|72|||
129752440|NCT02343406|467052071|FG001|Overall Study|Progressive disease|70|||
129752441|NCT02343406|467052072|FG002|Overall Study|Progressive disease|43|||
129752442|NCT02343406|467052073|FG003|Overall Study|Progressive disease|15|||
129752443|NCT02343406|467052074|FG004|Overall Study|Progressive disease|5|||
129752444|NCT02343406|467052070|FG000|Overall Study|Adverse Event|6|||
129752445|NCT02343406|467052071|FG001|Overall Study|Adverse Event|8|||
129752446|NCT02343406|467052072|FG002|Overall Study|Adverse Event|6|||
129809787|NCT04472429|467269428|FG000|Open-label Monotherapy Period|Death|0|||
129752447|NCT02343406|467052073|FG003|Overall Study|Adverse Event|3|||
129752448|NCT02343406|467052074|FG004|Overall Study|Adverse Event|0|||
129752449|NCT02343406|467052070|FG000|Overall Study|Withdrawal by Subject|6|||
129752450|NCT02343406|467052071|FG001|Overall Study|Withdrawal by Subject|4|||
129752451|NCT02343406|467052072|FG002|Overall Study|Withdrawal by Subject|8|||
129752452|NCT02343406|467052073|FG003|Overall Study|Withdrawal by Subject|3|||
129752453|NCT02343406|467052074|FG004|Overall Study|Withdrawal by Subject|0|||
129752454|NCT02343406|467052070|FG000|Overall Study|Death|2|||
129752455|NCT02343406|467052071|FG001|Overall Study|Death|1|||
129752456|NCT02343406|467052072|FG002|Overall Study|Death|0|||
129752457|NCT02343406|467052073|FG003|Overall Study|Death|0|||
129752458|NCT02343406|467052074|FG004|Overall Study|Death|0|||
129752459|NCT02343406|467052070|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
129752460|NCT02343406|467052071|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
129752461|NCT02343406|467052072|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
129752462|NCT02343406|467052073|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
129752463|NCT02343406|467052074|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
129752464|NCT02343406|467052070|FG000|Overall Study|Other primary malignancy|0|||
129752465|NCT02343406|467052071|FG001|Overall Study|Other primary malignancy|1|||
129752466|NCT02343406|467052072|FG002|Overall Study|Other primary malignancy|0|||
129752467|NCT02343406|467052073|FG003|Overall Study|Other primary malignancy|0|||
129752468|NCT02343406|467052074|FG004|Overall Study|Other primary malignancy|0|||
129752469|NCT02343406|467052070|FG000|Overall Study|Other, not specified|2|||
129752470|NCT02343406|467052071|FG001|Overall Study|Other, not specified|1|||
129752471|NCT02343406|467052072|FG002|Overall Study|Other, not specified|1|||
129752472|NCT02343406|467052073|FG003|Overall Study|Other, not specified|4|||
129752473|NCT02343406|467052074|FG004|Overall Study|Other, not specified|0|||
129752474|NCT02451124|467052075|FG000|Overall Study|Withdrawal by Subject|1|||
129752475|NCT00958165|467052076|FG000|Overall Study|Lost to Follow-up|5|||
129752476|NCT00958165|467052076|FG000|Overall Study|Not eligible|9|||
129752477|NCT00166439|467052080|FG000|Overall Study|Ineligible|5|||
129752478|NCT00615992|467052081|FG000|Overall Study|Protocol Violation|67|||
129752479|NCT00856297|467052082|FG000|Overall Study|Unable to classify|2|||
129752480|NCT00856297|467052083|FG001|Overall Study|Unable to classify|0|||
129752481|NCT00856297|467052084|FG002|Overall Study|Unable to classify|0|||
129752482|NCT00856297|467052085|FG003|Overall Study|Unable to classify|0|||
129752483|NCT00856297|467052086|FG004|Overall Study|Unable to classify|0|||
129752484|NCT01392547|467053830|FG000|Overall Study|Adverse Event|2|||
129752485|NCT01392547|467053830|FG000|Overall Study|Non-compliance|2|||
129752486|NCT01392547|467053830|FG000|Overall Study|Withdrawal criteria|3|||
129752487|NCT01392547|467053830|FG000|Overall Study|Unclassified|1|||
129752488|NCT00615017|467053831|FG000|Overall Study|Adverse Event|0|||
129752489|NCT00615017|467053832|FG001|Overall Study|Adverse Event|1|||
129752490|NCT00615017|467053833|FG002|Overall Study|Adverse Event|2|||
129752491|NCT00615017|467053834|FG003|Overall Study|Adverse Event|0|||
129752492|NCT00615017|467053835|FG004|Overall Study|Adverse Event|0|||
129752493|NCT00615017|467053836|FG005|Overall Study|Adverse Event|1|||
129752494|NCT00615017|467053831|FG000|Overall Study|Death|0|||
129752495|NCT00615017|467053832|FG001|Overall Study|Death|0|||
129752496|NCT00615017|467053833|FG002|Overall Study|Death|2|||
129752497|NCT00615017|467053834|FG003|Overall Study|Death|0|||
129752498|NCT00615017|467053835|FG004|Overall Study|Death|1|||
129752499|NCT00615017|467053836|FG005|Overall Study|Death|1|||
129752500|NCT00615017|467053831|FG000|Overall Study|Sepsis resolved|0|||
129752501|NCT00615017|467053832|FG001|Overall Study|Sepsis resolved|0|||
129809788|NCT04472429|467269429|FG001|Open-label Monotherapy Period|Death|0|||
129809789|NCT04472429|467269430|FG002|Open-label Monotherapy Period|Death|35|||
129809790|NCT04472429|467269428|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
129809791|NCT04472429|467269429|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
129809792|NCT04472429|467269430|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
129809793|NCT02319837|467269433|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
129752502|NCT00615017|467053833|FG002|Overall Study|Sepsis resolved|1|||
129752503|NCT00615017|467053834|FG003|Overall Study|Sepsis resolved|0|||
129752504|NCT00615017|467053835|FG004|Overall Study|Sepsis resolved|0|||
129752505|NCT00615017|467053836|FG005|Overall Study|Sepsis resolved|0|||
129752506|NCT00615017|467053831|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
129752507|NCT00615017|467053832|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
129752508|NCT00615017|467053833|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
129752509|NCT00615017|467053834|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
129752510|NCT00615017|467053835|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
129752511|NCT00615017|467053836|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
129752512|NCT00615017|467053831|FG000|Overall Study|Physician discontinued drug|0|||
129752513|NCT00615017|467053832|FG001|Overall Study|Physician discontinued drug|0|||
129896667|NCT00938340|467582118|FG000|Overall Study|Protocol Violation|1|||
129752514|NCT00615017|467053833|FG002|Overall Study|Physician discontinued drug|0|||
129752515|NCT00615017|467053834|FG003|Overall Study|Physician discontinued drug|0|||
129752516|NCT00615017|467053835|FG004|Overall Study|Physician discontinued drug|0|||
129752517|NCT00615017|467053836|FG005|Overall Study|Physician discontinued drug|1|||
129752518|NCT00806988|467053837|FG000|Overall Study|Death|15|||
129752519|NCT00806988|467053838|FG001|Overall Study|Death|16|||
129752520|NCT00806988|467053837|FG000|Overall Study|Withdrawal by Subject|8|||
129752521|NCT00806988|467053838|FG001|Overall Study|Withdrawal by Subject|8|||
129752522|NCT00806988|467053837|FG000|Overall Study|Lost to Follow-up|4|||
129752523|NCT00806988|467053838|FG001|Overall Study|Lost to Follow-up|19|||
129752524|NCT04775953|467053839|FG000|Overall Study|Lost to Follow-up|6|||
129752525|NCT04775953|467053840|FG001|Overall Study|Lost to Follow-up|11|||
129752526|NCT04775953|467053839|FG000|Overall Study|Death|5|||
129752527|NCT04775953|467053840|FG001|Overall Study|Death|4|||
129752528|NCT04775953|467053839|FG000|Overall Study|Withdrawal by Subject|3|||
129752529|NCT04775953|467053840|FG001|Overall Study|Withdrawal by Subject|3|||
129752530|NCT04775953|467053839|FG000|Overall Study|Protocol Violation|2|||
129752531|NCT04775953|467053840|FG001|Overall Study|Protocol Violation|0|||
129752532|NCT04775953|467053839|FG000|Overall Study|Participant non-compliance|0|||
129752533|NCT04775953|467053840|FG001|Overall Study|Participant non-compliance|1|||
129752534|NCT00855959|467053841|FG000|Overall Study|Adverse Event|2|||
129752535|NCT00855959|467053841|FG000|Overall Study|Lost to Follow-up|2|||
129752536|NCT00855959|467053841|FG000|Overall Study|Withdrawal by Subject|3|||
129752537|NCT00855959|467053841|FG000|Overall Study|Pregnancy|1|||
129752538|NCT00855959|467053841|FG000|Overall Study|Incorrect enrolment|1|||
129752539|NCT02813889|467053842|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
129752540|NCT02813889|467053843|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
129752541|NCT00368641|467053844|FG000|Overall Study|Adverse Event|2|||
129752542|NCT00368641|467053845|FG001|Overall Study|Adverse Event|1|||
129752543|NCT00368641|467053844|FG000|Overall Study|Death|1|||
129752544|NCT00368641|467053845|FG001|Overall Study|Death|0|||
129752545|NCT00368641|467053844|FG000|Overall Study|Withdrawal by Subject|1|||
129752546|NCT00368641|467053845|FG001|Overall Study|Withdrawal by Subject|0|||
129752547|NCT00368641|467053844|FG000|Overall Study|Sponsor decision to terminate study|2|||
129752548|NCT00368641|467053845|FG001|Overall Study|Sponsor decision to terminate study|5|||
129752549|NCT02517541|467053852|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
129752550|NCT02517541|467053852|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
129752551|NCT02517541|467053852|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
129752552|NCT02517541|467053852|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
129752553|NCT02517541|467053852|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
129752554|NCT02517541|467053852|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
129752555|NCT00699608|467053853|FG000|First Intervention|Withdrawal by Subject|0|||
129752556|NCT00699608|467053854|FG001|First Intervention|Withdrawal by Subject|0|||
129752557|NCT00699608|467053855|FG002|First Intervention|Withdrawal by Subject|1|||
129752558|NCT00699608|467053856|FG003|First Intervention|Withdrawal by Subject|0|||
129752559|NCT00699608|467053857|FG004|First Intervention|Withdrawal by Subject|0|||
129752560|NCT00699608|467053858|FG005|First Intervention|Withdrawal by Subject|0|||
129752561|NCT00699608|467053853|FG000|First Intervention|Protocol Violation|0|||
129752562|NCT00699608|467053854|FG001|First Intervention|Protocol Violation|0|||
129752563|NCT00699608|467053855|FG002|First Intervention|Protocol Violation|0|||
129752564|NCT00699608|467053856|FG003|First Intervention|Protocol Violation|0|||
129752565|NCT00699608|467053857|FG004|First Intervention|Protocol Violation|1|||
129752566|NCT00699608|467053858|FG005|First Intervention|Protocol Violation|0|||
129752567|NCT00699608|467053853|FG000|Second Intervention|Adverse Event|0|||
129752568|NCT00699608|467053854|FG001|Second Intervention|Adverse Event|0|||
129752569|NCT00699608|467053855|FG002|Second Intervention|Adverse Event|1|||
129809794|NCT02319837|467269434|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
129809795|NCT02319837|467269435|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
129809796|NCT02319837|467269433|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
129809797|NCT02319837|467269434|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
129809798|NCT02319837|467269435|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
129752570|NCT00699608|467053856|FG003|Second Intervention|Adverse Event|0|||
129752571|NCT00699608|467053857|FG004|Second Intervention|Adverse Event|0|||
129752572|NCT00699608|467053858|FG005|Second Intervention|Adverse Event|0|||
129752573|NCT00699608|467053853|FG000|Second Intervention|Withdrawal by Subject|0|||
129752574|NCT00699608|467053854|FG001|Second Intervention|Withdrawal by Subject|0|||
129752575|NCT00699608|467053855|FG002|Second Intervention|Withdrawal by Subject|0|||
129752576|NCT00699608|467053856|FG003|Second Intervention|Withdrawal by Subject|1|||
129752577|NCT00699608|467053857|FG004|Second Intervention|Withdrawal by Subject|0|||
129752578|NCT00699608|467053858|FG005|Second Intervention|Withdrawal by Subject|0|||
129752579|NCT03078556|467053861|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
129752580|NCT03078556|467053862|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
129752581|NCT03078556|467053863|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
129752582|NCT03078556|467053864|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
129752583|NCT03078556|467053861|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
129752584|NCT03078556|467053862|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
129752585|NCT03078556|467053863|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
129752586|NCT03078556|467053864|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
129752587|NCT03078556|467053861|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
129752588|NCT03078556|467053862|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
129752589|NCT03078556|467053863|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
129752590|NCT03078556|467053864|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
129752591|NCT03078556|467053861|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
129752592|NCT03078556|467053862|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
129752593|NCT03078556|467053863|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
129752594|NCT03078556|467053864|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
129752595|NCT04306510|467053865|FG000|Overall Study|Voluntarily withdrawal|1|||
129752596|NCT04306510|467053865|FG000|Overall Study|Enrolled but Not Treated|1|||
129752597|NCT04720417|467053866|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
129752598|NCT00496080|467053872|FG000|Overall Study|Lost to Follow-up|9|||
129752599|NCT00496080|467053872|FG000|Overall Study|Surgical re-intervention|7|||
129752600|NCT00496080|467053872|FG000|Overall Study|Withdrawal by Subject|5|||
129752601|NCT00496080|467053872|FG000|Overall Study|Physician Decision|6|||
129752602|NCT00570310|467053873|FG000|Overall Study|Adverse Event|1|||
129752603|NCT00570310|467053874|FG001|Overall Study|Adverse Event|2|||
129752604|NCT00570310|467053873|FG000|Overall Study|Lack of Efficacy|1|||
129752605|NCT00570310|467053874|FG001|Overall Study|Lack of Efficacy|4|||
129752606|NCT00887549|467053875|FG000|Induction Therapy|Adverse Event|8|||
129752607|NCT00887549|467053875|FG000|Induction Therapy|Physician Decision|1|||
129752608|NCT00887549|467053875|FG000|Induction Therapy|Progressive Disease|13|||
129752609|NCT00887549|467053875|FG000|Induction Therapy|Death due to Study Disease|4|||
129752610|NCT00887549|467053875|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
129752611|NCT00887549|467053875|FG000|Maintenance Therapy|Adverse Event|16|||
129752612|NCT00887549|467053875|FG000|Maintenance Therapy|Physician Decision|1|||
129752613|NCT00887549|467053875|FG000|Maintenance Therapy|Progressive Disease|25|||
129752614|NCT00887549|467053875|FG000|Maintenance Therapy|Death due to adverse event|1|||
129752615|NCT03472950|467053879|FG000|Overall Study|Lost to Follow-up|0|||
129752616|NCT03472950|467053880|FG001|Overall Study|Lost to Follow-up|1|||
129752617|NCT03472950|467053879|FG000|Overall Study|Adverse Event|0|||
129752618|NCT03472950|467053880|FG001|Overall Study|Adverse Event|3|||
129752619|NCT00377858|467053886|FG000|Overall Study|Withdrawal by Subject|12|||
129752620|NCT00377858|467053887|FG001|Overall Study|Withdrawal by Subject|11|||
129752621|NCT00377858|467053886|FG000|Overall Study|Lost to Follow-up|6|||
129752622|NCT00377858|467053887|FG001|Overall Study|Lost to Follow-up|1|||
129752623|NCT00377858|467053886|FG000|Overall Study|Physician Decision|5|||
129752624|NCT00377858|467053887|FG001|Overall Study|Physician Decision|5|||
129752625|NCT00377858|467053886|FG000|Overall Study|Protocol Violation|3|||
129752626|NCT00377858|467053887|FG001|Overall Study|Protocol Violation|4|||
129752627|NCT00377858|467053886|FG000|Overall Study|Adverse Event|2|||
129752628|NCT00377858|467053887|FG001|Overall Study|Adverse Event|1|||
129752629|NCT00377858|467053886|FG000|Overall Study|Entry Criteria Not Met|2|||
129752630|NCT00377858|467053887|FG001|Overall Study|Entry Criteria Not Met|0|||
129752631|NCT00377858|467053886|FG000|Overall Study|Sponsor Decision|1|||
129752632|NCT00377858|467053887|FG001|Overall Study|Sponsor Decision|2|||
129752633|NCT00377858|467053886|FG000|Overall Study|Death|0|||
129752634|NCT00377858|467053887|FG001|Overall Study|Death|3|||
129752635|NCT04034004|467053892|FG000|Overall Study|Withdrawal by Subject|1|||
129752636|NCT04034004|467053893|FG001|Overall Study|Withdrawal by Subject|2|||
129752637|NCT04034004|467053894|FG002|Overall Study|Withdrawal by Subject|2|||
129752638|NCT04034004|467053895|FG003|Overall Study|Withdrawal by Subject|3|||
129752639|NCT04034004|467053892|FG000|Overall Study|could not find vein to administer IV|2|||
129752640|NCT04034004|467053893|FG001|Overall Study|could not find vein to administer IV|1|||
129752641|NCT04034004|467053894|FG002|Overall Study|could not find vein to administer IV|0|||
129752642|NCT04034004|467053895|FG003|Overall Study|could not find vein to administer IV|0|||
129752643|NCT04034004|467053892|FG000|Overall Study|nurse accidentally unblinded subject|0|||
129752644|NCT04034004|467053893|FG001|Overall Study|nurse accidentally unblinded subject|0|||
129752645|NCT04034004|467053894|FG002|Overall Study|nurse accidentally unblinded subject|0|||
129752646|NCT04034004|467053895|FG003|Overall Study|nurse accidentally unblinded subject|1|||
129752647|NCT04526145|467053903|FG000|Overall Study|Withdrawal by Subject|5|||
129752648|NCT01502228|467053906|FG000|Overall Study|Death|1|||
129752649|NCT06964165|467053911|FG000|Overall Study|Withdrawal by Subject|0|||
129752650|NCT06964165|467053912|FG001|Overall Study|Withdrawal by Subject|1|||
129752651|NCT06964165|467053911|FG000|Overall Study|Ongoing at the time of analysis|15|||
129752652|NCT06964165|467053912|FG001|Overall Study|Ongoing at the time of analysis|14|||
129752653|NCT06964165|467053911|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
129752654|NCT06964165|467053912|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
129752655|NCT06964165|467053911|FG000|Overall Study|Participant removed due to non-compliance|0|||
129752656|NCT06964165|467053912|FG001|Overall Study|Participant removed due to non-compliance|1|||
129896668|NCT00938340|467582118|FG000|Overall Study|Adverse Event|1|||
129752657|NCT01514201|467053927|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
129752658|NCT01514201|467053928|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129896669|NCT02534896|467582119|FG000|Overall Study|Adverse Event|2|||
129752659|NCT01514201|467053929|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129752660|NCT01514201|467053930|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129752661|NCT01514201|467053927|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129752662|NCT01514201|467053928|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
129752663|NCT01514201|467053929|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
129752664|NCT01514201|467053930|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129752665|NCT01514201|467053927|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
129752666|NCT01514201|467053928|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
129752667|NCT01514201|467053929|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
129752668|NCT01514201|467053930|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129752669|NCT01514201|467053927|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
129752670|NCT01514201|467053928|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
129752671|NCT01514201|467053929|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129752672|NCT01514201|467053930|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129752673|NCT01514201|467053927|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
129752674|NCT01514201|467053928|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
129752675|NCT01514201|467053929|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
129752676|NCT01514201|467053930|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
129752677|NCT01514201|467053927|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
129752678|NCT01514201|467053928|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
129752679|NCT01514201|467053929|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
129752680|NCT01514201|467053930|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
129752681|NCT01514201|467053927|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
129752682|NCT01514201|467053928|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
129752683|NCT01514201|467053929|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
129752684|NCT01514201|467053930|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
129752685|NCT01514201|467053927|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129752686|NCT01514201|467053928|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129752687|NCT01514201|467053929|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
129752688|NCT01514201|467053930|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
129752689|NCT01514201|467053927|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
129752690|NCT01514201|467053928|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
129752691|NCT01514201|467053929|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
129752692|NCT01514201|467053930|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
129752693|NCT01514201|467053927|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129752694|NCT01514201|467053928|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129752695|NCT01514201|467053929|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
129752696|NCT01514201|467053930|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
129752697|NCT01514201|467053927|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129752698|NCT01514201|467053928|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129752699|NCT01514201|467053929|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
129752700|NCT01514201|467053930|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
129809799|NCT02319837|467269433|FG000|Study Treatment Phase|Adverse Event|73|||
129809800|NCT02319837|467269434|FG001|Study Treatment Phase|Adverse Event|36|||
129809801|NCT02319837|467269435|FG002|Study Treatment Phase|Adverse Event|63|||
129809802|NCT02319837|467269433|FG000|Study Treatment Phase|Development of castration resistance|0|||
129809803|NCT02319837|467269434|FG001|Study Treatment Phase|Development of castration resistance|2|||
129809804|NCT02319837|467269435|FG002|Study Treatment Phase|Development of castration resistance|0|||
129809805|NCT02319837|467269433|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
129809806|NCT02319837|467269434|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
129809807|NCT02319837|467269435|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
129809808|NCT02319837|467269433|FG000|Study Treatment Phase|Protocol Violation|2|||
129809809|NCT02319837|467269434|FG001|Study Treatment Phase|Protocol Violation|2|||
129809810|NCT02319837|467269435|FG002|Study Treatment Phase|Protocol Violation|1|||
129809811|NCT02319837|467269433|FG000|Study Treatment Phase|Lost to Follow-up|0|||
129809812|NCT02319837|467269434|FG001|Study Treatment Phase|Lost to Follow-up|1|||
129752701|NCT01514201|467053927|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129752702|NCT01514201|467053928|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129752703|NCT01514201|467053929|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
129809813|NCT02319837|467269435|FG002|Study Treatment Phase|Lost to Follow-up|0|||
129896670|NCT02534896|467582120|FG001|Overall Study|Adverse Event|1|||
129896671|NCT02534896|467582121|FG002|Overall Study|Adverse Event|1|||
129896672|NCT02534896|467582119|FG000|Overall Study|Insufficient therapeutic response|2|||
129809814|NCT02319837|467269433|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
129809815|NCT02319837|467269434|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
129809816|NCT02319837|467269435|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
129809817|NCT02319837|467269433|FG000|Study Treatment Phase|Other|0|||
129809818|NCT02319837|467269434|FG001|Study Treatment Phase|Other|1|||
129809819|NCT02319837|467269435|FG002|Study Treatment Phase|Other|0|||
129809820|NCT02319837|467269433|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
129809821|NCT02319837|467269434|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
129809822|NCT02319837|467269435|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
129809823|NCT02319837|467269433|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
129809824|NCT02319837|467269434|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
129809825|NCT02319837|467269435|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
129809826|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
129809827|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
129809828|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
129809829|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
129809830|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
129809831|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
129809832|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
129809833|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
129809834|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
129809835|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
129809836|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
129809837|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
129809838|NCT02319837|467269433|FG000|Long-Term Follow-Up Phase|Death|33|||
129809839|NCT02319837|467269434|FG001|Long-Term Follow-Up Phase|Death|54|||
129809840|NCT02319837|467269435|FG002|Long-Term Follow-Up Phase|Death|42|||
129809841|NCT01313312|467269436|FG000|Overall Study|Adverse Event|5|||
129809842|NCT01313312|467269436|FG000|Overall Study|Withdrawal by Subject|18|||
129809843|NCT01313312|467269436|FG000|Overall Study|Lack of Efficacy|3|||
129809844|NCT01313312|467269436|FG000|Overall Study|Investigator Decision|1|||
129809845|NCT01313312|467269436|FG000|Overall Study|Observational Phase|1|||
129809846|NCT01313312|467269436|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
129809847|NCT01313312|467269436|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
129809848|NCT01254331|467269438|FG000|Initial Phase|Adverse Event|3|||
129809849|NCT01254331|467269438|FG000|Initial Phase|Withdrawal by Subject|1|||
129809850|NCT01254331|467269438|FG000|Initial Phase|Pregnancy|1|||
129809851|NCT01254331|467269438|FG000|Extension Phase|Lack of Efficacy|1|||
129809852|NCT01254331|467269438|FG000|Extension Phase|Lost to Follow-up|3|||
129809853|NCT00892047|467269439|FG000|Overall Study|Adverse Event|2|||
129809854|NCT00892047|467269440|FG001|Overall Study|Adverse Event|2|||
129809855|NCT00892047|467269439|FG000|Overall Study|subject burden|2|||
129809856|NCT00892047|467269440|FG001|Overall Study|subject burden|3|||
129809857|NCT00892047|467269439|FG000|Overall Study|Lack of Efficacy|0|||
129809858|NCT00892047|467269440|FG001|Overall Study|Lack of Efficacy|2|||
129809859|NCT05306977|467269441|FG000|Overall Study|Withdrawal by Subject|1|||
129809860|NCT01612858|467269446|FG000|Overall Study|Withdrawal by Subject|5|||
129809861|NCT01612858|467269447|FG001|Overall Study|Withdrawal by Subject|1|||
129809862|NCT00660699|467269450|FG000|Overall Study|Withdrawal by Subject|2|||
129809863|NCT01752985|467269451|FG000|Treatment Period|Subject request to discontinue treatment|1|||
129809864|NCT01752985|467269452|FG001|Treatment Period|Subject request to discontinue treatment|0|||
129809865|NCT01752985|467269453|FG002|Treatment Period|Subject request to discontinue treatment|1|||
129809866|NCT01752985|467269451|FG000|Treatment Period|Subject no longer meets study criteria|0|||
129809867|NCT01752985|467269452|FG001|Treatment Period|Subject no longer meets study criteria|1|||
129809868|NCT01752985|467269453|FG002|Treatment Period|Subject no longer meets study criteria|1|||
129809869|NCT01752985|467269451|FG000|Treatment Period|Adverse Event|2|||
129896673|NCT02534896|467582120|FG001|Overall Study|Insufficient therapeutic response|0|||
129896674|NCT02534896|467582121|FG002|Overall Study|Insufficient therapeutic response|0|||
129896675|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
129896676|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
129896677|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
129896678|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
129896679|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Adverse Event|198|||
129896680|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Adverse Event|0|||
129896681|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Adverse Event|0|||
129896682|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Adverse Event|0|||
129752704|NCT01514201|467053930|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
129752705|NCT05888181|467053931|FG000|Overall Study|Lost to Follow-up|1|||
129752706|NCT05888181|467053932|FG001|Overall Study|Lost to Follow-up|1|||
129752707|NCT05888181|467053933|FG002|Overall Study|Lost to Follow-up|0|||
129752708|NCT02534909|467053939|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
129752709|NCT01625000|467053942|FG000|Overall Study|Physician Decision|15|||
129752710|NCT01625000|467053943|FG001|Overall Study|Physician Decision|7|||
129752711|NCT01625000|467053944|FG002|Overall Study|Physician Decision|7|||
129752712|NCT01625000|467053945|FG003|Overall Study|Physician Decision|2|||
129752713|NCT01625000|467053946|FG004|Overall Study|Physician Decision|15|||
129752714|NCT01625000|467053942|FG000|Overall Study|Protocol Violation|3|||
129752715|NCT01625000|467053943|FG001|Overall Study|Protocol Violation|10|||
129752716|NCT01625000|467053944|FG002|Overall Study|Protocol Violation|4|||
129752717|NCT01625000|467053945|FG003|Overall Study|Protocol Violation|1|||
129752718|NCT01625000|467053946|FG004|Overall Study|Protocol Violation|2|||
129752719|NCT01625000|467053942|FG000|Overall Study|Withdrawal by Subject|19|||
129752720|NCT01625000|467053943|FG001|Overall Study|Withdrawal by Subject|16|||
129752721|NCT01625000|467053944|FG002|Overall Study|Withdrawal by Subject|11|||
129752722|NCT01625000|467053945|FG003|Overall Study|Withdrawal by Subject|9|||
129752723|NCT01625000|467053946|FG004|Overall Study|Withdrawal by Subject|17|||
129752724|NCT01625000|467053942|FG000|Overall Study|Adverse Event (including Death)|15|||
129752725|NCT01625000|467053943|FG001|Overall Study|Adverse Event (including Death)|19|||
129752726|NCT01625000|467053944|FG002|Overall Study|Adverse Event (including Death)|11|||
129752727|NCT01625000|467053945|FG003|Overall Study|Adverse Event (including Death)|7|||
129752728|NCT01625000|467053946|FG004|Overall Study|Adverse Event (including Death)|21|||
129752729|NCT00577824|467053949|FG000|Overall Study|Adverse Event|6|||
129752730|NCT00577824|467053950|FG001|Overall Study|Adverse Event|18|||
129752731|NCT00577824|467053951|FG002|Overall Study|Adverse Event|1|||
129752732|NCT00577824|467053949|FG000|Overall Study|Patient decision|0|||
129752733|NCT00577824|467053950|FG001|Overall Study|Patient decision|1|||
129752734|NCT00577824|467053951|FG002|Overall Study|Patient decision|1|||
129752735|NCT00577824|467053949|FG000|Overall Study|Protocol Violation|1|||
129752736|NCT00577824|467053950|FG001|Overall Study|Protocol Violation|1|||
129752737|NCT00577824|467053951|FG002|Overall Study|Protocol Violation|0|||
129752738|NCT00362648|467053952|FG000|Overall Study|Adverse Event|12|||
129752739|NCT00362648|467053953|FG001|Overall Study|Adverse Event|21|||
129752740|NCT00362648|467053954|FG002|Overall Study|Adverse Event|1|||
129752741|NCT00362648|467053955|FG003|Overall Study|Adverse Event|0|||
129752742|NCT00362648|467053952|FG000|Overall Study|Lost to Follow-up|62|||
129752743|NCT00362648|467053953|FG001|Overall Study|Lost to Follow-up|69|||
129752744|NCT00362648|467053954|FG002|Overall Study|Lost to Follow-up|4|||
129752745|NCT00362648|467053955|FG003|Overall Study|Lost to Follow-up|3|||
129752746|NCT00362648|467053952|FG000|Overall Study|Protocol Violation|4|||
129752747|NCT00362648|467053953|FG001|Overall Study|Protocol Violation|2|||
129752748|NCT00362648|467053954|FG002|Overall Study|Protocol Violation|2|||
129752749|NCT00362648|467053955|FG003|Overall Study|Protocol Violation|2|||
129752750|NCT00362648|467053952|FG000|Overall Study|Withdrawal by Subject|48|||
129752751|NCT00362648|467053953|FG001|Overall Study|Withdrawal by Subject|42|||
129752752|NCT00362648|467053954|FG002|Overall Study|Withdrawal by Subject|2|||
129809870|NCT01752985|467269452|FG001|Treatment Period|Adverse Event|1|||
129809871|NCT01752985|467269453|FG002|Treatment Period|Adverse Event|2|||
129809872|NCT01752985|467269451|FG000|Treatment Period|Withdrawal by Subject|1|||
129809873|NCT01752985|467269452|FG001|Treatment Period|Withdrawal by Subject|1|||
129809874|NCT01752985|467269453|FG002|Treatment Period|Withdrawal by Subject|0|||
129809875|NCT01752985|467269451|FG000|Treatment Period|Lost to Follow-up|0|||
129809876|NCT01752985|467269452|FG001|Treatment Period|Lost to Follow-up|0|||
129809877|NCT01752985|467269453|FG002|Treatment Period|Lost to Follow-up|1|||
129752753|NCT00362648|467053955|FG003|Overall Study|Withdrawal by Subject|6|||
129752754|NCT03983304|467053956|FG000|Overall Study|Withdrawal by Subject|5|||
129752755|NCT03983304|467053956|FG000|Overall Study|Lost to Follow-up|2|||
129752756|NCT01518374|467053959|FG000|Overall Study|Withdrawal by Subject|2|||
129752757|NCT01518374|467053959|FG000|Overall Study|Protocol Violation|3|||
129752758|NCT01518374|467053959|FG000|Overall Study|Lost to Follow-up|2|||
129752759|NCT04300309|467053960|FG000|Overall Study|Lost to Follow-up|1|||
129752760|NCT04300309|467053961|FG001|Overall Study|Lost to Follow-up|0|||
129752761|NCT02362464|467053964|FG000|Overall Study|Switched to alternative therapy|1|||
129752762|NCT02362464|467053964|FG000|Overall Study|Refused further treatment|1|||
129809878|NCT01995825|467270968|FG000|Overall Study|Withdrawal by Subject|1|||
129752763|NCT02362464|467053964|FG000|Overall Study|Physician Decision|4|||
129752764|NCT04752332|467053965|FG000|Overall Study|Adverse Event|3|||
129809879|NCT01995825|467270969|FG001|Overall Study|Withdrawal by Subject|0|||
129752765|NCT04752332|467053966|FG001|Overall Study|Adverse Event|1|||
129752766|NCT04752332|467053965|FG000|Overall Study|Disease Relapse|1|||
129752767|NCT04752332|467053966|FG001|Overall Study|Disease Relapse|0|||
129752768|NCT04752332|467053965|FG000|Overall Study|Non-compliance With Study Drug|2|||
129752769|NCT04752332|467053966|FG001|Overall Study|Non-compliance With Study Drug|0|||
129809880|NCT01385566|467270970|FG000|Overall Study|Lost to Follow-up|1|||
129809881|NCT01385566|467270971|FG001|Overall Study|Lost to Follow-up|0|||
129752770|NCT04752332|467053965|FG000|Overall Study|Physician Decision|2|||
129752771|NCT04752332|467053966|FG001|Overall Study|Physician Decision|1|||
129752772|NCT04752332|467053965|FG000|Overall Study|Protocol Violation|1|||
129752773|NCT04752332|467053966|FG001|Overall Study|Protocol Violation|1|||
129752774|NCT04752332|467053965|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
129752775|NCT04752332|467053966|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
129752776|NCT04752332|467053965|FG000|Overall Study|Study Terminated by Sponsor|10|||
129809882|NCT01385566|467270972|FG002|Overall Study|Lost to Follow-up|0|||
129809883|NCT01385566|467270973|FG003|Overall Study|Lost to Follow-up|0|||
129809884|NCT01385566|467270974|FG004|Overall Study|Lost to Follow-up|0|||
129809885|NCT01385566|467270975|FG005|Overall Study|Lost to Follow-up|0|||
129809886|NCT01385566|467270970|FG000|Overall Study|Withdrawal by Subject|0|||
129809887|NCT01385566|467270971|FG001|Overall Study|Withdrawal by Subject|0|||
129809888|NCT01385566|467270972|FG002|Overall Study|Withdrawal by Subject|0|||
129809889|NCT01385566|467270973|FG003|Overall Study|Withdrawal by Subject|1|||
129809890|NCT01385566|467270974|FG004|Overall Study|Withdrawal by Subject|0|||
129809891|NCT01385566|467270975|FG005|Overall Study|Withdrawal by Subject|0|||
129809892|NCT00403234|467270978|FG000|Overall Study|Withdrawal by Subject|0|||
129896683|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Death|62|||
129896684|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Death|0|||
129896685|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Death|0|||
129809893|NCT00403234|467270979|FG001|Overall Study|Withdrawal by Subject|1|||
129809894|NCT00403234|467270980|FG002|Overall Study|Withdrawal by Subject|0|||
129809895|NCT00403234|467270981|FG003|Overall Study|Withdrawal by Subject|0|||
129809896|NCT00403234|467270978|FG000|Overall Study|Adverse Event|1|||
129809897|NCT00403234|467270979|FG001|Overall Study|Adverse Event|0|||
129809898|NCT00403234|467270980|FG002|Overall Study|Adverse Event|1|||
129809899|NCT00403234|467270981|FG003|Overall Study|Adverse Event|0|||
129809900|NCT04092582|467270982|FG000|Overall Study|Death|1|||
129809901|NCT04092582|467270983|FG001|Overall Study|Death|1|||
129809902|NCT04092582|467270982|FG000|Overall Study|Withdrawal by Subject|4|||
129809903|NCT04092582|467270983|FG001|Overall Study|Withdrawal by Subject|1|||
129809904|NCT04092582|467270982|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
129809905|NCT04092582|467270983|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
129809906|NCT00560105|467270990|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
129809907|NCT00560105|467270991|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
129809908|NCT02025621|467270997|FG000|Overall Study|Withdrawal by Subject|1|||
129809909|NCT02025621|467270998|FG001|Overall Study|Withdrawal by Subject|0|||
129809910|NCT02025621|467270997|FG000|Overall Study|Death|0|||
129809911|NCT02025621|467270998|FG001|Overall Study|Death|1|||
129809912|NCT02025621|467270997|FG000|Overall Study|No longer eligible|10|||
129809913|NCT02025621|467270998|FG001|Overall Study|No longer eligible|15|||
129809914|NCT02025621|467270997|FG000|Overall Study|Surgery initiated before infusion|3|||
129809915|NCT02025621|467270998|FG001|Overall Study|Surgery initiated before infusion|3|||
129809916|NCT01871532|467270999|FG000|Overall Study|Withdrawal by Subject|1|||
129809917|NCT01871532|467271000|FG001|Overall Study|Withdrawal by Subject|2|||
129809918|NCT02195583|467271002|FG000|Overall Study|Lost to Follow-up|1|||
129809919|NCT02195583|467271002|FG000|Overall Study|Withdrawal by Subject|4|||
129809920|NCT02195583|467271002|FG000|Overall Study|Adverse Event|2|||
129809921|NCT02195583|467271002|FG000|Overall Study|Other Reason|2|||
129809922|NCT01709513|467271003|FG000|Overall Study|Randomized but not treated|0|||
129809923|NCT01709513|467271004|FG001|Overall Study|Randomized but not treated|1|||
129896686|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Death|0|||
129896687|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
129896688|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
129896689|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
129896690|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
129896691|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Complicating disease|13|||
129752777|NCT04752332|467053966|FG001|Overall Study|Study Terminated by Sponsor|48|||
129752778|NCT04752332|467053965|FG000|Overall Study|Withdrawal by Subject|11|||
129752779|NCT04752332|467053966|FG001|Overall Study|Withdrawal by Subject|3|||
129809924|NCT01709513|467271005|FG002|Overall Study|Randomized but not treated|0|||
129896692|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Complicating disease|0|||
129896693|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Complicating disease|0|||
129896694|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Complicating disease|0|||
129752780|NCT00048347|467053967|FG000|Overall Study|Screen failure|2|||
129752781|NCT02058563|467053968|FG000|Overall Study|Lost to Follow-up|26|||
129752782|NCT02058563|467053969|FG001|Overall Study|Lost to Follow-up|22|||
129752783|NCT02058563|467053968|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
129809925|NCT01709513|467271003|FG000|Overall Study|Adverse Event|16|||
129809926|NCT01709513|467271004|FG001|Overall Study|Adverse Event|31|||
129809927|NCT01709513|467271005|FG002|Overall Study|Adverse Event|23|||
129809928|NCT01709513|467271003|FG000|Overall Study|Poor compliance to protocol|2|||
129809929|NCT01709513|467271004|FG001|Overall Study|Poor compliance to protocol|0|||
129809930|NCT01709513|467271005|FG002|Overall Study|Poor compliance to protocol|0|||
129752784|NCT02058563|467053969|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
129752785|NCT02058563|467053968|FG000|Overall Study|Consent Withdrawal|1|||
129752786|NCT02058563|467053969|FG001|Overall Study|Consent Withdrawal|1|||
129752787|NCT02058563|467053968|FG000|Overall Study|Other (patient incarcerated)|0|||
129752788|NCT02058563|467053969|FG001|Overall Study|Other (patient incarcerated)|1|||
129752789|NCT04039217|467053970|FG000|Overall Study|Lost to Follow-up|1|||
129752790|NCT04522141|467053971|FG000|Overall Study|Withdrawal by Subject|1|||
129752791|NCT04522141|467053972|FG001|Overall Study|Withdrawal by Subject|0|||
129752792|NCT03508609|467053973|FG000|Overall Study|Withdrawal by Subject|1|||
129752793|NCT00555217|467053974|FG000|Overall Study|Withdrawal by Subject|35|||
129752794|NCT00555217|467053975|FG001|Overall Study|Withdrawal by Subject|31|||
129752795|NCT00555217|467053974|FG000|Overall Study|Lost to Follow-up|19|||
129752796|NCT00555217|467053975|FG001|Overall Study|Lost to Follow-up|20|||
129752797|NCT00555217|467053974|FG000|Overall Study|close out sites|21|||
129752798|NCT00555217|467053975|FG001|Overall Study|close out sites|17|||
129752799|NCT01868477|467053976|FG000|Overall Study|Adverse Event|2|||
129752800|NCT01868477|467053977|FG001|Overall Study|Adverse Event|4|||
129752801|NCT01868477|467053976|FG000|Overall Study|Disease progression|1|||
129752802|NCT01868477|467053977|FG001|Overall Study|Disease progression|1|||
129752803|NCT01868477|467053976|FG000|Overall Study|Withdrawal by Subject|1|||
129752804|NCT01868477|467053977|FG001|Overall Study|Withdrawal by Subject|0|||
129752805|NCT00367835|467053980|FG000|Overall Study|Adverse Event|14|||
129752806|NCT00367835|467053981|FG001|Overall Study|Adverse Event|1|||
129752807|NCT00367835|467053980|FG000|Overall Study|Protocol Violation|1|||
129752808|NCT00367835|467053981|FG001|Overall Study|Protocol Violation|7|||
129752809|NCT00367835|467053980|FG000|Overall Study|Withdrawal by Subject|7|||
129752810|NCT00367835|467053981|FG001|Overall Study|Withdrawal by Subject|6|||
129752811|NCT00367835|467053980|FG000|Overall Study|Lost to Follow-up|1|||
129752812|NCT00367835|467053981|FG001|Overall Study|Lost to Follow-up|4|||
129752813|NCT00367835|467053980|FG000|Overall Study|Lack of Efficacy|3|||
129752814|NCT00367835|467053981|FG001|Overall Study|Lack of Efficacy|12|||
129752815|NCT00367835|467053980|FG000|Overall Study|Subject in juvenile detention center|1|||
129752816|NCT00367835|467053981|FG001|Overall Study|Subject in juvenile detention center|0|||
129752817|NCT00367835|467053980|FG000|Overall Study|refused blood collection|1|||
129752818|NCT00367835|467053981|FG001|Overall Study|refused blood collection|0|||
129752819|NCT00367835|467053980|FG000|Overall Study|Did not respond to calls|1|||
129752820|NCT00367835|467053981|FG001|Overall Study|Did not respond to calls|0|||
129752821|NCT00367835|467053980|FG000|Overall Study|History of lead poisoning|0|||
129752822|NCT00367835|467053981|FG001|Overall Study|History of lead poisoning|1|||
129752823|NCT03761810|467053983|FG000|Overall Study|Adverse Event|12|||
129752824|NCT03761810|467053984|FG001|Overall Study|Adverse Event|0|||
129752825|NCT03761810|467053983|FG000|Overall Study|Lost to Follow-up|15|||
129752826|NCT03761810|467053984|FG001|Overall Study|Lost to Follow-up|7|||
129752827|NCT03761810|467053983|FG000|Overall Study|Pregnancy|1|||
129752828|NCT03761810|467053984|FG001|Overall Study|Pregnancy|0|||
129752829|NCT03761810|467053983|FG000|Overall Study|Withdrawal by Subject|14|||
129752830|NCT03761810|467053984|FG001|Overall Study|Withdrawal by Subject|5|||
129752831|NCT03761810|467053983|FG000|Overall Study|Physician Decision|1|||
129752832|NCT03761810|467053984|FG001|Overall Study|Physician Decision|0|||
129752833|NCT03761810|467053983|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
129809931|NCT01709513|467271003|FG000|Overall Study|Other|3|||
129809932|NCT01709513|467271004|FG001|Overall Study|Other|11|||
129809933|NCT01709513|467271005|FG002|Overall Study|Other|7|||
129809934|NCT04218695|467271006|FG000|Overall Study|Adverse Event|1|||
129809935|NCT04218695|467271007|FG001|Overall Study|Adverse Event|0|||
129752834|NCT03761810|467053984|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129752835|NCT03761810|467053983|FG000|Overall Study|Other Than Specified|1|||
129752836|NCT03761810|467053984|FG001|Overall Study|Other Than Specified|0|||
129752837|NCT01574651|467053985|FG000|Overall Study|Lost to Follow-up|2|||
129752838|NCT01574651|467053986|FG001|Overall Study|Lost to Follow-up|4|||
129752839|NCT01574651|467053985|FG000|Overall Study|Administrative problems|0|||
129752840|NCT01574651|467053986|FG001|Overall Study|Administrative problems|1|||
129752841|NCT01574651|467053985|FG000|Overall Study|Death|3|||
129752842|NCT01574651|467053986|FG001|Overall Study|Death|3|||
129752843|NCT01574651|467053985|FG000|Overall Study|Patient's inability to use the device|0|||
129752844|NCT01574651|467053986|FG001|Overall Study|Patient's inability to use the device|1|||
129752845|NCT01574651|467053985|FG000|Overall Study|Adverse Event|36|||
129752846|NCT01574651|467053986|FG001|Overall Study|Adverse Event|27|||
129752847|NCT01574651|467053985|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129752848|NCT01574651|467053986|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129752849|NCT01574651|467053985|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129752850|NCT01574651|467053986|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129752851|NCT01574651|467053985|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129752852|NCT01574651|467053986|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129752853|NCT01574651|467053985|FG000|Overall Study|Protocol Violation|3|||
129752854|NCT01574651|467053986|FG001|Overall Study|Protocol Violation|5|||
129809936|NCT00983437|467271008|FG000|Overall Study|Adverse Event|9|||
129752855|NCT01574651|467053985|FG000|Overall Study|Withdrawal by Subject|9|||
129752856|NCT01574651|467053986|FG001|Overall Study|Withdrawal by Subject|10|||
129752857|NCT03887221|467053987|FG000|Overall Study|Protocol Violation|1|||
129752858|NCT03887221|467053988|FG001|Overall Study|Protocol Violation|0|||
129752859|NCT02092025|467053989|FG000|Overall Study|Case Report Forms Uncollected|44|||
129752860|NCT02092025|467053989|FG000|Overall Study|Protocol Deviation|24|||
129752861|NCT03228212|467053991|FG000|Period 1|Adverse Event|1|||
129752862|NCT03228212|467053992|FG001|Period 1|Adverse Event|0|||
129752863|NCT03228212|467053991|FG000|Period 1|no longer meets eligibility criteria|0|||
129752864|NCT03228212|467053992|FG001|Period 1|no longer meets eligibility criteria|1|||
129752865|NCT03228212|467053991|FG000|Period 2|Lost to Follow-up|1|||
129752866|NCT03228212|467053992|FG001|Period 2|Lost to Follow-up|0|||
129752867|NCT01807299|467053993|FG000|Overall Study|Protocol Violation|3|||
129752868|NCT01807299|467053994|FG001|Overall Study|Protocol Violation|1|||
129752869|NCT01807299|467053995|FG002|Overall Study|Protocol Violation|0|||
129752870|NCT01807299|467053996|FG003|Overall Study|Protocol Violation|2|||
129752871|NCT00811174|467053997|FG000|Overall Study|Protocol Violation|2|||
129752872|NCT00811174|467053997|FG000|Overall Study|Sponsors Decision|1|||
129752873|NCT02451943|467055033|FG000|Overall Study|Withdrawal by Subject|13|||
129752874|NCT02451943|467055034|FG001|Overall Study|Withdrawal by Subject|16|||
129752875|NCT02451943|467055033|FG000|Overall Study|Lost to Follow-up|3|||
129752876|NCT02451943|467055034|FG001|Overall Study|Lost to Follow-up|4|||
129752877|NCT02451943|467055033|FG000|Overall Study|Sponsor Decision|0|||
129752878|NCT02451943|467055034|FG001|Overall Study|Sponsor Decision|4|||
129752879|NCT01101035|467055036|FG000|Overall Study|Adverse Event|191|||
129752880|NCT01101035|467055037|FG001|Overall Study|Adverse Event|172|||
129752881|NCT01101035|467055036|FG000|Overall Study|Major Protocol Deviation|52|||
129752882|NCT01101035|467055037|FG001|Overall Study|Major Protocol Deviation|46|||
129752883|NCT01101035|467055036|FG000|Overall Study|Lost to Follow-up|226|||
129752884|NCT01101035|467055037|FG001|Overall Study|Lost to Follow-up|223|||
129752885|NCT01101035|467055036|FG000|Overall Study|Voluntary Withdrawal|595|||
129752886|NCT01101035|467055037|FG001|Overall Study|Voluntary Withdrawal|587|||
129752887|NCT01101035|467055036|FG000|Overall Study|Reason not Specified|333|||
129752888|NCT01101035|467055037|FG001|Overall Study|Reason not Specified|363|||
129752889|NCT00681629|467055038|FG000|Overall Study|Study termination|4|||
129752890|NCT00681629|467055039|FG001|Overall Study|Study termination|2|||
129752891|NCT00681629|467055038|FG000|Overall Study|Adverse Event|1|||
129752892|NCT00681629|467055039|FG001|Overall Study|Adverse Event|0|||
129752893|NCT01510158|467055047|FG000|Overall Study|Adverse Event|7|||
129752894|NCT01510158|467055048|FG001|Overall Study|Adverse Event|8|||
129752895|NCT01510158|467055049|FG002|Overall Study|Adverse Event|5|||
129752896|NCT01510158|467055047|FG000|Overall Study|Gout flare|1|||
129752897|NCT01510158|467055048|FG001|Overall Study|Gout flare|0|||
129752898|NCT01510158|467055049|FG002|Overall Study|Gout flare|0|||
129752899|NCT01510158|467055047|FG000|Overall Study|Protocol Violation|17|||
129752900|NCT01510158|467055048|FG001|Overall Study|Protocol Violation|16|||
129752901|NCT01510158|467055049|FG002|Overall Study|Protocol Violation|24|||
129752902|NCT01510158|467055047|FG000|Overall Study|Sponsor terminated study.|2|||
129752903|NCT01510158|467055048|FG001|Overall Study|Sponsor terminated study.|0|||
129752904|NCT01510158|467055049|FG002|Overall Study|Sponsor terminated study.|2|||
129752905|NCT01510158|467055047|FG000|Overall Study|Lost to Follow-up|13|||
129752906|NCT01510158|467055048|FG001|Overall Study|Lost to Follow-up|16|||
129752907|NCT01510158|467055049|FG002|Overall Study|Lost to Follow-up|9|||
129752908|NCT01510158|467055047|FG000|Overall Study|Withdrawal by Subject|10|||
129752909|NCT01510158|467055048|FG001|Overall Study|Withdrawal by Subject|13|||
129752910|NCT01510158|467055049|FG002|Overall Study|Withdrawal by Subject|10|||
129752911|NCT01510158|467055047|FG000|Overall Study|Death|1|||
129752912|NCT01510158|467055048|FG001|Overall Study|Death|0|||
129752913|NCT01510158|467055049|FG002|Overall Study|Death|0|||
129752914|NCT01442714|467055051|FG000|Overall Study|Death|11|||
129752915|NCT01442714|467055051|FG000|Overall Study|Withdrawal by Subject|1|||
129752916|NCT03314987|467055052|FG000|Overall Study|Lost to Follow-up|13|||
129752917|NCT03314987|467055053|FG001|Overall Study|Lost to Follow-up|13|||
129752918|NCT02751580|467055054|FG000|Overall Study|Lost to Follow-up|4|||
129752919|NCT02751580|467055054|FG000|Overall Study|Death|2|||
129752920|NCT04829916|467055058|FG000|Overall Study|Withdrawal by Subject|1|||
129752921|NCT04829916|467055059|FG001|Overall Study|Withdrawal by Subject|0|||
129752922|NCT02152761|467055066|FG000|Epoch: Treatment Epoch|Technical problems|0|||
129752923|NCT02152761|467055067|FG001|Epoch: Treatment Epoch|Technical problems|0|||
129752924|NCT02152761|467055068|FG002|Epoch: Treatment Epoch|Technical problems|0|||
129752925|NCT02152761|467055069|FG003|Epoch: Treatment Epoch|Technical problems|1|||
129752926|NCT02152761|467055066|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
129752927|NCT02152761|467055067|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
129752928|NCT02152761|467055068|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
129752929|NCT02152761|467055069|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
129752930|NCT02152761|467055066|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
129752931|NCT02152761|467055067|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
129752932|NCT02152761|467055068|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
129752933|NCT02152761|467055069|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
129896695|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
129896696|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
129896697|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
129752934|NCT02152761|467055066|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
129752935|NCT02152761|467055067|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
129752936|NCT02152761|467055068|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
129752937|NCT02152761|467055069|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
129752938|NCT02152761|467055066|FG000|Epoch: Treatment Epoch|Death|0|||
129752939|NCT02152761|467055067|FG001|Epoch: Treatment Epoch|Death|3|||
129752940|NCT02152761|467055068|FG002|Epoch: Treatment Epoch|Death|1|||
129752941|NCT02152761|467055069|FG003|Epoch: Treatment Epoch|Death|0|||
129752942|NCT02152761|467055066|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
129752943|NCT02152761|467055067|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
129752944|NCT02152761|467055068|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
129752945|NCT02152761|467055069|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
129752946|NCT02152761|467055066|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
129752947|NCT02152761|467055067|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
129752948|NCT02152761|467055068|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
129752949|NCT02152761|467055069|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
129752950|NCT02152761|467055066|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
129752951|NCT02152761|467055067|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
129752952|NCT02152761|467055068|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
129752953|NCT02152761|467055069|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
129752954|NCT02152761|467055066|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
129752955|NCT02152761|467055067|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
129752956|NCT02152761|467055068|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
129752957|NCT02152761|467055069|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
129752958|NCT02152761|467055066|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
129752959|NCT02152761|467055067|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
129752960|NCT02152761|467055068|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
129752961|NCT02152761|467055069|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
129752962|NCT04343755|467055070|FG000|Overall Study|Death|11|||
129752963|NCT04343755|467055070|FG000|Overall Study|Screen Failure|1|||
129752964|NCT03755882|467055071|FG000|Period 1|Protocol Violation|1|||
129752965|NCT03755882|467055072|FG001|Period 1|Protocol Violation|0|||
129752966|NCT03755882|467055071|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
129752967|NCT03755882|467055072|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
129752968|NCT02292446|467055073|FG000|Overall Study|Adverse Event|12|||
129752969|NCT02292446|467055073|FG000|Overall Study|Death|1|||
129752970|NCT02292446|467055073|FG000|Overall Study|Disease progression|2|||
129752971|NCT02292446|467055073|FG000|Overall Study|Subject/guardian decision|2|||
129752972|NCT02292446|467055073|FG000|Overall Study|Withdrawal by Subject|3|||
129752973|NCT01290757|467055076|FG000|Overall Study|Adverse Event|1|||
129752974|NCT01290757|467055077|FG001|Overall Study|Adverse Event|0|||
129752975|NCT01290757|467055076|FG000|Overall Study|Protocol Violation|1|||
129752976|NCT01290757|467055077|FG001|Overall Study|Protocol Violation|1|||
129752977|NCT01290757|467055076|FG000|Overall Study|Other|0|||
129752978|NCT01290757|467055077|FG001|Overall Study|Other|1|||
129752979|NCT00479336|467055079|FG000|Overall Study|Adverse Event|1|||
129752980|NCT00479336|467055080|FG001|Overall Study|Adverse Event|1|||
129752981|NCT00479336|467055081|FG002|Overall Study|Adverse Event|1|||
129752982|NCT00479336|467055082|FG003|Overall Study|Adverse Event|3|||
129752983|NCT00479336|467055079|FG000|Overall Study|Lack of Efficacy|1|||
129752984|NCT00479336|467055080|FG001|Overall Study|Lack of Efficacy|0|||
129752985|NCT00479336|467055081|FG002|Overall Study|Lack of Efficacy|0|||
129752986|NCT00479336|467055082|FG003|Overall Study|Lack of Efficacy|0|||
129752987|NCT00479336|467055079|FG000|Overall Study|Protocol Violation|0|||
129752988|NCT00479336|467055080|FG001|Overall Study|Protocol Violation|1|||
129752989|NCT00479336|467055081|FG002|Overall Study|Protocol Violation|0|||
129752990|NCT00479336|467055082|FG003|Overall Study|Protocol Violation|0|||
129752991|NCT00479336|467055079|FG000|Overall Study|Withdrawal by Subject|1|||
129752992|NCT00479336|467055080|FG001|Overall Study|Withdrawal by Subject|2|||
129752993|NCT00479336|467055081|FG002|Overall Study|Withdrawal by Subject|0|||
129752994|NCT00479336|467055082|FG003|Overall Study|Withdrawal by Subject|0|||
129752995|NCT00479336|467055079|FG000|Overall Study|Physician Decision|0|||
129752996|NCT00479336|467055080|FG001|Overall Study|Physician Decision|1|||
129752997|NCT00479336|467055081|FG002|Overall Study|Physician Decision|0|||
129752998|NCT00479336|467055082|FG003|Overall Study|Physician Decision|2|||
129752999|NCT00479336|467055079|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
129753000|NCT00479336|467055080|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
129753001|NCT00479336|467055081|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
129753002|NCT00479336|467055082|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
129753003|NCT03329846|467055083|FG000|Overall Study|Disease progression|4|||
129753004|NCT03329846|467055084|FG001|Overall Study|Disease progression|6|||
129753005|NCT03329846|467055083|FG000|Overall Study|Study drug toxicity|1|||
129753006|NCT03329846|467055084|FG001|Overall Study|Study drug toxicity|0|||
129753007|NCT03329846|467055083|FG000|Overall Study|Participant request to discontinue treatment|0|||
129753008|NCT03329846|467055084|FG001|Overall Study|Participant request to discontinue treatment|1|||
129753009|NCT03329846|467055083|FG000|Overall Study|Participant withdrew consent|1|||
129753010|NCT03329846|467055084|FG001|Overall Study|Participant withdrew consent|0|||
129753011|NCT03329846|467055083|FG000|Overall Study|Other reasons|2|||
129753012|NCT03329846|467055084|FG001|Overall Study|Other reasons|2|||
129753013|NCT03066193|467055085|FG000|Overall Study|Withdrawal by Subject|1|||
129753014|NCT02021643|467055086|FG000|Overall Study|Enrolled but Never Treated|1|||
129753015|NCT02021643|467055087|FG001|Overall Study|Enrolled but Never Treated|0|||
129753016|NCT02021643|467055088|FG002|Overall Study|Enrolled but Never Treated|0|||
129753017|NCT02021643|467055089|FG003|Overall Study|Enrolled but Never Treated|0|||
129753018|NCT02021643|467055086|FG000|Overall Study|Adverse Event|0|||
129753019|NCT02021643|467055087|FG001|Overall Study|Adverse Event|1|||
129753020|NCT02021643|467055088|FG002|Overall Study|Adverse Event|0|||
129753021|NCT02021643|467055089|FG003|Overall Study|Adverse Event|0|||
129753022|NCT02021643|467055086|FG000|Overall Study|Death|0|||
129753023|NCT02021643|467055087|FG001|Overall Study|Death|1|||
129753024|NCT02021643|467055088|FG002|Overall Study|Death|0|||
129753025|NCT02021643|467055089|FG003|Overall Study|Death|0|||
129753026|NCT02021643|467055086|FG000|Overall Study|Investigator's Discretion|1|||
129753027|NCT02021643|467055087|FG001|Overall Study|Investigator's Discretion|0|||
129753028|NCT02021643|467055088|FG002|Overall Study|Investigator's Discretion|0|||
129753029|NCT02021643|467055089|FG003|Overall Study|Investigator's Discretion|0|||
129753030|NCT02021643|467055086|FG000|Overall Study|Lack of Efficacy|7|||
129753031|NCT02021643|467055087|FG001|Overall Study|Lack of Efficacy|6|||
129753032|NCT02021643|467055088|FG002|Overall Study|Lack of Efficacy|0|||
129753033|NCT02021643|467055089|FG003|Overall Study|Lack of Efficacy|12|||
129753034|NCT02021643|467055086|FG000|Overall Study|Lost to Follow-up|0|||
129753035|NCT02021643|467055087|FG001|Overall Study|Lost to Follow-up|1|||
129753036|NCT02021643|467055088|FG002|Overall Study|Lost to Follow-up|0|||
129753037|NCT02021643|467055089|FG003|Overall Study|Lost to Follow-up|0|||
129753038|NCT02021643|467055086|FG000|Overall Study|Withdrew Consent|0|||
129753039|NCT02021643|467055087|FG001|Overall Study|Withdrew Consent|1|||
129753040|NCT02021643|467055088|FG002|Overall Study|Withdrew Consent|0|||
129753041|NCT02021643|467055089|FG003|Overall Study|Withdrew Consent|0|||
129753042|NCT04854551|467055090|FG000|Overall Study|Withdrawal by Subject|1|||
129753043|NCT04854551|467055091|FG001|Overall Study|Withdrawal by Subject|1|||
129753044|NCT02631551|467055092|FG000|Overall Study|Adverse Event|1|||
129753045|NCT02631551|467055093|FG001|Overall Study|Adverse Event|2|||
129753046|NCT02631551|467055094|FG002|Overall Study|Adverse Event|4|||
129753047|NCT02631551|467055095|FG003|Overall Study|Adverse Event|0|||
129753048|NCT02631551|467055092|FG000|Overall Study|Lack of Efficacy|0|||
129753049|NCT02631551|467055093|FG001|Overall Study|Lack of Efficacy|0|||
129753050|NCT02631551|467055094|FG002|Overall Study|Lack of Efficacy|1|||
129753051|NCT02631551|467055095|FG003|Overall Study|Lack of Efficacy|0|||
129753052|NCT02631551|467055092|FG000|Overall Study|Lost to Follow-up|1|||
129753053|NCT02631551|467055093|FG001|Overall Study|Lost to Follow-up|2|||
129753054|NCT02631551|467055094|FG002|Overall Study|Lost to Follow-up|0|||
129753055|NCT02631551|467055095|FG003|Overall Study|Lost to Follow-up|3|||
129753056|NCT02631551|467055092|FG000|Overall Study|Withdrawal by Subject|2|||
129753057|NCT02631551|467055093|FG001|Overall Study|Withdrawal by Subject|2|||
129753058|NCT02631551|467055094|FG002|Overall Study|Withdrawal by Subject|0|||
129753059|NCT02631551|467055095|FG003|Overall Study|Withdrawal by Subject|5|||
129753060|NCT02631551|467055092|FG000|Overall Study|Protocol deviation|3|||
129753061|NCT02631551|467055093|FG001|Overall Study|Protocol deviation|6|||
129753062|NCT02631551|467055094|FG002|Overall Study|Protocol deviation|3|||
129753063|NCT02631551|467055095|FG003|Overall Study|Protocol deviation|0|||
129753064|NCT02631551|467055092|FG000|Overall Study|Non-compliance with study procedures|0|||
129753065|NCT02631551|467055093|FG001|Overall Study|Non-compliance with study procedures|0|||
129753066|NCT02631551|467055094|FG002|Overall Study|Non-compliance with study procedures|1|||
129753067|NCT02631551|467055095|FG003|Overall Study|Non-compliance with study procedures|1|||
129753068|NCT02631551|467055092|FG000|Overall Study|Non-compliance with study drug|1|||
129753069|NCT02631551|467055093|FG001|Overall Study|Non-compliance with study drug|0|||
129753070|NCT02631551|467055094|FG002|Overall Study|Non-compliance with study drug|0|||
129753071|NCT02631551|467055095|FG003|Overall Study|Non-compliance with study drug|0|||
129753072|NCT02631551|467055092|FG000|Overall Study|Other, specific reasons not collected|5|||
129753073|NCT02631551|467055093|FG001|Overall Study|Other, specific reasons not collected|7|||
129753074|NCT02631551|467055094|FG002|Overall Study|Other, specific reasons not collected|2|||
129753075|NCT02631551|467055095|FG003|Overall Study|Other, specific reasons not collected|2|||
129753076|NCT04112303|467055096|FG000|Overall Study|Death|1|||
129753077|NCT05636852|467055104|FG000|Overall Study|Withdrawal by Subject|1|||
129753078|NCT05636852|467055104|FG000|Overall Study|Other than specified|1|||
129753079|NCT01076036|467055105|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
129753080|NCT03088917|467055106|FG000|Overall Study|In care/cured elsewhere|15|||
129753081|NCT03088917|467055106|FG000|Overall Study|Refuse re-evaluation|13|||
129753082|NCT03088917|467055106|FG000|Overall Study|Contact not established|13|||
129753083|NCT03088917|467055106|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
129753084|NCT03088917|467055106|FG000|Overall Study|Moved outside study region|50|||
129753085|NCT01221350|467055107|FG000|Overall Study|Discontinued intervention (GERD)|1|||
129753086|NCT01221350|467055108|FG001|Overall Study|Discontinued intervention (GERD)|0|||
129753087|NCT01221350|467055107|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
129753088|NCT01221350|467055108|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
129753089|NCT01221350|467055107|FG000|Overall Study|Withdrawal by Subject|4|||
129753090|NCT01221350|467055108|FG001|Overall Study|Withdrawal by Subject|2|||
129753091|NCT02735343|467055114|FG000|Overall Study|screen fail|0|||
129753092|NCT02735343|467055115|FG001|Overall Study|screen fail|2|||
129753093|NCT02204072|467055119|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
129753094|NCT02204072|467055120|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
129753095|NCT02204072|467055121|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
129753096|NCT02204072|467055122|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
129753097|NCT02204072|467055123|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
129753098|NCT02204072|467055119|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
129753099|NCT02204072|467055120|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
129753100|NCT02204072|467055121|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
129753101|NCT02204072|467055122|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
129753102|NCT02204072|467055123|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
129753103|NCT02204072|467055119|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
129753104|NCT02204072|467055120|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
129753105|NCT02204072|467055121|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
129753106|NCT02204072|467055122|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
129753107|NCT02204072|467055123|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
129753108|NCT02204072|467055119|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129753109|NCT02204072|467055120|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129753110|NCT02204072|467055121|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
129753111|NCT02204072|467055122|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129753112|NCT02204072|467055123|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
129809937|NCT00983437|467271008|FG000|Overall Study|Lack of Efficacy|1|||
129809938|NCT00983437|467271008|FG000|Overall Study|Withdrawal by Subject|8|||
129809939|NCT00983437|467271008|FG000|Overall Study|Noncompliance to Study Procedures|1|||
129809940|NCT00983437|467271008|FG000|Overall Study|Lost to Follow-up|2|||
129809941|NCT00983437|467271008|FG000|Overall Study|Other Reason|26|||
129809942|NCT01543958|467271009|FG000|Overall Study|Loss to follow-up|3|||
129809943|NCT01543958|467271009|FG000|Overall Study|ART initiation|1|||
129809944|NCT04019288|467271010|FG000|Overall Study|Death|1|||
129809945|NCT04019288|467271011|FG001|Overall Study|Death|0|||
129809946|NCT04019288|467271012|FG002|Overall Study|Death|0|||
129809947|NCT01945281|467271013|FG000|Overall Study|Adverse Event|1|||
129809948|NCT01945281|467271014|FG001|Overall Study|Adverse Event|0|||
129809949|NCT01945281|467271013|FG000|Overall Study|Death|3|||
129809950|NCT01945281|467271014|FG001|Overall Study|Death|3|||
129809951|NCT01945281|467271013|FG000|Overall Study|Physician Decision|1|||
129809952|NCT01945281|467271014|FG001|Overall Study|Physician Decision|1|||
129809953|NCT01945281|467271013|FG000|Overall Study|Technical Problems|1|||
129809954|NCT01945281|467271014|FG001|Overall Study|Technical Problems|0|||
129809955|NCT04401423|467271016|FG000|Overall Study|Withdrawal by Subject|3|||
129809956|NCT04401423|467271017|FG001|Overall Study|Withdrawal by Subject|1|||
129809957|NCT04401423|467271016|FG000|Overall Study|Physician Decision|2|||
129809958|NCT04401423|467271017|FG001|Overall Study|Physician Decision|1|||
129809959|NCT01702805|467271018|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
129753113|NCT04209205|467055127|FG000|Overall Study|Adverse Event|2|||
129753114|NCT04209205|467055128|FG001|Overall Study|Adverse Event|3|||
129753115|NCT04209205|467055127|FG000|Overall Study|Lost to Follow-up|3|||
129753116|NCT04209205|467055128|FG001|Overall Study|Lost to Follow-up|1|||
129753117|NCT04209205|467055127|FG000|Overall Study|Physician Decision|1|||
129753118|NCT04209205|467055128|FG001|Overall Study|Physician Decision|1|||
129753119|NCT04209205|467055127|FG000|Overall Study|Subject decision|10|||
129809960|NCT01702805|467271019|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
129809961|NCT01702805|467271018|FG000|Overall Study|Incomplete Follow-up|18|||
129809962|NCT01702805|467271019|FG001|Overall Study|Incomplete Follow-up|15|||
129809963|NCT01702805|467271018|FG000|Overall Study|Vital Status Assessment Only|40|||
129809964|NCT01702805|467271019|FG001|Overall Study|Vital Status Assessment Only|39|||
129809965|NCT01702805|467271018|FG000|Overall Study|Lost to Follow-up|5|||
129809966|NCT01702805|467271019|FG001|Overall Study|Lost to Follow-up|5|||
129809967|NCT00181155|467271023|FG000|Overall Study|Physician Decision|1|||
129809968|NCT00181155|467271024|FG001|Overall Study|Physician Decision|0|||
129809969|NCT00181155|467271023|FG000|Overall Study|Withdrawal by Subject|1|||
129809970|NCT00181155|467271024|FG001|Overall Study|Withdrawal by Subject|0|||
129809971|NCT01788228|467271025|FG000|Overall Study|Migrated/moved from study area|1|||
129809972|NCT01788228|467271026|FG001|Overall Study|Migrated/moved from study area|0|||
129809973|NCT01548287|467271030|FG000|Screening|No reason provided|0|||
129809974|NCT01548287|467271031|FG001|Screening|No reason provided|0|||
129809975|NCT01548287|467271032|FG002|Screening|No reason provided|0|||
129809976|NCT01548287|467271033|FG003|Screening|No reason provided|0|||
129753120|NCT04209205|467055128|FG001|Overall Study|Subject decision|10|||
129753121|NCT04209205|467055127|FG000|Overall Study|Progressive disease|1|||
129753122|NCT04209205|467055128|FG001|Overall Study|Progressive disease|0|||
129753123|NCT04209205|467055127|FG000|Overall Study|Protocol deviation|0|||
129753124|NCT04209205|467055128|FG001|Overall Study|Protocol deviation|1|||
129753125|NCT04209205|467055127|FG000|Overall Study|New therapy for study indication|1|||
129753126|NCT04209205|467055128|FG001|Overall Study|New therapy for study indication|0|||
129753127|NCT04209205|467055127|FG000|Overall Study|Adverse event - placebo not switched|0|||
129753128|NCT04209205|467055128|FG001|Overall Study|Adverse event - placebo not switched|1|||
129753129|NCT04209205|467055127|FG000|Overall Study|Subject decision - placebo not switched|0|||
129753130|NCT04209205|467055128|FG001|Overall Study|Subject decision - placebo not switched|5|||
129753131|NCT04209205|467055127|FG000|Overall Study|Death - placebo not switched|0|||
129753132|NCT04209205|467055128|FG001|Overall Study|Death - placebo not switched|1|||
129753133|NCT03197376|467055129|FG000|Primary and Booster Phase|Adverse Event|0|||
129753134|NCT03197376|467055130|FG001|Primary and Booster Phase|Adverse Event|0|||
129753135|NCT03197376|467055131|FG002|Primary and Booster Phase|Adverse Event|0|||
129753136|NCT03197376|467055132|FG003|Primary and Booster Phase|Adverse Event|1|||
129753137|NCT03197376|467055129|FG000|Primary and Booster Phase|Death|1|||
129753138|NCT03197376|467055130|FG001|Primary and Booster Phase|Death|0|||
129753139|NCT03197376|467055131|FG002|Primary and Booster Phase|Death|0|||
129753140|NCT03197376|467055132|FG003|Primary and Booster Phase|Death|2|||
129809977|NCT01548287|467271034|FG004|Screening|No reason provided|9|||
129809978|NCT01548287|467271030|FG000|Screening|Did not meet eligibility criteria|0|||
129809979|NCT01548287|467271031|FG001|Screening|Did not meet eligibility criteria|0|||
129809980|NCT01548287|467271032|FG002|Screening|Did not meet eligibility criteria|0|||
129809981|NCT01548287|467271033|FG003|Screening|Did not meet eligibility criteria|0|||
129809982|NCT01548287|467271034|FG004|Screening|Did not meet eligibility criteria|74|||
129809983|NCT01548287|467271030|FG000|Randomized Period|Did not meet inclusion criteria|0|||
129809984|NCT01548287|467271031|FG001|Randomized Period|Did not meet inclusion criteria|0|||
129809985|NCT01548287|467271032|FG002|Randomized Period|Did not meet inclusion criteria|2|||
129809986|NCT01548287|467271033|FG003|Randomized Period|Did not meet inclusion criteria|0|||
129809987|NCT01548287|467271034|FG004|Randomized Period|Did not meet inclusion criteria|0|||
129809988|NCT01548287|467271030|FG000|Randomized Period|Adverse Event|0|||
129809989|NCT01548287|467271031|FG001|Randomized Period|Adverse Event|2|||
129809990|NCT01548287|467271032|FG002|Randomized Period|Adverse Event|5|||
129809991|NCT01548287|467271033|FG003|Randomized Period|Adverse Event|0|||
129809992|NCT01548287|467271034|FG004|Randomized Period|Adverse Event|0|||
129809993|NCT02762578|467271035|FG000|Overall Study|Adverse Event|1|||
129809994|NCT02762578|467271036|FG001|Overall Study|Adverse Event|6|||
129809995|NCT02762578|467271035|FG000|Overall Study|Protocol Violation|4|||
129809996|NCT02762578|467271036|FG001|Overall Study|Protocol Violation|2|||
129809997|NCT02762578|467271035|FG000|Overall Study|Withdrawal by Subject|4|||
129809998|NCT02762578|467271036|FG001|Overall Study|Withdrawal by Subject|2|||
129809999|NCT02762578|467271035|FG000|Overall Study|Unclassified|6|||
129810000|NCT02762578|467271036|FG001|Overall Study|Unclassified|0|||
129810001|NCT00259610|467271037|FG000|Overall Study|Withdrawal by Subject|33|||
129810002|NCT00259610|467271038|FG001|Overall Study|Withdrawal by Subject|25|||
129753141|NCT03197376|467055129|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
129810003|NCT00259610|467271039|FG002|Overall Study|Withdrawal by Subject|29|||
129810004|NCT00259610|467271040|FG003|Overall Study|Withdrawal by Subject|19|||
129810005|NCT00259610|467271037|FG000|Overall Study|Lost to Follow-up|19|||
129810006|NCT00259610|467271038|FG001|Overall Study|Lost to Follow-up|8|||
129810007|NCT00259610|467271039|FG002|Overall Study|Lost to Follow-up|18|||
129810008|NCT00259610|467271040|FG003|Overall Study|Lost to Follow-up|15|||
129810009|NCT00259610|467271037|FG000|Overall Study|Physician Decision|6|||
129810010|NCT00259610|467271038|FG001|Overall Study|Physician Decision|4|||
129753142|NCT03197376|467055130|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
129753143|NCT03197376|467055131|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
129753144|NCT03197376|467055132|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
129753145|NCT03197376|467055129|FG000|Primary and Booster Phase|Physician Decision|1|||
129810011|NCT00259610|467271039|FG002|Overall Study|Physician Decision|7|||
129810012|NCT00259610|467271040|FG003|Overall Study|Physician Decision|2|||
129810013|NCT00259610|467271037|FG000|Overall Study|Death|1|||
129753146|NCT03197376|467055130|FG001|Primary and Booster Phase|Physician Decision|0|||
129753147|NCT03197376|467055131|FG002|Primary and Booster Phase|Physician Decision|1|||
129753148|NCT03197376|467055132|FG003|Primary and Booster Phase|Physician Decision|3|||
129753149|NCT03197376|467055129|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
129753150|NCT03197376|467055130|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
129753151|NCT03197376|467055131|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
129753152|NCT03197376|467055132|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
129753153|NCT03197376|467055129|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
129753154|NCT03197376|467055130|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
129753155|NCT03197376|467055131|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
129753156|NCT03197376|467055132|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
129753157|NCT03197376|467055129|FG000|Primary and Booster Phase|Not vaccine related|1|||
129753158|NCT03197376|467055130|FG001|Primary and Booster Phase|Not vaccine related|2|||
129753159|NCT03197376|467055131|FG002|Primary and Booster Phase|Not vaccine related|0|||
129753160|NCT03197376|467055132|FG003|Primary and Booster Phase|Not vaccine related|6|||
129753161|NCT03197376|467055129|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
129753162|NCT03197376|467055130|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
129753163|NCT03197376|467055131|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
129753164|NCT03197376|467055132|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
129753165|NCT03197376|467055129|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
129753166|NCT03197376|467055130|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
129753167|NCT03197376|467055131|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
129753168|NCT03197376|467055132|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
129753169|NCT03197376|467055129|FG000|Immune Persistence Phase|Not vaccine related|1|||
129753170|NCT03197376|467055130|FG001|Immune Persistence Phase|Not vaccine related|0|||
129753171|NCT03197376|467055131|FG002|Immune Persistence Phase|Not vaccine related|1|||
129753172|NCT03197376|467055132|FG003|Immune Persistence Phase|Not vaccine related|1|||
129753173|NCT01123395|467055133|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
129753174|NCT01123395|467055134|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
129753175|NCT03691571|467055135|FG000|Overall Study|Withdrawal by Subject|9|||
129753176|NCT03691571|467055136|FG001|Overall Study|Withdrawal by Subject|2|||
129753177|NCT00186901|467055139|FG000|Overall Study|Pregnancy|6|||
129753178|NCT00186901|467055140|FG001|Overall Study|Pregnancy|3|||
129753179|NCT00186901|467055141|FG002|Overall Study|Pregnancy|0|||
129753180|NCT00186901|467055139|FG000|Overall Study|Lost to Follow-up|6|||
129753181|NCT00186901|467055140|FG001|Overall Study|Lost to Follow-up|3|||
129753182|NCT00186901|467055141|FG002|Overall Study|Lost to Follow-up|0|||
129753183|NCT00186901|467055139|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
129753184|NCT00186901|467055140|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
129753185|NCT00186901|467055141|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
129753186|NCT00186901|467055139|FG000|Overall Study|ALL relapse or second malignancy|1|||
129753187|NCT00186901|467055140|FG001|Overall Study|ALL relapse or second malignancy|2|||
129753188|NCT00186901|467055141|FG002|Overall Study|ALL relapse or second malignancy|0|||
129753189|NCT00186901|467055139|FG000|Overall Study|Withdrawal by Subject|4|||
129753190|NCT00186901|467055140|FG001|Overall Study|Withdrawal by Subject|5|||
129753191|NCT00186901|467055141|FG002|Overall Study|Withdrawal by Subject|0|||
129753192|NCT00186901|467055139|FG000|Overall Study|Open label|3|||
129753193|NCT00186901|467055140|FG001|Overall Study|Open label|2|||
129753194|NCT00186901|467055141|FG002|Overall Study|Open label|0|||
129753195|NCT00186901|467055139|FG000|Overall Study|Limited adherence to study requirements|20|||
129753196|NCT00186901|467055140|FG001|Overall Study|Limited adherence to study requirements|23|||
129753197|NCT00186901|467055141|FG002|Overall Study|Limited adherence to study requirements|0|||
129753198|NCT00186901|467055139|FG000|Overall Study|Bone Mineral Density > 0|0|||
129753199|NCT00186901|467055140|FG001|Overall Study|Bone Mineral Density > 0|0|||
129753200|NCT00186901|467055141|FG002|Overall Study|Bone Mineral Density > 0|149|||
129753201|NCT00291486|467055146|FG000|Overall Study|Adverse Event|0|||
129753202|NCT00291486|467055147|FG001|Overall Study|Adverse Event|3|||
129753203|NCT00291486|467055148|FG002|Overall Study|Adverse Event|0|||
129753204|NCT00291486|467055149|FG003|Overall Study|Adverse Event|1|||
129753205|NCT00291486|467055150|FG004|Overall Study|Adverse Event|0|||
129753206|NCT00291486|467055146|FG000|Overall Study|Withdrawal by Subject|0|||
129753207|NCT00291486|467055147|FG001|Overall Study|Withdrawal by Subject|0|||
129753208|NCT00291486|467055148|FG002|Overall Study|Withdrawal by Subject|0|||
129753209|NCT00291486|467055149|FG003|Overall Study|Withdrawal by Subject|0|||
129753210|NCT00291486|467055150|FG004|Overall Study|Withdrawal by Subject|1|||
129753211|NCT00291486|467055146|FG000|Overall Study|Disease progression|1|||
129753212|NCT00291486|467055147|FG001|Overall Study|Disease progression|0|||
129753213|NCT00291486|467055148|FG002|Overall Study|Disease progression|1|||
129753214|NCT00291486|467055149|FG003|Overall Study|Disease progression|0|||
129753215|NCT00291486|467055150|FG004|Overall Study|Disease progression|0|||
129753216|NCT02487030|467055153|FG000|Overall Study|Lack of Efficacy|2|||
129753217|NCT02487030|467055154|FG001|Overall Study|Lack of Efficacy|4|||
129753218|NCT02487030|467055155|FG002|Overall Study|Lack of Efficacy|1|||
129753219|NCT02487030|467055156|FG003|Overall Study|Lack of Efficacy|0|||
129753220|NCT02487030|467055157|FG004|Overall Study|Lack of Efficacy|1|||
129753221|NCT02487030|467055158|FG005|Overall Study|Lack of Efficacy|0|||
129753222|NCT02487030|467055159|FG006|Overall Study|Lack of Efficacy|0|||
129753223|NCT02487030|467055153|FG000|Overall Study|Lost to Follow-up|0|||
129753224|NCT02487030|467055154|FG001|Overall Study|Lost to Follow-up|0|||
129753225|NCT02487030|467055155|FG002|Overall Study|Lost to Follow-up|1|||
129753226|NCT02487030|467055156|FG003|Overall Study|Lost to Follow-up|1|||
129753227|NCT02487030|467055157|FG004|Overall Study|Lost to Follow-up|0|||
129753228|NCT02487030|467055158|FG005|Overall Study|Lost to Follow-up|1|||
129753229|NCT02487030|467055159|FG006|Overall Study|Lost to Follow-up|0|||
129753230|NCT02487030|467055153|FG000|Overall Study|Adverse Event|0|||
129753231|NCT02487030|467055154|FG001|Overall Study|Adverse Event|0|||
129753232|NCT02487030|467055155|FG002|Overall Study|Adverse Event|0|||
129753233|NCT02487030|467055156|FG003|Overall Study|Adverse Event|1|||
129753234|NCT02487030|467055157|FG004|Overall Study|Adverse Event|0|||
129753235|NCT02487030|467055158|FG005|Overall Study|Adverse Event|0|||
129753236|NCT02487030|467055159|FG006|Overall Study|Adverse Event|0|||
129753237|NCT02487030|467055153|FG000|Overall Study|Death|0|||
129753238|NCT02487030|467055154|FG001|Overall Study|Death|0|||
129753239|NCT02487030|467055155|FG002|Overall Study|Death|0|||
129753240|NCT02487030|467055156|FG003|Overall Study|Death|0|||
129753241|NCT02487030|467055157|FG004|Overall Study|Death|1|||
129753242|NCT02487030|467055158|FG005|Overall Study|Death|0|||
129753243|NCT02487030|467055159|FG006|Overall Study|Death|0|||
129753244|NCT00264537|467055160|FG000|Overall Study|Death|0|||
129753245|NCT00264537|467055161|FG001|Overall Study|Death|3|||
129753246|NCT00264537|467055162|FG002|Overall Study|Death|3|||
129753247|NCT00264537|467055163|FG003|Overall Study|Death|2|||
129753248|NCT00264537|467055160|FG000|Overall Study|Lost to Follow-up|3|||
129753249|NCT00264537|467055161|FG001|Overall Study|Lost to Follow-up|4|||
129753250|NCT00264537|467055162|FG002|Overall Study|Lost to Follow-up|7|||
129753251|NCT00264537|467055163|FG003|Overall Study|Lost to Follow-up|6|||
129753252|NCT00264537|467055160|FG000|Overall Study|Adverse Event|21|||
129753253|NCT00264537|467055161|FG001|Overall Study|Adverse Event|32|||
129753254|NCT00264537|467055162|FG002|Overall Study|Adverse Event|24|||
129753255|NCT00264537|467055163|FG003|Overall Study|Adverse Event|34|||
129753256|NCT00264537|467055160|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129753257|NCT00264537|467055161|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129753258|NCT00264537|467055162|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
129753259|NCT00264537|467055163|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
129753260|NCT00264537|467055160|FG000|Overall Study|Other|21|||
129753261|NCT00264537|467055161|FG001|Overall Study|Other|11|||
129753262|NCT00264537|467055162|FG002|Overall Study|Other|10|||
129753263|NCT00264537|467055163|FG003|Overall Study|Other|11|||
129753264|NCT00264537|467055160|FG000|Overall Study|Not treated|0|||
129753265|NCT00264537|467055161|FG001|Overall Study|Not treated|2|||
129753266|NCT00264537|467055162|FG002|Overall Study|Not treated|1|||
129753267|NCT00264537|467055163|FG003|Overall Study|Not treated|0|||
129753268|NCT00999544|467056886|FG000|Overall Study|Withdrawal by Subject|1|||
129753269|NCT04864639|467056887|FG000|Overall Study|Death|1|||
129753270|NCT04864639|467056887|FG000|Overall Study|Lost to Follow-up|1|||
129753271|NCT01478971|467056896|FG000|Standard of Care Period|Adverse Event|1|||
129753272|NCT01478971|467056896|FG000|Standard of Care Period|Withdrawal by Subject|3|||
129753273|NCT01478971|467056896|FG000|Standard of Care Period|Death|8|||
129753274|NCT01478971|467056896|FG000|Standard of Care Period|Lost to Follow-up|9|||
129753275|NCT01478971|467056896|FG000|Standard of Care Period|Other|4|||
129753276|NCT01478971|467056896|FG000|Peginesatide Treatment Period|Adverse Event|1|||
129753277|NCT01478971|467056896|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
129753278|NCT01478971|467056896|FG000|Peginesatide Treatment Period|Death|4|||
129753279|NCT01478971|467056896|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
129753280|NCT01478971|467056896|FG000|Peginesatide Treatment Period|Other|4|||
129753281|NCT00584012|467056897|FG000|Overall Study|Withdrawal by Subject|1|||
129753282|NCT01525615|467056898|FG000|Overall Study|Adverse Event|11|||
129753283|NCT01525615|467056899|FG001|Overall Study|Adverse Event|7|||
129753284|NCT01525615|467056900|FG002|Overall Study|Adverse Event|5|||
129753285|NCT01525615|467056898|FG000|Overall Study|Lost to Follow-up|1|||
129753286|NCT01525615|467056899|FG001|Overall Study|Lost to Follow-up|0|||
129753287|NCT01525615|467056900|FG002|Overall Study|Lost to Follow-up|0|||
129753288|NCT01525615|467056898|FG000|Overall Study|Withdrawal by Subject|1|||
129753289|NCT01525615|467056899|FG001|Overall Study|Withdrawal by Subject|0|||
129753290|NCT01525615|467056900|FG002|Overall Study|Withdrawal by Subject|0|||
129753291|NCT01525615|467056898|FG000|Overall Study|Other reason not described above|1|||
129753292|NCT01525615|467056899|FG001|Overall Study|Other reason not described above|0|||
129753293|NCT01525615|467056900|FG002|Overall Study|Other reason not described above|1|||
129753294|NCT04050618|467056901|FG000|First Intervention|Withdrawal by Subject|2|||
129753295|NCT04050618|467056902|FG001|First Intervention|Withdrawal by Subject|0|||
129753296|NCT04050618|467056901|FG000|Second Intervention|Withdrawal by Subject|1|||
129753297|NCT04050618|467056902|FG001|Second Intervention|Withdrawal by Subject|0|||
129753298|NCT04404556|467056903|FG000|Intervention|Withdrawal by Subject|15|||
129753299|NCT04404556|467056904|FG001|Intervention|Withdrawal by Subject|3|||
129753300|NCT04404556|467056903|FG000|Intervention|Did not complete all intervention sessions|2|||
129753301|NCT04404556|467056904|FG001|Intervention|Did not complete all intervention sessions|1|||
129753302|NCT04404556|467056903|FG000|Post-Intervention|Missing Data|1|||
129753303|NCT04404556|467056904|FG001|Post-Intervention|Missing Data|2|||
129753304|NCT04404556|467056903|FG000|Follow-up 1|Withdrawal by Subject|5|||
129753305|NCT04404556|467056904|FG001|Follow-up 1|Withdrawal by Subject|1|||
129753306|NCT04404556|467056903|FG000|Follow-up 1|Missing Data|4|||
129753307|NCT04404556|467056904|FG001|Follow-up 1|Missing Data|7|||
129753308|NCT04404556|467056903|FG000|Follow-up 2|Withdrawal by Subject|1|||
129753309|NCT04404556|467056904|FG001|Follow-up 2|Withdrawal by Subject|1|||
129753310|NCT04404556|467056903|FG000|Follow-up 2|Missing Data|6|||
129753311|NCT04404556|467056904|FG001|Follow-up 2|Missing Data|5|||
129753312|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
129753313|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
129753314|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
129753315|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
129753316|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
129753317|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
129753318|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
129753319|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
129753320|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
129753321|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
129753322|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
129753323|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
129753324|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
129753325|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
129753326|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
129753327|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
129753328|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129753329|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
129753330|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129753331|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
129753332|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
129753333|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
129753334|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
129753335|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
129753336|NCT03777059|467056905|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
129753337|NCT03777059|467056906|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
129753338|NCT03777059|467056907|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
129753339|NCT03777059|467056908|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
129753340|NCT03777059|467056905|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
129753341|NCT03777059|467056906|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
129753342|NCT03777059|467056907|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
129753343|NCT03777059|467056908|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
129753344|NCT03777059|467056905|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
129753345|NCT03777059|467056906|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
129753346|NCT03777059|467056907|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
129753347|NCT03777059|467056908|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
129753348|NCT03777059|467056905|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
129753349|NCT03777059|467056906|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
129753350|NCT03777059|467056907|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
129753351|NCT03777059|467056908|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
129753352|NCT03777059|467056905|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
129753353|NCT03777059|467056906|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
129753354|NCT03777059|467056907|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
129753355|NCT03777059|467056908|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
129753356|NCT00763386|467056910|FG000|Overall Study|Adverse Event|43|||
129753357|NCT00763386|467056911|FG001|Overall Study|Adverse Event|33|||
129753358|NCT00763386|467056910|FG000|Overall Study|Death|1|||
129753359|NCT00763386|467056911|FG001|Overall Study|Death|2|||
129753360|NCT00763386|467056910|FG000|Overall Study|Lost to Follow-up|3|||
129753361|NCT00763386|467056911|FG001|Overall Study|Lost to Follow-up|3|||
129753362|NCT00763386|467056910|FG000|Overall Study|Withdrawal by Subject|0|||
129810014|NCT00259610|467271038|FG001|Overall Study|Death|1|||
129810015|NCT00259610|467271039|FG002|Overall Study|Death|2|||
129810016|NCT00259610|467271040|FG003|Overall Study|Death|0|||
129810017|NCT00259610|467271037|FG000|Overall Study|non medical reason|6|||
129810018|NCT00259610|467271038|FG001|Overall Study|non medical reason|2|||
129810019|NCT00259610|467271039|FG002|Overall Study|non medical reason|10|||
129810020|NCT00259610|467271040|FG003|Overall Study|non medical reason|3|||
129810021|NCT00259610|467271037|FG000|Overall Study|Adverse Event|3|||
129810022|NCT00259610|467271038|FG001|Overall Study|Adverse Event|4|||
129810023|NCT00259610|467271039|FG002|Overall Study|Adverse Event|5|||
129810024|NCT00259610|467271040|FG003|Overall Study|Adverse Event|2|||
129810025|NCT00259610|467271037|FG000|Overall Study|Serious Adverse Event|8|||
129810026|NCT00259610|467271038|FG001|Overall Study|Serious Adverse Event|2|||
129810027|NCT00259610|467271039|FG002|Overall Study|Serious Adverse Event|2|||
129810028|NCT00259610|467271040|FG003|Overall Study|Serious Adverse Event|2|||
129810029|NCT01611155|467271043|FG000|Overall Study|Adverse Event|1|||
129810030|NCT01611155|467271044|FG001|Overall Study|Adverse Event|1|||
129810031|NCT01611155|467271043|FG000|Overall Study|Refused further treatment|6|||
129810032|NCT01611155|467271044|FG001|Overall Study|Refused further treatment|4|||
129810033|NCT01611155|467271043|FG000|Overall Study|Disease progression|1|||
129810034|NCT01611155|467271044|FG001|Overall Study|Disease progression|0|||
129810035|NCT01611155|467271043|FG000|Overall Study|Withdrawal by Subject|1|||
129810036|NCT01611155|467271044|FG001|Overall Study|Withdrawal by Subject|0|||
129810037|NCT01611155|467271043|FG000|Overall Study|Alternative treatment|0|||
129810038|NCT01611155|467271044|FG001|Overall Study|Alternative treatment|1|||
129810039|NCT01611155|467271043|FG000|Overall Study|Ineligible patient|0|||
129810040|NCT01611155|467271044|FG001|Overall Study|Ineligible patient|1|||
129810041|NCT02699593|467271045|FG000|Period 1|Unsatisfactory Visual Response|0|||
129810042|NCT02699593|467271046|FG001|Period 1|Unsatisfactory Visual Response|1|||
129810043|NCT02699593|467271045|FG000|Period 1|Torn Contact Len|4|||
129810044|NCT02699593|467271046|FG001|Period 1|Torn Contact Len|3|||
129810045|NCT02699593|467271045|FG000|Period 1|Protocol Violation|0|||
129810046|NCT02699593|467271046|FG001|Period 1|Protocol Violation|1|||
129810047|NCT02699593|467271045|FG000|Period 1|Withdrawal by Subject|0|||
129810048|NCT02699593|467271046|FG001|Period 1|Withdrawal by Subject|1|||
129810049|NCT02699593|467271045|FG000|Period 1|Adverse Event|1|||
129810050|NCT02699593|467271046|FG001|Period 1|Adverse Event|1|||
129810051|NCT02699593|467271045|FG000|Period 2|Adverse Event|1|||
129810052|NCT02699593|467271046|FG001|Period 2|Adverse Event|1|||
129810053|NCT02699593|467271045|FG000|Period 2|Lost Contact Lens|0|||
129810054|NCT02699593|467271046|FG001|Period 2|Lost Contact Lens|1|||
129810055|NCT02699593|467271045|FG000|Period 2|Torn Contact Lens|1|||
129810056|NCT02699593|467271046|FG001|Period 2|Torn Contact Lens|0|||
129810057|NCT00868608|467271047|FG000|Overall Study|Withdrawal by Subject|3|||
129810058|NCT00868608|467271048|FG001|Overall Study|Withdrawal by Subject|1|||
129810059|NCT00868608|467271049|FG002|Overall Study|Withdrawal by Subject|0|||
129810060|NCT00868608|467271047|FG000|Overall Study|Lost to Follow-up|3|||
129810061|NCT00868608|467271048|FG001|Overall Study|Lost to Follow-up|0|||
129810062|NCT00868608|467271049|FG002|Overall Study|Lost to Follow-up|1|||
129810063|NCT00868608|467271047|FG000|Overall Study|Death|16|||
129810064|NCT00868608|467271048|FG001|Overall Study|Death|2|||
129810065|NCT00868608|467271049|FG002|Overall Study|Death|4|||
129810066|NCT00868608|467271047|FG000|Overall Study|Other - Unspecified|1|||
129810067|NCT00868608|467271048|FG001|Overall Study|Other - Unspecified|0|||
129810068|NCT00868608|467271049|FG002|Overall Study|Other - Unspecified|0|||
129810069|NCT03344796|467271050|FG000|Overall Study|Lost to Follow-up|0|||
129810070|NCT03344796|467271051|FG001|Overall Study|Lost to Follow-up|0|||
129810071|NCT03344796|467271052|FG002|Overall Study|Lost to Follow-up|0|||
129810072|NCT03344796|467271053|FG003|Overall Study|Lost to Follow-up|0|||
129810073|NCT03344796|467271054|FG004|Overall Study|Lost to Follow-up|0|||
129810074|NCT03344796|467271055|FG005|Overall Study|Lost to Follow-up|2|||
129810075|NCT02564796|467271058|FG000|Overall Study|Physician Decision|2|||
129810076|NCT02564796|467271059|FG001|Overall Study|Physician Decision|2|||
129810077|NCT00453063|467271060|FG000|Overall Study|Adverse Event|1|||
129810078|NCT00453063|467271061|FG001|Overall Study|Adverse Event|2|||
129810079|NCT00453063|467271060|FG000|Overall Study|Withdrawal by Subject|1|||
129810080|NCT00453063|467271061|FG001|Overall Study|Withdrawal by Subject|1|||
129810081|NCT00453063|467271060|FG000|Overall Study|Protocol Violation|1|||
129810082|NCT00453063|467271061|FG001|Overall Study|Protocol Violation|0|||
129810083|NCT00289783|467271062|FG000|Primary Phase|Adverse Event|10|||
129810084|NCT00289783|467271063|FG001|Primary Phase|Adverse Event|1|||
129810085|NCT00289783|467271062|FG000|Primary Phase|Protocol Violation|27|||
129810086|NCT00289783|467271063|FG001|Primary Phase|Protocol Violation|6|||
129810087|NCT00289783|467271062|FG000|Primary Phase|Withdrawal by Subject|93|||
129810088|NCT00289783|467271063|FG001|Primary Phase|Withdrawal by Subject|40|||
129810089|NCT00289783|467271062|FG000|Primary Phase|Lost to Follow-up|60|||
129810090|NCT00289783|467271063|FG001|Primary Phase|Lost to Follow-up|14|||
129810091|NCT00289783|467271062|FG000|Primary Phase|Migration from the study area|26|||
129753363|NCT00763386|467056911|FG001|Overall Study|Withdrawal by Subject|1|||
129753364|NCT00763386|467056910|FG000|Overall Study|CRF missing|0|||
129753365|NCT00763386|467056911|FG001|Overall Study|CRF missing|1|||
129753366|NCT00763386|467056910|FG000|Overall Study|Study Prosthesis Removed|1|||
129753367|NCT00763386|467056911|FG001|Overall Study|Study Prosthesis Removed|0|||
129753368|NCT00411671|467056912|FG000|Overall Study|Adverse Event|15|||
129753369|NCT00411671|467056912|FG000|Overall Study|Death|2|||
129753370|NCT00411671|467056912|FG000|Overall Study|Lost to Follow-up|3|||
129753371|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
129753372|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129753373|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129753374|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129753375|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129753376|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
129753377|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129753378|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129753379|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129753380|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129753381|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
129753382|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129753383|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129753384|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129753385|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129753386|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
129753387|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129753388|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129753389|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129753390|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129753391|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
129753392|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129753393|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129753394|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129753395|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129753396|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
129753397|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129753398|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129753399|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129753400|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129753401|NCT01173601|467056914|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
129753402|NCT01173601|467056915|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129753403|NCT01173601|467056916|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129753404|NCT01173601|467056917|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129753405|NCT01173601|467056918|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129753406|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
129753407|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
129753408|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
129753409|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
129896698|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
129896699|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
129753410|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
129753411|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
129753412|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
129753413|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
129753414|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
129753415|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
129753416|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129753417|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
129753418|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129753419|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
129896700|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
129896701|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
129896702|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
129896703|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Non-compliance|4|||
129753420|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
129753421|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129753422|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129753423|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129896704|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Non-compliance|0|||
129753424|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129753425|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129753426|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
129753427|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
129753428|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129753429|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
129753430|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129753431|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
129753432|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
129753433|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
129753434|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
129753435|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
129753436|NCT01173601|467056914|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129753437|NCT01173601|467056915|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129753438|NCT01173601|467056916|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129753439|NCT01173601|467056917|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129753440|NCT01173601|467056918|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
129753441|NCT03951077|467056919|FG000|Overall Study|Adverse Event|1|||
129753442|NCT03951077|467056920|FG001|Overall Study|Adverse Event|0|||
129753443|NCT03951077|467056921|FG002|Overall Study|Adverse Event|0|||
129753444|NCT03951077|467056922|FG003|Overall Study|Adverse Event|0|||
129753445|NCT03951077|467056923|FG004|Overall Study|Adverse Event|0|||
129753446|NCT03951077|467056924|FG005|Overall Study|Adverse Event|0|||
129753447|NCT03951077|467056919|FG000|Overall Study|Withdrawal by Subject|3|||
129753448|NCT03951077|467056920|FG001|Overall Study|Withdrawal by Subject|3|||
129753449|NCT03951077|467056921|FG002|Overall Study|Withdrawal by Subject|0|||
129753450|NCT03951077|467056922|FG003|Overall Study|Withdrawal by Subject|3|||
129753451|NCT03951077|467056923|FG004|Overall Study|Withdrawal by Subject|3|||
129753452|NCT03951077|467056924|FG005|Overall Study|Withdrawal by Subject|2|||
129753453|NCT03951077|467056919|FG000|Overall Study|Lost to Follow-up|1|||
129753454|NCT03951077|467056920|FG001|Overall Study|Lost to Follow-up|1|||
129753455|NCT03951077|467056921|FG002|Overall Study|Lost to Follow-up|2|||
129753456|NCT03951077|467056922|FG003|Overall Study|Lost to Follow-up|3|||
129753457|NCT03951077|467056923|FG004|Overall Study|Lost to Follow-up|2|||
129753458|NCT03951077|467056924|FG005|Overall Study|Lost to Follow-up|3|||
129753459|NCT03951077|467056919|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
129753460|NCT03951077|467056920|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
129753461|NCT03951077|467056921|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
129753462|NCT03951077|467056922|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
129753463|NCT03951077|467056923|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
129753464|NCT03951077|467056924|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
129753465|NCT03951077|467056919|FG000|Overall Study|Other, Not Specified|12|||
129753466|NCT03951077|467056920|FG001|Overall Study|Other, Not Specified|10|||
129753467|NCT03951077|467056921|FG002|Overall Study|Other, Not Specified|10|||
129753468|NCT03951077|467056922|FG003|Overall Study|Other, Not Specified|5|||
129753469|NCT03951077|467056923|FG004|Overall Study|Other, Not Specified|9|||
129753470|NCT03951077|467056924|FG005|Overall Study|Other, Not Specified|6|||
129753471|NCT03951077|467056919|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
129753472|NCT03951077|467056920|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
129753473|NCT03951077|467056921|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
129753474|NCT03951077|467056922|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
129753475|NCT03951077|467056923|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
129753476|NCT03951077|467056924|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
129753477|NCT01395901|467056927|FG000|Overall Study|Lost to Follow-up|4|||
129753478|NCT01395901|467056928|FG001|Overall Study|Lost to Follow-up|0|||
129753479|NCT01395901|467056927|FG000|Overall Study|Randomized but not received study drug|5|||
129753480|NCT01395901|467056928|FG001|Overall Study|Randomized but not received study drug|4|||
129753481|NCT01395901|467056927|FG000|Overall Study|Adverse Event|0|||
129753482|NCT01395901|467056928|FG001|Overall Study|Adverse Event|1|||
129753483|NCT01395901|467056927|FG000|Overall Study|Withdrawal of consent|1|||
129753484|NCT01395901|467056928|FG001|Overall Study|Withdrawal of consent|0|||
129753485|NCT00713544|467056934|FG000|Overall Study|Adverse Event|5|||
129810092|NCT00289783|467271063|FG001|Primary Phase|Migration from the study area|10|||
129753486|NCT00713544|467056935|FG001|Overall Study|Adverse Event|3|||
129810093|NCT00289783|467271062|FG000|Primary Phase|Other|32|||
129753487|NCT00713544|467056936|FG002|Overall Study|Adverse Event|7|||
129753488|NCT00713544|467056937|FG003|Overall Study|Adverse Event|7|||
129810094|NCT00289783|467271063|FG001|Primary Phase|Other|12|||
129810095|NCT00289783|467271062|FG000|Fourth Dose Phase|Adverse Event|1|||
129753489|NCT00713544|467056938|FG004|Overall Study|Adverse Event|3|||
129753490|NCT00713544|467056939|FG005|Overall Study|Adverse Event|5|||
129753491|NCT00713544|467056934|FG000|Overall Study|Withdrawal by Subject|2|||
129753492|NCT00713544|467056935|FG001|Overall Study|Withdrawal by Subject|0|||
129753493|NCT00713544|467056936|FG002|Overall Study|Withdrawal by Subject|3|||
129753494|NCT00713544|467056937|FG003|Overall Study|Withdrawal by Subject|2|||
129753495|NCT00713544|467056938|FG004|Overall Study|Withdrawal by Subject|3|||
129753496|NCT00713544|467056939|FG005|Overall Study|Withdrawal by Subject|1|||
129753497|NCT00713544|467056934|FG000|Overall Study|Protocol Violation|0|||
129753498|NCT00713544|467056935|FG001|Overall Study|Protocol Violation|0|||
129753499|NCT00713544|467056936|FG002|Overall Study|Protocol Violation|0|||
129753500|NCT00713544|467056937|FG003|Overall Study|Protocol Violation|0|||
129753501|NCT00713544|467056938|FG004|Overall Study|Protocol Violation|0|||
129753502|NCT00713544|467056939|FG005|Overall Study|Protocol Violation|1|||
129753503|NCT00713544|467056934|FG000|Overall Study|Physician Decision|0|||
129753504|NCT00713544|467056935|FG001|Overall Study|Physician Decision|0|||
129753505|NCT00713544|467056936|FG002|Overall Study|Physician Decision|0|||
129753506|NCT00713544|467056937|FG003|Overall Study|Physician Decision|0|||
129753507|NCT00713544|467056938|FG004|Overall Study|Physician Decision|0|||
129753508|NCT00713544|467056939|FG005|Overall Study|Physician Decision|2|||
129753509|NCT00713544|467056934|FG000|Overall Study|Lack of Efficacy|0|||
129753510|NCT00713544|467056935|FG001|Overall Study|Lack of Efficacy|1|||
129753511|NCT00713544|467056936|FG002|Overall Study|Lack of Efficacy|0|||
129753512|NCT00713544|467056937|FG003|Overall Study|Lack of Efficacy|1|||
129753513|NCT00713544|467056938|FG004|Overall Study|Lack of Efficacy|1|||
129753514|NCT00713544|467056939|FG005|Overall Study|Lack of Efficacy|0|||
129753515|NCT00713544|467056934|FG000|Overall Study|Lost to Follow-up|0|||
129753516|NCT00713544|467056935|FG001|Overall Study|Lost to Follow-up|0|||
129753517|NCT00713544|467056936|FG002|Overall Study|Lost to Follow-up|1|||
129753518|NCT00713544|467056937|FG003|Overall Study|Lost to Follow-up|0|||
129753519|NCT00713544|467056938|FG004|Overall Study|Lost to Follow-up|0|||
129753520|NCT00713544|467056939|FG005|Overall Study|Lost to Follow-up|0|||
129753521|NCT00713544|467056934|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129753522|NCT00713544|467056935|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
129753523|NCT00713544|467056936|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129753524|NCT00713544|467056937|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129753525|NCT00713544|467056938|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129753526|NCT00713544|467056939|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
129753527|NCT00713544|467056934|FG000|Overall Study|Incorrect enrollment|0|||
129753528|NCT00713544|467056935|FG001|Overall Study|Incorrect enrollment|1|||
129753529|NCT00713544|467056936|FG002|Overall Study|Incorrect enrollment|0|||
129753530|NCT00713544|467056937|FG003|Overall Study|Incorrect enrollment|0|||
129753531|NCT00713544|467056938|FG004|Overall Study|Incorrect enrollment|0|||
129753532|NCT00713544|467056939|FG005|Overall Study|Incorrect enrollment|0|||
129753533|NCT00713544|467056934|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
129753534|NCT00713544|467056935|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
129753535|NCT00713544|467056936|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
129753536|NCT00713544|467056937|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
129753537|NCT00713544|467056938|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
129753538|NCT00713544|467056939|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
129753539|NCT02380287|467056940|FG000|Overall Study|Adverse Event|0|||
129753540|NCT02380287|467056941|FG001|Overall Study|Adverse Event|0|||
129753541|NCT02380287|467056942|FG002|Overall Study|Adverse Event|1|||
129753542|NCT02380287|467056943|FG003|Overall Study|Adverse Event|0|||
129753543|NCT02380287|467056944|FG004|Overall Study|Adverse Event|0|||
129753544|NCT02380287|467056945|FG005|Overall Study|Adverse Event|0|||
129753545|NCT02380287|467056946|FG006|Overall Study|Adverse Event|0|||
129753546|NCT02380287|467056947|FG007|Overall Study|Adverse Event|0|||
129753547|NCT01641601|467056948|FG000|Overall Study|Study discontinued.|3|||
129753548|NCT01641601|467056949|FG001|Overall Study|Study discontinued.|5|||
129753549|NCT00950846|467056952|FG000|Overall Study|Death|6|||
129753550|NCT00950846|467056952|FG000|Overall Study|Lost to Follow-up|3|||
129753551|NCT00950846|467056952|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
129753552|NCT01799226|467056953|FG000|Overall Study|Withdrawal by Subject|1|||
129753553|NCT01799226|467056954|FG001|Overall Study|Withdrawal by Subject|0|||
129753554|NCT01799226|467056953|FG000|Overall Study|Disqualified at Day 14|1|||
129753555|NCT01799226|467056954|FG001|Overall Study|Disqualified at Day 14|0|||
129753556|NCT02178995|467056955|FG000|Double Blind|Adverse Event|0|||
129753557|NCT02178995|467056956|FG001|Double Blind|Adverse Event|0|||
129753558|NCT02178995|467056957|FG002|Double Blind|Adverse Event|0|||
129753559|NCT02178995|467056958|FG003|Double Blind|Adverse Event|0|||
129753560|NCT02178995|467056959|FG004|Double Blind|Adverse Event|0|||
129753561|NCT02178995|467056960|FG005|Double Blind|Adverse Event|1|||
129753562|NCT02178995|467056961|FG006|Double Blind|Adverse Event|0|||
129753563|NCT02178995|467056962|FG007|Double Blind|Adverse Event|1|||
129753564|NCT02178995|467056963|FG008|Double Blind|Adverse Event|1|||
129753565|NCT02178995|467056955|FG000|Double Blind|Lost to Follow-up|0|||
129753566|NCT02178995|467056956|FG001|Double Blind|Lost to Follow-up|1|||
129753567|NCT02178995|467056957|FG002|Double Blind|Lost to Follow-up|0|||
129753568|NCT02178995|467056958|FG003|Double Blind|Lost to Follow-up|0|||
129753569|NCT02178995|467056959|FG004|Double Blind|Lost to Follow-up|0|||
129753570|NCT02178995|467056960|FG005|Double Blind|Lost to Follow-up|0|||
129753571|NCT02178995|467056961|FG006|Double Blind|Lost to Follow-up|0|||
129753572|NCT02178995|467056962|FG007|Double Blind|Lost to Follow-up|1|||
129753573|NCT02178995|467056963|FG008|Double Blind|Lost to Follow-up|0|||
129753574|NCT02178995|467056955|FG000|Open Label|Adverse Event|2|||
129753575|NCT02178995|467056956|FG001|Open Label|Adverse Event|0|||
129753576|NCT02178995|467056957|FG002|Open Label|Adverse Event|0|||
129753577|NCT02178995|467056958|FG003|Open Label|Adverse Event|0|||
129753578|NCT02178995|467056959|FG004|Open Label|Adverse Event|0|||
129753579|NCT02178995|467056960|FG005|Open Label|Adverse Event|0|||
129753580|NCT02178995|467056961|FG006|Open Label|Adverse Event|0|||
129753581|NCT02178995|467056962|FG007|Open Label|Adverse Event|0|||
129753582|NCT02178995|467056963|FG008|Open Label|Adverse Event|0|||
129753583|NCT02274792|467056964|FG000|Overall Study|Withdrawal by Subject|13|||
129753584|NCT02274792|467056964|FG000|Overall Study|Lost to Follow-up|8|||
129753585|NCT02274792|467056964|FG000|Overall Study|Protocol Specified Criteria|2|||
129753586|NCT02274792|467056964|FG000|Overall Study|Sponsor Decision|2|||
129753587|NCT05258149|467056965|FG000|Period 1|Protocol Deviation|1|||
129753588|NCT05258149|467056966|FG001|Period 1|Protocol Deviation|0|||
129810096|NCT00289783|467271063|FG001|Fourth Dose Phase|Adverse Event|0|||
129810097|NCT00289783|467271062|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
129810098|NCT00289783|467271063|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
129810099|NCT00289783|467271062|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
129810100|NCT00289783|467271063|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
129810101|NCT00289783|467271062|FG000|Fourth Dose Phase|Migration from the study area|1|||
129810102|NCT00289783|467271063|FG001|Fourth Dose Phase|Migration from the study area|1|||
129810103|NCT00289783|467271062|FG000|Fourth Dose Phase|Other|22|||
129810104|NCT00289783|467271063|FG001|Fourth Dose Phase|Other|10|||
129810105|NCT00566995|467271066|FG000|Overall Study|Toxicity|4|||
129810106|NCT00566995|467271066|FG000|Overall Study|Withdrew consent|3|||
129810107|NCT03298867|467271076|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
129810108|NCT03298867|467271077|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
129810109|NCT03298867|467271076|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
129810110|NCT03298867|467271077|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
129810111|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
129810112|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
129810113|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
129810114|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
129810115|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
129810116|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
129810117|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
129810118|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
129810119|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
129810120|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
129810121|NCT03298867|467271076|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
129810122|NCT03298867|467271077|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
129810123|NCT03298867|467271076|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
129810124|NCT03298867|467271077|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
129810125|NCT00228384|467271078|FG000|Overall Study|Death|9|||
129810126|NCT00228384|467271079|FG001|Overall Study|Death|3|||
129810127|NCT00228384|467271078|FG000|Overall Study|Lost to Follow-up|6|||
129810128|NCT00228384|467271079|FG001|Overall Study|Lost to Follow-up|10|||
129810129|NCT00228384|467271078|FG000|Overall Study|Surgical Intervention (bypass)|5|||
129810130|NCT00228384|467271079|FG001|Overall Study|Surgical Intervention (bypass)|5|||
129810131|NCT00228384|467271078|FG000|Overall Study|Withdrawal by Subject|9|||
129810132|NCT00228384|467271079|FG001|Overall Study|Withdrawal by Subject|10|||
129810133|NCT00228384|467271078|FG000|Overall Study|Physician Decision|0|||
129810134|NCT00228384|467271079|FG001|Overall Study|Physician Decision|1|||
129810135|NCT01785069|467271081|FG000|Overall Study|Implanted with nonstudy device|1|||
129810136|NCT01785069|467271082|FG001|Overall Study|Implanted with nonstudy device|2|||
129810137|NCT01785069|467271083|FG002|Overall Study|Implanted with nonstudy device|1|||
129753589|NCT05258149|467056965|FG000|Period 1|Adverse Event|0|||
129753590|NCT05258149|467056966|FG001|Period 1|Adverse Event|1|||
129753591|NCT05258149|467056965|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
129753592|NCT05258149|467056966|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
129753593|NCT05258149|467056965|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
129810138|NCT01785069|467271084|FG003|Overall Study|Implanted with nonstudy device|0|||
129810139|NCT01785069|467271081|FG000|Overall Study|Death|0|||
129810140|NCT01785069|467271082|FG001|Overall Study|Death|0|||
129810141|NCT01785069|467271083|FG002|Overall Study|Death|2|||
129753594|NCT05258149|467056966|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
129753595|NCT05258149|467056965|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
129753596|NCT05258149|467056966|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
129753597|NCT00832416|467056975|FG000|Overall Study|Lack of Efficacy|17|||
129753598|NCT00832416|467056976|FG001|Overall Study|Lack of Efficacy|15|||
129753599|NCT00832416|467056977|FG002|Overall Study|Lack of Efficacy|13|||
129753600|NCT00832416|467056978|FG003|Overall Study|Lack of Efficacy|52|||
129753601|NCT00832416|467056975|FG000|Overall Study|Withdrawal by Subject|5|||
129753602|NCT00832416|467056976|FG001|Overall Study|Withdrawal by Subject|7|||
129753603|NCT00832416|467056977|FG002|Overall Study|Withdrawal by Subject|2|||
129753604|NCT00832416|467056978|FG003|Overall Study|Withdrawal by Subject|10|||
129753605|NCT00832416|467056975|FG000|Overall Study|Physician Decision|2|||
129753606|NCT00832416|467056976|FG001|Overall Study|Physician Decision|12|||
129753607|NCT00832416|467056977|FG002|Overall Study|Physician Decision|5|||
129753608|NCT00832416|467056978|FG003|Overall Study|Physician Decision|10|||
129753609|NCT00832416|467056975|FG000|Overall Study|Administrative|0|||
129753610|NCT00832416|467056976|FG001|Overall Study|Administrative|0|||
129753611|NCT00832416|467056977|FG002|Overall Study|Administrative|0|||
129753612|NCT00832416|467056978|FG003|Overall Study|Administrative|1|||
129753613|NCT00832416|467056975|FG000|Overall Study|Adverse Event|21|||
129753614|NCT00832416|467056976|FG001|Overall Study|Adverse Event|19|||
129753615|NCT00832416|467056977|FG002|Overall Study|Adverse Event|41|||
129753616|NCT00832416|467056978|FG003|Overall Study|Adverse Event|10|||
129753617|NCT00832416|467056975|FG000|Overall Study|Death|1|||
129753618|NCT00832416|467056976|FG001|Overall Study|Death|0|||
129753619|NCT00832416|467056977|FG002|Overall Study|Death|0|||
129753620|NCT00832416|467056978|FG003|Overall Study|Death|0|||
129753621|NCT02741596|467056985|FG000|Overall Study|Adverse Event|1|||
129753622|NCT02741596|467056986|FG001|Overall Study|Adverse Event|5|||
129753623|NCT02741596|467056985|FG000|Overall Study|Lost to Follow-up|1|||
129753624|NCT02741596|467056986|FG001|Overall Study|Lost to Follow-up|1|||
129753625|NCT02741596|467056985|FG000|Overall Study|Physician Decision|2|||
129753626|NCT02741596|467056986|FG001|Overall Study|Physician Decision|1|||
129753627|NCT02741596|467056985|FG000|Overall Study|Pregnancy|3|||
129753628|NCT02741596|467056986|FG001|Overall Study|Pregnancy|1|||
129753629|NCT02741596|467056985|FG000|Overall Study|Other (Unspecified)|0|||
129753630|NCT02741596|467056986|FG001|Overall Study|Other (Unspecified)|3|||
129753631|NCT02741596|467056985|FG000|Overall Study|Subject withdrawn-Other|17|||
129753632|NCT02741596|467056986|FG001|Overall Study|Subject withdrawn-Other|4|||
129753633|NCT02741596|467056985|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
129753634|NCT02741596|467056986|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
129753635|NCT02859246|467056989|FG000|Overall Study|Screen fails|3|||
129753636|NCT02859246|467056989|FG000|Overall Study|Adverse Event|1|||
129753637|NCT02859246|467056989|FG000|Overall Study|Withdrawal by Subject|1|||
129753638|NCT00100789|467056990|FG000|Overall Study|Adverse Event|10|||
129753639|NCT00100789|467056990|FG000|Overall Study|Withdrawal by Subject|1|||
129753640|NCT00100789|467056990|FG000|Overall Study|Progression/relapse|42|||
129753641|NCT00100789|467056990|FG000|Overall Study|Death|2|||
129753642|NCT00100789|467056990|FG000|Overall Study|Not protocol specified|5|||
129753643|NCT00100789|467056990|FG000|Overall Study|Ineligible|3|||
129753644|NCT00100789|467056990|FG000|Overall Study|Never received treatment|1|||
129753645|NCT01746368|467056991|FG000|Overall Study|Lost to Follow-up|2|||
129753646|NCT01746368|467056992|FG001|Overall Study|Lost to Follow-up|0|||
129753647|NCT01746368|467056991|FG000|Overall Study|Withdrawal by Subject|0|||
129753648|NCT01746368|467056992|FG001|Overall Study|Withdrawal by Subject|1|||
129753649|NCT05280717|467056993|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
129753650|NCT05280717|467056994|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
129753651|NCT05280717|467056995|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
129753652|NCT05280717|467056996|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129753653|NCT05280717|467056997|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129753654|NCT05280717|467056998|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129753655|NCT05280717|467056999|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
129753656|NCT05280717|467056993|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
129753657|NCT05280717|467056994|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129753658|NCT05280717|467056995|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129753659|NCT05280717|467056996|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129753660|NCT05280717|467056997|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129753661|NCT05280717|467056998|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129753662|NCT05280717|467056999|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
129753663|NCT05280717|467056993|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129753664|NCT05280717|467056994|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
129753665|NCT05280717|467056995|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129810142|NCT01785069|467271084|FG003|Overall Study|Death|0|||
129810143|NCT01785069|467271081|FG000|Overall Study|Subject choice|2|||
129810144|NCT01785069|467271082|FG001|Overall Study|Subject choice|2|||
129810145|NCT01785069|467271083|FG002|Overall Study|Subject choice|0|||
129810146|NCT01785069|467271084|FG003|Overall Study|Subject choice|1|||
129810147|NCT01785069|467271081|FG000|Overall Study|Lost to Follow-up|1|||
129753666|NCT05280717|467056996|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129753667|NCT05280717|467056997|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129753668|NCT05280717|467056998|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129753669|NCT05280717|467056999|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
129753670|NCT05280717|467056993|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129753671|NCT05280717|467056994|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129753672|NCT05280717|467056995|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
129753673|NCT05280717|467056996|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129753674|NCT05280717|467056997|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129753675|NCT05280717|467056998|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129753676|NCT05280717|467056999|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
129753677|NCT05280717|467056993|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129753678|NCT05280717|467056994|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129753679|NCT05280717|467056995|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129753680|NCT05280717|467056996|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129753681|NCT05280717|467056997|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129753682|NCT05280717|467056998|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
129753683|NCT05280717|467056999|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
129753684|NCT05280717|467056993|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129753685|NCT05280717|467056994|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129753686|NCT05280717|467056995|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129753687|NCT05280717|467056996|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129753688|NCT05280717|467056997|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129753689|NCT05280717|467056998|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
129753690|NCT05280717|467056999|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
129753691|NCT00080301|467057000|FG000|Overall Study|Randomized but Never Treated|5|||
129753692|NCT00080301|467057001|FG001|Overall Study|Randomized but Never Treated|10|||
129753693|NCT00080301|467057000|FG000|Overall Study|Still on Treatment as of CSR date|0|||
129753694|NCT00080301|467057001|FG001|Overall Study|Still on Treatment as of CSR date|1|||
129753695|NCT02518971|467057002|FG000|Overall Study|Lost to Follow-up|0|||
129753696|NCT02518971|467057003|FG001|Overall Study|Lost to Follow-up|1|||
129753697|NCT02518971|467057002|FG000|Overall Study|Physician Decision|6|||
129753698|NCT02518971|467057003|FG001|Overall Study|Physician Decision|6|||
129753699|NCT02518971|467057002|FG000|Overall Study|Protocol Violation|6|||
129753700|NCT02518971|467057003|FG001|Overall Study|Protocol Violation|4|||
129753701|NCT02518971|467057002|FG000|Overall Study|Withdrawal by Subject|4|||
129810148|NCT01785069|467271082|FG001|Overall Study|Lost to Follow-up|2|||
129810149|NCT01785069|467271083|FG002|Overall Study|Lost to Follow-up|4|||
129810150|NCT01785069|467271084|FG003|Overall Study|Lost to Follow-up|1|||
129810151|NCT01785069|467271081|FG000|Overall Study|Reason not Specified|1|||
129810152|NCT01785069|467271082|FG001|Overall Study|Reason not Specified|2|||
129810153|NCT01785069|467271083|FG002|Overall Study|Reason not Specified|1|||
129810154|NCT01785069|467271084|FG003|Overall Study|Reason not Specified|4|||
129810155|NCT01785069|467271081|FG000|Overall Study|Not evaluable|7|||
129810156|NCT01785069|467271082|FG001|Overall Study|Not evaluable|4|||
129810157|NCT01785069|467271083|FG002|Overall Study|Not evaluable|5|||
129810158|NCT01785069|467271084|FG003|Overall Study|Not evaluable|8|||
129810159|NCT05358444|467271093|FG000|Overall Study|Withdrawal by Subject|0|||
129810160|NCT05358444|467271094|FG001|Overall Study|Withdrawal by Subject|1|||
129810161|NCT05358444|467271093|FG000|Overall Study|Lost to Follow-up|0|||
129810162|NCT05358444|467271094|FG001|Overall Study|Lost to Follow-up|3|||
129810163|NCT04997304|467271097|FG000|Overall Study|Lost to Follow-up|11|||
129810164|NCT04997304|467271097|FG000|Overall Study|Death|1|||
129810165|NCT04997304|467271097|FG000|Overall Study|Withdrawal by Subject|14|||
129810166|NCT01453361|467271098|FG000|Overall Study|Disease Progression|6|||
129810167|NCT01453361|467271098|FG000|Overall Study|Screen-Failures|10|||
129810168|NCT02323113|467273147|FG000|Overall Study|Adverse Event|3|||
129810169|NCT02323113|467273148|FG001|Overall Study|Adverse Event|3|||
129810170|NCT02323113|467273149|FG002|Overall Study|Adverse Event|2|||
129753702|NCT02518971|467057003|FG001|Overall Study|Withdrawal by Subject|5|||
129753703|NCT02518971|467057002|FG000|Overall Study|Side effects|1|||
129810171|NCT02323113|467273150|FG003|Overall Study|Adverse Event|5|||
129810172|NCT02323113|467273151|FG004|Overall Study|Adverse Event|8|||
129810173|NCT02323113|467273152|FG005|Overall Study|Adverse Event|3|||
129810174|NCT02323113|467273153|FG006|Overall Study|Adverse Event|6|||
129810175|NCT02323113|467273154|FG007|Overall Study|Adverse Event|0|||
129810176|NCT02323113|467273147|FG000|Overall Study|Progressive Disease|0|||
129810177|NCT02323113|467273148|FG001|Overall Study|Progressive Disease|1|||
129810178|NCT02323113|467273149|FG002|Overall Study|Progressive Disease|1|||
129810179|NCT02323113|467273150|FG003|Overall Study|Progressive Disease|0|||
129810180|NCT02323113|467273151|FG004|Overall Study|Progressive Disease|0|||
129753704|NCT02518971|467057003|FG001|Overall Study|Side effects|0|||
129753705|NCT02518971|467057002|FG000|Overall Study|medication lost in mail|0|||
129753706|NCT02518971|467057003|FG001|Overall Study|medication lost in mail|1|||
129753707|NCT02518971|467057002|FG000|Overall Study|eligibility criteria no longer met|6|||
129753708|NCT02518971|467057003|FG001|Overall Study|eligibility criteria no longer met|3|||
129753709|NCT02336230|467057004|FG000|Overall Study|Adverse Event|1|||
129753710|NCT02336230|467057004|FG000|Overall Study|Withdrawal of consent|1|||
129753711|NCT02336230|467057004|FG000|Overall Study|Death|9|||
129753712|NCT02336230|467057004|FG000|Overall Study|Dose not received due to shipping delay|1|||
129753713|NCT02336230|467057004|FG000|Overall Study|Discontinuation of MSC infusion|1|||
129753714|NCT02524171|467057005|FG000|6-month Follow-up|Lost to Follow-up|53|||
129753715|NCT02524171|467057006|FG001|6-month Follow-up|Lost to Follow-up|45|||
129753716|NCT02524171|467057005|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
129753717|NCT02524171|467057006|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
129753718|NCT00757237|467057009|FG000|Overall Study|Lost to Follow-up|0|||
129753719|NCT00757237|467057010|FG001|Overall Study|Lost to Follow-up|1|||
129753720|NCT00757237|467057009|FG000|Overall Study|Protocol Violation|0|||
129753721|NCT00757237|467057010|FG001|Overall Study|Protocol Violation|2|||
129753722|NCT00757237|467057009|FG000|Overall Study|Physician Decision|2|||
129753723|NCT00757237|467057010|FG001|Overall Study|Physician Decision|3|||
129753724|NCT00757237|467057009|FG000|Overall Study|Withdrawal by Subject|8|||
129753725|NCT00757237|467057010|FG001|Overall Study|Withdrawal by Subject|12|||
129753726|NCT00757237|467057009|FG000|Overall Study|Safety or Tolerability|3|||
129753727|NCT00757237|467057010|FG001|Overall Study|Safety or Tolerability|5|||
129753728|NCT00757237|467057009|FG000|Overall Study|Other|0|||
129753729|NCT00757237|467057010|FG001|Overall Study|Other|2|||
129753730|NCT01345188|467057011|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
129753731|NCT01345188|467057011|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
129753732|NCT05150990|467057012|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
129753733|NCT05150990|467057013|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
129753734|NCT05150990|467057012|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
129753735|NCT05150990|467057013|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
129753736|NCT05150990|467057012|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
129753737|NCT05150990|467057013|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
129753738|NCT05150990|467057012|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
129753739|NCT05150990|467057013|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
129753740|NCT05150990|467057012|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
129753741|NCT05150990|467057013|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
129753742|NCT05150990|467057012|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
129753743|NCT05150990|467057013|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
129753744|NCT05150990|467057012|FG000|Overall Study|Death (unrelated to the intervention)|1|||
129753745|NCT05150990|467057013|FG001|Overall Study|Death (unrelated to the intervention)|2|||
129753746|NCT00466921|467057014|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
129753747|NCT00466921|467057014|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
129753748|NCT00466921|467057014|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
129753749|NCT00466921|467057014|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
129753750|NCT00466921|467057014|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
129753751|NCT00466921|467057014|FG000|Follow up for a Minimum of 1 Year|Death|6|||
129753752|NCT05447663|467057016|FG000|Overall Study|Study terminated by Sponsor|5|||
129753753|NCT05447663|467057016|FG000|Overall Study|Death|2|||
129753754|NCT05447663|467057016|FG000|Overall Study|Withdrawal by Subject|1|||
129810181|NCT02323113|467273152|FG005|Overall Study|Progressive Disease|3|||
129810182|NCT02323113|467273153|FG006|Overall Study|Progressive Disease|0|||
129810183|NCT02323113|467273154|FG007|Overall Study|Progressive Disease|0|||
129810184|NCT02323113|467273147|FG000|Overall Study|Symptomatic Deterioration|0|||
129810185|NCT02323113|467273148|FG001|Overall Study|Symptomatic Deterioration|0|||
129810186|NCT02323113|467273149|FG002|Overall Study|Symptomatic Deterioration|1|||
129810187|NCT02323113|467273150|FG003|Overall Study|Symptomatic Deterioration|0|||
129810188|NCT02323113|467273151|FG004|Overall Study|Symptomatic Deterioration|1|||
129810189|NCT02323113|467273152|FG005|Overall Study|Symptomatic Deterioration|0|||
129810190|NCT02323113|467273153|FG006|Overall Study|Symptomatic Deterioration|0|||
129753755|NCT01397461|467057017|FG000|Overall Study|Withdrawal by Subject|2|||
129753756|NCT01397461|467057018|FG001|Overall Study|Withdrawal by Subject|1|||
129753757|NCT01397461|467057019|FG002|Overall Study|Withdrawal by Subject|0|||
129753758|NCT01397461|467057017|FG000|Overall Study|Lost to Follow-up|0|||
129753759|NCT01397461|467057018|FG001|Overall Study|Lost to Follow-up|2|||
129753760|NCT01397461|467057019|FG002|Overall Study|Lost to Follow-up|1|||
129753761|NCT01397461|467057017|FG000|Overall Study|Lack of Efficacy|0|||
129753762|NCT01397461|467057018|FG001|Overall Study|Lack of Efficacy|3|||
129753763|NCT01397461|467057019|FG002|Overall Study|Lack of Efficacy|0|||
129753764|NCT01397461|467057017|FG000|Overall Study|Not treated|0|||
129753765|NCT01397461|467057018|FG001|Overall Study|Not treated|0|||
129753766|NCT01397461|467057019|FG002|Overall Study|Not treated|1|||
129753767|NCT05729568|467057036|FG000|Overall Study|Still on Study|52|||
129753768|NCT05729568|467057037|FG001|Overall Study|Still on Study|26|||
129753769|NCT05729568|467057036|FG000|Overall Study|Randomized but Never Treated|3|||
129753770|NCT05729568|467057037|FG001|Overall Study|Randomized but Never Treated|0|||
129753771|NCT05729568|467057036|FG000|Overall Study|Adverse Event|0|||
129753772|NCT05729568|467057037|FG001|Overall Study|Adverse Event|1|||
129753773|NCT05729568|467057036|FG000|Overall Study|Investigator's Discretion|1|||
129753774|NCT05729568|467057037|FG001|Overall Study|Investigator's Discretion|0|||
129753775|NCT04181762|467057038|FG000|Overall Study|Adverse Event|1|||
129753776|NCT04181762|467057039|FG001|Overall Study|Adverse Event|3|||
129753777|NCT04181762|467057038|FG000|Overall Study|Lost to Follow-up|1|||
129753778|NCT04181762|467057039|FG001|Overall Study|Lost to Follow-up|1|||
129753779|NCT04181762|467057038|FG000|Overall Study|Physician Decision|1|||
129753780|NCT04181762|467057039|FG001|Overall Study|Physician Decision|3|||
129753781|NCT04181762|467057038|FG000|Overall Study|Pregnancy|0|||
129753782|NCT04181762|467057039|FG001|Overall Study|Pregnancy|1|||
129753783|NCT04181762|467057038|FG000|Overall Study|Lack of Efficacy|2|||
129753784|NCT04181762|467057039|FG001|Overall Study|Lack of Efficacy|2|||
129753785|NCT04181762|467057038|FG000|Overall Study|Study terminated by sponsor|95|||
129753786|NCT04181762|467057039|FG001|Overall Study|Study terminated by sponsor|97|||
129753787|NCT04181762|467057038|FG000|Overall Study|Subject decision|11|||
129753788|NCT04181762|467057039|FG001|Overall Study|Subject decision|4|||
129753789|NCT04181762|467057038|FG000|Overall Study|Death|1|||
129753790|NCT04181762|467057039|FG001|Overall Study|Death|1|||
129753791|NCT04181762|467057038|FG000|Overall Study|Protocol deviation|1|||
129753792|NCT04181762|467057039|FG001|Overall Study|Protocol deviation|0|||
129753793|NCT04181762|467057038|FG000|Overall Study|Withdrawal of informed consent|1|||
129753794|NCT04181762|467057039|FG001|Overall Study|Withdrawal of informed consent|3|||
129753795|NCT06041919|467057040|FG000|Overall Study|Lost to Follow-up|1|||
129753796|NCT06041919|467057041|FG001|Overall Study|Lost to Follow-up|0|||
129753797|NCT06041919|467057042|FG002|Overall Study|Lost to Follow-up|0|||
129753798|NCT06041919|467057043|FG003|Overall Study|Lost to Follow-up|0|||
129753799|NCT06041919|467057044|FG004|Overall Study|Lost to Follow-up|0|||
129753800|NCT06041919|467057040|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
129753801|NCT06041919|467057041|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
129753802|NCT06041919|467057042|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
129753803|NCT06041919|467057043|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
129753804|NCT06041919|467057044|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
129753805|NCT00637416|467057047|FG000|Overall Study|Lost to Follow-up|1|||
129753806|NCT00637416|467057048|FG001|Overall Study|Lost to Follow-up|1|||
129753807|NCT00637416|467057047|FG000|Overall Study|Unable to take study drug|0|||
129753808|NCT00637416|467057048|FG001|Overall Study|Unable to take study drug|1|||
129753809|NCT01147055|467057049|FG000|First Intervention Period|Lost to Follow-up|1|||
129753810|NCT01147055|467057050|FG001|First Intervention Period|Lost to Follow-up|0|||
129753811|NCT05236257|467057083|FG000|Overall Study|Ongoing with study treatment|29|||
129753812|NCT05236257|467057084|FG001|Overall Study|Ongoing with study treatment|1|||
129753813|NCT05236257|467057083|FG000|Overall Study|Discontinued study treatment|22|||
129753814|NCT05236257|467057084|FG001|Overall Study|Discontinued study treatment|41|||
129753815|NCT00874848|467057087|FG000|Overall Study|Adverse Event|13|||
129753816|NCT00874848|467057088|FG001|Overall Study|Adverse Event|2|||
129753817|NCT00874848|467057087|FG000|Overall Study|Progressive neoplastic disease|38|||
129753818|NCT00874848|467057088|FG001|Overall Study|Progressive neoplastic disease|18|||
129753819|NCT00874848|467057087|FG000|Overall Study|Withdrawal by Subject|7|||
129753820|NCT00874848|467057088|FG001|Overall Study|Withdrawal by Subject|4|||
129896705|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Non-compliance|0|||
129896706|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Non-compliance|0|||
129896707|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Pain|4|||
129896708|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Pain|0|||
129896709|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Pain|0|||
129753821|NCT00874848|467057087|FG000|Overall Study|Noncompliance|1|||
129753822|NCT00874848|467057088|FG001|Overall Study|Noncompliance|1|||
129753823|NCT00874848|467057087|FG000|Overall Study|Failure to comply with protocol|0|||
129753824|NCT00874848|467057088|FG001|Overall Study|Failure to comply with protocol|1|||
129753825|NCT00874848|467057087|FG000|Overall Study|Physician Decision|0|||
129753826|NCT00874848|467057088|FG001|Overall Study|Physician Decision|2|||
129753827|NCT02713828|467057090|FG000|Overall Study|Death|2|||
129896710|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Pain|0|||
129896711|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
129753828|NCT02713828|467057091|FG001|Overall Study|Death|0|||
129753829|NCT02713828|467057090|FG000|Overall Study|Withdrawal by Subject|1|||
129753830|NCT02713828|467057091|FG001|Overall Study|Withdrawal by Subject|0|||
129753831|NCT02713828|467057090|FG000|Overall Study|study terminated but patient allowed to|2|||
129753832|NCT02713828|467057091|FG001|Overall Study|study terminated but patient allowed to|0|||
129753833|NCT01099397|467057093|FG000|Overall Study|Lost to Follow-up|4|||
129753834|NCT01099397|467057093|FG000|Overall Study|Protocol Violation|4|||
129753835|NCT01099397|467057093|FG000|Overall Study|Withdrawal by Subject|5|||
129753836|NCT00003199|467057098|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
129753837|NCT00003199|467057098|FG000|Overall Study|Lack of insurance clearance|2|||
129753838|NCT00003199|467057098|FG000|Overall Study|Screen fail|15|||
129753839|NCT02936635|467058660|FG000|Overall Study|Adverse Event|43|||
129753840|NCT02936635|467058661|FG001|Overall Study|Adverse Event|25|||
129753841|NCT02936635|467058660|FG000|Overall Study|Progressive Disease|10|||
129753842|NCT02936635|467058661|FG001|Overall Study|Progressive Disease|18|||
129753843|NCT02936635|467058660|FG000|Overall Study|Sponsor Discretion|10|||
129753844|NCT02936635|467058661|FG001|Overall Study|Sponsor Discretion|16|||
129753845|NCT02936635|467058660|FG000|Overall Study|Death|9|||
129753846|NCT02936635|467058661|FG001|Overall Study|Death|15|||
129753847|NCT02936635|467058660|FG000|Overall Study|Withdrawal by Subject|8|||
129753848|NCT02936635|467058661|FG001|Overall Study|Withdrawal by Subject|15|||
129753849|NCT02936635|467058660|FG000|Overall Study|Physician Decision|2|||
129753850|NCT02936635|467058661|FG001|Overall Study|Physician Decision|9|||
129753851|NCT02936635|467058660|FG000|Overall Study|Lost to Follow-up|1|||
129753852|NCT02936635|467058661|FG001|Overall Study|Lost to Follow-up|2|||
129753853|NCT02936635|467058660|FG000|Overall Study|Protocol Violation|1|||
129753854|NCT02936635|467058661|FG001|Overall Study|Protocol Violation|0|||
129753855|NCT02936635|467058660|FG000|Overall Study|Lack of effect/Entry into other study|31|||
129753856|NCT02936635|467058661|FG001|Overall Study|Lack of effect/Entry into other study|65|||
129753857|NCT02407223|467058662|FG000|Overall Study|Adverse Event|1|||
129753858|NCT02407223|467058663|FG001|Overall Study|Adverse Event|0|||
129753859|NCT02407223|467058664|FG002|Overall Study|Adverse Event|1|||
129753860|NCT02407223|467058662|FG000|Overall Study|Lack of Efficacy|6|||
129753861|NCT02407223|467058663|FG001|Overall Study|Lack of Efficacy|6|||
129753862|NCT02407223|467058664|FG002|Overall Study|Lack of Efficacy|4|||
129753863|NCT02407223|467058662|FG000|Overall Study|Lost to Follow-up|1|||
129753864|NCT02407223|467058663|FG001|Overall Study|Lost to Follow-up|0|||
129753865|NCT02407223|467058664|FG002|Overall Study|Lost to Follow-up|2|||
129753866|NCT02407223|467058662|FG000|Overall Study|Withdrawal by Subject|2|||
129753867|NCT02407223|467058663|FG001|Overall Study|Withdrawal by Subject|4|||
129753868|NCT02407223|467058664|FG002|Overall Study|Withdrawal by Subject|4|||
129753869|NCT02407223|467058662|FG000|Overall Study|Study Terminated by Sponsor|77|||
129753870|NCT02407223|467058663|FG001|Overall Study|Study Terminated by Sponsor|80|||
129753871|NCT02407223|467058664|FG002|Overall Study|Study Terminated by Sponsor|86|||
129753872|NCT02407223|467058662|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
129753873|NCT02407223|467058663|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
129753874|NCT02407223|467058664|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
129753875|NCT02407223|467058662|FG000|Overall Study|Other|29|||
129753876|NCT02407223|467058663|FG001|Overall Study|Other|27|||
129753877|NCT02407223|467058664|FG002|Overall Study|Other|25|||
129753878|NCT00447226|467058665|FG000|12-Week Open-label Phase|Adverse Event|0|||
129753879|NCT00447226|467058666|FG001|12-Week Open-label Phase|Adverse Event|3|||
129753880|NCT00447226|467058665|FG000|12-Week Open-label Phase|Protocol Violation|0|||
129753881|NCT00447226|467058666|FG001|12-Week Open-label Phase|Protocol Violation|1|||
129753882|NCT00447226|467058665|FG000|12-Week Open-label Phase|Disease Progression|0|||
129753883|NCT00447226|467058666|FG001|12-Week Open-label Phase|Disease Progression|20|||
129753884|NCT00447226|467058665|FG000|12-Week Open-label Phase|Physician Decision|0|||
129753885|NCT00447226|467058666|FG001|12-Week Open-label Phase|Physician Decision|1|||
129753886|NCT00447226|467058665|FG000|Double-blind Phase|Disease Progression|4|||
129753887|NCT00447226|467058666|FG001|Double-blind Phase|Disease Progression|3|||
129753888|NCT00502671|467058670|FG000|Overall Study|Disease Progression|13|||
129753889|NCT00502671|467058670|FG000|Overall Study|Personal Reasons|22|||
129753890|NCT00502671|467058670|FG000|Overall Study|Lost to Follow-up|7|||
129753891|NCT00502671|467058670|FG000|Overall Study|Protocol Violation|16|||
129753892|NCT00502671|467058670|FG000|Overall Study|Adverse Event|19|||
129753893|NCT00412893|467058673|FG000|Overall Study|Adverse Event|31|||
129753894|NCT00412893|467058674|FG001|Overall Study|Adverse Event|53|||
129753895|NCT00412893|467058673|FG000|Overall Study|Death|17|||
129445400|NCT03828292|465931279|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
129753896|NCT00412893|467058674|FG001|Overall Study|Death|21|||
129753897|NCT00412893|467058673|FG000|Overall Study|Insufficient Therapeutic Response|39|||
129753898|NCT00412893|467058674|FG001|Overall Study|Insufficient Therapeutic Response|23|||
129753899|NCT00412893|467058673|FG000|Overall Study|Lost to Follow-up|2|||
129753900|NCT00412893|467058674|FG001|Overall Study|Lost to Follow-up|1|||
129753901|NCT00412893|467058673|FG000|Overall Study|Violation of Selection at Entry|17|||
129753902|NCT00412893|467058674|FG001|Overall Study|Violation of Selection at Entry|10|||
129753903|NCT00412893|467058673|FG000|Overall Study|Other Protocol Violation|10|||
129753904|NCT00412893|467058674|FG001|Overall Study|Other Protocol Violation|6|||
129753905|NCT00412893|467058673|FG000|Overall Study|Did Not Cooperate|12|||
129753906|NCT00412893|467058674|FG001|Overall Study|Did Not Cooperate|9|||
129753907|NCT00412893|467058673|FG000|Overall Study|Administrative Reason|12|||
129753908|NCT00412893|467058674|FG001|Overall Study|Administrative Reason|15|||
129753909|NCT00412893|467058673|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
129753910|NCT00412893|467058674|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
129753911|NCT04473963|467058675|FG000|Overall Study|Withdrawal by Subject|1|||
129753912|NCT04473963|467058676|FG001|Overall Study|Withdrawal by Subject|1|||
129753913|NCT04473963|467058677|FG002|Overall Study|Withdrawal by Subject|0|||
129753914|NCT04473963|467058675|FG000|Overall Study|Not inducible in AF|0|||
129753915|NCT04473963|467058676|FG001|Overall Study|Not inducible in AF|0|||
129753916|NCT04473963|467058677|FG002|Overall Study|Not inducible in AF|2|||
129753917|NCT00587158|467058681|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
129753918|NCT00587158|467058682|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
129753919|NCT00587158|467058681|FG000|Overall Study|Physician Decision|0|||
129753920|NCT00587158|467058682|FG001|Overall Study|Physician Decision|1|||
129753921|NCT00587158|467058681|FG000|Overall Study|Lost to Follow-up|1|||
129753922|NCT00587158|467058682|FG001|Overall Study|Lost to Follow-up|2|||
129753923|NCT00587158|467058681|FG000|Overall Study|Death|0|||
129753924|NCT00587158|467058682|FG001|Overall Study|Death|1|||
129753925|NCT00587158|467058681|FG000|Overall Study|Subject did not want to take study med|0|||
129753926|NCT00587158|467058682|FG001|Overall Study|Subject did not want to take study med|1|||
129753927|NCT02114606|467058683|FG000|Overall Study|Unable to swallow Cytosponge|6|||
129753928|NCT00981461|467058684|FG000|Overall Study|Lost to Follow-up|5|||
129753929|NCT00981461|467058685|FG001|Overall Study|Lost to Follow-up|2|||
129753930|NCT03361293|467058694|FG000|Overall Study|Lost to Follow-up|0|||
129753931|NCT03361293|467058695|FG001|Overall Study|Lost to Follow-up|2|||
129753932|NCT03361293|467058694|FG000|Overall Study|Withdrawal by Subject|1|||
129753933|NCT03361293|467058695|FG001|Overall Study|Withdrawal by Subject|3|||
129753934|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
129753935|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
129753936|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
129753937|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
129753938|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
129753939|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
129753940|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
129753941|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
129753942|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
129753943|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
129753944|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
129753945|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
129753946|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
129753947|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
129753948|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
129753949|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
129753950|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
129753951|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
129753952|NCT01910402|467058698|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
129753953|NCT01910402|467058699|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
129753954|NCT01910402|467058700|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
129753955|NCT01910402|467058698|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
129753956|NCT01910402|467058699|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
129753957|NCT01910402|467058700|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
129753958|NCT01910402|467058698|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
129753959|NCT01910402|467058699|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
129753960|NCT01910402|467058700|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
129445401|NCT03828292|465931280|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
129753961|NCT01910402|467058698|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
129753962|NCT01910402|467058699|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
129753963|NCT01910402|467058700|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
129753964|NCT01910402|467058698|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
129753965|NCT01910402|467058699|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
129753966|NCT01910402|467058700|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
129753967|NCT01910402|467058698|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
129753968|NCT01910402|467058699|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
129753969|NCT01910402|467058700|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
129753970|NCT01910402|467058698|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
129753971|NCT01910402|467058699|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
129753972|NCT01910402|467058700|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
129753973|NCT00571038|467058701|FG000|Overall Study|Lost to Follow-up|1|||
129753974|NCT00571038|467058702|FG001|Overall Study|Lost to Follow-up|4|||
129753975|NCT00571038|467058701|FG000|Overall Study|Death|7|||
129753976|NCT00571038|467058702|FG001|Overall Study|Death|5|||
129753977|NCT00571038|467058701|FG000|Overall Study|Withdrawal by Subject|1|||
129753978|NCT00571038|467058702|FG001|Overall Study|Withdrawal by Subject|3|||
129753979|NCT00571038|467058701|FG000|Overall Study|Moved out of state|2|||
129753980|NCT00571038|467058702|FG001|Overall Study|Moved out of state|2|||
129753981|NCT01550757|467058703|FG000|Overall Study|Lost to Follow-up|21|||
129753982|NCT01550757|467058704|FG001|Overall Study|Lost to Follow-up|14|||
129753983|NCT01550757|467058705|FG002|Overall Study|Lost to Follow-up|42|||
129753984|NCT01550757|467058706|FG003|Overall Study|Lost to Follow-up|53|||
129753985|NCT01550757|467058703|FG000|Overall Study|Withdrawal by Subject|2|||
129753986|NCT01550757|467058704|FG001|Overall Study|Withdrawal by Subject|0|||
129753987|NCT01550757|467058705|FG002|Overall Study|Withdrawal by Subject|3|||
129753988|NCT01550757|467058706|FG003|Overall Study|Withdrawal by Subject|1|||
129753989|NCT00740584|467058708|FG000|Overall Study|Withdrawal by Subject|1|||
129753990|NCT00413218|467058710|FG000|Overall Study|Randomized but didn't receive study drug|2|||
129753991|NCT00413218|467058711|FG001|Overall Study|Randomized but didn't receive study drug|8|||
129753992|NCT00413218|467058710|FG000|Overall Study|Death|57|||
129753993|NCT00413218|467058711|FG001|Overall Study|Death|56|||
129753994|NCT00413218|467058710|FG000|Overall Study|Lost to Follow-up|14|||
129753995|NCT00413218|467058711|FG001|Overall Study|Lost to Follow-up|17|||
129753996|NCT00413218|467058710|FG000|Overall Study|Admin|20|||
129753997|NCT00413218|467058711|FG001|Overall Study|Admin|14|||
129753998|NCT00413218|467058710|FG000|Overall Study|Missing|1|||
129753999|NCT00413218|467058711|FG001|Overall Study|Missing|0|||
129754000|NCT00413218|467058710|FG000|Overall Study|Withdrawal by Subject|9|||
129754001|NCT00413218|467058711|FG001|Overall Study|Withdrawal by Subject|1|||
129754002|NCT01196026|467058713|FG000|Overall Study|Withdrawal by Subject|1|||
129754003|NCT01196026|467058714|FG001|Overall Study|Withdrawal by Subject|4|||
129754004|NCT01196026|467058715|FG002|Overall Study|Withdrawal by Subject|0|||
129754005|NCT01196026|467058716|FG003|Overall Study|Withdrawal by Subject|0|||
129754006|NCT01196026|467058717|FG004|Overall Study|Withdrawal by Subject|0|||
129754007|NCT01196026|467058718|FG005|Overall Study|Withdrawal by Subject|0|||
129754008|NCT01196026|467058713|FG000|Overall Study|Lost to Follow-up|0|||
129754009|NCT01196026|467058714|FG001|Overall Study|Lost to Follow-up|3|||
129754010|NCT01196026|467058715|FG002|Overall Study|Lost to Follow-up|0|||
129754011|NCT01196026|467058716|FG003|Overall Study|Lost to Follow-up|0|||
129754012|NCT01196026|467058717|FG004|Overall Study|Lost to Follow-up|1|||
129754013|NCT01196026|467058718|FG005|Overall Study|Lost to Follow-up|0|||
129754014|NCT01196026|467058713|FG000|Overall Study|Other|0|||
129754015|NCT01196026|467058714|FG001|Overall Study|Other|1|||
129754016|NCT01196026|467058715|FG002|Overall Study|Other|0|||
129754017|NCT01196026|467058716|FG003|Overall Study|Other|0|||
129754018|NCT01196026|467058717|FG004|Overall Study|Other|0|||
129754019|NCT01196026|467058718|FG005|Overall Study|Other|0|||
129754020|NCT01687296|467058719|FG000|Overall Study|Lack of Efficacy|1|||
129754021|NCT01687296|467058720|FG001|Overall Study|Lack of Efficacy|1|||
129754022|NCT01687296|467058719|FG000|Overall Study|Protocol Violation|0|||
129754023|NCT01687296|467058720|FG001|Overall Study|Protocol Violation|1|||
129754024|NCT01687296|467058719|FG000|Overall Study|Withdrawal by Subject|6|||
129754025|NCT01687296|467058720|FG001|Overall Study|Withdrawal by Subject|3|||
129754026|NCT03672292|467058724|FG000|Overall Study|Adverse Event|3|||
129754027|NCT03672292|467058725|FG001|Overall Study|Adverse Event|1|||
129754028|NCT03672292|467058724|FG000|Overall Study|Physician Decision|0|||
129754029|NCT03672292|467058725|FG001|Overall Study|Physician Decision|1|||
129754030|NCT03672292|467058724|FG000|Overall Study|Withdrawal by Subject|1|||
129754031|NCT03672292|467058725|FG001|Overall Study|Withdrawal by Subject|2|||
129754032|NCT03797586|467058726|FG000|Overall Study|Lost to Follow-up|3|||
129754033|NCT03797586|467058727|FG001|Overall Study|Lost to Follow-up|6|||
129754034|NCT03797586|467058726|FG000|Overall Study|Death|1|||
129754035|NCT03797586|467058727|FG001|Overall Study|Death|1|||
129810191|NCT02323113|467273154|FG007|Overall Study|Symptomatic Deterioration|0|||
129810192|NCT02323113|467273147|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
129810193|NCT02323113|467273148|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
129810194|NCT02323113|467273149|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810195|NCT02323113|467273150|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810196|NCT02323113|467273151|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810197|NCT02323113|467273152|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
129810198|NCT02323113|467273153|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810199|NCT02323113|467273154|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
129810200|NCT02323113|467273147|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810201|NCT02323113|467273148|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
129810202|NCT02323113|467273149|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810203|NCT02323113|467273150|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810204|NCT02323113|467273151|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129896712|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
129896713|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
129896714|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
129896715|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Hospice care|1|||
129896716|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Hospice care|0|||
129896717|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Hospice care|0|||
129896718|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Hospice care|0|||
129754036|NCT03797586|467058726|FG000|Overall Study|Adverse Event|0|||
129754037|NCT03797586|467058727|FG001|Overall Study|Adverse Event|2|||
129754038|NCT02864901|467058728|FG000|Overall Study|Withdrawal by Subject|1|||
129754039|NCT02864901|467058729|FG001|Overall Study|Withdrawal by Subject|0|||
129754040|NCT05730387|467058730|FG000|Overall Study|Stillbirth|0|||
129754041|NCT05730387|467058731|FG001|Overall Study|Stillbirth|262|||
129754042|NCT05730387|467058730|FG000|Overall Study|Died during or after delivery|2|||
129754043|NCT05730387|467058731|FG001|Overall Study|Died during or after delivery|85|||
129754044|NCT05730387|467058730|FG000|Overall Study|Died after being admitted|0|||
129754045|NCT05730387|467058731|FG001|Overall Study|Died after being admitted|44|||
129754046|NCT05730387|467058730|FG000|Overall Study|Lost to Follow-up|69|||
129754047|NCT05730387|467058731|FG001|Overall Study|Lost to Follow-up|77|||
129754048|NCT01219985|467058732|FG000|Overall Study|Physician Decision|20|||
129754049|NCT04797780|467058733|FG000|Overall Study|Lost to Follow-up|1|||
129754050|NCT04797780|467058734|FG001|Overall Study|Lost to Follow-up|1|||
129754051|NCT04797780|467058733|FG000|Overall Study|Withdrawal by Subject|14|||
129754052|NCT04797780|467058734|FG001|Overall Study|Withdrawal by Subject|9|||
129754053|NCT04797780|467058733|FG000|Overall Study|Death|49|||
129754054|NCT04797780|467058734|FG001|Overall Study|Death|20|||
129754055|NCT05973006|467058735|FG000|Overall Study|Early termination|3|||
129754056|NCT05973006|467058736|FG001|Overall Study|Early termination|9|||
129754057|NCT00132808|467058744|FG000|Stratum I|Adverse Event|2|||
129754058|NCT00132808|467058745|FG001|Stratum I|Adverse Event|1|||
129754059|NCT00132808|467058746|FG002|Stratum I|Adverse Event|0|||
129754060|NCT00132808|467058744|FG000|Stratum I|Lost to Follow-up|3|||
129754061|NCT00132808|467058745|FG001|Stratum I|Lost to Follow-up|4|||
129754062|NCT00132808|467058746|FG002|Stratum I|Lost to Follow-up|1|||
129754063|NCT00132808|467058744|FG000|Stratum I|Withdrawal by Subject|4|||
129754064|NCT00132808|467058745|FG001|Stratum I|Withdrawal by Subject|7|||
129754065|NCT00132808|467058746|FG002|Stratum I|Withdrawal by Subject|3|||
129754066|NCT00132808|467058744|FG000|Stratum I|Abnormal test procedure result (s)|0|||
129754067|NCT00132808|467058745|FG001|Stratum I|Abnormal test procedure result (s)|0|||
129754068|NCT00132808|467058746|FG002|Stratum I|Abnormal test procedure result (s)|1|||
129754069|NCT00132808|467058744|FG000|Stratum II|Adverse Event|1|||
129754070|NCT00132808|467058745|FG001|Stratum II|Adverse Event|2|||
129754071|NCT00132808|467058746|FG002|Stratum II|Adverse Event|1|||
129754072|NCT00132808|467058744|FG000|Stratum II|Death|1|||
129754073|NCT00132808|467058745|FG001|Stratum II|Death|0|||
129896719|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Physician Decision|1|||
129896720|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Physician Decision|0|||
129754074|NCT00132808|467058746|FG002|Stratum II|Death|0|||
129754075|NCT00132808|467058744|FG000|Stratum II|Lost to Follow-up|2|||
129754076|NCT00132808|467058745|FG001|Stratum II|Lost to Follow-up|2|||
129754077|NCT00132808|467058746|FG002|Stratum II|Lost to Follow-up|1|||
129754078|NCT00132808|467058744|FG000|Stratum II|Protocol Violation|0|||
129754079|NCT00132808|467058745|FG001|Stratum II|Protocol Violation|2|||
129754080|NCT00132808|467058746|FG002|Stratum II|Protocol Violation|1|||
129754081|NCT00132808|467058744|FG000|Stratum II|Withdrawal by Subject|4|||
129754082|NCT00132808|467058745|FG001|Stratum II|Withdrawal by Subject|9|||
129754083|NCT00132808|467058746|FG002|Stratum II|Withdrawal by Subject|6|||
129754084|NCT00924443|467058755|FG000|Overall Study|Physician Decision|2|||
129754085|NCT00924443|467058755|FG000|Overall Study|Protocol Violation|1|||
129754086|NCT00595478|467058761|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
129754087|NCT00595478|467058762|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
129754088|NCT00595478|467058761|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
129754089|NCT00595478|467058762|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
129754090|NCT03405818|467058765|FG000|Overall Study|Withdrawal by Subject|4|||
129754091|NCT03405818|467058765|FG000|Overall Study|Lost to Follow-up|4|||
129754092|NCT02363959|467058768|FG000|Overall Study|Medical instability|1|||
129754093|NCT02363959|467058769|FG001|Overall Study|Medical instability|0|||
129754094|NCT00950248|467058770|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
129754095|NCT00950248|467058771|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
129754096|NCT00950248|467058772|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
129754097|NCT00950248|467058770|FG000|Year 1: Baseline|worsening of symptoms|2|||
129754098|NCT00950248|467058771|FG001|Year 1: Baseline|worsening of symptoms|0|||
129754099|NCT00950248|467058772|FG002|Year 1: Baseline|worsening of symptoms|0|||
129754100|NCT00950248|467058770|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
129754101|NCT00950248|467058771|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
129754102|NCT00950248|467058772|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
129754103|NCT00950248|467058770|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
129754104|NCT00950248|467058771|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
129754105|NCT00950248|467058772|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
129754106|NCT00950248|467058770|FG000|Year 2&3 Treatment Randomization|Death|0|||
129754107|NCT00950248|467058771|FG001|Year 2&3 Treatment Randomization|Death|0|||
129754108|NCT00950248|467058772|FG002|Year 2&3 Treatment Randomization|Death|1|||
129754109|NCT00950248|467058770|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
129754110|NCT00950248|467058771|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
129754111|NCT00950248|467058772|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
129754112|NCT01900652|467058773|FG000|Overall Study|Progressive Disease|1|||
129754113|NCT01900652|467058774|FG001|Overall Study|Progressive Disease|0|||
129754114|NCT01900652|467058773|FG000|Overall Study|Consent withdrawn by subject|1|||
129754115|NCT01900652|467058774|FG001|Overall Study|Consent withdrawn by subject|1|||
129754116|NCT01900652|467058773|FG000|Overall Study|Death|3|||
129754117|NCT01900652|467058774|FG001|Overall Study|Death|0|||
129754118|NCT01900652|467058773|FG000|Overall Study|Adverse Event|2|||
129754119|NCT01900652|467058774|FG001|Overall Study|Adverse Event|1|||
129754120|NCT01900652|467058773|FG000|Overall Study|Physician Decision|1|||
129754121|NCT01900652|467058774|FG001|Overall Study|Physician Decision|1|||
129754122|NCT00869518|467058777|FG000|Overall Study|Lost to Follow-up|1|||
129754123|NCT00869518|467058778|FG001|Overall Study|Lost to Follow-up|1|||
129754124|NCT00947115|467058779|FG000|Overall Study|Missed reporting interval|3|||
129754125|NCT00947115|467058780|FG001|Overall Study|Missed reporting interval|4|||
129754126|NCT00947115|467058781|FG002|Overall Study|Missed reporting interval|2|||
129754127|NCT00947115|467058779|FG000|Overall Study|Physician Decision|0|||
129754128|NCT00947115|467058780|FG001|Overall Study|Physician Decision|2|||
129754129|NCT00947115|467058781|FG002|Overall Study|Physician Decision|0|||
129754130|NCT00947115|467058779|FG000|Overall Study|Death|0|||
129754131|NCT00947115|467058780|FG001|Overall Study|Death|1|||
129754132|NCT00947115|467058781|FG002|Overall Study|Death|1|||
129754133|NCT00947115|467058779|FG000|Overall Study|Migrated from study area|2|||
129754134|NCT00947115|467058780|FG001|Overall Study|Migrated from study area|0|||
129754135|NCT00947115|467058781|FG002|Overall Study|Migrated from study area|0|||
129754136|NCT00947115|467058779|FG000|Overall Study|Withdrawal by Subject|1|||
129754137|NCT00947115|467058780|FG001|Overall Study|Withdrawal by Subject|3|||
129754138|NCT00947115|467058781|FG002|Overall Study|Withdrawal by Subject|4|||
129754139|NCT00947115|467058779|FG000|Overall Study|Lost to Follow-up|11|||
129754140|NCT00947115|467058780|FG001|Overall Study|Lost to Follow-up|12|||
129754141|NCT00947115|467058781|FG002|Overall Study|Lost to Follow-up|8|||
129754142|NCT01223183|467058783|FG000|Imaging Day 1|Physician Decision|0|||
129754143|NCT01223183|467058784|FG001|Imaging Day 1|Physician Decision|1|||
129754144|NCT01223183|467058783|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
129754145|NCT01223183|467058784|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
129754146|NCT01223183|467058783|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
129754147|NCT01223183|467058784|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
129754148|NCT00900029|467058787|FG000|Overall Study|Lost to Follow-up|0|||
129754149|NCT00900029|467058788|FG001|Overall Study|Lost to Follow-up|2|||
129754150|NCT00900029|467058789|FG002|Overall Study|Lost to Follow-up|1|||
129754151|NCT00900029|467058790|FG003|Overall Study|Lost to Follow-up|4|||
129754152|NCT00900029|467058791|FG004|Overall Study|Lost to Follow-up|4|||
129754153|NCT00900029|467058787|FG000|Overall Study|Withdrawal by Subject|2|||
129754154|NCT00900029|467058788|FG001|Overall Study|Withdrawal by Subject|2|||
129754155|NCT00900029|467058789|FG002|Overall Study|Withdrawal by Subject|1|||
129754156|NCT00900029|467058790|FG003|Overall Study|Withdrawal by Subject|1|||
129754157|NCT00900029|467058791|FG004|Overall Study|Withdrawal by Subject|1|||
129896721|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Physician Decision|0|||
129754158|NCT00900029|467058787|FG000|Overall Study|Adverse Event|0|||
129754159|NCT00900029|467058788|FG001|Overall Study|Adverse Event|0|||
129754160|NCT00900029|467058789|FG002|Overall Study|Adverse Event|1|||
129754161|NCT00900029|467058790|FG003|Overall Study|Adverse Event|1|||
129754162|NCT00900029|467058791|FG004|Overall Study|Adverse Event|1|||
129754163|NCT00900029|467058787|FG000|Overall Study|Death|1|||
129754164|NCT00900029|467058788|FG001|Overall Study|Death|0|||
129754165|NCT00900029|467058789|FG002|Overall Study|Death|0|||
129754166|NCT00900029|467058790|FG003|Overall Study|Death|1|||
129754167|NCT00900029|467058791|FG004|Overall Study|Death|0|||
129754168|NCT00511238|467058794|FG000|Overall Study|Adverse Event|13|||
129754169|NCT00511238|467058795|FG001|Overall Study|Adverse Event|33|||
129754170|NCT00511238|467058794|FG000|Overall Study|Withdrawal by Subject|2|||
129754171|NCT00511238|467058795|FG001|Overall Study|Withdrawal by Subject|22|||
129754172|NCT00511238|467058794|FG000|Overall Study|Progressive Disease|23|||
129754173|NCT00511238|467058795|FG001|Overall Study|Progressive Disease|157|||
129754174|NCT00511238|467058794|FG000|Overall Study|various reasons|4|||
129754175|NCT00511238|467058795|FG001|Overall Study|various reasons|14|||
129754176|NCT03772665|467058796|FG000|Overall Study|Protocol Violation|1|||
129754177|NCT03772665|467058797|FG001|Overall Study|Protocol Violation|0|||
129754178|NCT00163020|467058798|FG000|Overall Study|Lost to Follow-up|0|||
129754179|NCT00163020|467058799|FG001|Overall Study|Lost to Follow-up|2|||
129754180|NCT03553758|467061762|FG000|Overall Study|Lost to Follow-up|1|||
129754181|NCT00922623|467061771|FG000|Overall Study|Other|4|||
129754182|NCT00922623|467061771|FG000|Overall Study|Lost to Follow-up|1|||
129754183|NCT02871635|467061772|FG000|Overall Study|Primary lack of efficacy|4|||
129754184|NCT02871635|467061773|FG001|Overall Study|Primary lack of efficacy|4|||
129754185|NCT02871635|467061772|FG000|Overall Study|Protocol Violation|3|||
129754186|NCT02871635|467061773|FG001|Overall Study|Protocol Violation|1|||
129754187|NCT02871635|467061772|FG000|Overall Study|Lost to Follow-up|1|||
129754188|NCT02871635|467061773|FG001|Overall Study|Lost to Follow-up|2|||
129754189|NCT02871635|467061772|FG000|Overall Study|Pregnancy|0|||
129754190|NCT02871635|467061773|FG001|Overall Study|Pregnancy|2|||
129754191|NCT02871635|467061772|FG000|Overall Study|Physician Decision|1|||
129754192|NCT02871635|467061773|FG001|Overall Study|Physician Decision|1|||
129754193|NCT02871635|467061772|FG000|Overall Study|Withdrawal by Subject|3|||
129754194|NCT02871635|467061773|FG001|Overall Study|Withdrawal by Subject|4|||
129754195|NCT02871635|467061772|FG000|Overall Study|Adverse Event|4|||
129754196|NCT02871635|467061773|FG001|Overall Study|Adverse Event|4|||
129754197|NCT02871635|467061772|FG000|Overall Study|Secondary lack of efficacy|2|||
129754198|NCT02871635|467061773|FG001|Overall Study|Secondary lack of efficacy|1|||
129754199|NCT02420379|467061774|FG000|Overall Study|Withdrawal by Subject|0|||
129754200|NCT02420379|467061775|FG001|Overall Study|Withdrawal by Subject|3|||
129754201|NCT02420379|467061774|FG000|Overall Study|Unable to complete due to schooling|0|||
129754202|NCT02420379|467061775|FG001|Overall Study|Unable to complete due to schooling|1|||
129754203|NCT02420379|467061774|FG000|Overall Study|Transitioned to commercial drug|1|||
129754204|NCT02420379|467061775|FG001|Overall Study|Transitioned to commercial drug|0|||
129754205|NCT01402817|467061776|FG000|Overall Study|Withdrawal by Subject|3|||
129754206|NCT01402817|467061776|FG000|Overall Study|Study Suspended by FDA|8|||
129754207|NCT01473732|467061778|FG000|Overall Study|Adverse Event|1|||
129754208|NCT01473732|467061779|FG001|Overall Study|Adverse Event|0|||
129754209|NCT01473732|467061778|FG000|Overall Study|Death|1|||
129810205|NCT02323113|467273152|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810206|NCT02323113|467273153|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810207|NCT02323113|467273154|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
129810208|NCT01663532|467273155|FG000|Overall Study|Lost to Follow-up|9|||
129810209|NCT01663532|467273156|FG001|Overall Study|Lost to Follow-up|10|||
129810210|NCT01663532|467273155|FG000|Overall Study|Adverse Event|7|||
129810211|NCT01663532|467273156|FG001|Overall Study|Adverse Event|13|||
129810212|NCT01663532|467273155|FG000|Overall Study|Met Withdrawal Criteria|7|||
129810213|NCT01663532|467273156|FG001|Overall Study|Met Withdrawal Criteria|6|||
129810214|NCT01663532|467273155|FG000|Overall Study|Physician Decision|1|||
129810215|NCT01663532|467273156|FG001|Overall Study|Physician Decision|1|||
129810216|NCT01663532|467273155|FG000|Overall Study|Withdrawal by Subject|35|||
129754210|NCT01473732|467061779|FG001|Overall Study|Death|0|||
129754211|NCT01217944|467061783|FG000|Overall Study|Protocol Violation|1|||
129754212|NCT01217944|467061784|FG001|Overall Study|Protocol Violation|1|||
129754213|NCT01217944|467061785|FG002|Overall Study|Protocol Violation|0|||
129754214|NCT01217944|467061783|FG000|Overall Study|Lost to Follow-up|3|||
129754215|NCT01217944|467061784|FG001|Overall Study|Lost to Follow-up|1|||
129754216|NCT01217944|467061785|FG002|Overall Study|Lost to Follow-up|0|||
129754217|NCT01217944|467061783|FG000|Overall Study|Withdrawal by Subject|1|||
129754218|NCT01217944|467061784|FG001|Overall Study|Withdrawal by Subject|2|||
129754219|NCT01217944|467061785|FG002|Overall Study|Withdrawal by Subject|0|||
129754220|NCT01217944|467061783|FG000|Overall Study|Lack of Efficacy|1|||
129754221|NCT01217944|467061784|FG001|Overall Study|Lack of Efficacy|0|||
129754222|NCT01217944|467061785|FG002|Overall Study|Lack of Efficacy|0|||
129754223|NCT00483405|467061786|FG000|Overall Study|Adverse Event|8|||
129754224|NCT00483405|467061786|FG000|Overall Study|Lack of Efficacy|14|||
129754225|NCT00483405|467061786|FG000|Overall Study|Death|3|||
129754226|NCT00483405|467061786|FG000|Overall Study|Withdrawal by Subject|2|||
129754227|NCT00483405|467061786|FG000|Overall Study|Other complicating disease|1|||
129754228|NCT04098809|467061787|FG000|Overall Study|Withdrawal by Subject|1|||
129754229|NCT04098809|467061788|FG001|Overall Study|Withdrawal by Subject|3|||
129754230|NCT04098809|467061787|FG000|Overall Study|Physician Decision|2|||
129754231|NCT04098809|467061788|FG001|Overall Study|Physician Decision|1|||
129754232|NCT00193206|467061789|FG000|Preoperative Therapy|Lack of Efficacy|2|||
129754233|NCT00193206|467061789|FG000|Preoperative Therapy|Adverse Event|2|||
129754234|NCT00193206|467061789|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
129754235|NCT00193206|467061789|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
129754236|NCT00193206|467061789|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
129754237|NCT00193206|467061789|FG000|Postoperative Therapy|Physician Decision|3|||
129754238|NCT00193206|467061789|FG000|Postoperative Therapy|Intercurrent Illness|2|||
129754239|NCT00193206|467061789|FG000|Postoperative Therapy|Lack of Efficacy|1|||
129754240|NCT00193206|467061789|FG000|Postoperative Therapy|Protocol Violation|1|||
129754241|NCT01426958|467061790|FG000|Overall Study|Adverse Event|2|||
129754242|NCT00991939|467061793|FG000|Overall Study|Lost to Follow-up|0|||
129754243|NCT00991939|467061794|FG001|Overall Study|Lost to Follow-up|1|||
129754244|NCT00991939|467061793|FG000|Overall Study|Withdrawal by Subject|1|||
129754245|NCT00991939|467061794|FG001|Overall Study|Withdrawal by Subject|0|||
129754246|NCT00991939|467061793|FG000|Overall Study|Entire study terminated|4|||
129754247|NCT00991939|467061794|FG001|Overall Study|Entire study terminated|1|||
129754248|NCT02073682|467061799|FG000|Overall Study|Low Creatinine Clearance|1|||
129754249|NCT02073682|467061800|FG001|Overall Study|Low Creatinine Clearance|2|||
129754250|NCT02073682|467061799|FG000|Overall Study|Death|86|||
129754251|NCT02073682|467061800|FG001|Overall Study|Death|100|||
129754252|NCT02073682|467061799|FG000|Overall Study|Cancer Cured|10|||
129754253|NCT02073682|467061800|FG001|Overall Study|Cancer Cured|15|||
129754254|NCT02073682|467061799|FG000|Overall Study|ID: Patient Noncompliance|1|||
129754255|NCT02073682|467061800|FG001|Overall Study|ID: Patient Noncompliance|2|||
129754256|NCT02073682|467061799|FG000|Overall Study|ID: Palliative Treatment Only|10|||
129754257|NCT02073682|467061800|FG001|Overall Study|ID: Palliative Treatment Only|7|||
129754258|NCT02073682|467061799|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
129754259|NCT02073682|467061800|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
129754260|NCT02073682|467061799|FG000|Overall Study|Platelet Count <50,000/mL|1|||
129754261|NCT02073682|467061800|FG001|Overall Study|Platelet Count <50,000/mL|2|||
129754262|NCT02073682|467061799|FG000|Overall Study|Surgery/Medical Procedure|3|||
129754263|NCT02073682|467061800|FG001|Overall Study|Surgery/Medical Procedure|1|||
129754264|NCT02073682|467061799|FG000|Overall Study|Withdrawal by Subject|6|||
129754265|NCT02073682|467061800|FG001|Overall Study|Withdrawal by Subject|8|||
129754266|NCT02073682|467061799|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
129754267|NCT02073682|467061800|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
129754268|NCT02073682|467061799|FG000|Overall Study|Cancer Progression|53|||
129754269|NCT02073682|467061800|FG001|Overall Study|Cancer Progression|33|||
129754270|NCT02073682|467061799|FG000|Overall Study|Protocol Violation|1|||
129754271|NCT02073682|467061800|FG001|Overall Study|Protocol Violation|0|||
129754272|NCT02073682|467061799|FG000|Overall Study|Adverse Event|79|||
129754273|NCT02073682|467061800|FG001|Overall Study|Adverse Event|62|||
129754274|NCT02073682|467061799|FG000|Overall Study|No reason provided|11|||
129754275|NCT02073682|467061800|FG001|Overall Study|No reason provided|9|||
129754276|NCT02073682|467061799|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
129754277|NCT02073682|467061800|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
129754278|NCT02073682|467061799|FG000|Overall Study|Lost to Follow-up|1|||
129754279|NCT02073682|467061800|FG001|Overall Study|Lost to Follow-up|1|||
129754280|NCT02073682|467061799|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
129754281|NCT02073682|467061800|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
129754282|NCT00181766|467061801|FG000|Overall Study|Lost to Follow-up|6|||
129754283|NCT00181766|467061801|FG000|Overall Study|Adverse Event|4|||
129754284|NCT00181766|467061801|FG000|Overall Study|non-compliance|2|||
129810217|NCT01663532|467273156|FG001|Overall Study|Withdrawal by Subject|17|||
129754285|NCT00855816|467061802|FG000|Overall Study|Withdrawal by Subject|22|||
129754286|NCT00855816|467061803|FG001|Overall Study|Withdrawal by Subject|15|||
129754287|NCT00855816|467061802|FG000|Overall Study|Lost to Follow-up|3|||
129754288|NCT00855816|467061803|FG001|Overall Study|Lost to Follow-up|5|||
129754289|NCT00855816|467061802|FG000|Overall Study|Death|1|||
129754290|NCT00855816|467061803|FG001|Overall Study|Death|0|||
129754291|NCT00855816|467061802|FG000|Overall Study|Became ineligible|0|||
129754292|NCT00855816|467061803|FG001|Overall Study|Became ineligible|1|||
129754293|NCT01965704|467061807|FG000|Overall Study|Withdrawal by Subject|2|||
129754294|NCT01965704|467061808|FG001|Overall Study|Withdrawal by Subject|2|||
129754295|NCT01965704|467061809|FG002|Overall Study|Withdrawal by Subject|1|||
129754296|NCT01965704|467061810|FG003|Overall Study|Withdrawal by Subject|1|||
129754297|NCT01965704|467061807|FG000|Overall Study|Delivered at home|1|||
129754298|NCT01965704|467061808|FG001|Overall Study|Delivered at home|1|||
129754299|NCT01965704|467061809|FG002|Overall Study|Delivered at home|0|||
129754300|NCT01965704|467061810|FG003|Overall Study|Delivered at home|0|||
129754301|NCT01965704|467061807|FG000|Overall Study|Experienced complications|0|||
129754302|NCT01965704|467061808|FG001|Overall Study|Experienced complications|0|||
129810218|NCT01663532|467273155|FG000|Overall Study|Lack of Efficacy|15|||
129810219|NCT01663532|467273156|FG001|Overall Study|Lack of Efficacy|60|||
129810220|NCT03539081|467273161|FG000|Overall Study|Withdrawal by Subject|2|||
129810221|NCT03539081|467273162|FG001|Overall Study|Withdrawal by Subject|3|||
129810222|NCT03539081|467273163|FG002|Overall Study|Withdrawal by Subject|0|||
129754303|NCT01965704|467061809|FG002|Overall Study|Experienced complications|2|||
129754304|NCT01965704|467061810|FG003|Overall Study|Experienced complications|2|||
129754305|NCT01965704|467061807|FG000|Overall Study|Adverse Event|0|||
129754306|NCT01965704|467061808|FG001|Overall Study|Adverse Event|0|||
129754307|NCT01965704|467061809|FG002|Overall Study|Adverse Event|1|||
129754308|NCT01965704|467061810|FG003|Overall Study|Adverse Event|1|||
129754309|NCT01965704|467061807|FG000|Overall Study|Did not meet inclusion criteria|0|||
129754310|NCT01965704|467061808|FG001|Overall Study|Did not meet inclusion criteria|0|||
129754311|NCT01965704|467061809|FG002|Overall Study|Did not meet inclusion criteria|1|||
129754312|NCT01965704|467061810|FG003|Overall Study|Did not meet inclusion criteria|1|||
129754313|NCT00687804|467061818|FG000|Core Study|Adverse Event|5|||
129754314|NCT00687804|467061819|FG001|Core Study|Adverse Event|3|||
129754315|NCT00687804|467061820|FG002|Core Study|Adverse Event|3|||
129754316|NCT00687804|467061818|FG000|Core Study|Abnormal laboratory value(s)|1|||
129754317|NCT00687804|467061819|FG001|Core Study|Abnormal laboratory value(s)|0|||
129754318|NCT00687804|467061820|FG002|Core Study|Abnormal laboratory value(s)|0|||
129754319|NCT00687804|467061818|FG000|Core Study|Lack of Efficacy|1|||
129754320|NCT00687804|467061819|FG001|Core Study|Lack of Efficacy|1|||
129754321|NCT00687804|467061820|FG002|Core Study|Lack of Efficacy|1|||
129754322|NCT00687804|467061818|FG000|Core Study|Withdrawal by Subject|4|||
129754323|NCT00687804|467061819|FG001|Core Study|Withdrawal by Subject|7|||
129754324|NCT00687804|467061820|FG002|Core Study|Withdrawal by Subject|7|||
129754325|NCT00687804|467061818|FG000|Core Study|Lost to Follow-up|0|||
129754326|NCT00687804|467061819|FG001|Core Study|Lost to Follow-up|1|||
129754327|NCT00687804|467061820|FG002|Core Study|Lost to Follow-up|0|||
129754328|NCT00687804|467061818|FG000|Core Study|Death|2|||
129754329|NCT00687804|467061819|FG001|Core Study|Death|2|||
129754330|NCT00687804|467061820|FG002|Core Study|Death|2|||
129754331|NCT00687804|467061818|FG000|Core Study|Protocol Violation|1|||
129754332|NCT00687804|467061819|FG001|Core Study|Protocol Violation|1|||
129754333|NCT00687804|467061820|FG002|Core Study|Protocol Violation|0|||
129754334|NCT00687804|467061818|FG000|Open-Label Extension Study|Adverse Event|2|||
129754335|NCT00687804|467061819|FG001|Open-Label Extension Study|Adverse Event|2|||
129754336|NCT00687804|467061820|FG002|Open-Label Extension Study|Adverse Event|2|||
129754337|NCT00687804|467061818|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
129754338|NCT00687804|467061819|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
129754339|NCT00687804|467061820|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
129810223|NCT03539081|467273161|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
129810224|NCT03539081|467273162|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
129810225|NCT03539081|467273163|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
129810226|NCT00799383|467273168|FG000|Overall Study|Protocol Violation|1|||
129810227|NCT00799383|467273169|FG001|Overall Study|Protocol Violation|1|||
129810228|NCT00799383|467273168|FG000|Overall Study|Adverse Event|0|||
129810229|NCT00799383|467273169|FG001|Overall Study|Adverse Event|1|||
129810230|NCT00799383|467273168|FG000|Overall Study|Lost to Follow-up|1|||
129810231|NCT00799383|467273169|FG001|Overall Study|Lost to Follow-up|2|||
129810232|NCT00799383|467273168|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
129810233|NCT00799383|467273169|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
129810234|NCT00799383|467273168|FG000|Overall Study|Withdrawal by Subject|0|||
129810235|NCT00799383|467273169|FG001|Overall Study|Withdrawal by Subject|1|||
129810236|NCT02165215|467273181|FG000|Induction Phase|Adverse Event|1|||
129810237|NCT02165215|467273182|FG001|Induction Phase|Adverse Event|0|||
129810238|NCT02165215|467273183|FG002|Induction Phase|Adverse Event|0|||
129810239|NCT02165215|467273181|FG000|Induction Phase|Withdrawal by Subject|10|||
129810240|NCT02165215|467273182|FG001|Induction Phase|Withdrawal by Subject|0|||
129810241|NCT02165215|467273183|FG002|Induction Phase|Withdrawal by Subject|0|||
129810242|NCT02165215|467273181|FG000|Induction Phase|Protocol Violation|1|||
129810243|NCT02165215|467273182|FG001|Induction Phase|Protocol Violation|0|||
129754340|NCT00687804|467061818|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
129754341|NCT00687804|467061819|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
129896722|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Physician Decision|0|||
129754342|NCT00687804|467061820|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
129754343|NCT00687804|467061818|FG000|Open-Label Extension Study|Administrative problems|1|||
129754344|NCT00687804|467061819|FG001|Open-Label Extension Study|Administrative problems|1|||
129754345|NCT00687804|467061820|FG002|Open-Label Extension Study|Administrative problems|0|||
129754346|NCT00687804|467061818|FG000|Open-Label Extension Study|Death|2|||
129754347|NCT00687804|467061819|FG001|Open-Label Extension Study|Death|3|||
129754348|NCT00687804|467061820|FG002|Open-Label Extension Study|Death|3|||
129754349|NCT04390243|467061821|FG000|Overall Study|Death|1|||
129810244|NCT02165215|467273183|FG002|Induction Phase|Protocol Violation|0|||
129896723|NCT01107626|467582122|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
129896724|NCT01107626|467582123|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
129896725|NCT01107626|467582124|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
129896726|NCT01107626|467582125|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
129896727|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
129754350|NCT04390243|467061821|FG000|Overall Study|Disease Progression|4|||
129754351|NCT04390243|467061821|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
129754352|NCT00799903|467061824|FG000|Overall Study|Investigator Site Closed|25|||
129754353|NCT00799903|467061825|FG001|Overall Study|Investigator Site Closed|23|||
129754354|NCT00799903|467061824|FG000|Overall Study|Withdrawal by Subject|179|||
129754355|NCT00799903|467061825|FG001|Overall Study|Withdrawal by Subject|175|||
129754356|NCT00799903|467061824|FG000|Overall Study|Lost to Follow-up|69|||
129754357|NCT00799903|467061825|FG001|Overall Study|Lost to Follow-up|80|||
129754358|NCT00556998|467061830|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
129754359|NCT00556998|467061830|FG000|Voriconazole Intravenous (IV)|Other|4|||
129754360|NCT00556998|467061830|FG000|Voriconazole Oral|Adverse Event|1|||
129754361|NCT00556998|467061830|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
129754362|NCT00216671|467061839|FG000|Overall Study|Adverse Event|4|||
129754363|NCT00216671|467061840|FG001|Overall Study|Adverse Event|9|||
129754364|NCT00216671|467061839|FG000|Overall Study|Pregnancy|0|||
129754365|NCT00216671|467061840|FG001|Overall Study|Pregnancy|1|||
129754366|NCT00216671|467061839|FG000|Overall Study|Withdrawal by Subject|4|||
129754367|NCT00216671|467061840|FG001|Overall Study|Withdrawal by Subject|2|||
129754368|NCT00216671|467061839|FG000|Overall Study|Refused Injections|3|||
129754369|NCT00216671|467061840|FG001|Overall Study|Refused Injections|13|||
129754370|NCT00216671|467061839|FG000|Overall Study|No Need to Continue Medication|1|||
129754371|NCT00216671|467061840|FG001|Overall Study|No Need to Continue Medication|1|||
129754372|NCT00216671|467061839|FG000|Overall Study|Insufficient Response|9|||
129754373|NCT00216671|467061840|FG001|Overall Study|Insufficient Response|4|||
129754374|NCT00216671|467061839|FG000|Overall Study|Lost to Follow-up|3|||
129754375|NCT00216671|467061840|FG001|Overall Study|Lost to Follow-up|5|||
129754376|NCT00216671|467061839|FG000|Overall Study|Non compliant|2|||
129754377|NCT00216671|467061840|FG001|Overall Study|Non compliant|2|||
129754378|NCT00216671|467061839|FG000|Overall Study|Ineligible|0|||
129754379|NCT00216671|467061840|FG001|Overall Study|Ineligible|2|||
129754380|NCT00216671|467061839|FG000|Overall Study|Physician Decision|1|||
129754381|NCT00216671|467061840|FG001|Overall Study|Physician Decision|1|||
129754382|NCT00216671|467061839|FG000|Overall Study|Protocol Violation|3|||
129754383|NCT00216671|467061840|FG001|Overall Study|Protocol Violation|5|||
129754384|NCT00216671|467061839|FG000|Overall Study|Relapse|1|||
129754385|NCT00216671|467061840|FG001|Overall Study|Relapse|0|||
129754386|NCT00216671|467061839|FG000|Overall Study|Investigator Illness|0|||
129754387|NCT00216671|467061840|FG001|Overall Study|Investigator Illness|1|||
129754388|NCT00216671|467061839|FG000|Overall Study|Patient Moved|0|||
129754389|NCT00216671|467061840|FG001|Overall Study|Patient Moved|1|||
129754390|NCT00216671|467061839|FG000|Overall Study|Ineligible, no efficacy data|2|||
129754391|NCT00216671|467061840|FG001|Overall Study|Ineligible, no efficacy data|2|||
129754392|NCT00216671|467061839|FG000|Overall Study|Insufficient Response Adverse Event|2|||
129754393|NCT00216671|467061840|FG001|Overall Study|Insufficient Response Adverse Event|1|||
129754394|NCT04961541|467061841|FG000|Overall Study|Adverse Event|0|||
129754395|NCT04961541|467061842|FG001|Overall Study|Adverse Event|0|||
129754396|NCT04961541|467061843|FG002|Overall Study|Adverse Event|0|||
129754397|NCT04961541|467061844|FG003|Overall Study|Adverse Event|0|||
129754398|NCT04961541|467061845|FG004|Overall Study|Adverse Event|0|||
129754399|NCT04961541|467061846|FG005|Overall Study|Adverse Event|1|||
129754400|NCT04961541|467061847|FG006|Overall Study|Adverse Event|0|||
129754401|NCT04961541|467061848|FG007|Overall Study|Adverse Event|0|||
129754402|NCT04961541|467061849|FG008|Overall Study|Adverse Event|0|||
129754403|NCT04961541|467061850|FG009|Overall Study|Adverse Event|0|||
129754404|NCT04961541|467061851|FG010|Overall Study|Adverse Event|0|||
129754405|NCT04961541|467061852|FG011|Overall Study|Adverse Event|0|||
129754406|NCT04961541|467061853|FG012|Overall Study|Adverse Event|0|||
129754407|NCT04961541|467061854|FG013|Overall Study|Adverse Event|0|||
129754408|NCT04961541|467061841|FG000|Overall Study|Lost to Follow-up|0|||
129896728|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
129754409|NCT04961541|467061842|FG001|Overall Study|Lost to Follow-up|0|||
129754410|NCT04961541|467061843|FG002|Overall Study|Lost to Follow-up|3|||
129754411|NCT04961541|467061844|FG003|Overall Study|Lost to Follow-up|0|||
129754412|NCT04961541|467061845|FG004|Overall Study|Lost to Follow-up|0|||
129754413|NCT04961541|467061846|FG005|Overall Study|Lost to Follow-up|0|||
129754414|NCT04961541|467061847|FG006|Overall Study|Lost to Follow-up|1|||
129754415|NCT04961541|467061848|FG007|Overall Study|Lost to Follow-up|1|||
129754416|NCT04961541|467061849|FG008|Overall Study|Lost to Follow-up|0|||
129754417|NCT04961541|467061850|FG009|Overall Study|Lost to Follow-up|1|||
129754418|NCT04961541|467061851|FG010|Overall Study|Lost to Follow-up|0|||
129754419|NCT04961541|467061852|FG011|Overall Study|Lost to Follow-up|0|||
129754420|NCT04961541|467061853|FG012|Overall Study|Lost to Follow-up|1|||
129810245|NCT02165215|467273181|FG000|Induction Phase|Physician Decision|1|||
129810246|NCT02165215|467273182|FG001|Induction Phase|Physician Decision|0|||
129810247|NCT02165215|467273183|FG002|Induction Phase|Physician Decision|0|||
129810248|NCT02165215|467273181|FG000|Induction Phase|Lack of Efficacy|2|||
129810249|NCT02165215|467273182|FG001|Induction Phase|Lack of Efficacy|0|||
129810250|NCT02165215|467273183|FG002|Induction Phase|Lack of Efficacy|0|||
129810251|NCT02165215|467273181|FG000|Induction Phase|Non-Compliance|2|||
129810252|NCT02165215|467273182|FG001|Induction Phase|Non-Compliance|0|||
129896729|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
129896730|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
129896731|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
129896732|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
129896733|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
129896734|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
129896735|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Death|0|||
129896736|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Death|8|||
129896737|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Death|2|||
129896738|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Death|13|||
129896739|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
129896740|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
129896741|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
129896742|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
129896743|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
129896744|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
129896745|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
129896746|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
129896747|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
129896748|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
129896749|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
129896750|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
129896751|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
129896752|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
129896753|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
129896754|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
129896755|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
129896756|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
129754421|NCT04961541|467061854|FG013|Overall Study|Lost to Follow-up|0|||
129754422|NCT04961541|467061841|FG000|Overall Study|Withdrawal by Subject|0|||
129754423|NCT04961541|467061842|FG001|Overall Study|Withdrawal by Subject|0|||
129754424|NCT04961541|467061843|FG002|Overall Study|Withdrawal by Subject|1|||
129754425|NCT04961541|467061844|FG003|Overall Study|Withdrawal by Subject|1|||
129754426|NCT04961541|467061845|FG004|Overall Study|Withdrawal by Subject|0|||
129754427|NCT04961541|467061846|FG005|Overall Study|Withdrawal by Subject|0|||
129754428|NCT04961541|467061847|FG006|Overall Study|Withdrawal by Subject|0|||
129754429|NCT04961541|467061848|FG007|Overall Study|Withdrawal by Subject|0|||
129754430|NCT04961541|467061849|FG008|Overall Study|Withdrawal by Subject|0|||
129754431|NCT04961541|467061850|FG009|Overall Study|Withdrawal by Subject|1|||
129754432|NCT04961541|467061851|FG010|Overall Study|Withdrawal by Subject|0|||
129754433|NCT04961541|467061852|FG011|Overall Study|Withdrawal by Subject|0|||
129754434|NCT04961541|467061853|FG012|Overall Study|Withdrawal by Subject|0|||
129754435|NCT04961541|467061854|FG013|Overall Study|Withdrawal by Subject|0|||
129754436|NCT03539601|467061856|FG000|Overall Study|Withdraw by parent/guardian|1|||
129754437|NCT03539601|467061857|FG001|Overall Study|Withdraw by parent/guardian|0|||
129810253|NCT02165215|467273183|FG002|Induction Phase|Non-Compliance|0|||
129810254|NCT02165215|467273181|FG000|Induction Phase|Lost to Follow-up|6|||
129810255|NCT02165215|467273182|FG001|Induction Phase|Lost to Follow-up|0|||
129896757|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
129754438|NCT03539601|467061858|FG002|Overall Study|Withdraw by parent/guardian|1|||
129754439|NCT03539601|467061859|FG003|Overall Study|Withdraw by parent/guardian|0|||
129754440|NCT03539601|467061856|FG000|Overall Study|Adverse Event|0|||
129810256|NCT02165215|467273183|FG002|Induction Phase|Lost to Follow-up|0|||
129810257|NCT02165215|467273181|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129896758|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
129896759|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
129754441|NCT03539601|467061857|FG001|Overall Study|Adverse Event|2|||
129754442|NCT03539601|467061858|FG002|Overall Study|Adverse Event|0|||
129810258|NCT02165215|467273182|FG001|Maintenance Phase|Withdrawal by Subject|7|||
129810259|NCT02165215|467273183|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129810260|NCT02165215|467273181|FG000|Maintenance Phase|Multiple reasons|0|||
129810261|NCT02165215|467273182|FG001|Maintenance Phase|Multiple reasons|2|||
129810262|NCT02165215|467273183|FG002|Maintenance Phase|Multiple reasons|1|||
129810263|NCT02165215|467273181|FG000|Maintenance Phase|Lost to Follow-up|0|||
129810264|NCT02165215|467273182|FG001|Maintenance Phase|Lost to Follow-up|2|||
129810265|NCT02165215|467273183|FG002|Maintenance Phase|Lost to Follow-up|0|||
129810266|NCT02165215|467273181|FG000|Maintenance Phase|Adverse Event|0|||
129810267|NCT02165215|467273182|FG001|Maintenance Phase|Adverse Event|1|||
129810268|NCT02165215|467273183|FG002|Maintenance Phase|Adverse Event|1|||
129810269|NCT00612040|467273184|FG000|Overall Study|Adverse Event|0|||
129810270|NCT00612040|467273185|FG001|Overall Study|Adverse Event|2|||
129754443|NCT03539601|467061859|FG003|Overall Study|Adverse Event|0|||
129754444|NCT03539601|467061856|FG000|Overall Study|Lost to Follow-up|2|||
129754445|NCT03539601|467061857|FG001|Overall Study|Lost to Follow-up|4|||
129754446|NCT03539601|467061858|FG002|Overall Study|Lost to Follow-up|5|||
129754447|NCT03539601|467061859|FG003|Overall Study|Lost to Follow-up|0|||
129754448|NCT03539601|467061856|FG000|Overall Study|Withdrawal by Subject|2|||
129754449|NCT03539601|467061857|FG001|Overall Study|Withdrawal by Subject|0|||
129754450|NCT03539601|467061858|FG002|Overall Study|Withdrawal by Subject|0|||
129754451|NCT03539601|467061859|FG003|Overall Study|Withdrawal by Subject|1|||
129754452|NCT03539601|467061856|FG000|Overall Study|Randomized but not treated|1|||
129754453|NCT03539601|467061857|FG001|Overall Study|Randomized but not treated|1|||
129754454|NCT03539601|467061858|FG002|Overall Study|Randomized but not treated|0|||
129754455|NCT03539601|467061859|FG003|Overall Study|Randomized but not treated|0|||
129754456|NCT01970306|467061860|FG000|Overall Study|Not eligible|3|||
129754457|NCT01970306|467061860|FG000|Overall Study|Not able to be treated|9|||
129754458|NCT00226811|467061861|FG000|Overall Study|Death|8|||
129754459|NCT00226811|467061861|FG000|Overall Study|Adverse Event|11|||
129754460|NCT00226811|467061861|FG000|Overall Study|Lack of Efficacy|55|||
129754461|NCT00226811|467061861|FG000|Overall Study|Withdrawal by Subject|2|||
129754462|NCT03081884|467061862|FG000|Overall Study|deferred prostate cancer treatment|1|||
129754463|NCT03081884|467061862|FG000|Overall Study|metastasis managed with systemic therapy|3|||
129754464|NCT03948334|467061864|FG000|Overall Study|Adverse Event|1|||
129754465|NCT03948334|467061865|FG001|Overall Study|Adverse Event|4|||
129754466|NCT03948334|467061864|FG000|Overall Study|Lack of Efficacy|2|||
129754467|NCT03948334|467061865|FG001|Overall Study|Lack of Efficacy|0|||
129754468|NCT03948334|467061864|FG000|Overall Study|Lost to Follow-up|1|||
129754469|NCT03948334|467061865|FG001|Overall Study|Lost to Follow-up|0|||
129754470|NCT03948334|467061864|FG000|Overall Study|Physician Decision|1|||
129754471|NCT03948334|467061865|FG001|Overall Study|Physician Decision|0|||
129754472|NCT03948334|467061864|FG000|Overall Study|Pregnancy|0|||
129754473|NCT03948334|467061865|FG001|Overall Study|Pregnancy|1|||
129754474|NCT03948334|467061864|FG000|Overall Study|Protocol Deviation|1|||
129754475|NCT03948334|467061865|FG001|Overall Study|Protocol Deviation|0|||
129754476|NCT03948334|467061864|FG000|Overall Study|Study terminated by Sponsor|50|||
129754477|NCT03948334|467061865|FG001|Overall Study|Study terminated by Sponsor|51|||
129754478|NCT03948334|467061864|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
129754479|NCT03948334|467061865|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
129754480|NCT01100320|467061868|FG000|Period 1|Withdrawal by Subject|2|||
129754481|NCT01100320|467061869|FG001|Period 1|Withdrawal by Subject|4|||
129754482|NCT01100320|467061868|FG000|Period 1|Positive Drug Screen|1|||
129754483|NCT01100320|467061869|FG001|Period 1|Positive Drug Screen|1|||
129754484|NCT01100320|467061868|FG000|Period 1|Adverse Event|2|||
129754485|NCT01100320|467061869|FG001|Period 1|Adverse Event|2|||
129754486|NCT01100320|467061868|FG000|Period 2|Withdrawal by Subject|1|||
129754487|NCT01100320|467061869|FG001|Period 2|Withdrawal by Subject|1|||
129754488|NCT00596752|467061870|FG000|Overall Study|Other Reason|44|||
129754489|NCT00596752|467061871|FG001|Overall Study|Other Reason|49|||
129754490|NCT00596752|467061870|FG000|Overall Study|Adverse Event|34|||
129754491|NCT00596752|467061871|FG001|Overall Study|Adverse Event|34|||
129754492|NCT00596752|467061870|FG000|Overall Study|Lost to Follow-up|22|||
129754493|NCT00596752|467061871|FG001|Overall Study|Lost to Follow-up|38|||
129754494|NCT00596752|467061870|FG000|Overall Study|Withdrawal by Subject|12|||
129754495|NCT00596752|467061871|FG001|Overall Study|Withdrawal by Subject|9|||
129754496|NCT00596752|467061870|FG000|Overall Study|Unsatisfactory Compliance|9|||
129754497|NCT00596752|467061871|FG001|Overall Study|Unsatisfactory Compliance|6|||
129754498|NCT00596752|467061870|FG000|Overall Study|Lack of Efficacy|4|||
129810271|NCT00612040|467273186|FG002|Overall Study|Adverse Event|1|||
129754499|NCT00596752|467061871|FG001|Overall Study|Lack of Efficacy|7|||
129754500|NCT00596752|467061870|FG000|Overall Study|Protocol Violation|1|||
129754501|NCT00596752|467061871|FG001|Overall Study|Protocol Violation|0|||
129754502|NCT04669301|467061872|FG000|Overall Study|Lost to Follow-up|0|||
129754503|NCT04669301|467061873|FG001|Overall Study|Lost to Follow-up|1|||
129754504|NCT04669301|467061874|FG002|Overall Study|Lost to Follow-up|0|||
129754505|NCT04669301|467061872|FG000|Overall Study|Withdrawal by Subject|3|||
129754506|NCT04669301|467061873|FG001|Overall Study|Withdrawal by Subject|2|||
129754507|NCT04669301|467061874|FG002|Overall Study|Withdrawal by Subject|0|||
129754508|NCT02940496|467061875|FG000|Overall Study|Adverse Event|1|||
129754509|NCT02940496|467061876|FG001|Overall Study|Adverse Event|0|||
129754510|NCT02940496|467061875|FG000|Overall Study|Death|2|||
129754511|NCT02940496|467061876|FG001|Overall Study|Death|0|||
129754512|NCT02940496|467061875|FG000|Overall Study|Hospice Care|1|||
129754513|NCT02940496|467061876|FG001|Overall Study|Hospice Care|0|||
129754514|NCT02940496|467061875|FG000|Overall Study|No MRE Done|1|||
129754515|NCT02940496|467061876|FG001|Overall Study|No MRE Done|0|||
129754516|NCT02940496|467061875|FG000|Overall Study|MRE Failure|1|||
129754517|NCT02940496|467061876|FG001|Overall Study|MRE Failure|0|||
129754518|NCT00548145|467061881|FG000|Overall Study|Death|0|||
129754519|NCT00548145|467061882|FG001|Overall Study|Death|1|||
129754520|NCT00548145|467061881|FG000|Overall Study|Withdrawal by Subject|0|||
129754521|NCT00548145|467061882|FG001|Overall Study|Withdrawal by Subject|2|||
129754522|NCT00548145|467061881|FG000|Overall Study|Physician Decision|1|||
129754523|NCT00548145|467061882|FG001|Overall Study|Physician Decision|1|||
129754524|NCT02119663|467061884|FG000|Overall Study|Disease progression|26|||
129754525|NCT02119663|467061885|FG001|Overall Study|Disease progression|27|||
129754526|NCT02119663|467061884|FG000|Overall Study|Adverse Event|5|||
129754527|NCT02119663|467061885|FG001|Overall Study|Adverse Event|5|||
129754528|NCT02119663|467061884|FG000|Overall Study|Death|3|||
129754529|NCT02119663|467061885|FG001|Overall Study|Death|2|||
129754530|NCT02119663|467061884|FG000|Overall Study|Physician Decision|1|||
129754531|NCT02119663|467061885|FG001|Overall Study|Physician Decision|2|||
129754532|NCT02119663|467061884|FG000|Overall Study|Other unspecified|2|||
129754533|NCT02119663|467061885|FG001|Overall Study|Other unspecified|0|||
129754534|NCT02119663|467061884|FG000|Overall Study|Subject decision|0|||
129754535|NCT02119663|467061885|FG001|Overall Study|Subject decision|1|||
129754536|NCT02119663|467061884|FG000|Overall Study|Study Terminated by the Sponsor|3|||
129754537|NCT02119663|467061885|FG001|Overall Study|Study Terminated by the Sponsor|4|||
129754538|NCT02863328|467061886|FG000|Overall Study|Lost to Follow-up|4|||
129754539|NCT02863328|467061887|FG001|Overall Study|Lost to Follow-up|10|||
129754540|NCT02863328|467061886|FG000|Overall Study|Withdrawal by Subject|7|||
129754541|NCT02863328|467061887|FG001|Overall Study|Withdrawal by Subject|12|||
129754542|NCT02863328|467061886|FG000|Overall Study|Died|0|||
129754543|NCT02863328|467061887|FG001|Overall Study|Died|1|||
129754544|NCT00892775|467061888|FG000|Overall Study|Protocol Violation|1|||
129754545|NCT00892775|467061889|FG001|Overall Study|Protocol Violation|0|||
129754546|NCT00892775|467061888|FG000|Overall Study|Subject difficulties with blood drawing|1|||
129754547|NCT00892775|467061889|FG001|Overall Study|Subject difficulties with blood drawing|0|||
129754548|NCT00892775|467061888|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
129754549|NCT00892775|467061889|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
129810272|NCT00612040|467273184|FG000|Overall Study|Protocol Violation|1|||
129810273|NCT00612040|467273185|FG001|Overall Study|Protocol Violation|2|||
129810274|NCT00612040|467273186|FG002|Overall Study|Protocol Violation|1|||
129810275|NCT00612040|467273184|FG000|Overall Study|Lack of Efficacy|2|||
129810276|NCT00612040|467273185|FG001|Overall Study|Lack of Efficacy|1|||
129810277|NCT00612040|467273186|FG002|Overall Study|Lack of Efficacy|0|||
129810278|NCT00612040|467273184|FG000|Overall Study|Unclassified|2|||
129896760|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
129896761|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
129754550|NCT00892775|467061888|FG000|Overall Study|Migrated/ moved from study area|1|||
129754551|NCT00892775|467061889|FG001|Overall Study|Migrated/ moved from study area|0|||
129754552|NCT00892775|467061888|FG000|Overall Study|Withdrawal by Subject|0|||
129754553|NCT00892775|467061889|FG001|Overall Study|Withdrawal by Subject|1|||
129754554|NCT00892775|467061888|FG000|Overall Study|Lost to Follow-up|1|||
129896762|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
129896763|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
129754555|NCT00892775|467061889|FG001|Overall Study|Lost to Follow-up|0|||
129754556|NCT00699660|467061890|FG000|Overall Study|Lost to Follow-up|4|||
129754557|NCT00699660|467061891|FG001|Overall Study|Lost to Follow-up|2|||
129754558|NCT00699660|467061890|FG000|Overall Study|missing reports and recording failures|10|||
129754559|NCT00699660|467061891|FG001|Overall Study|missing reports and recording failures|6|||
129754560|NCT00398320|467061892|FG000|Overall Study|Death|1|||
129810279|NCT00612040|467273185|FG001|Overall Study|Unclassified|2|||
129810280|NCT00612040|467273186|FG002|Overall Study|Unclassified|5|||
129810281|NCT02021331|467273187|FG000|Overall Study|Adverse Event|0|||
129754561|NCT00398320|467061892|FG000|Overall Study|Adverse Event|4|||
129754562|NCT00398320|467061892|FG000|Overall Study|Physician Decision|1|||
129810282|NCT02021331|467273188|FG001|Overall Study|Adverse Event|2|||
129810283|NCT00319553|467273191|FG000|Overall Study|Protocol Violation|1|||
129810284|NCT00319553|467273192|FG001|Overall Study|Protocol Violation|2|||
129810285|NCT00319553|467273191|FG000|Overall Study|Lost to Follow-up|2|||
129810286|NCT00319553|467273192|FG001|Overall Study|Lost to Follow-up|1|||
129810287|NCT00319553|467273191|FG000|Overall Study|Withdrawal by Subject|1|||
129810288|NCT00319553|467273192|FG001|Overall Study|Withdrawal by Subject|1|||
129810289|NCT01896102|467273193|FG000|Overall Study|Death|1|||
129754563|NCT00064792|467061893|FG000|Overall Study|Withdrawal by Subject|2|||
129810290|NCT01896102|467273193|FG000|Overall Study|Participant to receive allogenic transplant|2|||
129754564|NCT00064792|467061894|FG001|Overall Study|Withdrawal by Subject|0|||
129754565|NCT00064792|467061893|FG000|Overall Study|Adverse Event|3|||
129754566|NCT00064792|467061894|FG001|Overall Study|Adverse Event|0|||
129754567|NCT01870726|467061895|FG000|Overall Study|Withdrawal of informed consent|0|||
129754568|NCT01870726|467061896|FG001|Overall Study|Withdrawal of informed consent|0|||
129754569|NCT01870726|467061897|FG002|Overall Study|Withdrawal of informed consent|0|||
129754570|NCT01870726|467061898|FG003|Overall Study|Withdrawal of informed consent|1|||
129754571|NCT01870726|467061899|FG004|Overall Study|Withdrawal of informed consent|0|||
129754572|NCT01870726|467061900|FG005|Overall Study|Withdrawal of informed consent|0|||
129754573|NCT01870726|467061901|FG006|Overall Study|Withdrawal of informed consent|0|||
129754574|NCT01870726|467061895|FG000|Overall Study|Withdrawal by Subject|0|||
129754575|NCT01870726|467061896|FG001|Overall Study|Withdrawal by Subject|1|||
129754576|NCT01870726|467061897|FG002|Overall Study|Withdrawal by Subject|0|||
129754577|NCT01870726|467061898|FG003|Overall Study|Withdrawal by Subject|0|||
129754578|NCT01870726|467061899|FG004|Overall Study|Withdrawal by Subject|0|||
129754579|NCT01870726|467061900|FG005|Overall Study|Withdrawal by Subject|0|||
129754580|NCT01870726|467061901|FG006|Overall Study|Withdrawal by Subject|0|||
129754581|NCT01870726|467061895|FG000|Overall Study|Adverse Event|0|||
129754582|NCT01870726|467061896|FG001|Overall Study|Adverse Event|0|||
129754583|NCT01870726|467061897|FG002|Overall Study|Adverse Event|0|||
129754584|NCT01870726|467061898|FG003|Overall Study|Adverse Event|0|||
129754585|NCT01870726|467061899|FG004|Overall Study|Adverse Event|1|||
129754586|NCT01870726|467061900|FG005|Overall Study|Adverse Event|1|||
129754587|NCT01870726|467061901|FG006|Overall Study|Adverse Event|0|||
129754588|NCT01870726|467061895|FG000|Overall Study|Progressive disease|5|||
129754589|NCT01870726|467061896|FG001|Overall Study|Progressive disease|5|||
129754590|NCT01870726|467061897|FG002|Overall Study|Progressive disease|4|||
129754591|NCT01870726|467061898|FG003|Overall Study|Progressive disease|5|||
129754592|NCT01870726|467061899|FG004|Overall Study|Progressive disease|6|||
129754593|NCT01870726|467061900|FG005|Overall Study|Progressive disease|4|||
129754594|NCT01870726|467061901|FG006|Overall Study|Progressive disease|10|||
129754595|NCT03301350|467061902|FG000|Overall Study|Withdrawal by Subject|4|||
129754596|NCT03301350|467061902|FG000|Overall Study|Adverse Event|1|||
129754597|NCT03301350|467061902|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
129754598|NCT03301350|467061902|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
129754599|NCT03301350|467061902|FG000|Overall Study|no detail provided|1|||
129754600|NCT01248949|467061905|FG000|Overall Study|Lost to Follow-up|2|||
129754601|NCT01248949|467061906|FG001|Overall Study|Lost to Follow-up|2|||
129754602|NCT01248949|467061907|FG002|Overall Study|Lost to Follow-up|2|||
129754603|NCT01248949|467061908|FG003|Overall Study|Lost to Follow-up|1|||
129754604|NCT01248949|467061909|FG004|Overall Study|Lost to Follow-up|0|||
129754605|NCT01248949|467061905|FG000|Overall Study|Withdrawal by Subject|5|||
129754606|NCT01248949|467061906|FG001|Overall Study|Withdrawal by Subject|3|||
129810291|NCT01281865|467273202|FG000|Overall Study|Adverse Event|1|||
129810292|NCT01281865|467273203|FG001|Overall Study|Adverse Event|1|||
129810293|NCT01281865|467273202|FG000|Overall Study|Withdrawal by Subject|1|||
129810294|NCT01281865|467273203|FG001|Overall Study|Withdrawal by Subject|0|||
129810295|NCT01281865|467273202|FG000|Overall Study|Lack of Efficacy|1|||
129810296|NCT01281865|467273203|FG001|Overall Study|Lack of Efficacy|0|||
129896764|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
129896765|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
129810297|NCT02747875|467273204|FG000|Overall Study|Physician Decision|1|||
129810298|NCT02747875|467273205|FG001|Overall Study|Physician Decision|0|||
129810299|NCT02747875|467273204|FG000|Overall Study|Adverse Event|0|||
129754607|NCT01248949|467061907|FG002|Overall Study|Withdrawal by Subject|11|||
129754608|NCT01248949|467061908|FG003|Overall Study|Withdrawal by Subject|3|||
129754609|NCT01248949|467061909|FG004|Overall Study|Withdrawal by Subject|1|||
129754610|NCT01248949|467061905|FG000|Overall Study|Death|22|||
129754611|NCT01248949|467061906|FG001|Overall Study|Death|7|||
129754612|NCT01248949|467061907|FG002|Overall Study|Death|21|||
129896766|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
129754613|NCT01248949|467061908|FG003|Overall Study|Death|6|||
129754614|NCT01248949|467061909|FG004|Overall Study|Death|2|||
129810300|NCT02747875|467273205|FG001|Overall Study|Adverse Event|1|||
129810301|NCT03478657|467273206|FG000|Overall Study|Withdrawal by Subject|0|||
129754615|NCT01248949|467061905|FG000|Overall Study|Alternative Therapy|1|||
129754616|NCT01248949|467061906|FG001|Overall Study|Alternative Therapy|0|||
129754617|NCT01248949|467061907|FG002|Overall Study|Alternative Therapy|0|||
129754618|NCT01248949|467061908|FG003|Overall Study|Alternative Therapy|0|||
129754619|NCT01248949|467061909|FG004|Overall Study|Alternative Therapy|0|||
129754620|NCT01248949|467061905|FG000|Overall Study|Alternative Therapy.|1|||
129754621|NCT01248949|467061906|FG001|Overall Study|Alternative Therapy.|0|||
129754622|NCT01248949|467061907|FG002|Overall Study|Alternative Therapy.|0|||
129754623|NCT01248949|467061908|FG003|Overall Study|Alternative Therapy.|0|||
129754624|NCT01248949|467061909|FG004|Overall Study|Alternative Therapy.|0|||
129754625|NCT01248949|467061905|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
129754626|NCT01248949|467061906|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
129754627|NCT01248949|467061907|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
129754628|NCT01248949|467061908|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
129754629|NCT01248949|467061909|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
129754630|NCT01248949|467061905|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
129754631|NCT01248949|467061906|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
129754632|NCT01248949|467061907|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
129754633|NCT01248949|467061908|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
129754634|NCT01248949|467061909|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
129754635|NCT01248949|467061905|FG000|Overall Study|Participant Went To Hospice|0|||
129754636|NCT01248949|467061906|FG001|Overall Study|Participant Went To Hospice|0|||
129754637|NCT01248949|467061907|FG002|Overall Study|Participant Went To Hospice|1|||
129754638|NCT01248949|467061908|FG003|Overall Study|Participant Went To Hospice|0|||
129754639|NCT01248949|467061909|FG004|Overall Study|Participant Went To Hospice|0|||
129754640|NCT01248949|467061905|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
129754641|NCT01248949|467061906|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129754642|NCT01248949|467061907|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129754643|NCT01248949|467061908|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129754644|NCT01248949|467061909|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
129754645|NCT01248949|467061905|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
129754646|NCT01248949|467061906|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
129754647|NCT01248949|467061907|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
129754648|NCT01248949|467061908|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
129754649|NCT01248949|467061909|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
129754650|NCT01248949|467061905|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129754651|NCT01248949|467061906|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
129754652|NCT01248949|467061907|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129754653|NCT01248949|467061908|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129754654|NCT01248949|467061909|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
129754655|NCT01248949|467061905|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129754656|NCT01248949|467061906|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129754657|NCT01248949|467061907|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
129754658|NCT01248949|467061908|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129754659|NCT01248949|467061909|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
129810302|NCT03478657|467273207|FG001|Overall Study|Withdrawal by Subject|1|||
129810303|NCT02590003|467273208|FG000|Overall Study|Death|1|||
129810304|NCT02590003|467273209|FG001|Overall Study|Death|2|||
129810305|NCT01849783|467273211|FG000|Overall Study|Adverse Event|5|||
129810306|NCT01849783|467273211|FG000|Overall Study|Death|2|||
129810307|NCT01849783|467273211|FG000|Overall Study|Physician Decision|1|||
129810308|NCT01849783|467273211|FG000|Overall Study|Withdrawal by Subject|1|||
129810309|NCT01849783|467273211|FG000|Overall Study|Unable to comply|2|||
129810310|NCT01849783|467273211|FG000|Overall Study|Disease progression|11|||
129810311|NCT03948581|467273212|FG000|Overall Study|Lost to Follow-up|0|||
129810312|NCT03948581|467273213|FG001|Overall Study|Lost to Follow-up|1|||
129810313|NCT04457336|467273216|FG000|Period 2: Part A|Withdrawal by Subject|0|||
129810314|NCT04457336|467273217|FG001|Period 2: Part A|Withdrawal by Subject|1|||
129754660|NCT00286429|467061910|FG000|Overall Study|Adverse Event|4|||
129754661|NCT00286429|467061911|FG001|Overall Study|Adverse Event|1|||
129754662|NCT00286429|467061912|FG002|Overall Study|Adverse Event|6|||
129754663|NCT00286429|467061910|FG000|Overall Study|Lack of Efficacy|52|||
129754664|NCT00286429|467061911|FG001|Overall Study|Lack of Efficacy|27|||
129754665|NCT00286429|467061912|FG002|Overall Study|Lack of Efficacy|25|||
129754666|NCT00286429|467061910|FG000|Overall Study|Lost to Follow-up|2|||
129754667|NCT00286429|467061911|FG001|Overall Study|Lost to Follow-up|4|||
129810315|NCT04457336|467273218|FG002|Period 2: Part A|Withdrawal by Subject|1|||
129810316|NCT04457336|467273219|FG003|Period 2: Part A|Withdrawal by Subject|1|||
129754668|NCT00286429|467061912|FG002|Overall Study|Lost to Follow-up|3|||
129754669|NCT00286429|467061910|FG000|Overall Study|Physician Decision|10|||
129754670|NCT00286429|467061911|FG001|Overall Study|Physician Decision|7|||
129754671|NCT00286429|467061912|FG002|Overall Study|Physician Decision|7|||
129754672|NCT00286429|467061910|FG000|Overall Study|Protocol Violation|3|||
129754673|NCT00286429|467061911|FG001|Overall Study|Protocol Violation|5|||
129754674|NCT00286429|467061912|FG002|Overall Study|Protocol Violation|4|||
129754675|NCT00286429|467061910|FG000|Overall Study|Withdrawal by Subject|3|||
129754676|NCT00286429|467061911|FG001|Overall Study|Withdrawal by Subject|2|||
129754677|NCT00286429|467061912|FG002|Overall Study|Withdrawal by Subject|6|||
129754678|NCT00286429|467061910|FG000|Overall Study|Administrative Error|1|||
129754679|NCT00286429|467061911|FG001|Overall Study|Administrative Error|1|||
129754680|NCT00286429|467061912|FG002|Overall Study|Administrative Error|1|||
129754681|NCT00286429|467061910|FG000|Overall Study|Administrative Decision|0|||
129754682|NCT00286429|467061911|FG001|Overall Study|Administrative Decision|1|||
129754683|NCT00286429|467061912|FG002|Overall Study|Administrative Decision|0|||
129754684|NCT01746225|467061915|FG000|Overall Study|Death|1|||
129754685|NCT01746225|467061916|FG001|Overall Study|Death|0|||
129754686|NCT01746225|467061917|FG002|Overall Study|Death|1|||
129754687|NCT01746225|467061915|FG000|Overall Study|Withdrawal by Subject|5|||
129754688|NCT01746225|467061916|FG001|Overall Study|Withdrawal by Subject|15|||
129754689|NCT01746225|467061917|FG002|Overall Study|Withdrawal by Subject|19|||
129754690|NCT01746225|467061915|FG000|Overall Study|Physician Decision|14|||
129754691|NCT01746225|467061916|FG001|Overall Study|Physician Decision|11|||
129754692|NCT01746225|467061917|FG002|Overall Study|Physician Decision|3|||
129754693|NCT01746225|467061915|FG000|Overall Study|Adverse Event|15|||
129754694|NCT01746225|467061916|FG001|Overall Study|Adverse Event|12|||
129754695|NCT01746225|467061917|FG002|Overall Study|Adverse Event|17|||
129754696|NCT01746225|467061915|FG000|Overall Study|Continuing Treatment|5|||
129754697|NCT01746225|467061916|FG001|Overall Study|Continuing Treatment|8|||
129754698|NCT01746225|467061917|FG002|Overall Study|Continuing Treatment|3|||
129754699|NCT03915470|467061918|FG000|Overall Study|Death|3|||
129754700|NCT03915470|467061919|FG001|Overall Study|Death|1|||
129754701|NCT03915470|467061918|FG000|Overall Study|Adverse Event|1|||
129754702|NCT03915470|467061919|FG001|Overall Study|Adverse Event|0|||
129754703|NCT03915470|467061918|FG000|Overall Study|Physician Decision|1|||
129754704|NCT03915470|467061919|FG001|Overall Study|Physician Decision|0|||
129754705|NCT03915470|467061918|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
129754706|NCT03915470|467061919|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
129754707|NCT03160898|467061920|FG000|Overall Study|Adverse Event|4|||
129810317|NCT04457336|467273220|FG004|Period 2: Part A|Withdrawal by Subject|0|||
129810318|NCT04457336|467273221|FG005|Period 2: Part A|Withdrawal by Subject|0|||
129810319|NCT04457336|467273222|FG006|Period 2: Part A|Withdrawal by Subject|0|||
129810320|NCT04457336|467273223|FG007|Period 2: Part A|Withdrawal by Subject|0|||
129810321|NCT04457336|467273216|FG000|Period 2: Part A|Adverse Event|0|||
129810322|NCT04457336|467273217|FG001|Period 2: Part A|Adverse Event|0|||
129810323|NCT04457336|467273218|FG002|Period 2: Part A|Adverse Event|1|||
129810324|NCT04457336|467273219|FG003|Period 2: Part A|Adverse Event|1|||
129810325|NCT04457336|467273220|FG004|Period 2: Part A|Adverse Event|0|||
129810326|NCT04457336|467273221|FG005|Period 2: Part A|Adverse Event|0|||
129810327|NCT04457336|467273222|FG006|Period 2: Part A|Adverse Event|0|||
129810328|NCT04457336|467273223|FG007|Period 2: Part A|Adverse Event|0|||
129810329|NCT04457336|467273216|FG000|Period 2: Part A|Study Terminated|0|||
129810330|NCT04457336|467273217|FG001|Period 2: Part A|Study Terminated|0|||
129810331|NCT04457336|467273218|FG002|Period 2: Part A|Study Terminated|1|||
129754708|NCT03160898|467061921|FG001|Overall Study|Adverse Event|8|||
129754709|NCT03160898|467061922|FG002|Overall Study|Adverse Event|7|||
129754710|NCT03160898|467061923|FG003|Overall Study|Adverse Event|10|||
129754711|NCT03160898|467061920|FG000|Overall Study|Death|1|||
129754712|NCT03160898|467061921|FG001|Overall Study|Death|0|||
129754713|NCT03160898|467061922|FG002|Overall Study|Death|0|||
129754714|NCT03160898|467061923|FG003|Overall Study|Death|1|||
129754715|NCT03160898|467061920|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
129754716|NCT03160898|467061921|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
129810332|NCT04457336|467273219|FG003|Period 2: Part A|Study Terminated|0|||
129810333|NCT04457336|467273220|FG004|Period 2: Part A|Study Terminated|0|||
129810334|NCT04457336|467273221|FG005|Period 2: Part A|Study Terminated|0|||
129810335|NCT04457336|467273222|FG006|Period 2: Part A|Study Terminated|0|||
129810336|NCT04457336|467273223|FG007|Period 2: Part A|Study Terminated|0|||
129754717|NCT03160898|467061922|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
129754718|NCT03160898|467061923|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
129754719|NCT03160898|467061920|FG000|Overall Study|Lost to Follow-up|1|||
129754720|NCT03160898|467061921|FG001|Overall Study|Lost to Follow-up|1|||
129754721|NCT03160898|467061922|FG002|Overall Study|Lost to Follow-up|1|||
129754722|NCT03160898|467061923|FG003|Overall Study|Lost to Follow-up|2|||
129754723|NCT03160898|467061920|FG000|Overall Study|Physician Decision|1|||
129754724|NCT03160898|467061921|FG001|Overall Study|Physician Decision|0|||
129810337|NCT04457336|467273216|FG000|Period 2: Part A|Protocol Violation|0|||
129754725|NCT03160898|467061922|FG002|Overall Study|Physician Decision|0|||
129754726|NCT03160898|467061923|FG003|Overall Study|Physician Decision|1|||
129754727|NCT03160898|467061920|FG000|Overall Study|Progressive Disease|4|||
129754728|NCT03160898|467061921|FG001|Overall Study|Progressive Disease|1|||
129754729|NCT03160898|467061922|FG002|Overall Study|Progressive Disease|2|||
129754730|NCT03160898|467061923|FG003|Overall Study|Progressive Disease|1|||
129754731|NCT03160898|467061920|FG000|Overall Study|Protocol Violation|1|||
129754732|NCT03160898|467061921|FG001|Overall Study|Protocol Violation|0|||
129754733|NCT03160898|467061922|FG002|Overall Study|Protocol Violation|2|||
129754734|NCT03160898|467061923|FG003|Overall Study|Protocol Violation|0|||
129754735|NCT03160898|467061920|FG000|Overall Study|Sponsor Discretion|2|||
129754736|NCT03160898|467061921|FG001|Overall Study|Sponsor Discretion|0|||
129754737|NCT03160898|467061922|FG002|Overall Study|Sponsor Discretion|0|||
129754738|NCT03160898|467061923|FG003|Overall Study|Sponsor Discretion|0|||
129754739|NCT03160898|467061920|FG000|Overall Study|Withdrawal by Subject|1|||
129754740|NCT03160898|467061921|FG001|Overall Study|Withdrawal by Subject|3|||
129754741|NCT03160898|467061922|FG002|Overall Study|Withdrawal by Subject|2|||
129754742|NCT03160898|467061923|FG003|Overall Study|Withdrawal by Subject|1|||
129754743|NCT03160898|467061920|FG000|Overall Study|Other|2|||
129754744|NCT03160898|467061921|FG001|Overall Study|Other|0|||
129754745|NCT03160898|467061922|FG002|Overall Study|Other|2|||
129754746|NCT03160898|467061923|FG003|Overall Study|Other|2|||
129754747|NCT03245775|467061924|FG000|Overall Study|Lost to Follow-up|25|||
129754748|NCT03245775|467061925|FG001|Overall Study|Lost to Follow-up|26|||
129754749|NCT03245775|467061926|FG002|Overall Study|Lost to Follow-up|16|||
129754750|NCT03245775|467061927|FG003|Overall Study|Lost to Follow-up|16|||
129754751|NCT02978833|467061934|FG000|Overall Study|Study terminated|1|||
129754752|NCT02978833|467061935|FG001|Overall Study|Study terminated|1|||
129754753|NCT00103740|467061936|FG000|Period 1 - Core|Adverse Event|1|||
129754754|NCT00103740|467061937|FG001|Period 1 - Core|Adverse Event|0|||
129754755|NCT00103740|467061936|FG000|Period 1 - Core|Protocol Violation|3|||
129754756|NCT00103740|467061937|FG001|Period 1 - Core|Protocol Violation|2|||
129754757|NCT00103740|467061936|FG000|Period 1 - Core|Patient withdrew consent|3|||
129754758|NCT00103740|467061937|FG001|Period 1 - Core|Patient withdrew consent|2|||
129754759|NCT00103740|467061936|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
129754760|NCT00103740|467061937|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
129754761|NCT00103740|467061936|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
129754762|NCT00103740|467061937|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
129754763|NCT00103740|467061936|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
129754764|NCT00103740|467061937|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
129754765|NCT00103740|467061936|FG000|Period 2 - Extended Observation Period|Death|6|||
129754766|NCT00103740|467061937|FG001|Period 2 - Extended Observation Period|Death|2|||
129754767|NCT00103740|467061936|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
129754768|NCT00103740|467061937|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
129754769|NCT02663622|467061944|FG000|Overall Study|Death|3|||
129754770|NCT02663622|467061945|FG001|Overall Study|Death|1|||
129754771|NCT02663622|467061946|FG002|Overall Study|Death|1|||
129810338|NCT04457336|467273217|FG001|Period 2: Part A|Protocol Violation|1|||
129810339|NCT04457336|467273218|FG002|Period 2: Part A|Protocol Violation|0|||
129810340|NCT04457336|467273219|FG003|Period 2: Part A|Protocol Violation|0|||
129810341|NCT04457336|467273220|FG004|Period 2: Part A|Protocol Violation|0|||
129754772|NCT02663622|467061947|FG003|Overall Study|Death|8|||
129754773|NCT02663622|467061944|FG000|Overall Study|Protocol Violation|0|||
129754774|NCT02663622|467061945|FG001|Overall Study|Protocol Violation|0|||
129754775|NCT02663622|467061946|FG002|Overall Study|Protocol Violation|0|||
129754776|NCT02663622|467061947|FG003|Overall Study|Protocol Violation|1|||
129754777|NCT02587819|467061948|FG000|Overall Study|Adverse Event|1|||
129754778|NCT02587819|467061948|FG000|Overall Study|Lost to Follow-up|1|||
129754779|NCT01594931|467063363|FG000|Overall Study|Adverse Event|3|||
129754780|NCT01594931|467063364|FG001|Overall Study|Adverse Event|1|||
129754781|NCT01594931|467063365|FG002|Overall Study|Adverse Event|1|||
129754782|NCT01594931|467063363|FG000|Overall Study|Withdrawal by Subject|2|||
129754783|NCT01594931|467063364|FG001|Overall Study|Withdrawal by Subject|1|||
129754784|NCT01594931|467063365|FG002|Overall Study|Withdrawal by Subject|1|||
129754785|NCT01594931|467063363|FG000|Overall Study|Lack of Efficacy|7|||
129754786|NCT01594931|467063364|FG001|Overall Study|Lack of Efficacy|2|||
129754787|NCT01594931|467063365|FG002|Overall Study|Lack of Efficacy|2|||
129754788|NCT01594931|467063363|FG000|Overall Study|Lost to Follow-up|4|||
129754789|NCT01594931|467063364|FG001|Overall Study|Lost to Follow-up|3|||
129754790|NCT01594931|467063365|FG002|Overall Study|Lost to Follow-up|3|||
129754791|NCT01594931|467063363|FG000|Overall Study|Protocol Violation|2|||
129754792|NCT01594931|467063364|FG001|Overall Study|Protocol Violation|1|||
129754793|NCT01594931|467063365|FG002|Overall Study|Protocol Violation|0|||
129754794|NCT01594931|467063363|FG000|Overall Study|No defiined|11|||
129754795|NCT01594931|467063364|FG001|Overall Study|No defiined|4|||
129754796|NCT01594931|467063365|FG002|Overall Study|No defiined|7|||
129754797|NCT01467505|467063367|FG000|Overall Study|Adverse Event|1|||
129754798|NCT01467505|467063368|FG001|Overall Study|Adverse Event|0|||
129754799|NCT01467505|467063367|FG000|Overall Study|Withdrawal by Subject|4|||
129754800|NCT01467505|467063368|FG001|Overall Study|Withdrawal by Subject|0|||
129754801|NCT01467505|467063367|FG000|Overall Study|Study Terminated by Sponsor|28|||
129754802|NCT01467505|467063368|FG001|Overall Study|Study Terminated by Sponsor|3|||
129754803|NCT03449758|467063369|FG000|Overall Study|Major protocol deviation|1|||
129754804|NCT03449758|467063369|FG000|Overall Study|Treatment inefficacy|5|||
129754805|NCT03449758|467063369|FG000|Overall Study|Adverse Event|9|||
129754806|NCT03449758|467063369|FG000|Overall Study|Consent withdrawal|1|||
129754807|NCT03449758|467063369|FG000|Overall Study|Other unspecified reason|3|||
129754808|NCT00086047|467063382|FG000|Overall Study|Lost to Follow-up|7|||
129754809|NCT00086047|467063383|FG001|Overall Study|Lost to Follow-up|6|||
129754810|NCT00086047|467063382|FG000|Overall Study|Physician Decision|0|||
129754811|NCT00086047|467063383|FG001|Overall Study|Physician Decision|1|||
129754812|NCT03579940|467063384|FG000|Period 2|Withdrawal by Subject|0|||
129754813|NCT03579940|467063385|FG001|Period 2|Withdrawal by Subject|0|||
129754814|NCT03579940|467063386|FG002|Period 2|Withdrawal by Subject|1|||
129754815|NCT03579940|467063387|FG003|Period 2|Withdrawal by Subject|0|||
129754816|NCT03579940|467063388|FG004|Period 2|Withdrawal by Subject|0|||
129754817|NCT03579940|467063389|FG005|Period 2|Withdrawal by Subject|0|||
129754818|NCT03579940|467063390|FG006|Period 2|Withdrawal by Subject|0|||
129754819|NCT03579940|467063391|FG007|Period 2|Withdrawal by Subject|0|||
129754820|NCT03579940|467063392|FG008|Period 2|Withdrawal by Subject|0|||
129754821|NCT03579940|467063393|FG009|Period 2|Withdrawal by Subject|0|||
129754822|NCT03579940|467063394|FG010|Period 2|Withdrawal by Subject|0|||
129754823|NCT00671034|467063395|FG000|Overall Study|Adverse Event|5|||
129754824|NCT00671034|467063396|FG001|Overall Study|Adverse Event|7|||
129754825|NCT00671034|467063397|FG002|Overall Study|Adverse Event|1|||
129754826|NCT00671034|467063395|FG000|Overall Study|Death|3|||
129754827|NCT00671034|467063396|FG001|Overall Study|Death|2|||
129754828|NCT00671034|467063397|FG002|Overall Study|Death|1|||
129754829|NCT00671034|467063395|FG000|Overall Study|Physician Decision|12|||
129754830|NCT00671034|467063396|FG001|Overall Study|Physician Decision|4|||
129754831|NCT00671034|467063397|FG002|Overall Study|Physician Decision|5|||
129754832|NCT00671034|467063395|FG000|Overall Study|VHR ALL feature|8|||
129754833|NCT00671034|467063396|FG001|Overall Study|VHR ALL feature|3|||
129754834|NCT00671034|467063397|FG002|Overall Study|VHR ALL feature|5|||
129754835|NCT00671034|467063395|FG000|Overall Study|Refusal|5|||
129754836|NCT00671034|467063396|FG001|Overall Study|Refusal|3|||
129754837|NCT00671034|467063397|FG002|Overall Study|Refusal|5|||
129754838|NCT00671034|467063395|FG000|Overall Study|includes Alternative therapy, etc.|6|||
129754839|NCT00671034|467063396|FG001|Overall Study|includes Alternative therapy, etc.|1|||
129754840|NCT00671034|467063397|FG002|Overall Study|includes Alternative therapy, etc.|7|||
129754841|NCT00853151|467063398|FG000|Overall Study|Adverse Event|1|||
129754842|NCT00853151|467063399|FG001|Overall Study|Adverse Event|4|||
129754843|NCT00853151|467063400|FG002|Overall Study|Adverse Event|2|||
129754844|NCT00853151|467063401|FG003|Overall Study|Adverse Event|0|||
129754845|NCT00853151|467063398|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
129754846|NCT00853151|467063399|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129754847|NCT00853151|467063400|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129810342|NCT04457336|467273221|FG005|Period 2: Part A|Protocol Violation|0|||
129810343|NCT04457336|467273222|FG006|Period 2: Part A|Protocol Violation|0|||
129810344|NCT04457336|467273223|FG007|Period 2: Part A|Protocol Violation|0|||
129810345|NCT04457336|467273216|FG000|Period 2: Part A|Lost to Follow-up|0|||
129810346|NCT04457336|467273217|FG001|Period 2: Part A|Lost to Follow-up|1|||
129754848|NCT00853151|467063401|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129754849|NCT00853151|467063398|FG000|Overall Study|Lost to Follow-up|2|||
129810347|NCT04457336|467273218|FG002|Period 2: Part A|Lost to Follow-up|0|||
129754850|NCT00853151|467063399|FG001|Overall Study|Lost to Follow-up|0|||
129754851|NCT00853151|467063400|FG002|Overall Study|Lost to Follow-up|3|||
129754852|NCT00853151|467063401|FG003|Overall Study|Lost to Follow-up|0|||
129810348|NCT04457336|467273219|FG003|Period 2: Part A|Lost to Follow-up|0|||
129445402|NCT03828292|465931281|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
129754853|NCT00853151|467063398|FG000|Overall Study|Death|1|||
129754854|NCT00853151|467063399|FG001|Overall Study|Death|0|||
129754855|NCT00853151|467063400|FG002|Overall Study|Death|0|||
129754856|NCT00853151|467063401|FG003|Overall Study|Death|1|||
129754857|NCT00853151|467063398|FG000|Overall Study|Protocol Violation|0|||
129754858|NCT00853151|467063399|FG001|Overall Study|Protocol Violation|0|||
129754859|NCT00853151|467063400|FG002|Overall Study|Protocol Violation|0|||
129754860|NCT00853151|467063401|FG003|Overall Study|Protocol Violation|1|||
129754861|NCT00853151|467063398|FG000|Overall Study|Withdrawal by Subject|5|||
129754862|NCT00853151|467063399|FG001|Overall Study|Withdrawal by Subject|4|||
129754863|NCT00853151|467063400|FG002|Overall Study|Withdrawal by Subject|2|||
129754864|NCT00853151|467063401|FG003|Overall Study|Withdrawal by Subject|1|||
129754865|NCT00853151|467063398|FG000|Overall Study|Physician Decision|0|||
129754866|NCT00853151|467063399|FG001|Overall Study|Physician Decision|2|||
129754867|NCT00853151|467063400|FG002|Overall Study|Physician Decision|1|||
129754868|NCT00853151|467063401|FG003|Overall Study|Physician Decision|0|||
129754869|NCT00853151|467063398|FG000|Overall Study|Sponsor Decision|0|||
129754870|NCT00853151|467063399|FG001|Overall Study|Sponsor Decision|3|||
129754871|NCT00853151|467063400|FG002|Overall Study|Sponsor Decision|0|||
129754872|NCT00853151|467063401|FG003|Overall Study|Sponsor Decision|0|||
129754873|NCT00269919|467063402|FG000|Overall Study|Other|26|||
129754874|NCT00269919|467063402|FG000|Overall Study|Started but not treated|1|||
129754875|NCT02471014|467063405|FG000|Overall Study|Lost to Follow-up|2|||
129754876|NCT02471014|467063406|FG001|Overall Study|Lost to Follow-up|2|||
129754877|NCT01751984|467063407|FG000|Overall Study|Adverse Event|5|||
129754878|NCT01751984|467063408|FG001|Overall Study|Adverse Event|3|||
129754879|NCT01751984|467063407|FG000|Overall Study|Withdrawal by Subject|0|||
129754880|NCT01751984|467063408|FG001|Overall Study|Withdrawal by Subject|1|||
129754881|NCT01751984|467063407|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
129754882|NCT01751984|467063408|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
129754883|NCT01388907|467063409|FG000|Overall Study|Adverse Event|2|||
129754884|NCT01388907|467063410|FG001|Overall Study|Adverse Event|0|||
129754885|NCT03187132|467063411|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
129754886|NCT03187132|467063412|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
129754887|NCT03187132|467063411|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
129754888|NCT03187132|467063412|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
129754889|NCT03187132|467063411|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
129754890|NCT03187132|467063412|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
129754891|NCT03187132|467063411|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
129754892|NCT03187132|467063412|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
129754893|NCT03187132|467063411|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
129754894|NCT03187132|467063412|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
129754895|NCT03187132|467063411|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
129754896|NCT03187132|467063412|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
129754897|NCT03187132|467063411|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
129754898|NCT03187132|467063412|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
129754899|NCT03187132|467063411|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
129754900|NCT03187132|467063412|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
129754901|NCT03187132|467063411|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
129754902|NCT03187132|467063412|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
129754903|NCT03187132|467063411|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
129754904|NCT03187132|467063412|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
129754905|NCT03187132|467063411|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
129754906|NCT03187132|467063412|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
129754907|NCT02045095|467063413|FG000|Overall Study|Other|0|||
129754908|NCT02045095|467063414|FG001|Overall Study|Other|0|||
129754909|NCT02045095|467063415|FG002|Overall Study|Other|1|||
129754910|NCT02045095|467063416|FG003|Overall Study|Other|0|||
129754911|NCT02045095|467063417|FG004|Overall Study|Other|0|||
129754912|NCT02045095|467063418|FG005|Overall Study|Other|2|||
129754913|NCT02045095|467063419|FG006|Overall Study|Other|0|||
129754914|NCT02045095|467063413|FG000|Overall Study|Progressive Disease|3|||
129754915|NCT02045095|467063414|FG001|Overall Study|Progressive Disease|3|||
129754916|NCT02045095|467063415|FG002|Overall Study|Progressive Disease|2|||
129754917|NCT02045095|467063416|FG003|Overall Study|Progressive Disease|4|||
129754918|NCT02045095|467063417|FG004|Overall Study|Progressive Disease|2|||
129754919|NCT02045095|467063418|FG005|Overall Study|Progressive Disease|4|||
129754920|NCT02045095|467063419|FG006|Overall Study|Progressive Disease|1|||
129754921|NCT02045095|467063413|FG000|Overall Study|Withdrawal by Subject|0|||
129754922|NCT02045095|467063414|FG001|Overall Study|Withdrawal by Subject|0|||
129754923|NCT02045095|467063415|FG002|Overall Study|Withdrawal by Subject|0|||
129810349|NCT04457336|467273220|FG004|Period 2: Part A|Lost to Follow-up|0|||
129754924|NCT02045095|467063416|FG003|Overall Study|Withdrawal by Subject|0|||
129754925|NCT02045095|467063417|FG004|Overall Study|Withdrawal by Subject|3|||
129754926|NCT02045095|467063418|FG005|Overall Study|Withdrawal by Subject|0|||
129754927|NCT02045095|467063419|FG006|Overall Study|Withdrawal by Subject|0|||
129810350|NCT04457336|467273221|FG005|Period 2: Part A|Lost to Follow-up|0|||
129810351|NCT04457336|467273222|FG006|Period 2: Part A|Lost to Follow-up|0|||
129810352|NCT04457336|467273223|FG007|Period 2: Part A|Lost to Follow-up|0|||
129810353|NCT04457336|467273216|FG000|Period 2: Part A|Other|0|||
129810354|NCT04457336|467273217|FG001|Period 2: Part A|Other|1|||
129810355|NCT04457336|467273218|FG002|Period 2: Part A|Other|0|||
129810356|NCT04457336|467273219|FG003|Period 2: Part A|Other|0|||
129810357|NCT04457336|467273220|FG004|Period 2: Part A|Other|0|||
129810358|NCT04457336|467273221|FG005|Period 2: Part A|Other|0|||
129810359|NCT04457336|467273222|FG006|Period 2: Part A|Other|0|||
129810360|NCT04457336|467273223|FG007|Period 2: Part A|Other|0|||
129810361|NCT04457336|467273216|FG000|Period 2: Part A|Physician Decision|0|||
129810362|NCT04457336|467273217|FG001|Period 2: Part A|Physician Decision|0|||
129810363|NCT04457336|467273218|FG002|Period 2: Part A|Physician Decision|0|||
129810364|NCT04457336|467273219|FG003|Period 2: Part A|Physician Decision|1|||
129810365|NCT04457336|467273220|FG004|Period 2: Part A|Physician Decision|0|||
129810366|NCT04457336|467273221|FG005|Period 2: Part A|Physician Decision|0|||
129810367|NCT04457336|467273222|FG006|Period 2: Part A|Physician Decision|0|||
129810368|NCT04457336|467273223|FG007|Period 2: Part A|Physician Decision|0|||
129810369|NCT04457336|467273216|FG000|Period 3: Part B|Study Terminated|0|||
129810370|NCT04457336|467273217|FG001|Period 3: Part B|Study Terminated|0|||
129810371|NCT04457336|467273218|FG002|Period 3: Part B|Study Terminated|0|||
129810372|NCT04457336|467273219|FG003|Period 3: Part B|Study Terminated|0|||
129810373|NCT04457336|467273220|FG004|Period 3: Part B|Study Terminated|1|||
129754928|NCT02045095|467063413|FG000|Overall Study|Adverse Event|0|||
129754929|NCT02045095|467063414|FG001|Overall Study|Adverse Event|1|||
129754930|NCT02045095|467063415|FG002|Overall Study|Adverse Event|1|||
129754931|NCT02045095|467063416|FG003|Overall Study|Adverse Event|0|||
129754932|NCT02045095|467063417|FG004|Overall Study|Adverse Event|0|||
129754933|NCT02045095|467063418|FG005|Overall Study|Adverse Event|2|||
129754934|NCT02045095|467063419|FG006|Overall Study|Adverse Event|0|||
129754935|NCT03594773|467063420|FG000|Overall Study|Withdrawal by Subject|3|||
129754936|NCT03594773|467063421|FG001|Overall Study|Withdrawal by Subject|2|||
129754937|NCT03594773|467063420|FG000|Overall Study|Lost to Follow-up|3|||
129754938|NCT03594773|467063421|FG001|Overall Study|Lost to Follow-up|4|||
129754939|NCT00714415|467063423|FG000|Overall Study|Lack of Efficacy|1|||
129754940|NCT00714415|467063424|FG001|Overall Study|Lack of Efficacy|0|||
129754941|NCT00714415|467063423|FG000|Overall Study|Death|1|||
129754942|NCT00714415|467063424|FG001|Overall Study|Death|0|||
129754943|NCT01461707|467063427|FG000|Overall Study|Withdrawal by Subject|1|||
129754944|NCT01461707|467063428|FG001|Overall Study|Withdrawal by Subject|0|||
129754945|NCT03461146|467063434|FG000|Overall Study|Adverse Event|2|||
129754946|NCT03461146|467063434|FG000|Overall Study|Physician Decision|1|||
129754947|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
129754948|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
129754949|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
129754950|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
129754951|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
129754952|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
129754953|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
129754954|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
129754955|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
129754956|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
129754957|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
129754958|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
129754959|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
129754960|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
129754961|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
129754962|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
129810374|NCT04457336|467273221|FG005|Period 3: Part B|Study Terminated|10|||
129810375|NCT04457336|467273222|FG006|Period 3: Part B|Study Terminated|13|||
129810376|NCT04457336|467273223|FG007|Period 3: Part B|Study Terminated|0|||
129754963|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
129754964|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
129754965|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
129754966|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
129810377|NCT04457336|467273216|FG000|Period 3: Part B|Withdrawal by Subject|0|||
129810378|NCT04457336|467273217|FG001|Period 3: Part B|Withdrawal by Subject|0|||
129810379|NCT04457336|467273218|FG002|Period 3: Part B|Withdrawal by Subject|0|||
129810380|NCT04457336|467273219|FG003|Period 3: Part B|Withdrawal by Subject|0|||
129810381|NCT04457336|467273220|FG004|Period 3: Part B|Withdrawal by Subject|0|||
129810382|NCT04457336|467273221|FG005|Period 3: Part B|Withdrawal by Subject|1|||
129810383|NCT04457336|467273222|FG006|Period 3: Part B|Withdrawal by Subject|2|||
129810384|NCT04457336|467273223|FG007|Period 3: Part B|Withdrawal by Subject|0|||
129896767|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
129896768|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
129896769|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
129896770|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
129754967|NCT03573323|467063435|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
129754968|NCT03573323|467063436|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
129754969|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
129754970|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
129754971|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
129754972|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
129754973|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
129754974|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
129754975|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
129754976|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
129754977|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
129754978|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
129754979|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
129754980|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
129754981|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
129754982|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
129754983|NCT03573323|467063435|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
129754984|NCT03573323|467063436|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
129754985|NCT01338818|467063444|FG000|Overall Study|Adverse Event|8|||
129754986|NCT01338818|467063444|FG000|Overall Study|Lack of Efficacy|5|||
129754987|NCT01338818|467063444|FG000|Overall Study|no longer require study drug|1|||
129754988|NCT01338818|467063444|FG000|Overall Study|Withdrawal by Subject|11|||
129754989|NCT01338818|467063444|FG000|Overall Study|Lost to Follow-up|4|||
129754990|NCT01338818|467063444|FG000|Overall Study|Administrative problems|3|||
129754991|NCT01338818|467063444|FG000|Overall Study|Protocol Deviation|4|||
129754992|NCT02868554|467063445|FG000|Overall Study|Lost to Follow-up|3|||
129754993|NCT02868554|467063446|FG001|Overall Study|Lost to Follow-up|0|||
129754994|NCT02868554|467063447|FG002|Overall Study|Lost to Follow-up|1|||
129754995|NCT02714569|467063448|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
129754996|NCT02714569|467063449|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
129754997|NCT02714569|467063450|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
129754998|NCT02714569|467063451|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
129754999|NCT02714569|467063452|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
129755000|NCT02714569|467063453|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
129755001|NCT02714569|467063454|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
129755002|NCT02714569|467063455|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
129755003|NCT02714569|467063456|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
129755004|NCT02714569|467063457|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
129755005|NCT02714569|467063458|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
129755006|NCT02714569|467063448|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755007|NCT02714569|467063449|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755008|NCT02714569|467063450|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755009|NCT02714569|467063451|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
129755010|NCT02714569|467063452|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755011|NCT02714569|467063453|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755012|NCT02714569|467063454|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755013|NCT02714569|467063455|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755014|NCT02714569|467063456|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755015|NCT02714569|467063457|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755016|NCT02714569|467063458|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
129755017|NCT02714569|467063448|FG000|Part A Third Intervention|Adverse Event|0|||
129755018|NCT02714569|467063449|FG001|Part A Third Intervention|Adverse Event|0|||
129755019|NCT02714569|467063450|FG002|Part A Third Intervention|Adverse Event|1|||
129755020|NCT02714569|467063451|FG003|Part A Third Intervention|Adverse Event|0|||
129755021|NCT02714569|467063452|FG004|Part A Third Intervention|Adverse Event|0|||
129755022|NCT02714569|467063453|FG005|Part A Third Intervention|Adverse Event|0|||
129755023|NCT02714569|467063454|FG006|Part A Third Intervention|Adverse Event|0|||
129755024|NCT02714569|467063455|FG007|Part A Third Intervention|Adverse Event|0|||
129755025|NCT02714569|467063456|FG008|Part A Third Intervention|Adverse Event|0|||
129755026|NCT02714569|467063457|FG009|Part A Third Intervention|Adverse Event|0|||
129896771|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
129896772|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
129896773|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
129896774|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
129755027|NCT02714569|467063458|FG010|Part A Third Intervention|Adverse Event|0|||
129755028|NCT02714569|467063448|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
129755029|NCT02714569|467063449|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755030|NCT02714569|467063450|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755031|NCT02714569|467063451|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755032|NCT02714569|467063452|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755033|NCT02714569|467063453|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
129755034|NCT02714569|467063454|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755035|NCT02714569|467063455|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755036|NCT02714569|467063456|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755037|NCT02714569|467063457|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755038|NCT02714569|467063458|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
129755039|NCT02714569|467063448|FG000|Part B (Overall)|Lost to Follow-up|0|||
129755040|NCT02714569|467063449|FG001|Part B (Overall)|Lost to Follow-up|0|||
129755041|NCT02714569|467063450|FG002|Part B (Overall)|Lost to Follow-up|0|||
129755042|NCT02714569|467063451|FG003|Part B (Overall)|Lost to Follow-up|0|||
129755043|NCT02714569|467063452|FG004|Part B (Overall)|Lost to Follow-up|0|||
129755044|NCT02714569|467063453|FG005|Part B (Overall)|Lost to Follow-up|0|||
129755045|NCT02714569|467063454|FG006|Part B (Overall)|Lost to Follow-up|1|||
129755046|NCT02714569|467063455|FG007|Part B (Overall)|Lost to Follow-up|0|||
129755047|NCT02714569|467063456|FG008|Part B (Overall)|Lost to Follow-up|0|||
129755048|NCT02714569|467063457|FG009|Part B (Overall)|Lost to Follow-up|0|||
129755049|NCT02714569|467063458|FG010|Part B (Overall)|Lost to Follow-up|0|||
129755050|NCT02714569|467063448|FG000|Part B (Overall)|Withdrawal by Subject|0|||
129755051|NCT02714569|467063449|FG001|Part B (Overall)|Withdrawal by Subject|0|||
129755052|NCT02714569|467063450|FG002|Part B (Overall)|Withdrawal by Subject|0|||
129755053|NCT02714569|467063451|FG003|Part B (Overall)|Withdrawal by Subject|0|||
129755054|NCT02714569|467063452|FG004|Part B (Overall)|Withdrawal by Subject|0|||
129755055|NCT02714569|467063453|FG005|Part B (Overall)|Withdrawal by Subject|0|||
129755056|NCT02714569|467063454|FG006|Part B (Overall)|Withdrawal by Subject|0|||
129755057|NCT02714569|467063455|FG007|Part B (Overall)|Withdrawal by Subject|1|||
129755058|NCT02714569|467063456|FG008|Part B (Overall)|Withdrawal by Subject|0|||
129755059|NCT02714569|467063457|FG009|Part B (Overall)|Withdrawal by Subject|1|||
129755060|NCT02714569|467063458|FG010|Part B (Overall)|Withdrawal by Subject|0|||
129755061|NCT02714569|467063448|FG000|Part B (Overall)|Adverse Event|0|||
129755062|NCT02714569|467063449|FG001|Part B (Overall)|Adverse Event|0|||
129755063|NCT02714569|467063450|FG002|Part B (Overall)|Adverse Event|0|||
129755064|NCT02714569|467063451|FG003|Part B (Overall)|Adverse Event|0|||
129755065|NCT02714569|467063452|FG004|Part B (Overall)|Adverse Event|0|||
129755066|NCT02714569|467063453|FG005|Part B (Overall)|Adverse Event|0|||
129755067|NCT02714569|467063454|FG006|Part B (Overall)|Adverse Event|0|||
129755068|NCT02714569|467063455|FG007|Part B (Overall)|Adverse Event|0|||
129755069|NCT02714569|467063456|FG008|Part B (Overall)|Adverse Event|0|||
129755070|NCT02714569|467063457|FG009|Part B (Overall)|Adverse Event|1|||
129755071|NCT02714569|467063458|FG010|Part B (Overall)|Adverse Event|0|||
129755072|NCT00191308|467063459|FG000|Overall Study|Adverse Event|1|||
129755073|NCT01843023|467063460|FG000|Overall Study|Death|1|||
129755074|NCT01843023|467063461|FG001|Overall Study|Death|0|||
129755075|NCT01843023|467063460|FG000|Overall Study|Lost to Follow-up|24|||
129755076|NCT01843023|467063461|FG001|Overall Study|Lost to Follow-up|29|||
129755077|NCT01843023|467063460|FG000|Overall Study|Withdrawal by Subject|8|||
129755078|NCT01843023|467063461|FG001|Overall Study|Withdrawal by Subject|6|||
129896775|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
129755079|NCT00779025|467063462|FG000|Overall Study|Withdrawal by Subject|1|||
129755080|NCT03305770|467063463|FG000|Overall Study|Physician Decision - prior to dispense|0|||
129755081|NCT03305770|467063464|FG001|Overall Study|Physician Decision - prior to dispense|1|||
129755082|NCT03305770|467063463|FG000|Overall Study|Subject moved|1|||
129755083|NCT03305770|467063464|FG001|Overall Study|Subject moved|0|||
129755084|NCT03472326|467063467|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
129755085|NCT03472326|467063468|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
129755086|NCT03472326|467063469|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
129755087|NCT03472326|467063470|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
129755088|NCT03472326|467063467|FG000|Part 2: Combination Therapy|Pregnancy|0|||
129755089|NCT03472326|467063468|FG001|Part 2: Combination Therapy|Pregnancy|0|||
129755090|NCT03472326|467063469|FG002|Part 2: Combination Therapy|Pregnancy|0|||
129755091|NCT03472326|467063470|FG003|Part 2: Combination Therapy|Pregnancy|1|||
129755092|NCT00700713|467063471|FG000|Overall Study|Protocol Violation|1|||
129755093|NCT00700713|467063472|FG001|Overall Study|Protocol Violation|0|||
129755094|NCT00700713|467063473|FG002|Overall Study|Protocol Violation|1|||
129755095|NCT00700713|467063471|FG000|Overall Study|Withdrawal by Subject|0|||
129755096|NCT00700713|467063472|FG001|Overall Study|Withdrawal by Subject|0|||
129755097|NCT00700713|467063473|FG002|Overall Study|Withdrawal by Subject|1|||
129755098|NCT00550953|467063474|FG000|Overall Study|Adverse Event|4|||
129755099|NCT00550953|467063475|FG001|Overall Study|Adverse Event|3|||
129755100|NCT00550953|467063474|FG000|Overall Study|Not able to visit the site|2|||
129755101|NCT00550953|467063475|FG001|Overall Study|Not able to visit the site|3|||
129755102|NCT04980612|467063476|FG000|Overall Study|Withdrawal by Subject|7|||
129755103|NCT04980612|467063477|FG001|Overall Study|Withdrawal by Subject|5|||
129755104|NCT02446717|467063478|FG000|Overall Study|Adverse Event|0|||
129755105|NCT02446717|467063479|FG001|Overall Study|Adverse Event|0|||
129755106|NCT02446717|467063480|FG002|Overall Study|Adverse Event|1|||
129755107|NCT02446717|467063481|FG003|Overall Study|Adverse Event|0|||
129755108|NCT02446717|467063482|FG004|Overall Study|Adverse Event|0|||
129755109|NCT02446717|467063478|FG000|Overall Study|Lost to Follow-up|0|||
129755110|NCT02446717|467063479|FG001|Overall Study|Lost to Follow-up|1|||
129755111|NCT02446717|467063480|FG002|Overall Study|Lost to Follow-up|1|||
129755112|NCT02446717|467063481|FG003|Overall Study|Lost to Follow-up|0|||
129755113|NCT02446717|467063482|FG004|Overall Study|Lost to Follow-up|1|||
129755114|NCT02446717|467063478|FG000|Overall Study|Withdrew consent|0|||
129755115|NCT02446717|467063479|FG001|Overall Study|Withdrew consent|0|||
129755116|NCT02446717|467063480|FG002|Overall Study|Withdrew consent|0|||
129755117|NCT02446717|467063481|FG003|Overall Study|Withdrew consent|1|||
129755118|NCT02446717|467063482|FG004|Overall Study|Withdrew consent|0|||
129755119|NCT02680665|467063483|FG000|Overall Study|No visit after the first prescription|5|||
129755120|NCT01327599|467063484|FG000|Overall Study|Adverse Event|1|||
129755121|NCT01327599|467063484|FG000|Overall Study|Could Not Attend Visit|1|||
129755122|NCT01327599|467063484|FG000|Overall Study|Withdrawal of Consent|1|||
129755123|NCT05907395|467063487|FG000|Period 1|No longer met eligibility criteria|0|||
129755124|NCT05907395|467063488|FG001|Period 1|No longer met eligibility criteria|1|||
129755125|NCT05907395|467063489|FG002|Period 1|No longer met eligibility criteria|0|||
129755126|NCT05907395|467063490|FG003|Period 1|No longer met eligibility criteria|0|||
129755127|NCT05907395|467063491|FG004|Period 1|No longer met eligibility criteria|0|||
129755128|NCT05907395|467063492|FG005|Period 1|No longer met eligibility criteria|1|||
129755129|NCT05907395|467063493|FG006|Period 1|No longer met eligibility criteria|1|||
129755130|NCT05907395|467063494|FG007|Period 1|No longer met eligibility criteria|0|||
129755131|NCT05907395|467063495|FG008|Period 1|No longer met eligibility criteria|0|||
129755132|NCT05907395|467063496|FG009|Period 1|No longer met eligibility criteria|0|||
129755133|NCT05907395|467063497|FG010|Period 1|No longer met eligibility criteria|0|||
129755134|NCT05907395|467063498|FG011|Period 1|No longer met eligibility criteria|0|||
129755135|NCT05907395|467063487|FG000|Period 2|Adverse Event|0|||
129755136|NCT05907395|467063488|FG001|Period 2|Adverse Event|0|||
129755137|NCT05907395|467063489|FG002|Period 2|Adverse Event|0|||
129755138|NCT05907395|467063490|FG003|Period 2|Adverse Event|1|||
129755139|NCT05907395|467063491|FG004|Period 2|Adverse Event|0|||
129755140|NCT05907395|467063492|FG005|Period 2|Adverse Event|0|||
129755141|NCT05907395|467063493|FG006|Period 2|Adverse Event|0|||
129755142|NCT05907395|467063494|FG007|Period 2|Adverse Event|1|||
129755143|NCT05907395|467063495|FG008|Period 2|Adverse Event|0|||
129755144|NCT05907395|467063496|FG009|Period 2|Adverse Event|0|||
129755145|NCT05907395|467063497|FG010|Period 2|Adverse Event|0|||
129755146|NCT05907395|467063498|FG011|Period 2|Adverse Event|0|||
129755147|NCT05907395|467063487|FG000|Period 2|Personal reason|0|||
129755148|NCT05907395|467063488|FG001|Period 2|Personal reason|0|||
129755149|NCT05907395|467063489|FG002|Period 2|Personal reason|0|||
129755150|NCT05907395|467063490|FG003|Period 2|Personal reason|0|||
129755151|NCT05907395|467063491|FG004|Period 2|Personal reason|0|||
129755152|NCT05907395|467063492|FG005|Period 2|Personal reason|0|||
129755153|NCT05907395|467063493|FG006|Period 2|Personal reason|0|||
129755154|NCT05907395|467063494|FG007|Period 2|Personal reason|0|||
129755155|NCT05907395|467063495|FG008|Period 2|Personal reason|0|||
129755156|NCT05907395|467063496|FG009|Period 2|Personal reason|1|||
129755157|NCT05907395|467063497|FG010|Period 2|Personal reason|0|||
129755158|NCT05907395|467063498|FG011|Period 2|Personal reason|0|||
129755159|NCT05907395|467063487|FG000|Period 3|Adverse Event|0|||
129755160|NCT05907395|467063488|FG001|Period 3|Adverse Event|0|||
129755161|NCT05907395|467063489|FG002|Period 3|Adverse Event|0|||
129755162|NCT05907395|467063490|FG003|Period 3|Adverse Event|0|||
129755163|NCT05907395|467063491|FG004|Period 3|Adverse Event|1|||
129755164|NCT05907395|467063492|FG005|Period 3|Adverse Event|0|||
129755165|NCT05907395|467063493|FG006|Period 3|Adverse Event|0|||
129755166|NCT05907395|467063494|FG007|Period 3|Adverse Event|0|||
129755167|NCT05907395|467063495|FG008|Period 3|Adverse Event|0|||
129755168|NCT05907395|467063496|FG009|Period 3|Adverse Event|0|||
129755169|NCT05907395|467063497|FG010|Period 3|Adverse Event|0|||
129755170|NCT05907395|467063498|FG011|Period 3|Adverse Event|0|||
129755171|NCT00434109|467063499|FG000|Overall Study|Physician Decision|9|||
129755172|NCT00434109|467063499|FG000|Overall Study|Adverse Event|5|||
129755173|NCT00434109|467063499|FG000|Overall Study|Protocol Violation|1|||
129755174|NCT00434109|467063499|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
129755175|NCT01797263|467065677|FG000|Overall Study|Withdrawal by Subject|21|||
129755176|NCT01797263|467065678|FG001|Overall Study|Withdrawal by Subject|25|||
129755177|NCT01797263|467065677|FG000|Overall Study|Death|1|||
129755178|NCT01797263|467065678|FG001|Overall Study|Death|0|||
129755179|NCT01797263|467065677|FG000|Overall Study|Lost to Follow-up|15|||
129755180|NCT01797263|467065678|FG001|Overall Study|Lost to Follow-up|15|||
129755181|NCT01172535|467065679|FG000|Overall Study|Death|3|||
129755182|NCT01172535|467065679|FG000|Overall Study|Withdrawal by Subject|2|||
129755183|NCT01172535|467065679|FG000|Overall Study|Lost to Follow-up|1|||
129755184|NCT01172535|467065679|FG000|Overall Study|Ineligible at study entry|1|||
129755185|NCT01172535|467065679|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
129755186|NCT00988598|467065680|FG000|Overall Study|Withdrawal by Subject|2|||
129755187|NCT00988598|467065681|FG001|Overall Study|Withdrawal by Subject|0|||
129755188|NCT01450761|467065686|FG000|Randomization|Subject no longer meets study criteria|1|||
129755189|NCT01450761|467065687|FG001|Randomization|Subject no longer meets study criteria|2|||
129755190|NCT01450761|467065686|FG000|Randomization|Withdrawal by Subject|2|||
129755191|NCT01450761|467065687|FG001|Randomization|Withdrawal by Subject|0|||
129755192|NCT01450761|467065686|FG000|Randomization|Disease progression|0|||
129755193|NCT01450761|467065687|FG001|Randomization|Disease progression|2|||
129755194|NCT01450761|467065686|FG000|Randomization|Adverse Event unrelated to study drug|1|||
129755195|NCT01450761|467065687|FG001|Randomization|Adverse Event unrelated to study drug|0|||
129755196|NCT01450761|467065686|FG000|Randomization|Other|0|||
129755197|NCT01450761|467065687|FG001|Randomization|Other|1|||
129755198|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Disease progression|33|||
129755199|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Disease progression|32|||
129755200|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
129755201|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
129755202|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
129755203|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
129755204|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
129755205|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
129755206|NCT01450761|467065686|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
129755207|NCT01450761|467065687|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
129755208|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Death|3|||
129755209|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Death|3|||
129755210|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Other|2|||
129755211|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Other|2|||
129755212|NCT01450761|467065686|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
129755213|NCT01450761|467065687|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
129755214|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
129755215|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
129755216|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
129755217|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
129755218|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
129755219|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
129755220|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
129755221|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
129755222|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
129755223|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
129810385|NCT04457336|467273216|FG000|Period 4: Part C|Study Terminated|0|||
129810386|NCT04457336|467273217|FG001|Period 4: Part C|Study Terminated|0|||
129810387|NCT04457336|467273218|FG002|Period 4: Part C|Study Terminated|0|||
129810388|NCT04457336|467273219|FG003|Period 4: Part C|Study Terminated|0|||
129810389|NCT04457336|467273220|FG004|Period 4: Part C|Study Terminated|0|||
129755224|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Death|5|||
129755225|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Death|6|||
129755226|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
129755227|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
129755228|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
129755229|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
129810390|NCT04457336|467273221|FG005|Period 4: Part C|Study Terminated|0|||
129755230|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
129755231|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
129810391|NCT04457336|467273222|FG006|Period 4: Part C|Study Terminated|0|||
129810392|NCT04457336|467273223|FG007|Period 4: Part C|Study Terminated|30|||
129810393|NCT04457336|467273216|FG000|Period 4: Part C|Adverse Event|0|||
129810394|NCT04457336|467273217|FG001|Period 4: Part C|Adverse Event|0|||
129810395|NCT04457336|467273218|FG002|Period 4: Part C|Adverse Event|0|||
129810396|NCT04457336|467273219|FG003|Period 4: Part C|Adverse Event|0|||
129810397|NCT04457336|467273220|FG004|Period 4: Part C|Adverse Event|0|||
129810398|NCT04457336|467273221|FG005|Period 4: Part C|Adverse Event|0|||
129810399|NCT04457336|467273222|FG006|Period 4: Part C|Adverse Event|0|||
129810400|NCT04457336|467273223|FG007|Period 4: Part C|Adverse Event|2|||
129810401|NCT04457336|467273216|FG000|Period 4: Part C|Site Terminated|0|||
129810402|NCT04457336|467273217|FG001|Period 4: Part C|Site Terminated|0|||
129810403|NCT04457336|467273218|FG002|Period 4: Part C|Site Terminated|0|||
129810404|NCT04457336|467273219|FG003|Period 4: Part C|Site Terminated|0|||
129810405|NCT04457336|467273220|FG004|Period 4: Part C|Site Terminated|0|||
129810406|NCT04457336|467273221|FG005|Period 4: Part C|Site Terminated|0|||
129810407|NCT04457336|467273222|FG006|Period 4: Part C|Site Terminated|0|||
129810408|NCT04457336|467273223|FG007|Period 4: Part C|Site Terminated|1|||
129810409|NCT04457336|467273216|FG000|Period 4: Part C|Other|0|||
129810410|NCT04457336|467273217|FG001|Period 4: Part C|Other|0|||
129810411|NCT04457336|467273218|FG002|Period 4: Part C|Other|0|||
129810412|NCT04457336|467273219|FG003|Period 4: Part C|Other|0|||
129810413|NCT04457336|467273220|FG004|Period 4: Part C|Other|0|||
129810414|NCT04457336|467273221|FG005|Period 4: Part C|Other|0|||
129810415|NCT04457336|467273222|FG006|Period 4: Part C|Other|0|||
129810416|NCT04457336|467273223|FG007|Period 4: Part C|Other|2|||
129810417|NCT04457336|467273216|FG000|Period 4: Part C|Withdrawal by Subject|0|||
129810418|NCT04457336|467273217|FG001|Period 4: Part C|Withdrawal by Subject|0|||
129810419|NCT04457336|467273218|FG002|Period 4: Part C|Withdrawal by Subject|0|||
129810420|NCT04457336|467273219|FG003|Period 4: Part C|Withdrawal by Subject|0|||
129810421|NCT04457336|467273220|FG004|Period 4: Part C|Withdrawal by Subject|0|||
129810422|NCT04457336|467273221|FG005|Period 4: Part C|Withdrawal by Subject|0|||
129755232|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
129755233|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
129755234|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
129755235|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
129755236|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
129755237|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
129755238|NCT01450761|467065686|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
129755239|NCT01450761|467065687|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
129755240|NCT01818596|467065698|FG000|Overall Study|Enrolled but Not Treated|4|||
129755241|NCT01818596|467065699|FG001|Overall Study|Enrolled but Not Treated|0|||
129755242|NCT01818596|467065698|FG000|Overall Study|Adverse Event|7|||
129755243|NCT01818596|467065699|FG001|Overall Study|Adverse Event|0|||
129755244|NCT01818596|467065698|FG000|Overall Study|Death|3|||
129755245|NCT01818596|467065699|FG001|Overall Study|Death|0|||
129755246|NCT01818596|467065698|FG000|Overall Study|Investigator's Discretion|4|||
129755247|NCT01818596|467065699|FG001|Overall Study|Investigator's Discretion|0|||
129755248|NCT01818596|467065698|FG000|Overall Study|Protocol Violation|1|||
129755249|NCT01818596|467065699|FG001|Overall Study|Protocol Violation|0|||
129755250|NCT01818596|467065698|FG000|Overall Study|Withdrew Consent|5|||
129755251|NCT01818596|467065699|FG001|Overall Study|Withdrew Consent|0|||
129755252|NCT01818596|467065698|FG000|Overall Study|Lost to Follow-up|7|||
129755253|NCT01818596|467065699|FG001|Overall Study|Lost to Follow-up|0|||
129755254|NCT03801174|467065702|FG000|Overall Study|Withdrawal by Subject|14|||
129755255|NCT03801174|467065703|FG001|Overall Study|Withdrawal by Subject|15|||
129755256|NCT03801174|467065702|FG000|Overall Study|Death|1|||
129755257|NCT03801174|467065703|FG001|Overall Study|Death|0|||
129810423|NCT04457336|467273222|FG006|Period 4: Part C|Withdrawal by Subject|0|||
129896776|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
129755258|NCT03801174|467065702|FG000|Overall Study|Pregnancy|2|||
129755259|NCT03801174|467065703|FG001|Overall Study|Pregnancy|2|||
129755260|NCT03801174|467065702|FG000|Overall Study|Lost to Follow-up|19|||
129755261|NCT03801174|467065703|FG001|Overall Study|Lost to Follow-up|10|||
129755262|NCT03801174|467065702|FG000|Overall Study|Other|4|||
129755263|NCT03801174|467065703|FG001|Overall Study|Other|3|||
129810424|NCT04457336|467273223|FG007|Period 4: Part C|Withdrawal by Subject|3|||
129810425|NCT03330288|467273230|FG000|Overall Study|Other reason|1|||
129810426|NCT03330288|467273231|FG001|Overall Study|Other reason|1|||
129810427|NCT03330288|467273230|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
129810428|NCT03330288|467273231|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
129810429|NCT03330288|467273230|FG000|Overall Study|Adverse Event|1|||
129755264|NCT03801174|467065702|FG000|Overall Study|Lack of Efficacy|4|||
129755265|NCT03801174|467065703|FG001|Overall Study|Lack of Efficacy|0|||
129755266|NCT03801174|467065702|FG000|Overall Study|Unwilling to complete activities|5|||
129755267|NCT03801174|467065703|FG001|Overall Study|Unwilling to complete activities|6|||
129755268|NCT03801174|467065702|FG000|Overall Study|Moved out of area|3|||
129755269|NCT03801174|467065703|FG001|Overall Study|Moved out of area|0|||
129810430|NCT03330288|467273231|FG001|Overall Study|Adverse Event|0|||
129810431|NCT03330288|467273230|FG000|Overall Study|Withdrawal by Subject|1|||
129810432|NCT03330288|467273231|FG001|Overall Study|Withdrawal by Subject|0|||
129810433|NCT03330288|467273230|FG000|Overall Study|Lost to Follow-up|26|||
129810434|NCT03330288|467273231|FG001|Overall Study|Lost to Follow-up|7|||
129810435|NCT02693119|467273235|FG000|Open-Label Period|Withdrawal by Subject|0|||
129810436|NCT02693119|467273236|FG001|Open-Label Period|Withdrawal by Subject|1|||
129810437|NCT01719783|467273239|FG000|Dose 2|Physician Decision|1|||
129810438|NCT01719783|467273240|FG001|Dose 2|Physician Decision|0|||
129810439|NCT01350492|467273241|FG000|Intervention|Lost to Follow-up|2|||
129810440|NCT01350492|467273242|FG001|Intervention|Lost to Follow-up|5|||
129810441|NCT01350492|467273241|FG000|Intervention|Withdrawal by Subject|3|||
129810442|NCT01350492|467273242|FG001|Intervention|Withdrawal by Subject|1|||
129810443|NCT01350492|467273241|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
129810444|NCT01350492|467273242|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
129810445|NCT01350492|467273241|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
129810446|NCT01350492|467273242|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
129810447|NCT00939640|467273243|FG000|Overall Study|Physician Decision|1|||
129810448|NCT00005044|467273248|FG000|Overall Study|Protocol Violation|37|||
129810449|NCT00005044|467273249|FG001|Overall Study|Protocol Violation|46|||
129810450|NCT00005044|467273248|FG000|Overall Study|Withdrawal by Subject|1|||
129810451|NCT00005044|467273249|FG001|Overall Study|Withdrawal by Subject|5|||
129810452|NCT00005044|467273248|FG000|Overall Study|No protocol treatment|0|||
129810453|NCT00005044|467273249|FG001|Overall Study|No protocol treatment|1|||
129810454|NCT03988088|467273250|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
129810455|NCT03988088|467273251|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
129810456|NCT03988088|467273252|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
129810457|NCT03988088|467273253|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
129810458|NCT03988088|467273250|FG000|Open-Label Addendum|Lost to Follow-up|0|||
129810459|NCT03988088|467273251|FG001|Open-Label Addendum|Lost to Follow-up|0|||
129810460|NCT03988088|467273252|FG002|Open-Label Addendum|Lost to Follow-up|1|||
129810461|NCT03988088|467273253|FG003|Open-Label Addendum|Lost to Follow-up|0|||
129810462|NCT04431453|467273254|FG000|Overall Study|Withdrew Consent|0|||
129810463|NCT04431453|467273255|FG001|Overall Study|Withdrew Consent|1|||
129810464|NCT04431453|467273256|FG002|Overall Study|Withdrew Consent|0|||
129810465|NCT04431453|467273257|FG003|Overall Study|Withdrew Consent|2|||
129810466|NCT04431453|467273258|FG004|Overall Study|Withdrew Consent|0|||
129810467|NCT04431453|467273259|FG005|Overall Study|Withdrew Consent|0|||
129810468|NCT04431453|467273260|FG006|Overall Study|Withdrew Consent|0|||
129810469|NCT04431453|467273261|FG007|Overall Study|Withdrew Consent|0|||
129810470|NCT04431453|467273254|FG000|Overall Study|Death|1|||
129810471|NCT04431453|467273255|FG001|Overall Study|Death|0|||
129810472|NCT04431453|467273256|FG002|Overall Study|Death|0|||
129810473|NCT04431453|467273257|FG003|Overall Study|Death|0|||
129810474|NCT04431453|467273258|FG004|Overall Study|Death|0|||
129810475|NCT04431453|467273259|FG005|Overall Study|Death|0|||
129810476|NCT04431453|467273260|FG006|Overall Study|Death|0|||
129810477|NCT04431453|467273261|FG007|Overall Study|Death|1|||
129810478|NCT04431453|467273254|FG000|Overall Study|Lost to Follow-up|0|||
129810479|NCT04431453|467273255|FG001|Overall Study|Lost to Follow-up|0|||
129810480|NCT04431453|467273256|FG002|Overall Study|Lost to Follow-up|1|||
129810481|NCT04431453|467273257|FG003|Overall Study|Lost to Follow-up|1|||
129810482|NCT04431453|467273258|FG004|Overall Study|Lost to Follow-up|0|||
129810483|NCT04431453|467273259|FG005|Overall Study|Lost to Follow-up|0|||
129810484|NCT04431453|467273260|FG006|Overall Study|Lost to Follow-up|0|||
129810485|NCT04431453|467273261|FG007|Overall Study|Lost to Follow-up|0|||
129896777|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
129896778|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
129896779|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Pain|0|||
129896780|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Pain|0|||
129896781|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Pain|0|||
129896782|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Pain|1|||
129896783|NCT01107626|467582122|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
129810486|NCT04431453|467273254|FG000|Overall Study|Enrolled but Never Treated|0|||
129810487|NCT04431453|467273255|FG001|Overall Study|Enrolled but Never Treated|0|||
129810488|NCT04431453|467273256|FG002|Overall Study|Enrolled but Never Treated|0|||
129810489|NCT04431453|467273257|FG003|Overall Study|Enrolled but Never Treated|0|||
129810490|NCT04431453|467273258|FG004|Overall Study|Enrolled but Never Treated|1|||
129810491|NCT04431453|467273259|FG005|Overall Study|Enrolled but Never Treated|0|||
129810492|NCT04431453|467273260|FG006|Overall Study|Enrolled but Never Treated|0|||
129810493|NCT04431453|467273261|FG007|Overall Study|Enrolled but Never Treated|0|||
129896784|NCT01107626|467582123|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
129810494|NCT01768286|467273263|FG000|Overall Study|Randomized But Not Treated|0|||
129810495|NCT01768286|467273264|FG001|Overall Study|Randomized But Not Treated|0|||
129810496|NCT01768286|467273265|FG002|Overall Study|Randomized But Not Treated|1|||
129810497|NCT01768286|467273266|FG003|Overall Study|Randomized But Not Treated|0|||
129810498|NCT01768286|467273263|FG000|Overall Study|Lack of Efficacy|7|||
129810499|NCT01768286|467273264|FG001|Overall Study|Lack of Efficacy|4|||
129810500|NCT01768286|467273265|FG002|Overall Study|Lack of Efficacy|0|||
129810501|NCT01768286|467273266|FG003|Overall Study|Lack of Efficacy|1|||
129810502|NCT01768286|467273263|FG000|Overall Study|Withdrew Consent|0|||
129810503|NCT01768286|467273264|FG001|Overall Study|Withdrew Consent|0|||
129810504|NCT01768286|467273265|FG002|Overall Study|Withdrew Consent|1|||
129810505|NCT01768286|467273266|FG003|Overall Study|Withdrew Consent|0|||
129810506|NCT02083965|467273267|FG000|Treatment Period|Other|1|||
129810507|NCT02083965|467273268|FG001|Treatment Period|Other|0|||
129810508|NCT04502433|467273271|FG000|Overall Study|Death|2|||
129810509|NCT04502433|467273272|FG001|Overall Study|Death|4|||
129810510|NCT04502433|467273271|FG000|Overall Study|Lost to Follow-up|1|||
129810511|NCT04502433|467273272|FG001|Overall Study|Lost to Follow-up|0|||
129810512|NCT04502433|467273271|FG000|Overall Study|Physician Decision|0|||
129810513|NCT04502433|467273272|FG001|Overall Study|Physician Decision|1|||
129810514|NCT02935842|467273273|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
129810515|NCT02935842|467273274|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
129810516|NCT02935842|467273275|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
129810517|NCT02935842|467273276|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
129810518|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
129810519|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
129810520|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
129810521|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
129810522|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
129810523|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
129810524|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
129810525|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
129810526|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
129810527|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
129810528|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
129810529|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
129810530|NCT02935842|467273273|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
129810531|NCT02935842|467273274|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
129810532|NCT02935842|467273275|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
129810533|NCT02935842|467273276|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
129810534|NCT00911547|467273277|FG000|Overall Study|Adverse Event|8|||
129810535|NCT00911547|467273278|FG001|Overall Study|Adverse Event|27|||
129810536|NCT00911547|467273279|FG002|Overall Study|Adverse Event|11|||
129810537|NCT00911547|467273280|FG003|Overall Study|Adverse Event|6|||
129810538|NCT00911547|467273277|FG000|Overall Study|Lost to Follow-up|0|||
129896785|NCT01107626|467582124|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
129896786|NCT01107626|467582125|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
129896787|NCT04353037|467582126|FG000|Overall Study|Lost to Follow-up|0|||
129896788|NCT04353037|467582127|FG001|Overall Study|Lost to Follow-up|1|||
129896789|NCT04353037|467582128|FG002|Overall Study|Lost to Follow-up|2|||
129896790|NCT04353037|467582129|FG003|Overall Study|Lost to Follow-up|3|||
129896791|NCT04353037|467582126|FG000|Overall Study|Withdrawal by Subject|0|||
129810539|NCT00911547|467273278|FG001|Overall Study|Lost to Follow-up|0|||
129810540|NCT00911547|467273279|FG002|Overall Study|Lost to Follow-up|2|||
129810541|NCT00911547|467273280|FG003|Overall Study|Lost to Follow-up|1|||
129810542|NCT00911547|467273277|FG000|Overall Study|Protocol Violation|0|||
129810543|NCT00911547|467273278|FG001|Overall Study|Protocol Violation|5|||
129810544|NCT00911547|467273279|FG002|Overall Study|Protocol Violation|5|||
129810545|NCT00911547|467273280|FG003|Overall Study|Protocol Violation|1|||
129896792|NCT04353037|467582127|FG001|Overall Study|Withdrawal by Subject|2|||
129896793|NCT04353037|467582128|FG002|Overall Study|Withdrawal by Subject|3|||
129896794|NCT04353037|467582129|FG003|Overall Study|Withdrawal by Subject|5|||
129810546|NCT00911547|467273277|FG000|Overall Study|Withdrawal by Subject|3|||
129810547|NCT00911547|467273278|FG001|Overall Study|Withdrawal by Subject|10|||
129810548|NCT00911547|467273279|FG002|Overall Study|Withdrawal by Subject|4|||
129810549|NCT00911547|467273280|FG003|Overall Study|Withdrawal by Subject|8|||
129810550|NCT01201785|467273281|FG000|Overall Study|Lost to Follow-up|16|||
129896795|NCT04353037|467582126|FG000|Overall Study|Adverse Event|0|||
129896796|NCT04353037|467582127|FG001|Overall Study|Adverse Event|0|||
129896797|NCT04353037|467582128|FG002|Overall Study|Adverse Event|2|||
129896798|NCT04353037|467582129|FG003|Overall Study|Adverse Event|0|||
129810551|NCT04545385|467273284|FG000|Overall Study|Withdrawal by Subject|2|||
129896799|NCT04353037|467582126|FG000|Overall Study|Exposure Change|0|||
129896800|NCT04353037|467582127|FG001|Overall Study|Exposure Change|0|||
129810552|NCT04545385|467273285|FG001|Overall Study|Withdrawal by Subject|0|||
129810553|NCT04545385|467273284|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
129810554|NCT04545385|467273285|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
129755270|NCT00337207|467065706|FG000|Overall Study|Withdrawal by Subject|3|||
129755271|NCT00837213|467065716|FG000|Overall Study|Lost to Follow-up|3|||
129755272|NCT00837213|467065717|FG001|Overall Study|Lost to Follow-up|2|||
129755273|NCT00837213|467065716|FG000|Overall Study|Withdrawal by Subject|2|||
129755274|NCT00837213|467065717|FG001|Overall Study|Withdrawal by Subject|2|||
129755275|NCT00837213|467065716|FG000|Overall Study|not stated|1|||
129755276|NCT00837213|467065717|FG001|Overall Study|not stated|1|||
129755277|NCT02698826|467065719|FG000|Overall Study|Death|13|||
129755278|NCT02698826|467065719|FG000|Overall Study|Adverse Event|1|||
129755279|NCT02915263|467065720|FG000|Overall Study|Covid|3|||
129755280|NCT02915263|467065721|FG001|Overall Study|Covid|2|||
129755281|NCT01879683|467065725|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
129755282|NCT04317040|467065726|FG000|Overall Study|Lost to Follow-up|2|||
129755283|NCT04317040|467065727|FG001|Overall Study|Lost to Follow-up|0|||
129755284|NCT04317040|467065726|FG000|Overall Study|Death|16|||
129755285|NCT04317040|467065727|FG001|Overall Study|Death|18|||
129755286|NCT04317040|467065726|FG000|Overall Study|Withdrawal by Subject|0|||
129755287|NCT04317040|467065727|FG001|Overall Study|Withdrawal by Subject|1|||
129755288|NCT04317040|467065726|FG000|Overall Study|Incomplete assessments|0|||
129755289|NCT04317040|467065727|FG001|Overall Study|Incomplete assessments|1|||
129755290|NCT01177007|467065730|FG000|Overall Study|Lost to Follow-up|2|||
129755291|NCT01177007|467065730|FG000|Overall Study|Death|4|||
129755292|NCT01177007|467065730|FG000|Overall Study|Entered hospice care|5|||
129755293|NCT01177007|467065730|FG000|Overall Study|Required additional Y90 treatment|6|||
129755294|NCT01177007|467065730|FG000|Overall Study|Change in treatment modality|21|||
129755295|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Progressive disease|50|||
129755296|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Progressive disease|110|||
129755297|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Progressive disease|0|||
129755298|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Progressive disease|0|||
129755299|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
129755300|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
129755301|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129755302|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129755303|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Adverse Event|7|||
129755304|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Adverse Event|7|||
129755305|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129755306|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Adverse Event|0|||
129755307|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Other|1|||
129755308|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Other|3|||
129755309|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Other|0|||
129755310|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Other|0|||
129755311|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Physician Decision|6|||
129755312|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Physician Decision|3|||
129755313|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Physician Decision|0|||
129755314|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Physician Decision|0|||
129755315|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Death|1|||
129755316|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Death|1|||
129755317|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Death|0|||
129755318|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Death|0|||
129755319|NCT01695135|467065735|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
129755320|NCT01695135|467065736|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
129755321|NCT01695135|467065737|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
129755322|NCT01695135|467065738|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
129755323|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
129755324|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
129755325|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
129755326|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
129810555|NCT04545385|467273284|FG000|Overall Study|Study termination|10|||
129810556|NCT04545385|467273285|FG001|Overall Study|Study termination|10|||
129810557|NCT04545385|467273284|FG000|Overall Study|Sponsor decision|2|||
129810558|NCT04545385|467273285|FG001|Overall Study|Sponsor decision|2|||
129810559|NCT04545385|467273284|FG000|Overall Study|Other than specified|1|||
129810560|NCT04545385|467273285|FG001|Overall Study|Other than specified|0|||
129755327|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
129755328|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
129755329|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
129755330|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
129755331|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
129755332|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
129755333|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
129810561|NCT00915278|467273286|FG000|Overall Study|Death|1|||
129810562|NCT00915278|467273287|FG001|Overall Study|Death|0|||
129810563|NCT00915278|467273288|FG002|Overall Study|Death|0|||
129810564|NCT00915278|467273289|FG003|Overall Study|Death|0|||
129810565|NCT00915278|467273290|FG004|Overall Study|Death|0|||
129810566|NCT00915278|467273291|FG005|Overall Study|Death|0|||
129810567|NCT00915278|467273286|FG000|Overall Study|Lost to Follow-up|0|||
129810568|NCT00915278|467273287|FG001|Overall Study|Lost to Follow-up|1|||
129810569|NCT00915278|467273288|FG002|Overall Study|Lost to Follow-up|0|||
129810570|NCT00915278|467273289|FG003|Overall Study|Lost to Follow-up|0|||
129810571|NCT00915278|467273290|FG004|Overall Study|Lost to Follow-up|0|||
129810572|NCT00915278|467273291|FG005|Overall Study|Lost to Follow-up|0|||
129810573|NCT00915278|467273286|FG000|Overall Study|Withdrawal by Subject|0|||
129810574|NCT00915278|467273287|FG001|Overall Study|Withdrawal by Subject|1|||
129810575|NCT00915278|467273288|FG002|Overall Study|Withdrawal by Subject|0|||
129810576|NCT00915278|467273289|FG003|Overall Study|Withdrawal by Subject|0|||
129810577|NCT00915278|467273290|FG004|Overall Study|Withdrawal by Subject|1|||
129810578|NCT00915278|467273291|FG005|Overall Study|Withdrawal by Subject|4|||
129810579|NCT00915278|467273286|FG000|Overall Study|Adverse Event|4|||
129810580|NCT00915278|467273287|FG001|Overall Study|Adverse Event|1|||
129810581|NCT00915278|467273288|FG002|Overall Study|Adverse Event|0|||
129896801|NCT04353037|467582128|FG002|Overall Study|Exposure Change|0|||
129896802|NCT04353037|467582129|FG003|Overall Study|Exposure Change|2|||
129896803|NCT03710564|467582130|FG000|Overall Study|Study Terminated by Sponsor|104|||
129755334|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
129755335|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Other|0|||
129755336|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Other|0|||
129755337|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Other|4|||
129755338|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Other|7|||
129755339|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
129755340|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
129755341|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
129755342|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
129755343|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Death|0|||
129755344|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Death|0|||
129755345|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Death|2|||
129755346|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Death|7|||
129755347|NCT01695135|467065735|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
129755348|NCT01695135|467065736|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
129755349|NCT01695135|467065737|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
129755350|NCT01695135|467065738|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
129755351|NCT00684996|467065739|FG000|Overall Study|Adverse Event|1|||
129755352|NCT00684996|467065739|FG000|Overall Study|Refusal unrelated to adverse event|1|||
129755353|NCT00684996|467065739|FG000|Overall Study|Progression/relapse|2|||
129755354|NCT00684996|467065739|FG000|Overall Study|Other reasons not protocol specified|1|||
129755355|NCT03030417|467065742|FG000|Dose Expansion|Disease progression before treatment|0|||
129755356|NCT03030417|467065743|FG001|Dose Expansion|Disease progression before treatment|0|||
129755357|NCT03030417|467065744|FG002|Dose Expansion|Disease progression before treatment|0|||
129755358|NCT03030417|467065745|FG003|Dose Expansion|Disease progression before treatment|0|||
129755359|NCT03030417|467065746|FG004|Dose Expansion|Disease progression before treatment|0|||
129755360|NCT03030417|467065747|FG005|Dose Expansion|Disease progression before treatment|0|||
129755361|NCT03030417|467065748|FG006|Dose Expansion|Disease progression before treatment|0|||
129755362|NCT03030417|467065749|FG007|Dose Expansion|Disease progression before treatment|0|||
129755363|NCT03030417|467065750|FG008|Dose Expansion|Disease progression before treatment|0|||
129755364|NCT03030417|467065751|FG009|Dose Expansion|Disease progression before treatment|0|||
129755365|NCT03030417|467065752|FG010|Dose Expansion|Disease progression before treatment|0|||
129755366|NCT03030417|467065753|FG011|Dose Expansion|Disease progression before treatment|0|||
129755367|NCT03030417|467065754|FG012|Dose Expansion|Disease progression before treatment|1|||
129755368|NCT01076959|467065755|FG000|Overall Study|Adverse Event|767|||
129755369|NCT01076959|467065755|FG000|Overall Study|Lack of Efficacy|849|||
129755370|NCT01076959|467065755|FG000|Overall Study|Non-compliance|274|||
129755371|NCT01076959|467065755|FG000|Overall Study|Lost to Follow-up|241|||
129755372|NCT01076959|467065755|FG000|Overall Study|Other|119|||
129755373|NCT01078441|467065756|FG000|Overall Study|Withdrawal by Subject|1|||
129755374|NCT02175017|467065757|FG000|Overall Study|Did not receive the investigational product|1|||
129755375|NCT02175017|467065758|FG001|Overall Study|Did not receive the investigational product|2|||
129755376|NCT02175017|467065757|FG000|Overall Study|Withdrawal by Subject|6|||
129810582|NCT00915278|467273289|FG003|Overall Study|Adverse Event|0|||
129810583|NCT00915278|467273290|FG004|Overall Study|Adverse Event|0|||
129896804|NCT03710564|467582131|FG001|Overall Study|Study Terminated by Sponsor|55|||
129755377|NCT02175017|467065758|FG001|Overall Study|Withdrawal by Subject|3|||
129810584|NCT00915278|467273291|FG005|Overall Study|Adverse Event|0|||
129810585|NCT00915278|467273286|FG000|Overall Study|Progressive disease/clinical progression|0|||
129810586|NCT00915278|467273287|FG001|Overall Study|Progressive disease/clinical progression|0|||
129810587|NCT00915278|467273288|FG002|Overall Study|Progressive disease/clinical progression|0|||
129810588|NCT00915278|467273289|FG003|Overall Study|Progressive disease/clinical progression|3|||
129810589|NCT00915278|467273290|FG004|Overall Study|Progressive disease/clinical progression|1|||
129810590|NCT00915278|467273291|FG005|Overall Study|Progressive disease/clinical progression|2|||
129810591|NCT00915278|467273286|FG000|Overall Study|Infusion related AEs|0|||
129810592|NCT00915278|467273287|FG001|Overall Study|Infusion related AEs|0|||
129810593|NCT00915278|467273288|FG002|Overall Study|Infusion related AEs|0|||
129810594|NCT00915278|467273289|FG003|Overall Study|Infusion related AEs|0|||
129810595|NCT00915278|467273290|FG004|Overall Study|Infusion related AEs|0|||
129810596|NCT00915278|467273291|FG005|Overall Study|Infusion related AEs|2|||
129810597|NCT00915278|467273286|FG000|Overall Study|Admission to hospice|0|||
129810598|NCT00915278|467273287|FG001|Overall Study|Admission to hospice|0|||
129810599|NCT00915278|467273288|FG002|Overall Study|Admission to hospice|1|||
129810600|NCT00915278|467273289|FG003|Overall Study|Admission to hospice|0|||
129810601|NCT00915278|467273290|FG004|Overall Study|Admission to hospice|0|||
129810602|NCT00915278|467273291|FG005|Overall Study|Admission to hospice|0|||
129810603|NCT02151110|467273292|FG000|Overall Study|Withdrawal by Subject|0|||
129810604|NCT02151110|467273293|FG001|Overall Study|Withdrawal by Subject|0|||
129810605|NCT02151110|467273294|FG002|Overall Study|Withdrawal by Subject|0|||
129810606|NCT02151110|467273295|FG003|Overall Study|Withdrawal by Subject|0|||
129810607|NCT02151110|467273296|FG004|Overall Study|Withdrawal by Subject|0|||
129810608|NCT02151110|467273297|FG005|Overall Study|Withdrawal by Subject|0|||
129810609|NCT02151110|467273298|FG006|Overall Study|Withdrawal by Subject|0|||
129810610|NCT02151110|467273299|FG007|Overall Study|Withdrawal by Subject|1|||
129810611|NCT02151110|467273292|FG000|Overall Study|Lost to Follow-up|0|||
129810612|NCT02151110|467273293|FG001|Overall Study|Lost to Follow-up|0|||
129810613|NCT02151110|467273294|FG002|Overall Study|Lost to Follow-up|0|||
129810614|NCT02151110|467273295|FG003|Overall Study|Lost to Follow-up|0|||
129810615|NCT02151110|467273296|FG004|Overall Study|Lost to Follow-up|0|||
129810616|NCT02151110|467273297|FG005|Overall Study|Lost to Follow-up|0|||
129810617|NCT02151110|467273298|FG006|Overall Study|Lost to Follow-up|0|||
129810618|NCT02151110|467273299|FG007|Overall Study|Lost to Follow-up|2|||
129810619|NCT02369016|467273300|FG000|Overall Study|AE associated with clinical disease progression|2|||
129810620|NCT02369016|467273301|FG001|Overall Study|AE associated with clinical disease progression|1|||
129810621|NCT02369016|467273300|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
129810622|NCT02369016|467273301|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
129810623|NCT02369016|467273300|FG000|Overall Study|Progressive disease - clinical progression|1|||
129810624|NCT02369016|467273301|FG001|Overall Study|Progressive disease - clinical progression|4|||
129810625|NCT02369016|467273300|FG000|Overall Study|withdrawal by patient|4|||
129810626|NCT02369016|467273301|FG001|Overall Study|withdrawal by patient|0|||
129810627|NCT02369016|467273300|FG000|Overall Study|Progressive disease - radiological progression|6|||
129810628|NCT02369016|467273301|FG001|Overall Study|Progressive disease - radiological progression|2|||
129810629|NCT02229383|467273302|FG000|Overall Study|Adverse Event|7|||
129810630|NCT02229383|467273303|FG001|Overall Study|Adverse Event|4|||
129810631|NCT02229383|467273302|FG000|Overall Study|Death|0|||
129810632|NCT02229383|467273303|FG001|Overall Study|Death|1|||
129810633|NCT02229383|467273302|FG000|Overall Study|Lost to Follow-up|5|||
129810634|NCT02229383|467273303|FG001|Overall Study|Lost to Follow-up|3|||
129810635|NCT02229383|467273302|FG000|Overall Study|Withdrawal by Subject|4|||
129810636|NCT02229383|467273303|FG001|Overall Study|Withdrawal by Subject|6|||
129810637|NCT02229383|467273302|FG000|Overall Study|Did not receive treatment|1|||
129810638|NCT02229383|467273303|FG001|Overall Study|Did not receive treatment|0|||
129810639|NCT02229383|467273302|FG000|Overall Study|Other|3|||
129810640|NCT02229383|467273303|FG001|Overall Study|Other|8|||
129810641|NCT01201850|467273308|FG000|Overall Study|Tumor progression|4|||
129810642|NCT01817530|467273314|FG000|Overall Study|Exclusionary Medication Received|0|||
129810643|NCT01817530|467273315|FG001|Overall Study|Exclusionary Medication Received|0|||
129810644|NCT01817530|467273316|FG002|Overall Study|Exclusionary Medication Received|0|||
129810645|NCT01817530|467273317|FG003|Overall Study|Exclusionary Medication Received|0|||
129810646|NCT01817530|467273318|FG004|Overall Study|Exclusionary Medication Received|1|||
129810647|NCT01817530|467273319|FG005|Overall Study|Exclusionary Medication Received|0|||
129810648|NCT01817530|467273320|FG006|Overall Study|Exclusionary Medication Received|0|||
129810649|NCT01817530|467273321|FG007|Overall Study|Exclusionary Medication Received|0|||
129810650|NCT01817530|467273314|FG000|Overall Study|Adverse Event|6|||
129810651|NCT01817530|467273315|FG001|Overall Study|Adverse Event|3|||
129810652|NCT01817530|467273316|FG002|Overall Study|Adverse Event|2|||
129810653|NCT01817530|467273317|FG003|Overall Study|Adverse Event|5|||
129896805|NCT03710564|467582130|FG000|Overall Study|Withdrawal by Subject|57|||
129810654|NCT01817530|467273318|FG004|Overall Study|Adverse Event|0|||
129810655|NCT01817530|467273319|FG005|Overall Study|Adverse Event|10|||
129810656|NCT01817530|467273320|FG006|Overall Study|Adverse Event|5|||
129810657|NCT01817530|467273321|FG007|Overall Study|Adverse Event|8|||
129810658|NCT01817530|467273314|FG000|Overall Study|Subject Noncompliant|3|||
129755378|NCT02175017|467065757|FG000|Overall Study|Met an exclusion criteria|0|||
129755379|NCT02175017|467065758|FG001|Overall Study|Met an exclusion criteria|1|||
129755380|NCT02175017|467065757|FG000|Overall Study|Adverse Event|3|||
129755381|NCT02175017|467065758|FG001|Overall Study|Adverse Event|10|||
129755382|NCT02175017|467065757|FG000|Overall Study|Disease progression|20|||
129755383|NCT02175017|467065758|FG001|Overall Study|Disease progression|27|||
129755384|NCT02175017|467065757|FG000|Overall Study|Other than above reasons|3|||
129755385|NCT02175017|467065758|FG001|Overall Study|Other than above reasons|0|||
129755386|NCT02491983|467065759|FG000|Overall Study|Physician Decision|1|||
129755387|NCT02491983|467065760|FG001|Overall Study|Physician Decision|0|||
129755388|NCT02491983|467065759|FG000|Overall Study|Not meet selection criteria|1|||
129755389|NCT02491983|467065760|FG001|Overall Study|Not meet selection criteria|0|||
129755390|NCT02491983|467065759|FG000|Overall Study|Withdrawal by Subject|0|||
129755391|NCT02491983|467065760|FG001|Overall Study|Withdrawal by Subject|1|||
129755392|NCT04915729|467065761|FG000|Overall Study|Lost to Follow-up|20|||
129755393|NCT04915729|467065762|FG001|Overall Study|Lost to Follow-up|10|||
129755394|NCT04915729|467065761|FG000|Overall Study|Withdrawal by Subject|12|||
129755395|NCT04915729|467065762|FG001|Overall Study|Withdrawal by Subject|5|||
129755396|NCT04915729|467065761|FG000|Overall Study|Death|34|||
129755397|NCT04915729|467065762|FG001|Overall Study|Death|44|||
129755398|NCT04915729|467065761|FG000|Overall Study|not treated|3|||
129755399|NCT04915729|467065762|FG001|Overall Study|not treated|6|||
129755400|NCT04915729|467065761|FG000|Overall Study|Investigator removed subject|1|||
129755401|NCT04915729|467065762|FG001|Overall Study|Investigator removed subject|2|||
129755402|NCT04915729|467065761|FG000|Overall Study|questionnaire result not evaluated|1|||
129755403|NCT04915729|467065762|FG001|Overall Study|questionnaire result not evaluated|0|||
129755404|NCT04915729|467065761|FG000|Overall Study|refuse of hospital visit|1|||
129755405|NCT04915729|467065762|FG001|Overall Study|refuse of hospital visit|3|||
129755406|NCT04915729|467065761|FG000|Overall Study|Subject withdrew|1|||
129755407|NCT04915729|467065762|FG001|Overall Study|Subject withdrew|0|||
129755408|NCT01684202|467065763|FG000|Dose-escalation Period|Adverse Event|0|||
129755409|NCT01684202|467065764|FG001|Dose-escalation Period|Adverse Event|1|||
129755410|NCT01684202|467065765|FG002|Dose-escalation Period|Adverse Event|0|||
129755411|NCT01684202|467065766|FG003|Dose-escalation Period|Adverse Event|0|||
129755412|NCT01684202|467065763|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
129755413|NCT01684202|467065764|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
129755414|NCT01684202|467065765|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
129755415|NCT01684202|467065766|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
129755416|NCT01684202|467065763|FG000|Maintenance Period|Adverse Event|1|||
129755417|NCT01684202|467065764|FG001|Maintenance Period|Adverse Event|1|||
129755418|NCT01684202|467065765|FG002|Maintenance Period|Adverse Event|1|||
129755419|NCT01684202|467065766|FG003|Maintenance Period|Adverse Event|1|||
129755420|NCT01684202|467065763|FG000|Maintenance Period|Physician Decision|0|||
129755421|NCT01684202|467065764|FG001|Maintenance Period|Physician Decision|1|||
129755422|NCT01684202|467065765|FG002|Maintenance Period|Physician Decision|0|||
129755423|NCT01684202|467065766|FG003|Maintenance Period|Physician Decision|0|||
129755424|NCT01684202|467065763|FG000|Maintenance Period|Withdrawal by Subject|0|||
129755425|NCT01684202|467065764|FG001|Maintenance Period|Withdrawal by Subject|1|||
129755426|NCT01684202|467065765|FG002|Maintenance Period|Withdrawal by Subject|0|||
129755427|NCT01684202|467065766|FG003|Maintenance Period|Withdrawal by Subject|0|||
129755428|NCT03710642|467065770|FG000|Overall Study|Adverse Event|5|||
129755429|NCT03710642|467065771|FG001|Overall Study|Adverse Event|1|||
129755430|NCT03710642|467065770|FG000|Overall Study|non-site physician recommendation|1|||
129755431|NCT03710642|467065771|FG001|Overall Study|non-site physician recommendation|0|||
129755432|NCT03710642|467065770|FG000|Overall Study|Participant unwilling or unable to participate|1|||
129755433|NCT03710642|467065771|FG001|Overall Study|Participant unwilling or unable to participate|1|||
129755434|NCT03710642|467065770|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
129755435|NCT03710642|467065771|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
129755436|NCT03710642|467065770|FG000|Overall Study|NA-no code provided|1|||
129810659|NCT01817530|467273315|FG001|Overall Study|Subject Noncompliant|1|||
129810660|NCT01817530|467273316|FG002|Overall Study|Subject Noncompliant|0|||
129755437|NCT03710642|467065771|FG001|Overall Study|NA-no code provided|0|||
129755438|NCT03710642|467065770|FG000|Overall Study|Withdrawal by Subject|1|||
129755439|NCT03710642|467065771|FG001|Overall Study|Withdrawal by Subject|0|||
129810661|NCT01817530|467273317|FG003|Overall Study|Subject Noncompliant|4|||
129755440|NCT02741635|467065774|FG000|Overall Study|Withdrawal by Subject|1|||
129755441|NCT01427933|467065778|FG000|Overall Study|Withdrawal by Subject|5|||
129810662|NCT01817530|467273318|FG004|Overall Study|Subject Noncompliant|0|||
129810663|NCT01817530|467273319|FG005|Overall Study|Subject Noncompliant|1|||
129755442|NCT01427933|467065779|FG001|Overall Study|Withdrawal by Subject|8|||
129755443|NCT01427933|467065778|FG000|Overall Study|Lost to Follow-up|1|||
129755444|NCT01427933|467065779|FG001|Overall Study|Lost to Follow-up|5|||
129810664|NCT01817530|467273320|FG006|Overall Study|Subject Noncompliant|1|||
129810665|NCT01817530|467273321|FG007|Overall Study|Subject Noncompliant|1|||
129755445|NCT01427933|467065778|FG000|Overall Study|Other|1|||
129755446|NCT01427933|467065779|FG001|Overall Study|Other|0|||
129755447|NCT01427933|467065778|FG000|Overall Study|Investigator's Decision|1|||
129755448|NCT01427933|467065779|FG001|Overall Study|Investigator's Decision|0|||
129755449|NCT01633541|467065780|FG000|Overall Study|Death|1|||
129755450|NCT01633541|467065781|FG001|Overall Study|Death|0|||
129755451|NCT01010971|467065782|FG000|Overall Study|Adverse Event|2|||
129755452|NCT01010971|467065783|FG001|Overall Study|Adverse Event|4|||
129755453|NCT01010971|467065784|FG002|Overall Study|Adverse Event|3|||
129755454|NCT01010971|467065782|FG000|Overall Study|Withdrawal by Subject|0|||
129755455|NCT01010971|467065783|FG001|Overall Study|Withdrawal by Subject|2|||
129755456|NCT01010971|467065784|FG002|Overall Study|Withdrawal by Subject|5|||
129755457|NCT01010971|467065782|FG000|Overall Study|Lost to Follow-up|0|||
129755458|NCT01010971|467065783|FG001|Overall Study|Lost to Follow-up|2|||
129755459|NCT01010971|467065784|FG002|Overall Study|Lost to Follow-up|3|||
129755460|NCT01010971|467065782|FG000|Overall Study|Other|1|||
129755461|NCT01010971|467065783|FG001|Overall Study|Other|0|||
129755462|NCT01010971|467065784|FG002|Overall Study|Other|2|||
129755463|NCT03386721|467065785|FG000|Overall Study|Death|12|||
129755464|NCT03386721|467065786|FG001|Overall Study|Death|21|||
129755465|NCT03386721|467065787|FG002|Overall Study|Death|2|||
129755466|NCT03386721|467065788|FG003|Overall Study|Death|5|||
129755467|NCT03386721|467065789|FG004|Overall Study|Death|1|||
129755468|NCT03386721|467065790|FG005|Overall Study|Death|12|||
129755469|NCT03386721|467065791|FG006|Overall Study|Death|1|||
129755470|NCT03386721|467065792|FG007|Overall Study|Death|1|||
129755471|NCT03386721|467065793|FG008|Overall Study|Death|12|||
129755472|NCT03386721|467065794|FG009|Overall Study|Death|20|||
129755473|NCT03386721|467065795|FG010|Overall Study|Death|21|||
129755474|NCT03386721|467065796|FG011|Overall Study|Death|21|||
129755475|NCT03386721|467065797|FG012|Overall Study|Death|14|||
129755476|NCT03386721|467065798|FG013|Overall Study|Death|2|||
129755477|NCT03386721|467065799|FG014|Overall Study|Death|1|||
129755478|NCT03386721|467065785|FG000|Overall Study|Lost to Follow-up|1|||
129810666|NCT01817530|467273314|FG000|Overall Study|Lack of Efficacy|1|||
129810667|NCT01817530|467273315|FG001|Overall Study|Lack of Efficacy|0|||
129810668|NCT01817530|467273316|FG002|Overall Study|Lack of Efficacy|0|||
129810669|NCT01817530|467273317|FG003|Overall Study|Lack of Efficacy|0|||
129810670|NCT01817530|467273318|FG004|Overall Study|Lack of Efficacy|0|||
129810671|NCT01817530|467273319|FG005|Overall Study|Lack of Efficacy|1|||
129810672|NCT01817530|467273320|FG006|Overall Study|Lack of Efficacy|0|||
129810673|NCT01817530|467273321|FG007|Overall Study|Lack of Efficacy|1|||
129810674|NCT01817530|467273314|FG000|Overall Study|Pregnancy|0|||
129810675|NCT01817530|467273315|FG001|Overall Study|Pregnancy|0|||
129810676|NCT01817530|467273316|FG002|Overall Study|Pregnancy|0|||
129810677|NCT01817530|467273317|FG003|Overall Study|Pregnancy|0|||
129810678|NCT01817530|467273318|FG004|Overall Study|Pregnancy|0|||
129810679|NCT01817530|467273319|FG005|Overall Study|Pregnancy|1|||
129810680|NCT01817530|467273320|FG006|Overall Study|Pregnancy|0|||
129810681|NCT01817530|467273321|FG007|Overall Study|Pregnancy|0|||
129810682|NCT01817530|467273314|FG000|Overall Study|Other|0|||
129810683|NCT01817530|467273315|FG001|Overall Study|Other|1|||
129810684|NCT01817530|467273316|FG002|Overall Study|Other|0|||
129810685|NCT01817530|467273317|FG003|Overall Study|Other|0|||
129810686|NCT01817530|467273318|FG004|Overall Study|Other|1|||
129810687|NCT01817530|467273319|FG005|Overall Study|Other|0|||
129810688|NCT01817530|467273320|FG006|Overall Study|Other|5|||
129810689|NCT01817530|467273321|FG007|Overall Study|Other|0|||
129810690|NCT01817530|467273314|FG000|Overall Study|Surgery or Invasive Intervention|1|||
129810691|NCT01817530|467273315|FG001|Overall Study|Surgery or Invasive Intervention|0|||
129810692|NCT01817530|467273316|FG002|Overall Study|Surgery or Invasive Intervention|0|||
129810693|NCT01817530|467273317|FG003|Overall Study|Surgery or Invasive Intervention|0|||
129810694|NCT01817530|467273318|FG004|Overall Study|Surgery or Invasive Intervention|1|||
129810695|NCT01817530|467273319|FG005|Overall Study|Surgery or Invasive Intervention|1|||
129810696|NCT01817530|467273320|FG006|Overall Study|Surgery or Invasive Intervention|1|||
129810697|NCT01817530|467273321|FG007|Overall Study|Surgery or Invasive Intervention|0|||
129810698|NCT01817530|467273314|FG000|Overall Study|Consent Withdrawn by Subject|3|||
129810699|NCT01817530|467273315|FG001|Overall Study|Consent Withdrawn by Subject|4|||
129810700|NCT01817530|467273316|FG002|Overall Study|Consent Withdrawn by Subject|7|||
129810701|NCT01817530|467273317|FG003|Overall Study|Consent Withdrawn by Subject|3|||
129755479|NCT03386721|467065786|FG001|Overall Study|Lost to Follow-up|3|||
129755480|NCT03386721|467065787|FG002|Overall Study|Lost to Follow-up|0|||
129755481|NCT03386721|467065788|FG003|Overall Study|Lost to Follow-up|0|||
129755482|NCT03386721|467065789|FG004|Overall Study|Lost to Follow-up|0|||
129755483|NCT03386721|467065790|FG005|Overall Study|Lost to Follow-up|2|||
129755484|NCT03386721|467065791|FG006|Overall Study|Lost to Follow-up|1|||
129755485|NCT03386721|467065792|FG007|Overall Study|Lost to Follow-up|0|||
129755486|NCT03386721|467065793|FG008|Overall Study|Lost to Follow-up|1|||
129755487|NCT03386721|467065794|FG009|Overall Study|Lost to Follow-up|2|||
129755488|NCT03386721|467065795|FG010|Overall Study|Lost to Follow-up|1|||
129810702|NCT01817530|467273318|FG004|Overall Study|Consent Withdrawn by Subject|5|||
129810703|NCT01817530|467273319|FG005|Overall Study|Consent Withdrawn by Subject|3|||
129810704|NCT01817530|467273320|FG006|Overall Study|Consent Withdrawn by Subject|3|||
129810705|NCT01817530|467273321|FG007|Overall Study|Consent Withdrawn by Subject|10|||
129810706|NCT01817530|467273314|FG000|Overall Study|Lost to Follow-up|1|||
129810707|NCT01817530|467273315|FG001|Overall Study|Lost to Follow-up|4|||
129810708|NCT01817530|467273316|FG002|Overall Study|Lost to Follow-up|2|||
129810709|NCT01817530|467273317|FG003|Overall Study|Lost to Follow-up|1|||
129810710|NCT01817530|467273318|FG004|Overall Study|Lost to Follow-up|3|||
129810711|NCT01817530|467273319|FG005|Overall Study|Lost to Follow-up|2|||
129810712|NCT01817530|467273320|FG006|Overall Study|Lost to Follow-up|8|||
129810713|NCT01817530|467273321|FG007|Overall Study|Lost to Follow-up|4|||
129810714|NCT00404235|467273322|FG000|Overall Study|Withdrawal by Subject|1|||
129810715|NCT00404235|467273323|FG001|Overall Study|Withdrawal by Subject|2|||
129810716|NCT00594659|467273324|FG000|Overall Study|Lost to Follow-up|13|||
129810717|NCT00594659|467273325|FG001|Overall Study|Lost to Follow-up|9|||
129810718|NCT00594659|467273326|FG002|Overall Study|Lost to Follow-up|7|||
129810719|NCT04560998|467273332|FG000|Overall Study|Withdrawal by Subject|18|||
129810720|NCT04560998|467273333|FG001|Overall Study|Withdrawal by Subject|12|||
129810721|NCT04560998|467273332|FG000|Overall Study|Lost to Follow-up|8|||
129810722|NCT04560998|467273333|FG001|Overall Study|Lost to Follow-up|5|||
129810723|NCT04560998|467273332|FG000|Overall Study|Physician Decision|4|||
129810724|NCT04560998|467273333|FG001|Overall Study|Physician Decision|0|||
129810725|NCT01798004|467274927|FG000|Overall Study|Death|2|||
129810726|NCT01798004|467274927|FG000|Overall Study|Lack of Efficacy|8|||
129810727|NCT01798004|467274927|FG000|Overall Study|Physician Decision|25|||
129810728|NCT01798004|467274927|FG000|Overall Study|Withdrawal by Subject|4|||
129810729|NCT01798004|467274927|FG000|Overall Study|Ineligible|4|||
129810730|NCT01798004|467274927|FG000|Overall Study|Patient/parent refusal|7|||
129810731|NCT01798004|467274927|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
129810732|NCT01798004|467274927|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
129810733|NCT03281577|467274930|FG000|Overall Study|Adverse Event|0|||
129810734|NCT03281577|467274931|FG001|Overall Study|Adverse Event|0|||
129810735|NCT03281577|467274932|FG002|Overall Study|Adverse Event|0|||
129810736|NCT03281577|467274933|FG003|Overall Study|Adverse Event|1|||
129810737|NCT03281577|467274930|FG000|Overall Study|Withdrawal by Subject|1|||
129810738|NCT03281577|467274931|FG001|Overall Study|Withdrawal by Subject|0|||
129810739|NCT03281577|467274932|FG002|Overall Study|Withdrawal by Subject|0|||
129810740|NCT03281577|467274933|FG003|Overall Study|Withdrawal by Subject|0|||
129810741|NCT00443261|467274934|FG000|Overall Study|Death|1|||
129810742|NCT01433991|467274936|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
129810743|NCT01433991|467274937|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
129810744|NCT01433991|467274938|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
129810745|NCT01433991|467274939|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
129810746|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
129810747|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
129810748|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
129810749|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
129810750|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
129810751|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
129810752|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
129810753|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
129810754|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
129810755|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
129896806|NCT03710564|467582131|FG001|Overall Study|Withdrawal by Subject|25|||
129896807|NCT03710564|467582130|FG000|Overall Study|Death|10|||
129896808|NCT03710564|467582131|FG001|Overall Study|Death|4|||
129896809|NCT03710564|467582130|FG000|Overall Study|Lost to Follow-up|5|||
129896810|NCT03710564|467582131|FG001|Overall Study|Lost to Follow-up|4|||
129896811|NCT03710564|467582130|FG000|Overall Study|Protocol Violation|3|||
129896812|NCT03710564|467582131|FG001|Overall Study|Protocol Violation|2|||
129896813|NCT03710564|467582130|FG000|Overall Study|Adverse Event|3|||
129896814|NCT03710564|467582131|FG001|Overall Study|Adverse Event|0|||
129896815|NCT03710564|467582130|FG000|Overall Study|Physician Decision|2|||
129896816|NCT03710564|467582131|FG001|Overall Study|Physician Decision|3|||
129896817|NCT01674569|467582132|FG000|Overall Study|Adverse Event|0|||
129896818|NCT01674569|467582133|FG001|Overall Study|Adverse Event|2|||
129896819|NCT01674569|467582134|FG002|Overall Study|Adverse Event|0|||
129896820|NCT01674569|467582135|FG003|Overall Study|Adverse Event|1|||
129896821|NCT01674569|467582136|FG004|Overall Study|Adverse Event|2|||
129896822|NCT01674569|467582137|FG005|Overall Study|Adverse Event|2|||
129896823|NCT01674569|467582132|FG000|Overall Study|Protocol Violation|0|||
129810756|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
129810757|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
129810758|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
129896824|NCT01674569|467582133|FG001|Overall Study|Protocol Violation|1|||
129896825|NCT01674569|467582134|FG002|Overall Study|Protocol Violation|1|||
129896826|NCT01674569|467582135|FG003|Overall Study|Protocol Violation|0|||
129755489|NCT03386721|467065796|FG011|Overall Study|Lost to Follow-up|0|||
129755490|NCT03386721|467065797|FG012|Overall Study|Lost to Follow-up|0|||
129755491|NCT03386721|467065798|FG013|Overall Study|Lost to Follow-up|0|||
129755492|NCT03386721|467065799|FG014|Overall Study|Lost to Follow-up|0|||
129755493|NCT03386721|467065785|FG000|Overall Study|Reason not specified|3|||
129755494|NCT03386721|467065786|FG001|Overall Study|Reason not specified|0|||
129755495|NCT03386721|467065787|FG002|Overall Study|Reason not specified|0|||
129755496|NCT03386721|467065788|FG003|Overall Study|Reason not specified|0|||
129755497|NCT03386721|467065789|FG004|Overall Study|Reason not specified|0|||
129755498|NCT03386721|467065790|FG005|Overall Study|Reason not specified|3|||
129755499|NCT03386721|467065791|FG006|Overall Study|Reason not specified|1|||
129755500|NCT03386721|467065792|FG007|Overall Study|Reason not specified|0|||
129755501|NCT03386721|467065793|FG008|Overall Study|Reason not specified|0|||
129755502|NCT03386721|467065794|FG009|Overall Study|Reason not specified|1|||
129755503|NCT03386721|467065795|FG010|Overall Study|Reason not specified|2|||
129755504|NCT03386721|467065796|FG011|Overall Study|Reason not specified|6|||
129755505|NCT03386721|467065797|FG012|Overall Study|Reason not specified|1|||
129755506|NCT03386721|467065798|FG013|Overall Study|Reason not specified|0|||
129755507|NCT03386721|467065799|FG014|Overall Study|Reason not specified|0|||
129755508|NCT03386721|467065785|FG000|Overall Study|Progressive Disease|0|||
129755509|NCT03386721|467065786|FG001|Overall Study|Progressive Disease|0|||
129755510|NCT03386721|467065787|FG002|Overall Study|Progressive Disease|1|||
129755511|NCT03386721|467065788|FG003|Overall Study|Progressive Disease|0|||
129755512|NCT03386721|467065789|FG004|Overall Study|Progressive Disease|0|||
129755513|NCT03386721|467065790|FG005|Overall Study|Progressive Disease|1|||
129755514|NCT03386721|467065791|FG006|Overall Study|Progressive Disease|0|||
129755515|NCT03386721|467065792|FG007|Overall Study|Progressive Disease|0|||
129755516|NCT03386721|467065793|FG008|Overall Study|Progressive Disease|2|||
129755517|NCT03386721|467065794|FG009|Overall Study|Progressive Disease|1|||
129755518|NCT03386721|467065795|FG010|Overall Study|Progressive Disease|1|||
129755519|NCT03386721|467065796|FG011|Overall Study|Progressive Disease|0|||
129755520|NCT03386721|467065797|FG012|Overall Study|Progressive Disease|1|||
129755521|NCT03386721|467065798|FG013|Overall Study|Progressive Disease|0|||
129755522|NCT03386721|467065799|FG014|Overall Study|Progressive Disease|0|||
129755523|NCT03386721|467065785|FG000|Overall Study|Site Terminated by Sponsor|5|||
129755524|NCT03386721|467065786|FG001|Overall Study|Site Terminated by Sponsor|5|||
129755525|NCT03386721|467065787|FG002|Overall Study|Site Terminated by Sponsor|0|||
129755526|NCT03386721|467065788|FG003|Overall Study|Site Terminated by Sponsor|0|||
129755527|NCT03386721|467065789|FG004|Overall Study|Site Terminated by Sponsor|1|||
129755528|NCT03386721|467065790|FG005|Overall Study|Site Terminated by Sponsor|3|||
129755529|NCT03386721|467065791|FG006|Overall Study|Site Terminated by Sponsor|0|||
129755530|NCT03386721|467065792|FG007|Overall Study|Site Terminated by Sponsor|1|||
129755531|NCT03386721|467065793|FG008|Overall Study|Site Terminated by Sponsor|4|||
129755532|NCT03386721|467065794|FG009|Overall Study|Site Terminated by Sponsor|5|||
129755533|NCT03386721|467065795|FG010|Overall Study|Site Terminated by Sponsor|3|||
129755534|NCT03386721|467065796|FG011|Overall Study|Site Terminated by Sponsor|11|||
129755535|NCT03386721|467065797|FG012|Overall Study|Site Terminated by Sponsor|6|||
129755536|NCT03386721|467065798|FG013|Overall Study|Site Terminated by Sponsor|0|||
129755537|NCT03386721|467065799|FG014|Overall Study|Site Terminated by Sponsor|0|||
129755538|NCT03386721|467065785|FG000|Overall Study|Symptomatic Deterioration|0|||
129755539|NCT03386721|467065786|FG001|Overall Study|Symptomatic Deterioration|0|||
129755540|NCT03386721|467065787|FG002|Overall Study|Symptomatic Deterioration|0|||
129755541|NCT03386721|467065788|FG003|Overall Study|Symptomatic Deterioration|0|||
129755542|NCT03386721|467065789|FG004|Overall Study|Symptomatic Deterioration|0|||
129755543|NCT03386721|467065790|FG005|Overall Study|Symptomatic Deterioration|0|||
129755544|NCT03386721|467065791|FG006|Overall Study|Symptomatic Deterioration|0|||
129755545|NCT03386721|467065792|FG007|Overall Study|Symptomatic Deterioration|0|||
129755546|NCT03386721|467065793|FG008|Overall Study|Symptomatic Deterioration|1|||
129755547|NCT03386721|467065794|FG009|Overall Study|Symptomatic Deterioration|0|||
129755548|NCT03386721|467065795|FG010|Overall Study|Symptomatic Deterioration|0|||
129755549|NCT03386721|467065796|FG011|Overall Study|Symptomatic Deterioration|1|||
129755550|NCT03386721|467065797|FG012|Overall Study|Symptomatic Deterioration|0|||
129755551|NCT03386721|467065798|FG013|Overall Study|Symptomatic Deterioration|0|||
129755552|NCT03386721|467065799|FG014|Overall Study|Symptomatic Deterioration|0|||
129755553|NCT03386721|467065785|FG000|Overall Study|Withdrawal by Subject|1|||
129755554|NCT03386721|467065786|FG001|Overall Study|Withdrawal by Subject|2|||
129755555|NCT03386721|467065787|FG002|Overall Study|Withdrawal by Subject|0|||
129755556|NCT03386721|467065788|FG003|Overall Study|Withdrawal by Subject|0|||
129755557|NCT03386721|467065789|FG004|Overall Study|Withdrawal by Subject|0|||
129755558|NCT03386721|467065790|FG005|Overall Study|Withdrawal by Subject|0|||
129755559|NCT03386721|467065791|FG006|Overall Study|Withdrawal by Subject|0|||
129755560|NCT03386721|467065792|FG007|Overall Study|Withdrawal by Subject|0|||
129755561|NCT03386721|467065793|FG008|Overall Study|Withdrawal by Subject|2|||
129755562|NCT03386721|467065794|FG009|Overall Study|Withdrawal by Subject|1|||
129755563|NCT03386721|467065795|FG010|Overall Study|Withdrawal by Subject|3|||
129755564|NCT03386721|467065796|FG011|Overall Study|Withdrawal by Subject|2|||
129755565|NCT03386721|467065797|FG012|Overall Study|Withdrawal by Subject|3|||
129755566|NCT03386721|467065798|FG013|Overall Study|Withdrawal by Subject|0|||
129755567|NCT03386721|467065799|FG014|Overall Study|Withdrawal by Subject|0|||
129755568|NCT05114473|467065800|FG000|Overall Study|Lost to Follow-up|2|||
129755569|NCT05114473|467065801|FG001|Overall Study|Lost to Follow-up|2|||
129755570|NCT05114473|467065802|FG002|Overall Study|Lost to Follow-up|0|||
129755571|NCT02330055|467065803|FG000|Overall Study|technical issues|2|||
129755572|NCT02330055|467065804|FG001|Overall Study|technical issues|0|||
129755573|NCT02330055|467065803|FG000|Overall Study|participant forgot to wear device|5|||
129810759|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
129810760|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
129810761|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
129810762|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
129810763|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
129810764|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
129810765|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
129810766|NCT01433991|467274936|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
129810767|NCT01433991|467274937|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
129810768|NCT01433991|467274938|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
129810769|NCT01433991|467274939|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
129810770|NCT01673867|467274944|FG000|Randomization|Adverse event unrelated to study drug|1|||
129810771|NCT01673867|467274945|FG001|Randomization|Adverse event unrelated to study drug|0|||
129810772|NCT01673867|467274944|FG000|Randomization|Participant request to discontinue study treatment|0|||
129810773|NCT01673867|467274945|FG001|Randomization|Participant request to discontinue study treatment|4|||
129810774|NCT01673867|467274944|FG000|Randomization|Withdrawal by participant|0|||
129810775|NCT01673867|467274945|FG001|Randomization|Withdrawal by participant|12|||
129810776|NCT01673867|467274944|FG000|Randomization|Lost to Follow-up|0|||
129810777|NCT01673867|467274945|FG001|Randomization|Lost to Follow-up|1|||
129810778|NCT01673867|467274944|FG000|Randomization|Participant no longer meets study criteria|4|||
129810779|NCT01673867|467274945|FG001|Randomization|Participant no longer meets study criteria|5|||
129810780|NCT01673867|467274944|FG000|Treatment|Disease Progression|208|||
129810781|NCT01673867|467274945|FG001|Treatment|Disease Progression|178|||
129810782|NCT01673867|467274944|FG000|Treatment|Study Drug Toxicity|23|||
129810783|NCT01673867|467274945|FG001|Treatment|Study Drug Toxicity|43|||
129810784|NCT01673867|467274944|FG000|Treatment|Death|2|||
129810785|NCT01673867|467274945|FG001|Treatment|Death|3|||
129810786|NCT01673867|467274944|FG000|Treatment|Adverse event unrelated to study drug|23|||
129810787|NCT01673867|467274945|FG001|Treatment|Adverse event unrelated to study drug|10|||
129810788|NCT01673867|467274944|FG000|Treatment|Participant request to discontinue study treatment|7|||
129810789|NCT01673867|467274945|FG001|Treatment|Participant request to discontinue study treatment|17|||
129810790|NCT01673867|467274944|FG000|Treatment|Withdrawal by participant|5|||
129810791|NCT01673867|467274945|FG001|Treatment|Withdrawal by participant|5|||
129810792|NCT01673867|467274944|FG000|Treatment|Maximum clinical benefit|1|||
129810793|NCT01673867|467274945|FG001|Treatment|Maximum clinical benefit|10|||
129810794|NCT01673867|467274944|FG000|Treatment|Participant no longer meets study criteria|2|||
129810795|NCT01673867|467274945|FG001|Treatment|Participant no longer meets study criteria|0|||
129810796|NCT01673867|467274944|FG000|Treatment|Administrative reason by sponsor|3|||
129810797|NCT01673867|467274945|FG001|Treatment|Administrative reason by sponsor|0|||
129810798|NCT01673867|467274944|FG000|Treatment|Other reason|11|||
129810799|NCT01673867|467274945|FG001|Treatment|Other reason|2|||
129810800|NCT02550106|467274946|FG000|Overall Study|Adverse Event|1|||
129810801|NCT02550106|467274946|FG000|Overall Study|Lack of Efficacy|3|||
129810802|NCT02550106|467274946|FG000|Overall Study|Protocol Violation|6|||
129810803|NCT02550106|467274946|FG000|Overall Study|Withdrawal by Subject|2|||
129810804|NCT00354744|467274947|FG000|Overall Study|Adverse Event|2|||
129810805|NCT00354744|467274947|FG000|Overall Study|Death|2|||
129810806|NCT00354744|467274947|FG000|Overall Study|Lack of Efficacy|11|||
129810807|NCT00354744|467274947|FG000|Overall Study|Lost to Follow-up|2|||
129810808|NCT00354744|467274947|FG000|Overall Study|Physician Decision|11|||
129896827|NCT01674569|467582136|FG004|Overall Study|Protocol Violation|0|||
129896828|NCT01674569|467582137|FG005|Overall Study|Protocol Violation|0|||
129755574|NCT02330055|467065804|FG001|Overall Study|participant forgot to wear device|5|||
129755575|NCT02330055|467065803|FG000|Overall Study|data for less than 60 minutes|3|||
129755576|NCT02330055|467065804|FG001|Overall Study|data for less than 60 minutes|3|||
129755577|NCT02330055|467065803|FG000|Overall Study|participant did not sleep|0|||
129755578|NCT02330055|467065804|FG001|Overall Study|participant did not sleep|1|||
129755579|NCT01369784|467065808|FG000|Overall Study|Protocol Violation|12|||
129755580|NCT00782717|467065809|FG000|Overall Study|Adverse Event|2|||
129755581|NCT00782717|467065810|FG001|Overall Study|Adverse Event|5|||
129755582|NCT00782717|467065809|FG000|Overall Study|Patient decision unrelated to AE|6|||
129755583|NCT00782717|467065810|FG001|Overall Study|Patient decision unrelated to AE|3|||
129755584|NCT00782717|467065809|FG000|Overall Study|Noncompliance|2|||
129755585|NCT00782717|467065810|FG001|Overall Study|Noncompliance|1|||
129755586|NCT00782717|467065809|FG000|Overall Study|Treatment failure|3|||
129755587|NCT00782717|467065810|FG001|Overall Study|Treatment failure|14|||
129755588|NCT00782717|467065809|FG000|Overall Study|Enrollment close prior to surgery|1|||
129755589|NCT00782717|467065810|FG001|Overall Study|Enrollment close prior to surgery|0|||
129755590|NCT00782717|467065809|FG000|Overall Study|Did not meet entrance criteria|1|||
129755591|NCT00782717|467065810|FG001|Overall Study|Did not meet entrance criteria|3|||
129755592|NCT00782717|467065809|FG000|Overall Study|Exited in error|0|||
129755593|NCT00782717|467065810|FG001|Overall Study|Exited in error|2|||
129755594|NCT02905266|467065811|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
129755595|NCT02905266|467065812|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
129755596|NCT02905266|467065811|FG000|Treatment Phase Part 1|Disease Progression|6|||
129755597|NCT02905266|467065812|FG001|Treatment Phase Part 1|Disease Progression|7|||
129755598|NCT02905266|467065811|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
129755599|NCT02905266|467065812|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
129755600|NCT02905266|467065811|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
129755601|NCT02905266|467065812|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
129755602|NCT02905266|467065811|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
129755603|NCT02905266|467065812|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
129755604|NCT02905266|467065811|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
129755605|NCT02905266|467065812|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
129755606|NCT02905266|467065811|FG000|Transition From Part 1 to Part 2|Death|0|||
129755607|NCT02905266|467065812|FG001|Transition From Part 1 to Part 2|Death|1|||
129755608|NCT02905266|467065811|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
129755609|NCT02905266|467065812|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
129755610|NCT02905266|467065811|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
129755611|NCT02905266|467065812|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
129755612|NCT02905266|467065811|FG000|Maintenance Phase Part 2|Disease Progression|9|||
129755613|NCT02905266|467065812|FG001|Maintenance Phase Part 2|Disease Progression|2|||
129755614|NCT02905266|467065811|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
129755615|NCT02905266|467065812|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
129755616|NCT02905266|467065811|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
129755617|NCT02905266|467065812|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
129755618|NCT02292719|467065818|FG000|Overall Study|Withdrawal by Subject|0|||
129755619|NCT02292719|467065819|FG001|Overall Study|Withdrawal by Subject|0|||
129755620|NCT02292719|467065820|FG002|Overall Study|Withdrawal by Subject|0|||
129755621|NCT02292719|467065821|FG003|Overall Study|Withdrawal by Subject|1|||
129755622|NCT02292719|467065822|FG004|Overall Study|Withdrawal by Subject|1|||
129755623|NCT02292719|467065823|FG005|Overall Study|Withdrawal by Subject|0|||
129755624|NCT02292719|467065818|FG000|Overall Study|Subject enrolled in new study.|0|||
129755625|NCT02292719|467065819|FG001|Overall Study|Subject enrolled in new study.|0|||
129755626|NCT02292719|467065820|FG002|Overall Study|Subject enrolled in new study.|1|||
129755627|NCT02292719|467065821|FG003|Overall Study|Subject enrolled in new study.|0|||
129755628|NCT02292719|467065822|FG004|Overall Study|Subject enrolled in new study.|0|||
129755629|NCT02292719|467065823|FG005|Overall Study|Subject enrolled in new study.|0|||
129755630|NCT02586727|467065829|FG000|Overall Study|Lost to Follow-up|1|||
129755631|NCT02586727|467065830|FG001|Overall Study|Lost to Follow-up|0|||
129755632|NCT04378270|467065832|FG000|Overall Study|Lack of Efficacy|1|||
129810809|NCT00354744|467274947|FG000|Overall Study|Withdrawal by Subject|14|||
129810810|NCT01193530|467274948|FG000|Overall Study|Withdrawal by Subject|2|||
129810811|NCT01193530|467274949|FG001|Overall Study|Withdrawal by Subject|2|||
129810812|NCT01193530|467274948|FG000|Overall Study|Began Contraindicated Therapy|1|||
129810813|NCT01193530|467274949|FG001|Overall Study|Began Contraindicated Therapy|0|||
129810814|NCT01193530|467274948|FG000|Overall Study|Lost Light Box|0|||
129810815|NCT01193530|467274949|FG001|Overall Study|Lost Light Box|1|||
129755633|NCT04378270|467065832|FG000|Overall Study|Withdrawal by Subject|1|||
129755634|NCT04378270|467065832|FG000|Overall Study|Screen Failure|1|||
129755635|NCT04378270|467065832|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
129755636|NCT01132313|467065833|FG000|Overall Study|Lack of Efficacy|1|||
129755637|NCT01132313|467065834|FG001|Overall Study|Lack of Efficacy|0|||
129755638|NCT01132313|467065835|FG002|Overall Study|Lack of Efficacy|0|||
129755639|NCT01132313|467065836|FG003|Overall Study|Lack of Efficacy|0|||
129755640|NCT01132313|467065837|FG004|Overall Study|Lack of Efficacy|0|||
129755641|NCT01132313|467065838|FG005|Overall Study|Lack of Efficacy|0|||
129755642|NCT01132313|467065839|FG006|Overall Study|Lack of Efficacy|0|||
129755643|NCT01132313|467065840|FG007|Overall Study|Lack of Efficacy|3|||
129755644|NCT01132313|467065841|FG008|Overall Study|Lack of Efficacy|14|||
129755645|NCT01132313|467065842|FG009|Overall Study|Lack of Efficacy|16|||
129755646|NCT01132313|467065843|FG010|Overall Study|Lack of Efficacy|0|||
129755647|NCT01132313|467065844|FG011|Overall Study|Lack of Efficacy|0|||
129755648|NCT01132313|467065833|FG000|Overall Study|Not treated|2|||
129755649|NCT01132313|467065834|FG001|Overall Study|Not treated|0|||
129755650|NCT01132313|467065835|FG002|Overall Study|Not treated|0|||
129755651|NCT01132313|467065836|FG003|Overall Study|Not treated|0|||
129755652|NCT01132313|467065837|FG004|Overall Study|Not treated|2|||
129755653|NCT01132313|467065838|FG005|Overall Study|Not treated|1|||
129755654|NCT01132313|467065839|FG006|Overall Study|Not treated|3|||
129755655|NCT01132313|467065840|FG007|Overall Study|Not treated|0|||
129755656|NCT01132313|467065841|FG008|Overall Study|Not treated|0|||
129755657|NCT01132313|467065842|FG009|Overall Study|Not treated|0|||
129755658|NCT01132313|467065843|FG010|Overall Study|Not treated|0|||
129755659|NCT01132313|467065844|FG011|Overall Study|Not treated|0|||
129755660|NCT01132313|467065833|FG000|Overall Study|Adverse Event|0|||
129755661|NCT01132313|467065834|FG001|Overall Study|Adverse Event|0|||
129755662|NCT01132313|467065835|FG002|Overall Study|Adverse Event|4|||
129755663|NCT01132313|467065836|FG003|Overall Study|Adverse Event|10|||
129755664|NCT01132313|467065837|FG004|Overall Study|Adverse Event|19|||
129755665|NCT01132313|467065838|FG005|Overall Study|Adverse Event|6|||
129755666|NCT01132313|467065839|FG006|Overall Study|Adverse Event|5|||
129755667|NCT01132313|467065840|FG007|Overall Study|Adverse Event|3|||
129755668|NCT01132313|467065841|FG008|Overall Study|Adverse Event|7|||
129755669|NCT01132313|467065842|FG009|Overall Study|Adverse Event|2|||
129755670|NCT01132313|467065843|FG010|Overall Study|Adverse Event|0|||
129755671|NCT01132313|467065844|FG011|Overall Study|Adverse Event|0|||
129755672|NCT01132313|467065833|FG000|Overall Study|Protocol Violation|0|||
129755673|NCT01132313|467065834|FG001|Overall Study|Protocol Violation|0|||
129755674|NCT01132313|467065835|FG002|Overall Study|Protocol Violation|0|||
129755675|NCT01132313|467065836|FG003|Overall Study|Protocol Violation|1|||
129755676|NCT01132313|467065837|FG004|Overall Study|Protocol Violation|0|||
129755677|NCT01132313|467065838|FG005|Overall Study|Protocol Violation|0|||
129755678|NCT01132313|467065839|FG006|Overall Study|Protocol Violation|0|||
129755679|NCT01132313|467065840|FG007|Overall Study|Protocol Violation|0|||
129755680|NCT01132313|467065841|FG008|Overall Study|Protocol Violation|0|||
129755681|NCT01132313|467065842|FG009|Overall Study|Protocol Violation|0|||
129755682|NCT01132313|467065843|FG010|Overall Study|Protocol Violation|0|||
129755683|NCT01132313|467065844|FG011|Overall Study|Protocol Violation|0|||
129755684|NCT01132313|467065833|FG000|Overall Study|Lost to Follow-up|0|||
129755685|NCT01132313|467065834|FG001|Overall Study|Lost to Follow-up|0|||
129755686|NCT01132313|467065835|FG002|Overall Study|Lost to Follow-up|1|||
129755687|NCT01132313|467065836|FG003|Overall Study|Lost to Follow-up|0|||
129755688|NCT01132313|467065837|FG004|Overall Study|Lost to Follow-up|0|||
129755689|NCT01132313|467065838|FG005|Overall Study|Lost to Follow-up|0|||
129755690|NCT01132313|467065839|FG006|Overall Study|Lost to Follow-up|0|||
129755691|NCT01132313|467065840|FG007|Overall Study|Lost to Follow-up|1|||
129755692|NCT01132313|467065841|FG008|Overall Study|Lost to Follow-up|0|||
129755693|NCT01132313|467065842|FG009|Overall Study|Lost to Follow-up|0|||
129755694|NCT01132313|467065843|FG010|Overall Study|Lost to Follow-up|0|||
129755695|NCT01132313|467065844|FG011|Overall Study|Lost to Follow-up|0|||
129755696|NCT01132313|467065833|FG000|Overall Study|Withdrawal by Subject|0|||
129755697|NCT01132313|467065834|FG001|Overall Study|Withdrawal by Subject|0|||
129755698|NCT01132313|467065835|FG002|Overall Study|Withdrawal by Subject|3|||
129755699|NCT01132313|467065836|FG003|Overall Study|Withdrawal by Subject|3|||
129810816|NCT01193530|467274948|FG000|Overall Study|Returned home - out of state|0|||
129810817|NCT01193530|467274949|FG001|Overall Study|Returned home - out of state|1|||
129810818|NCT01193530|467274948|FG000|Overall Study|Non-Compliance|0|||
129810819|NCT01193530|467274949|FG001|Overall Study|Non-Compliance|1|||
129755700|NCT01132313|467065837|FG004|Overall Study|Withdrawal by Subject|6|||
129755701|NCT01132313|467065838|FG005|Overall Study|Withdrawal by Subject|0|||
129755702|NCT01132313|467065839|FG006|Overall Study|Withdrawal by Subject|1|||
129755703|NCT01132313|467065840|FG007|Overall Study|Withdrawal by Subject|0|||
129755704|NCT01132313|467065841|FG008|Overall Study|Withdrawal by Subject|0|||
129755705|NCT01132313|467065842|FG009|Overall Study|Withdrawal by Subject|2|||
129755706|NCT01132313|467065843|FG010|Overall Study|Withdrawal by Subject|0|||
129755707|NCT01132313|467065844|FG011|Overall Study|Withdrawal by Subject|0|||
129755708|NCT01132313|467065833|FG000|Overall Study|Lack of antiviral response|0|||
129755709|NCT01132313|467065834|FG001|Overall Study|Lack of antiviral response|0|||
129755710|NCT01132313|467065835|FG002|Overall Study|Lack of antiviral response|12|||
129755711|NCT01132313|467065836|FG003|Overall Study|Lack of antiviral response|18|||
129755712|NCT01132313|467065837|FG004|Overall Study|Lack of antiviral response|18|||
129755713|NCT01132313|467065838|FG005|Overall Study|Lack of antiviral response|18|||
129810820|NCT00926328|467274952|FG000|Overall Study|Lost to Follow-up|12|||
129810821|NCT00926328|467274953|FG001|Overall Study|Lost to Follow-up|14|||
129755714|NCT01132313|467065839|FG006|Overall Study|Lack of antiviral response|21|||
129896829|NCT01674569|467582132|FG000|Overall Study|Withdrawal by Subject|0|||
129896830|NCT01674569|467582133|FG001|Overall Study|Withdrawal by Subject|0|||
129755715|NCT01132313|467065840|FG007|Overall Study|Lack of antiviral response|0|||
129755716|NCT01132313|467065841|FG008|Overall Study|Lack of antiviral response|0|||
129755717|NCT01132313|467065842|FG009|Overall Study|Lack of antiviral response|0|||
129755718|NCT01132313|467065843|FG010|Overall Study|Lack of antiviral response|1|||
129755719|NCT01132313|467065844|FG011|Overall Study|Lack of antiviral response|0|||
129755720|NCT01132313|467065833|FG000|Overall Study|Other reason not defined above|0|||
129755721|NCT01132313|467065834|FG001|Overall Study|Other reason not defined above|0|||
129755722|NCT01132313|467065835|FG002|Overall Study|Other reason not defined above|0|||
129755723|NCT01132313|467065836|FG003|Overall Study|Other reason not defined above|0|||
129755724|NCT01132313|467065837|FG004|Overall Study|Other reason not defined above|0|||
129755725|NCT01132313|467065838|FG005|Overall Study|Other reason not defined above|0|||
129755726|NCT01132313|467065839|FG006|Overall Study|Other reason not defined above|0|||
129755727|NCT01132313|467065840|FG007|Overall Study|Other reason not defined above|1|||
129755728|NCT01132313|467065841|FG008|Overall Study|Other reason not defined above|0|||
129755729|NCT01132313|467065842|FG009|Overall Study|Other reason not defined above|0|||
129755730|NCT01132313|467065843|FG010|Overall Study|Other reason not defined above|0|||
129755731|NCT01132313|467065844|FG011|Overall Study|Other reason not defined above|0|||
129755732|NCT02715609|467065846|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
129755733|NCT02715609|467065847|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
129755734|NCT02715609|467065848|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
129755735|NCT02715609|467065846|FG000|Overall Study|Withdrawal by Subject|0|||
129755736|NCT02715609|467065847|FG001|Overall Study|Withdrawal by Subject|0|||
129755737|NCT02715609|467065848|FG002|Overall Study|Withdrawal by Subject|1|||
129755738|NCT03201419|467065849|FG000|Overall Study|Adverse Event|3|||
129755739|NCT03201419|467065850|FG001|Overall Study|Adverse Event|1|||
129755740|NCT03201419|467065851|FG002|Overall Study|Adverse Event|0|||
129755741|NCT03201419|467065852|FG003|Overall Study|Adverse Event|0|||
129755742|NCT03201419|467065853|FG004|Overall Study|Adverse Event|1|||
129755743|NCT03201419|467065854|FG005|Overall Study|Adverse Event|1|||
129755744|NCT03201419|467065855|FG006|Overall Study|Adverse Event|5|||
129755745|NCT03201419|467065856|FG007|Overall Study|Adverse Event|0|||
129755746|NCT03201419|467065857|FG008|Overall Study|Adverse Event|0|||
129755747|NCT03201419|467065849|FG000|Overall Study|Lost to Follow-up|1|||
129755748|NCT03201419|467065850|FG001|Overall Study|Lost to Follow-up|0|||
129755749|NCT03201419|467065851|FG002|Overall Study|Lost to Follow-up|0|||
129755750|NCT03201419|467065852|FG003|Overall Study|Lost to Follow-up|0|||
129755751|NCT03201419|467065853|FG004|Overall Study|Lost to Follow-up|0|||
129755752|NCT03201419|467065854|FG005|Overall Study|Lost to Follow-up|0|||
129755753|NCT03201419|467065855|FG006|Overall Study|Lost to Follow-up|0|||
129755754|NCT03201419|467065856|FG007|Overall Study|Lost to Follow-up|0|||
129755755|NCT03201419|467065857|FG008|Overall Study|Lost to Follow-up|0|||
129755756|NCT03201419|467065849|FG000|Overall Study|Protocol Deviation|0|||
129755757|NCT03201419|467065850|FG001|Overall Study|Protocol Deviation|0|||
129755758|NCT03201419|467065851|FG002|Overall Study|Protocol Deviation|0|||
129755759|NCT03201419|467065852|FG003|Overall Study|Protocol Deviation|0|||
129755760|NCT03201419|467065853|FG004|Overall Study|Protocol Deviation|0|||
129755761|NCT03201419|467065854|FG005|Overall Study|Protocol Deviation|0|||
129755762|NCT03201419|467065855|FG006|Overall Study|Protocol Deviation|1|||
129755763|NCT03201419|467065856|FG007|Overall Study|Protocol Deviation|0|||
129755764|NCT03201419|467065857|FG008|Overall Study|Protocol Deviation|0|||
129755765|NCT03201419|467065849|FG000|Overall Study|Withdrawal by Subject|4|||
129755766|NCT03201419|467065850|FG001|Overall Study|Withdrawal by Subject|2|||
129755767|NCT03201419|467065851|FG002|Overall Study|Withdrawal by Subject|1|||
129755768|NCT03201419|467065852|FG003|Overall Study|Withdrawal by Subject|0|||
129755769|NCT03201419|467065853|FG004|Overall Study|Withdrawal by Subject|0|||
129755770|NCT03201419|467065854|FG005|Overall Study|Withdrawal by Subject|0|||
129755771|NCT03201419|467065855|FG006|Overall Study|Withdrawal by Subject|0|||
129755772|NCT03201419|467065856|FG007|Overall Study|Withdrawal by Subject|1|||
129755773|NCT03201419|467065857|FG008|Overall Study|Withdrawal by Subject|2|||
129755774|NCT03201419|467065849|FG000|Overall Study|Other|0|||
129755775|NCT03201419|467065850|FG001|Overall Study|Other|0|||
129755776|NCT03201419|467065851|FG002|Overall Study|Other|1|||
129755777|NCT03201419|467065852|FG003|Overall Study|Other|0|||
129755778|NCT03201419|467065853|FG004|Overall Study|Other|0|||
129755779|NCT03201419|467065854|FG005|Overall Study|Other|0|||
129755780|NCT03201419|467065855|FG006|Overall Study|Other|0|||
129755781|NCT03201419|467065856|FG007|Overall Study|Other|0|||
129755782|NCT03201419|467065857|FG008|Overall Study|Other|0|||
129755783|NCT04544956|467065858|FG000|Overall Study|Withdrawal by Subject|1|||
129755784|NCT01657292|467065860|FG000|Overall Study|Adverse Event|6|||
129755785|NCT01657292|467065860|FG000|Overall Study|Withdrawal by Subject|2|||
129755786|NCT01657292|467065860|FG000|Overall Study|Violation of eligibility criteria|1|||
129755787|NCT01657292|467065860|FG000|Overall Study|Change of therapy|1|||
129755788|NCT00650845|467065861|FG000|Overall Study|Withdrawal by Subject|5|||
129755789|NCT00650845|467065862|FG001|Overall Study|Withdrawal by Subject|0|||
129755790|NCT00650845|467065861|FG000|Overall Study|Protocol Violation|0|||
129755791|NCT00650845|467065862|FG001|Overall Study|Protocol Violation|13|||
129755792|NCT04178720|467065863|FG000|Overall Study|Withdrawal by Subject|2|||
129755793|NCT04178720|467065864|FG001|Overall Study|Withdrawal by Subject|0|||
129755794|NCT04178720|467065863|FG000|Overall Study|Relocation|0|||
129755795|NCT04178720|467065864|FG001|Overall Study|Relocation|1|||
129755796|NCT03922620|467065865|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
129755797|NCT03922620|467065866|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
129755798|NCT04177212|467065867|FG000|Overall Study|Withdrawal by Subject|9|||
129755799|NCT04177212|467065868|FG001|Overall Study|Withdrawal by Subject|7|||
129755800|NCT04177212|467065867|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
129755801|NCT04177212|467065868|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
129755802|NCT04177212|467065867|FG000|Overall Study|Physician Decision|1|||
129755803|NCT04177212|467065868|FG001|Overall Study|Physician Decision|0|||
129755804|NCT04177212|467065867|FG000|Overall Study|Lost to Follow-up|0|||
129755805|NCT04177212|467065868|FG001|Overall Study|Lost to Follow-up|3|||
129755806|NCT04177212|467065867|FG000|Overall Study|Adverse Event|0|||
129755807|NCT04177212|467065868|FG001|Overall Study|Adverse Event|1|||
129755808|NCT04177212|467065867|FG000|Overall Study|Other|1|||
129755809|NCT04177212|467065868|FG001|Overall Study|Other|2|||
129755810|NCT04725500|467065869|FG000|Screening|Screen Failure|26|||
129755811|NCT04725500|467065869|FG000|Screening|Withdrawal by Subject|1|||
129755812|NCT04725500|467065869|FG000|2 Week Take Home|Screen Fail|5|||
129755813|NCT01792115|467065870|FG000|Overall Study|Lost to Follow-up|0|||
129755814|NCT01792115|467065871|FG001|Overall Study|Lost to Follow-up|1|||
129755815|NCT01792115|467065872|FG002|Overall Study|Lost to Follow-up|0|||
129755816|NCT00930930|467065874|FG000|Overall Study|Death|1|||
129755817|NCT00930930|467065875|FG001|Overall Study|Death|0|||
129755818|NCT00930930|467065874|FG000|Overall Study|Physician Decision|1|||
129755819|NCT00930930|467065875|FG001|Overall Study|Physician Decision|0|||
129755820|NCT00930930|467065874|FG000|Overall Study|Adverse Event|13|||
129755821|NCT00930930|467065875|FG001|Overall Study|Adverse Event|3|||
129755822|NCT00930930|467065874|FG000|Overall Study|Withdrawal by Subject|3|||
129755823|NCT00930930|467065875|FG001|Overall Study|Withdrawal by Subject|1|||
129755824|NCT00930930|467065874|FG000|Overall Study|Disease progression|2|||
129755825|NCT00930930|467065875|FG001|Overall Study|Disease progression|3|||
129755826|NCT00930930|467065874|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
129755827|NCT00930930|467065875|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
129755828|NCT00930930|467065874|FG000|Overall Study|patients not compliant|1|||
129755829|NCT00930930|467065875|FG001|Overall Study|patients not compliant|1|||
129755830|NCT04618744|467065876|FG000|Overall Study|Adverse Event|0|||
129755831|NCT04618744|467065877|FG001|Overall Study|Adverse Event|1|||
129755832|NCT04618744|467065876|FG000|Overall Study|Withdrawal by Subject|0|||
129755833|NCT04618744|467065877|FG001|Overall Study|Withdrawal by Subject|1|||
129755834|NCT01633788|467067905|FG000|Overall Study|Adverse Event|1|||
129755835|NCT01633788|467067906|FG001|Overall Study|Adverse Event|3|||
129755836|NCT01633788|467067907|FG002|Overall Study|Adverse Event|3|||
129755837|NCT01633788|467067908|FG003|Overall Study|Adverse Event|3|||
129755838|NCT01633788|467067905|FG000|Overall Study|Lost to Follow-up|2|||
129755839|NCT01633788|467067906|FG001|Overall Study|Lost to Follow-up|2|||
129755840|NCT01633788|467067907|FG002|Overall Study|Lost to Follow-up|2|||
129755841|NCT01633788|467067908|FG003|Overall Study|Lost to Follow-up|0|||
129755842|NCT01633788|467067905|FG000|Overall Study|Personal Reasons|3|||
129755843|NCT01633788|467067906|FG001|Overall Study|Personal Reasons|1|||
129755844|NCT01633788|467067907|FG002|Overall Study|Personal Reasons|1|||
129755845|NCT01633788|467067908|FG003|Overall Study|Personal Reasons|3|||
129755846|NCT01633788|467067905|FG000|Overall Study|Protocol Violation|1|||
129755847|NCT01633788|467067906|FG001|Overall Study|Protocol Violation|0|||
129755848|NCT01633788|467067907|FG002|Overall Study|Protocol Violation|1|||
129755849|NCT01633788|467067908|FG003|Overall Study|Protocol Violation|0|||
129755850|NCT01633788|467067905|FG000|Overall Study|Other Reasons|0|||
129755851|NCT01633788|467067906|FG001|Overall Study|Other Reasons|2|||
129755852|NCT01633788|467067907|FG002|Overall Study|Other Reasons|3|||
129755853|NCT01633788|467067908|FG003|Overall Study|Other Reasons|7|||
129755854|NCT01929226|467067909|FG000|Overall Study|Lost to Follow-up|4|||
129755855|NCT01929226|467067910|FG001|Overall Study|Lost to Follow-up|0|||
129755856|NCT01929226|467067909|FG000|Overall Study|Withdrawal by Subject|1|||
129755857|NCT01929226|467067910|FG001|Overall Study|Withdrawal by Subject|1|||
129755858|NCT02807623|467067913|FG000|Overall Study|Lost to Follow-up|23|||
129755859|NCT02807623|467067914|FG001|Overall Study|Lost to Follow-up|18|||
129755860|NCT02807623|467067915|FG002|Overall Study|Lost to Follow-up|22|||
129755861|NCT02807623|467067913|FG000|Overall Study|Drug intolerance|0|||
129755862|NCT02807623|467067914|FG001|Overall Study|Drug intolerance|1|||
129755863|NCT02807623|467067915|FG002|Overall Study|Drug intolerance|0|||
129755864|NCT02807623|467067913|FG000|Overall Study|incomplete blood draw|0|||
129755865|NCT02807623|467067914|FG001|Overall Study|incomplete blood draw|2|||
129755866|NCT02807623|467067915|FG002|Overall Study|incomplete blood draw|1|||
129755867|NCT00859547|467067916|FG000|Overall Study|Lost to Follow-up|1|||
129755868|NCT00859547|467067916|FG000|Overall Study|Parent withdrew consent|1|||
129755869|NCT03310723|467067918|FG000|Overall Study|Withdrawal by Subject|0|||
129755870|NCT03310723|467067919|FG001|Overall Study|Withdrawal by Subject|1|||
129755871|NCT03310723|467067918|FG000|Overall Study|Protocol Violation|0|||
129755872|NCT03310723|467067919|FG001|Overall Study|Protocol Violation|2|||
129755873|NCT02098746|467067920|FG000|Overall Study|Changes of Investigator|2|||
129755874|NCT02098746|467067920|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129755875|NCT02098746|467067920|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
129755876|NCT02098746|467067920|FG000|Overall Study|Data Not Available After Treatment|1|||
129755877|NCT01410890|467067921|FG000|Overall Study|Withdrawal by Subject|0|||
129755878|NCT01410890|467067922|FG001|Overall Study|Withdrawal by Subject|1|||
129755879|NCT00217425|467067925|FG000|Overall Study|Never started treatment|2|||
129755880|NCT00217425|467067925|FG000|Overall Study|Patient ineligible|5|||
129755881|NCT00217425|467067925|FG000|Overall Study|Lack of Efficacy|13|||
129755882|NCT00217425|467067925|FG000|Overall Study|Adverse Event|8|||
129755883|NCT00217425|467067925|FG000|Overall Study|Withdrawal by Subject|4|||
129755884|NCT00217425|467067925|FG000|Overall Study|Other complicating disease|1|||
129755885|NCT00217425|467067925|FG000|Overall Study|Other|4|||
129755886|NCT01121146|467067926|FG000|Overall Study|Death|17|||
129755887|NCT01121146|467067927|FG001|Overall Study|Death|15|||
129755888|NCT01121146|467067926|FG000|Overall Study|Adverse Event|2|||
129755889|NCT01121146|467067927|FG001|Overall Study|Adverse Event|11|||
129755890|NCT01121146|467067926|FG000|Overall Study|Lost to Follow-up|7|||
129755891|NCT01121146|467067927|FG001|Overall Study|Lost to Follow-up|16|||
129755892|NCT00997035|467067930|FG000|3-week Followup Visit|Lost to Follow-up|9|||
129755893|NCT00997035|467067931|FG001|3-week Followup Visit|Lost to Follow-up|6|||
129755894|NCT00997035|467067930|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
129755895|NCT00997035|467067931|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
129755896|NCT02544503|467067932|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
129755897|NCT02544503|467067933|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
129755898|NCT02544503|467067932|FG000|Overall Study|Lost to Follow-up|9|||
129755899|NCT02544503|467067933|FG001|Overall Study|Lost to Follow-up|0|||
129755900|NCT02544503|467067932|FG000|Overall Study|Withdrawal by Subject|1|||
129755901|NCT02544503|467067933|FG001|Overall Study|Withdrawal by Subject|0|||
129755902|NCT03922581|467067939|FG000|Overall Study|Lost to Follow-up|20|||
129755903|NCT03922581|467067940|FG001|Overall Study|Lost to Follow-up|9|||
129755904|NCT03922581|467067939|FG000|Overall Study|Physician Decision|1|||
129755905|NCT03922581|467067940|FG001|Overall Study|Physician Decision|1|||
129755906|NCT03922581|467067939|FG000|Overall Study|Withdrawal by Subject|1|||
129755907|NCT03922581|467067940|FG001|Overall Study|Withdrawal by Subject|0|||
129755908|NCT04685798|467067943|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
129755909|NCT04640311|467067944|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
129755910|NCT04640311|467067945|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755911|NCT04640311|467067946|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755912|NCT04640311|467067947|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755913|NCT04640311|467067948|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755914|NCT04640311|467067949|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755915|NCT04640311|467067950|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755916|NCT04640311|467067951|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755917|NCT04640311|467067952|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755918|NCT04640311|467067953|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755919|NCT04640311|467067954|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755920|NCT04640311|467067955|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755921|NCT04640311|467067956|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755922|NCT04640311|467067944|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755923|NCT04640311|467067945|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
129755924|NCT04640311|467067946|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755925|NCT04640311|467067947|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755926|NCT04640311|467067948|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755927|NCT04640311|467067949|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755928|NCT04640311|467067950|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755929|NCT04640311|467067951|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755930|NCT04640311|467067952|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755931|NCT04640311|467067953|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755932|NCT04640311|467067954|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755933|NCT04640311|467067955|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755934|NCT04640311|467067956|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
129755935|NCT04640311|467067944|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755936|NCT04640311|467067945|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
129755937|NCT04640311|467067946|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755938|NCT04640311|467067947|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755939|NCT04640311|467067948|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755940|NCT04640311|467067949|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755941|NCT04640311|467067950|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755942|NCT04640311|467067951|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755943|NCT04640311|467067952|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755944|NCT04640311|467067953|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755945|NCT04640311|467067954|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755946|NCT04640311|467067955|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755947|NCT04640311|467067956|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755948|NCT04640311|467067944|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
129755949|NCT04640311|467067945|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
129755950|NCT04640311|467067946|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
129755951|NCT04640311|467067947|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755952|NCT04640311|467067948|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755953|NCT04640311|467067949|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755954|NCT04640311|467067950|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755955|NCT04640311|467067951|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755956|NCT04640311|467067952|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755957|NCT04640311|467067953|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755958|NCT04640311|467067954|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755959|NCT04640311|467067955|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755960|NCT04640311|467067956|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
129755961|NCT04640311|467067944|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755962|NCT04640311|467067945|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755963|NCT04640311|467067946|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
129755964|NCT04640311|467067947|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129810822|NCT00726986|467274954|FG000|Induction Phase|Adverse Event|4|||
129810823|NCT00726986|467274954|FG000|Induction Phase|Withdrawal by Subject|2|||
129810824|NCT00726986|467274954|FG000|Induction Phase|Death|2|||
129810825|NCT00726986|467274954|FG000|Induction Phase|Lack of Efficacy|5|||
129810826|NCT00726986|467274954|FG000|Induction Phase|Secondary Disease|2|||
129810827|NCT00726986|467274954|FG000|Maintenance Phase|Adverse Event|1|||
129810828|NCT00726986|467274954|FG000|Maintenance Phase|Lack of Efficacy|2|||
129810829|NCT00289133|467274955|FG000|Overall Study|Non-study device implanted|12|||
129810830|NCT00289133|467274956|FG001|Overall Study|Non-study device implanted|0|||
129810831|NCT00289133|467274955|FG000|Overall Study|Protocol Violation|32|||
129810832|NCT00289133|467274956|FG001|Overall Study|Protocol Violation|38|||
129810833|NCT00289133|467274955|FG000|Overall Study|Withdrawal by Subject|9|||
129810834|NCT00289133|467274956|FG001|Overall Study|Withdrawal by Subject|10|||
129810835|NCT00289133|467274955|FG000|Overall Study|Death|5|||
129810836|NCT00289133|467274956|FG001|Overall Study|Death|10|||
129810837|NCT00289133|467274955|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
129810838|NCT00289133|467274956|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
129810839|NCT00289133|467274955|FG000|Overall Study|Physician Decision|41|||
129755965|NCT04640311|467067948|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755966|NCT04640311|467067949|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755967|NCT04640311|467067950|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755968|NCT04640311|467067951|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755969|NCT04640311|467067952|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755970|NCT04640311|467067953|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755971|NCT04640311|467067954|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755972|NCT04640311|467067955|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755973|NCT04640311|467067956|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
129755974|NCT04640311|467067944|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755975|NCT04640311|467067945|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755976|NCT04640311|467067946|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755977|NCT04640311|467067947|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
129755978|NCT04640311|467067948|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755979|NCT04640311|467067949|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755980|NCT04640311|467067950|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
129755981|NCT04640311|467067951|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755982|NCT04640311|467067952|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755983|NCT04640311|467067953|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755984|NCT04640311|467067954|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755985|NCT04640311|467067955|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755986|NCT04640311|467067956|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
129755987|NCT04640311|467067944|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755988|NCT04640311|467067945|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755989|NCT04640311|467067946|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755990|NCT04640311|467067947|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755991|NCT04640311|467067948|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755992|NCT04640311|467067949|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
129755993|NCT04640311|467067950|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755994|NCT04640311|467067951|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755995|NCT04640311|467067952|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
129755996|NCT04640311|467067953|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755997|NCT04640311|467067954|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755998|NCT04640311|467067955|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129755999|NCT04640311|467067956|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
129756000|NCT04640311|467067944|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756001|NCT04640311|467067945|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756002|NCT04640311|467067946|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756003|NCT04640311|467067947|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756004|NCT04640311|467067948|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756005|NCT04640311|467067949|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756006|NCT04640311|467067950|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
129756007|NCT04640311|467067951|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756008|NCT04640311|467067952|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756009|NCT04640311|467067953|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756010|NCT04640311|467067954|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
129756011|NCT04640311|467067955|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756012|NCT04640311|467067956|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
129756013|NCT04640311|467067944|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756014|NCT04640311|467067945|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756015|NCT04640311|467067946|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756016|NCT04640311|467067947|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756017|NCT04640311|467067948|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756018|NCT04640311|467067949|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756019|NCT04640311|467067950|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756020|NCT04640311|467067951|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756021|NCT04640311|467067952|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756022|NCT04640311|467067953|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756023|NCT04640311|467067954|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756024|NCT04640311|467067955|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
129756025|NCT04640311|467067956|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
129756026|NCT03956550|467067957|FG000|Overall Study|Sponsor decision|65|||
129756027|NCT03956550|467067958|FG001|Overall Study|Sponsor decision|66|||
129756028|NCT03956550|467067959|FG002|Overall Study|Sponsor decision|64|||
129756029|NCT03956550|467067957|FG000|Overall Study|Adverse Event|0|||
129756030|NCT03956550|467067958|FG001|Overall Study|Adverse Event|1|||
129756031|NCT03956550|467067959|FG002|Overall Study|Adverse Event|0|||
129756032|NCT03956550|467067957|FG000|Overall Study|Withdrawal by Subject|5|||
129756033|NCT03956550|467067958|FG001|Overall Study|Withdrawal by Subject|5|||
129756034|NCT03956550|467067959|FG002|Overall Study|Withdrawal by Subject|6|||
129756035|NCT00592904|467067962|FG000|Overall Study|Adverse Event|15|||
129756036|NCT00592904|467067963|FG001|Overall Study|Adverse Event|25|||
129756037|NCT00592904|467067964|FG002|Overall Study|Adverse Event|13|||
129756038|NCT00592904|467067965|FG003|Overall Study|Adverse Event|5|||
129756039|NCT00592904|467067962|FG000|Overall Study|Protocol Violation|1|||
129756040|NCT00592904|467067963|FG001|Overall Study|Protocol Violation|1|||
129756041|NCT00592904|467067964|FG002|Overall Study|Protocol Violation|0|||
129756042|NCT00592904|467067965|FG003|Overall Study|Protocol Violation|1|||
129756043|NCT00592904|467067962|FG000|Overall Study|Withdrawal by Subject|4|||
129756044|NCT00592904|467067963|FG001|Overall Study|Withdrawal by Subject|16|||
129756045|NCT00592904|467067964|FG002|Overall Study|Withdrawal by Subject|1|||
129756046|NCT00592904|467067965|FG003|Overall Study|Withdrawal by Subject|2|||
129756047|NCT00592904|467067962|FG000|Overall Study|Lack of Efficacy|2|||
129756048|NCT00592904|467067963|FG001|Overall Study|Lack of Efficacy|7|||
129756049|NCT00592904|467067964|FG002|Overall Study|Lack of Efficacy|2|||
129756050|NCT00592904|467067965|FG003|Overall Study|Lack of Efficacy|3|||
129756051|NCT00592904|467067962|FG000|Overall Study|Physician Decision|0|||
129756052|NCT00592904|467067963|FG001|Overall Study|Physician Decision|3|||
129756053|NCT00592904|467067964|FG002|Overall Study|Physician Decision|1|||
129756054|NCT00592904|467067965|FG003|Overall Study|Physician Decision|0|||
129756055|NCT00592904|467067962|FG000|Overall Study|Other|3|||
129756056|NCT00592904|467067963|FG001|Overall Study|Other|3|||
129756057|NCT00592904|467067964|FG002|Overall Study|Other|0|||
129756058|NCT00592904|467067965|FG003|Overall Study|Other|0|||
129756059|NCT03191630|467067966|FG000|Overall Study|Lost to Follow-up|7|||
129756060|NCT03191630|467067967|FG001|Overall Study|Lost to Follow-up|7|||
129810840|NCT00289133|467274956|FG001|Overall Study|Physician Decision|45|||
129810841|NCT00289133|467274955|FG000|Overall Study|Revision|8|||
129810842|NCT00289133|467274956|FG001|Overall Study|Revision|6|||
129810843|NCT00289133|467274955|FG000|Overall Study|Lost to Follow-up|92|||
129810844|NCT00289133|467274956|FG001|Overall Study|Lost to Follow-up|115|||
129810845|NCT01513343|467274959|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
129810846|NCT01513343|467274960|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
129810847|NCT01513343|467274959|FG000|Post Data Collection|Dropped/withdrew from study|7|||
129810848|NCT01513343|467274960|FG001|Post Data Collection|Dropped/withdrew from study|1|||
129810849|NCT01513343|467274959|FG000|Post Data Collection|Lost to Follow-up|10|||
129810850|NCT01513343|467274960|FG001|Post Data Collection|Lost to Follow-up|23|||
129810851|NCT01513343|467274959|FG000|6-month Follow-up|Lost to Follow-up|28|||
129810852|NCT01513343|467274960|FG001|6-month Follow-up|Lost to Follow-up|17|||
129810853|NCT01513343|467274959|FG000|12-month Follow-up|Lost to Follow-up|10|||
129810854|NCT01513343|467274960|FG001|12-month Follow-up|Lost to Follow-up|3|||
129810855|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
129810856|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
129810857|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Progression|3|||
129810858|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
129810859|NCT00064337|467274961|FG000|PBSCC or Induction/PBSCC|Death|2|||
129810860|NCT00064337|467274961|FG000|Transplant|Adverse Event|9|||
129810861|NCT00064337|467274961|FG000|Transplant|Not protocol-specified|5|||
129810862|NCT00064337|467274961|FG000|Transplant|Death|3|||
129810863|NCT00064337|467274961|FG000|Transplant|Patient Refusal|2|||
129810864|NCT00064337|467274961|FG000|Transplant|Progression|2|||
129810865|NCT00064337|467274961|FG000|Maintenance|Adverse Event|3|||
129810866|NCT00064337|467274961|FG000|Maintenance|Progression|2|||
129756061|NCT03369418|467067972|FG000|Overall Study|Withdrawal by Subject|3|||
129756062|NCT03369418|467067973|FG001|Overall Study|Withdrawal by Subject|3|||
129756063|NCT01485094|467067974|FG000|Overall Study|Adverse Event|1|||
129756064|NCT01485094|467067975|FG001|Overall Study|Adverse Event|1|||
129756065|NCT01485094|467067976|FG002|Overall Study|Adverse Event|1|||
129756066|NCT01485094|467067974|FG000|Overall Study|Lost to Follow-up|1|||
129756067|NCT01485094|467067975|FG001|Overall Study|Lost to Follow-up|0|||
129756068|NCT01485094|467067976|FG002|Overall Study|Lost to Follow-up|0|||
129756069|NCT01485094|467067974|FG000|Overall Study|Withdrawal by Subject|1|||
129756070|NCT01485094|467067975|FG001|Overall Study|Withdrawal by Subject|1|||
129756071|NCT01485094|467067976|FG002|Overall Study|Withdrawal by Subject|0|||
129756072|NCT01367834|467067980|FG000|Overall Study|Withdrawal by Subject|2|||
129756073|NCT01367834|467067981|FG001|Overall Study|Withdrawal by Subject|2|||
129756074|NCT01367834|467067980|FG000|Overall Study|Study was ended.|0|||
129756075|NCT01367834|467067981|FG001|Overall Study|Study was ended.|1|||
129756076|NCT01618669|467067991|FG000|Overall Study|Lost to Follow-up|1|||
129756077|NCT01618669|467067992|FG001|Overall Study|Lost to Follow-up|1|||
129756078|NCT01618669|467067991|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
129756079|NCT01618669|467067992|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
129756080|NCT01618669|467067991|FG000|Overall Study|Adverse Event|16|||
129756081|NCT01618669|467067992|FG001|Overall Study|Adverse Event|7|||
129756082|NCT01618669|467067991|FG000|Overall Study|Protocol Violation|5|||
129756083|NCT01618669|467067992|FG001|Overall Study|Protocol Violation|3|||
129756084|NCT01618669|467067991|FG000|Overall Study|Withdrawal by Subject|9|||
129756085|NCT01618669|467067992|FG001|Overall Study|Withdrawal by Subject|9|||
129756086|NCT01618669|467067991|FG000|Overall Study|Miscellaneous Reason|0|||
129756087|NCT01618669|467067992|FG001|Overall Study|Miscellaneous Reason|1|||
129756088|NCT01702558|467067993|FG000|Overall Study|Withdrawal by Subject|0|||
129756089|NCT01702558|467067994|FG001|Overall Study|Withdrawal by Subject|0|||
129756090|NCT01702558|467067995|FG002|Overall Study|Withdrawal by Subject|0|||
129756091|NCT01702558|467067996|FG003|Overall Study|Withdrawal by Subject|12|||
129756092|NCT01702558|467067997|FG004|Overall Study|Withdrawal by Subject|4|||
129756093|NCT01702558|467067993|FG000|Overall Study|Lost to Follow-up|0|||
129756094|NCT01702558|467067994|FG001|Overall Study|Lost to Follow-up|0|||
129756095|NCT01702558|467067995|FG002|Overall Study|Lost to Follow-up|0|||
129756096|NCT01702558|467067996|FG003|Overall Study|Lost to Follow-up|3|||
129756097|NCT01702558|467067997|FG004|Overall Study|Lost to Follow-up|0|||
129756098|NCT01702558|467067993|FG000|Overall Study|Death|4|||
129756099|NCT01702558|467067994|FG001|Overall Study|Death|3|||
129756100|NCT01702558|467067995|FG002|Overall Study|Death|3|||
129756101|NCT01702558|467067996|FG003|Overall Study|Death|16|||
129756102|NCT01702558|467067997|FG004|Overall Study|Death|20|||
129756103|NCT01702558|467067993|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
129756104|NCT01702558|467067994|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
129756105|NCT01702558|467067995|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
129756106|NCT01702558|467067996|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
129756107|NCT01702558|467067997|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
129756108|NCT01702558|467067993|FG000|Overall Study|Study Terminated by Sponsor|0|||
129756109|NCT01702558|467067994|FG001|Overall Study|Study Terminated by Sponsor|1|||
129756110|NCT01702558|467067995|FG002|Overall Study|Study Terminated by Sponsor|0|||
129756111|NCT01702558|467067996|FG003|Overall Study|Study Terminated by Sponsor|0|||
129756112|NCT01702558|467067997|FG004|Overall Study|Study Terminated by Sponsor|1|||
129756113|NCT01702558|467067993|FG000|Overall Study|Other|0|||
129756114|NCT01702558|467067994|FG001|Overall Study|Other|0|||
129756115|NCT01702558|467067995|FG002|Overall Study|Other|0|||
129756116|NCT01702558|467067996|FG003|Overall Study|Other|16|||
129756117|NCT01702558|467067997|FG004|Overall Study|Other|17|||
129756118|NCT03259087|467068002|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129756119|NCT03259087|467068003|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129756120|NCT03259087|467068004|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129756121|NCT03259087|467068005|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
129756122|NCT03259087|467068006|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
129756123|NCT03259087|467068002|FG000|Period 2 of Part 2|Adverse Event|0|||
129756124|NCT03259087|467068003|FG001|Period 2 of Part 2|Adverse Event|0|||
129756125|NCT03259087|467068004|FG002|Period 2 of Part 2|Adverse Event|0|||
129756126|NCT03259087|467068005|FG003|Period 2 of Part 2|Adverse Event|0|||
129756127|NCT03259087|467068006|FG004|Period 2 of Part 2|Adverse Event|1|||
129810867|NCT00064337|467274961|FG000|Maintenance|On treatment at time of analysis|2|||
129810868|NCT00064337|467274961|FG000|Maintenance|Not protocol-specified|2|||
129810869|NCT00064337|467274961|FG000|Maintenance|Death|1|||
129810870|NCT01397890|467274962|FG000|Overall Study|Withdrawal by Subject|7|||
129810871|NCT01397890|467274963|FG001|Overall Study|Withdrawal by Subject|11|||
129810872|NCT01397890|467274962|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
129756128|NCT04950465|467068007|FG000|Overall Study|Lost to Follow-up|1|||
129756129|NCT04950465|467068008|FG001|Overall Study|Lost to Follow-up|0|||
129756130|NCT04950465|467068009|FG002|Overall Study|Lost to Follow-up|0|||
129810873|NCT01397890|467274963|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
129810874|NCT01397890|467274962|FG000|Overall Study|Death|2|||
129810875|NCT01397890|467274963|FG001|Overall Study|Death|3|||
129810876|NCT01397890|467274962|FG000|Overall Study|Lost to Follow-up|1|||
129810877|NCT01397890|467274963|FG001|Overall Study|Lost to Follow-up|4|||
129756131|NCT02366195|467068010|FG000|Overall Study|Protocol-specified criteria|3|||
129756132|NCT02366195|467068010|FG000|Overall Study|Withdrawal by Subject|9|||
129756133|NCT02366195|467068010|FG000|Overall Study|Lost to Follow-up|1|||
129756134|NCT02366195|467068010|FG000|Overall Study|Death|41|||
129756135|NCT01788566|467068011|FG000|Overall Study|Death|4|||
129756136|NCT01788566|467068011|FG000|Overall Study|Adverse Event|1|||
129756137|NCT01788566|467068011|FG000|Overall Study|Clinical Progressive Disease|3|||
129756138|NCT01620086|467068014|FG000|Overall Study|Withdrawal by Subject|3|||
129756139|NCT01620086|467068015|FG001|Overall Study|Withdrawal by Subject|3|||
129756140|NCT01620086|467068016|FG002|Overall Study|Withdrawal by Subject|0|||
129756141|NCT01620086|467068014|FG000|Overall Study|failed study criteria|1|||
129756142|NCT01620086|467068015|FG001|Overall Study|failed study criteria|4|||
129756143|NCT01620086|467068016|FG002|Overall Study|failed study criteria|0|||
129756144|NCT01620086|467068014|FG000|Overall Study|Physician Decision|1|||
129756145|NCT01620086|467068015|FG001|Overall Study|Physician Decision|0|||
129756146|NCT01620086|467068016|FG002|Overall Study|Physician Decision|0|||
129756147|NCT02562716|467068017|FG000|Overall Study|Adverse Event|7|||
129756148|NCT02562716|467068018|FG001|Overall Study|Adverse Event|14|||
129756149|NCT02562716|467068017|FG000|Overall Study|Withdrawal unrelated to AE|7|||
129756150|NCT02562716|467068018|FG001|Overall Study|Withdrawal unrelated to AE|1|||
129756151|NCT02562716|467068017|FG000|Overall Study|Progression|8|||
129756152|NCT02562716|467068018|FG001|Overall Study|Progression|10|||
129756153|NCT02562716|467068017|FG000|Overall Study|Death|2|||
129756154|NCT02562716|467068018|FG001|Overall Study|Death|1|||
129756155|NCT02562716|467068017|FG000|Overall Study|Not protocol specified|4|||
129756156|NCT02562716|467068018|FG001|Overall Study|Not protocol specified|2|||
129756157|NCT01539759|467068019|FG000|Overall Study|Lost to Follow-up|6|||
129756158|NCT01539759|467068020|FG001|Overall Study|Lost to Follow-up|8|||
129756159|NCT01425801|467068021|FG000|Period 1|Withdrawal by Subject|0|||
129756160|NCT01425801|467068022|FG001|Period 1|Withdrawal by Subject|0|||
129756161|NCT01425801|467068023|FG002|Period 1|Withdrawal by Subject|0|||
129756162|NCT01425801|467068024|FG003|Period 1|Withdrawal by Subject|0|||
129756163|NCT01425801|467068025|FG004|Period 1|Withdrawal by Subject|1|||
129756164|NCT01425801|467068026|FG005|Period 1|Withdrawal by Subject|0|||
129756165|NCT01425801|467068021|FG000|Period 2|Withdrawal by Subject|0|||
129756166|NCT01425801|467068022|FG001|Period 2|Withdrawal by Subject|0|||
129756167|NCT01425801|467068023|FG002|Period 2|Withdrawal by Subject|0|||
129810878|NCT01397890|467274962|FG000|Overall Study|Condition under Investigation Worsened|1|||
129810879|NCT01397890|467274963|FG001|Overall Study|Condition under Investigation Worsened|3|||
129810880|NCT01397890|467274962|FG000|Overall Study|Adverse Event|1|||
129810881|NCT01397890|467274963|FG001|Overall Study|Adverse Event|2|||
129810882|NCT01397890|467274962|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
129810883|NCT01397890|467274963|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
129810884|NCT01397890|467274962|FG000|Overall Study|Others|2|||
129810885|NCT01397890|467274963|FG001|Overall Study|Others|1|||
129810886|NCT00002651|467274964|FG000|Induction|Adverse Event|44|||
129810887|NCT00002651|467274965|FG001|Induction|Adverse Event|0|||
129810888|NCT00002651|467274966|FG002|Induction|Adverse Event|0|||
129810889|NCT00002651|467274964|FG000|Induction|Refusal unrelated to adverse event|50|||
129810890|NCT00002651|467274965|FG001|Induction|Refusal unrelated to adverse event|0|||
129810891|NCT00002651|467274966|FG002|Induction|Refusal unrelated to adverse event|0|||
129810892|NCT00002651|467274964|FG000|Induction|Progression/relapse|274|||
129810893|NCT00002651|467274965|FG001|Induction|Progression/relapse|0|||
129810894|NCT00002651|467274966|FG002|Induction|Progression/relapse|0|||
129810895|NCT00002651|467274964|FG000|Induction|Death|62|||
129810896|NCT00002651|467274965|FG001|Induction|Death|0|||
129810897|NCT00002651|467274966|FG002|Induction|Death|0|||
129810898|NCT00002651|467274964|FG000|Induction|Other|823|||
129810899|NCT00002651|467274965|FG001|Induction|Other|0|||
129810900|NCT00002651|467274966|FG002|Induction|Other|0|||
129810901|NCT00002651|467274964|FG000|Induction|not eligible|90|||
129810902|NCT00002651|467274965|FG001|Induction|not eligible|0|||
129810903|NCT00002651|467274966|FG002|Induction|not eligible|0|||
129810904|NCT00002651|467274964|FG000|Consolidation and Randomization|Adverse Event|0|||
129810905|NCT00002651|467274965|FG001|Consolidation and Randomization|Adverse Event|36|||
129810906|NCT00002651|467274966|FG002|Consolidation and Randomization|Adverse Event|14|||
129810907|NCT00002651|467274964|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
129810908|NCT00002651|467274965|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
129810909|NCT00002651|467274966|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
129810910|NCT00002651|467274964|FG000|Consolidation and Randomization|Progression/relapse|0|||
129810911|NCT00002651|467274965|FG001|Consolidation and Randomization|Progression/relapse|295|||
129810912|NCT00002651|467274966|FG002|Consolidation and Randomization|Progression/relapse|298|||
129810913|NCT00002651|467274964|FG000|Consolidation and Randomization|Death|0|||
129810914|NCT00002651|467274965|FG001|Consolidation and Randomization|Death|38|||
129810915|NCT00002651|467274966|FG002|Consolidation and Randomization|Death|48|||
129810916|NCT00002651|467274964|FG000|Consolidation and Randomization|Other|0|||
129810917|NCT00002651|467274965|FG001|Consolidation and Randomization|Other|314|||
129756168|NCT01425801|467068024|FG003|Period 2|Withdrawal by Subject|0|||
129810918|NCT00002651|467274966|FG002|Consolidation and Randomization|Other|313|||
129756169|NCT01425801|467068025|FG004|Period 2|Withdrawal by Subject|1|||
129756170|NCT01425801|467068026|FG005|Period 2|Withdrawal by Subject|0|||
129756171|NCT01425801|467068021|FG000|Period 3|Stability criteria not fullfilled|0|||
129756172|NCT01425801|467068022|FG001|Period 3|Stability criteria not fullfilled|0|||
129756173|NCT01425801|467068023|FG002|Period 3|Stability criteria not fullfilled|1|||
129756174|NCT01425801|467068024|FG003|Period 3|Stability criteria not fullfilled|0|||
129756175|NCT01425801|467068025|FG004|Period 3|Stability criteria not fullfilled|0|||
129756176|NCT01425801|467068026|FG005|Period 3|Stability criteria not fullfilled|0|||
129756177|NCT01425801|467068021|FG000|Period 4|Not able to maintain visit schedule|0|||
129756178|NCT01425801|467068022|FG001|Period 4|Not able to maintain visit schedule|0|||
129756179|NCT01425801|467068023|FG002|Period 4|Not able to maintain visit schedule|1|||
129756180|NCT01425801|467068024|FG003|Period 4|Not able to maintain visit schedule|0|||
129810919|NCT00002651|467274964|FG000|Consolidation and Randomization|not eligible|0|||
129810920|NCT00002651|467274965|FG001|Consolidation and Randomization|not eligible|102|||
129810921|NCT00002651|467274966|FG002|Consolidation and Randomization|not eligible|112|||
129810922|NCT03741062|467274969|FG000|Overall Study|Protocol Violation|1|||
129810923|NCT03741062|467274970|FG001|Overall Study|Protocol Violation|0|||
129810924|NCT02763462|467274973|FG000|Overall Study|Protocol Violation|6|||
129810925|NCT03417219|467274974|FG000|Overall Study|Lost to Follow-up|0|||
129810926|NCT03417219|467274975|FG001|Overall Study|Lost to Follow-up|3|||
129810927|NCT00261807|467274976|FG000|Overall Study|Lost to Follow-up|2|||
129810928|NCT00261807|467274976|FG000|Overall Study|Adverse Event|2|||
129810929|NCT00261807|467274976|FG000|Overall Study|Death|1|||
129810930|NCT00261807|467274976|FG000|Overall Study|Protocol Violation|2|||
129810931|NCT02527161|467274979|FG000|Overall Study|Failed MRI|52|||
129810932|NCT02527161|467274979|FG000|Overall Study|Withdrawal by Subject|19|||
129810933|NCT02527161|467274979|FG000|Overall Study|Delay in or unfit for surgery|16|||
129810934|NCT02527161|467274979|FG000|Overall Study|MRI contraindication|6|||
129810935|NCT02527161|467274979|FG000|Overall Study|Consent violation|4|||
129810936|NCT02527161|467274979|FG000|Overall Study|Only Recruited to Part A|27|||
129810937|NCT02527161|467274979|FG000|Overall Study|Physician Decision|1|||
129810938|NCT02527161|467274979|FG000|Overall Study|Adverse Event|1|||
129810939|NCT02527161|467274979|FG000|Overall Study|Lost to Follow-up|6|||
129810940|NCT05209360|467274980|FG000|Overall Study|Withdrawal by Subject|0|||
129810941|NCT05209360|467274981|FG001|Overall Study|Withdrawal by Subject|0|||
129810942|NCT05209360|467274982|FG002|Overall Study|Withdrawal by Subject|1|||
129810943|NCT05209360|467274983|FG003|Overall Study|Withdrawal by Subject|0|||
129810944|NCT05209360|467274984|FG004|Overall Study|Withdrawal by Subject|0|||
129810945|NCT05209360|467274985|FG005|Overall Study|Withdrawal by Subject|0|||
129810946|NCT02100514|467274986|FG000|Treatment Period|Adverse Event|0|||
129810947|NCT02100514|467274987|FG001|Treatment Period|Adverse Event|5|||
129810948|NCT02100514|467274988|FG002|Treatment Period|Adverse Event|0|||
129810949|NCT02100514|467274989|FG003|Treatment Period|Adverse Event|0|||
129810950|NCT02100514|467274990|FG004|Treatment Period|Adverse Event|0|||
129810951|NCT02100514|467274986|FG000|Treatment Period|Death|2|||
129810952|NCT02100514|467274987|FG001|Treatment Period|Death|2|||
129810953|NCT02100514|467274988|FG002|Treatment Period|Death|0|||
129810954|NCT02100514|467274989|FG003|Treatment Period|Death|0|||
129810955|NCT02100514|467274990|FG004|Treatment Period|Death|0|||
129810956|NCT02100514|467274986|FG000|Treatment Period|Lost to Follow-up|5|||
129810957|NCT02100514|467274987|FG001|Treatment Period|Lost to Follow-up|17|||
129810958|NCT02100514|467274988|FG002|Treatment Period|Lost to Follow-up|0|||
129810959|NCT02100514|467274989|FG003|Treatment Period|Lost to Follow-up|0|||
129810960|NCT02100514|467274990|FG004|Treatment Period|Lost to Follow-up|0|||
129810961|NCT02100514|467274986|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810962|NCT02100514|467274987|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
129810963|NCT02100514|467274988|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810964|NCT02100514|467274989|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810965|NCT02100514|467274990|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
129810966|NCT02100514|467274986|FG000|Treatment Period|Protocol Violation|1|||
129810967|NCT02100514|467274987|FG001|Treatment Period|Protocol Violation|1|||
129810968|NCT02100514|467274988|FG002|Treatment Period|Protocol Violation|0|||
129810969|NCT02100514|467274989|FG003|Treatment Period|Protocol Violation|0|||
129810970|NCT02100514|467274990|FG004|Treatment Period|Protocol Violation|0|||
129810971|NCT02100514|467274986|FG000|Treatment Period|Withdrawal by Subject|12|||
129810972|NCT02100514|467274987|FG001|Treatment Period|Withdrawal by Subject|37|||
129810973|NCT02100514|467274988|FG002|Treatment Period|Withdrawal by Subject|0|||
129810974|NCT02100514|467274989|FG003|Treatment Period|Withdrawal by Subject|0|||
129810975|NCT02100514|467274990|FG004|Treatment Period|Withdrawal by Subject|0|||
129810976|NCT02100514|467274986|FG000|Treatment Period|Other|9|||
129810977|NCT02100514|467274987|FG001|Treatment Period|Other|11|||
129810978|NCT02100514|467274988|FG002|Treatment Period|Other|0|||
129810979|NCT02100514|467274989|FG003|Treatment Period|Other|0|||
129810980|NCT02100514|467274990|FG004|Treatment Period|Other|0|||
129810981|NCT02100514|467274986|FG000|Extension Period|Withdrew consent|0|||
129810982|NCT02100514|467274987|FG001|Extension Period|Withdrew consent|0|||
129810983|NCT02100514|467274988|FG002|Extension Period|Withdrew consent|2|||
129810984|NCT02100514|467274989|FG003|Extension Period|Withdrew consent|0|||
129810985|NCT02100514|467274990|FG004|Extension Period|Withdrew consent|0|||
129810986|NCT00724932|467274991|FG000|Overall Study|Lost to Follow-up|1|||
129810987|NCT00724932|467274992|FG001|Overall Study|Lost to Follow-up|0|||
129810988|NCT00724932|467274991|FG000|Overall Study|Not treated|4|||
129810989|NCT00724932|467274992|FG001|Overall Study|Not treated|3|||
129810990|NCT00762229|467274993|FG000|Overall Study|Lost to Follow-up|1|||
129810991|NCT00762229|467274994|FG001|Overall Study|Lost to Follow-up|1|||
129810992|NCT00762229|467274993|FG000|Overall Study|did not recveive intervention|0|||
129810993|NCT00762229|467274994|FG001|Overall Study|did not recveive intervention|1|||
129810994|NCT04203498|467274997|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
129810995|NCT04203498|467274998|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
129810996|NCT04203498|467274997|FG000|Overall Study|Withdrawal of patient consent|7|||
129810997|NCT04203498|467274998|FG001|Overall Study|Withdrawal of patient consent|2|||
129810998|NCT04203498|467274997|FG000|Overall Study|Adverse Event|4|||
129810999|NCT04203498|467274998|FG001|Overall Study|Adverse Event|1|||
129811000|NCT04203498|467274997|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
129811001|NCT04203498|467274998|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
129811002|NCT04203498|467274997|FG000|Overall Study|Did not receive IMP|2|||
129811003|NCT04203498|467274998|FG001|Overall Study|Did not receive IMP|0|||
129811004|NCT01235689|467275000|FG000|Overall Study|Adverse Event|12|||
129811005|NCT01235689|467275001|FG001|Overall Study|Adverse Event|16|||
129811006|NCT01235689|467275000|FG000|Overall Study|Lack of Efficacy|12|||
129811007|NCT01235689|467275001|FG001|Overall Study|Lack of Efficacy|5|||
129811008|NCT01235689|467275000|FG000|Overall Study|Withdrawal by Subject|3|||
129756181|NCT01425801|467068025|FG004|Period 4|Not able to maintain visit schedule|0|||
129756182|NCT01425801|467068026|FG005|Period 4|Not able to maintain visit schedule|0|||
129756183|NCT02728089|467068027|FG000|Overall Study|Physician Decision|2|||
129756184|NCT02728089|467068027|FG000|Overall Study|Withdrawal by Subject|1|||
129756185|NCT00731679|467068030|FG000|Overall Study|Adverse Event|7|||
129756186|NCT00731679|467068031|FG001|Overall Study|Adverse Event|8|||
129756187|NCT00731679|467068030|FG000|Overall Study|Withdrawal by Subject|8|||
129756188|NCT00731679|467068031|FG001|Overall Study|Withdrawal by Subject|8|||
129756189|NCT00731679|467068030|FG000|Overall Study|Lost to Follow-up|7|||
129756190|NCT00731679|467068031|FG001|Overall Study|Lost to Follow-up|8|||
129756191|NCT00731679|467068030|FG000|Overall Study|Noncompliance|0|||
129756192|NCT00731679|467068031|FG001|Overall Study|Noncompliance|1|||
129756193|NCT00731679|467068030|FG000|Overall Study|Pregnancy|0|||
129756194|NCT00731679|467068031|FG001|Overall Study|Pregnancy|1|||
129756195|NCT02488005|467068032|FG000|Overall Study|Lost to Follow-up|2|||
129756196|NCT02326597|467068039|FG000|Overall Study|Lost to Follow-up|42|||
129756197|NCT02326597|467068040|FG001|Overall Study|Lost to Follow-up|32|||
129756198|NCT04089761|467068043|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
129756199|NCT04089761|467068043|FG000|"Run In Phase"|Lost to Follow-up|1|||
129756200|NCT04089761|467068043|FG000|"Treatment Phase"|No evaluable data|5|||
129756201|NCT04089761|467068043|FG000|"Treatment Phase"|Lost to Follow-up|1|||
129756202|NCT04739436|467068044|FG000|Overall Study|Lost to Follow-up|21|||
129811009|NCT01235689|467275001|FG001|Overall Study|Withdrawal by Subject|4|||
129756203|NCT04739436|467068045|FG001|Overall Study|Lost to Follow-up|23|||
129756204|NCT04739436|467068044|FG000|Overall Study|Withdrawal by Subject|4|||
129756205|NCT04739436|467068045|FG001|Overall Study|Withdrawal by Subject|6|||
129756206|NCT04739436|467068044|FG000|Overall Study|not randomized properly|1|||
129756207|NCT04739436|467068045|FG001|Overall Study|not randomized properly|0|||
129756208|NCT04628780|467068046|FG000|Overall Study|Death|0|||
129756209|NCT04628780|467068047|FG001|Overall Study|Death|1|||
129756210|NCT04628780|467068048|FG002|Overall Study|Death|0|||
129756211|NCT04628780|467068049|FG003|Overall Study|Death|0|||
129811010|NCT01235689|467275000|FG000|Overall Study|Lost to Follow-up|1|||
129811011|NCT01235689|467275001|FG001|Overall Study|Lost to Follow-up|2|||
129811012|NCT01235689|467275000|FG000|Overall Study|Miscellaneous|1|||
129756212|NCT04628780|467068050|FG004|Overall Study|Death|1|||
129811013|NCT01235689|467275001|FG001|Overall Study|Miscellaneous|5|||
129811014|NCT01443078|467275002|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
129811015|NCT01443078|467275002|FG000|Overall Study|Withdrawal by Subject|1|||
129811016|NCT01443078|467275002|FG000|Overall Study|Patient had brain mets|1|||
129811017|NCT00389597|467275007|FG000|Overall Study|Lost to Follow-up|8|||
129811018|NCT00389597|467275008|FG001|Overall Study|Lost to Follow-up|6|||
129896831|NCT01674569|467582134|FG002|Overall Study|Withdrawal by Subject|1|||
129896832|NCT01674569|467582135|FG003|Overall Study|Withdrawal by Subject|0|||
129896833|NCT01674569|467582136|FG004|Overall Study|Withdrawal by Subject|0|||
129896834|NCT01674569|467582137|FG005|Overall Study|Withdrawal by Subject|0|||
129756213|NCT04628780|467068051|FG005|Overall Study|Death|0|||
129756214|NCT04628780|467068046|FG000|Overall Study|Physician Decision|2|||
129756215|NCT04628780|467068047|FG001|Overall Study|Physician Decision|0|||
129756216|NCT04628780|467068048|FG002|Overall Study|Physician Decision|0|||
129756217|NCT04628780|467068049|FG003|Overall Study|Physician Decision|0|||
129756218|NCT04628780|467068050|FG004|Overall Study|Physician Decision|2|||
129756219|NCT04628780|467068051|FG005|Overall Study|Physician Decision|0|||
129756220|NCT04628780|467068046|FG000|Overall Study|Progressive disease|2|||
129756221|NCT04628780|467068047|FG001|Overall Study|Progressive disease|2|||
129756222|NCT04628780|467068048|FG002|Overall Study|Progressive disease|2|||
129756223|NCT04628780|467068049|FG003|Overall Study|Progressive disease|3|||
129756224|NCT04628780|467068050|FG004|Overall Study|Progressive disease|9|||
129756225|NCT04628780|467068051|FG005|Overall Study|Progressive disease|4|||
129756226|NCT04628780|467068046|FG000|Overall Study|Withdrawal by Subject|0|||
129756227|NCT04628780|467068047|FG001|Overall Study|Withdrawal by Subject|1|||
129756228|NCT04628780|467068048|FG002|Overall Study|Withdrawal by Subject|2|||
129756229|NCT04628780|467068049|FG003|Overall Study|Withdrawal by Subject|0|||
129756230|NCT04628780|467068050|FG004|Overall Study|Withdrawal by Subject|3|||
129756231|NCT04628780|467068051|FG005|Overall Study|Withdrawal by Subject|1|||
129756232|NCT04628780|467068046|FG000|Overall Study|Global deterioration of health status|0|||
129756233|NCT04628780|467068047|FG001|Overall Study|Global deterioration of health status|0|||
129756234|NCT04628780|467068048|FG002|Overall Study|Global deterioration of health status|0|||
129756235|NCT04628780|467068049|FG003|Overall Study|Global deterioration of health status|0|||
129756236|NCT04628780|467068050|FG004|Overall Study|Global deterioration of health status|1|||
129756237|NCT04628780|467068051|FG005|Overall Study|Global deterioration of health status|1|||
129756238|NCT03622814|467068053|FG000|Overall Study|Lost to Follow-up|8|||
129756239|NCT03622814|467068054|FG001|Overall Study|Lost to Follow-up|14|||
129756240|NCT01156714|467068057|FG000|Overall Study|Withdrawal by Subject|9|||
129756241|NCT01156714|467068058|FG001|Overall Study|Withdrawal by Subject|4|||
129756242|NCT01156714|467068059|FG002|Overall Study|Withdrawal by Subject|3|||
129756243|NCT04896593|467068065|FG000|Overall Study|Withdrawal by Subject|2|||
129756244|NCT04896593|467068065|FG000|Overall Study|Lost to Follow-up|1|||
129756245|NCT04896593|467068065|FG000|Overall Study|Did not complete onboarding|2|||
129756246|NCT02777827|467068066|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
129756247|NCT02777827|467068067|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
129756248|NCT02777827|467068068|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
129756249|NCT02777827|467068069|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
129756250|NCT02777827|467068070|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
129756251|NCT02777827|467068071|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
129756252|NCT00176462|467068072|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
129756253|NCT00176462|467068073|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
129756254|NCT00176462|467068072|FG000|Induction (4 Weeks)|Death|1|||
129756255|NCT00176462|467068073|FG001|Induction (4 Weeks)|Death|2|||
129756256|NCT00176462|467068072|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
129756257|NCT00176462|467068073|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
129756258|NCT00176462|467068072|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
129756259|NCT00176462|467068073|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
129756260|NCT00176462|467068072|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
129756261|NCT00176462|467068073|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
129896835|NCT04555044|467582145|FG000|Overall Study|Adverse Event|0|||
129896836|NCT04555044|467582146|FG001|Overall Study|Adverse Event|1|||
129896837|NCT04088188|467582148|FG000|Overall Study|Withdrawal by Subject|2|||
129756262|NCT00176462|467068072|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
129756263|NCT00176462|467068073|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
129756264|NCT00176462|467068072|FG000|Consolidation (12 Weeks)|Not documented|0|||
129756265|NCT00176462|467068073|FG001|Consolidation (12 Weeks)|Not documented|1|||
129896838|NCT04088188|467582149|FG001|Overall Study|Withdrawal by Subject|0|||
129896839|NCT04088188|467582148|FG000|Overall Study|Adverse Event|2|||
129756266|NCT00176462|467068072|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
129756267|NCT00176462|467068073|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
129756268|NCT00176462|467068072|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
129756269|NCT00176462|467068073|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
129756270|NCT01408459|467068074|FG000|Overall Study|Withdrawal by Subject|1|||
129756271|NCT01408459|467068075|FG001|Overall Study|Withdrawal by Subject|1|||
129756272|NCT01301833|467068080|FG000|Overall Study|Adverse Event|7|||
129756273|NCT01301833|467068081|FG001|Overall Study|Adverse Event|5|||
129756274|NCT01301833|467068082|FG002|Overall Study|Adverse Event|5|||
129756275|NCT01301833|467068083|FG003|Overall Study|Adverse Event|5|||
129756276|NCT01301833|467068080|FG000|Overall Study|Lack of Efficacy|1|||
129896840|NCT04088188|467582149|FG001|Overall Study|Adverse Event|0|||
129896841|NCT03601507|467582152|FG000|Overall Study|Adverse Event|1|||
129756277|NCT01301833|467068081|FG001|Overall Study|Lack of Efficacy|1|||
129756278|NCT01301833|467068082|FG002|Overall Study|Lack of Efficacy|0|||
129756279|NCT01301833|467068083|FG003|Overall Study|Lack of Efficacy|0|||
129756280|NCT01301833|467068080|FG000|Overall Study|Physician Decision|3|||
129756281|NCT01301833|467068081|FG001|Overall Study|Physician Decision|1|||
129756282|NCT01301833|467068082|FG002|Overall Study|Physician Decision|1|||
129756283|NCT01301833|467068083|FG003|Overall Study|Physician Decision|0|||
129756284|NCT01301833|467068080|FG000|Overall Study|Withdrawal by Subject|3|||
129756285|NCT01301833|467068081|FG001|Overall Study|Withdrawal by Subject|1|||
129756286|NCT01301833|467068082|FG002|Overall Study|Withdrawal by Subject|1|||
129756287|NCT01301833|467068083|FG003|Overall Study|Withdrawal by Subject|2|||
129756288|NCT01301833|467068080|FG000|Overall Study|Personal matter|1|||
129756289|NCT01301833|467068081|FG001|Overall Study|Personal matter|0|||
129756290|NCT01301833|467068082|FG002|Overall Study|Personal matter|0|||
129756291|NCT01301833|467068083|FG003|Overall Study|Personal matter|0|||
129756292|NCT02709330|467068084|FG000|Overall Study|Death|5|||
129756293|NCT02709330|467068085|FG001|Overall Study|Death|0|||
129756294|NCT02709330|467068084|FG000|Overall Study|Lost to Follow-up|2|||
129756295|NCT02709330|467068085|FG001|Overall Study|Lost to Follow-up|0|||
129756296|NCT02709330|467068084|FG000|Overall Study|Physician Decision|2|||
129756297|NCT02709330|467068085|FG001|Overall Study|Physician Decision|0|||
129756298|NCT02709330|467068084|FG000|Overall Study|Withdrawal by Subject|4|||
129756299|NCT02709330|467068085|FG001|Overall Study|Withdrawal by Subject|0|||
129756300|NCT01279681|467068086|FG000|Overall Study|Disease Progression|9|||
129756301|NCT01279681|467068087|FG001|Overall Study|Disease Progression|6|||
129756302|NCT01279681|467068086|FG000|Overall Study|Withdrawal by Subject|3|||
129756303|NCT01279681|467068087|FG001|Overall Study|Withdrawal by Subject|4|||
129756304|NCT01279681|467068086|FG000|Overall Study|Adverse Event|2|||
129756305|NCT01279681|467068087|FG001|Overall Study|Adverse Event|3|||
129756306|NCT01279681|467068086|FG000|Overall Study|Death|0|||
129756307|NCT01279681|467068087|FG001|Overall Study|Death|1|||
129756308|NCT01279681|467068086|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
129756309|NCT01279681|467068087|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
129756310|NCT01279681|467068086|FG000|Overall Study|Physician Decision|1|||
129756311|NCT01279681|467068087|FG001|Overall Study|Physician Decision|0|||
129896842|NCT02107014|467582155|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
129896843|NCT03761784|467582156|FG000|Overall Study|Adverse Event|4|||
129896844|NCT03761784|467582157|FG001|Overall Study|Adverse Event|0|||
129756312|NCT01279681|467068086|FG000|Overall Study|Other Reason|0|||
129756313|NCT01279681|467068087|FG001|Overall Study|Other Reason|2|||
129756314|NCT00330759|467069581|FG000|Overall Study|Death|316|||
129756315|NCT00330759|467069582|FG001|Overall Study|Death|310|||
129756316|NCT00330759|467069581|FG000|Overall Study|Disease progression|104|||
129756317|NCT00330759|467069582|FG001|Overall Study|Disease progression|126|||
129756318|NCT00330759|467069581|FG000|Overall Study|Withdrawal by Subject|143|||
129756319|NCT00330759|467069582|FG001|Overall Study|Withdrawal by Subject|124|||
129756320|NCT00330759|467069581|FG000|Overall Study|Adverse Event|48|||
129756321|NCT00330759|467069582|FG001|Overall Study|Adverse Event|36|||
129756322|NCT00330759|467069581|FG000|Overall Study|Participant request|31|||
129756323|NCT00330759|467069582|FG001|Overall Study|Participant request|22|||
129756324|NCT00330759|467069581|FG000|Overall Study|Lost to Follow-up|16|||
129756325|NCT00330759|467069582|FG001|Overall Study|Lost to Follow-up|22|||
129756326|NCT00330759|467069581|FG000|Overall Study|Noncompliance|15|||
129756327|NCT00330759|467069582|FG001|Overall Study|Noncompliance|17|||
129756328|NCT00330759|467069581|FG000|Overall Study|Physician Decision|1|||
129756329|NCT00330759|467069582|FG001|Overall Study|Physician Decision|2|||
129756330|NCT00330759|467069581|FG000|Overall Study|Protocol deviation|0|||
129756331|NCT00330759|467069582|FG001|Overall Study|Protocol deviation|2|||
129756332|NCT00330759|467069581|FG000|Overall Study|Ineligibility determined|2|||
129756333|NCT00330759|467069582|FG001|Overall Study|Ineligibility determined|1|||
129756334|NCT00330759|467069581|FG000|Overall Study|Other|36|||
129756335|NCT00330759|467069582|FG001|Overall Study|Other|44|||
129756336|NCT01380769|467069587|FG000|Overall Study|Withdrawal by Subject|7|||
129756337|NCT01380769|467069588|FG001|Overall Study|Withdrawal by Subject|11|||
129756338|NCT01380769|467069587|FG000|Overall Study|Physician Decision|1|||
129756339|NCT01380769|467069588|FG001|Overall Study|Physician Decision|1|||
129756340|NCT01380769|467069587|FG000|Overall Study|Adverse Event|1|||
129756341|NCT01380769|467069588|FG001|Overall Study|Adverse Event|1|||
129756342|NCT01380769|467069587|FG000|Overall Study|Protocol Violation|0|||
129756343|NCT01380769|467069588|FG001|Overall Study|Protocol Violation|1|||
129756344|NCT03654690|467069589|FG000|Overall Study|Withdrawal by Subject|1|||
129756345|NCT03654690|467069590|FG001|Overall Study|Withdrawal by Subject|0|||
129756346|NCT03654690|467069591|FG002|Overall Study|Withdrawal by Subject|0|||
129756347|NCT00742183|467069594|FG000|Overall Study|Adverse Event|2|||
129756348|NCT00742183|467069595|FG001|Overall Study|Adverse Event|2|||
129756349|NCT00742183|467069594|FG000|Overall Study|Death|1|||
129756350|NCT00742183|467069595|FG001|Overall Study|Death|0|||
129896845|NCT03761784|467582156|FG000|Overall Study|Lost to Follow-up|10|||
129756351|NCT00742183|467069594|FG000|Overall Study|Physician Decision|0|||
129756352|NCT00742183|467069595|FG001|Overall Study|Physician Decision|2|||
129811019|NCT00389597|467275009|FG002|Overall Study|Lost to Follow-up|4|||
129811020|NCT00389597|467275010|FG003|Overall Study|Lost to Follow-up|6|||
129811021|NCT02106975|467275013|FG000|Overall Study|Death|25|||
129811022|NCT02106975|467275014|FG001|Overall Study|Death|39|||
129811023|NCT03546062|467275015|FG000|Overall Study|Adverse Event|6|||
129811024|NCT03546062|467275016|FG001|Overall Study|Adverse Event|5|||
129811025|NCT03546062|467275017|FG002|Overall Study|Adverse Event|8|||
129811026|NCT00087607|467275018|FG000|Overall Study|Adverse Event|14|||
129811027|NCT00087607|467275019|FG001|Overall Study|Adverse Event|24|||
129811028|NCT00087607|467275018|FG000|Overall Study|Death|0|||
129811029|NCT00087607|467275019|FG001|Overall Study|Death|1|||
129811030|NCT00087607|467275018|FG000|Overall Study|Insufficient Therapeutic Response|53|||
129811031|NCT00087607|467275019|FG001|Overall Study|Insufficient Therapeutic Response|42|||
129811032|NCT00087607|467275018|FG000|Overall Study|Failure to return|21|||
129811033|NCT00087607|467275019|FG001|Overall Study|Failure to return|17|||
129811034|NCT00087607|467275018|FG000|Overall Study|Withdrew Consent|12|||
129811035|NCT00087607|467275019|FG001|Overall Study|Withdrew Consent|16|||
129811036|NCT00087607|467275018|FG000|Overall Study|Administrative|12|||
129811037|NCT00087607|467275019|FG001|Overall Study|Administrative|12|||
129811038|NCT00087607|467275018|FG000|Overall Study|Refused Treatment|5|||
129811039|NCT00087607|467275019|FG001|Overall Study|Refused Treatment|7|||
129811040|NCT00087607|467275018|FG000|Overall Study|Other Protocol Violation|5|||
129811041|NCT00087607|467275019|FG001|Overall Study|Other Protocol Violation|2|||
129811042|NCT00087607|467275018|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129811043|NCT00087607|467275019|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129811044|NCT02015754|467275020|FG000|Overall Study|Disease progression|5|||
129811045|NCT02015754|467275020|FG000|Overall Study|Change in treatment modality|5|||
129811046|NCT02015754|467275020|FG000|Overall Study|Lost to Follow-up|1|||
129811047|NCT00939770|467275024|FG000|Overall Study|Adverse Event|1|||
129811048|NCT00939770|467275025|FG001|Overall Study|Adverse Event|1|||
129811049|NCT00939770|467275026|FG002|Overall Study|Adverse Event|0|||
129811050|NCT00939770|467275027|FG003|Overall Study|Adverse Event|0|||
129811051|NCT00939770|467275028|FG004|Overall Study|Adverse Event|6|||
129811052|NCT00939770|467275029|FG005|Overall Study|Adverse Event|2|||
129811053|NCT00939770|467275030|FG006|Overall Study|Adverse Event|1|||
129811054|NCT00939770|467275031|FG007|Overall Study|Adverse Event|1|||
129811055|NCT00939770|467275024|FG000|Overall Study|Lack of Efficacy|4|||
129811056|NCT00939770|467275025|FG001|Overall Study|Lack of Efficacy|6|||
129811057|NCT00939770|467275026|FG002|Overall Study|Lack of Efficacy|13|||
129811058|NCT00939770|467275027|FG003|Overall Study|Lack of Efficacy|9|||
129811059|NCT00939770|467275028|FG004|Overall Study|Lack of Efficacy|16|||
129811060|NCT00939770|467275029|FG005|Overall Study|Lack of Efficacy|8|||
129811061|NCT00939770|467275030|FG006|Overall Study|Lack of Efficacy|11|||
129811062|NCT00939770|467275031|FG007|Overall Study|Lack of Efficacy|1|||
129811063|NCT00939770|467275024|FG000|Overall Study|Lost to Follow-up|0|||
129811064|NCT00939770|467275025|FG001|Overall Study|Lost to Follow-up|0|||
129811065|NCT00939770|467275026|FG002|Overall Study|Lost to Follow-up|0|||
129811066|NCT00939770|467275027|FG003|Overall Study|Lost to Follow-up|0|||
129811067|NCT00939770|467275028|FG004|Overall Study|Lost to Follow-up|1|||
129811068|NCT00939770|467275029|FG005|Overall Study|Lost to Follow-up|0|||
129811069|NCT00939770|467275030|FG006|Overall Study|Lost to Follow-up|0|||
129811070|NCT00939770|467275031|FG007|Overall Study|Lost to Follow-up|0|||
129811071|NCT00939770|467275024|FG000|Overall Study|Physician Decision|0|||
129811072|NCT00939770|467275025|FG001|Overall Study|Physician Decision|0|||
129811073|NCT00939770|467275026|FG002|Overall Study|Physician Decision|2|||
129811074|NCT00939770|467275027|FG003|Overall Study|Physician Decision|0|||
129811075|NCT00939770|467275028|FG004|Overall Study|Physician Decision|7|||
129811076|NCT00939770|467275029|FG005|Overall Study|Physician Decision|1|||
129811077|NCT00939770|467275030|FG006|Overall Study|Physician Decision|0|||
129811078|NCT00939770|467275031|FG007|Overall Study|Physician Decision|6|||
129811079|NCT00939770|467275024|FG000|Overall Study|Protocol Violation|0|||
129811080|NCT00939770|467275025|FG001|Overall Study|Protocol Violation|0|||
129811081|NCT00939770|467275026|FG002|Overall Study|Protocol Violation|0|||
129811082|NCT00939770|467275027|FG003|Overall Study|Protocol Violation|0|||
129811083|NCT00939770|467275028|FG004|Overall Study|Protocol Violation|1|||
129811084|NCT00939770|467275029|FG005|Overall Study|Protocol Violation|0|||
129811085|NCT00939770|467275030|FG006|Overall Study|Protocol Violation|0|||
129811086|NCT00939770|467275031|FG007|Overall Study|Protocol Violation|0|||
129811087|NCT00939770|467275024|FG000|Overall Study|Withdrawal by Subject|0|||
129811088|NCT00939770|467275025|FG001|Overall Study|Withdrawal by Subject|1|||
129811089|NCT00939770|467275026|FG002|Overall Study|Withdrawal by Subject|5|||
129811090|NCT00939770|467275027|FG003|Overall Study|Withdrawal by Subject|2|||
129811091|NCT00939770|467275028|FG004|Overall Study|Withdrawal by Subject|6|||
129811092|NCT00939770|467275029|FG005|Overall Study|Withdrawal by Subject|0|||
129811093|NCT00939770|467275030|FG006|Overall Study|Withdrawal by Subject|2|||
129811094|NCT00939770|467275031|FG007|Overall Study|Withdrawal by Subject|2|||
129811095|NCT03137537|467275032|FG000|Overall Study|Adverse Event|0|||
129811096|NCT03137537|467275033|FG001|Overall Study|Adverse Event|1|||
129811097|NCT00293033|467275034|FG000|Open-label Titration Period|Adverse Event|10|||
129811098|NCT00293033|467275034|FG000|Open-label Titration Period|Death|3|||
129756353|NCT00742183|467069594|FG000|Overall Study|Lost to Follow-up|4|||
129756354|NCT00742183|467069595|FG001|Overall Study|Lost to Follow-up|4|||
129756355|NCT00742183|467069594|FG000|Overall Study|Required skin-graft|1|||
129756356|NCT00742183|467069595|FG001|Overall Study|Required skin-graft|1|||
129756357|NCT00742183|467069594|FG000|Overall Study|Withdrawal by Subject|1|||
129756358|NCT00742183|467069595|FG001|Overall Study|Withdrawal by Subject|0|||
129811099|NCT00293033|467275034|FG000|Open-label Titration Period|Lack of Efficacy|5|||
129811100|NCT00293033|467275034|FG000|Open-label Titration Period|Protocol Violation|2|||
129811101|NCT00293033|467275034|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
129811102|NCT00293033|467275034|FG000|Open-label Titration Period|Noncompliance and other|27|||
129811103|NCT00293033|467275034|FG000|Double-blind Treatment Period|Adverse Event|3|||
129811104|NCT00293033|467275034|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
129811105|NCT00293033|467275034|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
129811106|NCT00293033|467275034|FG000|Double-blind Treatment Period|Noncompliance|4|||
129811107|NCT00816595|467275035|FG000|Overall Study|Withdrawal by Subject|2|||
129811108|NCT00816595|467275036|FG001|Overall Study|Withdrawal by Subject|0|||
129811109|NCT00365508|467275040|FG000|Overall Study|Lost to Follow-up|139|||
129811110|NCT00365508|467275041|FG001|Overall Study|Lost to Follow-up|154|||
129811111|NCT00873912|467275049|FG000|Overall Study|Withdrawal by Subject|1|||
129811112|NCT00873912|467275050|FG001|Overall Study|Withdrawal by Subject|0|||
129811113|NCT00873912|467275049|FG000|Overall Study|Lost to Follow-up|2|||
129811114|NCT00873912|467275050|FG001|Overall Study|Lost to Follow-up|0|||
129811115|NCT01466153|467275051|FG000|Overall Study|Disease Progression|2|||
129811116|NCT01466153|467275052|FG001|Overall Study|Disease Progression|2|||
129811117|NCT01466153|467275053|FG002|Overall Study|Disease Progression|0|||
129811118|NCT01466153|467275051|FG000|Overall Study|Adverse Event|14|||
129811119|NCT01466153|467275052|FG001|Overall Study|Adverse Event|13|||
129811120|NCT01466153|467275053|FG002|Overall Study|Adverse Event|17|||
129811121|NCT01466153|467275051|FG000|Overall Study|Withdrawal of Consent|2|||
129811122|NCT01466153|467275052|FG001|Overall Study|Withdrawal of Consent|0|||
129811123|NCT01466153|467275053|FG002|Overall Study|Withdrawal of Consent|0|||
129811124|NCT01466153|467275051|FG000|Overall Study|Investigator Discretion|3|||
129811125|NCT01466153|467275052|FG001|Overall Study|Investigator Discretion|2|||
129811126|NCT01466153|467275053|FG002|Overall Study|Investigator Discretion|2|||
129811127|NCT01466153|467275051|FG000|Overall Study|Randomized-Not Treated|2|||
129811128|NCT01466153|467275052|FG001|Overall Study|Randomized-Not Treated|3|||
129811129|NCT01466153|467275053|FG002|Overall Study|Randomized-Not Treated|4|||
129811130|NCT01466153|467275051|FG000|Overall Study|Other-Unspecified|6|||
129811131|NCT01466153|467275052|FG001|Overall Study|Other-Unspecified|4|||
129811132|NCT01466153|467275053|FG002|Overall Study|Other-Unspecified|2|||
129811133|NCT05695209|467275060|FG000|3-months|Withdrawal by Subject|2|||
129811134|NCT05695209|467275061|FG001|3-months|Withdrawal by Subject|0|||
129811135|NCT05695209|467275060|FG000|3-months|Unable to contact for 3-month data collection|0|||
129811136|NCT05695209|467275061|FG001|3-months|Unable to contact for 3-month data collection|1|||
129811137|NCT05695209|467275060|FG000|6-months|Lost to Follow-up|1|||
129811138|NCT05695209|467275061|FG001|6-months|Lost to Follow-up|1|||
129811139|NCT03749447|467276341|FG000|Overall Study|Adverse Event|11|||
129811140|NCT03749447|467276342|FG001|Overall Study|Adverse Event|3|||
129811141|NCT03749447|467276341|FG000|Overall Study|Death|1|||
129811142|NCT03749447|467276342|FG001|Overall Study|Death|1|||
129811143|NCT03749447|467276341|FG000|Overall Study|Lost to Follow-up|2|||
129811144|NCT03749447|467276342|FG001|Overall Study|Lost to Follow-up|2|||
129811145|NCT03749447|467276341|FG000|Overall Study|Reason Not Specified|0|||
129811146|NCT03749447|467276342|FG001|Overall Study|Reason Not Specified|3|||
129811147|NCT03749447|467276341|FG000|Overall Study|Physician Decision|4|||
129811148|NCT03749447|467276342|FG001|Overall Study|Physician Decision|3|||
129811149|NCT03749447|467276341|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
129811150|NCT03749447|467276342|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
129811151|NCT03749447|467276341|FG000|Overall Study|Study Terminated By Sponsor|112|||
129811152|NCT03749447|467276342|FG001|Overall Study|Study Terminated By Sponsor|105|||
129811153|NCT03749447|467276341|FG000|Overall Study|Withdrawal by Subject|12|||
129811154|NCT03749447|467276342|FG001|Overall Study|Withdrawal by Subject|6|||
129756359|NCT00742183|467069594|FG000|Overall Study|Lack of Efficacy|0|||
129811155|NCT03749447|467276341|FG000|Overall Study|Non-compliance With Study Drug|0|||
129811156|NCT03749447|467276342|FG001|Overall Study|Non-compliance With Study Drug|1|||
129811157|NCT03486223|467276347|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
129811158|NCT03486223|467276348|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
129811159|NCT02279420|467276349|FG000|Overall Study|Lost to Follow-up|23|||
129756360|NCT00742183|467069595|FG001|Overall Study|Lack of Efficacy|3|||
129756361|NCT00786799|467069599|FG000|Overall Study|Lost to Follow-up|1|||
129811160|NCT01153347|467276352|FG000|Overall Study|Withdrawal by Subject|7|||
129811161|NCT01153347|467276353|FG001|Overall Study|Withdrawal by Subject|7|||
129811162|NCT01153347|467276354|FG002|Overall Study|Withdrawal by Subject|7|||
129756362|NCT00786799|467069600|FG001|Overall Study|Lost to Follow-up|1|||
129756363|NCT01080807|467069601|FG000|Overall Study|Adverse Event|9|||
129756364|NCT01080807|467069602|FG001|Overall Study|Adverse Event|1|||
129756365|NCT01080807|467069601|FG000|Overall Study|Lack of Efficacy|0|||
129756366|NCT01080807|467069602|FG001|Overall Study|Lack of Efficacy|1|||
129756367|NCT01080807|467069601|FG000|Overall Study|Withdrawal by Subject|7|||
129756368|NCT01080807|467069602|FG001|Overall Study|Withdrawal by Subject|2|||
129756369|NCT01080807|467069601|FG000|Overall Study|Protocol Violation|7|||
129756370|NCT01080807|467069602|FG001|Overall Study|Protocol Violation|6|||
129756371|NCT01080807|467069601|FG000|Overall Study|Lost to Follow-up|6|||
129756372|NCT01080807|467069602|FG001|Overall Study|Lost to Follow-up|4|||
129756373|NCT01080807|467069601|FG000|Overall Study|Noncompliance with drug administration|1|||
129756374|NCT01080807|467069602|FG001|Overall Study|Noncompliance with drug administration|1|||
129756375|NCT01080807|467069601|FG000|Overall Study|Noncompliance to study procedures|1|||
129756376|NCT01080807|467069602|FG001|Overall Study|Noncompliance to study procedures|1|||
129756377|NCT01080807|467069601|FG000|Overall Study|Began working day shift|0|||
129756378|NCT01080807|467069602|FG001|Overall Study|Began working day shift|2|||
129756379|NCT01080807|467069601|FG000|Overall Study|Laid off or terminated from job|1|||
129756380|NCT01080807|467069602|FG001|Overall Study|Laid off or terminated from job|2|||
129756381|NCT01080807|467069601|FG000|Overall Study|Stopped working consistent night shifts|0|||
129756382|NCT01080807|467069602|FG001|Overall Study|Stopped working consistent night shifts|1|||
129756383|NCT01080807|467069601|FG000|Overall Study|Work schedule changing|1|||
129756384|NCT01080807|467069602|FG001|Overall Study|Work schedule changing|1|||
129756385|NCT01080807|467069601|FG000|Overall Study|Work schedule and travel|0|||
129756386|NCT01080807|467069602|FG001|Overall Study|Work schedule and travel|1|||
129756387|NCT01080807|467069601|FG000|Overall Study|Switched to first shift|1|||
129756388|NCT01080807|467069602|FG001|Overall Study|Switched to first shift|0|||
129756389|NCT01080807|467069601|FG000|Overall Study|Moved away without notifying center|1|||
129756390|NCT01080807|467069602|FG001|Overall Study|Moved away without notifying center|0|||
129756391|NCT02223715|467069606|FG000|Overall Study|Death|31|||
129756392|NCT02223715|467069606|FG000|Overall Study|Lost to Follow-up|73|||
129756393|NCT01745367|467069607|FG000|Overall Study|Death|1|||
129756394|NCT01745367|467069608|FG001|Overall Study|Death|0|||
129756395|NCT01745367|467069607|FG000|Overall Study|Withdrawal by Subject|1|||
129756396|NCT01745367|467069608|FG001|Overall Study|Withdrawal by Subject|2|||
129756397|NCT01745367|467069607|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
129756398|NCT01745367|467069608|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
129756399|NCT01745367|467069607|FG000|Overall Study|Other Reasons Unspecified|0|||
129756400|NCT01745367|467069608|FG001|Overall Study|Other Reasons Unspecified|2|||
129756401|NCT01359904|467069610|FG000|Overall Study|Withdrawal by Subject|1|||
129756402|NCT01359904|467069611|FG001|Overall Study|Withdrawal by Subject|0|||
129756403|NCT02640547|467069613|FG000|Overall Study|Failure to Return|1|||
129756404|NCT02640547|467069613|FG000|Overall Study|Withdrawal by Subject|1|||
129756405|NCT02640547|467069613|FG000|Overall Study|Death|6|||
129756406|NCT02640547|467069613|FG000|Overall Study|Miscellaneous|3|||
129756407|NCT02525588|467069614|FG000|Overall Study|Death|3|||
129756408|NCT02525588|467069615|FG001|Overall Study|Death|1|||
129756409|NCT02525588|467069614|FG000|Overall Study|Lost to Follow-up|2|||
129756410|NCT02525588|467069615|FG001|Overall Study|Lost to Follow-up|0|||
129756411|NCT02525588|467069614|FG000|Overall Study|Withdrawal by Subject|1|||
129756412|NCT02525588|467069615|FG001|Overall Study|Withdrawal by Subject|1|||
129756413|NCT02525588|467069614|FG000|Overall Study|Adverse Event|0|||
129756414|NCT02525588|467069615|FG001|Overall Study|Adverse Event|1|||
129756415|NCT03018691|467069618|FG000|Overall Study|Adverse Event|1|||
129756416|NCT03018691|467069619|FG001|Overall Study|Adverse Event|1|||
129756417|NCT03018691|467069620|FG002|Overall Study|Adverse Event|4|||
129756418|NCT03018691|467069618|FG000|Overall Study|Lack of Efficacy|0|||
129811163|NCT01153347|467276355|FG003|Overall Study|Withdrawal by Subject|7|||
129811164|NCT01153347|467276352|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129811165|NCT01153347|467276353|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129811166|NCT01153347|467276354|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
129811167|NCT01153347|467276355|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129811168|NCT01153347|467276352|FG000|Overall Study|Adverse Event|3|||
129811169|NCT01153347|467276353|FG001|Overall Study|Adverse Event|9|||
129756419|NCT03018691|467069619|FG001|Overall Study|Lack of Efficacy|0|||
129756420|NCT03018691|467069620|FG002|Overall Study|Lack of Efficacy|1|||
129756421|NCT03018691|467069618|FG000|Overall Study|Withdrawal by Subject|0|||
129756422|NCT03018691|467069619|FG001|Overall Study|Withdrawal by Subject|0|||
129756423|NCT03018691|467069620|FG002|Overall Study|Withdrawal by Subject|1|||
129756424|NCT03018691|467069618|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129756425|NCT03018691|467069619|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129756426|NCT03018691|467069620|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129811170|NCT01153347|467276354|FG002|Overall Study|Adverse Event|21|||
129756427|NCT01020786|467069625|FG000|Induction Period|Entry Criteria Not Met|2|||
129756428|NCT01020786|467069625|FG000|Induction Period|Adverse Event|10|||
129756429|NCT01020786|467069625|FG000|Induction Period|Progressive Disease|31|||
129756430|NCT01020786|467069625|FG000|Induction Period|Investigator Decision|3|||
129811171|NCT01153347|467276355|FG003|Overall Study|Adverse Event|7|||
129756431|NCT01020786|467069625|FG000|Induction Period|Withdrawal by Subject|3|||
129756432|NCT01020786|467069625|FG000|Maintenance Period|Adverse Event|8|||
129756433|NCT01020786|467069625|FG000|Maintenance Period|Progressive Disease|43|||
129756434|NCT01020786|467069625|FG000|Maintenance Period|Withdrawal by Subject|8|||
129756435|NCT01020786|467069625|FG000|Maintenance Period|Sponsor Decision|1|||
129756436|NCT01521507|467069636|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
129756437|NCT01521507|467069637|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
129756438|NCT01521507|467069636|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
129756439|NCT01521507|467069637|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
129756440|NCT01521507|467069636|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
129756441|NCT01521507|467069637|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
129756442|NCT01521507|467069636|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
129756443|NCT01521507|467069637|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
129756444|NCT01521507|467069636|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
129756445|NCT01521507|467069637|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
129756446|NCT01521507|467069636|FG000|Stage 2: Observational Design|Physician Decision|1|||
129756447|NCT01521507|467069637|FG001|Stage 2: Observational Design|Physician Decision|0|||
129756448|NCT01358825|467069642|FG000|Overall Study|Blood sample not drawn|0|||
129756449|NCT01358825|467069643|FG001|Overall Study|Blood sample not drawn|1|||
129756450|NCT01479868|467069644|FG000|Overall Study|Adverse Event|1|||
129756451|NCT01479868|467069644|FG000|Overall Study|Lost to Follow-up|4|||
129756452|NCT01479868|467069644|FG000|Overall Study|Protocol Violation|1|||
129756453|NCT01479868|467069644|FG000|Overall Study|Withdrawal by Subject|1|||
129756454|NCT01479868|467069644|FG000|Overall Study|Sponsor's Decision|1|||
129756455|NCT01479868|467069644|FG000|Overall Study|Initiation of new HCV Therapy|1|||
129756456|NCT01508169|467069648|FG000|Overall Study|Adverse Event|1|||
129756457|NCT01508169|467069649|FG001|Overall Study|Adverse Event|0|||
129756458|NCT01508169|467069648|FG000|Overall Study|Withdrawal by Subject|1|||
129756459|NCT01508169|467069649|FG001|Overall Study|Withdrawal by Subject|0|||
129756460|NCT01508169|467069648|FG000|Overall Study|Lost to Follow-up|1|||
129756461|NCT01508169|467069649|FG001|Overall Study|Lost to Follow-up|2|||
129756462|NCT00580723|467069656|FG000|Overall Study|Did not want to participate in extension|3|||
129756463|NCT00580723|467069656|FG000|Overall Study|Lost to Follow-up|5|||
129756464|NCT05202418|467069657|FG000|Overall Study|Withdrawal by Subject|2|||
129756465|NCT05202418|467069658|FG001|Overall Study|Withdrawal by Subject|1|||
129756466|NCT05202418|467069657|FG000|Overall Study|Lost to Follow-up|1|||
129756467|NCT05202418|467069658|FG001|Overall Study|Lost to Follow-up|1|||
129756468|NCT02753946|467069659|FG000|Overall Study|Adverse Event|7|||
129756469|NCT02753946|467069660|FG001|Overall Study|Adverse Event|6|||
129756470|NCT02753946|467069659|FG000|Overall Study|Withdrawal by Subject|6|||
129756471|NCT02753946|467069660|FG001|Overall Study|Withdrawal by Subject|1|||
129756472|NCT02753946|467069659|FG000|Overall Study|Lack of Efficacy|1|||
129756473|NCT02753946|467069660|FG001|Overall Study|Lack of Efficacy|0|||
129756474|NCT02753946|467069659|FG000|Overall Study|Physician Decision|0|||
129756475|NCT02753946|467069660|FG001|Overall Study|Physician Decision|2|||
129811172|NCT01153347|467276352|FG000|Overall Study|Severe non-compliance to protocol|6|||
129811173|NCT01153347|467276353|FG001|Overall Study|Severe non-compliance to protocol|7|||
129811174|NCT01153347|467276354|FG002|Overall Study|Severe non-compliance to protocol|4|||
129811175|NCT01153347|467276355|FG003|Overall Study|Severe non-compliance to protocol|3|||
129811176|NCT01153347|467276352|FG000|Overall Study|Condition under investigation worsened|1|||
129811177|NCT01153347|467276353|FG001|Overall Study|Condition under investigation worsened|1|||
129756476|NCT02519439|467069661|FG000|Overall Study|Study Termination|19|||
129756477|NCT02519439|467069661|FG000|Overall Study|Withdrawal by Subject|1|||
129756478|NCT02519439|467069661|FG000|Overall Study|Adverse Event|1|||
129756479|NCT03901144|467069665|FG000|Overall Study|Lost to Follow-up|1|||
129756480|NCT03901144|467069666|FG001|Overall Study|Lost to Follow-up|1|||
129756481|NCT03901144|467069667|FG002|Overall Study|Lost to Follow-up|1|||
129756482|NCT03901144|467069668|FG003|Overall Study|Lost to Follow-up|1|||
129811178|NCT01153347|467276354|FG002|Overall Study|Condition under investigation worsened|0|||
129811179|NCT01153347|467276355|FG003|Overall Study|Condition under investigation worsened|0|||
129811180|NCT01153347|467276352|FG000|Overall Study|Lack of Efficacy|2|||
129896846|NCT03761784|467582157|FG001|Overall Study|Lost to Follow-up|7|||
129896847|NCT03761784|467582156|FG000|Overall Study|Pregnancy|1|||
129896848|NCT03761784|467582157|FG001|Overall Study|Pregnancy|0|||
129756483|NCT02294058|467069671|FG000|Overall Study|Adverse Event|16|||
129756484|NCT02294058|467069672|FG001|Overall Study|Adverse Event|7|||
129756485|NCT02294058|467069673|FG002|Overall Study|Adverse Event|13|||
129756486|NCT02294058|467069671|FG000|Overall Study|Lack of Efficacy|3|||
129756487|NCT02294058|467069672|FG001|Overall Study|Lack of Efficacy|3|||
129756488|NCT02294058|467069673|FG002|Overall Study|Lack of Efficacy|0|||
129896849|NCT03761784|467582156|FG000|Overall Study|Protocol Violation|2|||
129896850|NCT03761784|467582157|FG001|Overall Study|Protocol Violation|0|||
129445403|NCT03828292|465931282|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
129756489|NCT02294058|467069671|FG000|Overall Study|Lost to Follow-up|1|||
129756490|NCT02294058|467069672|FG001|Overall Study|Lost to Follow-up|0|||
129896851|NCT03761784|467582156|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
129896852|NCT03761784|467582157|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
129896853|NCT03761784|467582156|FG000|Overall Study|Withdrawal by Subject|9|||
129896854|NCT03761784|467582157|FG001|Overall Study|Withdrawal by Subject|4|||
129896855|NCT03761784|467582156|FG000|Overall Study|Physician Decision|1|||
129896856|NCT03761784|467582157|FG001|Overall Study|Physician Decision|0|||
129896857|NCT03761784|467582156|FG000|Overall Study|Other Than Specified|1|||
129896858|NCT03761784|467582157|FG001|Overall Study|Other Than Specified|0|||
129896859|NCT00586339|467582158|FG000|Overall Study|Withdrawal by Subject|1|||
129756491|NCT02294058|467069673|FG002|Overall Study|Lost to Follow-up|2|||
129756492|NCT02294058|467069671|FG000|Overall Study|Withdrawal by Subject|10|||
129756493|NCT02294058|467069672|FG001|Overall Study|Withdrawal by Subject|14|||
129756494|NCT02294058|467069673|FG002|Overall Study|Withdrawal by Subject|13|||
129756495|NCT02294058|467069671|FG000|Overall Study|Physician Decision|2|||
129756496|NCT02294058|467069672|FG001|Overall Study|Physician Decision|1|||
129756497|NCT02294058|467069673|FG002|Overall Study|Physician Decision|0|||
129756498|NCT02294058|467069671|FG000|Overall Study|Miscellaneous|4|||
129756499|NCT02294058|467069672|FG001|Overall Study|Miscellaneous|1|||
129756500|NCT02294058|467069673|FG002|Overall Study|Miscellaneous|1|||
129756501|NCT03575403|467069674|FG000|Overall Study|Adverse Event|1|||
129756502|NCT03575403|467069675|FG001|Overall Study|Adverse Event|0|||
129756503|NCT03575403|467069676|FG002|Overall Study|Adverse Event|0|||
129756504|NCT03575403|467069674|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
129756505|NCT03575403|467069675|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
129756506|NCT03575403|467069676|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
129756507|NCT03359174|467069679|FG000|Overall Study|Adverse Event|1|||
129756508|NCT01332994|467069683|FG000|Overall Study|Adverse Event|34|||
129756509|NCT01332994|467069683|FG000|Overall Study|Death|1|||
129756510|NCT01332994|467069683|FG000|Overall Study|Lack of Efficacy|1|||
129756511|NCT01332994|467069683|FG000|Overall Study|Lost to Follow-up|4|||
129756512|NCT01332994|467069683|FG000|Overall Study|Protocol Violation|6|||
129756513|NCT01332994|467069683|FG000|Overall Study|Withdrawal by Subject|15|||
129756514|NCT01332994|467069683|FG000|Overall Study|Administrative Problem|2|||
129756515|NCT01332994|467069683|FG000|Overall Study|Other|8|||
129756516|NCT02800863|467069684|FG000|Overall Study|Adverse Event|14|||
129756517|NCT02800863|467069684|FG000|Overall Study|Another Device Implanted|1|||
129756518|NCT02800863|467069684|FG000|Overall Study|Device Explanted|1|||
129756519|NCT02800863|467069684|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
129756520|NCT02800863|467069684|FG000|Overall Study|Health Issues|1|||
129756521|NCT02800863|467069684|FG000|Overall Study|Insurance Denial|8|||
129756522|NCT02800863|467069684|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
129756523|NCT02800863|467069684|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
129756524|NCT02800863|467069684|FG000|Overall Study|Screen Failure|1|||
129756525|NCT02800863|467069684|FG000|Overall Study|Sponsor Request|6|||
129756526|NCT02800863|467069684|FG000|Overall Study|Death|3|||
129756527|NCT02800863|467069684|FG000|Overall Study|Subject Implant at Another Facility|1|||
129756528|NCT02800863|467069684|FG000|Overall Study|Lost to Follow-up|26|||
129756529|NCT02800863|467069684|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
129756530|NCT02800863|467069684|FG000|Overall Study|Subject and/or Family Request|64|||
129756531|NCT02800863|467069684|FG000|Overall Study|Trial Failure|81|||
129756532|NCT02800863|467069684|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
129756533|NCT00279916|467069685|FG000|Overall Study|Withdrawal by Subject|4|||
129756534|NCT00279916|467069686|FG001|Overall Study|Withdrawal by Subject|3|||
129756535|NCT00279916|467069685|FG000|Overall Study|Lost to Follow-up|3|||
129756536|NCT00279916|467069686|FG001|Overall Study|Lost to Follow-up|2|||
129756537|NCT02717494|467069688|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
129756538|NCT02717494|467069689|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
129756539|NCT02717494|467069690|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
129756540|NCT02717494|467069688|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
129756541|NCT02717494|467069689|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
129756542|NCT02717494|467069690|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
129756543|NCT02717494|467069688|FG000|First Intervention (Step 1)|Death|0|||
129756544|NCT02717494|467069689|FG001|First Intervention (Step 1)|Death|0|||
129756545|NCT02717494|467069690|FG002|First Intervention (Step 1)|Death|1|||
129896860|NCT00586339|467582159|FG001|Overall Study|Withdrawal by Subject|3|||
129896861|NCT00586339|467582160|FG002|Overall Study|Withdrawal by Subject|1|||
129756546|NCT02717494|467069688|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
129756547|NCT02717494|467069689|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
129756548|NCT02717494|467069690|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
129896862|NCT00586339|467582158|FG000|Overall Study|Migrated/moved from study area|3|||
129756549|NCT00428948|467069693|FG000|Overall Study|Lost to Follow-up|15|||
129756550|NCT00428948|467069694|FG001|Overall Study|Lost to Follow-up|8|||
129756551|NCT00428948|467069693|FG000|Overall Study|Adverse Event|148|||
129756552|NCT00428948|467069694|FG001|Overall Study|Adverse Event|24|||
129756553|NCT00428948|467069693|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
129756554|NCT00428948|467069694|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
129756555|NCT00428948|467069693|FG000|Overall Study|Investigator Withdrew Subject|3|||
129756556|NCT00428948|467069694|FG001|Overall Study|Investigator Withdrew Subject|4|||
129756557|NCT00428948|467069693|FG000|Overall Study|Subject Withdrew Consent|50|||
129756558|NCT00428948|467069694|FG001|Overall Study|Subject Withdrew Consent|30|||
129756559|NCT00428948|467069693|FG000|Overall Study|Protocol Deviation|1|||
129756560|NCT00428948|467069694|FG001|Overall Study|Protocol Deviation|1|||
129756561|NCT04417361|467069696|FG000|Overall Study|Withdrawal by Subject|1|||
129756562|NCT04417361|467069697|FG001|Overall Study|Withdrawal by Subject|0|||
129756563|NCT04417361|467069696|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
129756564|NCT04417361|467069697|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
129756565|NCT01288989|467069698|FG000|Overall Study|Death|0|||
129756566|NCT01288989|467069699|FG001|Overall Study|Death|0|||
129756567|NCT01288989|467069700|FG002|Overall Study|Death|0|||
129756568|NCT01288989|467069701|FG003|Overall Study|Death|1|||
129756569|NCT01288989|467069702|FG004|Overall Study|Death|0|||
129756570|NCT01288989|467069698|FG000|Overall Study|Dose limiting toxicity|1|||
129756571|NCT01288989|467069699|FG001|Overall Study|Dose limiting toxicity|0|||
129756572|NCT01288989|467069700|FG002|Overall Study|Dose limiting toxicity|0|||
129756573|NCT01288989|467069701|FG003|Overall Study|Dose limiting toxicity|0|||
129756574|NCT01288989|467069702|FG004|Overall Study|Dose limiting toxicity|0|||
129756575|NCT01288989|467069698|FG000|Overall Study|Adverse Event|0|||
129756576|NCT01288989|467069699|FG001|Overall Study|Adverse Event|0|||
129756577|NCT01288989|467069700|FG002|Overall Study|Adverse Event|0|||
129756578|NCT01288989|467069701|FG003|Overall Study|Adverse Event|0|||
129756579|NCT01288989|467069702|FG004|Overall Study|Adverse Event|2|||
129756580|NCT01288989|467069698|FG000|Overall Study|Physician Decision|0|||
129756581|NCT01288989|467069699|FG001|Overall Study|Physician Decision|0|||
129756582|NCT01288989|467069700|FG002|Overall Study|Physician Decision|0|||
129756583|NCT01288989|467069701|FG003|Overall Study|Physician Decision|0|||
129756584|NCT01288989|467069702|FG004|Overall Study|Physician Decision|1|||
129756585|NCT01288989|467069698|FG000|Overall Study|Withdrawal by Subject|0|||
129756586|NCT01288989|467069699|FG001|Overall Study|Withdrawal by Subject|0|||
129756587|NCT01288989|467069700|FG002|Overall Study|Withdrawal by Subject|0|||
129756588|NCT01288989|467069701|FG003|Overall Study|Withdrawal by Subject|0|||
129756589|NCT01288989|467069702|FG004|Overall Study|Withdrawal by Subject|3|||
129756590|NCT00165672|467069704|FG000|Overall Study|Adverse Event|0|||
129756591|NCT00165672|467069705|FG001|Overall Study|Adverse Event|1|||
129756592|NCT04965688|467069711|FG000|Overall Study|Withdrawal by Subject|2|||
129756593|NCT05864586|467069712|FG000|Overall Study|Ineligible|4|||
129756594|NCT05864586|467069713|FG001|Overall Study|Ineligible|12|||
129756595|NCT05864586|467069712|FG000|Overall Study|Pregnancy|0|||
129756596|NCT05864586|467069713|FG001|Overall Study|Pregnancy|1|||
129756597|NCT05864586|467069712|FG000|Overall Study|Withdrawal by Subject|0|||
129756598|NCT05864586|467069713|FG001|Overall Study|Withdrawal by Subject|1|||
129756599|NCT00369577|467069714|FG000|Overall Study|Withdrawal by Subject|0|||
129756600|NCT00369577|467069715|FG001|Overall Study|Withdrawal by Subject|0|||
129811181|NCT01153347|467276353|FG001|Overall Study|Lack of Efficacy|2|||
129756601|NCT00369577|467069716|FG002|Overall Study|Withdrawal by Subject|1|||
129756602|NCT01059318|467069727|FG000|Core Study (26 Week)|Adverse Event|3|||
129756603|NCT01059318|467069727|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
129756604|NCT01059318|467069727|FG000|Extension (36 Week)|Adverse Event|3|||
129756605|NCT00983385|467069728|FG000|Observation Period|Not eligible to be dosed|20|||
129756606|NCT00983385|467069728|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
129756607|NCT00824473|467071133|FG000|Overall Study|Adverse Event|4|||
129756608|NCT00824473|467071134|FG001|Overall Study|Adverse Event|5|||
129756609|NCT00824473|467071133|FG000|Overall Study|Lack of Efficacy|2|||
129756610|NCT00824473|467071134|FG001|Overall Study|Lack of Efficacy|2|||
129756611|NCT00824473|467071133|FG000|Overall Study|Protocol Violation|2|||
129756612|NCT00824473|467071134|FG001|Overall Study|Protocol Violation|0|||
129756613|NCT00824473|467071133|FG000|Overall Study|Non-Compliance|4|||
129756614|NCT00824473|467071134|FG001|Overall Study|Non-Compliance|2|||
129756615|NCT00824473|467071133|FG000|Overall Study|Withdrawal by Subject|2|||
129756616|NCT00824473|467071134|FG001|Overall Study|Withdrawal by Subject|3|||
129756617|NCT00824473|467071133|FG000|Overall Study|Other|1|||
129756618|NCT00824473|467071134|FG001|Overall Study|Other|1|||
129756619|NCT02478463|467071135|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
129756620|NCT02478463|467071135|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
129756621|NCT02478463|467071135|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
129756622|NCT01814527|467071137|FG000|Overall Study|RTP greater than 30 days|6|||
129756623|NCT01814527|467071138|FG001|Overall Study|RTP greater than 30 days|1|||
129756624|NCT04524858|467071139|FG000|Overall Study|Adverse Event|1|||
129756625|NCT01363700|467071142|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129756626|NCT01363700|467071143|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
129756627|NCT01363700|467071144|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129756628|NCT01363700|467071145|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129756629|NCT01363700|467071146|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
129756630|NCT00113841|467071151|FG000|Overall Study|Disease progression|0|||
129756631|NCT00113841|467071152|FG001|Overall Study|Disease progression|2|||
129756632|NCT00113841|467071151|FG000|Overall Study|Non-compliant|1|||
129756633|NCT00113841|467071152|FG001|Overall Study|Non-compliant|0|||
129756634|NCT00148759|467071157|FG000|Overall Study|Withdrawal by Subject|1|||
129756635|NCT00148759|467071158|FG001|Overall Study|Withdrawal by Subject|1|||
129756636|NCT00148759|467071157|FG000|Overall Study|Lost to Follow-up|1|||
129756637|NCT00148759|467071158|FG001|Overall Study|Lost to Follow-up|0|||
129756638|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
129756639|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
129756640|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
129756641|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
129756642|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
129756643|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
129756644|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Death|7|||
129756645|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Death|5|||
129756646|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Death|6|||
129756647|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
129756648|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
129756649|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
129756650|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
129756651|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
129756652|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
129756653|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Other|1|||
129756654|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Other|0|||
129756655|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Other|0|||
129756656|NCT00104650|467071160|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
129811182|NCT01153347|467276354|FG002|Overall Study|Lack of Efficacy|0|||
129811183|NCT01153347|467276355|FG003|Overall Study|Lack of Efficacy|4|||
129811184|NCT01153347|467276352|FG000|Overall Study|Study-specific withdrawal criteria|4|||
129811185|NCT01153347|467276353|FG001|Overall Study|Study-specific withdrawal criteria|3|||
129811186|NCT01153347|467276354|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129811187|NCT01153347|467276355|FG003|Overall Study|Study-specific withdrawal criteria|2|||
129811188|NCT01153347|467276352|FG000|Overall Study|Lost to Follow-up|4|||
129811189|NCT01153347|467276353|FG001|Overall Study|Lost to Follow-up|9|||
129811190|NCT01153347|467276354|FG002|Overall Study|Lost to Follow-up|11|||
129811191|NCT01153347|467276355|FG003|Overall Study|Lost to Follow-up|8|||
129811192|NCT01153347|467276352|FG000|Overall Study|Other|5|||
129811193|NCT01153347|467276353|FG001|Overall Study|Other|5|||
129811194|NCT01153347|467276354|FG002|Overall Study|Other|4|||
129811195|NCT01153347|467276355|FG003|Overall Study|Other|0|||
129811196|NCT01153347|467276352|FG000|Overall Study|Death|1|||
129811197|NCT01153347|467276353|FG001|Overall Study|Death|0|||
129811198|NCT01153347|467276354|FG002|Overall Study|Death|0|||
129811199|NCT01153347|467276355|FG003|Overall Study|Death|0|||
129811200|NCT00297830|467276356|FG000|6 Month Visit|Death|1|||
129811201|NCT00297830|467276357|FG001|6 Month Visit|Death|0|||
129811202|NCT00297830|467276358|FG002|6 Month Visit|Death|2|||
129811203|NCT00297830|467276356|FG000|6 Month Visit|Withdrawal by Subject|2|||
129756657|NCT00104650|467071161|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
129756658|NCT00104650|467071162|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
129756659|NCT00104650|467071160|FG000|Follow-up Period|Physician Decision|1|||
129756660|NCT00104650|467071161|FG001|Follow-up Period|Physician Decision|1|||
129756661|NCT00104650|467071162|FG002|Follow-up Period|Physician Decision|0|||
129756662|NCT00104650|467071160|FG000|Follow-up Period|Adverse Event|1|||
129756663|NCT00104650|467071161|FG001|Follow-up Period|Adverse Event|0|||
129756664|NCT00104650|467071162|FG002|Follow-up Period|Adverse Event|1|||
129756665|NCT00104650|467071160|FG000|Follow-up Period|Withdrawal by Subject|0|||
129756666|NCT00104650|467071161|FG001|Follow-up Period|Withdrawal by Subject|3|||
129756667|NCT00104650|467071162|FG002|Follow-up Period|Withdrawal by Subject|3|||
129756668|NCT00104650|467071160|FG000|Follow-up Period|Death|6|||
129756669|NCT00104650|467071161|FG001|Follow-up Period|Death|6|||
129756670|NCT00104650|467071162|FG002|Follow-up Period|Death|4|||
129756671|NCT00104650|467071160|FG000|Follow-up Period|Disease progression|3|||
129756672|NCT00104650|467071161|FG001|Follow-up Period|Disease progression|1|||
129756673|NCT00104650|467071162|FG002|Follow-up Period|Disease progression|0|||
129756674|NCT00104650|467071160|FG000|Follow-up Period|Lost to Follow-up|0|||
129756675|NCT00104650|467071161|FG001|Follow-up Period|Lost to Follow-up|1|||
129756676|NCT00104650|467071162|FG002|Follow-up Period|Lost to Follow-up|2|||
129756677|NCT00104650|467071160|FG000|Follow-up Period|Other|0|||
129756678|NCT00104650|467071161|FG001|Follow-up Period|Other|1|||
129756679|NCT00104650|467071162|FG002|Follow-up Period|Other|0|||
129756680|NCT00773513|467071164|FG000|Overall Study|Renal Transplant|254|||
129756681|NCT00773513|467071165|FG001|Overall Study|Renal Transplant|263|||
129756682|NCT00773513|467071164|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
129756683|NCT00773513|467071165|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
129756684|NCT00773513|467071164|FG000|Overall Study|Withdrew Consent|68|||
129756685|NCT00773513|467071165|FG001|Overall Study|Withdrew Consent|69|||
129756686|NCT00773513|467071164|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
129756687|NCT00773513|467071165|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
129756688|NCT00773513|467071164|FG000|Overall Study|Failure to Return|22|||
129756689|NCT00773513|467071165|FG001|Overall Study|Failure to Return|8|||
129756690|NCT00773513|467071164|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129756691|NCT00773513|467071165|FG001|Overall Study|Insufficient Therapeutic Response|18|||
129756692|NCT00773513|467071164|FG000|Overall Study|Reason Not Specified|159|||
129756693|NCT00773513|467071165|FG001|Overall Study|Reason Not Specified|126|||
129756694|NCT00773513|467071164|FG000|Overall Study|Death|531|||
129756695|NCT00773513|467071165|FG001|Overall Study|Death|545|||
129756696|NCT01807598|467071166|FG000|Overall Study|Withdrawal by Subject|4|||
129756697|NCT01807598|467071166|FG000|Overall Study|Adverse Event|1|||
129756698|NCT01807598|467071166|FG000|Overall Study|Other Physician Decision|1|||
129756699|NCT03384940|467071173|FG000|Overall Study|Progressive disease|36|||
129756700|NCT03384940|467071174|FG001|Overall Study|Progressive disease|11|||
129756701|NCT03384940|467071175|FG002|Overall Study|Progressive disease|13|||
129756702|NCT03384940|467071173|FG000|Overall Study|Clinical progression|4|||
129756703|NCT03384940|467071174|FG001|Overall Study|Clinical progression|0|||
129756704|NCT03384940|467071175|FG002|Overall Study|Clinical progression|3|||
129756705|NCT03384940|467071173|FG000|Overall Study|Adverse Event|7|||
129756706|NCT03384940|467071174|FG001|Overall Study|Adverse Event|1|||
129756707|NCT03384940|467071175|FG002|Overall Study|Adverse Event|1|||
129756708|NCT03384940|467071173|FG000|Overall Study|Withdrawal by Subject|3|||
129756709|NCT03384940|467071174|FG001|Overall Study|Withdrawal by Subject|1|||
129756710|NCT03384940|467071175|FG002|Overall Study|Withdrawal by Subject|0|||
129756711|NCT03384940|467071173|FG000|Overall Study|Physician Decision|1|||
129756712|NCT03384940|467071174|FG001|Overall Study|Physician Decision|1|||
129756713|NCT03384940|467071175|FG002|Overall Study|Physician Decision|0|||
129756714|NCT03384940|467071173|FG000|Overall Study|Death|2|||
129756715|NCT03384940|467071174|FG001|Overall Study|Death|1|||
129756716|NCT03384940|467071175|FG002|Overall Study|Death|0|||
129756717|NCT03384940|467071173|FG000|Overall Study|Other|0|||
129756718|NCT03384940|467071174|FG001|Overall Study|Other|0|||
129756719|NCT03384940|467071175|FG002|Overall Study|Other|1|||
129756720|NCT03089580|467071181|FG000|Overall Study|Lost to Follow-up|2|||
129756721|NCT03087513|467071182|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
129756722|NCT04170543|467071183|FG000|Overall Study|Death|1|||
129756723|NCT04170543|467071184|FG001|Overall Study|Death|1|||
129756724|NCT04170543|467071185|FG002|Overall Study|Death|1|||
129756725|NCT04170543|467071186|FG003|Overall Study|Death|1|||
129756726|NCT04170543|467071187|FG004|Overall Study|Death|1|||
129756727|NCT04170543|467071183|FG000|Overall Study|Lost to Follow-up|3|||
129756728|NCT04170543|467071184|FG001|Overall Study|Lost to Follow-up|3|||
129756729|NCT04170543|467071185|FG002|Overall Study|Lost to Follow-up|0|||
129756730|NCT04170543|467071186|FG003|Overall Study|Lost to Follow-up|3|||
129756731|NCT04170543|467071187|FG004|Overall Study|Lost to Follow-up|1|||
129756732|NCT04170543|467071183|FG000|Overall Study|Withdrawal by Subject|13|||
129756733|NCT04170543|467071184|FG001|Overall Study|Withdrawal by Subject|6|||
129756734|NCT04170543|467071185|FG002|Overall Study|Withdrawal by Subject|5|||
129756735|NCT04170543|467071186|FG003|Overall Study|Withdrawal by Subject|4|||
129756736|NCT04170543|467071187|FG004|Overall Study|Withdrawal by Subject|9|||
129756737|NCT04170543|467071183|FG000|Overall Study|Not able to transition to phase 2b|8|||
129756738|NCT04170543|467071184|FG001|Overall Study|Not able to transition to phase 2b|0|||
129756739|NCT04170543|467071185|FG002|Overall Study|Not able to transition to phase 2b|10|||
129756740|NCT04170543|467071186|FG003|Overall Study|Not able to transition to phase 2b|0|||
129756741|NCT04170543|467071187|FG004|Overall Study|Not able to transition to phase 2b|6|||
129756742|NCT04170543|467071183|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
129756743|NCT04170543|467071184|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
129756744|NCT04170543|467071185|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
129756745|NCT04170543|467071186|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
129756746|NCT04170543|467071187|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
129756747|NCT04170543|467071183|FG000|Overall Study|Not Treated|0|||
129756748|NCT04170543|467071184|FG001|Overall Study|Not Treated|0|||
129756749|NCT04170543|467071185|FG002|Overall Study|Not Treated|0|||
129811204|NCT00297830|467276357|FG001|6 Month Visit|Withdrawal by Subject|1|||
129811205|NCT00297830|467276358|FG002|6 Month Visit|Withdrawal by Subject|1|||
129811206|NCT00297830|467276356|FG000|6 Month Visit|Adverse Event|0|||
129811207|NCT00297830|467276357|FG001|6 Month Visit|Adverse Event|1|||
129811208|NCT00297830|467276358|FG002|6 Month Visit|Adverse Event|0|||
129811209|NCT00297830|467276356|FG000|12 Month Visit|Lost to Follow-up|1|||
129811210|NCT00297830|467276357|FG001|12 Month Visit|Lost to Follow-up|0|||
129811211|NCT00297830|467276358|FG002|12 Month Visit|Lost to Follow-up|0|||
129811212|NCT00297830|467276356|FG000|12 Month Visit|Adverse Event|0|||
129811213|NCT00297830|467276357|FG001|12 Month Visit|Adverse Event|3|||
129811214|NCT00297830|467276358|FG002|12 Month Visit|Adverse Event|0|||
129811215|NCT00297830|467276356|FG000|12 Month Visit|Withdrawal by Subject|0|||
129811216|NCT00297830|467276357|FG001|12 Month Visit|Withdrawal by Subject|3|||
129811217|NCT00297830|467276358|FG002|12 Month Visit|Withdrawal by Subject|0|||
129811218|NCT05096221|467276361|FG000|Part 2|Physician Decision|0|||
129811219|NCT05096221|467276362|FG001|Part 2|Physician Decision|1|||
129811220|NCT04678661|467276364|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
129811221|NCT04678661|467276365|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
129811222|NCT04678661|467276364|FG000|Overall Study|Protocol Violation|2|||
129811223|NCT04678661|467276365|FG001|Overall Study|Protocol Violation|0|||
129811224|NCT04678661|467276364|FG000|Overall Study|Withdrawal by Subject|1|||
129811225|NCT04678661|467276365|FG001|Overall Study|Withdrawal by Subject|0|||
129811226|NCT04678661|467276364|FG000|Overall Study|Lost to Follow-up|2|||
129811227|NCT04678661|467276365|FG001|Overall Study|Lost to Follow-up|0|||
129811228|NCT04678661|467276364|FG000|Overall Study|Death|2|||
129811229|NCT04678661|467276365|FG001|Overall Study|Death|0|||
129811230|NCT03094169|467276366|FG000|Overall Study|Lack of Efficacy|0|||
129811231|NCT03094169|467276367|FG001|Overall Study|Lack of Efficacy|0|||
129811232|NCT03094169|467276368|FG002|Overall Study|Lack of Efficacy|0|||
129811233|NCT03094169|467276369|FG003|Overall Study|Lack of Efficacy|0|||
129811234|NCT03094169|467276370|FG004|Overall Study|Lack of Efficacy|0|||
129811235|NCT03094169|467276371|FG005|Overall Study|Lack of Efficacy|0|||
129811236|NCT03094169|467276372|FG006|Overall Study|Lack of Efficacy|0|||
129811237|NCT03094169|467276373|FG007|Overall Study|Lack of Efficacy|21|||
129811238|NCT03094169|467276366|FG000|Overall Study|Adverse Event|0|||
129811239|NCT03094169|467276367|FG001|Overall Study|Adverse Event|0|||
129811240|NCT03094169|467276368|FG002|Overall Study|Adverse Event|0|||
129811241|NCT03094169|467276369|FG003|Overall Study|Adverse Event|0|||
129811242|NCT03094169|467276370|FG004|Overall Study|Adverse Event|0|||
129811243|NCT03094169|467276371|FG005|Overall Study|Adverse Event|0|||
129811244|NCT03094169|467276372|FG006|Overall Study|Adverse Event|0|||
129811245|NCT03094169|467276373|FG007|Overall Study|Adverse Event|2|||
129811246|NCT03094169|467276366|FG000|Overall Study|Withdrawal by Subject|0|||
129811247|NCT03094169|467276367|FG001|Overall Study|Withdrawal by Subject|0|||
129756750|NCT04170543|467071186|FG003|Overall Study|Not Treated|0|||
129756751|NCT04170543|467071187|FG004|Overall Study|Not Treated|2|||
129811248|NCT03094169|467276368|FG002|Overall Study|Withdrawal by Subject|0|||
129811249|NCT03094169|467276369|FG003|Overall Study|Withdrawal by Subject|0|||
129811250|NCT03094169|467276370|FG004|Overall Study|Withdrawal by Subject|0|||
129445404|NCT03828292|465931283|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
129811251|NCT03094169|467276371|FG005|Overall Study|Withdrawal by Subject|0|||
129811252|NCT03094169|467276372|FG006|Overall Study|Withdrawal by Subject|1|||
129811253|NCT03094169|467276373|FG007|Overall Study|Withdrawal by Subject|1|||
129445405|NCT03828292|465931284|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
129811254|NCT03094169|467276366|FG000|Overall Study|Trial Termination|0|||
129756752|NCT04170543|467071183|FG000|Overall Study|(CRF)|16|||
129756753|NCT04170543|467071184|FG001|Overall Study|(CRF)|15|||
129756754|NCT04170543|467071185|FG002|Overall Study|(CRF)|12|||
129811255|NCT03094169|467276367|FG001|Overall Study|Trial Termination|0|||
129811256|NCT03094169|467276368|FG002|Overall Study|Trial Termination|0|||
129811257|NCT03094169|467276369|FG003|Overall Study|Trial Termination|0|||
129756755|NCT04170543|467071186|FG003|Overall Study|(CRF)|17|||
129756756|NCT04170543|467071187|FG004|Overall Study|(CRF)|17|||
129756757|NCT04170543|467071183|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
129756758|NCT04170543|467071184|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
129756759|NCT04170543|467071185|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
129756760|NCT04170543|467071186|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
129756761|NCT04170543|467071187|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
129756762|NCT00770601|467071188|FG000|Overall Study|Withdrawal by Subject|1|||
129811258|NCT03094169|467276370|FG004|Overall Study|Trial Termination|0|||
129811259|NCT03094169|467276371|FG005|Overall Study|Trial Termination|0|||
129811260|NCT03094169|467276372|FG006|Overall Study|Trial Termination|0|||
129811261|NCT03094169|467276373|FG007|Overall Study|Trial Termination|1|||
129811262|NCT04645953|467276374|FG000|Overall Study|Lost to Follow-up|2|||
129811263|NCT04645953|467276375|FG001|Overall Study|Lost to Follow-up|1|||
129811264|NCT04645953|467276376|FG002|Overall Study|Lost to Follow-up|1|||
129811265|NCT04645953|467276374|FG000|Overall Study|Withdrawal by Subject|0|||
129811266|NCT04645953|467276375|FG001|Overall Study|Withdrawal by Subject|1|||
129811267|NCT04645953|467276376|FG002|Overall Study|Withdrawal by Subject|0|||
129811268|NCT04645953|467276374|FG000|Overall Study|Physician Decision|0|||
129811269|NCT04645953|467276375|FG001|Overall Study|Physician Decision|1|||
129811270|NCT04645953|467276376|FG002|Overall Study|Physician Decision|0|||
129811271|NCT04645953|467276374|FG000|Overall Study|Discontinued Prior to Dosing|0|||
129811272|NCT04645953|467276375|FG001|Overall Study|Discontinued Prior to Dosing|0|||
129811273|NCT04645953|467276376|FG002|Overall Study|Discontinued Prior to Dosing|2|||
129811274|NCT04613375|467276377|FG000|Overall Study|Death|198|||
129811275|NCT04613375|467276377|FG000|Overall Study|Withdrawal by Subject|3|||
129811276|NCT01921387|467276378|FG000|Overall Study|Adverse Event|1|||
129811277|NCT01706146|467276381|FG000|Overall Study|Withdrawal by Subject|1|||
129811278|NCT01706146|467276381|FG000|Overall Study|Adverse Event|3|||
129811279|NCT01706146|467276381|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
129811280|NCT00675948|467276382|FG000|Overall Study|Adverse Event|23|||
129811281|NCT00675948|467276383|FG001|Overall Study|Adverse Event|1|||
129811282|NCT00675948|467276382|FG000|Overall Study|Lack of Efficacy|3|||
129811283|NCT00675948|467276383|FG001|Overall Study|Lack of Efficacy|0|||
129811284|NCT00675948|467276382|FG000|Overall Study|Withdrawal by Subject|7|||
129811285|NCT00675948|467276383|FG001|Overall Study|Withdrawal by Subject|0|||
129756763|NCT00801216|467071189|FG000|Overall Study|Screening Failure|2|||
129756764|NCT05481359|467071190|FG000|Overall Study|Lost to Follow-up|3|||
129756765|NCT05481359|467071190|FG000|Overall Study|Withdrawal by Subject|1|||
129756766|NCT00452790|467071192|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
129756767|NCT00452790|467071193|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
129811286|NCT00675948|467276382|FG000|Overall Study|Lost to Follow-up|2|||
129811287|NCT00675948|467276383|FG001|Overall Study|Lost to Follow-up|0|||
129811288|NCT00675948|467276382|FG000|Overall Study|Protocol Violation|1|||
129811289|NCT00675948|467276383|FG001|Overall Study|Protocol Violation|0|||
129756768|NCT00452790|467071192|FG000|Infant Series|Parent/legal guardian request|8|||
129756769|NCT00452790|467071193|FG001|Infant Series|Parent/legal guardian request|6|||
129811290|NCT00675948|467276382|FG000|Overall Study|Pain under control|1|||
129811291|NCT00675948|467276383|FG001|Overall Study|Pain under control|0|||
129811292|NCT00675948|467276382|FG000|Overall Study|Sponsor decision|0|||
129811293|NCT00675948|467276383|FG001|Overall Study|Sponsor decision|1|||
129811294|NCT00675948|467276382|FG000|Overall Study|Patient died|1|||
129811295|NCT00675948|467276383|FG001|Overall Study|Patient died|0|||
129811296|NCT00675948|467276382|FG000|Overall Study|Patient unable to comply with diaries|1|||
129811297|NCT00675948|467276383|FG001|Overall Study|Patient unable to comply with diaries|0|||
129811298|NCT00675948|467276382|FG000|Overall Study|Patient feels unable to take medication|0|||
129756770|NCT00452790|467071192|FG000|Infant Series|Failed to return|4|||
129756771|NCT00452790|467071193|FG001|Infant Series|Failed to return|1|||
129756772|NCT00452790|467071192|FG000|Infant Series|Protocol Violation|1|||
129756773|NCT00452790|467071193|FG001|Infant Series|Protocol Violation|3|||
129756774|NCT00452790|467071192|FG000|Infant Series|Lost to Follow-up|2|||
129896863|NCT00586339|467582159|FG001|Overall Study|Migrated/moved from study area|2|||
129896864|NCT00586339|467582160|FG002|Overall Study|Migrated/moved from study area|4|||
129896865|NCT00586339|467582158|FG000|Overall Study|Lost to Follow-up|3|||
129896866|NCT00586339|467582159|FG001|Overall Study|Lost to Follow-up|2|||
129896867|NCT00586339|467582160|FG002|Overall Study|Lost to Follow-up|1|||
129896868|NCT04305912|467582163|FG000|First Intervention|COVID-19 Suspension|2|||
129896869|NCT04305912|467582164|FG001|First Intervention|COVID-19 Suspension|0|||
129896870|NCT04305912|467582163|FG000|First Intervention|Withdrawal by Subject|0|||
129896871|NCT04305912|467582164|FG001|First Intervention|Withdrawal by Subject|1|||
129896872|NCT04305912|467582163|FG000|Second Intervention|Adverse Event|0|||
129896873|NCT04305912|467582164|FG001|Second Intervention|Adverse Event|1|||
129896874|NCT01649427|467582165|FG000|Overall Study|Adverse Event|1|||
129896875|NCT01649427|467582166|FG001|Overall Study|Adverse Event|1|||
129896876|NCT01649427|467582165|FG000|Overall Study|Withdrawal by Subject|8|||
129896877|NCT01649427|467582166|FG001|Overall Study|Withdrawal by Subject|7|||
129896878|NCT01649427|467582165|FG000|Overall Study|Lost to Follow-up|0|||
129896879|NCT01649427|467582166|FG001|Overall Study|Lost to Follow-up|1|||
129896880|NCT01649427|467582165|FG000|Overall Study|Graft loss|0|||
129896881|NCT01649427|467582166|FG001|Overall Study|Graft loss|1|||
129896882|NCT01649427|467582165|FG000|Overall Study|Surgical problems during nephrectomy|2|||
129896883|NCT01649427|467582166|FG001|Overall Study|Surgical problems during nephrectomy|2|||
129896884|NCT05196737|467582170|FG000|Non-intervention Week|Lost to Follow-up|2|||
129896885|NCT05196737|467582170|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
129896886|NCT04888585|467582171|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
129896887|NCT04888585|467582172|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
129896888|NCT04888585|467582173|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
129896889|NCT04888585|467582174|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
129896890|NCT04888585|467582175|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
129896891|NCT04888585|467582176|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896892|NCT04888585|467582177|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129756775|NCT00452790|467071193|FG001|Infant Series|Lost to Follow-up|2|||
129756776|NCT00452790|467071192|FG000|Infant Series|Adverse Event|1|||
129756777|NCT00452790|467071193|FG001|Infant Series|Adverse Event|2|||
129756778|NCT00452790|467071192|FG000|Infant Series|Other reasons|1|||
129756779|NCT00452790|467071193|FG001|Infant Series|Other reasons|2|||
129756780|NCT00452790|467071192|FG000|Infant Series|Investigator request|0|||
129756781|NCT00452790|467071193|FG001|Infant Series|Investigator request|1|||
129756782|NCT00452790|467071192|FG000|Infant Series|Death|0|||
129756783|NCT00452790|467071193|FG001|Infant Series|Death|1|||
129756784|NCT00452790|467071192|FG000|After Infant Series|Investigator request|10|||
129756785|NCT00452790|467071193|FG001|After Infant Series|Investigator request|10|||
129756786|NCT00452790|467071192|FG000|After Infant Series|Adverse Event|4|||
129756787|NCT00452790|467071193|FG001|After Infant Series|Adverse Event|1|||
129756788|NCT00452790|467071192|FG000|After Infant Series|Parent/legal guardian request|1|||
129811299|NCT00675948|467276383|FG001|Overall Study|Patient feels unable to take medication|1|||
129811300|NCT02582983|467276384|FG000|Overall Study|Death|3|||
129811301|NCT02582983|467276384|FG000|Overall Study|Withdrawal by Subject|2|||
129811302|NCT02582983|467276384|FG000|Overall Study|Adverse Event|1|||
129811303|NCT01081678|467276390|FG000|Overall Study|Ineligibility Determined|0|||
129811304|NCT01081678|467276391|FG001|Overall Study|Ineligibility Determined|0|||
129811305|NCT01081678|467276392|FG002|Overall Study|Ineligibility Determined|1|||
129811306|NCT01081678|467276393|FG003|Overall Study|Ineligibility Determined|1|||
129811307|NCT01081678|467276390|FG000|Overall Study|Noncompliance|3|||
129811308|NCT01081678|467276391|FG001|Overall Study|Noncompliance|4|||
129811309|NCT01081678|467276392|FG002|Overall Study|Noncompliance|5|||
129756789|NCT00452790|467071193|FG001|After Infant Series|Parent/legal guardian request|3|||
129896893|NCT04888585|467582178|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129756790|NCT00452790|467071192|FG000|After Infant Series|Lost to Follow-up|4|||
129811310|NCT01081678|467276393|FG003|Overall Study|Noncompliance|2|||
129811311|NCT01081678|467276390|FG000|Overall Study|Adverse Event|2|||
129811312|NCT01081678|467276391|FG001|Overall Study|Adverse Event|1|||
129896894|NCT04888585|467582179|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896895|NCT04888585|467582180|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896896|NCT04888585|467582181|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
129896897|NCT04888585|467582171|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129811313|NCT01081678|467276392|FG002|Overall Study|Adverse Event|2|||
129811314|NCT01081678|467276393|FG003|Overall Study|Adverse Event|2|||
129811315|NCT01081678|467276390|FG000|Overall Study|Withdrawal by Subject|15|||
129811316|NCT01081678|467276391|FG001|Overall Study|Withdrawal by Subject|7|||
129811317|NCT01081678|467276392|FG002|Overall Study|Withdrawal by Subject|17|||
129811318|NCT01081678|467276393|FG003|Overall Study|Withdrawal by Subject|14|||
129756791|NCT00452790|467071193|FG001|After Infant Series|Lost to Follow-up|0|||
129756792|NCT00452790|467071192|FG000|After Infant Series|Failed to return|1|||
129756793|NCT00452790|467071193|FG001|After Infant Series|Failed to return|0|||
129756794|NCT00452790|467071192|FG000|After Infant Series|Other reasons|1|||
129756795|NCT00452790|467071193|FG001|After Infant Series|Other reasons|0|||
129756796|NCT00452790|467071192|FG000|Toddler Dose|Failed to return|0|||
129756797|NCT00452790|467071193|FG001|Toddler Dose|Failed to return|1|||
129756798|NCT00452790|467071192|FG000|Toddler Dose|Parent/legal guardian request|0|||
129756799|NCT00452790|467071193|FG001|Toddler Dose|Parent/legal guardian request|1|||
129756800|NCT00319254|467071209|FG000|Overall Study|Withdrawal by Subject|4|||
129756801|NCT00319254|467071209|FG000|Overall Study|Death|46|||
129756802|NCT00319254|467071209|FG000|Overall Study|Lost to Follow-up|2|||
129756803|NCT00319254|467071209|FG000|Overall Study|Enrolled, Not Treated|2|||
129756804|NCT01505374|467071210|FG000|Overall Study|Lost to Follow-up|1|||
129756805|NCT01505374|467071211|FG001|Overall Study|Lost to Follow-up|0|||
129756806|NCT02360228|467071212|FG000|Overall Study|Withdrawal by Subject|1|||
129756807|NCT02360228|467071213|FG001|Overall Study|Withdrawal by Subject|0|||
129756808|NCT02360228|467071214|FG002|Overall Study|Withdrawal by Subject|0|||
129756809|NCT02360228|467071212|FG000|Overall Study|Self-discontinued medication|0|||
129756810|NCT02360228|467071213|FG001|Overall Study|Self-discontinued medication|1|||
129756811|NCT02360228|467071214|FG002|Overall Study|Self-discontinued medication|0|||
129756812|NCT02360228|467071212|FG000|Overall Study|Unstable symptoms during screening|0|||
129756813|NCT02360228|467071213|FG001|Overall Study|Unstable symptoms during screening|0|||
129756814|NCT02360228|467071214|FG002|Overall Study|Unstable symptoms during screening|1|||
129756815|NCT01712204|467071215|FG000|Overall Study|Adverse Event|3|||
129756816|NCT01712204|467071216|FG001|Overall Study|Adverse Event|1|||
129756817|NCT01712204|467071215|FG000|Overall Study|Withdrawal by Subject|3|||
129811319|NCT01081678|467276390|FG000|Overall Study|Administrative Decision|1|||
129811320|NCT01081678|467276391|FG001|Overall Study|Administrative Decision|0|||
129811321|NCT01081678|467276392|FG002|Overall Study|Administrative Decision|0|||
129811322|NCT01081678|467276393|FG003|Overall Study|Administrative Decision|1|||
129811323|NCT01081678|467276390|FG000|Overall Study|Lost to Follow-up|4|||
129811324|NCT01081678|467276391|FG001|Overall Study|Lost to Follow-up|1|||
129811325|NCT01081678|467276392|FG002|Overall Study|Lost to Follow-up|4|||
129811326|NCT01081678|467276393|FG003|Overall Study|Lost to Follow-up|3|||
129811327|NCT01081678|467276390|FG000|Overall Study|Death|2|||
129811328|NCT01081678|467276391|FG001|Overall Study|Death|2|||
129811329|NCT01081678|467276392|FG002|Overall Study|Death|2|||
129811330|NCT01081678|467276393|FG003|Overall Study|Death|6|||
129811331|NCT01081678|467276390|FG000|Overall Study|Other|0|||
129811332|NCT01081678|467276391|FG001|Overall Study|Other|1|||
129811333|NCT01081678|467276392|FG002|Overall Study|Other|0|||
129811334|NCT01081678|467276393|FG003|Overall Study|Other|0|||
129811335|NCT00444912|467276394|FG000|Overall Study|Death|1|||
129811336|NCT00444912|467276395|FG001|Overall Study|Death|2|||
129811337|NCT00444912|467276394|FG000|Overall Study|Lost to Follow-up|1|||
129811338|NCT00444912|467276395|FG001|Overall Study|Lost to Follow-up|0|||
129811339|NCT00444912|467276394|FG000|Overall Study|Participant Failed Mobilization|1|||
129811340|NCT00444912|467276395|FG001|Overall Study|Participant Failed Mobilization|0|||
129811341|NCT01007812|467276398|FG000|Period 1, One Week|Lost to Follow-up|0|||
129811342|NCT01007812|467276399|FG001|Period 1, One Week|Lost to Follow-up|1|||
129811343|NCT01007812|467276398|FG000|Period 1, One Week|Discomfort|1|||
129811344|NCT01007812|467276399|FG001|Period 1, One Week|Discomfort|0|||
129811345|NCT01091974|467276400|FG000|Overall Study|Did not start intervention|3|||
129811346|NCT01091974|467276401|FG001|Overall Study|Did not start intervention|1|||
129811347|NCT01091974|467276402|FG002|Overall Study|Did not start intervention|3|||
129896898|NCT04888585|467582172|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
129896899|NCT04888585|467582173|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
129896900|NCT04888585|467582174|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
129896901|NCT04888585|467582175|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
129811348|NCT01091974|467276403|FG003|Overall Study|Did not start intervention|1|||
129811349|NCT01091974|467276400|FG000|Overall Study|resumed sleep medication|0|||
129811350|NCT01091974|467276401|FG001|Overall Study|resumed sleep medication|0|||
129811351|NCT01091974|467276402|FG002|Overall Study|resumed sleep medication|1|||
129811352|NCT01091974|467276403|FG003|Overall Study|resumed sleep medication|2|||
129811353|NCT01091974|467276400|FG000|Overall Study|Withdrawal by Subject|1|||
129811354|NCT01091974|467276401|FG001|Overall Study|Withdrawal by Subject|3|||
129756818|NCT01712204|467071216|FG001|Overall Study|Withdrawal by Subject|3|||
129756819|NCT01712204|467071215|FG000|Overall Study|Lost to Follow-up|1|||
129756820|NCT01712204|467071216|FG001|Overall Study|Lost to Follow-up|0|||
129756821|NCT01712204|467071215|FG000|Overall Study|Protocol Violation|1|||
129756822|NCT01712204|467071216|FG001|Overall Study|Protocol Violation|1|||
129756823|NCT02452424|467071219|FG000|Overall Study|Death|2|||
129756824|NCT02452424|467071220|FG001|Overall Study|Death|2|||
129756825|NCT02452424|467071221|FG002|Overall Study|Death|2|||
129756826|NCT02452424|467071222|FG003|Overall Study|Death|6|||
129756827|NCT02452424|467071223|FG004|Overall Study|Death|2|||
129756828|NCT02452424|467071224|FG005|Overall Study|Death|0|||
129756829|NCT02452424|467071225|FG006|Overall Study|Death|5|||
129756830|NCT02452424|467071226|FG007|Overall Study|Death|1|||
129756831|NCT02452424|467071227|FG008|Overall Study|Death|3|||
129756832|NCT02452424|467071228|FG009|Overall Study|Death|1|||
129756833|NCT02452424|467071229|FG010|Overall Study|Death|0|||
129756834|NCT02452424|467071219|FG000|Overall Study|Lost to Follow-up|0|||
129756835|NCT02452424|467071220|FG001|Overall Study|Lost to Follow-up|1|||
129756836|NCT02452424|467071221|FG002|Overall Study|Lost to Follow-up|1|||
129756837|NCT02452424|467071222|FG003|Overall Study|Lost to Follow-up|0|||
129756838|NCT02452424|467071223|FG004|Overall Study|Lost to Follow-up|0|||
129756839|NCT02452424|467071224|FG005|Overall Study|Lost to Follow-up|0|||
129756840|NCT02452424|467071225|FG006|Overall Study|Lost to Follow-up|0|||
129756841|NCT02452424|467071226|FG007|Overall Study|Lost to Follow-up|0|||
129756842|NCT02452424|467071227|FG008|Overall Study|Lost to Follow-up|0|||
129756843|NCT02452424|467071228|FG009|Overall Study|Lost to Follow-up|0|||
129756844|NCT02452424|467071229|FG010|Overall Study|Lost to Follow-up|0|||
129756845|NCT02452424|467071219|FG000|Overall Study|Withdrawal by Subject|0|||
129756846|NCT02452424|467071220|FG001|Overall Study|Withdrawal by Subject|0|||
129756847|NCT02452424|467071221|FG002|Overall Study|Withdrawal by Subject|3|||
129756848|NCT02452424|467071222|FG003|Overall Study|Withdrawal by Subject|2|||
129756849|NCT02452424|467071223|FG004|Overall Study|Withdrawal by Subject|0|||
129756850|NCT02452424|467071224|FG005|Overall Study|Withdrawal by Subject|0|||
129756851|NCT02452424|467071225|FG006|Overall Study|Withdrawal by Subject|1|||
129756852|NCT02452424|467071226|FG007|Overall Study|Withdrawal by Subject|0|||
129756853|NCT02452424|467071227|FG008|Overall Study|Withdrawal by Subject|1|||
129756854|NCT02452424|467071228|FG009|Overall Study|Withdrawal by Subject|1|||
129756855|NCT02452424|467071229|FG010|Overall Study|Withdrawal by Subject|0|||
129756856|NCT02452424|467071219|FG000|Overall Study|Other|0|||
129756857|NCT02452424|467071220|FG001|Overall Study|Other|0|||
129756858|NCT02452424|467071221|FG002|Overall Study|Other|1|||
129756859|NCT02452424|467071222|FG003|Overall Study|Other|0|||
129756860|NCT02452424|467071223|FG004|Overall Study|Other|0|||
129756861|NCT02452424|467071224|FG005|Overall Study|Other|1|||
129756862|NCT02452424|467071225|FG006|Overall Study|Other|4|||
129756863|NCT02452424|467071226|FG007|Overall Study|Other|3|||
129756864|NCT02452424|467071227|FG008|Overall Study|Other|0|||
129756865|NCT02452424|467071228|FG009|Overall Study|Other|0|||
129756866|NCT02452424|467071229|FG010|Overall Study|Other|1|||
129756867|NCT02452424|467071219|FG000|Overall Study|Progressive disease (per RECIST)|0|||
129756868|NCT02452424|467071220|FG001|Overall Study|Progressive disease (per RECIST)|0|||
129756869|NCT02452424|467071221|FG002|Overall Study|Progressive disease (per RECIST)|0|||
129756870|NCT02452424|467071222|FG003|Overall Study|Progressive disease (per RECIST)|0|||
129756871|NCT02452424|467071223|FG004|Overall Study|Progressive disease (per RECIST)|0|||
129756872|NCT02452424|467071224|FG005|Overall Study|Progressive disease (per RECIST)|0|||
129756873|NCT02452424|467071225|FG006|Overall Study|Progressive disease (per RECIST)|0|||
129756874|NCT02452424|467071226|FG007|Overall Study|Progressive disease (per RECIST)|0|||
129756875|NCT02452424|467071227|FG008|Overall Study|Progressive disease (per RECIST)|2|||
129756876|NCT02452424|467071228|FG009|Overall Study|Progressive disease (per RECIST)|0|||
129756877|NCT02452424|467071229|FG010|Overall Study|Progressive disease (per RECIST)|0|||
129756878|NCT02452424|467071219|FG000|Overall Study|Adverse Event|0|||
129756879|NCT02452424|467071220|FG001|Overall Study|Adverse Event|0|||
129756880|NCT02452424|467071221|FG002|Overall Study|Adverse Event|0|||
129756881|NCT02452424|467071222|FG003|Overall Study|Adverse Event|0|||
129756882|NCT02452424|467071223|FG004|Overall Study|Adverse Event|0|||
129756883|NCT02452424|467071224|FG005|Overall Study|Adverse Event|0|||
129756884|NCT02452424|467071225|FG006|Overall Study|Adverse Event|0|||
129811355|NCT01091974|467276402|FG002|Overall Study|Withdrawal by Subject|2|||
129756885|NCT02452424|467071226|FG007|Overall Study|Adverse Event|0|||
129756886|NCT02452424|467071227|FG008|Overall Study|Adverse Event|0|||
129756887|NCT02452424|467071228|FG009|Overall Study|Adverse Event|0|||
129756888|NCT02452424|467071229|FG010|Overall Study|Adverse Event|1|||
129756889|NCT01463306|467071230|FG000|Overall Study|Adverse Event|6|||
129756890|NCT01463306|467071231|FG001|Overall Study|Adverse Event|9|||
129756891|NCT01463306|467071232|FG002|Overall Study|Adverse Event|3|||
129756892|NCT01463306|467071230|FG000|Overall Study|Death|3|||
129756893|NCT01463306|467071231|FG001|Overall Study|Death|3|||
129756894|NCT01463306|467071232|FG002|Overall Study|Death|0|||
129756895|NCT01463306|467071230|FG000|Overall Study|Lack of Efficacy|22|||
129811356|NCT01091974|467276403|FG003|Overall Study|Withdrawal by Subject|2|||
129756896|NCT01463306|467071231|FG001|Overall Study|Lack of Efficacy|16|||
129756897|NCT01463306|467071232|FG002|Overall Study|Lack of Efficacy|1|||
129756898|NCT01463306|467071230|FG000|Overall Study|Lost to Follow-up|5|||
129756899|NCT01463306|467071231|FG001|Overall Study|Lost to Follow-up|2|||
129756900|NCT01463306|467071232|FG002|Overall Study|Lost to Follow-up|0|||
129756901|NCT01463306|467071230|FG000|Overall Study|Protocol Violation|4|||
129756902|NCT01463306|467071231|FG001|Overall Study|Protocol Violation|0|||
129756903|NCT01463306|467071232|FG002|Overall Study|Protocol Violation|0|||
129756904|NCT01463306|467071230|FG000|Overall Study|Withdrawal by Subject|19|||
129756905|NCT01463306|467071231|FG001|Overall Study|Withdrawal by Subject|9|||
129756906|NCT01463306|467071232|FG002|Overall Study|Withdrawal by Subject|1|||
129756907|NCT01463306|467071230|FG000|Overall Study|Other|26|||
129756908|NCT01463306|467071231|FG001|Overall Study|Other|13|||
129756909|NCT01463306|467071232|FG002|Overall Study|Other|0|||
129756910|NCT01463306|467071230|FG000|Overall Study|Approval expiry at site|1|||
129756911|NCT01463306|467071231|FG001|Overall Study|Approval expiry at site|0|||
129756912|NCT01463306|467071232|FG002|Overall Study|Approval expiry at site|0|||
129756913|NCT04186871|467071235|FG000|Overall Study|Lack of Efficacy|0|||
129756914|NCT04186871|467071236|FG001|Overall Study|Lack of Efficacy|1|||
129756915|NCT04186871|467071237|FG002|Overall Study|Lack of Efficacy|0|||
129756916|NCT04186871|467071238|FG003|Overall Study|Lack of Efficacy|0|||
129756917|NCT04186871|467071239|FG004|Overall Study|Lack of Efficacy|1|||
129756918|NCT04186871|467071240|FG005|Overall Study|Lack of Efficacy|1|||
129756919|NCT04186871|467071235|FG000|Overall Study|Adverse Event|1|||
129756920|NCT04186871|467071236|FG001|Overall Study|Adverse Event|1|||
129756921|NCT04186871|467071237|FG002|Overall Study|Adverse Event|0|||
129756922|NCT04186871|467071238|FG003|Overall Study|Adverse Event|0|||
129756923|NCT04186871|467071239|FG004|Overall Study|Adverse Event|0|||
129756924|NCT04186871|467071240|FG005|Overall Study|Adverse Event|2|||
129756925|NCT04186871|467071235|FG000|Overall Study|Study terminated by sponsor|1|||
129756926|NCT04186871|467071236|FG001|Overall Study|Study terminated by sponsor|2|||
129756927|NCT04186871|467071237|FG002|Overall Study|Study terminated by sponsor|0|||
129756928|NCT04186871|467071238|FG003|Overall Study|Study terminated by sponsor|1|||
129756929|NCT04186871|467071239|FG004|Overall Study|Study terminated by sponsor|0|||
129756930|NCT04186871|467071240|FG005|Overall Study|Study terminated by sponsor|0|||
129756931|NCT04186871|467071235|FG000|Overall Study|Other reasons|0|||
129756932|NCT04186871|467071236|FG001|Overall Study|Other reasons|0|||
129756933|NCT04186871|467071237|FG002|Overall Study|Other reasons|0|||
129756934|NCT04186871|467071238|FG003|Overall Study|Other reasons|0|||
129756935|NCT04186871|467071239|FG004|Overall Study|Other reasons|0|||
129756936|NCT04186871|467071240|FG005|Overall Study|Other reasons|1|||
129756937|NCT04186871|467071235|FG000|Overall Study|Withdrawal by Subject|0|||
129756938|NCT04186871|467071236|FG001|Overall Study|Withdrawal by Subject|0|||
129756939|NCT04186871|467071237|FG002|Overall Study|Withdrawal by Subject|0|||
129756940|NCT04186871|467071238|FG003|Overall Study|Withdrawal by Subject|0|||
129756941|NCT04186871|467071239|FG004|Overall Study|Withdrawal by Subject|0|||
129756942|NCT04186871|467071240|FG005|Overall Study|Withdrawal by Subject|1|||
129756943|NCT04186871|467071235|FG000|Overall Study|Lost to Follow-up|0|||
129756944|NCT04186871|467071236|FG001|Overall Study|Lost to Follow-up|0|||
129756945|NCT04186871|467071237|FG002|Overall Study|Lost to Follow-up|0|||
129756946|NCT04186871|467071238|FG003|Overall Study|Lost to Follow-up|0|||
129756947|NCT04186871|467071239|FG004|Overall Study|Lost to Follow-up|0|||
129756948|NCT04186871|467071240|FG005|Overall Study|Lost to Follow-up|1|||
129756949|NCT03790917|467071241|FG000|Overall Study|Death|1|||
129756950|NCT02464410|467071242|FG000|Overall Study|Death|3|||
129756951|NCT02464410|467071243|FG001|Overall Study|Death|4|||
129756952|NCT02464410|467071242|FG000|Overall Study|Lost to Follow-up|7|||
129756953|NCT02464410|467071243|FG001|Overall Study|Lost to Follow-up|9|||
129756954|NCT02464410|467071242|FG000|Overall Study|Withdrawal by Subject|12|||
129756955|NCT02464410|467071243|FG001|Overall Study|Withdrawal by Subject|3|||
129756956|NCT02679287|467071254|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
129896902|NCT04888585|467582176|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129896903|NCT04888585|467582177|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129756957|NCT02679287|467071255|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
129756958|NCT02679287|467071254|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
129756959|NCT02679287|467071255|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
129756960|NCT02679287|467071254|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
129756961|NCT02679287|467071255|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
129756962|NCT02679287|467071254|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
129756963|NCT02679287|467071255|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
129756964|NCT02679287|467071254|FG000|Period 2|Work/Scheduling Conflict|1|||
129756965|NCT02679287|467071255|FG001|Period 2|Work/Scheduling Conflict|0|||
129756966|NCT02679287|467071254|FG000|Period 2|Disliked Mobile System|2|||
129756967|NCT02679287|467071255|FG001|Period 2|Disliked Mobile System|0|||
129756968|NCT02679287|467071254|FG000|Period 3|Work/Scheduling Conflict|0|||
129756969|NCT02679287|467071255|FG001|Period 3|Work/Scheduling Conflict|1|||
129811357|NCT01091974|467276400|FG000|Overall Study|side-effects|1|||
129811358|NCT01091974|467276401|FG001|Overall Study|side-effects|1|||
129811359|NCT01091974|467276402|FG002|Overall Study|side-effects|0|||
129811360|NCT01091974|467276403|FG003|Overall Study|side-effects|2|||
129811361|NCT02499783|467276404|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
129811362|NCT02499783|467276405|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
129811363|NCT02499783|467276406|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
129811364|NCT02499783|467276404|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
129811365|NCT02499783|467276405|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
129811366|NCT02499783|467276406|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
129811367|NCT02499783|467276404|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
129811368|NCT02499783|467276405|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
129811369|NCT02499783|467276406|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
129811370|NCT02499783|467276404|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
129811371|NCT02499783|467276405|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
129811372|NCT02499783|467276406|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
129811373|NCT02499783|467276404|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
129811374|NCT02499783|467276405|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
129811375|NCT02499783|467276406|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
129811376|NCT02499783|467276404|FG000|DB Period: Weeks 0-8|Other|1|||
129811377|NCT02499783|467276405|FG001|DB Period: Weeks 0-8|Other|1|||
129811378|NCT02499783|467276406|FG002|DB Period: Weeks 0-8|Other|0|||
129811379|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
129811380|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
129811381|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
129811382|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
129811383|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
129811384|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
129811385|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
129811386|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
129811387|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
129811388|NCT02499783|467276404|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
129811389|NCT02499783|467276405|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
129811390|NCT02499783|467276406|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
129811391|NCT01866293|467276407|FG000|Overall Study|Adverse Event|2|||
129811392|NCT00555971|467276409|FG000|Overall Study|Adverse Event|1|||
129811393|NCT00555971|467276410|FG001|Overall Study|Adverse Event|1|||
129811394|NCT00518284|467276411|FG000|Overall Study|Adverse Event|0|||
129811395|NCT00518284|467276412|FG001|Overall Study|Adverse Event|1|||
129811396|NCT00518284|467276413|FG002|Overall Study|Adverse Event|0|||
129811397|NCT00518284|467276414|FG003|Overall Study|Adverse Event|0|||
129811398|NCT00518284|467276411|FG000|Overall Study|Study Termination|0|||
129811399|NCT00518284|467276412|FG001|Overall Study|Study Termination|2|||
129811400|NCT00518284|467276413|FG002|Overall Study|Study Termination|1|||
129811401|NCT00518284|467276414|FG003|Overall Study|Study Termination|2|||
129811402|NCT00801632|467276415|FG000|Overall Study|Re-transplant|1|||
129811403|NCT00621582|467276416|FG000|Overall Study|Adverse Event|7|||
129811404|NCT00621582|467276416|FG000|Overall Study|Protocol Violation|57|||
129811405|NCT00621582|467276416|FG000|Overall Study|Lost to Follow-up|24|||
129811406|NCT00621582|467276416|FG000|Overall Study|issues not identified by investigators|18|||
129811407|NCT01387932|467276418|FG000|Randomized and Treated|Physician Decision|3|||
129811408|NCT01387932|467276419|FG001|Randomized and Treated|Physician Decision|2|||
129811409|NCT01387932|467276418|FG000|Randomized and Treated|Withdrawal by Subject|4|||
129896904|NCT04888585|467582178|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129756970|NCT01045694|467071257|FG000|Overall Study|Withdrawal by Subject|2|||
129756971|NCT01150097|467071262|FG000|Months 24 to 36 Post-transplantation|Death|2|||
129756972|NCT01150097|467071263|FG001|Months 24 to 36 Post-transplantation|Death|0|||
129756973|NCT01150097|467071264|FG002|Months 24 to 36 Post-transplantation|Death|0|||
129756974|NCT01150097|467071262|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
129756975|NCT01150097|467071263|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
129756976|NCT01150097|467071264|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
129756977|NCT01150097|467071262|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
129756978|NCT01150097|467071263|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
129756979|NCT01150097|467071264|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
129756980|NCT01150097|467071262|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
129756981|NCT01150097|467071263|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
129811410|NCT01387932|467276419|FG001|Randomized and Treated|Withdrawal by Subject|2|||
129811411|NCT01387932|467276418|FG000|Survival Follow-up|Liver Transplant|24|||
129811412|NCT01387932|467276419|FG001|Survival Follow-up|Liver Transplant|28|||
129811413|NCT01387932|467276418|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
129811414|NCT01387932|467276419|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
129811415|NCT01387932|467276418|FG000|Survival Follow-up|Withdrawal by Subject|2|||
129756982|NCT01150097|467071264|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
129756983|NCT01150097|467071262|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
129756984|NCT01150097|467071263|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
129756985|NCT01150097|467071264|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
129756986|NCT01150097|467071262|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
129756987|NCT01150097|467071263|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
129756988|NCT01150097|467071264|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
129756989|NCT01150097|467071262|FG000|Months 24 to 48 Post-transplantation|Death|2|||
129756990|NCT01150097|467071263|FG001|Months 24 to 48 Post-transplantation|Death|0|||
129756991|NCT01150097|467071264|FG002|Months 24 to 48 Post-transplantation|Death|0|||
129756992|NCT00992459|467071268|FG000|Overall Study|Withdrawal by Subject|0|||
129756993|NCT00992459|467071269|FG001|Overall Study|Withdrawal by Subject|1|||
129756994|NCT00992459|467071268|FG000|Overall Study|Adverse Event|1|||
129756995|NCT00992459|467071269|FG001|Overall Study|Adverse Event|0|||
129756996|NCT00543387|467071270|FG000|Panel 1 + Panel 2|Adverse Event|0|||
129756997|NCT00543387|467071271|FG001|Panel 1 + Panel 2|Adverse Event|1|||
129756998|NCT00543387|467071272|FG002|Panel 1 + Panel 2|Adverse Event|0|||
129756999|NCT00543387|467071273|FG003|Panel 1 + Panel 2|Adverse Event|0|||
129757000|NCT00543387|467071274|FG004|Panel 1 + Panel 2|Adverse Event|0|||
129757001|NCT00543387|467071275|FG005|Panel 1 + Panel 2|Adverse Event|0|||
129757002|NCT00543387|467071276|FG006|Panel 1 + Panel 2|Adverse Event|0|||
129757003|NCT00543387|467071277|FG007|Panel 1 + Panel 2|Adverse Event|1|||
129757004|NCT00543387|467071278|FG008|Panel 1 + Panel 2|Adverse Event|1|||
129757005|NCT00543387|467071279|FG009|Panel 1 + Panel 2|Adverse Event|0|||
129757006|NCT00543387|467071280|FG010|Panel 1 + Panel 2|Adverse Event|0|||
129757007|NCT00543387|467071270|FG000|Panel 1 + Panel 2|Physician Decision|0|||
129757008|NCT00543387|467071271|FG001|Panel 1 + Panel 2|Physician Decision|0|||
129757009|NCT00543387|467071272|FG002|Panel 1 + Panel 2|Physician Decision|1|||
129757010|NCT00543387|467071273|FG003|Panel 1 + Panel 2|Physician Decision|0|||
129757011|NCT00543387|467071274|FG004|Panel 1 + Panel 2|Physician Decision|0|||
129757012|NCT00543387|467071275|FG005|Panel 1 + Panel 2|Physician Decision|0|||
129757013|NCT00543387|467071276|FG006|Panel 1 + Panel 2|Physician Decision|0|||
129757014|NCT00543387|467071277|FG007|Panel 1 + Panel 2|Physician Decision|1|||
129757015|NCT00543387|467071278|FG008|Panel 1 + Panel 2|Physician Decision|0|||
129757016|NCT00543387|467071279|FG009|Panel 1 + Panel 2|Physician Decision|0|||
129757017|NCT00543387|467071280|FG010|Panel 1 + Panel 2|Physician Decision|0|||
129757018|NCT00543387|467071270|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129757019|NCT00543387|467071271|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
129757020|NCT00543387|467071272|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
129757021|NCT00543387|467071273|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129757022|NCT00543387|467071274|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129757023|NCT00543387|467071275|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
129757024|NCT00543387|467071276|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
129757025|NCT00543387|467071277|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
129757026|NCT00543387|467071278|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
129757027|NCT00543387|467071279|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
129757028|NCT00543387|467071280|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
129757029|NCT00543387|467071270|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757030|NCT00543387|467071271|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757031|NCT00543387|467071272|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757032|NCT00543387|467071273|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757033|NCT00543387|467071274|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757034|NCT00543387|467071275|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757035|NCT00543387|467071276|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
129757036|NCT00543387|467071277|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757037|NCT00543387|467071278|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757038|NCT00543387|467071279|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757039|NCT00543387|467071280|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
129757040|NCT00543387|467071270|FG000|Crossover Participants|Progressive Disease|0|||
129896905|NCT04888585|467582179|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129757041|NCT00543387|467071271|FG001|Crossover Participants|Progressive Disease|0|||
129757042|NCT00543387|467071272|FG002|Crossover Participants|Progressive Disease|0|||
129757043|NCT00543387|467071273|FG003|Crossover Participants|Progressive Disease|0|||
129896906|NCT04888585|467582180|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129757044|NCT00543387|467071274|FG004|Crossover Participants|Progressive Disease|0|||
129811416|NCT01387932|467276419|FG001|Survival Follow-up|Withdrawal by Subject|4|||
129757045|NCT00543387|467071275|FG005|Crossover Participants|Progressive Disease|0|||
129757046|NCT00543387|467071276|FG006|Crossover Participants|Progressive Disease|0|||
129757047|NCT00543387|467071277|FG007|Crossover Participants|Progressive Disease|0|||
129757048|NCT00543387|467071278|FG008|Crossover Participants|Progressive Disease|0|||
129757049|NCT00543387|467071279|FG009|Crossover Participants|Progressive Disease|1|||
129757050|NCT00543387|467071280|FG010|Crossover Participants|Progressive Disease|2|||
129757051|NCT00543387|467071270|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
129757052|NCT00543387|467071271|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
129757053|NCT00543387|467071272|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
129811417|NCT01387932|467276418|FG000|Survival Follow-up|Lost to Follow-up|6|||
129811418|NCT01387932|467276419|FG001|Survival Follow-up|Lost to Follow-up|5|||
129811419|NCT00205881|467276420|FG000|Overall Study|Withdrawal by Subject|16|||
129811420|NCT02217878|467276426|FG000|Overall Study|required morphine due to chest pain|1|||
129811421|NCT02217878|467276427|FG001|Overall Study|required morphine due to chest pain|2|||
129811422|NCT02217878|467276426|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
129811423|NCT02217878|467276427|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
129811424|NCT00334958|467276428|FG000|Overall Study|Medication Noncompliance|0|||
129811425|NCT00334958|467276429|FG001|Overall Study|Medication Noncompliance|3|||
129811426|NCT00334958|467276428|FG000|Overall Study|Protocol Violation|2|||
129811427|NCT00334958|467276429|FG001|Overall Study|Protocol Violation|2|||
129811428|NCT00334958|467276428|FG000|Overall Study|Request of the investigator or sponsor|0|||
129811429|NCT00334958|467276429|FG001|Overall Study|Request of the investigator or sponsor|1|||
129811430|NCT00334958|467276428|FG000|Overall Study|Withdrawal by Subject|7|||
129811431|NCT00334958|467276429|FG001|Overall Study|Withdrawal by Subject|4|||
129811432|NCT00334958|467276428|FG000|Overall Study|Adverse Event|27|||
129811433|NCT00334958|467276429|FG001|Overall Study|Adverse Event|12|||
129811434|NCT00334958|467276428|FG000|Overall Study|Other|1|||
129811435|NCT00334958|467276429|FG001|Overall Study|Other|2|||
129811436|NCT00622401|467276430|FG000|Overall Study|Disease progression prior to treatment|3|||
129811437|NCT00622401|467276431|FG001|Overall Study|Disease progression prior to treatment|2|||
129811438|NCT00622401|467276432|FG002|Overall Study|Disease progression prior to treatment|0|||
129811439|NCT00781274|467276436|FG000|Overall Study|Withdrawal by Subject|2|||
129811440|NCT02021773|467276440|FG000|Overall Study|Adverse Event|1|||
129811441|NCT02021773|467276441|FG001|Overall Study|Adverse Event|4|||
129811442|NCT02021773|467276442|FG002|Overall Study|Adverse Event|3|||
129811443|NCT02021773|467276440|FG000|Overall Study|Lack of Efficacy|2|||
129811444|NCT02021773|467276441|FG001|Overall Study|Lack of Efficacy|2|||
129811445|NCT02021773|467276442|FG002|Overall Study|Lack of Efficacy|2|||
129811446|NCT02021773|467276440|FG000|Overall Study|Protocol Violation|2|||
129811447|NCT02021773|467276441|FG001|Overall Study|Protocol Violation|3|||
129811448|NCT02021773|467276442|FG002|Overall Study|Protocol Violation|1|||
129811449|NCT02021773|467276440|FG000|Overall Study|Withdrawal by Subject|3|||
129811450|NCT02021773|467276441|FG001|Overall Study|Withdrawal by Subject|4|||
129811451|NCT02021773|467276442|FG002|Overall Study|Withdrawal by Subject|5|||
129811452|NCT02021773|467276440|FG000|Overall Study|Lost to Follow-up|1|||
129811453|NCT02021773|467276441|FG001|Overall Study|Lost to Follow-up|3|||
129811454|NCT02021773|467276442|FG002|Overall Study|Lost to Follow-up|0|||
129811455|NCT02021773|467276440|FG000|Overall Study|Reason not specified|3|||
129811456|NCT02021773|467276441|FG001|Overall Study|Reason not specified|0|||
129811457|NCT02021773|467276442|FG002|Overall Study|Reason not specified|0|||
129811458|NCT02243696|467276443|FG000|Overall Study|Death|282|||
129811459|NCT02243696|467276443|FG000|Overall Study|Withdrawal by Subject|79|||
129811460|NCT02243696|467276443|FG000|Overall Study|Lost to Follow-up|57|||
129811461|NCT02243696|467276443|FG000|Overall Study|Subject No Longer has Study System|42|||
129811462|NCT02243696|467276443|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
129811463|NCT02243696|467276443|FG000|Overall Study|Study Terminated for EP PASSION|961|||
129811464|NCT01534962|467276444|FG000|Overall Study|Randomized but did not start treatment|2|||
129811465|NCT01534962|467276445|FG001|Overall Study|Randomized but did not start treatment|0|||
129811466|NCT01534962|467276446|FG002|Overall Study|Randomized but did not start treatment|0|||
129896907|NCT04888585|467582181|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
129896908|NCT04888585|467582171|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896909|NCT04888585|467582172|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129811467|NCT01534962|467276447|FG003|Overall Study|Randomized but did not start treatment|1|||
129811468|NCT01534962|467276444|FG000|Overall Study|Discontinued at AF recurrence|35|||
129811469|NCT01534962|467276445|FG001|Overall Study|Discontinued at AF recurrence|26|||
129811470|NCT01534962|467276446|FG002|Overall Study|Discontinued at AF recurrence|24|||
129811471|NCT01534962|467276447|FG003|Overall Study|Discontinued at AF recurrence|31|||
129811472|NCT00190671|467276448|FG000|Overall Study|Satisfactory Response|4|||
129811473|NCT00190671|467276449|FG001|Overall Study|Satisfactory Response|7|||
129811474|NCT00190671|467276448|FG000|Overall Study|Lack of Efficacy|19|||
129896910|NCT04888585|467582173|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
129811475|NCT00190671|467276449|FG001|Overall Study|Lack of Efficacy|24|||
129811476|NCT00190671|467276448|FG000|Overall Study|Death from Study Disease|1|||
129811477|NCT00190671|467276449|FG001|Overall Study|Death from Study Disease|1|||
129811478|NCT00190671|467276448|FG000|Overall Study|Adverse Event|3|||
129811479|NCT00190671|467276449|FG001|Overall Study|Adverse Event|2|||
129811480|NCT00190671|467276448|FG000|Overall Study|Clinical Relapse|0|||
129811481|NCT00190671|467276449|FG001|Overall Study|Clinical Relapse|1|||
129811482|NCT00190671|467276448|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
129811483|NCT00190671|467276449|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
129811484|NCT00190671|467276448|FG000|Overall Study|Death from Other Causes|0|||
129811485|NCT00190671|467276449|FG001|Overall Study|Death from Other Causes|2|||
129811486|NCT00190671|467276448|FG000|Overall Study|Protocol Violation|0|||
129811487|NCT00190671|467276449|FG001|Overall Study|Protocol Violation|1|||
129811488|NCT00190671|467276448|FG000|Overall Study|Withdrawal by Subject|0|||
129811489|NCT00190671|467276449|FG001|Overall Study|Withdrawal by Subject|2|||
129811490|NCT00191269|467276450|FG000|Overall Study|Protocol Violation|0|||
129811491|NCT00191269|467276451|FG001|Overall Study|Protocol Violation|2|||
129811492|NCT00191269|467276450|FG000|Overall Study|Adverse Event|1|||
129811493|NCT00191269|467276451|FG001|Overall Study|Adverse Event|4|||
129811494|NCT00191269|467276450|FG000|Overall Study|Progression of Disease|4|||
129811495|NCT00191269|467276451|FG001|Overall Study|Progression of Disease|42|||
129811496|NCT00191269|467276450|FG000|Overall Study|Lack of Efficacy|1|||
129811497|NCT00191269|467276451|FG001|Overall Study|Lack of Efficacy|5|||
129811498|NCT00191269|467276450|FG000|Overall Study|Withdrawal by Subject|0|||
129811499|NCT00191269|467276451|FG001|Overall Study|Withdrawal by Subject|1|||
129811500|NCT00191269|467276450|FG000|Overall Study|Pathologic Aggrevation|0|||
129811501|NCT00191269|467276451|FG001|Overall Study|Pathologic Aggrevation|1|||
129757054|NCT00543387|467071273|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
129757055|NCT00543387|467071274|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
129811502|NCT00191269|467276450|FG000|Overall Study|Physician Decision|0|||
129811503|NCT00191269|467276451|FG001|Overall Study|Physician Decision|3|||
129811504|NCT00668707|467276457|FG000|Overall Study|Cancer Recurrence|58|||
129811505|NCT00668707|467276458|FG001|Overall Study|Cancer Recurrence|58|||
129811506|NCT00668707|467276457|FG000|Overall Study|Withdrawal by Subject|117|||
129811507|NCT00668707|467276458|FG001|Overall Study|Withdrawal by Subject|100|||
129811508|NCT00668707|467276457|FG000|Overall Study|Lost to Follow-up|3|||
129811509|NCT00668707|467276458|FG001|Overall Study|Lost to Follow-up|6|||
129811510|NCT00668707|467276457|FG000|Overall Study|Protocol Violation|10|||
129811511|NCT00668707|467276458|FG001|Overall Study|Protocol Violation|12|||
129811512|NCT00668707|467276457|FG000|Overall Study|Death|11|||
129811513|NCT00668707|467276458|FG001|Overall Study|Death|4|||
129811514|NCT00191139|467276460|FG000|Overall Study|Adverse Event|2|||
129811515|NCT00191139|467276461|FG001|Overall Study|Adverse Event|6|||
129811516|NCT00191139|467276460|FG000|Overall Study|Death|2|||
129811517|NCT00191139|467276461|FG001|Overall Study|Death|0|||
129811518|NCT00191139|467276460|FG000|Overall Study|Withdrawal by Subject|0|||
129811519|NCT00191139|467276461|FG001|Overall Study|Withdrawal by Subject|3|||
129811520|NCT00191139|467276460|FG000|Overall Study|Disease Progression|0|||
129896911|NCT04888585|467582174|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129757056|NCT00543387|467071275|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
129757057|NCT00543387|467071276|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
129757058|NCT00543387|467071277|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
129757059|NCT00543387|467071278|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
129757060|NCT00543387|467071279|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
129757061|NCT00543387|467071280|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
129757062|NCT01114828|467071281|FG000|Overall Study|Adverse Event|1|||
129757063|NCT01114828|467071282|FG001|Overall Study|Adverse Event|1|||
129757064|NCT01114828|467071281|FG000|Overall Study|Lack of Efficacy|0|||
129757065|NCT01114828|467071282|FG001|Overall Study|Lack of Efficacy|2|||
129757066|NCT01114828|467071281|FG000|Overall Study|Protocol Violation|2|||
129757067|NCT01114828|467071282|FG001|Overall Study|Protocol Violation|0|||
129811521|NCT00191139|467276461|FG001|Overall Study|Disease Progression|1|||
129811522|NCT00191139|467276460|FG000|Overall Study|Other|1|||
129811523|NCT00191139|467276461|FG001|Overall Study|Other|2|||
129811524|NCT03338010|467276462|FG000|Overall Study|Withdrawal by Subject|14|||
129811525|NCT03338010|467276463|FG001|Overall Study|Withdrawal by Subject|8|||
129811526|NCT03338010|467276462|FG000|Overall Study|Lost to Follow-up|4|||
129811527|NCT03338010|467276463|FG001|Overall Study|Lost to Follow-up|2|||
129811528|NCT03338010|467276462|FG000|Overall Study|Adverse Event|3|||
129811529|NCT03338010|467276463|FG001|Overall Study|Adverse Event|2|||
129811530|NCT03338010|467276462|FG000|Overall Study|Physician Decision|2|||
129811531|NCT03338010|467276463|FG001|Overall Study|Physician Decision|2|||
129811532|NCT03338010|467276462|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129811533|NCT03338010|467276463|FG001|Overall Study|Non-Compliance with Study Drug|3|||
129896912|NCT04888585|467582175|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
129811534|NCT03338010|467276462|FG000|Overall Study|Protocol Violation|0|||
129811535|NCT03338010|467276463|FG001|Overall Study|Protocol Violation|1|||
129757068|NCT01114828|467071281|FG000|Overall Study|Withdrawal by Subject|0|||
129757069|NCT01114828|467071282|FG001|Overall Study|Withdrawal by Subject|1|||
129757070|NCT00940498|467071283|FG000|Overall Study|Death|2|||
129757071|NCT00940498|467071284|FG001|Overall Study|Death|0|||
129757072|NCT00940498|467071285|FG002|Overall Study|Death|0|||
129757073|NCT00940498|467071286|FG003|Overall Study|Death|1|||
129757074|NCT00940498|467071287|FG004|Overall Study|Death|5|||
129757075|NCT00940498|467071288|FG005|Overall Study|Death|0|||
129757076|NCT00940498|467071289|FG006|Overall Study|Death|1|||
129757077|NCT00940498|467071290|FG007|Overall Study|Death|0|||
129757078|NCT00940498|467071283|FG000|Overall Study|Lost to Follow-up|1|||
129757079|NCT00940498|467071284|FG001|Overall Study|Lost to Follow-up|1|||
129757080|NCT00940498|467071285|FG002|Overall Study|Lost to Follow-up|2|||
129757081|NCT00940498|467071286|FG003|Overall Study|Lost to Follow-up|0|||
129757082|NCT00940498|467071287|FG004|Overall Study|Lost to Follow-up|1|||
129757083|NCT00940498|467071288|FG005|Overall Study|Lost to Follow-up|0|||
129757084|NCT00940498|467071289|FG006|Overall Study|Lost to Follow-up|0|||
129757085|NCT00940498|467071290|FG007|Overall Study|Lost to Follow-up|1|||
129757086|NCT00940498|467071283|FG000|Overall Study|Disease Progression|0|||
129757087|NCT00940498|467071284|FG001|Overall Study|Disease Progression|0|||
129757088|NCT00940498|467071285|FG002|Overall Study|Disease Progression|1|||
129757089|NCT00940498|467071286|FG003|Overall Study|Disease Progression|1|||
129757090|NCT00940498|467071287|FG004|Overall Study|Disease Progression|0|||
129757091|NCT00940498|467071288|FG005|Overall Study|Disease Progression|1|||
129757092|NCT00940498|467071289|FG006|Overall Study|Disease Progression|0|||
129757093|NCT00940498|467071290|FG007|Overall Study|Disease Progression|0|||
129757094|NCT00940498|467071283|FG000|Overall Study|Physician Decision|0|||
129757095|NCT00940498|467071284|FG001|Overall Study|Physician Decision|0|||
129757096|NCT00940498|467071285|FG002|Overall Study|Physician Decision|0|||
129757097|NCT00940498|467071286|FG003|Overall Study|Physician Decision|0|||
129757098|NCT00940498|467071287|FG004|Overall Study|Physician Decision|2|||
129757099|NCT00940498|467071288|FG005|Overall Study|Physician Decision|0|||
129757100|NCT00940498|467071289|FG006|Overall Study|Physician Decision|0|||
129757101|NCT00940498|467071290|FG007|Overall Study|Physician Decision|0|||
129757102|NCT00940498|467071283|FG000|Overall Study|Not treated due to disease related pain|0|||
129757103|NCT00940498|467071284|FG001|Overall Study|Not treated due to disease related pain|0|||
129757104|NCT00940498|467071285|FG002|Overall Study|Not treated due to disease related pain|0|||
129757105|NCT00940498|467071286|FG003|Overall Study|Not treated due to disease related pain|0|||
129757106|NCT00940498|467071287|FG004|Overall Study|Not treated due to disease related pain|1|||
129757107|NCT00940498|467071288|FG005|Overall Study|Not treated due to disease related pain|0|||
129757108|NCT00940498|467071289|FG006|Overall Study|Not treated due to disease related pain|0|||
129757109|NCT00940498|467071290|FG007|Overall Study|Not treated due to disease related pain|0|||
129757110|NCT03932760|467071291|FG000|Overall Study|Became Ineligible|2|||
129757111|NCT03932760|467071292|FG001|Overall Study|Became Ineligible|5|||
129757112|NCT03932760|467071291|FG000|Overall Study|Withdrawal by Subject|6|||
129757113|NCT03932760|467071292|FG001|Overall Study|Withdrawal by Subject|6|||
129757114|NCT03566082|467071293|FG000|Overall Study|Death|7|||
129757115|NCT03566082|467071293|FG000|Overall Study|Failures (revision required)|2|||
129757116|NCT03566082|467071293|FG000|Overall Study|Lost to Follow-up|8|||
129757117|NCT00227721|467072656|FG000|Overall Study|On study, but never treated.|1|||
129757118|NCT01389882|467072661|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
129757119|NCT01389882|467072662|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
129757120|NCT01389882|467072661|FG000|Overall Study|Withdrawal by Subject|0|||
129757121|NCT01389882|467072662|FG001|Overall Study|Withdrawal by Subject|1|||
129757122|NCT00961181|467072663|FG000|Overall Study|Death|2|||
129757123|NCT00961181|467072663|FG000|Overall Study|Withdrawal by Subject|2|||
129757124|NCT00961181|467072663|FG000|Overall Study|Lost to Follow-up|1|||
129757125|NCT01276639|467072678|FG000|Week 0 to 16|Death|1|||
129757126|NCT01276639|467072679|FG001|Week 0 to 16|Death|0|||
129757127|NCT01276639|467072680|FG002|Week 0 to 16|Death|0|||
129757128|NCT01276639|467072681|FG003|Week 0 to 16|Death|0|||
129757129|NCT01276639|467072682|FG004|Week 0 to 16|Death|0|||
129757130|NCT01276639|467072678|FG000|Week 0 to 16|Adverse Event|11|||
129757131|NCT01276639|467072679|FG001|Week 0 to 16|Adverse Event|8|||
129757132|NCT01276639|467072680|FG002|Week 0 to 16|Adverse Event|11|||
129757133|NCT01276639|467072681|FG003|Week 0 to 16|Adverse Event|0|||
129757134|NCT01276639|467072682|FG004|Week 0 to 16|Adverse Event|0|||
129757135|NCT01276639|467072678|FG000|Week 0 to 16|Lack of Efficacy|20|||
129757136|NCT01276639|467072679|FG001|Week 0 to 16|Lack of Efficacy|15|||
129757137|NCT01276639|467072680|FG002|Week 0 to 16|Lack of Efficacy|25|||
129757138|NCT01276639|467072681|FG003|Week 0 to 16|Lack of Efficacy|0|||
129757139|NCT01276639|467072682|FG004|Week 0 to 16|Lack of Efficacy|0|||
129757140|NCT01276639|467072678|FG000|Week 0 to 16|Lost to Follow-up|3|||
129757141|NCT01276639|467072679|FG001|Week 0 to 16|Lost to Follow-up|5|||
129757142|NCT01276639|467072680|FG002|Week 0 to 16|Lost to Follow-up|3|||
129757143|NCT01276639|467072681|FG003|Week 0 to 16|Lost to Follow-up|0|||
129757144|NCT01276639|467072682|FG004|Week 0 to 16|Lost to Follow-up|0|||
129757145|NCT01276639|467072678|FG000|Week 0 to 16|Withdrawal by Subject|8|||
129757146|NCT01276639|467072679|FG001|Week 0 to 16|Withdrawal by Subject|5|||
129757147|NCT01276639|467072680|FG002|Week 0 to 16|Withdrawal by Subject|4|||
129757148|NCT01276639|467072681|FG003|Week 0 to 16|Withdrawal by Subject|0|||
129757149|NCT01276639|467072682|FG004|Week 0 to 16|Withdrawal by Subject|0|||
129757150|NCT01276639|467072678|FG000|Week 0 to 16|Other|7|||
129757151|NCT01276639|467072679|FG001|Week 0 to 16|Other|7|||
129757152|NCT01276639|467072680|FG002|Week 0 to 16|Other|2|||
129757153|NCT01276639|467072681|FG003|Week 0 to 16|Other|0|||
129757154|NCT01276639|467072682|FG004|Week 0 to 16|Other|0|||
129757155|NCT01276639|467072678|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
129757156|NCT01276639|467072679|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
129757157|NCT01276639|467072680|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
129757158|NCT01276639|467072681|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
129757159|NCT01276639|467072682|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
129757160|NCT01276639|467072678|FG000|Week 16 to 52|Death|1|||
129757161|NCT01276639|467072679|FG001|Week 16 to 52|Death|0|||
129757162|NCT01276639|467072680|FG002|Week 16 to 52|Death|0|||
129757163|NCT01276639|467072681|FG003|Week 16 to 52|Death|0|||
129757164|NCT01276639|467072682|FG004|Week 16 to 52|Death|0|||
129757165|NCT01276639|467072678|FG000|Week 16 to 52|Adverse Event|10|||
129757166|NCT01276639|467072679|FG001|Week 16 to 52|Adverse Event|13|||
129757167|NCT01276639|467072680|FG002|Week 16 to 52|Adverse Event|0|||
129757168|NCT01276639|467072681|FG003|Week 16 to 52|Adverse Event|1|||
129757169|NCT01276639|467072682|FG004|Week 16 to 52|Adverse Event|3|||
129757170|NCT01276639|467072678|FG000|Week 16 to 52|Lack of Efficacy|99|||
129757171|NCT01276639|467072679|FG001|Week 16 to 52|Lack of Efficacy|71|||
129757172|NCT01276639|467072680|FG002|Week 16 to 52|Lack of Efficacy|0|||
129757173|NCT01276639|467072681|FG003|Week 16 to 52|Lack of Efficacy|14|||
129757174|NCT01276639|467072682|FG004|Week 16 to 52|Lack of Efficacy|13|||
129757175|NCT01276639|467072678|FG000|Week 16 to 52|Lost to Follow-up|3|||
129757176|NCT01276639|467072679|FG001|Week 16 to 52|Lost to Follow-up|1|||
129757177|NCT01276639|467072680|FG002|Week 16 to 52|Lost to Follow-up|0|||
129757178|NCT01276639|467072681|FG003|Week 16 to 52|Lost to Follow-up|0|||
129757179|NCT01276639|467072682|FG004|Week 16 to 52|Lost to Follow-up|1|||
129757180|NCT01276639|467072678|FG000|Week 16 to 52|Withdrawal by Subject|4|||
129757181|NCT01276639|467072679|FG001|Week 16 to 52|Withdrawal by Subject|4|||
129757182|NCT01276639|467072680|FG002|Week 16 to 52|Withdrawal by Subject|0|||
129757183|NCT01276639|467072681|FG003|Week 16 to 52|Withdrawal by Subject|0|||
129757184|NCT01276639|467072682|FG004|Week 16 to 52|Withdrawal by Subject|1|||
129757185|NCT01276639|467072678|FG000|Week 16 to 52|Other|10|||
129757186|NCT01276639|467072679|FG001|Week 16 to 52|Other|12|||
129757187|NCT01276639|467072680|FG002|Week 16 to 52|Other|0|||
129757188|NCT01276639|467072681|FG003|Week 16 to 52|Other|1|||
129757189|NCT01276639|467072682|FG004|Week 16 to 52|Other|3|||
129757190|NCT00466440|467072687|FG000|Overall Study|Adverse Event|0|||
129757191|NCT00466440|467072688|FG001|Overall Study|Adverse Event|3|||
129757192|NCT00466440|467072689|FG002|Overall Study|Adverse Event|1|||
129757193|NCT00466440|467072687|FG000|Overall Study|Death|1|||
129757194|NCT00466440|467072688|FG001|Overall Study|Death|1|||
129757195|NCT00466440|467072689|FG002|Overall Study|Death|0|||
129757196|NCT00466440|467072687|FG000|Overall Study|Progressive disease|13|||
129757197|NCT00466440|467072688|FG001|Overall Study|Progressive disease|5|||
129757198|NCT00466440|467072689|FG002|Overall Study|Progressive disease|4|||
129757199|NCT00466440|467072687|FG000|Overall Study|Lost to Follow-up|0|||
129757200|NCT00466440|467072688|FG001|Overall Study|Lost to Follow-up|1|||
129757201|NCT00466440|467072689|FG002|Overall Study|Lost to Follow-up|0|||
129757202|NCT00466440|467072687|FG000|Overall Study|Physician Decision|0|||
129811536|NCT01146665|467276466|FG000|Overall Study|Withdrawal by Subject|10|||
129811537|NCT01146665|467276467|FG001|Overall Study|Withdrawal by Subject|16|||
129811538|NCT02465515|467276468|FG000|Overall Study|Investigator site closed|4|||
129757203|NCT00466440|467072688|FG001|Overall Study|Physician Decision|1|||
129757204|NCT00466440|467072689|FG002|Overall Study|Physician Decision|2|||
129757205|NCT00466440|467072687|FG000|Overall Study|Protocol entry criteria not met|0|||
129757206|NCT00466440|467072688|FG001|Overall Study|Protocol entry criteria not met|0|||
129757207|NCT00466440|467072689|FG002|Overall Study|Protocol entry criteria not met|4|||
129811539|NCT02465515|467276469|FG001|Overall Study|Investigator site closed|5|||
129811540|NCT02465515|467276468|FG000|Overall Study|Withdrawal by Subject|74|||
129811541|NCT02465515|467276469|FG001|Overall Study|Withdrawal by Subject|43|||
129757208|NCT00466440|467072687|FG000|Overall Study|Withdrawal by Subject|0|||
129757209|NCT00466440|467072688|FG001|Overall Study|Withdrawal by Subject|1|||
129757210|NCT00466440|467072689|FG002|Overall Study|Withdrawal by Subject|0|||
129757211|NCT00466440|467072687|FG000|Overall Study|Sponsor decision|0|||
129757212|NCT00466440|467072688|FG001|Overall Study|Sponsor decision|0|||
129757213|NCT00466440|467072689|FG002|Overall Study|Sponsor decision|1|||
129811542|NCT02465515|467276468|FG000|Overall Study|Physician Decision|8|||
129811543|NCT02465515|467276469|FG001|Overall Study|Physician Decision|12|||
129811544|NCT02465515|467276468|FG000|Overall Study|Lost to Follow-up|68|||
129811545|NCT02465515|467276469|FG001|Overall Study|Lost to Follow-up|51|||
129757214|NCT00965081|467072690|FG000|Overall Study|Adverse Event|14|||
129757215|NCT00965081|467072691|FG001|Overall Study|Adverse Event|9|||
129757216|NCT00965081|467072690|FG000|Overall Study|Lack of Efficacy|2|||
129757217|NCT00965081|467072691|FG001|Overall Study|Lack of Efficacy|5|||
129757218|NCT00965081|467072690|FG000|Overall Study|Lost to Follow-up|4|||
129757219|NCT00965081|467072691|FG001|Overall Study|Lost to Follow-up|5|||
129757220|NCT00965081|467072690|FG000|Overall Study|Physician Decision|2|||
129757221|NCT00965081|467072691|FG001|Overall Study|Physician Decision|0|||
129757222|NCT00965081|467072690|FG000|Overall Study|Protocol Violation|2|||
129757223|NCT00965081|467072691|FG001|Overall Study|Protocol Violation|5|||
129757224|NCT00965081|467072690|FG000|Overall Study|Sponsor Decision|1|||
129757225|NCT00965081|467072691|FG001|Overall Study|Sponsor Decision|0|||
129757226|NCT00965081|467072690|FG000|Overall Study|Withdrawal by Subject|4|||
129757227|NCT00965081|467072691|FG001|Overall Study|Withdrawal by Subject|7|||
129757228|NCT00965081|467072690|FG000|Overall Study|Switched to Rescue Arm|5|||
129757229|NCT00965081|467072691|FG001|Overall Study|Switched to Rescue Arm|12|||
129757230|NCT00796666|467072694|FG000|Overall Study|Death|2|||
129757231|NCT00796666|467072695|FG001|Overall Study|Death|4|||
129757232|NCT00796666|467072694|FG000|Overall Study|Withdrawal by Subject|2|||
129757233|NCT00796666|467072695|FG001|Overall Study|Withdrawal by Subject|0|||
129757234|NCT00796666|467072694|FG000|Overall Study|Adverse Event|7|||
129757235|NCT00796666|467072695|FG001|Overall Study|Adverse Event|5|||
129757236|NCT00796666|467072694|FG000|Overall Study|Protocol Violation|1|||
129757237|NCT00796666|467072695|FG001|Overall Study|Protocol Violation|0|||
129757238|NCT00796666|467072694|FG000|Overall Study|Other|1|||
129757239|NCT00796666|467072695|FG001|Overall Study|Other|0|||
129757240|NCT00796666|467072694|FG000|Overall Study|Terminated by sponsor|53|||
129757241|NCT00796666|467072695|FG001|Overall Study|Terminated by sponsor|55|||
129757242|NCT00796666|467072694|FG000|Overall Study|Randomized and not treated|1|||
129757243|NCT00796666|467072695|FG001|Overall Study|Randomized and not treated|0|||
129757244|NCT00256724|467072698|FG000|Overall Study|Physician Decision|2|||
129757245|NCT00256724|467072699|FG001|Overall Study|Physician Decision|5|||
129757246|NCT00256724|467072698|FG000|Overall Study|Protocol Violation|3|||
129757247|NCT00256724|467072699|FG001|Overall Study|Protocol Violation|3|||
129757248|NCT01217463|467072700|FG000|Overall Study|Adverse Event|8|||
129757249|NCT01217463|467072701|FG001|Overall Study|Adverse Event|5|||
129757250|NCT01217463|467072700|FG000|Overall Study|Physician Decision|0|||
129757251|NCT01217463|467072701|FG001|Overall Study|Physician Decision|1|||
129757252|NCT01217463|467072700|FG000|Overall Study|Withdrawal by Subject|3|||
129757253|NCT01217463|467072701|FG001|Overall Study|Withdrawal by Subject|0|||
129757254|NCT01217463|467072700|FG000|Overall Study|Surgery on the Target Limb|0|||
129757255|NCT01217463|467072701|FG001|Overall Study|Surgery on the Target Limb|1|||
129757256|NCT01217463|467072700|FG000|Overall Study|Patient Non-compliant|1|||
129757257|NCT01217463|467072701|FG001|Overall Study|Patient Non-compliant|0|||
129757258|NCT01217463|467072700|FG000|Overall Study|Other|1|||
129757259|NCT01217463|467072701|FG001|Overall Study|Other|1|||
129757260|NCT02090426|467072705|FG000|Overall Study|Lost to Follow-up|12|||
129757261|NCT02090426|467072706|FG001|Overall Study|Lost to Follow-up|6|||
129757262|NCT01141712|467072707|FG000|Overall Study|Disease progression|3|||
129757263|NCT01012258|467072713|FG000|Overall Study|Death|14|||
129757264|NCT01012258|467072713|FG000|Overall Study|Lost to Follow-up|1|||
129757265|NCT01012258|467072713|FG000|Overall Study|Adverse Event|1|||
129757266|NCT01012258|467072713|FG000|Overall Study|Progressive Disease (PD)|18|||
129757267|NCT01012258|467072713|FG000|Overall Study|Symptomatic Deterioration|1|||
129757268|NCT01012258|467072713|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
129757269|NCT01012258|467072713|FG000|Overall Study|Another Tumor Discovered|1|||
129757270|NCT01012258|467072713|FG000|Overall Study|Ongoing|29|||
129757271|NCT03600740|467072714|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
129757272|NCT03571204|467072715|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
129757273|NCT03571204|467072716|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
129757274|NCT03571204|467072717|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
129757275|NCT03571204|467072715|FG000|Overall Study|Physician Decision|0|||
129757276|NCT03571204|467072716|FG001|Overall Study|Physician Decision|1|||
129757277|NCT03571204|467072717|FG002|Overall Study|Physician Decision|0|||
129757278|NCT02396212|467072718|FG000|Overall Study|Adverse Event|1|||
129757279|NCT02396212|467072718|FG000|Overall Study|Lack of Efficacy|2|||
129757280|NCT01623115|467072719|FG000|Overall Study|Randomized but not treated|0|||
129757281|NCT01623115|467072720|FG001|Overall Study|Randomized but not treated|1|||
129757282|NCT01623115|467072719|FG000|Overall Study|Physician Decision|1|||
129757283|NCT01623115|467072720|FG001|Overall Study|Physician Decision|0|||
129757284|NCT01623115|467072719|FG000|Overall Study|Participants moved|1|||
129757285|NCT01623115|467072720|FG001|Overall Study|Participants moved|5|||
129757286|NCT01623115|467072719|FG000|Overall Study|Adverse Event|10|||
129757287|NCT01623115|467072720|FG001|Overall Study|Adverse Event|13|||
129757288|NCT01623115|467072719|FG000|Overall Study|Poor compliance to protocol|4|||
129757289|NCT01623115|467072720|FG001|Overall Study|Poor compliance to protocol|10|||
129757290|NCT01623115|467072719|FG000|Overall Study|Consent withdrawn by participant|2|||
129757291|NCT01623115|467072720|FG001|Overall Study|Consent withdrawn by participant|6|||
129757292|NCT01623115|467072719|FG000|Overall Study|Related to study drug administration|0|||
129757293|NCT01623115|467072720|FG001|Overall Study|Related to study drug administration|2|||
129757294|NCT01623115|467072719|FG000|Overall Study|Last visit outside protocol visit window|14|||
129757295|NCT01623115|467072720|FG001|Overall Study|Last visit outside protocol visit window|26|||
129757296|NCT01623115|467072719|FG000|Overall Study|Site closure|1|||
129757297|NCT01623115|467072720|FG001|Overall Study|Site closure|7|||
129757298|NCT01623115|467072719|FG000|Overall Study|Death|0|||
129757299|NCT01623115|467072720|FG001|Overall Study|Death|4|||
129757300|NCT01623115|467072719|FG000|Overall Study|Other than specified above|0|||
129757301|NCT01623115|467072720|FG001|Overall Study|Other than specified above|3|||
129757302|NCT01454596|467072723|FG000|Overall Study|Death|0|||
129757303|NCT01454596|467072724|FG001|Overall Study|Death|0|||
129757304|NCT01454596|467072725|FG002|Overall Study|Death|0|||
129757305|NCT01454596|467072726|FG003|Overall Study|Death|0|||
129757306|NCT01454596|467072727|FG004|Overall Study|Death|0|||
129757307|NCT01454596|467072728|FG005|Overall Study|Death|0|||
129757308|NCT01454596|467072729|FG006|Overall Study|Death|0|||
129757309|NCT01454596|467072730|FG007|Overall Study|Death|0|||
129757310|NCT01454596|467072731|FG008|Overall Study|Death|0|||
129811546|NCT00751933|467276470|FG000|Overall Study|Withdrawal by Subject|0|||
129811547|NCT00751933|467276471|FG001|Overall Study|Withdrawal by Subject|1|||
129811548|NCT00751933|467276472|FG002|Overall Study|Withdrawal by Subject|0|||
129811549|NCT00751933|467276473|FG003|Overall Study|Withdrawal by Subject|0|||
129811550|NCT00751933|467276470|FG000|Overall Study|Physician Decision|0|||
129811551|NCT00751933|467276471|FG001|Overall Study|Physician Decision|0|||
129811552|NCT00751933|467276472|FG002|Overall Study|Physician Decision|1|||
129811553|NCT00751933|467276473|FG003|Overall Study|Physician Decision|1|||
129811554|NCT03846804|467276474|FG000|Overall Study|Refused blood draw|1|||
129811555|NCT03846804|467276474|FG000|Overall Study|Protocol Violation|1|||
129811556|NCT05248867|467276476|FG000|Double-blind Period|Lost to Follow-up|0|||
129811557|NCT05248867|467276477|FG001|Double-blind Period|Lost to Follow-up|3|||
129811558|NCT05248867|467276478|FG002|Double-blind Period|Lost to Follow-up|0|||
129811559|NCT05248867|467276479|FG003|Double-blind Period|Lost to Follow-up|0|||
129811560|NCT05248867|467276480|FG004|Double-blind Period|Lost to Follow-up|0|||
129811561|NCT05248867|467276481|FG005|Double-blind Period|Lost to Follow-up|0|||
129811562|NCT05248867|467276476|FG000|Double-blind Period|Withdrawal by Subject|5|||
129811563|NCT05248867|467276477|FG001|Double-blind Period|Withdrawal by Subject|14|||
129811564|NCT05248867|467276478|FG002|Double-blind Period|Withdrawal by Subject|0|||
129811565|NCT05248867|467276479|FG003|Double-blind Period|Withdrawal by Subject|0|||
129811566|NCT05248867|467276480|FG004|Double-blind Period|Withdrawal by Subject|0|||
129811567|NCT05248867|467276481|FG005|Double-blind Period|Withdrawal by Subject|0|||
129811568|NCT05248867|467276476|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811569|NCT05248867|467276477|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
129811570|NCT05248867|467276478|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811571|NCT05248867|467276479|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811572|NCT05248867|467276480|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811573|NCT05248867|467276481|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
129811574|NCT05248867|467276476|FG000|Double-blind Period|Other, not specified|3|||
129811575|NCT05248867|467276477|FG001|Double-blind Period|Other, not specified|8|||
129811576|NCT05248867|467276478|FG002|Double-blind Period|Other, not specified|0|||
129811577|NCT05248867|467276479|FG003|Double-blind Period|Other, not specified|0|||
129811578|NCT05248867|467276480|FG004|Double-blind Period|Other, not specified|0|||
129811579|NCT05248867|467276481|FG005|Double-blind Period|Other, not specified|0|||
129811580|NCT05248867|467276476|FG000|Open-label Period|Withdrawal by Subject|0|||
129811581|NCT05248867|467276477|FG001|Open-label Period|Withdrawal by Subject|0|||
129811582|NCT05248867|467276478|FG002|Open-label Period|Withdrawal by Subject|3|||
129811583|NCT05248867|467276479|FG003|Open-label Period|Withdrawal by Subject|1|||
129811584|NCT05248867|467276480|FG004|Open-label Period|Withdrawal by Subject|7|||
129811585|NCT05248867|467276481|FG005|Open-label Period|Withdrawal by Subject|9|||
129757311|NCT01454596|467072732|FG009|Overall Study|Death|1|||
129757312|NCT01454596|467072733|FG010|Overall Study|Death|1|||
129811586|NCT05248867|467276476|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811587|NCT05248867|467276477|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811588|NCT05248867|467276478|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811589|NCT05248867|467276479|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
129811590|NCT05248867|467276480|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811591|NCT05248867|467276481|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
129811592|NCT05248867|467276476|FG000|Open-label Period|Lost to Follow-up|0|||
129811593|NCT05248867|467276477|FG001|Open-label Period|Lost to Follow-up|0|||
129811594|NCT05248867|467276478|FG002|Open-label Period|Lost to Follow-up|0|||
129757313|NCT01454596|467072734|FG011|Overall Study|Death|0|||
129757314|NCT02721875|467072736|FG000|Overall Study|Progressive disease/relapse|1|||
129757315|NCT02721875|467072737|FG001|Overall Study|Progressive disease/relapse|0|||
129811595|NCT05248867|467276479|FG003|Open-label Period|Lost to Follow-up|0|||
129811596|NCT05248867|467276480|FG004|Open-label Period|Lost to Follow-up|5|||
129811597|NCT05248867|467276481|FG005|Open-label Period|Lost to Follow-up|2|||
129811598|NCT05248867|467276476|FG000|Open-label Period|COVID-19 Infection|0|||
129811599|NCT05248867|467276477|FG001|Open-label Period|COVID-19 Infection|0|||
129811600|NCT05248867|467276478|FG002|Open-label Period|COVID-19 Infection|0|||
129811601|NCT05248867|467276479|FG003|Open-label Period|COVID-19 Infection|0|||
129811602|NCT05248867|467276480|FG004|Open-label Period|COVID-19 Infection|1|||
129811603|NCT05248867|467276481|FG005|Open-label Period|COVID-19 Infection|0|||
129811604|NCT05248867|467276476|FG000|Open-label Period|Other, not specified|0|||
129811605|NCT05248867|467276477|FG001|Open-label Period|Other, not specified|0|||
129811606|NCT05248867|467276478|FG002|Open-label Period|Other, not specified|0|||
129811607|NCT05248867|467276479|FG003|Open-label Period|Other, not specified|0|||
129811608|NCT05248867|467276480|FG004|Open-label Period|Other, not specified|4|||
129811609|NCT05248867|467276481|FG005|Open-label Period|Other, not specified|0|||
129811610|NCT00345839|467276483|FG000|Overall Study|Withdrawal by Subject|91|||
129811611|NCT00345839|467276484|FG001|Overall Study|Withdrawal by Subject|98|||
129811612|NCT00345839|467276483|FG000|Overall Study|Lost to Follow-up|58|||
129811613|NCT00345839|467276484|FG001|Overall Study|Lost to Follow-up|61|||
129811614|NCT00743483|467276489|FG000|Baseline Period|Physician Decision|1|||
129811615|NCT00743483|467276489|FG000|Treatment Period|Adverse Event|1|||
129811616|NCT01088997|467276490|FG000|Overall Study|Physician Decision|1|||
129811617|NCT01088997|467276491|FG001|Overall Study|Physician Decision|1|||
129811618|NCT01088997|467276490|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
129811619|NCT01088997|467276491|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
129811620|NCT01088997|467276490|FG000|Overall Study|Excluded prior to receiving drug|1|||
129811621|NCT01088997|467276491|FG001|Overall Study|Excluded prior to receiving drug|1|||
129811622|NCT01218113|467278625|FG000|Overall Study|Withdrawal by Subject|1|||
129811623|NCT01218113|467278626|FG001|Overall Study|Withdrawal by Subject|0|||
129811624|NCT01218113|467278627|FG002|Overall Study|Withdrawal by Subject|1|||
129811625|NCT01218113|467278625|FG000|Overall Study|Lost to Follow-up|4|||
129811626|NCT01218113|467278626|FG001|Overall Study|Lost to Follow-up|1|||
129811627|NCT01218113|467278627|FG002|Overall Study|Lost to Follow-up|4|||
129811628|NCT01218113|467278625|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
129811629|NCT01218113|467278626|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
129811630|NCT01218113|467278627|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
129811631|NCT00967668|467278628|FG000|Overall Study|Withdrawal by Subject|13|||
129811632|NCT00967668|467278629|FG001|Overall Study|Withdrawal by Subject|8|||
129811633|NCT00967668|467278630|FG002|Overall Study|Withdrawal by Subject|8|||
129811634|NCT00967668|467278628|FG000|Overall Study|Death|0|||
129811635|NCT00967668|467278629|FG001|Overall Study|Death|2|||
129811636|NCT00967668|467278630|FG002|Overall Study|Death|4|||
129811637|NCT00967668|467278628|FG000|Overall Study|Removed due to behavior|1|||
129811638|NCT00967668|467278629|FG001|Overall Study|Removed due to behavior|1|||
129811639|NCT00967668|467278630|FG002|Overall Study|Removed due to behavior|2|||
129811640|NCT00967668|467278628|FG000|Overall Study|Refused Year 2|11|||
129811641|NCT00967668|467278629|FG001|Overall Study|Refused Year 2|6|||
129811642|NCT00967668|467278630|FG002|Overall Study|Refused Year 2|4|||
129811643|NCT00967668|467278628|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
129811644|NCT00967668|467278629|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
129811645|NCT00967668|467278630|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
129811646|NCT00967668|467278628|FG000|Overall Study|Lost to Follow-up|15|||
129811647|NCT00967668|467278629|FG001|Overall Study|Lost to Follow-up|9|||
129811648|NCT00967668|467278630|FG002|Overall Study|Lost to Follow-up|16|||
129811649|NCT00967668|467278628|FG000|Overall Study|Refused 12-mo assessment|3|||
129811650|NCT00967668|467278629|FG001|Overall Study|Refused 12-mo assessment|1|||
129811651|NCT00967668|467278630|FG002|Overall Study|Refused 12-mo assessment|9|||
129811652|NCT00967668|467278628|FG000|Overall Study|Pregnancy|1|||
129811653|NCT00967668|467278629|FG001|Overall Study|Pregnancy|0|||
129811654|NCT00967668|467278630|FG002|Overall Study|Pregnancy|0|||
129811655|NCT00115739|467278631|FG000|Overall Study|Lost to Follow-up|3|||
129811656|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
129811657|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
129811658|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
129811659|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
129811660|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
129811661|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
129811662|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
129811663|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
129811664|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
129811665|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
129896913|NCT04888585|467582176|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129757316|NCT00857285|467072738|FG000|Overall Study|Adverse Event|4|||
129757317|NCT00857285|467072739|FG001|Overall Study|Adverse Event|2|||
129757318|NCT00857285|467072738|FG000|Overall Study|Lack of Efficacy|0|||
129757319|NCT00857285|467072739|FG001|Overall Study|Lack of Efficacy|2|||
129757320|NCT00857285|467072738|FG000|Overall Study|Protocol Violation|3|||
129757321|NCT00857285|467072739|FG001|Overall Study|Protocol Violation|1|||
129757322|NCT00857285|467072738|FG000|Overall Study|Withdrawal by Subject|4|||
129757323|NCT00857285|467072739|FG001|Overall Study|Withdrawal by Subject|0|||
129757324|NCT00857285|467072738|FG000|Overall Study|Randomization criteria not met|1|||
129757325|NCT00857285|467072739|FG001|Overall Study|Randomization criteria not met|1|||
129757326|NCT00430716|467072742|FG000|Double Blind Phase|Death|1|||
129757327|NCT00430716|467072743|FG001|Double Blind Phase|Death|0|||
129757328|NCT00430716|467072744|FG002|Double Blind Phase|Death|0|||
129757329|NCT00430716|467072742|FG000|Double Blind Phase|No longer willing to participate|2|||
129757330|NCT00430716|467072743|FG001|Double Blind Phase|No longer willing to participate|1|||
129757331|NCT00430716|467072744|FG002|Double Blind Phase|No longer willing to participate|1|||
129757332|NCT00430716|467072742|FG000|Double Blind Phase|Other|0|||
129757333|NCT00430716|467072743|FG001|Double Blind Phase|Other|2|||
129757334|NCT00430716|467072744|FG002|Double Blind Phase|Other|0|||
129757335|NCT00430716|467072742|FG000|Double Blind Phase|Study terminated by sponsor|1|||
129757336|NCT00430716|467072743|FG001|Double Blind Phase|Study terminated by sponsor|1|||
129757337|NCT00430716|467072744|FG002|Double Blind Phase|Study terminated by sponsor|2|||
129757338|NCT00430716|467072742|FG000|Double Blind Phase|Adverse Event|1|||
129757339|NCT00430716|467072743|FG001|Double Blind Phase|Adverse Event|1|||
129757340|NCT00430716|467072744|FG002|Double Blind Phase|Adverse Event|3|||
129757341|NCT00430716|467072742|FG000|Double Blind Phase|Not treated|1|||
129757342|NCT00430716|467072743|FG001|Double Blind Phase|Not treated|0|||
129757343|NCT00430716|467072744|FG002|Double Blind Phase|Not treated|0|||
129757344|NCT00430716|467072742|FG000|Open Label Phase|Lost to Follow-up|1|||
129757345|NCT00430716|467072743|FG001|Open Label Phase|Lost to Follow-up|0|||
129757346|NCT00430716|467072744|FG002|Open Label Phase|Lost to Follow-up|1|||
129757347|NCT00430716|467072742|FG000|Open Label Phase|No longer willing to participate|0|||
129757348|NCT00430716|467072743|FG001|Open Label Phase|No longer willing to participate|1|||
129757349|NCT00430716|467072744|FG002|Open Label Phase|No longer willing to participate|1|||
129757350|NCT00430716|467072742|FG000|Open Label Phase|Other|3|||
129757351|NCT00430716|467072743|FG001|Open Label Phase|Other|1|||
129757352|NCT00430716|467072744|FG002|Open Label Phase|Other|1|||
129757353|NCT00430716|467072742|FG000|Open Label Phase|Protocol Violation|1|||
129757354|NCT00430716|467072743|FG001|Open Label Phase|Protocol Violation|0|||
129757355|NCT00430716|467072744|FG002|Open Label Phase|Protocol Violation|0|||
129757356|NCT00430716|467072742|FG000|Open Label Phase|Study terminated by sponsor|4|||
129757357|NCT00430716|467072743|FG001|Open Label Phase|Study terminated by sponsor|5|||
129757358|NCT00430716|467072744|FG002|Open Label Phase|Study terminated by sponsor|4|||
129757359|NCT01329978|467072748|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
129757360|NCT01329978|467072749|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
129757361|NCT01329978|467072750|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
129757362|NCT01329978|467072751|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
129757363|NCT01329978|467072752|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
129757364|NCT01329978|467072748|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
129757365|NCT01329978|467072749|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
129757366|NCT01329978|467072750|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
129757367|NCT01329978|467072751|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
129757368|NCT01329978|467072752|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
129757369|NCT01329978|467072748|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
129757370|NCT01329978|467072749|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
129757371|NCT01329978|467072750|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
129757372|NCT01329978|467072751|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
129757373|NCT01329978|467072752|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
129757374|NCT01329978|467072748|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129757375|NCT01329978|467072749|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
129757376|NCT01329978|467072750|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129757377|NCT01329978|467072751|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129757378|NCT01329978|467072752|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
129757379|NCT01329978|467072748|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129757380|NCT01329978|467072749|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
129757381|NCT01329978|467072750|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129757382|NCT01329978|467072751|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129757383|NCT01329978|467072752|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
129757384|NCT01329978|467072748|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
129757385|NCT01329978|467072749|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
129896914|NCT04888585|467582177|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896915|NCT04888585|467582178|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896916|NCT04888585|467582179|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129896917|NCT04888585|467582180|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129757386|NCT01329978|467072750|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
129757387|NCT01329978|467072751|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
129757388|NCT01329978|467072752|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
129757389|NCT01329978|467072748|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129757390|NCT01329978|467072749|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129757391|NCT01329978|467072750|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129757392|NCT01329978|467072751|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
129757393|NCT01329978|467072752|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
129757394|NCT01987102|467072757|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
129757395|NCT01987102|467072758|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
129757396|NCT01987102|467072757|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
129757397|NCT01987102|467072758|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
129757398|NCT01987102|467072757|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
129757399|NCT01987102|467072758|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
129757400|NCT01987102|467072757|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
129757401|NCT01987102|467072758|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
129757402|NCT01987102|467072757|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
129757403|NCT01987102|467072758|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
129757404|NCT01987102|467072757|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
129757405|NCT01987102|467072758|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
129757406|NCT01236521|467072761|FG000|Overall Study|Withdrawal by Subject|12|||
129757407|NCT01236521|467072762|FG001|Overall Study|Withdrawal by Subject|17|||
129757408|NCT01236521|467072761|FG000|Overall Study|Death|2|||
129757409|NCT01236521|467072762|FG001|Overall Study|Death|1|||
129757410|NCT01236521|467072761|FG000|Overall Study|Lost to Follow-up|9|||
129757411|NCT01236521|467072762|FG001|Overall Study|Lost to Follow-up|7|||
129757412|NCT03116685|467072767|FG000|Overall Study|Physician Decision|0|||
129757413|NCT03116685|467072768|FG001|Overall Study|Physician Decision|1|||
129757414|NCT00549445|467072777|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
129757415|NCT00549445|467072778|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
129757416|NCT01943591|467072779|FG000|Overall Study|Lost to Follow-up|3|||
129757417|NCT01943591|467072780|FG001|Overall Study|Lost to Follow-up|4|||
129757418|NCT01943591|467072779|FG000|Overall Study|Death|2|||
129757419|NCT01943591|467072780|FG001|Overall Study|Death|7|||
129757420|NCT03790111|467073957|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
129757421|NCT02796677|467073964|FG000|Overall Study|Adverse Event|11|||
129757422|NCT02796677|467073965|FG001|Overall Study|Adverse Event|22|||
129757423|NCT02796677|467073966|FG002|Overall Study|Adverse Event|14|||
129757424|NCT02796677|467073967|FG003|Overall Study|Adverse Event|14|||
129757425|NCT02796677|467073964|FG000|Overall Study|Protocol Violation|7|||
129757426|NCT02796677|467073965|FG001|Overall Study|Protocol Violation|5|||
129757427|NCT02796677|467073966|FG002|Overall Study|Protocol Violation|4|||
129757428|NCT02796677|467073967|FG003|Overall Study|Protocol Violation|8|||
129757429|NCT02796677|467073964|FG000|Overall Study|Lost to Follow-up|1|||
129757430|NCT02796677|467073965|FG001|Overall Study|Lost to Follow-up|5|||
129757431|NCT02796677|467073966|FG002|Overall Study|Lost to Follow-up|2|||
129757432|NCT02796677|467073967|FG003|Overall Study|Lost to Follow-up|2|||
129757433|NCT02796677|467073964|FG000|Overall Study|Lack of Efficacy|7|||
129757434|NCT02796677|467073965|FG001|Overall Study|Lack of Efficacy|9|||
129757435|NCT02796677|467073966|FG002|Overall Study|Lack of Efficacy|14|||
129757436|NCT02796677|467073967|FG003|Overall Study|Lack of Efficacy|20|||
129757437|NCT02796677|467073964|FG000|Overall Study|Withdrawal by Subject|4|||
129757438|NCT02796677|467073965|FG001|Overall Study|Withdrawal by Subject|14|||
129757439|NCT02796677|467073966|FG002|Overall Study|Withdrawal by Subject|6|||
129757440|NCT02796677|467073967|FG003|Overall Study|Withdrawal by Subject|7|||
129757441|NCT02796677|467073964|FG000|Overall Study|Progressive disease|6|||
129757442|NCT02796677|467073965|FG001|Overall Study|Progressive disease|15|||
129896918|NCT04888585|467582181|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
129757443|NCT02796677|467073966|FG002|Overall Study|Progressive disease|13|||
129896919|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
129757444|NCT02796677|467073967|FG003|Overall Study|Progressive disease|18|||
129757445|NCT02796677|467073964|FG000|Overall Study|Reason not mentioned|2|||
129757446|NCT02796677|467073965|FG001|Overall Study|Reason not mentioned|3|||
129757447|NCT02796677|467073966|FG002|Overall Study|Reason not mentioned|0|||
129757448|NCT02796677|467073967|FG003|Overall Study|Reason not mentioned|5|||
129757449|NCT03811340|467073970|FG000|Overall Study|subjects did not complete the survey.|90|||
129757450|NCT01045967|467073971|FG000|Second Intervention|Protocol Violation|0|||
129757451|NCT01045967|467073972|FG001|Second Intervention|Protocol Violation|1|||
129757452|NCT01777308|467073973|FG000|Overall Study|Withdrawal by Subject|5|||
129811666|NCT00787891|467278638|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
129811667|NCT00787891|467278639|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
129811668|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
129811669|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
129811670|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
129811671|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
129811672|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
129811673|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
129811674|NCT00787891|467278638|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
129811675|NCT00787891|467278639|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
129811676|NCT01970397|467278644|FG000|Overall Study|Adverse Event|0|||
129811677|NCT01970397|467278645|FG001|Overall Study|Adverse Event|1|||
129811678|NCT01970397|467278644|FG000|Overall Study|Lost to Follow-up|0|||
129811679|NCT01970397|467278645|FG001|Overall Study|Lost to Follow-up|1|||
129811680|NCT01970397|467278644|FG000|Overall Study|Personal Reasons|1|||
129811681|NCT01970397|467278645|FG001|Overall Study|Personal Reasons|2|||
129811682|NCT01970397|467278644|FG000|Overall Study|Protocol Violation|1|||
129811683|NCT01970397|467278645|FG001|Overall Study|Protocol Violation|1|||
129811684|NCT03305575|467278648|FG000|Overall Study|Physician Decision|1|||
129811685|NCT03305575|467278649|FG001|Overall Study|Physician Decision|0|||
129811686|NCT01819831|467278662|FG000|Overall Study|Withdrawal by Subject|1|||
129811687|NCT02034110|467278669|FG000|Overall Study|Physician Decision|0|||
129811688|NCT02034110|467278670|FG001|Overall Study|Physician Decision|0|||
129811689|NCT02034110|467278671|FG002|Overall Study|Physician Decision|0|||
129811690|NCT02034110|467278672|FG003|Overall Study|Physician Decision|0|||
129811691|NCT02034110|467278673|FG004|Overall Study|Physician Decision|2|||
129811692|NCT02034110|467278674|FG005|Overall Study|Physician Decision|0|||
129811693|NCT02034110|467278675|FG006|Overall Study|Physician Decision|1|||
129811694|NCT02034110|467278676|FG007|Overall Study|Physician Decision|0|||
129811695|NCT02034110|467278669|FG000|Overall Study|Lost to Follow-up|1|||
129811696|NCT02034110|467278670|FG001|Overall Study|Lost to Follow-up|0|||
129811697|NCT02034110|467278671|FG002|Overall Study|Lost to Follow-up|0|||
129811698|NCT02034110|467278672|FG003|Overall Study|Lost to Follow-up|0|||
129811699|NCT02034110|467278673|FG004|Overall Study|Lost to Follow-up|1|||
129811700|NCT02034110|467278674|FG005|Overall Study|Lost to Follow-up|0|||
129811701|NCT02034110|467278675|FG006|Overall Study|Lost to Follow-up|1|||
129811702|NCT02034110|467278676|FG007|Overall Study|Lost to Follow-up|0|||
129811703|NCT02034110|467278669|FG000|Overall Study|Withdrawal by Subject|5|||
129811704|NCT02034110|467278670|FG001|Overall Study|Withdrawal by Subject|7|||
129811705|NCT02034110|467278671|FG002|Overall Study|Withdrawal by Subject|0|||
129811706|NCT02034110|467278672|FG003|Overall Study|Withdrawal by Subject|3|||
129811707|NCT02034110|467278673|FG004|Overall Study|Withdrawal by Subject|7|||
129811708|NCT02034110|467278674|FG005|Overall Study|Withdrawal by Subject|0|||
129811709|NCT02034110|467278675|FG006|Overall Study|Withdrawal by Subject|3|||
129811710|NCT02034110|467278676|FG007|Overall Study|Withdrawal by Subject|1|||
129811711|NCT02034110|467278669|FG000|Overall Study|Study closed by sponsor|6|||
129811712|NCT02034110|467278670|FG001|Overall Study|Study closed by sponsor|2|||
129811713|NCT02034110|467278671|FG002|Overall Study|Study closed by sponsor|0|||
129811714|NCT02034110|467278672|FG003|Overall Study|Study closed by sponsor|6|||
129811715|NCT02034110|467278673|FG004|Overall Study|Study closed by sponsor|7|||
129811716|NCT02034110|467278674|FG005|Overall Study|Study closed by sponsor|0|||
129811717|NCT02034110|467278675|FG006|Overall Study|Study closed by sponsor|42|||
129811718|NCT02034110|467278676|FG007|Overall Study|Study closed by sponsor|0|||
129811719|NCT02835820|467278679|FG000|Overall Study|Baseline Screen Failure|0|||
129811720|NCT02835820|467278680|FG001|Overall Study|Baseline Screen Failure|3|||
129811721|NCT01751178|467278683|FG000|Overall Study|Adverse Event|2|||
129811722|NCT01751178|467278684|FG001|Overall Study|Adverse Event|0|||
129811723|NCT01751178|467278685|FG002|Overall Study|Adverse Event|0|||
129811724|NCT01751178|467278683|FG000|Overall Study|Other Reason (unknown)|1|||
129811725|NCT01751178|467278684|FG001|Overall Study|Other Reason (unknown)|0|||
129811726|NCT01751178|467278685|FG002|Overall Study|Other Reason (unknown)|2|||
129811727|NCT00288054|467278686|FG000|Overall Study|Protocol Violation|2|||
129811728|NCT00288054|467278686|FG000|Overall Study|Lack of Efficacy|16|||
129811729|NCT00288054|467278686|FG000|Overall Study|Adverse Event|3|||
129811730|NCT00288054|467278686|FG000|Overall Study|Withdrawal by Subject|1|||
129811731|NCT00288054|467278686|FG000|Overall Study|Not protocol specified|2|||
129811732|NCT03733470|467278699|FG000|Overall Study|PI Decision|1|||
129811733|NCT03733470|467278700|FG001|Overall Study|PI Decision|1|||
129811734|NCT01010061|467278701|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
129811735|NCT01010061|467278702|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
129811736|NCT01010061|467278701|FG000|Overall Study|Disease Progression|2|||
129811737|NCT01010061|467278702|FG001|Overall Study|Disease Progression|8|||
129811738|NCT01010061|467278701|FG000|Overall Study|Withdrew Consent|5|||
129811739|NCT01010061|467278702|FG001|Overall Study|Withdrew Consent|1|||
129811740|NCT01010061|467278701|FG000|Overall Study|Death|3|||
129811741|NCT01010061|467278702|FG001|Overall Study|Death|6|||
129757453|NCT01777308|467073974|FG001|Overall Study|Withdrawal by Subject|1|||
129757454|NCT01777308|467073973|FG000|Overall Study|Migrated/moved from study area|1|||
129757455|NCT01777308|467073974|FG001|Overall Study|Migrated/moved from study area|0|||
129757456|NCT01777308|467073973|FG000|Overall Study|Lost to Follow-up|7|||
129757457|NCT01777308|467073974|FG001|Overall Study|Lost to Follow-up|2|||
129757458|NCT01777308|467073973|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
129757459|NCT01777308|467073974|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
129757460|NCT03212326|467073975|FG000|Overall Study|Physician Decision|4|||
129757461|NCT02219464|467073977|FG000|Overall Study|Withdrawal by Subject|1|||
129757462|NCT02219464|467073978|FG001|Overall Study|Withdrawal by Subject|0|||
129757463|NCT02219464|467073977|FG000|Overall Study|case cancelled|1|||
129757464|NCT02219464|467073978|FG001|Overall Study|case cancelled|0|||
129757465|NCT02219464|467073977|FG000|Overall Study|catheter malfunction|1|||
129757466|NCT02219464|467073978|FG001|Overall Study|catheter malfunction|0|||
129757467|NCT00280917|467073979|FG000|Overall Study|Adverse Event|1|||
129757468|NCT00280917|467073980|FG001|Overall Study|Adverse Event|1|||
129757469|NCT00280917|467073981|FG002|Overall Study|Adverse Event|4|||
129757470|NCT00280917|467073982|FG003|Overall Study|Adverse Event|1|||
129757471|NCT00280917|467073979|FG000|Overall Study|Change Therapy|1|||
129757472|NCT00280917|467073980|FG001|Overall Study|Change Therapy|2|||
129757473|NCT00280917|467073981|FG002|Overall Study|Change Therapy|0|||
129757474|NCT00280917|467073982|FG003|Overall Study|Change Therapy|0|||
129757475|NCT00280917|467073979|FG000|Overall Study|Withdrawal by Subject|0|||
129757476|NCT00280917|467073980|FG001|Overall Study|Withdrawal by Subject|2|||
129757477|NCT00280917|467073981|FG002|Overall Study|Withdrawal by Subject|0|||
129757478|NCT00280917|467073982|FG003|Overall Study|Withdrawal by Subject|1|||
129757479|NCT00280917|467073979|FG000|Overall Study|Noncompliance|0|||
129757480|NCT00280917|467073980|FG001|Overall Study|Noncompliance|1|||
129757481|NCT00280917|467073981|FG002|Overall Study|Noncompliance|2|||
129757482|NCT00280917|467073982|FG003|Overall Study|Noncompliance|0|||
129757483|NCT01544920|467073995|FG000|Overall Study|Adverse Event|0|||
129757484|NCT01544920|467073996|FG001|Overall Study|Adverse Event|3|||
129757485|NCT01544920|467073995|FG000|Overall Study|Death|0|||
129757486|NCT01544920|467073996|FG001|Overall Study|Death|1|||
129757487|NCT01544920|467073995|FG000|Overall Study|Lost to Follow-up|11|||
129757488|NCT01544920|467073996|FG001|Overall Study|Lost to Follow-up|12|||
129757489|NCT01544920|467073995|FG000|Overall Study|Protocol Violation|0|||
129757490|NCT01544920|467073996|FG001|Overall Study|Protocol Violation|2|||
129757491|NCT01544920|467073995|FG000|Overall Study|Physician Decision|4|||
129757492|NCT01544920|467073996|FG001|Overall Study|Physician Decision|1|||
129757493|NCT01544920|467073995|FG000|Overall Study|Withdrawal by Subject|4|||
129757494|NCT01544920|467073996|FG001|Overall Study|Withdrawal by Subject|4|||
129757495|NCT00474955|467073999|FG000|Overall Study|Adverse Event|2|||
129757496|NCT00474955|467073999|FG000|Overall Study|Drug unavailability|1|||
129757497|NCT00474955|467073999|FG000|Overall Study|Personal reasons|5|||
129757498|NCT01135134|467074000|FG000|Overall Study|Adverse Event|1|||
129757499|NCT01135134|467074001|FG001|Overall Study|Adverse Event|1|||
129757500|NCT01135134|467074000|FG000|Overall Study|Did not meet protocol eligibility|1|||
129757501|NCT01135134|467074001|FG001|Overall Study|Did not meet protocol eligibility|0|||
129757502|NCT02576639|467074002|FG000|Overall Study|Withdrawal by Subject|1|||
129757503|NCT02576639|467074003|FG001|Overall Study|Withdrawal by Subject|2|||
129757504|NCT02576639|467074004|FG002|Overall Study|Withdrawal by Subject|1|||
129757505|NCT02576639|467074005|FG003|Overall Study|Withdrawal by Subject|0|||
129757506|NCT02576639|467074006|FG004|Overall Study|Withdrawal by Subject|1|||
129757507|NCT02576639|467074002|FG000|Overall Study|Adverse Event|1|||
129757508|NCT02576639|467074003|FG001|Overall Study|Adverse Event|0|||
129757509|NCT02576639|467074004|FG002|Overall Study|Adverse Event|1|||
129757510|NCT02576639|467074005|FG003|Overall Study|Adverse Event|1|||
129757511|NCT02576639|467074006|FG004|Overall Study|Adverse Event|2|||
129757512|NCT02576639|467074002|FG000|Overall Study|Physician Decision|0|||
129757513|NCT02576639|467074003|FG001|Overall Study|Physician Decision|0|||
129757514|NCT02576639|467074004|FG002|Overall Study|Physician Decision|0|||
129811742|NCT01010061|467278701|FG000|Overall Study|Administrative/Other|0|||
129811743|NCT01010061|467278702|FG001|Overall Study|Administrative/Other|1|||
129757515|NCT02576639|467074005|FG003|Overall Study|Physician Decision|0|||
129757516|NCT02576639|467074006|FG004|Overall Study|Physician Decision|1|||
129757517|NCT00255190|467074007|FG000|Overall Study|Adverse Event|17|||
129757518|NCT00255190|467074008|FG001|Overall Study|Adverse Event|36|||
129757519|NCT00255190|467074007|FG000|Overall Study|Protocol Violation|2|||
129757520|NCT00255190|467074008|FG001|Overall Study|Protocol Violation|2|||
129757521|NCT00255190|467074007|FG000|Overall Study|Lost to Follow-up|10|||
129757522|NCT00255190|467074008|FG001|Overall Study|Lost to Follow-up|27|||
129811744|NCT01010061|467278701|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
129757523|NCT00255190|467074007|FG000|Overall Study|Withdrew Consent|17|||
129757524|NCT00255190|467074008|FG001|Overall Study|Withdrew Consent|48|||
129757525|NCT00255190|467074007|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129757526|NCT00255190|467074008|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
129811745|NCT01010061|467278702|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129811746|NCT01010061|467278701|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129811747|NCT01010061|467278702|FG001|Overall Study|Insufficient Therapeutic Response|5|||
129811748|NCT01010061|467278701|FG000|Overall Study|Violation of Selection Criteria|0|||
129811749|NCT01010061|467278702|FG001|Overall Study|Violation of Selection Criteria|1|||
129811750|NCT01010061|467278701|FG000|Overall Study|Did Not Receive Treatment|2|||
129811751|NCT01010061|467278702|FG001|Overall Study|Did Not Receive Treatment|2|||
129811752|NCT03470441|467278703|FG000|Overall Study|Death|0|||
129811753|NCT03470441|467278704|FG001|Overall Study|Death|1|||
129811754|NCT03470441|467278705|FG002|Overall Study|Death|1|||
129811755|NCT03470441|467278706|FG003|Overall Study|Death|0|||
129811756|NCT03470441|467278703|FG000|Overall Study|Adverse Event|0|||
129811757|NCT03470441|467278704|FG001|Overall Study|Adverse Event|0|||
129811758|NCT03470441|467278705|FG002|Overall Study|Adverse Event|0|||
129811759|NCT03470441|467278706|FG003|Overall Study|Adverse Event|1|||
129811760|NCT03470441|467278703|FG000|Overall Study|Withdrawal by Subject|1|||
129811761|NCT03470441|467278704|FG001|Overall Study|Withdrawal by Subject|4|||
129811762|NCT03470441|467278705|FG002|Overall Study|Withdrawal by Subject|1|||
129811763|NCT03470441|467278706|FG003|Overall Study|Withdrawal by Subject|3|||
129811764|NCT03768414|467278707|FG000|Overall Study|Adverse Event or side effects|72|||
129811765|NCT03768414|467278708|FG001|Overall Study|Adverse Event or side effects|28|||
129811766|NCT03768414|467278707|FG000|Overall Study|Refusal unrelated to adverse event|33|||
129811767|NCT03768414|467278708|FG001|Overall Study|Refusal unrelated to adverse event|33|||
129811768|NCT03768414|467278707|FG000|Overall Study|Progression/relapse|132|||
129811769|NCT03768414|467278708|FG001|Overall Study|Progression/relapse|60|||
129811770|NCT03768414|467278707|FG000|Overall Study|Death|9|||
129811771|NCT03768414|467278708|FG001|Overall Study|Death|6|||
129811772|NCT03768414|467278707|FG000|Overall Study|Other - not protocol specified|45|||
129811773|NCT03768414|467278708|FG001|Overall Study|Other - not protocol specified|18|||
129811774|NCT03768414|467278707|FG000|Overall Study|Reason under review|3|||
129811775|NCT03768414|467278708|FG001|Overall Study|Reason under review|2|||
129811776|NCT02571777|467278709|FG000|Overall Study|Subject/guardian decision|34|||
129811777|NCT02571777|467278710|FG001|Overall Study|Subject/guardian decision|26|||
129811778|NCT02571777|467278711|FG002|Overall Study|Subject/guardian decision|26|||
129811779|NCT02571777|467278712|FG003|Overall Study|Subject/guardian decision|25|||
129811780|NCT02571777|467278713|FG004|Overall Study|Subject/guardian decision|27|||
129811781|NCT02571777|467278709|FG000|Overall Study|Protocol Deviation|2|||
129811782|NCT02571777|467278710|FG001|Overall Study|Protocol Deviation|3|||
129811783|NCT02571777|467278711|FG002|Overall Study|Protocol Deviation|4|||
129811784|NCT02571777|467278712|FG003|Overall Study|Protocol Deviation|8|||
129811785|NCT02571777|467278713|FG004|Overall Study|Protocol Deviation|4|||
129811786|NCT02571777|467278709|FG000|Overall Study|Death|1|||
129811787|NCT02571777|467278710|FG001|Overall Study|Death|1|||
129811788|NCT02571777|467278711|FG002|Overall Study|Death|4|||
129811789|NCT02571777|467278712|FG003|Overall Study|Death|0|||
129811790|NCT02571777|467278713|FG004|Overall Study|Death|0|||
129811791|NCT02571777|467278709|FG000|Overall Study|Lost to Follow-up|1|||
129811792|NCT02571777|467278710|FG001|Overall Study|Lost to Follow-up|1|||
129811793|NCT02571777|467278711|FG002|Overall Study|Lost to Follow-up|2|||
129811794|NCT02571777|467278712|FG003|Overall Study|Lost to Follow-up|0|||
129811795|NCT02571777|467278713|FG004|Overall Study|Lost to Follow-up|1|||
129811796|NCT02571777|467278709|FG000|Overall Study|Physician Decision|1|||
129811797|NCT02571777|467278710|FG001|Overall Study|Physician Decision|7|||
129811798|NCT02571777|467278711|FG002|Overall Study|Physician Decision|5|||
129811799|NCT02571777|467278712|FG003|Overall Study|Physician Decision|2|||
129811800|NCT02571777|467278713|FG004|Overall Study|Physician Decision|4|||
129811801|NCT02571777|467278709|FG000|Overall Study|Pregnancy|0|||
129811802|NCT02571777|467278710|FG001|Overall Study|Pregnancy|0|||
129811803|NCT02571777|467278711|FG002|Overall Study|Pregnancy|0|||
129811804|NCT02571777|467278712|FG003|Overall Study|Pregnancy|2|||
129811805|NCT02571777|467278713|FG004|Overall Study|Pregnancy|0|||
129811806|NCT03095612|467278721|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811807|NCT03095612|467278722|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
129811808|NCT03095612|467278723|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811809|NCT03095612|467278724|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811810|NCT03095612|467278725|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811811|NCT03095612|467278726|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811812|NCT03095612|467278727|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
129811813|NCT04447794|467278728|FG000|Overall Study|Lost to Follow-up|2|||
129811814|NCT04447794|467278729|FG001|Overall Study|Lost to Follow-up|3|||
129811815|NCT04447794|467278730|FG002|Overall Study|Lost to Follow-up|8|||
129811816|NCT04447794|467278728|FG000|Overall Study|Withdrawal by Subject|1|||
129811817|NCT04447794|467278729|FG001|Overall Study|Withdrawal by Subject|1|||
129811818|NCT04447794|467278730|FG002|Overall Study|Withdrawal by Subject|0|||
129811819|NCT02571075|467278733|FG000|Overall Study|Lost to Follow-up|20|||
129811820|NCT02571075|467278734|FG001|Overall Study|Lost to Follow-up|24|||
129811821|NCT00963937|467278737|FG000|Overall Study|Protocol Violation|1|||
129811822|NCT00963937|467278738|FG001|Overall Study|Protocol Violation|1|||
129811823|NCT00963937|467278739|FG002|Overall Study|Protocol Violation|0|||
129811824|NCT00963937|467278737|FG000|Overall Study|Physician Decision|18|||
129811825|NCT00963937|467278738|FG001|Overall Study|Physician Decision|10|||
129811826|NCT00963937|467278739|FG002|Overall Study|Physician Decision|4|||
129811827|NCT02197520|467278743|FG000|Period 1|Withdrawal by Subject|1|||
129811828|NCT02197520|467278744|FG001|Period 1|Withdrawal by Subject|0|||
129811829|NCT02197520|467278743|FG000|Period 2|Adverse Event|0|||
129811830|NCT02197520|467278744|FG001|Period 2|Adverse Event|2|||
129811831|NCT02197520|467278743|FG000|Period 2|Withdrawal by Subject|1|||
129811832|NCT02197520|467278744|FG001|Period 2|Withdrawal by Subject|0|||
129811833|NCT00369824|467278745|FG000|Overall Study|Adverse Event|0|||
129811834|NCT00369824|467278746|FG001|Overall Study|Adverse Event|2|||
129811835|NCT00369824|467278747|FG002|Overall Study|Adverse Event|0|||
129811836|NCT00369824|467278748|FG003|Overall Study|Adverse Event|0|||
129811837|NCT00369824|467278749|FG004|Overall Study|Adverse Event|1|||
129811838|NCT00369824|467278750|FG005|Overall Study|Adverse Event|0|||
129811839|NCT00369824|467278745|FG000|Overall Study|Protocol Violation|0|||
129811840|NCT00369824|467278746|FG001|Overall Study|Protocol Violation|1|||
129811841|NCT00369824|467278747|FG002|Overall Study|Protocol Violation|0|||
129811842|NCT00369824|467278748|FG003|Overall Study|Protocol Violation|1|||
129811843|NCT00369824|467278749|FG004|Overall Study|Protocol Violation|1|||
129811844|NCT00369824|467278750|FG005|Overall Study|Protocol Violation|0|||
129811845|NCT00369824|467278745|FG000|Overall Study|Withdrawal by Subject|9|||
129811846|NCT00369824|467278746|FG001|Overall Study|Withdrawal by Subject|5|||
129811847|NCT00369824|467278747|FG002|Overall Study|Withdrawal by Subject|5|||
129811848|NCT00369824|467278748|FG003|Overall Study|Withdrawal by Subject|4|||
129811849|NCT00369824|467278749|FG004|Overall Study|Withdrawal by Subject|6|||
129811850|NCT00369824|467278750|FG005|Overall Study|Withdrawal by Subject|2|||
129811851|NCT00369824|467278745|FG000|Overall Study|Lost to Follow-up|6|||
129811852|NCT00369824|467278746|FG001|Overall Study|Lost to Follow-up|11|||
129811853|NCT00369824|467278747|FG002|Overall Study|Lost to Follow-up|7|||
129811854|NCT00369824|467278748|FG003|Overall Study|Lost to Follow-up|8|||
129811855|NCT00369824|467278749|FG004|Overall Study|Lost to Follow-up|9|||
129811856|NCT00369824|467278750|FG005|Overall Study|Lost to Follow-up|6|||
129811857|NCT00369824|467278745|FG000|Overall Study|Other|0|||
129811858|NCT00369824|467278746|FG001|Overall Study|Other|0|||
129811859|NCT00369824|467278747|FG002|Overall Study|Other|0|||
129811860|NCT00369824|467278748|FG003|Overall Study|Other|2|||
129811861|NCT00369824|467278749|FG004|Overall Study|Other|1|||
129811862|NCT00369824|467278750|FG005|Overall Study|Other|3|||
129811863|NCT04528732|467278757|FG000|Overall Study|Death|1|||
129811864|NCT04528732|467278758|FG001|Overall Study|Death|0|||
129811865|NCT04528732|467278759|FG002|Overall Study|Death|1|||
129811866|NCT04528732|467278757|FG000|Overall Study|Lost to Follow-up|0|||
129811867|NCT04528732|467278758|FG001|Overall Study|Lost to Follow-up|1|||
129811868|NCT04528732|467278759|FG002|Overall Study|Lost to Follow-up|2|||
129811869|NCT03408483|467278760|FG000|Overall Study|Physician Decision|3|||
129811870|NCT03408483|467278761|FG001|Overall Study|Physician Decision|3|||
129811871|NCT03408483|467278760|FG000|Overall Study|Lost to Follow-up|3|||
129811872|NCT03408483|467278761|FG001|Overall Study|Lost to Follow-up|0|||
129811873|NCT02094677|467278762|FG000|Overall Study|Screening|3|||
129811874|NCT02094677|467278763|FG001|Overall Study|Screening|1|||
129811875|NCT05399641|467278764|FG000|Overall Study|Adverse Event|0|||
129811876|NCT05399641|467278765|FG001|Overall Study|Adverse Event|1|||
129811877|NCT05399641|467278766|FG002|Overall Study|Adverse Event|1|||
129811878|NCT05399641|467278764|FG000|Overall Study|Lost to Follow-up|1|||
129811879|NCT05399641|467278765|FG001|Overall Study|Lost to Follow-up|2|||
129811880|NCT05399641|467278766|FG002|Overall Study|Lost to Follow-up|2|||
129811881|NCT05399641|467278764|FG000|Overall Study|Physician Decision|1|||
129811882|NCT05399641|467278765|FG001|Overall Study|Physician Decision|3|||
129811883|NCT05399641|467278766|FG002|Overall Study|Physician Decision|3|||
129811884|NCT05399641|467278764|FG000|Overall Study|Withdrawal by Subject|4|||
129811885|NCT05399641|467278765|FG001|Overall Study|Withdrawal by Subject|11|||
129811886|NCT05399641|467278766|FG002|Overall Study|Withdrawal by Subject|7|||
129811887|NCT05399641|467278764|FG000|Overall Study|Reason not defined|3|||
129811888|NCT05399641|467278765|FG001|Overall Study|Reason not defined|5|||
129811889|NCT05399641|467278766|FG002|Overall Study|Reason not defined|6|||
129811890|NCT01300650|467278767|FG000|Overall Study|Adverse Event|1|||
129811891|NCT01702961|467278768|FG000|Overall Study|Additional treatment|3|||
129811892|NCT01702961|467278768|FG000|Overall Study|Progressive disease|5|||
129811893|NCT01702961|467278768|FG000|Overall Study|Relapse|20|||
129811894|NCT01702961|467278768|FG000|Overall Study|Death|6|||
129811895|NCT01702961|467278768|FG000|Overall Study|Lost to Follow-up|2|||
129811896|NCT01702961|467278768|FG000|Overall Study|Ongoing|11|||
129811897|NCT00674362|467278771|FG000|Double Blind|Adverse Event|6|||
129811898|NCT00674362|467278772|FG001|Double Blind|Adverse Event|6|||
129811899|NCT00674362|467278771|FG000|Double Blind|Lack of Efficacy|2|||
129811900|NCT00674362|467278772|FG001|Double Blind|Lack of Efficacy|6|||
129811901|NCT00674362|467278771|FG000|Double Blind|Loss of efficacy|0|||
129811902|NCT00674362|467278772|FG001|Double Blind|Loss of efficacy|1|||
129811903|NCT00674362|467278771|FG000|Double Blind|Withdrawal by Subject|4|||
129811904|NCT00674362|467278772|FG001|Double Blind|Withdrawal by Subject|3|||
129811905|NCT00674362|467278771|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
129811906|NCT00674362|467278772|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
129811907|NCT00674362|467278771|FG000|Double Blind|Other: Surgery|0|||
129811908|NCT00674362|467278772|FG001|Double Blind|Other: Surgery|1|||
129811909|NCT00674362|467278771|FG000|Open Label|Adverse Event|1|||
129811910|NCT00674362|467278772|FG001|Open Label|Adverse Event|0|||
129811911|NCT00674362|467278771|FG000|Open Label|Other: Subject moved to extension study|1|||
129811912|NCT00674362|467278772|FG001|Open Label|Other: Subject moved to extension study|0|||
129811913|NCT00923156|467278773|FG000|Overall Study|Adverse Event|0|||
129811914|NCT00923156|467278774|FG001|Overall Study|Adverse Event|2|||
129811915|NCT00923156|467278775|FG002|Overall Study|Adverse Event|1|||
129811916|NCT00923156|467278773|FG000|Overall Study|Abnormal laboratory values|0|||
129811917|NCT00923156|467278774|FG001|Overall Study|Abnormal laboratory values|0|||
129811918|NCT00923156|467278775|FG002|Overall Study|Abnormal laboratory values|1|||
129811919|NCT00923156|467278773|FG000|Overall Study|Withdrawal by Subject|0|||
129811920|NCT00923156|467278774|FG001|Overall Study|Withdrawal by Subject|1|||
129811921|NCT00923156|467278775|FG002|Overall Study|Withdrawal by Subject|0|||
129811922|NCT00923156|467278773|FG000|Overall Study|Death|0|||
129811923|NCT00923156|467278774|FG001|Overall Study|Death|1|||
129811924|NCT00923156|467278775|FG002|Overall Study|Death|0|||
129811925|NCT00923156|467278773|FG000|Overall Study|Lack of Efficacy|0|||
129811926|NCT00923156|467278774|FG001|Overall Study|Lack of Efficacy|0|||
129811927|NCT00923156|467278775|FG002|Overall Study|Lack of Efficacy|1|||
129811928|NCT04066023|467278777|FG000|Overall Study|Adverse Event|0|||
129811929|NCT04066023|467278778|FG001|Overall Study|Adverse Event|0|||
129811930|NCT04066023|467278779|FG002|Overall Study|Adverse Event|1|||
129811931|NCT04066023|467278777|FG000|Overall Study|Sponsor decision|3|||
129811932|NCT04066023|467278778|FG001|Overall Study|Sponsor decision|6|||
129811933|NCT04066023|467278779|FG002|Overall Study|Sponsor decision|2|||
129811934|NCT04066023|467278777|FG000|Overall Study|Physician Decision|0|||
129811935|NCT04066023|467278778|FG001|Overall Study|Physician Decision|0|||
129811936|NCT04066023|467278779|FG002|Overall Study|Physician Decision|1|||
129811937|NCT04066023|467278777|FG000|Overall Study|Lost to Follow-up|0|||
129811938|NCT04066023|467278778|FG001|Overall Study|Lost to Follow-up|1|||
129811939|NCT04066023|467278779|FG002|Overall Study|Lost to Follow-up|1|||
129811940|NCT04066023|467278777|FG000|Overall Study|Noncompliance|0|||
129811941|NCT04066023|467278778|FG001|Overall Study|Noncompliance|1|||
129811942|NCT04066023|467278779|FG002|Overall Study|Noncompliance|1|||
129811943|NCT03386448|467278780|FG000|Overall Study|Adverse Event|0|||
129811944|NCT03386448|467278781|FG001|Overall Study|Adverse Event|2|||
129811945|NCT03583697|467278782|FG000|Overall Study|Withdrawal by Subject|0|||
129811946|NCT03583697|467278783|FG001|Overall Study|Withdrawal by Subject|0|||
129811947|NCT03583697|467278784|FG002|Overall Study|Withdrawal by Subject|1|||
129811948|NCT03583697|467278782|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
129811949|NCT03583697|467278783|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
129811950|NCT03583697|467278784|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
129811951|NCT00114530|467278785|FG000|Overall Study|Death|3|||
129811952|NCT00114530|467278786|FG001|Overall Study|Death|11|||
129811953|NCT00114530|467278785|FG000|Overall Study|Lost to Follow-up|1|||
129811954|NCT00114530|467278786|FG001|Overall Study|Lost to Follow-up|1|||
129811955|NCT00114530|467278785|FG000|Overall Study|Physician Decision|1|||
129811956|NCT00114530|467278786|FG001|Overall Study|Physician Decision|1|||
129811957|NCT00114530|467278785|FG000|Overall Study|Withdrawal by Subject|2|||
129811958|NCT00114530|467278786|FG001|Overall Study|Withdrawal by Subject|6|||
129811959|NCT00114530|467278785|FG000|Overall Study|Breast Cancer|1|||
129811960|NCT00114530|467278786|FG001|Overall Study|Breast Cancer|0|||
129811961|NCT00114530|467278785|FG000|Overall Study|Subject decision after endpoint failure|0|||
129811962|NCT00114530|467278786|FG001|Overall Study|Subject decision after endpoint failure|1|||
129811963|NCT00114530|467278785|FG000|Overall Study|Ineligible|1|||
129811964|NCT00114530|467278786|FG001|Overall Study|Ineligible|0|||
129811965|NCT02538029|467278787|FG000|Overall Study|unable to complete cognitive assessments|1|||
129811966|NCT02538029|467278788|FG001|Overall Study|unable to complete cognitive assessments|0|||
129811967|NCT02538029|467278789|FG002|Overall Study|unable to complete cognitive assessments|1|||
129811968|NCT01064310|467278790|FG000|Period 1|Adverse Event|7|||
129811969|NCT01064310|467278791|FG001|Period 1|Adverse Event|10|||
129811970|NCT01064310|467278792|FG002|Period 1|Adverse Event|0|||
129811971|NCT01064310|467278790|FG000|Period 1|Physician Decision|1|||
129811972|NCT01064310|467278791|FG001|Period 1|Physician Decision|0|||
129811973|NCT01064310|467278792|FG002|Period 1|Physician Decision|0|||
129811974|NCT01064310|467278790|FG000|Period 1|Withdrawal by Subject|2|||
129811975|NCT01064310|467278791|FG001|Period 1|Withdrawal by Subject|2|||
129811976|NCT01064310|467278792|FG002|Period 1|Withdrawal by Subject|0|||
129811977|NCT01064310|467278790|FG000|Period 1|Lack of Efficacy|3|||
129811978|NCT01064310|467278791|FG001|Period 1|Lack of Efficacy|5|||
129811979|NCT01064310|467278792|FG002|Period 1|Lack of Efficacy|0|||
129811980|NCT01064310|467278790|FG000|Period 1|Entered Open-label Period|1|||
129811981|NCT01064310|467278791|FG001|Period 1|Entered Open-label Period|1|||
129811982|NCT01064310|467278792|FG002|Period 1|Entered Open-label Period|0|||
129811983|NCT01064310|467278790|FG000|Period 2|Adverse Event|2|||
129811984|NCT01064310|467278791|FG001|Period 2|Adverse Event|1|||
129811985|NCT01064310|467278792|FG002|Period 2|Adverse Event|0|||
129811986|NCT01064310|467278790|FG000|Period 2|Physician Decision|0|||
129811987|NCT01064310|467278791|FG001|Period 2|Physician Decision|1|||
129811988|NCT01064310|467278792|FG002|Period 2|Physician Decision|0|||
129811989|NCT01064310|467278790|FG000|Period 2|Entered Open-label Period|1|||
129811990|NCT01064310|467278791|FG001|Period 2|Entered Open-label Period|0|||
129811991|NCT01064310|467278792|FG002|Period 2|Entered Open-label Period|0|||
129811992|NCT01064310|467278790|FG000|Period 2|Lack of Efficacy|1|||
129811993|NCT01064310|467278791|FG001|Period 2|Lack of Efficacy|4|||
129811994|NCT01064310|467278792|FG002|Period 2|Lack of Efficacy|0|||
129811995|NCT01064310|467278790|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
129811996|NCT01064310|467278791|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
129811997|NCT01064310|467278792|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
129811998|NCT01064310|467278790|FG000|Open Label Pazopinib|Adverse Event|0|||
129811999|NCT01064310|467278791|FG001|Open Label Pazopinib|Adverse Event|0|||
129812000|NCT01064310|467278792|FG002|Open Label Pazopinib|Adverse Event|12|||
129812001|NCT01064310|467278790|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
129812002|NCT01064310|467278791|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
129812003|NCT01064310|467278792|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
129812004|NCT01064310|467278790|FG000|Open Label Pazopinib|Physician Decision|0|||
129812005|NCT01064310|467278791|FG001|Open Label Pazopinib|Physician Decision|0|||
129812006|NCT01064310|467278792|FG002|Open Label Pazopinib|Physician Decision|20|||
129812007|NCT00679432|467278793|FG000|Overall Study|Adverse Event|5|||
129812008|NCT00679432|467278794|FG001|Overall Study|Adverse Event|6|||
129812009|NCT00679432|467278795|FG002|Overall Study|Adverse Event|10|||
129812010|NCT00679432|467278796|FG003|Overall Study|Adverse Event|7|||
129812011|NCT00679432|467278793|FG000|Overall Study|Protocol Violation|1|||
129812012|NCT00679432|467278794|FG001|Overall Study|Protocol Violation|1|||
129812013|NCT00679432|467278795|FG002|Overall Study|Protocol Violation|2|||
129812014|NCT00679432|467278796|FG003|Overall Study|Protocol Violation|1|||
129812015|NCT00679432|467278793|FG000|Overall Study|Withdrawal by Subject|8|||
129812016|NCT00679432|467278794|FG001|Overall Study|Withdrawal by Subject|11|||
129812017|NCT00679432|467278795|FG002|Overall Study|Withdrawal by Subject|10|||
129812018|NCT00679432|467278796|FG003|Overall Study|Withdrawal by Subject|9|||
129812019|NCT00679432|467278793|FG000|Overall Study|Lost to Follow-up|1|||
129812020|NCT00679432|467278794|FG001|Overall Study|Lost to Follow-up|5|||
129812021|NCT00679432|467278795|FG002|Overall Study|Lost to Follow-up|4|||
129812022|NCT00679432|467278796|FG003|Overall Study|Lost to Follow-up|2|||
129812023|NCT00679432|467278793|FG000|Overall Study|Physician Decision|3|||
129812024|NCT00679432|467278794|FG001|Overall Study|Physician Decision|2|||
129812025|NCT00679432|467278795|FG002|Overall Study|Physician Decision|2|||
129812026|NCT00679432|467278796|FG003|Overall Study|Physician Decision|2|||
129812027|NCT00679432|467278793|FG000|Overall Study|Sponsor decision|1|||
129812028|NCT00679432|467278794|FG001|Overall Study|Sponsor decision|0|||
129812029|NCT00679432|467278795|FG002|Overall Study|Sponsor decision|0|||
129812030|NCT00679432|467278796|FG003|Overall Study|Sponsor decision|0|||
129812031|NCT00679432|467278793|FG000|Overall Study|Lack of Efficacy|13|||
129812032|NCT00679432|467278794|FG001|Overall Study|Lack of Efficacy|9|||
129812033|NCT00679432|467278795|FG002|Overall Study|Lack of Efficacy|14|||
129812034|NCT00679432|467278796|FG003|Overall Study|Lack of Efficacy|8|||
129812035|NCT00679432|467278793|FG000|Overall Study|Infectious colitis, normal histology|5|||
129812036|NCT00679432|467278794|FG001|Overall Study|Infectious colitis, normal histology|4|||
129812037|NCT00679432|467278795|FG002|Overall Study|Infectious colitis, normal histology|8|||
129757527|NCT00255190|467074007|FG000|Overall Study|Erosive esophagitis not healed|0|||
129757528|NCT00255190|467074008|FG001|Overall Study|Erosive esophagitis not healed|20|||
129757529|NCT00255190|467074007|FG000|Overall Study|Various|4|||
129757530|NCT00255190|467074008|FG001|Overall Study|Various|23|||
129757531|NCT01569841|467074011|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
129757532|NCT01569841|467074012|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
129757533|NCT01859923|467074013|FG000|Overall Study|Adverse Event|0|||
129757534|NCT01859923|467074014|FG001|Overall Study|Adverse Event|0|||
129757535|NCT01859923|467074015|FG002|Overall Study|Adverse Event|1|||
129757536|NCT01859923|467074016|FG003|Overall Study|Adverse Event|1|||
129757537|NCT00057863|467074019|FG000|Overall Study|Death|1|||
129757538|NCT00057863|467074019|FG000|Overall Study|Withdrawal by Subject|2|||
129757539|NCT00764361|467074020|FG000|Overall Study|Withdrawal by Subject|2|||
129757540|NCT00764361|467074021|FG001|Overall Study|Withdrawal by Subject|3|||
129757541|NCT00764361|467074020|FG000|Overall Study|Adverse Event|0|||
129757542|NCT00764361|467074021|FG001|Overall Study|Adverse Event|1|||
129757543|NCT02079038|467074025|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
129757544|NCT02079038|467074026|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
129757545|NCT02079038|467074025|FG000|Modified Intent to Treat Population|Death|1|||
129757546|NCT02079038|467074026|FG001|Modified Intent to Treat Population|Death|0|||
129757547|NCT02079038|467074025|FG000|Completed 6 Months|Lost to Follow-up|2|||
129757548|NCT02079038|467074026|FG001|Completed 6 Months|Lost to Follow-up|1|||
129757549|NCT01308736|467074027|FG000|Overall Study|Did not attend a single session|6|||
129757550|NCT01308736|467074028|FG001|Overall Study|Did not attend a single session|5|||
129757551|NCT03634085|467074029|FG000|Overall Study|Adverse Event|1|||
129757552|NCT03634085|467074030|FG001|Overall Study|Adverse Event|0|||
129757553|NCT03634085|467074029|FG000|Overall Study|Withdrawal by Subject|0|||
129757554|NCT03634085|467074030|FG001|Overall Study|Withdrawal by Subject|2|||
129757555|NCT00985465|467074033|FG000|Overall Study|Withdrawal by Subject|1|||
129757556|NCT00985465|467074034|FG001|Overall Study|Withdrawal by Subject|2|||
129757557|NCT00985465|467074033|FG000|Overall Study|Considered to be part of the other group|0|||
129757558|NCT00985465|467074034|FG001|Overall Study|Considered to be part of the other group|1|||
129757559|NCT04701333|467074035|FG000|Overall Study|Lost to Follow-up|3|||
129757560|NCT04701333|467074036|FG001|Overall Study|Lost to Follow-up|7|||
129757561|NCT04701333|467074035|FG000|Overall Study|Withdrawal by Subject|0|||
129757562|NCT04701333|467074036|FG001|Overall Study|Withdrawal by Subject|1|||
129757563|NCT01292187|467074037|FG000|Overall Study|Adverse Event|10|||
129757564|NCT01292187|467074038|FG001|Overall Study|Adverse Event|5|||
129757565|NCT01292187|467074037|FG000|Overall Study|Withdrawal by Subject|6|||
129757566|NCT01292187|467074038|FG001|Overall Study|Withdrawal by Subject|5|||
129757567|NCT01292187|467074037|FG000|Overall Study|All other reasons|1|||
129757568|NCT01292187|467074038|FG001|Overall Study|All other reasons|3|||
129757569|NCT01216202|467074041|FG000|Overall Study|Withdrawal by Subject|8|||
129757570|NCT01216202|467074042|FG001|Overall Study|Withdrawal by Subject|0|||
129757571|NCT01216202|467074041|FG000|Overall Study|Death|0|||
129757572|NCT01216202|467074042|FG001|Overall Study|Death|2|||
129757573|NCT01216202|467074041|FG000|Overall Study|Lost to Follow-up|14|||
129757574|NCT01216202|467074042|FG001|Overall Study|Lost to Follow-up|0|||
129757575|NCT02888106|467074050|FG000|Overall Study|Withdrawal by Subject|1|||
129757576|NCT02888106|467074051|FG001|Overall Study|Withdrawal by Subject|2|||
129757577|NCT02888106|467074052|FG002|Overall Study|Withdrawal by Subject|0|||
129757578|NCT02888106|467074053|FG003|Overall Study|Withdrawal by Subject|1|||
129757579|NCT02888106|467074054|FG004|Overall Study|Withdrawal by Subject|0|||
129757580|NCT02888106|467074055|FG005|Overall Study|Withdrawal by Subject|0|||
129757581|NCT02888106|467074050|FG000|Overall Study|Lost to Follow-up|1|||
129757582|NCT02888106|467074051|FG001|Overall Study|Lost to Follow-up|0|||
129757583|NCT02888106|467074052|FG002|Overall Study|Lost to Follow-up|0|||
129757584|NCT02888106|467074053|FG003|Overall Study|Lost to Follow-up|1|||
129757585|NCT02888106|467074054|FG004|Overall Study|Lost to Follow-up|0|||
129757586|NCT02888106|467074055|FG005|Overall Study|Lost to Follow-up|1|||
129757587|NCT02888106|467074050|FG000|Overall Study|Adverse Event|2|||
129812038|NCT00679432|467278796|FG003|Overall Study|Infectious colitis, normal histology|3|||
129812039|NCT00679432|467278793|FG000|Overall Study|Randomization error, return to prior Rx|0|||
129757588|NCT02888106|467074051|FG001|Overall Study|Adverse Event|0|||
129757589|NCT02888106|467074052|FG002|Overall Study|Adverse Event|0|||
129757590|NCT02888106|467074053|FG003|Overall Study|Adverse Event|0|||
129757591|NCT02888106|467074054|FG004|Overall Study|Adverse Event|0|||
129757592|NCT02888106|467074055|FG005|Overall Study|Adverse Event|0|||
129757593|NCT02888106|467074050|FG000|Overall Study|Withdrawal of consent|0|||
129757594|NCT02888106|467074051|FG001|Overall Study|Withdrawal of consent|0|||
129757595|NCT02888106|467074052|FG002|Overall Study|Withdrawal of consent|0|||
129757596|NCT02888106|467074053|FG003|Overall Study|Withdrawal of consent|0|||
129757597|NCT02888106|467074054|FG004|Overall Study|Withdrawal of consent|1|||
129757598|NCT02888106|467074055|FG005|Overall Study|Withdrawal of consent|0|||
129757599|NCT02888106|467074050|FG000|Overall Study|Pregnancy|1|||
129757600|NCT02888106|467074051|FG001|Overall Study|Pregnancy|0|||
129757601|NCT02888106|467074052|FG002|Overall Study|Pregnancy|0|||
129757602|NCT02888106|467074053|FG003|Overall Study|Pregnancy|0|||
129757603|NCT02888106|467074054|FG004|Overall Study|Pregnancy|0|||
129757604|NCT02888106|467074055|FG005|Overall Study|Pregnancy|0|||
129757605|NCT01188772|467074058|FG000|Overall Study|Randomized but Not Treated|0|||
129757606|NCT01188772|467074059|FG001|Overall Study|Randomized but Not Treated|1|||
129757607|NCT01188772|467074060|FG002|Overall Study|Randomized but Not Treated|0|||
129757608|NCT01188772|467074061|FG003|Overall Study|Randomized but Not Treated|0|||
129757609|NCT01188772|467074058|FG000|Overall Study|Adverse Event|0|||
129757610|NCT01188772|467074059|FG001|Overall Study|Adverse Event|1|||
129757611|NCT01188772|467074060|FG002|Overall Study|Adverse Event|2|||
129757612|NCT01188772|467074061|FG003|Overall Study|Adverse Event|0|||
129757613|NCT01188772|467074058|FG000|Overall Study|Lost to Follow-up|4|||
129757614|NCT01188772|467074059|FG001|Overall Study|Lost to Follow-up|1|||
129757615|NCT01188772|467074060|FG002|Overall Study|Lost to Follow-up|1|||
129757616|NCT01188772|467074061|FG003|Overall Study|Lost to Follow-up|1|||
129757617|NCT01188772|467074058|FG000|Overall Study|Non-responder|0|||
129757618|NCT01188772|467074059|FG001|Overall Study|Non-responder|0|||
129757619|NCT01188772|467074060|FG002|Overall Study|Non-responder|3|||
129757620|NCT01188772|467074061|FG003|Overall Study|Non-responder|0|||
129757621|NCT01188772|467074058|FG000|Overall Study|Physician Decision|0|||
129757622|NCT01188772|467074059|FG001|Overall Study|Physician Decision|0|||
129757623|NCT01188772|467074060|FG002|Overall Study|Physician Decision|1|||
129757624|NCT01188772|467074061|FG003|Overall Study|Physician Decision|0|||
129757625|NCT01188772|467074058|FG000|Overall Study|Terminated by Sponsor|0|||
129757626|NCT01188772|467074059|FG001|Overall Study|Terminated by Sponsor|0|||
129757627|NCT01188772|467074060|FG002|Overall Study|Terminated by Sponsor|1|||
129757628|NCT01188772|467074061|FG003|Overall Study|Terminated by Sponsor|0|||
129757629|NCT01188772|467074058|FG000|Overall Study|Treatment Failure|0|||
129757630|NCT01188772|467074059|FG001|Overall Study|Treatment Failure|0|||
129757631|NCT01188772|467074060|FG002|Overall Study|Treatment Failure|1|||
129757632|NCT01188772|467074061|FG003|Overall Study|Treatment Failure|0|||
129757633|NCT01188772|467074058|FG000|Overall Study|Virologic Failure|1|||
129757634|NCT01188772|467074059|FG001|Overall Study|Virologic Failure|0|||
129757635|NCT01188772|467074060|FG002|Overall Study|Virologic Failure|0|||
129757636|NCT01188772|467074061|FG003|Overall Study|Virologic Failure|0|||
129757637|NCT01188772|467074058|FG000|Overall Study|Withdrawal by Subject|0|||
129757638|NCT01188772|467074059|FG001|Overall Study|Withdrawal by Subject|0|||
129757639|NCT01188772|467074060|FG002|Overall Study|Withdrawal by Subject|2|||
129757640|NCT01188772|467074061|FG003|Overall Study|Withdrawal by Subject|0|||
129757641|NCT01433172|467074062|FG000|Overall Study|Withdrawal by Subject|0|||
129757642|NCT01433172|467074063|FG001|Overall Study|Withdrawal by Subject|1|||
129757643|NCT01433172|467074064|FG002|Overall Study|Withdrawal by Subject|0|||
129757644|NCT01433172|467074062|FG000|Overall Study|Disease Progression|0|||
129757645|NCT01433172|467074063|FG001|Overall Study|Disease Progression|0|||
129757646|NCT01433172|467074064|FG002|Overall Study|Disease Progression|1|||
129757647|NCT01433172|467074062|FG000|Overall Study|Death|0|||
129757648|NCT01433172|467074063|FG001|Overall Study|Death|2|||
129757649|NCT01433172|467074064|FG002|Overall Study|Death|0|||
129757650|NCT01894607|467074068|FG000|Overall Study|Ineligible|1|||
129757651|NCT04303559|467074069|FG000|Overall Study|Study closed due to poor enrollment.|1|||
129757652|NCT04037891|467074070|FG000|Open-label Period|Withdrawal by Subject|1|||
129757653|NCT04037891|467074071|FG001|Open-label Period|Withdrawal by Subject|0|||
129757654|NCT04037891|467074072|FG002|Open-label Period|Withdrawal by Subject|0|||
129757655|NCT04037891|467074070|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
129757656|NCT04037891|467074071|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
129757657|NCT04037891|467074072|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
129757658|NCT03446313|467074073|FG000|Overall Study|Lost to Follow-up|1|||
129757659|NCT03446313|467074074|FG001|Overall Study|Lost to Follow-up|2|||
129757660|NCT03446313|467074073|FG000|Overall Study|Failed primary screening|3|||
129757661|NCT03446313|467074074|FG001|Overall Study|Failed primary screening|0|||
129812040|NCT00679432|467278794|FG001|Overall Study|Randomization error, return to prior Rx|0|||
129812041|NCT00679432|467278795|FG002|Overall Study|Randomization error, return to prior Rx|3|||
129812042|NCT00679432|467278796|FG003|Overall Study|Randomization error, return to prior Rx|0|||
129812043|NCT02339584|467278797|FG000|Overall Study|Adverse Event|11|||
129812044|NCT02339584|467278798|FG001|Overall Study|Adverse Event|7|||
129757662|NCT03446313|467074073|FG000|Overall Study|Diagnosed with terminal cancer|1|||
129757663|NCT03446313|467074074|FG001|Overall Study|Diagnosed with terminal cancer|0|||
129757664|NCT03446313|467074073|FG000|Overall Study|Excluded from analysis|1|||
129757665|NCT03446313|467074074|FG001|Overall Study|Excluded from analysis|1|||
129757666|NCT04491136|467074075|FG000|Overall Study|Patient withdraw informed consent|9|||
129757667|NCT04491136|467074075|FG000|Overall Study|Adverse Event|2|||
129757668|NCT04491136|467074075|FG000|Overall Study|Death|3|||
129757669|NCT04491136|467074075|FG000|Overall Study|Lost to Follow-up|3|||
129757670|NCT04491136|467074075|FG000|Overall Study|Physician Decision|45|||
129757671|NCT04491136|467074075|FG000|Overall Study|sponsor terminated the study early|16|||
129757672|NCT04491136|467074075|FG000|Overall Study|Patient/guardian's decision|1|||
129757673|NCT01611194|467074076|FG000|Overall Study|Lost to Follow-up|0|||
129757674|NCT01611194|467074077|FG001|Overall Study|Lost to Follow-up|1|||
129757675|NCT01611194|467074076|FG000|Overall Study|Withdrawal by Subject|0|||
129757676|NCT01611194|467074077|FG001|Overall Study|Withdrawal by Subject|1|||
129757677|NCT01611194|467074076|FG000|Overall Study|drug use|0|||
129757678|NCT01611194|467074077|FG001|Overall Study|drug use|1|||
129757679|NCT00348673|467074078|FG000|Stage 1|Randomized but not Treated|0|||
129757680|NCT00348673|467074079|FG001|Stage 1|Randomized but not Treated|0|||
129757681|NCT00348673|467074080|FG002|Stage 1|Randomized but not Treated|1|||
129757682|NCT00348673|467074081|FG003|Stage 1|Randomized but not Treated|0|||
129757683|NCT00348673|467074082|FG004|Stage 1|Randomized but not Treated|0|||
129757684|NCT00348673|467074083|FG005|Stage 1|Randomized but not Treated|0|||
129757685|NCT00348673|467074084|FG006|Stage 1|Randomized but not Treated|0|||
129757686|NCT00348673|467074085|FG007|Stage 1|Randomized but not Treated|0|||
129896920|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896921|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896922|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896923|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896924|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896925|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896926|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
129757687|NCT00348673|467074086|FG008|Stage 1|Randomized but not Treated|0|||
129757688|NCT02719171|467076150|FG000|Overall Study|Adverse Event|1|||
129757689|NCT02719171|467076151|FG001|Overall Study|Adverse Event|2|||
129757690|NCT02719171|467076152|FG002|Overall Study|Adverse Event|0|||
129757691|NCT02719171|467076153|FG003|Overall Study|Adverse Event|0|||
129757692|NCT02719171|467076154|FG004|Overall Study|Adverse Event|2|||
129757693|NCT02719171|467076150|FG000|Overall Study|Lost to Follow-up|0|||
129757694|NCT02719171|467076151|FG001|Overall Study|Lost to Follow-up|0|||
129757695|NCT02719171|467076152|FG002|Overall Study|Lost to Follow-up|1|||
129757696|NCT02719171|467076153|FG003|Overall Study|Lost to Follow-up|0|||
129757697|NCT02719171|467076154|FG004|Overall Study|Lost to Follow-up|0|||
129757698|NCT02719171|467076150|FG000|Overall Study|Subject Withdrawal|0|||
129757699|NCT02719171|467076151|FG001|Overall Study|Subject Withdrawal|2|||
129757700|NCT02719171|467076152|FG002|Overall Study|Subject Withdrawal|2|||
129757701|NCT02719171|467076153|FG003|Overall Study|Subject Withdrawal|1|||
129757702|NCT02719171|467076154|FG004|Overall Study|Subject Withdrawal|0|||
129757703|NCT02719171|467076150|FG000|Overall Study|Other|0|||
129757704|NCT02719171|467076151|FG001|Overall Study|Other|0|||
129757705|NCT02719171|467076152|FG002|Overall Study|Other|0|||
129757706|NCT02719171|467076153|FG003|Overall Study|Other|1|||
129757707|NCT02719171|467076154|FG004|Overall Study|Other|0|||
129757708|NCT02614729|467076155|FG000|Overall Study|Withdrawal by Subject|1|||
129757709|NCT02614729|467076156|FG001|Overall Study|Withdrawal by Subject|0|||
129757710|NCT02539797|467076159|FG000|Overall Study|Lost to Follow-up|0|||
129757711|NCT02539797|467076160|FG001|Overall Study|Lost to Follow-up|1|||
129757712|NCT02539797|467076161|FG002|Overall Study|Lost to Follow-up|0|||
129757713|NCT03798717|467076163|FG000|Overall Study|Failed Screening|0|||
129757714|NCT03798717|467076164|FG001|Overall Study|Failed Screening|0|||
129757715|NCT03798717|467076165|FG002|Overall Study|Failed Screening|0|||
129757716|NCT03798717|467076166|FG003|Overall Study|Failed Screening|0|||
129757717|NCT03798717|467076167|FG004|Overall Study|Failed Screening|0|||
129757718|NCT03798717|467076168|FG005|Overall Study|Failed Screening|1|||
129757719|NCT03798717|467076163|FG000|Overall Study|Physician Decision|1|||
129757720|NCT03798717|467076164|FG001|Overall Study|Physician Decision|0|||
129757721|NCT03798717|467076165|FG002|Overall Study|Physician Decision|1|||
129757722|NCT03798717|467076166|FG003|Overall Study|Physician Decision|0|||
129757723|NCT03798717|467076167|FG004|Overall Study|Physician Decision|0|||
129757724|NCT03798717|467076168|FG005|Overall Study|Physician Decision|0|||
129757725|NCT03798717|467076163|FG000|Overall Study|Withdrawal by Subject|0|||
129757726|NCT03798717|467076164|FG001|Overall Study|Withdrawal by Subject|0|||
129757727|NCT03798717|467076165|FG002|Overall Study|Withdrawal by Subject|0|||
129757728|NCT03798717|467076166|FG003|Overall Study|Withdrawal by Subject|1|||
129757729|NCT03798717|467076167|FG004|Overall Study|Withdrawal by Subject|0|||
129757730|NCT03798717|467076168|FG005|Overall Study|Withdrawal by Subject|0|||
129757731|NCT03798717|467076163|FG000|Overall Study|Lost to Follow-up|1|||
129757732|NCT03798717|467076164|FG001|Overall Study|Lost to Follow-up|0|||
129757733|NCT03798717|467076165|FG002|Overall Study|Lost to Follow-up|0|||
129757734|NCT03798717|467076166|FG003|Overall Study|Lost to Follow-up|1|||
129757735|NCT03798717|467076167|FG004|Overall Study|Lost to Follow-up|0|||
129757736|NCT03798717|467076168|FG005|Overall Study|Lost to Follow-up|0|||
129757737|NCT03798717|467076163|FG000|Overall Study|Adverse Event|0|||
129757738|NCT03798717|467076164|FG001|Overall Study|Adverse Event|1|||
129757739|NCT03798717|467076165|FG002|Overall Study|Adverse Event|0|||
129757740|NCT03798717|467076166|FG003|Overall Study|Adverse Event|0|||
129757741|NCT03798717|467076167|FG004|Overall Study|Adverse Event|0|||
129757742|NCT03798717|467076168|FG005|Overall Study|Adverse Event|0|||
129757743|NCT03798717|467076163|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129757744|NCT03798717|467076164|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129757745|NCT03798717|467076165|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129757746|NCT03798717|467076166|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129757747|NCT03798717|467076167|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
129757748|NCT03798717|467076168|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
129757749|NCT04002960|467076170|FG000|Overall Study|Withdrawn prior to Completion|2|||
129757750|NCT00383786|467076185|FG000|Overall Study|Protocol Violation|2|||
129757751|NCT00383786|467076186|FG001|Overall Study|Protocol Violation|6|||
129757752|NCT00383786|467076185|FG000|Overall Study|Withdrawal by Subject|2|||
129757753|NCT00383786|467076186|FG001|Overall Study|Withdrawal by Subject|5|||
129757754|NCT00383786|467076185|FG000|Overall Study|Physician Decision|0|||
129757755|NCT00383786|467076186|FG001|Overall Study|Physician Decision|1|||
129757756|NCT00985673|467076187|FG000|Overall Study|Lost to Follow-up|6|||
129757757|NCT00985673|467076188|FG001|Overall Study|Lost to Follow-up|7|||
129757758|NCT00985673|467076189|FG002|Overall Study|Lost to Follow-up|6|||
129757759|NCT00985673|467076190|FG003|Overall Study|Lost to Follow-up|10|||
129757760|NCT00985673|467076191|FG004|Overall Study|Lost to Follow-up|5|||
129757761|NCT00985673|467076192|FG005|Overall Study|Lost to Follow-up|3|||
129757762|NCT00985673|467076187|FG000|Overall Study|Withdrawal by Subject|0|||
129757763|NCT00985673|467076188|FG001|Overall Study|Withdrawal by Subject|4|||
129757764|NCT00985673|467076189|FG002|Overall Study|Withdrawal by Subject|5|||
129757765|NCT00985673|467076190|FG003|Overall Study|Withdrawal by Subject|2|||
129757766|NCT00985673|467076191|FG004|Overall Study|Withdrawal by Subject|2|||
129757767|NCT00985673|467076192|FG005|Overall Study|Withdrawal by Subject|3|||
129757768|NCT00985673|467076187|FG000|Overall Study|Other|1|||
129757769|NCT00985673|467076188|FG001|Overall Study|Other|0|||
129757770|NCT00985673|467076189|FG002|Overall Study|Other|1|||
129757771|NCT00985673|467076190|FG003|Overall Study|Other|0|||
129757772|NCT00985673|467076191|FG004|Overall Study|Other|1|||
129757773|NCT00985673|467076192|FG005|Overall Study|Other|0|||
129757774|NCT02252146|467076193|FG000|Overall Study|Lack of Efficacy|4|||
129757775|NCT02252146|467076193|FG000|Overall Study|Entered hospice care|1|||
129757776|NCT02252146|467076193|FG000|Overall Study|Inability to travel to study site|1|||
129757777|NCT00531284|467076196|FG000|Overall Study|Progressive Disease|1|||
129757778|NCT00531284|467076197|FG001|Overall Study|Progressive Disease|3|||
129757779|NCT00531284|467076198|FG002|Overall Study|Progressive Disease|5|||
129757780|NCT00531284|467076199|FG003|Overall Study|Progressive Disease|42|||
129757781|NCT00531284|467076200|FG004|Overall Study|Progressive Disease|4|||
129757782|NCT00531284|467076201|FG005|Overall Study|Progressive Disease|4|||
129757783|NCT00531284|467076202|FG006|Overall Study|Progressive Disease|3|||
129757784|NCT00531284|467076203|FG007|Overall Study|Progressive Disease|8|||
129812045|NCT02339584|467278797|FG000|Overall Study|Lack of Efficacy|0|||
129812046|NCT02339584|467278798|FG001|Overall Study|Lack of Efficacy|1|||
129812047|NCT02339584|467278797|FG000|Overall Study|Physician Decision|1|||
129812048|NCT02339584|467278798|FG001|Overall Study|Physician Decision|2|||
129812049|NCT02339584|467278797|FG000|Overall Study|Protocol Violation|1|||
129812050|NCT02339584|467278798|FG001|Overall Study|Protocol Violation|1|||
129812051|NCT02339584|467278797|FG000|Overall Study|Withdrawal by Subject|2|||
129812052|NCT02339584|467278798|FG001|Overall Study|Withdrawal by Subject|4|||
129812053|NCT01084083|467278799|FG000|Overall Study|Adverse Event|5|||
129812054|NCT01084083|467278799|FG000|Overall Study|Death|1|||
129812055|NCT01084083|467278799|FG000|Overall Study|Withdrawal by Subject|2|||
129812056|NCT01084083|467278799|FG000|Overall Study|Complicating disease|1|||
129812057|NCT01084083|467278799|FG000|Overall Study|Other|2|||
129812058|NCT01084083|467278799|FG000|Overall Study|Never started assigned therapy|1|||
129812059|NCT01980940|467278800|FG000|Overall Study|Protocol Violation|0|||
129812060|NCT01980940|467278801|FG001|Overall Study|Protocol Violation|0|||
129812061|NCT01980940|467278802|FG002|Overall Study|Protocol Violation|0|||
129812062|NCT01980940|467278803|FG003|Overall Study|Protocol Violation|0|||
129812063|NCT01980940|467278804|FG004|Overall Study|Protocol Violation|0|||
129812064|NCT01980940|467278805|FG005|Overall Study|Protocol Violation|2|||
129812065|NCT01980940|467278806|FG006|Overall Study|Protocol Violation|0|||
129812066|NCT01980940|467278807|FG007|Overall Study|Protocol Violation|0|||
129812067|NCT05996718|467280239|FG000|Overall Study|Lost to Follow-up|3|||
129812068|NCT01713686|467280240|FG000|Overall Study|Lost to Follow-up|9|||
129757785|NCT00531284|467076204|FG008|Overall Study|Progressive Disease|6|||
129757786|NCT00531284|467076205|FG009|Overall Study|Progressive Disease|3|||
129757787|NCT00531284|467076206|FG010|Overall Study|Progressive Disease|3|||
129757788|NCT00531284|467076207|FG011|Overall Study|Progressive Disease|14|||
129757789|NCT00531284|467076208|FG012|Overall Study|Progressive Disease|2|||
129757790|NCT00531284|467076209|FG013|Overall Study|Progressive Disease|1|||
129757791|NCT00531284|467076210|FG014|Overall Study|Progressive Disease|2|||
129812069|NCT01713686|467280240|FG000|Overall Study|Withdrawal by Subject|6|||
129812070|NCT04840615|467280241|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
129812071|NCT04840615|467280242|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
129812072|NCT04840615|467280243|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
129812073|NCT00709761|467280247|FG000|Overall Study|Withdrawal by Subject|8|||
129812074|NCT00709761|467280247|FG000|Overall Study|study closed/terminated|17|||
129812075|NCT00709761|467280247|FG000|Overall Study|Lost to Follow-up|2|||
129812076|NCT01606800|467280248|FG000|Overall Study|Adverse Event|3|||
129812077|NCT01606800|467280249|FG001|Overall Study|Adverse Event|1|||
129812078|NCT01606800|467280248|FG000|Overall Study|Participant withdrew consent|0|||
129812079|NCT01606800|467280249|FG001|Overall Study|Participant withdrew consent|1|||
129812080|NCT01606800|467280248|FG000|Overall Study|Missing completion status|2|||
129812081|NCT01606800|467280249|FG001|Overall Study|Missing completion status|0|||
129812082|NCT00717197|467280254|FG000|Overall Study|Unable to purchase study drug|5|||
129812083|NCT00717197|467280254|FG000|Overall Study|Tumor Progression|1|||
129812084|NCT00717197|467280254|FG000|Overall Study|Physician Decision|1|||
129812085|NCT00982137|467280255|FG000|Overall Study|Lost to Follow-up|0|||
129812086|NCT00982137|467280256|FG001|Overall Study|Lost to Follow-up|0|||
129812087|NCT00982137|467280257|FG002|Overall Study|Lost to Follow-up|0|||
129812088|NCT00982137|467280258|FG003|Overall Study|Lost to Follow-up|1|||
129812089|NCT00982137|467280255|FG000|Overall Study|Withdrawal by Subject|0|||
129812090|NCT00982137|467280256|FG001|Overall Study|Withdrawal by Subject|1|||
129812091|NCT00982137|467280257|FG002|Overall Study|Withdrawal by Subject|0|||
129812092|NCT00982137|467280258|FG003|Overall Study|Withdrawal by Subject|0|||
129812093|NCT03311724|467280259|FG000|Overall Study|Physician Decision|0|||
129812094|NCT03311724|467280260|FG001|Overall Study|Physician Decision|0|||
129812095|NCT03311724|467280261|FG002|Overall Study|Physician Decision|0|||
129812096|NCT03311724|467280262|FG003|Overall Study|Physician Decision|1|||
129812097|NCT03311724|467280259|FG000|Overall Study|Protocol Violation|1|||
129812098|NCT03311724|467280260|FG001|Overall Study|Protocol Violation|0|||
129812099|NCT03311724|467280261|FG002|Overall Study|Protocol Violation|1|||
129812100|NCT03311724|467280262|FG003|Overall Study|Protocol Violation|0|||
129812101|NCT03311724|467280259|FG000|Overall Study|Withdrawal by Subject|1|||
129812102|NCT03311724|467280260|FG001|Overall Study|Withdrawal by Subject|1|||
129812103|NCT03311724|467280261|FG002|Overall Study|Withdrawal by Subject|0|||
129812104|NCT03311724|467280262|FG003|Overall Study|Withdrawal by Subject|0|||
129812105|NCT03311724|467280259|FG000|Overall Study|Lost to Follow-up|1|||
129812106|NCT03311724|467280260|FG001|Overall Study|Lost to Follow-up|0|||
129812107|NCT03311724|467280261|FG002|Overall Study|Lost to Follow-up|0|||
129812108|NCT03311724|467280262|FG003|Overall Study|Lost to Follow-up|0|||
129812109|NCT03311724|467280259|FG000|Overall Study|Sponsor Decision|0|||
129812110|NCT03311724|467280260|FG001|Overall Study|Sponsor Decision|0|||
129812111|NCT03311724|467280261|FG002|Overall Study|Sponsor Decision|1|||
129812112|NCT03311724|467280262|FG003|Overall Study|Sponsor Decision|0|||
129812113|NCT00395304|467280263|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129812114|NCT00395304|467280264|FG001|Treatment Period 1|Withdrawal by Subject|3|||
129812115|NCT00395304|467280265|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129812116|NCT00395304|467280266|FG003|Treatment Period 1|Withdrawal by Subject|2|||
129812117|NCT00395304|467280267|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129812118|NCT00395304|467280268|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129812119|NCT00395304|467280263|FG000|Treatment Period 1|Lost to Follow-up|1|||
129812120|NCT00395304|467280264|FG001|Treatment Period 1|Lost to Follow-up|0|||
129812121|NCT00395304|467280265|FG002|Treatment Period 1|Lost to Follow-up|0|||
129812122|NCT00395304|467280266|FG003|Treatment Period 1|Lost to Follow-up|1|||
129812123|NCT00395304|467280267|FG004|Treatment Period 1|Lost to Follow-up|0|||
129812124|NCT00395304|467280268|FG005|Treatment Period 1|Lost to Follow-up|1|||
129812125|NCT00395304|467280263|FG000|Treatment Period 1|Physician Decision|0|||
129812126|NCT00395304|467280264|FG001|Treatment Period 1|Physician Decision|1|||
129812127|NCT00395304|467280265|FG002|Treatment Period 1|Physician Decision|0|||
129812128|NCT00395304|467280266|FG003|Treatment Period 1|Physician Decision|0|||
129812129|NCT00395304|467280267|FG004|Treatment Period 1|Physician Decision|0|||
129812130|NCT00395304|467280268|FG005|Treatment Period 1|Physician Decision|0|||
129812131|NCT00395304|467280263|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129812132|NCT00395304|467280264|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129812133|NCT00395304|467280265|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129812134|NCT00395304|467280266|FG003|Treatment Period 2|Withdrawal by Subject|1|||
129812135|NCT00395304|467280267|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129812136|NCT00395304|467280268|FG005|Treatment Period 2|Withdrawal by Subject|2|||
129812137|NCT00395304|467280263|FG000|Treatment Period 2|Lost to Follow-up|0|||
129812138|NCT00395304|467280264|FG001|Treatment Period 2|Lost to Follow-up|3|||
129812139|NCT00395304|467280265|FG002|Treatment Period 2|Lost to Follow-up|0|||
129812140|NCT00395304|467280266|FG003|Treatment Period 2|Lost to Follow-up|0|||
129812141|NCT00395304|467280267|FG004|Treatment Period 2|Lost to Follow-up|0|||
129812142|NCT00395304|467280268|FG005|Treatment Period 2|Lost to Follow-up|0|||
129812143|NCT00395304|467280263|FG000|Treatment Period 2|Physician Decision|0|||
129812144|NCT00395304|467280264|FG001|Treatment Period 2|Physician Decision|0|||
129812145|NCT00395304|467280265|FG002|Treatment Period 2|Physician Decision|1|||
129757792|NCT00531284|467076211|FG015|Overall Study|Progressive Disease|11|||
129757793|NCT00531284|467076212|FG016|Overall Study|Progressive Disease|5|||
129757794|NCT00531284|467076196|FG000|Overall Study|Adverse Event|0|||
129757795|NCT00531284|467076197|FG001|Overall Study|Adverse Event|1|||
129757796|NCT00531284|467076198|FG002|Overall Study|Adverse Event|1|||
129757797|NCT00531284|467076199|FG003|Overall Study|Adverse Event|7|||
129757798|NCT00531284|467076200|FG004|Overall Study|Adverse Event|0|||
129757799|NCT00531284|467076201|FG005|Overall Study|Adverse Event|2|||
129757800|NCT00531284|467076202|FG006|Overall Study|Adverse Event|3|||
129757801|NCT00531284|467076203|FG007|Overall Study|Adverse Event|2|||
129757802|NCT00531284|467076204|FG008|Overall Study|Adverse Event|3|||
129757803|NCT00531284|467076205|FG009|Overall Study|Adverse Event|0|||
129757804|NCT00531284|467076206|FG010|Overall Study|Adverse Event|0|||
129757805|NCT00531284|467076207|FG011|Overall Study|Adverse Event|5|||
129757806|NCT00531284|467076208|FG012|Overall Study|Adverse Event|0|||
129757807|NCT00531284|467076209|FG013|Overall Study|Adverse Event|1|||
129757808|NCT00531284|467076210|FG014|Overall Study|Adverse Event|1|||
129757809|NCT00531284|467076211|FG015|Overall Study|Adverse Event|0|||
129757810|NCT00531284|467076212|FG016|Overall Study|Adverse Event|2|||
129757811|NCT00531284|467076196|FG000|Overall Study|Withdrawal by Subject|1|||
129757812|NCT00531284|467076197|FG001|Overall Study|Withdrawal by Subject|0|||
129757813|NCT00531284|467076198|FG002|Overall Study|Withdrawal by Subject|0|||
129757814|NCT00531284|467076199|FG003|Overall Study|Withdrawal by Subject|4|||
129757815|NCT00531284|467076200|FG004|Overall Study|Withdrawal by Subject|0|||
129757816|NCT00531284|467076201|FG005|Overall Study|Withdrawal by Subject|0|||
129757817|NCT00531284|467076202|FG006|Overall Study|Withdrawal by Subject|0|||
129757818|NCT00531284|467076203|FG007|Overall Study|Withdrawal by Subject|0|||
129757819|NCT00531284|467076204|FG008|Overall Study|Withdrawal by Subject|0|||
129757820|NCT00531284|467076205|FG009|Overall Study|Withdrawal by Subject|0|||
129757821|NCT00531284|467076206|FG010|Overall Study|Withdrawal by Subject|0|||
129757822|NCT00531284|467076207|FG011|Overall Study|Withdrawal by Subject|3|||
129757823|NCT00531284|467076208|FG012|Overall Study|Withdrawal by Subject|0|||
129757824|NCT00531284|467076209|FG013|Overall Study|Withdrawal by Subject|1|||
129757825|NCT00531284|467076210|FG014|Overall Study|Withdrawal by Subject|0|||
129757826|NCT00531284|467076211|FG015|Overall Study|Withdrawal by Subject|1|||
129757827|NCT00531284|467076212|FG016|Overall Study|Withdrawal by Subject|1|||
129757828|NCT00531284|467076196|FG000|Overall Study|Other|1|||
129757829|NCT00531284|467076197|FG001|Overall Study|Other|0|||
129757830|NCT00531284|467076198|FG002|Overall Study|Other|0|||
129757831|NCT00531284|467076199|FG003|Overall Study|Other|10|||
129757832|NCT00531284|467076200|FG004|Overall Study|Other|2|||
129757833|NCT00531284|467076201|FG005|Overall Study|Other|1|||
129757834|NCT00531284|467076202|FG006|Overall Study|Other|0|||
129757835|NCT00531284|467076203|FG007|Overall Study|Other|0|||
129757836|NCT00531284|467076204|FG008|Overall Study|Other|2|||
129757837|NCT00531284|467076205|FG009|Overall Study|Other|1|||
129757838|NCT00531284|467076206|FG010|Overall Study|Other|0|||
129757839|NCT00531284|467076207|FG011|Overall Study|Other|2|||
129757840|NCT00531284|467076208|FG012|Overall Study|Other|0|||
129757841|NCT00531284|467076209|FG013|Overall Study|Other|0|||
129757842|NCT00531284|467076210|FG014|Overall Study|Other|1|||
129757843|NCT00531284|467076211|FG015|Overall Study|Other|0|||
129757844|NCT00531284|467076212|FG016|Overall Study|Other|0|||
129757845|NCT00984256|467076213|FG000|Overall Study|Withdrawal by Subject|0|||
129757846|NCT00984256|467076214|FG001|Overall Study|Withdrawal by Subject|1|||
129757847|NCT03057496|467076215|FG000|Overall Study|Withdrawal by Subject|8|||
129757848|NCT03057496|467076215|FG000|Overall Study|Lost to Follow-up|5|||
129757849|NCT03057496|467076215|FG000|Overall Study|Did not use device during home trial|3|||
129757850|NCT03057496|467076215|FG000|Overall Study|Device failure|2|||
129757851|NCT03347123|467076223|FG000|Overall Study|Death|1|||
129757852|NCT03347123|467076224|FG001|Overall Study|Death|2|||
129757853|NCT03347123|467076225|FG002|Overall Study|Death|0|||
129757854|NCT03347123|467076226|FG003|Overall Study|Death|0|||
129757855|NCT03347123|467076227|FG004|Overall Study|Death|0|||
129757856|NCT03347123|467076228|FG005|Overall Study|Death|0|||
129757857|NCT03347123|467076229|FG006|Overall Study|Death|0|||
129757858|NCT03347123|467076223|FG000|Overall Study|Withdrawal by Subject|1|||
129757859|NCT03347123|467076224|FG001|Overall Study|Withdrawal by Subject|0|||
129757860|NCT03347123|467076225|FG002|Overall Study|Withdrawal by Subject|0|||
129812146|NCT00395304|467280266|FG003|Treatment Period 2|Physician Decision|0|||
129757861|NCT03347123|467076226|FG003|Overall Study|Withdrawal by Subject|0|||
129757862|NCT03347123|467076227|FG004|Overall Study|Withdrawal by Subject|0|||
129757863|NCT03347123|467076228|FG005|Overall Study|Withdrawal by Subject|0|||
129757864|NCT03347123|467076229|FG006|Overall Study|Withdrawal by Subject|0|||
129757865|NCT03347123|467076223|FG000|Overall Study|Reason not Specified|3|||
129757866|NCT03347123|467076224|FG001|Overall Study|Reason not Specified|4|||
129757867|NCT03347123|467076225|FG002|Overall Study|Reason not Specified|0|||
129757868|NCT03347123|467076226|FG003|Overall Study|Reason not Specified|0|||
129757869|NCT03347123|467076227|FG004|Overall Study|Reason not Specified|0|||
129757870|NCT03347123|467076228|FG005|Overall Study|Reason not Specified|0|||
129896927|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896928|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
129896929|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
129757871|NCT03347123|467076229|FG006|Overall Study|Reason not Specified|0|||
129757872|NCT01132807|467076232|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
129757873|NCT01132807|467076233|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
129757874|NCT01132807|467076234|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
129757875|NCT01132807|467076232|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
129757876|NCT01132807|467076233|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
129757877|NCT01132807|467076234|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
129757878|NCT01731912|467076237|FG000|Overall Study|noncompliance|2|||
129757879|NCT02222558|467076238|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
129757880|NCT02222558|467076239|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
129757881|NCT02222558|467076240|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
129757882|NCT02222558|467076241|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
129757883|NCT02222558|467076242|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
129757884|NCT02222558|467076243|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
129757885|NCT02222558|467076238|FG000|Period 3|Withdrawal by Subject|0|||
129757886|NCT02222558|467076239|FG001|Period 3|Withdrawal by Subject|0|||
129757887|NCT02222558|467076240|FG002|Period 3|Withdrawal by Subject|0|||
129812147|NCT00395304|467280267|FG004|Treatment Period 2|Physician Decision|0|||
129812148|NCT00395304|467280268|FG005|Treatment Period 2|Physician Decision|0|||
129812149|NCT00395304|467280263|FG000|Treatment Period 2|Other|0|||
129812150|NCT00395304|467280264|FG001|Treatment Period 2|Other|1|||
129812151|NCT00395304|467280265|FG002|Treatment Period 2|Other|0|||
129812152|NCT00395304|467280266|FG003|Treatment Period 2|Other|0|||
129812153|NCT00395304|467280267|FG004|Treatment Period 2|Other|0|||
129812154|NCT00395304|467280268|FG005|Treatment Period 2|Other|0|||
129812155|NCT00395304|467280263|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129812156|NCT00395304|467280264|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129812157|NCT00395304|467280265|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129812158|NCT00395304|467280266|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129812159|NCT00395304|467280267|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129812160|NCT00395304|467280268|FG005|Treatment Period 3|Withdrawal by Subject|1|||
129812161|NCT00395304|467280263|FG000|Treatment Period 3|Lost to Follow-up|1|||
129812162|NCT00395304|467280264|FG001|Treatment Period 3|Lost to Follow-up|1|||
129812163|NCT00395304|467280265|FG002|Treatment Period 3|Lost to Follow-up|0|||
129812164|NCT00395304|467280266|FG003|Treatment Period 3|Lost to Follow-up|0|||
129812165|NCT00395304|467280267|FG004|Treatment Period 3|Lost to Follow-up|0|||
129812166|NCT00395304|467280268|FG005|Treatment Period 3|Lost to Follow-up|0|||
129812167|NCT00395304|467280263|FG000|Treatment Period 3|Physician Decision|0|||
129812168|NCT00395304|467280264|FG001|Treatment Period 3|Physician Decision|1|||
129812169|NCT00395304|467280265|FG002|Treatment Period 3|Physician Decision|0|||
129812170|NCT00395304|467280266|FG003|Treatment Period 3|Physician Decision|0|||
129812171|NCT00395304|467280267|FG004|Treatment Period 3|Physician Decision|0|||
129812172|NCT00395304|467280268|FG005|Treatment Period 3|Physician Decision|0|||
129812173|NCT00395304|467280263|FG000|Treatment Period 3|Other|0|||
129812174|NCT00395304|467280264|FG001|Treatment Period 3|Other|0|||
129812175|NCT00395304|467280265|FG002|Treatment Period 3|Other|0|||
129812176|NCT00395304|467280266|FG003|Treatment Period 3|Other|1|||
129812177|NCT00395304|467280267|FG004|Treatment Period 3|Other|0|||
129812178|NCT00395304|467280268|FG005|Treatment Period 3|Other|0|||
129812179|NCT01389817|467280269|FG000|Overall Study|Physician Decision|1|||
129812180|NCT01389817|467280270|FG001|Overall Study|Physician Decision|0|||
129812181|NCT01389817|467280269|FG000|Overall Study|Lost to Follow-up|1|||
129812182|NCT01389817|467280270|FG001|Overall Study|Lost to Follow-up|0|||
129812183|NCT01389817|467280269|FG000|Overall Study|Withdrawal by Subject|2|||
129812184|NCT01389817|467280270|FG001|Overall Study|Withdrawal by Subject|0|||
129812185|NCT01749137|467280271|FG000|Overall Study|Adverse Event|4|||
129812186|NCT01749137|467280272|FG001|Overall Study|Adverse Event|4|||
129812187|NCT01749137|467280271|FG000|Overall Study|Lost to Follow-up|2|||
129812188|NCT01749137|467280272|FG001|Overall Study|Lost to Follow-up|3|||
129812189|NCT01749137|467280271|FG000|Overall Study|Physician Decision|1|||
129812190|NCT01749137|467280272|FG001|Overall Study|Physician Decision|0|||
129812191|NCT01749137|467280271|FG000|Overall Study|Withdrawal by Subject|8|||
129812192|NCT01749137|467280272|FG001|Overall Study|Withdrawal by Subject|4|||
129896930|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129896931|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129757888|NCT02222558|467076241|FG003|Period 3|Withdrawal by Subject|0|||
129757889|NCT02222558|467076242|FG004|Period 3|Withdrawal by Subject|0|||
129757890|NCT02222558|467076243|FG005|Period 3|Withdrawal by Subject|1|||
129757891|NCT00936702|467076244|FG000|Overall Study|Disease progression|34|||
129757892|NCT00936702|467076244|FG000|Overall Study|Adverse Event|8|||
129757893|NCT00936702|467076244|FG000|Overall Study|Withdrawal by Subject|2|||
129812193|NCT01434667|467280280|FG000|Overall Study|Lost to Follow-up|5|||
129812194|NCT01434667|467280281|FG001|Overall Study|Lost to Follow-up|10|||
129812195|NCT00621985|467280286|FG000|Dexamethasone Admission|Adverse Event|1|||
129812196|NCT02587234|467280287|FG000|Overall Study|Withdrawal by Subject|1|||
129812197|NCT02587234|467280288|FG001|Overall Study|Withdrawal by Subject|1|||
129812198|NCT02587234|467280287|FG000|Overall Study|Lost to Follow-up|0|||
129812199|NCT02587234|467280288|FG001|Overall Study|Lost to Follow-up|2|||
129812200|NCT01877265|467280289|FG000|Treatment Period 1|Sponsor Decision|0|||
129812201|NCT01877265|467280290|FG001|Treatment Period 1|Sponsor Decision|0|||
129812202|NCT01877265|467280291|FG002|Treatment Period 1|Sponsor Decision|1|||
129812203|NCT01877265|467280292|FG003|Treatment Period 1|Sponsor Decision|0|||
129812204|NCT01877265|467280293|FG004|Treatment Period 1|Sponsor Decision|0|||
129812205|NCT01877265|467280294|FG005|Treatment Period 1|Sponsor Decision|0|||
129812206|NCT01877265|467280289|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812207|NCT01877265|467280290|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812208|NCT01877265|467280291|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812209|NCT01877265|467280292|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812210|NCT01877265|467280293|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
129812211|NCT01877265|467280294|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
129812212|NCT01877265|467280289|FG000|Treatment Period 3|Lost to Follow-up|1|||
129812213|NCT01877265|467280290|FG001|Treatment Period 3|Lost to Follow-up|0|||
129812214|NCT01877265|467280291|FG002|Treatment Period 3|Lost to Follow-up|0|||
129812215|NCT01877265|467280292|FG003|Treatment Period 3|Lost to Follow-up|0|||
129812216|NCT01877265|467280293|FG004|Treatment Period 3|Lost to Follow-up|0|||
129812217|NCT01877265|467280294|FG005|Treatment Period 3|Lost to Follow-up|0|||
129812218|NCT03068130|467280297|FG000|Overall Study|Adverse Event|19|||
129812219|NCT03068130|467280297|FG000|Overall Study|Death|14|||
129812220|NCT03068130|467280297|FG000|Overall Study|Lost to Follow-up|4|||
129812221|NCT03068130|467280297|FG000|Overall Study|Withdrawal by Subject|26|||
129812222|NCT03068130|467280297|FG000|Overall Study|Administrative Reasons|3|||
129812223|NCT03068130|467280297|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
129812224|NCT03068130|467280297|FG000|Overall Study|Study terminated by sponsor|194|||
129812225|NCT03535844|467280302|FG000|Overall Study|Withdrawal by Subject|0|||
129812226|NCT03535844|467280303|FG001|Overall Study|Withdrawal by Subject|1|||
129812227|NCT03130257|467280304|FG000|Overall Study|Withdrawal by Subject|1|||
129812228|NCT03130257|467280305|FG001|Overall Study|Withdrawal by Subject|0|||
129812229|NCT03130257|467280306|FG002|Overall Study|Withdrawal by Subject|2|||
129812230|NCT00160693|467280308|FG000|Overall Study|Adverse Event|97|||
129812231|NCT00160693|467280308|FG000|Overall Study|Lack of Efficacy|30|||
129812232|NCT00160693|467280308|FG000|Overall Study|Protocol Violation|24|||
129812233|NCT00160693|467280308|FG000|Overall Study|Lost to Follow-up|15|||
129812234|NCT00160693|467280308|FG000|Overall Study|Withdrawal by Subject|54|||
129812235|NCT00160693|467280308|FG000|Overall Study|Study terminated by sponsor|15|||
129812236|NCT03039283|467280311|FG000|Overall Study|Protocol Violation|2|||
129812237|NCT01867424|467280312|FG000|Overall Study|Patient noncompliance|2|||
129812238|NCT01867424|467280313|FG001|Overall Study|Patient noncompliance|1|||
129812239|NCT01056653|467280314|FG000|Overall Study|Lost to Follow-up|0|||
129812240|NCT01056653|467280315|FG001|Overall Study|Lost to Follow-up|0|||
129812241|NCT01056653|467280316|FG002|Overall Study|Lost to Follow-up|2|||
129812242|NCT05386680|467280317|FG000|Overall Study|Guardian decision|2|||
129812243|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
129812244|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
129812245|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
129812246|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
129812247|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812248|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812249|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812250|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812251|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812252|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812253|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
129812254|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
129812255|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
129812256|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
129812257|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
129812258|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812259|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812260|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812261|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812262|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812263|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129896932|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129757894|NCT00936702|467076244|FG000|Overall Study|Alternative Treatment|1|||
129757895|NCT00936702|467076244|FG000|Overall Study|Other|1|||
129757896|NCT02532465|467076245|FG000|Overall Study|Protocol Violation|1|||
129757897|NCT02532465|467076246|FG001|Overall Study|Protocol Violation|0|||
129757898|NCT02532465|467076245|FG000|Overall Study|Lack of Efficacy|0|||
129757899|NCT02532465|467076246|FG001|Overall Study|Lack of Efficacy|1|||
129757900|NCT00354679|467076251|FG000|Overall Study|Patient Not Treated|1|||
129757901|NCT00622505|467076253|FG000|Overall Study|Adverse Event|9|||
129757902|NCT00622505|467076254|FG001|Overall Study|Adverse Event|7|||
129757903|NCT00622505|467076253|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
129757904|NCT00622505|467076254|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
129757905|NCT00622505|467076253|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129757906|NCT00622505|467076254|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129757907|NCT00622505|467076253|FG000|Overall Study|Withdrawal by Subject|12|||
129757908|NCT00622505|467076254|FG001|Overall Study|Withdrawal by Subject|5|||
129757909|NCT00622505|467076253|FG000|Overall Study|Administrative Problems|2|||
129757910|NCT00622505|467076254|FG001|Overall Study|Administrative Problems|4|||
129757911|NCT00622505|467076253|FG000|Overall Study|Death|2|||
129757912|NCT00622505|467076254|FG001|Overall Study|Death|2|||
129757913|NCT02420093|467076257|FG000|Overall Study|Withdrawal by Subject|1|||
129757914|NCT02420093|467076258|FG001|Overall Study|Withdrawal by Subject|1|||
129757915|NCT03244917|467076261|FG000|Overall Study|Lost to Follow-up|2|||
129757916|NCT03244917|467076262|FG001|Overall Study|Lost to Follow-up|2|||
129757917|NCT02159066|467076265|FG000|Part I|Adverse Event|7|||
129757918|NCT02159066|467076266|FG001|Part I|Adverse Event|5|||
129757919|NCT02159066|467076267|FG002|Part I|Adverse Event|0|||
129757920|NCT02159066|467076268|FG003|Part I|Adverse Event|0|||
129757921|NCT02159066|467076269|FG004|Part I|Adverse Event|0|||
129757922|NCT02159066|467076270|FG005|Part I|Adverse Event|0|||
129757923|NCT02159066|467076265|FG000|Part I|Death|11|||
129757924|NCT02159066|467076266|FG001|Part I|Death|9|||
129757925|NCT02159066|467076267|FG002|Part I|Death|0|||
129757926|NCT02159066|467076268|FG003|Part I|Death|0|||
129757927|NCT02159066|467076269|FG004|Part I|Death|0|||
129757928|NCT02159066|467076270|FG005|Part I|Death|0|||
129757929|NCT02159066|467076265|FG000|Part I|Progressive Disease|37|||
129757930|NCT02159066|467076266|FG001|Part I|Progressive Disease|46|||
129757931|NCT02159066|467076267|FG002|Part I|Progressive Disease|0|||
129757932|NCT02159066|467076268|FG003|Part I|Progressive Disease|0|||
129757933|NCT02159066|467076269|FG004|Part I|Progressive Disease|0|||
129757934|NCT02159066|467076270|FG005|Part I|Progressive Disease|0|||
129757935|NCT02159066|467076265|FG000|Part I|New Therapy for Study Indication|5|||
129757936|NCT02159066|467076266|FG001|Part I|New Therapy for Study Indication|4|||
129812264|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
129812265|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
129812266|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
129812267|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
129812268|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
129812269|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812270|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812271|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812272|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812273|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812274|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812275|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
129812276|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129757937|NCT02159066|467076267|FG002|Part I|New Therapy for Study Indication|0|||
129757938|NCT02159066|467076268|FG003|Part I|New Therapy for Study Indication|0|||
129757939|NCT02159066|467076269|FG004|Part I|New Therapy for Study Indication|0|||
129757940|NCT02159066|467076270|FG005|Part I|New Therapy for Study Indication|0|||
129757941|NCT02159066|467076265|FG000|Part I|Termination of participants from the study|3|||
129757942|NCT02159066|467076266|FG001|Part I|Termination of participants from the study|3|||
129757943|NCT02159066|467076267|FG002|Part I|Termination of participants from the study|0|||
129812277|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129757944|NCT02159066|467076268|FG003|Part I|Termination of participants from the study|0|||
129757945|NCT02159066|467076269|FG004|Part I|Termination of participants from the study|0|||
129757946|NCT02159066|467076270|FG005|Part I|Termination of participants from the study|0|||
129757947|NCT02159066|467076265|FG000|Part I|Physician Decision|2|||
129757948|NCT02159066|467076266|FG001|Part I|Physician Decision|9|||
129757949|NCT02159066|467076267|FG002|Part I|Physician Decision|0|||
129757950|NCT02159066|467076268|FG003|Part I|Physician Decision|0|||
129757951|NCT02159066|467076269|FG004|Part I|Physician Decision|0|||
129757952|NCT02159066|467076270|FG005|Part I|Physician Decision|0|||
129757953|NCT02159066|467076265|FG000|Part I|Participant/Guardian Decision|9|||
129757954|NCT02159066|467076266|FG001|Part I|Participant/Guardian Decision|3|||
129757955|NCT02159066|467076267|FG002|Part I|Participant/Guardian Decision|0|||
129757956|NCT02159066|467076268|FG003|Part I|Participant/Guardian Decision|0|||
129757957|NCT02159066|467076269|FG004|Part I|Participant/Guardian Decision|0|||
129757958|NCT02159066|467076270|FG005|Part I|Participant/Guardian Decision|0|||
129757959|NCT02159066|467076265|FG000|Part I|Missing Data|1|||
129757960|NCT02159066|467076266|FG001|Part I|Missing Data|0|||
129757961|NCT02159066|467076267|FG002|Part I|Missing Data|0|||
129757962|NCT02159066|467076268|FG003|Part I|Missing Data|0|||
129757963|NCT02159066|467076269|FG004|Part I|Missing Data|0|||
129757964|NCT02159066|467076270|FG005|Part I|Missing Data|0|||
129757965|NCT02159066|467076265|FG000|Part II|Adverse Event|0|||
129757966|NCT02159066|467076266|FG001|Part II|Adverse Event|0|||
129757967|NCT02159066|467076267|FG002|Part II|Adverse Event|1|||
129757968|NCT02159066|467076268|FG003|Part II|Adverse Event|0|||
129757969|NCT02159066|467076269|FG004|Part II|Adverse Event|1|||
129757970|NCT02159066|467076270|FG005|Part II|Adverse Event|1|||
129757971|NCT02159066|467076265|FG000|Part II|Death|0|||
129757972|NCT02159066|467076266|FG001|Part II|Death|0|||
129757973|NCT02159066|467076267|FG002|Part II|Death|1|||
129757974|NCT02159066|467076268|FG003|Part II|Death|0|||
129757975|NCT02159066|467076269|FG004|Part II|Death|2|||
129757976|NCT02159066|467076270|FG005|Part II|Death|1|||
129757977|NCT02159066|467076265|FG000|Part II|Progressive Disease|0|||
129757978|NCT02159066|467076266|FG001|Part II|Progressive Disease|0|||
129757979|NCT02159066|467076267|FG002|Part II|Progressive Disease|35|||
129757980|NCT02159066|467076268|FG003|Part II|Progressive Disease|1|||
129757981|NCT02159066|467076269|FG004|Part II|Progressive Disease|7|||
129757982|NCT02159066|467076270|FG005|Part II|Progressive Disease|4|||
129757983|NCT02159066|467076265|FG000|Part II|New Therapy for Study Indication|0|||
129757984|NCT02159066|467076266|FG001|Part II|New Therapy for Study Indication|0|||
129757985|NCT02159066|467076267|FG002|Part II|New Therapy for Study Indication|0|||
129757986|NCT02159066|467076268|FG003|Part II|New Therapy for Study Indication|0|||
129757987|NCT02159066|467076269|FG004|Part II|New Therapy for Study Indication|1|||
129757988|NCT02159066|467076270|FG005|Part II|New Therapy for Study Indication|0|||
129757989|NCT02159066|467076265|FG000|Part II|Physician Decision|0|||
129757990|NCT02159066|467076266|FG001|Part II|Physician Decision|0|||
129757991|NCT02159066|467076267|FG002|Part II|Physician Decision|1|||
129757992|NCT02159066|467076268|FG003|Part II|Physician Decision|0|||
129757993|NCT02159066|467076269|FG004|Part II|Physician Decision|0|||
129757994|NCT02159066|467076270|FG005|Part II|Physician Decision|0|||
129757995|NCT02159066|467076265|FG000|Part II|Participant/Guardian Decision|0|||
129757996|NCT02159066|467076266|FG001|Part II|Participant/Guardian Decision|0|||
129757997|NCT02159066|467076267|FG002|Part II|Participant/Guardian Decision|0|||
129757998|NCT02159066|467076268|FG003|Part II|Participant/Guardian Decision|0|||
129757999|NCT02159066|467076269|FG004|Part II|Participant/Guardian Decision|2|||
129758000|NCT02159066|467076270|FG005|Part II|Participant/Guardian Decision|0|||
129758001|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129758002|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129758003|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129758004|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758005|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758006|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758007|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758008|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758009|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758010|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758011|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758012|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758013|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
129758014|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758015|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
129758016|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758017|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129758018|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758019|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758020|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
129758021|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129758022|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
129758023|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
129758024|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758025|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129758026|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758027|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758028|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
129758029|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
129758030|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
129758031|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
129758032|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
129758033|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
129758034|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
129758035|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
129758036|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
129758037|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
129758038|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
129758039|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
129758040|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
129758041|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
129758042|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
129758043|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
129758044|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
129758045|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
129758046|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
129758047|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758048|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758049|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
129758050|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758051|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758052|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758053|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758054|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758055|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758056|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
129758057|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758058|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758059|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758060|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
129758061|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758062|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758063|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758064|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758065|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129758066|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129758067|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758068|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129758069|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758070|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129758071|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758072|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129758073|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758074|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
129758075|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
129758076|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758077|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758078|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758079|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
129758080|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758081|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758082|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758083|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758084|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758085|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758086|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
129758087|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758088|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758089|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129758090|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
129896933|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129812278|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812279|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
129812280|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812281|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812282|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812283|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812284|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812285|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812286|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
129812287|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
129812288|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
129812289|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
129812290|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
129812291|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812292|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812293|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812294|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812295|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812296|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812297|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
129812298|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
129812299|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
129812300|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
129812301|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
129812302|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812303|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812304|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812305|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812306|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812307|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812308|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
129812309|NCT01847274|467280318|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
129812310|NCT01847274|467280319|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
129812311|NCT01847274|467280320|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
129812312|NCT01847274|467280321|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
129812313|NCT01847274|467280322|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129758091|NCT01147666|467076271|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758092|NCT01147666|467076272|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758093|NCT01147666|467076273|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758094|NCT01147666|467076274|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758095|NCT01147666|467076275|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758096|NCT01147666|467076276|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758097|NCT01147666|467076277|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758098|NCT01147666|467076278|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758099|NCT01147666|467076279|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758100|NCT01147666|467076280|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758101|NCT01147666|467076281|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758102|NCT01147666|467076282|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
129758103|NCT01147666|467076283|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
129758104|NCT01147666|467076284|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
129758105|NCT01147666|467076285|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
129758106|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
129758107|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
129758108|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
129758109|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
129758110|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
129758111|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
129758112|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
129758113|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
129758114|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
129758115|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
129758116|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
129812314|NCT01847274|467280323|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812315|NCT01847274|467280324|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812316|NCT01847274|467280325|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129758117|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
129758118|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
129758119|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
129758120|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
129758121|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758122|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758123|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758124|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758125|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
129758126|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
129758127|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
129758128|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
129758129|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758130|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
129758131|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758132|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758133|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
129758134|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
129758135|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
129758136|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758137|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758138|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758139|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
129758140|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758141|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758142|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758143|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758144|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758145|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758146|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758147|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758148|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758149|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758150|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
129758151|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758152|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758153|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758154|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758155|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129758156|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129758157|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758158|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129758159|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758160|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129758161|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758162|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758163|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758164|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
129758165|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
129758166|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758167|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758168|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758169|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
129758170|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758171|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758172|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758173|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758174|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758175|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758176|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
129758177|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129812317|NCT01847274|467280326|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812318|NCT01847274|467280327|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129812319|NCT01847274|467280328|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
129758178|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758179|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758180|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
129758181|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758182|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758183|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758184|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758185|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758186|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758187|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758188|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758189|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758190|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758191|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758192|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758193|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
129758194|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758195|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
129758196|NCT01147666|467076271|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758197|NCT01147666|467076272|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758198|NCT01147666|467076273|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758199|NCT01147666|467076274|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758200|NCT01147666|467076275|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758201|NCT01147666|467076276|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758202|NCT01147666|467076277|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758203|NCT01147666|467076278|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758204|NCT01147666|467076279|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758205|NCT01147666|467076280|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758206|NCT01147666|467076281|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758207|NCT01147666|467076282|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758208|NCT01147666|467076283|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
129758209|NCT01147666|467076284|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
129758210|NCT01147666|467076285|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
129758211|NCT00296816|467076301|FG000|Overall Study|Disease Progression|37|||
129758212|NCT00296816|467076301|FG000|Overall Study|Adverse Event|18|||
129758213|NCT00296816|467076301|FG000|Overall Study|Investigator/Participant request|5|||
129758214|NCT00296816|467076301|FG000|Overall Study|Non-compliance|1|||
129758215|NCT00296816|467076301|FG000|Overall Study|Missing for end of treatment|4|||
129758216|NCT00296816|467076301|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
129758217|NCT00296816|467076301|FG000|Overall Study|Poor performance status|1|||
129758218|NCT00296816|467076301|FG000|Overall Study|Relocation to Florida|1|||
129758219|NCT00296816|467076301|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
129758220|NCT00296816|467076301|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
129758221|NCT00296816|467076301|FG000|Overall Study|Neuropathy/patient preference|1|||
129758222|NCT00296816|467076301|FG000|Overall Study|Proteinuria|1|||
129758223|NCT00296816|467076301|FG000|Overall Study|ineligibility due to radiation treatment|1|||
129758224|NCT01721161|467076303|FG000|Overall Study|Adverse Event|2|||
129758225|NCT01721161|467076304|FG001|Overall Study|Adverse Event|3|||
129758226|NCT01721161|467076303|FG000|Overall Study|Lost to Follow-up|1|||
129758227|NCT01721161|467076304|FG001|Overall Study|Lost to Follow-up|2|||
129758228|NCT01721161|467076303|FG000|Overall Study|Withdrawal by Subject|1|||
129758229|NCT01721161|467076304|FG001|Overall Study|Withdrawal by Subject|1|||
129758230|NCT01721161|467076303|FG000|Overall Study|Other|0|||
129758231|NCT01721161|467076304|FG001|Overall Study|Other|1|||
129758232|NCT03259555|467076322|FG000|Overall Study|Adverse Event|6|||
129758233|NCT03259555|467076323|FG001|Overall Study|Adverse Event|4|||
129812320|NCT01847274|467280318|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129758234|NCT03259555|467076322|FG000|Overall Study|Lack of Efficacy|6|||
129758235|NCT03259555|467076323|FG001|Overall Study|Lack of Efficacy|4|||
129758236|NCT03259555|467076322|FG000|Overall Study|Lost to Follow-up|0|||
129758237|NCT03259555|467076323|FG001|Overall Study|Lost to Follow-up|2|||
129758238|NCT03259555|467076322|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129758239|NCT03259555|467076323|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129758240|NCT03259555|467076322|FG000|Overall Study|Progressive Disease|0|||
129758241|NCT03259555|467076323|FG001|Overall Study|Progressive Disease|2|||
129758242|NCT03259555|467076322|FG000|Overall Study|Withdrawal by Subject|19|||
129758243|NCT03259555|467076323|FG001|Overall Study|Withdrawal by Subject|16|||
129758244|NCT03259555|467076322|FG000|Overall Study|Physician Decision|1|||
129812321|NCT01847274|467280319|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812322|NCT01847274|467280320|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129758245|NCT03259555|467076323|FG001|Overall Study|Physician Decision|2|||
129758246|NCT03259555|467076322|FG000|Overall Study|Other|1|||
129758247|NCT03259555|467076323|FG001|Overall Study|Other|0|||
129758248|NCT04393493|467076325|FG000|First 4 Days of Intervention|Early improvement|5|||
129758249|NCT04393493|467076326|FG001|First 4 Days of Intervention|Early improvement|7|||
129758250|NCT01125800|467076327|FG000|Phase I|Protocol Violation|0|||
129758251|NCT01125800|467076328|FG001|Phase I|Protocol Violation|3|||
129758252|NCT01125800|467076329|FG002|Phase I|Protocol Violation|1|||
129758253|NCT01125800|467076330|FG003|Phase I|Protocol Violation|1|||
129758254|NCT01125800|467076331|FG004|Phase I|Protocol Violation|0|||
129758255|NCT01125800|467076327|FG000|Phase I|Adverse Event|2|||
129758256|NCT01125800|467076328|FG001|Phase I|Adverse Event|2|||
129758257|NCT01125800|467076329|FG002|Phase I|Adverse Event|1|||
129758258|NCT01125800|467076330|FG003|Phase I|Adverse Event|7|||
129758259|NCT01125800|467076331|FG004|Phase I|Adverse Event|0|||
129758260|NCT01125800|467076327|FG000|Phase I|Administrative problems|1|||
129758261|NCT01125800|467076328|FG001|Phase I|Administrative problems|0|||
129758262|NCT01125800|467076329|FG002|Phase I|Administrative problems|0|||
129758263|NCT01125800|467076330|FG003|Phase I|Administrative problems|0|||
129758264|NCT01125800|467076331|FG004|Phase I|Administrative problems|0|||
129758265|NCT01125800|467076327|FG000|Phase I|Withdrawal by Subject|0|||
129758266|NCT01125800|467076328|FG001|Phase I|Withdrawal by Subject|0|||
129758267|NCT01125800|467076329|FG002|Phase I|Withdrawal by Subject|1|||
129758268|NCT01125800|467076330|FG003|Phase I|Withdrawal by Subject|0|||
129758269|NCT01125800|467076331|FG004|Phase I|Withdrawal by Subject|0|||
129758270|NCT01125800|467076327|FG000|Phase I|Disease progression|5|||
129758271|NCT01125800|467076328|FG001|Phase I|Disease progression|4|||
129758272|NCT01125800|467076329|FG002|Phase I|Disease progression|1|||
129758273|NCT01125800|467076330|FG003|Phase I|Disease progression|3|||
129758274|NCT01125800|467076331|FG004|Phase I|Disease progression|0|||
129758275|NCT01125800|467076327|FG000|Phase II|Protocol Violation|0|||
129758276|NCT01125800|467076328|FG001|Phase II|Protocol Violation|0|||
129758277|NCT01125800|467076329|FG002|Phase II|Protocol Violation|0|||
129758278|NCT01125800|467076330|FG003|Phase II|Protocol Violation|0|||
129758279|NCT01125800|467076331|FG004|Phase II|Protocol Violation|1|||
129758280|NCT01125800|467076327|FG000|Phase II|Adverse Event|0|||
129758281|NCT01125800|467076328|FG001|Phase II|Adverse Event|0|||
129758282|NCT01125800|467076329|FG002|Phase II|Adverse Event|0|||
129758283|NCT01125800|467076330|FG003|Phase II|Adverse Event|0|||
129758284|NCT01125800|467076331|FG004|Phase II|Adverse Event|2|||
129758285|NCT01125800|467076327|FG000|Phase II|Disease progression|0|||
129758286|NCT01125800|467076328|FG001|Phase II|Disease progression|0|||
129758287|NCT01125800|467076329|FG002|Phase II|Disease progression|0|||
129758288|NCT01125800|467076330|FG003|Phase II|Disease progression|1|||
129758289|NCT01125800|467076331|FG004|Phase II|Disease progression|8|||
129758290|NCT03370718|467076336|FG000|Overall Study|Withdrawal by Subject|1|||
129758291|NCT04970654|467076339|FG000|Overall Study|Withdrawal by parents/guardian|1|||
129758292|NCT04970654|467076340|FG001|Overall Study|Withdrawal by parents/guardian|2|||
129758293|NCT04970654|467076339|FG000|Overall Study|Unclassified|2|||
129758294|NCT04970654|467076340|FG001|Overall Study|Unclassified|1|||
129758295|NCT04970654|467076339|FG000|Overall Study|Lost to Follow-up|1|||
129758296|NCT04970654|467076340|FG001|Overall Study|Lost to Follow-up|0|||
129758297|NCT01572480|467076343|FG000|Participants Enrolled|Withdrawal by Subject|1|||
129758298|NCT01572480|467076343|FG000|Drug Administration|Discontinued drug/Off Study|1|||
129758299|NCT01572480|467076343|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
129758300|NCT01572480|467076343|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
129812323|NCT01847274|467280321|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812324|NCT01847274|467280322|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129758301|NCT06172348|467076344|FG000|Treatment Period 2|Adverse Event|0|||
129758302|NCT06172348|467076345|FG001|Treatment Period 2|Adverse Event|0|||
129758303|NCT06172348|467076346|FG002|Treatment Period 2|Adverse Event|1|||
129758304|NCT06172348|467076347|FG003|Treatment Period 2|Adverse Event|0|||
129758305|NCT06172348|467076348|FG004|Treatment Period 2|Adverse Event|0|||
129758306|NCT06172348|467076349|FG005|Treatment Period 2|Adverse Event|0|||
129758307|NCT02544321|467078581|FG000|Overall Study|Withdrawal by Subject|1|||
129758308|NCT02544321|467078582|FG001|Overall Study|Withdrawal by Subject|2|||
129758309|NCT02544321|467078581|FG000|Overall Study|Adverse Event|1|||
129758310|NCT02544321|467078582|FG001|Overall Study|Adverse Event|1|||
129758311|NCT02544321|467078581|FG000|Overall Study|Protocol Violation|0|||
129812325|NCT01847274|467280323|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
129758312|NCT02544321|467078582|FG001|Overall Study|Protocol Violation|1|||
129758313|NCT01517750|467078583|FG000|Overall Study|Lost to Follow-up|1|||
129758314|NCT01517750|467078584|FG001|Overall Study|Lost to Follow-up|2|||
129758315|NCT01517750|467078585|FG002|Overall Study|Lost to Follow-up|4|||
129758316|NCT01517750|467078586|FG003|Overall Study|Lost to Follow-up|1|||
129758317|NCT01584232|467078587|FG000|Overall Study|Adverse Event|3|||
129812326|NCT01847274|467280324|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129758318|NCT01584232|467078588|FG001|Overall Study|Adverse Event|1|||
129758319|NCT01584232|467078587|FG000|Overall Study|Withdrawal by Subject|2|||
129758320|NCT01584232|467078588|FG001|Overall Study|Withdrawal by Subject|1|||
129758321|NCT01584232|467078587|FG000|Overall Study|Physician Decision|2|||
129758322|NCT01584232|467078588|FG001|Overall Study|Physician Decision|1|||
129758323|NCT01584232|467078587|FG000|Overall Study|Lost to Follow-up|1|||
129758324|NCT01584232|467078588|FG001|Overall Study|Lost to Follow-up|0|||
129758325|NCT01307319|467078589|FG000|Overall Study|Adverse Event|2|||
129758326|NCT01307319|467078590|FG001|Overall Study|Adverse Event|2|||
129758327|NCT01307319|467078591|FG002|Overall Study|Adverse Event|1|||
129758328|NCT01307319|467078589|FG000|Overall Study|Lost to Follow-up|1|||
129758329|NCT01307319|467078590|FG001|Overall Study|Lost to Follow-up|0|||
129758330|NCT01307319|467078591|FG002|Overall Study|Lost to Follow-up|1|||
129758331|NCT01307319|467078589|FG000|Overall Study|Protocol Violation|1|||
129758332|NCT01307319|467078590|FG001|Overall Study|Protocol Violation|1|||
129758333|NCT01307319|467078591|FG002|Overall Study|Protocol Violation|0|||
129758334|NCT01307319|467078589|FG000|Overall Study|Withdrawal by Subject|0|||
129758335|NCT01307319|467078590|FG001|Overall Study|Withdrawal by Subject|1|||
129758336|NCT01307319|467078591|FG002|Overall Study|Withdrawal by Subject|2|||
129758337|NCT01307319|467078589|FG000|Overall Study|Other|0|||
129758338|NCT01307319|467078590|FG001|Overall Study|Other|4|||
129758339|NCT01307319|467078591|FG002|Overall Study|Other|3|||
129758340|NCT02723773|467078593|FG000|Overall Study|Adverse Event|934|||
129758341|NCT02723773|467078594|FG001|Overall Study|Adverse Event|3|||
129758342|NCT02723773|467078595|FG002|Overall Study|Adverse Event|1|||
129758343|NCT02723773|467078596|FG003|Overall Study|Adverse Event|9|||
129758344|NCT02723773|467078593|FG000|Overall Study|Protocol Violation|1|||
129758345|NCT02723773|467078594|FG001|Overall Study|Protocol Violation|0|||
129758346|NCT02723773|467078595|FG002|Overall Study|Protocol Violation|0|||
129758347|NCT02723773|467078596|FG003|Overall Study|Protocol Violation|0|||
129758348|NCT02723773|467078593|FG000|Overall Study|Withdrawal by Subject|360|||
129758349|NCT02723773|467078594|FG001|Overall Study|Withdrawal by Subject|5|||
129758350|NCT02723773|467078595|FG002|Overall Study|Withdrawal by Subject|6|||
129758351|NCT02723773|467078596|FG003|Overall Study|Withdrawal by Subject|10|||
129758352|NCT02723773|467078593|FG000|Overall Study|Migrated/moved from study area|37|||
129758353|NCT02723773|467078594|FG001|Overall Study|Migrated/moved from study area|0|||
129758354|NCT02723773|467078595|FG002|Overall Study|Migrated/moved from study area|0|||
129758355|NCT02723773|467078596|FG003|Overall Study|Migrated/moved from study area|1|||
129758356|NCT02723773|467078593|FG000|Overall Study|Lost to Follow-up|198|||
129758357|NCT02723773|467078594|FG001|Overall Study|Lost to Follow-up|0|||
129758358|NCT02723773|467078595|FG002|Overall Study|Lost to Follow-up|0|||
129758359|NCT02723773|467078596|FG003|Overall Study|Lost to Follow-up|0|||
129758360|NCT02723773|467078593|FG000|Overall Study|Other|189|||
129758361|NCT02723773|467078594|FG001|Overall Study|Other|1|||
129758362|NCT02723773|467078595|FG002|Overall Study|Other|2|||
129758363|NCT02723773|467078596|FG003|Overall Study|Other|2|||
129758364|NCT03629886|467078597|FG000|Overall Study|Migrated / moved from the study area|0|||
129758365|NCT03629886|467078598|FG001|Overall Study|Migrated / moved from the study area|55|||
129758366|NCT03629886|467078597|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
129758367|NCT03629886|467078598|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
129758368|NCT03629886|467078597|FG000|Overall Study|Study vaccine not administrated|0|||
129758369|NCT03629886|467078598|FG001|Overall Study|Study vaccine not administrated|3|||
129758370|NCT03629886|467078597|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
129758371|NCT03629886|467078598|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
129758372|NCT03629886|467078597|FG000|Overall Study|Refused vaccination step of the study|0|||
129758373|NCT03629886|467078598|FG001|Overall Study|Refused vaccination step of the study|44|||
129758374|NCT02730728|467078599|FG000|Overall Study|Withdrawal by Subject|0|||
129812327|NCT01847274|467280325|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812328|NCT01847274|467280326|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812329|NCT01847274|467280327|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812330|NCT01847274|467280328|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
129812331|NCT01847274|467280318|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812332|NCT01847274|467280319|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812333|NCT01847274|467280320|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812334|NCT01847274|467280321|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812335|NCT01847274|467280322|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
129812336|NCT01847274|467280323|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812337|NCT01847274|467280324|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129758375|NCT02730728|467078600|FG001|Overall Study|Withdrawal by Subject|1|||
129758376|NCT02730728|467078601|FG002|Overall Study|Withdrawal by Subject|0|||
129758377|NCT02730728|467078599|FG000|Overall Study|Lack of Efficacy|0|||
129758378|NCT02730728|467078600|FG001|Overall Study|Lack of Efficacy|1|||
129758379|NCT02730728|467078601|FG002|Overall Study|Lack of Efficacy|1|||
129758380|NCT01855412|467078602|FG000|Overall Study|Death|77|||
129758381|NCT01855412|467078603|FG001|Overall Study|Death|123|||
129758382|NCT01855412|467078604|FG002|Overall Study|Death|30|||
129758383|NCT01855412|467078602|FG000|Overall Study|Lost to Follow-up|28|||
129896934|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
129758384|NCT01855412|467078603|FG001|Overall Study|Lost to Follow-up|46|||
129758385|NCT01855412|467078604|FG002|Overall Study|Lost to Follow-up|15|||
129758386|NCT01855412|467078602|FG000|Overall Study|Withdrawal by Subject|77|||
129758387|NCT01855412|467078603|FG001|Overall Study|Withdrawal by Subject|123|||
129758388|NCT01855412|467078604|FG002|Overall Study|Withdrawal by Subject|24|||
129758389|NCT01855412|467078602|FG000|Overall Study|Physician Decision|25|||
129758390|NCT01855412|467078603|FG001|Overall Study|Physician Decision|31|||
129758391|NCT01855412|467078604|FG002|Overall Study|Physician Decision|3|||
129758392|NCT01855412|467078602|FG000|Overall Study|Site Closure|4|||
129758393|NCT01855412|467078603|FG001|Overall Study|Site Closure|18|||
129758394|NCT01855412|467078604|FG002|Overall Study|Site Closure|1|||
129758395|NCT01855412|467078602|FG000|Overall Study|Reason not Specified|1|||
129758396|NCT01855412|467078603|FG001|Overall Study|Reason not Specified|2|||
129758397|NCT01855412|467078604|FG002|Overall Study|Reason not Specified|3|||
129758398|NCT01702844|467078605|FG000|Overall Study|Adverse Event|9|||
129758399|NCT01702844|467078605|FG000|Overall Study|Death|1|||
129758400|NCT01702844|467078605|FG000|Overall Study|Withdrawal by Subject|3|||
129758401|NCT01702844|467078605|FG000|Overall Study|Physician Decision|6|||
129758402|NCT03431441|467078606|FG000|Overall Study|Withdrawal by Subject|2|||
129758403|NCT03431441|467078606|FG000|Overall Study|Adverse Event|2|||
129758404|NCT03431441|467078606|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
129758405|NCT00346216|467078607|FG000|Overall Study|Other|181|||
129758406|NCT00346216|467078608|FG001|Overall Study|Other|231|||
129758407|NCT00346216|467078609|FG002|Overall Study|Other|205|||
129758408|NCT00346216|467078607|FG000|Overall Study|No longer willing to participate|600|||
129758409|NCT00346216|467078608|FG001|Overall Study|No longer willing to participate|606|||
129758410|NCT00346216|467078609|FG002|Overall Study|No longer willing to participate|585|||
129758411|NCT00346216|467078607|FG000|Overall Study|Withdrawal by Subject|661|||
129758412|NCT00346216|467078608|FG001|Overall Study|Withdrawal by Subject|692|||
129758413|NCT00346216|467078609|FG002|Overall Study|Withdrawal by Subject|651|||
129758414|NCT00346216|467078607|FG000|Overall Study|Lost to Follow-up|611|||
129758415|NCT00346216|467078608|FG001|Overall Study|Lost to Follow-up|588|||
129758416|NCT00346216|467078609|FG002|Overall Study|Lost to Follow-up|542|||
129758417|NCT00346216|467078607|FG000|Overall Study|Physician Decision|80|||
129758418|NCT00346216|467078608|FG001|Overall Study|Physician Decision|76|||
129758419|NCT00346216|467078609|FG002|Overall Study|Physician Decision|59|||
129758420|NCT00346216|467078607|FG000|Overall Study|Does not meet entrance criteria|13|||
129758421|NCT00346216|467078608|FG001|Overall Study|Does not meet entrance criteria|10|||
129758422|NCT00346216|467078609|FG002|Overall Study|Does not meet entrance criteria|8|||
129758423|NCT00346216|467078607|FG000|Overall Study|Death|189|||
129758424|NCT00346216|467078608|FG001|Overall Study|Death|192|||
129758425|NCT00346216|467078609|FG002|Overall Study|Death|228|||
129758426|NCT00346216|467078607|FG000|Overall Study|Study terminated by sponsor|11|||
129758427|NCT00346216|467078608|FG001|Overall Study|Study terminated by sponsor|4|||
129758428|NCT00346216|467078609|FG002|Overall Study|Study terminated by sponsor|8|||
129758429|NCT00346216|467078607|FG000|Overall Study|Missing Subject Summary Status|62|||
129758430|NCT00346216|467078608|FG001|Overall Study|Missing Subject Summary Status|61|||
129758431|NCT00346216|467078609|FG002|Overall Study|Missing Subject Summary Status|62|||
129758432|NCT02043938|467078615|FG000|Overall Study|Withdrawal by Subject|7|||
129758433|NCT02043938|467078615|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
129758434|NCT02043938|467078615|FG000|Overall Study|No show by subject|1|||
129758435|NCT02043938|467078615|FG000|Overall Study|Investigator decision|1|||
129758436|NCT03985761|467078622|FG000|Overall Study|Withdrawal by Subject|2|||
129758437|NCT03985761|467078623|FG001|Overall Study|Withdrawal by Subject|3|||
129758438|NCT03400852|467078624|FG000|Blinded Treatment Period|Physician Decision|0|||
129758439|NCT03400852|467078625|FG001|Blinded Treatment Period|Physician Decision|1|||
129758440|NCT03400852|467078626|FG002|Blinded Treatment Period|Physician Decision|0|||
129758441|NCT03400852|467078624|FG000|Blinded Treatment Period|Adverse Event|1|||
129758442|NCT03400852|467078625|FG001|Blinded Treatment Period|Adverse Event|1|||
129758443|NCT03400852|467078626|FG002|Blinded Treatment Period|Adverse Event|0|||
129758444|NCT03400852|467078624|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
129758445|NCT03400852|467078625|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
129758446|NCT03400852|467078626|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
129758447|NCT03400852|467078624|FG000|Open Label Period|Physician Decision|0|||
129758448|NCT03400852|467078625|FG001|Open Label Period|Physician Decision|0|||
129758449|NCT03400852|467078626|FG002|Open Label Period|Physician Decision|1|||
129758450|NCT03400852|467078624|FG000|Open Label Period|Study terminated by sponsor|0|||
129758451|NCT03400852|467078625|FG001|Open Label Period|Study terminated by sponsor|0|||
129758452|NCT03400852|467078626|FG002|Open Label Period|Study terminated by sponsor|21|||
129758453|NCT00248495|467078627|FG000|Overall Study|Withdrawal by Subject|1|||
129758454|NCT03812380|467078628|FG000|Overall Study|Protocol Violation|3|||
129758455|NCT03812380|467078629|FG001|Overall Study|Protocol Violation|3|||
129758456|NCT03812380|467078628|FG000|Overall Study|Withdrawal by Subject|5|||
129758457|NCT03812380|467078629|FG001|Overall Study|Withdrawal by Subject|4|||
129758458|NCT03812380|467078628|FG000|Overall Study|Early termination of study|14|||
129758459|NCT03812380|467078629|FG001|Overall Study|Early termination of study|14|||
129758460|NCT02648204|467078630|FG000|Overall Study|Withdrawal by Subject|12|||
129758461|NCT02648204|467078631|FG001|Overall Study|Withdrawal by Subject|8|||
129758462|NCT02648204|467078632|FG002|Overall Study|Withdrawal by Subject|2|||
129758463|NCT02648204|467078633|FG003|Overall Study|Withdrawal by Subject|6|||
129758464|NCT02648204|467078630|FG000|Overall Study|Lost to Follow-up|5|||
129758465|NCT02648204|467078631|FG001|Overall Study|Lost to Follow-up|8|||
129758466|NCT02648204|467078632|FG002|Overall Study|Lost to Follow-up|4|||
129758467|NCT02648204|467078633|FG003|Overall Study|Lost to Follow-up|6|||
129758468|NCT02648204|467078630|FG000|Overall Study|Missing follow-up information|4|||
129758469|NCT02648204|467078631|FG001|Overall Study|Missing follow-up information|4|||
129758470|NCT02648204|467078632|FG002|Overall Study|Missing follow-up information|4|||
129758471|NCT02648204|467078633|FG003|Overall Study|Missing follow-up information|2|||
129758472|NCT02648204|467078630|FG000|Overall Study|Death|1|||
129758473|NCT02648204|467078631|FG001|Overall Study|Death|1|||
129812338|NCT01847274|467280325|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812339|NCT01847274|467280326|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812340|NCT01847274|467280327|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812341|NCT01847274|467280328|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
129812342|NCT01847274|467280318|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129758474|NCT02648204|467078632|FG002|Overall Study|Death|2|||
129758475|NCT02648204|467078633|FG003|Overall Study|Death|2|||
129758476|NCT02648204|467078630|FG000|Overall Study|Adverse Event|0|||
129758477|NCT02648204|467078631|FG001|Overall Study|Adverse Event|0|||
129758478|NCT02648204|467078632|FG002|Overall Study|Adverse Event|1|||
129758479|NCT02648204|467078633|FG003|Overall Study|Adverse Event|0|||
129758480|NCT02322281|467078634|FG000|Overall Study|Progressive Disease|42|||
129758481|NCT02322281|467078635|FG001|Overall Study|Progressive Disease|14|||
129758482|NCT02322281|467078636|FG002|Overall Study|Progressive Disease|49|||
129758483|NCT02322281|467078634|FG000|Overall Study|Adverse Event|3|||
129758484|NCT02322281|467078635|FG001|Overall Study|Adverse Event|4|||
129758485|NCT02322281|467078636|FG002|Overall Study|Adverse Event|6|||
129758486|NCT02322281|467078634|FG000|Overall Study|Death|3|||
129812343|NCT01847274|467280319|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812344|NCT01847274|467280320|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812345|NCT01847274|467280321|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812346|NCT01847274|467280322|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812347|NCT01847274|467280323|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812348|NCT01847274|467280324|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
129812349|NCT01847274|467280325|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812350|NCT01847274|467280326|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812351|NCT01847274|467280327|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812352|NCT01847274|467280328|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
129812353|NCT01847274|467280318|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812354|NCT01847274|467280319|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129758487|NCT02322281|467078635|FG001|Overall Study|Death|3|||
129758488|NCT02322281|467078636|FG002|Overall Study|Death|3|||
129758489|NCT02322281|467078634|FG000|Overall Study|Withdrawal by Subject|1|||
129758490|NCT02322281|467078635|FG001|Overall Study|Withdrawal by Subject|1|||
129812355|NCT01847274|467280320|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812356|NCT01847274|467280321|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812357|NCT01847274|467280322|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812358|NCT01847274|467280323|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812359|NCT01847274|467280324|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
129812360|NCT01847274|467280325|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812361|NCT01847274|467280326|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129758491|NCT02322281|467078636|FG002|Overall Study|Withdrawal by Subject|6|||
129758492|NCT02322281|467078634|FG000|Overall Study|Physician Decision|2|||
129758493|NCT02322281|467078635|FG001|Overall Study|Physician Decision|0|||
129758494|NCT02322281|467078636|FG002|Overall Study|Physician Decision|5|||
129758495|NCT02322281|467078634|FG000|Overall Study|Study Terminated by Sponsor|2|||
129758496|NCT02322281|467078635|FG001|Overall Study|Study Terminated by Sponsor|0|||
129758497|NCT02322281|467078636|FG002|Overall Study|Study Terminated by Sponsor|0|||
129758498|NCT02322281|467078634|FG000|Overall Study|Missing|0|||
129758499|NCT02322281|467078635|FG001|Overall Study|Missing|0|||
129758500|NCT02322281|467078636|FG002|Overall Study|Missing|1|||
129758501|NCT02322281|467078634|FG000|Overall Study|Miscellaneous|0|||
129758502|NCT02322281|467078635|FG001|Overall Study|Miscellaneous|0|||
129758503|NCT02322281|467078636|FG002|Overall Study|Miscellaneous|4|||
129758504|NCT01285401|467078637|FG000|Overall Study|Prematurely withdrawn from the study|17|||
129758505|NCT01285401|467078638|FG001|Overall Study|Prematurely withdrawn from the study|29|||
129758506|NCT02366312|467078650|FG000|Overall Study|Lost to Follow-up|0|||
129758507|NCT02366312|467078651|FG001|Overall Study|Lost to Follow-up|1|||
129758508|NCT03719131|467078655|FG000|Overall Study|Death|1|||
129758509|NCT03719131|467078656|FG001|Overall Study|Death|2|||
129758510|NCT00619515|467078657|FG000|Overall Study|Study Termination by IRB|73|||
129758511|NCT03294590|467078658|FG000|Overall Study|Lost to Follow-up|105|||
129758512|NCT03294590|467078659|FG001|Overall Study|Lost to Follow-up|107|||
129758513|NCT04862065|467078662|FG000|Screening|Protocol Violation|54|||
129758514|NCT04862065|467078663|FG001|Screening|Protocol Violation|0|||
129758515|NCT04862065|467078664|FG002|Screening|Protocol Violation|0|||
129758516|NCT04862065|467078662|FG000|Screening|Insufficient Sample|1|||
129758517|NCT04862065|467078663|FG001|Screening|Insufficient Sample|0|||
129758518|NCT04862065|467078664|FG002|Screening|Insufficient Sample|0|||
129758519|NCT04862065|467078662|FG000|Follow-Up|Lost to Follow-up|3|||
129758520|NCT04862065|467078663|FG001|Follow-Up|Lost to Follow-up|0|||
129758521|NCT04862065|467078664|FG002|Follow-Up|Lost to Follow-up|0|||
129758522|NCT01272232|467078668|FG000|Weeks 0-56|Adverse Event|39|||
129758523|NCT01272232|467078669|FG001|Weeks 0-56|Adverse Event|18|||
129758524|NCT01272232|467078670|FG002|Weeks 0-56|Adverse Event|7|||
129758525|NCT01272232|467078668|FG000|Weeks 0-56|Lack of Efficacy|0|||
129758526|NCT01272232|467078669|FG001|Weeks 0-56|Lack of Efficacy|0|||
129758527|NCT01272232|467078670|FG002|Weeks 0-56|Lack of Efficacy|3|||
129758528|NCT01272232|467078668|FG000|Weeks 0-56|Protocol Violation|12|||
129758529|NCT01272232|467078669|FG001|Weeks 0-56|Protocol Violation|8|||
129758530|NCT01272232|467078670|FG002|Weeks 0-56|Protocol Violation|13|||
129758531|NCT01272232|467078668|FG000|Weeks 0-56|Withdrawal criteria|32|||
129758532|NCT01272232|467078669|FG001|Weeks 0-56|Withdrawal criteria|14|||
129758533|NCT01272232|467078670|FG002|Weeks 0-56|Withdrawal criteria|37|||
129758534|NCT01272232|467078668|FG000|Weeks 0-56|Unclassified|16|||
129758535|NCT01272232|467078669|FG001|Weeks 0-56|Unclassified|7|||
129758536|NCT01272232|467078670|FG002|Weeks 0-56|Unclassified|12|||
129758537|NCT01272232|467078668|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
129758538|NCT01272232|467078669|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
129758539|NCT01272232|467078670|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
129758540|NCT01272232|467078668|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
129758541|NCT01272232|467078669|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
129758542|NCT01272232|467078670|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
129758543|NCT01272232|467078668|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
129758544|NCT01272232|467078669|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
129758545|NCT01272232|467078670|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
129758546|NCT01272232|467078668|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
129758547|NCT01272232|467078669|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
129758548|NCT01272232|467078670|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
129758549|NCT01272232|467078668|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
129758550|NCT01272232|467078669|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
129758551|NCT01272232|467078670|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
129758552|NCT00628030|467078673|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
129758553|NCT00628030|467078674|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
129758554|NCT00628030|467078673|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
129758555|NCT00628030|467078674|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
129758556|NCT00628030|467078673|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
129758557|NCT00628030|467078674|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
129758558|NCT01156480|467078676|FG000|Overall Study|change in diagnosis|0|||
129758559|NCT01156480|467078677|FG001|Overall Study|change in diagnosis|1|||
129896935|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
129758560|NCT03367858|467078678|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
129758561|NCT03367858|467078679|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
129758562|NCT03367858|467078678|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
129758563|NCT03367858|467078679|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
129758564|NCT03367858|467078678|FG000|3 Month Follow Up|Lost to Follow-up|8|||
129758565|NCT03367858|467078679|FG001|3 Month Follow Up|Lost to Follow-up|3|||
129758566|NCT03367858|467078678|FG000|3 Month Follow Up|Moved out of study area|2|||
129758567|NCT03367858|467078679|FG001|3 Month Follow Up|Moved out of study area|6|||
129758568|NCT03367858|467078678|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
129758569|NCT03367858|467078679|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
129758570|NCT03367858|467078678|FG000|3 Month Follow Up|MRI contraindication|2|||
129896936|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
129445406|NCT03828292|465931279|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
129758571|NCT03367858|467078679|FG001|3 Month Follow Up|MRI contraindication|1|||
129758572|NCT03367858|467078678|FG000|3 Month Follow Up|Incarcerated|0|||
129758573|NCT03367858|467078679|FG001|3 Month Follow Up|Incarcerated|1|||
129758574|NCT03367858|467078678|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
129758575|NCT03367858|467078679|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
129758576|NCT03367858|467078678|FG000|6 Month Follow Up|Lost to Follow-up|5|||
129758577|NCT03367858|467078679|FG001|6 Month Follow Up|Lost to Follow-up|2|||
129758578|NCT03367858|467078678|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
129758579|NCT03367858|467078679|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
129758580|NCT03367858|467078678|FG000|12 Month Follow Up|Lost to Follow-up|3|||
129758581|NCT03367858|467078679|FG001|12 Month Follow Up|Lost to Follow-up|3|||
129758582|NCT03367858|467078678|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
129758583|NCT03367858|467078679|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
129758584|NCT04276233|467078680|FG000|Overall Study|Adverse Event|1|||
129758585|NCT04276233|467078680|FG000|Overall Study|Lost to Follow-up|3|||
129758586|NCT04276233|467078680|FG000|Overall Study|Physician Decision|4|||
129758587|NCT04276233|467078680|FG000|Overall Study|Withdrawal by Subject|2|||
129758588|NCT01946139|467078681|FG000|Overall Study|Withdrawal by Subject|8|||
129758589|NCT01946139|467078681|FG000|Overall Study|ineligible|8|||
129758590|NCT01946139|467078681|FG000|Overall Study|Specimens not available|4|||
129758591|NCT03275740|467078688|FG000|Overall Study|Adverse Event|0|||
129758592|NCT03275740|467078689|FG001|Overall Study|Adverse Event|0|||
129758593|NCT03275740|467078690|FG002|Overall Study|Adverse Event|0|||
129758594|NCT03275740|467078691|FG003|Overall Study|Adverse Event|0|||
129758595|NCT03275740|467078692|FG004|Overall Study|Adverse Event|1|||
129758596|NCT03275740|467078693|FG005|Overall Study|Adverse Event|0|||
129758597|NCT03275740|467078694|FG006|Overall Study|Adverse Event|0|||
129758598|NCT03275740|467078695|FG007|Overall Study|Adverse Event|0|||
129758599|NCT03275740|467078696|FG008|Overall Study|Adverse Event|0|||
129758600|NCT03275740|467078697|FG009|Overall Study|Adverse Event|0|||
129758601|NCT03275740|467078698|FG010|Overall Study|Adverse Event|0|||
129758602|NCT03275740|467078699|FG011|Overall Study|Adverse Event|0|||
129758603|NCT03275740|467078688|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758604|NCT03275740|467078689|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758605|NCT03275740|467078690|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758606|NCT03275740|467078691|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758607|NCT03275740|467078692|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758608|NCT03275740|467078693|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
129758609|NCT03275740|467078694|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758610|NCT03275740|467078695|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758611|NCT03275740|467078696|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758612|NCT03275740|467078697|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758613|NCT03275740|467078698|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758614|NCT03275740|467078699|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
129758615|NCT03275740|467078688|FG000|Overall Study|Withdrawal by Subject|0|||
129758616|NCT03275740|467078689|FG001|Overall Study|Withdrawal by Subject|0|||
129758617|NCT03275740|467078690|FG002|Overall Study|Withdrawal by Subject|0|||
129758618|NCT03275740|467078691|FG003|Overall Study|Withdrawal by Subject|0|||
129758619|NCT03275740|467078692|FG004|Overall Study|Withdrawal by Subject|0|||
129758620|NCT03275740|467078693|FG005|Overall Study|Withdrawal by Subject|0|||
129758621|NCT03275740|467078694|FG006|Overall Study|Withdrawal by Subject|0|||
129758622|NCT03275740|467078695|FG007|Overall Study|Withdrawal by Subject|0|||
129758623|NCT03275740|467078696|FG008|Overall Study|Withdrawal by Subject|1|||
129758624|NCT03275740|467078697|FG009|Overall Study|Withdrawal by Subject|1|||
129758625|NCT03275740|467078698|FG010|Overall Study|Withdrawal by Subject|0|||
129758626|NCT03275740|467078699|FG011|Overall Study|Withdrawal by Subject|0|||
129758627|NCT03827655|467078701|FG000|Overall Study|Death|0|||
129758628|NCT03827655|467078702|FG001|Overall Study|Death|0|||
129758629|NCT03827655|467078703|FG002|Overall Study|Death|0|||
129758630|NCT03827655|467078704|FG003|Overall Study|Death|0|||
129758631|NCT03827655|467078705|FG004|Overall Study|Death|1|||
129758632|NCT03827655|467078701|FG000|Overall Study|Protocol Deviation|1|||
129758633|NCT03827655|467078702|FG001|Overall Study|Protocol Deviation|0|||
129758634|NCT03827655|467078703|FG002|Overall Study|Protocol Deviation|1|||
129758635|NCT03827655|467078704|FG003|Overall Study|Protocol Deviation|1|||
129758636|NCT03827655|467078705|FG004|Overall Study|Protocol Deviation|0|||
129758637|NCT03827655|467078701|FG000|Overall Study|Withdrawal by Subject|3|||
129758638|NCT03827655|467078702|FG001|Overall Study|Withdrawal by Subject|2|||
129758639|NCT03827655|467078703|FG002|Overall Study|Withdrawal by Subject|2|||
129758640|NCT03827655|467078704|FG003|Overall Study|Withdrawal by Subject|0|||
129758641|NCT03827655|467078705|FG004|Overall Study|Withdrawal by Subject|1|||
129758642|NCT03827655|467078701|FG000|Overall Study|Reason not Specified|3|||
129758643|NCT03827655|467078702|FG001|Overall Study|Reason not Specified|1|||
129758644|NCT03827655|467078703|FG002|Overall Study|Reason not Specified|1|||
129758645|NCT03827655|467078704|FG003|Overall Study|Reason not Specified|1|||
129758646|NCT03827655|467078705|FG004|Overall Study|Reason not Specified|1|||
129758647|NCT02336607|467078706|FG000|Overall Study|Physician Decision|1|||
129758648|NCT02336607|467078707|FG001|Overall Study|Physician Decision|4|||
129758649|NCT02336607|467078708|FG002|Overall Study|Physician Decision|3|||
129758650|NCT02336607|467078709|FG003|Overall Study|Physician Decision|15|||
129758651|NCT02336607|467078706|FG000|Overall Study|Lack of Efficacy|1|||
129758652|NCT02336607|467078707|FG001|Overall Study|Lack of Efficacy|0|||
129758653|NCT02336607|467078708|FG002|Overall Study|Lack of Efficacy|0|||
129758654|NCT02336607|467078709|FG003|Overall Study|Lack of Efficacy|2|||
129758655|NCT02336607|467078706|FG000|Overall Study|Lost to Follow-up|2|||
129758656|NCT02336607|467078707|FG001|Overall Study|Lost to Follow-up|1|||
129758657|NCT02336607|467078708|FG002|Overall Study|Lost to Follow-up|0|||
129758658|NCT02336607|467078709|FG003|Overall Study|Lost to Follow-up|21|||
129758659|NCT02336607|467078706|FG000|Overall Study|Protocol Violation|0|||
129758660|NCT02336607|467078707|FG001|Overall Study|Protocol Violation|1|||
129758661|NCT02336607|467078708|FG002|Overall Study|Protocol Violation|1|||
129758662|NCT02336607|467078709|FG003|Overall Study|Protocol Violation|3|||
129758663|NCT02336607|467078706|FG000|Overall Study|Adverse Event|0|||
129758664|NCT02336607|467078707|FG001|Overall Study|Adverse Event|2|||
129758665|NCT02336607|467078708|FG002|Overall Study|Adverse Event|2|||
129758666|NCT02336607|467078709|FG003|Overall Study|Adverse Event|26|||
129758667|NCT02336607|467078706|FG000|Overall Study|Withdrawal by Subject|0|||
129758668|NCT02336607|467078707|FG001|Overall Study|Withdrawal by Subject|2|||
129758669|NCT02336607|467078708|FG002|Overall Study|Withdrawal by Subject|0|||
129758670|NCT02336607|467078709|FG003|Overall Study|Withdrawal by Subject|20|||
129758671|NCT02552966|467078712|FG000|Overall Study|Lost to Follow-up|2|||
129758672|NCT02552966|467078712|FG000|Overall Study|Withdrawal by Subject|3|||
129758673|NCT01091675|467078715|FG000|Overall Study|Adverse Event|7|||
129758674|NCT01091675|467078715|FG000|Overall Study|Lack of Efficacy|27|||
129758675|NCT00614380|467078716|FG000|Overall Study|Adverse Event|14|||
129758676|NCT00614380|467078717|FG001|Overall Study|Adverse Event|4|||
129758677|NCT00614380|467078718|FG002|Overall Study|Adverse Event|0|||
129758678|NCT00614380|467078719|FG003|Overall Study|Adverse Event|0|||
129758679|NCT00614380|467078716|FG000|Overall Study|Lost to Follow-up|6|||
129758680|NCT00614380|467078717|FG001|Overall Study|Lost to Follow-up|1|||
129758681|NCT00614380|467078718|FG002|Overall Study|Lost to Follow-up|0|||
129758682|NCT00614380|467078719|FG003|Overall Study|Lost to Follow-up|0|||
129758683|NCT00614380|467078716|FG000|Overall Study|Non compliant with the protocol|12|||
129758684|NCT00614380|467078717|FG001|Overall Study|Non compliant with the protocol|2|||
129758685|NCT00614380|467078718|FG002|Overall Study|Non compliant with the protocol|1|||
129758686|NCT00614380|467078719|FG003|Overall Study|Non compliant with the protocol|2|||
129758687|NCT00614380|467078716|FG000|Overall Study|Consent withdrawn|3|||
129758688|NCT00614380|467078717|FG001|Overall Study|Consent withdrawn|1|||
129758689|NCT00614380|467078718|FG002|Overall Study|Consent withdrawn|0|||
129758690|NCT00614380|467078719|FG003|Overall Study|Consent withdrawn|0|||
129758691|NCT01670721|467078733|FG000|Overall Study|Participant's decision|15|||
129758692|NCT01670721|467078733|FG000|Overall Study|Other than specified above|38|||
129758693|NCT00191334|467078734|FG000|Overall Study|Adverse Event|4|||
129758694|NCT00191334|467078734|FG000|Overall Study|Disease Progression or Relapse|8|||
129758695|NCT00191334|467078734|FG000|Overall Study|Physician Decision|1|||
129758696|NCT00191334|467078734|FG000|Overall Study|Withdrawal by Subject|4|||
129758697|NCT05274958|467078735|FG000|Overall Study|Only completed 1 set of PROMs|22|||
129758698|NCT05274958|467078736|FG001|Overall Study|Only completed 1 set of PROMs|35|||
129758699|NCT05579977|467078744|FG000|Treatment Phase|Other|0|||
129758700|NCT05579977|467078745|FG001|Treatment Phase|Other|0|||
129758701|NCT05579977|467078746|FG002|Treatment Phase|Other|0|||
129758702|NCT05579977|467078747|FG003|Treatment Phase|Other|2|||
129758703|NCT05579977|467078748|FG004|Treatment Phase|Other|1|||
129758704|NCT05579977|467078749|FG005|Treatment Phase|Other|2|||
129758705|NCT05579977|467078750|FG006|Treatment Phase|Other|1|||
129758706|NCT05579977|467078751|FG007|Treatment Phase|Other|2|||
129758707|NCT05579977|467078752|FG008|Treatment Phase|Other|2|||
129758708|NCT05579977|467078753|FG009|Treatment Phase|Other|1|||
129812362|NCT01847274|467280327|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129812363|NCT01847274|467280328|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
129758709|NCT05579977|467078754|FG010|Treatment Phase|Other|0|||
129758710|NCT05579977|467078755|FG011|Treatment Phase|Other|0|||
129758711|NCT05579977|467078756|FG012|Treatment Phase|Other|3|||
129758712|NCT05579977|467078744|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
129758713|NCT05579977|467078745|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
129758714|NCT05579977|467078746|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
129758715|NCT05579977|467078747|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
129758716|NCT05579977|467078748|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
129758717|NCT05579977|467078749|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
129758718|NCT05579977|467078750|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
129758719|NCT05579977|467078751|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
129758720|NCT05579977|467078752|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
129758721|NCT05579977|467078753|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
129758722|NCT05579977|467078754|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
129758723|NCT05579977|467078755|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
129758724|NCT05579977|467078756|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
129758725|NCT05579977|467078744|FG000|Treatment Phase|Withdrawal by Subject|2|||
129758726|NCT05579977|467078745|FG001|Treatment Phase|Withdrawal by Subject|0|||
129758727|NCT05579977|467078746|FG002|Treatment Phase|Withdrawal by Subject|0|||
129758728|NCT05579977|467078747|FG003|Treatment Phase|Withdrawal by Subject|1|||
129758729|NCT05579977|467078748|FG004|Treatment Phase|Withdrawal by Subject|2|||
129758730|NCT05579977|467078749|FG005|Treatment Phase|Withdrawal by Subject|0|||
129758731|NCT05579977|467078750|FG006|Treatment Phase|Withdrawal by Subject|1|||
129758732|NCT05579977|467078751|FG007|Treatment Phase|Withdrawal by Subject|8|||
129758733|NCT05579977|467078752|FG008|Treatment Phase|Withdrawal by Subject|3|||
129758734|NCT05579977|467078753|FG009|Treatment Phase|Withdrawal by Subject|3|||
129758735|NCT05579977|467078754|FG010|Treatment Phase|Withdrawal by Subject|5|||
129758736|NCT05579977|467078755|FG011|Treatment Phase|Withdrawal by Subject|1|||
129758737|NCT05579977|467078756|FG012|Treatment Phase|Withdrawal by Subject|3|||
129758738|NCT05579977|467078744|FG000|Treatment Phase|Study terminated by sponsor|70|||
129758739|NCT05579977|467078745|FG001|Treatment Phase|Study terminated by sponsor|70|||
129758740|NCT05579977|467078746|FG002|Treatment Phase|Study terminated by sponsor|61|||
129758741|NCT05579977|467078747|FG003|Treatment Phase|Study terminated by sponsor|59|||
129758742|NCT05579977|467078748|FG004|Treatment Phase|Study terminated by sponsor|63|||
129758743|NCT05579977|467078749|FG005|Treatment Phase|Study terminated by sponsor|53|||
129758744|NCT05579977|467078750|FG006|Treatment Phase|Study terminated by sponsor|66|||
129758745|NCT05579977|467078751|FG007|Treatment Phase|Study terminated by sponsor|48|||
129758746|NCT05579977|467078752|FG008|Treatment Phase|Study terminated by sponsor|47|||
129758747|NCT05579977|467078753|FG009|Treatment Phase|Study terminated by sponsor|37|||
129758748|NCT05579977|467078754|FG010|Treatment Phase|Study terminated by sponsor|44|||
129758749|NCT05579977|467078755|FG011|Treatment Phase|Study terminated by sponsor|36|||
129758750|NCT05579977|467078756|FG012|Treatment Phase|Study terminated by sponsor|32|||
129758751|NCT05579977|467078744|FG000|Treatment Phase|Pregnancy|0|||
129758752|NCT05579977|467078745|FG001|Treatment Phase|Pregnancy|0|||
129758753|NCT05579977|467078746|FG002|Treatment Phase|Pregnancy|0|||
129758754|NCT05579977|467078747|FG003|Treatment Phase|Pregnancy|0|||
129758755|NCT05579977|467078748|FG004|Treatment Phase|Pregnancy|0|||
129758756|NCT05579977|467078749|FG005|Treatment Phase|Pregnancy|0|||
129758757|NCT05579977|467078750|FG006|Treatment Phase|Pregnancy|0|||
129758758|NCT05579977|467078751|FG007|Treatment Phase|Pregnancy|0|||
129758759|NCT05579977|467078752|FG008|Treatment Phase|Pregnancy|0|||
129758760|NCT05579977|467078753|FG009|Treatment Phase|Pregnancy|1|||
129758761|NCT05579977|467078754|FG010|Treatment Phase|Pregnancy|0|||
129758762|NCT05579977|467078755|FG011|Treatment Phase|Pregnancy|0|||
129758763|NCT05579977|467078756|FG012|Treatment Phase|Pregnancy|0|||
129758764|NCT05579977|467078744|FG000|Treatment Phase|Physician Decision|0|||
129758765|NCT05579977|467078745|FG001|Treatment Phase|Physician Decision|0|||
129758766|NCT05579977|467078746|FG002|Treatment Phase|Physician Decision|0|||
129758767|NCT05579977|467078747|FG003|Treatment Phase|Physician Decision|0|||
129758768|NCT05579977|467078748|FG004|Treatment Phase|Physician Decision|0|||
129758769|NCT05579977|467078749|FG005|Treatment Phase|Physician Decision|0|||
129758770|NCT05579977|467078750|FG006|Treatment Phase|Physician Decision|0|||
129758771|NCT05579977|467078751|FG007|Treatment Phase|Physician Decision|0|||
129758772|NCT05579977|467078752|FG008|Treatment Phase|Physician Decision|0|||
129758773|NCT05579977|467078753|FG009|Treatment Phase|Physician Decision|0|||
129812364|NCT01847274|467280318|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129758774|NCT05579977|467078754|FG010|Treatment Phase|Physician Decision|0|||
129758775|NCT05579977|467078755|FG011|Treatment Phase|Physician Decision|1|||
129758776|NCT05579977|467078756|FG012|Treatment Phase|Physician Decision|0|||
129758777|NCT05579977|467078744|FG000|Treatment Phase|Lost to Follow-up|0|||
129758778|NCT05579977|467078745|FG001|Treatment Phase|Lost to Follow-up|0|||
129758779|NCT05579977|467078746|FG002|Treatment Phase|Lost to Follow-up|0|||
129758780|NCT05579977|467078747|FG003|Treatment Phase|Lost to Follow-up|1|||
129758781|NCT05579977|467078748|FG004|Treatment Phase|Lost to Follow-up|1|||
129758782|NCT05579977|467078749|FG005|Treatment Phase|Lost to Follow-up|1|||
129758783|NCT05579977|467078750|FG006|Treatment Phase|Lost to Follow-up|0|||
129758784|NCT05579977|467078751|FG007|Treatment Phase|Lost to Follow-up|1|||
129758785|NCT05579977|467078752|FG008|Treatment Phase|Lost to Follow-up|2|||
129758786|NCT05579977|467078753|FG009|Treatment Phase|Lost to Follow-up|2|||
129758787|NCT05579977|467078754|FG010|Treatment Phase|Lost to Follow-up|1|||
129758788|NCT05579977|467078755|FG011|Treatment Phase|Lost to Follow-up|4|||
129758789|NCT05579977|467078756|FG012|Treatment Phase|Lost to Follow-up|3|||
129758790|NCT05579977|467078744|FG000|Treatment Phase|Death|1|||
129758791|NCT05579977|467078745|FG001|Treatment Phase|Death|0|||
129758792|NCT05579977|467078746|FG002|Treatment Phase|Death|0|||
129758793|NCT05579977|467078747|FG003|Treatment Phase|Death|0|||
129758794|NCT05579977|467078748|FG004|Treatment Phase|Death|0|||
129758795|NCT05579977|467078749|FG005|Treatment Phase|Death|0|||
129758796|NCT05579977|467078750|FG006|Treatment Phase|Death|0|||
129758797|NCT05579977|467078751|FG007|Treatment Phase|Death|0|||
129758798|NCT05579977|467078752|FG008|Treatment Phase|Death|0|||
129758799|NCT05579977|467078753|FG009|Treatment Phase|Death|0|||
129758800|NCT05579977|467078754|FG010|Treatment Phase|Death|0|||
129758801|NCT05579977|467078755|FG011|Treatment Phase|Death|0|||
129758802|NCT05579977|467078756|FG012|Treatment Phase|Death|0|||
129758803|NCT05579977|467078744|FG000|Treatment Phase|Adverse Event|0|||
129758804|NCT05579977|467078745|FG001|Treatment Phase|Adverse Event|3|||
129758805|NCT05579977|467078746|FG002|Treatment Phase|Adverse Event|11|||
129758806|NCT05579977|467078747|FG003|Treatment Phase|Adverse Event|10|||
129758807|NCT05579977|467078748|FG004|Treatment Phase|Adverse Event|5|||
129758808|NCT05579977|467078749|FG005|Treatment Phase|Adverse Event|17|||
129758809|NCT05579977|467078750|FG006|Treatment Phase|Adverse Event|5|||
129758810|NCT05579977|467078751|FG007|Treatment Phase|Adverse Event|5|||
129758811|NCT05579977|467078752|FG008|Treatment Phase|Adverse Event|12|||
129758812|NCT05579977|467078753|FG009|Treatment Phase|Adverse Event|20|||
129758813|NCT05579977|467078754|FG010|Treatment Phase|Adverse Event|15|||
129758814|NCT05579977|467078755|FG011|Treatment Phase|Adverse Event|24|||
129758815|NCT05579977|467078756|FG012|Treatment Phase|Adverse Event|23|||
129758816|NCT05579977|467078744|FG000|Treatment Phase|Randomized not treated|0|||
129758817|NCT05579977|467078745|FG001|Treatment Phase|Randomized not treated|0|||
129758818|NCT05579977|467078746|FG002|Treatment Phase|Randomized not treated|0|||
129758819|NCT05579977|467078747|FG003|Treatment Phase|Randomized not treated|0|||
129758820|NCT05579977|467078748|FG004|Treatment Phase|Randomized not treated|1|||
129758821|NCT05579977|467078749|FG005|Treatment Phase|Randomized not treated|0|||
129758822|NCT05579977|467078750|FG006|Treatment Phase|Randomized not treated|0|||
129758823|NCT05579977|467078751|FG007|Treatment Phase|Randomized not treated|0|||
129758824|NCT05579977|467078752|FG008|Treatment Phase|Randomized not treated|0|||
129758825|NCT05579977|467078753|FG009|Treatment Phase|Randomized not treated|0|||
129758826|NCT05579977|467078754|FG010|Treatment Phase|Randomized not treated|0|||
129758827|NCT05579977|467078755|FG011|Treatment Phase|Randomized not treated|0|||
129758828|NCT05579977|467078756|FG012|Treatment Phase|Randomized not treated|0|||
129758829|NCT05579977|467078744|FG000|Follow up|Death|1|||
129758830|NCT05579977|467078745|FG001|Follow up|Death|0|||
129758831|NCT05579977|467078746|FG002|Follow up|Death|0|||
129758832|NCT05579977|467078747|FG003|Follow up|Death|0|||
129758833|NCT05579977|467078748|FG004|Follow up|Death|0|||
129758834|NCT05579977|467078749|FG005|Follow up|Death|0|||
129758835|NCT05579977|467078750|FG006|Follow up|Death|0|||
129758836|NCT05579977|467078751|FG007|Follow up|Death|0|||
129758837|NCT05579977|467078752|FG008|Follow up|Death|0|||
129758838|NCT05579977|467078753|FG009|Follow up|Death|0|||
129758839|NCT05579977|467078754|FG010|Follow up|Death|0|||
129758840|NCT05579977|467078755|FG011|Follow up|Death|0|||
129758841|NCT05579977|467078756|FG012|Follow up|Death|0|||
129758842|NCT05579977|467078744|FG000|Follow up|Lost to Follow-up|0|||
129758843|NCT05579977|467078745|FG001|Follow up|Lost to Follow-up|0|||
129758844|NCT05579977|467078746|FG002|Follow up|Lost to Follow-up|0|||
129758845|NCT05579977|467078747|FG003|Follow up|Lost to Follow-up|1|||
129758846|NCT05579977|467078748|FG004|Follow up|Lost to Follow-up|1|||
129758847|NCT05579977|467078749|FG005|Follow up|Lost to Follow-up|2|||
129758848|NCT05579977|467078750|FG006|Follow up|Lost to Follow-up|1|||
129758849|NCT05579977|467078751|FG007|Follow up|Lost to Follow-up|1|||
129758850|NCT05579977|467078752|FG008|Follow up|Lost to Follow-up|3|||
129758851|NCT05579977|467078753|FG009|Follow up|Lost to Follow-up|2|||
129758852|NCT05579977|467078754|FG010|Follow up|Lost to Follow-up|2|||
129758853|NCT05579977|467078755|FG011|Follow up|Lost to Follow-up|4|||
129758854|NCT05579977|467078756|FG012|Follow up|Lost to Follow-up|4|||
129758855|NCT05579977|467078744|FG000|Follow up|Withdrawal by Subject|2|||
129758856|NCT05579977|467078745|FG001|Follow up|Withdrawal by Subject|0|||
129758857|NCT05579977|467078746|FG002|Follow up|Withdrawal by Subject|0|||
129758858|NCT05579977|467078747|FG003|Follow up|Withdrawal by Subject|0|||
129758859|NCT05579977|467078748|FG004|Follow up|Withdrawal by Subject|1|||
129758860|NCT05579977|467078749|FG005|Follow up|Withdrawal by Subject|0|||
129758861|NCT05579977|467078750|FG006|Follow up|Withdrawal by Subject|1|||
129758862|NCT05579977|467078751|FG007|Follow up|Withdrawal by Subject|4|||
129758863|NCT05579977|467078752|FG008|Follow up|Withdrawal by Subject|2|||
129758864|NCT05579977|467078753|FG009|Follow up|Withdrawal by Subject|3|||
129758865|NCT05579977|467078754|FG010|Follow up|Withdrawal by Subject|3|||
129758866|NCT05579977|467078755|FG011|Follow up|Withdrawal by Subject|1|||
129758867|NCT05579977|467078756|FG012|Follow up|Withdrawal by Subject|3|||
129758868|NCT00866814|467078757|FG000|Overall Study|Lost to Follow-up|12|||
129758869|NCT00866814|467078757|FG000|Overall Study|Adverse Event|2|||
129758870|NCT00866814|467078757|FG000|Overall Study|Physician Decision|1|||
129758871|NCT00866814|467078757|FG000|Overall Study|Death|1|||
129758872|NCT00866814|467078757|FG000|Overall Study|No longer wished to participate|1|||
129758873|NCT00866814|467078757|FG000|Overall Study|Unable to meet follow-up requirements|2|||
129758874|NCT00866814|467078757|FG000|Overall Study|Moved to area without study site|1|||
129758875|NCT01420926|467078760|FG000|Overall Study|Adverse Event|6|||
129758876|NCT01420926|467078761|FG001|Overall Study|Adverse Event|4|||
129758877|NCT01420926|467078760|FG000|Overall Study|Death|18|||
129758878|NCT01420926|467078761|FG001|Overall Study|Death|17|||
129758879|NCT01420926|467078760|FG000|Overall Study|Withdrawal by Subject|11|||
129758880|NCT01420926|467078761|FG001|Overall Study|Withdrawal by Subject|17|||
129758881|NCT01420926|467078760|FG000|Overall Study|Non-protocol treatment|17|||
129758882|NCT01420926|467078761|FG001|Overall Study|Non-protocol treatment|20|||
129758883|NCT01420926|467078760|FG000|Overall Study|Physician Decision|8|||
129758884|NCT01420926|467078761|FG001|Overall Study|Physician Decision|5|||
129758885|NCT01232868|467080942|FG000|Overall Study|Lost to Follow-up|2|||
129758886|NCT01232868|467080943|FG001|Overall Study|Lost to Follow-up|4|||
129758887|NCT04481243|467080944|FG000|Overall Study|Withdrawal by Subject|4|||
129758888|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129758889|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
129758890|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129758891|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129758892|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
129758893|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
129758894|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
129758895|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
129758896|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
129758897|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
129758898|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
129758899|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
129758900|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
129758901|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
129758902|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
129758903|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
129758904|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
129758905|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
129758906|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
129758907|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
129758908|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
129758909|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
129758910|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
129758911|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
129758912|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
129758913|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
129758914|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
129758915|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
129758916|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
129758917|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
129758918|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
129758919|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
129758920|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
129758921|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
129758922|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
129758923|NCT02831764|467080945|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129758924|NCT02831764|467080946|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
129758925|NCT02831764|467080947|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129758926|NCT02831764|467080948|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129758927|NCT02831764|467080949|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
129758928|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129758929|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129758930|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
129758931|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
129758932|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129758933|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129758934|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129758935|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
129758936|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129758937|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129758938|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129758939|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129758940|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
129758941|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
129758942|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129758943|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129758944|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129758945|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
129758946|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129758947|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
129758948|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129758949|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129758950|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
129758951|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
129758952|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129758953|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129812365|NCT01847274|467280319|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812366|NCT01847274|467280320|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812367|NCT01847274|467280321|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812368|NCT01847274|467280322|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812369|NCT01847274|467280323|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812370|NCT01847274|467280324|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
129812371|NCT01847274|467280325|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812372|NCT01847274|467280326|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812373|NCT01847274|467280327|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812374|NCT01847274|467280328|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
129812375|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812376|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812377|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812378|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812379|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812380|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812381|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
129812382|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
129812383|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
129812384|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
129812385|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
129812386|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812387|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812388|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812389|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812390|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129758954|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129758955|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
129758956|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
129758957|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129758958|NCT02831764|467080945|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129758959|NCT02831764|467080946|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129758960|NCT02831764|467080947|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
129758961|NCT02831764|467080948|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
129758962|NCT02831764|467080949|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129758963|NCT02831764|467080945|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129758964|NCT02831764|467080946|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129758965|NCT02831764|467080947|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129758966|NCT02831764|467080948|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129758967|NCT02831764|467080949|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
129758968|NCT02831764|467080945|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129758969|NCT02831764|467080946|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129758970|NCT02831764|467080947|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129758971|NCT02831764|467080948|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129758972|NCT02831764|467080949|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
129758973|NCT02831764|467080945|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129758974|NCT02831764|467080946|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129758975|NCT02831764|467080947|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129758976|NCT02831764|467080948|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129758977|NCT02831764|467080949|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
129758978|NCT02831764|467080945|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129758979|NCT02831764|467080946|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129758980|NCT02831764|467080947|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129758981|NCT02831764|467080948|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129758982|NCT02831764|467080949|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
129758983|NCT04564846|467080950|FG000|Overall Study|Withdrawal by Subject|2|||
129758984|NCT04564846|467080951|FG001|Overall Study|Withdrawal by Subject|1|||
129758985|NCT04564846|467080950|FG000|Overall Study|Physician Decision|0|||
129758986|NCT04564846|467080951|FG001|Overall Study|Physician Decision|1|||
129758987|NCT04564846|467080950|FG000|Overall Study|Lost to Follow-up|0|||
129758988|NCT04564846|467080951|FG001|Overall Study|Lost to Follow-up|1|||
129758989|NCT04564846|467080950|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
129758990|NCT04564846|467080951|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
129758991|NCT04564846|467080950|FG000|Overall Study|Subject non-compliance|1|||
129758992|NCT04564846|467080951|FG001|Overall Study|Subject non-compliance|0|||
129758993|NCT00865345|467080952|FG000|Overall Study|Withdrawal by Subject|2|||
129758994|NCT04388111|467080955|FG000|Overall Study|Lost to Follow-up|5|||
129758995|NCT04388111|467080956|FG001|Overall Study|Lost to Follow-up|3|||
129758996|NCT04388111|467080955|FG000|Overall Study|Adverse Event|1|||
129758997|NCT04388111|467080956|FG001|Overall Study|Adverse Event|1|||
129758998|NCT04388111|467080955|FG000|Overall Study|Protocol Violation|2|||
129758999|NCT04388111|467080956|FG001|Overall Study|Protocol Violation|4|||
129759000|NCT04388111|467080955|FG000|Overall Study|Withdrawal by Subject|1|||
129759001|NCT04388111|467080956|FG001|Overall Study|Withdrawal by Subject|0|||
129759002|NCT02735239|467080957|FG000|Overall Study|Adverse Event|0|||
129759003|NCT02735239|467080958|FG001|Overall Study|Adverse Event|0|||
129759004|NCT02735239|467080959|FG002|Overall Study|Adverse Event|4|||
129759005|NCT02735239|467080960|FG003|Overall Study|Adverse Event|0|||
129759006|NCT02735239|467080961|FG004|Overall Study|Adverse Event|0|||
129759007|NCT02735239|467080962|FG005|Overall Study|Adverse Event|0|||
129759008|NCT02735239|467080957|FG000|Overall Study|Death|1|||
129759009|NCT02735239|467080958|FG001|Overall Study|Death|1|||
129759010|NCT02735239|467080959|FG002|Overall Study|Death|0|||
129759011|NCT02735239|467080960|FG003|Overall Study|Death|0|||
129759012|NCT02735239|467080961|FG004|Overall Study|Death|0|||
129759013|NCT02735239|467080962|FG005|Overall Study|Death|0|||
129759014|NCT02735239|467080957|FG000|Overall Study|Physician Decision|0|||
129759015|NCT02735239|467080958|FG001|Overall Study|Physician Decision|0|||
129759016|NCT02735239|467080959|FG002|Overall Study|Physician Decision|1|||
129812391|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812392|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812393|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
129759017|NCT02735239|467080960|FG003|Overall Study|Physician Decision|0|||
129759018|NCT02735239|467080961|FG004|Overall Study|Physician Decision|0|||
129759019|NCT02735239|467080962|FG005|Overall Study|Physician Decision|0|||
129896937|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
129896938|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
129896939|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
129896940|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
129896941|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896942|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896943|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896944|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896945|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
129896946|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
129896947|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
129896948|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
129896949|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
129896950|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
129896951|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
129896952|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896953|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896954|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896955|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896956|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
129896957|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
129896958|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
129896959|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
129896960|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
129896961|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
129896962|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
129896963|NCT04888585|467582171|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896964|NCT04888585|467582172|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896965|NCT04888585|467582173|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896966|NCT04888585|467582174|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896967|NCT04888585|467582175|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896968|NCT04888585|467582176|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129759020|NCT02735239|467080957|FG000|Overall Study|Progressive disease|3|||
129759021|NCT02735239|467080958|FG001|Overall Study|Progressive disease|1|||
129759022|NCT02735239|467080959|FG002|Overall Study|Progressive disease|3|||
129759023|NCT02735239|467080960|FG003|Overall Study|Progressive disease|0|||
129759024|NCT02735239|467080961|FG004|Overall Study|Progressive disease|0|||
129759025|NCT02735239|467080962|FG005|Overall Study|Progressive disease|2|||
129759026|NCT02735239|467080957|FG000|Overall Study|Withdrawal by Subject|0|||
129759027|NCT02735239|467080958|FG001|Overall Study|Withdrawal by Subject|1|||
129759028|NCT02735239|467080959|FG002|Overall Study|Withdrawal by Subject|0|||
129759029|NCT02735239|467080960|FG003|Overall Study|Withdrawal by Subject|0|||
129759030|NCT02735239|467080961|FG004|Overall Study|Withdrawal by Subject|0|||
129759031|NCT02735239|467080962|FG005|Overall Study|Withdrawal by Subject|0|||
129759032|NCT00387881|467080963|FG000|Overall Study|Lost to Follow-up|23|||
129759033|NCT00387881|467080964|FG001|Overall Study|Lost to Follow-up|23|||
129759034|NCT00387881|467080963|FG000|Overall Study|Protocol Violation|2|||
129759035|NCT00387881|467080964|FG001|Overall Study|Protocol Violation|12|||
129759036|NCT00387881|467080963|FG000|Overall Study|Withdrawal by Subject|15|||
129759037|NCT00387881|467080964|FG001|Overall Study|Withdrawal by Subject|18|||
129759038|NCT00387881|467080963|FG000|Overall Study|Sponsor terminated Study|0|||
129759039|NCT00387881|467080964|FG001|Overall Study|Sponsor terminated Study|1|||
129759040|NCT00387881|467080963|FG000|Overall Study|Not eligible|6|||
129759041|NCT00387881|467080964|FG001|Overall Study|Not eligible|7|||
129759042|NCT00387881|467080963|FG000|Overall Study|No opportunity to treat headache|32|||
129759043|NCT00387881|467080964|FG001|Overall Study|No opportunity to treat headache|34|||
129759044|NCT00387881|467080963|FG000|Overall Study|Not otherwise specified|11|||
129759045|NCT00387881|467080964|FG001|Overall Study|Not otherwise specified|7|||
129759046|NCT01790594|467080966|FG000|Overall Study|Death|1|||
129759047|NCT01790594|467080967|FG001|Overall Study|Death|0|||
129759048|NCT01790594|467080968|FG002|Overall Study|Death|0|||
129759049|NCT01790594|467080966|FG000|Overall Study|Physician Decision|2|||
129759050|NCT01790594|467080967|FG001|Overall Study|Physician Decision|1|||
129759051|NCT01790594|467080968|FG002|Overall Study|Physician Decision|0|||
129759052|NCT01790594|467080966|FG000|Overall Study|Withdrawal by Subject|2|||
129759053|NCT01790594|467080967|FG001|Overall Study|Withdrawal by Subject|0|||
129759054|NCT01790594|467080968|FG002|Overall Study|Withdrawal by Subject|0|||
129759055|NCT01790594|467080966|FG000|Overall Study|Transplant was not done|0|||
129759056|NCT01790594|467080967|FG001|Overall Study|Transplant was not done|0|||
129759057|NCT01790594|467080968|FG002|Overall Study|Transplant was not done|3|||
129759058|NCT01790594|467080966|FG000|Overall Study|Terminated prior to week 76|0|||
129759059|NCT01790594|467080967|FG001|Overall Study|Terminated prior to week 76|2|||
129759060|NCT01790594|467080968|FG002|Overall Study|Terminated prior to week 76|0|||
129759061|NCT03291067|467080969|FG000|Overall Study|Adverse Event|0|||
129759062|NCT03291067|467080970|FG001|Overall Study|Adverse Event|2|||
129759063|NCT03291067|467080971|FG002|Overall Study|Adverse Event|17|||
129759064|NCT03291067|467080972|FG003|Overall Study|Adverse Event|3|||
129759065|NCT03291067|467080969|FG000|Overall Study|Lost to Follow-up|2|||
129759066|NCT03291067|467080970|FG001|Overall Study|Lost to Follow-up|1|||
129759067|NCT03291067|467080971|FG002|Overall Study|Lost to Follow-up|0|||
129759068|NCT03291067|467080972|FG003|Overall Study|Lost to Follow-up|1|||
129759069|NCT03291067|467080969|FG000|Overall Study|Physician Decision|0|||
129759070|NCT03291067|467080970|FG001|Overall Study|Physician Decision|0|||
129759071|NCT03291067|467080971|FG002|Overall Study|Physician Decision|1|||
129759072|NCT03291067|467080972|FG003|Overall Study|Physician Decision|0|||
129759073|NCT03291067|467080969|FG000|Overall Study|Protocol Violation|5|||
129759074|NCT03291067|467080970|FG001|Overall Study|Protocol Violation|3|||
129759075|NCT03291067|467080971|FG002|Overall Study|Protocol Violation|4|||
129759076|NCT03291067|467080972|FG003|Overall Study|Protocol Violation|2|||
129759077|NCT03291067|467080969|FG000|Overall Study|Withdrawal by Subject|3|||
129759078|NCT03291067|467080970|FG001|Overall Study|Withdrawal by Subject|4|||
129759079|NCT03291067|467080971|FG002|Overall Study|Withdrawal by Subject|7|||
129759080|NCT03291067|467080972|FG003|Overall Study|Withdrawal by Subject|5|||
129759081|NCT03291067|467080969|FG000|Overall Study|Other|0|||
129759082|NCT03291067|467080970|FG001|Overall Study|Other|4|||
129759083|NCT03291067|467080971|FG002|Overall Study|Other|4|||
129759084|NCT03291067|467080972|FG003|Overall Study|Other|6|||
129759085|NCT02038153|467080973|FG000|Overall Study|Withdrawal by Subject|1|||
129759086|NCT01050634|467080974|FG000|Overall Study|Enrolled, but Not Treated|56|||
129759087|NCT01050634|467080974|FG000|Overall Study|Death|2|||
129759088|NCT01050634|467080974|FG000|Overall Study|Adverse Event|42|||
129759089|NCT01050634|467080974|FG000|Overall Study|Lost to Follow-up|2|||
129759090|NCT01050634|467080974|FG000|Overall Study|Other|21|||
129759091|NCT01050634|467080974|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
129759092|NCT00496015|467080975|FG000|Overall Study|Other|1|||
129759093|NCT00496015|467080976|FG001|Overall Study|Other|0|||
129759094|NCT00496015|467080977|FG002|Overall Study|Other|0|||
129759095|NCT00496015|467080978|FG003|Overall Study|Other|1|||
129759096|NCT00496015|467080979|FG004|Overall Study|Other|0|||
129759097|NCT00527735|467080980|FG000|Overall Study|Disease progression|47|||
129759098|NCT00527735|467080981|FG001|Overall Study|Disease progression|61|||
129759099|NCT00527735|467080982|FG002|Overall Study|Disease progression|53|||
129759100|NCT00527735|467080980|FG000|Overall Study|Death|23|||
129759101|NCT00527735|467080981|FG001|Overall Study|Death|13|||
129759102|NCT00527735|467080982|FG002|Overall Study|Death|15|||
129759103|NCT00527735|467080980|FG000|Overall Study|Completed treatment in treatment phase|14|||
129812394|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812395|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
129812396|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
129812397|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129759104|NCT00527735|467080981|FG001|Overall Study|Completed treatment in treatment phase|13|||
129759105|NCT00527735|467080982|FG002|Overall Study|Completed treatment in treatment phase|18|||
129812398|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129759106|NCT00527735|467080980|FG000|Overall Study|Adverse Event|10|||
129759107|NCT00527735|467080981|FG001|Overall Study|Adverse Event|6|||
129759108|NCT00527735|467080982|FG002|Overall Study|Adverse Event|7|||
129759109|NCT00527735|467080980|FG000|Overall Study|Not identified|5|||
129896969|NCT04888585|467582177|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
129759110|NCT00527735|467080981|FG001|Overall Study|Not identified|5|||
129759111|NCT00527735|467080982|FG002|Overall Study|Not identified|5|||
129759112|NCT00527735|467080980|FG000|Overall Study|Withdrawal by Subject|5|||
129759113|NCT00527735|467080981|FG001|Overall Study|Withdrawal by Subject|4|||
129759114|NCT00527735|467080982|FG002|Overall Study|Withdrawal by Subject|3|||
129759115|NCT00527735|467080980|FG000|Overall Study|No longer met study criteria|2|||
129759116|NCT00527735|467080981|FG001|Overall Study|No longer met study criteria|2|||
129759117|NCT00527735|467080982|FG002|Overall Study|No longer met study criteria|1|||
129759118|NCT00527735|467080980|FG000|Overall Study|Lost to Follow-up|0|||
129759119|NCT00527735|467080981|FG001|Overall Study|Lost to Follow-up|0|||
129759120|NCT00527735|467080982|FG002|Overall Study|Lost to Follow-up|3|||
129759121|NCT00527735|467080980|FG000|Overall Study|Poor compliance or noncompliance|0|||
129759122|NCT00527735|467080981|FG001|Overall Study|Poor compliance or noncompliance|1|||
129759123|NCT00527735|467080982|FG002|Overall Study|Poor compliance or noncompliance|1|||
129759124|NCT00527735|467080980|FG000|Overall Study|Completed treatment during maintenance|2|||
129759125|NCT00527735|467080981|FG001|Overall Study|Completed treatment during maintenance|2|||
129759126|NCT00527735|467080982|FG002|Overall Study|Completed treatment during maintenance|1|||
129759127|NCT01535807|467080983|FG000|Overall Study|Withdrawal by Subject|1|||
129759128|NCT01535807|467080984|FG001|Overall Study|Withdrawal by Subject|1|||
129759129|NCT01535807|467080983|FG000|Overall Study|Data collection error|1|||
129759130|NCT01535807|467080984|FG001|Overall Study|Data collection error|1|||
129759131|NCT00404651|467080988|FG000|Overall Study|Serious Adverse Event|0|||
129759132|NCT00404651|467080989|FG001|Overall Study|Serious Adverse Event|0|||
129759133|NCT00404651|467080990|FG002|Overall Study|Serious Adverse Event|2|||
129759134|NCT00404651|467080991|FG003|Overall Study|Serious Adverse Event|0|||
129759135|NCT00404651|467080988|FG000|Overall Study|Protocol Violation|10|||
129759136|NCT00404651|467080989|FG001|Overall Study|Protocol Violation|5|||
129759137|NCT00404651|467080990|FG002|Overall Study|Protocol Violation|14|||
129759138|NCT00404651|467080991|FG003|Overall Study|Protocol Violation|5|||
129759139|NCT00404651|467080988|FG000|Overall Study|Lost to Follow-up|15|||
129759140|NCT00404651|467080989|FG001|Overall Study|Lost to Follow-up|11|||
129759141|NCT00404651|467080990|FG002|Overall Study|Lost to Follow-up|13|||
129759142|NCT00404651|467080991|FG003|Overall Study|Lost to Follow-up|10|||
129759143|NCT00404651|467080988|FG000|Overall Study|Withdrawal by Subject|14|||
129759144|NCT00404651|467080989|FG001|Overall Study|Withdrawal by Subject|12|||
129759145|NCT00404651|467080990|FG002|Overall Study|Withdrawal by Subject|16|||
129759146|NCT00404651|467080991|FG003|Overall Study|Withdrawal by Subject|6|||
129759147|NCT02123134|467081006|FG000|Overall Study|Withdrawal of consent|3|||
129759148|NCT02123134|467081007|FG001|Overall Study|Withdrawal of consent|2|||
129759149|NCT02123134|467081006|FG000|Overall Study|Administrative decision|0|||
129759150|NCT02123134|467081007|FG001|Overall Study|Administrative decision|1|||
129759151|NCT03010527|467081016|FG000|Overall Study|Death|0|||
129759152|NCT03010527|467081017|FG001|Overall Study|Death|0|||
129759153|NCT03010527|467081018|FG002|Overall Study|Death|1|||
129759154|NCT03010527|467081016|FG000|Overall Study|Adverse Event|0|||
129759155|NCT03010527|467081017|FG001|Overall Study|Adverse Event|4|||
129759156|NCT03010527|467081018|FG002|Overall Study|Adverse Event|2|||
129759157|NCT03010527|467081016|FG000|Overall Study|Protocol Violation|0|||
129759158|NCT03010527|467081017|FG001|Overall Study|Protocol Violation|1|||
129759159|NCT03010527|467081018|FG002|Overall Study|Protocol Violation|0|||
129759160|NCT03010527|467081016|FG000|Overall Study|Lost to Follow-up|0|||
129759161|NCT03010527|467081017|FG001|Overall Study|Lost to Follow-up|2|||
129759162|NCT03010527|467081018|FG002|Overall Study|Lost to Follow-up|1|||
129759163|NCT03010527|467081016|FG000|Overall Study|Withdrawal by Subject|0|||
129759164|NCT03010527|467081017|FG001|Overall Study|Withdrawal by Subject|3|||
129759165|NCT03010527|467081018|FG002|Overall Study|Withdrawal by Subject|4|||
129759166|NCT03010527|467081016|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
129759167|NCT03010527|467081017|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
129759168|NCT03010527|467081018|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
129896970|NCT04888585|467582178|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
129759169|NCT03010527|467081016|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
129759170|NCT03010527|467081017|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
129759171|NCT03010527|467081018|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
129759172|NCT03010527|467081016|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
129759173|NCT03010527|467081017|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
129759174|NCT03010527|467081018|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
129759175|NCT00764699|467081019|FG000|Overall Study|PI left and study terminated|3|||
129759176|NCT01755234|467081020|FG000|Overall Study|Lost to Follow-up|11|||
129759177|NCT01755234|467081021|FG001|Overall Study|Lost to Follow-up|6|||
129759178|NCT01755234|467081020|FG000|Overall Study|Change in surgical case|2|||
129759179|NCT01755234|467081021|FG001|Overall Study|Change in surgical case|1|||
129759180|NCT01755234|467081020|FG000|Overall Study|case cancelled|1|||
129759181|NCT01755234|467081021|FG001|Overall Study|case cancelled|0|||
129759182|NCT01755234|467081020|FG000|Overall Study|Withdrawal by Subject|0|||
129759183|NCT01755234|467081021|FG001|Overall Study|Withdrawal by Subject|1|||
129759184|NCT01755234|467081020|FG000|Overall Study|unblinded|1|||
129759185|NCT01755234|467081021|FG001|Overall Study|unblinded|0|||
129759186|NCT03001557|467081025|FG000|Core Phase|Randomized but not treated|0|||
129759187|NCT03001557|467081026|FG001|Core Phase|Randomized but not treated|0|||
129759188|NCT03001557|467081027|FG002|Core Phase|Randomized but not treated|1|||
129759189|NCT03001557|467081028|FG003|Core Phase|Randomized but not treated|0|||
129759190|NCT03001557|467081029|FG004|Core Phase|Randomized but not treated|0|||
129759191|NCT03001557|467081030|FG005|Core Phase|Randomized but not treated|0|||
129759192|NCT03001557|467081031|FG006|Core Phase|Randomized but not treated|0|||
129759193|NCT03001557|467081032|FG007|Core Phase|Randomized but not treated|0|||
129759194|NCT03001557|467081025|FG000|Extension Phase|Adverse Event|0|||
129759195|NCT03001557|467081026|FG001|Extension Phase|Adverse Event|0|||
129759196|NCT03001557|467081027|FG002|Extension Phase|Adverse Event|0|||
129759197|NCT03001557|467081028|FG003|Extension Phase|Adverse Event|0|||
129759198|NCT03001557|467081029|FG004|Extension Phase|Adverse Event|0|||
129759199|NCT03001557|467081030|FG005|Extension Phase|Adverse Event|2|||
129759200|NCT03001557|467081031|FG006|Extension Phase|Adverse Event|0|||
129759201|NCT03001557|467081032|FG007|Extension Phase|Adverse Event|0|||
129759202|NCT03001557|467081025|FG000|Extension Phase|Withdrawal by Subject|0|||
129759203|NCT03001557|467081026|FG001|Extension Phase|Withdrawal by Subject|0|||
129759204|NCT03001557|467081027|FG002|Extension Phase|Withdrawal by Subject|0|||
129759205|NCT03001557|467081028|FG003|Extension Phase|Withdrawal by Subject|0|||
129759206|NCT03001557|467081029|FG004|Extension Phase|Withdrawal by Subject|0|||
129759207|NCT03001557|467081030|FG005|Extension Phase|Withdrawal by Subject|1|||
129759208|NCT03001557|467081031|FG006|Extension Phase|Withdrawal by Subject|5|||
129759209|NCT03001557|467081032|FG007|Extension Phase|Withdrawal by Subject|2|||
129759210|NCT03001557|467081025|FG000|Extension Phase|Lost to Follow-up|0|||
129759211|NCT03001557|467081026|FG001|Extension Phase|Lost to Follow-up|0|||
129759212|NCT03001557|467081027|FG002|Extension Phase|Lost to Follow-up|0|||
129759213|NCT03001557|467081028|FG003|Extension Phase|Lost to Follow-up|0|||
129759214|NCT03001557|467081029|FG004|Extension Phase|Lost to Follow-up|0|||
129759215|NCT03001557|467081030|FG005|Extension Phase|Lost to Follow-up|0|||
129759216|NCT03001557|467081031|FG006|Extension Phase|Lost to Follow-up|2|||
129759217|NCT03001557|467081032|FG007|Extension Phase|Lost to Follow-up|1|||
129759218|NCT03001557|467081025|FG000|Extension Phase|Administrative Reason|0|||
129759219|NCT03001557|467081026|FG001|Extension Phase|Administrative Reason|0|||
129759220|NCT03001557|467081027|FG002|Extension Phase|Administrative Reason|0|||
129759221|NCT03001557|467081028|FG003|Extension Phase|Administrative Reason|0|||
129759222|NCT03001557|467081029|FG004|Extension Phase|Administrative Reason|0|||
129759223|NCT03001557|467081030|FG005|Extension Phase|Administrative Reason|1|||
129759224|NCT03001557|467081031|FG006|Extension Phase|Administrative Reason|3|||
129759225|NCT03001557|467081032|FG007|Extension Phase|Administrative Reason|3|||
129759226|NCT03001557|467081025|FG000|Extension Phase|Loss of caregiver|0|||
129759227|NCT03001557|467081026|FG001|Extension Phase|Loss of caregiver|0|||
129759228|NCT03001557|467081027|FG002|Extension Phase|Loss of caregiver|0|||
129759229|NCT03001557|467081028|FG003|Extension Phase|Loss of caregiver|0|||
129759230|NCT03001557|467081029|FG004|Extension Phase|Loss of caregiver|0|||
129759231|NCT03001557|467081030|FG005|Extension Phase|Loss of caregiver|0|||
129759232|NCT03001557|467081031|FG006|Extension Phase|Loss of caregiver|1|||
129759233|NCT03001557|467081032|FG007|Extension Phase|Loss of caregiver|0|||
129759234|NCT03001557|467081025|FG000|Extension Phase|Others|0|||
129759235|NCT03001557|467081026|FG001|Extension Phase|Others|0|||
129759236|NCT03001557|467081027|FG002|Extension Phase|Others|0|||
129759237|NCT03001557|467081028|FG003|Extension Phase|Others|0|||
129759238|NCT03001557|467081029|FG004|Extension Phase|Others|0|||
129759239|NCT03001557|467081030|FG005|Extension Phase|Others|1|||
129759240|NCT03001557|467081031|FG006|Extension Phase|Others|3|||
129759241|NCT03001557|467081032|FG007|Extension Phase|Others|0|||
129759242|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
129759243|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
129759244|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Death|1|||
129759245|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Death|2|||
129759246|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
129759247|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
129759248|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
129759249|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
129759250|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
129759251|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
129759252|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
129759253|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
129759254|NCT01794000|467081033|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
129759255|NCT01794000|467081034|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
129759256|NCT01794000|467081033|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
129759257|NCT01794000|467081034|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
129759258|NCT01176058|467081036|FG000|Overall Study|Adverse Event|1|||
129759259|NCT01176058|467081037|FG001|Overall Study|Adverse Event|0|||
129759260|NCT01176058|467081036|FG000|Overall Study|Insufficient clinical response|2|||
129759261|NCT01176058|467081037|FG001|Overall Study|Insufficient clinical response|2|||
129759262|NCT01176058|467081036|FG000|Overall Study|Insufficient mycological response|0|||
129759263|NCT01176058|467081037|FG001|Overall Study|Insufficient mycological response|1|||
129759264|NCT01176058|467081036|FG000|Overall Study|Withdrawal by Subject|1|||
129759265|NCT01176058|467081037|FG001|Overall Study|Withdrawal by Subject|0|||
129759266|NCT03480152|467081038|FG000|Phase I|Signed consent. Died before treatment.|1|||
129759267|NCT03480152|467081039|FG001|Phase I|Signed consent. Died before treatment.|0|||
129759268|NCT03480152|467081040|FG002|Phase I|Signed consent. Died before treatment.|0|||
129759269|NCT00687401|467081041|FG000|Overall Study|Protocol Violation|7|||
129759270|NCT00687401|467081041|FG000|Overall Study|Adverse Event|6|||
129759271|NCT00687401|467081041|FG000|Overall Study|Lack of Efficacy|6|||
129759272|NCT00687401|467081041|FG000|Overall Study|Withdrawal by Subject|4|||
129759273|NCT00687401|467081041|FG000|Overall Study|Did not return for visit|3|||
129759274|NCT00687401|467081041|FG000|Overall Study|For reasons different from those above|4|||
129759275|NCT02920892|467081042|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
129759276|NCT02920892|467081043|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
129759277|NCT02920892|467081044|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
129759278|NCT02920892|467081042|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
129759279|NCT02920892|467081043|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
129759280|NCT02920892|467081044|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
129759281|NCT02920892|467081042|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
129759282|NCT02920892|467081043|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
129759283|NCT02920892|467081044|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
129759284|NCT02920892|467081042|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
129759285|NCT02920892|467081043|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
129759286|NCT02920892|467081044|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
129759287|NCT02920892|467081042|FG000|Placebo-Controlled Period|Physician Decision|0|||
129759288|NCT02920892|467081043|FG001|Placebo-Controlled Period|Physician Decision|0|||
129759289|NCT02920892|467081044|FG002|Placebo-Controlled Period|Physician Decision|1|||
129759290|NCT02920892|467081042|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
129759291|NCT02920892|467081043|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
129759292|NCT02920892|467081044|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
129759293|NCT02920892|467081042|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129759294|NCT02920892|467081043|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
129759295|NCT02920892|467081044|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
129759296|NCT02920892|467081042|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
129759297|NCT02920892|467081043|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
129759298|NCT02920892|467081044|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
129759299|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759300|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759301|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759302|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
129759303|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759304|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759305|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759306|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759307|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759308|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
129759309|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
129759310|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
129759311|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129759312|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
129759313|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
129759314|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
129759315|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129759316|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129759317|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129759318|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
129759319|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
129759320|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129759321|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129759322|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129759323|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
129759324|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
129759325|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129759326|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129759327|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129759328|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
129759329|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
129759330|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
129759331|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
129759332|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
129759333|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
129759334|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
129759335|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
129759336|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
129759337|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
129759338|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
129759339|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
129759340|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759341|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
129759342|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759343|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
129759344|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759345|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759346|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759347|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759348|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
129759349|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
129759350|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759351|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759352|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759353|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
129759354|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
129759355|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759356|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759357|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759358|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
129759359|NCT02365649|467081045|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759360|NCT02365649|467081046|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759361|NCT02365649|467081047|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
129759362|NCT02365649|467081048|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759363|NCT02365649|467081049|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759364|NCT02365649|467081050|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759365|NCT02365649|467081051|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759366|NCT02365649|467081052|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759367|NCT02365649|467081053|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759368|NCT02365649|467081054|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
129759369|NCT02365649|467081045|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759370|NCT02365649|467081046|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759371|NCT02365649|467081047|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759372|NCT02365649|467081048|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759373|NCT02365649|467081049|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759374|NCT02365649|467081050|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759375|NCT02365649|467081051|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
129759376|NCT02365649|467081052|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759377|NCT02365649|467081053|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759378|NCT02365649|467081054|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
129759379|NCT02365649|467081045|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129759380|NCT02365649|467081046|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129759381|NCT02365649|467081047|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129759382|NCT02365649|467081048|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129759383|NCT02365649|467081049|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129759384|NCT02365649|467081050|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129812399|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812400|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129759385|NCT02365649|467081051|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
129759386|NCT02365649|467081052|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
129759387|NCT02365649|467081053|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
129759388|NCT02365649|467081054|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
129759389|NCT02365649|467081045|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129759390|NCT02365649|467081046|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129759391|NCT02365649|467081047|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129759392|NCT02365649|467081048|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129759393|NCT02365649|467081049|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129759394|NCT02365649|467081050|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
129759395|NCT02365649|467081051|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
129759396|NCT02365649|467081052|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
129759397|NCT02365649|467081053|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
129759398|NCT02365649|467081054|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
129759399|NCT02365649|467081045|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129759400|NCT02365649|467081046|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129759401|NCT02365649|467081047|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129759402|NCT02365649|467081048|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129812401|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812402|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812403|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812404|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
129759403|NCT02365649|467081049|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129759404|NCT02365649|467081050|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129759405|NCT02365649|467081051|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
129759406|NCT02365649|467081052|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
129759407|NCT02365649|467081053|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
129759408|NCT02365649|467081054|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
129759409|NCT02365649|467081045|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759410|NCT02365649|467081046|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759411|NCT02365649|467081047|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759412|NCT02365649|467081048|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759413|NCT02365649|467081049|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759414|NCT02365649|467081050|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759415|NCT02365649|467081051|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
129759416|NCT02365649|467081052|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759417|NCT02365649|467081053|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
129759418|NCT02365649|467081054|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
129759419|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
129759420|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
129759421|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
129759422|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
129812405|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
129812406|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
129812407|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
129812408|NCT01847274|467280318|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812409|NCT01847274|467280319|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812410|NCT01847274|467280320|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812411|NCT01847274|467280321|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812412|NCT01847274|467280322|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812413|NCT01847274|467280323|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129759423|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
129759424|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
129759425|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
129759426|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
129759427|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
129759428|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
129759429|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
129759430|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
129759431|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
129759432|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
129759433|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
129759434|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
129759435|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
129759436|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
129759437|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
129759438|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
129759439|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
129759440|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
129759441|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
129759442|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
129759443|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
129759444|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
129759445|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
129759446|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
129759447|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
129759448|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
129759449|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
129759450|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
129759451|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
129759452|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
129759453|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
129759454|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
129759455|NCT02586623|467081059|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
129759456|NCT02586623|467081060|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
129759457|NCT02586623|467081061|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
129759458|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
129759459|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
129759460|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
129759461|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
129759462|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
129759463|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
129759464|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
129759465|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
129759466|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
129759467|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
129759468|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
129759469|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
129759470|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
129759471|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
129759472|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
129759473|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
129759474|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
129759475|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
129759476|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
129759477|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
129759478|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
129759479|NCT02586623|467081059|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
129759480|NCT02586623|467081060|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
129759481|NCT02586623|467081061|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
129759482|NCT02910466|467081064|FG000|Overall Study|Adverse Event|1|||
129759483|NCT02910466|467081064|FG000|Overall Study|Withdrawal by Subject|3|||
129759484|NCT02910466|467081064|FG000|Overall Study|Lost to Follow-up|5|||
129759485|NCT02910466|467081064|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
129759486|NCT02910466|467081064|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
129759487|NCT04332107|467081073|FG000|Day 3|Lost to Follow-up|23|||
129759488|NCT04332107|467081074|FG001|Day 3|Lost to Follow-up|14|||
129812414|NCT01847274|467280324|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129759489|NCT04332107|467081073|FG000|Day 3|Missing outcome data|3|||
129759490|NCT04332107|467081074|FG001|Day 3|Missing outcome data|6|||
129759491|NCT04332107|467081073|FG000|Day 14|Lost to Follow-up|13|||
129759492|NCT04332107|467081074|FG001|Day 14|Lost to Follow-up|4|||
129759493|NCT04332107|467081073|FG000|Day 14|Missing outcome data|4|||
129759494|NCT04332107|467081074|FG001|Day 14|Missing outcome data|4|||
129759495|NCT04332107|467081073|FG000|Day 21|Lost to Follow-up|10|||
129759496|NCT04332107|467081074|FG001|Day 21|Lost to Follow-up|2|||
129759497|NCT00871871|467081079|FG000|Part I|Adverse Event|0|||
129759498|NCT00871871|467081080|FG001|Part I|Adverse Event|2|||
129759499|NCT00871871|467081081|FG002|Part I|Adverse Event|0|||
129759500|NCT00871871|467081082|FG003|Part I|Adverse Event|0|||
129759501|NCT00871871|467081079|FG000|Part I|Withdrawal by Subject|3|||
129759502|NCT00871871|467081080|FG001|Part I|Withdrawal by Subject|0|||
129759503|NCT00871871|467081081|FG002|Part I|Withdrawal by Subject|0|||
129759504|NCT00871871|467081082|FG003|Part I|Withdrawal by Subject|0|||
129759505|NCT00871871|467081079|FG000|Part I|Laboratory abnormality|0|||
129759506|NCT00871871|467081080|FG001|Part I|Laboratory abnormality|1|||
129759507|NCT00871871|467081081|FG002|Part I|Laboratory abnormality|0|||
129759508|NCT00871871|467081082|FG003|Part I|Laboratory abnormality|0|||
129759509|NCT00871871|467081079|FG000|Part II|Lack of Efficacy|0|||
129759510|NCT00871871|467081080|FG001|Part II|Lack of Efficacy|0|||
129759511|NCT00871871|467081081|FG002|Part II|Lack of Efficacy|1|||
129759512|NCT00871871|467081082|FG003|Part II|Lack of Efficacy|0|||
129759513|NCT00871871|467081079|FG000|Part II|Withdrawal by Subject|0|||
129759514|NCT00871871|467081080|FG001|Part II|Withdrawal by Subject|0|||
129759515|NCT00871871|467081081|FG002|Part II|Withdrawal by Subject|2|||
129759516|NCT00871871|467081082|FG003|Part II|Withdrawal by Subject|1|||
129759517|NCT00871871|467081079|FG000|Part II|Adverse Event|0|||
129759518|NCT00871871|467081080|FG001|Part II|Adverse Event|0|||
129759519|NCT00871871|467081081|FG002|Part II|Adverse Event|1|||
129759520|NCT00871871|467081082|FG003|Part II|Adverse Event|2|||
129759521|NCT00871871|467081079|FG000|Part II|Protocol Violation|0|||
129759522|NCT00871871|467081080|FG001|Part II|Protocol Violation|0|||
129759523|NCT00871871|467081081|FG002|Part II|Protocol Violation|0|||
129759524|NCT00871871|467081082|FG003|Part II|Protocol Violation|1|||
129759525|NCT01808196|467081086|FG000|Overall Study|Lost to Follow-up|1|||
129759526|NCT00479713|467081089|FG000|Overall Study|Adverse Event|8|||
129759527|NCT00479713|467081090|FG001|Overall Study|Adverse Event|6|||
129759528|NCT00479713|467081089|FG000|Overall Study|Death|1|||
129759529|NCT00479713|467081090|FG001|Overall Study|Death|0|||
129759530|NCT00479713|467081089|FG000|Overall Study|Lost to Follow-up|0|||
129759531|NCT00479713|467081090|FG001|Overall Study|Lost to Follow-up|1|||
129759532|NCT00479713|467081089|FG000|Overall Study|Protocol Violation|0|||
129759533|NCT00479713|467081090|FG001|Overall Study|Protocol Violation|1|||
129759534|NCT00479713|467081089|FG000|Overall Study|Withdrawal by Subject|4|||
129759535|NCT00479713|467081090|FG001|Overall Study|Withdrawal by Subject|1|||
129759536|NCT03863509|467081091|FG000|Overall Study|COVID-19 shutdown period|0|||
129759537|NCT03863509|467081092|FG001|Overall Study|COVID-19 shutdown period|4|||
129759538|NCT03863509|467081093|FG002|Overall Study|COVID-19 shutdown period|0|||
129759539|NCT03863509|467081091|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
129759540|NCT03863509|467081092|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
129759541|NCT03863509|467081093|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
129759542|NCT03863509|467081091|FG000|Overall Study|Lost to Follow-up|8|||
129759543|NCT03863509|467081092|FG001|Overall Study|Lost to Follow-up|0|||
129759544|NCT03863509|467081093|FG002|Overall Study|Lost to Follow-up|2|||
129759545|NCT03863509|467081091|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
129759546|NCT03863509|467081092|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
129759547|NCT03863509|467081093|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
129759548|NCT03863509|467081091|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
129759549|NCT03863509|467081092|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
129759550|NCT03863509|467081093|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
129759551|NCT00141102|467081094|FG000|Overall Study|Adverse Event|233|||
129759552|NCT00141102|467081095|FG001|Overall Study|Adverse Event|305|||
129759553|NCT00141102|467081094|FG000|Overall Study|Laboratory Abnormality|9|||
129759554|NCT00141102|467081095|FG001|Overall Study|Laboratory Abnormality|33|||
129759555|NCT00141102|467081094|FG000|Overall Study|Lack of Efficacy|21|||
129896971|NCT04888585|467582179|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
129759556|NCT00141102|467081095|FG001|Overall Study|Lack of Efficacy|26|||
129759557|NCT00141102|467081094|FG000|Overall Study|Lost to Follow-up|29|||
129759558|NCT00141102|467081095|FG001|Overall Study|Lost to Follow-up|32|||
129759559|NCT00141102|467081094|FG000|Overall Study|Other|87|||
129759560|NCT00141102|467081095|FG001|Overall Study|Other|76|||
129759561|NCT00141102|467081094|FG000|Overall Study|Withdrawal by Subject|112|||
129759562|NCT00141102|467081095|FG001|Overall Study|Withdrawal by Subject|142|||
129759563|NCT00141102|467081094|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
129759564|NCT00141102|467081095|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
129759565|NCT00141102|467081094|FG000|Overall Study|Death|2|||
129759566|NCT00141102|467081095|FG001|Overall Study|Death|2|||
129759567|NCT01063153|467081099|FG000|Overall Study|Found Ineligible During Screening|2|||
129759568|NCT01063153|467081100|FG001|Overall Study|Found Ineligible During Screening|0|||
129759569|NCT01063153|467081099|FG000|Overall Study|Lost to Follow-up|0|||
129759570|NCT01063153|467081100|FG001|Overall Study|Lost to Follow-up|7|||
129759571|NCT01063153|467081099|FG000|Overall Study|Withdrawal by Subject|0|||
129759572|NCT01063153|467081100|FG001|Overall Study|Withdrawal by Subject|1|||
129759573|NCT01063153|467081099|FG000|Overall Study|Physician Decision|0|||
129759574|NCT01063153|467081100|FG001|Overall Study|Physician Decision|4|||
129759575|NCT00350844|467081101|FG000|Overall Study|Lost to Follow-up|1|||
129759576|NCT02775916|467081104|FG000|Overall Study|Adverse Event|1|||
129759577|NCT02775916|467081105|FG001|Overall Study|Adverse Event|0|||
129759578|NCT02775916|467081104|FG000|Overall Study|Subject/Guardian Decision|2|||
129759579|NCT02775916|467081105|FG001|Overall Study|Subject/Guardian Decision|0|||
129759580|NCT03737123|467083435|FG000|Study Treatment|Adverse Event|2|||
129759581|NCT03737123|467083436|FG001|Study Treatment|Adverse Event|0|||
129759582|NCT03737123|467083435|FG000|Study Treatment|Disease Progression|2|||
129759583|NCT03737123|467083436|FG001|Study Treatment|Disease Progression|0|||
129759584|NCT03737123|467083435|FG000|Study Treatment|Withdrawal by Subject|2|||
129759585|NCT03737123|467083436|FG001|Study Treatment|Withdrawal by Subject|0|||
129759586|NCT03737123|467083435|FG000|Follow up|Death|1|||
129759587|NCT03737123|467083436|FG001|Follow up|Death|0|||
129759588|NCT03737123|467083435|FG000|Follow up|Withdrawal by Subject|1|||
129759589|NCT03737123|467083436|FG001|Follow up|Withdrawal by Subject|0|||
129759590|NCT03737123|467083435|FG000|Follow up|Termination of study|4|||
129759591|NCT03737123|467083436|FG001|Follow up|Termination of study|0|||
129759592|NCT02173769|467083437|FG000|Overall Study|Protocol Violation|4|||
129759593|NCT03016312|467083444|FG000|Overall Study|discontinued before the treatment started|0|||
129759594|NCT03016312|467083445|FG001|Overall Study|discontinued before the treatment started|1|||
129759595|NCT03016312|467083444|FG000|Overall Study|Withdrawal by Subject|37|||
129759596|NCT03016312|467083445|FG001|Overall Study|Withdrawal by Subject|44|||
129759597|NCT03016312|467083444|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
129759598|NCT03016312|467083445|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
129759599|NCT03016312|467083444|FG000|Overall Study|Physician Decision|1|||
129759600|NCT03016312|467083445|FG001|Overall Study|Physician Decision|3|||
129759601|NCT03016312|467083444|FG000|Overall Study|Lost to Follow-up|12|||
129759602|NCT03016312|467083445|FG001|Overall Study|Lost to Follow-up|12|||
129759603|NCT03016312|467083444|FG000|Overall Study|Death|210|||
129759604|NCT03016312|467083445|FG001|Overall Study|Death|184|||
129759605|NCT03016312|467083444|FG000|Overall Study|loss to contact|1|||
129759606|NCT03016312|467083445|FG001|Overall Study|loss to contact|0|||
129759607|NCT03016312|467083444|FG000|Overall Study|started a new cancer therapy|1|||
129759608|NCT03016312|467083445|FG001|Overall Study|started a new cancer therapy|0|||
129759609|NCT00308139|467083447|FG000|Overall Study|Adverse Event|20|||
129759610|NCT00308139|467083448|FG001|Overall Study|Adverse Event|14|||
129759611|NCT00308139|467083447|FG000|Overall Study|Lost to Follow-up|13|||
129759612|NCT00308139|467083448|FG001|Overall Study|Lost to Follow-up|8|||
129759613|NCT00308139|467083447|FG000|Overall Study|Protocol Violation|3|||
129759614|NCT00308139|467083448|FG001|Overall Study|Protocol Violation|2|||
129759615|NCT00308139|467083447|FG000|Overall Study|Withdrawal of Consent|40|||
129759616|NCT00308139|467083448|FG001|Overall Study|Withdrawal of Consent|42|||
129759617|NCT00308139|467083447|FG000|Overall Study|Investigator Decision|11|||
129759618|NCT00308139|467083448|FG001|Overall Study|Investigator Decision|10|||
129759619|NCT00308139|467083447|FG000|Overall Study|Loss of Glucose Control|5|||
129759620|NCT00308139|467083448|FG001|Overall Study|Loss of Glucose Control|7|||
129759621|NCT00308139|467083447|FG000|Overall Study|Administrative|1|||
129759622|NCT00308139|467083448|FG001|Overall Study|Administrative|4|||
129759623|NCT00308139|467083447|FG000|Overall Study|Other|1|||
129759624|NCT00308139|467083448|FG001|Overall Study|Other|0|||
129759625|NCT01884077|467083449|FG000|Overall Study|screen fail|0|||
129759626|NCT01884077|467083450|FG001|Overall Study|screen fail|2|||
129759627|NCT01884077|467083449|FG000|Overall Study|canceled surgery|2|||
129759628|NCT01884077|467083450|FG001|Overall Study|canceled surgery|0|||
129759629|NCT01884077|467083449|FG000|Overall Study|Lost to Follow-up|0|||
129759630|NCT01884077|467083450|FG001|Overall Study|Lost to Follow-up|4|||
129759631|NCT01884077|467083449|FG000|Overall Study|study closed|6|||
129759632|NCT01884077|467083450|FG001|Overall Study|study closed|4|||
129759633|NCT00981149|467083451|FG000|Overall Study|Lost to Follow-up|1|||
129759634|NCT00981149|467083452|FG001|Overall Study|Lost to Follow-up|2|||
129759635|NCT00981149|467083451|FG000|Overall Study|Withdrawal by Subject|1|||
129759636|NCT00981149|467083452|FG001|Overall Study|Withdrawal by Subject|1|||
129759637|NCT01220167|467083456|FG000|Period 3|Urine positive for substance abuse|0|||
129759638|NCT01220167|467083457|FG001|Period 3|Urine positive for substance abuse|1|||
129759639|NCT01220167|467083458|FG002|Period 3|Urine positive for substance abuse|0|||
129759640|NCT05789745|467083459|FG000|Overall Study|Withdrawal by Subject|0|||
129759641|NCT05789745|467083460|FG001|Overall Study|Withdrawal by Subject|0|||
129759642|NCT05789745|467083461|FG002|Overall Study|Withdrawal by Subject|0|||
129759643|NCT05789745|467083462|FG003|Overall Study|Withdrawal by Subject|0|||
129759644|NCT05789745|467083463|FG004|Overall Study|Withdrawal by Subject|1|||
129759645|NCT02634333|467083466|FG000|Overall Study|Completed out of Window|3|||
129759646|NCT02634333|467083467|FG001|Overall Study|Completed out of Window|2|||
129759647|NCT02634333|467083466|FG000|Overall Study|Missed Visit|5|||
129759648|NCT02634333|467083467|FG001|Overall Study|Missed Visit|2|||
129759649|NCT02634333|467083466|FG000|Overall Study|Lost to Follow-up|12|||
129759650|NCT02634333|467083467|FG001|Overall Study|Lost to Follow-up|7|||
129759651|NCT02634333|467083466|FG000|Overall Study|Withdrawal by Subject|9|||
129759652|NCT02634333|467083467|FG001|Overall Study|Withdrawal by Subject|13|||
129759653|NCT02634333|467083466|FG000|Overall Study|Death|11|||
129759654|NCT02634333|467083467|FG001|Overall Study|Death|8|||
129759655|NCT04537793|467083468|FG000|Part B (24 Weeks)|Adverse Event|0|||
129759656|NCT04537793|467083469|FG001|Part B (24 Weeks)|Adverse Event|1|||
129759657|NCT05470387|467083470|FG000|Overall Study|Protocol Violation|0|||
129759658|NCT05470387|467083471|FG001|Overall Study|Protocol Violation|3|||
129759659|NCT01255423|467083472|FG000|Overall Study|Abnormal Laboratory value|3|||
129759660|NCT01255423|467083473|FG001|Overall Study|Abnormal Laboratory value|2|||
129759661|NCT01255423|467083472|FG000|Overall Study|Use of prohibited medications|0|||
129759662|NCT01255423|467083473|FG001|Overall Study|Use of prohibited medications|1|||
129759663|NCT01858363|467083474|FG000|Overall Study|Death|35|||
129759664|NCT01858363|467083475|FG001|Overall Study|Death|9|||
129759665|NCT01858363|467083474|FG000|Overall Study|Withdrawal by Subject|28|||
129759666|NCT01858363|467083475|FG001|Overall Study|Withdrawal by Subject|14|||
129759667|NCT01858363|467083474|FG000|Overall Study|Lost to Follow-up|13|||
129759668|NCT01858363|467083475|FG001|Overall Study|Lost to Follow-up|3|||
129759669|NCT00101686|467083480|FG000|Overall Study|Progressive Disease|37|||
129759670|NCT00101686|467083481|FG001|Overall Study|Progressive Disease|28|||
129759671|NCT00101686|467083482|FG002|Overall Study|Progressive Disease|37|||
129759672|NCT00101686|467083483|FG003|Overall Study|Progressive Disease|38|||
129759673|NCT00101686|467083484|FG004|Overall Study|Progressive Disease|28|||
129759674|NCT00101686|467083485|FG005|Overall Study|Progressive Disease|25|||
129759675|NCT00101686|467083486|FG006|Overall Study|Progressive Disease|5|||
129759676|NCT00101686|467083487|FG007|Overall Study|Progressive Disease|7|||
129759677|NCT00101686|467083488|FG008|Overall Study|Progressive Disease|10|||
129759678|NCT00101686|467083489|FG009|Overall Study|Progressive Disease|8|||
129759679|NCT00101686|467083480|FG000|Overall Study|initiation other anti-cancer treatment|4|||
129759680|NCT00101686|467083481|FG001|Overall Study|initiation other anti-cancer treatment|3|||
129759681|NCT00101686|467083482|FG002|Overall Study|initiation other anti-cancer treatment|4|||
129759682|NCT00101686|467083483|FG003|Overall Study|initiation other anti-cancer treatment|3|||
129759683|NCT00101686|467083484|FG004|Overall Study|initiation other anti-cancer treatment|1|||
129759684|NCT00101686|467083485|FG005|Overall Study|initiation other anti-cancer treatment|1|||
129759685|NCT00101686|467083486|FG006|Overall Study|initiation other anti-cancer treatment|2|||
129759686|NCT00101686|467083487|FG007|Overall Study|initiation other anti-cancer treatment|2|||
129759687|NCT00101686|467083488|FG008|Overall Study|initiation other anti-cancer treatment|3|||
129759688|NCT00101686|467083489|FG009|Overall Study|initiation other anti-cancer treatment|3|||
129759689|NCT00101686|467083480|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
129759690|NCT00101686|467083481|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
129759691|NCT00101686|467083482|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
129759692|NCT00101686|467083483|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
129759693|NCT00101686|467083484|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
129759694|NCT00101686|467083485|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
129759695|NCT00101686|467083486|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
129759696|NCT00101686|467083487|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
129759697|NCT00101686|467083488|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
129759698|NCT00101686|467083489|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
129759699|NCT00101686|467083480|FG000|Overall Study|unacceptable toxicity|3|||
129759700|NCT00101686|467083481|FG001|Overall Study|unacceptable toxicity|9|||
129759701|NCT00101686|467083482|FG002|Overall Study|unacceptable toxicity|10|||
129759702|NCT00101686|467083483|FG003|Overall Study|unacceptable toxicity|6|||
129759703|NCT00101686|467083484|FG004|Overall Study|unacceptable toxicity|16|||
129759704|NCT00101686|467083485|FG005|Overall Study|unacceptable toxicity|10|||
129759705|NCT00101686|467083486|FG006|Overall Study|unacceptable toxicity|4|||
129759706|NCT00101686|467083487|FG007|Overall Study|unacceptable toxicity|2|||
129759707|NCT00101686|467083488|FG008|Overall Study|unacceptable toxicity|1|||
129759708|NCT00101686|467083489|FG009|Overall Study|unacceptable toxicity|4|||
129759709|NCT00101686|467083480|FG000|Overall Study|Randomized but did not receive treament|1|||
129759710|NCT00101686|467083481|FG001|Overall Study|Randomized but did not receive treament|6|||
129759711|NCT00101686|467083482|FG002|Overall Study|Randomized but did not receive treament|2|||
129759712|NCT00101686|467083483|FG003|Overall Study|Randomized but did not receive treament|2|||
129759713|NCT00101686|467083484|FG004|Overall Study|Randomized but did not receive treament|2|||
129896972|NCT04888585|467582180|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
129759714|NCT00101686|467083485|FG005|Overall Study|Randomized but did not receive treament|2|||
129759715|NCT00101686|467083486|FG006|Overall Study|Randomized but did not receive treament|0|||
129759716|NCT00101686|467083487|FG007|Overall Study|Randomized but did not receive treament|1|||
129759717|NCT00101686|467083488|FG008|Overall Study|Randomized but did not receive treament|0|||
129759718|NCT00101686|467083489|FG009|Overall Study|Randomized but did not receive treament|1|||
129759719|NCT00101686|467083480|FG000|Overall Study|intercurrent non-cancer related illness|0|||
129759720|NCT00101686|467083481|FG001|Overall Study|intercurrent non-cancer related illness|0|||
129759721|NCT00101686|467083482|FG002|Overall Study|intercurrent non-cancer related illness|2|||
129759722|NCT00101686|467083483|FG003|Overall Study|intercurrent non-cancer related illness|0|||
129759723|NCT00101686|467083484|FG004|Overall Study|intercurrent non-cancer related illness|1|||
129759724|NCT00101686|467083485|FG005|Overall Study|intercurrent non-cancer related illness|3|||
129759725|NCT00101686|467083486|FG006|Overall Study|intercurrent non-cancer related illness|1|||
129759726|NCT00101686|467083487|FG007|Overall Study|intercurrent non-cancer related illness|0|||
129759727|NCT00101686|467083488|FG008|Overall Study|intercurrent non-cancer related illness|1|||
129759728|NCT00101686|467083489|FG009|Overall Study|intercurrent non-cancer related illness|1|||
129759729|NCT00101686|467083480|FG000|Overall Study|Physician Decision|10|||
129759730|NCT00101686|467083481|FG001|Overall Study|Physician Decision|13|||
129759731|NCT00101686|467083482|FG002|Overall Study|Physician Decision|6|||
129759732|NCT00101686|467083483|FG003|Overall Study|Physician Decision|7|||
129759733|NCT00101686|467083484|FG004|Overall Study|Physician Decision|8|||
129759734|NCT00101686|467083485|FG005|Overall Study|Physician Decision|9|||
129759735|NCT00101686|467083486|FG006|Overall Study|Physician Decision|5|||
129759736|NCT00101686|467083487|FG007|Overall Study|Physician Decision|5|||
129759737|NCT00101686|467083488|FG008|Overall Study|Physician Decision|1|||
129759738|NCT00101686|467083489|FG009|Overall Study|Physician Decision|1|||
129759739|NCT00101686|467083480|FG000|Overall Study|Other|1|||
129759740|NCT00101686|467083481|FG001|Overall Study|Other|4|||
129759741|NCT00101686|467083482|FG002|Overall Study|Other|1|||
129759742|NCT00101686|467083483|FG003|Overall Study|Other|6|||
129759743|NCT00101686|467083484|FG004|Overall Study|Other|2|||
129759744|NCT00101686|467083485|FG005|Overall Study|Other|12|||
129759745|NCT00101686|467083486|FG006|Overall Study|Other|1|||
129759746|NCT00101686|467083487|FG007|Overall Study|Other|5|||
129759747|NCT00101686|467083488|FG008|Overall Study|Other|3|||
129759748|NCT00101686|467083489|FG009|Overall Study|Other|3|||
129759749|NCT00101686|467083480|FG000|Overall Study|Withdrawal by Subject|9|||
129759750|NCT00101686|467083481|FG001|Overall Study|Withdrawal by Subject|8|||
129759751|NCT00101686|467083482|FG002|Overall Study|Withdrawal by Subject|6|||
129759752|NCT00101686|467083483|FG003|Overall Study|Withdrawal by Subject|8|||
129759753|NCT00101686|467083484|FG004|Overall Study|Withdrawal by Subject|8|||
129759754|NCT00101686|467083485|FG005|Overall Study|Withdrawal by Subject|7|||
129759755|NCT00101686|467083486|FG006|Overall Study|Withdrawal by Subject|7|||
129759756|NCT00101686|467083487|FG007|Overall Study|Withdrawal by Subject|7|||
129759757|NCT00101686|467083488|FG008|Overall Study|Withdrawal by Subject|8|||
129759758|NCT00101686|467083489|FG009|Overall Study|Withdrawal by Subject|9|||
129759759|NCT00890825|467083490|FG000|Overall Study|Withdrawal by Subject|1|||
129759760|NCT00890825|467083491|FG001|Overall Study|Withdrawal by Subject|0|||
129759761|NCT00890825|467083490|FG000|Overall Study|Alive at data cut off (DCO)|13|||
129759762|NCT00890825|467083491|FG001|Overall Study|Alive at data cut off (DCO)|14|||
129759763|NCT04486235|467083494|FG000|Overall Study|Pregnancy|1|||
129759764|NCT04486235|467083495|FG001|Overall Study|Pregnancy|0|||
129759765|NCT04486235|467083494|FG000|Overall Study|Lost to Follow-up|1|||
129759766|NCT04486235|467083495|FG001|Overall Study|Lost to Follow-up|0|||
129759767|NCT02520726|467083496|FG000|Overall Study|Lost to Follow-up|3|||
129759768|NCT02520726|467083497|FG001|Overall Study|Lost to Follow-up|2|||
129759769|NCT01092728|467083498|FG000|Overall Study|Withdrawal by Subject|2|||
129759770|NCT01092728|467083499|FG001|Overall Study|Withdrawal by Subject|0|||
129759771|NCT01092728|467083498|FG000|Overall Study|Adverse Event|0|||
129759772|NCT01092728|467083499|FG001|Overall Study|Adverse Event|1|||
129759773|NCT01092728|467083498|FG000|Overall Study|Disease Progression|1|||
129759774|NCT01092728|467083499|FG001|Overall Study|Disease Progression|13|||
129759775|NCT01092728|467083498|FG000|Overall Study|Prohibited Concomitant Medications|1|||
129759776|NCT01092728|467083499|FG001|Overall Study|Prohibited Concomitant Medications|0|||
129759777|NCT00721396|467083500|FG000|Overall Study|Adverse Event|4|||
129759778|NCT00721396|467083501|FG001|Overall Study|Adverse Event|7|||
129759779|NCT00721396|467083502|FG002|Overall Study|Adverse Event|2|||
129759780|NCT00721396|467083503|FG003|Overall Study|Adverse Event|0|||
129759781|NCT00721396|467083500|FG000|Overall Study|Withdrawal by Subject|12|||
129759782|NCT00721396|467083501|FG001|Overall Study|Withdrawal by Subject|15|||
129759783|NCT00721396|467083502|FG002|Overall Study|Withdrawal by Subject|3|||
129759784|NCT00721396|467083503|FG003|Overall Study|Withdrawal by Subject|7|||
129759785|NCT00721396|467083500|FG000|Overall Study|Lost to Follow-up|7|||
129759786|NCT00721396|467083501|FG001|Overall Study|Lost to Follow-up|9|||
129759787|NCT00721396|467083502|FG002|Overall Study|Lost to Follow-up|3|||
129759788|NCT00721396|467083503|FG003|Overall Study|Lost to Follow-up|3|||
129759789|NCT00721396|467083500|FG000|Overall Study|Protocol Violation|4|||
129759790|NCT00721396|467083501|FG001|Overall Study|Protocol Violation|3|||
129759791|NCT00721396|467083502|FG002|Overall Study|Protocol Violation|1|||
129759792|NCT00721396|467083503|FG003|Overall Study|Protocol Violation|0|||
129759793|NCT00721396|467083500|FG000|Overall Study|Inappropriate enrollment|0|||
129759794|NCT00721396|467083501|FG001|Overall Study|Inappropriate enrollment|2|||
129759795|NCT00721396|467083502|FG002|Overall Study|Inappropriate enrollment|0|||
129759796|NCT00721396|467083503|FG003|Overall Study|Inappropriate enrollment|0|||
129759797|NCT00721396|467083500|FG000|Overall Study|Administrative reason|3|||
129759798|NCT00721396|467083501|FG001|Overall Study|Administrative reason|0|||
129759799|NCT00721396|467083502|FG002|Overall Study|Administrative reason|1|||
129759800|NCT00721396|467083503|FG003|Overall Study|Administrative reason|0|||
129759801|NCT03546621|467083504|FG000|Overall Study|Withdrawal by Subject|0|||
129759802|NCT03546621|467083505|FG001|Overall Study|Withdrawal by Subject|1|||
129759803|NCT03546621|467083506|FG002|Overall Study|Withdrawal by Subject|2|||
129759804|NCT03546621|467083507|FG003|Overall Study|Withdrawal by Subject|1|||
129759805|NCT03546621|467083504|FG000|Overall Study|Lost to Follow-up|0|||
129759806|NCT03546621|467083505|FG001|Overall Study|Lost to Follow-up|1|||
129759807|NCT03546621|467083506|FG002|Overall Study|Lost to Follow-up|0|||
129759808|NCT03546621|467083507|FG003|Overall Study|Lost to Follow-up|0|||
129759809|NCT03546621|467083504|FG000|Overall Study|Adverse Event|0|||
129759810|NCT03546621|467083505|FG001|Overall Study|Adverse Event|1|||
129759811|NCT03546621|467083506|FG002|Overall Study|Adverse Event|0|||
129759812|NCT03546621|467083507|FG003|Overall Study|Adverse Event|1|||
129759813|NCT03546621|467083504|FG000|Overall Study|Progressive disease|0|||
129759814|NCT03546621|467083505|FG001|Overall Study|Progressive disease|0|||
129759815|NCT03546621|467083506|FG002|Overall Study|Progressive disease|0|||
129759816|NCT03546621|467083507|FG003|Overall Study|Progressive disease|1|||
129759817|NCT01506271|467083509|FG000|Overall Study|Progressive disease|0|||
129759818|NCT01506271|467083510|FG001|Overall Study|Progressive disease|1|||
129759819|NCT01506271|467083511|FG002|Overall Study|Progressive disease|0|||
129759820|NCT01506271|467083509|FG000|Overall Study|Protocol Violation|3|||
129759821|NCT01506271|467083510|FG001|Overall Study|Protocol Violation|1|||
129759822|NCT01506271|467083511|FG002|Overall Study|Protocol Violation|0|||
129759823|NCT01506271|467083509|FG000|Overall Study|Death|0|||
129759824|NCT01506271|467083510|FG001|Overall Study|Death|1|||
129759825|NCT01506271|467083511|FG002|Overall Study|Death|0|||
129759826|NCT01506271|467083509|FG000|Overall Study|Adverse Event|0|||
129759827|NCT01506271|467083510|FG001|Overall Study|Adverse Event|2|||
129759828|NCT01506271|467083511|FG002|Overall Study|Adverse Event|0|||
129759829|NCT01506271|467083509|FG000|Overall Study|Insufficient supply of study drug|1|||
129759830|NCT01506271|467083510|FG001|Overall Study|Insufficient supply of study drug|0|||
129759831|NCT01506271|467083511|FG002|Overall Study|Insufficient supply of study drug|0|||
129759832|NCT01506271|467083509|FG000|Overall Study|Withdrawal by Subject|0|||
129759833|NCT01506271|467083510|FG001|Overall Study|Withdrawal by Subject|1|||
129759834|NCT01506271|467083511|FG002|Overall Study|Withdrawal by Subject|1|||
129759835|NCT01506271|467083509|FG000|Overall Study|Lost to Follow-up|0|||
129759836|NCT01506271|467083510|FG001|Overall Study|Lost to Follow-up|1|||
129759837|NCT01506271|467083511|FG002|Overall Study|Lost to Follow-up|2|||
129759838|NCT02021565|467083517|FG000|Baseline Through Intervention|Death|0|||
129759839|NCT02021565|467083518|FG001|Baseline Through Intervention|Death|1|||
129759840|NCT02021565|467083517|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
129759841|NCT02021565|467083518|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
129759842|NCT02021565|467083517|FG000|Baseline Through Intervention|Protocol Violation|0|||
129759843|NCT02021565|467083518|FG001|Baseline Through Intervention|Protocol Violation|7|||
129759844|NCT02021565|467083517|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
129759845|NCT02021565|467083518|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
129759846|NCT02021565|467083517|FG000|3-month Follow-up|Death|3|||
129759847|NCT02021565|467083518|FG001|3-month Follow-up|Death|0|||
129759848|NCT02021565|467083517|FG000|3-month Follow-up|Withdrawal by Subject|4|||
129759849|NCT02021565|467083518|FG001|3-month Follow-up|Withdrawal by Subject|0|||
129759850|NCT02021565|467083517|FG000|3-month Follow-up|Protocol Violation|3|||
129759851|NCT02021565|467083518|FG001|3-month Follow-up|Protocol Violation|2|||
129759852|NCT03040141|467083519|FG000|Overall Study|Death|1|||
129759853|NCT03040141|467083520|FG001|Overall Study|Death|2|||
129759854|NCT03040141|467083521|FG002|Overall Study|Death|3|||
129759855|NCT03040141|467083519|FG000|Overall Study|Withdrawal by Subject|3|||
129759856|NCT03040141|467083520|FG001|Overall Study|Withdrawal by Subject|1|||
129759857|NCT03040141|467083521|FG002|Overall Study|Withdrawal by Subject|1|||
129759858|NCT03040141|467083519|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
129759859|NCT03040141|467083520|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
129759860|NCT03040141|467083521|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
129759861|NCT03040141|467083519|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
129812415|NCT01847274|467280325|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812416|NCT01847274|467280326|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129812417|NCT01847274|467280327|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
129812418|NCT01847274|467280328|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
129759862|NCT03040141|467083520|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
129759863|NCT03040141|467083521|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
129759864|NCT03318549|467083522|FG000|Overall Study|Withdrawal by Subject|5|||
129759865|NCT03318549|467083523|FG001|Overall Study|Withdrawal by Subject|19|||
129759866|NCT03318549|467083524|FG002|Overall Study|Withdrawal by Subject|2|||
129759867|NCT03318549|467083525|FG003|Overall Study|Withdrawal by Subject|0|||
129759868|NCT03318549|467083526|FG004|Overall Study|Withdrawal by Subject|0|||
129759869|NCT03318549|467083527|FG005|Overall Study|Withdrawal by Subject|0|||
129759870|NCT03318549|467083528|FG006|Overall Study|Withdrawal by Subject|0|||
129759871|NCT03318549|467083522|FG000|Overall Study|Physician Decision|0|||
129759872|NCT03318549|467083523|FG001|Overall Study|Physician Decision|4|||
129759873|NCT03318549|467083524|FG002|Overall Study|Physician Decision|1|||
129759874|NCT03318549|467083525|FG003|Overall Study|Physician Decision|0|||
129759875|NCT03318549|467083526|FG004|Overall Study|Physician Decision|0|||
129759876|NCT03318549|467083527|FG005|Overall Study|Physician Decision|0|||
129759877|NCT03318549|467083528|FG006|Overall Study|Physician Decision|0|||
129759878|NCT03318549|467083522|FG000|Overall Study|Lost to Follow-up|0|||
129759879|NCT03318549|467083523|FG001|Overall Study|Lost to Follow-up|3|||
129759880|NCT03318549|467083524|FG002|Overall Study|Lost to Follow-up|3|||
129759881|NCT03318549|467083525|FG003|Overall Study|Lost to Follow-up|0|||
129759882|NCT03318549|467083526|FG004|Overall Study|Lost to Follow-up|0|||
129759883|NCT03318549|467083527|FG005|Overall Study|Lost to Follow-up|0|||
129759884|NCT03318549|467083528|FG006|Overall Study|Lost to Follow-up|0|||
129759885|NCT00462306|467083529|FG000|Overall Study|insufficient data|0|||
129759886|NCT00462306|467083530|FG001|Overall Study|insufficient data|13|||
129759887|NCT01391663|467083531|FG000|Overall Study|Withdrawal by Subject|0|||
129759888|NCT01391663|467083532|FG001|Overall Study|Withdrawal by Subject|0|||
129759889|NCT01391663|467083533|FG002|Overall Study|Withdrawal by Subject|1|||
129759890|NCT01391663|467083534|FG003|Overall Study|Withdrawal by Subject|0|||
129759891|NCT03515824|467083535|FG000|Overall Study|Death|3|||
129759892|NCT03515824|467083536|FG001|Overall Study|Death|2|||
129759893|NCT03515824|467083537|FG002|Overall Study|Death|6|||
129759894|NCT03515824|467083538|FG003|Overall Study|Death|0|||
129759895|NCT03515824|467083535|FG000|Overall Study|Lost to Follow-up|0|||
129759896|NCT03515824|467083536|FG001|Overall Study|Lost to Follow-up|1|||
129759897|NCT03515824|467083537|FG002|Overall Study|Lost to Follow-up|1|||
129759898|NCT03515824|467083538|FG003|Overall Study|Lost to Follow-up|0|||
129759899|NCT03515824|467083535|FG000|Overall Study|Study terminated by sponsor|0|||
129759900|NCT03515824|467083536|FG001|Overall Study|Study terminated by sponsor|1|||
129759901|NCT03515824|467083537|FG002|Overall Study|Study terminated by sponsor|6|||
129759902|NCT03515824|467083538|FG003|Overall Study|Study terminated by sponsor|0|||
129759903|NCT03515824|467083535|FG000|Overall Study|Status not recorded|0|||
129759904|NCT03515824|467083536|FG001|Overall Study|Status not recorded|0|||
129759905|NCT03515824|467083537|FG002|Overall Study|Status not recorded|2|||
129759906|NCT03515824|467083538|FG003|Overall Study|Status not recorded|0|||
129759907|NCT00920855|467083539|FG000|Overall Study|Adverse Event|1|||
129759908|NCT00920855|467083540|FG001|Overall Study|Adverse Event|1|||
129759909|NCT00920855|467083541|FG002|Overall Study|Adverse Event|4|||
129759910|NCT00920855|467083539|FG000|Overall Study|Withdrawal by Subject|2|||
129759911|NCT00920855|467083540|FG001|Overall Study|Withdrawal by Subject|1|||
129759912|NCT00920855|467083541|FG002|Overall Study|Withdrawal by Subject|6|||
129759913|NCT00920855|467083539|FG000|Overall Study|Disease progression|2|||
129759914|NCT00920855|467083540|FG001|Overall Study|Disease progression|1|||
129759915|NCT00920855|467083541|FG002|Overall Study|Disease progression|10|||
129759916|NCT00920855|467083539|FG000|Overall Study|Noncompliance to study medication|0|||
129759917|NCT00920855|467083540|FG001|Overall Study|Noncompliance to study medication|0|||
129759918|NCT00920855|467083541|FG002|Overall Study|Noncompliance to study medication|1|||
129759919|NCT00920855|467083539|FG000|Overall Study|Response plateau; started maintenance|0|||
129759920|NCT00920855|467083540|FG001|Overall Study|Response plateau; started maintenance|0|||
129759921|NCT00920855|467083541|FG002|Overall Study|Response plateau; started maintenance|1|||
129759922|NCT00539994|467083543|FG000|Overall Study|Lost to Follow-up|2|||
129759923|NCT00539994|467083544|FG001|Overall Study|Lost to Follow-up|1|||
129759924|NCT00539994|467083545|FG002|Overall Study|Lost to Follow-up|0|||
129759925|NCT00539994|467083543|FG000|Overall Study|Withdrawal by Subject|1|||
129759926|NCT00539994|467083544|FG001|Overall Study|Withdrawal by Subject|0|||
129759927|NCT00539994|467083545|FG002|Overall Study|Withdrawal by Subject|1|||
129759928|NCT00539994|467083543|FG000|Overall Study|Physician Decision|0|||
129759929|NCT00539994|467083544|FG001|Overall Study|Physician Decision|0|||
129759930|NCT00539994|467083545|FG002|Overall Study|Physician Decision|1|||
129759931|NCT00510835|467083547|FG000|Overall Study|Withdrawal by Subject|6|||
129759932|NCT00510835|467083548|FG001|Overall Study|Withdrawal by Subject|2|||
129759933|NCT00510835|467083549|FG002|Overall Study|Withdrawal by Subject|2|||
129759934|NCT03084796|467083550|FG000|Overall Study|Adverse Event|4|||
129759935|NCT03084796|467083551|FG001|Overall Study|Adverse Event|5|||
129759936|NCT03084796|467083552|FG002|Overall Study|Adverse Event|6|||
129759937|NCT03084796|467083553|FG003|Overall Study|Adverse Event|2|||
129759938|NCT03084796|467083554|FG004|Overall Study|Adverse Event|3|||
129759939|NCT03084796|467083555|FG005|Overall Study|Adverse Event|5|||
129759940|NCT03084796|467083550|FG000|Overall Study|Withdrawal by Subject|3|||
129759941|NCT03084796|467083551|FG001|Overall Study|Withdrawal by Subject|5|||
129759942|NCT03084796|467083552|FG002|Overall Study|Withdrawal by Subject|2|||
129759943|NCT03084796|467083553|FG003|Overall Study|Withdrawal by Subject|1|||
129759944|NCT03084796|467083554|FG004|Overall Study|Withdrawal by Subject|3|||
129759945|NCT03084796|467083555|FG005|Overall Study|Withdrawal by Subject|0|||
129759946|NCT03084796|467083550|FG000|Overall Study|Protocol Violation|0|||
129759947|NCT03084796|467083551|FG001|Overall Study|Protocol Violation|0|||
129759948|NCT03084796|467083552|FG002|Overall Study|Protocol Violation|1|||
129759949|NCT03084796|467083553|FG003|Overall Study|Protocol Violation|0|||
129759950|NCT03084796|467083554|FG004|Overall Study|Protocol Violation|1|||
129759951|NCT03084796|467083555|FG005|Overall Study|Protocol Violation|1|||
129759952|NCT03084796|467083550|FG000|Overall Study|Lack of Efficacy|0|||
129759953|NCT03084796|467083551|FG001|Overall Study|Lack of Efficacy|0|||
129759954|NCT03084796|467083552|FG002|Overall Study|Lack of Efficacy|1|||
129759955|NCT03084796|467083553|FG003|Overall Study|Lack of Efficacy|0|||
129759956|NCT03084796|467083554|FG004|Overall Study|Lack of Efficacy|1|||
129759957|NCT03084796|467083555|FG005|Overall Study|Lack of Efficacy|0|||
129759958|NCT03084796|467083550|FG000|Overall Study|Lost to Follow-up|0|||
129759959|NCT03084796|467083551|FG001|Overall Study|Lost to Follow-up|0|||
129759960|NCT03084796|467083552|FG002|Overall Study|Lost to Follow-up|1|||
129759961|NCT03084796|467083553|FG003|Overall Study|Lost to Follow-up|1|||
129759962|NCT03084796|467083554|FG004|Overall Study|Lost to Follow-up|3|||
129759963|NCT03084796|467083555|FG005|Overall Study|Lost to Follow-up|1|||
129759964|NCT03084796|467083550|FG000|Overall Study|Randomization error|0|||
129759965|NCT03084796|467083551|FG001|Overall Study|Randomization error|0|||
129759966|NCT03084796|467083552|FG002|Overall Study|Randomization error|1|||
129759967|NCT03084796|467083553|FG003|Overall Study|Randomization error|0|||
129759968|NCT03084796|467083554|FG004|Overall Study|Randomization error|0|||
129759969|NCT03084796|467083555|FG005|Overall Study|Randomization error|0|||
129759970|NCT05470985|467083556|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
129759971|NCT05470985|467083557|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
129759972|NCT05470985|467083556|FG000|Double Blind Treatment Period|Physician Decision|0|||
129759973|NCT05470985|467083557|FG001|Double Blind Treatment Period|Physician Decision|1|||
129759974|NCT05470985|467083556|FG000|Long Term Extension|Adverse Event|0|||
129759975|NCT05470985|467083557|FG001|Long Term Extension|Adverse Event|1|||
129759976|NCT05470985|467083556|FG000|Long Term Extension|Study terminated by sponsor|2|||
129759977|NCT05470985|467083557|FG001|Long Term Extension|Study terminated by sponsor|0|||
129759978|NCT02741245|467083561|FG000|Overall Study|Adverse Event|0|||
129759979|NCT02741245|467083562|FG001|Overall Study|Adverse Event|0|||
129759980|NCT02741245|467083563|FG002|Overall Study|Adverse Event|0|||
129759981|NCT02741245|467083564|FG003|Overall Study|Adverse Event|2|||
129759982|NCT02741245|467083565|FG004|Overall Study|Adverse Event|2|||
129759983|NCT02741245|467083561|FG000|Overall Study|Protocol Violation|0|||
129759984|NCT02741245|467083562|FG001|Overall Study|Protocol Violation|1|||
129759985|NCT02741245|467083563|FG002|Overall Study|Protocol Violation|0|||
129759986|NCT02741245|467083564|FG003|Overall Study|Protocol Violation|1|||
129759987|NCT02741245|467083565|FG004|Overall Study|Protocol Violation|0|||
129759988|NCT02741245|467083561|FG000|Overall Study|Withdrawal by Subject|0|||
129759989|NCT02741245|467083562|FG001|Overall Study|Withdrawal by Subject|0|||
129759990|NCT02741245|467083563|FG002|Overall Study|Withdrawal by Subject|0|||
129759991|NCT02741245|467083564|FG003|Overall Study|Withdrawal by Subject|1|||
129759992|NCT02741245|467083565|FG004|Overall Study|Withdrawal by Subject|0|||
129759993|NCT00607087|467083567|FG000|Overall Study|Withdrawal by Subject|9|||
129759994|NCT00607087|467083568|FG001|Overall Study|Withdrawal by Subject|4|||
129759995|NCT00607087|467083569|FG002|Overall Study|Withdrawal by Subject|4|||
129759996|NCT00607087|467083567|FG000|Overall Study|Adverse Event|3|||
129759997|NCT00607087|467083568|FG001|Overall Study|Adverse Event|2|||
129759998|NCT00607087|467083569|FG002|Overall Study|Adverse Event|3|||
129759999|NCT00607087|467083567|FG000|Overall Study|Other reason|1|||
129760000|NCT00607087|467083568|FG001|Overall Study|Other reason|5|||
129760001|NCT00607087|467083569|FG002|Overall Study|Other reason|2|||
129760002|NCT00607087|467083567|FG000|Overall Study|Poor compliance to protocol|1|||
129812419|NCT03727230|467280329|FG000|Overall Study|Lost to Follow-up|12|||
129812420|NCT04377620|467280331|FG000|Overall Study|Death|42|||
129812421|NCT04377620|467280332|FG001|Overall Study|Death|48|||
129760003|NCT00607087|467083568|FG001|Overall Study|Poor compliance to protocol|0|||
129760004|NCT00607087|467083569|FG002|Overall Study|Poor compliance to protocol|1|||
129760005|NCT00607087|467083567|FG000|Overall Study|Lost to Follow-up|1|||
129760006|NCT00607087|467083568|FG001|Overall Study|Lost to Follow-up|0|||
129760007|NCT00607087|467083569|FG002|Overall Study|Lost to Follow-up|0|||
129760008|NCT00607087|467083567|FG000|Period 1|Withdrawal by Subject|7|||
129760009|NCT00607087|467083568|FG001|Period 1|Withdrawal by Subject|2|||
129760010|NCT00607087|467083569|FG002|Period 1|Withdrawal by Subject|3|||
129760011|NCT00607087|467083567|FG000|Period 1|Adverse Event|3|||
129760012|NCT00607087|467083568|FG001|Period 1|Adverse Event|0|||
129812422|NCT04377620|467280333|FG002|Overall Study|Death|36|||
129812423|NCT04377620|467280331|FG000|Overall Study|Withdrawal by Subject|0|||
129760013|NCT00607087|467083569|FG002|Period 1|Adverse Event|0|||
129760014|NCT00607087|467083567|FG000|Period 1|Poor compliance to protocol|1|||
129760015|NCT00607087|467083568|FG001|Period 1|Poor compliance to protocol|0|||
129760016|NCT00607087|467083569|FG002|Period 1|Poor compliance to protocol|0|||
129760017|NCT00607087|467083567|FG000|Period 1|Lost to Follow-up|1|||
129760018|NCT00607087|467083568|FG001|Period 1|Lost to Follow-up|0|||
129760019|NCT00607087|467083569|FG002|Period 1|Lost to Follow-up|0|||
129760020|NCT00607087|467083567|FG000|Period 1|Other reason|0|||
129760021|NCT00607087|467083568|FG001|Period 1|Other reason|4|||
129760022|NCT00607087|467083569|FG002|Period 1|Other reason|2|||
129760023|NCT00607087|467083567|FG000|Period 2|Withdrawal by Subject|0|||
129760024|NCT00607087|467083568|FG001|Period 2|Withdrawal by Subject|1|||
129760025|NCT00607087|467083569|FG002|Period 2|Withdrawal by Subject|1|||
129760026|NCT00607087|467083567|FG000|Period 2|Other reason|1|||
129760027|NCT00607087|467083568|FG001|Period 2|Other reason|1|||
129760028|NCT00607087|467083569|FG002|Period 2|Other reason|0|||
129760029|NCT00607087|467083567|FG000|Period 2|Adverse Event|0|||
129760030|NCT00607087|467083568|FG001|Period 2|Adverse Event|1|||
129760031|NCT00607087|467083569|FG002|Period 2|Adverse Event|3|||
129760032|NCT00607087|467083567|FG000|Period 2|Poor compliance to protocol|0|||
129760033|NCT00607087|467083568|FG001|Period 2|Poor compliance to protocol|0|||
129760034|NCT00607087|467083569|FG002|Period 2|Poor compliance to protocol|1|||
129760035|NCT00607087|467083567|FG000|Period 3|Withdrawal by Subject|2|||
129760036|NCT00607087|467083568|FG001|Period 3|Withdrawal by Subject|1|||
129760037|NCT00607087|467083569|FG002|Period 3|Withdrawal by Subject|0|||
129760038|NCT00607087|467083567|FG000|Period 3|Adverse Event|0|||
129760039|NCT00607087|467083568|FG001|Period 3|Adverse Event|1|||
129760040|NCT00607087|467083569|FG002|Period 3|Adverse Event|0|||
129760041|NCT00154297|467083571|FG000|Overall Study|Death|5|||
129760042|NCT00154297|467083572|FG001|Overall Study|Death|2|||
129760043|NCT00154297|467083571|FG000|Overall Study|Withdrawal by Subject|0|||
129760044|NCT00154297|467083572|FG001|Overall Study|Withdrawal by Subject|5|||
129760045|NCT00154297|467083571|FG000|Overall Study|Lost to Follow-up|3|||
129760046|NCT00154297|467083572|FG001|Overall Study|Lost to Follow-up|0|||
129760047|NCT00650767|467083573|FG000|Overall Study|Adverse Event|0|||
129760048|NCT00650767|467083574|FG001|Overall Study|Adverse Event|3|||
129760049|NCT00650767|467083575|FG002|Overall Study|Adverse Event|10|||
129760050|NCT00650767|467083576|FG003|Overall Study|Adverse Event|8|||
129760051|NCT00650767|467083573|FG000|Overall Study|Death|1|||
129760052|NCT00650767|467083574|FG001|Overall Study|Death|0|||
129760053|NCT00650767|467083575|FG002|Overall Study|Death|0|||
129760054|NCT00650767|467083576|FG003|Overall Study|Death|0|||
129760055|NCT00650767|467083573|FG000|Overall Study|Withdrawal by Subject|2|||
129760056|NCT00650767|467083574|FG001|Overall Study|Withdrawal by Subject|4|||
129760057|NCT00650767|467083575|FG002|Overall Study|Withdrawal by Subject|3|||
129760058|NCT00650767|467083576|FG003|Overall Study|Withdrawal by Subject|3|||
129760059|NCT00650767|467083573|FG000|Overall Study|Lost to Follow-up|1|||
129760060|NCT00650767|467083574|FG001|Overall Study|Lost to Follow-up|1|||
129760061|NCT00650767|467083575|FG002|Overall Study|Lost to Follow-up|1|||
129760062|NCT00650767|467083576|FG003|Overall Study|Lost to Follow-up|0|||
129760063|NCT00650767|467083573|FG000|Overall Study|Other|1|||
129760064|NCT00650767|467083574|FG001|Overall Study|Other|1|||
129760065|NCT00650767|467083575|FG002|Overall Study|Other|0|||
129760066|NCT00650767|467083576|FG003|Overall Study|Other|0|||
129760067|NCT01774799|467083577|FG000|Overall Study|Lost to Follow-up|1|||
129760068|NCT01774799|467083578|FG001|Overall Study|Lost to Follow-up|1|||
129760069|NCT01774799|467083579|FG002|Overall Study|Lost to Follow-up|0|||
129760070|NCT01774799|467083580|FG003|Overall Study|Lost to Follow-up|0|||
129760071|NCT00990106|467083581|FG000|Overall Study|"too busy to continue"|1|||
129760072|NCT00990106|467083582|FG001|Overall Study|"too busy to continue"|2|||
129760073|NCT00990106|467083581|FG000|Overall Study|Lost to Follow-up|1|||
129760074|NCT00990106|467083582|FG001|Overall Study|Lost to Follow-up|3|||
129760075|NCT00990106|467083581|FG000|Overall Study|Withdrawal by Subject|2|||
129760076|NCT00990106|467083582|FG001|Overall Study|Withdrawal by Subject|1|||
129760077|NCT00990106|467083581|FG000|Overall Study|opted for open label prazosin|1|||
129760078|NCT00990106|467083582|FG001|Overall Study|opted for open label prazosin|1|||
129760079|NCT00990106|467083581|FG000|Overall Study|relocation/deployment|4|||
129760080|NCT00990106|467083582|FG001|Overall Study|relocation/deployment|1|||
129760081|NCT00990106|467083581|FG000|Overall Study|started exclusionary medication|0|||
129760082|NCT00990106|467083582|FG001|Overall Study|started exclusionary medication|1|||
129760083|NCT00990106|467083581|FG000|Overall Study|planned major surgery|0|||
129760084|NCT00990106|467083582|FG001|Overall Study|planned major surgery|1|||
129760085|NCT00990106|467083581|FG000|Overall Study|scheduling conflicts|0|||
129760086|NCT00990106|467083582|FG001|Overall Study|scheduling conflicts|2|||
129760087|NCT03064490|467083585|FG000|Overall Study|Physician Decision|5|||
129760088|NCT04158583|467083589|FG000|Overall Study|Withdrawal by Subject|1|||
129760089|NCT04158583|467083590|FG001|Overall Study|Withdrawal by Subject|1|||
129760090|NCT04158583|467083591|FG002|Overall Study|Withdrawal by Subject|0|||
129760091|NCT04158583|467083592|FG003|Overall Study|Withdrawal by Subject|0|||
129760092|NCT04158583|467083593|FG004|Overall Study|Withdrawal by Subject|1|||
129760093|NCT04158583|467083594|FG005|Overall Study|Withdrawal by Subject|0|||
129760094|NCT04158583|467083595|FG006|Overall Study|Withdrawal by Subject|0|||
129760095|NCT04158583|467083596|FG007|Overall Study|Withdrawal by Subject|0|||
129760096|NCT04158583|467083597|FG008|Overall Study|Withdrawal by Subject|2|||
129760097|NCT04158583|467083598|FG009|Overall Study|Withdrawal by Subject|0|||
129760098|NCT04158583|467083589|FG000|Overall Study|Study Terminated by Sponsor|0|||
129760099|NCT04158583|467083590|FG001|Overall Study|Study Terminated by Sponsor|0|||
129760100|NCT04158583|467083591|FG002|Overall Study|Study Terminated by Sponsor|0|||
129760101|NCT04158583|467083592|FG003|Overall Study|Study Terminated by Sponsor|1|||
129760102|NCT04158583|467083593|FG004|Overall Study|Study Terminated by Sponsor|0|||
129760103|NCT04158583|467083594|FG005|Overall Study|Study Terminated by Sponsor|0|||
129760104|NCT04158583|467083595|FG006|Overall Study|Study Terminated by Sponsor|0|||
129760105|NCT04158583|467083596|FG007|Overall Study|Study Terminated by Sponsor|0|||
129760106|NCT04158583|467083597|FG008|Overall Study|Study Terminated by Sponsor|0|||
129760107|NCT04158583|467083598|FG009|Overall Study|Study Terminated by Sponsor|0|||
129760108|NCT04158583|467083589|FG000|Overall Study|Progressive Disease|1|||
129760109|NCT04158583|467083590|FG001|Overall Study|Progressive Disease|0|||
129760110|NCT04158583|467083591|FG002|Overall Study|Progressive Disease|3|||
129760111|NCT04158583|467083592|FG003|Overall Study|Progressive Disease|5|||
129760112|NCT04158583|467083593|FG004|Overall Study|Progressive Disease|0|||
129760113|NCT04158583|467083594|FG005|Overall Study|Progressive Disease|1|||
129760114|NCT04158583|467083595|FG006|Overall Study|Progressive Disease|6|||
129760115|NCT04158583|467083596|FG007|Overall Study|Progressive Disease|2|||
129760116|NCT04158583|467083597|FG008|Overall Study|Progressive Disease|1|||
129760117|NCT04158583|467083598|FG009|Overall Study|Progressive Disease|2|||
129760118|NCT04158583|467083589|FG000|Overall Study|Lost to Follow-up|0|||
129760119|NCT04158583|467083590|FG001|Overall Study|Lost to Follow-up|0|||
129760120|NCT04158583|467083591|FG002|Overall Study|Lost to Follow-up|1|||
129760121|NCT04158583|467083592|FG003|Overall Study|Lost to Follow-up|1|||
129760122|NCT04158583|467083593|FG004|Overall Study|Lost to Follow-up|1|||
129760123|NCT04158583|467083594|FG005|Overall Study|Lost to Follow-up|0|||
129760124|NCT04158583|467083595|FG006|Overall Study|Lost to Follow-up|0|||
129760125|NCT04158583|467083596|FG007|Overall Study|Lost to Follow-up|0|||
129760126|NCT04158583|467083597|FG008|Overall Study|Lost to Follow-up|0|||
129760127|NCT04158583|467083598|FG009|Overall Study|Lost to Follow-up|0|||
129760128|NCT04158583|467083589|FG000|Overall Study|Due To Patient Status|0|||
129760129|NCT04158583|467083590|FG001|Overall Study|Due To Patient Status|0|||
129760130|NCT04158583|467083591|FG002|Overall Study|Due To Patient Status|0|||
129760131|NCT04158583|467083592|FG003|Overall Study|Due To Patient Status|0|||
129760132|NCT04158583|467083593|FG004|Overall Study|Due To Patient Status|0|||
129760133|NCT04158583|467083594|FG005|Overall Study|Due To Patient Status|0|||
129760134|NCT04158583|467083595|FG006|Overall Study|Due To Patient Status|0|||
129760135|NCT04158583|467083596|FG007|Overall Study|Due To Patient Status|0|||
129760136|NCT04158583|467083597|FG008|Overall Study|Due To Patient Status|1|||
129760137|NCT04158583|467083598|FG009|Overall Study|Due To Patient Status|0|||
129760138|NCT04158583|467083589|FG000|Overall Study|Death|3|||
129760139|NCT04158583|467083590|FG001|Overall Study|Death|4|||
129760140|NCT04158583|467083591|FG002|Overall Study|Death|2|||
129760141|NCT04158583|467083592|FG003|Overall Study|Death|2|||
129760142|NCT04158583|467083593|FG004|Overall Study|Death|4|||
129760143|NCT04158583|467083594|FG005|Overall Study|Death|3|||
129760144|NCT04158583|467083595|FG006|Overall Study|Death|5|||
129760145|NCT04158583|467083596|FG007|Overall Study|Death|2|||
129760146|NCT04158583|467083597|FG008|Overall Study|Death|0|||
129760147|NCT04158583|467083598|FG009|Overall Study|Death|1|||
129760148|NCT04158583|467083589|FG000|Overall Study|Clinical Progression Disease|0|||
129760149|NCT04158583|467083590|FG001|Overall Study|Clinical Progression Disease|0|||
129760150|NCT04158583|467083591|FG002|Overall Study|Clinical Progression Disease|0|||
129760151|NCT04158583|467083592|FG003|Overall Study|Clinical Progression Disease|1|||
129760152|NCT04158583|467083593|FG004|Overall Study|Clinical Progression Disease|0|||
129760153|NCT04158583|467083594|FG005|Overall Study|Clinical Progression Disease|0|||
129760154|NCT04158583|467083595|FG006|Overall Study|Clinical Progression Disease|0|||
129760155|NCT04158583|467083596|FG007|Overall Study|Clinical Progression Disease|0|||
129760156|NCT04158583|467083597|FG008|Overall Study|Clinical Progression Disease|0|||
129760157|NCT04158583|467083598|FG009|Overall Study|Clinical Progression Disease|0|||
129760158|NCT04158583|467083589|FG000|Overall Study|Clinical Progression|0|||
129760159|NCT04158583|467083590|FG001|Overall Study|Clinical Progression|0|||
129760160|NCT04158583|467083591|FG002|Overall Study|Clinical Progression|0|||
129760161|NCT04158583|467083592|FG003|Overall Study|Clinical Progression|0|||
129760162|NCT04158583|467083593|FG004|Overall Study|Clinical Progression|1|||
129760163|NCT04158583|467083594|FG005|Overall Study|Clinical Progression|0|||
129760164|NCT04158583|467083595|FG006|Overall Study|Clinical Progression|2|||
129760165|NCT04158583|467083596|FG007|Overall Study|Clinical Progression|0|||
129760166|NCT04158583|467083597|FG008|Overall Study|Clinical Progression|0|||
129760167|NCT04158583|467083598|FG009|Overall Study|Clinical Progression|0|||
129760168|NCT04158583|467083589|FG000|Overall Study|Clinical Deterioration|0|||
129760169|NCT04158583|467083590|FG001|Overall Study|Clinical Deterioration|0|||
129760170|NCT04158583|467083591|FG002|Overall Study|Clinical Deterioration|0|||
129760171|NCT04158583|467083592|FG003|Overall Study|Clinical Deterioration|1|||
129760172|NCT04158583|467083593|FG004|Overall Study|Clinical Deterioration|0|||
129760173|NCT04158583|467083594|FG005|Overall Study|Clinical Deterioration|0|||
129760174|NCT04158583|467083595|FG006|Overall Study|Clinical Deterioration|0|||
129760175|NCT04158583|467083596|FG007|Overall Study|Clinical Deterioration|0|||
129760176|NCT04158583|467083597|FG008|Overall Study|Clinical Deterioration|0|||
129760177|NCT04158583|467083598|FG009|Overall Study|Clinical Deterioration|1|||
129760178|NCT01871519|467083599|FG000|Overall Study|Death|26|||
129760179|NCT01871519|467083599|FG000|Overall Study|Lost to Follow-up|15|||
129760180|NCT01871519|467083599|FG000|Overall Study|Withdrawal by Subject|49|||
129760181|NCT02485704|467083600|FG000|Overall Study|Lost to Follow-up|4|||
129760182|NCT02485704|467083601|FG001|Overall Study|Lost to Follow-up|5|||
129760183|NCT02485704|467083600|FG000|Overall Study|Withdrawal by Subject|0|||
129760184|NCT02485704|467083601|FG001|Overall Study|Withdrawal by Subject|3|||
129760185|NCT02485704|467083600|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
129760186|NCT02485704|467083601|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
129760187|NCT01777776|467083602|FG000|Overall Study|Adverse Event|2|||
129760188|NCT01777776|467083603|FG001|Overall Study|Adverse Event|4|||
129760189|NCT01777776|467083604|FG002|Overall Study|Adverse Event|0|||
129760190|NCT01777776|467083605|FG003|Overall Study|Adverse Event|0|||
129760191|NCT01777776|467083602|FG000|Overall Study|Disease Progression|4|||
129760192|NCT01777776|467083603|FG001|Overall Study|Disease Progression|8|||
129760193|NCT01777776|467083604|FG002|Overall Study|Disease Progression|6|||
129760194|NCT01777776|467083605|FG003|Overall Study|Disease Progression|3|||
129760195|NCT01777776|467083602|FG000|Overall Study|Withdrawal by Subject|0|||
129760196|NCT01777776|467083603|FG001|Overall Study|Withdrawal by Subject|0|||
129760197|NCT01777776|467083604|FG002|Overall Study|Withdrawal by Subject|0|||
129760198|NCT01777776|467083605|FG003|Overall Study|Withdrawal by Subject|1|||
129760199|NCT04617782|467085240|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
129760200|NCT04617782|467085240|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
129760201|NCT04617782|467085240|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
129760202|NCT04617782|467085240|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
129760203|NCT04617782|467085240|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
129760204|NCT04617782|467085240|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
129760205|NCT04233801|467085250|FG000|Overall Study|Other than listed|0|||
129760206|NCT04233801|467085251|FG001|Overall Study|Other than listed|0|||
129760207|NCT04233801|467085252|FG002|Overall Study|Other than listed|1|||
129760208|NCT04233801|467085250|FG000|Overall Study|Withdrawal by Subject|0|||
129760209|NCT04233801|467085251|FG001|Overall Study|Withdrawal by Subject|2|||
129760210|NCT04233801|467085252|FG002|Overall Study|Withdrawal by Subject|3|||
129760211|NCT00928486|467085253|FG000|Overall Study|Adverse Event|2|||
129760212|NCT00928486|467085253|FG000|Overall Study|Disease Progression|7|||
129760213|NCT00928486|467085253|FG000|Overall Study|Withdrawal by Subject|1|||
129760214|NCT01342913|467085254|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
129760215|NCT01342913|467085255|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129760216|NCT01342913|467085256|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
129760217|NCT01342913|467085254|FG000|2-week Run-in Period|Physician Decision|6|||
129760218|NCT01342913|467085255|FG001|2-week Run-in Period|Physician Decision|0|||
129760219|NCT01342913|467085256|FG002|2-week Run-in Period|Physician Decision|0|||
129760220|NCT01342913|467085254|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
129760221|NCT01342913|467085255|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129760222|NCT01342913|467085256|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129760223|NCT01342913|467085254|FG000|2-week Run-in Period|Adverse Event|2|||
129760224|NCT01342913|467085255|FG001|2-week Run-in Period|Adverse Event|0|||
129760225|NCT01342913|467085256|FG002|2-week Run-in Period|Adverse Event|0|||
129760226|NCT01342913|467085254|FG000|2-week Run-in Period|Protocol Violation|5|||
129760227|NCT01342913|467085255|FG001|2-week Run-in Period|Protocol Violation|0|||
129760228|NCT01342913|467085256|FG002|2-week Run-in Period|Protocol Violation|0|||
129760229|NCT01342913|467085254|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
129760230|NCT01342913|467085255|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
129760231|NCT01342913|467085256|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
129760232|NCT01342913|467085254|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129760233|NCT01342913|467085255|FG001|Double-Blind Treatment Period|Adverse Event|3|||
129760234|NCT01342913|467085256|FG002|Double-Blind Treatment Period|Adverse Event|6|||
129760235|NCT01342913|467085254|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129812424|NCT04377620|467280332|FG001|Overall Study|Withdrawal by Subject|2|||
129812425|NCT04377620|467280333|FG002|Overall Study|Withdrawal by Subject|0|||
129812426|NCT02849678|467280334|FG000|Overall Study|Protocol Violation|3|||
129760236|NCT01342913|467085255|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
129760237|NCT01342913|467085256|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
129760238|NCT01342913|467085254|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129760239|NCT01342913|467085255|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
129760240|NCT01342913|467085256|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
129760241|NCT01342913|467085254|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129760242|NCT01342913|467085255|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129760243|NCT01342913|467085256|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
129760244|NCT01342913|467085254|FG000|Double-Blind Treatment Period|Physician Decision|0|||
129760245|NCT01342913|467085255|FG001|Double-Blind Treatment Period|Physician Decision|2|||
129760246|NCT01342913|467085256|FG002|Double-Blind Treatment Period|Physician Decision|0|||
129760247|NCT01342913|467085254|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129760248|NCT01342913|467085255|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129760249|NCT01342913|467085256|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
129760250|NCT04024891|467085260|FG000|Overall Study|Pregnancy|0|||
129760251|NCT04024891|467085261|FG001|Overall Study|Pregnancy|1|||
129760252|NCT01474317|467085265|FG000|Overall Study|Adverse Event|1|||
129760253|NCT01474317|467085265|FG000|Overall Study|Subject ineligible for study|1|||
129760254|NCT00453154|467085268|FG000|Double BIind Maintenance|Adverse Event|0|||
129760255|NCT00453154|467085269|FG001|Double BIind Maintenance|Adverse Event|0|||
129760256|NCT00453154|467085270|FG002|Double BIind Maintenance|Adverse Event|3|||
129760257|NCT00453154|467085271|FG003|Double BIind Maintenance|Adverse Event|12|||
129760258|NCT00453154|467085268|FG000|Double BIind Maintenance|Death|0|||
129760259|NCT00453154|467085269|FG001|Double BIind Maintenance|Death|0|||
129760260|NCT00453154|467085270|FG002|Double BIind Maintenance|Death|2|||
129760261|NCT00453154|467085271|FG003|Double BIind Maintenance|Death|1|||
129760262|NCT00453154|467085268|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
129760263|NCT00453154|467085269|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
129760264|NCT00453154|467085270|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
129760265|NCT00453154|467085271|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
129760266|NCT00453154|467085268|FG000|Double BIind Maintenance|Progression|0|||
129760267|NCT00453154|467085269|FG001|Double BIind Maintenance|Progression|0|||
129760268|NCT00453154|467085270|FG002|Double BIind Maintenance|Progression|29|||
129760269|NCT00453154|467085271|FG003|Double BIind Maintenance|Progression|26|||
129760270|NCT00453154|467085268|FG000|Double BIind Maintenance|Medical Issues|0|||
129760271|NCT00453154|467085269|FG001|Double BIind Maintenance|Medical Issues|0|||
129760272|NCT00453154|467085270|FG002|Double BIind Maintenance|Medical Issues|3|||
129760273|NCT00453154|467085271|FG003|Double BIind Maintenance|Medical Issues|1|||
129760274|NCT00453154|467085268|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
129760275|NCT00453154|467085269|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
129760276|NCT00453154|467085270|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
129760277|NCT00453154|467085271|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
129760278|NCT02152631|467085273|FG000|Overall Study|Adverse Event|32|||
129760279|NCT02152631|467085274|FG001|Overall Study|Adverse Event|4|||
129760280|NCT02152631|467085273|FG000|Overall Study|Withdrawal by Subject|13|||
129760281|NCT02152631|467085274|FG001|Overall Study|Withdrawal by Subject|16|||
129760282|NCT02152631|467085273|FG000|Overall Study|Noncompliance with study drug|1|||
129760283|NCT02152631|467085274|FG001|Overall Study|Noncompliance with study drug|0|||
129760284|NCT02152631|467085273|FG000|Overall Study|Physician Decision|1|||
129760285|NCT02152631|467085274|FG001|Overall Study|Physician Decision|2|||
129760286|NCT02152631|467085273|FG000|Overall Study|Lost to Follow-up|0|||
129760287|NCT02152631|467085274|FG001|Overall Study|Lost to Follow-up|1|||
129760288|NCT02152631|467085273|FG000|Overall Study|On Treatment|19|||
129760289|NCT02152631|467085274|FG001|Overall Study|On Treatment|3|||
129760290|NCT05473026|467085275|FG000|Overall Study|Lost to Follow-up|5|||
129760291|NCT05473026|467085276|FG001|Overall Study|Lost to Follow-up|2|||
129760292|NCT03683173|467085287|FG000|Completed Follow-up|Unavailable|235|||
129760293|NCT03683173|467085288|FG001|Completed Follow-up|Unavailable|217|||
129760294|NCT03683173|467085287|FG000|Completed Follow-up|Refused|69|||
129760295|NCT03683173|467085288|FG001|Completed Follow-up|Refused|59|||
129760296|NCT03683173|467085287|FG000|Completed Follow-up|Disconnected phone|65|||
129760297|NCT03683173|467085288|FG001|Completed Follow-up|Disconnected phone|95|||
129760298|NCT03683173|467085287|FG000|Completed Follow-up|Health issue/deceased|10|||
129760299|NCT03683173|467085288|FG001|Completed Follow-up|Health issue/deceased|4|||
129760300|NCT03683173|467085287|FG000|Completed Follow-up|Moved away|8|||
129760301|NCT03683173|467085288|FG001|Completed Follow-up|Moved away|1|||
129760302|NCT02647281|467085289|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760303|NCT02647281|467085290|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760304|NCT02647281|467085291|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760305|NCT02647281|467085292|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760306|NCT02647281|467085293|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760307|NCT02647281|467085294|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760308|NCT02647281|467085295|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760309|NCT02647281|467085296|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
129760310|NCT02647281|467085297|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
129760311|NCT05801991|467085298|FG000|Overall Study|Lost to Follow-up|1|||
129760312|NCT05801991|467085299|FG001|Overall Study|Lost to Follow-up|0|||
129760313|NCT02210000|467085300|FG000|Overall Study|Study Terminated|11|||
129760314|NCT02210000|467085301|FG001|Overall Study|Study Terminated|12|||
129760315|NCT02210000|467085300|FG000|Overall Study|Withdrawal by Subject|7|||
129760316|NCT02210000|467085301|FG001|Overall Study|Withdrawal by Subject|1|||
129760317|NCT02210000|467085300|FG000|Overall Study|Adverse Event|1|||
129760318|NCT02210000|467085301|FG001|Overall Study|Adverse Event|5|||
129760319|NCT02210000|467085300|FG000|Overall Study|Lost to Follow-up|0|||
129760320|NCT02210000|467085301|FG001|Overall Study|Lost to Follow-up|2|||
129760321|NCT02210000|467085300|FG000|Overall Study|Physician Decision|0|||
129760322|NCT02210000|467085301|FG001|Overall Study|Physician Decision|1|||
129760323|NCT01329263|467085304|FG000|Overall Study|Lost to Follow-up|4|||
129760324|NCT01329263|467085305|FG001|Overall Study|Lost to Follow-up|21|||
129760325|NCT01329263|467085304|FG000|Overall Study|Withdrawal by Subject|1|||
129760326|NCT01329263|467085305|FG001|Overall Study|Withdrawal by Subject|2|||
129760327|NCT01421017|467085306|FG000|Overall Study|Withdrawal by Subject|2|||
129760328|NCT01421017|467085307|FG001|Overall Study|Withdrawal by Subject|0|||
129760329|NCT01421017|467085308|FG002|Overall Study|Withdrawal by Subject|0|||
129760330|NCT01421017|467085306|FG000|Overall Study|POD|0|||
129760331|NCT01421017|467085307|FG001|Overall Study|POD|6|||
129760332|NCT01421017|467085308|FG002|Overall Study|POD|3|||
129760333|NCT00833040|467085311|FG000|Overall Study|Adverse Event|0|||
129760334|NCT00833040|467085312|FG001|Overall Study|Adverse Event|0|||
129760335|NCT00833040|467085313|FG002|Overall Study|Adverse Event|0|||
129760336|NCT00833040|467085314|FG003|Overall Study|Adverse Event|0|||
129760337|NCT00833040|467085315|FG004|Overall Study|Adverse Event|0|||
129760338|NCT00833040|467085316|FG005|Overall Study|Adverse Event|1|||
129760339|NCT02313766|467085317|FG000|Overall Study|surgery cancelled|1|||
129760340|NCT02313766|467085318|FG001|Overall Study|surgery cancelled|0|||
129760341|NCT02313766|467085319|FG002|Overall Study|surgery cancelled|0|||
129760342|NCT02313766|467085317|FG000|Overall Study|Lost to Follow-up|0|||
129760343|NCT02313766|467085318|FG001|Overall Study|Lost to Follow-up|2|||
129760344|NCT02313766|467085319|FG002|Overall Study|Lost to Follow-up|0|||
129760345|NCT02313766|467085317|FG000|Overall Study|Adverse Event|0|||
129760346|NCT02313766|467085318|FG001|Overall Study|Adverse Event|1|||
129760347|NCT02313766|467085319|FG002|Overall Study|Adverse Event|0|||
129760348|NCT03489863|467085320|FG000|Overall Study|Withdrawal by Subject|0|||
129760349|NCT03489863|467085321|FG001|Overall Study|Withdrawal by Subject|1|||
129760350|NCT02193776|467085323|FG000|Overall Study|Consent withdrawn|1|||
129760351|NCT02193776|467085324|FG001|Overall Study|Consent withdrawn|0|||
129760352|NCT02193776|467085325|FG002|Overall Study|Consent withdrawn|0|||
129760353|NCT02193776|467085326|FG003|Overall Study|Consent withdrawn|0|||
129760354|NCT02193776|467085323|FG000|Overall Study|Failure to comply with protocol|0|||
129760355|NCT02193776|467085324|FG001|Overall Study|Failure to comply with protocol|1|||
129760356|NCT02193776|467085325|FG002|Overall Study|Failure to comply with protocol|0|||
129760357|NCT02193776|467085326|FG003|Overall Study|Failure to comply with protocol|0|||
129760358|NCT02193776|467085323|FG000|Overall Study|Investigator/Sponsor decision|1|||
129760359|NCT02193776|467085324|FG001|Overall Study|Investigator/Sponsor decision|1|||
129760360|NCT02193776|467085325|FG002|Overall Study|Investigator/Sponsor decision|0|||
129760361|NCT02193776|467085326|FG003|Overall Study|Investigator/Sponsor decision|0|||
129760362|NCT02193776|467085323|FG000|Overall Study|Death|1|||
129760363|NCT02193776|467085324|FG001|Overall Study|Death|0|||
129760364|NCT02193776|467085325|FG002|Overall Study|Death|0|||
129760365|NCT02193776|467085326|FG003|Overall Study|Death|0|||
129760366|NCT02193776|467085323|FG000|Overall Study|Adverse event/Specific toxicity|5|||
129760367|NCT02193776|467085324|FG001|Overall Study|Adverse event/Specific toxicity|5|||
129760368|NCT02193776|467085325|FG002|Overall Study|Adverse event/Specific toxicity|2|||
129760369|NCT02193776|467085326|FG003|Overall Study|Adverse event/Specific toxicity|2|||
129760370|NCT00962208|467085328|FG000|Overall Study|Could not achieve good vision|9|||
129760371|NCT00962208|467085329|FG001|Overall Study|Could not achieve good vision|0|||
129760372|NCT00962208|467085328|FG000|Overall Study|Contraindicated to continue study|5|||
129760373|NCT00962208|467085329|FG001|Overall Study|Contraindicated to continue study|1|||
129760374|NCT00962208|467085328|FG000|Overall Study|Lost to Follow-up|0|||
129760375|NCT00962208|467085329|FG001|Overall Study|Lost to Follow-up|9|||
129760376|NCT00791388|467085330|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129760377|NCT00791388|467085331|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
129760378|NCT00791388|467085332|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129760379|NCT00791388|467085333|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129760380|NCT00791388|467085334|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
129760381|NCT00791388|467085330|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
129760382|NCT00791388|467085331|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129760383|NCT00791388|467085332|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129760384|NCT00791388|467085333|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129760385|NCT00791388|467085334|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
129760386|NCT00791388|467085330|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129760387|NCT00791388|467085331|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129760388|NCT00791388|467085332|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129760389|NCT00791388|467085333|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
129760390|NCT00791388|467085334|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
129760391|NCT02995980|467085335|FG000|Overall Study|Lost to Follow-up|14|||
129760392|NCT01458639|467085338|FG000|Overall Study|Physician Decision|4|||
129760393|NCT01458639|467085338|FG000|Overall Study|Equipment issue|1|||
129760394|NCT01458639|467085338|FG000|Overall Study|Inability to obtain subject blood sample|1|||
129760395|NCT02656017|467085339|FG000|Overall Study|Study burden|3|||
129760396|NCT02656017|467085340|FG001|Overall Study|Study burden|3|||
129760397|NCT02656017|467085339|FG000|Overall Study|Adverse Event|2|||
129760398|NCT02656017|467085340|FG001|Overall Study|Adverse Event|1|||
129760399|NCT02656017|467085339|FG000|Overall Study|Unable/unwilling to take study medication|2|||
129760400|NCT02656017|467085340|FG001|Overall Study|Unable/unwilling to take study medication|1|||
129760401|NCT02656017|467085339|FG000|Overall Study|Began Tolvaptan|1|||
129760402|NCT02656017|467085340|FG001|Overall Study|Began Tolvaptan|1|||
129760403|NCT02656017|467085339|FG000|Overall Study|Withdrawal by Subject|1|||
129760404|NCT02656017|467085340|FG001|Overall Study|Withdrawal by Subject|0|||
129760405|NCT02792231|467085341|FG000|Overall Study|Patient/guardian decision|32|||
129760406|NCT02792231|467085342|FG001|Overall Study|Patient/guardian decision|42|||
129760407|NCT02792231|467085341|FG000|Overall Study|Adverse Event|15|||
129760408|NCT02792231|467085342|FG001|Overall Study|Adverse Event|11|||
129760409|NCT02792231|467085341|FG000|Overall Study|Physician Decision|14|||
129760410|NCT02792231|467085342|FG001|Overall Study|Physician Decision|12|||
129760411|NCT02792231|467085341|FG000|Overall Study|Lack of Efficacy|7|||
129760412|NCT02792231|467085342|FG001|Overall Study|Lack of Efficacy|9|||
129760413|NCT02792231|467085341|FG000|Overall Study|Lost to Follow-up|9|||
129760414|NCT02792231|467085342|FG001|Overall Study|Lost to Follow-up|5|||
129760415|NCT02792231|467085341|FG000|Overall Study|Pregnancy|1|||
129760416|NCT02792231|467085342|FG001|Overall Study|Pregnancy|3|||
129760417|NCT02792231|467085341|FG000|Overall Study|Non-compliance with study treatment|2|||
129760418|NCT02792231|467085342|FG001|Overall Study|Non-compliance with study treatment|1|||
129760419|NCT02792231|467085341|FG000|Overall Study|Protocol deviation|2|||
129760420|NCT02792231|467085342|FG001|Overall Study|Protocol deviation|0|||
129760421|NCT02792231|467085341|FG000|Overall Study|Technical problems|0|||
129760422|NCT02792231|467085342|FG001|Overall Study|Technical problems|1|||
129760423|NCT05196828|467085343|FG000|Overall Study|Withdrawal by Subject|2|||
129760424|NCT05196828|467085344|FG001|Overall Study|Withdrawal by Subject|0|||
129760425|NCT05196828|467085343|FG000|Overall Study|Lost to Follow-up|0|||
129760426|NCT05196828|467085344|FG001|Overall Study|Lost to Follow-up|4|||
129760427|NCT05196828|467085343|FG000|Overall Study|Adverse Event|1|||
129760428|NCT05196828|467085344|FG001|Overall Study|Adverse Event|0|||
129760429|NCT03309878|467085345|FG000|Overall Study|Adverse Event|1|||
129760430|NCT03309878|467085346|FG001|Overall Study|Adverse Event|0|||
129760431|NCT03309878|467085347|FG002|Overall Study|Adverse Event|0|||
129760432|NCT03309878|467085348|FG003|Overall Study|Adverse Event|0|||
129760433|NCT03309878|467085345|FG000|Overall Study|Did not maintain eligibility|2|||
129760434|NCT03309878|467085346|FG001|Overall Study|Did not maintain eligibility|1|||
129760435|NCT03309878|467085347|FG002|Overall Study|Did not maintain eligibility|0|||
129760436|NCT03309878|467085348|FG003|Overall Study|Did not maintain eligibility|0|||
129760437|NCT03309878|467085345|FG000|Overall Study|Withdrawal by Subject|0|||
129760438|NCT03309878|467085346|FG001|Overall Study|Withdrawal by Subject|1|||
129760439|NCT03309878|467085347|FG002|Overall Study|Withdrawal by Subject|0|||
129760440|NCT03309878|467085348|FG003|Overall Study|Withdrawal by Subject|0|||
129760441|NCT01096316|467085349|FG000|Overall Study|Lost to Follow-up|15|||
129812427|NCT02849678|467280335|FG001|Overall Study|Protocol Violation|6|||
129812428|NCT00289991|467280336|FG000|Overall Study|Death|35|||
129812429|NCT00289991|467280337|FG001|Overall Study|Death|38|||
129760442|NCT01096316|467085350|FG001|Overall Study|Lost to Follow-up|9|||
129760443|NCT02836652|467085351|FG000|Overall Study|Death|3|||
129760444|NCT02836652|467085352|FG001|Overall Study|Death|3|||
129760445|NCT02836652|467085351|FG000|Overall Study|Transplant/Explant|3|||
129760446|NCT02836652|467085352|FG001|Overall Study|Transplant/Explant|4|||
129760447|NCT02836652|467085351|FG000|Overall Study|Withdrawn|9|||
129760448|NCT02836652|467085352|FG001|Overall Study|Withdrawn|9|||
129760449|NCT02836652|467085351|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
129760450|NCT02836652|467085352|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
129760451|NCT02349633|467085353|FG000|Overall Study|Death|0|||
129812430|NCT00289991|467280336|FG000|Overall Study|Adverse Event|15|||
129812431|NCT00289991|467280337|FG001|Overall Study|Adverse Event|13|||
129760452|NCT02349633|467085354|FG001|Overall Study|Death|1|||
129760453|NCT02349633|467085355|FG002|Overall Study|Death|0|||
129760454|NCT02349633|467085356|FG003|Overall Study|Death|0|||
129760455|NCT02349633|467085357|FG004|Overall Study|Death|0|||
129760456|NCT02349633|467085358|FG005|Overall Study|Death|1|||
129760457|NCT02349633|467085359|FG006|Overall Study|Death|1|||
129760458|NCT02349633|467085360|FG007|Overall Study|Death|1|||
129760459|NCT02349633|467085361|FG008|Overall Study|Death|0|||
129760460|NCT02349633|467085362|FG009|Overall Study|Death|1|||
129760461|NCT02349633|467085363|FG010|Overall Study|Death|0|||
129760462|NCT02349633|467085364|FG011|Overall Study|Death|0|||
129760463|NCT02349633|467085365|FG012|Overall Study|Death|0|||
129760464|NCT02349633|467085366|FG013|Overall Study|Death|0|||
129760465|NCT02349633|467085353|FG000|Overall Study|Withdrawal by Subject|0|||
129760466|NCT02349633|467085354|FG001|Overall Study|Withdrawal by Subject|0|||
129760467|NCT02349633|467085355|FG002|Overall Study|Withdrawal by Subject|0|||
129760468|NCT02349633|467085356|FG003|Overall Study|Withdrawal by Subject|1|||
129760469|NCT02349633|467085357|FG004|Overall Study|Withdrawal by Subject|0|||
129760470|NCT02349633|467085358|FG005|Overall Study|Withdrawal by Subject|0|||
129760471|NCT02349633|467085359|FG006|Overall Study|Withdrawal by Subject|0|||
129760472|NCT02349633|467085360|FG007|Overall Study|Withdrawal by Subject|2|||
129760473|NCT02349633|467085361|FG008|Overall Study|Withdrawal by Subject|2|||
129760474|NCT02349633|467085362|FG009|Overall Study|Withdrawal by Subject|1|||
129760475|NCT02349633|467085363|FG010|Overall Study|Withdrawal by Subject|0|||
129760476|NCT02349633|467085364|FG011|Overall Study|Withdrawal by Subject|0|||
129760477|NCT02349633|467085365|FG012|Overall Study|Withdrawal by Subject|0|||
129760478|NCT02349633|467085366|FG013|Overall Study|Withdrawal by Subject|0|||
129760479|NCT02349633|467085353|FG000|Overall Study|Withdrawal of informed consent|0|||
129760480|NCT02349633|467085354|FG001|Overall Study|Withdrawal of informed consent|0|||
129760481|NCT02349633|467085355|FG002|Overall Study|Withdrawal of informed consent|0|||
129760482|NCT02349633|467085356|FG003|Overall Study|Withdrawal of informed consent|1|||
129760483|NCT02349633|467085357|FG004|Overall Study|Withdrawal of informed consent|1|||
129760484|NCT02349633|467085358|FG005|Overall Study|Withdrawal of informed consent|0|||
129760485|NCT02349633|467085359|FG006|Overall Study|Withdrawal of informed consent|0|||
129760486|NCT02349633|467085360|FG007|Overall Study|Withdrawal of informed consent|3|||
129760487|NCT02349633|467085361|FG008|Overall Study|Withdrawal of informed consent|0|||
129760488|NCT02349633|467085362|FG009|Overall Study|Withdrawal of informed consent|0|||
129760489|NCT02349633|467085363|FG010|Overall Study|Withdrawal of informed consent|0|||
129760490|NCT02349633|467085364|FG011|Overall Study|Withdrawal of informed consent|0|||
129760491|NCT02349633|467085365|FG012|Overall Study|Withdrawal of informed consent|0|||
129760492|NCT02349633|467085366|FG013|Overall Study|Withdrawal of informed consent|0|||
129760493|NCT02349633|467085353|FG000|Overall Study|Transition to compassionate use|0|||
129760494|NCT02349633|467085354|FG001|Overall Study|Transition to compassionate use|0|||
129760495|NCT02349633|467085355|FG002|Overall Study|Transition to compassionate use|0|||
129760496|NCT02349633|467085356|FG003|Overall Study|Transition to compassionate use|0|||
129760497|NCT02349633|467085357|FG004|Overall Study|Transition to compassionate use|1|||
129760498|NCT02349633|467085358|FG005|Overall Study|Transition to compassionate use|0|||
129760499|NCT02349633|467085359|FG006|Overall Study|Transition to compassionate use|0|||
129760500|NCT02349633|467085360|FG007|Overall Study|Transition to compassionate use|3|||
129760501|NCT02349633|467085361|FG008|Overall Study|Transition to compassionate use|0|||
129760502|NCT02349633|467085362|FG009|Overall Study|Transition to compassionate use|1|||
129760503|NCT02349633|467085363|FG010|Overall Study|Transition to compassionate use|0|||
129760504|NCT02349633|467085364|FG011|Overall Study|Transition to compassionate use|0|||
129760505|NCT02349633|467085365|FG012|Overall Study|Transition to compassionate use|0|||
129760506|NCT02349633|467085366|FG013|Overall Study|Transition to compassionate use|0|||
129760507|NCT02349633|467085353|FG000|Overall Study|Early termination of survival follow-up|0|||
129760508|NCT02349633|467085354|FG001|Overall Study|Early termination of survival follow-up|0|||
129760509|NCT02349633|467085355|FG002|Overall Study|Early termination of survival follow-up|0|||
129760510|NCT02349633|467085356|FG003|Overall Study|Early termination of survival follow-up|0|||
129760511|NCT02349633|467085357|FG004|Overall Study|Early termination of survival follow-up|0|||
129760512|NCT02349633|467085358|FG005|Overall Study|Early termination of survival follow-up|0|||
129760513|NCT02349633|467085359|FG006|Overall Study|Early termination of survival follow-up|0|||
129760514|NCT02349633|467085360|FG007|Overall Study|Early termination of survival follow-up|4|||
129760515|NCT02349633|467085361|FG008|Overall Study|Early termination of survival follow-up|0|||
129812432|NCT00289991|467280336|FG000|Overall Study|Failure of prophylaxis|1|||
129760516|NCT02349633|467085362|FG009|Overall Study|Early termination of survival follow-up|0|||
129760517|NCT02349633|467085363|FG010|Overall Study|Early termination of survival follow-up|0|||
129760518|NCT02349633|467085364|FG011|Overall Study|Early termination of survival follow-up|0|||
129760519|NCT02349633|467085365|FG012|Overall Study|Early termination of survival follow-up|0|||
129760520|NCT02349633|467085366|FG013|Overall Study|Early termination of survival follow-up|0|||
129760521|NCT02349633|467085353|FG000|Overall Study|Termination by sponsor|0|||
129760522|NCT02349633|467085354|FG001|Overall Study|Termination by sponsor|0|||
129760523|NCT02349633|467085355|FG002|Overall Study|Termination by sponsor|0|||
129760524|NCT02349633|467085356|FG003|Overall Study|Termination by sponsor|0|||
129760525|NCT02349633|467085357|FG004|Overall Study|Termination by sponsor|0|||
129760526|NCT02349633|467085358|FG005|Overall Study|Termination by sponsor|0|||
129760527|NCT02349633|467085359|FG006|Overall Study|Termination by sponsor|0|||
129760528|NCT02349633|467085360|FG007|Overall Study|Termination by sponsor|1|||
129760529|NCT02349633|467085361|FG008|Overall Study|Termination by sponsor|0|||
129760530|NCT02349633|467085362|FG009|Overall Study|Termination by sponsor|2|||
129760531|NCT02349633|467085363|FG010|Overall Study|Termination by sponsor|0|||
129760532|NCT02349633|467085364|FG011|Overall Study|Termination by sponsor|0|||
129760533|NCT02349633|467085365|FG012|Overall Study|Termination by sponsor|0|||
129760534|NCT02349633|467085366|FG013|Overall Study|Termination by sponsor|0|||
129760535|NCT02349633|467085353|FG000|Overall Study|Other|0|||
129760536|NCT02349633|467085354|FG001|Overall Study|Other|0|||
129760537|NCT02349633|467085355|FG002|Overall Study|Other|0|||
129760538|NCT02349633|467085356|FG003|Overall Study|Other|0|||
129760539|NCT02349633|467085357|FG004|Overall Study|Other|0|||
129760540|NCT02349633|467085358|FG005|Overall Study|Other|0|||
129760541|NCT02349633|467085359|FG006|Overall Study|Other|0|||
129760542|NCT02349633|467085360|FG007|Overall Study|Other|2|||
129760543|NCT02349633|467085361|FG008|Overall Study|Other|0|||
129760544|NCT02349633|467085362|FG009|Overall Study|Other|0|||
129760545|NCT02349633|467085363|FG010|Overall Study|Other|0|||
129760546|NCT02349633|467085364|FG011|Overall Study|Other|0|||
129760547|NCT02349633|467085365|FG012|Overall Study|Other|0|||
129760548|NCT02349633|467085366|FG013|Overall Study|Other|0|||
129760549|NCT01008943|467085369|FG000|Overall Study|Withdrawal by Subject|1|||
129760550|NCT04244253|467085370|FG000|Overall Study|Adverse Event|2|||
129760551|NCT04244253|467085371|FG001|Overall Study|Adverse Event|2|||
129760552|NCT04244253|467085372|FG002|Overall Study|Adverse Event|4|||
129760553|NCT04244253|467085370|FG000|Overall Study|Protocol Violation|1|||
129760554|NCT04244253|467085371|FG001|Overall Study|Protocol Violation|2|||
129760555|NCT04244253|467085372|FG002|Overall Study|Protocol Violation|1|||
129760556|NCT04244253|467085370|FG000|Overall Study|Withdrawal by Subject|0|||
129760557|NCT04244253|467085371|FG001|Overall Study|Withdrawal by Subject|1|||
129760558|NCT04244253|467085372|FG002|Overall Study|Withdrawal by Subject|6|||
129760559|NCT04244253|467085370|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129760560|NCT04244253|467085371|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129760561|NCT04244253|467085372|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129760562|NCT04663321|467085373|FG000|Overall Study|Study terminated by Sponsor|2|||
129760563|NCT04663321|467085374|FG001|Overall Study|Study terminated by Sponsor|1|||
129760564|NCT04663321|467085375|FG002|Overall Study|Study terminated by Sponsor|2|||
129760565|NCT04663321|467085373|FG000|Overall Study|Withdrawal by Subject|10|||
129760566|NCT04663321|467085374|FG001|Overall Study|Withdrawal by Subject|3|||
129760567|NCT04663321|467085375|FG002|Overall Study|Withdrawal by Subject|2|||
129760568|NCT04663321|467085373|FG000|Overall Study|Not provided|0|||
129760569|NCT04663321|467085374|FG001|Overall Study|Not provided|0|||
129760570|NCT04663321|467085375|FG002|Overall Study|Not provided|1|||
129760571|NCT02611479|467085376|FG000|Baseline Enrollment|Exited study|13|||
129760572|NCT02611479|467085376|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
129760573|NCT02611479|467085376|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
129760574|NCT02611479|467085376|FG000|Data Cleaning|No baseline function or pain metrics|2|||
129760575|NCT00423657|467085380|FG000|Overall Study|Withdrew consent|10|||
129760576|NCT00423657|467085381|FG001|Overall Study|Withdrew consent|8|||
129760577|NCT00423657|467085380|FG000|Overall Study|Non-compliance|0|||
129760578|NCT00423657|467085381|FG001|Overall Study|Non-compliance|1|||
129760579|NCT00423657|467085380|FG000|Overall Study|Other|15|||
129760580|NCT00423657|467085381|FG001|Overall Study|Other|16|||
129760581|NCT00423657|467085380|FG000|Overall Study|Request of sponsor/investigator|1|||
129760582|NCT00423657|467085381|FG001|Overall Study|Request of sponsor/investigator|0|||
129760583|NCT02748863|467085382|FG000|Treatment Period 1|Adverse Event|0|||
129760584|NCT02748863|467085383|FG001|Treatment Period 1|Adverse Event|1|||
129760585|NCT02748863|467085384|FG002|Treatment Period 1|Adverse Event|0|||
129760586|NCT02748863|467085385|FG003|Treatment Period 1|Adverse Event|0|||
129760587|NCT02748863|467085386|FG004|Treatment Period 1|Adverse Event|0|||
129760588|NCT02748863|467085382|FG000|Treatment Period 1|Lack of Efficacy|0|||
129760589|NCT02748863|467085383|FG001|Treatment Period 1|Lack of Efficacy|0|||
129760590|NCT02748863|467085384|FG002|Treatment Period 1|Lack of Efficacy|1|||
129760591|NCT02748863|467085385|FG003|Treatment Period 1|Lack of Efficacy|0|||
129760592|NCT02748863|467085386|FG004|Treatment Period 1|Lack of Efficacy|0|||
129760593|NCT02748863|467085382|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129760594|NCT02748863|467085383|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129760595|NCT02748863|467085384|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129760596|NCT02748863|467085385|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129760597|NCT02748863|467085386|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129760598|NCT02748863|467085382|FG000|Treatment Period 2|Lost to Follow-up|2|||
129760599|NCT02748863|467085383|FG001|Treatment Period 2|Lost to Follow-up|0|||
129760600|NCT02748863|467085384|FG002|Treatment Period 2|Lost to Follow-up|0|||
129760601|NCT02748863|467085385|FG003|Treatment Period 2|Lost to Follow-up|0|||
129760602|NCT02748863|467085386|FG004|Treatment Period 2|Lost to Follow-up|0|||
129760603|NCT02748863|467085382|FG000|Treatment Period 2|Adverse Event|3|||
129760604|NCT02748863|467085383|FG001|Treatment Period 2|Adverse Event|2|||
129760605|NCT02748863|467085384|FG002|Treatment Period 2|Adverse Event|0|||
129760606|NCT02748863|467085385|FG003|Treatment Period 2|Adverse Event|2|||
129760607|NCT02748863|467085386|FG004|Treatment Period 2|Adverse Event|0|||
129760608|NCT02748863|467085382|FG000|Treatment Period 2|Lack of Efficacy|0|||
129760609|NCT02748863|467085383|FG001|Treatment Period 2|Lack of Efficacy|1|||
129760610|NCT02748863|467085384|FG002|Treatment Period 2|Lack of Efficacy|0|||
129760611|NCT02748863|467085385|FG003|Treatment Period 2|Lack of Efficacy|0|||
129760612|NCT02748863|467085386|FG004|Treatment Period 2|Lack of Efficacy|0|||
129760613|NCT02748863|467085382|FG000|Treatment Period 2|Pregnancy|0|||
129760614|NCT02748863|467085383|FG001|Treatment Period 2|Pregnancy|0|||
129760615|NCT02748863|467085384|FG002|Treatment Period 2|Pregnancy|0|||
129760616|NCT02748863|467085385|FG003|Treatment Period 2|Pregnancy|0|||
129760617|NCT02748863|467085386|FG004|Treatment Period 2|Pregnancy|1|||
129760618|NCT02422498|467085390|FG000|Overall Study|Inevaluable|4|||
129760619|NCT03206216|467085391|FG000|Overall Study|Withdrawal by Subject|0|||
129760620|NCT03206216|467085392|FG001|Overall Study|Withdrawal by Subject|1|||
129760621|NCT01960140|467085393|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
129760622|NCT00657046|467085395|FG000|Overall Study|Adverse Event|1|||
129760623|NCT00657046|467085396|FG001|Overall Study|Adverse Event|1|||
129760624|NCT00657046|467085397|FG002|Overall Study|Adverse Event|0|||
129760625|NCT00657046|467085395|FG000|Overall Study|Protocol Violation|2|||
129760626|NCT00657046|467085396|FG001|Overall Study|Protocol Violation|2|||
129760627|NCT00657046|467085397|FG002|Overall Study|Protocol Violation|0|||
129760628|NCT00657046|467085395|FG000|Overall Study|Withdrawal by Subject|1|||
129760629|NCT00657046|467085396|FG001|Overall Study|Withdrawal by Subject|0|||
129760630|NCT00657046|467085397|FG002|Overall Study|Withdrawal by Subject|0|||
129760631|NCT00657046|467085395|FG000|Overall Study|Death|0|||
129760632|NCT00657046|467085396|FG001|Overall Study|Death|0|||
129760633|NCT00657046|467085397|FG002|Overall Study|Death|1|||
129760634|NCT00657046|467085395|FG000|Overall Study|Surgery|0|||
129760635|NCT00657046|467085396|FG001|Overall Study|Surgery|0|||
129760636|NCT00657046|467085397|FG002|Overall Study|Surgery|1|||
129760637|NCT02525471|467085403|FG000|Overall Study|Screen Failure|6|||
129760638|NCT02525471|467085403|FG000|Overall Study|Withdrawal by Subject|4|||
129760639|NCT02525471|467085403|FG000|Overall Study|Death|1|||
129760640|NCT00867165|467085404|FG000|Overall Study|Adverse Event|3|||
129760641|NCT00867165|467085405|FG001|Overall Study|Adverse Event|0|||
129760642|NCT00867165|467085404|FG000|Overall Study|Withdrawal by Subject|1|||
129760643|NCT00867165|467085405|FG001|Overall Study|Withdrawal by Subject|0|||
129760644|NCT01054456|467085406|FG000|Overall Study|Other|1|||
129760645|NCT03935126|467085407|FG000|Overall Study|Study termination by sponsor|3|||
129760646|NCT03649217|467085408|FG000|Overall Study|subject had severe ataxia not initially found|1|||
129760647|NCT03649217|467085408|FG000|Overall Study|subject had cognitive issues not initially found|1|||
129760648|NCT00377520|467085413|FG000|Overall Study|Ineligible (Prior radiation)|1|||
129760649|NCT00320515|467085418|FG000|Overall Study|Death|33|||
129760650|NCT00320515|467085418|FG000|Overall Study|Lost to Follow-up|6|||
129760651|NCT00320515|467085418|FG000|Overall Study|Physician Decision|2|||
129760652|NCT00320515|467085418|FG000|Overall Study|Withdrawal by Subject|8|||
129760653|NCT00851786|467085419|FG000|Overall Study|Withdrawal by Subject|0|||
129760654|NCT00851786|467085420|FG001|Overall Study|Withdrawal by Subject|1|||
129760655|NCT00851786|467085419|FG000|Overall Study|Protocol Violation|0|||
129760656|NCT00851786|467085420|FG001|Overall Study|Protocol Violation|1|||
129760657|NCT00851786|467085419|FG000|Overall Study|Lost to Follow-up|1|||
129760658|NCT00851786|467085420|FG001|Overall Study|Lost to Follow-up|0|||
129760659|NCT00851786|467085419|FG000|Overall Study|Incarceration|1|||
129760660|NCT00851786|467085420|FG001|Overall Study|Incarceration|0|||
129760661|NCT00851786|467085419|FG000|Overall Study|Site Closure|1|||
129760662|NCT00851786|467085420|FG001|Overall Study|Site Closure|0|||
129760663|NCT00851786|467085419|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
129760664|NCT00851786|467085420|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
129760665|NCT00445549|467087004|FG000|Overall Study|progressive disease|12|||
129760666|NCT03858049|467087012|FG000|Overall Study|Adverse Event|16|||
129760667|NCT03858049|467087013|FG001|Overall Study|Adverse Event|9|||
129760668|NCT03858049|467087012|FG000|Overall Study|Other|1|||
129760669|NCT03858049|467087013|FG001|Overall Study|Other|1|||
129812433|NCT00289991|467280337|FG001|Overall Study|Failure of prophylaxis|1|||
129812434|NCT00289991|467280336|FG000|Overall Study|Fungal breakthrough infection|0|||
129760670|NCT02079740|467087014|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
129760671|NCT02079740|467087015|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
129760672|NCT02079740|467087016|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
129760673|NCT02079740|467087017|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
129760674|NCT02079740|467087018|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
129760675|NCT02079740|467087019|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
129812435|NCT00289991|467280337|FG001|Overall Study|Fungal breakthrough infection|1|||
129812436|NCT00289991|467280336|FG000|Overall Study|Lost to Follow-up|0|||
129760676|NCT02079740|467087020|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
129760677|NCT02079740|467087021|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
129760678|NCT02079740|467087022|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
129760679|NCT02079740|467087023|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
129760680|NCT02079740|467087024|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
129760681|NCT02079740|467087025|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
129760682|NCT02079740|467087026|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
129760683|NCT02079740|467087014|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
129760684|NCT02079740|467087015|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
129760685|NCT02079740|467087016|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
129760686|NCT02079740|467087017|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
129760687|NCT02079740|467087018|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
129760688|NCT02079740|467087019|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
129760689|NCT02079740|467087020|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
129760690|NCT02079740|467087021|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
129760691|NCT02079740|467087022|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
129760692|NCT02079740|467087023|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
129760693|NCT02079740|467087024|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
129760694|NCT02079740|467087025|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
129760695|NCT02079740|467087026|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
129760696|NCT02079740|467087014|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760697|NCT02079740|467087015|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760698|NCT02079740|467087016|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760699|NCT02079740|467087017|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760700|NCT02079740|467087018|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760701|NCT02079740|467087019|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760702|NCT02079740|467087020|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760703|NCT02079740|467087021|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
129760704|NCT02079740|467087022|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760705|NCT02079740|467087023|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760706|NCT02079740|467087024|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
129445407|NCT03828292|465931280|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
129445408|NCT03828292|465931281|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
129445409|NCT03828292|465931282|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
129445410|NCT03828292|465931283|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
129445411|NCT03828292|465931284|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
129445412|NCT04752475|465932782|FG000|Overall Study|Withdrawal by Subject|1|||
129445413|NCT04752475|465932783|FG001|Overall Study|Withdrawal by Subject|1|||
129445414|NCT02113579|465932786|FG000|Overall Study|Adverse Event|1|||
129445415|NCT02113579|465932787|FG001|Overall Study|Adverse Event|0|||
129445416|NCT02113579|465932786|FG000|Overall Study|Withdrawal by Subject|3|||
129445417|NCT02113579|465932787|FG001|Overall Study|Withdrawal by Subject|2|||
129445418|NCT02113579|465932786|FG000|Overall Study|Lost to Follow-up|6|||
129445419|NCT02113579|465932787|FG001|Overall Study|Lost to Follow-up|2|||
129445420|NCT00594516|465932790|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
129445421|NCT00594516|465932791|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
129445422|NCT00594516|465932792|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
129760707|NCT02079740|467087025|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760708|NCT02079740|467087026|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
129760709|NCT02079740|467087014|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760710|NCT02079740|467087015|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760711|NCT02079740|467087016|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760712|NCT02079740|467087017|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760713|NCT02079740|467087018|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760714|NCT02079740|467087019|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760715|NCT02079740|467087020|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760716|NCT02079740|467087021|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
129760717|NCT02079740|467087022|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760718|NCT02079740|467087023|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760719|NCT02079740|467087024|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760720|NCT02079740|467087025|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760721|NCT02079740|467087026|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
129760722|NCT02079740|467087014|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760723|NCT02079740|467087015|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760724|NCT02079740|467087016|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760725|NCT02079740|467087017|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760726|NCT02079740|467087018|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129445423|NCT00594516|465932790|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
129760727|NCT02079740|467087019|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760728|NCT02079740|467087020|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760729|NCT02079740|467087021|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760730|NCT02079740|467087022|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760731|NCT02079740|467087023|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
129760732|NCT02079740|467087024|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
129760733|NCT02079740|467087025|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
129760734|NCT02079740|467087026|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
129760735|NCT03493945|467087027|FG000|Phase I Dose Escalation|Ineligible|0|||
129760736|NCT03493945|467087028|FG001|Phase I Dose Escalation|Ineligible|0|||
129760737|NCT03493945|467087029|FG002|Phase I Dose Escalation|Ineligible|1|||
129760738|NCT03493945|467087030|FG003|Phase I Dose Escalation|Ineligible|0|||
129760739|NCT03493945|467087031|FG004|Phase I Dose Escalation|Ineligible|0|||
129760740|NCT03493945|467087032|FG005|Phase I Dose Escalation|Ineligible|0|||
129760741|NCT03493945|467087033|FG006|Phase I Dose Escalation|Ineligible|0|||
129760742|NCT03493945|467087027|FG000|Phase I Dose Escalation|New therapy|0|||
129760743|NCT03493945|467087028|FG001|Phase I Dose Escalation|New therapy|1|||
129760744|NCT03493945|467087029|FG002|Phase I Dose Escalation|New therapy|0|||
129760745|NCT03493945|467087030|FG003|Phase I Dose Escalation|New therapy|0|||
129760746|NCT03493945|467087031|FG004|Phase I Dose Escalation|New therapy|0|||
129760747|NCT03493945|467087032|FG005|Phase I Dose Escalation|New therapy|0|||
129760748|NCT03493945|467087033|FG006|Phase I Dose Escalation|New therapy|0|||
129760749|NCT03493945|467087027|FG000|Phase II Dose Expansion|Refused further treatment|0|||
129760750|NCT03493945|467087028|FG001|Phase II Dose Expansion|Refused further treatment|0|||
129760751|NCT03493945|467087029|FG002|Phase II Dose Expansion|Refused further treatment|0|||
129760752|NCT03493945|467087030|FG003|Phase II Dose Expansion|Refused further treatment|0|||
129760753|NCT03493945|467087031|FG004|Phase II Dose Expansion|Refused further treatment|1|||
129760754|NCT03493945|467087032|FG005|Phase II Dose Expansion|Refused further treatment|1|||
129760755|NCT03493945|467087033|FG006|Phase II Dose Expansion|Refused further treatment|0|||
129760756|NCT03493945|467087027|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
129760757|NCT03493945|467087028|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
129760758|NCT03493945|467087029|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
129760759|NCT03493945|467087030|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
129760760|NCT03493945|467087031|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
129760761|NCT03493945|467087032|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
129760762|NCT03493945|467087033|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
129760763|NCT01690052|467087038|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
129760764|NCT01690052|467087039|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
129760765|NCT02421172|467087040|FG000|Period 1|Adverse Event|1|||
129760766|NCT02421172|467087041|FG001|Period 1|Adverse Event|0|||
129760767|NCT02421172|467087042|FG002|Period 1|Adverse Event|0|||
129760768|NCT02421172|467087043|FG003|Period 1|Adverse Event|0|||
129760769|NCT02421172|467087044|FG004|Period 1|Adverse Event|0|||
129760770|NCT02421172|467087040|FG000|Period 1|Lost to Follow-up|3|||
129760771|NCT02421172|467087041|FG001|Period 1|Lost to Follow-up|1|||
129760772|NCT02421172|467087042|FG002|Period 1|Lost to Follow-up|0|||
129760773|NCT02421172|467087043|FG003|Period 1|Lost to Follow-up|0|||
129760774|NCT02421172|467087044|FG004|Period 1|Lost to Follow-up|0|||
129760775|NCT02421172|467087040|FG000|Period 1|Patient/guardian decision|0|||
129760776|NCT02421172|467087041|FG001|Period 1|Patient/guardian decision|1|||
129760777|NCT02421172|467087042|FG002|Period 1|Patient/guardian decision|0|||
129760778|NCT02421172|467087043|FG003|Period 1|Patient/guardian decision|0|||
129760779|NCT02421172|467087044|FG004|Period 1|Patient/guardian decision|0|||
129760780|NCT02421172|467087040|FG000|Period 2|Adverse Event|0|||
129760781|NCT02421172|467087041|FG001|Period 2|Adverse Event|0|||
129760782|NCT02421172|467087042|FG002|Period 2|Adverse Event|4|||
129760783|NCT02421172|467087043|FG003|Period 2|Adverse Event|0|||
129760784|NCT02421172|467087044|FG004|Period 2|Adverse Event|0|||
129760785|NCT02421172|467087040|FG000|Period 2|Lost to Follow-up|0|||
129760786|NCT02421172|467087041|FG001|Period 2|Lost to Follow-up|0|||
129760787|NCT02421172|467087042|FG002|Period 2|Lost to Follow-up|0|||
129760788|NCT02421172|467087043|FG003|Period 2|Lost to Follow-up|1|||
129760789|NCT02421172|467087044|FG004|Period 2|Lost to Follow-up|0|||
129760790|NCT02421172|467087040|FG000|Period 2|Patient/guardian decision|0|||
129812437|NCT00289991|467280337|FG001|Overall Study|Lost to Follow-up|1|||
129812438|NCT00289991|467280336|FG000|Overall Study|Withdrawal by Subject|2|||
129445424|NCT00594516|465932791|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
129760791|NCT02421172|467087041|FG001|Period 2|Patient/guardian decision|0|||
129760792|NCT02421172|467087042|FG002|Period 2|Patient/guardian decision|3|||
129760793|NCT02421172|467087043|FG003|Period 2|Patient/guardian decision|2|||
129760794|NCT02421172|467087044|FG004|Period 2|Patient/guardian decision|1|||
129760795|NCT00683878|467087045|FG000|Overall Study|Lack of Efficacy|3|||
129760796|NCT00683878|467087046|FG001|Overall Study|Lack of Efficacy|0|||
129760797|NCT00683878|467087047|FG002|Overall Study|Lack of Efficacy|1|||
129760798|NCT00683878|467087045|FG000|Overall Study|Adverse Event|4|||
129760799|NCT00683878|467087046|FG001|Overall Study|Adverse Event|3|||
129760800|NCT00683878|467087047|FG002|Overall Study|Adverse Event|3|||
129760801|NCT00683878|467087045|FG000|Overall Study|Withdrawal by Subject|9|||
129760802|NCT00683878|467087046|FG001|Overall Study|Withdrawal by Subject|8|||
129760803|NCT00683878|467087047|FG002|Overall Study|Withdrawal by Subject|6|||
129760804|NCT00683878|467087045|FG000|Overall Study|Death|0|||
129760805|NCT00683878|467087046|FG001|Overall Study|Death|1|||
129760806|NCT00683878|467087047|FG002|Overall Study|Death|0|||
129760807|NCT00683878|467087045|FG000|Overall Study|Lost to Follow-up|4|||
129760808|NCT00683878|467087046|FG001|Overall Study|Lost to Follow-up|2|||
129760809|NCT00683878|467087047|FG002|Overall Study|Lost to Follow-up|4|||
129760810|NCT00683878|467087045|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
129760811|NCT00683878|467087046|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
129760812|NCT00683878|467087047|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
129760813|NCT04319198|467087055|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
129760814|NCT04319198|467087056|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
129760815|NCT04319198|467087057|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
129760816|NCT04319198|467087055|FG000|Overall Study|Death|0|||
129760817|NCT04319198|467087056|FG001|Overall Study|Death|3|||
129760818|NCT04319198|467087057|FG002|Overall Study|Death|3|||
129760819|NCT04319198|467087055|FG000|Overall Study|Reason Not Specified|0|||
129760820|NCT04319198|467087056|FG001|Overall Study|Reason Not Specified|2|||
129760821|NCT04319198|467087057|FG002|Overall Study|Reason Not Specified|4|||
129760822|NCT04319198|467087055|FG000|Overall Study|Withdrawal of Consent|0|||
129760823|NCT04319198|467087056|FG001|Overall Study|Withdrawal of Consent|0|||
129760824|NCT04319198|467087057|FG002|Overall Study|Withdrawal of Consent|5|||
129760825|NCT04319198|467087055|FG000|Overall Study|Site Terminated by Sponsor|0|||
129760826|NCT04319198|467087056|FG001|Overall Study|Site Terminated by Sponsor|1|||
129760827|NCT04319198|467087057|FG002|Overall Study|Site Terminated by Sponsor|0|||
129760828|NCT01693029|467087058|FG000|Overall Study|Withdrawal by Subject|15|||
129760829|NCT01693029|467087059|FG001|Overall Study|Withdrawal by Subject|22|||
129760830|NCT01693029|467087058|FG000|Overall Study|Kidney transplantation|7|||
129760831|NCT01693029|467087059|FG001|Overall Study|Kidney transplantation|7|||
129760832|NCT01693029|467087058|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
129760833|NCT01693029|467087059|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
129760834|NCT01693029|467087058|FG000|Overall Study|Protocol Violation|6|||
129760835|NCT01693029|467087059|FG001|Overall Study|Protocol Violation|7|||
129760836|NCT01693029|467087058|FG000|Overall Study|Change in dialysis modality|2|||
129760837|NCT01693029|467087059|FG001|Overall Study|Change in dialysis modality|1|||
129760838|NCT01693029|467087058|FG000|Overall Study|Physician Decision|0|||
129760839|NCT01693029|467087059|FG001|Overall Study|Physician Decision|2|||
129760840|NCT01693029|467087058|FG000|Overall Study|Lost to Follow-up|0|||
129760841|NCT01693029|467087059|FG001|Overall Study|Lost to Follow-up|1|||
129760842|NCT01693029|467087058|FG000|Overall Study|Adverse Event|1|||
129760843|NCT01693029|467087059|FG001|Overall Study|Adverse Event|6|||
129760844|NCT01693029|467087058|FG000|Overall Study|Death|5|||
129760845|NCT01693029|467087059|FG001|Overall Study|Death|8|||
129760846|NCT01693029|467087058|FG000|Overall Study|Non-compliance|2|||
129760847|NCT01693029|467087059|FG001|Overall Study|Non-compliance|1|||
129760848|NCT00657540|467087060|FG000|Overall Study|Lost to Follow-up|1|||
129760849|NCT00657540|467087061|FG001|Overall Study|Lost to Follow-up|4|||
129760850|NCT04073186|467087067|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
129760851|NCT04073186|467087067|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
129760852|NCT04073186|467087067|FG000|First Wearing Cycle|Protocol Violation|1|||
129760853|NCT04073186|467087067|FG000|First Wearing Cycle|Lens Discomfort|2|||
129760854|NCT04073186|467087067|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
129760855|NCT04073186|467087067|FG000|Second Wearing Cycle|Adverse Event|1|||
129760856|NCT01453140|467087070|FG000|Overall Study|Adverse Event|3|||
129760857|NCT00743249|467087071|FG000|Overall Study|Adverse Event|0|||
129760858|NCT00743249|467087072|FG001|Overall Study|Adverse Event|4|||
129760859|NCT00743249|467087071|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
129760860|NCT00743249|467087072|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
129760861|NCT00743249|467087071|FG000|Overall Study|Unsuccessful insertion of stent|2|||
129760862|NCT00743249|467087072|FG001|Overall Study|Unsuccessful insertion of stent|1|||
129760863|NCT02653326|467087073|FG000|Overall Study|Lost to Follow-up|10|||
129760864|NCT02653326|467087074|FG001|Overall Study|Lost to Follow-up|7|||
129760865|NCT05767021|467087077|FG000|Overall Study|Adverse Event|2|||
129760866|NCT05767021|467087077|FG000|Overall Study|Protocol Deviation|1|||
129760867|NCT05767021|467087077|FG000|Overall Study|Withdrawal by Subject|1|||
129760868|NCT05767021|467087077|FG000|Overall Study|Physician Decision|1|||
129812439|NCT00289991|467280337|FG001|Overall Study|Withdrawal by Subject|12|||
129812440|NCT00289991|467280336|FG000|Overall Study|Other|5|||
129760869|NCT05767021|467087077|FG000|Overall Study|Lack of Efficacy|11|||
129760870|NCT05767021|467087077|FG000|Overall Study|Assigned Treatment by Mistake|1|||
129760871|NCT04154943|467087081|FG000|Overall Study|Study Ongoing|68|||
129760872|NCT04154943|467087081|FG000|Overall Study|Lost to Follow-up|1|||
129760873|NCT04154943|467087081|FG000|Overall Study|Decision by the Investigator|1|||
129760874|NCT04154943|467087081|FG000|Overall Study|Death|5|||
129760875|NCT04154943|467087081|FG000|Overall Study|Withdrawal by Subject|4|||
129760876|NCT01239381|467087082|FG000|Overall Study|Protocol Violation|1|||
129760877|NCT01239381|467087082|FG000|Overall Study|Withdrawal by Subject|1|||
129760878|NCT06237049|467087083|FG000|Overall Study|Death|0|||
129760879|NCT06237049|467087084|FG001|Overall Study|Death|0|||
129760880|NCT06237049|467087085|FG002|Overall Study|Death|0|||
129812441|NCT00289991|467280337|FG001|Overall Study|Other|14|||
129812442|NCT01606007|467280340|FG000|Overall Study|Reason 'Other' in the protocol|0|||
129812443|NCT01606007|467280341|FG001|Overall Study|Reason 'Other' in the protocol|1|||
129812444|NCT01606007|467280342|FG002|Overall Study|Reason 'Other' in the protocol|1|||
129812445|NCT01606007|467280340|FG000|Overall Study|Pregnancy|0|||
129812446|NCT01606007|467280341|FG001|Overall Study|Pregnancy|1|||
129812447|NCT01606007|467280342|FG002|Overall Study|Pregnancy|1|||
129812448|NCT01606007|467280340|FG000|Overall Study|Withdrawal by Subject|8|||
129812449|NCT01606007|467280341|FG001|Overall Study|Withdrawal by Subject|6|||
129812450|NCT01606007|467280342|FG002|Overall Study|Withdrawal by Subject|1|||
129812451|NCT01606007|467280340|FG000|Overall Study|Adverse Event|0|||
129896973|NCT04888585|467582181|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
129896974|NCT04927975|467582182|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
129896975|NCT04927975|467582183|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
129896976|NCT04927975|467582184|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
129760881|NCT06237049|467087086|FG003|Overall Study|Death|1|||
129760882|NCT06237049|467087083|FG000|Overall Study|Lost to Follow-up|11|||
129760883|NCT06237049|467087084|FG001|Overall Study|Lost to Follow-up|5|||
129760884|NCT06237049|467087085|FG002|Overall Study|Lost to Follow-up|8|||
129760885|NCT06237049|467087086|FG003|Overall Study|Lost to Follow-up|8|||
129760886|NCT06237049|467087083|FG000|Overall Study|Protocol Violation|0|||
129760887|NCT06237049|467087084|FG001|Overall Study|Protocol Violation|1|||
129760888|NCT06237049|467087085|FG002|Overall Study|Protocol Violation|0|||
129760889|NCT06237049|467087086|FG003|Overall Study|Protocol Violation|1|||
129760890|NCT06237049|467087083|FG000|Overall Study|Withdrawal by Subject|4|||
129760891|NCT06237049|467087084|FG001|Overall Study|Withdrawal by Subject|2|||
129760892|NCT06237049|467087085|FG002|Overall Study|Withdrawal by Subject|1|||
129760893|NCT06237049|467087086|FG003|Overall Study|Withdrawal by Subject|0|||
129760894|NCT02738008|467087087|FG000|Overall Study|Study Terminated by Sponsor|1|||
129760895|NCT02738008|467087088|FG001|Overall Study|Study Terminated by Sponsor|5|||
129760896|NCT02738008|467087089|FG002|Overall Study|Study Terminated by Sponsor|3|||
129760897|NCT02738008|467087087|FG000|Overall Study|Adverse Event|0|||
129760898|NCT02738008|467087088|FG001|Overall Study|Adverse Event|1|||
129760899|NCT02738008|467087089|FG002|Overall Study|Adverse Event|2|||
129760900|NCT04621448|467087090|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
129760901|NCT04621448|467087091|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
129760902|NCT04621448|467087092|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
129760903|NCT04621448|467087093|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
129760904|NCT04621448|467087090|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
129760905|NCT04621448|467087091|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
129760906|NCT04621448|467087092|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
129760907|NCT04621448|467087093|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
129760908|NCT04621448|467087090|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
129760909|NCT04621448|467087091|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
129760910|NCT04621448|467087092|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
129760911|NCT04621448|467087093|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
129760912|NCT04621448|467087090|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
129760913|NCT04621448|467087091|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
129760914|NCT04621448|467087092|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
129760915|NCT04621448|467087093|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
129760916|NCT03550378|467087094|FG000|Overall Study|Death|0|||
129760917|NCT03550378|467087095|FG001|Overall Study|Death|1|||
129760918|NCT04590014|467087098|FG000|Overall Study|Withdrawal by Subject|1|||
129760919|NCT04590014|467087099|FG001|Overall Study|Withdrawal by Subject|0|||
129896977|NCT04927975|467582185|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
129896978|NCT04927975|467582186|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
129896979|NCT04927975|467582187|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
129896980|NCT04927975|467582182|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129896981|NCT04927975|467582183|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129760920|NCT00468299|467087100|FG000|Overall Study|Withdrawal by Subject|0|||
129896982|NCT04927975|467582184|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129760921|NCT00468299|467087101|FG001|Overall Study|Withdrawal by Subject|1|||
129760922|NCT04264442|467087104|FG000|Overall Study|Lack of Efficacy|6|||
129760923|NCT04264442|467087104|FG000|Overall Study|Lost to Follow-up|2|||
129896983|NCT04927975|467582185|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
129760924|NCT04264442|467087104|FG000|Overall Study|Sponsor Decision|23|||
129812452|NCT01606007|467280341|FG001|Overall Study|Adverse Event|1|||
129812453|NCT01606007|467280342|FG002|Overall Study|Adverse Event|1|||
129896984|NCT04927975|467582186|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
129760925|NCT04264442|467087104|FG000|Overall Study|Withdrawal by Subject|11|||
129760926|NCT04264442|467087104|FG000|Overall Study|Study Termination|5|||
129760927|NCT01384734|467087106|FG000|Overall Study|Adverse Event|0|||
129760928|NCT01384734|467087107|FG001|Overall Study|Adverse Event|3|||
129760929|NCT01384734|467087108|FG002|Overall Study|Adverse Event|0|||
129760930|NCT01384734|467087109|FG003|Overall Study|Adverse Event|2|||
129760931|NCT01384734|467087110|FG004|Overall Study|Adverse Event|7|||
129760932|NCT01384734|467087106|FG000|Overall Study|Death|1|||
129760933|NCT01384734|467087107|FG001|Overall Study|Death|0|||
129760934|NCT01384734|467087108|FG002|Overall Study|Death|1|||
129760935|NCT01384734|467087109|FG003|Overall Study|Death|0|||
129760936|NCT01384734|467087110|FG004|Overall Study|Death|0|||
129760937|NCT01384734|467087106|FG000|Overall Study|Continuation criteria not met|0|||
129760938|NCT01384734|467087107|FG001|Overall Study|Continuation criteria not met|0|||
129760939|NCT01384734|467087108|FG002|Overall Study|Continuation criteria not met|1|||
129760940|NCT01384734|467087109|FG003|Overall Study|Continuation criteria not met|1|||
129760941|NCT01384734|467087110|FG004|Overall Study|Continuation criteria not met|0|||
129760942|NCT01384734|467087106|FG000|Overall Study|Lack of Efficacy|3|||
129760943|NCT01384734|467087107|FG001|Overall Study|Lack of Efficacy|7|||
129760944|NCT01384734|467087108|FG002|Overall Study|Lack of Efficacy|4|||
129760945|NCT01384734|467087109|FG003|Overall Study|Lack of Efficacy|4|||
129760946|NCT01384734|467087110|FG004|Overall Study|Lack of Efficacy|2|||
129760947|NCT01384734|467087106|FG000|Overall Study|Lost to Follow-up|5|||
129760948|NCT01384734|467087107|FG001|Overall Study|Lost to Follow-up|3|||
129760949|NCT01384734|467087108|FG002|Overall Study|Lost to Follow-up|3|||
129760950|NCT01384734|467087109|FG003|Overall Study|Lost to Follow-up|8|||
129760951|NCT01384734|467087110|FG004|Overall Study|Lost to Follow-up|5|||
129760952|NCT01384734|467087106|FG000|Overall Study|Non-compliance with study drug|1|||
129760953|NCT01384734|467087107|FG001|Overall Study|Non-compliance with study drug|2|||
129760954|NCT01384734|467087108|FG002|Overall Study|Non-compliance with study drug|6|||
129760955|NCT01384734|467087109|FG003|Overall Study|Non-compliance with study drug|0|||
129760956|NCT01384734|467087110|FG004|Overall Study|Non-compliance with study drug|2|||
129760957|NCT01384734|467087106|FG000|Overall Study|Pregnancy|0|||
129760958|NCT01384734|467087107|FG001|Overall Study|Pregnancy|1|||
129760959|NCT01384734|467087108|FG002|Overall Study|Pregnancy|0|||
129760960|NCT01384734|467087109|FG003|Overall Study|Pregnancy|0|||
129760961|NCT01384734|467087110|FG004|Overall Study|Pregnancy|1|||
129760962|NCT01384734|467087106|FG000|Overall Study|Sponsor terminated|0|||
129760963|NCT01384734|467087107|FG001|Overall Study|Sponsor terminated|0|||
129760964|NCT01384734|467087108|FG002|Overall Study|Sponsor terminated|0|||
129760965|NCT01384734|467087109|FG003|Overall Study|Sponsor terminated|0|||
129760966|NCT01384734|467087110|FG004|Overall Study|Sponsor terminated|1|||
129760967|NCT01384734|467087106|FG000|Overall Study|Withdrawal by Subject|5|||
129760968|NCT01384734|467087107|FG001|Overall Study|Withdrawal by Subject|5|||
129812454|NCT01606007|467280340|FG000|Overall Study|discontinue study treatment|0|||
129812455|NCT01606007|467280341|FG001|Overall Study|discontinue study treatment|2|||
129812456|NCT01606007|467280342|FG002|Overall Study|discontinue study treatment|1|||
129812457|NCT01606007|467280340|FG000|Overall Study|Lost to Follow-up|6|||
129812458|NCT01606007|467280341|FG001|Overall Study|Lost to Follow-up|8|||
129812459|NCT01606007|467280342|FG002|Overall Study|Lost to Follow-up|5|||
129812460|NCT01606007|467280340|FG000|Overall Study|Poor/Non-compliance|1|||
129812461|NCT01606007|467280341|FG001|Overall Study|Poor/Non-compliance|0|||
129812462|NCT01606007|467280342|FG002|Overall Study|Poor/Non-compliance|0|||
129812463|NCT03706079|467280343|FG000|Predecessor Study|Death|0|||
129812464|NCT03706079|467280344|FG001|Predecessor Study|Death|2|||
129812465|NCT03706079|467280345|FG002|Predecessor Study|Death|0|||
129812466|NCT03706079|467280346|FG003|Predecessor Study|Death|1|||
129812467|NCT03706079|467280347|FG004|Predecessor Study|Death|0|||
129812468|NCT03706079|467280348|FG005|Predecessor Study|Death|0|||
129812469|NCT03706079|467280343|FG000|Predecessor Study|Lost to Follow-up|5|||
129812470|NCT03706079|467280344|FG001|Predecessor Study|Lost to Follow-up|2|||
129812471|NCT03706079|467280345|FG002|Predecessor Study|Lost to Follow-up|0|||
129812472|NCT03706079|467280346|FG003|Predecessor Study|Lost to Follow-up|0|||
129812473|NCT03706079|467280347|FG004|Predecessor Study|Lost to Follow-up|1|||
129812474|NCT03706079|467280348|FG005|Predecessor Study|Lost to Follow-up|0|||
129812475|NCT03706079|467280343|FG000|Predecessor Study|Withdrawal by Subject|8|||
129760969|NCT01384734|467087108|FG002|Overall Study|Withdrawal by Subject|6|||
129760970|NCT01384734|467087109|FG003|Overall Study|Withdrawal by Subject|7|||
129760971|NCT01384734|467087110|FG004|Overall Study|Withdrawal by Subject|9|||
129760972|NCT01384734|467087106|FG000|Overall Study|Investigator relocating|0|||
129760973|NCT01384734|467087107|FG001|Overall Study|Investigator relocating|2|||
129760974|NCT01384734|467087108|FG002|Overall Study|Investigator relocating|0|||
129760975|NCT01384734|467087109|FG003|Overall Study|Investigator relocating|3|||
129760976|NCT01384734|467087110|FG004|Overall Study|Investigator relocating|1|||
129812476|NCT03706079|467280344|FG001|Predecessor Study|Withdrawal by Subject|15|||
129812477|NCT03706079|467280345|FG002|Predecessor Study|Withdrawal by Subject|0|||
129812478|NCT03706079|467280346|FG003|Predecessor Study|Withdrawal by Subject|5|||
129812479|NCT03706079|467280347|FG004|Predecessor Study|Withdrawal by Subject|2|||
129812480|NCT03706079|467280348|FG005|Predecessor Study|Withdrawal by Subject|0|||
129760977|NCT01384734|467087106|FG000|Overall Study|Unable to come back for visit|1|||
129760978|NCT01384734|467087107|FG001|Overall Study|Unable to come back for visit|0|||
129760979|NCT01384734|467087108|FG002|Overall Study|Unable to come back for visit|1|||
129760980|NCT01384734|467087109|FG003|Overall Study|Unable to come back for visit|1|||
129760981|NCT01384734|467087110|FG004|Overall Study|Unable to come back for visit|0|||
129760982|NCT01384734|467087106|FG000|Overall Study|Prison|0|||
129760983|NCT01384734|467087107|FG001|Overall Study|Prison|0|||
129760984|NCT01384734|467087108|FG002|Overall Study|Prison|1|||
129760985|NCT01384734|467087109|FG003|Overall Study|Prison|0|||
129760986|NCT01384734|467087110|FG004|Overall Study|Prison|0|||
129760987|NCT01384734|467087106|FG000|Overall Study|As per Exclusion criteria|0|||
129760988|NCT01384734|467087107|FG001|Overall Study|As per Exclusion criteria|1|||
129760989|NCT01384734|467087108|FG002|Overall Study|As per Exclusion criteria|0|||
129760990|NCT01384734|467087109|FG003|Overall Study|As per Exclusion criteria|0|||
129760991|NCT01384734|467087110|FG004|Overall Study|As per Exclusion criteria|0|||
129760992|NCT01384734|467087106|FG000|Overall Study|Missed End of treatment visit|0|||
129760993|NCT01384734|467087107|FG001|Overall Study|Missed End of treatment visit|0|||
129760994|NCT01384734|467087108|FG002|Overall Study|Missed End of treatment visit|0|||
129760995|NCT01384734|467087109|FG003|Overall Study|Missed End of treatment visit|1|||
129760996|NCT01384734|467087110|FG004|Overall Study|Missed End of treatment visit|0|||
129760997|NCT01384734|467087106|FG000|Overall Study|Adhesion problem|0|||
129760998|NCT01384734|467087107|FG001|Overall Study|Adhesion problem|0|||
129760999|NCT01384734|467087108|FG002|Overall Study|Adhesion problem|0|||
129761000|NCT01384734|467087109|FG003|Overall Study|Adhesion problem|1|||
129761001|NCT01384734|467087110|FG004|Overall Study|Adhesion problem|0|||
129761002|NCT01384734|467087106|FG000|Overall Study|Early termination|0|||
129761003|NCT01384734|467087107|FG001|Overall Study|Early termination|0|||
129761004|NCT01384734|467087108|FG002|Overall Study|Early termination|0|||
129761005|NCT01384734|467087109|FG003|Overall Study|Early termination|0|||
129761006|NCT01384734|467087110|FG004|Overall Study|Early termination|1|||
129761007|NCT01384734|467087106|FG000|Overall Study|Physician Decision|1|||
129761008|NCT01384734|467087107|FG001|Overall Study|Physician Decision|0|||
129761009|NCT01384734|467087108|FG002|Overall Study|Physician Decision|0|||
129761010|NCT01384734|467087109|FG003|Overall Study|Physician Decision|0|||
129761011|NCT01384734|467087110|FG004|Overall Study|Physician Decision|0|||
129761012|NCT01290523|467087111|FG000|Overall Study|Death|3|||
129761013|NCT03071263|467087112|FG000|Overall Study|Adverse Event|1|||
129761014|NCT03071263|467087113|FG001|Overall Study|Adverse Event|3|||
129761015|NCT03071263|467087112|FG000|Overall Study|Withdrawal by Subject|1|||
129761016|NCT03071263|467087113|FG001|Overall Study|Withdrawal by Subject|3|||
129761017|NCT03071263|467087112|FG000|Overall Study|Physician Decision|1|||
129761018|NCT03071263|467087113|FG001|Overall Study|Physician Decision|0|||
129761019|NCT03071263|467087112|FG000|Overall Study|Participant moved to another city|0|||
129761020|NCT03071263|467087113|FG001|Overall Study|Participant moved to another city|1|||
129761021|NCT01917747|467087114|FG000|Overall Study|Withdrawal by Subject|1|||
129761022|NCT01917747|467087115|FG001|Overall Study|Withdrawal by Subject|2|||
129761023|NCT01917747|467087114|FG000|Overall Study|Lost to Follow-up|18|||
129761024|NCT01917747|467087115|FG001|Overall Study|Lost to Follow-up|9|||
129761025|NCT00152503|467087117|FG000|Overall Study|Adverse Event|4|||
129761026|NCT02922725|467087118|FG000|Overall Study|Withdrawal by Subject|1|||
129761027|NCT02922725|467087119|FG001|Overall Study|Withdrawal by Subject|0|||
129761028|NCT02922725|467087120|FG002|Overall Study|Withdrawal by Subject|0|||
129761029|NCT01300234|467087121|FG000|Overall Study|Adverse Event|1|||
129761030|NCT01300234|467087122|FG001|Overall Study|Adverse Event|1|||
129761031|NCT01300234|467087121|FG000|Overall Study|Protocol Violation|2|||
129761032|NCT01300234|467087122|FG001|Overall Study|Protocol Violation|3|||
129761033|NCT01300234|467087121|FG000|Overall Study|Withdrawal by Subject|5|||
129761034|NCT01300234|467087122|FG001|Overall Study|Withdrawal by Subject|9|||
129761035|NCT01300234|467087121|FG000|Overall Study|Lost to Follow-up|14|||
129761036|NCT01300234|467087122|FG001|Overall Study|Lost to Follow-up|12|||
129761037|NCT01300234|467087121|FG000|Overall Study|Pregnancy|2|||
129761038|NCT01300234|467087122|FG001|Overall Study|Pregnancy|1|||
129761039|NCT01300234|467087121|FG000|Overall Study|Participant reached stopping critera|2|||
129761040|NCT01300234|467087122|FG001|Overall Study|Participant reached stopping critera|0|||
129761041|NCT01300234|467087121|FG000|Overall Study|Participant stopped medication|1|||
129761042|NCT01300234|467087122|FG001|Overall Study|Participant stopped medication|1|||
129761043|NCT01300234|467087121|FG000|Overall Study|Participant refused return to hospital|1|||
129761044|NCT01300234|467087122|FG001|Overall Study|Participant refused return to hospital|0|||
129761045|NCT03253679|467087123|FG000|Overall Study|Screen Failure|1|||
129761046|NCT04816214|467087125|FG000|Overall Study|Progressive Disease|4|||
129761047|NCT04816214|467087126|FG001|Overall Study|Progressive Disease|0|||
129761048|NCT04816214|467087127|FG002|Overall Study|Progressive Disease|0|||
129761049|NCT04816214|467087125|FG000|Overall Study|Death|1|||
129761050|NCT04816214|467087126|FG001|Overall Study|Death|0|||
129761051|NCT04816214|467087127|FG002|Overall Study|Death|0|||
129761052|NCT04816214|467087125|FG000|Overall Study|Study Terminated by Sponsor|1|||
129761053|NCT04816214|467087126|FG001|Overall Study|Study Terminated by Sponsor|0|||
129761054|NCT04816214|467087127|FG002|Overall Study|Study Terminated by Sponsor|0|||
129761055|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
129761056|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
129761057|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
129761058|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
129761059|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
129761060|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
129761061|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
129761062|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
129761063|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
129761064|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
129761065|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
129761066|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
129761067|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
129761068|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
129761069|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
129761070|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
129761071|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
129761072|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
129761073|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
129761074|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
129761075|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
129761076|NCT00550407|467087128|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
129761077|NCT00550407|467087129|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
129761078|NCT00550407|467087130|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
129761079|NCT00550407|467087128|FG000|26-Week Randomized Phase|Adverse Event|0|||
129761080|NCT00550407|467087129|FG001|26-Week Randomized Phase|Adverse Event|5|||
129761081|NCT00550407|467087130|FG002|26-Week Randomized Phase|Adverse Event|2|||
129761082|NCT00550407|467087128|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
129761083|NCT00550407|467087129|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
129761084|NCT00550407|467087130|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
129761085|NCT00550407|467087128|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
129761086|NCT00550407|467087129|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
129761087|NCT00550407|467087130|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
129761088|NCT00550407|467087128|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
129761089|NCT00550407|467087129|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
129761090|NCT00550407|467087130|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
129761091|NCT00584415|467087131|FG000|Overall Study|Adverse Event|7|||
129761092|NCT05051579|467087132|FG000|Overall Study|Withdrawal by Subject|3|||
129761093|NCT05051579|467087133|FG001|Overall Study|Withdrawal by Subject|5|||
129761094|NCT05051579|467087134|FG002|Overall Study|Withdrawal by Subject|2|||
129761095|NCT05051579|467087135|FG003|Overall Study|Withdrawal by Subject|1|||
129761096|NCT05051579|467087136|FG004|Overall Study|Withdrawal by Subject|4|||
129761097|NCT05051579|467087137|FG005|Overall Study|Withdrawal by Subject|0|||
129761098|NCT05051579|467087138|FG006|Overall Study|Withdrawal by Subject|4|||
129761099|NCT05051579|467087132|FG000|Overall Study|Lost to Follow-up|1|||
129761100|NCT05051579|467087133|FG001|Overall Study|Lost to Follow-up|0|||
129761101|NCT05051579|467087134|FG002|Overall Study|Lost to Follow-up|0|||
129761102|NCT05051579|467087135|FG003|Overall Study|Lost to Follow-up|0|||
129761103|NCT05051579|467087136|FG004|Overall Study|Lost to Follow-up|1|||
129761104|NCT05051579|467087137|FG005|Overall Study|Lost to Follow-up|0|||
129761105|NCT05051579|467087138|FG006|Overall Study|Lost to Follow-up|1|||
129761106|NCT05051579|467087132|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129761107|NCT05051579|467087133|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129761108|NCT05051579|467087134|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129761109|NCT05051579|467087135|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129761110|NCT05051579|467087136|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129761111|NCT05051579|467087137|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
129761112|NCT05051579|467087138|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
129761113|NCT05051579|467087132|FG000|Overall Study|Adverse Event|2|||
129761114|NCT05051579|467087133|FG001|Overall Study|Adverse Event|1|||
129761115|NCT05051579|467087134|FG002|Overall Study|Adverse Event|0|||
129761116|NCT05051579|467087135|FG003|Overall Study|Adverse Event|4|||
129761117|NCT05051579|467087136|FG004|Overall Study|Adverse Event|1|||
129761118|NCT05051579|467087137|FG005|Overall Study|Adverse Event|2|||
129812481|NCT03706079|467280343|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
129896985|NCT04927975|467582187|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
129896986|NCT04927975|467582182|FG000|Period 1 (Baseline-Week 24)|Death|0|||
129761119|NCT05051579|467087138|FG006|Overall Study|Adverse Event|0|||
129761120|NCT05051579|467087132|FG000|Overall Study|Inadvertent Enrollment|0|||
129761121|NCT05051579|467087133|FG001|Overall Study|Inadvertent Enrollment|0|||
129761122|NCT05051579|467087134|FG002|Overall Study|Inadvertent Enrollment|0|||
129761123|NCT05051579|467087135|FG003|Overall Study|Inadvertent Enrollment|0|||
129761124|NCT05051579|467087136|FG004|Overall Study|Inadvertent Enrollment|0|||
129761125|NCT05051579|467087137|FG005|Overall Study|Inadvertent Enrollment|0|||
129761126|NCT05051579|467087138|FG006|Overall Study|Inadvertent Enrollment|1|||
129761127|NCT05051579|467087132|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129761128|NCT05051579|467087133|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
129761129|NCT05051579|467087134|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129761130|NCT05051579|467087135|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129761131|NCT05051579|467087136|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129761132|NCT05051579|467087137|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129761133|NCT05051579|467087138|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
129761134|NCT05051579|467087132|FG000|Overall Study|Sponsor Decision|0|||
129761135|NCT05051579|467087133|FG001|Overall Study|Sponsor Decision|0|||
129761136|NCT05051579|467087134|FG002|Overall Study|Sponsor Decision|0|||
129761137|NCT05051579|467087135|FG003|Overall Study|Sponsor Decision|0|||
129761138|NCT05051579|467087136|FG004|Overall Study|Sponsor Decision|1|||
129761139|NCT05051579|467087137|FG005|Overall Study|Sponsor Decision|0|||
129761140|NCT05051579|467087138|FG006|Overall Study|Sponsor Decision|0|||
129761141|NCT05051579|467087132|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129812482|NCT03706079|467280344|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
129812483|NCT03706079|467280345|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812484|NCT03706079|467280346|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812485|NCT03706079|467280347|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812486|NCT03706079|467280348|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
129812487|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812488|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812489|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812490|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812491|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
129812492|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
129812493|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
129812494|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812495|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
129812496|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812497|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812498|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
129812499|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
129812500|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812501|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812502|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812503|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812504|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
129812505|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812506|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812507|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812508|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
129812509|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
129812510|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
129812511|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
129812512|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
129812513|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
129896987|NCT04927975|467582183|FG001|Period 1 (Baseline-Week 24)|Death|0|||
129896988|NCT04927975|467582184|FG002|Period 1 (Baseline-Week 24)|Death|0|||
129896989|NCT04927975|467582185|FG003|Period 1 (Baseline-Week 24)|Death|0|||
129896990|NCT04927975|467582186|FG004|Period 1 (Baseline-Week 24)|Death|0|||
129896991|NCT04927975|467582187|FG005|Period 1 (Baseline-Week 24)|Death|1|||
129761142|NCT05051579|467087133|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129761143|NCT05051579|467087134|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129761144|NCT05051579|467087135|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129761145|NCT05051579|467087136|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
129896992|NCT04927975|467582182|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
129896993|NCT04927975|467582183|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
129896994|NCT04927975|467582184|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
129896995|NCT04927975|467582185|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
129896996|NCT04927975|467582186|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
129896997|NCT04927975|467582187|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
129896998|NCT04927975|467582182|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
129896999|NCT04927975|467582183|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897000|NCT04927975|467582184|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897001|NCT04927975|467582185|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
129897002|NCT04927975|467582186|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897003|NCT04927975|467582187|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
129897004|NCT03568162|467582189|FG000|Overall Study|Adverse Event|0|||
129897005|NCT03568162|467582190|FG001|Overall Study|Adverse Event|1|||
129897006|NCT03568162|467582191|FG002|Overall Study|Adverse Event|2|||
129897007|NCT03568162|467582192|FG003|Overall Study|Adverse Event|0|||
129897008|NCT03568162|467582193|FG004|Overall Study|Adverse Event|0|||
129897009|NCT03568162|467582194|FG005|Overall Study|Adverse Event|1|||
129897010|NCT03568162|467582189|FG000|Overall Study|Death|0|||
129897011|NCT03568162|467582190|FG001|Overall Study|Death|0|||
129897012|NCT03568162|467582191|FG002|Overall Study|Death|0|||
129897013|NCT03568162|467582192|FG003|Overall Study|Death|0|||
129897014|NCT03568162|467582193|FG004|Overall Study|Death|1|||
129897015|NCT03568162|467582194|FG005|Overall Study|Death|0|||
129897016|NCT03568162|467582189|FG000|Overall Study|Lost to Follow-up|3|||
129897017|NCT03568162|467582190|FG001|Overall Study|Lost to Follow-up|2|||
129897018|NCT03568162|467582191|FG002|Overall Study|Lost to Follow-up|4|||
129897019|NCT03568162|467582192|FG003|Overall Study|Lost to Follow-up|2|||
129897020|NCT03568162|467582193|FG004|Overall Study|Lost to Follow-up|3|||
129897021|NCT03568162|467582194|FG005|Overall Study|Lost to Follow-up|2|||
129761146|NCT05051579|467087137|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129761147|NCT05051579|467087138|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
129761148|NCT00717249|467087139|FG000|Overall Study|Lens Discomfort|4|||
129761149|NCT00717249|467087140|FG001|Overall Study|Lens Discomfort|1|||
129761150|NCT00717249|467087139|FG000|Overall Study|Unsatisfactory visual Response|0|||
129761151|NCT00717249|467087140|FG001|Overall Study|Unsatisfactory visual Response|2|||
129761152|NCT00717249|467087139|FG000|Overall Study|Adverse Event|4|||
129761153|NCT00717249|467087140|FG001|Overall Study|Adverse Event|2|||
129761154|NCT00717249|467087139|FG000|Overall Study|Lost to Follow-up|2|||
129897022|NCT03568162|467582189|FG000|Overall Study|Physician Decision|0|||
129897023|NCT03568162|467582190|FG001|Overall Study|Physician Decision|1|||
129897024|NCT03568162|467582191|FG002|Overall Study|Physician Decision|1|||
129897025|NCT03568162|467582192|FG003|Overall Study|Physician Decision|0|||
129897026|NCT03568162|467582193|FG004|Overall Study|Physician Decision|1|||
129897027|NCT03568162|467582194|FG005|Overall Study|Physician Decision|0|||
129897028|NCT03568162|467582189|FG000|Overall Study|Pregnancy|0|||
129897029|NCT03568162|467582190|FG001|Overall Study|Pregnancy|0|||
129897030|NCT03568162|467582191|FG002|Overall Study|Pregnancy|0|||
129897031|NCT03568162|467582192|FG003|Overall Study|Pregnancy|1|||
129761155|NCT00717249|467087140|FG001|Overall Study|Lost to Follow-up|0|||
129761156|NCT00717249|467087139|FG000|Overall Study|Withdrawal by Subject|1|||
129761157|NCT00717249|467087140|FG001|Overall Study|Withdrawal by Subject|2|||
129761158|NCT00717249|467087139|FG000|Overall Study|Pregnancy|6|||
129761159|NCT00717249|467087140|FG001|Overall Study|Pregnancy|3|||
129761160|NCT00717249|467087139|FG000|Overall Study|Protocol Violation|0|||
129761161|NCT00717249|467087140|FG001|Overall Study|Protocol Violation|2|||
129761162|NCT00717249|467087139|FG000|Overall Study|Subject became Ineligible|1|||
129761163|NCT00717249|467087140|FG001|Overall Study|Subject became Ineligible|1|||
129761164|NCT00717249|467087139|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
129761165|NCT00717249|467087140|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
129761166|NCT00717249|467087139|FG000|Overall Study|Gastric Surgery|0|||
129761167|NCT00717249|467087140|FG001|Overall Study|Gastric Surgery|1|||
129761168|NCT00717249|467087139|FG000|Overall Study|Diagnosed with Diabetes|1|||
129761169|NCT00717249|467087140|FG001|Overall Study|Diagnosed with Diabetes|0|||
129761170|NCT00717249|467087139|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
129761171|NCT00717249|467087140|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
129761172|NCT00717249|467087139|FG000|Overall Study|Subject relocated|1|||
129761173|NCT00717249|467087140|FG001|Overall Study|Subject relocated|0|||
129761174|NCT00717249|467087139|FG000|Overall Study|Headaches|1|||
129761175|NCT00717249|467087140|FG001|Overall Study|Headaches|0|||
129761176|NCT00360412|467087141|FG000|Overall Study|Adverse Event|37|||
129761177|NCT00360412|467087142|FG001|Overall Study|Adverse Event|65|||
129761178|NCT00360412|467087141|FG000|Overall Study|Protocol Violation|2|||
129761179|NCT00360412|467087142|FG001|Overall Study|Protocol Violation|5|||
129761180|NCT00360412|467087141|FG000|Overall Study|Patient withdrew consent|27|||
129761181|NCT00360412|467087142|FG001|Overall Study|Patient withdrew consent|52|||
129761182|NCT00360412|467087141|FG000|Overall Study|Lack of therapeutic efficacy|46|||
129761183|NCT00360412|467087142|FG001|Overall Study|Lack of therapeutic efficacy|61|||
129761184|NCT00360412|467087141|FG000|Overall Study|Physician Decision|2|||
129761185|NCT00360412|467087142|FG001|Overall Study|Physician Decision|4|||
129812514|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
129812515|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
129812516|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
129812517|NCT03706079|467280343|FG000|Long Term Extension (DESTINATION)|Death|8|||
129812518|NCT03706079|467280344|FG001|Long Term Extension (DESTINATION)|Death|2|||
129812519|NCT03706079|467280345|FG002|Long Term Extension (DESTINATION)|Death|2|||
129812520|NCT03706079|467280346|FG003|Long Term Extension (DESTINATION)|Death|1|||
129812521|NCT03706079|467280347|FG004|Long Term Extension (DESTINATION)|Death|0|||
129812522|NCT03706079|467280348|FG005|Long Term Extension (DESTINATION)|Death|0|||
129812523|NCT00968513|467280349|FG000|Overall Study|Death|4|||
129812524|NCT00968513|467280350|FG001|Overall Study|Death|10|||
129812525|NCT00968513|467280351|FG002|Overall Study|Death|15|||
129812526|NCT05379231|467280352|FG000|Home Visit|Withdrawal by Subject|2|||
129812527|NCT05379231|467280352|FG000|In-lab Visit|Withdrawal by Subject|2|||
129812528|NCT01203098|467280359|FG000|Overall Study|Adverse Event|3|||
129812529|NCT01203098|467280360|FG001|Overall Study|Adverse Event|1|||
129812530|NCT01203098|467280361|FG002|Overall Study|Adverse Event|7|||
129812531|NCT01203098|467280359|FG000|Overall Study|Lost to Follow-up|0|||
129812532|NCT01203098|467280360|FG001|Overall Study|Lost to Follow-up|0|||
129812533|NCT01203098|467280361|FG002|Overall Study|Lost to Follow-up|1|||
129812534|NCT01203098|467280359|FG000|Overall Study|Physician Decision|2|||
129812535|NCT01203098|467280360|FG001|Overall Study|Physician Decision|2|||
129812536|NCT01203098|467280361|FG002|Overall Study|Physician Decision|0|||
129761186|NCT00360412|467087141|FG000|Overall Study|Other|5|||
129761187|NCT00360412|467087142|FG001|Overall Study|Other|6|||
129761188|NCT00360412|467087141|FG000|Overall Study|Study termination by Sponsor|214|||
129761189|NCT00360412|467087142|FG001|Overall Study|Study termination by Sponsor|469|||
129761190|NCT05148234|467087143|FG000|Phase I|Ineligible|0|||
129761191|NCT05148234|467087144|FG001|Phase I|Ineligible|0|||
129761192|NCT05148234|467087145|FG002|Phase I|Ineligible|0|||
129761193|NCT05148234|467087146|FG003|Phase I|Ineligible|0|||
129761194|NCT05148234|467087147|FG004|Phase I|Ineligible|0|||
129761195|NCT05148234|467087148|FG005|Phase I|Ineligible|0|||
129761196|NCT05148234|467087149|FG006|Phase I|Ineligible|0|||
129761197|NCT05148234|467087150|FG007|Phase I|Ineligible|1|||
129761198|NCT05148234|467087143|FG000|Phase I|Company closed the trial.|0|||
129761199|NCT05148234|467087144|FG001|Phase I|Company closed the trial.|1|||
129812537|NCT01203098|467280359|FG000|Overall Study|Withdrawal by Subject|1|||
129812538|NCT01203098|467280360|FG001|Overall Study|Withdrawal by Subject|1|||
129812539|NCT01203098|467280361|FG002|Overall Study|Withdrawal by Subject|3|||
129761200|NCT05148234|467087145|FG002|Phase I|Company closed the trial.|0|||
129761201|NCT05148234|467087146|FG003|Phase I|Company closed the trial.|0|||
129812540|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
129812541|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
129812542|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
129812543|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
129761202|NCT05148234|467087147|FG004|Phase I|Company closed the trial.|0|||
129761203|NCT05148234|467087148|FG005|Phase I|Company closed the trial.|0|||
129761204|NCT05148234|467087149|FG006|Phase I|Company closed the trial.|0|||
129761205|NCT05148234|467087150|FG007|Phase I|Company closed the trial.|0|||
129761206|NCT03061201|467087151|FG000|Overall Study|Participants Terminated at Month 36|0|||
129761207|NCT03061201|467087152|FG001|Overall Study|Participants Terminated at Month 36|1|||
129761208|NCT03061201|467087153|FG002|Overall Study|Participants Terminated at Month 36|0|||
129761209|NCT03061201|467087154|FG003|Overall Study|Participants Terminated at Month 36|1|||
129761210|NCT03061201|467087151|FG000|Overall Study|Lost to Follow-up|1|||
129761211|NCT03061201|467087152|FG001|Overall Study|Lost to Follow-up|0|||
129761212|NCT03061201|467087153|FG002|Overall Study|Lost to Follow-up|0|||
129761213|NCT03061201|467087154|FG003|Overall Study|Lost to Follow-up|0|||
129812544|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
129812545|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
129812546|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
129812547|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
129812548|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
129812549|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
129812550|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
129812551|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
129812552|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
129812553|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
129812554|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
129812555|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
129812556|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
129812557|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
129812558|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
129812559|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
129812560|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812561|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812562|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
129812563|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812564|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
129812565|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812566|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812567|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
129812568|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812569|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
129812570|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
129812571|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812572|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812573|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812574|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
129812575|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812576|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
129812577|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812578|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812579|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
129812580|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
129812581|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
129812582|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
129812583|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
129812584|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
129812585|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129812586|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129761214|NCT03062358|467087155|FG000|Overall Study|Death|269|||
129761215|NCT03062358|467087156|FG001|Overall Study|Death|145|||
129761216|NCT03062358|467087155|FG000|Overall Study|Withdrawal by Subject|2|||
129761217|NCT03062358|467087156|FG001|Overall Study|Withdrawal by Subject|1|||
129761218|NCT03062358|467087155|FG000|Overall Study|Sponsor Decision|29|||
129761219|NCT03062358|467087156|FG001|Overall Study|Sponsor Decision|7|||
129761220|NCT03861273|467087157|FG000|Screening Phase (3 Weeks)|Other|1|||
129761221|NCT03861273|467087157|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
129761222|NCT03861273|467087157|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
129761223|NCT03861273|467087157|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
129761224|NCT03861273|467087157|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
129761225|NCT03799341|467087158|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
129761226|NCT03799341|467087159|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
129761227|NCT03799341|467087160|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
129761228|NCT03799341|467087158|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
129761229|NCT03799341|467087159|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
129761230|NCT03799341|467087160|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
129761231|NCT03799341|467087158|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
129761232|NCT03799341|467087159|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
129761233|NCT03799341|467087160|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
129761234|NCT03799341|467087158|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
129761235|NCT03799341|467087159|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
129761236|NCT03799341|467087160|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
129761237|NCT03799341|467087158|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
129761238|NCT03799341|467087159|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
129761239|NCT03799341|467087160|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
129761240|NCT03799341|467087158|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
129761241|NCT03799341|467087159|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
129761242|NCT03799341|467087160|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
129761243|NCT01116648|467087161|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
129761244|NCT01116648|467087162|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
129761245|NCT01116648|467087163|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
129761246|NCT01116648|467087164|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
129761247|NCT01116648|467087165|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
129761248|NCT01116648|467087166|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
129761249|NCT01116648|467087167|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
129761250|NCT01116648|467087168|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
129761251|NCT01116648|467087169|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
129761252|NCT01116648|467087170|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
129761253|NCT01116648|467087171|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
129761254|NCT01116648|467087172|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
129761255|NCT01116648|467087173|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
129761256|NCT01116648|467087174|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
129761257|NCT01116648|467087175|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
129761258|NCT04539938|467087176|FG000|Overall Study|Death|30|||
129761259|NCT04539938|467087176|FG000|Overall Study|Withdrawal by Subject|4|||
129761260|NCT00410956|467087177|FG000|Overall Study|Adverse Event|1|||
129761261|NCT00410956|467087177|FG000|Overall Study|Death|2|||
129761262|NCT00410956|467087177|FG000|Overall Study|Lack of Efficacy|10|||
129761263|NCT00410956|467087177|FG000|Overall Study|Physician Decision|6|||
129761264|NCT01650194|467087178|FG000|Overall Study|Progressive Disease (PD)|35|||
129761265|NCT01650194|467087178|FG000|Overall Study|Withdrawal by Subject|2|||
129761266|NCT01650194|467087178|FG000|Overall Study|Miscellaneous|10|||
129897032|NCT03568162|467582193|FG004|Overall Study|Pregnancy|0|||
129761267|NCT00880698|467087181|FG000|Overall Study|Death|0|||
129761268|NCT00880698|467087182|FG001|Overall Study|Death|0|||
129761269|NCT00880698|467087183|FG002|Overall Study|Death|1|||
129897033|NCT03568162|467582194|FG005|Overall Study|Pregnancy|0|||
129761270|NCT00880698|467087184|FG003|Overall Study|Death|2|||
129761271|NCT00880698|467087181|FG000|Overall Study|Lost to Follow-up|1|||
129761272|NCT00880698|467087182|FG001|Overall Study|Lost to Follow-up|3|||
129761273|NCT00880698|467087183|FG002|Overall Study|Lost to Follow-up|0|||
129761274|NCT00880698|467087184|FG003|Overall Study|Lost to Follow-up|1|||
129761275|NCT00794950|467087185|FG000|BCG Induction|Withdrawal by Subject|2|||
129761276|NCT00794950|467087185|FG000|BCG Induction|ineligible|3|||
129761277|NCT00794950|467087185|FG000|BCG Induction|noncompliant w. BCG|1|||
129761278|NCT00794950|467087185|FG000|BCG Induction|Adverse Event|1|||
129761279|NCT00794950|467087185|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
129761280|NCT00794950|467087185|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
129761281|NCT00794950|467087185|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
129761282|NCT00794950|467087185|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
129761283|NCT00966654|467088186|FG000|Overall Study|Study was terminated,PI left institution|12|||
129761284|NCT01405768|467088191|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
129761285|NCT01405768|467088192|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
129761286|NCT02869633|467088195|FG000|Overall Study|Death|2|||
129761287|NCT02869633|467088196|FG001|Overall Study|Death|1|||
129761288|NCT02869633|467088195|FG000|Overall Study|Patient refused follow-up|1|||
129761289|NCT02869633|467088196|FG001|Overall Study|Patient refused follow-up|0|||
129761290|NCT02869633|467088195|FG000|Overall Study|Provider discretion|1|||
129761291|NCT02869633|467088196|FG001|Overall Study|Provider discretion|0|||
129761292|NCT02869633|467088195|FG000|Overall Study|Investigator decision|1|||
129761293|NCT02869633|467088196|FG001|Overall Study|Investigator decision|0|||
129761294|NCT02869633|467088195|FG000|Overall Study|Lost to Follow-up|0|||
129761295|NCT02869633|467088196|FG001|Overall Study|Lost to Follow-up|1|||
129761296|NCT02869633|467088195|FG000|Overall Study|Not eligible|6|||
129761297|NCT02869633|467088196|FG001|Overall Study|Not eligible|1|||
129761298|NCT02869633|467088195|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
129761299|NCT02869633|467088196|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
129761300|NCT02869633|467088195|FG000|Overall Study|Withdrawal by Subject|0|||
129761301|NCT02869633|467088196|FG001|Overall Study|Withdrawal by Subject|1|||
129761302|NCT01381016|467088197|FG000|Overall Study|Lost to Follow-up|1|||
129761303|NCT01381016|467088198|FG001|Overall Study|Lost to Follow-up|1|||
129761304|NCT01381016|467088197|FG000|Overall Study|Screen Failure|2|||
129761305|NCT01381016|467088198|FG001|Overall Study|Screen Failure|2|||
129761306|NCT01381016|467088197|FG000|Overall Study|Withdrawal by Subject|0|||
129761307|NCT01381016|467088198|FG001|Overall Study|Withdrawal by Subject|1|||
129761308|NCT01381016|467088197|FG000|Overall Study|Physician Decision|0|||
129761309|NCT01381016|467088198|FG001|Overall Study|Physician Decision|2|||
129761310|NCT01631435|467088199|FG000|Overall Study|Adverse Event|2|||
129761311|NCT01631435|467088199|FG000|Overall Study|Withdrawal by Subject|2|||
129761312|NCT01631435|467088199|FG000|Overall Study|incomplete study procedure|5|||
129761313|NCT01005251|467088203|FG000|Overall Study|Withdrawal by Subject|2|||
129761314|NCT01005251|467088204|FG001|Overall Study|Withdrawal by Subject|5|||
129761315|NCT01005251|467088205|FG002|Overall Study|Withdrawal by Subject|3|||
129761316|NCT01005251|467088206|FG003|Overall Study|Withdrawal by Subject|4|||
129761317|NCT01005251|467088207|FG004|Overall Study|Withdrawal by Subject|9|||
129761318|NCT01005251|467088203|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
129761319|NCT01005251|467088204|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129761320|NCT01005251|467088205|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
129761321|NCT01005251|467088206|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129761322|NCT01005251|467088207|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129761323|NCT01005251|467088203|FG000|Overall Study|Adverse Event|2|||
129761324|NCT01005251|467088204|FG001|Overall Study|Adverse Event|6|||
129761325|NCT01005251|467088205|FG002|Overall Study|Adverse Event|8|||
129761326|NCT01005251|467088206|FG003|Overall Study|Adverse Event|5|||
129761327|NCT01005251|467088207|FG004|Overall Study|Adverse Event|4|||
129761328|NCT01005251|467088203|FG000|Overall Study|Protocol Violation|1|||
129761329|NCT01005251|467088204|FG001|Overall Study|Protocol Violation|0|||
129761330|NCT01005251|467088205|FG002|Overall Study|Protocol Violation|0|||
129761331|NCT01005251|467088206|FG003|Overall Study|Protocol Violation|0|||
129761332|NCT01005251|467088207|FG004|Overall Study|Protocol Violation|2|||
129761333|NCT01005251|467088203|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
129761334|NCT01005251|467088204|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
129761335|NCT01005251|467088205|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
129761336|NCT01005251|467088206|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
129761337|NCT01005251|467088207|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
129761338|NCT01005251|467088203|FG000|Overall Study|Lost to Follow-up|1|||
129761339|NCT01005251|467088204|FG001|Overall Study|Lost to Follow-up|4|||
129761340|NCT01005251|467088205|FG002|Overall Study|Lost to Follow-up|2|||
129761341|NCT01005251|467088206|FG003|Overall Study|Lost to Follow-up|0|||
129761342|NCT01005251|467088207|FG004|Overall Study|Lost to Follow-up|0|||
129761343|NCT01005251|467088203|FG000|Overall Study|Physician Decision|0|||
129761344|NCT01005251|467088204|FG001|Overall Study|Physician Decision|0|||
129761345|NCT01005251|467088205|FG002|Overall Study|Physician Decision|0|||
129761346|NCT01005251|467088206|FG003|Overall Study|Physician Decision|0|||
129761347|NCT01005251|467088207|FG004|Overall Study|Physician Decision|2|||
129761348|NCT01005251|467088203|FG000|Overall Study|Patient moved|1|||
129761349|NCT01005251|467088204|FG001|Overall Study|Patient moved|0|||
129761350|NCT01005251|467088205|FG002|Overall Study|Patient moved|0|||
129761351|NCT01005251|467088206|FG003|Overall Study|Patient moved|0|||
129761352|NCT01005251|467088207|FG004|Overall Study|Patient moved|0|||
129761353|NCT01005251|467088203|FG000|Overall Study|Wrong drug dispensed|0|||
129761354|NCT01005251|467088204|FG001|Overall Study|Wrong drug dispensed|1|||
129761355|NCT01005251|467088205|FG002|Overall Study|Wrong drug dispensed|0|||
129761356|NCT01005251|467088206|FG003|Overall Study|Wrong drug dispensed|0|||
129761357|NCT01005251|467088207|FG004|Overall Study|Wrong drug dispensed|0|||
129761358|NCT01005251|467088203|FG000|Overall Study|Randomized in error|0|||
129761359|NCT01005251|467088204|FG001|Overall Study|Randomized in error|0|||
129761360|NCT01005251|467088205|FG002|Overall Study|Randomized in error|1|||
129761361|NCT01005251|467088206|FG003|Overall Study|Randomized in error|1|||
129761362|NCT01005251|467088207|FG004|Overall Study|Randomized in error|0|||
129761363|NCT01005251|467088203|FG000|Overall Study|Lack of Efficacy|0|||
129761364|NCT01005251|467088204|FG001|Overall Study|Lack of Efficacy|0|||
129761365|NCT01005251|467088205|FG002|Overall Study|Lack of Efficacy|1|||
129761366|NCT01005251|467088206|FG003|Overall Study|Lack of Efficacy|1|||
129761367|NCT01005251|467088207|FG004|Overall Study|Lack of Efficacy|0|||
129761368|NCT01169103|467088214|FG000|Overall Study|Lost to Follow-up|3|||
129761369|NCT01169103|467088215|FG001|Overall Study|Lost to Follow-up|3|||
129761370|NCT01169103|467088214|FG000|Overall Study|Withdrawal by Subject|3|||
129761371|NCT01169103|467088215|FG001|Overall Study|Withdrawal by Subject|1|||
129761372|NCT00141453|467088216|FG000|Overall Study|Protocol Violation|6|||
129761373|NCT00141453|467088217|FG001|Overall Study|Protocol Violation|5|||
129761374|NCT06039579|467088218|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761375|NCT06039579|467088219|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761376|NCT06039579|467088220|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761377|NCT06039579|467088221|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761378|NCT06039579|467088222|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761379|NCT06039579|467088223|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761380|NCT06039579|467088224|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
129761381|NCT06039579|467088225|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
129761382|NCT02469623|467088230|FG000|Overall Study|Not consented for long-term follow-up|4|||
129761383|NCT02469623|467088230|FG000|Overall Study|Lost to Follow-up|4|||
129761384|NCT02469623|467088230|FG000|Overall Study|Withdrawal by Subject|2|||
129761385|NCT02469623|467088230|FG000|Overall Study|Death|3|||
129761386|NCT02763644|467088231|FG000|Overall Study|Patient/guardian decision|1|||
129761387|NCT02763644|467088232|FG001|Overall Study|Patient/guardian decision|0|||
129761388|NCT02763644|467088231|FG000|Overall Study|Death|1|||
129761389|NCT02763644|467088232|FG001|Overall Study|Death|1|||
129761390|NCT02763644|467088231|FG000|Overall Study|Adverse Event|1|||
129761391|NCT02763644|467088232|FG001|Overall Study|Adverse Event|1|||
129761392|NCT00473434|467088233|FG000|Overall Study|Physician Decision|3|||
129761393|NCT00473434|467088233|FG000|Overall Study|Withdrawal by Subject|9|||
129761394|NCT00473434|467088233|FG000|Overall Study|Compliance|3|||
129761395|NCT00473434|467088233|FG000|Overall Study|Lack of Efficacy|3|||
129761396|NCT00473434|467088233|FG000|Overall Study|Adverse Event|3|||
129761397|NCT00473434|467088233|FG000|Overall Study|Patient was selling medication to others|1|||
129761398|NCT00473434|467088233|FG000|Overall Study|Safety evaluation|1|||
129761399|NCT00473434|467088233|FG000|Overall Study|Reason not specified|6|||
129761400|NCT00473434|467088233|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
129761401|NCT00473434|467088233|FG000|Overall Study|Switching to trial medication|1|||
129761402|NCT00473434|467088233|FG000|Overall Study|No longer required|1|||
129761403|NCT02356159|467088234|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129761404|NCT02356159|467088235|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129761405|NCT02356159|467088236|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129761406|NCT02356159|467088237|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129812587|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
129897034|NCT03568162|467582189|FG000|Overall Study|Protocol Violation|1|||
129761407|NCT02356159|467088238|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
129761408|NCT02356159|467088239|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
129761409|NCT00861705|467088240|FG000|Overall Study|Never Began Treatment|7|||
129761410|NCT00861705|467088241|FG001|Overall Study|Never Began Treatment|3|||
129761411|NCT00861705|467088242|FG002|Overall Study|Never Began Treatment|0|||
129761412|NCT00861705|467088243|FG003|Overall Study|Never Began Treatment|1|||
129761413|NCT06418152|467088244|FG000|Overall Study|Frequent DBS setting changes|1|||
129761414|NCT06418152|467088244|FG000|Overall Study|Withdrawal by Subject|2|||
129761415|NCT00667628|467088245|FG000|Overall Study|Lost to Follow-up|1|||
129761416|NCT00667628|467088246|FG001|Overall Study|Lost to Follow-up|0|||
129761417|NCT00667628|467088245|FG000|Overall Study|Death|6|||
129761418|NCT00667628|467088246|FG001|Overall Study|Death|6|||
129761419|NCT00667628|467088245|FG000|Overall Study|Investigator Considers in Best Interest|1|||
129761420|NCT00667628|467088246|FG001|Overall Study|Investigator Considers in Best Interest|0|||
129761421|NCT00667628|467088245|FG000|Overall Study|Sponsor Terminated Study|17|||
129761422|NCT00667628|467088246|FG001|Overall Study|Sponsor Terminated Study|21|||
129761423|NCT03360682|467088247|FG000|Overall Study|Adverse Event|3|||
129761424|NCT01962441|467088250|FG000|Randomized Period|Randomized but Never Treated|4|||
129761425|NCT01962441|467088251|FG001|Randomized Period|Randomized but Never Treated|2|||
129761426|NCT01962441|467088252|FG002|Randomized Period|Randomized but Never Treated|3|||
129761427|NCT01962441|467088250|FG000|Randomized Period|Lost to Follow-up|2|||
129761428|NCT01962441|467088251|FG001|Randomized Period|Lost to Follow-up|4|||
129761429|NCT01962441|467088252|FG002|Randomized Period|Lost to Follow-up|4|||
129761430|NCT01962441|467088250|FG000|Randomized Period|Withdrew Consent|3|||
129761431|NCT01962441|467088251|FG001|Randomized Period|Withdrew Consent|3|||
129761432|NCT01962441|467088252|FG002|Randomized Period|Withdrew Consent|2|||
129761433|NCT01962441|467088250|FG000|Randomized Period|Adverse Event|1|||
129761434|NCT01962441|467088251|FG001|Randomized Period|Adverse Event|1|||
129761435|NCT01962441|467088252|FG002|Randomized Period|Adverse Event|0|||
129761436|NCT01962441|467088250|FG000|Randomized Period|Death|0|||
129761437|NCT01962441|467088251|FG001|Randomized Period|Death|0|||
129761438|NCT01962441|467088252|FG002|Randomized Period|Death|2|||
129761439|NCT01962441|467088250|FG000|Randomized Period|Protocol Violation|0|||
129761440|NCT01962441|467088251|FG001|Randomized Period|Protocol Violation|1|||
129761441|NCT01962441|467088252|FG002|Randomized Period|Protocol Violation|0|||
129761442|NCT01962441|467088250|FG000|Retreatment Substudy|Lack of Efficacy|1|||
129761443|NCT01962441|467088251|FG001|Retreatment Substudy|Lack of Efficacy|0|||
129761444|NCT01962441|467088252|FG002|Retreatment Substudy|Lack of Efficacy|0|||
129761445|NCT01962441|467088250|FG000|Retreatment Substudy|Lost to Follow-up|1|||
129761446|NCT01962441|467088251|FG001|Retreatment Substudy|Lost to Follow-up|0|||
129761447|NCT01962441|467088252|FG002|Retreatment Substudy|Lost to Follow-up|0|||
129761448|NCT04908397|467088255|FG000|Overall Study|Withdrawal by Subject|2|||
129761449|NCT03100149|467088260|FG000|Overall Study|Adverse Event|0|||
129761450|NCT03100149|467088261|FG001|Overall Study|Adverse Event|1|||
129761451|NCT03100149|467088262|FG002|Overall Study|Adverse Event|0|||
129761452|NCT03100149|467088260|FG000|Overall Study|Participant Moved out of Country|0|||
129761453|NCT03100149|467088261|FG001|Overall Study|Participant Moved out of Country|0|||
129761454|NCT03100149|467088262|FG002|Overall Study|Participant Moved out of Country|1|||
129761455|NCT03100149|467088260|FG000|Overall Study|Withdrawal by Subject|0|||
129761456|NCT03100149|467088261|FG001|Overall Study|Withdrawal by Subject|3|||
129761457|NCT03100149|467088262|FG002|Overall Study|Withdrawal by Subject|1|||
129761458|NCT04972162|467088263|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
129812588|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129812589|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
129812590|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
129761459|NCT04972162|467088264|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
129761460|NCT01928927|467088265|FG000|Overall Study|Lost to Follow-up|1|||
129761461|NCT01928927|467088266|FG001|Overall Study|Lost to Follow-up|0|||
129761462|NCT01928927|467088265|FG000|Overall Study|Withdrawal by Subject|1|||
129761463|NCT01928927|467088266|FG001|Overall Study|Withdrawal by Subject|1|||
129812591|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
129812592|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
129812593|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
129812594|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
129812595|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812596|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
129812597|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812598|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812599|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
129812600|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129812601|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129897035|NCT03568162|467582190|FG001|Overall Study|Protocol Violation|0|||
129897036|NCT03568162|467582191|FG002|Overall Study|Protocol Violation|1|||
129812602|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129812603|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
129812604|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
129812605|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812606|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812607|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
129812608|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812609|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
129812610|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Change of location|0|||
129812611|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Change of location|0|||
129812612|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Change of location|0|||
129812613|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Change of location|1|||
129812614|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Change of location|0|||
129812615|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
129812616|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
129812617|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
129812618|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
129812619|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
129812620|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812621|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812622|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812623|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
129812624|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
129812625|NCT00730405|467280362|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
129812626|NCT00730405|467280363|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812627|NCT00730405|467280364|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812628|NCT00730405|467280365|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812629|NCT00730405|467280366|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
129812630|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
129812631|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
129812632|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
129812633|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
129812634|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
129812635|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
129812636|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
129812637|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
129812638|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
129812639|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
129812640|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
129812641|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
129812642|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
129812643|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
129812644|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
129812645|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Death|0|||
129812646|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Death|1|||
129812647|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Death|0|||
129812648|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Death|1|||
129812649|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Death|0|||
129812650|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Change of location|1|||
129812651|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Change of location|1|||
129812652|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Change of location|0|||
129812653|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Change of location|1|||
129812654|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Change of location|0|||
129812655|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
129812656|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
129812657|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
129812658|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
129812659|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
129897037|NCT03568162|467582192|FG003|Overall Study|Protocol Violation|1|||
129812660|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812661|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812662|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
129812663|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812664|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
129812665|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812666|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812667|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
129812668|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812669|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
129812670|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812671|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812672|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812673|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
129812674|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
129812675|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
129812676|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812677|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812678|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812679|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
129812680|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812681|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812682|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812683|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
129812684|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
129812685|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
129812686|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
129812687|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
129812688|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
129812689|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
129812690|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
129812691|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
129812692|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
129812693|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
129812694|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
129812695|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812696|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
129812697|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812698|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812699|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
129812700|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
129812701|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
129812702|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
129812703|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
129812704|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
129812705|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Missing|0|||
129812706|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Missing|0|||
129812707|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Missing|2|||
129812708|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Missing|0|||
129812709|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Missing|0|||
129812710|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812711|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812712|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812713|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
129812714|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
129812715|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129812716|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129812717|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
129812718|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129897038|NCT03568162|467582193|FG004|Overall Study|Protocol Violation|1|||
129812719|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
129812720|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
129812721|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
129812722|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
129812723|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
129812724|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
129812725|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812726|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812727|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
129812728|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812729|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
129812730|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812731|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812732|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812733|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
129812734|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
129812735|NCT00730405|467280362|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
129812736|NCT00730405|467280363|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812737|NCT00730405|467280364|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812738|NCT00730405|467280365|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812739|NCT00730405|467280366|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
129812740|NCT03851705|467280367|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
129812741|NCT03851705|467280368|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129812742|NCT03851705|467280369|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129812743|NCT03851705|467280370|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129812744|NCT03851705|467280367|FG000|Part 1: Double-Blind Period|Other reason|1|||
129812745|NCT03851705|467280368|FG001|Part 1: Double-Blind Period|Other reason|0|||
129812746|NCT03851705|467280369|FG002|Part 1: Double-Blind Period|Other reason|0|||
129812747|NCT03851705|467280370|FG003|Part 1: Double-Blind Period|Other reason|0|||
129812748|NCT03851705|467280367|FG000|Part 2: Open-Label Period|Other reason|0|||
129812749|NCT03851705|467280368|FG001|Part 2: Open-Label Period|Other reason|0|||
129812750|NCT03851705|467280369|FG002|Part 2: Open-Label Period|Other reason|0|||
129812751|NCT03851705|467280370|FG003|Part 2: Open-Label Period|Other reason|1|||
129812752|NCT03851705|467280367|FG000|Part 2: Open-Label Period|Death|0|||
129812753|NCT03851705|467280368|FG001|Part 2: Open-Label Period|Death|0|||
129812754|NCT03851705|467280369|FG002|Part 2: Open-Label Period|Death|3|||
129812755|NCT03851705|467280370|FG003|Part 2: Open-Label Period|Death|0|||
129812756|NCT03851705|467280367|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
129812757|NCT03851705|467280368|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
129812758|NCT03851705|467280369|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
129812759|NCT03851705|467280370|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
129812760|NCT01496807|467280374|FG000|Overall Study|Progressive Disease|21|||
129812761|NCT01496807|467280374|FG000|Overall Study|Participant preference/toxicity|8|||
129812762|NCT01496807|467280374|FG000|Overall Study|Change in diagnosis|1|||
129812763|NCT02591290|467280381|FG000|Overall Study|Withdrawal by Subject|2|||
129812764|NCT01306942|467280382|FG000|Phase I|Adverse Event|2|||
129812765|NCT01306942|467280383|FG001|Phase I|Adverse Event|2|||
129812766|NCT01306942|467280384|FG002|Phase I|Adverse Event|0|||
129812767|NCT01306942|467280385|FG003|Phase I|Adverse Event|0|||
129812768|NCT01306942|467280382|FG000|Phase I|Physician Decision|3|||
129812769|NCT01306942|467280383|FG001|Phase I|Physician Decision|1|||
129812770|NCT01306942|467280384|FG002|Phase I|Physician Decision|0|||
129812771|NCT01306942|467280385|FG003|Phase I|Physician Decision|0|||
129812772|NCT01306942|467280382|FG000|Phase II|Adverse Event|0|||
129812773|NCT01306942|467280383|FG001|Phase II|Adverse Event|0|||
129812774|NCT01306942|467280384|FG002|Phase II|Adverse Event|0|||
129812775|NCT01306942|467280385|FG003|Phase II|Adverse Event|6|||
129812776|NCT01306942|467280382|FG000|Phase II|Physician Decision|2|||
129812777|NCT01306942|467280383|FG001|Phase II|Physician Decision|0|||
129812778|NCT01306942|467280384|FG002|Phase II|Physician Decision|0|||
129812779|NCT01306942|467280385|FG003|Phase II|Physician Decision|5|||
129812780|NCT01306942|467280382|FG000|Phase II|Withdrawal by Subject|0|||
129812781|NCT01306942|467280383|FG001|Phase II|Withdrawal by Subject|0|||
129812782|NCT01306942|467280384|FG002|Phase II|Withdrawal by Subject|0|||
129812783|NCT01306942|467280385|FG003|Phase II|Withdrawal by Subject|2|||
129812784|NCT01306942|467280382|FG000|Phase II|Death|0|||
129812785|NCT01306942|467280383|FG001|Phase II|Death|0|||
129812786|NCT01306942|467280384|FG002|Phase II|Death|0|||
129812787|NCT01306942|467280385|FG003|Phase II|Death|1|||
129812788|NCT01306942|467280382|FG000|Phase II|Not finished treatment|0|||
129812789|NCT01306942|467280383|FG001|Phase II|Not finished treatment|0|||
129812790|NCT01306942|467280384|FG002|Phase II|Not finished treatment|0|||
129812791|NCT01306942|467280385|FG003|Phase II|Not finished treatment|1|||
129812792|NCT01306942|467280382|FG000|Phase II|Protocol Violation|0|||
129812793|NCT01306942|467280383|FG001|Phase II|Protocol Violation|0|||
129812794|NCT01306942|467280384|FG002|Phase II|Protocol Violation|0|||
129812795|NCT01306942|467280385|FG003|Phase II|Protocol Violation|1|||
129812796|NCT01390649|467280392|FG000|Overall Study|Physician Decision|1|||
129812797|NCT00282984|467280393|FG000|Overall Study|Death|2|||
129812798|NCT00282984|467280394|FG001|Overall Study|Death|5|||
129812799|NCT00282984|467280393|FG000|Overall Study|Adverse Event|8|||
129812800|NCT00282984|467280394|FG001|Overall Study|Adverse Event|5|||
129812801|NCT00282984|467280393|FG000|Overall Study|Lack of Efficacy|0|||
129812802|NCT00282984|467280394|FG001|Overall Study|Lack of Efficacy|2|||
129812803|NCT00282984|467280393|FG000|Overall Study|Lost to Follow-up|14|||
129812804|NCT00282984|467280394|FG001|Overall Study|Lost to Follow-up|10|||
129812805|NCT00282984|467280393|FG000|Overall Study|Withdrawal by Participant|22|||
129812806|NCT00282984|467280394|FG001|Overall Study|Withdrawal by Participant|34|||
129812807|NCT00282984|467280393|FG000|Overall Study|Participant stopped study medication|2|||
129812808|NCT00282984|467280394|FG001|Overall Study|Participant stopped study medication|2|||
129812809|NCT00282984|467280393|FG000|Overall Study|Participant only allowed phone follow-up|0|||
129812810|NCT00282984|467280394|FG001|Overall Study|Participant only allowed phone follow-up|1|||
129812811|NCT00282984|467280393|FG000|Overall Study|Participant used antipsychosis meds|0|||
129812812|NCT00282984|467280394|FG001|Overall Study|Participant used antipsychosis meds|1|||
129812813|NCT00282984|467280393|FG000|Overall Study|lack of motivation|1|||
129812814|NCT00282984|467280394|FG001|Overall Study|lack of motivation|0|||
129812815|NCT00282984|467280393|FG000|Overall Study|in prison|0|||
129812816|NCT00282984|467280394|FG001|Overall Study|in prison|1|||
129812817|NCT00282984|467280393|FG000|Overall Study|Protocol Violation|2|||
129812818|NCT00282984|467280394|FG001|Overall Study|Protocol Violation|0|||
129812819|NCT01128842|467280399|FG000|Overall Study|Adverse Event|1|||
129812820|NCT01128842|467280399|FG000|Overall Study|Disease Progression|6|||
129812821|NCT00824720|467280400|FG000|Overall Study|failed plug insertion|3|||
129812822|NCT00824720|467280401|FG001|Overall Study|failed plug insertion|1|||
129812823|NCT00824720|467280402|FG002|Overall Study|failed plug insertion|0|||
129812824|NCT00824720|467280400|FG000|Overall Study|Protocol Violation|0|||
129812825|NCT00824720|467280401|FG001|Overall Study|Protocol Violation|0|||
129812826|NCT00824720|467280402|FG002|Overall Study|Protocol Violation|1|||
129812827|NCT04731363|467280411|FG000|Overall Study|Could not obtain samples|0|||
129812828|NCT04731363|467280412|FG001|Overall Study|Could not obtain samples|1|||
129812829|NCT04731363|467280413|FG002|Overall Study|Could not obtain samples|0|||
129812830|NCT04731363|467280414|FG003|Overall Study|Could not obtain samples|0|||
129812831|NCT04731363|467280411|FG000|Overall Study|Physician Decision|0|||
129812832|NCT04731363|467280412|FG001|Overall Study|Physician Decision|1|||
129812833|NCT04731363|467280413|FG002|Overall Study|Physician Decision|0|||
129812834|NCT04731363|467280414|FG003|Overall Study|Physician Decision|0|||
129812835|NCT00688753|467282216|FG000|Overall Study|Disease progression|55|||
129812836|NCT00688753|467282216|FG000|Overall Study|Missing|1|||
129812837|NCT00688753|467282216|FG000|Overall Study|Death|9|||
129812838|NCT00688753|467282216|FG000|Overall Study|Withdrawal by Subject|3|||
129812839|NCT00688753|467282216|FG000|Overall Study|Adverse Event|20|||
129812840|NCT00688753|467282216|FG000|Overall Study|Protocol Violation|1|||
129812841|NCT00688753|467282216|FG000|Overall Study|Lost to Follow-up|3|||
129812842|NCT03187197|467282217|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
129812843|NCT03187197|467282218|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
129812844|NCT03187197|467282219|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
129812845|NCT03187197|467282217|FG000|Overall Study|Withdrawal by Subject|8|||
129812846|NCT03187197|467282218|FG001|Overall Study|Withdrawal by Subject|63|||
129812847|NCT03187197|467282219|FG002|Overall Study|Withdrawal by Subject|4|||
129812848|NCT03187197|467282217|FG000|Overall Study|Lost to Follow-up|1|||
129812849|NCT03187197|467282218|FG001|Overall Study|Lost to Follow-up|60|||
129812850|NCT03187197|467282219|FG002|Overall Study|Lost to Follow-up|7|||
129812851|NCT03187197|467282217|FG000|Overall Study|Adverse Event|6|||
129812852|NCT03187197|467282218|FG001|Overall Study|Adverse Event|29|||
129812853|NCT03187197|467282219|FG002|Overall Study|Adverse Event|0|||
129897039|NCT03568162|467582194|FG005|Overall Study|Protocol Violation|1|||
129812854|NCT03187197|467282217|FG000|Overall Study|Death|0|||
129812855|NCT03187197|467282218|FG001|Overall Study|Death|11|||
129812856|NCT03187197|467282219|FG002|Overall Study|Death|0|||
129812857|NCT03187197|467282217|FG000|Overall Study|Administrative problem|1|||
129812858|NCT03187197|467282218|FG001|Overall Study|Administrative problem|1|||
129812859|NCT03187197|467282219|FG002|Overall Study|Administrative problem|0|||
129812860|NCT03187197|467282217|FG000|Overall Study|Reason not listed|2|||
129812861|NCT03187197|467282218|FG001|Overall Study|Reason not listed|54|||
129897040|NCT03568162|467582189|FG000|Overall Study|Withdrawal by Subject|15|||
129812862|NCT03187197|467282219|FG002|Overall Study|Reason not listed|1|||
129812863|NCT03187197|467282217|FG000|Overall Study|Missing|1|||
129812864|NCT03187197|467282218|FG001|Overall Study|Missing|32|||
129812865|NCT03187197|467282219|FG002|Overall Study|Missing|3|||
129812866|NCT03187197|467282217|FG000|Overall Study|Status missing|2|||
129812867|NCT03187197|467282218|FG001|Overall Study|Status missing|33|||
129812868|NCT03187197|467282219|FG002|Overall Study|Status missing|3|||
129812869|NCT03187197|467282217|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
129812870|NCT03187197|467282218|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
129812871|NCT03187197|467282219|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
129812872|NCT00259649|467282220|FG000|Overall Study|Lost to Follow-up|7|||
129812873|NCT00259649|467282220|FG000|Overall Study|irregular menses|3|||
129812874|NCT02200211|467282223|FG000|Overall Study|Lost to Follow-up|7|||
129812875|NCT02200211|467282224|FG001|Overall Study|Lost to Follow-up|7|||
129812876|NCT02200211|467282225|FG002|Overall Study|Lost to Follow-up|1|||
129812877|NCT02200211|467282226|FG003|Overall Study|Lost to Follow-up|2|||
129812878|NCT02200211|467282223|FG000|Overall Study|Withdrawal by Subject|1|||
129812879|NCT02200211|467282224|FG001|Overall Study|Withdrawal by Subject|0|||
129812880|NCT02200211|467282225|FG002|Overall Study|Withdrawal by Subject|0|||
129812881|NCT02200211|467282226|FG003|Overall Study|Withdrawal by Subject|0|||
129812882|NCT00381485|467282227|FG000|Open-Label Run-In Period|Adverse Event|9|||
129812883|NCT00381485|467282228|FG001|Open-Label Run-In Period|Adverse Event|0|||
129812884|NCT00381485|467282229|FG002|Open-Label Run-In Period|Adverse Event|0|||
129812885|NCT00381485|467282230|FG003|Open-Label Run-In Period|Adverse Event|0|||
129812886|NCT00381485|467282227|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
129812887|NCT00381485|467282228|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
129812888|NCT00381485|467282229|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
129812889|NCT00381485|467282230|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
129812890|NCT00381485|467282227|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
129812891|NCT00381485|467282228|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
129812892|NCT00381485|467282229|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
129812893|NCT00381485|467282230|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
129812894|NCT00381485|467282227|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
129812895|NCT00381485|467282228|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
129812896|NCT00381485|467282229|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
129812897|NCT00381485|467282230|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
129812898|NCT00381485|467282227|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
129812899|NCT00381485|467282228|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
129812900|NCT00381485|467282229|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
129812901|NCT00381485|467282230|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
129812902|NCT00381485|467282227|FG000|Open-Label Run-In Period|Treatment failure|1|||
129812903|NCT00381485|467282228|FG001|Open-Label Run-In Period|Treatment failure|0|||
129812904|NCT00381485|467282229|FG002|Open-Label Run-In Period|Treatment failure|0|||
129812905|NCT00381485|467282230|FG003|Open-Label Run-In Period|Treatment failure|0|||
129812906|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129812907|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129812908|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Adverse Event|2|||
129812909|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Adverse Event|5|||
129812910|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
129812911|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
129812912|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
129812913|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
129812914|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129812915|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
129812916|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
129812917|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
129812918|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
129812919|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
129812920|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
129812921|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
129812922|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
129812923|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129812924|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
129812925|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129812926|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
129812927|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
129812928|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
129812929|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
129812930|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
129812931|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
129812932|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
129812933|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
129812934|NCT00381485|467282227|FG000|Double-Blind Treatment Period|Administrative|0|||
129812935|NCT00381485|467282228|FG001|Double-Blind Treatment Period|Administrative|1|||
129897041|NCT03568162|467582190|FG001|Overall Study|Withdrawal by Subject|15|||
129897042|NCT03568162|467582191|FG002|Overall Study|Withdrawal by Subject|26|||
129812936|NCT00381485|467282229|FG002|Double-Blind Treatment Period|Administrative|0|||
129812937|NCT00381485|467282230|FG003|Double-Blind Treatment Period|Administrative|1|||
129812938|NCT01235351|467282231|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
129812939|NCT01235351|467282232|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
129812940|NCT01918774|467282233|FG000|Overall Study|Lost prior to first CBTw session|4|||
129812941|NCT01918774|467282233|FG000|Overall Study|Lost to Follow-up|1|||
129812942|NCT01687998|467282234|FG000|Overall Study|Withdrawal by Subject|49|||
129812943|NCT01687998|467282235|FG001|Overall Study|Withdrawal by Subject|51|||
129812944|NCT01687998|467282234|FG000|Overall Study|Known to be Alive at Study End|54|||
129812945|NCT01687998|467282235|FG001|Overall Study|Known to be Alive at Study End|62|||
129812946|NCT01687998|467282234|FG000|Overall Study|Lost to Follow-up|9|||
129812947|NCT01687998|467282235|FG001|Overall Study|Lost to Follow-up|7|||
129812948|NCT00126191|467282240|FG000|Overall Study|Physician Decision|0|||
129812949|NCT00126191|467282241|FG001|Overall Study|Physician Decision|1|||
129812950|NCT00126191|467282240|FG000|Overall Study|Death|0|||
129812951|NCT00126191|467282241|FG001|Overall Study|Death|1|||
129812952|NCT01898806|467282242|FG000|Overall Study|Withdrawal by Subject|2|||
129812953|NCT01898806|467282242|FG000|Overall Study|Physician Decision|1|||
129812954|NCT01648101|467282243|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
129812955|NCT01648101|467282244|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
129812956|NCT01648101|467282245|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
129812957|NCT01648101|467282243|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
129812958|NCT01648101|467282244|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
129812959|NCT01648101|467282245|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
129812960|NCT01648101|467282243|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
129812961|NCT01648101|467282244|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
129812962|NCT01648101|467282245|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
129812963|NCT01648101|467282243|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
129812964|NCT01648101|467282244|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
129812965|NCT01648101|467282245|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
129812966|NCT01648101|467282243|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
129812967|NCT01648101|467282244|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
129812968|NCT01648101|467282245|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
129812969|NCT01648101|467282243|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
129812970|NCT01648101|467282244|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
129812971|NCT01648101|467282245|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
129812972|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
129812973|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
129812974|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
129812975|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
129812976|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
129812977|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
129812978|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
129812979|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
129812980|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
129812981|NCT01648101|467282243|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
129812982|NCT01648101|467282244|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
129812983|NCT01648101|467282245|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
129812984|NCT01648101|467282243|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
129812985|NCT01648101|467282244|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
129812986|NCT01648101|467282245|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
129812987|NCT03003390|467282246|FG000|Overall Study|Physician Decision|2|||
129812988|NCT03003390|467282247|FG001|Overall Study|Physician Decision|0|||
129812989|NCT03003390|467282246|FG000|Overall Study|Parent refused intervention|2|||
129812990|NCT03003390|467282247|FG001|Overall Study|Parent refused intervention|0|||
129812991|NCT00307294|467282260|FG000|Overall Study|Withdrawal by Subject|1|||
129812992|NCT00612690|467282261|FG000|Overall Study|Lost to Follow-up|72|||
129812993|NCT00612690|467282262|FG001|Overall Study|Lost to Follow-up|98|||
129812994|NCT00612690|467282261|FG000|Overall Study|Withdrawal by Subject|32|||
129812995|NCT00612690|467282262|FG001|Overall Study|Withdrawal by Subject|20|||
129812996|NCT00612690|467282261|FG000|Overall Study|Withdrawal by Site|11|||
129812997|NCT00612690|467282262|FG001|Overall Study|Withdrawal by Site|0|||
129812998|NCT02980601|467282264|FG000|Overall Study|Lost to Follow-up|2|||
129812999|NCT02980601|467282265|FG001|Overall Study|Lost to Follow-up|2|||
129813000|NCT02980601|467282264|FG000|Overall Study|Death|0|||
129813001|NCT02980601|467282265|FG001|Overall Study|Death|1|||
129813002|NCT02980601|467282264|FG000|Overall Study|Graft loss|1|||
129813003|NCT02980601|467282265|FG001|Overall Study|Graft loss|0|||
129813004|NCT02980601|467282264|FG000|Overall Study|Failed to sign consent|2|||
129813005|NCT02980601|467282265|FG001|Overall Study|Failed to sign consent|0|||
129813006|NCT00844831|467282266|FG000|Overall Study|Withdrawal by Subject|4|||
129813007|NCT00844831|467282266|FG000|Overall Study|Adverse Event|1|||
129813008|NCT00844831|467282266|FG000|Overall Study|Physician Decision|1|||
129813009|NCT01575769|467282267|FG000|Overall Study|Adverse Event|1|||
129813010|NCT01575769|467282267|FG000|Overall Study|Study terminated by sponsor|40|||
129813011|NCT01581931|467282274|FG000|Washout|Adverse Event|0|||
129813012|NCT01581931|467282275|FG001|Washout|Adverse Event|1|||
129813013|NCT03156543|467282276|FG000|Overall Study|Withdrawal by Subject|1|||
129813014|NCT03156543|467282277|FG001|Overall Study|Withdrawal by Subject|0|||
129813015|NCT02954237|467282278|FG000|Overall Study|Withdrawal by Subject|25|||
129813016|NCT02954237|467282278|FG000|Overall Study|Missed visit|16|||
129813017|NCT02954237|467282278|FG000|Overall Study|Death|2|||
129813018|NCT00674700|467282279|FG000|Year 1|Adverse Event|17|||
129813019|NCT00674700|467282280|FG001|Year 1|Adverse Event|20|||
129813020|NCT00674700|467282281|FG002|Year 1|Adverse Event|5|||
129813021|NCT00674700|467282279|FG000|Year 1|Withdrawal by Subject|7|||
129813022|NCT00674700|467282280|FG001|Year 1|Withdrawal by Subject|7|||
129813023|NCT00674700|467282281|FG002|Year 1|Withdrawal by Subject|6|||
129813024|NCT00674700|467282279|FG000|Year 1|Any other reason not above-mentioned|7|||
129813025|NCT00674700|467282280|FG001|Year 1|Any other reason not above-mentioned|7|||
129813026|NCT00674700|467282281|FG002|Year 1|Any other reason not above-mentioned|6|||
129813027|NCT00674700|467282279|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
129813028|NCT00674700|467282280|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
129813029|NCT00674700|467282281|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
129813030|NCT00674700|467282279|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
129813031|NCT00674700|467282280|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
129813032|NCT00674700|467282281|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
129813033|NCT00674700|467282279|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
129813034|NCT00674700|467282280|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
129813035|NCT00674700|467282281|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
129813036|NCT03797014|467282283|FG000|Overall Study|Withdrawal by Subject|1|||
129813037|NCT03797014|467282283|FG000|Overall Study|Lost to Follow-up|1|||
129813038|NCT03797014|467282283|FG000|Overall Study|Protocol Violation|1|||
129813039|NCT02871297|467282284|FG000|Overall Study|Adverse Event|34|||
129813040|NCT02871297|467282284|FG000|Overall Study|Lack of Efficacy|10|||
129813041|NCT02871297|467282284|FG000|Overall Study|Non-compliance with study drug|15|||
129813042|NCT02871297|467282284|FG000|Overall Study|Protocol Violation|3|||
129813043|NCT02871297|467282284|FG000|Overall Study|Withdrawal by Subject|20|||
129813044|NCT02871297|467282284|FG000|Overall Study|Lost to Follow-up|13|||
129813045|NCT02871297|467282284|FG000|Overall Study|Rolled over to 13546A|2|||
129813046|NCT02871297|467282284|FG000|Overall Study|Other than specified|39|||
129813047|NCT02966028|467282288|FG000|Overall Study|Adverse Event|7|||
129813048|NCT02966028|467282289|FG001|Overall Study|Adverse Event|13|||
129813049|NCT02966028|467282290|FG002|Overall Study|Adverse Event|10|||
129813050|NCT02966028|467282288|FG000|Overall Study|Physician Decision|1|||
129813051|NCT02966028|467282289|FG001|Overall Study|Physician Decision|0|||
129813052|NCT02966028|467282290|FG002|Overall Study|Physician Decision|2|||
129813053|NCT02966028|467282288|FG000|Overall Study|Withdrawal by Subject|7|||
129813054|NCT02966028|467282289|FG001|Overall Study|Withdrawal by Subject|5|||
129813055|NCT02966028|467282290|FG002|Overall Study|Withdrawal by Subject|5|||
129813056|NCT02966028|467282288|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
129813057|NCT02966028|467282289|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
129813058|NCT02966028|467282290|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
129813059|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
129813060|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
129813061|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
129813062|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813063|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813064|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813065|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
129813066|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
129813067|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
129813068|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
129813069|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813070|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813071|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813072|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
129813073|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
129813074|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813075|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813076|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813077|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129897043|NCT03568162|467582192|FG003|Overall Study|Withdrawal by Subject|22|||
129813078|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813079|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
129813080|NCT04115839|467282291|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813081|NCT04115839|467282292|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813082|NCT04115839|467282293|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
129813083|NCT04115839|467282294|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813084|NCT04115839|467282295|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813085|NCT04115839|467282296|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813086|NCT04115839|467282297|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
129813087|NCT04115839|467282291|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
129813088|NCT04115839|467282292|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
129813089|NCT04115839|467282293|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
129813090|NCT04115839|467282294|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
129813091|NCT04115839|467282295|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
129813092|NCT04115839|467282296|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
129813093|NCT04115839|467282297|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
129813094|NCT04115839|467282291|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813095|NCT04115839|467282292|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813096|NCT04115839|467282293|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813097|NCT04115839|467282294|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
129813098|NCT04115839|467282295|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
129813099|NCT04115839|467282296|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813100|NCT04115839|467282297|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
129813101|NCT00691015|467282301|FG000|Overall Study|Refused further treatment|1|||
129813102|NCT04160195|467282304|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
129813103|NCT04160195|467282305|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
129813104|NCT00590720|467282308|FG000|Overall Study|Lost to Follow-up|1|||
129813105|NCT00590720|467282309|FG001|Overall Study|Lost to Follow-up|0|||
129813106|NCT00590720|467282308|FG000|Overall Study|Withdrawal by Subject|0|||
129813107|NCT00590720|467282309|FG001|Overall Study|Withdrawal by Subject|1|||
129813108|NCT04189081|467282311|FG000|Overall Study|Lost to Follow-up|1|||
129813109|NCT04189081|467282312|FG001|Overall Study|Lost to Follow-up|0|||
129813110|NCT04189081|467282313|FG002|Overall Study|Lost to Follow-up|0|||
129813111|NCT04189081|467282311|FG000|Overall Study|Withdrawal by Subject|0|||
129813112|NCT04189081|467282312|FG001|Overall Study|Withdrawal by Subject|0|||
129813113|NCT04189081|467282313|FG002|Overall Study|Withdrawal by Subject|1|||
129813114|NCT01619423|467282314|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
129813115|NCT01619423|467282315|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
129813116|NCT01619423|467282316|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
129813117|NCT01619423|467282317|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
129813118|NCT00913497|467282320|FG000|Overall Study|Adverse Event|1|||
129813119|NCT00913497|467282320|FG000|Overall Study|Withdrawal by Subject|2|||
129813120|NCT02002091|467282321|FG000|Screening|Lost to Follow-up|10|||
129813121|NCT02002091|467282322|FG001|Screening|Lost to Follow-up|12|||
129813122|NCT02002091|467282321|FG000|Screening|Death|3|||
129813123|NCT02002091|467282322|FG001|Screening|Death|2|||
129813124|NCT03385564|467282324|FG000|Overall Study|Adverse Event|0|||
129813125|NCT03385564|467282325|FG001|Overall Study|Adverse Event|0|||
129813126|NCT03385564|467282326|FG002|Overall Study|Adverse Event|3|||
129813127|NCT03385564|467282327|FG003|Overall Study|Adverse Event|3|||
129813128|NCT03385564|467282324|FG000|Overall Study|Other than listed|0|||
129813129|NCT03385564|467282325|FG001|Overall Study|Other than listed|0|||
129813130|NCT03385564|467282326|FG002|Overall Study|Other than listed|0|||
129813131|NCT03385564|467282327|FG003|Overall Study|Other than listed|5|||
129813132|NCT03385564|467282324|FG000|Overall Study|Withdrawal by Subject|0|||
129813133|NCT03385564|467282325|FG001|Overall Study|Withdrawal by Subject|1|||
129813134|NCT03385564|467282326|FG002|Overall Study|Withdrawal by Subject|1|||
129813135|NCT03385564|467282327|FG003|Overall Study|Withdrawal by Subject|0|||
129813136|NCT03385564|467282324|FG000|Overall Study|Lack of Efficacy|0|||
129813137|NCT03385564|467282325|FG001|Overall Study|Lack of Efficacy|0|||
129813138|NCT03385564|467282326|FG002|Overall Study|Lack of Efficacy|0|||
129813139|NCT03385564|467282327|FG003|Overall Study|Lack of Efficacy|1|||
129813140|NCT03385564|467282324|FG000|Overall Study|Death|0|||
129813141|NCT03385564|467282325|FG001|Overall Study|Death|0|||
129813142|NCT03385564|467282326|FG002|Overall Study|Death|1|||
129813143|NCT03385564|467282327|FG003|Overall Study|Death|0|||
129813144|NCT00457301|467282336|FG000|Overall Study|Withdrawal by Subject|3|||
129813145|NCT00457301|467282337|FG001|Overall Study|Withdrawal by Subject|3|||
129813146|NCT00457301|467282336|FG000|Overall Study|Censored out of the study|15|||
129813147|NCT00457301|467282337|FG001|Overall Study|Censored out of the study|14|||
129813148|NCT00457301|467282336|FG000|Overall Study|Death|5|||
129813149|NCT00457301|467282337|FG001|Overall Study|Death|7|||
129813150|NCT00478231|467282338|FG000|Overall Study|Death|7|||
129813151|NCT00478231|467282338|FG000|Overall Study|Lack of Efficacy|47|||
129813152|NCT00478231|467282338|FG000|Overall Study|Lost to Follow-up|7|||
129813153|NCT00478231|467282338|FG000|Overall Study|Withdrawal by Subject|6|||
129813154|NCT00478231|467282338|FG000|Overall Study|Other|9|||
129813155|NCT00478231|467282338|FG000|Overall Study|Adverse Event|5|||
129813156|NCT00478231|467282338|FG000|Overall Study|Randomized, not treated|3|||
129813157|NCT00001880|467282340|FG000|Overall Study|Death|14|||
129813158|NCT00873015|467282341|FG000|Overall Study|Withdrawal by Subject|0|||
129813159|NCT00873015|467282342|FG001|Overall Study|Withdrawal by Subject|1|||
129813160|NCT00873015|467282343|FG002|Overall Study|Withdrawal by Subject|0|||
129813161|NCT00873015|467282344|FG003|Overall Study|Withdrawal by Subject|0|||
129813162|NCT04094883|467282345|FG000|Overall Study|Withdrawal by Subject|1|||
129813163|NCT01382212|467282346|FG000|Overall Study|Kidney transplant|1|||
129813164|NCT01382212|467282346|FG000|Overall Study|Withdrew consent|1|||
129813165|NCT01273597|467282347|FG000|Overall Study|Adverse Event|5|||
129813166|NCT01273597|467282347|FG000|Overall Study|Underwent Kidney Transplantation|2|||
129813167|NCT01273597|467282347|FG000|Overall Study|Reason Not Reported|1|||
129813168|NCT03329573|467282350|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
129813169|NCT03329573|467282351|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
129813170|NCT03329573|467282352|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
129813171|NCT03329573|467282353|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
129813172|NCT03329573|467282350|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
129813173|NCT03329573|467282351|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
129813174|NCT03329573|467282352|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129813175|NCT03329573|467282353|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129813176|NCT03329573|467282350|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
129813177|NCT03329573|467282351|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
129813178|NCT03329573|467282352|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
129813179|NCT03329573|467282353|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
129813180|NCT03329573|467282350|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
129813181|NCT03329573|467282351|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
129813182|NCT03329573|467282352|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
129813183|NCT03329573|467282353|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
129813184|NCT02777333|467282356|FG000|Overall Study|Withdrawal by Subject|0|||
129813185|NCT02777333|467282357|FG001|Overall Study|Withdrawal by Subject|1|||
129813186|NCT02777333|467282356|FG000|Overall Study|Lost to Follow-up|0|||
129813187|NCT02777333|467282357|FG001|Overall Study|Lost to Follow-up|1|||
129813188|NCT00837811|467282358|FG000|Overall Study|Adverse Event|4|||
129813189|NCT00837811|467282359|FG001|Overall Study|Adverse Event|6|||
129813190|NCT00837811|467282360|FG002|Overall Study|Adverse Event|0|||
129813191|NCT00837811|467282358|FG000|Overall Study|Death|1|||
129813192|NCT00837811|467282359|FG001|Overall Study|Death|1|||
129813193|NCT00837811|467282360|FG002|Overall Study|Death|0|||
129813194|NCT00837811|467282358|FG000|Overall Study|Lack of Efficacy|0|||
129813195|NCT00837811|467282359|FG001|Overall Study|Lack of Efficacy|11|||
129813196|NCT00837811|467282360|FG002|Overall Study|Lack of Efficacy|0|||
129813197|NCT00837811|467282358|FG000|Overall Study|Lost to Follow-up|1|||
129813198|NCT00837811|467282359|FG001|Overall Study|Lost to Follow-up|3|||
129813199|NCT00837811|467282360|FG002|Overall Study|Lost to Follow-up|0|||
129813200|NCT00837811|467282358|FG000|Overall Study|Physician Decision|0|||
129813201|NCT00837811|467282359|FG001|Overall Study|Physician Decision|2|||
129813202|NCT00837811|467282360|FG002|Overall Study|Physician Decision|1|||
129813203|NCT00837811|467282358|FG000|Overall Study|Withdrawal by Subject|1|||
129813204|NCT00837811|467282359|FG001|Overall Study|Withdrawal by Subject|9|||
129813205|NCT00837811|467282360|FG002|Overall Study|Withdrawal by Subject|0|||
129813206|NCT00837811|467282358|FG000|Overall Study|Sponsor Decision|0|||
129813207|NCT00837811|467282359|FG001|Overall Study|Sponsor Decision|2|||
129813208|NCT00837811|467282360|FG002|Overall Study|Sponsor Decision|0|||
129813209|NCT03307967|467282361|FG000|Overall Study|Lost to Follow-up|4|||
129813210|NCT02578316|467282362|FG000|Extension Phase|Progression of disease|6|||
129813211|NCT05372419|467282363|FG000|Overall Study|Protocol Deviation|1|||
129813212|NCT05372419|467282363|FG000|Overall Study|Withdrawal by Subject|5|||
129897044|NCT03568162|467582193|FG004|Overall Study|Withdrawal by Subject|6|||
129813213|NCT05372419|467282363|FG000|Overall Study|Lost to Follow-up|7|||
129813214|NCT04362072|467282367|FG000|Treatment|Adverse Event|1|||
129813215|NCT04362072|467282367|FG000|Treatment|Death|9|||
129813216|NCT04362072|467282367|FG000|Treatment|Physician Decision|2|||
129813217|NCT04362072|467282367|FG000|Treatment|Progressive disease|27|||
129813218|NCT04362072|467282367|FG000|Treatment|Withdrawal by Subject|4|||
129897045|NCT03568162|467582194|FG005|Overall Study|Withdrawal by Subject|9|||
129897046|NCT03568162|467582189|FG000|Overall Study|Others|3|||
129897047|NCT03568162|467582190|FG001|Overall Study|Others|4|||
129813219|NCT04362072|467282367|FG000|Treatment|Global deterioration of health status|1|||
129813220|NCT04362072|467282367|FG000|Treatment|Switched to commercial Lorlatinib|13|||
129813221|NCT04362072|467282367|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
129813222|NCT04362072|467282367|FG000|Treatment|Other|3|||
129813223|NCT04362072|467282367|FG000|Follow up|Death|2|||
129813224|NCT04362072|467282367|FG000|Follow up|Other|2|||
129813225|NCT01133522|467282368|FG000|Overall Study|Withdrawal by Subject|0|||
129813226|NCT01133522|467282369|FG001|Overall Study|Withdrawal by Subject|1|||
129813227|NCT01133522|467282370|FG002|Overall Study|Withdrawal by Subject|0|||
129897048|NCT03568162|467582191|FG002|Overall Study|Others|1|||
129813228|NCT01133522|467282371|FG003|Overall Study|Withdrawal by Subject|1|||
129813229|NCT01133522|467282372|FG004|Overall Study|Withdrawal by Subject|0|||
129813230|NCT01133522|467282373|FG005|Overall Study|Withdrawal by Subject|0|||
129813231|NCT01133522|467282374|FG006|Overall Study|Withdrawal by Subject|0|||
129813232|NCT01133522|467282375|FG007|Overall Study|Withdrawal by Subject|0|||
129813233|NCT01133522|467282376|FG008|Overall Study|Withdrawal by Subject|0|||
129813234|NCT01133522|467282377|FG009|Overall Study|Withdrawal by Subject|0|||
129813235|NCT01133522|467282368|FG000|Overall Study|Physician Decision|0|||
129813236|NCT01133522|467282369|FG001|Overall Study|Physician Decision|0|||
129813237|NCT01133522|467282370|FG002|Overall Study|Physician Decision|0|||
129813238|NCT01133522|467282371|FG003|Overall Study|Physician Decision|0|||
129813239|NCT01133522|467282372|FG004|Overall Study|Physician Decision|1|||
129813240|NCT01133522|467282373|FG005|Overall Study|Physician Decision|0|||
129813241|NCT01133522|467282374|FG006|Overall Study|Physician Decision|0|||
129813242|NCT01133522|467282375|FG007|Overall Study|Physician Decision|0|||
129813243|NCT01133522|467282376|FG008|Overall Study|Physician Decision|0|||
129813244|NCT01133522|467282377|FG009|Overall Study|Physician Decision|0|||
129813245|NCT02513394|467282380|FG000|Overall Study|Withdrawal by Subject|11|||
129813246|NCT02513394|467282381|FG001|Overall Study|Withdrawal by Subject|23|||
129813247|NCT02513394|467282380|FG000|Overall Study|Ineligible|1|||
129813248|NCT02513394|467282381|FG001|Overall Study|Ineligible|0|||
129813249|NCT04292743|467282382|FG000|Overall Study|Physician Decision|1|||
129813250|NCT04292743|467282383|FG001|Overall Study|Physician Decision|3|||
129813251|NCT04292743|467282384|FG002|Overall Study|Physician Decision|0|||
129813252|NCT04292743|467282385|FG003|Overall Study|Physician Decision|0|||
129813253|NCT04292743|467282382|FG000|Overall Study|Withdrawal by Subject|0|||
129813254|NCT04292743|467282383|FG001|Overall Study|Withdrawal by Subject|5|||
129813255|NCT04292743|467282384|FG002|Overall Study|Withdrawal by Subject|0|||
129813256|NCT04292743|467282385|FG003|Overall Study|Withdrawal by Subject|0|||
129813257|NCT04292743|467282382|FG000|Overall Study|Death|0|||
129813258|NCT04292743|467282383|FG001|Overall Study|Death|1|||
129813259|NCT04292743|467282384|FG002|Overall Study|Death|0|||
129813260|NCT04292743|467282385|FG003|Overall Study|Death|0|||
129813261|NCT04292743|467282382|FG000|Overall Study|Progression of Disease|2|||
129813262|NCT04292743|467282383|FG001|Overall Study|Progression of Disease|5|||
129813263|NCT04292743|467282384|FG002|Overall Study|Progression of Disease|0|||
129813264|NCT04292743|467282385|FG003|Overall Study|Progression of Disease|0|||
129813265|NCT04292743|467282382|FG000|Overall Study|No Treatment per protocol|0|||
129813266|NCT04292743|467282383|FG001|Overall Study|No Treatment per protocol|2|||
129813267|NCT04292743|467282384|FG002|Overall Study|No Treatment per protocol|0|||
129813268|NCT04292743|467282385|FG003|Overall Study|No Treatment per protocol|0|||
129813269|NCT05766423|467282386|FG000|Overall Study|Withdrawal by Subject|1|||
129813270|NCT05766423|467282387|FG001|Overall Study|Withdrawal by Subject|0|||
129813271|NCT05766423|467282386|FG000|Overall Study|Consented, not scheduled|3|||
129813272|NCT05766423|467282387|FG001|Overall Study|Consented, not scheduled|5|||
129813273|NCT02385045|467284119|FG000|Overall Study|Endoscopy could not be completed|4|||
129813274|NCT00042289|467284121|FG000|Overall Study|Lost to Follow-up|3|||
129813275|NCT00042289|467284122|FG001|Overall Study|Lost to Follow-up|0|||
129813276|NCT00042289|467284123|FG002|Overall Study|Lost to Follow-up|0|||
129813277|NCT00042289|467284124|FG003|Overall Study|Lost to Follow-up|1|||
129813278|NCT00042289|467284125|FG004|Overall Study|Lost to Follow-up|3|||
129813279|NCT00042289|467284126|FG005|Overall Study|Lost to Follow-up|3|||
129813280|NCT00042289|467284127|FG006|Overall Study|Lost to Follow-up|6|||
129813281|NCT00042289|467284128|FG007|Overall Study|Lost to Follow-up|1|||
129813282|NCT00042289|467284129|FG008|Overall Study|Lost to Follow-up|1|||
129813283|NCT00042289|467284130|FG009|Overall Study|Lost to Follow-up|0|||
129813284|NCT00042289|467284131|FG010|Overall Study|Lost to Follow-up|0|||
129813285|NCT00042289|467284132|FG011|Overall Study|Lost to Follow-up|0|||
129813286|NCT00042289|467284133|FG012|Overall Study|Lost to Follow-up|0|||
129813287|NCT00042289|467284134|FG013|Overall Study|Lost to Follow-up|0|||
129813288|NCT00042289|467284135|FG014|Overall Study|Lost to Follow-up|0|||
129813289|NCT00042289|467284136|FG015|Overall Study|Lost to Follow-up|1|||
129813290|NCT00042289|467284137|FG016|Overall Study|Lost to Follow-up|1|||
129813291|NCT00042289|467284138|FG017|Overall Study|Lost to Follow-up|0|||
129813292|NCT00042289|467284139|FG018|Overall Study|Lost to Follow-up|3|||
129813293|NCT00042289|467284140|FG019|Overall Study|Lost to Follow-up|2|||
129813294|NCT00042289|467284141|FG020|Overall Study|Lost to Follow-up|0|||
129813295|NCT00042289|467284142|FG021|Overall Study|Lost to Follow-up|0|||
129813296|NCT00042289|467284143|FG022|Overall Study|Lost to Follow-up|0|||
129813297|NCT00042289|467284144|FG023|Overall Study|Lost to Follow-up|0|||
129813298|NCT00042289|467284145|FG024|Overall Study|Lost to Follow-up|0|||
129813299|NCT00042289|467284146|FG025|Overall Study|Lost to Follow-up|0|||
129813300|NCT00042289|467284147|FG026|Overall Study|Lost to Follow-up|2|||
129813301|NCT00042289|467284148|FG027|Overall Study|Lost to Follow-up|2|||
129813302|NCT00042289|467284149|FG028|Overall Study|Lost to Follow-up|2|||
129813303|NCT00042289|467284150|FG029|Overall Study|Lost to Follow-up|0|||
129813304|NCT00042289|467284151|FG030|Overall Study|Lost to Follow-up|0|||
129813305|NCT00042289|467284152|FG031|Overall Study|Lost to Follow-up|2|||
129813306|NCT00042289|467284153|FG032|Overall Study|Lost to Follow-up|1|||
129813307|NCT00042289|467284154|FG033|Overall Study|Lost to Follow-up|1|||
129813308|NCT00042289|467284155|FG034|Overall Study|Lost to Follow-up|1|||
129813309|NCT00042289|467284156|FG035|Overall Study|Lost to Follow-up|2|||
129813310|NCT00042289|467284157|FG036|Overall Study|Lost to Follow-up|1|||
129813311|NCT00042289|467284158|FG037|Overall Study|Lost to Follow-up|1|||
129813312|NCT00042289|467284159|FG038|Overall Study|Lost to Follow-up|0|||
129813313|NCT00042289|467284160|FG039|Overall Study|Lost to Follow-up|5|||
129813314|NCT00042289|467284161|FG040|Overall Study|Lost to Follow-up|0|||
129813315|NCT00042289|467284162|FG041|Overall Study|Lost to Follow-up|2|||
129813316|NCT00042289|467284163|FG042|Overall Study|Lost to Follow-up|2|||
129813317|NCT00042289|467284164|FG043|Overall Study|Lost to Follow-up|0|||
129813318|NCT00042289|467284165|FG044|Overall Study|Lost to Follow-up|0|||
129813319|NCT00042289|467284166|FG045|Overall Study|Lost to Follow-up|1|||
129813320|NCT00042289|467284167|FG046|Overall Study|Lost to Follow-up|0|||
129813321|NCT00042289|467284121|FG000|Overall Study|Other reason|0|||
129813322|NCT00042289|467284122|FG001|Overall Study|Other reason|0|||
129813323|NCT00042289|467284123|FG002|Overall Study|Other reason|0|||
129813324|NCT00042289|467284124|FG003|Overall Study|Other reason|2|||
129813325|NCT00042289|467284125|FG004|Overall Study|Other reason|0|||
129813326|NCT00042289|467284126|FG005|Overall Study|Other reason|0|||
129813327|NCT00042289|467284127|FG006|Overall Study|Other reason|0|||
129813328|NCT00042289|467284128|FG007|Overall Study|Other reason|0|||
129813329|NCT00042289|467284129|FG008|Overall Study|Other reason|0|||
129813330|NCT00042289|467284130|FG009|Overall Study|Other reason|0|||
129813331|NCT00042289|467284131|FG010|Overall Study|Other reason|0|||
129813332|NCT00042289|467284132|FG011|Overall Study|Other reason|0|||
129813333|NCT00042289|467284133|FG012|Overall Study|Other reason|0|||
129813334|NCT00042289|467284134|FG013|Overall Study|Other reason|0|||
129813335|NCT00042289|467284135|FG014|Overall Study|Other reason|0|||
129813336|NCT00042289|467284136|FG015|Overall Study|Other reason|0|||
129813337|NCT00042289|467284137|FG016|Overall Study|Other reason|0|||
129813338|NCT00042289|467284138|FG017|Overall Study|Other reason|0|||
129813339|NCT00042289|467284139|FG018|Overall Study|Other reason|1|||
129813340|NCT00042289|467284140|FG019|Overall Study|Other reason|0|||
129813341|NCT00042289|467284141|FG020|Overall Study|Other reason|0|||
129813342|NCT00042289|467284142|FG021|Overall Study|Other reason|0|||
129813343|NCT00042289|467284143|FG022|Overall Study|Other reason|0|||
129813344|NCT00042289|467284144|FG023|Overall Study|Other reason|1|||
129813345|NCT00042289|467284145|FG024|Overall Study|Other reason|0|||
129813346|NCT00042289|467284146|FG025|Overall Study|Other reason|0|||
129813347|NCT00042289|467284147|FG026|Overall Study|Other reason|1|||
129813348|NCT00042289|467284148|FG027|Overall Study|Other reason|0|||
129813349|NCT00042289|467284149|FG028|Overall Study|Other reason|3|||
129813350|NCT00042289|467284150|FG029|Overall Study|Other reason|0|||
129813351|NCT00042289|467284151|FG030|Overall Study|Other reason|0|||
129813352|NCT00042289|467284152|FG031|Overall Study|Other reason|1|||
129813353|NCT00042289|467284153|FG032|Overall Study|Other reason|0|||
129813354|NCT00042289|467284154|FG033|Overall Study|Other reason|1|||
129813355|NCT00042289|467284155|FG034|Overall Study|Other reason|0|||
129813356|NCT00042289|467284156|FG035|Overall Study|Other reason|2|||
129813357|NCT00042289|467284157|FG036|Overall Study|Other reason|0|||
129813358|NCT00042289|467284158|FG037|Overall Study|Other reason|0|||
129813359|NCT00042289|467284159|FG038|Overall Study|Other reason|0|||
129813360|NCT00042289|467284160|FG039|Overall Study|Other reason|0|||
129813361|NCT00042289|467284161|FG040|Overall Study|Other reason|0|||
129813362|NCT00042289|467284162|FG041|Overall Study|Other reason|0|||
129813363|NCT00042289|467284163|FG042|Overall Study|Other reason|0|||
129813364|NCT00042289|467284164|FG043|Overall Study|Other reason|1|||
129813365|NCT00042289|467284165|FG044|Overall Study|Other reason|0|||
129813366|NCT00042289|467284166|FG045|Overall Study|Other reason|0|||
129813367|NCT00042289|467284167|FG046|Overall Study|Other reason|0|||
129813368|NCT00042289|467284121|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129813369|NCT00042289|467284122|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129813370|NCT00042289|467284123|FG002|Overall Study|Severe debilitation, unable to continue|0|||
129813371|NCT00042289|467284124|FG003|Overall Study|Severe debilitation, unable to continue|0|||
129813372|NCT00042289|467284125|FG004|Overall Study|Severe debilitation, unable to continue|0|||
129813373|NCT00042289|467284126|FG005|Overall Study|Severe debilitation, unable to continue|0|||
129813374|NCT00042289|467284127|FG006|Overall Study|Severe debilitation, unable to continue|0|||
129813375|NCT00042289|467284128|FG007|Overall Study|Severe debilitation, unable to continue|0|||
129813376|NCT00042289|467284129|FG008|Overall Study|Severe debilitation, unable to continue|0|||
129813377|NCT00042289|467284130|FG009|Overall Study|Severe debilitation, unable to continue|0|||
129813378|NCT00042289|467284131|FG010|Overall Study|Severe debilitation, unable to continue|0|||
129813379|NCT00042289|467284132|FG011|Overall Study|Severe debilitation, unable to continue|0|||
129813380|NCT00042289|467284133|FG012|Overall Study|Severe debilitation, unable to continue|0|||
129813381|NCT00042289|467284134|FG013|Overall Study|Severe debilitation, unable to continue|0|||
129813382|NCT00042289|467284135|FG014|Overall Study|Severe debilitation, unable to continue|0|||
129897049|NCT03568162|467582192|FG003|Overall Study|Others|4|||
129813383|NCT00042289|467284136|FG015|Overall Study|Severe debilitation, unable to continue|0|||
129813384|NCT00042289|467284137|FG016|Overall Study|Severe debilitation, unable to continue|0|||
129813385|NCT00042289|467284138|FG017|Overall Study|Severe debilitation, unable to continue|0|||
129813386|NCT00042289|467284139|FG018|Overall Study|Severe debilitation, unable to continue|0|||
129813387|NCT00042289|467284140|FG019|Overall Study|Severe debilitation, unable to continue|0|||
129813388|NCT00042289|467284141|FG020|Overall Study|Severe debilitation, unable to continue|0|||
129813389|NCT00042289|467284142|FG021|Overall Study|Severe debilitation, unable to continue|1|||
129813390|NCT00042289|467284143|FG022|Overall Study|Severe debilitation, unable to continue|0|||
129813391|NCT00042289|467284144|FG023|Overall Study|Severe debilitation, unable to continue|1|||
129813392|NCT00042289|467284145|FG024|Overall Study|Severe debilitation, unable to continue|0|||
129813393|NCT00042289|467284146|FG025|Overall Study|Severe debilitation, unable to continue|0|||
129813394|NCT00042289|467284147|FG026|Overall Study|Severe debilitation, unable to continue|0|||
129813395|NCT00042289|467284148|FG027|Overall Study|Severe debilitation, unable to continue|1|||
129813396|NCT00042289|467284149|FG028|Overall Study|Severe debilitation, unable to continue|0|||
129813397|NCT00042289|467284150|FG029|Overall Study|Severe debilitation, unable to continue|0|||
129813398|NCT00042289|467284151|FG030|Overall Study|Severe debilitation, unable to continue|0|||
129813399|NCT00042289|467284152|FG031|Overall Study|Severe debilitation, unable to continue|1|||
129813400|NCT00042289|467284153|FG032|Overall Study|Severe debilitation, unable to continue|1|||
129813401|NCT00042289|467284154|FG033|Overall Study|Severe debilitation, unable to continue|0|||
129813402|NCT00042289|467284155|FG034|Overall Study|Severe debilitation, unable to continue|0|||
129813403|NCT00042289|467284156|FG035|Overall Study|Severe debilitation, unable to continue|0|||
129813404|NCT00042289|467284157|FG036|Overall Study|Severe debilitation, unable to continue|0|||
129813405|NCT00042289|467284158|FG037|Overall Study|Severe debilitation, unable to continue|0|||
129813406|NCT00042289|467284159|FG038|Overall Study|Severe debilitation, unable to continue|0|||
129813407|NCT00042289|467284160|FG039|Overall Study|Severe debilitation, unable to continue|0|||
129813408|NCT00042289|467284161|FG040|Overall Study|Severe debilitation, unable to continue|0|||
129813409|NCT00042289|467284162|FG041|Overall Study|Severe debilitation, unable to continue|0|||
129813410|NCT00042289|467284163|FG042|Overall Study|Severe debilitation, unable to continue|0|||
129813411|NCT00042289|467284164|FG043|Overall Study|Severe debilitation, unable to continue|0|||
129813412|NCT00042289|467284165|FG044|Overall Study|Severe debilitation, unable to continue|0|||
129813413|NCT00042289|467284166|FG045|Overall Study|Severe debilitation, unable to continue|0|||
129813414|NCT00042289|467284167|FG046|Overall Study|Severe debilitation, unable to continue|0|||
129813415|NCT00042289|467284121|FG000|Overall Study|Site closed|0|||
129813416|NCT00042289|467284122|FG001|Overall Study|Site closed|0|||
129813417|NCT00042289|467284123|FG002|Overall Study|Site closed|0|||
129813418|NCT00042289|467284124|FG003|Overall Study|Site closed|0|||
129813419|NCT00042289|467284125|FG004|Overall Study|Site closed|0|||
129813420|NCT00042289|467284126|FG005|Overall Study|Site closed|0|||
129813421|NCT00042289|467284127|FG006|Overall Study|Site closed|0|||
129813422|NCT00042289|467284128|FG007|Overall Study|Site closed|0|||
129813423|NCT00042289|467284129|FG008|Overall Study|Site closed|0|||
129813424|NCT00042289|467284130|FG009|Overall Study|Site closed|0|||
129813425|NCT00042289|467284131|FG010|Overall Study|Site closed|0|||
129813426|NCT00042289|467284132|FG011|Overall Study|Site closed|0|||
129813427|NCT00042289|467284133|FG012|Overall Study|Site closed|0|||
129813428|NCT00042289|467284134|FG013|Overall Study|Site closed|0|||
129813429|NCT00042289|467284135|FG014|Overall Study|Site closed|0|||
129813430|NCT00042289|467284136|FG015|Overall Study|Site closed|0|||
129813431|NCT00042289|467284137|FG016|Overall Study|Site closed|0|||
129813432|NCT00042289|467284138|FG017|Overall Study|Site closed|0|||
129813433|NCT00042289|467284139|FG018|Overall Study|Site closed|0|||
129813434|NCT00042289|467284140|FG019|Overall Study|Site closed|0|||
129813435|NCT00042289|467284141|FG020|Overall Study|Site closed|0|||
129813436|NCT00042289|467284142|FG021|Overall Study|Site closed|0|||
129813437|NCT00042289|467284143|FG022|Overall Study|Site closed|0|||
129813438|NCT00042289|467284144|FG023|Overall Study|Site closed|0|||
129813439|NCT00042289|467284145|FG024|Overall Study|Site closed|0|||
129813440|NCT00042289|467284146|FG025|Overall Study|Site closed|0|||
129813441|NCT00042289|467284147|FG026|Overall Study|Site closed|0|||
129813442|NCT00042289|467284148|FG027|Overall Study|Site closed|0|||
129813443|NCT00042289|467284149|FG028|Overall Study|Site closed|0|||
129813444|NCT00042289|467284150|FG029|Overall Study|Site closed|0|||
129813445|NCT00042289|467284151|FG030|Overall Study|Site closed|0|||
129813446|NCT00042289|467284152|FG031|Overall Study|Site closed|3|||
129813447|NCT00042289|467284153|FG032|Overall Study|Site closed|0|||
129813448|NCT00042289|467284154|FG033|Overall Study|Site closed|0|||
129813449|NCT00042289|467284155|FG034|Overall Study|Site closed|0|||
129813450|NCT00042289|467284156|FG035|Overall Study|Site closed|0|||
129813451|NCT00042289|467284157|FG036|Overall Study|Site closed|1|||
129813452|NCT00042289|467284158|FG037|Overall Study|Site closed|0|||
129813453|NCT00042289|467284159|FG038|Overall Study|Site closed|0|||
129813454|NCT00042289|467284160|FG039|Overall Study|Site closed|0|||
129813455|NCT00042289|467284161|FG040|Overall Study|Site closed|0|||
129813456|NCT00042289|467284162|FG041|Overall Study|Site closed|0|||
129813457|NCT00042289|467284163|FG042|Overall Study|Site closed|1|||
129813458|NCT00042289|467284164|FG043|Overall Study|Site closed|0|||
129813459|NCT00042289|467284165|FG044|Overall Study|Site closed|0|||
129813460|NCT00042289|467284166|FG045|Overall Study|Site closed|0|||
129813461|NCT00042289|467284167|FG046|Overall Study|Site closed|0|||
129813462|NCT00042289|467284121|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
129813463|NCT00042289|467284122|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
129813464|NCT00042289|467284123|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
129813465|NCT00042289|467284124|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
129813466|NCT00042289|467284125|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
129813467|NCT00042289|467284126|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
129813468|NCT00042289|467284127|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
129813469|NCT00042289|467284128|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
129813470|NCT00042289|467284129|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
129813471|NCT00042289|467284130|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
129813472|NCT00042289|467284131|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
129813473|NCT00042289|467284132|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
129813474|NCT00042289|467284133|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
129813475|NCT00042289|467284134|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
129813476|NCT00042289|467284135|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
129813477|NCT00042289|467284136|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
129813478|NCT00042289|467284137|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
129813479|NCT00042289|467284138|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
129813480|NCT00042289|467284139|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
129813481|NCT00042289|467284140|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
129813482|NCT00042289|467284141|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
129813483|NCT00042289|467284142|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
129813484|NCT00042289|467284143|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
129813485|NCT00042289|467284144|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
129813486|NCT00042289|467284145|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
129813487|NCT00042289|467284146|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
129813488|NCT00042289|467284147|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
129813489|NCT00042289|467284148|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
129813490|NCT00042289|467284149|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
129813491|NCT00042289|467284150|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
129813492|NCT00042289|467284151|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
129813493|NCT00042289|467284152|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
129813494|NCT00042289|467284153|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
129813495|NCT00042289|467284154|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
129813496|NCT00042289|467284155|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
129813497|NCT00042289|467284156|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
129813498|NCT00042289|467284157|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
129813499|NCT00042289|467284158|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
129813500|NCT00042289|467284159|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
129813501|NCT00042289|467284160|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
129813502|NCT00042289|467284161|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
129813503|NCT00042289|467284162|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
129813504|NCT00042289|467284163|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
129813505|NCT00042289|467284164|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
129813506|NCT00042289|467284165|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
129813507|NCT00042289|467284166|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
129813508|NCT00042289|467284167|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
129813509|NCT00042289|467284121|FG000|Overall Study|Protocol Violation|0|||
129813510|NCT00042289|467284122|FG001|Overall Study|Protocol Violation|0|||
129813511|NCT00042289|467284123|FG002|Overall Study|Protocol Violation|0|||
129813512|NCT00042289|467284124|FG003|Overall Study|Protocol Violation|0|||
129813513|NCT00042289|467284125|FG004|Overall Study|Protocol Violation|0|||
129813514|NCT00042289|467284126|FG005|Overall Study|Protocol Violation|1|||
129813515|NCT00042289|467284127|FG006|Overall Study|Protocol Violation|0|||
129813516|NCT00042289|467284128|FG007|Overall Study|Protocol Violation|1|||
129813517|NCT00042289|467284129|FG008|Overall Study|Protocol Violation|0|||
129813518|NCT00042289|467284130|FG009|Overall Study|Protocol Violation|0|||
129813519|NCT00042289|467284131|FG010|Overall Study|Protocol Violation|0|||
129813520|NCT00042289|467284132|FG011|Overall Study|Protocol Violation|0|||
129813521|NCT00042289|467284133|FG012|Overall Study|Protocol Violation|0|||
129813522|NCT00042289|467284134|FG013|Overall Study|Protocol Violation|0|||
129813523|NCT00042289|467284135|FG014|Overall Study|Protocol Violation|0|||
129813524|NCT00042289|467284136|FG015|Overall Study|Protocol Violation|0|||
129813525|NCT00042289|467284137|FG016|Overall Study|Protocol Violation|0|||
129813526|NCT00042289|467284138|FG017|Overall Study|Protocol Violation|0|||
129813527|NCT00042289|467284139|FG018|Overall Study|Protocol Violation|0|||
129813528|NCT00042289|467284140|FG019|Overall Study|Protocol Violation|0|||
129813529|NCT00042289|467284141|FG020|Overall Study|Protocol Violation|0|||
129813530|NCT00042289|467284142|FG021|Overall Study|Protocol Violation|0|||
129813531|NCT00042289|467284143|FG022|Overall Study|Protocol Violation|0|||
129813532|NCT00042289|467284144|FG023|Overall Study|Protocol Violation|1|||
129813533|NCT00042289|467284145|FG024|Overall Study|Protocol Violation|1|||
129813534|NCT00042289|467284146|FG025|Overall Study|Protocol Violation|0|||
129813535|NCT00042289|467284147|FG026|Overall Study|Protocol Violation|2|||
129813536|NCT00042289|467284148|FG027|Overall Study|Protocol Violation|0|||
129813537|NCT00042289|467284149|FG028|Overall Study|Protocol Violation|0|||
129813538|NCT00042289|467284150|FG029|Overall Study|Protocol Violation|0|||
129813539|NCT00042289|467284151|FG030|Overall Study|Protocol Violation|1|||
129813540|NCT00042289|467284152|FG031|Overall Study|Protocol Violation|0|||
129813541|NCT00042289|467284153|FG032|Overall Study|Protocol Violation|0|||
129813542|NCT00042289|467284154|FG033|Overall Study|Protocol Violation|0|||
129813543|NCT00042289|467284155|FG034|Overall Study|Protocol Violation|0|||
129813544|NCT00042289|467284156|FG035|Overall Study|Protocol Violation|0|||
129813545|NCT00042289|467284157|FG036|Overall Study|Protocol Violation|0|||
129813546|NCT00042289|467284158|FG037|Overall Study|Protocol Violation|0|||
129813547|NCT00042289|467284159|FG038|Overall Study|Protocol Violation|0|||
129813548|NCT00042289|467284160|FG039|Overall Study|Protocol Violation|0|||
129813549|NCT00042289|467284161|FG040|Overall Study|Protocol Violation|0|||
129813550|NCT00042289|467284162|FG041|Overall Study|Protocol Violation|1|||
129813551|NCT00042289|467284163|FG042|Overall Study|Protocol Violation|1|||
129813552|NCT00042289|467284164|FG043|Overall Study|Protocol Violation|1|||
129813553|NCT00042289|467284165|FG044|Overall Study|Protocol Violation|0|||
129813554|NCT00042289|467284166|FG045|Overall Study|Protocol Violation|0|||
129813555|NCT00042289|467284167|FG046|Overall Study|Protocol Violation|0|||
129813556|NCT00042289|467284121|FG000|Overall Study|Withdrawal by Subject|4|||
129813557|NCT00042289|467284122|FG001|Overall Study|Withdrawal by Subject|1|||
129813558|NCT00042289|467284123|FG002|Overall Study|Withdrawal by Subject|0|||
129813559|NCT00042289|467284124|FG003|Overall Study|Withdrawal by Subject|2|||
129813560|NCT00042289|467284125|FG004|Overall Study|Withdrawal by Subject|0|||
129813561|NCT00042289|467284126|FG005|Overall Study|Withdrawal by Subject|2|||
129813562|NCT00042289|467284127|FG006|Overall Study|Withdrawal by Subject|0|||
129813563|NCT00042289|467284128|FG007|Overall Study|Withdrawal by Subject|0|||
129813564|NCT00042289|467284129|FG008|Overall Study|Withdrawal by Subject|0|||
129813565|NCT00042289|467284130|FG009|Overall Study|Withdrawal by Subject|1|||
129813566|NCT00042289|467284131|FG010|Overall Study|Withdrawal by Subject|0|||
129813567|NCT00042289|467284132|FG011|Overall Study|Withdrawal by Subject|0|||
129813568|NCT00042289|467284133|FG012|Overall Study|Withdrawal by Subject|2|||
129813569|NCT00042289|467284134|FG013|Overall Study|Withdrawal by Subject|0|||
129813570|NCT00042289|467284135|FG014|Overall Study|Withdrawal by Subject|0|||
129813571|NCT00042289|467284136|FG015|Overall Study|Withdrawal by Subject|0|||
129813572|NCT00042289|467284137|FG016|Overall Study|Withdrawal by Subject|0|||
129813573|NCT00042289|467284138|FG017|Overall Study|Withdrawal by Subject|0|||
129813574|NCT00042289|467284139|FG018|Overall Study|Withdrawal by Subject|0|||
129813575|NCT00042289|467284140|FG019|Overall Study|Withdrawal by Subject|0|||
129813576|NCT00042289|467284141|FG020|Overall Study|Withdrawal by Subject|0|||
129813577|NCT00042289|467284142|FG021|Overall Study|Withdrawal by Subject|1|||
129813578|NCT00042289|467284143|FG022|Overall Study|Withdrawal by Subject|1|||
129813579|NCT00042289|467284144|FG023|Overall Study|Withdrawal by Subject|1|||
129813580|NCT00042289|467284145|FG024|Overall Study|Withdrawal by Subject|0|||
129813581|NCT00042289|467284146|FG025|Overall Study|Withdrawal by Subject|0|||
129813582|NCT00042289|467284147|FG026|Overall Study|Withdrawal by Subject|1|||
129813583|NCT00042289|467284148|FG027|Overall Study|Withdrawal by Subject|0|||
129813584|NCT00042289|467284149|FG028|Overall Study|Withdrawal by Subject|2|||
129813585|NCT00042289|467284150|FG029|Overall Study|Withdrawal by Subject|0|||
129813586|NCT00042289|467284151|FG030|Overall Study|Withdrawal by Subject|0|||
129813587|NCT00042289|467284152|FG031|Overall Study|Withdrawal by Subject|1|||
129813588|NCT00042289|467284153|FG032|Overall Study|Withdrawal by Subject|2|||
129813589|NCT00042289|467284154|FG033|Overall Study|Withdrawal by Subject|1|||
129813590|NCT00042289|467284155|FG034|Overall Study|Withdrawal by Subject|0|||
129813591|NCT00042289|467284156|FG035|Overall Study|Withdrawal by Subject|0|||
129813592|NCT00042289|467284157|FG036|Overall Study|Withdrawal by Subject|0|||
129813593|NCT00042289|467284158|FG037|Overall Study|Withdrawal by Subject|1|||
129813594|NCT00042289|467284159|FG038|Overall Study|Withdrawal by Subject|0|||
129813595|NCT00042289|467284160|FG039|Overall Study|Withdrawal by Subject|0|||
129813596|NCT00042289|467284161|FG040|Overall Study|Withdrawal by Subject|0|||
129813597|NCT00042289|467284162|FG041|Overall Study|Withdrawal by Subject|0|||
129813598|NCT00042289|467284163|FG042|Overall Study|Withdrawal by Subject|1|||
129813599|NCT00042289|467284164|FG043|Overall Study|Withdrawal by Subject|0|||
129813600|NCT00042289|467284165|FG044|Overall Study|Withdrawal by Subject|0|||
129813601|NCT00042289|467284166|FG045|Overall Study|Withdrawal by Subject|0|||
129813602|NCT00042289|467284167|FG046|Overall Study|Withdrawal by Subject|0|||
129813603|NCT00745823|467284169|FG000|Overall Study|Adverse Event|5|||
129813604|NCT00745823|467284170|FG001|Overall Study|Adverse Event|3|||
129813605|NCT00745823|467284169|FG000|Overall Study|Lack of Efficacy|20|||
129813606|NCT00745823|467284170|FG001|Overall Study|Lack of Efficacy|6|||
129813607|NCT00745823|467284169|FG000|Overall Study|Lost to Follow-up|10|||
129813608|NCT00745823|467284170|FG001|Overall Study|Lost to Follow-up|11|||
129813609|NCT00745823|467284169|FG000|Overall Study|Physician Decision|10|||
129813610|NCT00745823|467284170|FG001|Overall Study|Physician Decision|5|||
129813611|NCT00745823|467284169|FG000|Overall Study|Pregnancy|0|||
129813612|NCT00745823|467284170|FG001|Overall Study|Pregnancy|4|||
129813613|NCT00745823|467284169|FG000|Overall Study|Withdrawal by Subject|14|||
129813614|NCT00745823|467284170|FG001|Overall Study|Withdrawal by Subject|8|||
129813615|NCT00745823|467284169|FG000|Overall Study|Study Terminated by Sponsor|326|||
129813616|NCT00745823|467284170|FG001|Overall Study|Study Terminated by Sponsor|349|||
129813617|NCT02955602|467284176|FG000|Overall Study|Adverse Event|0|||
129813618|NCT02955602|467284177|FG001|Overall Study|Adverse Event|3|||
129813619|NCT02955602|467284178|FG002|Overall Study|Adverse Event|0|||
129813620|NCT02955602|467284176|FG000|Overall Study|Withdrawal of informed consent|1|||
129813621|NCT02955602|467284177|FG001|Overall Study|Withdrawal of informed consent|3|||
129813622|NCT02955602|467284178|FG002|Overall Study|Withdrawal of informed consent|2|||
129813623|NCT02955602|467284176|FG000|Overall Study|Lost to Follow-up|0|||
129813624|NCT02955602|467284177|FG001|Overall Study|Lost to Follow-up|0|||
129813625|NCT02955602|467284178|FG002|Overall Study|Lost to Follow-up|1|||
129813626|NCT02955602|467284176|FG000|Overall Study|Other|0|||
129813627|NCT02955602|467284177|FG001|Overall Study|Other|1|||
129813628|NCT02955602|467284178|FG002|Overall Study|Other|3|||
129813629|NCT03000439|467284180|FG000|Open Label Part 1|Adverse Event|6|||
129813630|NCT03000439|467284181|FG001|Open Label Part 1|Adverse Event|0|||
129813631|NCT03000439|467284182|FG002|Open Label Part 1|Adverse Event|0|||
129813632|NCT03000439|467284183|FG003|Open Label Part 1|Adverse Event|0|||
129813633|NCT03000439|467284180|FG000|Open Label Part 1|Other|2|||
129813634|NCT03000439|467284181|FG001|Open Label Part 1|Other|0|||
129813635|NCT03000439|467284182|FG002|Open Label Part 1|Other|0|||
129813636|NCT03000439|467284183|FG003|Open Label Part 1|Other|0|||
129813637|NCT03000439|467284180|FG000|Open Label Part 1|Insufficient clinical response|16|||
129813638|NCT03000439|467284181|FG001|Open Label Part 1|Insufficient clinical response|0|||
129813639|NCT03000439|467284182|FG002|Open Label Part 1|Insufficient clinical response|0|||
129813640|NCT03000439|467284183|FG003|Open Label Part 1|Insufficient clinical response|0|||
129813641|NCT03000439|467284180|FG000|Open Label Part 2|Other|0|||
129813642|NCT03000439|467284181|FG001|Open Label Part 2|Other|5|||
129813643|NCT03000439|467284182|FG002|Open Label Part 2|Other|0|||
129813644|NCT03000439|467284183|FG003|Open Label Part 2|Other|0|||
129813645|NCT03000439|467284180|FG000|Open Label Part 2|Insufficient clinical response|0|||
129813646|NCT03000439|467284181|FG001|Open Label Part 2|Insufficient clinical response|12|||
129813647|NCT03000439|467284182|FG002|Open Label Part 2|Insufficient clinical response|0|||
129813648|NCT03000439|467284183|FG003|Open Label Part 2|Insufficient clinical response|0|||
129813649|NCT03000439|467284180|FG000|Double Blind Phase|Adverse Event|0|||
129813650|NCT03000439|467284181|FG001|Double Blind Phase|Adverse Event|0|||
129813651|NCT03000439|467284182|FG002|Double Blind Phase|Adverse Event|2|||
129813652|NCT03000439|467284183|FG003|Double Blind Phase|Adverse Event|1|||
129813653|NCT03000439|467284180|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
129813654|NCT03000439|467284181|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
129813655|NCT03000439|467284182|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
129813656|NCT03000439|467284183|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
129813657|NCT03000439|467284180|FG000|Double Blind Phase|Other|0|||
129813658|NCT03000439|467284181|FG001|Double Blind Phase|Other|0|||
129813659|NCT03000439|467284182|FG002|Double Blind Phase|Other|10|||
129813660|NCT03000439|467284183|FG003|Double Blind Phase|Other|11|||
129813661|NCT03000439|467284180|FG000|Double Blind Phase|Insufficient clinical response|0|||
129813662|NCT03000439|467284181|FG001|Double Blind Phase|Insufficient clinical response|0|||
129813663|NCT03000439|467284182|FG002|Double Blind Phase|Insufficient clinical response|0|||
129813664|NCT03000439|467284183|FG003|Double Blind Phase|Insufficient clinical response|2|||
129813665|NCT02370160|467284184|FG000|Overall Study|Death|3|||
129813666|NCT02370160|467284185|FG001|Overall Study|Death|4|||
129813667|NCT02370160|467284186|FG002|Overall Study|Death|1|||
129813668|NCT00592384|467284187|FG000|Overall Study|Withdrawal by Subject|5|||
129813669|NCT00592384|467284188|FG001|Overall Study|Withdrawal by Subject|6|||
129813670|NCT02151591|467284190|FG000|Overall Study|Lost to Follow-up|6|||
129813671|NCT02151591|467284191|FG001|Overall Study|Lost to Follow-up|3|||
129813672|NCT00684593|467284197|FG000|Overall Study|Adverse Event|0|||
129813673|NCT00684593|467284198|FG001|Overall Study|Adverse Event|2|||
129813674|NCT01001377|467284199|FG000|Overall Study|Ineligibility determined|2|||
129813675|NCT01001377|467284200|FG001|Overall Study|Ineligibility determined|0|||
129813676|NCT01001377|467284199|FG000|Overall Study|Withdrawal by Subject|19|||
129813677|NCT01001377|467284200|FG001|Overall Study|Withdrawal by Subject|20|||
129813678|NCT01001377|467284199|FG000|Overall Study|Lost to Follow-up|14|||
129813679|NCT01001377|467284200|FG001|Overall Study|Lost to Follow-up|17|||
129813680|NCT01001377|467284199|FG000|Overall Study|Death|391|||
129813681|NCT01001377|467284200|FG001|Overall Study|Death|384|||
129813682|NCT02193867|467284204|FG000|Overall Study|Death|2|||
129813683|NCT02193867|467284204|FG000|Overall Study|Sponsor Study Termination|2|||
129813684|NCT00964860|467284205|FG000|Overall Study|Withdrawal by Subject|0|||
129813685|NCT00964860|467284206|FG001|Overall Study|Withdrawal by Subject|1|||
129813686|NCT03716024|467284207|FG000|Overall Study|Randomized, not Treated|7|||
129813687|NCT03716024|467284208|FG001|Overall Study|Randomized, not Treated|8|||
129813688|NCT03716024|467284207|FG000|Overall Study|Adverse Event|1|||
129813689|NCT03716024|467284208|FG001|Overall Study|Adverse Event|2|||
129813690|NCT03716024|467284207|FG000|Overall Study|Treatment Failure|1|||
129813691|NCT03716024|467284208|FG001|Overall Study|Treatment Failure|0|||
129813692|NCT03716024|467284207|FG000|Overall Study|Lost to Follow-up|2|||
129813693|NCT03716024|467284208|FG001|Overall Study|Lost to Follow-up|6|||
129813694|NCT03716024|467284207|FG000|Overall Study|Withdrawal by Subject|0|||
129813695|NCT03716024|467284208|FG001|Overall Study|Withdrawal by Subject|1|||
129813696|NCT03716024|467284207|FG000|Overall Study|Missing Reason|0|||
129813697|NCT03716024|467284208|FG001|Overall Study|Missing Reason|1|||
129813698|NCT00867568|467284209|FG000|Overall Study|Lack of Efficacy|10|||
129813699|NCT00867568|467284209|FG000|Overall Study|Adverse Event|4|||
129813700|NCT00867568|467284209|FG000|Overall Study|Withdrawal by Subject|1|||
129813701|NCT03600818|467284214|FG000|Overall Study|Adverse Event|4|||
129813702|NCT03600818|467284215|FG001|Overall Study|Adverse Event|7|||
129813703|NCT03600818|467284214|FG000|Overall Study|Lack of Efficacy|9|||
129813704|NCT03600818|467284215|FG001|Overall Study|Lack of Efficacy|4|||
129813705|NCT03600818|467284214|FG000|Overall Study|Withdrawal by Subject|4|||
129813706|NCT03600818|467284215|FG001|Overall Study|Withdrawal by Subject|3|||
129813707|NCT03600818|467284214|FG000|Overall Study|Other-unspecified|5|||
129813708|NCT03600818|467284215|FG001|Overall Study|Other-unspecified|3|||
129813709|NCT03600818|467284214|FG000|Overall Study|Randomized and not treated|0|||
129813710|NCT03600818|467284215|FG001|Overall Study|Randomized and not treated|1|||
129813711|NCT04930965|467284219|FG000|Overall Study|Lost to Follow-up|7|||
129813712|NCT04930965|467284220|FG001|Overall Study|Lost to Follow-up|5|||
129813713|NCT01471171|467284223|FG000|Treatment Period 1|Adverse Event|4|||
129813714|NCT01471171|467284224|FG001|Treatment Period 1|Adverse Event|1|||
129813715|NCT01471171|467284223|FG000|Treatment Period 2|Adverse Event|1|||
129813716|NCT01471171|467284224|FG001|Treatment Period 2|Adverse Event|0|||
129813717|NCT03478930|467284225|FG000|Overall Study|Adverse Event|0|||
129813718|NCT03478930|467284226|FG001|Overall Study|Adverse Event|1|||
129813719|NCT03478930|467284225|FG000|Overall Study|Lack of Efficacy|3|||
129813720|NCT03478930|467284226|FG001|Overall Study|Lack of Efficacy|3|||
129813721|NCT03478930|467284225|FG000|Overall Study|Withdrawal by Subject|6|||
129813722|NCT03478930|467284226|FG001|Overall Study|Withdrawal by Subject|5|||
129813723|NCT00705484|467284231|FG000|Overall Study|Adverse Event|28|||
129813724|NCT00705484|467284232|FG001|Overall Study|Adverse Event|27|||
129813725|NCT00705484|467284231|FG000|Overall Study|Lost to Follow-up|169|||
129813726|NCT00705484|467284232|FG001|Overall Study|Lost to Follow-up|250|||
129813727|NCT00705484|467284231|FG000|Overall Study|Withdrawal by Subject|96|||
129813728|NCT00705484|467284232|FG001|Overall Study|Withdrawal by Subject|72|||
129813729|NCT00705484|467284231|FG000|Overall Study|Administrative|89|||
129813730|NCT00705484|467284232|FG001|Overall Study|Administrative|59|||
129813731|NCT02340975|467284234|FG000|Overall Study|Death|6|||
129813732|NCT02340975|467284235|FG001|Overall Study|Death|23|||
129813733|NCT02340975|467284236|FG002|Overall Study|Death|21|||
129813734|NCT02340975|467284237|FG003|Overall Study|Death|7|||
129813735|NCT02340975|467284238|FG004|Overall Study|Death|21|||
129813736|NCT02340975|467284239|FG005|Overall Study|Death|13|||
129813737|NCT02340975|467284234|FG000|Overall Study|Lost to Follow-up|0|||
129813738|NCT02340975|467284235|FG001|Overall Study|Lost to Follow-up|0|||
129813739|NCT02340975|467284236|FG002|Overall Study|Lost to Follow-up|0|||
129813740|NCT02340975|467284237|FG003|Overall Study|Lost to Follow-up|0|||
129813741|NCT02340975|467284238|FG004|Overall Study|Lost to Follow-up|2|||
129813742|NCT02340975|467284239|FG005|Overall Study|Lost to Follow-up|0|||
129813743|NCT02340975|467284234|FG000|Overall Study|Withdrawal by Subject|0|||
129813744|NCT02340975|467284235|FG001|Overall Study|Withdrawal by Subject|0|||
129813745|NCT02340975|467284236|FG002|Overall Study|Withdrawal by Subject|3|||
129813746|NCT02340975|467284237|FG003|Overall Study|Withdrawal by Subject|3|||
129813747|NCT02340975|467284238|FG004|Overall Study|Withdrawal by Subject|2|||
129813748|NCT02340975|467284239|FG005|Overall Study|Withdrawal by Subject|0|||
129813749|NCT02340975|467284234|FG000|Overall Study|Other|0|||
129813750|NCT02340975|467284235|FG001|Overall Study|Other|4|||
129813751|NCT02340975|467284236|FG002|Overall Study|Other|0|||
129813752|NCT02340975|467284237|FG003|Overall Study|Other|2|||
129813753|NCT02340975|467284238|FG004|Overall Study|Other|0|||
129813754|NCT02340975|467284239|FG005|Overall Study|Other|6|||
129813755|NCT02228460|467284242|FG000|Overall Study|Adverse Event|1|||
129813756|NCT02228460|467284242|FG000|Overall Study|Lost to Follow-up|1|||
129813757|NCT01243892|467284243|FG000|Overall Study|Did not meet eligibility criteria|2|||
129813758|NCT01243892|467284244|FG001|Overall Study|Did not meet eligibility criteria|0|||
129813759|NCT03982368|467284252|FG000|Overall Study|Adverse Event|6|||
129813760|NCT03982368|467284253|FG001|Overall Study|Adverse Event|4|||
129813761|NCT03982368|467284254|FG002|Overall Study|Adverse Event|3|||
129813762|NCT03982368|467284252|FG000|Overall Study|Lost to Follow-up|2|||
129813763|NCT03982368|467284253|FG001|Overall Study|Lost to Follow-up|1|||
129813764|NCT03982368|467284254|FG002|Overall Study|Lost to Follow-up|0|||
129813765|NCT03982368|467284252|FG000|Overall Study|Withdrawal by Subject|1|||
129813766|NCT03982368|467284253|FG001|Overall Study|Withdrawal by Subject|2|||
129813767|NCT03982368|467284254|FG002|Overall Study|Withdrawal by Subject|0|||
129813768|NCT03982368|467284252|FG000|Overall Study|unknow|4|||
129813769|NCT03982368|467284253|FG001|Overall Study|unknow|0|||
129813770|NCT03982368|467284254|FG002|Overall Study|unknow|2|||
129813771|NCT03087643|467284257|FG000|Overall Study|Withdrawal by Subject|2|||
129813772|NCT03087643|467284258|FG001|Overall Study|Withdrawal by Subject|4|||
129813773|NCT03087643|467284257|FG000|Overall Study|Death|2|||
129813774|NCT03087643|467284258|FG001|Overall Study|Death|2|||
129813775|NCT02083783|467284259|FG000|Overall Study|Withdrawal by Subject|1|||
129813776|NCT02083783|467284260|FG001|Overall Study|Withdrawal by Subject|0|||
129813777|NCT01546883|467284263|FG000|Overall Study|Withdrawal by Subject|3|||
129813778|NCT01546883|467284263|FG000|Overall Study|Adverse Event|4|||
129813779|NCT01546883|467284263|FG000|Overall Study|Lost to Follow-up|2|||
129813780|NCT01546883|467284263|FG000|Overall Study|early closure of study|2|||
129813781|NCT01546883|467284263|FG000|Overall Study|other unrelated illness|1|||
129813782|NCT02256631|467284267|FG000|Overall Study|Lost to Follow-up|1|||
129813783|NCT02256631|467284268|FG001|Overall Study|Lost to Follow-up|1|||
129813784|NCT02256631|467284269|FG002|Overall Study|Lost to Follow-up|0|||
129813785|NCT02256631|467284270|FG003|Overall Study|Lost to Follow-up|2|||
129813786|NCT02256631|467284271|FG004|Overall Study|Lost to Follow-up|0|||
129813787|NCT02256631|467284272|FG005|Overall Study|Lost to Follow-up|4|||
129813788|NCT02256631|467284273|FG006|Overall Study|Lost to Follow-up|1|||
129813789|NCT02256631|467284267|FG000|Overall Study|Withdrawal by Subject|0|||
129813790|NCT02256631|467284268|FG001|Overall Study|Withdrawal by Subject|0|||
129813791|NCT02256631|467284269|FG002|Overall Study|Withdrawal by Subject|0|||
129813792|NCT02256631|467284270|FG003|Overall Study|Withdrawal by Subject|1|||
129813793|NCT02256631|467284271|FG004|Overall Study|Withdrawal by Subject|1|||
129813794|NCT02256631|467284272|FG005|Overall Study|Withdrawal by Subject|0|||
129813795|NCT02256631|467284273|FG006|Overall Study|Withdrawal by Subject|1|||
129813796|NCT02256631|467284267|FG000|Overall Study|Unable to get to clinic|0|||
129813797|NCT02256631|467284268|FG001|Overall Study|Unable to get to clinic|2|||
129813798|NCT02256631|467284269|FG002|Overall Study|Unable to get to clinic|0|||
129813799|NCT02256631|467284270|FG003|Overall Study|Unable to get to clinic|1|||
129813800|NCT02256631|467284271|FG004|Overall Study|Unable to get to clinic|0|||
129813801|NCT02256631|467284272|FG005|Overall Study|Unable to get to clinic|1|||
129813802|NCT02256631|467284273|FG006|Overall Study|Unable to get to clinic|2|||
129813803|NCT03035409|467284276|FG000|Overall Study|Adverse Event|5|||
129813804|NCT03035409|467284276|FG000|Overall Study|Death|2|||
129813805|NCT03035409|467284276|FG000|Overall Study|Withdrawal by Subject|2|||
129813806|NCT03035409|467284276|FG000|Overall Study|Non compliance|4|||
129813807|NCT03035409|467284276|FG000|Overall Study|Patient was jittery|1|||
129813808|NCT03035409|467284276|FG000|Overall Study|Did not like Questionnaire|1|||
129813809|NCT03035409|467284276|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
129813810|NCT03035409|467284276|FG000|Overall Study|Did not like taking drugs|1|||
129813811|NCT01552694|467284279|FG000|Overall Study|Lost to Follow-up|0|||
129813812|NCT01552694|467284280|FG001|Overall Study|Lost to Follow-up|1|||
129813813|NCT01552694|467284279|FG000|Overall Study|Protocol Violation|0|||
129813814|NCT01552694|467284280|FG001|Overall Study|Protocol Violation|1|||
129813815|NCT03724032|467284281|FG000|Overall Study|Physician Decision|1|||
129813816|NCT03724032|467284282|FG001|Overall Study|Physician Decision|0|||
129813817|NCT03724032|467284283|FG002|Overall Study|Physician Decision|0|||
129813818|NCT03724032|467284281|FG000|Overall Study|Protocol Violation|2|||
129813819|NCT03724032|467284282|FG001|Overall Study|Protocol Violation|2|||
129813820|NCT03724032|467284283|FG002|Overall Study|Protocol Violation|1|||
129813821|NCT00361569|467284287|FG000|Overall Study|Protocol Violation|3|||
129813822|NCT00361569|467284288|FG001|Overall Study|Protocol Violation|2|||
129813823|NCT00361569|467284289|FG002|Overall Study|Protocol Violation|4|||
129813824|NCT00361569|467284290|FG003|Overall Study|Protocol Violation|2|||
129813825|NCT00361569|467284287|FG000|Overall Study|Withdrawal by Subject|2|||
129813826|NCT00361569|467284288|FG001|Overall Study|Withdrawal by Subject|1|||
129813827|NCT00361569|467284289|FG002|Overall Study|Withdrawal by Subject|9|||
129813828|NCT00361569|467284290|FG003|Overall Study|Withdrawal by Subject|14|||
129813829|NCT00361569|467284287|FG000|Overall Study|Adverse Event|3|||
129813830|NCT00361569|467284288|FG001|Overall Study|Adverse Event|5|||
129813831|NCT00361569|467284289|FG002|Overall Study|Adverse Event|2|||
129813832|NCT00361569|467284290|FG003|Overall Study|Adverse Event|2|||
129813833|NCT00361569|467284287|FG000|Overall Study|Lost to Follow-up|2|||
129813834|NCT00361569|467284288|FG001|Overall Study|Lost to Follow-up|3|||
129813835|NCT00361569|467284289|FG002|Overall Study|Lost to Follow-up|3|||
129813836|NCT00361569|467284290|FG003|Overall Study|Lost to Follow-up|2|||
129813837|NCT00361569|467284287|FG000|Overall Study|Not specified by investigator|2|||
129813838|NCT00361569|467284288|FG001|Overall Study|Not specified by investigator|0|||
129813839|NCT00361569|467284289|FG002|Overall Study|Not specified by investigator|0|||
129813840|NCT00361569|467284290|FG003|Overall Study|Not specified by investigator|1|||
129813841|NCT02639065|467284291|FG000|Study Treatment|Disease Progression|13|||
129813842|NCT02639065|467284291|FG000|Study Treatment|Adverse Event|9|||
129813843|NCT02639065|467284291|FG000|Study Treatment|Withdrawal by Subject|1|||
129813844|NCT02639065|467284291|FG000|Follow up|Subject refused to follow up|1|||
129813845|NCT02639065|467284291|FG000|Follow up|Symptomatic Deterioration|2|||
129813846|NCT02639065|467284291|FG000|Follow up|Death|2|||
129813847|NCT02639065|467284291|FG000|Follow up|Study Terminated|1|||
129813848|NCT02639065|467284291|FG000|Follow up|Disease Progression|3|||
129813849|NCT00481078|467284292|FG000|Overall Study|Progression of disease|11|||
129813850|NCT00481078|467284293|FG001|Overall Study|Progression of disease|11|||
129813851|NCT00481078|467284292|FG000|Overall Study|Adverse Event|15|||
129813852|NCT00481078|467284293|FG001|Overall Study|Adverse Event|3|||
129813853|NCT00481078|467284292|FG000|Overall Study|Death|5|||
129813854|NCT00481078|467284293|FG001|Overall Study|Death|3|||
129813855|NCT00481078|467284292|FG000|Overall Study|Intercurrent illness|1|||
129813856|NCT00481078|467284293|FG001|Overall Study|Intercurrent illness|0|||
129813857|NCT00481078|467284292|FG000|Overall Study|Withdrawal by Subject|7|||
129813858|NCT00481078|467284293|FG001|Overall Study|Withdrawal by Subject|1|||
129813859|NCT00481078|467284292|FG000|Overall Study|Information not available|1|||
129813860|NCT00481078|467284293|FG001|Overall Study|Information not available|0|||
129813861|NCT00481078|467284292|FG000|Overall Study|Received other treatment|2|||
129813862|NCT00481078|467284293|FG001|Overall Study|Received other treatment|1|||
129813863|NCT00481078|467284292|FG000|Overall Study|Brain metastasis|0|||
129813864|NCT00481078|467284293|FG001|Overall Study|Brain metastasis|1|||
129813865|NCT01558271|467284294|FG000|Overall Study|Adverse Event|6|||
129813866|NCT01558271|467284295|FG001|Overall Study|Adverse Event|3|||
129813867|NCT01558271|467284296|FG002|Overall Study|Adverse Event|4|||
129813868|NCT01558271|467284294|FG000|Overall Study|Lost to Follow-up|1|||
129813869|NCT01558271|467284295|FG001|Overall Study|Lost to Follow-up|0|||
129813870|NCT01558271|467284296|FG002|Overall Study|Lost to Follow-up|0|||
129813871|NCT01558271|467284294|FG000|Overall Study|Protocol Violation|1|||
129813872|NCT01558271|467284295|FG001|Overall Study|Protocol Violation|0|||
129813873|NCT01558271|467284296|FG002|Overall Study|Protocol Violation|0|||
129813874|NCT01558271|467284294|FG000|Overall Study|Withdrawal by Subject|10|||
129813875|NCT01558271|467284295|FG001|Overall Study|Withdrawal by Subject|6|||
129813876|NCT01558271|467284296|FG002|Overall Study|Withdrawal by Subject|12|||
129813877|NCT01558271|467284294|FG000|Overall Study|Physician Decision|0|||
129813878|NCT01558271|467284295|FG001|Overall Study|Physician Decision|2|||
129813879|NCT01558271|467284296|FG002|Overall Study|Physician Decision|1|||
129813880|NCT01845831|467284297|FG000|Inpatient Phase|Withdrawal by Subject|1|||
129813881|NCT01845831|467284298|FG001|Inpatient Phase|Withdrawal by Subject|1|||
129813882|NCT01845831|467284299|FG002|Inpatient Phase|Withdrawal by Subject|0|||
129813883|NCT01845831|467284300|FG003|Inpatient Phase|Withdrawal by Subject|0|||
129813884|NCT01845831|467284301|FG004|Inpatient Phase|Withdrawal by Subject|0|||
129813885|NCT00221403|467284302|FG000|Overall Study|Protocol Violation|1|||
129813886|NCT00221403|467284303|FG001|Overall Study|Protocol Violation|0|||
129813887|NCT00221403|467284304|FG002|Overall Study|Protocol Violation|0|||
129813888|NCT00221403|467284302|FG000|Overall Study|Physician Decision|1|||
129897050|NCT03568162|467582193|FG004|Overall Study|Others|2|||
129897051|NCT03568162|467582194|FG005|Overall Study|Others|1|||
129897052|NCT03717194|467582195|FG000|Overall Study|Withdrawal by Subject|2|||
129897053|NCT03717194|467582196|FG001|Overall Study|Withdrawal by Subject|4|||
129813889|NCT00221403|467284303|FG001|Overall Study|Physician Decision|0|||
129813890|NCT00221403|467284304|FG002|Overall Study|Physician Decision|0|||
129813891|NCT00221403|467284302|FG000|Overall Study|Withdrawal by Subject|0|||
129813892|NCT00221403|467284303|FG001|Overall Study|Withdrawal by Subject|3|||
129813893|NCT00221403|467284304|FG002|Overall Study|Withdrawal by Subject|0|||
129813894|NCT00221403|467284302|FG000|Overall Study|Lack of Efficacy|0|||
129813895|NCT00221403|467284303|FG001|Overall Study|Lack of Efficacy|1|||
129813896|NCT00221403|467284304|FG002|Overall Study|Lack of Efficacy|0|||
129813897|NCT00221403|467284302|FG000|Overall Study|Adverse Event|0|||
129813898|NCT00221403|467284303|FG001|Overall Study|Adverse Event|1|||
129813899|NCT00221403|467284304|FG002|Overall Study|Adverse Event|0|||
129813900|NCT02610725|467284305|FG000|Overall Study|Lost to Follow-up|197|||
129813901|NCT02610725|467284305|FG000|Overall Study|self-reported contraindication|9|||
129813902|NCT00826943|467284306|FG000|Overall Study|Withdrawal by Subject|0|||
129813903|NCT00826943|467284307|FG001|Overall Study|Withdrawal by Subject|0|||
129813904|NCT00826943|467284308|FG002|Overall Study|Withdrawal by Subject|0|||
129813905|NCT00826943|467284309|FG003|Overall Study|Withdrawal by Subject|0|||
129813906|NCT00826943|467284310|FG004|Overall Study|Withdrawal by Subject|1|||
129813907|NCT00826943|467284311|FG005|Overall Study|Withdrawal by Subject|0|||
129813908|NCT01348165|467284312|FG000|Overall Study|Adverse Event|0|||
129813909|NCT01348165|467284313|FG001|Overall Study|Adverse Event|0|||
129813910|NCT01348165|467284314|FG002|Overall Study|Adverse Event|0|||
129813911|NCT01348165|467284315|FG003|Overall Study|Adverse Event|0|||
129813912|NCT01348165|467284316|FG004|Overall Study|Adverse Event|0|||
129813913|NCT01348165|467284317|FG005|Overall Study|Adverse Event|0|||
129813914|NCT01348165|467284318|FG006|Overall Study|Adverse Event|1|||
129813915|NCT00074152|467284319|FG000|Overall Study|Death|21|||
129813916|NCT00074152|467284320|FG001|Overall Study|Death|9|||
129813917|NCT00074152|467284319|FG000|Overall Study|Lack of Efficacy|34|||
129813918|NCT00074152|467284320|FG001|Overall Study|Lack of Efficacy|24|||
129813919|NCT01063868|467284322|FG000|Overall Study|Adverse Event|9|||
129813920|NCT01063868|467284323|FG001|Overall Study|Adverse Event|7|||
129813921|NCT01063868|467284322|FG000|Overall Study|Withdrawal by Subject|3|||
129813922|NCT01063868|467284323|FG001|Overall Study|Withdrawal by Subject|1|||
129813923|NCT01063868|467284322|FG000|Overall Study|Study Terminated By Sponsor|23|||
129813924|NCT01063868|467284323|FG001|Overall Study|Study Terminated By Sponsor|4|||
129813925|NCT02469298|467286211|FG000|Overall Study|Protocol Violation|0|||
129813926|NCT02469298|467286212|FG001|Overall Study|Protocol Violation|1|||
129813927|NCT02469298|467286213|FG002|Overall Study|Protocol Violation|1|||
129813928|NCT02469298|467286214|FG003|Overall Study|Protocol Violation|0|||
129813929|NCT02469298|467286211|FG000|Overall Study|Lost to Follow-up|1|||
129813930|NCT02469298|467286212|FG001|Overall Study|Lost to Follow-up|0|||
129813931|NCT02469298|467286213|FG002|Overall Study|Lost to Follow-up|1|||
129813932|NCT02469298|467286214|FG003|Overall Study|Lost to Follow-up|0|||
129813933|NCT02469298|467286211|FG000|Overall Study|Physician Decision|0|||
129813934|NCT02469298|467286212|FG001|Overall Study|Physician Decision|0|||
129813935|NCT02469298|467286213|FG002|Overall Study|Physician Decision|0|||
129813936|NCT02469298|467286214|FG003|Overall Study|Physician Decision|1|||
129813937|NCT02469298|467286211|FG000|Overall Study|Withdrawal by Subject|0|||
129813938|NCT02469298|467286212|FG001|Overall Study|Withdrawal by Subject|0|||
129813939|NCT02469298|467286213|FG002|Overall Study|Withdrawal by Subject|0|||
129813940|NCT02469298|467286214|FG003|Overall Study|Withdrawal by Subject|1|||
129813941|NCT01664533|467286217|FG000|Overall Study|Death|42|||
129813942|NCT01664533|467286217|FG000|Overall Study|Lost to Follow-up|3|||
129813943|NCT01664533|467286217|FG000|Overall Study|Study termination|9|||
129813944|NCT01664533|467286217|FG000|Overall Study|Protocol Violation|3|||
129813945|NCT00290888|467286218|FG000|Overall Study|Physician Decision|3|||
129813946|NCT00290888|467286219|FG001|Overall Study|Physician Decision|1|||
129813947|NCT02397278|467286226|FG000|Overall Study|Withdrawal by Subject|0|||
129813948|NCT02397278|467286227|FG001|Overall Study|Withdrawal by Subject|2|||
129813949|NCT02397278|467286226|FG000|Overall Study|Deemed ineligible following surgery|1|||
129813950|NCT02397278|467286227|FG001|Overall Study|Deemed ineligible following surgery|1|||
129813951|NCT01397084|467286232|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
129813952|NCT01397084|467286232|FG000|Overall Study|Protocol Violation|2|||
129813953|NCT01397084|467286232|FG000|Overall Study|Adverse Event|2|||
129897054|NCT03717194|467582195|FG000|Overall Study|Adverse Event|1|||
129813954|NCT01397084|467286232|FG000|Overall Study|Withdrawal by Subject|1|||
129813955|NCT01397084|467286232|FG000|Overall Study|Lost to Follow-up|1|||
129813956|NCT01397084|467286232|FG000|Overall Study|Used other proton pump inhibitor|1|||
129813957|NCT02853604|467286233|FG000|Overall Study|Withdrawal by Subject|12|||
129897055|NCT03717194|467582196|FG001|Overall Study|Adverse Event|1|||
129897056|NCT02081391|467582198|FG000|12-hour Treatment|Withdrawal by Subject|3|||
129897057|NCT02081391|467582199|FG001|12-hour Treatment|Withdrawal by Subject|2|||
129897058|NCT02081391|467582200|FG002|12-hour Treatment|Withdrawal by Subject|0|||
129813958|NCT02853604|467286234|FG001|Overall Study|Withdrawal by Subject|35|||
129813959|NCT02853604|467286233|FG000|Overall Study|Lost to Follow-up|4|||
129813960|NCT02853604|467286234|FG001|Overall Study|Lost to Follow-up|8|||
129813961|NCT02853604|467286233|FG000|Overall Study|Death|1|||
129813962|NCT02853604|467286234|FG001|Overall Study|Death|5|||
129813963|NCT02853604|467286233|FG000|Overall Study|Miscellaneous|11|||
129813964|NCT02853604|467286234|FG001|Overall Study|Miscellaneous|2|||
129813965|NCT02853604|467286233|FG000|Overall Study|Progressive Disease|0|||
129813966|NCT02853604|467286234|FG001|Overall Study|Progressive Disease|2|||
129897059|NCT02081391|467582201|FG003|12-hour Treatment|Withdrawal by Subject|0|||
129813967|NCT04213079|467286235|FG000|Overall Study|Lost to Follow-up|0|||
129813968|NCT04213079|467286236|FG001|Overall Study|Lost to Follow-up|2|||
129813969|NCT04343261|467286237|FG000|Overall Study|Adverse Event|1|||
129813970|NCT04343261|467286237|FG000|Overall Study|received inadequate amount of antibodies|7|||
129813971|NCT05275400|467286241|FG000|Treatment Period|Adverse Event|7|||
129813972|NCT05275400|467286242|FG001|Treatment Period|Adverse Event|1|||
129813973|NCT05275400|467286241|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
129813974|NCT05275400|467286242|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
129813975|NCT05275400|467286241|FG000|Treatment Period|Death|5|||
129813976|NCT05275400|467286242|FG001|Treatment Period|Death|2|||
129813977|NCT05275400|467286241|FG000|Treatment Period|Protocol Violation|1|||
129813978|NCT05275400|467286242|FG001|Treatment Period|Protocol Violation|0|||
129813979|NCT05275400|467286241|FG000|Treatment Period|Physician Decision|5|||
129813980|NCT05275400|467286242|FG001|Treatment Period|Physician Decision|4|||
129813981|NCT05275400|467286241|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
129813982|NCT05275400|467286242|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
129813983|NCT05275400|467286241|FG000|Treatment Period|Withdrawal by Subject|30|||
129813984|NCT05275400|467286242|FG001|Treatment Period|Withdrawal by Subject|12|||
129813985|NCT05275400|467286241|FG000|Treatment Period|Lost to Follow-up|1|||
129813986|NCT05275400|467286242|FG001|Treatment Period|Lost to Follow-up|5|||
129813987|NCT05275400|467286241|FG000|Treatment Period|Lack of Efficacy|1|||
129813988|NCT05275400|467286242|FG001|Treatment Period|Lack of Efficacy|0|||
129813989|NCT05275400|467286241|FG000|Treatment Period|Sponsor Decision|1|||
129813990|NCT05275400|467286242|FG001|Treatment Period|Sponsor Decision|0|||
129813991|NCT05275400|467286241|FG000|Follow-Up Period|Death|2|||
129813992|NCT05275400|467286242|FG001|Follow-Up Period|Death|0|||
129813993|NCT05275400|467286241|FG000|Follow-Up Period|Protocol Violation|1|||
129813994|NCT05275400|467286242|FG001|Follow-Up Period|Protocol Violation|0|||
129813995|NCT05275400|467286241|FG000|Follow-Up Period|Withdrawal by Subject|3|||
129813996|NCT05275400|467286242|FG001|Follow-Up Period|Withdrawal by Subject|0|||
129813997|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Physician Decision|0|||
129813998|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Physician Decision|1|||
129813999|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Physician Decision|0|||
129814000|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
129814001|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
129814002|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
129814003|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
129814004|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
129814005|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
129814006|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Other|4|||
129814007|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Other|4|||
129814008|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Other|0|||
129814009|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
129814010|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
129814011|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
129814012|NCT02585960|467286243|FG000|PK/Safety Assessment Period|Screen Failure|0|||
129814013|NCT02585960|467286244|FG001|PK/Safety Assessment Period|Screen Failure|0|||
129814014|NCT02585960|467286245|FG002|PK/Safety Assessment Period|Screen Failure|1|||
129814015|NCT02585960|467286243|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
129814016|NCT02585960|467286244|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
129814017|NCT02585960|467286245|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
129814018|NCT02585960|467286243|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
129814019|NCT02585960|467286244|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
129814020|NCT02585960|467286245|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
129814021|NCT03639935|467286246|FG000|Overall Study|Death|3|||
129814022|NCT03639935|467286246|FG000|Overall Study|Adverse Event|1|||
129814023|NCT06333613|467286247|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
129814024|NCT03616600|467286249|FG000|Overall Study|Withdrawal by Subject|1|||
129814025|NCT03616600|467286250|FG001|Overall Study|Withdrawal by Subject|0|||
129814026|NCT03648541|467286251|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
129814027|NCT03648541|467286252|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
129814028|NCT03648541|467286251|FG000|Re-induction Period Only|Lack of Efficacy|7|||
129814029|NCT03648541|467286252|FG001|Re-induction Period Only|Lack of Efficacy|0|||
129814030|NCT03648541|467286251|FG000|Maintenance Period Only|Missing|0|||
129814031|NCT03648541|467286252|FG001|Maintenance Period Only|Missing|1|||
129814032|NCT03648541|467286251|FG000|Maintenance Period Only|Other not listed below|0|||
129814033|NCT03648541|467286252|FG001|Maintenance Period Only|Other not listed below|4|||
129814034|NCT03648541|467286251|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
129814035|NCT03648541|467286252|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
129814036|NCT03648541|467286251|FG000|Maintenance Period Only|Protocol Violation|0|||
129814037|NCT03648541|467286252|FG001|Maintenance Period Only|Protocol Violation|1|||
129814038|NCT03648541|467286251|FG000|Maintenance Period Only|Lack of Efficacy|0|||
129814039|NCT03648541|467286252|FG001|Maintenance Period Only|Lack of Efficacy|18|||
129814040|NCT03648541|467286251|FG000|Maintenance Period Only|Adverse Event|0|||
129814041|NCT03648541|467286252|FG001|Maintenance Period Only|Adverse Event|4|||
129814042|NCT03648541|467286251|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
129814043|NCT03648541|467286252|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
129814044|NCT04623216|467286255|FG000|Overall Study|Death|5|||
129814045|NCT04623216|467286256|FG001|Overall Study|Death|2|||
129814046|NCT04623216|467286257|FG002|Overall Study|Death|0|||
129814047|NCT04623216|467286258|FG003|Overall Study|Death|0|||
129814048|NCT04623216|467286255|FG000|Overall Study|Terminated by Sponsor|3|||
129814049|NCT04623216|467286256|FG001|Overall Study|Terminated by Sponsor|2|||
129814050|NCT04623216|467286257|FG002|Overall Study|Terminated by Sponsor|2|||
129814051|NCT04623216|467286258|FG003|Overall Study|Terminated by Sponsor|0|||
129814052|NCT04623216|467286255|FG000|Overall Study|Physician Decision|1|||
129814053|NCT04623216|467286256|FG001|Overall Study|Physician Decision|0|||
129814054|NCT04623216|467286257|FG002|Overall Study|Physician Decision|0|||
129814055|NCT04623216|467286258|FG003|Overall Study|Physician Decision|0|||
129814056|NCT01651039|467286259|FG000|Overall Study|Non-evaluables|5|||
129814057|NCT01651039|467286259|FG000|Overall Study|Physician Decision|2|||
129814058|NCT01651039|467286259|FG000|Overall Study|Withdrawal by Subject|1|||
129814059|NCT01651039|467286259|FG000|Overall Study|Progressive Disease|22|||
129814060|NCT02059395|467286260|FG000|Overall Study|Lost to Follow-up|2|||
129814061|NCT02059395|467286261|FG001|Overall Study|Lost to Follow-up|4|||
129814062|NCT00134082|467286262|FG000|Overall Study|Adverse Event|2|||
129814063|NCT00134082|467286262|FG000|Overall Study|Death|1|||
129814064|NCT01488370|467286263|FG000|Overall Study|Protocol Violation|0|||
129814065|NCT01488370|467286264|FG001|Overall Study|Protocol Violation|1|||
129814066|NCT01488370|467286265|FG002|Overall Study|Protocol Violation|1|||
129814067|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
129814068|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
129814069|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
129814070|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
129814071|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
129814072|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
129814073|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
129814074|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
129814075|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
129814076|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
129814077|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
129814078|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
129814079|NCT00044083|467286266|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
129814080|NCT00044083|467286267|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
129814081|NCT00044083|467286266|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
129814082|NCT00044083|467286267|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
129814083|NCT00044083|467286266|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
129814084|NCT00044083|467286267|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
129814085|NCT00044083|467286266|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
129814086|NCT00044083|467286267|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
129814087|NCT00119106|467286270|FG000|Overall Study|HIV infected at baseline|179|||
129814088|NCT00119106|467286271|FG001|Overall Study|HIV infected at baseline|178|||
129814089|NCT03066804|467286272|FG000|Overall Study|Physician Decision|0|||
129814090|NCT03066804|467286273|FG001|Overall Study|Physician Decision|4|||
129814091|NCT03066804|467286272|FG000|Overall Study|Death|23|||
129814092|NCT03066804|467286273|FG001|Overall Study|Death|17|||
129814093|NCT03066804|467286272|FG000|Overall Study|Withdrawal by Subject|19|||
129814094|NCT03066804|467286273|FG001|Overall Study|Withdrawal by Subject|25|||
129814095|NCT03066804|467286272|FG000|Overall Study|Lost to Follow-up|2|||
129814096|NCT03066804|467286273|FG001|Overall Study|Lost to Follow-up|0|||
129814097|NCT03066804|467286272|FG000|Overall Study|Adverse Event|2|||
129814098|NCT03066804|467286273|FG001|Overall Study|Adverse Event|3|||
129814099|NCT03066804|467286272|FG000|Overall Study|Technical problems|5|||
129814100|NCT03066804|467286273|FG001|Overall Study|Technical problems|1|||
129814101|NCT00329238|467286274|FG000|Overall Study|Adverse Event|147|||
129814102|NCT00329238|467286275|FG001|Overall Study|Adverse Event|129|||
129814103|NCT00329238|467286274|FG000|Overall Study|Protocol Violation|23|||
129814104|NCT00329238|467286275|FG001|Overall Study|Protocol Violation|34|||
129814105|NCT00329238|467286274|FG000|Overall Study|Lost to Follow-up|2|||
129814106|NCT00329238|467286275|FG001|Overall Study|Lost to Follow-up|6|||
129814107|NCT00329238|467286274|FG000|Overall Study|Withdrawal by Subject|64|||
129814108|NCT00329238|467286275|FG001|Overall Study|Withdrawal by Subject|58|||
129814109|NCT00329238|467286274|FG000|Overall Study|Other reason (not specified)|40|||
129814110|NCT00329238|467286275|FG001|Overall Study|Other reason (not specified)|54|||
129814111|NCT05393895|467286278|FG000|Overall Study|Adverse Event|2|||
129814112|NCT05393895|467286279|FG001|Overall Study|Adverse Event|3|||
129814113|NCT05393895|467286278|FG000|Overall Study|Lost to Follow-up|4|||
129814114|NCT05393895|467286279|FG001|Overall Study|Lost to Follow-up|3|||
129814115|NCT05393895|467286278|FG000|Overall Study|Protocol Violation|1|||
129814116|NCT05393895|467286279|FG001|Overall Study|Protocol Violation|0|||
129814117|NCT05393895|467286278|FG000|Overall Study|Withdrawal by Subject|1|||
129814118|NCT05393895|467286279|FG001|Overall Study|Withdrawal by Subject|4|||
129814119|NCT05537883|467286282|FG000|Overall Study|revisional surgery|4|||
129814120|NCT05537883|467286283|FG001|Overall Study|revisional surgery|2|||
129814121|NCT05537883|467286282|FG000|Overall Study|surgeries were cancelled|0|||
129814122|NCT05537883|467286283|FG001|Overall Study|surgeries were cancelled|2|||
129814123|NCT05537883|467286282|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
129814124|NCT05537883|467286283|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
129814125|NCT01328431|467286284|FG000|Baseline|Protocol Violation|0|||
129814126|NCT01328431|467286285|FG001|Baseline|Protocol Violation|2|||
129814127|NCT01328431|467286284|FG000|1 Month (1M)|Lost to Follow-up|55|||
129814128|NCT01328431|467286285|FG001|1 Month (1M)|Lost to Follow-up|58|||
129814129|NCT01328431|467286284|FG000|3 Month (3M)|Death|2|||
129814130|NCT01328431|467286285|FG001|3 Month (3M)|Death|2|||
129814131|NCT01328431|467286284|FG000|3 Month (3M)|Lost to Follow-up|75|||
129814132|NCT01328431|467286285|FG001|3 Month (3M)|Lost to Follow-up|70|||
129814133|NCT01328431|467286284|FG000|12 Month (12M)|Death|2|||
129814134|NCT01328431|467286285|FG001|12 Month (12M)|Death|6|||
129814135|NCT01328431|467286284|FG000|12 Month (12M)|Lost to Follow-up|82|||
129814136|NCT01328431|467286285|FG001|12 Month (12M)|Lost to Follow-up|91|||
129814137|NCT02296320|467286292|FG000|Overall Study|Withdrawal by Subject|4|||
129814138|NCT02296320|467286293|FG001|Overall Study|Withdrawal by Subject|0|||
129814139|NCT02296320|467286294|FG002|Overall Study|Withdrawal by Subject|2|||
129814140|NCT02296320|467286292|FG000|Overall Study|Death|24|||
129814141|NCT02296320|467286293|FG001|Overall Study|Death|3|||
129814142|NCT02296320|467286294|FG002|Overall Study|Death|27|||
129814143|NCT02296320|467286292|FG000|Overall Study|Lost to Follow-up|5|||
129814144|NCT02296320|467286293|FG001|Overall Study|Lost to Follow-up|2|||
129814145|NCT02296320|467286294|FG002|Overall Study|Lost to Follow-up|7|||
129814146|NCT02296320|467286292|FG000|Overall Study|Not treated|2|||
129814147|NCT02296320|467286293|FG001|Overall Study|Not treated|0|||
129814148|NCT02296320|467286294|FG002|Overall Study|Not treated|0|||
129814149|NCT02296320|467286292|FG000|Overall Study|Not - specified|0|||
129814150|NCT02296320|467286293|FG001|Overall Study|Not - specified|0|||
129814151|NCT02296320|467286294|FG002|Overall Study|Not - specified|1|||
129814152|NCT03310021|467286298|FG000|Overall Study|Withdrawal by Subject|0|||
129814153|NCT03310021|467286299|FG001|Overall Study|Withdrawal by Subject|0|||
129814154|NCT03310021|467286300|FG002|Overall Study|Withdrawal by Subject|0|||
129814155|NCT03310021|467286301|FG003|Overall Study|Withdrawal by Subject|0|||
129814156|NCT03310021|467286302|FG004|Overall Study|Withdrawal by Subject|0|||
129814157|NCT03310021|467286303|FG005|Overall Study|Withdrawal by Subject|0|||
129814158|NCT03310021|467286304|FG006|Overall Study|Withdrawal by Subject|1|||
129814159|NCT03310021|467286305|FG007|Overall Study|Withdrawal by Subject|0|||
129814160|NCT03310021|467286306|FG008|Overall Study|Withdrawal by Subject|0|||
129814161|NCT03310021|467286307|FG009|Overall Study|Withdrawal by Subject|0|||
129814162|NCT03310021|467286308|FG010|Overall Study|Withdrawal by Subject|0|||
129814163|NCT03310021|467286309|FG011|Overall Study|Withdrawal by Subject|0|||
129814164|NCT03310021|467286310|FG012|Overall Study|Withdrawal by Subject|0|||
129814165|NCT03310021|467286311|FG013|Overall Study|Withdrawal by Subject|0|||
129814166|NCT03310021|467286312|FG014|Overall Study|Withdrawal by Subject|0|||
129814167|NCT03310021|467286313|FG015|Overall Study|Withdrawal by Subject|0|||
129814168|NCT03310021|467286314|FG016|Overall Study|Withdrawal by Subject|0|||
129814169|NCT03310021|467286315|FG017|Overall Study|Withdrawal by Subject|0|||
129814170|NCT03310021|467286316|FG018|Overall Study|Withdrawal by Subject|0|||
129814171|NCT03310021|467286317|FG019|Overall Study|Withdrawal by Subject|0|||
129814172|NCT03310021|467286298|FG000|Overall Study|Lost to Follow-up|0|||
129814173|NCT03310021|467286299|FG001|Overall Study|Lost to Follow-up|0|||
129814174|NCT03310021|467286300|FG002|Overall Study|Lost to Follow-up|0|||
129814175|NCT03310021|467286301|FG003|Overall Study|Lost to Follow-up|0|||
129814176|NCT03310021|467286302|FG004|Overall Study|Lost to Follow-up|0|||
129814177|NCT03310021|467286303|FG005|Overall Study|Lost to Follow-up|0|||
129814178|NCT03310021|467286304|FG006|Overall Study|Lost to Follow-up|0|||
129814179|NCT03310021|467286305|FG007|Overall Study|Lost to Follow-up|0|||
129814180|NCT03310021|467286306|FG008|Overall Study|Lost to Follow-up|0|||
129814181|NCT03310021|467286307|FG009|Overall Study|Lost to Follow-up|0|||
129814182|NCT03310021|467286308|FG010|Overall Study|Lost to Follow-up|1|||
129814183|NCT03310021|467286309|FG011|Overall Study|Lost to Follow-up|0|||
129814184|NCT03310021|467286310|FG012|Overall Study|Lost to Follow-up|0|||
129814185|NCT03310021|467286311|FG013|Overall Study|Lost to Follow-up|0|||
129814186|NCT03310021|467286312|FG014|Overall Study|Lost to Follow-up|0|||
129814187|NCT03310021|467286313|FG015|Overall Study|Lost to Follow-up|0|||
129814188|NCT03310021|467286314|FG016|Overall Study|Lost to Follow-up|0|||
129814189|NCT03310021|467286315|FG017|Overall Study|Lost to Follow-up|0|||
129814190|NCT03310021|467286316|FG018|Overall Study|Lost to Follow-up|0|||
129814191|NCT03310021|467286317|FG019|Overall Study|Lost to Follow-up|0|||
129814192|NCT01427972|467286328|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814193|NCT01427972|467286329|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129897060|NCT02081391|467582198|FG000|12-hour Treatment|Physician Decision|4|||
129897061|NCT02081391|467582199|FG001|12-hour Treatment|Physician Decision|1|||
129814194|NCT01427972|467286330|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814195|NCT01427972|467286331|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814196|NCT01427972|467286332|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814197|NCT01427972|467286333|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814198|NCT01427972|467286334|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814199|NCT01427972|467286335|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
129814200|NCT01427972|467286336|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814201|NCT01427972|467286337|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814202|NCT01427972|467286338|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814203|NCT01427972|467286339|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
129814204|NCT01427972|467286328|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814205|NCT01427972|467286329|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814206|NCT01427972|467286330|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814207|NCT01427972|467286331|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814208|NCT01427972|467286332|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814209|NCT01427972|467286333|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
129814210|NCT01427972|467286334|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814211|NCT01427972|467286335|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814212|NCT01427972|467286336|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814213|NCT01427972|467286337|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814214|NCT01427972|467286338|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814215|NCT01427972|467286339|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
129814216|NCT01427972|467286328|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814217|NCT01427972|467286329|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
129814218|NCT01427972|467286330|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814219|NCT01427972|467286331|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814220|NCT01427972|467286332|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814221|NCT01427972|467286333|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814222|NCT01427972|467286334|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814223|NCT01427972|467286335|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814224|NCT01427972|467286336|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814225|NCT01427972|467286337|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814226|NCT01427972|467286338|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814227|NCT01427972|467286339|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
129814228|NCT00799422|467286343|FG000|First Week of Wear|Lost to Follow-up|0|||
129814229|NCT00799422|467286344|FG001|First Week of Wear|Lost to Follow-up|0|||
129814230|NCT00799422|467286345|FG002|First Week of Wear|Lost to Follow-up|1|||
129814231|NCT00799422|467286346|FG003|First Week of Wear|Lost to Follow-up|0|||
129814232|NCT00799422|467286347|FG004|First Week of Wear|Lost to Follow-up|0|||
129814233|NCT00799422|467286348|FG005|First Week of Wear|Lost to Follow-up|0|||
129814234|NCT00799422|467286343|FG000|First Week of Wear|Adverse Event|0|||
129814235|NCT00799422|467286344|FG001|First Week of Wear|Adverse Event|0|||
129814236|NCT00799422|467286345|FG002|First Week of Wear|Adverse Event|0|||
129814237|NCT00799422|467286346|FG003|First Week of Wear|Adverse Event|1|||
129814238|NCT00799422|467286347|FG004|First Week of Wear|Adverse Event|0|||
129814239|NCT00799422|467286348|FG005|First Week of Wear|Adverse Event|0|||
129814240|NCT00530946|467286349|FG000|Overall Study|Adverse Event|1|||
129814241|NCT00530946|467286350|FG001|Overall Study|Adverse Event|2|||
129814242|NCT00530946|467286351|FG002|Overall Study|Adverse Event|1|||
129814243|NCT00530946|467286352|FG003|Overall Study|Adverse Event|1|||
129814244|NCT00530946|467286349|FG000|Overall Study|Protocol Violation|0|||
129814245|NCT00530946|467286350|FG001|Overall Study|Protocol Violation|0|||
129814246|NCT00530946|467286351|FG002|Overall Study|Protocol Violation|0|||
129814247|NCT00530946|467286352|FG003|Overall Study|Protocol Violation|1|||
129814248|NCT00530946|467286349|FG000|Overall Study|Noncompliance|1|||
129814249|NCT00530946|467286350|FG001|Overall Study|Noncompliance|0|||
129814250|NCT00530946|467286351|FG002|Overall Study|Noncompliance|0|||
129814251|NCT00530946|467286352|FG003|Overall Study|Noncompliance|0|||
129814252|NCT00622284|467286353|FG000|Overall Study|Lack of Efficacy|45|||
129814253|NCT00622284|467286354|FG001|Overall Study|Lack of Efficacy|15|||
129814254|NCT00622284|467286353|FG000|Overall Study|Adverse Event|61|||
129814255|NCT00622284|467286354|FG001|Overall Study|Adverse Event|90|||
129814256|NCT00622284|467286353|FG000|Overall Study|Protocol Violation|12|||
129814257|NCT00622284|467286354|FG001|Overall Study|Protocol Violation|5|||
129814258|NCT00622284|467286353|FG000|Overall Study|Lost to Follow-up|11|||
129814259|NCT00622284|467286354|FG001|Overall Study|Lost to Follow-up|13|||
129814260|NCT00622284|467286353|FG000|Overall Study|Withdrawal by Subject|27|||
129814261|NCT00622284|467286354|FG001|Overall Study|Withdrawal by Subject|24|||
129814262|NCT00622284|467286353|FG000|Overall Study|Other reason (not specified)|33|||
129814263|NCT00622284|467286354|FG001|Overall Study|Other reason (not specified)|24|||
129814264|NCT00880009|467286355|FG000|Overall Study|Study terminated by sponsor|14|||
129814265|NCT00880009|467286355|FG000|Overall Study|Withdrawal by Subject|1|||
129814266|NCT00880009|467286355|FG000|Overall Study|Protocol Violation|1|||
129814267|NCT02412618|467286358|FG000|Overall Study|Withdrawal by Subject|1|||
129814268|NCT02412618|467286359|FG001|Overall Study|Withdrawal by Subject|1|||
129814269|NCT02412618|467286358|FG000|Overall Study|Expulsion|1|||
129814270|NCT02412618|467286359|FG001|Overall Study|Expulsion|1|||
129814271|NCT01253408|467286361|FG000|Overall Study|Adverse Event|0|||
129814272|NCT01253408|467286362|FG001|Overall Study|Adverse Event|1|||
129814273|NCT01253408|467286363|FG002|Overall Study|Adverse Event|0|||
129814274|NCT00629707|467286367|FG000|Overall Study|Withdrawal by Subject|0|||
129814275|NCT00629707|467286368|FG001|Overall Study|Withdrawal by Subject|1|||
129814276|NCT00629707|467286367|FG000|Overall Study|Physician Decision|0|||
129814277|NCT00629707|467286368|FG001|Overall Study|Physician Decision|1|||
129814278|NCT03736447|467286369|FG000|Overall Study|Adverse Event|5|||
129814279|NCT03736447|467286370|FG001|Overall Study|Adverse Event|1|||
129814280|NCT03736447|467286369|FG000|Overall Study|Withdrawal by Subject|5|||
129814281|NCT03736447|467286370|FG001|Overall Study|Withdrawal by Subject|1|||
129814282|NCT03736447|467286369|FG000|Overall Study|Lost to Follow-up|1|||
129814283|NCT03736447|467286370|FG001|Overall Study|Lost to Follow-up|0|||
129814284|NCT03736447|467286369|FG000|Overall Study|Physician Decision|1|||
129814285|NCT03736447|467286370|FG001|Overall Study|Physician Decision|0|||
129814286|NCT03736447|467286369|FG000|Overall Study|Continued commitment to study treatment|3|||
129814287|NCT03736447|467286370|FG001|Overall Study|Continued commitment to study treatment|0|||
129814288|NCT03736447|467286369|FG000|Overall Study|Taste aversion to study product|0|||
129814289|NCT03736447|467286370|FG001|Overall Study|Taste aversion to study product|1|||
129814290|NCT02619175|467286371|FG000|Overall Study|Withdrawal by Subject|1|||
129814291|NCT02619175|467286372|FG001|Overall Study|Withdrawal by Subject|0|||
129814292|NCT02619175|467286371|FG000|Overall Study|foot pain|1|||
129814293|NCT02619175|467286372|FG001|Overall Study|foot pain|0|||
129814294|NCT02657369|467286373|FG000|Overall Study|Death|27|||
129814295|NCT02657369|467286373|FG000|Overall Study|Study terminated by sponsor|7|||
129814296|NCT01594762|467286374|FG000|Overall Study|Withdrawal by Subject|1|||
129814297|NCT01594762|467286375|FG001|Overall Study|Withdrawal by Subject|0|||
129814298|NCT01594762|467286374|FG000|Overall Study|Lost to Follow-up|10|||
129814299|NCT01594762|467286375|FG001|Overall Study|Lost to Follow-up|10|||
129814300|NCT03547583|467286376|FG000|Overall Study|Adverse Event|16|||
129897062|NCT02081391|467582200|FG002|12-hour Treatment|Physician Decision|0|||
129814301|NCT03547583|467286377|FG001|Overall Study|Adverse Event|11|||
129814302|NCT03547583|467286378|FG002|Overall Study|Adverse Event|10|||
129814303|NCT03547583|467286376|FG000|Overall Study|Death|11|||
129814304|NCT03547583|467286377|FG001|Overall Study|Death|7|||
129814305|NCT03547583|467286378|FG002|Overall Study|Death|4|||
129814306|NCT03547583|467286376|FG000|Overall Study|Lost to Follow-up|1|||
129814307|NCT03547583|467286377|FG001|Overall Study|Lost to Follow-up|0|||
129814308|NCT03547583|467286378|FG002|Overall Study|Lost to Follow-up|0|||
129814309|NCT03547583|467286376|FG000|Overall Study|Non-compliance with study drug|0|||
129814310|NCT03547583|467286377|FG001|Overall Study|Non-compliance with study drug|0|||
129814311|NCT03547583|467286378|FG002|Overall Study|Non-compliance with study drug|1|||
129814312|NCT03547583|467286376|FG000|Overall Study|Physician Decision|1|||
129814313|NCT03547583|467286377|FG001|Overall Study|Physician Decision|0|||
129814314|NCT03547583|467286378|FG002|Overall Study|Physician Decision|3|||
129814315|NCT03547583|467286376|FG000|Overall Study|Protocol Violation|2|||
129814316|NCT03547583|467286377|FG001|Overall Study|Protocol Violation|1|||
129814317|NCT03547583|467286378|FG002|Overall Study|Protocol Violation|1|||
129814318|NCT03547583|467286376|FG000|Overall Study|Withdrawal by Subject|12|||
129814319|NCT03547583|467286377|FG001|Overall Study|Withdrawal by Subject|19|||
129814320|NCT03547583|467286378|FG002|Overall Study|Withdrawal by Subject|10|||
129814321|NCT03547583|467286376|FG000|Overall Study|Other|2|||
129814322|NCT03547583|467286377|FG001|Overall Study|Other|2|||
129814323|NCT03547583|467286378|FG002|Overall Study|Other|3|||
129814324|NCT00382252|467286379|FG000|Overall Study|Death|4|||
129814325|NCT00382252|467286379|FG000|Overall Study|Protocol Violation|8|||
129897063|NCT02081391|467582201|FG003|12-hour Treatment|Physician Decision|0|||
129897064|NCT02081391|467582198|FG000|12-hour Treatment|Lack of Efficacy|3|||
129897065|NCT02081391|467582199|FG001|12-hour Treatment|Lack of Efficacy|0|||
129897066|NCT02081391|467582200|FG002|12-hour Treatment|Lack of Efficacy|0|||
129897067|NCT02081391|467582201|FG003|12-hour Treatment|Lack of Efficacy|0|||
129897068|NCT02081391|467582198|FG000|12-hour Treatment|Adverse Event|4|||
129897069|NCT02081391|467582199|FG001|12-hour Treatment|Adverse Event|2|||
129897070|NCT02081391|467582200|FG002|12-hour Treatment|Adverse Event|0|||
129897071|NCT02081391|467582201|FG003|12-hour Treatment|Adverse Event|0|||
129814326|NCT00382252|467286379|FG000|Overall Study|Not treated by RFA|1|||
129814327|NCT05570500|467286385|FG000|Overall Study|Lost to Follow-up|7|||
129814328|NCT05570500|467286386|FG001|Overall Study|Lost to Follow-up|5|||
129814329|NCT04706091|467286387|FG000|Treatment 2|Withdrawal by Subject|1|||
129814330|NCT04706091|467286388|FG001|Treatment 2|Withdrawal by Subject|0|||
129814331|NCT02612727|467286389|FG000|Overall Study|Parent request|4|||
129814332|NCT02612727|467286390|FG001|Overall Study|Parent request|1|||
129814333|NCT02612727|467286389|FG000|Overall Study|Needed treatment incompatible with PT|1|||
129814334|NCT02612727|467286390|FG001|Overall Study|Needed treatment incompatible with PT|1|||
129814335|NCT02612727|467286389|FG000|Overall Study|Direct hyperbilirubinemia|0|||
129814336|NCT02612727|467286390|FG001|Overall Study|Direct hyperbilirubinemia|2|||
129814337|NCT01446289|467286391|FG000|Overall Study|Withdrawal by Subject|1|||
129814338|NCT01446289|467286392|FG001|Overall Study|Withdrawal by Subject|0|||
129814339|NCT01446289|467286393|FG002|Overall Study|Withdrawal by Subject|1|||
129814340|NCT01446289|467286394|FG003|Overall Study|Withdrawal by Subject|0|||
129814341|NCT02302807|467286395|FG000|Overall Study|Withdrawal by Subject|28|||
129814342|NCT02302807|467286396|FG001|Overall Study|Withdrawal by Subject|11|||
129814343|NCT02302807|467286395|FG000|Overall Study|Lost to Follow-up|4|||
129814344|NCT02302807|467286396|FG001|Overall Study|Lost to Follow-up|6|||
129814345|NCT02302807|467286395|FG000|Overall Study|Death|397|||
129814346|NCT02302807|467286396|FG001|Overall Study|Death|385|||
129814347|NCT02302807|467286395|FG000|Overall Study|Study Terminated By Sponsor|35|||
129814348|NCT02302807|467286396|FG001|Overall Study|Study Terminated By Sponsor|64|||
129814349|NCT02302807|467286395|FG000|Overall Study|Physician Decision|0|||
129814350|NCT02302807|467286396|FG001|Overall Study|Physician Decision|1|||
129814351|NCT05243641|467286397|FG000|Overall Study|Adverse Event|3|||
129814352|NCT05243641|467286398|FG001|Overall Study|Adverse Event|0|||
129814353|NCT05243641|467286399|FG002|Overall Study|Adverse Event|0|||
129814354|NCT05243641|467286400|FG003|Overall Study|Adverse Event|1|||
129814355|NCT05243641|467286401|FG004|Overall Study|Adverse Event|0|||
129814356|NCT05243641|467286402|FG005|Overall Study|Adverse Event|0|||
129814357|NCT05243641|467286397|FG000|Overall Study|Disease progression|4|||
129814358|NCT05243641|467286398|FG001|Overall Study|Disease progression|0|||
129814359|NCT05243641|467286399|FG002|Overall Study|Disease progression|0|||
129814360|NCT05243641|467286400|FG003|Overall Study|Disease progression|2|||
129814361|NCT05243641|467286401|FG004|Overall Study|Disease progression|0|||
129814362|NCT05243641|467286402|FG005|Overall Study|Disease progression|0|||
129814363|NCT04518306|467286403|FG000|Double-Blind Period|Run in failure|0|||
129814364|NCT04518306|467286404|FG001|Double-Blind Period|Run in failure|0|||
129814365|NCT04518306|467286405|FG002|Double-Blind Period|Run in failure|1|||
129814366|NCT04518306|467286403|FG000|Double-Blind Period|Adverse Event|0|||
129814367|NCT04518306|467286404|FG001|Double-Blind Period|Adverse Event|2|||
129814368|NCT04518306|467286405|FG002|Double-Blind Period|Adverse Event|2|||
129814369|NCT04518306|467286403|FG000|Double-Blind Period|Lost to Follow-up|1|||
129814370|NCT04518306|467286404|FG001|Double-Blind Period|Lost to Follow-up|2|||
129814371|NCT04518306|467286405|FG002|Double-Blind Period|Lost to Follow-up|2|||
129814372|NCT04518306|467286403|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
129814373|NCT04518306|467286404|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
129814374|NCT04518306|467286405|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
129814375|NCT04518306|467286403|FG000|Double-Blind Period|Other|0|||
129814376|NCT04518306|467286404|FG001|Double-Blind Period|Other|2|||
129814377|NCT04518306|467286405|FG002|Double-Blind Period|Other|0|||
129814378|NCT04518306|467286403|FG000|Double-Blind Period|Missing|0|||
129814379|NCT04518306|467286404|FG001|Double-Blind Period|Missing|1|||
129814380|NCT04518306|467286405|FG002|Double-Blind Period|Missing|0|||
129814381|NCT03904043|467286406|FG000|Overall Study|Adverse Event|1|||
129814382|NCT03904043|467286407|FG001|Overall Study|Adverse Event|1|||
129814383|NCT03904043|467286406|FG000|Overall Study|Withdrawal by Subject|1|||
129814384|NCT03904043|467286407|FG001|Overall Study|Withdrawal by Subject|0|||
129814385|NCT03904043|467286406|FG000|Overall Study|Non-compliance|1|||
129814386|NCT03904043|467286407|FG001|Overall Study|Non-compliance|0|||
129814387|NCT03904043|467286406|FG000|Overall Study|Did not start treatment|1|||
129814388|NCT03904043|467286407|FG001|Overall Study|Did not start treatment|0|||
129814389|NCT04487730|467288277|FG000|Overall Study|Withdrawal by Subject|3|||
129814390|NCT04487730|467288278|FG001|Overall Study|Withdrawal by Subject|1|||
129814391|NCT04487730|467288277|FG000|Overall Study|Lost to Follow-up|0|||
129814392|NCT04487730|467288278|FG001|Overall Study|Lost to Follow-up|1|||
129814393|NCT04487730|467288277|FG000|Overall Study|Physician Decision|0|||
129814394|NCT04487730|467288278|FG001|Overall Study|Physician Decision|1|||
129814395|NCT01473836|467288279|FG000|Overall Study|Adverse Event|4|||
129814396|NCT01473836|467288279|FG000|Overall Study|Lack of Efficacy|1|||
129814397|NCT01473836|467288279|FG000|Overall Study|Does not meet entrance criteria|1|||
129814398|NCT03291808|467288280|FG000|Overall Study|Lost to Follow-up|6|||
129814399|NCT03291808|467288280|FG000|Overall Study|Research burden|4|||
129814400|NCT03364023|467288281|FG000|Overall Study|Lost to Follow-up|3|||
129814401|NCT03364023|467288281|FG000|Overall Study|Death|14|||
129814402|NCT01892293|467288282|FG000|Overall Study|Apheresed but not treated|4|||
129814403|NCT03602482|467288283|FG000|Overall Study|Withdrawal by Subject|6|||
129814404|NCT03602482|467288284|FG001|Overall Study|Withdrawal by Subject|7|||
129814405|NCT03602482|467288285|FG002|Overall Study|Withdrawal by Subject|0|||
129814406|NCT03602482|467288286|FG003|Overall Study|Withdrawal by Subject|0|||
129814407|NCT02601469|467288287|FG000|Overall Study|Enrolled in Error|1|||
129814408|NCT02601469|467288288|FG001|Overall Study|Enrolled in Error|0|||
129814409|NCT04980040|467288289|FG000|Overall Study|Violated the Inclusion Criteria|260|||
129814410|NCT04980040|467288289|FG000|Overall Study|Violated the Administration & Dosage|225|||
129814411|NCT04980040|467288289|FG000|Overall Study|Lost to Safety-Follow-up|4|||
129814412|NCT04980040|467288289|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
129814413|NCT00618072|467288295|FG000|Overall Study|Lost to Follow-up|2|||
129814414|NCT00618072|467288296|FG001|Overall Study|Lost to Follow-up|0|||
129814415|NCT00618072|467288297|FG002|Overall Study|Lost to Follow-up|3|||
129814416|NCT00618072|467288295|FG000|Overall Study|Physician Decision|0|||
129897072|NCT02081391|467582198|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
129897073|NCT02081391|467582199|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
129897074|NCT02081391|467582200|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
129897075|NCT02081391|467582201|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
129897076|NCT02081391|467582198|FG000|12-hour Treatment|Further reasons|2|||
129814417|NCT00618072|467288296|FG001|Overall Study|Physician Decision|1|||
129814418|NCT00618072|467288297|FG002|Overall Study|Physician Decision|1|||
129814419|NCT03292588|467288298|FG000|Overall Study|Death|1|||
129814420|NCT03292588|467288299|FG001|Overall Study|Death|0|||
129814421|NCT03292588|467288298|FG000|Overall Study|Lost to Follow-up|12|||
129814422|NCT03292588|467288299|FG001|Overall Study|Lost to Follow-up|16|||
129814423|NCT03292588|467288298|FG000|Overall Study|Physician Decision|0|||
129814424|NCT03292588|467288299|FG001|Overall Study|Physician Decision|1|||
129814425|NCT03292588|467288298|FG000|Overall Study|Withdrawal by Subject|4|||
129814426|NCT03292588|467288299|FG001|Overall Study|Withdrawal by Subject|4|||
129814427|NCT03292588|467288298|FG000|Overall Study|Move out of town|1|||
129814428|NCT03292588|467288299|FG001|Overall Study|Move out of town|0|||
129814429|NCT03292588|467288298|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
129814430|NCT03292588|467288299|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
129814431|NCT00062374|467288300|FG000|Overall Study|Not treated|12|||
129814432|NCT03633695|467288303|FG000|Overall Study|Lost to Follow-up|4|||
129814433|NCT03633695|467288304|FG001|Overall Study|Lost to Follow-up|5|||
129814434|NCT03633695|467288303|FG000|Overall Study|Discontinued|8|||
129814435|NCT03633695|467288304|FG001|Overall Study|Discontinued|4|||
129814436|NCT00617773|467288312|FG000|Overall Study|Physician Decision|1|||
129814437|NCT00617773|467288312|FG000|Overall Study|Lack of compliance with the protocol|1|||
129814438|NCT00617773|467288312|FG000|Overall Study|Withdrawal by Subject|1|||
129814439|NCT00617773|467288312|FG000|Overall Study|Death|1|||
129814440|NCT00617773|467288312|FG000|Overall Study|Progressive disease|19|||
129814441|NCT00617773|467288312|FG000|Overall Study|Protocol Violation|1|||
129814442|NCT01751867|467288313|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
129814443|NCT01751867|467288314|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
129814444|NCT01751867|467288313|FG000|Overall Study|Diease Progression|4|||
129814445|NCT01751867|467288314|FG001|Overall Study|Diease Progression|18|||
129814446|NCT01751867|467288313|FG000|Overall Study|Adverse Event|8|||
129814447|NCT01751867|467288314|FG001|Overall Study|Adverse Event|15|||
129814448|NCT01751867|467288313|FG000|Overall Study|Poor Compliance|0|||
129814449|NCT01751867|467288314|FG001|Overall Study|Poor Compliance|5|||
129814450|NCT01751867|467288313|FG000|Overall Study|Withdrawal by Subject|3|||
129814451|NCT01751867|467288314|FG001|Overall Study|Withdrawal by Subject|1|||
129814452|NCT01751867|467288313|FG000|Overall Study|Physician Decision|4|||
129814453|NCT01751867|467288314|FG001|Overall Study|Physician Decision|7|||
129814454|NCT01751867|467288313|FG000|Overall Study|Protocol Violation|0|||
129814455|NCT01751867|467288314|FG001|Overall Study|Protocol Violation|2|||
129814456|NCT01751867|467288313|FG000|Overall Study|Death|0|||
129814457|NCT01751867|467288314|FG001|Overall Study|Death|5|||
129814458|NCT01751867|467288313|FG000|Overall Study|Other|11|||
129814459|NCT01751867|467288314|FG001|Overall Study|Other|37|||
129814460|NCT01751867|467288313|FG000|Overall Study|Randomized but not treated.|2|||
129814461|NCT01751867|467288314|FG001|Overall Study|Randomized but not treated.|1|||
129814462|NCT04932096|467288315|FG000|Overall Study|Withdrawal by Subject|1|||
129814463|NCT04932096|467288316|FG001|Overall Study|Withdrawal by Subject|1|||
129814464|NCT04932096|467288315|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
129814465|NCT04932096|467288316|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
129814466|NCT02170298|467288317|FG000|Overall Study|Withdrawal by Subject|0|||
129814467|NCT02170298|467288318|FG001|Overall Study|Withdrawal by Subject|1|||
129814468|NCT02170298|467288317|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
129814469|NCT02170298|467288318|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
129814470|NCT01976338|467288319|FG000|Overall Study|Physician Decision|0|||
129897077|NCT02081391|467582199|FG001|12-hour Treatment|Further reasons|1|||
129814471|NCT01976338|467288320|FG001|Overall Study|Physician Decision|1|||
129814472|NCT01976338|467288319|FG000|Overall Study|Lost to Follow-up|3|||
129814473|NCT01976338|467288320|FG001|Overall Study|Lost to Follow-up|0|||
129814474|NCT01976338|467288319|FG000|Overall Study|Withdrawal by Subject|5|||
129814475|NCT01976338|467288320|FG001|Overall Study|Withdrawal by Subject|2|||
129814476|NCT01976338|467288319|FG000|Overall Study|Adverse Event|5|||
129814477|NCT01976338|467288320|FG001|Overall Study|Adverse Event|1|||
129814478|NCT00777608|467288321|FG000|Overall Study|Lost to Follow-up|1|||
129814479|NCT00777608|467288322|FG001|Overall Study|Lost to Follow-up|1|||
129814480|NCT00777608|467288321|FG000|Overall Study|Withdrawal by Subject|1|||
129814481|NCT00777608|467288322|FG001|Overall Study|Withdrawal by Subject|3|||
129814482|NCT00777608|467288321|FG000|Overall Study|Protocol Violation|1|||
129814483|NCT00777608|467288322|FG001|Overall Study|Protocol Violation|0|||
129814484|NCT00777608|467288321|FG000|Overall Study|Investigator Decision|1|||
129814485|NCT00777608|467288322|FG001|Overall Study|Investigator Decision|2|||
129814486|NCT03766581|467288323|FG000|Randomization|Other reasons|2|||
129814487|NCT03766581|467288324|FG001|Randomization|Other reasons|1|||
129814488|NCT03766581|467288325|FG002|Randomization|Other reasons|0|||
129814489|NCT03766581|467288326|FG003|Randomization|Other reasons|1|||
129814490|NCT03766581|467288327|FG004|Randomization|Other reasons|0|||
129814491|NCT03766581|467288328|FG005|Randomization|Other reasons|0|||
129814492|NCT03766581|467288329|FG006|Randomization|Other reasons|0|||
129814493|NCT03766581|467288330|FG007|Randomization|Other reasons|0|||
129814494|NCT03766581|467288323|FG000|Randomization|Participant no longer meets study criteria|5|||
129814495|NCT03766581|467288324|FG001|Randomization|Participant no longer meets study criteria|3|||
129814496|NCT03766581|467288325|FG002|Randomization|Participant no longer meets study criteria|4|||
129814497|NCT03766581|467288326|FG003|Randomization|Participant no longer meets study criteria|0|||
129814498|NCT03766581|467288327|FG004|Randomization|Participant no longer meets study criteria|2|||
129814499|NCT03766581|467288328|FG005|Randomization|Participant no longer meets study criteria|3|||
129814500|NCT03766581|467288329|FG006|Randomization|Participant no longer meets study criteria|0|||
129814501|NCT03766581|467288330|FG007|Randomization|Participant no longer meets study criteria|1|||
129814502|NCT03766581|467288323|FG000|Randomization|Participant request to discontinue study treatment|1|||
129814503|NCT03766581|467288324|FG001|Randomization|Participant request to discontinue study treatment|0|||
129814504|NCT03766581|467288325|FG002|Randomization|Participant request to discontinue study treatment|0|||
129814505|NCT03766581|467288326|FG003|Randomization|Participant request to discontinue study treatment|0|||
129814506|NCT03766581|467288327|FG004|Randomization|Participant request to discontinue study treatment|1|||
129814507|NCT03766581|467288328|FG005|Randomization|Participant request to discontinue study treatment|2|||
129814508|NCT03766581|467288329|FG006|Randomization|Participant request to discontinue study treatment|0|||
129814509|NCT03766581|467288330|FG007|Randomization|Participant request to discontinue study treatment|0|||
129814510|NCT03766581|467288323|FG000|Randomization|Participant withdrew consent|1|||
129814511|NCT03766581|467288324|FG001|Randomization|Participant withdrew consent|0|||
129814512|NCT03766581|467288325|FG002|Randomization|Participant withdrew consent|1|||
129814513|NCT03766581|467288326|FG003|Randomization|Participant withdrew consent|2|||
129814514|NCT03766581|467288327|FG004|Randomization|Participant withdrew consent|1|||
129814515|NCT03766581|467288328|FG005|Randomization|Participant withdrew consent|1|||
129814516|NCT03766581|467288329|FG006|Randomization|Participant withdrew consent|0|||
129814517|NCT03766581|467288330|FG007|Randomization|Participant withdrew consent|0|||
129814518|NCT03766581|467288323|FG000|Treatment|Adverse Event|82|||
129814519|NCT03766581|467288324|FG001|Treatment|Adverse Event|44|||
129814520|NCT03766581|467288325|FG002|Treatment|Adverse Event|47|||
129814521|NCT03766581|467288326|FG003|Treatment|Adverse Event|46|||
129814522|NCT03766581|467288327|FG004|Treatment|Adverse Event|50|||
129814523|NCT03766581|467288328|FG005|Treatment|Adverse Event|77|||
129814524|NCT03766581|467288329|FG006|Treatment|Adverse Event|5|||
129814525|NCT03766581|467288330|FG007|Treatment|Adverse Event|2|||
129814526|NCT03766581|467288323|FG000|Treatment|Participant request to discontinue treatment|34|||
129814527|NCT03766581|467288324|FG001|Treatment|Participant request to discontinue treatment|6|||
129814528|NCT03766581|467288325|FG002|Treatment|Participant request to discontinue treatment|10|||
129814529|NCT03766581|467288326|FG003|Treatment|Participant request to discontinue treatment|10|||
129814530|NCT03766581|467288327|FG004|Treatment|Participant request to discontinue treatment|14|||
129814531|NCT03766581|467288328|FG005|Treatment|Participant request to discontinue treatment|15|||
129814532|NCT03766581|467288329|FG006|Treatment|Participant request to discontinue treatment|0|||
129814533|NCT03766581|467288330|FG007|Treatment|Participant request to discontinue treatment|1|||
129814534|NCT03766581|467288323|FG000|Treatment|Participant withdrew consent|11|||
129814535|NCT03766581|467288324|FG001|Treatment|Participant withdrew consent|4|||
129814536|NCT03766581|467288325|FG002|Treatment|Participant withdrew consent|5|||
129814537|NCT03766581|467288326|FG003|Treatment|Participant withdrew consent|5|||
129814538|NCT03766581|467288327|FG004|Treatment|Participant withdrew consent|4|||
129814539|NCT03766581|467288328|FG005|Treatment|Participant withdrew consent|4|||
129814540|NCT03766581|467288329|FG006|Treatment|Participant withdrew consent|0|||
129814541|NCT03766581|467288330|FG007|Treatment|Participant withdrew consent|0|||
129814542|NCT03766581|467288323|FG000|Treatment|Death|1|||
129814543|NCT03766581|467288324|FG001|Treatment|Death|0|||
129814544|NCT03766581|467288325|FG002|Treatment|Death|0|||
129814545|NCT03766581|467288326|FG003|Treatment|Death|0|||
129814546|NCT03766581|467288327|FG004|Treatment|Death|0|||
129814547|NCT03766581|467288328|FG005|Treatment|Death|0|||
129814548|NCT03766581|467288329|FG006|Treatment|Death|0|||
129814549|NCT03766581|467288330|FG007|Treatment|Death|0|||
129814550|NCT03766581|467288323|FG000|Treatment|Lost to Follow-up|1|||
129814551|NCT03766581|467288324|FG001|Treatment|Lost to Follow-up|0|||
129814552|NCT03766581|467288325|FG002|Treatment|Lost to Follow-up|0|||
129814553|NCT03766581|467288326|FG003|Treatment|Lost to Follow-up|1|||
129814554|NCT03766581|467288327|FG004|Treatment|Lost to Follow-up|0|||
129814555|NCT03766581|467288328|FG005|Treatment|Lost to Follow-up|0|||
129814556|NCT03766581|467288329|FG006|Treatment|Lost to Follow-up|0|||
129814557|NCT03766581|467288330|FG007|Treatment|Lost to Follow-up|0|||
129814558|NCT03766581|467288323|FG000|Treatment|Poor/Non compliance|2|||
129814559|NCT03766581|467288324|FG001|Treatment|Poor/Non compliance|2|||
129814560|NCT03766581|467288325|FG002|Treatment|Poor/Non compliance|1|||
129814561|NCT03766581|467288326|FG003|Treatment|Poor/Non compliance|1|||
129814562|NCT03766581|467288327|FG004|Treatment|Poor/Non compliance|1|||
129814563|NCT03766581|467288328|FG005|Treatment|Poor/Non compliance|1|||
129814564|NCT03766581|467288329|FG006|Treatment|Poor/Non compliance|0|||
129814565|NCT03766581|467288330|FG007|Treatment|Poor/Non compliance|0|||
129814566|NCT03766581|467288323|FG000|Treatment|Participant no longer meets study criteria|9|||
129814567|NCT03766581|467288324|FG001|Treatment|Participant no longer meets study criteria|1|||
129814568|NCT03766581|467288325|FG002|Treatment|Participant no longer meets study criteria|5|||
129814569|NCT03766581|467288326|FG003|Treatment|Participant no longer meets study criteria|4|||
129814570|NCT03766581|467288327|FG004|Treatment|Participant no longer meets study criteria|4|||
129814571|NCT03766581|467288328|FG005|Treatment|Participant no longer meets study criteria|4|||
129814572|NCT03766581|467288329|FG006|Treatment|Participant no longer meets study criteria|2|||
129814573|NCT03766581|467288330|FG007|Treatment|Participant no longer meets study criteria|0|||
129814574|NCT03766581|467288323|FG000|Treatment|Other reasons|13|||
129814575|NCT03766581|467288324|FG001|Treatment|Other reasons|8|||
129814576|NCT03766581|467288325|FG002|Treatment|Other reasons|3|||
129814577|NCT03766581|467288326|FG003|Treatment|Other reasons|7|||
129814578|NCT03766581|467288327|FG004|Treatment|Other reasons|3|||
129814579|NCT03766581|467288328|FG005|Treatment|Other reasons|3|||
129814580|NCT03766581|467288329|FG006|Treatment|Other reasons|0|||
129814581|NCT03766581|467288330|FG007|Treatment|Other reasons|0|||
129814582|NCT00520936|467288331|FG000|Overall Study|Physician Decision|0|||
129814583|NCT00520936|467288332|FG001|Overall Study|Physician Decision|2|||
129814584|NCT00520936|467288333|FG002|Overall Study|Physician Decision|1|||
129814585|NCT00520936|467288334|FG003|Overall Study|Physician Decision|0|||
129814586|NCT00520936|467288335|FG004|Overall Study|Physician Decision|0|||
129814587|NCT00520936|467288336|FG005|Overall Study|Physician Decision|0|||
129814588|NCT00520936|467288337|FG006|Overall Study|Physician Decision|0|||
129814589|NCT00520936|467288338|FG007|Overall Study|Physician Decision|0|||
129814590|NCT00520936|467288331|FG000|Overall Study|Withdrawal by Subject|0|||
129814591|NCT00520936|467288332|FG001|Overall Study|Withdrawal by Subject|0|||
129814592|NCT00520936|467288333|FG002|Overall Study|Withdrawal by Subject|0|||
129814593|NCT00520936|467288334|FG003|Overall Study|Withdrawal by Subject|0|||
129814594|NCT00520936|467288335|FG004|Overall Study|Withdrawal by Subject|0|||
129814595|NCT00520936|467288336|FG005|Overall Study|Withdrawal by Subject|0|||
129814596|NCT00520936|467288337|FG006|Overall Study|Withdrawal by Subject|0|||
129814597|NCT00520936|467288338|FG007|Overall Study|Withdrawal by Subject|1|||
129814598|NCT00520936|467288331|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
129814599|NCT00520936|467288332|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
129814600|NCT00520936|467288333|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
129814601|NCT00520936|467288334|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
129814602|NCT00520936|467288335|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
129814603|NCT00520936|467288336|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
129814604|NCT00520936|467288337|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
129814605|NCT00520936|467288338|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
129814606|NCT00520936|467288331|FG000|Overall Study|Death|0|||
129814607|NCT00520936|467288332|FG001|Overall Study|Death|0|||
129814608|NCT00520936|467288333|FG002|Overall Study|Death|0|||
129814609|NCT00520936|467288334|FG003|Overall Study|Death|0|||
129814610|NCT00520936|467288335|FG004|Overall Study|Death|0|||
129814611|NCT00520936|467288336|FG005|Overall Study|Death|0|||
129814612|NCT00520936|467288337|FG006|Overall Study|Death|1|||
129814613|NCT00520936|467288338|FG007|Overall Study|Death|0|||
129814614|NCT00520936|467288331|FG000|Overall Study|Protocol Violation|0|||
129814615|NCT00520936|467288332|FG001|Overall Study|Protocol Violation|1|||
129814616|NCT00520936|467288333|FG002|Overall Study|Protocol Violation|1|||
129814617|NCT00520936|467288334|FG003|Overall Study|Protocol Violation|0|||
129814618|NCT00520936|467288335|FG004|Overall Study|Protocol Violation|1|||
129814619|NCT00520936|467288336|FG005|Overall Study|Protocol Violation|0|||
129814620|NCT00520936|467288337|FG006|Overall Study|Protocol Violation|1|||
129814621|NCT00520936|467288338|FG007|Overall Study|Protocol Violation|0|||
129897078|NCT02081391|467582200|FG002|12-hour Treatment|Further reasons|0|||
129814622|NCT00587054|467288340|FG000|Overall Study|Patient not treated|9|||
129814623|NCT02099708|467288353|FG000|Overall Study|Data Not Available|30|||
129814624|NCT02099708|467288353|FG000|Overall Study|Lost to Follow-up|141|||
129814625|NCT02099708|467288353|FG000|Overall Study|Other|29|||
129814626|NCT05466682|467288357|FG000|Overall Study|Withdrawal by Subject|0|||
129814627|NCT05466682|467288358|FG001|Overall Study|Withdrawal by Subject|2|||
129814628|NCT05466682|467288357|FG000|Overall Study|Lost to Follow-up|2|||
129814629|NCT05466682|467288358|FG001|Overall Study|Lost to Follow-up|1|||
129814630|NCT01697566|467288359|FG000|Overall Study|Withdrawal by Subject|0|||
129814631|NCT01697566|467288360|FG001|Overall Study|Withdrawal by Subject|0|||
129814632|NCT01697566|467288361|FG002|Overall Study|Withdrawal by Subject|1|||
129814633|NCT01697566|467288362|FG003|Overall Study|Withdrawal by Subject|1|||
129814634|NCT01697566|467288359|FG000|Overall Study|Final biopsy not obtained|0|||
129814635|NCT01697566|467288360|FG001|Overall Study|Final biopsy not obtained|0|||
129814636|NCT01697566|467288361|FG002|Overall Study|Final biopsy not obtained|1|||
129814637|NCT01697566|467288362|FG003|Overall Study|Final biopsy not obtained|0|||
129814638|NCT03953820|467288364|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
129814639|NCT03953820|467288365|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
129814640|NCT03953820|467288366|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
129814641|NCT03953820|467288364|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
129814642|NCT03953820|467288365|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
129814643|NCT03953820|467288366|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
129814644|NCT03322631|467288372|FG000|Overall Study|Withdrawal by Subject|0|||
129814645|NCT03322631|467288373|FG001|Overall Study|Withdrawal by Subject|1|||
129814646|NCT03322631|467288374|FG002|Overall Study|Withdrawal by Subject|0|||
129814647|NCT03322631|467288375|FG003|Overall Study|Withdrawal by Subject|0|||
129814648|NCT03322631|467288372|FG000|Overall Study|Adverse Event|0|||
129814649|NCT03322631|467288373|FG001|Overall Study|Adverse Event|0|||
129814650|NCT03322631|467288374|FG002|Overall Study|Adverse Event|1|||
129814651|NCT03322631|467288375|FG003|Overall Study|Adverse Event|0|||
129814652|NCT02378961|467288376|FG000|Overall Study|Lack of Efficacy|4|||
129814653|NCT02378961|467288377|FG001|Overall Study|Lack of Efficacy|2|||
129814654|NCT02378961|467288378|FG002|Overall Study|Lack of Efficacy|0|||
129814655|NCT02378961|467288379|FG003|Overall Study|Lack of Efficacy|1|||
129814656|NCT02378961|467288376|FG000|Overall Study|Death|0|||
129814657|NCT02378961|467288377|FG001|Overall Study|Death|0|||
129814658|NCT02378961|467288378|FG002|Overall Study|Death|1|||
129814659|NCT02378961|467288379|FG003|Overall Study|Death|0|||
129814660|NCT01217801|467288380|FG000|Period 1|Protocol Violation|1|||
129814661|NCT01217801|467288381|FG001|Period 1|Protocol Violation|1|||
129814662|NCT01217801|467288380|FG000|Period 1|Withdrawal by Subject|0|||
129814663|NCT01217801|467288381|FG001|Period 1|Withdrawal by Subject|1|||
129814664|NCT04967443|467288385|FG000|Open Label Treatment|Death|1|||
129814665|NCT04967443|467288386|FG001|Open Label Treatment|Death|0|||
129814666|NCT04967443|467288387|FG002|Open Label Treatment|Death|0|||
129814667|NCT04967443|467288388|FG003|Open Label Treatment|Death|0|||
129814668|NCT04967443|467288389|FG004|Open Label Treatment|Death|0|||
129814669|NCT04967443|467288390|FG005|Open Label Treatment|Death|0|||
129814670|NCT04967443|467288391|FG006|Open Label Treatment|Death|0|||
129814671|NCT04967443|467288392|FG007|Open Label Treatment|Death|0|||
129814672|NCT04967443|467288385|FG000|Open Label Treatment|Lost to Follow-up|0|||
129814673|NCT04967443|467288386|FG001|Open Label Treatment|Lost to Follow-up|0|||
129814674|NCT04967443|467288387|FG002|Open Label Treatment|Lost to Follow-up|1|||
129814675|NCT04967443|467288388|FG003|Open Label Treatment|Lost to Follow-up|0|||
129814676|NCT04967443|467288389|FG004|Open Label Treatment|Lost to Follow-up|0|||
129814677|NCT04967443|467288390|FG005|Open Label Treatment|Lost to Follow-up|0|||
129814678|NCT04967443|467288391|FG006|Open Label Treatment|Lost to Follow-up|0|||
129814679|NCT04967443|467288392|FG007|Open Label Treatment|Lost to Follow-up|0|||
129814680|NCT04967443|467288385|FG000|Open Label Treatment|Withdrawal by Subject|0|||
129814681|NCT04967443|467288386|FG001|Open Label Treatment|Withdrawal by Subject|1|||
129814682|NCT04967443|467288387|FG002|Open Label Treatment|Withdrawal by Subject|0|||
129814683|NCT04967443|467288388|FG003|Open Label Treatment|Withdrawal by Subject|1|||
129814684|NCT04967443|467288389|FG004|Open Label Treatment|Withdrawal by Subject|0|||
129814685|NCT04967443|467288390|FG005|Open Label Treatment|Withdrawal by Subject|1|||
129814686|NCT04967443|467288391|FG006|Open Label Treatment|Withdrawal by Subject|2|||
129814687|NCT04967443|467288392|FG007|Open Label Treatment|Withdrawal by Subject|3|||
129814688|NCT04967443|467288385|FG000|Follow-Up|Death|1|||
129814689|NCT04967443|467288386|FG001|Follow-Up|Death|0|||
129814690|NCT04967443|467288387|FG002|Follow-Up|Death|0|||
129814691|NCT04967443|467288388|FG003|Follow-Up|Death|0|||
129814692|NCT04967443|467288389|FG004|Follow-Up|Death|0|||
129814693|NCT04967443|467288390|FG005|Follow-Up|Death|0|||
129814694|NCT04967443|467288391|FG006|Follow-Up|Death|0|||
129814695|NCT04967443|467288392|FG007|Follow-Up|Death|0|||
129814696|NCT04967443|467288385|FG000|Follow-Up|Lost to Follow-up|0|||
129814697|NCT04967443|467288386|FG001|Follow-Up|Lost to Follow-up|0|||
129814698|NCT04967443|467288387|FG002|Follow-Up|Lost to Follow-up|1|||
129814699|NCT04967443|467288388|FG003|Follow-Up|Lost to Follow-up|1|||
129814700|NCT04967443|467288389|FG004|Follow-Up|Lost to Follow-up|0|||
129814701|NCT04967443|467288390|FG005|Follow-Up|Lost to Follow-up|0|||
129814702|NCT04967443|467288391|FG006|Follow-Up|Lost to Follow-up|0|||
129814703|NCT04967443|467288392|FG007|Follow-Up|Lost to Follow-up|0|||
129814704|NCT04967443|467288385|FG000|Follow-Up|Withdrawal by Subject|0|||
129814705|NCT04967443|467288386|FG001|Follow-Up|Withdrawal by Subject|1|||
129814706|NCT04967443|467288387|FG002|Follow-Up|Withdrawal by Subject|0|||
129814707|NCT04967443|467288388|FG003|Follow-Up|Withdrawal by Subject|1|||
129814708|NCT04967443|467288389|FG004|Follow-Up|Withdrawal by Subject|0|||
129814709|NCT04967443|467288390|FG005|Follow-Up|Withdrawal by Subject|1|||
129814710|NCT04967443|467288391|FG006|Follow-Up|Withdrawal by Subject|2|||
129814711|NCT04967443|467288392|FG007|Follow-Up|Withdrawal by Subject|3|||
129814712|NCT02405780|467288393|FG000|Period I|Adverse Event|8|||
129814713|NCT02405780|467288394|FG001|Period I|Adverse Event|0|||
129814714|NCT02405780|467288395|FG002|Period I|Adverse Event|3|||
129814715|NCT02405780|467288396|FG003|Period I|Adverse Event|7|||
129814716|NCT02405780|467288393|FG000|Period I|Medical reasons|1|||
129814717|NCT02405780|467288394|FG001|Period I|Medical reasons|1|||
129814718|NCT02405780|467288395|FG002|Period I|Medical reasons|0|||
129814719|NCT02405780|467288396|FG003|Period I|Medical reasons|1|||
129814720|NCT02405780|467288393|FG000|Period I|Screening Failure|1|||
129814721|NCT02405780|467288394|FG001|Period I|Screening Failure|0|||
129814722|NCT02405780|467288395|FG002|Period I|Screening Failure|1|||
129814723|NCT02405780|467288396|FG003|Period I|Screening Failure|0|||
129814724|NCT02405780|467288393|FG000|Period I|Withdrawal by Subject|9|||
129814725|NCT02405780|467288394|FG001|Period I|Withdrawal by Subject|1|||
129814726|NCT02405780|467288395|FG002|Period I|Withdrawal by Subject|3|||
129814727|NCT02405780|467288396|FG003|Period I|Withdrawal by Subject|4|||
129814728|NCT02405780|467288393|FG000|Period I|Non-compliance with study procedures|8|||
129814729|NCT02405780|467288394|FG001|Period I|Non-compliance with study procedures|6|||
129814730|NCT02405780|467288395|FG002|Period I|Non-compliance with study procedures|8|||
129814731|NCT02405780|467288396|FG003|Period I|Non-compliance with study procedures|11|||
129814732|NCT02405780|467288393|FG000|Period II|Adverse Event|3|||
129814733|NCT02405780|467288394|FG001|Period II|Adverse Event|5|||
129814734|NCT02405780|467288395|FG002|Period II|Adverse Event|4|||
129814735|NCT02405780|467288396|FG003|Period II|Adverse Event|11|||
129814736|NCT02405780|467288393|FG000|Period II|Medical reason|0|||
129814737|NCT02405780|467288394|FG001|Period II|Medical reason|1|||
129814738|NCT02405780|467288395|FG002|Period II|Medical reason|0|||
129814739|NCT02405780|467288396|FG003|Period II|Medical reason|0|||
129814740|NCT02405780|467288393|FG000|Period II|Pregnancy|0|||
129814741|NCT02405780|467288394|FG001|Period II|Pregnancy|0|||
129814742|NCT02405780|467288395|FG002|Period II|Pregnancy|1|||
129814743|NCT02405780|467288396|FG003|Period II|Pregnancy|0|||
129814744|NCT02405780|467288393|FG000|Period II|Withdrawal by Subject|7|||
129814745|NCT02405780|467288394|FG001|Period II|Withdrawal by Subject|4|||
129814746|NCT02405780|467288395|FG002|Period II|Withdrawal by Subject|0|||
129814747|NCT02405780|467288396|FG003|Period II|Withdrawal by Subject|3|||
129814748|NCT02405780|467288393|FG000|Period II|Non-compliance with study procedures|5|||
129814749|NCT02405780|467288394|FG001|Period II|Non-compliance with study procedures|2|||
129814750|NCT02405780|467288395|FG002|Period II|Non-compliance with study procedures|7|||
129814751|NCT02405780|467288396|FG003|Period II|Non-compliance with study procedures|4|||
129814752|NCT01654536|467288397|FG000|Overall Study|Lost to Follow-up|5|||
129814753|NCT01654536|467288398|FG001|Overall Study|Lost to Follow-up|5|||
129814754|NCT01654536|467288397|FG000|Overall Study|Physician Decision|12|||
129814755|NCT01654536|467288398|FG001|Overall Study|Physician Decision|8|||
129814756|NCT01654536|467288397|FG000|Overall Study|Withdrawal by Subject|27|||
129814757|NCT01654536|467288398|FG001|Overall Study|Withdrawal by Subject|25|||
129814758|NCT04502693|467288402|FG000|Overall Study|Adverse Event|7|||
129814759|NCT04502693|467288403|FG001|Overall Study|Adverse Event|6|||
129814760|NCT04502693|467288404|FG002|Overall Study|Adverse Event|11|||
129814761|NCT04502693|467288405|FG003|Overall Study|Adverse Event|1|||
129814762|NCT04502693|467288402|FG000|Overall Study|Lost to Follow-up|32|||
129814763|NCT04502693|467288403|FG001|Overall Study|Lost to Follow-up|36|||
129814764|NCT04502693|467288404|FG002|Overall Study|Lost to Follow-up|69|||
129814765|NCT04502693|467288405|FG003|Overall Study|Lost to Follow-up|4|||
129814766|NCT04502693|467288402|FG000|Overall Study|Protocol Violation|8|||
129814767|NCT04502693|467288403|FG001|Overall Study|Protocol Violation|8|||
129814768|NCT04502693|467288404|FG002|Overall Study|Protocol Violation|16|||
129814769|NCT04502693|467288405|FG003|Overall Study|Protocol Violation|1|||
129814770|NCT04502693|467288402|FG000|Overall Study|Withdrawal by Subject|46|||
129814771|NCT04502693|467288403|FG001|Overall Study|Withdrawal by Subject|38|||
129814772|NCT04502693|467288404|FG002|Overall Study|Withdrawal by Subject|54|||
129814773|NCT04502693|467288405|FG003|Overall Study|Withdrawal by Subject|7|||
129814774|NCT04502693|467288402|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
129814775|NCT04502693|467288403|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
129814776|NCT04502693|467288404|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
129814777|NCT04502693|467288405|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129814778|NCT04502693|467288402|FG000|Overall Study|Other|1|||
129814779|NCT04502693|467288403|FG001|Overall Study|Other|0|||
129814780|NCT04502693|467288404|FG002|Overall Study|Other|1|||
129814781|NCT04502693|467288405|FG003|Overall Study|Other|1|||
129814782|NCT00602797|467288406|FG000|Overall Study|Adverse Event|1|||
129814783|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
129814784|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
129814785|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
129814786|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
129814787|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
129814788|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
129814789|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
129814790|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
129814791|NCT03943147|467288409|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
129814792|NCT03943147|467288410|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
129814793|NCT03943147|467288409|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
129814794|NCT03943147|467288410|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
129814795|NCT01318993|467288411|FG000|Overall Study|Adverse Event|53|||
129814796|NCT01318993|467288411|FG000|Overall Study|Lack of Efficacy|121|||
129814797|NCT01318993|467288411|FG000|Overall Study|Protocol Violation|3|||
129814798|NCT01318993|467288411|FG000|Overall Study|Protocol based stopping criteria|6|||
129814799|NCT01318993|467288411|FG000|Overall Study|Study closed or terminated|174|||
129814800|NCT01318993|467288411|FG000|Overall Study|Lost to Follow-up|4|||
129814801|NCT01318993|467288411|FG000|Overall Study|Physician Decision|13|||
129814802|NCT01318993|467288411|FG000|Overall Study|Withdrawal by Subject|24|||
129814803|NCT03334539|467288412|FG000|Overall Study|Adverse Event|3|||
129814804|NCT03334539|467288413|FG001|Overall Study|Adverse Event|5|||
129814805|NCT03334539|467288414|FG002|Overall Study|Adverse Event|0|||
129814806|NCT03334539|467288412|FG000|Overall Study|Withdrawal by Subject|0|||
129814807|NCT03334539|467288413|FG001|Overall Study|Withdrawal by Subject|1|||
129814808|NCT03334539|467288414|FG002|Overall Study|Withdrawal by Subject|1|||
129814809|NCT03334539|467288412|FG000|Overall Study|Administrative Reasons|1|||
129814810|NCT03334539|467288413|FG001|Overall Study|Administrative Reasons|0|||
129814811|NCT03334539|467288414|FG002|Overall Study|Administrative Reasons|0|||
129814812|NCT03334539|467288412|FG000|Overall Study|Hypertension Not Controlled|0|||
129814813|NCT03334539|467288413|FG001|Overall Study|Hypertension Not Controlled|1|||
129814814|NCT03334539|467288414|FG002|Overall Study|Hypertension Not Controlled|0|||
129814815|NCT00968201|467288415|FG000|Base Study - (Period II)|Adverse Event|8|||
129814816|NCT00968201|467288416|FG001|Base Study - (Period II)|Adverse Event|0|||
129814817|NCT00968201|467288417|FG002|Base Study - (Period II)|Adverse Event|16|||
129814818|NCT00968201|467288415|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
129814819|NCT00968201|467288416|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
129814820|NCT00968201|467288417|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
129814821|NCT00968201|467288415|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
129814822|NCT00968201|467288416|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
129814823|NCT00968201|467288417|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
129814824|NCT00968201|467288415|FG000|Base Study - (Period II)|Protocol Violation|12|||
129814825|NCT00968201|467288416|FG001|Base Study - (Period II)|Protocol Violation|0|||
129814826|NCT00968201|467288417|FG002|Base Study - (Period II)|Protocol Violation|12|||
129814827|NCT00968201|467288415|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
129814828|NCT00968201|467288416|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
129814829|NCT00968201|467288417|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
129814830|NCT00968201|467288415|FG000|Base Study - (Period II)|Site Error|0|||
129814831|NCT00968201|467288416|FG001|Base Study - (Period II)|Site Error|0|||
129814832|NCT00968201|467288417|FG002|Base Study - (Period II)|Site Error|1|||
129814833|NCT00968201|467288415|FG000|Extension Study - (Period III)|Adverse Event|0|||
129814834|NCT00968201|467288416|FG001|Extension Study - (Period III)|Adverse Event|5|||
129814835|NCT00968201|467288417|FG002|Extension Study - (Period III)|Adverse Event|22|||
129814836|NCT00968201|467288415|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
129814837|NCT00968201|467288416|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
129814838|NCT00968201|467288417|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
129814839|NCT00968201|467288415|FG000|Extension Study - (Period III)|Protocol Violation|0|||
129814840|NCT00968201|467288416|FG001|Extension Study - (Period III)|Protocol Violation|17|||
129814841|NCT00968201|467288417|FG002|Extension Study - (Period III)|Protocol Violation|14|||
129814842|NCT00968201|467288415|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
129814843|NCT00968201|467288416|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
129814844|NCT00968201|467288417|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
129814845|NCT00968201|467288415|FG000|Extension Study - (Period III)|Patient Relocated|0|||
129814846|NCT00968201|467288416|FG001|Extension Study - (Period III)|Patient Relocated|1|||
129814847|NCT00968201|467288417|FG002|Extension Study - (Period III)|Patient Relocated|1|||
129814848|NCT00968201|467288415|FG000|Extension Study - (Period III)|Noncompliance|0|||
129814849|NCT00968201|467288416|FG001|Extension Study - (Period III)|Noncompliance|0|||
129814850|NCT00968201|467288417|FG002|Extension Study - (Period III)|Noncompliance|3|||
129814851|NCT00968201|467288415|FG000|Extension Study - (Period III)|Other|0|||
129814852|NCT00968201|467288416|FG001|Extension Study - (Period III)|Other|0|||
129814853|NCT00968201|467288417|FG002|Extension Study - (Period III)|Other|2|||
129814854|NCT00968201|467288415|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
129814855|NCT00968201|467288416|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
129814856|NCT00968201|467288417|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
129814857|NCT04974697|467288419|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
129814858|NCT04974697|467288419|FG000|Overall Study|Lens discomfort|1|||
129814859|NCT02010775|467288420|FG000|Overall Study|Adverse Event|0|||
129814860|NCT02010775|467288421|FG001|Overall Study|Adverse Event|0|||
129814861|NCT02010775|467288422|FG002|Overall Study|Adverse Event|0|||
129814862|NCT02010775|467288423|FG003|Overall Study|Adverse Event|0|||
129814863|NCT02010775|467288424|FG004|Overall Study|Adverse Event|1|||
129814864|NCT02010775|467288420|FG000|Overall Study|Pregnancy|0|||
129814865|NCT02010775|467288421|FG001|Overall Study|Pregnancy|0|||
129814866|NCT02010775|467288422|FG002|Overall Study|Pregnancy|2|||
129814867|NCT02010775|467288423|FG003|Overall Study|Pregnancy|0|||
129814868|NCT02010775|467288424|FG004|Overall Study|Pregnancy|0|||
129814869|NCT02010775|467288420|FG000|Overall Study|Lost to Follow-up|2|||
129814870|NCT02010775|467288421|FG001|Overall Study|Lost to Follow-up|0|||
129814871|NCT02010775|467288422|FG002|Overall Study|Lost to Follow-up|0|||
129814872|NCT02010775|467288423|FG003|Overall Study|Lost to Follow-up|1|||
129814873|NCT02010775|467288424|FG004|Overall Study|Lost to Follow-up|1|||
129814874|NCT02010775|467288420|FG000|Overall Study|Personal Reasons|3|||
129814875|NCT02010775|467288421|FG001|Overall Study|Personal Reasons|3|||
129814876|NCT02010775|467288422|FG002|Overall Study|Personal Reasons|1|||
129814877|NCT02010775|467288423|FG003|Overall Study|Personal Reasons|2|||
129814878|NCT02010775|467288424|FG004|Overall Study|Personal Reasons|4|||
129814879|NCT02030041|467288427|FG000|Overall Study|Withdrawal by Subject|2|||
129814880|NCT02030041|467288428|FG001|Overall Study|Withdrawal by Subject|2|||
129814881|NCT02030041|467288429|FG002|Overall Study|Withdrawal by Subject|1|||
129814882|NCT01197560|467288430|FG000|Overall Study|Adverse Event|6|||
129814883|NCT01197560|467288431|FG001|Overall Study|Adverse Event|8|||
129814884|NCT01197560|467288430|FG000|Overall Study|Death|3|||
129814885|NCT01197560|467288431|FG001|Overall Study|Death|5|||
129814886|NCT01197560|467288430|FG000|Overall Study|Withdrawal by Subject|1|||
129814887|NCT01197560|467288431|FG001|Overall Study|Withdrawal by Subject|1|||
129814888|NCT01197560|467288430|FG000|Overall Study|Disease progression|40|||
129814889|NCT01197560|467288431|FG001|Overall Study|Disease progression|35|||
129814890|NCT01197560|467288430|FG000|Overall Study|Miscellaneous|4|||
129814891|NCT01197560|467288431|FG001|Overall Study|Miscellaneous|3|||
129814892|NCT01197560|467288430|FG000|Overall Study|Missing|0|||
129814893|NCT01197560|467288431|FG001|Overall Study|Missing|1|||
129814894|NCT05201703|467288432|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
129814895|NCT05201703|467288433|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
129814896|NCT05201703|467288432|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
129814897|NCT05201703|467288433|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
129814898|NCT02006719|467288434|FG000|Overall Study|Withdrawal by Subject|10|||
129814899|NCT02006719|467288435|FG001|Overall Study|Withdrawal by Subject|2|||
129814900|NCT02006719|467288434|FG000|Overall Study|Lost to Follow-up|5|||
129814901|NCT02006719|467288435|FG001|Overall Study|Lost to Follow-up|1|||
129814902|NCT02006719|467288434|FG000|Overall Study|Protocol Violation|2|||
129814903|NCT02006719|467288435|FG001|Overall Study|Protocol Violation|0|||
129814904|NCT02006719|467288434|FG000|Overall Study|Adverse Event|1|||
129814905|NCT02006719|467288435|FG001|Overall Study|Adverse Event|1|||
129814906|NCT02006719|467288434|FG000|Overall Study|Other/Unknown|0|||
129814907|NCT02006719|467288435|FG001|Overall Study|Other/Unknown|1|||
129814908|NCT02166905|467288439|FG000|Overall Study|Withdrawal by Subject|1|||
129814909|NCT02166905|467288440|FG001|Overall Study|Withdrawal by Subject|0|||
129814910|NCT02166905|467288441|FG002|Overall Study|Withdrawal by Subject|0|||
129814911|NCT02166905|467288442|FG003|Overall Study|Withdrawal by Subject|0|||
129814912|NCT02617628|467288443|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
129814913|NCT02617628|467288444|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
129814914|NCT03278873|467288448|FG000|Overall Study|Withdrawal by Subject|0|||
129814915|NCT03278873|467288449|FG001|Overall Study|Withdrawal by Subject|1|||
129814916|NCT03278873|467288450|FG002|Overall Study|Withdrawal by Subject|0|||
129814917|NCT03278873|467288451|FG003|Overall Study|Withdrawal by Subject|0|||
129814918|NCT03278873|467288448|FG000|Overall Study|Sponsor's decision|0|||
129814919|NCT03278873|467288449|FG001|Overall Study|Sponsor's decision|1|||
129814920|NCT03278873|467288450|FG002|Overall Study|Sponsor's decision|0|||
129814921|NCT03278873|467288451|FG003|Overall Study|Sponsor's decision|0|||
129814922|NCT03278873|467288448|FG000|Overall Study|Early Termination|2|||
129814923|NCT03278873|467288449|FG001|Overall Study|Early Termination|6|||
129814924|NCT03278873|467288450|FG002|Overall Study|Early Termination|0|||
129814925|NCT03278873|467288451|FG003|Overall Study|Early Termination|4|||
129814926|NCT03278873|467288448|FG000|Overall Study|Lost to Follow-up|0|||
129814927|NCT03278873|467288449|FG001|Overall Study|Lost to Follow-up|0|||
129814928|NCT03278873|467288450|FG002|Overall Study|Lost to Follow-up|2|||
129814929|NCT03278873|467288451|FG003|Overall Study|Lost to Follow-up|0|||
129814930|NCT03278873|467288448|FG000|Overall Study|The patient decided to withdraw via email|1|||
129814931|NCT03278873|467288449|FG001|Overall Study|The patient decided to withdraw via email|0|||
129814932|NCT03278873|467288450|FG002|Overall Study|The patient decided to withdraw via email|0|||
129814933|NCT03278873|467288451|FG003|Overall Study|The patient decided to withdraw via email|0|||
129814934|NCT03278873|467288448|FG000|Overall Study|The patient was unresponsive to contact|0|||
129814935|NCT03278873|467288449|FG001|Overall Study|The patient was unresponsive to contact|0|||
129814936|NCT03278873|467288450|FG002|Overall Study|The patient was unresponsive to contact|0|||
129814937|NCT03278873|467288451|FG003|Overall Study|The patient was unresponsive to contact|4|||
129814938|NCT03278873|467288448|FG000|Overall Study|The patient wished to participate no longer|0|||
129814939|NCT03278873|467288449|FG001|Overall Study|The patient wished to participate no longer|1|||
129814940|NCT03278873|467288450|FG002|Overall Study|The patient wished to participate no longer|0|||
129814941|NCT03278873|467288451|FG003|Overall Study|The patient wished to participate no longer|0|||
129814942|NCT03278873|467288448|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
129814943|NCT03278873|467288449|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
129814944|NCT03278873|467288450|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
129814945|NCT03278873|467288451|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
129814946|NCT02801331|467288452|FG000|Overall Study|Transferred to another hospital|8|||
129814947|NCT02801331|467288453|FG001|Overall Study|Transferred to another hospital|7|||
129814948|NCT02801331|467288452|FG000|Overall Study|Withdrawal by Subject|0|||
129814949|NCT02801331|467288453|FG001|Overall Study|Withdrawal by Subject|4|||
129814950|NCT02801331|467288452|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
129814951|NCT02801331|467288453|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
129814952|NCT04698187|467288460|FG000|Overall Study|Withdrawal by Subject|7|||
129814953|NCT04698187|467288460|FG000|Overall Study|Death|21|||
129814954|NCT04698187|467288460|FG000|Overall Study|Sponsor Decision|15|||
129814955|NCT04698187|467288460|FG000|Overall Study|In-transit Disease|1|||
129814956|NCT00540514|467290019|FG000|Overall Study|Still on treatment|3|||
129814957|NCT00540514|467290020|FG001|Overall Study|Still on treatment|0|||
129814958|NCT00540514|467290019|FG000|Overall Study|Unacceptable Toxicity|61|||
129814959|NCT00540514|467290020|FG001|Overall Study|Unacceptable Toxicity|62|||
129814960|NCT00540514|467290019|FG000|Overall Study|Adverse Event|20|||
129814961|NCT00540514|467290020|FG001|Overall Study|Adverse Event|24|||
129814962|NCT00540514|467290019|FG000|Overall Study|Physician Decision|86|||
129814963|NCT00540514|467290020|FG001|Overall Study|Physician Decision|99|||
129814964|NCT00540514|467290019|FG000|Overall Study|Protocol Deviation|3|||
129814965|NCT00540514|467290020|FG001|Overall Study|Protocol Deviation|4|||
129814966|NCT00540514|467290019|FG000|Overall Study|Lost to Follow-up|1|||
129814967|NCT00540514|467290020|FG001|Overall Study|Lost to Follow-up|1|||
129814968|NCT00540514|467290019|FG000|Overall Study|Withdrawal by Subject|65|||
129814969|NCT00540514|467290020|FG001|Overall Study|Withdrawal by Subject|67|||
129814970|NCT00540514|467290019|FG000|Overall Study|Excluded prior to treatment|7|||
129814971|NCT00540514|467290020|FG001|Overall Study|Excluded prior to treatment|7|||
129814972|NCT00540514|467290019|FG000|Overall Study|Paclitaxel not available|0|||
129814973|NCT00540514|467290020|FG001|Overall Study|Paclitaxel not available|2|||
129814974|NCT02501473|467290021|FG000|Overall Study|Study Terminated|2|||
129814975|NCT02501473|467290022|FG001|Overall Study|Study Terminated|3|||
129814976|NCT02501473|467290023|FG002|Overall Study|Study Terminated|7|||
129814977|NCT02501473|467290024|FG003|Overall Study|Study Terminated|9|||
129814978|NCT02501473|467290025|FG004|Overall Study|Study Terminated|2|||
129814979|NCT02501473|467290026|FG005|Overall Study|Study Terminated|10|||
129814980|NCT02501473|467290027|FG006|Overall Study|Study Terminated|1|||
129814981|NCT02501473|467290028|FG007|Overall Study|Study Terminated|0|||
129814982|NCT02501473|467290021|FG000|Overall Study|Withdrawal by Subject|0|||
129814983|NCT02501473|467290022|FG001|Overall Study|Withdrawal by Subject|0|||
129814984|NCT02501473|467290023|FG002|Overall Study|Withdrawal by Subject|3|||
129814985|NCT02501473|467290024|FG003|Overall Study|Withdrawal by Subject|3|||
129814986|NCT02501473|467290025|FG004|Overall Study|Withdrawal by Subject|2|||
129814987|NCT02501473|467290026|FG005|Overall Study|Withdrawal by Subject|2|||
129814988|NCT02501473|467290027|FG006|Overall Study|Withdrawal by Subject|0|||
129814989|NCT02501473|467290028|FG007|Overall Study|Withdrawal by Subject|0|||
129814990|NCT02501473|467290021|FG000|Overall Study|Death|0|||
129814991|NCT02501473|467290022|FG001|Overall Study|Death|0|||
129814992|NCT02501473|467290023|FG002|Overall Study|Death|1|||
129814993|NCT02501473|467290024|FG003|Overall Study|Death|1|||
129814994|NCT02501473|467290025|FG004|Overall Study|Death|0|||
129814995|NCT02501473|467290026|FG005|Overall Study|Death|1|||
129814996|NCT02501473|467290027|FG006|Overall Study|Death|0|||
129814997|NCT02501473|467290028|FG007|Overall Study|Death|0|||
129814998|NCT02501473|467290021|FG000|Overall Study|Lost to Follow-up|1|||
129814999|NCT02501473|467290022|FG001|Overall Study|Lost to Follow-up|0|||
129815000|NCT02501473|467290023|FG002|Overall Study|Lost to Follow-up|1|||
129815001|NCT02501473|467290024|FG003|Overall Study|Lost to Follow-up|0|||
129815002|NCT02501473|467290025|FG004|Overall Study|Lost to Follow-up|0|||
129815003|NCT02501473|467290026|FG005|Overall Study|Lost to Follow-up|1|||
129815004|NCT02501473|467290027|FG006|Overall Study|Lost to Follow-up|0|||
129815005|NCT02501473|467290028|FG007|Overall Study|Lost to Follow-up|0|||
129815006|NCT02501473|467290021|FG000|Overall Study|Reason not specified|0|||
129815007|NCT02501473|467290022|FG001|Overall Study|Reason not specified|0|||
129815008|NCT02501473|467290023|FG002|Overall Study|Reason not specified|1|||
129815009|NCT02501473|467290024|FG003|Overall Study|Reason not specified|1|||
129815010|NCT02501473|467290025|FG004|Overall Study|Reason not specified|0|||
129815011|NCT02501473|467290026|FG005|Overall Study|Reason not specified|0|||
129815012|NCT02501473|467290027|FG006|Overall Study|Reason not specified|0|||
129815013|NCT02501473|467290028|FG007|Overall Study|Reason not specified|0|||
129815014|NCT00907777|467290029|FG000|Overall Study|Withdrawal by Subject|0|||
129815015|NCT00907777|467290030|FG001|Overall Study|Withdrawal by Subject|1|||
129815016|NCT00105469|467290041|FG000|Overall Study|Adverse Event|9|||
129815017|NCT00105469|467290042|FG001|Overall Study|Adverse Event|8|||
129815018|NCT00105469|467290041|FG000|Overall Study|Protocol Violation|4|||
129815019|NCT00105469|467290042|FG001|Overall Study|Protocol Violation|0|||
129815020|NCT00105469|467290041|FG000|Overall Study|Withdrawal by Subject|2|||
129815021|NCT00105469|467290042|FG001|Overall Study|Withdrawal by Subject|3|||
129815022|NCT00105469|467290041|FG000|Overall Study|Lost to Follow-up|1|||
129815023|NCT00105469|467290042|FG001|Overall Study|Lost to Follow-up|0|||
129815024|NCT00105469|467290041|FG000|Overall Study|Lack of Efficacy|2|||
129815025|NCT00105469|467290042|FG001|Overall Study|Lack of Efficacy|0|||
129815026|NCT00105469|467290041|FG000|Overall Study|Other Reason|4|||
129815027|NCT00105469|467290042|FG001|Overall Study|Other Reason|0|||
129815028|NCT00599924|467290044|FG000|Overall Study|Lack of Efficacy|3|||
129815029|NCT00599924|467290045|FG001|Overall Study|Lack of Efficacy|5|||
129815030|NCT00599924|467290046|FG002|Overall Study|Lack of Efficacy|1|||
129815031|NCT00599924|467290047|FG003|Overall Study|Lack of Efficacy|2|||
129815032|NCT00599924|467290048|FG004|Overall Study|Lack of Efficacy|3|||
129815033|NCT00599924|467290049|FG005|Overall Study|Lack of Efficacy|2|||
129815034|NCT00599924|467290050|FG006|Overall Study|Lack of Efficacy|0|||
129815035|NCT00599924|467290044|FG000|Overall Study|Adverse Event|0|||
129815036|NCT00599924|467290045|FG001|Overall Study|Adverse Event|0|||
129815037|NCT00599924|467290046|FG002|Overall Study|Adverse Event|0|||
129815038|NCT00599924|467290047|FG003|Overall Study|Adverse Event|2|||
129815039|NCT00599924|467290048|FG004|Overall Study|Adverse Event|0|||
129815040|NCT00599924|467290049|FG005|Overall Study|Adverse Event|0|||
129815041|NCT00599924|467290050|FG006|Overall Study|Adverse Event|2|||
129815042|NCT00599924|467290044|FG000|Overall Study|Death|0|||
129897079|NCT02081391|467582201|FG003|12-hour Treatment|Further reasons|0|||
129897080|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
129897081|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
129897082|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
129897083|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
129897084|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
129897085|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
129815043|NCT00599924|467290045|FG001|Overall Study|Death|0|||
129815044|NCT00599924|467290046|FG002|Overall Study|Death|0|||
129815045|NCT00599924|467290047|FG003|Overall Study|Death|2|||
129815046|NCT00599924|467290048|FG004|Overall Study|Death|0|||
129815047|NCT00599924|467290049|FG005|Overall Study|Death|2|||
129815048|NCT00599924|467290050|FG006|Overall Study|Death|1|||
129815049|NCT00599924|467290044|FG000|Overall Study|Protocol Violation|0|||
129815050|NCT00599924|467290045|FG001|Overall Study|Protocol Violation|0|||
129815051|NCT00599924|467290046|FG002|Overall Study|Protocol Violation|0|||
129815052|NCT00599924|467290047|FG003|Overall Study|Protocol Violation|1|||
129815053|NCT00599924|467290048|FG004|Overall Study|Protocol Violation|0|||
129815054|NCT00599924|467290049|FG005|Overall Study|Protocol Violation|0|||
129815055|NCT00599924|467290050|FG006|Overall Study|Protocol Violation|0|||
129815056|NCT00599924|467290044|FG000|Overall Study|Withdrawal by Subject|0|||
129815057|NCT00599924|467290045|FG001|Overall Study|Withdrawal by Subject|0|||
129815058|NCT00599924|467290046|FG002|Overall Study|Withdrawal by Subject|1|||
129815059|NCT00599924|467290047|FG003|Overall Study|Withdrawal by Subject|0|||
129815060|NCT00599924|467290048|FG004|Overall Study|Withdrawal by Subject|1|||
129815061|NCT00599924|467290049|FG005|Overall Study|Withdrawal by Subject|0|||
129815062|NCT00599924|467290050|FG006|Overall Study|Withdrawal by Subject|0|||
129815063|NCT00599924|467290044|FG000|Overall Study|Other|0|||
129815064|NCT00599924|467290045|FG001|Overall Study|Other|0|||
129815065|NCT00599924|467290046|FG002|Overall Study|Other|0|||
129815066|NCT00599924|467290047|FG003|Overall Study|Other|1|||
129815067|NCT00599924|467290048|FG004|Overall Study|Other|2|||
129815068|NCT00599924|467290049|FG005|Overall Study|Other|0|||
129815069|NCT00599924|467290050|FG006|Overall Study|Other|2|||
129815070|NCT01806298|467290051|FG000|Overall Study|Adverse Event|3|||
129815071|NCT01806298|467290051|FG000|Overall Study|Protocol Non-compliance|1|||
129815072|NCT01806298|467290051|FG000|Overall Study|Withdrawal by Subject|1|||
129815073|NCT01806298|467290051|FG000|Overall Study|Other|5|||
129815074|NCT03808545|467290052|FG000|Overall Study|Withdrawal by Subject|1|||
129815075|NCT03808545|467290053|FG001|Overall Study|Withdrawal by Subject|1|||
129815076|NCT05035550|467290064|FG000|Overall Study|Withdrawal by Subject|3|||
129815077|NCT05035550|467290065|FG001|Overall Study|Withdrawal by Subject|0|||
129815078|NCT01396148|467290066|FG000|Overall Study|Patient Decision|1|||
129815079|NCT02732119|467290069|FG000|Phase I|Adverse Event|1|||
129815080|NCT02732119|467290070|FG001|Phase I|Adverse Event|3|||
129815081|NCT02732119|467290071|FG002|Phase I|Adverse Event|1|||
129815082|NCT02732119|467290072|FG003|Phase I|Adverse Event|0|||
129815083|NCT02732119|467290073|FG004|Phase I|Adverse Event|0|||
129815084|NCT02732119|467290069|FG000|Phase I|Progressive disease|7|||
129815085|NCT02732119|467290070|FG001|Phase I|Progressive disease|3|||
129815086|NCT02732119|467290071|FG002|Phase I|Progressive disease|2|||
129815087|NCT02732119|467290072|FG003|Phase I|Progressive disease|0|||
129815088|NCT02732119|467290073|FG004|Phase I|Progressive disease|0|||
129815089|NCT02732119|467290069|FG000|Phase I|Protocol deviation|0|||
129815090|NCT02732119|467290070|FG001|Phase I|Protocol deviation|1|||
129815091|NCT02732119|467290071|FG002|Phase I|Protocol deviation|0|||
129815092|NCT02732119|467290072|FG003|Phase I|Protocol deviation|0|||
129815093|NCT02732119|467290073|FG004|Phase I|Protocol deviation|0|||
129815094|NCT02732119|467290069|FG000|Phase I|Physician Decision|0|||
129815095|NCT02732119|467290070|FG001|Phase I|Physician Decision|3|||
129815096|NCT02732119|467290071|FG002|Phase I|Physician Decision|4|||
129815097|NCT02732119|467290072|FG003|Phase I|Physician Decision|0|||
129815098|NCT02732119|467290073|FG004|Phase I|Physician Decision|0|||
129815099|NCT02732119|467290069|FG000|Phase II|Adverse Event|0|||
129815100|NCT02732119|467290070|FG001|Phase II|Adverse Event|0|||
129815101|NCT02732119|467290071|FG002|Phase II|Adverse Event|0|||
129815102|NCT02732119|467290072|FG003|Phase II|Adverse Event|3|||
129815103|NCT02732119|467290073|FG004|Phase II|Adverse Event|3|||
129815104|NCT02732119|467290069|FG000|Phase II|Death|0|||
129815105|NCT02732119|467290070|FG001|Phase II|Death|0|||
129815106|NCT02732119|467290071|FG002|Phase II|Death|0|||
129815107|NCT02732119|467290072|FG003|Phase II|Death|1|||
129815108|NCT02732119|467290073|FG004|Phase II|Death|0|||
129815109|NCT02732119|467290069|FG000|Phase II|Progressive dissease|0|||
129815110|NCT02732119|467290070|FG001|Phase II|Progressive dissease|0|||
129815111|NCT02732119|467290071|FG002|Phase II|Progressive dissease|0|||
129815112|NCT02732119|467290072|FG003|Phase II|Progressive dissease|30|||
129815113|NCT02732119|467290073|FG004|Phase II|Progressive dissease|23|||
129815114|NCT02732119|467290069|FG000|Phase II|Study terminated by sponsor|0|||
129815115|NCT02732119|467290070|FG001|Phase II|Study terminated by sponsor|0|||
129815116|NCT02732119|467290071|FG002|Phase II|Study terminated by sponsor|0|||
129815117|NCT02732119|467290072|FG003|Phase II|Study terminated by sponsor|2|||
129815118|NCT02732119|467290073|FG004|Phase II|Study terminated by sponsor|2|||
129815119|NCT02732119|467290069|FG000|Phase II|Other|0|||
129815120|NCT02732119|467290070|FG001|Phase II|Other|0|||
129815121|NCT02732119|467290071|FG002|Phase II|Other|0|||
129815122|NCT02732119|467290072|FG003|Phase II|Other|2|||
129815123|NCT02732119|467290073|FG004|Phase II|Other|0|||
129815124|NCT02732119|467290069|FG000|Phase II|Physician Decision|0|||
129815125|NCT02732119|467290070|FG001|Phase II|Physician Decision|0|||
129815126|NCT02732119|467290071|FG002|Phase II|Physician Decision|0|||
129815127|NCT02732119|467290072|FG003|Phase II|Physician Decision|8|||
129815128|NCT02732119|467290073|FG004|Phase II|Physician Decision|5|||
129815129|NCT00003479|467290074|FG000|Overall Study|Not evaluable|3|||
129815130|NCT02128113|467290077|FG000|Overall Study|Withdrawal by Subject|3|||
129815131|NCT02128113|467290078|FG001|Overall Study|Withdrawal by Subject|1|||
129815132|NCT02128113|467290079|FG002|Overall Study|Withdrawal by Subject|0|||
129815133|NCT02128113|467290077|FG000|Overall Study|Protocol Violation|0|||
129815134|NCT02128113|467290078|FG001|Overall Study|Protocol Violation|1|||
129815135|NCT02128113|467290079|FG002|Overall Study|Protocol Violation|0|||
129815136|NCT02128113|467290077|FG000|Overall Study|Surgery cancelled|0|||
129815137|NCT02128113|467290078|FG001|Overall Study|Surgery cancelled|1|||
129815138|NCT02128113|467290079|FG002|Overall Study|Surgery cancelled|0|||
129815139|NCT02128113|467290077|FG000|Overall Study|Adverse Event|0|||
129815140|NCT02128113|467290078|FG001|Overall Study|Adverse Event|0|||
129815141|NCT02128113|467290079|FG002|Overall Study|Adverse Event|1|||
129815142|NCT01061177|467290080|FG000|Overall Study|Adverse Event|117|||
129815143|NCT01061177|467290080|FG000|Overall Study|Withdrawal by Subject|27|||
129815144|NCT01061177|467290080|FG000|Overall Study|Disease progression|17|||
129815145|NCT01061177|467290080|FG000|Overall Study|Protocol Violation|11|||
129815146|NCT01061177|467290080|FG000|Overall Study|Lost to Follow-up|9|||
129815147|NCT01061177|467290080|FG000|Overall Study|New cancer therapy|9|||
129815148|NCT01061177|467290080|FG000|Overall Study|Abnormal laboratory values|6|||
129815149|NCT01061177|467290080|FG000|Overall Study|Abnormal test procedure results|4|||
129815150|NCT01061177|467290080|FG000|Overall Study|Administratie problems|4|||
129815151|NCT01061177|467290080|FG000|Overall Study|Death|4|||
129815152|NCT02244606|467290093|FG000|Overall Study|Adverse Event|0|||
129815153|NCT02244606|467290094|FG001|Overall Study|Adverse Event|1|||
129815154|NCT02244606|467290095|FG002|Overall Study|Adverse Event|1|||
129815155|NCT02244606|467290096|FG003|Overall Study|Adverse Event|0|||
129815156|NCT02244606|467290093|FG000|Overall Study|Lost to Follow-up|2|||
129815157|NCT02244606|467290094|FG001|Overall Study|Lost to Follow-up|2|||
129815158|NCT02244606|467290095|FG002|Overall Study|Lost to Follow-up|1|||
129815159|NCT02244606|467290096|FG003|Overall Study|Lost to Follow-up|0|||
129815160|NCT02244606|467290093|FG000|Overall Study|Protocol Violation|0|||
129815161|NCT02244606|467290094|FG001|Overall Study|Protocol Violation|0|||
129815162|NCT02244606|467290095|FG002|Overall Study|Protocol Violation|0|||
129815163|NCT02244606|467290096|FG003|Overall Study|Protocol Violation|1|||
129815164|NCT02244606|467290093|FG000|Overall Study|Withdrawal by Subject|1|||
129815165|NCT02244606|467290094|FG001|Overall Study|Withdrawal by Subject|1|||
129815166|NCT02244606|467290095|FG002|Overall Study|Withdrawal by Subject|0|||
129815167|NCT02244606|467290096|FG003|Overall Study|Withdrawal by Subject|0|||
129815168|NCT02244606|467290093|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
129815169|NCT02244606|467290094|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
129815170|NCT02244606|467290095|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
129815171|NCT02244606|467290096|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
129815172|NCT00553644|467290097|FG000|Overall Study|Adverse Event|17|||
129815173|NCT00553644|467290097|FG000|Overall Study|Withdrawal by Subject|4|||
129815174|NCT00553644|467290097|FG000|Overall Study|Physician Decision|1|||
129815175|NCT00553644|467290097|FG000|Overall Study|Alternative therapy|6|||
129815176|NCT02197247|467290098|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
129815177|NCT02197247|467290098|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
129815178|NCT02197247|467290098|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
129815179|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
129815180|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
129815181|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
129815182|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
129815183|NCT02197247|467290098|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
129815184|NCT01930123|467290106|FG000|Overall Study|Adverse Event|1|||
129815185|NCT01930123|467290107|FG001|Overall Study|Adverse Event|0|||
129815186|NCT01930123|467290106|FG000|Overall Study|Physician Decision|21|||
129815187|NCT01930123|467290107|FG001|Overall Study|Physician Decision|8|||
129815188|NCT01930123|467290106|FG000|Overall Study|Withdrawal by Subject|1|||
129815189|NCT01930123|467290107|FG001|Overall Study|Withdrawal by Subject|0|||
129815190|NCT01447433|467290110|FG000|Overall Study|Lost to Follow-up|0|||
129815191|NCT01447433|467290111|FG001|Overall Study|Lost to Follow-up|2|||
129815192|NCT01447433|467290110|FG000|Overall Study|Withdrawal by Subject|3|||
129815193|NCT01447433|467290111|FG001|Overall Study|Withdrawal by Subject|3|||
129815194|NCT01447433|467290110|FG000|Overall Study|Protocol Violation|1|||
129815195|NCT01447433|467290111|FG001|Overall Study|Protocol Violation|1|||
129815196|NCT00036270|467290112|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
129815197|NCT00036270|467290113|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
129897086|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
129897087|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
129897088|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
129897089|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
129815198|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
129815199|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
129815200|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
129815201|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
129815202|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
129815203|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
129815204|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Other|277|||
129815205|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Other|288|||
129815206|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
129815207|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
129815208|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
129815209|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
129815210|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
129815211|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
129815212|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
129815213|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
129815214|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
129815215|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
129815216|NCT00036270|467290112|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
129815217|NCT00036270|467290113|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
129815218|NCT01964430|467290114|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
129815219|NCT01964430|467290115|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
129815220|NCT01964430|467290114|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
129815221|NCT01964430|467290115|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
129815222|NCT01964430|467290114|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
129815223|NCT01964430|467290115|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
129815224|NCT01964430|467290114|FG000|Treatment Period|Adverse Event|71|||
129815225|NCT01964430|467290115|FG001|Treatment Period|Adverse Event|37|||
129815226|NCT01964430|467290114|FG000|Treatment Period|Withdrawal by Subject|36|||
129815227|NCT01964430|467290115|FG001|Treatment Period|Withdrawal by Subject|27|||
129815228|NCT01964430|467290114|FG000|Treatment Period|Death|1|||
129815229|NCT01964430|467290115|FG001|Treatment Period|Death|3|||
129815230|NCT01964430|467290114|FG000|Treatment Period|Protocol Deviation|0|||
129815231|NCT01964430|467290115|FG001|Treatment Period|Protocol Deviation|1|||
129815232|NCT01964430|467290114|FG000|Treatment Period|Physician Decision|5|||
129815233|NCT01964430|467290115|FG001|Treatment Period|Physician Decision|4|||
129815234|NCT01964430|467290114|FG000|Treatment Period|Disease Relapse|28|||
129815235|NCT01964430|467290115|FG001|Treatment Period|Disease Relapse|38|||
129815236|NCT01964430|467290114|FG000|Treatment Period|Other reasons|1|||
129815237|NCT01964430|467290115|FG001|Treatment Period|Other reasons|3|||
129815238|NCT02516163|467290116|FG000|Overall Study|Withdrawal by Subject|1|||
129815239|NCT02516163|467290116|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
129815240|NCT02516163|467290116|FG000|Overall Study|Unfit/delay in surgery|3|||
129815241|NCT02516163|467290116|FG000|Overall Study|Use of incorrect measurement technique|5|||
129815242|NCT02516163|467290116|FG000|Overall Study|Data not recorded|2|||
129815243|NCT02516163|467290116|FG000|Overall Study|MRI contraindication exclusion|6|||
129815244|NCT02801396|467290117|FG000|Period 1|Withdrawal by Subject|0|||
129815245|NCT02801396|467290118|FG001|Period 1|Withdrawal by Subject|0|||
129815246|NCT02801396|467290119|FG002|Period 1|Withdrawal by Subject|0|||
129815247|NCT02801396|467290120|FG003|Period 1|Withdrawal by Subject|0|||
129815248|NCT02801396|467290121|FG004|Period 1|Withdrawal by Subject|1|||
129815249|NCT02801396|467290122|FG005|Period 1|Withdrawal by Subject|0|||
129815250|NCT01658072|467290125|FG000|Overall Study|Protocol Violation|4|||
129815251|NCT01658072|467290126|FG001|Overall Study|Protocol Violation|2|||
129815252|NCT01874054|467290128|FG000|Overall Study|Withdrawal by Subject|3|||
129815253|NCT01874054|467290128|FG000|Overall Study|Study Termination by Sponsor|42|||
129815254|NCT01874054|467290128|FG000|Overall Study|Lost to Follow-up|5|||
129815255|NCT01874054|467290128|FG000|Overall Study|Death|5|||
129815256|NCT00702923|467290129|FG000|Overall Study|Adverse Event|1|||
129815257|NCT00291577|467290130|FG000|Overall Study|Adverse Event|1|||
129815258|NCT00291577|467290130|FG000|Overall Study|Other|4|||
129815259|NCT00291577|467290130|FG000|Overall Study|Withdrawal by Subject|2|||
129815260|NCT00291577|467290130|FG000|Overall Study|Lack of Efficacy|14|||
129815261|NCT01587001|467290136|FG000|Overall Study|Lost to Follow-up|2|||
129815262|NCT01587001|467290137|FG001|Overall Study|Lost to Follow-up|0|||
129815263|NCT01587001|467290136|FG000|Overall Study|Insufficient samples to complete testing|4|||
129815264|NCT01587001|467290137|FG001|Overall Study|Insufficient samples to complete testing|1|||
129815265|NCT02756013|467290140|FG000|Overall Study|Adverse Event|1|||
129815266|NCT02756013|467290140|FG000|Overall Study|Hypersensitivity|1|||
129815267|NCT03706456|467290141|FG000|Overall Study|Adverse Event|1|||
129815268|NCT03706456|467290141|FG000|Overall Study|Lack of Efficacy|2|||
129815269|NCT02784431|467290142|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
129815270|NCT02784431|467290142|FG000|Overall Study|Early Study Termination|19|||
129815271|NCT02605824|467290143|FG000|Overall Study|Physician Decision|1|||
129815272|NCT02605824|467290144|FG001|Overall Study|Physician Decision|0|||
129815273|NCT00393029|467290145|FG000|Overall Study|Not treated|0|||
129815274|NCT00393029|467290146|FG001|Overall Study|Not treated|1|||
129815275|NCT04659161|467290147|FG000|Overall Study|Adverse Event|10|||
129815276|NCT04659161|467290148|FG001|Overall Study|Adverse Event|6|||
129815277|NCT04659161|467290147|FG000|Overall Study|Withdrawal by Subject|13|||
129815278|NCT04659161|467290148|FG001|Overall Study|Withdrawal by Subject|12|||
129815279|NCT04659161|467290147|FG000|Overall Study|Other|9|||
129815280|NCT04659161|467290148|FG001|Overall Study|Other|8|||
129815281|NCT03715530|467290149|FG000|Overall Study|Lost to Follow-up|3|||
129815282|NCT03715530|467290150|FG001|Overall Study|Lost to Follow-up|1|||
129815283|NCT03715530|467290151|FG002|Overall Study|Lost to Follow-up|2|||
129815284|NCT01929343|467290152|FG000|Overall Study|Physician Decision|0|||
129815285|NCT01929343|467290153|FG001|Overall Study|Physician Decision|2|||
129815286|NCT01929343|467290154|FG002|Overall Study|Physician Decision|0|||
129815287|NCT01929343|467290152|FG000|Overall Study|Withdrawal by Subject|1|||
129815288|NCT01929343|467290153|FG001|Overall Study|Withdrawal by Subject|0|||
129815289|NCT01929343|467290154|FG002|Overall Study|Withdrawal by Subject|0|||
129815290|NCT02197130|467290157|FG000|Overall Study|Adverse Event|13|||
129815291|NCT02197130|467290158|FG001|Overall Study|Adverse Event|4|||
129815292|NCT02197130|467290159|FG002|Overall Study|Adverse Event|23|||
129815293|NCT02197130|467290157|FG000|Overall Study|Death|0|||
129815294|NCT02197130|467290158|FG001|Overall Study|Death|1|||
129815295|NCT02197130|467290159|FG002|Overall Study|Death|0|||
129815296|NCT02197130|467290157|FG000|Overall Study|Lost to Follow-up|2|||
129815297|NCT02197130|467290158|FG001|Overall Study|Lost to Follow-up|0|||
129815298|NCT02197130|467290159|FG002|Overall Study|Lost to Follow-up|1|||
129815299|NCT02197130|467290157|FG000|Overall Study|Does not meet entrance criteria|0|||
129815300|NCT02197130|467290158|FG001|Overall Study|Does not meet entrance criteria|0|||
129815301|NCT02197130|467290159|FG002|Overall Study|Does not meet entrance criteria|1|||
129815302|NCT02197130|467290157|FG000|Overall Study|Withdrawal by Subject|0|||
129815303|NCT02197130|467290158|FG001|Overall Study|Withdrawal by Subject|3|||
129815304|NCT02197130|467290159|FG002|Overall Study|Withdrawal by Subject|4|||
129815305|NCT02197130|467290157|FG000|Overall Study|Other|1|||
129815306|NCT02197130|467290158|FG001|Overall Study|Other|0|||
129815307|NCT02197130|467290159|FG002|Overall Study|Other|3|||
129815308|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815309|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
129815310|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815311|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
129815312|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
129815313|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815314|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815315|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815316|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815317|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815318|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815319|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815320|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815321|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815322|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
129815323|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
129815324|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
129815325|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
129815326|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815327|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815328|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815329|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815330|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815331|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815332|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815333|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815334|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815335|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815336|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815337|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
129815338|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815339|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815340|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815341|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
129815342|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815343|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815344|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815345|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815346|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815347|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815348|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815349|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815350|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815351|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815352|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
129815353|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815354|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
129815355|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815356|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815357|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815358|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815359|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815360|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815361|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815362|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815363|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815364|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815365|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815366|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815367|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
129815368|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815369|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815370|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815371|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815372|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
129815373|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815374|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815375|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815376|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815377|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815378|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815379|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815380|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815381|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815382|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
129815383|NCT01737697|467290165|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815384|NCT01737697|467290166|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
129815385|NCT01737697|467290167|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
129815386|NCT01737697|467290168|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
129815387|NCT01737697|467290169|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
129815388|NCT01737697|467290170|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815389|NCT01737697|467290171|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815390|NCT01737697|467290172|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815391|NCT01737697|467290173|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815392|NCT01737697|467290174|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815393|NCT01737697|467290175|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815394|NCT01737697|467290176|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815395|NCT01737697|467290177|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815396|NCT01737697|467290178|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815397|NCT01737697|467290179|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
129815398|NCT01737697|467290165|FG000|Subacute Phase|Adverse Event|0|||
129815399|NCT01737697|467290166|FG001|Subacute Phase|Adverse Event|0|||
129897090|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
129815400|NCT01737697|467290167|FG002|Subacute Phase|Adverse Event|0|||
129815401|NCT01737697|467290168|FG003|Subacute Phase|Adverse Event|0|||
129815402|NCT01737697|467290169|FG004|Subacute Phase|Adverse Event|0|||
129815403|NCT01737697|467290170|FG005|Subacute Phase|Adverse Event|1|||
129815404|NCT01737697|467290171|FG006|Subacute Phase|Adverse Event|1|||
129815405|NCT01737697|467290172|FG007|Subacute Phase|Adverse Event|1|||
129815406|NCT01737697|467290173|FG008|Subacute Phase|Adverse Event|1|||
129815407|NCT01737697|467290174|FG009|Subacute Phase|Adverse Event|1|||
129815408|NCT01737697|467290175|FG010|Subacute Phase|Adverse Event|4|||
129815409|NCT01737697|467290176|FG011|Subacute Phase|Adverse Event|1|||
129815410|NCT01737697|467290177|FG012|Subacute Phase|Adverse Event|1|||
129815411|NCT01737697|467290178|FG013|Subacute Phase|Adverse Event|0|||
129815412|NCT01737697|467290179|FG014|Subacute Phase|Adverse Event|0|||
129815413|NCT01737697|467290165|FG000|Subacute Phase|Withdrawal by Subject|0|||
129815414|NCT01737697|467290166|FG001|Subacute Phase|Withdrawal by Subject|0|||
129815415|NCT01737697|467290167|FG002|Subacute Phase|Withdrawal by Subject|0|||
129815416|NCT01737697|467290168|FG003|Subacute Phase|Withdrawal by Subject|0|||
129815417|NCT01737697|467290169|FG004|Subacute Phase|Withdrawal by Subject|0|||
129815418|NCT01737697|467290170|FG005|Subacute Phase|Withdrawal by Subject|1|||
129815419|NCT01737697|467290171|FG006|Subacute Phase|Withdrawal by Subject|0|||
129815420|NCT01737697|467290172|FG007|Subacute Phase|Withdrawal by Subject|2|||
129815421|NCT01737697|467290173|FG008|Subacute Phase|Withdrawal by Subject|0|||
129815422|NCT01737697|467290174|FG009|Subacute Phase|Withdrawal by Subject|1|||
129815423|NCT01737697|467290175|FG010|Subacute Phase|Withdrawal by Subject|0|||
129815424|NCT01737697|467290176|FG011|Subacute Phase|Withdrawal by Subject|1|||
129815425|NCT01737697|467290177|FG012|Subacute Phase|Withdrawal by Subject|1|||
129815426|NCT01737697|467290178|FG013|Subacute Phase|Withdrawal by Subject|1|||
129815427|NCT01737697|467290179|FG014|Subacute Phase|Withdrawal by Subject|0|||
129815428|NCT01737697|467290165|FG000|Subacute Phase|Lost to Follow-up|0|||
129815429|NCT01737697|467290166|FG001|Subacute Phase|Lost to Follow-up|0|||
129815430|NCT01737697|467290167|FG002|Subacute Phase|Lost to Follow-up|0|||
129815431|NCT01737697|467290168|FG003|Subacute Phase|Lost to Follow-up|0|||
129815432|NCT01737697|467290169|FG004|Subacute Phase|Lost to Follow-up|0|||
129815433|NCT01737697|467290170|FG005|Subacute Phase|Lost to Follow-up|0|||
129815434|NCT01737697|467290171|FG006|Subacute Phase|Lost to Follow-up|0|||
129815435|NCT01737697|467290172|FG007|Subacute Phase|Lost to Follow-up|0|||
129815436|NCT01737697|467290173|FG008|Subacute Phase|Lost to Follow-up|0|||
129815437|NCT01737697|467290174|FG009|Subacute Phase|Lost to Follow-up|0|||
129815438|NCT01737697|467290175|FG010|Subacute Phase|Lost to Follow-up|0|||
129815439|NCT01737697|467290176|FG011|Subacute Phase|Lost to Follow-up|0|||
129815440|NCT01737697|467290177|FG012|Subacute Phase|Lost to Follow-up|0|||
129815441|NCT01737697|467290178|FG013|Subacute Phase|Lost to Follow-up|0|||
129815442|NCT01737697|467290179|FG014|Subacute Phase|Lost to Follow-up|1|||
129815443|NCT01737697|467290165|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
129815444|NCT01737697|467290166|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
129815445|NCT01737697|467290167|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
129815446|NCT01737697|467290168|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
129815447|NCT01737697|467290169|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
129815448|NCT01737697|467290170|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
129815449|NCT01737697|467290171|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
129815450|NCT01737697|467290172|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
129815451|NCT01737697|467290173|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
129815452|NCT01737697|467290174|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
129815453|NCT01737697|467290175|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
129815454|NCT01737697|467290176|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
129815455|NCT01737697|467290177|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
129815456|NCT01737697|467290178|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
129815457|NCT01737697|467290179|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
129815458|NCT01737697|467290165|FG000|Subacute Phase|Protocol Violation|0|||
129815459|NCT01737697|467290166|FG001|Subacute Phase|Protocol Violation|0|||
129815460|NCT01737697|467290167|FG002|Subacute Phase|Protocol Violation|0|||
129815461|NCT01737697|467290168|FG003|Subacute Phase|Protocol Violation|0|||
129815462|NCT01737697|467290169|FG004|Subacute Phase|Protocol Violation|0|||
129815463|NCT01737697|467290170|FG005|Subacute Phase|Protocol Violation|1|||
129815464|NCT01737697|467290171|FG006|Subacute Phase|Protocol Violation|0|||
129815465|NCT01737697|467290172|FG007|Subacute Phase|Protocol Violation|0|||
129815466|NCT01737697|467290173|FG008|Subacute Phase|Protocol Violation|0|||
129815467|NCT01737697|467290174|FG009|Subacute Phase|Protocol Violation|0|||
129815468|NCT01737697|467290175|FG010|Subacute Phase|Protocol Violation|1|||
129815469|NCT01737697|467290176|FG011|Subacute Phase|Protocol Violation|0|||
129815470|NCT01737697|467290177|FG012|Subacute Phase|Protocol Violation|0|||
129815471|NCT01737697|467290178|FG013|Subacute Phase|Protocol Violation|0|||
129815472|NCT01737697|467290179|FG014|Subacute Phase|Protocol Violation|0|||
129815473|NCT01737697|467290165|FG000|Subacute Phase|Physician Decision|0|||
129815474|NCT01737697|467290166|FG001|Subacute Phase|Physician Decision|0|||
129815475|NCT01737697|467290167|FG002|Subacute Phase|Physician Decision|0|||
129815476|NCT01737697|467290168|FG003|Subacute Phase|Physician Decision|0|||
129815477|NCT01737697|467290169|FG004|Subacute Phase|Physician Decision|0|||
129815478|NCT01737697|467290170|FG005|Subacute Phase|Physician Decision|0|||
129815479|NCT01737697|467290171|FG006|Subacute Phase|Physician Decision|0|||
129815480|NCT01737697|467290172|FG007|Subacute Phase|Physician Decision|0|||
129815481|NCT01737697|467290173|FG008|Subacute Phase|Physician Decision|1|||
129815482|NCT01737697|467290174|FG009|Subacute Phase|Physician Decision|0|||
129815483|NCT01737697|467290175|FG010|Subacute Phase|Physician Decision|0|||
129815484|NCT01737697|467290176|FG011|Subacute Phase|Physician Decision|0|||
129815485|NCT01737697|467290177|FG012|Subacute Phase|Physician Decision|0|||
129815486|NCT01737697|467290178|FG013|Subacute Phase|Physician Decision|0|||
129815487|NCT01737697|467290179|FG014|Subacute Phase|Physician Decision|0|||
129815488|NCT01737697|467290165|FG000|Subacute Phase|Death|0|||
129815489|NCT01737697|467290166|FG001|Subacute Phase|Death|0|||
129815490|NCT01737697|467290167|FG002|Subacute Phase|Death|0|||
129815491|NCT01737697|467290168|FG003|Subacute Phase|Death|0|||
129815492|NCT01737697|467290169|FG004|Subacute Phase|Death|0|||
129815493|NCT01737697|467290170|FG005|Subacute Phase|Death|0|||
129815494|NCT01737697|467290171|FG006|Subacute Phase|Death|0|||
129815495|NCT01737697|467290172|FG007|Subacute Phase|Death|0|||
129815496|NCT01737697|467290173|FG008|Subacute Phase|Death|0|||
129815497|NCT01737697|467290174|FG009|Subacute Phase|Death|0|||
129815498|NCT01737697|467290175|FG010|Subacute Phase|Death|1|||
129815499|NCT01737697|467290176|FG011|Subacute Phase|Death|0|||
129815500|NCT01737697|467290177|FG012|Subacute Phase|Death|0|||
129815501|NCT01737697|467290178|FG013|Subacute Phase|Death|0|||
129815502|NCT01737697|467290179|FG014|Subacute Phase|Death|0|||
129815503|NCT03338998|467290181|FG000|Treatment Period|Withdrawal by Subject|1|||
129815504|NCT03338998|467290182|FG001|Treatment Period|Withdrawal by Subject|1|||
129815505|NCT03338998|467290181|FG000|Treatment Period|Adverse Event|0|||
129815506|NCT03338998|467290182|FG001|Treatment Period|Adverse Event|2|||
129815507|NCT03338998|467290181|FG000|Treatment Period|Protocol deviation|1|||
129815508|NCT03338998|467290182|FG001|Treatment Period|Protocol deviation|0|||
129815509|NCT03338998|467290181|FG000|Treatment Period|Physician Decision|2|||
129815510|NCT03338998|467290182|FG001|Treatment Period|Physician Decision|0|||
129815511|NCT03338998|467290181|FG000|Treatment Period|Subject failed swallow test|4|||
129815512|NCT03338998|467290182|FG001|Treatment Period|Subject failed swallow test|0|||
129815513|NCT03338998|467290181|FG000|Safety Follow-Up Period|Adverse Event|0|||
129815514|NCT03338998|467290182|FG001|Safety Follow-Up Period|Adverse Event|1|||
129815515|NCT03338998|467290181|FG000|Safety Follow-Up Period|Protocol deviation|1|||
129815516|NCT03338998|467290182|FG001|Safety Follow-Up Period|Protocol deviation|0|||
129815517|NCT03338998|467290181|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
129815518|NCT03338998|467290182|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
129815519|NCT03288129|467290183|FG000|Overall Study|Adverse Event|10|||
129815520|NCT03288129|467290183|FG000|Overall Study|Lost to Follow-up|3|||
129815521|NCT03288129|467290183|FG000|Overall Study|Withdrawal by Subject|3|||
129815522|NCT03288129|467290183|FG000|Overall Study|Withdrawal of consent/assent|1|||
129815523|NCT03288129|467290183|FG000|Overall Study|Other|5|||
129815524|NCT00558558|467290188|FG000|Overall Study|Unable to swallow|1|||
129815525|NCT00558558|467290188|FG000|Overall Study|Withdrawal by Subject|1|||
129815526|NCT00558558|467290188|FG000|Overall Study|Lack of Efficacy|4|||
129815527|NCT05255068|467292334|FG000|Overall Study|Lost to Follow-up|0|||
129815528|NCT05255068|467292335|FG001|Overall Study|Lost to Follow-up|1|||
129815529|NCT00980057|467292340|FG000|Overall Study|Death|13|||
129815530|NCT00980057|467292341|FG001|Overall Study|Death|3|||
129815531|NCT00980057|467292340|FG000|Overall Study|Adverse Event|0|||
129815532|NCT00980057|467292341|FG001|Overall Study|Adverse Event|1|||
129815533|NCT00980057|467292340|FG000|Overall Study|Physician Decision|4|||
129815534|NCT00980057|467292341|FG001|Overall Study|Physician Decision|0|||
129815535|NCT00980057|467292340|FG000|Overall Study|Lost to Follow-up|1|||
129815536|NCT00980057|467292341|FG001|Overall Study|Lost to Follow-up|0|||
129815537|NCT00980057|467292340|FG000|Overall Study|Withdrawal by Subject|1|||
129815538|NCT00980057|467292341|FG001|Overall Study|Withdrawal by Subject|1|||
129815539|NCT01408485|467292345|FG000|Overall Study|Withdrawal by Subject|21|||
129815540|NCT01315678|467292346|FG000|Overall Study|Withdrawal by Subject|7|||
129815541|NCT01315678|467292347|FG001|Overall Study|Withdrawal by Subject|3|||
129815542|NCT01315678|467292346|FG000|Overall Study|Adverse Event|3|||
129815543|NCT01315678|467292347|FG001|Overall Study|Adverse Event|1|||
129815544|NCT01315678|467292346|FG000|Overall Study|Lost to Follow-up|1|||
129815545|NCT01315678|467292347|FG001|Overall Study|Lost to Follow-up|0|||
129815546|NCT01315678|467292346|FG000|Overall Study|similar reason to those listed above|3|||
129815547|NCT01315678|467292347|FG001|Overall Study|similar reason to those listed above|2|||
129815548|NCT00331682|467292348|FG000|Overall Study|Adverse Event|1|||
129815549|NCT00790023|467292349|FG000|Overall Study|Adverse Event|2|||
129815550|NCT00790023|467292350|FG001|Overall Study|Adverse Event|1|||
129815551|NCT00790023|467292351|FG002|Overall Study|Adverse Event|4|||
129815552|NCT00790023|467292349|FG000|Overall Study|Protocol Violation|2|||
129815553|NCT00790023|467292350|FG001|Overall Study|Protocol Violation|4|||
129815554|NCT00790023|467292351|FG002|Overall Study|Protocol Violation|2|||
129815555|NCT00790023|467292349|FG000|Overall Study|Withdrawal by Subject|2|||
129815556|NCT00790023|467292350|FG001|Overall Study|Withdrawal by Subject|0|||
129815557|NCT00790023|467292351|FG002|Overall Study|Withdrawal by Subject|6|||
129815558|NCT00790023|467292349|FG000|Overall Study|Lost to Follow-up|0|||
129815559|NCT00790023|467292350|FG001|Overall Study|Lost to Follow-up|0|||
129815560|NCT00790023|467292351|FG002|Overall Study|Lost to Follow-up|1|||
129815561|NCT00790023|467292349|FG000|Overall Study|Other|5|||
129815562|NCT00790023|467292350|FG001|Overall Study|Other|5|||
129897091|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
129897092|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
129815563|NCT00790023|467292351|FG002|Overall Study|Other|8|||
129815564|NCT01338792|467292352|FG000|Overall Study|Adverse Event|2|||
129815565|NCT01338792|467292352|FG000|Overall Study|Death|1|||
129815566|NCT01338792|467292352|FG000|Overall Study|Withdrawal by Subject|1|||
129815567|NCT00573469|467292353|FG000|Overall Study|Adverse Event|1|||
129815568|NCT00573469|467292354|FG001|Overall Study|Adverse Event|1|||
129815569|NCT00573469|467292355|FG002|Overall Study|Adverse Event|1|||
129815570|NCT00573469|467292353|FG000|Overall Study|Withdrawal by Subject|0|||
129815571|NCT00573469|467292354|FG001|Overall Study|Withdrawal by Subject|2|||
129815572|NCT00573469|467292355|FG002|Overall Study|Withdrawal by Subject|0|||
129815573|NCT00573469|467292353|FG000|Overall Study|Other|5|||
129815574|NCT00573469|467292354|FG001|Overall Study|Other|1|||
129815575|NCT00573469|467292355|FG002|Overall Study|Other|3|||
129815576|NCT02468414|467292356|FG000|Overall Study|Early Study Termination by Sponsor|1|||
129815577|NCT02468414|467292357|FG001|Overall Study|Early Study Termination by Sponsor|0|||
129815578|NCT02468414|467292356|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
129815579|NCT02468414|467292357|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
129815580|NCT02468414|467292356|FG000|Overall Study|Screen Failure|1|||
129815581|NCT02468414|467292357|FG001|Overall Study|Screen Failure|0|||
129815582|NCT00004978|467292358|FG000|Overall Study|Death|107|||
129815583|NCT00004978|467292359|FG001|Overall Study|Death|116|||
129815584|NCT00004978|467292358|FG000|Overall Study|Lost to Follow-up|101|||
129815585|NCT00004978|467292359|FG001|Overall Study|Lost to Follow-up|108|||
129815586|NCT00004978|467292358|FG000|Overall Study|Withdrawal by Subject|17|||
129815587|NCT00004978|467292359|FG001|Overall Study|Withdrawal by Subject|26|||
129815588|NCT00004978|467292358|FG000|Overall Study|site closure - not in analysis cohort|19|||
129815589|NCT00004978|467292359|FG001|Overall Study|site closure - not in analysis cohort|20|||
129815590|NCT01652703|467292360|FG000|Overall Study|Withdrawal by Subject|0|||
129815591|NCT01652703|467292361|FG001|Overall Study|Withdrawal by Subject|1|||
129815592|NCT01652703|467292362|FG002|Overall Study|Withdrawal by Subject|3|||
129815593|NCT01652703|467292363|FG003|Overall Study|Withdrawal by Subject|1|||
129815594|NCT01652703|467292364|FG004|Overall Study|Withdrawal by Subject|0|||
129815595|NCT01652703|467292365|FG005|Overall Study|Withdrawal by Subject|1|||
129815596|NCT01652703|467292360|FG000|Overall Study|Other|0|||
129815597|NCT01652703|467292361|FG001|Overall Study|Other|0|||
129815598|NCT01652703|467292362|FG002|Overall Study|Other|0|||
129815599|NCT01652703|467292363|FG003|Overall Study|Other|1|||
129815600|NCT01652703|467292364|FG004|Overall Study|Other|1|||
129815601|NCT01652703|467292365|FG005|Overall Study|Other|1|||
129815602|NCT03555591|467292369|FG000|Overall Study|Protocol Violation|77|||
129815603|NCT00187486|467292370|FG000|Overall Study|Protocol Violation|1|||
129815604|NCT02380677|467292371|FG000|Overall Study|Adverse Event|0|||
129815605|NCT02380677|467292372|FG001|Overall Study|Adverse Event|0|||
129815606|NCT02380677|467292373|FG002|Overall Study|Adverse Event|0|||
129815607|NCT02380677|467292374|FG003|Overall Study|Adverse Event|1|||
129815608|NCT02380677|467292375|FG004|Overall Study|Adverse Event|1|||
129815609|NCT02380677|467292376|FG005|Overall Study|Adverse Event|4|||
129815610|NCT02380677|467292377|FG006|Overall Study|Adverse Event|2|||
129815611|NCT02380677|467292378|FG007|Overall Study|Adverse Event|2|||
129815612|NCT02380677|467292379|FG008|Overall Study|Adverse Event|2|||
129815613|NCT02380677|467292380|FG009|Overall Study|Adverse Event|1|||
129815614|NCT02380677|467292381|FG010|Overall Study|Adverse Event|2|||
129815615|NCT02380677|467292382|FG011|Overall Study|Adverse Event|1|||
129815616|NCT02380677|467292371|FG000|Overall Study|Physician Decision|1|||
129815617|NCT02380677|467292372|FG001|Overall Study|Physician Decision|0|||
129815618|NCT02380677|467292373|FG002|Overall Study|Physician Decision|1|||
129815619|NCT02380677|467292374|FG003|Overall Study|Physician Decision|1|||
129815620|NCT02380677|467292375|FG004|Overall Study|Physician Decision|0|||
129815621|NCT02380677|467292376|FG005|Overall Study|Physician Decision|0|||
129815622|NCT02380677|467292377|FG006|Overall Study|Physician Decision|0|||
129815623|NCT02380677|467292378|FG007|Overall Study|Physician Decision|0|||
129815624|NCT02380677|467292379|FG008|Overall Study|Physician Decision|0|||
129815625|NCT02380677|467292380|FG009|Overall Study|Physician Decision|0|||
129815626|NCT02380677|467292381|FG010|Overall Study|Physician Decision|0|||
129815627|NCT02380677|467292382|FG011|Overall Study|Physician Decision|0|||
129815628|NCT02380677|467292371|FG000|Overall Study|Lack of Efficacy|0|||
129815629|NCT02380677|467292372|FG001|Overall Study|Lack of Efficacy|1|||
129815630|NCT02380677|467292373|FG002|Overall Study|Lack of Efficacy|2|||
129815631|NCT02380677|467292374|FG003|Overall Study|Lack of Efficacy|0|||
129815632|NCT02380677|467292375|FG004|Overall Study|Lack of Efficacy|4|||
129815633|NCT02380677|467292376|FG005|Overall Study|Lack of Efficacy|1|||
129815634|NCT02380677|467292377|FG006|Overall Study|Lack of Efficacy|1|||
129815635|NCT02380677|467292378|FG007|Overall Study|Lack of Efficacy|2|||
129815636|NCT02380677|467292379|FG008|Overall Study|Lack of Efficacy|2|||
129815637|NCT02380677|467292380|FG009|Overall Study|Lack of Efficacy|0|||
129815638|NCT02380677|467292381|FG010|Overall Study|Lack of Efficacy|2|||
129815639|NCT02380677|467292382|FG011|Overall Study|Lack of Efficacy|1|||
129815640|NCT02380677|467292371|FG000|Overall Study|Withdrawal by Subject|0|||
129815641|NCT02380677|467292372|FG001|Overall Study|Withdrawal by Subject|0|||
129815642|NCT02380677|467292373|FG002|Overall Study|Withdrawal by Subject|0|||
129815643|NCT02380677|467292374|FG003|Overall Study|Withdrawal by Subject|0|||
129815644|NCT02380677|467292375|FG004|Overall Study|Withdrawal by Subject|0|||
129815645|NCT02380677|467292376|FG005|Overall Study|Withdrawal by Subject|0|||
129815646|NCT02380677|467292377|FG006|Overall Study|Withdrawal by Subject|0|||
129815647|NCT02380677|467292378|FG007|Overall Study|Withdrawal by Subject|0|||
129815648|NCT02380677|467292379|FG008|Overall Study|Withdrawal by Subject|0|||
129815649|NCT02380677|467292380|FG009|Overall Study|Withdrawal by Subject|1|||
129815650|NCT02380677|467292381|FG010|Overall Study|Withdrawal by Subject|0|||
129815651|NCT02380677|467292382|FG011|Overall Study|Withdrawal by Subject|3|||
129815652|NCT02380677|467292371|FG000|Overall Study|Other|0|||
129815653|NCT02380677|467292372|FG001|Overall Study|Other|0|||
129815654|NCT02380677|467292373|FG002|Overall Study|Other|0|||
129815655|NCT02380677|467292374|FG003|Overall Study|Other|1|||
129815656|NCT02380677|467292375|FG004|Overall Study|Other|1|||
129815657|NCT02380677|467292376|FG005|Overall Study|Other|1|||
129815658|NCT02380677|467292377|FG006|Overall Study|Other|0|||
129815659|NCT02380677|467292378|FG007|Overall Study|Other|0|||
129815660|NCT02380677|467292379|FG008|Overall Study|Other|0|||
129815661|NCT02380677|467292380|FG009|Overall Study|Other|0|||
129815662|NCT02380677|467292381|FG010|Overall Study|Other|0|||
129815663|NCT02380677|467292382|FG011|Overall Study|Other|0|||
129815664|NCT01029795|467292387|FG000|Overall Study|Entry Criteria Not Met|2|||
129815665|NCT01029795|467292388|FG001|Overall Study|Entry Criteria Not Met|1|||
129815666|NCT01029795|467292387|FG000|Overall Study|Physician Decision|2|||
129815667|NCT01029795|467292388|FG001|Overall Study|Physician Decision|1|||
129815668|NCT01029795|467292387|FG000|Overall Study|Sponsor Decision|11|||
129815669|NCT01029795|467292388|FG001|Overall Study|Sponsor Decision|17|||
129815670|NCT01029795|467292387|FG000|Overall Study|Withdrawal by Subject|1|||
129815671|NCT01029795|467292388|FG001|Overall Study|Withdrawal by Subject|3|||
129815672|NCT03217175|467292389|FG000|Overall Study|Physician Decision|4|||
129815673|NCT03217175|467292390|FG001|Overall Study|Physician Decision|1|||
129815674|NCT01806545|467292396|FG000|Overall Study|Adverse Event|2|||
129815675|NCT01806545|467292397|FG001|Overall Study|Adverse Event|3|||
129815676|NCT01806545|467292396|FG000|Overall Study|Lost to Follow-up|1|||
129815677|NCT01806545|467292397|FG001|Overall Study|Lost to Follow-up|0|||
129815678|NCT01806545|467292396|FG000|Overall Study|Withdrawal by Subject|3|||
129815679|NCT01806545|467292397|FG001|Overall Study|Withdrawal by Subject|2|||
129815680|NCT01508650|467292398|FG000|Overall Study|Lost to Follow-up|0|||
129815681|NCT01508650|467292399|FG001|Overall Study|Lost to Follow-up|3|||
129815682|NCT02064894|467292400|FG000|Overall Study|Withdrawal by Subject|43|||
129815683|NCT02064894|467292401|FG001|Overall Study|Withdrawal by Subject|102|||
129815684|NCT02064894|467292402|FG002|Overall Study|Withdrawal by Subject|115|||
129815685|NCT00884312|467292411|FG000|Overall Study|Non-fatal Progressive Disease|0|||
129815686|NCT00884312|467292412|FG001|Overall Study|Non-fatal Progressive Disease|8|||
129815687|NCT00884312|467292411|FG000|Overall Study|Fatal Progressive Disease|0|||
129815688|NCT00884312|467292412|FG001|Overall Study|Fatal Progressive Disease|1|||
129897093|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
129897094|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
129897095|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
129897096|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
129897097|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
129897098|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
129897099|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
129897100|NCT02081391|467582198|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
129897101|NCT02081391|467582199|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
129897102|NCT02081391|467582200|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
129897103|NCT02081391|467582201|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
129815689|NCT00884312|467292411|FG000|Overall Study|Non-fatal Adverse Event|1|||
129815690|NCT00884312|467292412|FG001|Overall Study|Non-fatal Adverse Event|0|||
129815691|NCT00884312|467292411|FG000|Overall Study|Fatal Adverse Event|1|||
129815692|NCT00884312|467292412|FG001|Overall Study|Fatal Adverse Event|4|||
129815693|NCT00884312|467292411|FG000|Overall Study|Withdrawal by Subject|0|||
129815694|NCT00884312|467292412|FG001|Overall Study|Withdrawal by Subject|6|||
129815695|NCT00884312|467292411|FG000|Overall Study|Physician Decision|0|||
129815696|NCT00884312|467292412|FG001|Overall Study|Physician Decision|1|||
129815697|NCT00884312|467292411|FG000|Overall Study|Other|0|||
129815698|NCT00884312|467292412|FG001|Overall Study|Other|4|||
129815699|NCT00884312|467292411|FG000|Overall Study|Did Not Receive Study Drug|0|||
129815700|NCT00884312|467292412|FG001|Overall Study|Did Not Receive Study Drug|1|||
129815701|NCT00224042|467292413|FG000|Overall Study|Adverse Event|2|||
129815702|NCT00224042|467292414|FG001|Overall Study|Adverse Event|1|||
129815703|NCT00224042|467292413|FG000|Overall Study|Protocol Violation|0|||
129815704|NCT00224042|467292414|FG001|Overall Study|Protocol Violation|1|||
129815705|NCT00224042|467292413|FG000|Overall Study|Physician Decision|0|||
129815706|NCT00224042|467292414|FG001|Overall Study|Physician Decision|1|||
129815707|NCT00224042|467292413|FG000|Overall Study|Did not meet lab incusion criteria|2|||
129815708|NCT00224042|467292414|FG001|Overall Study|Did not meet lab incusion criteria|3|||
129815709|NCT00224042|467292413|FG000|Overall Study|Other|2|||
129815710|NCT00224042|467292414|FG001|Overall Study|Other|0|||
129815711|NCT00840450|467292415|FG000|Overall Study|Adverse Event|1|||
129815712|NCT00840450|467292415|FG000|Overall Study|Lack of Efficacy|2|||
129815713|NCT00617123|467292416|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
129815714|NCT00617123|467292417|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
129815715|NCT00617123|467292416|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
129815716|NCT00617123|467292417|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
129815717|NCT00617123|467292416|FG000|Referral Screening Period|Adverse Event|0|||
129815718|NCT00617123|467292417|FG001|Referral Screening Period|Adverse Event|1|||
129815719|NCT00617123|467292416|FG000|Study Treatment Period|Withdrawal by Subject|8|||
129815720|NCT00617123|467292417|FG001|Study Treatment Period|Withdrawal by Subject|12|||
129815721|NCT00617123|467292416|FG000|Study Treatment Period|Adverse Event|7|||
129815722|NCT00617123|467292417|FG001|Study Treatment Period|Adverse Event|3|||
129815723|NCT00617123|467292416|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
129815724|NCT00617123|467292417|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
129815725|NCT00617123|467292416|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
129815726|NCT00617123|467292417|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
129815727|NCT00133952|467292419|FG000|Overall Study|Adverse Event|1|||
129815728|NCT00133952|467292420|FG001|Overall Study|Adverse Event|2|||
129815729|NCT00133952|467292419|FG000|Overall Study|Death|3|||
129815730|NCT00133952|467292420|FG001|Overall Study|Death|2|||
129815731|NCT00133952|467292419|FG000|Overall Study|Lost to Follow-up|9|||
129815732|NCT00133952|467292420|FG001|Overall Study|Lost to Follow-up|14|||
129815733|NCT00133952|467292419|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
129815734|NCT00133952|467292420|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
129815735|NCT00133952|467292419|FG000|Overall Study|Protocol Violation|1|||
129815736|NCT00133952|467292420|FG001|Overall Study|Protocol Violation|1|||
129815737|NCT00133952|467292419|FG000|Overall Study|Withdrawal by Subject|20|||
129815738|NCT00133952|467292420|FG001|Overall Study|Withdrawal by Subject|4|||
129815739|NCT00133952|467292419|FG000|Overall Study|Physician Decision|4|||
129815740|NCT00133952|467292420|FG001|Overall Study|Physician Decision|3|||
129815741|NCT00133952|467292419|FG000|Overall Study|Sponsor Decision|0|||
129815742|NCT00133952|467292420|FG001|Overall Study|Sponsor Decision|1|||
129815743|NCT00299104|467292421|FG000|Treatment Period|Adverse Event|14|||
129815744|NCT00299104|467292422|FG001|Treatment Period|Adverse Event|9|||
129815745|NCT00299104|467292423|FG002|Treatment Period|Adverse Event|7|||
129815746|NCT00299104|467292421|FG000|Treatment Period|Death|1|||
129815747|NCT00299104|467292422|FG001|Treatment Period|Death|1|||
129815748|NCT00299104|467292423|FG002|Treatment Period|Death|1|||
129815749|NCT00299104|467292421|FG000|Treatment Period|Insufficient therapeutic response|34|||
129815750|NCT00299104|467292422|FG001|Treatment Period|Insufficient therapeutic response|13|||
129815751|NCT00299104|467292423|FG002|Treatment Period|Insufficient therapeutic response|8|||
129815752|NCT00299104|467292421|FG000|Treatment Period|Failure to return|9|||
129815753|NCT00299104|467292422|FG001|Treatment Period|Failure to return|8|||
129815754|NCT00299104|467292423|FG002|Treatment Period|Failure to return|8|||
129815755|NCT00299104|467292421|FG000|Treatment Period|Violation of selection criteria|1|||
129815756|NCT00299104|467292422|FG001|Treatment Period|Violation of selection criteria|2|||
129815757|NCT00299104|467292423|FG002|Treatment Period|Violation of selection criteria|0|||
129815758|NCT00299104|467292421|FG000|Treatment Period|Protocol Violation|1|||
129815759|NCT00299104|467292422|FG001|Treatment Period|Protocol Violation|1|||
129815760|NCT00299104|467292423|FG002|Treatment Period|Protocol Violation|0|||
129815761|NCT00299104|467292421|FG000|Treatment Period|Refused treatment|9|||
129815762|NCT00299104|467292422|FG001|Treatment Period|Refused treatment|2|||
129815763|NCT00299104|467292423|FG002|Treatment Period|Refused treatment|2|||
129815764|NCT00299104|467292421|FG000|Treatment Period|Withdrew consent|14|||
129815765|NCT00299104|467292422|FG001|Treatment Period|Withdrew consent|19|||
129815766|NCT00299104|467292423|FG002|Treatment Period|Withdrew consent|9|||
129815767|NCT00299104|467292421|FG000|Treatment Period|Administrative reasons|106|||
129815768|NCT00299104|467292422|FG001|Treatment Period|Administrative reasons|120|||
129815769|NCT00299104|467292423|FG002|Treatment Period|Administrative reasons|137|||
129815770|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Death|3|||
129815771|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Death|2|||
129815772|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Death|1|||
129815773|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
129897104|NCT01458275|467582202|FG000|Overall Study|Adverse Event|3|||
129815774|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
129815775|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
129815776|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
129815777|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
129815778|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
129815779|NCT00299104|467292421|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
129815780|NCT00299104|467292422|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
129815781|NCT00299104|467292423|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
129815782|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
129815783|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
129815784|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
129815785|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
129815786|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
129815787|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
129815788|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
129815789|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
129815790|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
129815791|NCT00299104|467292421|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
129815792|NCT00299104|467292422|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
129815793|NCT00299104|467292423|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
129815794|NCT00847379|467292424|FG000|Overall Study|Study terminated by Sponsor|59|||
129815795|NCT00847379|467292425|FG001|Overall Study|Study terminated by Sponsor|57|||
129815796|NCT00847379|467292426|FG002|Overall Study|Study terminated by Sponsor|57|||
129815797|NCT00003499|467292427|FG000|Overall Study|Not evaluable|8|||
129815798|NCT01727297|467292428|FG000|Overall Study|Death|13|||
129815799|NCT01727297|467292429|FG001|Overall Study|Death|0|||
129815800|NCT01727297|467292428|FG000|Overall Study|Protocol Violation|1|||
129815801|NCT01727297|467292429|FG001|Overall Study|Protocol Violation|10|||
129815802|NCT01727297|467292428|FG000|Overall Study|Adverse Event|3|||
129815803|NCT01727297|467292429|FG001|Overall Study|Adverse Event|1|||
129815804|NCT01727297|467292428|FG000|Overall Study|Lost to Follow-up|11|||
129815805|NCT01727297|467292429|FG001|Overall Study|Lost to Follow-up|0|||
129815806|NCT01727297|467292428|FG000|Overall Study|Withdrawal by Subject|26|||
129815807|NCT01727297|467292429|FG001|Overall Study|Withdrawal by Subject|27|||
129815808|NCT01727297|467292428|FG000|Overall Study|Physician Decision|19|||
129815809|NCT01727297|467292429|FG001|Overall Study|Physician Decision|5|||
129815810|NCT01727297|467292428|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
129815811|NCT01727297|467292429|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
129815812|NCT02042183|467292430|FG000|Overall Study|Physician Decision|7|||
129815813|NCT02042183|467292431|FG001|Overall Study|Physician Decision|2|||
129815814|NCT02042183|467292430|FG000|Overall Study|Lack of Efficacy|4|||
129815815|NCT02042183|467292431|FG001|Overall Study|Lack of Efficacy|3|||
129815816|NCT02042183|467292430|FG000|Overall Study|Non-compliance with Study Drug|2|||
129815817|NCT02042183|467292431|FG001|Overall Study|Non-compliance with Study Drug|3|||
129815818|NCT02042183|467292430|FG000|Overall Study|Adverse Event|17|||
129815819|NCT02042183|467292431|FG001|Overall Study|Adverse Event|6|||
129815820|NCT02042183|467292430|FG000|Overall Study|Other|3|||
129815821|NCT02042183|467292431|FG001|Overall Study|Other|3|||
129815822|NCT02042183|467292430|FG000|Overall Study|Withdrawal by Subject|21|||
129815823|NCT02042183|467292431|FG001|Overall Study|Withdrawal by Subject|16|||
129815824|NCT02042183|467292430|FG000|Overall Study|Site Terminated by Sponsor|2|||
129815825|NCT02042183|467292431|FG001|Overall Study|Site Terminated by Sponsor|1|||
129815826|NCT02042183|467292430|FG000|Overall Study|Lost to Follow-up|9|||
129815827|NCT02042183|467292431|FG001|Overall Study|Lost to Follow-up|2|||
129815828|NCT02864498|467292432|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
129815829|NCT02864498|467292433|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
129815830|NCT02864498|467292434|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
129815831|NCT02864498|467292432|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
129815832|NCT02864498|467292433|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
129815833|NCT02864498|467292434|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
129815834|NCT02864498|467292432|FG000|Overall Study|Investigator Discretion|0|||
129815835|NCT02864498|467292433|FG001|Overall Study|Investigator Discretion|2|||
129815836|NCT02864498|467292434|FG002|Overall Study|Investigator Discretion|1|||
129815837|NCT02864498|467292432|FG000|Overall Study|Lost to Follow-up|8|||
129815838|NCT02864498|467292433|FG001|Overall Study|Lost to Follow-up|6|||
129815839|NCT02864498|467292434|FG002|Overall Study|Lost to Follow-up|3|||
129815840|NCT02864498|467292432|FG000|Overall Study|Lack of Efficacy|5|||
129815841|NCT02864498|467292433|FG001|Overall Study|Lack of Efficacy|3|||
129815842|NCT02864498|467292434|FG002|Overall Study|Lack of Efficacy|3|||
129815843|NCT02864498|467292432|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
129815844|NCT02864498|467292433|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
129815845|NCT02864498|467292434|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
129897105|NCT01458275|467582203|FG001|Overall Study|Adverse Event|4|||
129815846|NCT02864498|467292432|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
129815847|NCT02864498|467292433|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
129815848|NCT02864498|467292434|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
129815849|NCT02864498|467292432|FG000|Overall Study|Subject moved out of the country.|0|||
129815850|NCT02864498|467292433|FG001|Overall Study|Subject moved out of the country.|0|||
129815851|NCT02864498|467292434|FG002|Overall Study|Subject moved out of the country.|1|||
129815852|NCT00378378|467292435|FG000|Overall Study|Withdrawal by Subject|0|||
129815853|NCT00378378|467292436|FG001|Overall Study|Withdrawal by Subject|1|||
129815854|NCT00378378|467292437|FG002|Overall Study|Withdrawal by Subject|0|||
129815855|NCT00378378|467292435|FG000|Overall Study|Treatment Failure|0|||
129815856|NCT00378378|467292436|FG001|Overall Study|Treatment Failure|0|||
129815857|NCT00378378|467292437|FG002|Overall Study|Treatment Failure|1|||
129815858|NCT00378378|467292435|FG000|Overall Study|Non-compliance with protocol|0|||
129815859|NCT00378378|467292436|FG001|Overall Study|Non-compliance with protocol|0|||
129815860|NCT00378378|467292437|FG002|Overall Study|Non-compliance with protocol|1|||
129815861|NCT03782792|467292440|FG000|Overall Study|Patient left the country|0|||
129815862|NCT03782792|467292441|FG001|Overall Study|Patient left the country|1|||
129815863|NCT03782792|467292440|FG000|Overall Study|Withdrawal by Subject|1|||
129815864|NCT03782792|467292441|FG001|Overall Study|Withdrawal by Subject|2|||
129815865|NCT00851747|467292443|FG000|Overall Study|Physician Decision|6|||
129815866|NCT00851747|467292444|FG001|Overall Study|Physician Decision|6|||
129815867|NCT00851747|467292445|FG002|Overall Study|Physician Decision|6|||
129815868|NCT01854710|467292446|FG000|Overall Study|Withdrawal by Subject|2|||
129815869|NCT01854710|467292447|FG001|Overall Study|Withdrawal by Subject|1|||
129815870|NCT01854710|467292448|FG002|Overall Study|Withdrawal by Subject|0|||
129815871|NCT01854710|467292449|FG003|Overall Study|Withdrawal by Subject|0|||
129815872|NCT01854710|467292450|FG004|Overall Study|Withdrawal by Subject|0|||
129815873|NCT01854710|467292451|FG005|Overall Study|Withdrawal by Subject|0|||
129815874|NCT01854710|467292446|FG000|Overall Study|CRI procedural error|2|||
129815875|NCT01854710|467292447|FG001|Overall Study|CRI procedural error|2|||
129815876|NCT01854710|467292448|FG002|Overall Study|CRI procedural error|2|||
129815877|NCT01854710|467292449|FG003|Overall Study|CRI procedural error|2|||
129815878|NCT01854710|467292450|FG004|Overall Study|CRI procedural error|2|||
129815879|NCT01854710|467292451|FG005|Overall Study|CRI procedural error|2|||
129815880|NCT00370032|467292452|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
129815881|NCT00370032|467292453|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
129815882|NCT00370032|467292452|FG000|Washout Period|Withdrawal by Subject|0|||
129815883|NCT00370032|467292453|FG001|Washout Period|Withdrawal by Subject|1|||
129815884|NCT00370032|467292452|FG000|Washout Period|Lost to Follow-up|0|||
129815885|NCT00370032|467292453|FG001|Washout Period|Lost to Follow-up|1|||
129815886|NCT00370032|467292452|FG000|Washout Period|Adverse Event|1|||
129815887|NCT00370032|467292453|FG001|Washout Period|Adverse Event|0|||
129815888|NCT00370032|467292452|FG000|Follow-up Period|Withdrawal by Subject|1|||
129815889|NCT00370032|467292453|FG001|Follow-up Period|Withdrawal by Subject|0|||
129815890|NCT01537393|467292454|FG000|Overall Study|Exclude prior to study|32|||
129815891|NCT01537393|467292455|FG001|Overall Study|Exclude prior to study|44|||
129815892|NCT01537393|467292454|FG000|Overall Study|Death|20|||
129815893|NCT01537393|467292455|FG001|Overall Study|Death|32|||
129815894|NCT01537393|467292454|FG000|Overall Study|Withdrawal by Subject|18|||
129815895|NCT01537393|467292455|FG001|Overall Study|Withdrawal by Subject|17|||
129815896|NCT01537393|467292454|FG000|Overall Study|Lost to Follow-up|53|||
129815897|NCT01537393|467292455|FG001|Overall Study|Lost to Follow-up|48|||
129815898|NCT01537393|467292454|FG000|Overall Study|Failure - Regrafted|28|||
129815899|NCT01537393|467292455|FG001|Overall Study|Failure - Regrafted|43|||
129815900|NCT01537393|467292454|FG000|Overall Study|Failure - Not regrafted|2|||
129815901|NCT01537393|467292455|FG001|Overall Study|Failure - Not regrafted|6|||
129815902|NCT01537393|467292454|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
129815903|NCT01537393|467292455|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
129815904|NCT01578187|467292456|FG000|Usability Phase|Withdrawal by Subject|1|||
129815905|NCT03208244|467292462|FG000|Overall Study|Death|1|||
129815906|NCT01709162|467292463|FG000|Overall Study|Disease progression|3|||
129815907|NCT01709162|467292464|FG001|Overall Study|Disease progression|3|||
129815908|NCT01709162|467292463|FG000|Overall Study|Study drug toxicity|2|||
129815909|NCT01709162|467292464|FG001|Overall Study|Study drug toxicity|0|||
129815910|NCT01709162|467292463|FG000|Overall Study|Administrative reason by sponsor|0|||
129815911|NCT01709162|467292464|FG001|Overall Study|Administrative reason by sponsor|1|||
129815912|NCT01709162|467292463|FG000|Overall Study|Other|1|||
129815913|NCT01709162|467292464|FG001|Overall Study|Other|0|||
129815914|NCT01709162|467292463|FG000|Overall Study|Withdrawal by Subject|0|||
129815915|NCT01709162|467292464|FG001|Overall Study|Withdrawal by Subject|1|||
129815916|NCT01844518|467292467|FG000|Overall Study|Adverse Event|7|||
129815917|NCT01844518|467292468|FG001|Overall Study|Adverse Event|1|||
129897106|NCT01458275|467582204|FG002|Overall Study|Adverse Event|1|||
129815918|NCT01844518|467292467|FG000|Overall Study|Lack of Efficacy|17|||
129815919|NCT01844518|467292468|FG001|Overall Study|Lack of Efficacy|5|||
129815920|NCT01844518|467292467|FG000|Overall Study|Participant's request to discontinue|4|||
129815921|NCT01844518|467292468|FG001|Overall Study|Participant's request to discontinue|1|||
129815922|NCT01844518|467292467|FG000|Overall Study|Poor/Non-compliance|1|||
129815923|NCT01844518|467292468|FG001|Overall Study|Poor/Non-compliance|0|||
129815924|NCT01844518|467292467|FG000|Overall Study|No Longer Met Study Criteria|2|||
129815925|NCT01844518|467292468|FG001|Overall Study|No Longer Met Study Criteria|0|||
129815926|NCT01844518|467292467|FG000|Overall Study|Withdrawal by Subject|9|||
129815927|NCT01844518|467292468|FG001|Overall Study|Withdrawal by Subject|0|||
129815928|NCT01844518|467292467|FG000|Overall Study|Pregnancy|1|||
129815929|NCT01844518|467292468|FG001|Overall Study|Pregnancy|0|||
129815930|NCT04584645|467292470|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
129815931|NCT04584645|467292471|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
129815932|NCT00390468|467292472|FG000|Overall Study|Protocol Violation|2|||
129815933|NCT00390468|467292472|FG000|Overall Study|Lack of Efficacy|1|||
129815934|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
129815935|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
129815936|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
129815937|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
129815938|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
129815939|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
129815940|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
129815941|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
129815942|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
129815943|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
129815944|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
129815945|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
129815946|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
129815947|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
129815948|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
129815949|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
129815950|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
129815951|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
129815952|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
129815953|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
129815954|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
129815955|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
129815956|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
129815957|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
129815958|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
129815959|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
129815960|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
129815961|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815962|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815963|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815964|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815965|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815966|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815967|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815968|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815969|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815970|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815971|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815972|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815973|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815974|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815975|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815976|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815977|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815978|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815979|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815980|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815981|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815982|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815983|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815984|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815985|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
129815986|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
129815987|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
129815988|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815989|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815990|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815991|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815992|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815993|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815994|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815995|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815996|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815997|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815998|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129815999|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816000|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816001|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816002|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816003|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816004|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816005|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816006|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816007|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816008|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816009|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816010|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816011|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
129816012|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
129816013|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
129816014|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816015|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816016|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816017|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816018|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816019|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816020|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816021|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816022|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816023|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816024|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816025|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816026|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816027|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816028|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816029|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816030|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816031|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816032|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816033|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816034|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816035|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816036|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816037|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
129816038|NCT03129100|467292473|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
129897107|NCT01458275|467582202|FG000|Overall Study|Lost to Follow-up|3|||
129816039|NCT03129100|467292474|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
129816040|NCT03129100|467292475|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816041|NCT03129100|467292476|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816042|NCT03129100|467292477|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816043|NCT03129100|467292478|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816044|NCT03129100|467292479|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816045|NCT03129100|467292480|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816046|NCT03129100|467292481|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816047|NCT03129100|467292482|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816048|NCT03129100|467292483|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816049|NCT03129100|467292484|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816050|NCT03129100|467292485|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816051|NCT03129100|467292486|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816052|NCT03129100|467292487|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816053|NCT03129100|467292488|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816054|NCT03129100|467292489|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816055|NCT03129100|467292490|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816056|NCT03129100|467292491|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816057|NCT03129100|467292492|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816058|NCT03129100|467292493|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816059|NCT03129100|467292494|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816060|NCT03129100|467292495|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816061|NCT03129100|467292496|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816062|NCT03129100|467292497|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816063|NCT03129100|467292498|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
129816064|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816065|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816066|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
129816067|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
129816068|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816069|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
129816070|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816071|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816072|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816073|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816074|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816075|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816076|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816077|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816078|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816079|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816080|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816081|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816082|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816083|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816084|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816085|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816086|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816087|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816088|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816089|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
129816090|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Death|0|||
129816091|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Death|0|||
129816092|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Death|1|||
129816093|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Death|0|||
129816094|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Death|0|||
129816095|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Death|0|||
129816096|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Death|0|||
129816097|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Death|0|||
129816098|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Death|0|||
129897108|NCT01458275|467582203|FG001|Overall Study|Lost to Follow-up|2|||
129897109|NCT01458275|467582204|FG002|Overall Study|Lost to Follow-up|5|||
129816099|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Death|0|||
129816100|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Death|0|||
129816101|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Death|0|||
129816102|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Death|0|||
129816103|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Death|0|||
129816104|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Death|0|||
129816105|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Death|0|||
129816106|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Death|0|||
129816107|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Death|0|||
129816108|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Death|0|||
129816109|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Death|0|||
129816110|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Death|0|||
129816111|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Death|0|||
129816112|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Death|0|||
129816113|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Death|0|||
129816114|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Death|0|||
129816115|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Death|0|||
129816116|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816117|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816118|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
129816119|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
129816120|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
129816121|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
129816122|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
129816123|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816124|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816125|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816126|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816127|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816128|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816129|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816130|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816131|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816132|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816133|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816134|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816135|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816136|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816137|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816138|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816139|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816140|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816141|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
129816142|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816143|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816144|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
129816145|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816146|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816147|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816148|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816149|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816150|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816151|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816152|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816153|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816154|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816155|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816156|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816157|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816158|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816159|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816160|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816161|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129897110|NCT01458275|467582202|FG000|Overall Study|Protocol Violation|5|||
129816162|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816163|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816164|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816165|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816166|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816167|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
129816168|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816169|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816170|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
129816171|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816172|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816173|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816174|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816175|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816176|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816177|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816178|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816179|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816180|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129897111|NCT01458275|467582203|FG001|Overall Study|Protocol Violation|5|||
129897112|NCT01458275|467582204|FG002|Overall Study|Protocol Violation|2|||
129897113|NCT01458275|467582202|FG000|Overall Study|Withdrawal by Subject|3|||
129897114|NCT01458275|467582203|FG001|Overall Study|Withdrawal by Subject|2|||
129897115|NCT01458275|467582204|FG002|Overall Study|Withdrawal by Subject|1|||
129897116|NCT02926937|467582205|FG000|Overall Study|Adverse Event|0|||
129897117|NCT02926937|467582206|FG001|Overall Study|Adverse Event|1|||
129897118|NCT02926937|467582207|FG002|Overall Study|Adverse Event|1|||
129897119|NCT02926937|467582205|FG000|Overall Study|Poor Compliance to Protocol|1|||
129897120|NCT02926937|467582206|FG001|Overall Study|Poor Compliance to Protocol|0|||
129897121|NCT02926937|467582207|FG002|Overall Study|Poor Compliance to Protocol|0|||
129897122|NCT02926937|467582205|FG000|Overall Study|Lost to Follow-up|4|||
129897123|NCT02926937|467582206|FG001|Overall Study|Lost to Follow-up|5|||
129897124|NCT02926937|467582207|FG002|Overall Study|Lost to Follow-up|0|||
129897125|NCT02926937|467582205|FG000|Overall Study|At the Participant's own Request|11|||
129897126|NCT02926937|467582206|FG001|Overall Study|At the Participant's own Request|5|||
129897127|NCT02926937|467582207|FG002|Overall Study|At the Participant's own Request|8|||
129897128|NCT02926937|467582205|FG000|Overall Study|Reason not Specified|3|||
129897129|NCT02926937|467582206|FG001|Overall Study|Reason not Specified|4|||
129897130|NCT02926937|467582207|FG002|Overall Study|Reason not Specified|2|||
129897131|NCT01559090|467582208|FG000|Stage I|Withdrawal by Subject|2|||
129897132|NCT01559090|467582209|FG001|Stage I|Withdrawal by Subject|2|||
129897133|NCT01559090|467582210|FG002|Stage I|Withdrawal by Subject|3|||
129897134|NCT01559090|467582208|FG000|Stage II|Withdrawal by Subject|1|||
129897135|NCT01559090|467582209|FG001|Stage II|Withdrawal by Subject|0|||
129897136|NCT01559090|467582210|FG002|Stage II|Withdrawal by Subject|0|||
129897137|NCT03722446|467582211|FG000|Overall Study|Protocol Violation|15|||
129897138|NCT03722446|467582212|FG001|Overall Study|Protocol Violation|2|||
129897139|NCT02908464|467582213|FG000|Overall Study|Withdrawal by Subject|2|||
129897140|NCT02908464|467582214|FG001|Overall Study|Withdrawal by Subject|1|||
129897141|NCT02908464|467582213|FG000|Overall Study|Found ineligible after randomization|0|||
129897142|NCT02908464|467582214|FG001|Overall Study|Found ineligible after randomization|2|||
129897143|NCT01168401|467584274|FG000|Overall Study|Lost to Follow-up|1|||
129897144|NCT01168401|467584275|FG001|Overall Study|Lost to Follow-up|1|||
129897145|NCT01168401|467584276|FG002|Overall Study|Lost to Follow-up|2|||
129897146|NCT01168401|467584277|FG003|Overall Study|Lost to Follow-up|1|||
129897147|NCT01168401|467584278|FG004|Overall Study|Lost to Follow-up|0|||
129816181|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816182|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816183|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816184|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816185|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816186|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816187|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816188|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816189|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129897148|NCT01168401|467584279|FG005|Overall Study|Lost to Follow-up|0|||
129897149|NCT01168401|467584280|FG006|Overall Study|Lost to Follow-up|0|||
129897150|NCT01168401|467584281|FG007|Overall Study|Lost to Follow-up|0|||
129897151|NCT01168401|467584282|FG008|Overall Study|Lost to Follow-up|0|||
129897152|NCT01168401|467584283|FG009|Overall Study|Lost to Follow-up|0|||
129897153|NCT01168401|467584284|FG010|Overall Study|Lost to Follow-up|0|||
129816190|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816191|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816192|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816193|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
129816194|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816195|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816196|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
129816197|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816198|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816199|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816200|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816201|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816202|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816203|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816204|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816205|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816206|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816207|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816208|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816209|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816210|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816211|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816212|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816213|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816214|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816215|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816216|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816217|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816218|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816219|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
129816220|NCT03129100|467292473|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816221|NCT03129100|467292474|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816222|NCT03129100|467292475|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816223|NCT03129100|467292476|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816224|NCT03129100|467292477|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
129816225|NCT03129100|467292478|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
129816226|NCT03129100|467292479|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
129816227|NCT03129100|467292480|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816228|NCT03129100|467292481|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816229|NCT03129100|467292482|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816230|NCT03129100|467292483|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816231|NCT03129100|467292484|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816232|NCT03129100|467292485|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816233|NCT03129100|467292486|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816234|NCT03129100|467292487|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816235|NCT03129100|467292488|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816236|NCT03129100|467292489|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816237|NCT03129100|467292490|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816238|NCT03129100|467292491|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816239|NCT03129100|467292492|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816240|NCT03129100|467292493|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816241|NCT03129100|467292494|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816242|NCT03129100|467292495|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816243|NCT03129100|467292496|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816244|NCT03129100|467292497|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816245|NCT03129100|467292498|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
129816246|NCT03129100|467292473|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816247|NCT03129100|467292474|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816248|NCT03129100|467292475|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816249|NCT03129100|467292476|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816250|NCT03129100|467292477|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816251|NCT03129100|467292478|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816252|NCT03129100|467292479|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816253|NCT03129100|467292480|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816254|NCT03129100|467292481|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816255|NCT03129100|467292482|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
129816256|NCT03129100|467292483|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816257|NCT03129100|467292484|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816258|NCT03129100|467292485|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816259|NCT03129100|467292486|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816260|NCT03129100|467292487|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816261|NCT03129100|467292488|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816262|NCT03129100|467292489|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816263|NCT03129100|467292490|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816264|NCT03129100|467292491|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816265|NCT03129100|467292492|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816266|NCT03129100|467292493|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816267|NCT03129100|467292494|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816268|NCT03129100|467292495|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816269|NCT03129100|467292496|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816270|NCT03129100|467292497|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816271|NCT03129100|467292498|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
129816272|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816273|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816274|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816275|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816276|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816277|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816278|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816279|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816280|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816281|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816282|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816283|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
129816284|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816285|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816286|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816287|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816288|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816289|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816290|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816291|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816292|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816293|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816294|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816295|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816296|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816297|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
129816298|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816299|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816300|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816301|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816302|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816303|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816304|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816305|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816306|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816307|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816308|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816309|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
129816310|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
129816311|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
129816312|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
129816313|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816314|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816315|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816316|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816317|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816318|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816319|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816320|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816321|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129445425|NCT00594516|465932792|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
129816322|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816323|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
129816324|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816325|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816326|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816327|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816328|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816329|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816330|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816331|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816332|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816333|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816334|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816335|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
129816336|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816337|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
129816338|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
129816339|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816340|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816341|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816342|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816343|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816344|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816345|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816346|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816347|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816348|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816349|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
129816350|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816351|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816352|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816353|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816354|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816355|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816356|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816357|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816358|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816359|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816360|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816361|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816362|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816363|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816364|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816365|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
129816366|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129897154|NCT01168401|467584274|FG000|Overall Study|Withdrawal by Subject|0|||
129445426|NCT00594516|465932790|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
129816367|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816368|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816369|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816370|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816371|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816372|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816373|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816374|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816375|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
129816376|NCT03129100|467292473|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816377|NCT03129100|467292474|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816378|NCT03129100|467292475|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816379|NCT03129100|467292476|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816380|NCT03129100|467292477|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816381|NCT03129100|467292478|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816382|NCT03129100|467292479|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816383|NCT03129100|467292480|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816384|NCT03129100|467292481|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816385|NCT03129100|467292482|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816386|NCT03129100|467292483|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816387|NCT03129100|467292484|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816388|NCT03129100|467292485|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
129816389|NCT03129100|467292486|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816390|NCT03129100|467292487|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
129816391|NCT03129100|467292488|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
129816392|NCT03129100|467292489|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816393|NCT03129100|467292490|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816394|NCT03129100|467292491|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816395|NCT03129100|467292492|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816396|NCT03129100|467292493|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816397|NCT03129100|467292494|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816398|NCT03129100|467292495|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816399|NCT03129100|467292496|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816400|NCT03129100|467292497|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816401|NCT03129100|467292498|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
129816402|NCT03129100|467292473|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816403|NCT03129100|467292474|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816404|NCT03129100|467292475|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816405|NCT03129100|467292476|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816406|NCT03129100|467292477|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816407|NCT03129100|467292478|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816408|NCT03129100|467292479|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816409|NCT03129100|467292480|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816410|NCT03129100|467292481|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816411|NCT03129100|467292482|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816412|NCT03129100|467292483|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816413|NCT03129100|467292484|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816414|NCT03129100|467292485|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816415|NCT03129100|467292486|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816416|NCT03129100|467292487|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816417|NCT03129100|467292488|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816418|NCT03129100|467292489|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816419|NCT03129100|467292490|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
129816420|NCT03129100|467292491|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816421|NCT03129100|467292492|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
129816422|NCT03129100|467292493|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816423|NCT03129100|467292494|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816424|NCT03129100|467292495|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816425|NCT03129100|467292496|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816426|NCT03129100|467292497|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816427|NCT03129100|467292498|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
129816428|NCT03129100|467292473|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816429|NCT03129100|467292474|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816430|NCT03129100|467292475|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816431|NCT03129100|467292476|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816432|NCT03129100|467292477|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816433|NCT03129100|467292478|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816434|NCT03129100|467292479|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816435|NCT03129100|467292480|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816436|NCT03129100|467292481|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816437|NCT03129100|467292482|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816438|NCT03129100|467292483|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816439|NCT03129100|467292484|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816440|NCT03129100|467292485|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816441|NCT03129100|467292486|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816442|NCT03129100|467292487|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816443|NCT03129100|467292488|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816444|NCT03129100|467292489|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816445|NCT03129100|467292490|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816446|NCT03129100|467292491|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816447|NCT03129100|467292492|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816448|NCT03129100|467292493|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
129816449|NCT03129100|467292494|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816450|NCT03129100|467292495|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816451|NCT03129100|467292496|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816452|NCT03129100|467292497|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816453|NCT03129100|467292498|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
129816454|NCT03129100|467292473|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
129816455|NCT03129100|467292474|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
129816456|NCT03129100|467292475|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
129816457|NCT03129100|467292476|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
129816458|NCT03129100|467292477|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
129816459|NCT03129100|467292478|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
129816460|NCT03129100|467292479|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
129816461|NCT03129100|467292480|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
129816462|NCT03129100|467292481|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
129816463|NCT03129100|467292482|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
129816464|NCT03129100|467292483|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
129816465|NCT03129100|467292484|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
129816466|NCT03129100|467292485|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
129816467|NCT03129100|467292486|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
129816468|NCT03129100|467292487|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
129816469|NCT03129100|467292488|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
129816470|NCT03129100|467292489|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
129816471|NCT03129100|467292490|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
129816472|NCT03129100|467292491|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
129816473|NCT03129100|467292492|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
129816474|NCT03129100|467292493|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
129816475|NCT03129100|467292494|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
129816476|NCT03129100|467292495|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
129816477|NCT03129100|467292496|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
129816478|NCT03129100|467292497|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
129816479|NCT03129100|467292498|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
129816480|NCT03129100|467292473|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816481|NCT03129100|467292474|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816482|NCT03129100|467292475|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816483|NCT03129100|467292476|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816484|NCT03129100|467292477|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816485|NCT03129100|467292478|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816486|NCT03129100|467292479|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816487|NCT03129100|467292480|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816488|NCT03129100|467292481|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816489|NCT03129100|467292482|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816490|NCT03129100|467292483|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816491|NCT03129100|467292484|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816492|NCT03129100|467292485|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816493|NCT03129100|467292486|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816494|NCT03129100|467292487|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816495|NCT03129100|467292488|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816496|NCT03129100|467292489|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816497|NCT03129100|467292490|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816498|NCT03129100|467292491|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816499|NCT03129100|467292492|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816500|NCT03129100|467292493|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
129816501|NCT03129100|467292494|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816502|NCT03129100|467292495|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816503|NCT03129100|467292496|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816504|NCT03129100|467292497|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816505|NCT03129100|467292498|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
129816506|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
129816507|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
129816508|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
129816509|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
129816510|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
129816511|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
129816512|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
129816513|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
129816514|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
129816515|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
129816516|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
129816517|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
129816518|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
129816519|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
129816520|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
129816521|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
129816522|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
129816523|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
129816524|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
129816525|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
129816526|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
129816527|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
129816528|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
129816529|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
129816530|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
129816531|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
129816532|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129897155|NCT01168401|467584275|FG001|Overall Study|Withdrawal by Subject|0|||
129897156|NCT01168401|467584276|FG002|Overall Study|Withdrawal by Subject|0|||
129816533|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816534|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816535|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816536|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816537|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816538|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816539|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816540|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816541|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816542|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129897157|NCT01168401|467584277|FG003|Overall Study|Withdrawal by Subject|1|||
129897158|NCT01168401|467584278|FG004|Overall Study|Withdrawal by Subject|0|||
129897159|NCT01168401|467584279|FG005|Overall Study|Withdrawal by Subject|0|||
129816543|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816544|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816545|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816546|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816547|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816548|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816549|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816550|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816551|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816552|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816553|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816554|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816555|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
129816556|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
129816557|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
129816558|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816559|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816560|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816561|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816562|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816563|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816564|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816565|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816566|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816567|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816568|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816569|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816570|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816571|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816572|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816573|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816574|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816575|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816576|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816577|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816578|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816579|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816580|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
129816581|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
129816582|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
129816583|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
129816584|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816585|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816586|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816587|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816588|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816589|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816590|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816591|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816592|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816593|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816594|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816595|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816596|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816597|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816598|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816599|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816600|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816601|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816602|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816603|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816604|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816605|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816606|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816607|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816608|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
129816609|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
129816610|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816611|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816612|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816613|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816614|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816615|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816616|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816617|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816618|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816619|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816620|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816621|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816622|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816623|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816624|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816625|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816626|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816627|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816628|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816629|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816630|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816631|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816632|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816633|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816634|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
129816635|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
129816636|NCT03129100|467292473|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
129816637|NCT03129100|467292474|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
129816638|NCT03129100|467292475|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
129816639|NCT03129100|467292476|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
129816640|NCT03129100|467292477|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
129816641|NCT03129100|467292478|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
129816642|NCT03129100|467292479|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
129816643|NCT03129100|467292480|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
129816644|NCT03129100|467292481|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
129816645|NCT03129100|467292482|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
129816646|NCT03129100|467292483|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
129816647|NCT03129100|467292484|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
129816648|NCT03129100|467292485|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
129816649|NCT03129100|467292486|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
129816650|NCT03129100|467292487|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
129816651|NCT03129100|467292488|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
129816652|NCT03129100|467292489|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
129816653|NCT03129100|467292490|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
129816654|NCT03129100|467292491|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
129816655|NCT03129100|467292492|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
129816656|NCT03129100|467292493|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
129816657|NCT03129100|467292494|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
129816658|NCT03129100|467292495|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
129816659|NCT03129100|467292496|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
129816660|NCT03129100|467292497|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
129816661|NCT03129100|467292498|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
129816662|NCT03845985|467292499|FG000|Overall Study|Lost to Follow-up|2|||
129816663|NCT03845985|467292500|FG001|Overall Study|Lost to Follow-up|1|||
129816664|NCT03845985|467292499|FG000|Overall Study|Physician Decision|1|||
129816665|NCT03845985|467292500|FG001|Overall Study|Physician Decision|0|||
129816666|NCT03845985|467292499|FG000|Overall Study|Withdrawal by Subject|4|||
129816667|NCT03845985|467292500|FG001|Overall Study|Withdrawal by Subject|1|||
129816668|NCT03302234|467292505|FG000|Overall Study|Death|191|||
129816669|NCT03302234|467292506|FG001|Overall Study|Death|192|||
129816670|NCT03302234|467292505|FG000|Overall Study|Withdrawal by Subject|2|||
129816671|NCT03302234|467292506|FG001|Overall Study|Withdrawal by Subject|2|||
129816672|NCT03302234|467292505|FG000|Overall Study|Sponsor Decision|90|||
129816673|NCT03302234|467292506|FG001|Overall Study|Sponsor Decision|89|||
129816674|NCT03302234|467292505|FG000|Overall Study|Laryngeal carcinoma|0|||
129816675|NCT03302234|467292506|FG001|Overall Study|Laryngeal carcinoma|1|||
129816676|NCT03302234|467292505|FG000|Overall Study|Not Reported|1|||
129816677|NCT03302234|467292506|FG001|Overall Study|Not Reported|0|||
129816678|NCT02795832|467292509|FG000|Overall Study|Adverse Event|0|||
129816679|NCT02795832|467292510|FG001|Overall Study|Adverse Event|0|||
129816680|NCT02795832|467292511|FG002|Overall Study|Adverse Event|0|||
129816681|NCT02795832|467292512|FG003|Overall Study|Adverse Event|0|||
129816682|NCT02795832|467292513|FG004|Overall Study|Adverse Event|0|||
129816683|NCT02795832|467292514|FG005|Overall Study|Adverse Event|3|||
129816684|NCT04523220|467292515|FG000|Main Treatment Period|Physician Decision|1|||
129816685|NCT04523220|467292516|FG001|Main Treatment Period|Physician Decision|1|||
129816686|NCT04523220|467292517|FG002|Main Treatment Period|Physician Decision|0|||
129816687|NCT04523220|467292515|FG000|Main Treatment Period|Other|5|||
129816688|NCT04523220|467292516|FG001|Main Treatment Period|Other|2|||
129816689|NCT04523220|467292517|FG002|Main Treatment Period|Other|4|||
129816690|NCT04523220|467292515|FG000|Main Treatment Period|Subject Decision|5|||
129816691|NCT04523220|467292516|FG001|Main Treatment Period|Subject Decision|7|||
129816692|NCT04523220|467292517|FG002|Main Treatment Period|Subject Decision|3|||
129816693|NCT04523220|467292515|FG000|Main Treatment Period|Death|5|||
129816694|NCT04523220|467292516|FG001|Main Treatment Period|Death|11|||
129816695|NCT04523220|467292517|FG002|Main Treatment Period|Death|4|||
129816696|NCT04523220|467292515|FG000|Main Treatment Period|Adverse Event|11|||
129816697|NCT04523220|467292516|FG001|Main Treatment Period|Adverse Event|9|||
129816698|NCT04523220|467292517|FG002|Main Treatment Period|Adverse Event|9|||
129816699|NCT04523220|467292515|FG000|Main Treatment Period|Withdrawal by Subject|3|||
129816700|NCT04523220|467292516|FG001|Main Treatment Period|Withdrawal by Subject|3|||
129816701|NCT04523220|467292517|FG002|Main Treatment Period|Withdrawal by Subject|4|||
129816702|NCT04523220|467292515|FG000|Main Treatment Period|Study drug never adminstered|10|||
129816703|NCT04523220|467292516|FG001|Main Treatment Period|Study drug never adminstered|3|||
129816704|NCT04523220|467292517|FG002|Main Treatment Period|Study drug never adminstered|5|||
129816705|NCT04523220|467292515|FG000|Extension Treatment Period|Physician Decision|1|||
129816706|NCT04523220|467292516|FG001|Extension Treatment Period|Physician Decision|0|||
129816707|NCT04523220|467292517|FG002|Extension Treatment Period|Physician Decision|3|||
129816708|NCT04523220|467292515|FG000|Extension Treatment Period|Other|2|||
129816709|NCT04523220|467292516|FG001|Extension Treatment Period|Other|6|||
129816710|NCT04523220|467292517|FG002|Extension Treatment Period|Other|6|||
129816711|NCT04523220|467292515|FG000|Extension Treatment Period|Subject Decision|5|||
129816712|NCT04523220|467292516|FG001|Extension Treatment Period|Subject Decision|2|||
129816713|NCT04523220|467292517|FG002|Extension Treatment Period|Subject Decision|4|||
129816714|NCT04523220|467292515|FG000|Extension Treatment Period|Death|6|||
129816715|NCT04523220|467292516|FG001|Extension Treatment Period|Death|4|||
129816716|NCT04523220|467292517|FG002|Extension Treatment Period|Death|7|||
129816717|NCT04523220|467292515|FG000|Extension Treatment Period|Adverse Event|6|||
129816718|NCT04523220|467292516|FG001|Extension Treatment Period|Adverse Event|7|||
129816719|NCT04523220|467292517|FG002|Extension Treatment Period|Adverse Event|9|||
129816720|NCT04523220|467292515|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
129816721|NCT04523220|467292516|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
129816722|NCT04523220|467292517|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
129816723|NCT04523220|467292515|FG000|Extension Treatment Period|Study drug never administered|0|||
129816724|NCT04523220|467292516|FG001|Extension Treatment Period|Study drug never administered|1|||
129816725|NCT04523220|467292517|FG002|Extension Treatment Period|Study drug never administered|0|||
129816726|NCT00571948|467292518|FG000|Overall Study|Lost to Follow-up|2|||
129816727|NCT00571948|467292519|FG001|Overall Study|Lost to Follow-up|0|||
129816728|NCT00571948|467292518|FG000|Overall Study|Withdrawal by Subject|1|||
129816729|NCT00571948|467292519|FG001|Overall Study|Withdrawal by Subject|2|||
129816730|NCT00571948|467292518|FG000|Overall Study|Protocol Violation|3|||
129816731|NCT00571948|467292519|FG001|Overall Study|Protocol Violation|3|||
129816732|NCT00571948|467292518|FG000|Overall Study|infant refused study meal|3|||
129816733|NCT00571948|467292519|FG001|Overall Study|infant refused study meal|4|||
129816734|NCT00571948|467292518|FG000|Overall Study|Parent were afraid of blood colection|2|||
129816735|NCT00571948|467292519|FG001|Overall Study|Parent were afraid of blood colection|5|||
129816736|NCT04112784|467292520|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
129816737|NCT04112784|467292520|FG000|Overall Study|Screen Failures|4|||
129816738|NCT00256750|467292521|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
129816739|NCT00256750|467292522|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
129816740|NCT00256750|467292523|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
129816741|NCT00256750|467292521|FG000|Transplanted Pre-Treatment|Other|2|||
129816742|NCT00256750|467292522|FG001|Transplanted Pre-Treatment|Other|0|||
129816743|NCT00256750|467292523|FG002|Transplanted Pre-Treatment|Other|0|||
129816744|NCT00256750|467292521|FG000|Transplanted Pre-Treatment|Death|1|||
129816745|NCT00256750|467292522|FG001|Transplanted Pre-Treatment|Death|0|||
129816746|NCT00256750|467292523|FG002|Transplanted Pre-Treatment|Death|0|||
129816747|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
129816748|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
129816749|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
129816750|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Death|3|||
129816751|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Death|2|||
129816752|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Death|4|||
129816753|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
129816754|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
129816755|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
129816756|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
129816757|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
129816758|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
129816759|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Other|5|||
129816760|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Other|4|||
129816761|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Other|2|||
129816762|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
129816763|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
129816764|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
129816765|NCT00256750|467292521|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
129816766|NCT00256750|467292522|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
129816767|NCT00256750|467292523|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
129816768|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
129816769|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
129816770|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
129816771|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
129816772|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
129816773|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
129816774|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Death|3|||
129816775|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Death|0|||
129816776|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Death|0|||
129816777|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
129816778|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
129816779|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
129816780|NCT00256750|467292521|FG000|Post-Transplant Treated (24 Months)|Other|2|||
129816781|NCT00256750|467292522|FG001|Post-Transplant Treated (24 Months)|Other|0|||
129816782|NCT00256750|467292523|FG002|Post-Transplant Treated (24 Months)|Other|1|||
129816783|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
129816784|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
129816785|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
129816786|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
129816787|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
129816788|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
129816789|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Death|0|||
129816790|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Death|2|||
129816791|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Death|1|||
129816792|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
129816793|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
129816794|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
129816795|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
129816796|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
129816797|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
129816798|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
129816799|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
129816800|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
129816801|NCT00256750|467292521|FG000|Post-Transplant Treated (36 Months)|Other|0|||
129816802|NCT00256750|467292522|FG001|Post-Transplant Treated (36 Months)|Other|1|||
129816803|NCT00256750|467292523|FG002|Post-Transplant Treated (36 Months)|Other|1|||
129816804|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
129816805|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
129816806|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
129816807|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
129816808|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
129816809|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
129816810|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
129816811|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
129816812|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
129816813|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
129816814|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
129816815|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
129816816|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
129816817|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
129816818|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
129816819|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
129816820|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
129816821|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
129816822|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
129816823|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
129816824|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
129816825|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
129816826|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
129816827|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
129816828|NCT00256750|467292521|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
129816829|NCT00256750|467292522|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
129816830|NCT00256750|467292523|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
129816831|NCT00211510|467292524|FG000|Overall Study|Physician Decision|3|||
129816832|NCT00211510|467292525|FG001|Overall Study|Physician Decision|1|||
129816833|NCT00211510|467292524|FG000|Overall Study|Withdrawal by Subject|3|||
129816834|NCT00211510|467292525|FG001|Overall Study|Withdrawal by Subject|1|||
129816835|NCT01962896|467292526|FG000|Overall Study|Lack of Efficacy|4|||
129816836|NCT01949506|467292529|FG000|Overall Study|Physician Decision|1|||
129816837|NCT02915016|467292530|FG000|Overall Study|Lost to Follow-up|4|||
129816838|NCT02915016|467292531|FG001|Overall Study|Lost to Follow-up|2|||
129816839|NCT02915016|467292532|FG002|Overall Study|Lost to Follow-up|5|||
129816840|NCT02915016|467292533|FG003|Overall Study|Lost to Follow-up|3|||
129816841|NCT02915016|467292534|FG004|Overall Study|Lost to Follow-up|5|||
129816842|NCT02915016|467292535|FG005|Overall Study|Lost to Follow-up|2|||
129816843|NCT02915016|467292536|FG006|Overall Study|Lost to Follow-up|8|||
129816844|NCT02915016|467292537|FG007|Overall Study|Lost to Follow-up|2|||
129816845|NCT02915016|467292530|FG000|Overall Study|Physician Decision|0|||
129816846|NCT02915016|467292531|FG001|Overall Study|Physician Decision|0|||
129816847|NCT02915016|467292532|FG002|Overall Study|Physician Decision|1|||
129816848|NCT02915016|467292533|FG003|Overall Study|Physician Decision|0|||
129816849|NCT02915016|467292534|FG004|Overall Study|Physician Decision|0|||
129816850|NCT02915016|467292535|FG005|Overall Study|Physician Decision|1|||
129816851|NCT02915016|467292536|FG006|Overall Study|Physician Decision|2|||
129816852|NCT02915016|467292537|FG007|Overall Study|Physician Decision|0|||
129816853|NCT02915016|467292530|FG000|Overall Study|Withdrawal by Subject|2|||
129816854|NCT02915016|467292531|FG001|Overall Study|Withdrawal by Subject|0|||
129816855|NCT02915016|467292532|FG002|Overall Study|Withdrawal by Subject|1|||
129816856|NCT02915016|467292533|FG003|Overall Study|Withdrawal by Subject|0|||
129816857|NCT02915016|467292534|FG004|Overall Study|Withdrawal by Subject|1|||
129816858|NCT02915016|467292535|FG005|Overall Study|Withdrawal by Subject|3|||
129816859|NCT02915016|467292536|FG006|Overall Study|Withdrawal by Subject|1|||
129816860|NCT02915016|467292537|FG007|Overall Study|Withdrawal by Subject|1|||
129816861|NCT02915016|467292530|FG000|Overall Study|Elected not to continue|0|||
129816862|NCT02915016|467292531|FG001|Overall Study|Elected not to continue|0|||
129816863|NCT02915016|467292532|FG002|Overall Study|Elected not to continue|0|||
129816864|NCT02915016|467292533|FG003|Overall Study|Elected not to continue|1|||
129816865|NCT02915016|467292534|FG004|Overall Study|Elected not to continue|0|||
129816866|NCT02915016|467292535|FG005|Overall Study|Elected not to continue|0|||
129816867|NCT02915016|467292536|FG006|Overall Study|Elected not to continue|1|||
129816868|NCT02915016|467292537|FG007|Overall Study|Elected not to continue|0|||
129816869|NCT02915016|467292530|FG000|Overall Study|HIV infection|1|||
129816870|NCT02915016|467292531|FG001|Overall Study|HIV infection|1|||
129816871|NCT02915016|467292532|FG002|Overall Study|HIV infection|1|||
129816872|NCT02915016|467292533|FG003|Overall Study|HIV infection|0|||
129816873|NCT02915016|467292534|FG004|Overall Study|HIV infection|1|||
129816874|NCT02915016|467292535|FG005|Overall Study|HIV infection|0|||
129816875|NCT02915016|467292536|FG006|Overall Study|HIV infection|0|||
129816876|NCT02915016|467292537|FG007|Overall Study|HIV infection|0|||
129816877|NCT02915016|467292530|FG000|Overall Study|Participant unable to adhere|0|||
129816878|NCT02915016|467292531|FG001|Overall Study|Participant unable to adhere|0|||
129816879|NCT02915016|467292532|FG002|Overall Study|Participant unable to adhere|0|||
129816880|NCT02915016|467292533|FG003|Overall Study|Participant unable to adhere|0|||
129816881|NCT02915016|467292534|FG004|Overall Study|Participant unable to adhere|0|||
129816882|NCT02915016|467292535|FG005|Overall Study|Participant unable to adhere|0|||
129816883|NCT02915016|467292536|FG006|Overall Study|Participant unable to adhere|0|||
129816884|NCT02915016|467292537|FG007|Overall Study|Participant unable to adhere|1|||
129816885|NCT05425745|467292547|FG000|Overall Study|Withdrawal of Consent|3|||
129816886|NCT05425745|467292548|FG001|Overall Study|Withdrawal of Consent|3|||
129816887|NCT05425745|467292547|FG000|Overall Study|Death|2|||
129816888|NCT05425745|467292548|FG001|Overall Study|Death|3|||
129816889|NCT05425745|467292547|FG000|Overall Study|Lost to Follow-up|1|||
129816890|NCT05425745|467292548|FG001|Overall Study|Lost to Follow-up|2|||
129816891|NCT05425745|467292547|FG000|Overall Study|Adverse Event|0|||
129816892|NCT05425745|467292548|FG001|Overall Study|Adverse Event|1|||
129816893|NCT05425745|467292547|FG000|Overall Study|Did not return for end of study visit|0|||
129816894|NCT05425745|467292548|FG001|Overall Study|Did not return for end of study visit|1|||
129816895|NCT05425745|467292547|FG000|Overall Study|End of study visit completed by phone|1|||
129816896|NCT05425745|467292548|FG001|Overall Study|End of study visit completed by phone|0|||
129816897|NCT05425745|467292547|FG000|Overall Study|Subject decision|1|||
129816898|NCT05425745|467292548|FG001|Overall Study|Subject decision|0|||
129816899|NCT02820753|467294152|FG000|2 Month|Withdrawal by Subject|3|||
129816900|NCT02820753|467294153|FG001|2 Month|Withdrawal by Subject|3|||
129816901|NCT02820753|467294152|FG000|2 Month|Lost to Follow-up|24|||
129816902|NCT02820753|467294153|FG001|2 Month|Lost to Follow-up|26|||
129816903|NCT02820753|467294152|FG000|2 Month|Stopped per NIH Hold|51|||
129816904|NCT02820753|467294153|FG001|2 Month|Stopped per NIH Hold|13|||
129816905|NCT02820753|467294152|FG000|6 Month|Withdrawal by Subject|2|||
129816906|NCT02820753|467294153|FG001|6 Month|Withdrawal by Subject|2|||
129816907|NCT02820753|467294152|FG000|6 Month|Lost to Follow-up|20|||
129816908|NCT02820753|467294153|FG001|6 Month|Lost to Follow-up|27|||
129816909|NCT02820753|467294152|FG000|6 Month|Stopped per NIH Hold|81|||
129816910|NCT02820753|467294153|FG001|6 Month|Stopped per NIH Hold|81|||
129816911|NCT02820753|467294152|FG000|6 Month|Death|0|||
129816912|NCT02820753|467294153|FG001|6 Month|Death|1|||
129816913|NCT02161731|467294154|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
129816914|NCT02161731|467294155|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
129816915|NCT02161731|467294154|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
129816916|NCT02161731|467294155|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
129816917|NCT03761277|467294156|FG000|Enrollment to Implant|Screen Failure|17|||
129816918|NCT03761277|467294156|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
129816919|NCT03761277|467294156|FG000|Enrollment to Implant|Physician Decision|2|||
129816920|NCT03761277|467294156|FG000|Enrollment to Implant|Site Closure|3|||
129816921|NCT03761277|467294156|FG000|Enrollment to Implant|Sponsor Request|2|||
129816922|NCT03761277|467294156|FG000|Post-Implant to 6 Months|Adverse Event|2|||
129816923|NCT03761277|467294156|FG000|Post-Implant to 6 Months|Death|1|||
129816924|NCT03761277|467294156|FG000|Post-Implant to 6 Months|Site Closure|2|||
129816925|NCT03761277|467294156|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
129816926|NCT03761277|467294156|FG000|6 Months to 12 Months|Physician Decision|2|||
129816927|NCT03761277|467294156|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
129816928|NCT02155608|467294157|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
129816929|NCT02155608|467294158|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
129816930|NCT02155608|467294157|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
129816931|NCT02155608|467294158|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
129816932|NCT01532414|467294159|FG000|Overall Study|Lost to Follow-up|3|||
129816933|NCT01532414|467294160|FG001|Overall Study|Lost to Follow-up|0|||
129816934|NCT01532414|467294161|FG002|Overall Study|Lost to Follow-up|1|||
129816935|NCT01532414|467294159|FG000|Overall Study|Withdrawal by Subject|3|||
129816936|NCT01532414|467294160|FG001|Overall Study|Withdrawal by Subject|0|||
129816937|NCT01532414|467294161|FG002|Overall Study|Withdrawal by Subject|0|||
129816938|NCT01532414|467294159|FG000|Overall Study|No V6 semen sample|0|||
129816939|NCT01532414|467294160|FG001|Overall Study|No V6 semen sample|1|||
129816940|NCT01532414|467294161|FG002|Overall Study|No V6 semen sample|0|||
129816941|NCT01532414|467294159|FG000|Overall Study|Adverse Event|0|||
129816942|NCT01532414|467294160|FG001|Overall Study|Adverse Event|1|||
129816943|NCT01532414|467294161|FG002|Overall Study|Adverse Event|1|||
129816944|NCT01532414|467294159|FG000|Overall Study|Unable to complete 24 hour PK|0|||
129816945|NCT01532414|467294160|FG001|Overall Study|Unable to complete 24 hour PK|0|||
129816946|NCT01532414|467294161|FG002|Overall Study|Unable to complete 24 hour PK|1|||
129816947|NCT01532414|467294159|FG000|Overall Study|Withdrawn by sponsor|1|||
129816948|NCT01532414|467294160|FG001|Overall Study|Withdrawn by sponsor|0|||
129816949|NCT01532414|467294161|FG002|Overall Study|Withdrawn by sponsor|0|||
129816950|NCT00429273|467294165|FG000|Overall Study|Lost to Follow-up|1|||
129816951|NCT00429273|467294166|FG001|Overall Study|Lost to Follow-up|2|||
129816952|NCT00429273|467294167|FG002|Overall Study|Lost to Follow-up|2|||
129816953|NCT00429273|467294165|FG000|Overall Study|Physician Decision|6|||
129816954|NCT00429273|467294166|FG001|Overall Study|Physician Decision|5|||
129816955|NCT00429273|467294167|FG002|Overall Study|Physician Decision|5|||
129816956|NCT00429273|467294165|FG000|Overall Study|Adverse Event|1|||
129816957|NCT00429273|467294166|FG001|Overall Study|Adverse Event|1|||
129816958|NCT00429273|467294167|FG002|Overall Study|Adverse Event|2|||
129816959|NCT01438957|467294168|FG000|Overall Study|Physician Decision|1|||
129816960|NCT01438957|467294169|FG001|Overall Study|Physician Decision|1|||
129816961|NCT01438957|467294170|FG002|Overall Study|Physician Decision|0|||
129816962|NCT01438957|467294171|FG003|Overall Study|Physician Decision|1|||
129816963|NCT01438957|467294172|FG004|Overall Study|Physician Decision|0|||
129816964|NCT03052725|467294173|FG000|Overall Study|Adverse Event|2|||
129816965|NCT03052725|467294174|FG001|Overall Study|Adverse Event|0|||
129816966|NCT03052725|467294173|FG000|Overall Study|Withdrawal by Subject|3|||
129816967|NCT03052725|467294174|FG001|Overall Study|Withdrawal by Subject|4|||
129816968|NCT03052725|467294173|FG000|Overall Study|Pregnancy|0|||
129816969|NCT03052725|467294174|FG001|Overall Study|Pregnancy|1|||
129816970|NCT03052725|467294173|FG000|Overall Study|Site closure|0|||
129816971|NCT03052725|467294174|FG001|Overall Study|Site closure|1|||
129816972|NCT03052725|467294173|FG000|Overall Study|Study terminated by sponsor|143|||
129816973|NCT03052725|467294174|FG001|Overall Study|Study terminated by sponsor|144|||
129816974|NCT00727025|467294180|FG000|Overall Study|Physician Decision|23|||
129816975|NCT02548650|467294187|FG000|Triple Therapy|Adverse Event|1|||
129816976|NCT02548650|467294188|FG001|Triple Therapy|Adverse Event|0|||
129816977|NCT02548650|467294187|FG000|Triple Therapy|Withdrawal by Subject|0|||
129816978|NCT02548650|467294188|FG001|Triple Therapy|Withdrawal by Subject|4|||
129816979|NCT02548650|467294187|FG000|Double Therapy|Adverse Event|1|||
129816980|NCT02548650|467294188|FG001|Double Therapy|Adverse Event|1|||
129816981|NCT02548650|467294187|FG000|Double Therapy|Withdrawal by Subject|0|||
129816982|NCT02548650|467294188|FG001|Double Therapy|Withdrawal by Subject|1|||
129816983|NCT01909674|467294189|FG000|Overall Study|Withdrawal by Subject|5|||
129816984|NCT01909674|467294190|FG001|Overall Study|Withdrawal by Subject|2|||
129816985|NCT00521014|467294191|FG000|Overall Study|Inevaluable, not treated|1|||
129816986|NCT02969369|467294192|FG000|Study|Adverse Event|1|||
129816987|NCT02969369|467294193|FG001|Study|Adverse Event|6|||
129816988|NCT02969369|467294192|FG000|Study|Lack of Efficacy|0|||
129816989|NCT02969369|467294193|FG001|Study|Lack of Efficacy|1|||
129816990|NCT02969369|467294192|FG000|Study|Lost to Follow-up|0|||
129816991|NCT02969369|467294193|FG001|Study|Lost to Follow-up|1|||
129816992|NCT02969369|467294192|FG000|Study|Withdrawal by Subject|3|||
129816993|NCT02969369|467294193|FG001|Study|Withdrawal by Subject|5|||
129816994|NCT02969369|467294192|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
129816995|NCT02969369|467294193|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
129816996|NCT02969369|467294192|FG000|Double-blind Period|Adverse Event|1|||
129816997|NCT02969369|467294193|FG001|Double-blind Period|Adverse Event|5|||
129816998|NCT02969369|467294192|FG000|Double-blind Period|Lost to Follow-up|0|||
129816999|NCT02969369|467294193|FG001|Double-blind Period|Lost to Follow-up|1|||
129817000|NCT02969369|467294192|FG000|Double-blind Period|Withdrawal by Subject|2|||
129817001|NCT02969369|467294193|FG001|Double-blind Period|Withdrawal by Subject|3|||
129817002|NCT02969369|467294192|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
129817003|NCT02969369|467294193|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
129817004|NCT02969369|467294192|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
129817005|NCT02969369|467294193|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
129817006|NCT02969369|467294192|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
129817007|NCT02969369|467294193|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
129817008|NCT02969369|467294192|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
129817009|NCT02969369|467294193|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
129817010|NCT04390191|467294194|FG000|Overall Study|Withdrawal by Subject|1|||
129817011|NCT04390191|467294195|FG001|Overall Study|Withdrawal by Subject|0|||
129817012|NCT02794883|467294196|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
129817013|NCT02794883|467294197|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
129817014|NCT02794883|467294198|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
129817015|NCT02794883|467294196|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
129817016|NCT02794883|467294197|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
129817017|NCT02794883|467294198|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
129817018|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
129817019|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
129817020|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
129817021|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
129817022|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
129817023|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
129817024|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
129817025|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
129817026|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
129817027|NCT02794883|467294196|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
129817028|NCT02794883|467294197|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
129817029|NCT02794883|467294198|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
129817030|NCT02794883|467294196|FG000|Follow-up Period (up to 2 Years)|Death|12|||
129817031|NCT02794883|467294197|FG001|Follow-up Period (up to 2 Years)|Death|10|||
129817032|NCT02794883|467294198|FG002|Follow-up Period (up to 2 Years)|Death|10|||
129817033|NCT03978832|467294199|FG000|Overall Study|Adverse Event|1|||
129817034|NCT03978832|467294199|FG000|Overall Study|Lost to Follow-up|1|||
129817035|NCT03978832|467294199|FG000|Overall Study|Withdrawal by Subject|6|||
129817036|NCT03978832|467294199|FG000|Overall Study|Physician Decision|2|||
129817037|NCT03978832|467294199|FG000|Overall Study|did not pass screening criteria|44|||
129817038|NCT00407797|467294206|FG000|Overall Study|Lost to Follow-up|2|||
129817039|NCT00407797|467294206|FG000|Overall Study|Adverse Event|6|||
129817040|NCT00407797|467294206|FG000|Overall Study|Other|7|||
129817041|NCT00407797|467294206|FG000|Overall Study|Withdrawal by Subject|3|||
129817042|NCT01812174|467294207|FG000|Overall Study|Death|1|||
129817043|NCT01812174|467294208|FG001|Overall Study|Death|0|||
129817044|NCT01812174|467294207|FG000|Overall Study|Protocol Violation|2|||
129817045|NCT01812174|467294208|FG001|Overall Study|Protocol Violation|0|||
129817046|NCT03132220|467294210|FG000|Overall Study|Lost to Follow-up|17|||
129817047|NCT03132220|467294211|FG001|Overall Study|Lost to Follow-up|8|||
129817048|NCT03132220|467294210|FG000|Overall Study|Withdrawal by Subject|1|||
129817049|NCT03132220|467294211|FG001|Overall Study|Withdrawal by Subject|4|||
129817050|NCT01051323|467294214|FG000|Overall Study|Discontinuation of treatment|103|||
129817051|NCT01051323|467294214|FG000|Overall Study|Transplantation|28|||
129897160|NCT01168401|467584280|FG006|Overall Study|Withdrawal by Subject|0|||
129817052|NCT01051323|467294214|FG000|Overall Study|Dialysis dependency|22|||
129817053|NCT01051323|467294214|FG000|Overall Study|Withdrawal by Subject|13|||
129817054|NCT01051323|467294214|FG000|Overall Study|Lost to Follow-up|31|||
129817055|NCT01051323|467294214|FG000|Overall Study|Death|129|||
129817056|NCT01051323|467294214|FG000|Overall Study|Hospitalization|28|||
129817057|NCT01051323|467294214|FG000|Overall Study|Other|148|||
129817058|NCT01051323|467294214|FG000|Overall Study|Missing|37|||
129817059|NCT00601458|467294215|FG000|Overall Study|Dosing Error|1|||
129817060|NCT00601458|467294216|FG001|Overall Study|Dosing Error|0|||
129817061|NCT00601458|467294217|FG002|Overall Study|Dosing Error|0|||
129817062|NCT00601458|467294215|FG000|Overall Study|Incomplete Data|0|||
129817063|NCT00601458|467294216|FG001|Overall Study|Incomplete Data|2|||
129817064|NCT00601458|467294217|FG002|Overall Study|Incomplete Data|0|||
129817065|NCT00601458|467294215|FG000|Overall Study|Protocol Violation|3|||
129817066|NCT00601458|467294216|FG001|Overall Study|Protocol Violation|2|||
129817067|NCT00601458|467294217|FG002|Overall Study|Protocol Violation|1|||
129817068|NCT00601458|467294215|FG000|Overall Study|Early Termination|0|||
129817069|NCT00601458|467294216|FG001|Overall Study|Early Termination|1|||
129817070|NCT00601458|467294217|FG002|Overall Study|Early Termination|1|||
129817071|NCT00518986|467294218|FG000|Overall Study|Adverse Event|12|||
129817072|NCT00518986|467294219|FG001|Overall Study|Adverse Event|7|||
129817073|NCT00518986|467294218|FG000|Overall Study|Lack of Efficacy|0|||
129817074|NCT00518986|467294219|FG001|Overall Study|Lack of Efficacy|2|||
129817075|NCT00518986|467294218|FG000|Overall Study|Lost to Follow-up|3|||
129817076|NCT00518986|467294219|FG001|Overall Study|Lost to Follow-up|2|||
129817077|NCT00518986|467294218|FG000|Overall Study|Physician Decision|0|||
129817078|NCT00518986|467294219|FG001|Overall Study|Physician Decision|3|||
129817079|NCT00518986|467294218|FG000|Overall Study|Protocol Violation|5|||
129817080|NCT00518986|467294219|FG001|Overall Study|Protocol Violation|7|||
129817081|NCT00518986|467294218|FG000|Overall Study|Withdrawal by Subject|4|||
129817082|NCT00518986|467294219|FG001|Overall Study|Withdrawal by Subject|4|||
129817083|NCT00518986|467294218|FG000|Overall Study|Non-Specific|2|||
129817084|NCT00518986|467294219|FG001|Overall Study|Non-Specific|1|||
129817085|NCT05683249|467294220|FG000|Overall Study|Adverse Event|3|||
129817086|NCT05683249|467294221|FG001|Overall Study|Adverse Event|1|||
129817087|NCT05683249|467294220|FG000|Overall Study|Lack of Efficacy|0|||
129817088|NCT05683249|467294221|FG001|Overall Study|Lack of Efficacy|2|||
129817089|NCT05683249|467294220|FG000|Overall Study|Lost to Follow-up|6|||
129817090|NCT05683249|467294221|FG001|Overall Study|Lost to Follow-up|5|||
129817091|NCT05683249|467294220|FG000|Overall Study|Non-compliance with Study Drug|2|||
129817092|NCT05683249|467294221|FG001|Overall Study|Non-compliance with Study Drug|0|||
129817093|NCT05683249|467294220|FG000|Overall Study|Protocol Violation|6|||
129817094|NCT05683249|467294221|FG001|Overall Study|Protocol Violation|3|||
129817095|NCT05683249|467294220|FG000|Overall Study|Withdrawal by Subject|9|||
129817096|NCT05683249|467294221|FG001|Overall Study|Withdrawal by Subject|8|||
129817097|NCT05683249|467294220|FG000|Overall Study|Other|0|||
129817098|NCT05683249|467294221|FG001|Overall Study|Other|2|||
129817099|NCT05229406|467294222|FG000|Overall Study|Withdrawal by Subject|1|||
129817100|NCT05229406|467294223|FG001|Overall Study|Withdrawal by Subject|2|||
129817101|NCT01637272|467294225|FG000|Overall Study|Adverse Event|6|||
129817102|NCT01637272|467294225|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129817103|NCT01637272|467294225|FG000|Overall Study|Withdrawal by Subject|3|||
129817104|NCT01637272|467294225|FG000|Overall Study|Lost to Follow-up|2|||
129817105|NCT01637272|467294225|FG000|Overall Study|completed core, did not enter ext. phase|4|||
129817106|NCT01637272|467294225|FG000|Overall Study|Administrative problems|1|||
129817107|NCT01637272|467294225|FG000|Overall Study|Protocol Violation|2|||
129817108|NCT01496612|467294226|FG000|1st Intervention|Adverse Event|1|||
129817109|NCT01496612|467294227|FG001|1st Intervention|Adverse Event|0|||
129817110|NCT01496612|467294226|FG000|1st Intervention|Withdrawal by Subject|1|||
129817111|NCT01496612|467294227|FG001|1st Intervention|Withdrawal by Subject|0|||
129817112|NCT03708328|467294235|FG000|Overall Study|Death|3|||
129817113|NCT03708328|467294236|FG001|Overall Study|Death|3|||
129817114|NCT03708328|467294237|FG002|Overall Study|Death|4|||
129817115|NCT03708328|467294238|FG003|Overall Study|Death|2|||
129817116|NCT03708328|467294239|FG004|Overall Study|Death|2|||
129817117|NCT03708328|467294240|FG005|Overall Study|Death|13|||
129817118|NCT03708328|467294241|FG006|Overall Study|Death|26|||
129817119|NCT03708328|467294242|FG007|Overall Study|Death|18|||
129817120|NCT03708328|467294243|FG008|Overall Study|Death|13|||
129817121|NCT03708328|467294244|FG009|Overall Study|Death|8|||
129817122|NCT03708328|467294235|FG000|Overall Study|Lost to Follow-up|0|||
129817123|NCT03708328|467294236|FG001|Overall Study|Lost to Follow-up|1|||
129817124|NCT03708328|467294237|FG002|Overall Study|Lost to Follow-up|0|||
129817125|NCT03708328|467294238|FG003|Overall Study|Lost to Follow-up|1|||
129817126|NCT03708328|467294239|FG004|Overall Study|Lost to Follow-up|0|||
129817127|NCT03708328|467294240|FG005|Overall Study|Lost to Follow-up|3|||
129817128|NCT03708328|467294241|FG006|Overall Study|Lost to Follow-up|3|||
129817129|NCT03708328|467294242|FG007|Overall Study|Lost to Follow-up|0|||
129817130|NCT03708328|467294243|FG008|Overall Study|Lost to Follow-up|0|||
129817131|NCT03708328|467294244|FG009|Overall Study|Lost to Follow-up|1|||
129817132|NCT03708328|467294235|FG000|Overall Study|Physician Decision|0|||
129817133|NCT03708328|467294236|FG001|Overall Study|Physician Decision|0|||
129817134|NCT03708328|467294237|FG002|Overall Study|Physician Decision|0|||
129817135|NCT03708328|467294238|FG003|Overall Study|Physician Decision|0|||
129817136|NCT03708328|467294239|FG004|Overall Study|Physician Decision|0|||
129817137|NCT03708328|467294240|FG005|Overall Study|Physician Decision|1|||
129817138|NCT03708328|467294241|FG006|Overall Study|Physician Decision|0|||
129817139|NCT03708328|467294242|FG007|Overall Study|Physician Decision|0|||
129817140|NCT03708328|467294243|FG008|Overall Study|Physician Decision|0|||
129817141|NCT03708328|467294244|FG009|Overall Study|Physician Decision|0|||
129817142|NCT03708328|467294235|FG000|Overall Study|Withdrawal by Subject|0|||
129817143|NCT03708328|467294236|FG001|Overall Study|Withdrawal by Subject|0|||
129817144|NCT03708328|467294237|FG002|Overall Study|Withdrawal by Subject|0|||
129817145|NCT03708328|467294238|FG003|Overall Study|Withdrawal by Subject|0|||
129817146|NCT03708328|467294239|FG004|Overall Study|Withdrawal by Subject|1|||
129817147|NCT03708328|467294240|FG005|Overall Study|Withdrawal by Subject|0|||
129817148|NCT03708328|467294241|FG006|Overall Study|Withdrawal by Subject|2|||
129817149|NCT03708328|467294242|FG007|Overall Study|Withdrawal by Subject|4|||
129817150|NCT03708328|467294243|FG008|Overall Study|Withdrawal by Subject|1|||
129817151|NCT03708328|467294244|FG009|Overall Study|Withdrawal by Subject|5|||
129817152|NCT03708328|467294235|FG000|Overall Study|Study Closed Locally|0|||
129817153|NCT03708328|467294236|FG001|Overall Study|Study Closed Locally|0|||
129817154|NCT03708328|467294237|FG002|Overall Study|Study Closed Locally|0|||
129817155|NCT03708328|467294238|FG003|Overall Study|Study Closed Locally|0|||
129817156|NCT03708328|467294239|FG004|Overall Study|Study Closed Locally|0|||
129817157|NCT03708328|467294240|FG005|Overall Study|Study Closed Locally|0|||
129817158|NCT03708328|467294241|FG006|Overall Study|Study Closed Locally|0|||
129817159|NCT03708328|467294242|FG007|Overall Study|Study Closed Locally|1|||
129817160|NCT03708328|467294243|FG008|Overall Study|Study Closed Locally|0|||
129817161|NCT03708328|467294244|FG009|Overall Study|Study Closed Locally|0|||
129817162|NCT03708328|467294235|FG000|Overall Study|Study Ended By Sponsor|0|||
129817163|NCT03708328|467294236|FG001|Overall Study|Study Ended By Sponsor|0|||
129817164|NCT03708328|467294237|FG002|Overall Study|Study Ended By Sponsor|0|||
129817165|NCT03708328|467294238|FG003|Overall Study|Study Ended By Sponsor|0|||
129817166|NCT03708328|467294239|FG004|Overall Study|Study Ended By Sponsor|0|||
129817167|NCT03708328|467294240|FG005|Overall Study|Study Ended By Sponsor|1|||
129817168|NCT03708328|467294241|FG006|Overall Study|Study Ended By Sponsor|0|||
129817169|NCT03708328|467294242|FG007|Overall Study|Study Ended By Sponsor|1|||
129817170|NCT03708328|467294243|FG008|Overall Study|Study Ended By Sponsor|0|||
129897161|NCT01168401|467584281|FG007|Overall Study|Withdrawal by Subject|0|||
129897162|NCT01168401|467584282|FG008|Overall Study|Withdrawal by Subject|0|||
129897163|NCT01168401|467584283|FG009|Overall Study|Withdrawal by Subject|0|||
129897164|NCT01168401|467584284|FG010|Overall Study|Withdrawal by Subject|0|||
129897165|NCT00672256|467584286|FG000|Overall Study|PI dropped, bad data|44|||
129897166|NCT01268891|467584294|FG000|Overall Study|Adverse Event|3|||
129897167|NCT01268891|467584295|FG001|Overall Study|Adverse Event|7|||
129897168|NCT01268891|467584294|FG000|Overall Study|Lack of Efficacy|1|||
129897169|NCT01268891|467584295|FG001|Overall Study|Lack of Efficacy|0|||
129897170|NCT01268891|467584294|FG000|Overall Study|Withdrawal of Consent|3|||
129897171|NCT01268891|467584295|FG001|Overall Study|Withdrawal of Consent|1|||
129897172|NCT01268891|467584294|FG000|Overall Study|Administrative or other reason(s)|1|||
129897173|NCT01268891|467584295|FG001|Overall Study|Administrative or other reason(s)|0|||
129897174|NCT00991276|467584296|FG000|First Intervention Period|Adverse Event|0|||
129897175|NCT00991276|467584297|FG001|First Intervention Period|Adverse Event|1|||
129897176|NCT00991276|467584298|FG002|First Intervention Period|Adverse Event|0|||
129897177|NCT00991276|467584299|FG003|First Intervention Period|Adverse Event|1|||
129897178|NCT00991276|467584300|FG004|First Intervention Period|Adverse Event|0|||
129897179|NCT00991276|467584301|FG005|First Intervention Period|Adverse Event|0|||
129897180|NCT00991276|467584296|FG000|First Intervention Period|Protocol Violation|0|||
129897181|NCT00991276|467584297|FG001|First Intervention Period|Protocol Violation|0|||
129897182|NCT00991276|467584298|FG002|First Intervention Period|Protocol Violation|0|||
129897183|NCT00991276|467584299|FG003|First Intervention Period|Protocol Violation|0|||
129897184|NCT00991276|467584300|FG004|First Intervention Period|Protocol Violation|2|||
129897185|NCT00991276|467584301|FG005|First Intervention Period|Protocol Violation|0|||
129897186|NCT00991276|467584296|FG000|First Intervention Period|Insufficient clinical response|0|||
129897187|NCT00991276|467584297|FG001|First Intervention Period|Insufficient clinical response|0|||
129817171|NCT03708328|467294244|FG009|Overall Study|Study Ended By Sponsor|0|||
129817172|NCT03708328|467294235|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817173|NCT03708328|467294236|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817174|NCT03708328|467294237|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129897188|NCT00991276|467584298|FG002|First Intervention Period|Insufficient clinical response|0|||
129897189|NCT00991276|467584299|FG003|First Intervention Period|Insufficient clinical response|0|||
129897190|NCT00991276|467584300|FG004|First Intervention Period|Insufficient clinical response|1|||
129897191|NCT00991276|467584301|FG005|First Intervention Period|Insufficient clinical response|0|||
129817175|NCT03708328|467294238|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817176|NCT03708328|467294239|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817177|NCT03708328|467294240|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817178|NCT03708328|467294241|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817179|NCT03708328|467294242|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817180|NCT03708328|467294243|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
129817181|NCT03708328|467294244|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
129817182|NCT02695329|467294247|FG000|Overall Study|Adverse Event|1|||
129817183|NCT02695329|467294248|FG001|Overall Study|Adverse Event|0|||
129817184|NCT02695329|467294247|FG000|Overall Study|Poor X-ray quality for measurement|4|||
129817185|NCT02695329|467294248|FG001|Overall Study|Poor X-ray quality for measurement|5|||
129817186|NCT03648983|467294250|FG000|Overall Study|Study was terminated due to PI departure|95|||
129817187|NCT01269463|467294251|FG000|First Intervention|Withdrawal by Subject|1|||
129817188|NCT01269463|467294252|FG001|First Intervention|Withdrawal by Subject|0|||
129817189|NCT01269463|467294251|FG000|First Intervention|Adverse Event|1|||
129817190|NCT01269463|467294252|FG001|First Intervention|Adverse Event|0|||
129817191|NCT01269463|467294251|FG000|First Intervention|Lack of Efficacy|0|||
129817192|NCT01269463|467294252|FG001|First Intervention|Lack of Efficacy|1|||
129817193|NCT01269463|467294251|FG000|First Intervention|Physician Decision|0|||
129817194|NCT01269463|467294252|FG001|First Intervention|Physician Decision|1|||
129817195|NCT04404361|467294256|FG000|Overall Study|Death|12|||
129817196|NCT04404361|467294257|FG001|Overall Study|Death|12|||
129817197|NCT04404361|467294256|FG000|Overall Study|Withdrawal by Subject|13|||
129817198|NCT04404361|467294257|FG001|Overall Study|Withdrawal by Subject|5|||
129817199|NCT04404361|467294256|FG000|Overall Study|Lost to Follow-up|6|||
129817200|NCT04404361|467294257|FG001|Overall Study|Lost to Follow-up|3|||
129817201|NCT04404361|467294256|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
129817202|NCT04404361|467294257|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
129817203|NCT02862171|467294258|FG000|Overall Study|Death|1|||
129817204|NCT02862171|467294258|FG000|Overall Study|Lost to Follow-up|13|||
129817205|NCT02862171|467294258|FG000|Overall Study|Withdrawal by Subject|57|||
129817206|NCT02862171|467294258|FG000|Overall Study|Non-compliance|4|||
129817207|NCT02862171|467294258|FG000|Overall Study|HIV-1 seroconversion|18|||
129817208|NCT02549937|467294260|FG000|Overall Study|Death|0|||
129817209|NCT02549937|467294261|FG001|Overall Study|Death|1|||
129817210|NCT02549937|467294262|FG002|Overall Study|Death|0|||
129817211|NCT02549937|467294263|FG003|Overall Study|Death|1|||
129817212|NCT02549937|467294264|FG004|Overall Study|Death|0|||
129817213|NCT02549937|467294265|FG005|Overall Study|Death|8|||
129817214|NCT02549937|467294266|FG006|Overall Study|Death|0|||
129817215|NCT02549937|467294267|FG007|Overall Study|Death|0|||
129817216|NCT02549937|467294268|FG008|Overall Study|Death|19|||
129817217|NCT02549937|467294260|FG000|Overall Study|No follow up required|3|||
129817218|NCT02549937|467294261|FG001|Overall Study|No follow up required|6|||
129897192|NCT00991276|467584296|FG000|First Intervention Period|Other|0|||
129897193|NCT00991276|467584297|FG001|First Intervention Period|Other|0|||
129897194|NCT00991276|467584298|FG002|First Intervention Period|Other|0|||
129897195|NCT00991276|467584299|FG003|First Intervention Period|Other|1|||
129897196|NCT00991276|467584300|FG004|First Intervention Period|Other|1|||
129897197|NCT00991276|467584301|FG005|First Intervention Period|Other|0|||
129897198|NCT00991276|467584296|FG000|First Intervention Period|Withdrawal by Subject|0|||
129897199|NCT00991276|467584297|FG001|First Intervention Period|Withdrawal by Subject|1|||
129897200|NCT00991276|467584298|FG002|First Intervention Period|Withdrawal by Subject|0|||
129897201|NCT00991276|467584299|FG003|First Intervention Period|Withdrawal by Subject|1|||
129897202|NCT00991276|467584300|FG004|First Intervention Period|Withdrawal by Subject|0|||
129897203|NCT00991276|467584301|FG005|First Intervention Period|Withdrawal by Subject|1|||
129897204|NCT00991276|467584296|FG000|First Intervention Period|Lost to Follow-up|0|||
129897205|NCT00991276|467584297|FG001|First Intervention Period|Lost to Follow-up|1|||
129817219|NCT02549937|467294262|FG002|Overall Study|No follow up required|3|||
129817220|NCT02549937|467294263|FG003|Overall Study|No follow up required|8|||
129897206|NCT00991276|467584298|FG002|First Intervention Period|Lost to Follow-up|0|||
129897207|NCT00991276|467584299|FG003|First Intervention Period|Lost to Follow-up|1|||
129897208|NCT00991276|467584300|FG004|First Intervention Period|Lost to Follow-up|0|||
129897209|NCT00991276|467584301|FG005|First Intervention Period|Lost to Follow-up|0|||
129897210|NCT00991276|467584296|FG000|Second Intervention Period|Adverse Event|0|||
129897211|NCT00991276|467584297|FG001|Second Intervention Period|Adverse Event|2|||
129817221|NCT02549937|467294264|FG004|Overall Study|No follow up required|12|||
129817222|NCT02549937|467294265|FG005|Overall Study|No follow up required|21|||
129817223|NCT02549937|467294266|FG006|Overall Study|No follow up required|9|||
129817224|NCT02549937|467294267|FG007|Overall Study|No follow up required|11|||
129817225|NCT02549937|467294268|FG008|Overall Study|No follow up required|0|||
129817226|NCT02549937|467294260|FG000|Overall Study|Other|0|||
129817227|NCT02549937|467294261|FG001|Overall Study|Other|0|||
129817228|NCT02549937|467294262|FG002|Overall Study|Other|0|||
129817229|NCT02549937|467294263|FG003|Overall Study|Other|0|||
129817230|NCT02549937|467294264|FG004|Overall Study|Other|1|||
129817231|NCT02549937|467294265|FG005|Overall Study|Other|0|||
129817232|NCT02549937|467294266|FG006|Overall Study|Other|3|||
129817233|NCT02549937|467294267|FG007|Overall Study|Other|2|||
129817234|NCT02549937|467294268|FG008|Overall Study|Other|3|||
129817235|NCT02549937|467294260|FG000|Overall Study|Lost to Follow-up|0|||
129817236|NCT02549937|467294261|FG001|Overall Study|Lost to Follow-up|0|||
129817237|NCT02549937|467294262|FG002|Overall Study|Lost to Follow-up|0|||
129817238|NCT02549937|467294263|FG003|Overall Study|Lost to Follow-up|0|||
129817239|NCT02549937|467294264|FG004|Overall Study|Lost to Follow-up|0|||
129817240|NCT02549937|467294265|FG005|Overall Study|Lost to Follow-up|0|||
129817241|NCT02549937|467294266|FG006|Overall Study|Lost to Follow-up|0|||
129817242|NCT02549937|467294267|FG007|Overall Study|Lost to Follow-up|0|||
129817243|NCT02549937|467294268|FG008|Overall Study|Lost to Follow-up|3|||
129817244|NCT02549937|467294260|FG000|Overall Study|Withdrawal by Subject|0|||
129817245|NCT02549937|467294261|FG001|Overall Study|Withdrawal by Subject|0|||
129817246|NCT02549937|467294262|FG002|Overall Study|Withdrawal by Subject|0|||
129817247|NCT02549937|467294263|FG003|Overall Study|Withdrawal by Subject|0|||
129817248|NCT02549937|467294264|FG004|Overall Study|Withdrawal by Subject|0|||
129817249|NCT02549937|467294265|FG005|Overall Study|Withdrawal by Subject|1|||
129817250|NCT02549937|467294266|FG006|Overall Study|Withdrawal by Subject|4|||
129817251|NCT02549937|467294267|FG007|Overall Study|Withdrawal by Subject|3|||
129817252|NCT02549937|467294268|FG008|Overall Study|Withdrawal by Subject|2|||
129817253|NCT02549937|467294260|FG000|Overall Study|Sponsor Decision|0|||
129817254|NCT02549937|467294261|FG001|Overall Study|Sponsor Decision|0|||
129817255|NCT02549937|467294262|FG002|Overall Study|Sponsor Decision|0|||
129817256|NCT02549937|467294263|FG003|Overall Study|Sponsor Decision|0|||
129817257|NCT02549937|467294264|FG004|Overall Study|Sponsor Decision|0|||
129817258|NCT02549937|467294265|FG005|Overall Study|Sponsor Decision|0|||
129817259|NCT02549937|467294266|FG006|Overall Study|Sponsor Decision|0|||
129817260|NCT02549937|467294267|FG007|Overall Study|Sponsor Decision|0|||
129817261|NCT02549937|467294268|FG008|Overall Study|Sponsor Decision|6|||
129817262|NCT03930797|467294269|FG000|Overall Study|Lost to Follow-up|3|||
129817263|NCT03930797|467294270|FG001|Overall Study|Lost to Follow-up|10|||
129817264|NCT00662012|467294271|FG000|Overall Study|Lost to Follow-up|85|||
129817265|NCT00662012|467294271|FG000|Overall Study|Death|1|||
129817266|NCT00662012|467294271|FG000|Overall Study|Withdrawal by Subject|1|||
129817267|NCT02144012|467294274|FG000|Overall Study|Adverse Event|1|||
129817268|NCT02144012|467294275|FG001|Overall Study|Adverse Event|0|||
129817269|NCT02144012|467294274|FG000|Overall Study|Death|1|||
129817270|NCT02144012|467294275|FG001|Overall Study|Death|0|||
129817271|NCT02144012|467294274|FG000|Overall Study|Withdrawal by Subject|11|||
129817272|NCT02144012|467294275|FG001|Overall Study|Withdrawal by Subject|3|||
129817273|NCT02144012|467294274|FG000|Overall Study|Study Terminated by Sponsor|18|||
129817274|NCT02144012|467294275|FG001|Overall Study|Study Terminated by Sponsor|12|||
129817275|NCT02144012|467294274|FG000|Overall Study|Other|3|||
129817276|NCT02144012|467294275|FG001|Overall Study|Other|0|||
129817277|NCT02674529|467295840|FG000|Overall Study|Lost to Follow-up|1|||
129817278|NCT02674529|467295841|FG001|Overall Study|Lost to Follow-up|2|||
129817279|NCT02674529|467295840|FG000|Overall Study|Withdrawal by Subject|2|||
129817280|NCT02674529|467295841|FG001|Overall Study|Withdrawal by Subject|1|||
129817281|NCT02674529|467295840|FG000|Overall Study|Physician Decision|0|||
129817282|NCT02674529|467295841|FG001|Overall Study|Physician Decision|1|||
129817283|NCT02674529|467295840|FG000|Overall Study|Protocol Violation|0|||
129817284|NCT02674529|467295841|FG001|Overall Study|Protocol Violation|1|||
129817285|NCT02891850|467295842|FG000|Overall Study|Adverse Event|3|||
129817286|NCT02891850|467295843|FG001|Overall Study|Adverse Event|0|||
129817287|NCT02891850|467295842|FG000|Overall Study|Death|0|||
129817288|NCT02891850|467295843|FG001|Overall Study|Death|4|||
129817289|NCT02891850|467295842|FG000|Overall Study|Physician Decision|1|||
129817290|NCT02891850|467295843|FG001|Overall Study|Physician Decision|0|||
129817291|NCT02891850|467295842|FG000|Overall Study|Pregnancy|1|||
129817292|NCT02891850|467295843|FG001|Overall Study|Pregnancy|0|||
129817293|NCT02891850|467295842|FG000|Overall Study|Withdrawal by Subject|2|||
129817294|NCT02891850|467295843|FG001|Overall Study|Withdrawal by Subject|3|||
129817295|NCT00630396|467295844|FG000|Overall Study|Death|4|||
129817296|NCT00630396|467295844|FG000|Overall Study|Lost to Follow-up|3|||
129817297|NCT00903695|467295848|FG000|Overall Study|medical exclusion after 1st testing|1|||
129817298|NCT00903695|467295849|FG001|Overall Study|medical exclusion after 1st testing|0|||
129817299|NCT00903695|467295848|FG000|Overall Study|lung cancer|1|||
129817300|NCT00903695|467295849|FG001|Overall Study|lung cancer|0|||
129817301|NCT00543140|467295850|FG000|Overall Study|Lost to Follow-up|33|||
129817302|NCT00543140|467295850|FG000|Overall Study|Withdrawal by Subject|13|||
129817303|NCT00543140|467295850|FG000|Overall Study|Protocol Violation|10|||
129817304|NCT00543140|467295850|FG000|Overall Study|Insufficient weight loss|10|||
129817305|NCT00543140|467295850|FG000|Overall Study|SAE leading to explant of SAGB|3|||
129817306|NCT00543140|467295850|FG000|Overall Study|Death|1|||
129817307|NCT00543140|467295850|FG000|Overall Study|Subject moved|1|||
129817308|NCT00543140|467295850|FG000|Overall Study|Conversion to different procedure|1|||
129817309|NCT00578812|467295851|FG000|Overall Study|Not treated|6|||
129817310|NCT00578812|467295852|FG001|Overall Study|Not treated|7|||
129817311|NCT04532164|467295855|FG000|Overall Study|Adverse Event|1|||
129817312|NCT04532164|467295855|FG000|Overall Study|Protocol Violation|5|||
129817313|NCT04532164|467295855|FG000|Overall Study|Lost to Follow-up|1|||
129817314|NCT04532164|467295855|FG000|Overall Study|Found to be Ineligible|3|||
129817315|NCT04532164|467295855|FG000|Overall Study|Withdrawal by Subject|14|||
129817316|NCT02269241|467295862|FG000|Overall Study|Lost to Follow-up|269|||
129817317|NCT02269241|467295862|FG000|Overall Study|Withdrawal by Subject|155|||
129817318|NCT02269241|467295862|FG000|Overall Study|Protocol Violation|1|||
129817319|NCT02269241|467295862|FG000|Overall Study|Physician Decision|7|||
129817320|NCT02269241|467295862|FG000|Overall Study|Pregnancy|15|||
129817321|NCT02269241|467295862|FG000|Overall Study|Wish for pregnancy|5|||
129817322|NCT02269241|467295862|FG000|Overall Study|Development of an exclusion criteria|16|||
129817323|NCT02269241|467295862|FG000|Overall Study|Adverse Event|113|||
129817324|NCT02269241|467295862|FG000|Overall Study|At the specific request of the sponsor|20|||
129817325|NCT02269241|467295862|FG000|Overall Study|Several reasons not classified|53|||
129817326|NCT02269241|467295862|FG000|Overall Study|Screening failures|546|||
129817327|NCT02270957|467295863|FG000|Overall Study|Lack of Efficacy|2|||
129817328|NCT02270957|467295864|FG001|Overall Study|Lack of Efficacy|4|||
129817329|NCT02270957|467295863|FG000|Overall Study|Adverse Event|2|||
129817330|NCT02270957|467295864|FG001|Overall Study|Adverse Event|0|||
129817331|NCT01218204|467295865|FG000|Part B Washout|Adverse Event|0|||
129817332|NCT01218204|467295866|FG001|Part B Washout|Adverse Event|1|||
129817333|NCT01218204|467295867|FG002|Part B Washout|Adverse Event|0|||
129817334|NCT01218204|467295868|FG003|Part B Washout|Adverse Event|0|||
129817335|NCT01218204|467295865|FG000|Part B Washout|Lost to Follow-up|0|||
129817336|NCT01218204|467295866|FG001|Part B Washout|Lost to Follow-up|2|||
129817337|NCT01218204|467295867|FG002|Part B Washout|Lost to Follow-up|0|||
129817338|NCT01218204|467295868|FG003|Part B Washout|Lost to Follow-up|0|||
129817339|NCT01218204|467295865|FG000|Part B Washout|Physician Decision|0|||
129817340|NCT01218204|467295866|FG001|Part B Washout|Physician Decision|14|||
129817341|NCT01218204|467295867|FG002|Part B Washout|Physician Decision|0|||
129817342|NCT01218204|467295868|FG003|Part B Washout|Physician Decision|0|||
129817343|NCT01218204|467295865|FG000|Part B Washout|Withdrawal by Subject|0|||
129817344|NCT01218204|467295866|FG001|Part B Washout|Withdrawal by Subject|14|||
129817345|NCT01218204|467295867|FG002|Part B Washout|Withdrawal by Subject|0|||
129817346|NCT01218204|467295868|FG003|Part B Washout|Withdrawal by Subject|0|||
129817347|NCT01218204|467295865|FG000|Part B Washout|Reached defined stopping criteria|0|||
129817348|NCT01218204|467295866|FG001|Part B Washout|Reached defined stopping criteria|2|||
129817349|NCT01218204|467295867|FG002|Part B Washout|Reached defined stopping criteria|0|||
129817350|NCT01218204|467295868|FG003|Part B Washout|Reached defined stopping criteria|0|||
129817351|NCT01218204|467295865|FG000|Part B Washout|Did not meet continuation criteria|0|||
129817352|NCT01218204|467295866|FG001|Part B Washout|Did not meet continuation criteria|112|||
129817353|NCT01218204|467295867|FG002|Part B Washout|Did not meet continuation criteria|0|||
129817354|NCT01218204|467295868|FG003|Part B Washout|Did not meet continuation criteria|0|||
129817355|NCT01218204|467295865|FG000|Part B Run-in|Adverse Event|0|||
129817356|NCT01218204|467295866|FG001|Part B Run-in|Adverse Event|0|||
129817357|NCT01218204|467295867|FG002|Part B Run-in|Adverse Event|1|||
129817358|NCT01218204|467295868|FG003|Part B Run-in|Adverse Event|0|||
129817359|NCT01218204|467295865|FG000|Part B Run-in|Protocol Violation|0|||
129817360|NCT01218204|467295866|FG001|Part B Run-in|Protocol Violation|0|||
129817361|NCT01218204|467295867|FG002|Part B Run-in|Protocol Violation|2|||
129817362|NCT01218204|467295868|FG003|Part B Run-in|Protocol Violation|0|||
129817363|NCT01218204|467295865|FG000|Part B Run-in|Withdrawal by Subject|0|||
129817364|NCT01218204|467295866|FG001|Part B Run-in|Withdrawal by Subject|0|||
129817365|NCT01218204|467295867|FG002|Part B Run-in|Withdrawal by Subject|3|||
129817366|NCT01218204|467295868|FG003|Part B Run-in|Withdrawal by Subject|0|||
129817367|NCT01218204|467295865|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
129817368|NCT01218204|467295866|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
129817369|NCT01218204|467295867|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
129817370|NCT01218204|467295868|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
129897212|NCT00991276|467584298|FG002|Second Intervention Period|Adverse Event|0|||
129817371|NCT01218204|467295865|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
129817372|NCT01218204|467295866|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
129817373|NCT01218204|467295867|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
129817374|NCT01218204|467295868|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
129817375|NCT00545168|467295869|FG000|Overall Study|Lost to Follow-up|5|||
129817376|NCT00545168|467295870|FG001|Overall Study|Lost to Follow-up|5|||
129817377|NCT00545168|467295871|FG002|Overall Study|Lost to Follow-up|5|||
129817378|NCT00545168|467295869|FG000|Overall Study|Withdrawal by Subject|9|||
129817379|NCT00545168|467295870|FG001|Overall Study|Withdrawal by Subject|0|||
129817380|NCT00545168|467295871|FG002|Overall Study|Withdrawal by Subject|13|||
129817381|NCT00545168|467295869|FG000|Overall Study|Protocol Violation|1|||
129817382|NCT00545168|467295870|FG001|Overall Study|Protocol Violation|0|||
129817383|NCT00545168|467295871|FG002|Overall Study|Protocol Violation|1|||
129817384|NCT00545168|467295869|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
129817385|NCT00545168|467295870|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
129817386|NCT00545168|467295871|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
129817387|NCT01987505|467295872|FG000|Overall Study|Other|9|||
129817388|NCT01987505|467295872|FG000|Overall Study|Withdrawal by Subject|2|||
129817389|NCT01987505|467295872|FG000|Overall Study|Other Reason|2|||
129817390|NCT01987505|467295872|FG000|Overall Study|Lost to Follow-up|15|||
129817391|NCT01987505|467295872|FG000|Overall Study|Investigator Decision|2|||
129817392|NCT01987505|467295872|FG000|Overall Study|Death|4|||
129817393|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
129817394|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
129817395|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
129817396|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
129817397|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
129817398|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
129817399|NCT00489541|467295873|FG000|12-Month Clinical Follow-up|Death|3|||
129817400|NCT00489541|467295874|FG001|12-Month Clinical Follow-up|Death|2|||
129817401|NCT00489541|467295873|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
129817402|NCT00489541|467295874|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
129817403|NCT00489541|467295873|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
129817404|NCT00489541|467295874|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
129817405|NCT05131646|467295875|FG000|Overall Study|Withdrawal by Subject|1|||
129817406|NCT05131646|467295876|FG001|Overall Study|Withdrawal by Subject|0|||
129817407|NCT05131646|467295877|FG002|Overall Study|Withdrawal by Subject|0|||
129817408|NCT03266107|467295878|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
129817409|NCT03266107|467295878|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
129817410|NCT03266107|467295878|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
129817411|NCT03266107|467295878|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
129817412|NCT01191801|467295883|FG000|Overall Study|Death|36|||
129817413|NCT01191801|467295884|FG001|Overall Study|Death|12|||
129817414|NCT01191801|467295883|FG000|Overall Study|Lack of Efficacy|176|||
129817415|NCT01191801|467295884|FG001|Overall Study|Lack of Efficacy|258|||
129817416|NCT01191801|467295883|FG000|Overall Study|Adverse Event|9|||
129817417|NCT01191801|467295884|FG001|Overall Study|Adverse Event|8|||
129817418|NCT01191801|467295883|FG000|Overall Study|Protocol Violation|2|||
129817419|NCT01191801|467295884|FG001|Overall Study|Protocol Violation|4|||
129817420|NCT01191801|467295883|FG000|Overall Study|Physician Decision|47|||
129817421|NCT01191801|467295884|FG001|Overall Study|Physician Decision|24|||
129817422|NCT01191801|467295883|FG000|Overall Study|Withdrawal by Subject|1|||
129817423|NCT01191801|467295884|FG001|Overall Study|Withdrawal by Subject|4|||
129817424|NCT01191801|467295883|FG000|Overall Study|Not Provided|45|||
129817425|NCT01191801|467295884|FG001|Overall Study|Not Provided|27|||
129817426|NCT05147350|467295892|FG000|Overall Study|Death|2|||
129817427|NCT05147350|467295893|FG001|Overall Study|Death|3|||
129817428|NCT05147350|467295894|FG002|Overall Study|Death|3|||
129817429|NCT05147350|467295895|FG003|Overall Study|Death|2|||
129817430|NCT05147350|467295896|FG004|Overall Study|Death|2|||
129817431|NCT05147350|467295897|FG005|Overall Study|Death|1|||
129817432|NCT05147350|467295898|FG006|Overall Study|Death|1|||
129817433|NCT05147350|467295899|FG007|Overall Study|Death|3|||
129817434|NCT05147350|467295892|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
129817435|NCT05147350|467295893|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
129817436|NCT05147350|467295894|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
129817437|NCT05147350|467295895|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
129817438|NCT05147350|467295896|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
129817439|NCT05147350|467295897|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
129817440|NCT05147350|467295898|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
129817441|NCT05147350|467295899|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
129817442|NCT05147350|467295892|FG000|Overall Study|Withdrawal by Subject|0|||
129817443|NCT05147350|467295893|FG001|Overall Study|Withdrawal by Subject|0|||
129817444|NCT05147350|467295894|FG002|Overall Study|Withdrawal by Subject|3|||
129817445|NCT05147350|467295895|FG003|Overall Study|Withdrawal by Subject|1|||
129817446|NCT05147350|467295896|FG004|Overall Study|Withdrawal by Subject|1|||
129817447|NCT05147350|467295897|FG005|Overall Study|Withdrawal by Subject|0|||
129817448|NCT05147350|467295898|FG006|Overall Study|Withdrawal by Subject|1|||
129817449|NCT05147350|467295899|FG007|Overall Study|Withdrawal by Subject|0|||
129817450|NCT05147350|467295892|FG000|Overall Study|Other Reasons|0|||
129817451|NCT05147350|467295893|FG001|Overall Study|Other Reasons|0|||
129817452|NCT05147350|467295894|FG002|Overall Study|Other Reasons|2|||
129817453|NCT05147350|467295895|FG003|Overall Study|Other Reasons|0|||
129817454|NCT05147350|467295896|FG004|Overall Study|Other Reasons|0|||
129817455|NCT05147350|467295897|FG005|Overall Study|Other Reasons|2|||
129817456|NCT05147350|467295898|FG006|Overall Study|Other Reasons|1|||
129817457|NCT05147350|467295899|FG007|Overall Study|Other Reasons|1|||
129817458|NCT01539538|467295900|FG000|Overall Study|Adverse Event|13|||
129817459|NCT01539538|467295901|FG001|Overall Study|Adverse Event|18|||
129817460|NCT01539538|467295900|FG000|Overall Study|Lack of Efficacy|13|||
129817461|NCT01539538|467295901|FG001|Overall Study|Lack of Efficacy|16|||
129817462|NCT01539538|467295900|FG000|Overall Study|Withdrawal by Subject|2|||
129817463|NCT01539538|467295901|FG001|Overall Study|Withdrawal by Subject|3|||
129817464|NCT01539538|467295900|FG000|Overall Study|PCA no longer required or PCA problem|3|||
129817465|NCT01539538|467295901|FG001|Overall Study|PCA no longer required or PCA problem|7|||
129817466|NCT01192516|467295906|FG000|Overall Study|Lost to Follow-up|7|||
129817467|NCT01192516|467295907|FG001|Overall Study|Lost to Follow-up|10|||
129817468|NCT01192516|467295908|FG002|Overall Study|Lost to Follow-up|7|||
129817469|NCT01192516|467295906|FG000|Overall Study|Withdrawal by Subject|4|||
129817470|NCT01192516|467295907|FG001|Overall Study|Withdrawal by Subject|4|||
129817471|NCT01192516|467295908|FG002|Overall Study|Withdrawal by Subject|1|||
129817472|NCT01192516|467295906|FG000|Overall Study|started new treatment|5|||
129817473|NCT01192516|467295907|FG001|Overall Study|started new treatment|1|||
129817474|NCT01192516|467295908|FG002|Overall Study|started new treatment|0|||
129817475|NCT01192516|467295906|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
129817476|NCT01192516|467295907|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
129817477|NCT01192516|467295908|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
129817478|NCT01256008|467295909|FG000|Overall Study|Lost to Follow-up|6|||
129817479|NCT01256008|467295910|FG001|Overall Study|Lost to Follow-up|4|||
129817480|NCT01256008|467295911|FG002|Overall Study|Lost to Follow-up|11|||
129817481|NCT01256008|467295909|FG000|Overall Study|Withdrawal by Subject|2|||
129817482|NCT01256008|467295910|FG001|Overall Study|Withdrawal by Subject|3|||
129817483|NCT01256008|467295911|FG002|Overall Study|Withdrawal by Subject|10|||
129817484|NCT02321800|467295914|FG000|Overall Study|Withdrawal by Subject|3|||
129817485|NCT02321800|467295915|FG001|Overall Study|Withdrawal by Subject|3|||
129817486|NCT02321800|467295914|FG000|Overall Study|Death|1|||
129817487|NCT02321800|467295915|FG001|Overall Study|Death|0|||
129817488|NCT02321800|467295914|FG000|Overall Study|Protocol Violation|1|||
129817489|NCT02321800|467295915|FG001|Overall Study|Protocol Violation|0|||
129817490|NCT02321800|467295914|FG000|Overall Study|Lost to Follow-up|10|||
129817491|NCT02321800|467295915|FG001|Overall Study|Lost to Follow-up|4|||
129817492|NCT02321800|467295914|FG000|Overall Study|Adverse Event|2|||
129817493|NCT02321800|467295915|FG001|Overall Study|Adverse Event|3|||
129817494|NCT02321800|467295914|FG000|Overall Study|Other, Miscellaneous|3|||
129817495|NCT02321800|467295915|FG001|Overall Study|Other, Miscellaneous|1|||
129817496|NCT01336764|467295919|FG000|Overall Study|Withdrawal by Subject|5|||
129817497|NCT01336764|467295920|FG001|Overall Study|Withdrawal by Subject|5|||
129817498|NCT00730132|467295921|FG000|Overall Study|Protocol Violation|154|||
129817499|NCT00730132|467295921|FG000|Overall Study|Death|1|||
129817500|NCT01626391|467295922|FG000|Overall Study|Physician Decision|1|||
129817501|NCT01626391|467295923|FG001|Overall Study|Physician Decision|0|||
129817502|NCT01626391|467295922|FG000|Overall Study|Withdrawal by Subject|1|||
129817503|NCT01626391|467295923|FG001|Overall Study|Withdrawal by Subject|0|||
129817504|NCT00320411|467295924|FG000|Overall Study|No investigational product admin.|4|||
129817505|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
129817506|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
129817507|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817508|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817509|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817510|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
129817511|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
129817512|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
129817513|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817514|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817515|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817516|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
129817517|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
129817518|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
129817519|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817520|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817521|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817522|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
129817523|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
129817524|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
129817525|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817526|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817527|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817528|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
129817529|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
129817530|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
129817531|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817532|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817533|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817534|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
129817535|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817536|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
129817537|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817538|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817539|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817540|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
129817541|NCT00843024|467295926|FG000|Single-blind Placebo Run-In Phase|Other|0|||
129817542|NCT00843024|467295927|FG001|Single-blind Placebo Run-In Phase|Other|1|||
129817543|NCT00843024|467295928|FG002|Single-blind Placebo Run-In Phase|Other|0|||
129817544|NCT00843024|467295929|FG003|Single-blind Placebo Run-In Phase|Other|0|||
129817545|NCT00843024|467295930|FG004|Single-blind Placebo Run-In Phase|Other|0|||
129817546|NCT00843024|467295931|FG005|Single-blind Placebo Run-In Phase|Other|0|||
129817547|NCT00843024|467295926|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
129817548|NCT00843024|467295927|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
129817549|NCT00843024|467295928|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
129817550|NCT00843024|467295929|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
129817551|NCT00843024|467295930|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
129817552|NCT00843024|467295931|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
129817553|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129817554|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
129817555|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
129817556|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
129817557|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
129817558|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
129817559|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817560|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817561|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817562|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
129817563|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129817564|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
129817565|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
129817566|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
129817567|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
129817568|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
129817569|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
129817570|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
129817571|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Physician Decision|0|||
129817572|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Physician Decision|0|||
129817573|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Physician Decision|0|||
129817574|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Physician Decision|3|||
129817575|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Physician Decision|1|||
129817576|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Physician Decision|1|||
129817577|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129817578|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Adverse Event|0|||
129817579|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Adverse Event|0|||
129817580|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Adverse Event|0|||
129817581|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Adverse Event|1|||
129817582|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Adverse Event|1|||
129817583|NCT00843024|467295926|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817584|NCT00843024|467295927|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817585|NCT00843024|467295928|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817586|NCT00843024|467295929|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817587|NCT00843024|467295930|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
129817588|NCT00843024|467295931|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
129817589|NCT01032837|467295932|FG000|Overall Study|Adverse event/internal illness|0|||
129817590|NCT01032837|467295933|FG001|Overall Study|Adverse event/internal illness|1|||
129817591|NCT01032837|467295934|FG002|Overall Study|Adverse event/internal illness|0|||
129817592|NCT01032837|467295935|FG003|Overall Study|Adverse event/internal illness|1|||
129817593|NCT01032837|467295932|FG000|Overall Study|Withdrew consent|0|||
129817594|NCT01032837|467295933|FG001|Overall Study|Withdrew consent|2|||
129817595|NCT01032837|467295934|FG002|Overall Study|Withdrew consent|0|||
129817596|NCT01032837|467295935|FG003|Overall Study|Withdrew consent|1|||
129817597|NCT01032837|467295932|FG000|Overall Study|Failed to return|0|||
129817598|NCT01032837|467295933|FG001|Overall Study|Failed to return|0|||
129817599|NCT01032837|467295934|FG002|Overall Study|Failed to return|1|||
129817600|NCT01032837|467295935|FG003|Overall Study|Failed to return|0|||
129817601|NCT01032837|467295932|FG000|Overall Study|Refused treatment|0|||
129817602|NCT01032837|467295933|FG001|Overall Study|Refused treatment|0|||
129817603|NCT01032837|467295934|FG002|Overall Study|Refused treatment|0|||
129817604|NCT01032837|467295935|FG003|Overall Study|Refused treatment|1|||
129817605|NCT02615145|467295937|FG000|Overall Study|Did Not Start Treatment|0|||
129817606|NCT02615145|467295938|FG001|Overall Study|Did Not Start Treatment|0|||
129817607|NCT02615145|467295939|FG002|Overall Study|Did Not Start Treatment|1|||
129817608|NCT02615145|467295940|FG003|Overall Study|Did Not Start Treatment|1|||
129817609|NCT02615145|467295937|FG000|Overall Study|Failure to Return|20|||
129817610|NCT02615145|467295938|FG001|Overall Study|Failure to Return|10|||
129817611|NCT02615145|467295939|FG002|Overall Study|Failure to Return|7|||
129817612|NCT02615145|467295940|FG003|Overall Study|Failure to Return|0|||
129817613|NCT02615145|467295937|FG000|Overall Study|Death|2|||
129817614|NCT02615145|467295938|FG001|Overall Study|Death|3|||
129817615|NCT02615145|467295939|FG002|Overall Study|Death|0|||
129817616|NCT02615145|467295940|FG003|Overall Study|Death|0|||
129817617|NCT02615145|467295937|FG000|Overall Study|Other, Not Specified|5|||
129817618|NCT02615145|467295938|FG001|Overall Study|Other, Not Specified|2|||
129817619|NCT02615145|467295939|FG002|Overall Study|Other, Not Specified|0|||
129817620|NCT02615145|467295940|FG003|Overall Study|Other, Not Specified|0|||
129817621|NCT03727347|467295941|FG000|Overall Study|Withdrawal by Subject|2|||
129817622|NCT03727347|467295941|FG000|Overall Study|Lost to Follow-up|1|||
129817623|NCT01487200|467295944|FG000|Overall Study|Withdrawal by Subject|0|||
129817624|NCT01487200|467295945|FG001|Overall Study|Withdrawal by Subject|1|||
129817625|NCT01487200|467295946|FG002|Overall Study|Withdrawal by Subject|0|||
129817626|NCT01487200|467295947|FG003|Overall Study|Withdrawal by Subject|0|||
129817627|NCT02837783|467295948|FG000|Overall Study|Adverse Event|1|||
129817628|NCT02837783|467295949|FG001|Overall Study|Adverse Event|0|||
129817629|NCT02837783|467295948|FG000|Overall Study|Other, Not Specified|1|||
129817630|NCT02837783|467295949|FG001|Overall Study|Other, Not Specified|2|||
129817631|NCT02216591|467295950|FG000|Overall Study|Lost to Follow-up|0|||
129817632|NCT02216591|467295951|FG001|Overall Study|Lost to Follow-up|1|||
129817633|NCT01866930|467295952|FG000|Treatment Period|Other|1|||
129817634|NCT01866930|467295953|FG001|Treatment Period|Other|0|||
129817635|NCT01866930|467295952|FG000|Treatment Period|Death|0|||
129817636|NCT01866930|467295953|FG001|Treatment Period|Death|2|||
129817637|NCT01866930|467295952|FG000|Treatment Period|Poor/non compliance|0|||
129817638|NCT01866930|467295953|FG001|Treatment Period|Poor/non compliance|2|||
129817639|NCT01866930|467295952|FG000|Treatment Period|No longer meets study criteria|0|||
129817640|NCT01866930|467295953|FG001|Treatment Period|No longer meets study criteria|1|||
129817641|NCT01866930|467295952|FG000|Treatment Period|Withdrawal by Subject|2|||
129817642|NCT01866930|467295953|FG001|Treatment Period|Withdrawal by Subject|8|||
129817643|NCT01866930|467295952|FG000|Treatment Period|Lack of Efficacy|1|||
129817644|NCT01866930|467295953|FG001|Treatment Period|Lack of Efficacy|9|||
129817645|NCT01866930|467295952|FG000|Treatment Period|Adverse Event|4|||
129817646|NCT01866930|467295953|FG001|Treatment Period|Adverse Event|12|||
129817647|NCT01866930|467295952|FG000|Treatment Period|Lost to Follow-up|1|||
129817648|NCT01866930|467295953|FG001|Treatment Period|Lost to Follow-up|1|||
129817649|NCT01866930|467295952|FG000|Follow-up Period|Lost to Follow-up|1|||
129817650|NCT01866930|467295953|FG001|Follow-up Period|Lost to Follow-up|1|||
129817651|NCT01866930|467295952|FG000|Follow-up Period|Other|1|||
129817652|NCT01866930|467295953|FG001|Follow-up Period|Other|5|||
129817653|NCT01866930|467295952|FG000|Follow-up Period|No longer required per protocol|1|||
129817654|NCT01866930|467295953|FG001|Follow-up Period|No longer required per protocol|0|||
129817655|NCT01866930|467295952|FG000|Follow-up Period|Withdrawal by Subject|3|||
129817656|NCT01866930|467295953|FG001|Follow-up Period|Withdrawal by Subject|3|||
129817657|NCT00279305|467295956|FG000|Overall Study|Pregnancy|1|||
129817658|NCT00279305|467295957|FG001|Overall Study|Pregnancy|0|||
129817659|NCT00279305|467295956|FG000|Overall Study|Withdrawal by Subject|2|||
129817660|NCT00279305|467295957|FG001|Overall Study|Withdrawal by Subject|0|||
129817661|NCT00279305|467295956|FG000|Overall Study|Dificulting establishing IV|1|||
129817662|NCT00279305|467295957|FG001|Overall Study|Dificulting establishing IV|0|||
129817663|NCT00279305|467295956|FG000|Overall Study|FDA Safety Alert|4|||
129817664|NCT00279305|467295957|FG001|Overall Study|FDA Safety Alert|1|||
129817665|NCT01744197|467295964|FG000|Overall Study|Received 1 patch|2|||
129817666|NCT01744197|467295965|FG001|Overall Study|Received 1 patch|1|||
129817667|NCT01744197|467295964|FG000|Overall Study|No patch received|2|||
129817668|NCT01744197|467295965|FG001|Overall Study|No patch received|2|||
129817669|NCT00317356|467295966|FG000|Overall Study|Adverse Event|0|||
129817670|NCT00317356|467295967|FG001|Overall Study|Adverse Event|0|||
129817671|NCT00317356|467295968|FG002|Overall Study|Adverse Event|1|||
129817672|NCT00317356|467295969|FG003|Overall Study|Adverse Event|0|||
129817673|NCT00317356|467295966|FG000|Overall Study|Lack of Efficacy|1|||
129817674|NCT00317356|467295967|FG001|Overall Study|Lack of Efficacy|1|||
129817675|NCT00317356|467295968|FG002|Overall Study|Lack of Efficacy|0|||
129817676|NCT00317356|467295969|FG003|Overall Study|Lack of Efficacy|3|||
129817677|NCT00317356|467295966|FG000|Overall Study|Physician Decision|0|||
129817678|NCT00317356|467295967|FG001|Overall Study|Physician Decision|1|||
129817679|NCT00317356|467295968|FG002|Overall Study|Physician Decision|0|||
129817680|NCT00317356|467295969|FG003|Overall Study|Physician Decision|0|||
129817681|NCT00621153|467295976|FG000|Overall Study|Safety Reason|8|||
129817682|NCT00621153|467295977|FG001|Overall Study|Safety Reason|7|||
129817683|NCT00621153|467295976|FG000|Overall Study|Adverse Event|3|||
129817684|NCT00621153|467295977|FG001|Overall Study|Adverse Event|2|||
129817685|NCT00621153|467295976|FG000|Overall Study|Lost to Follow-up|5|||
129817686|NCT00621153|467295977|FG001|Overall Study|Lost to Follow-up|1|||
129817687|NCT00621153|467295976|FG000|Overall Study|Withdrawal by Subject|4|||
129817688|NCT00621153|467295977|FG001|Overall Study|Withdrawal by Subject|5|||
129817689|NCT00753415|467295978|FG000|Part A|Disease progression|1|||
129817690|NCT00753415|467295979|FG001|Part A|Disease progression|0|||
129817691|NCT00753415|467295980|FG002|Part A|Disease progression|1|||
129817692|NCT00753415|467295981|FG003|Part A|Disease progression|2|||
129817693|NCT00753415|467295982|FG004|Part A|Disease progression|0|||
129817694|NCT00753415|467295983|FG005|Part A|Disease progression|0|||
129817695|NCT00753415|467295984|FG006|Part A|Disease progression|0|||
129817696|NCT00753415|467295985|FG007|Part A|Disease progression|0|||
129445427|NCT00594516|465932791|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
129445428|NCT00594516|465932792|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
129445429|NCT00594516|465932790|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
129445430|NCT00594516|465932791|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
129445431|NCT00594516|465932792|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
129445432|NCT00594516|465932790|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
129445433|NCT00594516|465932791|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
129445434|NCT00594516|465932792|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
129445435|NCT00594516|465932790|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
129445436|NCT00594516|465932791|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
129445437|NCT00594516|465932792|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
129445438|NCT00594516|465932790|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
129445439|NCT00594516|465932791|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
129445440|NCT00594516|465932792|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
129445441|NCT00594516|465932790|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
129445442|NCT00594516|465932791|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
129445443|NCT00594516|465932792|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
129445444|NCT00594516|465932790|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
129445445|NCT00594516|465932791|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
129445446|NCT00594516|465932792|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
129445447|NCT02217436|465932793|FG000|Overall Study|Protocol Violation|1|||
129445448|NCT02217436|465932794|FG001|Overall Study|Protocol Violation|1|||
129445449|NCT02217436|465932793|FG000|Overall Study|Incomplete data|0|||
129445450|NCT02217436|465932794|FG001|Overall Study|Incomplete data|1|||
129445451|NCT00993954|465932797|FG000|Overall Study|Protocol Violation|21|||
129445452|NCT00993954|465932798|FG001|Overall Study|Protocol Violation|2|||
129445453|NCT04439071|465932807|FG000|Overall Study|Lost to Follow-up|0|||
129445454|NCT04439071|465932808|FG001|Overall Study|Lost to Follow-up|3|||
129445455|NCT04439071|465932807|FG000|Overall Study|Withdrawal by Subject|3|||
129445456|NCT04439071|465932808|FG001|Overall Study|Withdrawal by Subject|8|||
129445457|NCT04439071|465932807|FG000|Overall Study|Death|6|||
129445458|NCT04439071|465932808|FG001|Overall Study|Death|4|||
129817697|NCT00753415|467295986|FG008|Part A|Disease progression|0|||
129817698|NCT00753415|467295987|FG009|Part A|Disease progression|0|||
129817699|NCT00753415|467295978|FG000|Part A|Withdrawal by Subject|0|||
129817700|NCT00753415|467295979|FG001|Part A|Withdrawal by Subject|0|||
129897213|NCT00991276|467584299|FG003|Second Intervention Period|Adverse Event|1|||
129817701|NCT00753415|467295980|FG002|Part A|Withdrawal by Subject|1|||
129817702|NCT00753415|467295981|FG003|Part A|Withdrawal by Subject|0|||
129817703|NCT00753415|467295982|FG004|Part A|Withdrawal by Subject|0|||
129817704|NCT00753415|467295983|FG005|Part A|Withdrawal by Subject|0|||
129817705|NCT00753415|467295984|FG006|Part A|Withdrawal by Subject|0|||
129817706|NCT00753415|467295985|FG007|Part A|Withdrawal by Subject|0|||
129817707|NCT00753415|467295986|FG008|Part A|Withdrawal by Subject|0|||
129817708|NCT00753415|467295987|FG009|Part A|Withdrawal by Subject|0|||
129817709|NCT00753415|467295978|FG000|Part B|Lost to Follow-up|0|||
129817710|NCT00753415|467295979|FG001|Part B|Lost to Follow-up|0|||
129817711|NCT00753415|467295980|FG002|Part B|Lost to Follow-up|0|||
129817712|NCT00753415|467295981|FG003|Part B|Lost to Follow-up|0|||
129817713|NCT00753415|467295982|FG004|Part B|Lost to Follow-up|0|||
129817714|NCT00753415|467295983|FG005|Part B|Lost to Follow-up|0|||
129817715|NCT00753415|467295984|FG006|Part B|Lost to Follow-up|0|||
129817716|NCT00753415|467295985|FG007|Part B|Lost to Follow-up|1|||
129817717|NCT00753415|467295986|FG008|Part B|Lost to Follow-up|1|||
129817718|NCT00753415|467295987|FG009|Part B|Lost to Follow-up|0|||
129817719|NCT00753415|467295978|FG000|Part B|Disease progression|0|||
129817720|NCT00753415|467295979|FG001|Part B|Disease progression|0|||
129817721|NCT00753415|467295980|FG002|Part B|Disease progression|0|||
129817722|NCT00753415|467295981|FG003|Part B|Disease progression|0|||
129817723|NCT00753415|467295982|FG004|Part B|Disease progression|0|||
129817724|NCT00753415|467295983|FG005|Part B|Disease progression|0|||
129817725|NCT00753415|467295984|FG006|Part B|Disease progression|0|||
129817726|NCT00753415|467295985|FG007|Part B|Disease progression|0|||
129817727|NCT00753415|467295986|FG008|Part B|Disease progression|2|||
129817728|NCT00753415|467295987|FG009|Part B|Disease progression|1|||
129817729|NCT04212650|467295988|FG000|Overall Study|Withdrawal by Subject|1|||
129817730|NCT04212650|467295989|FG001|Overall Study|Withdrawal by Subject|0|||
129817731|NCT04419714|467295990|FG000|Overall Study|Technical Fault|5|||
129817732|NCT04419714|467295990|FG000|Overall Study|Protocol Deviation|2|||
129817733|NCT04419714|467295990|FG000|Overall Study|Withdrawal by Subject|1|||
129897214|NCT00991276|467584300|FG004|Second Intervention Period|Adverse Event|1|||
129897215|NCT00991276|467584301|FG005|Second Intervention Period|Adverse Event|0|||
129897216|NCT00991276|467584296|FG000|Second Intervention Period|Protocol Violation|1|||
129897217|NCT00991276|467584297|FG001|Second Intervention Period|Protocol Violation|0|||
129897218|NCT00991276|467584298|FG002|Second Intervention Period|Protocol Violation|0|||
129897219|NCT00991276|467584299|FG003|Second Intervention Period|Protocol Violation|0|||
129897220|NCT00991276|467584300|FG004|Second Intervention Period|Protocol Violation|0|||
129897221|NCT00991276|467584301|FG005|Second Intervention Period|Protocol Violation|0|||
129897222|NCT00991276|467584296|FG000|Second Intervention Period|Other|0|||
129897223|NCT00991276|467584297|FG001|Second Intervention Period|Other|0|||
129897224|NCT00991276|467584298|FG002|Second Intervention Period|Other|0|||
129897225|NCT00991276|467584299|FG003|Second Intervention Period|Other|1|||
129897226|NCT00991276|467584300|FG004|Second Intervention Period|Other|0|||
129897227|NCT00991276|467584301|FG005|Second Intervention Period|Other|1|||
129897228|NCT00991276|467584296|FG000|Third Intervention Period|Protocol Violation|1|||
129897229|NCT00991276|467584297|FG001|Third Intervention Period|Protocol Violation|0|||
129897230|NCT00991276|467584298|FG002|Third Intervention Period|Protocol Violation|0|||
129897231|NCT00991276|467584299|FG003|Third Intervention Period|Protocol Violation|0|||
129897232|NCT00991276|467584300|FG004|Third Intervention Period|Protocol Violation|0|||
129897233|NCT00991276|467584301|FG005|Third Intervention Period|Protocol Violation|0|||
129897234|NCT00991276|467584296|FG000|Third Intervention Period|Other|0|||
129897235|NCT00991276|467584297|FG001|Third Intervention Period|Other|0|||
129897236|NCT00991276|467584298|FG002|Third Intervention Period|Other|0|||
129897237|NCT00991276|467584299|FG003|Third Intervention Period|Other|0|||
129897238|NCT00991276|467584300|FG004|Third Intervention Period|Other|0|||
129897239|NCT00991276|467584301|FG005|Third Intervention Period|Other|1|||
129897240|NCT00991276|467584296|FG000|Third Intervention Period|Adverse Event|0|||
129897241|NCT00991276|467584297|FG001|Third Intervention Period|Adverse Event|0|||
129897242|NCT00991276|467584298|FG002|Third Intervention Period|Adverse Event|1|||
129897243|NCT00991276|467584299|FG003|Third Intervention Period|Adverse Event|0|||
129897244|NCT00991276|467584300|FG004|Third Intervention Period|Adverse Event|0|||
129897245|NCT00991276|467584301|FG005|Third Intervention Period|Adverse Event|0|||
129897246|NCT00991276|467584296|FG000|Third Intervention Period|Withdrawal by Subject|0|||
129897247|NCT00991276|467584297|FG001|Third Intervention Period|Withdrawal by Subject|0|||
129897248|NCT00991276|467584298|FG002|Third Intervention Period|Withdrawal by Subject|0|||
129897249|NCT00991276|467584299|FG003|Third Intervention Period|Withdrawal by Subject|1|||
129897250|NCT00991276|467584300|FG004|Third Intervention Period|Withdrawal by Subject|0|||
129897251|NCT00991276|467584301|FG005|Third Intervention Period|Withdrawal by Subject|0|||
129897252|NCT01720043|467584302|FG000|Overall Study|Withdrawal by Subject|1|||
129897253|NCT01688973|467584303|FG000|Overall Study|Ineligible|2|||
129897254|NCT01688973|467584304|FG001|Overall Study|Ineligible|3|||
129897255|NCT00711646|467584305|FG000|Overall Study|Adverse Event|6|||
129897256|NCT00711646|467584306|FG001|Overall Study|Adverse Event|1|||
129897257|NCT00711646|467584305|FG000|Overall Study|Withdrawal by Subject|4|||
129897258|NCT00711646|467584306|FG001|Overall Study|Withdrawal by Subject|0|||
129897259|NCT00711646|467584305|FG000|Overall Study|Protocol Violation|0|||
129897260|NCT00711646|467584306|FG001|Overall Study|Protocol Violation|1|||
129817734|NCT04023526|467297483|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
129817735|NCT04023526|467297484|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
129817736|NCT04023526|467297483|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
129817737|NCT04023526|467297484|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
129817738|NCT00056316|467297486|FG000|Overall Study|Withdrawal by Subject|2|||
129817739|NCT00056316|467297487|FG001|Overall Study|Withdrawal by Subject|2|||
129817740|NCT00056316|467297486|FG000|Overall Study|Death/NH placement of pt|1|||
129817741|NCT00056316|467297487|FG001|Overall Study|Death/NH placement of pt|1|||
129817742|NCT02599129|467297489|FG000|Overall Study|Lack of Efficacy|2|||
129817743|NCT02599129|467297490|FG001|Overall Study|Lack of Efficacy|2|||
129817744|NCT02599129|467297489|FG000|Overall Study|Lost to Follow-up|1|||
129817745|NCT02599129|467297490|FG001|Overall Study|Lost to Follow-up|0|||
129817746|NCT02599129|467297489|FG000|Overall Study|Withdrawal by Subject|2|||
129817747|NCT02599129|467297490|FG001|Overall Study|Withdrawal by Subject|1|||
129817748|NCT03489720|467297491|FG000|Overall Study|Withdrawal by Subject|2|||
129817749|NCT03489720|467297492|FG001|Overall Study|Withdrawal by Subject|0|||
129817750|NCT00166114|467297498|FG000|Overall Study|Protocol Violation|2|||
129817751|NCT00166114|467297499|FG001|Overall Study|Protocol Violation|1|||
129817752|NCT00166114|467297498|FG000|Overall Study|Withdrawal by Subject|10|||
129817753|NCT00166114|467297499|FG001|Overall Study|Withdrawal by Subject|4|||
129817754|NCT00166114|467297498|FG000|Overall Study|Adverse Event|2|||
129817755|NCT00166114|467297499|FG001|Overall Study|Adverse Event|1|||
129817756|NCT00127660|467297506|FG000|Overall Study|Protocol Violation|3|||
129817757|NCT00127660|467297507|FG001|Overall Study|Protocol Violation|3|||
129817758|NCT00127660|467297508|FG002|Overall Study|Protocol Violation|5|||
129817759|NCT00127660|467297509|FG003|Overall Study|Protocol Violation|0|||
129817760|NCT05228132|467297510|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
129817761|NCT05228132|467297510|FG000|Overall Study|Adverse Event|3|||
129817762|NCT05228132|467297510|FG000|Overall Study|Lost to Follow-up|1|||
129817763|NCT05228132|467297510|FG000|Overall Study|Arteriovenous-fistula mature|1|||
129817764|NCT00420927|467297513|FG000|Period 1|Adverse Event|19|||
129817765|NCT00420927|467297514|FG001|Period 1|Adverse Event|15|||
129817766|NCT00420927|467297515|FG002|Period 1|Adverse Event|0|||
129817767|NCT00420927|467297516|FG003|Period 1|Adverse Event|0|||
129817768|NCT00420927|467297517|FG004|Period 1|Adverse Event|0|||
129817769|NCT00420927|467297518|FG005|Period 1|Adverse Event|0|||
129817770|NCT00420927|467297519|FG006|Period 1|Adverse Event|0|||
129817771|NCT00420927|467297513|FG000|Period 1|Withdrawal by Subject|7|||
129817772|NCT00420927|467297514|FG001|Period 1|Withdrawal by Subject|12|||
129817773|NCT00420927|467297515|FG002|Period 1|Withdrawal by Subject|0|||
129817774|NCT00420927|467297516|FG003|Period 1|Withdrawal by Subject|0|||
129817775|NCT00420927|467297517|FG004|Period 1|Withdrawal by Subject|0|||
129817776|NCT00420927|467297518|FG005|Period 1|Withdrawal by Subject|0|||
129817777|NCT00420927|467297519|FG006|Period 1|Withdrawal by Subject|0|||
129817778|NCT00420927|467297513|FG000|Period 1|Lost to Follow-up|8|||
129817779|NCT00420927|467297514|FG001|Period 1|Lost to Follow-up|6|||
129817780|NCT00420927|467297515|FG002|Period 1|Lost to Follow-up|0|||
129817781|NCT00420927|467297516|FG003|Period 1|Lost to Follow-up|0|||
129817782|NCT00420927|467297517|FG004|Period 1|Lost to Follow-up|0|||
129817783|NCT00420927|467297518|FG005|Period 1|Lost to Follow-up|0|||
129817784|NCT00420927|467297519|FG006|Period 1|Lost to Follow-up|0|||
129817785|NCT00420927|467297513|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
129817786|NCT00420927|467297514|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
129817787|NCT00420927|467297515|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817788|NCT00420927|467297516|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817789|NCT00420927|467297517|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817790|NCT00420927|467297518|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817791|NCT00420927|467297519|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
129817792|NCT00420927|467297513|FG000|Period 1|Death|2|||
129817793|NCT00420927|467297514|FG001|Period 1|Death|0|||
129817794|NCT00420927|467297515|FG002|Period 1|Death|0|||
129817795|NCT00420927|467297516|FG003|Period 1|Death|0|||
129817796|NCT00420927|467297517|FG004|Period 1|Death|0|||
129817797|NCT00420927|467297518|FG005|Period 1|Death|0|||
129817798|NCT00420927|467297519|FG006|Period 1|Death|0|||
129817799|NCT00420927|467297513|FG000|Period 1|Subject moved/relocated|0|||
129817800|NCT00420927|467297514|FG001|Period 1|Subject moved/relocated|2|||
129817801|NCT00420927|467297515|FG002|Period 1|Subject moved/relocated|0|||
129817802|NCT00420927|467297516|FG003|Period 1|Subject moved/relocated|0|||
129817803|NCT00420927|467297517|FG004|Period 1|Subject moved/relocated|0|||
129817804|NCT00420927|467297518|FG005|Period 1|Subject moved/relocated|0|||
129817805|NCT00420927|467297519|FG006|Period 1|Subject moved/relocated|0|||
129817806|NCT00420927|467297513|FG000|Period 1|Noncompliant with study drug|1|||
129817807|NCT00420927|467297514|FG001|Period 1|Noncompliant with study drug|1|||
129817808|NCT00420927|467297515|FG002|Period 1|Noncompliant with study drug|0|||
129817809|NCT00420927|467297516|FG003|Period 1|Noncompliant with study drug|0|||
129817810|NCT00420927|467297517|FG004|Period 1|Noncompliant with study drug|0|||
129817811|NCT00420927|467297518|FG005|Period 1|Noncompliant with study drug|0|||
129817812|NCT00420927|467297519|FG006|Period 1|Noncompliant with study drug|0|||
129817813|NCT00420927|467297513|FG000|Period 1|Randomization error|1|||
129817814|NCT00420927|467297514|FG001|Period 1|Randomization error|0|||
129817815|NCT00420927|467297515|FG002|Period 1|Randomization error|0|||
129817816|NCT00420927|467297516|FG003|Period 1|Randomization error|0|||
129817817|NCT00420927|467297517|FG004|Period 1|Randomization error|0|||
129817818|NCT00420927|467297518|FG005|Period 1|Randomization error|0|||
129817819|NCT00420927|467297519|FG006|Period 1|Randomization error|0|||
129817820|NCT00420927|467297513|FG000|Period 1|Suspected tuberculosis/positive test|1|||
129817821|NCT00420927|467297514|FG001|Period 1|Suspected tuberculosis/positive test|1|||
129817822|NCT00420927|467297515|FG002|Period 1|Suspected tuberculosis/positive test|0|||
129817823|NCT00420927|467297516|FG003|Period 1|Suspected tuberculosis/positive test|0|||
129817824|NCT00420927|467297517|FG004|Period 1|Suspected tuberculosis/positive test|0|||
129817825|NCT00420927|467297518|FG005|Period 1|Suspected tuberculosis/positive test|0|||
129817826|NCT00420927|467297519|FG006|Period 1|Suspected tuberculosis/positive test|0|||
129817827|NCT00420927|467297513|FG000|Period 1|Study site closure|0|||
129817828|NCT00420927|467297514|FG001|Period 1|Study site closure|1|||
129817829|NCT00420927|467297515|FG002|Period 1|Study site closure|0|||
129817830|NCT00420927|467297516|FG003|Period 1|Study site closure|0|||
129817831|NCT00420927|467297517|FG004|Period 1|Study site closure|0|||
129817832|NCT00420927|467297518|FG005|Period 1|Study site closure|0|||
129817833|NCT00420927|467297519|FG006|Period 1|Study site closure|0|||
129817834|NCT00420927|467297513|FG000|Period 1|Subject received new diagnosis|0|||
129817835|NCT00420927|467297514|FG001|Period 1|Subject received new diagnosis|2|||
129817836|NCT00420927|467297515|FG002|Period 1|Subject received new diagnosis|0|||
129817837|NCT00420927|467297516|FG003|Period 1|Subject received new diagnosis|0|||
129817838|NCT00420927|467297517|FG004|Period 1|Subject received new diagnosis|0|||
129817839|NCT00420927|467297518|FG005|Period 1|Subject received new diagnosis|0|||
129817840|NCT00420927|467297519|FG006|Period 1|Subject received new diagnosis|0|||
129817841|NCT00420927|467297513|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
129817842|NCT00420927|467297514|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
129817843|NCT00420927|467297515|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
129817844|NCT00420927|467297516|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
129817845|NCT00420927|467297517|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
129817846|NCT00420927|467297518|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
129817847|NCT00420927|467297519|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
129817848|NCT00420927|467297513|FG000|Period 1|Failed to meet entry criteria|8|||
129817849|NCT00420927|467297514|FG001|Period 1|Failed to meet entry criteria|7|||
129817850|NCT00420927|467297515|FG002|Period 1|Failed to meet entry criteria|0|||
129817851|NCT00420927|467297516|FG003|Period 1|Failed to meet entry criteria|0|||
129817852|NCT00420927|467297517|FG004|Period 1|Failed to meet entry criteria|0|||
129817853|NCT00420927|467297518|FG005|Period 1|Failed to meet entry criteria|0|||
129817854|NCT00420927|467297519|FG006|Period 1|Failed to meet entry criteria|0|||
129817855|NCT00420927|467297513|FG000|Period 1|Took prohibited medication|1|||
129817856|NCT00420927|467297514|FG001|Period 1|Took prohibited medication|3|||
129817857|NCT00420927|467297515|FG002|Period 1|Took prohibited medication|0|||
129817858|NCT00420927|467297516|FG003|Period 1|Took prohibited medication|0|||
129817859|NCT00420927|467297517|FG004|Period 1|Took prohibited medication|0|||
129817860|NCT00420927|467297518|FG005|Period 1|Took prohibited medication|0|||
129817861|NCT00420927|467297519|FG006|Period 1|Took prohibited medication|0|||
129817862|NCT00420927|467297513|FG000|Period 2|Adverse Event|0|||
129817863|NCT00420927|467297514|FG001|Period 2|Adverse Event|0|||
129817864|NCT00420927|467297515|FG002|Period 2|Adverse Event|7|||
129817865|NCT00420927|467297516|FG003|Period 2|Adverse Event|3|||
129817866|NCT00420927|467297517|FG004|Period 2|Adverse Event|17|||
129817867|NCT00420927|467297518|FG005|Period 2|Adverse Event|6|||
129817868|NCT00420927|467297519|FG006|Period 2|Adverse Event|20|||
129817869|NCT00420927|467297513|FG000|Period 2|Withdrawal by Subject|0|||
129817870|NCT00420927|467297514|FG001|Period 2|Withdrawal by Subject|0|||
129817871|NCT00420927|467297515|FG002|Period 2|Withdrawal by Subject|1|||
129817872|NCT00420927|467297516|FG003|Period 2|Withdrawal by Subject|3|||
129817873|NCT00420927|467297517|FG004|Period 2|Withdrawal by Subject|11|||
129817874|NCT00420927|467297518|FG005|Period 2|Withdrawal by Subject|2|||
129817875|NCT00420927|467297519|FG006|Period 2|Withdrawal by Subject|12|||
129817876|NCT00420927|467297513|FG000|Period 2|Lost to Follow-up|0|||
129817877|NCT00420927|467297514|FG001|Period 2|Lost to Follow-up|0|||
129817878|NCT00420927|467297515|FG002|Period 2|Lost to Follow-up|2|||
129817879|NCT00420927|467297516|FG003|Period 2|Lost to Follow-up|2|||
129817880|NCT00420927|467297517|FG004|Period 2|Lost to Follow-up|6|||
129817881|NCT00420927|467297518|FG005|Period 2|Lost to Follow-up|3|||
129817882|NCT00420927|467297519|FG006|Period 2|Lost to Follow-up|9|||
129817883|NCT00420927|467297513|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
129817884|NCT00420927|467297514|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
129817885|NCT00420927|467297515|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
129817886|NCT00420927|467297516|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
129817887|NCT00420927|467297517|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
129817888|NCT00420927|467297518|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
129817889|NCT00420927|467297519|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
129817890|NCT00420927|467297513|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
129817891|NCT00420927|467297514|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
129817892|NCT00420927|467297515|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
129445459|NCT04439071|465932807|FG000|Overall Study|Other than specified|3|||
129817893|NCT00420927|467297516|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
129817894|NCT00420927|467297517|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
129817895|NCT00420927|467297518|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
129817896|NCT00420927|467297519|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
129817897|NCT00420927|467297513|FG000|Period 2|Subject unable to find transportation|0|||
129817898|NCT00420927|467297514|FG001|Period 2|Subject unable to find transportation|0|||
129817899|NCT00420927|467297515|FG002|Period 2|Subject unable to find transportation|0|||
129817900|NCT00420927|467297516|FG003|Period 2|Subject unable to find transportation|0|||
129817901|NCT00420927|467297517|FG004|Period 2|Subject unable to find transportation|0|||
129817902|NCT00420927|467297518|FG005|Period 2|Subject unable to find transportation|0|||
129817903|NCT00420927|467297519|FG006|Period 2|Subject unable to find transportation|1|||
129817904|NCT00420927|467297513|FG000|Period 2|Physician Decision|0|||
129817905|NCT00420927|467297514|FG001|Period 2|Physician Decision|0|||
129817906|NCT00420927|467297515|FG002|Period 2|Physician Decision|0|||
129817907|NCT00420927|467297516|FG003|Period 2|Physician Decision|0|||
129817908|NCT00420927|467297517|FG004|Period 2|Physician Decision|1|||
129817909|NCT00420927|467297518|FG005|Period 2|Physician Decision|1|||
129817910|NCT00420927|467297519|FG006|Period 2|Physician Decision|0|||
129817911|NCT00420927|467297513|FG000|Period 2|Sponsor decision|0|||
129817912|NCT00420927|467297514|FG001|Period 2|Sponsor decision|0|||
129817913|NCT00420927|467297515|FG002|Period 2|Sponsor decision|1|||
129817914|NCT00420927|467297516|FG003|Period 2|Sponsor decision|0|||
129817915|NCT00420927|467297517|FG004|Period 2|Sponsor decision|0|||
129817916|NCT00420927|467297518|FG005|Period 2|Sponsor decision|0|||
129817917|NCT00420927|467297519|FG006|Period 2|Sponsor decision|1|||
129817918|NCT00420927|467297513|FG000|Period 2|Randomization error|0|||
129817919|NCT00420927|467297514|FG001|Period 2|Randomization error|0|||
129817920|NCT00420927|467297515|FG002|Period 2|Randomization error|0|||
129817921|NCT00420927|467297516|FG003|Period 2|Randomization error|0|||
129817922|NCT00420927|467297517|FG004|Period 2|Randomization error|1|||
129817923|NCT00420927|467297518|FG005|Period 2|Randomization error|1|||
129817924|NCT00420927|467297519|FG006|Period 2|Randomization error|0|||
129817925|NCT00420927|467297513|FG000|Period 2|Noncompliant with study drug|0|||
129817926|NCT00420927|467297514|FG001|Period 2|Noncompliant with study drug|0|||
129817927|NCT00420927|467297515|FG002|Period 2|Noncompliant with study drug|0|||
129817928|NCT00420927|467297516|FG003|Period 2|Noncompliant with study drug|1|||
129817929|NCT00420927|467297517|FG004|Period 2|Noncompliant with study drug|0|||
129817930|NCT00420927|467297518|FG005|Period 2|Noncompliant with study drug|0|||
129817931|NCT00420927|467297519|FG006|Period 2|Noncompliant with study drug|2|||
129817932|NCT00420927|467297513|FG000|Period 2|Methotrexate intolerance|0|||
129817933|NCT00420927|467297514|FG001|Period 2|Methotrexate intolerance|0|||
129817934|NCT00420927|467297515|FG002|Period 2|Methotrexate intolerance|0|||
129817935|NCT00420927|467297516|FG003|Period 2|Methotrexate intolerance|0|||
129817936|NCT00420927|467297517|FG004|Period 2|Methotrexate intolerance|0|||
129817937|NCT00420927|467297518|FG005|Period 2|Methotrexate intolerance|0|||
129817938|NCT00420927|467297519|FG006|Period 2|Methotrexate intolerance|1|||
129817939|NCT00420927|467297513|FG000|Period 2|Took prohibited medication|0|||
129817940|NCT00420927|467297514|FG001|Period 2|Took prohibited medication|0|||
129817941|NCT00420927|467297515|FG002|Period 2|Took prohibited medication|0|||
129817942|NCT00420927|467297516|FG003|Period 2|Took prohibited medication|0|||
129817943|NCT00420927|467297517|FG004|Period 2|Took prohibited medication|1|||
129817944|NCT00420927|467297518|FG005|Period 2|Took prohibited medication|0|||
129817945|NCT00420927|467297519|FG006|Period 2|Took prohibited medication|0|||
129817946|NCT03018704|467297520|FG000|Overall Study|Lost to Follow-up|1|||
129817947|NCT03018704|467297521|FG001|Overall Study|Lost to Follow-up|1|||
129817948|NCT00642460|467297525|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817949|NCT00642460|467297526|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
129817950|NCT00642460|467297527|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
129817951|NCT00642460|467297528|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817952|NCT00642460|467297529|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817953|NCT00642460|467297530|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
129817954|NCT00642460|467297525|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
129817955|NCT00642460|467297526|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817956|NCT00642460|467297527|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817957|NCT00642460|467297528|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817958|NCT00642460|467297529|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817959|NCT00642460|467297530|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
129817960|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
129817961|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
129817962|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817963|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817964|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817965|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
129817966|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Death|0|||
129817967|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Death|1|||
129817968|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Death|0|||
129817969|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Death|2|||
129817970|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Death|0|||
129817971|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Death|0|||
129817972|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
129817973|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
129817974|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129897261|NCT00711646|467584305|FG000|Overall Study|Lost to Follow-up|1|||
129897262|NCT00711646|467584306|FG001|Overall Study|Lost to Follow-up|0|||
129817975|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129817976|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129817977|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
129817978|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
129817979|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
129817980|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817981|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817982|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817983|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
129817984|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817985|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
129817986|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817987|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817988|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817989|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
129817990|NCT00642460|467297525|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817991|NCT00642460|467297526|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817992|NCT00642460|467297527|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817993|NCT00642460|467297528|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
129817994|NCT00642460|467297529|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817995|NCT00642460|467297530|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
129817996|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129817997|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129817998|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129817999|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
129818000|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
129818001|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
129818002|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818003|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818004|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818005|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
129818006|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
129818007|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
129818008|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818009|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818010|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818011|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
129818012|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
129818013|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
129818014|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818015|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818016|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818017|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
129818018|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
129818019|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
129818020|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Other|0|||
129818021|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Other|0|||
129818022|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Other|0|||
129818023|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Other|0|||
129818024|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Other|2|||
129818025|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Other|2|||
129818026|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Death|0|||
129818027|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Death|0|||
129818028|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Death|0|||
129818029|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Death|0|||
129818030|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Death|0|||
129818031|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Death|3|||
129818032|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818033|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818034|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818035|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818036|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
129818037|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
129818038|NCT00642460|467297525|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818039|NCT00642460|467297526|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818040|NCT00642460|467297527|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818041|NCT00642460|467297528|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
129818042|NCT00642460|467297529|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
129818043|NCT00642460|467297530|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
129818044|NCT02557646|467297533|FG000|Overall Study|Adverse Event|40|||
129818045|NCT02557646|467297533|FG000|Overall Study|Death|1|||
129818046|NCT02557646|467297533|FG000|Overall Study|Lack of Efficacy|186|||
129818047|NCT02557646|467297533|FG000|Overall Study|Withdrawal by Subject|18|||
129818048|NCT02557646|467297533|FG000|Overall Study|Lost to Follow-up|17|||
129818049|NCT02557646|467297533|FG000|Overall Study|Other|14|||
129818050|NCT04448171|467297534|FG000|Overall Study|Procedure Cancelled|1|||
129818051|NCT04448171|467297535|FG001|Overall Study|Procedure Cancelled|0|||
129818052|NCT04448171|467297534|FG000|Overall Study|Protocol Violation|1|||
129818053|NCT04448171|467297535|FG001|Overall Study|Protocol Violation|0|||
129818054|NCT02088047|467297536|FG000|Overall Study|Withdrawal by Subject|1|||
129818055|NCT02088047|467297537|FG001|Overall Study|Withdrawal by Subject|0|||
129818056|NCT04605484|467297540|FG000|Overall Study|Lost to Follow-up|0|||
129818057|NCT04605484|467297541|FG001|Overall Study|Lost to Follow-up|1|||
129818058|NCT04605484|467297542|FG002|Overall Study|Lost to Follow-up|1|||
129818059|NCT04605484|467297540|FG000|Overall Study|Other|0|||
129818060|NCT04605484|467297541|FG001|Overall Study|Other|1|||
129818061|NCT04605484|467297542|FG002|Overall Study|Other|0|||
129818062|NCT00459953|467297543|FG000|Overall Study|not analyzed-household member in study|1|||
129818063|NCT00459953|467297544|FG001|Overall Study|not analyzed-household member in study|1|||
129818064|NCT01233258|467297546|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818065|NCT01233258|467297547|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818066|NCT01233258|467297548|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818067|NCT01233258|467297549|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
129818068|NCT01233258|467297550|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
129818069|NCT01233258|467297551|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
129818070|NCT01233258|467297546|FG000|First Intervention (6 Months)|Protocol Violation|0|||
129818071|NCT01233258|467297547|FG001|First Intervention (6 Months)|Protocol Violation|0|||
129818072|NCT01233258|467297548|FG002|First Intervention (6 Months)|Protocol Violation|1|||
129818073|NCT01233258|467297549|FG003|First Intervention (6 Months)|Protocol Violation|0|||
129818074|NCT01233258|467297550|FG004|First Intervention (6 Months)|Protocol Violation|0|||
129818075|NCT01233258|467297551|FG005|First Intervention (6 Months)|Protocol Violation|0|||
129818076|NCT01233258|467297546|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
129818077|NCT01233258|467297547|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818078|NCT01233258|467297548|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818079|NCT01233258|467297549|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818080|NCT01233258|467297550|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818081|NCT01233258|467297551|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
129818082|NCT01049308|467297552|FG000|Pill Counts|Withdrawal by Subject|83|||
129818083|NCT03926169|467297557|FG000|Period A|Adverse Event|2|||
129818084|NCT03926169|467297558|FG001|Period A|Adverse Event|2|||
129818085|NCT03926169|467297559|FG002|Period A|Adverse Event|1|||
129818086|NCT03926169|467297557|FG000|Period A|Withdrawal by Subject|2|||
129818087|NCT03926169|467297558|FG001|Period A|Withdrawal by Subject|2|||
129818088|NCT03926169|467297559|FG002|Period A|Withdrawal by Subject|2|||
129818089|NCT03926169|467297557|FG000|Period A|Lost to Follow-up|3|||
129818090|NCT03926169|467297558|FG001|Period A|Lost to Follow-up|1|||
129818091|NCT03926169|467297559|FG002|Period A|Lost to Follow-up|0|||
129818092|NCT03926169|467297557|FG000|Period A|Lack of Efficacy|0|||
129818093|NCT03926169|467297558|FG001|Period A|Lack of Efficacy|2|||
129818094|NCT03926169|467297559|FG002|Period A|Lack of Efficacy|2|||
129818095|NCT03926169|467297557|FG000|Period A|COVID-19 Infection|0|||
129818096|NCT03926169|467297558|FG001|Period A|COVID-19 Infection|1|||
129818097|NCT03926169|467297559|FG002|Period A|COVID-19 Infection|0|||
129818098|NCT03926169|467297557|FG000|Period A|COVID-19 Logistical Restrictions|0|||
129818099|NCT03926169|467297558|FG001|Period A|COVID-19 Logistical Restrictions|2|||
129818100|NCT03926169|467297559|FG002|Period A|COVID-19 Logistical Restrictions|1|||
129818101|NCT03926169|467297557|FG000|Period A|Other, Not Specified|1|||
129818102|NCT03926169|467297558|FG001|Period A|Other, Not Specified|0|||
129818103|NCT03926169|467297559|FG002|Period A|Other, Not Specified|0|||
129818104|NCT03926169|467297557|FG000|Period B|Adverse Event|3|||
129818105|NCT03926169|467297558|FG001|Period B|Adverse Event|1|||
129818106|NCT03926169|467297559|FG002|Period B|Adverse Event|1|||
129818107|NCT03926169|467297557|FG000|Period B|Withdrawal by Subject|1|||
129818108|NCT03926169|467297558|FG001|Period B|Withdrawal by Subject|3|||
129818109|NCT03926169|467297559|FG002|Period B|Withdrawal by Subject|0|||
129818110|NCT03926169|467297557|FG000|Period B|Lack of Efficacy|3|||
129818111|NCT03926169|467297558|FG001|Period B|Lack of Efficacy|1|||
129818112|NCT03926169|467297559|FG002|Period B|Lack of Efficacy|1|||
129818113|NCT03926169|467297557|FG000|Period B|Lost to Follow-up|1|||
129818114|NCT03926169|467297558|FG001|Period B|Lost to Follow-up|1|||
129818115|NCT03926169|467297559|FG002|Period B|Lost to Follow-up|4|||
129818116|NCT03926169|467297557|FG000|Period B|Other, Not Specified|62|||
129818117|NCT03926169|467297558|FG001|Period B|Other, Not Specified|57|||
129818118|NCT03926169|467297559|FG002|Period B|Other, Not Specified|65|||
129818119|NCT02439138|467297561|FG000|Overall Study|Adverse Event|1|||
129818120|NCT02439138|467297561|FG000|Overall Study|PI decision to terminate the study|2|||
129818121|NCT00006237|467297562|FG000|Overall Study|Adverse Event|39|||
129818122|NCT00006237|467297563|FG001|Overall Study|Adverse Event|29|||
129818123|NCT00006237|467297562|FG000|Overall Study|Death|1|||
129818124|NCT00006237|467297563|FG001|Overall Study|Death|0|||
129818125|NCT00006237|467297562|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
129818126|NCT00006237|467297563|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
129818127|NCT00006237|467297562|FG000|Overall Study|Progression/relapse|54|||
129818128|NCT00006237|467297563|FG001|Overall Study|Progression/relapse|2|||
129818129|NCT00006237|467297562|FG000|Overall Study|Not eligible|9|||
129818130|NCT00006237|467297563|FG001|Overall Study|Not eligible|20|||
129818131|NCT00006237|467297562|FG000|Overall Study|Withdrawal by Subject|0|||
129818132|NCT00006237|467297563|FG001|Overall Study|Withdrawal by Subject|1|||
129818133|NCT00006237|467297562|FG000|Overall Study|Not protocol specified|14|||
129818134|NCT00006237|467297563|FG001|Overall Study|Not protocol specified|5|||
129818135|NCT01846416|467297564|FG000|Treatment Phase|Death|2|||
129818136|NCT01846416|467297565|FG001|Treatment Phase|Death|9|||
129818137|NCT01846416|467297566|FG002|Treatment Phase|Death|1|||
129818138|NCT01846416|467297564|FG000|Treatment Phase|Withdrawal by Subject|2|||
129818139|NCT01846416|467297565|FG001|Treatment Phase|Withdrawal by Subject|4|||
129818140|NCT01846416|467297566|FG002|Treatment Phase|Withdrawal by Subject|2|||
129818141|NCT01846416|467297564|FG000|Treatment Phase|Other|1|||
129818142|NCT01846416|467297565|FG001|Treatment Phase|Other|5|||
129818143|NCT01846416|467297566|FG002|Treatment Phase|Other|1|||
129818144|NCT01846416|467297564|FG000|Treatment Phase|Physician Decision|1|||
129818145|NCT01846416|467297565|FG001|Treatment Phase|Physician Decision|2|||
129818146|NCT01846416|467297566|FG002|Treatment Phase|Physician Decision|0|||
129897263|NCT00711646|467584305|FG000|Overall Study|administrative decision|0|||
129818147|NCT01846416|467297564|FG000|Treatment Phase|Adverse Event|3|||
129818148|NCT01846416|467297565|FG001|Treatment Phase|Adverse Event|4|||
129818149|NCT01846416|467297566|FG002|Treatment Phase|Adverse Event|0|||
129818150|NCT01846416|467297564|FG000|Treatment Phase|Non-compliance|0|||
129818151|NCT01846416|467297565|FG001|Treatment Phase|Non-compliance|2|||
129818152|NCT01846416|467297566|FG002|Treatment Phase|Non-compliance|0|||
129818153|NCT01846416|467297564|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
129818154|NCT01846416|467297565|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
129818155|NCT01846416|467297566|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
129818156|NCT01846416|467297564|FG000|Treatment Phase|Progressive Disease|21|||
129818157|NCT01846416|467297565|FG001|Treatment Phase|Progressive Disease|63|||
129818158|NCT01846416|467297566|FG002|Treatment Phase|Progressive Disease|9|||
129818159|NCT01846416|467297564|FG000|Survival Follow-up|Death|21|||
129818160|NCT01846416|467297565|FG001|Survival Follow-up|Death|62|||
129818161|NCT01846416|467297566|FG002|Survival Follow-up|Death|9|||
129818162|NCT01846416|467297564|FG000|Survival Follow-up|Lost to Follow-up|0|||
129818163|NCT01846416|467297565|FG001|Survival Follow-up|Lost to Follow-up|2|||
129818164|NCT01846416|467297566|FG002|Survival Follow-up|Lost to Follow-up|2|||
129818165|NCT01846416|467297564|FG000|Survival Follow-up|Withdrawal by Subject|2|||
129818166|NCT01846416|467297565|FG001|Survival Follow-up|Withdrawal by Subject|7|||
129818167|NCT01846416|467297566|FG002|Survival Follow-up|Withdrawal by Subject|0|||
129818168|NCT01846416|467297564|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
129818169|NCT01846416|467297565|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
129818170|NCT01846416|467297566|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
129818171|NCT01846416|467297564|FG000|Survival Follow-up|Other|3|||
129818172|NCT01846416|467297565|FG001|Survival Follow-up|Other|1|||
129818173|NCT01846416|467297566|FG002|Survival Follow-up|Other|1|||
129818174|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
129818175|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
129818176|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
129818177|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818178|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818179|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818180|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818181|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818182|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818183|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818184|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
129818185|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
129818186|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129897264|NCT00711646|467584306|FG001|Overall Study|administrative decision|1|||
129897265|NCT00711646|467584305|FG000|Overall Study|patient non-compliance|1|||
129818187|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
129818188|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818189|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818190|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129897266|NCT00711646|467584306|FG001|Overall Study|patient non-compliance|0|||
129818191|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818192|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818193|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818194|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129897267|NCT00269399|467584307|FG000|Overall Study|Lack of Efficacy|27|||
129818195|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
129818196|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
129818197|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
129818198|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
129818199|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818200|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818201|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818202|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818203|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818204|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818205|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818206|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
129818207|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
129818208|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
129818209|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818210|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818211|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818212|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818213|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818214|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818215|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818216|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818217|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
129818218|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
129818219|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
129818220|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
129818221|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818222|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818223|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818224|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818225|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818226|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818227|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818228|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
129818229|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818230|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
129818231|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
129818232|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818233|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818234|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818235|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818236|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818237|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818238|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818239|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
129818240|NCT02207244|467297569|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818241|NCT02207244|467297570|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
129818242|NCT02207244|467297571|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818243|NCT02207244|467297572|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818244|NCT02207244|467297573|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818245|NCT02207244|467297574|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818246|NCT02207244|467297575|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818247|NCT02207244|467297576|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818248|NCT02207244|467297577|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818249|NCT02207244|467297578|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818250|NCT02207244|467297579|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
129818251|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818252|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818253|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818254|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818255|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
129818256|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
129818257|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818258|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818259|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818260|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818261|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
129818262|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818263|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818264|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818265|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818266|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818267|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
129818268|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818269|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818270|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818271|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818272|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
129818273|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818274|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818275|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818276|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
129818277|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
129818278|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
129818279|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818280|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818281|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818282|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818283|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
129818284|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818285|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818286|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818287|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
129818288|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
129818289|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
129818290|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818291|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818292|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818293|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818294|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
129818295|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818296|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818297|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818298|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
129818299|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818300|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
129818301|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818302|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818303|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818304|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818305|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
129818306|NCT02207244|467297569|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818307|NCT02207244|467297570|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818308|NCT02207244|467297571|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818309|NCT02207244|467297572|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
129818310|NCT02207244|467297573|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818311|NCT02207244|467297574|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818312|NCT02207244|467297575|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818313|NCT02207244|467297576|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818314|NCT02207244|467297577|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818315|NCT02207244|467297578|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818316|NCT02207244|467297579|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
129818317|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818318|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818319|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818320|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129897268|NCT00269399|467584308|FG001|Overall Study|Lack of Efficacy|10|||
129818321|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818322|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818323|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
129818324|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
129818325|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
129818326|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
129818327|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
129818328|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818329|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818330|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818331|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818332|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818333|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818334|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818335|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
129818336|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818337|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818338|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
129818339|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818340|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818341|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818342|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818343|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818344|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818345|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
129818346|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
129818347|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
129818348|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
129818349|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
129818350|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818351|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818352|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818353|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818354|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818355|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818356|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
129818357|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
129818358|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818359|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
129818360|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
129818361|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818362|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818363|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818364|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818365|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818366|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818367|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
129818368|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
129818369|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
129818370|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
129818371|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
129818372|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818373|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818374|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818375|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818376|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818377|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818378|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818379|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
129818380|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
129818381|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818382|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
129818383|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818384|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818385|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818386|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818387|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818388|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818389|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818390|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818391|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
129818392|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818393|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
129818394|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818395|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818396|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818397|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818398|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818399|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818400|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818401|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
129818402|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818403|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818404|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
129818405|NCT02207244|467297569|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818406|NCT02207244|467297570|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818407|NCT02207244|467297571|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818408|NCT02207244|467297572|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818409|NCT02207244|467297573|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818410|NCT02207244|467297574|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818411|NCT02207244|467297575|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
129818412|NCT02207244|467297576|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818413|NCT02207244|467297577|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818414|NCT02207244|467297578|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818415|NCT02207244|467297579|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
129818416|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818417|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818418|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818419|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818420|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818421|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818422|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818423|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818424|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
129818425|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
129818426|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
129818427|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818428|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818429|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818430|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129897269|NCT00269399|467584307|FG000|Overall Study|Adverse Event|10|||
129818431|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818432|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818433|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818434|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818435|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
129818436|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
129818437|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
129818438|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818439|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818440|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818441|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818442|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818443|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818444|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818445|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818446|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
129818447|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
129818448|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
129818449|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818450|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818451|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818452|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818453|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818454|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818455|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818456|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818457|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
129818458|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
129818459|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
129818460|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
129818461|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
129818462|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
129818463|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
129818464|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
129818465|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
129818466|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
129818467|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
129818468|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
129818469|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
129818470|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
129818471|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
129818472|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
129818473|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
129818474|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
129818475|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
129818476|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
129818477|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
129818478|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
129818479|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
129818480|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
129818481|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
129818482|NCT02207244|467297569|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818483|NCT02207244|467297570|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818484|NCT02207244|467297571|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818485|NCT02207244|467297572|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818486|NCT02207244|467297573|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818487|NCT02207244|467297574|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818488|NCT02207244|467297575|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818489|NCT02207244|467297576|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818490|NCT02207244|467297577|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818491|NCT02207244|467297578|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
129818492|NCT02207244|467297579|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
129818493|NCT00039130|467297580|FG000|Overall Study|Adverse Event|11|||
129818494|NCT00039130|467297580|FG000|Overall Study|Death|9|||
129818495|NCT00039130|467297580|FG000|Overall Study|Withdrawal by Subject|3|||
129818496|NCT00039130|467297580|FG000|Overall Study|Progression|2|||
129818497|NCT00039130|467297580|FG000|Overall Study|Subsequent treatment|2|||
129818498|NCT00039130|467297580|FG000|Overall Study|Physician Decision|3|||
129818499|NCT01950741|467297581|FG000|Overall Study|Lost to Follow-up|1|||
129818500|NCT01950741|467297581|FG000|Overall Study|Death|1|||
129818501|NCT01950741|467297581|FG000|Overall Study|Withdrawal by Subject|1|||
129897270|NCT00269399|467584308|FG001|Overall Study|Adverse Event|4|||
129818502|NCT02521870|467297582|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818503|NCT02521870|467297583|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
129818504|NCT02521870|467297584|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818505|NCT02521870|467297585|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818506|NCT02521870|467297586|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818507|NCT02521870|467297587|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818508|NCT02521870|467297588|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818509|NCT02521870|467297589|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818510|NCT02521870|467297590|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818511|NCT02521870|467297591|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818512|NCT02521870|467297592|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818513|NCT02521870|467297593|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129818514|NCT02521870|467297582|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
129818515|NCT02521870|467297583|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
129818516|NCT02521870|467297584|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
129818517|NCT02521870|467297585|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
129818518|NCT02521870|467297586|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
129818519|NCT02521870|467297587|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
129818520|NCT02521870|467297588|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
129818521|NCT02521870|467297589|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
129818522|NCT02521870|467297590|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
129818523|NCT02521870|467297591|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
129818524|NCT02521870|467297592|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
129818525|NCT02521870|467297593|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
129818526|NCT02521870|467297582|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
129818527|NCT02521870|467297583|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
129818528|NCT02521870|467297584|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
129818529|NCT02521870|467297585|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
129818530|NCT02521870|467297586|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
129818531|NCT02521870|467297587|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
129818532|NCT02521870|467297588|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
129818533|NCT02521870|467297589|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
129818534|NCT02521870|467297590|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
129818535|NCT02521870|467297591|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
129818536|NCT02521870|467297592|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
129818537|NCT02521870|467297593|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
129818538|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818539|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818540|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818541|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818542|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
129818543|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818544|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818545|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818546|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818547|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
129818548|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
129818549|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129818550|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
129818551|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
129818552|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
129818553|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
129818554|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
129818555|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
129818556|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
129818557|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
129818558|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
129818559|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
129818560|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
129818561|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
129818562|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
129818563|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
129818564|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
129818565|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
129818566|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
129818567|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
129818568|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
129818569|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
129818570|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
129818571|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
129818572|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
129818573|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
129818574|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Death|0|||
129818575|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Death|0|||
129818576|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Death|0|||
129818577|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Death|0|||
129818578|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Death|1|||
129818579|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Death|1|||
129818580|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Death|3|||
129818581|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Death|1|||
129818582|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Death|1|||
129818583|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Death|5|||
129818584|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Death|2|||
129818585|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Death|2|||
129818586|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Other|0|||
129818587|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Other|0|||
129818588|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Other|0|||
129818589|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Other|0|||
129818590|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Other|10|||
129818591|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Other|3|||
129818592|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Other|2|||
129818593|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Other|0|||
129818594|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Other|10|||
129818595|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Other|5|||
129818596|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Other|1|||
129818597|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Other|7|||
129818598|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818599|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818600|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818601|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818602|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
129818603|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818604|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818605|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818606|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818607|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818608|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818609|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129818610|NCT02521870|467297582|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818611|NCT02521870|467297583|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818612|NCT02521870|467297584|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818613|NCT02521870|467297585|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818614|NCT02521870|467297586|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
129818615|NCT02521870|467297587|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818616|NCT02521870|467297588|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818617|NCT02521870|467297589|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818618|NCT02521870|467297590|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818619|NCT02521870|467297591|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818620|NCT02521870|467297592|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818621|NCT02521870|467297593|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
129818622|NCT00519831|467297594|FG000|Overall Study|Adverse Event|3|||
129818623|NCT02854631|467297595|FG000|Overall Study|Adverse Event|1|||
129818624|NCT02854631|467297596|FG001|Overall Study|Adverse Event|2|||
129818625|NCT02854631|467297595|FG000|Overall Study|Withdrew Consent|3|||
129818626|NCT02854631|467297596|FG001|Overall Study|Withdrew Consent|2|||
129818627|NCT02854631|467297595|FG000|Overall Study|Investigator's Discretion|2|||
129818628|NCT02854631|467297596|FG001|Overall Study|Investigator's Discretion|0|||
129818629|NCT02854631|467297595|FG000|Overall Study|Death|12|||
129818630|NCT02854631|467297596|FG001|Overall Study|Death|8|||
129818631|NCT02854631|467297595|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
129818632|NCT02854631|467297596|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
129818633|NCT02854631|467297595|FG000|Overall Study|Protocol Violation|0|||
129818634|NCT02854631|467297596|FG001|Overall Study|Protocol Violation|1|||
129818635|NCT02854631|467297595|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
129818636|NCT02854631|467297596|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
129818637|NCT02854631|467297595|FG000|Overall Study|Lost to Follow-up|4|||
129818638|NCT02854631|467297596|FG001|Overall Study|Lost to Follow-up|2|||
129818639|NCT03200860|467297597|FG000|Overall Study|Withdrawal by Subject|1|||
129818640|NCT03200860|467297598|FG001|Overall Study|Withdrawal by Subject|0|||
129818641|NCT04342897|467297599|FG000|Overall Study|Death|7|||
129818642|NCT04342897|467297600|FG001|Overall Study|Death|4|||
129818643|NCT04342897|467297599|FG000|Overall Study|Lost to Follow-up|6|||
129818644|NCT04342897|467297600|FG001|Overall Study|Lost to Follow-up|6|||
129818645|NCT04342897|467297599|FG000|Overall Study|Withdrawal by Subject|1|||
129818646|NCT04342897|467297600|FG001|Overall Study|Withdrawal by Subject|2|||
129818647|NCT02634320|467297602|FG000|Overall Study|Adverse Event|2|||
129818648|NCT02634320|467297602|FG000|Overall Study|Lost to Follow-up|3|||
129818649|NCT02634320|467297602|FG000|Overall Study|Moved out of area|2|||
129818650|NCT02634320|467297602|FG000|Overall Study|Out of window for study visits|1|||
129818651|NCT02634320|467297602|FG000|Overall Study|Protocol Violation|1|||
129818652|NCT02634320|467297602|FG000|Overall Study|Withdrawal by Subject|5|||
129818653|NCT02634320|467297602|FG000|Overall Study|Lack of Efficacy|2|||
129818654|NCT03919799|467297606|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
129818655|NCT03919799|467297607|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
129818656|NCT03919799|467297608|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
129818657|NCT03919799|467297609|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
129818658|NCT03919799|467297610|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
129818659|NCT03919799|467297606|FG000|DB Period (28 Weeks)|Adverse Event|1|||
129818660|NCT03919799|467297607|FG001|DB Period (28 Weeks)|Adverse Event|1|||
129818661|NCT03919799|467297608|FG002|DB Period (28 Weeks)|Adverse Event|1|||
129818662|NCT03919799|467297609|FG003|DB Period (28 Weeks)|Adverse Event|0|||
129818663|NCT03919799|467297610|FG004|DB Period (28 Weeks)|Adverse Event|0|||
129818664|NCT03919799|467297606|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818665|NCT03919799|467297607|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
129818666|NCT03919799|467297608|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818667|NCT03919799|467297609|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818668|NCT03919799|467297610|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
129818669|NCT03919799|467297606|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818670|NCT03919799|467297607|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
129818671|NCT03919799|467297608|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818672|NCT03919799|467297609|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818673|NCT03919799|467297610|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
129818674|NCT03919799|467297606|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
129818675|NCT03919799|467297607|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
129818676|NCT03919799|467297608|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
129818677|NCT03919799|467297609|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
129818678|NCT03919799|467297610|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
129818679|NCT04656691|467297615|FG000|Overall Study|Adverse Event|1|||
129818680|NCT03199274|467297616|FG000|Overall Study|Withdrawal by Subject|4|||
129818681|NCT03199274|467297617|FG001|Overall Study|Withdrawal by Subject|0|||
129818682|NCT03199274|467297616|FG000|Overall Study|Lost to Follow-up|0|||
129818683|NCT03199274|467297617|FG001|Overall Study|Lost to Follow-up|1|||
129818684|NCT03199274|467297616|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
129818685|NCT03199274|467297617|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
129818686|NCT05980182|467297623|FG000|Overall Study|Lost to Follow-up|10|||
129818687|NCT05475236|467297624|FG000|Overall Study|Withdrawal by Subject|0|||
129818688|NCT05475236|467297625|FG001|Overall Study|Withdrawal by Subject|1|||
129818689|NCT00638378|467298788|FG000|Overall Study|Death|2|||
129818690|NCT00638378|467298788|FG000|Overall Study|Adverse Event|1|||
129818691|NCT00638378|467298788|FG000|Overall Study|Disease progression|15|||
129818692|NCT00638378|467298788|FG000|Overall Study|Physician Decision|4|||
129818693|NCT01411774|467298806|FG000|Overall Study|Withdrawal by Subject|0|||
129818694|NCT01411774|467298807|FG001|Overall Study|Withdrawal by Subject|3|||
129818695|NCT02990910|467298813|FG000|Overall Study|Lack of Efficacy|6|||
129818696|NCT02990910|467298814|FG001|Overall Study|Lack of Efficacy|10|||
129818697|NCT00309387|467298819|FG000|Overall Study|Death|72|||
129818698|NCT00309387|467298820|FG001|Overall Study|Death|73|||
129818699|NCT00309387|467298819|FG000|Overall Study|Lost to Follow-up|70|||
129818700|NCT00309387|467298820|FG001|Overall Study|Lost to Follow-up|86|||
129818701|NCT02483520|467298821|FG000|Overall Study|Lost to Follow-up|3|||
129818702|NCT02483520|467298822|FG001|Overall Study|Lost to Follow-up|4|||
129818703|NCT02483520|467298821|FG000|Overall Study|Withdrawal by Subject|4|||
129818704|NCT02483520|467298822|FG001|Overall Study|Withdrawal by Subject|14|||
129818705|NCT02483520|467298821|FG000|Overall Study|Hospitalized|2|||
129818706|NCT02483520|467298822|FG001|Overall Study|Hospitalized|3|||
129818707|NCT02483520|467298821|FG000|Overall Study|Moved to LTC|2|||
129818708|NCT02483520|467298822|FG001|Overall Study|Moved to LTC|3|||
129818709|NCT03902574|467298832|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
129818710|NCT03902574|467298833|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
129818711|NCT03902574|467298834|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
129818712|NCT04492618|467298836|FG000|Overall Study|Withdrawal by Subject|1|||
129818713|NCT02101060|467298841|FG000|Overall Study|Adverse Event|1|||
129818714|NCT02101060|467298842|FG001|Overall Study|Adverse Event|0|||
129818715|NCT02101060|467298841|FG000|Overall Study|Withdrawal by Subject|1|||
129818716|NCT02101060|467298842|FG001|Overall Study|Withdrawal by Subject|1|||
129818717|NCT02101060|467298841|FG000|Overall Study|Lost to Follow-up|3|||
129818718|NCT02101060|467298842|FG001|Overall Study|Lost to Follow-up|3|||
129818719|NCT00743340|467298846|FG000|Overall Study|Study medication non-compliance|1|||
129818720|NCT00743340|467298846|FG000|Overall Study|Lost to Follow-up|1|||
129818721|NCT00743340|467298846|FG000|Overall Study|Withdrawal from the Study|5|||
129818722|NCT00743340|467298846|FG000|Overall Study|Protocol Violation|1|||
129818723|NCT00743340|467298846|FG000|Overall Study|Virologic failure|8|||
129818724|NCT00743340|467298846|FG000|Overall Study|Pregnancy|1|||
129818725|NCT00743340|467298846|FG000|Overall Study|Rolled over to other Gilead Study|23|||
129818726|NCT00743340|467298846|FG000|Overall Study|Participant Relocated|1|||
129818727|NCT01402492|467298851|FG000|Overall Study|Withdrawal by Subject|17|||
129818728|NCT01402492|467298852|FG001|Overall Study|Withdrawal by Subject|11|||
129818729|NCT01402492|467298853|FG002|Overall Study|Withdrawal by Subject|11|||
129818730|NCT01402492|467298851|FG000|Overall Study|Adverse Event|2|||
129818731|NCT01402492|467298852|FG001|Overall Study|Adverse Event|3|||
129818732|NCT01402492|467298853|FG002|Overall Study|Adverse Event|4|||
129818733|NCT01402492|467298851|FG000|Overall Study|Physician Decision|0|||
129818734|NCT01402492|467298852|FG001|Overall Study|Physician Decision|3|||
129818735|NCT01402492|467298853|FG002|Overall Study|Physician Decision|0|||
129818736|NCT01402492|467298851|FG000|Overall Study|Incarcerated (N=3)|2|||
129818737|NCT01402492|467298852|FG001|Overall Study|Incarcerated (N=3)|0|||
129818738|NCT01402492|467298853|FG002|Overall Study|Incarcerated (N=3)|1|||
129818739|NCT00814164|467298854|FG000|Overall Study|Progression|7|||
129818740|NCT00814164|467298854|FG000|Overall Study|not stated|7|||
129818741|NCT00814164|467298854|FG000|Overall Study|Death|5|||
129818742|NCT01169493|467298860|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
129818743|NCT01169493|467298861|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
129818744|NCT01169493|467298862|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
129818745|NCT01169493|467298863|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
129818746|NCT01169493|467298864|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
129818747|NCT01169493|467298865|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
129818748|NCT01169493|467298860|FG000|Period 3 (6 Months)|Adverse Event|0|||
129818749|NCT01169493|467298861|FG001|Period 3 (6 Months)|Adverse Event|1|||
129818750|NCT01169493|467298862|FG002|Period 3 (6 Months)|Adverse Event|0|||
129818751|NCT01169493|467298863|FG003|Period 3 (6 Months)|Adverse Event|0|||
129818752|NCT01169493|467298864|FG004|Period 3 (6 Months)|Adverse Event|0|||
129818753|NCT01169493|467298865|FG005|Period 3 (6 Months)|Adverse Event|0|||
129818754|NCT01169493|467298860|FG000|Period 3 (6 Months)|Physician Decision|0|||
129818755|NCT01169493|467298861|FG001|Period 3 (6 Months)|Physician Decision|1|||
129818756|NCT01169493|467298862|FG002|Period 3 (6 Months)|Physician Decision|1|||
129818757|NCT01169493|467298863|FG003|Period 3 (6 Months)|Physician Decision|0|||
129818758|NCT01169493|467298864|FG004|Period 3 (6 Months)|Physician Decision|0|||
129818759|NCT01169493|467298865|FG005|Period 3 (6 Months)|Physician Decision|0|||
129818760|NCT02266225|467298869|FG000|Overall Study|Lost to Follow-up|2|||
129818761|NCT02266225|467298869|FG000|Overall Study|Death|1|||
129818762|NCT02266225|467298869|FG000|Overall Study|Withdrawal by Subject|13|||
129818763|NCT02246660|467298870|FG000|Overall Study|Withdrawal by Subject|0|||
129818764|NCT02246660|467298871|FG001|Overall Study|Withdrawal by Subject|1|||
129818765|NCT02246660|467298872|FG002|Overall Study|Withdrawal by Subject|0|||
129818766|NCT02246660|467298870|FG000|Overall Study|Death|0|||
129818767|NCT02246660|467298871|FG001|Overall Study|Death|0|||
129818768|NCT02246660|467298872|FG002|Overall Study|Death|1|||
129818769|NCT00660309|467298875|FG000|Overall Study|Adverse Event|2|||
129818770|NCT00660309|467298876|FG001|Overall Study|Adverse Event|0|||
129818771|NCT00660309|467298875|FG000|Overall Study|Withdrawal by Subject|0|||
129818772|NCT00660309|467298876|FG001|Overall Study|Withdrawal by Subject|3|||
129818773|NCT02573311|467298879|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
129818774|NCT02573311|467298880|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
129818775|NCT02573311|467298879|FG000|Disposition for Part 2|Physician Decision|25|||
129818776|NCT02573311|467298880|FG001|Disposition for Part 2|Physician Decision|7|||
129818777|NCT02573311|467298879|FG000|Disposition for Part 2|Adverse Event|36|||
129818778|NCT02573311|467298880|FG001|Disposition for Part 2|Adverse Event|5|||
129818779|NCT02573311|467298879|FG000|Disposition for Part 2|Lost to Follow-up|76|||
129818780|NCT02573311|467298880|FG001|Disposition for Part 2|Lost to Follow-up|7|||
129818781|NCT02573311|467298879|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
129818782|NCT02573311|467298880|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
129818783|NCT02573311|467298879|FG000|Disposition for Part 2|Investigator decision|0|||
129818784|NCT02573311|467298880|FG001|Disposition for Part 2|Investigator decision|1|||
129818785|NCT02573311|467298879|FG000|Disposition for Part 2|Other than specified above|13|||
129818786|NCT02573311|467298880|FG001|Disposition for Part 2|Other than specified above|3|||
129818787|NCT04171531|467298882|FG000|Overall Study|Lost to Follow-up|4|||
129818788|NCT04171531|467298883|FG001|Overall Study|Lost to Follow-up|5|||
129818789|NCT04171531|467298882|FG000|Overall Study|Consent only through 6 months|1|||
129818790|NCT04171531|467298883|FG001|Overall Study|Consent only through 6 months|1|||
129818791|NCT04171531|467298882|FG000|Overall Study|Insurance did not cover procedure|0|||
129818792|NCT04171531|467298883|FG001|Overall Study|Insurance did not cover procedure|1|||
129818793|NCT04171531|467298882|FG000|Overall Study|Physician Decision|0|||
129818794|NCT04171531|467298883|FG001|Overall Study|Physician Decision|3|||
129818795|NCT04171531|467298882|FG000|Overall Study|Withdrawal by Subject|1|||
129818796|NCT04171531|467298883|FG001|Overall Study|Withdrawal by Subject|5|||
129818797|NCT03366337|467298886|FG000|Overall Study|Lost to Follow-up|1|||
129818798|NCT03366337|467298887|FG001|Overall Study|Lost to Follow-up|0|||
129818799|NCT03366337|467298888|FG002|Overall Study|Lost to Follow-up|1|||
129818800|NCT03366337|467298889|FG003|Overall Study|Lost to Follow-up|0|||
129818801|NCT03366337|467298886|FG000|Overall Study|Withdrawal by Subject|2|||
129818802|NCT03366337|467298887|FG001|Overall Study|Withdrawal by Subject|0|||
129818803|NCT03366337|467298888|FG002|Overall Study|Withdrawal by Subject|1|||
129818804|NCT03366337|467298889|FG003|Overall Study|Withdrawal by Subject|1|||
129818805|NCT05288062|467298891|FG000|Overall Study|Ineligible|0|||
129818806|NCT05288062|467298892|FG001|Overall Study|Ineligible|0|||
129818807|NCT05288062|467298893|FG002|Overall Study|Ineligible|1|||
129818808|NCT05288062|467298894|FG003|Overall Study|Ineligible|0|||
129818809|NCT05288062|467298891|FG000|Overall Study|Withdrawal by Subject|0|||
129818810|NCT05288062|467298892|FG001|Overall Study|Withdrawal by Subject|0|||
129818811|NCT05288062|467298893|FG002|Overall Study|Withdrawal by Subject|1|||
129818812|NCT05288062|467298894|FG003|Overall Study|Withdrawal by Subject|0|||
129818813|NCT01370356|467298895|FG000|Overall Study|Death|1|||
129818814|NCT01370356|467298896|FG001|Overall Study|Death|0|||
129818815|NCT01370356|467298895|FG000|Overall Study|Lack of Efficacy|6|||
129818816|NCT01370356|467298896|FG001|Overall Study|Lack of Efficacy|28|||
129818817|NCT01370356|467298895|FG000|Overall Study|Lost to Follow-up|76|||
129818818|NCT01370356|467298896|FG001|Overall Study|Lost to Follow-up|81|||
129818819|NCT01370356|467298895|FG000|Overall Study|Withdrawal by Subject|54|||
129818820|NCT01370356|467298896|FG001|Overall Study|Withdrawal by Subject|59|||
129818821|NCT01370356|467298895|FG000|Overall Study|Reason not specified|39|||
129818822|NCT01370356|467298896|FG001|Overall Study|Reason not specified|43|||
129818823|NCT01370356|467298895|FG000|Overall Study|Protocol Violation|3|||
129818824|NCT01370356|467298896|FG001|Overall Study|Protocol Violation|3|||
129818825|NCT01370356|467298895|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
129818826|NCT01370356|467298896|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
129818827|NCT01370356|467298895|FG000|Overall Study|AE Not Related to Study Drug|1|||
129818828|NCT01370356|467298896|FG001|Overall Study|AE Not Related to Study Drug|4|||
129818829|NCT00040664|467298897|FG000|Overall Study|Adverse Event|12|||
129818830|NCT00040664|467298898|FG001|Overall Study|Adverse Event|3|||
129818831|NCT00040664|467298899|FG002|Overall Study|Adverse Event|2|||
129818832|NCT00040664|467298900|FG003|Overall Study|Adverse Event|7|||
129818833|NCT00040664|467298897|FG000|Overall Study|Lack of Efficacy|9|||
129818834|NCT00040664|467298898|FG001|Overall Study|Lack of Efficacy|2|||
129818835|NCT00040664|467298899|FG002|Overall Study|Lack of Efficacy|3|||
129818836|NCT00040664|467298900|FG003|Overall Study|Lack of Efficacy|4|||
129818837|NCT00040664|467298897|FG000|Overall Study|Insufficient CD4 response|1|||
129818838|NCT00040664|467298898|FG001|Overall Study|Insufficient CD4 response|0|||
129818839|NCT00040664|467298899|FG002|Overall Study|Insufficient CD4 response|1|||
129818840|NCT00040664|467298900|FG003|Overall Study|Insufficient CD4 response|0|||
129818841|NCT00040664|467298897|FG000|Overall Study|Lost to Follow-up|4|||
129818842|NCT00040664|467298898|FG001|Overall Study|Lost to Follow-up|2|||
129818843|NCT00040664|467298899|FG002|Overall Study|Lost to Follow-up|0|||
129818844|NCT00040664|467298900|FG003|Overall Study|Lost to Follow-up|2|||
129818845|NCT00040664|467298897|FG000|Overall Study|Protocol Violation|2|||
129818846|NCT00040664|467298898|FG001|Overall Study|Protocol Violation|1|||
129818847|NCT00040664|467298899|FG002|Overall Study|Protocol Violation|0|||
129818848|NCT00040664|467298900|FG003|Overall Study|Protocol Violation|1|||
129818849|NCT00040664|467298897|FG000|Overall Study|Withdrawal by Subject|7|||
129818850|NCT00040664|467298898|FG001|Overall Study|Withdrawal by Subject|0|||
129818851|NCT00040664|467298899|FG002|Overall Study|Withdrawal by Subject|3|||
129818852|NCT00040664|467298900|FG003|Overall Study|Withdrawal by Subject|4|||
129818853|NCT00040664|467298897|FG000|Overall Study|Pregnancy|3|||
129818854|NCT00040664|467298898|FG001|Overall Study|Pregnancy|0|||
129818855|NCT00040664|467298899|FG002|Overall Study|Pregnancy|0|||
129818856|NCT00040664|467298900|FG003|Overall Study|Pregnancy|3|||
129818857|NCT00040664|467298897|FG000|Overall Study|Medication adherence/compliance problems|8|||
129818858|NCT00040664|467298898|FG001|Overall Study|Medication adherence/compliance problems|2|||
129818859|NCT00040664|467298899|FG002|Overall Study|Medication adherence/compliance problems|1|||
129818860|NCT00040664|467298900|FG003|Overall Study|Medication adherence/compliance problems|5|||
129818861|NCT00040664|467298897|FG000|Overall Study|Poor taste|2|||
129818862|NCT00040664|467298898|FG001|Overall Study|Poor taste|0|||
129818863|NCT00040664|467298899|FG002|Overall Study|Poor taste|2|||
129818864|NCT00040664|467298900|FG003|Overall Study|Poor taste|0|||
129818865|NCT00040664|467298897|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
129818866|NCT00040664|467298898|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
129818867|NCT00040664|467298899|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
129818868|NCT00040664|467298900|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
129818869|NCT00040664|467298897|FG000|Overall Study|Change of formulation|2|||
129818870|NCT00040664|467298898|FG001|Overall Study|Change of formulation|2|||
129818871|NCT00040664|467298899|FG002|Overall Study|Change of formulation|0|||
129818872|NCT00040664|467298900|FG003|Overall Study|Change of formulation|0|||
129818873|NCT00040664|467298897|FG000|Overall Study|Non-viability of oral suspension|1|||
129818874|NCT00040664|467298898|FG001|Overall Study|Non-viability of oral suspension|0|||
129818875|NCT00040664|467298899|FG002|Overall Study|Non-viability of oral suspension|1|||
129818876|NCT00040664|467298900|FG003|Overall Study|Non-viability of oral suspension|0|||
129818877|NCT00729651|467298901|FG000|Overall Study|Withdrawal by Subject|5|||
129818878|NCT00729651|467298902|FG001|Overall Study|Withdrawal by Subject|6|||
129818879|NCT00729651|467298901|FG000|Overall Study|Lost to Follow-up|5|||
129818880|NCT00729651|467298902|FG001|Overall Study|Lost to Follow-up|4|||
129818881|NCT00729651|467298901|FG000|Overall Study|Protocol Violation|0|||
129818882|NCT00729651|467298902|FG001|Overall Study|Protocol Violation|1|||
129818883|NCT00729651|467298901|FG000|Overall Study|Adverse Event|7|||
129818884|NCT00729651|467298902|FG001|Overall Study|Adverse Event|3|||
129818885|NCT00729651|467298901|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
129818886|NCT00729651|467298902|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
129818887|NCT00729651|467298901|FG000|Overall Study|Subject's private reason|2|||
129818888|NCT00729651|467298902|FG001|Overall Study|Subject's private reason|0|||
129818889|NCT01218243|467298903|FG000|Overall Study|Lack of Efficacy|1|||
129818890|NCT01218243|467298904|FG001|Overall Study|Lack of Efficacy|1|||
129818891|NCT01218243|467298903|FG000|Overall Study|Lost to Follow-up|3|||
129818892|NCT01218243|467298904|FG001|Overall Study|Lost to Follow-up|3|||
129818893|NCT01218243|467298903|FG000|Overall Study|Protocol Violation|5|||
129818894|NCT01218243|467298904|FG001|Overall Study|Protocol Violation|10|||
129818895|NCT00844896|467298911|FG000|Overall Study|Lost to Follow-up|12|||
129818896|NCT00844896|467298912|FG001|Overall Study|Lost to Follow-up|16|||
129818897|NCT00844896|467298911|FG000|Overall Study|Parents did not have time to complete|0|||
129818898|NCT00844896|467298912|FG001|Overall Study|Parents did not have time to complete|1|||
129818899|NCT02233647|467298913|FG000|Overall Study|Adverse Event|1|||
129818900|NCT02846779|467298917|FG000|Overall Study|Lost Enrollment|83|||
129818901|NCT02846779|467298918|FG001|Overall Study|Lost Enrollment|82|||
129818902|NCT02846779|467298919|FG002|Overall Study|Lost Enrollment|86|||
129818903|NCT02846779|467298917|FG000|Overall Study|Less than 31 days of follow-up|56|||
129818904|NCT02846779|467298918|FG001|Overall Study|Less than 31 days of follow-up|45|||
129818905|NCT02846779|467298919|FG002|Overall Study|Less than 31 days of follow-up|52|||
129818906|NCT02324569|467300870|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129818907|NCT02324569|467300871|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
129818908|NCT02324569|467300870|FG000|Overall Study|Voluntary Withdrawal|3|||
129818909|NCT02324569|467300871|FG001|Overall Study|Voluntary Withdrawal|6|||
129818910|NCT02324569|467300870|FG000|Overall Study|Lack of Efficacy|2|||
129818911|NCT02324569|467300871|FG001|Overall Study|Lack of Efficacy|3|||
129818912|NCT02324569|467300870|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
129818913|NCT02324569|467300871|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
129818914|NCT02324569|467300870|FG000|Overall Study|Inconvenient Schedule|2|||
129818915|NCT02324569|467300871|FG001|Overall Study|Inconvenient Schedule|0|||
129818916|NCT01943292|467300878|FG000|Overall Study|Withdrawal by Subject|1|||
129818917|NCT01943292|467300879|FG001|Overall Study|Withdrawal by Subject|0|||
129818918|NCT01943292|467300880|FG002|Overall Study|Withdrawal by Subject|0|||
129818919|NCT00911820|467300881|FG000|Overall Study|RECIST progression|12|||
129818920|NCT00911820|467300882|FG001|Overall Study|RECIST progression|8|||
129818921|NCT00911820|467300881|FG000|Overall Study|Adverse Event|8|||
129818922|NCT00911820|467300882|FG001|Overall Study|Adverse Event|8|||
129818923|NCT00911820|467300881|FG000|Overall Study|Clinical Progression|7|||
129818924|NCT00911820|467300882|FG001|Overall Study|Clinical Progression|5|||
129818925|NCT00911820|467300881|FG000|Overall Study|Physician Decision|5|||
129818926|NCT00911820|467300882|FG001|Overall Study|Physician Decision|9|||
129818927|NCT00911820|467300881|FG000|Overall Study|Decline in Performance Status|4|||
129818928|NCT00911820|467300882|FG001|Overall Study|Decline in Performance Status|2|||
129818929|NCT00911820|467300881|FG000|Overall Study|Withdrawal by Subject|3|||
129818930|NCT00911820|467300882|FG001|Overall Study|Withdrawal by Subject|4|||
129818931|NCT00911820|467300881|FG000|Overall Study|Death|1|||
129818932|NCT00911820|467300882|FG001|Overall Study|Death|2|||
129818933|NCT00911820|467300881|FG000|Overall Study|Pursue surgery|1|||
129818934|NCT00911820|467300882|FG001|Overall Study|Pursue surgery|1|||
129818935|NCT00911820|467300881|FG000|Overall Study|Pursue Radiation|1|||
129818936|NCT00911820|467300882|FG001|Overall Study|Pursue Radiation|0|||
129818937|NCT00911820|467300881|FG000|Overall Study|Still on Therapy|2|||
129818938|NCT00911820|467300882|FG001|Overall Study|Still on Therapy|2|||
129818939|NCT00911820|467300881|FG000|Overall Study|Pathology Not Confirmed|1|||
129818940|NCT00911820|467300882|FG001|Overall Study|Pathology Not Confirmed|0|||
129818941|NCT00911820|467300881|FG000|Overall Study|Withdraw before Receive Treatment|0|||
129818942|NCT00911820|467300882|FG001|Overall Study|Withdraw before Receive Treatment|2|||
129818943|NCT01852110|467300883|FG000|Overall Study|Adverse Event|12|||
129818944|NCT01852110|467300884|FG001|Overall Study|Adverse Event|5|||
129818945|NCT01852110|467300885|FG002|Overall Study|Adverse Event|0|||
129818946|NCT01852110|467300886|FG003|Overall Study|Adverse Event|0|||
129818947|NCT01852110|467300887|FG004|Overall Study|Adverse Event|0|||
129818948|NCT01852110|467300888|FG005|Overall Study|Adverse Event|0|||
129818949|NCT01852110|467300883|FG000|Overall Study|Lost to Follow-up|1|||
129818950|NCT01852110|467300884|FG001|Overall Study|Lost to Follow-up|3|||
129818951|NCT01852110|467300885|FG002|Overall Study|Lost to Follow-up|0|||
129818952|NCT01852110|467300886|FG003|Overall Study|Lost to Follow-up|0|||
129818953|NCT01852110|467300887|FG004|Overall Study|Lost to Follow-up|0|||
129818954|NCT01852110|467300888|FG005|Overall Study|Lost to Follow-up|0|||
129818955|NCT01852110|467300883|FG000|Overall Study|Non-compliance with Study Drug|2|||
129818956|NCT01852110|467300884|FG001|Overall Study|Non-compliance with Study Drug|1|||
129818957|NCT01852110|467300885|FG002|Overall Study|Non-compliance with Study Drug|0|||
129818958|NCT01852110|467300886|FG003|Overall Study|Non-compliance with Study Drug|0|||
129818959|NCT01852110|467300887|FG004|Overall Study|Non-compliance with Study Drug|0|||
129818960|NCT01852110|467300888|FG005|Overall Study|Non-compliance with Study Drug|0|||
129818961|NCT01852110|467300883|FG000|Overall Study|Physician Decision|1|||
129818962|NCT01852110|467300884|FG001|Overall Study|Physician Decision|0|||
129818963|NCT01852110|467300885|FG002|Overall Study|Physician Decision|0|||
129818964|NCT01852110|467300886|FG003|Overall Study|Physician Decision|0|||
129818965|NCT01852110|467300887|FG004|Overall Study|Physician Decision|0|||
129818966|NCT01852110|467300888|FG005|Overall Study|Physician Decision|0|||
129818967|NCT01852110|467300883|FG000|Overall Study|Protocol Violation|0|||
129818968|NCT01852110|467300884|FG001|Overall Study|Protocol Violation|1|||
129818969|NCT01852110|467300885|FG002|Overall Study|Protocol Violation|0|||
129818970|NCT01852110|467300886|FG003|Overall Study|Protocol Violation|0|||
129818971|NCT01852110|467300887|FG004|Overall Study|Protocol Violation|0|||
129818972|NCT01852110|467300888|FG005|Overall Study|Protocol Violation|0|||
129818973|NCT01852110|467300883|FG000|Overall Study|Study Terminated by Sponsor|30|||
129818974|NCT01852110|467300884|FG001|Overall Study|Study Terminated by Sponsor|32|||
129818975|NCT01852110|467300885|FG002|Overall Study|Study Terminated by Sponsor|0|||
129818976|NCT01852110|467300886|FG003|Overall Study|Study Terminated by Sponsor|0|||
129818977|NCT01852110|467300887|FG004|Overall Study|Study Terminated by Sponsor|0|||
129818978|NCT01852110|467300888|FG005|Overall Study|Study Terminated by Sponsor|0|||
129818979|NCT01852110|467300883|FG000|Overall Study|Withdrawal by Subject|4|||
129818980|NCT01852110|467300884|FG001|Overall Study|Withdrawal by Subject|4|||
129818981|NCT01852110|467300885|FG002|Overall Study|Withdrawal by Subject|0|||
129818982|NCT01852110|467300886|FG003|Overall Study|Withdrawal by Subject|0|||
129818983|NCT01852110|467300887|FG004|Overall Study|Withdrawal by Subject|0|||
129818984|NCT01852110|467300888|FG005|Overall Study|Withdrawal by Subject|0|||
129818985|NCT00410046|467300891|FG000|Overall Study|Adverse Event|3|||
129818986|NCT00410046|467300891|FG000|Overall Study|Withdrawal by Subject|1|||
129818987|NCT00410046|467300891|FG000|Overall Study|Lost to Follow-up|1|||
129818988|NCT03098550|467300892|FG000|Overall Study|Disease Progression|30|||
129818989|NCT03098550|467300893|FG001|Overall Study|Disease Progression|19|||
129818990|NCT03098550|467300894|FG002|Overall Study|Disease Progression|41|||
129818991|NCT03098550|467300892|FG000|Overall Study|Study Drug Toxicity|2|||
129818992|NCT03098550|467300893|FG001|Overall Study|Study Drug Toxicity|1|||
129818993|NCT03098550|467300894|FG002|Overall Study|Study Drug Toxicity|0|||
129818994|NCT03098550|467300892|FG000|Overall Study|Death|1|||
129818995|NCT03098550|467300893|FG001|Overall Study|Death|0|||
129818996|NCT03098550|467300894|FG002|Overall Study|Death|0|||
129818997|NCT03098550|467300892|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
129818998|NCT03098550|467300893|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
129818999|NCT03098550|467300894|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
129819000|NCT03098550|467300892|FG000|Overall Study|Administrative reason by sponsor|0|||
129819001|NCT03098550|467300893|FG001|Overall Study|Administrative reason by sponsor|0|||
129819002|NCT03098550|467300894|FG002|Overall Study|Administrative reason by sponsor|1|||
129819003|NCT03098550|467300892|FG000|Overall Study|Other reasons|2|||
129819004|NCT03098550|467300893|FG001|Overall Study|Other reasons|0|||
129819005|NCT03098550|467300894|FG002|Overall Study|Other reasons|0|||
129819006|NCT00381095|467300902|FG000|Overall Study|Death|3|||
129819007|NCT00381095|467300903|FG001|Overall Study|Death|4|||
129819008|NCT00381095|467300902|FG000|Overall Study|Lack of Efficacy|2|||
129819009|NCT00381095|467300903|FG001|Overall Study|Lack of Efficacy|4|||
129819010|NCT00381095|467300902|FG000|Overall Study|Other|2|||
129819011|NCT00381095|467300903|FG001|Overall Study|Other|2|||
129819012|NCT00381095|467300902|FG000|Overall Study|Protocol Violation|1|||
129819013|NCT00381095|467300903|FG001|Overall Study|Protocol Violation|1|||
129819014|NCT00381095|467300902|FG000|Overall Study|Withdrawal by Subject|3|||
129819015|NCT00381095|467300903|FG001|Overall Study|Withdrawal by Subject|3|||
129819016|NCT00381095|467300902|FG000|Overall Study|Adverse Event|2|||
129819017|NCT00381095|467300903|FG001|Overall Study|Adverse Event|7|||
129819018|NCT01104493|467300904|FG000|Overall Study|Lost to Follow-up|0|||
129819019|NCT01104493|467300905|FG001|Overall Study|Lost to Follow-up|2|||
129819020|NCT01342796|467300907|FG000|Overall Study|Withdrawal by Subject|2|||
129819021|NCT01342796|467300908|FG001|Overall Study|Withdrawal by Subject|0|||
129819022|NCT01342796|467300907|FG000|Overall Study|Lost to Follow-up|0|||
129819023|NCT01342796|467300908|FG001|Overall Study|Lost to Follow-up|3|||
129819024|NCT01342796|467300907|FG000|Overall Study|Inappropriate enrollment|1|||
129819025|NCT01342796|467300908|FG001|Overall Study|Inappropriate enrollment|0|||
129819026|NCT02485301|467300909|FG000|Overall Study|Serious Adverse Events|2|||
129819027|NCT02485301|467300910|FG001|Overall Study|Serious Adverse Events|1|||
129819028|NCT02485301|467300909|FG000|Overall Study|Protocol Violation|0|||
129819029|NCT02485301|467300910|FG001|Overall Study|Protocol Violation|1|||
129819030|NCT02485301|467300909|FG000|Overall Study|Withdrawal by Subject|6|||
129819031|NCT02485301|467300910|FG001|Overall Study|Withdrawal by Subject|7|||
129819032|NCT02485301|467300909|FG000|Overall Study|Migrated/moved from study area|10|||
129819033|NCT02485301|467300910|FG001|Overall Study|Migrated/moved from study area|19|||
129819034|NCT02485301|467300909|FG000|Overall Study|Lost to Follow-up|17|||
129819035|NCT02485301|467300910|FG001|Overall Study|Lost to Follow-up|17|||
129819036|NCT02485301|467300909|FG000|Overall Study|Other|3|||
129819037|NCT02485301|467300910|FG001|Overall Study|Other|4|||
129819038|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819039|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819040|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819041|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819042|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819043|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
129819044|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
129819045|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819046|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819047|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819048|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819049|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819050|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
129819051|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
129819052|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819053|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819054|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819055|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819056|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819057|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
129819058|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
129819059|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819060|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819061|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819062|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819063|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819064|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
129819065|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
129819066|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
129819067|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
129819068|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
129819069|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
129819070|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
129819071|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
129819072|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
129819073|NCT01059825|467300914|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
129819074|NCT01059825|467300915|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
129819075|NCT01059825|467300916|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
129819076|NCT01059825|467300917|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
129819077|NCT01059825|467300918|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
129819078|NCT01059825|467300919|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
129819079|NCT01059825|467300920|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
129819080|NCT01059825|467300914|FG000|Treatment Period|Lost to Follow-up|2|||
129819081|NCT01059825|467300915|FG001|Treatment Period|Lost to Follow-up|1|||
129819082|NCT01059825|467300916|FG002|Treatment Period|Lost to Follow-up|0|||
129819083|NCT01059825|467300917|FG003|Treatment Period|Lost to Follow-up|1|||
129819084|NCT01059825|467300918|FG004|Treatment Period|Lost to Follow-up|2|||
129819085|NCT01059825|467300919|FG005|Treatment Period|Lost to Follow-up|0|||
129819086|NCT01059825|467300920|FG006|Treatment Period|Lost to Follow-up|0|||
129819087|NCT01059825|467300914|FG000|Treatment Period|Withdrawal by Subject|3|||
129819088|NCT01059825|467300915|FG001|Treatment Period|Withdrawal by Subject|0|||
129819089|NCT01059825|467300916|FG002|Treatment Period|Withdrawal by Subject|1|||
129819090|NCT01059825|467300917|FG003|Treatment Period|Withdrawal by Subject|5|||
129819091|NCT01059825|467300918|FG004|Treatment Period|Withdrawal by Subject|4|||
129819092|NCT01059825|467300919|FG005|Treatment Period|Withdrawal by Subject|1|||
129819093|NCT01059825|467300920|FG006|Treatment Period|Withdrawal by Subject|0|||
129819094|NCT01059825|467300914|FG000|Treatment Period|Other reason not specified|1|||
129819095|NCT01059825|467300915|FG001|Treatment Period|Other reason not specified|2|||
129819096|NCT01059825|467300916|FG002|Treatment Period|Other reason not specified|1|||
129819097|NCT01059825|467300917|FG003|Treatment Period|Other reason not specified|2|||
129819098|NCT01059825|467300918|FG004|Treatment Period|Other reason not specified|0|||
129819099|NCT01059825|467300919|FG005|Treatment Period|Other reason not specified|0|||
129819100|NCT01059825|467300920|FG006|Treatment Period|Other reason not specified|0|||
129819101|NCT01059825|467300914|FG000|Treatment Period|Protocol Violation|0|||
129819102|NCT01059825|467300915|FG001|Treatment Period|Protocol Violation|0|||
129819103|NCT01059825|467300916|FG002|Treatment Period|Protocol Violation|1|||
129819104|NCT01059825|467300917|FG003|Treatment Period|Protocol Violation|1|||
129819105|NCT01059825|467300918|FG004|Treatment Period|Protocol Violation|1|||
129819106|NCT01059825|467300919|FG005|Treatment Period|Protocol Violation|1|||
129819107|NCT01059825|467300920|FG006|Treatment Period|Protocol Violation|0|||
129819108|NCT01059825|467300914|FG000|Treatment Period|Adverse event related to study drug|1|||
129819109|NCT01059825|467300915|FG001|Treatment Period|Adverse event related to study drug|0|||
129819110|NCT01059825|467300916|FG002|Treatment Period|Adverse event related to study drug|1|||
129819111|NCT01059825|467300917|FG003|Treatment Period|Adverse event related to study drug|1|||
129819112|NCT01059825|467300918|FG004|Treatment Period|Adverse event related to study drug|0|||
129819113|NCT01059825|467300919|FG005|Treatment Period|Adverse event related to study drug|0|||
129819114|NCT01059825|467300920|FG006|Treatment Period|Adverse event related to study drug|0|||
129819115|NCT01059825|467300914|FG000|Treatment Period|Insufficient clinical response|3|||
129819116|NCT01059825|467300915|FG001|Treatment Period|Insufficient clinical response|0|||
129819117|NCT01059825|467300916|FG002|Treatment Period|Insufficient clinical response|0|||
129819118|NCT01059825|467300917|FG003|Treatment Period|Insufficient clinical response|0|||
129819119|NCT01059825|467300918|FG004|Treatment Period|Insufficient clinical response|0|||
129819120|NCT01059825|467300919|FG005|Treatment Period|Insufficient clinical response|0|||
129819121|NCT01059825|467300920|FG006|Treatment Period|Insufficient clinical response|0|||
129819122|NCT01059825|467300914|FG000|Treatment Period|Adverse event not related to study drug|0|||
129819123|NCT01059825|467300915|FG001|Treatment Period|Adverse event not related to study drug|1|||
129819124|NCT01059825|467300916|FG002|Treatment Period|Adverse event not related to study drug|2|||
129819125|NCT01059825|467300917|FG003|Treatment Period|Adverse event not related to study drug|1|||
129819126|NCT01059825|467300918|FG004|Treatment Period|Adverse event not related to study drug|1|||
129819127|NCT01059825|467300919|FG005|Treatment Period|Adverse event not related to study drug|1|||
129819128|NCT01059825|467300920|FG006|Treatment Period|Adverse event not related to study drug|0|||
129819129|NCT02495168|467300921|FG000|Overall Study|Other than Specified|18|||
129819130|NCT02495168|467300922|FG001|Overall Study|Other than Specified|22|||
129819131|NCT02495168|467300923|FG002|Overall Study|Other than Specified|5|||
129819132|NCT02495168|467300921|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
129819133|NCT02495168|467300922|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
129819134|NCT02495168|467300923|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
129819135|NCT02495168|467300921|FG000|Overall Study|Physician Decision|1|||
129819136|NCT02495168|467300922|FG001|Overall Study|Physician Decision|1|||
129819137|NCT02495168|467300923|FG002|Overall Study|Physician Decision|0|||
129819138|NCT02495168|467300921|FG000|Overall Study|Lost to Follow-up|10|||
129819139|NCT02495168|467300922|FG001|Overall Study|Lost to Follow-up|6|||
129819140|NCT02495168|467300923|FG002|Overall Study|Lost to Follow-up|1|||
129819141|NCT02495168|467300921|FG000|Overall Study|Withdrawal by Subject|1|||
129819142|NCT02495168|467300922|FG001|Overall Study|Withdrawal by Subject|4|||
129819143|NCT02495168|467300923|FG002|Overall Study|Withdrawal by Subject|2|||
129819144|NCT02495168|467300921|FG000|Overall Study|Protocol Violation|0|||
129819145|NCT02495168|467300922|FG001|Overall Study|Protocol Violation|10|||
129819146|NCT02495168|467300923|FG002|Overall Study|Protocol Violation|1|||
129819147|NCT02495168|467300921|FG000|Overall Study|Adverse Event|4|||
129819148|NCT02495168|467300922|FG001|Overall Study|Adverse Event|8|||
129819149|NCT02495168|467300923|FG002|Overall Study|Adverse Event|3|||
129819150|NCT02495168|467300921|FG000|Overall Study|Lack of Efficacy|0|||
129819151|NCT02495168|467300922|FG001|Overall Study|Lack of Efficacy|0|||
129819152|NCT02495168|467300923|FG002|Overall Study|Lack of Efficacy|3|||
129819153|NCT04626297|467300926|FG000|Overall Study|Adverse Event|5|||
129819154|NCT04626297|467300927|FG001|Overall Study|Adverse Event|3|||
129819155|NCT04626297|467300926|FG000|Overall Study|Lost to Follow-up|7|||
129819156|NCT04626297|467300927|FG001|Overall Study|Lost to Follow-up|3|||
129819157|NCT04626297|467300926|FG000|Overall Study|Protocol Violation|5|||
129819158|NCT04626297|467300927|FG001|Overall Study|Protocol Violation|1|||
129819159|NCT04626297|467300926|FG000|Overall Study|Withdrawal by Subject|20|||
129819160|NCT04626297|467300927|FG001|Overall Study|Withdrawal by Subject|6|||
129819161|NCT04626297|467300926|FG000|Overall Study|Sponsor decision|2|||
129819162|NCT04626297|467300927|FG001|Overall Study|Sponsor decision|1|||
129819163|NCT03521934|467300934|FG000|Overall Study|Death|65|||
129819164|NCT03521934|467300935|FG001|Overall Study|Death|73|||
129819165|NCT03521934|467300934|FG000|Overall Study|Withdrawal by Subject|18|||
129819166|NCT03521934|467300935|FG001|Overall Study|Withdrawal by Subject|23|||
129819167|NCT03521934|467300934|FG000|Overall Study|Site Terminated by Sponsor|39|||
129819168|NCT03521934|467300935|FG001|Overall Study|Site Terminated by Sponsor|35|||
129819169|NCT03521934|467300934|FG000|Overall Study|Study Terminated by Sponsor|483|||
129819170|NCT03521934|467300935|FG001|Overall Study|Study Terminated by Sponsor|477|||
129819171|NCT03521934|467300934|FG000|Overall Study|Reason not Specified|3|||
129819172|NCT03521934|467300935|FG001|Overall Study|Reason not Specified|6|||
129819173|NCT03020160|467300936|FG000|Overall Study|Withdrawal by Subject|1|||
129819174|NCT03020160|467300937|FG001|Overall Study|Withdrawal by Subject|0|||
129819175|NCT01513473|467300938|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
129819176|NCT01513473|467300939|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
129819177|NCT01513473|467300938|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
129819178|NCT01513473|467300939|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
129819179|NCT01513473|467300938|FG000|Main Trial (26 Weeks)|Unclassified|0|||
129819180|NCT01513473|467300939|FG001|Main Trial (26 Weeks)|Unclassified|2|||
129819181|NCT01513473|467300938|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
129819182|NCT01513473|467300939|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
129819183|NCT01513473|467300938|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
129819184|NCT01513473|467300939|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
129819185|NCT03462082|467300940|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819186|NCT03462082|467300941|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819187|NCT03462082|467300942|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819188|NCT03462082|467300943|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819189|NCT03462082|467300944|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819190|NCT03462082|467300945|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
129819191|NCT03462082|467300946|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
129819192|NCT03462082|467300947|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
129819193|NCT01425281|467300952|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
129819194|NCT01425281|467300953|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
129819195|NCT01425281|467300952|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
129819196|NCT01425281|467300953|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
129819197|NCT01425281|467300952|FG000|At 180-day Clinical Follow-up|Death|0|||
129819198|NCT01425281|467300953|FG001|At 180-day Clinical Follow-up|Death|1|||
129819199|NCT01425281|467300952|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
129819200|NCT01425281|467300953|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
129819201|NCT01425281|467300952|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
129819202|NCT01425281|467300953|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
129819203|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
129819204|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
129819205|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Death|2|||
129819206|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Death|0|||
129819207|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
129819208|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
129819209|NCT01425281|467300952|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
129819210|NCT01425281|467300953|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
129819211|NCT01425281|467300952|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
129819212|NCT01425281|467300953|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
129819213|NCT01425281|467300952|FG000|At 3-year Clinical Follow-up|Death|2|||
129819214|NCT01425281|467300953|FG001|At 3-year Clinical Follow-up|Death|3|||
129819215|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Death|7|||
129819216|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Death|3|||
129819217|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
129819218|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
129819219|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
129819220|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
129819221|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
129819222|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
129819223|NCT01425281|467300952|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
129819224|NCT01425281|467300953|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
129819225|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Death|2|||
129819226|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Death|0|||
129819227|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
129819228|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
129819229|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
129819230|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
129819231|NCT01425281|467300952|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
129819232|NCT01425281|467300953|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
129819233|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Left Oranization|1|||
129819234|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Left Oranization|1|||
129819235|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
129819236|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
129819237|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
129819238|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
129819239|NCT03454997|467300954|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
129819240|NCT03454997|467300955|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
129819241|NCT03454997|467300954|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
129819242|NCT03454997|467300955|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
129819243|NCT03454997|467300954|FG000|Overall Study|Client with SMI - Left organization|0|||
129819244|NCT03454997|467300955|FG001|Overall Study|Client with SMI - Left organization|1|||
129819245|NCT03454997|467300954|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
129819246|NCT03454997|467300955|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
129819247|NCT00299975|467300957|FG000|Overall Study|Adverse Event|1|||
129819248|NCT00299975|467300958|FG001|Overall Study|Adverse Event|0|||
129819249|NCT00299975|467300959|FG002|Overall Study|Adverse Event|2|||
129819250|NCT00299975|467300957|FG000|Overall Study|Pregnancy|0|||
129819251|NCT00299975|467300958|FG001|Overall Study|Pregnancy|0|||
129819252|NCT00299975|467300959|FG002|Overall Study|Pregnancy|1|||
129819253|NCT00299975|467300957|FG000|Overall Study|Lack of Efficacy|1|||
129819254|NCT00299975|467300958|FG001|Overall Study|Lack of Efficacy|0|||
129819255|NCT00299975|467300959|FG002|Overall Study|Lack of Efficacy|1|||
129819256|NCT00299975|467300957|FG000|Overall Study|Lost to Follow-up|1|||
129819257|NCT00299975|467300958|FG001|Overall Study|Lost to Follow-up|0|||
129819258|NCT00299975|467300959|FG002|Overall Study|Lost to Follow-up|0|||
129819259|NCT00299975|467300957|FG000|Overall Study|Withdrawal by Subject|0|||
129819260|NCT00299975|467300958|FG001|Overall Study|Withdrawal by Subject|1|||
129819261|NCT00299975|467300959|FG002|Overall Study|Withdrawal by Subject|3|||
129819262|NCT00299975|467300957|FG000|Overall Study|Physician Decision|0|||
129819263|NCT00299975|467300958|FG001|Overall Study|Physician Decision|0|||
129819264|NCT00299975|467300959|FG002|Overall Study|Physician Decision|1|||
129819265|NCT00982878|467300960|FG000|Overall Study|Physician Decision|1|||
129819266|NCT03167411|467300961|FG000|Overall Study|Adverse Event|0|||
129819267|NCT03167411|467300962|FG001|Overall Study|Adverse Event|1|||
129819268|NCT02627144|467300965|FG000|Overall Study|Serious adverse event|32|||
129819269|NCT02627144|467300965|FG000|Overall Study|Cancer progression|171|||
129819270|NCT02627144|467300965|FG000|Overall Study|Death from cancer|20|||
129819271|NCT02627144|467300965|FG000|Overall Study|Death from other cause|8|||
129819272|NCT02627144|467300965|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
129819273|NCT02627144|467300965|FG000|Overall Study|Administrative reasons|65|||
129819274|NCT02627144|467300965|FG000|Overall Study|Lost to Follow-up|8|||
129819275|NCT02627144|467300965|FG000|Overall Study|Enrolled, not treated|6|||
129819276|NCT02627144|467300965|FG000|Overall Study|Other|17|||
129819277|NCT01906008|467300970|FG000|Overall Study|Lost to Follow-up|2|||
129819278|NCT01906008|467300971|FG001|Overall Study|Lost to Follow-up|0|||
129819279|NCT01906008|467300970|FG000|Overall Study|Oxaliplatin toxicity|2|||
129819280|NCT01906008|467300971|FG001|Overall Study|Oxaliplatin toxicity|0|||
129819281|NCT01906008|467300970|FG000|Overall Study|Protocol Violation|0|||
129819282|NCT01906008|467300971|FG001|Overall Study|Protocol Violation|1|||
129819283|NCT01906008|467300970|FG000|Overall Study|Withdrawal by Subject|1|||
129819284|NCT01906008|467300971|FG001|Overall Study|Withdrawal by Subject|5|||
129819285|NCT01906008|467300970|FG000|Overall Study|Did not start study med|3|||
129819286|NCT01906008|467300971|FG001|Overall Study|Did not start study med|4|||
129819287|NCT01906008|467300970|FG000|Overall Study|Oxaliplatin stops|10|||
129819288|NCT01906008|467300971|FG001|Overall Study|Oxaliplatin stops|8|||
129819289|NCT01906008|467300970|FG000|Overall Study|Hospice|1|||
129819290|NCT01906008|467300971|FG001|Overall Study|Hospice|0|||
129819291|NCT01906008|467300970|FG000|Overall Study|Physician Decision|3|||
129819292|NCT01906008|467300971|FG001|Overall Study|Physician Decision|3|||
129819293|NCT01906008|467300970|FG000|Overall Study|Lack of compliance of study med|5|||
129819294|NCT01906008|467300971|FG001|Overall Study|Lack of compliance of study med|3|||
129819295|NCT01906008|467300970|FG000|Overall Study|Adverse Event|0|||
129819296|NCT01906008|467300971|FG001|Overall Study|Adverse Event|3|||
129819297|NCT02651922|467300973|FG000|Overall Study|due to exclusion criteria|2|||
129819298|NCT00171730|467300975|FG000|Overall Study|Adverse Event|3|||
129819299|NCT00171730|467300975|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129819300|NCT00171730|467300975|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
129819301|NCT00171730|467300975|FG000|Overall Study|Withdrawal by Subject|3|||
129819302|NCT02220205|467300976|FG000|Overall Study|Withdrawal by Subject|1|||
129819303|NCT02220205|467300977|FG001|Overall Study|Withdrawal by Subject|0|||
129819304|NCT01465997|467300978|FG000|Overall Study|Adverse Event|12|||
129819305|NCT01465997|467300979|FG001|Overall Study|Adverse Event|22|||
129819306|NCT01465997|467300978|FG000|Overall Study|Lack of Efficacy|13|||
129819307|NCT01465997|467300979|FG001|Overall Study|Lack of Efficacy|1|||
129819308|NCT01465997|467300978|FG000|Overall Study|Protocol Violation|1|||
129819309|NCT01465997|467300979|FG001|Overall Study|Protocol Violation|4|||
129819310|NCT01465997|467300978|FG000|Overall Study|Lost to Follow-up|6|||
129819311|NCT01465997|467300979|FG001|Overall Study|Lost to Follow-up|9|||
129819312|NCT01465997|467300978|FG000|Overall Study|Withdrawal by Subject|32|||
129819313|NCT01465997|467300979|FG001|Overall Study|Withdrawal by Subject|35|||
129819314|NCT01465997|467300978|FG000|Overall Study|investigator's decision|1|||
129819315|NCT01465997|467300979|FG001|Overall Study|investigator's decision|1|||
129819316|NCT01465997|467300978|FG000|Overall Study|Death|0|||
129819317|NCT01465997|467300979|FG001|Overall Study|Death|1|||
129819318|NCT01465997|467300978|FG000|Overall Study|sponsor's decision|1|||
129819319|NCT01465997|467300979|FG001|Overall Study|sponsor's decision|1|||
129819320|NCT01465997|467300978|FG000|Overall Study|subject withdrew consent|1|||
129819321|NCT01465997|467300979|FG001|Overall Study|subject withdrew consent|0|||
129819322|NCT01465997|467300978|FG000|Overall Study|local lab unblinded site|1|||
129819323|NCT01465997|467300979|FG001|Overall Study|local lab unblinded site|0|||
129819324|NCT01465997|467300978|FG000|Overall Study|withdrew before follow-up|0|||
129819325|NCT01465997|467300979|FG001|Overall Study|withdrew before follow-up|13|||
129819326|NCT01465997|467300978|FG000|Overall Study|decision by site staff|0|||
129819327|NCT01465997|467300979|FG001|Overall Study|decision by site staff|1|||
129819328|NCT01465997|467300978|FG000|Overall Study|subject left participation SP0993|0|||
129819329|NCT01465997|467300979|FG001|Overall Study|subject left participation SP0993|1|||
129819330|NCT04862585|467300980|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
129819331|NCT04862585|467300981|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
129819332|NCT04862585|467300980|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
129819333|NCT04862585|467300981|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
129819334|NCT04862585|467300980|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
129819335|NCT04862585|467300981|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
129819336|NCT04862585|467300980|FG000|Overall Study|one withdrew without providing a reason|0|||
129819337|NCT04862585|467300981|FG001|Overall Study|one withdrew without providing a reason|1|||
129819338|NCT00211809|467300982|FG000|Overall Study|Lack of Efficacy|1|||
129819339|NCT00211809|467300982|FG000|Overall Study|Lost to Follow-up|2|||
129819340|NCT00211809|467300982|FG000|Overall Study|Pregnancy|1|||
129819341|NCT00211809|467300982|FG000|Overall Study|side effects|2|||
129819342|NCT00496470|467300983|FG000|Overall Study|Adverse Event|8|||
129819343|NCT00496470|467300984|FG001|Overall Study|Adverse Event|10|||
129819344|NCT00496470|467300983|FG000|Overall Study|Withdrawal by Subject|5|||
129819345|NCT00496470|467300984|FG001|Overall Study|Withdrawal by Subject|12|||
129819346|NCT00496470|467300983|FG000|Overall Study|Incorrectly enrolled|13|||
129819347|NCT00496470|467300984|FG001|Overall Study|Incorrectly enrolled|5|||
129819348|NCT00496470|467300983|FG000|Overall Study|Other reason|0|||
129819349|NCT00496470|467300984|FG001|Overall Study|Other reason|2|||
129819350|NCT01217814|467300985|FG000|Overall Study|Adverse Event|1|||
129819351|NCT01217814|467300986|FG001|Overall Study|Adverse Event|1|||
129819352|NCT01217814|467300987|FG002|Overall Study|Adverse Event|0|||
129819353|NCT01217814|467300985|FG000|Overall Study|Lack of Efficacy|0|||
129819354|NCT01217814|467300986|FG001|Overall Study|Lack of Efficacy|0|||
129819355|NCT01217814|467300987|FG002|Overall Study|Lack of Efficacy|1|||
129819356|NCT01756898|467300988|FG000|Overall Study|Adverse Event|7|||
129819357|NCT01756898|467300989|FG001|Overall Study|Adverse Event|1|||
129819358|NCT01756898|467300990|FG002|Overall Study|Adverse Event|0|||
129819359|NCT01756898|467300991|FG003|Overall Study|Adverse Event|0|||
129819360|NCT01756898|467300988|FG000|Overall Study|Lack of Efficacy|4|||
129819361|NCT01756898|467300989|FG001|Overall Study|Lack of Efficacy|7|||
129819362|NCT01756898|467300990|FG002|Overall Study|Lack of Efficacy|6|||
129819363|NCT01756898|467300991|FG003|Overall Study|Lack of Efficacy|6|||
129819364|NCT01756898|467300988|FG000|Overall Study|Lost to Follow-up|2|||
129819365|NCT01756898|467300989|FG001|Overall Study|Lost to Follow-up|4|||
129819366|NCT01756898|467300990|FG002|Overall Study|Lost to Follow-up|2|||
129819367|NCT01756898|467300991|FG003|Overall Study|Lost to Follow-up|3|||
129819368|NCT01756898|467300988|FG000|Overall Study|Protocol Violation|1|||
129819369|NCT01756898|467300989|FG001|Overall Study|Protocol Violation|2|||
129819370|NCT01756898|467300990|FG002|Overall Study|Protocol Violation|2|||
129819371|NCT01756898|467300991|FG003|Overall Study|Protocol Violation|1|||
129819372|NCT01756898|467300988|FG000|Overall Study|Withdrew Consent|5|||
129819373|NCT01756898|467300989|FG001|Overall Study|Withdrew Consent|3|||
129819374|NCT01756898|467300990|FG002|Overall Study|Withdrew Consent|5|||
129819375|NCT01756898|467300991|FG003|Overall Study|Withdrew Consent|6|||
129897271|NCT00269399|467584307|FG000|Overall Study|Withdrawal by Subject|2|||
129819376|NCT01756898|467300988|FG000|Overall Study|Other|0|||
129819377|NCT01756898|467300989|FG001|Overall Study|Other|2|||
129819378|NCT01756898|467300990|FG002|Overall Study|Other|2|||
129819379|NCT01756898|467300991|FG003|Overall Study|Other|0|||
129819380|NCT00496054|467300996|FG000|Overall Study|Adverse Event|1|||
129819381|NCT00496054|467300996|FG000|Overall Study|Lost to Follow-up|7|||
129819382|NCT00471328|467301003|FG000|Core Phase|Adverse Event|18|||
129819383|NCT00471328|467301004|FG001|Core Phase|Adverse Event|6|||
129819384|NCT00471328|467301003|FG000|Core Phase|Death|8|||
129819385|NCT00471328|467301004|FG001|Core Phase|Death|4|||
129819386|NCT00471328|467301003|FG000|Core Phase|Withdrawal by Subject|2|||
129819387|NCT00471328|467301004|FG001|Core Phase|Withdrawal by Subject|2|||
129819388|NCT00471328|467301003|FG000|Core Phase|Abnormal laboratory value|1|||
129819389|NCT00471328|467301004|FG001|Core Phase|Abnormal laboratory value|0|||
129819390|NCT00471328|467301003|FG000|Core Phase|Disease Progression|78|||
129819391|NCT00471328|467301004|FG001|Core Phase|Disease Progression|53|||
129819392|NCT00471328|467301003|FG000|Core Phase|Administrative Problem|0|||
129819393|NCT00471328|467301004|FG001|Core Phase|Administrative Problem|1|||
129819394|NCT00471328|467301003|FG000|Core Phase|Protocol Deviation|0|||
129819395|NCT00471328|467301004|FG001|Core Phase|Protocol Deviation|1|||
129819396|NCT00471328|467301003|FG000|Extension Phase|Adverse Event|3|||
129819397|NCT00471328|467301004|FG001|Extension Phase|Adverse Event|12|||
129819398|NCT00471328|467301003|FG000|Extension Phase|Withdrawal by Subject|0|||
129897272|NCT00269399|467584308|FG001|Overall Study|Withdrawal by Subject|5|||
129897273|NCT00269399|467584307|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
129897274|NCT00269399|467584308|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
129897275|NCT00269399|467584307|FG000|Overall Study|Other|0|||
129819399|NCT00471328|467301004|FG001|Extension Phase|Withdrawal by Subject|2|||
129819400|NCT00471328|467301003|FG000|Extension Phase|Death|1|||
129819401|NCT00471328|467301004|FG001|Extension Phase|Death|7|||
129819402|NCT00471328|467301003|FG000|Extension Phase|Protocol Deviation|3|||
129819403|NCT00471328|467301004|FG001|Extension Phase|Protocol Deviation|1|||
129819404|NCT00471328|467301003|FG000|Extension Phase|Treatment duration as per protocol|0|||
129819405|NCT00471328|467301004|FG001|Extension Phase|Treatment duration as per protocol|1|||
129819406|NCT00471328|467301003|FG000|Extension Phase|Disease Progression|32|||
129819407|NCT00471328|467301004|FG001|Extension Phase|Disease Progression|44|||
129819408|NCT00471328|467301003|FG000|Extension Phase|New cancer Therapy|1|||
129819409|NCT00471328|467301004|FG001|Extension Phase|New cancer Therapy|0|||
129819410|NCT00471328|467301003|FG000|Extension Phase|Administrative Problem|1|||
129819411|NCT00471328|467301004|FG001|Extension Phase|Administrative Problem|0|||
129819412|NCT01835587|467301005|FG000|Overall Study|Disease Recurrence or Relapse|0|||
129819413|NCT01835587|467301006|FG001|Overall Study|Disease Recurrence or Relapse|3|||
129819414|NCT01835587|467301007|FG002|Overall Study|Disease Recurrence or Relapse|0|||
129819415|NCT01835587|467301008|FG003|Overall Study|Disease Recurrence or Relapse|3|||
129819416|NCT01835587|467301005|FG000|Overall Study|Withdrawal by Subject|2|||
129819417|NCT01835587|467301006|FG001|Overall Study|Withdrawal by Subject|0|||
129819418|NCT01835587|467301007|FG002|Overall Study|Withdrawal by Subject|0|||
129819419|NCT01835587|467301008|FG003|Overall Study|Withdrawal by Subject|3|||
129819420|NCT01835587|467301005|FG000|Overall Study|Adverse Event|0|||
129819421|NCT01835587|467301006|FG001|Overall Study|Adverse Event|0|||
129819422|NCT01835587|467301007|FG002|Overall Study|Adverse Event|2|||
129819423|NCT01835587|467301008|FG003|Overall Study|Adverse Event|2|||
129819424|NCT01835587|467301005|FG000|Overall Study|Death|0|||
129819425|NCT01835587|467301006|FG001|Overall Study|Death|0|||
129819426|NCT01835587|467301007|FG002|Overall Study|Death|0|||
129819427|NCT01835587|467301008|FG003|Overall Study|Death|1|||
129819428|NCT01835587|467301005|FG000|Overall Study|Miscellaneous|0|||
129819429|NCT01835587|467301006|FG001|Overall Study|Miscellaneous|1|||
129819430|NCT01835587|467301007|FG002|Overall Study|Miscellaneous|0|||
129819431|NCT01835587|467301008|FG003|Overall Study|Miscellaneous|0|||
129819432|NCT02132130|467301009|FG000|Overall Study|Lost to Follow-up|0|||
129819433|NCT02132130|467301010|FG001|Overall Study|Lost to Follow-up|2|||
129819434|NCT02132130|467301011|FG002|Overall Study|Lost to Follow-up|0|||
129819435|NCT02132130|467301012|FG003|Overall Study|Lost to Follow-up|0|||
129819436|NCT02132130|467301009|FG000|Overall Study|Withdrawal by Subject|0|||
129819437|NCT02132130|467301010|FG001|Overall Study|Withdrawal by Subject|0|||
129819438|NCT02132130|467301011|FG002|Overall Study|Withdrawal by Subject|0|||
129819439|NCT02132130|467301012|FG003|Overall Study|Withdrawal by Subject|1|||
129819440|NCT00838578|467301013|FG000|Overall Study|Protocol Violation|2|||
129819441|NCT00357968|467301014|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
129819442|NCT00357968|467301015|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
129819443|NCT00357968|467301014|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
129819444|NCT00357968|467301015|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
129819445|NCT00439244|467301032|FG000|Overall Study|Adverse Event|5|||
129819446|NCT00439244|467301033|FG001|Overall Study|Adverse Event|2|||
129819447|NCT00439244|467301034|FG002|Overall Study|Adverse Event|3|||
129819448|NCT00439244|467301032|FG000|Overall Study|Withdrawal by Subject|3|||
129819449|NCT00439244|467301033|FG001|Overall Study|Withdrawal by Subject|1|||
129819450|NCT00439244|467301034|FG002|Overall Study|Withdrawal by Subject|2|||
129819451|NCT00439244|467301032|FG000|Overall Study|Lost to Follow-up|2|||
129819452|NCT00439244|467301033|FG001|Overall Study|Lost to Follow-up|1|||
129819453|NCT00439244|467301034|FG002|Overall Study|Lost to Follow-up|2|||
129819454|NCT00439244|467301032|FG000|Overall Study|Death|0|||
129819455|NCT00439244|467301033|FG001|Overall Study|Death|1|||
129819456|NCT00439244|467301034|FG002|Overall Study|Death|0|||
129819457|NCT00439244|467301032|FG000|Overall Study|Protocol Violation|0|||
129819458|NCT00439244|467301033|FG001|Overall Study|Protocol Violation|1|||
129819459|NCT00439244|467301034|FG002|Overall Study|Protocol Violation|0|||
129819460|NCT00439244|467301032|FG000|Overall Study|Administrative problems|1|||
129819461|NCT00439244|467301033|FG001|Overall Study|Administrative problems|0|||
129819462|NCT00439244|467301034|FG002|Overall Study|Administrative problems|0|||
129819463|NCT04102020|467301035|FG000|Overall Study|Adverse Event|1|||
129819464|NCT04102020|467301036|FG001|Overall Study|Adverse Event|0|||
129819465|NCT04102020|467301037|FG002|Overall Study|Adverse Event|0|||
129819466|NCT04102020|467301038|FG003|Overall Study|Adverse Event|1|||
129819467|NCT04102020|467301039|FG004|Overall Study|Adverse Event|0|||
129819468|NCT04102020|467301035|FG000|Overall Study|Withdrawal by Subject|0|||
129819469|NCT04102020|467301036|FG001|Overall Study|Withdrawal by Subject|1|||
129819470|NCT04102020|467301037|FG002|Overall Study|Withdrawal by Subject|1|||
129819471|NCT04102020|467301038|FG003|Overall Study|Withdrawal by Subject|1|||
129819472|NCT04102020|467301039|FG004|Overall Study|Withdrawal by Subject|1|||
129819473|NCT04102020|467301035|FG000|Overall Study|Death|1|||
129819474|NCT04102020|467301036|FG001|Overall Study|Death|4|||
129819475|NCT04102020|467301037|FG002|Overall Study|Death|1|||
129819476|NCT04102020|467301038|FG003|Overall Study|Death|1|||
129819477|NCT04102020|467301039|FG004|Overall Study|Death|0|||
129819478|NCT04102020|467301035|FG000|Overall Study|Physician Decision|1|||
129819479|NCT04102020|467301036|FG001|Overall Study|Physician Decision|2|||
129819480|NCT04102020|467301037|FG002|Overall Study|Physician Decision|2|||
129819481|NCT04102020|467301038|FG003|Overall Study|Physician Decision|0|||
129819482|NCT04102020|467301039|FG004|Overall Study|Physician Decision|1|||
129819483|NCT04102020|467301035|FG000|Overall Study|COVID-19 Infection|1|||
129819484|NCT04102020|467301036|FG001|Overall Study|COVID-19 Infection|0|||
129819485|NCT04102020|467301037|FG002|Overall Study|COVID-19 Infection|0|||
129819486|NCT04102020|467301038|FG003|Overall Study|COVID-19 Infection|0|||
129819487|NCT04102020|467301039|FG004|Overall Study|COVID-19 Infection|0|||
129819488|NCT04102020|467301035|FG000|Overall Study|Not disclosed|5|||
129819489|NCT04102020|467301036|FG001|Overall Study|Not disclosed|3|||
129819490|NCT04102020|467301037|FG002|Overall Study|Not disclosed|8|||
129819491|NCT04102020|467301038|FG003|Overall Study|Not disclosed|0|||
129819492|NCT04102020|467301039|FG004|Overall Study|Not disclosed|1|||
129819493|NCT04102020|467301035|FG000|Overall Study|MIssing|1|||
129819494|NCT04102020|467301036|FG001|Overall Study|MIssing|0|||
129819495|NCT04102020|467301037|FG002|Overall Study|MIssing|1|||
129819496|NCT04102020|467301038|FG003|Overall Study|MIssing|1|||
129819497|NCT04102020|467301039|FG004|Overall Study|MIssing|1|||
129819498|NCT04102020|467301035|FG000|Overall Study|Continuing in ongoing study|13|||
129819499|NCT04102020|467301036|FG001|Overall Study|Continuing in ongoing study|13|||
129819500|NCT04102020|467301037|FG002|Overall Study|Continuing in ongoing study|7|||
129819501|NCT04102020|467301038|FG003|Overall Study|Continuing in ongoing study|26|||
129819502|NCT04102020|467301039|FG004|Overall Study|Continuing in ongoing study|12|||
129819503|NCT04600921|467301042|FG000|Overall Study|Withdrawal by Subject|3|||
129819504|NCT04600921|467301043|FG001|Overall Study|Withdrawal by Subject|5|||
129819505|NCT04600921|467301042|FG000|Overall Study|Death|0|||
129819506|NCT04600921|467301043|FG001|Overall Study|Death|1|||
129819507|NCT02239978|467302677|FG000|Overall Study|Withdrawal by Subject|2|||
129819508|NCT02239978|467302678|FG001|Overall Study|Withdrawal by Subject|0|||
129819509|NCT00996216|467302684|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
129819510|NCT00996216|467302684|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
129819511|NCT00996216|467302684|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
129819512|NCT00482612|467302691|FG000|In-treatment Period|No study medication administered|0|||
129819513|NCT00482612|467302692|FG001|In-treatment Period|No study medication administered|0|||
129819514|NCT00482612|467302693|FG002|In-treatment Period|No study medication administered|1|||
129819515|NCT00482612|467302694|FG003|In-treatment Period|No study medication administered|0|||
129819516|NCT00482612|467302691|FG000|Follow-up Period|Other|4|||
129819517|NCT00482612|467302692|FG001|Follow-up Period|Other|2|||
129819518|NCT00482612|467302693|FG002|Follow-up Period|Other|1|||
129819519|NCT00482612|467302694|FG003|Follow-up Period|Other|2|||
129819520|NCT00482612|467302691|FG000|Follow-up Period|Lack of compliance|0|||
129819521|NCT00482612|467302692|FG001|Follow-up Period|Lack of compliance|0|||
129819522|NCT00482612|467302693|FG002|Follow-up Period|Lack of compliance|1|||
129819523|NCT00482612|467302694|FG003|Follow-up Period|Lack of compliance|0|||
129819524|NCT00482612|467302691|FG000|Follow-up Period|Lost to Follow-up|0|||
129819525|NCT00482612|467302692|FG001|Follow-up Period|Lost to Follow-up|4|||
129819526|NCT00482612|467302693|FG002|Follow-up Period|Lost to Follow-up|2|||
129819527|NCT00482612|467302694|FG003|Follow-up Period|Lost to Follow-up|1|||
129819528|NCT00482612|467302691|FG000|Follow-up Period|Adverse Event|4|||
129819529|NCT00482612|467302692|FG001|Follow-up Period|Adverse Event|7|||
129819530|NCT00482612|467302693|FG002|Follow-up Period|Adverse Event|9|||
129819531|NCT00482612|467302694|FG003|Follow-up Period|Adverse Event|0|||
129819532|NCT00482612|467302691|FG000|Follow-up Period|Lack of Efficacy|2|||
129819533|NCT00482612|467302692|FG001|Follow-up Period|Lack of Efficacy|0|||
129819534|NCT00482612|467302693|FG002|Follow-up Period|Lack of Efficacy|1|||
129819535|NCT00482612|467302694|FG003|Follow-up Period|Lack of Efficacy|0|||
129897276|NCT00269399|467584308|FG001|Overall Study|Other|4|||
129897277|NCT00269399|467584307|FG000|Overall Study|Development of exclusion criteria|0|||
129897278|NCT00269399|467584308|FG001|Overall Study|Development of exclusion criteria|1|||
129819536|NCT00482612|467302691|FG000|Follow-up Period|Withdrawal by Subject|3|||
129819537|NCT00482612|467302692|FG001|Follow-up Period|Withdrawal by Subject|5|||
129819538|NCT00482612|467302693|FG002|Follow-up Period|Withdrawal by Subject|7|||
129819539|NCT00482612|467302694|FG003|Follow-up Period|Withdrawal by Subject|2|||
129819540|NCT00482612|467302691|FG000|Follow-up Period|Reasons not related to trial|1|||
129819541|NCT00482612|467302692|FG001|Follow-up Period|Reasons not related to trial|0|||
129819542|NCT00482612|467302693|FG002|Follow-up Period|Reasons not related to trial|1|||
129819543|NCT00482612|467302694|FG003|Follow-up Period|Reasons not related to trial|3|||
129819544|NCT01366521|467302695|FG000|Overall Study|Adverse Event|1|||
129819545|NCT01366521|467302696|FG001|Overall Study|Adverse Event|0|||
129819546|NCT01366521|467302697|FG002|Overall Study|Adverse Event|0|||
129819547|NCT01366521|467302698|FG003|Overall Study|Adverse Event|0|||
129819548|NCT01366521|467302695|FG000|Overall Study|Protocol Violation|0|||
129819549|NCT01366521|467302696|FG001|Overall Study|Protocol Violation|0|||
129819550|NCT01366521|467302697|FG002|Overall Study|Protocol Violation|1|||
129819551|NCT01366521|467302698|FG003|Overall Study|Protocol Violation|0|||
129897279|NCT03441360|467584309|FG000|Overall Study|Radiological disease progression|5|||
129819552|NCT01366521|467302695|FG000|Overall Study|Physician Decision|0|||
129819553|NCT01366521|467302696|FG001|Overall Study|Physician Decision|0|||
129819554|NCT01366521|467302697|FG002|Overall Study|Physician Decision|1|||
129819555|NCT01366521|467302698|FG003|Overall Study|Physician Decision|0|||
129819556|NCT01366521|467302695|FG000|Overall Study|Withdrawal by Subject|0|||
129819557|NCT01366521|467302696|FG001|Overall Study|Withdrawal by Subject|1|||
129819558|NCT01366521|467302697|FG002|Overall Study|Withdrawal by Subject|0|||
129819559|NCT01366521|467302698|FG003|Overall Study|Withdrawal by Subject|0|||
129819560|NCT00684307|467302699|FG000|Overall Study|Adverse Event|11|||
129819561|NCT00684307|467302700|FG001|Overall Study|Adverse Event|6|||
129819562|NCT00684307|467302701|FG002|Overall Study|Adverse Event|15|||
129819563|NCT00684307|467302702|FG003|Overall Study|Adverse Event|16|||
129819564|NCT00684307|467302703|FG004|Overall Study|Adverse Event|8|||
129819565|NCT00684307|467302699|FG000|Overall Study|Development of increasing Liver Function|0|||
129819566|NCT00684307|467302700|FG001|Overall Study|Development of increasing Liver Function|2|||
129819567|NCT00684307|467302701|FG002|Overall Study|Development of increasing Liver Function|0|||
129819568|NCT00684307|467302702|FG003|Overall Study|Development of increasing Liver Function|1|||
129819569|NCT00684307|467302703|FG004|Overall Study|Development of increasing Liver Function|0|||
129819570|NCT00684307|467302699|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
129819571|NCT00684307|467302700|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
129819572|NCT00684307|467302701|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
129819573|NCT00684307|467302702|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
129819574|NCT00684307|467302703|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
129819575|NCT00684307|467302699|FG000|Overall Study|Incorrect enrolment or randomization|4|||
129819576|NCT00684307|467302700|FG001|Overall Study|Incorrect enrolment or randomization|0|||
129819577|NCT00684307|467302701|FG002|Overall Study|Incorrect enrolment or randomization|0|||
129819578|NCT00684307|467302702|FG003|Overall Study|Incorrect enrolment or randomization|0|||
129819579|NCT00684307|467302703|FG004|Overall Study|Incorrect enrolment or randomization|0|||
129819580|NCT00684307|467302699|FG000|Overall Study|Interupted IP for more than 7 days|0|||
129819581|NCT00684307|467302700|FG001|Overall Study|Interupted IP for more than 7 days|4|||
129819582|NCT00684307|467302701|FG002|Overall Study|Interupted IP for more than 7 days|1|||
129819583|NCT00684307|467302702|FG003|Overall Study|Interupted IP for more than 7 days|3|||
129819584|NCT00684307|467302703|FG004|Overall Study|Interupted IP for more than 7 days|3|||
129819585|NCT00684307|467302699|FG000|Overall Study|Severe non compliance to protocol|1|||
129819586|NCT00684307|467302700|FG001|Overall Study|Severe non compliance to protocol|0|||
129819587|NCT00684307|467302701|FG002|Overall Study|Severe non compliance to protocol|0|||
129819588|NCT00684307|467302702|FG003|Overall Study|Severe non compliance to protocol|1|||
129819589|NCT00684307|467302703|FG004|Overall Study|Severe non compliance to protocol|2|||
129819590|NCT00684307|467302699|FG000|Overall Study|Participant not willing to continue|7|||
129819591|NCT00684307|467302700|FG001|Overall Study|Participant not willing to continue|10|||
129819592|NCT00684307|467302701|FG002|Overall Study|Participant not willing to continue|11|||
129819593|NCT00684307|467302702|FG003|Overall Study|Participant not willing to continue|5|||
129819594|NCT00684307|467302703|FG004|Overall Study|Participant not willing to continue|8|||
129819595|NCT00684307|467302699|FG000|Overall Study|Criteria from the CSR|0|||
129819596|NCT00684307|467302700|FG001|Overall Study|Criteria from the CSR|0|||
129819597|NCT00684307|467302701|FG002|Overall Study|Criteria from the CSR|1|||
129819598|NCT00684307|467302702|FG003|Overall Study|Criteria from the CSR|3|||
129819599|NCT00684307|467302703|FG004|Overall Study|Criteria from the CSR|3|||
129819600|NCT00759031|467302704|FG000|First Intervention (1 Day)|Physician Decision|1|||
129819601|NCT00759031|467302705|FG001|First Intervention (1 Day)|Physician Decision|0|||
129819602|NCT00759031|467302704|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129819603|NCT00759031|467302705|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129819604|NCT00759031|467302704|FG000|First Intervention (1 Day)|Screening failure|1|||
129819605|NCT00759031|467302705|FG001|First Intervention (1 Day)|Screening failure|0|||
129819606|NCT02430311|467302706|FG000|Part A|Adverse Event|0|||
129819607|NCT02430311|467302707|FG001|Part A|Adverse Event|1|||
129819608|NCT02430311|467302706|FG000|Part A|Withdrawal by Subject|1|||
129819609|NCT02430311|467302707|FG001|Part A|Withdrawal by Subject|0|||
129819610|NCT02430311|467302706|FG000|Part B|Meet study-specific withdrawal criteria|6|||
129819611|NCT02430311|467302707|FG001|Part B|Meet study-specific withdrawal criteria|6|||
129819612|NCT02430311|467302706|FG000|Part B|Withdrawal by Subject|2|||
129819613|NCT02430311|467302707|FG001|Part B|Withdrawal by Subject|2|||
129819614|NCT02430311|467302706|FG000|Part B|Adverse Event|1|||
129819615|NCT02430311|467302707|FG001|Part B|Adverse Event|0|||
129819616|NCT02430311|467302706|FG000|Part B|Death|1|||
129819617|NCT02430311|467302707|FG001|Part B|Death|0|||
129819618|NCT03506815|467302708|FG000|Overall Study|Adverse Event|8|||
129897280|NCT03441360|467584310|FG001|Overall Study|Radiological disease progression|6|||
129897281|NCT03441360|467584311|FG002|Overall Study|Radiological disease progression|4|||
129819619|NCT03506815|467302709|FG001|Overall Study|Adverse Event|0|||
129819620|NCT03506815|467302708|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
129819621|NCT03506815|467302709|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
129819622|NCT03506815|467302708|FG000|Overall Study|Protocol Violation|1|||
129897282|NCT03441360|467584309|FG000|Overall Study|Clinical disease progression|2|||
129819623|NCT03506815|467302709|FG001|Overall Study|Protocol Violation|0|||
129819624|NCT03506815|467302708|FG000|Overall Study|Elective Surgery|1|||
129819625|NCT03506815|467302709|FG001|Overall Study|Elective Surgery|0|||
129819626|NCT04160091|467302710|FG000|Overall Study|Terminated by Sponsor|7|||
129819627|NCT04160091|467302711|FG001|Overall Study|Terminated by Sponsor|3|||
129819628|NCT04160091|467302712|FG002|Overall Study|Terminated by Sponsor|5|||
129819629|NCT04160091|467302713|FG003|Overall Study|Terminated by Sponsor|2|||
129819630|NCT04160091|467302710|FG000|Overall Study|Noncompliance|0|||
129819631|NCT04160091|467302711|FG001|Overall Study|Noncompliance|0|||
129819632|NCT04160091|467302712|FG002|Overall Study|Noncompliance|0|||
129819633|NCT04160091|467302713|FG003|Overall Study|Noncompliance|1|||
129819634|NCT04160091|467302710|FG000|Overall Study|Withdrawal by Subject|0|||
129819635|NCT04160091|467302711|FG001|Overall Study|Withdrawal by Subject|0|||
129819636|NCT04160091|467302712|FG002|Overall Study|Withdrawal by Subject|0|||
129819637|NCT04160091|467302713|FG003|Overall Study|Withdrawal by Subject|1|||
129819638|NCT01599234|467302718|FG000|Overall Study|Adverse Event|9|||
129819639|NCT01599234|467302719|FG001|Overall Study|Adverse Event|5|||
129819640|NCT01599234|467302718|FG000|Overall Study|Withdrawal by Subject|2|||
129819641|NCT01599234|467302719|FG001|Overall Study|Withdrawal by Subject|1|||
129819642|NCT01599234|467302718|FG000|Overall Study|Lost to Follow-up|1|||
129819643|NCT01599234|467302719|FG001|Overall Study|Lost to Follow-up|2|||
129819644|NCT01599234|467302718|FG000|Overall Study|Lack of Efficacy|2|||
129819645|NCT01599234|467302719|FG001|Overall Study|Lack of Efficacy|4|||
129819646|NCT01599234|467302718|FG000|Overall Study|Unable to operate spray|1|||
129819647|NCT01599234|467302719|FG001|Overall Study|Unable to operate spray|0|||
129819648|NCT01599234|467302718|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
129819649|NCT01599234|467302719|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
129819650|NCT01599234|467302718|FG000|Overall Study|Death|1|||
129819651|NCT01599234|467302719|FG001|Overall Study|Death|0|||
129819652|NCT01599234|467302718|FG000|Overall Study|Patient would not stop driving|1|||
129819653|NCT01599234|467302719|FG001|Overall Study|Patient would not stop driving|0|||
129819654|NCT01599234|467302718|FG000|Overall Study|Contra-indication discovered|0|||
129819655|NCT01599234|467302719|FG001|Overall Study|Contra-indication discovered|1|||
129819656|NCT01599234|467302718|FG000|Overall Study|Pregnancy|0|||
129819657|NCT01599234|467302719|FG001|Overall Study|Pregnancy|1|||
129819658|NCT02899988|467302729|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
129819659|NCT02899988|467302730|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
129819660|NCT02899988|467302731|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819661|NCT02899988|467302732|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819662|NCT02899988|467302733|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819663|NCT02899988|467302734|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819664|NCT02899988|467302735|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819665|NCT02899988|467302736|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819666|NCT02899988|467302737|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819667|NCT02899988|467302738|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819668|NCT02899988|467302739|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129819669|NCT02899988|467302729|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
129819670|NCT02899988|467302730|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
129819671|NCT02899988|467302731|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
129819672|NCT02899988|467302732|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
129819673|NCT02899988|467302733|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129819674|NCT02899988|467302734|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
129819675|NCT02899988|467302735|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
129819676|NCT02899988|467302736|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
129819677|NCT02899988|467302737|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
129819678|NCT02899988|467302738|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
129819679|NCT02899988|467302739|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
129819680|NCT02899988|467302729|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
129819681|NCT02899988|467302730|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
129819682|NCT02899988|467302731|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
129819683|NCT02899988|467302732|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
129819684|NCT02899988|467302733|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
129819685|NCT02899988|467302734|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
129819686|NCT02899988|467302735|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
129819687|NCT02899988|467302736|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
129819688|NCT02899988|467302737|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
129819689|NCT02899988|467302738|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
129819690|NCT02899988|467302739|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
129819691|NCT02899988|467302729|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819692|NCT02899988|467302730|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819693|NCT02899988|467302731|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819694|NCT02899988|467302732|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
129819695|NCT02899988|467302733|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
129819696|NCT02899988|467302734|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819697|NCT02899988|467302735|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
129819698|NCT02899988|467302736|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819699|NCT02899988|467302737|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819700|NCT02899988|467302738|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
129819701|NCT02899988|467302739|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
129819702|NCT02899988|467302729|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819703|NCT02899988|467302730|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819704|NCT02899988|467302731|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819705|NCT02899988|467302732|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819706|NCT02899988|467302733|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819707|NCT02899988|467302734|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
129819708|NCT02899988|467302735|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819709|NCT02899988|467302736|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
129819710|NCT02899988|467302737|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819711|NCT02899988|467302738|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819712|NCT02899988|467302739|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
129819713|NCT02899988|467302729|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819714|NCT02899988|467302730|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819715|NCT02899988|467302731|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819716|NCT02899988|467302732|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819717|NCT02899988|467302733|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
129819718|NCT02899988|467302734|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819719|NCT02899988|467302735|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
129819720|NCT02899988|467302736|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
129819721|NCT02899988|467302737|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
129819722|NCT02899988|467302738|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
129819723|NCT02899988|467302739|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
129819724|NCT01401283|467302740|FG000|Overall Study|surgery cancelled|5|||
129819725|NCT01401283|467302741|FG001|Overall Study|surgery cancelled|8|||
129819726|NCT01401283|467302740|FG000|Overall Study|preoperative arrhythmia|5|||
129819727|NCT01401283|467302741|FG001|Overall Study|preoperative arrhythmia|0|||
129819728|NCT01401283|467302740|FG000|Overall Study|no central venous access|0|||
129819729|NCT01401283|467302741|FG001|Overall Study|no central venous access|1|||
129819730|NCT01401283|467302740|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
129819731|NCT01401283|467302741|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
129819732|NCT02433483|467302742|FG000|Overall Study|Unacceptable toxicity|1|||
129819733|NCT02433483|467302742|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
129819734|NCT04271605|467302746|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
129819735|NCT03342690|467302747|FG000|Overall Study|Missing Information|9|||
129819736|NCT03342690|467302747|FG000|Overall Study|Protocol Violation|16|||
129819737|NCT00085631|467302748|FG000|Overall Study|Missing Data|4|||
129819738|NCT00085631|467302749|FG001|Overall Study|Missing Data|11|||
129819739|NCT00085631|467302750|FG002|Overall Study|Missing Data|7|||
129819740|NCT00411645|467302751|FG000|Overall Study|Consent Withdrawn|13|||
129819741|NCT00411645|467302752|FG001|Overall Study|Consent Withdrawn|22|||
129819742|NCT00411645|467302751|FG000|Overall Study|Death|56|||
129819743|NCT00411645|467302752|FG001|Overall Study|Death|135|||
129819744|NCT00411645|467302751|FG000|Overall Study|Investigator/Sponsor Decision|10|||
129819745|NCT00411645|467302752|FG001|Overall Study|Investigator/Sponsor Decision|7|||
129819746|NCT00411645|467302751|FG000|Overall Study|Lost to Follow-up|2|||
129819747|NCT00411645|467302752|FG001|Overall Study|Lost to Follow-up|0|||
129819748|NCT01750242|467302755|FG000|Overall Study|Unreadable Images|3|||
129819749|NCT01025752|467302767|FG000|Overall Study|Lost to Follow-up|7|||
129819750|NCT01025752|467302768|FG001|Overall Study|Lost to Follow-up|10|||
129819751|NCT01025752|467302767|FG000|Overall Study|Physician Decision|1|||
129819752|NCT01025752|467302768|FG001|Overall Study|Physician Decision|3|||
129819753|NCT01417234|467302771|FG000|Overall Study|Subject non-compliant|3|||
129819754|NCT00023764|467302772|FG000|Overall Study|Other|1|||
129819755|NCT00023764|467302772|FG000|Overall Study|Adverse Event|4|||
129819756|NCT00023764|467302772|FG000|Overall Study|Withdrawal by Subject|1|||
129819757|NCT00023764|467302772|FG000|Overall Study|Progression of disease|6|||
129819758|NCT00023764|467302772|FG000|Overall Study|patient received other treatment|1|||
129819759|NCT00023764|467302772|FG000|Overall Study|delay in obtaining staging images|1|||
129819760|NCT04294472|467302773|FG000|Overall Study|Adverse Event|0|||
129897283|NCT03441360|467584310|FG001|Overall Study|Clinical disease progression|2|||
129819761|NCT04294472|467302774|FG001|Overall Study|Adverse Event|1|||
129819762|NCT04294472|467302775|FG002|Overall Study|Adverse Event|1|||
129819763|NCT04294472|467302773|FG000|Overall Study|Randomized but not treated|0|||
129897284|NCT03441360|467584311|FG002|Overall Study|Clinical disease progression|0|||
129897285|NCT03441360|467584309|FG000|Overall Study|Adverse Event|1|||
129897286|NCT03441360|467584310|FG001|Overall Study|Adverse Event|0|||
129897287|NCT03441360|467584311|FG002|Overall Study|Adverse Event|1|||
129897288|NCT03396835|467584312|FG000|Overall Study|Withdrawn prior to completion|1|||
129819764|NCT04294472|467302774|FG001|Overall Study|Randomized but not treated|1|||
129819765|NCT04294472|467302775|FG002|Overall Study|Randomized but not treated|1|||
129819766|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
129819767|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
129819768|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
129819769|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
129819770|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
129819771|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129819772|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
129819773|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
129819774|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Other|1|||
129819775|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Other|4|||
129819776|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Other|3|||
129819777|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Other|6|||
129819778|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
129819779|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
129819780|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
129819781|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
129819782|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
129819783|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
129819784|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
129819785|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
129819786|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129819787|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
129819788|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
129819789|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
129819790|NCT02925494|467302782|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
129819791|NCT02925494|467302783|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
129819792|NCT02925494|467302784|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
129819793|NCT02925494|467302785|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
129819794|NCT06149247|467302790|FG000|Overall Study|Adverse Event|0|||
129819795|NCT06149247|467302791|FG001|Overall Study|Adverse Event|1|||
129819796|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
129819797|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819798|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
129819799|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819800|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819801|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819802|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819803|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819804|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
129819805|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
129819806|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
129819807|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
129819808|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819809|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819810|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819811|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819812|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819813|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
129819814|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819815|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
129819816|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819817|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819818|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819819|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819820|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819821|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819822|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
129819823|NCT02289417|467302792|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
129819824|NCT02289417|467302793|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819825|NCT02289417|467302794|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819826|NCT02289417|467302795|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819827|NCT02289417|467302796|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819828|NCT02289417|467302797|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819829|NCT02289417|467302798|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819830|NCT02289417|467302799|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819831|NCT02289417|467302800|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
129819832|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819833|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
129819834|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
129819835|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
129819836|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
129819837|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
129819838|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819839|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819840|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
129819841|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819842|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819843|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
129819844|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819845|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819846|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819847|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819848|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819849|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
129819850|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819851|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
129819852|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
129819853|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
129819854|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
129819855|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
129819856|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819857|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819858|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
129819859|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819860|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819861|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
129819862|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819863|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
129819864|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
129819865|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819866|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819867|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
129819868|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819869|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819870|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819871|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819872|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819873|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819874|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
129819875|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819876|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
129819877|NCT02289417|467302792|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819878|NCT02289417|467302793|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819879|NCT02289417|467302794|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819880|NCT02289417|467302795|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
129819881|NCT02289417|467302796|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819882|NCT02289417|467302797|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819883|NCT02289417|467302798|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
129819884|NCT02289417|467302799|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819885|NCT02289417|467302800|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
129819886|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
129819887|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
129819888|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
129819889|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
129819890|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
129819891|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
129819892|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
129819893|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
129819894|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
129819895|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819896|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819897|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819898|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819899|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819900|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819901|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
129819902|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
129819903|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
129819904|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819905|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819906|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819907|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819908|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819909|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819910|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
129819911|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
129819912|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
129819913|NCT02289417|467302792|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819914|NCT02289417|467302793|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819915|NCT02289417|467302794|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819916|NCT02289417|467302795|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819917|NCT02289417|467302796|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819918|NCT02289417|467302797|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819919|NCT02289417|467302798|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819920|NCT02289417|467302799|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
129819921|NCT02289417|467302800|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
129819922|NCT04786990|467302801|FG000|Overall Study|Withdrawal by Subject|1|||
129819923|NCT04786990|467302801|FG000|Overall Study|Adverse Event|1|||
129819924|NCT04786990|467302801|FG000|Overall Study|Lost to Follow-up|1|||
129819925|NCT04786990|467302801|FG000|Overall Study|Noncompliance|1|||
129819926|NCT04786990|467302801|FG000|Overall Study|Unable to complete site visits|1|||
129819927|NCT04786990|467302801|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
129819928|NCT01782222|467302802|FG000|Overall Study|Adverse Event|4|||
129819929|NCT01782222|467302803|FG001|Overall Study|Adverse Event|5|||
129819930|NCT01782222|467302804|FG002|Overall Study|Adverse Event|3|||
129819931|NCT01782222|467302802|FG000|Overall Study|Lack of Efficacy|2|||
129819932|NCT01782222|467302803|FG001|Overall Study|Lack of Efficacy|1|||
129819933|NCT01782222|467302804|FG002|Overall Study|Lack of Efficacy|0|||
129819934|NCT01782222|467302802|FG000|Overall Study|Protocol Violation|1|||
129819935|NCT01782222|467302803|FG001|Overall Study|Protocol Violation|0|||
129819936|NCT01782222|467302804|FG002|Overall Study|Protocol Violation|0|||
129819937|NCT01782222|467302802|FG000|Overall Study|Withdrawal by Subject|1|||
129819938|NCT01782222|467302803|FG001|Overall Study|Withdrawal by Subject|4|||
129819939|NCT01782222|467302804|FG002|Overall Study|Withdrawal by Subject|1|||
129819940|NCT01782222|467302802|FG000|Overall Study|Moved to other state|0|||
129819941|NCT01782222|467302803|FG001|Overall Study|Moved to other state|1|||
129819942|NCT01782222|467302804|FG002|Overall Study|Moved to other state|0|||
129819943|NCT01500694|467302805|FG000|Overall Study|Adverse Event|4|||
129819944|NCT01500694|467302806|FG001|Overall Study|Adverse Event|3|||
129819945|NCT01500694|467302805|FG000|Overall Study|Protocol Violation|0|||
129819946|NCT01500694|467302806|FG001|Overall Study|Protocol Violation|1|||
129819947|NCT01500694|467302805|FG000|Overall Study|Withdrawal by Subject|23|||
129819948|NCT01500694|467302806|FG001|Overall Study|Withdrawal by Subject|14|||
129819949|NCT01500694|467302805|FG000|Overall Study|Lost to Follow-up|2|||
129445460|NCT04439071|465932808|FG001|Overall Study|Other than specified|3|||
129819950|NCT01500694|467302806|FG001|Overall Study|Lost to Follow-up|3|||
129819951|NCT01500694|467302805|FG000|Overall Study|Lack of Efficacy|14|||
129819952|NCT01500694|467302806|FG001|Overall Study|Lack of Efficacy|5|||
129819953|NCT01500694|467302805|FG000|Overall Study|Other|9|||
129819954|NCT01500694|467302806|FG001|Overall Study|Other|3|||
129819955|NCT00833794|467302809|FG000|Open-label Phase|Adverse Event|225|||
129819956|NCT00833794|467302810|FG001|Open-label Phase|Adverse Event|0|||
129819957|NCT00833794|467302809|FG000|Open-label Phase|Lack of Efficacy|28|||
129819958|NCT00833794|467302810|FG001|Open-label Phase|Lack of Efficacy|0|||
129819959|NCT00833794|467302809|FG000|Open-label Phase|Withdrawal by Subject|48|||
129819960|NCT00833794|467302810|FG001|Open-label Phase|Withdrawal by Subject|0|||
129819961|NCT00833794|467302809|FG000|Open-label Phase|Physician Decision|20|||
129819962|NCT00833794|467302810|FG001|Open-label Phase|Physician Decision|0|||
129819963|NCT00833794|467302809|FG000|Open-label Phase|Administrative reason|1|||
129819964|NCT00833794|467302810|FG001|Open-label Phase|Administrative reason|0|||
129819965|NCT00833794|467302809|FG000|Open-label Phase|Protocol Violation|47|||
129819966|NCT00833794|467302810|FG001|Open-label Phase|Protocol Violation|0|||
129819967|NCT00833794|467302809|FG000|Open-label Phase|Did not complete wash-out period|12|||
129819968|NCT00833794|467302810|FG001|Open-label Phase|Did not complete wash-out period|0|||
129819969|NCT00833794|467302809|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
129819970|NCT00833794|467302810|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
129819971|NCT00833794|467302809|FG000|Double-blind Phase|Adverse Event|44|||
129819972|NCT00833794|467302810|FG001|Double-blind Phase|Adverse Event|11|||
129819973|NCT00833794|467302809|FG000|Double-blind Phase|Lack of Efficacy|34|||
129819974|NCT00833794|467302810|FG001|Double-blind Phase|Lack of Efficacy|22|||
129819975|NCT00833794|467302809|FG000|Double-blind Phase|Withdrawal by Subject|23|||
129819976|NCT00833794|467302810|FG001|Double-blind Phase|Withdrawal by Subject|6|||
129819977|NCT00833794|467302809|FG000|Double-blind Phase|Physician Decision|4|||
129819978|NCT00833794|467302810|FG001|Double-blind Phase|Physician Decision|7|||
129819979|NCT00833794|467302809|FG000|Double-blind Phase|Administrative reason|1|||
129819980|NCT00833794|467302810|FG001|Double-blind Phase|Administrative reason|3|||
129819981|NCT04051008|467302811|FG000|Overall Study|Withdrawal by Subject|2|||
129819982|NCT04051008|467302812|FG001|Overall Study|Withdrawal by Subject|0|||
129819983|NCT04051008|467302813|FG002|Overall Study|Withdrawal by Subject|1|||
129819984|NCT03310775|467302823|FG000|Overall Study|Lost to Follow-up|2|||
129819985|NCT03310775|467302824|FG001|Overall Study|Lost to Follow-up|3|||
129819986|NCT03310775|467302823|FG000|Overall Study|aggravation of depression|0|||
129819987|NCT03310775|467302824|FG001|Overall Study|aggravation of depression|1|||
129819988|NCT00600483|467302825|FG000|Overall Study|Lost to Follow-up|26|||
129819989|NCT00600483|467302826|FG001|Overall Study|Lost to Follow-up|47|||
129819990|NCT00600483|467302825|FG000|Overall Study|Randomized but not treated|10|||
129819991|NCT00600483|467302826|FG001|Overall Study|Randomized but not treated|0|||
129819992|NCT01482884|467302827|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
129819993|NCT01482884|467302828|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
129819994|NCT01482884|467302827|FG000|Overall Study|Protocol Violation|1|||
129819995|NCT01482884|467302828|FG001|Overall Study|Protocol Violation|0|||
129819996|NCT01482884|467302827|FG000|Overall Study|Lost to Follow-up|2|||
129819997|NCT01482884|467302828|FG001|Overall Study|Lost to Follow-up|2|||
129819998|NCT01482884|467302827|FG000|Overall Study|Lack of Efficacy|0|||
129819999|NCT01482884|467302828|FG001|Overall Study|Lack of Efficacy|1|||
129820000|NCT01482884|467302827|FG000|Overall Study|Adverse Event|2|||
129820001|NCT01482884|467302828|FG001|Overall Study|Adverse Event|1|||
129820002|NCT01482884|467302827|FG000|Overall Study|Withdrawal by Subject|8|||
129820003|NCT01482884|467302828|FG001|Overall Study|Withdrawal by Subject|13|||
129820004|NCT00580606|467302829|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
129820005|NCT00580606|467302830|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
129820006|NCT00580606|467302829|FG000|Open Label (OL)|Withdrawal by Subject|4|||
129820007|NCT00580606|467302830|FG001|Open Label (OL)|Withdrawal by Subject|6|||
129820008|NCT00580606|467302829|FG000|Open Label (OL)|Dosing Symptoms|0|||
129445461|NCT04439071|465932807|FG000|Overall Study|Randomized but not treated|2|||
129820009|NCT00580606|467302830|FG001|Open Label (OL)|Dosing Symptoms|1|||
129820010|NCT00580606|467302829|FG000|Open Label (OL)|Lost to Follow-up|0|||
129820011|NCT00580606|467302830|FG001|Open Label (OL)|Lost to Follow-up|1|||
129445462|NCT04439071|465932808|FG001|Overall Study|Randomized but not treated|0|||
129445463|NCT03085758|465932809|FG000|Overall Study|Death|26|||
129445464|NCT03085758|465932810|FG001|Overall Study|Death|24|||
129445465|NCT03085758|465932811|FG002|Overall Study|Death|53|||
129445466|NCT03085758|465932809|FG000|Overall Study|Lost to Follow-up|1|||
129445467|NCT03085758|465932810|FG001|Overall Study|Lost to Follow-up|1|||
129445468|NCT03085758|465932811|FG002|Overall Study|Lost to Follow-up|1|||
129445469|NCT03085758|465932809|FG000|Overall Study|Withdrawal by Subject|2|||
129445470|NCT03085758|465932810|FG001|Overall Study|Withdrawal by Subject|2|||
129445471|NCT03085758|465932811|FG002|Overall Study|Withdrawal by Subject|1|||
129445472|NCT03085758|465932809|FG000|Overall Study|Refusal to recall it up to day 90|0|||
129445473|NCT03085758|465932810|FG001|Overall Study|Refusal to recall it up to day 90|0|||
129445474|NCT03085758|465932811|FG002|Overall Study|Refusal to recall it up to day 90|1|||
129445475|NCT03085758|465932809|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
129445476|NCT03085758|465932810|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
129445477|NCT03085758|465932811|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
129445478|NCT04004429|465932814|FG000|Overall Study|Protocol Violation|1|||
129445479|NCT04004429|465932815|FG001|Overall Study|Protocol Violation|0|||
129445480|NCT04004429|465932816|FG002|Overall Study|Protocol Violation|0|||
129445481|NCT04004429|465932814|FG000|Overall Study|Physician Decision|0|||
129445482|NCT04004429|465932815|FG001|Overall Study|Physician Decision|1|||
129445483|NCT04004429|465932816|FG002|Overall Study|Physician Decision|1|||
129445484|NCT04004429|465932814|FG000|Overall Study|Withdrawal by Subject|1|||
129445485|NCT04004429|465932815|FG001|Overall Study|Withdrawal by Subject|1|||
129445486|NCT04004429|465932816|FG002|Overall Study|Withdrawal by Subject|1|||
129445487|NCT01122576|465932817|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
129445488|NCT01122576|465932818|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
129445489|NCT01122576|465932819|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
129445490|NCT01122576|465932817|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
129445491|NCT01122576|465932818|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
129445492|NCT01122576|465932819|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
129445493|NCT01122576|465932817|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
129445494|NCT01122576|465932818|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
129445495|NCT01122576|465932819|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
129445496|NCT00381563|465932824|FG000|Overall Study|Withdrawal by Subject|5|||
129445497|NCT00381563|465932825|FG001|Overall Study|Withdrawal by Subject|5|||
129445498|NCT00381563|465932824|FG000|Overall Study|Lost to Follow-up|2|||
129445499|NCT00381563|465932825|FG001|Overall Study|Lost to Follow-up|0|||
129445500|NCT00381563|465932824|FG000|Overall Study|Protocol Violation|0|||
129445501|NCT00381563|465932825|FG001|Overall Study|Protocol Violation|1|||
129445502|NCT00931944|465932827|FG000|Overall Study|Adverse Event|4|||
129445503|NCT00931944|465932827|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
129445504|NCT00931944|465932827|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
129445505|NCT00931944|465932827|FG000|Overall Study|Death|28|||
129445506|NCT00931944|465932827|FG000|Overall Study|Other|2|||
129445507|NCT01109173|465932828|FG000|Overall Study|Adverse Event|15|||
129445508|NCT01109173|465932829|FG001|Overall Study|Adverse Event|17|||
129445509|NCT01109173|465932830|FG002|Overall Study|Adverse Event|9|||
129445510|NCT01109173|465932831|FG003|Overall Study|Adverse Event|6|||
129445511|NCT01109173|465932828|FG000|Overall Study|Lost to Follow-up|0|||
129820012|NCT00580606|467302829|FG000|Open Label (OL)|Pregnancy|0|||
129820013|NCT00580606|467302830|FG001|Open Label (OL)|Pregnancy|1|||
129820014|NCT00580606|467302829|FG000|Open Label (OL)|Non-compliance|2|||
129820015|NCT00580606|467302830|FG001|Open Label (OL)|Non-compliance|0|||
129820016|NCT00580606|467302829|FG000|Open Label (OL)|Physician Decision|1|||
129820017|NCT00580606|467302830|FG001|Open Label (OL)|Physician Decision|1|||
129820018|NCT00580606|467302829|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
129820019|NCT00580606|467302830|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
129820020|NCT03655691|467302833|FG000|Overall Study|Adverse Event|0|||
129820021|NCT03655691|467302834|FG001|Overall Study|Adverse Event|0|||
129820022|NCT03655691|467302835|FG002|Overall Study|Adverse Event|1|||
129820023|NCT03655691|467302833|FG000|Overall Study|Lost to Follow-up|1|||
129820024|NCT03655691|467302834|FG001|Overall Study|Lost to Follow-up|1|||
129820025|NCT03655691|467302835|FG002|Overall Study|Lost to Follow-up|2|||
129820026|NCT03655691|467302833|FG000|Overall Study|Protocol Violation|0|||
129820027|NCT03655691|467302834|FG001|Overall Study|Protocol Violation|1|||
129820028|NCT03655691|467302835|FG002|Overall Study|Protocol Violation|0|||
129820029|NCT03655691|467302833|FG000|Overall Study|Withdrawal by Subject|1|||
129820030|NCT03655691|467302834|FG001|Overall Study|Withdrawal by Subject|1|||
129445512|NCT01109173|465932829|FG001|Overall Study|Lost to Follow-up|1|||
129820031|NCT03655691|467302835|FG002|Overall Study|Withdrawal by Subject|0|||
129820032|NCT01325584|467302838|FG000|Overall Study|Death|1|||
129820033|NCT00887978|467302839|FG000|Overall Study|Adverse Event|18|||
129820034|NCT00887978|467302840|FG001|Overall Study|Adverse Event|5|||
129445513|NCT01109173|465932830|FG002|Overall Study|Lost to Follow-up|0|||
129445514|NCT01109173|465932831|FG003|Overall Study|Lost to Follow-up|0|||
129445515|NCT01109173|465932828|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
129820035|NCT00887978|467302839|FG000|Overall Study|Clinical Worsening|4|||
129820036|NCT00887978|467302840|FG001|Overall Study|Clinical Worsening|4|||
129820037|NCT00887978|467302839|FG000|Overall Study|Death|2|||
129820038|NCT00887978|467302840|FG001|Overall Study|Death|3|||
129820039|NCT00887978|467302839|FG000|Overall Study|Withdrawal by Subject|1|||
129820040|NCT00887978|467302840|FG001|Overall Study|Withdrawal by Subject|2|||
129820041|NCT00887978|467302839|FG000|Overall Study|Lost to Follow-up|0|||
129820042|NCT00887978|467302840|FG001|Overall Study|Lost to Follow-up|1|||
129820043|NCT05353985|467302847|FG000|Overall Study|Adverse Event|5|||
129820044|NCT05353985|467302848|FG001|Overall Study|Adverse Event|7|||
129820045|NCT05353985|467302847|FG000|Overall Study|Lost to Follow-up|1|||
129820046|NCT05353985|467302848|FG001|Overall Study|Lost to Follow-up|1|||
129820047|NCT05353985|467302847|FG000|Overall Study|Protocol Violation|1|||
129820048|NCT05353985|467302848|FG001|Overall Study|Protocol Violation|0|||
129820049|NCT05353985|467302847|FG000|Overall Study|Withdrawal by Subject|13|||
129820050|NCT05353985|467302848|FG001|Overall Study|Withdrawal by Subject|17|||
129820051|NCT05353985|467302847|FG000|Overall Study|Reason Not Specified|1|||
129820052|NCT05353985|467302848|FG001|Overall Study|Reason Not Specified|0|||
129820053|NCT05353985|467302847|FG000|Overall Study|Randomized in Error & Not Treated|0|||
129820054|NCT05353985|467302848|FG001|Overall Study|Randomized in Error & Not Treated|1|||
129820055|NCT00793403|467304703|FG000|Overall Study|Other|73|||
129820056|NCT00842712|467304704|FG000|Safety Run-in Part|Adverse Event|0|||
129820057|NCT00842712|467304705|FG001|Safety Run-in Part|Adverse Event|1|||
129820058|NCT00842712|467304706|FG002|Safety Run-in Part|Adverse Event|0|||
129820059|NCT00842712|467304707|FG003|Safety Run-in Part|Adverse Event|0|||
129820060|NCT00842712|467304708|FG004|Safety Run-in Part|Adverse Event|0|||
129820061|NCT00842712|467304709|FG005|Safety Run-in Part|Adverse Event|0|||
129820062|NCT00842712|467304710|FG006|Safety Run-in Part|Adverse Event|0|||
129820063|NCT00842712|467304704|FG000|Safety Run-in Part|Progressive disease|3|||
129820064|NCT00842712|467304705|FG001|Safety Run-in Part|Progressive disease|1|||
129820065|NCT00842712|467304706|FG002|Safety Run-in Part|Progressive disease|0|||
129820066|NCT00842712|467304707|FG003|Safety Run-in Part|Progressive disease|1|||
129820067|NCT00842712|467304708|FG004|Safety Run-in Part|Progressive disease|0|||
129820068|NCT00842712|467304709|FG005|Safety Run-in Part|Progressive disease|0|||
129820069|NCT00842712|467304710|FG006|Safety Run-in Part|Progressive disease|0|||
129820070|NCT00842712|467304704|FG000|Randomized Part|Randomized but not treated|0|||
129820071|NCT00842712|467304705|FG001|Randomized Part|Randomized but not treated|0|||
129820072|NCT00842712|467304706|FG002|Randomized Part|Randomized but not treated|0|||
129820073|NCT00842712|467304707|FG003|Randomized Part|Randomized but not treated|0|||
129820074|NCT00842712|467304708|FG004|Randomized Part|Randomized but not treated|0|||
129820075|NCT00842712|467304709|FG005|Randomized Part|Randomized but not treated|1|||
129820076|NCT00842712|467304710|FG006|Randomized Part|Randomized but not treated|4|||
129820077|NCT00842712|467304704|FG000|Randomized Part|Ongoing at cut-off date|0|||
129820078|NCT00842712|467304705|FG001|Randomized Part|Ongoing at cut-off date|0|||
129820079|NCT00842712|467304706|FG002|Randomized Part|Ongoing at cut-off date|0|||
129820080|NCT00842712|467304707|FG003|Randomized Part|Ongoing at cut-off date|0|||
129820081|NCT00842712|467304708|FG004|Randomized Part|Ongoing at cut-off date|0|||
129820082|NCT00842712|467304709|FG005|Randomized Part|Ongoing at cut-off date|0|||
129820083|NCT00842712|467304710|FG006|Randomized Part|Ongoing at cut-off date|2|||
129820084|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820085|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820086|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820087|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
129820088|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
129820089|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
129820090|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820091|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820092|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820093|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
129820094|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Other|1|||
129820095|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Other|1|||
129820096|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Other|0|||
129820097|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Other|0|||
129820098|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Other|0|||
129820099|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
129820100|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
129820101|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
129820102|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
129820103|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
129820104|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820105|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820106|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820107|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
129820108|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
129820109|NCT02310568|467304712|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129897289|NCT03396835|467584312|FG000|Overall Study|Did not meet criteria for data analysis|1|||
129820110|NCT02310568|467304713|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129820111|NCT02310568|467304714|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129820112|NCT02310568|467304715|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
129820113|NCT02310568|467304716|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
129820114|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
129820115|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
129820116|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
129820117|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
129820118|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
129820119|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Other|0|||
129820120|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Other|1|||
129820121|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Other|1|||
129820122|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Other|0|||
129820123|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Other|0|||
129820124|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
129820125|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
129820126|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
129820127|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
129820128|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
129820129|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820130|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820131|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820132|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
129820133|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
129820134|NCT02310568|467304712|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820135|NCT02310568|467304713|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820136|NCT02310568|467304714|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820137|NCT02310568|467304715|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
129820138|NCT02310568|467304716|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
129820139|NCT01384760|467304717|FG000|Overall Study|Lost to Follow-up|0|||
129820140|NCT01384760|467304718|FG001|Overall Study|Lost to Follow-up|6|||
129820141|NCT01384760|467304717|FG000|Overall Study|Protocol Violation|16|||
129820142|NCT01384760|467304718|FG001|Overall Study|Protocol Violation|0|||
129820143|NCT00963547|467304719|FG000|Overall Study|Adverse Event|0|||
129820144|NCT00963547|467304720|FG001|Overall Study|Adverse Event|1|||
129820145|NCT00963547|467304721|FG002|Overall Study|Adverse Event|0|||
129820146|NCT00963547|467304722|FG003|Overall Study|Adverse Event|1|||
129820147|NCT00963547|467304723|FG004|Overall Study|Adverse Event|0|||
129820148|NCT00963547|467304724|FG005|Overall Study|Adverse Event|0|||
129820149|NCT00963547|467304725|FG006|Overall Study|Adverse Event|0|||
129820150|NCT00963547|467304719|FG000|Overall Study|Physician Decision|1|||
129820151|NCT00963547|467304720|FG001|Overall Study|Physician Decision|1|||
129820152|NCT00963547|467304721|FG002|Overall Study|Physician Decision|0|||
129820153|NCT00963547|467304722|FG003|Overall Study|Physician Decision|0|||
129820154|NCT00963547|467304723|FG004|Overall Study|Physician Decision|0|||
129820155|NCT00963547|467304724|FG005|Overall Study|Physician Decision|0|||
129820156|NCT00963547|467304725|FG006|Overall Study|Physician Decision|0|||
129820157|NCT00963547|467304719|FG000|Overall Study|Progressive Disease|3|||
129820158|NCT00963547|467304720|FG001|Overall Study|Progressive Disease|8|||
129820159|NCT00963547|467304721|FG002|Overall Study|Progressive Disease|9|||
129820160|NCT00963547|467304722|FG003|Overall Study|Progressive Disease|5|||
129820161|NCT00963547|467304723|FG004|Overall Study|Progressive Disease|0|||
129820162|NCT00963547|467304724|FG005|Overall Study|Progressive Disease|0|||
129820163|NCT00963547|467304725|FG006|Overall Study|Progressive Disease|0|||
129820164|NCT00963547|467304719|FG000|Overall Study|Withdrawal by Subject|0|||
129820165|NCT00963547|467304720|FG001|Overall Study|Withdrawal by Subject|0|||
129820166|NCT00963547|467304721|FG002|Overall Study|Withdrawal by Subject|3|||
129820167|NCT00963547|467304722|FG003|Overall Study|Withdrawal by Subject|0|||
129820168|NCT00963547|467304723|FG004|Overall Study|Withdrawal by Subject|0|||
129820169|NCT00963547|467304724|FG005|Overall Study|Withdrawal by Subject|0|||
129820170|NCT00963547|467304725|FG006|Overall Study|Withdrawal by Subject|0|||
129820171|NCT00963547|467304719|FG000|Overall Study|Reason Unknown|0|||
129820172|NCT00963547|467304720|FG001|Overall Study|Reason Unknown|1|||
129820173|NCT00963547|467304721|FG002|Overall Study|Reason Unknown|0|||
129820174|NCT00963547|467304722|FG003|Overall Study|Reason Unknown|0|||
129820175|NCT00963547|467304723|FG004|Overall Study|Reason Unknown|0|||
129820176|NCT00963547|467304724|FG005|Overall Study|Reason Unknown|0|||
129820177|NCT00963547|467304725|FG006|Overall Study|Reason Unknown|0|||
129820178|NCT00660023|467304731|FG000|Overall Study|Adverse Event|2|||
129820179|NCT00660023|467304731|FG000|Overall Study|Death|8|||
129820180|NCT00660023|467304731|FG000|Overall Study|Blood Transfusion|5|||
129820181|NCT00660023|467304731|FG000|Overall Study|Renal Transplantation|3|||
129820182|NCT00660023|467304731|FG000|Overall Study|Withdrawal by Subject|1|||
129820183|NCT00660023|467304731|FG000|Overall Study|Missed Pregnancy Test|1|||
129820184|NCT00660023|467304731|FG000|Overall Study|Other Screening Failure|9|||
129820185|NCT04180488|467304732|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
129820186|NCT04180488|467304733|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
129897290|NCT03467724|467584313|FG000|Overall Study|Lost to Follow-up|5|||
129820187|NCT04180488|467304734|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
129820188|NCT04180488|467304735|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
129820189|NCT04180488|467304736|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
129820190|NCT04180488|467304737|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
129820191|NCT04180488|467304732|FG000|Overall Study|Withdrawal by Subject|8|||
129820192|NCT04180488|467304733|FG001|Overall Study|Withdrawal by Subject|4|||
129820193|NCT04180488|467304734|FG002|Overall Study|Withdrawal by Subject|5|||
129820194|NCT04180488|467304735|FG003|Overall Study|Withdrawal by Subject|2|||
129820195|NCT04180488|467304736|FG004|Overall Study|Withdrawal by Subject|8|||
129820196|NCT04180488|467304737|FG005|Overall Study|Withdrawal by Subject|6|||
129820197|NCT04180488|467304732|FG000|Overall Study|Adverse Event|3|||
129820198|NCT04180488|467304733|FG001|Overall Study|Adverse Event|2|||
129820199|NCT04180488|467304734|FG002|Overall Study|Adverse Event|0|||
129820200|NCT04180488|467304735|FG003|Overall Study|Adverse Event|0|||
129820201|NCT04180488|467304736|FG004|Overall Study|Adverse Event|0|||
129820202|NCT04180488|467304737|FG005|Overall Study|Adverse Event|0|||
129820203|NCT04180488|467304732|FG000|Overall Study|Poor compliance to protocol|0|||
129820204|NCT04180488|467304733|FG001|Overall Study|Poor compliance to protocol|0|||
129820205|NCT04180488|467304734|FG002|Overall Study|Poor compliance to protocol|1|||
129820206|NCT04180488|467304735|FG003|Overall Study|Poor compliance to protocol|0|||
129820207|NCT04180488|467304736|FG004|Overall Study|Poor compliance to protocol|0|||
129820208|NCT04180488|467304737|FG005|Overall Study|Poor compliance to protocol|0|||
129820209|NCT01327885|467304743|FG000|Overall Study|Disease progression-according to RECIST|173|||
129820210|NCT01327885|467304744|FG001|Overall Study|Disease progression-according to RECIST|165|||
129820211|NCT01327885|467304743|FG000|Overall Study|Clinical progression|24|||
129820212|NCT01327885|467304744|FG001|Overall Study|Clinical progression|27|||
129820213|NCT01327885|467304743|FG000|Overall Study|Adverse Event|14|||
129820214|NCT01327885|467304744|FG001|Overall Study|Adverse Event|10|||
129820215|NCT01327885|467304743|FG000|Overall Study|Subject choice|5|||
129820216|NCT01327885|467304744|FG001|Overall Study|Subject choice|10|||
129820217|NCT01327885|467304743|FG000|Overall Study|Other|8|||
129820218|NCT01327885|467304744|FG001|Overall Study|Other|6|||
129820219|NCT01327885|467304743|FG000|Overall Study|Withdrawal of consent from study|3|||
129820220|NCT01327885|467304744|FG001|Overall Study|Withdrawal of consent from study|4|||
129820221|NCT01327885|467304743|FG000|Overall Study|Not treated|1|||
129820222|NCT01327885|467304744|FG001|Overall Study|Not treated|1|||
129820223|NCT01327885|467304743|FG000|Overall Study|Administrative decision|0|||
129820224|NCT01327885|467304744|FG001|Overall Study|Administrative decision|1|||
129820225|NCT03824912|467304747|FG000|Overall Study|Lost to Follow-up|18|||
129820226|NCT03824912|467304748|FG001|Overall Study|Lost to Follow-up|15|||
129820227|NCT03824912|467304749|FG002|Overall Study|Lost to Follow-up|8|||
129820228|NCT03824912|467304747|FG000|Overall Study|Negative Baseline Culture Result|118|||
129820229|NCT03824912|467304748|FG001|Overall Study|Negative Baseline Culture Result|112|||
129820230|NCT03824912|467304749|FG002|Overall Study|Negative Baseline Culture Result|57|||
129820231|NCT03824912|467304747|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129820232|NCT03824912|467304748|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129820233|NCT03824912|467304749|FG002|Overall Study|Non-Compliance with Study Drug|1|||
129820234|NCT03824912|467304747|FG000|Overall Study|Protocol Violation|1|||
129820235|NCT03824912|467304748|FG001|Overall Study|Protocol Violation|4|||
129820236|NCT03824912|467304749|FG002|Overall Study|Protocol Violation|1|||
129820237|NCT03824912|467304747|FG000|Overall Study|Withdrawal by Subject|3|||
129820238|NCT03824912|467304748|FG001|Overall Study|Withdrawal by Subject|2|||
129820239|NCT03824912|467304749|FG002|Overall Study|Withdrawal by Subject|1|||
129820240|NCT03824912|467304747|FG000|Overall Study|Participation in another study|0|||
129820241|NCT03824912|467304748|FG001|Overall Study|Participation in another study|1|||
129820242|NCT03824912|467304749|FG002|Overall Study|Participation in another study|0|||
129820243|NCT02511184|467304750|FG000|Overall Study|Death|1|||
129820244|NCT02511184|467304751|FG001|Overall Study|Death|0|||
129820245|NCT02511184|467304750|FG000|Overall Study|Lost to Follow-up|0|||
129820246|NCT02511184|467304751|FG001|Overall Study|Lost to Follow-up|1|||
129820247|NCT02511184|467304750|FG000|Overall Study|Study terminated by sponsor|1|||
129820248|NCT02511184|467304751|FG001|Overall Study|Study terminated by sponsor|5|||
129820249|NCT02511184|467304750|FG000|Overall Study|Withdrawal by Subject|0|||
129820250|NCT02511184|467304751|FG001|Overall Study|Withdrawal by Subject|1|||
129820251|NCT01963403|467304754|FG000|Overall Study|Lost to Follow-up|2|||
129820252|NCT01963403|467304755|FG001|Overall Study|Lost to Follow-up|3|||
129820253|NCT01963403|467304754|FG000|Overall Study|Implant removal|0|||
129820254|NCT01963403|467304755|FG001|Overall Study|Implant removal|1|||
129897291|NCT03467724|467584313|FG000|Overall Study|Withdrawal by Subject|1|||
129820255|NCT00549302|467304758|FG000|Double-Blind|Death|2|||
129820256|NCT00549302|467304759|FG001|Double-Blind|Death|9|||
129820257|NCT00549302|467304760|FG002|Double-Blind|Death|0|||
129820258|NCT00549302|467304758|FG000|Double-Blind|Adverse Event|3|||
129820259|NCT00549302|467304759|FG001|Double-Blind|Adverse Event|16|||
129820260|NCT00549302|467304760|FG002|Double-Blind|Adverse Event|0|||
129820261|NCT00549302|467304758|FG000|Double-Blind|Withdrawal by Subject|3|||
129820262|NCT00549302|467304759|FG001|Double-Blind|Withdrawal by Subject|8|||
129820263|NCT00549302|467304760|FG002|Double-Blind|Withdrawal by Subject|0|||
129820264|NCT00549302|467304758|FG000|Double-Blind|Investigator Decision|1|||
129820265|NCT00549302|467304759|FG001|Double-Blind|Investigator Decision|5|||
129820266|NCT00549302|467304760|FG002|Double-Blind|Investigator Decision|0|||
129820267|NCT00549302|467304758|FG000|Double-Blind|Sponsor Decision|0|||
129820268|NCT00549302|467304759|FG001|Double-Blind|Sponsor Decision|1|||
129820269|NCT00549302|467304760|FG002|Double-Blind|Sponsor Decision|0|||
129820270|NCT00549302|467304758|FG000|Double-Blind|Lost to Follow-up|1|||
129820271|NCT00549302|467304759|FG001|Double-Blind|Lost to Follow-up|2|||
129820272|NCT00549302|467304760|FG002|Double-Blind|Lost to Follow-up|0|||
129820273|NCT00549302|467304758|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
129820274|NCT00549302|467304759|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
129820275|NCT00549302|467304760|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
129820276|NCT00549302|467304758|FG000|Double-Blind|New condition or starts new therapy|0|||
129820277|NCT00549302|467304759|FG001|Double-Blind|New condition or starts new therapy|2|||
129820278|NCT00549302|467304760|FG002|Double-Blind|New condition or starts new therapy|0|||
129820279|NCT00549302|467304758|FG000|Open-Label|Adverse Event|0|||
129820280|NCT00549302|467304759|FG001|Open-Label|Adverse Event|0|||
129820281|NCT00549302|467304760|FG002|Open-Label|Adverse Event|11|||
129820282|NCT00549302|467304758|FG000|Open-Label|Death|0|||
129820283|NCT00549302|467304759|FG001|Open-Label|Death|0|||
129820284|NCT00549302|467304760|FG002|Open-Label|Death|40|||
129820285|NCT00549302|467304758|FG000|Open-Label|Investigator Decision|0|||
129820286|NCT00549302|467304759|FG001|Open-Label|Investigator Decision|0|||
129820287|NCT00549302|467304760|FG002|Open-Label|Investigator Decision|5|||
129820288|NCT00549302|467304758|FG000|Open-Label|Lost to Follow-up|0|||
129820289|NCT00549302|467304759|FG001|Open-Label|Lost to Follow-up|0|||
129820290|NCT00549302|467304760|FG002|Open-Label|Lost to Follow-up|2|||
129820291|NCT00549302|467304758|FG000|Open-Label|Other|0|||
129820292|NCT00549302|467304759|FG001|Open-Label|Other|0|||
129820293|NCT00549302|467304760|FG002|Open-Label|Other|3|||
129820294|NCT00549302|467304758|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
129820295|NCT00549302|467304759|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
129820296|NCT00549302|467304760|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
129820297|NCT00549302|467304758|FG000|Open-Label|Withdrawal by Subject|0|||
129820298|NCT00549302|467304759|FG001|Open-Label|Withdrawal by Subject|0|||
129820299|NCT00549302|467304760|FG002|Open-Label|Withdrawal by Subject|6|||
129820300|NCT03585504|467304761|FG000|Overall Study|Lost to Follow-up|26|||
129820301|NCT03585504|467304762|FG001|Overall Study|Lost to Follow-up|29|||
129820302|NCT01414114|467304763|FG000|Overall Study|Adverse Event|2|||
129820303|NCT01414114|467304763|FG000|Overall Study|Withdrawal by Subject|1|||
129820304|NCT01414114|467304763|FG000|Overall Study|Other|2|||
129820305|NCT00105482|467304764|FG000|Overall Study|Adverse Event|1|||
129820306|NCT00105482|467304765|FG001|Overall Study|Adverse Event|1|||
129820307|NCT00105482|467304764|FG000|Overall Study|Lost to Follow-up|26|||
129820308|NCT00105482|467304765|FG001|Overall Study|Lost to Follow-up|17|||
129820309|NCT00105482|467304764|FG000|Overall Study|Withdrawal by Subject|0|||
129820310|NCT00105482|467304765|FG001|Overall Study|Withdrawal by Subject|1|||
129820311|NCT00105482|467304764|FG000|Overall Study|Lost Interest|29|||
129820312|NCT00105482|467304765|FG001|Overall Study|Lost Interest|32|||
129820313|NCT00105482|467304764|FG000|Overall Study|Scheduling Conflict|2|||
129820314|NCT00105482|467304765|FG001|Overall Study|Scheduling Conflict|3|||
129820315|NCT00105482|467304764|FG000|Overall Study|Withdrawn by PI|1|||
129820316|NCT00105482|467304765|FG001|Overall Study|Withdrawn by PI|1|||
129820317|NCT05620563|467304766|FG000|Overall Study|Adverse Event|3|||
129820318|NCT05620563|467304767|FG001|Overall Study|Adverse Event|1|||
129820319|NCT05620563|467304766|FG000|Overall Study|Lost to Follow-up|0|||
129820320|NCT05620563|467304767|FG001|Overall Study|Lost to Follow-up|2|||
129820321|NCT05620563|467304766|FG000|Overall Study|Protocol Deviation|1|||
129820322|NCT05620563|467304767|FG001|Overall Study|Protocol Deviation|2|||
129897292|NCT03467724|467584313|FG000|Overall Study|Protocol Violation|1|||
129897293|NCT03467724|467584313|FG000|Overall Study|Adverse Event|1|||
129820323|NCT05620563|467304766|FG000|Overall Study|Withdrawal by Subject|3|||
129820324|NCT05620563|467304767|FG001|Overall Study|Withdrawal by Subject|3|||
129820325|NCT05620563|467304766|FG000|Overall Study|Physician Decision|0|||
129820326|NCT05620563|467304767|FG001|Overall Study|Physician Decision|1|||
129820327|NCT02085785|467304772|FG000|Overall Study|Withdrawal by Subject|2|||
129820328|NCT02085785|467304773|FG001|Overall Study|Withdrawal by Subject|1|||
129820329|NCT02085785|467304772|FG000|Overall Study|Lost to Follow-up|0|||
129820330|NCT02085785|467304773|FG001|Overall Study|Lost to Follow-up|1|||
129820331|NCT00779467|467304774|FG000|Overall Study|Lack of Efficacy|11|||
129820332|NCT00779467|467304775|FG001|Overall Study|Lack of Efficacy|2|||
129820333|NCT00779467|467304776|FG002|Overall Study|Lack of Efficacy|6|||
129820334|NCT00779467|467304777|FG003|Overall Study|Lack of Efficacy|11|||
129820335|NCT00779467|467304774|FG000|Overall Study|failed inclusion criteria|3|||
129820336|NCT00779467|467304775|FG001|Overall Study|failed inclusion criteria|3|||
129820337|NCT00779467|467304776|FG002|Overall Study|failed inclusion criteria|1|||
129820338|NCT00779467|467304777|FG003|Overall Study|failed inclusion criteria|2|||
129820339|NCT00779467|467304774|FG000|Overall Study|missing data|1|||
129820340|NCT00779467|467304775|FG001|Overall Study|missing data|0|||
129820341|NCT00779467|467304776|FG002|Overall Study|missing data|1|||
129820342|NCT00779467|467304777|FG003|Overall Study|missing data|4|||
129820343|NCT00779467|467304774|FG000|Overall Study|technical issue|0|||
129820344|NCT00779467|467304775|FG001|Overall Study|technical issue|0|||
129820345|NCT00779467|467304776|FG002|Overall Study|technical issue|2|||
129820346|NCT00779467|467304777|FG003|Overall Study|technical issue|1|||
129820347|NCT00779467|467304774|FG000|Overall Study|unavailable research staff|0|||
129820348|NCT00779467|467304775|FG001|Overall Study|unavailable research staff|0|||
129820349|NCT00779467|467304776|FG002|Overall Study|unavailable research staff|0|||
129820350|NCT00779467|467304777|FG003|Overall Study|unavailable research staff|1|||
129820351|NCT02692703|467304778|FG000|Overall Study|Lost to Follow-up|1|||
129820352|NCT02692703|467304778|FG000|Overall Study|Other|1|||
129820353|NCT04118166|467304779|FG000|Overall Study|Adverse Event|1|||
129820354|NCT05048784|467304780|FG000|Period 1|Adverse Event|3|||
129820355|NCT05048784|467304781|FG001|Period 1|Adverse Event|1|||
129820356|NCT05048784|467304782|FG002|Period 1|Adverse Event|0|||
129820357|NCT05048784|467304783|FG003|Period 1|Adverse Event|0|||
129820358|NCT05048784|467304780|FG000|Period 2|Lost to Follow-up|0|||
129820359|NCT05048784|467304781|FG001|Period 2|Lost to Follow-up|1|||
129820360|NCT05048784|467304782|FG002|Period 2|Lost to Follow-up|0|||
129820361|NCT05048784|467304783|FG003|Period 2|Lost to Follow-up|0|||
129820362|NCT04016285|467304786|FG000|Overall Study|Did not progress to surgery|2|||
129820363|NCT04016285|467304787|FG001|Overall Study|Did not progress to surgery|5|||
129820364|NCT04016285|467304786|FG000|Overall Study|Failed to collect outcome data|5|||
129820365|NCT04016285|467304787|FG001|Overall Study|Failed to collect outcome data|3|||
129820366|NCT00284050|467304789|FG000|Overall Study|Adverse Event|1|||
129820367|NCT00284050|467304790|FG001|Overall Study|Adverse Event|1|||
129820368|NCT00284050|467304791|FG002|Overall Study|Adverse Event|1|||
129820369|NCT00284050|467304789|FG000|Overall Study|Lack of Efficacy|0|||
129820370|NCT00284050|467304790|FG001|Overall Study|Lack of Efficacy|1|||
129820371|NCT00284050|467304791|FG002|Overall Study|Lack of Efficacy|3|||
129820372|NCT00284050|467304789|FG000|Overall Study|Protocol Violation|0|||
129820373|NCT00284050|467304790|FG001|Overall Study|Protocol Violation|1|||
129820374|NCT00284050|467304791|FG002|Overall Study|Protocol Violation|2|||
129820375|NCT00284050|467304789|FG000|Overall Study|Withdrawal by Subject|2|||
129820376|NCT00284050|467304790|FG001|Overall Study|Withdrawal by Subject|2|||
129820377|NCT00284050|467304791|FG002|Overall Study|Withdrawal by Subject|2|||
129820378|NCT00284050|467304789|FG000|Overall Study|Lost to Follow-up|1|||
129820379|NCT00284050|467304790|FG001|Overall Study|Lost to Follow-up|0|||
129820380|NCT00284050|467304791|FG002|Overall Study|Lost to Follow-up|1|||
129820381|NCT00284050|467304789|FG000|Overall Study|Death|1|||
129820382|NCT00284050|467304790|FG001|Overall Study|Death|0|||
129820383|NCT00284050|467304791|FG002|Overall Study|Death|0|||
129820384|NCT02573350|467304793|FG000|Overall Study|Lost to Follow-up|2|||
129820385|NCT02573350|467304794|FG001|Overall Study|Lost to Follow-up|1|||
129820386|NCT02573350|467304793|FG000|Overall Study|Adverse Event|3|||
129820387|NCT02573350|467304794|FG001|Overall Study|Adverse Event|4|||
129820388|NCT02573350|467304793|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
129820389|NCT02573350|467304794|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
129820390|NCT02573350|467304793|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
129820391|NCT02573350|467304794|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
129820392|NCT02573350|467304793|FG000|Overall Study|Subject withdrew consent to participate|6|||
129820393|NCT02573350|467304794|FG001|Overall Study|Subject withdrew consent to participate|1|||
129820394|NCT02573350|467304793|FG000|Overall Study|Protocol Deviation|1|||
129820395|NCT02573350|467304794|FG001|Overall Study|Protocol Deviation|1|||
129820396|NCT02708121|467304797|FG000|Overall Study|Withdrawn by Study Team|1|||
129820397|NCT02708121|467304798|FG001|Overall Study|Withdrawn by Study Team|1|||
129820398|NCT02708121|467304797|FG000|Overall Study|Withdrawal by Subject|0|||
129820399|NCT02708121|467304798|FG001|Overall Study|Withdrawal by Subject|4|||
129820400|NCT01833520|467304799|FG000|Overall Study|Lack of Efficacy|3|||
129820401|NCT01833520|467304800|FG001|Overall Study|Lack of Efficacy|3|||
129820402|NCT01833520|467304801|FG002|Overall Study|Lack of Efficacy|8|||
129820403|NCT01833520|467304802|FG003|Overall Study|Lack of Efficacy|3|||
129820404|NCT02547649|467304803|FG000|Overall Study|Lost to Follow-up|3|||
129820405|NCT02547649|467304804|FG001|Overall Study|Lost to Follow-up|1|||
129820406|NCT02547649|467304805|FG002|Overall Study|Lost to Follow-up|1|||
129820407|NCT02547649|467304803|FG000|Overall Study|Not vaccinated|0|||
129820408|NCT02547649|467304804|FG001|Overall Study|Not vaccinated|0|||
129820409|NCT02547649|467304805|FG002|Overall Study|Not vaccinated|1|||
129820410|NCT02547649|467304803|FG000|Overall Study|Withdrawal by Subject|0|||
129820411|NCT02547649|467304804|FG001|Overall Study|Withdrawal by Subject|4|||
129820412|NCT02547649|467304805|FG002|Overall Study|Withdrawal by Subject|2|||
129820413|NCT01484197|467304810|FG000|Treatment Period 1|Adverse Event|1|||
129820414|NCT01484197|467304811|FG001|Treatment Period 1|Adverse Event|0|||
129820415|NCT01484197|467304812|FG002|Treatment Period 1|Adverse Event|0|||
129820416|NCT01484197|467304813|FG003|Treatment Period 1|Adverse Event|0|||
129445516|NCT01109173|465932829|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
129820417|NCT01484197|467304810|FG000|Treatment Period 2|Subject withdrew consent|0|||
129820418|NCT01484197|467304811|FG001|Treatment Period 2|Subject withdrew consent|0|||
129820419|NCT01484197|467304812|FG002|Treatment Period 2|Subject withdrew consent|0|||
129820420|NCT01484197|467304813|FG003|Treatment Period 2|Subject withdrew consent|1|||
129820421|NCT02706691|467304815|FG000|Overall Study|Adverse Event|1|||
129820422|NCT01980992|467304816|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
129820423|NCT01980992|467304817|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
129820424|NCT01980992|467304816|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
129820425|NCT01980992|467304817|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
129820426|NCT01980992|467304816|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
129820427|NCT01980992|467304817|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
129820428|NCT01980992|467304816|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
129820429|NCT01980992|467304817|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
129820430|NCT01980992|467304816|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
129820431|NCT01980992|467304817|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
129820432|NCT01980992|467304816|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
129820433|NCT01980992|467304817|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
129820434|NCT05025241|467304821|FG000|Screening|Failed Screening|5|||
129820435|NCT05025241|467304821|FG000|Treatment and Follow Up|Adverse Event|3|||
129820436|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129897294|NCT02236559|467584323|FG000|Overall Study|Met Exclusion|3|||
129897295|NCT02236559|467584324|FG001|Overall Study|Met Exclusion|6|||
129445517|NCT01109173|465932830|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
129445518|NCT01109173|465932831|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
129445519|NCT01109173|465932828|FG000|Overall Study|Noncompliance|0|||
129445520|NCT01109173|465932829|FG001|Overall Study|Noncompliance|1|||
129445521|NCT01109173|465932830|FG002|Overall Study|Noncompliance|0|||
129445522|NCT01109173|465932831|FG003|Overall Study|Noncompliance|0|||
129445523|NCT01109173|465932828|FG000|Overall Study|Treatment Failure|25|||
129445524|NCT01109173|465932829|FG001|Overall Study|Treatment Failure|32|||
129445525|NCT01109173|465932830|FG002|Overall Study|Treatment Failure|69|||
129445526|NCT01109173|465932831|FG003|Overall Study|Treatment Failure|64|||
129445527|NCT01109173|465932828|FG000|Overall Study|Protocol Violation|4|||
129445528|NCT01109173|465932829|FG001|Overall Study|Protocol Violation|5|||
129445529|NCT01109173|465932830|FG002|Overall Study|Protocol Violation|1|||
129445530|NCT01109173|465932831|FG003|Overall Study|Protocol Violation|2|||
129445531|NCT01109173|465932828|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
129445532|NCT01109173|465932829|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
129445533|NCT01109173|465932830|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
129445534|NCT01109173|465932831|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
129445535|NCT01109173|465932828|FG000|Overall Study|Not Specifiied|5|||
129445536|NCT01109173|465932829|FG001|Overall Study|Not Specifiied|4|||
129445537|NCT01109173|465932830|FG002|Overall Study|Not Specifiied|9|||
129445538|NCT01109173|465932831|FG003|Overall Study|Not Specifiied|14|||
129445539|NCT00006392|465932838|FG000|Overall Study|Ineligible|11|||
129445540|NCT00006392|465932839|FG001|Overall Study|Ineligible|3|||
129445541|NCT00006392|465932840|FG002|Overall Study|Ineligible|5|||
129445542|NCT00006392|465932841|FG003|Overall Study|Ineligible|5|||
129445543|NCT00006392|465932838|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
129445544|NCT00006392|465932839|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
129445545|NCT00006392|465932840|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
129445546|NCT00006392|465932841|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
129445547|NCT02459769|465932842|FG000|Overall Study|Withdrawal by Subject|7|||
129445548|NCT02459769|465932843|FG001|Overall Study|Withdrawal by Subject|4|||
129445549|NCT02459769|465932844|FG002|Overall Study|Withdrawal by Subject|8|||
129445550|NCT02459769|465932845|FG003|Overall Study|Withdrawal by Subject|5|||
129445551|NCT02459769|465932842|FG000|Overall Study|Lost to Follow-up|1|||
129445552|NCT02459769|465932843|FG001|Overall Study|Lost to Follow-up|0|||
129445553|NCT02459769|465932844|FG002|Overall Study|Lost to Follow-up|1|||
129445554|NCT02459769|465932845|FG003|Overall Study|Lost to Follow-up|0|||
129445555|NCT01186796|465932846|FG000|Overall Study|Adverse Event|3|||
129445556|NCT01186796|465932847|FG001|Overall Study|Adverse Event|0|||
129445557|NCT01186796|465932846|FG000|Overall Study|Withdrawal by Subject|1|||
129445558|NCT01186796|465932847|FG001|Overall Study|Withdrawal by Subject|1|||
129445559|NCT01186796|465932846|FG000|Overall Study|Protocol Violation|0|||
129445560|NCT01186796|465932847|FG001|Overall Study|Protocol Violation|1|||
129445561|NCT01287364|465932849|FG000|Overall Study|Adverse Event|0|||
129445562|NCT01287364|465932850|FG001|Overall Study|Adverse Event|3|||
129445563|NCT01287364|465932849|FG000|Overall Study|Protocol Violation|5|||
129445564|NCT01287364|465932850|FG001|Overall Study|Protocol Violation|5|||
129897296|NCT02236559|467584323|FG000|Overall Study|Did not Meet Inclusion|3|||
129897297|NCT02236559|467584324|FG001|Overall Study|Did not Meet Inclusion|3|||
129897298|NCT02236559|467584323|FG000|Overall Study|Subject Did Not Consent|4|||
129445565|NCT01287364|465932849|FG000|Overall Study|Other Reason|4|||
129820437|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
129820438|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820439|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820440|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820441|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
129820442|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
129820443|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
129820444|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
129820445|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
129820446|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
129820447|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
129820448|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
129820449|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
129820450|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
129820451|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
129820452|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
129820453|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
129820454|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820455|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820456|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820457|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820458|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
129820459|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
129820460|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820461|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
129820462|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820463|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820464|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820465|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
129820466|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
129820467|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
129820468|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
129820469|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
129820470|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
129820471|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
129820472|NCT02603419|467304823|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820473|NCT02603419|467304824|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820474|NCT02603419|467304825|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820475|NCT02603419|467304826|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
129820476|NCT02603419|467304827|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820477|NCT02603419|467304828|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
129820478|NCT02603419|467304823|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820479|NCT02603419|467304824|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820480|NCT02603419|467304825|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820481|NCT02603419|467304826|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820482|NCT02603419|467304827|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
129820483|NCT02603419|467304828|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
129820484|NCT02603419|467304823|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820485|NCT02603419|467304824|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820486|NCT02603419|467304825|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820487|NCT02603419|467304826|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820488|NCT02603419|467304827|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
129820489|NCT02603419|467304828|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
129820490|NCT02603419|467304823|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820491|NCT02603419|467304824|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820492|NCT02603419|467304825|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820493|NCT02603419|467304826|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820494|NCT02603419|467304827|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
129820495|NCT02603419|467304828|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
129820496|NCT02850965|467304829|FG000|Overall Study|Other than listed|3|||
129820497|NCT02850965|467304830|FG001|Overall Study|Other than listed|4|||
129820498|NCT02850965|467304829|FG000|Overall Study|Protocol Violation|0|||
129820499|NCT02850965|467304830|FG001|Overall Study|Protocol Violation|2|||
129897299|NCT02236559|467584324|FG001|Overall Study|Subject Did Not Consent|2|||
129897300|NCT02236559|467584323|FG000|Overall Study|Physician Decision|1|||
129897301|NCT02236559|467584324|FG001|Overall Study|Physician Decision|1|||
129897302|NCT02236559|467584323|FG000|Overall Study|Withdrawal by Subject|1|||
129897303|NCT02236559|467584324|FG001|Overall Study|Withdrawal by Subject|0|||
129897304|NCT03721016|467584325|FG000|Overall Study|Adverse Event|0|||
129897305|NCT03721016|467584326|FG001|Overall Study|Adverse Event|1|||
129897306|NCT03721016|467584327|FG002|Overall Study|Adverse Event|1|||
129897307|NCT03721016|467584325|FG000|Overall Study|Withdrawal by Subject|8|||
129897308|NCT03721016|467584326|FG001|Overall Study|Withdrawal by Subject|16|||
129897309|NCT03721016|467584327|FG002|Overall Study|Withdrawal by Subject|13|||
129897310|NCT03721016|467584325|FG000|Overall Study|Lost to Follow-up|4|||
129897311|NCT03721016|467584326|FG001|Overall Study|Lost to Follow-up|6|||
129897312|NCT03721016|467584327|FG002|Overall Study|Lost to Follow-up|5|||
129897313|NCT03721016|467584325|FG000|Overall Study|Physician Decision|0|||
129897314|NCT03721016|467584326|FG001|Overall Study|Physician Decision|1|||
129897315|NCT03721016|467584327|FG002|Overall Study|Physician Decision|2|||
129897316|NCT03721016|467584325|FG000|Overall Study|Protocol Violation|0|||
129897317|NCT03721016|467584326|FG001|Overall Study|Protocol Violation|1|||
129897318|NCT03721016|467584327|FG002|Overall Study|Protocol Violation|0|||
129897319|NCT03721016|467584325|FG000|Overall Study|Site terminated by sponsor|3|||
129897320|NCT03721016|467584326|FG001|Overall Study|Site terminated by sponsor|7|||
129897321|NCT03721016|467584327|FG002|Overall Study|Site terminated by sponsor|6|||
129897322|NCT03721016|467584325|FG000|Overall Study|Subject exited early due to COVID-19|1|||
129897323|NCT03721016|467584326|FG001|Overall Study|Subject exited early due to COVID-19|0|||
129897324|NCT03721016|467584327|FG002|Overall Study|Subject exited early due to COVID-19|0|||
129897325|NCT01149681|467584330|FG000|Overall Study|Withdrawal by Subject|7|||
129897326|NCT01149681|467584330|FG000|Overall Study|Progressive disease|1|||
129897327|NCT01149681|467584330|FG000|Overall Study|Physician Decision|2|||
129897328|NCT01149681|467584330|FG000|Overall Study|adverse events nonrelated study drug|2|||
129897329|NCT02232178|467584331|FG000|Overall Study|Lost to Follow-up|0|||
129897330|NCT02232178|467584332|FG001|Overall Study|Lost to Follow-up|1|||
129897331|NCT02232178|467584333|FG002|Overall Study|Lost to Follow-up|0|||
129897332|NCT02232178|467584331|FG000|Overall Study|ineligibility|0|||
129897333|NCT02232178|467584332|FG001|Overall Study|ineligibility|0|||
129897334|NCT02232178|467584333|FG002|Overall Study|ineligibility|1|||
129897335|NCT02232178|467584331|FG000|Overall Study|surgical complication|1|||
129897336|NCT02232178|467584332|FG001|Overall Study|surgical complication|0|||
129897337|NCT02232178|467584333|FG002|Overall Study|surgical complication|0|||
129897338|NCT00817635|467584334|FG000|Overall Study|Adverse Event|1|||
129897339|NCT00817635|467584335|FG001|Overall Study|Adverse Event|0|||
129897340|NCT00817635|467584336|FG002|Overall Study|Adverse Event|0|||
129897341|NCT00817635|467584337|FG003|Overall Study|Adverse Event|1|||
129897342|NCT00817635|467584338|FG004|Overall Study|Adverse Event|1|||
129897343|NCT00817635|467584334|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129897344|NCT00817635|467584335|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
129897345|NCT00817635|467584336|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129897346|NCT00817635|467584337|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
129897347|NCT00817635|467584338|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
129897348|NCT00817635|467584334|FG000|Overall Study|Withdrawal by Subject|2|||
129897349|NCT00817635|467584335|FG001|Overall Study|Withdrawal by Subject|1|||
129897350|NCT00817635|467584336|FG002|Overall Study|Withdrawal by Subject|0|||
129820500|NCT02850965|467304829|FG000|Overall Study|Lost to Follow-up|5|||
129820501|NCT02850965|467304830|FG001|Overall Study|Lost to Follow-up|3|||
129820502|NCT02850965|467304829|FG000|Overall Study|Lack of Efficacy|4|||
129820503|NCT02850965|467304830|FG001|Overall Study|Lack of Efficacy|8|||
129820504|NCT02850965|467304829|FG000|Overall Study|Adverse Event|3|||
129820505|NCT02850965|467304830|FG001|Overall Study|Adverse Event|2|||
129820506|NCT02850965|467304829|FG000|Overall Study|Withdrawal by Subject|3|||
129820507|NCT02850965|467304830|FG001|Overall Study|Withdrawal by Subject|4|||
129820508|NCT02850965|467304829|FG000|Overall Study|Physician Decision|0|||
129820509|NCT02850965|467304830|FG001|Overall Study|Physician Decision|1|||
129820510|NCT02850965|467304829|FG000|Overall Study|Randomized but not treated|0|||
129820511|NCT02850965|467304830|FG001|Overall Study|Randomized but not treated|1|||
129820512|NCT02007109|467304836|FG000|Overall Study|Diary not returned or excluded|102|||
129820513|NCT02007109|467304836|FG000|Overall Study|Excluded - Age<7yo|9|||
129820514|NCT01858389|467304838|FG000|Overall Study|Death|1|||
129820515|NCT01858389|467304839|FG001|Overall Study|Death|3|||
129820516|NCT01858389|467304838|FG000|Overall Study|Study terminated by sponsor|0|||
129820517|NCT01858389|467304839|FG001|Overall Study|Study terminated by sponsor|2|||
129820518|NCT01858389|467304838|FG000|Overall Study|Withdrawal by Subject|0|||
129820519|NCT01858389|467304839|FG001|Overall Study|Withdrawal by Subject|1|||
129820520|NCT01858389|467304838|FG000|Overall Study|Progressive disease|10|||
129820521|NCT01858389|467304839|FG001|Overall Study|Progressive disease|11|||
129820522|NCT01858389|467304838|FG000|Overall Study|Other|2|||
129820523|NCT01858389|467304839|FG001|Overall Study|Other|4|||
129820524|NCT01858389|467304838|FG000|Overall Study|Adverse Event|3|||
129820525|NCT01858389|467304839|FG001|Overall Study|Adverse Event|1|||
129820526|NCT01858389|467304838|FG000|Overall Study|Did not receive treatment|0|||
129820527|NCT01858389|467304839|FG001|Overall Study|Did not receive treatment|3|||
129820528|NCT03572062|467304840|FG000|Overall Study|Adverse Event|0|||
129820529|NCT03572062|467304841|FG001|Overall Study|Adverse Event|0|||
129820530|NCT03572062|467304842|FG002|Overall Study|Adverse Event|0|||
129820531|NCT03572062|467304843|FG003|Overall Study|Adverse Event|0|||
129820532|NCT03572062|467304844|FG004|Overall Study|Adverse Event|0|||
129820533|NCT03572062|467304845|FG005|Overall Study|Adverse Event|0|||
129820534|NCT03572062|467304846|FG006|Overall Study|Adverse Event|0|||
129820535|NCT03572062|467304847|FG007|Overall Study|Adverse Event|0|||
129820536|NCT03572062|467304848|FG008|Overall Study|Adverse Event|1|||
129820537|NCT03572062|467304849|FG009|Overall Study|Adverse Event|3|||
129820538|NCT03572062|467304840|FG000|Overall Study|Death|0|||
129820539|NCT03572062|467304841|FG001|Overall Study|Death|0|||
129820540|NCT03572062|467304842|FG002|Overall Study|Death|0|||
129820541|NCT03572062|467304843|FG003|Overall Study|Death|0|||
129820542|NCT03572062|467304844|FG004|Overall Study|Death|0|||
129820543|NCT03572062|467304845|FG005|Overall Study|Death|1|||
129820544|NCT03572062|467304846|FG006|Overall Study|Death|0|||
129820545|NCT03572062|467304847|FG007|Overall Study|Death|0|||
129820546|NCT03572062|467304848|FG008|Overall Study|Death|0|||
129820547|NCT03572062|467304849|FG009|Overall Study|Death|0|||
129820548|NCT03572062|467304840|FG000|Overall Study|Lost to Follow-up|0|||
129820549|NCT03572062|467304841|FG001|Overall Study|Lost to Follow-up|0|||
129820550|NCT03572062|467304842|FG002|Overall Study|Lost to Follow-up|0|||
129820551|NCT03572062|467304843|FG003|Overall Study|Lost to Follow-up|0|||
129820552|NCT03572062|467304844|FG004|Overall Study|Lost to Follow-up|0|||
129820553|NCT03572062|467304845|FG005|Overall Study|Lost to Follow-up|1|||
129820554|NCT03572062|467304846|FG006|Overall Study|Lost to Follow-up|1|||
129820555|NCT03572062|467304847|FG007|Overall Study|Lost to Follow-up|0|||
129820556|NCT03572062|467304848|FG008|Overall Study|Lost to Follow-up|0|||
129820557|NCT03572062|467304849|FG009|Overall Study|Lost to Follow-up|0|||
129820558|NCT03572062|467304840|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820559|NCT03572062|467304841|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820560|NCT03572062|467304842|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820561|NCT03572062|467304843|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820562|NCT03572062|467304844|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820563|NCT03572062|467304845|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820564|NCT03572062|467304846|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820565|NCT03572062|467304847|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820566|NCT03572062|467304848|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
129820567|NCT03572062|467304849|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
129820568|NCT03572062|467304840|FG000|Overall Study|Study Terminated By Sponsor|0|||
129820569|NCT03572062|467304841|FG001|Overall Study|Study Terminated By Sponsor|0|||
129820570|NCT03572062|467304842|FG002|Overall Study|Study Terminated By Sponsor|0|||
129820571|NCT03572062|467304843|FG003|Overall Study|Study Terminated By Sponsor|0|||
129820572|NCT03572062|467304844|FG004|Overall Study|Study Terminated By Sponsor|0|||
129820573|NCT03572062|467304845|FG005|Overall Study|Study Terminated By Sponsor|0|||
129820574|NCT03572062|467304846|FG006|Overall Study|Study Terminated By Sponsor|0|||
129820575|NCT03572062|467304847|FG007|Overall Study|Study Terminated By Sponsor|0|||
129820576|NCT03572062|467304848|FG008|Overall Study|Study Terminated By Sponsor|29|||
129820577|NCT03572062|467304849|FG009|Overall Study|Study Terminated By Sponsor|27|||
129820578|NCT03572062|467304840|FG000|Overall Study|Physician Decision|0|||
129820579|NCT03572062|467304841|FG001|Overall Study|Physician Decision|0|||
129820580|NCT03572062|467304842|FG002|Overall Study|Physician Decision|0|||
129820581|NCT03572062|467304843|FG003|Overall Study|Physician Decision|0|||
129820582|NCT03572062|467304844|FG004|Overall Study|Physician Decision|0|||
129820583|NCT03572062|467304845|FG005|Overall Study|Physician Decision|0|||
129820584|NCT03572062|467304846|FG006|Overall Study|Physician Decision|0|||
129820585|NCT03572062|467304847|FG007|Overall Study|Physician Decision|0|||
129820586|NCT03572062|467304848|FG008|Overall Study|Physician Decision|1|||
129820587|NCT03572062|467304849|FG009|Overall Study|Physician Decision|0|||
129820588|NCT03572062|467304840|FG000|Overall Study|Withdrawal by Subject|0|||
129820589|NCT03572062|467304841|FG001|Overall Study|Withdrawal by Subject|0|||
129820590|NCT03572062|467304842|FG002|Overall Study|Withdrawal by Subject|0|||
129820591|NCT03572062|467304843|FG003|Overall Study|Withdrawal by Subject|0|||
129820592|NCT03572062|467304844|FG004|Overall Study|Withdrawal by Subject|0|||
129820593|NCT03572062|467304845|FG005|Overall Study|Withdrawal by Subject|0|||
129820594|NCT03572062|467304846|FG006|Overall Study|Withdrawal by Subject|0|||
129820595|NCT03572062|467304847|FG007|Overall Study|Withdrawal by Subject|0|||
129820596|NCT03572062|467304848|FG008|Overall Study|Withdrawal by Subject|0|||
129820597|NCT03572062|467304849|FG009|Overall Study|Withdrawal by Subject|1|||
129820598|NCT03572062|467304840|FG000|Overall Study|Randomized But Not Treated|0|||
129820599|NCT03572062|467304841|FG001|Overall Study|Randomized But Not Treated|0|||
129820600|NCT03572062|467304842|FG002|Overall Study|Randomized But Not Treated|0|||
129820601|NCT03572062|467304843|FG003|Overall Study|Randomized But Not Treated|0|||
129820602|NCT03572062|467304844|FG004|Overall Study|Randomized But Not Treated|1|||
129820603|NCT03572062|467304845|FG005|Overall Study|Randomized But Not Treated|2|||
129820604|NCT03572062|467304846|FG006|Overall Study|Randomized But Not Treated|0|||
129820605|NCT03572062|467304847|FG007|Overall Study|Randomized But Not Treated|1|||
129820606|NCT03572062|467304848|FG008|Overall Study|Randomized But Not Treated|0|||
129820607|NCT03572062|467304849|FG009|Overall Study|Randomized But Not Treated|0|||
129820608|NCT00458211|467304850|FG000|Overall Study|Lack of Efficacy|12|||
129820609|NCT00458211|467304850|FG000|Overall Study|Withdrawal by Subject|2|||
129820610|NCT00458211|467304850|FG000|Overall Study|Protocol Violation|2|||
129820611|NCT00646776|467304851|FG000|Overall Study|Adverse Event|1|||
129820612|NCT00646776|467304852|FG001|Overall Study|Adverse Event|9|||
129820613|NCT00646776|467304851|FG000|Overall Study|Investigator discretion|0|||
129820614|NCT00646776|467304852|FG001|Overall Study|Investigator discretion|4|||
129820615|NCT00126568|467304853|FG000|Overall Study|Death|2|||
129820616|NCT03031678|467304855|FG000|Overall Study|Study closed prior to completion|1|||
129820617|NCT01753856|467304856|FG000|Overall Study|Adverse Event|1|||
129820618|NCT01753856|467304857|FG001|Overall Study|Adverse Event|0|||
129820619|NCT01753856|467304856|FG000|Overall Study|Withdrawal by Subject|0|||
129820620|NCT01753856|467304857|FG001|Overall Study|Withdrawal by Subject|2|||
129820621|NCT01753856|467304856|FG000|Overall Study|Sponsor Decision|2|||
129820622|NCT01753856|467304857|FG001|Overall Study|Sponsor Decision|0|||
129820623|NCT00434330|467304862|FG000|Overall Study|Adverse Event|0|||
129820624|NCT00434330|467304863|FG001|Overall Study|Adverse Event|0|||
129820625|NCT00434330|467304864|FG002|Overall Study|Adverse Event|1|||
129820626|NCT00434330|467304865|FG003|Overall Study|Adverse Event|0|||
129820627|NCT00434330|467304866|FG004|Overall Study|Adverse Event|0|||
129820628|NCT00434330|467304867|FG005|Overall Study|Adverse Event|0|||
129820629|NCT00434330|467304862|FG000|Overall Study|Death|1|||
129820630|NCT00434330|467304863|FG001|Overall Study|Death|0|||
129820631|NCT00434330|467304864|FG002|Overall Study|Death|0|||
129820632|NCT00434330|467304865|FG003|Overall Study|Death|0|||
129820633|NCT00434330|467304866|FG004|Overall Study|Death|1|||
129820634|NCT00434330|467304867|FG005|Overall Study|Death|1|||
129820635|NCT00434330|467304862|FG000|Overall Study|Withdrawal by Subject|0|||
129820636|NCT00434330|467304863|FG001|Overall Study|Withdrawal by Subject|0|||
129820637|NCT00434330|467304864|FG002|Overall Study|Withdrawal by Subject|1|||
129820638|NCT00434330|467304865|FG003|Overall Study|Withdrawal by Subject|1|||
129820639|NCT00434330|467304866|FG004|Overall Study|Withdrawal by Subject|0|||
129820640|NCT00434330|467304867|FG005|Overall Study|Withdrawal by Subject|0|||
129820641|NCT00434330|467304862|FG000|Overall Study|Renal transplant|0|||
129820642|NCT00434330|467304863|FG001|Overall Study|Renal transplant|0|||
129820643|NCT00434330|467304864|FG002|Overall Study|Renal transplant|0|||
129820644|NCT00434330|467304865|FG003|Overall Study|Renal transplant|1|||
129820645|NCT00434330|467304866|FG004|Overall Study|Renal transplant|0|||
129820646|NCT00434330|467304867|FG005|Overall Study|Renal transplant|0|||
129820647|NCT00434330|467304862|FG000|Overall Study|Subject Not Compliant With Study|0|||
129820648|NCT00434330|467304863|FG001|Overall Study|Subject Not Compliant With Study|0|||
129820649|NCT00434330|467304864|FG002|Overall Study|Subject Not Compliant With Study|1|||
129820650|NCT00434330|467304865|FG003|Overall Study|Subject Not Compliant With Study|0|||
129820651|NCT00434330|467304866|FG004|Overall Study|Subject Not Compliant With Study|0|||
129820652|NCT00434330|467304867|FG005|Overall Study|Subject Not Compliant With Study|0|||
129820653|NCT03278613|467304868|FG000|Overall Study|Lost to Follow-up|3|||
129820654|NCT03278613|467304869|FG001|Overall Study|Lost to Follow-up|1|||
129820655|NCT04847557|467304870|FG000|Overall Study|Adverse Event|1|||
129820656|NCT04847557|467304871|FG001|Overall Study|Adverse Event|0|||
129820657|NCT04847557|467304870|FG000|Overall Study|Death|19|||
129820658|NCT04847557|467304871|FG001|Overall Study|Death|15|||
129820659|NCT04847557|467304870|FG000|Overall Study|Lost to Follow-up|3|||
129820660|NCT04847557|467304871|FG001|Overall Study|Lost to Follow-up|6|||
129820661|NCT04847557|467304870|FG000|Overall Study|Physician Decision|1|||
129820662|NCT04847557|467304871|FG001|Overall Study|Physician Decision|0|||
129820663|NCT04847557|467304870|FG000|Overall Study|Protocol Violation|0|||
129820664|NCT04847557|467304871|FG001|Overall Study|Protocol Violation|1|||
129820665|NCT04847557|467304870|FG000|Overall Study|Withdrawal by Subject|8|||
129820666|NCT04847557|467304871|FG001|Overall Study|Withdrawal by Subject|14|||
129820667|NCT02700815|467307375|FG000|Overall Study|Adverse Event|0|||
129820668|NCT02700815|467307376|FG001|Overall Study|Adverse Event|6|||
129820669|NCT02700815|467307377|FG002|Overall Study|Adverse Event|2|||
129820670|NCT02700815|467307378|FG003|Overall Study|Adverse Event|3|||
129820671|NCT02700815|467307375|FG000|Overall Study|Lack of Efficacy|0|||
129820672|NCT02700815|467307376|FG001|Overall Study|Lack of Efficacy|0|||
129820673|NCT02700815|467307377|FG002|Overall Study|Lack of Efficacy|1|||
129820674|NCT02700815|467307378|FG003|Overall Study|Lack of Efficacy|2|||
129820675|NCT02700815|467307375|FG000|Overall Study|Lost to Follow-up|1|||
129820676|NCT02700815|467307376|FG001|Overall Study|Lost to Follow-up|0|||
129820677|NCT02700815|467307377|FG002|Overall Study|Lost to Follow-up|0|||
129820678|NCT02700815|467307378|FG003|Overall Study|Lost to Follow-up|1|||
129820679|NCT02700815|467307375|FG000|Overall Study|Refusal to continue medication|0|||
129820680|NCT02700815|467307376|FG001|Overall Study|Refusal to continue medication|1|||
129820681|NCT02700815|467307377|FG002|Overall Study|Refusal to continue medication|0|||
129820682|NCT02700815|467307378|FG003|Overall Study|Refusal to continue medication|1|||
129820683|NCT02700815|467307375|FG000|Overall Study|Withdrawal by Subject|0|||
129820684|NCT02700815|467307376|FG001|Overall Study|Withdrawal by Subject|0|||
129820685|NCT02700815|467307377|FG002|Overall Study|Withdrawal by Subject|1|||
129820686|NCT02700815|467307378|FG003|Overall Study|Withdrawal by Subject|0|||
129820687|NCT02154490|467307379|FG000|Overall Study|No tissue submitted|23|||
129820688|NCT02154490|467307379|FG000|Overall Study|No biomarker results|167|||
129820689|NCT02154490|467307379|FG000|Overall Study|Not assigned to a sub-study|270|||
129820690|NCT02154490|467307379|FG000|Overall Study|Did not register to a sub-study|749|||
129820691|NCT02961751|467307382|FG000|Overall Study|Lost to Follow-up|11|||
129820692|NCT02961751|467307382|FG000|Overall Study|Physician Decision|2|||
129820693|NCT02961751|467307382|FG000|Overall Study|Not Eligible at Enrollment|1|||
129820694|NCT02961751|467307382|FG000|Overall Study|Protocol Violation|1|||
129820695|NCT02989194|467307388|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
129820696|NCT02989194|467307389|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
129820697|NCT02989194|467307390|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
129820698|NCT02989194|467307388|FG000|Overall Study|Lost to Follow-up|0|||
129820699|NCT02989194|467307389|FG001|Overall Study|Lost to Follow-up|1|||
129820700|NCT02989194|467307390|FG002|Overall Study|Lost to Follow-up|0|||
129820701|NCT02989194|467307388|FG000|Overall Study|Withdrawal by Subject|0|||
129820702|NCT02989194|467307389|FG001|Overall Study|Withdrawal by Subject|1|||
129820703|NCT02989194|467307390|FG002|Overall Study|Withdrawal by Subject|0|||
129820704|NCT01549860|467307391|FG000|Overall Study|Withdrawal by Subject|1|||
129820705|NCT01549860|467307392|FG001|Overall Study|Withdrawal by Subject|0|||
129820706|NCT01549860|467307391|FG000|Overall Study|Physician Decision|1|||
129820707|NCT01549860|467307392|FG001|Overall Study|Physician Decision|1|||
129820708|NCT01224431|467307395|FG000|Overall Study|not randomized|0|||
129820709|NCT01224431|467307396|FG001|Overall Study|not randomized|4|||
129820710|NCT01224431|467307395|FG000|Overall Study|no video record|0|||
129820711|NCT01224431|467307396|FG001|Overall Study|no video record|1|||
129820712|NCT02041286|467307399|FG000|Overall Study|Adverse Event|1|||
129820713|NCT01349790|467307415|FG000|Overall Study|Investigator Judgement|3|||
129820714|NCT01349790|467307415|FG000|Overall Study|Death|2|||
129820715|NCT01349790|467307415|FG000|Overall Study|Withdrawal by Patient|2|||
129820716|NCT01349790|467307415|FG000|Overall Study|Adverse Event|1|||
129820717|NCT01349790|467307415|FG000|Overall Study|Lost to Follow-up|1|||
129820718|NCT00885105|467307416|FG000|Overall Study|Withdrawal by Subject|0|||
129820719|NCT00885105|467307417|FG001|Overall Study|Withdrawal by Subject|8|||
129820720|NCT00885105|467307416|FG000|Overall Study|Adverse Event|1|||
129820721|NCT00885105|467307417|FG001|Overall Study|Adverse Event|0|||
129820722|NCT00885105|467307416|FG000|Overall Study|Protocol Violation|0|||
129820723|NCT00885105|467307417|FG001|Overall Study|Protocol Violation|2|||
129820724|NCT03519932|467307418|FG000|First Intervention|Adverse Event|1|||
129820725|NCT03519932|467307419|FG001|First Intervention|Adverse Event|3|||
129820726|NCT02254486|467307420|FG000|Overall Study|Adverse Event|1|||
129820727|NCT02254486|467307421|FG001|Overall Study|Adverse Event|1|||
129820728|NCT02254486|467307420|FG000|Overall Study|Lack of Efficacy|1|||
129820729|NCT02254486|467307421|FG001|Overall Study|Lack of Efficacy|0|||
129820730|NCT02254486|467307420|FG000|Overall Study|Lost to Follow-up|2|||
129820731|NCT02254486|467307421|FG001|Overall Study|Lost to Follow-up|4|||
129820732|NCT02254486|467307420|FG000|Overall Study|Protocol Violation|1|||
129820733|NCT02254486|467307421|FG001|Overall Study|Protocol Violation|2|||
129820734|NCT02254486|467307420|FG000|Overall Study|Withdrawal by Subject|17|||
129820735|NCT02254486|467307421|FG001|Overall Study|Withdrawal by Subject|15|||
129820736|NCT02254486|467307420|FG000|Overall Study|GFR<60mL/min|16|||
129820737|NCT02254486|467307421|FG001|Overall Study|GFR<60mL/min|21|||
129820738|NCT02254486|467307420|FG000|Overall Study|Various|12|||
129820739|NCT02254486|467307421|FG001|Overall Study|Various|12|||
129820740|NCT01350414|467307422|FG000|Overall Study|Lost to Follow-up|13|||
129820741|NCT01350414|467307422|FG000|Overall Study|Withdrawal by Subject|4|||
129820742|NCT01350414|467307422|FG000|Overall Study|Physician Decision|2|||
129820743|NCT02743520|467307423|FG000|Overall Study|Withdrawal by Subject|1|||
129820744|NCT01749514|467307424|FG000|Overall Study|Lost to Follow-up|0|||
129820745|NCT01749514|467307425|FG001|Overall Study|Lost to Follow-up|0|||
129820746|NCT01749514|467307426|FG002|Overall Study|Lost to Follow-up|0|||
129820747|NCT01749514|467307427|FG003|Overall Study|Lost to Follow-up|0|||
129820748|NCT01749514|467307428|FG004|Overall Study|Lost to Follow-up|0|||
129820749|NCT01749514|467307429|FG005|Overall Study|Lost to Follow-up|0|||
129820750|NCT01749514|467307430|FG006|Overall Study|Lost to Follow-up|0|||
129820751|NCT01749514|467307431|FG007|Overall Study|Lost to Follow-up|1|||
129820752|NCT01749514|467307424|FG000|Overall Study|Withdrawal by Subject|0|||
129820753|NCT01749514|467307425|FG001|Overall Study|Withdrawal by Subject|0|||
129820754|NCT01749514|467307426|FG002|Overall Study|Withdrawal by Subject|0|||
129820755|NCT01749514|467307427|FG003|Overall Study|Withdrawal by Subject|0|||
129820756|NCT01749514|467307428|FG004|Overall Study|Withdrawal by Subject|0|||
129820757|NCT01749514|467307429|FG005|Overall Study|Withdrawal by Subject|1|||
129820758|NCT01749514|467307430|FG006|Overall Study|Withdrawal by Subject|0|||
129820759|NCT01749514|467307431|FG007|Overall Study|Withdrawal by Subject|1|||
129820760|NCT01749514|467307424|FG000|Overall Study|Not Reported|0|||
129820761|NCT01749514|467307425|FG001|Overall Study|Not Reported|0|||
129820762|NCT01749514|467307426|FG002|Overall Study|Not Reported|0|||
129820763|NCT01749514|467307427|FG003|Overall Study|Not Reported|0|||
129820764|NCT01749514|467307428|FG004|Overall Study|Not Reported|0|||
129820765|NCT01749514|467307429|FG005|Overall Study|Not Reported|0|||
129820766|NCT01749514|467307430|FG006|Overall Study|Not Reported|0|||
129820767|NCT01749514|467307431|FG007|Overall Study|Not Reported|5|||
129820768|NCT01979016|467307433|FG000|Overall Study|Withdrawal by Subject|2|||
129820769|NCT01979016|467307434|FG001|Overall Study|Withdrawal by Subject|0|||
129820770|NCT01979016|467307433|FG000|Overall Study|Adverse Event|0|||
129820771|NCT01979016|467307434|FG001|Overall Study|Adverse Event|1|||
129820772|NCT00938639|467307435|FG000|Overall Study|Moved away from study area|0|||
129820773|NCT00938639|467307436|FG001|Overall Study|Moved away from study area|1|||
129820774|NCT00938639|467307435|FG000|Overall Study|Lost to Follow-up|1|||
129820775|NCT00938639|467307436|FG001|Overall Study|Lost to Follow-up|2|||
129820776|NCT00938639|467307435|FG000|Overall Study|Family issues|1|||
129820777|NCT00938639|467307436|FG001|Overall Study|Family issues|1|||
129820778|NCT00938639|467307435|FG000|Overall Study|Participant noncompliance|1|||
129820779|NCT00938639|467307436|FG001|Overall Study|Participant noncompliance|0|||
129820780|NCT02509156|467307437|FG000|Randomized Phase|Death|1|||
129820781|NCT02509156|467307438|FG001|Randomized Phase|Death|0|||
129820782|NCT02509156|467307437|FG000|Randomized Phase|Withdrawal by Subject|1|||
129820783|NCT02509156|467307438|FG001|Randomized Phase|Withdrawal by Subject|1|||
129820784|NCT04326231|467307439|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
129820785|NCT03765918|467307442|FG000|Overall Study|Death|109|||
129820786|NCT03765918|467307443|FG001|Overall Study|Death|127|||
129820787|NCT03765918|467307442|FG000|Overall Study|Lost to Follow-up|2|||
129820788|NCT03765918|467307443|FG001|Overall Study|Lost to Follow-up|3|||
129820789|NCT03765918|467307442|FG000|Overall Study|Withdrawal by Subject|12|||
129820790|NCT03765918|467307443|FG001|Overall Study|Withdrawal by Subject|16|||
129820791|NCT03765918|467307442|FG000|Overall Study|Participants Ongoing|240|||
129820792|NCT03765918|467307443|FG001|Overall Study|Participants Ongoing|205|||
129820793|NCT04202965|467307444|FG000|Overall Study|Adverse Event|3|||
129820794|NCT04202965|467307444|FG000|Overall Study|Did not meet inclusion criteria|1|||
129820795|NCT00006903|467307445|FG000|Overall Study|Still receiving treatment|0|||
129820796|NCT00006903|467307446|FG001|Overall Study|Still receiving treatment|0|||
129820797|NCT00006903|467307447|FG002|Overall Study|Still receiving treatment|1|||
129897351|NCT00817635|467584337|FG003|Overall Study|Withdrawal by Subject|1|||
129820798|NCT00006903|467307445|FG000|Overall Study|Refused further treatment|0|||
129820799|NCT00006903|467307446|FG001|Overall Study|Refused further treatment|2|||
129820800|NCT00006903|467307447|FG002|Overall Study|Refused further treatment|1|||
129820801|NCT00006903|467307445|FG000|Overall Study|Adverse Event|0|||
129820802|NCT00006903|467307446|FG001|Overall Study|Adverse Event|0|||
129820803|NCT00006903|467307447|FG002|Overall Study|Adverse Event|1|||
129820804|NCT00006903|467307445|FG000|Overall Study|Death|0|||
129820805|NCT00006903|467307446|FG001|Overall Study|Death|1|||
129820806|NCT00006903|467307447|FG002|Overall Study|Death|0|||
129820807|NCT00006903|467307445|FG000|Overall Study|Patient never treated|0|||
129820808|NCT00006903|467307446|FG001|Overall Study|Patient never treated|0|||
129820809|NCT00006903|467307447|FG002|Overall Study|Patient never treated|1|||
129820810|NCT00006903|467307445|FG000|Overall Study|Ineligible|10|||
129897352|NCT00817635|467584338|FG004|Overall Study|Withdrawal by Subject|2|||
129445566|NCT01287364|465932850|FG001|Overall Study|Other Reason|2|||
129445567|NCT03681951|465932862|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
129445568|NCT03681951|465932863|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445569|NCT03681951|465932864|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445570|NCT03681951|465932865|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445571|NCT03681951|465932866|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445572|NCT03681951|465932867|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445573|NCT03681951|465932868|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445574|NCT03681951|465932869|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
129445575|NCT03681951|465932862|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
129445576|NCT03681951|465932863|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445577|NCT03681951|465932864|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445578|NCT03681951|465932865|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445579|NCT03681951|465932866|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445580|NCT03681951|465932867|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445581|NCT03681951|465932868|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445582|NCT03681951|465932869|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
129445583|NCT03681951|465932862|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
129445584|NCT03681951|465932863|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445585|NCT03681951|465932864|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445586|NCT03681951|465932865|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445587|NCT03681951|465932866|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445588|NCT03681951|465932867|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445589|NCT03681951|465932868|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445590|NCT03681951|465932869|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
129445591|NCT00628251|465932870|FG000|Randomised Part|Withdrawal by Subject|0|||
129445592|NCT00628251|465932871|FG001|Randomised Part|Withdrawal by Subject|0|||
129445593|NCT00628251|465932872|FG002|Randomised Part|Withdrawal by Subject|1|||
129445594|NCT00628251|465932870|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
129445595|NCT00628251|465932871|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
129445596|NCT00628251|465932872|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
129445597|NCT00628251|465932870|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
129445598|NCT00628251|465932871|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
129445599|NCT00628251|465932872|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
129445600|NCT00628251|465932870|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
129445601|NCT00628251|465932871|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
129445602|NCT00628251|465932872|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
129445603|NCT00628251|465932870|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
129445604|NCT00628251|465932871|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
129445605|NCT00628251|465932872|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
129445606|NCT00628251|465932870|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
129445607|NCT00628251|465932871|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
129445608|NCT00628251|465932872|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
129445609|NCT01020448|465932873|FG000|Pre-assignment|Adverse Event|6|||
129445610|NCT01020448|465932873|FG000|Pre-assignment|Withdrawal by Subject|5|||
129445611|NCT01020448|465932873|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
129445612|NCT01020448|465932873|FG000|Treatment|Adverse Event|11|||
129445613|NCT01020448|465932873|FG000|Treatment|Consent Withdrawn|3|||
129445614|NCT01020448|465932873|FG000|Treatment|Disease Progression|2|||
129445615|NCT01020448|465932873|FG000|Treatment|Lack of Efficacy|8|||
129445616|NCT01020448|465932873|FG000|Treatment|Lost to Follow-up|2|||
129445617|NCT02545322|465932874|FG000|Overall Study|Withdrawal by Subject|3|||
129445618|NCT01968070|465932875|FG000|Period 1|Withdrawal by Subject|0|||
129445619|NCT01968070|465932876|FG001|Period 1|Withdrawal by Subject|1|||
129445620|NCT01968070|465932877|FG002|Period 1|Withdrawal by Subject|0|||
129445621|NCT01968070|465932878|FG003|Period 1|Withdrawal by Subject|0|||
129445622|NCT01968070|465932879|FG004|Period 1|Withdrawal by Subject|0|||
129445623|NCT01968070|465932880|FG005|Period 1|Withdrawal by Subject|0|||
129445624|NCT01968070|465932881|FG006|Period 1|Withdrawal by Subject|1|||
129445625|NCT01968070|465932882|FG007|Period 1|Withdrawal by Subject|0|||
129445626|NCT01968070|465932883|FG008|Period 1|Withdrawal by Subject|0|||
129445627|NCT01968070|465932884|FG009|Period 1|Withdrawal by Subject|0|||
129445628|NCT01968070|465932885|FG010|Period 1|Withdrawal by Subject|0|||
129445629|NCT01968070|465932886|FG011|Period 1|Withdrawal by Subject|0|||
129445630|NCT01968070|465932887|FG012|Period 1|Withdrawal by Subject|0|||
129445631|NCT01968070|465932888|FG013|Period 1|Withdrawal by Subject|0|||
129445632|NCT01968070|465932889|FG014|Period 1|Withdrawal by Subject|0|||
129820811|NCT00006903|467307446|FG001|Overall Study|Ineligible|1|||
129445633|NCT01968070|465932890|FG015|Period 1|Withdrawal by Subject|1|||
129445634|NCT01968070|465932891|FG016|Period 1|Withdrawal by Subject|0|||
129820812|NCT00006903|467307447|FG002|Overall Study|Ineligible|2|||
129820813|NCT01366209|467307452|FG000|Overall Study|Adverse Event|6|||
129820814|NCT01366209|467307453|FG001|Overall Study|Adverse Event|7|||
129820815|NCT01366209|467307452|FG000|Overall Study|Withdrawal by Subject|4|||
129820816|NCT01366209|467307453|FG001|Overall Study|Withdrawal by Subject|4|||
129820817|NCT01366209|467307452|FG000|Overall Study|Death|12|||
129820818|NCT01366209|467307453|FG001|Overall Study|Death|19|||
129820819|NCT01366209|467307452|FG000|Overall Study|Lung transplantation|6|||
129820820|NCT01366209|467307453|FG001|Overall Study|Lung transplantation|1|||
129820821|NCT01366209|467307452|FG000|Overall Study|Lost to Follow-up|2|||
129820822|NCT01366209|467307453|FG001|Overall Study|Lost to Follow-up|1|||
129820823|NCT01366209|467307452|FG000|Overall Study|Physician Decision|1|||
129820824|NCT01366209|467307453|FG001|Overall Study|Physician Decision|0|||
129820825|NCT01366209|467307452|FG000|Overall Study|Sponsors decision|0|||
129820826|NCT01366209|467307453|FG001|Overall Study|Sponsors decision|1|||
129820827|NCT01366209|467307452|FG000|Overall Study|Withdrew consent|4|||
129820828|NCT01366209|467307453|FG001|Overall Study|Withdrew consent|3|||
129820829|NCT02670837|467307454|FG000|Overall Study|Death|2|||
129820830|NCT02670837|467307455|FG001|Overall Study|Death|0|||
129820831|NCT02670837|467307456|FG002|Overall Study|Death|0|||
129820832|NCT01053221|467307457|FG000|Overall Study|The study was closed prematurely|5|||
129820833|NCT01053221|467307458|FG001|Overall Study|The study was closed prematurely|9|||
129820834|NCT00752232|467307459|FG000|Overall Study|Protocol Violation|0|||
129820835|NCT00752232|467307460|FG001|Overall Study|Protocol Violation|0|||
129820836|NCT00752232|467307461|FG002|Overall Study|Protocol Violation|0|||
129820837|NCT00752232|467307462|FG003|Overall Study|Protocol Violation|0|||
129820838|NCT00752232|467307463|FG004|Overall Study|Protocol Violation|0|||
129820839|NCT00752232|467307464|FG005|Overall Study|Protocol Violation|1|||
129820840|NCT00752232|467307465|FG006|Overall Study|Protocol Violation|0|||
129820841|NCT00752232|467307459|FG000|Overall Study|Caregiver request|2|||
129820842|NCT00752232|467307460|FG001|Overall Study|Caregiver request|0|||
129820843|NCT00752232|467307461|FG002|Overall Study|Caregiver request|0|||
129820844|NCT00752232|467307462|FG003|Overall Study|Caregiver request|0|||
129820845|NCT00752232|467307463|FG004|Overall Study|Caregiver request|1|||
129820846|NCT00752232|467307464|FG005|Overall Study|Caregiver request|0|||
129820847|NCT00752232|467307465|FG006|Overall Study|Caregiver request|0|||
129820848|NCT00752232|467307459|FG000|Overall Study|Investigator request|0|||
129820849|NCT00752232|467307460|FG001|Overall Study|Investigator request|0|||
129820850|NCT00752232|467307461|FG002|Overall Study|Investigator request|0|||
129820851|NCT00752232|467307462|FG003|Overall Study|Investigator request|0|||
129820852|NCT00752232|467307463|FG004|Overall Study|Investigator request|1|||
129820853|NCT00752232|467307464|FG005|Overall Study|Investigator request|0|||
129820854|NCT00752232|467307465|FG006|Overall Study|Investigator request|0|||
129820855|NCT00752232|467307459|FG000|Overall Study|Subject request|0|||
129820856|NCT00752232|467307460|FG001|Overall Study|Subject request|0|||
129820857|NCT00752232|467307461|FG002|Overall Study|Subject request|1|||
129820858|NCT00752232|467307462|FG003|Overall Study|Subject request|0|||
129820859|NCT00752232|467307463|FG004|Overall Study|Subject request|0|||
129820860|NCT00752232|467307464|FG005|Overall Study|Subject request|0|||
129820861|NCT00752232|467307465|FG006|Overall Study|Subject request|0|||
129820862|NCT00752232|467307459|FG000|Overall Study|Group home admission|0|||
129820863|NCT00752232|467307460|FG001|Overall Study|Group home admission|0|||
129820864|NCT00752232|467307461|FG002|Overall Study|Group home admission|0|||
129820865|NCT00752232|467307462|FG003|Overall Study|Group home admission|1|||
129820866|NCT00752232|467307463|FG004|Overall Study|Group home admission|0|||
129820867|NCT00752232|467307464|FG005|Overall Study|Group home admission|0|||
129820868|NCT00752232|467307465|FG006|Overall Study|Group home admission|0|||
129820869|NCT00752232|467307459|FG000|Overall Study|Caregiver could not attend the subject|0|||
129820870|NCT00752232|467307460|FG001|Overall Study|Caregiver could not attend the subject|0|||
129820871|NCT00752232|467307461|FG002|Overall Study|Caregiver could not attend the subject|0|||
129820872|NCT00752232|467307462|FG003|Overall Study|Caregiver could not attend the subject|0|||
129820873|NCT00752232|467307463|FG004|Overall Study|Caregiver could not attend the subject|1|||
129820874|NCT00752232|467307464|FG005|Overall Study|Caregiver could not attend the subject|0|||
129820875|NCT00752232|467307465|FG006|Overall Study|Caregiver could not attend the subject|0|||
129820876|NCT01919723|467307466|FG000|Overall Study|Blood Samples Hemolyzed|2|||
129897353|NCT00817635|467584334|FG000|Overall Study|Lost to Follow-up|0|||
129897354|NCT00817635|467584335|FG001|Overall Study|Lost to Follow-up|1|||
129897355|NCT00817635|467584336|FG002|Overall Study|Lost to Follow-up|0|||
129820877|NCT01919723|467307467|FG001|Overall Study|Blood Samples Hemolyzed|2|||
129820878|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
129820879|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
129820880|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
129820881|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
129820882|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
129820883|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
129820884|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
129897356|NCT00817635|467584337|FG003|Overall Study|Lost to Follow-up|1|||
129820885|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
129820886|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
129820887|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
129820888|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Death|2|||
129820889|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Death|1|||
129820890|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Death|4|||
129820891|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Death|0|||
129820892|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Death|0|||
129820893|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
129820894|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
129820895|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
129820896|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
129820897|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
129820898|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Other Reason|1|||
129820899|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Other Reason|3|||
129820900|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Other Reason|2|||
129820901|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Other Reason|0|||
129820902|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Other Reason|0|||
129820903|NCT00555321|467307468|FG000|Treatment Phase up to 12-months|Never treated|2|||
129820904|NCT00555321|467307469|FG001|Treatment Phase up to 12-months|Never treated|3|||
129820905|NCT00555321|467307470|FG002|Treatment Phase up to 12-months|Never treated|1|||
129820906|NCT00555321|467307471|FG003|Treatment Phase up to 12-months|Never treated|0|||
129820907|NCT00555321|467307472|FG004|Treatment Phase up to 12-months|Never treated|4|||
129820908|NCT00555321|467307468|FG000|Long-term Extension Phase|Adverse Event|2|||
129820909|NCT00555321|467307469|FG001|Long-term Extension Phase|Adverse Event|5|||
129820910|NCT00555321|467307470|FG002|Long-term Extension Phase|Adverse Event|2|||
129820911|NCT00555321|467307471|FG003|Long-term Extension Phase|Adverse Event|1|||
129820912|NCT00555321|467307472|FG004|Long-term Extension Phase|Adverse Event|0|||
129820913|NCT00555321|467307468|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
129820914|NCT00555321|467307469|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
129820915|NCT00555321|467307470|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
129820916|NCT00555321|467307471|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
129820917|NCT00555321|467307472|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
129820918|NCT00555321|467307468|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
129820919|NCT00555321|467307469|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
129820920|NCT00555321|467307470|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
129820921|NCT00555321|467307471|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
129820922|NCT00555321|467307472|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
129820923|NCT00555321|467307468|FG000|Long-term Extension Phase|Death|2|||
129820924|NCT00555321|467307469|FG001|Long-term Extension Phase|Death|0|||
129820925|NCT00555321|467307470|FG002|Long-term Extension Phase|Death|0|||
129820926|NCT00555321|467307471|FG003|Long-term Extension Phase|Death|3|||
129820927|NCT00555321|467307472|FG004|Long-term Extension Phase|Death|0|||
129820928|NCT00555321|467307468|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820929|NCT00555321|467307469|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820930|NCT00555321|467307470|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820931|NCT00555321|467307471|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
129820932|NCT00555321|467307472|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
129820933|NCT00555321|467307468|FG000|Long-term Extension Phase|Other Reason|1|||
129820934|NCT00555321|467307469|FG001|Long-term Extension Phase|Other Reason|0|||
129820935|NCT00555321|467307470|FG002|Long-term Extension Phase|Other Reason|2|||
129820936|NCT00555321|467307471|FG003|Long-term Extension Phase|Other Reason|0|||
129820937|NCT00555321|467307472|FG004|Long-term Extension Phase|Other Reason|0|||
129820938|NCT00582166|467307475|FG000|Overall Study|Death|1|||
129820939|NCT00582166|467307475|FG000|Overall Study|Ineligible pathology|1|||
129820940|NCT02532972|467307476|FG000|Overall Study|Withdrawal by Subject|1|||
129820941|NCT01606436|467307477|FG000|Overall Study|Withdrawal by Subject|0|||
129820942|NCT01606436|467307478|FG001|Overall Study|Withdrawal by Subject|0|||
129820943|NCT01606436|467307479|FG002|Overall Study|Withdrawal by Subject|1|||
129820944|NCT01606436|467307480|FG003|Overall Study|Withdrawal by Subject|1|||
129820945|NCT01606436|467307481|FG004|Overall Study|Withdrawal by Subject|1|||
129820946|NCT01606436|467307482|FG005|Overall Study|Withdrawal by Subject|0|||
129820947|NCT01606436|467307477|FG000|Overall Study|Adverse Event|0|||
129820948|NCT01606436|467307478|FG001|Overall Study|Adverse Event|0|||
129820949|NCT01606436|467307479|FG002|Overall Study|Adverse Event|1|||
129820950|NCT01606436|467307480|FG003|Overall Study|Adverse Event|0|||
129820951|NCT01606436|467307481|FG004|Overall Study|Adverse Event|0|||
129820952|NCT01606436|467307482|FG005|Overall Study|Adverse Event|0|||
129820953|NCT01606436|467307477|FG000|Overall Study|Sponsor Decision|0|||
129820954|NCT01606436|467307478|FG001|Overall Study|Sponsor Decision|0|||
129820955|NCT01606436|467307479|FG002|Overall Study|Sponsor Decision|0|||
129820956|NCT01606436|467307480|FG003|Overall Study|Sponsor Decision|1|||
129820957|NCT01606436|467307481|FG004|Overall Study|Sponsor Decision|0|||
129820958|NCT01606436|467307482|FG005|Overall Study|Sponsor Decision|0|||
129820959|NCT02859454|467307483|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
129820960|NCT03944954|467307484|FG000|Overall Study|Withdrawal by Subject|22|||
129820961|NCT03944954|467307485|FG001|Overall Study|Withdrawal by Subject|4|||
129820962|NCT03944954|467307484|FG000|Overall Study|Lost to Follow-up|18|||
129820963|NCT03944954|467307485|FG001|Overall Study|Lost to Follow-up|0|||
129820964|NCT03944954|467307484|FG000|Overall Study|Failed Medical Screening|7|||
129820965|NCT03944954|467307485|FG001|Overall Study|Failed Medical Screening|0|||
129820966|NCT02268084|467307486|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
129820967|NCT02268084|467307487|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
129820968|NCT02268084|467307486|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
129820969|NCT02268084|467307487|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
129820970|NCT05227027|467307488|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
129820971|NCT05227027|467307489|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
129820972|NCT03334448|467307493|FG000|Washout|Personal Reason|0|||
129820973|NCT03334448|467307494|FG001|Washout|Personal Reason|1|||
129820974|NCT03334448|467307495|FG002|Washout|Personal Reason|0|||
129820975|NCT03334448|467307496|FG003|Washout|Personal Reason|0|||
129820976|NCT03334448|467307493|FG000|Washout|Protocol Violation|0|||
129820977|NCT03334448|467307494|FG001|Washout|Protocol Violation|0|||
129820978|NCT03334448|467307495|FG002|Washout|Protocol Violation|0|||
129820979|NCT03334448|467307496|FG003|Washout|Protocol Violation|1|||
129820980|NCT01683383|467307498|FG000|Overall Study|Infant was not transported|1|||
129820981|NCT01683383|467307499|FG001|Overall Study|Infant was not transported|0|||
129820982|NCT00855920|467307500|FG000|Overall Study|Protocol Violation|0|||
129820983|NCT00855920|467307501|FG001|Overall Study|Protocol Violation|0|||
129820984|NCT00855920|467307502|FG002|Overall Study|Protocol Violation|2|||
129820985|NCT00855920|467307500|FG000|Overall Study|Adverse Event|2|||
129820986|NCT00855920|467307501|FG001|Overall Study|Adverse Event|1|||
129820987|NCT00855920|467307502|FG002|Overall Study|Adverse Event|1|||
129820988|NCT00855920|467307500|FG000|Overall Study|Lack of Efficacy|2|||
129820989|NCT00855920|467307501|FG001|Overall Study|Lack of Efficacy|2|||
129820990|NCT00855920|467307502|FG002|Overall Study|Lack of Efficacy|2|||
129820991|NCT00855920|467307500|FG000|Overall Study|Withdrawal by Subject|2|||
129820992|NCT00855920|467307501|FG001|Overall Study|Withdrawal by Subject|3|||
129820993|NCT00855920|467307502|FG002|Overall Study|Withdrawal by Subject|2|||
129820994|NCT00855920|467307500|FG000|Overall Study|Lost to Follow-up|1|||
129820995|NCT00855920|467307501|FG001|Overall Study|Lost to Follow-up|0|||
129820996|NCT00855920|467307502|FG002|Overall Study|Lost to Follow-up|2|||
129820997|NCT00855920|467307500|FG000|Overall Study|Death|0|||
129820998|NCT00855920|467307501|FG001|Overall Study|Death|1|||
129820999|NCT00855920|467307502|FG002|Overall Study|Death|0|||
129821000|NCT00855920|467307500|FG000|Overall Study|Decision by the sponsor|0|||
129821001|NCT00855920|467307501|FG001|Overall Study|Decision by the sponsor|1|||
129821002|NCT00855920|467307502|FG002|Overall Study|Decision by the sponsor|1|||
129821003|NCT00855920|467307500|FG000|Overall Study|Other than specified above|1|||
129821004|NCT00855920|467307501|FG001|Overall Study|Other than specified above|1|||
129821005|NCT00855920|467307502|FG002|Overall Study|Other than specified above|1|||
129821006|NCT00996307|467307503|FG000|Overall Study|Adverse Event|0|||
129821007|NCT00996307|467307504|FG001|Overall Study|Adverse Event|1|||
129821008|NCT00996307|467307505|FG002|Overall Study|Adverse Event|0|||
129821009|NCT00996307|467307506|FG003|Overall Study|Adverse Event|0|||
129821010|NCT00996307|467307503|FG000|Overall Study|Withdrawal by Subject|3|||
129821011|NCT00996307|467307504|FG001|Overall Study|Withdrawal by Subject|2|||
129821012|NCT00996307|467307505|FG002|Overall Study|Withdrawal by Subject|5|||
129821013|NCT00996307|467307506|FG003|Overall Study|Withdrawal by Subject|5|||
129897357|NCT00817635|467584338|FG004|Overall Study|Lost to Follow-up|0|||
129821014|NCT00996307|467307503|FG000|Overall Study|Lost to Follow-up|13|||
129821015|NCT00996307|467307504|FG001|Overall Study|Lost to Follow-up|13|||
129821016|NCT00996307|467307505|FG002|Overall Study|Lost to Follow-up|7|||
129821017|NCT00996307|467307506|FG003|Overall Study|Lost to Follow-up|15|||
129821018|NCT00996307|467307503|FG000|Overall Study|Administrative reason|0|||
129821019|NCT00996307|467307504|FG001|Overall Study|Administrative reason|1|||
129821020|NCT00996307|467307505|FG002|Overall Study|Administrative reason|0|||
129821021|NCT00996307|467307506|FG003|Overall Study|Administrative reason|0|||
129821022|NCT00996307|467307503|FG000|Overall Study|Unable to classify|4|||
129821023|NCT00996307|467307504|FG001|Overall Study|Unable to classify|0|||
129821024|NCT00996307|467307505|FG002|Overall Study|Unable to classify|2|||
129821025|NCT00996307|467307506|FG003|Overall Study|Unable to classify|1|||
129821026|NCT02496611|467307509|FG000|Overall Study|Lost to Follow-up|2|||
129445635|NCT01968070|465932892|FG017|Period 1|Withdrawal by Subject|0|||
129445636|NCT01968070|465932875|FG000|Period 1|Protocol Violation|0|||
129821027|NCT02496611|467307510|FG001|Overall Study|Lost to Follow-up|1|||
129821028|NCT02496611|467307509|FG000|Overall Study|Withdrawal by Subject|5|||
129821029|NCT02496611|467307510|FG001|Overall Study|Withdrawal by Subject|2|||
129821030|NCT02788357|467307514|FG000|Overall Study|Lost to Follow-up|3|||
129821031|NCT02788357|467307515|FG001|Overall Study|Lost to Follow-up|0|||
129821032|NCT01365910|467307516|FG000|Overall Study|Withdrawal by Subject|7|||
129821033|NCT01365910|467307516|FG000|Overall Study|disease progression|18|||
129821034|NCT01365910|467307516|FG000|Overall Study|Adverse Event|3|||
129821035|NCT01365910|467307516|FG000|Overall Study|other complicating disease|1|||
129821036|NCT01365910|467307516|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
129821037|NCT00371137|467307517|FG000|Overall Study|Adverse Event|20|||
129821038|NCT00371137|467307518|FG001|Overall Study|Adverse Event|35|||
129821039|NCT00371137|467307519|FG002|Overall Study|Adverse Event|42|||
129821040|NCT00371137|467307517|FG000|Overall Study|Withdrawal by Subject|11|||
129821041|NCT00371137|467307518|FG001|Overall Study|Withdrawal by Subject|10|||
129821042|NCT00371137|467307519|FG002|Overall Study|Withdrawal by Subject|15|||
129821043|NCT00371137|467307517|FG000|Overall Study|Lost to Follow-up|6|||
129821044|NCT00371137|467307518|FG001|Overall Study|Lost to Follow-up|3|||
129821045|NCT00371137|467307519|FG002|Overall Study|Lost to Follow-up|5|||
129821046|NCT00371137|467307517|FG000|Overall Study|Lack of Efficacy|30|||
129821047|NCT00371137|467307518|FG001|Overall Study|Lack of Efficacy|12|||
129821048|NCT00371137|467307519|FG002|Overall Study|Lack of Efficacy|13|||
129821049|NCT00371137|467307517|FG000|Overall Study|Sponsor Decision|2|||
129821050|NCT00371137|467307518|FG001|Overall Study|Sponsor Decision|1|||
129821051|NCT00371137|467307519|FG002|Overall Study|Sponsor Decision|2|||
129445637|NCT01968070|465932876|FG001|Period 1|Protocol Violation|0|||
129445638|NCT01968070|465932877|FG002|Period 1|Protocol Violation|0|||
129445639|NCT01968070|465932878|FG003|Period 1|Protocol Violation|1|||
129445640|NCT01968070|465932879|FG004|Period 1|Protocol Violation|1|||
129445641|NCT01968070|465932880|FG005|Period 1|Protocol Violation|0|||
129445642|NCT01968070|465932881|FG006|Period 1|Protocol Violation|0|||
129445643|NCT01968070|465932882|FG007|Period 1|Protocol Violation|0|||
129445644|NCT01968070|465932883|FG008|Period 1|Protocol Violation|0|||
129445645|NCT01968070|465932884|FG009|Period 1|Protocol Violation|0|||
129445646|NCT01968070|465932885|FG010|Period 1|Protocol Violation|0|||
129445647|NCT01968070|465932886|FG011|Period 1|Protocol Violation|0|||
129445648|NCT01968070|465932887|FG012|Period 1|Protocol Violation|0|||
129445649|NCT01968070|465932888|FG013|Period 1|Protocol Violation|0|||
129445650|NCT01968070|465932889|FG014|Period 1|Protocol Violation|0|||
129445651|NCT01968070|465932890|FG015|Period 1|Protocol Violation|0|||
129445652|NCT01968070|465932891|FG016|Period 1|Protocol Violation|0|||
129445653|NCT01968070|465932892|FG017|Period 1|Protocol Violation|0|||
129445654|NCT01968070|465932875|FG000|Period 1|Lost to Follow-up|0|||
129445655|NCT01968070|465932876|FG001|Period 1|Lost to Follow-up|0|||
129445656|NCT01968070|465932877|FG002|Period 1|Lost to Follow-up|0|||
129445657|NCT01968070|465932878|FG003|Period 1|Lost to Follow-up|1|||
129445658|NCT01968070|465932879|FG004|Period 1|Lost to Follow-up|0|||
129445659|NCT01968070|465932880|FG005|Period 1|Lost to Follow-up|0|||
129445660|NCT01968070|465932881|FG006|Period 1|Lost to Follow-up|0|||
129445661|NCT01968070|465932882|FG007|Period 1|Lost to Follow-up|0|||
129445662|NCT01968070|465932883|FG008|Period 1|Lost to Follow-up|0|||
129445663|NCT01968070|465932884|FG009|Period 1|Lost to Follow-up|0|||
129445664|NCT01968070|465932885|FG010|Period 1|Lost to Follow-up|0|||
129445665|NCT01968070|465932886|FG011|Period 1|Lost to Follow-up|0|||
129445666|NCT01968070|465932887|FG012|Period 1|Lost to Follow-up|0|||
129445667|NCT01968070|465932888|FG013|Period 1|Lost to Follow-up|0|||
129445668|NCT01968070|465932889|FG014|Period 1|Lost to Follow-up|0|||
129445669|NCT01968070|465932890|FG015|Period 1|Lost to Follow-up|0|||
129445670|NCT01968070|465932891|FG016|Period 1|Lost to Follow-up|0|||
129445671|NCT01968070|465932892|FG017|Period 1|Lost to Follow-up|0|||
129445672|NCT01968070|465932875|FG000|Period 1|Adverse Event|0|||
129445673|NCT01968070|465932876|FG001|Period 1|Adverse Event|0|||
129445674|NCT01968070|465932877|FG002|Period 1|Adverse Event|0|||
129445675|NCT01968070|465932878|FG003|Period 1|Adverse Event|0|||
129445676|NCT01968070|465932879|FG004|Period 1|Adverse Event|0|||
129445677|NCT01968070|465932880|FG005|Period 1|Adverse Event|0|||
129445678|NCT01968070|465932881|FG006|Period 1|Adverse Event|1|||
129821052|NCT00371137|467307517|FG000|Overall Study|Physician Decision|1|||
129821053|NCT00371137|467307518|FG001|Overall Study|Physician Decision|1|||
129821054|NCT00371137|467307519|FG002|Overall Study|Physician Decision|1|||
129821055|NCT00371137|467307517|FG000|Overall Study|Protocol Violation|2|||
129821056|NCT00371137|467307518|FG001|Overall Study|Protocol Violation|1|||
129821057|NCT00371137|467307519|FG002|Overall Study|Protocol Violation|1|||
129821058|NCT00536198|467307520|FG000|Overall Study|Lost to Follow-up|15|||
129445679|NCT01968070|465932882|FG007|Period 1|Adverse Event|0|||
129445680|NCT01968070|465932883|FG008|Period 1|Adverse Event|0|||
129445681|NCT01968070|465932884|FG009|Period 1|Adverse Event|0|||
129445682|NCT01968070|465932885|FG010|Period 1|Adverse Event|0|||
129445683|NCT01968070|465932886|FG011|Period 1|Adverse Event|0|||
129821059|NCT00536198|467307521|FG001|Overall Study|Lost to Follow-up|14|||
129821060|NCT00536198|467307520|FG000|Overall Study|Withdrawal by Subject|16|||
129821061|NCT00536198|467307521|FG001|Overall Study|Withdrawal by Subject|12|||
129821062|NCT00536198|467307520|FG000|Overall Study|Adverse Event|2|||
129821063|NCT00536198|467307521|FG001|Overall Study|Adverse Event|2|||
129821064|NCT00536198|467307520|FG000|Overall Study|Rescue|3|||
129821065|NCT00536198|467307521|FG001|Overall Study|Rescue|9|||
129821066|NCT00536198|467307520|FG000|Overall Study|Pregnancy|1|||
129821067|NCT00536198|467307521|FG001|Overall Study|Pregnancy|1|||
129821068|NCT00536198|467307520|FG000|Overall Study|Protocol Violation|0|||
129821069|NCT00536198|467307521|FG001|Overall Study|Protocol Violation|1|||
129821070|NCT02013791|467307522|FG000|Period 1|Lost to Follow-up|0|||
129821071|NCT02013791|467307523|FG001|Period 1|Lost to Follow-up|0|||
129821072|NCT02013791|467307524|FG002|Period 1|Lost to Follow-up|0|||
129821073|NCT02013791|467307525|FG003|Period 1|Lost to Follow-up|1|||
129821074|NCT02013791|467307526|FG004|Period 1|Lost to Follow-up|0|||
129821075|NCT02013791|467307527|FG005|Period 1|Lost to Follow-up|0|||
129821076|NCT02013791|467307528|FG006|Period 1|Lost to Follow-up|1|||
129821077|NCT02013791|467307529|FG007|Period 1|Lost to Follow-up|1|||
129821078|NCT02013791|467307530|FG008|Period 1|Lost to Follow-up|0|||
129821079|NCT02013791|467307522|FG000|Period 1|Other Miscellaneous Reasons|0|||
129821080|NCT02013791|467307523|FG001|Period 1|Other Miscellaneous Reasons|2|||
129821081|NCT02013791|467307524|FG002|Period 1|Other Miscellaneous Reasons|0|||
129821082|NCT02013791|467307525|FG003|Period 1|Other Miscellaneous Reasons|0|||
129821083|NCT02013791|467307526|FG004|Period 1|Other Miscellaneous Reasons|0|||
129821084|NCT02013791|467307527|FG005|Period 1|Other Miscellaneous Reasons|0|||
129821085|NCT02013791|467307528|FG006|Period 1|Other Miscellaneous Reasons|0|||
129821086|NCT02013791|467307529|FG007|Period 1|Other Miscellaneous Reasons|0|||
129821087|NCT02013791|467307530|FG008|Period 1|Other Miscellaneous Reasons|0|||
129821088|NCT03798483|467307531|FG000|Overall Study|Lost to Follow-up|2|||
129821089|NCT01666782|467307532|FG000|Overall Study|Received 2 doses of vaccine|0|||
129821090|NCT01666782|467307533|FG001|Overall Study|Received 2 doses of vaccine|1|||
129821091|NCT01666782|467307532|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
129821092|NCT01666782|467307533|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
129821093|NCT01691781|467307545|FG000|Overall Study|Withdrawal by Subject|4|||
129821094|NCT01691781|467307546|FG001|Overall Study|Withdrawal by Subject|3|||
129821095|NCT01691781|467307545|FG000|Overall Study|Physician Decision|1|||
129821096|NCT01691781|467307546|FG001|Overall Study|Physician Decision|1|||
129821097|NCT01691781|467307545|FG000|Overall Study|Protocol Violation|2|||
129821098|NCT01691781|467307546|FG001|Overall Study|Protocol Violation|2|||
129821099|NCT01691781|467307545|FG000|Overall Study|Adverse Event|0|||
129821100|NCT01691781|467307546|FG001|Overall Study|Adverse Event|1|||
129821101|NCT01605877|467307547|FG000|Overall Study|Withdrawal by Subject|1|||
129821102|NCT01918085|467307550|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
129821103|NCT01918085|467307551|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
129821104|NCT00687323|467307558|FG000|Overall Study|Death|25|||
129821105|NCT00687323|467307558|FG000|Overall Study|Withdrawal by Subject|1|||
129821106|NCT00687323|467307558|FG000|Overall Study|Excluded from efficacy evaluations|6|||
129821107|NCT00687323|467307558|FG000|Overall Study|Screen failure|148|||
129821108|NCT00679302|467307561|FG000|Overall Study|Lost to Follow-up|8|||
129821109|NCT00679302|467307562|FG001|Overall Study|Lost to Follow-up|4|||
129821110|NCT05109442|467307565|FG000|Overall Study|Withdrawal by Subject|0|||
129821111|NCT05109442|467307566|FG001|Overall Study|Withdrawal by Subject|0|||
129821112|NCT05109442|467307567|FG002|Overall Study|Withdrawal by Subject|1|||
129821113|NCT05109442|467307568|FG003|Overall Study|Withdrawal by Subject|0|||
129821114|NCT05109442|467307569|FG004|Overall Study|Withdrawal by Subject|0|||
129821115|NCT05109442|467307570|FG005|Overall Study|Withdrawal by Subject|0|||
129821116|NCT05109442|467307565|FG000|Overall Study|Adverse Event|0|||
129821117|NCT05109442|467307566|FG001|Overall Study|Adverse Event|1|||
129821118|NCT05109442|467307567|FG002|Overall Study|Adverse Event|5|||
129821119|NCT05109442|467307568|FG003|Overall Study|Adverse Event|0|||
129821120|NCT05109442|467307569|FG004|Overall Study|Adverse Event|0|||
129821121|NCT05109442|467307570|FG005|Overall Study|Adverse Event|2|||
129821122|NCT05109442|467307565|FG000|Overall Study|Death|0|||
129821123|NCT05109442|467307566|FG001|Overall Study|Death|0|||
129821124|NCT05109442|467307567|FG002|Overall Study|Death|4|||
129821125|NCT05109442|467307568|FG003|Overall Study|Death|0|||
129821126|NCT05109442|467307569|FG004|Overall Study|Death|0|||
129821127|NCT05109442|467307570|FG005|Overall Study|Death|1|||
129821128|NCT05109442|467307565|FG000|Overall Study|Physician Decision|1|||
129821129|NCT05109442|467307566|FG001|Overall Study|Physician Decision|0|||
129821130|NCT05109442|467307567|FG002|Overall Study|Physician Decision|1|||
129821131|NCT05109442|467307568|FG003|Overall Study|Physician Decision|0|||
129821132|NCT05109442|467307569|FG004|Overall Study|Physician Decision|0|||
129821133|NCT05109442|467307570|FG005|Overall Study|Physician Decision|2|||
129821134|NCT05109442|467307565|FG000|Overall Study|Other than listed|0|||
129821135|NCT05109442|467307566|FG001|Overall Study|Other than listed|0|||
129821136|NCT05109442|467307567|FG002|Overall Study|Other than listed|9|||
129821137|NCT05109442|467307568|FG003|Overall Study|Other than listed|2|||
129821138|NCT05109442|467307569|FG004|Overall Study|Other than listed|0|||
129821139|NCT05109442|467307570|FG005|Overall Study|Other than listed|8|||
129821140|NCT05109442|467307565|FG000|Overall Study|Lack of Efficacy|3|||
129821141|NCT05109442|467307566|FG001|Overall Study|Lack of Efficacy|5|||
129821142|NCT05109442|467307567|FG002|Overall Study|Lack of Efficacy|29|||
129821143|NCT05109442|467307568|FG003|Overall Study|Lack of Efficacy|10|||
129821144|NCT05109442|467307569|FG004|Overall Study|Lack of Efficacy|11|||
129821145|NCT05109442|467307570|FG005|Overall Study|Lack of Efficacy|17|||
129821146|NCT04853225|467307571|FG000|Overall Study|Withdrawal by Subject|81|||
129821147|NCT04853225|467307572|FG001|Overall Study|Withdrawal by Subject|4|||
129821148|NCT04853225|467307573|FG002|Overall Study|Withdrawal by Subject|1|||
129821149|NCT04853225|467307571|FG000|Overall Study|Physician Decision|12|||
129821150|NCT04853225|467307572|FG001|Overall Study|Physician Decision|4|||
129821151|NCT04853225|467307573|FG002|Overall Study|Physician Decision|1|||
129821152|NCT04853225|467307571|FG000|Overall Study|Lost to Follow-up|50|||
129821153|NCT04853225|467307572|FG001|Overall Study|Lost to Follow-up|0|||
129821154|NCT04853225|467307573|FG002|Overall Study|Lost to Follow-up|0|||
129821155|NCT04853225|467307571|FG000|Overall Study|Other|102|||
129821156|NCT04853225|467307572|FG001|Overall Study|Other|11|||
129821157|NCT04853225|467307573|FG002|Overall Study|Other|5|||
129821158|NCT04853225|467307571|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
129821159|NCT04853225|467307572|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
129821160|NCT04853225|467307573|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
129821161|NCT04853225|467307571|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
129821162|NCT04853225|467307572|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
129821163|NCT04853225|467307573|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
129821164|NCT03918447|467307574|FG000|Overall Study|Death|1|||
129821165|NCT03918447|467307575|FG001|Overall Study|Death|0|||
129821166|NCT03918447|467307574|FG000|Overall Study|Lost to Follow-up|13|||
129821167|NCT03918447|467307575|FG001|Overall Study|Lost to Follow-up|6|||
129821168|NCT03918447|467307574|FG000|Overall Study|Withdrawal by Subject|19|||
129821169|NCT03918447|467307575|FG001|Overall Study|Withdrawal by Subject|17|||
129821170|NCT03918447|467307574|FG000|Overall Study|Study Terminated by Sponsor|195|||
129821171|NCT03918447|467307575|FG001|Overall Study|Study Terminated by Sponsor|197|||
129821172|NCT03918447|467307574|FG000|Overall Study|Reason not Specified|0|||
129821173|NCT03918447|467307575|FG001|Overall Study|Reason not Specified|1|||
129821174|NCT01405456|467307576|FG000|Overall Study|Lost to Follow-up|2|||
129821175|NCT01405456|467307577|FG001|Overall Study|Lost to Follow-up|1|||
129821176|NCT01405456|467307576|FG000|Overall Study|Physician Decision|1|||
129821177|NCT01405456|467307577|FG001|Overall Study|Physician Decision|0|||
129821178|NCT01937559|467307578|FG000|Overall Study|Physician Decision|3|||
129821179|NCT01937559|467307579|FG001|Overall Study|Physician Decision|3|||
129821180|NCT01937559|467307580|FG002|Overall Study|Physician Decision|0|||
129821181|NCT01937559|467307578|FG000|Overall Study|Withdrawal by Subject|6|||
129821182|NCT01937559|467307579|FG001|Overall Study|Withdrawal by Subject|4|||
129821183|NCT01937559|467307580|FG002|Overall Study|Withdrawal by Subject|0|||
129821184|NCT01937559|467307578|FG000|Overall Study|screen fail|2|||
129821185|NCT01937559|467307579|FG001|Overall Study|screen fail|4|||
129821186|NCT01937559|467307580|FG002|Overall Study|screen fail|0|||
129821187|NCT03909295|467308977|FG000|Overall Study|Adverse Event|2|||
129821188|NCT03909295|467308977|FG000|Overall Study|Study terminated by sponsor|50|||
129821189|NCT00720434|467308978|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
129821190|NCT00720434|467308979|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
129821191|NCT00720434|467308980|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
129821192|NCT00720434|467308981|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
129821193|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
129821194|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
129821195|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
129821196|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
129821197|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
129821198|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
129821199|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
129821200|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
129821201|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
129821202|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
129821203|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
129821204|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
129821205|NCT00720434|467308978|FG000|Open-Label Period (Week 5-72)|Other|4|||
129821206|NCT00720434|467308979|FG001|Open-Label Period (Week 5-72)|Other|3|||
129821207|NCT00720434|467308980|FG002|Open-Label Period (Week 5-72)|Other|3|||
129821208|NCT00720434|467308981|FG003|Open-Label Period (Week 5-72)|Other|2|||
129821209|NCT03138889|467308989|FG000|Overall Study|Withdrawal by Subject|5|||
129821210|NCT03138889|467308990|FG001|Overall Study|Withdrawal by Subject|5|||
129821211|NCT03138889|467308991|FG002|Overall Study|Withdrawal by Subject|0|||
129821212|NCT03138889|467308992|FG003|Overall Study|Withdrawal by Subject|2|||
129821213|NCT03138889|467308993|FG004|Overall Study|Withdrawal by Subject|1|||
129821214|NCT03138889|467308994|FG005|Overall Study|Withdrawal by Subject|3|||
129821215|NCT03138889|467308995|FG006|Overall Study|Withdrawal by Subject|0|||
129821216|NCT03138889|467308996|FG007|Overall Study|Withdrawal by Subject|1|||
129821217|NCT02289690|467308999|FG000|Overall Study|Adverse Event Related to Progression|0|||
129821218|NCT02289690|467309000|FG001|Overall Study|Adverse Event Related to Progression|1|||
129821219|NCT02289690|467309001|FG002|Overall Study|Adverse Event Related to Progression|1|||
129821220|NCT02289690|467309002|FG003|Overall Study|Adverse Event Related to Progression|0|||
129821221|NCT02289690|467309003|FG004|Overall Study|Adverse Event Related to Progression|1|||
129821222|NCT02289690|467309004|FG005|Overall Study|Adverse Event Related to Progression|0|||
129821223|NCT02289690|467309005|FG006|Overall Study|Adverse Event Related to Progression|1|||
129821224|NCT02289690|467309006|FG007|Overall Study|Adverse Event Related to Progression|0|||
129821225|NCT02289690|467309007|FG008|Overall Study|Adverse Event Related to Progression|0|||
129821226|NCT02289690|467309008|FG009|Overall Study|Adverse Event Related to Progression|0|||
129821227|NCT02289690|467308999|FG000|Overall Study|Withdrawal by Subject|1|||
129821228|NCT02289690|467309000|FG001|Overall Study|Withdrawal by Subject|0|||
129821229|NCT02289690|467309001|FG002|Overall Study|Withdrawal by Subject|0|||
129821230|NCT02289690|467309002|FG003|Overall Study|Withdrawal by Subject|0|||
129821231|NCT02289690|467309003|FG004|Overall Study|Withdrawal by Subject|1|||
129821232|NCT02289690|467309004|FG005|Overall Study|Withdrawal by Subject|1|||
129821233|NCT02289690|467309005|FG006|Overall Study|Withdrawal by Subject|0|||
129821234|NCT02289690|467309006|FG007|Overall Study|Withdrawal by Subject|0|||
129821235|NCT02289690|467309007|FG008|Overall Study|Withdrawal by Subject|4|||
129821236|NCT02289690|467309008|FG009|Overall Study|Withdrawal by Subject|2|||
129821237|NCT02289690|467308999|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
129821238|NCT02289690|467309000|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
129821239|NCT02289690|467309001|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
129821240|NCT02289690|467309002|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
129821241|NCT02289690|467309003|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
129821242|NCT02289690|467309004|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
129821243|NCT02289690|467309005|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
129821244|NCT02289690|467309006|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
129821245|NCT02289690|467309007|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
129821246|NCT02289690|467309008|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
129821247|NCT02289690|467308999|FG000|Overall Study|Lost to Follow-up|0|||
129821248|NCT02289690|467309000|FG001|Overall Study|Lost to Follow-up|0|||
129821249|NCT02289690|467309001|FG002|Overall Study|Lost to Follow-up|0|||
129821250|NCT02289690|467309002|FG003|Overall Study|Lost to Follow-up|0|||
129821251|NCT02289690|467309003|FG004|Overall Study|Lost to Follow-up|0|||
129821252|NCT02289690|467309004|FG005|Overall Study|Lost to Follow-up|0|||
129821253|NCT02289690|467309005|FG006|Overall Study|Lost to Follow-up|0|||
129821254|NCT02289690|467309006|FG007|Overall Study|Lost to Follow-up|1|||
129821255|NCT02289690|467309007|FG008|Overall Study|Lost to Follow-up|0|||
129821256|NCT02289690|467309008|FG009|Overall Study|Lost to Follow-up|2|||
129821257|NCT02289690|467308999|FG000|Overall Study|Death|0|||
129821258|NCT02289690|467309000|FG001|Overall Study|Death|0|||
129821259|NCT02289690|467309001|FG002|Overall Study|Death|0|||
129821260|NCT02289690|467309002|FG003|Overall Study|Death|0|||
129821261|NCT02289690|467309003|FG004|Overall Study|Death|0|||
129821262|NCT02289690|467309004|FG005|Overall Study|Death|0|||
129821263|NCT02289690|467309005|FG006|Overall Study|Death|0|||
129821264|NCT02289690|467309006|FG007|Overall Study|Death|49|||
129821265|NCT02289690|467309007|FG008|Overall Study|Death|45|||
129821266|NCT02289690|467309008|FG009|Overall Study|Death|41|||
129821267|NCT02289690|467308999|FG000|Overall Study|Sponsor Discontinued Study|0|||
129821268|NCT02289690|467309000|FG001|Overall Study|Sponsor Discontinued Study|0|||
129821269|NCT02289690|467309001|FG002|Overall Study|Sponsor Discontinued Study|0|||
129821270|NCT02289690|467309002|FG003|Overall Study|Sponsor Discontinued Study|0|||
129821271|NCT02289690|467309003|FG004|Overall Study|Sponsor Discontinued Study|0|||
129821272|NCT02289690|467309004|FG005|Overall Study|Sponsor Discontinued Study|0|||
129821273|NCT02289690|467309005|FG006|Overall Study|Sponsor Discontinued Study|0|||
129821274|NCT02289690|467309006|FG007|Overall Study|Sponsor Discontinued Study|9|||
129821275|NCT02289690|467309007|FG008|Overall Study|Sponsor Discontinued Study|7|||
129821276|NCT02289690|467309008|FG009|Overall Study|Sponsor Discontinued Study|15|||
129821277|NCT02289690|467308999|FG000|Overall Study|Other|0|||
129821278|NCT02289690|467309000|FG001|Overall Study|Other|0|||
129821279|NCT02289690|467309001|FG002|Overall Study|Other|0|||
129821280|NCT02289690|467309002|FG003|Overall Study|Other|1|||
129821281|NCT02289690|467309003|FG004|Overall Study|Other|1|||
129821282|NCT02289690|467309004|FG005|Overall Study|Other|0|||
129821283|NCT02289690|467309005|FG006|Overall Study|Other|1|||
129821284|NCT02289690|467309006|FG007|Overall Study|Other|2|||
129821285|NCT02289690|467309007|FG008|Overall Study|Other|3|||
129821286|NCT02289690|467309008|FG009|Overall Study|Other|1|||
129821287|NCT04166435|467309015|FG000|Overall Study|2 patients ineligible for response|2|||
129821288|NCT00865124|467309018|FG000|Overall Study|Physician Decision|2|||
129821289|NCT00865124|467309019|FG001|Overall Study|Physician Decision|1|||
129821290|NCT00865124|467309020|FG002|Overall Study|Physician Decision|0|||
129821291|NCT00865124|467309018|FG000|Overall Study|Withdrawn consent|2|||
129821292|NCT00865124|467309019|FG001|Overall Study|Withdrawn consent|0|||
129821293|NCT00865124|467309020|FG002|Overall Study|Withdrawn consent|0|||
129821294|NCT04983264|467309021|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
129821295|NCT04983264|467309022|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
129821296|NCT04983264|467309023|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
129821297|NCT04983264|467309021|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
129821298|NCT04983264|467309022|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
129821299|NCT04983264|467309023|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
129821300|NCT03042533|467309028|FG000|Overall Study|MD left program|1|||
129821301|NCT03042533|467309029|FG001|Overall Study|MD left program|4|||
129821302|NCT03042533|467309030|FG002|Overall Study|MD left program|1|||
129821303|NCT02551731|467309039|FG000|Overall Study|Withdrawal by Subject|2|||
129821304|NCT01678911|467309046|FG000|Second Intervention|Lost to Follow-up|2|||
129821305|NCT01678911|467309047|FG001|Second Intervention|Lost to Follow-up|0|||
129821306|NCT00356369|467309048|FG000|Active Phase|Withdrawal by Subject|2|||
129821307|NCT00356369|467309049|FG001|Active Phase|Withdrawal by Subject|1|||
129821308|NCT02117648|467309053|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
129821309|NCT02117648|467309053|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
129821310|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
129821311|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
129821312|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
129821313|NCT02117648|467309053|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
129821314|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
129821315|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
129821316|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
129821317|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
129821318|NCT02117648|467309053|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
129821319|NCT01985867|467309054|FG000|Overall Study|Lost to Follow-up|3|||
129821320|NCT01985867|467309055|FG001|Overall Study|Lost to Follow-up|4|||
129821321|NCT01985867|467309054|FG000|Overall Study|Adverse Event|3|||
129821322|NCT01985867|467309055|FG001|Overall Study|Adverse Event|2|||
129821323|NCT01985867|467309054|FG000|Overall Study|Lack of Efficacy|1|||
129821324|NCT01985867|467309055|FG001|Overall Study|Lack of Efficacy|0|||
129821325|NCT00553514|467309058|FG000|Overall Study|Protocol deviation|0|||
129821326|NCT00553514|467309059|FG001|Overall Study|Protocol deviation|0|||
129821327|NCT00553514|467309060|FG002|Overall Study|Protocol deviation|0|||
129821328|NCT00553514|467309061|FG003|Overall Study|Protocol deviation|1|||
129821329|NCT00553514|467309062|FG004|Overall Study|Protocol deviation|0|||
129821330|NCT00553514|467309058|FG000|Overall Study|Lack of ovarian response|4|||
129821331|NCT00553514|467309059|FG001|Overall Study|Lack of ovarian response|5|||
129821332|NCT00553514|467309060|FG002|Overall Study|Lack of ovarian response|5|||
129821333|NCT00553514|467309061|FG003|Overall Study|Lack of ovarian response|5|||
129821334|NCT00553514|467309062|FG004|Overall Study|Lack of ovarian response|6|||
129821335|NCT00553514|467309058|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
129821336|NCT00553514|467309059|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129821337|NCT00553514|467309060|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129821338|NCT00553514|467309061|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129821339|NCT00553514|467309062|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
129821340|NCT00553514|467309058|FG000|Overall Study|Risk of multiple pregnancy|0|||
129821341|NCT00553514|467309059|FG001|Overall Study|Risk of multiple pregnancy|2|||
129821342|NCT00553514|467309060|FG002|Overall Study|Risk of multiple pregnancy|0|||
129821343|NCT00553514|467309061|FG003|Overall Study|Risk of multiple pregnancy|1|||
129821344|NCT00553514|467309062|FG004|Overall Study|Risk of multiple pregnancy|0|||
129821345|NCT00553514|467309058|FG000|Overall Study|Other|1|||
129821346|NCT00553514|467309059|FG001|Overall Study|Other|1|||
129821347|NCT00553514|467309060|FG002|Overall Study|Other|0|||
129821348|NCT00553514|467309061|FG003|Overall Study|Other|0|||
129821349|NCT00553514|467309062|FG004|Overall Study|Other|1|||
129821350|NCT01442675|467309069|FG000|Overall Study|Protocol Violation|6|||
129821351|NCT01442675|467309069|FG000|Overall Study|Lost to Follow-up|2|||
129821352|NCT01442675|467309069|FG000|Overall Study|Withdrawal by Subject|4|||
129821353|NCT04502589|467309070|FG000|Overall Study|Physician Decision|1|||
129821354|NCT04502589|467309071|FG001|Overall Study|Physician Decision|0|||
129821355|NCT02725710|467309074|FG000|Overall Study|Lost to Follow-up|1|||
129821356|NCT02725710|467309075|FG001|Overall Study|Lost to Follow-up|0|||
129821357|NCT01927367|467309078|FG000|Overall Study|Withdrawal by Subject|7|||
129821358|NCT01927367|467309079|FG001|Overall Study|Withdrawal by Subject|4|||
129821359|NCT01927367|467309078|FG000|Overall Study|No baseline data|0|||
129821360|NCT01927367|467309079|FG001|Overall Study|No baseline data|1|||
129821361|NCT00598832|467309082|FG000|Overall Study|Lack of Efficacy|3|||
129821362|NCT00598832|467309083|FG001|Overall Study|Lack of Efficacy|7|||
129821363|NCT00598832|467309082|FG000|Overall Study|Adverse Event|6|||
129821364|NCT00598832|467309083|FG001|Overall Study|Adverse Event|2|||
129821365|NCT00598832|467309082|FG000|Overall Study|Withdrawal by Subject|25|||
129821366|NCT00598832|467309083|FG001|Overall Study|Withdrawal by Subject|36|||
129821367|NCT00598832|467309082|FG000|Overall Study|Protocol Violation|0|||
129821368|NCT00598832|467309083|FG001|Overall Study|Protocol Violation|2|||
129821369|NCT00598832|467309082|FG000|Overall Study|Lost to Follow-up|24|||
129821370|NCT00598832|467309083|FG001|Overall Study|Lost to Follow-up|29|||
129821371|NCT00598832|467309082|FG000|Overall Study|Pregnancy|2|||
129821372|NCT00598832|467309083|FG001|Overall Study|Pregnancy|2|||
129821373|NCT00598832|467309082|FG000|Overall Study|Physician Decision|1|||
129821374|NCT00598832|467309083|FG001|Overall Study|Physician Decision|4|||
129821375|NCT00598832|467309082|FG000|Overall Study|Non compliance|1|||
129821376|NCT00598832|467309083|FG001|Overall Study|Non compliance|0|||
129821377|NCT02760069|467309084|FG000|Overall Study|Withdrawal by Subject|0|||
129821378|NCT02760069|467309085|FG001|Overall Study|Withdrawal by Subject|1|||
129821379|NCT02760069|467309086|FG002|Overall Study|Withdrawal by Subject|1|||
129821380|NCT02142959|467309096|FG000|Overall Study|Adverse Event|1|||
129821381|NCT02142959|467309097|FG001|Overall Study|Adverse Event|0|||
129821382|NCT02142959|467309098|FG002|Overall Study|Adverse Event|0|||
129821383|NCT02142959|467309096|FG000|Overall Study|Death|0|||
129821384|NCT02142959|467309097|FG001|Overall Study|Death|1|||
129821385|NCT02142959|467309098|FG002|Overall Study|Death|0|||
129821386|NCT02142959|467309096|FG000|Overall Study|Withdrawal by Subject|3|||
129821387|NCT02142959|467309097|FG001|Overall Study|Withdrawal by Subject|1|||
129821388|NCT02142959|467309098|FG002|Overall Study|Withdrawal by Subject|3|||
129821389|NCT02142959|467309096|FG000|Overall Study|Administrative Reasons|1|||
129821390|NCT02142959|467309097|FG001|Overall Study|Administrative Reasons|0|||
129821391|NCT02142959|467309098|FG002|Overall Study|Administrative Reasons|1|||
129821392|NCT02142959|467309096|FG000|Overall Study|Missing|0|||
129821393|NCT02142959|467309097|FG001|Overall Study|Missing|1|||
129821394|NCT02142959|467309098|FG002|Overall Study|Missing|0|||
129821395|NCT02142959|467309096|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
129821396|NCT02142959|467309097|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
129821397|NCT02142959|467309098|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
129821398|NCT02142959|467309096|FG000|Overall Study|Patient didn't complete end of study visit|0|||
129821399|NCT02142959|467309097|FG001|Overall Study|Patient didn't complete end of study visit|0|||
129821400|NCT02142959|467309098|FG002|Overall Study|Patient didn't complete end of study visit|1|||
129821401|NCT03547687|467309099|FG000|Overall Study|Withdrawal by Subject|1|||
129821402|NCT03547687|467309099|FG000|Overall Study|Death|1|||
129821403|NCT02547454|467309103|FG000|Overall Study|Due to hemodialysis|53|||
129821404|NCT02547454|467309103|FG000|Overall Study|Due to transplantation|1|||
129821405|NCT02547454|467309103|FG000|Overall Study|Due to no further need to treat|4|||
129821406|NCT02547454|467309103|FG000|Overall Study|Death|38|||
129821407|NCT02547454|467309103|FG000|Overall Study|Lost to Follow-up|26|||
129821408|NCT02547454|467309103|FG000|Overall Study|Other|39|||
129821409|NCT02547454|467309103|FG000|Overall Study|No data|11|||
129821410|NCT03694821|467309105|FG000|Overall Study|Study terminated|4|||
129821411|NCT03694821|467309106|FG001|Overall Study|Study terminated|8|||
129821412|NCT03694821|467309107|FG002|Overall Study|Study terminated|4|||
129821413|NCT00203996|467309108|FG000|Overall Study|Lost to Follow-up|0|||
129821414|NCT00203996|467309109|FG001|Overall Study|Lost to Follow-up|0|||
129821415|NCT00203996|467309110|FG002|Overall Study|Lost to Follow-up|0|||
129821416|NCT00203996|467309111|FG003|Overall Study|Lost to Follow-up|1|||
129821417|NCT00203996|467309112|FG004|Overall Study|Lost to Follow-up|0|||
129821418|NCT00203996|467309113|FG005|Overall Study|Lost to Follow-up|0|||
129821419|NCT00203996|467309114|FG006|Overall Study|Lost to Follow-up|0|||
129821420|NCT00203996|467309115|FG007|Overall Study|Lost to Follow-up|0|||
129897358|NCT00817635|467584334|FG000|Overall Study|Administrative Problems|0|||
129897359|NCT00817635|467584335|FG001|Overall Study|Administrative Problems|0|||
129897360|NCT00817635|467584336|FG002|Overall Study|Administrative Problems|0|||
129897361|NCT00817635|467584337|FG003|Overall Study|Administrative Problems|0|||
129897362|NCT00817635|467584338|FG004|Overall Study|Administrative Problems|1|||
129821421|NCT00203996|467309116|FG008|Overall Study|Lost to Follow-up|0|||
129897363|NCT00817635|467584334|FG000|Overall Study|Protocol Violation|5|||
129897364|NCT00817635|467584335|FG001|Overall Study|Protocol Violation|1|||
129821422|NCT00203996|467309117|FG009|Overall Study|Lost to Follow-up|0|||
129821423|NCT00203996|467309108|FG000|Overall Study|Protocol Violation|0|||
129821424|NCT00203996|467309109|FG001|Overall Study|Protocol Violation|0|||
129821425|NCT00203996|467309110|FG002|Overall Study|Protocol Violation|0|||
129821426|NCT00203996|467309111|FG003|Overall Study|Protocol Violation|6|||
129821427|NCT00203996|467309112|FG004|Overall Study|Protocol Violation|1|||
129821428|NCT00203996|467309113|FG005|Overall Study|Protocol Violation|0|||
129821429|NCT00203996|467309114|FG006|Overall Study|Protocol Violation|0|||
129821430|NCT00203996|467309115|FG007|Overall Study|Protocol Violation|0|||
129821431|NCT00203996|467309116|FG008|Overall Study|Protocol Violation|0|||
129821432|NCT00203996|467309117|FG009|Overall Study|Protocol Violation|0|||
129821433|NCT00203996|467309108|FG000|Overall Study|Physician Decision|0|||
129821434|NCT00203996|467309109|FG001|Overall Study|Physician Decision|0|||
129821435|NCT00203996|467309110|FG002|Overall Study|Physician Decision|0|||
129821436|NCT00203996|467309111|FG003|Overall Study|Physician Decision|2|||
129821437|NCT00203996|467309112|FG004|Overall Study|Physician Decision|0|||
129821438|NCT00203996|467309113|FG005|Overall Study|Physician Decision|0|||
129821439|NCT00203996|467309114|FG006|Overall Study|Physician Decision|0|||
129821440|NCT00203996|467309115|FG007|Overall Study|Physician Decision|0|||
129821441|NCT00203996|467309116|FG008|Overall Study|Physician Decision|0|||
129821442|NCT00203996|467309117|FG009|Overall Study|Physician Decision|1|||
129821443|NCT00203996|467309108|FG000|Overall Study|CPAP machine malfunction|0|||
129821444|NCT00203996|467309109|FG001|Overall Study|CPAP machine malfunction|0|||
129821445|NCT00203996|467309110|FG002|Overall Study|CPAP machine malfunction|0|||
129821446|NCT00203996|467309111|FG003|Overall Study|CPAP machine malfunction|1|||
129821447|NCT00203996|467309112|FG004|Overall Study|CPAP machine malfunction|0|||
129821448|NCT00203996|467309113|FG005|Overall Study|CPAP machine malfunction|0|||
129821449|NCT00203996|467309114|FG006|Overall Study|CPAP machine malfunction|0|||
129821450|NCT00203996|467309115|FG007|Overall Study|CPAP machine malfunction|0|||
129821451|NCT00203996|467309116|FG008|Overall Study|CPAP machine malfunction|0|||
129821452|NCT00203996|467309117|FG009|Overall Study|CPAP machine malfunction|0|||
129821453|NCT00203996|467309108|FG000|Overall Study|Scheduling issue|0|||
129821454|NCT00203996|467309109|FG001|Overall Study|Scheduling issue|0|||
129821455|NCT00203996|467309110|FG002|Overall Study|Scheduling issue|0|||
129821456|NCT00203996|467309111|FG003|Overall Study|Scheduling issue|0|||
129821457|NCT00203996|467309112|FG004|Overall Study|Scheduling issue|0|||
129821458|NCT00203996|467309113|FG005|Overall Study|Scheduling issue|0|||
129821459|NCT00203996|467309114|FG006|Overall Study|Scheduling issue|0|||
129821460|NCT00203996|467309115|FG007|Overall Study|Scheduling issue|2|||
129821461|NCT00203996|467309116|FG008|Overall Study|Scheduling issue|0|||
129821462|NCT00203996|467309117|FG009|Overall Study|Scheduling issue|0|||
129821463|NCT03064451|467309118|FG000|Overall Study|Lost to Follow-up|1|||
129821464|NCT03064451|467309118|FG000|Overall Study|Mapping Failure|4|||
129821465|NCT03064451|467309118|FG000|Overall Study|Exited prior to procedure|8|||
129821466|NCT03064451|467309118|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
129821467|NCT00750204|467309119|FG000|Overall Study|study halted prematurely|1|||
129821468|NCT00750204|467309120|FG001|Overall Study|study halted prematurely|1|||
129821469|NCT00850564|467309121|FG000|Overall Study|Withdrawal by Subject|2|||
129821470|NCT01774968|467309122|FG000|Overall Study|Adverse Event|4|||
129821471|NCT01774968|467309123|FG001|Overall Study|Adverse Event|4|||
129821472|NCT01774968|467309122|FG000|Overall Study|Death|0|||
129821473|NCT01774968|467309123|FG001|Overall Study|Death|1|||
129821474|NCT01774968|467309122|FG000|Overall Study|Lost to Follow-up|1|||
129821475|NCT01774968|467309123|FG001|Overall Study|Lost to Follow-up|3|||
129821476|NCT01774968|467309122|FG000|Overall Study|Physician Decision|5|||
129821477|NCT01774968|467309123|FG001|Overall Study|Physician Decision|1|||
129821478|NCT01774968|467309122|FG000|Overall Study|Protocol Violation|14|||
129821479|NCT01774968|467309123|FG001|Overall Study|Protocol Violation|13|||
129821480|NCT01774968|467309122|FG000|Overall Study|Sponsor Decision|0|||
129821481|NCT01774968|467309123|FG001|Overall Study|Sponsor Decision|2|||
129821482|NCT01774968|467309122|FG000|Overall Study|Withdrawal by Subject|6|||
129821483|NCT01774968|467309123|FG001|Overall Study|Withdrawal by Subject|11|||
129821484|NCT05355805|467309126|FG000|Overall Study|Lost to Follow-up|6|||
129897365|NCT00817635|467584336|FG002|Overall Study|Protocol Violation|3|||
129821485|NCT05355805|467309127|FG001|Overall Study|Lost to Follow-up|11|||
129821486|NCT05355805|467309128|FG002|Overall Study|Lost to Follow-up|10|||
129821487|NCT05355805|467309129|FG003|Overall Study|Lost to Follow-up|6|||
129821488|NCT05355805|467309126|FG000|Overall Study|Decision by Sponsor|0|||
129821489|NCT05355805|467309127|FG001|Overall Study|Decision by Sponsor|0|||
129821490|NCT05355805|467309128|FG002|Overall Study|Decision by Sponsor|1|||
129821491|NCT05355805|467309129|FG003|Overall Study|Decision by Sponsor|0|||
129821492|NCT05355805|467309126|FG000|Overall Study|Withdrawal by Subject|7|||
129821493|NCT05355805|467309127|FG001|Overall Study|Withdrawal by Subject|14|||
129821494|NCT05355805|467309128|FG002|Overall Study|Withdrawal by Subject|15|||
129821495|NCT05355805|467309129|FG003|Overall Study|Withdrawal by Subject|13|||
129821496|NCT02167893|467309130|FG000|Overall Study|Investigator transferred|85|||
129821497|NCT02167893|467309130|FG000|Overall Study|Investigator health reasons|10|||
129821498|NCT02167893|467309130|FG000|Overall Study|Case report forms not collected|68|||
129821499|NCT04818840|467309131|FG000|Overall Study|Lost to Follow-up|0|||
129821500|NCT04818840|467309132|FG001|Overall Study|Lost to Follow-up|5|||
129821501|NCT04818840|467309131|FG000|Overall Study|Physician Decision|1|||
129821502|NCT04818840|467309132|FG001|Overall Study|Physician Decision|0|||
129821503|NCT04818840|467309131|FG000|Overall Study|Site Terminated by Sponsor|0|||
129821504|NCT04818840|467309132|FG001|Overall Study|Site Terminated by Sponsor|3|||
129821505|NCT04818840|467309131|FG000|Overall Study|Study Terminated by Sponsor|43|||
129821506|NCT04818840|467309132|FG001|Overall Study|Study Terminated by Sponsor|7|||
129821507|NCT04818840|467309131|FG000|Overall Study|Withdrawal by Subject|0|||
129821508|NCT04818840|467309132|FG001|Overall Study|Withdrawal by Subject|1|||
129821509|NCT00524368|467310558|FG000|Overall Study|Adverse Event|10|||
129821510|NCT00524368|467310559|FG001|Overall Study|Adverse Event|12|||
129821511|NCT00524368|467310558|FG000|Overall Study|Lost to Follow-up|9|||
129821512|NCT00524368|467310559|FG001|Overall Study|Lost to Follow-up|13|||
129821513|NCT00524368|467310558|FG000|Overall Study|Withdrawal by Subject|4|||
129821514|NCT00524368|467310559|FG001|Overall Study|Withdrawal by Subject|5|||
129821515|NCT00524368|467310558|FG000|Overall Study|Non-compliant|8|||
129821516|NCT00524368|467310559|FG001|Overall Study|Non-compliant|9|||
129821517|NCT00524368|467310558|FG000|Overall Study|Reached a Virologic Endpoint|3|||
129821518|NCT00524368|467310559|FG001|Overall Study|Reached a Virologic Endpoint|2|||
129821519|NCT00524368|467310558|FG000|Overall Study|Sponsor's Decision|2|||
129821520|NCT00524368|467310559|FG001|Overall Study|Sponsor's Decision|0|||
129821521|NCT00524368|467310558|FG000|Overall Study|Ineligible to Continue the study|2|||
129821522|NCT00524368|467310559|FG001|Overall Study|Ineligible to Continue the study|5|||
129821523|NCT00524368|467310558|FG000|Overall Study|Other|3|||
129821524|NCT00524368|467310559|FG001|Overall Study|Other|2|||
129821525|NCT00793598|467310560|FG000|Overall Study|Patient Request|0|||
129821526|NCT00793598|467310561|FG001|Overall Study|Patient Request|1|||
129821527|NCT00793598|467310562|FG002|Overall Study|Patient Request|0|||
129821528|NCT00793598|467310563|FG003|Overall Study|Patient Request|0|||
129821529|NCT00793598|467310564|FG004|Overall Study|Patient Request|0|||
129821530|NCT00793598|467310565|FG005|Overall Study|Patient Request|0|||
129821531|NCT00793598|467310566|FG006|Overall Study|Patient Request|0|||
129821532|NCT00793598|467310567|FG007|Overall Study|Patient Request|0|||
129821533|NCT00793598|467310560|FG000|Overall Study|Protocol Violation|0|||
129821534|NCT00793598|467310561|FG001|Overall Study|Protocol Violation|0|||
129821535|NCT00793598|467310562|FG002|Overall Study|Protocol Violation|0|||
129821536|NCT00793598|467310563|FG003|Overall Study|Protocol Violation|0|||
129821537|NCT00793598|467310564|FG004|Overall Study|Protocol Violation|0|||
129821538|NCT00793598|467310565|FG005|Overall Study|Protocol Violation|0|||
129821539|NCT00793598|467310566|FG006|Overall Study|Protocol Violation|0|||
129821540|NCT00793598|467310567|FG007|Overall Study|Protocol Violation|1|||
129821541|NCT00793598|467310560|FG000|Overall Study|Subject not dosed|0|||
129821542|NCT00793598|467310561|FG001|Overall Study|Subject not dosed|0|||
129821543|NCT00793598|467310562|FG002|Overall Study|Subject not dosed|0|||
129821544|NCT00793598|467310563|FG003|Overall Study|Subject not dosed|0|||
129821545|NCT00793598|467310564|FG004|Overall Study|Subject not dosed|0|||
129821546|NCT00793598|467310565|FG005|Overall Study|Subject not dosed|1|||
129821547|NCT00793598|467310566|FG006|Overall Study|Subject not dosed|0|||
129821548|NCT00793598|467310567|FG007|Overall Study|Subject not dosed|0|||
129821549|NCT02373202|467310578|FG000|Overall Study|Adverse Event|2|||
129821550|NCT02373202|467310579|FG001|Overall Study|Adverse Event|5|||
129821551|NCT02373202|467310580|FG002|Overall Study|Adverse Event|2|||
129821552|NCT02373202|467310581|FG003|Overall Study|Adverse Event|1|||
129821553|NCT02373202|467310578|FG000|Overall Study|Lack of Efficacy|0|||
129821554|NCT02373202|467310579|FG001|Overall Study|Lack of Efficacy|0|||
129821555|NCT02373202|467310580|FG002|Overall Study|Lack of Efficacy|1|||
129821556|NCT02373202|467310581|FG003|Overall Study|Lack of Efficacy|0|||
129821557|NCT02373202|467310578|FG000|Overall Study|Other|0|||
129821558|NCT02373202|467310579|FG001|Overall Study|Other|1|||
129821559|NCT02373202|467310580|FG002|Overall Study|Other|0|||
129821560|NCT02373202|467310581|FG003|Overall Study|Other|0|||
129821561|NCT01411228|467310583|FG000|Overall Study|Lost to Follow-up|0|||
129821562|NCT01411228|467310584|FG001|Overall Study|Lost to Follow-up|0|||
129821563|NCT01411228|467310585|FG002|Overall Study|Lost to Follow-up|1|||
129821564|NCT01411228|467310583|FG000|Overall Study|Withdrawal by Subject|1|||
129821565|NCT01411228|467310584|FG001|Overall Study|Withdrawal by Subject|0|||
129821566|NCT01411228|467310585|FG002|Overall Study|Withdrawal by Subject|0|||
129821567|NCT02141282|467310586|FG000|Overall Study|Adverse event, not related to progression|8|||
129821568|NCT02141282|467310587|FG001|Overall Study|Adverse event, not related to progression|1|||
129821569|NCT02141282|467310588|FG002|Overall Study|Adverse event, not related to progression|3|||
129821570|NCT02141282|467310589|FG003|Overall Study|Adverse event, not related to progression|1|||
129821571|NCT02141282|467310586|FG000|Overall Study|Adverse event, related to progression|1|||
129821572|NCT02141282|467310587|FG001|Overall Study|Adverse event, related to progression|0|||
129821573|NCT02141282|467310588|FG002|Overall Study|Adverse event, related to progression|2|||
129821574|NCT02141282|467310589|FG003|Overall Study|Adverse event, related to progression|0|||
129821575|NCT02141282|467310586|FG000|Overall Study|COVID-19 infection|1|||
129821576|NCT02141282|467310587|FG001|Overall Study|COVID-19 infection|0|||
129821577|NCT02141282|467310588|FG002|Overall Study|COVID-19 infection|0|||
129821578|NCT02141282|467310589|FG003|Overall Study|COVID-19 infection|0|||
129821579|NCT02141282|467310586|FG000|Overall Study|Lost to Follow-up|0|||
129821580|NCT02141282|467310587|FG001|Overall Study|Lost to Follow-up|0|||
129821581|NCT02141282|467310588|FG002|Overall Study|Lost to Follow-up|4|||
129821582|NCT02141282|467310589|FG003|Overall Study|Lost to Follow-up|2|||
129821583|NCT02141282|467310586|FG000|Overall Study|Other, not specified|14|||
129821584|NCT02141282|467310587|FG001|Overall Study|Other, not specified|11|||
129821585|NCT02141282|467310588|FG002|Overall Study|Other, not specified|23|||
129821586|NCT02141282|467310589|FG003|Overall Study|Other, not specified|9|||
129821587|NCT02141282|467310586|FG000|Overall Study|Progressive disease, Richter's|4|||
129821588|NCT02141282|467310587|FG001|Overall Study|Progressive disease, Richter's|1|||
129821589|NCT02141282|467310588|FG002|Overall Study|Progressive disease, Richter's|1|||
129821590|NCT02141282|467310589|FG003|Overall Study|Progressive disease, Richter's|1|||
129821591|NCT02141282|467310586|FG000|Overall Study|Progressive disease per protocol|12|||
129821592|NCT02141282|467310587|FG001|Overall Study|Progressive disease per protocol|7|||
129821593|NCT02141282|467310588|FG002|Overall Study|Progressive disease per protocol|9|||
129821594|NCT02141282|467310589|FG003|Overall Study|Progressive disease per protocol|2|||
129821595|NCT02141282|467310586|FG000|Overall Study|Stem cell transplant|1|||
129821596|NCT02141282|467310587|FG001|Overall Study|Stem cell transplant|0|||
129821597|NCT02141282|467310588|FG002|Overall Study|Stem cell transplant|1|||
129821598|NCT02141282|467310589|FG003|Overall Study|Stem cell transplant|0|||
129821599|NCT02141282|467310586|FG000|Overall Study|Study terminated by Sponsor|0|||
129821600|NCT02141282|467310587|FG001|Overall Study|Study terminated by Sponsor|1|||
129821601|NCT02141282|467310588|FG002|Overall Study|Study terminated by Sponsor|0|||
129821602|NCT02141282|467310589|FG003|Overall Study|Study terminated by Sponsor|0|||
129821603|NCT02141282|467310586|FG000|Overall Study|Subject non-compliance|0|||
129821604|NCT02141282|467310587|FG001|Overall Study|Subject non-compliance|0|||
129821605|NCT02141282|467310588|FG002|Overall Study|Subject non-compliance|1|||
129821606|NCT02141282|467310589|FG003|Overall Study|Subject non-compliance|0|||
129821607|NCT02141282|467310586|FG000|Overall Study|Withdrew consent|2|||
129821608|NCT02141282|467310587|FG001|Overall Study|Withdrew consent|0|||
129821609|NCT02141282|467310588|FG002|Overall Study|Withdrew consent|4|||
129821610|NCT02141282|467310589|FG003|Overall Study|Withdrew consent|0|||
129821611|NCT01752907|467310592|FG000|Overall Study|Withdrawal by Subject|4|||
129821612|NCT01752907|467310593|FG001|Overall Study|Withdrawal by Subject|10|||
129821613|NCT01752907|467310592|FG000|Overall Study|Lost to Follow-up|2|||
129821614|NCT01752907|467310593|FG001|Overall Study|Lost to Follow-up|1|||
129821615|NCT01752907|467310592|FG000|Overall Study|Decision by Sponsor|6|||
129821616|NCT01752907|467310593|FG001|Overall Study|Decision by Sponsor|9|||
129821617|NCT02670083|467310600|FG000|Overall Study|Adverse Event|16|||
129821618|NCT02670083|467310601|FG001|Overall Study|Adverse Event|13|||
129821619|NCT02670083|467310600|FG000|Overall Study|Death|4|||
129821620|NCT02670083|467310601|FG001|Overall Study|Death|6|||
129821621|NCT02670083|467310600|FG000|Overall Study|Lost to Follow-up|2|||
129821622|NCT02670083|467310601|FG001|Overall Study|Lost to Follow-up|2|||
129821623|NCT02670083|467310600|FG000|Overall Study|Multiple Reasons|9|||
129897366|NCT00817635|467584337|FG003|Overall Study|Protocol Violation|2|||
129445684|NCT01968070|465932887|FG012|Period 1|Adverse Event|0|||
129821624|NCT02670083|467310601|FG001|Overall Study|Multiple Reasons|9|||
129821625|NCT02670083|467310600|FG000|Overall Study|Physician Decision|0|||
129821626|NCT02670083|467310601|FG001|Overall Study|Physician Decision|2|||
129821627|NCT02670083|467310600|FG000|Overall Study|Study Terminated By Sponsor|257|||
129821628|NCT02670083|467310601|FG001|Overall Study|Study Terminated By Sponsor|254|||
129821629|NCT02670083|467310600|FG000|Overall Study|Symptomatic Deterioration|0|||
129821630|NCT02670083|467310601|FG001|Overall Study|Symptomatic Deterioration|2|||
129821631|NCT02670083|467310600|FG000|Overall Study|Withdrawal by Subject|32|||
129821632|NCT02670083|467310601|FG001|Overall Study|Withdrawal by Subject|31|||
129821633|NCT02670083|467310600|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129821634|NCT02670083|467310601|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129821635|NCT02057406|467310603|FG000|Overall Study|Physician Decision|0|||
129821636|NCT02057406|467310604|FG001|Overall Study|Physician Decision|0|||
129821637|NCT02057406|467310605|FG002|Overall Study|Physician Decision|2|||
129821638|NCT02057406|467310603|FG000|Overall Study|Withdrawal by Subject|0|||
129821639|NCT02057406|467310604|FG001|Overall Study|Withdrawal by Subject|2|||
129821640|NCT02057406|467310605|FG002|Overall Study|Withdrawal by Subject|0|||
129821641|NCT02057406|467310603|FG000|Overall Study|Lost to Follow-up|0|||
129821642|NCT02057406|467310604|FG001|Overall Study|Lost to Follow-up|0|||
129821643|NCT02057406|467310605|FG002|Overall Study|Lost to Follow-up|1|||
129821644|NCT02057406|467310603|FG000|Overall Study|Death|1|||
129821645|NCT02057406|467310604|FG001|Overall Study|Death|0|||
129821646|NCT02057406|467310605|FG002|Overall Study|Death|0|||
129821647|NCT02057406|467310603|FG000|Overall Study|Protocol Violation|0|||
129897367|NCT00817635|467584338|FG004|Overall Study|Protocol Violation|3|||
129897368|NCT01020838|467584343|FG000|Overall Study|Death|90|||
129897369|NCT01020838|467584343|FG000|Overall Study|Adverse Event|1|||
129897370|NCT01020838|467584343|FG000|Overall Study|Withdrawal by Subject|9|||
129897371|NCT01020838|467584343|FG000|Overall Study|Lost to Follow-up|6|||
129897372|NCT01020838|467584343|FG000|Overall Study|Most common: Study ended by sponsor|77|||
129897373|NCT01167426|467584344|FG000|Overall Study|Lost to Follow-up|6|||
129897374|NCT01167426|467584344|FG000|Overall Study|Protocol Violation|1|||
129897375|NCT01167426|467584344|FG000|Overall Study|Withdrawal by Subject|2|||
129897376|NCT01167426|467584344|FG000|Overall Study|Sponsor Decision|1|||
129897377|NCT02993471|467584345|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
129897378|NCT02993471|467584345|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
129897379|NCT01908634|467584347|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
129897380|NCT01908634|467584347|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
129897381|NCT04176458|467584348|FG000|Overall Study|Covid 19|4|||
129897382|NCT01570751|467584349|FG000|Period A (16 Weeks)|Protocol Violation|1|||
129821648|NCT02057406|467310604|FG001|Overall Study|Protocol Violation|1|||
129821649|NCT02057406|467310605|FG002|Overall Study|Protocol Violation|0|||
129821650|NCT02057406|467310603|FG000|Overall Study|Patient transportation issues|0|||
129821651|NCT02057406|467310604|FG001|Overall Study|Patient transportation issues|0|||
129897383|NCT01570751|467584350|FG001|Period A (16 Weeks)|Protocol Violation|1|||
129897384|NCT01570751|467584349|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
129897385|NCT01570751|467584350|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
129897386|NCT01570751|467584349|FG000|Period A (16 Weeks)|Unclassified|2|||
129897387|NCT01570751|467584350|FG001|Period A (16 Weeks)|Unclassified|3|||
129821652|NCT02057406|467310605|FG002|Overall Study|Patient transportation issues|1|||
129821653|NCT02425046|467310606|FG000|Overall Study|Lost to Follow-up|52|||
129821654|NCT02425046|467310607|FG001|Overall Study|Lost to Follow-up|50|||
129821655|NCT02425046|467310608|FG002|Overall Study|Lost to Follow-up|56|||
129821656|NCT02425046|467310606|FG000|Overall Study|Withdrawal by Subject|16|||
129821657|NCT02425046|467310607|FG001|Overall Study|Withdrawal by Subject|12|||
129821658|NCT02425046|467310608|FG002|Overall Study|Withdrawal by Subject|0|||
129821659|NCT03654651|467310609|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129821660|NCT03654651|467310610|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
129821661|NCT02904512|467310615|FG000|Overall Study|Withdrawal by Subject|1|||
129821662|NCT02904512|467310616|FG001|Overall Study|Withdrawal by Subject|0|||
129821663|NCT02904512|467310615|FG000|Overall Study|Transferred to ICU|1|||
129821664|NCT02904512|467310616|FG001|Overall Study|Transferred to ICU|0|||
129821665|NCT02904512|467310615|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
129821666|NCT02904512|467310616|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
129821667|NCT00267046|467310623|FG000|Overall Study|Disease progression|4|||
129821668|NCT00267046|467310624|FG001|Overall Study|Disease progression|2|||
129821669|NCT00267046|467310623|FG000|Overall Study|Chemotoxicity|2|||
129821670|NCT00267046|467310624|FG001|Overall Study|Chemotoxicity|0|||
129821671|NCT00267046|467310623|FG000|Overall Study|Open-label palifermin|2|||
129821672|NCT00267046|467310624|FG001|Overall Study|Open-label palifermin|7|||
129821673|NCT00267046|467310623|FG000|Overall Study|Surgery|3|||
129821674|NCT00267046|467310624|FG001|Overall Study|Surgery|1|||
129821675|NCT00267046|467310623|FG000|Overall Study|Withdrawal by Subject|1|||
129821676|NCT00267046|467310624|FG001|Overall Study|Withdrawal by Subject|0|||
129821677|NCT00267046|467310623|FG000|Overall Study|Radiation|0|||
129821678|NCT00267046|467310624|FG001|Overall Study|Radiation|1|||
129821679|NCT00460408|467310625|FG000|Overall Study|Adverse Event|1|||
129821680|NCT00460408|467310626|FG001|Overall Study|Adverse Event|0|||
129821681|NCT00460408|467310627|FG002|Overall Study|Adverse Event|0|||
129821682|NCT00460408|467310628|FG003|Overall Study|Adverse Event|0|||
129821683|NCT00460408|467310625|FG000|Overall Study|Death|7|||
129821684|NCT00460408|467310626|FG001|Overall Study|Death|0|||
129821685|NCT00460408|467310627|FG002|Overall Study|Death|0|||
129821686|NCT00460408|467310628|FG003|Overall Study|Death|0|||
129821687|NCT00460408|467310625|FG000|Overall Study|Lost to Follow-up|11|||
129821688|NCT00460408|467310626|FG001|Overall Study|Lost to Follow-up|0|||
129821689|NCT00460408|467310627|FG002|Overall Study|Lost to Follow-up|1|||
129821690|NCT00460408|467310628|FG003|Overall Study|Lost to Follow-up|0|||
129821691|NCT00460408|467310625|FG000|Overall Study|Withdrawal by Subject|31|||
129821692|NCT00460408|467310626|FG001|Overall Study|Withdrawal by Subject|0|||
129821693|NCT00460408|467310627|FG002|Overall Study|Withdrawal by Subject|0|||
129821694|NCT00460408|467310628|FG003|Overall Study|Withdrawal by Subject|0|||
129821695|NCT00460408|467310625|FG000|Overall Study|Insufficient clinical response|5|||
129821696|NCT00460408|467310626|FG001|Overall Study|Insufficient clinical response|1|||
129821697|NCT00460408|467310627|FG002|Overall Study|Insufficient clinical response|5|||
129821698|NCT00460408|467310628|FG003|Overall Study|Insufficient clinical response|0|||
129821699|NCT00460408|467310625|FG000|Overall Study|Other|12|||
129821700|NCT00460408|467310626|FG001|Overall Study|Other|2|||
129821701|NCT00460408|467310627|FG002|Overall Study|Other|0|||
129821702|NCT00460408|467310628|FG003|Overall Study|Other|0|||
129821703|NCT01986985|467310629|FG000|Overall Study|Withdrawal by Subject|4|||
129821704|NCT01986985|467310629|FG000|Overall Study|Scan not completed due to malfunction|3|||
129821705|NCT02288559|467310631|FG000|Overall Study|Adverse Event|1|||
129821706|NCT02288559|467310632|FG001|Overall Study|Adverse Event|1|||
129821707|NCT02288559|467310633|FG002|Overall Study|Adverse Event|5|||
129821708|NCT02288559|467310634|FG003|Overall Study|Adverse Event|0|||
129821709|NCT02288559|467310631|FG000|Overall Study|Death|0|||
129821710|NCT02288559|467310632|FG001|Overall Study|Death|0|||
129821711|NCT02288559|467310633|FG002|Overall Study|Death|1|||
129821712|NCT02288559|467310634|FG003|Overall Study|Death|0|||
129821713|NCT02288559|467310631|FG000|Overall Study|Lost to Follow-up|0|||
129821714|NCT02288559|467310632|FG001|Overall Study|Lost to Follow-up|0|||
129821715|NCT02288559|467310633|FG002|Overall Study|Lost to Follow-up|0|||
129821716|NCT02288559|467310634|FG003|Overall Study|Lost to Follow-up|1|||
129821717|NCT02288559|467310631|FG000|Overall Study|Withdrawal by Subject|0|||
129821718|NCT02288559|467310632|FG001|Overall Study|Withdrawal by Subject|0|||
129821719|NCT02288559|467310633|FG002|Overall Study|Withdrawal by Subject|2|||
129821720|NCT02288559|467310634|FG003|Overall Study|Withdrawal by Subject|1|||
129821721|NCT02288559|467310631|FG000|Overall Study|Reason Not Specified|0|||
129821722|NCT02288559|467310632|FG001|Overall Study|Reason Not Specified|0|||
129821723|NCT02288559|467310633|FG002|Overall Study|Reason Not Specified|3|||
129821724|NCT02288559|467310634|FG003|Overall Study|Reason Not Specified|0|||
129821725|NCT03303079|467310635|FG000|Overall Study|Adverse Event|0|||
129821726|NCT03303079|467310636|FG001|Overall Study|Adverse Event|1|||
129821727|NCT03303079|467310637|FG002|Overall Study|Adverse Event|3|||
129821728|NCT03303079|467310635|FG000|Overall Study|Protocol Violation|5|||
129821729|NCT03303079|467310636|FG001|Overall Study|Protocol Violation|4|||
129821730|NCT03303079|467310637|FG002|Overall Study|Protocol Violation|7|||
129821731|NCT03303079|467310635|FG000|Overall Study|Withdrawal by Subject|2|||
129821732|NCT03303079|467310636|FG001|Overall Study|Withdrawal by Subject|4|||
129821733|NCT03303079|467310637|FG002|Overall Study|Withdrawal by Subject|2|||
129821734|NCT03303079|467310635|FG000|Overall Study|Other than specified|0|||
129821735|NCT03303079|467310636|FG001|Overall Study|Other than specified|2|||
129821736|NCT03303079|467310637|FG002|Overall Study|Other than specified|0|||
129821737|NCT02005445|467310638|FG000|Overall Study|Dual study enrollment|0|||
129821738|NCT02005445|467310639|FG001|Overall Study|Dual study enrollment|1|||
129821739|NCT01111149|467310640|FG000|Overall Study|Protocol Violation|1|||
129821740|NCT01111149|467310641|FG001|Overall Study|Protocol Violation|1|||
129821741|NCT01111149|467310642|FG002|Overall Study|Protocol Violation|2|||
129821742|NCT01111149|467310640|FG000|Overall Study|Withdrawal by Subject|1|||
129821743|NCT01111149|467310641|FG001|Overall Study|Withdrawal by Subject|0|||
129821744|NCT01111149|467310642|FG002|Overall Study|Withdrawal by Subject|2|||
129821745|NCT00759954|467310643|FG000|Overall Study|Personal reason|1|||
129821746|NCT00759954|467310644|FG001|Overall Study|Personal reason|0|||
129821747|NCT00759954|467310643|FG000|Overall Study|Adverse Event|1|||
129821748|NCT00759954|467310644|FG001|Overall Study|Adverse Event|2|||
129821749|NCT00137046|467310652|FG000|Overall Study|Death|2|||
129821750|NCT00137046|467310653|FG001|Overall Study|Death|1|||
129821751|NCT00137046|467310652|FG000|Overall Study|Adverse Event|16|||
129821752|NCT00137046|467310653|FG001|Overall Study|Adverse Event|5|||
129821753|NCT00137046|467310652|FG000|Overall Study|Laboratory Abnormality|2|||
129821754|NCT00137046|467310653|FG001|Overall Study|Laboratory Abnormality|0|||
129821755|NCT00137046|467310652|FG000|Overall Study|Lack of Efficacy|13|||
129821756|NCT00137046|467310653|FG001|Overall Study|Lack of Efficacy|1|||
129821757|NCT00137046|467310652|FG000|Overall Study|Lost to Follow-up|8|||
129821758|NCT00137046|467310653|FG001|Overall Study|Lost to Follow-up|24|||
129821759|NCT00137046|467310652|FG000|Overall Study|Other|23|||
129821760|NCT00137046|467310653|FG001|Overall Study|Other|19|||
129821761|NCT00137046|467310652|FG000|Overall Study|Withdrawal by Subject|33|||
129821762|NCT00137046|467310653|FG001|Overall Study|Withdrawal by Subject|42|||
129821763|NCT00137046|467310652|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
129821764|NCT00137046|467310653|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
129821765|NCT00137046|467310652|FG000|Overall Study|Withdrew prior to study treatment|1|||
129821766|NCT00137046|467310653|FG001|Overall Study|Withdrew prior to study treatment|1|||
129821767|NCT00160251|467310654|FG000|Prior to Amendment 2|Adverse Event|2|||
129821768|NCT00160251|467310655|FG001|Prior to Amendment 2|Adverse Event|1|||
129821769|NCT00160251|467310656|FG002|Prior to Amendment 2|Adverse Event|3|||
129821770|NCT00160251|467310657|FG003|Prior to Amendment 2|Adverse Event|1|||
129821771|NCT00160251|467310658|FG004|Prior to Amendment 2|Adverse Event|1|||
129821772|NCT00160251|467310659|FG005|Prior to Amendment 2|Adverse Event|1|||
129821773|NCT00160251|467310660|FG006|Prior to Amendment 2|Adverse Event|1|||
129821774|NCT00160251|467310661|FG007|Prior to Amendment 2|Adverse Event|0|||
129821775|NCT00160251|467310654|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
129821776|NCT00160251|467310655|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
129821777|NCT00160251|467310656|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
129821778|NCT00160251|467310657|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
129821779|NCT00160251|467310658|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
129821780|NCT00160251|467310659|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
129821781|NCT00160251|467310660|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
129821782|NCT00160251|467310661|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
129821783|NCT00160251|467310654|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
129821784|NCT00160251|467310655|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
129821785|NCT00160251|467310656|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
129821786|NCT00160251|467310657|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
129821787|NCT00160251|467310658|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
129821788|NCT00160251|467310659|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
129821789|NCT00160251|467310660|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
129821790|NCT00160251|467310661|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
129821791|NCT00160251|467310654|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
129821792|NCT00160251|467310655|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
129821793|NCT00160251|467310656|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
129821794|NCT00160251|467310657|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
129897388|NCT01570751|467584349|FG000|Period B (16 Weeks)|Adverse Event|1|||
129897389|NCT01570751|467584350|FG001|Period B (16 Weeks)|Adverse Event|0|||
129821795|NCT00160251|467310658|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
129821796|NCT00160251|467310659|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
129821797|NCT00160251|467310660|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
129821798|NCT00160251|467310661|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
129821799|NCT00160251|467310654|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
129821800|NCT00160251|467310655|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
129821801|NCT00160251|467310656|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
129821802|NCT00160251|467310657|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
129821803|NCT00160251|467310658|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
129821804|NCT00160251|467310659|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
129821805|NCT00160251|467310660|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
129821806|NCT00160251|467310661|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
129821807|NCT00160251|467310654|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
129821808|NCT00160251|467310655|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
129821809|NCT00160251|467310656|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
129821810|NCT00160251|467310657|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
129821811|NCT00160251|467310658|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
129821812|NCT00160251|467310659|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
129821813|NCT00160251|467310660|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
129821814|NCT00160251|467310661|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
129821815|NCT00160251|467310654|FG000|Post-amendment 2|Adverse Event|0|||
129821816|NCT00160251|467310655|FG001|Post-amendment 2|Adverse Event|0|||
129821817|NCT00160251|467310656|FG002|Post-amendment 2|Adverse Event|0|||
129821818|NCT00160251|467310657|FG003|Post-amendment 2|Adverse Event|0|||
129821819|NCT00160251|467310658|FG004|Post-amendment 2|Adverse Event|0|||
129821820|NCT00160251|467310659|FG005|Post-amendment 2|Adverse Event|0|||
129821821|NCT00160251|467310660|FG006|Post-amendment 2|Adverse Event|0|||
129821822|NCT00160251|467310661|FG007|Post-amendment 2|Adverse Event|20|||
129821823|NCT00160251|467310654|FG000|Post-amendment 2|Lack of Efficacy|0|||
129821824|NCT00160251|467310655|FG001|Post-amendment 2|Lack of Efficacy|0|||
129821825|NCT00160251|467310656|FG002|Post-amendment 2|Lack of Efficacy|0|||
129821826|NCT00160251|467310657|FG003|Post-amendment 2|Lack of Efficacy|0|||
129821827|NCT00160251|467310658|FG004|Post-amendment 2|Lack of Efficacy|0|||
129821828|NCT00160251|467310659|FG005|Post-amendment 2|Lack of Efficacy|0|||
129821829|NCT00160251|467310660|FG006|Post-amendment 2|Lack of Efficacy|0|||
129821830|NCT00160251|467310661|FG007|Post-amendment 2|Lack of Efficacy|24|||
129821831|NCT00160251|467310654|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821832|NCT00160251|467310655|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821833|NCT00160251|467310656|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821834|NCT00160251|467310657|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821835|NCT00160251|467310658|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821836|NCT00160251|467310659|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821837|NCT00160251|467310660|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
129821838|NCT00160251|467310661|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
129821839|NCT02730455|467310663|FG000|Overall Study|Death|5|||
129821840|NCT02730455|467310664|FG001|Overall Study|Death|6|||
129821841|NCT02730455|467310665|FG002|Overall Study|Death|4|||
129821842|NCT02730455|467310663|FG000|Overall Study|Consent withdrawn|2|||
129821843|NCT02730455|467310664|FG001|Overall Study|Consent withdrawn|4|||
129821844|NCT02730455|467310665|FG002|Overall Study|Consent withdrawn|1|||
129821845|NCT02730455|467310663|FG000|Overall Study|Lost to Follow-up|3|||
129821846|NCT02730455|467310664|FG001|Overall Study|Lost to Follow-up|1|||
129821847|NCT02730455|467310665|FG002|Overall Study|Lost to Follow-up|4|||
129821848|NCT02730455|467310663|FG000|Overall Study|Other|1|||
129821849|NCT02730455|467310664|FG001|Overall Study|Other|1|||
129821850|NCT02730455|467310665|FG002|Overall Study|Other|2|||
129821851|NCT02730455|467310663|FG000|Overall Study|Other|2|||
129821852|NCT02730455|467310664|FG001|Overall Study|Other|2|||
129821853|NCT02730455|467310665|FG002|Overall Study|Other|0|||
129821854|NCT01018186|467310672|FG000|2-week Run-in Period|Protocol Violation|1|||
129821855|NCT01018186|467310673|FG001|2-week Run-in Period|Protocol Violation|0|||
129821856|NCT01018186|467310674|FG002|2-week Run-in Period|Protocol Violation|0|||
129821857|NCT01018186|467310675|FG003|2-week Run-in Period|Protocol Violation|0|||
129821858|NCT01018186|467310672|FG000|2-week Run-in Period|Lost to Follow-up|2|||
129821859|NCT01018186|467310673|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129821860|NCT01018186|467310674|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129821861|NCT01018186|467310675|FG003|2-week Run-in Period|Lost to Follow-up|0|||
129821862|NCT01018186|467310672|FG000|2-week Run-in Period|Physician Decision|3|||
129897390|NCT01570751|467584349|FG000|Period B (16 Weeks)|Protocol Violation|0|||
129897391|NCT01570751|467584350|FG001|Period B (16 Weeks)|Protocol Violation|1|||
129897392|NCT00588666|467584352|FG000|Overall Study|Adverse Event|4|||
129821863|NCT01018186|467310673|FG001|2-week Run-in Period|Physician Decision|0|||
129821864|NCT01018186|467310674|FG002|2-week Run-in Period|Physician Decision|0|||
129821865|NCT01018186|467310675|FG003|2-week Run-in Period|Physician Decision|0|||
129821866|NCT01018186|467310672|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
129821867|NCT01018186|467310673|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129821868|NCT01018186|467310674|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129821869|NCT01018186|467310675|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
129821870|NCT01018186|467310672|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
129897393|NCT04582877|467584357|FG000|Overall Study|Did not use device measurement|5|||
129897394|NCT04582877|467584357|FG000|Overall Study|No fractional flow reserve test results|2|||
129821871|NCT01018186|467310673|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129821872|NCT01018186|467310674|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129821873|NCT01018186|467310675|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129821874|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
129821875|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
129821876|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
129821877|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
129821878|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
129821879|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
129821880|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
129821881|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
129821882|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
129821883|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
129821884|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
129821885|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
129821886|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
129821887|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
129821888|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
129821889|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
129821890|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
129821891|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
129821892|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
129821893|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
129821894|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
129821895|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
129821896|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
129821897|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
129821898|NCT01018186|467310672|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129821899|NCT01018186|467310673|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
129821900|NCT01018186|467310674|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
129821901|NCT01018186|467310675|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
129821902|NCT03049280|467310676|FG000|Overall Study|Physician Decision|1|||
129821903|NCT03552198|467310677|FG000|Overall Study|Lost to Follow-up|42|||
129821904|NCT03552198|467310678|FG001|Overall Study|Lost to Follow-up|48|||
129821905|NCT03552198|467310679|FG002|Overall Study|Lost to Follow-up|15|||
129821906|NCT03552198|467310680|FG003|Overall Study|Lost to Follow-up|19|||
129821907|NCT03552198|467310677|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
129821908|NCT03552198|467310678|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
129821909|NCT03552198|467310679|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
129821910|NCT03552198|467310680|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
129821911|NCT03552198|467310677|FG000|Overall Study|Did not receive air alerts|1|||
129821912|NCT03552198|467310678|FG001|Overall Study|Did not receive air alerts|0|||
129821913|NCT03552198|467310679|FG002|Overall Study|Did not receive air alerts|0|||
129821914|NCT03552198|467310680|FG003|Overall Study|Did not receive air alerts|1|||
129821915|NCT03235154|467310681|FG000|Overall Study|Withdrawal by Subject|1|||
129821916|NCT03235154|467310681|FG000|Overall Study|Adverse Event|1|||
129821917|NCT03235154|467310681|FG000|Overall Study|Lost to Follow-up|2|||
129821918|NCT00276744|467310682|FG000|PART A|Reason unknown|98|||
129821919|NCT00640601|467310688|FG000|Overall Study|Adverse Event|43|||
129821920|NCT00640601|467310688|FG000|Overall Study|Withdrawal by Subject|20|||
129821921|NCT00640601|467310688|FG000|Overall Study|Protocol Violation|6|||
129821922|NCT00640601|467310688|FG000|Overall Study|Lack of Efficacy|16|||
129821923|NCT00640601|467310688|FG000|Overall Study|Lost to Follow-up|9|||
129821924|NCT00640601|467310688|FG000|Overall Study|Physician Decision|8|||
129821925|NCT00640601|467310688|FG000|Overall Study|treatment naive, combination therapy|10|||
129821926|NCT03681405|467310689|FG000|Overall Study|Found to be ineligible after randomized|1|||
129821927|NCT03681405|467310690|FG001|Overall Study|Found to be ineligible after randomized|0|||
129821928|NCT03978520|467310691|FG000|Overall Study|Adverse Event|2|||
129821929|NCT03978520|467310692|FG001|Overall Study|Adverse Event|5|||
129821930|NCT03978520|467310693|FG002|Overall Study|Adverse Event|3|||
129821931|NCT03978520|467310694|FG003|Overall Study|Adverse Event|5|||
129821932|NCT03978520|467310695|FG004|Overall Study|Adverse Event|6|||
129821933|NCT03978520|467310691|FG000|Overall Study|Withdrawal by Subject|10|||
129821934|NCT03978520|467310692|FG001|Overall Study|Withdrawal by Subject|4|||
129821935|NCT03978520|467310693|FG002|Overall Study|Withdrawal by Subject|5|||
129821936|NCT03978520|467310694|FG003|Overall Study|Withdrawal by Subject|6|||
129821937|NCT03978520|467310695|FG004|Overall Study|Withdrawal by Subject|5|||
129821938|NCT03978520|467310691|FG000|Overall Study|Lost to Follow-up|2|||
129821939|NCT03978520|467310692|FG001|Overall Study|Lost to Follow-up|2|||
129897395|NCT04582877|467584357|FG000|Overall Study|Protocol Violation|1|||
129897396|NCT04012853|467584358|FG000|Overall Study|Withdrawal by Subject|1|||
129821940|NCT03978520|467310693|FG002|Overall Study|Lost to Follow-up|2|||
129821941|NCT03978520|467310694|FG003|Overall Study|Lost to Follow-up|0|||
129821942|NCT03978520|467310695|FG004|Overall Study|Lost to Follow-up|1|||
129821943|NCT03978520|467310691|FG000|Overall Study|COVID-19 infection|0|||
129821944|NCT03978520|467310692|FG001|Overall Study|COVID-19 infection|1|||
129821945|NCT03978520|467310693|FG002|Overall Study|COVID-19 infection|0|||
129821946|NCT03978520|467310694|FG003|Overall Study|COVID-19 infection|0|||
129821947|NCT03978520|467310695|FG004|Overall Study|COVID-19 infection|0|||
129821948|NCT03978520|467310691|FG000|Overall Study|Other, not specified|9|||
129821949|NCT03978520|467310692|FG001|Overall Study|Other, not specified|4|||
129821950|NCT03978520|467310693|FG002|Overall Study|Other, not specified|1|||
129821951|NCT03978520|467310694|FG003|Overall Study|Other, not specified|1|||
129821952|NCT03978520|467310695|FG004|Overall Study|Other, not specified|2|||
129821953|NCT03978520|467310691|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
129821954|NCT03978520|467310692|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
129821955|NCT03978520|467310693|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
129821956|NCT03978520|467310694|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
129821957|NCT03978520|467310695|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
129821958|NCT02860169|467310696|FG000|Part A|Withdrawal by Subject|1|||
129821959|NCT02860169|467310696|FG000|Part A|Other (Screening failure)|6|||
129821960|NCT02860169|467310696|FG000|Part A|Other (Survey not completed)|3|||
129821961|NCT02860169|467310696|FG000|Part A|Other (did not completed consent)|1|||
129821962|NCT02860169|467310696|FG000|Part B|Other (Screening failure)|10|||
129821963|NCT02860169|467310696|FG000|Part B|Withdrawal by Subject|1|||
129821964|NCT02860169|467310696|FG000|Part C|Other (Screening failure)|1|||
129821965|NCT01648205|467310699|FG000|Placebo|Pregnancy|1|||
129821966|NCT01648205|467310699|FG000|Placebo|Withdrawal by Subject|1|||
129821967|NCT01648205|467310699|FG000|Placebo|Protocol Violation|2|||
129821968|NCT01648205|467310699|FG000|Ranolazine|Death|1|||
129821969|NCT01648205|467310699|FG000|Ranolazine|Withdrawal by Subject|1|||
129821970|NCT01648205|467310699|FG000|Ranolazine|Protocol Violation|3|||
129821971|NCT03667924|467310702|FG000|Baseline Completed|Lost to Follow-up|0|||
129821972|NCT03667924|467310703|FG001|Baseline Completed|Lost to Follow-up|2|||
129821973|NCT03667924|467310704|FG002|Baseline Completed|Lost to Follow-up|0|||
129821974|NCT03667924|467310702|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
129821975|NCT03667924|467310703|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
129821976|NCT03667924|467310704|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
129821977|NCT03667924|467310702|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
129821978|NCT03667924|467310703|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
129821979|NCT03667924|467310704|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
129821980|NCT03667924|467310702|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
129821981|NCT03667924|467310703|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
129821982|NCT03667924|467310704|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
129821983|NCT03667924|467310702|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
129821984|NCT03667924|467310703|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
129821985|NCT03667924|467310704|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
129821986|NCT03667924|467310702|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
129821987|NCT03667924|467310703|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
129821988|NCT03667924|467310704|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
129821989|NCT03667924|467310702|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
129821990|NCT03667924|467310703|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
129821991|NCT03667924|467310704|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
129821992|NCT04557371|467310710|FG000|Overall Study|Covid-19-related|0|||
129821993|NCT04557371|467310711|FG001|Overall Study|Covid-19-related|1|||
129821994|NCT04557371|467310712|FG002|Overall Study|Covid-19-related|0|||
129821995|NCT04557371|467310710|FG000|Overall Study|Withdrawal by Subject|0|||
129821996|NCT04557371|467310711|FG001|Overall Study|Withdrawal by Subject|1|||
129821997|NCT04557371|467310712|FG002|Overall Study|Withdrawal by Subject|0|||
129821998|NCT04557371|467310710|FG000|Overall Study|Adverse Event|1|||
129821999|NCT04557371|467310711|FG001|Overall Study|Adverse Event|0|||
129822000|NCT04557371|467310712|FG002|Overall Study|Adverse Event|0|||
129822001|NCT00897104|467310715|FG000|Overall Study|Lost to Follow-up|12|||
129822002|NCT00897104|467310716|FG001|Overall Study|Lost to Follow-up|17|||
129822003|NCT00897104|467310717|FG002|Overall Study|Lost to Follow-up|2|||
129822004|NCT00897104|467310715|FG000|Overall Study|Pregnancy|0|||
129822005|NCT00897104|467310716|FG001|Overall Study|Pregnancy|1|||
129822006|NCT00897104|467310717|FG002|Overall Study|Pregnancy|0|||
129822007|NCT00897104|467310715|FG000|Overall Study|Protocol Violation|0|||
129822008|NCT00897104|467310716|FG001|Overall Study|Protocol Violation|1|||
129822009|NCT00897104|467310717|FG002|Overall Study|Protocol Violation|0|||
129822010|NCT00897104|467310715|FG000|Overall Study|Withdrawal by Subject|23|||
129822011|NCT00897104|467310716|FG001|Overall Study|Withdrawal by Subject|27|||
129822012|NCT00897104|467310717|FG002|Overall Study|Withdrawal by Subject|3|||
129822013|NCT00897104|467310715|FG000|Overall Study|Abnormal Prestudy Labs|2|||
129822014|NCT00897104|467310716|FG001|Overall Study|Abnormal Prestudy Labs|0|||
129822015|NCT00897104|467310717|FG002|Overall Study|Abnormal Prestudy Labs|0|||
129822016|NCT00897104|467310715|FG000|Overall Study|Abnormal Baseline ECG|2|||
129822017|NCT00897104|467310716|FG001|Overall Study|Abnormal Baseline ECG|2|||
129822018|NCT00897104|467310717|FG002|Overall Study|Abnormal Baseline ECG|0|||
129822019|NCT00897104|467310715|FG000|Overall Study|Need for Concom. Med.|0|||
129822020|NCT00897104|467310716|FG001|Overall Study|Need for Concom. Med.|1|||
129822021|NCT00897104|467310717|FG002|Overall Study|Need for Concom. Med.|1|||
129822022|NCT00897104|467310715|FG000|Overall Study|Lack of Migraine Attack|20|||
129822023|NCT00897104|467310716|FG001|Overall Study|Lack of Migraine Attack|22|||
129822024|NCT00897104|467310717|FG002|Overall Study|Lack of Migraine Attack|1|||
129822025|NCT00897104|467310715|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129822026|NCT00897104|467310716|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129822027|NCT00897104|467310717|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129822028|NCT00897104|467310715|FG000|Overall Study|Other|3|||
129822029|NCT00897104|467310716|FG001|Overall Study|Other|0|||
129822030|NCT00897104|467310717|FG002|Overall Study|Other|0|||
129822031|NCT00897104|467310715|FG000|Overall Study|Protocol Violation|1|||
129822032|NCT00897104|467310716|FG001|Overall Study|Protocol Violation|0|||
129822033|NCT00897104|467310717|FG002|Overall Study|Protocol Violation|0|||
129822034|NCT00897104|467310715|FG000|Overall Study|Withdrawal by Subject|0|||
129822035|NCT00897104|467310716|FG001|Overall Study|Withdrawal by Subject|0|||
129822036|NCT00897104|467310717|FG002|Overall Study|Withdrawal by Subject|1|||
129822037|NCT00477971|467310718|FG000|Overall Study|Disease progression|6|||
129822038|NCT00477971|467310719|FG001|Overall Study|Disease progression|0|||
129822039|NCT00477971|467310718|FG000|Overall Study|Withdrawal by Subject|3|||
129822040|NCT00477971|467310719|FG001|Overall Study|Withdrawal by Subject|1|||
129822041|NCT00477971|467310718|FG000|Overall Study|Adverse Event|3|||
129822042|NCT00477971|467310719|FG001|Overall Study|Adverse Event|0|||
129822043|NCT00477971|467310718|FG000|Overall Study|Death|2|||
129822044|NCT00477971|467310719|FG001|Overall Study|Death|4|||
129822045|NCT00477971|467310718|FG000|Overall Study|Alternative treatment|3|||
129822046|NCT00477971|467310719|FG001|Overall Study|Alternative treatment|1|||
129822047|NCT00531232|467313180|FG000|Overall Study|Investigator decision|0|||
129822048|NCT00531232|467313181|FG001|Overall Study|Investigator decision|0|||
129822049|NCT00531232|467313182|FG002|Overall Study|Investigator decision|4|||
129822050|NCT00531232|467313180|FG000|Overall Study|Participants refused further treatment|0|||
129822051|NCT00531232|467313181|FG001|Overall Study|Participants refused further treatment|1|||
129822052|NCT00531232|467313182|FG002|Overall Study|Participants refused further treatment|2|||
129822053|NCT00531232|467313180|FG000|Overall Study|Adverse events (AEs)|1|||
129822054|NCT00531232|467313181|FG001|Overall Study|Adverse events (AEs)|2|||
129822055|NCT00531232|467313182|FG002|Overall Study|Adverse events (AEs)|2|||
129822056|NCT00531232|467313180|FG000|Overall Study|Treatment failure|1|||
129822057|NCT00531232|467313181|FG001|Overall Study|Treatment failure|3|||
129822058|NCT00531232|467313182|FG002|Overall Study|Treatment failure|7|||
129822059|NCT00531232|467313180|FG000|Overall Study|Disease recurrence|0|||
129822060|NCT00531232|467313181|FG001|Overall Study|Disease recurrence|0|||
129822061|NCT00531232|467313182|FG002|Overall Study|Disease recurrence|1|||
129822062|NCT00531232|467313180|FG000|Overall Study|Deceased|2|||
129822063|NCT00531232|467313181|FG001|Overall Study|Deceased|2|||
129822064|NCT00531232|467313182|FG002|Overall Study|Deceased|2|||
129822065|NCT00531232|467313180|FG000|Overall Study|Withdrawal by Subject|0|||
129822066|NCT00531232|467313181|FG001|Overall Study|Withdrawal by Subject|1|||
129445685|NCT01968070|465932888|FG013|Period 1|Adverse Event|0|||
129822067|NCT00531232|467313182|FG002|Overall Study|Withdrawal by Subject|2|||
129822068|NCT00531232|467313180|FG000|Overall Study|Other|0|||
129822069|NCT00531232|467313181|FG001|Overall Study|Other|0|||
129822070|NCT00531232|467313182|FG002|Overall Study|Other|5|||
129822071|NCT02345850|467313188|FG000|Overall Study|Not transplanted|10|||
129822072|NCT02345850|467313189|FG001|Overall Study|Not transplanted|5|||
129822073|NCT02345850|467313190|FG002|Overall Study|Not transplanted|4|||
129822074|NCT02345850|467313188|FG000|Overall Study|Lost to Follow-up|2|||
129822075|NCT02345850|467313189|FG001|Overall Study|Lost to Follow-up|3|||
129822076|NCT02345850|467313190|FG002|Overall Study|Lost to Follow-up|2|||
129822077|NCT02345850|467313188|FG000|Overall Study|Withdrawal by Subject|1|||
129822078|NCT02345850|467313189|FG001|Overall Study|Withdrawal by Subject|0|||
129822079|NCT02345850|467313190|FG002|Overall Study|Withdrawal by Subject|0|||
129822080|NCT01991067|467313197|FG000|Overall Study|Lost to Follow-up|6|||
129822081|NCT01991067|467313198|FG001|Overall Study|Lost to Follow-up|5|||
129822082|NCT00464087|467313202|FG000|Overall Study|No PCI per inclusion criteria|0|||
129822083|NCT00464087|467313203|FG001|Overall Study|No PCI per inclusion criteria|0|||
129822084|NCT00464087|467313204|FG002|Overall Study|No PCI per inclusion criteria|29|||
129822085|NCT00609492|467313205|FG000|Overall Study|Withdrawal by Subject|0|||
129822086|NCT00609492|467313206|FG001|Overall Study|Withdrawal by Subject|2|||
129822087|NCT00609492|467313207|FG002|Overall Study|Withdrawal by Subject|3|||
129822088|NCT00609492|467313205|FG000|Overall Study|Lost to Follow-up|1|||
129822089|NCT00609492|467313206|FG001|Overall Study|Lost to Follow-up|1|||
129822090|NCT00609492|467313207|FG002|Overall Study|Lost to Follow-up|4|||
129822091|NCT00418314|467313208|FG000|Overall Study|Withdrawal by Subject|1|||
129822092|NCT00418314|467313209|FG001|Overall Study|Withdrawal by Subject|2|||
129822093|NCT02692716|467313210|FG000|Overall Study|Lost to Follow-up|2|||
129822094|NCT02692716|467313211|FG001|Overall Study|Lost to Follow-up|5|||
129822095|NCT02692716|467313210|FG000|Overall Study|Withdrawal by Subject|3|||
129822096|NCT02692716|467313211|FG001|Overall Study|Withdrawal by Subject|1|||
129822097|NCT02782780|467313216|FG000|Overall Study|dropped out after randomization.|7|||
129822098|NCT02782780|467313217|FG001|Overall Study|dropped out after randomization.|5|||
129822099|NCT02782780|467313216|FG000|Overall Study|Protocol Violation|0|||
129822100|NCT02782780|467313217|FG001|Overall Study|Protocol Violation|2|||
129822101|NCT03562481|467313218|FG000|First Intervention|Lost to Follow-up|1|||
129822102|NCT03562481|467313219|FG001|First Intervention|Lost to Follow-up|0|||
129822103|NCT00856284|467313220|FG000|Overall Study|Hyperglycemic rescue|231|||
129822104|NCT00856284|467313221|FG001|Overall Study|Hyperglycemic rescue|201|||
129822105|NCT00856284|467313222|FG002|Overall Study|Hyperglycemic rescue|235|||
129822106|NCT00856284|467313220|FG000|Overall Study|Adverse Event|60|||
129822107|NCT00856284|467313221|FG001|Overall Study|Adverse Event|74|||
129822108|NCT00856284|467313222|FG002|Overall Study|Adverse Event|82|||
129822109|NCT00856284|467313220|FG000|Overall Study|Major protocol deviation|24|||
129822110|NCT00856284|467313221|FG001|Overall Study|Major protocol deviation|16|||
129822111|NCT00856284|467313222|FG002|Overall Study|Major protocol deviation|15|||
129822112|NCT00856284|467313220|FG000|Overall Study|Lost to Follow-up|20|||
129822113|NCT00856284|467313221|FG001|Overall Study|Lost to Follow-up|22|||
129822114|NCT00856284|467313222|FG002|Overall Study|Lost to Follow-up|28|||
129822115|NCT00856284|467313220|FG000|Overall Study|Voluntary withdrawal|48|||
129822116|NCT00856284|467313221|FG001|Overall Study|Voluntary withdrawal|52|||
129822117|NCT00856284|467313222|FG002|Overall Study|Voluntary withdrawal|62|||
129822118|NCT00856284|467313220|FG000|Overall Study|Pregnancy|1|||
129822119|NCT00856284|467313221|FG001|Overall Study|Pregnancy|2|||
129822120|NCT00856284|467313222|FG002|Overall Study|Pregnancy|0|||
129822121|NCT00856284|467313220|FG000|Overall Study|Investigator discretion|9|||
129822122|NCT00856284|467313221|FG001|Overall Study|Investigator discretion|8|||
129822123|NCT00856284|467313222|FG002|Overall Study|Investigator discretion|10|||
129822124|NCT00856284|467313220|FG000|Overall Study|Other|15|||
129822125|NCT00856284|467313221|FG001|Overall Study|Other|17|||
129822126|NCT00856284|467313222|FG002|Overall Study|Other|14|||
129822127|NCT00856284|467313220|FG000|Overall Study|Randomized in error|0|||
129822128|NCT00856284|467313221|FG001|Overall Study|Randomized in error|0|||
129822129|NCT00856284|467313222|FG002|Overall Study|Randomized in error|1|||
129822130|NCT03247530|467313226|FG000|Overall Study|Withdrawal by caregiver|19|||
129822131|NCT03247530|467313227|FG001|Overall Study|Withdrawal by caregiver|8|||
129822132|NCT03247530|467313228|FG002|Overall Study|Withdrawal by caregiver|10|||
129822133|NCT03247530|467313226|FG000|Overall Study|Lost to Follow-up|3|||
129822134|NCT03247530|467313227|FG001|Overall Study|Lost to Follow-up|9|||
129822135|NCT03247530|467313228|FG002|Overall Study|Lost to Follow-up|6|||
129822136|NCT03247530|467313226|FG000|Overall Study|Adverse Event|2|||
129822137|NCT03247530|467313227|FG001|Overall Study|Adverse Event|5|||
129822138|NCT03247530|467313228|FG002|Overall Study|Adverse Event|2|||
129822139|NCT03247530|467313226|FG000|Overall Study|Failure to follow procedure|1|||
129822140|NCT03247530|467313227|FG001|Overall Study|Failure to follow procedure|1|||
129822141|NCT03247530|467313228|FG002|Overall Study|Failure to follow procedure|1|||
129822142|NCT03247530|467313226|FG000|Overall Study|Withdrawal by Subject|1|||
129822143|NCT03247530|467313227|FG001|Overall Study|Withdrawal by Subject|1|||
129822144|NCT03247530|467313228|FG002|Overall Study|Withdrawal by Subject|0|||
129822145|NCT03247530|467313226|FG000|Overall Study|Study medication misuse|0|||
129822146|NCT03247530|467313227|FG001|Overall Study|Study medication misuse|1|||
129822147|NCT03247530|467313228|FG002|Overall Study|Study medication misuse|0|||
129822148|NCT03247530|467313226|FG000|Overall Study|Other, multiple categories|1|||
129822149|NCT03247530|467313227|FG001|Overall Study|Other, multiple categories|3|||
129822150|NCT03247530|467313228|FG002|Overall Study|Other, multiple categories|1|||
129822151|NCT01442493|467313232|FG000|Overall Study|withdrawn from study|3|||
129822152|NCT01442493|467313233|FG001|Overall Study|withdrawn from study|2|||
129822153|NCT03315208|467313235|FG000|Overall Study|Lost to Follow-up|11|||
129822154|NCT03315208|467313236|FG001|Overall Study|Lost to Follow-up|6|||
129822155|NCT03315208|467313235|FG000|Overall Study|Withdrawal by Subject|2|||
129822156|NCT03315208|467313236|FG001|Overall Study|Withdrawal by Subject|0|||
129822157|NCT02875860|467313237|FG000|Overall Study|Withdrawal by Subject|0|||
129822158|NCT02875860|467313238|FG001|Overall Study|Withdrawal by Subject|1|||
129822159|NCT02320149|467313239|FG000|Overall Study|Adverse Event|3|||
129822160|NCT02320149|467313240|FG001|Overall Study|Adverse Event|7|||
129822161|NCT02320149|467313239|FG000|Overall Study|Withdrawal of Consent|28|||
129822162|NCT02320149|467313240|FG001|Overall Study|Withdrawal of Consent|32|||
129822163|NCT02320149|467313239|FG000|Overall Study|Lost to Follow-up|21|||
129822164|NCT02320149|467313240|FG001|Overall Study|Lost to Follow-up|34|||
129822165|NCT02320149|467313239|FG000|Overall Study|Protocol Violation|2|||
129822166|NCT02320149|467313240|FG001|Overall Study|Protocol Violation|1|||
129822167|NCT02320149|467313239|FG000|Overall Study|Noncompliance with Study Treatment|7|||
129822168|NCT02320149|467313240|FG001|Overall Study|Noncompliance with Study Treatment|2|||
129822169|NCT02320149|467313239|FG000|Overall Study|Lack of Efficacy|0|||
129822170|NCT02320149|467313240|FG001|Overall Study|Lack of Efficacy|1|||
129822171|NCT02320149|467313239|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129822172|NCT02320149|467313240|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129822173|NCT01156311|467313244|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
129822174|NCT01156311|467313245|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
129822175|NCT01156311|467313246|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
129822176|NCT01156311|467313247|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
129822177|NCT01156311|467313244|FG000|2-Month Monotherapy Period|Physician Decision|0|||
129822178|NCT01156311|467313245|FG001|2-Month Monotherapy Period|Physician Decision|1|||
129822179|NCT01156311|467313246|FG002|2-Month Monotherapy Period|Physician Decision|0|||
129822180|NCT01156311|467313247|FG003|2-Month Monotherapy Period|Physician Decision|0|||
129822181|NCT01156311|467313244|FG000|2-Month Monotherapy Period|Other|1|||
129822182|NCT01156311|467313245|FG001|2-Month Monotherapy Period|Other|0|||
129822183|NCT01156311|467313246|FG002|2-Month Monotherapy Period|Other|0|||
129822184|NCT01156311|467313247|FG003|2-Month Monotherapy Period|Other|0|||
129822185|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
129822186|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
129822187|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
129822188|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
129822189|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
129822190|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
129822191|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
129822192|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
129822193|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
129822194|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
129822195|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
129822196|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
129822197|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
129822198|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
129822199|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
129822200|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
129822201|NCT01156311|467313244|FG000|6-month Add-on Therapy Period|Other|0|||
129822202|NCT01156311|467313245|FG001|6-month Add-on Therapy Period|Other|0|||
129822203|NCT01156311|467313246|FG002|6-month Add-on Therapy Period|Other|1|||
129822204|NCT01156311|467313247|FG003|6-month Add-on Therapy Period|Other|2|||
129822205|NCT01741701|467313248|FG000|Overall Study|Adverse Event|5|||
129822206|NCT01741701|467313249|FG001|Overall Study|Adverse Event|1|||
129822207|NCT01741701|467313248|FG000|Overall Study|Withdrawal by Subject|0|||
129822208|NCT01741701|467313249|FG001|Overall Study|Withdrawal by Subject|1|||
129822209|NCT01359449|467313254|FG000|Overall Study|Lost to Follow-up|1|||
129822210|NCT01359449|467313255|FG001|Overall Study|Lost to Follow-up|0|||
129822211|NCT01359449|467313254|FG000|Overall Study|Protocol Violation|0|||
129822212|NCT01359449|467313255|FG001|Overall Study|Protocol Violation|2|||
129822213|NCT01359449|467313254|FG000|Overall Study|Withdrawal by Subject|3|||
129822214|NCT01359449|467313255|FG001|Overall Study|Withdrawal by Subject|2|||
129445686|NCT01968070|465932889|FG014|Period 1|Adverse Event|0|||
129822215|NCT00372112|467313256|FG000|Overall Study|Adverse Event|0|||
129822216|NCT00372112|467313257|FG001|Overall Study|Adverse Event|1|||
129822217|NCT00372112|467313258|FG002|Overall Study|Adverse Event|1|||
129822218|NCT00372112|467313259|FG003|Overall Study|Adverse Event|1|||
129822219|NCT00372112|467313256|FG000|Overall Study|Withdrawal by Subject|0|||
129822220|NCT00372112|467313257|FG001|Overall Study|Withdrawal by Subject|0|||
129822221|NCT00372112|467313258|FG002|Overall Study|Withdrawal by Subject|2|||
129822222|NCT00372112|467313259|FG003|Overall Study|Withdrawal by Subject|1|||
129822223|NCT00372112|467313256|FG000|Overall Study|Exacerbation|0|||
129822224|NCT00372112|467313257|FG001|Overall Study|Exacerbation|0|||
129822225|NCT00372112|467313258|FG002|Overall Study|Exacerbation|0|||
129822226|NCT00372112|467313259|FG003|Overall Study|Exacerbation|1|||
129822227|NCT00372112|467313256|FG000|Overall Study|PR >240 at Visit 3|0|||
129822228|NCT00372112|467313257|FG001|Overall Study|PR >240 at Visit 3|0|||
129822229|NCT00372112|467313258|FG002|Overall Study|PR >240 at Visit 3|0|||
129822230|NCT00372112|467313259|FG003|Overall Study|PR >240 at Visit 3|1|||
129822231|NCT00372112|467313256|FG000|Overall Study|Hepatitis B|1|||
129822232|NCT00372112|467313257|FG001|Overall Study|Hepatitis B|0|||
129822233|NCT00372112|467313258|FG002|Overall Study|Hepatitis B|0|||
129822234|NCT00372112|467313259|FG003|Overall Study|Hepatitis B|0|||
129822235|NCT00372112|467313256|FG000|Overall Study|Other-protocol violation|0|||
129822236|NCT00372112|467313257|FG001|Overall Study|Other-protocol violation|0|||
129822237|NCT00372112|467313258|FG002|Overall Study|Other-protocol violation|1|||
129822238|NCT00372112|467313259|FG003|Overall Study|Other-protocol violation|0|||
129822239|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
129822240|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
129822241|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
129822242|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
129822243|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
129822244|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
129822245|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
129822246|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
129822247|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Patient Request|1|||
129822248|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Patient Request|0|||
129822249|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
129822250|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
129822251|NCT04649060|467313274|FG000|Arm A/Arm B Treatment|Other|1|||
129822252|NCT04649060|467313275|FG001|Arm A/Arm B Treatment|Other|0|||
129822253|NCT04649060|467313274|FG000|Crossover (Arm B)|Adverse Event|0|||
129822254|NCT04649060|467313275|FG001|Crossover (Arm B)|Adverse Event|1|||
129822255|NCT04649060|467313274|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
129822256|NCT04649060|467313275|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
129822257|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
129822258|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
129822259|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
129822260|NCT03033394|467313276|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
129822261|NCT03033394|467313276|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
129822262|NCT02036294|467313277|FG000|Overall Study|Death|7|||
129822263|NCT02036294|467313278|FG001|Overall Study|Death|8|||
129822264|NCT02036294|467313277|FG000|Overall Study|Withdrawal by Subject|2|||
129822265|NCT02036294|467313278|FG001|Overall Study|Withdrawal by Subject|3|||
129822266|NCT01830972|467313279|FG000|Part II|Withdrawal by Subject|2|||
129822267|NCT01830972|467313280|FG001|Part II|Withdrawal by Subject|2|||
129822268|NCT01830972|467313279|FG000|Part III|Withdrawal by Subject|1|||
129822269|NCT01830972|467313280|FG001|Part III|Withdrawal by Subject|0|||
129822270|NCT01830972|467313279|FG000|Part III|Noncompliance|1|||
129822271|NCT01830972|467313280|FG001|Part III|Noncompliance|0|||
129822272|NCT01830972|467313279|FG000|Part IV|Withdrawal by Subject|2|||
129822273|NCT01830972|467313280|FG001|Part IV|Withdrawal by Subject|1|||
129822274|NCT01830972|467313279|FG000|Part IV|Non-Compliance|1|||
129822275|NCT01830972|467313280|FG001|Part IV|Non-Compliance|0|||
129822276|NCT01426373|467313284|FG000|Overall Study|Adverse Event|6|||
129822277|NCT01426373|467313284|FG000|Overall Study|Lost to Follow-up|14|||
129822278|NCT01426373|467313284|FG000|Overall Study|Participant Convenience|10|||
129822279|NCT01426373|467313284|FG000|Overall Study|Miscellaneous Reasons|4|||
129822280|NCT04952402|467313285|FG000|Overall Study|Lost to Follow-up|1|||
129822281|NCT04952402|467313286|FG001|Overall Study|Lost to Follow-up|3|||
129822282|NCT04952402|467313285|FG000|Overall Study|Lack Of Venous Access|0|||
129822283|NCT04952402|467313286|FG001|Overall Study|Lack Of Venous Access|1|||
129822284|NCT00726661|467313287|FG000|Overall Study|Lost to Follow-up|36|||
129822285|NCT00726661|467313288|FG001|Overall Study|Lost to Follow-up|11|||
129822286|NCT00726661|467313287|FG000|Overall Study|Withdrawal by Subject|17|||
129822287|NCT00726661|467313288|FG001|Overall Study|Withdrawal by Subject|13|||
129822288|NCT00726661|467313287|FG000|Overall Study|Trial terminated by sponsor|214|||
129822289|NCT00726661|467313288|FG001|Overall Study|Trial terminated by sponsor|187|||
129822290|NCT00726661|467313287|FG000|Overall Study|Death|475|||
129822291|NCT00726661|467313288|FG001|Overall Study|Death|159|||
129822292|NCT00726661|467313287|FG000|Overall Study|Physician Decision|25|||
129822293|NCT00726661|467313288|FG001|Overall Study|Physician Decision|13|||
129822294|NCT00726661|467313287|FG000|Overall Study|Other|47|||
129822295|NCT00726661|467313288|FG001|Overall Study|Other|35|||
129822296|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
129822297|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
129822298|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
129822299|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
129822300|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
129822301|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
129822302|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
129822303|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
129822304|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
129822305|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
129822306|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
129822307|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
129822308|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
129822309|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
129822310|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
129822311|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
129822312|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
129822313|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
129822314|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
129822315|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
129822316|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
129822317|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
129822318|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
129822319|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
129822320|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
129822321|NCT01285310|467313289|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
129822322|NCT01285310|467313290|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
129822323|NCT01285310|467313291|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
129822324|NCT01285310|467313292|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
129822325|NCT01285310|467313293|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
129822326|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
129822327|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
129822328|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
129822329|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
129822330|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
129822331|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
129822332|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
129822333|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
129822334|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
129822335|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
129822336|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
129822337|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
129822338|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
129822339|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
129822340|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
129822341|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
129822342|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
129897397|NCT04012853|467584359|FG001|Overall Study|Withdrawal by Subject|1|||
129822343|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
129822344|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
129822345|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
129822346|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
129822347|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
129822348|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
129822349|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
129822350|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
129822351|NCT01285310|467313289|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
129822352|NCT01285310|467313290|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
129822353|NCT01285310|467313291|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
129822354|NCT01285310|467313292|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
129822355|NCT01285310|467313293|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
129822356|NCT01574326|467313294|FG000|Overall Study|Randomized but not treated|0|||
129822357|NCT01574326|467313295|FG001|Overall Study|Randomized but not treated|1|||
129822358|NCT01574326|467313294|FG000|Overall Study|Withdrawal by Participant|2|||
129822359|NCT01574326|467313295|FG001|Overall Study|Withdrawal by Participant|4|||
129822360|NCT01574326|467313294|FG000|Overall Study|Physician Decision|5|||
129822361|NCT01574326|467313295|FG001|Overall Study|Physician Decision|3|||
129822362|NCT01574326|467313294|FG000|Overall Study|Adverse Event|1|||
129822363|NCT01574326|467313295|FG001|Overall Study|Adverse Event|3|||
129822364|NCT01574326|467313294|FG000|Overall Study|Other: Mainly kidney transplant|8|||
129822365|NCT01574326|467313295|FG001|Overall Study|Other: Mainly kidney transplant|8|||
129822366|NCT04997161|467313318|FG000|Overall Study|Study terminated by sponsor|3|||
129822367|NCT00005937|467313319|FG000|Overall Study|Lack of Efficacy|5|||
129822368|NCT01574612|467313320|FG000|Overall Study|Adverse Event|3|||
129822369|NCT01574612|467313320|FG000|Overall Study|non compliant with drug|2|||
129822370|NCT01574612|467313320|FG000|Overall Study|Withdrawal by Subject|1|||
129822371|NCT01574612|467313320|FG000|Overall Study|Lost to Follow-up|2|||
129822372|NCT02407704|467313323|FG000|Overall Study|Lost to Follow-up|0|||
129822373|NCT02407704|467313324|FG001|Overall Study|Lost to Follow-up|0|||
129822374|NCT02407704|467313325|FG002|Overall Study|Lost to Follow-up|0|||
129822375|NCT02407704|467313326|FG003|Overall Study|Lost to Follow-up|2|||
129822376|NCT02407704|467313323|FG000|Overall Study|Protocol Violation|0|||
129822377|NCT02407704|467313324|FG001|Overall Study|Protocol Violation|0|||
129822378|NCT02407704|467313325|FG002|Overall Study|Protocol Violation|0|||
129822379|NCT02407704|467313326|FG003|Overall Study|Protocol Violation|1|||
129822380|NCT02407704|467313323|FG000|Overall Study|Withdrawal by Subject|0|||
129822381|NCT02407704|467313324|FG001|Overall Study|Withdrawal by Subject|0|||
129822382|NCT02407704|467313325|FG002|Overall Study|Withdrawal by Subject|1|||
129822383|NCT02407704|467313326|FG003|Overall Study|Withdrawal by Subject|0|||
129822384|NCT01957644|467313329|FG000|Overall Study|Adverse Event|4|||
129822385|NCT01957644|467313330|FG001|Overall Study|Adverse Event|2|||
129822386|NCT01957644|467313331|FG002|Overall Study|Adverse Event|0|||
129822387|NCT01957644|467313332|FG003|Overall Study|Adverse Event|0|||
129822388|NCT01957644|467313333|FG004|Overall Study|Adverse Event|1|||
129822389|NCT01957644|467313329|FG000|Overall Study|Progressive disease / relapse|0|||
129822390|NCT01957644|467313330|FG001|Overall Study|Progressive disease / relapse|1|||
129822391|NCT01957644|467313331|FG002|Overall Study|Progressive disease / relapse|0|||
129822392|NCT01957644|467313332|FG003|Overall Study|Progressive disease / relapse|1|||
129822393|NCT01957644|467313333|FG004|Overall Study|Progressive disease / relapse|0|||
129822394|NCT01957644|467313329|FG000|Overall Study|Other reason|1|||
129822395|NCT01957644|467313330|FG001|Overall Study|Other reason|2|||
129822396|NCT01957644|467313331|FG002|Overall Study|Other reason|1|||
129822397|NCT01957644|467313332|FG003|Overall Study|Other reason|1|||
129822398|NCT01957644|467313333|FG004|Overall Study|Other reason|0|||
129822399|NCT01957644|467313329|FG000|Overall Study|Withdrawal by Subject|1|||
129822400|NCT01957644|467313330|FG001|Overall Study|Withdrawal by Subject|0|||
129822401|NCT01957644|467313331|FG002|Overall Study|Withdrawal by Subject|0|||
129822402|NCT01957644|467313332|FG003|Overall Study|Withdrawal by Subject|0|||
129822403|NCT01957644|467313333|FG004|Overall Study|Withdrawal by Subject|0|||
129822404|NCT01957644|467313329|FG000|Overall Study|Protocol Violation|0|||
129822405|NCT01957644|467313330|FG001|Overall Study|Protocol Violation|1|||
129822406|NCT01957644|467313331|FG002|Overall Study|Protocol Violation|0|||
129897398|NCT04012853|467584358|FG000|Overall Study|Protocol Violation|1|||
129897399|NCT04012853|467584359|FG001|Overall Study|Protocol Violation|0|||
129897400|NCT04012853|467584358|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
129897401|NCT04012853|467584359|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
129897402|NCT03055767|467584360|FG000|Open-Label Period|Lost to Follow-up|0|||
129897403|NCT03055767|467584361|FG001|Open-Label Period|Lost to Follow-up|0|||
129897404|NCT03055767|467584362|FG002|Open-Label Period|Lost to Follow-up|2|||
129897405|NCT03055767|467584363|FG003|Open-Label Period|Lost to Follow-up|0|||
129897406|NCT03055767|467584360|FG000|Open-Label Period|Withdrawal by Subject|0|||
129897407|NCT03055767|467584361|FG001|Open-Label Period|Withdrawal by Subject|0|||
129897408|NCT03055767|467584362|FG002|Open-Label Period|Withdrawal by Subject|0|||
129897409|NCT03055767|467584363|FG003|Open-Label Period|Withdrawal by Subject|1|||
129822407|NCT01957644|467313332|FG003|Overall Study|Protocol Violation|0|||
129822408|NCT01957644|467313333|FG004|Overall Study|Protocol Violation|0|||
129822409|NCT04044716|467313334|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
129822410|NCT04044716|467313335|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
129822411|NCT04044716|467313336|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
129822412|NCT04044716|467313334|FG000|Overall Study|Lost to Follow-up|2|||
129822413|NCT04044716|467313335|FG001|Overall Study|Lost to Follow-up|3|||
129822414|NCT04044716|467313336|FG002|Overall Study|Lost to Follow-up|0|||
129822415|NCT01324999|467313337|FG000|Overall Study|Adverse Event|3|||
129822416|NCT01324999|467313337|FG000|Overall Study|Withdrawal by Subject|2|||
129822417|NCT00230607|467313338|FG000|Overall Study|Other|3|||
129822418|NCT00071513|467313339|FG000|Intervention Component|Withdrawal by Subject|2|||
129822419|NCT00071513|467313340|FG001|Intervention Component|Withdrawal by Subject|3|||
129822420|NCT00071513|467313339|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
129822421|NCT00071513|467313340|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
129822422|NCT01244425|467313342|FG000|Overall Study|Withdrawal by Subject|2|||
129822423|NCT01244425|467313343|FG001|Overall Study|Withdrawal by Subject|2|||
129822424|NCT01244425|467313342|FG000|Overall Study|Adverse Event|1|||
129822425|NCT01244425|467313343|FG001|Overall Study|Adverse Event|1|||
129822426|NCT02743871|467313344|FG000|Overall Study|Lost to Follow-up|0|||
129822427|NCT02743871|467313345|FG001|Overall Study|Lost to Follow-up|0|||
129822428|NCT02743871|467313346|FG002|Overall Study|Lost to Follow-up|0|||
129822429|NCT02743871|467313347|FG003|Overall Study|Lost to Follow-up|1|||
129822430|NCT02743871|467313348|FG004|Overall Study|Lost to Follow-up|0|||
129822431|NCT02743871|467313349|FG005|Overall Study|Lost to Follow-up|0|||
129822432|NCT02743871|467313350|FG006|Overall Study|Lost to Follow-up|1|||
129822433|NCT02743871|467313351|FG007|Overall Study|Lost to Follow-up|0|||
129822434|NCT02743871|467313352|FG008|Overall Study|Lost to Follow-up|0|||
129822435|NCT02743871|467313353|FG009|Overall Study|Lost to Follow-up|0|||
129822436|NCT02743871|467313354|FG010|Overall Study|Lost to Follow-up|0|||
129822437|NCT02743871|467313355|FG011|Overall Study|Lost to Follow-up|2|||
129822438|NCT02743871|467313356|FG012|Overall Study|Lost to Follow-up|0|||
129822439|NCT02743871|467313357|FG013|Overall Study|Lost to Follow-up|0|||
129822440|NCT02743871|467313344|FG000|Overall Study|Withdrawal by Subject|0|||
129822441|NCT02743871|467313345|FG001|Overall Study|Withdrawal by Subject|0|||
129822442|NCT02743871|467313346|FG002|Overall Study|Withdrawal by Subject|0|||
129822443|NCT02743871|467313347|FG003|Overall Study|Withdrawal by Subject|0|||
129822444|NCT02743871|467313348|FG004|Overall Study|Withdrawal by Subject|0|||
129822445|NCT02743871|467313349|FG005|Overall Study|Withdrawal by Subject|0|||
129822446|NCT02743871|467313350|FG006|Overall Study|Withdrawal by Subject|0|||
129822447|NCT02743871|467313351|FG007|Overall Study|Withdrawal by Subject|0|||
129822448|NCT02743871|467313352|FG008|Overall Study|Withdrawal by Subject|0|||
129822449|NCT02743871|467313353|FG009|Overall Study|Withdrawal by Subject|0|||
129822450|NCT02743871|467313354|FG010|Overall Study|Withdrawal by Subject|1|||
129822451|NCT02743871|467313355|FG011|Overall Study|Withdrawal by Subject|0|||
129822452|NCT02743871|467313356|FG012|Overall Study|Withdrawal by Subject|12|||
129822453|NCT02743871|467313357|FG013|Overall Study|Withdrawal by Subject|6|||
129822454|NCT02743871|467313344|FG000|Overall Study|Adverse Event|1|||
129822455|NCT02743871|467313345|FG001|Overall Study|Adverse Event|0|||
129822456|NCT02743871|467313346|FG002|Overall Study|Adverse Event|0|||
129822457|NCT02743871|467313347|FG003|Overall Study|Adverse Event|0|||
129822458|NCT02743871|467313348|FG004|Overall Study|Adverse Event|0|||
129822459|NCT02743871|467313349|FG005|Overall Study|Adverse Event|0|||
129822460|NCT02743871|467313350|FG006|Overall Study|Adverse Event|0|||
129822461|NCT02743871|467313351|FG007|Overall Study|Adverse Event|0|||
129822462|NCT02743871|467313352|FG008|Overall Study|Adverse Event|0|||
129822463|NCT02743871|467313353|FG009|Overall Study|Adverse Event|0|||
129822464|NCT02743871|467313354|FG010|Overall Study|Adverse Event|0|||
129822465|NCT02743871|467313355|FG011|Overall Study|Adverse Event|0|||
129822466|NCT02743871|467313356|FG012|Overall Study|Adverse Event|0|||
129822467|NCT02743871|467313357|FG013|Overall Study|Adverse Event|0|||
129822468|NCT02743871|467313344|FG000|Overall Study|Other|0|||
129822469|NCT02743871|467313345|FG001|Overall Study|Other|0|||
129822470|NCT02743871|467313346|FG002|Overall Study|Other|0|||
129822471|NCT02743871|467313347|FG003|Overall Study|Other|0|||
129822472|NCT02743871|467313348|FG004|Overall Study|Other|0|||
129822473|NCT02743871|467313349|FG005|Overall Study|Other|0|||
129822474|NCT02743871|467313350|FG006|Overall Study|Other|0|||
129822475|NCT02743871|467313351|FG007|Overall Study|Other|0|||
129822476|NCT02743871|467313352|FG008|Overall Study|Other|0|||
129822477|NCT02743871|467313353|FG009|Overall Study|Other|0|||
129822478|NCT02743871|467313354|FG010|Overall Study|Other|0|||
129822479|NCT02743871|467313355|FG011|Overall Study|Other|1|||
129822480|NCT02743871|467313356|FG012|Overall Study|Other|1|||
129822481|NCT02743871|467313357|FG013|Overall Study|Other|1|||
129822482|NCT02743871|467313344|FG000|Overall Study|Protocol Violation|0|||
129822483|NCT02743871|467313345|FG001|Overall Study|Protocol Violation|0|||
129822484|NCT02743871|467313346|FG002|Overall Study|Protocol Violation|0|||
129822485|NCT02743871|467313347|FG003|Overall Study|Protocol Violation|0|||
129822486|NCT02743871|467313348|FG004|Overall Study|Protocol Violation|0|||
129822487|NCT02743871|467313349|FG005|Overall Study|Protocol Violation|0|||
129822488|NCT02743871|467313350|FG006|Overall Study|Protocol Violation|0|||
129822489|NCT02743871|467313351|FG007|Overall Study|Protocol Violation|0|||
129822490|NCT02743871|467313352|FG008|Overall Study|Protocol Violation|0|||
129822491|NCT02743871|467313353|FG009|Overall Study|Protocol Violation|0|||
129822492|NCT02743871|467313354|FG010|Overall Study|Protocol Violation|0|||
129822493|NCT02743871|467313355|FG011|Overall Study|Protocol Violation|0|||
129822494|NCT02743871|467313356|FG012|Overall Study|Protocol Violation|2|||
129822495|NCT02743871|467313357|FG013|Overall Study|Protocol Violation|0|||
129822496|NCT02848651|467313358|FG000|Overall Study|Death|85|||
129822497|NCT02848651|467313358|FG000|Overall Study|Lost to Follow-up|1|||
129822498|NCT02848651|467313358|FG000|Overall Study|Non-Compliance|1|||
129822499|NCT02848651|467313358|FG000|Overall Study|Symptomatic Deterioration|1|||
129822500|NCT02848651|467313358|FG000|Overall Study|Physician Decision|4|||
129822501|NCT02848651|467313358|FG000|Overall Study|Withdrawal by Subject|14|||
129822502|NCT01059799|467313365|FG000|Overall Study|Adverse Event|2|||
129822503|NCT01059799|467313366|FG001|Overall Study|Adverse Event|3|||
129822504|NCT01059799|467313365|FG000|Overall Study|Lack of Efficacy|1|||
129822505|NCT01059799|467313366|FG001|Overall Study|Lack of Efficacy|0|||
129822506|NCT01059799|467313365|FG000|Overall Study|Protocol Violation|3|||
129822507|NCT01059799|467313366|FG001|Overall Study|Protocol Violation|2|||
129822508|NCT01059799|467313365|FG000|Overall Study|Withdrawal criteria|13|||
129822509|NCT01059799|467313366|FG001|Overall Study|Withdrawal criteria|2|||
129822510|NCT01059799|467313365|FG000|Overall Study|Other|12|||
129822511|NCT01059799|467313366|FG001|Overall Study|Other|3|||
129822512|NCT03700671|467313367|FG000|Overall Study|Lack of Efficacy|1|||
129822513|NCT03700671|467313368|FG001|Overall Study|Lack of Efficacy|2|||
129822514|NCT04203238|467315031|FG000|Overall Study|Withdrawal by Subject|1|||
129822515|NCT04203238|467315032|FG001|Overall Study|Withdrawal by Subject|1|||
129822516|NCT04203238|467315031|FG000|Overall Study|Covid-19|3|||
129822517|NCT04203238|467315032|FG001|Overall Study|Covid-19|0|||
129822518|NCT01955733|467315033|FG000|Period 1|Lost to Follow-up|1|||
129822519|NCT01955733|467315034|FG001|Period 1|Lost to Follow-up|0|||
129822520|NCT01955733|467315035|FG002|Period 1|Lost to Follow-up|0|||
129822521|NCT01955733|467315033|FG000|Period 2|Adverse Event|1|||
129822522|NCT01955733|467315034|FG001|Period 2|Adverse Event|0|||
129822523|NCT01955733|467315035|FG002|Period 2|Adverse Event|0|||
129822524|NCT01955733|467315033|FG000|Period 2|Physician Decision|0|||
129822525|NCT01955733|467315034|FG001|Period 2|Physician Decision|0|||
129822526|NCT01955733|467315035|FG002|Period 2|Physician Decision|1|||
129822527|NCT01955733|467315033|FG000|Period 2|Withdrawal by Subject|1|||
129822528|NCT01955733|467315034|FG001|Period 2|Withdrawal by Subject|3|||
129822529|NCT01955733|467315035|FG002|Period 2|Withdrawal by Subject|2|||
129822530|NCT01955733|467315033|FG000|Period 2|Study terminated by sponsor|8|||
129822531|NCT01955733|467315034|FG001|Period 2|Study terminated by sponsor|14|||
129822532|NCT01955733|467315035|FG002|Period 2|Study terminated by sponsor|16|||
129822533|NCT01955733|467315033|FG000|Period 2|Lost to Follow-up|2|||
129822534|NCT01955733|467315034|FG001|Period 2|Lost to Follow-up|0|||
129822535|NCT01955733|467315035|FG002|Period 2|Lost to Follow-up|0|||
129822536|NCT01955733|467315033|FG000|Period 2|Other not defined above|0|||
129822537|NCT01955733|467315034|FG001|Period 2|Other not defined above|2|||
129822538|NCT01955733|467315035|FG002|Period 2|Other not defined above|2|||
129822539|NCT00733408|467315036|FG000|Overall Study|Adverse Event|4|||
129822540|NCT02762266|467315037|FG000|Overall Study|Physician Decision|2|||
129822541|NCT02762266|467315038|FG001|Overall Study|Physician Decision|0|||
129822542|NCT01438424|467315039|FG000|Overall Study|Continuing treatment|29|||
129822543|NCT01438424|467315039|FG000|Overall Study|Minimal virologic response|95|||
129822544|NCT01438424|467315039|FG000|Overall Study|Not identified|55|||
129822545|NCT01438424|467315039|FG000|Overall Study|Withdrawal by Subject|104|||
129822546|NCT01438424|467315039|FG000|Overall Study|Progression of chronic hepatitis B|22|||
129822547|NCT01438424|467315039|FG000|Overall Study|Death|22|||
129822548|NCT01438424|467315039|FG000|Overall Study|Adverse Event|17|||
129822549|NCT01438424|467315039|FG000|Overall Study|Lost to Follow-up|17|||
129822550|NCT01438424|467315039|FG000|Overall Study|Abnormal laboratory test result|14|||
129822551|NCT01438424|467315039|FG000|Overall Study|Need for drug prohibited by protocol|14|||
129822552|NCT01438424|467315039|FG000|Overall Study|Pregnancy|7|||
129822553|NCT01438424|467315039|FG000|Overall Study|No longer met inclusion criteria|1|||
129822554|NCT01438424|467315039|FG000|Overall Study|Participant noncompliance|20|||
129822555|NCT02064868|467315044|FG000|Overall Study|Lost to Follow-up|14|||
129822556|NCT02064868|467315045|FG001|Overall Study|Lost to Follow-up|8|||
129822557|NCT02064868|467315044|FG000|Overall Study|Physician Decision|1|||
129822558|NCT02064868|467315045|FG001|Overall Study|Physician Decision|0|||
129822559|NCT02064868|467315044|FG000|Overall Study|Withdrawal by Subject|14|||
129822560|NCT02064868|467315045|FG001|Overall Study|Withdrawal by Subject|3|||
129822561|NCT02064868|467315044|FG000|Overall Study|Technical Problems or Missing|5|||
129822562|NCT02064868|467315045|FG001|Overall Study|Technical Problems or Missing|2|||
129822563|NCT00931762|467315049|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
129822564|NCT00931762|467315049|FG000|Overall Study|Administrative Problems|5|||
129822565|NCT00931762|467315049|FG000|Overall Study|Death|1|||
129822566|NCT00931762|467315049|FG000|Overall Study|Disease Progression|3|||
129822567|NCT00931762|467315049|FG000|Overall Study|Adverse Event (s)|11|||
129822568|NCT00931762|467315049|FG000|Overall Study|Subject withdrew consent|13|||
129822569|NCT02664441|467315050|FG000|Randomization|Withdrawal by Subject|0|||
129822570|NCT02664441|467315051|FG001|Randomization|Withdrawal by Subject|1|||
129822571|NCT02664441|467315050|FG000|36-week Randomized Trial|Adverse Event|2|||
129822572|NCT02664441|467315051|FG001|36-week Randomized Trial|Adverse Event|0|||
129822573|NCT02664441|467315050|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
129822574|NCT02664441|467315051|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
129822575|NCT02664441|467315050|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
129822576|NCT02664441|467315051|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
129822577|NCT02664441|467315050|FG000|18-week Open Label Extension|Adverse Event|1|||
129822578|NCT02664441|467315051|FG001|18-week Open Label Extension|Adverse Event|0|||
129822579|NCT02664441|467315050|FG000|18-week Open Label Extension|Physician Decision|1|||
129822580|NCT02664441|467315051|FG001|18-week Open Label Extension|Physician Decision|0|||
129822581|NCT02664441|467315050|FG000|18-week Open Label Extension|Death|1|||
129822582|NCT02664441|467315051|FG001|18-week Open Label Extension|Death|0|||
129822583|NCT02664441|467315050|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
129822584|NCT02664441|467315051|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
129822585|NCT01413191|467315052|FG000|Overall Study|Lost to Follow-up|5|||
129822586|NCT01413191|467315052|FG000|Overall Study|Disease Progression|5|||
129822587|NCT01413191|467315052|FG000|Overall Study|Death|1|||
129822588|NCT01702454|467315053|FG000|Overall Study|Consent withdrawal|0|||
129822589|NCT01702454|467315054|FG001|Overall Study|Consent withdrawal|1|||
129822590|NCT01702454|467315053|FG000|Overall Study|Migrated/moved from study area|0|||
129822591|NCT01702454|467315054|FG001|Overall Study|Migrated/moved from study area|1|||
129822592|NCT01702454|467315053|FG000|Overall Study|Lost to Follow-up|3|||
129822593|NCT01702454|467315054|FG001|Overall Study|Lost to Follow-up|6|||
129822594|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
129822595|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
129822596|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
129822597|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
129822598|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
129822599|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
129822600|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
129822601|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
129822602|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
129897410|NCT02759731|467584364|FG000|Overall Study|Did not complete treatment.|8|||
129897411|NCT00763282|467584369|FG000|Overall Study|Withdrawal by Subject|6|||
129822603|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
129822604|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
129822605|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
129897412|NCT00763282|467584370|FG001|Overall Study|Withdrawal by Subject|5|||
129897413|NCT00763282|467584369|FG000|Overall Study|Death|4|||
129822606|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
129822607|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
129822608|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
129822609|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
129822610|NCT03510884|467315055|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
129822611|NCT03510884|467315056|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
129822612|NCT03510884|467315057|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
129822613|NCT03510884|467315058|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
129822614|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
129822615|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
129822616|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
129822617|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
129822618|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
129822619|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
129822620|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
129822621|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
129822622|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
129822623|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
129822624|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
129822625|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
129822626|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
129822627|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
129822628|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
129822629|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
129822630|NCT03510884|467315055|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
129822631|NCT03510884|467315056|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
129822632|NCT03510884|467315057|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
129822633|NCT03510884|467315058|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
129822634|NCT01529346|467315060|FG000|Overall Study|Lost to Follow-up|2|||
129822635|NCT01529346|467315061|FG001|Overall Study|Lost to Follow-up|0|||
129822636|NCT01529346|467315062|FG002|Overall Study|Lost to Follow-up|1|||
129822637|NCT01529346|467315063|FG003|Overall Study|Lost to Follow-up|0|||
129822638|NCT01529346|467315064|FG004|Overall Study|Lost to Follow-up|0|||
129822639|NCT01529346|467315060|FG000|Overall Study|Other|0|||
129822640|NCT01529346|467315061|FG001|Overall Study|Other|1|||
129822641|NCT01529346|467315062|FG002|Overall Study|Other|1|||
129822642|NCT01529346|467315063|FG003|Overall Study|Other|0|||
129822643|NCT01529346|467315064|FG004|Overall Study|Other|0|||
129822644|NCT00589914|467315070|FG000|Overall Study|Adverse Event|19|||
129822645|NCT00589914|467315071|FG001|Overall Study|Adverse Event|10|||
129822646|NCT00589914|467315070|FG000|Overall Study|Death|2|||
129822647|NCT00589914|467315071|FG001|Overall Study|Death|0|||
129822648|NCT00589914|467315070|FG000|Overall Study|Lack of Efficacy|40|||
129822649|NCT00589914|467315071|FG001|Overall Study|Lack of Efficacy|43|||
129822650|NCT00589914|467315070|FG000|Overall Study|Lost to Follow-up|11|||
129822651|NCT00589914|467315071|FG001|Overall Study|Lost to Follow-up|18|||
129822652|NCT00589914|467315070|FG000|Overall Study|Pregnancy|1|||
129822653|NCT00589914|467315071|FG001|Overall Study|Pregnancy|0|||
129822654|NCT00589914|467315070|FG000|Overall Study|Withdrawal by Subject|55|||
129822655|NCT00589914|467315071|FG001|Overall Study|Withdrawal by Subject|49|||
129822656|NCT00589914|467315070|FG000|Overall Study|Other|22|||
129822657|NCT00589914|467315071|FG001|Overall Study|Other|17|||
129822658|NCT01594125|467315072|FG000|Overall Study|Withdrawal by Subject|1|||
129822659|NCT01594125|467315073|FG001|Overall Study|Withdrawal by Subject|0|||
129822660|NCT01594125|467315074|FG002|Overall Study|Withdrawal by Subject|0|||
129822661|NCT01594125|467315075|FG003|Overall Study|Withdrawal by Subject|1|||
129822662|NCT01594125|467315076|FG004|Overall Study|Withdrawal by Subject|0|||
129822663|NCT01594125|467315072|FG000|Overall Study|Progressive Disease|3|||
129822664|NCT01594125|467315073|FG001|Overall Study|Progressive Disease|12|||
129822665|NCT01594125|467315074|FG002|Overall Study|Progressive Disease|3|||
129822666|NCT01594125|467315075|FG003|Overall Study|Progressive Disease|3|||
129822667|NCT01594125|467315076|FG004|Overall Study|Progressive Disease|7|||
129822668|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
129822669|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
129822670|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
129822671|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
129822672|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
129822673|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
129822674|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
129822675|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
129822676|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
129822677|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
129822678|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
129822679|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
129822680|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
129822681|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
129822682|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
129822683|NCT01124422|467315078|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
129822684|NCT01124422|467315079|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
129822685|NCT01124422|467315080|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
129822686|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
129822687|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
129822688|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
129822689|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
129822690|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
129822691|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
129822692|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
129822693|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
129822694|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
129822695|NCT01124422|467315078|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
129822696|NCT01124422|467315079|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
129822697|NCT01124422|467315080|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
129822698|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Death|3|||
129822699|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Death|3|||
129822700|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Death|0|||
129822701|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Death|0|||
129822702|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
129822703|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
129822704|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
129822705|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
129822706|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
129822707|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
129822708|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
129822709|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
129822710|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
129822711|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
129822712|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
129822713|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
129822714|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
129822715|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
129822716|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
129822717|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
129822718|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
129822719|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
129822720|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
129822721|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
129822722|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
129822723|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
129822724|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
129822725|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
129822726|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Other|6|||
129822727|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Other|3|||
129822728|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Other|0|||
129822729|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Other|0|||
129822730|NCT02051608|467315085|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
129822731|NCT02051608|467315086|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
129822732|NCT02051608|467315087|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
129822733|NCT02051608|467315088|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
129822734|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Adverse Event|0|||
129822735|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Adverse Event|0|||
129822736|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Adverse Event|6|||
129822737|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Adverse Event|8|||
129897414|NCT00763282|467584370|FG001|Overall Study|Death|3|||
129897415|NCT00763282|467584369|FG000|Overall Study|Lost to Follow-up|22|||
129897416|NCT00763282|467584370|FG001|Overall Study|Lost to Follow-up|26|||
129897417|NCT00742274|467584371|FG000|Overall Study|Death|1|||
129822738|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Death|0|||
129445687|NCT01968070|465932890|FG015|Period 1|Adverse Event|0|||
129897418|NCT00742274|467584372|FG001|Overall Study|Death|0|||
129897419|NCT00742274|467584371|FG000|Overall Study|Withdrawal by Subject|1|||
129822739|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Death|0|||
129822740|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Death|7|||
129822741|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Death|4|||
129822742|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
129822743|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
129822744|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
129822745|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
129822746|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
129822747|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
129822748|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
129822749|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
129822750|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129822751|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
129822752|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
129822753|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
129822754|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
129822755|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
129822756|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
129822757|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
129822758|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Physician Decision|0|||
129822759|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Physician Decision|0|||
129822760|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Physician Decision|8|||
129822761|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Physician Decision|5|||
129822762|NCT02051608|467315085|FG000|Part 2: Open-label Extension|Other|0|||
129822763|NCT02051608|467315086|FG001|Part 2: Open-label Extension|Other|0|||
129822764|NCT02051608|467315087|FG002|Part 2: Open-label Extension|Other|9|||
129822765|NCT02051608|467315088|FG003|Part 2: Open-label Extension|Other|9|||
129822766|NCT04876274|467315089|FG000|Overall Study|Lost to Follow-up|9|||
129822767|NCT04876274|467315090|FG001|Overall Study|Lost to Follow-up|12|||
129822768|NCT03454893|467315091|FG000|Overall Study|Study Terminated by the Sponsor|5|||
129822769|NCT03454893|467315091|FG000|Overall Study|Did not pass screening|4|||
129822770|NCT01948050|467315094|FG000|Overall Study|Withdrawal by Subject|0|||
129822771|NCT01948050|467315095|FG001|Overall Study|Withdrawal by Subject|1|||
129822772|NCT00558025|467315096|FG000|Overall Study|Adverse Event|1|||
129822773|NCT00558025|467315097|FG001|Overall Study|Adverse Event|1|||
129822774|NCT00558025|467315096|FG000|Overall Study|Withdrawal by Subject|2|||
129822775|NCT00558025|467315097|FG001|Overall Study|Withdrawal by Subject|2|||
129822776|NCT00558025|467315096|FG000|Overall Study|Protocol Violation|1|||
129822777|NCT00558025|467315097|FG001|Overall Study|Protocol Violation|0|||
129822778|NCT00449540|467315098|FG000|Pretreatment Phase|No migraine experienced|66|||
129822779|NCT00449540|467315099|FG001|Pretreatment Phase|No migraine experienced|0|||
129822780|NCT00449540|467315100|FG002|Pretreatment Phase|No migraine experienced|0|||
129822781|NCT00449540|467315098|FG000|Treatment Phase|did not experience or treat migraine|0|||
129822782|NCT00449540|467315099|FG001|Treatment Phase|did not experience or treat migraine|20|||
129822783|NCT00449540|467315100|FG002|Treatment Phase|did not experience or treat migraine|17|||
129822784|NCT00010374|467315103|FG000|Overall Study|False positive phrenic nerve test|1|||
129822785|NCT01961323|467315104|FG000|Overall Study|Withdrawal by Subject|7|||
129822786|NCT01961323|467315104|FG000|Overall Study|Lost to Follow-up|8|||
129822787|NCT01961323|467315104|FG000|Overall Study|screen failure|34|||
129822788|NCT01881776|467315108|FG000|Overall Study|Lost to Follow-up|1|||
129822789|NCT01881776|467315109|FG001|Overall Study|Lost to Follow-up|2|||
129822790|NCT01881776|467315110|FG002|Overall Study|Lost to Follow-up|1|||
129822791|NCT01881776|467315108|FG000|Overall Study|Protocol Violation|0|||
129822792|NCT01881776|467315109|FG001|Overall Study|Protocol Violation|2|||
129822793|NCT01881776|467315110|FG002|Overall Study|Protocol Violation|1|||
129822794|NCT02393547|467315113|FG000|Overall Study|Adverse Event|2|||
129822795|NCT02393547|467315113|FG000|Overall Study|Withdrawal by Subject|3|||
129822796|NCT02393547|467315113|FG000|Overall Study|Lost to Follow-up|1|||
129822797|NCT02205814|467315114|FG000|Overall Study|Lost to Follow-up|0|||
129822798|NCT02205814|467315115|FG001|Overall Study|Lost to Follow-up|0|||
129822799|NCT02205814|467315116|FG002|Overall Study|Lost to Follow-up|0|||
129822800|NCT02205814|467315117|FG003|Overall Study|Lost to Follow-up|1|||
129822801|NCT02205814|467315114|FG000|Overall Study|Lack of Efficacy|1|||
129822802|NCT02205814|467315115|FG001|Overall Study|Lack of Efficacy|0|||
129822803|NCT02205814|467315116|FG002|Overall Study|Lack of Efficacy|1|||
129822804|NCT02205814|467315117|FG003|Overall Study|Lack of Efficacy|1|||
129822805|NCT02205814|467315114|FG000|Overall Study|Physician Decision|0|||
129822806|NCT02205814|467315115|FG001|Overall Study|Physician Decision|0|||
129822807|NCT02205814|467315116|FG002|Overall Study|Physician Decision|1|||
129822808|NCT02205814|467315117|FG003|Overall Study|Physician Decision|0|||
129822809|NCT02205814|467315114|FG000|Overall Study|Protocol Violation|1|||
129822810|NCT02205814|467315115|FG001|Overall Study|Protocol Violation|0|||
129822811|NCT02205814|467315116|FG002|Overall Study|Protocol Violation|0|||
129822812|NCT02205814|467315117|FG003|Overall Study|Protocol Violation|1|||
129822813|NCT02205814|467315114|FG000|Overall Study|Withdrawal by Subject|0|||
129822814|NCT02205814|467315115|FG001|Overall Study|Withdrawal by Subject|1|||
129822815|NCT02205814|467315116|FG002|Overall Study|Withdrawal by Subject|2|||
129822816|NCT02205814|467315117|FG003|Overall Study|Withdrawal by Subject|1|||
129822817|NCT02205814|467315114|FG000|Overall Study|not compliant with study procedures|0|||
129822818|NCT02205814|467315115|FG001|Overall Study|not compliant with study procedures|0|||
129822819|NCT02205814|467315116|FG002|Overall Study|not compliant with study procedures|1|||
129822820|NCT02205814|467315117|FG003|Overall Study|not compliant with study procedures|0|||
129822821|NCT00143403|467315118|FG000|Overall Study|Adverse Event|3|||
129822822|NCT00143403|467315119|FG001|Overall Study|Adverse Event|8|||
129822823|NCT00143403|467315118|FG000|Overall Study|Death|1|||
129822824|NCT00143403|467315119|FG001|Overall Study|Death|0|||
129822825|NCT00143403|467315118|FG000|Overall Study|Withdrawal by Subject|3|||
129822826|NCT00143403|467315119|FG001|Overall Study|Withdrawal by Subject|12|||
129822827|NCT00143403|467315118|FG000|Overall Study|Relapse|15|||
129822828|NCT00143403|467315119|FG001|Overall Study|Relapse|7|||
129822829|NCT00143403|467315118|FG000|Overall Study|Protocol Violation|2|||
129822830|NCT00143403|467315119|FG001|Overall Study|Protocol Violation|2|||
129822831|NCT00143403|467315118|FG000|Overall Study|specified by site|4|||
129822832|NCT00143403|467315119|FG001|Overall Study|specified by site|9|||
129822833|NCT00143403|467315118|FG000|Overall Study|Randomized Not Treated|7|||
129822834|NCT00143403|467315119|FG001|Overall Study|Randomized Not Treated|8|||
129822835|NCT00514540|467315120|FG000|First-Line Chemo|Withdrawal by Subject|1|||
129822836|NCT00514540|467315120|FG000|First-Line Chemo|Protocol Violation|7|||
129822837|NCT00514540|467315120|FG000|Second-Line|Physician/Patient Decision|31|||
129822838|NCT02326025|467315123|FG000|Overall Study|Adverse Event|3|||
129822839|NCT02326025|467315124|FG001|Overall Study|Adverse Event|0|||
129822840|NCT02326025|467315123|FG000|Overall Study|Physician Decision|1|||
129822841|NCT02326025|467315124|FG001|Overall Study|Physician Decision|2|||
129822842|NCT02326025|467315123|FG000|Overall Study|Physician and Participant Decision|1|||
129822843|NCT02326025|467315124|FG001|Overall Study|Physician and Participant Decision|0|||
129822844|NCT02326025|467315123|FG000|Overall Study|Withdrawal by Subject|0|||
129822845|NCT02326025|467315124|FG001|Overall Study|Withdrawal by Subject|2|||
129822846|NCT02326025|467315123|FG000|Overall Study|Protocol Violation|0|||
129822847|NCT02326025|467315124|FG001|Overall Study|Protocol Violation|1|||
129822848|NCT01714635|467315134|FG000|Overall Study|Discontinued|1|||
129822849|NCT01714635|467315135|FG001|Overall Study|Discontinued|0|||
129822850|NCT01714635|467315136|FG002|Overall Study|Discontinued|2|||
129822851|NCT01714635|467315134|FG000|Overall Study|Missed 6-month exam|1|||
129822852|NCT01714635|467315135|FG001|Overall Study|Missed 6-month exam|0|||
129822853|NCT01714635|467315136|FG002|Overall Study|Missed 6-month exam|0|||
129822854|NCT01846611|467315137|FG000|Overall Study|Lost to Follow-up|4|||
129822855|NCT01846611|467315138|FG001|Overall Study|Lost to Follow-up|6|||
129822856|NCT01846611|467315137|FG000|Overall Study|Withdrawal by Subject|15|||
129822857|NCT01846611|467315138|FG001|Overall Study|Withdrawal by Subject|19|||
129822858|NCT01846611|467315137|FG000|Overall Study|Other|19|||
129822859|NCT01846611|467315138|FG001|Overall Study|Other|18|||
129822860|NCT00662363|467315139|FG000|Overall Study|Withdrawal by Subject|6|||
129822861|NCT00662363|467315140|FG001|Overall Study|Withdrawal by Subject|5|||
129822862|NCT00662363|467315139|FG000|Overall Study|Adverse Event|0|||
129822863|NCT00662363|467315140|FG001|Overall Study|Adverse Event|3|||
129822864|NCT00662363|467315139|FG000|Overall Study|Discharged early from rehab|4|||
129822865|NCT00662363|467315140|FG001|Overall Study|Discharged early from rehab|1|||
129822866|NCT00662363|467315139|FG000|Overall Study|Protocol Violation|1|||
129822867|NCT00662363|467315140|FG001|Overall Study|Protocol Violation|1|||
129822868|NCT02744391|467315141|FG000|Overall Study|Lost to Follow-up|9|||
129822869|NCT02744391|467315141|FG000|Overall Study|Physician Decision|2|||
129822870|NCT02744391|467315141|FG000|Overall Study|Withdrawal by Subject|3|||
129822871|NCT01428453|467315142|FG000|Overall Study|Adverse Event|2|||
129822872|NCT01428453|467315143|FG001|Overall Study|Adverse Event|7|||
129822873|NCT01428453|467315142|FG000|Overall Study|Protocol Violation|1|||
129822874|NCT01428453|467315143|FG001|Overall Study|Protocol Violation|0|||
129822875|NCT01428453|467315142|FG000|Overall Study|Lost to Follow-up|0|||
129822876|NCT01428453|467315143|FG001|Overall Study|Lost to Follow-up|1|||
129822877|NCT01428453|467315142|FG000|Overall Study|Withdrawal by Subject|3|||
129822878|NCT01428453|467315143|FG001|Overall Study|Withdrawal by Subject|1|||
129822879|NCT01996709|467315144|FG000|Overall Study|Withdrawal by Subject|1|||
129822880|NCT01996709|467315145|FG001|Overall Study|Withdrawal by Subject|0|||
129822881|NCT01996709|467315144|FG000|Overall Study|Lost to Follow-up|3|||
129822882|NCT01996709|467315145|FG001|Overall Study|Lost to Follow-up|0|||
129822883|NCT01996709|467315144|FG000|Overall Study|Subject Non-Compliant|1|||
129822884|NCT01996709|467315145|FG001|Overall Study|Subject Non-Compliant|0|||
129822885|NCT01996709|467315144|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
129822886|NCT01996709|467315145|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
129822887|NCT03789318|467315154|FG000|Overall Study|Adverse Event|0|||
129822888|NCT03789318|467315155|FG001|Overall Study|Adverse Event|0|||
129822889|NCT03789318|467315156|FG002|Overall Study|Adverse Event|1|||
129822890|NCT03789318|467315157|FG003|Overall Study|Adverse Event|1|||
129822891|NCT03789318|467315158|FG004|Overall Study|Adverse Event|0|||
129822892|NCT03789318|467315154|FG000|Overall Study|Lost to Follow-up|0|||
129822893|NCT03789318|467315155|FG001|Overall Study|Lost to Follow-up|0|||
129822894|NCT03789318|467315156|FG002|Overall Study|Lost to Follow-up|1|||
129822895|NCT03789318|467315157|FG003|Overall Study|Lost to Follow-up|0|||
129822896|NCT03789318|467315158|FG004|Overall Study|Lost to Follow-up|0|||
129822897|NCT03789318|467315154|FG000|Overall Study|Withdrawal by Subject|0|||
129822898|NCT03789318|467315155|FG001|Overall Study|Withdrawal by Subject|0|||
129822899|NCT03789318|467315156|FG002|Overall Study|Withdrawal by Subject|1|||
129822900|NCT03789318|467315157|FG003|Overall Study|Withdrawal by Subject|0|||
129822901|NCT03789318|467315158|FG004|Overall Study|Withdrawal by Subject|0|||
129822902|NCT02480114|467315159|FG000|Overall Study|Not completing surveys|3|||
129822903|NCT02480114|467315160|FG001|Overall Study|Not completing surveys|2|||
129822904|NCT02480114|467315159|FG000|Overall Study|Withdrawal by Subject|2|||
129822905|NCT02480114|467315160|FG001|Overall Study|Withdrawal by Subject|4|||
129822906|NCT02480114|467315159|FG000|Overall Study|Disease progression|3|||
129822907|NCT02480114|467315160|FG001|Overall Study|Disease progression|0|||
129822908|NCT02480114|467315159|FG000|Overall Study|Improper completion of survey|1|||
129822909|NCT02480114|467315160|FG001|Overall Study|Improper completion of survey|1|||
129822910|NCT02480114|467315159|FG000|Overall Study|Not eligible|0|||
129822911|NCT02480114|467315160|FG001|Overall Study|Not eligible|1|||
129822912|NCT01535053|467315161|FG000|Overall Study|Ineligible|1|||
129822913|NCT01535053|467315162|FG001|Overall Study|Ineligible|2|||
129822914|NCT00512707|467315163|FG000|Overall Study|Lost to Follow-up|5|||
129822915|NCT00512707|467315164|FG001|Overall Study|Lost to Follow-up|11|||
129822916|NCT00512707|467315163|FG000|Overall Study|Developed skin irritation|2|||
129822917|NCT00512707|467315164|FG001|Overall Study|Developed skin irritation|1|||
129822918|NCT00512707|467315163|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
129822919|NCT00512707|467315164|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
129822920|NCT00512707|467315163|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
129822921|NCT00512707|467315164|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
129822922|NCT01317160|467315165|FG000|Overall Study|Incorrect inclusion|1|||
129822923|NCT01317160|467315166|FG001|Overall Study|Incorrect inclusion|1|||
129822924|NCT01317160|467315165|FG000|Overall Study|Lost to Follow-up|3|||
129822925|NCT01317160|467315166|FG001|Overall Study|Lost to Follow-up|3|||
129822926|NCT01317160|467315165|FG000|Overall Study|Withdrawal by Subject|0|||
129822927|NCT01317160|467315166|FG001|Overall Study|Withdrawal by Subject|2|||
129822928|NCT04405037|467315173|FG000|Overall Study|Withdrawal by Subject|1|||
129822929|NCT04405037|467315174|FG001|Overall Study|Withdrawal by Subject|0|||
129822930|NCT04405037|467315173|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
129822931|NCT04405037|467315174|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
129822932|NCT01134783|467316474|FG000|Overall Study|Pregnancy|16|||
129822933|NCT01134783|467316475|FG001|Overall Study|Pregnancy|8|||
129822934|NCT01134783|467316474|FG000|Overall Study|Withdrawal by Subject|15|||
129822935|NCT01134783|467316475|FG001|Overall Study|Withdrawal by Subject|9|||
129822936|NCT01134783|467316474|FG000|Overall Study|Lost to Follow-up|5|||
129822937|NCT01134783|467316475|FG001|Overall Study|Lost to Follow-up|20|||
129822938|NCT04221009|467316476|FG000|Overall Study|Withdrawal by Subject|4|||
129822939|NCT04232124|467316477|FG000|Overall Study|Lost to Follow-up|3|||
129822940|NCT02329730|467316478|FG000|Overall Study|Protocol Violation|0|||
129822941|NCT02329730|467316479|FG001|Overall Study|Protocol Violation|0|||
129822942|NCT02329730|467316480|FG002|Overall Study|Protocol Violation|0|||
129822943|NCT02329730|467316481|FG003|Overall Study|Protocol Violation|0|||
129822944|NCT02329730|467316482|FG004|Overall Study|Protocol Violation|2|||
129822945|NCT02329730|467316483|FG005|Overall Study|Protocol Violation|2|||
129822946|NCT02329730|467316484|FG006|Overall Study|Protocol Violation|0|||
129822947|NCT02329730|467316485|FG007|Overall Study|Protocol Violation|0|||
129822948|NCT02329730|467316486|FG008|Overall Study|Protocol Violation|0|||
129822949|NCT02329730|467316487|FG009|Overall Study|Protocol Violation|0|||
129822950|NCT02329730|467316488|FG010|Overall Study|Protocol Violation|0|||
129822951|NCT02329730|467316489|FG011|Overall Study|Protocol Violation|0|||
129822952|NCT02329730|467316478|FG000|Overall Study|Withdrawal by Subject|0|||
129822953|NCT02329730|467316479|FG001|Overall Study|Withdrawal by Subject|0|||
129822954|NCT02329730|467316480|FG002|Overall Study|Withdrawal by Subject|0|||
129822955|NCT02329730|467316481|FG003|Overall Study|Withdrawal by Subject|0|||
129822956|NCT02329730|467316482|FG004|Overall Study|Withdrawal by Subject|1|||
129822957|NCT02329730|467316483|FG005|Overall Study|Withdrawal by Subject|0|||
129822958|NCT02329730|467316484|FG006|Overall Study|Withdrawal by Subject|1|||
129822959|NCT02329730|467316485|FG007|Overall Study|Withdrawal by Subject|1|||
129822960|NCT02329730|467316486|FG008|Overall Study|Withdrawal by Subject|1|||
129822961|NCT02329730|467316487|FG009|Overall Study|Withdrawal by Subject|1|||
129822962|NCT02329730|467316488|FG010|Overall Study|Withdrawal by Subject|0|||
129822963|NCT02329730|467316489|FG011|Overall Study|Withdrawal by Subject|0|||
129822964|NCT02392247|467316494|FG000|Overall Study|Withdrawal by Subject|1|||
129822965|NCT02392247|467316494|FG000|Overall Study|Surgery cancelled; no data|1|||
129822966|NCT03010254|467316495|FG000|Overall Study|Adverse Event|0|||
129822967|NCT03010254|467316496|FG001|Overall Study|Adverse Event|1|||
129822968|NCT03010254|467316495|FG000|Overall Study|Lost to Follow-up|4|||
129822969|NCT03010254|467316496|FG001|Overall Study|Lost to Follow-up|0|||
129822970|NCT03010254|467316495|FG000|Overall Study|Withdrawal by Subject|1|||
129822971|NCT03010254|467316496|FG001|Overall Study|Withdrawal by Subject|1|||
129822972|NCT03010254|467316495|FG000|Overall Study|Other|2|||
129822973|NCT03010254|467316496|FG001|Overall Study|Other|3|||
129822974|NCT01404325|467316497|FG000|Overall Study|Lost to Follow-up|1|||
129822975|NCT01404325|467316498|FG001|Overall Study|Lost to Follow-up|0|||
129822976|NCT01404325|467316497|FG000|Overall Study|Death|2|||
129822977|NCT01404325|467316498|FG001|Overall Study|Death|0|||
129822978|NCT01404325|467316497|FG000|Overall Study|Graft loss/Retransplantation|1|||
129822979|NCT01404325|467316498|FG001|Overall Study|Graft loss/Retransplantation|0|||
129822980|NCT01404325|467316497|FG000|Overall Study|non-specified reason|0|||
129822981|NCT01404325|467316498|FG001|Overall Study|non-specified reason|2|||
129822982|NCT03312933|467316503|FG000|Overall Study|Protocol Violation|15|||
129822983|NCT03312933|467316503|FG000|Overall Study|Lost to Follow-up|36|||
129822984|NCT03312933|467316503|FG000|Overall Study|Withdrawal by Subject|3|||
129822985|NCT00224055|467316509|FG000|Overall Study|Adverse Event|9|||
129822986|NCT00224055|467316510|FG001|Overall Study|Adverse Event|3|||
129822987|NCT00224055|467316509|FG000|Overall Study|Lost to Follow-up|1|||
129822988|NCT00224055|467316510|FG001|Overall Study|Lost to Follow-up|2|||
129822989|NCT00224055|467316509|FG000|Overall Study|Protocol Violation|1|||
129822990|NCT00224055|467316510|FG001|Overall Study|Protocol Violation|1|||
129822991|NCT00224055|467316509|FG000|Overall Study|Inclusion Violation|3|||
129822992|NCT00224055|467316510|FG001|Overall Study|Inclusion Violation|6|||
129822993|NCT00224055|467316509|FG000|Overall Study|Withdrawal by Subject|0|||
129822994|NCT00224055|467316510|FG001|Overall Study|Withdrawal by Subject|2|||
129822995|NCT00224055|467316509|FG000|Overall Study|Other|1|||
129822996|NCT00224055|467316510|FG001|Overall Study|Other|0|||
129822997|NCT04317066|467316511|FG000|Overall Study|Sponsor decision|5|||
129822998|NCT04317066|467316511|FG000|Overall Study|Death|2|||
129822999|NCT00848081|467316514|FG000|Overall Study|Adverse Event|6|||
129823000|NCT00848081|467316515|FG001|Overall Study|Adverse Event|7|||
129823001|NCT00848081|467316514|FG000|Overall Study|Protocol Violation|8|||
129823002|NCT00848081|467316515|FG001|Overall Study|Protocol Violation|5|||
129823003|NCT00848081|467316514|FG000|Overall Study|Lost to Follow-up|1|||
129823004|NCT00848081|467316515|FG001|Overall Study|Lost to Follow-up|0|||
129823005|NCT00848081|467316514|FG000|Overall Study|Physician Decision|0|||
129823006|NCT00848081|467316515|FG001|Overall Study|Physician Decision|3|||
129823007|NCT00848081|467316514|FG000|Overall Study|Withdrawal by Subject|5|||
129823008|NCT00848081|467316515|FG001|Overall Study|Withdrawal by Subject|3|||
129823009|NCT02014597|467316516|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
129823010|NCT02014597|467316517|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
129823011|NCT00754624|467316518|FG000|Overall Study|Adverse Event|16|||
129823012|NCT00754624|467316518|FG000|Overall Study|Death|1|||
129823013|NCT00754624|467316518|FG000|Overall Study|Physician Decision|8|||
129823014|NCT00754624|467316518|FG000|Overall Study|Protocol Violation|1|||
129823015|NCT00754624|467316518|FG000|Overall Study|Withdrawal by Subject|28|||
129823016|NCT00754624|467316518|FG000|Overall Study|Various|12|||
129823017|NCT00754624|467316518|FG000|Overall Study|Lost to Follow-up|3|||
129823018|NCT00710710|467316521|FG000|Overall Study|Consent withdrawn|2|||
129823019|NCT00710710|467316522|FG001|Overall Study|Consent withdrawn|2|||
129823020|NCT00710710|467316521|FG000|Overall Study|Protocol Violation|0|||
129823021|NCT00710710|467316522|FG001|Overall Study|Protocol Violation|1|||
129823022|NCT00710710|467316521|FG000|Overall Study|Adverse Event|3|||
129823023|NCT00710710|467316522|FG001|Overall Study|Adverse Event|3|||
129823024|NCT00710710|467316521|FG000|Overall Study|Progressive disease|40|||
129823025|NCT00710710|467316522|FG001|Overall Study|Progressive disease|38|||
129823026|NCT00715078|467316523|FG000|Overall Study|Death|29|||
129445688|NCT01968070|465932891|FG016|Period 1|Adverse Event|0|||
129445689|NCT01968070|465932892|FG017|Period 1|Adverse Event|0|||
129823027|NCT00715078|467316524|FG001|Overall Study|Death|36|||
129823028|NCT00715078|467316525|FG002|Overall Study|Death|36|||
129823029|NCT00715078|467316523|FG000|Overall Study|Withdrawal by Subject|1|||
129823030|NCT00715078|467316524|FG001|Overall Study|Withdrawal by Subject|0|||
129823031|NCT00715078|467316525|FG002|Overall Study|Withdrawal by Subject|1|||
129823032|NCT00715078|467316523|FG000|Overall Study|Unable to start due to disease prog.|0|||
129823033|NCT00715078|467316524|FG001|Overall Study|Unable to start due to disease prog.|0|||
129823034|NCT00715078|467316525|FG002|Overall Study|Unable to start due to disease prog.|1|||
129823035|NCT02618434|467316532|FG000|Overall Study|Withdrawal by Subject|0|||
129823036|NCT02618434|467316533|FG001|Overall Study|Withdrawal by Subject|2|||
129823037|NCT02618434|467316534|FG002|Overall Study|Withdrawal by Subject|3|||
129823038|NCT02618434|467316532|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
129823039|NCT02618434|467316533|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
129823040|NCT02618434|467316534|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
129823041|NCT02618434|467316532|FG000|Overall Study|Lost to Follow-up|3|||
129823042|NCT02618434|467316533|FG001|Overall Study|Lost to Follow-up|1|||
129823043|NCT02618434|467316534|FG002|Overall Study|Lost to Follow-up|3|||
129823044|NCT02618434|467316532|FG000|Overall Study|Adverse Event|1|||
129823045|NCT02618434|467316533|FG001|Overall Study|Adverse Event|0|||
129823046|NCT02618434|467316534|FG002|Overall Study|Adverse Event|12|||
129823047|NCT02618434|467316532|FG000|Overall Study|Physician Decision|0|||
129823048|NCT02618434|467316533|FG001|Overall Study|Physician Decision|1|||
129823049|NCT02618434|467316534|FG002|Overall Study|Physician Decision|0|||
129823050|NCT02618434|467316532|FG000|Overall Study|Protocol Violation|0|||
129823051|NCT02618434|467316533|FG001|Overall Study|Protocol Violation|0|||
129823052|NCT02618434|467316534|FG002|Overall Study|Protocol Violation|1|||
129823053|NCT02618434|467316532|FG000|Overall Study|Other, Multiple categories|1|||
129823054|NCT02618434|467316533|FG001|Overall Study|Other, Multiple categories|1|||
129823055|NCT02618434|467316534|FG002|Overall Study|Other, Multiple categories|1|||
129823056|NCT03590041|467316535|FG000|Overall Study|Protocol Violation|4|||
129823057|NCT03590041|467316536|FG001|Overall Study|Protocol Violation|3|||
129823058|NCT03590041|467316535|FG000|Overall Study|No session data recorded|14|||
129823059|NCT03590041|467316536|FG001|Overall Study|No session data recorded|2|||
129823060|NCT01402544|467316537|FG000|Overall Study|Withdrawal by Subject|6|||
129823061|NCT00142584|467316538|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
129823062|NCT00142584|467316539|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
129823063|NCT00142584|467316538|FG000|Overall Study|Withdrawal by Subject|30|||
129823064|NCT00142584|467316539|FG001|Overall Study|Withdrawal by Subject|16|||
129823065|NCT00142584|467316538|FG000|Overall Study|Lost to Follow-up|22|||
129823066|NCT00142584|467316539|FG001|Overall Study|Lost to Follow-up|12|||
129823067|NCT00142584|467316538|FG000|Overall Study|Adverse Event|14|||
129823068|NCT00142584|467316539|FG001|Overall Study|Adverse Event|5|||
129823069|NCT00142584|467316538|FG000|Overall Study|Protocol Violation|4|||
129823070|NCT00142584|467316539|FG001|Overall Study|Protocol Violation|7|||
129823071|NCT00142584|467316538|FG000|Overall Study|Treatment Failure|2|||
129823072|NCT00142584|467316539|FG001|Overall Study|Treatment Failure|0|||
129823073|NCT01314443|467316541|FG000|Overall Study|Withdrawal by Subject|2|||
129823074|NCT01314443|467316542|FG001|Overall Study|Withdrawal by Subject|1|||
129823075|NCT01314443|467316543|FG002|Overall Study|Withdrawal by Subject|1|||
129823076|NCT01314443|467316544|FG003|Overall Study|Withdrawal by Subject|1|||
129823077|NCT01314443|467316541|FG000|Overall Study|Protocol Violation|2|||
129823078|NCT01314443|467316542|FG001|Overall Study|Protocol Violation|2|||
129823079|NCT01314443|467316543|FG002|Overall Study|Protocol Violation|1|||
129823080|NCT01314443|467316544|FG003|Overall Study|Protocol Violation|1|||
129823081|NCT02709785|467316546|FG000|Overall Study|Withdrawal by Subject|1|||
129823082|NCT02709785|467316547|FG001|Overall Study|Withdrawal by Subject|2|||
129823083|NCT02709785|467316548|FG002|Overall Study|Withdrawal by Subject|1|||
129823084|NCT00276159|467316551|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
129823085|NCT00333866|467316552|FG000|Overall Study|Adverse Event|23|||
129823086|NCT00333866|467316553|FG001|Overall Study|Adverse Event|37|||
129823087|NCT00333866|467316554|FG002|Overall Study|Adverse Event|38|||
129823088|NCT00333866|467316555|FG003|Overall Study|Adverse Event|47|||
129823089|NCT00333866|467316552|FG000|Overall Study|Other|3|||
129823090|NCT00333866|467316553|FG001|Overall Study|Other|2|||
129823091|NCT00333866|467316554|FG002|Overall Study|Other|2|||
129823092|NCT00333866|467316555|FG003|Overall Study|Other|2|||
129823093|NCT00333866|467316552|FG000|Overall Study|Lack of Efficacy|8|||
129823094|NCT00333866|467316553|FG001|Overall Study|Lack of Efficacy|6|||
129823095|NCT00333866|467316554|FG002|Overall Study|Lack of Efficacy|3|||
129823096|NCT00333866|467316555|FG003|Overall Study|Lack of Efficacy|5|||
129897420|NCT00742274|467584372|FG001|Overall Study|Withdrawal by Subject|2|||
129897421|NCT00742274|467584371|FG000|Overall Study|Removed for medical reasons|1|||
129897422|NCT00742274|467584372|FG001|Overall Study|Removed for medical reasons|1|||
129823097|NCT00333866|467316552|FG000|Overall Study|Lost to Follow-up|1|||
129897423|NCT00335556|467584375|FG000|Overall Study|Death|0|||
129823098|NCT00333866|467316553|FG001|Overall Study|Lost to Follow-up|2|||
129823099|NCT00333866|467316554|FG002|Overall Study|Lost to Follow-up|2|||
129823100|NCT00333866|467316555|FG003|Overall Study|Lost to Follow-up|2|||
129823101|NCT00333866|467316552|FG000|Overall Study|Withdrawal by Subject|8|||
129823102|NCT00333866|467316553|FG001|Overall Study|Withdrawal by Subject|14|||
129897424|NCT00335556|467584376|FG001|Overall Study|Death|5|||
129823103|NCT00333866|467316554|FG002|Overall Study|Withdrawal by Subject|4|||
129823104|NCT00333866|467316555|FG003|Overall Study|Withdrawal by Subject|9|||
129823105|NCT00333866|467316552|FG000|Overall Study|Randomized but not Treated|5|||
129823106|NCT00333866|467316553|FG001|Overall Study|Randomized but not Treated|3|||
129823107|NCT00333866|467316554|FG002|Overall Study|Randomized but not Treated|2|||
129823108|NCT00333866|467316555|FG003|Overall Study|Randomized but not Treated|1|||
129823109|NCT02927431|467316559|FG000|Overall Study|Withdrawal by Subject|0|||
129823110|NCT02927431|467316560|FG001|Overall Study|Withdrawal by Subject|0|||
129823111|NCT02927431|467316561|FG002|Overall Study|Withdrawal by Subject|1|||
129823112|NCT00673465|467316564|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823113|NCT00673465|467316565|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823114|NCT00673465|467316566|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823115|NCT00673465|467316567|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823116|NCT00673465|467316568|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
129823117|NCT00673465|467316569|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
129823118|NCT00673465|467316570|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823119|NCT00673465|467316571|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823120|NCT00673465|467316572|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823121|NCT00673465|467316573|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823122|NCT00673465|467316574|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823123|NCT00673465|467316575|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
129823124|NCT00673465|467316564|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823125|NCT00673465|467316565|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823126|NCT00673465|467316566|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823127|NCT00673465|467316567|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823128|NCT00673465|467316568|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
129823129|NCT00673465|467316569|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823130|NCT00673465|467316570|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823131|NCT00673465|467316571|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823132|NCT00673465|467316572|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823133|NCT00673465|467316573|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823134|NCT00673465|467316574|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823135|NCT00673465|467316575|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
129823136|NCT00429104|467316576|FG000|Overall Study|Protocol Violation|1|||
129823137|NCT01829191|467316577|FG000|Overall Study|Relocation|0|||
129823138|NCT01829191|467316578|FG001|Overall Study|Relocation|1|||
129823139|NCT01829191|467316577|FG000|Overall Study|Lens discomfort|0|||
129823140|NCT01829191|467316578|FG001|Overall Study|Lens discomfort|3|||
129823141|NCT01829191|467316577|FG000|Overall Study|Lens handling difficulty|1|||
129823142|NCT01829191|467316578|FG001|Overall Study|Lens handling difficulty|4|||
129823143|NCT01829191|467316577|FG000|Overall Study|Protocol Violation|4|||
129823144|NCT01829191|467316578|FG001|Overall Study|Protocol Violation|1|||
129823145|NCT01829191|467316577|FG000|Overall Study|Withdrawal by Subject|2|||
129823146|NCT01829191|467316578|FG001|Overall Study|Withdrawal by Subject|3|||
129823147|NCT01829191|467316577|FG000|Overall Study|Lost to Follow-up|0|||
129823148|NCT01829191|467316578|FG001|Overall Study|Lost to Follow-up|1|||
129823149|NCT01829191|467316577|FG000|Overall Study|Subject was fit for ortho - k|0|||
129823150|NCT01829191|467316578|FG001|Overall Study|Subject was fit for ortho - k|1|||
129823151|NCT01907815|467316579|FG000|Overall Study|Withdrawal by Subject|1|||
129823152|NCT01907815|467316580|FG001|Overall Study|Withdrawal by Subject|0|||
129823153|NCT01276353|467316581|FG000|Double-blind|Adverse Event|2|||
129823154|NCT01276353|467316582|FG001|Double-blind|Adverse Event|0|||
129823155|NCT01276353|467316581|FG000|Double-blind|Withdrawal by Subject|1|||
129823156|NCT01276353|467316582|FG001|Double-blind|Withdrawal by Subject|0|||
129823157|NCT01276353|467316581|FG000|Extension|Adverse Event|2|||
129823158|NCT01276353|467316582|FG001|Extension|Adverse Event|5|||
129823159|NCT01276353|467316581|FG000|Extension|Withdrawal by Subject|1|||
129823160|NCT01276353|467316582|FG001|Extension|Withdrawal by Subject|2|||
129823161|NCT01276353|467316581|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
129823162|NCT01276353|467316582|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
129823163|NCT01276353|467316581|FG000|Extension|Physician Decision|1|||
129823164|NCT01276353|467316582|FG001|Extension|Physician Decision|0|||
129823165|NCT01276353|467316581|FG000|Extension|Prohibited concomitant medications|0|||
129823166|NCT01276353|467316582|FG001|Extension|Prohibited concomitant medications|1|||
129823167|NCT00587639|467316583|FG000|Overall Study|Withdrawal by Subject|1|||
129823168|NCT01996982|467316584|FG000|Overall Study|PI/team left institution|7|||
129823169|NCT01195415|467316585|FG000|Overall Study|No repeat biopsy due to progression|2|||
129823170|NCT00533845|467316586|FG000|Overall Study|Physician Decision|1|||
129823171|NCT00533845|467316587|FG001|Overall Study|Physician Decision|0|||
129823172|NCT01288469|467316593|FG000|Overall Study|Adverse Event|4|||
129823173|NCT01288469|467316594|FG001|Overall Study|Adverse Event|1|||
129823174|NCT01288469|467316595|FG002|Overall Study|Adverse Event|1|||
129823175|NCT01288469|467316593|FG000|Overall Study|Poor compliance to protocol|0|||
129823176|NCT01288469|467316594|FG001|Overall Study|Poor compliance to protocol|1|||
129823177|NCT01288469|467316595|FG002|Overall Study|Poor compliance to protocol|0|||
129823178|NCT01288469|467316593|FG000|Overall Study|Participant Moved|1|||
129823179|NCT01288469|467316594|FG001|Overall Study|Participant Moved|0|||
129823180|NCT01288469|467316595|FG002|Overall Study|Participant Moved|0|||
129823181|NCT01288469|467316593|FG000|Overall Study|Consent withdrawn by subject|1|||
129823182|NCT01288469|467316594|FG001|Overall Study|Consent withdrawn by subject|1|||
129823183|NCT01288469|467316595|FG002|Overall Study|Consent withdrawn by subject|1|||
129823184|NCT01288469|467316593|FG000|Overall Study|Exclusion criteria finally met|1|||
129823185|NCT01288469|467316594|FG001|Overall Study|Exclusion criteria finally met|0|||
129823186|NCT01288469|467316595|FG002|Overall Study|Exclusion criteria finally met|0|||
129823187|NCT00110149|467316596|FG000|Overall Study|Physician Decision|3|||
129823188|NCT00563381|467316597|FG000|Overall Study|Adverse Event|264|||
129823189|NCT00563381|467316598|FG001|Overall Study|Adverse Event|292|||
129823190|NCT00563381|467316597|FG000|Overall Study|Protocol Violation|66|||
129823191|NCT00563381|467316598|FG001|Overall Study|Protocol Violation|74|||
129823192|NCT00563381|467316597|FG000|Overall Study|Lost to Follow-up|7|||
129823193|NCT00563381|467316598|FG001|Overall Study|Lost to Follow-up|15|||
129823194|NCT00563381|467316597|FG000|Overall Study|Withdrawal by Subject|192|||
129823195|NCT00563381|467316598|FG001|Overall Study|Withdrawal by Subject|209|||
129823196|NCT00563381|467316597|FG000|Overall Study|Lack of Efficacy|32|||
129823197|NCT00563381|467316598|FG001|Overall Study|Lack of Efficacy|24|||
129823198|NCT00563381|467316597|FG000|Overall Study|Individual different reasons|24|||
129823199|NCT00563381|467316598|FG001|Overall Study|Individual different reasons|34|||
129823200|NCT02452398|467316601|FG000|Overall Study|Adverse Event|1|||
129823201|NCT02452398|467316601|FG000|Overall Study|Lost to Follow-up|28|||
129823202|NCT02452398|467316601|FG000|Overall Study|Physician Decision|2|||
129823203|NCT02452398|467316601|FG000|Overall Study|Withdrawal by Subject|6|||
129823204|NCT02452398|467316601|FG000|Overall Study|Moved away|4|||
129823205|NCT00001723|467316605|FG000|Overall Study|Lack of Efficacy|6|||
129823206|NCT00001723|467316606|FG001|Overall Study|Lack of Efficacy|7|||
129823207|NCT00001723|467316605|FG000|Overall Study|Lack of family interest|4|||
129823208|NCT00001723|467316606|FG001|Overall Study|Lack of family interest|5|||
129823209|NCT00001723|467316605|FG000|Overall Study|Lost to Follow-up|2|||
129823210|NCT00001723|467316606|FG001|Overall Study|Lost to Follow-up|2|||
129823211|NCT00001723|467316605|FG000|Overall Study|medication intolerance|1|||
129823212|NCT00001723|467316606|FG001|Overall Study|medication intolerance|2|||
129823213|NCT00927784|467316607|FG000|Overall Study|Death|1|||
129823214|NCT00927784|467316608|FG001|Overall Study|Death|0|||
129823215|NCT00927784|467316607|FG000|Overall Study|Withdrawal by Subject|1|||
129823216|NCT00927784|467316608|FG001|Overall Study|Withdrawal by Subject|0|||
129823217|NCT02170051|467316609|FG000|Overall Study|Withdrawal by Subject|10|||
129823218|NCT02170051|467316610|FG001|Overall Study|Withdrawal by Subject|10|||
129823219|NCT02170051|467316609|FG000|Overall Study|Lost to Follow-up|1|||
129823220|NCT02170051|467316610|FG001|Overall Study|Lost to Follow-up|3|||
129823221|NCT02643082|467316611|FG000|Period 1|Adverse Event|1|||
129823222|NCT02643082|467316612|FG001|Period 1|Adverse Event|0|||
129823223|NCT01867021|467316613|FG000|Overall Study|Adverse Event|0|||
129823224|NCT01867021|467316614|FG001|Overall Study|Adverse Event|1|||
129823225|NCT01867021|467316613|FG000|Overall Study|Not Eligible|0|||
129823226|NCT01867021|467316614|FG001|Overall Study|Not Eligible|1|||
129823227|NCT01867021|467316613|FG000|Overall Study|Death|1|||
129823228|NCT01867021|467316614|FG001|Overall Study|Death|0|||
129823229|NCT01867021|467316613|FG000|Overall Study|Lost to Follow-up|0|||
129823230|NCT01867021|467316614|FG001|Overall Study|Lost to Follow-up|2|||
129823231|NCT01867021|467316613|FG000|Overall Study|Withdrawal by Subject|1|||
129823232|NCT01867021|467316614|FG001|Overall Study|Withdrawal by Subject|6|||
129823233|NCT00881712|467316615|FG000|Overall Study|Death|1|||
129823234|NCT00881712|467316616|FG001|Overall Study|Death|0|||
129823235|NCT00881712|467316617|FG002|Overall Study|Death|0|||
129823236|NCT00881712|467316615|FG000|Overall Study|Withdrawal by Subject|1|||
129823237|NCT00881712|467316616|FG001|Overall Study|Withdrawal by Subject|0|||
129823238|NCT00881712|467316617|FG002|Overall Study|Withdrawal by Subject|0|||
129823239|NCT02505867|467316620|FG000|Overall Study|Lack of Efficacy|6|||
129823240|NCT02505867|467316621|FG001|Overall Study|Lack of Efficacy|6|||
129823241|NCT01862874|467316622|FG000|Overall Study|Randomized not treated|1|||
129823242|NCT01862874|467316623|FG001|Overall Study|Randomized not treated|0|||
129823243|NCT01862874|467316622|FG000|Overall Study|Adverse Event|0|||
129823244|NCT01862874|467316623|FG001|Overall Study|Adverse Event|3|||
129823245|NCT01862874|467316622|FG000|Overall Study|Lost to Follow-up|26|||
129823246|NCT01862874|467316623|FG001|Overall Study|Lost to Follow-up|29|||
129823247|NCT01862874|467316622|FG000|Overall Study|Physician Decision|5|||
129823248|NCT01862874|467316623|FG001|Overall Study|Physician Decision|3|||
129823249|NCT01862874|467316622|FG000|Overall Study|Withdrawn by parent/guardian|1|||
129823250|NCT01862874|467316623|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129823251|NCT01862874|467316622|FG000|Overall Study|Withdrawal by Subject|46|||
129823252|NCT01862874|467316623|FG001|Overall Study|Withdrawal by Subject|40|||
129823253|NCT01862874|467316622|FG000|Overall Study|Death|0|||
129823254|NCT01862874|467316623|FG001|Overall Study|Death|1|||
129823255|NCT02260921|467316624|FG000|Overall Study|Adverse Event|1|||
129823256|NCT02260921|467316625|FG001|Overall Study|Adverse Event|0|||
129823257|NCT02260921|467316624|FG000|Overall Study|Lost to Follow-up|4|||
129823258|NCT02260921|467316625|FG001|Overall Study|Lost to Follow-up|3|||
129823259|NCT02260921|467316624|FG000|Overall Study|Withdraw Consent|4|||
129823260|NCT02260921|467316625|FG001|Overall Study|Withdraw Consent|1|||
129823261|NCT02260921|467316624|FG000|Overall Study|Death|1|||
129823262|NCT02260921|467316625|FG001|Overall Study|Death|0|||
129823263|NCT02260921|467316624|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
129823264|NCT02260921|467316625|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
129823265|NCT03241342|467316631|FG000|Overall Study|Adverse Event|5|||
129823266|NCT03241342|467316632|FG001|Overall Study|Adverse Event|8|||
129823267|NCT03241342|467316633|FG002|Overall Study|Adverse Event|4|||
129823268|NCT03241342|467316631|FG000|Overall Study|Lack of Efficacy|0|||
129823269|NCT03241342|467316632|FG001|Overall Study|Lack of Efficacy|0|||
129823270|NCT03241342|467316633|FG002|Overall Study|Lack of Efficacy|1|||
129823271|NCT03241342|467316631|FG000|Overall Study|noncompliance with study drug|2|||
129823272|NCT03241342|467316632|FG001|Overall Study|noncompliance with study drug|1|||
129823273|NCT03241342|467316633|FG002|Overall Study|noncompliance with study drug|1|||
129823274|NCT03241342|467316631|FG000|Overall Study|sponsor decision|0|||
129823275|NCT03241342|467316632|FG001|Overall Study|sponsor decision|1|||
129823276|NCT03241342|467316633|FG002|Overall Study|sponsor decision|2|||
129823277|NCT03241342|467316631|FG000|Overall Study|not reported|15|||
129823278|NCT03241342|467316632|FG001|Overall Study|not reported|21|||
129823279|NCT03241342|467316633|FG002|Overall Study|not reported|19|||
129823280|NCT02068443|467318505|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129823281|NCT02068443|467318506|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
129823282|NCT02068443|467318507|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
129823283|NCT02068443|467318505|FG000|Overall Study|Voluntary Withdrawal|4|||
129823284|NCT02068443|467318506|FG001|Overall Study|Voluntary Withdrawal|0|||
129823285|NCT02068443|467318507|FG002|Overall Study|Voluntary Withdrawal|1|||
129823286|NCT02068443|467318505|FG000|Overall Study|Lack of Efficacy|2|||
129823287|NCT02068443|467318506|FG001|Overall Study|Lack of Efficacy|1|||
129823288|NCT02068443|467318507|FG002|Overall Study|Lack of Efficacy|0|||
129823289|NCT02068443|467318505|FG000|Overall Study|Other Reason Not Specified|1|||
129897425|NCT00335556|467584377|FG002|Overall Study|Death|0|||
129897426|NCT00335556|467584378|FG003|Overall Study|Death|0|||
129897427|NCT00335556|467584379|FG004|Overall Study|Death|1|||
129897428|NCT00335556|467584380|FG005|Overall Study|Death|0|||
129897429|NCT00335556|467584375|FG000|Overall Study|Lack of Efficacy|0|||
129897430|NCT00335556|467584376|FG001|Overall Study|Lack of Efficacy|19|||
129897431|NCT00335556|467584377|FG002|Overall Study|Lack of Efficacy|3|||
129897432|NCT00335556|467584378|FG003|Overall Study|Lack of Efficacy|3|||
129897433|NCT00335556|467584379|FG004|Overall Study|Lack of Efficacy|0|||
129897434|NCT00335556|467584380|FG005|Overall Study|Lack of Efficacy|1|||
129897435|NCT00335556|467584375|FG000|Overall Study|Physician Decision|0|||
129897436|NCT00335556|467584376|FG001|Overall Study|Physician Decision|6|||
129897437|NCT00335556|467584377|FG002|Overall Study|Physician Decision|2|||
129897438|NCT00335556|467584378|FG003|Overall Study|Physician Decision|1|||
129897439|NCT00335556|467584379|FG004|Overall Study|Physician Decision|0|||
129897440|NCT00335556|467584380|FG005|Overall Study|Physician Decision|0|||
129897441|NCT00335556|467584375|FG000|Overall Study|Ineligible|2|||
129897442|NCT00335556|467584376|FG001|Overall Study|Ineligible|0|||
129897443|NCT00335556|467584377|FG002|Overall Study|Ineligible|0|||
129897444|NCT00335556|467584378|FG003|Overall Study|Ineligible|0|||
129897445|NCT00335556|467584379|FG004|Overall Study|Ineligible|0|||
129897446|NCT00335556|467584380|FG005|Overall Study|Ineligible|0|||
129823290|NCT02068443|467318506|FG001|Overall Study|Other Reason Not Specified|0|||
129823291|NCT02068443|467318507|FG002|Overall Study|Other Reason Not Specified|0|||
129823292|NCT01986855|467318508|FG000|Overall Study|Adverse Event|1|||
129823293|NCT01986855|467318509|FG001|Overall Study|Adverse Event|0|||
129823294|NCT01986855|467318510|FG002|Overall Study|Adverse Event|0|||
129823295|NCT01986855|467318508|FG000|Overall Study|Death|3|||
129823296|NCT01986855|467318509|FG001|Overall Study|Death|4|||
129823297|NCT01986855|467318510|FG002|Overall Study|Death|4|||
129823298|NCT01986855|467318508|FG000|Overall Study|Lost to Follow-up|2|||
129823299|NCT01986855|467318509|FG001|Overall Study|Lost to Follow-up|1|||
129823300|NCT01986855|467318510|FG002|Overall Study|Lost to Follow-up|0|||
129823301|NCT01986855|467318508|FG000|Overall Study|Screen Failure|0|||
129897447|NCT00335556|467584375|FG000|Overall Study|Refusal of further protocol therapy|0|||
129823302|NCT01986855|467318509|FG001|Overall Study|Screen Failure|1|||
129823303|NCT01986855|467318510|FG002|Overall Study|Screen Failure|0|||
129823304|NCT01986855|467318508|FG000|Overall Study|Participant Moved|0|||
129823305|NCT01986855|467318509|FG001|Overall Study|Participant Moved|0|||
129823306|NCT01986855|467318510|FG002|Overall Study|Participant Moved|2|||
129823307|NCT01986855|467318508|FG000|Overall Study|Withdrawal by Subject|7|||
129823308|NCT01986855|467318509|FG001|Overall Study|Withdrawal by Subject|8|||
129823309|NCT01986855|467318510|FG002|Overall Study|Withdrawal by Subject|5|||
129897448|NCT00335556|467584376|FG001|Overall Study|Refusal of further protocol therapy|4|||
129897449|NCT00335556|467584377|FG002|Overall Study|Refusal of further protocol therapy|0|||
129823310|NCT00664742|467318511|FG000|Overall Study|Withdrawn due to adverse events|3|||
129823311|NCT00664742|467318511|FG000|Overall Study|Withdrawal by Subject|31|||
129823312|NCT00664742|467318511|FG000|Overall Study|Lost to Follow-up|92|||
129897450|NCT00335556|467584378|FG003|Overall Study|Refusal of further protocol therapy|1|||
129897451|NCT00335556|467584379|FG004|Overall Study|Refusal of further protocol therapy|0|||
129823313|NCT02825992|467318512|FG000|Overall Study|Withdrawal by Subject|4|||
129823314|NCT02825992|467318512|FG000|Overall Study|Lost to Follow-up|2|||
129823315|NCT02825992|467318512|FG000|Overall Study|Procedure terminated|2|||
129823316|NCT02279173|467318513|FG000|Overall Study|Protocol-specified Criteria|67|||
129823317|NCT02279173|467318513|FG000|Overall Study|Withdrawal by Subject|20|||
129823318|NCT02279173|467318513|FG000|Overall Study|Decision by Sponsor|4|||
129823319|NCT02279173|467318513|FG000|Overall Study|Lost to Follow-up|3|||
129823320|NCT00157950|467318514|FG000|Overall Study|Death|1|||
129823321|NCT00157950|467318515|FG001|Overall Study|Death|0|||
129823322|NCT00386776|467318520|FG000|Overall Study|Withdrawal by Subject|8|||
129823323|NCT01500629|467318521|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
129823324|NCT01500629|467318522|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
129823325|NCT00588848|467318523|FG000|Overall Study|Physician Decision|0|||
129823326|NCT00588848|467318524|FG001|Overall Study|Physician Decision|3|||
129823327|NCT01499667|467318525|FG000|Overall Study|administrative problems|4|||
129823328|NCT01499667|467318526|FG001|Overall Study|administrative problems|5|||
129823329|NCT01499667|467318527|FG002|Overall Study|administrative problems|5|||
129823330|NCT01499667|467318525|FG000|Overall Study|Protocol Violation|1|||
129823331|NCT01499667|467318526|FG001|Overall Study|Protocol Violation|3|||
129823332|NCT01499667|467318527|FG002|Overall Study|Protocol Violation|2|||
129823333|NCT01499667|467318525|FG000|Overall Study|Adverse Event|0|||
129823334|NCT01499667|467318526|FG001|Overall Study|Adverse Event|2|||
129823335|NCT01499667|467318527|FG002|Overall Study|Adverse Event|2|||
129823336|NCT01499667|467318525|FG000|Overall Study|Withdrawal by Subject|2|||
129823337|NCT01499667|467318526|FG001|Overall Study|Withdrawal by Subject|1|||
129823338|NCT01499667|467318527|FG002|Overall Study|Withdrawal by Subject|1|||
129823339|NCT01499667|467318525|FG000|Overall Study|Lack of Efficacy|2|||
129823340|NCT01499667|467318526|FG001|Overall Study|Lack of Efficacy|0|||
129823341|NCT01499667|467318527|FG002|Overall Study|Lack of Efficacy|0|||
129823342|NCT02902965|467318528|FG000|Overall Study|Withdrawal by Subject|10|||
129823343|NCT02673489|467318529|FG000|Treatment Period|Lost to Follow-up|3|||
129823344|NCT02673489|467318530|FG001|Treatment Period|Lost to Follow-up|0|||
129823345|NCT02673489|467318529|FG000|Treatment Period|Participant request to discontinue|1|||
129823346|NCT02673489|467318530|FG001|Treatment Period|Participant request to discontinue|1|||
129823347|NCT02673489|467318529|FG000|Treatment Period|Participant moved to another province|1|||
129823348|NCT02673489|467318530|FG001|Treatment Period|Participant moved to another province|0|||
129823349|NCT02673489|467318529|FG000|Treatment Period|Participant was incarcerated|0|||
129823350|NCT02673489|467318530|FG001|Treatment Period|Participant was incarcerated|1|||
129823351|NCT02673489|467318529|FG000|Treatment Period|Adverse Event|0|||
129823352|NCT02673489|467318530|FG001|Treatment Period|Adverse Event|1|||
129823353|NCT02673489|467318529|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
129823354|NCT02673489|467318530|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
129823355|NCT02673489|467318529|FG000|Follow Up Period|Unable to return for follow-up|0|||
129823356|NCT02673489|467318530|FG001|Follow Up Period|Unable to return for follow-up|1|||
129823357|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
129823358|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
129823359|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
129823360|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
129823361|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
129897452|NCT00335556|467584380|FG005|Overall Study|Refusal of further protocol therapy|0|||
129897453|NCT02365298|467584383|FG000|Period 2|incorrect Rx dispensed|1|||
129897454|NCT02365298|467584384|FG001|Period 2|incorrect Rx dispensed|0|||
129897455|NCT02365298|467584383|FG000|Period 2|Discontinued at request of Sponsor|1|||
129897456|NCT02365298|467584384|FG001|Period 2|Discontinued at request of Sponsor|0|||
129897457|NCT02365298|467584383|FG000|Period 2|Test Article longer available|0|||
129897458|NCT02365298|467584384|FG001|Period 2|Test Article longer available|1|||
129897459|NCT02365298|467584383|FG000|Period 2|Protocol Violation|0|||
129897460|NCT02365298|467584384|FG001|Period 2|Protocol Violation|1|||
129897461|NCT01878890|467584385|FG000|Overall Study|Protocol Violation|0|||
129897462|NCT01878890|467584386|FG001|Overall Study|Protocol Violation|1|||
129897463|NCT01878890|467584387|FG002|Overall Study|Protocol Violation|0|||
129897464|NCT01878890|467584388|FG003|Overall Study|Protocol Violation|0|||
129897465|NCT02974010|467584389|FG000|Overall Study|Lost to Follow-up|3|||
129897466|NCT02974010|467584390|FG001|Overall Study|Lost to Follow-up|1|||
129897467|NCT02974010|467584391|FG002|Overall Study|Lost to Follow-up|0|||
129823362|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
129823363|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
129823364|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
129823365|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
129823366|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
129897468|NCT02974010|467584392|FG003|Overall Study|Lost to Follow-up|0|||
129897469|NCT02974010|467584389|FG000|Overall Study|Withdrawal by Subject|2|||
129823367|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
129823368|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
129823369|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
129823370|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
129823371|NCT00293254|467318531|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
129823372|NCT00293254|467318532|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
129823373|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
129823374|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
129823375|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Death|4|||
129823376|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Death|1|||
129823377|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
129823378|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
129823379|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
129823380|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
129823381|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
129823382|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
129823383|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
129823384|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
129823385|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
129823386|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
129823387|NCT00293254|467318531|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
129823388|NCT00293254|467318532|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
129823389|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
129823390|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
129823391|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
129823392|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
129823393|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
129823394|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
129823395|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
129823396|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
129823397|NCT00293254|467318531|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
129823398|NCT00293254|467318532|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
129823399|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
129823400|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
129823401|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
129823402|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
129823403|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
129823404|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
129823405|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
129823406|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
129823407|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
129823408|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
129823409|NCT00293254|467318531|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
129823410|NCT00293254|467318532|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
129823411|NCT02335489|467318533|FG000|Overall Study|Sponsor terminated study|4|||
129823412|NCT02335489|467318533|FG000|Overall Study|Lost to Follow-up|1|||
129823413|NCT02335489|467318533|FG000|Overall Study|Withdrawal by Subject|2|||
129823414|NCT02335489|467318533|FG000|Overall Study|Physician Decision|2|||
129823415|NCT02335489|467318533|FG000|Overall Study|Lack of Efficacy|1|||
129823416|NCT00503308|467318534|FG000|Overall Study|Protocol Violation|2|||
129823417|NCT00503308|467318535|FG001|Overall Study|Protocol Violation|1|||
129823418|NCT02233309|467318537|FG000|Overall Study|Physician Decision|5|||
129823419|NCT00232817|467318538|FG000|Overall Study|Protocol Violation|2|||
129823420|NCT00232817|467318539|FG001|Overall Study|Protocol Violation|1|||
129823421|NCT00799487|467318540|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
129897470|NCT02974010|467584390|FG001|Overall Study|Withdrawal by Subject|1|||
129897471|NCT02974010|467584391|FG002|Overall Study|Withdrawal by Subject|0|||
129897472|NCT02974010|467584392|FG003|Overall Study|Withdrawal by Subject|0|||
129897473|NCT02974010|467584389|FG000|Overall Study|Adverse Event|0|||
129897474|NCT02974010|467584390|FG001|Overall Study|Adverse Event|1|||
129823422|NCT00799487|467318541|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
129823423|NCT00799487|467318542|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
129823424|NCT00799487|467318540|FG000|Dose Adjustment Period|Adverse Event|2|||
129823425|NCT00799487|467318541|FG001|Dose Adjustment Period|Adverse Event|0|||
129823426|NCT00799487|467318542|FG002|Dose Adjustment Period|Adverse Event|0|||
129823427|NCT00799487|467318540|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
129823428|NCT00799487|467318541|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
129897475|NCT02974010|467584391|FG002|Overall Study|Adverse Event|0|||
129823429|NCT00799487|467318542|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
129823430|NCT00799487|467318540|FG000|Dose Adjustment Period|Investigator Discretion|2|||
129823431|NCT00799487|467318541|FG001|Dose Adjustment Period|Investigator Discretion|0|||
129823432|NCT00799487|467318542|FG002|Dose Adjustment Period|Investigator Discretion|0|||
129823433|NCT00799487|467318540|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
129823434|NCT00799487|467318541|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
129823435|NCT00799487|467318542|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
129823436|NCT00799487|467318540|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
129823437|NCT00799487|467318541|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
129823438|NCT00799487|467318542|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
129823439|NCT00799487|467318540|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
129823440|NCT00799487|467318541|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
129823441|NCT00799487|467318542|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
129823442|NCT00799487|467318540|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
129823443|NCT00799487|467318541|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
129823444|NCT00799487|467318542|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
129823445|NCT00799487|467318540|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
129823446|NCT00799487|467318541|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
129823447|NCT00799487|467318542|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
129823448|NCT00799487|467318540|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
129823449|NCT00799487|467318541|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
129823450|NCT00799487|467318542|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
129823451|NCT00799487|467318540|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
129823452|NCT00799487|467318541|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
129823453|NCT00799487|467318542|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
129823454|NCT00799487|467318540|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
129823455|NCT00799487|467318541|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
129823456|NCT00799487|467318542|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
129823457|NCT04481750|467318543|FG000|Period 1 (Fasted)|Adverse Event|0|||
129823458|NCT04481750|467318544|FG001|Period 1 (Fasted)|Adverse Event|0|||
129823459|NCT04481750|467318545|FG002|Period 1 (Fasted)|Adverse Event|1|||
129823460|NCT04481750|467318546|FG003|Period 1 (Fasted)|Adverse Event|0|||
129823461|NCT04481750|467318547|FG004|Period 1 (Fasted)|Adverse Event|0|||
129823462|NCT04481750|467318548|FG005|Period 1 (Fasted)|Adverse Event|0|||
129823463|NCT04481750|467318549|FG006|Period 1 (Fasted)|Adverse Event|0|||
129823464|NCT04481750|467318550|FG007|Period 1 (Fasted)|Adverse Event|0|||
129823465|NCT04481750|467318551|FG008|Period 1 (Fasted)|Adverse Event|0|||
129823466|NCT04481750|467318552|FG009|Period 1 (Fasted)|Adverse Event|0|||
129823467|NCT04481750|467318553|FG010|Period 1 (Fasted)|Adverse Event|0|||
129823468|NCT03263442|467318554|FG000|Inpatient Phase|Death|1|||
129823469|NCT03263442|467318555|FG001|Inpatient Phase|Death|0|||
129823470|NCT03263442|467318554|FG000|Inpatient Phase|Withdrawal by Subject|1|||
129823471|NCT03263442|467318555|FG001|Inpatient Phase|Withdrawal by Subject|0|||
129823472|NCT03263442|467318554|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
129823473|NCT03263442|467318555|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
129823474|NCT03263442|467318554|FG000|1-month Follow-Up|Lost to Follow-up|1|||
129823475|NCT03263442|467318555|FG001|1-month Follow-Up|Lost to Follow-up|0|||
129823476|NCT03263442|467318554|FG000|3-month Follow-Up|Lost to Follow-up|1|||
129823477|NCT03263442|467318555|FG001|3-month Follow-Up|Lost to Follow-up|3|||
129823478|NCT03263442|467318554|FG000|6-month Follow-Up|Lost to Follow-up|2|||
129823479|NCT03263442|467318555|FG001|6-month Follow-Up|Lost to Follow-up|2|||
129823480|NCT01463878|467318556|FG000|Overall Study|no longer met criteria for tube feed|2|||
129823481|NCT01463878|467318557|FG001|Overall Study|no longer met criteria for tube feed|2|||
129823482|NCT02436889|467318558|FG000|Overall Study|No improvement in symptoms|1|||
129823483|NCT02436889|467318559|FG001|Overall Study|No improvement in symptoms|0|||
129823484|NCT02436889|467318558|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
129823485|NCT02436889|467318559|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
129897476|NCT02974010|467584392|FG003|Overall Study|Adverse Event|0|||
129897477|NCT02974010|467584389|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
129897478|NCT02974010|467584390|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
129897479|NCT02974010|467584391|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
129897480|NCT02974010|467584392|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
129897481|NCT02974010|467584389|FG000|Overall Study|Lack of Efficacy|0|||
129897482|NCT02974010|467584390|FG001|Overall Study|Lack of Efficacy|0|||
129823486|NCT01084174|467318560|FG000|Overall Study|gastrointestinal symptoms|1|||
129823487|NCT01084174|467318561|FG001|Overall Study|gastrointestinal symptoms|1|||
129823488|NCT01084174|467318560|FG000|Overall Study|Eosinophilic esophagitis|0|||
129823489|NCT01084174|467318561|FG001|Overall Study|Eosinophilic esophagitis|1|||
129823490|NCT01084174|467318560|FG000|Overall Study|Anaphylaxis|0|||
129823491|NCT01084174|467318561|FG001|Overall Study|Anaphylaxis|1|||
129823492|NCT01084174|467318560|FG000|Overall Study|Participant noncompliance|0|||
129823493|NCT01084174|467318561|FG001|Overall Study|Participant noncompliance|1|||
129823494|NCT01034462|467318562|FG000|Overall Study|Adverse Event|7|||
129823495|NCT01034462|467318563|FG001|Overall Study|Adverse Event|17|||
129823496|NCT01034462|467318562|FG000|Overall Study|Lack of Efficacy|4|||
129823497|NCT01034462|467318563|FG001|Overall Study|Lack of Efficacy|4|||
129823498|NCT01034462|467318562|FG000|Overall Study|Protocol Violation|10|||
129823499|NCT01034462|467318563|FG001|Overall Study|Protocol Violation|7|||
129823500|NCT01034462|467318562|FG000|Overall Study|Withdrawal by Subject|9|||
129823501|NCT01034462|467318563|FG001|Overall Study|Withdrawal by Subject|8|||
129823502|NCT01034462|467318562|FG000|Overall Study|Lost to Follow-up|14|||
129823503|NCT01034462|467318563|FG001|Overall Study|Lost to Follow-up|16|||
129823504|NCT01034462|467318562|FG000|Overall Study|Other reasons|1|||
129823505|NCT01034462|467318563|FG001|Overall Study|Other reasons|2|||
129823506|NCT01484873|467318564|FG000|Overall Study|Withdrawal by Subject|2|||
129823507|NCT02564042|467318565|FG000|Overall Study|Adverse Event|4|||
129823508|NCT02564042|467318566|FG001|Overall Study|Adverse Event|4|||
129823509|NCT02564042|467318567|FG002|Overall Study|Adverse Event|3|||
129823510|NCT02564042|467318568|FG003|Overall Study|Adverse Event|0|||
129823511|NCT02564042|467318569|FG004|Overall Study|Adverse Event|0|||
129823512|NCT02564042|467318570|FG005|Overall Study|Adverse Event|1|||
129823513|NCT02564042|467318565|FG000|Overall Study|Lost to Follow-up|1|||
129823514|NCT02564042|467318566|FG001|Overall Study|Lost to Follow-up|1|||
129823515|NCT02564042|467318567|FG002|Overall Study|Lost to Follow-up|1|||
129823516|NCT02564042|467318568|FG003|Overall Study|Lost to Follow-up|0|||
129823517|NCT02564042|467318569|FG004|Overall Study|Lost to Follow-up|1|||
129823518|NCT02564042|467318570|FG005|Overall Study|Lost to Follow-up|1|||
129823519|NCT02564042|467318565|FG000|Overall Study|Physician Decision|1|||
129823520|NCT02564042|467318566|FG001|Overall Study|Physician Decision|0|||
129823521|NCT02564042|467318567|FG002|Overall Study|Physician Decision|0|||
129823522|NCT02564042|467318568|FG003|Overall Study|Physician Decision|1|||
129823523|NCT02564042|467318569|FG004|Overall Study|Physician Decision|0|||
129823524|NCT02564042|467318570|FG005|Overall Study|Physician Decision|0|||
129823525|NCT02564042|467318565|FG000|Overall Study|Withdrawal by Subject|5|||
129823526|NCT02564042|467318566|FG001|Overall Study|Withdrawal by Subject|3|||
129823527|NCT02564042|467318567|FG002|Overall Study|Withdrawal by Subject|2|||
129823528|NCT02564042|467318568|FG003|Overall Study|Withdrawal by Subject|2|||
129823529|NCT02564042|467318569|FG004|Overall Study|Withdrawal by Subject|10|||
129823530|NCT02564042|467318570|FG005|Overall Study|Withdrawal by Subject|12|||
129823531|NCT01549392|467318571|FG000|Overall Study|Withdrawal by Subject|1|||
129823532|NCT01549392|467318572|FG001|Overall Study|Withdrawal by Subject|0|||
129823533|NCT01356966|467318573|FG000|Overall Study|Withdrawal by Subject|1|||
129823534|NCT01356966|467318574|FG001|Overall Study|Withdrawal by Subject|2|||
129823535|NCT01356966|467318573|FG000|Overall Study|Physician Decision|1|||
129823536|NCT01356966|467318574|FG001|Overall Study|Physician Decision|0|||
129823537|NCT02743806|467318575|FG000|Overall Study|Adverse Event|9|||
129823538|NCT02743806|467318575|FG000|Overall Study|Lost to Follow-up|8|||
129823539|NCT02743806|467318575|FG000|Overall Study|Voluntary Withdrawal|54|||
129823540|NCT02743806|467318575|FG000|Overall Study|Study Termination|65|||
129823541|NCT02743806|467318575|FG000|Overall Study|Pregnancy|6|||
129823542|NCT02743806|467318575|FG000|Overall Study|No Longer Clinically Benefiting|27|||
129823543|NCT02743806|467318575|FG000|Overall Study|Reason Not Specified|12|||
129823544|NCT00849381|467318576|FG000|Overall Study|Adverse Event|1|||
129823545|NCT00849381|467318576|FG000|Overall Study|Lost to Follow-up|129|||
129823546|NCT00849381|467318576|FG000|Overall Study|Protocol Violation|5|||
129823547|NCT00849381|467318576|FG000|Overall Study|Withdrawal by Subject|6|||
129823548|NCT00849381|467318576|FG000|Overall Study|Other|4|||
129823549|NCT02289898|467318581|FG000|Overall Study|Death|5|||
129823550|NCT02289898|467318582|FG001|Overall Study|Death|4|||
129823551|NCT02289898|467318583|FG002|Overall Study|Death|3|||
129823552|NCT02289898|467318581|FG000|Overall Study|Physician Decision|2|||
129823553|NCT02289898|467318582|FG001|Overall Study|Physician Decision|5|||
129823554|NCT02289898|467318583|FG002|Overall Study|Physician Decision|2|||
129823555|NCT02289898|467318581|FG000|Overall Study|Withdrawal by Subject|0|||
129823556|NCT02289898|467318582|FG001|Overall Study|Withdrawal by Subject|4|||
129823557|NCT02289898|467318583|FG002|Overall Study|Withdrawal by Subject|1|||
129823558|NCT02289898|467318581|FG000|Overall Study|Adverse Event|3|||
129823559|NCT02289898|467318582|FG001|Overall Study|Adverse Event|5|||
129823560|NCT02289898|467318583|FG002|Overall Study|Adverse Event|5|||
129823561|NCT02289898|467318581|FG000|Overall Study|Disease progression|34|||
129823562|NCT02289898|467318582|FG001|Overall Study|Disease progression|28|||
129823563|NCT02289898|467318583|FG002|Overall Study|Disease progression|34|||
129823564|NCT02289898|467318581|FG000|Overall Study|Use of another anticancer therapy|0|||
129823565|NCT02289898|467318582|FG001|Overall Study|Use of another anticancer therapy|0|||
129823566|NCT02289898|467318583|FG002|Overall Study|Use of another anticancer therapy|1|||
129823567|NCT02289898|467318581|FG000|Overall Study|Other|8|||
129823568|NCT02289898|467318582|FG001|Overall Study|Other|7|||
129823569|NCT02289898|467318583|FG002|Overall Study|Other|10|||
129823570|NCT01828281|467318584|FG000|Overall Study|Withdrawal by Subject|1|||
129823571|NCT01828281|467318585|FG001|Overall Study|Withdrawal by Subject|0|||
129823572|NCT03070782|467318586|FG000|Overall Study|Adverse Event|3|||
129823573|NCT03070782|467318587|FG001|Overall Study|Adverse Event|0|||
129823574|NCT03070782|467318588|FG002|Overall Study|Adverse Event|3|||
129823575|NCT03070782|467318589|FG003|Overall Study|Adverse Event|1|||
129823576|NCT03070782|467318590|FG004|Overall Study|Adverse Event|6|||
129823577|NCT03070782|467318591|FG005|Overall Study|Adverse Event|2|||
129823578|NCT03070782|467318586|FG000|Overall Study|Withdrawal by Subject|2|||
129823579|NCT03070782|467318587|FG001|Overall Study|Withdrawal by Subject|1|||
129823580|NCT03070782|467318588|FG002|Overall Study|Withdrawal by Subject|1|||
129823581|NCT03070782|467318589|FG003|Overall Study|Withdrawal by Subject|0|||
129823582|NCT03070782|467318590|FG004|Overall Study|Withdrawal by Subject|4|||
129823583|NCT03070782|467318591|FG005|Overall Study|Withdrawal by Subject|3|||
129823584|NCT03070782|467318586|FG000|Overall Study|Reason Not Specified|2|||
129823585|NCT03070782|467318587|FG001|Overall Study|Reason Not Specified|0|||
129823586|NCT03070782|467318588|FG002|Overall Study|Reason Not Specified|0|||
129823587|NCT03070782|467318589|FG003|Overall Study|Reason Not Specified|1|||
129823588|NCT03070782|467318590|FG004|Overall Study|Reason Not Specified|2|||
129823589|NCT03070782|467318591|FG005|Overall Study|Reason Not Specified|1|||
129823590|NCT03070782|467318586|FG000|Overall Study|Ineligibility|0|||
129823591|NCT03070782|467318587|FG001|Overall Study|Ineligibility|0|||
129823592|NCT03070782|467318588|FG002|Overall Study|Ineligibility|0|||
129823593|NCT03070782|467318589|FG003|Overall Study|Ineligibility|1|||
129823594|NCT03070782|467318590|FG004|Overall Study|Ineligibility|0|||
129823595|NCT03070782|467318591|FG005|Overall Study|Ineligibility|1|||
129823596|NCT03070782|467318586|FG000|Overall Study|Pregnancy|0|||
129823597|NCT03070782|467318587|FG001|Overall Study|Pregnancy|0|||
129823598|NCT03070782|467318588|FG002|Overall Study|Pregnancy|0|||
129823599|NCT03070782|467318589|FG003|Overall Study|Pregnancy|1|||
129823600|NCT03070782|467318590|FG004|Overall Study|Pregnancy|0|||
129823601|NCT03070782|467318591|FG005|Overall Study|Pregnancy|0|||
129823602|NCT03070782|467318586|FG000|Overall Study|Investigator Judgement|0|||
129823603|NCT03070782|467318587|FG001|Overall Study|Investigator Judgement|0|||
129823604|NCT03070782|467318588|FG002|Overall Study|Investigator Judgement|0|||
129823605|NCT03070782|467318589|FG003|Overall Study|Investigator Judgement|1|||
129823606|NCT03070782|467318590|FG004|Overall Study|Investigator Judgement|0|||
129823607|NCT03070782|467318591|FG005|Overall Study|Investigator Judgement|0|||
129823608|NCT01083576|467318592|FG000|Overall Study|Treatment Failure|6|||
129823609|NCT01083576|467318593|FG001|Overall Study|Treatment Failure|1|||
129823610|NCT03527966|467318594|FG000|Overall Study|Lost to Follow-up|3|||
129823611|NCT03527966|467318595|FG001|Overall Study|Lost to Follow-up|0|||
129823612|NCT02746874|467318596|FG000|Overall Study|Withdrawal by Subject|0|||
129823613|NCT02746874|467318597|FG001|Overall Study|Withdrawal by Subject|1|||
129823614|NCT02746874|467318596|FG000|Overall Study|Surgery Date Changed|0|||
129823615|NCT02746874|467318597|FG001|Overall Study|Surgery Date Changed|2|||
129823616|NCT00022633|467318600|FG000|Overall Study|Adverse Event|11|||
129823617|NCT00022633|467318601|FG001|Overall Study|Adverse Event|1|||
129823618|NCT00022633|467318600|FG000|Overall Study|Refusal unrelated to adverse event|1|||
129823619|NCT00022633|467318601|FG001|Overall Study|Refusal unrelated to adverse event|0|||
129823620|NCT00022633|467318600|FG000|Overall Study|Progression/relapse|9|||
129823621|NCT00022633|467318601|FG001|Overall Study|Progression/relapse|2|||
129823622|NCT00022633|467318600|FG000|Overall Study|Death|4|||
129823623|NCT00022633|467318601|FG001|Overall Study|Death|0|||
129823624|NCT00022633|467318600|FG000|Overall Study|Other - not protocol specified|3|||
129823625|NCT00022633|467318601|FG001|Overall Study|Other - not protocol specified|2|||
129823626|NCT00022633|467318600|FG000|Overall Study|Ineligible|4|||
129823627|NCT00022633|467318601|FG001|Overall Study|Ineligible|0|||
129823628|NCT00487747|467318602|FG000|Overall Study|Adverse Event|1|||
129823629|NCT00487747|467318602|FG000|Overall Study|Lost to Follow-up|9|||
129823630|NCT00487747|467318602|FG000|Overall Study|Lack of Efficacy|1|||
129823631|NCT03402386|467318613|FG000|Overall Study|Adverse Event|3|||
129823632|NCT03402386|467318613|FG000|Overall Study|Physician Decision|1|||
129823633|NCT03402386|467318613|FG000|Overall Study|Difficult to control Hb|2|||
129823634|NCT02485574|467318620|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
129823635|NCT00255047|467318622|FG000|Overall Study|Serious Adverse Events|2|||
129823636|NCT00255047|467318623|FG001|Overall Study|Serious Adverse Events|1|||
129823637|NCT00255047|467318624|FG002|Overall Study|Serious Adverse Events|2|||
129823638|NCT00255047|467318625|FG003|Overall Study|Serious Adverse Events|1|||
129823639|NCT00255047|467318622|FG000|Overall Study|Adverse Event|0|||
129823640|NCT00255047|467318623|FG001|Overall Study|Adverse Event|3|||
129823641|NCT00255047|467318624|FG002|Overall Study|Adverse Event|2|||
129823642|NCT00255047|467318625|FG003|Overall Study|Adverse Event|1|||
129823643|NCT00255047|467318622|FG000|Overall Study|Protocol Violation|13|||
129823644|NCT00255047|467318623|FG001|Overall Study|Protocol Violation|13|||
129823645|NCT00255047|467318624|FG002|Overall Study|Protocol Violation|16|||
129823646|NCT00255047|467318625|FG003|Overall Study|Protocol Violation|20|||
129823647|NCT00255047|467318622|FG000|Overall Study|Lost to Follow-up|9|||
129823648|NCT00255047|467318623|FG001|Overall Study|Lost to Follow-up|8|||
129823649|NCT00255047|467318624|FG002|Overall Study|Lost to Follow-up|5|||
129823650|NCT00255047|467318625|FG003|Overall Study|Lost to Follow-up|6|||
129823651|NCT00255047|467318622|FG000|Overall Study|Withdrawal by Subject|24|||
129823652|NCT00255047|467318623|FG001|Overall Study|Withdrawal by Subject|23|||
129823653|NCT00255047|467318624|FG002|Overall Study|Withdrawal by Subject|25|||
129823654|NCT00255047|467318625|FG003|Overall Study|Withdrawal by Subject|18|||
129823655|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
129823656|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
129823657|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
129823658|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
129823659|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
129823660|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
129823661|NCT01957553|467318627|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
129823662|NCT01957553|467318628|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
129823663|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
129823664|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
129823665|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
129823666|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
129823667|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
129823668|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
129823669|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
129823670|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
129823671|NCT01957553|467318627|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
129823672|NCT01957553|467318628|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
129823673|NCT01333059|467318629|FG000|Overall Study|Physician Decision|3|||
129823674|NCT01333059|467318630|FG001|Overall Study|Physician Decision|3|||
129823675|NCT01333059|467318629|FG000|Overall Study|Protocol Violation|3|||
129823676|NCT01333059|467318630|FG001|Overall Study|Protocol Violation|0|||
129823677|NCT01348347|467318631|FG000|Overall Study|Withdrawal by Subject|1|||
129823678|NCT01348347|467318632|FG001|Overall Study|Withdrawal by Subject|1|||
129823679|NCT01348347|467318633|FG002|Overall Study|Withdrawal by Subject|1|||
129823680|NCT01348347|467318631|FG000|Overall Study|Progressive disease|2|||
129823681|NCT01348347|467318632|FG001|Overall Study|Progressive disease|5|||
129823682|NCT01348347|467318633|FG002|Overall Study|Progressive disease|5|||
129823683|NCT00748033|467318634|FG000|Overall Study|Adverse Event|0|||
129823684|NCT00748033|467318635|FG001|Overall Study|Adverse Event|1|||
129823685|NCT03060629|467318636|FG000|Overall Study|Death|4|||
129823686|NCT03060629|467318637|FG001|Overall Study|Death|5|||
129823687|NCT03060629|467318636|FG000|Overall Study|Withdrawal by Subject|50|||
129823688|NCT03060629|467318637|FG001|Overall Study|Withdrawal by Subject|35|||
129823689|NCT03060629|467318636|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
129823690|NCT03060629|467318637|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
129823691|NCT03060629|467318636|FG000|Overall Study|Participant Relocate|15|||
129823692|NCT03060629|467318637|FG001|Overall Study|Participant Relocate|15|||
129823693|NCT03060629|467318636|FG000|Overall Study|Unable to Contact Participant|34|||
129823694|NCT03060629|467318637|FG001|Overall Study|Unable to Contact Participant|23|||
129823695|NCT03060629|467318636|FG000|Overall Study|Investigator Decision|7|||
129823696|NCT03060629|467318637|FG001|Overall Study|Investigator Decision|7|||
129823697|NCT03060629|467318636|FG000|Overall Study|Study Terminated by Sponsor|1100|||
129823698|NCT03060629|467318637|FG001|Overall Study|Study Terminated by Sponsor|1123|||
129823699|NCT03060629|467318636|FG000|Overall Study|Other|4|||
129823700|NCT03060629|467318637|FG001|Overall Study|Other|4|||
129823701|NCT01405742|467318638|FG000|Overall Study|Lost to Follow-up|1|||
129823702|NCT01405742|467318639|FG001|Overall Study|Lost to Follow-up|0|||
129823703|NCT03672747|467318641|FG000|Overall Study|Lost to Follow-up|1|||
129823704|NCT03672747|467318642|FG001|Overall Study|Lost to Follow-up|1|||
129823705|NCT03672747|467318643|FG002|Overall Study|Lost to Follow-up|2|||
129823706|NCT03672747|467318644|FG003|Overall Study|Lost to Follow-up|2|||
129823707|NCT03672747|467318645|FG004|Overall Study|Lost to Follow-up|2|||
129823708|NCT03672747|467318646|FG005|Overall Study|Lost to Follow-up|1|||
129823709|NCT01782495|467318650|FG000|Overall Study|Adverse Event|0|||
129823710|NCT01782495|467318651|FG001|Overall Study|Adverse Event|0|||
129823711|NCT01782495|467318652|FG002|Overall Study|Adverse Event|0|||
129823712|NCT01782495|467318653|FG003|Overall Study|Adverse Event|0|||
129823713|NCT01782495|467318654|FG004|Overall Study|Adverse Event|0|||
129823714|NCT01782495|467318655|FG005|Overall Study|Adverse Event|0|||
129823715|NCT01782495|467318656|FG006|Overall Study|Adverse Event|0|||
129823716|NCT01782495|467318657|FG007|Overall Study|Adverse Event|2|||
129823717|NCT01782495|467318658|FG008|Overall Study|Adverse Event|0|||
129823718|NCT01782495|467318659|FG009|Overall Study|Adverse Event|0|||
129823719|NCT01782495|467318660|FG010|Overall Study|Adverse Event|0|||
129823720|NCT01782495|467318650|FG000|Overall Study|Withdrew Consent|0|||
129823721|NCT01782495|467318651|FG001|Overall Study|Withdrew Consent|1|||
129823722|NCT01782495|467318652|FG002|Overall Study|Withdrew Consent|0|||
129823723|NCT01782495|467318653|FG003|Overall Study|Withdrew Consent|0|||
129823724|NCT01782495|467318654|FG004|Overall Study|Withdrew Consent|0|||
129823725|NCT01782495|467318655|FG005|Overall Study|Withdrew Consent|0|||
129823726|NCT01782495|467318656|FG006|Overall Study|Withdrew Consent|0|||
129823727|NCT01782495|467318657|FG007|Overall Study|Withdrew Consent|1|||
129823728|NCT01782495|467318658|FG008|Overall Study|Withdrew Consent|0|||
129823729|NCT01782495|467318659|FG009|Overall Study|Withdrew Consent|0|||
129823730|NCT01782495|467318660|FG010|Overall Study|Withdrew Consent|0|||
129823731|NCT03428360|467318661|FG000|Overall Study|Informed consent withdrawn|5|||
129823732|NCT03428360|467318661|FG000|Overall Study|Withdrawal by Subject|4|||
129823733|NCT03428360|467318661|FG000|Overall Study|Lost to Follow-up|5|||
129823734|NCT03428360|467318661|FG000|Overall Study|Physician Decision|2|||
129823735|NCT03428360|467318661|FG000|Overall Study|Informed consent withdrawn|5|||
129823736|NCT03428360|467318661|FG000|Overall Study|Study terminated by sponsor|10|||
129823737|NCT03428360|467318661|FG000|Overall Study|Non-compliant with study|1|||
129823738|NCT03428360|467318661|FG000|Overall Study|Non-compliant with study drug|3|||
129823739|NCT03428360|467318661|FG000|Overall Study|Death|3|||
129823740|NCT03428360|467318661|FG000|Overall Study|Adverse Event|1|||
129823741|NCT03428360|467318661|FG000|Overall Study|Not on antiepileptic drug|1|||
129823742|NCT03334903|467318665|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
129823743|NCT03334903|467318666|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
129823744|NCT03334903|467318665|FG000|Overall Study|Protocol Violation|1|||
129823745|NCT03334903|467318666|FG001|Overall Study|Protocol Violation|3|||
129823746|NCT03334903|467318665|FG000|Overall Study|Surgery postponed|1|||
129823747|NCT03334903|467318666|FG001|Overall Study|Surgery postponed|0|||
129823748|NCT03334903|467318665|FG000|Overall Study|Adverse Event|1|||
129823749|NCT03334903|467318666|FG001|Overall Study|Adverse Event|1|||
129823750|NCT03334903|467318665|FG000|Overall Study|Withdrawal by Subject|0|||
129823751|NCT03334903|467318666|FG001|Overall Study|Withdrawal by Subject|1|||
129823752|NCT03032705|467318667|FG000|Overall Study|Lost to Follow-up|16|||
129823753|NCT03032705|467318668|FG001|Overall Study|Lost to Follow-up|17|||
129823754|NCT03032705|467318667|FG000|Overall Study|did not quality|6|||
129823755|NCT03032705|467318668|FG001|Overall Study|did not quality|6|||
129823756|NCT02759471|467318669|FG000|Overall Study|discomfort|2|||
129823757|NCT02927080|467320197|FG000|Overall Study|Withdrawal by Subject|0|||
129823758|NCT02927080|467320198|FG001|Overall Study|Withdrawal by Subject|0|||
129823759|NCT02927080|467320199|FG002|Overall Study|Withdrawal by Subject|0|||
129823760|NCT02927080|467320200|FG003|Overall Study|Withdrawal by Subject|0|||
129823761|NCT02927080|467320201|FG004|Overall Study|Withdrawal by Subject|1|||
129823762|NCT02927080|467320202|FG005|Overall Study|Withdrawal by Subject|0|||
129823763|NCT02927080|467320203|FG006|Overall Study|Withdrawal by Subject|1|||
129823764|NCT02927080|467320204|FG007|Overall Study|Withdrawal by Subject|1|||
129823765|NCT02927080|467320205|FG008|Overall Study|Withdrawal by Subject|0|||
129823766|NCT02927080|467320206|FG009|Overall Study|Withdrawal by Subject|2|||
129823767|NCT02927080|467320197|FG000|Overall Study|Willingness to comply with protocol|0|||
129823768|NCT02927080|467320198|FG001|Overall Study|Willingness to comply with protocol|0|||
129823769|NCT02927080|467320199|FG002|Overall Study|Willingness to comply with protocol|0|||
129823770|NCT02927080|467320200|FG003|Overall Study|Willingness to comply with protocol|0|||
129823771|NCT02927080|467320201|FG004|Overall Study|Willingness to comply with protocol|0|||
129823772|NCT02927080|467320202|FG005|Overall Study|Willingness to comply with protocol|0|||
129823773|NCT02927080|467320203|FG006|Overall Study|Willingness to comply with protocol|0|||
129823774|NCT02927080|467320204|FG007|Overall Study|Willingness to comply with protocol|0|||
129823775|NCT02927080|467320205|FG008|Overall Study|Willingness to comply with protocol|0|||
129823776|NCT02927080|467320206|FG009|Overall Study|Willingness to comply with protocol|1|||
129823777|NCT02927080|467320197|FG000|Overall Study|Study terminated by Sponsor|0|||
129823778|NCT02927080|467320198|FG001|Overall Study|Study terminated by Sponsor|0|||
129823779|NCT02927080|467320199|FG002|Overall Study|Study terminated by Sponsor|0|||
129823780|NCT02927080|467320200|FG003|Overall Study|Study terminated by Sponsor|0|||
129823781|NCT02927080|467320201|FG004|Overall Study|Study terminated by Sponsor|0|||
129823782|NCT02927080|467320202|FG005|Overall Study|Study terminated by Sponsor|0|||
129823783|NCT02927080|467320203|FG006|Overall Study|Study terminated by Sponsor|6|||
129823784|NCT02927080|467320204|FG007|Overall Study|Study terminated by Sponsor|7|||
129823785|NCT02927080|467320205|FG008|Overall Study|Study terminated by Sponsor|2|||
129823786|NCT02927080|467320206|FG009|Overall Study|Study terminated by Sponsor|3|||
129823787|NCT02927080|467320197|FG000|Overall Study|Adverse Event|0|||
129823788|NCT02927080|467320198|FG001|Overall Study|Adverse Event|1|||
129823789|NCT02927080|467320199|FG002|Overall Study|Adverse Event|0|||
129823790|NCT02927080|467320200|FG003|Overall Study|Adverse Event|0|||
129823791|NCT02927080|467320201|FG004|Overall Study|Adverse Event|0|||
129823792|NCT02927080|467320202|FG005|Overall Study|Adverse Event|0|||
129823793|NCT02927080|467320203|FG006|Overall Study|Adverse Event|0|||
129823794|NCT02927080|467320204|FG007|Overall Study|Adverse Event|1|||
129823795|NCT02927080|467320205|FG008|Overall Study|Adverse Event|0|||
129823796|NCT02927080|467320206|FG009|Overall Study|Adverse Event|1|||
129823797|NCT02927080|467320197|FG000|Overall Study|Other|0|||
129823798|NCT02927080|467320198|FG001|Overall Study|Other|0|||
129823799|NCT02927080|467320199|FG002|Overall Study|Other|0|||
129823800|NCT02927080|467320200|FG003|Overall Study|Other|0|||
129823801|NCT02927080|467320201|FG004|Overall Study|Other|0|||
129823802|NCT02927080|467320202|FG005|Overall Study|Other|0|||
129823803|NCT02927080|467320203|FG006|Overall Study|Other|1|||
129823804|NCT02927080|467320204|FG007|Overall Study|Other|0|||
129823805|NCT02927080|467320205|FG008|Overall Study|Other|1|||
129823806|NCT02927080|467320206|FG009|Overall Study|Other|0|||
129823807|NCT02892760|467320207|FG000|Overall Study|Withdrawal by Subject|3|||
129823808|NCT02259582|467320208|FG000|Overall Study|Physician Decision|0|||
129823809|NCT02259582|467320209|FG001|Overall Study|Physician Decision|1|||
129823810|NCT02259582|467320210|FG002|Overall Study|Physician Decision|0|||
129823811|NCT02259582|467320208|FG000|Overall Study|Death|0|||
129823812|NCT02259582|467320209|FG001|Overall Study|Death|0|||
129823813|NCT02259582|467320210|FG002|Overall Study|Death|1|||
129823814|NCT02259582|467320208|FG000|Overall Study|Adverse Event|1|||
129823815|NCT02259582|467320209|FG001|Overall Study|Adverse Event|0|||
129823816|NCT02259582|467320210|FG002|Overall Study|Adverse Event|1|||
129823817|NCT02259582|467320208|FG000|Overall Study|Withdrawal by Subject|0|||
129823818|NCT02259582|467320209|FG001|Overall Study|Withdrawal by Subject|0|||
129823819|NCT02259582|467320210|FG002|Overall Study|Withdrawal by Subject|1|||
129823820|NCT02259582|467320208|FG000|Overall Study|Disease progression|14|||
129823821|NCT02259582|467320209|FG001|Overall Study|Disease progression|15|||
129823822|NCT02259582|467320210|FG002|Overall Study|Disease progression|17|||
129823823|NCT02259582|467320208|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
129823824|NCT02259582|467320209|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
129823825|NCT02259582|467320210|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
129823826|NCT00531050|467320211|FG000|Part 1: Period 1|Adverse Event|0|||
129823827|NCT00531050|467320212|FG001|Part 1: Period 1|Adverse Event|1|||
129823828|NCT00531050|467320213|FG002|Part 1: Period 1|Adverse Event|0|||
129823829|NCT00531050|467320214|FG003|Part 1: Period 1|Adverse Event|0|||
129823830|NCT00531050|467320215|FG004|Part 1: Period 1|Adverse Event|0|||
129823831|NCT00531050|467320216|FG005|Part 1: Period 1|Adverse Event|0|||
129823832|NCT00531050|467320211|FG000|Part 1: Period 1|Protocol Deviation|0|||
129823833|NCT00531050|467320212|FG001|Part 1: Period 1|Protocol Deviation|0|||
129823834|NCT00531050|467320213|FG002|Part 1: Period 1|Protocol Deviation|0|||
129823835|NCT00531050|467320214|FG003|Part 1: Period 1|Protocol Deviation|1|||
129823836|NCT00531050|467320215|FG004|Part 1: Period 1|Protocol Deviation|0|||
129823837|NCT00531050|467320216|FG005|Part 1: Period 1|Protocol Deviation|0|||
129823838|NCT00531050|467320211|FG000|Part 1: Period 3|Adverse Event|1|||
129823839|NCT00531050|467320212|FG001|Part 1: Period 3|Adverse Event|0|||
129823840|NCT00531050|467320213|FG002|Part 1: Period 3|Adverse Event|0|||
129823841|NCT00531050|467320214|FG003|Part 1: Period 3|Adverse Event|0|||
129823842|NCT00531050|467320215|FG004|Part 1: Period 3|Adverse Event|0|||
129823843|NCT00531050|467320216|FG005|Part 1: Period 3|Adverse Event|0|||
129823844|NCT00531050|467320211|FG000|Part 2: Period 1|Adverse Event|0|||
129823845|NCT00531050|467320212|FG001|Part 2: Period 1|Adverse Event|0|||
129823846|NCT00531050|467320213|FG002|Part 2: Period 1|Adverse Event|0|||
129823847|NCT00531050|467320214|FG003|Part 2: Period 1|Adverse Event|0|||
129823848|NCT00531050|467320215|FG004|Part 2: Period 1|Adverse Event|0|||
129823849|NCT00531050|467320216|FG005|Part 2: Period 1|Adverse Event|1|||
129823850|NCT00531050|467320211|FG000|Part 2: Period 3|Abnormal test procedure|1|||
129823851|NCT00531050|467320212|FG001|Part 2: Period 3|Abnormal test procedure|0|||
129823852|NCT00531050|467320213|FG002|Part 2: Period 3|Abnormal test procedure|0|||
129823853|NCT00531050|467320214|FG003|Part 2: Period 3|Abnormal test procedure|0|||
129823854|NCT00531050|467320215|FG004|Part 2: Period 3|Abnormal test procedure|0|||
129823855|NCT00531050|467320216|FG005|Part 2: Period 3|Abnormal test procedure|1|||
129823856|NCT00475176|467320219|FG000|Overall Study|Adverse Event|2|||
129823857|NCT00475176|467320219|FG000|Overall Study|Withdrawal by Subject|1|||
129823858|NCT00475176|467320219|FG000|Overall Study|Protocol Violation|1|||
129823859|NCT03804879|467320220|FG000|Overall Study|Adverse Event|3|||
129823860|NCT03804879|467320221|FG001|Overall Study|Adverse Event|0|||
129823861|NCT03804879|467320220|FG000|Overall Study|Study Terminated By Sponsor|10|||
129823862|NCT03804879|467320221|FG001|Overall Study|Study Terminated By Sponsor|12|||
129823863|NCT03804879|467320220|FG000|Overall Study|Withdrawal by Subject|3|||
129823864|NCT03804879|467320221|FG001|Overall Study|Withdrawal by Subject|1|||
129823865|NCT01585428|467320222|FG000|Overall Study|Death during treatment|1|||
129823866|NCT01585428|467320223|FG001|Overall Study|Death during treatment|0|||
129823867|NCT04273217|467320225|FG000|Overall Study|Lost to Follow-up|0|||
129823868|NCT04273217|467320226|FG001|Overall Study|Lost to Follow-up|0|||
129823869|NCT04273217|467320227|FG002|Overall Study|Lost to Follow-up|0|||
129823870|NCT04273217|467320228|FG003|Overall Study|Lost to Follow-up|0|||
129823871|NCT04273217|467320229|FG004|Overall Study|Lost to Follow-up|0|||
129823872|NCT04273217|467320230|FG005|Overall Study|Lost to Follow-up|1|||
129823873|NCT04273217|467320225|FG000|Overall Study|Participant non-compliance|0|||
129823874|NCT04273217|467320226|FG001|Overall Study|Participant non-compliance|0|||
129823875|NCT04273217|467320227|FG002|Overall Study|Participant non-compliance|0|||
129823876|NCT04273217|467320228|FG003|Overall Study|Participant non-compliance|0|||
129823877|NCT04273217|467320229|FG004|Overall Study|Participant non-compliance|1|||
129823878|NCT04273217|467320230|FG005|Overall Study|Participant non-compliance|0|||
129823879|NCT04273217|467320225|FG000|Overall Study|Positive urine drug screen|1|||
129823880|NCT04273217|467320226|FG001|Overall Study|Positive urine drug screen|0|||
129823881|NCT04273217|467320227|FG002|Overall Study|Positive urine drug screen|1|||
129823882|NCT04273217|467320228|FG003|Overall Study|Positive urine drug screen|0|||
129823883|NCT04273217|467320229|FG004|Overall Study|Positive urine drug screen|0|||
129823884|NCT04273217|467320230|FG005|Overall Study|Positive urine drug screen|1|||
129823885|NCT01988103|467320231|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
129823886|NCT01988103|467320232|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
129823887|NCT01988103|467320233|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
129823888|NCT01988103|467320234|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
129823889|NCT01988103|467320235|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
129823890|NCT01988103|467320231|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
129823891|NCT01988103|467320232|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
129823892|NCT01988103|467320233|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
129823893|NCT01988103|467320234|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
129823894|NCT01988103|467320235|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
129823895|NCT01988103|467320231|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
129823896|NCT01988103|467320232|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
129823897|NCT01988103|467320233|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
129823898|NCT01988103|467320234|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129823899|NCT01988103|467320235|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
129823900|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
129823901|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
129823902|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
129823903|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
129823904|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
129823905|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
129823906|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
129823907|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
129823908|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
129823909|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
129823910|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
129823911|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
129823912|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
129823913|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
129823914|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
129823915|NCT01988103|467320231|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
129823916|NCT01988103|467320232|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
129823917|NCT01988103|467320233|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
129823918|NCT01988103|467320234|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
129823919|NCT01988103|467320235|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
129823920|NCT00311623|467320242|FG000|Overall Study|Physician Decision|0|||
129823921|NCT00311623|467320243|FG001|Overall Study|Physician Decision|0|||
129823922|NCT00311623|467320244|FG002|Overall Study|Physician Decision|2|||
129823923|NCT03998189|467320245|FG000|Overall Study|Lack of Efficacy|0|||
129823924|NCT03998189|467320246|FG001|Overall Study|Lack of Efficacy|1|||
129823925|NCT03414424|467320247|FG000|Overall Study|Screened out after consent|0|||
129823926|NCT03414424|467320248|FG001|Overall Study|Screened out after consent|2|||
129823927|NCT03414424|467320247|FG000|Overall Study|Lost to Follow-up|0|||
129823928|NCT03414424|467320248|FG001|Overall Study|Lost to Follow-up|1|||
129823929|NCT01949051|467320254|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
129823930|NCT01949051|467320255|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823931|NCT01949051|467320256|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823932|NCT01949051|467320257|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
129823933|NCT01949051|467320258|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823934|NCT01949051|467320259|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
129823935|NCT01949051|467320254|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
129823936|NCT01949051|467320255|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823937|NCT01949051|467320256|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823938|NCT01949051|467320257|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823939|NCT01949051|467320258|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823940|NCT01949051|467320259|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
129823941|NCT01949051|467320254|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823942|NCT01949051|467320255|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823943|NCT01949051|467320256|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823944|NCT01949051|467320257|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823945|NCT01949051|467320258|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
129823946|NCT01949051|467320259|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
129823947|NCT01949051|467320254|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823948|NCT01949051|467320255|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
129823949|NCT01949051|467320256|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823950|NCT01949051|467320257|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823951|NCT01949051|467320258|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823952|NCT01949051|467320259|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
129823953|NCT01949051|467320254|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823954|NCT01949051|467320255|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823955|NCT01949051|467320256|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
129823956|NCT01949051|467320257|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823957|NCT01949051|467320258|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823958|NCT01949051|467320259|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
129823959|NCT02611778|467320261|FG000|Overall Study|Withdrawal by Subject|2|||
129823960|NCT02611778|467320262|FG001|Overall Study|Withdrawal by Subject|8|||
129823961|NCT02611778|467320261|FG000|Overall Study|Adverse Event|1|||
129823962|NCT02611778|467320262|FG001|Overall Study|Adverse Event|2|||
129823963|NCT02611778|467320261|FG000|Overall Study|Death|2|||
129823964|NCT02611778|467320262|FG001|Overall Study|Death|1|||
129823965|NCT02611778|467320261|FG000|Overall Study|Protocol Violation|1|||
129823966|NCT02611778|467320262|FG001|Overall Study|Protocol Violation|0|||
129823967|NCT02611778|467320261|FG000|Overall Study|Lost to Follow-up|3|||
129823968|NCT02611778|467320262|FG001|Overall Study|Lost to Follow-up|1|||
129823969|NCT02611778|467320261|FG000|Overall Study|Need for alternative treatment|1|||
129823970|NCT02611778|467320262|FG001|Overall Study|Need for alternative treatment|0|||
129823971|NCT02611778|467320261|FG000|Overall Study|Other Reason|2|||
129823972|NCT02611778|467320262|FG001|Overall Study|Other Reason|1|||
129823973|NCT02956486|467320277|FG000|Core Phase|Adverse Event|51|||
129823974|NCT02956486|467320278|FG001|Core Phase|Adverse Event|88|||
129823975|NCT02956486|467320279|FG002|Core Phase|Adverse Event|0|||
129823976|NCT02956486|467320277|FG000|Core Phase|Lost to Follow-up|8|||
129823977|NCT02956486|467320278|FG001|Core Phase|Lost to Follow-up|6|||
129823978|NCT02956486|467320279|FG002|Core Phase|Lost to Follow-up|0|||
129823979|NCT02956486|467320277|FG000|Core Phase|Inadequate therapeutic effect|4|||
129823980|NCT02956486|467320278|FG001|Core Phase|Inadequate therapeutic effect|5|||
129823981|NCT02956486|467320279|FG002|Core Phase|Inadequate therapeutic effect|0|||
129823982|NCT02956486|467320277|FG000|Core Phase|Withdrawal by Subject|101|||
129823983|NCT02956486|467320278|FG001|Core Phase|Withdrawal by Subject|104|||
129823984|NCT02956486|467320279|FG002|Core Phase|Withdrawal by Subject|0|||
129823985|NCT02956486|467320277|FG000|Core Phase|Study terminated by sponsor|888|||
129823986|NCT02956486|467320278|FG001|Core Phase|Study terminated by sponsor|848|||
129823987|NCT02956486|467320279|FG002|Core Phase|Study terminated by sponsor|0|||
129823988|NCT02956486|467320277|FG000|Core Phase|Other|27|||
129823989|NCT02956486|467320278|FG001|Core Phase|Other|18|||
129823990|NCT02956486|467320279|FG002|Core Phase|Other|0|||
129823991|NCT02956486|467320277|FG000|Core Phase|Not treated|0|||
129823992|NCT02956486|467320278|FG001|Core Phase|Not treated|3|||
129823993|NCT02956486|467320279|FG002|Core Phase|Not treated|0|||
129823994|NCT02956486|467320277|FG000|Extension Phase|Adverse Event|0|||
129823995|NCT02956486|467320278|FG001|Extension Phase|Adverse Event|0|||
129823996|NCT02956486|467320279|FG002|Extension Phase|Adverse Event|2|||
129823997|NCT02956486|467320277|FG000|Extension Phase|Study terminated by sponsor|0|||
129823998|NCT02956486|467320278|FG001|Extension Phase|Study terminated by sponsor|0|||
129823999|NCT02956486|467320279|FG002|Extension Phase|Study terminated by sponsor|16|||
129824000|NCT02956486|467320277|FG000|Extension Phase|Not Treated|0|||
129824001|NCT02956486|467320278|FG001|Extension Phase|Not Treated|0|||
129824002|NCT02956486|467320279|FG002|Extension Phase|Not Treated|1|||
129824003|NCT03325075|467320282|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
129824004|NCT03325075|467320283|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
129824005|NCT03325075|467320284|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
129824006|NCT03325075|467320285|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
129824007|NCT03325075|467320282|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129824008|NCT03325075|467320283|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
129824009|NCT03325075|467320284|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129824010|NCT03325075|467320285|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
129824011|NCT03325075|467320282|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
129824012|NCT03325075|467320283|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
129824013|NCT03325075|467320284|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
129824014|NCT03325075|467320285|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
129824015|NCT00422591|467320286|FG000|Overall Study|Physician Decision|4|||
129824016|NCT00422591|467320286|FG000|Overall Study|Withdrawal by Subject|2|||
129824017|NCT01408914|467320289|FG000|Overall Study|Could not complete tx in protocol period|5|||
129824018|NCT01408914|467320290|FG001|Overall Study|Could not complete tx in protocol period|5|||
129824019|NCT01408914|467320291|FG002|Overall Study|Could not complete tx in protocol period|6|||
129824020|NCT01408914|467320289|FG000|Overall Study|Lost to Follow-up|4|||
129824021|NCT01408914|467320290|FG001|Overall Study|Lost to Follow-up|1|||
129824022|NCT01408914|467320291|FG002|Overall Study|Lost to Follow-up|2|||
129824023|NCT01408914|467320289|FG000|Overall Study|Physician Decision|1|||
129824024|NCT01408914|467320290|FG001|Overall Study|Physician Decision|1|||
129824025|NCT01408914|467320291|FG002|Overall Study|Physician Decision|0|||
129824026|NCT01408914|467320289|FG000|Overall Study|Withdrawal by Subject|1|||
129824027|NCT01408914|467320290|FG001|Overall Study|Withdrawal by Subject|0|||
129824028|NCT01408914|467320291|FG002|Overall Study|Withdrawal by Subject|1|||
129824029|NCT01408914|467320289|FG000|Overall Study|Moved out of study jurisdiction|1|||
129824030|NCT01408914|467320290|FG001|Overall Study|Moved out of study jurisdiction|1|||
129824031|NCT01408914|467320291|FG002|Overall Study|Moved out of study jurisdiction|0|||
129824032|NCT01408914|467320289|FG000|Overall Study|Late exclusion|0|||
129824033|NCT01408914|467320290|FG001|Overall Study|Late exclusion|3|||
129824034|NCT01408914|467320291|FG002|Overall Study|Late exclusion|3|||
129824035|NCT01408914|467320289|FG000|Overall Study|Change in local TB/HIV norms|0|||
129824036|NCT01408914|467320290|FG001|Overall Study|Change in local TB/HIV norms|1|||
129824037|NCT01408914|467320291|FG002|Overall Study|Change in local TB/HIV norms|1|||
129824038|NCT00330616|467320294|FG000|Overall Study|Adverse Event|13|||
129824039|NCT00330616|467320294|FG000|Overall Study|Lack of Efficacy|1|||
129824040|NCT00330616|467320294|FG000|Overall Study|Lost to Follow-up|2|||
129824041|NCT00330616|467320294|FG000|Overall Study|Withdrawal by Subject|4|||
129824042|NCT00330616|467320294|FG000|Overall Study|Other|1|||
129824043|NCT00811473|467320295|FG000|Overall Study|Adverse Event|3|||
129824044|NCT00811473|467320296|FG001|Overall Study|Adverse Event|12|||
129824045|NCT00811473|467320295|FG000|Overall Study|Lost to Follow-up|5|||
129824046|NCT00811473|467320296|FG001|Overall Study|Lost to Follow-up|1|||
129824047|NCT00811473|467320295|FG000|Overall Study|Withdrawal by Subject|2|||
129824048|NCT00811473|467320296|FG001|Overall Study|Withdrawal by Subject|4|||
129824049|NCT00811473|467320295|FG000|Overall Study|Severe non-compliance to protocol|2|||
129824050|NCT00811473|467320296|FG001|Overall Study|Severe non-compliance to protocol|4|||
129824051|NCT00811473|467320295|FG000|Overall Study|Lack of therapeutic response|4|||
129824052|NCT00811473|467320296|FG001|Overall Study|Lack of therapeutic response|1|||
129824053|NCT00811473|467320295|FG000|Overall Study|Condition under investigation worsened|1|||
129824054|NCT00811473|467320296|FG001|Overall Study|Condition under investigation worsened|3|||
129824055|NCT00811473|467320295|FG000|Overall Study|Other 2|4|||
129824056|NCT00811473|467320296|FG001|Overall Study|Other 2|1|||
129824057|NCT00811473|467320295|FG000|Overall Study|Incorrect Enrollment|1|||
129824058|NCT00811473|467320296|FG001|Overall Study|Incorrect Enrollment|0|||
129824059|NCT00811473|467320295|FG000|Overall Study|Safety Reasons|1|||
129824060|NCT00811473|467320296|FG001|Overall Study|Safety Reasons|0|||
129824061|NCT00667368|467320304|FG000|Overall Study|Lost to Follow-up|176|||
129824062|NCT00667368|467320305|FG001|Overall Study|Lost to Follow-up|155|||
129824063|NCT00667368|467320304|FG000|Overall Study|Discontinued early|24|||
129824064|NCT00667368|467320305|FG001|Overall Study|Discontinued early|17|||
129824065|NCT01585194|467320308|FG000|Overall Study|Withdrawal by Subject|1|||
129824066|NCT01585194|467320308|FG000|Overall Study|Physician Decision|2|||
129824067|NCT01585194|467320308|FG000|Overall Study|Lack of insurance|1|||
129824068|NCT00732615|467320309|FG000|Overall Study|Withdrawal by Subject|3|||
129824069|NCT00732615|467320310|FG001|Overall Study|Withdrawal by Subject|1|||
129824070|NCT00732615|467320309|FG000|Overall Study|Lost to Follow-up|0|||
129824071|NCT00732615|467320310|FG001|Overall Study|Lost to Follow-up|1|||
129824072|NCT00732615|467320309|FG000|Overall Study|Adverse Event|0|||
129824073|NCT00732615|467320310|FG001|Overall Study|Adverse Event|2|||
129824074|NCT00732615|467320309|FG000|Overall Study|Physician Decision|3|||
129824075|NCT00732615|467320310|FG001|Overall Study|Physician Decision|0|||
129824076|NCT00732615|467320309|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
129824077|NCT00732615|467320310|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
129824078|NCT03566823|467320311|FG000|Overall Study|Lack of Efficacy|0|||
129824079|NCT03566823|467320312|FG001|Overall Study|Lack of Efficacy|1|||
129824080|NCT03566823|467320313|FG002|Overall Study|Lack of Efficacy|0|||
129824081|NCT03566823|467320311|FG000|Overall Study|Withdrawal by Subject|1|||
129824082|NCT03566823|467320312|FG001|Overall Study|Withdrawal by Subject|2|||
129824083|NCT03566823|467320313|FG002|Overall Study|Withdrawal by Subject|0|||
129824084|NCT03566823|467320311|FG000|Overall Study|Adverse Event|1|||
129824085|NCT03566823|467320312|FG001|Overall Study|Adverse Event|0|||
129824086|NCT03566823|467320313|FG002|Overall Study|Adverse Event|2|||
129824087|NCT02733367|467320314|FG000|Overall Study|Withdrawal by Subject|6|||
129824088|NCT00191789|467320317|FG000|Overall Study|Adverse Event|5|||
129824089|NCT00191789|467320317|FG000|Overall Study|Patient: Satisfactory Response|5|||
129824090|NCT00191789|467320317|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
129824091|NCT00191789|467320317|FG000|Overall Study|Withdrawal by Subject|4|||
129824092|NCT00191789|467320317|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
129824093|NCT00191789|467320317|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
129824094|NCT00191789|467320317|FG000|Overall Study|Death - Not Study-Drug Related|1|||
129824095|NCT01922089|467320320|FG000|Overall Study|Adverse Event|18|||
129824096|NCT01922089|467320321|FG001|Overall Study|Adverse Event|13|||
129824097|NCT01922089|467320320|FG000|Overall Study|Protocol Deviation|10|||
129824098|NCT01922089|467320321|FG001|Overall Study|Protocol Deviation|7|||
129824099|NCT01922089|467320320|FG000|Overall Study|Withdrawal by Subject|3|||
129824100|NCT01922089|467320321|FG001|Overall Study|Withdrawal by Subject|4|||
129824101|NCT01922089|467320320|FG000|Overall Study|administrative problems|4|||
129824102|NCT01922089|467320321|FG001|Overall Study|administrative problems|1|||
129824103|NCT01922089|467320320|FG000|Overall Study|Physician Decision|2|||
129824104|NCT01922089|467320321|FG001|Overall Study|Physician Decision|3|||
129824105|NCT01922089|467320320|FG000|Overall Study|Death|2|||
129824106|NCT01922089|467320321|FG001|Overall Study|Death|1|||
129824107|NCT01922089|467320320|FG000|Overall Study|Lost to Follow-up|0|||
129824108|NCT01922089|467320321|FG001|Overall Study|Lost to Follow-up|1|||
129824109|NCT04903626|467320325|FG000|Overall Study|Lost to Follow-up|6|||
129824110|NCT04903626|467320325|FG000|Overall Study|Withdrawal by Subject|1|||
129824111|NCT04903626|467320325|FG000|Overall Study|Other, Not Specified|1|||
129824112|NCT00165776|467320329|FG000|Overall Study|Lack of Efficacy|0|||
129824113|NCT00165776|467320330|FG001|Overall Study|Lack of Efficacy|0|||
129824114|NCT00165776|467320331|FG002|Overall Study|Lack of Efficacy|0|||
129824115|NCT00165776|467320332|FG003|Overall Study|Lack of Efficacy|1|||
129824116|NCT00165776|467320329|FG000|Overall Study|Withdrawal by Subject|4|||
129824117|NCT00165776|467320330|FG001|Overall Study|Withdrawal by Subject|1|||
129824118|NCT00165776|467320331|FG002|Overall Study|Withdrawal by Subject|2|||
129824119|NCT00165776|467320332|FG003|Overall Study|Withdrawal by Subject|0|||
129824120|NCT00165776|467320329|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
129824121|NCT00165776|467320330|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
129824122|NCT00165776|467320331|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
129824123|NCT00165776|467320332|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
129824124|NCT01850524|467320341|FG000|Overall Study|Lost to Follow-up|5|||
129824125|NCT01850524|467320342|FG001|Overall Study|Lost to Follow-up|10|||
129824126|NCT01850524|467320341|FG000|Overall Study|Withdrawal by Subject|24|||
129824127|NCT01850524|467320342|FG001|Overall Study|Withdrawal by Subject|22|||
129824128|NCT01850524|467320341|FG000|Overall Study|Reason not Specified|142|||
129824129|NCT01850524|467320342|FG001|Overall Study|Reason not Specified|141|||
129824130|NCT00368355|467320343|FG000|Overall Study|Adverse Event|1|||
129824131|NCT00368355|467320344|FG001|Overall Study|Adverse Event|0|||
129824132|NCT00368355|467320343|FG000|Overall Study|Death|2|||
129824133|NCT00368355|467320344|FG001|Overall Study|Death|4|||
129824134|NCT00368355|467320343|FG000|Overall Study|Relapse|6|||
129824135|NCT00368355|467320344|FG001|Overall Study|Relapse|10|||
129824136|NCT00368355|467320343|FG000|Overall Study|Subsequent transplant|0|||
129824137|NCT00368355|467320344|FG001|Overall Study|Subsequent transplant|3|||
129824138|NCT00368355|467320343|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
129824139|NCT00368355|467320344|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
129824140|NCT00396591|467320349|FG000|Overall Study|Disease Progression|13|||
129824141|NCT00396591|467320349|FG000|Overall Study|Adverse Event|2|||
129824142|NCT00396591|467320349|FG000|Overall Study|Participant request|1|||
129824143|NCT01013701|467320350|FG000|Overall Study|study prematurely terminated|7|||
129824144|NCT02671422|467320353|FG000|Overall Study|Lost to Follow-up|1|||
129824145|NCT02671422|467320353|FG000|Overall Study|Adverse Event|68|||
129824146|NCT02671422|467320353|FG000|Overall Study|Lack of Efficacy|1|||
129824147|NCT02671422|467320353|FG000|Overall Study|Lost to Follow-up|4|||
129824148|NCT02671422|467320353|FG000|Overall Study|Withdrawal by Subject|7|||
129824149|NCT02671422|467320353|FG000|Overall Study|Progressive Disease|156|||
129824150|NCT02671422|467320353|FG000|Overall Study|Worsening of Disease|4|||
129824151|NCT02671422|467320353|FG000|Overall Study|Sponsor decision|5|||
129824152|NCT02671422|467320353|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
129824153|NCT02671422|467320353|FG000|Overall Study|Not treated with Vargatef®|3|||
129824154|NCT02671422|467320353|FG000|Overall Study|Other not defined above|3|||
129824155|NCT04772755|467320354|FG000|Overall Study|Withdrawal by Subject|1|||
129824156|NCT04772755|467320355|FG001|Overall Study|Withdrawal by Subject|0|||
129824157|NCT04772755|467320354|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
129824158|NCT04772755|467320355|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
129824159|NCT01905657|467320356|FG000|Overall Study|Adverse Event|23|||
129824160|NCT01905657|467320357|FG001|Overall Study|Adverse Event|17|||
129824161|NCT01905657|467320358|FG002|Overall Study|Adverse Event|18|||
129824162|NCT01905657|467320356|FG000|Overall Study|Clinical Progression|103|||
129824163|NCT01905657|467320357|FG001|Overall Study|Clinical Progression|78|||
129824164|NCT01905657|467320358|FG002|Overall Study|Clinical Progression|59|||
129824165|NCT01905657|467320356|FG000|Overall Study|Death|40|||
129824166|NCT01905657|467320357|FG001|Overall Study|Death|43|||
129824167|NCT01905657|467320358|FG002|Overall Study|Death|47|||
129824168|NCT01905657|467320356|FG000|Overall Study|Excluded Medication|13|||
129824169|NCT01905657|467320357|FG001|Overall Study|Excluded Medication|16|||
129824170|NCT01905657|467320358|FG002|Overall Study|Excluded Medication|9|||
129824171|NCT01905657|467320356|FG000|Overall Study|Lost to Follow-up|1|||
129824172|NCT01905657|467320357|FG001|Overall Study|Lost to Follow-up|2|||
129824173|NCT01905657|467320358|FG002|Overall Study|Lost to Follow-up|1|||
129824174|NCT01905657|467320356|FG000|Overall Study|Physician Decision|5|||
129824175|NCT01905657|467320357|FG001|Overall Study|Physician Decision|8|||
129824176|NCT01905657|467320358|FG002|Overall Study|Physician Decision|12|||
129824177|NCT01905657|467320356|FG000|Overall Study|Protocol Violation|2|||
129824178|NCT01905657|467320357|FG001|Overall Study|Protocol Violation|1|||
129824179|NCT01905657|467320358|FG002|Overall Study|Protocol Violation|1|||
129824180|NCT01905657|467320356|FG000|Overall Study|Screen Failure|0|||
129824181|NCT01905657|467320357|FG001|Overall Study|Screen Failure|1|||
129824182|NCT01905657|467320358|FG002|Overall Study|Screen Failure|0|||
129824183|NCT01905657|467320356|FG000|Overall Study|Withdrawal by Subject|15|||
129824184|NCT01905657|467320357|FG001|Overall Study|Withdrawal by Subject|21|||
129824185|NCT01905657|467320358|FG002|Overall Study|Withdrawal by Subject|53|||
129824186|NCT01905657|467320356|FG000|Overall Study|Sponsor Decision|1|||
129824187|NCT01905657|467320357|FG001|Overall Study|Sponsor Decision|0|||
129824188|NCT01905657|467320358|FG002|Overall Study|Sponsor Decision|0|||
129824189|NCT04702997|467320359|FG000|Overall Study|Withdrawal by Subject|1|||
129824190|NCT04702997|467320360|FG001|Overall Study|Withdrawal by Subject|1|||
129824191|NCT01386554|467320365|FG000|Overall Study|Lost to Follow-up|0|||
129824192|NCT01386554|467320366|FG001|Overall Study|Lost to Follow-up|0|||
129824193|NCT01386554|467320367|FG002|Overall Study|Lost to Follow-up|1|||
129824194|NCT01386554|467320365|FG000|Overall Study|Adverse Event|2|||
129824195|NCT01386554|467320366|FG001|Overall Study|Adverse Event|5|||
129824196|NCT01386554|467320367|FG002|Overall Study|Adverse Event|2|||
129824197|NCT01386554|467320365|FG000|Overall Study|Progressive disease|1|||
129824198|NCT01386554|467320366|FG001|Overall Study|Progressive disease|2|||
129824199|NCT01386554|467320367|FG002|Overall Study|Progressive disease|2|||
129824200|NCT01386554|467320365|FG000|Overall Study|Administration of live vaccines|0|||
129824201|NCT01386554|467320366|FG001|Overall Study|Administration of live vaccines|1|||
129824202|NCT01386554|467320367|FG002|Overall Study|Administration of live vaccines|0|||
129824203|NCT01386554|467320365|FG000|Overall Study|Investigator discretion|0|||
129824204|NCT01386554|467320366|FG001|Overall Study|Investigator discretion|0|||
129824205|NCT01386554|467320367|FG002|Overall Study|Investigator discretion|1|||
129824206|NCT01386554|467320365|FG000|Overall Study|Reason not collected|0|||
129824207|NCT01386554|467320366|FG001|Overall Study|Reason not collected|1|||
129824208|NCT01386554|467320367|FG002|Overall Study|Reason not collected|0|||
129824209|NCT02879305|467320369|FG000|Overall Study|Investigator Site Closed|55|||
129824210|NCT02879305|467320370|FG001|Overall Study|Investigator Site Closed|57|||
129824211|NCT02879305|467320369|FG000|Overall Study|Withdrawal by Subject|44|||
129824212|NCT02879305|467320370|FG001|Overall Study|Withdrawal by Subject|42|||
129824213|NCT02879305|467320369|FG000|Overall Study|Lost to Follow-up|17|||
129824214|NCT02879305|467320370|FG001|Overall Study|Lost to Follow-up|12|||
129824215|NCT02879305|467320369|FG000|Overall Study|Other|1|||
129824216|NCT02879305|467320370|FG001|Overall Study|Other|0|||
129824217|NCT00001596|467322311|FG000|Overall Study|Death|1|||
129824218|NCT00001596|467322312|FG001|Overall Study|Death|0|||
129824219|NCT00001596|467322311|FG000|Overall Study|Withdrawal by Subject|3|||
129824220|NCT00001596|467322312|FG001|Overall Study|Withdrawal by Subject|1|||
129824221|NCT00001596|467322311|FG000|Overall Study|Study Termination|12|||
129824222|NCT00001596|467322312|FG001|Overall Study|Study Termination|9|||
129824223|NCT00001596|467322311|FG000|Overall Study|Adverse Event|1|||
129824224|NCT00001596|467322312|FG001|Overall Study|Adverse Event|0|||
129824225|NCT00463346|467322313|FG000|Overall Study|Withdrawal by Subject|3|||
129824226|NCT00463346|467322314|FG001|Overall Study|Withdrawal by Subject|3|||
129824227|NCT04067544|467322317|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
129824228|NCT02282020|467322320|FG000|Overall Study|Objective Disease Progression|128|||
129824229|NCT02282020|467322321|FG001|Overall Study|Objective Disease Progression|30|||
129824230|NCT02282020|467322320|FG000|Overall Study|Adverse Event|18|||
129824231|NCT02282020|467322321|FG001|Overall Study|Adverse Event|15|||
129824232|NCT02282020|467322320|FG000|Overall Study|Withdrawal by Subject|7|||
129824233|NCT02282020|467322321|FG001|Overall Study|Withdrawal by Subject|10|||
129824234|NCT02282020|467322320|FG000|Overall Study|Miscellaneous|5|||
129824235|NCT02282020|467322321|FG001|Overall Study|Miscellaneous|19|||
129824236|NCT02282020|467322320|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
129824237|NCT02282020|467322321|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
129824238|NCT02282020|467322320|FG000|Overall Study|Developed Discontinuation Criteria|0|||
129824239|NCT02282020|467322321|FG001|Overall Study|Developed Discontinuation Criteria|2|||
129824240|NCT02282020|467322320|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
129824241|NCT02282020|467322321|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
129824242|NCT00082355|467322322|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
129824243|NCT00082355|467322322|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
129824244|NCT00082355|467322322|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
129824245|NCT00759863|467322324|FG000|Overall Study|Death, moved, or lost contact|20|||
129824246|NCT00759863|467322325|FG001|Overall Study|Death, moved, or lost contact|18|||
129824247|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
129824248|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
129824249|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
129824250|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
129824251|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
129824252|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
129824253|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
129824254|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
129824255|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Other|4|||
129824256|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Other|1|||
129824257|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
129824258|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
129824259|NCT00303498|467322333|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
129824260|NCT00303498|467322334|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
129824261|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
129824262|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
129824263|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Death|1|||
129824264|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Death|0|||
129824265|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
129824266|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
129824267|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
129824268|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
129824269|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
129824270|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
129824271|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
129824272|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
129824273|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Other|1|||
129824274|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Other|0|||
129824275|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
129824276|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
129824277|NCT00303498|467322333|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
129824278|NCT00303498|467322334|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
129824279|NCT00460031|467322335|FG000|Overall Study|Adverse Event|5|||
129824280|NCT00460031|467322335|FG000|Overall Study|Withdrawal by Subject|5|||
129824281|NCT00460031|467322335|FG000|Overall Study|Death|1|||
129824282|NCT04532099|467322336|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
129824283|NCT04532099|467322337|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
129824284|NCT04532099|467322338|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
129824285|NCT00644995|467322348|FG000|Overall Study|Lost to Follow-up|1|||
129824286|NCT00644995|467322349|FG001|Overall Study|Lost to Follow-up|4|||
129824287|NCT00644995|467322348|FG000|Overall Study|Refused|1|||
129824288|NCT00644995|467322349|FG001|Overall Study|Refused|0|||
129824289|NCT02066233|467322355|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
129824290|NCT02066233|467322356|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
129824291|NCT00103142|467322357|FG000|Overall Study|Adverse Event|1|||
129824292|NCT00103142|467322358|FG001|Overall Study|Adverse Event|0|||
129824293|NCT00103142|467322357|FG000|Overall Study|Progression of disease|2|||
129824294|NCT00103142|467322358|FG001|Overall Study|Progression of disease|1|||
129824295|NCT02772081|467322359|FG000|Overall Study|Physician Decision|1|||
129824296|NCT02772081|467322360|FG001|Overall Study|Physician Decision|1|||
129824297|NCT02772081|467322359|FG000|Overall Study|Death|1|||
129824298|NCT02772081|467322360|FG001|Overall Study|Death|1|||
129824299|NCT02598076|467322361|FG000|Overall Study|Lost to Follow-up|2|||
129824300|NCT02598076|467322362|FG001|Overall Study|Lost to Follow-up|3|||
129824301|NCT01946425|467322363|FG000|Overall Study|Protocol Violation|1|||
129824302|NCT01946425|467322364|FG001|Overall Study|Protocol Violation|0|||
129824303|NCT01946425|467322363|FG000|Overall Study|Withdrawal by Subject|1|||
129824304|NCT01946425|467322364|FG001|Overall Study|Withdrawal by Subject|0|||
129824305|NCT03227029|467322365|FG000|Overall Study|Child Wheezed (no treatment)|0|||
129824306|NCT03227029|467322366|FG001|Overall Study|Child Wheezed (no treatment)|1|||
129824307|NCT03227029|467322367|FG002|Overall Study|Child Wheezed (no treatment)|0|||
129824308|NCT03227029|467322365|FG000|Overall Study|No post RSV season visit due to COVID|3|||
129824309|NCT03227029|467322366|FG001|Overall Study|No post RSV season visit due to COVID|3|||
129824310|NCT03227029|467322367|FG002|Overall Study|No post RSV season visit due to COVID|2|||
129824311|NCT03227029|467322365|FG000|Overall Study|Not able to get to clinic|0|||
129824312|NCT03227029|467322366|FG001|Overall Study|Not able to get to clinic|0|||
129824313|NCT03227029|467322367|FG002|Overall Study|Not able to get to clinic|1|||
129824314|NCT03227029|467322365|FG000|Overall Study|Withdrawal by Subject|1|||
129824315|NCT03227029|467322366|FG001|Overall Study|Withdrawal by Subject|0|||
129824316|NCT03227029|467322367|FG002|Overall Study|Withdrawal by Subject|0|||
129824317|NCT03227029|467322365|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
129824318|NCT03227029|467322366|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
129824319|NCT03227029|467322367|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
129824320|NCT00390858|467322368|FG000|Overall Study|Adverse Event|6|||
129824321|NCT00390858|467322369|FG001|Overall Study|Adverse Event|2|||
129824322|NCT00390858|467322368|FG000|Overall Study|Lack of Efficacy|0|||
129824323|NCT00390858|467322369|FG001|Overall Study|Lack of Efficacy|1|||
129824324|NCT00390858|467322368|FG000|Overall Study|Withdrawal by Subject|3|||
129824325|NCT00390858|467322369|FG001|Overall Study|Withdrawal by Subject|4|||
129824326|NCT01113801|467322370|FG000|Overall Study|Adverse Event|4|||
129824327|NCT01113801|467322371|FG001|Overall Study|Adverse Event|0|||
129824328|NCT01113801|467322372|FG002|Overall Study|Adverse Event|2|||
129824329|NCT01113801|467322373|FG003|Overall Study|Adverse Event|6|||
129824330|NCT01113801|467322370|FG000|Overall Study|Death|4|||
129824331|NCT01113801|467322371|FG001|Overall Study|Death|5|||
129824332|NCT01113801|467322372|FG002|Overall Study|Death|3|||
129824333|NCT01113801|467322373|FG003|Overall Study|Death|4|||
129824334|NCT01113801|467322370|FG000|Overall Study|Protocol Violation|0|||
129824335|NCT01113801|467322371|FG001|Overall Study|Protocol Violation|1|||
129824336|NCT01113801|467322372|FG002|Overall Study|Protocol Violation|0|||
129824337|NCT01113801|467322373|FG003|Overall Study|Protocol Violation|0|||
129445690|NCT01968070|465932875|FG000|Period 1|Physician Decision|0|||
129824338|NCT01113801|467322370|FG000|Overall Study|Withdrawal by Subject|9|||
129824339|NCT01113801|467322371|FG001|Overall Study|Withdrawal by Subject|7|||
129824340|NCT01113801|467322372|FG002|Overall Study|Withdrawal by Subject|7|||
129824341|NCT01113801|467322373|FG003|Overall Study|Withdrawal by Subject|8|||
129824342|NCT01113801|467322370|FG000|Overall Study|Physician Decision|2|||
129824343|NCT01113801|467322371|FG001|Overall Study|Physician Decision|2|||
129824344|NCT01113801|467322372|FG002|Overall Study|Physician Decision|3|||
129824345|NCT01113801|467322373|FG003|Overall Study|Physician Decision|3|||
129824346|NCT01113801|467322370|FG000|Overall Study|Sponsor Decision|15|||
129824347|NCT01113801|467322371|FG001|Overall Study|Sponsor Decision|21|||
129824348|NCT01113801|467322372|FG002|Overall Study|Sponsor Decision|20|||
129824349|NCT01113801|467322373|FG003|Overall Study|Sponsor Decision|15|||
129824350|NCT01113801|467322370|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
129824351|NCT01113801|467322371|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
129824352|NCT01113801|467322372|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
129824353|NCT01113801|467322373|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
129824354|NCT01506479|467322374|FG000|Overall Study|Lost to Follow-up|1|||
129824355|NCT01506479|467322375|FG001|Overall Study|Lost to Follow-up|2|||
129824356|NCT01506479|467322376|FG002|Overall Study|Lost to Follow-up|2|||
129824357|NCT01506479|467322374|FG000|Overall Study|Withdrawal by Subject|1|||
129824358|NCT01506479|467322375|FG001|Overall Study|Withdrawal by Subject|2|||
129824359|NCT01506479|467322376|FG002|Overall Study|Withdrawal by Subject|1|||
129824360|NCT01506479|467322374|FG000|Overall Study|Missing assessment|1|||
129824361|NCT01506479|467322375|FG001|Overall Study|Missing assessment|0|||
129824362|NCT01506479|467322376|FG002|Overall Study|Missing assessment|0|||
129824363|NCT01506479|467322374|FG000|Overall Study|Adverse Event|0|||
129824364|NCT01506479|467322375|FG001|Overall Study|Adverse Event|1|||
129824365|NCT01506479|467322376|FG002|Overall Study|Adverse Event|0|||
129824366|NCT01782859|467322377|FG000|Overall Study|Protocol Violation|6|||
129824367|NCT01782859|467322378|FG001|Overall Study|Protocol Violation|6|||
129824368|NCT01782859|467322377|FG000|Overall Study|Withdrawal by Subject|0|||
129824369|NCT01782859|467322378|FG001|Overall Study|Withdrawal by Subject|1|||
129824370|NCT03318315|467322381|FG000|Overall Study|Lost to Follow-up|3|||
129824371|NCT03318315|467322382|FG001|Overall Study|Lost to Follow-up|2|||
129824372|NCT03318315|467322383|FG002|Overall Study|Lost to Follow-up|1|||
129824373|NCT03318315|467322381|FG000|Overall Study|Protocol Violation|1|||
129824374|NCT03318315|467322382|FG001|Overall Study|Protocol Violation|1|||
129824375|NCT03318315|467322383|FG002|Overall Study|Protocol Violation|1|||
129824376|NCT03318315|467322381|FG000|Overall Study|Withdrawal by Subject|0|||
129824377|NCT03318315|467322382|FG001|Overall Study|Withdrawal by Subject|0|||
129824378|NCT03318315|467322383|FG002|Overall Study|Withdrawal by Subject|2|||
129824379|NCT01896531|467322384|FG000|Overall Study|Death|57|||
129824380|NCT01896531|467322385|FG001|Overall Study|Death|59|||
129824381|NCT01896531|467322384|FG000|Overall Study|Lost to Follow-up|3|||
129824382|NCT01896531|467322385|FG001|Overall Study|Lost to Follow-up|0|||
129824383|NCT01896531|467322384|FG000|Overall Study|Non-compliance|0|||
129824384|NCT01896531|467322385|FG001|Overall Study|Non-compliance|1|||
129824385|NCT01896531|467322384|FG000|Overall Study|Study Ended by Sponsor|7|||
129824386|NCT01896531|467322385|FG001|Overall Study|Study Ended by Sponsor|20|||
129824387|NCT01896531|467322384|FG000|Overall Study|Withdrawal by Subject|3|||
129824388|NCT01896531|467322385|FG001|Overall Study|Withdrawal by Subject|2|||
129824389|NCT01896531|467322384|FG000|Overall Study|Death Prior to Treatment|1|||
129824390|NCT01896531|467322385|FG001|Overall Study|Death Prior to Treatment|0|||
129824391|NCT00770289|467322388|FG000|Overall Study|Other|6|||
129824392|NCT02659631|467322389|FG000|Overall Study|Lost to Follow-up|0|||
129824393|NCT02659631|467322390|FG001|Overall Study|Lost to Follow-up|0|||
129824394|NCT02659631|467322391|FG002|Overall Study|Lost to Follow-up|2|||
129824395|NCT02659631|467322392|FG003|Overall Study|Lost to Follow-up|0|||
129824396|NCT02659631|467322393|FG004|Overall Study|Lost to Follow-up|0|||
129824397|NCT02659631|467322394|FG005|Overall Study|Lost to Follow-up|1|||
129824398|NCT02659631|467322395|FG006|Overall Study|Lost to Follow-up|0|||
129824399|NCT02659631|467322396|FG007|Overall Study|Lost to Follow-up|0|||
129824400|NCT02659631|467322397|FG008|Overall Study|Lost to Follow-up|0|||
129824401|NCT02659631|467322398|FG009|Overall Study|Lost to Follow-up|0|||
129824402|NCT02659631|467322389|FG000|Overall Study|Withdrawal prior to treatment|0|||
129824403|NCT02659631|467322390|FG001|Overall Study|Withdrawal prior to treatment|0|||
129824404|NCT02659631|467322391|FG002|Overall Study|Withdrawal prior to treatment|0|||
129824405|NCT02659631|467322392|FG003|Overall Study|Withdrawal prior to treatment|0|||
129824406|NCT02659631|467322393|FG004|Overall Study|Withdrawal prior to treatment|1|||
129824407|NCT02659631|467322394|FG005|Overall Study|Withdrawal prior to treatment|0|||
129824408|NCT02659631|467322395|FG006|Overall Study|Withdrawal prior to treatment|0|||
129824409|NCT02659631|467322396|FG007|Overall Study|Withdrawal prior to treatment|0|||
129824410|NCT02659631|467322397|FG008|Overall Study|Withdrawal prior to treatment|0|||
129824411|NCT02659631|467322398|FG009|Overall Study|Withdrawal prior to treatment|0|||
129824412|NCT02659631|467322389|FG000|Overall Study|Participant refused further follow-up|0|||
129824413|NCT02659631|467322390|FG001|Overall Study|Participant refused further follow-up|0|||
129824414|NCT02659631|467322391|FG002|Overall Study|Participant refused further follow-up|0|||
129824415|NCT02659631|467322392|FG003|Overall Study|Participant refused further follow-up|1|||
129897483|NCT02974010|467584391|FG002|Overall Study|Lack of Efficacy|1|||
129897484|NCT02974010|467584392|FG003|Overall Study|Lack of Efficacy|0|||
129824416|NCT02659631|467322393|FG004|Overall Study|Participant refused further follow-up|0|||
129897485|NCT00320489|467584393|FG000|Overall Study|Adverse Event|26|||
129824417|NCT02659631|467322394|FG005|Overall Study|Participant refused further follow-up|0|||
129824418|NCT02659631|467322395|FG006|Overall Study|Participant refused further follow-up|0|||
129897486|NCT00320489|467584394|FG001|Overall Study|Adverse Event|25|||
129897487|NCT00320489|467584393|FG000|Overall Study|Clinical Relapse|26|||
129824419|NCT02659631|467322396|FG007|Overall Study|Participant refused further follow-up|0|||
129824420|NCT02659631|467322397|FG008|Overall Study|Participant refused further follow-up|1|||
129824421|NCT02659631|467322398|FG009|Overall Study|Participant refused further follow-up|0|||
129824422|NCT02659631|467322389|FG000|Overall Study|Death (follow-up phase)|1|||
129824423|NCT02659631|467322390|FG001|Overall Study|Death (follow-up phase)|2|||
129824424|NCT02659631|467322391|FG002|Overall Study|Death (follow-up phase)|1|||
129824425|NCT02659631|467322392|FG003|Overall Study|Death (follow-up phase)|1|||
129824426|NCT02659631|467322393|FG004|Overall Study|Death (follow-up phase)|3|||
129824427|NCT02659631|467322394|FG005|Overall Study|Death (follow-up phase)|2|||
129824428|NCT02659631|467322395|FG006|Overall Study|Death (follow-up phase)|0|||
129824429|NCT02659631|467322396|FG007|Overall Study|Death (follow-up phase)|3|||
129824430|NCT02659631|467322397|FG008|Overall Study|Death (follow-up phase)|1|||
129824431|NCT02659631|467322398|FG009|Overall Study|Death (follow-up phase)|0|||
129824432|NCT02659631|467322389|FG000|Overall Study|Death (treatment phase)|0|||
129824433|NCT02659631|467322390|FG001|Overall Study|Death (treatment phase)|0|||
129824434|NCT02659631|467322391|FG002|Overall Study|Death (treatment phase)|0|||
129824435|NCT02659631|467322392|FG003|Overall Study|Death (treatment phase)|0|||
129824436|NCT02659631|467322393|FG004|Overall Study|Death (treatment phase)|1|||
129824437|NCT02659631|467322394|FG005|Overall Study|Death (treatment phase)|0|||
129824438|NCT02659631|467322395|FG006|Overall Study|Death (treatment phase)|1|||
129824439|NCT02659631|467322396|FG007|Overall Study|Death (treatment phase)|0|||
129824440|NCT02659631|467322397|FG008|Overall Study|Death (treatment phase)|0|||
129824441|NCT02659631|467322398|FG009|Overall Study|Death (treatment phase)|0|||
129824442|NCT02377466|467322399|FG000|Overall Study|Other: Randomized and not treated|0|||
129824443|NCT02377466|467322400|FG001|Overall Study|Other: Randomized and not treated|2|||
129824444|NCT00495170|467322401|FG000|Overall Study|Lost to Follow-up|9|||
129824445|NCT00495170|467322401|FG000|Overall Study|Withdrawal by Subject|3|||
129824446|NCT00495170|467322401|FG000|Overall Study|Inappropriate staging|8|||
129824447|NCT04210310|467322402|FG000|Overall Study|Lost to Follow-up|32|||
129824448|NCT04210310|467322403|FG001|Overall Study|Lost to Follow-up|1|||
129824449|NCT02049957|467322412|FG000|Overall Study|Progressive Disease|5|||
129824450|NCT02049957|467322413|FG001|Overall Study|Progressive Disease|4|||
129824451|NCT02049957|467322414|FG002|Overall Study|Progressive Disease|2|||
129824452|NCT02049957|467322415|FG003|Overall Study|Progressive Disease|2|||
129824453|NCT02049957|467322416|FG004|Overall Study|Progressive Disease|6|||
129824454|NCT02049957|467322417|FG005|Overall Study|Progressive Disease|35|||
129824455|NCT02049957|467322418|FG006|Overall Study|Progressive Disease|7|||
129824456|NCT02049957|467322419|FG007|Overall Study|Progressive Disease|26|||
129824457|NCT02049957|467322420|FG008|Overall Study|Progressive Disease|6|||
129824458|NCT02049957|467322412|FG000|Overall Study|Adverse Event|1|||
129824459|NCT02049957|467322413|FG001|Overall Study|Adverse Event|1|||
129824460|NCT02049957|467322414|FG002|Overall Study|Adverse Event|1|||
129824461|NCT02049957|467322415|FG003|Overall Study|Adverse Event|0|||
129824462|NCT02049957|467322416|FG004|Overall Study|Adverse Event|0|||
129824463|NCT02049957|467322417|FG005|Overall Study|Adverse Event|5|||
129824464|NCT02049957|467322418|FG006|Overall Study|Adverse Event|0|||
129824465|NCT02049957|467322419|FG007|Overall Study|Adverse Event|6|||
129824466|NCT02049957|467322420|FG008|Overall Study|Adverse Event|1|||
129824467|NCT02049957|467322412|FG000|Overall Study|Study Terminated by Sponsor|0|||
129824468|NCT02049957|467322413|FG001|Overall Study|Study Terminated by Sponsor|1|||
129824469|NCT02049957|467322414|FG002|Overall Study|Study Terminated by Sponsor|0|||
129824470|NCT02049957|467322415|FG003|Overall Study|Study Terminated by Sponsor|0|||
129824471|NCT02049957|467322416|FG004|Overall Study|Study Terminated by Sponsor|0|||
129824472|NCT02049957|467322417|FG005|Overall Study|Study Terminated by Sponsor|0|||
129824473|NCT02049957|467322418|FG006|Overall Study|Study Terminated by Sponsor|1|||
129824474|NCT02049957|467322419|FG007|Overall Study|Study Terminated by Sponsor|0|||
129824475|NCT02049957|467322420|FG008|Overall Study|Study Terminated by Sponsor|0|||
129824476|NCT02049957|467322412|FG000|Overall Study|Withdrawal by Subject|0|||
129445691|NCT01968070|465932876|FG001|Period 1|Physician Decision|0|||
129445692|NCT01968070|465932877|FG002|Period 1|Physician Decision|0|||
129445693|NCT01968070|465932878|FG003|Period 1|Physician Decision|0|||
129445694|NCT01968070|465932879|FG004|Period 1|Physician Decision|0|||
129445695|NCT01968070|465932880|FG005|Period 1|Physician Decision|0|||
129445696|NCT01968070|465932881|FG006|Period 1|Physician Decision|0|||
129824477|NCT02049957|467322413|FG001|Overall Study|Withdrawal by Subject|0|||
129824478|NCT02049957|467322414|FG002|Overall Study|Withdrawal by Subject|0|||
129824479|NCT02049957|467322415|FG003|Overall Study|Withdrawal by Subject|1|||
129824480|NCT02049957|467322416|FG004|Overall Study|Withdrawal by Subject|0|||
129824481|NCT02049957|467322417|FG005|Overall Study|Withdrawal by Subject|2|||
129824482|NCT02049957|467322418|FG006|Overall Study|Withdrawal by Subject|0|||
129897488|NCT00320489|467584394|FG001|Overall Study|Clinical Relapse|20|||
129445697|NCT01968070|465932882|FG007|Period 1|Physician Decision|0|||
129824483|NCT02049957|467322419|FG007|Overall Study|Withdrawal by Subject|3|||
129824484|NCT02049957|467322420|FG008|Overall Study|Withdrawal by Subject|1|||
129824485|NCT02049957|467322412|FG000|Overall Study|Physician Decision|0|||
129824486|NCT02049957|467322413|FG001|Overall Study|Physician Decision|0|||
129824487|NCT02049957|467322414|FG002|Overall Study|Physician Decision|0|||
129824488|NCT02049957|467322415|FG003|Overall Study|Physician Decision|0|||
129824489|NCT02049957|467322416|FG004|Overall Study|Physician Decision|0|||
129824490|NCT02049957|467322417|FG005|Overall Study|Physician Decision|1|||
129824491|NCT02049957|467322418|FG006|Overall Study|Physician Decision|0|||
129824492|NCT02049957|467322419|FG007|Overall Study|Physician Decision|0|||
129824493|NCT02049957|467322420|FG008|Overall Study|Physician Decision|0|||
129824494|NCT02622321|467322421|FG000|Overall Study|Withdrawal by Subject|2|||
129824495|NCT02622321|467322422|FG001|Overall Study|Withdrawal by Subject|0|||
129824496|NCT02622321|467322423|FG002|Overall Study|Withdrawal by Subject|0|||
129824497|NCT02622321|467322424|FG003|Overall Study|Withdrawal by Subject|0|||
129824498|NCT02622321|467322421|FG000|Overall Study|Death|0|||
129824499|NCT02622321|467322422|FG001|Overall Study|Death|0|||
129824500|NCT02622321|467322423|FG002|Overall Study|Death|1|||
129824501|NCT02622321|467322424|FG003|Overall Study|Death|0|||
129824502|NCT02622321|467322421|FG000|Overall Study|Physician Decision|1|||
129824503|NCT02622321|467322422|FG001|Overall Study|Physician Decision|0|||
129824504|NCT02622321|467322423|FG002|Overall Study|Physician Decision|0|||
129824505|NCT02622321|467322424|FG003|Overall Study|Physician Decision|0|||
129824506|NCT00241280|467322426|FG000|Overall Study|Adverse Event|2|||
129824507|NCT00241280|467322427|FG001|Overall Study|Adverse Event|6|||
129824508|NCT00241280|467322426|FG000|Overall Study|Discomfort|11|||
129824509|NCT00241280|467322427|FG001|Overall Study|Discomfort|16|||
129824510|NCT00241280|467322426|FG000|Overall Study|Pregnancy|1|||
129824511|NCT00241280|467322427|FG001|Overall Study|Pregnancy|5|||
129824512|NCT00241280|467322426|FG000|Overall Study|Lost to Follow-up|5|||
129824513|NCT00241280|467322427|FG001|Overall Study|Lost to Follow-up|8|||
129824514|NCT00241280|467322426|FG000|Overall Study|Withdrawal by Subject|7|||
129824515|NCT00241280|467322427|FG001|Overall Study|Withdrawal by Subject|4|||
129824516|NCT00241280|467322426|FG000|Overall Study|Protocol Violation|4|||
129824517|NCT00241280|467322427|FG001|Overall Study|Protocol Violation|10|||
129824518|NCT00241280|467322426|FG000|Overall Study|Relocation|4|||
129824519|NCT00241280|467322427|FG001|Overall Study|Relocation|4|||
129824520|NCT00241280|467322426|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
129824521|NCT00241280|467322427|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
129824522|NCT00241280|467322426|FG000|Overall Study|Unsatisfactory Visual Response|1|||
129824523|NCT00241280|467322427|FG001|Overall Study|Unsatisfactory Visual Response|1|||
129824524|NCT00241280|467322426|FG000|Overall Study|Diabetic|1|||
129824525|NCT00241280|467322427|FG001|Overall Study|Diabetic|0|||
129824526|NCT00241280|467322426|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
129824527|NCT00241280|467322427|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
129824528|NCT00241280|467322426|FG000|Overall Study|Dispensed incorrect test article|1|||
129824529|NCT00241280|467322427|FG001|Overall Study|Dispensed incorrect test article|2|||
129824530|NCT00241280|467322426|FG000|Overall Study|Unacceptable Fit|0|||
129824531|NCT00241280|467322427|FG001|Overall Study|Unacceptable Fit|1|||
129824532|NCT00241280|467322426|FG000|Overall Study|Scheduling Conflict|0|||
129824533|NCT00241280|467322427|FG001|Overall Study|Scheduling Conflict|2|||
129824534|NCT00241280|467322426|FG000|Overall Study|History of Ocular Surgery|0|||
129897489|NCT00320489|467584393|FG000|Overall Study|Death|0|||
129824535|NCT00241280|467322427|FG001|Overall Study|History of Ocular Surgery|1|||
129824536|NCT00241280|467322426|FG000|Overall Study|Coating on Lens|1|||
129824537|NCT00241280|467322427|FG001|Overall Study|Coating on Lens|0|||
129824538|NCT00241280|467322426|FG000|Overall Study|Excessive Dryness|0|||
129824539|NCT00241280|467322427|FG001|Overall Study|Excessive Dryness|1|||
129824540|NCT00965718|467322428|FG000|Overall Study|Withdrawal by Subject|4|||
129824541|NCT01958008|467322429|FG000|Overall Study|Worsening of disease under study|0|||
129824542|NCT01958008|467322430|FG001|Overall Study|Worsening of disease under study|0|||
129824543|NCT01958008|467322431|FG002|Overall Study|Worsening of disease under study|1|||
129824544|NCT01958008|467322432|FG003|Overall Study|Worsening of disease under study|0|||
129824545|NCT01958008|467322429|FG000|Overall Study|Other adverse event|1|||
129824546|NCT01958008|467322430|FG001|Overall Study|Other adverse event|0|||
129824547|NCT01958008|467322431|FG002|Overall Study|Other adverse event|0|||
129824548|NCT01958008|467322432|FG003|Overall Study|Other adverse event|0|||
129824549|NCT01634360|467322434|FG000|Overall Study|Adverse Event|10|||
129824550|NCT01634360|467322435|FG001|Overall Study|Adverse Event|34|||
129824551|NCT01634360|467322434|FG000|Overall Study|subject withdrew consent|13|||
129824552|NCT01634360|467322435|FG001|Overall Study|subject withdrew consent|23|||
129824553|NCT01634360|467322434|FG000|Overall Study|Protocol Violation|1|||
129824554|NCT01634360|467322435|FG001|Overall Study|Protocol Violation|1|||
129824555|NCT01634360|467322434|FG000|Overall Study|Lack of Efficacy|4|||
129824556|NCT01634360|467322435|FG001|Overall Study|Lack of Efficacy|14|||
129824557|NCT01634360|467322434|FG000|Overall Study|Other|3|||
129824558|NCT01634360|467322435|FG001|Overall Study|Other|20|||
129824559|NCT01634360|467322434|FG000|Overall Study|Study termination by sponsor|18|||
129824560|NCT01634360|467322435|FG001|Overall Study|Study termination by sponsor|44|||
129824561|NCT02028065|467322438|FG000|Randomization Through Start Treatment|Not treated|1|||
129824562|NCT02028065|467322439|FG001|Randomization Through Start Treatment|Not treated|3|||
129824563|NCT02028065|467322440|FG002|Randomization Through Start Treatment|Not treated|3|||
129824564|NCT02028065|467322438|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
129824565|NCT02028065|467322439|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
129824566|NCT02028065|467322440|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
129824567|NCT02028065|467322438|FG000|Treatment Through Study Completion|Physician Decision|1|||
129824568|NCT02028065|467322439|FG001|Treatment Through Study Completion|Physician Decision|0|||
129824569|NCT02028065|467322440|FG002|Treatment Through Study Completion|Physician Decision|0|||
129824570|NCT02028065|467322438|FG000|Treatment Through Study Completion|Protocol Violation|1|||
129824571|NCT02028065|467322439|FG001|Treatment Through Study Completion|Protocol Violation|4|||
129824572|NCT02028065|467322440|FG002|Treatment Through Study Completion|Protocol Violation|0|||
129824573|NCT02028065|467322438|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
129824574|NCT02028065|467322439|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
129824575|NCT02028065|467322440|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
129824576|NCT02028065|467322438|FG000|Treatment Through Study Completion|Adverse Event|3|||
129824577|NCT02028065|467322439|FG001|Treatment Through Study Completion|Adverse Event|3|||
129824578|NCT02028065|467322440|FG002|Treatment Through Study Completion|Adverse Event|5|||
129824579|NCT01414855|467322441|FG000|Overall Study|Death|17|||
129824580|NCT01414855|467322441|FG000|Overall Study|Lost to Follow-up|5|||
129824581|NCT01414855|467322441|FG000|Overall Study|Withdrawal by Subject|7|||
129824582|NCT00877383|467322445|FG000|Overall Study|Adverse Event|13|||
129824583|NCT00877383|467322446|FG001|Overall Study|Adverse Event|14|||
129824584|NCT00877383|467322445|FG000|Overall Study|Lost to Follow-up|5|||
129824585|NCT00877383|467322446|FG001|Overall Study|Lost to Follow-up|3|||
129824586|NCT00877383|467322445|FG000|Overall Study|Subject withdrew consent|3|||
129824587|NCT00877383|467322446|FG001|Overall Study|Subject withdrew consent|12|||
129824588|NCT00877383|467322445|FG000|Overall Study|Subject no longer requires study drug|2|||
129824589|NCT00877383|467322446|FG001|Overall Study|Subject no longer requires study drug|0|||
129824590|NCT00877383|467322445|FG000|Overall Study|Administrative problems|2|||
129824591|NCT00877383|467322446|FG001|Overall Study|Administrative problems|0|||
129824592|NCT00877383|467322445|FG000|Overall Study|Protocol deviation|2|||
129824593|NCT00877383|467322446|FG001|Overall Study|Protocol deviation|6|||
129824594|NCT00877383|467322445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129824595|NCT00877383|467322446|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129824596|NCT00877383|467322445|FG000|Overall Study|Death|1|||
129824597|NCT00877383|467322446|FG001|Overall Study|Death|2|||
129824598|NCT04851314|467322447|FG000|Overall Study|Unable to complete research set-up procedures|0|||
129824599|NCT04851314|467322448|FG001|Overall Study|Unable to complete research set-up procedures|2|||
129824600|NCT04851314|467322447|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
129824601|NCT04851314|467322448|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
129824602|NCT02107482|467322455|FG000|Overall Study|inconveinence|2|||
129824603|NCT02107482|467322455|FG000|Overall Study|Lost to Follow-up|1|||
129824604|NCT02107482|467322455|FG000|Overall Study|Lack of Efficacy|1|||
129824605|NCT04868890|467322456|FG000|Overall Study|Death|2|||
129824606|NCT04868890|467322457|FG001|Overall Study|Death|1|||
129824607|NCT04868890|467322456|FG000|Overall Study|Withdrawal by Subject|1|||
129824608|NCT04868890|467322457|FG001|Overall Study|Withdrawal by Subject|5|||
129824609|NCT00867009|467322458|FG000|Induction Period|Nonserious Adverse Event|5|||
129824610|NCT00867009|467322458|FG000|Induction Period|Serious Adverse Event|10|||
129824611|NCT00867009|467322458|FG000|Induction Period|Death due to serious adverse event|6|||
129824612|NCT00867009|467322458|FG000|Induction Period|Death due to Study Disease|4|||
129824613|NCT00867009|467322458|FG000|Induction Period|Protocol Violation|1|||
129824614|NCT00867009|467322458|FG000|Induction Period|Withdrawal by Subject|8|||
129824615|NCT00867009|467322458|FG000|Induction Period|Physician Decision|3|||
129824616|NCT00867009|467322458|FG000|Induction Period|Progressive Disease (PD)|25|||
129824617|NCT00867009|467322458|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
129824618|NCT03358290|467322460|FG000|Overall Study|Study discontinued by Sponsor|0|||
129824619|NCT03358290|467322461|FG001|Overall Study|Study discontinued by Sponsor|1|||
129824620|NCT03358290|467322462|FG002|Overall Study|Study discontinued by Sponsor|1|||
129824621|NCT03358290|467322463|FG003|Overall Study|Study discontinued by Sponsor|0|||
129824622|NCT03358290|467322464|FG004|Overall Study|Study discontinued by Sponsor|0|||
129824623|NCT03358290|467322460|FG000|Overall Study|Adverse Event|0|||
129824624|NCT03358290|467322461|FG001|Overall Study|Adverse Event|0|||
129824625|NCT03358290|467322462|FG002|Overall Study|Adverse Event|1|||
129824626|NCT03358290|467322463|FG003|Overall Study|Adverse Event|2|||
129824627|NCT03358290|467322464|FG004|Overall Study|Adverse Event|0|||
129824628|NCT03358290|467322460|FG000|Overall Study|Withdrawal by Subject|0|||
129824629|NCT03358290|467322461|FG001|Overall Study|Withdrawal by Subject|0|||
129824630|NCT03358290|467322462|FG002|Overall Study|Withdrawal by Subject|0|||
129824631|NCT03358290|467322463|FG003|Overall Study|Withdrawal by Subject|0|||
129824632|NCT03358290|467322464|FG004|Overall Study|Withdrawal by Subject|1|||
129824633|NCT01339429|467322465|FG000|Overall Study|Withdrawal by Subject|1|||
129824634|NCT01339429|467322465|FG000|Overall Study|Physician Decision|3|||
129824635|NCT00459667|467322466|FG000|Overall Study|Adverse Event|9|||
129824636|NCT00459667|467322467|FG001|Overall Study|Adverse Event|12|||
129824637|NCT00459667|467322468|FG002|Overall Study|Adverse Event|8|||
129824638|NCT00459667|467322466|FG000|Overall Study|Lost to Follow-up|5|||
129824639|NCT00459667|467322467|FG001|Overall Study|Lost to Follow-up|9|||
129824640|NCT00459667|467322468|FG002|Overall Study|Lost to Follow-up|3|||
129824641|NCT00459667|467322466|FG000|Overall Study|Pregnancy|1|||
129824642|NCT00459667|467322467|FG001|Overall Study|Pregnancy|1|||
129824643|NCT00459667|467322468|FG002|Overall Study|Pregnancy|1|||
129824644|NCT00459667|467322466|FG000|Overall Study|Protocol Violation|1|||
129824645|NCT00459667|467322467|FG001|Overall Study|Protocol Violation|0|||
129824646|NCT00459667|467322468|FG002|Overall Study|Protocol Violation|0|||
129824647|NCT00459667|467322466|FG000|Overall Study|Withdrawal by Subject|3|||
129824648|NCT00459667|467322467|FG001|Overall Study|Withdrawal by Subject|5|||
129824649|NCT00459667|467322468|FG002|Overall Study|Withdrawal by Subject|5|||
129824650|NCT00459667|467322466|FG000|Overall Study|Other disease modifying treatment|1|||
129824651|NCT00459667|467322467|FG001|Overall Study|Other disease modifying treatment|2|||
129824652|NCT00459667|467322468|FG002|Overall Study|Other disease modifying treatment|1|||
129824653|NCT00459667|467322466|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
129824654|NCT00459667|467322467|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
129824655|NCT00459667|467322468|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
129824656|NCT00459667|467322466|FG000|Overall Study|No treatment administered|6|||
129824657|NCT00459667|467322467|FG001|Overall Study|No treatment administered|3|||
129824658|NCT00459667|467322468|FG002|Overall Study|No treatment administered|1|||
129824659|NCT04140292|467322469|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
129824660|NCT04140292|467322470|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
129824661|NCT00556712|467322471|FG000|Overall Study|Adverse Event|7|||
129824662|NCT00556712|467322472|FG001|Overall Study|Adverse Event|19|||
129824663|NCT00556712|467322471|FG000|Overall Study|Death|5|||
129824664|NCT00556712|467322472|FG001|Overall Study|Death|10|||
129824665|NCT00556712|467322471|FG000|Overall Study|Progressive Disease|383|||
129824666|NCT00556712|467322472|FG001|Overall Study|Progressive Disease|320|||
129824667|NCT00556712|467322471|FG000|Overall Study|Protocol Violation|3|||
129824668|NCT00556712|467322472|FG001|Overall Study|Protocol Violation|2|||
129824669|NCT00556712|467322471|FG000|Overall Study|Refused Treatment|17|||
129824670|NCT00556712|467322472|FG001|Overall Study|Refused Treatment|16|||
129824671|NCT00556712|467322471|FG000|Overall Study|Failure to Return|2|||
129824672|NCT00556712|467322472|FG001|Overall Study|Failure to Return|3|||
129824673|NCT00556712|467322471|FG000|Overall Study|Other|2|||
129824674|NCT00556712|467322472|FG001|Overall Study|Other|2|||
129824675|NCT00556712|467322471|FG000|Overall Study|Ongoing at Data Cutoff|32|||
129824676|NCT00556712|467322472|FG001|Overall Study|Ongoing at Data Cutoff|66|||
129824677|NCT04080297|467322474|FG000|Overall Study|Adverse Event|1|||
129824678|NCT04080297|467322475|FG001|Overall Study|Adverse Event|3|||
129824679|NCT04080297|467322474|FG000|Overall Study|concurrent illness|1|||
129824680|NCT04080297|467322475|FG001|Overall Study|concurrent illness|0|||
129824681|NCT02200445|467322476|FG000|Overall Study|Lack of Efficacy|1|||
129824682|NCT02200445|467322477|FG001|Overall Study|Lack of Efficacy|2|||
129824683|NCT02200445|467322478|FG002|Overall Study|Lack of Efficacy|2|||
129824684|NCT02200445|467322476|FG000|Overall Study|Adverse Event|0|||
129824685|NCT02200445|467322477|FG001|Overall Study|Adverse Event|2|||
129824686|NCT02200445|467322478|FG002|Overall Study|Adverse Event|0|||
129897490|NCT00320489|467584394|FG001|Overall Study|Death|2|||
129824687|NCT00353262|467322482|FG000|Overall Study|Adverse Event|8|||
129824688|NCT00353262|467322482|FG000|Overall Study|Withdrawal by Subject|2|||
129824689|NCT00353262|467322482|FG000|Overall Study|Insufficient Therapeutic Response|13|||
129824690|NCT00353262|467322482|FG000|Overall Study|Progression|1|||
129824691|NCT00353262|467322482|FG000|Overall Study|Surgery|4|||
129824692|NCT00353262|467322482|FG000|Overall Study|Break from Chemotherapy|1|||
129824693|NCT01853826|467324703|FG000|Overall Study|Patients who switched to commercial drug|11|||
129824694|NCT01853826|467324703|FG000|Overall Study|Patient refused to continue medication|21|||
129824695|NCT01853826|467324703|FG000|Overall Study|Lost to Follow-up|2|||
129824696|NCT01853826|467324703|FG000|Overall Study|Non-compliant with protocol|4|||
129824697|NCT01853826|467324703|FG000|Overall Study|Other adverse events (AE)|62|||
129824698|NCT01853826|467324703|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
129824699|NCT01853826|467324703|FG000|Overall Study|Progressive disease|342|||
129824700|NCT01853826|467324703|FG000|Overall Study|Other than listed|13|||
129445698|NCT01968070|465932883|FG008|Period 1|Physician Decision|0|||
129445699|NCT01968070|465932884|FG009|Period 1|Physician Decision|0|||
129445700|NCT01968070|465932885|FG010|Period 1|Physician Decision|0|||
129824701|NCT01853826|467324703|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
129824702|NCT00982488|467324707|FG000|Overall Study|Administrative reason by sponsor|81|||
129824703|NCT00982488|467324708|FG001|Overall Study|Administrative reason by sponsor|3|||
129824704|NCT00982488|467324709|FG002|Overall Study|Administrative reason by sponsor|11|||
129824705|NCT00982488|467324710|FG003|Overall Study|Administrative reason by sponsor|0|||
129824706|NCT00982488|467324711|FG004|Overall Study|Administrative reason by sponsor|0|||
129824707|NCT00982488|467324707|FG000|Overall Study|Adverse event unrelated to study drug|5|||
129824708|NCT00982488|467324708|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129824709|NCT00982488|467324709|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129824710|NCT00982488|467324710|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129824711|NCT00982488|467324711|FG004|Overall Study|Adverse event unrelated to study drug|0|||
129824712|NCT00982488|467324707|FG000|Overall Study|Death|11|||
129824713|NCT00982488|467324708|FG001|Overall Study|Death|0|||
129824714|NCT00982488|467324709|FG002|Overall Study|Death|2|||
129824715|NCT00982488|467324710|FG003|Overall Study|Death|0|||
129824716|NCT00982488|467324711|FG004|Overall Study|Death|0|||
129824717|NCT00982488|467324707|FG000|Overall Study|Disease progression|30|||
129824718|NCT00982488|467324708|FG001|Overall Study|Disease progression|5|||
129824719|NCT00982488|467324709|FG002|Overall Study|Disease progression|10|||
129824720|NCT00982488|467324710|FG003|Overall Study|Disease progression|1|||
129824721|NCT00982488|467324711|FG004|Overall Study|Disease progression|1|||
129824722|NCT00982488|467324707|FG000|Overall Study|Lost to Follow-up|1|||
129824723|NCT00982488|467324708|FG001|Overall Study|Lost to Follow-up|0|||
129824724|NCT00982488|467324709|FG002|Overall Study|Lost to Follow-up|0|||
129897491|NCT00320489|467584393|FG000|Overall Study|Entry Criteria Exclusion|2|||
129897492|NCT00320489|467584394|FG001|Overall Study|Entry Criteria Exclusion|4|||
129824725|NCT00982488|467324710|FG003|Overall Study|Lost to Follow-up|0|||
129824726|NCT00982488|467324711|FG004|Overall Study|Lost to Follow-up|0|||
129824727|NCT00982488|467324707|FG000|Overall Study|Maximum clinical benefit|1|||
129824728|NCT00982488|467324708|FG001|Overall Study|Maximum clinical benefit|1|||
129824729|NCT00982488|467324709|FG002|Overall Study|Maximum clinical benefit|1|||
129824730|NCT00982488|467324710|FG003|Overall Study|Maximum clinical benefit|0|||
129824731|NCT00982488|467324711|FG004|Overall Study|Maximum clinical benefit|0|||
129824732|NCT00982488|467324707|FG000|Overall Study|Other|15|||
129824733|NCT00982488|467324708|FG001|Overall Study|Other|1|||
129824734|NCT00982488|467324709|FG002|Overall Study|Other|3|||
129824735|NCT00982488|467324710|FG003|Overall Study|Other|1|||
129824736|NCT00982488|467324711|FG004|Overall Study|Other|0|||
129824737|NCT00982488|467324707|FG000|Overall Study|Poor compliance/noncompliance|0|||
129824738|NCT00982488|467324708|FG001|Overall Study|Poor compliance/noncompliance|1|||
129824739|NCT00982488|467324709|FG002|Overall Study|Poor compliance/noncompliance|0|||
129824740|NCT00982488|467324710|FG003|Overall Study|Poor compliance/noncompliance|0|||
129824741|NCT00982488|467324711|FG004|Overall Study|Poor compliance/noncompliance|0|||
129824742|NCT00982488|467324707|FG000|Overall Study|Stem cell transplant|2|||
129824743|NCT00982488|467324708|FG001|Overall Study|Stem cell transplant|0|||
129824744|NCT00982488|467324709|FG002|Overall Study|Stem cell transplant|0|||
129824745|NCT00982488|467324710|FG003|Overall Study|Stem cell transplant|1|||
129824746|NCT00982488|467324711|FG004|Overall Study|Stem cell transplant|0|||
129824747|NCT00982488|467324707|FG000|Overall Study|Study drug toxicity|34|||
129824748|NCT00982488|467324708|FG001|Overall Study|Study drug toxicity|1|||
129824749|NCT00982488|467324709|FG002|Overall Study|Study drug toxicity|6|||
129824750|NCT00982488|467324710|FG003|Overall Study|Study drug toxicity|0|||
129824751|NCT00982488|467324711|FG004|Overall Study|Study drug toxicity|0|||
129824752|NCT00982488|467324707|FG000|Overall Study|Withdrawal by Subject|5|||
129824753|NCT00982488|467324708|FG001|Overall Study|Withdrawal by Subject|1|||
129824754|NCT00982488|467324709|FG002|Overall Study|Withdrawal by Subject|1|||
129824755|NCT00982488|467324710|FG003|Overall Study|Withdrawal by Subject|0|||
129824756|NCT00982488|467324711|FG004|Overall Study|Withdrawal by Subject|0|||
129824757|NCT00180414|467324720|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
129824758|NCT00180414|467324721|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
129824759|NCT01572909|467324722|FG000|Overall Study|Adverse Event|7|||
129824760|NCT01572909|467324723|FG001|Overall Study|Adverse Event|2|||
129824761|NCT01572909|467324722|FG000|Overall Study|Death|3|||
129824762|NCT01572909|467324723|FG001|Overall Study|Death|1|||
129824763|NCT01572909|467324722|FG000|Overall Study|Lost to Follow-up|8|||
129824764|NCT01572909|467324723|FG001|Overall Study|Lost to Follow-up|7|||
129824765|NCT01572909|467324722|FG000|Overall Study|Physician Decision|1|||
129824766|NCT01572909|467324723|FG001|Overall Study|Physician Decision|1|||
129824767|NCT01572909|467324722|FG000|Overall Study|Technical Issues|1|||
129824768|NCT01572909|467324723|FG001|Overall Study|Technical Issues|0|||
129824769|NCT01572909|467324722|FG000|Overall Study|Withdrawal by Subject|12|||
129824770|NCT01572909|467324723|FG001|Overall Study|Withdrawal by Subject|11|||
129824771|NCT01572909|467324722|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
129824772|NCT01572909|467324723|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
129824773|NCT03641651|467324724|FG000|Overall Study|organizational issues at one study site|1|||
129824774|NCT04779489|467324725|FG000|Overall Study|Physician Decision|1|||
129824775|NCT00623727|467324726|FG000|Double Blind (DB)|Adverse Event|1|||
129824776|NCT00623727|467324727|FG001|Double Blind (DB)|Adverse Event|3|||
129824777|NCT00623727|467324726|FG000|Double Blind (DB)|Physician Decision|0|||
129824778|NCT00623727|467324727|FG001|Double Blind (DB)|Physician Decision|1|||
129824779|NCT00623727|467324726|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
129824780|NCT00623727|467324727|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
129824781|NCT00623727|467324726|FG000|Double Blind (DB)|Lack of Efficacy|2|||
129824782|NCT00623727|467324727|FG001|Double Blind (DB)|Lack of Efficacy|2|||
129824783|NCT00623727|467324726|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
129824784|NCT00623727|467324727|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
129824785|NCT00623727|467324726|FG000|Double Blind (DB)|Lost to Follow-up|1|||
129824786|NCT00623727|467324727|FG001|Double Blind (DB)|Lost to Follow-up|1|||
129824787|NCT00623727|467324726|FG000|Double Blind (DB)|Protocol Violation|2|||
129824788|NCT00623727|467324727|FG001|Double Blind (DB)|Protocol Violation|2|||
129824789|NCT00623727|467324726|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
129824790|NCT00623727|467324727|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
129824791|NCT00623727|467324726|FG000|Open Label Follow-up|Study termination|0|||
129824792|NCT00623727|467324727|FG001|Open Label Follow-up|Study termination|6|||
129824793|NCT00623727|467324726|FG000|Open Label Follow-up|Participant convenience|0|||
129824794|NCT00623727|467324727|FG001|Open Label Follow-up|Participant convenience|1|||
129824795|NCT00951665|467324728|FG000|Phase 1b|Adverse Event|2|||
129824796|NCT00951665|467324729|FG001|Phase 1b|Adverse Event|1|||
129824797|NCT00951665|467324730|FG002|Phase 1b|Adverse Event|0|||
129824798|NCT00951665|467324731|FG003|Phase 1b|Adverse Event|1|||
129824799|NCT00951665|467324732|FG004|Phase 1b|Adverse Event|0|||
129824800|NCT00951665|467324733|FG005|Phase 1b|Adverse Event|0|||
129824801|NCT00951665|467324728|FG000|Phase 1b|Death|1|||
129824802|NCT00951665|467324729|FG001|Phase 1b|Death|0|||
129824803|NCT00951665|467324730|FG002|Phase 1b|Death|2|||
129824804|NCT00951665|467324731|FG003|Phase 1b|Death|0|||
129824805|NCT00951665|467324732|FG004|Phase 1b|Death|0|||
129824806|NCT00951665|467324733|FG005|Phase 1b|Death|0|||
129824807|NCT00951665|467324728|FG000|Phase 1b|Physician Decision|4|||
129824808|NCT00951665|467324729|FG001|Phase 1b|Physician Decision|0|||
129824809|NCT00951665|467324730|FG002|Phase 1b|Physician Decision|1|||
129824810|NCT00951665|467324731|FG003|Phase 1b|Physician Decision|0|||
129824811|NCT00951665|467324732|FG004|Phase 1b|Physician Decision|0|||
129824812|NCT00951665|467324733|FG005|Phase 1b|Physician Decision|0|||
129824813|NCT00951665|467324728|FG000|Phase 1b|Withdrawal by Subject|0|||
129824814|NCT00951665|467324729|FG001|Phase 1b|Withdrawal by Subject|1|||
129824815|NCT00951665|467324730|FG002|Phase 1b|Withdrawal by Subject|0|||
129824816|NCT00951665|467324731|FG003|Phase 1b|Withdrawal by Subject|0|||
129824817|NCT00951665|467324732|FG004|Phase 1b|Withdrawal by Subject|0|||
129824818|NCT00951665|467324733|FG005|Phase 1b|Withdrawal by Subject|0|||
129824819|NCT00951665|467324728|FG000|Phase 1b|Disease Progression|13|||
129824820|NCT00951665|467324729|FG001|Phase 1b|Disease Progression|2|||
129824821|NCT00951665|467324730|FG002|Phase 1b|Disease Progression|14|||
129824822|NCT00951665|467324731|FG003|Phase 1b|Disease Progression|0|||
129824823|NCT00951665|467324732|FG004|Phase 1b|Disease Progression|0|||
129824824|NCT00951665|467324733|FG005|Phase 1b|Disease Progression|0|||
129824825|NCT00951665|467324728|FG000|Phase 1b|Protocol Violation|2|||
129824826|NCT00951665|467324729|FG001|Phase 1b|Protocol Violation|0|||
129824827|NCT00951665|467324730|FG002|Phase 1b|Protocol Violation|0|||
129824828|NCT00951665|467324731|FG003|Phase 1b|Protocol Violation|0|||
129824829|NCT00951665|467324732|FG004|Phase 1b|Protocol Violation|0|||
129824830|NCT00951665|467324733|FG005|Phase 1b|Protocol Violation|0|||
129824831|NCT00951665|467324728|FG000|Phase 2a|Adverse Event|0|||
129824832|NCT00951665|467324729|FG001|Phase 2a|Adverse Event|0|||
129824833|NCT00951665|467324730|FG002|Phase 2a|Adverse Event|0|||
129824834|NCT00951665|467324731|FG003|Phase 2a|Adverse Event|0|||
129824835|NCT00951665|467324732|FG004|Phase 2a|Adverse Event|2|||
129824836|NCT00951665|467324733|FG005|Phase 2a|Adverse Event|0|||
129824837|NCT00951665|467324728|FG000|Phase 2a|Death|0|||
129824838|NCT00951665|467324729|FG001|Phase 2a|Death|0|||
129824839|NCT00951665|467324730|FG002|Phase 2a|Death|0|||
129824840|NCT00951665|467324731|FG003|Phase 2a|Death|0|||
129824841|NCT00951665|467324732|FG004|Phase 2a|Death|1|||
129824842|NCT00951665|467324733|FG005|Phase 2a|Death|1|||
129824843|NCT00951665|467324728|FG000|Phase 2a|Lost to Follow-up|0|||
129824844|NCT00951665|467324729|FG001|Phase 2a|Lost to Follow-up|0|||
129824845|NCT00951665|467324730|FG002|Phase 2a|Lost to Follow-up|0|||
129824846|NCT00951665|467324731|FG003|Phase 2a|Lost to Follow-up|0|||
129824847|NCT00951665|467324732|FG004|Phase 2a|Lost to Follow-up|1|||
129824848|NCT00951665|467324733|FG005|Phase 2a|Lost to Follow-up|0|||
129824849|NCT00951665|467324728|FG000|Phase 2a|Physician Decision|0|||
129824850|NCT00951665|467324729|FG001|Phase 2a|Physician Decision|0|||
129824851|NCT00951665|467324730|FG002|Phase 2a|Physician Decision|0|||
129824852|NCT00951665|467324731|FG003|Phase 2a|Physician Decision|0|||
129824853|NCT00951665|467324732|FG004|Phase 2a|Physician Decision|0|||
129824854|NCT00951665|467324733|FG005|Phase 2a|Physician Decision|1|||
129824855|NCT00951665|467324728|FG000|Phase 2a|Withdrawal by Subject|0|||
129824856|NCT00951665|467324729|FG001|Phase 2a|Withdrawal by Subject|0|||
129824857|NCT00951665|467324730|FG002|Phase 2a|Withdrawal by Subject|0|||
129824858|NCT00951665|467324731|FG003|Phase 2a|Withdrawal by Subject|0|||
129824859|NCT00951665|467324732|FG004|Phase 2a|Withdrawal by Subject|2|||
129824860|NCT00951665|467324733|FG005|Phase 2a|Withdrawal by Subject|0|||
129824861|NCT00951665|467324728|FG000|Phase 2a|Disease Progression|0|||
129824862|NCT00951665|467324729|FG001|Phase 2a|Disease Progression|0|||
129824863|NCT00951665|467324730|FG002|Phase 2a|Disease Progression|0|||
129824864|NCT00951665|467324731|FG003|Phase 2a|Disease Progression|0|||
129824865|NCT00951665|467324732|FG004|Phase 2a|Disease Progression|6|||
129824866|NCT00951665|467324733|FG005|Phase 2a|Disease Progression|5|||
129824867|NCT01199289|467324734|FG000|Overall Study|Ineligibility determined|2|||
129824868|NCT01199289|467324735|FG001|Overall Study|Ineligibility determined|1|||
129824869|NCT01199289|467324736|FG002|Overall Study|Ineligibility determined|0|||
129824870|NCT01199289|467324737|FG003|Overall Study|Ineligibility determined|0|||
129824871|NCT01199289|467324734|FG000|Overall Study|Protocol Violation|1|||
129824872|NCT01199289|467324735|FG001|Overall Study|Protocol Violation|0|||
129824873|NCT01199289|467324736|FG002|Overall Study|Protocol Violation|0|||
129824874|NCT01199289|467324737|FG003|Overall Study|Protocol Violation|1|||
129824875|NCT01199289|467324734|FG000|Overall Study|Noncompliance|1|||
129824876|NCT01199289|467324735|FG001|Overall Study|Noncompliance|0|||
129824877|NCT01199289|467324736|FG002|Overall Study|Noncompliance|2|||
129824878|NCT01199289|467324737|FG003|Overall Study|Noncompliance|0|||
129824879|NCT01199289|467324734|FG000|Overall Study|Adverse Event|0|||
129824880|NCT01199289|467324735|FG001|Overall Study|Adverse Event|3|||
129824881|NCT01199289|467324736|FG002|Overall Study|Adverse Event|1|||
129824882|NCT01199289|467324737|FG003|Overall Study|Adverse Event|4|||
129824883|NCT01199289|467324734|FG000|Overall Study|Full consent withdrawn|2|||
129824884|NCT01199289|467324735|FG001|Overall Study|Full consent withdrawn|2|||
129824885|NCT01199289|467324736|FG002|Overall Study|Full consent withdrawn|2|||
129824886|NCT01199289|467324737|FG003|Overall Study|Full consent withdrawn|3|||
129824887|NCT01199289|467324734|FG000|Overall Study|Administrative decision|0|||
129824888|NCT01199289|467324735|FG001|Overall Study|Administrative decision|0|||
129824889|NCT01199289|467324736|FG002|Overall Study|Administrative decision|0|||
129824890|NCT01199289|467324737|FG003|Overall Study|Administrative decision|1|||
129824891|NCT01199289|467324734|FG000|Overall Study|Lost to Follow-up|0|||
129824892|NCT01199289|467324735|FG001|Overall Study|Lost to Follow-up|0|||
129824893|NCT01199289|467324736|FG002|Overall Study|Lost to Follow-up|0|||
129824894|NCT01199289|467324737|FG003|Overall Study|Lost to Follow-up|1|||
129824895|NCT01199289|467324734|FG000|Overall Study|Protocol-specified criteria|3|||
129824896|NCT01199289|467324735|FG001|Overall Study|Protocol-specified criteria|0|||
129824897|NCT01199289|467324736|FG002|Overall Study|Protocol-specified criteria|0|||
129824898|NCT01199289|467324737|FG003|Overall Study|Protocol-specified criteria|1|||
129824899|NCT01199289|467324734|FG000|Overall Study|Pregnancy|0|||
129824900|NCT01199289|467324735|FG001|Overall Study|Pregnancy|1|||
129824901|NCT01199289|467324736|FG002|Overall Study|Pregnancy|0|||
129824902|NCT01199289|467324737|FG003|Overall Study|Pregnancy|1|||
129824903|NCT02723084|467324738|FG000|Overall Study|Withdrawal by Subject|1|||
129824904|NCT02723084|467324739|FG001|Overall Study|Withdrawal by Subject|1|||
129824905|NCT02723084|467324738|FG000|Overall Study|Lost to Follow-up|3|||
129824906|NCT02723084|467324739|FG001|Overall Study|Lost to Follow-up|0|||
129824907|NCT02450903|467324745|FG000|Overall Study|Adverse Event|3|||
129824908|NCT02450903|467324745|FG000|Overall Study|Progressive disease|15|||
129824909|NCT02450903|467324745|FG000|Overall Study|Switched to commercial drug|1|||
129824910|NCT02450903|467324745|FG000|Overall Study|Subject/guardian decision|1|||
129824911|NCT01164956|467324746|FG000|Overall Study|Side Effects|1|||
129824912|NCT01164956|467324747|FG001|Overall Study|Side Effects|0|||
129824913|NCT01164956|467324748|FG002|Overall Study|Side Effects|1|||
129824914|NCT03020407|467324755|FG000|Overall Study|Withdrawal by Subject|2|||
129824915|NCT03020407|467324756|FG001|Overall Study|Withdrawal by Subject|1|||
129824916|NCT03020407|467324755|FG000|Overall Study|Lost to Follow-up|2|||
129824917|NCT03020407|467324756|FG001|Overall Study|Lost to Follow-up|3|||
129824918|NCT03020407|467324755|FG000|Overall Study|Protocol Violation|0|||
129824919|NCT03020407|467324756|FG001|Overall Study|Protocol Violation|1|||
129824920|NCT00708162|467324757|FG000|Randomized Phase|Randomized but Not Treated|7|||
129824921|NCT00708162|467324758|FG001|Randomized Phase|Randomized but Not Treated|5|||
129824922|NCT00708162|467324757|FG000|Randomized Phase|Participant Noncompliance|40|||
129824923|NCT00708162|467324758|FG001|Randomized Phase|Participant Noncompliance|32|||
129824924|NCT00708162|467324757|FG000|Randomized Phase|Lost to Follow-up|34|||
129824925|NCT00708162|467324758|FG001|Randomized Phase|Lost to Follow-up|34|||
129824926|NCT00708162|467324757|FG000|Randomized Phase|Withdrew Consent|31|||
129824927|NCT00708162|467324758|FG001|Randomized Phase|Withdrew Consent|22|||
129824928|NCT00708162|467324757|FG000|Randomized Phase|Lack of Efficacy|14|||
129824929|NCT00708162|467324758|FG001|Randomized Phase|Lack of Efficacy|19|||
129824930|NCT00708162|467324757|FG000|Randomized Phase|Protocol Violation|10|||
129824931|NCT00708162|467324758|FG001|Randomized Phase|Protocol Violation|11|||
129824932|NCT00708162|467324757|FG000|Randomized Phase|Adverse Event|8|||
129824933|NCT00708162|467324758|FG001|Randomized Phase|Adverse Event|12|||
129824934|NCT00708162|467324757|FG000|Randomized Phase|Investigator's Discretion|7|||
129824935|NCT00708162|467324758|FG001|Randomized Phase|Investigator's Discretion|10|||
129824936|NCT00708162|467324757|FG000|Randomized Phase|Death|2|||
129824937|NCT00708162|467324758|FG001|Randomized Phase|Death|9|||
129824938|NCT00708162|467324757|FG000|Randomized Phase|Pregnancy|3|||
129824939|NCT00708162|467324758|FG001|Randomized Phase|Pregnancy|0|||
129824940|NCT00708162|467324757|FG000|Open-Label Phase|Lost to Follow-up|10|||
129824941|NCT00708162|467324758|FG001|Open-Label Phase|Lost to Follow-up|8|||
129824942|NCT00708162|467324757|FG000|Open-Label Phase|Withdrew Consent|12|||
129445701|NCT01968070|465932886|FG011|Period 1|Physician Decision|1|||
129445702|NCT01968070|465932887|FG012|Period 1|Physician Decision|0|||
129445703|NCT01968070|465932888|FG013|Period 1|Physician Decision|0|||
129445704|NCT01968070|465932889|FG014|Period 1|Physician Decision|0|||
129445705|NCT01968070|465932890|FG015|Period 1|Physician Decision|0|||
129445706|NCT01968070|465932891|FG016|Period 1|Physician Decision|0|||
129824943|NCT00708162|467324758|FG001|Open-Label Phase|Withdrew Consent|6|||
129824944|NCT00708162|467324757|FG000|Open-Label Phase|Participant Noncompliance|7|||
129824945|NCT00708162|467324758|FG001|Open-Label Phase|Participant Noncompliance|7|||
129824946|NCT00708162|467324757|FG000|Open-Label Phase|Lack of Efficacy|7|||
129824947|NCT00708162|467324758|FG001|Open-Label Phase|Lack of Efficacy|4|||
129824948|NCT00708162|467324757|FG000|Open-Label Phase|Investigator's Discretion|3|||
129824949|NCT00708162|467324758|FG001|Open-Label Phase|Investigator's Discretion|2|||
129824950|NCT00708162|467324757|FG000|Open-Label Phase|Death|3|||
129824951|NCT00708162|467324758|FG001|Open-Label Phase|Death|1|||
129824952|NCT00708162|467324757|FG000|Open-Label Phase|Adverse Event|1|||
129824953|NCT00708162|467324758|FG001|Open-Label Phase|Adverse Event|2|||
129824954|NCT00708162|467324757|FG000|Open-Label Phase|Other|1|||
129824955|NCT00708162|467324758|FG001|Open-Label Phase|Other|0|||
129824956|NCT02699554|467324759|FG000|Overall Study|Lost to Follow-up|9|||
129824957|NCT00708643|467324760|FG000|Overall Study|Adverse Event|0|||
129824958|NCT00708643|467324761|FG001|Overall Study|Adverse Event|1|||
129824959|NCT00788151|467324762|FG000|Overall Study|Other adverse event|0|||
129824960|NCT00788151|467324763|FG001|Overall Study|Other adverse event|2|||
129824961|NCT00788151|467324762|FG000|Overall Study|Protocol Violation|0|||
129824962|NCT00788151|467324763|FG001|Overall Study|Protocol Violation|1|||
129824963|NCT00788151|467324762|FG000|Overall Study|Withdrawal by Subject|13|||
129824964|NCT00788151|467324763|FG001|Overall Study|Withdrawal by Subject|6|||
129824965|NCT00788151|467324762|FG000|Overall Study|Enrolled but not treated|1|||
129824966|NCT00788151|467324763|FG001|Overall Study|Enrolled but not treated|1|||
129824967|NCT00503009|467324764|FG000|Overall Study|Protocol Violation|1|||
129824968|NCT00503009|467324765|FG001|Overall Study|Protocol Violation|0|||
129824969|NCT00503009|467324766|FG002|Overall Study|Protocol Violation|1|||
129824970|NCT00503009|467324764|FG000|Overall Study|Withdrawal by Subject|0|||
129824971|NCT00503009|467324765|FG001|Overall Study|Withdrawal by Subject|1|||
129824972|NCT00503009|467324766|FG002|Overall Study|Withdrawal by Subject|1|||
129824973|NCT00503009|467324764|FG000|Overall Study|Physician Decision|0|||
129824974|NCT00503009|467324765|FG001|Overall Study|Physician Decision|1|||
129824975|NCT00503009|467324766|FG002|Overall Study|Physician Decision|1|||
129824976|NCT01349803|467324767|FG000|Overall Study|Adverse Event|0|||
129824977|NCT01349803|467324768|FG001|Overall Study|Adverse Event|0|||
129824978|NCT01349803|467324769|FG002|Overall Study|Adverse Event|0|||
129824979|NCT01349803|467324770|FG003|Overall Study|Adverse Event|2|||
129824980|NCT01349803|467324767|FG000|Overall Study|Withdrawal by Subject|1|||
129824981|NCT01349803|467324768|FG001|Overall Study|Withdrawal by Subject|0|||
129824982|NCT01349803|467324769|FG002|Overall Study|Withdrawal by Subject|0|||
129824983|NCT01349803|467324770|FG003|Overall Study|Withdrawal by Subject|0|||
129824984|NCT01349803|467324767|FG000|Overall Study|Protocol-specified criteria|0|||
129824985|NCT01349803|467324768|FG001|Overall Study|Protocol-specified criteria|1|||
129824986|NCT01349803|467324769|FG002|Overall Study|Protocol-specified criteria|3|||
129824987|NCT01349803|467324770|FG003|Overall Study|Protocol-specified criteria|0|||
129824988|NCT01710033|467324771|FG000|Stage 2|Adverse Event|0|||
129824989|NCT01710033|467324772|FG001|Stage 2|Adverse Event|0|||
129824990|NCT01710033|467324773|FG002|Stage 2|Adverse Event|0|||
129824991|NCT01710033|467324774|FG003|Stage 2|Adverse Event|0|||
129824992|NCT01710033|467324775|FG004|Stage 2|Adverse Event|1|||
129824993|NCT00100815|467324776|FG000|Overall Study|Progression|24|||
129824994|NCT00100815|467324776|FG000|Overall Study|Adverse Event|18|||
129824995|NCT00100815|467324776|FG000|Overall Study|Death|4|||
129824996|NCT00100815|467324776|FG000|Overall Study|Other|3|||
129824997|NCT01647282|467324778|FG000|Overall Study|Physician Decision|7|||
129897493|NCT00320489|467584393|FG000|Overall Study|Lack of Efficacy|16|||
129897494|NCT00320489|467584394|FG001|Overall Study|Lack of Efficacy|7|||
129824998|NCT01647282|467324779|FG001|Overall Study|Physician Decision|5|||
129824999|NCT01244906|467324781|FG000|Overall Study|Death|2|||
129825000|NCT01244906|467324781|FG000|Overall Study|Progression of disease post treatment|6|||
129825001|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
129825002|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
129897495|NCT00320489|467584393|FG000|Overall Study|Lost to Follow-up|21|||
129825003|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
129825004|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
129825005|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
129825006|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
129825007|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825008|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825009|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825010|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
129825011|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
129825012|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
129825013|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
129825014|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
129825015|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
129825016|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
129825017|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
129825018|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
129825019|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825020|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825021|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825022|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
129825023|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
129825024|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
129825025|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
129825026|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
129825027|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
129825028|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
129825029|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
129825030|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
129825031|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
129825032|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
129825033|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
129825034|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
129825035|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
129825036|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
129825037|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825038|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825039|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825040|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
129825041|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
129825042|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
129825043|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
129825044|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
129825045|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
129825046|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
129825047|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
129825048|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
129825049|NCT03720470|467324782|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825050|NCT03720470|467324783|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825051|NCT03720470|467324784|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825052|NCT03720470|467324785|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825053|NCT03720470|467324786|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
129825054|NCT03720470|467324787|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
129825055|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
129825056|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
129825057|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
129825058|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
129825059|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
129825060|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
129825061|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825062|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825063|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
129445707|NCT01968070|465932892|FG017|Period 1|Physician Decision|0|||
129825064|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825065|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825066|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
129825067|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825068|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825069|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825070|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
129825071|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
129825072|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
129825073|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825074|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825075|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825076|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825077|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
129825078|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
129825079|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825080|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825081|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
129825082|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825083|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825084|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
129825085|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
129825086|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
129825087|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
129825088|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
129825089|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
129825090|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
129825091|NCT03720470|467324782|FG000|Treatment Period: Final 4 Weeks|Other|0|||
129825092|NCT03720470|467324783|FG001|Treatment Period: Final 4 Weeks|Other|1|||
129825093|NCT03720470|467324784|FG002|Treatment Period: Final 4 Weeks|Other|0|||
129825094|NCT03720470|467324785|FG003|Treatment Period: Final 4 Weeks|Other|2|||
129825095|NCT03720470|467324786|FG004|Treatment Period: Final 4 Weeks|Other|1|||
129825096|NCT03720470|467324787|FG005|Treatment Period: Final 4 Weeks|Other|0|||
129825097|NCT00453921|467324788|FG000|Overall Study|Withdrawal by Subject|1|||
129445708|NCT01968070|465932875|FG000|Period 2|Withdrawal by Subject|0|||
129825098|NCT00453921|467324789|FG001|Overall Study|Withdrawal by Subject|1|||
129825099|NCT00453921|467324790|FG002|Overall Study|Withdrawal by Subject|1|||
129825100|NCT00453921|467324791|FG003|Overall Study|Withdrawal by Subject|1|||
129825101|NCT00453921|467324788|FG000|Overall Study|Lost to Follow-up|0|||
129825102|NCT00453921|467324789|FG001|Overall Study|Lost to Follow-up|0|||
129897496|NCT00320489|467584394|FG001|Overall Study|Lost to Follow-up|22|||
129825103|NCT00453921|467324790|FG002|Overall Study|Lost to Follow-up|1|||
129825104|NCT00453921|467324791|FG003|Overall Study|Lost to Follow-up|0|||
129825105|NCT00993291|467324795|FG000|Overall Study|Withdrawal by Subject|1|||
129825106|NCT02763189|467324796|FG000|Overall Study|Device failure|0|||
129825107|NCT02763189|467324797|FG001|Overall Study|Device failure|2|||
129825108|NCT00573534|467324802|FG000|Overall Study|oppositional behavior|3|||
129825109|NCT00467259|467324807|FG000|Overall Study|Adverse Event|24|||
129825110|NCT00467259|467324808|FG001|Overall Study|Adverse Event|90|||
129825111|NCT00467259|467324807|FG000|Overall Study|Protocol Violation|1|||
129825112|NCT00467259|467324808|FG001|Overall Study|Protocol Violation|7|||
129825113|NCT00467259|467324807|FG000|Overall Study|Withdrawal by Subject|34|||
129825114|NCT00467259|467324808|FG001|Overall Study|Withdrawal by Subject|108|||
129825115|NCT00467259|467324807|FG000|Overall Study|Physician Decision|0|||
129825116|NCT00467259|467324808|FG001|Overall Study|Physician Decision|2|||
129825117|NCT00467259|467324807|FG000|Overall Study|Lost to Follow-up|14|||
129825118|NCT00467259|467324808|FG001|Overall Study|Lost to Follow-up|34|||
129825119|NCT00467259|467324807|FG000|Overall Study|Site Closed|2|||
129825120|NCT00467259|467324808|FG001|Overall Study|Site Closed|1|||
129825121|NCT01129960|467324816|FG000|Overall Study|Withdrawal by Subject|3|||
129825122|NCT01129960|467324817|FG001|Overall Study|Withdrawal by Subject|0|||
129825123|NCT01129960|467324818|FG002|Overall Study|Withdrawal by Subject|3|||
129825124|NCT01129960|467324819|FG003|Overall Study|Withdrawal by Subject|2|||
129825125|NCT01129960|467324816|FG000|Overall Study|Lack of Efficacy|1|||
129825126|NCT01129960|467324817|FG001|Overall Study|Lack of Efficacy|1|||
129825127|NCT01129960|467324818|FG002|Overall Study|Lack of Efficacy|1|||
129825128|NCT01129960|467324819|FG003|Overall Study|Lack of Efficacy|1|||
129825129|NCT01129960|467324816|FG000|Overall Study|Adverse Event|23|||
129825130|NCT01129960|467324817|FG001|Overall Study|Adverse Event|16|||
129825131|NCT01129960|467324818|FG002|Overall Study|Adverse Event|16|||
129825132|NCT01129960|467324819|FG003|Overall Study|Adverse Event|7|||
129825133|NCT01129960|467324816|FG000|Overall Study|Protocol Violation|1|||
129825134|NCT01129960|467324817|FG001|Overall Study|Protocol Violation|2|||
129825135|NCT01129960|467324818|FG002|Overall Study|Protocol Violation|3|||
129825136|NCT01129960|467324819|FG003|Overall Study|Protocol Violation|0|||
129825137|NCT01129960|467324816|FG000|Overall Study|Lost to Follow-up|0|||
129825138|NCT01129960|467324817|FG001|Overall Study|Lost to Follow-up|2|||
129825139|NCT01129960|467324818|FG002|Overall Study|Lost to Follow-up|3|||
129825140|NCT01129960|467324819|FG003|Overall Study|Lost to Follow-up|3|||
129825141|NCT01129960|467324816|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
129825142|NCT01129960|467324817|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
129825143|NCT01129960|467324818|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
129825144|NCT01129960|467324819|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
129825145|NCT01129960|467324816|FG000|Overall Study|Physician Decision|1|||
129825146|NCT01129960|467324817|FG001|Overall Study|Physician Decision|0|||
129825147|NCT01129960|467324818|FG002|Overall Study|Physician Decision|0|||
129825148|NCT01129960|467324819|FG003|Overall Study|Physician Decision|0|||
129825149|NCT01129960|467324816|FG000|Overall Study|Pregnancy|1|||
129825150|NCT01129960|467324817|FG001|Overall Study|Pregnancy|0|||
129825151|NCT01129960|467324818|FG002|Overall Study|Pregnancy|0|||
129825152|NCT01129960|467324819|FG003|Overall Study|Pregnancy|0|||
129825153|NCT04285879|467324820|FG000|Overall Study|Lost to Follow-up|1|||
129825154|NCT04285879|467324821|FG001|Overall Study|Lost to Follow-up|8|||
129825155|NCT04285879|467324820|FG000|Overall Study|medical/surgical exclusion|16|||
129825156|NCT04285879|467324821|FG001|Overall Study|medical/surgical exclusion|0|||
129825157|NCT02056340|467324823|FG000|Overall Study|Lost to Follow-up|5|||
129825158|NCT02056340|467324824|FG001|Overall Study|Lost to Follow-up|5|||
129825159|NCT02056340|467324823|FG000|Overall Study|Withdrawal by Subject|2|||
129825160|NCT02056340|467324824|FG001|Overall Study|Withdrawal by Subject|6|||
129825161|NCT04900220|467324825|FG000|Overall Study|Lost to Follow-up|1|||
129825162|NCT04900220|467324826|FG001|Overall Study|Lost to Follow-up|1|||
129825163|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
129825164|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
129825165|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
129897497|NCT00320489|467584393|FG000|Overall Study|Physician Decision|8|||
129825166|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
129825167|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Death|7|||
129825168|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Death|5|||
129825169|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
129825170|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
129825171|NCT02999854|467324832|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
129825172|NCT02999854|467324833|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
129825173|NCT02999854|467324832|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
129825174|NCT02999854|467324833|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
129825175|NCT02999854|467324832|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
129825176|NCT02999854|467324833|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
129897498|NCT00320489|467584394|FG001|Overall Study|Physician Decision|8|||
129825177|NCT02999854|467324832|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
129825178|NCT02999854|467324833|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
129825179|NCT01085591|467324834|FG000|Overall Study|Adverse Event|0|||
129825180|NCT01085591|467324835|FG001|Overall Study|Adverse Event|1|||
129825181|NCT01085591|467324836|FG002|Overall Study|Adverse Event|3|||
129825182|NCT01085591|467324834|FG000|Overall Study|Physician Decision|1|||
129825183|NCT01085591|467324835|FG001|Overall Study|Physician Decision|0|||
129825184|NCT01085591|467324836|FG002|Overall Study|Physician Decision|1|||
129825185|NCT01085591|467324834|FG000|Overall Study|Withdrawal by Subject|0|||
129825186|NCT01085591|467324835|FG001|Overall Study|Withdrawal by Subject|2|||
129825187|NCT01085591|467324836|FG002|Overall Study|Withdrawal by Subject|1|||
129825188|NCT01085591|467324834|FG000|Overall Study|Lost to Follow-up|0|||
129825189|NCT01085591|467324835|FG001|Overall Study|Lost to Follow-up|1|||
129825190|NCT01085591|467324836|FG002|Overall Study|Lost to Follow-up|1|||
129825191|NCT01085591|467324834|FG000|Overall Study|Protocol Violation|1|||
129825192|NCT01085591|467324835|FG001|Overall Study|Protocol Violation|1|||
129825193|NCT01085591|467324836|FG002|Overall Study|Protocol Violation|1|||
129825194|NCT01085591|467324834|FG000|Overall Study|Other|0|||
129825195|NCT01085591|467324835|FG001|Overall Study|Other|1|||
129825196|NCT01085591|467324836|FG002|Overall Study|Other|0|||
129825197|NCT01085591|467324834|FG000|Overall Study|Not Properly Consented|1|||
129825198|NCT01085591|467324835|FG001|Overall Study|Not Properly Consented|0|||
129825199|NCT01085591|467324836|FG002|Overall Study|Not Properly Consented|0|||
129825200|NCT00847704|467324837|FG000|Overall Study|Withdrawal by Subject|1|||
129825201|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
129825202|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
129825203|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
129825204|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
129825205|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
129825206|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
129825207|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
129825208|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
129825209|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
129825210|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
129825211|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
129825212|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
129825213|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
129825214|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
129825215|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
129825216|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
129825217|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
129825218|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
129825219|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
129825220|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
129825221|NCT01962207|467324838|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
129825222|NCT01962207|467324839|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
129825223|NCT01962207|467324840|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
129825224|NCT01962207|467324841|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
129825225|NCT03036072|467324844|FG000|Overall Study|Death|0|||
129825226|NCT03036072|467324845|FG001|Overall Study|Death|1|||
129825227|NCT03036072|467324844|FG000|Overall Study|Withdrawal by Subject|0|||
129825228|NCT03036072|467324845|FG001|Overall Study|Withdrawal by Subject|1|||
129825229|NCT03036072|467324844|FG000|Overall Study|Physician Decision|0|||
129825230|NCT03036072|467324845|FG001|Overall Study|Physician Decision|1|||
129825231|NCT02484729|467324846|FG000|Overall Study|Failure of IntelliCap Error|0|||
129825232|NCT02484729|467324847|FG001|Overall Study|Failure of IntelliCap Error|0|||
129825233|NCT02484729|467324848|FG002|Overall Study|Failure of IntelliCap Error|0|||
129825234|NCT02484729|467324849|FG003|Overall Study|Failure of IntelliCap Error|0|||
129825235|NCT02484729|467324850|FG004|Overall Study|Failure of IntelliCap Error|0|||
129825236|NCT02484729|467324851|FG005|Overall Study|Failure of IntelliCap Error|0|||
129825237|NCT02484729|467324852|FG006|Overall Study|Failure of IntelliCap Error|0|||
129825238|NCT02484729|467324853|FG007|Overall Study|Failure of IntelliCap Error|0|||
129825239|NCT02484729|467324854|FG008|Overall Study|Failure of IntelliCap Error|0|||
129825240|NCT02484729|467324855|FG009|Overall Study|Failure of IntelliCap Error|1|||
129825241|NCT02111850|467324858|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825242|NCT02111850|467324859|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825243|NCT02111850|467324860|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825244|NCT02111850|467324861|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825245|NCT02111850|467324862|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
129825246|NCT02111850|467324863|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825247|NCT02111850|467324864|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825248|NCT02111850|467324865|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825249|NCT02111850|467324866|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825250|NCT02111850|467324867|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825251|NCT02111850|467324868|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
129825252|NCT00665847|467324869|FG000|Overall Study|Adverse Event|8|||
129825253|NCT00665847|467324869|FG000|Overall Study|Withdrawal by Subject|2|||
129825254|NCT00665847|467324869|FG000|Overall Study|Subject non-compliant|8|||
129825255|NCT00665847|467324869|FG000|Overall Study|Subject reached a virologic endpoint|4|||
129825256|NCT00665847|467324869|FG000|Overall Study|Resistance to TMC125|1|||
129825257|NCT00665847|467324869|FG000|Overall Study|Subject ineligible to continue the trial|1|||
129825258|NCT00665847|467324869|FG000|Overall Study|Switch to Commercial Medication|1|||
129825259|NCT03605303|467324870|FG000|Period 1|Study Terminated|2|||
129825260|NCT03605303|467324871|FG001|Period 1|Study Terminated|1|||
129825261|NCT02626520|467324874|FG000|Overall Study|Physician Decision|1|||
129825262|NCT02626520|467324875|FG001|Overall Study|Physician Decision|1|||
129825263|NCT02626520|467324874|FG000|Overall Study|Adverse Event|0|||
129825264|NCT02626520|467324875|FG001|Overall Study|Adverse Event|4|||
129825265|NCT02626520|467324874|FG000|Overall Study|Lack of Efficacy|0|||
129825266|NCT02626520|467324875|FG001|Overall Study|Lack of Efficacy|2|||
129825267|NCT02626520|467324874|FG000|Overall Study|Did not start protocol therapy|0|||
129825268|NCT02626520|467324875|FG001|Overall Study|Did not start protocol therapy|2|||
129825269|NCT02626520|467324874|FG000|Overall Study|Study terminated|0|||
129825270|NCT02626520|467324875|FG001|Overall Study|Study terminated|1|||
129825271|NCT00492115|467324876|FG000|Overall Study|Withdrawal by Subject|3|||
129825272|NCT00492115|467324877|FG001|Overall Study|Withdrawal by Subject|4|||
129825273|NCT03564145|467324880|FG000|Overall Study|Adverse Event|4|||
129825274|NCT03564145|467324880|FG000|Overall Study|Lost to Follow-up|21|||
129825275|NCT03564145|467324880|FG000|Overall Study|Protocol Violation|2|||
129825276|NCT03564145|467324880|FG000|Overall Study|Withdrawal by Subject|48|||
129825277|NCT03564145|467324880|FG000|Overall Study|Study Terminated by Sponsor|146|||
129825278|NCT03564145|467324880|FG000|Overall Study|Physician Decision|1|||
129825279|NCT03564145|467324880|FG000|Overall Study|Other Than Specified|1|||
129825280|NCT03564145|467324880|FG000|Overall Study|Pregnancy|1|||
129825281|NCT03915496|467324881|FG000|Overall Study|Adverse Event|2|||
129825282|NCT03915496|467324882|FG001|Overall Study|Adverse Event|1|||
129825283|NCT03915496|467324883|FG002|Overall Study|Adverse Event|2|||
129825284|NCT01031069|467324884|FG000|Overall Study|Serious Adverse Event|0|||
129825285|NCT01031069|467324885|FG001|Overall Study|Serious Adverse Event|1|||
129825286|NCT01031069|467324886|FG002|Overall Study|Serious Adverse Event|0|||
129825287|NCT01031069|467324887|FG003|Overall Study|Serious Adverse Event|0|||
129825288|NCT01031069|467324884|FG000|Overall Study|Withdrawal by Subject|2|||
129825289|NCT01031069|467324885|FG001|Overall Study|Withdrawal by Subject|3|||
129825290|NCT01031069|467324886|FG002|Overall Study|Withdrawal by Subject|18|||
129825291|NCT01031069|467324887|FG003|Overall Study|Withdrawal by Subject|18|||
129825292|NCT01031069|467324884|FG000|Overall Study|Migrated/moved from study area|1|||
129825293|NCT01031069|467324885|FG001|Overall Study|Migrated/moved from study area|2|||
129825294|NCT01031069|467324886|FG002|Overall Study|Migrated/moved from study area|1|||
129825295|NCT01031069|467324887|FG003|Overall Study|Migrated/moved from study area|1|||
129825296|NCT01031069|467324884|FG000|Overall Study|Lost to Follow-up|9|||
129825297|NCT01031069|467324885|FG001|Overall Study|Lost to Follow-up|5|||
129825298|NCT01031069|467324886|FG002|Overall Study|Lost to Follow-up|21|||
129825299|NCT01031069|467324887|FG003|Overall Study|Lost to Follow-up|15|||
129825300|NCT01031069|467324884|FG000|Overall Study|Other|0|||
129825301|NCT01031069|467324885|FG001|Overall Study|Other|0|||
129825302|NCT01031069|467324886|FG002|Overall Study|Other|1|||
129825303|NCT01031069|467324887|FG003|Overall Study|Other|0|||
129825304|NCT05286307|467324888|FG000|Overall Study|Incomplete outcome assessments|2|||
129825305|NCT05286307|467324889|FG001|Overall Study|Incomplete outcome assessments|1|||
129825306|NCT05286307|467324888|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
129825307|NCT05286307|467324889|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
129825308|NCT05286307|467324888|FG000|Overall Study|Lost to follow up at 6 months|25|||
129825309|NCT05286307|467324889|FG001|Overall Study|Lost to follow up at 6 months|35|||
129825310|NCT05286307|467324888|FG000|Overall Study|Study medication not available|1|||
129825311|NCT05286307|467324889|FG001|Overall Study|Study medication not available|1|||
129825312|NCT01103284|467324890|FG000|Overall Study|Death|2|||
129825313|NCT01103284|467324891|FG001|Overall Study|Death|0|||
129825314|NCT01103284|467324890|FG000|Overall Study|Lost to Follow-up|9|||
129825315|NCT01103284|467324891|FG001|Overall Study|Lost to Follow-up|10|||
129825316|NCT01103284|467324890|FG000|Overall Study|Pregnancy|3|||
129825317|NCT01103284|467324891|FG001|Overall Study|Pregnancy|1|||
129825318|NCT01103284|467324890|FG000|Overall Study|Protocol Violation|12|||
129825319|NCT01103284|467324891|FG001|Overall Study|Protocol Violation|5|||
129825320|NCT01103284|467324890|FG000|Overall Study|Adverse Event|0|||
129825321|NCT01103284|467324891|FG001|Overall Study|Adverse Event|5|||
129825322|NCT01103284|467324890|FG000|Overall Study|Withdrawal by Subject|14|||
129825323|NCT01103284|467324891|FG001|Overall Study|Withdrawal by Subject|18|||
129825324|NCT01103284|467324890|FG000|Overall Study|Dermal Hypersensitivity|0|||
129825325|NCT01103284|467324891|FG001|Overall Study|Dermal Hypersensitivity|1|||
129825326|NCT01103284|467324890|FG000|Overall Study|Termination by the Sponsor|0|||
129825327|NCT01103284|467324891|FG001|Overall Study|Termination by the Sponsor|1|||
129825328|NCT01103284|467324890|FG000|Overall Study|Not described|2|||
129825329|NCT01103284|467324891|FG001|Overall Study|Not described|1|||
129825330|NCT01103284|467324890|FG000|Overall Study|Missing CRF entries for study completion|0|||
129825331|NCT01103284|467324891|FG001|Overall Study|Missing CRF entries for study completion|2|||
129825332|NCT05024058|467326499|FG000|Treatment|Study terminated by sponsor|5|||
129825333|NCT05024058|467326500|FG001|Treatment|Study terminated by sponsor|6|||
129825334|NCT05024058|467326501|FG002|Treatment|Study terminated by sponsor|4|||
129825335|NCT05024058|467326502|FG003|Treatment|Study terminated by sponsor|2|||
129825336|NCT05024058|467326503|FG004|Treatment|Study terminated by sponsor|3|||
129825337|NCT05024058|467326504|FG005|Treatment|Study terminated by sponsor|3|||
129825338|NCT05024058|467326505|FG006|Treatment|Study terminated by sponsor|1|||
129825339|NCT05024058|467326506|FG007|Treatment|Study terminated by sponsor|3|||
129825340|NCT05024058|467326507|FG008|Treatment|Study terminated by sponsor|6|||
129825341|NCT05024058|467326508|FG009|Treatment|Study terminated by sponsor|6|||
129825342|NCT05024058|467326499|FG000|Follow-up|Withdrawal by Subject|1|||
129825343|NCT05024058|467326500|FG001|Follow-up|Withdrawal by Subject|0|||
129825344|NCT05024058|467326501|FG002|Follow-up|Withdrawal by Subject|1|||
129825345|NCT05024058|467326502|FG003|Follow-up|Withdrawal by Subject|0|||
129825346|NCT05024058|467326503|FG004|Follow-up|Withdrawal by Subject|0|||
129825347|NCT05024058|467326504|FG005|Follow-up|Withdrawal by Subject|0|||
129825348|NCT05024058|467326505|FG006|Follow-up|Withdrawal by Subject|0|||
129825349|NCT05024058|467326506|FG007|Follow-up|Withdrawal by Subject|1|||
129825350|NCT05024058|467326507|FG008|Follow-up|Withdrawal by Subject|0|||
129825351|NCT05024058|467326508|FG009|Follow-up|Withdrawal by Subject|1|||
129825352|NCT00501293|467326509|FG000|Optimization Period|Enrolled in error|1|||
129825353|NCT00501293|467326510|FG001|Optimization Period|Enrolled in error|0|||
129825354|NCT00501293|467326509|FG000|Maintenance Period|Withdrawal by Subject|14|||
129825355|NCT00501293|467326510|FG001|Maintenance Period|Withdrawal by Subject|13|||
129825356|NCT00501293|467326509|FG000|Maintenance Period|Lost to Follow-up|12|||
129825357|NCT00501293|467326510|FG001|Maintenance Period|Lost to Follow-up|7|||
129825358|NCT00501293|467326509|FG000|Maintenance Period|Adverse Event|6|||
129825359|NCT00501293|467326510|FG001|Maintenance Period|Adverse Event|6|||
129825360|NCT00501293|467326509|FG000|Maintenance Period|Protocol Violation|2|||
129825361|NCT00501293|467326510|FG001|Maintenance Period|Protocol Violation|1|||
129825362|NCT00501293|467326509|FG000|Maintenance Period|Lack of Efficacy|4|||
129825363|NCT00501293|467326510|FG001|Maintenance Period|Lack of Efficacy|1|||
129825364|NCT00501293|467326509|FG000|Maintenance Period|Noncompliant with study medication|5|||
129825365|NCT00501293|467326510|FG001|Maintenance Period|Noncompliant with study medication|0|||
129825366|NCT00501293|467326509|FG000|Maintenance Period|Went into rehabilitation|1|||
129825367|NCT00501293|467326510|FG001|Maintenance Period|Went into rehabilitation|0|||
129825368|NCT00501293|467326509|FG000|Maintenance Period|Would not wear patch|1|||
129825369|NCT00501293|467326510|FG001|Maintenance Period|Would not wear patch|0|||
129825370|NCT00501293|467326509|FG000|Maintenance Period|Application site reaction|1|||
129825371|NCT00501293|467326510|FG001|Maintenance Period|Application site reaction|0|||
129825372|NCT00127712|467326511|FG000|Overall Study|Adverse Event|3|||
129825373|NCT00127712|467326512|FG001|Overall Study|Adverse Event|0|||
129825374|NCT00127712|467326511|FG000|Overall Study|Lack of GI access to continue|2|||
129825375|NCT00127712|467326512|FG001|Overall Study|Lack of GI access to continue|0|||
129825376|NCT02642614|467326513|FG000|Overall Study|Adverse Event|1|||
129825377|NCT02642614|467326514|FG001|Overall Study|Adverse Event|1|||
129825378|NCT02642614|467326515|FG002|Overall Study|Adverse Event|2|||
129825379|NCT02642614|467326516|FG003|Overall Study|Adverse Event|2|||
129825380|NCT02642614|467326513|FG000|Overall Study|Lost to Follow-up|1|||
129825381|NCT02642614|467326514|FG001|Overall Study|Lost to Follow-up|0|||
129825382|NCT02642614|467326515|FG002|Overall Study|Lost to Follow-up|0|||
129825383|NCT02642614|467326516|FG003|Overall Study|Lost to Follow-up|0|||
129825384|NCT02642614|467326513|FG000|Overall Study|Withdrawal by Subject|1|||
129825385|NCT02642614|467326514|FG001|Overall Study|Withdrawal by Subject|1|||
129825386|NCT02642614|467326515|FG002|Overall Study|Withdrawal by Subject|0|||
129825387|NCT02642614|467326516|FG003|Overall Study|Withdrawal by Subject|0|||
129825388|NCT00967798|467326517|FG000|Overall Study|Withdrawal by Subject|5|||
129825389|NCT00967798|467326518|FG001|Overall Study|Withdrawal by Subject|2|||
129825390|NCT00967798|467326517|FG000|Overall Study|Lost to Follow-up|4|||
129825391|NCT00967798|467326518|FG001|Overall Study|Lost to Follow-up|1|||
129825392|NCT01320085|467326519|FG000|Overall Study|Disease Progression|26|||
129825393|NCT01320085|467326520|FG001|Overall Study|Disease Progression|93|||
129825394|NCT01320085|467326521|FG002|Overall Study|Disease Progression|17|||
129825395|NCT01320085|467326519|FG000|Overall Study|Adverse Event|12|||
129825396|NCT01320085|467326520|FG001|Overall Study|Adverse Event|20|||
129825397|NCT01320085|467326521|FG002|Overall Study|Adverse Event|5|||
129825398|NCT01320085|467326519|FG000|Overall Study|Withdrawal by Subject|2|||
129825399|NCT01320085|467326520|FG001|Overall Study|Withdrawal by Subject|4|||
129825400|NCT01320085|467326521|FG002|Overall Study|Withdrawal by Subject|1|||
129825401|NCT01320085|467326519|FG000|Overall Study|Protocol Deviation|1|||
129825402|NCT01320085|467326520|FG001|Overall Study|Protocol Deviation|0|||
129825403|NCT01320085|467326521|FG002|Overall Study|Protocol Deviation|1|||
129825404|NCT01320085|467326519|FG000|Overall Study|Administrative problems|0|||
129825405|NCT01320085|467326520|FG001|Overall Study|Administrative problems|0|||
129825406|NCT01320085|467326521|FG002|Overall Study|Administrative problems|1|||
129825407|NCT03316131|467326522|FG000|Treatment Period 2|Protocol deviation|1|||
129825408|NCT03316131|467326523|FG001|Treatment Period 2|Protocol deviation|0|||
129825409|NCT01409564|467326524|FG000|Overall Study|low medication compliance|4|||
129825410|NCT01409564|467326525|FG001|Overall Study|low medication compliance|3|||
129825411|NCT01409564|467326524|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
129825412|NCT01409564|467326525|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
129825413|NCT01525550|467326531|FG000|Overall Study|Lost to Follow-up|8|||
129825414|NCT01525550|467326532|FG001|Overall Study|Lost to Follow-up|2|||
129825415|NCT01525550|467326531|FG000|Overall Study|Death|19|||
129825416|NCT01525550|467326532|FG001|Overall Study|Death|28|||
129825417|NCT01525550|467326531|FG000|Overall Study|Other|0|||
129825418|NCT01525550|467326532|FG001|Overall Study|Other|4|||
129825419|NCT01525550|467326531|FG000|Overall Study|Sponsor's Decision|30|||
129825420|NCT01525550|467326532|FG001|Overall Study|Sponsor's Decision|11|||
129825421|NCT01525550|467326531|FG000|Overall Study|Withdrawal by Subject|4|||
129825422|NCT01525550|467326532|FG001|Overall Study|Withdrawal by Subject|0|||
129825423|NCT00723892|467326538|FG000|Overall Study|Participant not tracked|33|||
129825424|NCT00723892|467326539|FG001|Overall Study|Participant not tracked|35|||
129825425|NCT00723892|467326538|FG000|Overall Study|Virological criterion|24|||
129825426|NCT00723892|467326539|FG001|Overall Study|Virological criterion|9|||
129825427|NCT00723892|467326538|FG000|Overall Study|Withdrawal by Subject|6|||
129825428|NCT00723892|467326539|FG001|Overall Study|Withdrawal by Subject|9|||
129825429|NCT00723892|467326538|FG000|Overall Study|End planned|11|||
129825430|NCT00723892|467326539|FG001|Overall Study|End planned|7|||
129825431|NCT00723892|467326538|FG000|Overall Study|Bad tolerance|5|||
129825432|NCT00723892|467326539|FG001|Overall Study|Bad tolerance|5|||
129825433|NCT00723892|467326538|FG000|Overall Study|Multiple reasons|17|||
129825434|NCT00723892|467326539|FG001|Overall Study|Multiple reasons|12|||
129825435|NCT00723892|467326538|FG000|Overall Study|Other|6|||
129825436|NCT00723892|467326539|FG001|Overall Study|Other|3|||
129825437|NCT00723892|467326538|FG000|Overall Study|Study end|1|||
129825438|NCT00723892|467326539|FG001|Overall Study|Study end|3|||
129825439|NCT00723892|467326538|FG000|Overall Study|Weight loss|1|||
129825440|NCT00723892|467326539|FG001|Overall Study|Weight loss|3|||
129825441|NCT00723892|467326538|FG000|Overall Study|Alcohol abuse|0|||
129825442|NCT00723892|467326539|FG001|Overall Study|Alcohol abuse|1|||
129825443|NCT00723892|467326538|FG000|Overall Study|Intercurrent infection|2|||
129825444|NCT00723892|467326539|FG001|Overall Study|Intercurrent infection|0|||
129825445|NCT00723892|467326538|FG000|Overall Study|Drug addiction|1|||
129825446|NCT00723892|467326539|FG001|Overall Study|Drug addiction|0|||
129825447|NCT02411292|467326543|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
129825448|NCT02411292|467326543|FG000|Overall Study|Death|2|||
129825449|NCT02411292|467326543|FG000|Overall Study|Lost to Follow-up|3|||
129825450|NCT02232425|467326544|FG000|Overall Study|Lost to Follow-up|6|||
129825451|NCT02232425|467326545|FG001|Overall Study|Lost to Follow-up|2|||
129825452|NCT02232425|467326544|FG000|Overall Study|Adverse Event|2|||
129825453|NCT02232425|467326545|FG001|Overall Study|Adverse Event|0|||
129825454|NCT02232425|467326544|FG000|Overall Study|Withdrawal by Subject|5|||
129825455|NCT02232425|467326545|FG001|Overall Study|Withdrawal by Subject|6|||
129825456|NCT02232425|467326544|FG000|Overall Study|Lack of Efficacy|1|||
129825457|NCT02232425|467326545|FG001|Overall Study|Lack of Efficacy|0|||
129825458|NCT00665353|467326546|FG000|Study Step 1|Adverse Event|1|||
129825459|NCT00665353|467326546|FG000|Study Step 1|Withdrawal by Subject|2|||
129825460|NCT00665353|467326546|FG000|Study Step 2|Lost to Follow-up|2|||
129897499|NCT00320489|467584393|FG000|Overall Study|Protocol Violation|4|||
129825461|NCT00665353|467326546|FG000|Study Step 2|Lack of Efficacy|12|||
129825462|NCT00498602|467326547|FG000|Overall Study|Death|0|||
129825463|NCT00498602|467326548|FG001|Overall Study|Death|0|||
129825464|NCT00498602|467326549|FG002|Overall Study|Death|0|||
129825465|NCT00498602|467326550|FG003|Overall Study|Death|0|||
129825466|NCT00498602|467326551|FG004|Overall Study|Death|0|||
129825467|NCT00498602|467326552|FG005|Overall Study|Death|1|||
129825468|NCT00498602|467326553|FG006|Overall Study|Death|0|||
129825469|NCT00498602|467326547|FG000|Overall Study|Lack of Efficacy|1|||
129825470|NCT00498602|467326548|FG001|Overall Study|Lack of Efficacy|0|||
129825471|NCT00498602|467326549|FG002|Overall Study|Lack of Efficacy|0|||
129825472|NCT00498602|467326550|FG003|Overall Study|Lack of Efficacy|0|||
129825473|NCT00498602|467326551|FG004|Overall Study|Lack of Efficacy|0|||
129825474|NCT00498602|467326552|FG005|Overall Study|Lack of Efficacy|0|||
129825475|NCT00498602|467326553|FG006|Overall Study|Lack of Efficacy|0|||
129825476|NCT00498602|467326547|FG000|Overall Study|Lost to Follow-up|0|||
129825477|NCT00498602|467326548|FG001|Overall Study|Lost to Follow-up|2|||
129825478|NCT00498602|467326549|FG002|Overall Study|Lost to Follow-up|0|||
129825479|NCT00498602|467326550|FG003|Overall Study|Lost to Follow-up|2|||
129825480|NCT00498602|467326551|FG004|Overall Study|Lost to Follow-up|0|||
129825481|NCT00498602|467326552|FG005|Overall Study|Lost to Follow-up|0|||
129825482|NCT00498602|467326553|FG006|Overall Study|Lost to Follow-up|0|||
129825483|NCT00498602|467326547|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129825484|NCT00498602|467326548|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129825485|NCT00498602|467326549|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
129825486|NCT00498602|467326550|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
129825487|NCT00498602|467326551|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129825488|NCT00498602|467326552|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129825489|NCT00498602|467326553|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129825490|NCT00498602|467326547|FG000|Overall Study|AE not related to Study Drug|1|||
129825491|NCT00498602|467326548|FG001|Overall Study|AE not related to Study Drug|3|||
129825492|NCT00498602|467326549|FG002|Overall Study|AE not related to Study Drug|0|||
129825493|NCT00498602|467326550|FG003|Overall Study|AE not related to Study Drug|0|||
129825494|NCT00498602|467326551|FG004|Overall Study|AE not related to Study Drug|2|||
129825495|NCT00498602|467326552|FG005|Overall Study|AE not related to Study Drug|2|||
129825496|NCT00498602|467326553|FG006|Overall Study|AE not related to Study Drug|1|||
129825497|NCT00498602|467326547|FG000|Overall Study|Caregiver Request|2|||
129825498|NCT00498602|467326548|FG001|Overall Study|Caregiver Request|2|||
129825499|NCT00498602|467326549|FG002|Overall Study|Caregiver Request|2|||
129825500|NCT00498602|467326550|FG003|Overall Study|Caregiver Request|0|||
129825501|NCT00498602|467326551|FG004|Overall Study|Caregiver Request|1|||
129825502|NCT00498602|467326552|FG005|Overall Study|Caregiver Request|2|||
129825503|NCT00498602|467326553|FG006|Overall Study|Caregiver Request|0|||
129825504|NCT00498602|467326547|FG000|Overall Study|Investigator Request|0|||
129825505|NCT00498602|467326548|FG001|Overall Study|Investigator Request|0|||
129825506|NCT00498602|467326549|FG002|Overall Study|Investigator Request|1|||
129825507|NCT00498602|467326550|FG003|Overall Study|Investigator Request|0|||
129825508|NCT00498602|467326551|FG004|Overall Study|Investigator Request|0|||
129825509|NCT00498602|467326552|FG005|Overall Study|Investigator Request|0|||
129825510|NCT00498602|467326553|FG006|Overall Study|Investigator Request|0|||
129825511|NCT00498602|467326547|FG000|Overall Study|Subject Request|3|||
129825512|NCT00498602|467326548|FG001|Overall Study|Subject Request|0|||
129825513|NCT00498602|467326549|FG002|Overall Study|Subject Request|1|||
129825514|NCT00498602|467326550|FG003|Overall Study|Subject Request|1|||
129825515|NCT00498602|467326551|FG004|Overall Study|Subject Request|1|||
129825516|NCT00498602|467326552|FG005|Overall Study|Subject Request|4|||
129825517|NCT00498602|467326553|FG006|Overall Study|Subject Request|1|||
129825518|NCT00498602|467326547|FG000|Overall Study|Other|2|||
129825519|NCT00498602|467326548|FG001|Overall Study|Other|3|||
129825520|NCT00498602|467326549|FG002|Overall Study|Other|1|||
129825521|NCT00498602|467326550|FG003|Overall Study|Other|0|||
129825522|NCT00498602|467326551|FG004|Overall Study|Other|0|||
129825523|NCT00498602|467326552|FG005|Overall Study|Other|3|||
129825524|NCT00498602|467326553|FG006|Overall Study|Other|0|||
129825525|NCT03103919|467326557|FG000|Overall Study|Adverse Event|2|||
129825526|NCT03103919|467326558|FG001|Overall Study|Adverse Event|2|||
129825527|NCT01291173|467326559|FG000|Overall Study|Adverse Event|0|||
129825528|NCT01291173|467326560|FG001|Overall Study|Adverse Event|3|||
129825529|NCT01291173|467326561|FG002|Overall Study|Adverse Event|1|||
129825530|NCT01291173|467326562|FG003|Overall Study|Adverse Event|3|||
129825531|NCT01291173|467326559|FG000|Overall Study|Protocol Violation|7|||
129825532|NCT01291173|467326560|FG001|Overall Study|Protocol Violation|2|||
129825533|NCT01291173|467326561|FG002|Overall Study|Protocol Violation|2|||
129825534|NCT01291173|467326562|FG003|Overall Study|Protocol Violation|5|||
129825535|NCT01291173|467326559|FG000|Overall Study|Withdrawal by Subject|6|||
129825536|NCT01291173|467326560|FG001|Overall Study|Withdrawal by Subject|4|||
129825537|NCT01291173|467326561|FG002|Overall Study|Withdrawal by Subject|4|||
129825538|NCT01291173|467326562|FG003|Overall Study|Withdrawal by Subject|2|||
129897500|NCT00320489|467584394|FG001|Overall Study|Protocol Violation|4|||
129897501|NCT00320489|467584393|FG000|Overall Study|Sponsor Decision|3|||
129825539|NCT01291173|467326559|FG000|Overall Study|Lost to Follow-up|4|||
129825540|NCT01291173|467326560|FG001|Overall Study|Lost to Follow-up|6|||
129825541|NCT01291173|467326561|FG002|Overall Study|Lost to Follow-up|3|||
129825542|NCT01291173|467326562|FG003|Overall Study|Lost to Follow-up|2|||
129825543|NCT01291173|467326559|FG000|Overall Study|Unable to meet visit schedule|0|||
129825544|NCT01291173|467326560|FG001|Overall Study|Unable to meet visit schedule|0|||
129825545|NCT01291173|467326561|FG002|Overall Study|Unable to meet visit schedule|1|||
129825546|NCT01291173|467326562|FG003|Overall Study|Unable to meet visit schedule|0|||
129825547|NCT01291173|467326559|FG000|Overall Study|Lack of compliance|0|||
129825548|NCT01291173|467326560|FG001|Overall Study|Lack of compliance|0|||
129825549|NCT01291173|467326561|FG002|Overall Study|Lack of compliance|0|||
129825550|NCT01291173|467326562|FG003|Overall Study|Lack of compliance|1|||
129825551|NCT01291173|467326559|FG000|Overall Study|Subject was unblinded|0|||
129825552|NCT01291173|467326560|FG001|Overall Study|Subject was unblinded|0|||
129825553|NCT01291173|467326561|FG002|Overall Study|Subject was unblinded|1|||
129825554|NCT01291173|467326562|FG003|Overall Study|Subject was unblinded|0|||
129825555|NCT01291173|467326559|FG000|Overall Study|Excluded therapy|0|||
129825556|NCT01291173|467326560|FG001|Overall Study|Excluded therapy|0|||
129825557|NCT01291173|467326561|FG002|Overall Study|Excluded therapy|1|||
129825558|NCT01291173|467326562|FG003|Overall Study|Excluded therapy|0|||
129825559|NCT01846507|467326563|FG000|Overall Study|Lost to Follow-up|4|||
129825560|NCT01846507|467326563|FG000|Overall Study|Protocol Violation|1|||
129825561|NCT01846507|467326563|FG000|Overall Study|Missing data|2|||
129825562|NCT02436356|467326564|FG000|Overall Study|Excluded by MRI Screening|0|||
129825563|NCT02436356|467326565|FG001|Overall Study|Excluded by MRI Screening|0|||
129825564|NCT02436356|467326566|FG002|Overall Study|Excluded by MRI Screening|2|||
129825565|NCT02436356|467326564|FG000|Overall Study|Lost to Follow-up|0|||
129825566|NCT02436356|467326565|FG001|Overall Study|Lost to Follow-up|1|||
129825567|NCT02436356|467326566|FG002|Overall Study|Lost to Follow-up|0|||
129825568|NCT02436356|467326564|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
129825569|NCT02436356|467326565|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
129825570|NCT02436356|467326566|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
129825571|NCT02436356|467326564|FG000|Overall Study|Excluded due to other medical conditions|3|||
129825572|NCT02436356|467326565|FG001|Overall Study|Excluded due to other medical conditions|0|||
129825573|NCT02436356|467326566|FG002|Overall Study|Excluded due to other medical conditions|0|||
129825574|NCT02436356|467326564|FG000|Overall Study|Withdrawal by Subject|1|||
129825575|NCT02436356|467326565|FG001|Overall Study|Withdrawal by Subject|0|||
129825576|NCT02436356|467326566|FG002|Overall Study|Withdrawal by Subject|0|||
129825577|NCT04577118|467326567|FG000|Overall Study|Withdrawal by Subject|4|||
129825578|NCT00674661|467326568|FG000|Overall Study|Other|5|||
129825579|NCT00674661|467326569|FG001|Overall Study|Other|7|||
129825580|NCT00674661|467326568|FG000|Overall Study|Lost to Follow-up|6|||
129825581|NCT00674661|467326569|FG001|Overall Study|Lost to Follow-up|3|||
129825582|NCT00674661|467326568|FG000|Overall Study|Withdrawal by Subject|0|||
129825583|NCT00674661|467326569|FG001|Overall Study|Withdrawal by Subject|5|||
129825584|NCT03108027|467326570|FG000|Period 1|Subject/Guardian Decision|0|||
129825585|NCT03108027|467326571|FG001|Period 1|Subject/Guardian Decision|0|||
129825586|NCT03108027|467326572|FG002|Period 1|Subject/Guardian Decision|0|||
129825587|NCT03108027|467326573|FG003|Period 1|Subject/Guardian Decision|2|||
129825588|NCT03108027|467326574|FG004|Period 1|Subject/Guardian Decision|0|||
129825589|NCT03108027|467326575|FG005|Period 1|Subject/Guardian Decision|0|||
129825590|NCT03108027|467326570|FG000|Period 3|Adverse Event|0|||
129825591|NCT03108027|467326571|FG001|Period 3|Adverse Event|1|||
129825592|NCT03108027|467326572|FG002|Period 3|Adverse Event|0|||
129825593|NCT03108027|467326573|FG003|Period 3|Adverse Event|0|||
129825594|NCT03108027|467326574|FG004|Period 3|Adverse Event|0|||
129825595|NCT03108027|467326575|FG005|Period 3|Adverse Event|0|||
129825596|NCT00268996|467326576|FG000|Overall Study|Adverse Event|11|||
129825597|NCT00268996|467326577|FG001|Overall Study|Adverse Event|7|||
129825598|NCT00268996|467326576|FG000|Overall Study|Lost to Follow-up|3|||
129825599|NCT00268996|467326577|FG001|Overall Study|Lost to Follow-up|1|||
129825600|NCT00268996|467326576|FG000|Overall Study|Withdrawal by Subject|5|||
129825601|NCT00268996|467326577|FG001|Overall Study|Withdrawal by Subject|11|||
129825602|NCT00268996|467326576|FG000|Overall Study|Non-compliance|1|||
129825603|NCT00268996|467326577|FG001|Overall Study|Non-compliance|0|||
129825604|NCT00268996|467326576|FG000|Overall Study|Other|1|||
129825605|NCT00268996|467326577|FG001|Overall Study|Other|1|||
129825606|NCT00451321|467326580|FG000|Overall Study|Lost to Follow-up|3|||
129825607|NCT00451321|467326581|FG001|Overall Study|Lost to Follow-up|3|||
129825608|NCT00451321|467326582|FG002|Overall Study|Lost to Follow-up|1|||
129825609|NCT00451321|467326583|FG003|Overall Study|Lost to Follow-up|3|||
129825610|NCT00451321|467326584|FG004|Overall Study|Lost to Follow-up|0|||
129825611|NCT00451321|467326585|FG005|Overall Study|Lost to Follow-up|1|||
129825612|NCT00451321|467326586|FG006|Overall Study|Lost to Follow-up|0|||
129825613|NCT00451321|467326587|FG007|Overall Study|Lost to Follow-up|0|||
129825614|NCT00451321|467326580|FG000|Overall Study|Withdrawal by Subject|3|||
129825615|NCT00451321|467326581|FG001|Overall Study|Withdrawal by Subject|1|||
129825616|NCT00451321|467326582|FG002|Overall Study|Withdrawal by Subject|0|||
129825617|NCT00451321|467326583|FG003|Overall Study|Withdrawal by Subject|4|||
129825618|NCT00451321|467326584|FG004|Overall Study|Withdrawal by Subject|0|||
129825619|NCT00451321|467326585|FG005|Overall Study|Withdrawal by Subject|0|||
129825620|NCT00451321|467326586|FG006|Overall Study|Withdrawal by Subject|0|||
129825621|NCT00451321|467326587|FG007|Overall Study|Withdrawal by Subject|0|||
129825622|NCT00451321|467326580|FG000|Overall Study|Study closed/terminated|1|||
129825623|NCT00451321|467326581|FG001|Overall Study|Study closed/terminated|1|||
129825624|NCT00451321|467326582|FG002|Overall Study|Study closed/terminated|17|||
129825625|NCT00451321|467326583|FG003|Overall Study|Study closed/terminated|5|||
129825626|NCT00451321|467326584|FG004|Overall Study|Study closed/terminated|7|||
129825627|NCT00451321|467326585|FG005|Overall Study|Study closed/terminated|7|||
129825628|NCT00451321|467326586|FG006|Overall Study|Study closed/terminated|5|||
129825629|NCT00451321|467326587|FG007|Overall Study|Study closed/terminated|3|||
129825630|NCT00451321|467326580|FG000|Overall Study|Sponsor decision to amend protocol|0|||
129825631|NCT00451321|467326581|FG001|Overall Study|Sponsor decision to amend protocol|0|||
129825632|NCT00451321|467326582|FG002|Overall Study|Sponsor decision to amend protocol|0|||
129825633|NCT00451321|467326583|FG003|Overall Study|Sponsor decision to amend protocol|0|||
129825634|NCT00451321|467326584|FG004|Overall Study|Sponsor decision to amend protocol|0|||
129825635|NCT00451321|467326585|FG005|Overall Study|Sponsor decision to amend protocol|1|||
129825636|NCT00451321|467326586|FG006|Overall Study|Sponsor decision to amend protocol|1|||
129825637|NCT00451321|467326587|FG007|Overall Study|Sponsor decision to amend protocol|3|||
129825638|NCT01528254|467326590|FG000|Overall Study|Administrative problems|96|||
129825639|NCT01528254|467326591|FG001|Overall Study|Administrative problems|94|||
129825640|NCT01528254|467326590|FG000|Overall Study|Adverse Event|28|||
129825641|NCT01528254|467326591|FG001|Overall Study|Adverse Event|44|||
129825642|NCT01528254|467326590|FG000|Overall Study|Lost to Follow-up|17|||
129825643|NCT01528254|467326591|FG001|Overall Study|Lost to Follow-up|24|||
129825644|NCT01528254|467326590|FG000|Overall Study|Death|13|||
129825645|NCT01528254|467326591|FG001|Overall Study|Death|9|||
129825646|NCT01528254|467326590|FG000|Overall Study|Protocol deviation|9|||
129825647|NCT01528254|467326591|FG001|Overall Study|Protocol deviation|19|||
129825648|NCT01528254|467326590|FG000|Overall Study|New therapy for study indication|8|||
129825649|NCT01528254|467326591|FG001|Overall Study|New therapy for study indication|6|||
129825650|NCT01528254|467326590|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129825651|NCT01528254|467326591|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129825652|NCT01528254|467326590|FG000|Overall Study|Withdrawal by Subject|5|||
129825653|NCT01528254|467326591|FG001|Overall Study|Withdrawal by Subject|4|||
129825654|NCT01528254|467326590|FG000|Overall Study|Abnormal laboratory value(s)|3|||
129825655|NCT01528254|467326591|FG001|Overall Study|Abnormal laboratory value(s)|7|||
129825656|NCT01528254|467326590|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129825657|NCT01528254|467326591|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129825658|NCT01528254|467326590|FG000|Overall Study|No longer requires study drug|1|||
129825659|NCT01528254|467326591|FG001|Overall Study|No longer requires study drug|1|||
129825660|NCT02196558|467326597|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
129825661|NCT02196558|467326598|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
129825662|NCT02196558|467326599|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
129825663|NCT02196558|467326597|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
129825664|NCT02196558|467326598|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
129825665|NCT02196558|467326599|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
129825666|NCT02196558|467326597|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
129825667|NCT02196558|467326598|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
129825668|NCT02196558|467326599|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
129825669|NCT02196558|467326597|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
129825670|NCT02196558|467326598|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
129825671|NCT02196558|467326599|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
129825672|NCT02196558|467326597|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
129897502|NCT00320489|467584394|FG001|Overall Study|Sponsor Decision|3|||
129897503|NCT00320489|467584393|FG000|Overall Study|Withdrawal by Subject|39|||
129897504|NCT00320489|467584394|FG001|Overall Study|Withdrawal by Subject|41|||
129897505|NCT03441984|467584395|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897506|NCT03441984|467584396|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897507|NCT03441984|467584397|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
129897508|NCT03441984|467584398|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897509|NCT03441984|467584399|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897510|NCT03441984|467584400|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897511|NCT03441984|467584401|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897512|NCT03441984|467584402|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897513|NCT03441984|467584403|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897514|NCT03441984|467584404|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897515|NCT03441984|467584405|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897516|NCT03441984|467584406|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
129897517|NCT00746330|467584408|FG000|Period 1|Abnormal test procedure result|0|||
129897518|NCT00746330|467584409|FG001|Period 1|Abnormal test procedure result|0|||
129897519|NCT00746330|467584410|FG002|Period 1|Abnormal test procedure result|1|||
129897520|NCT00746330|467584411|FG003|Period 1|Abnormal test procedure result|0|||
129897521|NCT01981850|467584412|FG000|Main Phase Stage 1|Death|2|||
129897522|NCT01981850|467584413|FG001|Main Phase Stage 1|Death|0|||
129897523|NCT01981850|467584414|FG002|Main Phase Stage 1|Death|0|||
129897524|NCT01981850|467584415|FG003|Main Phase Stage 1|Death|0|||
129897525|NCT01981850|467584416|FG004|Main Phase Stage 1|Death|0|||
129897526|NCT01981850|467584417|FG005|Main Phase Stage 1|Death|0|||
129897527|NCT01981850|467584418|FG006|Main Phase Stage 1|Death|0|||
129897528|NCT01981850|467584419|FG007|Main Phase Stage 1|Death|0|||
129897529|NCT01981850|467584420|FG008|Main Phase Stage 1|Death|0|||
129897530|NCT01981850|467584421|FG009|Main Phase Stage 1|Death|0|||
129897531|NCT01981850|467584412|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
129897532|NCT01981850|467584413|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897533|NCT01981850|467584414|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897534|NCT01981850|467584415|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129825673|NCT02196558|467326598|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
129825674|NCT02196558|467326599|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
129825675|NCT02669433|467326603|FG000|Overall Study|Protocol Violation|0|||
129825676|NCT02669433|467326604|FG001|Overall Study|Protocol Violation|4|||
129825677|NCT02669433|467326605|FG002|Overall Study|Protocol Violation|1|||
129897535|NCT01981850|467584416|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897536|NCT01981850|467584417|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129825678|NCT02669433|467326603|FG000|Overall Study|Disease Progression|1|||
129445709|NCT01968070|465932876|FG001|Period 2|Withdrawal by Subject|0|||
129825679|NCT02669433|467326604|FG001|Overall Study|Disease Progression|0|||
129825680|NCT02669433|467326605|FG002|Overall Study|Disease Progression|0|||
129825681|NCT02669433|467326603|FG000|Overall Study|Physician Decision|1|||
129825682|NCT02669433|467326604|FG001|Overall Study|Physician Decision|1|||
129825683|NCT02669433|467326605|FG002|Overall Study|Physician Decision|0|||
129825684|NCT02669433|467326603|FG000|Overall Study|Adverse Event|6|||
129825685|NCT02669433|467326604|FG001|Overall Study|Adverse Event|7|||
129825686|NCT02669433|467326605|FG002|Overall Study|Adverse Event|10|||
129825687|NCT02669433|467326603|FG000|Overall Study|Sponsor Termination|1|||
129825688|NCT02669433|467326604|FG001|Overall Study|Sponsor Termination|0|||
129825689|NCT02669433|467326605|FG002|Overall Study|Sponsor Termination|1|||
129825690|NCT02669433|467326603|FG000|Overall Study|Withdrawal by Subject|5|||
129825691|NCT02669433|467326604|FG001|Overall Study|Withdrawal by Subject|1|||
129825692|NCT02669433|467326605|FG002|Overall Study|Withdrawal by Subject|0|||
129825693|NCT02669433|467326603|FG000|Overall Study|Withdrawal by Caregiver|1|||
129825694|NCT02669433|467326604|FG001|Overall Study|Withdrawal by Caregiver|0|||
129825695|NCT02669433|467326605|FG002|Overall Study|Withdrawal by Caregiver|2|||
129825696|NCT02669433|467326603|FG000|Overall Study|Death|0|||
129825697|NCT02669433|467326604|FG001|Overall Study|Death|1|||
129825698|NCT02669433|467326605|FG002|Overall Study|Death|1|||
129825699|NCT00576927|467326606|FG000|Clinical Assessment|Lack of Efficacy|24|||
129825700|NCT00576927|467326606|FG000|Clinical Assessment|Death|1|||
129825701|NCT00576927|467326606|FG000|Clinical Assessment|Withdrawal by Subject|10|||
129825702|NCT00576927|467326606|FG000|Clinical Assessment|Physician Decision|1|||
129825703|NCT00576927|467326606|FG000|Baseline|Physician Decision|9|||
129825704|NCT00576927|467326606|FG000|Baseline|Medication Change by PCP of subject|1|||
129825705|NCT00576927|467326606|FG000|Baseline|Withdrawal by Subject|3|||
129825706|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
129825707|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
129825708|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
129825709|NCT00576927|467326606|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
129825710|NCT00576927|467326606|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
129825711|NCT03266094|467326607|FG000|Overall Study|Lost to Follow-up|1|||
129825712|NCT03266094|467326607|FG000|Overall Study|Withdrawal by Subject|1|||
129825713|NCT03128892|467326608|FG000|Overall Study|Withdrawal by Subject|2|||
129825714|NCT03128892|467326608|FG000|Overall Study|Physician Decision|1|||
129825715|NCT00459108|467326610|FG000|Overall Study|Withdrawal by Subject|5|||
129825716|NCT00459108|467326610|FG000|Overall Study|Adverse Event|3|||
129825717|NCT00459108|467326610|FG000|Overall Study|Death|2|||
129825718|NCT00459108|467326610|FG000|Overall Study|Progression|1|||
129825719|NCT03473808|467326615|FG000|Overall Study|Withdrawal by Subject|1|||
129825720|NCT02157298|467326616|FG000|Overall Study|Adverse Event|1|||
129825721|NCT02157298|467326617|FG001|Overall Study|Adverse Event|0|||
129825722|NCT02157298|467326616|FG000|Overall Study|Subject no longer meets study criteria|1|||
129825723|NCT02157298|467326617|FG001|Overall Study|Subject no longer meets study criteria|2|||
129825724|NCT02157298|467326616|FG000|Overall Study|Poor/Non-compliance|1|||
129825725|NCT02157298|467326617|FG001|Overall Study|Poor/Non-compliance|0|||
129825726|NCT02157298|467326616|FG000|Overall Study|Withdrawal by Subject|1|||
129825727|NCT02157298|467326617|FG001|Overall Study|Withdrawal by Subject|0|||
129825728|NCT03171415|467326618|FG000|Overall Study|Lost to Follow-up|0|||
129825729|NCT03171415|467326619|FG001|Overall Study|Lost to Follow-up|0|||
129825730|NCT03171415|467326620|FG002|Overall Study|Lost to Follow-up|0|||
129825731|NCT03171415|467326621|FG003|Overall Study|Lost to Follow-up|0|||
129825732|NCT03171415|467326622|FG004|Overall Study|Lost to Follow-up|2|||
129825733|NCT04059094|467326623|FG000|Overall Study|Adverse Event|0|||
129825734|NCT04059094|467326624|FG001|Overall Study|Adverse Event|0|||
129825735|NCT04059094|467326625|FG002|Overall Study|Adverse Event|0|||
129825736|NCT04059094|467326626|FG003|Overall Study|Adverse Event|0|||
129825737|NCT04059094|467326627|FG004|Overall Study|Adverse Event|1|||
129825738|NCT04059094|467326623|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825739|NCT04059094|467326624|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
129825740|NCT04059094|467326625|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825741|NCT04059094|467326626|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825742|NCT04059094|467326627|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
129825743|NCT00883116|467326632|FG000|Overall Study|Adverse event unrelated to study drug|5|||
129825744|NCT00883116|467326633|FG001|Overall Study|Adverse event unrelated to study drug|10|||
129825745|NCT00883116|467326632|FG000|Overall Study|Death|6|||
129825746|NCT00883116|467326633|FG001|Overall Study|Death|2|||
129825747|NCT00883116|467326632|FG000|Overall Study|Disease progression|130|||
129825748|NCT00883116|467326633|FG001|Overall Study|Disease progression|128|||
129825749|NCT00883116|467326632|FG000|Overall Study|Lost to Follow-up|0|||
129825750|NCT00883116|467326633|FG001|Overall Study|Lost to Follow-up|1|||
129825751|NCT00883116|467326632|FG000|Overall Study|Maximum clinical benefit|13|||
129825752|NCT00883116|467326633|FG001|Overall Study|Maximum clinical benefit|46|||
129825753|NCT00883116|467326632|FG000|Overall Study|Not identified|3|||
129825754|NCT00883116|467326633|FG001|Overall Study|Not identified|6|||
129825755|NCT00883116|467326632|FG000|Overall Study|Study drug toxicity|36|||
129825756|NCT00883116|467326633|FG001|Overall Study|Study drug toxicity|16|||
129825757|NCT00883116|467326632|FG000|Overall Study|Withdrawal by Subject|14|||
129825758|NCT00883116|467326633|FG001|Overall Study|Withdrawal by Subject|8|||
129825759|NCT00883116|467326632|FG000|Overall Study|No longer meets study criteria|2|||
129825760|NCT00883116|467326633|FG001|Overall Study|No longer meets study criteria|2|||
129825761|NCT03715764|467326634|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
129825762|NCT03715764|467326635|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
129825763|NCT03715764|467326634|FG000|3 Month Follow-up|Lost to Follow-up|2|||
129825764|NCT03715764|467326635|FG001|3 Month Follow-up|Lost to Follow-up|2|||
129825765|NCT03715764|467326634|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
129825766|NCT03715764|467326635|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
129825767|NCT03715764|467326634|FG000|6 Month Follow-up|Lost to Follow-up|3|||
129825768|NCT03715764|467326635|FG001|6 Month Follow-up|Lost to Follow-up|0|||
129825769|NCT03715764|467326634|FG000|12 Month Follow-up|Lost to Follow-up|2|||
129825770|NCT03715764|467326635|FG001|12 Month Follow-up|Lost to Follow-up|3|||
129825771|NCT03715764|467326634|FG000|12 Month Follow-up|Pregnancy|0|||
129825772|NCT03715764|467326635|FG001|12 Month Follow-up|Pregnancy|1|||
129825773|NCT03715764|467326634|FG000|12 Month Follow-up|Surgery|2|||
129825774|NCT03715764|467326635|FG001|12 Month Follow-up|Surgery|0|||
129825775|NCT03715764|467326634|FG000|12 Month Follow-up|Wrong address|1|||
129825776|NCT03715764|467326635|FG001|12 Month Follow-up|Wrong address|0|||
129825777|NCT03715764|467326634|FG000|12 Month Follow-up|No symptoms|1|||
129825778|NCT03715764|467326635|FG001|12 Month Follow-up|No symptoms|0|||
129825779|NCT03715764|467326634|FG000|12 Month Follow-up|Changed primary care centre|0|||
129825780|NCT03715764|467326635|FG001|12 Month Follow-up|Changed primary care centre|1|||
129825781|NCT00818662|467326641|FG000|Overall Study|Adverse Event|5|||
129825782|NCT00818662|467326642|FG001|Overall Study|Adverse Event|14|||
129825783|NCT00818662|467326643|FG002|Overall Study|Adverse Event|4|||
129825784|NCT00818662|467326644|FG003|Overall Study|Adverse Event|3|||
129825785|NCT00818662|467326641|FG000|Overall Study|Withdrawal by Subject|5|||
129825786|NCT00818662|467326642|FG001|Overall Study|Withdrawal by Subject|4|||
129825787|NCT00818662|467326643|FG002|Overall Study|Withdrawal by Subject|2|||
129825788|NCT00818662|467326644|FG003|Overall Study|Withdrawal by Subject|2|||
129825789|NCT00818662|467326641|FG000|Overall Study|Death|1|||
129825790|NCT00818662|467326642|FG001|Overall Study|Death|3|||
129825791|NCT00818662|467326643|FG002|Overall Study|Death|0|||
129825792|NCT00818662|467326644|FG003|Overall Study|Death|0|||
129825793|NCT00818662|467326641|FG000|Overall Study|Physician Decision|1|||
129825794|NCT00818662|467326642|FG001|Overall Study|Physician Decision|0|||
129825795|NCT00818662|467326643|FG002|Overall Study|Physician Decision|0|||
129825796|NCT00818662|467326644|FG003|Overall Study|Physician Decision|0|||
129825797|NCT00818662|467326641|FG000|Overall Study|Lost to Follow-up|0|||
129825798|NCT00818662|467326642|FG001|Overall Study|Lost to Follow-up|0|||
129825799|NCT00818662|467326643|FG002|Overall Study|Lost to Follow-up|0|||
129825800|NCT00818662|467326644|FG003|Overall Study|Lost to Follow-up|1|||
129825801|NCT00818662|467326641|FG000|Overall Study|Unwilling or Unable to Participate|4|||
129825802|NCT00818662|467326642|FG001|Overall Study|Unwilling or Unable to Participate|6|||
129825803|NCT00818662|467326643|FG002|Overall Study|Unwilling or Unable to Participate|2|||
129825804|NCT00818662|467326644|FG003|Overall Study|Unwilling or Unable to Participate|4|||
129825805|NCT00818662|467326641|FG000|Overall Study|Protocol Violation|1|||
129825806|NCT00818662|467326642|FG001|Overall Study|Protocol Violation|1|||
129825807|NCT00818662|467326643|FG002|Overall Study|Protocol Violation|0|||
129825808|NCT00818662|467326644|FG003|Overall Study|Protocol Violation|0|||
129825809|NCT00818662|467326641|FG000|Overall Study|Requires a Prohibited Medication|1|||
129825810|NCT00818662|467326642|FG001|Overall Study|Requires a Prohibited Medication|0|||
129825811|NCT00818662|467326643|FG002|Overall Study|Requires a Prohibited Medication|0|||
129825812|NCT00818662|467326644|FG003|Overall Study|Requires a Prohibited Medication|0|||
129825813|NCT00818662|467326641|FG000|Overall Study|Safety Risk|1|||
129825814|NCT00818662|467326642|FG001|Overall Study|Safety Risk|1|||
129825815|NCT00818662|467326643|FG002|Overall Study|Safety Risk|0|||
129825816|NCT00818662|467326644|FG003|Overall Study|Safety Risk|1|||
129825817|NCT00818662|467326641|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
129825818|NCT00818662|467326642|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
129825819|NCT00818662|467326643|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
129825820|NCT00818662|467326644|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
129825821|NCT00818662|467326641|FG000|Overall Study|Participant's health declined|0|||
129825822|NCT00818662|467326642|FG001|Overall Study|Participant's health declined|0|||
129825823|NCT00818662|467326643|FG002|Overall Study|Participant's health declined|0|||
129825824|NCT00818662|467326644|FG003|Overall Study|Participant's health declined|1|||
129825825|NCT00818662|467326641|FG000|Overall Study|Caregiver to pursue other treatment|0|||
129825826|NCT00818662|467326642|FG001|Overall Study|Caregiver to pursue other treatment|1|||
129825827|NCT00818662|467326643|FG002|Overall Study|Caregiver to pursue other treatment|0|||
129825828|NCT00818662|467326644|FG003|Overall Study|Caregiver to pursue other treatment|0|||
129825829|NCT00818662|467326641|FG000|Overall Study|Moving out of state|0|||
129825830|NCT00818662|467326642|FG001|Overall Study|Moving out of state|0|||
129825831|NCT00818662|467326643|FG002|Overall Study|Moving out of state|0|||
129825832|NCT00818662|467326644|FG003|Overall Study|Moving out of state|1|||
129825833|NCT00818662|467326641|FG000|Overall Study|Declined move to another study site|1|||
129825834|NCT00818662|467326642|FG001|Overall Study|Declined move to another study site|0|||
129825835|NCT00818662|467326643|FG002|Overall Study|Declined move to another study site|0|||
129825836|NCT00818662|467326644|FG003|Overall Study|Declined move to another study site|0|||
129825837|NCT00818662|467326641|FG000|Overall Study|Change in living situation|0|||
129825838|NCT00818662|467326642|FG001|Overall Study|Change in living situation|0|||
129825839|NCT00818662|467326643|FG002|Overall Study|Change in living situation|0|||
129825840|NCT00818662|467326644|FG003|Overall Study|Change in living situation|1|||
129825841|NCT00818662|467326641|FG000|Overall Study|Study partner decision|0|||
129825842|NCT00818662|467326642|FG001|Overall Study|Study partner decision|0|||
129825843|NCT00818662|467326643|FG002|Overall Study|Study partner decision|0|||
129825844|NCT00818662|467326644|FG003|Overall Study|Study partner decision|1|||
129825845|NCT00818662|467326641|FG000|Overall Study|Admitted to long term nursing care|0|||
129825846|NCT00818662|467326642|FG001|Overall Study|Admitted to long term nursing care|1|||
129825847|NCT00818662|467326643|FG002|Overall Study|Admitted to long term nursing care|0|||
129825848|NCT00818662|467326644|FG003|Overall Study|Admitted to long term nursing care|0|||
129825849|NCT01472081|467326645|FG000|Overall Study|Continuing treatment at time of analysis|1|||
129825850|NCT01472081|467326646|FG001|Overall Study|Continuing treatment at time of analysis|4|||
129825851|NCT01472081|467326647|FG002|Overall Study|Continuing treatment at time of analysis|1|||
129825852|NCT01472081|467326648|FG003|Overall Study|Continuing treatment at time of analysis|8|||
129825853|NCT01472081|467326649|FG004|Overall Study|Continuing treatment at time of analysis|9|||
129825854|NCT01472081|467326650|FG005|Overall Study|Continuing treatment at time of analysis|0|||
129825855|NCT01472081|467326645|FG000|Overall Study|Disease Progression|4|||
129825856|NCT01472081|467326646|FG001|Overall Study|Disease Progression|10|||
129825857|NCT01472081|467326647|FG002|Overall Study|Disease Progression|12|||
129825858|NCT01472081|467326648|FG003|Overall Study|Disease Progression|31|||
129825859|NCT01472081|467326649|FG004|Overall Study|Disease Progression|22|||
129825860|NCT01472081|467326650|FG005|Overall Study|Disease Progression|3|||
129825861|NCT01472081|467326645|FG000|Overall Study|Study drug toxicity|2|||
129825862|NCT01472081|467326646|FG001|Overall Study|Study drug toxicity|9|||
129825863|NCT01472081|467326647|FG002|Overall Study|Study drug toxicity|4|||
129825864|NCT01472081|467326648|FG003|Overall Study|Study drug toxicity|6|||
129825865|NCT01472081|467326649|FG004|Overall Study|Study drug toxicity|13|||
129825866|NCT01472081|467326650|FG005|Overall Study|Study drug toxicity|2|||
129825867|NCT01472081|467326645|FG000|Overall Study|Death|0|||
129825868|NCT01472081|467326646|FG001|Overall Study|Death|0|||
129825869|NCT01472081|467326647|FG002|Overall Study|Death|0|||
129825870|NCT01472081|467326648|FG003|Overall Study|Death|0|||
129825871|NCT01472081|467326649|FG004|Overall Study|Death|1|||
129825872|NCT01472081|467326650|FG005|Overall Study|Death|0|||
129897537|NCT01981850|467584418|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129825873|NCT01472081|467326645|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
129825874|NCT01472081|467326646|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
129825875|NCT01472081|467326647|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
129825876|NCT01472081|467326648|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
129825877|NCT01472081|467326649|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
129825878|NCT01472081|467326650|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
129825879|NCT01472081|467326645|FG000|Overall Study|Withdrawal by Subject|0|||
129825880|NCT01472081|467326646|FG001|Overall Study|Withdrawal by Subject|0|||
129825881|NCT01472081|467326647|FG002|Overall Study|Withdrawal by Subject|0|||
129825882|NCT01472081|467326648|FG003|Overall Study|Withdrawal by Subject|0|||
129825883|NCT01472081|467326649|FG004|Overall Study|Withdrawal by Subject|0|||
129825884|NCT01472081|467326650|FG005|Overall Study|Withdrawal by Subject|1|||
129825885|NCT01472081|467326645|FG000|Overall Study|Poor/non-compliance|0|||
129825886|NCT01472081|467326646|FG001|Overall Study|Poor/non-compliance|0|||
129825887|NCT01472081|467326647|FG002|Overall Study|Poor/non-compliance|1|||
129825888|NCT01472081|467326648|FG003|Overall Study|Poor/non-compliance|0|||
129825889|NCT01472081|467326649|FG004|Overall Study|Poor/non-compliance|1|||
129825890|NCT01472081|467326650|FG005|Overall Study|Poor/non-compliance|0|||
129825891|NCT01472081|467326645|FG000|Overall Study|No longer meets study criteria|0|||
129825892|NCT01472081|467326646|FG001|Overall Study|No longer meets study criteria|0|||
129825893|NCT01472081|467326647|FG002|Overall Study|No longer meets study criteria|1|||
129825894|NCT01472081|467326648|FG003|Overall Study|No longer meets study criteria|0|||
129825895|NCT01472081|467326649|FG004|Overall Study|No longer meets study criteria|0|||
129825896|NCT01472081|467326650|FG005|Overall Study|No longer meets study criteria|0|||
129825897|NCT01472081|467326645|FG000|Overall Study|Subject request to discontinue treatment|0|||
129825898|NCT01472081|467326646|FG001|Overall Study|Subject request to discontinue treatment|3|||
129825899|NCT01472081|467326647|FG002|Overall Study|Subject request to discontinue treatment|1|||
129825900|NCT01472081|467326648|FG003|Overall Study|Subject request to discontinue treatment|1|||
129825901|NCT01472081|467326649|FG004|Overall Study|Subject request to discontinue treatment|0|||
129825902|NCT01472081|467326650|FG005|Overall Study|Subject request to discontinue treatment|0|||
129825903|NCT01705652|467326651|FG000|Overall Study|Adverse Event|1|||
129825904|NCT01705652|467326652|FG001|Overall Study|Adverse Event|0|||
129825905|NCT01705652|467326651|FG000|Overall Study|Withdrawal by Subject|1|||
129825906|NCT01705652|467326652|FG001|Overall Study|Withdrawal by Subject|2|||
129825907|NCT01705652|467326651|FG000|Overall Study|non-compliance|1|||
129825908|NCT01705652|467326652|FG001|Overall Study|non-compliance|1|||
129825909|NCT01686633|467326654|FG000|Overall Study|Lack of Efficacy|33|||
129825910|NCT01686633|467326655|FG001|Overall Study|Lack of Efficacy|13|||
129825911|NCT01686633|467326656|FG002|Overall Study|Lack of Efficacy|11|||
129825912|NCT01686633|467326654|FG000|Overall Study|Withdrawal by Subject|8|||
129897538|NCT01981850|467584419|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897539|NCT01981850|467584420|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897540|NCT01981850|467584421|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
129897541|NCT01981850|467584412|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
129897542|NCT01981850|467584413|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
129825913|NCT01686633|467326655|FG001|Overall Study|Withdrawal by Subject|8|||
129825914|NCT01686633|467326656|FG002|Overall Study|Withdrawal by Subject|5|||
129825915|NCT01686633|467326654|FG000|Overall Study|Physician Decision|3|||
129825916|NCT01686633|467326655|FG001|Overall Study|Physician Decision|4|||
129825917|NCT01686633|467326656|FG002|Overall Study|Physician Decision|4|||
129825918|NCT01686633|467326654|FG000|Overall Study|Adverse Event|4|||
129825919|NCT01686633|467326655|FG001|Overall Study|Adverse Event|3|||
129825920|NCT01686633|467326656|FG002|Overall Study|Adverse Event|3|||
129825921|NCT01686633|467326654|FG000|Overall Study|Protocol Violation|2|||
129825922|NCT01686633|467326655|FG001|Overall Study|Protocol Violation|3|||
129825923|NCT01686633|467326656|FG002|Overall Study|Protocol Violation|0|||
129825924|NCT01686633|467326654|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
129825925|NCT01686633|467326655|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
129825926|NCT01686633|467326656|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
129825927|NCT01686633|467326654|FG000|Overall Study|Lost to Follow-up|0|||
129825928|NCT01686633|467326655|FG001|Overall Study|Lost to Follow-up|1|||
129445710|NCT01968070|465932877|FG002|Period 2|Withdrawal by Subject|0|||
129825929|NCT01686633|467326656|FG002|Overall Study|Lost to Follow-up|1|||
129825930|NCT00397982|467328965|FG000|Overall Study|Withdrawal by Subject|1|||
129825931|NCT00397982|467328965|FG000|Overall Study|Adverse Event|1|||
129825932|NCT00397982|467328965|FG000|Overall Study|noncompliance|1|||
129825933|NCT00397982|467328965|FG000|Overall Study|Unrelated health issues|1|||
129825934|NCT04244786|467328966|FG000|Overall Study|Adverse Event|0|||
129825935|NCT04244786|467328967|FG001|Overall Study|Adverse Event|0|||
129825936|NCT04244786|467328968|FG002|Overall Study|Adverse Event|2|||
129825937|NCT04244786|467328966|FG000|Overall Study|Withdrawal by Subject|0|||
129825938|NCT04244786|467328967|FG001|Overall Study|Withdrawal by Subject|0|||
129825939|NCT04244786|467328968|FG002|Overall Study|Withdrawal by Subject|5|||
129825940|NCT00613938|467328975|FG000|Overall Study|Withdrawal by Subject|2|||
129825941|NCT00613938|467328976|FG001|Overall Study|Withdrawal by Subject|4|||
129825942|NCT00613938|467328977|FG002|Overall Study|Withdrawal by Subject|9|||
129825943|NCT00613938|467328978|FG003|Overall Study|Withdrawal by Subject|9|||
129825944|NCT00613938|467328975|FG000|Overall Study|Adverse Event|1|||
129825945|NCT00613938|467328976|FG001|Overall Study|Adverse Event|4|||
129825946|NCT00613938|467328977|FG002|Overall Study|Adverse Event|8|||
129825947|NCT00613938|467328978|FG003|Overall Study|Adverse Event|5|||
129825948|NCT00613938|467328975|FG000|Overall Study|Lack of Efficacy|16|||
129825949|NCT00613938|467328976|FG001|Overall Study|Lack of Efficacy|18|||
129825950|NCT00613938|467328977|FG002|Overall Study|Lack of Efficacy|5|||
129825951|NCT00613938|467328978|FG003|Overall Study|Lack of Efficacy|9|||
129825952|NCT00613938|467328975|FG000|Overall Study|Other|1|||
129825953|NCT00613938|467328976|FG001|Overall Study|Other|2|||
129825954|NCT00613938|467328977|FG002|Overall Study|Other|1|||
129825955|NCT00613938|467328978|FG003|Overall Study|Other|3|||
129825956|NCT02636868|467328979|FG000|Overall Study|Death|0|||
129825957|NCT02636868|467328980|FG001|Overall Study|Death|1|||
129825958|NCT02636868|467328981|FG002|Overall Study|Death|2|||
129825959|NCT03220217|467328982|FG000|Overall Study|Withdrawal by Subject|0|||
129825960|NCT03220217|467328983|FG001|Overall Study|Withdrawal by Subject|1|||
129825961|NCT03220217|467328984|FG002|Overall Study|Withdrawal by Subject|0|||
129825962|NCT03220217|467328982|FG000|Overall Study|Subject Missed Procedure|0|||
129825963|NCT03220217|467328983|FG001|Overall Study|Subject Missed Procedure|0|||
129825964|NCT03220217|467328984|FG002|Overall Study|Subject Missed Procedure|1|||
129825965|NCT03025542|467328985|FG000|Overall Study|Adverse Event|0|||
129825966|NCT03025542|467328986|FG001|Overall Study|Adverse Event|2|||
129825967|NCT03025542|467328985|FG000|Overall Study|Lost to Follow-up|1|||
129825968|NCT03025542|467328986|FG001|Overall Study|Lost to Follow-up|0|||
129825969|NCT03025542|467328985|FG000|Overall Study|Withdrawal by Subject|1|||
129825970|NCT03025542|467328986|FG001|Overall Study|Withdrawal by Subject|0|||
129825971|NCT03745937|467328988|FG000|Overall Study|Withdrawal by Subject|0|||
129825972|NCT03745937|467328989|FG001|Overall Study|Withdrawal by Subject|0|||
129825973|NCT03745937|467328990|FG002|Overall Study|Withdrawal by Subject|0|||
129825974|NCT03745937|467328991|FG003|Overall Study|Withdrawal by Subject|1|||
129825975|NCT03745937|467328988|FG000|Overall Study|Not-specifed|0|||
129825976|NCT03745937|467328989|FG001|Overall Study|Not-specifed|1|||
129825977|NCT03745937|467328990|FG002|Overall Study|Not-specifed|0|||
129825978|NCT03745937|467328991|FG003|Overall Study|Not-specifed|1|||
129825979|NCT00696696|467328997|FG000|Overall Study|Adverse Event|5|||
129825980|NCT00696696|467328997|FG000|Overall Study|Withdrawal by Subject|8|||
129825981|NCT00696696|467328997|FG000|Overall Study|Physician Decision|2|||
129825982|NCT00696696|467328997|FG000|Overall Study|Death|3|||
129825983|NCT02507505|467328998|FG000|Overall Study|Withdrawal by Subject|13|||
129825984|NCT02507505|467328999|FG001|Overall Study|Withdrawal by Subject|11|||
129825985|NCT02507505|467328998|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
129825986|NCT02507505|467328999|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
129825987|NCT02507505|467328998|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
129825988|NCT02507505|467328999|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
129825989|NCT02507505|467328998|FG000|Overall Study|Death before receipt of anesthesia|0|||
129825990|NCT02507505|467328999|FG001|Overall Study|Death before receipt of anesthesia|1|||
129825991|NCT03182829|467329000|FG000|Overall Study|Protocol Violation|12|||
129825992|NCT03182829|467329001|FG001|Overall Study|Protocol Violation|12|||
129825993|NCT03182829|467329000|FG000|Overall Study|Other|4|||
129825994|NCT03182829|467329001|FG001|Overall Study|Other|3|||
129825995|NCT00254540|467329002|FG000|Overall Study|Adverse Event|6|||
129825996|NCT00254540|467329003|FG001|Overall Study|Adverse Event|7|||
129825997|NCT00254540|467329002|FG000|Overall Study|Lack of Efficacy|13|||
129825998|NCT00254540|467329003|FG001|Overall Study|Lack of Efficacy|13|||
129825999|NCT00254540|467329002|FG000|Overall Study|Death|0|||
129826000|NCT00254540|467329003|FG001|Overall Study|Death|1|||
129826001|NCT00254540|467329002|FG000|Overall Study|Laboratory Test Abnormality|0|||
129826002|NCT00254540|467329003|FG001|Overall Study|Laboratory Test Abnormality|1|||
129826003|NCT00225251|467329004|FG000|Overall Study|Withdrawal by Subject|1|||
129826004|NCT00225251|467329005|FG001|Overall Study|Withdrawal by Subject|1|||
129826005|NCT03045328|467329006|FG000|Overall Study|Withdrawal by Subject|2|||
129826006|NCT01313767|467329012|FG000|Overall Study|Adverse Event|1|||
129826007|NCT01313767|467329013|FG001|Overall Study|Adverse Event|0|||
129826008|NCT01313767|467329012|FG000|Overall Study|Lost to Follow-up|1|||
129826009|NCT01313767|467329013|FG001|Overall Study|Lost to Follow-up|0|||
129826010|NCT01313767|467329012|FG000|Overall Study|Withdrawal by Subject|2|||
129826011|NCT01313767|467329013|FG001|Overall Study|Withdrawal by Subject|1|||
129826012|NCT01313767|467329012|FG000|Overall Study|Protocol Violation|3|||
129826013|NCT01313767|467329013|FG001|Overall Study|Protocol Violation|1|||
129826014|NCT01287897|467329014|FG000|Overall Study|Adverse Event|5|||
129826015|NCT01287897|467329015|FG001|Overall Study|Adverse Event|3|||
129826016|NCT01287897|467329016|FG002|Overall Study|Adverse Event|6|||
129826017|NCT01287897|467329017|FG003|Overall Study|Adverse Event|4|||
129826018|NCT01287897|467329014|FG000|Overall Study|Lack of Efficacy|2|||
129826019|NCT01287897|467329015|FG001|Overall Study|Lack of Efficacy|0|||
129826020|NCT01287897|467329016|FG002|Overall Study|Lack of Efficacy|0|||
129826021|NCT01287897|467329017|FG003|Overall Study|Lack of Efficacy|0|||
129826022|NCT01287897|467329014|FG000|Overall Study|Protocol Violation|1|||
129826023|NCT01287897|467329015|FG001|Overall Study|Protocol Violation|1|||
129826024|NCT01287897|467329016|FG002|Overall Study|Protocol Violation|0|||
129826025|NCT01287897|467329017|FG003|Overall Study|Protocol Violation|1|||
129826026|NCT01287897|467329014|FG000|Overall Study|Lost to Follow-up|0|||
129826027|NCT01287897|467329015|FG001|Overall Study|Lost to Follow-up|0|||
129826028|NCT01287897|467329016|FG002|Overall Study|Lost to Follow-up|2|||
129826029|NCT01287897|467329017|FG003|Overall Study|Lost to Follow-up|0|||
129826030|NCT01287897|467329014|FG000|Overall Study|Withdrawal by Subject|1|||
129826031|NCT01287897|467329015|FG001|Overall Study|Withdrawal by Subject|5|||
129826032|NCT01287897|467329016|FG002|Overall Study|Withdrawal by Subject|3|||
129826033|NCT01287897|467329017|FG003|Overall Study|Withdrawal by Subject|2|||
129826034|NCT01287897|467329014|FG000|Overall Study|Not consented properly|0|||
129826035|NCT01287897|467329015|FG001|Overall Study|Not consented properly|1|||
129826036|NCT01287897|467329016|FG002|Overall Study|Not consented properly|0|||
129826037|NCT01287897|467329017|FG003|Overall Study|Not consented properly|0|||
129826038|NCT01287897|467329014|FG000|Overall Study|Not meeting entrance criteria|1|||
129826039|NCT01287897|467329015|FG001|Overall Study|Not meeting entrance criteria|1|||
129826040|NCT01287897|467329016|FG002|Overall Study|Not meeting entrance criteria|0|||
129826041|NCT01287897|467329017|FG003|Overall Study|Not meeting entrance criteria|0|||
129826042|NCT01287897|467329014|FG000|Overall Study|Other|1|||
129826043|NCT01287897|467329015|FG001|Overall Study|Other|0|||
129826044|NCT01287897|467329016|FG002|Overall Study|Other|1|||
129826045|NCT01287897|467329017|FG003|Overall Study|Other|0|||
129826046|NCT00065507|467329018|FG000|Overall Study|Death|16|||
129826047|NCT00065507|467329019|FG001|Overall Study|Death|17|||
129826048|NCT00065507|467329018|FG000|Overall Study|Adverse Event|4|||
129826049|NCT00065507|467329019|FG001|Overall Study|Adverse Event|3|||
129826050|NCT00065507|467329018|FG000|Overall Study|Lack of Efficacy|0|||
129826051|NCT00065507|467329019|FG001|Overall Study|Lack of Efficacy|6|||
129826052|NCT00065507|467329018|FG000|Overall Study|Poor/Non-compliance|3|||
129826053|NCT00065507|467329019|FG001|Overall Study|Poor/Non-compliance|2|||
129826054|NCT00065507|467329018|FG000|Overall Study|Lost to Follow-up|3|||
129826055|NCT00065507|467329019|FG001|Overall Study|Lost to Follow-up|0|||
129826056|NCT00065507|467329018|FG000|Overall Study|Subject Withdrew Consent|2|||
129826057|NCT00065507|467329019|FG001|Overall Study|Subject Withdrew Consent|1|||
129826058|NCT00065507|467329018|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
129826059|NCT00065507|467329019|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
129826060|NCT02169739|467329020|FG000|Overall Study|Lost to Follow-up|0|||
129826061|NCT02169739|467329021|FG001|Overall Study|Lost to Follow-up|4|||
129826062|NCT03635957|467329022|FG000|Run-In Period|Lost to Follow-up|1|||
129826063|NCT03635957|467329022|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
129826064|NCT00350636|467329023|FG000|Overall Study|Adverse Event|19|||
129826065|NCT00350636|467329024|FG001|Overall Study|Adverse Event|13|||
129826066|NCT00350636|467329023|FG000|Overall Study|Protocol Violation|1|||
129826067|NCT00350636|467329024|FG001|Overall Study|Protocol Violation|3|||
129826068|NCT00350636|467329023|FG000|Overall Study|Withdrawal by Subject|13|||
129826069|NCT00350636|467329024|FG001|Overall Study|Withdrawal by Subject|17|||
129826070|NCT00350636|467329023|FG000|Overall Study|Lost to Follow-up|9|||
129826071|NCT00350636|467329024|FG001|Overall Study|Lost to Follow-up|8|||
129826072|NCT00350636|467329023|FG000|Overall Study|Physician Decision|0|||
129826073|NCT00350636|467329024|FG001|Overall Study|Physician Decision|2|||
129826074|NCT00350636|467329023|FG000|Overall Study|Other|1|||
129826075|NCT00350636|467329024|FG001|Overall Study|Other|2|||
129826076|NCT01042236|467329029|FG000|Treatment Period 1|Adverse Event|0|||
129826077|NCT01042236|467329030|FG001|Treatment Period 1|Adverse Event|1|||
129826078|NCT01042236|467329031|FG002|Treatment Period 1|Adverse Event|0|||
129826079|NCT01042236|467329032|FG003|Treatment Period 1|Adverse Event|0|||
129826080|NCT01042236|467329033|FG004|Treatment Period 1|Adverse Event|1|||
129826081|NCT01042236|467329034|FG005|Treatment Period 1|Adverse Event|0|||
129826082|NCT01042236|467329029|FG000|Treatment Period 3|Adverse Event|0|||
129826083|NCT01042236|467329030|FG001|Treatment Period 3|Adverse Event|0|||
129826084|NCT01042236|467329031|FG002|Treatment Period 3|Adverse Event|0|||
129826085|NCT01042236|467329032|FG003|Treatment Period 3|Adverse Event|1|||
129826086|NCT01042236|467329033|FG004|Treatment Period 3|Adverse Event|0|||
129826087|NCT01042236|467329034|FG005|Treatment Period 3|Adverse Event|0|||
129826088|NCT01042236|467329029|FG000|Treatment Period 3|Protocol Violation|0|||
129826089|NCT01042236|467329030|FG001|Treatment Period 3|Protocol Violation|0|||
129826090|NCT01042236|467329031|FG002|Treatment Period 3|Protocol Violation|0|||
129826091|NCT01042236|467329032|FG003|Treatment Period 3|Protocol Violation|1|||
129826092|NCT01042236|467329033|FG004|Treatment Period 3|Protocol Violation|0|||
129826093|NCT01042236|467329034|FG005|Treatment Period 3|Protocol Violation|0|||
129826094|NCT00227903|467329035|FG000|Overall Study|Withdrawal by Subject|2|||
129826095|NCT00227903|467329036|FG001|Overall Study|Withdrawal by Subject|5|||
129826096|NCT00227903|467329035|FG000|Overall Study|Subject moved out of area|1|||
129826097|NCT00227903|467329036|FG001|Overall Study|Subject moved out of area|2|||
129826098|NCT00227903|467329035|FG000|Overall Study|Lost to Follow-up|1|||
129826099|NCT00227903|467329036|FG001|Overall Study|Lost to Follow-up|3|||
129826100|NCT00227903|467329035|FG000|Overall Study|Miscarriage|1|||
129826101|NCT00227903|467329036|FG001|Overall Study|Miscarriage|0|||
129826102|NCT01475331|467329037|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
129826103|NCT01475331|467329038|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
129826104|NCT01475331|467329037|FG000|Overall Study|excessive main duct communication|1|||
129826105|NCT01475331|467329038|FG001|Overall Study|excessive main duct communication|1|||
129826106|NCT01475331|467329037|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
129826107|NCT01475331|467329038|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
129826108|NCT01475331|467329037|FG000|Overall Study|Sign of malignancy during the procedure|2|||
129826109|NCT01475331|467329038|FG001|Overall Study|Sign of malignancy during the procedure|0|||
129826110|NCT01475331|467329037|FG000|Overall Study|cyst found to be prohibitively small|0|||
129826111|NCT01475331|467329038|FG001|Overall Study|cyst found to be prohibitively small|1|||
129826112|NCT03683758|467329040|FG000|Overall Study|Non-study commitment conflict|1|||
129826113|NCT03683758|467329041|FG001|Overall Study|Non-study commitment conflict|3|||
129826114|NCT03683758|467329040|FG000|Overall Study|Illness preventing participation|1|||
129826115|NCT03683758|467329041|FG001|Overall Study|Illness preventing participation|0|||
129826116|NCT03683758|467329040|FG000|Overall Study|Adverse Event|1|||
129826117|NCT03683758|467329041|FG001|Overall Study|Adverse Event|0|||
129826118|NCT01172847|467329042|FG000|Overall Study|Withdrawal by Subject|3|||
129826119|NCT01163279|467329043|FG000|Overall Study|Withdrawal by Subject|2|||
129826120|NCT01163279|467329044|FG001|Overall Study|Withdrawal by Subject|0|||
129826121|NCT01601626|467329045|FG000|Overall Study|Death|1|||
129826122|NCT01601626|467329046|FG001|Overall Study|Death|1|||
129826123|NCT01601626|467329047|FG002|Overall Study|Death|1|||
129826124|NCT01601626|467329045|FG000|Overall Study|Lost to Follow-up|1|||
129826125|NCT01601626|467329046|FG001|Overall Study|Lost to Follow-up|2|||
129826126|NCT01601626|467329047|FG002|Overall Study|Lost to Follow-up|0|||
129826127|NCT01601626|467329045|FG000|Overall Study|Unable to Get to Clinic|0|||
129826128|NCT01601626|467329046|FG001|Overall Study|Unable to Get to Clinic|1|||
129826129|NCT01601626|467329047|FG002|Overall Study|Unable to Get to Clinic|0|||
129826130|NCT01601626|467329045|FG000|Overall Study|Withdrawal by Subject|0|||
129826131|NCT01601626|467329046|FG001|Overall Study|Withdrawal by Subject|1|||
129826132|NCT01601626|467329047|FG002|Overall Study|Withdrawal by Subject|1|||
129826133|NCT01601626|467329045|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
129826134|NCT01601626|467329046|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
129826135|NCT01601626|467329047|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
129826136|NCT02632552|467329051|FG000|Overall Study|Lost to Follow-up|14|||
129826137|NCT02632552|467329052|FG001|Overall Study|Lost to Follow-up|8|||
129826138|NCT02632552|467329051|FG000|Overall Study|Withdrawal by Subject|2|||
129826139|NCT02632552|467329052|FG001|Overall Study|Withdrawal by Subject|0|||
129826140|NCT02632552|467329051|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
129826141|NCT02632552|467329052|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
129826142|NCT02728895|467329053|FG000|Overall Study|Other|1|||
129826143|NCT02728895|467329054|FG001|Overall Study|Other|2|||
129826144|NCT02728895|467329053|FG000|Overall Study|Withdrawal by Subject|0|||
129826145|NCT02728895|467329054|FG001|Overall Study|Withdrawal by Subject|3|||
129826146|NCT00810407|467329057|FG000|Overall Study|Protocol Violation|3|||
129826147|NCT00810407|467329057|FG000|Overall Study|No Visit After First Day of Treatment|3|||
129826148|NCT02426892|467329059|FG000|Overall Study|Adverse Event|2|||
129826149|NCT02426892|467329059|FG000|Overall Study|Lack of Efficacy|17|||
129826150|NCT02426892|467329059|FG000|Overall Study|Withdrawal by Subject|1|||
129826151|NCT02574247|467329060|FG000|Overall Study|Withdrawal by Subject|1|||
129826152|NCT02574247|467329061|FG001|Overall Study|Withdrawal by Subject|0|||
129826153|NCT02574247|467329062|FG002|Overall Study|Withdrawal by Subject|0|||
129826154|NCT02574247|467329060|FG000|Overall Study|Did not meet inclusion criteria|4|||
129826155|NCT02574247|467329061|FG001|Overall Study|Did not meet inclusion criteria|3|||
129826156|NCT02574247|467329062|FG002|Overall Study|Did not meet inclusion criteria|5|||
129826157|NCT01382446|467329063|FG000|Overall Study|Withdrawal by Subject|0|||
129826158|NCT01382446|467329064|FG001|Overall Study|Withdrawal by Subject|1|||
129826159|NCT01382446|467329063|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
129826160|NCT01382446|467329064|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
129826161|NCT01166763|467329067|FG000|Overall Study|Withdrawal by Subject|3|||
129826162|NCT04339296|467329068|FG000|Overall Study|Refuse to participate after allocation|1|||
129826163|NCT04339296|467329069|FG001|Overall Study|Refuse to participate after allocation|1|||
129826164|NCT04339296|467329068|FG000|Overall Study|Withdrew after completion of baseline|2|||
129826165|NCT04339296|467329069|FG001|Overall Study|Withdrew after completion of baseline|1|||
129826166|NCT04339296|467329068|FG000|Overall Study|Lost to Follow-up|0|||
129826167|NCT04339296|467329069|FG001|Overall Study|Lost to Follow-up|4|||
129826168|NCT04339296|467329068|FG000|Overall Study|Discontinued intervention|5|||
129826169|NCT04339296|467329069|FG001|Overall Study|Discontinued intervention|3|||
129826170|NCT01909479|467329070|FG000|From Baseline to Week 26|Adverse Event|3|||
129826171|NCT01909479|467329071|FG001|From Baseline to Week 26|Adverse Event|2|||
129826172|NCT01909479|467329070|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
129826173|NCT01909479|467329071|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
129826174|NCT01909479|467329070|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
129826175|NCT01909479|467329071|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
129826176|NCT01909479|467329070|FG000|26 - 52 Weeks|Adverse Event|0|||
129826177|NCT01909479|467329071|FG001|26 - 52 Weeks|Adverse Event|1|||
129826178|NCT01909479|467329070|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
129826179|NCT01909479|467329071|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
129826180|NCT01909479|467329070|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
129826181|NCT01909479|467329071|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
129826182|NCT01909479|467329070|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
129826183|NCT01909479|467329071|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
129826184|NCT01909479|467329070|FG000|52 Weeks to End of Study|Adverse Event|2|||
129826185|NCT01909479|467329071|FG001|52 Weeks to End of Study|Adverse Event|1|||
129826186|NCT01909479|467329070|FG000|52 Weeks to End of Study|Death|0|||
129826187|NCT01909479|467329071|FG001|52 Weeks to End of Study|Death|1|||
129826188|NCT01909479|467329070|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
129826189|NCT01909479|467329071|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
129826190|NCT01909479|467329070|FG000|52 Weeks to End of Study|Protocol Violation|1|||
129826191|NCT01909479|467329071|FG001|52 Weeks to End of Study|Protocol Violation|0|||
129826192|NCT01909479|467329070|FG000|52 Weeks to End of Study|Progressive disease|1|||
129826193|NCT01909479|467329071|FG001|52 Weeks to End of Study|Progressive disease|1|||
129826194|NCT01909479|467329070|FG000|52 Weeks to End of Study|Personal reasons|2|||
129826195|NCT01909479|467329071|FG001|52 Weeks to End of Study|Personal reasons|1|||
129826196|NCT01909479|467329070|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
129826197|NCT01909479|467329071|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
129826198|NCT01909479|467329070|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
129826199|NCT01909479|467329071|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
129826200|NCT01909479|467329070|FG000|52 Weeks to End of Study|Lack of contact|1|||
129826201|NCT01909479|467329071|FG001|52 Weeks to End of Study|Lack of contact|0|||
129826202|NCT01909479|467329070|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
129826203|NCT01909479|467329071|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
129826204|NCT01909479|467329070|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
129826205|NCT01909479|467329071|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
129826206|NCT04446377|467329072|FG000|Overall Study|Withdrawal by Subject|6|||
129826207|NCT04446377|467329073|FG001|Overall Study|Withdrawal by Subject|1|||
129826208|NCT04446377|467329072|FG000|Overall Study|Physician Decision|1|||
129826209|NCT04446377|467329073|FG001|Overall Study|Physician Decision|1|||
129826210|NCT04446377|467329072|FG000|Overall Study|Lost to Follow-up|0|||
129826211|NCT04446377|467329073|FG001|Overall Study|Lost to Follow-up|2|||
129826212|NCT04446377|467329072|FG000|Overall Study|Not eligible|0|||
129826213|NCT04446377|467329073|FG001|Overall Study|Not eligible|1|||
129826214|NCT03557151|467329076|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
129826215|NCT03557151|467329077|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
129826216|NCT03557151|467329076|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
129826217|NCT03557151|467329077|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
129826218|NCT03557151|467329076|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
129826219|NCT03557151|467329077|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
129826220|NCT01414075|467329078|FG000|Overall Study|Adverse Event|1|||
129826221|NCT01414075|467329079|FG001|Overall Study|Adverse Event|0|||
129826222|NCT01414075|467329080|FG002|Overall Study|Adverse Event|1|||
129826223|NCT01414075|467329081|FG003|Overall Study|Adverse Event|0|||
129826224|NCT01414075|467329078|FG000|Overall Study|Death|1|||
129826225|NCT01414075|467329079|FG001|Overall Study|Death|0|||
129826226|NCT01414075|467329080|FG002|Overall Study|Death|0|||
129826227|NCT01414075|467329081|FG003|Overall Study|Death|1|||
129826228|NCT01414075|467329078|FG000|Overall Study|Withdrawal by Subject|0|||
129826229|NCT01414075|467329079|FG001|Overall Study|Withdrawal by Subject|0|||
129826230|NCT01414075|467329080|FG002|Overall Study|Withdrawal by Subject|0|||
129826231|NCT01414075|467329081|FG003|Overall Study|Withdrawal by Subject|1|||
129826232|NCT01414075|467329078|FG000|Overall Study|Other than specified|1|||
129826233|NCT01414075|467329079|FG001|Overall Study|Other than specified|0|||
129826234|NCT01414075|467329080|FG002|Overall Study|Other than specified|1|||
129826235|NCT01414075|467329081|FG003|Overall Study|Other than specified|0|||
129826236|NCT01187043|467329083|FG000|Overall Study|Adverse Event|0|||
129826237|NCT01187043|467329084|FG001|Overall Study|Adverse Event|0|||
129826238|NCT01187043|467329085|FG002|Overall Study|Adverse Event|0|||
129826239|NCT01187043|467329086|FG003|Overall Study|Adverse Event|0|||
129826240|NCT01187043|467329087|FG004|Overall Study|Adverse Event|1|||
129897543|NCT01981850|467584414|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
129826241|NCT01187043|467329083|FG000|Overall Study|Unable to make scheduled visits|1|||
129826242|NCT01187043|467329084|FG001|Overall Study|Unable to make scheduled visits|0|||
129826243|NCT01187043|467329085|FG002|Overall Study|Unable to make scheduled visits|4|||
129826244|NCT01187043|467329086|FG003|Overall Study|Unable to make scheduled visits|0|||
129826245|NCT01187043|467329087|FG004|Overall Study|Unable to make scheduled visits|1|||
129826246|NCT03198234|467329089|FG000|Overall Study|Relapse of primary disease|0|||
129826247|NCT03198234|467329090|FG001|Overall Study|Relapse of primary disease|1|||
129826248|NCT03198234|467329091|FG002|Overall Study|Relapse of primary disease|0|||
129826249|NCT01361464|467329092|FG000|Overall Study|Death|1|||
129826250|NCT01361464|467329092|FG000|Overall Study|Withdrawal by Subject|2|||
129826251|NCT01106898|467329096|FG000|Overall Study|Adverse Event|6|||
129826252|NCT01722071|467329097|FG000|Overall Study|Protocol Violation|1|||
129826253|NCT01722071|467329098|FG001|Overall Study|Protocol Violation|0|||
129826254|NCT00541034|467329099|FG000|Overall Study|Non-Compliance|3|||
129826255|NCT01505868|467329100|FG000|Overall Study|Withdrawal by Subject|1|||
129826256|NCT01505868|467329101|FG001|Overall Study|Withdrawal by Subject|0|||
129826257|NCT01505868|467329102|FG002|Overall Study|Withdrawal by Subject|0|||
129826258|NCT01505868|467329103|FG003|Overall Study|Withdrawal by Subject|0|||
129826259|NCT01505868|467329104|FG004|Overall Study|Withdrawal by Subject|0|||
129826260|NCT02062879|467329105|FG000|Overall Study|Withdrawal by Subject|4|||
129826261|NCT02062879|467329106|FG001|Overall Study|Withdrawal by Subject|1|||
129826262|NCT02289079|467329107|FG000|Overall Study|Physician Decision|2|||
129826263|NCT02289079|467329108|FG001|Overall Study|Physician Decision|0|||
129826264|NCT02289079|467329107|FG000|Overall Study|Lost to Follow-up|0|||
129826265|NCT02289079|467329108|FG001|Overall Study|Lost to Follow-up|1|||
129826266|NCT00680043|467329109|FG000|Overall Study|Withdrawal by Subject|1|||
129826267|NCT00680043|467329110|FG001|Overall Study|Withdrawal by Subject|0|||
129826268|NCT00680043|467329111|FG002|Overall Study|Withdrawal by Subject|0|||
129826269|NCT00680043|467329109|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
129826270|NCT00680043|467329110|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
129826271|NCT00680043|467329111|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
129826272|NCT00680043|467329109|FG000|Overall Study|Renal Transplant|1|||
129826273|NCT00680043|467329110|FG001|Overall Study|Renal Transplant|0|||
129826274|NCT00680043|467329111|FG002|Overall Study|Renal Transplant|4|||
129826275|NCT00553150|467329112|FG000|Overall Study|Withdrawal by Subject|0|||
129826276|NCT00553150|467329113|FG001|Overall Study|Withdrawal by Subject|0|||
129826277|NCT00553150|467329114|FG002|Overall Study|Withdrawal by Subject|0|||
129826278|NCT00553150|467329115|FG003|Overall Study|Withdrawal by Subject|2|||
129826279|NCT00553150|467329112|FG000|Overall Study|Protocol Violation|0|||
129826280|NCT00553150|467329113|FG001|Overall Study|Protocol Violation|0|||
129826281|NCT00553150|467329114|FG002|Overall Study|Protocol Violation|0|||
129826282|NCT00553150|467329115|FG003|Overall Study|Protocol Violation|1|||
129826283|NCT00553150|467329112|FG000|Overall Study|Ineligible|0|||
129826284|NCT00553150|467329113|FG001|Overall Study|Ineligible|0|||
129826285|NCT00553150|467329114|FG002|Overall Study|Ineligible|0|||
129826286|NCT00553150|467329115|FG003|Overall Study|Ineligible|1|||
129826287|NCT03061331|467329116|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
129826288|NCT03061331|467329117|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
129826289|NCT02625259|467329118|FG000|First Intervention (Day 1)|Other|0|||
129826290|NCT02625259|467329119|FG001|First Intervention (Day 1)|Other|0|||
129826291|NCT02625259|467329120|FG002|First Intervention (Day 1)|Other|1|||
129826292|NCT02625259|467329121|FG003|First Intervention (Day 1)|Other|0|||
129826293|NCT02625259|467329122|FG004|First Intervention (Day 1)|Other|0|||
129826294|NCT02625259|467329118|FG000|First Intervention (Day 1)|Adverse Event|2|||
129826295|NCT02625259|467329119|FG001|First Intervention (Day 1)|Adverse Event|1|||
129826296|NCT02625259|467329120|FG002|First Intervention (Day 1)|Adverse Event|0|||
129826297|NCT02625259|467329121|FG003|First Intervention (Day 1)|Adverse Event|0|||
129826298|NCT02625259|467329122|FG004|First Intervention (Day 1)|Adverse Event|0|||
129826299|NCT02625259|467329118|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826300|NCT02625259|467329119|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826301|NCT02625259|467329120|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826302|NCT02625259|467329121|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
129826303|NCT02625259|467329122|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
129826304|NCT01980875|467329123|FG000|Overall Study|Withdrew Consent|1|||
129826305|NCT01980875|467329124|FG001|Overall Study|Withdrew Consent|1|||
129826306|NCT01980875|467329125|FG002|Overall Study|Withdrew Consent|1|||
129826307|NCT01980875|467329123|FG000|Overall Study|Study Terminated by Sponsor|7|||
129897544|NCT01981850|467584415|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
129826308|NCT01980875|467329124|FG001|Overall Study|Study Terminated by Sponsor|24|||
129826309|NCT01980875|467329125|FG002|Overall Study|Study Terminated by Sponsor|22|||
129826310|NCT01980875|467329123|FG000|Overall Study|Lost to Follow-up|0|||
129826311|NCT01980875|467329124|FG001|Overall Study|Lost to Follow-up|0|||
129826312|NCT01980875|467329125|FG002|Overall Study|Lost to Follow-up|1|||
129826313|NCT02998840|467329126|FG000|Overall Study|Lost to Follow-up|1|||
129826314|NCT02998840|467329127|FG001|Overall Study|Lost to Follow-up|1|||
129826315|NCT02998840|467329128|FG002|Overall Study|Lost to Follow-up|2|||
129826316|NCT02998840|467329129|FG003|Overall Study|Lost to Follow-up|3|||
129826317|NCT02998840|467329126|FG000|Overall Study|Withdrawal by Subject|1|||
129826318|NCT02998840|467329127|FG001|Overall Study|Withdrawal by Subject|1|||
129826319|NCT02998840|467329128|FG002|Overall Study|Withdrawal by Subject|0|||
129826320|NCT02998840|467329129|FG003|Overall Study|Withdrawal by Subject|1|||
129826321|NCT02998840|467329126|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
129826322|NCT02998840|467329127|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
129826323|NCT02998840|467329128|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
129826324|NCT02998840|467329129|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
129826325|NCT00513474|467329133|FG000|Overall Study|Death|6|||
129826326|NCT00513474|467329134|FG001|Overall Study|Death|9|||
129826327|NCT00513474|467329133|FG000|Overall Study|Participant Withdrew Consent|1|||
129826328|NCT00513474|467329134|FG001|Overall Study|Participant Withdrew Consent|0|||
129826329|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Adverse Event|82|||
129826330|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Death|6|||
129826331|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
129826332|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
129897545|NCT01981850|467584416|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
129897546|NCT01981850|467584417|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
129897547|NCT01981850|467584418|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
129897548|NCT01981850|467584419|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
129897549|NCT01981850|467584420|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
129897550|NCT01981850|467584421|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
129897551|NCT01981850|467584412|FG000|Main Phase Stage 1|Various reasons|0|||
129897552|NCT01981850|467584413|FG001|Main Phase Stage 1|Various reasons|0|||
129897553|NCT01981850|467584414|FG002|Main Phase Stage 1|Various reasons|2|||
129897554|NCT01981850|467584415|FG003|Main Phase Stage 1|Various reasons|0|||
129897555|NCT01981850|467584416|FG004|Main Phase Stage 1|Various reasons|0|||
129897556|NCT01981850|467584417|FG005|Main Phase Stage 1|Various reasons|0|||
129897557|NCT01981850|467584418|FG006|Main Phase Stage 1|Various reasons|0|||
129897558|NCT01981850|467584419|FG007|Main Phase Stage 1|Various reasons|0|||
129897559|NCT01981850|467584420|FG008|Main Phase Stage 1|Various reasons|0|||
129897560|NCT01981850|467584421|FG009|Main Phase Stage 1|Various reasons|0|||
129897561|NCT01981850|467584412|FG000|Main Phase Stage 2|Adverse Event|0|||
129897562|NCT01981850|467584413|FG001|Main Phase Stage 2|Adverse Event|0|||
129897563|NCT01981850|467584414|FG002|Main Phase Stage 2|Adverse Event|0|||
129897564|NCT01981850|467584415|FG003|Main Phase Stage 2|Adverse Event|0|||
129897565|NCT01981850|467584416|FG004|Main Phase Stage 2|Adverse Event|6|||
129897566|NCT01981850|467584417|FG005|Main Phase Stage 2|Adverse Event|5|||
129897567|NCT01981850|467584418|FG006|Main Phase Stage 2|Adverse Event|7|||
129897568|NCT01981850|467584419|FG007|Main Phase Stage 2|Adverse Event|0|||
129897569|NCT01981850|467584420|FG008|Main Phase Stage 2|Adverse Event|0|||
129897570|NCT01981850|467584421|FG009|Main Phase Stage 2|Adverse Event|0|||
129897571|NCT01981850|467584412|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897572|NCT01981850|467584413|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897573|NCT01981850|467584414|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897574|NCT01981850|467584415|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897575|NCT01981850|467584416|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
129897576|NCT01981850|467584417|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
129897577|NCT01981850|467584418|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
129897578|NCT01981850|467584419|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897579|NCT01981850|467584420|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897580|NCT01981850|467584421|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
129897581|NCT01981850|467584412|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
129897582|NCT01981850|467584413|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
129897583|NCT01981850|467584414|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
129897584|NCT01981850|467584415|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
129897585|NCT01981850|467584416|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
129897586|NCT01981850|467584417|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
129897587|NCT01981850|467584418|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
129826333|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
129826334|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
129826335|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
129826336|NCT00195676|467329140|FG000|Period O - Open-label Treatment|Other reasons|68|||
129826337|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
129897588|NCT01981850|467584419|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
129897589|NCT01981850|467584420|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
129897590|NCT01981850|467584421|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
129897591|NCT01981850|467584412|FG000|Main Phase Stage 2|Various reasons|0|||
129897592|NCT01981850|467584413|FG001|Main Phase Stage 2|Various reasons|0|||
129897593|NCT01981850|467584414|FG002|Main Phase Stage 2|Various reasons|0|||
129897594|NCT01981850|467584415|FG003|Main Phase Stage 2|Various reasons|0|||
129897595|NCT01981850|467584416|FG004|Main Phase Stage 2|Various reasons|2|||
129897596|NCT01981850|467584417|FG005|Main Phase Stage 2|Various reasons|0|||
129897597|NCT01981850|467584418|FG006|Main Phase Stage 2|Various reasons|1|||
129897598|NCT01981850|467584419|FG007|Main Phase Stage 2|Various reasons|0|||
129897599|NCT01981850|467584420|FG008|Main Phase Stage 2|Various reasons|0|||
129897600|NCT01981850|467584421|FG009|Main Phase Stage 2|Various reasons|0|||
129897601|NCT01981850|467584412|FG000|Main Phase Stage 2|Progressive Disease|0|||
129897602|NCT01981850|467584413|FG001|Main Phase Stage 2|Progressive Disease|0|||
129897603|NCT01981850|467584414|FG002|Main Phase Stage 2|Progressive Disease|0|||
129897604|NCT01981850|467584415|FG003|Main Phase Stage 2|Progressive Disease|0|||
129897605|NCT01981850|467584416|FG004|Main Phase Stage 2|Progressive Disease|0|||
129897606|NCT01981850|467584417|FG005|Main Phase Stage 2|Progressive Disease|6|||
129897607|NCT01981850|467584418|FG006|Main Phase Stage 2|Progressive Disease|6|||
129897608|NCT01981850|467584419|FG007|Main Phase Stage 2|Progressive Disease|0|||
129897609|NCT01981850|467584420|FG008|Main Phase Stage 2|Progressive Disease|0|||
129897610|NCT01981850|467584421|FG009|Main Phase Stage 2|Progressive Disease|0|||
129897611|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Adverse Event|0|||
129897612|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Adverse Event|0|||
129897613|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Adverse Event|0|||
129897614|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Adverse Event|0|||
129897615|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Adverse Event|0|||
129897616|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Adverse Event|0|||
129897617|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Adverse Event|0|||
129897618|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Adverse Event|2|||
129897619|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Adverse Event|1|||
129897620|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Adverse Event|8|||
129897621|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897622|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897623|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897624|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897625|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897626|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897627|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
129897628|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
129897629|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
129897630|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
129897631|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Various reasons|0|||
129897632|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Various reasons|0|||
129897633|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Various reasons|0|||
129897634|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Various reasons|0|||
129897635|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Various reasons|0|||
129897636|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Various reasons|0|||
129826338|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
129826339|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
129826340|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
129826341|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
129826342|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
129826343|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
129826344|NCT00195676|467329140|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
129826345|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
129826346|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
129826347|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
129826348|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
129826349|NCT00195676|467329140|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
129826350|NCT01189812|467329141|FG000|Overall Study|Withdrawal by Subject|2|||
129826351|NCT01189812|467329142|FG001|Overall Study|Withdrawal by Subject|3|||
129826352|NCT01189812|467329141|FG000|Overall Study|Adverse Event|1|||
129826353|NCT01189812|467329142|FG001|Overall Study|Adverse Event|0|||
129826354|NCT01189812|467329141|FG000|Overall Study|Out of Window|4|||
129826355|NCT01189812|467329142|FG001|Overall Study|Out of Window|3|||
129826356|NCT01189812|467329141|FG000|Overall Study|Moved out of State|1|||
129826357|NCT01189812|467329142|FG001|Overall Study|Moved out of State|2|||
129826358|NCT00535223|467329144|FG000|Overall Study|Withdrawal by Subject|4|||
129826359|NCT00535223|467329145|FG001|Overall Study|Withdrawal by Subject|1|||
129826360|NCT02953314|467329146|FG000|Overall Study|Adverse Event|0|||
129826361|NCT02953314|467329147|FG001|Overall Study|Adverse Event|1|||
129826362|NCT02953314|467329146|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129826363|NCT02953314|467329147|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129897637|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Various reasons|0|||
129897638|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Various reasons|3|||
129826364|NCT01765153|467329148|FG000|Training Phase 1|Format of intervention differed|1|||
129826365|NCT01765153|467329149|FG001|Training Phase 1|Format of intervention differed|0|||
129897639|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Various reasons|1|||
129826366|NCT01765153|467329148|FG000|Training Phase 1|Poor participation in intervention|0|||
129826367|NCT01765153|467329149|FG001|Training Phase 1|Poor participation in intervention|1|||
129826368|NCT01765153|467329148|FG000|Rest Phase 1|Withdrawal by Subject|0|||
129826369|NCT01765153|467329149|FG001|Rest Phase 1|Withdrawal by Subject|1|||
129826370|NCT01765153|467329148|FG000|Training Phase 2|Withdrawal by Subject|0|||
129826371|NCT01765153|467329149|FG001|Training Phase 2|Withdrawal by Subject|1|||
129826372|NCT01765153|467329148|FG000|Rest Phase 2|Lost to Follow-up|2|||
129826373|NCT01765153|467329149|FG001|Rest Phase 2|Lost to Follow-up|1|||
129826374|NCT02554812|467329150|FG000|Overall Study|Adverse Event|2|||
129826375|NCT02554812|467329151|FG001|Overall Study|Adverse Event|5|||
129826376|NCT02554812|467329152|FG002|Overall Study|Adverse Event|3|||
129826377|NCT02554812|467329153|FG003|Overall Study|Adverse Event|0|||
129826378|NCT02554812|467329154|FG004|Overall Study|Adverse Event|5|||
129826379|NCT02554812|467329155|FG005|Overall Study|Adverse Event|0|||
129826380|NCT02554812|467329156|FG006|Overall Study|Adverse Event|1|||
129826381|NCT02554812|467329157|FG007|Overall Study|Adverse Event|6|||
129826382|NCT02554812|467329158|FG008|Overall Study|Adverse Event|2|||
129826383|NCT02554812|467329159|FG009|Overall Study|Adverse Event|2|||
129826384|NCT02554812|467329160|FG010|Overall Study|Adverse Event|1|||
129826385|NCT02554812|467329161|FG011|Overall Study|Adverse Event|2|||
129826386|NCT02554812|467329162|FG012|Overall Study|Adverse Event|0|||
129826387|NCT02554812|467329163|FG013|Overall Study|Adverse Event|3|||
129826388|NCT02554812|467329164|FG014|Overall Study|Adverse Event|2|||
129826389|NCT02554812|467329165|FG015|Overall Study|Adverse Event|1|||
129826390|NCT02554812|467329166|FG016|Overall Study|Adverse Event|0|||
129826391|NCT02554812|467329167|FG017|Overall Study|Adverse Event|1|||
129826392|NCT02554812|467329168|FG018|Overall Study|Adverse Event|0|||
129826393|NCT02554812|467329169|FG019|Overall Study|Adverse Event|0|||
129826394|NCT02554812|467329170|FG020|Overall Study|Adverse Event|0|||
129826395|NCT02554812|467329171|FG021|Overall Study|Adverse Event|2|||
129826396|NCT02554812|467329172|FG022|Overall Study|Adverse Event|1|||
129826397|NCT02554812|467329173|FG023|Overall Study|Adverse Event|1|||
129826398|NCT02554812|467329174|FG024|Overall Study|Adverse Event|1|||
129826399|NCT02554812|467329175|FG025|Overall Study|Adverse Event|2|||
129826400|NCT02554812|467329176|FG026|Overall Study|Adverse Event|1|||
129826401|NCT02554812|467329150|FG000|Overall Study|Death|1|||
129826402|NCT02554812|467329151|FG001|Overall Study|Death|2|||
129897640|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Various reasons|3|||
129897641|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
129897642|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
129897643|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
129897644|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
129897645|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
129897646|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
129897647|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
129897648|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
129897649|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
129897650|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
129897651|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897652|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897653|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897654|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897655|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897656|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897657|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129826403|NCT02554812|467329152|FG002|Overall Study|Death|2|||
129826404|NCT02554812|467329153|FG003|Overall Study|Death|2|||
129826405|NCT02554812|467329154|FG004|Overall Study|Death|0|||
129826406|NCT02554812|467329155|FG005|Overall Study|Death|1|||
129826407|NCT02554812|467329156|FG006|Overall Study|Death|1|||
129826408|NCT02554812|467329157|FG007|Overall Study|Death|1|||
129826409|NCT02554812|467329158|FG008|Overall Study|Death|0|||
129826410|NCT02554812|467329159|FG009|Overall Study|Death|0|||
129826411|NCT02554812|467329160|FG010|Overall Study|Death|0|||
129826412|NCT02554812|467329161|FG011|Overall Study|Death|0|||
129826413|NCT02554812|467329162|FG012|Overall Study|Death|0|||
129826414|NCT02554812|467329163|FG013|Overall Study|Death|0|||
129826415|NCT02554812|467329164|FG014|Overall Study|Death|1|||
129826416|NCT02554812|467329165|FG015|Overall Study|Death|1|||
129826417|NCT02554812|467329166|FG016|Overall Study|Death|1|||
129897658|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129826418|NCT02554812|467329167|FG017|Overall Study|Death|0|||
129826419|NCT02554812|467329168|FG018|Overall Study|Death|1|||
129826420|NCT02554812|467329169|FG019|Overall Study|Death|2|||
129826421|NCT02554812|467329170|FG020|Overall Study|Death|0|||
129826422|NCT02554812|467329171|FG021|Overall Study|Death|1|||
129826423|NCT02554812|467329172|FG022|Overall Study|Death|1|||
129826424|NCT02554812|467329173|FG023|Overall Study|Death|0|||
129826425|NCT02554812|467329174|FG024|Overall Study|Death|0|||
129826426|NCT02554812|467329175|FG025|Overall Study|Death|0|||
129826427|NCT02554812|467329176|FG026|Overall Study|Death|0|||
129826428|NCT02554812|467329150|FG000|Overall Study|Lost to Follow-up|0|||
129826429|NCT02554812|467329151|FG001|Overall Study|Lost to Follow-up|1|||
129826430|NCT02554812|467329152|FG002|Overall Study|Lost to Follow-up|0|||
129826431|NCT02554812|467329153|FG003|Overall Study|Lost to Follow-up|0|||
129826432|NCT02554812|467329154|FG004|Overall Study|Lost to Follow-up|0|||
129826433|NCT02554812|467329155|FG005|Overall Study|Lost to Follow-up|0|||
129826434|NCT02554812|467329156|FG006|Overall Study|Lost to Follow-up|0|||
129826435|NCT02554812|467329157|FG007|Overall Study|Lost to Follow-up|0|||
129826436|NCT02554812|467329158|FG008|Overall Study|Lost to Follow-up|0|||
129826437|NCT02554812|467329159|FG009|Overall Study|Lost to Follow-up|0|||
129826438|NCT02554812|467329160|FG010|Overall Study|Lost to Follow-up|0|||
129826439|NCT02554812|467329161|FG011|Overall Study|Lost to Follow-up|0|||
129826440|NCT02554812|467329162|FG012|Overall Study|Lost to Follow-up|0|||
129826441|NCT02554812|467329163|FG013|Overall Study|Lost to Follow-up|0|||
129826442|NCT02554812|467329164|FG014|Overall Study|Lost to Follow-up|0|||
129826443|NCT02554812|467329165|FG015|Overall Study|Lost to Follow-up|0|||
129826444|NCT02554812|467329166|FG016|Overall Study|Lost to Follow-up|0|||
129826445|NCT02554812|467329167|FG017|Overall Study|Lost to Follow-up|0|||
129826446|NCT02554812|467329168|FG018|Overall Study|Lost to Follow-up|0|||
129826447|NCT02554812|467329169|FG019|Overall Study|Lost to Follow-up|0|||
129826448|NCT02554812|467329170|FG020|Overall Study|Lost to Follow-up|0|||
129826449|NCT02554812|467329171|FG021|Overall Study|Lost to Follow-up|0|||
129826450|NCT02554812|467329172|FG022|Overall Study|Lost to Follow-up|0|||
129826451|NCT02554812|467329173|FG023|Overall Study|Lost to Follow-up|0|||
129826452|NCT02554812|467329174|FG024|Overall Study|Lost to Follow-up|0|||
129826453|NCT02554812|467329175|FG025|Overall Study|Lost to Follow-up|0|||
129826454|NCT02554812|467329176|FG026|Overall Study|Lost to Follow-up|0|||
129826455|NCT02554812|467329150|FG000|Overall Study|Global deterioration of health status|4|||
129826456|NCT02554812|467329151|FG001|Overall Study|Global deterioration of health status|3|||
129826457|NCT02554812|467329152|FG002|Overall Study|Global deterioration of health status|3|||
129826458|NCT02554812|467329153|FG003|Overall Study|Global deterioration of health status|2|||
129826459|NCT02554812|467329154|FG004|Overall Study|Global deterioration of health status|5|||
129826460|NCT02554812|467329155|FG005|Overall Study|Global deterioration of health status|0|||
129826461|NCT02554812|467329156|FG006|Overall Study|Global deterioration of health status|2|||
129826462|NCT02554812|467329157|FG007|Overall Study|Global deterioration of health status|1|||
129826463|NCT02554812|467329158|FG008|Overall Study|Global deterioration of health status|1|||
129826464|NCT02554812|467329159|FG009|Overall Study|Global deterioration of health status|1|||
129826465|NCT02554812|467329160|FG010|Overall Study|Global deterioration of health status|2|||
129826466|NCT02554812|467329161|FG011|Overall Study|Global deterioration of health status|1|||
129826467|NCT02554812|467329162|FG012|Overall Study|Global deterioration of health status|0|||
129826468|NCT02554812|467329163|FG013|Overall Study|Global deterioration of health status|0|||
129826469|NCT02554812|467329164|FG014|Overall Study|Global deterioration of health status|0|||
129826470|NCT02554812|467329165|FG015|Overall Study|Global deterioration of health status|1|||
129826471|NCT02554812|467329166|FG016|Overall Study|Global deterioration of health status|0|||
129826472|NCT02554812|467329167|FG017|Overall Study|Global deterioration of health status|0|||
129826473|NCT02554812|467329168|FG018|Overall Study|Global deterioration of health status|0|||
129826474|NCT02554812|467329169|FG019|Overall Study|Global deterioration of health status|0|||
129826475|NCT02554812|467329170|FG020|Overall Study|Global deterioration of health status|0|||
129826476|NCT02554812|467329171|FG021|Overall Study|Global deterioration of health status|0|||
129826477|NCT02554812|467329172|FG022|Overall Study|Global deterioration of health status|0|||
129826478|NCT02554812|467329173|FG023|Overall Study|Global deterioration of health status|0|||
129826479|NCT02554812|467329174|FG024|Overall Study|Global deterioration of health status|0|||
129826480|NCT02554812|467329175|FG025|Overall Study|Global deterioration of health status|0|||
129826481|NCT02554812|467329176|FG026|Overall Study|Global deterioration of health status|0|||
129826482|NCT02554812|467329150|FG000|Overall Study|Progressive disease|20|||
129826483|NCT02554812|467329151|FG001|Overall Study|Progressive disease|16|||
129826484|NCT02554812|467329152|FG002|Overall Study|Progressive disease|19|||
129826485|NCT02554812|467329153|FG003|Overall Study|Progressive disease|18|||
129826486|NCT02554812|467329154|FG004|Overall Study|Progressive disease|21|||
129826487|NCT02554812|467329155|FG005|Overall Study|Progressive disease|15|||
129826488|NCT02554812|467329156|FG006|Overall Study|Progressive disease|6|||
129826489|NCT02554812|467329157|FG007|Overall Study|Progressive disease|13|||
129826490|NCT02554812|467329158|FG008|Overall Study|Progressive disease|6|||
129826491|NCT02554812|467329159|FG009|Overall Study|Progressive disease|6|||
129826492|NCT02554812|467329160|FG010|Overall Study|Progressive disease|8|||
129826493|NCT02554812|467329161|FG011|Overall Study|Progressive disease|8|||
129826494|NCT02554812|467329162|FG012|Overall Study|Progressive disease|6|||
129826495|NCT02554812|467329163|FG013|Overall Study|Progressive disease|10|||
129826496|NCT02554812|467329164|FG014|Overall Study|Progressive disease|20|||
129826497|NCT02554812|467329165|FG015|Overall Study|Progressive disease|6|||
129826498|NCT02554812|467329166|FG016|Overall Study|Progressive disease|3|||
129826499|NCT02554812|467329167|FG017|Overall Study|Progressive disease|3|||
129826500|NCT02554812|467329168|FG018|Overall Study|Progressive disease|11|||
129826501|NCT02554812|467329169|FG019|Overall Study|Progressive disease|7|||
129826502|NCT02554812|467329170|FG020|Overall Study|Progressive disease|11|||
129826503|NCT02554812|467329171|FG021|Overall Study|Progressive disease|6|||
129826504|NCT02554812|467329172|FG022|Overall Study|Progressive disease|9|||
129826505|NCT02554812|467329173|FG023|Overall Study|Progressive disease|9|||
129826506|NCT02554812|467329174|FG024|Overall Study|Progressive disease|4|||
129826507|NCT02554812|467329175|FG025|Overall Study|Progressive disease|5|||
129826508|NCT02554812|467329176|FG026|Overall Study|Progressive disease|5|||
129826509|NCT02554812|467329150|FG000|Overall Study|Other|0|||
129826510|NCT02554812|467329151|FG001|Overall Study|Other|0|||
129826511|NCT02554812|467329152|FG002|Overall Study|Other|2|||
129826512|NCT02554812|467329153|FG003|Overall Study|Other|3|||
129826513|NCT02554812|467329154|FG004|Overall Study|Other|2|||
129826514|NCT02554812|467329155|FG005|Overall Study|Other|1|||
129826515|NCT02554812|467329156|FG006|Overall Study|Other|0|||
129826516|NCT02554812|467329157|FG007|Overall Study|Other|0|||
129826517|NCT02554812|467329158|FG008|Overall Study|Other|1|||
129826518|NCT02554812|467329159|FG009|Overall Study|Other|1|||
129826519|NCT02554812|467329160|FG010|Overall Study|Other|0|||
129826520|NCT02554812|467329161|FG011|Overall Study|Other|0|||
129826521|NCT02554812|467329162|FG012|Overall Study|Other|1|||
129826522|NCT02554812|467329163|FG013|Overall Study|Other|0|||
129826523|NCT02554812|467329164|FG014|Overall Study|Other|1|||
129826524|NCT02554812|467329165|FG015|Overall Study|Other|0|||
129826525|NCT02554812|467329166|FG016|Overall Study|Other|0|||
129826526|NCT02554812|467329167|FG017|Overall Study|Other|0|||
129826527|NCT02554812|467329168|FG018|Overall Study|Other|0|||
129826528|NCT02554812|467329169|FG019|Overall Study|Other|0|||
129826529|NCT02554812|467329170|FG020|Overall Study|Other|0|||
129826530|NCT02554812|467329171|FG021|Overall Study|Other|2|||
129826531|NCT02554812|467329172|FG022|Overall Study|Other|0|||
129826532|NCT02554812|467329173|FG023|Overall Study|Other|0|||
129826533|NCT02554812|467329174|FG024|Overall Study|Other|0|||
129826534|NCT02554812|467329175|FG025|Overall Study|Other|0|||
129826535|NCT02554812|467329176|FG026|Overall Study|Other|0|||
129826536|NCT02554812|467329150|FG000|Overall Study|Withdrawal by Subject|1|||
129826537|NCT02554812|467329151|FG001|Overall Study|Withdrawal by Subject|0|||
129826538|NCT02554812|467329152|FG002|Overall Study|Withdrawal by Subject|0|||
129826539|NCT02554812|467329153|FG003|Overall Study|Withdrawal by Subject|2|||
129826540|NCT02554812|467329154|FG004|Overall Study|Withdrawal by Subject|2|||
129826541|NCT02554812|467329155|FG005|Overall Study|Withdrawal by Subject|3|||
129826542|NCT02554812|467329156|FG006|Overall Study|Withdrawal by Subject|0|||
129826543|NCT02554812|467329157|FG007|Overall Study|Withdrawal by Subject|0|||
129826544|NCT02554812|467329158|FG008|Overall Study|Withdrawal by Subject|1|||
129826545|NCT02554812|467329159|FG009|Overall Study|Withdrawal by Subject|1|||
129826546|NCT02554812|467329160|FG010|Overall Study|Withdrawal by Subject|0|||
129826547|NCT02554812|467329161|FG011|Overall Study|Withdrawal by Subject|1|||
129826548|NCT02554812|467329162|FG012|Overall Study|Withdrawal by Subject|1|||
129826549|NCT02554812|467329163|FG013|Overall Study|Withdrawal by Subject|1|||
129826550|NCT02554812|467329164|FG014|Overall Study|Withdrawal by Subject|1|||
129826551|NCT02554812|467329165|FG015|Overall Study|Withdrawal by Subject|1|||
129826552|NCT02554812|467329166|FG016|Overall Study|Withdrawal by Subject|3|||
129826553|NCT02554812|467329167|FG017|Overall Study|Withdrawal by Subject|1|||
129826554|NCT02554812|467329168|FG018|Overall Study|Withdrawal by Subject|0|||
129826555|NCT02554812|467329169|FG019|Overall Study|Withdrawal by Subject|2|||
129826556|NCT02554812|467329170|FG020|Overall Study|Withdrawal by Subject|0|||
129826557|NCT02554812|467329171|FG021|Overall Study|Withdrawal by Subject|1|||
129826558|NCT02554812|467329172|FG022|Overall Study|Withdrawal by Subject|0|||
129826559|NCT02554812|467329173|FG023|Overall Study|Withdrawal by Subject|1|||
129826560|NCT02554812|467329174|FG024|Overall Study|Withdrawal by Subject|0|||
129826561|NCT02554812|467329175|FG025|Overall Study|Withdrawal by Subject|0|||
129826562|NCT02554812|467329176|FG026|Overall Study|Withdrawal by Subject|1|||
129826563|NCT02554812|467329150|FG000|Overall Study|Physician Decision|1|||
129826564|NCT02554812|467329151|FG001|Overall Study|Physician Decision|0|||
129826565|NCT02554812|467329152|FG002|Overall Study|Physician Decision|0|||
129826566|NCT02554812|467329153|FG003|Overall Study|Physician Decision|1|||
129826567|NCT02554812|467329154|FG004|Overall Study|Physician Decision|0|||
129826568|NCT02554812|467329155|FG005|Overall Study|Physician Decision|1|||
129826569|NCT02554812|467329156|FG006|Overall Study|Physician Decision|0|||
129826570|NCT02554812|467329157|FG007|Overall Study|Physician Decision|0|||
129826571|NCT02554812|467329158|FG008|Overall Study|Physician Decision|0|||
129826572|NCT02554812|467329159|FG009|Overall Study|Physician Decision|0|||
129826573|NCT02554812|467329160|FG010|Overall Study|Physician Decision|1|||
129826574|NCT02554812|467329161|FG011|Overall Study|Physician Decision|0|||
129826575|NCT02554812|467329162|FG012|Overall Study|Physician Decision|0|||
129826576|NCT02554812|467329163|FG013|Overall Study|Physician Decision|0|||
129826577|NCT02554812|467329164|FG014|Overall Study|Physician Decision|0|||
129826578|NCT02554812|467329165|FG015|Overall Study|Physician Decision|0|||
129826579|NCT02554812|467329166|FG016|Overall Study|Physician Decision|1|||
129826580|NCT02554812|467329167|FG017|Overall Study|Physician Decision|1|||
129826581|NCT02554812|467329168|FG018|Overall Study|Physician Decision|0|||
129826582|NCT02554812|467329169|FG019|Overall Study|Physician Decision|1|||
129826583|NCT02554812|467329170|FG020|Overall Study|Physician Decision|1|||
129826584|NCT02554812|467329171|FG021|Overall Study|Physician Decision|0|||
129826585|NCT02554812|467329172|FG022|Overall Study|Physician Decision|1|||
129826586|NCT02554812|467329173|FG023|Overall Study|Physician Decision|0|||
129826587|NCT02554812|467329174|FG024|Overall Study|Physician Decision|0|||
129826588|NCT02554812|467329175|FG025|Overall Study|Physician Decision|0|||
129826589|NCT02554812|467329176|FG026|Overall Study|Physician Decision|0|||
129826590|NCT02554812|467329150|FG000|Overall Study|Study terminated by sponsor|0|||
129826591|NCT02554812|467329151|FG001|Overall Study|Study terminated by sponsor|0|||
129826592|NCT02554812|467329152|FG002|Overall Study|Study terminated by sponsor|0|||
129826593|NCT02554812|467329153|FG003|Overall Study|Study terminated by sponsor|0|||
129826594|NCT02554812|467329154|FG004|Overall Study|Study terminated by sponsor|0|||
129826595|NCT02554812|467329155|FG005|Overall Study|Study terminated by sponsor|0|||
129826596|NCT02554812|467329156|FG006|Overall Study|Study terminated by sponsor|0|||
129826597|NCT02554812|467329157|FG007|Overall Study|Study terminated by sponsor|0|||
129826598|NCT02554812|467329158|FG008|Overall Study|Study terminated by sponsor|0|||
129826599|NCT02554812|467329159|FG009|Overall Study|Study terminated by sponsor|0|||
129826600|NCT02554812|467329160|FG010|Overall Study|Study terminated by sponsor|0|||
129826601|NCT02554812|467329161|FG011|Overall Study|Study terminated by sponsor|0|||
129826602|NCT02554812|467329162|FG012|Overall Study|Study terminated by sponsor|0|||
129826603|NCT02554812|467329163|FG013|Overall Study|Study terminated by sponsor|0|||
129826604|NCT02554812|467329164|FG014|Overall Study|Study terminated by sponsor|0|||
129826605|NCT02554812|467329165|FG015|Overall Study|Study terminated by sponsor|0|||
129826606|NCT02554812|467329166|FG016|Overall Study|Study terminated by sponsor|0|||
129826607|NCT02554812|467329167|FG017|Overall Study|Study terminated by sponsor|0|||
129826608|NCT02554812|467329168|FG018|Overall Study|Study terminated by sponsor|0|||
129826609|NCT02554812|467329169|FG019|Overall Study|Study terminated by sponsor|0|||
129826610|NCT02554812|467329170|FG020|Overall Study|Study terminated by sponsor|0|||
129826611|NCT02554812|467329171|FG021|Overall Study|Study terminated by sponsor|0|||
129826612|NCT02554812|467329172|FG022|Overall Study|Study terminated by sponsor|0|||
129826613|NCT02554812|467329173|FG023|Overall Study|Study terminated by sponsor|0|||
129826614|NCT02554812|467329174|FG024|Overall Study|Study terminated by sponsor|1|||
129826615|NCT02554812|467329175|FG025|Overall Study|Study terminated by sponsor|0|||
129826616|NCT02554812|467329176|FG026|Overall Study|Study terminated by sponsor|0|||
129826617|NCT02554812|467329150|FG000|Overall Study|No longer meets eligibility criteria|0|||
129826618|NCT02554812|467329151|FG001|Overall Study|No longer meets eligibility criteria|1|||
129826619|NCT02554812|467329152|FG002|Overall Study|No longer meets eligibility criteria|0|||
129826620|NCT02554812|467329153|FG003|Overall Study|No longer meets eligibility criteria|0|||
129826621|NCT02554812|467329154|FG004|Overall Study|No longer meets eligibility criteria|0|||
129826622|NCT02554812|467329155|FG005|Overall Study|No longer meets eligibility criteria|0|||
129826623|NCT02554812|467329156|FG006|Overall Study|No longer meets eligibility criteria|0|||
129826624|NCT02554812|467329157|FG007|Overall Study|No longer meets eligibility criteria|0|||
129826625|NCT02554812|467329158|FG008|Overall Study|No longer meets eligibility criteria|0|||
129826626|NCT02554812|467329159|FG009|Overall Study|No longer meets eligibility criteria|0|||
129826627|NCT02554812|467329160|FG010|Overall Study|No longer meets eligibility criteria|0|||
129826628|NCT02554812|467329161|FG011|Overall Study|No longer meets eligibility criteria|0|||
129826629|NCT02554812|467329162|FG012|Overall Study|No longer meets eligibility criteria|0|||
129826630|NCT02554812|467329163|FG013|Overall Study|No longer meets eligibility criteria|0|||
129826631|NCT02554812|467329164|FG014|Overall Study|No longer meets eligibility criteria|0|||
129826632|NCT02554812|467329165|FG015|Overall Study|No longer meets eligibility criteria|0|||
129826633|NCT02554812|467329166|FG016|Overall Study|No longer meets eligibility criteria|0|||
129826634|NCT02554812|467329167|FG017|Overall Study|No longer meets eligibility criteria|0|||
129826635|NCT02554812|467329168|FG018|Overall Study|No longer meets eligibility criteria|0|||
129826636|NCT02554812|467329169|FG019|Overall Study|No longer meets eligibility criteria|0|||
129826637|NCT02554812|467329170|FG020|Overall Study|No longer meets eligibility criteria|0|||
129826638|NCT02554812|467329171|FG021|Overall Study|No longer meets eligibility criteria|0|||
129826639|NCT02554812|467329172|FG022|Overall Study|No longer meets eligibility criteria|0|||
129826640|NCT02554812|467329173|FG023|Overall Study|No longer meets eligibility criteria|0|||
129826641|NCT02554812|467329174|FG024|Overall Study|No longer meets eligibility criteria|0|||
129826642|NCT02554812|467329175|FG025|Overall Study|No longer meets eligibility criteria|0|||
129826643|NCT02554812|467329176|FG026|Overall Study|No longer meets eligibility criteria|0|||
129826644|NCT02081690|467331356|FG000|Overall Study|Death|3|||
129826645|NCT02081690|467331356|FG000|Overall Study|Physician Decision|3|||
129826646|NCT02081690|467331356|FG000|Overall Study|Withdrawal by Subject|1|||
129826647|NCT03204981|467331358|FG000|Overall Study|Physician Decision|2|||
129826648|NCT03204981|467331358|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
129826649|NCT00312494|467331361|FG000|Overall Study|Randomized; not treated with study drug|9|||
129826650|NCT00312494|467331362|FG001|Overall Study|Randomized; not treated with study drug|10|||
129445711|NCT01968070|465932878|FG003|Period 2|Withdrawal by Subject|0|||
129826651|NCT00312494|467331363|FG002|Overall Study|Randomized; not treated with study drug|5|||
129826652|NCT00312494|467331361|FG000|Overall Study|Adverse Event|33|||
129826653|NCT00312494|467331362|FG001|Overall Study|Adverse Event|15|||
129826654|NCT00312494|467331363|FG002|Overall Study|Adverse Event|11|||
129826655|NCT00312494|467331361|FG000|Overall Study|Lack of Efficacy|4|||
129826656|NCT00312494|467331362|FG001|Overall Study|Lack of Efficacy|6|||
129826657|NCT00312494|467331363|FG002|Overall Study|Lack of Efficacy|8|||
129826658|NCT00312494|467331361|FG000|Overall Study|Laboratory abnormality|1|||
129826659|NCT00312494|467331362|FG001|Overall Study|Laboratory abnormality|0|||
129826660|NCT00312494|467331363|FG002|Overall Study|Laboratory abnormality|0|||
129826661|NCT00312494|467331361|FG000|Overall Study|Lost to Follow-up|8|||
129826662|NCT00312494|467331362|FG001|Overall Study|Lost to Follow-up|8|||
129826663|NCT00312494|467331363|FG002|Overall Study|Lost to Follow-up|8|||
129826664|NCT00312494|467331361|FG000|Overall Study|Withdrawal by Subject|6|||
129826665|NCT00312494|467331362|FG001|Overall Study|Withdrawal by Subject|9|||
129826666|NCT00312494|467331363|FG002|Overall Study|Withdrawal by Subject|10|||
129826667|NCT00312494|467331361|FG000|Overall Study|Other|10|||
129826668|NCT00312494|467331362|FG001|Overall Study|Other|10|||
129826669|NCT00312494|467331363|FG002|Overall Study|Other|1|||
129826670|NCT02734810|467331366|FG000|Overall Study|Adverse Event|1|||
129826671|NCT02734810|467331367|FG001|Overall Study|Adverse Event|0|||
129826672|NCT02734810|467331366|FG000|Overall Study|Lack of Efficacy|1|||
129826673|NCT02734810|467331367|FG001|Overall Study|Lack of Efficacy|0|||
129826674|NCT00488345|467331368|FG000|Overall Study|Adverse Event|0|||
129826675|NCT00488345|467331369|FG001|Overall Study|Adverse Event|1|||
129826676|NCT00488345|467331370|FG002|Overall Study|Adverse Event|1|||
129826677|NCT00488345|467331368|FG000|Overall Study|Unable to administer antibiotics at home|0|||
129826678|NCT00488345|467331369|FG001|Overall Study|Unable to administer antibiotics at home|1|||
129826679|NCT00488345|467331370|FG002|Overall Study|Unable to administer antibiotics at home|0|||
129826680|NCT00488345|467331368|FG000|Overall Study|Institutional Review Board review|0|||
129826681|NCT00488345|467331369|FG001|Overall Study|Institutional Review Board review|0|||
129826682|NCT00488345|467331370|FG002|Overall Study|Institutional Review Board review|1|||
129826683|NCT00488345|467331368|FG000|Overall Study|Surgical team recommendation|0|||
129826684|NCT00488345|467331369|FG001|Overall Study|Surgical team recommendation|1|||
129826685|NCT00488345|467331370|FG002|Overall Study|Surgical team recommendation|0|||
129826686|NCT00488345|467331368|FG000|Overall Study|Parent/legal guardian request|0|||
129826687|NCT00488345|467331369|FG001|Overall Study|Parent/legal guardian request|1|||
129826688|NCT00488345|467331370|FG002|Overall Study|Parent/legal guardian request|1|||
129826689|NCT00903617|467331376|FG000|Overall Study|Adverse Event|0|||
129826690|NCT00903617|467331377|FG001|Overall Study|Adverse Event|1|||
129826691|NCT00903617|467331378|FG002|Overall Study|Adverse Event|1|||
129826692|NCT00903617|467331379|FG003|Overall Study|Adverse Event|0|||
129826693|NCT00903617|467331376|FG000|Overall Study|Protocol-defined stopping criteria|0|||
129826694|NCT00903617|467331377|FG001|Overall Study|Protocol-defined stopping criteria|2|||
129826695|NCT00903617|467331378|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129826696|NCT00903617|467331379|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129826697|NCT00903617|467331376|FG000|Overall Study|Lost to Follow-up|2|||
129826698|NCT00903617|467331377|FG001|Overall Study|Lost to Follow-up|0|||
129826699|NCT00903617|467331378|FG002|Overall Study|Lost to Follow-up|1|||
129826700|NCT00903617|467331379|FG003|Overall Study|Lost to Follow-up|1|||
129826701|NCT00903617|467331376|FG000|Overall Study|Withdrawal by Subject|1|||
129826702|NCT00903617|467331377|FG001|Overall Study|Withdrawal by Subject|2|||
129826703|NCT00903617|467331378|FG002|Overall Study|Withdrawal by Subject|3|||
129826704|NCT00903617|467331379|FG003|Overall Study|Withdrawal by Subject|0|||
129826705|NCT01104636|467331380|FG000|Overall Study|Lack of Efficacy|43|||
129826706|NCT01104636|467331380|FG000|Overall Study|Lost to Follow-up|24|||
129826707|NCT01104636|467331380|FG000|Overall Study|Withdrawal by Subject|4|||
129826708|NCT01104636|467331380|FG000|Overall Study|Other|43|||
129826709|NCT01104636|467331380|FG000|Overall Study|Study terminated by sponsor|1|||
129826710|NCT01104636|467331380|FG000|Overall Study|Pregnancy|2|||
129826711|NCT01104636|467331380|FG000|Overall Study|Adverse Event|40|||
129826712|NCT01104636|467331380|FG000|Overall Study|Ongoing|21|||
129826713|NCT01706003|467331381|FG000|Overall Study|Withdrawal by Subject|2|||
129826714|NCT01706003|467331382|FG001|Overall Study|Withdrawal by Subject|0|||
129826715|NCT01706003|467331381|FG000|Overall Study|Not scheduled|3|||
129826716|NCT01706003|467331382|FG001|Overall Study|Not scheduled|0|||
129826717|NCT01706003|467331381|FG000|Overall Study|Lost to Follow-up|6|||
129826718|NCT01706003|467331382|FG001|Overall Study|Lost to Follow-up|4|||
129826719|NCT00407563|467331383|FG000|Overall Study|Patient continues on treatment|1|||
129826720|NCT03055260|467331384|FG000|Overall Study|Withdrawal by Subject|1|||
129826721|NCT03055260|467331385|FG001|Overall Study|Withdrawal by Subject|0|||
129826722|NCT00592839|467331386|FG000|Overall Study|Withdrawal by Subject|1|||
129826723|NCT00592839|467331387|FG001|Overall Study|Withdrawal by Subject|1|||
129826724|NCT00592839|467331388|FG002|Overall Study|Withdrawal by Subject|3|||
129826725|NCT00592839|467331386|FG000|Overall Study|Protocol Violation|1|||
129826726|NCT00592839|467331387|FG001|Overall Study|Protocol Violation|1|||
129826727|NCT00592839|467331388|FG002|Overall Study|Protocol Violation|2|||
129826728|NCT00592839|467331386|FG000|Overall Study|Adverse Event|0|||
129826729|NCT00592839|467331387|FG001|Overall Study|Adverse Event|1|||
129826730|NCT00592839|467331388|FG002|Overall Study|Adverse Event|0|||
129826731|NCT00592839|467331386|FG000|Overall Study|Lost to Follow-up|0|||
129826732|NCT00592839|467331387|FG001|Overall Study|Lost to Follow-up|1|||
129826733|NCT00592839|467331388|FG002|Overall Study|Lost to Follow-up|1|||
129826734|NCT00249444|467331394|FG000|Overall Study|Lost to Follow-up|2|||
129826735|NCT00249444|467331395|FG001|Overall Study|Lost to Follow-up|2|||
129826736|NCT00249444|467331394|FG000|Overall Study|non-compliant|9|||
129826737|NCT00249444|467331395|FG001|Overall Study|non-compliant|11|||
129826738|NCT00249444|467331394|FG000|Overall Study|Adverse Event|1|||
129826739|NCT00249444|467331395|FG001|Overall Study|Adverse Event|1|||
129826740|NCT00249444|467331394|FG000|Overall Study|life event|0|||
129826741|NCT00249444|467331395|FG001|Overall Study|life event|1|||
129826742|NCT00936910|467331398|FG000|Overall Study|Lack of Efficacy|3|||
129826743|NCT00412854|467331399|FG000|Overall Study|Withdrawn due to adverse events|1|||
129826744|NCT00412854|467331400|FG001|Overall Study|Withdrawn due to adverse events|5|||
129826745|NCT00412854|467331399|FG000|Overall Study|Withdrawn for other reasons|13|||
129826746|NCT00412854|467331400|FG001|Overall Study|Withdrawn for other reasons|11|||
129826747|NCT04483011|467331404|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
129826748|NCT04483011|467331405|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
129826749|NCT03518073|467331406|FG000|Overall Study|Adverse Event|2|||
129826750|NCT03518073|467331407|FG001|Overall Study|Adverse Event|4|||
129826751|NCT03518073|467331408|FG002|Overall Study|Adverse Event|2|||
129826752|NCT03518073|467331406|FG000|Overall Study|Death|2|||
129826753|NCT03518073|467331407|FG001|Overall Study|Death|1|||
129826754|NCT03518073|467331408|FG002|Overall Study|Death|3|||
129826755|NCT03518073|467331406|FG000|Overall Study|Lost to Follow-up|1|||
129826756|NCT03518073|467331407|FG001|Overall Study|Lost to Follow-up|0|||
129826757|NCT03518073|467331408|FG002|Overall Study|Lost to Follow-up|1|||
129826758|NCT03518073|467331406|FG000|Overall Study|Physician Decision|5|||
129826759|NCT03518073|467331407|FG001|Overall Study|Physician Decision|0|||
129826760|NCT03518073|467331408|FG002|Overall Study|Physician Decision|2|||
129826761|NCT03518073|467331406|FG000|Overall Study|Progressive disease|1|||
129826762|NCT03518073|467331407|FG001|Overall Study|Progressive disease|1|||
129826763|NCT03518073|467331408|FG002|Overall Study|Progressive disease|1|||
129826764|NCT03518073|467331406|FG000|Overall Study|Protocol Violation|1|||
129826765|NCT03518073|467331407|FG001|Overall Study|Protocol Violation|0|||
129826766|NCT03518073|467331408|FG002|Overall Study|Protocol Violation|0|||
129826767|NCT03518073|467331406|FG000|Overall Study|Withdrawal by Subject|30|||
129826768|NCT03518073|467331407|FG001|Overall Study|Withdrawal by Subject|34|||
129826769|NCT03518073|467331408|FG002|Overall Study|Withdrawal by Subject|29|||
129826770|NCT03518073|467331406|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
129826771|NCT03518073|467331407|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
129826772|NCT03518073|467331408|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
129826773|NCT03518073|467331406|FG000|Overall Study|Covid-19|1|||
129826774|NCT03518073|467331407|FG001|Overall Study|Covid-19|2|||
129826775|NCT03518073|467331408|FG002|Overall Study|Covid-19|1|||
129826776|NCT03045081|467331409|FG000|Overall Study|Withdrawal by Subject|6|||
129826777|NCT03045081|467331410|FG001|Overall Study|Withdrawal by Subject|11|||
129826778|NCT01485640|467331411|FG000|Overall Study|Adverse Event|10|||
129826779|NCT01485640|467331411|FG000|Overall Study|Lack of Efficacy|2|||
129826780|NCT01485640|467331411|FG000|Overall Study|Protocol Violation|1|||
129826781|NCT01485640|467331411|FG000|Overall Study|Withdrawal by Subject|14|||
129826782|NCT01485640|467331411|FG000|Overall Study|Terminated by Sponsor|95|||
129826783|NCT01853046|467331412|FG000|Overall Study|Withdrawal by Subject|1|||
129826784|NCT01853046|467331413|FG001|Overall Study|Withdrawal by Subject|1|||
129826785|NCT01853046|467331412|FG000|Overall Study|Adverse Event|4|||
129826786|NCT01853046|467331413|FG001|Overall Study|Adverse Event|2|||
129826787|NCT01853046|467331412|FG000|Overall Study|Disease progression|13|||
129826788|NCT01853046|467331413|FG001|Overall Study|Disease progression|3|||
129826789|NCT02057198|467331421|FG000|Overall Study|Death|0|||
129826790|NCT02057198|467331422|FG001|Overall Study|Death|0|||
129826791|NCT02057198|467331423|FG002|Overall Study|Death|1|||
129826792|NCT02057198|467331421|FG000|Overall Study|Discharged early; lost to followup|0|||
129826793|NCT02057198|467331422|FG001|Overall Study|Discharged early; lost to followup|1|||
129826794|NCT02057198|467331423|FG002|Overall Study|Discharged early; lost to followup|0|||
129826795|NCT02489344|467331426|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
129826796|NCT02489344|467331426|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
129826797|NCT02489344|467331426|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
129826798|NCT02489344|467331426|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
129826799|NCT00546637|467331429|FG000|Overall Study|Adverse Event|46|||
129826800|NCT00546637|467331430|FG001|Overall Study|Adverse Event|20|||
129826801|NCT00546637|467331429|FG000|Overall Study|Lack of Efficacy|5|||
129826802|NCT00546637|467331430|FG001|Overall Study|Lack of Efficacy|5|||
129826803|NCT00546637|467331429|FG000|Overall Study|Lost to Follow-up|2|||
129826804|NCT00546637|467331430|FG001|Overall Study|Lost to Follow-up|2|||
129826805|NCT00546637|467331429|FG000|Overall Study|Other|10|||
129826806|NCT00546637|467331430|FG001|Overall Study|Other|12|||
129826807|NCT00546637|467331429|FG000|Overall Study|Withdrawal by Subject|7|||
129826808|NCT00546637|467331430|FG001|Overall Study|Withdrawal by Subject|9|||
129826809|NCT00546637|467331429|FG000|Overall Study|Randomized, but not treated|3|||
129826810|NCT00546637|467331430|FG001|Overall Study|Randomized, but not treated|1|||
129826811|NCT01074450|467331431|FG000|First Intervention|Emesis in Dosing Interval|0|||
129826812|NCT01074450|467331432|FG001|First Intervention|Emesis in Dosing Interval|2|||
129826813|NCT01074450|467331431|FG000|Second Intervention|Protocol Violation|1|||
129826814|NCT01074450|467331432|FG001|Second Intervention|Protocol Violation|0|||
129826815|NCT01074450|467331431|FG000|Second Intervention|Physician Decision|0|||
129826816|NCT01074450|467331432|FG001|Second Intervention|Physician Decision|1|||
129826817|NCT02968563|467331437|FG000|Overall Study|Adverse Event|0|||
129826818|NCT02968563|467331438|FG001|Overall Study|Adverse Event|6|||
129826819|NCT02968563|467331437|FG000|Overall Study|Death|1|||
129826820|NCT02968563|467331438|FG001|Overall Study|Death|1|||
129826821|NCT02968563|467331437|FG000|Overall Study|Lost to Follow-up|0|||
129826822|NCT02968563|467331438|FG001|Overall Study|Lost to Follow-up|1|||
129826823|NCT03178773|467331439|FG000|Overall Study|Death|0|||
129826824|NCT03178773|467331440|FG001|Overall Study|Death|1|||
129826825|NCT03178773|467331439|FG000|Overall Study|Lost to Follow-up|29|||
129826826|NCT03178773|467331440|FG001|Overall Study|Lost to Follow-up|25|||
129826827|NCT03178773|467331439|FG000|Overall Study|Withdrawal by Subject|10|||
129826828|NCT03178773|467331440|FG001|Overall Study|Withdrawal by Subject|14|||
129826829|NCT02604212|467331447|FG000|Overall Study|Study Terminated by Sponsor|2|||
129826830|NCT02604212|467331448|FG001|Overall Study|Study Terminated by Sponsor|1|||
129826831|NCT02604212|467331449|FG002|Overall Study|Study Terminated by Sponsor|3|||
129826832|NCT02604212|467331450|FG003|Overall Study|Study Terminated by Sponsor|3|||
129826833|NCT02604212|467331447|FG000|Overall Study|Withdrawal by Subject|0|||
129826834|NCT02604212|467331448|FG001|Overall Study|Withdrawal by Subject|0|||
129826835|NCT02604212|467331449|FG002|Overall Study|Withdrawal by Subject|1|||
129826836|NCT02604212|467331450|FG003|Overall Study|Withdrawal by Subject|0|||
129826837|NCT01119131|467331451|FG000|Overall Study|Adverse Event|1|||
129826838|NCT01119131|467331452|FG001|Overall Study|Adverse Event|1|||
129826839|NCT01119131|467331453|FG002|Overall Study|Adverse Event|1|||
129826840|NCT01119131|467331451|FG000|Overall Study|Non-Compliance|1|||
129826841|NCT01119131|467331452|FG001|Overall Study|Non-Compliance|0|||
129826842|NCT01119131|467331453|FG002|Overall Study|Non-Compliance|4|||
129826843|NCT01119131|467331451|FG000|Overall Study|Physician Decision|0|||
129826844|NCT01119131|467331452|FG001|Overall Study|Physician Decision|0|||
129826845|NCT01119131|467331453|FG002|Overall Study|Physician Decision|1|||
129826846|NCT00909389|467331456|FG000|Overall Study|Adverse Event|6|||
129826847|NCT00909389|467331456|FG000|Overall Study|Death|4|||
129826848|NCT00909389|467331456|FG000|Overall Study|Poor Compliance|16|||
129826849|NCT00909389|467331456|FG000|Overall Study|Lost to Follow-up|4|||
129826850|NCT00909389|467331456|FG000|Overall Study|No Information|103|||
129826851|NCT00003492|467331457|FG000|Overall Study|Not evaluable|6|||
129826852|NCT00597766|467331460|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
129826853|NCT00597766|467331461|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
129826854|NCT00597766|467331462|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
129826855|NCT00597766|467331460|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
129826856|NCT00597766|467331461|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
129826857|NCT00597766|467331462|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
129826858|NCT00737282|467331464|FG000|Overall Study|Study prematurely terminated|175|||
129826859|NCT02810392|467331466|FG000|Overall Study|Subject too ill to continue|1|||
129826860|NCT02810392|467331467|FG001|Overall Study|Subject too ill to continue|0|||
129826861|NCT02810392|467331466|FG000|Overall Study|COVID 19 research restrictions|0|||
129826862|NCT02810392|467331467|FG001|Overall Study|COVID 19 research restrictions|1|||
129826863|NCT00840294|467331468|FG000|Overall Study|Withdrawal by Subject|2|||
129826864|NCT00840294|467331469|FG001|Overall Study|Withdrawal by Subject|1|||
129826865|NCT00840294|467331468|FG000|Overall Study|Protocol Violation|1|||
129826866|NCT00840294|467331469|FG001|Overall Study|Protocol Violation|3|||
129826867|NCT00840294|467331468|FG000|Overall Study|Illness|0|||
129826868|NCT00840294|467331469|FG001|Overall Study|Illness|1|||
129826869|NCT00453544|467331472|FG000|Overall Study|Withdrawal by Subject|1|||
129826870|NCT00453544|467331473|FG001|Overall Study|Withdrawal by Subject|0|||
129826871|NCT00453544|467331474|FG002|Overall Study|Withdrawal by Subject|0|||
129826872|NCT00453544|467331475|FG003|Overall Study|Withdrawal by Subject|0|||
129826873|NCT00453544|467331472|FG000|Overall Study|Primary outcome measure not completed|1|||
129826874|NCT00453544|467331473|FG001|Overall Study|Primary outcome measure not completed|1|||
129826875|NCT00453544|467331474|FG002|Overall Study|Primary outcome measure not completed|0|||
129826876|NCT00453544|467331475|FG003|Overall Study|Primary outcome measure not completed|1|||
129826877|NCT02457910|467331476|FG000|Overall Study|Withdrawal by Subject|0|||
129826878|NCT02457910|467331477|FG001|Overall Study|Withdrawal by Subject|0|||
129826879|NCT02457910|467331478|FG002|Overall Study|Withdrawal by Subject|0|||
129826880|NCT02457910|467331479|FG003|Overall Study|Withdrawal by Subject|0|||
129826881|NCT02457910|467331480|FG004|Overall Study|Withdrawal by Subject|0|||
129826882|NCT02457910|467331481|FG005|Overall Study|Withdrawal by Subject|1|||
129826883|NCT02457910|467331476|FG000|Overall Study|Adverse Event|0|||
129826884|NCT02457910|467331477|FG001|Overall Study|Adverse Event|2|||
129826885|NCT02457910|467331478|FG002|Overall Study|Adverse Event|1|||
129826886|NCT02457910|467331479|FG003|Overall Study|Adverse Event|1|||
129826887|NCT02457910|467331480|FG004|Overall Study|Adverse Event|1|||
129826888|NCT02457910|467331481|FG005|Overall Study|Adverse Event|3|||
129826889|NCT02457910|467331476|FG000|Overall Study|Disease progression|3|||
129826890|NCT02457910|467331477|FG001|Overall Study|Disease progression|3|||
129826891|NCT02457910|467331478|FG002|Overall Study|Disease progression|1|||
129826892|NCT02457910|467331479|FG003|Overall Study|Disease progression|1|||
129826893|NCT02457910|467331480|FG004|Overall Study|Disease progression|4|||
129826894|NCT02457910|467331481|FG005|Overall Study|Disease progression|6|||
129826895|NCT02457910|467331476|FG000|Overall Study|Other complicating illness|0|||
129826896|NCT02457910|467331477|FG001|Overall Study|Other complicating illness|0|||
129826897|NCT02457910|467331478|FG002|Overall Study|Other complicating illness|0|||
129826898|NCT02457910|467331479|FG003|Overall Study|Other complicating illness|0|||
129826899|NCT02457910|467331480|FG004|Overall Study|Other complicating illness|0|||
129826900|NCT02457910|467331481|FG005|Overall Study|Other complicating illness|1|||
129826901|NCT02457910|467331476|FG000|Overall Study|Death|0|||
129826902|NCT02457910|467331477|FG001|Overall Study|Death|0|||
129826903|NCT02457910|467331478|FG002|Overall Study|Death|1|||
129826904|NCT02457910|467331479|FG003|Overall Study|Death|0|||
129826905|NCT02457910|467331480|FG004|Overall Study|Death|0|||
129826906|NCT02457910|467331481|FG005|Overall Study|Death|0|||
129826907|NCT00619801|467331482|FG000|Overall Study|Lack of Efficacy|0|||
129826908|NCT00619801|467331483|FG001|Overall Study|Lack of Efficacy|1|||
129826909|NCT00619801|467331482|FG000|Overall Study|Withdrawal by Subject|1|||
129826910|NCT00619801|467331483|FG001|Overall Study|Withdrawal by Subject|1|||
129826911|NCT00619801|467331482|FG000|Overall Study|Loss of efficacy|0|||
129826912|NCT00619801|467331483|FG001|Overall Study|Loss of efficacy|1|||
129826913|NCT03721276|467331486|FG000|Overall Study|Lost to Follow-up|5|||
129826914|NCT03721276|467331487|FG001|Overall Study|Lost to Follow-up|3|||
129826915|NCT03721276|467331486|FG000|Overall Study|Adverse Event|0|||
129826916|NCT03721276|467331487|FG001|Overall Study|Adverse Event|1|||
129826917|NCT01340898|467331488|FG000|Primary Phase|Serious Adverse Events|0|||
129826918|NCT01340898|467331489|FG001|Primary Phase|Serious Adverse Events|0|||
129826919|NCT01340898|467331490|FG002|Primary Phase|Serious Adverse Events|1|||
129826920|NCT01340898|467331488|FG000|Primary Phase|Withdrawal by Subject|8|||
129826921|NCT01340898|467331489|FG001|Primary Phase|Withdrawal by Subject|7|||
129826922|NCT01340898|467331490|FG002|Primary Phase|Withdrawal by Subject|5|||
129826923|NCT01340898|467331488|FG000|Primary Phase|Migrated/moved from study area|4|||
129826924|NCT01340898|467331489|FG001|Primary Phase|Migrated/moved from study area|1|||
129826925|NCT01340898|467331490|FG002|Primary Phase|Migrated/moved from study area|0|||
129826926|NCT01340898|467331488|FG000|Primary Phase|Lost to Follow-up|4|||
129826927|NCT01340898|467331489|FG001|Primary Phase|Lost to Follow-up|1|||
129826928|NCT01340898|467331490|FG002|Primary Phase|Lost to Follow-up|0|||
129826929|NCT01340898|467331488|FG000|Booster Phase|Withdrawal by Subject|3|||
129826930|NCT01340898|467331489|FG001|Booster Phase|Withdrawal by Subject|0|||
129826931|NCT01340898|467331490|FG002|Booster Phase|Withdrawal by Subject|4|||
129826932|NCT01340898|467331488|FG000|Booster Phase|Migrated/moved from study area|3|||
129826933|NCT01340898|467331489|FG001|Booster Phase|Migrated/moved from study area|0|||
129826934|NCT01340898|467331490|FG002|Booster Phase|Migrated/moved from study area|0|||
129826935|NCT01340898|467331488|FG000|Booster Phase|Lost to Follow-up|4|||
129826936|NCT01340898|467331489|FG001|Booster Phase|Lost to Follow-up|2|||
129826937|NCT01340898|467331490|FG002|Booster Phase|Lost to Follow-up|3|||
129826938|NCT01214629|467331492|FG000|Overall Study|Progressive Disease|1|||
129826939|NCT01214629|467331493|FG001|Overall Study|Progressive Disease|1|||
129826940|NCT01214629|467331494|FG002|Overall Study|Progressive Disease|0|||
129826941|NCT01214629|467331495|FG003|Overall Study|Progressive Disease|1|||
129826942|NCT01214629|467331496|FG004|Overall Study|Progressive Disease|2|||
129826943|NCT01214629|467331497|FG005|Overall Study|Progressive Disease|3|||
129826944|NCT01214629|467331498|FG006|Overall Study|Progressive Disease|1|||
129826945|NCT01214629|467331499|FG007|Overall Study|Progressive Disease|1|||
129826946|NCT01214629|467331500|FG008|Overall Study|Progressive Disease|1|||
129826947|NCT01214629|467331501|FG009|Overall Study|Progressive Disease|5|||
129826948|NCT01214629|467331502|FG010|Overall Study|Progressive Disease|1|||
129826949|NCT01214629|467331492|FG000|Overall Study|Adverse Event|0|||
129826950|NCT01214629|467331493|FG001|Overall Study|Adverse Event|0|||
129826951|NCT01214629|467331494|FG002|Overall Study|Adverse Event|0|||
129826952|NCT01214629|467331495|FG003|Overall Study|Adverse Event|1|||
129826953|NCT01214629|467331496|FG004|Overall Study|Adverse Event|0|||
129826954|NCT01214629|467331497|FG005|Overall Study|Adverse Event|1|||
129826955|NCT01214629|467331498|FG006|Overall Study|Adverse Event|0|||
129826956|NCT01214629|467331499|FG007|Overall Study|Adverse Event|0|||
129826957|NCT01214629|467331500|FG008|Overall Study|Adverse Event|0|||
129826958|NCT01214629|467331501|FG009|Overall Study|Adverse Event|1|||
129826959|NCT01214629|467331502|FG010|Overall Study|Adverse Event|0|||
129826960|NCT01214629|467331492|FG000|Overall Study|Physician Decision|0|||
129826961|NCT01214629|467331493|FG001|Overall Study|Physician Decision|0|||
129826962|NCT01214629|467331494|FG002|Overall Study|Physician Decision|0|||
129826963|NCT01214629|467331495|FG003|Overall Study|Physician Decision|0|||
129826964|NCT01214629|467331496|FG004|Overall Study|Physician Decision|0|||
129826965|NCT01214629|467331497|FG005|Overall Study|Physician Decision|0|||
129826966|NCT01214629|467331498|FG006|Overall Study|Physician Decision|0|||
129826967|NCT01214629|467331499|FG007|Overall Study|Physician Decision|0|||
129826968|NCT01214629|467331500|FG008|Overall Study|Physician Decision|0|||
129826969|NCT01214629|467331501|FG009|Overall Study|Physician Decision|0|||
129826970|NCT01214629|467331502|FG010|Overall Study|Physician Decision|1|||
129826971|NCT01214629|467331492|FG000|Overall Study|Withdrawal by Subject|0|||
129826972|NCT01214629|467331493|FG001|Overall Study|Withdrawal by Subject|0|||
129826973|NCT01214629|467331494|FG002|Overall Study|Withdrawal by Subject|0|||
129826974|NCT01214629|467331495|FG003|Overall Study|Withdrawal by Subject|0|||
129826975|NCT01214629|467331496|FG004|Overall Study|Withdrawal by Subject|0|||
129826976|NCT01214629|467331497|FG005|Overall Study|Withdrawal by Subject|0|||
129826977|NCT01214629|467331498|FG006|Overall Study|Withdrawal by Subject|0|||
129826978|NCT01214629|467331499|FG007|Overall Study|Withdrawal by Subject|0|||
129826979|NCT01214629|467331500|FG008|Overall Study|Withdrawal by Subject|0|||
129826980|NCT01214629|467331501|FG009|Overall Study|Withdrawal by Subject|1|||
129826981|NCT01214629|467331502|FG010|Overall Study|Withdrawal by Subject|0|||
129826982|NCT01829230|467331503|FG000|Overall Study|Protocol Violation|0|||
129826983|NCT01829230|467331504|FG001|Overall Study|Protocol Violation|2|||
129826984|NCT01829230|467331503|FG000|Overall Study|Withdrawal by Subject|0|||
129826985|NCT01829230|467331504|FG001|Overall Study|Withdrawal by Subject|1|||
129826986|NCT01829230|467331503|FG000|Overall Study|Lost to Follow-up|1|||
129826987|NCT01829230|467331504|FG001|Overall Study|Lost to Follow-up|1|||
129826988|NCT04501666|467331505|FG000|Overall Study|Physician Decision|0|||
129826989|NCT04501666|467331506|FG001|Overall Study|Physician Decision|1|||
129826990|NCT04501666|467331505|FG000|Overall Study|Adverse Event|12|||
129826991|NCT04501666|467331506|FG001|Overall Study|Adverse Event|4|||
129826992|NCT04501666|467331505|FG000|Overall Study|Subject's request|10|||
129826993|NCT04501666|467331506|FG001|Overall Study|Subject's request|6|||
129826994|NCT04501666|467331505|FG000|Overall Study|Protocol Deviation|2|||
129826995|NCT04501666|467331506|FG001|Overall Study|Protocol Deviation|1|||
129826996|NCT04501666|467331505|FG000|Overall Study|Other-- site permanently closing|0|||
129826997|NCT04501666|467331506|FG001|Overall Study|Other-- site permanently closing|1|||
129826998|NCT03021265|467331507|FG000|Overall Study|Adverse Event|29|||
129826999|NCT03021265|467331507|FG000|Overall Study|Lack of Efficacy|3|||
129827000|NCT03021265|467331507|FG000|Overall Study|Improved|17|||
129827001|NCT03021265|467331507|FG000|Overall Study|Lost to Follow-up|67|||
129827002|NCT03021265|467331507|FG000|Overall Study|No reason given|2|||
129827003|NCT03021265|467331507|FG000|Overall Study|No visit since the first visit|4|||
129827004|NCT01338493|467331508|FG000|Enrolled|Withdrawal by Subject|1|||
129827005|NCT01338493|467331508|FG000|Enrolled|Patient not implanted|4|||
129827006|NCT01338493|467331508|FG000|Discharge|Death|1|||
129827007|NCT01338493|467331508|FG000|Discharge|Missed visit|1|||
129827008|NCT01338493|467331508|FG000|6 Months Follow up|Lost to Follow-up|11|||
129827009|NCT01338493|467331508|FG000|6 Months Follow up|Missed visit|8|||
129827010|NCT01338493|467331508|FG000|12 Months Follow up|Lost to Follow-up|9|||
129827011|NCT00642941|467331509|FG000|Overall Study|Physician Decision|3|||
129827012|NCT00642941|467331510|FG001|Overall Study|Physician Decision|1|||
129827013|NCT00642941|467331511|FG002|Overall Study|Physician Decision|0|||
129445712|NCT01968070|465932879|FG004|Period 2|Withdrawal by Subject|1|||
129445713|NCT01968070|465932880|FG005|Period 2|Withdrawal by Subject|0|||
129827014|NCT00642941|467331512|FG003|Overall Study|Physician Decision|0|||
129827015|NCT00642941|467331513|FG004|Overall Study|Physician Decision|0|||
129827016|NCT00642941|467331514|FG005|Overall Study|Physician Decision|0|||
129827017|NCT00642941|467331515|FG006|Overall Study|Physician Decision|1|||
129827018|NCT00642941|467331516|FG007|Overall Study|Physician Decision|0|||
129827019|NCT00642941|467331517|FG008|Overall Study|Physician Decision|0|||
129827020|NCT00642941|467331518|FG009|Overall Study|Physician Decision|1|||
129827021|NCT00642941|467331519|FG010|Overall Study|Physician Decision|0|||
129827022|NCT00642941|467331520|FG011|Overall Study|Physician Decision|1|||
129827023|NCT00642941|467331509|FG000|Overall Study|Death|4|||
129827024|NCT00642941|467331510|FG001|Overall Study|Death|0|||
129827025|NCT00642941|467331511|FG002|Overall Study|Death|1|||
129827026|NCT00642941|467331512|FG003|Overall Study|Death|1|||
129827027|NCT00642941|467331513|FG004|Overall Study|Death|2|||
129827028|NCT00642941|467331514|FG005|Overall Study|Death|1|||
129827029|NCT00642941|467331515|FG006|Overall Study|Death|0|||
129827030|NCT00642941|467331516|FG007|Overall Study|Death|0|||
129827031|NCT00642941|467331517|FG008|Overall Study|Death|0|||
129827032|NCT00642941|467331518|FG009|Overall Study|Death|0|||
129827033|NCT00642941|467331519|FG010|Overall Study|Death|0|||
129827034|NCT00642941|467331520|FG011|Overall Study|Death|1|||
129827035|NCT00642941|467331509|FG000|Overall Study|Study closed by Sponsor|0|||
129827036|NCT00642941|467331510|FG001|Overall Study|Study closed by Sponsor|1|||
129827037|NCT00642941|467331511|FG002|Overall Study|Study closed by Sponsor|0|||
129827038|NCT00642941|467331512|FG003|Overall Study|Study closed by Sponsor|0|||
129827039|NCT00642941|467331513|FG004|Overall Study|Study closed by Sponsor|0|||
129827040|NCT00642941|467331514|FG005|Overall Study|Study closed by Sponsor|0|||
129827041|NCT00642941|467331515|FG006|Overall Study|Study closed by Sponsor|0|||
129827042|NCT00642941|467331516|FG007|Overall Study|Study closed by Sponsor|0|||
129827043|NCT00642941|467331517|FG008|Overall Study|Study closed by Sponsor|0|||
129827044|NCT00642941|467331518|FG009|Overall Study|Study closed by Sponsor|0|||
129827045|NCT00642941|467331519|FG010|Overall Study|Study closed by Sponsor|0|||
129827046|NCT00642941|467331520|FG011|Overall Study|Study closed by Sponsor|0|||
129827047|NCT00642941|467331509|FG000|Overall Study|Withdrawal by Subject|1|||
129827048|NCT00642941|467331510|FG001|Overall Study|Withdrawal by Subject|0|||
129827049|NCT00642941|467331511|FG002|Overall Study|Withdrawal by Subject|0|||
129827050|NCT00642941|467331512|FG003|Overall Study|Withdrawal by Subject|2|||
129827051|NCT00642941|467331513|FG004|Overall Study|Withdrawal by Subject|0|||
129827052|NCT00642941|467331514|FG005|Overall Study|Withdrawal by Subject|0|||
129827053|NCT00642941|467331515|FG006|Overall Study|Withdrawal by Subject|2|||
129827054|NCT00642941|467331516|FG007|Overall Study|Withdrawal by Subject|0|||
129827055|NCT00642941|467331517|FG008|Overall Study|Withdrawal by Subject|1|||
129827056|NCT00642941|467331518|FG009|Overall Study|Withdrawal by Subject|0|||
129827057|NCT00642941|467331519|FG010|Overall Study|Withdrawal by Subject|0|||
129827058|NCT00642941|467331520|FG011|Overall Study|Withdrawal by Subject|1|||
129827059|NCT00642941|467331509|FG000|Overall Study|Protocol Violation|0|||
129827060|NCT00642941|467331510|FG001|Overall Study|Protocol Violation|0|||
129827061|NCT00642941|467331511|FG002|Overall Study|Protocol Violation|0|||
129827062|NCT00642941|467331512|FG003|Overall Study|Protocol Violation|0|||
129827063|NCT00642941|467331513|FG004|Overall Study|Protocol Violation|0|||
129827064|NCT00642941|467331514|FG005|Overall Study|Protocol Violation|0|||
129827065|NCT00642941|467331515|FG006|Overall Study|Protocol Violation|1|||
129827066|NCT00642941|467331516|FG007|Overall Study|Protocol Violation|0|||
129827067|NCT00642941|467331517|FG008|Overall Study|Protocol Violation|0|||
129827068|NCT00642941|467331518|FG009|Overall Study|Protocol Violation|0|||
129827069|NCT00642941|467331519|FG010|Overall Study|Protocol Violation|0|||
129827070|NCT00642941|467331520|FG011|Overall Study|Protocol Violation|0|||
129827071|NCT00642941|467331509|FG000|Overall Study|Adverse Event|1|||
129827072|NCT00642941|467331510|FG001|Overall Study|Adverse Event|1|||
129827073|NCT00642941|467331511|FG002|Overall Study|Adverse Event|0|||
129827074|NCT00642941|467331512|FG003|Overall Study|Adverse Event|0|||
129827075|NCT00642941|467331513|FG004|Overall Study|Adverse Event|0|||
129827076|NCT00642941|467331514|FG005|Overall Study|Adverse Event|0|||
129827077|NCT00642941|467331515|FG006|Overall Study|Adverse Event|1|||
129827078|NCT00642941|467331516|FG007|Overall Study|Adverse Event|1|||
129827079|NCT00642941|467331517|FG008|Overall Study|Adverse Event|0|||
129827080|NCT00642941|467331518|FG009|Overall Study|Adverse Event|1|||
129827081|NCT00642941|467331519|FG010|Overall Study|Adverse Event|0|||
129827082|NCT00642941|467331520|FG011|Overall Study|Adverse Event|0|||
129827083|NCT00642941|467331509|FG000|Overall Study|Other|1|||
129827084|NCT00642941|467331510|FG001|Overall Study|Other|1|||
129827085|NCT00642941|467331511|FG002|Overall Study|Other|1|||
129897659|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
129897660|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
129897661|NCT01981850|467584412|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
129445714|NCT01968070|465932881|FG006|Period 2|Withdrawal by Subject|0|||
129897662|NCT01981850|467584413|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
129445715|NCT01968070|465932882|FG007|Period 2|Withdrawal by Subject|0|||
129445716|NCT01968070|465932883|FG008|Period 2|Withdrawal by Subject|0|||
129827086|NCT00642941|467331512|FG003|Overall Study|Other|1|||
129827087|NCT00642941|467331513|FG004|Overall Study|Other|0|||
129827088|NCT00642941|467331514|FG005|Overall Study|Other|1|||
129827089|NCT00642941|467331515|FG006|Overall Study|Other|0|||
129827090|NCT00642941|467331516|FG007|Overall Study|Other|1|||
129827091|NCT00642941|467331517|FG008|Overall Study|Other|0|||
129827092|NCT00642941|467331518|FG009|Overall Study|Other|0|||
129827093|NCT00642941|467331519|FG010|Overall Study|Other|0|||
129827094|NCT00642941|467331520|FG011|Overall Study|Other|1|||
129827095|NCT00642941|467331509|FG000|Overall Study|Disease progression|60|||
129827096|NCT00642941|467331510|FG001|Overall Study|Disease progression|50|||
129827097|NCT00642941|467331511|FG002|Overall Study|Disease progression|5|||
129827098|NCT00642941|467331512|FG003|Overall Study|Disease progression|36|||
129827099|NCT00642941|467331513|FG004|Overall Study|Disease progression|23|||
129897663|NCT01981850|467584414|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897664|NCT01981850|467584415|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897665|NCT01981850|467584416|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
129827100|NCT00642941|467331514|FG005|Overall Study|Disease progression|39|||
129827101|NCT00642941|467331515|FG006|Overall Study|Disease progression|18|||
129827102|NCT00642941|467331516|FG007|Overall Study|Disease progression|12|||
129827103|NCT00642941|467331517|FG008|Overall Study|Disease progression|10|||
129827104|NCT00642941|467331518|FG009|Overall Study|Disease progression|7|||
129827105|NCT00642941|467331519|FG010|Overall Study|Disease progression|12|||
129827106|NCT00642941|467331520|FG011|Overall Study|Disease progression|7|||
129827107|NCT00656474|467331521|FG000|Overall Study|Other Reason|1|||
129827108|NCT01614067|467331523|FG000|Overall Study|Pregnancy|1|||
129827109|NCT01614067|467331524|FG001|Overall Study|Pregnancy|0|||
129827110|NCT01614067|467331523|FG000|Overall Study|Physician Decision|6|||
129827111|NCT01614067|467331524|FG001|Overall Study|Physician Decision|5|||
129827112|NCT01614067|467331523|FG000|Overall Study|Withdrawal by Subject|0|||
129827113|NCT01614067|467331524|FG001|Overall Study|Withdrawal by Subject|1|||
129827114|NCT01614067|467331523|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
129827115|NCT01614067|467331524|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
129827116|NCT00056407|467331525|FG000|Overall Study|Adverse Event|282|||
129827117|NCT00056407|467331526|FG001|Overall Study|Adverse Event|364|||
129827118|NCT00056407|467331525|FG000|Overall Study|Withdrawal by Subject|377|||
129827119|NCT00056407|467331526|FG001|Overall Study|Withdrawal by Subject|361|||
129827120|NCT00056407|467331525|FG000|Overall Study|Lost to Follow-up|123|||
129827121|NCT00056407|467331526|FG001|Overall Study|Lost to Follow-up|113|||
129827122|NCT00056407|467331525|FG000|Overall Study|Protocol Violation|104|||
129827123|NCT00056407|467331526|FG001|Overall Study|Protocol Violation|95|||
129827124|NCT00056407|467331525|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
129827125|NCT00056407|467331526|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
129827126|NCT00056407|467331525|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
129827127|NCT00056407|467331526|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
129827128|NCT00056407|467331525|FG000|Overall Study|Missing|25|||
129827129|NCT00056407|467331526|FG001|Overall Study|Missing|34|||
129827130|NCT00616655|467331527|FG000|Overall Study|Adverse Event|10|||
129827131|NCT00616655|467331528|FG001|Overall Study|Adverse Event|7|||
129827132|NCT00616655|467331529|FG002|Overall Study|Adverse Event|12|||
129827133|NCT00616655|467331527|FG000|Overall Study|Lack of Efficacy|5|||
129827134|NCT00616655|467331528|FG001|Overall Study|Lack of Efficacy|5|||
129827135|NCT00616655|467331529|FG002|Overall Study|Lack of Efficacy|5|||
129827136|NCT00616655|467331527|FG000|Overall Study|Lost to Follow-up|3|||
129827137|NCT00616655|467331528|FG001|Overall Study|Lost to Follow-up|12|||
129827138|NCT00616655|467331529|FG002|Overall Study|Lost to Follow-up|10|||
129827139|NCT00616655|467331527|FG000|Overall Study|Protocol Violation|2|||
129827140|NCT00616655|467331528|FG001|Overall Study|Protocol Violation|4|||
129827141|NCT00616655|467331529|FG002|Overall Study|Protocol Violation|3|||
129827142|NCT00616655|467331527|FG000|Overall Study|Withdrawal by Subject|9|||
129827143|NCT00616655|467331528|FG001|Overall Study|Withdrawal by Subject|7|||
129827144|NCT00616655|467331529|FG002|Overall Study|Withdrawal by Subject|11|||
129827145|NCT00616655|467331527|FG000|Overall Study|Does not meet in/ex criteria|0|||
129827146|NCT00616655|467331528|FG001|Overall Study|Does not meet in/ex criteria|0|||
129827147|NCT00616655|467331529|FG002|Overall Study|Does not meet in/ex criteria|2|||
129827148|NCT00616655|467331527|FG000|Overall Study|Other|6|||
129827149|NCT00616655|467331528|FG001|Overall Study|Other|6|||
129827150|NCT00616655|467331529|FG002|Overall Study|Other|5|||
129827151|NCT02663674|467331532|FG000|Overall Study|Lost to Follow-up|5|||
129827152|NCT02663674|467331533|FG001|Overall Study|Lost to Follow-up|4|||
129827153|NCT02663674|467331532|FG000|Overall Study|Withdrawal by Subject|1|||
129827154|NCT02663674|467331533|FG001|Overall Study|Withdrawal by Subject|4|||
129827155|NCT02663674|467331532|FG000|Overall Study|Physician Decision|1|||
129827156|NCT02663674|467331533|FG001|Overall Study|Physician Decision|1|||
129827157|NCT02663674|467331532|FG000|Overall Study|Other Event (Health Related)|0|||
129827158|NCT02663674|467331533|FG001|Overall Study|Other Event (Health Related)|1|||
129827159|NCT00415909|467332668|FG000|Overall Study|Withdrawal by Subject|2|||
129827160|NCT00415909|467332668|FG000|Overall Study|Death|1|||
129827161|NCT02355691|467332673|FG000|Overall Study|Loss of Research Personnel|7|||
129827162|NCT02355691|467332674|FG001|Overall Study|Loss of Research Personnel|9|||
129827163|NCT02345811|467332677|FG000|First Intervention|Withdrawal by Subject|1|||
129827164|NCT02345811|467332678|FG001|First Intervention|Withdrawal by Subject|1|||
129827165|NCT00462761|467332679|FG000|Overall Study|Adverse Event|6|||
129827166|NCT00462761|467332679|FG000|Overall Study|Withdrawal by Subject|9|||
129827167|NCT00462761|467332679|FG000|Overall Study|Physician Decision|5|||
129827168|NCT00462761|467332679|FG000|Overall Study|Disease progression|43|||
129827169|NCT00462761|467332679|FG000|Overall Study|Death|12|||
129827170|NCT00462761|467332679|FG000|Overall Study|Other|1|||
129827171|NCT02522286|467332680|FG000|Overall Study|Withdrawal by Subject|3|||
129827172|NCT02522286|467332681|FG001|Overall Study|Withdrawal by Subject|0|||
129827173|NCT02522286|467332682|FG002|Overall Study|Withdrawal by Subject|0|||
129827174|NCT02522286|467332683|FG003|Overall Study|Withdrawal by Subject|3|||
129827175|NCT02877082|467332684|FG000|Overall Study|Trial was closed early|5|||
129827176|NCT03480750|467332685|FG000|Overall Study|Withdrawal by Subject|0|||
129827177|NCT03480750|467332686|FG001|Overall Study|Withdrawal by Subject|1|||
129827178|NCT03480750|467332687|FG002|Overall Study|Withdrawal by Subject|0|||
129827179|NCT03480750|467332688|FG003|Overall Study|Withdrawal by Subject|0|||
129827180|NCT03480750|467332689|FG004|Overall Study|Withdrawal by Subject|0|||
129827181|NCT03480750|467332690|FG005|Overall Study|Withdrawal by Subject|0|||
129827182|NCT03480750|467332685|FG000|Overall Study|The interruption in Trientine shippment|0|||
129827183|NCT03480750|467332686|FG001|Overall Study|The interruption in Trientine shippment|0|||
129827184|NCT03480750|467332687|FG002|Overall Study|The interruption in Trientine shippment|0|||
129827185|NCT03480750|467332688|FG003|Overall Study|The interruption in Trientine shippment|0|||
129827186|NCT03480750|467332689|FG004|Overall Study|The interruption in Trientine shippment|0|||
129827187|NCT03480750|467332690|FG005|Overall Study|The interruption in Trientine shippment|1|||
129827188|NCT00605813|467332691|FG000|Overall Study|Protocol Violation|25|||
129827189|NCT01132482|467332692|FG000|Overall Study|Adverse Event|1|||
129827190|NCT01132482|467332693|FG001|Overall Study|Adverse Event|0|||
129827191|NCT00174915|467332698|FG000|Overall Study|Lost to Follow-up|19|||
129827192|NCT00174915|467332699|FG001|Overall Study|Lost to Follow-up|17|||
129827193|NCT00174915|467332700|FG002|Overall Study|Lost to Follow-up|9|||
129827194|NCT00174915|467332701|FG003|Overall Study|Lost to Follow-up|17|||
129827195|NCT00174915|467332702|FG004|Overall Study|Lost to Follow-up|10|||
129827196|NCT00174915|467332698|FG000|Overall Study|Adverse Event|18|||
129827197|NCT00174915|467332699|FG001|Overall Study|Adverse Event|16|||
129827198|NCT00174915|467332700|FG002|Overall Study|Adverse Event|11|||
129827199|NCT00174915|467332701|FG003|Overall Study|Adverse Event|18|||
129827200|NCT00174915|467332702|FG004|Overall Study|Adverse Event|5|||
129827201|NCT00174915|467332698|FG000|Overall Study|Personal Reason(s)|16|||
129827202|NCT00174915|467332699|FG001|Overall Study|Personal Reason(s)|16|||
129827203|NCT00174915|467332700|FG002|Overall Study|Personal Reason(s)|9|||
129827204|NCT00174915|467332701|FG003|Overall Study|Personal Reason(s)|9|||
129827205|NCT00174915|467332702|FG004|Overall Study|Personal Reason(s)|9|||
129827206|NCT00174915|467332698|FG000|Overall Study|Other|15|||
129827207|NCT00174915|467332699|FG001|Overall Study|Other|8|||
129827208|NCT00174915|467332700|FG002|Overall Study|Other|6|||
129827209|NCT00174915|467332701|FG003|Overall Study|Other|5|||
129827210|NCT00174915|467332702|FG004|Overall Study|Other|3|||
129827211|NCT00174915|467332698|FG000|Overall Study|Gout Flare|13|||
129827212|NCT00174915|467332699|FG001|Overall Study|Gout Flare|6|||
129827213|NCT00174915|467332700|FG002|Overall Study|Gout Flare|8|||
129827214|NCT00174915|467332701|FG003|Overall Study|Gout Flare|1|||
129827215|NCT00174915|467332702|FG004|Overall Study|Gout Flare|0|||
129827216|NCT00174915|467332698|FG000|Overall Study|Protocol Violation|6|||
129445717|NCT01968070|465932884|FG009|Period 2|Withdrawal by Subject|0|||
129827217|NCT00174915|467332699|FG001|Overall Study|Protocol Violation|3|||
129827218|NCT00174915|467332700|FG002|Overall Study|Protocol Violation|3|||
129827219|NCT00174915|467332701|FG003|Overall Study|Protocol Violation|6|||
129827220|NCT00174915|467332702|FG004|Overall Study|Protocol Violation|3|||
129827221|NCT00174915|467332698|FG000|Overall Study|Therapeutic Failure|6|||
129827222|NCT00174915|467332699|FG001|Overall Study|Therapeutic Failure|3|||
129827223|NCT00174915|467332700|FG002|Overall Study|Therapeutic Failure|2|||
129827224|NCT00174915|467332701|FG003|Overall Study|Therapeutic Failure|1|||
129827225|NCT00174915|467332702|FG004|Overall Study|Therapeutic Failure|3|||
129827226|NCT03060447|467332707|FG000|Overall Study|Withdrawal by Subject|2|||
129827227|NCT03060447|467332708|FG001|Overall Study|Withdrawal by Subject|0|||
129827228|NCT00573755|467332709|FG000|Overall Study|Still receiving treatment|1|||
129827229|NCT00573755|467332710|FG001|Overall Study|Still receiving treatment|0|||
129827230|NCT03274440|467332714|FG000|Overall Study|Time commitment too great|1|||
129827231|NCT03274440|467332715|FG001|Overall Study|Time commitment too great|0|||
129827232|NCT03274440|467332716|FG002|Overall Study|Time commitment too great|0|||
129827233|NCT03274440|467332717|FG003|Overall Study|Time commitment too great|1|||
129827234|NCT03274440|467332718|FG004|Overall Study|Time commitment too great|0|||
129827235|NCT03274440|467332719|FG005|Overall Study|Time commitment too great|0|||
129827236|NCT00450450|467332720|FG000|Overall Study|Death|1|||
129827237|NCT00450450|467332721|FG001|Overall Study|Death|3|||
129827238|NCT00450450|467332720|FG000|Overall Study|Relapse|2|||
129827239|NCT00450450|467332721|FG001|Overall Study|Relapse|0|||
129827240|NCT00450450|467332720|FG000|Overall Study|Missing Data|2|||
129827241|NCT00450450|467332721|FG001|Overall Study|Missing Data|0|||
129827242|NCT04984993|467332722|FG000|Overall Study|Withdrawal by Subject|8|||
129827243|NCT04984993|467332723|FG001|Overall Study|Withdrawal by Subject|2|||
129827244|NCT04984993|467332722|FG000|Overall Study|Lost to Follow-up|2|||
129827245|NCT04984993|467332723|FG001|Overall Study|Lost to Follow-up|2|||
129827246|NCT04984993|467332722|FG000|Overall Study|Both patients moved to another country|4|||
129827247|NCT04984993|467332723|FG001|Overall Study|Both patients moved to another country|0|||
129827248|NCT02865187|467332724|FG000|Overall Study|Lost to Follow-up|12|||
129827249|NCT02865187|467332725|FG001|Overall Study|Lost to Follow-up|7|||
129827250|NCT02865187|467332724|FG000|Overall Study|Adverse Event|1|||
129827251|NCT02865187|467332725|FG001|Overall Study|Adverse Event|0|||
129827252|NCT01110707|467332726|FG000|Overall Study|Protocol Violation|0|||
129827253|NCT01110707|467332727|FG001|Overall Study|Protocol Violation|3|||
129827254|NCT02369341|467332728|FG000|Overall Study|Migrated/moved from study area|1|||
129827255|NCT02369341|467332729|FG001|Overall Study|Migrated/moved from study area|0|||
129827256|NCT03287804|467332730|FG000|Overall Study|Death|1|||
129827257|NCT03287804|467332730|FG000|Overall Study|Physician Decision|2|||
129827258|NCT03287804|467332730|FG000|Overall Study|Progressive disease|8|||
129827259|NCT02710045|467332736|FG000|Overall Study|Death|1|||
129827260|NCT02710045|467332737|FG001|Overall Study|Death|2|||
129827261|NCT02710045|467332738|FG002|Overall Study|Death|0|||
129827262|NCT02710045|467332736|FG000|Overall Study|Withdrawal by Subject|6|||
129827263|NCT02710045|467332737|FG001|Overall Study|Withdrawal by Subject|6|||
129827264|NCT02710045|467332738|FG002|Overall Study|Withdrawal by Subject|2|||
129827265|NCT02710045|467332736|FG000|Overall Study|Protocol Violation|1|||
129827266|NCT02710045|467332737|FG001|Overall Study|Protocol Violation|2|||
129827267|NCT02710045|467332738|FG002|Overall Study|Protocol Violation|3|||
129827268|NCT02710045|467332736|FG000|Overall Study|Lost to Follow-up|3|||
129827269|NCT02710045|467332737|FG001|Overall Study|Lost to Follow-up|6|||
129827270|NCT02710045|467332738|FG002|Overall Study|Lost to Follow-up|7|||
129827271|NCT02710045|467332736|FG000|Overall Study|Physician Decision|0|||
129827272|NCT02710045|467332737|FG001|Overall Study|Physician Decision|0|||
129827273|NCT02710045|467332738|FG002|Overall Study|Physician Decision|1|||
129827274|NCT02710045|467332736|FG000|Overall Study|Poor Attendance|0|||
129827275|NCT02710045|467332737|FG001|Overall Study|Poor Attendance|1|||
129827276|NCT02710045|467332738|FG002|Overall Study|Poor Attendance|0|||
129827277|NCT01275833|467332739|FG000|Overall Study|Study terminated|1|||
129827278|NCT01275833|467332740|FG001|Overall Study|Study terminated|1|||
129827279|NCT02707991|467332742|FG000|Overall Study|Protocol Violation|1|||
129827280|NCT02707991|467332743|FG001|Overall Study|Protocol Violation|0|||
129827281|NCT02707991|467332742|FG000|Overall Study|Became ineligible|0|||
129827282|NCT02707991|467332743|FG001|Overall Study|Became ineligible|1|||
129827283|NCT02733991|467332744|FG000|Overall Study|Adverse Event|1|||
129827284|NCT02733991|467332745|FG001|Overall Study|Adverse Event|0|||
129827285|NCT02733991|467332744|FG000|Overall Study|Withdrawal by Subject|0|||
129827286|NCT02733991|467332745|FG001|Overall Study|Withdrawal by Subject|5|||
129827287|NCT04191499|467332746|FG000|Overall Study|Adverse Event|1|||
129827288|NCT04191499|467332747|FG001|Overall Study|Adverse Event|0|||
129827289|NCT04191499|467332746|FG000|Overall Study|Death|42|||
129827290|NCT04191499|467332747|FG001|Overall Study|Death|55|||
129827291|NCT04191499|467332746|FG000|Overall Study|Lost to Follow-up|4|||
129827292|NCT04191499|467332747|FG001|Overall Study|Lost to Follow-up|1|||
129827293|NCT04191499|467332746|FG000|Overall Study|Physician Decision|1|||
129827294|NCT04191499|467332747|FG001|Overall Study|Physician Decision|0|||
129827295|NCT04191499|467332746|FG000|Overall Study|Progressive Disease|1|||
129827296|NCT04191499|467332747|FG001|Overall Study|Progressive Disease|0|||
129827297|NCT04191499|467332746|FG000|Overall Study|Symptomatic Deterioration|1|||
129827298|NCT04191499|467332747|FG001|Overall Study|Symptomatic Deterioration|0|||
129827299|NCT04191499|467332746|FG000|Overall Study|Withdrawal by Subject|7|||
129827300|NCT04191499|467332747|FG001|Overall Study|Withdrawal by Subject|11|||
129827301|NCT04191499|467332746|FG000|Overall Study|Ongoing in the study|104|||
129827302|NCT04191499|467332747|FG001|Overall Study|Ongoing in the study|97|||
129827303|NCT00680745|467332748|FG000|Overall Study|Withdrawal by Subject|8|||
129827304|NCT00680745|467332749|FG001|Overall Study|Withdrawal by Subject|3|||
129827305|NCT00680745|467332750|FG002|Overall Study|Withdrawal by Subject|2|||
129827306|NCT00680745|467332751|FG003|Overall Study|Withdrawal by Subject|8|||
129827307|NCT00680745|467332748|FG000|Overall Study|Lost to Follow-up|0|||
129827308|NCT00680745|467332749|FG001|Overall Study|Lost to Follow-up|1|||
129827309|NCT00680745|467332750|FG002|Overall Study|Lost to Follow-up|1|||
129827310|NCT00680745|467332751|FG003|Overall Study|Lost to Follow-up|0|||
129827311|NCT00680745|467332748|FG000|Overall Study|Death|1|||
129827312|NCT00680745|467332749|FG001|Overall Study|Death|0|||
129827313|NCT00680745|467332750|FG002|Overall Study|Death|1|||
129827314|NCT00680745|467332751|FG003|Overall Study|Death|0|||
129827315|NCT00680745|467332748|FG000|Overall Study|Adverse Event|5|||
129827316|NCT00680745|467332749|FG001|Overall Study|Adverse Event|3|||
129827317|NCT00680745|467332750|FG002|Overall Study|Adverse Event|3|||
129827318|NCT00680745|467332751|FG003|Overall Study|Adverse Event|3|||
129827319|NCT00680745|467332748|FG000|Overall Study|Poor/Non-compliance|0|||
129827320|NCT00680745|467332749|FG001|Overall Study|Poor/Non-compliance|3|||
129827321|NCT00680745|467332750|FG002|Overall Study|Poor/Non-compliance|0|||
129827322|NCT00680745|467332751|FG003|Overall Study|Poor/Non-compliance|0|||
129827323|NCT00680745|467332748|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129827324|NCT00680745|467332749|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
129897666|NCT01981850|467584417|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
129827325|NCT00680745|467332750|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
129827326|NCT00680745|467332751|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
129827327|NCT00680745|467332748|FG000|Overall Study|False Treatment|0|||
129827328|NCT00680745|467332749|FG001|Overall Study|False Treatment|1|||
129827329|NCT00680745|467332750|FG002|Overall Study|False Treatment|3|||
129827330|NCT00680745|467332751|FG003|Overall Study|False Treatment|0|||
129827331|NCT02612428|467332752|FG000|VTL-308|Death|14|||
129827332|NCT02612428|467332753|FG001|VTL-308|Death|16|||
129827333|NCT02612428|467332752|FG000|VTL-308|Withdrawal by Subject|0|||
129827334|NCT02612428|467332753|FG001|VTL-308|Withdrawal by Subject|1|||
129827335|NCT02612428|467332752|FG000|VTL-308E|Death|9|||
129827336|NCT02612428|467332753|FG001|VTL-308E|Death|7|||
129827337|NCT02612428|467332752|FG000|VTL-308E|Lost to Follow-up|2|||
129827338|NCT02612428|467332753|FG001|VTL-308E|Lost to Follow-up|0|||
129827339|NCT00742001|467332754|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
129827340|NCT00742001|467332755|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
129827341|NCT00742001|467332756|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
129827342|NCT00137423|467332757|FG000|Overall Study|Adverse Event|7|||
129827343|NCT00137423|467332758|FG001|Overall Study|Adverse Event|9|||
129827344|NCT00137423|467332757|FG000|Overall Study|consent withdrawn|1|||
129827345|NCT00137423|467332758|FG001|Overall Study|consent withdrawn|1|||
129827346|NCT00137423|467332757|FG000|Overall Study|Lack of Efficacy|31|||
129827347|NCT00137423|467332758|FG001|Overall Study|Lack of Efficacy|33|||
129827348|NCT00137423|467332757|FG000|Overall Study|Death|0|||
129827349|NCT00137423|467332758|FG001|Overall Study|Death|1|||
129827350|NCT01928329|467332759|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
129827351|NCT01928329|467332760|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
129827352|NCT01928329|467332759|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
129827353|NCT01928329|467332760|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
129827354|NCT01928329|467332759|FG000|Overall Study|Adverse Event|5|||
129827355|NCT01928329|467332760|FG001|Overall Study|Adverse Event|3|||
129827356|NCT01928329|467332759|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
129827357|NCT01928329|467332760|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
129827358|NCT01928329|467332759|FG000|Overall Study|Withdrawal by Subject|1|||
129827359|NCT01928329|467332760|FG001|Overall Study|Withdrawal by Subject|5|||
129827360|NCT01928329|467332759|FG000|Overall Study|Physician Decision|1|||
129827361|NCT01928329|467332760|FG001|Overall Study|Physician Decision|1|||
129827362|NCT03187262|467332762|FG000|Induction|Lack of Efficacy|2|||
129827363|NCT03187262|467332762|FG000|Induction|Progressive Disease|4|||
129827364|NCT03187262|467332762|FG000|Consolidation|Progressive Disease|5|||
129827365|NCT02617511|467332763|FG000|Overall Study|Withdrawal by Subject|1|||
129827366|NCT02617511|467332764|FG001|Overall Study|Withdrawal by Subject|0|||
129827367|NCT02141997|467332765|FG000|Overall Study|Adverse Event|0|||
129827368|NCT02141997|467332766|FG001|Overall Study|Adverse Event|2|||
129827369|NCT02141997|467332767|FG002|Overall Study|Adverse Event|0|||
129827370|NCT02141997|467332768|FG003|Overall Study|Adverse Event|1|||
129827371|NCT02141997|467332765|FG000|Overall Study|Participant noncompliance|1|||
129827372|NCT02141997|467332766|FG001|Overall Study|Participant noncompliance|0|||
129827373|NCT02141997|467332767|FG002|Overall Study|Participant noncompliance|0|||
129827374|NCT02141997|467332768|FG003|Overall Study|Participant noncompliance|0|||
129827375|NCT02141997|467332765|FG000|Overall Study|Withdrew consent|1|||
129827376|NCT02141997|467332766|FG001|Overall Study|Withdrew consent|0|||
129827377|NCT02141997|467332767|FG002|Overall Study|Withdrew consent|3|||
129827378|NCT02141997|467332768|FG003|Overall Study|Withdrew consent|0|||
129827379|NCT02141997|467332765|FG000|Overall Study|Other|1|||
129827380|NCT02141997|467332766|FG001|Overall Study|Other|4|||
129827381|NCT02141997|467332767|FG002|Overall Study|Other|0|||
129827382|NCT02141997|467332768|FG003|Overall Study|Other|0|||
129827383|NCT04105998|467332771|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
129827384|NCT04105998|467332772|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
129827385|NCT00450333|467332773|FG000|Overall Study|Study terminated|47|||
129827386|NCT00450333|467332774|FG001|Overall Study|Study terminated|54|||
129827387|NCT00450333|467332775|FG002|Overall Study|Study terminated|16|||
129827388|NCT00450333|467332776|FG003|Overall Study|Study terminated|21|||
129827389|NCT00450333|467332773|FG000|Overall Study|Adverse Event|1|||
129827390|NCT00450333|467332774|FG001|Overall Study|Adverse Event|7|||
129827391|NCT00450333|467332775|FG002|Overall Study|Adverse Event|2|||
129827392|NCT00450333|467332776|FG003|Overall Study|Adverse Event|2|||
129827393|NCT00450333|467332773|FG000|Overall Study|Protocol Violation|1|||
129827394|NCT00450333|467332774|FG001|Overall Study|Protocol Violation|0|||
129827395|NCT00450333|467332775|FG002|Overall Study|Protocol Violation|1|||
129827396|NCT00450333|467332776|FG003|Overall Study|Protocol Violation|0|||
129827397|NCT00450333|467332773|FG000|Overall Study|Withdrawal by Subject|1|||
129827398|NCT00450333|467332774|FG001|Overall Study|Withdrawal by Subject|0|||
129827399|NCT00450333|467332775|FG002|Overall Study|Withdrawal by Subject|3|||
129827400|NCT00450333|467332776|FG003|Overall Study|Withdrawal by Subject|0|||
129827401|NCT00450333|467332773|FG000|Overall Study|Kidney transplant|1|||
129827402|NCT00450333|467332774|FG001|Overall Study|Kidney transplant|0|||
129827403|NCT00450333|467332775|FG002|Overall Study|Kidney transplant|1|||
129827404|NCT00450333|467332776|FG003|Overall Study|Kidney transplant|3|||
129827405|NCT00450333|467332773|FG000|Overall Study|Death|3|||
129827406|NCT00450333|467332774|FG001|Overall Study|Death|2|||
129827407|NCT00450333|467332775|FG002|Overall Study|Death|2|||
129827408|NCT00450333|467332776|FG003|Overall Study|Death|2|||
129827409|NCT00416078|467332777|FG000|Overall Study|Death|3|||
129827410|NCT00416078|467332778|FG001|Overall Study|Death|4|||
129827411|NCT00416078|467332777|FG000|Overall Study|Withdrawal by Subject|3|||
129827412|NCT00416078|467332778|FG001|Overall Study|Withdrawal by Subject|2|||
129827413|NCT00416078|467332777|FG000|Overall Study|Physician Decision|1|||
129827414|NCT00416078|467332778|FG001|Overall Study|Physician Decision|0|||
129827415|NCT00416078|467332777|FG000|Overall Study|Lost to Follow-up|4|||
129827416|NCT00416078|467332778|FG001|Overall Study|Lost to Follow-up|2|||
129827417|NCT00461682|467332782|FG000|Overall Study|Protocol Violation|1|||
129827418|NCT04128267|467332786|FG000|Overall Study|Withdrawal by Subject|6|||
129827419|NCT04128267|467332786|FG000|Overall Study|Death|2|||
129827420|NCT04128267|467332786|FG000|Overall Study|Disease progression|1|||
129827421|NCT04128267|467332786|FG000|Overall Study|Participant had other medical issues|4|||
129827422|NCT04128267|467332786|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
129827423|NCT01698801|467332789|FG000|Treatment Phase|Adverse Event|4|||
129827424|NCT01698801|467332789|FG000|Treatment Phase|Protocol Violation|1|||
129827425|NCT01698801|467332789|FG000|Treatment Phase|Other|4|||
129827426|NCT01698801|467332789|FG000|Treatment Phase|Withdrawal by Subject|1|||
129827427|NCT01698801|467332789|FG000|Treatment Phase|Disease progression|1|||
129827428|NCT01698801|467332789|FG000|Follow Up Phase|Withdrawal by Subject|1|||
129827429|NCT01698801|467332789|FG000|Follow Up Phase|Death|4|||
129827430|NCT03761147|467332790|FG000|Overall Study|Withdrawal by Subject|6|||
129827431|NCT03761147|467332791|FG001|Overall Study|Withdrawal by Subject|1|||
129827432|NCT03761147|467332790|FG000|Overall Study|Adverse Event|1|||
129827433|NCT03761147|467332791|FG001|Overall Study|Adverse Event|3|||
129827434|NCT03232281|467333933|FG000|Overall Study|Adverse Event|1|||
129827435|NCT03232281|467333934|FG001|Overall Study|Adverse Event|1|||
129827436|NCT03232281|467333933|FG000|Overall Study|Withdrawal by Subject|5|||
129827437|NCT03232281|467333934|FG001|Overall Study|Withdrawal by Subject|4|||
129827438|NCT03232281|467333933|FG000|Overall Study|Protocol Deviation|1|||
129827439|NCT03232281|467333934|FG001|Overall Study|Protocol Deviation|1|||
129827440|NCT02132767|467333936|FG000|Overall Study|Death|3|||
129827441|NCT02132767|467333937|FG001|Overall Study|Death|2|||
129827442|NCT02132767|467333936|FG000|Overall Study|Withdrawal by Subject|10|||
129827443|NCT02132767|467333937|FG001|Overall Study|Withdrawal by Subject|9|||
129827444|NCT02132767|467333936|FG000|Overall Study|Lost to Follow-up|4|||
129827445|NCT02132767|467333937|FG001|Overall Study|Lost to Follow-up|4|||
129827446|NCT00778700|467333940|FG000|Overall Study|Adverse Event|6|||
129827447|NCT00778700|467333941|FG001|Overall Study|Adverse Event|1|||
129827448|NCT00778700|467333942|FG002|Overall Study|Adverse Event|3|||
129827449|NCT00778700|467333943|FG003|Overall Study|Adverse Event|5|||
129827450|NCT00778700|467333940|FG000|Overall Study|Protocol Violation|1|||
129827451|NCT00778700|467333941|FG001|Overall Study|Protocol Violation|1|||
129827452|NCT00778700|467333942|FG002|Overall Study|Protocol Violation|0|||
129827453|NCT00778700|467333943|FG003|Overall Study|Protocol Violation|0|||
129827454|NCT00778700|467333940|FG000|Overall Study|Subject Withdrew Consent|6|||
129827455|NCT00778700|467333941|FG001|Overall Study|Subject Withdrew Consent|4|||
129827456|NCT00778700|467333942|FG002|Overall Study|Subject Withdrew Consent|1|||
129827457|NCT00778700|467333943|FG003|Overall Study|Subject Withdrew Consent|4|||
129827458|NCT00778700|467333940|FG000|Overall Study|Lost to Follow-up|3|||
129827459|NCT00778700|467333941|FG001|Overall Study|Lost to Follow-up|1|||
129827460|NCT00778700|467333942|FG002|Overall Study|Lost to Follow-up|0|||
129827461|NCT00778700|467333943|FG003|Overall Study|Lost to Follow-up|1|||
129827462|NCT00778700|467333940|FG000|Overall Study|Reason not Specified|2|||
129827463|NCT00778700|467333941|FG001|Overall Study|Reason not Specified|0|||
129827464|NCT00778700|467333942|FG002|Overall Study|Reason not Specified|1|||
129827465|NCT00778700|467333943|FG003|Overall Study|Reason not Specified|3|||
129827466|NCT00778700|467333940|FG000|Overall Study|Other|0|||
129827467|NCT00778700|467333941|FG001|Overall Study|Other|0|||
129827468|NCT00778700|467333942|FG002|Overall Study|Other|1|||
129827469|NCT00778700|467333943|FG003|Overall Study|Other|0|||
129827470|NCT04267133|467333944|FG000|Overall Study|Withdrawal by Subject|1|||
129827471|NCT04267133|467333944|FG000|Overall Study|Adverse Event|4|||
129827472|NCT04008030|467333946|FG000|Pre-Treatment|Withdrawal by Subject|0|||
129827473|NCT04008030|467333947|FG001|Pre-Treatment|Withdrawal by Subject|0|||
129827474|NCT04008030|467333948|FG002|Pre-Treatment|Withdrawal by Subject|9|||
129827475|NCT04008030|467333946|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
129827476|NCT04008030|467333947|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
129827477|NCT04008030|467333948|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
129827478|NCT04008030|467333946|FG000|Pre-Treatment|Other reasons|0|||
129827479|NCT04008030|467333947|FG001|Pre-Treatment|Other reasons|1|||
129827480|NCT04008030|467333948|FG002|Pre-Treatment|Other reasons|6|||
129827481|NCT04008030|467333946|FG000|Treatment|Withdrawal by Subject|1|||
129827482|NCT04008030|467333947|FG001|Treatment|Withdrawal by Subject|1|||
129827483|NCT04008030|467333948|FG002|Treatment|Withdrawal by Subject|1|||
129827484|NCT04008030|467333946|FG000|Treatment|Death|2|||
129827485|NCT04008030|467333947|FG001|Treatment|Death|4|||
129827486|NCT04008030|467333948|FG002|Treatment|Death|0|||
129827487|NCT04008030|467333946|FG000|Treatment|Pregnancy|0|||
129827488|NCT04008030|467333947|FG001|Treatment|Pregnancy|1|||
129827489|NCT04008030|467333948|FG002|Treatment|Pregnancy|0|||
129827490|NCT04008030|467333946|FG000|Treatment|Participant no longer meets study criteria|0|||
129827491|NCT04008030|467333947|FG001|Treatment|Participant no longer meets study criteria|1|||
129827492|NCT04008030|467333948|FG002|Treatment|Participant no longer meets study criteria|0|||
129827493|NCT04008030|467333946|FG000|Treatment|Other reasons|5|||
129827494|NCT04008030|467333947|FG001|Treatment|Other reasons|13|||
129827495|NCT04008030|467333948|FG002|Treatment|Other reasons|6|||
129827496|NCT04008030|467333946|FG000|Treatment|Disease Progression|137|||
129827497|NCT04008030|467333947|FG001|Treatment|Disease Progression|82|||
129827498|NCT04008030|467333948|FG002|Treatment|Disease Progression|85|||
129827499|NCT04008030|467333946|FG000|Treatment|Study drug toxicity|28|||
129827500|NCT04008030|467333947|FG001|Treatment|Study drug toxicity|48|||
129827501|NCT04008030|467333948|FG002|Treatment|Study drug toxicity|8|||
129827502|NCT04008030|467333946|FG000|Treatment|Adverse Event unrelated to study drug|28|||
129827503|NCT04008030|467333947|FG001|Treatment|Adverse Event unrelated to study drug|22|||
129827504|NCT04008030|467333948|FG002|Treatment|Adverse Event unrelated to study drug|6|||
129827505|NCT04008030|467333946|FG000|Treatment|Maximum Clinical Benefit|0|||
129827506|NCT04008030|467333947|FG001|Treatment|Maximum Clinical Benefit|1|||
129827507|NCT04008030|467333948|FG002|Treatment|Maximum Clinical Benefit|9|||
129827508|NCT04008030|467333946|FG000|Treatment|On-going treatment|13|||
129827509|NCT04008030|467333947|FG001|Treatment|On-going treatment|20|||
129827510|NCT04008030|467333948|FG002|Treatment|On-going treatment|0|||
129827511|NCT00003901|467333951|FG000|Overall Study|Adverse Event|1|||
129827512|NCT00003901|467333951|FG000|Overall Study|Withdrawal by Subject|1|||
129827513|NCT00003901|467333951|FG000|Overall Study|Ineligible|6|||
129827514|NCT00003901|467333951|FG000|Overall Study|CT Scan not within protocol requirement|2|||
129827515|NCT00003901|467333951|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
129827516|NCT00003901|467333951|FG000|Overall Study|Medical problems|6|||
129827517|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
129827518|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
129827519|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827520|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827521|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827522|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
129827523|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
129827524|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
129827525|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827526|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827527|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827528|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
129827529|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827530|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
129827531|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827532|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827533|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827534|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
129827535|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
129827536|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
129827537|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827538|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827539|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827540|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
129827541|NCT01496313|467333958|FG000|Randomized Period (up to 14 Months)|Other|1|||
129827542|NCT01496313|467333959|FG001|Randomized Period (up to 14 Months)|Other|2|||
129827543|NCT01496313|467333960|FG002|Randomized Period (up to 14 Months)|Other|0|||
129827544|NCT01496313|467333961|FG003|Randomized Period (up to 14 Months)|Other|0|||
129827545|NCT01496313|467333962|FG004|Randomized Period (up to 14 Months)|Other|0|||
129827546|NCT01496313|467333963|FG005|Randomized Period (up to 14 Months)|Other|0|||
129827547|NCT01496313|467333958|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827548|NCT01496313|467333959|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827549|NCT01496313|467333960|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827550|NCT01496313|467333961|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827551|NCT01496313|467333962|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
129827552|NCT01496313|467333963|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
129827553|NCT01496313|467333958|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827554|NCT01496313|467333959|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827555|NCT01496313|467333960|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827556|NCT01496313|467333961|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827557|NCT01496313|467333962|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
129827558|NCT01496313|467333963|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
129827559|NCT01496313|467333958|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
129827560|NCT01496313|467333959|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
129827561|NCT01496313|467333960|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
129827562|NCT01496313|467333961|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
129827563|NCT01496313|467333962|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
129827564|NCT01496313|467333963|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
129827565|NCT01050257|467333964|FG000|Overall Study|Adverse Event|4|||
129827566|NCT01050257|467333965|FG001|Overall Study|Adverse Event|4|||
129827567|NCT01050257|467333966|FG002|Overall Study|Adverse Event|2|||
129827568|NCT01050257|467333964|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
129827569|NCT01050257|467333965|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
129827570|NCT01050257|467333966|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
129827571|NCT01050257|467333964|FG000|Overall Study|Withdrawal by Subject|0|||
129827572|NCT01050257|467333965|FG001|Overall Study|Withdrawal by Subject|3|||
129827573|NCT01050257|467333966|FG002|Overall Study|Withdrawal by Subject|0|||
129827574|NCT01050257|467333964|FG000|Overall Study|No reason specified|0|||
129827575|NCT01050257|467333965|FG001|Overall Study|No reason specified|0|||
129827576|NCT01050257|467333966|FG002|Overall Study|No reason specified|2|||
129827577|NCT01050257|467333964|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
129827578|NCT01050257|467333965|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
129897667|NCT01981850|467584418|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897668|NCT01981850|467584419|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
129897669|NCT01981850|467584420|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
129827579|NCT01050257|467333966|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
129827580|NCT01050257|467333964|FG000|Overall Study|Violation criteria|0|||
129827581|NCT01050257|467333965|FG001|Overall Study|Violation criteria|1|||
129827582|NCT01050257|467333966|FG002|Overall Study|Violation criteria|0|||
129827583|NCT01050257|467333964|FG000|Overall Study|Failure to return|0|||
129827584|NCT01050257|467333965|FG001|Overall Study|Failure to return|2|||
129827585|NCT01050257|467333966|FG002|Overall Study|Failure to return|0|||
129827586|NCT01050257|467333964|FG000|Overall Study|Death|0|||
129827587|NCT01050257|467333965|FG001|Overall Study|Death|0|||
129827588|NCT01050257|467333966|FG002|Overall Study|Death|1|||
129827589|NCT00278109|467333968|FG000|Overall Study|Adverse Event|3|||
129827590|NCT00278109|467333968|FG000|Overall Study|social circumstances|1|||
129827591|NCT02580357|467333969|FG000|Overall Study|Lost to Follow-up|2|||
129827592|NCT02580357|467333970|FG001|Overall Study|Lost to Follow-up|0|||
129827593|NCT02580357|467333971|FG002|Overall Study|Lost to Follow-up|0|||
129827594|NCT02580357|467333969|FG000|Overall Study|Protocol Violation|1|||
129827595|NCT02580357|467333970|FG001|Overall Study|Protocol Violation|0|||
129827596|NCT02580357|467333971|FG002|Overall Study|Protocol Violation|0|||
129827597|NCT02064166|467333972|FG000|Overall Study|Adverse Event|1|||
129827598|NCT02064166|467333973|FG001|Overall Study|Adverse Event|0|||
129827599|NCT00383149|467333977|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
129827600|NCT00383149|467333977|FG000|Overall Study|Death|2|||
129827601|NCT00383149|467333977|FG000|Overall Study|Disease Progression|38|||
129827602|NCT00383149|467333977|FG000|Overall Study|Lost to Follow-up|1|||
129827603|NCT00383149|467333977|FG000|Overall Study|Other|1|||
129827604|NCT00383149|467333977|FG000|Overall Study|Study Drug Toxicity|4|||
129827605|NCT00383149|467333977|FG000|Overall Study|Request to Discontinue Treatment|4|||
129827606|NCT00383149|467333977|FG000|Overall Study|Participant Withdrew Consent|1|||
129827607|NCT00969150|467334006|FG000|Overall Study|Adverse Event|4|||
129827608|NCT00969150|467334007|FG001|Overall Study|Adverse Event|14|||
129827609|NCT00969150|467334006|FG000|Overall Study|Lack of Efficacy|1|||
129827610|NCT00969150|467334007|FG001|Overall Study|Lack of Efficacy|1|||
129827611|NCT00969150|467334006|FG000|Overall Study|Protocol Violation|9|||
129827612|NCT00969150|467334007|FG001|Overall Study|Protocol Violation|12|||
129827613|NCT00969150|467334006|FG000|Overall Study|Withdrawal by Subject|13|||
129827614|NCT00969150|467334007|FG001|Overall Study|Withdrawal by Subject|9|||
129827615|NCT00969150|467334006|FG000|Overall Study|Lost to Follow-up|5|||
129827616|NCT00969150|467334007|FG001|Overall Study|Lost to Follow-up|4|||
129827617|NCT00969150|467334006|FG000|Overall Study|Other reasons|1|||
129827618|NCT00969150|467334007|FG001|Overall Study|Other reasons|0|||
129827619|NCT00309842|467334011|FG000|Overall Study|Lost to Follow-up|1|||
129827620|NCT01026792|467334012|FG000|Overall Study|Protocol Violation|1|||
129827621|NCT00423150|467334013|FG000|Overall Study|Adverse Event|11|||
129827622|NCT00423150|467334013|FG000|Overall Study|Progression of disease being studied|69|||
129827623|NCT00423150|467334013|FG000|Overall Study|Withdrawal by Subject|1|||
129827624|NCT00423150|467334013|FG000|Overall Study|Non-compliance with protocol|1|||
129827625|NCT00423150|467334013|FG000|Overall Study|Administrative|4|||
129827626|NCT03204305|467334014|FG000|Overall Study|Lost to Follow-up|6|||
129827627|NCT03204305|467334015|FG001|Overall Study|Lost to Follow-up|4|||
129827628|NCT03204305|467334016|FG002|Overall Study|Lost to Follow-up|0|||
129827629|NCT03204305|467334017|FG003|Overall Study|Lost to Follow-up|0|||
129827630|NCT03204305|467334014|FG000|Overall Study|Physician Decision|1|||
129827631|NCT03204305|467334015|FG001|Overall Study|Physician Decision|0|||
129827632|NCT03204305|467334016|FG002|Overall Study|Physician Decision|0|||
129827633|NCT03204305|467334017|FG003|Overall Study|Physician Decision|0|||
129827634|NCT03204305|467334014|FG000|Overall Study|failure to place arterial line|2|||
129827635|NCT03204305|467334015|FG001|Overall Study|failure to place arterial line|1|||
129827636|NCT03204305|467334016|FG002|Overall Study|failure to place arterial line|0|||
129827637|NCT03204305|467334017|FG003|Overall Study|failure to place arterial line|0|||
129827638|NCT03204305|467334014|FG000|Overall Study|Withdrawal by Subject|2|||
129827639|NCT03204305|467334015|FG001|Overall Study|Withdrawal by Subject|0|||
129827640|NCT03204305|467334016|FG002|Overall Study|Withdrawal by Subject|0|||
129827641|NCT03204305|467334017|FG003|Overall Study|Withdrawal by Subject|0|||
129827642|NCT02045797|467334018|FG000|Overall Study|Adverse Event|3|||
129827643|NCT02045797|467334019|FG001|Overall Study|Adverse Event|1|||
129827644|NCT02045797|467334020|FG002|Overall Study|Adverse Event|0|||
129827645|NCT02045797|467334018|FG000|Overall Study|Lack of Efficacy|1|||
129827646|NCT02045797|467334019|FG001|Overall Study|Lack of Efficacy|0|||
129827647|NCT02045797|467334020|FG002|Overall Study|Lack of Efficacy|0|||
129827648|NCT02045797|467334018|FG000|Overall Study|Lost to Follow-up|2|||
129827649|NCT02045797|467334019|FG001|Overall Study|Lost to Follow-up|3|||
129827650|NCT02045797|467334020|FG002|Overall Study|Lost to Follow-up|1|||
129827651|NCT02045797|467334018|FG000|Overall Study|Physician Decision|0|||
129827652|NCT02045797|467334019|FG001|Overall Study|Physician Decision|1|||
129827653|NCT02045797|467334020|FG002|Overall Study|Physician Decision|0|||
129827654|NCT02045797|467334018|FG000|Overall Study|Withdrawal by Subject|1|||
129827655|NCT02045797|467334019|FG001|Overall Study|Withdrawal by Subject|2|||
129827656|NCT02045797|467334020|FG002|Overall Study|Withdrawal by Subject|0|||
129827657|NCT00101907|467334024|FG000|Overall Study|Adverse Event|1|||
129827658|NCT00101907|467334025|FG001|Overall Study|Adverse Event|0|||
129827659|NCT00101907|467334026|FG002|Overall Study|Adverse Event|0|||
129827660|NCT00101907|467334027|FG003|Overall Study|Adverse Event|0|||
129827661|NCT00101907|467334028|FG004|Overall Study|Adverse Event|0|||
129827662|NCT00101907|467334029|FG005|Overall Study|Adverse Event|0|||
129827663|NCT00101907|467334024|FG000|Overall Study|Death|0|||
129827664|NCT00101907|467334025|FG001|Overall Study|Death|1|||
129827665|NCT00101907|467334026|FG002|Overall Study|Death|0|||
129827666|NCT00101907|467334027|FG003|Overall Study|Death|0|||
129827667|NCT00101907|467334028|FG004|Overall Study|Death|3|||
129827668|NCT00101907|467334029|FG005|Overall Study|Death|0|||
129827669|NCT00101907|467334024|FG000|Overall Study|Physician Decision|0|||
129827670|NCT00101907|467334025|FG001|Overall Study|Physician Decision|0|||
129827671|NCT00101907|467334026|FG002|Overall Study|Physician Decision|0|||
129827672|NCT00101907|467334027|FG003|Overall Study|Physician Decision|1|||
129827673|NCT00101907|467334028|FG004|Overall Study|Physician Decision|1|||
129827674|NCT00101907|467334029|FG005|Overall Study|Physician Decision|0|||
129827675|NCT00101907|467334024|FG000|Overall Study|Withdrawal by Subject|1|||
129827676|NCT00101907|467334025|FG001|Overall Study|Withdrawal by Subject|0|||
129827677|NCT00101907|467334026|FG002|Overall Study|Withdrawal by Subject|1|||
129827678|NCT00101907|467334027|FG003|Overall Study|Withdrawal by Subject|0|||
129827679|NCT00101907|467334028|FG004|Overall Study|Withdrawal by Subject|1|||
129827680|NCT00101907|467334029|FG005|Overall Study|Withdrawal by Subject|0|||
129827681|NCT03279692|467334032|FG000|Overall Study|Withdrawal by Subject|1|||
129827682|NCT04219891|467334036|FG000|Overall Study|Lost to Follow-up|3|||
129827683|NCT04219891|467334036|FG000|Overall Study|Withdrawal by Subject|2|||
129827684|NCT04958785|467335084|FG000|Overall Study|Study Terminated by Sponsor|4|||
129827685|NCT04958785|467335085|FG001|Overall Study|Study Terminated by Sponsor|10|||
129827686|NCT04958785|467335086|FG002|Overall Study|Study Terminated by Sponsor|7|||
129827687|NCT04958785|467335087|FG003|Overall Study|Study Terminated by Sponsor|6|||
129827688|NCT04958785|467335088|FG004|Overall Study|Study Terminated by Sponsor|34|||
129827689|NCT04958785|467335084|FG000|Overall Study|Death|2|||
129827690|NCT04958785|467335085|FG001|Overall Study|Death|3|||
129827691|NCT04958785|467335086|FG002|Overall Study|Death|4|||
129827692|NCT04958785|467335087|FG003|Overall Study|Death|5|||
129827693|NCT04958785|467335088|FG004|Overall Study|Death|5|||
129827694|NCT04958785|467335084|FG000|Overall Study|Withdrew consent|2|||
129827695|NCT04958785|467335085|FG001|Overall Study|Withdrew consent|0|||
129827696|NCT04958785|467335086|FG002|Overall Study|Withdrew consent|3|||
129827697|NCT04958785|467335087|FG003|Overall Study|Withdrew consent|1|||
129827698|NCT04958785|467335088|FG004|Overall Study|Withdrew consent|0|||
129827699|NCT04958785|467335084|FG000|Overall Study|Investigator's discretion|0|||
129827700|NCT04958785|467335085|FG001|Overall Study|Investigator's discretion|1|||
129827701|NCT04958785|467335086|FG002|Overall Study|Investigator's discretion|0|||
129827702|NCT04958785|467335087|FG003|Overall Study|Investigator's discretion|1|||
129827703|NCT04958785|467335088|FG004|Overall Study|Investigator's discretion|2|||
129827704|NCT04958785|467335084|FG000|Overall Study|Adverse Event|0|||
129827705|NCT04958785|467335085|FG001|Overall Study|Adverse Event|0|||
129827706|NCT04958785|467335086|FG002|Overall Study|Adverse Event|0|||
129827707|NCT04958785|467335087|FG003|Overall Study|Adverse Event|0|||
129827708|NCT04958785|467335088|FG004|Overall Study|Adverse Event|1|||
129827709|NCT04958785|467335084|FG000|Overall Study|Lost to Follow-up|0|||
129827710|NCT04958785|467335085|FG001|Overall Study|Lost to Follow-up|0|||
129827711|NCT04958785|467335086|FG002|Overall Study|Lost to Follow-up|0|||
129827712|NCT04958785|467335087|FG003|Overall Study|Lost to Follow-up|0|||
129827713|NCT04958785|467335088|FG004|Overall Study|Lost to Follow-up|1|||
129827714|NCT03274687|467335089|FG000|Overall Study|Protocol Violation|1|||
129827715|NCT03274687|467335090|FG001|Overall Study|Protocol Violation|1|||
129827716|NCT04734652|467335095|FG000|Overall Study|Withdrawal by Subject|2|||
129827717|NCT04734652|467335096|FG001|Overall Study|Withdrawal by Subject|0|||
129827718|NCT04734652|467335095|FG000|Overall Study|Death|0|||
129827719|NCT04734652|467335096|FG001|Overall Study|Death|1|||
129827720|NCT05104476|467335106|FG000|Overall Study|Randomized But Not Treated|1|||
129827721|NCT05104476|467335107|FG001|Overall Study|Randomized But Not Treated|2|||
129827722|NCT05104476|467335106|FG000|Overall Study|Adverse Event|2|||
129827723|NCT05104476|467335107|FG001|Overall Study|Adverse Event|2|||
129827724|NCT05104476|467335106|FG000|Overall Study|Withdrawal by Subject|3|||
129827725|NCT05104476|467335107|FG001|Overall Study|Withdrawal by Subject|3|||
129827726|NCT05104476|467335106|FG000|Overall Study|Other Than Specified|0|||
129827727|NCT05104476|467335107|FG001|Overall Study|Other Than Specified|3|||
129827728|NCT04519645|467335109|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
129827729|NCT04519645|467335110|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
129827730|NCT04519645|467335111|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
129827731|NCT04519645|467335109|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
129827732|NCT04519645|467335110|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
129827733|NCT04519645|467335111|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
129827734|NCT04519645|467335109|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
129827735|NCT04519645|467335110|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
129827736|NCT04519645|467335111|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
129827737|NCT04519645|467335109|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
129827738|NCT04519645|467335110|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
129827739|NCT04519645|467335111|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
129827740|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827741|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
129827742|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827743|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827744|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827745|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827746|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
129827747|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
129827748|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
129827749|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
129827750|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
129827751|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
129827752|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
129827753|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
129827754|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
129827755|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
129827756|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
129827757|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
129827758|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
129827759|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
129827760|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
129827761|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827762|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
129827763|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827764|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827765|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827766|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
129827767|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
129827768|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
129827769|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
129827770|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
129827771|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
129827772|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
129827773|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
129827774|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
129827775|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827776|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827777|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827778|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827779|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827780|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
129827781|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
129827782|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
129827783|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
129827784|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
129827785|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
129827786|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
129827787|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
129827788|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
129827789|NCT03742037|467335112|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827790|NCT03742037|467335113|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827791|NCT03742037|467335114|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827792|NCT03742037|467335115|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827793|NCT03742037|467335116|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129897670|NCT01981850|467584421|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
129827794|NCT03742037|467335117|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
129827795|NCT03742037|467335118|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
129827796|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
129827797|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
129827798|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
129827799|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
129827800|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
129827801|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
129827802|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
129827803|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827804|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827805|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
129827806|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
129827807|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827808|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
129827809|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
129827810|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827811|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
129827812|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
129827813|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827814|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827815|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827816|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
129827817|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
129827818|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827819|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827820|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827821|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827822|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
129827823|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
129827824|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
129827825|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
129827826|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
129827827|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
129827828|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
129827829|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
129827830|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
129827831|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
129827832|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827833|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
129827834|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827835|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827836|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
129827837|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
129827838|NCT03742037|467335112|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827839|NCT03742037|467335113|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827840|NCT03742037|467335114|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
129827841|NCT03742037|467335115|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827842|NCT03742037|467335116|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827843|NCT03742037|467335117|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827844|NCT03742037|467335118|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
129827845|NCT04447755|467335119|FG000|Overall Study|Death|9|||
129827846|NCT04447755|467335120|FG001|Overall Study|Death|16|||
129827847|NCT04447755|467335121|FG002|Overall Study|Death|8|||
129827848|NCT04447755|467335122|FG003|Overall Study|Death|9|||
129827849|NCT04447755|467335123|FG004|Overall Study|Death|8|||
129827850|NCT04447755|467335124|FG005|Overall Study|Death|9|||
129827851|NCT04447755|467335125|FG006|Overall Study|Death|55|||
129827852|NCT04447755|467335119|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129827853|NCT04447755|467335120|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129827854|NCT04447755|467335121|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129827855|NCT04447755|467335122|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129827856|NCT04447755|467335123|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129827857|NCT04447755|467335124|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129827858|NCT04447755|467335125|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
129827859|NCT04447755|467335119|FG000|Overall Study|Sponsor Decision|0|||
129827860|NCT04447755|467335120|FG001|Overall Study|Sponsor Decision|0|||
129827861|NCT04447755|467335121|FG002|Overall Study|Sponsor Decision|0|||
129827862|NCT04447755|467335122|FG003|Overall Study|Sponsor Decision|0|||
129827863|NCT04447755|467335123|FG004|Overall Study|Sponsor Decision|1|||
129827864|NCT04447755|467335124|FG005|Overall Study|Sponsor Decision|0|||
129827865|NCT04447755|467335125|FG006|Overall Study|Sponsor Decision|10|||
129827866|NCT04447755|467335119|FG000|Overall Study|Lost to Follow-up|0|||
129827867|NCT04447755|467335120|FG001|Overall Study|Lost to Follow-up|0|||
129827868|NCT04447755|467335121|FG002|Overall Study|Lost to Follow-up|0|||
129827869|NCT04447755|467335122|FG003|Overall Study|Lost to Follow-up|0|||
129827870|NCT04447755|467335123|FG004|Overall Study|Lost to Follow-up|0|||
129827871|NCT04447755|467335124|FG005|Overall Study|Lost to Follow-up|0|||
129827872|NCT04447755|467335125|FG006|Overall Study|Lost to Follow-up|1|||
129827873|NCT02375113|467335128|FG000|Overall Study|Undisclosed Reason(s).|1|||
129827874|NCT02375113|467335129|FG001|Overall Study|Undisclosed Reason(s).|1|||
129827875|NCT02375113|467335128|FG000|Overall Study|Poor adherence (<70%).|1|||
129827876|NCT02375113|467335129|FG001|Overall Study|Poor adherence (<70%).|0|||
129827877|NCT02375113|467335128|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
129827878|NCT02375113|467335129|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
129827879|NCT04387435|467335135|FG000|Overall Study|Physician Decision|1|||
129827880|NCT03855280|467335136|FG000|Treatment Phase|Adverse Event|1|||
129827881|NCT03855280|467335136|FG000|Treatment Phase|Withdrawal by Subject|1|||
129827882|NCT03855280|467335136|FG000|Continuation Phase|Protocol Violation|1|||
129827883|NCT03855280|467335136|FG000|Continuation Phase|Adverse Event|1|||
129827884|NCT03855280|467335136|FG000|Continuation Phase|Sponsor Concluded Study|1|||
129827885|NCT03338855|467335137|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
129827886|NCT03338855|467335138|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
129827887|NCT00511667|467335139|FG000|Overall Study|Adverse Event|1|||
129827888|NCT00511667|467335140|FG001|Overall Study|Adverse Event|0|||
129827889|NCT00511667|467335139|FG000|Overall Study|Protocol Violation|1|||
129827890|NCT00511667|467335140|FG001|Overall Study|Protocol Violation|1|||
129827891|NCT00511667|467335139|FG000|Overall Study|Withdrawal by Subject|2|||
129827892|NCT00511667|467335140|FG001|Overall Study|Withdrawal by Subject|0|||
129827893|NCT00511667|467335139|FG000|Overall Study|Site terminated|6|||
129827894|NCT00511667|467335140|FG001|Overall Study|Site terminated|1|||
129827895|NCT00511667|467335139|FG000|Overall Study|Other|2|||
129827896|NCT00511667|467335140|FG001|Overall Study|Other|1|||
129827897|NCT02335099|467335141|FG000|Treatment|Withdrawal by Subject|1|||
129827898|NCT02335099|467335142|FG001|Treatment|Withdrawal by Subject|3|||
129827899|NCT02335099|467335141|FG000|Treatment|Lost to Follow-up|2|||
129827900|NCT02335099|467335142|FG001|Treatment|Lost to Follow-up|0|||
129827901|NCT02335099|467335141|FG000|Treatment|Death|1|||
129827902|NCT02335099|467335142|FG001|Treatment|Death|0|||
129827903|NCT02335099|467335141|FG000|Treatment|Adverse Event|1|||
129827904|NCT02335099|467335142|FG001|Treatment|Adverse Event|2|||
129827905|NCT02335099|467335141|FG000|Follow-up|Death|0|||
129827906|NCT02335099|467335142|FG001|Follow-up|Death|1|||
129827907|NCT00484939|467335145|FG000|Overall Study|Death|9|||
129827908|NCT00484939|467335146|FG001|Overall Study|Death|13|||
129827909|NCT00484939|467335145|FG000|Overall Study|Adverse Event|22|||
129827910|NCT00484939|467335146|FG001|Overall Study|Adverse Event|12|||
129827911|NCT00484939|467335145|FG000|Overall Study|Patient Withdrew Consent|19|||
129827912|NCT00484939|467335146|FG001|Overall Study|Patient Withdrew Consent|10|||
129827913|NCT00484939|467335145|FG000|Overall Study|Protocol Violation|3|||
129827914|NCT00484939|467335146|FG001|Overall Study|Protocol Violation|3|||
129827915|NCT00484939|467335145|FG000|Overall Study|Lost to Follow-up|0|||
129827916|NCT00484939|467335146|FG001|Overall Study|Lost to Follow-up|3|||
129827917|NCT00484939|467335145|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
129897671|NCT02524288|467584422|FG000|Overall Study|Adverse Event|115|||
129827918|NCT00484939|467335146|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
129827919|NCT00484939|467335145|FG000|Overall Study|Disease progression|67|||
129827920|NCT00484939|467335146|FG001|Overall Study|Disease progression|88|||
129827921|NCT00484939|467335145|FG000|Overall Study|Screen Failure|2|||
129827922|NCT00484939|467335146|FG001|Overall Study|Screen Failure|2|||
129827923|NCT00484939|467335145|FG000|Overall Study|Reason Not Specified|11|||
129827924|NCT00484939|467335146|FG001|Overall Study|Reason Not Specified|6|||
129827925|NCT01474876|467335149|FG000|Overall Study|Adverse Event|11|||
129827926|NCT01474876|467335150|FG001|Overall Study|Adverse Event|5|||
129827927|NCT01474876|467335151|FG002|Overall Study|Adverse Event|0|||
129827928|NCT01474876|467335149|FG000|Overall Study|Serious Adverse Event|2|||
129827929|NCT01474876|467335150|FG001|Overall Study|Serious Adverse Event|3|||
129827930|NCT01474876|467335151|FG002|Overall Study|Serious Adverse Event|0|||
129827931|NCT01474876|467335149|FG000|Overall Study|Lost to Follow-up|5|||
129827932|NCT01474876|467335150|FG001|Overall Study|Lost to Follow-up|4|||
129827933|NCT01474876|467335151|FG002|Overall Study|Lost to Follow-up|0|||
129827934|NCT01474876|467335149|FG000|Overall Study|Investigator's decision|28|||
129827935|NCT01474876|467335150|FG001|Overall Study|Investigator's decision|6|||
129827936|NCT01474876|467335151|FG002|Overall Study|Investigator's decision|0|||
129827937|NCT01474876|467335149|FG000|Overall Study|Patient's request|19|||
129827938|NCT01474876|467335150|FG001|Overall Study|Patient's request|5|||
129827939|NCT01474876|467335151|FG002|Overall Study|Patient's request|0|||
129827940|NCT01474876|467335149|FG000|Overall Study|Investigator's decision and pt request|1|||
129827941|NCT01474876|467335150|FG001|Overall Study|Investigator's decision and pt request|0|||
129827942|NCT01474876|467335151|FG002|Overall Study|Investigator's decision and pt request|0|||
129827943|NCT01523886|467335152|FG000|Overall Study|surgery cancelled|0|||
129827944|NCT01523886|467335153|FG001|Overall Study|surgery cancelled|1|||
129827945|NCT01173718|467335163|FG000|Overall Study|Death|17|||
129827946|NCT01173718|467335163|FG000|Overall Study|Abandonment of study graft|27|||
129827947|NCT01367158|467335164|FG000|Overall Study|Withdrew consent|0|||
129827948|NCT01367158|467335165|FG001|Overall Study|Withdrew consent|2|||
129827949|NCT01367158|467335166|FG002|Overall Study|Withdrew consent|1|||
129827950|NCT01367158|467335167|FG003|Overall Study|Withdrew consent|0|||
129827951|NCT01367158|467335168|FG004|Overall Study|Withdrew consent|2|||
129827952|NCT01367158|467335169|FG005|Overall Study|Withdrew consent|0|||
129827953|NCT01367158|467335170|FG006|Overall Study|Withdrew consent|0|||
129827954|NCT01367158|467335171|FG007|Overall Study|Withdrew consent|1|||
129827955|NCT01367158|467335172|FG008|Overall Study|Withdrew consent|0|||
129827956|NCT01367158|467335173|FG009|Overall Study|Withdrew consent|0|||
129827957|NCT01367158|467335174|FG010|Overall Study|Withdrew consent|0|||
129827958|NCT01367158|467335164|FG000|Overall Study|Lost to Follow-up|0|||
129827959|NCT01367158|467335165|FG001|Overall Study|Lost to Follow-up|0|||
129827960|NCT01367158|467335166|FG002|Overall Study|Lost to Follow-up|0|||
129827961|NCT01367158|467335167|FG003|Overall Study|Lost to Follow-up|1|||
129827962|NCT01367158|467335168|FG004|Overall Study|Lost to Follow-up|0|||
129827963|NCT01367158|467335169|FG005|Overall Study|Lost to Follow-up|2|||
129827964|NCT01367158|467335170|FG006|Overall Study|Lost to Follow-up|0|||
129827965|NCT01367158|467335171|FG007|Overall Study|Lost to Follow-up|1|||
129827966|NCT01367158|467335172|FG008|Overall Study|Lost to Follow-up|0|||
129827967|NCT01367158|467335173|FG009|Overall Study|Lost to Follow-up|0|||
129827968|NCT01367158|467335174|FG010|Overall Study|Lost to Follow-up|1|||
129827969|NCT01367158|467335164|FG000|Overall Study|Protocol Violation|0|||
129827970|NCT01367158|467335165|FG001|Overall Study|Protocol Violation|1|||
129827971|NCT01367158|467335166|FG002|Overall Study|Protocol Violation|0|||
129827972|NCT01367158|467335167|FG003|Overall Study|Protocol Violation|0|||
129827973|NCT01367158|467335168|FG004|Overall Study|Protocol Violation|0|||
129827974|NCT01367158|467335169|FG005|Overall Study|Protocol Violation|0|||
129827975|NCT01367158|467335170|FG006|Overall Study|Protocol Violation|0|||
129827976|NCT01367158|467335171|FG007|Overall Study|Protocol Violation|0|||
129827977|NCT01367158|467335172|FG008|Overall Study|Protocol Violation|0|||
129827978|NCT01367158|467335173|FG009|Overall Study|Protocol Violation|0|||
129827979|NCT01367158|467335174|FG010|Overall Study|Protocol Violation|0|||
129827980|NCT02226003|467335175|FG000|Overall Study|Lost to Follow-up|2|||
129827981|NCT02226003|467335176|FG001|Overall Study|Lost to Follow-up|1|||
129827982|NCT02226003|467335177|FG002|Overall Study|Lost to Follow-up|3|||
129827983|NCT02226003|467335175|FG000|Overall Study|Withdrawal by Subject|0|||
129827984|NCT02226003|467335176|FG001|Overall Study|Withdrawal by Subject|0|||
129827985|NCT02226003|467335177|FG002|Overall Study|Withdrawal by Subject|3|||
129827986|NCT01499563|467335180|FG000|Overall Study|Withdrawal by Subject|10|||
129827987|NCT01499563|467335181|FG001|Overall Study|Withdrawal by Subject|11|||
129827988|NCT01499563|467335182|FG002|Overall Study|Withdrawal by Subject|7|||
129827989|NCT01499563|467335183|FG003|Overall Study|Withdrawal by Subject|8|||
129445718|NCT01968070|465932885|FG010|Period 2|Withdrawal by Subject|0|||
129827990|NCT01499563|467335180|FG000|Overall Study|Physician Decision|2|||
129827991|NCT01499563|467335181|FG001|Overall Study|Physician Decision|1|||
129827992|NCT01499563|467335182|FG002|Overall Study|Physician Decision|3|||
129827993|NCT01499563|467335183|FG003|Overall Study|Physician Decision|0|||
129827994|NCT01499563|467335180|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
129827995|NCT01499563|467335181|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
129827996|NCT01499563|467335182|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
129827997|NCT01499563|467335183|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
129827998|NCT01499563|467335180|FG000|Overall Study|Adverse Event|2|||
129827999|NCT01499563|467335181|FG001|Overall Study|Adverse Event|0|||
129828000|NCT01499563|467335182|FG002|Overall Study|Adverse Event|1|||
129828001|NCT01499563|467335183|FG003|Overall Study|Adverse Event|3|||
129828002|NCT01499563|467335180|FG000|Overall Study|Lack of Efficacy|0|||
129828003|NCT01499563|467335181|FG001|Overall Study|Lack of Efficacy|1|||
129828004|NCT01499563|467335182|FG002|Overall Study|Lack of Efficacy|6|||
129828005|NCT01499563|467335183|FG003|Overall Study|Lack of Efficacy|3|||
129828006|NCT01499563|467335180|FG000|Overall Study|Other|8|||
129828007|NCT01499563|467335181|FG001|Overall Study|Other|6|||
129828008|NCT01499563|467335182|FG002|Overall Study|Other|6|||
129828009|NCT01499563|467335183|FG003|Overall Study|Other|4|||
129828010|NCT00597012|467335188|FG000|Overall Study|Death|1|||
129828011|NCT00597012|467335189|FG001|Overall Study|Death|1|||
129828012|NCT00597012|467335188|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
129828013|NCT00597012|467335189|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
129828014|NCT00597012|467335188|FG000|Overall Study|Withdrawal by Subject|7|||
129828015|NCT00597012|467335189|FG001|Overall Study|Withdrawal by Subject|4|||
129828016|NCT00597012|467335188|FG000|Overall Study|Ineligible|2|||
129828017|NCT00597012|467335189|FG001|Overall Study|Ineligible|0|||
129828018|NCT00597012|467335188|FG000|Overall Study|Lost to Follow-up|0|||
129828019|NCT00597012|467335189|FG001|Overall Study|Lost to Follow-up|2|||
129828020|NCT00587561|467335693|FG000|Overall Study|Lost to Follow-up|6|||
129828021|NCT00587561|467335694|FG001|Overall Study|Lost to Follow-up|4|||
129828022|NCT00410761|467335695|FG000|Randomized Treatment Period|Adverse Event|34|||
129828023|NCT00410761|467335696|FG001|Randomized Treatment Period|Adverse Event|3|||
129828024|NCT00410761|467335695|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
129828025|NCT00410761|467335696|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
129828026|NCT00410761|467335695|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
129828027|NCT00410761|467335696|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
129828028|NCT00410761|467335695|FG000|Randomized Treatment Period|Other|69|||
129828029|NCT00410761|467335696|FG001|Randomized Treatment Period|Other|21|||
129828030|NCT00410761|467335695|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
129828031|NCT00410761|467335696|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
129828032|NCT00410761|467335695|FG000|Open-Label Treatment Period|Adverse Event|13|||
129828033|NCT00410761|467335696|FG001|Open-Label Treatment Period|Adverse Event|15|||
129828034|NCT00410761|467335695|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
129828035|NCT00410761|467335696|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
129828036|NCT00410761|467335695|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
129828037|NCT00410761|467335696|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
129828038|NCT00410761|467335695|FG000|Open-Label Treatment Period|Other|18|||
129828039|NCT00410761|467335696|FG001|Open-Label Treatment Period|Other|9|||
129828040|NCT02926924|467335698|FG000|Overall Study|withdrawal - reason unknown|0|||
129828041|NCT02926924|467335699|FG001|Overall Study|withdrawal - reason unknown|1|||
129828042|NCT04568590|467335702|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
129828043|NCT02268864|467335703|FG000|Overall Study|Withdrawal by Subject|2|||
129828044|NCT02268864|467335704|FG001|Overall Study|Withdrawal by Subject|0|||
129828045|NCT02268864|467335705|FG002|Overall Study|Withdrawal by Subject|0|||
129828046|NCT02268864|467335703|FG000|Overall Study|Death|0|||
129828047|NCT02268864|467335704|FG001|Overall Study|Death|1|||
129828048|NCT02268864|467335705|FG002|Overall Study|Death|0|||
129828049|NCT05407675|467335706|FG000|Overall Study|Withdrawal by Subject|0|||
129828050|NCT05407675|467335707|FG001|Overall Study|Withdrawal by Subject|2|||
129828051|NCT05407675|467335708|FG002|Overall Study|Withdrawal by Subject|3|||
129828052|NCT05407675|467335709|FG003|Overall Study|Withdrawal by Subject|5|||
129828053|NCT05407675|467335710|FG004|Overall Study|Withdrawal by Subject|0|||
129828054|NCT05407675|467335711|FG005|Overall Study|Withdrawal by Subject|2|||
129828055|NCT05407675|467335712|FG006|Overall Study|Withdrawal by Subject|0|||
129828056|NCT05407675|467335713|FG007|Overall Study|Withdrawal by Subject|0|||
129828057|NCT05407675|467335714|FG008|Overall Study|Withdrawal by Subject|2|||
129828058|NCT05407675|467335715|FG009|Overall Study|Withdrawal by Subject|0|||
129828059|NCT05407675|467335716|FG010|Overall Study|Withdrawal by Subject|1|||
129828060|NCT05407675|467335717|FG011|Overall Study|Withdrawal by Subject|0|||
129828061|NCT05407675|467335718|FG012|Overall Study|Withdrawal by Subject|0|||
129828062|NCT05407675|467335706|FG000|Overall Study|Site terminated by sponsor|0|||
129828063|NCT05407675|467335707|FG001|Overall Study|Site terminated by sponsor|0|||
129828064|NCT05407675|467335708|FG002|Overall Study|Site terminated by sponsor|1|||
129828065|NCT05407675|467335709|FG003|Overall Study|Site terminated by sponsor|0|||
129828066|NCT05407675|467335710|FG004|Overall Study|Site terminated by sponsor|2|||
129828067|NCT05407675|467335711|FG005|Overall Study|Site terminated by sponsor|0|||
129828068|NCT05407675|467335712|FG006|Overall Study|Site terminated by sponsor|1|||
129828069|NCT05407675|467335713|FG007|Overall Study|Site terminated by sponsor|0|||
129828070|NCT05407675|467335714|FG008|Overall Study|Site terminated by sponsor|0|||
129828071|NCT05407675|467335715|FG009|Overall Study|Site terminated by sponsor|2|||
129828072|NCT05407675|467335716|FG010|Overall Study|Site terminated by sponsor|2|||
129828073|NCT05407675|467335717|FG011|Overall Study|Site terminated by sponsor|2|||
129828074|NCT05407675|467335718|FG012|Overall Study|Site terminated by sponsor|1|||
129828075|NCT05407675|467335706|FG000|Overall Study|Disease Progression|0|||
129828076|NCT05407675|467335707|FG001|Overall Study|Disease Progression|0|||
129828077|NCT05407675|467335708|FG002|Overall Study|Disease Progression|0|||
129828078|NCT05407675|467335709|FG003|Overall Study|Disease Progression|0|||
129828079|NCT05407675|467335710|FG004|Overall Study|Disease Progression|0|||
129828080|NCT05407675|467335711|FG005|Overall Study|Disease Progression|0|||
129828081|NCT05407675|467335712|FG006|Overall Study|Disease Progression|0|||
129828082|NCT05407675|467335713|FG007|Overall Study|Disease Progression|0|||
129828083|NCT05407675|467335714|FG008|Overall Study|Disease Progression|0|||
129828084|NCT05407675|467335715|FG009|Overall Study|Disease Progression|0|||
129828085|NCT05407675|467335716|FG010|Overall Study|Disease Progression|1|||
129828086|NCT05407675|467335717|FG011|Overall Study|Disease Progression|0|||
129828087|NCT05407675|467335718|FG012|Overall Study|Disease Progression|0|||
129828088|NCT05407675|467335706|FG000|Overall Study|Physician Decision|0|||
129828089|NCT05407675|467335707|FG001|Overall Study|Physician Decision|0|||
129828090|NCT05407675|467335708|FG002|Overall Study|Physician Decision|0|||
129828091|NCT05407675|467335709|FG003|Overall Study|Physician Decision|0|||
129828092|NCT05407675|467335710|FG004|Overall Study|Physician Decision|0|||
129828093|NCT05407675|467335711|FG005|Overall Study|Physician Decision|0|||
129828094|NCT05407675|467335712|FG006|Overall Study|Physician Decision|0|||
129828095|NCT05407675|467335713|FG007|Overall Study|Physician Decision|0|||
129828096|NCT05407675|467335714|FG008|Overall Study|Physician Decision|0|||
129828097|NCT05407675|467335715|FG009|Overall Study|Physician Decision|0|||
129828098|NCT05407675|467335716|FG010|Overall Study|Physician Decision|1|||
129828099|NCT05407675|467335717|FG011|Overall Study|Physician Decision|0|||
129828100|NCT05407675|467335718|FG012|Overall Study|Physician Decision|0|||
129828101|NCT05407675|467335706|FG000|Overall Study|Other reasons|0|||
129828102|NCT05407675|467335707|FG001|Overall Study|Other reasons|0|||
129828103|NCT05407675|467335708|FG002|Overall Study|Other reasons|0|||
129828104|NCT05407675|467335709|FG003|Overall Study|Other reasons|0|||
129828105|NCT05407675|467335710|FG004|Overall Study|Other reasons|0|||
129828106|NCT05407675|467335711|FG005|Overall Study|Other reasons|0|||
129828107|NCT05407675|467335712|FG006|Overall Study|Other reasons|0|||
129828108|NCT05407675|467335713|FG007|Overall Study|Other reasons|0|||
129828109|NCT05407675|467335714|FG008|Overall Study|Other reasons|1|||
129828110|NCT05407675|467335715|FG009|Overall Study|Other reasons|1|||
129828111|NCT05407675|467335716|FG010|Overall Study|Other reasons|1|||
129828112|NCT05407675|467335717|FG011|Overall Study|Other reasons|1|||
129828113|NCT05407675|467335718|FG012|Overall Study|Other reasons|0|||
129828114|NCT05407675|467335706|FG000|Overall Study|Death|3|||
129828115|NCT05407675|467335707|FG001|Overall Study|Death|4|||
129828116|NCT05407675|467335708|FG002|Overall Study|Death|3|||
129828117|NCT05407675|467335709|FG003|Overall Study|Death|6|||
129828118|NCT05407675|467335710|FG004|Overall Study|Death|0|||
129828119|NCT05407675|467335711|FG005|Overall Study|Death|2|||
129828120|NCT05407675|467335712|FG006|Overall Study|Death|4|||
129828121|NCT05407675|467335713|FG007|Overall Study|Death|2|||
129828122|NCT05407675|467335714|FG008|Overall Study|Death|2|||
129828123|NCT05407675|467335715|FG009|Overall Study|Death|4|||
129828124|NCT05407675|467335716|FG010|Overall Study|Death|2|||
129828125|NCT05407675|467335717|FG011|Overall Study|Death|1|||
129828126|NCT05407675|467335718|FG012|Overall Study|Death|0|||
129828127|NCT05407675|467335706|FG000|Overall Study|Adverse Event|0|||
129828128|NCT05407675|467335707|FG001|Overall Study|Adverse Event|0|||
129828129|NCT05407675|467335708|FG002|Overall Study|Adverse Event|0|||
129828130|NCT05407675|467335709|FG003|Overall Study|Adverse Event|0|||
129828131|NCT05407675|467335710|FG004|Overall Study|Adverse Event|1|||
129828132|NCT05407675|467335711|FG005|Overall Study|Adverse Event|0|||
129828133|NCT05407675|467335712|FG006|Overall Study|Adverse Event|0|||
129828134|NCT05407675|467335713|FG007|Overall Study|Adverse Event|0|||
129828135|NCT05407675|467335714|FG008|Overall Study|Adverse Event|0|||
129828136|NCT05407675|467335715|FG009|Overall Study|Adverse Event|0|||
129828137|NCT05407675|467335716|FG010|Overall Study|Adverse Event|0|||
129828138|NCT05407675|467335717|FG011|Overall Study|Adverse Event|1|||
129828139|NCT05407675|467335718|FG012|Overall Study|Adverse Event|0|||
129828140|NCT05407675|467335706|FG000|Overall Study|Ongoing Treatment|0|||
129828141|NCT05407675|467335707|FG001|Overall Study|Ongoing Treatment|0|||
129828142|NCT05407675|467335708|FG002|Overall Study|Ongoing Treatment|0|||
129828143|NCT05407675|467335709|FG003|Overall Study|Ongoing Treatment|0|||
129828144|NCT05407675|467335710|FG004|Overall Study|Ongoing Treatment|0|||
129828145|NCT05407675|467335711|FG005|Overall Study|Ongoing Treatment|0|||
129828146|NCT05407675|467335712|FG006|Overall Study|Ongoing Treatment|0|||
129828147|NCT05407675|467335713|FG007|Overall Study|Ongoing Treatment|0|||
129828148|NCT05407675|467335714|FG008|Overall Study|Ongoing Treatment|1|||
129828149|NCT05407675|467335715|FG009|Overall Study|Ongoing Treatment|0|||
129828150|NCT05407675|467335716|FG010|Overall Study|Ongoing Treatment|0|||
129828151|NCT05407675|467335717|FG011|Overall Study|Ongoing Treatment|0|||
129828152|NCT05407675|467335718|FG012|Overall Study|Ongoing Treatment|0|||
129828153|NCT00857220|467335719|FG000|Overall Study|Adverse Event|35|||
129828154|NCT00857220|467335719|FG000|Overall Study|Death|1|||
129828155|NCT00857220|467335719|FG000|Overall Study|Lack of Efficacy|11|||
129828156|NCT00857220|467335719|FG000|Overall Study|Lost to Follow-up|30|||
129828157|NCT00857220|467335719|FG000|Overall Study|Physician Decision|4|||
129828158|NCT00857220|467335719|FG000|Overall Study|Protocol Violation|16|||
129828159|NCT00857220|467335719|FG000|Overall Study|Withdrawal by Subject|67|||
129828160|NCT00857220|467335719|FG000|Overall Study|Clinical Hold|6|||
129828161|NCT00857220|467335719|FG000|Overall Study|Site Closed|5|||
129828162|NCT00857220|467335719|FG000|Overall Study|Miscellaneous|8|||
129828163|NCT03698994|467335720|FG000|Overall Study|Adverse Event|2|||
129828164|NCT03698994|467335720|FG000|Overall Study|Death|1|||
129828165|NCT03698994|467335720|FG000|Overall Study|Physician Decision|1|||
129828166|NCT03698994|467335720|FG000|Overall Study|Withdrawal by Subject|3|||
129828167|NCT03698994|467335720|FG000|Overall Study|Progressive Disease|12|||
129828168|NCT03251079|467335726|FG000|Overall Study|Withdrawal by Subject|1|||
129828169|NCT02472795|467335733|FG000|Overall Study|Adverse Event|0|||
129828170|NCT02472795|467335734|FG001|Overall Study|Adverse Event|1|||
129828171|NCT02472795|467335735|FG002|Overall Study|Adverse Event|0|||
129828172|NCT02472795|467335736|FG003|Overall Study|Adverse Event|0|||
129828173|NCT02472795|467335737|FG004|Overall Study|Adverse Event|2|||
129828174|NCT02472795|467335733|FG000|Overall Study|Withdrawal by Subject|0|||
129828175|NCT02472795|467335734|FG001|Overall Study|Withdrawal by Subject|0|||
129828176|NCT02472795|467335735|FG002|Overall Study|Withdrawal by Subject|0|||
129828177|NCT02472795|467335736|FG003|Overall Study|Withdrawal by Subject|0|||
129828178|NCT02472795|467335737|FG004|Overall Study|Withdrawal by Subject|1|||
129828179|NCT04166513|467335738|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
129828180|NCT04166513|467335739|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
129828181|NCT04166513|467335740|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
129828182|NCT04166513|467335741|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
129828183|NCT04166513|467335738|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
129828184|NCT04166513|467335739|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
129828185|NCT04166513|467335740|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
129828186|NCT04166513|467335741|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
129828187|NCT04166513|467335738|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
129828188|NCT04166513|467335739|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
129828189|NCT04166513|467335740|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
129828190|NCT04166513|467335741|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
129828191|NCT04166513|467335738|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
129828192|NCT04166513|467335739|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
129828193|NCT04166513|467335740|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
129828194|NCT04166513|467335741|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
129828195|NCT04166513|467335738|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
129828196|NCT04166513|467335739|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
129828197|NCT04166513|467335740|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
129828198|NCT04166513|467335741|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
129828199|NCT00202644|467337254|FG000|Overall Study|Adverse Event|12|||
129828200|NCT00202644|467337255|FG001|Overall Study|Adverse Event|13|||
129828201|NCT00202644|467337254|FG000|Overall Study|Withdrawal by Subject|8|||
129828202|NCT00202644|467337255|FG001|Overall Study|Withdrawal by Subject|6|||
129828203|NCT00202644|467337254|FG000|Overall Study|Lack of Efficacy|6|||
129828204|NCT00202644|467337255|FG001|Overall Study|Lack of Efficacy|6|||
129828205|NCT00202644|467337254|FG000|Overall Study|Lost to Follow-up|0|||
129828206|NCT00202644|467337255|FG001|Overall Study|Lost to Follow-up|1|||
129828207|NCT00202644|467337254|FG000|Overall Study|Other|9|||
129828208|NCT00202644|467337255|FG001|Overall Study|Other|1|||
129828209|NCT03724812|467337262|FG000|Overall Study|Missed Visit|1|||
129828210|NCT03724812|467337262|FG000|Overall Study|Death|2|||
129828211|NCT03724812|467337262|FG000|Overall Study|Withdrawal by Subject|1|||
129828212|NCT01851720|467337263|FG000|Overall Study|Lost to Follow-up|0|||
129828213|NCT01851720|467337264|FG001|Overall Study|Lost to Follow-up|1|||
129828214|NCT01870583|467337267|FG000|Overall Study|Protocol Violation|0|||
129828215|NCT01870583|467337268|FG001|Overall Study|Protocol Violation|5|||
129828216|NCT01870583|467337269|FG002|Overall Study|Protocol Violation|3|||
129828217|NCT01870583|467337267|FG000|Overall Study|Lost to Follow-up|11|||
129828218|NCT01870583|467337268|FG001|Overall Study|Lost to Follow-up|13|||
129828219|NCT01870583|467337269|FG002|Overall Study|Lost to Follow-up|5|||
129828220|NCT04741074|467337270|FG000|Overall Study|Withdrawal by Subject|1|||
129828221|NCT04741074|467337271|FG001|Overall Study|Withdrawal by Subject|1|||
129828222|NCT04741074|467337270|FG000|Overall Study|Study terminated prematurely|1|||
129828223|NCT04741074|467337271|FG001|Overall Study|Study terminated prematurely|0|||
129828224|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Death|3|||
129828225|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Death|2|||
129828226|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Death|4|||
129828227|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Death|3|||
129828228|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Death|0|||
129828229|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Death|0|||
129828230|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828231|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
129897672|NCT02524288|467584422|FG000|Overall Study|Lost to Follow-up|216|||
129897673|NCT02524288|467584422|FG000|Overall Study|Non-Compliance With Protocol|32|||
129828232|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
129828233|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828234|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828235|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
129828236|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
129828237|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828238|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828239|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828240|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828241|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
129828242|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
129828243|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
129828244|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
129828245|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
129828246|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
129828247|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
129828248|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828249|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828250|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
129828251|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
129828252|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828253|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
129828254|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
129828255|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
129828256|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
129828257|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
129828258|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
129828259|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
129828260|NCT02432846|467337272|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828261|NCT02432846|467337273|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828262|NCT02432846|467337274|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
129828263|NCT02432846|467337275|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828264|NCT02432846|467337276|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828265|NCT02432846|467337277|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
129828266|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
129828267|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
129828268|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
129828269|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
129828270|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
129828271|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
129828272|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828273|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828274|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828275|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
129828276|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
129828277|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
129828278|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828279|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828280|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828281|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828282|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
129828283|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
129828284|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828285|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828286|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828287|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
129828288|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
129828289|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
129828290|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129828291|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129828292|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129828293|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
129897674|NCT02524288|467584422|FG000|Overall Study|Non-Compliance With Study Drug|14|||
129828294|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
129828295|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
129828296|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828297|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828298|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828299|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
129828300|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
129828301|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
129828302|NCT02432846|467337272|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828303|NCT02432846|467337273|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828304|NCT02432846|467337274|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828305|NCT02432846|467337275|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828306|NCT02432846|467337276|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
129828307|NCT02432846|467337277|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
129828308|NCT01770379|467337278|FG000|Overall Study|Technical issues|1|||
129828309|NCT01770379|467337279|FG001|Overall Study|Technical issues|0|||
129828310|NCT01770379|467337280|FG002|Overall Study|Technical issues|0|||
129828311|NCT01770379|467337278|FG000|Overall Study|Withdrawal by Subject|7|||
129828312|NCT01770379|467337279|FG001|Overall Study|Withdrawal by Subject|10|||
129828313|NCT01770379|467337280|FG002|Overall Study|Withdrawal by Subject|7|||
129828314|NCT01770379|467337278|FG000|Overall Study|study terminated by sponsor|22|||
129828315|NCT01770379|467337279|FG001|Overall Study|study terminated by sponsor|23|||
129828316|NCT01770379|467337280|FG002|Overall Study|study terminated by sponsor|22|||
129828317|NCT01770379|467337278|FG000|Overall Study|Protocol Violation|0|||
129828318|NCT01770379|467337279|FG001|Overall Study|Protocol Violation|1|||
129828319|NCT01770379|467337280|FG002|Overall Study|Protocol Violation|1|||
129828320|NCT01770379|467337278|FG000|Overall Study|Physician Decision|0|||
129828321|NCT01770379|467337279|FG001|Overall Study|Physician Decision|1|||
129828322|NCT01770379|467337280|FG002|Overall Study|Physician Decision|2|||
129828323|NCT01770379|467337278|FG000|Overall Study|Lost to Follow-up|0|||
129828324|NCT01770379|467337279|FG001|Overall Study|Lost to Follow-up|0|||
129828325|NCT01770379|467337280|FG002|Overall Study|Lost to Follow-up|2|||
129828326|NCT01770379|467337278|FG000|Overall Study|Lack of Efficacy|8|||
129828327|NCT01770379|467337279|FG001|Overall Study|Lack of Efficacy|6|||
129828328|NCT01770379|467337280|FG002|Overall Study|Lack of Efficacy|6|||
129828329|NCT01770379|467337278|FG000|Overall Study|Adverse Event|1|||
129828330|NCT01770379|467337279|FG001|Overall Study|Adverse Event|3|||
129828331|NCT01770379|467337280|FG002|Overall Study|Adverse Event|2|||
129828332|NCT03045887|467337281|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
129828333|NCT03045887|467337282|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828334|NCT03045887|467337283|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828335|NCT03045887|467337284|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828336|NCT03045887|467337285|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828337|NCT03045887|467337286|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828338|NCT03045887|467337287|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828339|NCT03045887|467337288|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828340|NCT03045887|467337289|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828341|NCT03045887|467337290|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
129828342|NCT03045887|467337281|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828343|NCT03045887|467337282|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828344|NCT03045887|467337283|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828345|NCT03045887|467337284|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
129828346|NCT03045887|467337285|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828347|NCT03045887|467337286|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828348|NCT03045887|467337287|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828349|NCT03045887|467337288|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828350|NCT03045887|467337289|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129828351|NCT03045887|467337290|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
129897675|NCT02524288|467584422|FG000|Overall Study|Pregnancy Wish|6|||
129897676|NCT02524288|467584422|FG000|Overall Study|Protocol Violation|6|||
129828352|NCT03045887|467337281|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
129828353|NCT03045887|467337282|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828354|NCT03045887|467337283|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828355|NCT03045887|467337284|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828356|NCT03045887|467337285|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828357|NCT03045887|467337286|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828358|NCT03045887|467337287|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828359|NCT03045887|467337288|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828360|NCT03045887|467337289|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828361|NCT03045887|467337290|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
129828362|NCT03045887|467337281|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828363|NCT03045887|467337282|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828364|NCT03045887|467337283|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
129828365|NCT03045887|467337284|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
129828366|NCT03045887|467337285|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828367|NCT03045887|467337286|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828368|NCT03045887|467337287|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828369|NCT03045887|467337288|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828370|NCT03045887|467337289|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828371|NCT03045887|467337290|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
129828372|NCT03045887|467337281|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828373|NCT03045887|467337282|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828374|NCT03045887|467337283|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828375|NCT03045887|467337284|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
129828376|NCT03045887|467337285|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828377|NCT03045887|467337286|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828378|NCT03045887|467337287|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828379|NCT03045887|467337288|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828380|NCT03045887|467337289|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828381|NCT03045887|467337290|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
129828382|NCT01912287|467337292|FG000|Overall Study|Ineligible|1|||
129828383|NCT01912287|467337293|FG001|Overall Study|Ineligible|0|||
129828384|NCT01912287|467337294|FG002|Overall Study|Ineligible|1|||
129828385|NCT01912287|467337292|FG000|Overall Study|No-show|0|||
129828386|NCT01912287|467337293|FG001|Overall Study|No-show|0|||
129828387|NCT01912287|467337294|FG002|Overall Study|No-show|1|||
129828388|NCT01912287|467337292|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
129828389|NCT01912287|467337293|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
129828390|NCT01912287|467337294|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
129828391|NCT01912287|467337292|FG000|Overall Study|Felt treatment no longer needed|0|||
129828392|NCT01912287|467337293|FG001|Overall Study|Felt treatment no longer needed|1|||
129828393|NCT01912287|467337294|FG002|Overall Study|Felt treatment no longer needed|0|||
129828394|NCT01912287|467337292|FG000|Overall Study|Life circumstances|4|||
129828395|NCT01912287|467337293|FG001|Overall Study|Life circumstances|2|||
129828396|NCT01912287|467337294|FG002|Overall Study|Life circumstances|0|||
129828397|NCT01912287|467337292|FG000|Overall Study|Lost Interest|1|||
129828398|NCT01912287|467337293|FG001|Overall Study|Lost Interest|0|||
129828399|NCT01912287|467337294|FG002|Overall Study|Lost Interest|0|||
129828400|NCT01912287|467337292|FG000|Overall Study|Uknown reason - subject drop out|5|||
129828401|NCT01912287|467337293|FG001|Overall Study|Uknown reason - subject drop out|7|||
129828402|NCT01912287|467337294|FG002|Overall Study|Uknown reason - subject drop out|3|||
129828403|NCT01912287|467337292|FG000|Overall Study|Missed Assesment|1|||
129828404|NCT01912287|467337293|FG001|Overall Study|Missed Assesment|1|||
129828405|NCT01912287|467337294|FG002|Overall Study|Missed Assesment|1|||
129828406|NCT01912287|467337292|FG000|Overall Study|Scheduling/change in availability|17|||
129828407|NCT01912287|467337293|FG001|Overall Study|Scheduling/change in availability|10|||
129828408|NCT01912287|467337294|FG002|Overall Study|Scheduling/change in availability|8|||
129828409|NCT03914326|467337297|FG000|Overall Study|Withdrawal by Subject|27|||
129828410|NCT03914326|467337298|FG001|Overall Study|Withdrawal by Subject|34|||
129828411|NCT03914326|467337297|FG000|Overall Study|Lost to Follow-up|43|||
129828412|NCT03914326|467337298|FG001|Overall Study|Lost to Follow-up|51|||
129828413|NCT03914326|467337297|FG000|Overall Study|Randomised more than once|0|||
129828414|NCT03914326|467337298|FG001|Overall Study|Randomised more than once|1|||
129828415|NCT03226392|467337303|FG000|Overall Study|Protocol Deviation|1|||
129828416|NCT03226392|467337304|FG001|Overall Study|Protocol Deviation|0|||
129828417|NCT03226392|467337303|FG000|Overall Study|Physician Decision|1|||
129828418|NCT03226392|467337304|FG001|Overall Study|Physician Decision|0|||
129828419|NCT03226392|467337303|FG000|Overall Study|Lost to Follow-up|1|||
129828420|NCT03226392|467337304|FG001|Overall Study|Lost to Follow-up|0|||
129828421|NCT03226392|467337303|FG000|Overall Study|Adverse Event|1|||
129828422|NCT03226392|467337304|FG001|Overall Study|Adverse Event|0|||
129828423|NCT03226392|467337303|FG000|Overall Study|Technical Problems|0|||
129828424|NCT03226392|467337304|FG001|Overall Study|Technical Problems|2|||
129828425|NCT03226392|467337303|FG000|Overall Study|Subject/Guardian Decision|7|||
129828426|NCT03226392|467337304|FG001|Overall Study|Subject/Guardian Decision|6|||
129828427|NCT04788953|467337305|FG000|Overall Study|Adverse Event|1|||
129828428|NCT04788953|467337306|FG001|Overall Study|Adverse Event|1|||
129828429|NCT04788953|467337305|FG000|Overall Study|Withdrawal by Subject|1|||
129828430|NCT04788953|467337306|FG001|Overall Study|Withdrawal by Subject|0|||
129828431|NCT04788953|467337305|FG000|Overall Study|Protocol Violation|0|||
129828432|NCT04788953|467337306|FG001|Overall Study|Protocol Violation|1|||
129828433|NCT00937157|467337307|FG000|Overall Study|Pregnancy|1|||
129828434|NCT00937157|467337307|FG000|Overall Study|Lost to Follow-up|3|||
129828435|NCT00469092|467337308|FG000|Overall Study|Adverse Event|5|||
129828436|NCT00469092|467337309|FG001|Overall Study|Adverse Event|4|||
129828437|NCT00469092|467337308|FG000|Overall Study|Lack of Efficacy|1|||
129828438|NCT00469092|467337309|FG001|Overall Study|Lack of Efficacy|0|||
129828439|NCT00469092|467337308|FG000|Overall Study|Lost to Follow-up|1|||
129828440|NCT00469092|467337309|FG001|Overall Study|Lost to Follow-up|2|||
129828441|NCT00469092|467337308|FG000|Overall Study|Protocol Violation|3|||
129828442|NCT00469092|467337309|FG001|Overall Study|Protocol Violation|3|||
129828443|NCT00469092|467337308|FG000|Overall Study|Withdrawal by Subject|4|||
129828444|NCT00469092|467337309|FG001|Overall Study|Withdrawal by Subject|4|||
129828445|NCT00469092|467337308|FG000|Overall Study|Withdrawal Criteria|3|||
129828446|NCT00469092|467337309|FG001|Overall Study|Withdrawal Criteria|4|||
129828447|NCT00469092|467337308|FG000|Overall Study|Incorrectly Randomised|4|||
129828448|NCT00469092|467337309|FG001|Overall Study|Incorrectly Randomised|3|||
129828449|NCT00469092|467337308|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
129828450|NCT00469092|467337309|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
129828451|NCT00469092|467337308|FG000|Overall Study|Use of lipid lowering drug|1|||
129828452|NCT00469092|467337309|FG001|Overall Study|Use of lipid lowering drug|0|||
129828453|NCT00469092|467337308|FG000|Overall Study|Hypoglycaemic Episodes|1|||
129828454|NCT00469092|467337309|FG001|Overall Study|Hypoglycaemic Episodes|1|||
129828455|NCT00469092|467337308|FG000|Overall Study|Abnormal lab value|1|||
129828456|NCT00469092|467337309|FG001|Overall Study|Abnormal lab value|0|||
129828457|NCT00469092|467337308|FG000|Overall Study|Use of Corticosteroid|1|||
129828458|NCT00469092|467337309|FG001|Overall Study|Use of Corticosteroid|0|||
129828459|NCT02024867|467337310|FG000|Overall Study|Protocol Violation|3|||
129828460|NCT02024867|467337311|FG001|Overall Study|Protocol Violation|3|||
129828461|NCT02024867|467337310|FG000|Overall Study|Lost to Follow-up|6|||
129828462|NCT02024867|467337311|FG001|Overall Study|Lost to Follow-up|4|||
129828463|NCT01998633|467337313|FG000|Overall Study|Death|1|||
129828464|NCT00413192|467337314|FG000|Overall Study|Disease progression|26|||
129828465|NCT00413192|467337315|FG001|Overall Study|Disease progression|31|||
129828466|NCT00413192|467337316|FG002|Overall Study|Disease progression|16|||
129828467|NCT00413192|467337317|FG003|Overall Study|Disease progression|25|||
129828468|NCT00413192|467337314|FG000|Overall Study|Toxicity|3|||
129828469|NCT00413192|467337315|FG001|Overall Study|Toxicity|2|||
129828470|NCT00413192|467337316|FG002|Overall Study|Toxicity|2|||
129828471|NCT00413192|467337317|FG003|Overall Study|Toxicity|2|||
129828472|NCT00413192|467337314|FG000|Overall Study|Withdrawal by Subject|3|||
129828473|NCT00413192|467337315|FG001|Overall Study|Withdrawal by Subject|5|||
129828474|NCT00413192|467337316|FG002|Overall Study|Withdrawal by Subject|0|||
129828475|NCT00413192|467337317|FG003|Overall Study|Withdrawal by Subject|1|||
129828476|NCT00413192|467337314|FG000|Overall Study|Intercurrent illness|0|||
129828477|NCT00413192|467337315|FG001|Overall Study|Intercurrent illness|0|||
129828478|NCT00413192|467337316|FG002|Overall Study|Intercurrent illness|0|||
129828479|NCT00413192|467337317|FG003|Overall Study|Intercurrent illness|1|||
129828480|NCT00413192|467337314|FG000|Overall Study|Intercurrent death|0|||
129828481|NCT00413192|467337315|FG001|Overall Study|Intercurrent death|1|||
129828482|NCT00413192|467337316|FG002|Overall Study|Intercurrent death|0|||
129828483|NCT00413192|467337317|FG003|Overall Study|Intercurrent death|0|||
129828484|NCT00413192|467337314|FG000|Overall Study|Other|5|||
129828485|NCT00413192|467337315|FG001|Overall Study|Other|1|||
129828486|NCT00413192|467337316|FG002|Overall Study|Other|1|||
129828487|NCT00413192|467337317|FG003|Overall Study|Other|2|||
129828488|NCT00413192|467337314|FG000|Overall Study|Not treated|0|||
129828489|NCT00413192|467337315|FG001|Overall Study|Not treated|0|||
129828490|NCT00413192|467337316|FG002|Overall Study|Not treated|0|||
129828491|NCT00413192|467337317|FG003|Overall Study|Not treated|1|||
129828492|NCT02631850|467337318|FG000|Treatment Period|Lost to Follow-up|0|||
129828493|NCT02631850|467337319|FG001|Treatment Period|Lost to Follow-up|1|||
129828494|NCT02631850|467337320|FG002|Treatment Period|Lost to Follow-up|0|||
129828495|NCT02631850|467337321|FG003|Treatment Period|Lost to Follow-up|0|||
129828496|NCT02631850|467337318|FG000|Treatment Period|Protocol Violation|1|||
129828497|NCT02631850|467337319|FG001|Treatment Period|Protocol Violation|0|||
129828498|NCT02631850|467337320|FG002|Treatment Period|Protocol Violation|0|||
129828499|NCT02631850|467337321|FG003|Treatment Period|Protocol Violation|0|||
129828500|NCT02631850|467337318|FG000|Treatment Period|Withdrawal by Subject|0|||
129828501|NCT02631850|467337319|FG001|Treatment Period|Withdrawal by Subject|5|||
129828502|NCT02631850|467337320|FG002|Treatment Period|Withdrawal by Subject|2|||
129828503|NCT02631850|467337321|FG003|Treatment Period|Withdrawal by Subject|2|||
129828504|NCT02631850|467337318|FG000|Treatment Period|Adverse Event|1|||
129828505|NCT02631850|467337319|FG001|Treatment Period|Adverse Event|0|||
129828506|NCT02631850|467337320|FG002|Treatment Period|Adverse Event|2|||
129828507|NCT02631850|467337321|FG003|Treatment Period|Adverse Event|3|||
129828508|NCT02631850|467337318|FG000|Treatment Period|Family medical issue|1|||
129828509|NCT02631850|467337319|FG001|Treatment Period|Family medical issue|0|||
129828510|NCT02631850|467337320|FG002|Treatment Period|Family medical issue|0|||
129828511|NCT02631850|467337321|FG003|Treatment Period|Family medical issue|0|||
129828512|NCT02631850|467337318|FG000|6 Month Follow up|Lost to Follow-up|5|||
129828513|NCT02631850|467337319|FG001|6 Month Follow up|Lost to Follow-up|8|||
129828514|NCT02631850|467337320|FG002|6 Month Follow up|Lost to Follow-up|3|||
129828515|NCT02631850|467337321|FG003|6 Month Follow up|Lost to Follow-up|5|||
129828516|NCT02631850|467337318|FG000|6 Month Follow up|Withdrawal by Subject|1|||
129828517|NCT02631850|467337319|FG001|6 Month Follow up|Withdrawal by Subject|0|||
129828518|NCT02631850|467337320|FG002|6 Month Follow up|Withdrawal by Subject|0|||
129828519|NCT02631850|467337321|FG003|6 Month Follow up|Withdrawal by Subject|2|||
129828520|NCT02631850|467337318|FG000|6 Month Follow up|Adverse Event|1|||
129828521|NCT02631850|467337319|FG001|6 Month Follow up|Adverse Event|4|||
129828522|NCT02631850|467337320|FG002|6 Month Follow up|Adverse Event|1|||
129828523|NCT02631850|467337321|FG003|6 Month Follow up|Adverse Event|3|||
129828524|NCT02631850|467337318|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
129828525|NCT02631850|467337319|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
129828526|NCT02631850|467337320|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
129828527|NCT02631850|467337321|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
129828528|NCT03992781|467337324|FG000|Overall Study|Lost to Follow-up|5|||
129828529|NCT03992781|467337324|FG000|Overall Study|Adverse Event|1|||
129828530|NCT03992781|467337324|FG000|Overall Study|Lack of Efficacy|5|||
129828531|NCT02118012|467337325|FG000|Overall Study|Adverse Event|0|||
129828532|NCT02118012|467337326|FG001|Overall Study|Adverse Event|1|||
129828533|NCT02118012|467337325|FG000|Overall Study|Physician Decision|0|||
129828534|NCT02118012|467337326|FG001|Overall Study|Physician Decision|1|||
129828535|NCT00171223|467337327|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
129828536|NCT00171223|467337328|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
129828537|NCT00171223|467337329|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
129828538|NCT00171223|467337327|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
129828539|NCT00171223|467337328|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
129445719|NCT01968070|465932886|FG011|Period 2|Withdrawal by Subject|0|||
129828540|NCT00171223|467337329|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
129828541|NCT00171223|467337327|FG000|Overall Study|Abnormal Procedure|1|||
129828542|NCT00171223|467337328|FG001|Overall Study|Abnormal Procedure|0|||
129828543|NCT00171223|467337329|FG002|Overall Study|Abnormal Procedure|0|||
129828544|NCT00171223|467337327|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
129828545|NCT00171223|467337328|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
129828546|NCT00171223|467337329|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
129828547|NCT00171223|467337327|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
129828548|NCT00171223|467337328|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
129828549|NCT00171223|467337329|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
129828550|NCT00171223|467337327|FG000|Overall Study|Protocol Violation|2|||
129828551|NCT00171223|467337328|FG001|Overall Study|Protocol Violation|2|||
129828552|NCT00171223|467337329|FG002|Overall Study|Protocol Violation|3|||
129828553|NCT00171223|467337327|FG000|Overall Study|Participant Withdrew Consent|12|||
129828554|NCT00171223|467337328|FG001|Overall Study|Participant Withdrew Consent|21|||
129828555|NCT00171223|467337329|FG002|Overall Study|Participant Withdrew Consent|15|||
129828556|NCT00171223|467337327|FG000|Overall Study|Lost to Follow-up|5|||
129828557|NCT00171223|467337328|FG001|Overall Study|Lost to Follow-up|2|||
129828558|NCT00171223|467337329|FG002|Overall Study|Lost to Follow-up|3|||
129828559|NCT00171223|467337327|FG000|Overall Study|Administrative Problems|4|||
129828560|NCT00171223|467337328|FG001|Overall Study|Administrative Problems|7|||
129828561|NCT00171223|467337329|FG002|Overall Study|Administrative Problems|6|||
129828562|NCT00171223|467337327|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
129445720|NCT01968070|465932887|FG012|Period 2|Withdrawal by Subject|0|||
129828563|NCT00171223|467337328|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
129828564|NCT00171223|467337329|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
129828565|NCT00171223|467337327|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
129828566|NCT00171223|467337328|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
129828567|NCT00171223|467337329|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
129828568|NCT00455429|467337330|FG000|Overall Study|Study Terminated by Sponsor|0|||
129828569|NCT00455429|467337331|FG001|Overall Study|Study Terminated by Sponsor|0|||
129828570|NCT00455429|467337332|FG002|Overall Study|Study Terminated by Sponsor|0|||
129828571|NCT00455429|467337333|FG003|Overall Study|Study Terminated by Sponsor|3|||
129828572|NCT00455429|467337330|FG000|Overall Study|Lost to Follow-up|1|||
129828573|NCT00455429|467337331|FG001|Overall Study|Lost to Follow-up|0|||
129828574|NCT00455429|467337332|FG002|Overall Study|Lost to Follow-up|0|||
129828575|NCT00455429|467337333|FG003|Overall Study|Lost to Follow-up|3|||
129828576|NCT00455429|467337330|FG000|Overall Study|Withdrawal by Subject|0|||
129828577|NCT00455429|467337331|FG001|Overall Study|Withdrawal by Subject|1|||
129828578|NCT00455429|467337332|FG002|Overall Study|Withdrawal by Subject|1|||
129828579|NCT00455429|467337333|FG003|Overall Study|Withdrawal by Subject|0|||
129828580|NCT00455429|467337330|FG000|Overall Study|Lack of Efficacy|0|||
129828581|NCT00455429|467337331|FG001|Overall Study|Lack of Efficacy|1|||
129828582|NCT00455429|467337332|FG002|Overall Study|Lack of Efficacy|0|||
129828583|NCT00455429|467337333|FG003|Overall Study|Lack of Efficacy|1|||
129828584|NCT00455429|467337330|FG000|Overall Study|Adverse Event|0|||
129828585|NCT00455429|467337331|FG001|Overall Study|Adverse Event|1|||
129828586|NCT00455429|467337332|FG002|Overall Study|Adverse Event|0|||
129828587|NCT00455429|467337333|FG003|Overall Study|Adverse Event|3|||
129828588|NCT00455429|467337330|FG000|Overall Study|Randomly assigned but not treated|0|||
129828589|NCT00455429|467337331|FG001|Overall Study|Randomly assigned but not treated|0|||
129828590|NCT00455429|467337332|FG002|Overall Study|Randomly assigned but not treated|0|||
129828591|NCT00455429|467337333|FG003|Overall Study|Randomly assigned but not treated|2|||
129828592|NCT00455429|467337330|FG000|Overall Study|Personal Reason|1|||
129828593|NCT00455429|467337331|FG001|Overall Study|Personal Reason|0|||
129828594|NCT00455429|467337332|FG002|Overall Study|Personal Reason|0|||
129828595|NCT00455429|467337333|FG003|Overall Study|Personal Reason|0|||
129828596|NCT00455429|467337330|FG000|Overall Study|Non-compliance|0|||
129828597|NCT00455429|467337331|FG001|Overall Study|Non-compliance|0|||
129828598|NCT00455429|467337332|FG002|Overall Study|Non-compliance|0|||
129828599|NCT00455429|467337333|FG003|Overall Study|Non-compliance|1|||
129828600|NCT00455429|467337330|FG000|Overall Study|Other|0|||
129828601|NCT00455429|467337331|FG001|Overall Study|Other|2|||
129828602|NCT00455429|467337332|FG002|Overall Study|Other|0|||
129828603|NCT00455429|467337333|FG003|Overall Study|Other|1|||
129828604|NCT01165554|467337334|FG000|Overall Study|Withdrawal by Subject|23|||
129828605|NCT02951156|467337341|FG000|Overall Study|Death|3|||
129828606|NCT02951156|467337342|FG001|Overall Study|Death|8|||
129828607|NCT02951156|467337343|FG002|Overall Study|Death|5|||
129828608|NCT02951156|467337341|FG000|Overall Study|Progressive disease|1|||
129828609|NCT02951156|467337342|FG001|Overall Study|Progressive disease|0|||
129828610|NCT02951156|467337343|FG002|Overall Study|Progressive disease|1|||
129828611|NCT02951156|467337341|FG000|Overall Study|Withdrawal by Subject|0|||
129828612|NCT02951156|467337342|FG001|Overall Study|Withdrawal by Subject|0|||
129828613|NCT02951156|467337343|FG002|Overall Study|Withdrawal by Subject|1|||
129828614|NCT02951156|467337341|FG000|Overall Study|Study terminated by sponsor|0|||
129828615|NCT02951156|467337342|FG001|Overall Study|Study terminated by sponsor|0|||
129828616|NCT02951156|467337343|FG002|Overall Study|Study terminated by sponsor|1|||
129828617|NCT02951156|467337341|FG000|Overall Study|Other|5|||
129828618|NCT02951156|467337342|FG001|Overall Study|Other|1|||
129828619|NCT02951156|467337343|FG002|Overall Study|Other|2|||
129828620|NCT04351087|467337344|FG000|Overall Study|Lost to Follow-up|7|||
129828621|NCT04351087|467337345|FG001|Overall Study|Lost to Follow-up|3|||
129828622|NCT04351087|467337344|FG000|Overall Study|Withdrawal by Subject|3|||
129828623|NCT04351087|467337345|FG001|Overall Study|Withdrawal by Subject|4|||
129828624|NCT04351087|467337344|FG000|Overall Study|Lack of Efficacy|3|||
129828625|NCT04351087|467337345|FG001|Overall Study|Lack of Efficacy|2|||
129828626|NCT01603459|467337348|FG000|Overall Study|Adverse Event|5|||
129828627|NCT01603459|467337348|FG000|Overall Study|Withdrawal by Subject|5|||
129828628|NCT01603459|467337348|FG000|Overall Study|Lost to Follow-up|3|||
129828629|NCT01603459|467337348|FG000|Overall Study|Predefined discontinuation criteria|3|||
129828630|NCT01603459|467337348|FG000|Overall Study|Non-compliance|1|||
129828631|NCT01603459|467337348|FG000|Overall Study|Administrative reason|1|||
129828632|NCT03519347|467337351|FG000|Interventional Crossover Period 1|Death|0|||
129897677|NCT02524288|467584422|FG000|Overall Study|Screen Failure|2|||
129828633|NCT03519347|467337352|FG001|Interventional Crossover Period 1|Death|0|||
129828634|NCT03519347|467337353|FG002|Interventional Crossover Period 1|Death|0|||
129828635|NCT03519347|467337354|FG003|Interventional Crossover Period 1|Death|1|||
129828636|NCT05517382|467337355|FG000|Overall Study|Lost to Follow-up|0|||
129828637|NCT05517382|467337356|FG001|Overall Study|Lost to Follow-up|1|||
129828638|NCT01641692|467337357|FG000|Treatment Period 1|Adverse Event|1|||
129828639|NCT01641692|467337358|FG001|Treatment Period 1|Adverse Event|0|||
129828640|NCT01641692|467337359|FG002|Treatment Period 1|Adverse Event|0|||
129828641|NCT01641692|467337360|FG003|Treatment Period 1|Adverse Event|0|||
129828642|NCT01641692|467337361|FG004|Treatment Period 1|Adverse Event|0|||
129828643|NCT01641692|467337362|FG005|Treatment Period 1|Adverse Event|0|||
129828644|NCT01641692|467337363|FG006|Treatment Period 1|Adverse Event|0|||
129828645|NCT01641692|467337364|FG007|Treatment Period 1|Adverse Event|0|||
129897678|NCT02524288|467584422|FG000|Overall Study|Site Discontinued Study Participation|1|||
129828646|NCT01641692|467337357|FG000|Treatment Period 1|Lack of Efficacy|0|||
129828647|NCT01641692|467337358|FG001|Treatment Period 1|Lack of Efficacy|0|||
129828648|NCT01641692|467337359|FG002|Treatment Period 1|Lack of Efficacy|0|||
129828649|NCT01641692|467337360|FG003|Treatment Period 1|Lack of Efficacy|0|||
129828650|NCT01641692|467337361|FG004|Treatment Period 1|Lack of Efficacy|0|||
129828651|NCT01641692|467337362|FG005|Treatment Period 1|Lack of Efficacy|0|||
129828652|NCT01641692|467337363|FG006|Treatment Period 1|Lack of Efficacy|0|||
129828653|NCT01641692|467337364|FG007|Treatment Period 1|Lack of Efficacy|1|||
129828654|NCT01641692|467337357|FG000|Treatment Period 1|Protocol Violation|1|||
129828655|NCT01641692|467337358|FG001|Treatment Period 1|Protocol Violation|0|||
129828656|NCT01641692|467337359|FG002|Treatment Period 1|Protocol Violation|0|||
129828657|NCT01641692|467337360|FG003|Treatment Period 1|Protocol Violation|0|||
129828658|NCT01641692|467337361|FG004|Treatment Period 1|Protocol Violation|2|||
129828659|NCT01641692|467337362|FG005|Treatment Period 1|Protocol Violation|0|||
129828660|NCT01641692|467337363|FG006|Treatment Period 1|Protocol Violation|0|||
129828661|NCT01641692|467337364|FG007|Treatment Period 1|Protocol Violation|0|||
129828662|NCT01641692|467337357|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828663|NCT01641692|467337358|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828664|NCT01641692|467337359|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828665|NCT01641692|467337360|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828666|NCT01641692|467337361|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
129828667|NCT01641692|467337362|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828668|NCT01641692|467337363|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
129828669|NCT01641692|467337364|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
129828670|NCT01641692|467337357|FG000|Treatment Period 1|Lost to Follow-up|0|||
129828671|NCT01641692|467337358|FG001|Treatment Period 1|Lost to Follow-up|0|||
129828672|NCT01641692|467337359|FG002|Treatment Period 1|Lost to Follow-up|1|||
129828673|NCT01641692|467337360|FG003|Treatment Period 1|Lost to Follow-up|0|||
129828674|NCT01641692|467337361|FG004|Treatment Period 1|Lost to Follow-up|0|||
129828675|NCT01641692|467337362|FG005|Treatment Period 1|Lost to Follow-up|0|||
129828676|NCT01641692|467337363|FG006|Treatment Period 1|Lost to Follow-up|0|||
129828677|NCT01641692|467337364|FG007|Treatment Period 1|Lost to Follow-up|0|||
129828678|NCT01641692|467337357|FG000|Treatment Period 1|Physician Decision|0|||
129828679|NCT01641692|467337358|FG001|Treatment Period 1|Physician Decision|0|||
129828680|NCT01641692|467337359|FG002|Treatment Period 1|Physician Decision|0|||
129828681|NCT01641692|467337360|FG003|Treatment Period 1|Physician Decision|0|||
129828682|NCT01641692|467337361|FG004|Treatment Period 1|Physician Decision|1|||
129828683|NCT01641692|467337362|FG005|Treatment Period 1|Physician Decision|0|||
129828684|NCT01641692|467337363|FG006|Treatment Period 1|Physician Decision|0|||
129828685|NCT01641692|467337364|FG007|Treatment Period 1|Physician Decision|0|||
129828686|NCT01641692|467337357|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129828687|NCT01641692|467337358|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129828688|NCT01641692|467337359|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129828689|NCT01641692|467337360|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129828690|NCT01641692|467337361|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129828691|NCT01641692|467337362|FG005|Treatment Period 1|Withdrawal by Subject|2|||
129828692|NCT01641692|467337363|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129828693|NCT01641692|467337364|FG007|Treatment Period 1|Withdrawal by Subject|1|||
129828694|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
129828695|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828696|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828697|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828698|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828699|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828700|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828701|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
129828702|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828703|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828704|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828705|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828706|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828707|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828708|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
129828709|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129828710|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828711|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828712|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
129828713|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828714|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
129828715|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828716|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828717|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828718|NCT01641692|467337357|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828719|NCT01641692|467337358|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828720|NCT01641692|467337359|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129828721|NCT01641692|467337360|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828722|NCT01641692|467337361|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828723|NCT01641692|467337362|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129828724|NCT01641692|467337363|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129828725|NCT01641692|467337364|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129828726|NCT01641692|467337357|FG000|Treatment Period 2|Lack of Efficacy|1|||
129828727|NCT01641692|467337358|FG001|Treatment Period 2|Lack of Efficacy|0|||
129828728|NCT01641692|467337359|FG002|Treatment Period 2|Lack of Efficacy|0|||
129828729|NCT01641692|467337360|FG003|Treatment Period 2|Lack of Efficacy|0|||
129828730|NCT01641692|467337361|FG004|Treatment Period 2|Lack of Efficacy|0|||
129828731|NCT01641692|467337362|FG005|Treatment Period 2|Lack of Efficacy|0|||
129828732|NCT01641692|467337363|FG006|Treatment Period 2|Lack of Efficacy|0|||
129828733|NCT01641692|467337364|FG007|Treatment Period 2|Lack of Efficacy|0|||
129828734|NCT01641692|467337357|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
129828735|NCT01641692|467337358|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828736|NCT01641692|467337359|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828737|NCT01641692|467337360|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828738|NCT01641692|467337361|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828739|NCT01641692|467337362|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828740|NCT01641692|467337363|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828741|NCT01641692|467337364|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
129828742|NCT01641692|467337357|FG000|Treatment Period 2|Lost to Follow-up|0|||
129828743|NCT01641692|467337358|FG001|Treatment Period 2|Lost to Follow-up|0|||
129828744|NCT01641692|467337359|FG002|Treatment Period 2|Lost to Follow-up|0|||
129828745|NCT01641692|467337360|FG003|Treatment Period 2|Lost to Follow-up|0|||
129828746|NCT01641692|467337361|FG004|Treatment Period 2|Lost to Follow-up|0|||
129828747|NCT01641692|467337362|FG005|Treatment Period 2|Lost to Follow-up|1|||
129828748|NCT01641692|467337363|FG006|Treatment Period 2|Lost to Follow-up|0|||
129828749|NCT01641692|467337364|FG007|Treatment Period 2|Lost to Follow-up|0|||
129828750|NCT01641692|467337357|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129828751|NCT01641692|467337358|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129828752|NCT01641692|467337359|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129828753|NCT01641692|467337360|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129828754|NCT01641692|467337361|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129828755|NCT01641692|467337362|FG005|Treatment Period 2|Withdrawal by Subject|1|||
129828756|NCT01641692|467337363|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129828757|NCT01641692|467337364|FG007|Treatment Period 2|Withdrawal by Subject|1|||
129828758|NCT01641692|467337357|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828759|NCT01641692|467337358|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828760|NCT01641692|467337359|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828761|NCT01641692|467337360|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828762|NCT01641692|467337361|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
129828763|NCT01641692|467337362|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828764|NCT01641692|467337363|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
129828765|NCT01641692|467337364|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
129828766|NCT01641692|467337357|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828767|NCT01641692|467337358|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828768|NCT01641692|467337359|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129828769|NCT01641692|467337360|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828770|NCT01641692|467337361|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828771|NCT01641692|467337362|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129828772|NCT01641692|467337363|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129828773|NCT01641692|467337364|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129828774|NCT01641692|467337357|FG000|Treatment Period 3|Adverse Event|0|||
129828775|NCT01641692|467337358|FG001|Treatment Period 3|Adverse Event|0|||
129828776|NCT01641692|467337359|FG002|Treatment Period 3|Adverse Event|0|||
129828777|NCT01641692|467337360|FG003|Treatment Period 3|Adverse Event|0|||
129828778|NCT01641692|467337361|FG004|Treatment Period 3|Adverse Event|0|||
129828779|NCT01641692|467337362|FG005|Treatment Period 3|Adverse Event|0|||
129828780|NCT01641692|467337363|FG006|Treatment Period 3|Adverse Event|1|||
129828781|NCT01641692|467337364|FG007|Treatment Period 3|Adverse Event|0|||
129828782|NCT01641692|467337357|FG000|Treatment Period 3|Protocol Violation|0|||
129828783|NCT01641692|467337358|FG001|Treatment Period 3|Protocol Violation|0|||
129828784|NCT01641692|467337359|FG002|Treatment Period 3|Protocol Violation|1|||
129828785|NCT01641692|467337360|FG003|Treatment Period 3|Protocol Violation|0|||
129828786|NCT01641692|467337361|FG004|Treatment Period 3|Protocol Violation|0|||
129828787|NCT01641692|467337362|FG005|Treatment Period 3|Protocol Violation|0|||
129828788|NCT01641692|467337363|FG006|Treatment Period 3|Protocol Violation|0|||
129828789|NCT01641692|467337364|FG007|Treatment Period 3|Protocol Violation|0|||
129828790|NCT01641692|467337357|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828791|NCT01641692|467337358|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828792|NCT01641692|467337359|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828793|NCT01641692|467337360|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828794|NCT01641692|467337361|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828795|NCT01641692|467337362|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828796|NCT01641692|467337363|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
129828797|NCT01641692|467337364|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
129828798|NCT01641692|467337357|FG000|Treatment Period 3|Lost to Follow-up|0|||
129828799|NCT01641692|467337358|FG001|Treatment Period 3|Lost to Follow-up|1|||
129828800|NCT01641692|467337359|FG002|Treatment Period 3|Lost to Follow-up|0|||
129828801|NCT01641692|467337360|FG003|Treatment Period 3|Lost to Follow-up|0|||
129828802|NCT01641692|467337361|FG004|Treatment Period 3|Lost to Follow-up|0|||
129828803|NCT01641692|467337362|FG005|Treatment Period 3|Lost to Follow-up|0|||
129828804|NCT01641692|467337363|FG006|Treatment Period 3|Lost to Follow-up|0|||
129828805|NCT01641692|467337364|FG007|Treatment Period 3|Lost to Follow-up|0|||
129828806|NCT01641692|467337357|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828807|NCT01641692|467337358|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828808|NCT01641692|467337359|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828809|NCT01641692|467337360|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828810|NCT01641692|467337361|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828811|NCT01641692|467337362|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
129828812|NCT01641692|467337363|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828813|NCT01641692|467337364|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
129828814|NCT01641692|467337357|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828815|NCT01641692|467337358|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
129828816|NCT01641692|467337359|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828817|NCT01641692|467337360|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828818|NCT01641692|467337361|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
129828819|NCT01641692|467337362|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828820|NCT01641692|467337363|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
129828821|NCT01641692|467337364|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
129828822|NCT04948450|467337369|FG000|Overall Study|Return home|1|||
129828823|NCT04948450|467337370|FG001|Overall Study|Return home|3|||
129828824|NCT05198843|467337373|FG000|Overall Study|Lack of Efficacy|1|||
129828825|NCT01721330|467337374|FG000|Overall Study|Withdrawal by Subject|0|||
129828826|NCT01721330|467337375|FG001|Overall Study|Withdrawal by Subject|1|||
129828827|NCT00296374|467337376|FG000|Overall Study|Adverse Event|14|||
129828828|NCT00296374|467337377|FG001|Overall Study|Adverse Event|10|||
129828829|NCT00296374|467337378|FG002|Overall Study|Adverse Event|7|||
129828830|NCT00296374|467337376|FG000|Overall Study|Withdrawal by Subject|3|||
129828831|NCT00296374|467337377|FG001|Overall Study|Withdrawal by Subject|5|||
129828832|NCT00296374|467337378|FG002|Overall Study|Withdrawal by Subject|11|||
129828833|NCT00296374|467337376|FG000|Overall Study|Incorrect enrollment|3|||
129828834|NCT00296374|467337377|FG001|Overall Study|Incorrect enrollment|3|||
129828835|NCT00296374|467337378|FG002|Overall Study|Incorrect enrollment|4|||
129828836|NCT00296374|467337376|FG000|Overall Study|Protocol Violation|1|||
129828837|NCT00296374|467337377|FG001|Overall Study|Protocol Violation|2|||
129828838|NCT00296374|467337378|FG002|Overall Study|Protocol Violation|3|||
129828839|NCT00296374|467337376|FG000|Overall Study|Lost to Follow-up|3|||
129828840|NCT00296374|467337377|FG001|Overall Study|Lost to Follow-up|1|||
129828841|NCT00296374|467337378|FG002|Overall Study|Lost to Follow-up|1|||
129828842|NCT00296374|467337376|FG000|Overall Study|Relocated to another state|1|||
129828843|NCT00296374|467337377|FG001|Overall Study|Relocated to another state|0|||
129445721|NCT01968070|465932888|FG013|Period 2|Withdrawal by Subject|0|||
129445722|NCT01968070|465932889|FG014|Period 2|Withdrawal by Subject|0|||
129828844|NCT00296374|467337378|FG002|Overall Study|Relocated to another state|0|||
129828845|NCT00296374|467337376|FG000|Overall Study|Stopped drug before end of study visit|0|||
129828846|NCT00296374|467337377|FG001|Overall Study|Stopped drug before end of study visit|1|||
129828847|NCT00296374|467337378|FG002|Overall Study|Stopped drug before end of study visit|0|||
129828848|NCT00296374|467337376|FG000|Overall Study|Nephrologist introduced ACE|0|||
129828849|NCT00296374|467337377|FG001|Overall Study|Nephrologist introduced ACE|1|||
129828850|NCT00296374|467337378|FG002|Overall Study|Nephrologist introduced ACE|0|||
129828851|NCT00296374|467337376|FG000|Overall Study|Pregnancy|0|||
129828852|NCT00296374|467337377|FG001|Overall Study|Pregnancy|0|||
129828853|NCT00296374|467337378|FG002|Overall Study|Pregnancy|2|||
129828854|NCT00296374|467337376|FG000|Overall Study|Other|0|||
129828855|NCT00296374|467337377|FG001|Overall Study|Other|0|||
129828856|NCT00296374|467337378|FG002|Overall Study|Other|1|||
129828857|NCT01786629|467338819|FG000|Overall Study|Lack of Efficacy|0|||
129828858|NCT01786629|467338820|FG001|Overall Study|Lack of Efficacy|4|||
129828859|NCT01786629|467338819|FG000|Overall Study|Adverse Event|0|||
129828860|NCT01786629|467338820|FG001|Overall Study|Adverse Event|1|||
129828861|NCT02750592|467338825|FG000|Overall Study|Adverse Event|3|||
129828862|NCT02750592|467338825|FG000|Overall Study|Lack of Efficacy|2|||
129828863|NCT02981342|467338828|FG000|Overall Study|Adverse Event|0|||
129828864|NCT02981342|467338829|FG001|Overall Study|Adverse Event|0|||
129828865|NCT02981342|467338830|FG002|Overall Study|Adverse Event|0|||
129828866|NCT02981342|467338831|FG003|Overall Study|Adverse Event|1|||
129828867|NCT02981342|467338828|FG000|Overall Study|Death|0|||
129828868|NCT02981342|467338829|FG001|Overall Study|Death|9|||
129828869|NCT02981342|467338830|FG002|Overall Study|Death|9|||
129828870|NCT02981342|467338831|FG003|Overall Study|Death|4|||
129828871|NCT02981342|467338828|FG000|Overall Study|Withdrawal by Subject|0|||
129828872|NCT02981342|467338829|FG001|Overall Study|Withdrawal by Subject|0|||
129828873|NCT02981342|467338830|FG002|Overall Study|Withdrawal by Subject|3|||
129828874|NCT02981342|467338831|FG003|Overall Study|Withdrawal by Subject|1|||
129828875|NCT02981342|467338828|FG000|Overall Study|Study closed by sponsor|0|||
129828876|NCT02981342|467338829|FG001|Overall Study|Study closed by sponsor|0|||
129828877|NCT02981342|467338830|FG002|Overall Study|Study closed by sponsor|1|||
129828878|NCT02981342|467338831|FG003|Overall Study|Study closed by sponsor|1|||
129828879|NCT02981342|467338828|FG000|Overall Study|Randomized, Never Treated|0|||
129828880|NCT02981342|467338829|FG001|Overall Study|Randomized, Never Treated|1|||
129828881|NCT02981342|467338830|FG002|Overall Study|Randomized, Never Treated|0|||
129828882|NCT02981342|467338831|FG003|Overall Study|Randomized, Never Treated|7|||
129828883|NCT02981342|467338828|FG000|Overall Study|Lost to Follow-up|0|||
129828884|NCT02981342|467338829|FG001|Overall Study|Lost to Follow-up|1|||
129828885|NCT02981342|467338830|FG002|Overall Study|Lost to Follow-up|0|||
129828886|NCT02981342|467338831|FG003|Overall Study|Lost to Follow-up|0|||
129828887|NCT05333900|467338832|FG000|Overall Study|Protocol Violation|0|||
129828888|NCT05333900|467338833|FG001|Overall Study|Protocol Violation|1|||
129828889|NCT05333900|467338832|FG000|Overall Study|Withdrawal by Subject|0|||
129828890|NCT05333900|467338833|FG001|Overall Study|Withdrawal by Subject|1|||
129828891|NCT05333900|467338832|FG000|Overall Study|COVID-19 Pandemic|1|||
129897679|NCT02524288|467584422|FG000|Overall Study|Study Terminated By Sponsor|1417|||
129828892|NCT05333900|467338833|FG001|Overall Study|COVID-19 Pandemic|1|||
129828893|NCT01394523|467338836|FG000|Overall Study|Unable to place block|1|||
129828894|NCT01394523|467338837|FG001|Overall Study|Unable to place block|0|||
129828895|NCT01394523|467338838|FG002|Overall Study|Unable to place block|0|||
129828896|NCT02389998|467338839|FG000|Overall Study|car accident|1|||
129828897|NCT02389998|467338840|FG001|Overall Study|car accident|0|||
129828898|NCT03525574|467338841|FG000|Overall Study|Adverse Event|15|||
129828899|NCT03525574|467338842|FG001|Overall Study|Adverse Event|0|||
129828900|NCT03525574|467338841|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
129828901|NCT03525574|467338842|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129828902|NCT03525574|467338841|FG000|Overall Study|Lost to Follow-up|4|||
129828903|NCT03525574|467338842|FG001|Overall Study|Lost to Follow-up|0|||
129828904|NCT03525574|467338841|FG000|Overall Study|Commercial drug is Available for participant|48|||
129828905|NCT03525574|467338842|FG001|Overall Study|Commercial drug is Available for participant|0|||
129828906|NCT03525574|467338841|FG000|Overall Study|Death|1|||
129828907|NCT03525574|467338842|FG001|Overall Study|Death|0|||
129828908|NCT03525574|467338841|FG000|Overall Study|Other non-compliance|2|||
129828909|NCT03525574|467338842|FG001|Overall Study|Other non-compliance|0|||
129828910|NCT03525574|467338841|FG000|Overall Study|Physician Decision|6|||
129828911|NCT03525574|467338842|FG001|Overall Study|Physician Decision|0|||
129828912|NCT03525574|467338841|FG000|Overall Study|Other|58|||
129828913|NCT03525574|467338842|FG001|Overall Study|Other|0|||
129828914|NCT03525574|467338841|FG000|Overall Study|Enrolled but never dosed|1|||
129828915|NCT03525574|467338842|FG001|Overall Study|Enrolled but never dosed|0|||
129828916|NCT03525574|467338841|FG000|Overall Study|Not enrolled in 105 study|0|||
129828917|NCT03525574|467338842|FG001|Overall Study|Not enrolled in 105 study|3|||
129828918|NCT02150954|467338845|FG000|Overall Study|Protocol Violation|1|||
129828919|NCT02150954|467338846|FG001|Overall Study|Protocol Violation|0|||
129828920|NCT03814746|467338847|FG000|Overall Study|Participant decision|9|||
129828921|NCT03814746|467338848|FG001|Overall Study|Participant decision|6|||
129828922|NCT03814746|467338849|FG002|Overall Study|Participant decision|15|||
129828923|NCT03814746|467338847|FG000|Overall Study|Physician Decision|2|||
129828924|NCT03814746|467338848|FG001|Overall Study|Physician Decision|2|||
129828925|NCT03814746|467338849|FG002|Overall Study|Physician Decision|4|||
129828926|NCT03814746|467338847|FG000|Overall Study|Death|2|||
129828927|NCT03814746|467338848|FG001|Overall Study|Death|2|||
129828928|NCT03814746|467338849|FG002|Overall Study|Death|2|||
129828929|NCT03814746|467338847|FG000|Overall Study|Adverse Event|2|||
129828930|NCT03814746|467338848|FG001|Overall Study|Adverse Event|2|||
129828931|NCT03814746|467338849|FG002|Overall Study|Adverse Event|1|||
129828932|NCT03814746|467338847|FG000|Overall Study|Lost to Follow-up|2|||
129828933|NCT03814746|467338848|FG001|Overall Study|Lost to Follow-up|1|||
129828934|NCT03814746|467338849|FG002|Overall Study|Lost to Follow-up|2|||
129828935|NCT03814746|467338847|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129828936|NCT03814746|467338848|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129828937|NCT03814746|467338849|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129828938|NCT03814746|467338847|FG000|Overall Study|Pregnancy|0|||
129828939|NCT03814746|467338848|FG001|Overall Study|Pregnancy|1|||
129828940|NCT03814746|467338849|FG002|Overall Study|Pregnancy|1|||
129828941|NCT03814746|467338847|FG000|Overall Study|Protocol Violation|1|||
129828942|NCT03814746|467338848|FG001|Overall Study|Protocol Violation|0|||
129828943|NCT03814746|467338849|FG002|Overall Study|Protocol Violation|0|||
129828944|NCT01086540|467338858|FG000|Overall Study|Death|3|||
129828945|NCT01086540|467338859|FG001|Overall Study|Death|1|||
129828946|NCT01086540|467338858|FG000|Overall Study|Physician Decision|2|||
129828947|NCT01086540|467338859|FG001|Overall Study|Physician Decision|1|||
129828948|NCT01086540|467338858|FG000|Overall Study|Addition of new therapy for PAH|1|||
129828949|NCT01086540|467338859|FG001|Overall Study|Addition of new therapy for PAH|0|||
129828950|NCT00518323|467338860|FG000|Overall Study|Lack of Efficacy|14|||
129828951|NCT00518323|467338861|FG001|Overall Study|Lack of Efficacy|2|||
129828952|NCT00518323|467338862|FG002|Overall Study|Lack of Efficacy|4|||
129828953|NCT00518323|467338863|FG003|Overall Study|Lack of Efficacy|20|||
129828954|NCT00518323|467338860|FG000|Overall Study|Withdrawal by Subject|1|||
129828955|NCT00518323|467338861|FG001|Overall Study|Withdrawal by Subject|2|||
129828956|NCT00518323|467338862|FG002|Overall Study|Withdrawal by Subject|4|||
129828957|NCT00518323|467338863|FG003|Overall Study|Withdrawal by Subject|2|||
129828958|NCT00518323|467338860|FG000|Overall Study|Lost to Follow-up|0|||
129828959|NCT00518323|467338861|FG001|Overall Study|Lost to Follow-up|2|||
129828960|NCT00518323|467338862|FG002|Overall Study|Lost to Follow-up|1|||
129828961|NCT00518323|467338863|FG003|Overall Study|Lost to Follow-up|3|||
129828962|NCT00518323|467338860|FG000|Overall Study|Adverse Event|1|||
129828963|NCT00518323|467338861|FG001|Overall Study|Adverse Event|1|||
129828964|NCT00518323|467338862|FG002|Overall Study|Adverse Event|1|||
129828965|NCT00518323|467338863|FG003|Overall Study|Adverse Event|0|||
129828966|NCT00518323|467338860|FG000|Overall Study|Prohibited medication and others|3|||
129828967|NCT00518323|467338861|FG001|Overall Study|Prohibited medication and others|1|||
129828968|NCT00518323|467338862|FG002|Overall Study|Prohibited medication and others|1|||
129828969|NCT00518323|467338863|FG003|Overall Study|Prohibited medication and others|0|||
129828970|NCT03164928|467338864|FG000|Overall Study|Lost to Follow-up|1|||
129828971|NCT03164928|467338865|FG001|Overall Study|Lost to Follow-up|0|||
129828972|NCT02278263|467338866|FG000|Overall Study|Protocol Violation|7|||
129828973|NCT02278263|467338867|FG001|Overall Study|Protocol Violation|0|||
129828974|NCT02278263|467338868|FG002|Overall Study|Protocol Violation|9|||
129828975|NCT01998737|467338869|FG000|Overall Study|Corrupted database|23|||
129828976|NCT01998737|467338870|FG001|Overall Study|Corrupted database|0|||
129828977|NCT03997383|467338873|FG000|Double-blind Treatment Period|Adverse Event|4|||
129828978|NCT03997383|467338874|FG001|Double-blind Treatment Period|Adverse Event|3|||
129828979|NCT03997383|467338873|FG000|Double-blind Treatment Period|Death|4|||
129828980|NCT03997383|467338874|FG001|Double-blind Treatment Period|Death|4|||
129828981|NCT03997383|467338873|FG000|Double-blind Treatment Period|Physician Decision|2|||
129828982|NCT03997383|467338874|FG001|Double-blind Treatment Period|Physician Decision|0|||
129828983|NCT03997383|467338873|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
129828984|NCT03997383|467338874|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
129828985|NCT03997383|467338873|FG000|Open-label Extension Period|Ongoing|148|||
129828986|NCT03997383|467338874|FG001|Open-label Extension Period|Ongoing|151|||
129828987|NCT03997383|467338873|FG000|Open-label Extension Period|Adverse Event|4|||
129828988|NCT03997383|467338874|FG001|Open-label Extension Period|Adverse Event|1|||
129828989|NCT03997383|467338873|FG000|Open-label Extension Period|Death|8|||
129828990|NCT03997383|467338874|FG001|Open-label Extension Period|Death|9|||
129828991|NCT03997383|467338873|FG000|Open-label Extension Period|Physician Decision|1|||
129828992|NCT03997383|467338874|FG001|Open-label Extension Period|Physician Decision|1|||
129828993|NCT03997383|467338873|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
129828994|NCT03997383|467338874|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
129828995|NCT03997383|467338873|FG000|Open-label Extension Period|Reason Not Specified|2|||
129828996|NCT03997383|467338874|FG001|Open-label Extension Period|Reason Not Specified|0|||
129828997|NCT03880019|467338875|FG000|Overall Study|Competing disease|1|||
129828998|NCT00326950|467338876|FG000|Overall Study|Progressive Disease|1|||
129828999|NCT01266460|467338882|FG000|Overall Study|Adverse Event|3|||
129829000|NCT01266460|467338882|FG000|Overall Study|Withdrawal by Subject|5|||
129829001|NCT01266460|467338882|FG000|Overall Study|Disease Progression|18|||
129829002|NCT01266460|467338882|FG000|Overall Study|Not otherwise specified|8|||
129829003|NCT01132547|467338887|FG000|Overall Study|Withdrawal by Subject|3|||
129829004|NCT01132547|467338888|FG001|Overall Study|Withdrawal by Subject|1|||
129829005|NCT01132547|467338887|FG000|Overall Study|Death|1|||
129829006|NCT01132547|467338888|FG001|Overall Study|Death|0|||
129829007|NCT05811234|467338889|FG000|Overall Study|Loss of Effectiveness|2|||
129829008|NCT05811234|467338889|FG000|Overall Study|Adverse Event|4|||
129829009|NCT05811234|467338889|FG000|Overall Study|Pregnancy|1|||
129829010|NCT05811234|467338889|FG000|Overall Study|Disease progression|1|||
129829011|NCT05811234|467338889|FG000|Overall Study|Withdrawal by Subject|4|||
129829012|NCT05811234|467338889|FG000|Overall Study|Lost to Follow-up|13|||
129829013|NCT05811234|467338889|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
129829014|NCT04499781|467338890|FG000|Overall Study|Lost to Follow-up|2|||
129829015|NCT04499781|467338891|FG001|Overall Study|Lost to Follow-up|3|||
129829016|NCT04499781|467338890|FG000|Overall Study|Withdrawal by Subject|2|||
129829017|NCT04499781|467338891|FG001|Overall Study|Withdrawal by Subject|0|||
129829018|NCT00730912|467338911|FG000|Overall Study|Discontinued|0|||
129829019|NCT00730912|467338912|FG001|Overall Study|Discontinued|0|||
129829020|NCT00730912|467338913|FG002|Overall Study|Discontinued|1|||
129829021|NCT04053023|467338920|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
129829022|NCT04053023|467338921|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
129829023|NCT04103892|467338922|FG000|Overall Study|Adverse Event|0|||
129829024|NCT04103892|467338923|FG001|Overall Study|Adverse Event|0|||
129829025|NCT04103892|467338924|FG002|Overall Study|Adverse Event|0|||
129829026|NCT04103892|467338925|FG003|Overall Study|Adverse Event|3|||
129829027|NCT04103892|467338922|FG000|Overall Study|Lost to Follow-up|0|||
129829028|NCT04103892|467338923|FG001|Overall Study|Lost to Follow-up|0|||
129445723|NCT01968070|465932890|FG015|Period 2|Withdrawal by Subject|0|||
129445724|NCT01968070|465932891|FG016|Period 2|Withdrawal by Subject|0|||
129445725|NCT01968070|465932892|FG017|Period 2|Withdrawal by Subject|0|||
129445726|NCT00108069|465932897|FG000|Overall Study|Never rec'd study drug|0|||
129445727|NCT00108069|465932898|FG001|Overall Study|Never rec'd study drug|1|||
129445728|NCT00108069|465932897|FG000|Overall Study|Adverse Event|1|||
129445729|NCT00108069|465932898|FG001|Overall Study|Adverse Event|1|||
129445730|NCT00108069|465932897|FG000|Overall Study|Withdrawal by Subject|1|||
129445731|NCT00108069|465932898|FG001|Overall Study|Withdrawal by Subject|0|||
129445732|NCT00108069|465932897|FG000|Overall Study|Death|1|||
129445733|NCT00108069|465932898|FG001|Overall Study|Death|0|||
129829029|NCT04103892|467338924|FG002|Overall Study|Lost to Follow-up|2|||
129829030|NCT04103892|467338925|FG003|Overall Study|Lost to Follow-up|0|||
129829031|NCT04103892|467338922|FG000|Overall Study|Protocol Violation|0|||
129829032|NCT04103892|467338923|FG001|Overall Study|Protocol Violation|0|||
129445734|NCT00108069|465932897|FG000|Overall Study|Progessive disease|27|||
129829033|NCT04103892|467338924|FG002|Overall Study|Protocol Violation|1|||
129829034|NCT04103892|467338925|FG003|Overall Study|Protocol Violation|1|||
129829035|NCT04103892|467338922|FG000|Overall Study|Withdrawal by Subject|1|||
129829036|NCT04103892|467338923|FG001|Overall Study|Withdrawal by Subject|0|||
129829037|NCT04103892|467338924|FG002|Overall Study|Withdrawal by Subject|2|||
129829038|NCT04103892|467338925|FG003|Overall Study|Withdrawal by Subject|5|||
129829039|NCT04103892|467338922|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
129829040|NCT04103892|467338923|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
129829041|NCT04103892|467338924|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
129829042|NCT04103892|467338925|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
129445735|NCT00108069|465932898|FG001|Overall Study|Progessive disease|11|||
129445736|NCT00995007|465932899|FG000|Overall Study|Withdrew consent|1|||
129829043|NCT03424265|467338926|FG000|Overall Study|screening failure|1|||
129829044|NCT03424265|467338927|FG001|Overall Study|screening failure|0|||
129829045|NCT03424265|467338926|FG000|Overall Study|Withdrawal by Subject|0|||
129829046|NCT03424265|467338927|FG001|Overall Study|Withdrawal by Subject|2|||
129829047|NCT00894322|467338934|FG000|Overall Study|Withdrawal by Subject|1|||
129829048|NCT00894322|467338935|FG001|Overall Study|Withdrawal by Subject|0|||
129829049|NCT00894322|467338936|FG002|Overall Study|Withdrawal by Subject|0|||
129829050|NCT02738450|467338945|FG000|Overall Study|Withdrawal by Subject|0|||
129829051|NCT02738450|467338946|FG001|Overall Study|Withdrawal by Subject|2|||
129829052|NCT02738450|467338947|FG002|Overall Study|Withdrawal by Subject|0|||
129829053|NCT00399360|467338949|FG000|Overall Study|Lost to Follow-up|2|||
129829054|NCT00399360|467338950|FG001|Overall Study|Lost to Follow-up|1|||
129829055|NCT00399360|467338951|FG002|Overall Study|Lost to Follow-up|2|||
129829056|NCT00399360|467338952|FG003|Overall Study|Lost to Follow-up|4|||
129829057|NCT00399360|467338949|FG000|Overall Study|Adverse Event|0|||
129829058|NCT00399360|467338950|FG001|Overall Study|Adverse Event|0|||
129829059|NCT00399360|467338951|FG002|Overall Study|Adverse Event|1|||
129829060|NCT00399360|467338952|FG003|Overall Study|Adverse Event|0|||
129829061|NCT00399360|467338949|FG000|Overall Study|Withdrawal by Subject|0|||
129829062|NCT00399360|467338950|FG001|Overall Study|Withdrawal by Subject|2|||
129829063|NCT00399360|467338951|FG002|Overall Study|Withdrawal by Subject|0|||
129829064|NCT00399360|467338952|FG003|Overall Study|Withdrawal by Subject|2|||
129829065|NCT01412021|467338954|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
129829066|NCT01412021|467338954|FG000|Overall Study|Treatment Prior to Approval|3|||
129829067|NCT01412021|467338954|FG000|Overall Study|Transferred to Other Hospital|9|||
129829068|NCT01166178|467338955|FG000|Overall Study|Withdrawal by Subject|1|||
129829069|NCT01166178|467338956|FG001|Overall Study|Withdrawal by Subject|0|||
129829070|NCT01166178|467338955|FG000|Overall Study|Study was terminated|20|||
129829071|NCT01166178|467338956|FG001|Overall Study|Study was terminated|8|||
129829072|NCT07114198|467338958|FG000|Overall Study|Protocol Violation|1|||
129829073|NCT07114198|467338959|FG001|Overall Study|Protocol Violation|1|||
129829074|NCT00670800|467340790|FG000|Overall Study|2 controls were insulin resistant|0|||
129829075|NCT00670800|467340791|FG001|Overall Study|2 controls were insulin resistant|2|||
129829076|NCT04736199|467340792|FG000|Overall Study|Adverse Event|28|||
129829077|NCT04736199|467340793|FG001|Overall Study|Adverse Event|22|||
129829078|NCT04736199|467340792|FG000|Overall Study|Death|9|||
129829079|NCT04736199|467340793|FG001|Overall Study|Death|3|||
129829080|NCT04736199|467340792|FG000|Overall Study|Lost to Follow-up|4|||
129829081|NCT04736199|467340793|FG001|Overall Study|Lost to Follow-up|1|||
129829082|NCT04736199|467340792|FG000|Overall Study|Physician Decision|5|||
129829083|NCT04736199|467340793|FG001|Overall Study|Physician Decision|9|||
129829084|NCT04736199|467340792|FG000|Overall Study|Withdrawal by Subject|21|||
129829085|NCT04736199|467340793|FG001|Overall Study|Withdrawal by Subject|9|||
129829086|NCT04736199|467340792|FG000|Overall Study|Progressive disease|120|||
129829087|NCT04736199|467340793|FG001|Overall Study|Progressive disease|101|||
129829088|NCT04736199|467340792|FG000|Overall Study|Subject decision|13|||
129829089|NCT04736199|467340793|FG001|Overall Study|Subject decision|13|||
129829090|NCT04736199|467340792|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
129829091|NCT04736199|467340793|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
129829092|NCT04736199|467340792|FG000|Overall Study|Additional primary malignancy|1|||
129829093|NCT04736199|467340793|FG001|Overall Study|Additional primary malignancy|0|||
129829094|NCT04736199|467340792|FG000|Overall Study|Non-compliance with study drug|0|||
129829095|NCT04736199|467340793|FG001|Overall Study|Non-compliance with study drug|1|||
129829096|NCT04736199|467340792|FG000|Overall Study|Other reason|0|||
129829097|NCT04736199|467340793|FG001|Overall Study|Other reason|1|||
129829098|NCT04736199|467340792|FG000|Overall Study|Ongoing with study drug|240|||
129829099|NCT04736199|467340793|FG001|Overall Study|Ongoing with study drug|63|||
129829100|NCT04736199|467340792|FG000|Overall Study|Study drug never administered|3|||
129829101|NCT04736199|467340793|FG001|Overall Study|Study drug never administered|0|||
129829102|NCT04318080|467340794|FG000|Overall Study|Study closed by sponsor|10|||
129829103|NCT04318080|467340795|FG001|Overall Study|Study closed by sponsor|22|||
129829104|NCT04318080|467340794|FG000|Overall Study|Death|3|||
129829105|NCT04318080|467340795|FG001|Overall Study|Death|9|||
129829106|NCT04318080|467340794|FG000|Overall Study|Withdrawal by Subject|1|||
129829107|NCT04318080|467340795|FG001|Overall Study|Withdrawal by Subject|0|||
129829108|NCT04318080|467340794|FG000|Overall Study|Protocol Deviation|1|||
129829109|NCT04318080|467340795|FG001|Overall Study|Protocol Deviation|0|||
129829110|NCT06308822|467340796|FG000|Overall Study|Mutation Status Not Confirmed|17|||
129829111|NCT06308822|467340796|FG000|Overall Study|Adverse Event|1|||
129829112|NCT06308822|467340796|FG000|Overall Study|Death|5|||
129829113|NCT06308822|467340796|FG000|Overall Study|Disease progression|8|||
129829114|NCT06308822|467340796|FG000|Overall Study|Withdrawal by Subject|1|||
129829115|NCT06308822|467340796|FG000|Overall Study|Physician Decision|3|||
129829116|NCT03712904|467340797|FG000|Overall Study|Death|0|||
129829117|NCT03712904|467340798|FG001|Overall Study|Death|1|||
129829118|NCT03712904|467340797|FG000|Overall Study|Withdrawal by Subject|0|||
129897680|NCT02524288|467584422|FG000|Overall Study|Subject Moved|32|||
129829119|NCT03712904|467340798|FG001|Overall Study|Withdrawal by Subject|1|||
129829120|NCT03712904|467340797|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
129829121|NCT03712904|467340798|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
129829122|NCT01852942|467340799|FG000|Overall Study|Physician Decision|1|||
129829123|NCT01852942|467340800|FG001|Overall Study|Physician Decision|0|||
129829124|NCT01852942|467340799|FG000|Overall Study|Death|1|||
129829125|NCT01852942|467340800|FG001|Overall Study|Death|1|||
129829126|NCT01852942|467340799|FG000|Overall Study|Withdrawal by Subject|2|||
129829127|NCT01852942|467340800|FG001|Overall Study|Withdrawal by Subject|3|||
129829128|NCT01852942|467340799|FG000|Overall Study|Lost to Follow-up|1|||
129829129|NCT01852942|467340800|FG001|Overall Study|Lost to Follow-up|2|||
129829130|NCT01921179|467340801|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
129829131|NCT01921179|467340802|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
129829132|NCT01921179|467340801|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
129829133|NCT01921179|467340802|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
129829134|NCT05608005|467340809|FG000|Overall Study|Adverse Event|2|||
129829135|NCT05608005|467340810|FG001|Overall Study|Adverse Event|1|||
129829136|NCT05608005|467340811|FG002|Overall Study|Adverse Event|3|||
129829137|NCT05608005|467340809|FG000|Overall Study|Protocol Violation|2|||
129829138|NCT05608005|467340810|FG001|Overall Study|Protocol Violation|3|||
129829139|NCT05608005|467340811|FG002|Overall Study|Protocol Violation|0|||
129829140|NCT05608005|467340809|FG000|Overall Study|Withdrawal by Subject|10|||
129829141|NCT05608005|467340810|FG001|Overall Study|Withdrawal by Subject|12|||
129829142|NCT05608005|467340811|FG002|Overall Study|Withdrawal by Subject|4|||
129829143|NCT05608005|467340809|FG000|Overall Study|Lost to Follow-up|25|||
129829144|NCT05608005|467340810|FG001|Overall Study|Lost to Follow-up|27|||
129829145|NCT05608005|467340811|FG002|Overall Study|Lost to Follow-up|15|||
129829146|NCT05608005|467340809|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
129829147|NCT05608005|467340810|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
129829148|NCT05608005|467340811|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
129829149|NCT04708886|467340812|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
129829150|NCT04708886|467340812|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
129829151|NCT01372501|467340813|FG000|Overall Study|Adverse Event|4|||
129829152|NCT01372501|467340813|FG000|Overall Study|Device migration|1|||
129829153|NCT01466348|467340814|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
129829154|NCT01466348|467340815|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
129829155|NCT03989440|467340816|FG000|Overall Study|COVID-19 travel restrictions|0|||
129829156|NCT03989440|467340817|FG001|Overall Study|COVID-19 travel restrictions|0|||
129829157|NCT03989440|467340818|FG002|Overall Study|COVID-19 travel restrictions|1|||
129829158|NCT03989440|467340819|FG003|Overall Study|COVID-19 travel restrictions|0|||
129829159|NCT03989440|467340820|FG004|Overall Study|COVID-19 travel restrictions|0|||
129829160|NCT03989440|467340821|FG005|Overall Study|COVID-19 travel restrictions|0|||
129829161|NCT03989440|467340816|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
129829162|NCT03989440|467340817|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
129829163|NCT03989440|467340818|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
129829164|NCT03989440|467340819|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
129829165|NCT03989440|467340820|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
129829166|NCT03989440|467340821|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
129829167|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
129829168|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
129829169|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
129829170|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
129829171|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
129829172|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
129829173|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
129829174|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
129829175|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
129829176|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
129829177|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
129829178|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
129829179|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
129829180|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
129829181|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
129829182|NCT03970733|467340824|FG000|Main Study Phase (18 Months)|Other|1|||
129829183|NCT03970733|467340825|FG001|Main Study Phase (18 Months)|Other|1|||
129829184|NCT03970733|467340826|FG002|Main Study Phase (18 Months)|Other|0|||
129829185|NCT03970733|467340827|FG003|Main Study Phase (18 Months)|Other|0|||
129829186|NCT03970733|467340828|FG004|Main Study Phase (18 Months)|Other|0|||
129829187|NCT03970733|467340824|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829188|NCT03970733|467340825|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829189|NCT03970733|467340826|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829190|NCT03970733|467340827|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
129829191|NCT03970733|467340828|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
129829192|NCT02189473|467340832|FG000|Overall Study|Death|22|||
129829193|NCT02189473|467340833|FG001|Overall Study|Death|23|||
129829194|NCT02189473|467340832|FG000|Overall Study|Lost to Follow-up|1|||
129829195|NCT02189473|467340833|FG001|Overall Study|Lost to Follow-up|2|||
129829196|NCT01955161|467340834|FG000|Overall Study|Withdrawal before treatment|2|||
129829197|NCT01955161|467340835|FG001|Overall Study|Withdrawal before treatment|0|||
129829198|NCT01955161|467340836|FG002|Overall Study|Withdrawal before treatment|1|||
129829199|NCT01955161|467340834|FG000|Overall Study|Adverse Event|10|||
129829200|NCT01955161|467340835|FG001|Overall Study|Adverse Event|14|||
129829201|NCT01955161|467340836|FG002|Overall Study|Adverse Event|15|||
129829202|NCT01955161|467340834|FG000|Overall Study|Death|1|||
129829203|NCT01955161|467340835|FG001|Overall Study|Death|1|||
129829204|NCT01955161|467340836|FG002|Overall Study|Death|3|||
129829205|NCT01955161|467340834|FG000|Overall Study|Withdrawal by Subject|9|||
129829206|NCT01955161|467340835|FG001|Overall Study|Withdrawal by Subject|8|||
129829207|NCT01955161|467340836|FG002|Overall Study|Withdrawal by Subject|12|||
129829208|NCT01955161|467340834|FG000|Overall Study|Protocol Violation|2|||
129829209|NCT01955161|467340835|FG001|Overall Study|Protocol Violation|0|||
129829210|NCT01955161|467340836|FG002|Overall Study|Protocol Violation|0|||
129829211|NCT01955161|467340834|FG000|Overall Study|Other reason: physician decision|0|||
129829212|NCT01955161|467340835|FG001|Overall Study|Other reason: physician decision|1|||
129829213|NCT01955161|467340836|FG002|Overall Study|Other reason: physician decision|1|||
129829214|NCT01955161|467340834|FG000|Overall Study|Other reason: disallowed medication|1|||
129829215|NCT01955161|467340835|FG001|Overall Study|Other reason: disallowed medication|0|||
129829216|NCT01955161|467340836|FG002|Overall Study|Other reason: disallowed medication|1|||
129829217|NCT01955161|467340834|FG000|Overall Study|Other reason: caregiver unavailable|1|||
129829218|NCT01955161|467340835|FG001|Overall Study|Other reason: caregiver unavailable|0|||
129829219|NCT01955161|467340836|FG002|Overall Study|Other reason: caregiver unavailable|0|||
129829220|NCT01955161|467340834|FG000|Overall Study|Other reason: moved to nursing home|0|||
129829221|NCT01955161|467340835|FG001|Overall Study|Other reason: moved to nursing home|1|||
129829222|NCT01955161|467340836|FG002|Overall Study|Other reason: moved to nursing home|0|||
129829223|NCT01955161|467340834|FG000|Overall Study|Other reason: insufficient compliance|0|||
129829224|NCT01955161|467340835|FG001|Overall Study|Other reason: insufficient compliance|0|||
129829225|NCT01955161|467340836|FG002|Overall Study|Other reason: insufficient compliance|1|||
129829226|NCT01955161|467340834|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
129829227|NCT01955161|467340835|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
129829228|NCT01955161|467340836|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
129829229|NCT01955161|467340834|FG000|Overall Study|Other reason: patient's will|0|||
129829230|NCT01955161|467340835|FG001|Overall Study|Other reason: patient's will|0|||
129829231|NCT01955161|467340836|FG002|Overall Study|Other reason: patient's will|1|||
129829232|NCT02784821|467340839|FG000|Overall Study|Death|0|||
129829233|NCT02784821|467340840|FG001|Overall Study|Death|5|||
129829234|NCT02784821|467340841|FG002|Overall Study|Death|4|||
129829235|NCT02784821|467340842|FG003|Overall Study|Death|5|||
129829236|NCT01277523|467340843|FG000|Overall Study|Adverse Event|1|||
129829237|NCT01277523|467340844|FG001|Overall Study|Adverse Event|0|||
129829238|NCT01277523|467340845|FG002|Overall Study|Adverse Event|0|||
129829239|NCT01277523|467340843|FG000|Overall Study|Protocol Violation|2|||
129829240|NCT01277523|467340844|FG001|Overall Study|Protocol Violation|0|||
129829241|NCT01277523|467340845|FG002|Overall Study|Protocol Violation|0|||
129829242|NCT01277523|467340843|FG000|Overall Study|Other Reason not Defined|0|||
129829243|NCT01277523|467340844|FG001|Overall Study|Other Reason not Defined|1|||
129829244|NCT01277523|467340845|FG002|Overall Study|Other Reason not Defined|0|||
129829245|NCT01881230|467340851|FG000|Overall Study|Death|2|||
129829246|NCT01881230|467340852|FG001|Overall Study|Death|0|||
129829247|NCT01881230|467340853|FG002|Overall Study|Death|1|||
129829248|NCT01881230|467340851|FG000|Overall Study|Adverse Event|9|||
129829249|NCT01881230|467340852|FG001|Overall Study|Adverse Event|13|||
129829250|NCT01881230|467340853|FG002|Overall Study|Adverse Event|12|||
129829251|NCT01881230|467340851|FG000|Overall Study|Progressive Disease|31|||
129829252|NCT01881230|467340852|FG001|Overall Study|Progressive Disease|35|||
129829253|NCT01881230|467340853|FG002|Overall Study|Progressive Disease|36|||
129829254|NCT01881230|467340851|FG000|Overall Study|Symptomatic Deterioration|3|||
129829255|NCT01881230|467340852|FG001|Overall Study|Symptomatic Deterioration|3|||
129829256|NCT01881230|467340853|FG002|Overall Study|Symptomatic Deterioration|1|||
129445737|NCT00995007|465932900|FG001|Overall Study|Withdrew consent|0|||
129829257|NCT01881230|467340851|FG000|Overall Study|Withdrawal by Subject|6|||
129829258|NCT01881230|467340852|FG001|Overall Study|Withdrawal by Subject|4|||
129829259|NCT01881230|467340853|FG002|Overall Study|Withdrawal by Subject|6|||
129829260|NCT01881230|467340851|FG000|Overall Study|Physician Decision|4|||
129897681|NCT02524288|467584422|FG000|Overall Study|Withdrawal by Subject|76|||
129445738|NCT00995007|465932899|FG000|Overall Study|Refused further treatment|8|||
129445739|NCT00995007|465932900|FG001|Overall Study|Refused further treatment|2|||
129445740|NCT00995007|465932899|FG000|Overall Study|Toxicity|8|||
129445741|NCT00995007|465932900|FG001|Overall Study|Toxicity|0|||
129829261|NCT01881230|467340852|FG001|Overall Study|Physician Decision|3|||
129829262|NCT01881230|467340853|FG002|Overall Study|Physician Decision|6|||
129829263|NCT01881230|467340851|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129829264|NCT01881230|467340852|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129829265|NCT01881230|467340853|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129829266|NCT01881230|467340851|FG000|Overall Study|Given Commercially Available Drug|0|||
129829267|NCT01881230|467340852|FG001|Overall Study|Given Commercially Available Drug|0|||
129829268|NCT01881230|467340853|FG002|Overall Study|Given Commercially Available Drug|2|||
129829269|NCT01881230|467340851|FG000|Overall Study|Protocol Violation|1|||
129829270|NCT01881230|467340852|FG001|Overall Study|Protocol Violation|1|||
129829271|NCT01881230|467340853|FG002|Overall Study|Protocol Violation|0|||
129829272|NCT01881230|467340851|FG000|Overall Study|Miscellaneous|3|||
129829273|NCT01881230|467340852|FG001|Overall Study|Miscellaneous|3|||
129829274|NCT01881230|467340853|FG002|Overall Study|Miscellaneous|0|||
129829275|NCT01881230|467340851|FG000|Overall Study|Untreated: Other|0|||
129829276|NCT01881230|467340852|FG001|Overall Study|Untreated: Other|0|||
129829277|NCT01881230|467340853|FG002|Overall Study|Untreated: Other|1|||
129829278|NCT01881230|467340851|FG000|Overall Study|Untreated: Death|0|||
129829279|NCT01881230|467340852|FG001|Overall Study|Untreated: Death|0|||
129829280|NCT01881230|467340853|FG002|Overall Study|Untreated: Death|1|||
129829281|NCT01881230|467340851|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
129829282|NCT01881230|467340852|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
129829283|NCT01881230|467340853|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
129829284|NCT00112502|467340854|FG000|Overall Study|Withdrawal by Subject|0|||
129829285|NCT00112502|467340855|FG001|Overall Study|Withdrawal by Subject|1|||
129829286|NCT00112502|467340856|FG002|Overall Study|Withdrawal by Subject|1|||
129829287|NCT00112502|467340857|FG003|Overall Study|Withdrawal by Subject|4|||
129829288|NCT00112502|467340858|FG004|Overall Study|Withdrawal by Subject|2|||
129829289|NCT00112502|467340859|FG005|Overall Study|Withdrawal by Subject|5|||
129829290|NCT00112502|467340860|FG006|Overall Study|Withdrawal by Subject|3|||
129829291|NCT00112502|467340861|FG007|Overall Study|Withdrawal by Subject|7|||
129829292|NCT02385266|467340862|FG000|Overall Study|Withdrawal by Subject|1|||
129829293|NCT02385266|467340863|FG001|Overall Study|Withdrawal by Subject|3|||
129829294|NCT01030523|467340864|FG000|Initial Study (5 Years)|Death|1|||
129829295|NCT01030523|467340865|FG001|Initial Study (5 Years)|Death|0|||
129829296|NCT01030523|467340864|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
129829297|NCT01030523|467340865|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
129829298|NCT01030523|467340864|FG000|Initial Study (5 Years)|Implant failure|1|||
129829299|NCT01030523|467340865|FG001|Initial Study (5 Years)|Implant failure|0|||
129829300|NCT01030523|467340864|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
129829301|NCT01030523|467340865|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
129829302|NCT01030523|467340864|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
129829303|NCT01030523|467340865|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
129829304|NCT01030523|467340864|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
129829305|NCT01030523|467340865|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
129829306|NCT02357901|467340872|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
129829307|NCT02357901|467340873|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
129829308|NCT02357901|467340874|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
129829309|NCT02357901|467340875|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
129829310|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
129829311|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
129829312|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
129829313|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
129829314|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
129829315|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
129829316|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
129829317|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
129829318|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
129829319|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
129829320|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
129829321|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
129445742|NCT01910116|465932902|FG000|Overall Study|Adverse Event|0|||
129829322|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
129829323|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
129829324|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
129829325|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
129829326|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
129445743|NCT01910116|465932903|FG001|Overall Study|Adverse Event|3|||
129897682|NCT02524288|467584422|FG000|Overall Study|Pregnancy|22|||
129897683|NCT02524288|467584422|FG000|Overall Study|Physician Decision|2|||
129445744|NCT01910116|465932902|FG000|Overall Study|Lack of Efficacy|3|||
129829327|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
129829328|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
129829329|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
129829330|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
129829331|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
129829332|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
129829333|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
129829334|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
129829335|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
129829336|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
129829337|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
129829338|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
129829339|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
129829340|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
129829341|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
129829342|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
129829343|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
129829344|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
129829345|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
129829346|NCT02357901|467340872|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
129829347|NCT02357901|467340873|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
129829348|NCT02357901|467340874|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
129829349|NCT02357901|467340875|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
129829350|NCT00491387|467340881|FG000|Overall Study|study terminated|20|||
129829351|NCT00227305|467340885|FG000|Overall Study|Adverse Event|40|||
129829352|NCT00227305|467340885|FG000|Overall Study|Withdrawal by Subject|42|||
129829353|NCT00227305|467340885|FG000|Overall Study|Lost to Follow-up|33|||
129829354|NCT00227305|467340885|FG000|Overall Study|Study specific discontinuation|13|||
129829355|NCT00227305|467340885|FG000|Overall Study|MOVED OUT OF AREA|3|||
129829356|NCT00227305|467340885|FG000|Overall Study|Lack of Efficacy|7|||
129829357|NCT00227305|467340885|FG000|Overall Study|Physician Decision|3|||
129829358|NCT00227305|467340885|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
129829359|NCT00227305|467340885|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
129829360|NCT00227305|467340885|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
129829361|NCT00483379|467340886|FG000|Treatment Period|Adverse Event|1|||
129829362|NCT00483379|467340887|FG001|Treatment Period|Adverse Event|0|||
129829363|NCT00483379|467340886|FG000|Treatment Period|Withdrawal by Subject|1|||
129829364|NCT00483379|467340887|FG001|Treatment Period|Withdrawal by Subject|0|||
129829365|NCT03311659|467340888|FG000|Overall Study|Protocol Violation|1|||
129829366|NCT00071760|467340889|FG000|Overall Study|Adverse Event|2|||
129829367|NCT00071760|467340890|FG001|Overall Study|Adverse Event|1|||
129829368|NCT00071760|467340889|FG000|Overall Study|Lost to Follow-up|0|||
129829369|NCT00071760|467340890|FG001|Overall Study|Lost to Follow-up|3|||
129829370|NCT00071760|467340889|FG000|Overall Study|Protocol Violation|1|||
129829371|NCT00071760|467340890|FG001|Overall Study|Protocol Violation|0|||
129829372|NCT00071760|467340889|FG000|Overall Study|Withdrawal by Subject|0|||
129829373|NCT00071760|467340890|FG001|Overall Study|Withdrawal by Subject|1|||
129829374|NCT00071760|467340889|FG000|Overall Study|Insufficient Viral Load Response|1|||
129829375|NCT00071760|467340890|FG001|Overall Study|Insufficient Viral Load Response|1|||
129829376|NCT00071760|467340889|FG000|Overall Study|Lack of availability of RTV|1|||
129829377|NCT00071760|467340890|FG001|Overall Study|Lack of availability of RTV|0|||
129829378|NCT00071760|467340889|FG000|Overall Study|Physician Decision|2|||
129829379|NCT00071760|467340890|FG001|Overall Study|Physician Decision|1|||
129829380|NCT00071760|467340889|FG000|Overall Study|Relocation|0|||
129829381|NCT00071760|467340890|FG001|Overall Study|Relocation|1|||
129829382|NCT01994629|467340891|FG000|Overall Study|Withdrawal by Subject|1|||
129829383|NCT01994629|467340892|FG001|Overall Study|Withdrawal by Subject|0|||
129829384|NCT01994629|467340891|FG000|Overall Study|Lost to Follow-up|0|||
129829385|NCT01994629|467340892|FG001|Overall Study|Lost to Follow-up|3|||
129829386|NCT03338062|467340893|FG000|Overall Study|Alternative Therapy|1|||
129829387|NCT03338062|467340894|FG001|Overall Study|Alternative Therapy|0|||
129829388|NCT01558752|467340895|FG000|Overall Study|Physician Decision|2|||
129829389|NCT01558752|467340896|FG001|Overall Study|Physician Decision|0|||
129829390|NCT04340362|467340900|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
129829391|NCT01170091|467340901|FG000|Overall Study|Missing efficacy evaluation|3|||
129829392|NCT01170091|467340901|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
129829393|NCT00391274|467340909|FG000|Overall Study|Death Due to Study Disease|55|||
129829394|NCT00391274|467340910|FG001|Overall Study|Death Due to Study Disease|45|||
129829395|NCT00391274|467340909|FG000|Overall Study|Lost to Follow-up|0|||
129829396|NCT00391274|467340910|FG001|Overall Study|Lost to Follow-up|3|||
129897684|NCT00517933|467584423|FG000|Period 1|Death|2|||
129829397|NCT00391274|467340909|FG000|Overall Study|Physician Decision|4|||
129829398|NCT00391274|467340910|FG001|Overall Study|Physician Decision|2|||
129829399|NCT00391274|467340909|FG000|Overall Study|Withdrawal by Subject|0|||
129829400|NCT00391274|467340910|FG001|Overall Study|Withdrawal by Subject|3|||
129829401|NCT00391274|467340909|FG000|Overall Study|Death Due to Adverse Event|1|||
129829402|NCT00391274|467340910|FG001|Overall Study|Death Due to Adverse Event|3|||
129829403|NCT00391274|467340909|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
129829404|NCT00391274|467340910|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
129829405|NCT00391274|467340909|FG000|Overall Study|Death Not Study Related|0|||
129829406|NCT00391274|467340910|FG001|Overall Study|Death Not Study Related|1|||
129829407|NCT03051607|467340911|FG000|Overall Study|Adverse Event|66|||
129829408|NCT03341533|467340912|FG000|Overall Study|Withdrawal by Subject|1|||
129829409|NCT03341533|467340913|FG001|Overall Study|Withdrawal by Subject|1|||
129829410|NCT03341533|467340912|FG000|Overall Study|Not eligible after randomization|2|||
129829411|NCT03341533|467340913|FG001|Overall Study|Not eligible after randomization|1|||
129829412|NCT03447990|467340914|FG000|Overall Study|Withdrawal by Subject|0|||
129829413|NCT03447990|467340915|FG001|Overall Study|Withdrawal by Subject|0|||
129829414|NCT03447990|467340916|FG002|Overall Study|Withdrawal by Subject|0|||
129829415|NCT03447990|467340917|FG003|Overall Study|Withdrawal by Subject|0|||
129829416|NCT03447990|467340918|FG004|Overall Study|Withdrawal by Subject|0|||
129829417|NCT03447990|467340919|FG005|Overall Study|Withdrawal by Subject|0|||
129829418|NCT03447990|467340920|FG006|Overall Study|Withdrawal by Subject|1|||
129829419|NCT03658538|467340930|FG000|Overall Study|Death|2|||
129829420|NCT03658538|467340931|FG001|Overall Study|Death|1|||
129829421|NCT03658538|467340930|FG000|Overall Study|Cancer diagnosis|1|||
129829422|NCT03658538|467340931|FG001|Overall Study|Cancer diagnosis|0|||
129829423|NCT03658538|467340930|FG000|Overall Study|Change residence|1|||
129829424|NCT03658538|467340931|FG001|Overall Study|Change residence|2|||
129829425|NCT03658538|467340930|FG000|Overall Study|Lost to Follow-up|3|||
129829426|NCT03658538|467340931|FG001|Overall Study|Lost to Follow-up|3|||
129829427|NCT03658538|467340930|FG000|Overall Study|Unblinded|2|||
129829428|NCT03658538|467340931|FG001|Overall Study|Unblinded|3|||
129829429|NCT03658538|467340930|FG000|Overall Study|Physician Decision|0|||
129829430|NCT03658538|467340931|FG001|Overall Study|Physician Decision|1|||
129829431|NCT03658538|467340930|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
129829432|NCT03658538|467340931|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
129445745|NCT01910116|465932903|FG001|Overall Study|Lack of Efficacy|4|||
129829433|NCT03658538|467340930|FG000|Overall Study|Evicted from home|1|||
129829434|NCT03658538|467340931|FG001|Overall Study|Evicted from home|0|||
129829435|NCT02446990|467340932|FG000|Overall Study|Death|485|||
129829436|NCT02446990|467340933|FG001|Overall Study|Death|458|||
129829437|NCT02446990|467340932|FG000|Overall Study|Lost to Follow-up|3|||
129829438|NCT02446990|467340933|FG001|Overall Study|Lost to Follow-up|1|||
129829439|NCT02446990|467340932|FG000|Overall Study|Physician Decision|1|||
129829440|NCT02446990|467340933|FG001|Overall Study|Physician Decision|0|||
129829441|NCT02446990|467340932|FG000|Overall Study|Withdrawal by Subject|231|||
129829442|NCT02446990|467340933|FG001|Overall Study|Withdrawal by Subject|199|||
129829443|NCT03333044|467340934|FG000|Overall Study|Pregnancy|1|||
129829444|NCT03333044|467340935|FG001|Overall Study|Pregnancy|0|||
129829445|NCT03333044|467340936|FG002|Overall Study|Pregnancy|0|||
129829446|NCT03333044|467340934|FG000|Overall Study|Lost to Follow-up|0|||
129829447|NCT03333044|467340935|FG001|Overall Study|Lost to Follow-up|14|||
129829448|NCT03333044|467340936|FG002|Overall Study|Lost to Follow-up|6|||
129829449|NCT03649711|467340937|FG000|Overall Study|Adverse Event|0|||
129829450|NCT03649711|467340938|FG001|Overall Study|Adverse Event|1|||
129829451|NCT03649711|467340939|FG002|Overall Study|Adverse Event|0|||
129829452|NCT03649711|467340937|FG000|Overall Study|Kidney Transplant|1|||
129829453|NCT03649711|467340938|FG001|Overall Study|Kidney Transplant|0|||
129829454|NCT03649711|467340939|FG002|Overall Study|Kidney Transplant|0|||
129829455|NCT03188094|467340944|FG000|Overall Study|Screen failure|1|||
129829456|NCT03188094|467340945|FG001|Overall Study|Screen failure|0|||
129829457|NCT03188094|467340946|FG002|Overall Study|Screen failure|0|||
129445746|NCT01910116|465932902|FG000|Overall Study|Lost to Follow-up|1|||
129829458|NCT03188094|467340944|FG000|Overall Study|Pregnancy|3|||
129829459|NCT03188094|467340945|FG001|Overall Study|Pregnancy|0|||
129829460|NCT03188094|467340946|FG002|Overall Study|Pregnancy|0|||
129829461|NCT03188094|467340944|FG000|Overall Study|Ineligible|1|||
129829462|NCT03188094|467340945|FG001|Overall Study|Ineligible|0|||
129829463|NCT03188094|467340946|FG002|Overall Study|Ineligible|0|||
129829464|NCT03188094|467340944|FG000|Overall Study|Lost to Follow-up|0|||
129829465|NCT03188094|467340945|FG001|Overall Study|Lost to Follow-up|0|||
129829466|NCT03188094|467340946|FG002|Overall Study|Lost to Follow-up|17|||
129829467|NCT04537234|467340947|FG000|Overall Study|Withdrawal by Subject|2|||
129445747|NCT01910116|465932903|FG001|Overall Study|Lost to Follow-up|0|||
129829468|NCT04537234|467340948|FG001|Overall Study|Withdrawal by Subject|0|||
129829469|NCT05478252|467340949|FG000|Overall Study|Withdrawal by Subject|2|||
129829470|NCT05478252|467340950|FG001|Overall Study|Withdrawal by Subject|3|||
129829471|NCT05478252|467340949|FG000|Overall Study|Lost to Follow-up|4|||
129829472|NCT05478252|467340950|FG001|Overall Study|Lost to Follow-up|2|||
129829473|NCT05478252|467340949|FG000|Overall Study|Physician Decision|1|||
129829474|NCT05478252|467340950|FG001|Overall Study|Physician Decision|1|||
129829475|NCT05478252|467340949|FG000|Overall Study|Death|1|||
129829476|NCT05478252|467340950|FG001|Overall Study|Death|0|||
129829477|NCT00858442|467342783|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
129829478|NCT00858442|467342784|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
129829479|NCT03329690|467342788|FG000|Overall Study|Progressive disease per RECIST|85|||
129829480|NCT03329690|467342789|FG001|Overall Study|Progressive disease per RECIST|44|||
129829481|NCT03329690|467342790|FG002|Overall Study|Progressive disease per RECIST|6|||
129829482|NCT03329690|467342791|FG003|Overall Study|Progressive disease per RECIST|16|||
129829483|NCT03329690|467342792|FG004|Overall Study|Progressive disease per RECIST|20|||
129829484|NCT03329690|467342788|FG000|Overall Study|Clinical progression|7|||
129829485|NCT03329690|467342789|FG001|Overall Study|Clinical progression|4|||
129829486|NCT03329690|467342790|FG002|Overall Study|Clinical progression|1|||
129829487|NCT03329690|467342791|FG003|Overall Study|Clinical progression|1|||
129829488|NCT03329690|467342792|FG004|Overall Study|Clinical progression|1|||
129829489|NCT03329690|467342788|FG000|Overall Study|Adverse Event|22|||
129829490|NCT03329690|467342789|FG001|Overall Study|Adverse Event|4|||
129829491|NCT03329690|467342790|FG002|Overall Study|Adverse Event|0|||
129829492|NCT03329690|467342791|FG003|Overall Study|Adverse Event|1|||
129829493|NCT03329690|467342792|FG004|Overall Study|Adverse Event|2|||
129829494|NCT03329690|467342788|FG000|Overall Study|Death|2|||
129829495|NCT03329690|467342789|FG001|Overall Study|Death|0|||
129829496|NCT03329690|467342790|FG002|Overall Study|Death|0|||
129829497|NCT03329690|467342791|FG003|Overall Study|Death|1|||
129829498|NCT03329690|467342792|FG004|Overall Study|Death|0|||
129829499|NCT03329690|467342788|FG000|Overall Study|Withdrawal by Subject|2|||
129829500|NCT03329690|467342789|FG001|Overall Study|Withdrawal by Subject|3|||
129829501|NCT03329690|467342790|FG002|Overall Study|Withdrawal by Subject|0|||
129829502|NCT03329690|467342791|FG003|Overall Study|Withdrawal by Subject|1|||
129829503|NCT03329690|467342792|FG004|Overall Study|Withdrawal by Subject|0|||
129829504|NCT03329690|467342788|FG000|Overall Study|Physician Decision|1|||
129829505|NCT03329690|467342789|FG001|Overall Study|Physician Decision|0|||
129829506|NCT03329690|467342790|FG002|Overall Study|Physician Decision|0|||
129829507|NCT03329690|467342791|FG003|Overall Study|Physician Decision|0|||
129829508|NCT03329690|467342792|FG004|Overall Study|Physician Decision|1|||
129829509|NCT03329690|467342788|FG000|Overall Study|Miscellaneous|6|||
129829510|NCT03329690|467342789|FG001|Overall Study|Miscellaneous|0|||
129829511|NCT03329690|467342790|FG002|Overall Study|Miscellaneous|0|||
129829512|NCT03329690|467342791|FG003|Overall Study|Miscellaneous|0|||
129829513|NCT03329690|467342792|FG004|Overall Study|Miscellaneous|0|||
129829514|NCT03329690|467342788|FG000|Overall Study|Did not receive treatment|1|||
129829515|NCT03329690|467342789|FG001|Overall Study|Did not receive treatment|0|||
129829516|NCT03329690|467342790|FG002|Overall Study|Did not receive treatment|0|||
129829517|NCT03329690|467342791|FG003|Overall Study|Did not receive treatment|1|||
129829518|NCT03329690|467342792|FG004|Overall Study|Did not receive treatment|0|||
129829519|NCT02337907|467342794|FG000|Overall Study|Other than listed|1|||
129829520|NCT02337907|467342795|FG001|Overall Study|Other than listed|0|||
129829521|NCT02337907|467342796|FG002|Overall Study|Other than listed|0|||
129829522|NCT02337907|467342797|FG003|Overall Study|Other than listed|1|||
129829523|NCT02337907|467342798|FG004|Overall Study|Other than listed|1|||
129829524|NCT02337907|467342799|FG005|Overall Study|Other than listed|0|||
129829525|NCT02337907|467342794|FG000|Overall Study|Withdrawal by Subject|2|||
129829526|NCT02337907|467342795|FG001|Overall Study|Withdrawal by Subject|3|||
129829527|NCT02337907|467342796|FG002|Overall Study|Withdrawal by Subject|0|||
129829528|NCT02337907|467342797|FG003|Overall Study|Withdrawal by Subject|2|||
129829529|NCT02337907|467342798|FG004|Overall Study|Withdrawal by Subject|5|||
129829530|NCT02337907|467342799|FG005|Overall Study|Withdrawal by Subject|0|||
129829531|NCT02337907|467342794|FG000|Overall Study|Lost to Follow-up|0|||
129829532|NCT02337907|467342795|FG001|Overall Study|Lost to Follow-up|0|||
129829533|NCT02337907|467342796|FG002|Overall Study|Lost to Follow-up|0|||
129829534|NCT02337907|467342797|FG003|Overall Study|Lost to Follow-up|0|||
129829535|NCT02337907|467342798|FG004|Overall Study|Lost to Follow-up|0|||
129829536|NCT02337907|467342799|FG005|Overall Study|Lost to Follow-up|1|||
129829537|NCT02337907|467342794|FG000|Overall Study|Adverse Event|1|||
129829538|NCT02337907|467342795|FG001|Overall Study|Adverse Event|1|||
129829539|NCT02337907|467342796|FG002|Overall Study|Adverse Event|1|||
129829540|NCT02337907|467342797|FG003|Overall Study|Adverse Event|1|||
129829541|NCT02337907|467342798|FG004|Overall Study|Adverse Event|4|||
129829542|NCT02337907|467342799|FG005|Overall Study|Adverse Event|0|||
129829543|NCT02488681|467342804|FG000|Overall Study|Implant unsuccessful|7|||
129829544|NCT03165110|467342805|FG000|Overall Study|Anroid phone software incompatibility|1|||
129829545|NCT05533632|467342806|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
129829546|NCT05533632|467342806|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
129829547|NCT05533632|467342806|FG000|Overall Study|Lost to Follow-up|1|||
129897685|NCT00517933|467584424|FG001|Period 1|Death|1|||
129829548|NCT05533632|467342806|FG000|Overall Study|Withdrawal by Subject|4|||
129829549|NCT05533632|467342806|FG000|Overall Study|Adverse Event|4|||
129829550|NCT04327388|467342809|FG000|Overall Study|Adverse Event|17|||
129829551|NCT04327388|467342810|FG001|Overall Study|Adverse Event|18|||
129829552|NCT04327388|467342811|FG002|Overall Study|Adverse Event|9|||
129829553|NCT04327388|467342809|FG000|Overall Study|Other|1|||
129829554|NCT04327388|467342810|FG001|Overall Study|Other|2|||
129829555|NCT04327388|467342811|FG002|Overall Study|Other|0|||
129829556|NCT04327388|467342809|FG000|Overall Study|Randomized and not treated|2|||
129829557|NCT04327388|467342810|FG001|Overall Study|Randomized and not treated|0|||
129829558|NCT04327388|467342811|FG002|Overall Study|Randomized and not treated|2|||
129829559|NCT04120974|467342812|FG000|Overall Study|Death|1|||
129829560|NCT04120974|467342812|FG000|Overall Study|Physician Decision|1|||
129829561|NCT04120974|467342812|FG000|Overall Study|Lost to Follow-up|6|||
129829562|NCT01519960|467342813|FG000|Overall Study|Withdrawal from the study|26|||
129829563|NCT01519960|467342814|FG001|Overall Study|Withdrawal from the study|22|||
129829564|NCT01519960|467342815|FG002|Overall Study|Withdrawal from the study|5|||
129829565|NCT01387347|467342816|FG000|Overall Study|Lost to Follow-up|2|||
129829566|NCT01387347|467342817|FG001|Overall Study|Lost to Follow-up|1|||
129829567|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
129829568|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
129829569|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
129829570|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
129829571|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
129829572|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
129829573|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
129829574|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
129829575|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
129829576|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
129829577|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
129829578|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
129829579|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
129829580|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
129829581|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
129829582|NCT00561080|467342820|FG000|Vaccination Period (up to Month 4)|Other|0|||
129829583|NCT00561080|467342821|FG001|Vaccination Period (up to Month 4)|Other|2|||
129829584|NCT00561080|467342822|FG002|Vaccination Period (up to Month 4)|Other|1|||
129829585|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
129829586|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
129829587|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
129829588|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
129829589|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
129829590|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
129829591|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
129829592|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
129829593|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
129829594|NCT00561080|467342820|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
129829595|NCT00561080|467342821|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
129829596|NCT00561080|467342822|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
129829597|NCT00238121|467342823|FG000|Overall Study|Withdrawal by Subject|1|||
129829598|NCT00238121|467342824|FG001|Overall Study|Withdrawal by Subject|1|||
129829599|NCT00238121|467342823|FG000|Overall Study|Adverse Event|2|||
129829600|NCT00238121|467342824|FG001|Overall Study|Adverse Event|1|||
129829601|NCT03255382|467342825|FG000|Overall Study|Adverse Event|3|||
129829602|NCT03255382|467342826|FG001|Overall Study|Adverse Event|0|||
129829603|NCT03255382|467342825|FG000|Overall Study|Lost to Follow-up|2|||
129829604|NCT03255382|467342826|FG001|Overall Study|Lost to Follow-up|0|||
129829605|NCT03255382|467342825|FG000|Overall Study|Withdrawal by Subject|2|||
129829606|NCT03255382|467342826|FG001|Overall Study|Withdrawal by Subject|0|||
129829607|NCT03255382|467342825|FG000|Overall Study|Other|6|||
129829608|NCT03255382|467342826|FG001|Overall Study|Other|0|||
129897686|NCT00517933|467584423|FG000|Period 1|Adverse Event|4|||
129829609|NCT02221284|467342829|FG000|Overall Study|Case Report Forms Uncollected|56|||
129829610|NCT02221284|467342829|FG000|Overall Study|Protocol Deviation|5|||
129829611|NCT03526458|467342832|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
129829612|NCT03526458|467342833|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
129829613|NCT03526458|467342832|FG000|Overall Study|Stone passed, surgery cancelled|2|||
129829614|NCT03526458|467342833|FG001|Overall Study|Stone passed, surgery cancelled|1|||
129829615|NCT03526458|467342832|FG000|Overall Study|Withdrawal by Subject|1|||
129829616|NCT03526458|467342833|FG001|Overall Study|Withdrawal by Subject|0|||
129829617|NCT03526458|467342832|FG000|Overall Study|Physician Decision|2|||
129829618|NCT03526458|467342833|FG001|Overall Study|Physician Decision|1|||
129829619|NCT03526458|467342832|FG000|Overall Study|Lack of equipment|1|||
129829620|NCT03526458|467342833|FG001|Overall Study|Lack of equipment|1|||
129829621|NCT00529542|467342834|FG000|Overall Study|Withdrawal by Subject|1|||
129829622|NCT00529542|467342835|FG001|Overall Study|Withdrawal by Subject|0|||
129829623|NCT00529542|467342834|FG000|Overall Study|Lost to Follow-up|0|||
129829624|NCT00529542|467342835|FG001|Overall Study|Lost to Follow-up|1|||
129829625|NCT02587065|467342837|FG000|Overall Study|Adverse Event|14|||
129829626|NCT02587065|467342837|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
129829627|NCT02587065|467342837|FG000|Overall Study|Non-adherence to the Protocol|3|||
129829628|NCT02587065|467342837|FG000|Overall Study|Discontinuation of Study Medication|2|||
129829629|NCT02587065|467342837|FG000|Overall Study|Reason not Specified|3|||
129829630|NCT05104567|467342839|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829631|NCT05104567|467342840|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
129829632|NCT05104567|467342841|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829633|NCT05104567|467342842|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829634|NCT05104567|467342843|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829635|NCT05104567|467342844|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829636|NCT05104567|467342845|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
129829637|NCT05104567|467342839|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
129829638|NCT05104567|467342840|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
129829639|NCT05104567|467342841|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
129829640|NCT05104567|467342842|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
129829641|NCT05104567|467342843|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
129829642|NCT05104567|467342844|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
129829643|NCT05104567|467342845|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
129829644|NCT05104567|467342839|FG000|Overall Study|Progressive disease|3|||
129829645|NCT05104567|467342840|FG001|Overall Study|Progressive disease|13|||
129829646|NCT05104567|467342841|FG002|Overall Study|Progressive disease|13|||
129829647|NCT05104567|467342842|FG003|Overall Study|Progressive disease|17|||
129829648|NCT05104567|467342843|FG004|Overall Study|Progressive disease|17|||
129829649|NCT05104567|467342844|FG005|Overall Study|Progressive disease|28|||
129829650|NCT05104567|467342845|FG006|Overall Study|Progressive disease|24|||
129829651|NCT05104567|467342839|FG000|Overall Study|Withdrawal by Subject|1|||
129829652|NCT05104567|467342840|FG001|Overall Study|Withdrawal by Subject|1|||
129829653|NCT05104567|467342841|FG002|Overall Study|Withdrawal by Subject|2|||
129829654|NCT05104567|467342842|FG003|Overall Study|Withdrawal by Subject|0|||
129829655|NCT05104567|467342843|FG004|Overall Study|Withdrawal by Subject|0|||
129829656|NCT05104567|467342844|FG005|Overall Study|Withdrawal by Subject|0|||
129829657|NCT05104567|467342845|FG006|Overall Study|Withdrawal by Subject|0|||
129829658|NCT05104567|467342839|FG000|Overall Study|Other|1|||
129829659|NCT05104567|467342840|FG001|Overall Study|Other|1|||
129829660|NCT05104567|467342841|FG002|Overall Study|Other|1|||
129829661|NCT05104567|467342842|FG003|Overall Study|Other|0|||
129829662|NCT05104567|467342843|FG004|Overall Study|Other|0|||
129829663|NCT05104567|467342844|FG005|Overall Study|Other|0|||
129829664|NCT05104567|467342845|FG006|Overall Study|Other|0|||
129829665|NCT00733746|467342850|FG000|Overall Study|Ineligible|5|||
129829666|NCT05778786|467342851|FG000|Period 1|COVID-19 Related|3|||
129829667|NCT05778786|467342852|FG001|Period 1|COVID-19 Related|3|||
129829668|NCT05778786|467342851|FG000|Period 1|Withdrew Consent during Study|1|||
129829669|NCT05778786|467342852|FG001|Period 1|Withdrew Consent during Study|0|||
129829670|NCT05778786|467342851|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
129829671|NCT05778786|467342852|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
129829672|NCT05778786|467342851|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
129829673|NCT05778786|467342852|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
129829674|NCT02113956|467342856|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
129829675|NCT02113956|467342857|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
129829676|NCT02113956|467342856|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
129829677|NCT02113956|467342857|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
129897687|NCT00517933|467584424|FG001|Period 1|Adverse Event|4|||
129897688|NCT00517933|467584423|FG000|Period 1|Lost to Follow-up|2|||
129897689|NCT00517933|467584424|FG001|Period 1|Lost to Follow-up|0|||
129829678|NCT02113956|467342856|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
129829679|NCT02113956|467342857|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
129829680|NCT01602380|467342858|FG000|Overall Study|Death|147|||
129829681|NCT01602380|467342859|FG001|Overall Study|Death|145|||
129829682|NCT01602380|467342858|FG000|Overall Study|Withdrawal by Subject|39|||
129829683|NCT01602380|467342859|FG001|Overall Study|Withdrawal by Subject|41|||
129829684|NCT01602380|467342858|FG000|Overall Study|Lost to Follow-up|15|||
129829685|NCT01602380|467342859|FG001|Overall Study|Lost to Follow-up|12|||
129829686|NCT01602380|467342858|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129829687|NCT01602380|467342859|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
129829688|NCT01602380|467342858|FG000|Overall Study|Other|2|||
129829689|NCT01602380|467342859|FG001|Overall Study|Other|0|||
129829690|NCT01064401|467342861|FG000|Overall Study|Adverse Event|47|||
129829691|NCT01064401|467342862|FG001|Overall Study|Adverse Event|56|||
129829692|NCT01064401|467342861|FG000|Overall Study|Lack of Efficacy|46|||
129829693|NCT01064401|467342862|FG001|Overall Study|Lack of Efficacy|23|||
129829694|NCT01064401|467342861|FG000|Overall Study|Lost to Follow-up|12|||
129829695|NCT01064401|467342862|FG001|Overall Study|Lost to Follow-up|9|||
129829696|NCT01064401|467342861|FG000|Overall Study|Consent Withdrawn|98|||
129829697|NCT01064401|467342862|FG001|Overall Study|Consent Withdrawn|80|||
129829698|NCT01064401|467342861|FG000|Overall Study|Investigator Decision|4|||
129829699|NCT01064401|467342862|FG001|Overall Study|Investigator Decision|6|||
129829700|NCT01064401|467342861|FG000|Overall Study|Death|4|||
129829701|NCT01064401|467342862|FG001|Overall Study|Death|0|||
129829702|NCT01064401|467342861|FG000|Overall Study|Pregnancy|4|||
129829703|NCT01064401|467342862|FG001|Overall Study|Pregnancy|7|||
129829704|NCT01064401|467342861|FG000|Overall Study|Noncompliance|7|||
129829705|NCT01064401|467342862|FG001|Overall Study|Noncompliance|8|||
129829706|NCT01064401|467342861|FG000|Overall Study|Site Closure|4|||
129829707|NCT01064401|467342862|FG001|Overall Study|Site Closure|5|||
129829708|NCT01064401|467342861|FG000|Overall Study|Other|2|||
129829709|NCT01064401|467342862|FG001|Overall Study|Other|1|||
129829710|NCT03158051|467342863|FG000|Overall Study|Lost to Follow-up|41|||
129829711|NCT03158051|467342864|FG001|Overall Study|Lost to Follow-up|47|||
129829712|NCT03158051|467342863|FG000|Overall Study|Physician Decision|6|||
129829713|NCT03158051|467342864|FG001|Overall Study|Physician Decision|7|||
129829714|NCT03158051|467342863|FG000|Overall Study|Withdrawal by Subject|24|||
129829715|NCT03158051|467342864|FG001|Overall Study|Withdrawal by Subject|15|||
129829716|NCT03158051|467342863|FG000|Overall Study|Death|0|||
129829717|NCT03158051|467342864|FG001|Overall Study|Death|1|||
129829718|NCT02738151|467342865|FG000|Overall Study|Randomized but not treated|4|||
129829719|NCT02738151|467342866|FG001|Overall Study|Randomized but not treated|1|||
129829720|NCT02738151|467342865|FG000|Overall Study|Adverse Event|4|||
129829721|NCT02738151|467342866|FG001|Overall Study|Adverse Event|5|||
129829722|NCT02738151|467342865|FG000|Overall Study|Hypoglycemia|0|||
129829723|NCT02738151|467342866|FG001|Overall Study|Hypoglycemia|1|||
129829724|NCT02738151|467342865|FG000|Overall Study|Poor Compliance to Protocol|4|||
129829725|NCT02738151|467342866|FG001|Overall Study|Poor Compliance to Protocol|3|||
129829726|NCT02738151|467342865|FG000|Overall Study|Other than specified above|11|||
129829727|NCT02738151|467342866|FG001|Overall Study|Other than specified above|21|||
129829728|NCT02005250|467342867|FG000|Overall Study|Lost to Follow-up|15|||
129829729|NCT02005250|467342868|FG001|Overall Study|Lost to Follow-up|5|||
129829730|NCT02588833|467342869|FG000|Part 1|Withdrawal by Subject|1|||
129829731|NCT02588833|467342870|FG001|Part 1|Withdrawal by Subject|0|||
129829732|NCT02588833|467342869|FG000|Part 2A|Physician Decision|0|||
129829733|NCT02588833|467342870|FG001|Part 2A|Physician Decision|1|||
129829734|NCT02588833|467342869|FG000|Part 2A|Withdrawal by Subject|0|||
129829735|NCT02588833|467342870|FG001|Part 2A|Withdrawal by Subject|1|||
129829736|NCT02588833|467342869|FG000|Part 2B|Adverse Event|0|||
129829737|NCT02588833|467342870|FG001|Part 2B|Adverse Event|1|||
129829738|NCT02588833|467342869|FG000|Part 2C|Adverse Event|0|||
129829739|NCT02588833|467342870|FG001|Part 2C|Adverse Event|1|||
129829740|NCT02588833|467342869|FG000|Part 2C|Withdrawal by Subject|0|||
129829741|NCT02588833|467342870|FG001|Part 2C|Withdrawal by Subject|1|||
129829742|NCT02588833|467342869|FG000|Part 3 (Safety Follow-up)|Other|0|||
129829743|NCT02588833|467342870|FG001|Part 3 (Safety Follow-up)|Other|2|||
129829744|NCT04007094|467342876|FG000|Overall Study|Lost to Follow-up|1|||
129829745|NCT04007094|467342877|FG001|Overall Study|Lost to Follow-up|1|||
129829746|NCT02921776|467342878|FG000|Overall Study|patient deterioration, fatigue|2|||
129829747|NCT02921776|467342879|FG001|Overall Study|patient deterioration, fatigue|6|||
129829748|NCT02921776|467342880|FG002|Overall Study|patient deterioration, fatigue|0|||
129829749|NCT02921776|467342881|FG003|Overall Study|patient deterioration, fatigue|0|||
129829750|NCT02921776|467342882|FG004|Overall Study|patient deterioration, fatigue|0|||
129829751|NCT02921776|467342883|FG005|Overall Study|patient deterioration, fatigue|0|||
129829752|NCT02921776|467342884|FG006|Overall Study|patient deterioration, fatigue|0|||
129829753|NCT02921776|467342885|FG007|Overall Study|patient deterioration, fatigue|0|||
129829754|NCT02921776|467342878|FG000|Overall Study|Withdrawal by Subject|0|||
129829755|NCT02921776|467342879|FG001|Overall Study|Withdrawal by Subject|2|||
129829756|NCT02921776|467342880|FG002|Overall Study|Withdrawal by Subject|0|||
129829757|NCT02921776|467342881|FG003|Overall Study|Withdrawal by Subject|1|||
129829758|NCT02921776|467342882|FG004|Overall Study|Withdrawal by Subject|1|||
129829759|NCT02921776|467342883|FG005|Overall Study|Withdrawal by Subject|0|||
129829760|NCT02921776|467342884|FG006|Overall Study|Withdrawal by Subject|8|||
129829761|NCT02921776|467342885|FG007|Overall Study|Withdrawal by Subject|1|||
129829762|NCT02921776|467342878|FG000|Overall Study|Death|0|||
129829763|NCT02921776|467342879|FG001|Overall Study|Death|0|||
129829764|NCT02921776|467342880|FG002|Overall Study|Death|0|||
129829765|NCT02921776|467342881|FG003|Overall Study|Death|2|||
129829766|NCT02921776|467342882|FG004|Overall Study|Death|0|||
129829767|NCT02921776|467342883|FG005|Overall Study|Death|0|||
129829768|NCT02921776|467342884|FG006|Overall Study|Death|0|||
129829769|NCT02921776|467342885|FG007|Overall Study|Death|0|||
129829770|NCT02921776|467342878|FG000|Overall Study|extubation or early discharge|0|||
129829771|NCT02921776|467342879|FG001|Overall Study|extubation or early discharge|0|||
129829772|NCT02921776|467342880|FG002|Overall Study|extubation or early discharge|0|||
129829773|NCT02921776|467342881|FG003|Overall Study|extubation or early discharge|5|||
129829774|NCT02921776|467342882|FG004|Overall Study|extubation or early discharge|5|||
129829775|NCT02921776|467342883|FG005|Overall Study|extubation or early discharge|0|||
129829776|NCT02921776|467342884|FG006|Overall Study|extubation or early discharge|0|||
129829777|NCT02921776|467342885|FG007|Overall Study|extubation or early discharge|0|||
129829778|NCT02921776|467342878|FG000|Overall Study|Lost to Follow-up|0|||
129829779|NCT02921776|467342879|FG001|Overall Study|Lost to Follow-up|0|||
129829780|NCT02921776|467342880|FG002|Overall Study|Lost to Follow-up|0|||
129829781|NCT02921776|467342881|FG003|Overall Study|Lost to Follow-up|0|||
129829782|NCT02921776|467342882|FG004|Overall Study|Lost to Follow-up|0|||
129829783|NCT02921776|467342883|FG005|Overall Study|Lost to Follow-up|2|||
129829784|NCT02921776|467342884|FG006|Overall Study|Lost to Follow-up|3|||
129829785|NCT02921776|467342885|FG007|Overall Study|Lost to Follow-up|6|||
129829786|NCT02070744|467342891|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829787|NCT02070744|467342892|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829788|NCT02070744|467342893|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829789|NCT02070744|467342894|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
129829790|NCT02070744|467342895|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
129829791|NCT02070744|467342891|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829792|NCT02070744|467342892|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829793|NCT02070744|467342893|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829794|NCT02070744|467342894|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
129829795|NCT02070744|467342895|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
129829796|NCT02070744|467342891|FG000|OLE Phase (48 Weeks)|Other|0|||
129829797|NCT02070744|467342892|FG001|OLE Phase (48 Weeks)|Other|0|||
129829798|NCT02070744|467342893|FG002|OLE Phase (48 Weeks)|Other|0|||
129829799|NCT02070744|467342894|FG003|OLE Phase (48 Weeks)|Other|0|||
129829800|NCT02070744|467342895|FG004|OLE Phase (48 Weeks)|Other|1|||
129829801|NCT04199117|467342896|FG000|Overall Study|Withdrawal by Subject|3|||
129829802|NCT04199117|467342897|FG001|Overall Study|Withdrawal by Subject|0|||
129829803|NCT04199117|467342898|FG002|Overall Study|Withdrawal by Subject|0|||
129829804|NCT04199117|467342899|FG003|Overall Study|Withdrawal by Subject|1|||
129829805|NCT04199117|467342900|FG004|Overall Study|Withdrawal by Subject|1|||
129829806|NCT04199117|467342901|FG005|Overall Study|Withdrawal by Subject|0|||
129829807|NCT04199117|467342902|FG006|Overall Study|Withdrawal by Subject|0|||
129829808|NCT04199117|467342903|FG007|Overall Study|Withdrawal by Subject|2|||
129829809|NCT04199117|467342904|FG008|Overall Study|Withdrawal by Subject|0|||
129829810|NCT04199117|467342905|FG009|Overall Study|Withdrawal by Subject|0|||
129829811|NCT04199117|467342906|FG010|Overall Study|Withdrawal by Subject|1|||
129829812|NCT04199117|467342907|FG011|Overall Study|Withdrawal by Subject|1|||
129829813|NCT04199117|467342908|FG012|Overall Study|Withdrawal by Subject|2|||
129829814|NCT04199117|467342909|FG013|Overall Study|Withdrawal by Subject|1|||
129829815|NCT04199117|467342910|FG014|Overall Study|Withdrawal by Subject|1|||
129829816|NCT04199117|467342911|FG015|Overall Study|Withdrawal by Subject|1|||
129829817|NCT04199117|467342896|FG000|Overall Study|Death|1|||
129829818|NCT04199117|467342897|FG001|Overall Study|Death|1|||
129829819|NCT04199117|467342898|FG002|Overall Study|Death|0|||
129829820|NCT04199117|467342899|FG003|Overall Study|Death|0|||
129829821|NCT04199117|467342900|FG004|Overall Study|Death|0|||
129829822|NCT04199117|467342901|FG005|Overall Study|Death|0|||
129829823|NCT04199117|467342902|FG006|Overall Study|Death|0|||
129829824|NCT04199117|467342903|FG007|Overall Study|Death|0|||
129829825|NCT04199117|467342904|FG008|Overall Study|Death|0|||
129829826|NCT04199117|467342905|FG009|Overall Study|Death|0|||
129829827|NCT04199117|467342906|FG010|Overall Study|Death|0|||
129829828|NCT04199117|467342907|FG011|Overall Study|Death|1|||
129829829|NCT04199117|467342908|FG012|Overall Study|Death|0|||
129829830|NCT04199117|467342909|FG013|Overall Study|Death|1|||
129829831|NCT04199117|467342910|FG014|Overall Study|Death|0|||
129829832|NCT04199117|467342911|FG015|Overall Study|Death|0|||
129829833|NCT04199117|467342896|FG000|Overall Study|Withdrawal by PI|0|||
129829834|NCT04199117|467342897|FG001|Overall Study|Withdrawal by PI|0|||
129829835|NCT04199117|467342898|FG002|Overall Study|Withdrawal by PI|0|||
129829836|NCT04199117|467342899|FG003|Overall Study|Withdrawal by PI|0|||
129829837|NCT04199117|467342900|FG004|Overall Study|Withdrawal by PI|0|||
129829838|NCT04199117|467342901|FG005|Overall Study|Withdrawal by PI|0|||
129829839|NCT04199117|467342902|FG006|Overall Study|Withdrawal by PI|0|||
129829840|NCT04199117|467342903|FG007|Overall Study|Withdrawal by PI|0|||
129829841|NCT04199117|467342904|FG008|Overall Study|Withdrawal by PI|0|||
129829842|NCT04199117|467342905|FG009|Overall Study|Withdrawal by PI|0|||
129829843|NCT04199117|467342906|FG010|Overall Study|Withdrawal by PI|0|||
129829844|NCT04199117|467342907|FG011|Overall Study|Withdrawal by PI|0|||
129829845|NCT04199117|467342908|FG012|Overall Study|Withdrawal by PI|1|||
129829846|NCT04199117|467342909|FG013|Overall Study|Withdrawal by PI|0|||
129829847|NCT04199117|467342910|FG014|Overall Study|Withdrawal by PI|0|||
129829848|NCT04199117|467342911|FG015|Overall Study|Withdrawal by PI|0|||
129829849|NCT04439253|467344322|FG000|Overall Study|Adverse Event|1|||
129829850|NCT04439253|467344322|FG000|Overall Study|Disease progression|2|||
129829851|NCT04439253|467344322|FG000|Overall Study|Complicating disease|1|||
129829852|NCT00702403|467344323|FG000|From Consent to Engraftment|Progressive leukemia|6|||
129829853|NCT00702403|467344323|FG000|From Consent to Engraftment|Critically ill|2|||
129829854|NCT00702403|467344323|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
129829855|NCT00702403|467344323|FG000|From Consent to Engraftment|Myocardial infarction|1|||
129829856|NCT00702403|467344323|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
129829857|NCT00702403|467344323|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
129829858|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
129829859|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
129829860|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Non-compliance|2|||
129829861|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
129829862|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
129829863|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Suicide|1|||
129829864|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
129829865|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
129829866|NCT00702403|467344323|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
129829867|NCT00380978|467344325|FG000|Overall Study|Refused allocated intervention|0|||
129829868|NCT00380978|467344326|FG001|Overall Study|Refused allocated intervention|6|||
129829869|NCT00380978|467344325|FG000|Overall Study|Wrong study envelope|0|||
129829870|NCT00380978|467344326|FG001|Overall Study|Wrong study envelope|2|||
129829871|NCT00380978|467344325|FG000|Overall Study|Allocation prior to analgesia request|1|||
129829872|NCT00380978|467344326|FG001|Overall Study|Allocation prior to analgesia request|2|||
129829873|NCT00380978|467344325|FG000|Overall Study|Parous patient|1|||
129829874|NCT00380978|467344326|FG001|Overall Study|Parous patient|0|||
129829875|NCT04146545|467344327|FG000|Overall Study|deemed ineligible after randomization|1|||
129829876|NCT04146545|467344328|FG001|Overall Study|deemed ineligible after randomization|0|||
129829877|NCT01729754|467344329|FG000|Part 1|Adverse Event|2|||
129829878|NCT01729754|467344330|FG001|Part 1|Adverse Event|0|||
129829879|NCT01729754|467344331|FG002|Part 1|Adverse Event|0|||
129829880|NCT01729754|467344332|FG003|Part 1|Adverse Event|1|||
129829881|NCT01729754|467344333|FG004|Part 1|Adverse Event|0|||
129829882|NCT01729754|467344334|FG005|Part 1|Adverse Event|0|||
129829883|NCT01729754|467344335|FG006|Part 1|Adverse Event|2|||
129829884|NCT01729754|467344336|FG007|Part 1|Adverse Event|0|||
129829885|NCT01729754|467344337|FG008|Part 1|Adverse Event|0|||
129829886|NCT01729754|467344338|FG009|Part 1|Adverse Event|5|||
129829887|NCT01729754|467344329|FG000|Part 1|Lack of Efficacy|1|||
129829888|NCT01729754|467344330|FG001|Part 1|Lack of Efficacy|0|||
129829889|NCT01729754|467344331|FG002|Part 1|Lack of Efficacy|0|||
129829890|NCT01729754|467344332|FG003|Part 1|Lack of Efficacy|0|||
129829891|NCT01729754|467344333|FG004|Part 1|Lack of Efficacy|0|||
129829892|NCT01729754|467344334|FG005|Part 1|Lack of Efficacy|0|||
129829893|NCT01729754|467344335|FG006|Part 1|Lack of Efficacy|2|||
129829894|NCT01729754|467344336|FG007|Part 1|Lack of Efficacy|0|||
129445748|NCT01910116|465932902|FG000|Overall Study|Protocol Violation|1|||
129829895|NCT01729754|467344337|FG008|Part 1|Lack of Efficacy|0|||
129829896|NCT01729754|467344338|FG009|Part 1|Lack of Efficacy|0|||
129829897|NCT01729754|467344329|FG000|Part 1|Lost to Follow-up|1|||
129829898|NCT01729754|467344330|FG001|Part 1|Lost to Follow-up|0|||
129829899|NCT01729754|467344331|FG002|Part 1|Lost to Follow-up|0|||
129445749|NCT01910116|465932903|FG001|Overall Study|Protocol Violation|2|||
129829900|NCT01729754|467344332|FG003|Part 1|Lost to Follow-up|2|||
129829901|NCT01729754|467344333|FG004|Part 1|Lost to Follow-up|0|||
129829902|NCT01729754|467344334|FG005|Part 1|Lost to Follow-up|0|||
129829903|NCT01729754|467344335|FG006|Part 1|Lost to Follow-up|3|||
129829904|NCT01729754|467344336|FG007|Part 1|Lost to Follow-up|0|||
129829905|NCT01729754|467344337|FG008|Part 1|Lost to Follow-up|0|||
129829906|NCT01729754|467344338|FG009|Part 1|Lost to Follow-up|3|||
129829907|NCT01729754|467344329|FG000|Part 1|Non-compliance with Study Drug|1|||
129829908|NCT01729754|467344330|FG001|Part 1|Non-compliance with Study Drug|0|||
129829909|NCT01729754|467344331|FG002|Part 1|Non-compliance with Study Drug|0|||
129829910|NCT01729754|467344332|FG003|Part 1|Non-compliance with Study Drug|0|||
129829911|NCT01729754|467344333|FG004|Part 1|Non-compliance with Study Drug|0|||
129829912|NCT01729754|467344334|FG005|Part 1|Non-compliance with Study Drug|0|||
129829913|NCT01729754|467344335|FG006|Part 1|Non-compliance with Study Drug|0|||
129829914|NCT01729754|467344336|FG007|Part 1|Non-compliance with Study Drug|0|||
129829915|NCT01729754|467344337|FG008|Part 1|Non-compliance with Study Drug|0|||
129829916|NCT01729754|467344338|FG009|Part 1|Non-compliance with Study Drug|0|||
129829917|NCT01729754|467344329|FG000|Part 1|Physician Decision|0|||
129829918|NCT01729754|467344330|FG001|Part 1|Physician Decision|0|||
129829919|NCT01729754|467344331|FG002|Part 1|Physician Decision|0|||
129829920|NCT01729754|467344332|FG003|Part 1|Physician Decision|0|||
129829921|NCT01729754|467344333|FG004|Part 1|Physician Decision|0|||
129829922|NCT01729754|467344334|FG005|Part 1|Physician Decision|0|||
129829923|NCT01729754|467344335|FG006|Part 1|Physician Decision|0|||
129829924|NCT01729754|467344336|FG007|Part 1|Physician Decision|0|||
129829925|NCT01729754|467344337|FG008|Part 1|Physician Decision|0|||
129829926|NCT01729754|467344338|FG009|Part 1|Physician Decision|4|||
129829927|NCT01729754|467344329|FG000|Part 1|Pregnancy|0|||
129829928|NCT01729754|467344330|FG001|Part 1|Pregnancy|0|||
129829929|NCT01729754|467344331|FG002|Part 1|Pregnancy|0|||
129829930|NCT01729754|467344332|FG003|Part 1|Pregnancy|1|||
129829931|NCT01729754|467344333|FG004|Part 1|Pregnancy|0|||
129829932|NCT01729754|467344334|FG005|Part 1|Pregnancy|0|||
129829933|NCT01729754|467344335|FG006|Part 1|Pregnancy|0|||
129829934|NCT01729754|467344336|FG007|Part 1|Pregnancy|0|||
129829935|NCT01729754|467344337|FG008|Part 1|Pregnancy|0|||
129829936|NCT01729754|467344338|FG009|Part 1|Pregnancy|1|||
129829937|NCT01729754|467344329|FG000|Part 1|Progressive Disease|0|||
129829938|NCT01729754|467344330|FG001|Part 1|Progressive Disease|0|||
129829939|NCT01729754|467344331|FG002|Part 1|Progressive Disease|0|||
129829940|NCT01729754|467344332|FG003|Part 1|Progressive Disease|0|||
129829941|NCT01729754|467344333|FG004|Part 1|Progressive Disease|0|||
129829942|NCT01729754|467344334|FG005|Part 1|Progressive Disease|0|||
129829943|NCT01729754|467344335|FG006|Part 1|Progressive Disease|0|||
129829944|NCT01729754|467344336|FG007|Part 1|Progressive Disease|0|||
129829945|NCT01729754|467344337|FG008|Part 1|Progressive Disease|0|||
129829946|NCT01729754|467344338|FG009|Part 1|Progressive Disease|1|||
129829947|NCT01729754|467344329|FG000|Part 1|Protocol Violation|2|||
129829948|NCT01729754|467344330|FG001|Part 1|Protocol Violation|0|||
129829949|NCT01729754|467344331|FG002|Part 1|Protocol Violation|0|||
129829950|NCT01729754|467344332|FG003|Part 1|Protocol Violation|1|||
129829951|NCT01729754|467344333|FG004|Part 1|Protocol Violation|0|||
129829952|NCT01729754|467344334|FG005|Part 1|Protocol Violation|0|||
129829953|NCT01729754|467344335|FG006|Part 1|Protocol Violation|1|||
129829954|NCT01729754|467344336|FG007|Part 1|Protocol Violation|0|||
129829955|NCT01729754|467344337|FG008|Part 1|Protocol Violation|0|||
129829956|NCT01729754|467344338|FG009|Part 1|Protocol Violation|0|||
129829957|NCT01729754|467344329|FG000|Part 1|Withdrawal by Subject|5|||
129829958|NCT01729754|467344330|FG001|Part 1|Withdrawal by Subject|0|||
129829959|NCT01729754|467344331|FG002|Part 1|Withdrawal by Subject|0|||
129829960|NCT01729754|467344332|FG003|Part 1|Withdrawal by Subject|7|||
129829961|NCT01729754|467344333|FG004|Part 1|Withdrawal by Subject|0|||
129829962|NCT01729754|467344334|FG005|Part 1|Withdrawal by Subject|0|||
129829963|NCT01729754|467344335|FG006|Part 1|Withdrawal by Subject|5|||
129829964|NCT01729754|467344336|FG007|Part 1|Withdrawal by Subject|0|||
129829965|NCT01729754|467344337|FG008|Part 1|Withdrawal by Subject|0|||
129829966|NCT01729754|467344338|FG009|Part 1|Withdrawal by Subject|6|||
129829967|NCT01729754|467344329|FG000|Part 1|Other Protocol Specified Criteria|2|||
129829968|NCT01729754|467344330|FG001|Part 1|Other Protocol Specified Criteria|0|||
129829969|NCT01729754|467344331|FG002|Part 1|Other Protocol Specified Criteria|0|||
129829970|NCT01729754|467344332|FG003|Part 1|Other Protocol Specified Criteria|0|||
129829971|NCT01729754|467344333|FG004|Part 1|Other Protocol Specified Criteria|0|||
129829972|NCT01729754|467344334|FG005|Part 1|Other Protocol Specified Criteria|0|||
129829973|NCT01729754|467344335|FG006|Part 1|Other Protocol Specified Criteria|1|||
129829974|NCT01729754|467344336|FG007|Part 1|Other Protocol Specified Criteria|0|||
129829975|NCT01729754|467344337|FG008|Part 1|Other Protocol Specified Criteria|0|||
129829976|NCT01729754|467344338|FG009|Part 1|Other Protocol Specified Criteria|4|||
129829977|NCT01729754|467344329|FG000|Part 2|Adverse Event|2|||
129829978|NCT01729754|467344330|FG001|Part 2|Adverse Event|0|||
129829979|NCT01729754|467344331|FG002|Part 2|Adverse Event|0|||
129829980|NCT01729754|467344332|FG003|Part 2|Adverse Event|0|||
129829981|NCT01729754|467344333|FG004|Part 2|Adverse Event|0|||
129829982|NCT01729754|467344334|FG005|Part 2|Adverse Event|0|||
129829983|NCT01729754|467344335|FG006|Part 2|Adverse Event|0|||
129829984|NCT01729754|467344336|FG007|Part 2|Adverse Event|0|||
129829985|NCT01729754|467344337|FG008|Part 2|Adverse Event|1|||
129829986|NCT01729754|467344338|FG009|Part 2|Adverse Event|2|||
129829987|NCT01729754|467344329|FG000|Part 2|Lack of Efficacy|0|||
129829988|NCT01729754|467344330|FG001|Part 2|Lack of Efficacy|0|||
129829989|NCT01729754|467344331|FG002|Part 2|Lack of Efficacy|0|||
129829990|NCT01729754|467344332|FG003|Part 2|Lack of Efficacy|0|||
129829991|NCT01729754|467344333|FG004|Part 2|Lack of Efficacy|0|||
129829992|NCT01729754|467344334|FG005|Part 2|Lack of Efficacy|0|||
129829993|NCT01729754|467344335|FG006|Part 2|Lack of Efficacy|0|||
129829994|NCT01729754|467344336|FG007|Part 2|Lack of Efficacy|0|||
129829995|NCT01729754|467344337|FG008|Part 2|Lack of Efficacy|2|||
129829996|NCT01729754|467344338|FG009|Part 2|Lack of Efficacy|2|||
129829997|NCT01729754|467344329|FG000|Part 2|Lost to Follow-up|0|||
129829998|NCT01729754|467344330|FG001|Part 2|Lost to Follow-up|0|||
129829999|NCT01729754|467344331|FG002|Part 2|Lost to Follow-up|0|||
129830000|NCT01729754|467344332|FG003|Part 2|Lost to Follow-up|2|||
129830001|NCT01729754|467344333|FG004|Part 2|Lost to Follow-up|0|||
129830002|NCT01729754|467344334|FG005|Part 2|Lost to Follow-up|0|||
129830003|NCT01729754|467344335|FG006|Part 2|Lost to Follow-up|0|||
129830004|NCT01729754|467344336|FG007|Part 2|Lost to Follow-up|1|||
129830005|NCT01729754|467344337|FG008|Part 2|Lost to Follow-up|0|||
129830006|NCT01729754|467344338|FG009|Part 2|Lost to Follow-up|2|||
129830007|NCT01729754|467344329|FG000|Part 2|Non-Compliance with Study Drug|0|||
129830008|NCT01729754|467344330|FG001|Part 2|Non-Compliance with Study Drug|0|||
129830009|NCT01729754|467344331|FG002|Part 2|Non-Compliance with Study Drug|0|||
129830010|NCT01729754|467344332|FG003|Part 2|Non-Compliance with Study Drug|0|||
129830011|NCT01729754|467344333|FG004|Part 2|Non-Compliance with Study Drug|0|||
129830012|NCT01729754|467344334|FG005|Part 2|Non-Compliance with Study Drug|0|||
129830013|NCT01729754|467344335|FG006|Part 2|Non-Compliance with Study Drug|0|||
129830014|NCT01729754|467344336|FG007|Part 2|Non-Compliance with Study Drug|0|||
129830015|NCT01729754|467344337|FG008|Part 2|Non-Compliance with Study Drug|0|||
129830016|NCT01729754|467344338|FG009|Part 2|Non-Compliance with Study Drug|1|||
129830017|NCT01729754|467344329|FG000|Part 2|Pregnancy|0|||
129830018|NCT01729754|467344330|FG001|Part 2|Pregnancy|0|||
129830019|NCT01729754|467344331|FG002|Part 2|Pregnancy|0|||
129830020|NCT01729754|467344332|FG003|Part 2|Pregnancy|1|||
129830021|NCT01729754|467344333|FG004|Part 2|Pregnancy|0|||
129830022|NCT01729754|467344334|FG005|Part 2|Pregnancy|0|||
129830023|NCT01729754|467344335|FG006|Part 2|Pregnancy|0|||
129830024|NCT01729754|467344336|FG007|Part 2|Pregnancy|0|||
129830025|NCT01729754|467344337|FG008|Part 2|Pregnancy|0|||
129830026|NCT01729754|467344338|FG009|Part 2|Pregnancy|1|||
129830027|NCT01729754|467344329|FG000|Part 2|Withdrawal by Subject|3|||
129830028|NCT01729754|467344330|FG001|Part 2|Withdrawal by Subject|0|||
129830029|NCT01729754|467344331|FG002|Part 2|Withdrawal by Subject|0|||
129830030|NCT01729754|467344332|FG003|Part 2|Withdrawal by Subject|2|||
129830031|NCT01729754|467344333|FG004|Part 2|Withdrawal by Subject|0|||
129830032|NCT01729754|467344334|FG005|Part 2|Withdrawal by Subject|0|||
129830033|NCT01729754|467344335|FG006|Part 2|Withdrawal by Subject|0|||
129830034|NCT01729754|467344336|FG007|Part 2|Withdrawal by Subject|1|||
129830035|NCT01729754|467344337|FG008|Part 2|Withdrawal by Subject|1|||
129830036|NCT01729754|467344338|FG009|Part 2|Withdrawal by Subject|4|||
129830037|NCT01729754|467344329|FG000|Part 2|Other Protocol Specified Criteria|1|||
129830038|NCT01729754|467344330|FG001|Part 2|Other Protocol Specified Criteria|0|||
129830039|NCT01729754|467344331|FG002|Part 2|Other Protocol Specified Criteria|0|||
129830040|NCT01729754|467344332|FG003|Part 2|Other Protocol Specified Criteria|0|||
129830041|NCT01729754|467344333|FG004|Part 2|Other Protocol Specified Criteria|0|||
129830042|NCT01729754|467344334|FG005|Part 2|Other Protocol Specified Criteria|0|||
129830043|NCT01729754|467344335|FG006|Part 2|Other Protocol Specified Criteria|0|||
129830044|NCT01729754|467344336|FG007|Part 2|Other Protocol Specified Criteria|1|||
129830045|NCT01729754|467344337|FG008|Part 2|Other Protocol Specified Criteria|0|||
129830046|NCT01729754|467344338|FG009|Part 2|Other Protocol Specified Criteria|0|||
129830047|NCT01729754|467344329|FG000|Part 3|Adverse Event|0|||
129830048|NCT01729754|467344330|FG001|Part 3|Adverse Event|0|||
129830049|NCT01729754|467344331|FG002|Part 3|Adverse Event|1|||
129897690|NCT00517933|467584423|FG000|Period 1|Underwent lung transplant|0|||
129830050|NCT01729754|467344332|FG003|Part 3|Adverse Event|0|||
129830051|NCT01729754|467344333|FG004|Part 3|Adverse Event|0|||
129830052|NCT01729754|467344334|FG005|Part 3|Adverse Event|5|||
129830053|NCT01729754|467344335|FG006|Part 3|Adverse Event|0|||
129830054|NCT01729754|467344336|FG007|Part 3|Adverse Event|0|||
129830055|NCT01729754|467344337|FG008|Part 3|Adverse Event|0|||
129830056|NCT01729754|467344338|FG009|Part 3|Adverse Event|3|||
129830057|NCT01729754|467344329|FG000|Part 3|Death|0|||
129830058|NCT01729754|467344330|FG001|Part 3|Death|0|||
129830059|NCT01729754|467344331|FG002|Part 3|Death|0|||
129830060|NCT01729754|467344332|FG003|Part 3|Death|0|||
129830061|NCT01729754|467344333|FG004|Part 3|Death|0|||
129830062|NCT01729754|467344334|FG005|Part 3|Death|2|||
129830063|NCT01729754|467344335|FG006|Part 3|Death|0|||
129830064|NCT01729754|467344336|FG007|Part 3|Death|0|||
129830065|NCT01729754|467344337|FG008|Part 3|Death|0|||
129830066|NCT01729754|467344338|FG009|Part 3|Death|0|||
129830067|NCT01729754|467344329|FG000|Part 3|Lack of Efficacy|0|||
129830068|NCT01729754|467344330|FG001|Part 3|Lack of Efficacy|0|||
129830069|NCT01729754|467344331|FG002|Part 3|Lack of Efficacy|0|||
129830070|NCT01729754|467344332|FG003|Part 3|Lack of Efficacy|0|||
129830071|NCT01729754|467344333|FG004|Part 3|Lack of Efficacy|2|||
129830072|NCT01729754|467344334|FG005|Part 3|Lack of Efficacy|0|||
129830073|NCT01729754|467344335|FG006|Part 3|Lack of Efficacy|0|||
129830074|NCT01729754|467344336|FG007|Part 3|Lack of Efficacy|0|||
129830075|NCT01729754|467344337|FG008|Part 3|Lack of Efficacy|0|||
129830076|NCT01729754|467344338|FG009|Part 3|Lack of Efficacy|4|||
129830077|NCT01729754|467344329|FG000|Part 3|Lost to Follow-up|0|||
129830078|NCT01729754|467344330|FG001|Part 3|Lost to Follow-up|1|||
129830079|NCT01729754|467344331|FG002|Part 3|Lost to Follow-up|2|||
129830080|NCT01729754|467344332|FG003|Part 3|Lost to Follow-up|0|||
129830081|NCT01729754|467344333|FG004|Part 3|Lost to Follow-up|0|||
129830082|NCT01729754|467344334|FG005|Part 3|Lost to Follow-up|3|||
129830083|NCT01729754|467344335|FG006|Part 3|Lost to Follow-up|0|||
129830084|NCT01729754|467344336|FG007|Part 3|Lost to Follow-up|0|||
129830085|NCT01729754|467344337|FG008|Part 3|Lost to Follow-up|1|||
129830086|NCT01729754|467344338|FG009|Part 3|Lost to Follow-up|0|||
129830087|NCT01729754|467344329|FG000|Part 3|Physician Decision|0|||
129830088|NCT01729754|467344330|FG001|Part 3|Physician Decision|0|||
129830089|NCT01729754|467344331|FG002|Part 3|Physician Decision|1|||
129830090|NCT01729754|467344332|FG003|Part 3|Physician Decision|0|||
129830091|NCT01729754|467344333|FG004|Part 3|Physician Decision|0|||
129830092|NCT01729754|467344334|FG005|Part 3|Physician Decision|0|||
129830093|NCT01729754|467344335|FG006|Part 3|Physician Decision|0|||
129830094|NCT01729754|467344336|FG007|Part 3|Physician Decision|0|||
129830095|NCT01729754|467344337|FG008|Part 3|Physician Decision|0|||
129830096|NCT01729754|467344338|FG009|Part 3|Physician Decision|0|||
129830097|NCT01729754|467344329|FG000|Part 3|Withdrawal by Subject|0|||
129830098|NCT01729754|467344330|FG001|Part 3|Withdrawal by Subject|4|||
129830099|NCT01729754|467344331|FG002|Part 3|Withdrawal by Subject|1|||
129830100|NCT01729754|467344332|FG003|Part 3|Withdrawal by Subject|0|||
129830101|NCT01729754|467344333|FG004|Part 3|Withdrawal by Subject|2|||
129830102|NCT01729754|467344334|FG005|Part 3|Withdrawal by Subject|1|||
129830103|NCT01729754|467344335|FG006|Part 3|Withdrawal by Subject|0|||
129830104|NCT01729754|467344336|FG007|Part 3|Withdrawal by Subject|2|||
129830105|NCT01729754|467344337|FG008|Part 3|Withdrawal by Subject|0|||
129830106|NCT01729754|467344338|FG009|Part 3|Withdrawal by Subject|0|||
129830107|NCT01729754|467344329|FG000|Part 3|Other Protocol Specified Criteria|0|||
129830108|NCT01729754|467344330|FG001|Part 3|Other Protocol Specified Criteria|0|||
129830109|NCT01729754|467344331|FG002|Part 3|Other Protocol Specified Criteria|0|||
129830110|NCT01729754|467344332|FG003|Part 3|Other Protocol Specified Criteria|0|||
129830111|NCT01729754|467344333|FG004|Part 3|Other Protocol Specified Criteria|0|||
129830112|NCT01729754|467344334|FG005|Part 3|Other Protocol Specified Criteria|2|||
129830113|NCT01729754|467344335|FG006|Part 3|Other Protocol Specified Criteria|0|||
129830114|NCT01729754|467344336|FG007|Part 3|Other Protocol Specified Criteria|1|||
129830115|NCT01729754|467344337|FG008|Part 3|Other Protocol Specified Criteria|0|||
129830116|NCT01729754|467344338|FG009|Part 3|Other Protocol Specified Criteria|0|||
129830117|NCT00773292|467344339|FG000|Treatment 48 Weeks|Adverse Event|1|||
129830118|NCT00773292|467344339|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
129830119|NCT02794103|467344340|FG000|Overall Study|Loss to follow up due to high sedation|3|||
129830120|NCT04608500|467344341|FG000|Overall Study|Adverse Event|2|||
129830121|NCT04608500|467344342|FG001|Overall Study|Adverse Event|0|||
129830122|NCT04608500|467344341|FG000|Overall Study|Lost to Follow-up|15|||
129830123|NCT04608500|467344342|FG001|Overall Study|Lost to Follow-up|9|||
129830124|NCT04608500|467344341|FG000|Overall Study|Participant request|11|||
129445750|NCT01910116|465932902|FG000|Overall Study|Withdrawal by Subject|8|||
129445751|NCT01910116|465932903|FG001|Overall Study|Withdrawal by Subject|3|||
129445752|NCT01910116|465932902|FG000|Overall Study|uncertain allocation|1|||
129830125|NCT04608500|467344342|FG001|Overall Study|Participant request|7|||
129830126|NCT04608500|467344341|FG000|Overall Study|Protocol Violation|1|||
129830127|NCT04608500|467344342|FG001|Overall Study|Protocol Violation|0|||
129830128|NCT04608500|467344341|FG000|Overall Study|Other|6|||
129830129|NCT04608500|467344342|FG001|Overall Study|Other|2|||
129830130|NCT00542919|467344343|FG000|Overall Study|Adverse Event|1|||
129830131|NCT00542919|467344344|FG001|Overall Study|Adverse Event|5|||
129830132|NCT00542919|467344345|FG002|Overall Study|Adverse Event|1|||
129830133|NCT00542919|467344343|FG000|Overall Study|Withdrawal by Subject|1|||
129830134|NCT00542919|467344344|FG001|Overall Study|Withdrawal by Subject|0|||
129830135|NCT00542919|467344345|FG002|Overall Study|Withdrawal by Subject|3|||
129830136|NCT00542919|467344343|FG000|Overall Study|Physician Decision|2|||
129830137|NCT00542919|467344344|FG001|Overall Study|Physician Decision|2|||
129830138|NCT00542919|467344345|FG002|Overall Study|Physician Decision|1|||
129830139|NCT00542919|467344343|FG000|Overall Study|Sponsor Decision|1|||
129830140|NCT00542919|467344344|FG001|Overall Study|Sponsor Decision|0|||
129830141|NCT00542919|467344345|FG002|Overall Study|Sponsor Decision|0|||
129830142|NCT00542919|467344343|FG000|Overall Study|Lost to Follow-up|2|||
129830143|NCT00542919|467344344|FG001|Overall Study|Lost to Follow-up|0|||
129830144|NCT00542919|467344345|FG002|Overall Study|Lost to Follow-up|1|||
129830145|NCT02747420|467344346|FG000|Overall Study|Lost to Follow-up|4|||
129830146|NCT02747420|467344347|FG001|Overall Study|Lost to Follow-up|2|||
129830147|NCT02747420|467344346|FG000|Overall Study|Withdrawal by Subject|3|||
129830148|NCT02747420|467344347|FG001|Overall Study|Withdrawal by Subject|2|||
129830149|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
129830150|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830151|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830152|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830153|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830154|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830155|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830156|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830157|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
129830158|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830159|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
129830160|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830161|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830162|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830163|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830164|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830165|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830166|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
129830167|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
129830168|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
129830169|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
129830170|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
129830171|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
129830172|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
129830173|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
129830174|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
129830175|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
129830176|NCT03662542|467344348|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
129830177|NCT03662542|467344349|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830178|NCT03662542|467344350|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830179|NCT03662542|467344351|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830180|NCT03662542|467344352|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830181|NCT03662542|467344353|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830182|NCT03662542|467344354|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830183|NCT03662542|467344355|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830184|NCT03662542|467344356|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
129830185|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830186|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830187|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830188|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830189|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830190|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
129830191|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830192|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830193|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
129830194|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830195|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830196|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830197|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
129830198|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
129830199|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830200|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830201|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830202|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
129830203|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830204|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830205|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830206|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
129830207|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
129830208|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
129830209|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830210|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830211|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
129830212|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129897691|NCT00517933|467584424|FG001|Period 1|Underwent lung transplant|1|||
129897692|NCT00517933|467584423|FG000|Period 2|Death|2|||
129897693|NCT00517933|467584424|FG001|Period 2|Death|4|||
129897694|NCT00517933|467584423|FG000|Period 2|Adverse Event|2|||
129445753|NCT01910116|465932903|FG001|Overall Study|uncertain allocation|3|||
129830213|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830214|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830215|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830216|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
129830217|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
129830218|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830219|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830220|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
129830221|NCT03662542|467344348|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830222|NCT03662542|467344349|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830223|NCT03662542|467344350|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830224|NCT03662542|467344351|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830225|NCT03662542|467344352|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830226|NCT03662542|467344353|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
129830227|NCT03662542|467344354|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830228|NCT03662542|467344355|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830229|NCT03662542|467344356|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
129830230|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830231|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830232|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830233|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830234|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830235|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830236|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830237|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
129830238|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
129830239|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830240|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830241|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830242|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830243|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830244|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830245|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
129830246|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
129830247|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
129830248|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830249|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830250|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830251|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830252|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830253|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830254|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
129830255|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
129830256|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
129830257|NCT03662542|467344348|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830258|NCT03662542|467344349|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830259|NCT03662542|467344350|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830260|NCT03662542|467344351|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830261|NCT03662542|467344352|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830262|NCT03662542|467344353|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
129830263|NCT03662542|467344354|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
129830264|NCT03662542|467344355|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
129830265|NCT03662542|467344356|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
129830266|NCT01217060|467344357|FG000|Overall Study|Withdrawal by Subject|1|||
129830267|NCT03388138|467344362|FG000|Overall Study|Protocol Violation|1|||
129830268|NCT03388138|467344363|FG001|Overall Study|Protocol Violation|0|||
129830269|NCT01528072|467344366|FG000|Overall Study|Withdrawal by Subject|5|||
129830270|NCT01528072|467344366|FG000|Overall Study|Physician Decision|1|||
129830271|NCT01528072|467344366|FG000|Overall Study|Determined not eligible by AEAC|1|||
129830272|NCT01528072|467344366|FG000|Overall Study|Missed Visit|2|||
129830273|NCT01528072|467344366|FG000|Overall Study|Lost to Follow-up|5|||
129830274|NCT01528072|467344366|FG000|Overall Study|Explanted|2|||
129830275|NCT01528072|467344366|FG000|Overall Study|Site Closure|4|||
129897695|NCT00517933|467584424|FG001|Period 2|Adverse Event|4|||
129445754|NCT01910116|465932902|FG000|Overall Study|incomplete data|0|||
129830276|NCT01528072|467344366|FG000|Overall Study|Death|2|||
129830277|NCT01528072|467344366|FG000|Overall Study|Early Termination of Study|52|||
129830278|NCT01859494|467344369|FG000|Overall Study|Adverse Event|1|||
129830279|NCT02769247|467344378|FG000|Overall Study|Withdrawal by Subject|1|||
129830280|NCT02769247|467344379|FG001|Overall Study|Withdrawal by Subject|0|||
129830281|NCT02769247|467344380|FG002|Overall Study|Withdrawal by Subject|0|||
129830282|NCT02769247|467344381|FG003|Overall Study|Withdrawal by Subject|1|||
129830283|NCT02769247|467344378|FG000|Overall Study|Protocol Violation|0|||
129830284|NCT02769247|467344379|FG001|Overall Study|Protocol Violation|0|||
129830285|NCT02769247|467344380|FG002|Overall Study|Protocol Violation|1|||
129830286|NCT02769247|467344381|FG003|Overall Study|Protocol Violation|0|||
129830287|NCT02769247|467344378|FG000|Overall Study|Physician Decision|1|||
129830288|NCT02769247|467344379|FG001|Overall Study|Physician Decision|0|||
129830289|NCT02769247|467344380|FG002|Overall Study|Physician Decision|0|||
129830290|NCT02769247|467344381|FG003|Overall Study|Physician Decision|0|||
129830291|NCT01462084|467344387|FG000|Overall Study|Withdrawal by Subject|1|||
129830292|NCT01462084|467344388|FG001|Overall Study|Withdrawal by Subject|0|||
129830293|NCT01462084|467344387|FG000|Overall Study|Protocol Violation|1|||
129830294|NCT01462084|467344388|FG001|Overall Study|Protocol Violation|1|||
129830295|NCT05089682|467344389|FG000|Overall Study|Withdrawal by Subject|2|||
129830296|NCT01996826|467344390|FG000|Overall Study|Lost to Follow-up|6|||
129830297|NCT01996826|467344391|FG001|Overall Study|Lost to Follow-up|2|||
129830298|NCT01996826|467344390|FG000|Overall Study|Physician Decision|1|||
129830299|NCT01996826|467344391|FG001|Overall Study|Physician Decision|1|||
129830300|NCT00695396|467344392|FG000|Overall Study|Study Closed Prematurely|5|||
129830301|NCT00695396|467344393|FG001|Overall Study|Study Closed Prematurely|6|||
129830302|NCT00695396|467344394|FG002|Overall Study|Study Closed Prematurely|8|||
129830303|NCT00695396|467344392|FG000|Overall Study|Withdrawal by Subject|2|||
129830304|NCT00695396|467344393|FG001|Overall Study|Withdrawal by Subject|2|||
129830305|NCT00695396|467344394|FG002|Overall Study|Withdrawal by Subject|0|||
129830306|NCT01514760|467344396|FG000|Overall Study|Lost to Follow-up|2|||
129830307|NCT02092662|467344397|FG000|Overall Study|Lost to Follow-up|13|||
129830308|NCT02092662|467344398|FG001|Overall Study|Lost to Follow-up|0|||
129830309|NCT02418468|467344399|FG000|Overall Study|Adverse Event|1|||
129830310|NCT02418468|467344400|FG001|Overall Study|Adverse Event|0|||
129830311|NCT02418468|467344399|FG000|Overall Study|Withdrawal of informed consent|1|||
129830312|NCT02418468|467344400|FG001|Overall Study|Withdrawal of informed consent|1|||
129830313|NCT02914769|467344401|FG000|Overall Study|Protocol Violation|3|||
129830314|NCT02914769|467344402|FG001|Overall Study|Protocol Violation|2|||
129830315|NCT02914769|467344401|FG000|Overall Study|Withdrawal by Subject|0|||
129830316|NCT02914769|467344402|FG001|Overall Study|Withdrawal by Subject|1|||
129830317|NCT01592344|467344403|FG000|Overall Study|Adverse Event|1|||
129830318|NCT01592344|467344404|FG001|Overall Study|Adverse Event|1|||
129830319|NCT01592344|467344403|FG000|Overall Study|Lack of Efficacy|1|||
129830320|NCT01592344|467344404|FG001|Overall Study|Lack of Efficacy|0|||
129830321|NCT01592344|467344403|FG000|Overall Study|not available at primary outcome visit|2|||
129830322|NCT01592344|467344404|FG001|Overall Study|not available at primary outcome visit|4|||
129830323|NCT00099437|467344405|FG000|Overall Study|Lost to Follow-up|30|||
129830324|NCT00099437|467344406|FG001|Overall Study|Lost to Follow-up|33|||
129830325|NCT00099437|467344405|FG000|Overall Study|Death|293|||
129830326|NCT00099437|467344406|FG001|Overall Study|Death|261|||
129830327|NCT00099437|467344405|FG000|Overall Study|Withdrawal by Subject|6|||
129830328|NCT00099437|467344406|FG001|Overall Study|Withdrawal by Subject|10|||
129830329|NCT00099437|467344405|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
129830330|NCT00099437|467344406|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
129830331|NCT02809677|467344409|FG000|Overall Study|Withdrawal by Subject|8|||
129830332|NCT04969224|467344410|FG000|Overall Study|Adverse Event|1|||
129830333|NCT04969224|467344410|FG000|Overall Study|Enrolled but never dosed|1|||
129830334|NCT00613015|467344411|FG000|Overall Study|Lost to Follow-up|0|||
129830335|NCT00613015|467344412|FG001|Overall Study|Lost to Follow-up|1|||
129830336|NCT00613015|467344413|FG002|Overall Study|Lost to Follow-up|3|||
129830337|NCT00613015|467344414|FG003|Overall Study|Lost to Follow-up|3|||
129830338|NCT00613015|467344415|FG004|Overall Study|Lost to Follow-up|2|||
129830339|NCT00613015|467344416|FG005|Overall Study|Lost to Follow-up|3|||
129830340|NCT04256785|467344417|FG000|Overall Study|Adverse Event|8|||
129830341|NCT04256785|467344418|FG001|Overall Study|Adverse Event|6|||
129830342|NCT04256785|467344417|FG000|Overall Study|Lack of Efficacy|3|||
129830343|NCT04256785|467344418|FG001|Overall Study|Lack of Efficacy|4|||
129830344|NCT04256785|467344417|FG000|Overall Study|Lost to Follow-up|7|||
129830345|NCT04256785|467344418|FG001|Overall Study|Lost to Follow-up|7|||
129830346|NCT04256785|467344417|FG000|Overall Study|Protocol Violation|1|||
129830347|NCT04256785|467344418|FG001|Overall Study|Protocol Violation|0|||
129830348|NCT04256785|467344417|FG000|Overall Study|Withdrawal by Subject|4|||
129830349|NCT04256785|467344418|FG001|Overall Study|Withdrawal by Subject|1|||
129830350|NCT04256785|467344417|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
129830351|NCT04256785|467344418|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
129830352|NCT03559257|467344424|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
129830353|NCT03559257|467344425|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
129830354|NCT03559257|467344424|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129830355|NCT03559257|467344425|FG001|Double Blind Treatment Period|Protocol Violation|4|||
129830356|NCT03559257|467344424|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
129830357|NCT03559257|467344425|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
129830358|NCT03559257|467344424|FG000|Double Blind Treatment Period|Adverse Event|0|||
129830359|NCT03559257|467344425|FG001|Double Blind Treatment Period|Adverse Event|1|||
129830360|NCT03559257|467344424|FG000|Double Blind Treatment Period|Screen Failure|0|||
129830361|NCT03559257|467344425|FG001|Double Blind Treatment Period|Screen Failure|1|||
129830362|NCT03559257|467344424|FG000|Open-label Treatment Period|Adverse Event|1|||
129830363|NCT03559257|467344425|FG001|Open-label Treatment Period|Adverse Event|4|||
129830364|NCT03559257|467344424|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
129830365|NCT03559257|467344425|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
129830366|NCT03559257|467344424|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
129830367|NCT03559257|467344425|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129830368|NCT03559257|467344424|FG000|Open-label Treatment Period|Protocol Violation|2|||
129830369|NCT03559257|467344425|FG001|Open-label Treatment Period|Protocol Violation|0|||
129830370|NCT03559257|467344424|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
129830371|NCT03559257|467344425|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129830372|NCT03559257|467344424|FG000|Open-label Treatment Period|Physician Decision|0|||
129830373|NCT03559257|467344425|FG001|Open-label Treatment Period|Physician Decision|1|||
129830374|NCT01288287|467344426|FG000|Overall Study|Lost to Follow-up|8|||
129830375|NCT01288287|467344426|FG000|Overall Study|Withdrawal by Subject|4|||
129830376|NCT01288287|467344426|FG000|Overall Study|Lack of Efficacy|13|||
129830377|NCT01288287|467344426|FG000|Overall Study|Other Reason|13|||
129830378|NCT01288287|467344426|FG000|Overall Study|Unknown Reason|1|||
129830379|NCT01288287|467344426|FG000|Overall Study|Unknown Status|7|||
129830380|NCT01092182|467344427|FG000|Overall Study|Death|0|||
129830381|NCT01092182|467344428|FG001|Overall Study|Death|5|||
129830382|NCT01092182|467344429|FG002|Overall Study|Death|3|||
129830383|NCT01092182|467344427|FG000|Overall Study|participant safety|1|||
129830384|NCT01092182|467344428|FG001|Overall Study|participant safety|2|||
129830385|NCT01092182|467344429|FG002|Overall Study|participant safety|0|||
129830386|NCT01092182|467344427|FG000|Overall Study|Physician Decision|0|||
129830387|NCT01092182|467344428|FG001|Overall Study|Physician Decision|6|||
129830388|NCT01092182|467344429|FG002|Overall Study|Physician Decision|0|||
129830389|NCT01092182|467344427|FG000|Overall Study|Did not meet criteria|0|||
129830390|NCT01092182|467344428|FG001|Overall Study|Did not meet criteria|0|||
129830391|NCT01092182|467344429|FG002|Overall Study|Did not meet criteria|25|||
129830392|NCT01092182|467344427|FG000|Overall Study|Non-compliance|0|||
129830393|NCT01092182|467344428|FG001|Overall Study|Non-compliance|3|||
129830394|NCT01092182|467344429|FG002|Overall Study|Non-compliance|0|||
129830395|NCT01092182|467344427|FG000|Overall Study|Participant refused follow-up|0|||
129830396|NCT01092182|467344428|FG001|Overall Study|Participant refused follow-up|2|||
129830397|NCT01092182|467344429|FG002|Overall Study|Participant refused follow-up|0|||
129830398|NCT02515045|467344436|FG000|Overall Study|Adverse Event|0|||
129830399|NCT02515045|467344437|FG001|Overall Study|Adverse Event|3|||
129830400|NCT02515045|467344438|FG002|Overall Study|Adverse Event|3|||
129830401|NCT02515045|467344436|FG000|Overall Study|Lost to Follow-up|0|||
129830402|NCT02515045|467344437|FG001|Overall Study|Lost to Follow-up|1|||
129830403|NCT02515045|467344438|FG002|Overall Study|Lost to Follow-up|1|||
129830404|NCT01675128|467344441|FG000|Overall Study|Disease progression on study|1|||
129830405|NCT01675128|467344442|FG001|Overall Study|Disease progression on study|1|||
129830406|NCT01675128|467344443|FG002|Overall Study|Disease progression on study|1|||
129830407|NCT01675128|467344441|FG000|Overall Study|Refused further treatment|1|||
129830408|NCT01675128|467344442|FG001|Overall Study|Refused further treatment|0|||
129830409|NCT01675128|467344443|FG002|Overall Study|Refused further treatment|0|||
129830410|NCT01675128|467344441|FG000|Overall Study|Pulmonary complication; off study|0|||
129830411|NCT01675128|467344442|FG001|Overall Study|Pulmonary complication; off study|1|||
129830412|NCT01675128|467344443|FG002|Overall Study|Pulmonary complication; off study|0|||
129830413|NCT00832585|467344452|FG000|Overall Study|Withdrawal by Subject|1|||
129830414|NCT00832585|467344452|FG000|Overall Study|Lost to Follow-up|1|||
129830415|NCT01374087|467344458|FG000|Overall Study|Adverse Event|1|||
129830416|NCT01374087|467344459|FG001|Overall Study|Adverse Event|0|||
129830417|NCT01374087|467344458|FG000|Overall Study|Disease progression|2|||
129830418|NCT01374087|467344459|FG001|Overall Study|Disease progression|2|||
129830419|NCT01374087|467344458|FG000|Overall Study|Study discontinued|13|||
129830420|NCT01374087|467344459|FG001|Overall Study|Study discontinued|13|||
129830421|NCT03011307|467344460|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
129830422|NCT03011307|467344461|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
129830423|NCT03011307|467344460|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
129830424|NCT03011307|467344461|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
129830425|NCT03011307|467344460|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
129830426|NCT03011307|467344461|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
129830427|NCT00271947|467344462|FG000|Overall Study|Lost to Follow-up|1|||
129830428|NCT02677987|467344463|FG000|Overall Study|Withdrawal by Subject|3|||
129830429|NCT02677987|467344464|FG001|Overall Study|Withdrawal by Subject|0|||
129830430|NCT02677987|467344463|FG000|Overall Study|Lost to Follow-up|1|||
129830431|NCT02677987|467344464|FG001|Overall Study|Lost to Follow-up|0|||
129830432|NCT01522365|467344467|FG000|Overall Study|Withdrawal by Subject|1|||
129830433|NCT01522365|467344468|FG001|Overall Study|Withdrawal by Subject|1|||
129830434|NCT01522365|467344467|FG000|Overall Study|Lost to Follow-up|1|||
129830435|NCT01522365|467344468|FG001|Overall Study|Lost to Follow-up|1|||
129830436|NCT00673179|467344469|FG000|Overall Study|Toxicity/Complications|3|||
129830437|NCT00673179|467344470|FG001|Overall Study|Toxicity/Complications|0|||
129830438|NCT02466555|467344471|FG000|Overall Study|Lost to Follow-up|2|||
129830439|NCT04170348|467344472|FG000|Overall Study|Lost to Follow-up|2|||
129830440|NCT04170348|467344473|FG001|Overall Study|Lost to Follow-up|2|||
129830441|NCT04170348|467344472|FG000|Overall Study|Withdrawal by Subject|1|||
129830442|NCT04170348|467344473|FG001|Overall Study|Withdrawal by Subject|5|||
129830443|NCT04170348|467344472|FG000|Overall Study|Non-adherence|1|||
129830444|NCT04170348|467344473|FG001|Overall Study|Non-adherence|1|||
129830445|NCT04170348|467344472|FG000|Overall Study|Adverse Event|1|||
129830446|NCT04170348|467344473|FG001|Overall Study|Adverse Event|0|||
129830447|NCT01120756|467344474|FG000|Overall Study|Withdrawal by Subject|1|||
129830448|NCT01120756|467344475|FG001|Overall Study|Withdrawal by Subject|1|||
129830449|NCT03760146|467344481|FG000|Overall Study|Adverse Event|11|||
129830450|NCT03760146|467344482|FG001|Overall Study|Adverse Event|8|||
129830451|NCT03760146|467344483|FG002|Overall Study|Adverse Event|0|||
129830452|NCT03760146|467344484|FG003|Overall Study|Adverse Event|0|||
129830453|NCT03760146|467344485|FG004|Overall Study|Adverse Event|0|||
129830454|NCT03760146|467344486|FG005|Overall Study|Adverse Event|0|||
129830455|NCT03760146|467344481|FG000|Overall Study|Death|1|||
129830456|NCT03760146|467344482|FG001|Overall Study|Death|0|||
129830457|NCT03760146|467344483|FG002|Overall Study|Death|0|||
129830458|NCT03760146|467344484|FG003|Overall Study|Death|0|||
129830459|NCT03760146|467344485|FG004|Overall Study|Death|0|||
129830460|NCT03760146|467344486|FG005|Overall Study|Death|0|||
129830461|NCT03760146|467344481|FG000|Overall Study|Lost to Follow-up|41|||
129830462|NCT03760146|467344482|FG001|Overall Study|Lost to Follow-up|28|||
129830463|NCT03760146|467344483|FG002|Overall Study|Lost to Follow-up|9|||
129830464|NCT03760146|467344484|FG003|Overall Study|Lost to Follow-up|2|||
129830465|NCT03760146|467344485|FG004|Overall Study|Lost to Follow-up|14|||
129830466|NCT03760146|467344486|FG005|Overall Study|Lost to Follow-up|8|||
129830467|NCT03760146|467344481|FG000|Overall Study|No longer met eligibility criteria|3|||
129830468|NCT03760146|467344482|FG001|Overall Study|No longer met eligibility criteria|9|||
129830469|NCT03760146|467344483|FG002|Overall Study|No longer met eligibility criteria|0|||
129830470|NCT03760146|467344484|FG003|Overall Study|No longer met eligibility criteria|0|||
129830471|NCT03760146|467344485|FG004|Overall Study|No longer met eligibility criteria|1|||
129830472|NCT03760146|467344486|FG005|Overall Study|No longer met eligibility criteria|0|||
129830473|NCT03760146|467344481|FG000|Overall Study|Protocol Violation|21|||
129830474|NCT03760146|467344482|FG001|Overall Study|Protocol Violation|13|||
129830475|NCT03760146|467344483|FG002|Overall Study|Protocol Violation|1|||
129830476|NCT03760146|467344484|FG003|Overall Study|Protocol Violation|0|||
129830477|NCT03760146|467344485|FG004|Overall Study|Protocol Violation|1|||
129830478|NCT03760146|467344486|FG005|Overall Study|Protocol Violation|0|||
129830479|NCT03760146|467344481|FG000|Overall Study|Withdrawal by Subject|19|||
129830480|NCT03760146|467344482|FG001|Overall Study|Withdrawal by Subject|20|||
129830481|NCT03760146|467344483|FG002|Overall Study|Withdrawal by Subject|1|||
129830482|NCT03760146|467344484|FG003|Overall Study|Withdrawal by Subject|0|||
129830483|NCT03760146|467344485|FG004|Overall Study|Withdrawal by Subject|1|||
129830484|NCT03760146|467344486|FG005|Overall Study|Withdrawal by Subject|0|||
129830485|NCT01082965|467344487|FG000|Overall Study|Protocol Violation|0|||
129830486|NCT01082965|467344488|FG001|Overall Study|Protocol Violation|1|||
129830487|NCT01082965|467344487|FG000|Overall Study|Other|1|||
129830488|NCT01082965|467344488|FG001|Overall Study|Other|1|||
129830489|NCT03839212|467344490|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
129830490|NCT00445965|467344491|FG000|Overall Study|Adverse Event|2|||
129830491|NCT00445965|467344491|FG000|Overall Study|Physician Decision|1|||
129830492|NCT00445965|467344491|FG000|Overall Study|Enrolled but not treated|1|||
129830493|NCT00445965|467344491|FG000|Overall Study|Removed due to progressive disease|29|||
129830494|NCT00679263|467344492|FG000|Visit 2/Dose 1|Adverse Event|1|||
129830495|NCT00679263|467344493|FG001|Visit 2/Dose 1|Adverse Event|0|||
129830496|NCT00679263|467344494|FG002|Visit 2/Dose 1|Adverse Event|0|||
129830497|NCT00679263|467344492|FG000|Visit 2/Dose 1|subject not compliance|1|||
129830498|NCT00679263|467344493|FG001|Visit 2/Dose 1|subject not compliance|1|||
129830499|NCT00679263|467344494|FG002|Visit 2/Dose 1|subject not compliance|0|||
129830500|NCT01464346|467344498|FG000|Overall Study|Withdrawal by Subject|0|||
129830501|NCT01464346|467344499|FG001|Overall Study|Withdrawal by Subject|0|||
129830502|NCT01464346|467344500|FG002|Overall Study|Withdrawal by Subject|1|||
129830503|NCT03999892|467344501|FG000|Overall Study|Lost to Follow-up|1|||
129830504|NCT02295995|467344502|FG000|Overall Study|Lost to Follow-up|5|||
129830505|NCT02295995|467344503|FG001|Overall Study|Lost to Follow-up|1|||
129830506|NCT02447081|467344504|FG000|Overall Study|Death|161|||
129830507|NCT02447081|467344504|FG000|Overall Study|Lost to Follow-up|36|||
129830508|NCT02447081|467344504|FG000|Overall Study|Visit not completed|17|||
129830509|NCT02447081|467344504|FG000|Overall Study|unsuccessful implant procedure|10|||
129830510|NCT02406651|467344507|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
129830511|NCT02255981|467346026|FG000|Overall Study|Lost to Follow-up|3|||
129830512|NCT02255981|467346026|FG000|Overall Study|Withdrawal by Subject|1|||
129830513|NCT01046682|467346029|FG000|Overall Study|Adverse Event|2|||
129830514|NCT01046682|467346030|FG001|Overall Study|Adverse Event|0|||
129830515|NCT00371254|467346031|FG000|Overall Study|Disease progression|13|||
129830516|NCT00371254|467346032|FG001|Overall Study|Disease progression|13|||
129830517|NCT00371254|467346031|FG000|Overall Study|Study drug toxicity|3|||
129830518|NCT00371254|467346032|FG001|Overall Study|Study drug toxicity|5|||
129830519|NCT00371254|467346031|FG000|Overall Study|Subject request|5|||
129830520|NCT00371254|467346032|FG001|Overall Study|Subject request|0|||
129830521|NCT00371254|467346031|FG000|Overall Study|Investigator Decision|2|||
129830522|NCT00371254|467346032|FG001|Overall Study|Investigator Decision|0|||
129830523|NCT00371254|467346031|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129830524|NCT00371254|467346032|FG001|Overall Study|Adverse event unrelated to study drug|1|||
129830525|NCT00371254|467346031|FG000|Overall Study|Lost to Follow-up|0|||
129830526|NCT00371254|467346032|FG001|Overall Study|Lost to Follow-up|1|||
129830527|NCT00371254|467346031|FG000|Overall Study|Withdrawal by Subject|0|||
129830528|NCT00371254|467346032|FG001|Overall Study|Withdrawal by Subject|1|||
129830529|NCT02246673|467346035|FG000|Overall Study|Sponsor Decision|1|||
129830530|NCT02246673|467346036|FG001|Overall Study|Sponsor Decision|0|||
129830531|NCT02246673|467346037|FG002|Overall Study|Sponsor Decision|0|||
129830532|NCT02246673|467346038|FG003|Overall Study|Sponsor Decision|0|||
129830533|NCT02246673|467346039|FG004|Overall Study|Sponsor Decision|0|||
129830534|NCT02246673|467346035|FG000|Overall Study|Withdrawal by Subject|0|||
129830535|NCT02246673|467346036|FG001|Overall Study|Withdrawal by Subject|0|||
129830536|NCT02246673|467346037|FG002|Overall Study|Withdrawal by Subject|0|||
129830537|NCT02246673|467346038|FG003|Overall Study|Withdrawal by Subject|0|||
129830538|NCT02246673|467346039|FG004|Overall Study|Withdrawal by Subject|1|||
129830539|NCT02246673|467346035|FG000|Overall Study|Lost to Follow-up|0|||
129830540|NCT02246673|467346036|FG001|Overall Study|Lost to Follow-up|0|||
129830541|NCT02246673|467346037|FG002|Overall Study|Lost to Follow-up|0|||
129830542|NCT02246673|467346038|FG003|Overall Study|Lost to Follow-up|1|||
129830543|NCT02246673|467346039|FG004|Overall Study|Lost to Follow-up|0|||
129830544|NCT02246673|467346035|FG000|Overall Study|Protocol Violation|0|||
129830545|NCT02246673|467346036|FG001|Overall Study|Protocol Violation|0|||
129830546|NCT02246673|467346037|FG002|Overall Study|Protocol Violation|0|||
129830547|NCT02246673|467346038|FG003|Overall Study|Protocol Violation|1|||
129830548|NCT02246673|467346039|FG004|Overall Study|Protocol Violation|0|||
129830549|NCT05413369|467346044|FG000|Overall Study|Adverse Event|1|||
129830550|NCT05413369|467346045|FG001|Overall Study|Adverse Event|1|||
129830551|NCT05413369|467346044|FG000|Overall Study|Withdrawal by Subject|13|||
129830552|NCT05413369|467346045|FG001|Overall Study|Withdrawal by Subject|4|||
129830553|NCT05413369|467346044|FG000|Overall Study|Non-compliance with study schedule|2|||
129830554|NCT05413369|467346045|FG001|Overall Study|Non-compliance with study schedule|1|||
129830555|NCT05413369|467346044|FG000|Overall Study|Other|1|||
129830556|NCT05413369|467346045|FG001|Overall Study|Other|1|||
129830557|NCT00720057|467346046|FG000|Overall Study|Lost to Follow-up|0|||
129830558|NCT00720057|467346047|FG001|Overall Study|Lost to Follow-up|2|||
129830559|NCT00720057|467346046|FG000|Overall Study|Protocol Violation|1|||
129830560|NCT00720057|467346047|FG001|Overall Study|Protocol Violation|0|||
129830561|NCT00720057|467346046|FG000|Overall Study|Withdrawal by Subject|0|||
129830562|NCT00720057|467346047|FG001|Overall Study|Withdrawal by Subject|1|||
129830563|NCT02726074|467346051|FG000|Overall Study|Withdrawal by Subject|4|||
129830564|NCT02726074|467346051|FG000|Overall Study|Adverse Event|14|||
129830565|NCT02726074|467346051|FG000|Overall Study|Protocol Violation|3|||
129830566|NCT02726074|467346051|FG000|Overall Study|Lost to Follow-up|2|||
129830567|NCT02726074|467346051|FG000|Overall Study|Others|3|||
129830568|NCT01679002|467346052|FG000|Overall Study|Adverse Event|1|||
129830569|NCT01679002|467346053|FG001|Overall Study|Adverse Event|1|||
129830570|NCT01679002|467346054|FG002|Overall Study|Adverse Event|0|||
129830571|NCT01179477|467346058|FG000|Overall Study|Death|542|||
129830572|NCT01179477|467346058|FG000|Overall Study|Unsuccessful implant|80|||
129830573|NCT01179477|467346058|FG000|Overall Study|Non-death withdrawal|438|||
129830574|NCT01179477|467346058|FG000|Overall Study|Did not complete final visit|27|||
129830575|NCT00975481|467346065|FG000|Second Intervention Period|Adverse Event|2|||
129830576|NCT00975481|467346066|FG001|Second Intervention Period|Adverse Event|1|||
129830577|NCT00975481|467346067|FG002|Second Intervention Period|Adverse Event|0|||
129830578|NCT00975481|467346068|FG003|Second Intervention Period|Adverse Event|0|||
129830579|NCT00975481|467346069|FG004|Second Intervention Period|Adverse Event|0|||
129830580|NCT00975481|467346070|FG005|Second Intervention Period|Adverse Event|0|||
129830581|NCT00975481|467346065|FG000|Second Intervention Period|Withdrawal by Subject|0|||
129830582|NCT00975481|467346066|FG001|Second Intervention Period|Withdrawal by Subject|0|||
129830583|NCT00975481|467346067|FG002|Second Intervention Period|Withdrawal by Subject|1|||
129830584|NCT00975481|467346068|FG003|Second Intervention Period|Withdrawal by Subject|0|||
129897696|NCT00517933|467584423|FG000|Period 2|Physician Decision|1|||
129830585|NCT00975481|467346069|FG004|Second Intervention Period|Withdrawal by Subject|0|||
129830586|NCT00975481|467346070|FG005|Second Intervention Period|Withdrawal by Subject|0|||
129830587|NCT00975481|467346065|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
129830588|NCT00975481|467346066|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
129830589|NCT00975481|467346067|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
129830590|NCT00975481|467346068|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
129830591|NCT00975481|467346069|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
129830592|NCT00975481|467346070|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
129830593|NCT00975481|467346065|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
129830594|NCT00975481|467346066|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
129830595|NCT00975481|467346067|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
129830596|NCT00975481|467346068|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
129830597|NCT00975481|467346069|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
129830598|NCT00975481|467346070|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
129830599|NCT00643682|467346071|FG000|Overall Study|did not keep appointment|522|||
129830600|NCT00643682|467346072|FG001|Overall Study|did not keep appointment|509|||
129830601|NCT03630120|467346076|FG000|Overall Study|Disease progression|0|||
129830602|NCT03630120|467346077|FG001|Overall Study|Disease progression|1|||
129830603|NCT03630120|467346078|FG002|Overall Study|Disease progression|1|||
129830604|NCT03630120|467346079|FG003|Overall Study|Disease progression|1|||
129830605|NCT03755414|467346081|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
129830606|NCT03755414|467346082|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
129830607|NCT03755414|467346083|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
129830608|NCT03755414|467346081|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
129830609|NCT03755414|467346082|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
129830610|NCT03755414|467346083|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
129830611|NCT03755414|467346081|FG000|Overall Study|Non-compliance|0|||
129830612|NCT03755414|467346082|FG001|Overall Study|Non-compliance|1|||
129830613|NCT03755414|467346083|FG002|Overall Study|Non-compliance|0|||
129830614|NCT02153112|467346084|FG000|Overall Study|Adverse Event|0|||
129830615|NCT02153112|467346085|FG001|Overall Study|Adverse Event|0|||
129830616|NCT02153112|467346086|FG002|Overall Study|Adverse Event|1|||
129830617|NCT02153112|467346087|FG003|Overall Study|Adverse Event|0|||
129830618|NCT02153112|467346088|FG004|Overall Study|Adverse Event|0|||
129830619|NCT02153112|467346089|FG005|Overall Study|Adverse Event|0|||
129830620|NCT02153112|467346090|FG006|Overall Study|Adverse Event|0|||
129830621|NCT02153112|467346091|FG007|Overall Study|Adverse Event|0|||
129830622|NCT02153112|467346092|FG008|Overall Study|Adverse Event|0|||
129830623|NCT02153112|467346093|FG009|Overall Study|Adverse Event|0|||
129830624|NCT02153112|467346084|FG000|Overall Study|Lost to Follow-up|1|||
129830625|NCT02153112|467346085|FG001|Overall Study|Lost to Follow-up|1|||
129830626|NCT02153112|467346086|FG002|Overall Study|Lost to Follow-up|0|||
129830627|NCT02153112|467346087|FG003|Overall Study|Lost to Follow-up|0|||
129830628|NCT02153112|467346088|FG004|Overall Study|Lost to Follow-up|2|||
129830629|NCT02153112|467346089|FG005|Overall Study|Lost to Follow-up|1|||
129830630|NCT02153112|467346090|FG006|Overall Study|Lost to Follow-up|1|||
129830631|NCT02153112|467346091|FG007|Overall Study|Lost to Follow-up|0|||
129830632|NCT02153112|467346092|FG008|Overall Study|Lost to Follow-up|1|||
129830633|NCT02153112|467346093|FG009|Overall Study|Lost to Follow-up|1|||
129830634|NCT02153112|467346084|FG000|Overall Study|Withdrawal by Subject|3|||
129830635|NCT02153112|467346085|FG001|Overall Study|Withdrawal by Subject|1|||
129830636|NCT02153112|467346086|FG002|Overall Study|Withdrawal by Subject|2|||
129830637|NCT02153112|467346087|FG003|Overall Study|Withdrawal by Subject|2|||
129830638|NCT02153112|467346088|FG004|Overall Study|Withdrawal by Subject|1|||
129830639|NCT02153112|467346089|FG005|Overall Study|Withdrawal by Subject|1|||
129830640|NCT02153112|467346090|FG006|Overall Study|Withdrawal by Subject|7|||
129830641|NCT02153112|467346091|FG007|Overall Study|Withdrawal by Subject|2|||
129830642|NCT02153112|467346092|FG008|Overall Study|Withdrawal by Subject|13|||
129830643|NCT02153112|467346093|FG009|Overall Study|Withdrawal by Subject|12|||
129830644|NCT02153112|467346084|FG000|Overall Study|Reason not Specified|0|||
129830645|NCT02153112|467346085|FG001|Overall Study|Reason not Specified|0|||
129830646|NCT02153112|467346086|FG002|Overall Study|Reason not Specified|0|||
129830647|NCT02153112|467346087|FG003|Overall Study|Reason not Specified|0|||
129830648|NCT02153112|467346088|FG004|Overall Study|Reason not Specified|0|||
129830649|NCT02153112|467346089|FG005|Overall Study|Reason not Specified|0|||
129830650|NCT02153112|467346090|FG006|Overall Study|Reason not Specified|0|||
129830651|NCT02153112|467346091|FG007|Overall Study|Reason not Specified|0|||
129830652|NCT02153112|467346092|FG008|Overall Study|Reason not Specified|1|||
129830653|NCT02153112|467346093|FG009|Overall Study|Reason not Specified|1|||
129830654|NCT00449644|467346099|FG000|Overall Study|Adverse Event|0|||
129830655|NCT00449644|467346100|FG001|Overall Study|Adverse Event|0|||
129830656|NCT00449644|467346101|FG002|Overall Study|Adverse Event|3|||
129830657|NCT00449644|467346102|FG003|Overall Study|Adverse Event|5|||
129830658|NCT00449644|467346099|FG000|Overall Study|Death|1|||
129830659|NCT00449644|467346100|FG001|Overall Study|Death|0|||
129830660|NCT00449644|467346101|FG002|Overall Study|Death|6|||
129830661|NCT00449644|467346102|FG003|Overall Study|Death|1|||
129830662|NCT00449644|467346099|FG000|Overall Study|Lost to Follow-up|1|||
129830663|NCT00449644|467346100|FG001|Overall Study|Lost to Follow-up|1|||
129830664|NCT00449644|467346101|FG002|Overall Study|Lost to Follow-up|5|||
129830665|NCT00449644|467346102|FG003|Overall Study|Lost to Follow-up|3|||
129830666|NCT00449644|467346099|FG000|Overall Study|Pregnancy|0|||
129830667|NCT00449644|467346100|FG001|Overall Study|Pregnancy|0|||
129830668|NCT00449644|467346101|FG002|Overall Study|Pregnancy|3|||
129830669|NCT00449644|467346102|FG003|Overall Study|Pregnancy|2|||
129830670|NCT00449644|467346099|FG000|Overall Study|Protocol Violation|4|||
129830671|NCT00449644|467346100|FG001|Overall Study|Protocol Violation|4|||
129830672|NCT00449644|467346101|FG002|Overall Study|Protocol Violation|3|||
129830673|NCT00449644|467346102|FG003|Overall Study|Protocol Violation|7|||
129830674|NCT00449644|467346099|FG000|Overall Study|Withdrawal by Subject|3|||
129830675|NCT00449644|467346100|FG001|Overall Study|Withdrawal by Subject|4|||
129830676|NCT00449644|467346101|FG002|Overall Study|Withdrawal by Subject|6|||
129830677|NCT00449644|467346102|FG003|Overall Study|Withdrawal by Subject|7|||
129830678|NCT00449644|467346099|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
129830679|NCT00449644|467346100|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
129830680|NCT00449644|467346101|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
129830681|NCT00449644|467346102|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
129830682|NCT00449644|467346099|FG000|Overall Study|Other|1|||
129830683|NCT00449644|467346100|FG001|Overall Study|Other|4|||
129830684|NCT00449644|467346101|FG002|Overall Study|Other|1|||
129830685|NCT00449644|467346102|FG003|Overall Study|Other|0|||
129830686|NCT00449644|467346099|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
129830687|NCT00449644|467346100|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
129830688|NCT00449644|467346101|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
129830689|NCT00449644|467346102|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
129830690|NCT01559012|467346105|FG000|Overall Study|Withdrawal by Subject|0|||
129830691|NCT01559012|467346106|FG001|Overall Study|Withdrawal by Subject|1|||
129830692|NCT02291055|467346107|FG000|Overall Study|Death|2|||
129830693|NCT02291055|467346108|FG001|Overall Study|Death|2|||
129830694|NCT02291055|467346109|FG002|Overall Study|Death|5|||
129830695|NCT02291055|467346110|FG003|Overall Study|Death|8|||
129830696|NCT02291055|467346111|FG004|Overall Study|Death|12|||
129830697|NCT02291055|467346107|FG000|Overall Study|Lost to Follow-up|0|||
129830698|NCT02291055|467346108|FG001|Overall Study|Lost to Follow-up|0|||
129830699|NCT02291055|467346109|FG002|Overall Study|Lost to Follow-up|0|||
129830700|NCT02291055|467346110|FG003|Overall Study|Lost to Follow-up|1|||
129830701|NCT02291055|467346111|FG004|Overall Study|Lost to Follow-up|2|||
129830702|NCT02291055|467346107|FG000|Overall Study|Withdrawal by Subject|3|||
129830703|NCT02291055|467346108|FG001|Overall Study|Withdrawal by Subject|1|||
129830704|NCT02291055|467346109|FG002|Overall Study|Withdrawal by Subject|1|||
129830705|NCT02291055|467346110|FG003|Overall Study|Withdrawal by Subject|5|||
129830706|NCT02291055|467346111|FG004|Overall Study|Withdrawal by Subject|10|||
129830707|NCT02291055|467346107|FG000|Overall Study|Progressive Disease|0|||
129830708|NCT02291055|467346108|FG001|Overall Study|Progressive Disease|0|||
129830709|NCT02291055|467346109|FG002|Overall Study|Progressive Disease|1|||
129830710|NCT02291055|467346110|FG003|Overall Study|Progressive Disease|4|||
129830711|NCT02291055|467346111|FG004|Overall Study|Progressive Disease|2|||
129830712|NCT02291055|467346107|FG000|Overall Study|Study Terminated by Sponsor|0|||
129830713|NCT02291055|467346108|FG001|Overall Study|Study Terminated by Sponsor|0|||
129830714|NCT02291055|467346109|FG002|Overall Study|Study Terminated by Sponsor|0|||
129830715|NCT02291055|467346110|FG003|Overall Study|Study Terminated by Sponsor|5|||
129830716|NCT02291055|467346111|FG004|Overall Study|Study Terminated by Sponsor|1|||
129830717|NCT02291055|467346107|FG000|Overall Study|Other|0|||
129830718|NCT02291055|467346108|FG001|Overall Study|Other|2|||
129830719|NCT02291055|467346109|FG002|Overall Study|Other|1|||
129830720|NCT02291055|467346110|FG003|Overall Study|Other|4|||
129830721|NCT02291055|467346111|FG004|Overall Study|Other|0|||
129830722|NCT00853723|467346112|FG000|Overall Study|Adverse Event|3|||
129830723|NCT00853723|467346113|FG001|Overall Study|Adverse Event|4|||
129830724|NCT00853723|467346114|FG002|Overall Study|Adverse Event|1|||
129830725|NCT00853723|467346112|FG000|Overall Study|Withdrawal by Subject|2|||
129830726|NCT00853723|467346113|FG001|Overall Study|Withdrawal by Subject|1|||
129830727|NCT00853723|467346114|FG002|Overall Study|Withdrawal by Subject|0|||
129830728|NCT00853723|467346112|FG000|Overall Study|Protocol Violation|1|||
129830729|NCT00853723|467346113|FG001|Overall Study|Protocol Violation|2|||
129830730|NCT00853723|467346114|FG002|Overall Study|Protocol Violation|1|||
129830731|NCT01531387|467346115|FG000|Overall Study|Early termination of study|11|||
129830732|NCT01531387|467346116|FG001|Overall Study|Early termination of study|11|||
129830733|NCT01848756|467346119|FG000|Overall Study|Adverse Event|1|||
129830734|NCT01848756|467346119|FG000|Overall Study|Withdrawal by Subject|1|||
129830735|NCT01848756|467346119|FG000|Overall Study|Enrolled in Error|1|||
129830736|NCT02075658|467346120|FG000|Overall Study|Physician Decision|2|||
129830737|NCT02075658|467346121|FG001|Overall Study|Physician Decision|2|||
129830738|NCT01498458|467346122|FG000|Overall Study|Adverse Event|4|||
129830739|NCT01498458|467346122|FG000|Overall Study|Physician Decision|3|||
129830740|NCT00718328|467346123|FG000|Overall Study|Lost to Follow-up|1|||
129830741|NCT00718328|467346124|FG001|Overall Study|Lost to Follow-up|0|||
129830742|NCT02865915|467346125|FG000|Overall Study|Pregnancy|1|||
129830743|NCT02865915|467346126|FG001|Overall Study|Pregnancy|0|||
129830744|NCT02865915|467346125|FG000|Overall Study|Withdrawal by Subject|1|||
129830745|NCT02865915|467346126|FG001|Overall Study|Withdrawal by Subject|1|||
129830746|NCT02865915|467346125|FG000|Overall Study|Adverse Event|0|||
129830747|NCT02865915|467346126|FG001|Overall Study|Adverse Event|4|||
129830748|NCT02865915|467346125|FG000|Overall Study|Lost to Follow-up|0|||
129830749|NCT02865915|467346126|FG001|Overall Study|Lost to Follow-up|1|||
129830750|NCT02865915|467346125|FG000|Overall Study|Protocol Violation|0|||
129830751|NCT02865915|467346126|FG001|Overall Study|Protocol Violation|1|||
129830752|NCT02865915|467346125|FG000|Overall Study|Study terminated by sponsor|23|||
129830753|NCT02865915|467346126|FG001|Overall Study|Study terminated by sponsor|18|||
129830754|NCT02865915|467346125|FG000|Overall Study|Dosing group discontinued|0|||
129830755|NCT02865915|467346126|FG001|Overall Study|Dosing group discontinued|5|||
129830756|NCT02946047|467346133|FG000|Overall Study|Adverse Event|1|||
129830757|NCT02946047|467346134|FG001|Overall Study|Adverse Event|0|||
129830758|NCT02946047|467346135|FG002|Overall Study|Adverse Event|0|||
129830759|NCT02946047|467346136|FG003|Overall Study|Adverse Event|0|||
129830760|NCT04350788|467346144|FG000|Overall Study|Lost to Follow-up|6|||
129830761|NCT04350788|467346145|FG001|Overall Study|Lost to Follow-up|2|||
129830762|NCT04350788|467346144|FG000|Overall Study|Withdrawal by Subject|2|||
129830763|NCT04350788|467346145|FG001|Overall Study|Withdrawal by Subject|4|||
129830764|NCT04350788|467346144|FG000|Overall Study|Protocol Violation|4|||
129830765|NCT04350788|467346145|FG001|Overall Study|Protocol Violation|0|||
129830766|NCT01581307|467346146|FG000|Overall Study|Withdrawal by Subject|1|||
129830767|NCT00378209|467346149|FG000|Overall Study|Progressive disease|11|||
129830768|NCT00378209|467346149|FG000|Overall Study|Adverse Event|3|||
129830769|NCT00378209|467346149|FG000|Overall Study|Initiation of non-protocol therapy|3|||
129830770|NCT00378209|467346149|FG000|Overall Study|Physician Decision|3|||
129830771|NCT00378209|467346149|FG000|Overall Study|Death|1|||
129830772|NCT00378209|467346149|FG000|Overall Study|Treatment delay|1|||
129830773|NCT01894581|467346152|FG000|Overall Study|Withdrawal by Subject|2|||
129830774|NCT01894581|467346153|FG001|Overall Study|Withdrawal by Subject|3|||
129830775|NCT01894581|467346152|FG000|Overall Study|Screen Failure|3|||
129830776|NCT01894581|467346153|FG001|Overall Study|Screen Failure|4|||
129830777|NCT03313804|467346157|FG000|Treatment|Death|5|||
129830778|NCT03313804|467346157|FG000|Treatment|still on treatment|2|||
129830779|NCT03313804|467346157|FG000|Follow Up|still on follow up|3|||
129830780|NCT03795298|467346158|FG000|Overall Study|Death|34|||
129830781|NCT03795298|467346159|FG001|Overall Study|Death|29|||
129830782|NCT03795298|467346158|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
129830783|NCT03795298|467346159|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
129830784|NCT03795298|467346158|FG000|Overall Study|Lost to Follow-up|28|||
129830785|NCT03795298|467346159|FG001|Overall Study|Lost to Follow-up|17|||
129830786|NCT03795298|467346158|FG000|Overall Study|Physician Decision|5|||
129830787|NCT03795298|467346159|FG001|Overall Study|Physician Decision|4|||
129830788|NCT03795298|467346158|FG000|Overall Study|Withdrawal by Subject|43|||
129830789|NCT03795298|467346159|FG001|Overall Study|Withdrawal by Subject|28|||
129830790|NCT03795298|467346158|FG000|Overall Study|Reason not reported|7|||
129830791|NCT03795298|467346159|FG001|Overall Study|Reason not reported|9|||
129830792|NCT01252940|467346160|FG000|Main Study Phase|Randomized but not treated|4|||
129830793|NCT01252940|467346161|FG001|Main Study Phase|Randomized but not treated|2|||
129830794|NCT01252940|467346160|FG000|Main Study Phase|Adverse Event|3|||
129830795|NCT01252940|467346161|FG001|Main Study Phase|Adverse Event|1|||
129830796|NCT01252940|467346160|FG000|Main Study Phase|Lack of Efficacy|1|||
129830797|NCT01252940|467346161|FG001|Main Study Phase|Lack of Efficacy|0|||
129830798|NCT01252940|467346160|FG000|Main Study Phase|Lost to Follow-up|6|||
129830799|NCT01252940|467346161|FG001|Main Study Phase|Lost to Follow-up|1|||
129830800|NCT01252940|467346160|FG000|Main Study Phase|Physician Decision|1|||
129830801|NCT01252940|467346161|FG001|Main Study Phase|Physician Decision|0|||
129830802|NCT01252940|467346160|FG000|Main Study Phase|Protocol Violation|4|||
129830803|NCT01252940|467346161|FG001|Main Study Phase|Protocol Violation|2|||
129830804|NCT01252940|467346160|FG000|Main Study Phase|Withdrawal by Subject|6|||
129830805|NCT01252940|467346161|FG001|Main Study Phase|Withdrawal by Subject|5|||
129830806|NCT01252940|467346160|FG000|Main Study Phase|Subject Non-compliance|1|||
129830807|NCT01252940|467346161|FG001|Main Study Phase|Subject Non-compliance|1|||
129830808|NCT01252940|467346160|FG000|Extension Phase|Adverse Event|2|||
129830809|NCT01252940|467346161|FG001|Extension Phase|Adverse Event|1|||
129830810|NCT01252940|467346160|FG000|Extension Phase|Lack of Efficacy|1|||
129830811|NCT01252940|467346161|FG001|Extension Phase|Lack of Efficacy|0|||
129830812|NCT01252940|467346160|FG000|Extension Phase|Lost to Follow-up|5|||
129830813|NCT01252940|467346161|FG001|Extension Phase|Lost to Follow-up|0|||
129830814|NCT01252940|467346160|FG000|Extension Phase|Physician Decision|0|||
129830815|NCT01252940|467346161|FG001|Extension Phase|Physician Decision|1|||
129830816|NCT01252940|467346160|FG000|Extension Phase|Subject Non-compliance|1|||
129830817|NCT01252940|467346161|FG001|Extension Phase|Subject Non-compliance|0|||
129830818|NCT01252940|467346160|FG000|Extension Phase|Withdrawal by Subject|1|||
129830819|NCT01252940|467346161|FG001|Extension Phase|Withdrawal by Subject|1|||
129830820|NCT04814433|467346164|FG000|Overall Study|Survey not returned|4|||
129830821|NCT04814433|467346165|FG001|Overall Study|Survey not returned|8|||
129830822|NCT04814433|467346166|FG002|Overall Study|Survey not returned|4|||
129830823|NCT04814433|467346167|FG003|Overall Study|Survey not returned|5|||
129830824|NCT02496533|467346170|FG000|Overall Study|Lack of data on outcome|3|||
129830825|NCT02496533|467346171|FG001|Overall Study|Lack of data on outcome|0|||
129830826|NCT02496533|467346170|FG000|Overall Study|Patient did not complete all measures|0|||
129830827|NCT02496533|467346171|FG001|Overall Study|Patient did not complete all measures|4|||
129830828|NCT02496533|467346170|FG000|Overall Study|Late for radiologic testing|0|||
129830829|NCT02496533|467346171|FG001|Overall Study|Late for radiologic testing|2|||
129830830|NCT01816893|467346174|FG000|Washout Period|Withdrawal by Subject|2|||
129830831|NCT01816893|467346175|FG001|Washout Period|Withdrawal by Subject|0|||
129830832|NCT02016625|467347781|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
129830833|NCT02016625|467347782|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
129830834|NCT02016625|467347781|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
129830835|NCT02016625|467347782|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
129830836|NCT02016625|467347781|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
129830837|NCT02016625|467347782|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
129830838|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
129830839|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
129830840|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
129830841|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
129830842|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
129830843|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
129830844|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
129830845|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
129830846|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
129830847|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
129830848|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
129830849|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
129830850|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
129830851|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
129830852|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
129830853|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
129830854|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
129830855|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
129830856|NCT00887354|467347783|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
129830857|NCT00887354|467347784|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
129830858|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
129445755|NCT01910116|465932903|FG001|Overall Study|incomplete data|1|||
129445756|NCT03606980|465932904|FG000|Overall Study|Lost to Follow-up|3|||
129445757|NCT03606980|465932905|FG001|Overall Study|Lost to Follow-up|2|||
129445758|NCT03606980|465932906|FG002|Overall Study|Lost to Follow-up|3|||
129830859|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
129830860|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
129830861|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
129830862|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
129830863|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
129830864|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
129830865|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
129830866|NCT00887354|467347783|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
129830867|NCT00887354|467347784|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
129830868|NCT00914810|467347787|FG000|Overall Study|Withdrawal by Subject|1|||
129830869|NCT00914810|467347788|FG001|Overall Study|Withdrawal by Subject|0|||
129830870|NCT00914810|467347787|FG000|Overall Study|Relocated out of state|1|||
129830871|NCT00914810|467347788|FG001|Overall Study|Relocated out of state|0|||
129830872|NCT00914810|467347787|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
129830873|NCT00914810|467347788|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
129830874|NCT01465022|467347789|FG000|Overall Study|Lost to Follow-up|15|||
129830875|NCT01465022|467347790|FG001|Overall Study|Lost to Follow-up|14|||
129830876|NCT01465022|467347791|FG002|Overall Study|Lost to Follow-up|0|||
129830877|NCT01465022|467347789|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
129830878|NCT01465022|467347790|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
129830879|NCT01465022|467347791|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
129830880|NCT01465022|467347789|FG000|Overall Study|Not Randomized|0|||
129830881|NCT01465022|467347790|FG001|Overall Study|Not Randomized|0|||
129830882|NCT01465022|467347791|FG002|Overall Study|Not Randomized|70|||
129830883|NCT01327300|467347792|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
129830884|NCT01327300|467347793|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
129830885|NCT03257631|467347807|FG000|Overall Study|Death|1|||
129830886|NCT03257631|467347808|FG001|Overall Study|Death|0|||
129830887|NCT03257631|467347809|FG002|Overall Study|Death|1|||
129830888|NCT03257631|467347810|FG003|Overall Study|Death|1|||
129830889|NCT03257631|467347807|FG000|Overall Study|Progressive Disease|10|||
129830890|NCT03257631|467347808|FG001|Overall Study|Progressive Disease|9|||
129830891|NCT03257631|467347809|FG002|Overall Study|Progressive Disease|17|||
129830892|NCT03257631|467347810|FG003|Overall Study|Progressive Disease|8|||
129830893|NCT03257631|467347807|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129830894|NCT03257631|467347808|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129830895|NCT03257631|467347809|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129830896|NCT03257631|467347810|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
129830897|NCT03257631|467347807|FG000|Overall Study|Adverse Event|0|||
129830898|NCT03257631|467347808|FG001|Overall Study|Adverse Event|0|||
129830899|NCT03257631|467347809|FG002|Overall Study|Adverse Event|2|||
129830900|NCT03257631|467347810|FG003|Overall Study|Adverse Event|0|||
129830901|NCT02529137|467347811|FG000|Overall Study|Discontinuation for different reasons|8|||
129830902|NCT01290666|467347815|FG000|Overall Study|Lost to Follow-up|11|||
129830903|NCT01290666|467347815|FG000|Overall Study|Withdrawal by Subject|23|||
129830904|NCT01290666|467347815|FG000|Overall Study|Early Termination of Study|4|||
129830905|NCT03036098|467347816|FG000|Pre-Treatment|Other Reasons|1|||
129830906|NCT03036098|467347817|FG001|Pre-Treatment|Other Reasons|2|||
129830907|NCT03036098|467347818|FG002|Pre-Treatment|Other Reasons|0|||
129830908|NCT03036098|467347819|FG003|Pre-Treatment|Other Reasons|5|||
129830909|NCT03036098|467347816|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
129830910|NCT03036098|467347817|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
129830911|NCT03036098|467347818|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
129830912|NCT03036098|467347819|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
129830913|NCT03036098|467347816|FG000|Pre-Treatment|Withdrawal by Subject|1|||
129830914|NCT03036098|467347817|FG001|Pre-Treatment|Withdrawal by Subject|14|||
129830915|NCT03036098|467347818|FG002|Pre-Treatment|Withdrawal by Subject|0|||
129830916|NCT03036098|467347819|FG003|Pre-Treatment|Withdrawal by Subject|5|||
129830917|NCT03036098|467347816|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
129830918|NCT03036098|467347817|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
129830919|NCT03036098|467347818|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
129830920|NCT03036098|467347819|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
129830921|NCT03036098|467347816|FG000|Treatment|Disease Progression|130|||
129830922|NCT03036098|467347817|FG001|Treatment|Disease Progression|77|||
129830923|NCT03036098|467347818|FG002|Treatment|Disease Progression|168|||
129830924|NCT03036098|467347819|FG003|Treatment|Disease Progression|50|||
129830925|NCT03036098|467347816|FG000|Treatment|Study Drug Toxicity|95|||
129830926|NCT03036098|467347817|FG001|Treatment|Study Drug Toxicity|45|||
129830927|NCT03036098|467347818|FG002|Treatment|Study Drug Toxicity|26|||
129830928|NCT03036098|467347819|FG003|Treatment|Study Drug Toxicity|22|||
129830929|NCT03036098|467347816|FG000|Treatment|Death|9|||
129830930|NCT03036098|467347817|FG001|Treatment|Death|3|||
129830931|NCT03036098|467347818|FG002|Treatment|Death|1|||
129830932|NCT03036098|467347819|FG003|Treatment|Death|2|||
129830933|NCT03036098|467347816|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
129830934|NCT03036098|467347817|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
129830935|NCT03036098|467347818|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
129830936|NCT03036098|467347819|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
129830937|NCT03036098|467347816|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
129830938|NCT03036098|467347817|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
129830939|NCT03036098|467347818|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
129830940|NCT03036098|467347819|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
129830941|NCT03036098|467347816|FG000|Treatment|Withdrawal by Subject|2|||
129830942|NCT03036098|467347817|FG001|Treatment|Withdrawal by Subject|9|||
129830943|NCT03036098|467347818|FG002|Treatment|Withdrawal by Subject|2|||
129830944|NCT03036098|467347819|FG003|Treatment|Withdrawal by Subject|4|||
129830945|NCT03036098|467347816|FG000|Treatment|Maximum Clinical Benefit|6|||
129830946|NCT03036098|467347817|FG001|Treatment|Maximum Clinical Benefit|1|||
129830947|NCT03036098|467347818|FG002|Treatment|Maximum Clinical Benefit|6|||
129830948|NCT03036098|467347819|FG003|Treatment|Maximum Clinical Benefit|10|||
129830949|NCT03036098|467347816|FG000|Treatment|Poor/Non Compliance|1|||
129830950|NCT03036098|467347817|FG001|Treatment|Poor/Non Compliance|2|||
129830951|NCT03036098|467347818|FG002|Treatment|Poor/Non Compliance|0|||
129830952|NCT03036098|467347819|FG003|Treatment|Poor/Non Compliance|1|||
129830953|NCT03036098|467347816|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
129830954|NCT03036098|467347817|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
129830955|NCT03036098|467347818|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
129830956|NCT03036098|467347819|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
129830957|NCT03036098|467347816|FG000|Treatment|Administrative Reason by Sponsor|1|||
129830958|NCT03036098|467347817|FG001|Treatment|Administrative Reason by Sponsor|0|||
129830959|NCT03036098|467347818|FG002|Treatment|Administrative Reason by Sponsor|2|||
129830960|NCT03036098|467347819|FG003|Treatment|Administrative Reason by Sponsor|1|||
129830961|NCT03036098|467347816|FG000|Treatment|Other Reasons|31|||
129830962|NCT03036098|467347817|FG001|Treatment|Other Reasons|5|||
129830963|NCT03036098|467347818|FG002|Treatment|Other Reasons|21|||
129830964|NCT03036098|467347819|FG003|Treatment|Other Reasons|8|||
129830965|NCT03036098|467347816|FG000|Treatment|Ongoing Treatment|0|||
129830966|NCT03036098|467347817|FG001|Treatment|Ongoing Treatment|0|||
129830967|NCT03036098|467347818|FG002|Treatment|Ongoing Treatment|23|||
129830968|NCT03036098|467347819|FG003|Treatment|Ongoing Treatment|0|||
129830969|NCT02063854|467347821|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
129830970|NCT02063854|467347822|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
129830971|NCT02063854|467347823|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
129830972|NCT02063854|467347824|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
129830973|NCT02063854|467347825|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
129830974|NCT02063854|467347826|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
129830975|NCT02063854|467347827|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
129830976|NCT02063854|467347821|FG000|Overall Study|Major Protocol Deviation|0|||
129830977|NCT02063854|467347822|FG001|Overall Study|Major Protocol Deviation|0|||
129830978|NCT02063854|467347823|FG002|Overall Study|Major Protocol Deviation|3|||
129830979|NCT02063854|467347824|FG003|Overall Study|Major Protocol Deviation|0|||
129830980|NCT02063854|467347825|FG004|Overall Study|Major Protocol Deviation|0|||
129830981|NCT02063854|467347826|FG005|Overall Study|Major Protocol Deviation|0|||
129830982|NCT02063854|467347827|FG006|Overall Study|Major Protocol Deviation|0|||
129830983|NCT02063854|467347821|FG000|Overall Study|Voluntary Withdrawal|2|||
129830984|NCT02063854|467347822|FG001|Overall Study|Voluntary Withdrawal|0|||
129830985|NCT02063854|467347823|FG002|Overall Study|Voluntary Withdrawal|8|||
129830986|NCT02063854|467347824|FG003|Overall Study|Voluntary Withdrawal|1|||
129830987|NCT02063854|467347825|FG004|Overall Study|Voluntary Withdrawal|3|||
129830988|NCT02063854|467347826|FG005|Overall Study|Voluntary Withdrawal|6|||
129830989|NCT02063854|467347827|FG006|Overall Study|Voluntary Withdrawal|1|||
129830990|NCT02063854|467347821|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
129445759|NCT03606980|465932904|FG000|Overall Study|Withdrawal by Subject|1|||
129830991|NCT02063854|467347822|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
129830992|NCT02063854|467347823|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
129830993|NCT02063854|467347824|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
129830994|NCT02063854|467347825|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
129830995|NCT02063854|467347826|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
129830996|NCT02063854|467347827|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
129830997|NCT02063854|467347821|FG000|Overall Study|Reason Not Specified|1|||
129830998|NCT02063854|467347822|FG001|Overall Study|Reason Not Specified|0|||
129830999|NCT02063854|467347823|FG002|Overall Study|Reason Not Specified|0|||
129831000|NCT02063854|467347824|FG003|Overall Study|Reason Not Specified|0|||
129831001|NCT02063854|467347825|FG004|Overall Study|Reason Not Specified|0|||
129831002|NCT02063854|467347826|FG005|Overall Study|Reason Not Specified|0|||
129831003|NCT02063854|467347827|FG006|Overall Study|Reason Not Specified|0|||
129831004|NCT02063854|467347821|FG000|Overall Study|Did Not Receive Study Drug|0|||
129445760|NCT03606980|465932905|FG001|Overall Study|Withdrawal by Subject|0|||
129445761|NCT03606980|465932906|FG002|Overall Study|Withdrawal by Subject|4|||
129445762|NCT02469896|465932909|FG000|Overall Study|Withdrawal by Subject|2|||
129445763|NCT02469896|465932910|FG001|Overall Study|Withdrawal by Subject|0|||
129445764|NCT01294150|465932911|FG000|Overall Study|Physician Decision|2|||
129831005|NCT02063854|467347822|FG001|Overall Study|Did Not Receive Study Drug|0|||
129831006|NCT02063854|467347823|FG002|Overall Study|Did Not Receive Study Drug|0|||
129831007|NCT02063854|467347824|FG003|Overall Study|Did Not Receive Study Drug|0|||
129831008|NCT02063854|467347825|FG004|Overall Study|Did Not Receive Study Drug|0|||
129831009|NCT02063854|467347826|FG005|Overall Study|Did Not Receive Study Drug|1|||
129831010|NCT02063854|467347827|FG006|Overall Study|Did Not Receive Study Drug|0|||
129831011|NCT03538158|467347828|FG000|Overall Study|Lost to Follow-up|13|||
129831012|NCT03538158|467347829|FG001|Overall Study|Lost to Follow-up|7|||
129831013|NCT03538158|467347828|FG000|Overall Study|Withdrawal by Subject|2|||
129831014|NCT03538158|467347829|FG001|Overall Study|Withdrawal by Subject|1|||
129831015|NCT00772707|467347830|FG000|Overall Study|Withdrawn|3|||
129831016|NCT01454570|467347831|FG000|Overall Study|Withdrawal by Subject|2|||
129831017|NCT01454570|467347831|FG000|Overall Study|Screen Failure|7|||
129831018|NCT04356963|467347833|FG000|First Session|Withdrawal by Subject|1|||
129831019|NCT04356963|467347833|FG000|Second Session|Withdrawal by Subject|3|||
129831020|NCT04356963|467347833|FG000|Second Session|Lost to Follow-up|1|||
129831021|NCT04356963|467347833|FG000|Third Session|Lost to Follow-up|6|||
129831022|NCT04356963|467347833|FG000|Third Session|Withdrawal by Subject|1|||
129831023|NCT01176266|467347840|FG000|Overall Study|Death|6|||
129831024|NCT01176266|467347840|FG000|Overall Study|Withdrawal by Subject|3|||
129831025|NCT05075850|467347841|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
129831026|NCT00271609|467347842|FG000|Overall Study|Adverse Event|11|||
129831027|NCT00271609|467347843|FG001|Overall Study|Adverse Event|3|||
129831028|NCT00271609|467347842|FG000|Overall Study|Withdrawal by Subject|2|||
129831029|NCT00271609|467347843|FG001|Overall Study|Withdrawal by Subject|0|||
129831030|NCT02188589|467347844|FG000|Overall Study|Withdrawal by Subject|5|||
129831031|NCT00741039|467347848|FG000|Overall Study|Patient non-compliance|2|||
129831032|NCT00741039|467347849|FG001|Overall Study|Patient non-compliance|0|||
129831033|NCT00878709|467347850|FG000|Overall Study|Withdrawal by Subject|197|||
129831034|NCT00878709|467347851|FG001|Overall Study|Withdrawal by Subject|120|||
129831035|NCT00878709|467347850|FG000|Overall Study|Lost to Follow-up|35|||
129831036|NCT00878709|467347851|FG001|Overall Study|Lost to Follow-up|33|||
129831037|NCT00878709|467347850|FG000|Overall Study|Other Reasons|93|||
129831038|NCT00878709|467347851|FG001|Overall Study|Other Reasons|84|||
129831039|NCT01712854|467347852|FG000|Overall Study|Physician Decision|1|||
129831040|NCT00768300|467347857|FG000|Overall Study|Randomized but not treated|1|||
129831041|NCT00768300|467347858|FG001|Overall Study|Randomized but not treated|1|||
129831042|NCT00768300|467347857|FG000|Overall Study|Adverse Event|10|||
129831043|NCT00768300|467347858|FG001|Overall Study|Adverse Event|2|||
129831044|NCT00768300|467347857|FG000|Overall Study|Protocol Violation|6|||
129831045|NCT00768300|467347858|FG001|Overall Study|Protocol Violation|1|||
129831046|NCT00768300|467347857|FG000|Overall Study|Withdrawal by Subject|13|||
129831047|NCT00768300|467347858|FG001|Overall Study|Withdrawal by Subject|7|||
129831048|NCT00768300|467347857|FG000|Overall Study|Physician Decision|2|||
129831049|NCT00768300|467347858|FG001|Overall Study|Physician Decision|3|||
129831050|NCT00768300|467347857|FG000|Overall Study|Study discontinued by Sponsor|271|||
129831051|NCT00768300|467347858|FG001|Overall Study|Study discontinued by Sponsor|140|||
129831052|NCT00768300|467347857|FG000|Overall Study|Death|21|||
129831053|NCT00768300|467347858|FG001|Overall Study|Death|5|||
129831054|NCT00768300|467347857|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
129831055|NCT00768300|467347858|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
129831056|NCT00768300|467347857|FG000|Overall Study|Screen failure following randomization|1|||
129831057|NCT00768300|467347858|FG001|Overall Study|Screen failure following randomization|0|||
129445765|NCT01294150|465932912|FG001|Overall Study|Physician Decision|2|||
129445766|NCT03675776|465932913|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
129831058|NCT00768300|467347857|FG000|Overall Study|Received lung transplant|1|||
129831059|NCT00768300|467347858|FG001|Overall Study|Received lung transplant|1|||
129831060|NCT00768300|467347857|FG000|Overall Study|Lost to Follow-up|0|||
129831061|NCT00768300|467347858|FG001|Overall Study|Lost to Follow-up|1|||
129831062|NCT00768300|467347857|FG000|Overall Study|Began prohibited concomitant medication|0|||
129831063|NCT00768300|467347858|FG001|Overall Study|Began prohibited concomitant medication|1|||
129831064|NCT00768300|467347857|FG000|Overall Study|Treated but never dosed with Study drug|1|||
129831065|NCT00768300|467347858|FG001|Overall Study|Treated but never dosed with Study drug|0|||
129831066|NCT00768300|467347857|FG000|Overall Study|Missing data|1|||
129831067|NCT00768300|467347858|FG001|Overall Study|Missing data|0|||
129831068|NCT00322842|467347861|FG000|Overall Study|Withdrawal by Subject|0|||
129831069|NCT00322842|467347862|FG001|Overall Study|Withdrawal by Subject|1|||
129831070|NCT00322842|467347861|FG000|Overall Study|Lost to Follow-up|0|||
129831071|NCT00322842|467347862|FG001|Overall Study|Lost to Follow-up|1|||
129831072|NCT00322842|467347861|FG000|Overall Study|Refused transplant|1|||
129831073|NCT00322842|467347862|FG001|Overall Study|Refused transplant|0|||
129831074|NCT00322842|467347861|FG000|Overall Study|Death|1|||
129831075|NCT00322842|467347862|FG001|Overall Study|Death|0|||
129831076|NCT02068222|467347865|FG000|Overall Study|Lost to Follow-up|1|||
129831077|NCT01782664|467347867|FG000|Overall Study|Adverse Event|2|||
129831078|NCT01782664|467347868|FG001|Overall Study|Adverse Event|2|||
129831079|NCT01782664|467347869|FG002|Overall Study|Adverse Event|2|||
129831080|NCT01782664|467347870|FG003|Overall Study|Adverse Event|2|||
129831081|NCT01782664|467347871|FG004|Overall Study|Adverse Event|0|||
129831082|NCT01782664|467347872|FG005|Overall Study|Adverse Event|0|||
129831083|NCT01782664|467347867|FG000|Overall Study|Lack of Efficacy|2|||
129831084|NCT01782664|467347868|FG001|Overall Study|Lack of Efficacy|0|||
129831085|NCT01782664|467347869|FG002|Overall Study|Lack of Efficacy|2|||
129831086|NCT01782664|467347870|FG003|Overall Study|Lack of Efficacy|2|||
129831087|NCT01782664|467347871|FG004|Overall Study|Lack of Efficacy|0|||
129831088|NCT01782664|467347872|FG005|Overall Study|Lack of Efficacy|0|||
129831089|NCT01782664|467347867|FG000|Overall Study|Protocol Violation|0|||
129831090|NCT01782664|467347868|FG001|Overall Study|Protocol Violation|1|||
129831091|NCT01782664|467347869|FG002|Overall Study|Protocol Violation|0|||
129831092|NCT01782664|467347870|FG003|Overall Study|Protocol Violation|1|||
129831093|NCT01782664|467347871|FG004|Overall Study|Protocol Violation|0|||
129831094|NCT01782664|467347872|FG005|Overall Study|Protocol Violation|0|||
129831095|NCT01782664|467347867|FG000|Overall Study|Withdrawal by Subject|2|||
129831096|NCT01782664|467347868|FG001|Overall Study|Withdrawal by Subject|2|||
129831097|NCT01782664|467347869|FG002|Overall Study|Withdrawal by Subject|0|||
129831098|NCT01782664|467347870|FG003|Overall Study|Withdrawal by Subject|0|||
129831099|NCT01782664|467347871|FG004|Overall Study|Withdrawal by Subject|0|||
129831100|NCT01782664|467347872|FG005|Overall Study|Withdrawal by Subject|0|||
129831101|NCT00651755|467347874|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
129831102|NCT00651755|467347875|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
129831103|NCT00651755|467347874|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
129831104|NCT00651755|467347875|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
129831105|NCT00624052|467347876|FG000|Overall Study|Adverse Event|7|||
129831106|NCT00624052|467347877|FG001|Overall Study|Adverse Event|6|||
129831107|NCT00624052|467347878|FG002|Overall Study|Adverse Event|0|||
129831108|NCT00624052|467347879|FG003|Overall Study|Adverse Event|3|||
129831109|NCT00624052|467347876|FG000|Overall Study|Lack of Efficacy|1|||
129831110|NCT00624052|467347877|FG001|Overall Study|Lack of Efficacy|1|||
129831111|NCT00624052|467347878|FG002|Overall Study|Lack of Efficacy|0|||
129831112|NCT00624052|467347879|FG003|Overall Study|Lack of Efficacy|0|||
129831113|NCT00624052|467347876|FG000|Overall Study|Lost to Follow-up|2|||
129831114|NCT00624052|467347877|FG001|Overall Study|Lost to Follow-up|3|||
129831115|NCT00624052|467347878|FG002|Overall Study|Lost to Follow-up|1|||
129831116|NCT00624052|467347879|FG003|Overall Study|Lost to Follow-up|0|||
129831117|NCT00624052|467347876|FG000|Overall Study|Non compliant with the protocol|2|||
129831118|NCT00624052|467347877|FG001|Overall Study|Non compliant with the protocol|1|||
129831119|NCT00624052|467347878|FG002|Overall Study|Non compliant with the protocol|1|||
129831120|NCT00624052|467347879|FG003|Overall Study|Non compliant with the protocol|1|||
129831121|NCT00624052|467347876|FG000|Overall Study|Consent withdrawn|3|||
129831122|NCT00624052|467347877|FG001|Overall Study|Consent withdrawn|1|||
129831123|NCT00624052|467347878|FG002|Overall Study|Consent withdrawn|1|||
129831124|NCT00624052|467347879|FG003|Overall Study|Consent withdrawn|0|||
129831125|NCT00624052|467347876|FG000|Overall Study|Changed job/ran out if meds|0|||
129831126|NCT00624052|467347877|FG001|Overall Study|Changed job/ran out if meds|2|||
129831127|NCT00624052|467347878|FG002|Overall Study|Changed job/ran out if meds|0|||
129831128|NCT00624052|467347879|FG003|Overall Study|Changed job/ran out if meds|0|||
129831129|NCT00281684|467347882|FG000|Overall Study|Lost to Follow-up|0|||
129831130|NCT00281684|467347883|FG001|Overall Study|Lost to Follow-up|0|||
129831131|NCT00281684|467347884|FG002|Overall Study|Lost to Follow-up|1|||
129831132|NCT00281684|467347885|FG003|Overall Study|Lost to Follow-up|0|||
129831133|NCT00281684|467347882|FG000|Overall Study|Withdrawal by Subject|1|||
129831134|NCT00281684|467347883|FG001|Overall Study|Withdrawal by Subject|0|||
129831135|NCT00281684|467347884|FG002|Overall Study|Withdrawal by Subject|0|||
129831136|NCT00281684|467347885|FG003|Overall Study|Withdrawal by Subject|0|||
129831137|NCT00698581|467347888|FG000|Overall Study|Lack of Efficacy|23|||
129831138|NCT00698581|467347889|FG001|Overall Study|Lack of Efficacy|11|||
129831139|NCT00698581|467347888|FG000|Overall Study|Withdrawal by Subject|6|||
129831140|NCT00698581|467347889|FG001|Overall Study|Withdrawal by Subject|0|||
129831141|NCT00698581|467347888|FG000|Overall Study|Other reason|9|||
129831142|NCT00698581|467347889|FG001|Overall Study|Other reason|1|||
129831143|NCT00698581|467347888|FG000|Overall Study|SAE, non-fatal|1|||
129831144|NCT00698581|467347889|FG001|Overall Study|SAE, non-fatal|0|||
129831145|NCT00698581|467347888|FG000|Overall Study|AE, non-serious non-fatal|4|||
129831146|NCT00698581|467347889|FG001|Overall Study|AE, non-serious non-fatal|0|||
129831147|NCT00698581|467347888|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129897697|NCT00517933|467584424|FG001|Period 2|Physician Decision|0|||
129831148|NCT00698581|467347889|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129831149|NCT00698581|467347888|FG000|Overall Study|AE of unknown type|1|||
129831150|NCT00698581|467347889|FG001|Overall Study|AE of unknown type|0|||
129831151|NCT03642717|467347890|FG000|Overall Study|Lost to Follow-up|2|||
129831152|NCT03642717|467347890|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
129831153|NCT03642717|467347890|FG000|Overall Study|Taken study drug prior to contract date|3|||
129831154|NCT00946712|467347891|FG000|Overall Study|Adverse Event|118|||
129831155|NCT00946712|467347892|FG001|Overall Study|Adverse Event|124|||
129831156|NCT00946712|467347891|FG000|Overall Study|Disease progression|308|||
129831157|NCT00946712|467347892|FG001|Overall Study|Disease progression|404|||
129831158|NCT00946712|467347891|FG000|Overall Study|Death|21|||
129831159|NCT00946712|467347892|FG001|Overall Study|Death|22|||
129831160|NCT00946712|467347891|FG000|Overall Study|No treatment given|25|||
129831161|NCT00946712|467347892|FG001|Overall Study|No treatment given|29|||
129831162|NCT00946712|467347891|FG000|Overall Study|Other reasons|61|||
129831163|NCT00946712|467347892|FG001|Overall Study|Other reasons|73|||
129831164|NCT00946712|467347891|FG000|Overall Study|On Treatment|0|||
129831165|NCT00946712|467347892|FG001|Overall Study|On Treatment|4|||
129831166|NCT00946712|467347891|FG000|Overall Study|Ineligible|14|||
129831167|NCT00946712|467347892|FG001|Overall Study|Ineligible|6|||
129831168|NCT00302458|467347893|FG000|Overall Study|Lost to Follow-up|1|||
129831169|NCT00302458|467347893|FG000|Overall Study|Ineligible after screening|1|||
129831170|NCT00302458|467347893|FG000|Overall Study|Withdrawal by Subject|1|||
129831171|NCT02642432|467347896|FG000|Overall Study|Adverse Event|2|||
129831172|NCT02642432|467347896|FG000|Overall Study|Withdrew Consent|1|||
129831173|NCT02642432|467347896|FG000|Overall Study|Lost to Follow-up|2|||
129831174|NCT02642432|467347896|FG000|Overall Study|Other|3|||
129831175|NCT03245008|467347897|FG000|Overall Study|Adverse Event|15|||
129831176|NCT03245008|467347898|FG001|Overall Study|Adverse Event|18|||
129831177|NCT03245008|467347899|FG002|Overall Study|Adverse Event|15|||
129831178|NCT03245008|467347900|FG003|Overall Study|Adverse Event|0|||
129831179|NCT03245008|467347901|FG004|Overall Study|Adverse Event|1|||
129831180|NCT03245008|467347897|FG000|Overall Study|Lack of Efficacy|0|||
129831181|NCT03245008|467347898|FG001|Overall Study|Lack of Efficacy|1|||
129831182|NCT03245008|467347899|FG002|Overall Study|Lack of Efficacy|0|||
129831183|NCT03245008|467347900|FG003|Overall Study|Lack of Efficacy|0|||
129831184|NCT03245008|467347901|FG004|Overall Study|Lack of Efficacy|0|||
129831185|NCT03245008|467347897|FG000|Overall Study|Lost to Follow-up|4|||
129831186|NCT03245008|467347898|FG001|Overall Study|Lost to Follow-up|1|||
129831187|NCT03245008|467347899|FG002|Overall Study|Lost to Follow-up|0|||
129831188|NCT03245008|467347900|FG003|Overall Study|Lost to Follow-up|0|||
129831189|NCT03245008|467347901|FG004|Overall Study|Lost to Follow-up|1|||
129831190|NCT03245008|467347897|FG000|Overall Study|Physician Decision|1|||
129831191|NCT03245008|467347898|FG001|Overall Study|Physician Decision|3|||
129831192|NCT03245008|467347899|FG002|Overall Study|Physician Decision|4|||
129831193|NCT03245008|467347900|FG003|Overall Study|Physician Decision|0|||
129831194|NCT03245008|467347901|FG004|Overall Study|Physician Decision|0|||
129831195|NCT03245008|467347897|FG000|Overall Study|Protocol Violation|0|||
129831196|NCT03245008|467347898|FG001|Overall Study|Protocol Violation|1|||
129831197|NCT03245008|467347899|FG002|Overall Study|Protocol Violation|0|||
129831198|NCT03245008|467347900|FG003|Overall Study|Protocol Violation|0|||
129831199|NCT03245008|467347901|FG004|Overall Study|Protocol Violation|0|||
129831200|NCT03245008|467347897|FG000|Overall Study|Withdrawal by Subject|20|||
129831201|NCT03245008|467347898|FG001|Overall Study|Withdrawal by Subject|19|||
129831202|NCT03245008|467347899|FG002|Overall Study|Withdrawal by Subject|11|||
129831203|NCT03245008|467347900|FG003|Overall Study|Withdrawal by Subject|0|||
129831204|NCT03245008|467347901|FG004|Overall Study|Withdrawal by Subject|0|||
129831205|NCT03245008|467347897|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129831206|NCT03245008|467347898|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129831207|NCT03245008|467347899|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
129831208|NCT03245008|467347900|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
129831209|NCT03245008|467347901|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
129831210|NCT03245008|467347897|FG000|Overall Study|Failure to meet randomization criteria|0|||
129831211|NCT03245008|467347898|FG001|Overall Study|Failure to meet randomization criteria|1|||
129831212|NCT03245008|467347899|FG002|Overall Study|Failure to meet randomization criteria|0|||
129831213|NCT03245008|467347900|FG003|Overall Study|Failure to meet randomization criteria|1|||
129831214|NCT03245008|467347901|FG004|Overall Study|Failure to meet randomization criteria|0|||
129831215|NCT01286012|467347902|FG000|Overall Study|Adverse Event|3|||
129831216|NCT01286012|467347903|FG001|Overall Study|Adverse Event|3|||
129831217|NCT01286012|467347902|FG000|Overall Study|Death|2|||
129831218|NCT01286012|467347903|FG001|Overall Study|Death|3|||
129831219|NCT01286012|467347902|FG000|Overall Study|Protocol Violation|1|||
129831220|NCT01286012|467347903|FG001|Overall Study|Protocol Violation|1|||
129831221|NCT01286012|467347902|FG000|Overall Study|Withdrawal by Subject|4|||
129831222|NCT01286012|467347903|FG001|Overall Study|Withdrawal by Subject|4|||
129831223|NCT01286012|467347902|FG000|Overall Study|Physician Decision|2|||
129831224|NCT01286012|467347903|FG001|Overall Study|Physician Decision|0|||
129897698|NCT00517933|467584423|FG000|Period 2|Withdrawal by Subject|1|||
129831225|NCT01286012|467347902|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
129831226|NCT01286012|467347903|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
129831227|NCT00663052|467347907|FG000|Overall Study|Adverse Event|6|||
129831228|NCT00663052|467347908|FG001|Overall Study|Adverse Event|3|||
129831229|NCT00663052|467347907|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
129831230|NCT00663052|467347908|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129831231|NCT00663052|467347907|FG000|Overall Study|Protocol Violation|1|||
129831232|NCT00663052|467347908|FG001|Overall Study|Protocol Violation|0|||
129831233|NCT00663052|467347907|FG000|Overall Study|Withdrawal by Subject|2|||
129831234|NCT00663052|467347908|FG001|Overall Study|Withdrawal by Subject|5|||
129831235|NCT00663052|467347907|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
129831236|NCT00663052|467347908|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
129831237|NCT00663052|467347907|FG000|Overall Study|Other|0|||
129831238|NCT00663052|467347908|FG001|Overall Study|Other|1|||
129831239|NCT05760300|467347911|FG000|Overall Study|Adverse Event|0|||
129831240|NCT05760300|467347912|FG001|Overall Study|Adverse Event|0|||
129831241|NCT05760300|467347913|FG002|Overall Study|Adverse Event|1|||
129831242|NCT05760300|467347914|FG003|Overall Study|Adverse Event|0|||
129831243|NCT05760300|467347911|FG000|Overall Study|Participant Decision|1|||
129831244|NCT05760300|467347912|FG001|Overall Study|Participant Decision|0|||
129831245|NCT05760300|467347913|FG002|Overall Study|Participant Decision|0|||
129831246|NCT05760300|467347914|FG003|Overall Study|Participant Decision|0|||
129831247|NCT04690751|467347924|FG000|Overall Study|Protocol Violation|0|||
129831248|NCT04690751|467347925|FG001|Overall Study|Protocol Violation|1|||
129831249|NCT04690751|467347926|FG002|Overall Study|Protocol Violation|0|||
129831250|NCT04690751|467347927|FG003|Overall Study|Protocol Violation|1|||
129831251|NCT04690751|467347928|FG004|Overall Study|Protocol Violation|2|||
129831252|NCT04690751|467347929|FG005|Overall Study|Protocol Violation|0|||
129831253|NCT04690751|467347924|FG000|Overall Study|Adverse Event|0|||
129831254|NCT04690751|467347925|FG001|Overall Study|Adverse Event|0|||
129831255|NCT04690751|467347926|FG002|Overall Study|Adverse Event|1|||
129831256|NCT04690751|467347927|FG003|Overall Study|Adverse Event|0|||
129831257|NCT04690751|467347928|FG004|Overall Study|Adverse Event|0|||
129831258|NCT04690751|467347929|FG005|Overall Study|Adverse Event|0|||
129831259|NCT04690751|467347924|FG000|Overall Study|Positive urine drug screen test|0|||
129831260|NCT04690751|467347925|FG001|Overall Study|Positive urine drug screen test|0|||
129831261|NCT04690751|467347926|FG002|Overall Study|Positive urine drug screen test|0|||
129831262|NCT04690751|467347927|FG003|Overall Study|Positive urine drug screen test|0|||
129831263|NCT04690751|467347928|FG004|Overall Study|Positive urine drug screen test|1|||
129831264|NCT04690751|467347929|FG005|Overall Study|Positive urine drug screen test|0|||
129831265|NCT04364620|467347930|FG000|Overall Study|Disease Progression|20|||
129831266|NCT04364620|467347930|FG000|Overall Study|Adverse Event|5|||
129831267|NCT04364620|467347930|FG000|Overall Study|Physician Decision|4|||
129831268|NCT04364620|467347930|FG000|Overall Study|Death|3|||
129831269|NCT04364620|467347930|FG000|Overall Study|Other|2|||
129831270|NCT04364620|467347930|FG000|Overall Study|Withdrawal by Subject|1|||
129831271|NCT03971695|467349113|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831272|NCT03971695|467349114|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831273|NCT03971695|467349115|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831274|NCT03971695|467349116|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
129831275|NCT03971695|467349117|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
129831276|NCT03971695|467349118|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831277|NCT03971695|467349119|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831278|NCT03971695|467349120|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831279|NCT03971695|467349121|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
129831280|NCT03971695|467349122|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
129831281|NCT03971695|467349123|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
129831282|NCT03971695|467349124|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
129831283|NCT03971695|467349125|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
129831284|NCT02155738|467349133|FG000|Overall Study|Missing critical information|1|||
129831285|NCT02155738|467349134|FG001|Overall Study|Missing critical information|0|||
129831286|NCT02155738|467349135|FG002|Overall Study|Missing critical information|0|||
129831287|NCT02155738|467349136|FG003|Overall Study|Missing critical information|1|||
129831288|NCT01190254|467349137|FG000|Overall Study|Adverse Event|3|||
129831289|NCT01190254|467349138|FG001|Overall Study|Adverse Event|6|||
129831290|NCT01190254|467349139|FG002|Overall Study|Adverse Event|8|||
129831291|NCT01190254|467349137|FG000|Overall Study|Lack of Efficacy|7|||
129831292|NCT01190254|467349138|FG001|Overall Study|Lack of Efficacy|4|||
129831293|NCT01190254|467349139|FG002|Overall Study|Lack of Efficacy|5|||
129831294|NCT01190254|467349137|FG000|Overall Study|Lost to Follow-up|4|||
129831295|NCT01190254|467349138|FG001|Overall Study|Lost to Follow-up|2|||
129831296|NCT01190254|467349139|FG002|Overall Study|Lost to Follow-up|0|||
129831297|NCT01190254|467349137|FG000|Overall Study|Withdrawal by Subject|4|||
129831298|NCT01190254|467349138|FG001|Overall Study|Withdrawal by Subject|5|||
129831299|NCT01190254|467349139|FG002|Overall Study|Withdrawal by Subject|7|||
129831300|NCT01190254|467349137|FG000|Overall Study|Protocol Violation|2|||
129831301|NCT01190254|467349138|FG001|Overall Study|Protocol Violation|0|||
129831302|NCT01190254|467349139|FG002|Overall Study|Protocol Violation|2|||
129831303|NCT01190254|467349137|FG000|Overall Study|Did not meet protocol eligibility|1|||
129831304|NCT01190254|467349138|FG001|Overall Study|Did not meet protocol eligibility|0|||
129831305|NCT01190254|467349139|FG002|Overall Study|Did not meet protocol eligibility|0|||
129831306|NCT02356783|467349140|FG000|Overall Study|Lost to Follow-up|1|||
129831307|NCT02356783|467349141|FG001|Overall Study|Lost to Follow-up|3|||
129831308|NCT02603809|467349142|FG000|Overall Study|Withdrawal by Subject|4|||
129831309|NCT02603809|467349143|FG001|Overall Study|Withdrawal by Subject|1|||
129831310|NCT02603809|467349144|FG002|Overall Study|Withdrawal by Subject|2|||
129831311|NCT02603809|467349145|FG003|Overall Study|Withdrawal by Subject|3|||
129831312|NCT02603809|467349146|FG004|Overall Study|Withdrawal by Subject|3|||
129831313|NCT02603809|467349147|FG005|Overall Study|Withdrawal by Subject|4|||
129831314|NCT02603809|467349142|FG000|Overall Study|Lost to Follow-up|2|||
129831315|NCT02603809|467349143|FG001|Overall Study|Lost to Follow-up|3|||
129831316|NCT02603809|467349144|FG002|Overall Study|Lost to Follow-up|1|||
129831317|NCT02603809|467349145|FG003|Overall Study|Lost to Follow-up|4|||
129831318|NCT02603809|467349146|FG004|Overall Study|Lost to Follow-up|2|||
129831319|NCT02603809|467349147|FG005|Overall Study|Lost to Follow-up|2|||
129831320|NCT02603809|467349142|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
129831321|NCT02603809|467349143|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
129831322|NCT02603809|467349144|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
129831323|NCT02603809|467349145|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
129831324|NCT02603809|467349146|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
129831325|NCT02603809|467349147|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
129831326|NCT02603809|467349142|FG000|Overall Study|Physician Decision|0|||
129831327|NCT02603809|467349143|FG001|Overall Study|Physician Decision|0|||
129831328|NCT02603809|467349144|FG002|Overall Study|Physician Decision|0|||
129831329|NCT02603809|467349145|FG003|Overall Study|Physician Decision|1|||
129831330|NCT02603809|467349146|FG004|Overall Study|Physician Decision|2|||
129831331|NCT02603809|467349147|FG005|Overall Study|Physician Decision|1|||
129831332|NCT02603809|467349142|FG000|Overall Study|Adverse Event|3|||
129831333|NCT02603809|467349143|FG001|Overall Study|Adverse Event|0|||
129831334|NCT02603809|467349144|FG002|Overall Study|Adverse Event|2|||
129831335|NCT02603809|467349145|FG003|Overall Study|Adverse Event|2|||
129831336|NCT02603809|467349146|FG004|Overall Study|Adverse Event|1|||
129831337|NCT02603809|467349147|FG005|Overall Study|Adverse Event|1|||
129831338|NCT02603809|467349142|FG000|Overall Study|Lack of Efficacy|0|||
129831339|NCT02603809|467349143|FG001|Overall Study|Lack of Efficacy|1|||
129831340|NCT02603809|467349144|FG002|Overall Study|Lack of Efficacy|0|||
129831341|NCT02603809|467349145|FG003|Overall Study|Lack of Efficacy|0|||
129831342|NCT02603809|467349146|FG004|Overall Study|Lack of Efficacy|0|||
129831343|NCT02603809|467349147|FG005|Overall Study|Lack of Efficacy|1|||
129831344|NCT04729127|467349148|FG000|Overall Study|Suspended/Terminated EI Services|4|||
129831345|NCT04729127|467349149|FG001|Overall Study|Suspended/Terminated EI Services|0|||
129831346|NCT04729127|467349150|FG002|Overall Study|Suspended/Terminated EI Services|4|||
129831347|NCT04729127|467349151|FG003|Overall Study|Suspended/Terminated EI Services|6|||
129831348|NCT04729127|467349152|FG004|Overall Study|Suspended/Terminated EI Services|0|||
129831349|NCT04729127|467349153|FG005|Overall Study|Suspended/Terminated EI Services|6|||
129831350|NCT04729127|467349154|FG006|Overall Study|Suspended/Terminated EI Services|2|||
129831351|NCT04729127|467349155|FG007|Overall Study|Suspended/Terminated EI Services|0|||
129831352|NCT04729127|467349156|FG008|Overall Study|Suspended/Terminated EI Services|2|||
129831353|NCT04729127|467349148|FG000|Overall Study|Withdrawal by Subject|1|||
129831354|NCT04729127|467349149|FG001|Overall Study|Withdrawal by Subject|0|||
129831355|NCT04729127|467349150|FG002|Overall Study|Withdrawal by Subject|1|||
129831356|NCT04729127|467349151|FG003|Overall Study|Withdrawal by Subject|0|||
129831357|NCT04729127|467349152|FG004|Overall Study|Withdrawal by Subject|0|||
129831358|NCT04729127|467349153|FG005|Overall Study|Withdrawal by Subject|0|||
129831359|NCT04729127|467349154|FG006|Overall Study|Withdrawal by Subject|0|||
129831360|NCT04729127|467349155|FG007|Overall Study|Withdrawal by Subject|0|||
129831361|NCT04729127|467349156|FG008|Overall Study|Withdrawal by Subject|0|||
129831362|NCT04729127|467349148|FG000|Overall Study|Switched Agency/Setting|1|||
129831363|NCT04729127|467349149|FG001|Overall Study|Switched Agency/Setting|0|||
129831364|NCT04729127|467349150|FG002|Overall Study|Switched Agency/Setting|1|||
129831365|NCT04729127|467349151|FG003|Overall Study|Switched Agency/Setting|1|||
129831366|NCT04729127|467349152|FG004|Overall Study|Switched Agency/Setting|0|||
129831367|NCT04729127|467349153|FG005|Overall Study|Switched Agency/Setting|1|||
129831368|NCT04729127|467349154|FG006|Overall Study|Switched Agency/Setting|1|||
129831369|NCT04729127|467349155|FG007|Overall Study|Switched Agency/Setting|0|||
129831370|NCT04729127|467349156|FG008|Overall Study|Switched Agency/Setting|1|||
129831371|NCT01365507|467349157|FG000|Overall Study|Withdrawal Criteria|8|||
129831372|NCT01365507|467349158|FG001|Overall Study|Withdrawal Criteria|5|||
129831373|NCT01365507|467349157|FG000|Overall Study|Unclassified|1|||
129831374|NCT01365507|467349158|FG001|Overall Study|Unclassified|4|||
129831375|NCT00192504|467349161|FG000|Overall Study|Lost to Follow-up|1|||
129831376|NCT00192504|467349162|FG001|Overall Study|Lost to Follow-up|0|||
129831377|NCT00192504|467349163|FG002|Overall Study|Lost to Follow-up|0|||
129831378|NCT00192504|467349164|FG003|Overall Study|Lost to Follow-up|0|||
129831379|NCT00192504|467349161|FG000|Overall Study|Dosing window missed|0|||
129831380|NCT00192504|467349162|FG001|Overall Study|Dosing window missed|0|||
129831381|NCT00192504|467349163|FG002|Overall Study|Dosing window missed|1|||
129831382|NCT00192504|467349164|FG003|Overall Study|Dosing window missed|0|||
129831383|NCT01139450|467349165|FG000|Overall Study|Withdrawal by Subject|7|||
129831384|NCT01139450|467349166|FG001|Overall Study|Withdrawal by Subject|10|||
129831385|NCT01139450|467349167|FG002|Overall Study|Withdrawal by Subject|13|||
129831386|NCT01139450|467349165|FG000|Overall Study|Lack of Efficacy|3|||
129831387|NCT01139450|467349166|FG001|Overall Study|Lack of Efficacy|1|||
129831388|NCT01139450|467349167|FG002|Overall Study|Lack of Efficacy|8|||
129831389|NCT01139450|467349165|FG000|Overall Study|Protocol Violation|6|||
129831390|NCT01139450|467349166|FG001|Overall Study|Protocol Violation|5|||
129831391|NCT01139450|467349167|FG002|Overall Study|Protocol Violation|2|||
129831392|NCT01139450|467349165|FG000|Overall Study|Lost to Follow-up|9|||
129831393|NCT01139450|467349166|FG001|Overall Study|Lost to Follow-up|7|||
129831394|NCT01139450|467349167|FG002|Overall Study|Lost to Follow-up|11|||
129831395|NCT01139450|467349165|FG000|Overall Study|Administrative|0|||
129831396|NCT01139450|467349166|FG001|Overall Study|Administrative|0|||
129831397|NCT01139450|467349167|FG002|Overall Study|Administrative|1|||
129831398|NCT01139450|467349165|FG000|Overall Study|Adverse Event|2|||
129831399|NCT01139450|467349166|FG001|Overall Study|Adverse Event|2|||
129831400|NCT01139450|467349167|FG002|Overall Study|Adverse Event|3|||
129831401|NCT05129488|467349176|FG000|Overall Study|Protocol Violation|3|||
129831402|NCT04782856|467349177|FG000|Overall Study|Withdrawal by Subject|0|||
129831403|NCT04782856|467349178|FG001|Overall Study|Withdrawal by Subject|1|||
129831404|NCT03020823|467349179|FG000|Overall Study|Physician Decision|4|||
129831405|NCT03020823|467349179|FG000|Overall Study|Lack of Efficacy|4|||
129831406|NCT03020823|467349179|FG000|Overall Study|Adverse Event|2|||
129831407|NCT03739112|467349180|FG000|Overall Study|Adverse Event|2|||
129831408|NCT03739112|467349181|FG001|Overall Study|Adverse Event|2|||
129831409|NCT03739112|467349180|FG000|Overall Study|Withdrawal by Subject|38|||
129831410|NCT03739112|467349181|FG001|Overall Study|Withdrawal by Subject|19|||
129831411|NCT03739112|467349180|FG000|Overall Study|Lost to Follow-up|31|||
129831412|NCT03739112|467349181|FG001|Overall Study|Lost to Follow-up|33|||
129831413|NCT03739112|467349180|FG000|Overall Study|Protocol Deviation|12|||
129831414|NCT03739112|467349181|FG001|Overall Study|Protocol Deviation|9|||
129831415|NCT03739112|467349180|FG000|Overall Study|Physician Decision|1|||
129831416|NCT03739112|467349181|FG001|Overall Study|Physician Decision|0|||
129831417|NCT03739112|467349180|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
129831418|NCT03739112|467349181|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
129831419|NCT03739112|467349180|FG000|Overall Study|Site went on hold|65|||
129831420|NCT03739112|467349181|FG001|Overall Study|Site went on hold|67|||
129831421|NCT03739112|467349180|FG000|Overall Study|Other than specified|8|||
129831422|NCT03739112|467349181|FG001|Overall Study|Other than specified|5|||
129831423|NCT03739112|467349180|FG000|Overall Study|Randomized but not vaccinated|31|||
129831424|NCT03739112|467349181|FG001|Overall Study|Randomized but not vaccinated|25|||
129831425|NCT04307446|467349182|FG000|Overall Study|Lost to Follow-up|2|||
129831426|NCT04307446|467349183|FG001|Overall Study|Lost to Follow-up|0|||
129831427|NCT01652664|467349186|FG000|Overall Study|Treatment Failure|5|||
129831428|NCT01652664|467349187|FG001|Overall Study|Treatment Failure|1|||
129831429|NCT01652664|467349186|FG000|Overall Study|Inadequate IOP control|1|||
129831430|NCT01652664|467349187|FG001|Overall Study|Inadequate IOP control|0|||
129831431|NCT00297037|467349188|FG000|Overall Study|Withdrawal by Subject|2|||
129831432|NCT00297037|467349189|FG001|Overall Study|Withdrawal by Subject|0|||
129831433|NCT00405587|467349192|FG000|Overall Study|Death|0|||
129831434|NCT00405587|467349193|FG001|Overall Study|Death|0|||
129831435|NCT00405587|467349194|FG002|Overall Study|Death|0|||
129831436|NCT00405587|467349195|FG003|Overall Study|Death|1|||
129831437|NCT00405587|467349192|FG000|Overall Study|Disease Progression|22|||
129831438|NCT00405587|467349193|FG001|Overall Study|Disease Progression|23|||
129831439|NCT00405587|467349194|FG002|Overall Study|Disease Progression|21|||
129831440|NCT00405587|467349195|FG003|Overall Study|Disease Progression|17|||
129831441|NCT00405587|467349192|FG000|Overall Study|Physician Decision|3|||
129831442|NCT00405587|467349193|FG001|Overall Study|Physician Decision|2|||
129831443|NCT00405587|467349194|FG002|Overall Study|Physician Decision|0|||
129831444|NCT00405587|467349195|FG003|Overall Study|Physician Decision|0|||
129831445|NCT00405587|467349192|FG000|Overall Study|Adverse Event|1|||
129831446|NCT00405587|467349193|FG001|Overall Study|Adverse Event|0|||
129831447|NCT00405587|467349194|FG002|Overall Study|Adverse Event|0|||
129831448|NCT00405587|467349195|FG003|Overall Study|Adverse Event|0|||
129831449|NCT00405587|467349192|FG000|Overall Study|Lost to Follow-up|0|||
129831450|NCT00405587|467349193|FG001|Overall Study|Lost to Follow-up|1|||
129831451|NCT00405587|467349194|FG002|Overall Study|Lost to Follow-up|1|||
129831452|NCT00405587|467349195|FG003|Overall Study|Lost to Follow-up|0|||
129831453|NCT00405587|467349192|FG000|Overall Study|Radiation induced necrosis|0|||
129831454|NCT00405587|467349193|FG001|Overall Study|Radiation induced necrosis|1|||
129831455|NCT00405587|467349194|FG002|Overall Study|Radiation induced necrosis|0|||
129831456|NCT00405587|467349195|FG003|Overall Study|Radiation induced necrosis|0|||
129831457|NCT00405587|467349192|FG000|Overall Study|Withdrawal by Subject|0|||
129831458|NCT00405587|467349193|FG001|Overall Study|Withdrawal by Subject|0|||
129831459|NCT00405587|467349194|FG002|Overall Study|Withdrawal by Subject|0|||
129831460|NCT00405587|467349195|FG003|Overall Study|Withdrawal by Subject|2|||
129831461|NCT00405587|467349192|FG000|Overall Study|Participant not dosed|0|||
129831462|NCT00405587|467349193|FG001|Overall Study|Participant not dosed|1|||
129831463|NCT00405587|467349194|FG002|Overall Study|Participant not dosed|0|||
129831464|NCT00405587|467349195|FG003|Overall Study|Participant not dosed|0|||
129831465|NCT06027866|467349196|FG000|Overall Study|Withdrawal by Subject|2|||
129831466|NCT00507442|467349199|FG000|Overall Study|Adverse Event|8|||
129831467|NCT00507442|467349200|FG001|Overall Study|Adverse Event|11|||
129831468|NCT00507442|467349201|FG002|Overall Study|Adverse Event|4|||
129831469|NCT00507442|467349202|FG003|Overall Study|Adverse Event|1|||
129831470|NCT00507442|467349199|FG000|Overall Study|Protocol Violation|0|||
129831471|NCT00507442|467349200|FG001|Overall Study|Protocol Violation|1|||
129831472|NCT00507442|467349201|FG002|Overall Study|Protocol Violation|0|||
129831473|NCT00507442|467349202|FG003|Overall Study|Protocol Violation|0|||
129831474|NCT00507442|467349199|FG000|Overall Study|Lost to Follow-up|0|||
129831475|NCT00507442|467349200|FG001|Overall Study|Lost to Follow-up|0|||
129831476|NCT00507442|467349201|FG002|Overall Study|Lost to Follow-up|1|||
129831477|NCT00507442|467349202|FG003|Overall Study|Lost to Follow-up|0|||
129831478|NCT00507442|467349199|FG000|Overall Study|Physician Decision|0|||
129831479|NCT00507442|467349200|FG001|Overall Study|Physician Decision|2|||
129831480|NCT00507442|467349201|FG002|Overall Study|Physician Decision|4|||
129831481|NCT00507442|467349202|FG003|Overall Study|Physician Decision|1|||
129831482|NCT00507442|467349199|FG000|Overall Study|Progressive Disease|2|||
129831483|NCT00507442|467349200|FG001|Overall Study|Progressive Disease|4|||
129831484|NCT00507442|467349201|FG002|Overall Study|Progressive Disease|2|||
129831485|NCT00507442|467349202|FG003|Overall Study|Progressive Disease|0|||
129831486|NCT00507442|467349199|FG000|Overall Study|Withdrawal by Subject|4|||
129831487|NCT00507442|467349200|FG001|Overall Study|Withdrawal by Subject|4|||
129831488|NCT00507442|467349201|FG002|Overall Study|Withdrawal by Subject|2|||
129831489|NCT00507442|467349202|FG003|Overall Study|Withdrawal by Subject|1|||
129831490|NCT00507442|467349199|FG000|Overall Study|Other|2|||
129831491|NCT00507442|467349200|FG001|Overall Study|Other|5|||
129831492|NCT00507442|467349201|FG002|Overall Study|Other|2|||
129831493|NCT00507442|467349202|FG003|Overall Study|Other|2|||
129831494|NCT00930579|467349203|FG000|Overall Study|Withdrawal by Subject|1|||
129831495|NCT00930579|467349203|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
129831496|NCT02672423|467349204|FG000|Period 1|Adverse Event|0|||
129831497|NCT02672423|467349205|FG001|Period 1|Adverse Event|0|||
129831498|NCT02672423|467349206|FG002|Period 1|Adverse Event|0|||
129831499|NCT02672423|467349207|FG003|Period 1|Adverse Event|0|||
129831500|NCT02672423|467349208|FG004|Period 1|Adverse Event|1|||
129831501|NCT02672423|467349209|FG005|Period 1|Adverse Event|0|||
129831502|NCT02672423|467349210|FG006|Period 1|Adverse Event|0|||
129831503|NCT02672423|467349211|FG007|Period 1|Adverse Event|0|||
129831504|NCT02672423|467349212|FG008|Period 1|Adverse Event|0|||
129831505|NCT02672423|467349213|FG009|Period 1|Adverse Event|0|||
129831506|NCT02672423|467349204|FG000|Period 2|Withdrawal by Subject|0|||
129831507|NCT02672423|467349205|FG001|Period 2|Withdrawal by Subject|0|||
129831508|NCT02672423|467349206|FG002|Period 2|Withdrawal by Subject|1|||
129831509|NCT02672423|467349207|FG003|Period 2|Withdrawal by Subject|0|||
129831510|NCT02672423|467349208|FG004|Period 2|Withdrawal by Subject|0|||
129831511|NCT02672423|467349209|FG005|Period 2|Withdrawal by Subject|0|||
129831512|NCT02672423|467349210|FG006|Period 2|Withdrawal by Subject|0|||
129831513|NCT02672423|467349211|FG007|Period 2|Withdrawal by Subject|0|||
129831514|NCT02672423|467349212|FG008|Period 2|Withdrawal by Subject|0|||
129831515|NCT02672423|467349213|FG009|Period 2|Withdrawal by Subject|0|||
129831516|NCT02672423|467349204|FG000|Period 3|Withdrawal by Subject|0|||
129831517|NCT02672423|467349205|FG001|Period 3|Withdrawal by Subject|0|||
129831518|NCT02672423|467349206|FG002|Period 3|Withdrawal by Subject|0|||
129831519|NCT02672423|467349207|FG003|Period 3|Withdrawal by Subject|0|||
129831520|NCT02672423|467349208|FG004|Period 3|Withdrawal by Subject|0|||
129831521|NCT02672423|467349209|FG005|Period 3|Withdrawal by Subject|0|||
129831522|NCT02672423|467349210|FG006|Period 3|Withdrawal by Subject|0|||
129831523|NCT02672423|467349211|FG007|Period 3|Withdrawal by Subject|1|||
129831524|NCT02672423|467349212|FG008|Period 3|Withdrawal by Subject|0|||
129831525|NCT02672423|467349213|FG009|Period 3|Withdrawal by Subject|0|||
129831526|NCT02672423|467349204|FG000|Period 3|Physician Decision|0|||
129831527|NCT02672423|467349205|FG001|Period 3|Physician Decision|0|||
129831528|NCT02672423|467349206|FG002|Period 3|Physician Decision|0|||
129831529|NCT02672423|467349207|FG003|Period 3|Physician Decision|0|||
129831530|NCT02672423|467349208|FG004|Period 3|Physician Decision|0|||
129831531|NCT02672423|467349209|FG005|Period 3|Physician Decision|1|||
129831532|NCT02672423|467349210|FG006|Period 3|Physician Decision|0|||
129831533|NCT02672423|467349211|FG007|Period 3|Physician Decision|0|||
129831534|NCT02672423|467349212|FG008|Period 3|Physician Decision|0|||
129831535|NCT02672423|467349213|FG009|Period 3|Physician Decision|0|||
129831536|NCT00536107|467349217|FG000|Overall Study|Death|5|||
129831537|NCT00536107|467349218|FG001|Overall Study|Death|1|||
129831538|NCT00536107|467349217|FG000|Overall Study|Incorrect enrolment|1|||
129831539|NCT00536107|467349218|FG001|Overall Study|Incorrect enrolment|0|||
129831540|NCT00536107|467349217|FG000|Overall Study|Withdrawal by Subject|0|||
129831541|NCT00536107|467349218|FG001|Overall Study|Withdrawal by Subject|1|||
129831542|NCT00536107|467349217|FG000|Overall Study|Study Termination|2|||
129831543|NCT00536107|467349218|FG001|Overall Study|Study Termination|4|||
129831544|NCT04829318|467349219|FG000|Overall Study|Adverse Event|6|||
129831545|NCT04829318|467349219|FG000|Overall Study|Death|1|||
129831546|NCT04829318|467349219|FG000|Overall Study|Lost to Follow-up|1|||
129831547|NCT04829318|467349219|FG000|Overall Study|Physician Decision|1|||
129831548|NCT04829318|467349219|FG000|Overall Study|Withdrawal by Subject|19|||
129831549|NCT04829318|467349219|FG000|Overall Study|Site terminated by sponsor|1|||
129831550|NCT04829318|467349219|FG000|Overall Study|Sponsor decision|5|||
129831551|NCT04829318|467349219|FG000|Overall Study|Other|1|||
129831552|NCT01265849|467349225|FG000|Overall Study|Randomized//Treatment not initiated|1|||
129831553|NCT01265849|467349226|FG001|Overall Study|Randomized//Treatment not initiated|4|||
129831554|NCT01265849|467349227|FG002|Overall Study|Randomized//Treatment not initiated|0|||
129831555|NCT01265849|467349225|FG000|Overall Study|Physician Decision|1|||
129831556|NCT01265849|467349226|FG001|Overall Study|Physician Decision|2|||
129897699|NCT00517933|467584424|FG001|Period 2|Withdrawal by Subject|3|||
129897700|NCT00517933|467584423|FG000|Period 2|Underwent lung transplant|0|||
129831557|NCT01265849|467349227|FG002|Overall Study|Physician Decision|0|||
129831558|NCT01265849|467349225|FG000|Overall Study|Lost to Follow-up|18|||
129831559|NCT01265849|467349226|FG001|Overall Study|Lost to Follow-up|15|||
129831560|NCT01265849|467349227|FG002|Overall Study|Lost to Follow-up|5|||
129831561|NCT01265849|467349225|FG000|Overall Study|Not otherwise specified|1|||
129897701|NCT00517933|467584424|FG001|Period 2|Underwent lung transplant|2|||
129831562|NCT01265849|467349226|FG001|Overall Study|Not otherwise specified|6|||
129831563|NCT01265849|467349227|FG002|Overall Study|Not otherwise specified|1|||
129831564|NCT01265849|467349225|FG000|Overall Study|Withdrawal by Subject|25|||
129831565|NCT01265849|467349226|FG001|Overall Study|Withdrawal by Subject|34|||
129831566|NCT01265849|467349227|FG002|Overall Study|Withdrawal by Subject|13|||
129831567|NCT03194321|467349229|FG000|Overall Study|Withdrawal by Subject|1|||
129831568|NCT03194321|467349229|FG000|Overall Study|Lost to Follow-up|1|||
129831569|NCT03194321|467349229|FG000|Overall Study|Travel for Follow-up|1|||
129831570|NCT03803774|467349230|FG000|Dose Escalation|Withdrawal by Subject|0|||
129831571|NCT03803774|467349231|FG001|Dose Escalation|Withdrawal by Subject|0|||
129831572|NCT03803774|467349232|FG002|Dose Escalation|Withdrawal by Subject|0|||
129831573|NCT03803774|467349233|FG003|Dose Escalation|Withdrawal by Subject|1|||
129831574|NCT03803774|467349234|FG004|Dose Escalation|Withdrawal by Subject|0|||
129831575|NCT00003641|467349236|FG000|Overall Study|Withdrawal by Subject|0|||
129831576|NCT00003641|467349237|FG001|Overall Study|Withdrawal by Subject|100|||
129831577|NCT00003641|467349236|FG000|Overall Study|Adverse Event|0|||
129831578|NCT00003641|467349237|FG001|Overall Study|Adverse Event|38|||
129831579|NCT00003641|467349236|FG000|Overall Study|Disease progression|0|||
129831580|NCT00003641|467349237|FG001|Overall Study|Disease progression|2|||
129831581|NCT00003641|467349236|FG000|Overall Study|Unknown/missing|0|||
129831582|NCT00003641|467349237|FG001|Overall Study|Unknown/missing|22|||
129831583|NCT00003641|467349236|FG000|Overall Study|Should not receive interferon therapy|2|||
129831584|NCT00003641|467349237|FG001|Overall Study|Should not receive interferon therapy|0|||
129831585|NCT00003641|467349236|FG000|Overall Study|Never started interferon|567|||
129831586|NCT00003641|467349237|FG001|Overall Study|Never started interferon|12|||
129831587|NCT02154581|467349239|FG000|Overall Study|Lost to Follow-up|7|||
129831588|NCT02154581|467349240|FG001|Overall Study|Lost to Follow-up|8|||
129831589|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
129831590|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
129831591|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
129831592|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
129831593|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
129897702|NCT00121199|467584426|FG000|Overall Study|Adverse Event|11|||
129831594|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
129831595|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
129831596|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
129831597|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
129831598|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
129831599|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
129831600|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
129831601|NCT03659916|467349241|FG000|Treatment Period (72 Weeks)|Other|1|||
129831602|NCT03659916|467349242|FG001|Treatment Period (72 Weeks)|Other|3|||
129831603|NCT03659916|467349243|FG002|Treatment Period (72 Weeks)|Other|9|||
129831604|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
129831605|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
129831606|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
129831607|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
129831608|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
129831609|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
129831610|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
129831611|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
129831612|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
129831613|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
129831614|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
129831615|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
129831616|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
129831617|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
129831618|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
129831619|NCT03659916|467349241|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
129831620|NCT03659916|467349242|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
129831621|NCT03659916|467349243|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
129831622|NCT03886220|467349244|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
129831623|NCT03886220|467349245|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
129831624|NCT03886220|467349244|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
129831625|NCT03886220|467349245|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129831626|NCT03886220|467349244|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
129831627|NCT03886220|467349245|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129831628|NCT03615105|467349248|FG000|Overall Study|Protocol Violation|1|||
129831629|NCT03615105|467349249|FG001|Overall Study|Protocol Violation|0|||
129831630|NCT03615105|467349250|FG002|Overall Study|Protocol Violation|0|||
129831631|NCT03615105|467349248|FG000|Overall Study|Death|0|||
129831632|NCT03615105|467349249|FG001|Overall Study|Death|2|||
129831633|NCT03615105|467349250|FG002|Overall Study|Death|0|||
129831634|NCT03482791|467349251|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
129831635|NCT03482791|467349252|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
129831636|NCT01344161|467349254|FG000|Overall Study|Lost to Follow-up|4|||
129831637|NCT01344161|467349255|FG001|Overall Study|Lost to Follow-up|1|||
129831638|NCT01344161|467349254|FG000|Overall Study|Pregnancy|0|||
129831639|NCT01344161|467349255|FG001|Overall Study|Pregnancy|1|||
129831640|NCT01344161|467349254|FG000|Overall Study|Protocol Violation|1|||
129831641|NCT01344161|467349255|FG001|Overall Study|Protocol Violation|1|||
129831642|NCT03759379|467352097|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
129831643|NCT03759379|467352098|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
129831644|NCT03759379|467352097|FG000|Treatment Period|Death|2|||
129831645|NCT03759379|467352098|FG001|Treatment Period|Death|3|||
129831646|NCT03759379|467352097|FG000|Treatment Period|Lost to Follow-up|1|||
129831647|NCT03759379|467352098|FG001|Treatment Period|Lost to Follow-up|0|||
129831648|NCT03759379|467352097|FG000|Treatment Period|Physician Decision|0|||
129831649|NCT03759379|467352098|FG001|Treatment Period|Physician Decision|1|||
129831650|NCT04579380|467352100|FG000|Overall Study|Death|9|||
129831651|NCT04579380|467352101|FG001|Overall Study|Death|22|||
129831652|NCT04579380|467352102|FG002|Overall Study|Death|22|||
129831653|NCT04579380|467352103|FG003|Overall Study|Death|17|||
129831654|NCT04579380|467352104|FG004|Overall Study|Death|6|||
129831655|NCT04579380|467352105|FG005|Overall Study|Death|21|||
129831656|NCT04579380|467352106|FG006|Overall Study|Death|10|||
129831657|NCT04579380|467352107|FG007|Overall Study|Death|11|||
129831658|NCT04579380|467352108|FG008|Overall Study|Death|25|||
129831659|NCT04579380|467352100|FG000|Overall Study|Withdrawal by Subject|0|||
129831660|NCT04579380|467352101|FG001|Overall Study|Withdrawal by Subject|3|||
129831661|NCT04579380|467352102|FG002|Overall Study|Withdrawal by Subject|4|||
129831662|NCT04579380|467352103|FG003|Overall Study|Withdrawal by Subject|0|||
129831663|NCT04579380|467352104|FG004|Overall Study|Withdrawal by Subject|1|||
129831664|NCT04579380|467352105|FG005|Overall Study|Withdrawal by Subject|2|||
129831665|NCT04579380|467352106|FG006|Overall Study|Withdrawal by Subject|0|||
129831666|NCT04579380|467352107|FG007|Overall Study|Withdrawal by Subject|1|||
129831667|NCT04579380|467352108|FG008|Overall Study|Withdrawal by Subject|2|||
129831668|NCT04579380|467352100|FG000|Overall Study|Ongoing|2|||
129831669|NCT04579380|467352101|FG001|Overall Study|Ongoing|6|||
129831670|NCT04579380|467352102|FG002|Overall Study|Ongoing|4|||
129831671|NCT04579380|467352103|FG003|Overall Study|Ongoing|8|||
129831672|NCT04579380|467352104|FG004|Overall Study|Ongoing|5|||
129831673|NCT04579380|467352105|FG005|Overall Study|Ongoing|8|||
129831674|NCT04579380|467352106|FG006|Overall Study|Ongoing|3|||
129831675|NCT04579380|467352107|FG007|Overall Study|Ongoing|19|||
129831676|NCT04579380|467352108|FG008|Overall Study|Ongoing|6|||
129831677|NCT02967692|467352109|FG000|Overall Study|Progressive disease|3|||
129831678|NCT02967692|467352110|FG001|Overall Study|Progressive disease|15|||
129831679|NCT02967692|467352111|FG002|Overall Study|Progressive disease|114|||
129831680|NCT02967692|467352112|FG003|Overall Study|Progressive disease|151|||
129831681|NCT02967692|467352109|FG000|Overall Study|Subject/guardian decision|1|||
129831682|NCT02967692|467352110|FG001|Overall Study|Subject/guardian decision|1|||
129831683|NCT02967692|467352111|FG002|Overall Study|Subject/guardian decision|14|||
129831684|NCT02967692|467352112|FG003|Overall Study|Subject/guardian decision|22|||
129831685|NCT02967692|467352109|FG000|Overall Study|Death|0|||
129831686|NCT02967692|467352110|FG001|Overall Study|Death|1|||
129831687|NCT02967692|467352111|FG002|Overall Study|Death|13|||
129831688|NCT02967692|467352112|FG003|Overall Study|Death|13|||
129831689|NCT02967692|467352109|FG000|Overall Study|Protocol deviation|1|||
129831690|NCT02967692|467352110|FG001|Overall Study|Protocol deviation|0|||
129831691|NCT02967692|467352111|FG002|Overall Study|Protocol deviation|1|||
129831692|NCT02967692|467352112|FG003|Overall Study|Protocol deviation|1|||
129831693|NCT02967692|467352109|FG000|Overall Study|Lost to Follow-up|0|||
129831694|NCT02967692|467352110|FG001|Overall Study|Lost to Follow-up|0|||
129831695|NCT02967692|467352111|FG002|Overall Study|Lost to Follow-up|1|||
129831696|NCT02967692|467352112|FG003|Overall Study|Lost to Follow-up|0|||
129831697|NCT02967692|467352109|FG000|Overall Study|Physician Decision|0|||
129831698|NCT02967692|467352110|FG001|Overall Study|Physician Decision|0|||
129831699|NCT02967692|467352111|FG002|Overall Study|Physician Decision|22|||
129831700|NCT02967692|467352112|FG003|Overall Study|Physician Decision|13|||
129831701|NCT02967692|467352109|FG000|Overall Study|Adverse Event|2|||
129831702|NCT02967692|467352110|FG001|Overall Study|Adverse Event|9|||
129831703|NCT02967692|467352111|FG002|Overall Study|Adverse Event|60|||
129831704|NCT02967692|467352112|FG003|Overall Study|Adverse Event|28|||
129831705|NCT02967692|467352109|FG000|Overall Study|Study terminated by sponsor|2|||
129831706|NCT02967692|467352110|FG001|Overall Study|Study terminated by sponsor|1|||
129831707|NCT02967692|467352111|FG002|Overall Study|Study terminated by sponsor|42|||
129831708|NCT02967692|467352112|FG003|Overall Study|Study terminated by sponsor|37|||
129831709|NCT01536379|467352113|FG000|Overall Study|Adverse Event|1|||
129831710|NCT01536379|467352114|FG001|Overall Study|Adverse Event|2|||
129831711|NCT01536379|467352113|FG000|Overall Study|Withdrawal by Subject|1|||
129831712|NCT01536379|467352114|FG001|Overall Study|Withdrawal by Subject|1|||
129831713|NCT00939809|467352120|FG000|Overall Study|Adverse Event|2|||
129831714|NCT00939809|467352120|FG000|Overall Study|Death|1|||
129831715|NCT04447417|467352121|FG000|Overall Study|Withdrawal by Subject|1|||
129831716|NCT04447417|467352122|FG001|Overall Study|Withdrawal by Subject|0|||
129831717|NCT04447417|467352121|FG000|Overall Study|Failure to meet inclusion criteria|1|||
129831718|NCT04447417|467352122|FG001|Overall Study|Failure to meet inclusion criteria|0|||
129831719|NCT04447417|467352121|FG000|Overall Study|Lost to Follow-up|1|||
129831720|NCT04447417|467352122|FG001|Overall Study|Lost to Follow-up|0|||
129831721|NCT00066066|467352123|FG000|Overall Study|Lost to Follow-up|6|||
129831722|NCT00066066|467352124|FG001|Overall Study|Lost to Follow-up|4|||
129831723|NCT00066066|467352125|FG002|Overall Study|Lost to Follow-up|7|||
129831724|NCT00066066|467352126|FG003|Overall Study|Lost to Follow-up|4|||
129831725|NCT00066066|467352127|FG004|Overall Study|Lost to Follow-up|3|||
129831726|NCT00066066|467352128|FG005|Overall Study|Lost to Follow-up|5|||
129831727|NCT02268409|467352129|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
129831728|NCT02268409|467352129|FG000|Overall Study|Death|1|||
129831729|NCT02268409|467352129|FG000|Overall Study|Lost to Follow-up|1|||
129831730|NCT02268409|467352129|FG000|Overall Study|Protocol Violation|3|||
129831731|NCT02268409|467352129|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
129831732|NCT02268409|467352129|FG000|Overall Study|Withdrawal by Subject|5|||
129831733|NCT00156533|467352133|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
129831734|NCT00156533|467352134|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
129831735|NCT00156533|467352135|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
129831736|NCT00156533|467352136|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
129831737|NCT00156533|467352133|FG000|Overall Study|Withdrawal by Subject|1|||
129831738|NCT00156533|467352134|FG001|Overall Study|Withdrawal by Subject|0|||
129831739|NCT00156533|467352135|FG002|Overall Study|Withdrawal by Subject|0|||
129831740|NCT00156533|467352136|FG003|Overall Study|Withdrawal by Subject|1|||
129831741|NCT00156533|467352133|FG000|Overall Study|Failed Screening|1|||
129831742|NCT00156533|467352134|FG001|Overall Study|Failed Screening|0|||
129831743|NCT00156533|467352135|FG002|Overall Study|Failed Screening|1|||
129831744|NCT00156533|467352136|FG003|Overall Study|Failed Screening|1|||
129831745|NCT02608268|467352137|FG000|Overall Study|Adverse Event|0|||
129831746|NCT02608268|467352138|FG001|Overall Study|Adverse Event|0|||
129831747|NCT02608268|467352139|FG002|Overall Study|Adverse Event|1|||
129831748|NCT02608268|467352140|FG003|Overall Study|Adverse Event|0|||
129831749|NCT02608268|467352141|FG004|Overall Study|Adverse Event|0|||
129831750|NCT02608268|467352142|FG005|Overall Study|Adverse Event|0|||
129831751|NCT02608268|467352143|FG006|Overall Study|Adverse Event|0|||
129831752|NCT02608268|467352144|FG007|Overall Study|Adverse Event|0|||
129831753|NCT02608268|467352145|FG008|Overall Study|Adverse Event|0|||
129831754|NCT02608268|467352146|FG009|Overall Study|Adverse Event|0|||
129831755|NCT02608268|467352147|FG010|Overall Study|Adverse Event|0|||
129831756|NCT02608268|467352148|FG011|Overall Study|Adverse Event|0|||
129831757|NCT02608268|467352149|FG012|Overall Study|Adverse Event|2|||
129831758|NCT02608268|467352150|FG013|Overall Study|Adverse Event|0|||
129831759|NCT02608268|467352151|FG014|Overall Study|Adverse Event|0|||
129831760|NCT02608268|467352152|FG015|Overall Study|Adverse Event|0|||
129831761|NCT02608268|467352153|FG016|Overall Study|Adverse Event|0|||
129831762|NCT02608268|467352154|FG017|Overall Study|Adverse Event|0|||
129831763|NCT02608268|467352155|FG018|Overall Study|Adverse Event|0|||
129831764|NCT02608268|467352156|FG019|Overall Study|Adverse Event|0|||
129831765|NCT02608268|467352157|FG020|Overall Study|Adverse Event|1|||
129831766|NCT02608268|467352158|FG021|Overall Study|Adverse Event|1|||
129831767|NCT02608268|467352159|FG022|Overall Study|Adverse Event|0|||
129831768|NCT02608268|467352160|FG023|Overall Study|Adverse Event|0|||
129831769|NCT02608268|467352161|FG024|Overall Study|Adverse Event|1|||
129831770|NCT02608268|467352162|FG025|Overall Study|Adverse Event|0|||
129831771|NCT02608268|467352163|FG026|Overall Study|Adverse Event|0|||
129831772|NCT02608268|467352164|FG027|Overall Study|Adverse Event|0|||
129831773|NCT02608268|467352165|FG028|Overall Study|Adverse Event|1|||
129831774|NCT02608268|467352166|FG029|Overall Study|Adverse Event|0|||
129897703|NCT00121199|467584426|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129897704|NCT00121199|467584426|FG000|Overall Study|Progression/Relapse|1|||
129831775|NCT02608268|467352137|FG000|Overall Study|Death|1|||
129831776|NCT02608268|467352138|FG001|Overall Study|Death|0|||
129831777|NCT02608268|467352139|FG002|Overall Study|Death|0|||
129831778|NCT02608268|467352140|FG003|Overall Study|Death|0|||
129831779|NCT02608268|467352141|FG004|Overall Study|Death|0|||
129831780|NCT02608268|467352142|FG005|Overall Study|Death|0|||
129831781|NCT02608268|467352143|FG006|Overall Study|Death|0|||
129831782|NCT02608268|467352144|FG007|Overall Study|Death|0|||
129831783|NCT02608268|467352145|FG008|Overall Study|Death|1|||
129831784|NCT02608268|467352146|FG009|Overall Study|Death|1|||
129831785|NCT02608268|467352147|FG010|Overall Study|Death|0|||
129831786|NCT02608268|467352148|FG011|Overall Study|Death|0|||
129831787|NCT02608268|467352149|FG012|Overall Study|Death|0|||
129831788|NCT02608268|467352150|FG013|Overall Study|Death|0|||
129831789|NCT02608268|467352151|FG014|Overall Study|Death|0|||
129831790|NCT02608268|467352152|FG015|Overall Study|Death|1|||
129831791|NCT02608268|467352153|FG016|Overall Study|Death|0|||
129831792|NCT02608268|467352154|FG017|Overall Study|Death|1|||
129831793|NCT02608268|467352155|FG018|Overall Study|Death|0|||
129831794|NCT02608268|467352156|FG019|Overall Study|Death|1|||
129831795|NCT02608268|467352157|FG020|Overall Study|Death|1|||
129831796|NCT02608268|467352158|FG021|Overall Study|Death|0|||
129897705|NCT00121199|467584426|FG000|Overall Study|Death|3|||
129897706|NCT00121199|467584426|FG000|Overall Study|Other - Not Protocol Specified|3|||
129831797|NCT02608268|467352159|FG022|Overall Study|Death|0|||
129831798|NCT02608268|467352160|FG023|Overall Study|Death|0|||
129831799|NCT02608268|467352161|FG024|Overall Study|Death|1|||
129831800|NCT02608268|467352162|FG025|Overall Study|Death|2|||
129831801|NCT02608268|467352163|FG026|Overall Study|Death|0|||
129831802|NCT02608268|467352164|FG027|Overall Study|Death|1|||
129831803|NCT02608268|467352165|FG028|Overall Study|Death|4|||
129831804|NCT02608268|467352166|FG029|Overall Study|Death|0|||
129831805|NCT02608268|467352137|FG000|Overall Study|Physician Decision|0|||
129831806|NCT02608268|467352138|FG001|Overall Study|Physician Decision|0|||
129831807|NCT02608268|467352139|FG002|Overall Study|Physician Decision|0|||
129831808|NCT02608268|467352140|FG003|Overall Study|Physician Decision|0|||
129831809|NCT02608268|467352141|FG004|Overall Study|Physician Decision|0|||
129831810|NCT02608268|467352142|FG005|Overall Study|Physician Decision|0|||
129831811|NCT02608268|467352143|FG006|Overall Study|Physician Decision|0|||
129831812|NCT02608268|467352144|FG007|Overall Study|Physician Decision|0|||
129831813|NCT02608268|467352145|FG008|Overall Study|Physician Decision|0|||
129831814|NCT02608268|467352146|FG009|Overall Study|Physician Decision|0|||
129831815|NCT02608268|467352147|FG010|Overall Study|Physician Decision|1|||
129831816|NCT02608268|467352148|FG011|Overall Study|Physician Decision|0|||
129831817|NCT02608268|467352149|FG012|Overall Study|Physician Decision|0|||
129831818|NCT02608268|467352150|FG013|Overall Study|Physician Decision|1|||
129831819|NCT02608268|467352151|FG014|Overall Study|Physician Decision|0|||
129831820|NCT02608268|467352152|FG015|Overall Study|Physician Decision|0|||
129831821|NCT02608268|467352153|FG016|Overall Study|Physician Decision|0|||
129831822|NCT02608268|467352154|FG017|Overall Study|Physician Decision|0|||
129831823|NCT02608268|467352155|FG018|Overall Study|Physician Decision|0|||
129831824|NCT02608268|467352156|FG019|Overall Study|Physician Decision|0|||
129831825|NCT02608268|467352157|FG020|Overall Study|Physician Decision|0|||
129831826|NCT02608268|467352158|FG021|Overall Study|Physician Decision|0|||
129831827|NCT02608268|467352159|FG022|Overall Study|Physician Decision|1|||
129831828|NCT02608268|467352160|FG023|Overall Study|Physician Decision|1|||
129831829|NCT02608268|467352161|FG024|Overall Study|Physician Decision|1|||
129831830|NCT02608268|467352162|FG025|Overall Study|Physician Decision|0|||
129831831|NCT02608268|467352163|FG026|Overall Study|Physician Decision|0|||
129831832|NCT02608268|467352164|FG027|Overall Study|Physician Decision|2|||
129831833|NCT02608268|467352165|FG028|Overall Study|Physician Decision|1|||
129831834|NCT02608268|467352166|FG029|Overall Study|Physician Decision|1|||
129831835|NCT02608268|467352137|FG000|Overall Study|Progressive disease|12|||
129831836|NCT02608268|467352138|FG001|Overall Study|Progressive disease|8|||
129831837|NCT02608268|467352139|FG002|Overall Study|Progressive disease|13|||
129831838|NCT02608268|467352140|FG003|Overall Study|Progressive disease|5|||
129831839|NCT02608268|467352141|FG004|Overall Study|Progressive disease|2|||
129831840|NCT02608268|467352142|FG005|Overall Study|Progressive disease|4|||
129831841|NCT02608268|467352143|FG006|Overall Study|Progressive disease|6|||
129831842|NCT02608268|467352144|FG007|Overall Study|Progressive disease|2|||
129831843|NCT02608268|467352145|FG008|Overall Study|Progressive disease|5|||
129831844|NCT02608268|467352146|FG009|Overall Study|Progressive disease|6|||
129831845|NCT02608268|467352147|FG010|Overall Study|Progressive disease|5|||
129831846|NCT02608268|467352148|FG011|Overall Study|Progressive disease|5|||
129831847|NCT02608268|467352149|FG012|Overall Study|Progressive disease|4|||
129831848|NCT02608268|467352150|FG013|Overall Study|Progressive disease|11|||
129831849|NCT02608268|467352151|FG014|Overall Study|Progressive disease|6|||
129831850|NCT02608268|467352152|FG015|Overall Study|Progressive disease|3|||
129831851|NCT02608268|467352153|FG016|Overall Study|Progressive disease|5|||
129831852|NCT02608268|467352154|FG017|Overall Study|Progressive disease|5|||
129831853|NCT02608268|467352155|FG018|Overall Study|Progressive disease|5|||
129831854|NCT02608268|467352156|FG019|Overall Study|Progressive disease|2|||
129831855|NCT02608268|467352157|FG020|Overall Study|Progressive disease|10|||
129831856|NCT02608268|467352158|FG021|Overall Study|Progressive disease|4|||
129831857|NCT02608268|467352159|FG022|Overall Study|Progressive disease|5|||
129831858|NCT02608268|467352160|FG023|Overall Study|Progressive disease|5|||
129831859|NCT02608268|467352161|FG024|Overall Study|Progressive disease|3|||
129831860|NCT02608268|467352162|FG025|Overall Study|Progressive disease|11|||
129831861|NCT02608268|467352163|FG026|Overall Study|Progressive disease|16|||
129831862|NCT02608268|467352164|FG027|Overall Study|Progressive disease|11|||
129831863|NCT02608268|467352165|FG028|Overall Study|Progressive disease|10|||
129831864|NCT02608268|467352166|FG029|Overall Study|Progressive disease|15|||
129831865|NCT02608268|467352137|FG000|Overall Study|Subject/guardian decision|1|||
129831866|NCT02608268|467352138|FG001|Overall Study|Subject/guardian decision|1|||
129831867|NCT02608268|467352139|FG002|Overall Study|Subject/guardian decision|2|||
129831868|NCT02608268|467352140|FG003|Overall Study|Subject/guardian decision|0|||
129831869|NCT02608268|467352141|FG004|Overall Study|Subject/guardian decision|0|||
129831870|NCT02608268|467352142|FG005|Overall Study|Subject/guardian decision|0|||
129831871|NCT02608268|467352143|FG006|Overall Study|Subject/guardian decision|0|||
129831872|NCT02608268|467352144|FG007|Overall Study|Subject/guardian decision|0|||
129831873|NCT02608268|467352145|FG008|Overall Study|Subject/guardian decision|2|||
129831874|NCT02608268|467352146|FG009|Overall Study|Subject/guardian decision|2|||
129831875|NCT02608268|467352147|FG010|Overall Study|Subject/guardian decision|0|||
129831876|NCT02608268|467352148|FG011|Overall Study|Subject/guardian decision|1|||
129831877|NCT02608268|467352149|FG012|Overall Study|Subject/guardian decision|0|||
129831878|NCT02608268|467352150|FG013|Overall Study|Subject/guardian decision|1|||
129831879|NCT02608268|467352151|FG014|Overall Study|Subject/guardian decision|0|||
129831880|NCT02608268|467352152|FG015|Overall Study|Subject/guardian decision|1|||
129831881|NCT02608268|467352153|FG016|Overall Study|Subject/guardian decision|0|||
129831882|NCT02608268|467352154|FG017|Overall Study|Subject/guardian decision|0|||
129831883|NCT02608268|467352155|FG018|Overall Study|Subject/guardian decision|1|||
129831884|NCT02608268|467352156|FG019|Overall Study|Subject/guardian decision|0|||
129831885|NCT02608268|467352157|FG020|Overall Study|Subject/guardian decision|0|||
129831886|NCT02608268|467352158|FG021|Overall Study|Subject/guardian decision|0|||
129831887|NCT02608268|467352159|FG022|Overall Study|Subject/guardian decision|1|||
129831888|NCT02608268|467352160|FG023|Overall Study|Subject/guardian decision|0|||
129831889|NCT02608268|467352161|FG024|Overall Study|Subject/guardian decision|0|||
129831890|NCT02608268|467352162|FG025|Overall Study|Subject/guardian decision|1|||
129831891|NCT02608268|467352163|FG026|Overall Study|Subject/guardian decision|1|||
129831892|NCT02608268|467352164|FG027|Overall Study|Subject/guardian decision|1|||
129831893|NCT02608268|467352165|FG028|Overall Study|Subject/guardian decision|1|||
129831894|NCT02608268|467352166|FG029|Overall Study|Subject/guardian decision|0|||
129831895|NCT03873987|467352167|FG000|Overall Study|Adverse Event|1|||
129831896|NCT03873987|467352168|FG001|Overall Study|Adverse Event|0|||
129831897|NCT03873987|467352167|FG000|Overall Study|staff was unable to start a new IV line|1|||
129831898|NCT03873987|467352168|FG001|Overall Study|staff was unable to start a new IV line|0|||
129831899|NCT03873987|467352167|FG000|Overall Study|Lost to Follow-up|0|||
129831900|NCT03873987|467352168|FG001|Overall Study|Lost to Follow-up|1|||
129831901|NCT02520011|467352170|FG000|Overall Study|Adverse Event|0|||
129831902|NCT02520011|467352171|FG001|Overall Study|Adverse Event|1|||
129831903|NCT02520011|467352172|FG002|Overall Study|Adverse Event|2|||
129831904|NCT02520011|467352170|FG000|Overall Study|Death|0|||
129831905|NCT02520011|467352171|FG001|Overall Study|Death|8|||
129831906|NCT02520011|467352172|FG002|Overall Study|Death|1|||
129831907|NCT02520011|467352170|FG000|Overall Study|Lack of Efficacy|4|||
129831908|NCT02520011|467352171|FG001|Overall Study|Lack of Efficacy|26|||
129831909|NCT02520011|467352172|FG002|Overall Study|Lack of Efficacy|4|||
129831910|NCT02520011|467352170|FG000|Overall Study|Physician Decision|0|||
129831911|NCT02520011|467352171|FG001|Overall Study|Physician Decision|2|||
129831912|NCT02520011|467352172|FG002|Overall Study|Physician Decision|0|||
129831913|NCT02520011|467352170|FG000|Overall Study|Withdrawal by Subject|1|||
129831914|NCT02520011|467352171|FG001|Overall Study|Withdrawal by Subject|3|||
129831915|NCT02520011|467352172|FG002|Overall Study|Withdrawal by Subject|0|||
129831916|NCT02520011|467352170|FG000|Overall Study|Protocol Deviation|0|||
129831917|NCT02520011|467352171|FG001|Overall Study|Protocol Deviation|1|||
129831918|NCT02520011|467352172|FG002|Overall Study|Protocol Deviation|0|||
129831919|NCT02520011|467352170|FG000|Overall Study|Patient went to hospice|0|||
129831920|NCT02520011|467352171|FG001|Overall Study|Patient went to hospice|1|||
129831921|NCT02520011|467352172|FG002|Overall Study|Patient went to hospice|0|||
129831922|NCT02520011|467352170|FG000|Overall Study|Progressive disease following response|0|||
129831923|NCT02520011|467352171|FG001|Overall Study|Progressive disease following response|4|||
129831924|NCT02520011|467352172|FG002|Overall Study|Progressive disease following response|2|||
129831925|NCT01063764|467352173|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
129831926|NCT01063764|467352173|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
129831927|NCT01063764|467352173|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
129831928|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
129831929|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
129831930|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
129831931|NCT01063764|467352173|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
129831932|NCT00697515|467352174|FG000|Dose Optimization Period|Adverse Event|4|||
129831933|NCT00697515|467352175|FG001|Dose Optimization Period|Adverse Event|0|||
129831934|NCT00697515|467352174|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
129831935|NCT00697515|467352175|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
129831936|NCT00697515|467352174|FG000|Dose Optimization Period|Lost to Follow-up|2|||
129831937|NCT00697515|467352175|FG001|Dose Optimization Period|Lost to Follow-up|0|||
129831938|NCT00697515|467352174|FG000|Dose Optimization Period|sponsor request|2|||
129831939|NCT00697515|467352175|FG001|Dose Optimization Period|sponsor request|0|||
129831940|NCT00697515|467352174|FG000|Dose Optimization Period|called to active duty|1|||
129831941|NCT00697515|467352175|FG001|Dose Optimization Period|called to active duty|0|||
129831942|NCT00697515|467352174|FG000|Dose Optimization Period|elevated QTc|1|||
129897707|NCT00121199|467584426|FG000|Overall Study|Ineligible|9|||
129897708|NCT04109118|467584427|FG000|Overall Study|Lost to Follow-up|3|||
129897709|NCT03235349|467584430|FG000|Overall Study|Adverse Event|1|||
129897710|NCT03235349|467584430|FG000|Overall Study|Other|1|||
129897711|NCT00819910|467584434|FG000|Overall Study|Adverse Event|0|||
129831943|NCT00697515|467352175|FG001|Dose Optimization Period|elevated QTc|0|||
129831944|NCT00697515|467352174|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
129831945|NCT00697515|467352175|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
129831946|NCT00697515|467352174|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
129897712|NCT00819910|467584435|FG001|Overall Study|Adverse Event|0|||
129897713|NCT00819910|467584436|FG002|Overall Study|Adverse Event|2|||
129897714|NCT00819910|467584437|FG003|Overall Study|Adverse Event|1|||
129897715|NCT00819910|467584434|FG000|Overall Study|Withdrawal by Subject|1|||
129897716|NCT00819910|467584435|FG001|Overall Study|Withdrawal by Subject|1|||
129897717|NCT00819910|467584436|FG002|Overall Study|Withdrawal by Subject|1|||
129897718|NCT00819910|467584437|FG003|Overall Study|Withdrawal by Subject|0|||
129897719|NCT00819910|467584434|FG000|Overall Study|Lost to Follow-up|1|||
129831947|NCT00697515|467352175|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
129897720|NCT00819910|467584435|FG001|Overall Study|Lost to Follow-up|0|||
129831948|NCT00697515|467352174|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
129831949|NCT00697515|467352175|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
129831950|NCT00697515|467352174|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
129831951|NCT00697515|467352175|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
129831952|NCT01727141|467352177|FG000|Overall Study|Physician Decision|0|||
129831953|NCT01727141|467352178|FG001|Overall Study|Physician Decision|1|||
129831954|NCT01727141|467352179|FG002|Overall Study|Physician Decision|0|||
129831955|NCT01727141|467352180|FG003|Overall Study|Physician Decision|2|||
129831956|NCT01727141|467352177|FG000|Overall Study|Lost to Follow-up|0|||
129831957|NCT01727141|467352178|FG001|Overall Study|Lost to Follow-up|2|||
129831958|NCT01727141|467352179|FG002|Overall Study|Lost to Follow-up|0|||
129831959|NCT01727141|467352180|FG003|Overall Study|Lost to Follow-up|0|||
129831960|NCT01727141|467352177|FG000|Overall Study|Death|0|||
129831961|NCT01727141|467352178|FG001|Overall Study|Death|1|||
129831962|NCT01727141|467352179|FG002|Overall Study|Death|1|||
129831963|NCT01727141|467352180|FG003|Overall Study|Death|1|||
129831964|NCT01727141|467352177|FG000|Overall Study|Protocol deviation|1|||
129831965|NCT01727141|467352178|FG001|Overall Study|Protocol deviation|1|||
129831966|NCT01727141|467352179|FG002|Overall Study|Protocol deviation|0|||
129831967|NCT01727141|467352180|FG003|Overall Study|Protocol deviation|1|||
129831968|NCT01727141|467352177|FG000|Overall Study|Withdrawal by Subject|4|||
129831969|NCT01727141|467352178|FG001|Overall Study|Withdrawal by Subject|4|||
129831970|NCT01727141|467352179|FG002|Overall Study|Withdrawal by Subject|2|||
129831971|NCT01727141|467352180|FG003|Overall Study|Withdrawal by Subject|11|||
129831972|NCT04014075|467352183|FG000|Overall Study|Progressive Disease|53|||
129831973|NCT04014075|467352183|FG000|Overall Study|Adverse Event|15|||
129831974|NCT04014075|467352183|FG000|Overall Study|Clinical Progression|4|||
129831975|NCT04014075|467352183|FG000|Overall Study|Death|2|||
129831976|NCT04014075|467352183|FG000|Overall Study|Withdrawal by Subject|2|||
129831977|NCT04014075|467352183|FG000|Overall Study|Miscellaneous|2|||
129831978|NCT04014075|467352183|FG000|Overall Study|Physician Decision|1|||
129831979|NCT02603432|467352184|FG000|Overall Study|Adverse Event|1|||
129831980|NCT02603432|467352185|FG001|Overall Study|Adverse Event|0|||
129831981|NCT02603432|467352184|FG000|Overall Study|Death|221|||
129831982|NCT02603432|467352185|FG001|Overall Study|Death|242|||
129831983|NCT02603432|467352184|FG000|Overall Study|Lost to Follow-up|3|||
129831984|NCT02603432|467352185|FG001|Overall Study|Lost to Follow-up|9|||
129831985|NCT02603432|467352184|FG000|Overall Study|Progressive Disease|7|||
129831986|NCT02603432|467352185|FG001|Overall Study|Progressive Disease|5|||
129831987|NCT02603432|467352184|FG000|Overall Study|Withdrawal by Subject|12|||
129831988|NCT02603432|467352185|FG001|Overall Study|Withdrawal by Subject|18|||
129831989|NCT02603432|467352184|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
129831990|NCT02603432|467352185|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129831991|NCT02603432|467352184|FG000|Overall Study|Study terminated by sponsor|74|||
129831992|NCT02603432|467352185|FG001|Overall Study|Study terminated by sponsor|75|||
129831993|NCT02603432|467352184|FG000|Overall Study|Other|13|||
129831994|NCT02603432|467352185|FG001|Overall Study|Other|0|||
129831995|NCT05954052|467352189|FG000|Overall Study|Adverse Event|1|||
129831996|NCT01957462|467352190|FG000|Test Period 1|Withdrawal by Subject|1|||
129831997|NCT01957462|467352191|FG001|Test Period 1|Withdrawal by Subject|0|||
129831998|NCT01957462|467352190|FG000|Test Period 1|Adverse Event|1|||
129831999|NCT01957462|467352191|FG001|Test Period 1|Adverse Event|0|||
129832000|NCT02584504|467352192|FG000|Double-blind Treatment|Participant withdrew consent|0|||
129832001|NCT02584504|467352193|FG001|Double-blind Treatment|Participant withdrew consent|0|||
129832002|NCT02584504|467352194|FG002|Double-blind Treatment|Participant withdrew consent|1|||
129832003|NCT02584504|467352192|FG000|Double-blind Treatment|Adverse Event|0|||
129832004|NCT02584504|467352193|FG001|Double-blind Treatment|Adverse Event|1|||
129832005|NCT02584504|467352194|FG002|Double-blind Treatment|Adverse Event|0|||
129832006|NCT02584504|467352192|FG000|Double-blind Treatment|Family Matter|0|||
129832007|NCT02584504|467352193|FG001|Double-blind Treatment|Family Matter|1|||
129832008|NCT02584504|467352194|FG002|Double-blind Treatment|Family Matter|0|||
129832009|NCT02584504|467352192|FG000|Open-label Treatment|Participant withdrew consent|0|||
129832010|NCT02584504|467352193|FG001|Open-label Treatment|Participant withdrew consent|0|||
129832011|NCT02584504|467352194|FG002|Open-label Treatment|Participant withdrew consent|4|||
129832012|NCT02584504|467352192|FG000|Open-label Treatment|Adverse Event|2|||
129832013|NCT02584504|467352193|FG001|Open-label Treatment|Adverse Event|2|||
129832014|NCT02584504|467352194|FG002|Open-label Treatment|Adverse Event|3|||
129832015|NCT02584504|467352192|FG000|Open-label Treatment|Physician Decision|0|||
129832016|NCT02584504|467352193|FG001|Open-label Treatment|Physician Decision|1|||
129832017|NCT02584504|467352194|FG002|Open-label Treatment|Physician Decision|0|||
129832018|NCT02584504|467352192|FG000|Open-label Treatment|Entered but not treated|0|||
129832019|NCT02584504|467352193|FG001|Open-label Treatment|Entered but not treated|1|||
129832020|NCT02584504|467352194|FG002|Open-label Treatment|Entered but not treated|1|||
129832021|NCT03102918|467352195|FG000|Overall Study|Protocol Violation|1|||
129832022|NCT03102918|467352196|FG001|Overall Study|Protocol Violation|0|||
129832023|NCT04765358|467352199|FG000|Overall Study|Withdrawal by Subject|1|||
129832024|NCT02731729|467352200|FG000|Overall Study|Death|2|||
129832025|NCT02731729|467352201|FG001|Overall Study|Death|2|||
129832026|NCT02731729|467352200|FG000|Overall Study|Study terminated by Sponsor|6|||
129445767|NCT03675776|465932914|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
129445768|NCT03675776|465932915|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
129445769|NCT03675776|465932913|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
129445770|NCT03675776|465932914|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
129445771|NCT03675776|465932915|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
129445772|NCT02401412|465932916|FG000|Overall Study|Lost to Follow-up|1|||
129445773|NCT02401412|465932917|FG001|Overall Study|Lost to Follow-up|0|||
129445774|NCT02401412|465932916|FG000|Overall Study|Discontinued Intervention|15|||
129445775|NCT02401412|465932917|FG001|Overall Study|Discontinued Intervention|21|||
129445776|NCT02401412|465932916|FG000|Overall Study|Withdrawal by Subject|4|||
129445777|NCT02401412|465932917|FG001|Overall Study|Withdrawal by Subject|4|||
129445778|NCT02401412|465932916|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
129832027|NCT02731729|467352201|FG001|Overall Study|Study terminated by Sponsor|6|||
129832028|NCT02731729|467352200|FG000|Overall Study|Withdrawal by Subject|1|||
129832029|NCT02731729|467352201|FG001|Overall Study|Withdrawal by Subject|0|||
129832030|NCT03446040|467352206|FG000|Overall Study|Disease progression|3|||
129832031|NCT03446040|467352207|FG001|Overall Study|Disease progression|3|||
129832032|NCT03446040|467352208|FG002|Overall Study|Disease progression|3|||
129832033|NCT03446040|467352209|FG003|Overall Study|Disease progression|4|||
129832034|NCT03446040|467352210|FG004|Overall Study|Disease progression|4|||
129832035|NCT03446040|467352211|FG005|Overall Study|Disease progression|6|||
129832036|NCT03446040|467352212|FG006|Overall Study|Disease progression|3|||
129832037|NCT03446040|467352213|FG007|Overall Study|Disease progression|4|||
129832038|NCT03446040|467352214|FG008|Overall Study|Disease progression|2|||
129832039|NCT03446040|467352215|FG009|Overall Study|Disease progression|4|||
129832040|NCT03446040|467352216|FG010|Overall Study|Disease progression|9|||
129832041|NCT03446040|467352217|FG011|Overall Study|Disease progression|3|||
129832042|NCT03446040|467352218|FG012|Overall Study|Disease progression|7|||
129832043|NCT03446040|467352219|FG013|Overall Study|Disease progression|7|||
129832044|NCT03446040|467352206|FG000|Overall Study|Study drug toxicity|0|||
129832045|NCT03446040|467352207|FG001|Overall Study|Study drug toxicity|0|||
129832046|NCT03446040|467352208|FG002|Overall Study|Study drug toxicity|0|||
129832047|NCT03446040|467352209|FG003|Overall Study|Study drug toxicity|0|||
129832048|NCT03446040|467352210|FG004|Overall Study|Study drug toxicity|0|||
129832049|NCT03446040|467352211|FG005|Overall Study|Study drug toxicity|0|||
129832050|NCT03446040|467352212|FG006|Overall Study|Study drug toxicity|0|||
129832051|NCT03446040|467352213|FG007|Overall Study|Study drug toxicity|0|||
129832052|NCT03446040|467352214|FG008|Overall Study|Study drug toxicity|1|||
129832053|NCT03446040|467352215|FG009|Overall Study|Study drug toxicity|0|||
129832054|NCT03446040|467352216|FG010|Overall Study|Study drug toxicity|0|||
129832055|NCT03446040|467352217|FG011|Overall Study|Study drug toxicity|0|||
129832056|NCT03446040|467352218|FG012|Overall Study|Study drug toxicity|0|||
129832057|NCT03446040|467352219|FG013|Overall Study|Study drug toxicity|0|||
129832058|NCT03446040|467352206|FG000|Overall Study|Adverse Event|0|||
129832059|NCT03446040|467352207|FG001|Overall Study|Adverse Event|0|||
129832060|NCT03446040|467352208|FG002|Overall Study|Adverse Event|0|||
129832061|NCT03446040|467352209|FG003|Overall Study|Adverse Event|0|||
129832062|NCT03446040|467352210|FG004|Overall Study|Adverse Event|0|||
129832063|NCT03446040|467352211|FG005|Overall Study|Adverse Event|2|||
129832064|NCT03446040|467352212|FG006|Overall Study|Adverse Event|0|||
129832065|NCT03446040|467352213|FG007|Overall Study|Adverse Event|0|||
129832066|NCT03446040|467352214|FG008|Overall Study|Adverse Event|1|||
129832067|NCT03446040|467352215|FG009|Overall Study|Adverse Event|0|||
129832068|NCT03446040|467352216|FG010|Overall Study|Adverse Event|0|||
129832069|NCT03446040|467352217|FG011|Overall Study|Adverse Event|0|||
129832070|NCT03446040|467352218|FG012|Overall Study|Adverse Event|0|||
129832071|NCT03446040|467352219|FG013|Overall Study|Adverse Event|0|||
129832072|NCT03446040|467352206|FG000|Overall Study|Death|0|||
129832073|NCT03446040|467352207|FG001|Overall Study|Death|0|||
129445779|NCT02401412|465932917|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
129445780|NCT02401412|465932916|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
129445781|NCT02401412|465932917|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
129832074|NCT03446040|467352208|FG002|Overall Study|Death|0|||
129832075|NCT03446040|467352209|FG003|Overall Study|Death|0|||
129832076|NCT03446040|467352210|FG004|Overall Study|Death|0|||
129832077|NCT03446040|467352211|FG005|Overall Study|Death|0|||
129832078|NCT03446040|467352212|FG006|Overall Study|Death|0|||
129832079|NCT03446040|467352213|FG007|Overall Study|Death|0|||
129832080|NCT03446040|467352214|FG008|Overall Study|Death|0|||
129832081|NCT03446040|467352215|FG009|Overall Study|Death|0|||
129832082|NCT03446040|467352216|FG010|Overall Study|Death|1|||
129832083|NCT03446040|467352217|FG011|Overall Study|Death|0|||
129832084|NCT03446040|467352218|FG012|Overall Study|Death|0|||
129832085|NCT03446040|467352219|FG013|Overall Study|Death|2|||
129832086|NCT03446040|467352206|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
129832087|NCT03446040|467352207|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
129832088|NCT03446040|467352208|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
129832089|NCT03446040|467352209|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
129832090|NCT03446040|467352210|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
129832091|NCT03446040|467352211|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
129832092|NCT03446040|467352212|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
129832093|NCT03446040|467352213|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
129832094|NCT03446040|467352214|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
129832095|NCT03446040|467352215|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
129832096|NCT03446040|467352216|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
129832097|NCT03446040|467352217|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
129832098|NCT03446040|467352218|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
129832099|NCT03446040|467352219|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
129832100|NCT03446040|467352206|FG000|Overall Study|Participant withdrew consent|0|||
129832101|NCT03446040|467352207|FG001|Overall Study|Participant withdrew consent|0|||
129832102|NCT03446040|467352208|FG002|Overall Study|Participant withdrew consent|0|||
129832103|NCT03446040|467352209|FG003|Overall Study|Participant withdrew consent|0|||
129832104|NCT03446040|467352210|FG004|Overall Study|Participant withdrew consent|0|||
129832105|NCT03446040|467352211|FG005|Overall Study|Participant withdrew consent|1|||
129832106|NCT03446040|467352212|FG006|Overall Study|Participant withdrew consent|0|||
129832107|NCT03446040|467352213|FG007|Overall Study|Participant withdrew consent|1|||
129832108|NCT03446040|467352214|FG008|Overall Study|Participant withdrew consent|0|||
129832109|NCT03446040|467352215|FG009|Overall Study|Participant withdrew consent|0|||
129832110|NCT03446040|467352216|FG010|Overall Study|Participant withdrew consent|0|||
129832111|NCT03446040|467352217|FG011|Overall Study|Participant withdrew consent|0|||
129832112|NCT03446040|467352218|FG012|Overall Study|Participant withdrew consent|0|||
129832113|NCT03446040|467352219|FG013|Overall Study|Participant withdrew consent|0|||
129897721|NCT00819910|467584436|FG002|Overall Study|Lost to Follow-up|0|||
129897722|NCT00819910|467584437|FG003|Overall Study|Lost to Follow-up|0|||
129897723|NCT00299702|467584438|FG000|Overall Study|Death|1|||
129897724|NCT00299702|467584439|FG001|Overall Study|Death|0|||
129832114|NCT03446040|467352206|FG000|Overall Study|Not reported|0|||
129832115|NCT03446040|467352207|FG001|Overall Study|Not reported|0|||
129832116|NCT03446040|467352208|FG002|Overall Study|Not reported|1|||
129832117|NCT03446040|467352209|FG003|Overall Study|Not reported|0|||
129832118|NCT03446040|467352210|FG004|Overall Study|Not reported|0|||
129832119|NCT03446040|467352211|FG005|Overall Study|Not reported|0|||
129832120|NCT03446040|467352212|FG006|Overall Study|Not reported|0|||
129832121|NCT03446040|467352213|FG007|Overall Study|Not reported|0|||
129832122|NCT03446040|467352214|FG008|Overall Study|Not reported|0|||
129832123|NCT03446040|467352215|FG009|Overall Study|Not reported|0|||
129832124|NCT03446040|467352216|FG010|Overall Study|Not reported|0|||
129832125|NCT03446040|467352217|FG011|Overall Study|Not reported|0|||
129832126|NCT03446040|467352218|FG012|Overall Study|Not reported|0|||
129832127|NCT03446040|467352219|FG013|Overall Study|Not reported|0|||
129832128|NCT02066467|467352220|FG000|Overall Study|Did not undergo implant procedure|24|||
129832129|NCT02066467|467352220|FG000|Overall Study|Attempted to implant withoput success|43|||
129832130|NCT02066467|467352220|FG000|Overall Study|Consent ineligible|1|||
129832131|NCT02066467|467352220|FG000|Overall Study|Death|54|||
129832132|NCT02066467|467352220|FG000|Overall Study|Lost to Follow-up|51|||
129832133|NCT02066467|467352220|FG000|Overall Study|Adverse Event|20|||
129832134|NCT02066467|467352220|FG000|Overall Study|Withdrawal by Subject|16|||
129832135|NCT02066467|467352220|FG000|Overall Study|Physician Decision|2|||
129832136|NCT02066467|467352220|FG000|Overall Study|Not defined|4|||
129832137|NCT00456521|467352221|FG000|Overall Study|Adverse Event|150|||
129832138|NCT00456521|467352222|FG001|Overall Study|Adverse Event|25|||
129832139|NCT00456521|467352221|FG000|Overall Study|Withdrawal by Subject|43|||
129832140|NCT00456521|467352222|FG001|Overall Study|Withdrawal by Subject|24|||
129832141|NCT00456521|467352221|FG000|Overall Study|Lost to Follow-up|22|||
129832142|NCT00456521|467352222|FG001|Overall Study|Lost to Follow-up|17|||
129832143|NCT00456521|467352221|FG000|Overall Study|Lack of Efficacy|3|||
129832144|NCT00456521|467352222|FG001|Overall Study|Lack of Efficacy|6|||
129832145|NCT00456521|467352221|FG000|Overall Study|Protocol Violation|4|||
129832146|NCT00456521|467352222|FG001|Overall Study|Protocol Violation|0|||
129832147|NCT00456521|467352221|FG000|Overall Study|Pregnancy|1|||
129832148|NCT00456521|467352222|FG001|Overall Study|Pregnancy|1|||
129832149|NCT00456521|467352221|FG000|Overall Study|Drug non-compliance, moved, other|26|||
129832150|NCT00456521|467352222|FG001|Overall Study|Drug non-compliance, moved, other|11|||
129832151|NCT01316276|467352223|FG000|Overall Study|Death|1|||
129832152|NCT01316276|467352223|FG000|Overall Study|Adverse Event|19|||
129832153|NCT01316276|467352223|FG000|Overall Study|Withdrawal of consent|24|||
129832154|NCT01316276|467352223|FG000|Overall Study|Lost to Follow-up|1|||
129832155|NCT01316276|467352223|FG000|Overall Study|Other|22|||
129832156|NCT00605475|467352224|FG000|Overall Study|Abnormal Laboratory Values|0|||
129832157|NCT00605475|467352225|FG001|Overall Study|Abnormal Laboratory Values|0|||
129832158|NCT00605475|467352226|FG002|Overall Study|Abnormal Laboratory Values|0|||
129832159|NCT00605475|467352227|FG003|Overall Study|Abnormal Laboratory Values|0|||
129832160|NCT00605475|467352228|FG004|Overall Study|Abnormal Laboratory Values|0|||
129832161|NCT00605475|467352229|FG005|Overall Study|Abnormal Laboratory Values|0|||
129832162|NCT00605475|467352230|FG006|Overall Study|Abnormal Laboratory Values|0|||
129832163|NCT00605475|467352231|FG007|Overall Study|Abnormal Laboratory Values|0|||
129832164|NCT00605475|467352232|FG008|Overall Study|Abnormal Laboratory Values|1|||
129832165|NCT00605475|467352233|FG009|Overall Study|Abnormal Laboratory Values|0|||
129832166|NCT00605475|467352224|FG000|Overall Study|Administrative problems|0|||
129832167|NCT00605475|467352225|FG001|Overall Study|Administrative problems|0|||
129832168|NCT00605475|467352226|FG002|Overall Study|Administrative problems|0|||
129832169|NCT00605475|467352227|FG003|Overall Study|Administrative problems|0|||
129832170|NCT00605475|467352228|FG004|Overall Study|Administrative problems|0|||
129832171|NCT00605475|467352229|FG005|Overall Study|Administrative problems|0|||
129832172|NCT00605475|467352230|FG006|Overall Study|Administrative problems|1|||
129832173|NCT00605475|467352231|FG007|Overall Study|Administrative problems|0|||
129832174|NCT00605475|467352232|FG008|Overall Study|Administrative problems|0|||
129832175|NCT00605475|467352233|FG009|Overall Study|Administrative problems|0|||
129832176|NCT00605475|467352224|FG000|Overall Study|Lost to Follow-up|0|||
129832177|NCT00605475|467352225|FG001|Overall Study|Lost to Follow-up|0|||
129832178|NCT00605475|467352226|FG002|Overall Study|Lost to Follow-up|0|||
129832179|NCT00605475|467352227|FG003|Overall Study|Lost to Follow-up|0|||
129832180|NCT00605475|467352228|FG004|Overall Study|Lost to Follow-up|0|||
129832181|NCT00605475|467352229|FG005|Overall Study|Lost to Follow-up|0|||
129832182|NCT00605475|467352230|FG006|Overall Study|Lost to Follow-up|0|||
129832183|NCT00605475|467352231|FG007|Overall Study|Lost to Follow-up|0|||
129832184|NCT00605475|467352232|FG008|Overall Study|Lost to Follow-up|1|||
129832185|NCT00605475|467352233|FG009|Overall Study|Lost to Follow-up|1|||
129832186|NCT00605475|467352224|FG000|Overall Study|Protocol Violation|0|||
129832187|NCT00605475|467352225|FG001|Overall Study|Protocol Violation|0|||
129832188|NCT00605475|467352226|FG002|Overall Study|Protocol Violation|0|||
129832189|NCT00605475|467352227|FG003|Overall Study|Protocol Violation|0|||
129832190|NCT00605475|467352228|FG004|Overall Study|Protocol Violation|1|||
129832191|NCT00605475|467352229|FG005|Overall Study|Protocol Violation|0|||
129832192|NCT00605475|467352230|FG006|Overall Study|Protocol Violation|0|||
129832193|NCT00605475|467352231|FG007|Overall Study|Protocol Violation|0|||
129832194|NCT00605475|467352232|FG008|Overall Study|Protocol Violation|0|||
129832195|NCT00605475|467352233|FG009|Overall Study|Protocol Violation|0|||
129832196|NCT00605475|467352224|FG000|Overall Study|Withdrawal by Subject|0|||
129832197|NCT00605475|467352225|FG001|Overall Study|Withdrawal by Subject|0|||
129832198|NCT00605475|467352226|FG002|Overall Study|Withdrawal by Subject|0|||
129832199|NCT00605475|467352227|FG003|Overall Study|Withdrawal by Subject|0|||
129832200|NCT00605475|467352228|FG004|Overall Study|Withdrawal by Subject|0|||
129832201|NCT00605475|467352229|FG005|Overall Study|Withdrawal by Subject|2|||
129832202|NCT00605475|467352230|FG006|Overall Study|Withdrawal by Subject|0|||
129832203|NCT00605475|467352231|FG007|Overall Study|Withdrawal by Subject|0|||
129832204|NCT00605475|467352232|FG008|Overall Study|Withdrawal by Subject|0|||
129832205|NCT00605475|467352233|FG009|Overall Study|Withdrawal by Subject|1|||
129832206|NCT02596854|467352234|FG000|Overall Study|Withdrawn|8|||
129832207|NCT00076011|467352235|FG000|Overall Study|Death|1|||
129832208|NCT00076011|467352235|FG000|Overall Study|Adverse Event|10|||
129832209|NCT00076011|467352235|FG000|Overall Study|Lack of Efficacy|25|||
129832210|NCT00076011|467352235|FG000|Overall Study|Withdrawal by Subject|1|||
129832211|NCT00076011|467352235|FG000|Overall Study|Study terminated by sponsor|3|||
129832212|NCT00076011|467352235|FG000|Overall Study|Other|11|||
129832213|NCT00076011|467352235|FG000|Overall Study|Ongoing|1|||
129832214|NCT00581776|467352236|FG000|Overall Study|Disease progression or no response|3|||
129832215|NCT00464568|467352241|FG000|Overall Study|Adverse Event|2|||
129832216|NCT02410954|467352242|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
129832217|NCT02410954|467352243|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
129832218|NCT02410954|467352242|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
129832219|NCT02410954|467352243|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
129832220|NCT00949325|467352244|FG000|Overall Study|Adverse Event|0|||
129832221|NCT00949325|467352245|FG001|Overall Study|Adverse Event|2|||
129832222|NCT00949325|467352246|FG002|Overall Study|Adverse Event|0|||
129832223|NCT00791518|467352247|FG000|Overall Study|Protocol Violation|93|||
129832224|NCT01520363|467352248|FG000|Overall Study|Withdrawal by Subject|2|||
129832225|NCT01520363|467352249|FG001|Overall Study|Withdrawal by Subject|0|||
129832226|NCT05172544|467352254|FG000|Overall Study|Withdrawal by Subject|1|||
129832227|NCT05172544|467352255|FG001|Overall Study|Withdrawal by Subject|0|||
129832228|NCT05172544|467352256|FG002|Overall Study|Withdrawal by Subject|0|||
129832229|NCT05172544|467352254|FG000|Overall Study|Physician Decision|0|||
129832230|NCT05172544|467352255|FG001|Overall Study|Physician Decision|0|||
129832231|NCT05172544|467352256|FG002|Overall Study|Physician Decision|1|||
129832232|NCT00728130|467352257|FG000|Overall Study|Withdrawal by Subject|1|||
129832233|NCT00728130|467352257|FG000|Overall Study|Paperwork not completed in time|1|||
129832234|NCT00728130|467352257|FG000|Overall Study|Physician Decision|1|||
129832235|NCT02073279|467352260|FG000|Double-blind Period|Adverse Event|1|||
129832236|NCT02073279|467352261|FG001|Double-blind Period|Adverse Event|1|||
129832237|NCT02073279|467352260|FG000|Double-blind Period|Switched to another treatment|1|||
129832238|NCT02073279|467352261|FG001|Double-blind Period|Switched to another treatment|2|||
129832239|NCT02073279|467352260|FG000|Double-blind Period|Protocol Violation|0|||
129832240|NCT02073279|467352261|FG001|Double-blind Period|Protocol Violation|1|||
129832241|NCT02073279|467352260|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
129832242|NCT02073279|467352261|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
129832243|NCT02073279|467352260|FG000|Double-blind Period|Withdrawal by Subject|2|||
129832244|NCT02073279|467352261|FG001|Double-blind Period|Withdrawal by Subject|2|||
129832245|NCT02073279|467352260|FG000|Open-label Extension Period|Adverse Event|1|||
129832246|NCT02073279|467352261|FG001|Open-label Extension Period|Adverse Event|0|||
129832247|NCT02073279|467352260|FG000|Open-label Extension Period|Lack of Efficacy|1|||
129832248|NCT02073279|467352261|FG001|Open-label Extension Period|Lack of Efficacy|0|||
129832249|NCT02073279|467352260|FG000|Open-label Extension Period|Lost to Follow-up|0|||
129832250|NCT02073279|467352261|FG001|Open-label Extension Period|Lost to Follow-up|4|||
129832251|NCT02073279|467352260|FG000|Open-label Extension Period|Switched to another treatment|1|||
129832252|NCT02073279|467352261|FG001|Open-label Extension Period|Switched to another treatment|4|||
129832253|NCT02073279|467352260|FG000|Open-label Extension Period|Protocol Violation|0|||
129832254|NCT02073279|467352261|FG001|Open-label Extension Period|Protocol Violation|1|||
129832255|NCT02073279|467352260|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
129832256|NCT02073279|467352261|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
129832257|NCT02073279|467352260|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
129832258|NCT02073279|467352261|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
129832259|NCT00973479|467352262|FG000|Overall Study|Lost to Follow-up|0|||
129832260|NCT00973479|467352263|FG001|Overall Study|Lost to Follow-up|3|||
129832261|NCT00973479|467352262|FG000|Overall Study|Death|2|||
129832262|NCT00973479|467352263|FG001|Overall Study|Death|2|||
129832263|NCT00973479|467352262|FG000|Overall Study|Withdrawal by Subject|15|||
129832264|NCT00973479|467352263|FG001|Overall Study|Withdrawal by Subject|16|||
129832265|NCT00973479|467352262|FG000|Overall Study|Lack of Efficacy|5|||
129832266|NCT00973479|467352263|FG001|Overall Study|Lack of Efficacy|7|||
129832267|NCT00973479|467352262|FG000|Overall Study|Adverse Event|12|||
129832268|NCT00973479|467352263|FG001|Overall Study|Adverse Event|32|||
129832269|NCT00973479|467352262|FG000|Overall Study|Protocol Violation|2|||
129832270|NCT00973479|467352263|FG001|Overall Study|Protocol Violation|2|||
129832271|NCT00973479|467352262|FG000|Overall Study|Other|1|||
129832272|NCT00973479|467352263|FG001|Overall Study|Other|7|||
129832273|NCT00362115|467352264|FG000|Overall Study|Adverse Event|0|||
129832274|NCT00362115|467352265|FG001|Overall Study|Adverse Event|1|||
129832275|NCT00362115|467352266|FG002|Overall Study|Adverse Event|1|||
129832276|NCT00362115|467352267|FG003|Overall Study|Adverse Event|1|||
129832277|NCT00362115|467352268|FG004|Overall Study|Adverse Event|2|||
129832278|NCT00362115|467352269|FG005|Overall Study|Adverse Event|2|||
129832279|NCT00362115|467352270|FG006|Overall Study|Adverse Event|1|||
129832280|NCT00362115|467352264|FG000|Overall Study|Protocol Violation|0|||
129832281|NCT00362115|467352265|FG001|Overall Study|Protocol Violation|0|||
129832282|NCT00362115|467352266|FG002|Overall Study|Protocol Violation|0|||
129832283|NCT00362115|467352267|FG003|Overall Study|Protocol Violation|0|||
129832284|NCT00362115|467352268|FG004|Overall Study|Protocol Violation|0|||
129832285|NCT00362115|467352269|FG005|Overall Study|Protocol Violation|1|||
129832286|NCT00362115|467352270|FG006|Overall Study|Protocol Violation|0|||
129832287|NCT00362115|467352264|FG000|Overall Study|Lost to Follow-up|0|||
129832288|NCT00362115|467352265|FG001|Overall Study|Lost to Follow-up|1|||
129832289|NCT00362115|467352266|FG002|Overall Study|Lost to Follow-up|0|||
129832290|NCT00362115|467352267|FG003|Overall Study|Lost to Follow-up|0|||
129832291|NCT00362115|467352268|FG004|Overall Study|Lost to Follow-up|2|||
129832292|NCT00362115|467352269|FG005|Overall Study|Lost to Follow-up|0|||
129832293|NCT00362115|467352270|FG006|Overall Study|Lost to Follow-up|1|||
129832294|NCT00362115|467352264|FG000|Overall Study|Withdrawal by Subject|1|||
129832295|NCT00362115|467352265|FG001|Overall Study|Withdrawal by Subject|3|||
129832296|NCT00362115|467352266|FG002|Overall Study|Withdrawal by Subject|1|||
129832297|NCT00362115|467352267|FG003|Overall Study|Withdrawal by Subject|0|||
129832298|NCT00362115|467352268|FG004|Overall Study|Withdrawal by Subject|1|||
129832299|NCT00362115|467352269|FG005|Overall Study|Withdrawal by Subject|3|||
129832300|NCT00362115|467352270|FG006|Overall Study|Withdrawal by Subject|4|||
129832301|NCT00362115|467352264|FG000|Overall Study|Lack of Efficacy|1|||
129832302|NCT00362115|467352265|FG001|Overall Study|Lack of Efficacy|0|||
129832303|NCT00362115|467352266|FG002|Overall Study|Lack of Efficacy|5|||
129832304|NCT00362115|467352267|FG003|Overall Study|Lack of Efficacy|2|||
129832305|NCT00362115|467352268|FG004|Overall Study|Lack of Efficacy|2|||
129832306|NCT00362115|467352269|FG005|Overall Study|Lack of Efficacy|0|||
129832307|NCT00362115|467352270|FG006|Overall Study|Lack of Efficacy|3|||
129832308|NCT00362115|467352264|FG000|Overall Study|Physician Decision|0|||
129832309|NCT00362115|467352265|FG001|Overall Study|Physician Decision|0|||
129832310|NCT00362115|467352266|FG002|Overall Study|Physician Decision|0|||
129832311|NCT00362115|467352267|FG003|Overall Study|Physician Decision|0|||
129832312|NCT00362115|467352268|FG004|Overall Study|Physician Decision|0|||
129832313|NCT00362115|467352269|FG005|Overall Study|Physician Decision|0|||
129832314|NCT00362115|467352270|FG006|Overall Study|Physician Decision|3|||
129832315|NCT00362115|467352264|FG000|Overall Study|Other|0|||
129832316|NCT00362115|467352265|FG001|Overall Study|Other|1|||
129832317|NCT00362115|467352266|FG002|Overall Study|Other|0|||
129832318|NCT00362115|467352267|FG003|Overall Study|Other|1|||
129832319|NCT00362115|467352268|FG004|Overall Study|Other|0|||
129832320|NCT00362115|467352269|FG005|Overall Study|Other|1|||
129832321|NCT00362115|467352270|FG006|Overall Study|Other|0|||
129832322|NCT03965962|467352271|FG000|Overall Study|Adverse Event|1|||
129832323|NCT03965962|467352272|FG001|Overall Study|Adverse Event|0|||
129832324|NCT03965962|467352273|FG002|Overall Study|Adverse Event|0|||
129832325|NCT03965962|467352274|FG003|Overall Study|Adverse Event|0|||
129832326|NCT03965962|467352271|FG000|Overall Study|Protocol Violation|21|||
129832327|NCT03965962|467352272|FG001|Overall Study|Protocol Violation|4|||
129832328|NCT03965962|467352273|FG002|Overall Study|Protocol Violation|10|||
129832329|NCT03965962|467352274|FG003|Overall Study|Protocol Violation|5|||
129832330|NCT03965962|467352271|FG000|Overall Study|Lost to Follow-up|0|||
129832331|NCT03965962|467352272|FG001|Overall Study|Lost to Follow-up|1|||
129832332|NCT03965962|467352273|FG002|Overall Study|Lost to Follow-up|0|||
129832333|NCT03965962|467352274|FG003|Overall Study|Lost to Follow-up|0|||
129832334|NCT03965962|467352271|FG000|Overall Study|Withdrawal by Subject|3|||
129832335|NCT03965962|467352272|FG001|Overall Study|Withdrawal by Subject|0|||
129832336|NCT03965962|467352273|FG002|Overall Study|Withdrawal by Subject|0|||
129832337|NCT03965962|467352274|FG003|Overall Study|Withdrawal by Subject|1|||
129832338|NCT01408030|467352279|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
129832339|NCT01408030|467352280|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
129832340|NCT01408030|467352281|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
129832341|NCT01408030|467352282|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
129832342|NCT01408030|467352279|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
129832343|NCT01408030|467352280|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
129832344|NCT01408030|467352281|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
129832345|NCT01408030|467352282|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
129832346|NCT01408030|467352279|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
129832347|NCT01408030|467352280|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
129832348|NCT01408030|467352281|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
129832349|NCT01408030|467352282|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
129832350|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
129832351|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
129832352|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
129832353|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
129832354|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
129832355|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
129832356|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
129832357|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
129832358|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
129832359|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
129832360|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
129832361|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
129832362|NCT01408030|467352279|FG000|Observation Phase (Off Drug)|Other|1|||
129832363|NCT01408030|467352280|FG001|Observation Phase (Off Drug)|Other|1|||
129832364|NCT01408030|467352281|FG002|Observation Phase (Off Drug)|Other|1|||
129832365|NCT01408030|467352282|FG003|Observation Phase (Off Drug)|Other|1|||
129832366|NCT05214768|467352283|FG000|Induction Period|Withdrawal by Subject|1|||
129832367|NCT05214768|467352284|FG001|Induction Period|Withdrawal by Subject|0|||
129832368|NCT05214768|467352285|FG002|Induction Period|Withdrawal by Subject|0|||
129832369|NCT05214768|467352286|FG003|Induction Period|Withdrawal by Subject|0|||
129832370|NCT05214768|467352287|FG004|Induction Period|Withdrawal by Subject|0|||
129832371|NCT05214768|467352288|FG005|Induction Period|Withdrawal by Subject|0|||
129832372|NCT05214768|467352283|FG000|Induction Period|Physician Decision|1|||
129832373|NCT05214768|467352284|FG001|Induction Period|Physician Decision|0|||
129832374|NCT05214768|467352285|FG002|Induction Period|Physician Decision|0|||
129832375|NCT05214768|467352286|FG003|Induction Period|Physician Decision|0|||
129832376|NCT05214768|467352287|FG004|Induction Period|Physician Decision|0|||
129832377|NCT05214768|467352288|FG005|Induction Period|Physician Decision|0|||
129832378|NCT05214768|467352283|FG000|Maintenance Period|Other Reasons|0|||
129832379|NCT05214768|467352284|FG001|Maintenance Period|Other Reasons|0|||
129832380|NCT05214768|467352285|FG002|Maintenance Period|Other Reasons|1|||
129832381|NCT05214768|467352286|FG003|Maintenance Period|Other Reasons|1|||
129832382|NCT05214768|467352287|FG004|Maintenance Period|Other Reasons|0|||
129832383|NCT05214768|467352288|FG005|Maintenance Period|Other Reasons|0|||
129832384|NCT05214768|467352283|FG000|Maintenance Period|Withdrawal by Subject|0|||
129832385|NCT05214768|467352284|FG001|Maintenance Period|Withdrawal by Subject|0|||
129832386|NCT05214768|467352285|FG002|Maintenance Period|Withdrawal by Subject|0|||
129832387|NCT05214768|467352286|FG003|Maintenance Period|Withdrawal by Subject|1|||
129832388|NCT05214768|467352287|FG004|Maintenance Period|Withdrawal by Subject|0|||
129832389|NCT05214768|467352288|FG005|Maintenance Period|Withdrawal by Subject|0|||
129832390|NCT05214768|467352283|FG000|Maintenance Period|Lack of Efficacy|0|||
129832391|NCT05214768|467352284|FG001|Maintenance Period|Lack of Efficacy|0|||
129832392|NCT05214768|467352285|FG002|Maintenance Period|Lack of Efficacy|1|||
129832393|NCT05214768|467352286|FG003|Maintenance Period|Lack of Efficacy|0|||
129832394|NCT05214768|467352287|FG004|Maintenance Period|Lack of Efficacy|1|||
129832395|NCT05214768|467352288|FG005|Maintenance Period|Lack of Efficacy|0|||
129832396|NCT05214768|467352283|FG000|Open Label Extension Period|Physician Decision|0|||
129832397|NCT05214768|467352284|FG001|Open Label Extension Period|Physician Decision|0|||
129832398|NCT05214768|467352285|FG002|Open Label Extension Period|Physician Decision|0|||
129832399|NCT05214768|467352286|FG003|Open Label Extension Period|Physician Decision|0|||
129832400|NCT05214768|467352287|FG004|Open Label Extension Period|Physician Decision|0|||
129832401|NCT05214768|467352288|FG005|Open Label Extension Period|Physician Decision|1|||
129832402|NCT05214768|467352283|FG000|Open Label Extension Period|Lack of Efficacy|0|||
129832403|NCT05214768|467352284|FG001|Open Label Extension Period|Lack of Efficacy|0|||
129832404|NCT05214768|467352285|FG002|Open Label Extension Period|Lack of Efficacy|0|||
129832405|NCT05214768|467352286|FG003|Open Label Extension Period|Lack of Efficacy|0|||
129832406|NCT05214768|467352287|FG004|Open Label Extension Period|Lack of Efficacy|0|||
129832407|NCT05214768|467352288|FG005|Open Label Extension Period|Lack of Efficacy|1|||
129832408|NCT05214768|467352283|FG000|Open Label Extension Period|Ongoing Study|0|||
129832409|NCT05214768|467352284|FG001|Open Label Extension Period|Ongoing Study|0|||
129832410|NCT05214768|467352285|FG002|Open Label Extension Period|Ongoing Study|0|||
129832411|NCT05214768|467352286|FG003|Open Label Extension Period|Ongoing Study|0|||
129832412|NCT05214768|467352287|FG004|Open Label Extension Period|Ongoing Study|0|||
129832413|NCT05214768|467352288|FG005|Open Label Extension Period|Ongoing Study|42|||
129832414|NCT04303780|467352289|FG000|Overall Study|Death|104|||
129832415|NCT04303780|467352290|FG001|Overall Study|Death|85|||
129832416|NCT04303780|467352289|FG000|Overall Study|Lost to Follow-up|5|||
129832417|NCT04303780|467352290|FG001|Overall Study|Lost to Follow-up|2|||
129832418|NCT04303780|467352289|FG000|Overall Study|Withdrawal by Subject|12|||
129832419|NCT04303780|467352290|FG001|Overall Study|Withdrawal by Subject|39|||
129832420|NCT04303780|467352289|FG000|Overall Study|Ongoing in study|50|||
129832421|NCT04303780|467352290|FG001|Overall Study|Ongoing in study|45|||
129832422|NCT01239368|467353944|FG000|Overall Study|Principal investigator discretion|1|||
129832423|NCT01239368|467353945|FG001|Overall Study|Principal investigator discretion|0|||
129832424|NCT01239368|467353946|FG002|Overall Study|Principal investigator discretion|0|||
129832425|NCT01239368|467353947|FG003|Overall Study|Principal investigator discretion|0|||
129832426|NCT01239368|467353948|FG004|Overall Study|Principal investigator discretion|1|||
129832427|NCT01239368|467353949|FG005|Overall Study|Principal investigator discretion|2|||
129832428|NCT01239368|467353950|FG006|Overall Study|Principal investigator discretion|0|||
129832429|NCT01239368|467353951|FG007|Overall Study|Principal investigator discretion|0|||
129832430|NCT01239368|467353952|FG008|Overall Study|Principal investigator discretion|0|||
129832431|NCT01239368|467353953|FG009|Overall Study|Principal investigator discretion|1|||
129832432|NCT01239368|467353944|FG000|Overall Study|Disease progression on study|1|||
129832433|NCT01239368|467353945|FG001|Overall Study|Disease progression on study|1|||
129832434|NCT01239368|467353946|FG002|Overall Study|Disease progression on study|1|||
129832435|NCT01239368|467353947|FG003|Overall Study|Disease progression on study|1|||
129832436|NCT01239368|467353948|FG004|Overall Study|Disease progression on study|4|||
129832437|NCT01239368|467353949|FG005|Overall Study|Disease progression on study|2|||
129832438|NCT01239368|467353950|FG006|Overall Study|Disease progression on study|5|||
129832439|NCT01239368|467353951|FG007|Overall Study|Disease progression on study|0|||
129832440|NCT01239368|467353952|FG008|Overall Study|Disease progression on study|0|||
129832441|NCT01239368|467353953|FG009|Overall Study|Disease progression on study|2|||
129832442|NCT01239368|467353944|FG000|Overall Study|Refused further treatment|0|||
129832443|NCT01239368|467353945|FG001|Overall Study|Refused further treatment|0|||
129832444|NCT01239368|467353946|FG002|Overall Study|Refused further treatment|0|||
129832445|NCT01239368|467353947|FG003|Overall Study|Refused further treatment|0|||
129832446|NCT01239368|467353948|FG004|Overall Study|Refused further treatment|0|||
129832447|NCT01239368|467353949|FG005|Overall Study|Refused further treatment|0|||
129832448|NCT01239368|467353950|FG006|Overall Study|Refused further treatment|0|||
129832449|NCT01239368|467353951|FG007|Overall Study|Refused further treatment|0|||
129832450|NCT01239368|467353952|FG008|Overall Study|Refused further treatment|0|||
129832451|NCT01239368|467353953|FG009|Overall Study|Refused further treatment|1|||
129832452|NCT01239368|467353944|FG000|Overall Study|Death|0|||
129832453|NCT01239368|467353945|FG001|Overall Study|Death|0|||
129832454|NCT01239368|467353946|FG002|Overall Study|Death|0|||
129832455|NCT01239368|467353947|FG003|Overall Study|Death|0|||
129832456|NCT01239368|467353948|FG004|Overall Study|Death|0|||
129832457|NCT01239368|467353949|FG005|Overall Study|Death|0|||
129832458|NCT01239368|467353950|FG006|Overall Study|Death|1|||
129832459|NCT01239368|467353951|FG007|Overall Study|Death|0|||
129832460|NCT01239368|467353952|FG008|Overall Study|Death|0|||
129832461|NCT01239368|467353953|FG009|Overall Study|Death|0|||
129832462|NCT01254227|467353958|FG000|Overall Study|Withdrawal by Subject|6|||
129832463|NCT01254227|467353958|FG000|Overall Study|Lost to Follow-up|6|||
129832464|NCT01254227|467353958|FG000|Overall Study|Adverse Event|5|||
129832465|NCT01254227|467353958|FG000|Overall Study|Abnormal test procedure result|5|||
129832466|NCT01254227|467353958|FG000|Overall Study|Administrative problems|2|||
129832467|NCT01254227|467353958|FG000|Overall Study|Death|1|||
129832468|NCT01254227|467353958|FG000|Overall Study|Protocol deviation|1|||
129832469|NCT03265249|467353961|FG000|Overall Study|Withdrawal by Subject|0|||
129832470|NCT03265249|467353962|FG001|Overall Study|Withdrawal by Subject|1|||
129832471|NCT01614990|467353963|FG000|Overall Study|Protocol Violation|1|||
129832472|NCT01614990|467353964|FG001|Overall Study|Protocol Violation|1|||
129832473|NCT01012622|467353967|FG000|Overall Study|Withdrawal by Subject|6|||
129832474|NCT01012622|467353967|FG000|Overall Study|Lost to Follow-up|5|||
129832475|NCT01012622|467353967|FG000|Overall Study|Adverse Event|7|||
129832476|NCT01012622|467353967|FG000|Overall Study|non-compliance with the drug|9|||
129832477|NCT01012622|467353967|FG000|Overall Study|Other|1|||
129832478|NCT01012622|467353967|FG000|Overall Study|screening failure|1|||
129832479|NCT01012622|467353967|FG000|Overall Study|withdrawal of consent by a parent|2|||
129832480|NCT00706641|467353969|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
129832481|NCT00706641|467353969|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
129832482|NCT00706641|467353969|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
129832483|NCT02535741|467353972|FG000|Overall Study|Adverse Event|3|||
129832484|NCT02535741|467353972|FG000|Overall Study|Withdrawal by Subject|9|||
129832485|NCT02535741|467353972|FG000|Overall Study|Lost to Follow-up|10|||
129832486|NCT02535741|467353972|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
129832487|NCT02535741|467353972|FG000|Overall Study|Missing data|6|||
129832488|NCT00798369|467353973|FG000|Overall Study|Subject withdrew consent|0|||
129832489|NCT00798369|467353974|FG001|Overall Study|Subject withdrew consent|0|||
129832490|NCT00798369|467353975|FG002|Overall Study|Subject withdrew consent|1|||
129832491|NCT00798369|467353976|FG003|Overall Study|Subject withdrew consent|1|||
129832492|NCT00798369|467353977|FG004|Overall Study|Subject withdrew consent|0|||
129832493|NCT00798369|467353978|FG005|Overall Study|Subject withdrew consent|2|||
129832494|NCT00798369|467353973|FG000|Overall Study|Lost to Follow-up|1|||
129832495|NCT00798369|467353974|FG001|Overall Study|Lost to Follow-up|1|||
129832496|NCT00798369|467353975|FG002|Overall Study|Lost to Follow-up|1|||
129832497|NCT00798369|467353976|FG003|Overall Study|Lost to Follow-up|0|||
129832498|NCT00798369|467353977|FG004|Overall Study|Lost to Follow-up|1|||
129832499|NCT00798369|467353978|FG005|Overall Study|Lost to Follow-up|0|||
129832500|NCT00798369|467353973|FG000|Overall Study|Adminstrative problems|0|||
129832501|NCT00798369|467353974|FG001|Overall Study|Adminstrative problems|0|||
129832502|NCT00798369|467353975|FG002|Overall Study|Adminstrative problems|0|||
129832503|NCT00798369|467353976|FG003|Overall Study|Adminstrative problems|0|||
129832504|NCT00798369|467353977|FG004|Overall Study|Adminstrative problems|0|||
129832505|NCT00798369|467353978|FG005|Overall Study|Adminstrative problems|1|||
129832506|NCT04475588|467353979|FG000|Overall Study|Adverse Event|2|||
129832507|NCT04475588|467353980|FG001|Overall Study|Adverse Event|0|||
129832508|NCT04762680|467353981|FG000|Phase 2|Adverse Event|0|||
129832509|NCT04762680|467353982|FG001|Phase 2|Adverse Event|1|||
129832510|NCT04762680|467353983|FG002|Phase 2|Adverse Event|0|||
129832511|NCT04762680|467353984|FG003|Phase 2|Adverse Event|0|||
129832512|NCT04762680|467353985|FG004|Phase 2|Adverse Event|0|||
129832513|NCT04762680|467353986|FG005|Phase 2|Adverse Event|0|||
129832514|NCT04762680|467353987|FG006|Phase 2|Adverse Event|0|||
129832515|NCT04762680|467353988|FG007|Phase 2|Adverse Event|0|||
129832516|NCT04762680|467353989|FG008|Phase 2|Adverse Event|0|||
129832517|NCT04762680|467353990|FG009|Phase 2|Adverse Event|0|||
129832518|NCT04762680|467353991|FG010|Phase 2|Adverse Event|0|||
129832519|NCT04762680|467353992|FG011|Phase 2|Adverse Event|0|||
129832520|NCT04762680|467353993|FG012|Phase 2|Adverse Event|0|||
129832521|NCT04762680|467353994|FG013|Phase 2|Adverse Event|0|||
129832522|NCT04762680|467353995|FG014|Phase 2|Adverse Event|0|||
129832523|NCT04762680|467353996|FG015|Phase 2|Adverse Event|0|||
129832524|NCT04762680|467353997|FG016|Phase 2|Adverse Event|0|||
129832525|NCT04762680|467353998|FG017|Phase 2|Adverse Event|0|||
129832526|NCT04762680|467353999|FG018|Phase 2|Adverse Event|0|||
129832527|NCT04762680|467354000|FG019|Phase 2|Adverse Event|0|||
129832528|NCT04762680|467354001|FG020|Phase 2|Adverse Event|0|||
129832529|NCT04762680|467354002|FG021|Phase 2|Adverse Event|0|||
129832530|NCT04762680|467353981|FG000|Phase 2|Protocol Violation|5|||
129832531|NCT04762680|467353982|FG001|Phase 2|Protocol Violation|5|||
129832532|NCT04762680|467353983|FG002|Phase 2|Protocol Violation|1|||
129832533|NCT04762680|467353984|FG003|Phase 2|Protocol Violation|0|||
129832534|NCT04762680|467353985|FG004|Phase 2|Protocol Violation|0|||
129832535|NCT04762680|467353986|FG005|Phase 2|Protocol Violation|0|||
129832536|NCT04762680|467353987|FG006|Phase 2|Protocol Violation|0|||
129832537|NCT04762680|467353988|FG007|Phase 2|Protocol Violation|0|||
129832538|NCT04762680|467353989|FG008|Phase 2|Protocol Violation|0|||
129832539|NCT04762680|467353990|FG009|Phase 2|Protocol Violation|0|||
129832540|NCT04762680|467353991|FG010|Phase 2|Protocol Violation|0|||
129832541|NCT04762680|467353992|FG011|Phase 2|Protocol Violation|0|||
129832542|NCT04762680|467353993|FG012|Phase 2|Protocol Violation|0|||
129832543|NCT04762680|467353994|FG013|Phase 2|Protocol Violation|0|||
129832544|NCT04762680|467353995|FG014|Phase 2|Protocol Violation|0|||
129832545|NCT04762680|467353996|FG015|Phase 2|Protocol Violation|0|||
129832546|NCT04762680|467353997|FG016|Phase 2|Protocol Violation|0|||
129832547|NCT04762680|467353998|FG017|Phase 2|Protocol Violation|0|||
129832548|NCT04762680|467353999|FG018|Phase 2|Protocol Violation|0|||
129832549|NCT04762680|467354000|FG019|Phase 2|Protocol Violation|0|||
129832550|NCT04762680|467354001|FG020|Phase 2|Protocol Violation|0|||
129832551|NCT04762680|467354002|FG021|Phase 2|Protocol Violation|0|||
129832552|NCT04762680|467353981|FG000|Phase 2|Withdrawal by Subject|23|||
129832553|NCT04762680|467353982|FG001|Phase 2|Withdrawal by Subject|21|||
129832554|NCT04762680|467353983|FG002|Phase 2|Withdrawal by Subject|28|||
129832555|NCT04762680|467353984|FG003|Phase 2|Withdrawal by Subject|0|||
129832556|NCT04762680|467353985|FG004|Phase 2|Withdrawal by Subject|0|||
129832557|NCT04762680|467353986|FG005|Phase 2|Withdrawal by Subject|0|||
129832558|NCT04762680|467353987|FG006|Phase 2|Withdrawal by Subject|0|||
129832559|NCT04762680|467353988|FG007|Phase 2|Withdrawal by Subject|0|||
129832560|NCT04762680|467353989|FG008|Phase 2|Withdrawal by Subject|0|||
129832561|NCT04762680|467353990|FG009|Phase 2|Withdrawal by Subject|0|||
129832562|NCT04762680|467353991|FG010|Phase 2|Withdrawal by Subject|0|||
129832563|NCT04762680|467353992|FG011|Phase 2|Withdrawal by Subject|0|||
129832564|NCT04762680|467353993|FG012|Phase 2|Withdrawal by Subject|0|||
129832565|NCT04762680|467353994|FG013|Phase 2|Withdrawal by Subject|0|||
129832566|NCT04762680|467353995|FG014|Phase 2|Withdrawal by Subject|0|||
129832567|NCT04762680|467353996|FG015|Phase 2|Withdrawal by Subject|0|||
129832568|NCT04762680|467353997|FG016|Phase 2|Withdrawal by Subject|0|||
129832569|NCT04762680|467353998|FG017|Phase 2|Withdrawal by Subject|0|||
129832570|NCT04762680|467353999|FG018|Phase 2|Withdrawal by Subject|0|||
129832571|NCT04762680|467354000|FG019|Phase 2|Withdrawal by Subject|0|||
129832572|NCT04762680|467354001|FG020|Phase 2|Withdrawal by Subject|0|||
129832573|NCT04762680|467354002|FG021|Phase 2|Withdrawal by Subject|0|||
129832574|NCT04762680|467353981|FG000|Phase 2|Lost to Follow-up|14|||
129832575|NCT04762680|467353982|FG001|Phase 2|Lost to Follow-up|8|||
129832576|NCT04762680|467353983|FG002|Phase 2|Lost to Follow-up|9|||
129832577|NCT04762680|467353984|FG003|Phase 2|Lost to Follow-up|0|||
129832578|NCT04762680|467353985|FG004|Phase 2|Lost to Follow-up|0|||
129832579|NCT04762680|467353986|FG005|Phase 2|Lost to Follow-up|0|||
129832580|NCT04762680|467353987|FG006|Phase 2|Lost to Follow-up|0|||
129832581|NCT04762680|467353988|FG007|Phase 2|Lost to Follow-up|0|||
129832582|NCT04762680|467353989|FG008|Phase 2|Lost to Follow-up|0|||
129832583|NCT04762680|467353990|FG009|Phase 2|Lost to Follow-up|0|||
129832584|NCT04762680|467353991|FG010|Phase 2|Lost to Follow-up|0|||
129832585|NCT04762680|467353992|FG011|Phase 2|Lost to Follow-up|0|||
129832586|NCT04762680|467353993|FG012|Phase 2|Lost to Follow-up|0|||
129832587|NCT04762680|467353994|FG013|Phase 2|Lost to Follow-up|0|||
129832588|NCT04762680|467353995|FG014|Phase 2|Lost to Follow-up|0|||
129832589|NCT04762680|467353996|FG015|Phase 2|Lost to Follow-up|0|||
129832590|NCT04762680|467353997|FG016|Phase 2|Lost to Follow-up|0|||
129832591|NCT04762680|467353998|FG017|Phase 2|Lost to Follow-up|0|||
129832592|NCT04762680|467353999|FG018|Phase 2|Lost to Follow-up|0|||
129832593|NCT04762680|467354000|FG019|Phase 2|Lost to Follow-up|0|||
129832594|NCT04762680|467354001|FG020|Phase 2|Lost to Follow-up|0|||
129832595|NCT04762680|467354002|FG021|Phase 2|Lost to Follow-up|0|||
129832596|NCT04762680|467353981|FG000|Phase 3|Adverse Event|0|||
129832597|NCT04762680|467353982|FG001|Phase 3|Adverse Event|0|||
129832598|NCT04762680|467353983|FG002|Phase 3|Adverse Event|0|||
129832599|NCT04762680|467353984|FG003|Phase 3|Adverse Event|1|||
129832600|NCT04762680|467353985|FG004|Phase 3|Adverse Event|0|||
129832601|NCT04762680|467353986|FG005|Phase 3|Adverse Event|0|||
129832602|NCT04762680|467353987|FG006|Phase 3|Adverse Event|0|||
129832603|NCT04762680|467353988|FG007|Phase 3|Adverse Event|0|||
129832604|NCT04762680|467353989|FG008|Phase 3|Adverse Event|0|||
129832605|NCT04762680|467353990|FG009|Phase 3|Adverse Event|0|||
129832606|NCT04762680|467353991|FG010|Phase 3|Adverse Event|0|||
129832607|NCT04762680|467353992|FG011|Phase 3|Adverse Event|0|||
129832608|NCT04762680|467353993|FG012|Phase 3|Adverse Event|0|||
129832609|NCT04762680|467353994|FG013|Phase 3|Adverse Event|0|||
129832610|NCT04762680|467353995|FG014|Phase 3|Adverse Event|0|||
129832611|NCT04762680|467353996|FG015|Phase 3|Adverse Event|0|||
129832612|NCT04762680|467353997|FG016|Phase 3|Adverse Event|0|||
129832613|NCT04762680|467353998|FG017|Phase 3|Adverse Event|3|||
129832614|NCT04762680|467353999|FG018|Phase 3|Adverse Event|0|||
129832615|NCT04762680|467354000|FG019|Phase 3|Adverse Event|0|||
129832616|NCT04762680|467354001|FG020|Phase 3|Adverse Event|0|||
129832617|NCT04762680|467354002|FG021|Phase 3|Adverse Event|0|||
129832618|NCT04762680|467353981|FG000|Phase 3|Protocol Violation|0|||
129832619|NCT04762680|467353982|FG001|Phase 3|Protocol Violation|0|||
129832620|NCT04762680|467353983|FG002|Phase 3|Protocol Violation|0|||
129832621|NCT04762680|467353984|FG003|Phase 3|Protocol Violation|4|||
129832622|NCT04762680|467353985|FG004|Phase 3|Protocol Violation|1|||
129832623|NCT04762680|467353986|FG005|Phase 3|Protocol Violation|5|||
129832624|NCT04762680|467353987|FG006|Phase 3|Protocol Violation|1|||
129832625|NCT04762680|467353988|FG007|Phase 3|Protocol Violation|0|||
129832626|NCT04762680|467353989|FG008|Phase 3|Protocol Violation|0|||
129832627|NCT04762680|467353990|FG009|Phase 3|Protocol Violation|0|||
129832628|NCT04762680|467353991|FG010|Phase 3|Protocol Violation|0|||
129832629|NCT04762680|467353992|FG011|Phase 3|Protocol Violation|2|||
129832630|NCT04762680|467353993|FG012|Phase 3|Protocol Violation|3|||
129832631|NCT04762680|467353994|FG013|Phase 3|Protocol Violation|0|||
129832632|NCT04762680|467353995|FG014|Phase 3|Protocol Violation|0|||
129832633|NCT04762680|467353996|FG015|Phase 3|Protocol Violation|1|||
129832634|NCT04762680|467353997|FG016|Phase 3|Protocol Violation|0|||
129832635|NCT04762680|467353998|FG017|Phase 3|Protocol Violation|10|||
129832636|NCT04762680|467353999|FG018|Phase 3|Protocol Violation|0|||
129832637|NCT04762680|467354000|FG019|Phase 3|Protocol Violation|0|||
129832638|NCT04762680|467354001|FG020|Phase 3|Protocol Violation|0|||
129832639|NCT04762680|467354002|FG021|Phase 3|Protocol Violation|0|||
129832640|NCT04762680|467353981|FG000|Phase 3|Withdrawal by Subject|0|||
129832641|NCT04762680|467353982|FG001|Phase 3|Withdrawal by Subject|0|||
129832642|NCT04762680|467353983|FG002|Phase 3|Withdrawal by Subject|0|||
129832643|NCT04762680|467353984|FG003|Phase 3|Withdrawal by Subject|13|||
129832644|NCT04762680|467353985|FG004|Phase 3|Withdrawal by Subject|17|||
129832645|NCT04762680|467353986|FG005|Phase 3|Withdrawal by Subject|12|||
129832646|NCT04762680|467353987|FG006|Phase 3|Withdrawal by Subject|8|||
129832647|NCT04762680|467353988|FG007|Phase 3|Withdrawal by Subject|3|||
129832648|NCT04762680|467353989|FG008|Phase 3|Withdrawal by Subject|2|||
129832649|NCT04762680|467353990|FG009|Phase 3|Withdrawal by Subject|4|||
129832650|NCT04762680|467353991|FG010|Phase 3|Withdrawal by Subject|3|||
129832651|NCT04762680|467353992|FG011|Phase 3|Withdrawal by Subject|1|||
129832652|NCT04762680|467353993|FG012|Phase 3|Withdrawal by Subject|3|||
129832653|NCT04762680|467353994|FG013|Phase 3|Withdrawal by Subject|2|||
129832654|NCT04762680|467353995|FG014|Phase 3|Withdrawal by Subject|1|||
129832655|NCT04762680|467353996|FG015|Phase 3|Withdrawal by Subject|4|||
129832656|NCT04762680|467353997|FG016|Phase 3|Withdrawal by Subject|6|||
129832657|NCT04762680|467353998|FG017|Phase 3|Withdrawal by Subject|32|||
129832658|NCT04762680|467353999|FG018|Phase 3|Withdrawal by Subject|0|||
129832659|NCT04762680|467354000|FG019|Phase 3|Withdrawal by Subject|0|||
129832660|NCT04762680|467354001|FG020|Phase 3|Withdrawal by Subject|0|||
129832661|NCT04762680|467354002|FG021|Phase 3|Withdrawal by Subject|0|||
129832662|NCT04762680|467353981|FG000|Phase 3|Lost to Follow-up|0|||
129832663|NCT04762680|467353982|FG001|Phase 3|Lost to Follow-up|0|||
129832664|NCT04762680|467353983|FG002|Phase 3|Lost to Follow-up|0|||
129832665|NCT04762680|467353984|FG003|Phase 3|Lost to Follow-up|9|||
129832666|NCT04762680|467353985|FG004|Phase 3|Lost to Follow-up|22|||
129832667|NCT04762680|467353986|FG005|Phase 3|Lost to Follow-up|24|||
129832668|NCT04762680|467353987|FG006|Phase 3|Lost to Follow-up|2|||
129832669|NCT04762680|467353988|FG007|Phase 3|Lost to Follow-up|4|||
129832670|NCT04762680|467353989|FG008|Phase 3|Lost to Follow-up|6|||
129832671|NCT04762680|467353990|FG009|Phase 3|Lost to Follow-up|4|||
129832672|NCT04762680|467353991|FG010|Phase 3|Lost to Follow-up|3|||
129832673|NCT04762680|467353992|FG011|Phase 3|Lost to Follow-up|0|||
129832674|NCT04762680|467353993|FG012|Phase 3|Lost to Follow-up|5|||
129832675|NCT04762680|467353994|FG013|Phase 3|Lost to Follow-up|4|||
129832676|NCT04762680|467353995|FG014|Phase 3|Lost to Follow-up|6|||
129832677|NCT04762680|467353996|FG015|Phase 3|Lost to Follow-up|1|||
129832678|NCT04762680|467353997|FG016|Phase 3|Lost to Follow-up|1|||
129832679|NCT04762680|467353998|FG017|Phase 3|Lost to Follow-up|66|||
129832680|NCT04762680|467353999|FG018|Phase 3|Lost to Follow-up|0|||
129832681|NCT04762680|467354000|FG019|Phase 3|Lost to Follow-up|0|||
129832682|NCT04762680|467354001|FG020|Phase 3|Lost to Follow-up|0|||
129832683|NCT04762680|467354002|FG021|Phase 3|Lost to Follow-up|0|||
129832684|NCT04762680|467353981|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832685|NCT04762680|467353982|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832686|NCT04762680|467353983|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832687|NCT04762680|467353984|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832688|NCT04762680|467353985|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832689|NCT04762680|467353986|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832690|NCT04762680|467353987|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832691|NCT04762680|467353988|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832692|NCT04762680|467353989|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832693|NCT04762680|467353990|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832694|NCT04762680|467353991|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832695|NCT04762680|467353992|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832696|NCT04762680|467353993|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832697|NCT04762680|467353994|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832698|NCT04762680|467353995|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832699|NCT04762680|467353996|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832700|NCT04762680|467353997|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832701|NCT04762680|467353998|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832702|NCT04762680|467353999|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832703|NCT04762680|467354000|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832704|NCT04762680|467354001|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
129832705|NCT04762680|467354002|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
129832706|NCT04762680|467353981|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832707|NCT04762680|467353982|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832708|NCT04762680|467353983|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832709|NCT04762680|467353984|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832710|NCT04762680|467353985|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832711|NCT04762680|467353986|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832712|NCT04762680|467353987|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832713|NCT04762680|467353988|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832714|NCT04762680|467353989|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832715|NCT04762680|467353990|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832716|NCT04762680|467353991|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832717|NCT04762680|467353992|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832718|NCT04762680|467353993|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832719|NCT04762680|467353994|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832720|NCT04762680|467353995|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832721|NCT04762680|467353996|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832722|NCT04762680|467353997|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832723|NCT04762680|467353998|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832724|NCT04762680|467353999|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832725|NCT04762680|467354000|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
129832726|NCT04762680|467354001|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832727|NCT04762680|467354002|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
129832728|NCT02082210|467354003|FG000|Overall Study|Death|0|||
129832729|NCT02082210|467354004|FG001|Overall Study|Death|0|||
129832730|NCT02082210|467354005|FG002|Overall Study|Death|1|||
129832731|NCT02082210|467354006|FG003|Overall Study|Death|1|||
129832732|NCT02082210|467354007|FG004|Overall Study|Death|1|||
129832733|NCT02082210|467354008|FG005|Overall Study|Death|0|||
129832734|NCT02082210|467354003|FG000|Overall Study|Withdrawal by Subject|0|||
129832735|NCT02082210|467354004|FG001|Overall Study|Withdrawal by Subject|0|||
129832736|NCT02082210|467354005|FG002|Overall Study|Withdrawal by Subject|0|||
129832737|NCT02082210|467354006|FG003|Overall Study|Withdrawal by Subject|1|||
129832738|NCT02082210|467354007|FG004|Overall Study|Withdrawal by Subject|2|||
129832739|NCT02082210|467354008|FG005|Overall Study|Withdrawal by Subject|2|||
129832740|NCT02082210|467354003|FG000|Overall Study|Clinical Progression|0|||
129832741|NCT02082210|467354004|FG001|Overall Study|Clinical Progression|0|||
129832742|NCT02082210|467354005|FG002|Overall Study|Clinical Progression|0|||
129832743|NCT02082210|467354006|FG003|Overall Study|Clinical Progression|1|||
129832744|NCT02082210|467354007|FG004|Overall Study|Clinical Progression|0|||
129832745|NCT02082210|467354008|FG005|Overall Study|Clinical Progression|0|||
129832746|NCT02082210|467354003|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832747|NCT02082210|467354004|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832748|NCT02082210|467354005|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
129832749|NCT02082210|467354006|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
129832750|NCT02082210|467354007|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832751|NCT02082210|467354008|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
129832752|NCT02082210|467354003|FG000|Overall Study|Physician Decision|0|||
129832753|NCT02082210|467354004|FG001|Overall Study|Physician Decision|0|||
129832754|NCT02082210|467354005|FG002|Overall Study|Physician Decision|1|||
129832755|NCT02082210|467354006|FG003|Overall Study|Physician Decision|1|||
129832756|NCT02082210|467354007|FG004|Overall Study|Physician Decision|0|||
129832757|NCT02082210|467354008|FG005|Overall Study|Physician Decision|0|||
129832758|NCT04461015|467354022|FG000|Overall Study|IV access lost during the study|0|||
129832759|NCT04461015|467354023|FG001|Overall Study|IV access lost during the study|1|||
129832760|NCT04461015|467354022|FG000|Overall Study|Withdrawal by Subject|0|||
129832761|NCT04461015|467354023|FG001|Overall Study|Withdrawal by Subject|1|||
129832762|NCT03615326|467354025|FG000|Overall Study|Death|266|||
129832763|NCT03615326|467354026|FG001|Overall Study|Death|286|||
129832764|NCT03615326|467354027|FG002|Overall Study|Death|14|||
129832765|NCT03615326|467354028|FG003|Overall Study|Death|17|||
129832766|NCT03615326|467354025|FG000|Overall Study|Lost to Follow-up|0|||
129832767|NCT03615326|467354026|FG001|Overall Study|Lost to Follow-up|1|||
129832768|NCT03615326|467354027|FG002|Overall Study|Lost to Follow-up|0|||
129832769|NCT03615326|467354028|FG003|Overall Study|Lost to Follow-up|0|||
129832770|NCT03615326|467354025|FG000|Overall Study|Withdrawal by Subject|1|||
129832771|NCT03615326|467354026|FG001|Overall Study|Withdrawal by Subject|3|||
129832772|NCT03615326|467354027|FG002|Overall Study|Withdrawal by Subject|0|||
129832773|NCT03615326|467354028|FG003|Overall Study|Withdrawal by Subject|0|||
129832774|NCT03615326|467354025|FG000|Overall Study|Participants Ongoing|83|||
129832775|NCT03615326|467354026|FG001|Overall Study|Participants Ongoing|58|||
129832776|NCT03615326|467354027|FG002|Overall Study|Participants Ongoing|6|||
129832777|NCT03615326|467354028|FG003|Overall Study|Participants Ongoing|3|||
129832778|NCT03425331|467354041|FG000|Overall Study|Withdrawal by Subject|1|||
129832779|NCT03425331|467354041|FG000|Overall Study|Death|1|||
129832780|NCT03425331|467354041|FG000|Overall Study|Adverse Event|1|||
129832781|NCT03425331|467354041|FG000|Overall Study|Disease Progression|2|||
129832782|NCT02864251|467354044|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
129832783|NCT02864251|467354045|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
129832784|NCT02864251|467354046|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
129445782|NCT00882310|465932918|FG000|Overall Study|Screen Failure|10|||
129445783|NCT00882310|465932918|FG000|Overall Study|Never received treatment|1|||
129445784|NCT00882310|465932918|FG000|Overall Study|Death|6|||
129445785|NCT00882310|465932918|FG000|Overall Study|Progression of disease|4|||
129445786|NCT00882310|465932918|FG000|Overall Study|Adverse Event|1|||
129445787|NCT01351623|465932925|FG000|Overall Study|Protocol Violation|2|||
129445788|NCT01351623|465932925|FG000|Overall Study|Adverse Event|4|||
129445789|NCT01351623|465932925|FG000|Overall Study|Withdrawal by Subject|1|||
129445790|NCT01351623|465932925|FG000|Overall Study|Death|2|||
129445791|NCT04201821|465932926|FG000|Overall Study|Withdrawal by Subject|2|||
129445792|NCT01130974|465932927|FG000|Overall Study|Protocol Violation|10|||
129445793|NCT01130974|465932928|FG001|Overall Study|Protocol Violation|10|||
129445794|NCT01130974|465932927|FG000|Overall Study|Withdrawal by Subject|0|||
129445795|NCT01130974|465932928|FG001|Overall Study|Withdrawal by Subject|1|||
129445796|NCT01130974|465932927|FG000|Overall Study|Ineligibility criteria|5|||
129445797|NCT01130974|465932928|FG001|Overall Study|Ineligibility criteria|2|||
129445798|NCT00387764|465932929|FG000|Overall Study|Adverse Event|12|||
129445799|NCT00387764|465932929|FG000|Overall Study|Withdrawal by Subject|8|||
129832785|NCT02864251|467354044|FG000|Pre-Treatment|Withdrawal by Participant|0|||
129832786|NCT02864251|467354045|FG001|Pre-Treatment|Withdrawal by Participant|0|||
129445800|NCT00387764|465932929|FG000|Overall Study|Sponsor Terminated Study|1|||
129445801|NCT00387764|465932929|FG000|Overall Study|Physician Decision|1|||
129445802|NCT00387764|465932929|FG000|Overall Study|Other|2|||
129832787|NCT02864251|467354046|FG002|Pre-Treatment|Withdrawal by Participant|4|||
129832788|NCT02864251|467354044|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
129832789|NCT02864251|467354045|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
129832790|NCT02864251|467354046|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
129832791|NCT02864251|467354044|FG000|Pre-Treatment|Other Reasons|0|||
129832792|NCT02864251|467354045|FG001|Pre-Treatment|Other Reasons|1|||
129832793|NCT02864251|467354046|FG002|Pre-Treatment|Other Reasons|1|||
129832794|NCT02864251|467354044|FG000|Treatment|Disease Progression|109|||
129832795|NCT02864251|467354045|FG001|Treatment|Disease Progression|52|||
129832796|NCT02864251|467354046|FG002|Treatment|Disease Progression|101|||
129832797|NCT02864251|467354044|FG000|Treatment|Study Drug Toxicity|9|||
129832798|NCT02864251|467354045|FG001|Treatment|Study Drug Toxicity|4|||
129832799|NCT02864251|467354046|FG002|Treatment|Study Drug Toxicity|10|||
129832800|NCT02864251|467354044|FG000|Treatment|Death|0|||
129832801|NCT02864251|467354045|FG001|Treatment|Death|2|||
129832802|NCT02864251|467354046|FG002|Treatment|Death|3|||
129832803|NCT02864251|467354044|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
129832804|NCT02864251|467354045|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
129832805|NCT02864251|467354046|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
129832806|NCT02864251|467354044|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
129832807|NCT02864251|467354045|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
129832808|NCT02864251|467354046|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
129832809|NCT02864251|467354044|FG000|Treatment|Withdrawal by Participant|8|||
129832810|NCT02864251|467354045|FG001|Treatment|Withdrawal by Participant|5|||
129832811|NCT02864251|467354046|FG002|Treatment|Withdrawal by Participant|13|||
129832812|NCT02864251|467354044|FG000|Treatment|Maximum Clinical Benefit|1|||
129832813|NCT02864251|467354045|FG001|Treatment|Maximum Clinical Benefit|0|||
129832814|NCT02864251|467354046|FG002|Treatment|Maximum Clinical Benefit|1|||
129832815|NCT02864251|467354044|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
129832816|NCT02864251|467354045|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
129832817|NCT02864251|467354046|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
129832818|NCT02864251|467354044|FG000|Treatment|Other Reasons|1|||
129832819|NCT02864251|467354045|FG001|Treatment|Other Reasons|1|||
129832820|NCT02864251|467354046|FG002|Treatment|Other Reasons|4|||
129832821|NCT02864251|467354044|FG000|Treatment|Administrative Reason by Sponsor|1|||
129832822|NCT02864251|467354045|FG001|Treatment|Administrative Reason by Sponsor|0|||
129832823|NCT02864251|467354046|FG002|Treatment|Administrative Reason by Sponsor|0|||
129832824|NCT03506373|467354049|FG000|Overall Study|Adverse Event|6|||
129832825|NCT03506373|467354049|FG000|Overall Study|Withdrawal by Subject|2|||
129832826|NCT03506373|467354049|FG000|Overall Study|Disease progression|5|||
129832827|NCT03506373|467354049|FG000|Overall Study|Other|3|||
129832828|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
129832829|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
129832830|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
129832831|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
129832832|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
129832833|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
129832834|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
129832835|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
129832836|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
129832837|NCT00885755|467354050|FG000|Part I: Trastuzumab+Taxane|Death|0|||
129832838|NCT00885755|467354051|FG001|Part I: Trastuzumab+Taxane|Death|0|||
129832839|NCT00885755|467354052|FG002|Part I: Trastuzumab+Taxane|Death|1|||
129832840|NCT00885755|467354050|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
129832841|NCT00885755|467354051|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
129832842|NCT00885755|467354052|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
129832843|NCT05442554|467354053|FG000|Overall Study|Adverse Event|1|||
129832844|NCT01852812|467354054|FG000|Overall Study|Adverse Event|0|||
129832845|NCT01852812|467354055|FG001|Overall Study|Adverse Event|0|||
129832846|NCT01852812|467354056|FG002|Overall Study|Adverse Event|1|||
129832847|NCT01852812|467354054|FG000|Overall Study|Non-compliance With Study Drug|0|||
129832848|NCT01852812|467354055|FG001|Overall Study|Non-compliance With Study Drug|1|||
129832849|NCT01852812|467354056|FG002|Overall Study|Non-compliance With Study Drug|0|||
129832850|NCT02250443|467354057|FG000|Overall Study|Administrative problems|7|||
129832851|NCT02250443|467354057|FG000|Overall Study|Adverse Event|3|||
129832852|NCT01549964|467354058|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
129832853|NCT01549964|467354059|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
129832854|NCT01549964|467354060|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
129832855|NCT01549964|467354061|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
129832856|NCT01549964|467354058|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
129832857|NCT01549964|467354059|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
129832858|NCT01549964|467354060|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
129832859|NCT01549964|467354061|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
129832860|NCT01549964|467354058|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
129832861|NCT01549964|467354059|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
129832862|NCT01549964|467354060|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
129832863|NCT01549964|467354061|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
129832864|NCT01549964|467354058|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
129832865|NCT01549964|467354059|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
129832866|NCT01549964|467354060|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
129832867|NCT01549964|467354061|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
129832868|NCT01549964|467354058|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
129832869|NCT01549964|467354059|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
129832870|NCT01549964|467354060|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
129832871|NCT01549964|467354061|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
129832872|NCT01549964|467354058|FG000|24-Week Treatment Period|Other|1|||
129832873|NCT01549964|467354059|FG001|24-Week Treatment Period|Other|0|||
129832874|NCT01549964|467354060|FG002|24-Week Treatment Period|Other|1|||
129832875|NCT01549964|467354061|FG003|24-Week Treatment Period|Other|0|||
129832876|NCT01549964|467354058|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129832877|NCT01549964|467354059|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129832878|NCT01549964|467354060|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
129832879|NCT01549964|467354061|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
129832880|NCT01549964|467354058|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
129832881|NCT01549964|467354059|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
129832882|NCT01549964|467354060|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
129832883|NCT01549964|467354061|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
129832884|NCT01549964|467354058|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
129832885|NCT01549964|467354059|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
129832886|NCT01549964|467354060|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
129832887|NCT01549964|467354061|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
129832888|NCT01549964|467354058|FG000|80-Week Extension Period|Pregnancy|0|||
129832889|NCT01549964|467354059|FG001|80-Week Extension Period|Pregnancy|0|||
129832890|NCT01549964|467354060|FG002|80-Week Extension Period|Pregnancy|1|||
129832891|NCT01549964|467354061|FG003|80-Week Extension Period|Pregnancy|0|||
129832892|NCT01549964|467354058|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
129832893|NCT01549964|467354059|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
129832894|NCT01549964|467354060|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
129832895|NCT01549964|467354061|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
129832896|NCT01549964|467354058|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
129832897|NCT01549964|467354059|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
129832898|NCT01549964|467354060|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
129832899|NCT01549964|467354061|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
129832900|NCT01549964|467354058|FG000|80-Week Extension Period|Lost to Follow-up|1|||
129832901|NCT01549964|467354059|FG001|80-Week Extension Period|Lost to Follow-up|0|||
129832902|NCT01549964|467354060|FG002|80-Week Extension Period|Lost to Follow-up|2|||
129832903|NCT01549964|467354061|FG003|80-Week Extension Period|Lost to Follow-up|1|||
129832904|NCT01549964|467354058|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
129832905|NCT01549964|467354059|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
129832906|NCT01549964|467354060|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
129832907|NCT01549964|467354061|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
129832908|NCT02290821|467354062|FG000|Overall Study|Withdrawal by Subject|1|||
129832909|NCT02290821|467354063|FG001|Overall Study|Withdrawal by Subject|1|||
129832910|NCT02290821|467354062|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
129832911|NCT02290821|467354063|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
129832912|NCT02290821|467354062|FG000|Overall Study|Lost to Follow-up|3|||
129832913|NCT02290821|467354063|FG001|Overall Study|Lost to Follow-up|2|||
129832914|NCT00751348|467354068|FG000|Overall Study|Withdrawal by Subject|5|||
129832915|NCT00751348|467354069|FG001|Overall Study|Withdrawal by Subject|2|||
129832916|NCT00751348|467354068|FG000|Overall Study|Migration from study area|1|||
129832917|NCT00751348|467354069|FG001|Overall Study|Migration from study area|0|||
129832918|NCT02039674|467354072|FG000|Overall Study|Adverse Event|0|||
129832919|NCT02039674|467354073|FG001|Overall Study|Adverse Event|0|||
129832920|NCT02039674|467354074|FG002|Overall Study|Adverse Event|0|||
129832921|NCT02039674|467354075|FG003|Overall Study|Adverse Event|1|||
129832922|NCT02039674|467354076|FG004|Overall Study|Adverse Event|0|||
129832923|NCT02039674|467354077|FG005|Overall Study|Adverse Event|0|||
129832924|NCT02039674|467354078|FG006|Overall Study|Adverse Event|0|||
129445803|NCT00387764|465932929|FG000|Overall Study|Death|7|||
129445804|NCT01184053|465932930|FG000|Overall Study|progression while on treatment|3|||
129832925|NCT02039674|467354079|FG007|Overall Study|Adverse Event|0|||
129832926|NCT02039674|467354080|FG008|Overall Study|Adverse Event|2|||
129445805|NCT04313153|465934526|FG000|Overall Study|Adverse Event (includes Death)|14|||
129445806|NCT04313153|465934527|FG001|Overall Study|Adverse Event (includes Death)|19|||
129445807|NCT04313153|465934528|FG002|Overall Study|Adverse Event (includes Death)|10|||
129445808|NCT04313153|465934526|FG000|Overall Study|Physician Decision|4|||
129832927|NCT02039674|467354081|FG009|Overall Study|Adverse Event|1|||
129832928|NCT02039674|467354082|FG010|Overall Study|Adverse Event|0|||
129832929|NCT02039674|467354083|FG011|Overall Study|Adverse Event|2|||
129832930|NCT02039674|467354084|FG012|Overall Study|Adverse Event|3|||
129832931|NCT02039674|467354085|FG013|Overall Study|Adverse Event|1|||
129832932|NCT02039674|467354072|FG000|Overall Study|Death|2|||
129832933|NCT02039674|467354073|FG001|Overall Study|Death|0|||
129832934|NCT02039674|467354074|FG002|Overall Study|Death|2|||
129832935|NCT02039674|467354075|FG003|Overall Study|Death|3|||
129832936|NCT02039674|467354076|FG004|Overall Study|Death|0|||
129832937|NCT02039674|467354077|FG005|Overall Study|Death|0|||
129832938|NCT02039674|467354078|FG006|Overall Study|Death|1|||
129832939|NCT02039674|467354079|FG007|Overall Study|Death|0|||
129832940|NCT02039674|467354080|FG008|Overall Study|Death|2|||
129832941|NCT02039674|467354081|FG009|Overall Study|Death|0|||
129832942|NCT02039674|467354082|FG010|Overall Study|Death|1|||
129832943|NCT02039674|467354083|FG011|Overall Study|Death|3|||
129832944|NCT02039674|467354084|FG012|Overall Study|Death|2|||
129832945|NCT02039674|467354085|FG013|Overall Study|Death|8|||
129832946|NCT02039674|467354072|FG000|Overall Study|Excluded Medication|1|||
129832947|NCT02039674|467354073|FG001|Overall Study|Excluded Medication|1|||
129832948|NCT02039674|467354074|FG002|Overall Study|Excluded Medication|0|||
129832949|NCT02039674|467354075|FG003|Overall Study|Excluded Medication|1|||
129832950|NCT02039674|467354076|FG004|Overall Study|Excluded Medication|0|||
129832951|NCT02039674|467354077|FG005|Overall Study|Excluded Medication|1|||
129832952|NCT02039674|467354078|FG006|Overall Study|Excluded Medication|0|||
129832953|NCT02039674|467354079|FG007|Overall Study|Excluded Medication|0|||
129832954|NCT02039674|467354080|FG008|Overall Study|Excluded Medication|2|||
129832955|NCT02039674|467354081|FG009|Overall Study|Excluded Medication|3|||
129832956|NCT02039674|467354082|FG010|Overall Study|Excluded Medication|5|||
129832957|NCT02039674|467354083|FG011|Overall Study|Excluded Medication|6|||
129832958|NCT02039674|467354084|FG012|Overall Study|Excluded Medication|8|||
129832959|NCT02039674|467354085|FG013|Overall Study|Excluded Medication|3|||
129832960|NCT02039674|467354072|FG000|Overall Study|Lost to Follow-up|0|||
129832961|NCT02039674|467354073|FG001|Overall Study|Lost to Follow-up|0|||
129832962|NCT02039674|467354074|FG002|Overall Study|Lost to Follow-up|0|||
129832963|NCT02039674|467354075|FG003|Overall Study|Lost to Follow-up|0|||
129832964|NCT02039674|467354076|FG004|Overall Study|Lost to Follow-up|1|||
129832965|NCT02039674|467354077|FG005|Overall Study|Lost to Follow-up|1|||
129832966|NCT02039674|467354078|FG006|Overall Study|Lost to Follow-up|0|||
129832967|NCT02039674|467354079|FG007|Overall Study|Lost to Follow-up|0|||
129832968|NCT02039674|467354080|FG008|Overall Study|Lost to Follow-up|0|||
129832969|NCT02039674|467354081|FG009|Overall Study|Lost to Follow-up|0|||
129832970|NCT02039674|467354082|FG010|Overall Study|Lost to Follow-up|0|||
129832971|NCT02039674|467354083|FG011|Overall Study|Lost to Follow-up|2|||
129832972|NCT02039674|467354084|FG012|Overall Study|Lost to Follow-up|2|||
129832973|NCT02039674|467354085|FG013|Overall Study|Lost to Follow-up|1|||
129832974|NCT02039674|467354072|FG000|Overall Study|Physician Decision|0|||
129832975|NCT02039674|467354073|FG001|Overall Study|Physician Decision|0|||
129832976|NCT02039674|467354074|FG002|Overall Study|Physician Decision|0|||
129832977|NCT02039674|467354075|FG003|Overall Study|Physician Decision|0|||
129832978|NCT02039674|467354076|FG004|Overall Study|Physician Decision|0|||
129832979|NCT02039674|467354077|FG005|Overall Study|Physician Decision|0|||
129832980|NCT02039674|467354078|FG006|Overall Study|Physician Decision|0|||
129832981|NCT02039674|467354079|FG007|Overall Study|Physician Decision|0|||
129832982|NCT02039674|467354080|FG008|Overall Study|Physician Decision|0|||
129832983|NCT02039674|467354081|FG009|Overall Study|Physician Decision|0|||
129832984|NCT02039674|467354082|FG010|Overall Study|Physician Decision|0|||
129832985|NCT02039674|467354083|FG011|Overall Study|Physician Decision|1|||
129832986|NCT02039674|467354084|FG012|Overall Study|Physician Decision|1|||
129832987|NCT02039674|467354085|FG013|Overall Study|Physician Decision|0|||
129832988|NCT02039674|467354072|FG000|Overall Study|Progressive Disease|8|||
129832989|NCT02039674|467354073|FG001|Overall Study|Progressive Disease|8|||
129832990|NCT02039674|467354074|FG002|Overall Study|Progressive Disease|6|||
129832991|NCT02039674|467354075|FG003|Overall Study|Progressive Disease|7|||
129832992|NCT02039674|467354076|FG004|Overall Study|Progressive Disease|9|||
129832993|NCT02039674|467354077|FG005|Overall Study|Progressive Disease|10|||
129832994|NCT02039674|467354078|FG006|Overall Study|Progressive Disease|1|||
129832995|NCT02039674|467354079|FG007|Overall Study|Progressive Disease|3|||
129832996|NCT02039674|467354080|FG008|Overall Study|Progressive Disease|6|||
129832997|NCT02039674|467354081|FG009|Overall Study|Progressive Disease|4|||
129832998|NCT02039674|467354082|FG010|Overall Study|Progressive Disease|0|||
129832999|NCT02039674|467354083|FG011|Overall Study|Progressive Disease|34|||
129833000|NCT02039674|467354084|FG012|Overall Study|Progressive Disease|34|||
129833001|NCT02039674|467354085|FG013|Overall Study|Progressive Disease|18|||
129833002|NCT02039674|467354072|FG000|Overall Study|Withdrawal by Subject|1|||
129833003|NCT02039674|467354073|FG001|Overall Study|Withdrawal by Subject|2|||
129833004|NCT02039674|467354074|FG002|Overall Study|Withdrawal by Subject|3|||
129833005|NCT02039674|467354075|FG003|Overall Study|Withdrawal by Subject|0|||
129833006|NCT02039674|467354076|FG004|Overall Study|Withdrawal by Subject|1|||
129833007|NCT02039674|467354077|FG005|Overall Study|Withdrawal by Subject|0|||
129833008|NCT02039674|467354078|FG006|Overall Study|Withdrawal by Subject|0|||
129833009|NCT02039674|467354079|FG007|Overall Study|Withdrawal by Subject|0|||
129833010|NCT02039674|467354080|FG008|Overall Study|Withdrawal by Subject|0|||
129833011|NCT02039674|467354081|FG009|Overall Study|Withdrawal by Subject|1|||
129833012|NCT02039674|467354082|FG010|Overall Study|Withdrawal by Subject|1|||
129833013|NCT02039674|467354083|FG011|Overall Study|Withdrawal by Subject|4|||
129833014|NCT02039674|467354084|FG012|Overall Study|Withdrawal by Subject|6|||
129833015|NCT02039674|467354085|FG013|Overall Study|Withdrawal by Subject|2|||
129833016|NCT02039674|467354072|FG000|Overall Study|Clinical Progression|0|||
129833017|NCT02039674|467354073|FG001|Overall Study|Clinical Progression|0|||
129833018|NCT02039674|467354074|FG002|Overall Study|Clinical Progression|0|||
129833019|NCT02039674|467354075|FG003|Overall Study|Clinical Progression|0|||
129833020|NCT02039674|467354076|FG004|Overall Study|Clinical Progression|0|||
129833021|NCT02039674|467354077|FG005|Overall Study|Clinical Progression|0|||
129833022|NCT02039674|467354078|FG006|Overall Study|Clinical Progression|1|||
129833023|NCT02039674|467354079|FG007|Overall Study|Clinical Progression|0|||
129833024|NCT02039674|467354080|FG008|Overall Study|Clinical Progression|0|||
129833025|NCT02039674|467354081|FG009|Overall Study|Clinical Progression|0|||
129833026|NCT02039674|467354082|FG010|Overall Study|Clinical Progression|0|||
129833027|NCT02039674|467354083|FG011|Overall Study|Clinical Progression|0|||
129833028|NCT02039674|467354084|FG012|Overall Study|Clinical Progression|1|||
129833029|NCT02039674|467354085|FG013|Overall Study|Clinical Progression|0|||
129833030|NCT02039674|467354072|FG000|Overall Study|Sponsor Decision|1|||
129833031|NCT02039674|467354073|FG001|Overall Study|Sponsor Decision|1|||
129833032|NCT02039674|467354074|FG002|Overall Study|Sponsor Decision|1|||
129833033|NCT02039674|467354075|FG003|Overall Study|Sponsor Decision|1|||
129833034|NCT02039674|467354076|FG004|Overall Study|Sponsor Decision|1|||
129833035|NCT02039674|467354077|FG005|Overall Study|Sponsor Decision|0|||
129833036|NCT02039674|467354078|FG006|Overall Study|Sponsor Decision|0|||
129833037|NCT02039674|467354079|FG007|Overall Study|Sponsor Decision|0|||
129833038|NCT02039674|467354080|FG008|Overall Study|Sponsor Decision|0|||
129833039|NCT02039674|467354081|FG009|Overall Study|Sponsor Decision|3|||
129833040|NCT02039674|467354082|FG010|Overall Study|Sponsor Decision|0|||
129833041|NCT02039674|467354083|FG011|Overall Study|Sponsor Decision|8|||
129833042|NCT02039674|467354084|FG012|Overall Study|Sponsor Decision|5|||
129833043|NCT02039674|467354085|FG013|Overall Study|Sponsor Decision|0|||
129833044|NCT02039674|467354072|FG000|Overall Study|Other|0|||
129833045|NCT02039674|467354073|FG001|Overall Study|Other|0|||
129833046|NCT02039674|467354074|FG002|Overall Study|Other|0|||
129833047|NCT02039674|467354075|FG003|Overall Study|Other|0|||
129833048|NCT02039674|467354076|FG004|Overall Study|Other|0|||
129833049|NCT02039674|467354077|FG005|Overall Study|Other|0|||
129833050|NCT02039674|467354078|FG006|Overall Study|Other|0|||
129833051|NCT02039674|467354079|FG007|Overall Study|Other|0|||
129833052|NCT02039674|467354080|FG008|Overall Study|Other|0|||
129833053|NCT02039674|467354081|FG009|Overall Study|Other|0|||
129833054|NCT02039674|467354082|FG010|Overall Study|Other|0|||
129833055|NCT02039674|467354083|FG011|Overall Study|Other|0|||
129833056|NCT02039674|467354084|FG012|Overall Study|Other|1|||
129833057|NCT02039674|467354085|FG013|Overall Study|Other|0|||
129833058|NCT01826487|467354086|FG000|Overall Study|Adverse Event|1|||
129833059|NCT01826487|467354087|FG001|Overall Study|Adverse Event|1|||
129833060|NCT01826487|467354086|FG000|Overall Study|Lost to Follow-up|1|||
129833061|NCT01826487|467354087|FG001|Overall Study|Lost to Follow-up|0|||
129833062|NCT01826487|467354086|FG000|Overall Study|Withdrawal by Subject|1|||
129833063|NCT01826487|467354087|FG001|Overall Study|Withdrawal by Subject|3|||
129833064|NCT01826487|467354086|FG000|Overall Study|Protocol Violation|1|||
129833065|NCT01826487|467354087|FG001|Overall Study|Protocol Violation|1|||
129833066|NCT01358357|467354088|FG000|Open Label Phase|Adverse Event|0|||
129833067|NCT01358357|467354089|FG001|Open Label Phase|Adverse Event|0|||
129833068|NCT01358357|467354090|FG002|Open Label Phase|Adverse Event|59|||
129833069|NCT01358357|467354088|FG000|Open Label Phase|Lack of Efficacy|0|||
129833070|NCT01358357|467354089|FG001|Open Label Phase|Lack of Efficacy|0|||
129833071|NCT01358357|467354090|FG002|Open Label Phase|Lack of Efficacy|107|||
129833072|NCT01358357|467354088|FG000|Open Label Phase|Lost to Follow-up|0|||
129833073|NCT01358357|467354089|FG001|Open Label Phase|Lost to Follow-up|0|||
129833074|NCT01358357|467354090|FG002|Open Label Phase|Lost to Follow-up|76|||
129833075|NCT01358357|467354088|FG000|Open Label Phase|Protocol Violation|0|||
129833076|NCT01358357|467354089|FG001|Open Label Phase|Protocol Violation|0|||
129833077|NCT01358357|467354090|FG002|Open Label Phase|Protocol Violation|45|||
129833078|NCT01358357|467354088|FG000|Open Label Phase|Withdrawal by Subject|0|||
129833079|NCT01358357|467354089|FG001|Open Label Phase|Withdrawal by Subject|0|||
129833080|NCT01358357|467354090|FG002|Open Label Phase|Withdrawal by Subject|112|||
129833081|NCT01358357|467354088|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
129833082|NCT01358357|467354089|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
129833083|NCT01358357|467354090|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
129833084|NCT01358357|467354088|FG000|Open Label Phase|Terminated at study completion|0|||
129445809|NCT04313153|465934527|FG001|Overall Study|Physician Decision|2|||
129445810|NCT04313153|465934528|FG002|Overall Study|Physician Decision|1|||
129833085|NCT01358357|467354089|FG001|Open Label Phase|Terminated at study completion|0|||
129833086|NCT01358357|467354090|FG002|Open Label Phase|Terminated at study completion|5|||
129833087|NCT01358357|467354088|FG000|Open Label Phase|Mood episode|0|||
129833088|NCT01358357|467354089|FG001|Open Label Phase|Mood episode|0|||
129833089|NCT01358357|467354090|FG002|Open Label Phase|Mood episode|42|||
129833090|NCT01358357|467354088|FG000|Double-Blind Phase|Adverse Event|8|||
129833091|NCT01358357|467354089|FG001|Double-Blind Phase|Adverse Event|5|||
129833092|NCT01358357|467354090|FG002|Double-Blind Phase|Adverse Event|0|||
129833093|NCT01358357|467354088|FG000|Double-Blind Phase|Lost to Follow-up|5|||
129833094|NCT01358357|467354089|FG001|Double-Blind Phase|Lost to Follow-up|7|||
129833095|NCT01358357|467354090|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129833096|NCT01358357|467354088|FG000|Double-Blind Phase|Protocol Violation|1|||
129833097|NCT01358357|467354089|FG001|Double-Blind Phase|Protocol Violation|11|||
129833098|NCT01358357|467354090|FG002|Double-Blind Phase|Protocol Violation|0|||
129833099|NCT01358357|467354088|FG000|Double-Blind Phase|Protocol Violation|16|||
129833100|NCT01358357|467354089|FG001|Double-Blind Phase|Protocol Violation|12|||
129833101|NCT01358357|467354090|FG002|Double-Blind Phase|Protocol Violation|0|||
129833102|NCT01358357|467354088|FG000|Double-Blind Phase|Terminated at study completion|2|||
129833103|NCT01358357|467354089|FG001|Double-Blind Phase|Terminated at study completion|0|||
129833104|NCT01358357|467354090|FG002|Double-Blind Phase|Terminated at study completion|0|||
129833105|NCT01358357|467354088|FG000|Double-Blind Phase|Recurrence of mood event|48|||
129833106|NCT01358357|467354089|FG001|Double-Blind Phase|Recurrence of mood event|64|||
129833107|NCT01358357|467354090|FG002|Double-Blind Phase|Recurrence of mood event|0|||
129833108|NCT01358357|467354088|FG000|Double-Blind Phase|Administrative|0|||
129833109|NCT01358357|467354089|FG001|Double-Blind Phase|Administrative|1|||
129833110|NCT01358357|467354090|FG002|Double-Blind Phase|Administrative|0|||
129833111|NCT02136576|467354091|FG000|Overall Study|Lost to Follow-up|2|||
129833112|NCT02136576|467354092|FG001|Overall Study|Lost to Follow-up|0|||
129833113|NCT02136576|467354093|FG002|Overall Study|Lost to Follow-up|0|||
129833114|NCT00537381|467354094|FG000|Overall Study|Adverse Event|13|||
129833115|NCT00537381|467354095|FG001|Overall Study|Adverse Event|9|||
129833116|NCT00537381|467354094|FG000|Overall Study|Death|3|||
129833117|NCT00537381|467354095|FG001|Overall Study|Death|3|||
129833118|NCT00537381|467354094|FG000|Overall Study|Withdrawal by Subject|5|||
129833119|NCT00537381|467354095|FG001|Overall Study|Withdrawal by Subject|14|||
129833120|NCT00537381|467354094|FG000|Overall Study|Physician Decision|7|||
129833121|NCT00537381|467354095|FG001|Overall Study|Physician Decision|6|||
129833122|NCT00537381|467354094|FG000|Overall Study|Disease Progression|9|||
129833123|NCT00537381|467354095|FG001|Overall Study|Disease Progression|18|||
129833124|NCT00537381|467354094|FG000|Overall Study|Sponsor decision|14|||
129833125|NCT00537381|467354095|FG001|Overall Study|Sponsor decision|9|||
129833126|NCT00537381|467354094|FG000|Overall Study|Other|5|||
129833127|NCT00537381|467354095|FG001|Overall Study|Other|3|||
129833128|NCT02590939|467354096|FG000|Overall Study|Withdrawal by Subject|3|||
129833129|NCT02590939|467354097|FG001|Overall Study|Withdrawal by Subject|1|||
129833130|NCT02590939|467354096|FG000|Overall Study|Failed the nociceptive test|2|||
129833131|NCT02590939|467354097|FG001|Overall Study|Failed the nociceptive test|1|||
129833132|NCT02081079|467354099|FG000|Overall Study|Lack of Efficacy|3|||
129833133|NCT02081079|467354100|FG001|Overall Study|Lack of Efficacy|2|||
129833134|NCT02081079|467354099|FG000|Overall Study|Lost to Follow-up|1|||
129833135|NCT02081079|467354100|FG001|Overall Study|Lost to Follow-up|0|||
129833136|NCT02225743|467354101|FG000|Overall Study|Withdrawal by Subject|18|||
129833137|NCT00729183|467354106|FG000|Overall Study|Adverse Event|11|||
129833138|NCT00729183|467354107|FG001|Overall Study|Adverse Event|5|||
129833139|NCT00729183|467354106|FG000|Overall Study|Lack of Efficacy|0|||
129833140|NCT00729183|467354107|FG001|Overall Study|Lack of Efficacy|1|||
129833141|NCT00729183|467354106|FG000|Overall Study|Lost to Follow-up|3|||
129833142|NCT00729183|467354107|FG001|Overall Study|Lost to Follow-up|1|||
129833143|NCT00729183|467354106|FG000|Overall Study|Physician Decision|1|||
129833144|NCT00729183|467354107|FG001|Overall Study|Physician Decision|1|||
129833145|NCT00729183|467354106|FG000|Overall Study|Protocol Violation|1|||
129833146|NCT00729183|467354107|FG001|Overall Study|Protocol Violation|0|||
129833147|NCT00729183|467354106|FG000|Overall Study|Withdrawal by Subject|9|||
129833148|NCT00729183|467354107|FG001|Overall Study|Withdrawal by Subject|7|||
129833149|NCT02867709|467354110|FG000|Treatment Period|Adverse Event|1|||
129833150|NCT02867709|467354111|FG001|Treatment Period|Adverse Event|1|||
129833151|NCT02867709|467354112|FG002|Treatment Period|Adverse Event|2|||
129833152|NCT02867709|467354110|FG000|Treatment Period|Withdrawal of Consent|7|||
129833153|NCT02867709|467354111|FG001|Treatment Period|Withdrawal of Consent|9|||
129833154|NCT02867709|467354112|FG002|Treatment Period|Withdrawal of Consent|8|||
129833155|NCT02867709|467354110|FG000|Treatment Period|Lost to Follow-up|17|||
129833156|NCT02867709|467354111|FG001|Treatment Period|Lost to Follow-up|20|||
129833157|NCT02867709|467354112|FG002|Treatment Period|Lost to Follow-up|20|||
129445811|NCT04313153|465934526|FG000|Overall Study|Withdrawal by Subject|7|||
129833158|NCT02867709|467354110|FG000|Treatment Period|Lack of Qualifying Event|42|||
129833159|NCT02867709|467354111|FG001|Treatment Period|Lack of Qualifying Event|55|||
129833160|NCT02867709|467354112|FG002|Treatment Period|Lack of Qualifying Event|42|||
129833161|NCT02867709|467354110|FG000|Treatment Period|Protocol Violation|3|||
129833162|NCT02867709|467354111|FG001|Treatment Period|Protocol Violation|2|||
129833163|NCT02867709|467354112|FG002|Treatment Period|Protocol Violation|3|||
129833164|NCT02867709|467354110|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
129833165|NCT02867709|467354111|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
129833166|NCT02867709|467354112|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
129833167|NCT02867709|467354110|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
129833168|NCT02867709|467354111|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
129833169|NCT02867709|467354112|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
129833170|NCT02867709|467354110|FG000|Safety Follow-up Period|Pregnancy|0|||
129833171|NCT02867709|467354111|FG001|Safety Follow-up Period|Pregnancy|1|||
129833172|NCT02867709|467354112|FG002|Safety Follow-up Period|Pregnancy|0|||
129833173|NCT02867709|467354110|FG000|Safety Follow-up Period|Protocol Violation|0|||
129833174|NCT02867709|467354111|FG001|Safety Follow-up Period|Protocol Violation|1|||
129833175|NCT02867709|467354112|FG002|Safety Follow-up Period|Protocol Violation|1|||
129833176|NCT05497284|467354113|FG000|Overall Study|Adverse Event|1|||
129833177|NCT05497284|467354114|FG001|Overall Study|Adverse Event|0|||
129833178|NCT05497284|467354113|FG000|Overall Study|Physician Decision|0|||
129833179|NCT05497284|467354114|FG001|Overall Study|Physician Decision|1|||
129833180|NCT05497284|467354113|FG000|Overall Study|Study terminated by sponsor|7|||
129833181|NCT05497284|467354114|FG001|Overall Study|Study terminated by sponsor|4|||
129833182|NCT05497284|467354113|FG000|Overall Study|Subject Decision|0|||
129833183|NCT05497284|467354114|FG001|Overall Study|Subject Decision|1|||
129833184|NCT03878446|467354115|FG000|Overall Study|Withdrawn by parent or guardian|1|||
129833185|NCT03878446|467354116|FG001|Overall Study|Withdrawn by parent or guardian|0|||
129833186|NCT03878446|467354117|FG002|Overall Study|Withdrawn by parent or guardian|0|||
129833187|NCT03878446|467354118|FG003|Overall Study|Withdrawn by parent or guardian|0|||
129833188|NCT03878446|467354119|FG004|Overall Study|Withdrawn by parent or guardian|0|||
129833189|NCT05041322|467354120|FG000|Baseline|Withdrawal by Subject|1|||
129833190|NCT05041322|467354121|FG001|Baseline|Withdrawal by Subject|0|||
129833191|NCT05041322|467354120|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
129833192|NCT05041322|467354121|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
129833193|NCT05041322|467354120|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
129833194|NCT05041322|467354121|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
129833195|NCT01502423|467354122|FG000|Overall Study|Withdrawal by Subject|0|||
129833196|NCT01502423|467354123|FG001|Overall Study|Withdrawal by Subject|1|||
129833197|NCT00567892|467354124|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833198|NCT00567892|467354125|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833199|NCT00567892|467354126|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
129833200|NCT00567892|467354127|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
129833201|NCT00567892|467354124|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833202|NCT00567892|467354125|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833203|NCT00567892|467354126|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
129833204|NCT00567892|467354127|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
129833205|NCT04383743|467354128|FG000|Overall Study|Withdrawal by Subject|1|||
129833206|NCT04383743|467354128|FG000|Overall Study|Adverse Event|1|||
129833207|NCT04837131|467354129|FG000|Overall Study|Death|1|||
129833208|NCT04837131|467354129|FG000|Overall Study|Withdrawal by Subject|1|||
129833209|NCT04837131|467354129|FG000|Overall Study|Adverse Event|1|||
129833210|NCT04837131|467354129|FG000|Overall Study|Protocol Violation|1|||
129833211|NCT04709575|467355526|FG000|Overall Study|Withdrawal by Subject|6|||
129833212|NCT04709575|467355527|FG001|Overall Study|Withdrawal by Subject|2|||
129833213|NCT04709575|467355526|FG000|Overall Study|Lost to Follow-up|2|||
129833214|NCT04709575|467355527|FG001|Overall Study|Lost to Follow-up|2|||
129833215|NCT04709575|467355526|FG000|Overall Study|Adverse Event|1|||
129833216|NCT04709575|467355527|FG001|Overall Study|Adverse Event|0|||
129833217|NCT04709575|467355526|FG000|Overall Study|Protocol Violation|1|||
129833218|NCT04709575|467355527|FG001|Overall Study|Protocol Violation|1|||
129833219|NCT03181399|467355528|FG000|6 Months on Treatment|Protocol non-compliance|7|||
129833220|NCT03181399|467355528|FG000|6 Months on Treatment|Adverse Event|4|||
129833221|NCT03181399|467355528|FG000|6 Months on Treatment|Tried alternative treatment|2|||
129833222|NCT03181399|467355528|FG000|6 Months on Treatment|Lost to Follow-up|2|||
129833223|NCT03181399|467355528|FG000|6 Months on Treatment|Personal reasons|1|||
129445812|NCT04313153|465934527|FG001|Overall Study|Withdrawal by Subject|6|||
129833224|NCT03181399|467355528|FG000|3 Months Off-treatment|Parent unable to travel|1|||
129833225|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
129445813|NCT04313153|465934528|FG002|Overall Study|Withdrawal by Subject|2|||
129445814|NCT04313153|465934526|FG000|Overall Study|Lack of Efficacy|3|||
129445815|NCT04313153|465934527|FG001|Overall Study|Lack of Efficacy|3|||
129445816|NCT04313153|465934528|FG002|Overall Study|Lack of Efficacy|0|||
129833226|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
129833227|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
129445817|NCT04313153|465934526|FG000|Overall Study|Lost to Follow-up|1|||
129833228|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
129833229|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
129833230|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
129833231|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
129833232|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
129833233|NCT01541969|467355533|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
129833234|NCT01541969|467355534|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
129833235|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
129833236|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
129833237|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
129833238|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
129833239|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
129833240|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
129833241|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
129833242|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
129833243|NCT01541969|467355533|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
129833244|NCT01541969|467355534|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
129833245|NCT05123222|467355535|FG000|Overall Study|Lost to Follow-up|2|||
129833246|NCT05123222|467355536|FG001|Overall Study|Lost to Follow-up|0|||
129833247|NCT05123222|467355537|FG002|Overall Study|Lost to Follow-up|0|||
129833248|NCT05123222|467355538|FG003|Overall Study|Lost to Follow-up|0|||
129833249|NCT05123222|467355535|FG000|Overall Study|Protocol Violation|0|||
129833250|NCT05123222|467355536|FG001|Overall Study|Protocol Violation|0|||
129833251|NCT05123222|467355537|FG002|Overall Study|Protocol Violation|1|||
129833252|NCT05123222|467355538|FG003|Overall Study|Protocol Violation|0|||
129833253|NCT02255500|467355543|FG000|Overall Study|Withdrawal by Subject|1|||
129833254|NCT02255500|467355544|FG001|Overall Study|Withdrawal by Subject|0|||
129833255|NCT00265343|467355545|FG000|Overall Study|Adverse Event|10|||
129833256|NCT00265343|467355546|FG001|Overall Study|Adverse Event|7|||
129833257|NCT00265343|467355545|FG000|Overall Study|Withdrawal by Subject|3|||
129833258|NCT00265343|467355546|FG001|Overall Study|Withdrawal by Subject|9|||
129833259|NCT00265343|467355545|FG000|Overall Study|Other|8|||
129833260|NCT00265343|467355546|FG001|Overall Study|Other|3|||
129833261|NCT04865354|467355547|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
129833262|NCT04865354|467355548|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
129833263|NCT04865354|467355547|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
129833264|NCT04865354|467355548|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
129833265|NCT04865354|467355547|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
129833266|NCT04865354|467355548|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
129833267|NCT00588822|467355553|FG000|Overall Study|progression of disease|8|||
129833268|NCT03616912|467355560|FG000|Overall Study|Adverse Event|17|||
129833269|NCT03616912|467355561|FG001|Overall Study|Adverse Event|21|||
129833270|NCT03616912|467355562|FG002|Overall Study|Adverse Event|9|||
129833271|NCT03616912|467355563|FG003|Overall Study|Adverse Event|0|||
129833272|NCT03616912|467355564|FG004|Overall Study|Adverse Event|0|||
129833273|NCT03616912|467355565|FG005|Overall Study|Adverse Event|0|||
129833274|NCT03616912|467355560|FG000|Overall Study|Death|1|||
129833275|NCT03616912|467355561|FG001|Overall Study|Death|1|||
129833276|NCT03616912|467355562|FG002|Overall Study|Death|0|||
129833277|NCT03616912|467355563|FG003|Overall Study|Death|0|||
129833278|NCT03616912|467355564|FG004|Overall Study|Death|0|||
129445818|NCT04313153|465934527|FG001|Overall Study|Lost to Follow-up|0|||
129445819|NCT04313153|465934528|FG002|Overall Study|Lost to Follow-up|2|||
129833279|NCT03616912|467355565|FG005|Overall Study|Death|0|||
129833280|NCT03616912|467355560|FG000|Overall Study|Lack of Efficacy|13|||
129833281|NCT03616912|467355561|FG001|Overall Study|Lack of Efficacy|6|||
129833282|NCT03616912|467355562|FG002|Overall Study|Lack of Efficacy|8|||
129833283|NCT03616912|467355563|FG003|Overall Study|Lack of Efficacy|4|||
129833284|NCT03616912|467355564|FG004|Overall Study|Lack of Efficacy|5|||
129833285|NCT03616912|467355565|FG005|Overall Study|Lack of Efficacy|1|||
129833286|NCT03616912|467355560|FG000|Overall Study|Lost to Follow-up|1|||
129833287|NCT03616912|467355561|FG001|Overall Study|Lost to Follow-up|2|||
129897725|NCT00299702|467584438|FG000|Overall Study|Adverse Event|0|||
129833288|NCT03616912|467355562|FG002|Overall Study|Lost to Follow-up|3|||
129445820|NCT04313153|465934526|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
129833289|NCT03616912|467355563|FG003|Overall Study|Lost to Follow-up|0|||
129833290|NCT03616912|467355564|FG004|Overall Study|Lost to Follow-up|0|||
129897726|NCT00299702|467584439|FG001|Overall Study|Adverse Event|4|||
129833291|NCT03616912|467355565|FG005|Overall Study|Lost to Follow-up|0|||
129833292|NCT03616912|467355560|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
129833293|NCT03616912|467355561|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
129833294|NCT03616912|467355562|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
129833295|NCT03616912|467355563|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
129833296|NCT03616912|467355564|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
129833297|NCT03616912|467355565|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
129833298|NCT03616912|467355560|FG000|Overall Study|Withdrawal by Subject|12|||
129833299|NCT03616912|467355561|FG001|Overall Study|Withdrawal by Subject|12|||
129833300|NCT03616912|467355562|FG002|Overall Study|Withdrawal by Subject|15|||
129833301|NCT03616912|467355563|FG003|Overall Study|Withdrawal by Subject|2|||
129833302|NCT03616912|467355564|FG004|Overall Study|Withdrawal by Subject|0|||
129833303|NCT03616912|467355565|FG005|Overall Study|Withdrawal by Subject|2|||
129833304|NCT03616912|467355560|FG000|Overall Study|Study Terminated by Sponsor|0|||
129833305|NCT03616912|467355561|FG001|Overall Study|Study Terminated by Sponsor|0|||
129833306|NCT03616912|467355562|FG002|Overall Study|Study Terminated by Sponsor|0|||
129833307|NCT03616912|467355563|FG003|Overall Study|Study Terminated by Sponsor|10|||
129833308|NCT03616912|467355564|FG004|Overall Study|Study Terminated by Sponsor|9|||
129833309|NCT03616912|467355565|FG005|Overall Study|Study Terminated by Sponsor|11|||
129833310|NCT03616912|467355560|FG000|Overall Study|Protocol Deviation|1|||
129833311|NCT03616912|467355561|FG001|Overall Study|Protocol Deviation|1|||
129833312|NCT03616912|467355562|FG002|Overall Study|Protocol Deviation|0|||
129833313|NCT03616912|467355563|FG003|Overall Study|Protocol Deviation|0|||
129833314|NCT03616912|467355564|FG004|Overall Study|Protocol Deviation|0|||
129833315|NCT03616912|467355565|FG005|Overall Study|Protocol Deviation|0|||
129833316|NCT03616912|467355560|FG000|Overall Study|Pregnancy|1|||
129833317|NCT03616912|467355561|FG001|Overall Study|Pregnancy|0|||
129833318|NCT03616912|467355562|FG002|Overall Study|Pregnancy|4|||
129833319|NCT03616912|467355563|FG003|Overall Study|Pregnancy|0|||
129833320|NCT03616912|467355564|FG004|Overall Study|Pregnancy|0|||
129833321|NCT03616912|467355565|FG005|Overall Study|Pregnancy|0|||
129833322|NCT03616912|467355560|FG000|Overall Study|Protocol Violation|1|||
129833323|NCT03616912|467355561|FG001|Overall Study|Protocol Violation|0|||
129833324|NCT03616912|467355562|FG002|Overall Study|Protocol Violation|2|||
129833325|NCT03616912|467355563|FG003|Overall Study|Protocol Violation|0|||
129833326|NCT03616912|467355564|FG004|Overall Study|Protocol Violation|0|||
129833327|NCT03616912|467355565|FG005|Overall Study|Protocol Violation|0|||
129833328|NCT03616912|467355560|FG000|Overall Study|Physician Decision|2|||
129833329|NCT03616912|467355561|FG001|Overall Study|Physician Decision|0|||
129833330|NCT03616912|467355562|FG002|Overall Study|Physician Decision|0|||
129833331|NCT03616912|467355563|FG003|Overall Study|Physician Decision|0|||
129833332|NCT03616912|467355564|FG004|Overall Study|Physician Decision|1|||
129833333|NCT03616912|467355565|FG005|Overall Study|Physician Decision|0|||
129833334|NCT03616912|467355560|FG000|Overall Study|Randomized But Never Treated|0|||
129833335|NCT03616912|467355561|FG001|Overall Study|Randomized But Never Treated|2|||
129833336|NCT03616912|467355562|FG002|Overall Study|Randomized But Never Treated|0|||
129833337|NCT03616912|467355563|FG003|Overall Study|Randomized But Never Treated|0|||
129833338|NCT03616912|467355564|FG004|Overall Study|Randomized But Never Treated|0|||
129833339|NCT03616912|467355565|FG005|Overall Study|Randomized But Never Treated|0|||
129833340|NCT01649375|467355566|FG000|Up to Week 16|Adverse Event|2|||
129833341|NCT01649375|467355567|FG001|Up to Week 16|Adverse Event|5|||
129833342|NCT01649375|467355568|FG002|Up to Week 16|Adverse Event|4|||
129833343|NCT01649375|467355569|FG003|Up to Week 16|Adverse Event|0|||
129833344|NCT01649375|467355570|FG004|Up to Week 16|Adverse Event|0|||
129833345|NCT01649375|467355566|FG000|Up to Week 16|Lack of Efficacy|0|||
129833346|NCT01649375|467355567|FG001|Up to Week 16|Lack of Efficacy|0|||
129833347|NCT01649375|467355568|FG002|Up to Week 16|Lack of Efficacy|1|||
129833348|NCT01649375|467355569|FG003|Up to Week 16|Lack of Efficacy|0|||
129833349|NCT01649375|467355570|FG004|Up to Week 16|Lack of Efficacy|0|||
129833350|NCT01649375|467355566|FG000|Up to Week 16|Physician Decision|0|||
129833351|NCT01649375|467355567|FG001|Up to Week 16|Physician Decision|0|||
129833352|NCT01649375|467355568|FG002|Up to Week 16|Physician Decision|1|||
129833353|NCT01649375|467355569|FG003|Up to Week 16|Physician Decision|0|||
129833354|NCT01649375|467355570|FG004|Up to Week 16|Physician Decision|0|||
129833355|NCT01649375|467355566|FG000|Up to Week 16|Withdrawal by Subject|2|||
129833356|NCT01649375|467355567|FG001|Up to Week 16|Withdrawal by Subject|1|||
129833357|NCT01649375|467355568|FG002|Up to Week 16|Withdrawal by Subject|2|||
129833358|NCT01649375|467355569|FG003|Up to Week 16|Withdrawal by Subject|0|||
129833359|NCT01649375|467355570|FG004|Up to Week 16|Withdrawal by Subject|0|||
129833360|NCT01649375|467355566|FG000|Up to Week 16|Death|1|||
129833361|NCT01649375|467355567|FG001|Up to Week 16|Death|0|||
129833362|NCT01649375|467355568|FG002|Up to Week 16|Death|0|||
129833363|NCT01649375|467355569|FG003|Up to Week 16|Death|0|||
129445821|NCT04313153|465934527|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
129445822|NCT04313153|465934528|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
129445823|NCT04313153|465934526|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
129445824|NCT04313153|465934527|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
129445825|NCT04313153|465934528|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
129445826|NCT04313153|465934526|FG000|Overall Study|Change in Dialysis Modality|0|||
129445827|NCT04313153|465934527|FG001|Overall Study|Change in Dialysis Modality|1|||
129445828|NCT04313153|465934528|FG002|Overall Study|Change in Dialysis Modality|2|||
129445829|NCT04313153|465934526|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
129445830|NCT04313153|465934527|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
129445831|NCT04313153|465934528|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
129445832|NCT04313153|465934526|FG000|Overall Study|Other|5|||
129445833|NCT04313153|465934527|FG001|Overall Study|Other|3|||
129445834|NCT04313153|465934528|FG002|Overall Study|Other|2|||
129445835|NCT04641299|465934529|FG000|Overall Study|Adverse Event|0|||
129445836|NCT04641299|465934530|FG001|Overall Study|Adverse Event|0|||
129445837|NCT04641299|465934531|FG002|Overall Study|Adverse Event|2|||
129445838|NCT04641299|465934532|FG003|Overall Study|Adverse Event|0|||
129445839|NCT04641299|465934529|FG000|Overall Study|Lost to Follow-up|0|||
129445840|NCT04641299|465934530|FG001|Overall Study|Lost to Follow-up|1|||
129445841|NCT04641299|465934531|FG002|Overall Study|Lost to Follow-up|0|||
129445842|NCT04641299|465934532|FG003|Overall Study|Lost to Follow-up|0|||
129445843|NCT04641299|465934529|FG000|Overall Study|Withdrawal by Subject|1|||
129445844|NCT04641299|465934530|FG001|Overall Study|Withdrawal by Subject|0|||
129833364|NCT01649375|467355570|FG004|Up to Week 16|Death|0|||
129833365|NCT01649375|467355566|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
129833366|NCT01649375|467355567|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
129833367|NCT01649375|467355568|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
129833368|NCT01649375|467355569|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
129833369|NCT01649375|467355570|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
129833370|NCT01649375|467355566|FG000|Week 16 up to Week 260|Non-compliance|0|||
129833371|NCT01649375|467355567|FG001|Week 16 up to Week 260|Non-compliance|1|||
129833372|NCT01649375|467355568|FG002|Week 16 up to Week 260|Non-compliance|0|||
129833373|NCT01649375|467355569|FG003|Week 16 up to Week 260|Non-compliance|1|||
129833374|NCT01649375|467355570|FG004|Week 16 up to Week 260|Non-compliance|0|||
129833375|NCT01649375|467355566|FG000|Week 16 up to Week 260|Physician Decision|0|||
129833376|NCT01649375|467355567|FG001|Week 16 up to Week 260|Physician Decision|2|||
129833377|NCT01649375|467355568|FG002|Week 16 up to Week 260|Physician Decision|0|||
129833378|NCT01649375|467355569|FG003|Week 16 up to Week 260|Physician Decision|0|||
129833379|NCT01649375|467355570|FG004|Week 16 up to Week 260|Physician Decision|0|||
129833380|NCT01649375|467355566|FG000|Week 16 up to Week 260|Technical issues|0|||
129833381|NCT01649375|467355567|FG001|Week 16 up to Week 260|Technical issues|1|||
129833382|NCT01649375|467355568|FG002|Week 16 up to Week 260|Technical issues|0|||
129833383|NCT01649375|467355569|FG003|Week 16 up to Week 260|Technical issues|1|||
129833384|NCT01649375|467355570|FG004|Week 16 up to Week 260|Technical issues|0|||
129833385|NCT01649375|467355566|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
129445845|NCT04641299|465934531|FG002|Overall Study|Withdrawal by Subject|0|||
129445846|NCT04641299|465934532|FG003|Overall Study|Withdrawal by Subject|0|||
129445847|NCT04641299|465934529|FG000|Overall Study|Reason not given|1|||
129445848|NCT04641299|465934530|FG001|Overall Study|Reason not given|0|||
129833386|NCT01649375|467355567|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
129833387|NCT01649375|467355568|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
129833388|NCT01649375|467355569|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
129445849|NCT04641299|465934531|FG002|Overall Study|Reason not given|0|||
129445850|NCT04641299|465934532|FG003|Overall Study|Reason not given|0|||
129445851|NCT01016964|465934535|FG000|Overall Study|Lost to Follow-up|3|||
129833389|NCT01649375|467355570|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
129833390|NCT01649375|467355566|FG000|Week 16 up to Week 260|Death|1|||
129833391|NCT01649375|467355567|FG001|Week 16 up to Week 260|Death|1|||
129833392|NCT01649375|467355568|FG002|Week 16 up to Week 260|Death|0|||
129833393|NCT01649375|467355569|FG003|Week 16 up to Week 260|Death|0|||
129833394|NCT01649375|467355570|FG004|Week 16 up to Week 260|Death|0|||
129833395|NCT01649375|467355566|FG000|Week 16 up to Week 260|Adverse Event|5|||
129833396|NCT01649375|467355567|FG001|Week 16 up to Week 260|Adverse Event|2|||
129833397|NCT01649375|467355568|FG002|Week 16 up to Week 260|Adverse Event|0|||
129833398|NCT01649375|467355569|FG003|Week 16 up to Week 260|Adverse Event|3|||
129833399|NCT01649375|467355570|FG004|Week 16 up to Week 260|Adverse Event|2|||
129833400|NCT01856790|467355571|FG000|Closed Loop Control|Withdrawal by Subject|2|||
129833401|NCT01856790|467355571|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
129833402|NCT04091646|467355572|FG000|Overall Study|Adverse Event|2|||
129833403|NCT04091646|467355573|FG001|Overall Study|Adverse Event|1|||
129833404|NCT04091646|467355572|FG000|Overall Study|Lost to Follow-up|6|||
129833405|NCT04091646|467355573|FG001|Overall Study|Lost to Follow-up|2|||
129833406|NCT04091646|467355572|FG000|Overall Study|Protocol Violation|0|||
129833407|NCT04091646|467355573|FG001|Overall Study|Protocol Violation|1|||
129833408|NCT04091646|467355572|FG000|Overall Study|Withdrawal by Subject|4|||
129833409|NCT04091646|467355573|FG001|Overall Study|Withdrawal by Subject|1|||
129833410|NCT04091646|467355572|FG000|Overall Study|Participant Incarcerated|1|||
129833411|NCT04091646|467355573|FG001|Overall Study|Participant Incarcerated|0|||
129833412|NCT01762943|467355574|FG000|Overall Study|Physician Decision|1|||
129833413|NCT01762943|467355575|FG001|Overall Study|Physician Decision|1|||
129833414|NCT01762943|467355574|FG000|Overall Study|Protocol Violation|1|||
129833415|NCT01762943|467355575|FG001|Overall Study|Protocol Violation|0|||
129833416|NCT01762943|467355574|FG000|Overall Study|Withdrawal by Subject|2|||
129833417|NCT01762943|467355575|FG001|Overall Study|Withdrawal by Subject|1|||
129833418|NCT00539838|467355576|FG000|Overall Study|Fail to return|2|||
129833419|NCT00539838|467355577|FG001|Overall Study|Fail to return|0|||
129833420|NCT00539838|467355578|FG002|Overall Study|Fail to return|0|||
129833421|NCT00539838|467355576|FG000|Overall Study|Withdrawal by Subject|0|||
129833422|NCT00539838|467355577|FG001|Overall Study|Withdrawal by Subject|4|||
129833423|NCT00539838|467355578|FG002|Overall Study|Withdrawal by Subject|0|||
129833424|NCT00539838|467355576|FG000|Overall Study|Death|0|||
129833425|NCT00539838|467355577|FG001|Overall Study|Death|2|||
129833426|NCT00539838|467355578|FG002|Overall Study|Death|0|||
129833427|NCT00539838|467355576|FG000|Overall Study|Did not cooperate|1|||
129833428|NCT00539838|467355577|FG001|Overall Study|Did not cooperate|0|||
129833429|NCT00539838|467355578|FG002|Overall Study|Did not cooperate|1|||
129833430|NCT00539838|467355576|FG000|Overall Study|Administrative|4|||
129833431|NCT00539838|467355577|FG001|Overall Study|Administrative|0|||
129833432|NCT00539838|467355578|FG002|Overall Study|Administrative|8|||
129833433|NCT04343521|467355579|FG000|Overall Study|Adverse Event|0|||
129833434|NCT04343521|467355580|FG001|Overall Study|Adverse Event|2|||
129833435|NCT04343521|467355579|FG000|Overall Study|Death|1|||
129833436|NCT04343521|467355580|FG001|Overall Study|Death|2|||
129833437|NCT04343521|467355579|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
129833438|NCT04343521|467355580|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
129833439|NCT04343521|467355579|FG000|Overall Study|Withdrawal by Subject|70|||
129833440|NCT04343521|467355580|FG001|Overall Study|Withdrawal by Subject|95|||
129833441|NCT04343521|467355579|FG000|Overall Study|Withdrawal by study team|6|||
129833442|NCT04343521|467355580|FG001|Overall Study|Withdrawal by study team|12|||
129833443|NCT00107198|467355581|FG000|Overall Study|Lack of Efficacy|28|||
129833444|NCT00107198|467355581|FG000|Overall Study|Lost to Follow-up|12|||
129833445|NCT00107198|467355581|FG000|Overall Study|Protocol Violation|1|||
129833446|NCT00107198|467355581|FG000|Overall Study|Withdrawal by Subject|6|||
129833447|NCT00107198|467355581|FG000|Overall Study|Ineligible|5|||
129833448|NCT02120950|467355582|FG000|Overall Study|Adverse Event|5|||
129833449|NCT02120950|467355583|FG001|Overall Study|Adverse Event|4|||
129833450|NCT02120950|467355584|FG002|Overall Study|Adverse Event|3|||
129833451|NCT02120950|467355582|FG000|Overall Study|Death|3|||
129833452|NCT02120950|467355583|FG001|Overall Study|Death|0|||
129833453|NCT02120950|467355584|FG002|Overall Study|Death|1|||
129833454|NCT02120950|467355582|FG000|Overall Study|Withdrawal by Subject|6|||
129833455|NCT02120950|467355583|FG001|Overall Study|Withdrawal by Subject|3|||
129833456|NCT02120950|467355584|FG002|Overall Study|Withdrawal by Subject|2|||
129833457|NCT02120950|467355582|FG000|Overall Study|Protocol Violation|1|||
129833458|NCT02120950|467355583|FG001|Overall Study|Protocol Violation|1|||
129833459|NCT02120950|467355584|FG002|Overall Study|Protocol Violation|7|||
129833460|NCT02120950|467355582|FG000|Overall Study|Other reasons|5|||
129833461|NCT02120950|467355583|FG001|Overall Study|Other reasons|4|||
129833462|NCT02120950|467355584|FG002|Overall Study|Other reasons|1|||
129833463|NCT02120950|467355582|FG000|Overall Study|Lost to Follow-up|0|||
129833464|NCT02120950|467355583|FG001|Overall Study|Lost to Follow-up|2|||
129833465|NCT02120950|467355584|FG002|Overall Study|Lost to Follow-up|1|||
129833466|NCT02424383|467355585|FG000|Overall Study|Withdrawal by Subject|32|||
129833467|NCT02424383|467355585|FG000|Overall Study|Death|170|||
129833468|NCT02424383|467355585|FG000|Overall Study|Sponsor's decision|3|||
129833469|NCT02424383|467355585|FG000|Overall Study|Investigator's decision|44|||
129833470|NCT02424383|467355585|FG000|Overall Study|Lost to Follow-up|81|||
129833471|NCT02424383|467355585|FG000|Overall Study|Other|7|||
129833472|NCT02424383|467355585|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
129833473|NCT01817725|467355586|FG000|Overall Study|Withdrawal by Subject|1|||
129833474|NCT02438722|467355589|FG000|Overall Study|Adverse Event|12|||
129833475|NCT02438722|467355590|FG001|Overall Study|Adverse Event|9|||
129833476|NCT02438722|467355589|FG000|Overall Study|Refusal unrelated to AE|2|||
129833477|NCT02438722|467355590|FG001|Overall Study|Refusal unrelated to AE|5|||
129833478|NCT02438722|467355589|FG000|Overall Study|Disease progression/relapse|46|||
129833479|NCT02438722|467355590|FG001|Overall Study|Disease progression/relapse|51|||
129833480|NCT02438722|467355589|FG000|Overall Study|Death|0|||
129833481|NCT02438722|467355590|FG001|Overall Study|Death|3|||
129833482|NCT02438722|467355589|FG000|Overall Study|Physician Decision|2|||
129833483|NCT02438722|467355590|FG001|Overall Study|Physician Decision|2|||
129833484|NCT02438722|467355589|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
129833485|NCT02438722|467355590|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
129833486|NCT02438722|467355589|FG000|Overall Study|Withdrawal by Subject|0|||
129445852|NCT01016964|465934536|FG001|Overall Study|Lost to Follow-up|3|||
129833487|NCT02438722|467355590|FG001|Overall Study|Withdrawal by Subject|1|||
129833488|NCT02438722|467355589|FG000|Overall Study|On protocol treatment|15|||
129833489|NCT02438722|467355590|FG001|Overall Study|On protocol treatment|14|||
129833490|NCT02438722|467355589|FG000|Overall Study|Did not receive protocol treatment|5|||
129833491|NCT02438722|467355590|FG001|Overall Study|Did not receive protocol treatment|0|||
129833492|NCT00909779|467355591|FG000|Overall Study|Adverse Event|53|||
129833493|NCT00909779|467355592|FG001|Overall Study|Adverse Event|55|||
129833494|NCT00909779|467355591|FG000|Overall Study|Lack of Efficacy|7|||
129833495|NCT00909779|467355592|FG001|Overall Study|Lack of Efficacy|4|||
129833496|NCT00909779|467355591|FG000|Overall Study|Lost to Follow-up|19|||
129833497|NCT00909779|467355592|FG001|Overall Study|Lost to Follow-up|15|||
129833498|NCT00909779|467355591|FG000|Overall Study|Physician Decision|8|||
129833499|NCT00909779|467355592|FG001|Overall Study|Physician Decision|2|||
129833500|NCT00909779|467355591|FG000|Overall Study|Protocol Violation|2|||
129833501|NCT00909779|467355592|FG001|Overall Study|Protocol Violation|5|||
129833502|NCT00909779|467355591|FG000|Overall Study|Withdrawal by Subject|116|||
129833503|NCT00909779|467355592|FG001|Overall Study|Withdrawal by Subject|80|||
129833504|NCT00909779|467355591|FG000|Overall Study|Site Ceasing Operation|2|||
129833505|NCT00909779|467355592|FG001|Overall Study|Site Ceasing Operation|2|||
129833506|NCT00909779|467355591|FG000|Overall Study|Medical Monitor Decision|1|||
129833507|NCT00909779|467355592|FG001|Overall Study|Medical Monitor Decision|0|||
129833508|NCT00909779|467355591|FG000|Overall Study|Noncompliance|1|||
129833509|NCT00909779|467355592|FG001|Overall Study|Noncompliance|1|||
129833510|NCT00909779|467355591|FG000|Overall Study|Randomized in error|1|||
129833511|NCT00909779|467355592|FG001|Overall Study|Randomized in error|1|||
129833512|NCT02738333|467355596|FG000|Overall Study|Death|1|||
129833513|NCT02738333|467355597|FG001|Overall Study|Death|0|||
129833514|NCT02738333|467355598|FG002|Overall Study|Death|0|||
129833515|NCT02738333|467355596|FG000|Overall Study|Lost to Follow-up|1|||
129833516|NCT02738333|467355597|FG001|Overall Study|Lost to Follow-up|0|||
129833517|NCT02738333|467355598|FG002|Overall Study|Lost to Follow-up|0|||
129833518|NCT01498952|467355600|FG000|Overall Study|Death|2|||
129833519|NCT01498952|467355601|FG001|Overall Study|Death|2|||
129833520|NCT01498952|467355602|FG002|Overall Study|Death|0|||
129833521|NCT01498952|467355603|FG003|Overall Study|Death|0|||
129833522|NCT01498952|467355604|FG004|Overall Study|Death|0|||
129833523|NCT00579826|467355605|FG000|Overall Study|Withdrawal by Subject|5|||
129833524|NCT00579826|467355606|FG001|Overall Study|Withdrawal by Subject|3|||
129833525|NCT04191382|467355607|FG000|Overall Study|Withdrawal by Subject|1|||
129833526|NCT04191382|467355608|FG001|Overall Study|Withdrawal by Subject|0|||
129833527|NCT04191382|467355609|FG002|Overall Study|Withdrawal by Subject|0|||
129833528|NCT05237206|467355610|FG000|Overall Study|screen failure-did not receive treatment|8|||
129833529|NCT05237206|467355610|FG000|Overall Study|did not receive treatment|3|||
129833530|NCT00454987|467355616|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
129833531|NCT00454987|467355617|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
129833532|NCT00454987|467355618|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
129833533|NCT00454987|467355616|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
129833534|NCT00454987|467355617|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
129833535|NCT00454987|467355618|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
129833536|NCT00454987|467355616|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
129833537|NCT00454987|467355617|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
129833538|NCT00454987|467355618|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
129833539|NCT02205333|467355619|FG000|Overall Study|Death|5|||
129833540|NCT02205333|467355620|FG001|Overall Study|Death|6|||
129833541|NCT02205333|467355621|FG002|Overall Study|Death|2|||
129833542|NCT02205333|467355622|FG003|Overall Study|Death|6|||
129833543|NCT02205333|467355623|FG004|Overall Study|Death|5|||
129833544|NCT02205333|467355624|FG005|Overall Study|Death|3|||
129833545|NCT02205333|467355625|FG006|Overall Study|Death|3|||
129833546|NCT02205333|467355626|FG007|Overall Study|Death|2|||
129833547|NCT02205333|467355627|FG008|Overall Study|Death|0|||
129833548|NCT02205333|467355619|FG000|Overall Study|Withdrawal by Subject|1|||
129833549|NCT02205333|467355620|FG001|Overall Study|Withdrawal by Subject|0|||
129833550|NCT02205333|467355621|FG002|Overall Study|Withdrawal by Subject|0|||
129833551|NCT02205333|467355622|FG003|Overall Study|Withdrawal by Subject|1|||
129833552|NCT02205333|467355623|FG004|Overall Study|Withdrawal by Subject|0|||
129833553|NCT02205333|467355624|FG005|Overall Study|Withdrawal by Subject|0|||
129833554|NCT02205333|467355625|FG006|Overall Study|Withdrawal by Subject|2|||
129833555|NCT02205333|467355626|FG007|Overall Study|Withdrawal by Subject|0|||
129833556|NCT02205333|467355627|FG008|Overall Study|Withdrawal by Subject|0|||
129833557|NCT01476696|467355628|FG000|Overall Study|Sponsor decision|2|||
129833558|NCT01476696|467355629|FG001|Overall Study|Sponsor decision|1|||
129833559|NCT01476696|467355630|FG002|Overall Study|Sponsor decision|0|||
129833560|NCT01476696|467355628|FG000|Overall Study|Withdrawal by Subject|1|||
129833561|NCT01476696|467355629|FG001|Overall Study|Withdrawal by Subject|0|||
129833562|NCT01476696|467355630|FG002|Overall Study|Withdrawal by Subject|0|||
129833563|NCT02009046|467355631|FG000|Overall Study|Lost to Follow-up|256|||
129833564|NCT02009046|467355632|FG001|Overall Study|Lost to Follow-up|206|||
129833565|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|5|||
129833566|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833567|NCT00304356|467355638|FG000|Nitazoxanide|number is 0|1|||
129833568|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833569|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833570|NCT00304356|467355638|FG000|Nitazoxanide|Physician Decision|1|||
129833571|NCT01737047|467355639|FG000|Overall Study|Death|10|||
129833572|NCT01737047|467355640|FG001|Overall Study|Death|0|||
129833573|NCT01737047|467355641|FG002|Overall Study|Death|1|||
129833574|NCT01737047|467355639|FG000|Overall Study|Withdrawal by Subject|17|||
129833575|NCT01737047|467355640|FG001|Overall Study|Withdrawal by Subject|11|||
129833576|NCT01737047|467355641|FG002|Overall Study|Withdrawal by Subject|4|||
129833577|NCT00335972|467355642|FG000|Overall Study|not given treatments|0|||
129833578|NCT00335972|467355643|FG001|Overall Study|not given treatments|3|||
129833579|NCT03082599|467355646|FG000|Overall Study|Lost to Follow-up|1|||
129833580|NCT03082599|467355647|FG001|Overall Study|Lost to Follow-up|0|||
129833581|NCT00323115|467355648|FG000|Vaccine Administration|Adverse Event|1|||
129833582|NCT00323115|467355648|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
129833583|NCT00489853|467357803|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
129833584|NCT00489853|467357804|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
129833585|NCT00489853|467357805|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
129833586|NCT00489853|467357803|FG000|Wash-out Period 1|Adverse Event|0|||
129833587|NCT00489853|467357804|FG001|Wash-out Period 1|Adverse Event|1|||
129833588|NCT00489853|467357805|FG002|Wash-out Period 1|Adverse Event|1|||
129833589|NCT00489853|467357803|FG000|Wash-out Period 1|Protocol Violation|0|||
129833590|NCT00489853|467357804|FG001|Wash-out Period 1|Protocol Violation|1|||
129833591|NCT00489853|467357805|FG002|Wash-out Period 1|Protocol Violation|1|||
129833592|NCT00489853|467357803|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
129833593|NCT00489853|467357804|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
129833594|NCT00489853|467357805|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
129833595|NCT00489853|467357803|FG000|Wash-out Period 2|Adverse Event|1|||
129833596|NCT00489853|467357804|FG001|Wash-out Period 2|Adverse Event|1|||
129833597|NCT00489853|467357805|FG002|Wash-out Period 2|Adverse Event|0|||
129833598|NCT00489853|467357803|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
129833599|NCT00489853|467357804|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
129833600|NCT00489853|467357805|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
129833601|NCT00489853|467357803|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
129833602|NCT00489853|467357804|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
129833603|NCT00489853|467357805|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
129833604|NCT04254978|467357808|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
129833605|NCT04254978|467357808|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
129833606|NCT04254978|467357808|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
129833607|NCT04254978|467357808|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
129833608|NCT04254978|467357808|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
129833609|NCT04254978|467357808|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
129833610|NCT02515942|467357809|FG000|Overall Study|Adverse Event|5|||
129833611|NCT02515942|467357810|FG001|Overall Study|Adverse Event|0|||
129833612|NCT02515942|467357811|FG002|Overall Study|Adverse Event|0|||
129833613|NCT02515942|467357809|FG000|Overall Study|Death|0|||
129833614|NCT02515942|467357810|FG001|Overall Study|Death|0|||
129833615|NCT02515942|467357811|FG002|Overall Study|Death|1|||
129833616|NCT02515942|467357809|FG000|Overall Study|Lack of Efficacy|0|||
129833617|NCT02515942|467357810|FG001|Overall Study|Lack of Efficacy|0|||
129833618|NCT02515942|467357811|FG002|Overall Study|Lack of Efficacy|1|||
129833619|NCT02515942|467357809|FG000|Overall Study|Lost to Follow-up|2|||
129833620|NCT02515942|467357810|FG001|Overall Study|Lost to Follow-up|0|||
129833621|NCT02515942|467357811|FG002|Overall Study|Lost to Follow-up|0|||
129833622|NCT02515942|467357809|FG000|Overall Study|Withdrawal by Subject|0|||
129833623|NCT02515942|467357810|FG001|Overall Study|Withdrawal by Subject|3|||
129833624|NCT02515942|467357811|FG002|Overall Study|Withdrawal by Subject|2|||
129833625|NCT02436759|467357812|FG000|Overall Study|Adverse Event|3|||
129833626|NCT02436759|467357813|FG001|Overall Study|Adverse Event|0|||
129833627|NCT02436759|467357812|FG000|Overall Study|Protocol Violation|1|||
129833628|NCT02436759|467357813|FG001|Overall Study|Protocol Violation|0|||
129833629|NCT02436759|467357812|FG000|Overall Study|Withdrawal by Subject|0|||
129833630|NCT02436759|467357813|FG001|Overall Study|Withdrawal by Subject|1|||
129833631|NCT00902564|467357814|FG000|Overall Study|Withdrawal by Subject|2|||
129833632|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
129833633|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
129833634|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
129833635|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
129833636|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
129833637|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
129833638|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
129833639|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
129833640|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
129897727|NCT00299702|467584438|FG000|Overall Study|Lost to Follow-up|18|||
129833641|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
129833642|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
129833643|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
129833644|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
129833645|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
129833646|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
129833647|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
129833648|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
129833649|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
129833650|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
129445853|NCT01920594|465934537|FG000|Overall Study|Adverse Event|4|||
129445854|NCT01920594|465934538|FG001|Overall Study|Adverse Event|2|||
129445855|NCT01920594|465934537|FG000|Overall Study|Lost to Follow-up|1|||
129445856|NCT01920594|465934538|FG001|Overall Study|Lost to Follow-up|0|||
129445857|NCT01920594|465934537|FG000|Overall Study|Recovery|2|||
129445858|NCT01920594|465934538|FG001|Overall Study|Recovery|0|||
129445859|NCT01920594|465934537|FG000|Overall Study|Investigator discretion|0|||
129445860|NCT01920594|465934538|FG001|Overall Study|Investigator discretion|1|||
129445861|NCT00928564|465934539|FG000|Overall Study|Lost to Follow-up|6|||
129445862|NCT00928564|465934540|FG001|Overall Study|Lost to Follow-up|0|||
129445863|NCT02460497|465934544|FG000|Overall Study|Participant Requested Withdrawal|4|||
129445864|NCT02460497|465934544|FG000|Overall Study|Non-Compliance|1|||
129445865|NCT02460497|465934544|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
129445866|NCT02460497|465934544|FG000|Overall Study|Lost to Follow-up|2|||
129445867|NCT02460497|465934544|FG000|Overall Study|Investigator Decision|1|||
129445868|NCT02012296|465934549|FG000|Overall Study|Lack of Efficacy|0|||
129445869|NCT02012296|465934550|FG001|Overall Study|Lack of Efficacy|0|||
129445870|NCT02012296|465934551|FG002|Overall Study|Lack of Efficacy|15|||
129445871|NCT02012296|465934549|FG000|Overall Study|Adverse Event|0|||
129445872|NCT02012296|465934550|FG001|Overall Study|Adverse Event|0|||
129445873|NCT02012296|465934551|FG002|Overall Study|Adverse Event|2|||
129445874|NCT02012296|465934549|FG000|Overall Study|Early study closure|0|||
129445875|NCT02012296|465934550|FG001|Overall Study|Early study closure|0|||
129445876|NCT02012296|465934551|FG002|Overall Study|Early study closure|5|||
129445877|NCT02012296|465934549|FG000|Overall Study|Protocol Violation|0|||
129445878|NCT02012296|465934550|FG001|Overall Study|Protocol Violation|1|||
129445879|NCT02012296|465934551|FG002|Overall Study|Protocol Violation|0|||
129445880|NCT01448213|465934552|FG000|Overall Study|Lost to Follow-up|12|||
129445881|NCT01448213|465934553|FG001|Overall Study|Lost to Follow-up|10|||
129445882|NCT01448213|465934552|FG000|Overall Study|Adverse Event|4|||
129445883|NCT01448213|465934553|FG001|Overall Study|Adverse Event|10|||
129445884|NCT01448213|465934552|FG000|Overall Study|Protocol Violation|1|||
129445885|NCT01448213|465934553|FG001|Overall Study|Protocol Violation|2|||
129445886|NCT01330914|465934554|FG000|Overall Study|Withdrawal by Subject|4|||
129445887|NCT01330914|465934554|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
129445888|NCT02615470|465934555|FG000|Overall Study|Lost to Follow-up|21|||
129445889|NCT02615470|465934556|FG001|Overall Study|Lost to Follow-up|32|||
129833651|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
129833652|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
129833653|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
129833654|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
129833655|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
129833656|NCT00277212|467357815|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
129833657|NCT00277212|467357816|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
129833658|NCT00277212|467357817|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
129833659|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
129833660|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
129833661|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
129833662|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
129833663|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
129833664|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
129833665|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
129833666|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
129833667|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
129445890|NCT01650285|465934559|FG000|Overall Study|Adverse Event|1|||
129445891|NCT00659529|465934560|FG000|Overall Study|Withdrawal by Subject|4|||
129445892|NCT00659529|465934560|FG000|Overall Study|Protocol Violation|3|||
129445893|NCT00659529|465934560|FG000|Overall Study|Screen failure|9|||
129445894|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
129445895|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
129445896|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
129445897|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
129445898|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
129833668|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
129833669|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
129833670|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
129833671|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
129833672|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
129833673|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
129833674|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
129833675|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
129833676|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
129833677|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
129833678|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
129833679|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
129833680|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
129833681|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
129833682|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
129833683|NCT00277212|467357815|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
129833684|NCT00277212|467357816|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
129833685|NCT00277212|467357817|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
129833686|NCT03336216|467357818|FG000|Randomization|Not reported|2|||
129833687|NCT03336216|467357819|FG001|Randomization|Not reported|0|||
129833688|NCT03336216|467357820|FG002|Randomization|Not reported|1|||
129833689|NCT03336216|467357821|FG003|Randomization|Not reported|0|||
129833690|NCT03336216|467357818|FG000|Randomization|Other reasons|1|||
129833691|NCT03336216|467357819|FG001|Randomization|Other reasons|1|||
129833692|NCT03336216|467357820|FG002|Randomization|Other reasons|1|||
129833693|NCT03336216|467357821|FG003|Randomization|Other reasons|0|||
129833694|NCT03336216|467357818|FG000|Randomization|Participant no longer meets study criteria|0|||
129833695|NCT03336216|467357819|FG001|Randomization|Participant no longer meets study criteria|2|||
129833696|NCT03336216|467357820|FG002|Randomization|Participant no longer meets study criteria|4|||
129833697|NCT03336216|467357821|FG003|Randomization|Participant no longer meets study criteria|1|||
129833698|NCT03336216|467357818|FG000|Randomization|Lost to Follow-up|1|||
129833699|NCT03336216|467357819|FG001|Randomization|Lost to Follow-up|0|||
129833700|NCT03336216|467357820|FG002|Randomization|Lost to Follow-up|0|||
129833701|NCT03336216|467357821|FG003|Randomization|Lost to Follow-up|0|||
129833702|NCT03336216|467357818|FG000|Randomization|Participant withdrew consent|9|||
129833703|NCT03336216|467357819|FG001|Randomization|Participant withdrew consent|1|||
129833704|NCT03336216|467357820|FG002|Randomization|Participant withdrew consent|0|||
129833705|NCT03336216|467357821|FG003|Randomization|Participant withdrew consent|0|||
129833706|NCT03336216|467357818|FG000|Randomization|Adverse Event|1|||
129833707|NCT03336216|467357819|FG001|Randomization|Adverse Event|1|||
129833708|NCT03336216|467357820|FG002|Randomization|Adverse Event|0|||
129833709|NCT03336216|467357821|FG003|Randomization|Adverse Event|0|||
129833710|NCT03336216|467357818|FG000|Treatment|Adverse Event|2|||
129833711|NCT03336216|467357819|FG001|Treatment|Adverse Event|3|||
129833712|NCT03336216|467357820|FG002|Treatment|Adverse Event|4|||
129833713|NCT03336216|467357821|FG003|Treatment|Adverse Event|4|||
129833714|NCT03336216|467357818|FG000|Treatment|Participant request to discontinue treatment|2|||
129833715|NCT03336216|467357819|FG001|Treatment|Participant request to discontinue treatment|1|||
129833716|NCT03336216|467357820|FG002|Treatment|Participant request to discontinue treatment|2|||
129833717|NCT03336216|467357821|FG003|Treatment|Participant request to discontinue treatment|2|||
129833718|NCT03336216|467357818|FG000|Treatment|Participant withdrew consent|7|||
129833719|NCT03336216|467357819|FG001|Treatment|Participant withdrew consent|2|||
129833720|NCT03336216|467357820|FG002|Treatment|Participant withdrew consent|3|||
129833721|NCT03336216|467357821|FG003|Treatment|Participant withdrew consent|2|||
129833722|NCT03336216|467357818|FG000|Treatment|Death|2|||
129833723|NCT03336216|467357819|FG001|Treatment|Death|3|||
129833724|NCT03336216|467357820|FG002|Treatment|Death|3|||
129833725|NCT03336216|467357821|FG003|Treatment|Death|4|||
129833726|NCT03336216|467357818|FG000|Treatment|Participant no longer meets study criteria|0|||
129833727|NCT03336216|467357819|FG001|Treatment|Participant no longer meets study criteria|1|||
129833728|NCT03336216|467357820|FG002|Treatment|Participant no longer meets study criteria|0|||
129833729|NCT03336216|467357821|FG003|Treatment|Participant no longer meets study criteria|0|||
129833730|NCT03336216|467357818|FG000|Treatment|Other reasons|2|||
129833731|NCT03336216|467357819|FG001|Treatment|Other reasons|0|||
129833732|NCT03336216|467357820|FG002|Treatment|Other reasons|0|||
129833733|NCT03336216|467357821|FG003|Treatment|Other reasons|3|||
129833734|NCT03336216|467357818|FG000|Treatment|Disease progression|23|||
129833735|NCT03336216|467357819|FG001|Treatment|Disease progression|34|||
129833736|NCT03336216|467357820|FG002|Treatment|Disease progression|33|||
129833737|NCT03336216|467357821|FG003|Treatment|Disease progression|26|||
129833738|NCT03336216|467357818|FG000|Treatment|Study drug toxicity|0|||
129833739|NCT03336216|467357819|FG001|Treatment|Study drug toxicity|3|||
129833740|NCT03336216|467357820|FG002|Treatment|Study drug toxicity|2|||
129833741|NCT03336216|467357821|FG003|Treatment|Study drug toxicity|0|||
129833742|NCT03336216|467357818|FG000|Treatment|Adverse Event unrelated to study drug|1|||
129833743|NCT03336216|467357819|FG001|Treatment|Adverse Event unrelated to study drug|1|||
129833744|NCT03336216|467357820|FG002|Treatment|Adverse Event unrelated to study drug|1|||
129833745|NCT03336216|467357821|FG003|Treatment|Adverse Event unrelated to study drug|0|||
129833746|NCT03336216|467357818|FG000|Treatment|Disease Recurrence|1|||
129833747|NCT03336216|467357819|FG001|Treatment|Disease Recurrence|0|||
129833748|NCT03336216|467357820|FG002|Treatment|Disease Recurrence|0|||
129833749|NCT03336216|467357821|FG003|Treatment|Disease Recurrence|0|||
129833750|NCT03239470|467357822|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
129833751|NCT03239470|467357823|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
129833752|NCT00922766|467357824|FG000|Overall Study|Death|3|||
129833753|NCT00922766|467357824|FG000|Overall Study|Withdrawal by Subject|2|||
129833754|NCT00922766|467357824|FG000|Overall Study|Other|1|||
129833755|NCT00922766|467357824|FG000|Overall Study|Adverse Event|1|||
129833756|NCT01231581|467357827|FG000|Overall Study|Lost to Follow-up|2|||
129833757|NCT01231581|467357828|FG001|Overall Study|Lost to Follow-up|2|||
129833758|NCT01231581|467357827|FG000|Overall Study|Withdrawal by Subject|6|||
129833759|NCT01231581|467357828|FG001|Overall Study|Withdrawal by Subject|9|||
129833760|NCT01231581|467357827|FG000|Overall Study|Study Closed/Terminated|6|||
129833761|NCT01231581|467357828|FG001|Overall Study|Study Closed/Terminated|5|||
129833762|NCT01231581|467357827|FG000|Overall Study|Death|65|||
129833763|NCT01231581|467357828|FG001|Overall Study|Death|64|||
129833764|NCT01231581|467357827|FG000|Overall Study|Ongoing|1|||
129833765|NCT01231581|467357828|FG001|Overall Study|Ongoing|0|||
129833766|NCT02510794|467357829|FG000|Overall Study|Adverse Event|0|||
129833767|NCT02510794|467357830|FG001|Overall Study|Adverse Event|1|||
129833768|NCT02510794|467357831|FG002|Overall Study|Adverse Event|0|||
129833769|NCT02510794|467357832|FG003|Overall Study|Adverse Event|0|||
129833770|NCT02510794|467357829|FG000|Overall Study|Death|1|||
129833771|NCT02510794|467357830|FG001|Overall Study|Death|2|||
129833772|NCT02510794|467357831|FG002|Overall Study|Death|1|||
129833773|NCT02510794|467357832|FG003|Overall Study|Death|1|||
129833774|NCT02510794|467357829|FG000|Overall Study|Lack of Efficacy|3|||
129833775|NCT02510794|467357830|FG001|Overall Study|Lack of Efficacy|1|||
129833776|NCT02510794|467357831|FG002|Overall Study|Lack of Efficacy|1|||
129833777|NCT02510794|467357832|FG003|Overall Study|Lack of Efficacy|0|||
129833778|NCT02510794|467357829|FG000|Overall Study|Participant moved out of the area|0|||
129833779|NCT02510794|467357830|FG001|Overall Study|Participant moved out of the area|0|||
129833780|NCT02510794|467357831|FG002|Overall Study|Participant moved out of the area|0|||
129833781|NCT02510794|467357832|FG003|Overall Study|Participant moved out of the area|1|||
129833782|NCT02510794|467357829|FG000|Overall Study|Physician Decision|3|||
129833783|NCT02510794|467357830|FG001|Overall Study|Physician Decision|0|||
129833784|NCT02510794|467357831|FG002|Overall Study|Physician Decision|0|||
129833785|NCT02510794|467357832|FG003|Overall Study|Physician Decision|0|||
129833786|NCT02510794|467357829|FG000|Overall Study|Protocol Violation|0|||
129833787|NCT02510794|467357830|FG001|Overall Study|Protocol Violation|0|||
129897728|NCT00299702|467584439|FG001|Overall Study|Lost to Follow-up|10|||
129897729|NCT00299702|467584438|FG000|Overall Study|Withdrawal by Subject|25|||
129897730|NCT00299702|467584439|FG001|Overall Study|Withdrawal by Subject|23|||
129897731|NCT00299702|467584438|FG000|Overall Study|Pregnancy|0|||
129897732|NCT00299702|467584439|FG001|Overall Study|Pregnancy|1|||
129897733|NCT00299702|467584438|FG000|Overall Study|Insufficient Response|4|||
129897734|NCT00299702|467584439|FG001|Overall Study|Insufficient Response|3|||
129897735|NCT00299702|467584438|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
129897736|NCT00299702|467584439|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
129897737|NCT00751036|467584440|FG000|Overall Study|Disease Progression|28|||
129897738|NCT00751036|467584441|FG001|Overall Study|Disease Progression|29|||
129897739|NCT00751036|467584440|FG000|Overall Study|Adverse Event|6|||
129897740|NCT00751036|467584441|FG001|Overall Study|Adverse Event|4|||
129833788|NCT02510794|467357831|FG002|Overall Study|Protocol Violation|1|||
129833789|NCT02510794|467357832|FG003|Overall Study|Protocol Violation|0|||
129833790|NCT02510794|467357829|FG000|Overall Study|Withdrawal by Subject|1|||
129833791|NCT02510794|467357830|FG001|Overall Study|Withdrawal by Subject|2|||
129833792|NCT02510794|467357831|FG002|Overall Study|Withdrawal by Subject|4|||
129833793|NCT02510794|467357832|FG003|Overall Study|Withdrawal by Subject|3|||
129833794|NCT01124604|467357833|FG000|Overall Study|Adverse Event|10|||
129833795|NCT01124604|467357834|FG001|Overall Study|Adverse Event|1|||
129833796|NCT01124604|467357833|FG000|Overall Study|Lack of Efficacy|1|||
129833797|NCT01124604|467357834|FG001|Overall Study|Lack of Efficacy|0|||
129833798|NCT01124604|467357833|FG000|Overall Study|Withdrawal by Subject|4|||
129833799|NCT01124604|467357834|FG001|Overall Study|Withdrawal by Subject|0|||
129897741|NCT00751036|467584440|FG000|Overall Study|Administrative Problems|3|||
129897742|NCT00751036|467584441|FG001|Overall Study|Administrative Problems|4|||
129897743|NCT00751036|467584440|FG000|Overall Study|Withdrawal by Subject|5|||
129897744|NCT00751036|467584441|FG001|Overall Study|Withdrawal by Subject|2|||
129897745|NCT00751036|467584440|FG000|Overall Study|Death|3|||
129897746|NCT00751036|467584441|FG001|Overall Study|Death|3|||
129897747|NCT00751036|467584440|FG000|Overall Study|Lost to Follow-up|0|||
129897748|NCT00751036|467584441|FG001|Overall Study|Lost to Follow-up|1|||
129897749|NCT00751036|467584440|FG000|Overall Study|Protocol Violation|1|||
129897750|NCT00751036|467584441|FG001|Overall Study|Protocol Violation|0|||
129897751|NCT00751036|467584440|FG000|Overall Study|Missing end of Treatment Page|2|||
129897752|NCT00751036|467584441|FG001|Overall Study|Missing end of Treatment Page|3|||
129897753|NCT05460663|467584442|FG000|Overall Study|Withdrawal by Subject|2|||
129897754|NCT05460663|467584443|FG001|Overall Study|Withdrawal by Subject|5|||
129897755|NCT05273801|467584444|FG000|Overall Study|Physician Decision|1|||
129897756|NCT05526911|467586455|FG000|Overall Study|Adverse Event|2|||
129897757|NCT05025449|467586456|FG000|Overall Study|Withdrawal by Subject|1|||
129897758|NCT05025449|467586456|FG000|Overall Study|Patient emergently taken to operating room|1|||
129897759|NCT00613301|467586457|FG000|Overall Study|Adverse Event|49|||
129897760|NCT00613301|467586457|FG000|Overall Study|Lost to Follow-up|88|||
129897761|NCT00613301|467586457|FG000|Overall Study|Withdrawal by Subject|5|||
129897762|NCT00613301|467586457|FG000|Overall Study|Death|6|||
129897763|NCT00613301|467586457|FG000|Overall Study|Lack of Efficacy|13|||
129897764|NCT00613301|467586457|FG000|Overall Study|Physician Decision|2|||
129897765|NCT00613301|467586457|FG000|Overall Study|No data was collected|53|||
129897766|NCT00613301|467586457|FG000|Overall Study|Irregularly enrolled patients|12|||
129897767|NCT00569946|467586458|FG000|Overall Study|Adverse Event|16|||
129897768|NCT00569946|467586458|FG000|Overall Study|Objective Progression or Relapse|42|||
129445899|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
129833800|NCT01124604|467357833|FG000|Overall Study|Disease Progression|0|||
129445900|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
129833801|NCT01124604|467357834|FG001|Overall Study|Disease Progression|1|||
129833802|NCT02658890|467357840|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833803|NCT02658890|467357841|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833804|NCT02658890|467357842|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833805|NCT02658890|467357843|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833806|NCT02658890|467357844|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833807|NCT02658890|467357845|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833808|NCT02658890|467357846|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833809|NCT02658890|467357847|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833810|NCT02658890|467357848|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129833811|NCT02658890|467357849|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833812|NCT02658890|467357850|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833813|NCT02658890|467357851|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833814|NCT02658890|467357852|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833815|NCT02658890|467357853|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129897769|NCT00569946|467586458|FG000|Overall Study|Global Deterioration of Health Status|1|||
129897770|NCT00762463|467586460|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
129897771|NCT00762463|467586461|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
129897772|NCT00762463|467586462|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
129897773|NCT00762463|467586463|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
129445901|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
129833816|NCT02658890|467357854|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833817|NCT02658890|467357855|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833818|NCT02658890|467357856|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833819|NCT02658890|467357857|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833820|NCT02658890|467357858|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833821|NCT02658890|467357859|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833822|NCT02658890|467357860|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833823|NCT02658890|467357861|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833824|NCT02658890|467357862|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833825|NCT02658890|467357863|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833826|NCT02658890|467357864|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833827|NCT02658890|467357865|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833828|NCT02658890|467357866|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129833829|NCT02658890|467357840|FG000|Treatment Phase|Adverse Event|0|||
129833830|NCT02658890|467357841|FG001|Treatment Phase|Adverse Event|1|||
129833831|NCT02658890|467357842|FG002|Treatment Phase|Adverse Event|2|||
129833832|NCT02658890|467357843|FG003|Treatment Phase|Adverse Event|2|||
129833833|NCT02658890|467357844|FG004|Treatment Phase|Adverse Event|1|||
129833834|NCT02658890|467357845|FG005|Treatment Phase|Adverse Event|0|||
129833835|NCT02658890|467357846|FG006|Treatment Phase|Adverse Event|0|||
129833836|NCT02658890|467357847|FG007|Treatment Phase|Adverse Event|2|||
129833837|NCT02658890|467357848|FG008|Treatment Phase|Adverse Event|1|||
129833838|NCT02658890|467357849|FG009|Treatment Phase|Adverse Event|2|||
129833839|NCT02658890|467357850|FG010|Treatment Phase|Adverse Event|3|||
129833840|NCT02658890|467357851|FG011|Treatment Phase|Adverse Event|0|||
129833841|NCT02658890|467357852|FG012|Treatment Phase|Adverse Event|1|||
129833842|NCT02658890|467357853|FG013|Treatment Phase|Adverse Event|4|||
129833843|NCT02658890|467357854|FG014|Treatment Phase|Adverse Event|0|||
129833844|NCT02658890|467357855|FG015|Treatment Phase|Adverse Event|0|||
129833845|NCT02658890|467357856|FG016|Treatment Phase|Adverse Event|0|||
129833846|NCT02658890|467357857|FG017|Treatment Phase|Adverse Event|0|||
129833847|NCT02658890|467357858|FG018|Treatment Phase|Adverse Event|5|||
129833848|NCT02658890|467357859|FG019|Treatment Phase|Adverse Event|1|||
129833849|NCT02658890|467357860|FG020|Treatment Phase|Adverse Event|3|||
129833850|NCT02658890|467357861|FG021|Treatment Phase|Adverse Event|0|||
129833851|NCT02658890|467357862|FG022|Treatment Phase|Adverse Event|5|||
129833852|NCT02658890|467357863|FG023|Treatment Phase|Adverse Event|0|||
129833853|NCT02658890|467357864|FG024|Treatment Phase|Adverse Event|0|||
129833854|NCT02658890|467357865|FG025|Treatment Phase|Adverse Event|2|||
129833855|NCT02658890|467357866|FG026|Treatment Phase|Adverse Event|1|||
129833856|NCT02658890|467357840|FG000|Treatment Phase|Death|0|||
129833857|NCT02658890|467357841|FG001|Treatment Phase|Death|0|||
129833858|NCT02658890|467357842|FG002|Treatment Phase|Death|0|||
129833859|NCT02658890|467357843|FG003|Treatment Phase|Death|0|||
129833860|NCT02658890|467357844|FG004|Treatment Phase|Death|0|||
129833861|NCT02658890|467357845|FG005|Treatment Phase|Death|0|||
129833862|NCT02658890|467357846|FG006|Treatment Phase|Death|0|||
129833863|NCT02658890|467357847|FG007|Treatment Phase|Death|0|||
129833864|NCT02658890|467357848|FG008|Treatment Phase|Death|0|||
129833865|NCT02658890|467357849|FG009|Treatment Phase|Death|0|||
129833866|NCT02658890|467357850|FG010|Treatment Phase|Death|0|||
129833867|NCT02658890|467357851|FG011|Treatment Phase|Death|0|||
129833868|NCT02658890|467357852|FG012|Treatment Phase|Death|0|||
129833869|NCT02658890|467357853|FG013|Treatment Phase|Death|0|||
129833870|NCT02658890|467357854|FG014|Treatment Phase|Death|0|||
129833871|NCT02658890|467357855|FG015|Treatment Phase|Death|0|||
129833872|NCT02658890|467357856|FG016|Treatment Phase|Death|0|||
129833873|NCT02658890|467357857|FG017|Treatment Phase|Death|0|||
129833874|NCT02658890|467357858|FG018|Treatment Phase|Death|1|||
129833875|NCT02658890|467357859|FG019|Treatment Phase|Death|0|||
129833876|NCT02658890|467357860|FG020|Treatment Phase|Death|0|||
129833877|NCT02658890|467357861|FG021|Treatment Phase|Death|0|||
129833878|NCT02658890|467357862|FG022|Treatment Phase|Death|0|||
129833879|NCT02658890|467357863|FG023|Treatment Phase|Death|0|||
129833880|NCT02658890|467357864|FG024|Treatment Phase|Death|0|||
129833881|NCT02658890|467357865|FG025|Treatment Phase|Death|0|||
129833882|NCT02658890|467357866|FG026|Treatment Phase|Death|0|||
129833883|NCT02658890|467357840|FG000|Treatment Phase|Lost to Follow-up|0|||
129833884|NCT02658890|467357841|FG001|Treatment Phase|Lost to Follow-up|0|||
129833885|NCT02658890|467357842|FG002|Treatment Phase|Lost to Follow-up|0|||
129833886|NCT02658890|467357843|FG003|Treatment Phase|Lost to Follow-up|0|||
129833887|NCT02658890|467357844|FG004|Treatment Phase|Lost to Follow-up|0|||
129833888|NCT02658890|467357845|FG005|Treatment Phase|Lost to Follow-up|0|||
129833889|NCT02658890|467357846|FG006|Treatment Phase|Lost to Follow-up|1|||
129833890|NCT02658890|467357847|FG007|Treatment Phase|Lost to Follow-up|0|||
129833891|NCT02658890|467357848|FG008|Treatment Phase|Lost to Follow-up|0|||
129833892|NCT02658890|467357849|FG009|Treatment Phase|Lost to Follow-up|0|||
129833893|NCT02658890|467357850|FG010|Treatment Phase|Lost to Follow-up|0|||
129833894|NCT02658890|467357851|FG011|Treatment Phase|Lost to Follow-up|0|||
129833895|NCT02658890|467357852|FG012|Treatment Phase|Lost to Follow-up|0|||
129833896|NCT02658890|467357853|FG013|Treatment Phase|Lost to Follow-up|0|||
129833897|NCT02658890|467357854|FG014|Treatment Phase|Lost to Follow-up|0|||
129833898|NCT02658890|467357855|FG015|Treatment Phase|Lost to Follow-up|0|||
129833899|NCT02658890|467357856|FG016|Treatment Phase|Lost to Follow-up|0|||
129833900|NCT02658890|467357857|FG017|Treatment Phase|Lost to Follow-up|0|||
129833901|NCT02658890|467357858|FG018|Treatment Phase|Lost to Follow-up|0|||
129833902|NCT02658890|467357859|FG019|Treatment Phase|Lost to Follow-up|0|||
129833903|NCT02658890|467357860|FG020|Treatment Phase|Lost to Follow-up|0|||
129833904|NCT02658890|467357861|FG021|Treatment Phase|Lost to Follow-up|0|||
129833905|NCT02658890|467357862|FG022|Treatment Phase|Lost to Follow-up|0|||
129833906|NCT02658890|467357863|FG023|Treatment Phase|Lost to Follow-up|0|||
129833907|NCT02658890|467357864|FG024|Treatment Phase|Lost to Follow-up|0|||
129833908|NCT02658890|467357865|FG025|Treatment Phase|Lost to Follow-up|0|||
129833909|NCT02658890|467357866|FG026|Treatment Phase|Lost to Follow-up|0|||
129833910|NCT02658890|467357840|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
129833911|NCT02658890|467357841|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
129833912|NCT02658890|467357842|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
129833913|NCT02658890|467357843|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
129833914|NCT02658890|467357844|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
129833915|NCT02658890|467357845|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
129833916|NCT02658890|467357846|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
129833917|NCT02658890|467357847|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
129833918|NCT02658890|467357848|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
129833919|NCT02658890|467357849|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
129833920|NCT02658890|467357850|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
129833921|NCT02658890|467357851|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
129833922|NCT02658890|467357852|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
129833923|NCT02658890|467357853|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
129833924|NCT02658890|467357854|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
129833925|NCT02658890|467357855|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
129833926|NCT02658890|467357856|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
129833927|NCT02658890|467357857|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
129833928|NCT02658890|467357858|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
129833929|NCT02658890|467357859|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
129833930|NCT02658890|467357860|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
129833931|NCT02658890|467357861|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
129833932|NCT02658890|467357862|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
129833933|NCT02658890|467357863|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
129833934|NCT02658890|467357864|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
129833935|NCT02658890|467357865|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
129833936|NCT02658890|467357866|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
129833937|NCT02658890|467357840|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
129833938|NCT02658890|467357841|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
129833939|NCT02658890|467357842|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
129833940|NCT02658890|467357843|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
129833941|NCT02658890|467357844|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
129833942|NCT02658890|467357845|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
129833943|NCT02658890|467357846|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
129833944|NCT02658890|467357847|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
129833945|NCT02658890|467357848|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
129833946|NCT02658890|467357849|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
129833947|NCT02658890|467357850|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
129833948|NCT02658890|467357851|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
129833949|NCT02658890|467357852|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
129833950|NCT02658890|467357853|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
129833951|NCT02658890|467357854|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
129833952|NCT02658890|467357855|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
129833953|NCT02658890|467357856|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
129833954|NCT02658890|467357857|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
129833955|NCT02658890|467357858|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
129833956|NCT02658890|467357859|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
129833957|NCT02658890|467357860|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
129833958|NCT02658890|467357861|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
129833959|NCT02658890|467357862|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
129833960|NCT02658890|467357863|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
129833961|NCT02658890|467357864|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
129833962|NCT02658890|467357865|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
129833963|NCT02658890|467357866|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
129833964|NCT02658890|467357840|FG000|Treatment Phase|Other Reasons|0|||
129833965|NCT02658890|467357841|FG001|Treatment Phase|Other Reasons|0|||
129833966|NCT02658890|467357842|FG002|Treatment Phase|Other Reasons|0|||
129833967|NCT02658890|467357843|FG003|Treatment Phase|Other Reasons|0|||
129833968|NCT02658890|467357844|FG004|Treatment Phase|Other Reasons|0|||
129833969|NCT02658890|467357845|FG005|Treatment Phase|Other Reasons|0|||
129833970|NCT02658890|467357846|FG006|Treatment Phase|Other Reasons|1|||
129833971|NCT02658890|467357847|FG007|Treatment Phase|Other Reasons|0|||
129833972|NCT02658890|467357848|FG008|Treatment Phase|Other Reasons|1|||
129833973|NCT02658890|467357849|FG009|Treatment Phase|Other Reasons|0|||
129833974|NCT02658890|467357850|FG010|Treatment Phase|Other Reasons|0|||
129833975|NCT02658890|467357851|FG011|Treatment Phase|Other Reasons|0|||
129833976|NCT02658890|467357852|FG012|Treatment Phase|Other Reasons|0|||
129833977|NCT02658890|467357853|FG013|Treatment Phase|Other Reasons|2|||
129833978|NCT02658890|467357854|FG014|Treatment Phase|Other Reasons|0|||
129833979|NCT02658890|467357855|FG015|Treatment Phase|Other Reasons|0|||
129833980|NCT02658890|467357856|FG016|Treatment Phase|Other Reasons|0|||
129833981|NCT02658890|467357857|FG017|Treatment Phase|Other Reasons|0|||
129833982|NCT02658890|467357858|FG018|Treatment Phase|Other Reasons|1|||
129833983|NCT02658890|467357859|FG019|Treatment Phase|Other Reasons|0|||
129833984|NCT02658890|467357860|FG020|Treatment Phase|Other Reasons|0|||
129833985|NCT02658890|467357861|FG021|Treatment Phase|Other Reasons|0|||
129833986|NCT02658890|467357862|FG022|Treatment Phase|Other Reasons|0|||
129833987|NCT02658890|467357863|FG023|Treatment Phase|Other Reasons|0|||
129833988|NCT02658890|467357864|FG024|Treatment Phase|Other Reasons|1|||
129833989|NCT02658890|467357865|FG025|Treatment Phase|Other Reasons|0|||
129833990|NCT02658890|467357866|FG026|Treatment Phase|Other Reasons|1|||
129833991|NCT02658890|467357840|FG000|Treatment Phase|Progressive Disease|6|||
129833992|NCT02658890|467357841|FG001|Treatment Phase|Progressive Disease|7|||
129833993|NCT02658890|467357842|FG002|Treatment Phase|Progressive Disease|6|||
129833994|NCT02658890|467357843|FG003|Treatment Phase|Progressive Disease|12|||
129833995|NCT02658890|467357844|FG004|Treatment Phase|Progressive Disease|6|||
129833996|NCT02658890|467357845|FG005|Treatment Phase|Progressive Disease|18|||
129833997|NCT02658890|467357846|FG006|Treatment Phase|Progressive Disease|12|||
129833998|NCT02658890|467357847|FG007|Treatment Phase|Progressive Disease|19|||
129833999|NCT02658890|467357848|FG008|Treatment Phase|Progressive Disease|26|||
129834000|NCT02658890|467357849|FG009|Treatment Phase|Progressive Disease|8|||
129834001|NCT02658890|467357850|FG010|Treatment Phase|Progressive Disease|7|||
129834002|NCT02658890|467357851|FG011|Treatment Phase|Progressive Disease|9|||
129834003|NCT02658890|467357852|FG012|Treatment Phase|Progressive Disease|8|||
129834004|NCT02658890|467357853|FG013|Treatment Phase|Progressive Disease|29|||
129834005|NCT02658890|467357854|FG014|Treatment Phase|Progressive Disease|6|||
129834006|NCT02658890|467357855|FG015|Treatment Phase|Progressive Disease|2|||
129834007|NCT02658890|467357856|FG016|Treatment Phase|Progressive Disease|32|||
129834008|NCT02658890|467357857|FG017|Treatment Phase|Progressive Disease|14|||
129834009|NCT02658890|467357858|FG018|Treatment Phase|Progressive Disease|40|||
129834010|NCT02658890|467357859|FG019|Treatment Phase|Progressive Disease|32|||
129834011|NCT02658890|467357860|FG020|Treatment Phase|Progressive Disease|19|||
129834012|NCT02658890|467357861|FG021|Treatment Phase|Progressive Disease|30|||
129834013|NCT02658890|467357862|FG022|Treatment Phase|Progressive Disease|15|||
129834014|NCT02658890|467357863|FG023|Treatment Phase|Progressive Disease|0|||
129834015|NCT02658890|467357864|FG024|Treatment Phase|Progressive Disease|0|||
129834016|NCT02658890|467357865|FG025|Treatment Phase|Progressive Disease|14|||
129834017|NCT02658890|467357866|FG026|Treatment Phase|Progressive Disease|11|||
129834018|NCT02658890|467357840|FG000|Treatment Phase|Study Drug Toxicity|0|||
129834019|NCT02658890|467357841|FG001|Treatment Phase|Study Drug Toxicity|0|||
129834020|NCT02658890|467357842|FG002|Treatment Phase|Study Drug Toxicity|2|||
129897774|NCT00762463|467586460|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
129979658|NCT00403767|467889417|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
129834021|NCT02658890|467357843|FG003|Treatment Phase|Study Drug Toxicity|0|||
129834022|NCT02658890|467357844|FG004|Treatment Phase|Study Drug Toxicity|0|||
129834023|NCT02658890|467357845|FG005|Treatment Phase|Study Drug Toxicity|0|||
129834024|NCT02658890|467357846|FG006|Treatment Phase|Study Drug Toxicity|0|||
129834025|NCT02658890|467357847|FG007|Treatment Phase|Study Drug Toxicity|0|||
129834026|NCT02658890|467357848|FG008|Treatment Phase|Study Drug Toxicity|3|||
129834027|NCT02658890|467357849|FG009|Treatment Phase|Study Drug Toxicity|0|||
129834028|NCT02658890|467357850|FG010|Treatment Phase|Study Drug Toxicity|1|||
129834029|NCT02658890|467357851|FG011|Treatment Phase|Study Drug Toxicity|1|||
129834030|NCT02658890|467357852|FG012|Treatment Phase|Study Drug Toxicity|2|||
129834031|NCT02658890|467357853|FG013|Treatment Phase|Study Drug Toxicity|9|||
129834032|NCT02658890|467357854|FG014|Treatment Phase|Study Drug Toxicity|0|||
129445902|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
129834033|NCT02658890|467357855|FG015|Treatment Phase|Study Drug Toxicity|1|||
129834034|NCT02658890|467357856|FG016|Treatment Phase|Study Drug Toxicity|1|||
129834035|NCT02658890|467357857|FG017|Treatment Phase|Study Drug Toxicity|0|||
129834036|NCT02658890|467357858|FG018|Treatment Phase|Study Drug Toxicity|8|||
129834037|NCT02658890|467357859|FG019|Treatment Phase|Study Drug Toxicity|3|||
129897775|NCT00762463|467586461|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
129897776|NCT00762463|467586462|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
129897777|NCT00762463|467586463|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
129897778|NCT00762463|467586460|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
129897779|NCT00762463|467586461|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
129897780|NCT00762463|467586462|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
129897781|NCT00762463|467586463|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
129897782|NCT00762463|467586460|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
129897783|NCT00762463|467586461|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
129445903|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
129445904|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
129445905|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
129834038|NCT02658890|467357860|FG020|Treatment Phase|Study Drug Toxicity|2|||
129834039|NCT02658890|467357861|FG021|Treatment Phase|Study Drug Toxicity|0|||
129834040|NCT02658890|467357862|FG022|Treatment Phase|Study Drug Toxicity|8|||
129834041|NCT02658890|467357863|FG023|Treatment Phase|Study Drug Toxicity|0|||
129834042|NCT02658890|467357864|FG024|Treatment Phase|Study Drug Toxicity|0|||
129834043|NCT02658890|467357865|FG025|Treatment Phase|Study Drug Toxicity|2|||
129834044|NCT02658890|467357866|FG026|Treatment Phase|Study Drug Toxicity|0|||
129834045|NCT02658890|467357840|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834046|NCT02658890|467357841|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834047|NCT02658890|467357842|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834048|NCT02658890|467357843|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834049|NCT02658890|467357844|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834050|NCT02658890|467357845|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834051|NCT02658890|467357846|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834052|NCT02658890|467357847|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834053|NCT02658890|467357848|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834054|NCT02658890|467357849|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834055|NCT02658890|467357850|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834056|NCT02658890|467357851|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834057|NCT02658890|467357852|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834058|NCT02658890|467357853|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834059|NCT02658890|467357854|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834060|NCT02658890|467357855|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834061|NCT02658890|467357856|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834062|NCT02658890|467357857|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834063|NCT02658890|467357858|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834064|NCT02658890|467357859|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834065|NCT02658890|467357860|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834066|NCT02658890|467357861|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834067|NCT02658890|467357862|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
129834068|NCT02658890|467357863|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834069|NCT02658890|467357864|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834070|NCT02658890|467357865|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834071|NCT02658890|467357866|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
129834072|NCT02658890|467357840|FG000|Treatment Phase|Withdrawal by Subject|0|||
129834073|NCT02658890|467357841|FG001|Treatment Phase|Withdrawal by Subject|1|||
129834074|NCT02658890|467357842|FG002|Treatment Phase|Withdrawal by Subject|0|||
129834075|NCT02658890|467357843|FG003|Treatment Phase|Withdrawal by Subject|0|||
129834076|NCT02658890|467357844|FG004|Treatment Phase|Withdrawal by Subject|0|||
129834077|NCT02658890|467357845|FG005|Treatment Phase|Withdrawal by Subject|0|||
129834078|NCT02658890|467357846|FG006|Treatment Phase|Withdrawal by Subject|1|||
129834079|NCT02658890|467357847|FG007|Treatment Phase|Withdrawal by Subject|0|||
129834080|NCT02658890|467357848|FG008|Treatment Phase|Withdrawal by Subject|0|||
129834081|NCT02658890|467357849|FG009|Treatment Phase|Withdrawal by Subject|1|||
129834082|NCT02658890|467357850|FG010|Treatment Phase|Withdrawal by Subject|0|||
129834083|NCT02658890|467357851|FG011|Treatment Phase|Withdrawal by Subject|0|||
129834084|NCT02658890|467357852|FG012|Treatment Phase|Withdrawal by Subject|1|||
129834085|NCT02658890|467357853|FG013|Treatment Phase|Withdrawal by Subject|3|||
129834086|NCT02658890|467357854|FG014|Treatment Phase|Withdrawal by Subject|0|||
129834087|NCT02658890|467357855|FG015|Treatment Phase|Withdrawal by Subject|0|||
129834088|NCT02658890|467357856|FG016|Treatment Phase|Withdrawal by Subject|1|||
129834089|NCT02658890|467357857|FG017|Treatment Phase|Withdrawal by Subject|0|||
129834090|NCT02658890|467357858|FG018|Treatment Phase|Withdrawal by Subject|4|||
129834091|NCT02658890|467357859|FG019|Treatment Phase|Withdrawal by Subject|3|||
129834092|NCT02658890|467357860|FG020|Treatment Phase|Withdrawal by Subject|0|||
129834093|NCT02658890|467357861|FG021|Treatment Phase|Withdrawal by Subject|4|||
129834094|NCT02658890|467357862|FG022|Treatment Phase|Withdrawal by Subject|1|||
129834095|NCT02658890|467357863|FG023|Treatment Phase|Withdrawal by Subject|1|||
129834096|NCT02658890|467357864|FG024|Treatment Phase|Withdrawal by Subject|0|||
129834097|NCT02658890|467357865|FG025|Treatment Phase|Withdrawal by Subject|0|||
129834098|NCT02658890|467357866|FG026|Treatment Phase|Withdrawal by Subject|0|||
129834099|NCT02474199|467357867|FG000|Overall Study|Lost to Follow-up|1|||
129834100|NCT02474199|467357868|FG001|Overall Study|Lost to Follow-up|0|||
129834101|NCT02474199|467357869|FG002|Overall Study|Lost to Follow-up|0|||
129834102|NCT02474199|467357870|FG003|Overall Study|Lost to Follow-up|0|||
129834103|NCT02474199|467357867|FG000|Overall Study|Withdrawal by Subject|1|||
129834104|NCT02474199|467357868|FG001|Overall Study|Withdrawal by Subject|2|||
129834105|NCT02474199|467357869|FG002|Overall Study|Withdrawal by Subject|0|||
129834106|NCT02474199|467357870|FG003|Overall Study|Withdrawal by Subject|1|||
129834107|NCT02474199|467357867|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
129834108|NCT02474199|467357868|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
129834109|NCT02474199|467357869|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
129834110|NCT02474199|467357870|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
129834111|NCT02474199|467357867|FG000|Overall Study|Did not meet eligibility criteria|0|||
129834112|NCT02474199|467357868|FG001|Overall Study|Did not meet eligibility criteria|0|||
129834113|NCT02474199|467357869|FG002|Overall Study|Did not meet eligibility criteria|2|||
129834114|NCT02474199|467357870|FG003|Overall Study|Did not meet eligibility criteria|2|||
129834115|NCT03090100|467357871|FG000|Overall Study|Adverse Event|9|||
129834116|NCT03090100|467357872|FG001|Overall Study|Adverse Event|11|||
129834117|NCT03090100|467357871|FG000|Overall Study|Pregnancy|1|||
129834118|NCT03090100|467357872|FG001|Overall Study|Pregnancy|1|||
129834119|NCT03090100|467357871|FG000|Overall Study|Lack of Efficacy|2|||
129834120|NCT03090100|467357872|FG001|Overall Study|Lack of Efficacy|7|||
129834121|NCT03090100|467357871|FG000|Overall Study|Lost to Follow-up|2|||
129834122|NCT03090100|467357872|FG001|Overall Study|Lost to Follow-up|2|||
129834123|NCT03090100|467357871|FG000|Overall Study|Withdrawal by Subject|7|||
129834124|NCT03090100|467357872|FG001|Overall Study|Withdrawal by Subject|19|||
129834125|NCT03090100|467357871|FG000|Overall Study|Protocol Violation|2|||
129834126|NCT03090100|467357872|FG001|Overall Study|Protocol Violation|6|||
129834127|NCT03090100|467357871|FG000|Overall Study|Non-compliance|2|||
129834128|NCT03090100|467357872|FG001|Overall Study|Non-compliance|0|||
129834129|NCT03090100|467357871|FG000|Overall Study|Other|2|||
129834130|NCT03090100|467357872|FG001|Overall Study|Other|2|||
129834131|NCT00159588|467357873|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
129834132|NCT00159588|467357874|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
129834133|NCT00159588|467357875|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
129834134|NCT01660711|467357876|FG000|Overall Study|Adverse Event|7|||
129834135|NCT01660711|467357876|FG000|Overall Study|Withdrawal by Subject|1|||
129834136|NCT03253848|467357878|FG000|Overall Study|Adverse Event|7|||
129834137|NCT03253848|467357878|FG000|Overall Study|Death|5|||
129834138|NCT03253848|467357878|FG000|Overall Study|initiation of other treatments|3|||
129834139|NCT03253848|467357878|FG000|Overall Study|Other complicating disease|1|||
129834140|NCT03253848|467357878|FG000|Overall Study|Withdrawal by Subject|1|||
129834141|NCT03253848|467357878|FG000|Overall Study|Declining health|1|||
129834142|NCT05352815|467357879|FG000|Overall Study|Withdrawal by Subject|28|||
129834143|NCT05352815|467357880|FG001|Overall Study|Withdrawal by Subject|24|||
129834144|NCT05352815|467357879|FG000|Overall Study|Lost to Follow-up|4|||
129834145|NCT05352815|467357880|FG001|Overall Study|Lost to Follow-up|7|||
129834146|NCT05352815|467357879|FG000|Overall Study|Death|2|||
129834147|NCT05352815|467357880|FG001|Overall Study|Death|3|||
129834148|NCT05352815|467357879|FG000|Overall Study|Site closure|1|||
129834149|NCT05352815|467357880|FG001|Overall Study|Site closure|0|||
129834150|NCT02759120|467357881|FG000|Overall Study|Death|34|||
129834151|NCT02759120|467357882|FG001|Overall Study|Death|36|||
129834152|NCT02759120|467357881|FG000|Overall Study|Lost to Follow-up|4|||
129834153|NCT02759120|467357882|FG001|Overall Study|Lost to Follow-up|7|||
129834154|NCT02759120|467357881|FG000|Overall Study|Physician Decision|3|||
129834155|NCT02759120|467357882|FG001|Overall Study|Physician Decision|0|||
129834156|NCT02759120|467357881|FG000|Overall Study|Withdrawal by Subject|28|||
129834157|NCT02759120|467357882|FG001|Overall Study|Withdrawal by Subject|15|||
129897784|NCT00762463|467586462|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
129834158|NCT02759120|467357881|FG000|Overall Study|Moved out of area|3|||
129834159|NCT02759120|467357882|FG001|Overall Study|Moved out of area|4|||
129834160|NCT02759120|467357881|FG000|Overall Study|Lung transplant|3|||
129834161|NCT02759120|467357882|FG001|Overall Study|Lung transplant|5|||
129834162|NCT02759120|467357881|FG000|Overall Study|Other reason not completed|10|||
129834163|NCT02759120|467357882|FG001|Overall Study|Other reason not completed|12|||
129834164|NCT03056755|467357884|FG000|Treatment- Core Phase|Progressive disease|89|||
129834165|NCT03056755|467357885|FG001|Treatment- Core Phase|Progressive disease|88|||
129445906|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
129834166|NCT03056755|467357886|FG002|Treatment- Core Phase|Progressive disease|90|||
129445907|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
129445908|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
129445909|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
129445910|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
129445911|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
129445912|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
129445913|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
129445914|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
129445915|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
129445916|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
129445917|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
129445918|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
129445919|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
129445920|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
129445921|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
129445922|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
129445923|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
129445924|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
129445925|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
129445926|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
129445927|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
129445928|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
129445929|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
129445930|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
129445931|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
129445932|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
129445933|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
129445934|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
129445935|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
129445936|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
129445937|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
129445938|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
129445939|NCT03627767|465934565|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
129445940|NCT03627767|465934566|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
129445941|NCT03627767|465934567|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
129445942|NCT03627767|465934568|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
129445943|NCT03627767|465934569|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
129445944|NCT03627767|465934565|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
129445945|NCT03627767|465934566|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
129445946|NCT03627767|465934567|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
129445947|NCT03627767|465934568|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
129445948|NCT03627767|465934569|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
129445949|NCT03627767|465934565|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129445950|NCT03627767|465934566|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129834167|NCT03056755|467357884|FG000|Treatment- Core Phase|Adverse Event|20|||
129834168|NCT03056755|467357885|FG001|Treatment- Core Phase|Adverse Event|14|||
129834169|NCT03056755|467357886|FG002|Treatment- Core Phase|Adverse Event|13|||
129834170|NCT03056755|467357884|FG000|Treatment- Core Phase|Physician Decision|7|||
129834171|NCT03056755|467357885|FG001|Treatment- Core Phase|Physician Decision|13|||
129834172|NCT03056755|467357886|FG002|Treatment- Core Phase|Physician Decision|5|||
129834173|NCT03056755|467357884|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
129834174|NCT03056755|467357885|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
129834175|NCT03056755|467357886|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
129834176|NCT03056755|467357884|FG000|Treatment- Core Phase|Death|3|||
129834177|NCT03056755|467357885|FG001|Treatment- Core Phase|Death|2|||
129834178|NCT03056755|467357886|FG002|Treatment- Core Phase|Death|4|||
129834179|NCT03056755|467357884|FG000|Treatment- Core Phase|Protocol deviation|1|||
129834180|NCT03056755|467357885|FG001|Treatment- Core Phase|Protocol deviation|1|||
129834181|NCT03056755|467357886|FG002|Treatment- Core Phase|Protocol deviation|0|||
129834182|NCT03056755|467357884|FG000|Treatment- Core Phase|Technical problems|1|||
129834183|NCT03056755|467357885|FG001|Treatment- Core Phase|Technical problems|0|||
129834184|NCT03056755|467357886|FG002|Treatment- Core Phase|Technical problems|0|||
129834185|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
129979659|NCT00403767|467889418|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
129834186|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
129834187|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
129834188|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
129834189|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
129834190|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
129834191|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
129834192|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
129834193|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
129834194|NCT03056755|467357884|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
129834195|NCT03056755|467357885|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
129834196|NCT03056755|467357886|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
129834197|NCT03406858|467357887|FG000|Overall Study|Failure to receive treatment drug.|1|||
129834198|NCT03406858|467357887|FG000|Overall Study|ineligible|1|||
129834199|NCT02419742|467357888|FG000|Overall Study|Adverse Event|2|||
129834200|NCT02419742|467357889|FG001|Overall Study|Adverse Event|0|||
129834201|NCT02419742|467357888|FG000|Overall Study|Disease Progression|0|||
129834202|NCT02419742|467357889|FG001|Overall Study|Disease Progression|1|||
129834203|NCT02419742|467357888|FG000|Overall Study|Withdrew Consent|2|||
129834204|NCT02419742|467357889|FG001|Overall Study|Withdrew Consent|1|||
129834205|NCT02419742|467357888|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
129834206|NCT02419742|467357889|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
129834207|NCT05071183|467357898|FG000|Overall Study|Death|1|||
129834208|NCT05071183|467357899|FG001|Overall Study|Death|2|||
129834209|NCT05071183|467357900|FG002|Overall Study|Death|0|||
129834210|NCT05071183|467357898|FG000|Overall Study|Other Reasons|1|||
129834211|NCT05071183|467357899|FG001|Overall Study|Other Reasons|3|||
129834212|NCT05071183|467357900|FG002|Overall Study|Other Reasons|2|||
129834213|NCT02532647|467357908|FG000|Overall Study|Did not receive trial medication|1|||
129834214|NCT02532647|467357909|FG001|Overall Study|Did not receive trial medication|0|||
129834215|NCT02532647|467357910|FG002|Overall Study|Did not receive trial medication|1|||
129834216|NCT02211131|467357911|FG000|Overall Study|Death|26|||
129834217|NCT02211131|467357912|FG001|Overall Study|Death|16|||
129834218|NCT02211131|467357911|FG000|Overall Study|Lost to Follow-up|4|||
129834219|NCT02211131|467357912|FG001|Overall Study|Lost to Follow-up|3|||
129834220|NCT02211131|467357911|FG000|Overall Study|Decision by Sponsor|1|||
129834221|NCT02211131|467357912|FG001|Overall Study|Decision by Sponsor|1|||
129834222|NCT02211131|467357911|FG000|Overall Study|Withdrawal by Subject|3|||
129834223|NCT02211131|467357912|FG001|Overall Study|Withdrawal by Subject|8|||
129834224|NCT02939560|467357914|FG000|Overall Study|Withdrawal by Subject|2|||
129834225|NCT02939560|467357914|FG000|Overall Study|Protocol Violation|1|||
129834226|NCT03340025|467357915|FG000|Overall Study|Lost to Follow-up|2|||
129834227|NCT03340025|467357916|FG001|Overall Study|Lost to Follow-up|2|||
129834228|NCT03897179|467357924|FG000|Overall Study|Withdrawal by Subject|1|||
129834229|NCT00704535|467357925|FG000|Overall Study|Adverse Event|2|||
129834230|NCT00704535|467357925|FG000|Overall Study|Death|2|||
129834231|NCT00704535|467357925|FG000|Overall Study|Lost to Follow-up|8|||
129834232|NCT00704535|467357925|FG000|Overall Study|Protocol Violation|10|||
129897785|NCT00762463|467586463|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
129897786|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
129897787|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
129897788|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
129897789|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
129897790|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
129897791|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
129834233|NCT00704535|467357925|FG000|Overall Study|Completed status not on Case Report Form|124|||
129834234|NCT01480076|467357926|FG000|Overall Study|Run-in Failure|52|||
129834235|NCT01480076|467357926|FG000|Overall Study|Adverse Event|39|||
129834236|NCT01480076|467357926|FG000|Overall Study|Death|2|||
129834237|NCT01480076|467357926|FG000|Overall Study|Disease Progression|5|||
129834238|NCT01480076|467357926|FG000|Overall Study|Non-compliance With Study Protocol|15|||
129834239|NCT01480076|467357926|FG000|Overall Study|Withdrawal by Subject|105|||
129834240|NCT01480076|467357926|FG000|Overall Study|Lost to Follow-up|7|||
129834241|NCT01480076|467357926|FG000|Overall Study|Investigator Decision|13|||
129897792|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
129834242|NCT01480076|467357926|FG000|Overall Study|Other|52|||
129834243|NCT02625090|467357933|FG000|Overall Study|Participant wants to be pregnant|2|||
129834244|NCT02625090|467357933|FG000|Overall Study|For the Promoter|1|||
129834245|NCT02625090|467357933|FG000|Overall Study|Sponsor's Decision|9|||
129834246|NCT02625090|467357933|FG000|Overall Study|Somnolence|1|||
129834247|NCT02625090|467357933|FG000|Overall Study|Study terminated by Sponsor|7|||
129834248|NCT02625090|467357933|FG000|Overall Study|Negative Benefit/Risk|1|||
129445951|NCT03627767|465934567|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
129445952|NCT03627767|465934568|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
129445953|NCT03627767|465934569|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
129445954|NCT03627767|465934565|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
129445955|NCT03627767|465934566|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
129445956|NCT03627767|465934567|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
129445957|NCT03627767|465934568|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
129445958|NCT03627767|465934569|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
129445959|NCT03627767|465934565|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129445960|NCT03627767|465934566|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
129445961|NCT03627767|465934567|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
129445962|NCT03627767|465934568|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
129445963|NCT03627767|465934569|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
129445964|NCT03627767|465934565|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
129445965|NCT03627767|465934566|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
129445966|NCT03627767|465934567|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
129445967|NCT03627767|465934568|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
129445968|NCT03627767|465934569|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
129445969|NCT03627767|465934565|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
129445970|NCT03627767|465934566|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
129445971|NCT03627767|465934567|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
129445972|NCT03627767|465934568|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
129445973|NCT03627767|465934569|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
129445974|NCT03627767|465934565|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
129445975|NCT03627767|465934566|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
129445976|NCT03627767|465934567|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
129445977|NCT03627767|465934568|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
129445978|NCT03627767|465934569|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
129445979|NCT03627767|465934565|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
129445980|NCT03627767|465934566|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
129445981|NCT03627767|465934567|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
129445982|NCT03627767|465934568|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
129445983|NCT03627767|465934569|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
129445984|NCT03627767|465934565|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
129834249|NCT02625090|467357933|FG000|Overall Study|Protocol Deviation|2|||
129834250|NCT02625090|467357933|FG000|Overall Study|Lack of Efficacy|16|||
129834251|NCT02625090|467357933|FG000|Overall Study|Adverse Event|3|||
129834252|NCT02439320|467357934|FG000|Overall Study|Adverse Event|0|||
129834253|NCT02439320|467357935|FG001|Overall Study|Adverse Event|2|||
129834254|NCT02439320|467357936|FG002|Overall Study|Adverse Event|0|||
129834255|NCT02439320|467357934|FG000|Overall Study|Lost to Follow-up|37|||
129834256|NCT02439320|467357935|FG001|Overall Study|Lost to Follow-up|34|||
129834257|NCT02439320|467357936|FG002|Overall Study|Lost to Follow-up|42|||
129834258|NCT02439320|467357934|FG000|Overall Study|Death|0|||
129834259|NCT02439320|467357935|FG001|Overall Study|Death|1|||
129834260|NCT02439320|467357936|FG002|Overall Study|Death|0|||
129834261|NCT02439320|467357934|FG000|Overall Study|Noncompliance with Protocol|10|||
129834262|NCT02439320|467357935|FG001|Overall Study|Noncompliance with Protocol|11|||
129834263|NCT02439320|467357936|FG002|Overall Study|Noncompliance with Protocol|7|||
129834264|NCT02439320|467357934|FG000|Overall Study|Pregnancy|0|||
129834265|NCT02439320|467357935|FG001|Overall Study|Pregnancy|1|||
129834266|NCT02439320|467357936|FG002|Overall Study|Pregnancy|1|||
129834267|NCT02439320|467357934|FG000|Overall Study|Withdrawal by Subject|12|||
129834268|NCT02439320|467357935|FG001|Overall Study|Withdrawal by Subject|16|||
129834269|NCT02439320|467357936|FG002|Overall Study|Withdrawal by Subject|14|||
129834270|NCT02439320|467357934|FG000|Overall Study|Physician Decision|2|||
129834271|NCT02439320|467357935|FG001|Overall Study|Physician Decision|1|||
129834272|NCT02439320|467357936|FG002|Overall Study|Physician Decision|0|||
129834273|NCT02439320|467357934|FG000|Overall Study|Sponsor Request|0|||
129834274|NCT02439320|467357935|FG001|Overall Study|Sponsor Request|2|||
129834275|NCT02439320|467357936|FG002|Overall Study|Sponsor Request|1|||
129834276|NCT02439320|467357934|FG000|Overall Study|Randomization Failure|35|||
129834277|NCT02439320|467357935|FG001|Overall Study|Randomization Failure|46|||
129834278|NCT02439320|467357936|FG002|Overall Study|Randomization Failure|34|||
129834279|NCT02972632|467357937|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129834280|NCT02972632|467357937|FG000|Overall Study|Lost to Follow-up|4|||
129834281|NCT02972632|467357937|FG000|Overall Study|Voluntary Withdrawal|10|||
129834282|NCT01251380|467357942|FG000|Overall Study|Other (Not otherwise specified)|12|||
129834283|NCT01251380|467357942|FG000|Overall Study|Withdrawal by Subject|6|||
129834284|NCT01251380|467357942|FG000|Overall Study|Lack of Efficacy|1|||
129834285|NCT01251380|467357942|FG000|Overall Study|Adverse Event|1|||
129834286|NCT01251380|467357942|FG000|Overall Study|Lost to Follow-up|2|||
129834287|NCT03054870|467357946|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
129834288|NCT03054870|467357946|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
129834289|NCT01154218|467357947|FG000|Third Intervention Period|Adverse Event|0|||
129834290|NCT01154218|467357948|FG001|Third Intervention Period|Adverse Event|1|||
129834291|NCT01154218|467357949|FG002|Third Intervention Period|Adverse Event|0|||
129834292|NCT01154218|467357950|FG003|Third Intervention Period|Adverse Event|0|||
129834293|NCT01154218|467357947|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129834294|NCT01154218|467357948|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129834295|NCT01154218|467357949|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
129834296|NCT01154218|467357950|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
129834297|NCT01154218|467357947|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
129834298|NCT01154218|467357948|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
129834299|NCT01154218|467357949|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
129834300|NCT01154218|467357950|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
129834301|NCT00129129|467357951|FG000|Primary Phase|Adverse Event|2|||
129834302|NCT00129129|467357952|FG001|Primary Phase|Adverse Event|1|||
129834303|NCT00129129|467357953|FG002|Primary Phase|Adverse Event|0|||
129834304|NCT00129129|467357954|FG003|Primary Phase|Adverse Event|0|||
129834305|NCT00129129|467357955|FG004|Primary Phase|Adverse Event|0|||
129834306|NCT00129129|467357951|FG000|Primary Phase|Withdrawal by Subject|12|||
129834307|NCT00129129|467357952|FG001|Primary Phase|Withdrawal by Subject|10|||
129834308|NCT00129129|467357953|FG002|Primary Phase|Withdrawal by Subject|0|||
129834309|NCT00129129|467357954|FG003|Primary Phase|Withdrawal by Subject|0|||
129834310|NCT00129129|467357955|FG004|Primary Phase|Withdrawal by Subject|0|||
129834311|NCT00129129|467357951|FG000|Primary Phase|Migration from study area|1|||
129834312|NCT00129129|467357952|FG001|Primary Phase|Migration from study area|3|||
129834313|NCT00129129|467357953|FG002|Primary Phase|Migration from study area|0|||
129834314|NCT00129129|467357954|FG003|Primary Phase|Migration from study area|0|||
129834315|NCT00129129|467357955|FG004|Primary Phase|Migration from study area|0|||
129834316|NCT00129129|467357951|FG000|Primary Phase|Lost to Follow-up|8|||
129834317|NCT00129129|467357952|FG001|Primary Phase|Lost to Follow-up|6|||
129834318|NCT00129129|467357953|FG002|Primary Phase|Lost to Follow-up|0|||
129834319|NCT00129129|467357954|FG003|Primary Phase|Lost to Follow-up|0|||
129834320|NCT00129129|467357955|FG004|Primary Phase|Lost to Follow-up|0|||
129834321|NCT00129129|467357951|FG000|Primary Phase|Other|2|||
129834322|NCT00129129|467357952|FG001|Primary Phase|Other|5|||
129834323|NCT00129129|467357953|FG002|Primary Phase|Other|0|||
129834324|NCT00129129|467357954|FG003|Primary Phase|Other|0|||
129834325|NCT00129129|467357955|FG004|Primary Phase|Other|0|||
129834326|NCT00129129|467357951|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
129834327|NCT00129129|467357952|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
129834328|NCT00129129|467357953|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
129834329|NCT00129129|467357954|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
129834330|NCT00129129|467357955|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
129834331|NCT00129129|467357951|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
129834332|NCT00129129|467357952|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
129834333|NCT00129129|467357953|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
129834334|NCT00129129|467357954|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
129834335|NCT00129129|467357955|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
129834336|NCT00129129|467357951|FG000|Fourth Dose Phase|Migration from study area|0|||
129834337|NCT00129129|467357952|FG001|Fourth Dose Phase|Migration from study area|0|||
129834338|NCT00129129|467357953|FG002|Fourth Dose Phase|Migration from study area|0|||
129834339|NCT00129129|467357954|FG003|Fourth Dose Phase|Migration from study area|0|||
129834340|NCT00129129|467357955|FG004|Fourth Dose Phase|Migration from study area|2|||
129834341|NCT00129129|467357951|FG000|Fourth Dose Phase|Other|0|||
129834342|NCT00129129|467357952|FG001|Fourth Dose Phase|Other|0|||
129834343|NCT00129129|467357953|FG002|Fourth Dose Phase|Other|0|||
129834344|NCT00129129|467357954|FG003|Fourth Dose Phase|Other|1|||
129834345|NCT00129129|467357955|FG004|Fourth Dose Phase|Other|1|||
129834346|NCT00129129|467357951|FG000|Fourth Dose Phase|Protocol Violation|0|||
129834347|NCT00129129|467357952|FG001|Fourth Dose Phase|Protocol Violation|0|||
129834348|NCT00129129|467357953|FG002|Fourth Dose Phase|Protocol Violation|0|||
129834349|NCT00129129|467357954|FG003|Fourth Dose Phase|Protocol Violation|1|||
129834350|NCT00129129|467357955|FG004|Fourth Dose Phase|Protocol Violation|0|||
129834351|NCT02140567|467357958|FG000|Overall Study|Problems with recording equipment|6|||
129834352|NCT02882854|467357959|FG000|Overall Study|Lost to Follow-up|1|||
129834353|NCT02882854|467357960|FG001|Overall Study|Lost to Follow-up|2|||
129834354|NCT02882854|467357959|FG000|Overall Study|Physician Decision|0|||
129834355|NCT02882854|467357960|FG001|Overall Study|Physician Decision|1|||
129834356|NCT03774433|467357966|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
129834357|NCT00108160|467357967|FG000|Overall Study|Lost to Follow-up|25|||
129834358|NCT00108160|467357968|FG001|Overall Study|Lost to Follow-up|12|||
129834359|NCT00108160|467357967|FG000|Overall Study|Death|1|||
129834360|NCT00108160|467357968|FG001|Overall Study|Death|2|||
129834361|NCT00108160|467357967|FG000|Overall Study|Withdrawal by Subject|4|||
129834362|NCT00108160|467357968|FG001|Overall Study|Withdrawal by Subject|2|||
129834363|NCT00108160|467357967|FG000|Overall Study|Protocol Violation|9|||
129834364|NCT00108160|467357968|FG001|Overall Study|Protocol Violation|5|||
129834365|NCT00004888|467359461|FG000|Overall Study|Adverse Event|5|||
129834366|NCT00004888|467359462|FG001|Overall Study|Adverse Event|10|||
129834367|NCT00004888|467359461|FG000|Overall Study|Withdrawal by Subject|0|||
129834368|NCT00004888|467359462|FG001|Overall Study|Withdrawal by Subject|3|||
129834369|NCT00004888|467359461|FG000|Overall Study|Physician Decision|1|||
129834370|NCT00004888|467359462|FG001|Overall Study|Physician Decision|1|||
129834371|NCT00004888|467359461|FG000|Overall Study|Progressive Disease|4|||
129834372|NCT00004888|467359462|FG001|Overall Study|Progressive Disease|9|||
129834373|NCT00004888|467359461|FG000|Overall Study|Death without progressive disease|0|||
129834374|NCT00004888|467359462|FG001|Overall Study|Death without progressive disease|1|||
129834375|NCT00004888|467359461|FG000|Overall Study|Toxic death|1|||
129834376|NCT00004888|467359462|FG001|Overall Study|Toxic death|0|||
129834377|NCT02579265|467359463|FG000|Overall Study|Weaned off earlier than 28 days|44|||
129834378|NCT02579265|467359464|FG001|Overall Study|Weaned off earlier than 28 days|43|||
129834379|NCT02579265|467359463|FG000|Overall Study|Adverse Event|2|||
129834380|NCT02579265|467359464|FG001|Overall Study|Adverse Event|0|||
129834381|NCT02579265|467359463|FG000|Overall Study|Any other reason not specified|0|||
129834382|NCT02579265|467359464|FG001|Overall Study|Any other reason not specified|2|||
129834383|NCT02579265|467359463|FG000|Overall Study|Withdrawal by Subject|2|||
129834384|NCT02579265|467359464|FG001|Overall Study|Withdrawal by Subject|0|||
129834385|NCT02579265|467359463|FG000|Overall Study|Physician Decision|1|||
129445985|NCT03627767|465934566|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
129445986|NCT03627767|465934567|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
129445987|NCT03627767|465934568|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
129445988|NCT03627767|465934569|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
129445989|NCT03627767|465934565|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
129834386|NCT02579265|467359464|FG001|Overall Study|Physician Decision|0|||
129834387|NCT02579265|467359463|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
129834388|NCT02579265|467359464|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
129834389|NCT02174848|467359465|FG000|Overall Study|Adverse Event|2|||
129834390|NCT02174848|467359466|FG001|Overall Study|Adverse Event|1|||
129834391|NCT02174848|467359465|FG000|Overall Study|Withdrawal by Subject|3|||
129834392|NCT02174848|467359466|FG001|Overall Study|Withdrawal by Subject|3|||
129834393|NCT02174848|467359465|FG000|Overall Study|Lost to Follow-up|0|||
129834394|NCT02174848|467359466|FG001|Overall Study|Lost to Follow-up|1|||
129834395|NCT02174848|467359465|FG000|Overall Study|Worsening of disease|1|||
129834396|NCT02174848|467359466|FG001|Overall Study|Worsening of disease|1|||
129834397|NCT02174848|467359465|FG000|Overall Study|Unable to comply with study requirements|1|||
129834398|NCT02174848|467359466|FG001|Overall Study|Unable to comply with study requirements|0|||
129834399|NCT00644969|467359470|FG000|Treatment Phase|Randomized, not treated|1|||
129834400|NCT00644969|467359471|FG001|Treatment Phase|Randomized, not treated|0|||
129834401|NCT00644969|467359470|FG000|Treatment Phase|Adverse Event|3|||
129834402|NCT00644969|467359471|FG001|Treatment Phase|Adverse Event|0|||
129897793|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
129897794|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
129897795|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
129897796|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
129897797|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
129897798|NCT00762463|467586460|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
129897799|NCT00762463|467586461|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
129897800|NCT00762463|467586462|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
129897801|NCT00762463|467586463|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
129897802|NCT01306331|467586466|FG000|Overall Study|Adverse Event|28|||
129897803|NCT01306331|467586467|FG001|Overall Study|Adverse Event|25|||
129897804|NCT01306331|467586466|FG000|Overall Study|Lost to Follow-up|321|||
129897805|NCT01306331|467586467|FG001|Overall Study|Lost to Follow-up|323|||
129897806|NCT01306331|467586466|FG000|Overall Study|Physician Decision|26|||
129445990|NCT03627767|465934566|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
129834403|NCT00644969|467359470|FG000|Treatment Phase|Withdrawal by Subject|4|||
129834404|NCT00644969|467359471|FG001|Treatment Phase|Withdrawal by Subject|0|||
129834405|NCT00644969|467359470|FG000|Treatment Phase|Lost to Follow-up|2|||
129834406|NCT00644969|467359471|FG001|Treatment Phase|Lost to Follow-up|2|||
129834407|NCT00644969|467359470|FG000|Treatment Phase|Other|4|||
129834408|NCT00644969|467359471|FG001|Treatment Phase|Other|1|||
129834409|NCT00644969|467359470|FG000|Post Treatment Phase|Death|1|||
129834410|NCT00644969|467359471|FG001|Post Treatment Phase|Death|0|||
129834411|NCT00644969|467359470|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
129834412|NCT00644969|467359471|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
129834413|NCT00644969|467359470|FG000|Post Treatment Phase|Lost to Follow-up|4|||
129897807|NCT01306331|467586467|FG001|Overall Study|Physician Decision|22|||
129897808|NCT01306331|467586466|FG000|Overall Study|Pregnancy|136|||
129834414|NCT00644969|467359471|FG001|Post Treatment Phase|Lost to Follow-up|1|||
129834415|NCT00644969|467359470|FG000|Post Treatment Phase|Other|1|||
129834416|NCT00644969|467359471|FG001|Post Treatment Phase|Other|0|||
129834417|NCT00666757|467359479|FG000|Overall Study|Lost to Follow-up|39|||
129834418|NCT00666757|467359480|FG001|Overall Study|Lost to Follow-up|35|||
129834419|NCT00666757|467359479|FG000|Overall Study|Protocol Violation|23|||
129834420|NCT00666757|467359480|FG001|Overall Study|Protocol Violation|24|||
129834421|NCT00666757|467359479|FG000|Overall Study|Adverse Event|22|||
129834422|NCT00666757|467359480|FG001|Overall Study|Adverse Event|12|||
129834423|NCT00666757|467359479|FG000|Overall Study|Withdrawal by Subject|13|||
129834424|NCT00666757|467359480|FG001|Overall Study|Withdrawal by Subject|17|||
129834425|NCT00666757|467359479|FG000|Overall Study|Lack of Efficacy|3|||
129834426|NCT00666757|467359480|FG001|Overall Study|Lack of Efficacy|6|||
129834427|NCT00666757|467359479|FG000|Overall Study|Physician Decision|0|||
129834428|NCT00666757|467359480|FG001|Overall Study|Physician Decision|2|||
129834429|NCT00666757|467359479|FG000|Overall Study|Sponsor decision|0|||
129834430|NCT00666757|467359480|FG001|Overall Study|Sponsor decision|1|||
129834431|NCT00952341|467359485|FG000|Cycle 1|Adverse Event|4|||
129834432|NCT00952341|467359486|FG001|Cycle 1|Adverse Event|1|||
129834433|NCT00952341|467359485|FG000|Cycle 1|Withdrawal by Subject|3|||
129834434|NCT00952341|467359486|FG001|Cycle 1|Withdrawal by Subject|8|||
129834435|NCT00952341|467359485|FG000|Cycle 1|Protocol Violation|2|||
129834436|NCT00952341|467359486|FG001|Cycle 1|Protocol Violation|1|||
129834437|NCT00952341|467359485|FG000|Cycle 1|Lost to Follow-up|11|||
129834438|NCT00952341|467359486|FG001|Cycle 1|Lost to Follow-up|2|||
129834439|NCT00952341|467359485|FG000|Cycle 1|Physician Decision|0|||
129834440|NCT00952341|467359486|FG001|Cycle 1|Physician Decision|1|||
129834441|NCT00952341|467359485|FG000|Cycle 2|Withdrawal by Subject|1|||
129834442|NCT00952341|467359486|FG001|Cycle 2|Withdrawal by Subject|1|||
129834443|NCT00952341|467359485|FG000|Cycle 2|Protocol Violation|1|||
129834444|NCT00952341|467359486|FG001|Cycle 2|Protocol Violation|0|||
129834445|NCT00952341|467359485|FG000|Cycle 2|Lost to Follow-up|6|||
129834446|NCT00952341|467359486|FG001|Cycle 2|Lost to Follow-up|9|||
129834447|NCT00952341|467359485|FG000|Cycle 2|Physician Decision|1|||
129834448|NCT00952341|467359486|FG001|Cycle 2|Physician Decision|1|||
129834449|NCT00952341|467359485|FG000|Cycle 2|Progressive Disease|0|||
129834450|NCT00952341|467359486|FG001|Cycle 2|Progressive Disease|1|||
129834451|NCT04920123|467359487|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
129834452|NCT04920123|467359488|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129834453|NCT04920123|467359489|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
129834454|NCT00278954|467359492|FG000|Overall Study|Adverse Event|3|||
129834455|NCT00278954|467359492|FG000|Overall Study|Lost to Follow-up|1|||
129834456|NCT00278954|467359492|FG000|Overall Study|Withdrawal by Subject|1|||
129834457|NCT02420691|467359498|FG000|Overall Study|Adverse Event|3|||
129834458|NCT02420691|467359498|FG000|Overall Study|Withdrawal by Subject|3|||
129834459|NCT02503332|467359501|FG000|Overall Study|Adverse Event|17|||
129834460|NCT02503332|467359502|FG001|Overall Study|Adverse Event|5|||
129834461|NCT02503332|467359503|FG002|Overall Study|Adverse Event|3|||
129834462|NCT02503332|467359504|FG003|Overall Study|Adverse Event|1|||
129834463|NCT02503332|467359501|FG000|Overall Study|Investigator's Decision|5|||
129834464|NCT02503332|467359502|FG001|Overall Study|Investigator's Decision|1|||
129834465|NCT02503332|467359503|FG002|Overall Study|Investigator's Decision|0|||
129834466|NCT02503332|467359504|FG003|Overall Study|Investigator's Decision|0|||
129834467|NCT02503332|467359501|FG000|Overall Study|Sponsor's Decision|1|||
129834468|NCT02503332|467359502|FG001|Overall Study|Sponsor's Decision|0|||
129834469|NCT02503332|467359503|FG002|Overall Study|Sponsor's Decision|0|||
129834470|NCT02503332|467359504|FG003|Overall Study|Sponsor's Decision|1|||
129834471|NCT02503332|467359501|FG000|Overall Study|Subject Request|6|||
129834472|NCT02503332|467359502|FG001|Overall Study|Subject Request|5|||
129834473|NCT02503332|467359503|FG002|Overall Study|Subject Request|2|||
129834474|NCT02503332|467359504|FG003|Overall Study|Subject Request|1|||
129834475|NCT02503332|467359501|FG000|Overall Study|Death|0|||
129834476|NCT02503332|467359502|FG001|Overall Study|Death|2|||
129834477|NCT02503332|467359503|FG002|Overall Study|Death|2|||
129834478|NCT02503332|467359504|FG003|Overall Study|Death|0|||
129834479|NCT02503332|467359501|FG000|Overall Study|Other|5|||
129834480|NCT02503332|467359502|FG001|Overall Study|Other|6|||
129834481|NCT02503332|467359503|FG002|Overall Study|Other|1|||
129834482|NCT02503332|467359504|FG003|Overall Study|Other|1|||
129834483|NCT01413360|467359505|FG000|Overall Study|Lost to Follow-up|2|||
129834484|NCT01413360|467359505|FG000|Overall Study|Adverse Event|1|||
129834485|NCT05694546|467359508|FG000|Overall Study|Lost to Follow-up|11|||
129834486|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
129834487|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
129834488|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
129834489|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
129834490|NCT01589445|467359512|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
129834491|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
129834492|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
129897809|NCT01306331|467586467|FG001|Overall Study|Pregnancy|151|||
129834493|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
129834494|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
129834495|NCT01589445|467359512|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
129834496|NCT01488097|467359521|FG000|Overall Study|Lost to Follow-up|1|||
129834497|NCT02016482|467359525|FG000|Period A|Adverse Event|3|||
129834498|NCT02016482|467359526|FG001|Period A|Adverse Event|5|||
129834499|NCT02016482|467359525|FG000|Period A|Withdrawal by Subject|3|||
129834500|NCT02016482|467359526|FG001|Period A|Withdrawal by Subject|4|||
129834501|NCT02016482|467359525|FG000|Period A|Lost to Follow-up|3|||
129834502|NCT02016482|467359526|FG001|Period A|Lost to Follow-up|3|||
129834503|NCT02016482|467359525|FG000|Period A|Lack of Efficacy|2|||
129834504|NCT02016482|467359526|FG001|Period A|Lack of Efficacy|1|||
129834505|NCT02016482|467359525|FG000|Period A|Other|3|||
129834506|NCT02016482|467359526|FG001|Period A|Other|0|||
129834507|NCT02016482|467359525|FG000|Period A|Protocol Violation|0|||
129834508|NCT02016482|467359526|FG001|Period A|Protocol Violation|1|||
129834509|NCT02016482|467359525|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
129834510|NCT02016482|467359526|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
129834511|NCT02016482|467359525|FG000|Period B|Withdrawal by Subject|1|||
129834512|NCT02016482|467359526|FG001|Period B|Withdrawal by Subject|1|||
129834513|NCT02016482|467359525|FG000|Period B|Lost to Follow-up|2|||
129834514|NCT02016482|467359526|FG001|Period B|Lost to Follow-up|0|||
129834515|NCT02016482|467359525|FG000|Period B|Lack of Efficacy|6|||
129834516|NCT02016482|467359526|FG001|Period B|Lack of Efficacy|4|||
129834517|NCT02016482|467359525|FG000|Period B|Other|4|||
129834518|NCT02016482|467359526|FG001|Period B|Other|0|||
129834519|NCT02016482|467359525|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
129834520|NCT02016482|467359526|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
129834521|NCT03089606|467359540|FG000|Overall Study|Progression after Cycle 1|1|||
129834522|NCT01709695|467359544|FG000|Overall Study|Withdrawal by Subject|1|||
129834523|NCT01709695|467359545|FG001|Overall Study|Withdrawal by Subject|1|||
129834524|NCT02802592|467359546|FG000|Overall Study|Study terminated due to loss of funding|4|||
129834525|NCT01150123|467359548|FG000|Overall Study|Withdrawal by Subject|1|||
129834526|NCT01150123|467359549|FG001|Overall Study|Withdrawal by Subject|1|||
129834527|NCT01150123|467359550|FG002|Overall Study|Withdrawal by Subject|2|||
129834528|NCT01150123|467359551|FG003|Overall Study|Withdrawal by Subject|1|||
129834529|NCT01150123|467359552|FG004|Overall Study|Withdrawal by Subject|1|||
129834530|NCT01150123|467359553|FG005|Overall Study|Withdrawal by Subject|1|||
129834531|NCT01150123|467359554|FG006|Overall Study|Withdrawal by Subject|0|||
129834532|NCT01150123|467359555|FG007|Overall Study|Withdrawal by Subject|3|||
129834533|NCT01150123|467359556|FG008|Overall Study|Withdrawal by Subject|2|||
129834534|NCT01150123|467359557|FG009|Overall Study|Withdrawal by Subject|0|||
129834535|NCT01150123|467359558|FG010|Overall Study|Withdrawal by Subject|1|||
129834536|NCT01150123|467359559|FG011|Overall Study|Withdrawal by Subject|0|||
129834537|NCT01150123|467359560|FG012|Overall Study|Withdrawal by Subject|1|||
129834538|NCT01150123|467359561|FG013|Overall Study|Withdrawal by Subject|0|||
129834539|NCT01150123|467359562|FG014|Overall Study|Withdrawal by Subject|0|||
129834540|NCT01150123|467359563|FG015|Overall Study|Withdrawal by Subject|1|||
129834541|NCT01150123|467359564|FG016|Overall Study|Withdrawal by Subject|0|||
129834542|NCT01150123|467359565|FG017|Overall Study|Withdrawal by Subject|1|||
129834543|NCT01150123|467359548|FG000|Overall Study|Lost to Follow-up|2|||
129834544|NCT01150123|467359549|FG001|Overall Study|Lost to Follow-up|1|||
129834545|NCT01150123|467359550|FG002|Overall Study|Lost to Follow-up|2|||
129834546|NCT01150123|467359551|FG003|Overall Study|Lost to Follow-up|2|||
129834547|NCT01150123|467359552|FG004|Overall Study|Lost to Follow-up|2|||
129834548|NCT01150123|467359553|FG005|Overall Study|Lost to Follow-up|5|||
129834549|NCT01150123|467359554|FG006|Overall Study|Lost to Follow-up|0|||
129834550|NCT01150123|467359555|FG007|Overall Study|Lost to Follow-up|0|||
129834551|NCT01150123|467359556|FG008|Overall Study|Lost to Follow-up|3|||
129834552|NCT01150123|467359557|FG009|Overall Study|Lost to Follow-up|1|||
129834553|NCT01150123|467359558|FG010|Overall Study|Lost to Follow-up|1|||
129834554|NCT01150123|467359559|FG011|Overall Study|Lost to Follow-up|1|||
129834555|NCT01150123|467359560|FG012|Overall Study|Lost to Follow-up|2|||
129834556|NCT01150123|467359561|FG013|Overall Study|Lost to Follow-up|0|||
129834557|NCT01150123|467359562|FG014|Overall Study|Lost to Follow-up|0|||
129834558|NCT01150123|467359563|FG015|Overall Study|Lost to Follow-up|0|||
129834559|NCT01150123|467359564|FG016|Overall Study|Lost to Follow-up|0|||
129834560|NCT01150123|467359565|FG017|Overall Study|Lost to Follow-up|0|||
129834561|NCT02347189|467359568|FG000|Overall Study|No implant attempted of study device|9|||
129834562|NCT02347189|467359568|FG000|Overall Study|No primary outcome data available|2|||
129834563|NCT00735878|467359569|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
129834564|NCT00735878|467359570|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
129834565|NCT00735878|467359571|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
129834566|NCT00994240|467359572|FG000|Overall Study|Lost to Follow-up|3|||
129834567|NCT00994240|467359573|FG001|Overall Study|Lost to Follow-up|2|||
129834568|NCT00994240|467359572|FG000|Overall Study|Withdrawal by Subject|1|||
129834569|NCT00994240|467359573|FG001|Overall Study|Withdrawal by Subject|0|||
129834570|NCT00994240|467359572|FG000|Overall Study|study termination|2|||
129834571|NCT00994240|467359573|FG001|Overall Study|study termination|3|||
129834572|NCT00352846|467359574|FG000|Overall Study|Disease progression|0|||
129834573|NCT00352846|467359575|FG001|Overall Study|Disease progression|2|||
129834574|NCT00352846|467359574|FG000|Overall Study|Withdrawal by Subject|3|||
129834575|NCT00352846|467359575|FG001|Overall Study|Withdrawal by Subject|8|||
129834576|NCT00352846|467359574|FG000|Overall Study|Ineligible|3|||
129834577|NCT00352846|467359575|FG001|Overall Study|Ineligible|2|||
129834578|NCT00352846|467359574|FG000|Overall Study|Non-compliance|2|||
129834579|NCT00352846|467359575|FG001|Overall Study|Non-compliance|0|||
129834580|NCT00352846|467359574|FG000|Overall Study|Death|0|||
129834581|NCT00352846|467359575|FG001|Overall Study|Death|1|||
129834582|NCT00788827|467359576|FG000|Overall Study|Lack of Efficacy|2|||
129834583|NCT01527682|467359583|FG000|Overall Study|Protocol Violation|8|||
129834584|NCT01586819|467359584|FG000|Overall Study|Withdrawal by Subject|1|||
129834585|NCT01586819|467359585|FG001|Overall Study|Withdrawal by Subject|0|||
129834586|NCT01359254|467359586|FG000|Overall Study|Death|1|||
129834587|NCT01359254|467359587|FG001|Overall Study|Death|0|||
129834588|NCT03979638|467359589|FG000|Period 1|Physician Decision|1|||
129834589|NCT03979638|467359590|FG001|Period 1|Physician Decision|1|||
129834590|NCT03979638|467359589|FG000|Period 1|Withdrawal by Subject|4|||
129834591|NCT03979638|467359590|FG001|Period 1|Withdrawal by Subject|3|||
129834592|NCT03979638|467359589|FG000|Period 1|Study terminated by Sponsor|1|||
129834593|NCT03979638|467359590|FG001|Period 1|Study terminated by Sponsor|3|||
129834594|NCT03979638|467359589|FG000|Period 1|Protocol Violation|1|||
129834595|NCT03979638|467359590|FG001|Period 1|Protocol Violation|0|||
129834596|NCT03979638|467359589|FG000|Period 2|Study terminated by Sponsor|1|||
129834597|NCT03979638|467359590|FG001|Period 2|Study terminated by Sponsor|1|||
129834598|NCT04248933|467359593|FG000|Overall Study|Lost to Follow-up|9|||
129834599|NCT04248933|467359593|FG000|Overall Study|Withdrawal by Subject|2|||
129834600|NCT00578942|467359594|FG000|Overall Study|Lost to Follow-up|1|||
129834601|NCT00600938|467359605|FG000|Core Study|Abnormal test procedure result(s)|3|||
129834602|NCT00600938|467359606|FG001|Core Study|Abnormal test procedure result(s)|2|||
129834603|NCT00600938|467359607|FG002|Core Study|Abnormal test procedure result(s)|0|||
129834604|NCT00600938|467359608|FG003|Core Study|Abnormal test procedure result(s)|0|||
129834605|NCT00600938|467359605|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
129834606|NCT00600938|467359606|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
129834607|NCT00600938|467359607|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
129834608|NCT00600938|467359608|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
129834609|NCT00600938|467359605|FG000|Core Study|Patient withdrew consent|7|||
129834610|NCT00600938|467359606|FG001|Core Study|Patient withdrew consent|12|||
129834611|NCT00600938|467359607|FG002|Core Study|Patient withdrew consent|0|||
129834612|NCT00600938|467359608|FG003|Core Study|Patient withdrew consent|0|||
129834613|NCT00600938|467359605|FG000|Core Study|Lost to Follow-up|3|||
129834614|NCT00600938|467359606|FG001|Core Study|Lost to Follow-up|2|||
129834615|NCT00600938|467359607|FG002|Core Study|Lost to Follow-up|0|||
129834616|NCT00600938|467359608|FG003|Core Study|Lost to Follow-up|0|||
129834617|NCT00600938|467359605|FG000|Core Study|Death|1|||
129834618|NCT00600938|467359606|FG001|Core Study|Death|1|||
129834619|NCT00600938|467359607|FG002|Core Study|Death|0|||
129834620|NCT00600938|467359608|FG003|Core Study|Death|0|||
129834621|NCT00600938|467359605|FG000|Core Study|Protocol Violation|1|||
129834622|NCT00600938|467359606|FG001|Core Study|Protocol Violation|2|||
129445991|NCT03627767|465934567|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
129445992|NCT03627767|465934568|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
129445993|NCT03627767|465934569|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
129445994|NCT04163900|465934572|FG000|Overall Study|Radiological disease progression|112|||
129445995|NCT04163900|465934573|FG001|Overall Study|Radiological disease progression|127|||
129834623|NCT00600938|467359607|FG002|Core Study|Protocol Violation|0|||
129834624|NCT00600938|467359608|FG003|Core Study|Protocol Violation|0|||
129834625|NCT00600938|467359605|FG000|Extension Study|Adverse Event|1|||
129834626|NCT00600938|467359606|FG001|Extension Study|Adverse Event|0|||
129834627|NCT00600938|467359607|FG002|Extension Study|Adverse Event|2|||
129834628|NCT00600938|467359608|FG003|Extension Study|Adverse Event|0|||
129834629|NCT00600938|467359605|FG000|Extension Study|Abnormal test procedure results|0|||
129834630|NCT00600938|467359606|FG001|Extension Study|Abnormal test procedure results|1|||
129834631|NCT00600938|467359607|FG002|Extension Study|Abnormal test procedure results|1|||
129834632|NCT00600938|467359608|FG003|Extension Study|Abnormal test procedure results|1|||
129834633|NCT00600938|467359605|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
129834634|NCT00600938|467359606|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
129834635|NCT00600938|467359607|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
129834636|NCT00600938|467359608|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
129834637|NCT00600938|467359605|FG000|Extension Study|Withdrawal by Subject|2|||
129834638|NCT00600938|467359606|FG001|Extension Study|Withdrawal by Subject|2|||
129445996|NCT04163900|465934572|FG000|Overall Study|Study closure|98|||
129445997|NCT04163900|465934573|FG001|Overall Study|Study closure|133|||
129445998|NCT04163900|465934572|FG000|Overall Study|Adverse Event|78|||
129834639|NCT00600938|467359607|FG002|Extension Study|Withdrawal by Subject|3|||
129834640|NCT00600938|467359608|FG003|Extension Study|Withdrawal by Subject|0|||
129897810|NCT01306331|467586466|FG000|Overall Study|Protocol Violation|154|||
129834641|NCT00600938|467359605|FG000|Extension Study|Lost to Follow-up|1|||
129834642|NCT00600938|467359606|FG001|Extension Study|Lost to Follow-up|1|||
129834643|NCT00600938|467359607|FG002|Extension Study|Lost to Follow-up|2|||
129834644|NCT00600938|467359608|FG003|Extension Study|Lost to Follow-up|0|||
129834645|NCT00600938|467359605|FG000|Extension Study|Death|1|||
129834646|NCT00600938|467359606|FG001|Extension Study|Death|0|||
129834647|NCT00600938|467359607|FG002|Extension Study|Death|0|||
129834648|NCT00600938|467359608|FG003|Extension Study|Death|0|||
129834649|NCT04056195|467359609|FG000|Overall Study|Adverse Event|1|||
129834650|NCT04056195|467359610|FG001|Overall Study|Adverse Event|0|||
129834651|NCT04056195|467359611|FG002|Overall Study|Adverse Event|0|||
129834652|NCT04056195|467359609|FG000|Overall Study|Withdrawal by Subject|0|||
129834653|NCT04056195|467359610|FG001|Overall Study|Withdrawal by Subject|1|||
129834654|NCT04056195|467359611|FG002|Overall Study|Withdrawal by Subject|1|||
129834655|NCT04056195|467359609|FG000|Overall Study|Physician Decision|1|||
129834656|NCT04056195|467359610|FG001|Overall Study|Physician Decision|1|||
129834657|NCT04056195|467359611|FG002|Overall Study|Physician Decision|1|||
129834658|NCT00549562|467359612|FG000|Overall Study|Adverse Event|1|||
129834659|NCT00549562|467359612|FG000|Overall Study|Lack of Efficacy|1|||
129834660|NCT04365556|467359615|FG000|Overall Study|No longer eligible due to treatment plan|1|||
129834661|NCT04365556|467359616|FG001|Overall Study|No longer eligible due to treatment plan|0|||
129834662|NCT04365556|467359615|FG000|Overall Study|Lost to Follow-up|3|||
129834663|NCT04365556|467359616|FG001|Overall Study|Lost to Follow-up|2|||
129834664|NCT04439318|467359619|FG000|Overall Study|Ineligible|1|||
129834665|NCT04439318|467359619|FG000|Overall Study|Never Started Treatment|3|||
129834666|NCT04439318|467359619|FG000|Overall Study|Adverse Event|10|||
129834667|NCT04439318|467359619|FG000|Overall Study|Death|2|||
129834668|NCT04439318|467359619|FG000|Overall Study|Disease Progression|25|||
129834669|NCT04439318|467359619|FG000|Overall Study|Other Complicating Disease|2|||
129834670|NCT04439318|467359619|FG000|Overall Study|Withdrawal by Subject|4|||
129834671|NCT04439318|467359619|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
129834672|NCT04439318|467359619|FG000|Overall Study|Non-Compliance|1|||
129834673|NCT04439318|467359619|FG000|Overall Study|Still on Treatment|1|||
129834674|NCT00699972|467360981|FG000|Overall Study|Adverse Event|7|||
129834675|NCT00699972|467360982|FG001|Overall Study|Adverse Event|9|||
129834676|NCT00699972|467360983|FG002|Overall Study|Adverse Event|24|||
129834677|NCT00699972|467360981|FG000|Overall Study|Lost to Follow-up|0|||
129834678|NCT00699972|467360982|FG001|Overall Study|Lost to Follow-up|2|||
129834679|NCT00699972|467360983|FG002|Overall Study|Lost to Follow-up|0|||
129834680|NCT00699972|467360981|FG000|Overall Study|Withdrawal by Subject|3|||
129834681|NCT00699972|467360982|FG001|Overall Study|Withdrawal by Subject|7|||
129834682|NCT00699972|467360983|FG002|Overall Study|Withdrawal by Subject|4|||
129834683|NCT00699972|467360981|FG000|Overall Study|Lack of Efficacy|2|||
129834684|NCT00699972|467360982|FG001|Overall Study|Lack of Efficacy|0|||
129834685|NCT00699972|467360983|FG002|Overall Study|Lack of Efficacy|2|||
129834686|NCT00699972|467360981|FG000|Overall Study|Administrative/Other|3|||
129834687|NCT00699972|467360982|FG001|Overall Study|Administrative/Other|1|||
129834688|NCT00699972|467360983|FG002|Overall Study|Administrative/Other|4|||
129834689|NCT00699972|467360981|FG000|Overall Study|Randomized, Not Treated|1|||
129834690|NCT00699972|467360982|FG001|Overall Study|Randomized, Not Treated|0|||
129834691|NCT00699972|467360983|FG002|Overall Study|Randomized, Not Treated|1|||
129834692|NCT03509675|467360988|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
129834693|NCT03509675|467360989|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
129834694|NCT03509675|467360988|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
129834695|NCT03509675|467360989|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
129834696|NCT03509675|467360988|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
129834697|NCT03509675|467360989|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
129834698|NCT03509675|467360988|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
129834699|NCT03509675|467360989|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
129834700|NCT01023581|467360992|FG000|Overall Study|Adverse Event|4|||
129834701|NCT01023581|467360993|FG001|Overall Study|Adverse Event|4|||
129897811|NCT01306331|467586467|FG001|Overall Study|Protocol Violation|124|||
129897812|NCT01306331|467586466|FG000|Overall Study|Withdrawal by Subject|163|||
129834702|NCT01023581|467360994|FG002|Overall Study|Adverse Event|7|||
129897813|NCT01306331|467586467|FG001|Overall Study|Withdrawal by Subject|152|||
129834703|NCT01023581|467360995|FG003|Overall Study|Adverse Event|3|||
129834704|NCT01023581|467360996|FG004|Overall Study|Adverse Event|2|||
129834705|NCT01023581|467360997|FG005|Overall Study|Adverse Event|5|||
129834706|NCT01023581|467360998|FG006|Overall Study|Adverse Event|11|||
129834707|NCT01023581|467360992|FG000|Overall Study|Major protocol deviation|2|||
129834708|NCT01023581|467360993|FG001|Overall Study|Major protocol deviation|0|||
129834709|NCT01023581|467360994|FG002|Overall Study|Major protocol deviation|3|||
129834710|NCT01023581|467360995|FG003|Overall Study|Major protocol deviation|0|||
129834711|NCT01023581|467360996|FG004|Overall Study|Major protocol deviation|0|||
129834712|NCT01023581|467360997|FG005|Overall Study|Major protocol deviation|0|||
129834713|NCT01023581|467360998|FG006|Overall Study|Major protocol deviation|0|||
129834714|NCT01023581|467360992|FG000|Overall Study|Lost to Follow-up|4|||
129834715|NCT01023581|467360993|FG001|Overall Study|Lost to Follow-up|8|||
129834716|NCT01023581|467360994|FG002|Overall Study|Lost to Follow-up|7|||
129834717|NCT01023581|467360995|FG003|Overall Study|Lost to Follow-up|2|||
129834718|NCT01023581|467360996|FG004|Overall Study|Lost to Follow-up|5|||
129834719|NCT01023581|467360997|FG005|Overall Study|Lost to Follow-up|2|||
129834720|NCT01023581|467360998|FG006|Overall Study|Lost to Follow-up|2|||
129834721|NCT01023581|467360992|FG000|Overall Study|Withdrawal by Subject|13|||
129834722|NCT01023581|467360993|FG001|Overall Study|Withdrawal by Subject|8|||
129834723|NCT01023581|467360994|FG002|Overall Study|Withdrawal by Subject|16|||
129834724|NCT01023581|467360995|FG003|Overall Study|Withdrawal by Subject|10|||
129834725|NCT01023581|467360996|FG004|Overall Study|Withdrawal by Subject|6|||
129834726|NCT01023581|467360997|FG005|Overall Study|Withdrawal by Subject|8|||
129834727|NCT01023581|467360998|FG006|Overall Study|Withdrawal by Subject|5|||
129834728|NCT01023581|467360992|FG000|Overall Study|Pregnancy|0|||
129834729|NCT01023581|467360993|FG001|Overall Study|Pregnancy|0|||
129834730|NCT01023581|467360994|FG002|Overall Study|Pregnancy|0|||
129834731|NCT01023581|467360995|FG003|Overall Study|Pregnancy|2|||
129834732|NCT01023581|467360996|FG004|Overall Study|Pregnancy|0|||
129834733|NCT01023581|467360997|FG005|Overall Study|Pregnancy|1|||
129834734|NCT01023581|467360998|FG006|Overall Study|Pregnancy|0|||
129834735|NCT01023581|467360992|FG000|Overall Study|Lack of Efficacy|9|||
129834736|NCT01023581|467360993|FG001|Overall Study|Lack of Efficacy|3|||
129834737|NCT01023581|467360994|FG002|Overall Study|Lack of Efficacy|6|||
129834738|NCT01023581|467360995|FG003|Overall Study|Lack of Efficacy|2|||
129834739|NCT01023581|467360996|FG004|Overall Study|Lack of Efficacy|1|||
129834740|NCT01023581|467360997|FG005|Overall Study|Lack of Efficacy|2|||
129834741|NCT01023581|467360998|FG006|Overall Study|Lack of Efficacy|1|||
129834742|NCT01023581|467360992|FG000|Overall Study|Physician Decision|2|||
129834743|NCT01023581|467360993|FG001|Overall Study|Physician Decision|0|||
129834744|NCT01023581|467360994|FG002|Overall Study|Physician Decision|2|||
129834745|NCT01023581|467360995|FG003|Overall Study|Physician Decision|1|||
129834746|NCT01023581|467360996|FG004|Overall Study|Physician Decision|1|||
129834747|NCT01023581|467360997|FG005|Overall Study|Physician Decision|1|||
129834748|NCT01023581|467360998|FG006|Overall Study|Physician Decision|1|||
129834749|NCT01023581|467360992|FG000|Overall Study|Other|1|||
129897814|NCT01306331|467586466|FG000|Overall Study|Not sexually active|29|||
129897815|NCT01306331|467586467|FG001|Overall Study|Not sexually active|28|||
129897816|NCT01306331|467586466|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
129897817|NCT01306331|467586467|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
129897818|NCT01306331|467586466|FG000|Overall Study|Other|34|||
129897819|NCT01306331|467586467|FG001|Overall Study|Other|32|||
129897820|NCT04048135|467586470|FG000|Overall Study|Withdrawal by Subject|1|||
129897821|NCT04048135|467586471|FG001|Overall Study|Withdrawal by Subject|1|||
129897822|NCT04048135|467586472|FG002|Overall Study|Withdrawal by Subject|1|||
129897823|NCT04048135|467586473|FG003|Overall Study|Withdrawal by Subject|2|||
129897824|NCT04048135|467586474|FG004|Overall Study|Withdrawal by Subject|0|||
129897825|NCT04048135|467586475|FG005|Overall Study|Withdrawal by Subject|0|||
129897826|NCT04048135|467586476|FG006|Overall Study|Withdrawal by Subject|1|||
129834750|NCT01023581|467360993|FG001|Overall Study|Other|0|||
129834751|NCT01023581|467360994|FG002|Overall Study|Other|1|||
129834752|NCT01023581|467360995|FG003|Overall Study|Other|0|||
129834753|NCT01023581|467360996|FG004|Overall Study|Other|1|||
129834754|NCT01023581|467360997|FG005|Overall Study|Other|0|||
129834755|NCT01023581|467360998|FG006|Overall Study|Other|0|||
129897827|NCT04048135|467586477|FG007|Overall Study|Withdrawal by Subject|1|||
129834756|NCT01723163|467360999|FG000|Treatment Phase|Withdrawal by Subject|14|||
129834757|NCT01723163|467361000|FG001|Treatment Phase|Withdrawal by Subject|6|||
129834758|NCT01723163|467360999|FG000|Treatment Phase|Withdrawal by PI|5|||
129834759|NCT01723163|467361000|FG001|Treatment Phase|Withdrawal by PI|1|||
129834760|NCT01723163|467360999|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
129834761|NCT01723163|467361000|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
129897828|NCT04048135|467586470|FG000|Overall Study|Adverse Event|0|||
129897829|NCT04048135|467586471|FG001|Overall Study|Adverse Event|0|||
129897830|NCT04048135|467586472|FG002|Overall Study|Adverse Event|0|||
129834762|NCT01723163|467360999|FG000|3-Month Follow-up|Unable to Contact|12|||
129834763|NCT01723163|467361000|FG001|3-Month Follow-up|Unable to Contact|19|||
129834764|NCT01723163|467360999|FG000|6-Month Follow-up|Death|1|||
129834765|NCT01723163|467361000|FG001|6-Month Follow-up|Death|0|||
129834766|NCT01723163|467360999|FG000|6-Month Follow-up|Unable to Contact|17|||
129834767|NCT01723163|467361000|FG001|6-Month Follow-up|Unable to Contact|15|||
129834768|NCT01723163|467360999|FG000|12-Month Follow-up|Death|1|||
129834769|NCT01723163|467361000|FG001|12-Month Follow-up|Death|0|||
129834770|NCT01723163|467360999|FG000|12-Month Follow-up|Unable to Contact|23|||
129834771|NCT01723163|467361000|FG001|12-Month Follow-up|Unable to Contact|28|||
129834772|NCT05664490|467361008|FG000|Overall Study|Withdrawal by Subject|0|||
129834773|NCT05664490|467361009|FG001|Overall Study|Withdrawal by Subject|1|||
129834774|NCT05664490|467361008|FG000|Overall Study|Lost to Follow-up|14|||
129834775|NCT05664490|467361009|FG001|Overall Study|Lost to Follow-up|22|||
129834776|NCT00325754|467361010|FG000|Overall Study|Adverse Event|4|||
129834777|NCT00325754|467361011|FG001|Overall Study|Adverse Event|1|||
129834778|NCT03412084|467361014|FG000|Overall Study|Withdrawal by Subject|2|||
129834779|NCT03412084|467361015|FG001|Overall Study|Withdrawal by Subject|0|||
129834780|NCT03412084|467361014|FG000|Overall Study|Participant moved|1|||
129834781|NCT03412084|467361015|FG001|Overall Study|Participant moved|0|||
129834782|NCT03412084|467361014|FG000|Overall Study|Lost to Follow-up|1|||
129834783|NCT03412084|467361015|FG001|Overall Study|Lost to Follow-up|1|||
129834784|NCT01289847|467361022|FG000|Overall Study|Patient could not comply with visits|1|||
129834785|NCT02872116|467361025|FG000|Pre-Treatment|Disease Progression|0|||
129834786|NCT02872116|467361026|FG001|Pre-Treatment|Disease Progression|1|||
129834787|NCT02872116|467361027|FG002|Pre-Treatment|Disease Progression|0|||
129834788|NCT02872116|467361025|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
129834789|NCT02872116|467361026|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
129834790|NCT02872116|467361027|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
129834791|NCT02872116|467361025|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
129834792|NCT02872116|467361026|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
129834793|NCT02872116|467361027|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
129834794|NCT02872116|467361025|FG000|Pre-Treatment|Participant withdrew consent|2|||
129834795|NCT02872116|467361026|FG001|Pre-Treatment|Participant withdrew consent|20|||
129834796|NCT02872116|467361027|FG002|Pre-Treatment|Participant withdrew consent|3|||
129834797|NCT02872116|467361025|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
129897831|NCT04048135|467586473|FG003|Overall Study|Adverse Event|1|||
129897832|NCT04048135|467586474|FG004|Overall Study|Adverse Event|1|||
129897833|NCT04048135|467586475|FG005|Overall Study|Adverse Event|0|||
129897834|NCT04048135|467586476|FG006|Overall Study|Adverse Event|0|||
129897835|NCT04048135|467586477|FG007|Overall Study|Adverse Event|0|||
129897836|NCT04048135|467586470|FG000|Overall Study|Protocol Violation|0|||
129897837|NCT04048135|467586471|FG001|Overall Study|Protocol Violation|0|||
129834798|NCT02872116|467361026|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
129834799|NCT02872116|467361027|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
129834800|NCT02872116|467361025|FG000|Pre-Treatment|Other reasons|1|||
129834801|NCT02872116|467361026|FG001|Pre-Treatment|Other reasons|2|||
129834802|NCT02872116|467361027|FG002|Pre-Treatment|Other reasons|2|||
129834803|NCT02872116|467361025|FG000|Treatment|Death|121|||
129834804|NCT02872116|467361026|FG001|Treatment|Death|94|||
129834805|NCT02872116|467361027|FG002|Treatment|Death|68|||
129834806|NCT02872116|467361025|FG000|Treatment|Lost to Follow-up|5|||
129834807|NCT02872116|467361026|FG001|Treatment|Lost to Follow-up|7|||
129834808|NCT02872116|467361027|FG002|Treatment|Lost to Follow-up|3|||
129834809|NCT02872116|467361025|FG000|Treatment|Participant withdrew consent|20|||
129834810|NCT02872116|467361026|FG001|Treatment|Participant withdrew consent|40|||
129834811|NCT02872116|467361027|FG002|Treatment|Participant withdrew consent|8|||
129834812|NCT02872116|467361025|FG000|Treatment|Other reasons|13|||
129834813|NCT02872116|467361026|FG001|Treatment|Other reasons|12|||
129834814|NCT02872116|467361027|FG002|Treatment|Other reasons|5|||
129834815|NCT01324388|467361032|FG000|Part 1 of Study|Adverse Event|2|||
129834816|NCT01324388|467361033|FG001|Part 1 of Study|Adverse Event|0|||
129834817|NCT01324388|467361034|FG002|Part 1 of Study|Adverse Event|0|||
129834818|NCT01324388|467361035|FG003|Part 1 of Study|Adverse Event|0|||
129834819|NCT01324388|467361032|FG000|Part 1 of Study|Protocol Violation|1|||
129834820|NCT01324388|467361033|FG001|Part 1 of Study|Protocol Violation|2|||
129834821|NCT01324388|467361034|FG002|Part 1 of Study|Protocol Violation|0|||
129834822|NCT01324388|467361035|FG003|Part 1 of Study|Protocol Violation|0|||
129834823|NCT01324388|467361032|FG000|Part 1 of Study|Physician Decision|1|||
129834824|NCT01324388|467361033|FG001|Part 1 of Study|Physician Decision|0|||
129834825|NCT01324388|467361034|FG002|Part 1 of Study|Physician Decision|0|||
129834826|NCT01324388|467361035|FG003|Part 1 of Study|Physician Decision|0|||
129834827|NCT01324388|467361032|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
129834828|NCT01324388|467361033|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
129834829|NCT01324388|467361034|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
129834830|NCT01324388|467361035|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
129834831|NCT01324388|467361032|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129834832|NCT01324388|467361033|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129834833|NCT01324388|467361034|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
129834834|NCT01324388|467361035|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
129834835|NCT02171260|467361039|FG000|Overall Study|Death|0|||
129834836|NCT02171260|467361040|FG001|Overall Study|Death|0|||
129834837|NCT02171260|467361041|FG002|Overall Study|Death|0|||
129834838|NCT02171260|467361042|FG003|Overall Study|Death|1|||
129834839|NCT02171260|467361039|FG000|Overall Study|Physician Decision|1|||
129834840|NCT02171260|467361040|FG001|Overall Study|Physician Decision|0|||
129834841|NCT02171260|467361041|FG002|Overall Study|Physician Decision|1|||
129834842|NCT02171260|467361042|FG003|Overall Study|Physician Decision|0|||
129834843|NCT02171260|467361039|FG000|Overall Study|Withdrawal by Subject|1|||
129834844|NCT02171260|467361040|FG001|Overall Study|Withdrawal by Subject|0|||
129834845|NCT02171260|467361041|FG002|Overall Study|Withdrawal by Subject|0|||
129834846|NCT02171260|467361042|FG003|Overall Study|Withdrawal by Subject|0|||
129834847|NCT02171260|467361039|FG000|Overall Study|Evidence of progressive disease|4|||
129834848|NCT02171260|467361040|FG001|Overall Study|Evidence of progressive disease|6|||
129834849|NCT02171260|467361041|FG002|Overall Study|Evidence of progressive disease|4|||
129834850|NCT02171260|467361042|FG003|Overall Study|Evidence of progressive disease|4|||
129834851|NCT00323492|467361043|FG000|Study Phase 1|Adverse Event|2|||
129834852|NCT00323492|467361044|FG001|Study Phase 1|Adverse Event|0|||
129834853|NCT00323492|467361045|FG002|Study Phase 1|Adverse Event|0|||
129834854|NCT00323492|467361043|FG000|Study Phase 2|Adverse Event|1|||
129834855|NCT00323492|467361044|FG001|Study Phase 2|Adverse Event|0|||
129834856|NCT00323492|467361045|FG002|Study Phase 2|Adverse Event|0|||
129834857|NCT00323492|467361043|FG000|Study Phase 2|Physician Decision|1|||
129834858|NCT00323492|467361044|FG001|Study Phase 2|Physician Decision|0|||
129834859|NCT00323492|467361045|FG002|Study Phase 2|Physician Decision|0|||
129834860|NCT00323492|467361043|FG000|Study Phase 2|Lost to Follow-up|1|||
129834861|NCT00323492|467361044|FG001|Study Phase 2|Lost to Follow-up|0|||
129834862|NCT00323492|467361045|FG002|Study Phase 2|Lost to Follow-up|0|||
129834863|NCT00323492|467361043|FG000|Study Phase 2|Withdrawal by Subject|0|||
129834864|NCT00323492|467361044|FG001|Study Phase 2|Withdrawal by Subject|1|||
129897838|NCT04048135|467586472|FG002|Overall Study|Protocol Violation|0|||
129897839|NCT04048135|467586473|FG003|Overall Study|Protocol Violation|0|||
129897840|NCT04048135|467586474|FG004|Overall Study|Protocol Violation|0|||
129445999|NCT04163900|465934573|FG001|Overall Study|Adverse Event|32|||
129446000|NCT04163900|465934572|FG000|Overall Study|Withdrawal by Subject|37|||
129446001|NCT04163900|465934573|FG001|Overall Study|Withdrawal by Subject|34|||
129446002|NCT04163900|465934572|FG000|Overall Study|Death|29|||
129446003|NCT04163900|465934573|FG001|Overall Study|Death|16|||
129446004|NCT04163900|465934572|FG000|Overall Study|Physician Decision|17|||
129446005|NCT04163900|465934573|FG001|Overall Study|Physician Decision|25|||
129446006|NCT04163900|465934572|FG000|Overall Study|Clinical disease progression|14|||
129446007|NCT04163900|465934573|FG001|Overall Study|Clinical disease progression|13|||
129446008|NCT04163900|465934572|FG000|Overall Study|Protocol Violation|3|||
129446009|NCT04163900|465934573|FG001|Overall Study|Protocol Violation|4|||
129446010|NCT04163900|465934572|FG000|Overall Study|Lost to Follow-up|0|||
129446011|NCT04163900|465934573|FG001|Overall Study|Lost to Follow-up|1|||
129446012|NCT01873417|465934574|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
129446013|NCT01873417|465934574|FG000|Overall Study|Adverse Event|24|||
129446014|NCT01873417|465934574|FG000|Overall Study|Lost to Follow-up|2|||
129446015|NCT01873417|465934574|FG000|Overall Study|Withdrawal by Subject|2|||
129446016|NCT01873417|465934574|FG000|Overall Study|Physician Decision|3|||
129446017|NCT00785044|465934575|FG000|Overall Study|Dosed at non-participating sites|152|||
129446018|NCT00785044|465934575|FG000|Overall Study|Death|77|||
129446019|NCT00785044|465934575|FG000|Overall Study|Lost to Follow-up|266|||
129446020|NCT00785044|465934575|FG000|Overall Study|Withdrawal by Subject|1|||
129446021|NCT01830855|465934576|FG000|Overall Study|Other|7|||
129446022|NCT01830855|465934577|FG001|Overall Study|Other|1|||
129446023|NCT01830855|465934578|FG002|Overall Study|Other|4|||
129446024|NCT01830855|465934579|FG003|Overall Study|Other|4|||
129446025|NCT01830855|465934576|FG000|Overall Study|Medication error without associated AE|1|||
129446026|NCT01830855|465934577|FG001|Overall Study|Medication error without associated AE|0|||
129446027|NCT01830855|465934578|FG002|Overall Study|Medication error without associated AE|0|||
129446028|NCT01830855|465934579|FG003|Overall Study|Medication error without associated AE|1|||
129446029|NCT01830855|465934576|FG000|Overall Study|Pregnancy|3|||
129446030|NCT01830855|465934577|FG001|Overall Study|Pregnancy|1|||
129446031|NCT01830855|465934578|FG002|Overall Study|Pregnancy|2|||
129446032|NCT01830855|465934579|FG003|Overall Study|Pregnancy|1|||
129446033|NCT01830855|465934576|FG000|Overall Study|No longer meets eligibility criteria|11|||
129446034|NCT01830855|465934577|FG001|Overall Study|No longer meets eligibility criteria|2|||
129446035|NCT01830855|465934578|FG002|Overall Study|No longer meets eligibility criteria|3|||
129446036|NCT01830855|465934579|FG003|Overall Study|No longer meets eligibility criteria|5|||
129446037|NCT01830855|465934576|FG000|Overall Study|Adverse Event|11|||
129446038|NCT01830855|465934577|FG001|Overall Study|Adverse Event|5|||
129446039|NCT01830855|465934578|FG002|Overall Study|Adverse Event|6|||
129446040|NCT01830855|465934579|FG003|Overall Study|Adverse Event|3|||
129446041|NCT01830855|465934576|FG000|Overall Study|Protocol deviation|10|||
129834865|NCT00323492|467361045|FG002|Study Phase 2|Withdrawal by Subject|0|||
129834866|NCT00323492|467361043|FG000|Study Phase 2|Noncompliance with study schedule|0|||
129834867|NCT00323492|467361044|FG001|Study Phase 2|Noncompliance with study schedule|0|||
129834868|NCT00323492|467361045|FG002|Study Phase 2|Noncompliance with study schedule|1|||
129834869|NCT00323492|467361043|FG000|Study Phase 2|Protocol Violation|1|||
129834870|NCT00323492|467361044|FG001|Study Phase 2|Protocol Violation|0|||
129834871|NCT00323492|467361045|FG002|Study Phase 2|Protocol Violation|0|||
129834872|NCT02486042|467361046|FG000|Overall Study|Physician Decision|1|||
129834873|NCT02486042|467361047|FG001|Overall Study|Physician Decision|7|||
129834874|NCT02486042|467361046|FG000|Overall Study|Hospital transfer|2|||
129834875|NCT02486042|467361047|FG001|Overall Study|Hospital transfer|2|||
129834876|NCT02486042|467361046|FG000|Overall Study|Withdrawal by Subject|0|||
129834877|NCT02486042|467361047|FG001|Overall Study|Withdrawal by Subject|2|||
129834878|NCT01466387|467361048|FG000|Overall Study|Adverse Event|0|||
129834879|NCT01466387|467361049|FG001|Overall Study|Adverse Event|0|||
129834880|NCT01466387|467361050|FG002|Overall Study|Adverse Event|1|||
129834881|NCT01466387|467361051|FG003|Overall Study|Adverse Event|1|||
129834882|NCT01466387|467361052|FG004|Overall Study|Adverse Event|0|||
129834883|NCT01466387|467361053|FG005|Overall Study|Adverse Event|0|||
129834884|NCT01466387|467361048|FG000|Overall Study|Lost to Follow-up|0|||
129834885|NCT01466387|467361049|FG001|Overall Study|Lost to Follow-up|0|||
129834886|NCT01466387|467361050|FG002|Overall Study|Lost to Follow-up|0|||
129897841|NCT04048135|467586475|FG005|Overall Study|Protocol Violation|1|||
129446042|NCT01830855|465934577|FG001|Overall Study|Protocol deviation|5|||
129446043|NCT01830855|465934578|FG002|Overall Study|Protocol deviation|6|||
129446044|NCT01830855|465934579|FG003|Overall Study|Protocol deviation|6|||
129446045|NCT01830855|465934576|FG000|Overall Study|Withdrawal by Subject|33|||
129446046|NCT01830855|465934577|FG001|Overall Study|Withdrawal by Subject|14|||
129446047|NCT01830855|465934578|FG002|Overall Study|Withdrawal by Subject|10|||
129446048|NCT01830855|465934579|FG003|Overall Study|Withdrawal by Subject|12|||
129446049|NCT01830855|465934576|FG000|Overall Study|No longer willing to participate|32|||
129446050|NCT01830855|465934577|FG001|Overall Study|No longer willing to participate|13|||
129834887|NCT01466387|467361051|FG003|Overall Study|Lost to Follow-up|0|||
129834888|NCT01466387|467361052|FG004|Overall Study|Lost to Follow-up|0|||
129834889|NCT01466387|467361053|FG005|Overall Study|Lost to Follow-up|1|||
129834890|NCT01466387|467361048|FG000|Overall Study|Protocol Violation|1|||
129834891|NCT01466387|467361049|FG001|Overall Study|Protocol Violation|0|||
129834892|NCT01466387|467361050|FG002|Overall Study|Protocol Violation|0|||
129834893|NCT01466387|467361051|FG003|Overall Study|Protocol Violation|1|||
129834894|NCT01466387|467361052|FG004|Overall Study|Protocol Violation|0|||
129834895|NCT01466387|467361053|FG005|Overall Study|Protocol Violation|0|||
129834896|NCT04404855|467361057|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
129834897|NCT04404855|467361058|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
129834898|NCT03320564|467361059|FG000|Overall Study|Protocol Violation|1|||
129834899|NCT01124643|467361060|FG000|Overall Study|Death|1|||
129834900|NCT04220411|467361061|FG000|Overall Study|Adverse Event|0|||
129834901|NCT04220411|467361062|FG001|Overall Study|Adverse Event|0|||
129834902|NCT04220411|467361063|FG002|Overall Study|Adverse Event|0|||
129834903|NCT04220411|467361064|FG003|Overall Study|Adverse Event|1|||
129834904|NCT02028988|467361065|FG000|Overall Study|Withdrawal by Subject|2|||
129834905|NCT02680639|467361068|FG000|Screening Period|Screen Failure|7|||
129834906|NCT02680639|467361069|FG001|Screening Period|Screen Failure|0|||
129834907|NCT02680639|467361070|FG002|Screening Period|Screen Failure|0|||
129834908|NCT01063595|467361071|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
129834909|NCT01063595|467361072|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
129834910|NCT01063595|467361071|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
129834911|NCT01063595|467361072|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
129834912|NCT01063595|467361071|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
129834913|NCT01063595|467361072|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
129834914|NCT01063595|467361071|FG000|First Intervention|Adverse Event|1|||
129834915|NCT01063595|467361072|FG001|First Intervention|Adverse Event|4|||
129834916|NCT01063595|467361071|FG000|First Intervention|Withdrawal by Subject|1|||
129834917|NCT01063595|467361072|FG001|First Intervention|Withdrawal by Subject|0|||
129834918|NCT01063595|467361071|FG000|First Intervention|Reason not Specified|0|||
129834919|NCT01063595|467361072|FG001|First Intervention|Reason not Specified|1|||
129834920|NCT02678676|467361073|FG000|Overall Study|Death|619|||
129834921|NCT02678676|467361074|FG001|Overall Study|Death|649|||
129834922|NCT02678676|467361073|FG000|Overall Study|Withdrawal by Subject|13|||
129834923|NCT02678676|467361074|FG001|Overall Study|Withdrawal by Subject|5|||
129834924|NCT02678676|467361073|FG000|Overall Study|Lost to Follow-up|171|||
129834925|NCT02678676|467361074|FG001|Overall Study|Lost to Follow-up|151|||
129834926|NCT02678676|467361073|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
129834927|NCT02678676|467361074|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
129834928|NCT00747435|467361075|FG000|Overall Study|Lost to Follow-up|2|||
129834929|NCT00747435|467361075|FG000|Overall Study|Withdrawal by Subject|3|||
129834930|NCT00747435|467361075|FG000|Overall Study|Still undergoing follow up|1|||
129834931|NCT00851799|467361076|FG000|Overall Study|Death|1|||
129834932|NCT00851799|467361077|FG001|Overall Study|Death|0|||
129834933|NCT00851799|467361078|FG002|Overall Study|Death|1|||
129834934|NCT00851799|467361076|FG000|Overall Study|Lost to Follow-up|5|||
129834935|NCT00851799|467361077|FG001|Overall Study|Lost to Follow-up|3|||
129834936|NCT00851799|467361078|FG002|Overall Study|Lost to Follow-up|10|||
129834937|NCT00851799|467361076|FG000|Overall Study|Not able to get to clinic|8|||
129834938|NCT00851799|467361077|FG001|Overall Study|Not able to get to clinic|5|||
129834939|NCT00851799|467361078|FG002|Overall Study|Not able to get to clinic|9|||
129834940|NCT00851799|467361076|FG000|Overall Study|Not willing to adhere to requirements|1|||
129834941|NCT00851799|467361077|FG001|Overall Study|Not willing to adhere to requirements|2|||
129834942|NCT00851799|467361078|FG002|Overall Study|Not willing to adhere to requirements|2|||
129834943|NCT00851799|467361076|FG000|Overall Study|Withdrew consent prior study completion|1|||
129834944|NCT00851799|467361077|FG001|Overall Study|Withdrew consent prior study completion|2|||
129834945|NCT00851799|467361078|FG002|Overall Study|Withdrew consent prior study completion|1|||
129834946|NCT00851799|467361076|FG000|Overall Study|Severe Debilitation|0|||
129834947|NCT00851799|467361077|FG001|Overall Study|Severe Debilitation|1|||
129834948|NCT00851799|467361078|FG002|Overall Study|Severe Debilitation|0|||
129834949|NCT00851799|467361076|FG000|Overall Study|Completed protocol due to pregnancy|0|||
129834950|NCT00851799|467361077|FG001|Overall Study|Completed protocol due to pregnancy|0|||
129834951|NCT00851799|467361078|FG002|Overall Study|Completed protocol due to pregnancy|1|||
129834952|NCT01342510|467361092|FG000|Overall Study|Protocol Violation|12|||
129834953|NCT01342510|467361093|FG001|Overall Study|Protocol Violation|6|||
129834954|NCT01342510|467361094|FG002|Overall Study|Protocol Violation|13|||
129834955|NCT01342510|467361095|FG003|Overall Study|Protocol Violation|11|||
129834956|NCT01449526|467361096|FG000|Overall Study|Lost to Follow-up|1|||
129834957|NCT01449526|467361097|FG001|Overall Study|Lost to Follow-up|2|||
129834958|NCT01449526|467361096|FG000|Overall Study|Withdrawal by Subject|1|||
129834959|NCT01449526|467361097|FG001|Overall Study|Withdrawal by Subject|1|||
129834960|NCT01449526|467361096|FG000|Overall Study|Symptoms/complaints|0|||
129834961|NCT01449526|467361097|FG001|Overall Study|Symptoms/complaints|1|||
129834962|NCT01449526|467361096|FG000|Overall Study|Lack of Motivation|0|||
129834963|NCT01449526|467361097|FG001|Overall Study|Lack of Motivation|1|||
129834964|NCT01449526|467361096|FG000|Overall Study|Cannot maintain visits|0|||
129446051|NCT01830855|465934578|FG002|Overall Study|No longer willing to participate|12|||
129446052|NCT01830855|465934579|FG003|Overall Study|No longer willing to participate|17|||
129446053|NCT01830855|465934576|FG000|Overall Study|Lost to Follow-up|47|||
129446054|NCT01830855|465934577|FG001|Overall Study|Lost to Follow-up|20|||
129446055|NCT01830855|465934578|FG002|Overall Study|Lost to Follow-up|23|||
129446056|NCT01830855|465934579|FG003|Overall Study|Lost to Follow-up|33|||
129446057|NCT01667081|465934580|FG000|Overall Study|Death|43|||
129446058|NCT01667081|465934581|FG001|Overall Study|Death|3|||
129446059|NCT01667081|465934580|FG000|Overall Study|Lost to Follow-up|99|||
129446060|NCT01667081|465934581|FG001|Overall Study|Lost to Follow-up|48|||
129446061|NCT01667081|465934580|FG000|Overall Study|Physician Decision|16|||
129446062|NCT01667081|465934581|FG001|Overall Study|Physician Decision|2|||
129446063|NCT01667081|465934580|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
129446064|NCT01667081|465934581|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
129446065|NCT01667081|465934580|FG000|Overall Study|Withdrawal by Subject|90|||
129446066|NCT01667081|465934581|FG001|Overall Study|Withdrawal by Subject|35|||
129446067|NCT03034460|465934582|FG000|Overall Study|Adverse Event|0|||
129446068|NCT03034460|465934583|FG001|Overall Study|Adverse Event|1|||
129446069|NCT03034460|465934582|FG000|Overall Study|Withdrawal by Subject|2|||
129446070|NCT03034460|465934583|FG001|Overall Study|Withdrawal by Subject|2|||
129446071|NCT03034460|465934582|FG000|Overall Study|Personal Reasons|1|||
129446072|NCT03034460|465934583|FG001|Overall Study|Personal Reasons|0|||
129446073|NCT00295633|465934584|FG000|Overall Study|Lack of Efficacy|19|||
129446074|NCT00295633|465934585|FG001|Overall Study|Lack of Efficacy|7|||
129446075|NCT00295633|465934586|FG002|Overall Study|Lack of Efficacy|16|||
129446076|NCT00295633|465934584|FG000|Overall Study|Withdrawal of consent by subject|16|||
129446077|NCT00295633|465934585|FG001|Overall Study|Withdrawal of consent by subject|16|||
129446078|NCT00295633|465934586|FG002|Overall Study|Withdrawal of consent by subject|26|||
129446079|NCT00295633|465934584|FG000|Overall Study|Adverse Event|9|||
129446080|NCT00295633|465934585|FG001|Overall Study|Adverse Event|17|||
129446081|NCT00295633|465934586|FG002|Overall Study|Adverse Event|9|||
129446082|NCT00295633|465934584|FG000|Overall Study|Lost to Follow-up|6|||
129446083|NCT00295633|465934585|FG001|Overall Study|Lost to Follow-up|11|||
129446084|NCT00295633|465934586|FG002|Overall Study|Lost to Follow-up|7|||
129446085|NCT00295633|465934584|FG000|Overall Study|Physician Decision|9|||
129446086|NCT00295633|465934585|FG001|Overall Study|Physician Decision|10|||
129446087|NCT00295633|465934586|FG002|Overall Study|Physician Decision|8|||
129446088|NCT00295633|465934584|FG000|Overall Study|Poor/Noncompliance|2|||
129446089|NCT00295633|465934585|FG001|Overall Study|Poor/Noncompliance|2|||
129446090|NCT00295633|465934586|FG002|Overall Study|Poor/Noncompliance|6|||
129446091|NCT00295633|465934584|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
129446092|NCT00295633|465934585|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
129446093|NCT00295633|465934586|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
129446094|NCT00295633|465934584|FG000|Overall Study|Death|1|||
129446095|NCT00295633|465934585|FG001|Overall Study|Death|1|||
129446096|NCT00295633|465934586|FG002|Overall Study|Death|0|||
129446097|NCT00295633|465934584|FG000|Overall Study|Administrative reason by sponsor|0|||
129834965|NCT01449526|467361097|FG001|Overall Study|Cannot maintain visits|1|||
129834966|NCT01400516|467361099|FG000|Primary Trial|Withdrawal by Subject|0|||
129834967|NCT01400516|467361100|FG001|Primary Trial|Withdrawal by Subject|2|||
129834968|NCT01132495|467361103|FG000|Overall Study|Various reasons|40|||
129834969|NCT01132495|467361104|FG001|Overall Study|Various reasons|38|||
129834970|NCT01132495|467361105|FG002|Overall Study|Various reasons|20|||
129834971|NCT01132495|467361106|FG003|Overall Study|Various reasons|12|||
129834972|NCT00082433|467361113|FG000|Overall Study|Adverse Event|12|||
129834973|NCT00082433|467361114|FG001|Overall Study|Adverse Event|17|||
129834974|NCT00082433|467361113|FG000|Overall Study|Death|8|||
129834975|NCT00082433|467361114|FG001|Overall Study|Death|18|||
129834976|NCT00082433|467361113|FG000|Overall Study|Disease Progression/Relapse|270|||
129834977|NCT00082433|467361114|FG001|Overall Study|Disease Progression/Relapse|388|||
129834978|NCT00082433|467361113|FG000|Overall Study|Physician Decision|50|||
129834979|NCT00082433|467361114|FG001|Overall Study|Physician Decision|61|||
129834980|NCT00082433|467361113|FG000|Overall Study|Lost to Follow-up|1|||
129834981|NCT00082433|467361114|FG001|Overall Study|Lost to Follow-up|2|||
129897842|NCT04048135|467586476|FG006|Overall Study|Protocol Violation|0|||
129446098|NCT00295633|465934585|FG001|Overall Study|Administrative reason by sponsor|0|||
129446099|NCT00295633|465934586|FG002|Overall Study|Administrative reason by sponsor|1|||
129446100|NCT01950247|465934587|FG000|Overall Study|Withdrawal by Subject|28|||
129446101|NCT01950247|465934588|FG001|Overall Study|Withdrawal by Subject|13|||
129446102|NCT01950247|465934587|FG000|Overall Study|Lost to Follow-up|18|||
129446103|NCT01950247|465934588|FG001|Overall Study|Lost to Follow-up|16|||
129446104|NCT01950247|465934587|FG000|Overall Study|Physician Decision|3|||
129446105|NCT01950247|465934588|FG001|Overall Study|Physician Decision|4|||
129834982|NCT00082433|467361113|FG000|Overall Study|Study Drug Toxicity|179|||
129834983|NCT00082433|467361114|FG001|Overall Study|Study Drug Toxicity|66|||
129834984|NCT00082433|467361113|FG000|Overall Study|Withdrawal by Subject|55|||
129834985|NCT00082433|467361114|FG001|Overall Study|Withdrawal by Subject|30|||
129834986|NCT00082433|467361113|FG000|Overall Study|Still On Treatment|2|||
129834987|NCT00082433|467361114|FG001|Overall Study|Still On Treatment|1|||
129834988|NCT00082433|467361113|FG000|Overall Study|Not Treated|12|||
129834989|NCT00082433|467361114|FG001|Overall Study|Not Treated|11|||
129834990|NCT00082433|467361113|FG000|Overall Study|Ineligible|2|||
129834991|NCT00082433|467361114|FG001|Overall Study|Ineligible|1|||
129834992|NCT00082433|467361113|FG000|Overall Study|Noncompliance|2|||
129834993|NCT00082433|467361114|FG001|Overall Study|Noncompliance|1|||
129834994|NCT00082433|467361113|FG000|Overall Study|New primary cancer|1|||
129834995|NCT00082433|467361114|FG001|Overall Study|New primary cancer|0|||
129834996|NCT00082433|467361113|FG000|Overall Study|Impending surgery|0|||
129834997|NCT00082433|467361114|FG001|Overall Study|Impending surgery|1|||
129834998|NCT01796197|467361117|FG000|Overall Study|Lost to Follow-up|1|||
129834999|NCT01796197|467361117|FG000|Overall Study|Lack of Efficacy|1|||
129835000|NCT01380184|467361118|FG000|Part 1 (19 Days)|Adverse Event|1|||
129835001|NCT01380184|467361118|FG000|Part 2|Adverse Event|5|||
129835002|NCT01380184|467361118|FG000|Part 2|Disease Progression|8|||
129835003|NCT01380184|467361118|FG000|Part 2|Lost to Follow-up|1|||
129835004|NCT04097821|467361119|FG000|Overall Study|Subject Decision|0|||
129835005|NCT04097821|467361120|FG001|Overall Study|Subject Decision|0|||
129835006|NCT04097821|467361121|FG002|Overall Study|Subject Decision|0|||
129835007|NCT04097821|467361122|FG003|Overall Study|Subject Decision|1|||
129835008|NCT04097821|467361123|FG004|Overall Study|Subject Decision|2|||
129835009|NCT04097821|467361124|FG005|Overall Study|Subject Decision|2|||
129835010|NCT04097821|467361125|FG006|Overall Study|Subject Decision|0|||
129835011|NCT04097821|467361126|FG007|Overall Study|Subject Decision|1|||
129835012|NCT04097821|467361119|FG000|Overall Study|Death|0|||
129835013|NCT04097821|467361120|FG001|Overall Study|Death|0|||
129835014|NCT04097821|467361121|FG002|Overall Study|Death|3|||
129835015|NCT04097821|467361122|FG003|Overall Study|Death|1|||
129835016|NCT04097821|467361123|FG004|Overall Study|Death|0|||
129835017|NCT04097821|467361124|FG005|Overall Study|Death|0|||
129835018|NCT04097821|467361125|FG006|Overall Study|Death|0|||
129835019|NCT04097821|467361126|FG007|Overall Study|Death|0|||
129835020|NCT04097821|467361119|FG000|Overall Study|Physician Decision|1|||
129835021|NCT04097821|467361120|FG001|Overall Study|Physician Decision|2|||
129835022|NCT04097821|467361121|FG002|Overall Study|Physician Decision|0|||
129835023|NCT04097821|467361122|FG003|Overall Study|Physician Decision|0|||
129835024|NCT04097821|467361123|FG004|Overall Study|Physician Decision|0|||
129835025|NCT04097821|467361124|FG005|Overall Study|Physician Decision|0|||
129835026|NCT04097821|467361125|FG006|Overall Study|Physician Decision|0|||
129835027|NCT04097821|467361126|FG007|Overall Study|Physician Decision|0|||
129835028|NCT04097821|467361119|FG000|Overall Study|Adverse Event|0|||
129835029|NCT04097821|467361120|FG001|Overall Study|Adverse Event|0|||
129835030|NCT04097821|467361121|FG002|Overall Study|Adverse Event|1|||
129835031|NCT04097821|467361122|FG003|Overall Study|Adverse Event|1|||
129835032|NCT04097821|467361123|FG004|Overall Study|Adverse Event|0|||
129835033|NCT04097821|467361124|FG005|Overall Study|Adverse Event|0|||
129835034|NCT04097821|467361125|FG006|Overall Study|Adverse Event|0|||
129835035|NCT04097821|467361126|FG007|Overall Study|Adverse Event|0|||
129835036|NCT04097821|467361119|FG000|Overall Study|New Therapy For Study Indication|0|||
129835037|NCT04097821|467361120|FG001|Overall Study|New Therapy For Study Indication|0|||
129835038|NCT04097821|467361121|FG002|Overall Study|New Therapy For Study Indication|0|||
129835039|NCT04097821|467361122|FG003|Overall Study|New Therapy For Study Indication|0|||
129835040|NCT04097821|467361123|FG004|Overall Study|New Therapy For Study Indication|0|||
129835041|NCT04097821|467361124|FG005|Overall Study|New Therapy For Study Indication|0|||
129835042|NCT04097821|467361125|FG006|Overall Study|New Therapy For Study Indication|1|||
129835043|NCT04097821|467361126|FG007|Overall Study|New Therapy For Study Indication|0|||
129835044|NCT04243538|467361127|FG000|Overall Study|Withdrawal by Subject|0|||
129835045|NCT04243538|467361128|FG001|Overall Study|Withdrawal by Subject|2|||
129835046|NCT04243538|467361127|FG000|Overall Study|Lost to Follow-up|0|||
129835047|NCT04243538|467361128|FG001|Overall Study|Lost to Follow-up|3|||
129835048|NCT03532295|467361129|FG000|Overall Study|Did not start treatment|0|||
129835049|NCT03532295|467361130|FG001|Overall Study|Did not start treatment|2|||
129835050|NCT02776917|467361131|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
129835051|NCT02449239|467362730|FG000|Induction Phase|Lack of Efficacy|64|||
129835052|NCT02449239|467362730|FG000|Induction Phase|Adverse Event|1|||
129835053|NCT02449239|467362730|FG000|Induction Phase|Lost to Follow-up|1|||
129835054|NCT02449239|467362730|FG000|Induction Phase|Protocol Violation|1|||
129835055|NCT02449239|467362730|FG000|Induction Phase|Physician Decision|1|||
129835056|NCT02449239|467362730|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
129835057|NCT02449239|467362730|FG000|Induction Phase|Withdrawal by Subject|1|||
129835058|NCT02449239|467362730|FG000|Maintenance Month 3|Lack of Efficacy|14|||
129835059|NCT02449239|467362730|FG000|Maintenance Month 6|Lack of Efficacy|10|||
129835060|NCT02449239|467362730|FG000|Maintenance Month 6|Adverse Event|2|||
129835061|NCT02449239|467362730|FG000|Maintenance Month 6|Physician Decision|1|||
129835062|NCT02449239|467362730|FG000|Maintenance Month 9|Lack of Efficacy|2|||
129835063|NCT02449239|467362730|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
129835064|NCT02449239|467362730|FG000|Maintenance Month 12|Lack of Efficacy|5|||
129897843|NCT04048135|467586477|FG007|Overall Study|Protocol Violation|0|||
129897844|NCT00172185|467586478|FG000|Overall Study|Adverse Event|0|||
129897845|NCT00172185|467586479|FG001|Overall Study|Adverse Event|1|||
129897846|NCT00172185|467586480|FG002|Overall Study|Adverse Event|3|||
129897847|NCT00172185|467586481|FG003|Overall Study|Adverse Event|4|||
129897848|NCT00172185|467586478|FG000|Overall Study|Physician Decision|0|||
129897849|NCT00172185|467586479|FG001|Overall Study|Physician Decision|0|||
129897850|NCT00172185|467586480|FG002|Overall Study|Physician Decision|1|||
129897851|NCT00172185|467586481|FG003|Overall Study|Physician Decision|0|||
129897852|NCT00172185|467586478|FG000|Overall Study|SPONSOR Decision|0|||
129897853|NCT00172185|467586479|FG001|Overall Study|SPONSOR Decision|1|||
129897854|NCT00172185|467586480|FG002|Overall Study|SPONSOR Decision|0|||
129897855|NCT00172185|467586481|FG003|Overall Study|SPONSOR Decision|0|||
129897856|NCT00172185|467586478|FG000|Overall Study|Withdrawal by Subject|0|||
129897857|NCT00172185|467586479|FG001|Overall Study|Withdrawal by Subject|0|||
129897858|NCT00172185|467586480|FG002|Overall Study|Withdrawal by Subject|1|||
129897859|NCT00172185|467586481|FG003|Overall Study|Withdrawal by Subject|0|||
129897860|NCT01677936|467586482|FG000|Overall Study|Lost to Follow-up|4|||
129897861|NCT01677936|467586483|FG001|Overall Study|Lost to Follow-up|1|||
129897862|NCT01677936|467586482|FG000|Overall Study|Protocol Violation|3|||
129897863|NCT01677936|467586483|FG001|Overall Study|Protocol Violation|0|||
129897864|NCT01677936|467586482|FG000|Overall Study|Adverse Event|1|||
129897865|NCT01677936|467586483|FG001|Overall Study|Adverse Event|0|||
129897866|NCT01677936|467586482|FG000|Overall Study|Lost to Follow-up|1|||
129897867|NCT01677936|467586483|FG001|Overall Study|Lost to Follow-up|0|||
129897868|NCT01677936|467586482|FG000|Overall Study|Protocol Violation|0|||
129897869|NCT01677936|467586483|FG001|Overall Study|Protocol Violation|4|||
129897870|NCT00349908|467586492|FG000|Overall Study|Withdrawal by Subject|0|||
129897871|NCT00349908|467586493|FG001|Overall Study|Withdrawal by Subject|4|||
129897872|NCT04565249|467586494|FG000|Overall Study|Death|0|||
129897873|NCT04565249|467586495|FG001|Overall Study|Death|0|||
129897874|NCT04565249|467586496|FG002|Overall Study|Death|0|||
129897875|NCT04565249|467586497|FG003|Overall Study|Death|1|||
129897876|NCT00151996|467586498|FG000|Overall Study|Adverse Event|3|||
129897877|NCT00151996|467586499|FG001|Overall Study|Adverse Event|2|||
129897878|NCT00151996|467586498|FG000|Overall Study|Withdrawal by Subject|1|||
129897879|NCT00151996|467586499|FG001|Overall Study|Withdrawal by Subject|1|||
129897880|NCT00151996|467586498|FG000|Overall Study|Protocol Violation|1|||
129835065|NCT02449239|467362730|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
129835066|NCT02449239|467362730|FG000|Maintenance Month 12|Subject moved from area|1|||
129835067|NCT02449239|467362730|FG000|Maintenance Month 15|Lack of Efficacy|1|||
129835068|NCT02449239|467362730|FG000|Maintenance Month 21|Lack of Efficacy|1|||
129835069|NCT02449239|467362730|FG000|Maintenance Month 21|Sponsor decision|1|||
129835070|NCT03314584|467362737|FG000|Overall Study|Withdrawal by Subject|3|||
129835071|NCT03314584|467362738|FG001|Overall Study|Withdrawal by Subject|3|||
129835072|NCT03314584|467362737|FG000|Overall Study|Lost to Follow-up|4|||
129835073|NCT03314584|467362738|FG001|Overall Study|Lost to Follow-up|0|||
129835074|NCT06134817|467362739|FG000|Overall Study|Physician Departure - termination of study|1|||
129835075|NCT02053753|467362751|FG000|Overall Study|Withdrawal by Subject|2|||
129835076|NCT02053753|467362752|FG001|Overall Study|Withdrawal by Subject|4|||
129835077|NCT02053753|467362751|FG000|Overall Study|Decision by Sponsor|1|||
129835078|NCT02053753|467362752|FG001|Overall Study|Decision by Sponsor|1|||
129835079|NCT02053753|467362751|FG000|Overall Study|Lost to Follow-up|4|||
129835080|NCT02053753|467362752|FG001|Overall Study|Lost to Follow-up|3|||
129835081|NCT02023151|467362757|FG000|Overall Study|Lost to Follow-up|4|||
129835082|NCT04064294|467362758|FG000|Overall Study|Adverse Event|1|||
129897881|NCT00151996|467586499|FG001|Overall Study|Protocol Violation|2|||
129897882|NCT00151996|467586498|FG000|Overall Study|Sponsor's decision|0|||
129835083|NCT04064294|467362759|FG001|Overall Study|Adverse Event|0|||
129835084|NCT04064294|467362760|FG002|Overall Study|Adverse Event|0|||
129897883|NCT00151996|467586499|FG001|Overall Study|Sponsor's decision|2|||
129897884|NCT01649791|467586506|FG000|Overall Study|Disease Progression|2|||
129897885|NCT01649791|467586506|FG000|Overall Study|Adverse Event|1|||
129897886|NCT01801930|467586507|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
129835085|NCT03450707|467362761|FG000|Overall Study|Outside enrollment window|4|||
129835086|NCT03450707|467362762|FG001|Overall Study|Outside enrollment window|1|||
129835087|NCT03450707|467362761|FG000|Overall Study|Death|1|||
129835088|NCT03450707|467362762|FG001|Overall Study|Death|0|||
129446106|NCT01950247|465934587|FG000|Overall Study|Adverse Event|3|||
129446107|NCT01950247|465934588|FG001|Overall Study|Adverse Event|2|||
129446108|NCT01950247|465934587|FG000|Overall Study|Death|1|||
129446109|NCT01950247|465934588|FG001|Overall Study|Death|1|||
129446110|NCT01950247|465934587|FG000|Overall Study|Not Defined|4|||
129446111|NCT01950247|465934588|FG001|Overall Study|Not Defined|10|||
129446112|NCT01798992|465934589|FG000|Overall Study|Administrative withdrawal|0|||
129446113|NCT01798992|465934590|FG001|Overall Study|Administrative withdrawal|1|||
129446114|NCT01798992|465934591|FG002|Overall Study|Administrative withdrawal|0|||
129446115|NCT01798992|465934592|FG003|Overall Study|Administrative withdrawal|1|||
129446116|NCT01798992|465934589|FG000|Overall Study|Lost to Follow-up|0|||
129446117|NCT01798992|465934590|FG001|Overall Study|Lost to Follow-up|1|||
129446118|NCT01798992|465934591|FG002|Overall Study|Lost to Follow-up|1|||
129446119|NCT01798992|465934592|FG003|Overall Study|Lost to Follow-up|0|||
129446120|NCT01798992|465934589|FG000|Overall Study|Insufficient biopsy tissue|0|||
129446121|NCT01798992|465934590|FG001|Overall Study|Insufficient biopsy tissue|0|||
129446122|NCT01798992|465934591|FG002|Overall Study|Insufficient biopsy tissue|1|||
129446123|NCT01798992|465934592|FG003|Overall Study|Insufficient biopsy tissue|0|||
129446124|NCT00763971|465934593|FG000|Overall Study|Adverse Event|5|||
129446125|NCT00763971|465934594|FG001|Overall Study|Adverse Event|2|||
129446126|NCT00763971|465934595|FG002|Overall Study|Adverse Event|4|||
129446127|NCT00763971|465934593|FG000|Overall Study|Protocol Violation|3|||
129446128|NCT00763971|465934594|FG001|Overall Study|Protocol Violation|3|||
129446129|NCT00763971|465934595|FG002|Overall Study|Protocol Violation|2|||
129835089|NCT03450707|467362761|FG000|Overall Study|Indication for thiamine|1|||
129835090|NCT03450707|467362762|FG001|Overall Study|Indication for thiamine|1|||
129835091|NCT03450707|467362761|FG000|Overall Study|Evidence of traumatic brain injury|1|||
129835092|NCT03450707|467362762|FG001|Overall Study|Evidence of traumatic brain injury|0|||
129835093|NCT03450707|467362761|FG000|Overall Study|Following commands|0|||
129835094|NCT03450707|467362762|FG001|Overall Study|Following commands|3|||
129835095|NCT03450707|467362761|FG000|Overall Study|Lactate < 3.5|0|||
129446130|NCT00763971|465934593|FG000|Overall Study|Withdrawal by Subject|4|||
129446131|NCT00763971|465934594|FG001|Overall Study|Withdrawal by Subject|5|||
129835096|NCT03450707|467362762|FG001|Overall Study|Lactate < 3.5|2|||
129835097|NCT03450707|467362761|FG000|Overall Study|Rearrest with ECMO|0|||
129835098|NCT03450707|467362762|FG001|Overall Study|Rearrest with ECMO|1|||
129446132|NCT00763971|465934595|FG002|Overall Study|Withdrawal by Subject|5|||
129446133|NCT00763971|465934593|FG000|Overall Study|Lost to Follow-up|0|||
129446134|NCT00763971|465934594|FG001|Overall Study|Lost to Follow-up|1|||
129446135|NCT00763971|465934595|FG002|Overall Study|Lost to Follow-up|0|||
129446136|NCT00763971|465934593|FG000|Overall Study|Lack of Efficacy|11|||
129446137|NCT00763971|465934594|FG001|Overall Study|Lack of Efficacy|22|||
129446138|NCT00763971|465934595|FG002|Overall Study|Lack of Efficacy|54|||
129446139|NCT00763971|465934593|FG000|Overall Study|Unable to swallow capsule|2|||
129446140|NCT00763971|465934594|FG001|Overall Study|Unable to swallow capsule|1|||
129446141|NCT00763971|465934595|FG002|Overall Study|Unable to swallow capsule|1|||
129446142|NCT00763971|465934593|FG000|Overall Study|Personal reason|3|||
129446143|NCT00763971|465934594|FG001|Overall Study|Personal reason|0|||
129446144|NCT00763971|465934595|FG002|Overall Study|Personal reason|0|||
129446145|NCT00763971|465934593|FG000|Overall Study|Exclusion criteria met|1|||
129446146|NCT00763971|465934594|FG001|Overall Study|Exclusion criteria met|0|||
129446147|NCT00763971|465934595|FG002|Overall Study|Exclusion criteria met|0|||
129835099|NCT03450707|467362761|FG000|Overall Study|Indication for thiamine + head CT results|0|||
129446148|NCT00763971|465934593|FG000|Overall Study|Sponsor decision|1|||
129446149|NCT00763971|465934594|FG001|Overall Study|Sponsor decision|0|||
129446150|NCT00763971|465934595|FG002|Overall Study|Sponsor decision|0|||
129446151|NCT00763971|465934593|FG000|Overall Study|Due to holiday season|2|||
129446152|NCT00763971|465934594|FG001|Overall Study|Due to holiday season|0|||
129446153|NCT00763971|465934595|FG002|Overall Study|Due to holiday season|1|||
129446154|NCT00763971|465934593|FG000|Overall Study|Randomization error|0|||
129446155|NCT00763971|465934594|FG001|Overall Study|Randomization error|0|||
129446156|NCT00763971|465934595|FG002|Overall Study|Randomization error|1|||
129446157|NCT00763971|465934593|FG000|Overall Study|Medical monitor decision|0|||
129446158|NCT00763971|465934594|FG001|Overall Study|Medical monitor decision|0|||
129446159|NCT00763971|465934595|FG002|Overall Study|Medical monitor decision|1|||
129446160|NCT00763971|465934593|FG000|Overall Study|Moved to another country|0|||
129446161|NCT00763971|465934594|FG001|Overall Study|Moved to another country|1|||
129446162|NCT00763971|465934595|FG002|Overall Study|Moved to another country|0|||
129446163|NCT00763971|465934593|FG000|Overall Study|Subject wanted dose reduction|0|||
129446164|NCT00763971|465934594|FG001|Overall Study|Subject wanted dose reduction|1|||
129446165|NCT00763971|465934595|FG002|Overall Study|Subject wanted dose reduction|0|||
129446166|NCT00763971|465934593|FG000|Overall Study|Lack of availability|0|||
129446167|NCT00763971|465934594|FG001|Overall Study|Lack of availability|1|||
129446168|NCT00763971|465934595|FG002|Overall Study|Lack of availability|0|||
129446169|NCT00763971|465934593|FG000|Overall Study|Performed final visit on phone|0|||
129446170|NCT00763971|465934594|FG001|Overall Study|Performed final visit on phone|1|||
129446171|NCT00763971|465934595|FG002|Overall Study|Performed final visit on phone|0|||
129446172|NCT00763971|465934593|FG000|Overall Study|Participation in 489-326 required|1|||
129446173|NCT00763971|465934594|FG001|Overall Study|Participation in 489-326 required|0|||
129446174|NCT00763971|465934595|FG002|Overall Study|Participation in 489-326 required|0|||
129446175|NCT03334409|465934597|FG000|Overall Study|Did not meet inclusion criteria|1|||
129446176|NCT03334409|465934598|FG001|Overall Study|Did not meet inclusion criteria|0|||
129446177|NCT05372653|465934601|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
129446178|NCT05372653|465934602|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
129446179|NCT05372653|465934601|FG000|Overall Study|Adverse Event|0|||
129446180|NCT05372653|465934602|FG001|Overall Study|Adverse Event|1|||
129446181|NCT00711529|465934603|FG000|Overall Study|Protocol Violation|2|||
129446182|NCT00711529|465934604|FG001|Overall Study|Protocol Violation|0|||
129446183|NCT00711529|465934603|FG000|Overall Study|Withdrawal by Subject|2|||
129446184|NCT00711529|465934604|FG001|Overall Study|Withdrawal by Subject|6|||
129446185|NCT03740997|465934608|FG000|Overall Study|Withdrawal by Subject|1|||
129446186|NCT03740997|465934609|FG001|Overall Study|Withdrawal by Subject|0|||
129446187|NCT03740997|465934608|FG000|Overall Study|Participant was unable to complete study procedures|1|||
129446188|NCT03740997|465934609|FG001|Overall Study|Participant was unable to complete study procedures|0|||
129446189|NCT01829425|465934611|FG000|Overall Study|Withdrawal by Subject|4|||
129446190|NCT01829425|465934612|FG001|Overall Study|Withdrawal by Subject|3|||
129446191|NCT01829425|465934611|FG000|Overall Study|Lost to Follow-up|2|||
129446192|NCT01829425|465934612|FG001|Overall Study|Lost to Follow-up|1|||
129446193|NCT04178967|465934613|FG000|Induction Period|Adverse Event|4|||
129446194|NCT04178967|465934614|FG001|Induction Period|Adverse Event|6|||
129835100|NCT03450707|467362762|FG001|Overall Study|Indication for thiamine + head CT results|1|||
129446195|NCT04178967|465934615|FG002|Induction Period|Adverse Event|0|||
129446196|NCT04178967|465934616|FG003|Induction Period|Adverse Event|0|||
129835101|NCT03450707|467362761|FG000|Overall Study|Family/patient goals of care|0|||
129446197|NCT04178967|465934617|FG004|Induction Period|Adverse Event|0|||
129446198|NCT04178967|465934618|FG005|Induction Period|Adverse Event|0|||
129446199|NCT04178967|465934619|FG006|Induction Period|Adverse Event|0|||
129446200|NCT04178967|465934620|FG007|Induction Period|Adverse Event|0|||
129446201|NCT04178967|465934621|FG008|Induction Period|Adverse Event|0|||
129446202|NCT04178967|465934622|FG009|Induction Period|Adverse Event|0|||
129446203|NCT04178967|465934623|FG010|Induction Period|Adverse Event|0|||
129446204|NCT04178967|465934613|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
129446205|NCT04178967|465934614|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
129446206|NCT04178967|465934615|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
129897887|NCT01801930|467586508|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
129897888|NCT01801930|467586509|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
129897889|NCT01801930|467586510|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
129897890|NCT01801930|467586507|FG000|Overall Study|DLT occurs|0|||
129897891|NCT01801930|467586508|FG001|Overall Study|DLT occurs|1|||
129897892|NCT01801930|467586509|FG002|Overall Study|DLT occurs|0|||
129897893|NCT01801930|467586510|FG003|Overall Study|DLT occurs|0|||
129897894|NCT00930813|467586520|FG000|Overall Study|Death|4|||
129897895|NCT00930813|467586521|FG001|Overall Study|Death|5|||
129897896|NCT00930813|467586520|FG000|Overall Study|Withdrawal by Subject|2|||
129897897|NCT00930813|467586521|FG001|Overall Study|Withdrawal by Subject|5|||
129897898|NCT00930813|467586520|FG000|Overall Study|Lost to Follow-up|2|||
129897899|NCT00930813|467586521|FG001|Overall Study|Lost to Follow-up|4|||
129897900|NCT03999554|467586523|FG000|Overall Study|Lost to Follow-up|4|||
129897901|NCT03999554|467586524|FG001|Overall Study|Lost to Follow-up|5|||
129897902|NCT03999554|467586525|FG002|Overall Study|Lost to Follow-up|4|||
129897903|NCT03999554|467586526|FG003|Overall Study|Lost to Follow-up|5|||
129897904|NCT03999554|467586527|FG004|Overall Study|Lost to Follow-up|8|||
129897905|NCT03999554|467586523|FG000|Overall Study|Protocol Violation|0|||
129897906|NCT03999554|467586524|FG001|Overall Study|Protocol Violation|0|||
129897907|NCT03999554|467586525|FG002|Overall Study|Protocol Violation|5|||
129897908|NCT03999554|467586526|FG003|Overall Study|Protocol Violation|0|||
129897909|NCT03999554|467586527|FG004|Overall Study|Protocol Violation|0|||
129897910|NCT03999554|467586523|FG000|Overall Study|Pregnancy|0|||
129897911|NCT03999554|467586524|FG001|Overall Study|Pregnancy|0|||
129897912|NCT03999554|467586525|FG002|Overall Study|Pregnancy|1|||
129897913|NCT03999554|467586526|FG003|Overall Study|Pregnancy|0|||
129897914|NCT03999554|467586527|FG004|Overall Study|Pregnancy|0|||
129897915|NCT03999554|467586523|FG000|Overall Study|Withdrawal by Subject|2|||
129897916|NCT03999554|467586524|FG001|Overall Study|Withdrawal by Subject|2|||
129897917|NCT03999554|467586525|FG002|Overall Study|Withdrawal by Subject|2|||
129897918|NCT03999554|467586526|FG003|Overall Study|Withdrawal by Subject|1|||
129897919|NCT03999554|467586527|FG004|Overall Study|Withdrawal by Subject|1|||
129897920|NCT03999554|467586523|FG000|Overall Study|failure to comply with protocol requirements|0|||
129897921|NCT03999554|467586524|FG001|Overall Study|failure to comply with protocol requirements|0|||
129897922|NCT03999554|467586525|FG002|Overall Study|failure to comply with protocol requirements|0|||
129897923|NCT03999554|467586526|FG003|Overall Study|failure to comply with protocol requirements|1|||
129897924|NCT03999554|467586527|FG004|Overall Study|failure to comply with protocol requirements|0|||
129897925|NCT03102710|467586528|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
129897926|NCT03102710|467586529|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
129897927|NCT03102710|467586530|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
129897928|NCT03102710|467586528|FG000|Overall Study|Technical issues during final MRI scan|0|||
129897929|NCT03102710|467586529|FG001|Overall Study|Technical issues during final MRI scan|1|||
129897930|NCT03102710|467586530|FG002|Overall Study|Technical issues during final MRI scan|0|||
129897931|NCT03102710|467586528|FG000|Overall Study|Nausea during MRI scan|0|||
129897932|NCT03102710|467586529|FG001|Overall Study|Nausea during MRI scan|1|||
129897933|NCT03102710|467586530|FG002|Overall Study|Nausea during MRI scan|0|||
129897934|NCT03102710|467586528|FG000|Overall Study|Subject unable to attend final session|0|||
129835102|NCT03450707|467362762|FG001|Overall Study|Family/patient goals of care|1|||
129835103|NCT00481195|467362763|FG000|Overall Study|Adverse Event|16|||
129835104|NCT00481195|467362764|FG001|Overall Study|Adverse Event|11|||
129835105|NCT00481195|467362763|FG000|Overall Study|Lack of Efficacy|1|||
129835106|NCT00481195|467362764|FG001|Overall Study|Lack of Efficacy|3|||
129835107|NCT00481195|467362763|FG000|Overall Study|Lost to Follow-up|4|||
129835108|NCT00481195|467362764|FG001|Overall Study|Lost to Follow-up|6|||
129835109|NCT00481195|467362763|FG000|Overall Study|Physician Decision|3|||
129835110|NCT00481195|467362764|FG001|Overall Study|Physician Decision|1|||
129835111|NCT00481195|467362763|FG000|Overall Study|Protocol Violation|10|||
129835112|NCT00481195|467362764|FG001|Overall Study|Protocol Violation|7|||
129835113|NCT00481195|467362763|FG000|Overall Study|Withdrawal by Subject|3|||
129835114|NCT00481195|467362764|FG001|Overall Study|Withdrawal by Subject|9|||
129835115|NCT00481195|467362763|FG000|Overall Study|Miscellaneous|2|||
129835116|NCT00481195|467362764|FG001|Overall Study|Miscellaneous|2|||
129835117|NCT03343483|467362765|FG000|Overall Study|Death|0|||
129835118|NCT03343483|467362766|FG001|Overall Study|Death|3|||
129835119|NCT03343483|467362765|FG000|Overall Study|Lost to Follow-up|9|||
129835120|NCT03343483|467362766|FG001|Overall Study|Lost to Follow-up|13|||
129835121|NCT03343483|467362765|FG000|Overall Study|Withdrawal by Subject|8|||
129835122|NCT03343483|467362766|FG001|Overall Study|Withdrawal by Subject|17|||
129897935|NCT03102710|467586529|FG001|Overall Study|Subject unable to attend final session|1|||
129897936|NCT03102710|467586530|FG002|Overall Study|Subject unable to attend final session|0|||
129835123|NCT01505608|467362767|FG000|Phase I|Lack of Efficacy|0|||
129835124|NCT01505608|467362768|FG001|Phase I|Lack of Efficacy|4|||
129835125|NCT01505608|467362767|FG000|Phase I|Adverse Event|0|||
129835126|NCT01505608|467362768|FG001|Phase I|Adverse Event|1|||
129835127|NCT01505608|467362767|FG000|Phase I|Withdrawal by Subject|0|||
129835128|NCT01505608|467362768|FG001|Phase I|Withdrawal by Subject|1|||
129835129|NCT01505608|467362767|FG000|Phase II|Lack of Efficacy|2|||
129835130|NCT01505608|467362768|FG001|Phase II|Lack of Efficacy|1|||
129835131|NCT01505608|467362767|FG000|Phase II|Protocol Violation|0|||
129835132|NCT01505608|467362768|FG001|Phase II|Protocol Violation|1|||
129835133|NCT03975647|467362769|FG000|Overall Study|Death|71|||
129835134|NCT03975647|467362770|FG001|Overall Study|Death|63|||
129835135|NCT03975647|467362769|FG000|Overall Study|Lost to Follow-up|2|||
129835136|NCT03975647|467362770|FG001|Overall Study|Lost to Follow-up|2|||
129835137|NCT03975647|467362769|FG000|Overall Study|Subject withdrawal of consent|7|||
129835138|NCT03975647|467362770|FG001|Overall Study|Subject withdrawal of consent|11|||
129835139|NCT02404350|467362771|FG000|Overall Study|Adverse Event|2|||
129835140|NCT02404350|467362772|FG001|Overall Study|Adverse Event|2|||
129835141|NCT02404350|467362773|FG002|Overall Study|Adverse Event|3|||
129835142|NCT02404350|467362774|FG003|Overall Study|Adverse Event|9|||
129835143|NCT02404350|467362771|FG000|Overall Study|Lack of Efficacy|3|||
129835144|NCT02404350|467362772|FG001|Overall Study|Lack of Efficacy|1|||
129835145|NCT02404350|467362773|FG002|Overall Study|Lack of Efficacy|0|||
129835146|NCT02404350|467362774|FG003|Overall Study|Lack of Efficacy|3|||
129835147|NCT02404350|467362771|FG000|Overall Study|Lost to Follow-up|2|||
129835148|NCT02404350|467362772|FG001|Overall Study|Lost to Follow-up|0|||
129835149|NCT02404350|467362773|FG002|Overall Study|Lost to Follow-up|0|||
129835150|NCT02404350|467362774|FG003|Overall Study|Lost to Follow-up|1|||
129897937|NCT01101165|467586531|FG000|Period 1|Adverse Event|1|||
129897938|NCT01101165|467586532|FG001|Period 1|Adverse Event|2|||
129897939|NCT01101165|467586531|FG000|Period 1|Withdrawal by Subject|0|||
129897940|NCT01101165|467586532|FG001|Period 1|Withdrawal by Subject|2|||
129897941|NCT01101165|467586531|FG000|Period 1|Positive Drug Screen|0|||
129897942|NCT01101165|467586532|FG001|Period 1|Positive Drug Screen|1|||
129897943|NCT01101165|467586531|FG000|Period 1|Lost to Follow-up|1|||
129897944|NCT01101165|467586532|FG001|Period 1|Lost to Follow-up|0|||
129897945|NCT01101165|467586531|FG000|Period 2|Withdrawal by Subject|3|||
129897946|NCT01101165|467586532|FG001|Period 2|Withdrawal by Subject|1|||
129897947|NCT01101165|467586531|FG000|Period 2|Adverse Event|1|||
129897948|NCT01101165|467586532|FG001|Period 2|Adverse Event|0|||
129897949|NCT00015457|467586533|FG000|First Intervention|Adverse Event|0|||
129897950|NCT00015457|467586534|FG001|First Intervention|Adverse Event|2|||
129897951|NCT00015457|467586533|FG000|First Intervention|Lack of Efficacy|0|||
129897952|NCT00015457|467586534|FG001|First Intervention|Lack of Efficacy|1|||
129897953|NCT00015457|467586533|FG000|Second Intervention|Withdrawal by Subject|1|||
129897954|NCT00015457|467586534|FG001|Second Intervention|Withdrawal by Subject|0|||
129897955|NCT02317705|467586535|FG000|Overall Study|Withdrawal by Subject|3|||
129897956|NCT02317705|467586535|FG000|Overall Study|Physician Decision|1|||
129897957|NCT02317705|467586535|FG000|Overall Study|Drug not usable|1|||
129897958|NCT02219490|467586536|FG000|Overall Study|Adverse Event|24|||
129897959|NCT02219490|467586536|FG000|Overall Study|Withdrew consent|96|||
129897960|NCT02219490|467586536|FG000|Overall Study|Lost to Follow-up|126|||
129897961|NCT02219490|467586536|FG000|Overall Study|COVID-19 infection|2|||
129897962|NCT02219490|467586536|FG000|Overall Study|COVID-19 logistical restrictions|33|||
129897963|NCT02219490|467586536|FG000|Overall Study|Other, not specified|57|||
129897964|NCT01599325|467586537|FG000|Primary Parent Phase|Adverse Event|5|||
129835151|NCT02404350|467362771|FG000|Overall Study|Physician Decision|1|||
129835152|NCT02404350|467362772|FG001|Overall Study|Physician Decision|0|||
129835153|NCT02404350|467362773|FG002|Overall Study|Physician Decision|0|||
129897965|NCT01599325|467586537|FG000|Primary Parent Phase|Disease Progression|7|||
129897966|NCT01599325|467586537|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
129897967|NCT01599325|467586537|FG000|Primary Parent Phase|Death|13|||
129897968|NCT01599325|467586537|FG000|Primary Parent Phase|Protocol Violation|1|||
129897969|NCT01599325|467586537|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
129897970|NCT01599325|467586537|FG000|Primary Parent Phase|Other|2|||
129897971|NCT01599325|467586537|FG000|Extension Phase|Study Closure|1|||
129897972|NCT01599325|467586537|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
129897973|NCT01599325|467586537|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
129835154|NCT02404350|467362774|FG003|Overall Study|Physician Decision|2|||
129835155|NCT02404350|467362771|FG000|Overall Study|Pregnancy|0|||
129897974|NCT01599325|467586537|FG000|Extension Phase|Disease Progression|1|||
129446207|NCT04178967|465934616|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
129446208|NCT04178967|465934617|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
129446209|NCT04178967|465934618|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
129446210|NCT04178967|465934619|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
129446211|NCT04178967|465934620|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
129446212|NCT04178967|465934621|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
129446213|NCT04178967|465934622|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
129446214|NCT04178967|465934623|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
129446215|NCT04178967|465934613|FG000|Induction Period|Lack of Efficacy|4|||
129446216|NCT04178967|465934614|FG001|Induction Period|Lack of Efficacy|1|||
129446217|NCT04178967|465934615|FG002|Induction Period|Lack of Efficacy|0|||
129446218|NCT04178967|465934616|FG003|Induction Period|Lack of Efficacy|0|||
129446219|NCT04178967|465934617|FG004|Induction Period|Lack of Efficacy|0|||
129446220|NCT04178967|465934618|FG005|Induction Period|Lack of Efficacy|0|||
129446221|NCT04178967|465934619|FG006|Induction Period|Lack of Efficacy|0|||
129446222|NCT04178967|465934620|FG007|Induction Period|Lack of Efficacy|0|||
129446223|NCT04178967|465934621|FG008|Induction Period|Lack of Efficacy|0|||
129446224|NCT04178967|465934622|FG009|Induction Period|Lack of Efficacy|0|||
129446225|NCT04178967|465934623|FG010|Induction Period|Lack of Efficacy|0|||
129446226|NCT04178967|465934613|FG000|Induction Period|Protocol Violation|0|||
129446227|NCT04178967|465934614|FG001|Induction Period|Protocol Violation|6|||
129446228|NCT04178967|465934615|FG002|Induction Period|Protocol Violation|0|||
129446229|NCT04178967|465934616|FG003|Induction Period|Protocol Violation|0|||
129446230|NCT04178967|465934617|FG004|Induction Period|Protocol Violation|0|||
129446231|NCT04178967|465934618|FG005|Induction Period|Protocol Violation|0|||
129446232|NCT04178967|465934619|FG006|Induction Period|Protocol Violation|0|||
129446233|NCT04178967|465934620|FG007|Induction Period|Protocol Violation|0|||
129446234|NCT04178967|465934621|FG008|Induction Period|Protocol Violation|0|||
129446235|NCT04178967|465934622|FG009|Induction Period|Protocol Violation|0|||
129446236|NCT04178967|465934623|FG010|Induction Period|Protocol Violation|0|||
129446237|NCT04178967|465934613|FG000|Induction Period|Withdrawal by Subject|6|||
129446238|NCT04178967|465934614|FG001|Induction Period|Withdrawal by Subject|4|||
129446239|NCT04178967|465934615|FG002|Induction Period|Withdrawal by Subject|0|||
129446240|NCT04178967|465934616|FG003|Induction Period|Withdrawal by Subject|0|||
129446241|NCT04178967|465934617|FG004|Induction Period|Withdrawal by Subject|0|||
129446242|NCT04178967|465934618|FG005|Induction Period|Withdrawal by Subject|0|||
129446243|NCT04178967|465934619|FG006|Induction Period|Withdrawal by Subject|0|||
129446244|NCT04178967|465934620|FG007|Induction Period|Withdrawal by Subject|0|||
129446245|NCT04178967|465934621|FG008|Induction Period|Withdrawal by Subject|0|||
129446246|NCT04178967|465934622|FG009|Induction Period|Withdrawal by Subject|0|||
129446247|NCT04178967|465934623|FG010|Induction Period|Withdrawal by Subject|0|||
129446248|NCT04178967|465934613|FG000|Induction Period|Lost to Follow-up|2|||
129446249|NCT04178967|465934614|FG001|Induction Period|Lost to Follow-up|0|||
129446250|NCT04178967|465934615|FG002|Induction Period|Lost to Follow-up|0|||
129446251|NCT04178967|465934616|FG003|Induction Period|Lost to Follow-up|0|||
129446252|NCT04178967|465934617|FG004|Induction Period|Lost to Follow-up|0|||
129446253|NCT04178967|465934618|FG005|Induction Period|Lost to Follow-up|0|||
129446254|NCT04178967|465934619|FG006|Induction Period|Lost to Follow-up|0|||
129446255|NCT04178967|465934620|FG007|Induction Period|Lost to Follow-up|0|||
129446256|NCT04178967|465934621|FG008|Induction Period|Lost to Follow-up|0|||
129446257|NCT04178967|465934622|FG009|Induction Period|Lost to Follow-up|0|||
129446258|NCT04178967|465934623|FG010|Induction Period|Lost to Follow-up|0|||
129446259|NCT04178967|465934613|FG000|Induction Period|Participant Missed Study Visits|0|||
129835156|NCT02404350|467362772|FG001|Overall Study|Pregnancy|0|||
129835157|NCT02404350|467362773|FG002|Overall Study|Pregnancy|0|||
129835158|NCT02404350|467362774|FG003|Overall Study|Pregnancy|1|||
129835159|NCT02404350|467362771|FG000|Overall Study|Withdrawal by Subject|7|||
129835160|NCT02404350|467362772|FG001|Overall Study|Withdrawal by Subject|3|||
129835161|NCT02404350|467362773|FG002|Overall Study|Withdrawal by Subject|3|||
129835162|NCT02404350|467362774|FG003|Overall Study|Withdrawal by Subject|19|||
129835163|NCT02404350|467362771|FG000|Overall Study|Due to Non-compliance with treatment|0|||
129835164|NCT02404350|467362772|FG001|Overall Study|Due to Non-compliance with treatment|0|||
129835165|NCT02404350|467362773|FG002|Overall Study|Due to Non-compliance with treatment|0|||
129835166|NCT02404350|467362774|FG003|Overall Study|Due to Non-compliance with treatment|1|||
129446260|NCT04178967|465934614|FG001|Induction Period|Participant Missed Study Visits|1|||
129446261|NCT04178967|465934615|FG002|Induction Period|Participant Missed Study Visits|0|||
129446262|NCT04178967|465934616|FG003|Induction Period|Participant Missed Study Visits|0|||
129446263|NCT04178967|465934617|FG004|Induction Period|Participant Missed Study Visits|0|||
129446264|NCT04178967|465934618|FG005|Induction Period|Participant Missed Study Visits|0|||
129446265|NCT04178967|465934619|FG006|Induction Period|Participant Missed Study Visits|0|||
129446266|NCT04178967|465934620|FG007|Induction Period|Participant Missed Study Visits|0|||
129446267|NCT04178967|465934621|FG008|Induction Period|Participant Missed Study Visits|0|||
129446268|NCT04178967|465934622|FG009|Induction Period|Participant Missed Study Visits|0|||
129446269|NCT04178967|465934623|FG010|Induction Period|Participant Missed Study Visits|0|||
129446270|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
129835167|NCT02404350|467362771|FG000|Overall Study|Due to Technical problems|0|||
129835168|NCT02404350|467362772|FG001|Overall Study|Due to Technical problems|0|||
129835169|NCT02404350|467362773|FG002|Overall Study|Due to Technical problems|0|||
129835170|NCT02404350|467362774|FG003|Overall Study|Due to Technical problems|1|||
129835171|NCT02319031|467362775|FG000|Treatment Period|Death|1|||
129835172|NCT02319031|467362776|FG001|Treatment Period|Death|0|||
129835173|NCT02871739|467362777|FG000|Overall Study|Lost to Follow-up|3|||
129835174|NCT02871739|467362778|FG001|Overall Study|Lost to Follow-up|2|||
129835175|NCT02871739|467362779|FG002|Overall Study|Lost to Follow-up|0|||
129835176|NCT02871739|467362780|FG003|Overall Study|Lost to Follow-up|2|||
129835177|NCT00439556|467362781|FG000|Overall Study|Patient was taken off study for non-comp|0|||
129835178|NCT00439556|467362782|FG001|Overall Study|Patient was taken off study for non-comp|1|||
129835179|NCT00439556|467362783|FG002|Overall Study|Patient was taken off study for non-comp|0|||
129835180|NCT01405963|467362786|FG000|Overall Study|Moved Away|2|||
129835181|NCT01405963|467362787|FG001|Overall Study|Moved Away|0|||
129835182|NCT01405963|467362786|FG000|Overall Study|Adverse Event|0|||
129835183|NCT01405963|467362787|FG001|Overall Study|Adverse Event|1|||
129835184|NCT01405963|467362786|FG000|Overall Study|Lost to Follow-up|0|||
129835185|NCT01405963|467362787|FG001|Overall Study|Lost to Follow-up|1|||
129835186|NCT01085097|467362788|FG000|Overall Study|Adverse Event|0|||
129835187|NCT01085097|467362789|FG001|Overall Study|Adverse Event|0|||
129835188|NCT01085097|467362790|FG002|Overall Study|Adverse Event|2|||
129835189|NCT01085097|467362788|FG000|Overall Study|Treatment failure|2|||
129835190|NCT01085097|467362789|FG001|Overall Study|Treatment failure|0|||
129835191|NCT01085097|467362790|FG002|Overall Study|Treatment failure|0|||
129835192|NCT01498640|467362793|FG000|Overall Study|Lost to Follow-up|1|||
129835193|NCT01498640|467362793|FG000|Overall Study|Death|1|||
129835194|NCT01498640|467362793|FG000|Overall Study|Other|3|||
129835195|NCT01524692|467362798|FG000|Overall Study|Withdrawal by Subject|3|||
129835196|NCT04007523|467362800|FG000|Overall Study|Withdrawal by Subject|0|||
129835197|NCT04007523|467362801|FG001|Overall Study|Withdrawal by Subject|1|||
129835198|NCT04007523|467362802|FG002|Overall Study|Withdrawal by Subject|1|||
129835199|NCT04007523|467362803|FG003|Overall Study|Withdrawal by Subject|0|||
129835200|NCT04007523|467362800|FG000|Overall Study|ICU Transfer|0|||
129835201|NCT04007523|467362801|FG001|Overall Study|ICU Transfer|1|||
129835202|NCT04007523|467362802|FG002|Overall Study|ICU Transfer|0|||
129835203|NCT04007523|467362803|FG003|Overall Study|ICU Transfer|0|||
129835204|NCT04007523|467362800|FG000|Overall Study|COVID hospital closure|0|||
129835205|NCT04007523|467362801|FG001|Overall Study|COVID hospital closure|0|||
129835206|NCT04007523|467362802|FG002|Overall Study|COVID hospital closure|1|||
129835207|NCT04007523|467362803|FG003|Overall Study|COVID hospital closure|2|||
129835208|NCT04007523|467362800|FG000|Overall Study|Surgery cancelled|0|||
129835209|NCT04007523|467362801|FG001|Overall Study|Surgery cancelled|0|||
129835210|NCT04007523|467362802|FG002|Overall Study|Surgery cancelled|1|||
129835211|NCT04007523|467362803|FG003|Overall Study|Surgery cancelled|1|||
129835212|NCT02197806|467362807|FG000|Overall Study|Adverse Event|0|||
129835213|NCT02197806|467362808|FG001|Overall Study|Adverse Event|1|||
129835214|NCT02197806|467362809|FG002|Overall Study|Adverse Event|0|||
129835215|NCT02197806|467362810|FG003|Overall Study|Adverse Event|1|||
129835216|NCT03065244|467362818|FG000|Overall Study|Lost to Follow-up|1|||
129835217|NCT03065244|467362819|FG001|Overall Study|Lost to Follow-up|1|||
129835218|NCT03065244|467362818|FG000|Overall Study|Diagnosed with a different disease|1|||
129835219|NCT03065244|467362819|FG001|Overall Study|Diagnosed with a different disease|1|||
129835220|NCT03065244|467362818|FG000|Overall Study|Protocol Violation|0|||
129835221|NCT03065244|467362819|FG001|Overall Study|Protocol Violation|1|||
129835222|NCT03065244|467362818|FG000|Overall Study|Withdrawal by Subject|1|||
129835223|NCT03065244|467362819|FG001|Overall Study|Withdrawal by Subject|1|||
129835224|NCT03717480|467362820|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
129835225|NCT01708174|467362823|FG000|Treatment Period|Withdrawal by Subject|1|||
129835226|NCT01708174|467362824|FG001|Treatment Period|Withdrawal by Subject|0|||
129835227|NCT01708174|467362825|FG002|Treatment Period|Withdrawal by Subject|0|||
129835228|NCT01708174|467362823|FG000|Treatment Period|Progressive disease|0|||
129835229|NCT01708174|467362824|FG001|Treatment Period|Progressive disease|1|||
129835230|NCT01708174|467362825|FG002|Treatment Period|Progressive disease|0|||
129835231|NCT01708174|467362823|FG000|Treatment Period|Death|0|||
129835232|NCT01708174|467362824|FG001|Treatment Period|Death|0|||
129835233|NCT01708174|467362825|FG002|Treatment Period|Death|1|||
129835234|NCT01708174|467362823|FG000|Treatment Period|Adverse Event|0|||
129835235|NCT01708174|467362824|FG001|Treatment Period|Adverse Event|1|||
129835236|NCT01708174|467362825|FG002|Treatment Period|Adverse Event|0|||
129835237|NCT01894152|467362826|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
129835238|NCT01774786|467362827|FG000|Overall Study|Death|300|||
129835239|NCT01774786|467362828|FG001|Overall Study|Death|319|||
129835240|NCT01774786|467362827|FG000|Overall Study|Lost to Follow-up|6|||
129835241|NCT01774786|467362828|FG001|Overall Study|Lost to Follow-up|7|||
129835242|NCT01774786|467362827|FG000|Overall Study|Withdrawal by Subject|18|||
129835243|NCT01774786|467362828|FG001|Overall Study|Withdrawal by Subject|14|||
129835244|NCT01774786|467362827|FG000|Overall Study|Physician Decision|2|||
129835245|NCT01774786|467362828|FG001|Overall Study|Physician Decision|0|||
129835246|NCT01774786|467362827|FG000|Overall Study|Non-compliance|0|||
129835247|NCT01774786|467362828|FG001|Overall Study|Non-compliance|1|||
129835248|NCT01774786|467362827|FG000|Overall Study|Reason Not Specified|2|||
129835249|NCT01774786|467362828|FG001|Overall Study|Reason Not Specified|5|||
129835250|NCT00075582|467362829|FG000|Overall Study|Adverse Event|3|||
129835251|NCT00075582|467362830|FG001|Overall Study|Adverse Event|1|||
129835252|NCT00075582|467362829|FG000|Overall Study|Lack of Efficacy|4|||
129835253|NCT00075582|467362830|FG001|Overall Study|Lack of Efficacy|8|||
129835254|NCT00075582|467362829|FG000|Overall Study|Physician Decision|5|||
129835255|NCT00075582|467362830|FG001|Overall Study|Physician Decision|8|||
129835256|NCT00075582|467362829|FG000|Overall Study|Withdrawal by Subject|2|||
129835257|NCT00075582|467362830|FG001|Overall Study|Withdrawal by Subject|2|||
129835258|NCT00075582|467362829|FG000|Overall Study|Ineligible for study|36|||
129835259|NCT00075582|467362830|FG001|Overall Study|Ineligible for study|16|||
129835260|NCT02268812|467362831|FG000|Overall Study|Adverse Event|8|||
129835261|NCT02268812|467362832|FG001|Overall Study|Adverse Event|26|||
129835262|NCT02268812|467362833|FG002|Overall Study|Adverse Event|7|||
129835263|NCT02268812|467362834|FG003|Overall Study|Adverse Event|10|||
129835264|NCT02268812|467362831|FG000|Overall Study|Protocol deviation|0|||
129835265|NCT02268812|467362832|FG001|Overall Study|Protocol deviation|0|||
129835266|NCT02268812|467362833|FG002|Overall Study|Protocol deviation|1|||
129835267|NCT02268812|467362834|FG003|Overall Study|Protocol deviation|0|||
129835268|NCT02268812|467362831|FG000|Overall Study|Withdrawal by Subject|0|||
129835269|NCT02268812|467362832|FG001|Overall Study|Withdrawal by Subject|1|||
129835270|NCT02268812|467362833|FG002|Overall Study|Withdrawal by Subject|0|||
129835271|NCT02268812|467362834|FG003|Overall Study|Withdrawal by Subject|0|||
129835272|NCT02268812|467362831|FG000|Overall Study|Physician Decision|3|||
129835273|NCT02268812|467362832|FG001|Overall Study|Physician Decision|1|||
129835274|NCT02268812|467362833|FG002|Overall Study|Physician Decision|0|||
129835275|NCT02268812|467362834|FG003|Overall Study|Physician Decision|1|||
129835276|NCT02268812|467362831|FG000|Overall Study|Other|5|||
129835277|NCT02268812|467362832|FG001|Overall Study|Other|4|||
129835278|NCT02268812|467362833|FG002|Overall Study|Other|1|||
129835279|NCT02268812|467362834|FG003|Overall Study|Other|3|||
129835280|NCT02385084|467362835|FG000|Period 2|Protocol Violation|0|||
129835281|NCT02385084|467362836|FG001|Period 2|Protocol Violation|0|||
129835282|NCT02385084|467362837|FG002|Period 2|Protocol Violation|1|||
129835283|NCT02385084|467362838|FG003|Period 2|Protocol Violation|0|||
129835284|NCT02385084|467362839|FG004|Period 2|Protocol Violation|0|||
129835285|NCT02385084|467362840|FG005|Period 2|Protocol Violation|0|||
129835286|NCT05045144|467362841|FG000|Overall Study|Lost to Follow-up|3|||
129835287|NCT05045144|467362842|FG001|Overall Study|Lost to Follow-up|2|||
129835288|NCT05045144|467362843|FG002|Overall Study|Lost to Follow-up|3|||
129835289|NCT05045144|467362844|FG003|Overall Study|Lost to Follow-up|5|||
129835290|NCT05045144|467362845|FG004|Overall Study|Lost to Follow-up|13|||
129835291|NCT05045144|467362841|FG000|Overall Study|Withdrawal by Subject|0|||
129835292|NCT05045144|467362842|FG001|Overall Study|Withdrawal by Subject|1|||
129835293|NCT05045144|467362843|FG002|Overall Study|Withdrawal by Subject|0|||
129835294|NCT05045144|467362844|FG003|Overall Study|Withdrawal by Subject|0|||
129835295|NCT05045144|467362845|FG004|Overall Study|Withdrawal by Subject|0|||
129835296|NCT05045144|467362841|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835297|NCT05045144|467362842|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835298|NCT05045144|467362843|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129835299|NCT05045144|467362844|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835300|NCT05045144|467362845|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129835301|NCT02965703|467362850|FG000|Overall Study|Withdrawal by Subject|6|||
129835302|NCT02965703|467362851|FG001|Overall Study|Withdrawal by Subject|3|||
129835303|NCT02965703|467362852|FG002|Overall Study|Withdrawal by Subject|1|||
129835304|NCT02965703|467362850|FG000|Overall Study|Protocol Violation|1|||
129835305|NCT02965703|467362851|FG001|Overall Study|Protocol Violation|0|||
129835306|NCT02965703|467362852|FG002|Overall Study|Protocol Violation|0|||
129835307|NCT02965703|467362850|FG000|Overall Study|Adverse Event|1|||
129835308|NCT02965703|467362851|FG001|Overall Study|Adverse Event|1|||
129835309|NCT02965703|467362852|FG002|Overall Study|Adverse Event|0|||
129835310|NCT02965703|467362850|FG000|Overall Study|Lost to Follow-up|2|||
129835311|NCT02965703|467362851|FG001|Overall Study|Lost to Follow-up|1|||
129835312|NCT02965703|467362852|FG002|Overall Study|Lost to Follow-up|1|||
129835313|NCT00744627|467362853|FG000|Overall Study|Adverse Event|6|||
129835314|NCT00744627|467362854|FG001|Overall Study|Adverse Event|9|||
129835315|NCT00744627|467362853|FG000|Overall Study|Lack of Efficacy|7|||
129835316|NCT00744627|467362854|FG001|Overall Study|Lack of Efficacy|3|||
129835317|NCT00744627|467362853|FG000|Overall Study|Noncompliance|0|||
129835318|NCT00744627|467362854|FG001|Overall Study|Noncompliance|1|||
129835319|NCT00744627|467362853|FG000|Overall Study|Protocol Deviations|0|||
129835320|NCT00744627|467362854|FG001|Overall Study|Protocol Deviations|2|||
129835321|NCT00744627|467362853|FG000|Overall Study|Voluntary Withdrawal|9|||
129835322|NCT00744627|467362854|FG001|Overall Study|Voluntary Withdrawal|6|||
129835323|NCT00744627|467362853|FG000|Overall Study|Lost to Follow-up|2|||
129835324|NCT00744627|467362854|FG001|Overall Study|Lost to Follow-up|1|||
129835325|NCT00744627|467362853|FG000|Overall Study|Other|1|||
129835326|NCT00744627|467362854|FG001|Overall Study|Other|0|||
129835327|NCT00768144|467362855|FG000|Overall Study|Adverse Event|13|||
129835328|NCT00768144|467362855|FG000|Overall Study|Progressive Disease|21|||
129835329|NCT00768144|467362855|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
129835330|NCT00768144|467362855|FG000|Overall Study|Pt Withdrew Consent|1|||
129835331|NCT02268786|467362856|FG000|Overall Study|No Euploid Embryos available|42|||
129835332|NCT02268786|467362857|FG001|Overall Study|No Euploid Embryos available|0|||
129835333|NCT02268786|467362856|FG000|Overall Study|Withdrawal by Subject|7|||
129835334|NCT02268786|467362857|FG001|Overall Study|Withdrawal by Subject|14|||
129835335|NCT02268786|467362856|FG000|Overall Study|Thaw Failure|6|||
129835336|NCT02268786|467362857|FG001|Overall Study|Thaw Failure|4|||
129835337|NCT02268786|467362856|FG000|Overall Study|Protocol Violation|1|||
129835338|NCT02268786|467362857|FG001|Overall Study|Protocol Violation|0|||
129835339|NCT04251221|467362858|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
129835340|NCT04251221|467362859|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
129835341|NCT01319877|467362860|FG000|Overall Study|Lost to Follow-up|100|||
129835342|NCT01319877|467362861|FG001|Overall Study|Lost to Follow-up|37|||
129835343|NCT01319877|467362860|FG000|Overall Study|Physician Decision|2|||
129835344|NCT01319877|467362861|FG001|Overall Study|Physician Decision|0|||
129835345|NCT01319877|467362860|FG000|Overall Study|Disease Progression|2|||
129835346|NCT01319877|467362861|FG001|Overall Study|Disease Progression|2|||
129835347|NCT01319877|467362860|FG000|Overall Study|Withdrawal by Subject|0|||
129835348|NCT01319877|467362861|FG001|Overall Study|Withdrawal by Subject|1|||
129835349|NCT01319877|467362860|FG000|Overall Study|Reason Not Specified|4|||
129835350|NCT01319877|467362861|FG001|Overall Study|Reason Not Specified|5|||
129835351|NCT02968979|467362862|FG000|Overall Study|Protocol Violation|7|||
129835352|NCT02968979|467362862|FG000|Overall Study|Withdrawal by Subject|1|||
129835353|NCT03745144|467362863|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
129835354|NCT03745144|467362864|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
129835355|NCT03745144|467362865|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
129835356|NCT03745144|467362863|FG000|Period 1|Other|0|||
129835357|NCT03745144|467362864|FG001|Period 1|Other|0|||
129835358|NCT03745144|467362865|FG002|Period 1|Other|1|||
129835359|NCT00896337|467362866|FG000|Overall Study|Death|7|||
129835360|NCT00896337|467362866|FG000|Overall Study|Withdrawal by Subject|7|||
129835361|NCT00896337|467362866|FG000|Overall Study|Lost to Follow-up|11|||
129835362|NCT04668950|467362867|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
129835363|NCT04668950|467362868|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
129835364|NCT04668950|467362867|FG000|Overall Study|Could not confirm started study medication|15|||
129835365|NCT04668950|467362868|FG001|Overall Study|Could not confirm started study medication|15|||
129835366|NCT04668950|467362867|FG000|Overall Study|Could not confirm baseline status|6|||
129835367|NCT04668950|467362868|FG001|Overall Study|Could not confirm baseline status|2|||
129835368|NCT04668950|467362867|FG000|Overall Study|Drop out and did not start medication|15|||
129835369|NCT04668950|467362868|FG001|Overall Study|Drop out and did not start medication|17|||
129835370|NCT04668950|467362867|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
129835371|NCT04668950|467362868|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
129835372|NCT04668950|467362867|FG000|Overall Study|Other|2|||
129835373|NCT04668950|467362868|FG001|Overall Study|Other|4|||
129835374|NCT04059146|467362874|FG000|Overall Study|Withdrawal by Subject|0|||
129835375|NCT04059146|467362875|FG001|Overall Study|Withdrawal by Subject|1|||
129835376|NCT05756790|467362881|FG000|Overall Study|Withdrawal by Subject|1|||
129835377|NCT05756790|467362882|FG001|Overall Study|Withdrawal by Subject|1|||
129835378|NCT05756790|467362883|FG002|Overall Study|Withdrawal by Subject|1|||
129835379|NCT05756790|467362884|FG003|Overall Study|Withdrawal by Subject|1|||
129835380|NCT05756790|467362885|FG004|Overall Study|Withdrawal by Subject|0|||
129835381|NCT05756790|467362886|FG005|Overall Study|Withdrawal by Subject|0|||
129835382|NCT05756790|467362881|FG000|Overall Study|Protocol Violation|0|||
129835383|NCT05756790|467362882|FG001|Overall Study|Protocol Violation|0|||
129835384|NCT05756790|467362883|FG002|Overall Study|Protocol Violation|1|||
129835385|NCT05756790|467362884|FG003|Overall Study|Protocol Violation|1|||
129897975|NCT01599325|467586537|FG000|Extension Phase|Withdrawal by Subject|8|||
129835386|NCT05756790|467362885|FG004|Overall Study|Protocol Violation|0|||
129897976|NCT03404843|467586539|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
129835387|NCT05756790|467362886|FG005|Overall Study|Protocol Violation|0|||
129835388|NCT05756790|467362881|FG000|Overall Study|Ineligible|0|||
129835389|NCT05756790|467362882|FG001|Overall Study|Ineligible|0|||
129835390|NCT05756790|467362883|FG002|Overall Study|Ineligible|0|||
129835391|NCT05756790|467362884|FG003|Overall Study|Ineligible|0|||
129835392|NCT05756790|467362885|FG004|Overall Study|Ineligible|2|||
129835393|NCT05756790|467362886|FG005|Overall Study|Ineligible|2|||
129835394|NCT00502697|467364158|FG000|Overall Study|Withdrawal by Subject|3|||
129835395|NCT00502697|467364159|FG001|Overall Study|Withdrawal by Subject|1|||
129835396|NCT00502697|467364158|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
129835397|NCT00502697|467364159|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
129835398|NCT00502697|467364158|FG000|Overall Study|found not to meet eligibility criteria|3|||
129835399|NCT00502697|467364159|FG001|Overall Study|found not to meet eligibility criteria|4|||
129835400|NCT00502697|467364158|FG000|Overall Study|did not meet assignment criteria|4|||
129835401|NCT00502697|467364159|FG001|Overall Study|did not meet assignment criteria|2|||
129835402|NCT01545817|467364161|FG000|Pazopanib|Disease progression|51|||
129835403|NCT01545817|467364162|FG001|Pazopanib|Disease progression|0|||
129835404|NCT01545817|467364161|FG000|Pazopanib|Adverse Event|19|||
129835405|NCT01545817|467364162|FG001|Pazopanib|Adverse Event|0|||
129835406|NCT01545817|467364161|FG000|Pazopanib|Other reason|4|||
129835407|NCT01545817|467364162|FG001|Pazopanib|Other reason|0|||
129835408|NCT01545817|467364161|FG000|Everolimus|Other reason|0|||
129835409|NCT01545817|467364162|FG001|Everolimus|Other reason|7|||
129835410|NCT01545817|467364161|FG000|Everolimus|Disease progression|0|||
129835411|NCT01545817|467364162|FG001|Everolimus|Disease progression|25|||
129835412|NCT01545817|467364161|FG000|Everolimus|Adverse Event|0|||
129835413|NCT01545817|467364162|FG001|Everolimus|Adverse Event|6|||
129835414|NCT00589108|467364168|FG000|Overall Study|Lost to Follow-up|1|||
129835415|NCT00589108|467364169|FG001|Overall Study|Lost to Follow-up|1|||
129835416|NCT00589108|467364170|FG002|Overall Study|Lost to Follow-up|1|||
129835417|NCT00589108|467364168|FG000|Overall Study|Death|3|||
129835418|NCT00589108|467364169|FG001|Overall Study|Death|3|||
129835419|NCT00589108|467364170|FG002|Overall Study|Death|4|||
129835420|NCT03026257|467364175|FG000|Overall Study|Adverse Event|3|||
129446271|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
129835421|NCT03026257|467364176|FG001|Overall Study|Adverse Event|0|||
129835422|NCT03026257|467364177|FG002|Overall Study|Adverse Event|0|||
129835423|NCT03026257|467364178|FG003|Overall Study|Adverse Event|0|||
129835424|NCT03026257|467364179|FG004|Overall Study|Adverse Event|0|||
129835425|NCT03026257|467364180|FG005|Overall Study|Adverse Event|0|||
129835426|NCT03026257|467364175|FG000|Overall Study|Lost to Follow-up|1|||
129835427|NCT03026257|467364176|FG001|Overall Study|Lost to Follow-up|0|||
129835428|NCT03026257|467364177|FG002|Overall Study|Lost to Follow-up|0|||
129835429|NCT03026257|467364178|FG003|Overall Study|Lost to Follow-up|0|||
129835430|NCT03026257|467364179|FG004|Overall Study|Lost to Follow-up|0|||
129835431|NCT03026257|467364180|FG005|Overall Study|Lost to Follow-up|0|||
129835432|NCT03026257|467364175|FG000|Overall Study|Protocol Violation|1|||
129835433|NCT03026257|467364176|FG001|Overall Study|Protocol Violation|0|||
129835434|NCT03026257|467364177|FG002|Overall Study|Protocol Violation|0|||
129835435|NCT03026257|467364178|FG003|Overall Study|Protocol Violation|1|||
129835436|NCT03026257|467364179|FG004|Overall Study|Protocol Violation|1|||
129835437|NCT03026257|467364180|FG005|Overall Study|Protocol Violation|0|||
129835438|NCT03026257|467364175|FG000|Overall Study|Withdrawal by Subject|1|||
129835439|NCT03026257|467364176|FG001|Overall Study|Withdrawal by Subject|1|||
129835440|NCT03026257|467364177|FG002|Overall Study|Withdrawal by Subject|0|||
129835441|NCT03026257|467364178|FG003|Overall Study|Withdrawal by Subject|0|||
129835442|NCT03026257|467364179|FG004|Overall Study|Withdrawal by Subject|0|||
129835443|NCT03026257|467364180|FG005|Overall Study|Withdrawal by Subject|0|||
129835444|NCT04380857|467364181|FG000|Overall Study|Lost to Follow-up|3|||
129835445|NCT04380857|467364182|FG001|Overall Study|Lost to Follow-up|3|||
129835446|NCT00838201|467364183|FG000|Overall Study|Investigator decision, or other reasons|2|||
129835447|NCT00838201|467364184|FG001|Overall Study|Investigator decision, or other reasons|3|||
129835448|NCT00838201|467364183|FG000|Overall Study|Noncompliance|0|||
129835449|NCT00838201|467364184|FG001|Overall Study|Noncompliance|1|||
129835450|NCT00838201|467364183|FG000|Overall Study|Administrative decision|1|||
129835451|NCT00838201|467364184|FG001|Overall Study|Administrative decision|2|||
129835452|NCT00838201|467364183|FG000|Overall Study|Disease progression|3|||
129835453|NCT00838201|467364184|FG001|Overall Study|Disease progression|3|||
129835454|NCT00838201|467364183|FG000|Overall Study|Consent withdrawn|16|||
129835455|NCT00838201|467364184|FG001|Overall Study|Consent withdrawn|19|||
129835456|NCT00838201|467364183|FG000|Overall Study|Lost to Follow-up|4|||
129835457|NCT00838201|467364184|FG001|Overall Study|Lost to Follow-up|3|||
129835458|NCT00838201|467364183|FG000|Overall Study|Adverse Event|5|||
129835459|NCT00838201|467364184|FG001|Overall Study|Adverse Event|9|||
129835460|NCT00838201|467364183|FG000|Overall Study|Death|11|||
129835461|NCT00838201|467364184|FG001|Overall Study|Death|13|||
129835462|NCT02558790|467364185|FG000|Overall Study|Lost to Follow-up|2|||
129835463|NCT02558790|467364185|FG000|Overall Study|Physician Decision|1|||
129835464|NCT02558790|467364185|FG000|Overall Study|Withdrawal by Subject|1|||
129835465|NCT02558790|467364185|FG000|Overall Study|Screen Fail|3|||
129835466|NCT05228470|467364186|FG000|Overall Study|Death|6|||
129835467|NCT05228470|467364187|FG001|Overall Study|Death|11|||
129835468|NCT05228470|467364186|FG000|Overall Study|Withdrawal by Subject|1|||
129835469|NCT05228470|467364187|FG001|Overall Study|Withdrawal by Subject|8|||
129835470|NCT05228470|467364186|FG000|Overall Study|Ongoing|1|||
129835471|NCT05228470|467364187|FG001|Overall Study|Ongoing|11|||
129835472|NCT05620576|467364188|FG000|Overall Study|Adverse Event|1|||
129835473|NCT05620576|467364189|FG001|Overall Study|Adverse Event|1|||
129835474|NCT05620576|467364188|FG000|Overall Study|Lost to Follow-up|3|||
129835475|NCT05620576|467364189|FG001|Overall Study|Lost to Follow-up|1|||
129835476|NCT05620576|467364188|FG000|Overall Study|Physician Decision|0|||
129835477|NCT05620576|467364189|FG001|Overall Study|Physician Decision|1|||
129835478|NCT05620576|467364188|FG000|Overall Study|Protocol Deviation|1|||
129835479|NCT05620576|467364189|FG001|Overall Study|Protocol Deviation|1|||
129835480|NCT05620576|467364188|FG000|Overall Study|Withdrawal by Subject|2|||
129835481|NCT05620576|467364189|FG001|Overall Study|Withdrawal by Subject|3|||
129835482|NCT02622828|467364190|FG000|Overall Study|participant withdrew|3|||
129835483|NCT02780804|467364193|FG000|Overall Study|Death|1|||
129835484|NCT02780804|467364194|FG001|Overall Study|Death|0|||
129835485|NCT02780804|467364195|FG002|Overall Study|Death|0|||
129835486|NCT02780804|467364193|FG000|Overall Study|Lack of Efficacy|5|||
129835487|NCT02780804|467364194|FG001|Overall Study|Lack of Efficacy|8|||
129835488|NCT02780804|467364195|FG002|Overall Study|Lack of Efficacy|4|||
129835489|NCT02780804|467364193|FG000|Overall Study|Physician Decision|0|||
129835490|NCT02780804|467364194|FG001|Overall Study|Physician Decision|0|||
129835491|NCT02780804|467364195|FG002|Overall Study|Physician Decision|2|||
129835492|NCT02780804|467364193|FG000|Overall Study|Withdrawal by Subject|0|||
129835493|NCT02780804|467364194|FG001|Overall Study|Withdrawal by Subject|1|||
129835494|NCT02780804|467364195|FG002|Overall Study|Withdrawal by Subject|0|||
129897977|NCT03404843|467586540|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
129835495|NCT01921829|467364198|FG000|Overall Study|Withdrawal by Subject|0|||
129835496|NCT01921829|467364199|FG001|Overall Study|Withdrawal by Subject|1|||
129835497|NCT04476030|467364200|FG000|Overall Study|Withdrawal by Subject|20|||
129835498|NCT04476030|467364201|FG001|Overall Study|Withdrawal by Subject|16|||
129835499|NCT04476030|467364200|FG000|Overall Study|Adverse Event|10|||
129835500|NCT04476030|467364201|FG001|Overall Study|Adverse Event|11|||
129835501|NCT04476030|467364200|FG000|Overall Study|Lost to Follow-up|7|||
129835502|NCT04476030|467364201|FG001|Overall Study|Lost to Follow-up|4|||
129897978|NCT00567164|467586541|FG000|Overall Study|Withdrawal by Subject|171|||
129835503|NCT04476030|467364200|FG000|Overall Study|Physician Decision|1|||
129835504|NCT04476030|467364201|FG001|Overall Study|Physician Decision|1|||
129835505|NCT04476030|467364200|FG000|Overall Study|Protocol Deviation|2|||
129835506|NCT04476030|467364201|FG001|Overall Study|Protocol Deviation|0|||
129446272|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
129446273|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
129446274|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
129446275|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
129446276|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
129446277|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
129446278|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
129446279|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
129446280|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
129446281|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446282|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446283|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446284|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446285|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446286|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
129446287|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446288|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446289|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446290|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446291|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
129446292|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446293|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446294|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446295|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
129446296|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446297|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446298|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446299|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446300|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446301|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446302|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
129446303|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446304|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446305|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446306|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446307|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446308|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446309|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
129446310|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446311|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446312|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446313|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
129446314|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446315|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446316|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446317|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446318|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
129446319|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
129446320|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446321|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
129446322|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446323|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446324|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
129446325|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
129446326|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
129446327|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
129446328|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
129446329|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
129446330|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
129446331|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
129835507|NCT04476030|467364200|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
129835508|NCT04476030|467364201|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
129835509|NCT04476030|467364200|FG000|Overall Study|Randomized but not Dosed|2|||
129835510|NCT04476030|467364201|FG001|Overall Study|Randomized but not Dosed|8|||
129835511|NCT02256891|467364208|FG000|Overall Study|Death|0|||
129446332|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
129446333|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
129446334|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
129446335|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
129446336|NCT04178967|465934613|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446337|NCT04178967|465934614|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446338|NCT04178967|465934615|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446339|NCT04178967|465934616|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
129446340|NCT04178967|465934617|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446341|NCT04178967|465934618|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
129446342|NCT04178967|465934619|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
129446343|NCT04178967|465934620|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
129446344|NCT04178967|465934621|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446345|NCT04178967|465934622|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446346|NCT04178967|465934623|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
129446347|NCT04178967|465934613|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446348|NCT04178967|465934614|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446349|NCT04178967|465934615|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446350|NCT04178967|465934616|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446351|NCT04178967|465934617|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446352|NCT04178967|465934618|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446353|NCT04178967|465934619|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446354|NCT04178967|465934620|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446355|NCT04178967|465934621|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
129446356|NCT04178967|465934622|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
129446357|NCT04178967|465934623|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
129446358|NCT04178967|465934613|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446359|NCT04178967|465934614|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446360|NCT04178967|465934615|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446361|NCT04178967|465934616|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446362|NCT04178967|465934617|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446363|NCT04178967|465934618|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446364|NCT04178967|465934619|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446365|NCT04178967|465934620|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129446366|NCT04178967|465934621|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
129446367|NCT04178967|465934622|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
129446368|NCT04178967|465934623|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
129446369|NCT04178967|465934613|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446370|NCT04178967|465934614|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446371|NCT04178967|465934615|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446372|NCT04178967|465934616|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446373|NCT04178967|465934617|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446374|NCT04178967|465934618|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446375|NCT04178967|465934619|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446376|NCT04178967|465934620|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446377|NCT04178967|465934621|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446378|NCT04178967|465934622|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
129446379|NCT04178967|465934623|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129446380|NCT04178967|465934613|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446381|NCT04178967|465934614|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446382|NCT04178967|465934615|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446383|NCT04178967|465934616|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446384|NCT04178967|465934617|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446385|NCT04178967|465934618|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446386|NCT04178967|465934619|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129446387|NCT04178967|465934620|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129835512|NCT02256891|467364209|FG001|Overall Study|Death|2|||
129835513|NCT02256891|467364208|FG000|Overall Study|Lost to Follow-up|0|||
129835514|NCT02256891|467364209|FG001|Overall Study|Lost to Follow-up|3|||
129446388|NCT04178967|465934621|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
129446389|NCT04178967|465934622|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
129446390|NCT04178967|465934623|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
129446391|NCT04178967|465934613|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446392|NCT04178967|465934614|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446393|NCT04178967|465934615|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446394|NCT04178967|465934616|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446395|NCT04178967|465934617|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446396|NCT04178967|465934618|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446397|NCT04178967|465934619|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446398|NCT04178967|465934620|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446399|NCT04178967|465934621|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446400|NCT04178967|465934622|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
129446401|NCT04178967|465934623|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
129446402|NCT04178967|465934613|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446403|NCT04178967|465934614|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446404|NCT04178967|465934615|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446405|NCT04178967|465934616|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446406|NCT04178967|465934617|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446407|NCT04178967|465934618|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129835515|NCT02256891|467364208|FG000|Overall Study|Physician Decision|7|||
129835516|NCT02256891|467364209|FG001|Overall Study|Physician Decision|3|||
129835517|NCT02256891|467364208|FG000|Overall Study|Screen Fail|5|||
129835518|NCT02256891|467364209|FG001|Overall Study|Screen Fail|4|||
129835519|NCT02256891|467364208|FG000|Overall Study|Equipment Malfunction|0|||
129835520|NCT02256891|467364209|FG001|Overall Study|Equipment Malfunction|1|||
129835521|NCT01344447|467364210|FG000|Overall Study|Adverse Event|1|||
129835522|NCT01344447|467364210|FG000|Overall Study|Protocol Violation|1|||
129835523|NCT01344447|467364210|FG000|Overall Study|Withdrawal by Subject|1|||
129835524|NCT01344447|467364210|FG000|Overall Study|The contrast was not seen|1|||
129835525|NCT01344447|467364210|FG000|Overall Study|Physician Decision|1|||
129835526|NCT01344447|467364210|FG000|Overall Study|MRA unsuccessful|1|||
129835527|NCT01344447|467364210|FG000|Overall Study|Bolus tracking failed|1|||
129835528|NCT01344447|467364210|FG000|Overall Study|Error of power injector|1|||
129835529|NCT04214288|467364219|FG000|Overall Study|Ongoing in the study|41|||
129835530|NCT04214288|467364220|FG001|Overall Study|Ongoing in the study|51|||
129835531|NCT04214288|467364221|FG002|Overall Study|Ongoing in the study|12|||
129835532|NCT04214288|467364222|FG003|Overall Study|Ongoing in the study|39|||
129835533|NCT04214288|467364219|FG000|Overall Study|Adverse Event|1|||
129835534|NCT04214288|467364220|FG001|Overall Study|Adverse Event|0|||
129835535|NCT04214288|467364221|FG002|Overall Study|Adverse Event|0|||
129835536|NCT04214288|467364222|FG003|Overall Study|Adverse Event|0|||
129835537|NCT04214288|467364219|FG000|Overall Study|Death|22|||
129835538|NCT04214288|467364220|FG001|Overall Study|Death|13|||
129835539|NCT04214288|467364221|FG002|Overall Study|Death|7|||
129835540|NCT04214288|467364222|FG003|Overall Study|Death|19|||
129835541|NCT04214288|467364219|FG000|Overall Study|Lost to Follow-up|1|||
129835542|NCT04214288|467364220|FG001|Overall Study|Lost to Follow-up|2|||
129835543|NCT04214288|467364221|FG002|Overall Study|Lost to Follow-up|1|||
129835544|NCT04214288|467364222|FG003|Overall Study|Lost to Follow-up|0|||
129835545|NCT04214288|467364219|FG000|Overall Study|Other|1|||
129835546|NCT04214288|467364220|FG001|Overall Study|Other|2|||
129835547|NCT04214288|467364221|FG002|Overall Study|Other|0|||
129835548|NCT04214288|467364222|FG003|Overall Study|Other|6|||
129835549|NCT04214288|467364219|FG000|Overall Study|Protocol Violation|0|||
129835550|NCT04214288|467364220|FG001|Overall Study|Protocol Violation|1|||
129835551|NCT04214288|467364221|FG002|Overall Study|Protocol Violation|0|||
129897979|NCT00567164|467586542|FG001|Overall Study|Withdrawal by Subject|21|||
129897980|NCT00567164|467586543|FG002|Overall Study|Withdrawal by Subject|17|||
129897981|NCT00567164|467586541|FG000|Overall Study|Protocol Violation|23|||
129897982|NCT00567164|467586542|FG001|Overall Study|Protocol Violation|4|||
129897983|NCT00567164|467586543|FG002|Overall Study|Protocol Violation|2|||
129897984|NCT00567164|467586541|FG000|Overall Study|Adverse Event|92|||
129897985|NCT00567164|467586542|FG001|Overall Study|Adverse Event|13|||
129897986|NCT00567164|467586543|FG002|Overall Study|Adverse Event|9|||
129897987|NCT00567164|467586541|FG000|Overall Study|Death|0|||
129897988|NCT00567164|467586542|FG001|Overall Study|Death|0|||
129897989|NCT00567164|467586543|FG002|Overall Study|Death|1|||
129897990|NCT00567164|467586541|FG000|Overall Study|Lost to Follow-up|202|||
129897991|NCT00567164|467586542|FG001|Overall Study|Lost to Follow-up|23|||
129897992|NCT00567164|467586543|FG002|Overall Study|Lost to Follow-up|21|||
129835552|NCT04214288|467364222|FG003|Overall Study|Protocol Violation|0|||
129897993|NCT00567164|467586541|FG000|Overall Study|Pregnancy|20|||
129897994|NCT00567164|467586542|FG001|Overall Study|Pregnancy|4|||
129897995|NCT00567164|467586543|FG002|Overall Study|Pregnancy|6|||
129897996|NCT00567164|467586541|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
129835553|NCT04214288|467364219|FG000|Overall Study|Withdrawal by Subject|8|||
129835554|NCT04214288|467364220|FG001|Overall Study|Withdrawal by Subject|4|||
129835555|NCT04214288|467364221|FG002|Overall Study|Withdrawal by Subject|0|||
129835556|NCT04214288|467364222|FG003|Overall Study|Withdrawal by Subject|9|||
129835557|NCT01990495|467364229|FG000|Overall Study|Physician Decision|5|||
129835558|NCT01990495|467364230|FG001|Overall Study|Physician Decision|4|||
129835559|NCT01928862|467364231|FG000|Overall Study|Lost to Follow-up|1|||
129835560|NCT01928862|467364232|FG001|Overall Study|Lost to Follow-up|0|||
129835561|NCT01928862|467364233|FG002|Overall Study|Lost to Follow-up|0|||
129897997|NCT00567164|467586542|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
129835562|NCT01928862|467364234|FG003|Overall Study|Lost to Follow-up|0|||
129835563|NCT01928862|467364235|FG004|Overall Study|Lost to Follow-up|1|||
129835564|NCT04649164|467364236|FG000|Overall Study|Withdrawal by Subject|1|||
129835565|NCT04649164|467364237|FG001|Overall Study|Withdrawal by Subject|1|||
129835566|NCT04649164|467364238|FG002|Overall Study|Withdrawal by Subject|2|||
129446408|NCT04178967|465934619|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446409|NCT04178967|465934620|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129835567|NCT04649164|467364236|FG000|Overall Study|Participant's care recipient expired|0|||
129835568|NCT04649164|467364237|FG001|Overall Study|Participant's care recipient expired|0|||
129835569|NCT04649164|467364238|FG002|Overall Study|Participant's care recipient expired|2|||
129835570|NCT03168464|467364239|FG000|Overall Study|Death|9|||
129835571|NCT03168464|467364239|FG000|Overall Study|Progression of disease|6|||
129835572|NCT02286193|467364244|FG000|Overall Study|Referred: CRS unable to make contact|62|||
129835573|NCT02286193|467364244|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
129835574|NCT02286193|467364244|FG000|Overall Study|Referred: Declined service|38|||
129835575|NCT02932904|467364245|FG000|Overall Study|Reason not Specified|1|||
129835576|NCT02932904|467364246|FG001|Overall Study|Reason not Specified|0|||
129835577|NCT02932904|467364247|FG002|Overall Study|Reason not Specified|2|||
129835578|NCT02932904|467364248|FG003|Overall Study|Reason not Specified|2|||
129835579|NCT02932904|467364245|FG000|Overall Study|Noncompliance with Study Drug|2|||
129835580|NCT02932904|467364246|FG001|Overall Study|Noncompliance with Study Drug|3|||
129835581|NCT02932904|467364247|FG002|Overall Study|Noncompliance with Study Drug|3|||
129835582|NCT02932904|467364248|FG003|Overall Study|Noncompliance with Study Drug|4|||
129835583|NCT02932904|467364245|FG000|Overall Study|Pregnancy|0|||
129835584|NCT02932904|467364246|FG001|Overall Study|Pregnancy|1|||
129835585|NCT02932904|467364247|FG002|Overall Study|Pregnancy|1|||
129835586|NCT02932904|467364248|FG003|Overall Study|Pregnancy|0|||
129835587|NCT02932904|467364245|FG000|Overall Study|Study Termination|0|||
129835588|NCT02932904|467364246|FG001|Overall Study|Study Termination|1|||
129835589|NCT02932904|467364247|FG002|Overall Study|Study Termination|0|||
129835590|NCT02932904|467364248|FG003|Overall Study|Study Termination|0|||
129835591|NCT02932904|467364245|FG000|Overall Study|Voluntary Withdrawal|2|||
129835592|NCT02932904|467364246|FG001|Overall Study|Voluntary Withdrawal|1|||
129835593|NCT02932904|467364247|FG002|Overall Study|Voluntary Withdrawal|4|||
129835594|NCT02932904|467364248|FG003|Overall Study|Voluntary Withdrawal|2|||
129835595|NCT02932904|467364245|FG000|Overall Study|Lost to Follow-up|5|||
129835596|NCT02932904|467364246|FG001|Overall Study|Lost to Follow-up|3|||
129835597|NCT02932904|467364247|FG002|Overall Study|Lost to Follow-up|6|||
129835598|NCT02932904|467364248|FG003|Overall Study|Lost to Follow-up|0|||
129835599|NCT02932904|467364245|FG000|Overall Study|Significant Protocol Deviation|2|||
129835600|NCT02932904|467364246|FG001|Overall Study|Significant Protocol Deviation|3|||
129835601|NCT02932904|467364247|FG002|Overall Study|Significant Protocol Deviation|6|||
129835602|NCT02932904|467364248|FG003|Overall Study|Significant Protocol Deviation|1|||
129835603|NCT02932904|467364245|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129835604|NCT02932904|467364246|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
129835605|NCT02932904|467364247|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129835606|NCT02932904|467364248|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
129835607|NCT02932904|467364245|FG000|Overall Study|Randomized But Not Treated|1|||
129835608|NCT02932904|467364246|FG001|Overall Study|Randomized But Not Treated|1|||
129835609|NCT02932904|467364247|FG002|Overall Study|Randomized But Not Treated|0|||
129835610|NCT02932904|467364248|FG003|Overall Study|Randomized But Not Treated|2|||
129835611|NCT00337103|467364249|FG000|Overall Study|Progressive Disease|414|||
129835612|NCT00337103|467364250|FG001|Overall Study|Progressive Disease|410|||
129835613|NCT00337103|467364249|FG000|Overall Study|Adverse Event|45|||
129835614|NCT00337103|467364250|FG001|Overall Study|Adverse Event|59|||
129835615|NCT00337103|467364249|FG000|Overall Study|Subject Choice|34|||
129835616|NCT00337103|467364250|FG001|Overall Study|Subject Choice|27|||
129835617|NCT00337103|467364249|FG000|Overall Study|Clinical Progression|27|||
129835618|NCT00337103|467364250|FG001|Overall Study|Clinical Progression|24|||
129835619|NCT00337103|467364249|FG000|Overall Study|Physician Decision|15|||
129835620|NCT00337103|467364250|FG001|Overall Study|Physician Decision|14|||
129835621|NCT00337103|467364249|FG000|Overall Study|Withdrawal by Subject|8|||
129835622|NCT00337103|467364250|FG001|Overall Study|Withdrawal by Subject|5|||
129835623|NCT00337103|467364249|FG000|Overall Study|Other|5|||
129835624|NCT00337103|467364250|FG001|Overall Study|Other|6|||
129835625|NCT00337103|467364249|FG000|Overall Study|Entry Criteria Not Met|4|||
129835626|NCT00337103|467364250|FG001|Overall Study|Entry Criteria Not Met|1|||
129835627|NCT00337103|467364249|FG000|Overall Study|Lost to Follow-up|1|||
129835628|NCT00337103|467364250|FG001|Overall Study|Lost to Follow-up|2|||
129835629|NCT00337103|467364249|FG000|Overall Study|Death|1|||
129835630|NCT00337103|467364250|FG001|Overall Study|Death|0|||
129835631|NCT01577758|467364251|FG000|Dose Escalation Phase|Adverse Event|0|||
129835632|NCT01577758|467364252|FG001|Dose Escalation Phase|Adverse Event|0|||
129835633|NCT01577758|467364253|FG002|Dose Escalation Phase|Adverse Event|0|||
129835634|NCT01577758|467364254|FG003|Dose Escalation Phase|Adverse Event|0|||
129835635|NCT01577758|467364255|FG004|Dose Escalation Phase|Adverse Event|0|||
129835636|NCT01577758|467364256|FG005|Dose Escalation Phase|Adverse Event|2|||
129835637|NCT01577758|467364257|FG006|Dose Escalation Phase|Adverse Event|1|||
129835638|NCT01577758|467364258|FG007|Dose Escalation Phase|Adverse Event|0|||
129835639|NCT01577758|467364251|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835640|NCT01577758|467364252|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835641|NCT01577758|467364253|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
129835642|NCT01577758|467364254|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835643|NCT01577758|467364255|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
129835644|NCT01577758|467364256|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
129835645|NCT01577758|467364257|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835646|NCT01577758|467364258|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
129835647|NCT01577758|467364251|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129835648|NCT01577758|467364252|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129835649|NCT01577758|467364253|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129835650|NCT01577758|467364254|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129835651|NCT01577758|467364255|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
129835652|NCT01577758|467364256|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
129835653|NCT01577758|467364257|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
129446410|NCT04178967|465934621|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446411|NCT04178967|465934622|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
129446412|NCT04178967|465934623|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
129446413|NCT01230554|465934624|FG000|Overall Study|Lost to Follow-up|2|||
129446414|NCT01230554|465934624|FG000|Overall Study|Inability to maintain visit schedule|1|||
129446415|NCT03933397|465934625|FG000|Overall Study|No emergency department visit|65|||
129446416|NCT03933397|465934626|FG001|Overall Study|No emergency department visit|71|||
129446417|NCT03933397|465934625|FG000|Overall Study|Missed emergency department visit|25|||
129446418|NCT03933397|465934626|FG001|Overall Study|Missed emergency department visit|30|||
129446419|NCT03933397|465934625|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
129446420|NCT03933397|465934626|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
129446421|NCT03933397|465934625|FG000|Overall Study|Withdrawal by Subject|1|||
129446422|NCT03933397|465934626|FG001|Overall Study|Withdrawal by Subject|0|||
129446423|NCT03933397|465934625|FG000|Overall Study|Physician Decision|1|||
129446424|NCT03933397|465934626|FG001|Overall Study|Physician Decision|1|||
129446425|NCT03933397|465934625|FG000|Overall Study|missing pain score|1|||
129446426|NCT03933397|465934626|FG001|Overall Study|missing pain score|1|||
129835654|NCT01577758|467364258|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
129835655|NCT01577758|467364251|FG000|Dose Escalation Phase|Progression Disease|2|||
129446427|NCT03933397|465934625|FG000|Overall Study|Confirmed COVID-19|1|||
129835656|NCT01577758|467364252|FG001|Dose Escalation Phase|Progression Disease|2|||
129835657|NCT01577758|467364253|FG002|Dose Escalation Phase|Progression Disease|1|||
129835658|NCT01577758|467364254|FG003|Dose Escalation Phase|Progression Disease|2|||
129835659|NCT01577758|467364255|FG004|Dose Escalation Phase|Progression Disease|5|||
129835660|NCT01577758|467364256|FG005|Dose Escalation Phase|Progression Disease|0|||
129835661|NCT01577758|467364257|FG006|Dose Escalation Phase|Progression Disease|0|||
129835662|NCT01577758|467364258|FG007|Dose Escalation Phase|Progression Disease|0|||
129835663|NCT01577758|467364251|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835664|NCT01577758|467364252|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835665|NCT01577758|467364253|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835666|NCT01577758|467364254|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835667|NCT01577758|467364255|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835668|NCT01577758|467364256|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835669|NCT01577758|467364257|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
129835670|NCT01577758|467364258|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
129835671|NCT01577758|467364251|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835672|NCT01577758|467364252|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835673|NCT01577758|467364253|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835674|NCT01577758|467364254|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835675|NCT01577758|467364255|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835676|NCT01577758|467364256|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835677|NCT01577758|467364257|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
129835678|NCT01577758|467364258|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
129835679|NCT01577758|467364251|FG000|mCRC Expansion Phase|Progression Disease|0|||
129446428|NCT03933397|465934626|FG001|Overall Study|Confirmed COVID-19|2|||
129446429|NCT04029116|465934627|FG000|Overall Study|Adverse Event|0|||
129446430|NCT04029116|465934628|FG001|Overall Study|Adverse Event|2|||
129446431|NCT04029116|465934627|FG000|Overall Study|Lost to Follow-up|3|||
129446432|NCT04029116|465934628|FG001|Overall Study|Lost to Follow-up|5|||
129446433|NCT04029116|465934627|FG000|Overall Study|Physician Decision|2|||
129446434|NCT04029116|465934628|FG001|Overall Study|Physician Decision|0|||
129835680|NCT01577758|467364252|FG001|mCRC Expansion Phase|Progression Disease|0|||
129835681|NCT01577758|467364253|FG002|mCRC Expansion Phase|Progression Disease|0|||
129835682|NCT01577758|467364254|FG003|mCRC Expansion Phase|Progression Disease|0|||
129835683|NCT01577758|467364255|FG004|mCRC Expansion Phase|Progression Disease|0|||
129835684|NCT01577758|467364256|FG005|mCRC Expansion Phase|Progression Disease|0|||
129835685|NCT01577758|467364257|FG006|mCRC Expansion Phase|Progression Disease|0|||
129835686|NCT01577758|467364258|FG007|mCRC Expansion Phase|Progression Disease|19|||
129835687|NCT00600756|467364262|FG000|Analysis After 6 Months|Adverse Event|43|||
129835688|NCT00600756|467364263|FG001|Analysis After 6 Months|Adverse Event|33|||
129835689|NCT00600756|467364262|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
129835690|NCT00600756|467364263|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
129835691|NCT00600756|467364262|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
129835692|NCT00600756|467364263|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
129835693|NCT00600756|467364262|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
129835694|NCT00600756|467364263|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
129835695|NCT00600756|467364262|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
129835696|NCT00600756|467364263|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
129835697|NCT00600756|467364262|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
129835698|NCT00600756|467364263|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
129835699|NCT00600756|467364262|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
129835700|NCT00600756|467364263|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
129835701|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
129835702|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
129835703|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
129835704|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
129835705|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
129835706|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
129835707|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
129835708|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
129835709|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
129835710|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
129835711|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
129835712|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
129835713|NCT00600756|467364262|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
129835714|NCT00600756|467364263|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
129835715|NCT01256593|467364264|FG000|Overall Study|Protocol Violation|26|||
129835716|NCT01256593|467364264|FG000|Overall Study|No Drug Administration Information|2|||
129835717|NCT01256593|467364264|FG000|Overall Study|No Visit After Treatment|186|||
129835718|NCT04414553|467364265|FG000|Overall Study|Lost to Follow-up|20|||
129835719|NCT03519971|467364273|FG000|Overall Study|Death|142|||
129835720|NCT03519971|467364274|FG001|Overall Study|Death|69|||
129835721|NCT03519971|467364273|FG000|Overall Study|Lost to Follow-up|0|||
129835722|NCT03519971|467364274|FG001|Overall Study|Lost to Follow-up|1|||
129446435|NCT04029116|465934627|FG000|Overall Study|Pregnancy|1|||
129446436|NCT04029116|465934628|FG001|Overall Study|Pregnancy|2|||
129446437|NCT04029116|465934627|FG000|Overall Study|Withdrawal by Subject|4|||
129446438|NCT04029116|465934628|FG001|Overall Study|Withdrawal by Subject|6|||
129446439|NCT04029116|465934627|FG000|Overall Study|Other|2|||
129446440|NCT04029116|465934628|FG001|Overall Study|Other|1|||
129446441|NCT04246801|465934629|FG000|Overall Study|Adverse Event|1|||
129446442|NCT04246801|465934630|FG001|Overall Study|Adverse Event|1|||
129446443|NCT04246801|465934629|FG000|Overall Study|Protocol Violation|1|||
129446444|NCT04246801|465934630|FG001|Overall Study|Protocol Violation|1|||
129446445|NCT04246801|465934629|FG000|Overall Study|Lack of Efficacy|0|||
129446446|NCT04246801|465934630|FG001|Overall Study|Lack of Efficacy|2|||
129446447|NCT04246801|465934629|FG000|Overall Study|Lost to Follow-up|1|||
129446448|NCT04246801|465934630|FG001|Overall Study|Lost to Follow-up|1|||
129446449|NCT04246801|465934629|FG000|Overall Study|Withdrawal by Subject|2|||
129446450|NCT04246801|465934630|FG001|Overall Study|Withdrawal by Subject|1|||
129446451|NCT03684642|465934631|FG000|Overall Study|Adverse Event|6|||
129446452|NCT03684642|465934632|FG001|Overall Study|Adverse Event|15|||
129446453|NCT03684642|465934633|FG002|Overall Study|Adverse Event|11|||
129446454|NCT03684642|465934631|FG000|Overall Study|Withdrawal by Subject|35|||
129446455|NCT03684642|465934632|FG001|Overall Study|Withdrawal by Subject|53|||
129446456|NCT03684642|465934633|FG002|Overall Study|Withdrawal by Subject|23|||
129446457|NCT03684642|465934631|FG000|Overall Study|Lack of Efficacy|0|||
129446458|NCT03684642|465934632|FG001|Overall Study|Lack of Efficacy|0|||
129446459|NCT03684642|465934633|FG002|Overall Study|Lack of Efficacy|1|||
129446460|NCT03684642|465934631|FG000|Overall Study|Poor compliance to protocol|0|||
129446461|NCT03684642|465934632|FG001|Overall Study|Poor compliance to protocol|4|||
129446462|NCT03684642|465934633|FG002|Overall Study|Poor compliance to protocol|1|||
129446463|NCT03684642|465934631|FG000|Overall Study|Other than specified|62|||
129446464|NCT03684642|465934632|FG001|Overall Study|Other than specified|60|||
129446465|NCT03684642|465934633|FG002|Overall Study|Other than specified|67|||
129446466|NCT03684642|465934631|FG000|Overall Study|Randomized and not treated|0|||
129446467|NCT03684642|465934632|FG001|Overall Study|Randomized and not treated|0|||
129446468|NCT03684642|465934633|FG002|Overall Study|Randomized and not treated|1|||
129446469|NCT03684642|465934631|FG000|Overall Study|Missing completion status but alive at last contact|0|||
129446470|NCT03684642|465934632|FG001|Overall Study|Missing completion status but alive at last contact|1|||
129446471|NCT03684642|465934633|FG002|Overall Study|Missing completion status but alive at last contact|2|||
129446472|NCT02966223|465934641|FG000|Overall Study|Physician Decision|3|||
129446473|NCT02966223|465934641|FG000|Overall Study|Withdrawal by Subject|11|||
129446474|NCT02966223|465934641|FG000|Overall Study|Lost to Follow-up|1|||
129446475|NCT01326728|465934642|FG000|Overall Study|Death|13|||
129446476|NCT01326728|465934643|FG001|Overall Study|Death|0|||
129446477|NCT01326728|465934642|FG000|Overall Study|Early closure of study|34|||
129446478|NCT01326728|465934643|FG001|Overall Study|Early closure of study|9|||
129835723|NCT03519971|467364273|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
129835724|NCT03519971|467364274|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
129835725|NCT03519971|467364273|FG000|Overall Study|Withdrawal by Subject|3|||
129835726|NCT03519971|467364274|FG001|Overall Study|Withdrawal by Subject|2|||
129835727|NCT03519971|467364273|FG000|Overall Study|Other|1|||
129835728|NCT03519971|467364274|FG001|Overall Study|Other|0|||
129835729|NCT04544293|467364276|FG000|Double-blind|Adverse Event|2|||
129835730|NCT04544293|467364277|FG001|Double-blind|Adverse Event|1|||
129835731|NCT04544293|467364276|FG000|Double-blind|Pregnancy|0|||
129835732|NCT04544293|467364277|FG001|Double-blind|Pregnancy|1|||
129835733|NCT04544293|467364276|FG000|Double-blind|Lost to Follow-up|0|||
129835734|NCT04544293|467364277|FG001|Double-blind|Lost to Follow-up|1|||
129835735|NCT04544293|467364276|FG000|Open-Label Extension|Study ongoing|79|||
129835736|NCT04544293|467364277|FG001|Open-Label Extension|Study ongoing|81|||
129835737|NCT00642668|467364283|FG000|Overall Study|Lost to Follow-up|1|||
129835738|NCT00642668|467364283|FG000|Overall Study|Adverse Event|2|||
129835739|NCT00642668|467364283|FG000|Overall Study|Death|2|||
129835740|NCT00642668|467364283|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129835741|NCT00642668|467364283|FG000|Overall Study|Failure to Return|1|||
129835742|NCT00642668|467364283|FG000|Overall Study|Dialysis Initiation|5|||
129835743|NCT00642668|467364283|FG000|Overall Study|Blood Transfusion|2|||
129835744|NCT03608774|467364284|FG000|Overall Study|Lost to Follow-up|5|||
129835745|NCT03608774|467364285|FG001|Overall Study|Lost to Follow-up|5|||
129835746|NCT03608774|467364284|FG000|Overall Study|Withdrawal by Subject|1|||
129835747|NCT03608774|467364285|FG001|Overall Study|Withdrawal by Subject|0|||
129835748|NCT03608774|467364284|FG000|Overall Study|Protocol Violation|1|||
129835749|NCT03608774|467364285|FG001|Overall Study|Protocol Violation|0|||
129446479|NCT03785678|465934646|FG000|Overall Study|Death|44|||
129446480|NCT03785678|465934647|FG001|Overall Study|Death|42|||
129446481|NCT03785678|465934646|FG000|Overall Study|Lost to Follow-up|4|||
129446482|NCT03785678|465934647|FG001|Overall Study|Lost to Follow-up|2|||
129446483|NCT03785678|465934646|FG000|Overall Study|Physician Decision|0|||
129446484|NCT03785678|465934647|FG001|Overall Study|Physician Decision|2|||
129835750|NCT03608774|467364284|FG000|Overall Study|Not eligible at enrollment|0|||
129835751|NCT03608774|467364285|FG001|Overall Study|Not eligible at enrollment|1|||
129446485|NCT03785678|465934646|FG000|Overall Study|Withdrawal by Subject|5|||
129897998|NCT00567164|467586543|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
129897999|NCT00567164|467586541|FG000|Overall Study|Missing|1|||
129898000|NCT00567164|467586542|FG001|Overall Study|Missing|0|||
129898001|NCT00567164|467586543|FG002|Overall Study|Missing|0|||
129835752|NCT03608774|467364284|FG000|Overall Study|Health related event|0|||
129835753|NCT03608774|467364285|FG001|Overall Study|Health related event|1|||
129835754|NCT01177540|467364286|FG000|Overall Study|Adverse Event|1|||
129835755|NCT01177540|467364287|FG001|Overall Study|Adverse Event|0|||
129835756|NCT02910167|467364288|FG000|Overall Study|Adverse Event|1|||
129835757|NCT02910167|467364288|FG000|Overall Study|Lost to Follow-up|18|||
129835758|NCT03913091|467364289|FG000|Overall Study|Lost to Follow-up|18|||
129835759|NCT03913091|467364290|FG001|Overall Study|Lost to Follow-up|11|||
129835760|NCT03913091|467364289|FG000|Overall Study|Required additional meds/surgery|1|||
129835761|NCT03913091|467364290|FG001|Overall Study|Required additional meds/surgery|2|||
129835762|NCT03913091|467364289|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
129835763|NCT03913091|467364290|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
129835764|NCT04477304|467364291|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
129835765|NCT04477304|467364292|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
129835766|NCT03256552|467366054|FG000|Overall Study|Protocol Violation|1|||
129835767|NCT03256552|467366054|FG000|Overall Study|Physician Decision|1|||
129835768|NCT03256552|467366054|FG000|Overall Study|Adverse Event|1|||
129835769|NCT03256552|467366054|FG000|Overall Study|Withdrawal by Subject|2|||
129835770|NCT05083442|467366055|FG000|Overall Study|Lost to Follow-up|1|||
129835771|NCT05083442|467366056|FG001|Overall Study|Lost to Follow-up|0|||
129835772|NCT05083442|467366055|FG000|Overall Study|Lack of Efficacy|0|||
129835773|NCT05083442|467366056|FG001|Overall Study|Lack of Efficacy|1|||
129835774|NCT05083442|467366055|FG000|Overall Study|Withdrawal by Subject|1|||
129835775|NCT05083442|467366056|FG001|Overall Study|Withdrawal by Subject|3|||
129835776|NCT05083442|467366055|FG000|Overall Study|scheduling difficulties|1|||
129835777|NCT05083442|467366056|FG001|Overall Study|scheduling difficulties|2|||
129835778|NCT03387813|467366066|FG000|Overall Study|Death|40|||
129835779|NCT03387813|467366067|FG001|Overall Study|Death|37|||
129835780|NCT03387813|467366068|FG002|Overall Study|Death|190|||
129835781|NCT03387813|467366066|FG000|Overall Study|Withdrawal by Subject|9|||
129835782|NCT03387813|467366067|FG001|Overall Study|Withdrawal by Subject|19|||
129835783|NCT03387813|467366068|FG002|Overall Study|Withdrawal by Subject|32|||
129835784|NCT03387813|467366066|FG000|Overall Study|Lost to Follow-up|3|||
129835785|NCT03387813|467366067|FG001|Overall Study|Lost to Follow-up|9|||
129835786|NCT03387813|467366068|FG002|Overall Study|Lost to Follow-up|15|||
129835787|NCT03387813|467366066|FG000|Overall Study|Non-Compliance|6|||
129835788|NCT03387813|467366067|FG001|Overall Study|Non-Compliance|6|||
129835789|NCT03387813|467366068|FG002|Overall Study|Non-Compliance|31|||
129835790|NCT03387813|467366066|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
129835791|NCT03387813|467366067|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
129835792|NCT03387813|467366068|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
129835793|NCT04327999|467366069|FG000|Overall Study|Protocol Violation|1|||
129835794|NCT03792672|467366070|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
129835795|NCT03792672|467366071|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835796|NCT03792672|467366072|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835797|NCT03792672|467366073|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
129835798|NCT03792672|467366074|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835799|NCT03792672|467366075|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
129835800|NCT03792672|467366070|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
129835801|NCT03792672|467366071|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
129835802|NCT03792672|467366072|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
129835803|NCT03792672|467366073|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
129835804|NCT03792672|467366074|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
129835805|NCT03792672|467366075|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
129835806|NCT03792672|467366070|FG000|Treatment Period 4 (2 Days)|Other|1|||
129835807|NCT03792672|467366071|FG001|Treatment Period 4 (2 Days)|Other|0|||
129835808|NCT03792672|467366072|FG002|Treatment Period 4 (2 Days)|Other|0|||
129835809|NCT03792672|467366073|FG003|Treatment Period 4 (2 Days)|Other|0|||
129835810|NCT03792672|467366074|FG004|Treatment Period 4 (2 Days)|Other|0|||
129835811|NCT03792672|467366075|FG005|Treatment Period 4 (2 Days)|Other|0|||
129835812|NCT00006478|467366077|FG000|Overall Study|Vaccine could not be produced|1|||
129835813|NCT00006478|467366077|FG000|Overall Study|Physician Decision|6|||
129835814|NCT03161483|467366083|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
129835815|NCT03161483|467366084|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
129898002|NCT02430532|467586550|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
129835816|NCT03161483|467366085|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
129835817|NCT03161483|467366086|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
129835818|NCT03161483|467366083|FG000|Treatment Period|Death|1|||
129835819|NCT03161483|467366084|FG001|Treatment Period|Death|0|||
129835820|NCT03161483|467366085|FG002|Treatment Period|Death|0|||
129898003|NCT02430532|467586551|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
129898004|NCT02430532|467586550|FG000|Overall Study|Consent Withdrawn|0|||
129446486|NCT03785678|465934647|FG001|Overall Study|Withdrawal by Subject|3|||
129446487|NCT02374021|465934651|FG000|Overall Study|Adverse Event|1|||
129446488|NCT02374021|465934652|FG001|Overall Study|Adverse Event|0|||
129446489|NCT02374021|465934651|FG000|Overall Study|Lost to Follow-up|3|||
129446490|NCT02374021|465934652|FG001|Overall Study|Lost to Follow-up|2|||
129446491|NCT02374021|465934651|FG000|Overall Study|Physician Decision|0|||
129446492|NCT02374021|465934652|FG001|Overall Study|Physician Decision|3|||
129446493|NCT02374021|465934651|FG000|Overall Study|Withdrawal by Subject|6|||
129446494|NCT02374021|465934652|FG001|Overall Study|Withdrawal by Subject|5|||
129446495|NCT02374021|465934651|FG000|Overall Study|Poor Adherence|0|||
129446496|NCT02374021|465934652|FG001|Overall Study|Poor Adherence|1|||
129446497|NCT02374021|465934651|FG000|Overall Study|Scan protocol not followed|0|||
129446498|NCT02374021|465934652|FG001|Overall Study|Scan protocol not followed|1|||
129446499|NCT02374021|465934651|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
129446500|NCT02374021|465934652|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
129446501|NCT00805025|465934653|FG000|Overall Study|Screened but not enrolled/treated|42|||
129446502|NCT00805025|465934653|FG000|Overall Study|Adverse Event|4|||
129446503|NCT00805025|465934653|FG000|Overall Study|Withdrawal by Subject|2|||
129446504|NCT00805025|465934653|FG000|Overall Study|Physician Decision|1|||
129446505|NCT00375219|465934654|FG000|Overall Study|Failure to achieve a response|16|||
129446506|NCT00375219|465934655|FG001|Overall Study|Failure to achieve a response|2|||
129446507|NCT00375219|465934656|FG002|Overall Study|Failure to achieve a response|0|||
129446508|NCT00375219|465934654|FG000|Overall Study|Adverse Event|8|||
129446509|NCT00375219|465934655|FG001|Overall Study|Adverse Event|2|||
129446510|NCT00375219|465934656|FG002|Overall Study|Adverse Event|1|||
129446511|NCT00375219|465934654|FG000|Overall Study|Protocol Violation|1|||
129446512|NCT00375219|465934655|FG001|Overall Study|Protocol Violation|0|||
129446513|NCT00375219|465934656|FG002|Overall Study|Protocol Violation|1|||
129835821|NCT03161483|467366086|FG003|Treatment Period|Death|0|||
129835822|NCT03161483|467366083|FG000|Treatment Period|Adverse Event|5|||
129835823|NCT03161483|467366084|FG001|Treatment Period|Adverse Event|2|||
129835824|NCT03161483|467366085|FG002|Treatment Period|Adverse Event|1|||
129835825|NCT03161483|467366086|FG003|Treatment Period|Adverse Event|11|||
129835826|NCT03161483|467366083|FG000|Treatment Period|Pregnancy|1|||
129835827|NCT03161483|467366084|FG001|Treatment Period|Pregnancy|0|||
129835828|NCT03161483|467366085|FG002|Treatment Period|Pregnancy|0|||
129835829|NCT03161483|467366086|FG003|Treatment Period|Pregnancy|0|||
129835830|NCT03161483|467366083|FG000|Treatment Period|Lack of Efficacy|0|||
129835831|NCT03161483|467366084|FG001|Treatment Period|Lack of Efficacy|0|||
129835832|NCT03161483|467366085|FG002|Treatment Period|Lack of Efficacy|0|||
129835833|NCT03161483|467366086|FG003|Treatment Period|Lack of Efficacy|1|||
129835834|NCT03161483|467366083|FG000|Treatment Period|Withdrawal by Subject|2|||
129835835|NCT03161483|467366084|FG001|Treatment Period|Withdrawal by Subject|5|||
129835836|NCT03161483|467366085|FG002|Treatment Period|Withdrawal by Subject|2|||
129835837|NCT03161483|467366086|FG003|Treatment Period|Withdrawal by Subject|6|||
129835838|NCT03161483|467366083|FG000|Treatment Period|Lost to Follow-up|0|||
129835839|NCT03161483|467366084|FG001|Treatment Period|Lost to Follow-up|0|||
129835840|NCT03161483|467366085|FG002|Treatment Period|Lost to Follow-up|0|||
129835841|NCT03161483|467366086|FG003|Treatment Period|Lost to Follow-up|1|||
129835842|NCT03161483|467366083|FG000|Treatment Period|Protocol Violation|0|||
129835843|NCT03161483|467366084|FG001|Treatment Period|Protocol Violation|0|||
129835844|NCT03161483|467366085|FG002|Treatment Period|Protocol Violation|0|||
129835845|NCT03161483|467366086|FG003|Treatment Period|Protocol Violation|1|||
129835846|NCT03161483|467366083|FG000|Treatment Period|Other reasons|1|||
129446514|NCT00375219|465934654|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
129446515|NCT00375219|465934655|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
129446516|NCT00375219|465934656|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
129835847|NCT03161483|467366084|FG001|Treatment Period|Other reasons|1|||
129835848|NCT03161483|467366085|FG002|Treatment Period|Other reasons|0|||
129835849|NCT03161483|467366086|FG003|Treatment Period|Other reasons|0|||
129835850|NCT04238728|467366097|FG000|Overall Study|Withdrawal by Subject|1|||
129835851|NCT04238728|467366097|FG000|Overall Study|Lost to Follow-up|2|||
129835852|NCT05389657|467366099|FG000|Overall Study|Lost to Follow-up|7|||
129835853|NCT05389657|467366100|FG001|Overall Study|Lost to Follow-up|8|||
129835854|NCT01907828|467366101|FG000|Overall Study|Exclusion criteria not met|0|||
129835855|NCT01907828|467366102|FG001|Overall Study|Exclusion criteria not met|1|||
129835856|NCT01907828|467366101|FG000|Overall Study|Withdrawal by Subject|3|||
129835857|NCT01907828|467366102|FG001|Overall Study|Withdrawal by Subject|4|||
129835858|NCT01907828|467366101|FG000|Overall Study|Lost to Follow-up|3|||
129446517|NCT00375219|465934654|FG000|Overall Study|Lost to Follow-up|1|||
129835859|NCT01907828|467366102|FG001|Overall Study|Lost to Follow-up|0|||
129835860|NCT01907828|467366101|FG000|Overall Study|Participant refused 24-month follow-up|1|||
129835861|NCT01907828|467366102|FG001|Overall Study|Participant refused 24-month follow-up|0|||
129898005|NCT02430532|467586551|FG001|Overall Study|Consent Withdrawn|2|||
129835862|NCT01907828|467366101|FG000|Overall Study|Participant met exclusion criteria|0|||
129835863|NCT01907828|467366102|FG001|Overall Study|Participant met exclusion criteria|1|||
129446518|NCT00375219|465934655|FG001|Overall Study|Lost to Follow-up|1|||
129835864|NCT01073865|467366108|FG000|Overall Study|Reasons other than below|19|||
129835865|NCT01073865|467366109|FG001|Overall Study|Reasons other than below|31|||
129835866|NCT01073865|467366108|FG000|Overall Study|Lost to Follow-up|1|||
129835867|NCT01073865|467366109|FG001|Overall Study|Lost to Follow-up|1|||
129835868|NCT01073865|467366108|FG000|Overall Study|Death|3|||
129835869|NCT01073865|467366109|FG001|Overall Study|Death|2|||
129835870|NCT01073865|467366108|FG000|Overall Study|Withdrawal by Subject|5|||
129835871|NCT01073865|467366109|FG001|Overall Study|Withdrawal by Subject|5|||
129835872|NCT03261947|467366115|FG000|Overall Study|Death|10|||
129835873|NCT03261947|467366116|FG001|Overall Study|Death|13|||
129835874|NCT03261947|467366117|FG002|Overall Study|Death|17|||
129835875|NCT03261947|467366118|FG003|Overall Study|Death|12|||
129835876|NCT03261947|467366119|FG004|Overall Study|Death|8|||
129835877|NCT03261947|467366115|FG000|Overall Study|Lost to Follow-up|0|||
129835878|NCT03261947|467366116|FG001|Overall Study|Lost to Follow-up|0|||
129835879|NCT03261947|467366117|FG002|Overall Study|Lost to Follow-up|2|||
129835880|NCT03261947|467366118|FG003|Overall Study|Lost to Follow-up|1|||
129835881|NCT03261947|467366119|FG004|Overall Study|Lost to Follow-up|0|||
129835882|NCT03261947|467366115|FG000|Overall Study|Withdrawal by Subject|0|||
129835883|NCT03261947|467366116|FG001|Overall Study|Withdrawal by Subject|0|||
129835884|NCT03261947|467366117|FG002|Overall Study|Withdrawal by Subject|3|||
129835885|NCT03261947|467366118|FG003|Overall Study|Withdrawal by Subject|0|||
129835886|NCT03261947|467366119|FG004|Overall Study|Withdrawal by Subject|1|||
129835887|NCT03261947|467366115|FG000|Overall Study|Site Terminated by Sponsor|0|||
129835888|NCT03261947|467366116|FG001|Overall Study|Site Terminated by Sponsor|0|||
129835889|NCT03261947|467366117|FG002|Overall Study|Site Terminated by Sponsor|4|||
129835890|NCT03261947|467366118|FG003|Overall Study|Site Terminated by Sponsor|7|||
129835891|NCT03261947|467366119|FG004|Overall Study|Site Terminated by Sponsor|5|||
129835892|NCT03261947|467366115|FG000|Overall Study|Reason not Specified|2|||
129835893|NCT03261947|467366116|FG001|Overall Study|Reason not Specified|0|||
129835894|NCT03261947|467366117|FG002|Overall Study|Reason not Specified|4|||
129835895|NCT03261947|467366118|FG003|Overall Study|Reason not Specified|1|||
129835896|NCT03261947|467366119|FG004|Overall Study|Reason not Specified|3|||
129835897|NCT03969992|467366120|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
129835898|NCT03969992|467366121|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
129835899|NCT03969992|467366122|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
129835900|NCT03969992|467366120|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
129835901|NCT03969992|467366121|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
129835902|NCT03969992|467366122|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
129835903|NCT03969992|467366120|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
129835904|NCT03969992|467366121|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
129835905|NCT03969992|467366122|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
129835906|NCT03969992|467366120|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
129835907|NCT03969992|467366121|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
129835908|NCT03969992|467366122|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
129835909|NCT03969992|467366120|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
129835910|NCT03969992|467366121|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
129835911|NCT03969992|467366122|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
129835912|NCT00228917|467366127|FG000|Overall Study|Migrated/moved from study area|0|||
129835913|NCT00228917|467366128|FG001|Overall Study|Migrated/moved from study area|0|||
129898006|NCT02430532|467586550|FG000|Overall Study|Adverse Event|0|||
129898007|NCT02430532|467586551|FG001|Overall Study|Adverse Event|1|||
129835914|NCT00228917|467366129|FG002|Overall Study|Migrated/moved from study area|0|||
129835915|NCT00228917|467366130|FG003|Overall Study|Migrated/moved from study area|0|||
129898008|NCT03256344|467586552|FG000|Overall Study|Death|6|||
129898009|NCT03256344|467586553|FG001|Overall Study|Death|22|||
129446519|NCT00375219|465934656|FG002|Overall Study|Lost to Follow-up|0|||
129446520|NCT00375219|465934654|FG000|Overall Study|Disease progression|18|||
129446521|NCT00375219|465934655|FG001|Overall Study|Disease progression|9|||
129446522|NCT00375219|465934656|FG002|Overall Study|Disease progression|12|||
129446523|NCT00375219|465934654|FG000|Overall Study|Death|4|||
129446524|NCT00375219|465934655|FG001|Overall Study|Death|3|||
129446525|NCT00375219|465934656|FG002|Overall Study|Death|7|||
129446526|NCT00375219|465934654|FG000|Overall Study|Hematologic resistance|1|||
129446527|NCT00375219|465934655|FG001|Overall Study|Hematologic resistance|0|||
129446528|NCT00375219|465934656|FG002|Overall Study|Hematologic resistance|0|||
129446529|NCT00375219|465934654|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
129446530|NCT00375219|465934655|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
129446531|NCT00375219|465934656|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
129446532|NCT00375219|465934654|FG000|Overall Study|Allograft|2|||
129446533|NCT00375219|465934655|FG001|Overall Study|Allograft|0|||
129446534|NCT00375219|465934656|FG002|Overall Study|Allograft|0|||
129446535|NCT00375219|465934654|FG000|Overall Study|Cord blood transplantation|1|||
129446536|NCT00375219|465934655|FG001|Overall Study|Cord blood transplantation|0|||
129446537|NCT00375219|465934656|FG002|Overall Study|Cord blood transplantation|0|||
129446538|NCT00375219|465934654|FG000|Overall Study|Withdrawal by Subject|1|||
129446539|NCT00375219|465934655|FG001|Overall Study|Withdrawal by Subject|0|||
129446540|NCT00375219|465934656|FG002|Overall Study|Withdrawal by Subject|0|||
129446541|NCT01667107|465934657|FG000|Overall Study|Adverse Event|4|||
129446542|NCT01667107|465934658|FG001|Overall Study|Adverse Event|3|||
129446543|NCT01667107|465934657|FG000|Overall Study|Tolerability issues|0|||
129446544|NCT01667107|465934658|FG001|Overall Study|Tolerability issues|2|||
129446545|NCT01667107|465934657|FG000|Overall Study|Protocol Violation|0|||
129446546|NCT01667107|465934658|FG001|Overall Study|Protocol Violation|1|||
129446547|NCT01667107|465934657|FG000|Overall Study|Lack of Efficacy|0|||
129446548|NCT01667107|465934658|FG001|Overall Study|Lack of Efficacy|1|||
129446549|NCT01162239|465934661|FG000|Treatment Phase|Withdrawal by Subject|1|||
129446550|NCT01162239|465934662|FG001|Treatment Phase|Withdrawal by Subject|3|||
129446551|NCT01162239|465934663|FG002|Treatment Phase|Withdrawal by Subject|2|||
129446552|NCT01162239|465934664|FG003|Treatment Phase|Withdrawal by Subject|3|||
129446553|NCT01162239|465934661|FG000|Treatment Phase|Death|0|||
129446554|NCT01162239|465934662|FG001|Treatment Phase|Death|0|||
129446555|NCT01162239|465934663|FG002|Treatment Phase|Death|0|||
129446556|NCT01162239|465934664|FG003|Treatment Phase|Death|1|||
129446557|NCT01162239|465934661|FG000|Treatment Phase|Lost to Follow-up|5|||
129446558|NCT01162239|465934662|FG001|Treatment Phase|Lost to Follow-up|4|||
129446559|NCT01162239|465934663|FG002|Treatment Phase|Lost to Follow-up|2|||
129446560|NCT01162239|465934664|FG003|Treatment Phase|Lost to Follow-up|1|||
129446561|NCT01162239|465934661|FG000|Extended Follow-up|Lost to Follow-up|8|||
129446562|NCT01162239|465934662|FG001|Extended Follow-up|Lost to Follow-up|13|||
129446563|NCT01162239|465934663|FG002|Extended Follow-up|Lost to Follow-up|8|||
129446564|NCT01162239|465934664|FG003|Extended Follow-up|Lost to Follow-up|6|||
129446565|NCT00228566|465934665|FG000|Overall Study|Adverse Event|31|||
129446566|NCT00228566|465934665|FG000|Overall Study|Lack of Efficacy|14|||
129446567|NCT00228566|465934665|FG000|Overall Study|Lost to Follow-up|16|||
129446568|NCT00228566|465934665|FG000|Overall Study|Physician Decision|5|||
129446569|NCT00228566|465934665|FG000|Overall Study|Withdrawal by Subject|4|||
129446570|NCT00228566|465934665|FG000|Overall Study|Miscellaneous|1|||
129446571|NCT04448756|465934668|FG000|Overall Study|Adverse Event|0|||
129446572|NCT04448756|465934669|FG001|Overall Study|Adverse Event|1|||
129446573|NCT04448756|465934670|FG002|Overall Study|Adverse Event|0|||
129446574|NCT04448756|465934668|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
129446575|NCT04448756|465934669|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
129446576|NCT04448756|465934670|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
129446577|NCT04448756|465934668|FG000|Overall Study|Withdrawal by Subject|0|||
129446578|NCT04448756|465934669|FG001|Overall Study|Withdrawal by Subject|3|||
129446579|NCT04448756|465934670|FG002|Overall Study|Withdrawal by Subject|1|||
129446580|NCT04448756|465934668|FG000|Overall Study|Death|2|||
129835916|NCT00228917|467366131|FG004|Overall Study|Migrated/moved from study area|0|||
129835917|NCT00228917|467366132|FG005|Overall Study|Migrated/moved from study area|2|||
129835918|NCT00228917|467366133|FG006|Overall Study|Migrated/moved from study area|0|||
129835919|NCT00228917|467366134|FG007|Overall Study|Migrated/moved from study area|0|||
129835920|NCT00409617|467366135|FG000|Overall Study|Adverse Event|57|||
129835921|NCT00409617|467366135|FG000|Overall Study|Lack of Efficacy|54|||
129835922|NCT00409617|467366135|FG000|Overall Study|Lost to Follow-up|2|||
129835923|NCT00409617|467366135|FG000|Overall Study|Protocol Violation|24|||
129446581|NCT04448756|465934669|FG001|Overall Study|Death|1|||
129446582|NCT04448756|465934670|FG002|Overall Study|Death|0|||
129835924|NCT00409617|467366135|FG000|Overall Study|Withdrawal by Subject|8|||
129835925|NCT00409617|467366135|FG000|Overall Study|Administrative reasons|1|||
129898010|NCT03256344|467586552|FG000|Overall Study|Withdrawal by Subject|3|||
129446583|NCT00232141|465934671|FG000|Overall Study|Adverse Event|9|||
129446584|NCT00232141|465934672|FG001|Overall Study|Adverse Event|4|||
129446585|NCT00232141|465934671|FG000|Overall Study|Lack of Efficacy|0|||
129446586|NCT00232141|465934672|FG001|Overall Study|Lack of Efficacy|3|||
129446587|NCT00232141|465934671|FG000|Overall Study|Lost to Follow-up|9|||
129446588|NCT00232141|465934672|FG001|Overall Study|Lost to Follow-up|6|||
129835926|NCT00409617|467366135|FG000|Overall Study|Not described|14|||
129835927|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
129446589|NCT00232141|465934671|FG000|Overall Study|Other|8|||
129446590|NCT00232141|465934672|FG001|Overall Study|Other|10|||
129446591|NCT00232141|465934671|FG000|Overall Study|Withdrawal by Subject|5|||
129446592|NCT00232141|465934672|FG001|Overall Study|Withdrawal by Subject|3|||
129446593|NCT01479829|465934676|FG000|Overall Study|Withdrawal by Subject|8|||
129446594|NCT01479829|465934677|FG001|Overall Study|Withdrawal by Subject|10|||
129446595|NCT00601250|465934678|FG000|Overall Study|Adverse Event|3|||
129446596|NCT00601250|465934679|FG001|Overall Study|Adverse Event|9|||
129446597|NCT00601250|465934678|FG000|Overall Study|Protocol Violation|3|||
129446598|NCT00601250|465934679|FG001|Overall Study|Protocol Violation|2|||
129446599|NCT00601250|465934678|FG000|Overall Study|Lost to Follow-up|2|||
129446600|NCT00601250|465934679|FG001|Overall Study|Lost to Follow-up|6|||
129446601|NCT00601250|465934678|FG000|Overall Study|Withdrawal by Subject|4|||
129446602|NCT00601250|465934679|FG001|Overall Study|Withdrawal by Subject|13|||
129446603|NCT00601250|465934678|FG000|Overall Study|Other incl. lack of efficacy|2|||
129446604|NCT00601250|465934679|FG001|Overall Study|Other incl. lack of efficacy|9|||
129446605|NCT01791803|465934684|FG000|Overall Study|Withdrawal by Subject|0|||
129446606|NCT01791803|465934685|FG001|Overall Study|Withdrawal by Subject|0|||
129446607|NCT01791803|465934686|FG002|Overall Study|Withdrawal by Subject|0|||
129446608|NCT01791803|465934687|FG003|Overall Study|Withdrawal by Subject|2|||
129446609|NCT01791803|465934684|FG000|Overall Study|Physician Decision|0|||
129446610|NCT01791803|465934685|FG001|Overall Study|Physician Decision|2|||
129446611|NCT01791803|465934686|FG002|Overall Study|Physician Decision|0|||
129446612|NCT01791803|465934687|FG003|Overall Study|Physician Decision|1|||
129446613|NCT01791803|465934684|FG000|Overall Study|Death|0|||
129446614|NCT01791803|465934685|FG001|Overall Study|Death|0|||
129446615|NCT01791803|465934686|FG002|Overall Study|Death|2|||
129446616|NCT01791803|465934687|FG003|Overall Study|Death|2|||
129446617|NCT04572854|465934688|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
129446618|NCT04572854|465934689|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
129446619|NCT04572854|465934690|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
129446620|NCT04572854|465934691|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
129446621|NCT04572854|465934688|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
129446622|NCT04572854|465934689|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
129446623|NCT04572854|465934690|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
129446624|NCT04572854|465934691|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
129446625|NCT00972777|465934693|FG000|Overall Study|Adverse Event|3|||
129446626|NCT00972777|465934694|FG001|Overall Study|Adverse Event|2|||
129446627|NCT00972777|465934693|FG000|Overall Study|Lost to Follow-up|0|||
129446628|NCT00972777|465934694|FG001|Overall Study|Lost to Follow-up|4|||
129446629|NCT00972777|465934693|FG000|Overall Study|Withdrawal by Subject|4|||
129446630|NCT00972777|465934694|FG001|Overall Study|Withdrawal by Subject|5|||
129446631|NCT00972777|465934693|FG000|Overall Study|Physician Decision|4|||
129446632|NCT00972777|465934694|FG001|Overall Study|Physician Decision|0|||
129446633|NCT00972777|465934693|FG000|Overall Study|Protocol Violation|0|||
129446634|NCT00972777|465934694|FG001|Overall Study|Protocol Violation|2|||
129446635|NCT00972777|465934693|FG000|Overall Study|Screening Failure|2|||
129835928|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
129835929|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
129835930|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
129835931|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
129835932|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
129835933|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
129835934|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129835935|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129446636|NCT00972777|465934694|FG001|Overall Study|Screening Failure|1|||
129835936|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
129835937|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
129835938|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
129835939|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
129446637|NCT00972777|465934693|FG000|Overall Study|Missed visit|1|||
129446638|NCT00972777|465934694|FG001|Overall Study|Missed visit|0|||
129446639|NCT01093326|465934695|FG000|Overall Study|Death|0|||
129446640|NCT01093326|465934696|FG001|Overall Study|Death|1|||
129446641|NCT01093326|465934697|FG002|Overall Study|Death|0|||
129446642|NCT01093326|465934695|FG000|Overall Study|Lack of Efficacy|7|||
129446643|NCT01093326|465934696|FG001|Overall Study|Lack of Efficacy|6|||
129446644|NCT01093326|465934697|FG002|Overall Study|Lack of Efficacy|3|||
129446645|NCT01093326|465934695|FG000|Overall Study|Lost to Follow-up|2|||
129446646|NCT01093326|465934696|FG001|Overall Study|Lost to Follow-up|5|||
129446647|NCT01093326|465934697|FG002|Overall Study|Lost to Follow-up|4|||
129446648|NCT01093326|465934695|FG000|Overall Study|Physician Decision|3|||
129835940|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
129835941|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
129835942|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
129835943|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835944|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835945|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835946|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
129835947|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
129835948|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
129835949|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
129835950|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
129835951|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
129835952|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835953|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
129835954|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835955|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835956|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
129835957|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835958|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835959|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835960|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
129835961|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
129835962|NCT03373383|467366144|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
129835963|NCT03373383|467366145|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
129835964|NCT03373383|467366146|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
129835965|NCT03373383|467366147|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
129835966|NCT03373383|467366148|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
129835967|NCT03373383|467366144|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
129835968|NCT03373383|467366145|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835969|NCT03373383|467366146|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835970|NCT03373383|467366147|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835971|NCT03373383|467366148|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
129835972|NCT03818516|467366150|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
129835973|NCT04372602|467366151|FG000|Overall Study|Withdrawal by Subject|1|||
129835974|NCT04372602|467366152|FG001|Overall Study|Withdrawal by Subject|1|||
129835975|NCT04372602|467366151|FG000|Overall Study|Adverse Event|0|||
129835976|NCT04372602|467366152|FG001|Overall Study|Adverse Event|1|||
129835977|NCT04372602|467366151|FG000|Overall Study|Transitioned to comfort care|0|||
129835978|NCT04372602|467366152|FG001|Overall Study|Transitioned to comfort care|1|||
129835979|NCT02907359|467366153|FG000|Overall Study|Death|234|||
129835980|NCT02907359|467366154|FG001|Overall Study|Death|117|||
129835981|NCT02907359|467366153|FG000|Overall Study|Withdrawal by Subject|6|||
129835982|NCT02907359|467366154|FG001|Overall Study|Withdrawal by Subject|11|||
129835983|NCT02907359|467366153|FG000|Overall Study|Lost to Follow-up|1|||
129835984|NCT02907359|467366154|FG001|Overall Study|Lost to Follow-up|0|||
129835985|NCT02739269|467366159|FG000|Overall Study|Protocol Violation|5|||
129898011|NCT03256344|467586553|FG001|Overall Study|Withdrawal by Subject|3|||
129898012|NCT03256344|467586552|FG000|Overall Study|Sponsor Decision|1|||
129898013|NCT03256344|467586553|FG001|Overall Study|Sponsor Decision|0|||
129446649|NCT01093326|465934696|FG001|Overall Study|Physician Decision|1|||
129446650|NCT01093326|465934697|FG002|Overall Study|Physician Decision|3|||
129446651|NCT01093326|465934695|FG000|Overall Study|Withdrawal by Subject|30|||
129446652|NCT01093326|465934696|FG001|Overall Study|Withdrawal by Subject|27|||
129446653|NCT01093326|465934697|FG002|Overall Study|Withdrawal by Subject|26|||
129446654|NCT01093326|465934695|FG000|Overall Study|Adverse Event|2|||
129446655|NCT01093326|465934696|FG001|Overall Study|Adverse Event|1|||
129446656|NCT01093326|465934697|FG002|Overall Study|Adverse Event|4|||
129446657|NCT01093326|465934695|FG000|Overall Study|Other|0|||
129446658|NCT01093326|465934696|FG001|Overall Study|Other|0|||
129446659|NCT01093326|465934697|FG002|Overall Study|Other|1|||
129446660|NCT01444456|465934698|FG000|Overall Study|Withdrawal by Subject|21|||
129446661|NCT01444456|465934698|FG000|Overall Study|Physician Decision|9|||
129446662|NCT01444456|465934698|FG000|Overall Study|Lost to Follow-up|37|||
129446663|NCT01444456|465934698|FG000|Overall Study|Death|73|||
129446664|NCT01444456|465934698|FG000|Overall Study|Ineligibility determined|23|||
129446665|NCT01444456|465934698|FG000|Overall Study|Other|18|||
129446666|NCT01444456|465934698|FG000|Overall Study|Not treated|104|||
129446667|NCT04263896|465934699|FG000|Overall Study|Withdrawal by Subject|2|||
129446668|NCT04263896|465934700|FG001|Overall Study|Withdrawal by Subject|4|||
129898014|NCT01670019|467586562|FG000|Overall Study|Adverse Event|3|||
129446669|NCT04263896|465934699|FG000|Overall Study|converted to open procedure|0|||
129446670|NCT04263896|465934700|FG001|Overall Study|converted to open procedure|1|||
129446671|NCT04263896|465934699|FG000|Overall Study|Lost to Follow-up|9|||
129446672|NCT04263896|465934700|FG001|Overall Study|Lost to Follow-up|11|||
129446673|NCT04263896|465934699|FG000|Overall Study|surveys lost in mail|5|||
129446674|NCT04263896|465934700|FG001|Overall Study|surveys lost in mail|3|||
129446675|NCT04263896|465934699|FG000|Overall Study|excluded from analysis|1|||
129446676|NCT04263896|465934700|FG001|Overall Study|excluded from analysis|0|||
129446677|NCT00523718|465935918|FG000|Overall Study|Withdrawal by Subject|1|||
129446678|NCT00523718|465935919|FG001|Overall Study|Withdrawal by Subject|0|||
129446679|NCT00523718|465935918|FG000|Overall Study|Protocol Violation|2|||
129446680|NCT00523718|465935919|FG001|Overall Study|Protocol Violation|0|||
129446681|NCT00332839|465935920|FG000|Core (Months 0 - 12)|Administrative problems|1|||
129446682|NCT00332839|465935921|FG001|Core (Months 0 - 12)|Administrative problems|1|||
129446683|NCT00332839|465935920|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
129446684|NCT00332839|465935921|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
129446685|NCT00332839|465935920|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
129446686|NCT00332839|465935921|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
129446687|NCT00332839|465935920|FG000|Core (Months 0 - 12)|Adverse Event|5|||
129446688|NCT00332839|465935921|FG001|Core (Months 0 - 12)|Adverse Event|15|||
129446689|NCT00332839|465935920|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
129446690|NCT00332839|465935921|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
129446691|NCT00332839|465935920|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
129446692|NCT00332839|465935921|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
129446693|NCT00332839|465935920|FG000|Follow-up (Months 12 - 60)|Death|1|||
129446694|NCT00332839|465935921|FG001|Follow-up (Months 12 - 60)|Death|1|||
129446695|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Adverse Event|2|||
129446696|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Adverse Event|2|||
129446697|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Adverse Event|4|||
129446698|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Adverse Event|0|||
129446699|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Adverse Event|0|||
129446700|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Progressive disease|0|||
129446701|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Progressive disease|0|||
129446702|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Progressive disease|1|||
129446703|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Progressive disease|0|||
129446704|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Progressive disease|0|||
129446705|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
129446706|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
129446707|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
129446708|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
129446709|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
129446710|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
129446711|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
129446712|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
129446713|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
129446714|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
129446715|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
129446716|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
129446717|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
129446718|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
129446719|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
129446720|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
129446721|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
129446722|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
129446723|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
129446724|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
129446725|NCT03523728|465935923|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
129446726|NCT03523728|465935924|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
129446727|NCT03523728|465935925|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
129446728|NCT03523728|465935926|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
129446729|NCT03523728|465935927|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
129446730|NCT03523728|465935923|FG000|Stage 2 (24 Months)|Adverse Event|0|||
129446731|NCT03523728|465935924|FG001|Stage 2 (24 Months)|Adverse Event|0|||
129446732|NCT03523728|465935925|FG002|Stage 2 (24 Months)|Adverse Event|0|||
129446733|NCT03523728|465935926|FG003|Stage 2 (24 Months)|Adverse Event|1|||
129446734|NCT03523728|465935927|FG004|Stage 2 (24 Months)|Adverse Event|2|||
129446735|NCT03523728|465935923|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
129446736|NCT03523728|465935924|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
129446737|NCT03523728|465935925|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
129446738|NCT03523728|465935926|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
129446739|NCT03523728|465935927|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
129446740|NCT03523728|465935923|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
129446741|NCT03523728|465935924|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
129446742|NCT03523728|465935925|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
129446743|NCT03523728|465935926|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
129898015|NCT01670019|467586563|FG001|Overall Study|Adverse Event|0|||
129898016|NCT01670019|467586562|FG000|Overall Study|Withdrawal by Subject|6|||
129898017|NCT01670019|467586563|FG001|Overall Study|Withdrawal by Subject|0|||
129898018|NCT00580801|467586564|FG000|Overall Study|Physician Decision|1|||
129898019|NCT00580801|467586565|FG001|Overall Study|Physician Decision|0|||
129898020|NCT00580801|467586566|FG002|Overall Study|Physician Decision|0|||
129898021|NCT00580801|467586564|FG000|Overall Study|Adverse Event|2|||
129898022|NCT00580801|467586565|FG001|Overall Study|Adverse Event|0|||
129898023|NCT00580801|467586566|FG002|Overall Study|Adverse Event|0|||
129898024|NCT00580801|467586564|FG000|Overall Study|Lost to Follow-up|2|||
129898025|NCT00580801|467586565|FG001|Overall Study|Lost to Follow-up|0|||
129898026|NCT00580801|467586566|FG002|Overall Study|Lost to Follow-up|0|||
129898027|NCT00580801|467586564|FG000|Overall Study|Reached a virologic endpoint|0|||
129898028|NCT00580801|467586565|FG001|Overall Study|Reached a virologic endpoint|1|||
129898029|NCT00580801|467586566|FG002|Overall Study|Reached a virologic endpoint|2|||
129898030|NCT00580801|467586564|FG000|Overall Study|Participant non-compliant|0|||
129898031|NCT00580801|467586565|FG001|Overall Study|Participant non-compliant|0|||
129898032|NCT00580801|467586566|FG002|Overall Study|Participant non-compliant|1|||
129898033|NCT00580801|467586564|FG000|Overall Study|Travel|1|||
129898034|NCT00580801|467586565|FG001|Overall Study|Travel|0|||
129898035|NCT00580801|467586566|FG002|Overall Study|Travel|0|||
129898036|NCT00502593|467586567|FG000|Overall Study|Withdrawn unspecified reason|1|||
129898037|NCT00502593|467586568|FG001|Overall Study|Withdrawn unspecified reason|1|||
129898038|NCT00502593|467586569|FG002|Overall Study|Withdrawn unspecified reason|3|||
129898039|NCT00502593|467586570|FG003|Overall Study|Withdrawn unspecified reason|1|||
129898040|NCT00502593|467586571|FG004|Overall Study|Withdrawn unspecified reason|2|||
129898041|NCT00502593|467586572|FG005|Overall Study|Withdrawn unspecified reason|0|||
129898042|NCT00502593|467586573|FG006|Overall Study|Withdrawn unspecified reason|2|||
129898043|NCT00502593|467586574|FG007|Overall Study|Withdrawn unspecified reason|0|||
129898044|NCT00502593|467586575|FG008|Overall Study|Withdrawn unspecified reason|0|||
129898045|NCT00502593|467586576|FG009|Overall Study|Withdrawn unspecified reason|0|||
129898046|NCT00502593|467586577|FG010|Overall Study|Withdrawn unspecified reason|0|||
129898047|NCT00502593|467586578|FG011|Overall Study|Withdrawn unspecified reason|0|||
129898048|NCT00502593|467586567|FG000|Overall Study|Withdrawal by Subject|0|||
129898049|NCT00502593|467586568|FG001|Overall Study|Withdrawal by Subject|0|||
129898050|NCT00502593|467586569|FG002|Overall Study|Withdrawal by Subject|6|||
129898051|NCT00502593|467586570|FG003|Overall Study|Withdrawal by Subject|2|||
129898052|NCT00502593|467586571|FG004|Overall Study|Withdrawal by Subject|2|||
129898053|NCT00502593|467586572|FG005|Overall Study|Withdrawal by Subject|0|||
129898054|NCT00502593|467586573|FG006|Overall Study|Withdrawal by Subject|3|||
129898055|NCT00502593|467586574|FG007|Overall Study|Withdrawal by Subject|0|||
129898056|NCT00502593|467586575|FG008|Overall Study|Withdrawal by Subject|3|||
129898057|NCT00502593|467586576|FG009|Overall Study|Withdrawal by Subject|0|||
129898058|NCT00502593|467586577|FG010|Overall Study|Withdrawal by Subject|1|||
129898059|NCT00502593|467586578|FG011|Overall Study|Withdrawal by Subject|0|||
129898060|NCT00502593|467586567|FG000|Overall Study|Lost to Follow-up|2|||
129898061|NCT00502593|467586568|FG001|Overall Study|Lost to Follow-up|1|||
129898062|NCT00502593|467586569|FG002|Overall Study|Lost to Follow-up|1|||
129898063|NCT00502593|467586570|FG003|Overall Study|Lost to Follow-up|1|||
129898064|NCT00502593|467586571|FG004|Overall Study|Lost to Follow-up|0|||
129898065|NCT00502593|467586572|FG005|Overall Study|Lost to Follow-up|0|||
129898066|NCT00502593|467586573|FG006|Overall Study|Lost to Follow-up|0|||
129898067|NCT00502593|467586574|FG007|Overall Study|Lost to Follow-up|0|||
129898068|NCT00502593|467586575|FG008|Overall Study|Lost to Follow-up|3|||
129898069|NCT00502593|467586576|FG009|Overall Study|Lost to Follow-up|0|||
129898070|NCT00502593|467586577|FG010|Overall Study|Lost to Follow-up|1|||
129898071|NCT00502593|467586578|FG011|Overall Study|Lost to Follow-up|0|||
129898072|NCT01664104|467586579|FG000|Overall Study|Adverse Event|6|||
129898073|NCT01664104|467586579|FG000|Overall Study|Lack of Efficacy|2|||
129898074|NCT01664104|467586579|FG000|Overall Study|Withdrawal by Subject|1|||
129898075|NCT01664104|467586579|FG000|Overall Study|Lost to Follow-up|4|||
129898076|NCT01664104|467586579|FG000|Overall Study|Other|1|||
129835986|NCT02739269|467366160|FG001|Overall Study|Protocol Violation|0|||
129835987|NCT02739269|467366159|FG000|Overall Study|Cycle cancellation|2|||
129835988|NCT02739269|467366160|FG001|Overall Study|Cycle cancellation|2|||
129835989|NCT02739269|467366159|FG000|Overall Study|Withdrawal by Subject|0|||
129835990|NCT02739269|467366160|FG001|Overall Study|Withdrawal by Subject|2|||
129835991|NCT00923559|467366161|FG000|Overall Study|Lost to Follow-up|2|||
129835992|NCT00923559|467366162|FG001|Overall Study|Lost to Follow-up|3|||
129835993|NCT01951157|467366163|FG000|Overall Study|Progressive Disease|12|||
129835994|NCT01951157|467366164|FG001|Overall Study|Progressive Disease|13|||
129835995|NCT01951157|467366165|FG002|Overall Study|Progressive Disease|10|||
129835996|NCT01951157|467366163|FG000|Overall Study|Treatment-unrelated AE|1|||
129835997|NCT01951157|467366164|FG001|Overall Study|Treatment-unrelated AE|0|||
129835998|NCT01951157|467366165|FG002|Overall Study|Treatment-unrelated AE|3|||
129835999|NCT01951157|467366163|FG000|Overall Study|Study Termination|0|||
129836000|NCT01951157|467366164|FG001|Overall Study|Study Termination|0|||
129836001|NCT01951157|467366165|FG002|Overall Study|Study Termination|1|||
129836002|NCT01951157|467366163|FG000|Overall Study|Physician Decision|5|||
129836003|NCT01951157|467366164|FG001|Overall Study|Physician Decision|3|||
129836004|NCT01951157|467366165|FG002|Overall Study|Physician Decision|2|||
129836005|NCT01951157|467366163|FG000|Overall Study|Non-treatmentrelated death|2|||
129836006|NCT01951157|467366164|FG001|Overall Study|Non-treatmentrelated death|2|||
129836007|NCT01951157|467366165|FG002|Overall Study|Non-treatmentrelated death|2|||
129836008|NCT01951157|467366163|FG000|Overall Study|No treated|0|||
129836009|NCT01951157|467366164|FG001|Overall Study|No treated|1|||
129836010|NCT01951157|467366165|FG002|Overall Study|No treated|0|||
129836011|NCT01951157|467366163|FG000|Overall Study|Treatment-related AE|2|||
129836012|NCT01951157|467366164|FG001|Overall Study|Treatment-related AE|0|||
129836013|NCT01951157|467366165|FG002|Overall Study|Treatment-related AE|4|||
129836014|NCT01951157|467366163|FG000|Overall Study|Consent withdrawn by subject|0|||
129836015|NCT01951157|467366164|FG001|Overall Study|Consent withdrawn by subject|1|||
129836016|NCT01951157|467366165|FG002|Overall Study|Consent withdrawn by subject|3|||
129836017|NCT01951157|467366163|FG000|Overall Study|Treatment-related death|0|||
129836018|NCT01951157|467366164|FG001|Overall Study|Treatment-related death|2|||
129836019|NCT01951157|467366165|FG002|Overall Study|Treatment-related death|0|||
129836020|NCT00329407|467366171|FG000|Overall Study|Withdrawal by Subject|1|||
129836021|NCT00978068|467366172|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
129836022|NCT00978068|467366173|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
129836023|NCT00978068|467366172|FG000|Overall Study|Death|1|||
129836024|NCT00978068|467366173|FG001|Overall Study|Death|2|||
129836025|NCT00978068|467366172|FG000|Overall Study|Lost to Follow-up|1|||
129836026|NCT00978068|467366173|FG001|Overall Study|Lost to Follow-up|2|||
129836027|NCT00978068|467366172|FG000|Overall Study|Physician Decision|0|||
129836028|NCT00978068|467366173|FG001|Overall Study|Physician Decision|1|||
129836029|NCT00978068|467366172|FG000|Overall Study|Unable to Comply with Study|0|||
129836030|NCT00978068|467366173|FG001|Overall Study|Unable to Comply with Study|2|||
129836031|NCT03560531|467366174|FG000|Overall Study|Death|4|||
129836032|NCT03560531|467366175|FG001|Overall Study|Death|1|||
129836033|NCT03560531|467366176|FG002|Overall Study|Death|1|||
129836034|NCT03560531|467366177|FG003|Overall Study|Death|2|||
129836035|NCT03560531|467366178|FG004|Overall Study|Death|6|||
129836036|NCT03560531|467366179|FG005|Overall Study|Death|1|||
129836037|NCT03560531|467366180|FG006|Overall Study|Death|4|||
129836038|NCT03560531|467366181|FG007|Overall Study|Death|8|||
129898077|NCT01664104|467586579|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
129836039|NCT03560531|467366182|FG008|Overall Study|Death|1|||
129836040|NCT03560531|467366183|FG009|Overall Study|Death|3|||
129836041|NCT03560531|467366184|FG010|Overall Study|Death|2|||
129836042|NCT03560531|467366185|FG011|Overall Study|Death|0|||
129836043|NCT03560531|467366186|FG012|Overall Study|Death|4|||
129836044|NCT03560531|467366187|FG013|Overall Study|Death|1|||
129836045|NCT03560531|467366174|FG000|Overall Study|Lost to Follow-up|1|||
129836046|NCT03560531|467366175|FG001|Overall Study|Lost to Follow-up|1|||
129836047|NCT03560531|467366176|FG002|Overall Study|Lost to Follow-up|0|||
129836048|NCT03560531|467366177|FG003|Overall Study|Lost to Follow-up|0|||
129836049|NCT03560531|467366178|FG004|Overall Study|Lost to Follow-up|0|||
129836050|NCT03560531|467366179|FG005|Overall Study|Lost to Follow-up|0|||
129836051|NCT03560531|467366180|FG006|Overall Study|Lost to Follow-up|1|||
129836052|NCT03560531|467366181|FG007|Overall Study|Lost to Follow-up|0|||
129836053|NCT03560531|467366182|FG008|Overall Study|Lost to Follow-up|0|||
129836054|NCT03560531|467366183|FG009|Overall Study|Lost to Follow-up|0|||
129836055|NCT03560531|467366184|FG010|Overall Study|Lost to Follow-up|0|||
129836056|NCT03560531|467366185|FG011|Overall Study|Lost to Follow-up|0|||
129446744|NCT03523728|465935927|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
129836057|NCT03560531|467366186|FG012|Overall Study|Lost to Follow-up|0|||
129836058|NCT03560531|467366187|FG013|Overall Study|Lost to Follow-up|0|||
129836059|NCT03560531|467366174|FG000|Overall Study|Withdrawal by Subject|1|||
129836060|NCT03560531|467366175|FG001|Overall Study|Withdrawal by Subject|0|||
129836061|NCT03560531|467366176|FG002|Overall Study|Withdrawal by Subject|0|||
129836062|NCT03560531|467366177|FG003|Overall Study|Withdrawal by Subject|0|||
129836063|NCT03560531|467366178|FG004|Overall Study|Withdrawal by Subject|0|||
129836064|NCT03560531|467366179|FG005|Overall Study|Withdrawal by Subject|0|||
129836065|NCT03560531|467366180|FG006|Overall Study|Withdrawal by Subject|0|||
129836066|NCT03560531|467366181|FG007|Overall Study|Withdrawal by Subject|3|||
129836067|NCT03560531|467366182|FG008|Overall Study|Withdrawal by Subject|2|||
129836068|NCT03560531|467366183|FG009|Overall Study|Withdrawal by Subject|0|||
129836069|NCT03560531|467366184|FG010|Overall Study|Withdrawal by Subject|0|||
129836070|NCT03560531|467366185|FG011|Overall Study|Withdrawal by Subject|0|||
129836071|NCT03560531|467366186|FG012|Overall Study|Withdrawal by Subject|2|||
129836072|NCT03560531|467366187|FG013|Overall Study|Withdrawal by Subject|0|||
129836073|NCT03560531|467366174|FG000|Overall Study|Study end per-protocol|1|||
129836074|NCT03560531|467366175|FG001|Overall Study|Study end per-protocol|1|||
129836075|NCT03560531|467366176|FG002|Overall Study|Study end per-protocol|2|||
129836076|NCT03560531|467366177|FG003|Overall Study|Study end per-protocol|0|||
129836077|NCT03560531|467366178|FG004|Overall Study|Study end per-protocol|1|||
129836078|NCT03560531|467366179|FG005|Overall Study|Study end per-protocol|0|||
129836079|NCT03560531|467366180|FG006|Overall Study|Study end per-protocol|0|||
129836080|NCT03560531|467366181|FG007|Overall Study|Study end per-protocol|0|||
129836081|NCT03560531|467366182|FG008|Overall Study|Study end per-protocol|0|||
129836082|NCT03560531|467366183|FG009|Overall Study|Study end per-protocol|0|||
129836083|NCT03560531|467366184|FG010|Overall Study|Study end per-protocol|0|||
129836084|NCT03560531|467366185|FG011|Overall Study|Study end per-protocol|0|||
129836085|NCT03560531|467366186|FG012|Overall Study|Study end per-protocol|0|||
129446745|NCT03523728|465935923|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
129836086|NCT03560531|467366187|FG013|Overall Study|Study end per-protocol|0|||
129836087|NCT03560531|467366174|FG000|Overall Study|Early study termination by sponsor|9|||
129836088|NCT03560531|467366175|FG001|Overall Study|Early study termination by sponsor|0|||
129446746|NCT03523728|465935924|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
129446747|NCT03523728|465935925|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
129446748|NCT03523728|465935926|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
129446749|NCT03523728|465935927|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
129446750|NCT03523728|465935923|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
129446751|NCT03523728|465935924|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
129446752|NCT03523728|465935925|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
129446753|NCT03523728|465935926|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
129446754|NCT03523728|465935927|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
129446755|NCT00621751|465935928|FG000|Overall Study|Adverse Event|0|||
129446756|NCT00621751|465935929|FG001|Overall Study|Adverse Event|1|||
129446757|NCT00419120|465935931|FG000|Long Term Follow up Period|study ongoing|10|||
129446758|NCT00710879|465935932|FG000|Overall Study|Lost to Follow-up|2|||
129446759|NCT00710879|465935933|FG001|Overall Study|Lost to Follow-up|1|||
129446760|NCT00710879|465935932|FG000|Overall Study|Protocol Violation|0|||
129446761|NCT00710879|465935933|FG001|Overall Study|Protocol Violation|3|||
129446762|NCT01809132|465935934|FG000|Overall Study|Withdrawal by Subject|0|||
129446763|NCT01809132|465935935|FG001|Overall Study|Withdrawal by Subject|0|||
129446764|NCT01809132|465935936|FG002|Overall Study|Withdrawal by Subject|1|||
129446765|NCT03349775|465935937|FG000|Overall Study|Side Effects|1|||
129446766|NCT03349775|465935938|FG001|Overall Study|Side Effects|2|||
129446767|NCT03349775|465935937|FG000|Overall Study|Withdrawal by Subject|1|||
129446768|NCT03349775|465935938|FG001|Overall Study|Withdrawal by Subject|1|||
129446769|NCT03349775|465935937|FG000|Overall Study|No primary outcome measurements|0|||
129446770|NCT03349775|465935938|FG001|Overall Study|No primary outcome measurements|1|||
129446771|NCT01516970|465935939|FG000|Overall Study|Lost to Follow-up|7|||
129446772|NCT01516970|465935940|FG001|Overall Study|Lost to Follow-up|8|||
129898078|NCT01467700|467586581|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
129898079|NCT01467700|467586582|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
129898080|NCT01467700|467586583|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
129898081|NCT01467700|467586584|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
129898082|NCT01467700|467586581|FG000|Overall Study|Major Protocol Deviation|3|||
129898083|NCT01467700|467586582|FG001|Overall Study|Major Protocol Deviation|3|||
129898084|NCT01467700|467586583|FG002|Overall Study|Major Protocol Deviation|2|||
129898085|NCT01467700|467586584|FG003|Overall Study|Major Protocol Deviation|3|||
129898086|NCT01467700|467586581|FG000|Overall Study|Lost to Follow-up|6|||
129898087|NCT01467700|467586582|FG001|Overall Study|Lost to Follow-up|5|||
129898088|NCT01467700|467586583|FG002|Overall Study|Lost to Follow-up|2|||
129898089|NCT01467700|467586584|FG003|Overall Study|Lost to Follow-up|3|||
129898090|NCT01467700|467586581|FG000|Overall Study|Voluntary Withdrawal|5|||
129898091|NCT01467700|467586582|FG001|Overall Study|Voluntary Withdrawal|7|||
129898092|NCT01467700|467586583|FG002|Overall Study|Voluntary Withdrawal|6|||
129898093|NCT01467700|467586584|FG003|Overall Study|Voluntary Withdrawal|2|||
129898094|NCT01467700|467586581|FG000|Overall Study|Study Termination|6|||
129898095|NCT01467700|467586582|FG001|Overall Study|Study Termination|5|||
129898096|NCT01467700|467586583|FG002|Overall Study|Study Termination|10|||
129898097|NCT01467700|467586584|FG003|Overall Study|Study Termination|7|||
129898098|NCT01467700|467586581|FG000|Overall Study|Pregnancy|0|||
129898099|NCT01467700|467586582|FG001|Overall Study|Pregnancy|1|||
129898100|NCT01467700|467586583|FG002|Overall Study|Pregnancy|1|||
129898101|NCT01467700|467586584|FG003|Overall Study|Pregnancy|0|||
129898102|NCT01467700|467586581|FG000|Overall Study|Lack of Efficacy|2|||
129446773|NCT01516970|465935939|FG000|Overall Study|Adverse Event|1|||
129446774|NCT01516970|465935940|FG001|Overall Study|Adverse Event|5|||
129446775|NCT01516970|465935939|FG000|Overall Study|Withdrawal by Subject|1|||
129898103|NCT01467700|467586582|FG001|Overall Study|Lack of Efficacy|0|||
129898104|NCT01467700|467586583|FG002|Overall Study|Lack of Efficacy|2|||
129898105|NCT01467700|467586584|FG003|Overall Study|Lack of Efficacy|1|||
129898106|NCT01467700|467586581|FG000|Overall Study|Reason not Specified|1|||
129898107|NCT01467700|467586582|FG001|Overall Study|Reason not Specified|3|||
129898108|NCT01467700|467586583|FG002|Overall Study|Reason not Specified|2|||
129898109|NCT01467700|467586584|FG003|Overall Study|Reason not Specified|8|||
129898110|NCT03396913|467586587|FG000|Overall Study|Lost to Follow-up|0|||
129898111|NCT03396913|467586588|FG001|Overall Study|Lost to Follow-up|6|||
129898112|NCT00813488|467586589|FG000|Titration Period 1|Adverse Event|6|||
129898113|NCT00813488|467586590|FG001|Titration Period 1|Adverse Event|1|||
129898114|NCT00813488|467586589|FG000|Titration Period 1|Lack of Efficacy|9|||
129898115|NCT00813488|467586590|FG001|Titration Period 1|Lack of Efficacy|7|||
129898116|NCT00813488|467586589|FG000|Titration Period 1|Withdrawal by Subject|2|||
129898117|NCT00813488|467586590|FG001|Titration Period 1|Withdrawal by Subject|2|||
129898118|NCT00813488|467586589|FG000|Titration Period 1|Protocol Violation|4|||
129898119|NCT00813488|467586590|FG001|Titration Period 1|Protocol Violation|3|||
129898120|NCT00813488|467586589|FG000|Titration Period 1|Non-compliance to study medication|4|||
129898121|NCT00813488|467586590|FG001|Titration Period 1|Non-compliance to study medication|1|||
129898122|NCT00813488|467586589|FG000|Titration Period 1|Non-compliance to study procedures|2|||
129898123|NCT00813488|467586590|FG001|Titration Period 1|Non-compliance to study procedures|2|||
129898124|NCT00813488|467586589|FG000|Titration Period 1|Technical Difficulties|0|||
129898125|NCT00813488|467586590|FG001|Titration Period 1|Technical Difficulties|1|||
129898126|NCT00813488|467586589|FG000|Titration Period 2|Adverse Event|2|||
129898127|NCT00813488|467586590|FG001|Titration Period 2|Adverse Event|3|||
129898128|NCT00813488|467586589|FG000|Titration Period 2|Lack of Efficacy|8|||
129898129|NCT00813488|467586590|FG001|Titration Period 2|Lack of Efficacy|4|||
129898130|NCT00813488|467586589|FG000|Titration Period 2|Protocol Violation|3|||
129898131|NCT00813488|467586590|FG001|Titration Period 2|Protocol Violation|2|||
129446776|NCT01516970|465935940|FG001|Overall Study|Withdrawal by Subject|1|||
129446777|NCT01516970|465935939|FG000|Overall Study|Other|9|||
129446778|NCT01516970|465935940|FG001|Overall Study|Other|7|||
129898132|NCT00813488|467586589|FG000|Titration Period 2|Lost to Follow-up|1|||
129898133|NCT00813488|467586590|FG001|Titration Period 2|Lost to Follow-up|0|||
129898134|NCT00813488|467586589|FG000|Titration Period 2|Non-compliance with study procedures|2|||
129898135|NCT00813488|467586590|FG001|Titration Period 2|Non-compliance with study procedures|1|||
129446779|NCT00434421|465935941|FG000|Overall Study|Withdrawal by Subject|1|||
129446780|NCT00434421|465935941|FG000|Overall Study|Non-compliance with study treatment|1|||
129446781|NCT01756040|465935942|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
129446782|NCT01756040|465935942|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
129836089|NCT03560531|467366176|FG002|Overall Study|Early study termination by sponsor|0|||
129836090|NCT03560531|467366177|FG003|Overall Study|Early study termination by sponsor|4|||
129836091|NCT03560531|467366178|FG004|Overall Study|Early study termination by sponsor|8|||
129836092|NCT03560531|467366179|FG005|Overall Study|Early study termination by sponsor|2|||
129836093|NCT03560531|467366180|FG006|Overall Study|Early study termination by sponsor|5|||
129836094|NCT03560531|467366181|FG007|Overall Study|Early study termination by sponsor|64|||
129836095|NCT03560531|467366182|FG008|Overall Study|Early study termination by sponsor|7|||
129446783|NCT01756040|465935942|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
129836096|NCT03560531|467366183|FG009|Overall Study|Early study termination by sponsor|2|||
129836097|NCT03560531|467366184|FG010|Overall Study|Early study termination by sponsor|16|||
129836098|NCT03560531|467366185|FG011|Overall Study|Early study termination by sponsor|2|||
129836099|NCT03560531|467366186|FG012|Overall Study|Early study termination by sponsor|6|||
129836100|NCT03560531|467366187|FG013|Overall Study|Early study termination by sponsor|2|||
129836101|NCT01200797|467366190|FG000|Overall Study|symptomatic deterioration|2|||
129446784|NCT01205438|465935943|FG000|Overall Study|Adverse Event|19|||
129836102|NCT01200797|467366190|FG000|Overall Study|Adverse Event|4|||
129836103|NCT01200797|467366190|FG000|Overall Study|Disease Progression|13|||
129836104|NCT02818777|467366194|FG000|Overall Study|Adverse Event|3|||
129836105|NCT01623596|467366196|FG000|Overall Study|Abnormal laboratory values|2|||
129836106|NCT01623596|467366197|FG001|Overall Study|Abnormal laboratory values|0|||
129836107|NCT01623596|467366196|FG000|Overall Study|Administrative problems|9|||
129836108|NCT01623596|467366197|FG001|Overall Study|Administrative problems|13|||
129836109|NCT01623596|467366196|FG000|Overall Study|Adverse Event|20|||
129836110|NCT01623596|467366197|FG001|Overall Study|Adverse Event|29|||
129836111|NCT01623596|467366196|FG000|Overall Study|Death|0|||
129836112|NCT01623596|467366197|FG001|Overall Study|Death|2|||
129836113|NCT01623596|467366196|FG000|Overall Study|Lost to Follow-up|12|||
129836114|NCT01623596|467366197|FG001|Overall Study|Lost to Follow-up|16|||
129836115|NCT01623596|467366196|FG000|Overall Study|Withdrawal by Subject|13|||
129836116|NCT01623596|467366197|FG001|Overall Study|Withdrawal by Subject|31|||
129836117|NCT01623596|467366196|FG000|Overall Study|Patient no longer requires study drug|1|||
129836118|NCT01623596|467366197|FG001|Overall Study|Patient no longer requires study drug|0|||
129836119|NCT01623596|467366196|FG000|Overall Study|Protocol Violation|0|||
129836120|NCT01623596|467366197|FG001|Overall Study|Protocol Violation|6|||
129836121|NCT01623596|467366196|FG000|Overall Study|Lack of Efficacy|5|||
129836122|NCT01623596|467366197|FG001|Overall Study|Lack of Efficacy|3|||
129836123|NCT01324349|467366201|FG000|Overall Study|Death|1|||
129836124|NCT01324349|467366202|FG001|Overall Study|Death|1|||
129836125|NCT01324349|467366201|FG000|Overall Study|Withdrawal by Subject|0|||
129836126|NCT01324349|467366202|FG001|Overall Study|Withdrawal by Subject|1|||
129836127|NCT00748215|467366203|FG000|Overall Study|Withdrawal by Subject|7|||
129836128|NCT00748215|467366204|FG001|Overall Study|Withdrawal by Subject|7|||
129836129|NCT00748215|467366203|FG000|Overall Study|Treatment change|2|||
129446785|NCT01205438|465935944|FG001|Overall Study|Adverse Event|17|||
129836130|NCT00748215|467366204|FG001|Overall Study|Treatment change|1|||
129836131|NCT00748215|467366203|FG000|Overall Study|Change in patient condition|0|||
129836132|NCT00748215|467366204|FG001|Overall Study|Change in patient condition|3|||
129836133|NCT00748215|467366203|FG000|Overall Study|Non-compliant|0|||
129836134|NCT00748215|467366204|FG001|Overall Study|Non-compliant|2|||
129446786|NCT01205438|465935945|FG002|Overall Study|Adverse Event|24|||
129836135|NCT00748215|467366203|FG000|Overall Study|Adverse Event|0|||
129836136|NCT00748215|467366204|FG001|Overall Study|Adverse Event|5|||
129836137|NCT03200899|467366211|FG000|Overall Study|Lost to Follow-up|10|||
129836138|NCT03200899|467366212|FG001|Overall Study|Lost to Follow-up|23|||
129836139|NCT00026793|467366214|FG000|Overall Study|Death on study due to underlying disease|4|||
129836140|NCT00026793|467366214|FG000|Overall Study|Physician Decision|2|||
129836141|NCT00026793|467366214|FG000|Overall Study|Off study|2|||
129836142|NCT04151290|467366215|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
129836143|NCT00969553|467366216|FG000|Overall Study|Progressive disease (PD)|2|||
129836144|NCT00969553|467366217|FG001|Overall Study|Progressive disease (PD)|2|||
129836145|NCT00969553|467366218|FG002|Overall Study|Progressive disease (PD)|6|||
129836146|NCT00969553|467366219|FG003|Overall Study|Progressive disease (PD)|9|||
129836147|NCT00969553|467366220|FG004|Overall Study|Progressive disease (PD)|2|||
129836148|NCT00969553|467366221|FG005|Overall Study|Progressive disease (PD)|4|||
129836149|NCT00969553|467366222|FG006|Overall Study|Progressive disease (PD)|2|||
129836150|NCT00969553|467366223|FG007|Overall Study|Progressive disease (PD)|12|||
129836151|NCT00969553|467366224|FG008|Overall Study|Progressive disease (PD)|3|||
129836152|NCT00969553|467366216|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836153|NCT00969553|467366217|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836154|NCT00969553|467366218|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836155|NCT00969553|467366219|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836156|NCT00969553|467366220|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
129836157|NCT00969553|467366221|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836158|NCT00969553|467366222|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836159|NCT00969553|467366223|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836160|NCT00969553|467366224|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
129836161|NCT00969553|467366216|FG000|Overall Study|Other Adverse Event|0|||
129836162|NCT00969553|467366217|FG001|Overall Study|Other Adverse Event|0|||
129836163|NCT00969553|467366218|FG002|Overall Study|Other Adverse Event|0|||
129836164|NCT00969553|467366219|FG003|Overall Study|Other Adverse Event|1|||
129836165|NCT00969553|467366220|FG004|Overall Study|Other Adverse Event|0|||
129836166|NCT00969553|467366221|FG005|Overall Study|Other Adverse Event|0|||
129836167|NCT00969553|467366222|FG006|Overall Study|Other Adverse Event|1|||
129836168|NCT00969553|467366223|FG007|Overall Study|Other Adverse Event|0|||
129836169|NCT00969553|467366224|FG008|Overall Study|Other Adverse Event|0|||
129836170|NCT00969553|467366216|FG000|Overall Study|Refused cont. medication|1|||
129446787|NCT01205438|465935943|FG000|Overall Study|Death|1|||
129446788|NCT01205438|465935944|FG001|Overall Study|Death|1|||
129898136|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
129898137|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
129898138|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
129898139|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
129898140|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
129898141|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
129898142|NCT00813488|467586589|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
129898143|NCT00813488|467586590|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
129898144|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
129898145|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
129898146|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
129898147|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
129898148|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
129898149|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
129898150|NCT00813488|467586589|FG000|Double-blind Treatment Period 2|Other|1|||
129898151|NCT00813488|467586590|FG001|Double-blind Treatment Period 2|Other|0|||
129898152|NCT00813488|467586589|FG000|Open-label Extension|Adverse Event|1|||
129898153|NCT00813488|467586590|FG001|Open-label Extension|Adverse Event|2|||
129898154|NCT00813488|467586589|FG000|Open-label Extension|Lack of Efficacy|3|||
129898155|NCT00813488|467586590|FG001|Open-label Extension|Lack of Efficacy|0|||
129898156|NCT00813488|467586589|FG000|Open-label Extension|Withdrawal by Subject|0|||
129898157|NCT00813488|467586590|FG001|Open-label Extension|Withdrawal by Subject|2|||
129898158|NCT00813488|467586589|FG000|Open-label Extension|Protocol Violation|1|||
129898159|NCT00813488|467586590|FG001|Open-label Extension|Protocol Violation|2|||
129898160|NCT00813488|467586589|FG000|Open-label Extension|Non-compliance study medication|4|||
129898161|NCT00813488|467586590|FG001|Open-label Extension|Non-compliance study medication|0|||
129898162|NCT00813488|467586589|FG000|Open-label Extension|Non-compliance study procedures|2|||
129898163|NCT00813488|467586590|FG001|Open-label Extension|Non-compliance study procedures|1|||
129898164|NCT00813488|467586589|FG000|Open-label Extension|Other|1|||
129898165|NCT00813488|467586590|FG001|Open-label Extension|Other|0|||
129898166|NCT01729871|467586592|FG000|Overall Study|Adverse Event|7|||
129898167|NCT01729871|467586593|FG001|Overall Study|Adverse Event|7|||
129898168|NCT01729871|467586592|FG000|Overall Study|Death|0|||
129898169|NCT01729871|467586593|FG001|Overall Study|Death|1|||
129898170|NCT01729871|467586592|FG000|Overall Study|Lack of Efficacy|0|||
129898171|NCT01729871|467586593|FG001|Overall Study|Lack of Efficacy|1|||
129898172|NCT01729871|467586592|FG000|Overall Study|Physician Decision|0|||
129898173|NCT01729871|467586593|FG001|Overall Study|Physician Decision|2|||
129898174|NCT01729871|467586592|FG000|Overall Study|Protocol Violation|1|||
129898175|NCT01729871|467586593|FG001|Overall Study|Protocol Violation|0|||
129898176|NCT01729871|467586592|FG000|Overall Study|Withdrawal by Subject|0|||
129898177|NCT01729871|467586593|FG001|Overall Study|Withdrawal by Subject|3|||
129898178|NCT01729871|467586592|FG000|Overall Study|Other|4|||
129898179|NCT01729871|467586593|FG001|Overall Study|Other|9|||
129898180|NCT01143077|467586594|FG000|Overall Study|Lack of Efficacy|0|||
129898181|NCT01143077|467586595|FG001|Overall Study|Lack of Efficacy|2|||
129898182|NCT01143077|467586596|FG002|Overall Study|Lack of Efficacy|1|||
129898183|NCT01143077|467586594|FG000|Overall Study|Adverse Event|5|||
129898184|NCT01143077|467586595|FG001|Overall Study|Adverse Event|6|||
129898185|NCT01143077|467586596|FG002|Overall Study|Adverse Event|5|||
129898186|NCT01143077|467586594|FG000|Overall Study|Lost to Follow-up|2|||
129898187|NCT01143077|467586595|FG001|Overall Study|Lost to Follow-up|3|||
129898188|NCT01143077|467586596|FG002|Overall Study|Lost to Follow-up|4|||
129898189|NCT01143077|467586594|FG000|Overall Study|Protocol Violation|2|||
129898190|NCT01143077|467586595|FG001|Overall Study|Protocol Violation|0|||
129898191|NCT01143077|467586596|FG002|Overall Study|Protocol Violation|0|||
129898192|NCT01143077|467586594|FG000|Overall Study|Withdrawal by Subject|4|||
129898193|NCT01143077|467586595|FG001|Overall Study|Withdrawal by Subject|3|||
129898194|NCT01143077|467586596|FG002|Overall Study|Withdrawal by Subject|3|||
129898195|NCT01143077|467586594|FG000|Overall Study|Non-compliance with study drug|0|||
129898196|NCT01143077|467586595|FG001|Overall Study|Non-compliance with study drug|1|||
129446789|NCT01205438|465935945|FG002|Overall Study|Death|3|||
129446790|NCT01205438|465935943|FG000|Overall Study|Entry Criteria Not Met|16|||
129446791|NCT01205438|465935944|FG001|Overall Study|Entry Criteria Not Met|15|||
129446792|NCT01205438|465935945|FG002|Overall Study|Entry Criteria Not Met|13|||
129446793|NCT01205438|465935943|FG000|Overall Study|Lack of Efficacy|14|||
129446794|NCT01205438|465935944|FG001|Overall Study|Lack of Efficacy|11|||
129446795|NCT01205438|465935945|FG002|Overall Study|Lack of Efficacy|14|||
129446796|NCT01205438|465935943|FG000|Overall Study|Lost to Follow-up|6|||
129836171|NCT00969553|467366217|FG001|Overall Study|Refused cont. medication|1|||
129836172|NCT00969553|467366218|FG002|Overall Study|Refused cont. medication|0|||
129836173|NCT00969553|467366219|FG003|Overall Study|Refused cont. medication|2|||
129836174|NCT00969553|467366220|FG004|Overall Study|Refused cont. medication|0|||
129836175|NCT00969553|467366221|FG005|Overall Study|Refused cont. medication|0|||
129836176|NCT00969553|467366222|FG006|Overall Study|Refused cont. medication|0|||
129836177|NCT00969553|467366223|FG007|Overall Study|Refused cont. medication|1|||
129836178|NCT00969553|467366224|FG008|Overall Study|Refused cont. medication|0|||
129836179|NCT00969553|467366216|FG000|Overall Study|Not specified above|0|||
129836180|NCT00969553|467366217|FG001|Overall Study|Not specified above|0|||
129836181|NCT00969553|467366218|FG002|Overall Study|Not specified above|0|||
129836182|NCT00969553|467366219|FG003|Overall Study|Not specified above|4|||
129836183|NCT00969553|467366220|FG004|Overall Study|Not specified above|0|||
129836184|NCT00969553|467366221|FG005|Overall Study|Not specified above|0|||
129836185|NCT00969553|467366222|FG006|Overall Study|Not specified above|1|||
129836186|NCT00969553|467366223|FG007|Overall Study|Not specified above|1|||
129836187|NCT00969553|467366224|FG008|Overall Study|Not specified above|0|||
129836188|NCT01077804|467366226|FG000|Overall Study|Unreachable|102|||
129836189|NCT01077804|467366226|FG000|Overall Study|Refused to continue|79|||
129836190|NCT01077804|467366226|FG000|Overall Study|Other|18|||
129836191|NCT00136084|467368104|FG000|Overall Study|Death|12|||
129836192|NCT00136084|467368105|FG001|Overall Study|Death|5|||
129836193|NCT00136084|467368104|FG000|Overall Study|Unacceptable toxicity|8|||
129836194|NCT00136084|467368105|FG001|Overall Study|Unacceptable toxicity|11|||
129836195|NCT00136084|467368104|FG000|Overall Study|Relapse|20|||
129836196|NCT00136084|467368105|FG001|Overall Study|Relapse|23|||
129836197|NCT00136084|467368104|FG000|Overall Study|Lost to Follow-up|2|||
129836198|NCT00136084|467368105|FG001|Overall Study|Lost to Follow-up|0|||
129836199|NCT00136084|467368104|FG000|Overall Study|No Response|1|||
129836200|NCT00136084|467368105|FG001|Overall Study|No Response|2|||
129836201|NCT00136084|467368104|FG000|Overall Study|Withdrawal by Subject|5|||
129836202|NCT00136084|467368105|FG001|Overall Study|Withdrawal by Subject|1|||
129836203|NCT00997503|467368106|FG000|Overall Study|Death|53|||
129836204|NCT00997503|467368106|FG000|Overall Study|Withdrawal by Subject|76|||
129836205|NCT00997503|467368106|FG000|Overall Study|Lost to Follow-up|33|||
129836206|NCT00997503|467368106|FG000|Overall Study|Adverse Event|3|||
129836207|NCT00997503|467368106|FG000|Overall Study|Physician Decision|10|||
129836208|NCT00997503|467368106|FG000|Overall Study|Missed 12-month follow-up|85|||
129836209|NCT00997503|467368106|FG000|Overall Study|Other reason|13|||
129836210|NCT00116831|467368107|FG000|Overall Study|Adverse Event|14|||
129836211|NCT00116831|467368108|FG001|Overall Study|Adverse Event|16|||
129836212|NCT00116831|467368107|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
129836213|NCT00116831|467368108|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
129836214|NCT00116831|467368107|FG000|Overall Study|Lost to Follow-up|8|||
129836215|NCT00116831|467368108|FG001|Overall Study|Lost to Follow-up|6|||
129836216|NCT00116831|467368107|FG000|Overall Study|Protocol Violation|3|||
129836217|NCT00116831|467368108|FG001|Overall Study|Protocol Violation|6|||
129836218|NCT00116831|467368107|FG000|Overall Study|Hypoglycaemic events|1|||
129836219|NCT00116831|467368108|FG001|Overall Study|Hypoglycaemic events|0|||
129836220|NCT00116831|467368107|FG000|Overall Study|Low haemoglobin on screening|1|||
129836221|NCT00116831|467368108|FG001|Overall Study|Low haemoglobin on screening|0|||
129836222|NCT00116831|467368107|FG000|Overall Study|Withdrawn investigational product|1|||
129836223|NCT00116831|467368108|FG001|Overall Study|Withdrawn investigational product|0|||
129836224|NCT00116831|467368107|FG000|Overall Study|Withdrawal by Subject|32|||
129836225|NCT00116831|467368108|FG001|Overall Study|Withdrawal by Subject|32|||
129836226|NCT00116831|467368107|FG000|Overall Study|Insufficient therapeutic effect|0|||
129836227|NCT00116831|467368108|FG001|Overall Study|Insufficient therapeutic effect|1|||
129836228|NCT00116831|467368107|FG000|Overall Study|Missing data for participant|1|||
129836229|NCT00116831|467368108|FG001|Overall Study|Missing data for participant|0|||
129836230|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
129836231|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
129836232|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
129836233|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
129836234|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
129836235|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
129836236|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
129836237|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
129836238|NCT00380393|467368109|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
129446797|NCT01205438|465935944|FG001|Overall Study|Lost to Follow-up|7|||
129836239|NCT00380393|467368110|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
129836240|NCT00380393|467368109|FG000|Month 14|Withdrawal by Subject|9|||
129836241|NCT00380393|467368110|FG001|Month 14|Withdrawal by Subject|7|||
129836242|NCT00380393|467368109|FG000|Month 14|Death|1|||
129836243|NCT00380393|467368110|FG001|Month 14|Death|0|||
129836244|NCT00380393|467368109|FG000|Month 14|Lost to Follow-up|0|||
129836245|NCT00380393|467368110|FG001|Month 14|Lost to Follow-up|1|||
129836246|NCT00380393|467368109|FG000|Month 14|Migrated/moved from study area|39|||
129836247|NCT00380393|467368110|FG001|Month 14|Migrated/moved from study area|42|||
129836248|NCT00380393|467368109|FG000|Month 14|Protocol Violation|2|||
129836249|NCT00380393|467368110|FG001|Month 14|Protocol Violation|0|||
129836250|NCT00380393|467368109|FG000|Month 14|Others|6|||
129836251|NCT00380393|467368110|FG001|Month 14|Others|6|||
129836252|NCT01933048|467368111|FG000|Overall Study|Lost to Follow-up|15|||
129836253|NCT01933048|467368112|FG001|Overall Study|Lost to Follow-up|18|||
129836254|NCT01933048|467368111|FG000|Overall Study|personal reasons|1|||
129836255|NCT01933048|467368112|FG001|Overall Study|personal reasons|1|||
129836256|NCT01933048|467368111|FG000|Overall Study|Protocol Violation|7|||
129836257|NCT01933048|467368112|FG001|Overall Study|Protocol Violation|8|||
129836258|NCT01933048|467368111|FG000|Overall Study|Physician Decision|1|||
129836259|NCT01933048|467368112|FG001|Overall Study|Physician Decision|0|||
129836260|NCT01933048|467368111|FG000|Overall Study|unknown reasons|1|||
129836261|NCT01933048|467368112|FG001|Overall Study|unknown reasons|1|||
129836262|NCT02476968|467368113|FG000|Overall Study|Other|0|||
129836263|NCT02476968|467368114|FG001|Overall Study|Other|2|||
129836264|NCT02476968|467368115|FG002|Overall Study|Other|0|||
129836265|NCT02476968|467368113|FG000|Overall Study|Lost to Follow-up|10|||
129836266|NCT02476968|467368114|FG001|Overall Study|Lost to Follow-up|0|||
129836267|NCT02476968|467368115|FG002|Overall Study|Lost to Follow-up|1|||
129836268|NCT02476968|467368113|FG000|Overall Study|Death|48|||
129836269|NCT02476968|467368114|FG001|Overall Study|Death|8|||
129836270|NCT02476968|467368115|FG002|Overall Study|Death|1|||
129836271|NCT02476968|467368113|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129836272|NCT02476968|467368114|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129836273|NCT02476968|467368115|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
129836274|NCT02476968|467368113|FG000|Overall Study|Patient decision|37|||
129836275|NCT02476968|467368114|FG001|Overall Study|Patient decision|8|||
129836276|NCT02476968|467368115|FG002|Overall Study|Patient decision|0|||
129836277|NCT01859507|467368116|FG000|Overall Study|left the country|4|||
129836278|NCT02404311|467368117|FG000|Part A: Month 0-18|Death|2|||
129836279|NCT02404311|467368118|FG001|Part A: Month 0-18|Death|0|||
129836280|NCT02404311|467368119|FG002|Part A: Month 0-18|Death|0|||
129836281|NCT02404311|467368120|FG003|Part A: Month 0-18|Death|0|||
129836282|NCT02404311|467368121|FG004|Part A: Month 0-18|Death|0|||
129836283|NCT02404311|467368117|FG000|Part A: Month 0-18|Physician Decision|1|||
129836284|NCT02404311|467368118|FG001|Part A: Month 0-18|Physician Decision|0|||
129836285|NCT02404311|467368119|FG002|Part A: Month 0-18|Physician Decision|0|||
129836286|NCT02404311|467368120|FG003|Part A: Month 0-18|Physician Decision|0|||
129836287|NCT02404311|467368121|FG004|Part A: Month 0-18|Physician Decision|0|||
129836288|NCT02404311|467368117|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
129836289|NCT02404311|467368118|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
129836290|NCT02404311|467368119|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
129836291|NCT02404311|467368120|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
129836292|NCT02404311|467368121|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
129836293|NCT02404311|467368117|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
129836294|NCT02404311|467368118|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
129836295|NCT02404311|467368119|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
129836296|NCT02404311|467368120|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
129836297|NCT02404311|467368121|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
129836298|NCT02404311|467368117|FG000|Part A: Month 0-18|HIV Infection|6|||
129836299|NCT02404311|467368118|FG001|Part A: Month 0-18|HIV Infection|2|||
129836300|NCT02404311|467368119|FG002|Part A: Month 0-18|HIV Infection|0|||
129836301|NCT02404311|467368120|FG003|Part A: Month 0-18|HIV Infection|0|||
129836302|NCT02404311|467368121|FG004|Part A: Month 0-18|HIV Infection|0|||
129836303|NCT02404311|467368117|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
129836304|NCT02404311|467368118|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
129836305|NCT02404311|467368119|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
129836306|NCT02404311|467368120|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
129446798|NCT01205438|465935945|FG002|Overall Study|Lost to Follow-up|8|||
129446799|NCT01205438|465935943|FG000|Overall Study|Withdrawal by Subject|19|||
129446800|NCT01205438|465935944|FG001|Overall Study|Withdrawal by Subject|25|||
129446801|NCT01205438|465935945|FG002|Overall Study|Withdrawal by Subject|19|||
129446802|NCT01205438|465935943|FG000|Overall Study|Physician Decision|0|||
129446803|NCT01205438|465935944|FG001|Overall Study|Physician Decision|3|||
129446804|NCT01205438|465935945|FG002|Overall Study|Physician Decision|2|||
129446805|NCT01205438|465935943|FG000|Overall Study|Protocol Violation|2|||
129446806|NCT01205438|465935944|FG001|Overall Study|Protocol Violation|7|||
129446807|NCT01205438|465935945|FG002|Overall Study|Protocol Violation|4|||
129446808|NCT01205438|465935943|FG000|Overall Study|Sponsor Decision|0|||
129446809|NCT01205438|465935944|FG001|Overall Study|Sponsor Decision|1|||
129446810|NCT01205438|465935945|FG002|Overall Study|Sponsor Decision|1|||
129446811|NCT03631667|465935950|FG000|Overall Study|Withdrawal by Subject|3|||
129446812|NCT00884325|465935951|FG000|Overall Study|Lost to Follow-up|1|||
129446813|NCT00884325|465935952|FG001|Overall Study|Lost to Follow-up|2|||
129446814|NCT00884325|465935951|FG000|Overall Study|Lack of Efficacy|0|||
129446815|NCT00884325|465935952|FG001|Overall Study|Lack of Efficacy|1|||
129446816|NCT00884325|465935951|FG000|Overall Study|Withdrawal by Subject|1|||
129446817|NCT00884325|465935952|FG001|Overall Study|Withdrawal by Subject|1|||
129446818|NCT00884325|465935951|FG000|Overall Study|Not provided|1|||
129446819|NCT00884325|465935952|FG001|Overall Study|Not provided|0|||
129446820|NCT00892177|465935953|FG000|Phase II|Ineligible|0|||
129446821|NCT00892177|465935954|FG001|Phase II|Ineligible|0|||
129446822|NCT00892177|465935955|FG002|Phase II|Ineligible|0|||
129446823|NCT00892177|465935956|FG003|Phase II|Ineligible|0|||
129446824|NCT00892177|465935957|FG004|Phase II|Ineligible|1|||
129446825|NCT00892177|465935958|FG005|Phase II|Ineligible|1|||
129446826|NCT00892177|465935953|FG000|Phase II|Withdrawal by Subject|0|||
129446827|NCT00892177|465935954|FG001|Phase II|Withdrawal by Subject|0|||
129446828|NCT00892177|465935955|FG002|Phase II|Withdrawal by Subject|0|||
129446829|NCT00892177|465935956|FG003|Phase II|Withdrawal by Subject|0|||
129836307|NCT02404311|467368121|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
129836308|NCT00218296|467368129|FG000|Overall Study|Lost to Follow-up|9|||
129836309|NCT00218296|467368130|FG001|Overall Study|Lost to Follow-up|7|||
129836310|NCT00218296|467368129|FG000|Overall Study|Withdrawal by Subject|36|||
129836311|NCT00218296|467368130|FG001|Overall Study|Withdrawal by Subject|47|||
129836312|NCT00218296|467368129|FG000|Overall Study|Randomized but did not enter treatment|66|||
129836313|NCT00218296|467368130|FG001|Overall Study|Randomized but did not enter treatment|67|||
129836314|NCT00097721|467368131|FG000|Overall Study|Adverse Event|8|||
129836315|NCT00097721|467368132|FG001|Overall Study|Adverse Event|1|||
129836316|NCT00097721|467368131|FG000|Overall Study|Withdrawal by Subject|6|||
129836317|NCT00097721|467368132|FG001|Overall Study|Withdrawal by Subject|1|||
129836318|NCT00097721|467368131|FG000|Overall Study|Progressive Disease|55|||
129836319|NCT00097721|467368132|FG001|Overall Study|Progressive Disease|27|||
129836320|NCT00097721|467368131|FG000|Overall Study|Physician Decision|1|||
129836321|NCT00097721|467368132|FG001|Overall Study|Physician Decision|3|||
129836322|NCT00097721|467368131|FG000|Overall Study|Reason not given|1|||
129836323|NCT00097721|467368132|FG001|Overall Study|Reason not given|1|||
129836324|NCT01752855|467368136|FG000|Overall Study|Adverse Event|1|||
129836325|NCT01752855|467368137|FG001|Overall Study|Adverse Event|0|||
129836326|NCT01752855|467368136|FG000|Overall Study|Withdrew Consent|0|||
129836327|NCT01752855|467368137|FG001|Overall Study|Withdrew Consent|2|||
129836328|NCT01752855|467368136|FG000|Overall Study|Lack of Efficacy|0|||
129836329|NCT01752855|467368137|FG001|Overall Study|Lack of Efficacy|2|||
129836330|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
129836331|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
129836332|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
129836333|NCT01478321|467368138|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
129446830|NCT00892177|465935957|FG004|Phase II|Withdrawal by Subject|4|||
129836334|NCT01478321|467368138|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
129836335|NCT01478321|467368138|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
129836336|NCT01478321|467368138|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
129836337|NCT01478321|467368138|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
129836338|NCT00634088|467368141|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
129836339|NCT00634088|467368142|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
129836340|NCT00634088|467368143|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
129446831|NCT00892177|465935958|FG005|Phase II|Withdrawal by Subject|1|||
129446832|NCT01446016|465935961|FG000|Overall Study|Lost to Follow-up|3|||
129446833|NCT01446016|465935961|FG000|Overall Study|Withdrawal by Subject|1|||
129836341|NCT00634088|467368144|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
129836342|NCT00634088|467368141|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
129836343|NCT00634088|467368142|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
129446834|NCT01446016|465935961|FG000|Overall Study|Toxicity|3|||
129446835|NCT01087957|465935971|FG000|Overall Study|Death|2|||
129446836|NCT01087957|465935972|FG001|Overall Study|Death|2|||
129836344|NCT00634088|467368143|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
129836345|NCT00634088|467368144|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
129446837|NCT01087957|465935971|FG000|Overall Study|Lost to Follow-up|3|||
129446838|NCT01087957|465935972|FG001|Overall Study|Lost to Follow-up|4|||
129446839|NCT01087957|465935971|FG000|Overall Study|Protocol Violation|13|||
129446840|NCT01087957|465935972|FG001|Overall Study|Protocol Violation|25|||
129446841|NCT01087957|465935971|FG000|Overall Study|Withdrawal by Subject|18|||
129446842|NCT01087957|465935972|FG001|Overall Study|Withdrawal by Subject|15|||
129446843|NCT01087957|465935971|FG000|Overall Study|Physician Decision|5|||
129446844|NCT01087957|465935972|FG001|Overall Study|Physician Decision|9|||
129446845|NCT01186939|465935973|FG000|Overall Study|Death|7|||
129898197|NCT01143077|467586596|FG002|Overall Study|Non-compliance with study drug|1|||
129898198|NCT01143077|467586594|FG000|Overall Study|Administrative|1|||
129898199|NCT01143077|467586595|FG001|Overall Study|Administrative|0|||
129898200|NCT01143077|467586596|FG002|Overall Study|Administrative|0|||
129898201|NCT01143077|467586594|FG000|Overall Study|Principal Investigator Decision|2|||
129898202|NCT01143077|467586595|FG001|Overall Study|Principal Investigator Decision|0|||
129898203|NCT01143077|467586596|FG002|Overall Study|Principal Investigator Decision|1|||
129898204|NCT00871429|467586602|FG000|Overall Study|Lost to Follow-up|6|||
129898205|NCT00871429|467586602|FG000|Overall Study|Withdrawal by Subject|17|||
129898206|NCT00871429|467586602|FG000|Overall Study|Questionnaire not completed|1|||
129898207|NCT01772719|467586605|FG000|Overall Study|Withdrawal by Subject|3|||
129898208|NCT01772719|467586605|FG000|Overall Study|Adverse Event|2|||
129898209|NCT01772719|467586605|FG000|Overall Study|Protocol Violation|1|||
129898210|NCT01772719|467586605|FG000|Overall Study|Lost to Follow-up|1|||
129898211|NCT00477412|467586606|FG000|Overall Study|Death|0|||
129898212|NCT00477412|467586607|FG001|Overall Study|Death|0|||
129898213|NCT00477412|467586608|FG002|Overall Study|Death|0|||
129898214|NCT00477412|467586609|FG003|Overall Study|Death|4|||
129898215|NCT00477412|467586606|FG000|Overall Study|Lost to Follow-up|0|||
129898216|NCT00477412|467586607|FG001|Overall Study|Lost to Follow-up|0|||
129898217|NCT00477412|467586608|FG002|Overall Study|Lost to Follow-up|0|||
129898218|NCT00477412|467586609|FG003|Overall Study|Lost to Follow-up|1|||
129898219|NCT00477412|467586606|FG000|Overall Study|Withdrawal by Subject|0|||
129898220|NCT00477412|467586607|FG001|Overall Study|Withdrawal by Subject|0|||
129898221|NCT00477412|467586608|FG002|Overall Study|Withdrawal by Subject|0|||
129898222|NCT00477412|467586609|FG003|Overall Study|Withdrawal by Subject|2|||
129898223|NCT00477412|467586606|FG000|Overall Study|Second Malignancy|0|||
129898224|NCT00477412|467586607|FG001|Overall Study|Second Malignancy|0|||
129898225|NCT00477412|467586608|FG002|Overall Study|Second Malignancy|0|||
129898226|NCT00477412|467586609|FG003|Overall Study|Second Malignancy|1|||
129898227|NCT00477412|467586606|FG000|Overall Study|Adverse Event|1|||
129898228|NCT00477412|467586607|FG001|Overall Study|Adverse Event|0|||
129898229|NCT00477412|467586608|FG002|Overall Study|Adverse Event|1|||
129898230|NCT00477412|467586609|FG003|Overall Study|Adverse Event|0|||
129898231|NCT03820986|467586611|FG000|Overall Study|Death|177|||
129898232|NCT03820986|467586612|FG001|Overall Study|Death|156|||
129898233|NCT03820986|467586611|FG000|Overall Study|Lost to Follow-up|0|||
129898234|NCT03820986|467586612|FG001|Overall Study|Lost to Follow-up|1|||
129898235|NCT03820986|467586611|FG000|Overall Study|Withdrawal by Subject|8|||
129898236|NCT03820986|467586612|FG001|Overall Study|Withdrawal by Subject|3|||
129898237|NCT03820986|467586611|FG000|Overall Study|Ongoing|149|||
129898238|NCT03820986|467586612|FG001|Overall Study|Ongoing|180|||
129898239|NCT05790408|467588280|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
129898240|NCT02145182|467588281|FG000|Overall Study|Adverse Event|4|||
129898241|NCT02145182|467588282|FG001|Overall Study|Adverse Event|1|||
129898242|NCT02145182|467588281|FG000|Overall Study|Death|7|||
129898243|NCT02145182|467588282|FG001|Overall Study|Death|7|||
129898244|NCT02145182|467588281|FG000|Overall Study|Lost to Follow-up|2|||
129898245|NCT02145182|467588282|FG001|Overall Study|Lost to Follow-up|2|||
129898246|NCT02145182|467588281|FG000|Overall Study|Pre-transplant Withdrawal|0|||
129898247|NCT02145182|467588282|FG001|Overall Study|Pre-transplant Withdrawal|2|||
129898248|NCT02145182|467588281|FG000|Overall Study|Withdrawal by Subject|5|||
129446846|NCT01186939|465935973|FG000|Overall Study|Withdrawal by Subject|2|||
129446847|NCT01186939|465935973|FG000|Overall Study|No longer receiving clinical benefit|17|||
129446848|NCT01186939|465935973|FG000|Overall Study|Program closed|5|||
129446849|NCT01186939|465935973|FG000|Overall Study|Sponsor decision|4|||
129446850|NCT01186939|465935973|FG000|Overall Study|Started additional treatment|1|||
129898249|NCT02145182|467588282|FG001|Overall Study|Withdrawal by Subject|4|||
129898250|NCT02274493|467588283|FG000|Overall Study|Withdrawal by Subject|1|||
129898251|NCT00558363|467588284|FG000|Overall Study|Physician Decision|18|||
129898252|NCT00558363|467588285|FG001|Overall Study|Physician Decision|4|||
129898253|NCT00558363|467588284|FG000|Overall Study|Withdrawal by Subject|11|||
129898254|NCT00558363|467588285|FG001|Overall Study|Withdrawal by Subject|4|||
129898255|NCT00558363|467588284|FG000|Overall Study|Adverse Event|5|||
129446851|NCT01186939|465935973|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
129898256|NCT00558363|467588285|FG001|Overall Study|Adverse Event|5|||
129898257|NCT00558363|467588284|FG000|Overall Study|Lack of Efficacy|2|||
129446852|NCT01186939|465935973|FG000|Overall Study|Myocardial infarction|1|||
129446853|NCT01186939|465935973|FG000|Overall Study|Bone marrow transplant|1|||
129898258|NCT00558363|467588285|FG001|Overall Study|Lack of Efficacy|2|||
129898259|NCT00558363|467588284|FG000|Overall Study|Protocol Violation|2|||
129898260|NCT00558363|467588285|FG001|Overall Study|Protocol Violation|1|||
129898261|NCT00558363|467588284|FG000|Overall Study|Lost to Follow-up|0|||
129898262|NCT00558363|467588285|FG001|Overall Study|Lost to Follow-up|1|||
129898263|NCT00558363|467588284|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
129898264|NCT00558363|467588285|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
129898265|NCT00558363|467588284|FG000|Overall Study|Randomized in Error|1|||
129898266|NCT00558363|467588285|FG001|Overall Study|Randomized in Error|2|||
129898267|NCT00558363|467588284|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
129898268|NCT00558363|467588285|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
129898269|NCT03736785|467588296|FG000|Overall Study|Adverse Event|1|||
129898270|NCT03736785|467588297|FG001|Overall Study|Adverse Event|1|||
129836346|NCT00634088|467368141|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
129836347|NCT00634088|467368142|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
129836348|NCT00634088|467368143|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
129836349|NCT00634088|467368144|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
129836350|NCT00634088|467368141|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
129836351|NCT00634088|467368142|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
129836352|NCT00634088|467368143|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
129836353|NCT00634088|467368144|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
129836354|NCT00634088|467368141|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
129836355|NCT00634088|467368142|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
129836356|NCT00634088|467368143|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
129836357|NCT00634088|467368144|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
129836358|NCT00634088|467368141|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
129836359|NCT00634088|467368142|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
129836360|NCT00634088|467368143|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
129836361|NCT00634088|467368144|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
129836362|NCT01203072|467368147|FG000|Overall Study|Adverse Event|5|||
129836363|NCT01203072|467368148|FG001|Overall Study|Adverse Event|3|||
129836364|NCT01203072|467368149|FG002|Overall Study|Adverse Event|2|||
129836365|NCT01203072|467368150|FG003|Overall Study|Adverse Event|4|||
129836366|NCT01203072|467368151|FG004|Overall Study|Adverse Event|2|||
129836367|NCT01203072|467368147|FG000|Overall Study|Lack of Efficacy|1|||
129836368|NCT01203072|467368148|FG001|Overall Study|Lack of Efficacy|0|||
129898271|NCT03736785|467588298|FG002|Overall Study|Adverse Event|1|||
129898272|NCT03736785|467588296|FG000|Overall Study|Death|1|||
129898273|NCT03736785|467588297|FG001|Overall Study|Death|0|||
129898274|NCT03736785|467588298|FG002|Overall Study|Death|1|||
129836369|NCT01203072|467368149|FG002|Overall Study|Lack of Efficacy|0|||
129836370|NCT01203072|467368150|FG003|Overall Study|Lack of Efficacy|0|||
129836371|NCT01203072|467368151|FG004|Overall Study|Lack of Efficacy|0|||
129836372|NCT01203072|467368147|FG000|Overall Study|Lost to Follow-up|0|||
129836373|NCT01203072|467368148|FG001|Overall Study|Lost to Follow-up|1|||
129836374|NCT01203072|467368149|FG002|Overall Study|Lost to Follow-up|0|||
129836375|NCT01203072|467368150|FG003|Overall Study|Lost to Follow-up|0|||
129446854|NCT01186939|465935973|FG000|Overall Study|Transformation to AML|1|||
129836376|NCT01203072|467368151|FG004|Overall Study|Lost to Follow-up|0|||
129836377|NCT01203072|467368147|FG000|Overall Study|Protocol Violation|2|||
129836378|NCT01203072|467368148|FG001|Overall Study|Protocol Violation|0|||
129836379|NCT01203072|467368149|FG002|Overall Study|Protocol Violation|0|||
129836380|NCT01203072|467368150|FG003|Overall Study|Protocol Violation|0|||
129836381|NCT01203072|467368151|FG004|Overall Study|Protocol Violation|1|||
129836382|NCT01203072|467368147|FG000|Overall Study|Withdrawal by Subject|2|||
129836383|NCT01203072|467368148|FG001|Overall Study|Withdrawal by Subject|2|||
129836384|NCT01203072|467368149|FG002|Overall Study|Withdrawal by Subject|1|||
129836385|NCT01203072|467368150|FG003|Overall Study|Withdrawal by Subject|2|||
129836386|NCT01203072|467368151|FG004|Overall Study|Withdrawal by Subject|3|||
129836387|NCT01293240|467368162|FG000|Overall Study|Noncompliance|2|||
129836388|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
129836389|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
129836390|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
129836391|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
129836392|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
129836393|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
129836394|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
129836395|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
129836396|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
129836397|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
129836398|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
129836399|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
129836400|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
129836401|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
129836402|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
129836403|NCT03735667|467368164|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
129836404|NCT03735667|467368165|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
129836405|NCT03735667|467368166|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
129836406|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
129836407|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
129836408|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
129836409|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
129836410|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
129836411|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
129836412|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
129836413|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
129836414|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
129836415|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
129836416|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
129836417|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
129836418|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
129836419|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
129836420|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
129836421|NCT03735667|467368164|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
129836422|NCT03735667|467368165|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
129836423|NCT03735667|467368166|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
129836424|NCT01987427|467368169|FG000|Overall Study|Adverse Event|4|||
129836425|NCT01987427|467368170|FG001|Overall Study|Adverse Event|2|||
129836426|NCT01987427|467368171|FG002|Overall Study|Adverse Event|8|||
129836427|NCT01987427|467368169|FG000|Overall Study|Lost to Follow-up|6|||
129836428|NCT01987427|467368170|FG001|Overall Study|Lost to Follow-up|6|||
129836429|NCT01987427|467368171|FG002|Overall Study|Lost to Follow-up|9|||
129836430|NCT01987427|467368169|FG000|Overall Study|Withdrawal by Subject|2|||
129836431|NCT01987427|467368170|FG001|Overall Study|Withdrawal by Subject|1|||
129898275|NCT03736785|467588296|FG000|Overall Study|Lost to Follow-up|0|||
129898276|NCT03736785|467588297|FG001|Overall Study|Lost to Follow-up|2|||
129898277|NCT03736785|467588298|FG002|Overall Study|Lost to Follow-up|3|||
129898278|NCT03736785|467588296|FG000|Overall Study|Non compliance with study drug|1|||
129898279|NCT03736785|467588297|FG001|Overall Study|Non compliance with study drug|1|||
129898280|NCT03736785|467588298|FG002|Overall Study|Non compliance with study drug|0|||
129898281|NCT03736785|467588296|FG000|Overall Study|Physician Decision|0|||
129898282|NCT03736785|467588297|FG001|Overall Study|Physician Decision|1|||
129898283|NCT03736785|467588298|FG002|Overall Study|Physician Decision|1|||
129898284|NCT03736785|467588296|FG000|Overall Study|Protocol Violation|1|||
129898285|NCT03736785|467588297|FG001|Overall Study|Protocol Violation|4|||
129898286|NCT03736785|467588298|FG002|Overall Study|Protocol Violation|3|||
129898287|NCT03736785|467588296|FG000|Overall Study|Sponsor Decision|1|||
129898288|NCT03736785|467588297|FG001|Overall Study|Sponsor Decision|0|||
129898289|NCT03736785|467588298|FG002|Overall Study|Sponsor Decision|0|||
129898290|NCT03736785|467588296|FG000|Overall Study|Unknown/Missing data|3|||
129898291|NCT03736785|467588297|FG001|Overall Study|Unknown/Missing data|2|||
129898292|NCT03736785|467588298|FG002|Overall Study|Unknown/Missing data|1|||
129898293|NCT03736785|467588296|FG000|Overall Study|Withdrawal by Subject|9|||
129898294|NCT03736785|467588297|FG001|Overall Study|Withdrawal by Subject|6|||
129898295|NCT03736785|467588298|FG002|Overall Study|Withdrawal by Subject|4|||
129898296|NCT01744691|467588300|FG000|Overall Study|Progressive Disease|18|||
129898297|NCT01744691|467588300|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
129898298|NCT01744691|467588300|FG000|Overall Study|Withdrawal of consent for treatment|3|||
129898299|NCT01744691|467588300|FG000|Overall Study|Physician Decision|4|||
129898300|NCT02701361|467588302|FG000|Overall Study|Lost to Follow-up|5|||
129898301|NCT02701361|467588303|FG001|Overall Study|Lost to Follow-up|2|||
129898302|NCT02701361|467588304|FG002|Overall Study|Lost to Follow-up|1|||
129898303|NCT02701361|467588302|FG000|Overall Study|Withdrawal by Subject|4|||
129898304|NCT02701361|467588303|FG001|Overall Study|Withdrawal by Subject|0|||
129898305|NCT02701361|467588304|FG002|Overall Study|Withdrawal by Subject|0|||
129898306|NCT02701361|467588302|FG000|Overall Study|timed out in rehab center|0|||
129898307|NCT02701361|467588303|FG001|Overall Study|timed out in rehab center|1|||
129898308|NCT02701361|467588304|FG002|Overall Study|timed out in rehab center|0|||
129898309|NCT02701361|467588302|FG000|Overall Study|incarceration|0|||
129898310|NCT02701361|467588303|FG001|Overall Study|incarceration|0|||
129898311|NCT02701361|467588304|FG002|Overall Study|incarceration|1|||
129898312|NCT04588480|467588305|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
129898313|NCT04588480|467588306|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
129898314|NCT04588480|467588307|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
129898315|NCT04588480|467588305|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
129898316|NCT04588480|467588306|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
129898317|NCT04588480|467588307|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
129898318|NCT01190150|467588312|FG000|First Treatment|Withdrawal by Subject|1|||
129898319|NCT01190150|467588313|FG001|First Treatment|Withdrawal by Subject|0|||
129898320|NCT01190150|467588312|FG000|Washout|Withdrawal by Subject|0|||
129898321|NCT01190150|467588313|FG001|Washout|Withdrawal by Subject|1|||
129898322|NCT01190150|467588312|FG000|Washout|Difficulty in adherence|0|||
129898323|NCT01190150|467588313|FG001|Washout|Difficulty in adherence|1|||
129898324|NCT00843193|467588319|FG000|Overall Study|Adverse Event|2|||
129898325|NCT00843193|467588320|FG001|Overall Study|Adverse Event|4|||
129898326|NCT00843193|467588319|FG000|Overall Study|Lack of Efficacy|1|||
129898327|NCT00843193|467588320|FG001|Overall Study|Lack of Efficacy|1|||
129446855|NCT00616434|465935978|FG000|Overall Study|Adverse Event|5|||
129446856|NCT00616434|465935979|FG001|Overall Study|Adverse Event|2|||
129446857|NCT00616434|465935978|FG000|Overall Study|Physician Decision|0|||
129446858|NCT00616434|465935979|FG001|Overall Study|Physician Decision|4|||
129446859|NCT00616434|465935978|FG000|Overall Study|Withdrawal by Subject|1|||
129446860|NCT00616434|465935979|FG001|Overall Study|Withdrawal by Subject|1|||
129446861|NCT00616434|465935978|FG000|Overall Study|Protocol deviation|0|||
129446862|NCT00616434|465935979|FG001|Overall Study|Protocol deviation|1|||
129446863|NCT01754857|465935980|FG000|Overall Study|Adverse Event|7|||
129446864|NCT01754857|465935980|FG000|Overall Study|Disease progression|3|||
129446865|NCT01754857|465935980|FG000|Overall Study|Physician Decision|2|||
129446866|NCT01754857|465935980|FG000|Overall Study|Withdrawal by Subject|3|||
129446867|NCT01754857|465935980|FG000|Overall Study|other complicating disease|1|||
129446868|NCT01754857|465935980|FG000|Overall Study|ineligible to continue onto maintenance|1|||
129446869|NCT01754857|465935980|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
129446870|NCT01754857|465935980|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
129446871|NCT01509079|465935981|FG000|Overall Study|Lack of Efficacy|0|||
129446872|NCT01509079|465935982|FG001|Overall Study|Lack of Efficacy|2|||
129446873|NCT01509079|465935981|FG000|Overall Study|started an excluded medication|0|||
129446874|NCT01509079|465935982|FG001|Overall Study|started an excluded medication|1|||
129446875|NCT01399190|465935985|FG000|Overall Study|Not Eligible for Final Analysis|5|||
129446876|NCT01399190|465935985|FG000|Overall Study|Adverse Event|8|||
129446877|NCT01399190|465935985|FG000|Overall Study|Participant's Request|5|||
129446878|NCT01399190|465935985|FG000|Overall Study|Physician Decision|2|||
129446879|NCT00436618|465935989|FG000|Overall Study|Withdrawal by Subject|5|||
129446880|NCT00436618|465935990|FG001|Overall Study|Withdrawal by Subject|8|||
129446881|NCT00436618|465935991|FG002|Overall Study|Withdrawal by Subject|11|||
129446882|NCT00436618|465935989|FG000|Overall Study|Adverse Event|8|||
129446883|NCT00436618|465935990|FG001|Overall Study|Adverse Event|8|||
129446884|NCT00436618|465935991|FG002|Overall Study|Adverse Event|9|||
129446885|NCT00436618|465935989|FG000|Overall Study|Alternate Treatment|3|||
129446886|NCT00436618|465935990|FG001|Overall Study|Alternate Treatment|4|||
129446887|NCT00436618|465935991|FG002|Overall Study|Alternate Treatment|12|||
129446888|NCT00436618|465935989|FG000|Overall Study|Other Medical Problems|3|||
129446889|NCT00436618|465935990|FG001|Overall Study|Other Medical Problems|1|||
129446890|NCT00436618|465935991|FG002|Overall Study|Other Medical Problems|7|||
129446891|NCT00436618|465935989|FG000|Overall Study|Death|4|||
129446892|NCT00436618|465935990|FG001|Overall Study|Death|2|||
129446893|NCT00436618|465935991|FG002|Overall Study|Death|3|||
129446894|NCT00436618|465935989|FG000|Overall Study|New Primary or Other Reasons|6|||
129446895|NCT00436618|465935990|FG001|Overall Study|New Primary or Other Reasons|2|||
129446896|NCT00436618|465935991|FG002|Overall Study|New Primary or Other Reasons|12|||
129446897|NCT00436618|465935989|FG000|Overall Study|Still on treatment|1|||
129446898|NCT00436618|465935990|FG001|Overall Study|Still on treatment|2|||
129446899|NCT00436618|465935991|FG002|Overall Study|Still on treatment|7|||
129446900|NCT00698204|465935992|FG000|Overall Study|Withdrawal by Subject|1|||
129446901|NCT00698204|465935993|FG001|Overall Study|Withdrawal by Subject|0|||
129446902|NCT03083847|465935994|FG000|Main|Physician Decision|0|||
129446903|NCT03083847|465935995|FG001|Main|Physician Decision|0|||
129446904|NCT03083847|465935996|FG002|Main|Physician Decision|0|||
129446905|NCT03083847|465935997|FG003|Main|Physician Decision|0|||
129446906|NCT03083847|465935998|FG004|Main|Physician Decision|0|||
129446907|NCT03083847|465935999|FG005|Main|Physician Decision|1|||
129446908|NCT03083847|465936000|FG006|Main|Physician Decision|0|||
129446909|NCT03083847|465936001|FG007|Main|Physician Decision|0|||
129446910|NCT03083847|465936002|FG008|Main|Physician Decision|0|||
129446911|NCT03083847|465936003|FG009|Main|Physician Decision|0|||
129446912|NCT03083847|465935994|FG000|Main|Pregnancy|0|||
129446913|NCT03083847|465935995|FG001|Main|Pregnancy|0|||
129446914|NCT03083847|465935996|FG002|Main|Pregnancy|0|||
129446915|NCT03083847|465935997|FG003|Main|Pregnancy|0|||
129446916|NCT03083847|465935998|FG004|Main|Pregnancy|0|||
129836432|NCT01987427|467368171|FG002|Overall Study|Withdrawal by Subject|3|||
129836433|NCT01987427|467368169|FG000|Overall Study|Lack of Efficacy|1|||
129836434|NCT01987427|467368170|FG001|Overall Study|Lack of Efficacy|0|||
129446917|NCT03083847|465935999|FG005|Main|Pregnancy|0|||
129446918|NCT03083847|465936000|FG006|Main|Pregnancy|0|||
129446919|NCT03083847|465936001|FG007|Main|Pregnancy|1|||
129446920|NCT03083847|465936002|FG008|Main|Pregnancy|0|||
129446921|NCT03083847|465936003|FG009|Main|Pregnancy|0|||
129446922|NCT03083847|465935994|FG000|Main|Adverse Event|0|||
129446923|NCT03083847|465935995|FG001|Main|Adverse Event|0|||
129446924|NCT03083847|465935996|FG002|Main|Adverse Event|0|||
129446925|NCT03083847|465935997|FG003|Main|Adverse Event|0|||
129446926|NCT03083847|465935998|FG004|Main|Adverse Event|0|||
129446927|NCT03083847|465935999|FG005|Main|Adverse Event|0|||
129446928|NCT03083847|465936000|FG006|Main|Adverse Event|0|||
129836435|NCT01987427|467368171|FG002|Overall Study|Lack of Efficacy|0|||
129446929|NCT03083847|465936001|FG007|Main|Adverse Event|2|||
129446930|NCT03083847|465936002|FG008|Main|Adverse Event|0|||
129446931|NCT03083847|465936003|FG009|Main|Adverse Event|0|||
129898328|NCT00843193|467588319|FG000|Overall Study|Protocol Violation|1|||
129898329|NCT00843193|467588320|FG001|Overall Study|Protocol Violation|2|||
129898330|NCT00843193|467588319|FG000|Overall Study|Lost to Follow-up|1|||
129898331|NCT00843193|467588320|FG001|Overall Study|Lost to Follow-up|0|||
129898332|NCT00843193|467588319|FG000|Overall Study|Physician Decision|0|||
129898333|NCT00843193|467588320|FG001|Overall Study|Physician Decision|1|||
129898334|NCT00843193|467588319|FG000|Overall Study|Withdrawal by Subject|3|||
129898335|NCT00843193|467588320|FG001|Overall Study|Withdrawal by Subject|3|||
129898336|NCT04511650|467588321|FG000|Overall Study|Lost to Follow-up|1|||
129898337|NCT04511650|467588322|FG001|Overall Study|Lost to Follow-up|0|||
129898338|NCT04511650|467588323|FG002|Overall Study|Lost to Follow-up|0|||
129898339|NCT04511650|467588321|FG000|Overall Study|Withdrawal by Subject|1|||
129898340|NCT04511650|467588322|FG001|Overall Study|Withdrawal by Subject|0|||
129898341|NCT04511650|467588323|FG002|Overall Study|Withdrawal by Subject|0|||
129898342|NCT04511650|467588321|FG000|Overall Study|reason not provided|0|||
129898343|NCT04511650|467588322|FG001|Overall Study|reason not provided|0|||
129898344|NCT04511650|467588323|FG002|Overall Study|reason not provided|1|||
129898345|NCT04511650|467588321|FG000|Overall Study|Death|1|||
129898346|NCT04511650|467588322|FG001|Overall Study|Death|1|||
129898347|NCT04511650|467588323|FG002|Overall Study|Death|1|||
129898348|NCT00544440|467588325|FG000|Overall Study|Other|1|||
129898349|NCT00544440|467588325|FG000|Overall Study|Adverse Event|1|||
129898350|NCT00544440|467588325|FG000|Overall Study|Withdrawal by Subject|2|||
129898351|NCT00544440|467588325|FG000|Overall Study|Subject Non-compliance|1|||
129898352|NCT00544440|467588325|FG000|Overall Study|Progressive Disease|47|||
129898353|NCT00544440|467588325|FG000|Overall Study|Other|5|||
129898354|NCT03586167|467588327|FG000|Overall Study|Other|1|||
129898355|NCT03586167|467588328|FG001|Overall Study|Other|0|||
129898356|NCT00591838|467588329|FG000|Overall Study|Withdrawal by Subject|0|||
129898357|NCT00591838|467588330|FG001|Overall Study|Withdrawal by Subject|0|||
129898358|NCT00591838|467588331|FG002|Overall Study|Withdrawal by Subject|0|||
129898359|NCT00591838|467588332|FG003|Overall Study|Withdrawal by Subject|1|||
129898360|NCT00591838|467588333|FG004|Overall Study|Withdrawal by Subject|0|||
129898361|NCT04163458|467588336|FG000|Overall Study|Protocol Deviation|7|||
129898362|NCT04163458|467588337|FG001|Overall Study|Protocol Deviation|13|||
129898363|NCT04163458|467588336|FG000|Overall Study|Adverse Event|5|||
129898364|NCT04163458|467588337|FG001|Overall Study|Adverse Event|8|||
129898365|NCT04163458|467588336|FG000|Overall Study|Due to COVID-19 pandemic|4|||
129898366|NCT04163458|467588337|FG001|Overall Study|Due to COVID-19 pandemic|2|||
129898367|NCT04163458|467588336|FG000|Overall Study|Participant withdrew consent|2|||
129898368|NCT04163458|467588337|FG001|Overall Study|Participant withdrew consent|3|||
129898369|NCT04163458|467588336|FG000|Overall Study|Randomization failure|2|||
129898370|NCT04163458|467588337|FG001|Overall Study|Randomization failure|2|||
129898371|NCT04163458|467588336|FG000|Overall Study|Other|4|||
129898372|NCT04163458|467588337|FG001|Overall Study|Other|2|||
129898373|NCT03523962|467588339|FG000|Closed Fractures|Death|86|||
129898374|NCT03523962|467588340|FG001|Closed Fractures|Death|71|||
129898375|NCT03523962|467588341|FG002|Closed Fractures|Death|0|||
129898376|NCT03523962|467588342|FG003|Closed Fractures|Death|0|||
129898377|NCT03523962|467588339|FG000|Closed Fractures|Lost to Follow-up|62|||
129898378|NCT03523962|467588340|FG001|Closed Fractures|Lost to Follow-up|36|||
129898379|NCT03523962|467588341|FG002|Closed Fractures|Lost to Follow-up|0|||
129898380|NCT03523962|467588342|FG003|Closed Fractures|Lost to Follow-up|0|||
129898381|NCT03523962|467588339|FG000|Closed Fractures|Withdrawal by Subject|19|||
129898382|NCT03523962|467588340|FG001|Closed Fractures|Withdrawal by Subject|29|||
129898383|NCT03523962|467588341|FG002|Closed Fractures|Withdrawal by Subject|0|||
129898384|NCT03523962|467588342|FG003|Closed Fractures|Withdrawal by Subject|0|||
129898385|NCT03523962|467588339|FG000|Closed Fractures|Incarceration|1|||
129898386|NCT03523962|467588340|FG001|Closed Fractures|Incarceration|4|||
129898387|NCT03523962|467588341|FG002|Closed Fractures|Incarceration|0|||
129898388|NCT03523962|467588342|FG003|Closed Fractures|Incarceration|0|||
129898389|NCT03523962|467588339|FG000|Open Fractures|Death|0|||
129898390|NCT03523962|467588340|FG001|Open Fractures|Death|0|||
129898391|NCT03523962|467588341|FG002|Open Fractures|Death|11|||
129898392|NCT03523962|467588342|FG003|Open Fractures|Death|6|||
129898393|NCT03523962|467588339|FG000|Open Fractures|Lost to Follow-up|0|||
129898394|NCT03523962|467588340|FG001|Open Fractures|Lost to Follow-up|0|||
129898395|NCT03523962|467588341|FG002|Open Fractures|Lost to Follow-up|15|||
129898396|NCT03523962|467588342|FG003|Open Fractures|Lost to Follow-up|8|||
129898397|NCT03523962|467588339|FG000|Open Fractures|Withdrawal by Subject|0|||
129898398|NCT03523962|467588340|FG001|Open Fractures|Withdrawal by Subject|0|||
129898399|NCT03523962|467588341|FG002|Open Fractures|Withdrawal by Subject|6|||
129898400|NCT03523962|467588342|FG003|Open Fractures|Withdrawal by Subject|2|||
129898401|NCT03523962|467588339|FG000|Open Fractures|Incarceration|0|||
129898402|NCT03523962|467588340|FG001|Open Fractures|Incarceration|0|||
129898403|NCT03523962|467588341|FG002|Open Fractures|Incarceration|1|||
129898404|NCT03523962|467588342|FG003|Open Fractures|Incarceration|0|||
129898405|NCT01081145|467588346|FG000|Open-Label Phase|Lack of Efficacy|56|||
129898406|NCT01081145|467588347|FG001|Open-Label Phase|Lack of Efficacy|0|||
129898407|NCT01081145|467588346|FG000|Open-Label Phase|Response criteria not met|46|||
129836436|NCT01987427|467368169|FG000|Overall Study|Other|1|||
129836437|NCT01987427|467368170|FG001|Overall Study|Other|1|||
129836438|NCT01987427|467368171|FG002|Overall Study|Other|0|||
129836439|NCT02547129|467368175|FG000|Overall Study|Difficulty with ongoing infection|1|||
129836440|NCT02547129|467368176|FG001|Overall Study|Difficulty with ongoing infection|0|||
129836441|NCT03925324|467368177|FG000|Overall Study|Death|1|||
129836442|NCT03925324|467368178|FG001|Overall Study|Death|1|||
129836443|NCT00805766|467368179|FG000|Screening Period|Adverse Event|1|||
129836444|NCT00805766|467368179|FG000|Screening Period|Lack of Efficacy|2|||
129836445|NCT00805766|467368179|FG000|Screening Period|Pregnancy|1|||
129836446|NCT00805766|467368179|FG000|Screening Period|Responder|2|||
129836447|NCT00805766|467368179|FG000|Increased Dose Period|Adverse Event|4|||
129836448|NCT00805766|467368179|FG000|Increased Dose Period|Lack of Efficacy|7|||
129836449|NCT00805766|467368179|FG000|Increased Dose Period|Pregnancy|1|||
129836450|NCT00805766|467368179|FG000|Increased Dose Period|Withdrawal by Subject|1|||
129836451|NCT02063737|467368182|FG000|Overall Study|Lost to Follow-up|11|||
129836452|NCT02063737|467368183|FG001|Overall Study|Lost to Follow-up|4|||
129836453|NCT02159521|467368184|FG000|Overall Study|Enrolled but not treated|3|||
129836454|NCT02159521|467368184|FG000|Overall Study|Withdrawal by Subject|7|||
129836455|NCT02159521|467368184|FG000|Overall Study|Lost to Follow-up|6|||
129836456|NCT02159521|467368184|FG000|Overall Study|Death|1|||
129836457|NCT02159521|467368184|FG000|Overall Study|Other than specified|1|||
129836458|NCT00694369|467368187|FG000|Overall Study|Adverse Event|0|||
129836459|NCT00694369|467368188|FG001|Overall Study|Adverse Event|1|||
129836460|NCT00694369|467368189|FG002|Overall Study|Adverse Event|0|||
129836461|NCT00694369|467368190|FG003|Overall Study|Adverse Event|1|||
129836462|NCT00694369|467368191|FG004|Overall Study|Adverse Event|3|||
129836463|NCT00694369|467368187|FG000|Overall Study|Lost to Follow-up|0|||
129836464|NCT00694369|467368188|FG001|Overall Study|Lost to Follow-up|0|||
129836465|NCT00694369|467368189|FG002|Overall Study|Lost to Follow-up|1|||
129836466|NCT00694369|467368190|FG003|Overall Study|Lost to Follow-up|1|||
129836467|NCT00694369|467368191|FG004|Overall Study|Lost to Follow-up|0|||
129836468|NCT00694369|467368187|FG000|Overall Study|Physician Decision|0|||
129836469|NCT00694369|467368188|FG001|Overall Study|Physician Decision|0|||
129836470|NCT00694369|467368189|FG002|Overall Study|Physician Decision|0|||
129836471|NCT00694369|467368190|FG003|Overall Study|Physician Decision|0|||
129836472|NCT00694369|467368191|FG004|Overall Study|Physician Decision|1|||
129836473|NCT00694369|467368187|FG000|Overall Study|Protocol Violation|0|||
129836474|NCT00694369|467368188|FG001|Overall Study|Protocol Violation|1|||
129836475|NCT00694369|467368189|FG002|Overall Study|Protocol Violation|0|||
129836476|NCT00694369|467368190|FG003|Overall Study|Protocol Violation|0|||
129836477|NCT00694369|467368191|FG004|Overall Study|Protocol Violation|0|||
129836478|NCT00694369|467368187|FG000|Overall Study|Withdrawal by Subject|1|||
129836479|NCT00694369|467368188|FG001|Overall Study|Withdrawal by Subject|1|||
129836480|NCT00694369|467368189|FG002|Overall Study|Withdrawal by Subject|1|||
129836481|NCT00694369|467368190|FG003|Overall Study|Withdrawal by Subject|1|||
129836482|NCT00694369|467368191|FG004|Overall Study|Withdrawal by Subject|2|||
129836483|NCT00907374|467368194|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
129836484|NCT00907374|467368195|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
129836485|NCT00594464|467368198|FG000|Overall Study|Withdrawal by Subject|1|||
129836486|NCT00594464|467368198|FG000|Overall Study|Delay in operation|2|||
129836487|NCT00775437|467368199|FG000|Overall Study|Loss of efficacy|2|||
129836488|NCT00775437|467368199|FG000|Overall Study|Withdrawal by Subject|3|||
129836489|NCT00775437|467368199|FG000|Overall Study|Lost to Follow-up|1|||
129836490|NCT03131440|467368200|FG000|Overall Study|Withdrawal by Subject|1|||
129836491|NCT03131440|467368201|FG001|Overall Study|Withdrawal by Subject|3|||
129836492|NCT03131440|467368202|FG002|Overall Study|Withdrawal by Subject|0|||
129836493|NCT03131440|467368203|FG003|Overall Study|Withdrawal by Subject|0|||
129836494|NCT03131440|467368204|FG004|Overall Study|Withdrawal by Subject|1|||
129836495|NCT03131440|467368205|FG005|Overall Study|Withdrawal by Subject|0|||
129836496|NCT03131440|467368206|FG006|Overall Study|Withdrawal by Subject|0|||
129836497|NCT03131440|467368207|FG007|Overall Study|Withdrawal by Subject|1|||
129836498|NCT03131440|467368208|FG008|Overall Study|Withdrawal by Subject|1|||
129836499|NCT03131440|467368209|FG009|Overall Study|Withdrawal by Subject|1|||
129836500|NCT03131440|467368210|FG010|Overall Study|Withdrawal by Subject|0|||
129836501|NCT03131440|467368211|FG011|Overall Study|Withdrawal by Subject|1|||
129836502|NCT03131440|467368212|FG012|Overall Study|Withdrawal by Subject|1|||
129836503|NCT03131440|467368213|FG013|Overall Study|Withdrawal by Subject|0|||
129836504|NCT03131440|467368214|FG014|Overall Study|Withdrawal by Subject|1|||
129836505|NCT03131440|467368215|FG015|Overall Study|Withdrawal by Subject|0|||
129836506|NCT03131440|467368216|FG016|Overall Study|Withdrawal by Subject|0|||
129836507|NCT03131440|467368217|FG017|Overall Study|Withdrawal by Subject|0|||
129836508|NCT03131440|467368218|FG018|Overall Study|Withdrawal by Subject|1|||
129836509|NCT03131440|467368219|FG019|Overall Study|Withdrawal by Subject|0|||
129836510|NCT03131440|467368220|FG020|Overall Study|Withdrawal by Subject|1|||
129836511|NCT03131440|467368221|FG021|Overall Study|Withdrawal by Subject|1|||
129836512|NCT03131440|467368222|FG022|Overall Study|Withdrawal by Subject|1|||
129836513|NCT03131440|467368223|FG023|Overall Study|Withdrawal by Subject|0|||
129446932|NCT03083847|465935994|FG000|Main|Withdrawal by Subject|0|||
129446933|NCT03083847|465935995|FG001|Main|Withdrawal by Subject|0|||
129446934|NCT03083847|465935996|FG002|Main|Withdrawal by Subject|0|||
129446935|NCT03083847|465935997|FG003|Main|Withdrawal by Subject|0|||
129446936|NCT03083847|465935998|FG004|Main|Withdrawal by Subject|0|||
129446937|NCT03083847|465935999|FG005|Main|Withdrawal by Subject|0|||
129446938|NCT03083847|465936000|FG006|Main|Withdrawal by Subject|1|||
129446939|NCT03083847|465936001|FG007|Main|Withdrawal by Subject|1|||
129446940|NCT03083847|465936002|FG008|Main|Withdrawal by Subject|0|||
129446941|NCT03083847|465936003|FG009|Main|Withdrawal by Subject|0|||
129446942|NCT01949155|465936005|FG000|Overall Study|Lost to Follow-up|1|||
129446943|NCT01949155|465936006|FG001|Overall Study|Lost to Follow-up|0|||
129446944|NCT01949155|465936005|FG000|Overall Study|Protocol Violation|1|||
129446945|NCT01949155|465936006|FG001|Overall Study|Protocol Violation|0|||
129446946|NCT00314249|465936007|FG000|Overall Study|Adverse Event|73|||
129446947|NCT00314249|465936008|FG001|Overall Study|Adverse Event|94|||
129446948|NCT00314249|465936007|FG000|Overall Study|Lack of Efficacy|33|||
129446949|NCT00314249|465936008|FG001|Overall Study|Lack of Efficacy|24|||
129446950|NCT00314249|465936007|FG000|Overall Study|Withdrawal by Subject|21|||
129446951|NCT00314249|465936008|FG001|Overall Study|Withdrawal by Subject|28|||
129446952|NCT00314249|465936007|FG000|Overall Study|Lost to Follow-up|15|||
129446953|NCT00314249|465936008|FG001|Overall Study|Lost to Follow-up|9|||
129446954|NCT00314249|465936007|FG000|Overall Study|Physician Decision|1|||
129446955|NCT00314249|465936008|FG001|Overall Study|Physician Decision|1|||
129446956|NCT00314249|465936007|FG000|Overall Study|Withdrawn for other reasons|4|||
129446957|NCT00314249|465936008|FG001|Overall Study|Withdrawn for other reasons|1|||
129446958|NCT00314249|465936007|FG000|Overall Study|Non-Compliant|5|||
129446959|NCT00314249|465936008|FG001|Overall Study|Non-Compliant|6|||
129446960|NCT00210184|465936009|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
129446961|NCT01118325|465936012|FG000|Overall Study|Adverse Event|1|||
129446962|NCT01118325|465936013|FG001|Overall Study|Adverse Event|0|||
129446963|NCT01118325|465936014|FG002|Overall Study|Adverse Event|1|||
129446964|NCT00975715|465936015|FG000|Titration Period|Adverse Event|6|||
129446965|NCT00975715|465936016|FG001|Titration Period|Adverse Event|0|||
129446966|NCT00975715|465936015|FG000|Titration Period|Protocol Violation|1|||
129446967|NCT00975715|465936016|FG001|Titration Period|Protocol Violation|0|||
129446968|NCT00975715|465936015|FG000|Maintenance Period|Adverse Event|2|||
129446969|NCT00975715|465936016|FG001|Maintenance Period|Adverse Event|1|||
129446970|NCT01674712|465936023|FG000|Overall Study|Adverse Event|5|||
129446971|NCT01674712|465936024|FG001|Overall Study|Adverse Event|6|||
129446972|NCT01674712|465936025|FG002|Overall Study|Adverse Event|3|||
129446973|NCT01674712|465936026|FG003|Overall Study|Adverse Event|4|||
129446974|NCT01674712|465936027|FG004|Overall Study|Adverse Event|6|||
129446975|NCT01674712|465936023|FG000|Overall Study|Lost to Follow-up|1|||
129446976|NCT01674712|465936024|FG001|Overall Study|Lost to Follow-up|0|||
129446977|NCT01674712|465936025|FG002|Overall Study|Lost to Follow-up|0|||
129446978|NCT01674712|465936026|FG003|Overall Study|Lost to Follow-up|0|||
129446979|NCT01674712|465936027|FG004|Overall Study|Lost to Follow-up|0|||
129446980|NCT01674712|465936023|FG000|Overall Study|Protocol Violation|2|||
129446981|NCT01674712|465936024|FG001|Overall Study|Protocol Violation|0|||
129446982|NCT01674712|465936025|FG002|Overall Study|Protocol Violation|0|||
129446983|NCT01674712|465936026|FG003|Overall Study|Protocol Violation|0|||
129446984|NCT01674712|465936027|FG004|Overall Study|Protocol Violation|0|||
129446985|NCT01674712|465936023|FG000|Overall Study|Withdrawal by Subject|2|||
129446986|NCT01674712|465936024|FG001|Overall Study|Withdrawal by Subject|2|||
129446987|NCT01674712|465936025|FG002|Overall Study|Withdrawal by Subject|5|||
129446988|NCT01674712|465936026|FG003|Overall Study|Withdrawal by Subject|4|||
129446989|NCT01674712|465936027|FG004|Overall Study|Withdrawal by Subject|3|||
129446990|NCT01674712|465936023|FG000|Overall Study|Administrative|0|||
129446991|NCT01674712|465936024|FG001|Overall Study|Administrative|1|||
129446992|NCT01674712|465936025|FG002|Overall Study|Administrative|0|||
129446993|NCT01674712|465936026|FG003|Overall Study|Administrative|0|||
129446994|NCT01674712|465936027|FG004|Overall Study|Administrative|1|||
129446995|NCT01674712|465936023|FG000|Overall Study|Lack of Efficacy|0|||
129446996|NCT01674712|465936024|FG001|Overall Study|Lack of Efficacy|0|||
129446997|NCT01674712|465936025|FG002|Overall Study|Lack of Efficacy|1|||
129446998|NCT01674712|465936026|FG003|Overall Study|Lack of Efficacy|0|||
129446999|NCT01674712|465936027|FG004|Overall Study|Lack of Efficacy|1|||
129447000|NCT00874770|465936028|FG000|Overall Study|Lack of Efficacy|2|||
129447001|NCT00874770|465936029|FG001|Overall Study|Lack of Efficacy|0|||
129447002|NCT00874770|465936030|FG002|Overall Study|Lack of Efficacy|0|||
129447003|NCT00874770|465936031|FG003|Overall Study|Lack of Efficacy|2|||
129447004|NCT00874770|465936028|FG000|Overall Study|Adverse Event|1|||
129447005|NCT00874770|465936029|FG001|Overall Study|Adverse Event|1|||
129447006|NCT00874770|465936030|FG002|Overall Study|Adverse Event|4|||
129447007|NCT00874770|465936031|FG003|Overall Study|Adverse Event|2|||
129447008|NCT00874770|465936028|FG000|Overall Study|Lost to Follow-up|1|||
129447009|NCT00874770|465936029|FG001|Overall Study|Lost to Follow-up|0|||
129447010|NCT00874770|465936030|FG002|Overall Study|Lost to Follow-up|0|||
129836514|NCT03131440|467368224|FG024|Overall Study|Withdrawal by Subject|0|||
129836515|NCT03131440|467368225|FG025|Overall Study|Withdrawal by Subject|0|||
129836516|NCT03131440|467368226|FG026|Overall Study|Withdrawal by Subject|0|||
129836517|NCT03131440|467368227|FG027|Overall Study|Withdrawal by Subject|0|||
129836518|NCT03131440|467368228|FG028|Overall Study|Withdrawal by Subject|0|||
129836519|NCT03131440|467368229|FG029|Overall Study|Withdrawal by Subject|0|||
129836520|NCT03131440|467368230|FG030|Overall Study|Withdrawal by Subject|1|||
129836521|NCT03131440|467368231|FG031|Overall Study|Withdrawal by Subject|0|||
129836522|NCT03131440|467368200|FG000|Overall Study|Lost to Follow-up|0|||
129836523|NCT03131440|467368201|FG001|Overall Study|Lost to Follow-up|0|||
129836524|NCT03131440|467368202|FG002|Overall Study|Lost to Follow-up|0|||
129836525|NCT03131440|467368203|FG003|Overall Study|Lost to Follow-up|0|||
129836526|NCT03131440|467368204|FG004|Overall Study|Lost to Follow-up|0|||
129836527|NCT03131440|467368205|FG005|Overall Study|Lost to Follow-up|1|||
129836528|NCT03131440|467368206|FG006|Overall Study|Lost to Follow-up|0|||
129836529|NCT03131440|467368207|FG007|Overall Study|Lost to Follow-up|0|||
129447011|NCT00874770|465936031|FG003|Overall Study|Lost to Follow-up|1|||
129836530|NCT03131440|467368208|FG008|Overall Study|Lost to Follow-up|0|||
129836531|NCT03131440|467368209|FG009|Overall Study|Lost to Follow-up|0|||
129836532|NCT03131440|467368210|FG010|Overall Study|Lost to Follow-up|0|||
129898408|NCT01081145|467588347|FG001|Open-Label Phase|Response criteria not met|0|||
129898409|NCT01081145|467588346|FG000|Open-Label Phase|Adverse Event|42|||
129898410|NCT01081145|467588347|FG001|Open-Label Phase|Adverse Event|0|||
129898411|NCT01081145|467588346|FG000|Open-Label Phase|Withdrawal by Subject|41|||
129898412|NCT01081145|467588347|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129898413|NCT01081145|467588346|FG000|Open-Label Phase|Other|12|||
129898414|NCT01081145|467588347|FG001|Open-Label Phase|Other|0|||
129898415|NCT01081145|467588346|FG000|Open-Label Phase|Lost to Follow-up|11|||
129898416|NCT01081145|467588347|FG001|Open-Label Phase|Lost to Follow-up|0|||
129898417|NCT01081145|467588346|FG000|Open-Label Phase|Protocol Violation|4|||
129898418|NCT01081145|467588347|FG001|Open-Label Phase|Protocol Violation|0|||
129898419|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
129898420|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
129898421|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
129898422|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
129898423|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
129898424|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
129898425|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
129898426|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
129898427|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
129898428|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
129898429|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
129898430|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
129898431|NCT01081145|467588346|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
129898432|NCT01081145|467588347|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
129898433|NCT03394027|467588351|FG000|Overall Study|Ineligible|3|||
129898434|NCT03394027|467588352|FG001|Overall Study|Ineligible|1|||
129898435|NCT03394027|467588353|FG002|Overall Study|Ineligible|3|||
129898436|NCT03394027|467588351|FG000|Overall Study|Participant declined to participate before treatment started|0|||
129898437|NCT03394027|467588352|FG001|Overall Study|Participant declined to participate before treatment started|0|||
129898438|NCT03394027|467588353|FG002|Overall Study|Participant declined to participate before treatment started|1|||
129898439|NCT01018511|467588355|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
129898440|NCT01018511|467588356|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
129898441|NCT01018511|467588357|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
129898442|NCT01018511|467588358|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
129898443|NCT01018511|467588355|FG000|Overall Study|Adverse Event|5|||
129898444|NCT01018511|467588356|FG001|Overall Study|Adverse Event|9|||
129898445|NCT01018511|467588357|FG002|Overall Study|Adverse Event|13|||
129898446|NCT01018511|467588358|FG003|Overall Study|Adverse Event|10|||
129898447|NCT01018511|467588355|FG000|Overall Study|Lack of Efficacy|4|||
129898448|NCT01018511|467588356|FG001|Overall Study|Lack of Efficacy|1|||
129898449|NCT01018511|467588357|FG002|Overall Study|Lack of Efficacy|1|||
129898450|NCT01018511|467588358|FG003|Overall Study|Lack of Efficacy|2|||
129898451|NCT01018511|467588355|FG000|Overall Study|Withdrawal by Subject|6|||
129898452|NCT01018511|467588356|FG001|Overall Study|Withdrawal by Subject|5|||
129898453|NCT01018511|467588357|FG002|Overall Study|Withdrawal by Subject|11|||
129898454|NCT01018511|467588358|FG003|Overall Study|Withdrawal by Subject|9|||
129898455|NCT01018511|467588355|FG000|Overall Study|Lost to Follow-up|0|||
129898456|NCT01018511|467588356|FG001|Overall Study|Lost to Follow-up|0|||
129898457|NCT01018511|467588357|FG002|Overall Study|Lost to Follow-up|1|||
129898458|NCT01018511|467588358|FG003|Overall Study|Lost to Follow-up|0|||
129898459|NCT01018511|467588355|FG000|Overall Study|Protocol Violation|5|||
129898460|NCT01018511|467588356|FG001|Overall Study|Protocol Violation|8|||
129836533|NCT03131440|467368211|FG011|Overall Study|Lost to Follow-up|0|||
129447012|NCT00874770|465936028|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
129447013|NCT00874770|465936029|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
129447014|NCT00874770|465936030|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
129447015|NCT00874770|465936031|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
129447016|NCT05395104|465936032|FG000|Overall Study|Met Liver Stopping Criteria|1|||
129447017|NCT05395104|465936032|FG000|Overall Study|Withdrawal by Subject|1|||
129447018|NCT03974334|465936033|FG000|Overall Study|Lost to Follow-up|1|||
129447019|NCT00024167|465936034|FG000|Overall Study|Death|53|||
129447020|NCT00024167|465936035|FG001|Overall Study|Death|47|||
129447021|NCT01379573|465936050|FG000|Overall Study|Lost to Follow-up|1|||
129447022|NCT01379573|465936050|FG000|Overall Study|Screen Failure|10|||
129447023|NCT00962390|465936051|FG000|Overall Study|Adverse Event|0|||
129836534|NCT03131440|467368212|FG012|Overall Study|Lost to Follow-up|0|||
129836535|NCT03131440|467368213|FG013|Overall Study|Lost to Follow-up|0|||
129836536|NCT03131440|467368214|FG014|Overall Study|Lost to Follow-up|0|||
129836537|NCT03131440|467368215|FG015|Overall Study|Lost to Follow-up|0|||
129836538|NCT03131440|467368216|FG016|Overall Study|Lost to Follow-up|0|||
129836539|NCT03131440|467368217|FG017|Overall Study|Lost to Follow-up|0|||
129836540|NCT03131440|467368218|FG018|Overall Study|Lost to Follow-up|0|||
129836541|NCT03131440|467368219|FG019|Overall Study|Lost to Follow-up|2|||
129836542|NCT03131440|467368220|FG020|Overall Study|Lost to Follow-up|1|||
129836543|NCT03131440|467368221|FG021|Overall Study|Lost to Follow-up|0|||
129836544|NCT03131440|467368222|FG022|Overall Study|Lost to Follow-up|1|||
129836545|NCT03131440|467368223|FG023|Overall Study|Lost to Follow-up|0|||
129836546|NCT03131440|467368224|FG024|Overall Study|Lost to Follow-up|1|||
129836547|NCT03131440|467368225|FG025|Overall Study|Lost to Follow-up|0|||
129836548|NCT03131440|467368226|FG026|Overall Study|Lost to Follow-up|0|||
129836549|NCT03131440|467368227|FG027|Overall Study|Lost to Follow-up|2|||
129836550|NCT03131440|467368228|FG028|Overall Study|Lost to Follow-up|0|||
129836551|NCT03131440|467368229|FG029|Overall Study|Lost to Follow-up|2|||
129836552|NCT03131440|467368230|FG030|Overall Study|Lost to Follow-up|0|||
129836553|NCT03131440|467368231|FG031|Overall Study|Lost to Follow-up|0|||
129836554|NCT03131440|467368200|FG000|Overall Study|Death|0|||
129836555|NCT03131440|467368201|FG001|Overall Study|Death|0|||
129836556|NCT03131440|467368202|FG002|Overall Study|Death|0|||
129836557|NCT03131440|467368203|FG003|Overall Study|Death|0|||
129836558|NCT03131440|467368204|FG004|Overall Study|Death|0|||
129836559|NCT03131440|467368205|FG005|Overall Study|Death|0|||
129836560|NCT03131440|467368206|FG006|Overall Study|Death|0|||
129836561|NCT03131440|467368207|FG007|Overall Study|Death|0|||
129836562|NCT03131440|467368208|FG008|Overall Study|Death|0|||
129836563|NCT03131440|467368209|FG009|Overall Study|Death|0|||
129836564|NCT03131440|467368210|FG010|Overall Study|Death|0|||
129836565|NCT03131440|467368211|FG011|Overall Study|Death|0|||
129836566|NCT03131440|467368212|FG012|Overall Study|Death|0|||
129836567|NCT03131440|467368213|FG013|Overall Study|Death|0|||
129836568|NCT03131440|467368214|FG014|Overall Study|Death|0|||
129836569|NCT03131440|467368215|FG015|Overall Study|Death|0|||
129836570|NCT03131440|467368216|FG016|Overall Study|Death|0|||
129836571|NCT03131440|467368217|FG017|Overall Study|Death|0|||
129836572|NCT03131440|467368218|FG018|Overall Study|Death|0|||
129836573|NCT03131440|467368219|FG019|Overall Study|Death|0|||
129836574|NCT03131440|467368220|FG020|Overall Study|Death|0|||
129836575|NCT03131440|467368221|FG021|Overall Study|Death|0|||
129836576|NCT03131440|467368222|FG022|Overall Study|Death|0|||
129447024|NCT00962390|465936052|FG001|Overall Study|Adverse Event|0|||
129447025|NCT00962390|465936053|FG002|Overall Study|Adverse Event|3|||
129836577|NCT03131440|467368223|FG023|Overall Study|Death|0|||
129836578|NCT03131440|467368224|FG024|Overall Study|Death|0|||
129836579|NCT03131440|467368225|FG025|Overall Study|Death|1|||
129836580|NCT03131440|467368226|FG026|Overall Study|Death|0|||
129836581|NCT03131440|467368227|FG027|Overall Study|Death|0|||
129836582|NCT03131440|467368228|FG028|Overall Study|Death|0|||
129836583|NCT03131440|467368229|FG029|Overall Study|Death|0|||
129836584|NCT03131440|467368230|FG030|Overall Study|Death|0|||
129836585|NCT03131440|467368231|FG031|Overall Study|Death|0|||
129836586|NCT00746941|467368234|FG000|Overall Study|Death|2|||
129447026|NCT00962390|465936054|FG003|Overall Study|Adverse Event|1|||
129836587|NCT00746941|467368235|FG001|Overall Study|Death|0|||
129836588|NCT00746941|467368236|FG002|Overall Study|Death|0|||
129836589|NCT00746941|467368237|FG003|Overall Study|Death|6|||
129836590|NCT00746941|467368234|FG000|Overall Study|Physician Decision|0|||
129447027|NCT00962390|465936051|FG000|Overall Study|Lost to Follow-up|2|||
129447028|NCT00962390|465936052|FG001|Overall Study|Lost to Follow-up|2|||
129447029|NCT00962390|465936053|FG002|Overall Study|Lost to Follow-up|0|||
129836591|NCT00746941|467368235|FG001|Overall Study|Physician Decision|0|||
129836592|NCT00746941|467368236|FG002|Overall Study|Physician Decision|2|||
129836593|NCT00746941|467368237|FG003|Overall Study|Physician Decision|0|||
129836594|NCT00746941|467368234|FG000|Overall Study|Withdrawal by Subject|3|||
129836595|NCT00746941|467368235|FG001|Overall Study|Withdrawal by Subject|0|||
129836596|NCT00746941|467368236|FG002|Overall Study|Withdrawal by Subject|0|||
129836597|NCT00746941|467368237|FG003|Overall Study|Withdrawal by Subject|2|||
129836598|NCT00746941|467368234|FG000|Overall Study|Other, reason not provided|2|||
129836599|NCT00746941|467368235|FG001|Overall Study|Other, reason not provided|4|||
129836600|NCT00746941|467368236|FG002|Overall Study|Other, reason not provided|0|||
129836601|NCT00746941|467368237|FG003|Overall Study|Other, reason not provided|4|||
129836602|NCT00746941|467368234|FG000|Overall Study|Adverse Event|0|||
129836603|NCT00746941|467368235|FG001|Overall Study|Adverse Event|0|||
129836604|NCT00746941|467368236|FG002|Overall Study|Adverse Event|0|||
129836605|NCT00746941|467368237|FG003|Overall Study|Adverse Event|1|||
129836606|NCT03316885|467368238|FG000|Overall Study|Adverse Event|1|||
129836607|NCT03316885|467368238|FG000|Overall Study|Death|10|||
129836608|NCT03316885|467368238|FG000|Overall Study|Lost to Follow-up|4|||
129836609|NCT03316885|467368238|FG000|Overall Study|Withdrawal by Subject|9|||
129836610|NCT03316885|467368238|FG000|Overall Study|COVID related|8|||
129836611|NCT04371380|467368239|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
129836612|NCT04371380|467368240|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
129836613|NCT04371380|467368241|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
129836614|NCT00680901|467368250|FG000|Overall Study|Ongoing: On Study Treatment|1|||
129836615|NCT00680901|467368251|FG001|Overall Study|Ongoing: On Study Treatment|0|||
129836616|NCT00680901|467368250|FG000|Overall Study|Ongoing: In Follow Up|1|||
129836617|NCT00680901|467368251|FG001|Overall Study|Ongoing: In Follow Up|0|||
129836618|NCT00680901|467368250|FG000|Overall Study|Adverse Event|1|||
129836619|NCT00680901|467368251|FG001|Overall Study|Adverse Event|1|||
129836620|NCT00680901|467368250|FG000|Overall Study|Lost to Follow-up|3|||
129836621|NCT00680901|467368251|FG001|Overall Study|Lost to Follow-up|5|||
129836622|NCT00680901|467368250|FG000|Overall Study|Subject decided to withdraw from the study|4|||
129836623|NCT00680901|467368251|FG001|Overall Study|Subject decided to withdraw from the study|15|||
129836624|NCT00680901|467368250|FG000|Overall Study|Sponsor decision|1|||
129836625|NCT00680901|467368251|FG001|Overall Study|Sponsor decision|0|||
129836626|NCT00680901|467368250|FG000|Overall Study|Physician Decision|0|||
129836627|NCT00680901|467368251|FG001|Overall Study|Physician Decision|2|||
129836628|NCT00680901|467368250|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
129836629|NCT00680901|467368251|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
129836630|NCT00680901|467368250|FG000|Overall Study|Other protocol defined stopping criteria|17|||
129836631|NCT00680901|467368251|FG001|Overall Study|Other protocol defined stopping criteria|17|||
129836632|NCT04809220|467368254|FG000|Overall Study|Adverse Event|4|||
129836633|NCT04809220|467368255|FG001|Overall Study|Adverse Event|0|||
129836634|NCT04809220|467368254|FG000|Overall Study|Death|1|||
129836635|NCT04809220|467368255|FG001|Overall Study|Death|0|||
129836636|NCT04809220|467368254|FG000|Overall Study|Lost to Follow-up|3|||
129836637|NCT04809220|467368255|FG001|Overall Study|Lost to Follow-up|0|||
129836638|NCT04809220|467368254|FG000|Overall Study|Physician Decision|0|||
129836639|NCT04809220|467368255|FG001|Overall Study|Physician Decision|1|||
129836640|NCT04809220|467368254|FG000|Overall Study|Withdrawal by Subject|9|||
129836641|NCT04809220|467368255|FG001|Overall Study|Withdrawal by Subject|5|||
129836642|NCT04809220|467368254|FG000|Overall Study|Due to long-term overseas business trips|1|||
129836643|NCT04809220|467368255|FG001|Overall Study|Due to long-term overseas business trips|0|||
129836644|NCT01062555|467368256|FG000|Phase 1|Death|10|||
129836645|NCT01062555|467368257|FG001|Phase 1|Death|17|||
129836646|NCT01062555|467368258|FG002|Phase 1|Death|0|||
129836647|NCT01062555|467368259|FG003|Phase 1|Death|0|||
129836648|NCT01062555|467368256|FG000|Phase 1|Graft Failure|12|||
129836649|NCT01062555|467368257|FG001|Phase 1|Graft Failure|8|||
129836650|NCT01062555|467368258|FG002|Phase 1|Graft Failure|0|||
129836651|NCT01062555|467368259|FG003|Phase 1|Graft Failure|0|||
129836652|NCT01062555|467368256|FG000|Phase 1|Withdrawal by Subject|1|||
129836653|NCT01062555|467368257|FG001|Phase 1|Withdrawal by Subject|1|||
129836654|NCT01062555|467368258|FG002|Phase 1|Withdrawal by Subject|0|||
129836655|NCT01062555|467368259|FG003|Phase 1|Withdrawal by Subject|0|||
129836656|NCT01062555|467368256|FG000|Phase 2|Death|0|||
129836657|NCT01062555|467368257|FG001|Phase 2|Death|0|||
129836658|NCT01062555|467368258|FG002|Phase 2|Death|8|||
129836659|NCT01062555|467368259|FG003|Phase 2|Death|3|||
129836660|NCT01062555|467368256|FG000|Phase 2|Graft failure|0|||
129836661|NCT01062555|467368257|FG001|Phase 2|Graft failure|0|||
129836662|NCT01062555|467368258|FG002|Phase 2|Graft failure|7|||
129836663|NCT01062555|467368259|FG003|Phase 2|Graft failure|4|||
129836664|NCT01062555|467368256|FG000|Phase 2|Withdrawal by Subject|0|||
129836665|NCT01062555|467368257|FG001|Phase 2|Withdrawal by Subject|0|||
129836666|NCT01062555|467368258|FG002|Phase 2|Withdrawal by Subject|0|||
129836667|NCT01062555|467368259|FG003|Phase 2|Withdrawal by Subject|7|||
129447030|NCT00962390|465936054|FG003|Overall Study|Lost to Follow-up|0|||
129836668|NCT01062555|467368256|FG000|Phase 2|Protocol Violation|0|||
129836669|NCT01062555|467368257|FG001|Phase 2|Protocol Violation|0|||
129836670|NCT01062555|467368258|FG002|Phase 2|Protocol Violation|0|||
129836671|NCT01062555|467368259|FG003|Phase 2|Protocol Violation|3|||
129836672|NCT01062555|467368256|FG000|Phase 2|Physician Decision|0|||
129836673|NCT01062555|467368257|FG001|Phase 2|Physician Decision|0|||
129836674|NCT01062555|467368258|FG002|Phase 2|Physician Decision|0|||
129836675|NCT01062555|467368259|FG003|Phase 2|Physician Decision|17|||
129836676|NCT02641379|467368262|FG000|Overall Study|Exclusion criterion during screening|1|||
129898461|NCT01018511|467588357|FG002|Overall Study|Protocol Violation|7|||
129836677|NCT02641379|467368263|FG001|Overall Study|Exclusion criterion during screening|0|||
129836678|NCT02641379|467368264|FG002|Overall Study|Exclusion criterion during screening|0|||
129836679|NCT02641379|467368265|FG003|Overall Study|Exclusion criterion during screening|1|||
129836680|NCT02641379|467368266|FG004|Overall Study|Exclusion criterion during screening|2|||
129836681|NCT02641379|467368267|FG005|Overall Study|Exclusion criterion during screening|0|||
129836682|NCT02641379|467368268|FG006|Overall Study|Exclusion criterion during screening|0|||
129836683|NCT02641379|467368269|FG007|Overall Study|Exclusion criterion during screening|0|||
129836684|NCT02641379|467368270|FG008|Overall Study|Exclusion criterion during screening|0|||
129836685|NCT02641379|467368271|FG009|Overall Study|Exclusion criterion during screening|0|||
129836686|NCT02641379|467368272|FG010|Overall Study|Exclusion criterion during screening|0|||
129836687|NCT02641379|467368262|FG000|Overall Study|Withdrawal of informed consent|0|||
129836688|NCT02641379|467368263|FG001|Overall Study|Withdrawal of informed consent|1|||
129836689|NCT02641379|467368264|FG002|Overall Study|Withdrawal of informed consent|0|||
129836690|NCT02641379|467368265|FG003|Overall Study|Withdrawal of informed consent|0|||
129836691|NCT02641379|467368266|FG004|Overall Study|Withdrawal of informed consent|0|||
129836692|NCT02641379|467368267|FG005|Overall Study|Withdrawal of informed consent|0|||
129836693|NCT02641379|467368268|FG006|Overall Study|Withdrawal of informed consent|0|||
129836694|NCT02641379|467368269|FG007|Overall Study|Withdrawal of informed consent|1|||
129836695|NCT02641379|467368270|FG008|Overall Study|Withdrawal of informed consent|0|||
129836696|NCT02641379|467368271|FG009|Overall Study|Withdrawal of informed consent|0|||
129836697|NCT02641379|467368272|FG010|Overall Study|Withdrawal of informed consent|0|||
129836698|NCT02641379|467368262|FG000|Overall Study|Adverse Event|7|||
129836699|NCT02641379|467368263|FG001|Overall Study|Adverse Event|8|||
129836700|NCT02641379|467368264|FG002|Overall Study|Adverse Event|2|||
129836701|NCT02641379|467368265|FG003|Overall Study|Adverse Event|2|||
129836702|NCT02641379|467368266|FG004|Overall Study|Adverse Event|5|||
129836703|NCT02641379|467368267|FG005|Overall Study|Adverse Event|1|||
129836704|NCT02641379|467368268|FG006|Overall Study|Adverse Event|5|||
129836705|NCT02641379|467368269|FG007|Overall Study|Adverse Event|0|||
129836706|NCT02641379|467368270|FG008|Overall Study|Adverse Event|1|||
129836707|NCT02641379|467368271|FG009|Overall Study|Adverse Event|1|||
129836708|NCT02641379|467368272|FG010|Overall Study|Adverse Event|5|||
129836709|NCT02641379|467368262|FG000|Overall Study|Lack of Efficacy|0|||
129836710|NCT02641379|467368263|FG001|Overall Study|Lack of Efficacy|0|||
129836711|NCT02641379|467368264|FG002|Overall Study|Lack of Efficacy|2|||
129836712|NCT02641379|467368265|FG003|Overall Study|Lack of Efficacy|0|||
129836713|NCT02641379|467368266|FG004|Overall Study|Lack of Efficacy|0|||
129836714|NCT02641379|467368267|FG005|Overall Study|Lack of Efficacy|2|||
129836715|NCT02641379|467368268|FG006|Overall Study|Lack of Efficacy|0|||
129836716|NCT02641379|467368269|FG007|Overall Study|Lack of Efficacy|5|||
129836717|NCT02641379|467368270|FG008|Overall Study|Lack of Efficacy|0|||
129836718|NCT02641379|467368271|FG009|Overall Study|Lack of Efficacy|0|||
129836719|NCT02641379|467368272|FG010|Overall Study|Lack of Efficacy|0|||
129836720|NCT02641379|467368262|FG000|Overall Study|Participant unable to attend study visit|4|||
129836721|NCT02641379|467368263|FG001|Overall Study|Participant unable to attend study visit|10|||
129836722|NCT02641379|467368264|FG002|Overall Study|Participant unable to attend study visit|1|||
129836723|NCT02641379|467368265|FG003|Overall Study|Participant unable to attend study visit|2|||
129836724|NCT02641379|467368266|FG004|Overall Study|Participant unable to attend study visit|5|||
129836725|NCT02641379|467368267|FG005|Overall Study|Participant unable to attend study visit|1|||
129836726|NCT02641379|467368268|FG006|Overall Study|Participant unable to attend study visit|1|||
129447031|NCT00962390|465936051|FG000|Overall Study|Protocol Violation|1|||
129836727|NCT02641379|467368269|FG007|Overall Study|Participant unable to attend study visit|1|||
129836728|NCT02641379|467368270|FG008|Overall Study|Participant unable to attend study visit|0|||
129836729|NCT02641379|467368271|FG009|Overall Study|Participant unable to attend study visit|2|||
129836730|NCT02641379|467368272|FG010|Overall Study|Participant unable to attend study visit|0|||
129836731|NCT02641379|467368262|FG000|Overall Study|Participant's compliance|0|||
129836732|NCT02641379|467368263|FG001|Overall Study|Participant's compliance|1|||
129836733|NCT02641379|467368264|FG002|Overall Study|Participant's compliance|0|||
129836734|NCT02641379|467368265|FG003|Overall Study|Participant's compliance|1|||
129836735|NCT02641379|467368266|FG004|Overall Study|Participant's compliance|0|||
129836736|NCT02641379|467368267|FG005|Overall Study|Participant's compliance|2|||
129836737|NCT02641379|467368268|FG006|Overall Study|Participant's compliance|0|||
129836738|NCT02641379|467368269|FG007|Overall Study|Participant's compliance|0|||
129836739|NCT02641379|467368270|FG008|Overall Study|Participant's compliance|1|||
129836740|NCT02641379|467368271|FG009|Overall Study|Participant's compliance|1|||
129836741|NCT02641379|467368272|FG010|Overall Study|Participant's compliance|1|||
129836742|NCT02641379|467368262|FG000|Overall Study|Participant cannot be reached|4|||
129836743|NCT02641379|467368263|FG001|Overall Study|Participant cannot be reached|4|||
129836744|NCT02641379|467368264|FG002|Overall Study|Participant cannot be reached|0|||
129836745|NCT02641379|467368265|FG003|Overall Study|Participant cannot be reached|8|||
129898462|NCT01018511|467588358|FG003|Overall Study|Protocol Violation|9|||
129836746|NCT02641379|467368266|FG004|Overall Study|Participant cannot be reached|2|||
129836747|NCT02641379|467368267|FG005|Overall Study|Participant cannot be reached|1|||
129836748|NCT02641379|467368268|FG006|Overall Study|Participant cannot be reached|0|||
129898463|NCT01018511|467588355|FG000|Overall Study|Miscellaneous|0|||
129898464|NCT01018511|467588356|FG001|Overall Study|Miscellaneous|2|||
129898465|NCT01018511|467588357|FG002|Overall Study|Miscellaneous|0|||
129898466|NCT01018511|467588358|FG003|Overall Study|Miscellaneous|0|||
129898467|NCT04523181|467588359|FG000|Overall Study|Withdrawal by Subject|4|||
129898468|NCT04523181|467588360|FG001|Overall Study|Withdrawal by Subject|5|||
129898469|NCT04523181|467588359|FG000|Overall Study|Lost to Follow-up|2|||
129898470|NCT04523181|467588360|FG001|Overall Study|Lost to Follow-up|3|||
129898471|NCT04523181|467588359|FG000|Overall Study|Physician Decision|1|||
129898472|NCT04523181|467588360|FG001|Overall Study|Physician Decision|0|||
129898473|NCT04523181|467588359|FG000|Overall Study|Transferred to external facility.|1|||
129898474|NCT04523181|467588360|FG001|Overall Study|Transferred to external facility.|1|||
129898475|NCT04550039|467588361|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
129898476|NCT04550039|467588362|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
129898477|NCT04550039|467588361|FG000|Overall Study|patient self-withdrew from study|0|||
129898478|NCT04550039|467588362|FG001|Overall Study|patient self-withdrew from study|1|||
129898479|NCT04391309|467588363|FG000|Overall Study|Death|1|||
129898480|NCT04391309|467588364|FG001|Overall Study|Death|1|||
129898481|NCT04391309|467588363|FG000|Overall Study|Lost to Follow-up|3|||
129898482|NCT04391309|467588364|FG001|Overall Study|Lost to Follow-up|2|||
129898483|NCT04391309|467588363|FG000|Overall Study|Withdrawal by Subject|2|||
129898484|NCT04391309|467588364|FG001|Overall Study|Withdrawal by Subject|2|||
129898485|NCT00881335|467588371|FG000|Overall Study|Lost to Follow-up|3|||
129898486|NCT00881335|467588372|FG001|Overall Study|Lost to Follow-up|2|||
129898487|NCT05824351|467588375|FG000|Overall Study|Adverse Event|6|||
129898488|NCT00828945|467588376|FG000|Overall Study|Death|4|||
129898489|NCT00828945|467588376|FG000|Overall Study|Participant was missing|1|||
129898490|NCT00828945|467588376|FG000|Overall Study|Other|36|||
129898491|NCT02482233|467588381|FG000|Overall Study|Lost to Follow-up|1|||
129898492|NCT02482233|467588382|FG001|Overall Study|Lost to Follow-up|1|||
129898493|NCT03822351|467588383|FG000|Overall Study|Death|27|||
129898494|NCT03822351|467588384|FG001|Overall Study|Death|23|||
129898495|NCT03822351|467588385|FG002|Overall Study|Death|24|||
129898496|NCT03822351|467588383|FG000|Overall Study|Lost to Follow-up|6|||
129898497|NCT03822351|467588384|FG001|Overall Study|Lost to Follow-up|2|||
129898498|NCT03822351|467588385|FG002|Overall Study|Lost to Follow-up|1|||
129898499|NCT03822351|467588383|FG000|Overall Study|Withdrawal by Subject|10|||
129898500|NCT03822351|467588384|FG001|Overall Study|Withdrawal by Subject|4|||
129898501|NCT03822351|467588385|FG002|Overall Study|Withdrawal by Subject|6|||
129898502|NCT03822351|467588383|FG000|Overall Study|Progressive Disease|2|||
129898503|NCT03822351|467588384|FG001|Overall Study|Progressive Disease|1|||
129898504|NCT03822351|467588385|FG002|Overall Study|Progressive Disease|0|||
129898505|NCT03822351|467588383|FG000|Overall Study|Not Treated|1|||
129898506|NCT03822351|467588384|FG001|Overall Study|Not Treated|1|||
129898507|NCT03822351|467588385|FG002|Overall Study|Not Treated|1|||
129898508|NCT00462943|467588386|FG000|Overall Study|Failure to achieve a response|5|||
129898509|NCT00462943|467588387|FG001|Overall Study|Failure to achieve a response|5|||
129898510|NCT00462943|467588388|FG002|Overall Study|Failure to achieve a response|1|||
129898511|NCT00462943|467588386|FG000|Overall Study|Adverse Event|6|||
129898512|NCT00462943|467588387|FG001|Overall Study|Adverse Event|4|||
129898513|NCT00462943|467588388|FG002|Overall Study|Adverse Event|1|||
129898514|NCT00462943|467588386|FG000|Overall Study|Protocol Violation|1|||
129898515|NCT00462943|467588387|FG001|Overall Study|Protocol Violation|0|||
129898516|NCT00462943|467588388|FG002|Overall Study|Protocol Violation|0|||
129898517|NCT00462943|467588386|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
129898518|NCT00462943|467588387|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
129898519|NCT00462943|467588388|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
129898520|NCT00462943|467588386|FG000|Overall Study|Disease Progression|15|||
129898521|NCT00462943|467588387|FG001|Overall Study|Disease Progression|15|||
129898522|NCT00462943|467588388|FG002|Overall Study|Disease Progression|9|||
129898523|NCT00462943|467588386|FG000|Overall Study|Death|5|||
129898524|NCT00462943|467588387|FG001|Overall Study|Death|2|||
129898525|NCT00462943|467588388|FG002|Overall Study|Death|7|||
129836749|NCT02641379|467368269|FG007|Overall Study|Participant cannot be reached|1|||
129836750|NCT02641379|467368270|FG008|Overall Study|Participant cannot be reached|0|||
129836751|NCT02641379|467368271|FG009|Overall Study|Participant cannot be reached|2|||
129836752|NCT02641379|467368272|FG010|Overall Study|Participant cannot be reached|1|||
129836753|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 24|15|||
129836754|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 24|21|||
129836755|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 24|62|||
129836756|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 24|0|||
129836757|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 24|0|||
129836758|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 24|6|||
129836759|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 24|3|||
129836760|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 24|8|||
129836761|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 24|0|||
129836762|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 24|1|||
129836763|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 24|0|||
129836764|NCT02641379|467368262|FG000|Overall Study|PCR positive at follow up 2|1|||
129836765|NCT02641379|467368263|FG001|Overall Study|PCR positive at follow up 2|0|||
129836766|NCT02641379|467368264|FG002|Overall Study|PCR positive at follow up 2|0|||
129836767|NCT02641379|467368265|FG003|Overall Study|PCR positive at follow up 2|0|||
129836768|NCT02641379|467368266|FG004|Overall Study|PCR positive at follow up 2|0|||
129836769|NCT02641379|467368267|FG005|Overall Study|PCR positive at follow up 2|0|||
129836770|NCT02641379|467368268|FG006|Overall Study|PCR positive at follow up 2|0|||
129836771|NCT02641379|467368269|FG007|Overall Study|PCR positive at follow up 2|0|||
129836772|NCT02641379|467368270|FG008|Overall Study|PCR positive at follow up 2|0|||
129836773|NCT02641379|467368271|FG009|Overall Study|PCR positive at follow up 2|0|||
129836774|NCT02641379|467368272|FG010|Overall Study|PCR positive at follow up 2|0|||
129836775|NCT02641379|467368262|FG000|Overall Study|Participant showed relapse|1|||
129836776|NCT02641379|467368263|FG001|Overall Study|Participant showed relapse|0|||
129836777|NCT02641379|467368264|FG002|Overall Study|Participant showed relapse|0|||
129836778|NCT02641379|467368265|FG003|Overall Study|Participant showed relapse|0|||
129836779|NCT02641379|467368266|FG004|Overall Study|Participant showed relapse|0|||
129836780|NCT02641379|467368267|FG005|Overall Study|Participant showed relapse|0|||
129836781|NCT02641379|467368268|FG006|Overall Study|Participant showed relapse|1|||
129836782|NCT02641379|467368269|FG007|Overall Study|Participant showed relapse|0|||
129836783|NCT02641379|467368270|FG008|Overall Study|Participant showed relapse|0|||
129836784|NCT02641379|467368271|FG009|Overall Study|Participant showed relapse|0|||
129836785|NCT02641379|467368272|FG010|Overall Study|Participant showed relapse|0|||
129836786|NCT02641379|467368262|FG000|Overall Study|Participant stopped study/treatment|1|||
129836787|NCT02641379|467368263|FG001|Overall Study|Participant stopped study/treatment|3|||
129836788|NCT02641379|467368264|FG002|Overall Study|Participant stopped study/treatment|1|||
129836789|NCT02641379|467368265|FG003|Overall Study|Participant stopped study/treatment|0|||
129836790|NCT02641379|467368266|FG004|Overall Study|Participant stopped study/treatment|0|||
129836791|NCT02641379|467368267|FG005|Overall Study|Participant stopped study/treatment|1|||
129836792|NCT02641379|467368268|FG006|Overall Study|Participant stopped study/treatment|2|||
129836793|NCT02641379|467368269|FG007|Overall Study|Participant stopped study/treatment|0|||
129836794|NCT02641379|467368270|FG008|Overall Study|Participant stopped study/treatment|1|||
129836795|NCT02641379|467368271|FG009|Overall Study|Participant stopped study/treatment|0|||
129836796|NCT02641379|467368272|FG010|Overall Study|Participant stopped study/treatment|0|||
129836797|NCT02641379|467368262|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
129836798|NCT02641379|467368263|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
129836799|NCT02641379|467368264|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
129836800|NCT02641379|467368265|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
129836801|NCT02641379|467368266|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
129836802|NCT02641379|467368267|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
129836803|NCT02641379|467368268|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
129836804|NCT02641379|467368269|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
129836805|NCT02641379|467368270|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
129836806|NCT02641379|467368271|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
129836807|NCT02641379|467368272|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
129836808|NCT02641379|467368262|FG000|Overall Study|Financial problems|0|||
129836809|NCT02641379|467368263|FG001|Overall Study|Financial problems|1|||
129836810|NCT02641379|467368264|FG002|Overall Study|Financial problems|0|||
129836811|NCT02641379|467368265|FG003|Overall Study|Financial problems|0|||
129836812|NCT02641379|467368266|FG004|Overall Study|Financial problems|0|||
129836813|NCT02641379|467368267|FG005|Overall Study|Financial problems|0|||
129836814|NCT02641379|467368268|FG006|Overall Study|Financial problems|0|||
129836815|NCT02641379|467368269|FG007|Overall Study|Financial problems|0|||
129836816|NCT02641379|467368270|FG008|Overall Study|Financial problems|0|||
129836817|NCT02641379|467368271|FG009|Overall Study|Financial problems|0|||
129836818|NCT02641379|467368272|FG010|Overall Study|Financial problems|0|||
129836819|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 68|0|||
129836820|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 68|1|||
129836821|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 68|0|||
129836822|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 68|0|||
129836823|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 68|0|||
129836824|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 68|0|||
129836825|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 68|0|||
129836826|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 68|0|||
129836827|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 68|0|||
129836828|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 68|0|||
129836829|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 68|0|||
129836830|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 48|0|||
129836831|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 48|1|||
129836832|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 48|0|||
129836833|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 48|0|||
129836834|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 48|0|||
129836835|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 48|0|||
129836836|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 48|0|||
129836837|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 48|0|||
129836838|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 48|0|||
129836839|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 48|0|||
129836840|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 48|0|||
129836841|NCT02641379|467368262|FG000|Overall Study|PCR not performed at Week 12|0|||
129836842|NCT02641379|467368263|FG001|Overall Study|PCR not performed at Week 12|0|||
129836843|NCT02641379|467368264|FG002|Overall Study|PCR not performed at Week 12|1|||
129836844|NCT02641379|467368265|FG003|Overall Study|PCR not performed at Week 12|0|||
129836845|NCT02641379|467368266|FG004|Overall Study|PCR not performed at Week 12|0|||
129836846|NCT02641379|467368267|FG005|Overall Study|PCR not performed at Week 12|0|||
129836847|NCT02641379|467368268|FG006|Overall Study|PCR not performed at Week 12|0|||
129836848|NCT02641379|467368269|FG007|Overall Study|PCR not performed at Week 12|0|||
129836849|NCT02641379|467368270|FG008|Overall Study|PCR not performed at Week 12|0|||
129836850|NCT02641379|467368271|FG009|Overall Study|PCR not performed at Week 12|0|||
129836851|NCT02641379|467368272|FG010|Overall Study|PCR not performed at Week 12|0|||
129836852|NCT02641379|467368262|FG000|Overall Study|No PCR at baseline|0|||
129836853|NCT02641379|467368263|FG001|Overall Study|No PCR at baseline|0|||
129836854|NCT02641379|467368264|FG002|Overall Study|No PCR at baseline|1|||
129836855|NCT02641379|467368265|FG003|Overall Study|No PCR at baseline|0|||
129836856|NCT02641379|467368266|FG004|Overall Study|No PCR at baseline|0|||
129836857|NCT02641379|467368267|FG005|Overall Study|No PCR at baseline|0|||
129836858|NCT02641379|467368268|FG006|Overall Study|No PCR at baseline|0|||
129836859|NCT02641379|467368269|FG007|Overall Study|No PCR at baseline|0|||
129836860|NCT02641379|467368270|FG008|Overall Study|No PCR at baseline|0|||
129836861|NCT02641379|467368271|FG009|Overall Study|No PCR at baseline|0|||
129836862|NCT02641379|467368272|FG010|Overall Study|No PCR at baseline|0|||
129836863|NCT02641379|467368262|FG000|Overall Study|PCR positive at Week 28|0|||
129836864|NCT02641379|467368263|FG001|Overall Study|PCR positive at Week 28|0|||
129836865|NCT02641379|467368264|FG002|Overall Study|PCR positive at Week 28|1|||
129836866|NCT02641379|467368265|FG003|Overall Study|PCR positive at Week 28|0|||
129836867|NCT02641379|467368266|FG004|Overall Study|PCR positive at Week 28|0|||
129836868|NCT02641379|467368267|FG005|Overall Study|PCR positive at Week 28|0|||
129836869|NCT02641379|467368268|FG006|Overall Study|PCR positive at Week 28|0|||
129836870|NCT02641379|467368269|FG007|Overall Study|PCR positive at Week 28|0|||
129836871|NCT02641379|467368270|FG008|Overall Study|PCR positive at Week 28|0|||
129836872|NCT02641379|467368271|FG009|Overall Study|PCR positive at Week 28|0|||
129836873|NCT02641379|467368272|FG010|Overall Study|PCR positive at Week 28|0|||
129836874|NCT02641379|467368262|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
129836875|NCT02641379|467368263|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
129836876|NCT02641379|467368264|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
129836877|NCT02641379|467368265|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
129836878|NCT02641379|467368266|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
129836879|NCT02641379|467368267|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
129836880|NCT02641379|467368268|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
129836881|NCT02641379|467368269|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
129836882|NCT02641379|467368270|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
129836883|NCT02641379|467368271|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
129836884|NCT02641379|467368272|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
129836885|NCT02641379|467368262|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
129836886|NCT02641379|467368263|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
129836887|NCT02641379|467368264|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
129836888|NCT02641379|467368265|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
129836889|NCT02641379|467368266|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
129836890|NCT02641379|467368267|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
129836891|NCT02641379|467368268|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
129836892|NCT02641379|467368269|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
129836893|NCT02641379|467368270|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
129836894|NCT02641379|467368271|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
129836895|NCT02641379|467368272|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
129836896|NCT02641379|467368262|FG000|Overall Study|Baseline viral load unavailable|0|||
129836897|NCT02641379|467368263|FG001|Overall Study|Baseline viral load unavailable|0|||
129836898|NCT02641379|467368264|FG002|Overall Study|Baseline viral load unavailable|0|||
129836899|NCT02641379|467368265|FG003|Overall Study|Baseline viral load unavailable|1|||
129836900|NCT02641379|467368266|FG004|Overall Study|Baseline viral load unavailable|0|||
129836901|NCT02641379|467368267|FG005|Overall Study|Baseline viral load unavailable|0|||
129836902|NCT02641379|467368268|FG006|Overall Study|Baseline viral load unavailable|0|||
129836903|NCT02641379|467368269|FG007|Overall Study|Baseline viral load unavailable|0|||
129836904|NCT02641379|467368270|FG008|Overall Study|Baseline viral load unavailable|0|||
129836905|NCT02641379|467368271|FG009|Overall Study|Baseline viral load unavailable|0|||
129836906|NCT02641379|467368272|FG010|Overall Study|Baseline viral load unavailable|0|||
129836907|NCT02641379|467368262|FG000|Overall Study|Blood could not be drawn|0|||
129836908|NCT02641379|467368263|FG001|Overall Study|Blood could not be drawn|0|||
129836909|NCT02641379|467368264|FG002|Overall Study|Blood could not be drawn|0|||
129836910|NCT02641379|467368265|FG003|Overall Study|Blood could not be drawn|0|||
129836911|NCT02641379|467368266|FG004|Overall Study|Blood could not be drawn|1|||
129836912|NCT02641379|467368267|FG005|Overall Study|Blood could not be drawn|0|||
129836913|NCT02641379|467368268|FG006|Overall Study|Blood could not be drawn|0|||
129836914|NCT02641379|467368269|FG007|Overall Study|Blood could not be drawn|0|||
129836915|NCT02641379|467368270|FG008|Overall Study|Blood could not be drawn|0|||
129836916|NCT02641379|467368271|FG009|Overall Study|Blood could not be drawn|0|||
129836917|NCT02641379|467368272|FG010|Overall Study|Blood could not be drawn|0|||
129836918|NCT02641379|467368262|FG000|Overall Study|Protocol Violation|0|||
129836919|NCT02641379|467368263|FG001|Overall Study|Protocol Violation|0|||
129836920|NCT02641379|467368264|FG002|Overall Study|Protocol Violation|0|||
129836921|NCT02641379|467368265|FG003|Overall Study|Protocol Violation|0|||
129836922|NCT02641379|467368266|FG004|Overall Study|Protocol Violation|2|||
129836923|NCT02641379|467368267|FG005|Overall Study|Protocol Violation|0|||
129836924|NCT02641379|467368268|FG006|Overall Study|Protocol Violation|0|||
129836925|NCT02641379|467368269|FG007|Overall Study|Protocol Violation|0|||
129836926|NCT02641379|467368270|FG008|Overall Study|Protocol Violation|1|||
129836927|NCT02641379|467368271|FG009|Overall Study|Protocol Violation|0|||
129836928|NCT02641379|467368272|FG010|Overall Study|Protocol Violation|0|||
129836929|NCT02641379|467368262|FG000|Overall Study|Participation in sili rescue study|0|||
129836930|NCT02641379|467368263|FG001|Overall Study|Participation in sili rescue study|0|||
129836931|NCT02641379|467368264|FG002|Overall Study|Participation in sili rescue study|0|||
129836932|NCT02641379|467368265|FG003|Overall Study|Participation in sili rescue study|0|||
129836933|NCT02641379|467368266|FG004|Overall Study|Participation in sili rescue study|0|||
129898526|NCT00462943|467588386|FG000|Overall Study|Stem Cell Transplant|1|||
129898527|NCT00462943|467588387|FG001|Overall Study|Stem Cell Transplant|1|||
129898528|NCT00462943|467588388|FG002|Overall Study|Stem Cell Transplant|0|||
129898529|NCT00462943|467588386|FG000|Overall Study|Bone Marrow Transplant|1|||
129898530|NCT00462943|467588387|FG001|Overall Study|Bone Marrow Transplant|0|||
129898531|NCT00462943|467588388|FG002|Overall Study|Bone Marrow Transplant|0|||
129898532|NCT00462943|467588386|FG000|Overall Study|Required Lymphocyte Infusion|1|||
129898533|NCT00462943|467588387|FG001|Overall Study|Required Lymphocyte Infusion|0|||
129898534|NCT00462943|467588388|FG002|Overall Study|Required Lymphocyte Infusion|0|||
129898535|NCT00462943|467588386|FG000|Overall Study|Transplant - not specified|1|||
129898536|NCT00462943|467588387|FG001|Overall Study|Transplant - not specified|0|||
129898537|NCT00462943|467588388|FG002|Overall Study|Transplant - not specified|1|||
129898538|NCT00462943|467588386|FG000|Overall Study|Physician Decision|1|||
129898539|NCT00462943|467588387|FG001|Overall Study|Physician Decision|0|||
129898540|NCT00462943|467588388|FG002|Overall Study|Physician Decision|0|||
129898541|NCT00462943|467588386|FG000|Overall Study|Withdrawal by Subject|0|||
129898542|NCT00462943|467588387|FG001|Overall Study|Withdrawal by Subject|1|||
129898543|NCT00462943|467588388|FG002|Overall Study|Withdrawal by Subject|0|||
129898544|NCT00708097|467588394|FG000|Period 1|Protocol Violation|0|||
129898545|NCT00708097|467588395|FG001|Period 1|Protocol Violation|1|||
129898546|NCT00708097|467588396|FG002|Period 1|Protocol Violation|0|||
129898547|NCT00708097|467588397|FG003|Period 1|Protocol Violation|2|||
129898548|NCT00708097|467588398|FG004|Period 1|Protocol Violation|0|||
129898549|NCT00708097|467588394|FG000|Period 1|Other Reason|0|||
129898550|NCT00708097|467588395|FG001|Period 1|Other Reason|0|||
129898551|NCT00708097|467588396|FG002|Period 1|Other Reason|0|||
129836934|NCT02641379|467368267|FG005|Overall Study|Participation in sili rescue study|1|||
129836935|NCT02641379|467368268|FG006|Overall Study|Participation in sili rescue study|0|||
129836936|NCT02641379|467368269|FG007|Overall Study|Participation in sili rescue study|0|||
129836937|NCT02641379|467368270|FG008|Overall Study|Participation in sili rescue study|0|||
129836938|NCT02641379|467368271|FG009|Overall Study|Participation in sili rescue study|0|||
129836939|NCT02641379|467368272|FG010|Overall Study|Participation in sili rescue study|0|||
129836940|NCT02641379|467368262|FG000|Overall Study|Lost to Follow-up|0|||
129836941|NCT02641379|467368263|FG001|Overall Study|Lost to Follow-up|0|||
129836942|NCT02641379|467368264|FG002|Overall Study|Lost to Follow-up|0|||
129836943|NCT02641379|467368265|FG003|Overall Study|Lost to Follow-up|0|||
129836944|NCT02641379|467368266|FG004|Overall Study|Lost to Follow-up|0|||
129836945|NCT02641379|467368267|FG005|Overall Study|Lost to Follow-up|0|||
129836946|NCT02641379|467368268|FG006|Overall Study|Lost to Follow-up|0|||
129836947|NCT02641379|467368269|FG007|Overall Study|Lost to Follow-up|0|||
129836948|NCT02641379|467368270|FG008|Overall Study|Lost to Follow-up|1|||
129836949|NCT02641379|467368271|FG009|Overall Study|Lost to Follow-up|0|||
129836950|NCT02641379|467368272|FG010|Overall Study|Lost to Follow-up|0|||
129836951|NCT02641379|467368262|FG000|Overall Study|Source data not found|0|||
129836952|NCT02641379|467368263|FG001|Overall Study|Source data not found|0|||
129836953|NCT02641379|467368264|FG002|Overall Study|Source data not found|0|||
129836954|NCT02641379|467368265|FG003|Overall Study|Source data not found|0|||
129836955|NCT02641379|467368266|FG004|Overall Study|Source data not found|0|||
129836956|NCT02641379|467368267|FG005|Overall Study|Source data not found|1|||
129836957|NCT02641379|467368268|FG006|Overall Study|Source data not found|0|||
129836958|NCT02641379|467368269|FG007|Overall Study|Source data not found|0|||
129836959|NCT02641379|467368270|FG008|Overall Study|Source data not found|0|||
129836960|NCT02641379|467368271|FG009|Overall Study|Source data not found|0|||
129836961|NCT02641379|467368272|FG010|Overall Study|Source data not found|0|||
129836962|NCT02641379|467368262|FG000|Overall Study|Participant showed weight reduction|0|||
129836963|NCT02641379|467368263|FG001|Overall Study|Participant showed weight reduction|0|||
129836964|NCT02641379|467368264|FG002|Overall Study|Participant showed weight reduction|0|||
129836965|NCT02641379|467368265|FG003|Overall Study|Participant showed weight reduction|0|||
129836966|NCT02641379|467368266|FG004|Overall Study|Participant showed weight reduction|0|||
129836967|NCT02641379|467368267|FG005|Overall Study|Participant showed weight reduction|0|||
129836968|NCT02641379|467368268|FG006|Overall Study|Participant showed weight reduction|0|||
129836969|NCT02641379|467368269|FG007|Overall Study|Participant showed weight reduction|1|||
129836970|NCT02641379|467368270|FG008|Overall Study|Participant showed weight reduction|0|||
129836971|NCT02641379|467368271|FG009|Overall Study|Participant showed weight reduction|0|||
129836972|NCT02641379|467368272|FG010|Overall Study|Participant showed weight reduction|0|||
129836973|NCT02641379|467368262|FG000|Overall Study|Non-response Week 12|0|||
129836974|NCT02641379|467368263|FG001|Overall Study|Non-response Week 12|0|||
129836975|NCT02641379|467368264|FG002|Overall Study|Non-response Week 12|0|||
129898552|NCT00708097|467588397|FG003|Period 1|Other Reason|0|||
129898553|NCT00708097|467588398|FG004|Period 1|Other Reason|1|||
129898554|NCT00708097|467588394|FG000|Period 2|Protocol Violation|0|||
129898555|NCT00708097|467588395|FG001|Period 2|Protocol Violation|1|||
129898556|NCT00708097|467588396|FG002|Period 2|Protocol Violation|1|||
129836976|NCT02641379|467368265|FG003|Overall Study|Non-response Week 12|0|||
129898557|NCT00708097|467588397|FG003|Period 2|Protocol Violation|1|||
129898558|NCT00708097|467588398|FG004|Period 2|Protocol Violation|0|||
129836977|NCT02641379|467368266|FG004|Overall Study|Non-response Week 12|0|||
129836978|NCT02641379|467368267|FG005|Overall Study|Non-response Week 12|0|||
129836979|NCT02641379|467368268|FG006|Overall Study|Non-response Week 12|0|||
129836980|NCT02641379|467368269|FG007|Overall Study|Non-response Week 12|1|||
129836981|NCT02641379|467368270|FG008|Overall Study|Non-response Week 12|0|||
129836982|NCT02641379|467368271|FG009|Overall Study|Non-response Week 12|0|||
129836983|NCT02641379|467368272|FG010|Overall Study|Non-response Week 12|0|||
129836984|NCT02641379|467368262|FG000|Overall Study|No 2 Log drop at Week 12|0|||
129836985|NCT02641379|467368263|FG001|Overall Study|No 2 Log drop at Week 12|0|||
129836986|NCT02641379|467368264|FG002|Overall Study|No 2 Log drop at Week 12|0|||
129836987|NCT02641379|467368265|FG003|Overall Study|No 2 Log drop at Week 12|0|||
129836988|NCT02641379|467368266|FG004|Overall Study|No 2 Log drop at Week 12|0|||
129836989|NCT02641379|467368267|FG005|Overall Study|No 2 Log drop at Week 12|0|||
129836990|NCT02641379|467368268|FG006|Overall Study|No 2 Log drop at Week 12|0|||
129836991|NCT02641379|467368269|FG007|Overall Study|No 2 Log drop at Week 12|0|||
129836992|NCT02641379|467368270|FG008|Overall Study|No 2 Log drop at Week 12|0|||
129836993|NCT02641379|467368271|FG009|Overall Study|No 2 Log drop at Week 12|0|||
129836994|NCT02641379|467368272|FG010|Overall Study|No 2 Log drop at Week 12|1|||
129836995|NCT02641379|467368262|FG000|Overall Study|Negative PCR result|0|||
129836996|NCT02641379|467368263|FG001|Overall Study|Negative PCR result|0|||
129836997|NCT02641379|467368264|FG002|Overall Study|Negative PCR result|0|||
129836998|NCT02641379|467368265|FG003|Overall Study|Negative PCR result|0|||
129836999|NCT02641379|467368266|FG004|Overall Study|Negative PCR result|0|||
129837000|NCT02641379|467368267|FG005|Overall Study|Negative PCR result|0|||
129837001|NCT02641379|467368268|FG006|Overall Study|Negative PCR result|0|||
129837002|NCT02641379|467368269|FG007|Overall Study|Negative PCR result|0|||
129837003|NCT02641379|467368270|FG008|Overall Study|Negative PCR result|0|||
129837004|NCT02641379|467368271|FG009|Overall Study|Negative PCR result|1|||
129837005|NCT02641379|467368272|FG010|Overall Study|Negative PCR result|0|||
129837006|NCT02641379|467368262|FG000|Overall Study|Participant's PCR high|0|||
129837007|NCT02641379|467368263|FG001|Overall Study|Participant's PCR high|0|||
129837008|NCT02641379|467368264|FG002|Overall Study|Participant's PCR high|0|||
129837009|NCT02641379|467368265|FG003|Overall Study|Participant's PCR high|0|||
129837010|NCT02641379|467368266|FG004|Overall Study|Participant's PCR high|0|||
129837011|NCT02641379|467368267|FG005|Overall Study|Participant's PCR high|0|||
129837012|NCT02641379|467368268|FG006|Overall Study|Participant's PCR high|0|||
129837013|NCT02641379|467368269|FG007|Overall Study|Participant's PCR high|1|||
129837014|NCT02641379|467368270|FG008|Overall Study|Participant's PCR high|0|||
129837015|NCT02641379|467368271|FG009|Overall Study|Participant's PCR high|0|||
129837016|NCT02641379|467368272|FG010|Overall Study|Participant's PCR high|0|||
129837017|NCT02641379|467368262|FG000|Overall Study|Participant treated after Week 24|0|||
129837018|NCT02641379|467368263|FG001|Overall Study|Participant treated after Week 24|0|||
129837019|NCT02641379|467368264|FG002|Overall Study|Participant treated after Week 24|0|||
129837020|NCT02641379|467368265|FG003|Overall Study|Participant treated after Week 24|0|||
129837021|NCT02641379|467368266|FG004|Overall Study|Participant treated after Week 24|0|||
129837022|NCT02641379|467368267|FG005|Overall Study|Participant treated after Week 24|0|||
129837023|NCT02641379|467368268|FG006|Overall Study|Participant treated after Week 24|0|||
129837024|NCT02641379|467368269|FG007|Overall Study|Participant treated after Week 24|0|||
129837025|NCT02641379|467368270|FG008|Overall Study|Participant treated after Week 24|1|||
129837026|NCT02641379|467368271|FG009|Overall Study|Participant treated after Week 24|0|||
129837027|NCT02641379|467368272|FG010|Overall Study|Participant treated after Week 24|0|||
129837028|NCT02641379|467368262|FG000|Overall Study|Missing PCR result at Week 8|0|||
129837029|NCT02641379|467368263|FG001|Overall Study|Missing PCR result at Week 8|0|||
129837030|NCT02641379|467368264|FG002|Overall Study|Missing PCR result at Week 8|0|||
129837031|NCT02641379|467368265|FG003|Overall Study|Missing PCR result at Week 8|0|||
129837032|NCT02641379|467368266|FG004|Overall Study|Missing PCR result at Week 8|0|||
129837033|NCT02641379|467368267|FG005|Overall Study|Missing PCR result at Week 8|0|||
129837034|NCT02641379|467368268|FG006|Overall Study|Missing PCR result at Week 8|0|||
129837035|NCT02641379|467368269|FG007|Overall Study|Missing PCR result at Week 8|0|||
129837036|NCT02641379|467368270|FG008|Overall Study|Missing PCR result at Week 8|0|||
129837037|NCT02641379|467368271|FG009|Overall Study|Missing PCR result at Week 8|1|||
129837038|NCT02641379|467368272|FG010|Overall Study|Missing PCR result at Week 8|0|||
129837039|NCT02641379|467368262|FG000|Overall Study|PCR positive|0|||
129837040|NCT02641379|467368263|FG001|Overall Study|PCR positive|0|||
129837041|NCT02641379|467368264|FG002|Overall Study|PCR positive|0|||
129837042|NCT02641379|467368265|FG003|Overall Study|PCR positive|0|||
129837043|NCT02641379|467368266|FG004|Overall Study|PCR positive|0|||
129837044|NCT02641379|467368267|FG005|Overall Study|PCR positive|0|||
129837045|NCT02641379|467368268|FG006|Overall Study|PCR positive|1|||
129837046|NCT02641379|467368269|FG007|Overall Study|PCR positive|0|||
129447032|NCT00962390|465936052|FG001|Overall Study|Protocol Violation|0|||
129837047|NCT02641379|467368270|FG008|Overall Study|PCR positive|0|||
129837048|NCT02641379|467368271|FG009|Overall Study|PCR positive|0|||
129837049|NCT02641379|467368272|FG010|Overall Study|PCR positive|0|||
129837050|NCT04964128|467368273|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
129837051|NCT04964128|467368273|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
129837052|NCT01471379|467368274|FG000|Overall Study|Adverse Event|1|||
129837053|NCT01471379|467368275|FG001|Overall Study|Adverse Event|0|||
129837054|NCT01471379|467368276|FG002|Overall Study|Adverse Event|0|||
129837055|NCT01471379|467368274|FG000|Overall Study|Study terminated|0|||
129837056|NCT01471379|467368275|FG001|Overall Study|Study terminated|1|||
129837057|NCT01471379|467368276|FG002|Overall Study|Study terminated|0|||
129837058|NCT02120794|467368277|FG000|Overall Study|Withdrawal by Subject|43|||
129837059|NCT02120794|467368277|FG000|Overall Study|Adverse Event|10|||
129837060|NCT02120794|467368277|FG000|Overall Study|Physician Decision|4|||
129837061|NCT02120794|467368277|FG000|Overall Study|Due to insurance coverage|1|||
129837062|NCT01644175|467368280|FG000|Overall Study|Randomized But Not Treated|0|||
129837063|NCT01644175|467368281|FG001|Overall Study|Randomized But Not Treated|2|||
129837064|NCT01644175|467368280|FG000|Overall Study|Adverse Event|8|||
129837065|NCT01644175|467368281|FG001|Overall Study|Adverse Event|13|||
129837066|NCT01644175|467368280|FG000|Overall Study|Death|1|||
129837067|NCT01644175|467368281|FG001|Overall Study|Death|2|||
129837068|NCT01644175|467368280|FG000|Overall Study|Poor compliance to protocol|9|||
129837069|NCT01644175|467368281|FG001|Overall Study|Poor compliance to protocol|10|||
129837070|NCT01644175|467368280|FG000|Overall Study|Physician Decision|1|||
129837071|NCT01644175|467368281|FG001|Overall Study|Physician Decision|2|||
129837072|NCT01644175|467368280|FG000|Overall Study|Participant Moved|1|||
129837073|NCT01644175|467368281|FG001|Overall Study|Participant Moved|2|||
129837074|NCT01644175|467368280|FG000|Overall Study|Consent withdrawn by participant|3|||
129837075|NCT01644175|467368281|FG001|Overall Study|Consent withdrawn by participant|4|||
129837076|NCT01644175|467368280|FG000|Overall Study|Related to Autoinjector Administration|2|||
129837077|NCT01644175|467368281|FG001|Overall Study|Related to Autoinjector Administration|1|||
129837078|NCT01644175|467368280|FG000|Overall Study|Last visit outside protocol visit window|4|||
129837079|NCT01644175|467368281|FG001|Overall Study|Last visit outside protocol visit window|11|||
129837080|NCT01644175|467368280|FG000|Overall Study|Selection criteria finally not met|0|||
129837081|NCT01644175|467368281|FG001|Overall Study|Selection criteria finally not met|1|||
129837082|NCT01644175|467368280|FG000|Overall Study|Site closure|2|||
129837083|NCT01644175|467368281|FG001|Overall Study|Site closure|2|||
129837084|NCT01644175|467368280|FG000|Overall Study|Lost to Follow-up|1|||
129837085|NCT01644175|467368281|FG001|Overall Study|Lost to Follow-up|0|||
129837086|NCT01644175|467368280|FG000|Overall Study|Other than specified above|0|||
129837087|NCT01644175|467368281|FG001|Overall Study|Other than specified above|3|||
129837088|NCT01070316|467368299|FG000|Extension Phase|Lack of Efficacy|3|||
129837089|NCT01070316|467368299|FG000|Extension Phase|Withdrawal by Subject|1|||
129837090|NCT00692770|467368302|FG000|Overall Study|Protocol Violation|2|||
129837091|NCT00692770|467368303|FG001|Overall Study|Protocol Violation|7|||
129837092|NCT00692770|467368302|FG000|Overall Study|Withdrawal by Subject|97|||
129837093|NCT00692770|467368303|FG001|Overall Study|Withdrawal by Subject|36|||
129837094|NCT00692770|467368302|FG000|Overall Study|Adverse Event|136|||
129837095|NCT00692770|467368303|FG001|Overall Study|Adverse Event|41|||
129837096|NCT00692770|467368302|FG000|Overall Study|Death|10|||
129837097|NCT00692770|467368303|FG001|Overall Study|Death|5|||
129837098|NCT00692770|467368302|FG000|Overall Study|Lost to Follow-up|7|||
129837099|NCT00692770|467368303|FG001|Overall Study|Lost to Follow-up|3|||
129837100|NCT00692770|467368302|FG000|Overall Study|Non-compliant with study medication|11|||
129837101|NCT00692770|467368303|FG001|Overall Study|Non-compliant with study medication|5|||
129837102|NCT00692770|467368302|FG000|Overall Study|Progression by clinical judgment|2|||
129837103|NCT00692770|467368303|FG001|Overall Study|Progression by clinical judgment|3|||
129837104|NCT00692770|467368302|FG000|Overall Study|Physician decision not protocol driven|10|||
129837105|NCT00692770|467368303|FG001|Overall Study|Physician decision not protocol driven|14|||
129837106|NCT00692770|467368302|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
129837107|NCT00692770|467368303|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
129837108|NCT00692770|467368302|FG000|Overall Study|Protocol driven decision point|3|||
129837109|NCT00692770|467368303|FG001|Overall Study|Protocol driven decision point|7|||
129837110|NCT00692770|467368302|FG000|Overall Study|Completed all planned assessments|79|||
129837111|NCT00692770|467368303|FG001|Overall Study|Completed all planned assessments|101|||
129837112|NCT00692770|467368302|FG000|Overall Study|Radiological and clinical progression|8|||
129837113|NCT00692770|467368303|FG001|Overall Study|Radiological and clinical progression|8|||
129837114|NCT00692770|467368302|FG000|Overall Study|Clinical endpoint reached|16|||
129837115|NCT00692770|467368303|FG001|Overall Study|Clinical endpoint reached|43|||
129837116|NCT00692770|467368302|FG000|Overall Study|Study terminated by sponsor|2|||
129837117|NCT00692770|467368303|FG001|Overall Study|Study terminated by sponsor|2|||
129837118|NCT00692770|467368302|FG000|Overall Study|Randomized but not treated|3|||
129837119|NCT00692770|467368303|FG001|Overall Study|Randomized but not treated|4|||
129837120|NCT04248816|467368304|FG000|Overall Study|Ineligible post-randomization|7|||
129837121|NCT04248816|467368305|FG001|Overall Study|Ineligible post-randomization|21|||
129837122|NCT04248816|467368306|FG002|Overall Study|Ineligible post-randomization|25|||
129837123|NCT02620046|467368309|FG000|Overall Study|Adverse Event|22|||
129837124|NCT02620046|467368310|FG001|Overall Study|Adverse Event|42|||
129837125|NCT02620046|467368309|FG000|Overall Study|Lost to Follow-up|4|||
129837126|NCT02620046|467368310|FG001|Overall Study|Lost to Follow-up|10|||
129837127|NCT02620046|467368309|FG000|Overall Study|Withdrawal by Subject|36|||
129837128|NCT02620046|467368310|FG001|Overall Study|Withdrawal by Subject|66|||
129837129|NCT02620046|467368309|FG000|Overall Study|Site Termination|3|||
129837130|NCT02620046|467368310|FG001|Overall Study|Site Termination|3|||
129837131|NCT02620046|467368309|FG000|Overall Study|Pregnancy|3|||
129837132|NCT02620046|467368310|FG001|Overall Study|Pregnancy|7|||
129837133|NCT02620046|467368309|FG000|Overall Study|Lack of Efficacy|81|||
129837134|NCT02620046|467368310|FG001|Overall Study|Lack of Efficacy|146|||
129837135|NCT02620046|467368309|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
129837136|NCT02620046|467368310|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
129837137|NCT02620046|467368309|FG000|Overall Study|Reason Not Specified|13|||
129837138|NCT02620046|467368310|FG001|Overall Study|Reason Not Specified|21|||
129837139|NCT02620046|467368309|FG000|Overall Study|Significant Protocol Deviation|0|||
129837140|NCT02620046|467368310|FG001|Overall Study|Significant Protocol Deviation|1|||
129837141|NCT00427635|467369552|FG000|Treatment Phase|Withdrawal by Subject|1|||
129837142|NCT00427635|467369553|FG001|Treatment Phase|Withdrawal by Subject|0|||
129837143|NCT00427635|467369552|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
129837144|NCT00427635|467369553|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
129837145|NCT03711162|467369556|FG000|Overall Study|Adverse Event|5|||
129837146|NCT03711162|467369557|FG001|Overall Study|Adverse Event|2|||
129837147|NCT03711162|467369558|FG002|Overall Study|Adverse Event|4|||
129837148|NCT03711162|467369556|FG000|Overall Study|Death|11|||
129837149|NCT03711162|467369557|FG001|Overall Study|Death|7|||
129837150|NCT03711162|467369558|FG002|Overall Study|Death|8|||
129837151|NCT03711162|467369556|FG000|Overall Study|Lost to Follow-up|1|||
129837152|NCT03711162|467369557|FG001|Overall Study|Lost to Follow-up|0|||
129837153|NCT03711162|467369558|FG002|Overall Study|Lost to Follow-up|1|||
129837154|NCT03711162|467369556|FG000|Overall Study|Study Terminated by Sponsor|139|||
129837155|NCT03711162|467369557|FG001|Overall Study|Study Terminated by Sponsor|152|||
129837156|NCT03711162|467369558|FG002|Overall Study|Study Terminated by Sponsor|146|||
129837157|NCT03711162|467369556|FG000|Overall Study|Withdrawal by Subject|17|||
129837158|NCT03711162|467369557|FG001|Overall Study|Withdrawal by Subject|10|||
129837159|NCT03711162|467369558|FG002|Overall Study|Withdrawal by Subject|10|||
129837160|NCT03711162|467369556|FG000|Overall Study|Miscellaneous|1|||
129837161|NCT03711162|467369557|FG001|Overall Study|Miscellaneous|2|||
129837162|NCT03711162|467369558|FG002|Overall Study|Miscellaneous|2|||
129837163|NCT03711162|467369556|FG000|Overall Study|Not Treated|1|||
129837164|NCT03711162|467369557|FG001|Overall Study|Not Treated|0|||
129837165|NCT03711162|467369558|FG002|Overall Study|Not Treated|1|||
129837166|NCT03711162|467369556|FG000|Overall Study|Physician Decision|0|||
129837167|NCT03711162|467369557|FG001|Overall Study|Physician Decision|2|||
129837168|NCT03711162|467369558|FG002|Overall Study|Physician Decision|0|||
129837169|NCT03711162|467369556|FG000|Overall Study|Lack of Efficacy|0|||
129837170|NCT03711162|467369557|FG001|Overall Study|Lack of Efficacy|0|||
129837171|NCT03711162|467369558|FG002|Overall Study|Lack of Efficacy|2|||
129837172|NCT03711162|467369556|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
129837173|NCT03711162|467369557|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
129837174|NCT03711162|467369558|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
129837175|NCT00394212|467369561|FG000|Overall Study|Lost to Follow-up|3|||
129837176|NCT00394212|467369562|FG001|Overall Study|Lost to Follow-up|0|||
129837177|NCT00394212|467369561|FG000|Overall Study|Withdrawal by Subject|4|||
129837178|NCT00394212|467369562|FG001|Overall Study|Withdrawal by Subject|1|||
129837179|NCT00588445|467369563|FG000|Overall Study|Protocol Violation|1|||
129837180|NCT00588445|467369563|FG000|Overall Study|Withdrawal by Subject|3|||
129837181|NCT00588445|467369563|FG000|Overall Study|Disease Progression|1|||
129837182|NCT00588445|467369563|FG000|Overall Study|Not Treated|10|||
129837183|NCT03240133|467369564|FG000|Overall Study|Withdrawal by Subject|0|||
129837184|NCT03240133|467369565|FG001|Overall Study|Withdrawal by Subject|1|||
129837185|NCT03240133|467369566|FG002|Overall Study|Withdrawal by Subject|0|||
129837186|NCT03240133|467369564|FG000|Overall Study|Adverse Event|1|||
129837187|NCT03240133|467369565|FG001|Overall Study|Adverse Event|1|||
129837188|NCT03240133|467369566|FG002|Overall Study|Adverse Event|0|||
129837189|NCT03240133|467369564|FG000|Overall Study|Rash|1|||
129837190|NCT03240133|467369565|FG001|Overall Study|Rash|0|||
129837191|NCT03240133|467369566|FG002|Overall Study|Rash|0|||
129837192|NCT03240133|467369564|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
129837193|NCT03240133|467369565|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
129898559|NCT04358549|467589998|FG000|Overall Study|Adverse Event|0|||
129898560|NCT04358549|467589999|FG001|Overall Study|Adverse Event|1|||
129898561|NCT04358549|467589998|FG000|Overall Study|Death|1|||
129898562|NCT04358549|467589999|FG001|Overall Study|Death|0|||
129898563|NCT04358549|467589998|FG000|Overall Study|Lost to Follow-up|2|||
129898564|NCT04358549|467589999|FG001|Overall Study|Lost to Follow-up|1|||
129898565|NCT04358549|467589998|FG000|Overall Study|Withdrawal by Subject|6|||
129898566|NCT04358549|467589999|FG001|Overall Study|Withdrawal by Subject|6|||
129898567|NCT04358549|467589998|FG000|Overall Study|Start remdesivir|1|||
129898568|NCT04358549|467589999|FG001|Overall Study|Start remdesivir|0|||
129898569|NCT01118377|467590000|FG000|Overall Study|Did Not Receive Study Medication|1|||
129898570|NCT01118377|467590000|FG000|Overall Study|Death|38|||
129898571|NCT01118377|467590000|FG000|Overall Study|Failure to Return|3|||
129898572|NCT03837028|467590001|FG000|Overall Study|Lost to Follow-up|4|||
129898573|NCT03837028|467590002|FG001|Overall Study|Lost to Follow-up|0|||
129898574|NCT03837028|467590003|FG002|Overall Study|Lost to Follow-up|2|||
129898575|NCT03837028|467590004|FG003|Overall Study|Lost to Follow-up|0|||
129898576|NCT03837028|467590001|FG000|Overall Study|Withdrawal by Subject|12|||
129898577|NCT03837028|467590002|FG001|Overall Study|Withdrawal by Subject|11|||
129898578|NCT03837028|467590003|FG002|Overall Study|Withdrawal by Subject|11|||
129898579|NCT03837028|467590004|FG003|Overall Study|Withdrawal by Subject|7|||
129898580|NCT04867902|467590005|FG000|Overall Study|Lost to Follow-up|1|||
129898581|NCT04867902|467590005|FG000|Overall Study|Withdrawal by Subject|2|||
129898582|NCT04867902|467590005|FG000|Overall Study|Protocol Violation|1|||
129898583|NCT05355116|467590006|FG000|Overall Study|Withdrawal by Subject|2|||
129898584|NCT01090024|467590007|FG000|Period 1|Met exclusion criteria|0|||
129898585|NCT01090024|467590008|FG001|Period 1|Met exclusion criteria|0|||
129898586|NCT01090024|467590009|FG002|Period 1|Met exclusion criteria|0|||
129898587|NCT01090024|467590010|FG003|Period 1|Met exclusion criteria|0|||
129898588|NCT01090024|467590011|FG004|Period 1|Met exclusion criteria|0|||
129898589|NCT01090024|467590012|FG005|Period 1|Met exclusion criteria|0|||
129898590|NCT01090024|467590013|FG006|Period 1|Met exclusion criteria|0|||
129898591|NCT01090024|467590014|FG007|Period 1|Met exclusion criteria|0|||
129898592|NCT01090024|467590015|FG008|Period 1|Met exclusion criteria|0|||
129898593|NCT01090024|467590016|FG009|Period 1|Met exclusion criteria|0|||
129898594|NCT01090024|467590017|FG010|Period 1|Met exclusion criteria|0|||
129898595|NCT01090024|467590018|FG011|Period 1|Met exclusion criteria|0|||
129898596|NCT01090024|467590019|FG012|Period 1|Met exclusion criteria|0|||
129898597|NCT01090024|467590020|FG013|Period 1|Met exclusion criteria|0|||
129898598|NCT01090024|467590021|FG014|Period 1|Met exclusion criteria|1|||
129898599|NCT01090024|467590022|FG015|Period 1|Met exclusion criteria|0|||
129898600|NCT01090024|467590023|FG016|Period 1|Met exclusion criteria|0|||
129898601|NCT01090024|467590024|FG017|Period 1|Met exclusion criteria|0|||
129898602|NCT01090024|467590007|FG000|Period 1|Adverse Event|0|||
129837194|NCT03240133|467369566|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
129837195|NCT03240133|467369564|FG000|Overall Study|Intercurrent illness.|0|||
129837196|NCT03240133|467369565|FG001|Overall Study|Intercurrent illness.|1|||
129837197|NCT03240133|467369566|FG002|Overall Study|Intercurrent illness.|0|||
129837198|NCT03240133|467369564|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
129837199|NCT03240133|467369565|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
129837200|NCT03240133|467369566|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
129837201|NCT01176292|467369570|FG000|Overall Study|Lost to Follow-up|2|||
129837202|NCT01176292|467369571|FG001|Overall Study|Lost to Follow-up|4|||
129837203|NCT01176292|467369570|FG000|Overall Study|Adverse Event|1|||
129837204|NCT01176292|467369571|FG001|Overall Study|Adverse Event|1|||
129837205|NCT01176292|467369570|FG000|Overall Study|Physician Decision|0|||
129837206|NCT01176292|467369571|FG001|Overall Study|Physician Decision|2|||
129837207|NCT01176292|467369570|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
129837208|NCT01176292|467369571|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
129837209|NCT00110812|467369572|FG000|Main Study|Death|0|||
129837210|NCT00110812|467369573|FG001|Main Study|Death|0|||
129837211|NCT00110812|467369574|FG002|Main Study|Death|2|||
129837212|NCT00110812|467369572|FG000|Main Study|Withdrawal by Subject|0|||
129837213|NCT00110812|467369573|FG001|Main Study|Withdrawal by Subject|0|||
129837214|NCT00110812|467369574|FG002|Main Study|Withdrawal by Subject|1|||
129837215|NCT00110812|467369572|FG000|Main Study|Lost to Follow-up|8|||
129837216|NCT00110812|467369573|FG001|Main Study|Lost to Follow-up|11|||
129837217|NCT00110812|467369574|FG002|Main Study|Lost to Follow-up|10|||
129837218|NCT00110812|467369572|FG000|Extended Follow-up|Death|1|||
129837219|NCT00110812|467369573|FG001|Extended Follow-up|Death|0|||
129837220|NCT00110812|467369574|FG002|Extended Follow-up|Death|3|||
129837221|NCT00110812|467369572|FG000|Extended Follow-up|Withdrawal by Subject|0|||
129837222|NCT00110812|467369573|FG001|Extended Follow-up|Withdrawal by Subject|1|||
129837223|NCT00110812|467369574|FG002|Extended Follow-up|Withdrawal by Subject|0|||
129837224|NCT00110812|467369572|FG000|Extended Follow-up|Lost to Follow-up|1|||
129837225|NCT00110812|467369573|FG001|Extended Follow-up|Lost to Follow-up|3|||
129837226|NCT00110812|467369574|FG002|Extended Follow-up|Lost to Follow-up|1|||
129837227|NCT01446965|467369576|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
129837228|NCT01446965|467369577|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
129837229|NCT01446965|467369576|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
129837230|NCT01446965|467369577|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
129837231|NCT02852265|467369578|FG000|3-month Follow-up|Lost to Follow-up|1|||
129837232|NCT02852265|467369579|FG001|3-month Follow-up|Lost to Follow-up|1|||
129837233|NCT01828034|467369582|FG000|Overall Study|Withdrawal by Subject|0|||
129837234|NCT01828034|467369583|FG001|Overall Study|Withdrawal by Subject|0|||
129837235|NCT01828034|467369584|FG002|Overall Study|Withdrawal by Subject|0|||
129837236|NCT01828034|467369585|FG003|Overall Study|Withdrawal by Subject|1|||
129837237|NCT02871375|467369586|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
129837238|NCT02871375|467369587|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
129837239|NCT01988571|467369590|FG000|Overall Study|Death|3|||
129837240|NCT01988571|467369591|FG001|Overall Study|Death|1|||
129837241|NCT01988571|467369590|FG000|Overall Study|Physician Decision|2|||
129837242|NCT01988571|467369591|FG001|Overall Study|Physician Decision|1|||
129837243|NCT01988571|467369590|FG000|Overall Study|Lost to Follow-up|3|||
129898603|NCT01090024|467590008|FG001|Period 1|Adverse Event|0|||
129837244|NCT01988571|467369591|FG001|Overall Study|Lost to Follow-up|0|||
129837245|NCT01988571|467369590|FG000|Overall Study|Withdrawal by Subject|31|||
129837246|NCT01988571|467369591|FG001|Overall Study|Withdrawal by Subject|33|||
129837247|NCT00004412|467369592|FG000|Randomized Period|Moved to Crossover Period|3|||
129837248|NCT00004412|467369593|FG001|Randomized Period|Moved to Crossover Period|0|||
129898604|NCT01090024|467590009|FG002|Period 1|Adverse Event|0|||
129837249|NCT00004412|467369594|FG002|Randomized Period|Moved to Crossover Period|0|||
129837250|NCT01364428|467369597|FG000|Overall Study|Adverse Event|1|||
129837251|NCT01364428|467369598|FG001|Overall Study|Adverse Event|2|||
129837252|NCT01364428|467369597|FG000|Overall Study|Protocol Violation|2|||
129837253|NCT01364428|467369598|FG001|Overall Study|Protocol Violation|0|||
129837254|NCT01364428|467369597|FG000|Overall Study|Withdrawal Criteria|14|||
129837255|NCT01364428|467369598|FG001|Overall Study|Withdrawal Criteria|10|||
129837256|NCT01364428|467369597|FG000|Overall Study|Other|3|||
129837257|NCT01364428|467369598|FG001|Overall Study|Other|3|||
129837258|NCT00743652|467369599|FG000|Overall Study|Parent/Legal Guardian Request|3|||
129837259|NCT00743652|467369600|FG001|Overall Study|Parent/Legal Guardian Request|2|||
129898605|NCT01090024|467590010|FG003|Period 1|Adverse Event|0|||
129837260|NCT00743652|467369601|FG002|Overall Study|Parent/Legal Guardian Request|2|||
129837261|NCT00743652|467369602|FG003|Overall Study|Parent/Legal Guardian Request|2|||
129837262|NCT00743652|467369603|FG004|Overall Study|Parent/Legal Guardian Request|0|||
129837263|NCT00743652|467369599|FG000|Overall Study|Adverse Event|3|||
129898606|NCT01090024|467590011|FG004|Period 1|Adverse Event|0|||
129898607|NCT01090024|467590012|FG005|Period 1|Adverse Event|0|||
129898608|NCT01090024|467590013|FG006|Period 1|Adverse Event|0|||
129898609|NCT01090024|467590014|FG007|Period 1|Adverse Event|0|||
129898610|NCT01090024|467590015|FG008|Period 1|Adverse Event|0|||
129898611|NCT01090024|467590016|FG009|Period 1|Adverse Event|1|||
129898612|NCT01090024|467590017|FG010|Period 1|Adverse Event|0|||
129898613|NCT01090024|467590018|FG011|Period 1|Adverse Event|1|||
129898614|NCT01090024|467590019|FG012|Period 1|Adverse Event|0|||
129898615|NCT01090024|467590020|FG013|Period 1|Adverse Event|0|||
129898616|NCT01090024|467590021|FG014|Period 1|Adverse Event|0|||
129898617|NCT01090024|467590022|FG015|Period 1|Adverse Event|0|||
129898618|NCT01090024|467590023|FG016|Period 1|Adverse Event|0|||
129898619|NCT01090024|467590024|FG017|Period 1|Adverse Event|1|||
129898620|NCT01090024|467590007|FG000|Period 1|Withdrawal by Subject|0|||
129898621|NCT01090024|467590008|FG001|Period 1|Withdrawal by Subject|0|||
129898622|NCT01090024|467590009|FG002|Period 1|Withdrawal by Subject|0|||
129837264|NCT00743652|467369600|FG001|Overall Study|Adverse Event|0|||
129837265|NCT00743652|467369601|FG002|Overall Study|Adverse Event|0|||
129837266|NCT00743652|467369602|FG003|Overall Study|Adverse Event|0|||
129837267|NCT00743652|467369603|FG004|Overall Study|Adverse Event|0|||
129837268|NCT00743652|467369599|FG000|Overall Study|Death|2|||
129837269|NCT00743652|467369600|FG001|Overall Study|Death|0|||
129837270|NCT00743652|467369601|FG002|Overall Study|Death|0|||
129837271|NCT00743652|467369602|FG003|Overall Study|Death|0|||
129837272|NCT00743652|467369603|FG004|Overall Study|Death|0|||
129837273|NCT00743652|467369599|FG000|Overall Study|Investigator Request|0|||
129837274|NCT00743652|467369600|FG001|Overall Study|Investigator Request|0|||
129837275|NCT00743652|467369601|FG002|Overall Study|Investigator Request|0|||
129837276|NCT00743652|467369602|FG003|Overall Study|Investigator Request|2|||
129837277|NCT00743652|467369603|FG004|Overall Study|Investigator Request|0|||
129837278|NCT00743652|467369599|FG000|Overall Study|Other|1|||
129837279|NCT00743652|467369600|FG001|Overall Study|Other|1|||
129837280|NCT00743652|467369601|FG002|Overall Study|Other|0|||
129898623|NCT01090024|467590010|FG003|Period 1|Withdrawal by Subject|1|||
129898624|NCT01090024|467590011|FG004|Period 1|Withdrawal by Subject|0|||
129898625|NCT01090024|467590012|FG005|Period 1|Withdrawal by Subject|0|||
129837281|NCT00743652|467369602|FG003|Overall Study|Other|0|||
129837282|NCT00743652|467369603|FG004|Overall Study|Other|0|||
129837283|NCT00743652|467369599|FG000|Overall Study|Lost to Follow-up|1|||
129898626|NCT01090024|467590013|FG006|Period 1|Withdrawal by Subject|0|||
129837284|NCT00743652|467369600|FG001|Overall Study|Lost to Follow-up|0|||
129837285|NCT00743652|467369601|FG002|Overall Study|Lost to Follow-up|0|||
129837286|NCT00743652|467369602|FG003|Overall Study|Lost to Follow-up|0|||
129837287|NCT00743652|467369603|FG004|Overall Study|Lost to Follow-up|0|||
129898627|NCT01090024|467590014|FG007|Period 1|Withdrawal by Subject|0|||
129898628|NCT01090024|467590015|FG008|Period 1|Withdrawal by Subject|0|||
129898629|NCT01090024|467590016|FG009|Period 1|Withdrawal by Subject|0|||
129898630|NCT01090024|467590017|FG010|Period 1|Withdrawal by Subject|0|||
129898631|NCT01090024|467590018|FG011|Period 1|Withdrawal by Subject|0|||
129837288|NCT02689258|467369604|FG000|Overall Study|Subject Non-Compliance|0|||
129837289|NCT02689258|467369605|FG001|Overall Study|Subject Non-Compliance|1|||
129837290|NCT02689258|467369606|FG002|Overall Study|Subject Non-Compliance|0|||
129837291|NCT02689258|467369607|FG003|Overall Study|Subject Non-Compliance|0|||
129837292|NCT02689258|467369608|FG004|Overall Study|Subject Non-Compliance|0|||
129837293|NCT02689258|467369609|FG005|Overall Study|Subject Non-Compliance|0|||
129837294|NCT02689258|467369610|FG006|Overall Study|Subject Non-Compliance|0|||
129837295|NCT02689258|467369611|FG007|Overall Study|Subject Non-Compliance|0|||
129837296|NCT02689258|467369612|FG008|Overall Study|Subject Non-Compliance|0|||
129837297|NCT02689258|467369613|FG009|Overall Study|Subject Non-Compliance|0|||
129837298|NCT02689258|467369614|FG010|Overall Study|Subject Non-Compliance|0|||
129837299|NCT02689258|467369615|FG011|Overall Study|Subject Non-Compliance|0|||
129837300|NCT02689258|467369604|FG000|Overall Study|Subject Refusal to Continue|0|||
129837301|NCT02689258|467369605|FG001|Overall Study|Subject Refusal to Continue|1|||
129837302|NCT02689258|467369606|FG002|Overall Study|Subject Refusal to Continue|0|||
129837303|NCT02689258|467369607|FG003|Overall Study|Subject Refusal to Continue|0|||
129837304|NCT02689258|467369608|FG004|Overall Study|Subject Refusal to Continue|0|||
129837305|NCT02689258|467369609|FG005|Overall Study|Subject Refusal to Continue|0|||
129837306|NCT02689258|467369610|FG006|Overall Study|Subject Refusal to Continue|0|||
129837307|NCT02689258|467369611|FG007|Overall Study|Subject Refusal to Continue|0|||
129837308|NCT02689258|467369612|FG008|Overall Study|Subject Refusal to Continue|1|||
129837309|NCT02689258|467369613|FG009|Overall Study|Subject Refusal to Continue|0|||
129837310|NCT02689258|467369614|FG010|Overall Study|Subject Refusal to Continue|0|||
129837311|NCT02689258|467369615|FG011|Overall Study|Subject Refusal to Continue|1|||
129837312|NCT02689258|467369604|FG000|Overall Study|Other|0|||
129837313|NCT02689258|467369605|FG001|Overall Study|Other|2|||
129837314|NCT02689258|467369606|FG002|Overall Study|Other|0|||
129837315|NCT02689258|467369607|FG003|Overall Study|Other|0|||
129837316|NCT02689258|467369608|FG004|Overall Study|Other|1|||
129837317|NCT02689258|467369609|FG005|Overall Study|Other|0|||
129837318|NCT02689258|467369610|FG006|Overall Study|Other|0|||
129837319|NCT02689258|467369611|FG007|Overall Study|Other|0|||
129837320|NCT02689258|467369612|FG008|Overall Study|Other|1|||
129837321|NCT02689258|467369613|FG009|Overall Study|Other|0|||
129837322|NCT02689258|467369614|FG010|Overall Study|Other|0|||
129837323|NCT02689258|467369615|FG011|Overall Study|Other|0|||
129837324|NCT06049043|467369625|FG000|Overall Study|Lost to Follow-up|11|||
129837325|NCT06049043|467369626|FG001|Overall Study|Lost to Follow-up|9|||
129837326|NCT01354496|467369630|FG000|Period 1|Adverse Event|0|||
129837327|NCT01354496|467369631|FG001|Period 1|Adverse Event|0|||
129837328|NCT01354496|467369632|FG002|Period 1|Adverse Event|1|||
129837329|NCT01354496|467369633|FG003|Period 1|Adverse Event|0|||
129837330|NCT01354496|467369634|FG004|Period 1|Adverse Event|0|||
129837331|NCT01354496|467369635|FG005|Period 1|Adverse Event|0|||
129837332|NCT01354496|467369630|FG000|Period 1|Physician Decision|0|||
129837333|NCT01354496|467369631|FG001|Period 1|Physician Decision|0|||
129837334|NCT01354496|467369632|FG002|Period 1|Physician Decision|1|||
129837335|NCT01354496|467369633|FG003|Period 1|Physician Decision|0|||
129837336|NCT01354496|467369634|FG004|Period 1|Physician Decision|0|||
129837337|NCT01354496|467369635|FG005|Period 1|Physician Decision|0|||
129837338|NCT01354496|467369630|FG000|Period 2|Adverse Event|0|||
129837339|NCT01354496|467369631|FG001|Period 2|Adverse Event|0|||
129837340|NCT01354496|467369632|FG002|Period 2|Adverse Event|0|||
129837341|NCT01354496|467369633|FG003|Period 2|Adverse Event|1|||
129837342|NCT01354496|467369634|FG004|Period 2|Adverse Event|0|||
129837343|NCT01354496|467369635|FG005|Period 2|Adverse Event|0|||
129837344|NCT01354496|467369630|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837345|NCT01354496|467369631|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
129837346|NCT01354496|467369632|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837347|NCT01354496|467369633|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
129837348|NCT01354496|467369634|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837349|NCT01354496|467369635|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
129837350|NCT03216850|467369636|FG000|Overall Study|Pre-analytical error|6|||
129837351|NCT03190889|467369637|FG000|Overall Study|Lost to Follow-up|7|||
129837352|NCT03190889|467369638|FG001|Overall Study|Lost to Follow-up|7|||
129837353|NCT03190889|467369639|FG002|Overall Study|Lost to Follow-up|3|||
129898632|NCT01090024|467590019|FG012|Period 1|Withdrawal by Subject|0|||
129837354|NCT03190889|467369637|FG000|Overall Study|Withdrawal by Subject|1|||
129837355|NCT03190889|467369638|FG001|Overall Study|Withdrawal by Subject|1|||
129837356|NCT03190889|467369639|FG002|Overall Study|Withdrawal by Subject|2|||
129837357|NCT03190889|467369637|FG000|Overall Study|Did not complete protocol|4|||
129837358|NCT03190889|467369638|FG001|Overall Study|Did not complete protocol|9|||
129837359|NCT03190889|467369639|FG002|Overall Study|Did not complete protocol|0|||
129837360|NCT03190889|467369637|FG000|Overall Study|COVID-19|1|||
129837361|NCT03190889|467369638|FG001|Overall Study|COVID-19|0|||
129837362|NCT03190889|467369639|FG002|Overall Study|COVID-19|2|||
129837363|NCT01228747|467369640|FG000|Overall Study|Adverse Event|8|||
129837364|NCT01228747|467369641|FG001|Overall Study|Adverse Event|4|||
129837365|NCT01228747|467369640|FG000|Overall Study|Lack of Efficacy|40|||
129837366|NCT01228747|467369641|FG001|Overall Study|Lack of Efficacy|27|||
129837367|NCT01228747|467369640|FG000|Overall Study|Protocol Violation|6|||
129837368|NCT01228747|467369641|FG001|Overall Study|Protocol Violation|5|||
129447033|NCT00962390|465936053|FG002|Overall Study|Protocol Violation|0|||
129447034|NCT00962390|465936054|FG003|Overall Study|Protocol Violation|0|||
129447035|NCT00962390|465936051|FG000|Overall Study|Withdrawal by Subject|1|||
129447036|NCT00962390|465936052|FG001|Overall Study|Withdrawal by Subject|1|||
129447037|NCT00962390|465936053|FG002|Overall Study|Withdrawal by Subject|1|||
129447038|NCT00962390|465936054|FG003|Overall Study|Withdrawal by Subject|0|||
129447039|NCT02613884|465936055|FG000|Overall Study|Death|1|||
129447040|NCT02613884|465936055|FG000|Overall Study|Lost to Follow-up|1|||
129447041|NCT00770770|465936056|FG000|Overall Study|Lost to Follow-up|1|||
129447042|NCT00770770|465936057|FG001|Overall Study|Lost to Follow-up|0|||
129447043|NCT00770770|465936056|FG000|Overall Study|Withdrawal by Subject|1|||
129447044|NCT00770770|465936057|FG001|Overall Study|Withdrawal by Subject|0|||
129447045|NCT00770770|465936056|FG000|Overall Study|Death|0|||
129447046|NCT00770770|465936057|FG001|Overall Study|Death|1|||
129447047|NCT00770770|465936056|FG000|Overall Study|Study Terminated|8|||
129447048|NCT00770770|465936057|FG001|Overall Study|Study Terminated|0|||
129447049|NCT00685685|465936068|FG000|Washout Period of 7 Days|Adverse Event|2|||
129837369|NCT01228747|467369640|FG000|Overall Study|Lost to Follow-up|4|||
129837370|NCT01228747|467369641|FG001|Overall Study|Lost to Follow-up|3|||
129837371|NCT01228747|467369640|FG000|Overall Study|Withdrawal by Subject|5|||
129837372|NCT01228747|467369641|FG001|Overall Study|Withdrawal by Subject|1|||
129837373|NCT01228747|467369640|FG000|Overall Study|Other Reason|2|||
129837374|NCT01228747|467369641|FG001|Overall Study|Other Reason|5|||
129837375|NCT00500292|467369645|FG000|Overall Study|Adverse Event|3|||
129837376|NCT00500292|467369646|FG001|Overall Study|Adverse Event|6|||
129837377|NCT00500292|467369647|FG002|Overall Study|Adverse Event|4|||
129837378|NCT00500292|467369645|FG000|Overall Study|Condition under investigation worsened|21|||
129837379|NCT00500292|467369646|FG001|Overall Study|Condition under investigation worsened|23|||
129837380|NCT00500292|467369647|FG002|Overall Study|Condition under investigation worsened|19|||
129837381|NCT00500292|467369645|FG000|Overall Study|Withdrawal by Subject|0|||
129837382|NCT00500292|467369646|FG001|Overall Study|Withdrawal by Subject|1|||
129837383|NCT00500292|467369647|FG002|Overall Study|Withdrawal by Subject|0|||
129837384|NCT00500292|467369645|FG000|Overall Study|Other|1|||
129837385|NCT00500292|467369646|FG001|Overall Study|Other|1|||
129837386|NCT00500292|467369647|FG002|Overall Study|Other|4|||
129837387|NCT04982250|467369650|FG000|Overall Study|Lost to Follow-up|0|||
129837388|NCT04982250|467369651|FG001|Overall Study|Lost to Follow-up|26|||
129837389|NCT04982250|467369652|FG002|Overall Study|Lost to Follow-up|0|||
129837390|NCT04982250|467369653|FG003|Overall Study|Lost to Follow-up|0|||
129837391|NCT04982250|467369654|FG004|Overall Study|Lost to Follow-up|72|||
129837392|NCT04982250|467369655|FG005|Overall Study|Lost to Follow-up|69|||
129837393|NCT04982250|467369650|FG000|Overall Study|Not Eligible to Enroll|0|||
129837394|NCT04982250|467369651|FG001|Overall Study|Not Eligible to Enroll|0|||
129837395|NCT04982250|467369652|FG002|Overall Study|Not Eligible to Enroll|0|||
129837396|NCT04982250|467369653|FG003|Overall Study|Not Eligible to Enroll|0|||
129837397|NCT04982250|467369654|FG004|Overall Study|Not Eligible to Enroll|10|||
129837398|NCT04982250|467369655|FG005|Overall Study|Not Eligible to Enroll|7|||
129837399|NCT01148511|467369657|FG000|Exposed to Study Drug|Protocol Violation|2|||
129837400|NCT01148511|467369658|FG001|Exposed to Study Drug|Protocol Violation|0|||
129837401|NCT01148511|467369659|FG002|Exposed to Study Drug|Protocol Violation|0|||
129837402|NCT01148511|467369657|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
129837403|NCT01148511|467369658|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
129837404|NCT01148511|467369659|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
129837405|NCT01148511|467369657|FG000|Randomized|Adverse Event|0|||
129837406|NCT01148511|467369658|FG001|Randomized|Adverse Event|1|||
129837407|NCT01148511|467369659|FG002|Randomized|Adverse Event|0|||
129837408|NCT01148511|467369657|FG000|Randomized|Protocol Violation|0|||
129837409|NCT01148511|467369658|FG001|Randomized|Protocol Violation|2|||
129837410|NCT01148511|467369659|FG002|Randomized|Protocol Violation|1|||
129837411|NCT01148511|467369657|FG000|Randomized|Lost to Follow-up|0|||
129837412|NCT01148511|467369658|FG001|Randomized|Lost to Follow-up|1|||
129837413|NCT01148511|467369659|FG002|Randomized|Lost to Follow-up|1|||
129837414|NCT01148511|467369657|FG000|Randomized|Consent withdrawal|0|||
129447050|NCT00685685|465936069|FG001|Washout Period of 7 Days|Adverse Event|0|||
129837415|NCT01148511|467369658|FG001|Randomized|Consent withdrawal|5|||
129837416|NCT01148511|467369659|FG002|Randomized|Consent withdrawal|3|||
129837417|NCT01148511|467369657|FG000|Randomized|Other|0|||
129837418|NCT01148511|467369658|FG001|Randomized|Other|1|||
129837419|NCT01148511|467369659|FG002|Randomized|Other|1|||
129837420|NCT04258605|467369661|FG000|Overall Study|Death|1|||
129837421|NCT04258605|467369662|FG001|Overall Study|Death|0|||
129837422|NCT04258605|467369661|FG000|Overall Study|Early study termination|21|||
129837423|NCT04258605|467369662|FG001|Overall Study|Early study termination|2|||
129837424|NCT00856908|467369679|FG000|Overall Study|Lost to Follow-up|1|||
129447051|NCT00685685|465936068|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
129447052|NCT00685685|465936069|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129447053|NCT04513665|465936070|FG000|Overall Study|Adverse Event|2|||
129447054|NCT04513665|465936071|FG001|Overall Study|Adverse Event|0|||
129837425|NCT00856908|467369680|FG001|Overall Study|Lost to Follow-up|0|||
129447055|NCT04513665|465936070|FG000|Overall Study|Lack of Efficacy|14|||
129837426|NCT01712256|467369683|FG000|Overall Study|Lost to Follow-up|1|||
129837427|NCT02196324|467369686|FG000|Overall Study|Withdrawal by Subject|8|||
129837428|NCT02196324|467369687|FG001|Overall Study|Withdrawal by Subject|4|||
129837429|NCT02196324|467369686|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
129837430|NCT02196324|467369687|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
129837431|NCT02196324|467369686|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
129837432|NCT02196324|467369687|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
129447056|NCT04513665|465936071|FG001|Overall Study|Lack of Efficacy|0|||
129837433|NCT02196324|467369686|FG000|Overall Study|Other|1|||
129837434|NCT02196324|467369687|FG001|Overall Study|Other|0|||
129837435|NCT04327986|467369688|FG000|Overall Study|Physician Decision|2|||
129837436|NCT04327986|467369689|FG001|Overall Study|Physician Decision|0|||
129837437|NCT04327986|467369690|FG002|Overall Study|Physician Decision|0|||
129837438|NCT04327986|467369688|FG000|Overall Study|Death|1|||
129837439|NCT04327986|467369689|FG001|Overall Study|Death|0|||
129837440|NCT04327986|467369690|FG002|Overall Study|Death|0|||
129837441|NCT00655564|467369691|FG000|Overall Study|Adverse Event|1|||
129837442|NCT00655564|467369691|FG000|Overall Study|Lost to Follow-up|1|||
129837443|NCT00655564|467369691|FG000|Overall Study|Desired Alternate Therapy|1|||
129837444|NCT00560950|467369693|FG000|Overall Study|Lost to Follow-up|1|||
129837445|NCT00560950|467369694|FG001|Overall Study|Lost to Follow-up|0|||
129837446|NCT02917031|467369695|FG000|Overall Study|Reason not specified|7|||
129837447|NCT02917031|467369696|FG001|Overall Study|Reason not specified|5|||
129837448|NCT02917031|467369697|FG002|Overall Study|Reason not specified|6|||
129837449|NCT02917031|467369695|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
129837450|NCT02917031|467369696|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
129837451|NCT02917031|467369697|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
129837452|NCT02917031|467369695|FG000|Overall Study|Withdrawal by Subject|3|||
129837453|NCT02917031|467369696|FG001|Overall Study|Withdrawal by Subject|3|||
129837454|NCT02917031|467369697|FG002|Overall Study|Withdrawal by Subject|0|||
129837455|NCT02917031|467369695|FG000|Overall Study|Physician Decision|1|||
129837456|NCT02917031|467369696|FG001|Overall Study|Physician Decision|0|||
129837457|NCT02917031|467369697|FG002|Overall Study|Physician Decision|0|||
129837458|NCT02917031|467369695|FG000|Overall Study|Adverse Event|4|||
129837459|NCT02917031|467369696|FG001|Overall Study|Adverse Event|1|||
129837460|NCT02917031|467369697|FG002|Overall Study|Adverse Event|5|||
129837461|NCT02917031|467369695|FG000|Overall Study|Death|2|||
129837462|NCT02917031|467369696|FG001|Overall Study|Death|3|||
129837463|NCT02917031|467369697|FG002|Overall Study|Death|4|||
129837464|NCT02181556|467371601|FG000|Overall Study|Withdrawal by Subject|1|||
129837465|NCT01940120|467371602|FG000|Overall Study|Death|40|||
129837466|NCT01940120|467371602|FG000|Overall Study|Withdrawal by Subject|8|||
129837467|NCT01572038|467371604|FG000|Overall Study|Death|648|||
129837468|NCT01572038|467371604|FG000|Overall Study|Withdrawal by Subject|204|||
129837469|NCT01572038|467371604|FG000|Overall Study|Lost to Follow-up|81|||
129837470|NCT01572038|467371604|FG000|Overall Study|Physician Decision|20|||
129837471|NCT01572038|467371604|FG000|Overall Study|Patient Decision|14|||
129837472|NCT01572038|467371604|FG000|Overall Study|Progressive Disease|8|||
129837473|NCT01572038|467371604|FG000|Overall Study|Site Closed Before Completing Form|6|||
129837474|NCT01572038|467371604|FG000|Overall Study|Enrolled into Another Trial|3|||
129837475|NCT01572038|467371604|FG000|Overall Study|Participated in Another Trial|3|||
129837476|NCT01572038|467371604|FG000|Overall Study|Termination by Sponsor|2|||
129837477|NCT01572038|467371604|FG000|Overall Study|Patient Deterioration|1|||
129837478|NCT01572038|467371604|FG000|Overall Study|Sponsor Decision|1|||
129837479|NCT01888497|467371605|FG000|Washout Period 1|Withdrawal by Subject|0|||
129837480|NCT01888497|467371606|FG001|Washout Period 1|Withdrawal by Subject|0|||
129837481|NCT01888497|467371607|FG002|Washout Period 1|Withdrawal by Subject|1|||
129837482|NCT01888497|467371608|FG003|Washout Period 1|Withdrawal by Subject|1|||
129837483|NCT01888497|467371605|FG000|Washout Period 2|Adverse Event|0|||
129837484|NCT01888497|467371606|FG001|Washout Period 2|Adverse Event|0|||
129837485|NCT01888497|467371607|FG002|Washout Period 2|Adverse Event|0|||
129837486|NCT01888497|467371608|FG003|Washout Period 2|Adverse Event|1|||
129837487|NCT01888497|467371605|FG000|Washout Period 2|Withdrawal by Subject|0|||
129837488|NCT01888497|467371606|FG001|Washout Period 2|Withdrawal by Subject|0|||
129837489|NCT01888497|467371607|FG002|Washout Period 2|Withdrawal by Subject|0|||
129837490|NCT01888497|467371608|FG003|Washout Period 2|Withdrawal by Subject|1|||
129837491|NCT04152447|467371609|FG000|Overall Study|Lost to Follow-up|1|||
129837492|NCT04152447|467371610|FG001|Overall Study|Lost to Follow-up|0|||
129837493|NCT04152447|467371609|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
129837494|NCT04152447|467371610|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
129837495|NCT04152447|467371609|FG000|Overall Study|Withdrawal by Subject|0|||
129837496|NCT04152447|467371610|FG001|Overall Study|Withdrawal by Subject|1|||
129837497|NCT04152447|467371609|FG000|Overall Study|Found ineligible after enrolling|1|||
129837498|NCT04152447|467371610|FG001|Overall Study|Found ineligible after enrolling|1|||
129837499|NCT04152447|467371609|FG000|Overall Study|Did not receive VR headset in time.|0|||
129837500|NCT04152447|467371610|FG001|Overall Study|Did not receive VR headset in time.|2|||
129837501|NCT03034954|467371611|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
129837502|NCT03034954|467371612|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
129837503|NCT04200248|467371617|FG000|Overall Study|Personal reasons|0|||
129837504|NCT04200248|467371618|FG001|Overall Study|Personal reasons|0|||
129837505|NCT04200248|467371619|FG002|Overall Study|Personal reasons|1|||
129837506|NCT04200248|467371617|FG000|Overall Study|Discontinued prior to treatment|3|||
129837507|NCT04200248|467371618|FG001|Overall Study|Discontinued prior to treatment|3|||
129837508|NCT04200248|467371619|FG002|Overall Study|Discontinued prior to treatment|2|||
129898633|NCT01090024|467590020|FG013|Period 1|Withdrawal by Subject|0|||
129447057|NCT02608879|465936073|FG000|Overall Study|Lost to Follow-up|1|||
129447058|NCT02608879|465936074|FG001|Overall Study|Lost to Follow-up|0|||
129447059|NCT02608879|465936075|FG002|Overall Study|Lost to Follow-up|0|||
129447060|NCT02608879|465936073|FG000|Overall Study|Did not meet continuation criteria|0|||
129447061|NCT02608879|465936074|FG001|Overall Study|Did not meet continuation criteria|0|||
129447062|NCT02608879|465936075|FG002|Overall Study|Did not meet continuation criteria|3|||
129837509|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
129837510|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
129837511|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
129837512|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
129837513|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
129837514|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
129837515|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
129837516|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
129837517|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
129837518|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
129837519|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
129837520|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
129837521|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
129837522|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
129837523|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
129837524|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
129837525|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
129837526|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
129837527|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
129837528|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
129837529|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
129837530|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
129837531|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
129837532|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
129837533|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
129837534|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
129837535|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
129837536|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
129837537|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
129837538|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
129837539|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
129837540|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
129837541|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
129837542|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
129837543|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
129837544|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
129837545|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
129837546|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
129837547|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
129837548|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
129837549|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
129837550|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
129837551|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
129837552|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
129837553|NCT01218516|467371622|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
129837554|NCT01218516|467371623|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
129837555|NCT01218516|467371624|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
129837556|NCT01218516|467371625|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
129837557|NCT04171414|467371626|FG000|Overall Study|Death|1|||
129837558|NCT04171414|467371626|FG000|Overall Study|Withdrawal by Subject|1|||
129837559|NCT01714310|467371627|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
129837560|NCT01714310|467371628|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
129447063|NCT04223791|465936076|FG000|Overall Study|Lost to Follow-up|0|||
129447064|NCT04223791|465936077|FG001|Overall Study|Lost to Follow-up|4|||
129447065|NCT04223791|465936076|FG000|Overall Study|Physician Decision|5|||
129447066|NCT04223791|465936077|FG001|Overall Study|Physician Decision|1|||
129447067|NCT04223791|465936076|FG000|Overall Study|Protocol Violation|1|||
129447068|NCT04223791|465936077|FG001|Overall Study|Protocol Violation|1|||
129898634|NCT01090024|467590021|FG014|Period 1|Withdrawal by Subject|0|||
129837561|NCT01714310|467371629|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
129837562|NCT01714310|467371627|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
129837563|NCT01714310|467371628|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
129837564|NCT01714310|467371629|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
129837565|NCT01714310|467371627|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
129837566|NCT01714310|467371628|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
129837567|NCT01714310|467371629|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
129837568|NCT01714310|467371627|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
129837569|NCT01714310|467371628|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
129837570|NCT01714310|467371629|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
129837571|NCT02586493|467371634|FG000|Overall Study|Adverse Event|4|||
129837572|NCT02586493|467371634|FG000|Overall Study|Protocol Violation|6|||
129837573|NCT02586493|467371634|FG000|Overall Study|Lost to Follow-up|1|||
129837574|NCT02586493|467371634|FG000|Overall Study|Withdrawal by Subject|1|||
129837575|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
129837576|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
129837577|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
129837578|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
129837579|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
129837580|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
129898635|NCT01090024|467590022|FG015|Period 1|Withdrawal by Subject|0|||
129898636|NCT01090024|467590023|FG016|Period 1|Withdrawal by Subject|0|||
129898637|NCT01090024|467590024|FG017|Period 1|Withdrawal by Subject|0|||
129898638|NCT01090024|467590007|FG000|Period 1|Lost to Follow-up|0|||
129898639|NCT01090024|467590008|FG001|Period 1|Lost to Follow-up|1|||
129898640|NCT01090024|467590009|FG002|Period 1|Lost to Follow-up|0|||
129898641|NCT01090024|467590010|FG003|Period 1|Lost to Follow-up|0|||
129898642|NCT01090024|467590011|FG004|Period 1|Lost to Follow-up|0|||
129898643|NCT01090024|467590012|FG005|Period 1|Lost to Follow-up|0|||
129898644|NCT01090024|467590013|FG006|Period 1|Lost to Follow-up|0|||
129898645|NCT01090024|467590014|FG007|Period 1|Lost to Follow-up|0|||
129898646|NCT01090024|467590015|FG008|Period 1|Lost to Follow-up|0|||
129898647|NCT01090024|467590016|FG009|Period 1|Lost to Follow-up|0|||
129898648|NCT01090024|467590017|FG010|Period 1|Lost to Follow-up|0|||
129898649|NCT01090024|467590018|FG011|Period 1|Lost to Follow-up|0|||
129898650|NCT01090024|467590019|FG012|Period 1|Lost to Follow-up|0|||
129898651|NCT01090024|467590020|FG013|Period 1|Lost to Follow-up|0|||
129898652|NCT01090024|467590021|FG014|Period 1|Lost to Follow-up|0|||
129898653|NCT01090024|467590022|FG015|Period 1|Lost to Follow-up|0|||
129898654|NCT01090024|467590023|FG016|Period 1|Lost to Follow-up|0|||
129898655|NCT01090024|467590024|FG017|Period 1|Lost to Follow-up|0|||
129898656|NCT01090024|467590007|FG000|Period 2|Lost to Follow-up|0|||
129898657|NCT01090024|467590008|FG001|Period 2|Lost to Follow-up|0|||
129898658|NCT01090024|467590009|FG002|Period 2|Lost to Follow-up|0|||
129898659|NCT01090024|467590010|FG003|Period 2|Lost to Follow-up|1|||
129898660|NCT01090024|467590011|FG004|Period 2|Lost to Follow-up|0|||
129898661|NCT01090024|467590012|FG005|Period 2|Lost to Follow-up|0|||
129898662|NCT01090024|467590013|FG006|Period 2|Lost to Follow-up|0|||
129898663|NCT01090024|467590014|FG007|Period 2|Lost to Follow-up|0|||
129898664|NCT01090024|467590015|FG008|Period 2|Lost to Follow-up|0|||
129898665|NCT01090024|467590016|FG009|Period 2|Lost to Follow-up|0|||
129898666|NCT01090024|467590017|FG010|Period 2|Lost to Follow-up|0|||
129898667|NCT01090024|467590018|FG011|Period 2|Lost to Follow-up|0|||
129898668|NCT01090024|467590019|FG012|Period 2|Lost to Follow-up|0|||
129898669|NCT01090024|467590020|FG013|Period 2|Lost to Follow-up|0|||
129898670|NCT01090024|467590021|FG014|Period 2|Lost to Follow-up|0|||
129898671|NCT01090024|467590022|FG015|Period 2|Lost to Follow-up|0|||
129898672|NCT01090024|467590023|FG016|Period 2|Lost to Follow-up|0|||
129898673|NCT01090024|467590024|FG017|Period 2|Lost to Follow-up|0|||
129898674|NCT01090024|467590007|FG000|Period 2|Adverse Event|1|||
129898675|NCT01090024|467590008|FG001|Period 2|Adverse Event|0|||
129898676|NCT01090024|467590009|FG002|Period 2|Adverse Event|0|||
129898677|NCT01090024|467590010|FG003|Period 2|Adverse Event|0|||
129898678|NCT01090024|467590011|FG004|Period 2|Adverse Event|0|||
129898679|NCT01090024|467590012|FG005|Period 2|Adverse Event|0|||
129898680|NCT01090024|467590013|FG006|Period 2|Adverse Event|0|||
129898681|NCT01090024|467590014|FG007|Period 2|Adverse Event|0|||
129898682|NCT01090024|467590015|FG008|Period 2|Adverse Event|0|||
129898683|NCT01090024|467590016|FG009|Period 2|Adverse Event|0|||
129898684|NCT01090024|467590017|FG010|Period 2|Adverse Event|0|||
129898685|NCT01090024|467590018|FG011|Period 2|Adverse Event|0|||
129898686|NCT01090024|467590019|FG012|Period 2|Adverse Event|0|||
129898687|NCT01090024|467590020|FG013|Period 2|Adverse Event|0|||
129898688|NCT01090024|467590021|FG014|Period 2|Adverse Event|0|||
129447069|NCT04223791|465936076|FG000|Overall Study|Withdrawal by Subject|10|||
129447070|NCT04223791|465936077|FG001|Overall Study|Withdrawal by Subject|12|||
129447071|NCT04223791|465936076|FG000|Overall Study|Pregnancy|1|||
129447072|NCT04223791|465936077|FG001|Overall Study|Pregnancy|1|||
129447073|NCT04223791|465936076|FG000|Overall Study|Ongoing in Study|305|||
129447074|NCT04223791|465936077|FG001|Overall Study|Ongoing in Study|302|||
129447075|NCT05586269|465937448|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
129447076|NCT05586269|465937449|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
129447077|NCT05586269|465937450|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
129447078|NCT05586269|465937451|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
129447079|NCT05586269|465937448|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
129447080|NCT05586269|465937449|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
129447081|NCT05586269|465937450|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
129447082|NCT05586269|465937451|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
129447083|NCT03441334|465937453|FG000|Overall Study|Withdrawal by Subject|1|||
129447084|NCT03441334|465937454|FG001|Overall Study|Withdrawal by Subject|0|||
129447085|NCT00088907|465937455|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
129447086|NCT00088907|465937456|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
129447087|NCT00088907|465937455|FG000|Randomized Study (Step 1)|Adverse Event|14|||
129447088|NCT00088907|465937456|FG001|Randomized Study (Step 1)|Adverse Event|19|||
129447089|NCT00088907|465937455|FG000|Randomized Study (Step 1)|Death|11|||
129447090|NCT00088907|465937456|FG001|Randomized Study (Step 1)|Death|12|||
129447091|NCT00088907|465937455|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
129447092|NCT00088907|465937456|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
129837581|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
129837582|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
129837583|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
129837584|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
129837585|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
129837586|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
129837587|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
129837588|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
129837589|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
129837590|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Death|5|||
129837591|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Death|0|||
129837592|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Death|2|||
129837593|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Death|0|||
129837594|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Death|4|||
129837595|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
129837596|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
129837597|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
129837598|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
129837599|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
129837600|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
129837601|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
129837602|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
129837603|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
129837604|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
129837605|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
129837606|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
129837607|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
129837608|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
129837609|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
129837610|NCT01604343|467371638|FG000|Prior to W52 Administration(Through W52)|Other|15|||
129837611|NCT01604343|467371639|FG001|Prior to W52 Administration(Through W52)|Other|0|||
129837612|NCT01604343|467371640|FG002|Prior to W52 Administration(Through W52)|Other|10|||
129837613|NCT01604343|467371641|FG003|Prior to W52 Administration(Through W52)|Other|0|||
129837614|NCT01604343|467371642|FG004|Prior to W52 Administration(Through W52)|Other|6|||
129837615|NCT01604343|467371638|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
129837616|NCT01604343|467371639|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
129837617|NCT01604343|467371640|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
129837618|NCT01604343|467371641|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
129837619|NCT01604343|467371642|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
129837620|NCT01604343|467371638|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
129837621|NCT01604343|467371639|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
129837622|NCT01604343|467371640|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
129837623|NCT01604343|467371641|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
129447093|NCT00088907|465937455|FG000|Randomized Study (Step 1)|complicating disease|3|||
129447094|NCT00088907|465937456|FG001|Randomized Study (Step 1)|complicating disease|1|||
129447095|NCT00088907|465937455|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
129447096|NCT00088907|465937456|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
129447097|NCT00088907|465937455|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
129447098|NCT00088907|465937456|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
129447099|NCT00088907|465937455|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
129447100|NCT00088907|465937456|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
129447101|NCT00088907|465937455|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
129447102|NCT00088907|465937456|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
129447103|NCT00088907|465937455|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
129447104|NCT00088907|465937456|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
129447105|NCT00088907|465937455|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
129447106|NCT00088907|465937456|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
129447107|NCT03426787|465937461|FG000|Overall Study|Withdrawal by Subject|6|||
129447108|NCT03426787|465937461|FG000|Overall Study|Lost to Follow-up|7|||
129447109|NCT03426787|465937461|FG000|Overall Study|Unrelated to intervention death|1|||
129447110|NCT00395863|465937462|FG000|Overall Study|Patients did not complete both exams|2|||
129447111|NCT00395863|465937463|FG001|Overall Study|Patients did not complete both exams|3|||
129447112|NCT02592551|465937466|FG000|Overall Study|Not evaluable|1|||
129447113|NCT02592551|465937467|FG001|Overall Study|Not evaluable|3|||
129447114|NCT02592551|465937468|FG002|Overall Study|Not evaluable|0|||
129447115|NCT01876251|465937469|FG000|Overall Study|Clinical progression|1|||
129447116|NCT01876251|465937470|FG001|Overall Study|Clinical progression|0|||
129898689|NCT01090024|467590022|FG015|Period 2|Adverse Event|0|||
129447117|NCT01876251|465937471|FG002|Overall Study|Clinical progression|0|||
129447118|NCT01876251|465937469|FG000|Overall Study|Death|2|||
129447119|NCT01876251|465937470|FG001|Overall Study|Death|0|||
129447120|NCT01876251|465937471|FG002|Overall Study|Death|1|||
129447121|NCT01876251|465937469|FG000|Overall Study|Participant started new treatment|1|||
129447122|NCT01876251|465937470|FG001|Overall Study|Participant started new treatment|0|||
129898690|NCT01090024|467590023|FG016|Period 2|Adverse Event|0|||
129447123|NCT01876251|465937471|FG002|Overall Study|Participant started new treatment|1|||
129898691|NCT01090024|467590024|FG017|Period 2|Adverse Event|0|||
129898692|NCT01090024|467590007|FG000|Period 3|Withdrawal by Subject|0|||
129898693|NCT01090024|467590008|FG001|Period 3|Withdrawal by Subject|0|||
129898694|NCT01090024|467590009|FG002|Period 3|Withdrawal by Subject|0|||
129898695|NCT01090024|467590010|FG003|Period 3|Withdrawal by Subject|0|||
129898696|NCT01090024|467590011|FG004|Period 3|Withdrawal by Subject|0|||
129898697|NCT01090024|467590012|FG005|Period 3|Withdrawal by Subject|0|||
129898698|NCT01090024|467590013|FG006|Period 3|Withdrawal by Subject|0|||
129898699|NCT01090024|467590014|FG007|Period 3|Withdrawal by Subject|0|||
129898700|NCT01090024|467590015|FG008|Period 3|Withdrawal by Subject|0|||
129898701|NCT01090024|467590016|FG009|Period 3|Withdrawal by Subject|0|||
129898702|NCT01090024|467590017|FG010|Period 3|Withdrawal by Subject|0|||
129898703|NCT01090024|467590018|FG011|Period 3|Withdrawal by Subject|0|||
129898704|NCT01090024|467590019|FG012|Period 3|Withdrawal by Subject|0|||
129898705|NCT01090024|467590020|FG013|Period 3|Withdrawal by Subject|0|||
129898706|NCT01090024|467590021|FG014|Period 3|Withdrawal by Subject|0|||
129898707|NCT01090024|467590022|FG015|Period 3|Withdrawal by Subject|1|||
129898708|NCT01090024|467590023|FG016|Period 3|Withdrawal by Subject|0|||
129898709|NCT01090024|467590024|FG017|Period 3|Withdrawal by Subject|0|||
129898710|NCT01090024|467590007|FG000|Period 3|Protocol Violation|0|||
129898711|NCT01090024|467590008|FG001|Period 3|Protocol Violation|0|||
129898712|NCT01090024|467590009|FG002|Period 3|Protocol Violation|0|||
129898713|NCT01090024|467590010|FG003|Period 3|Protocol Violation|0|||
129898714|NCT01090024|467590011|FG004|Period 3|Protocol Violation|0|||
129898715|NCT01090024|467590012|FG005|Period 3|Protocol Violation|0|||
129898716|NCT01090024|467590013|FG006|Period 3|Protocol Violation|0|||
129898717|NCT01090024|467590014|FG007|Period 3|Protocol Violation|0|||
129898718|NCT01090024|467590015|FG008|Period 3|Protocol Violation|1|||
129898719|NCT01090024|467590016|FG009|Period 3|Protocol Violation|0|||
129898720|NCT01090024|467590017|FG010|Period 3|Protocol Violation|0|||
129898721|NCT01090024|467590018|FG011|Period 3|Protocol Violation|0|||
129898722|NCT01090024|467590019|FG012|Period 3|Protocol Violation|0|||
129898723|NCT01090024|467590020|FG013|Period 3|Protocol Violation|0|||
129898724|NCT01090024|467590021|FG014|Period 3|Protocol Violation|0|||
129898725|NCT01090024|467590022|FG015|Period 3|Protocol Violation|0|||
129898726|NCT01090024|467590023|FG016|Period 3|Protocol Violation|0|||
129898727|NCT01090024|467590024|FG017|Period 3|Protocol Violation|0|||
129898728|NCT01090024|467590007|FG000|Period 3|Adverse Event|0|||
129898729|NCT01090024|467590008|FG001|Period 3|Adverse Event|0|||
129898730|NCT01090024|467590009|FG002|Period 3|Adverse Event|0|||
129837624|NCT01604343|467371642|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
129837625|NCT01604343|467371638|FG000|Week 52 to Week 104|Adverse Event|0|||
129837626|NCT01604343|467371639|FG001|Week 52 to Week 104|Adverse Event|12|||
129837627|NCT01604343|467371640|FG002|Week 52 to Week 104|Adverse Event|26|||
129837628|NCT01604343|467371641|FG003|Week 52 to Week 104|Adverse Event|21|||
129837629|NCT01604343|467371642|FG004|Week 52 to Week 104|Adverse Event|27|||
129837630|NCT01604343|467371638|FG000|Week 52 to Week 104|Death|0|||
129837631|NCT01604343|467371639|FG001|Week 52 to Week 104|Death|4|||
129837632|NCT01604343|467371640|FG002|Week 52 to Week 104|Death|2|||
129837633|NCT01604343|467371641|FG003|Week 52 to Week 104|Death|5|||
129837634|NCT01604343|467371642|FG004|Week 52 to Week 104|Death|0|||
129837635|NCT01604343|467371638|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
129837636|NCT01604343|467371639|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
129837637|NCT01604343|467371640|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
129837638|NCT01604343|467371641|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
129837639|NCT01604343|467371642|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
129837640|NCT01604343|467371638|FG000|Week 52 to Week 104|Physician Decision|0|||
129837641|NCT01604343|467371639|FG001|Week 52 to Week 104|Physician Decision|1|||
129898731|NCT01090024|467590010|FG003|Period 3|Adverse Event|0|||
129898732|NCT01090024|467590011|FG004|Period 3|Adverse Event|0|||
129898733|NCT01090024|467590012|FG005|Period 3|Adverse Event|1|||
129898734|NCT01090024|467590013|FG006|Period 3|Adverse Event|0|||
129898735|NCT01090024|467590014|FG007|Period 3|Adverse Event|0|||
129898736|NCT01090024|467590015|FG008|Period 3|Adverse Event|0|||
129898737|NCT01090024|467590016|FG009|Period 3|Adverse Event|0|||
129898738|NCT01090024|467590017|FG010|Period 3|Adverse Event|0|||
129837642|NCT01604343|467371640|FG002|Week 52 to Week 104|Physician Decision|0|||
129898739|NCT01090024|467590018|FG011|Period 3|Adverse Event|0|||
129898740|NCT01090024|467590019|FG012|Period 3|Adverse Event|0|||
129898741|NCT01090024|467590020|FG013|Period 3|Adverse Event|0|||
129898742|NCT01090024|467590021|FG014|Period 3|Adverse Event|0|||
129837643|NCT01604343|467371641|FG003|Week 52 to Week 104|Physician Decision|0|||
129837644|NCT01604343|467371642|FG004|Week 52 to Week 104|Physician Decision|2|||
129837645|NCT01604343|467371638|FG000|Week 52 to Week 104|Pregnancy|0|||
129837646|NCT01604343|467371639|FG001|Week 52 to Week 104|Pregnancy|0|||
129898743|NCT01090024|467590022|FG015|Period 3|Adverse Event|0|||
129898744|NCT01090024|467590023|FG016|Period 3|Adverse Event|0|||
129898745|NCT01090024|467590024|FG017|Period 3|Adverse Event|0|||
129898746|NCT00567879|467590029|FG000|Overall Study|Adverse Event|2|||
129898747|NCT00567879|467590030|FG001|Overall Study|Adverse Event|0|||
129898748|NCT00567879|467590031|FG002|Overall Study|Adverse Event|1|||
129898749|NCT00567879|467590032|FG003|Overall Study|Adverse Event|0|||
129898750|NCT00567879|467590033|FG004|Overall Study|Adverse Event|1|||
129898751|NCT00567879|467590034|FG005|Overall Study|Adverse Event|0|||
129898752|NCT00567879|467590029|FG000|Overall Study|Abnormal test procedure(s)|0|||
129898753|NCT00567879|467590030|FG001|Overall Study|Abnormal test procedure(s)|0|||
129898754|NCT00567879|467590031|FG002|Overall Study|Abnormal test procedure(s)|1|||
129898755|NCT00567879|467590032|FG003|Overall Study|Abnormal test procedure(s)|0|||
129837647|NCT01604343|467371640|FG002|Week 52 to Week 104|Pregnancy|1|||
129837648|NCT01604343|467371641|FG003|Week 52 to Week 104|Pregnancy|2|||
129837649|NCT01604343|467371642|FG004|Week 52 to Week 104|Pregnancy|1|||
129837650|NCT01604343|467371638|FG000|Week 52 to Week 104|Other|0|||
129837651|NCT01604343|467371639|FG001|Week 52 to Week 104|Other|11|||
129837652|NCT01604343|467371640|FG002|Week 52 to Week 104|Other|11|||
129837653|NCT01604343|467371641|FG003|Week 52 to Week 104|Other|6|||
129837654|NCT01604343|467371642|FG004|Week 52 to Week 104|Other|3|||
129837655|NCT01604343|467371638|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
129837656|NCT01604343|467371639|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
129837657|NCT01604343|467371640|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
129837658|NCT01604343|467371641|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
129837659|NCT01604343|467371642|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
129837660|NCT01604343|467371638|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
129837661|NCT01604343|467371639|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
129837662|NCT01604343|467371640|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
129837663|NCT01604343|467371641|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
129837664|NCT01604343|467371642|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
129837665|NCT01604343|467371638|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
129837666|NCT01604343|467371639|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
129837667|NCT01604343|467371640|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
129837668|NCT01604343|467371641|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
129837669|NCT01604343|467371642|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
129837670|NCT02346136|467371659|FG000|Overall Study|Withdrawal by Subject|7|||
129837671|NCT02346136|467371660|FG001|Overall Study|Withdrawal by Subject|5|||
129837672|NCT02346136|467371659|FG000|Overall Study|Death|1|||
129837673|NCT02346136|467371660|FG001|Overall Study|Death|0|||
129837674|NCT02346136|467371659|FG000|Overall Study|Study termination|14|||
129837675|NCT02346136|467371660|FG001|Overall Study|Study termination|18|||
129837676|NCT00453999|467371664|FG000|Overall Study|Adverse Event|1|||
129837677|NCT00453999|467371665|FG001|Overall Study|Adverse Event|2|||
129837678|NCT00453999|467371666|FG002|Overall Study|Adverse Event|1|||
129837679|NCT00453999|467371664|FG000|Overall Study|Lost to Follow-up|0|||
129837680|NCT00453999|467371665|FG001|Overall Study|Lost to Follow-up|1|||
129837681|NCT00453999|467371666|FG002|Overall Study|Lost to Follow-up|1|||
129837682|NCT00453999|467371664|FG000|Overall Study|Withdrawal by Subject|2|||
129837683|NCT00453999|467371665|FG001|Overall Study|Withdrawal by Subject|1|||
129837684|NCT00453999|467371666|FG002|Overall Study|Withdrawal by Subject|1|||
129837685|NCT00453999|467371664|FG000|Overall Study|Subject Request|2|||
129837686|NCT00453999|467371665|FG001|Overall Study|Subject Request|1|||
129837687|NCT00453999|467371666|FG002|Overall Study|Subject Request|0|||
129837688|NCT04960228|467371680|FG000|Overall Study|Withdrawal by Subject|216|||
129837689|NCT04960228|467371681|FG001|Overall Study|Withdrawal by Subject|35|||
129837690|NCT04960228|467371680|FG000|Overall Study|Failed attention check|69|||
129837691|NCT04960228|467371681|FG001|Overall Study|Failed attention check|148|||
129837692|NCT04960228|467371680|FG000|Overall Study|Flagged for response quality by Dynata|3|||
129837693|NCT04960228|467371681|FG001|Overall Study|Flagged for response quality by Dynata|3|||
129837694|NCT02129803|467371685|FG000|Overall Study|Protocol Violation|4|||
129837695|NCT02129803|467371686|FG001|Overall Study|Protocol Violation|0|||
129837696|NCT02129803|467371685|FG000|Overall Study|Physician Decision|0|||
129837697|NCT02129803|467371686|FG001|Overall Study|Physician Decision|1|||
129837698|NCT02129803|467371685|FG000|Overall Study|Difficulty sleeping|1|||
129837699|NCT02129803|467371686|FG001|Overall Study|Difficulty sleeping|0|||
129837700|NCT02129803|467371685|FG000|Overall Study|Morning headache|0|||
129837701|NCT02129803|467371686|FG001|Overall Study|Morning headache|1|||
129837702|NCT02129803|467371685|FG000|Overall Study|Withdrawal by Subject|1|||
129837703|NCT02129803|467371686|FG001|Overall Study|Withdrawal by Subject|1|||
129837704|NCT00149747|467371687|FG000|Overall Study|Death|1|||
129837705|NCT00149747|467371688|FG001|Overall Study|Death|0|||
129837706|NCT00149747|467371687|FG000|Overall Study|Withdrawal by Subject|3|||
129837707|NCT00149747|467371688|FG001|Overall Study|Withdrawal by Subject|3|||
129837708|NCT04753164|467371689|FG000|Overall Study|Adverse Event|0|||
129837709|NCT04753164|467371690|FG001|Overall Study|Adverse Event|2|||
129837710|NCT04753164|467371689|FG000|Overall Study|Withdrawal by Subject|9|||
129837711|NCT04753164|467371690|FG001|Overall Study|Withdrawal by Subject|7|||
129837712|NCT04753164|467371689|FG000|Overall Study|Lost to Follow-up|6|||
129837713|NCT04753164|467371690|FG001|Overall Study|Lost to Follow-up|6|||
129837714|NCT04753164|467371689|FG000|Overall Study|Other|12|||
129837715|NCT04753164|467371690|FG001|Overall Study|Other|5|||
129837716|NCT01183975|467371696|FG000|Overall Study|Lost to Follow-up|73|||
129837717|NCT03742141|467371700|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
129837718|NCT04180020|467371701|FG000|Overall Study|missed visit|18|||
129837719|NCT04180020|467371702|FG001|Overall Study|missed visit|16|||
129837720|NCT04180020|467371701|FG000|Overall Study|Death|2|||
129837721|NCT04180020|467371702|FG001|Overall Study|Death|3|||
129837722|NCT04180020|467371701|FG000|Overall Study|Withdrawal by Subject|1|||
129837723|NCT04180020|467371702|FG001|Overall Study|Withdrawal by Subject|5|||
129837724|NCT04180020|467371701|FG000|Overall Study|incarcerated|1|||
129837725|NCT04180020|467371702|FG001|Overall Study|incarcerated|1|||
129837726|NCT04180020|467371701|FG000|Overall Study|Physician Decision|0|||
129837727|NCT04180020|467371702|FG001|Overall Study|Physician Decision|2|||
129837728|NCT00405548|467371703|FG000|Overall Study|Cognitive Memory problems on study day|1|||
129837729|NCT00405548|467371704|FG001|Overall Study|Cognitive Memory problems on study day|0|||
129837730|NCT00405548|467371703|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
129837731|NCT00405548|467371704|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
129837732|NCT00405548|467371703|FG000|Overall Study|Unable to self-administer shots|1|||
129837733|NCT00405548|467371704|FG001|Overall Study|Unable to self-administer shots|0|||
129837734|NCT00405548|467371703|FG000|Overall Study|Venous access failed during study day|1|||
129837735|NCT00405548|467371704|FG001|Overall Study|Venous access failed during study day|0|||
129837736|NCT00405548|467371703|FG000|Overall Study|Withdrawal by Subject|1|||
129837737|NCT00405548|467371704|FG001|Overall Study|Withdrawal by Subject|0|||
129837738|NCT03554291|467371705|FG000|Overall Study|Death|2|||
129837739|NCT03554291|467371706|FG001|Overall Study|Death|1|||
129837740|NCT03554291|467371705|FG000|Overall Study|Lost to Follow-up|1|||
129837741|NCT03554291|467371706|FG001|Overall Study|Lost to Follow-up|0|||
129837742|NCT03554291|467371705|FG000|Overall Study|Withdrawal by Subject|1|||
129837743|NCT03554291|467371706|FG001|Overall Study|Withdrawal by Subject|0|||
129837744|NCT03554291|467371705|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
129837745|NCT03554291|467371706|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
129837746|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Death|3|||
129837747|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Death|2|||
129837748|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Death|0|||
129837749|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Death|0|||
129837750|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Death|0|||
129837751|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Death|0|||
129837752|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Death|0|||
129837753|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Death|0|||
129837754|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
129837755|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837756|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837757|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837758|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837759|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837760|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837761|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
129837762|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837763|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
129837764|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837765|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837766|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837767|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837768|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837769|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
129837770|NCT02036502|467371707|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
129837771|NCT02036502|467371708|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
129837772|NCT02036502|467371709|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
129837773|NCT02036502|467371710|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
129837774|NCT02036502|467371711|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
129837775|NCT02036502|467371712|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
129837776|NCT02036502|467371713|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
129837777|NCT02036502|467371714|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
129837778|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837779|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837780|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
129837781|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
129837782|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
129837783|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129447124|NCT01876251|465937469|FG000|Overall Study|Participant refused further follow-up|0|||
129447125|NCT01876251|465937470|FG001|Overall Study|Participant refused further follow-up|0|||
129447126|NCT01876251|465937471|FG002|Overall Study|Participant refused further follow-up|1|||
129447127|NCT01876251|465937469|FG000|Overall Study|Study terminated|1|||
129447128|NCT01876251|465937470|FG001|Overall Study|Study terminated|0|||
129447129|NCT01876251|465937471|FG002|Overall Study|Study terminated|0|||
129447130|NCT01876251|465937469|FG000|Overall Study|Objective progression or relapse|10|||
129447131|NCT01876251|465937470|FG001|Overall Study|Objective progression or relapse|3|||
129447132|NCT01876251|465937471|FG002|Overall Study|Objective progression or relapse|8|||
129447133|NCT00268437|465937472|FG000|Overall Study|Ineligible|1|||
129447134|NCT02020863|465937476|FG000|Overall Study|Discovery of Metastatic disease|4|||
129447135|NCT02020863|465937476|FG000|Overall Study|Team chose not to place an a line|1|||
129447136|NCT00907257|465937480|FG000|Overall Study|Adverse Event|0|||
129447137|NCT00907257|465937481|FG001|Overall Study|Adverse Event|4|||
129447138|NCT00907257|465937480|FG000|Overall Study|Protocol Violation|1|||
129447139|NCT00907257|465937481|FG001|Overall Study|Protocol Violation|2|||
129447140|NCT00907257|465937480|FG000|Overall Study|Lost to Follow-up|3|||
129447141|NCT00907257|465937481|FG001|Overall Study|Lost to Follow-up|3|||
129447142|NCT00907257|465937480|FG000|Overall Study|Withdrawal by Subject|1|||
129447143|NCT00907257|465937481|FG001|Overall Study|Withdrawal by Subject|2|||
129447144|NCT00907257|465937480|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
129447145|NCT00907257|465937481|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
129837784|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837785|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
129837786|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837787|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837788|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
129837789|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837790|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837791|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837792|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837793|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
129837794|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Death|0|||
129837795|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Death|0|||
129837796|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Death|1|||
129837797|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Death|0|||
129837798|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Death|0|||
129837799|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Death|0|||
129447146|NCT00907257|465937480|FG000|Overall Study|Moved|1|||
129447147|NCT00907257|465937481|FG001|Overall Study|Moved|0|||
129447148|NCT00907257|465937480|FG000|Overall Study|Personal Reasons|6|||
129447149|NCT00907257|465937481|FG001|Overall Study|Personal Reasons|1|||
129447150|NCT00283049|465937482|FG000|Overall Study|Adverse Event|6|||
129447151|NCT00283049|465937483|FG001|Overall Study|Adverse Event|1|||
129447152|NCT00283049|465937484|FG002|Overall Study|Adverse Event|4|||
129837800|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Death|0|||
129837801|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Death|0|||
129837802|NCT02036502|467371707|FG000|Part 2:Dose Confirmation|Not treated|0|||
129837803|NCT02036502|467371708|FG001|Part 2:Dose Confirmation|Not treated|0|||
129837804|NCT02036502|467371709|FG002|Part 2:Dose Confirmation|Not treated|0|||
129837805|NCT02036502|467371710|FG003|Part 2:Dose Confirmation|Not treated|1|||
129837806|NCT02036502|467371711|FG004|Part 2:Dose Confirmation|Not treated|0|||
129837807|NCT02036502|467371712|FG005|Part 2:Dose Confirmation|Not treated|0|||
129837808|NCT02036502|467371713|FG006|Part 2:Dose Confirmation|Not treated|0|||
129837809|NCT02036502|467371714|FG007|Part 2:Dose Confirmation|Not treated|0|||
129837810|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Adverse Event|0|||
129837811|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Adverse Event|0|||
129837812|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Adverse Event|0|||
129837813|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Adverse Event|0|||
129837814|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Adverse Event|0|||
129837815|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Adverse Event|4|||
129837816|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Adverse Event|0|||
129837817|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Adverse Event|2|||
129837818|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Death|0|||
129837819|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Death|0|||
129837820|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Death|0|||
129837821|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Death|0|||
129837822|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Death|0|||
129837823|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Death|24|||
129837824|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Death|0|||
129837825|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Death|3|||
129837826|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837827|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837828|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837829|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837830|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837831|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837832|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
129837833|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
129837834|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Physician Decision|0|||
129837835|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Physician Decision|0|||
129837836|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Physician Decision|0|||
129837837|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Physician Decision|0|||
129837838|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Physician Decision|0|||
129837839|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Physician Decision|1|||
129837840|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Physician Decision|0|||
129837841|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Physician Decision|0|||
129837842|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
129837843|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
129837844|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
129837845|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
129837846|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
129837847|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
129837848|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
129837849|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
129837850|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837851|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837852|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129447153|NCT00283049|465937482|FG000|Overall Study|Protocol Violation|3|||
129447154|NCT00283049|465937483|FG001|Overall Study|Protocol Violation|0|||
129447155|NCT00283049|465937484|FG002|Overall Study|Protocol Violation|3|||
129447156|NCT00283049|465937482|FG000|Overall Study|Death|1|||
129447157|NCT00283049|465937483|FG001|Overall Study|Death|1|||
129447158|NCT00283049|465937484|FG002|Overall Study|Death|1|||
129447159|NCT00283049|465937482|FG000|Overall Study|Lack of Efficacy|0|||
129447160|NCT00283049|465937483|FG001|Overall Study|Lack of Efficacy|1|||
129447161|NCT00283049|465937484|FG002|Overall Study|Lack of Efficacy|1|||
129447162|NCT00283049|465937482|FG000|Overall Study|Lost to Follow-up|4|||
129447163|NCT00283049|465937483|FG001|Overall Study|Lost to Follow-up|2|||
129837853|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837854|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837855|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
129837856|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
129837857|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
129837858|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837859|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129447164|NCT00283049|465937484|FG002|Overall Study|Lost to Follow-up|5|||
129447165|NCT00283049|465937482|FG000|Overall Study|Withdrawal by Subject|26|||
129837860|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837861|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837862|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
129837863|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
129837864|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
129837865|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
129837866|NCT02036502|467371707|FG000|Part 3:Dose Expansion|Not Treated|0|||
129837867|NCT02036502|467371708|FG001|Part 3:Dose Expansion|Not Treated|0|||
129837868|NCT02036502|467371709|FG002|Part 3:Dose Expansion|Not Treated|0|||
129837869|NCT02036502|467371710|FG003|Part 3:Dose Expansion|Not Treated|0|||
129837870|NCT02036502|467371711|FG004|Part 3:Dose Expansion|Not Treated|0|||
129837871|NCT02036502|467371712|FG005|Part 3:Dose Expansion|Not Treated|2|||
129837872|NCT02036502|467371713|FG006|Part 3:Dose Expansion|Not Treated|0|||
129837873|NCT02036502|467371714|FG007|Part 3:Dose Expansion|Not Treated|0|||
129837874|NCT02741700|467371715|FG000|Overall Study|Lost to Follow-up|17|||
129837875|NCT02741700|467371716|FG001|Overall Study|Lost to Follow-up|8|||
129837876|NCT02741700|467371715|FG000|Overall Study|Withdrawal by Subject|2|||
129837877|NCT02741700|467371716|FG001|Overall Study|Withdrawal by Subject|5|||
129837878|NCT02741700|467371715|FG000|Overall Study|Physician Decision|3|||
129837879|NCT02741700|467371716|FG001|Overall Study|Physician Decision|0|||
129837880|NCT02741700|467371715|FG000|Overall Study|Moved out of State|0|||
129837881|NCT02741700|467371716|FG001|Overall Study|Moved out of State|1|||
129837882|NCT02741700|467371715|FG000|Overall Study|Death|4|||
129837883|NCT02741700|467371716|FG001|Overall Study|Death|5|||
129837884|NCT00811577|467371717|FG000|Overall Study|Lost to Follow-up|7|||
129837885|NCT00811577|467371718|FG001|Overall Study|Lost to Follow-up|1|||
129837886|NCT00811577|467371717|FG000|Overall Study|Withdrawal by Subject|3|||
129837887|NCT00811577|467371718|FG001|Overall Study|Withdrawal by Subject|0|||
129837888|NCT01068509|467371719|FG000|Overall Study|Death|0|||
129837889|NCT01068509|467371720|FG001|Overall Study|Death|0|||
129837890|NCT01068509|467371721|FG002|Overall Study|Death|1|||
129837891|NCT01068509|467371719|FG000|Overall Study|Disease Progression|5|||
129837892|NCT01068509|467371720|FG001|Overall Study|Disease Progression|20|||
129837893|NCT01068509|467371721|FG002|Overall Study|Disease Progression|18|||
129837894|NCT01068509|467371719|FG000|Overall Study|Lost to Follow-up|1|||
129837895|NCT01068509|467371720|FG001|Overall Study|Lost to Follow-up|0|||
129837896|NCT01068509|467371721|FG002|Overall Study|Lost to Follow-up|0|||
129837897|NCT01068509|467371719|FG000|Overall Study|Withdrew Consent|0|||
129837898|NCT01068509|467371720|FG001|Overall Study|Withdrew Consent|1|||
129837899|NCT01068509|467371721|FG002|Overall Study|Withdrew Consent|2|||
129837900|NCT01068509|467371719|FG000|Overall Study|Reason Not Specified|0|||
129447166|NCT00283049|465937483|FG001|Overall Study|Withdrawal by Subject|24|||
129447167|NCT00283049|465937484|FG002|Overall Study|Withdrawal by Subject|19|||
129447168|NCT00283049|465937482|FG000|Overall Study|Discontinuation of Study|18|||
129447169|NCT00283049|465937483|FG001|Overall Study|Discontinuation of Study|16|||
129447170|NCT00283049|465937484|FG002|Overall Study|Discontinuation of Study|20|||
129447171|NCT00283049|465937482|FG000|Overall Study|No longer requires study treatment|0|||
129447172|NCT00283049|465937483|FG001|Overall Study|No longer requires study treatment|0|||
129447173|NCT00283049|465937484|FG002|Overall Study|No longer requires study treatment|1|||
129447174|NCT01628107|465937485|FG000|Overall Study|Withdrawal by Subject|17|||
129447175|NCT01628107|465937485|FG000|Overall Study|Lost to Follow-up|4|||
129447176|NCT01628107|465937485|FG000|Overall Study|Adverse Event|33|||
129447177|NCT01628107|465937485|FG000|Overall Study|Physician Decision|2|||
129447178|NCT01628107|465937485|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
129447179|NCT01628107|465937485|FG000|Overall Study|Non-compliant with Study Procedures|10|||
129447180|NCT01628107|465937485|FG000|Overall Study|Not Treated|8|||
129447181|NCT01628107|465937485|FG000|Overall Study|Sponsor Decision|11|||
129447182|NCT01628107|465937485|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
129447183|NCT01628107|465937485|FG000|Overall Study|Relocated|8|||
129447184|NCT01628107|465937485|FG000|Overall Study|Kidney Transplant|9|||
129447185|NCT01628107|465937485|FG000|Overall Study|Use of Standard of Care|9|||
129447186|NCT01086410|465937486|FG000|Overall Study|Adverse Event|1|||
129447187|NCT01086410|465937487|FG001|Overall Study|Adverse Event|0|||
129447188|NCT01086410|465937488|FG002|Overall Study|Adverse Event|0|||
129447189|NCT01086410|465937489|FG003|Overall Study|Adverse Event|2|||
129447190|NCT01086410|465937486|FG000|Overall Study|Lack of Efficacy|1|||
129447191|NCT01086410|465937487|FG001|Overall Study|Lack of Efficacy|1|||
129447192|NCT01086410|465937488|FG002|Overall Study|Lack of Efficacy|0|||
129447193|NCT01086410|465937489|FG003|Overall Study|Lack of Efficacy|0|||
129447194|NCT01086410|465937486|FG000|Overall Study|Protocol Violation|1|||
129447195|NCT01086410|465937487|FG001|Overall Study|Protocol Violation|1|||
129447196|NCT01086410|465937488|FG002|Overall Study|Protocol Violation|0|||
129447197|NCT01086410|465937489|FG003|Overall Study|Protocol Violation|0|||
129447198|NCT01086410|465937486|FG000|Overall Study|Lost to Follow-up|0|||
129447199|NCT01086410|465937487|FG001|Overall Study|Lost to Follow-up|0|||
129447200|NCT01086410|465937488|FG002|Overall Study|Lost to Follow-up|1|||
129447201|NCT01086410|465937489|FG003|Overall Study|Lost to Follow-up|0|||
129447202|NCT02953639|465937490|FG000|Overall Study|Adverse Event|2|||
129447203|NCT02953639|465937491|FG001|Overall Study|Adverse Event|0|||
129447204|NCT02953639|465937492|FG002|Overall Study|Adverse Event|1|||
129447205|NCT02953639|465937490|FG000|Overall Study|Lost to Follow-up|8|||
129447206|NCT02953639|465937491|FG001|Overall Study|Lost to Follow-up|4|||
129447207|NCT02953639|465937492|FG002|Overall Study|Lost to Follow-up|3|||
129447208|NCT02953639|465937490|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129447209|NCT02953639|465937491|FG001|Overall Study|Non-Compliance With Study Drug|2|||
129447210|NCT02953639|465937492|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129447211|NCT02953639|465937490|FG000|Overall Study|Multiple Reasons|1|||
129447212|NCT02953639|465937491|FG001|Overall Study|Multiple Reasons|0|||
129447213|NCT02953639|465937492|FG002|Overall Study|Multiple Reasons|1|||
129447214|NCT02953639|465937490|FG000|Overall Study|Physician Decision|1|||
129447215|NCT02953639|465937491|FG001|Overall Study|Physician Decision|0|||
129447216|NCT02953639|465937492|FG002|Overall Study|Physician Decision|0|||
129447217|NCT02953639|465937490|FG000|Overall Study|Withdrawal by Subject|7|||
129447218|NCT02953639|465937491|FG001|Overall Study|Withdrawal by Subject|8|||
129447219|NCT02953639|465937492|FG002|Overall Study|Withdrawal by Subject|10|||
129447220|NCT02953639|465937490|FG000|Overall Study|Completed or Discontinued information is missing|1|||
129447221|NCT02953639|465937491|FG001|Overall Study|Completed or Discontinued information is missing|0|||
129447222|NCT02953639|465937492|FG002|Overall Study|Completed or Discontinued information is missing|0|||
129447223|NCT04196803|465937493|FG000|Overall Study|Withdrawal by Subject|1|||
129447224|NCT04196803|465937494|FG001|Overall Study|Withdrawal by Subject|3|||
129447225|NCT04196803|465937493|FG000|Overall Study|Adverse Event|4|||
129447226|NCT04196803|465937494|FG001|Overall Study|Adverse Event|2|||
129447227|NCT04196803|465937493|FG000|Overall Study|Lost to Follow-up|0|||
129447228|NCT04196803|465937494|FG001|Overall Study|Lost to Follow-up|1|||
129447229|NCT01022996|465937495|FG000|Overall Study|Adverse Event|14|||
129837901|NCT01068509|467371720|FG001|Overall Study|Reason Not Specified|1|||
129837902|NCT01068509|467371721|FG002|Overall Study|Reason Not Specified|0|||
129837903|NCT02442778|467371722|FG000|Overall Study|Adverse Event|2|||
129447230|NCT01022996|465937495|FG000|Overall Study|Withdrawal by Subject|3|||
129447231|NCT01022996|465937495|FG000|Overall Study|Lost to Follow-up|1|||
129447232|NCT01022996|465937495|FG000|Overall Study|Administrative problems|6|||
129447233|NCT01022996|465937495|FG000|Overall Study|Disease Progression|32|||
129447234|NCT01022996|465937495|FG000|Overall Study|Protocol Violation|1|||
129447235|NCT00930722|465937496|FG000|Overall Study|Lost to Follow-up|16|||
129447236|NCT00930722|465937496|FG000|Overall Study|No longer willing to participate|9|||
129447237|NCT00930722|465937496|FG000|Overall Study|Study terminated by sponsor|2|||
129447238|NCT01069120|465937497|FG000|Overall Study|Study prematurely terminated|27|||
129447239|NCT05097716|465937498|FG000|Period 1|Adverse Event|1|||
129898756|NCT00567879|467590033|FG004|Overall Study|Abnormal test procedure(s)|0|||
129837904|NCT02442778|467371723|FG001|Overall Study|Adverse Event|6|||
129837905|NCT02442778|467371724|FG002|Overall Study|Adverse Event|6|||
129837906|NCT02442778|467371722|FG000|Overall Study|Death|0|||
129837907|NCT02442778|467371723|FG001|Overall Study|Death|2|||
129837908|NCT02442778|467371724|FG002|Overall Study|Death|0|||
129837909|NCT02442778|467371722|FG000|Overall Study|Lack of Efficacy|1|||
129837910|NCT02442778|467371723|FG001|Overall Study|Lack of Efficacy|0|||
129837911|NCT02442778|467371724|FG002|Overall Study|Lack of Efficacy|0|||
129837912|NCT02442778|467371722|FG000|Overall Study|Lost to Follow-up|1|||
129837913|NCT02442778|467371723|FG001|Overall Study|Lost to Follow-up|1|||
129837914|NCT02442778|467371724|FG002|Overall Study|Lost to Follow-up|1|||
129837915|NCT02442778|467371722|FG000|Overall Study|Non-compliance with study drug|2|||
129837916|NCT02442778|467371723|FG001|Overall Study|Non-compliance with study drug|0|||
129837917|NCT02442778|467371724|FG002|Overall Study|Non-compliance with study drug|1|||
129837918|NCT02442778|467371722|FG000|Overall Study|Physician Decision|1|||
129837919|NCT02442778|467371723|FG001|Overall Study|Physician Decision|1|||
129837920|NCT02442778|467371724|FG002|Overall Study|Physician Decision|1|||
129837921|NCT02442778|467371722|FG000|Overall Study|Protocol Deviation|3|||
129837922|NCT02442778|467371723|FG001|Overall Study|Protocol Deviation|0|||
129837923|NCT02442778|467371724|FG002|Overall Study|Protocol Deviation|1|||
129837924|NCT02442778|467371722|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
129837925|NCT02442778|467371723|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
129837926|NCT02442778|467371724|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
129837927|NCT02442778|467371722|FG000|Overall Study|Withdrawal by Subject|4|||
129837928|NCT02442778|467371723|FG001|Overall Study|Withdrawal by Subject|4|||
129837929|NCT02442778|467371724|FG002|Overall Study|Withdrawal by Subject|3|||
129837930|NCT02442778|467371722|FG000|Overall Study|Reason not specified|1|||
129837931|NCT02442778|467371723|FG001|Overall Study|Reason not specified|4|||
129837932|NCT02442778|467371724|FG002|Overall Study|Reason not specified|0|||
129837933|NCT01165138|467371725|FG000|Overall Study|Adverse Event|0|||
129837934|NCT01165138|467371726|FG001|Overall Study|Adverse Event|1|||
129837935|NCT01165138|467371727|FG002|Overall Study|Adverse Event|0|||
129837936|NCT01165138|467371728|FG003|Overall Study|Adverse Event|2|||
129837937|NCT01165138|467371725|FG000|Overall Study|Lack of Efficacy|0|||
129837938|NCT01165138|467371726|FG001|Overall Study|Lack of Efficacy|32|||
129837939|NCT01165138|467371727|FG002|Overall Study|Lack of Efficacy|6|||
129837940|NCT01165138|467371728|FG003|Overall Study|Lack of Efficacy|7|||
129837941|NCT01165138|467371725|FG000|Overall Study|Protocol Violation|0|||
129837942|NCT01165138|467371726|FG001|Overall Study|Protocol Violation|7|||
129837943|NCT01165138|467371727|FG002|Overall Study|Protocol Violation|0|||
129837944|NCT01165138|467371728|FG003|Overall Study|Protocol Violation|2|||
129837945|NCT01165138|467371725|FG000|Overall Study|Lost to Follow-up|0|||
129837946|NCT01165138|467371726|FG001|Overall Study|Lost to Follow-up|0|||
129837947|NCT01165138|467371727|FG002|Overall Study|Lost to Follow-up|1|||
129837948|NCT01165138|467371728|FG003|Overall Study|Lost to Follow-up|2|||
129837949|NCT01165138|467371725|FG000|Overall Study|Physician Decision|0|||
129837950|NCT01165138|467371726|FG001|Overall Study|Physician Decision|6|||
129837951|NCT01165138|467371727|FG002|Overall Study|Physician Decision|7|||
129837952|NCT01165138|467371728|FG003|Overall Study|Physician Decision|6|||
129837953|NCT01165138|467371725|FG000|Overall Study|Withdrawal by Subject|0|||
129837954|NCT01165138|467371726|FG001|Overall Study|Withdrawal by Subject|6|||
129837955|NCT01165138|467371727|FG002|Overall Study|Withdrawal by Subject|6|||
129837956|NCT01165138|467371728|FG003|Overall Study|Withdrawal by Subject|3|||
129837957|NCT01418937|467371729|FG000|Overall Study|Lost to Follow-up|5|||
129837958|NCT01418937|467371729|FG000|Overall Study|Protocol Violation|1|||
129837959|NCT01418937|467371729|FG000|Overall Study|Pregnancy|1|||
129837960|NCT01418937|467371729|FG000|Overall Study|Withdrawal by Subject|1|||
129837961|NCT00962104|467371730|FG000|Overall Study|Adverse Event|10|||
129837962|NCT00962104|467371731|FG001|Overall Study|Adverse Event|3|||
129837963|NCT00962104|467371730|FG000|Overall Study|Entry Criteria Not Met|1|||
129837964|NCT00962104|467371731|FG001|Overall Study|Entry Criteria Not Met|2|||
129837965|NCT00962104|467371730|FG000|Overall Study|Lack of Efficacy|0|||
129837966|NCT00962104|467371731|FG001|Overall Study|Lack of Efficacy|1|||
129837967|NCT00962104|467371730|FG000|Overall Study|Lost to Follow-up|10|||
129837968|NCT00962104|467371731|FG001|Overall Study|Lost to Follow-up|4|||
129837969|NCT00962104|467371730|FG000|Overall Study|Physician Decision|1|||
129837970|NCT00962104|467371731|FG001|Overall Study|Physician Decision|0|||
129837971|NCT00962104|467371730|FG000|Overall Study|Protocol Violation|6|||
129837972|NCT00962104|467371731|FG001|Overall Study|Protocol Violation|8|||
129837973|NCT00962104|467371730|FG000|Overall Study|Sponsor Decision|0|||
129837974|NCT00962104|467371731|FG001|Overall Study|Sponsor Decision|1|||
129837975|NCT00962104|467371730|FG000|Overall Study|Withdrawal by Subject|10|||
129837976|NCT00962104|467371731|FG001|Overall Study|Withdrawal by Subject|6|||
129837977|NCT00962104|467371730|FG000|Overall Study|Other|2|||
129837978|NCT00962104|467371731|FG001|Overall Study|Other|0|||
129837979|NCT02013167|467371732|FG000|Overall Study|Withdrawal by Subject|15|||
129837980|NCT02013167|467371733|FG001|Overall Study|Withdrawal by Subject|14|||
129837981|NCT02013167|467371732|FG000|Overall Study|Sponsor Decision|1|||
129837982|NCT02013167|467371733|FG001|Overall Study|Sponsor Decision|3|||
129837983|NCT02013167|467371732|FG000|Overall Study|Lost to Follow-up|0|||
129837984|NCT02013167|467371733|FG001|Overall Study|Lost to Follow-up|1|||
129837985|NCT02013167|467371732|FG000|Overall Study|Death|85|||
129837986|NCT02013167|467371733|FG001|Overall Study|Death|160|||
129837987|NCT00603746|467371734|FG000|Overall Study|Adverse Event|2|||
129837988|NCT00603746|467371735|FG001|Overall Study|Adverse Event|3|||
129837989|NCT00603746|467371736|FG002|Overall Study|Adverse Event|0|||
129837990|NCT00603746|467371737|FG003|Overall Study|Adverse Event|1|||
129837991|NCT00603746|467371738|FG004|Overall Study|Adverse Event|0|||
129837992|NCT00603746|467371739|FG005|Overall Study|Adverse Event|4|||
129837993|NCT00603746|467371734|FG000|Overall Study|Lack of Efficacy|34|||
129837994|NCT00603746|467371735|FG001|Overall Study|Lack of Efficacy|11|||
129837995|NCT00603746|467371736|FG002|Overall Study|Lack of Efficacy|6|||
129837996|NCT00603746|467371737|FG003|Overall Study|Lack of Efficacy|11|||
129837997|NCT00603746|467371738|FG004|Overall Study|Lack of Efficacy|12|||
129837998|NCT00603746|467371739|FG005|Overall Study|Lack of Efficacy|8|||
129837999|NCT00603746|467371734|FG000|Overall Study|Protocol Violation|0|||
129838000|NCT00603746|467371735|FG001|Overall Study|Protocol Violation|3|||
129838001|NCT00603746|467371736|FG002|Overall Study|Protocol Violation|1|||
129838002|NCT00603746|467371737|FG003|Overall Study|Protocol Violation|0|||
129838003|NCT00603746|467371738|FG004|Overall Study|Protocol Violation|1|||
129838004|NCT00603746|467371739|FG005|Overall Study|Protocol Violation|0|||
129838005|NCT00603746|467371734|FG000|Overall Study|Lost to Follow-up|0|||
129838006|NCT00603746|467371735|FG001|Overall Study|Lost to Follow-up|1|||
129838007|NCT00603746|467371736|FG002|Overall Study|Lost to Follow-up|1|||
129838008|NCT00603746|467371737|FG003|Overall Study|Lost to Follow-up|0|||
129838009|NCT00603746|467371738|FG004|Overall Study|Lost to Follow-up|0|||
129838010|NCT00603746|467371739|FG005|Overall Study|Lost to Follow-up|0|||
129838011|NCT00603746|467371734|FG000|Overall Study|Physician Decision|1|||
129838012|NCT00603746|467371735|FG001|Overall Study|Physician Decision|0|||
129838013|NCT00603746|467371736|FG002|Overall Study|Physician Decision|0|||
129838014|NCT00603746|467371737|FG003|Overall Study|Physician Decision|0|||
129838015|NCT00603746|467371738|FG004|Overall Study|Physician Decision|1|||
129838016|NCT00603746|467371739|FG005|Overall Study|Physician Decision|0|||
129838017|NCT00603746|467371734|FG000|Overall Study|Withdrawal by Subject|1|||
129838018|NCT00603746|467371735|FG001|Overall Study|Withdrawal by Subject|0|||
129838019|NCT00603746|467371736|FG002|Overall Study|Withdrawal by Subject|0|||
129838020|NCT00603746|467371737|FG003|Overall Study|Withdrawal by Subject|1|||
129838021|NCT00603746|467371738|FG004|Overall Study|Withdrawal by Subject|3|||
129838022|NCT00603746|467371739|FG005|Overall Study|Withdrawal by Subject|1|||
129838023|NCT01113879|467371742|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
129838024|NCT01113879|467371743|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
129838025|NCT03323658|467371745|FG000|Overall Study|Adverse Event|0|||
129838026|NCT03323658|467371746|FG001|Overall Study|Adverse Event|1|||
129838027|NCT03323658|467371747|FG002|Overall Study|Adverse Event|0|||
129447240|NCT05097716|465937498|FG000|Period 1|Close contact with highly-transmissible infection|1|||
129447241|NCT03945591|465937501|FG000|Overall Study|Participant not transplanted|1|||
129447242|NCT03945591|465937501|FG000|Overall Study|Change in treatment plan|3|||
129447243|NCT03945591|465937501|FG000|Overall Study|Adverse Event|1|||
129447244|NCT01970488|465937503|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
129447245|NCT01970488|465937504|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
129447246|NCT01970488|465937505|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
129447247|NCT01970488|465937506|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
129838028|NCT00615056|467371748|FG000|Overall Study|Death|31|||
129838029|NCT00615056|467371749|FG001|Overall Study|Death|31|||
129838030|NCT00615056|467371750|FG002|Overall Study|Death|21|||
129838031|NCT00615056|467371751|FG003|Overall Study|Death|23|||
129838032|NCT00615056|467371748|FG000|Overall Study|Lost to Follow-up|1|||
129838033|NCT00615056|467371749|FG001|Overall Study|Lost to Follow-up|2|||
129838034|NCT00615056|467371750|FG002|Overall Study|Lost to Follow-up|4|||
129838035|NCT00615056|467371751|FG003|Overall Study|Lost to Follow-up|5|||
129838036|NCT00615056|467371748|FG000|Overall Study|Other|13|||
129838037|NCT00615056|467371749|FG001|Overall Study|Other|15|||
129838038|NCT00615056|467371750|FG002|Overall Study|Other|10|||
129838039|NCT00615056|467371751|FG003|Overall Study|Other|7|||
129838040|NCT00615056|467371748|FG000|Overall Study|Objective progression or relapse|0|||
129838041|NCT00615056|467371749|FG001|Overall Study|Objective progression or relapse|2|||
129838042|NCT00615056|467371750|FG002|Overall Study|Objective progression or relapse|0|||
129838043|NCT00615056|467371751|FG003|Overall Study|Objective progression or relapse|0|||
129838044|NCT00615056|467371748|FG000|Overall Study|Withdrawal by Subject|0|||
129838045|NCT00615056|467371749|FG001|Overall Study|Withdrawal by Subject|1|||
129838046|NCT00615056|467371750|FG002|Overall Study|Withdrawal by Subject|1|||
129838047|NCT00615056|467371751|FG003|Overall Study|Withdrawal by Subject|0|||
129838048|NCT00615056|467371748|FG000|Overall Study|Discontinued by Sponsor|1|||
129838049|NCT00615056|467371749|FG001|Overall Study|Discontinued by Sponsor|0|||
129838050|NCT00615056|467371750|FG002|Overall Study|Discontinued by Sponsor|0|||
129838051|NCT00615056|467371751|FG003|Overall Study|Discontinued by Sponsor|0|||
129838052|NCT00615056|467371748|FG000|Overall Study|Randomized but not treated|3|||
129838053|NCT00615056|467371749|FG001|Overall Study|Randomized but not treated|0|||
129838054|NCT00615056|467371750|FG002|Overall Study|Randomized but not treated|0|||
129838055|NCT00615056|467371751|FG003|Overall Study|Randomized but not treated|0|||
129838056|NCT00717769|467371752|FG000|Overall Study|Adverse Event|9|||
129838057|NCT00717769|467371753|FG001|Overall Study|Adverse Event|6|||
129838058|NCT00717769|467371754|FG002|Overall Study|Adverse Event|1|||
129838059|NCT00717769|467371752|FG000|Overall Study|Lack of compliance|0|||
129838060|NCT00717769|467371753|FG001|Overall Study|Lack of compliance|2|||
129838061|NCT00717769|467371754|FG002|Overall Study|Lack of compliance|0|||
129838062|NCT00717769|467371752|FG000|Overall Study|Lost to Follow-up|3|||
129838063|NCT00717769|467371753|FG001|Overall Study|Lost to Follow-up|4|||
129838064|NCT00717769|467371754|FG002|Overall Study|Lost to Follow-up|0|||
129838065|NCT00717769|467371752|FG000|Overall Study|Lack of Efficacy|1|||
129838066|NCT00717769|467371753|FG001|Overall Study|Lack of Efficacy|2|||
129838067|NCT00717769|467371754|FG002|Overall Study|Lack of Efficacy|0|||
129838068|NCT00717769|467371752|FG000|Overall Study|Protocol Violation|0|||
129838069|NCT00717769|467371753|FG001|Overall Study|Protocol Violation|2|||
129838070|NCT00717769|467371754|FG002|Overall Study|Protocol Violation|0|||
129838071|NCT00717769|467371752|FG000|Overall Study|Sponsor decision|1|||
129838072|NCT00717769|467371753|FG001|Overall Study|Sponsor decision|0|||
129838073|NCT00717769|467371754|FG002|Overall Study|Sponsor decision|10|||
129838074|NCT00717769|467371752|FG000|Overall Study|Withdrew consent|2|||
129838075|NCT00717769|467371753|FG001|Overall Study|Withdrew consent|2|||
129838076|NCT00717769|467371754|FG002|Overall Study|Withdrew consent|0|||
129838077|NCT02276612|467371755|FG000|Overall Study|Death|1|||
129838078|NCT02276612|467371756|FG001|Overall Study|Death|0|||
129838079|NCT02276612|467371755|FG000|Overall Study|Pregnancy|1|||
129838080|NCT02276612|467371756|FG001|Overall Study|Pregnancy|0|||
129838081|NCT02276612|467371755|FG000|Overall Study|Withdrew Consent|1|||
129838082|NCT02276612|467371756|FG001|Overall Study|Withdrew Consent|0|||
129838083|NCT02276612|467371755|FG000|Overall Study|Lost to Follow-up|1|||
129838084|NCT02276612|467371756|FG001|Overall Study|Lost to Follow-up|0|||
129838085|NCT00262067|467371757|FG000|Overall Study|Death|190|||
129838086|NCT00262067|467371758|FG001|Overall Study|Death|89|||
129838087|NCT00262067|467371759|FG002|Overall Study|Death|186|||
129838088|NCT00262067|467371760|FG003|Overall Study|Death|99|||
129838089|NCT00262067|467371757|FG000|Overall Study|Lost to Follow-up|5|||
129838090|NCT00262067|467371758|FG001|Overall Study|Lost to Follow-up|4|||
129838091|NCT00262067|467371759|FG002|Overall Study|Lost to Follow-up|7|||
129838092|NCT00262067|467371760|FG003|Overall Study|Lost to Follow-up|5|||
129838093|NCT00262067|467371757|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
129838094|NCT00262067|467371758|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
129838095|NCT00262067|467371759|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
129838096|NCT00262067|467371760|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
129838097|NCT00262067|467371757|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
129838098|NCT00262067|467371758|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
129838099|NCT00262067|467371759|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
129838100|NCT00262067|467371760|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
129838101|NCT02849548|467371761|FG000|Overall Study|Lost to Follow-up|1|||
129838102|NCT02849548|467371762|FG001|Overall Study|Lost to Follow-up|2|||
129838103|NCT02849548|467371761|FG000|Overall Study|Protocol Violation|1|||
129838104|NCT02849548|467371762|FG001|Overall Study|Protocol Violation|0|||
129838105|NCT02357147|467371764|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
129838106|NCT02357147|467371765|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
129838107|NCT02357147|467371764|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
129838108|NCT02357147|467371765|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
129838109|NCT02357147|467371764|FG000|Combination Treatment Phase|Investigator Discretion|1|||
129838110|NCT02357147|467371765|FG001|Combination Treatment Phase|Investigator Discretion|1|||
129838111|NCT02357147|467371764|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
129838112|NCT02357147|467371765|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
129838113|NCT02357147|467371764|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
129838114|NCT02357147|467371765|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
129838115|NCT02357147|467371764|FG000|Combination Treatment Phase|Adverse Event|12|||
129838116|NCT02357147|467371765|FG001|Combination Treatment Phase|Adverse Event|4|||
129838117|NCT02357147|467371764|FG000|Combination Treatment Phase|Death|1|||
129838118|NCT02357147|467371765|FG001|Combination Treatment Phase|Death|1|||
129838119|NCT02357147|467371764|FG000|Combination Treatment Phase|Sponsor Decision|0|||
129838120|NCT02357147|467371765|FG001|Combination Treatment Phase|Sponsor Decision|12|||
129838121|NCT02357147|467371764|FG000|Combination Treatment Phase|Other|1|||
129838122|NCT02357147|467371765|FG001|Combination Treatment Phase|Other|0|||
129838123|NCT02357147|467371764|FG000|Combination Treatment Phase|Not treated|0|||
129838124|NCT02357147|467371765|FG001|Combination Treatment Phase|Not treated|2|||
129838125|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
129838126|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
129838127|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
129838128|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
129838129|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
129838130|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
129838131|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Adverse Event|0|||
129838132|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Adverse Event|3|||
129838133|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
129838134|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
129838135|NCT02357147|467371764|FG000|Maintenance Treatment Phase|Not Treated|1|||
129838136|NCT02357147|467371765|FG001|Maintenance Treatment Phase|Not Treated|0|||
129838137|NCT00256698|467371766|FG000|Overall Study|Withdrawal by Subject|7|||
129838138|NCT00256698|467371767|FG001|Overall Study|Withdrawal by Subject|7|||
129838139|NCT00256698|467371766|FG000|Overall Study|Adverse Event|13|||
129838140|NCT00256698|467371767|FG001|Overall Study|Adverse Event|6|||
129838141|NCT00256698|467371766|FG000|Overall Study|Protocol Violation|6|||
129838142|NCT00256698|467371767|FG001|Overall Study|Protocol Violation|5|||
129838143|NCT00256698|467371766|FG000|Overall Study|Lost to Follow-up|1|||
129838144|NCT00256698|467371767|FG001|Overall Study|Lost to Follow-up|3|||
129838145|NCT00256698|467371766|FG000|Overall Study|disease progression|97|||
129838146|NCT00256698|467371767|FG001|Overall Study|disease progression|105|||
129838147|NCT00256698|467371766|FG000|Overall Study|still ongoing at data cut-off|41|||
129838148|NCT00256698|467371767|FG001|Overall Study|still ongoing at data cut-off|46|||
129838149|NCT00256698|467371766|FG000|Overall Study|withdrawn due to osteoporosis|1|||
129838150|NCT00256698|467371767|FG001|Overall Study|withdrawn due to osteoporosis|0|||
129838151|NCT00256698|467371766|FG000|Overall Study|Prematurely Discontinued|1|||
129838152|NCT00256698|467371767|FG001|Overall Study|Prematurely Discontinued|0|||
129838153|NCT03962543|467371768|FG000|Treatment Phase|Death|0|||
129838154|NCT03962543|467371769|FG001|Treatment Phase|Death|1|||
129838155|NCT03962543|467371768|FG000|Treatment Phase|Withdrawal by Subject|3|||
129838156|NCT03962543|467371769|FG001|Treatment Phase|Withdrawal by Subject|0|||
129838157|NCT03962543|467371768|FG000|Treatment Phase|Adverse Event|3|||
129838158|NCT03962543|467371769|FG001|Treatment Phase|Adverse Event|12|||
129838159|NCT03962543|467371768|FG000|Treatment Phase|Lost to Follow-up|1|||
129838160|NCT03962543|467371769|FG001|Treatment Phase|Lost to Follow-up|2|||
129838161|NCT03962543|467371768|FG000|Treatment Phase|Radiographic PD|9|||
129838162|NCT03962543|467371769|FG001|Treatment Phase|Radiographic PD|3|||
129838163|NCT03962543|467371768|FG000|Treatment Phase|Participant Decision|3|||
129838164|NCT03962543|467371769|FG001|Treatment Phase|Participant Decision|8|||
129838165|NCT03962543|467371768|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
129838166|NCT03962543|467371769|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
129838167|NCT03962543|467371768|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
129838168|NCT03962543|467371769|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
129838169|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
129838170|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
129838171|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
129838172|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
129838173|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
129838174|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
129838175|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
129838176|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
129838177|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
129838178|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
129838179|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
129838180|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
129838181|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
129838182|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
129838183|NCT03962543|467371768|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
129838184|NCT03962543|467371769|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
129838185|NCT03264404|467373206|FG000|Overall Study|Death|2|||
129838186|NCT03264404|467373206|FG000|Overall Study|Physician Decision|1|||
129838187|NCT03264404|467373206|FG000|Overall Study|Disease Progression|28|||
129838188|NCT03264404|467373206|FG000|Overall Study|Adverse Event|1|||
129838189|NCT03264404|467373206|FG000|Overall Study|Off study prior to treatment|2|||
129838190|NCT03036566|467373209|FG000|Overall Study|Lost to Follow-up|3|||
129838191|NCT01852292|467373213|FG000|Overall Study|Untreated - did not receive study drug|3|||
129838192|NCT01852292|467373214|FG001|Overall Study|Untreated - did not receive study drug|1|||
129838193|NCT01852292|467373213|FG000|Overall Study|Death|9|||
129838194|NCT01852292|467373214|FG001|Overall Study|Death|8|||
129838195|NCT01852292|467373213|FG000|Overall Study|Patient/guardian decision|8|||
129838196|NCT01852292|467373214|FG001|Overall Study|Patient/guardian decision|4|||
129838197|NCT01852292|467373213|FG000|Overall Study|Adverse Event|8|||
129838198|NCT01852292|467373214|FG001|Overall Study|Adverse Event|11|||
129838199|NCT01852292|467373213|FG000|Overall Study|Physician Decision|6|||
129838200|NCT01852292|467373214|FG001|Overall Study|Physician Decision|2|||
129838201|NCT01852292|467373213|FG000|Overall Study|Protocol Violation|2|||
129838202|NCT01852292|467373214|FG001|Overall Study|Protocol Violation|0|||
129838203|NCT01852292|467373213|FG000|Overall Study|Non-compliance with study treatment|1|||
129838204|NCT01852292|467373214|FG001|Overall Study|Non-compliance with study treatment|0|||
129838205|NCT01852292|467373213|FG000|Overall Study|Study terminated by Sponsor|0|||
129838206|NCT01852292|467373214|FG001|Overall Study|Study terminated by Sponsor|1|||
129838207|NCT01852292|467373213|FG000|Overall Study|Progressive disease|42|||
129838208|NCT01852292|467373214|FG001|Overall Study|Progressive disease|52|||
129447248|NCT01970488|465937507|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
129447249|NCT01970488|465937503|FG000|Part 1: Through Week 16|Protocol Violation|1|||
129447250|NCT01970488|465937504|FG001|Part 1: Through Week 16|Protocol Violation|2|||
129447251|NCT01970488|465937505|FG002|Part 1: Through Week 16|Protocol Violation|0|||
129447252|NCT01970488|465937506|FG003|Part 1: Through Week 16|Protocol Violation|0|||
129447253|NCT01970488|465937507|FG004|Part 1: Through Week 16|Protocol Violation|0|||
129447254|NCT01970488|465937503|FG000|Part 1: Through Week 16|Adverse Event|6|||
129447255|NCT01970488|465937504|FG001|Part 1: Through Week 16|Adverse Event|5|||
129447256|NCT01970488|465937505|FG002|Part 1: Through Week 16|Adverse Event|0|||
129447257|NCT01970488|465937506|FG003|Part 1: Through Week 16|Adverse Event|0|||
129447258|NCT01970488|465937507|FG004|Part 1: Through Week 16|Adverse Event|0|||
129447259|NCT01970488|465937503|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
129447260|NCT01970488|465937504|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
129447261|NCT01970488|465937505|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
129447262|NCT01970488|465937506|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
129447263|NCT01970488|465937507|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
129447264|NCT01970488|465937503|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
129447265|NCT01970488|465937504|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
129447266|NCT01970488|465937505|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
129447267|NCT01970488|465937506|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
129447268|NCT01970488|465937507|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
129447269|NCT01970488|465937503|FG000|Part 2: Post Week 16|Physician Decision|0|||
129447270|NCT01970488|465937504|FG001|Part 2: Post Week 16|Physician Decision|0|||
129447271|NCT01970488|465937505|FG002|Part 2: Post Week 16|Physician Decision|0|||
129447272|NCT01970488|465937506|FG003|Part 2: Post Week 16|Physician Decision|0|||
129447273|NCT01970488|465937507|FG004|Part 2: Post Week 16|Physician Decision|1|||
129447274|NCT01970488|465937503|FG000|Part 2: Post Week 16|Non-compliance|0|||
129447275|NCT01970488|465937504|FG001|Part 2: Post Week 16|Non-compliance|0|||
129447276|NCT01970488|465937505|FG002|Part 2: Post Week 16|Non-compliance|1|||
129447277|NCT01970488|465937506|FG003|Part 2: Post Week 16|Non-compliance|0|||
129447278|NCT01970488|465937507|FG004|Part 2: Post Week 16|Non-compliance|0|||
129447279|NCT01970488|465937503|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
129447280|NCT01970488|465937504|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
129447281|NCT01970488|465937505|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
129447282|NCT01970488|465937506|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
129447283|NCT01970488|465937507|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
129447284|NCT01970488|465937503|FG000|Part 2: Post Week 16|Adverse Event|0|||
129447285|NCT01970488|465937504|FG001|Part 2: Post Week 16|Adverse Event|0|||
129447286|NCT01970488|465937505|FG002|Part 2: Post Week 16|Adverse Event|5|||
129447287|NCT01970488|465937506|FG003|Part 2: Post Week 16|Adverse Event|1|||
129447288|NCT01970488|465937507|FG004|Part 2: Post Week 16|Adverse Event|1|||
129447289|NCT01970488|465937503|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
129838209|NCT01914666|467373217|FG000|Treatment Period|Lack of Efficacy|0|||
129838210|NCT01914666|467373218|FG001|Treatment Period|Lack of Efficacy|0|||
129838211|NCT01914666|467373219|FG002|Treatment Period|Lack of Efficacy|2|||
129838212|NCT01914666|467373217|FG000|Treatment Period|Adverse Event|10|||
129838213|NCT01914666|467373218|FG001|Treatment Period|Adverse Event|4|||
129838214|NCT01914666|467373219|FG002|Treatment Period|Adverse Event|2|||
129838215|NCT01914666|467373217|FG000|Treatment Period|Withdrawal by Subject|3|||
129838216|NCT01914666|467373218|FG001|Treatment Period|Withdrawal by Subject|2|||
129447290|NCT01970488|465937504|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
129447291|NCT01970488|465937505|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
129447292|NCT01970488|465937506|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
129447293|NCT01970488|465937507|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
129447294|NCT01970488|465937503|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
129838217|NCT01914666|467373219|FG002|Treatment Period|Withdrawal by Subject|2|||
129838218|NCT01914666|467373217|FG000|Treatment Period|Physician Decision|0|||
129838219|NCT01914666|467373218|FG001|Treatment Period|Physician Decision|0|||
129838220|NCT01914666|467373219|FG002|Treatment Period|Physician Decision|2|||
129838221|NCT02586012|467373220|FG000|Overall Study|Withdrawal by Subject|1|||
129838222|NCT02586012|467373221|FG001|Overall Study|Withdrawal by Subject|1|||
129838223|NCT02586012|467373222|FG002|Overall Study|Withdrawal by Subject|0|||
129838224|NCT02586012|467373223|FG003|Overall Study|Withdrawal by Subject|1|||
129838225|NCT02586012|467373224|FG004|Overall Study|Withdrawal by Subject|0|||
129838226|NCT02586012|467373225|FG005|Overall Study|Withdrawal by Subject|2|||
129838227|NCT02586012|467373220|FG000|Overall Study|Protocol Violation|0|||
129838228|NCT02586012|467373221|FG001|Overall Study|Protocol Violation|0|||
129838229|NCT02586012|467373222|FG002|Overall Study|Protocol Violation|0|||
129838230|NCT02586012|467373223|FG003|Overall Study|Protocol Violation|0|||
129838231|NCT02586012|467373224|FG004|Overall Study|Protocol Violation|0|||
129838232|NCT02586012|467373225|FG005|Overall Study|Protocol Violation|1|||
129838233|NCT02586012|467373220|FG000|Overall Study|study terminated|0|||
129838234|NCT02586012|467373221|FG001|Overall Study|study terminated|2|||
129838235|NCT02586012|467373222|FG002|Overall Study|study terminated|1|||
129898757|NCT00567879|467590034|FG005|Overall Study|Abnormal test procedure(s)|0|||
129898758|NCT00567879|467590029|FG000|Overall Study|Withdrawal by Subject|0|||
129898759|NCT00567879|467590030|FG001|Overall Study|Withdrawal by Subject|0|||
129898760|NCT00567879|467590031|FG002|Overall Study|Withdrawal by Subject|3|||
129898761|NCT00567879|467590032|FG003|Overall Study|Withdrawal by Subject|1|||
129898762|NCT00567879|467590033|FG004|Overall Study|Withdrawal by Subject|0|||
129898763|NCT00567879|467590034|FG005|Overall Study|Withdrawal by Subject|0|||
129898764|NCT00567879|467590029|FG000|Overall Study|New cancer therapy|0|||
129898765|NCT00567879|467590030|FG001|Overall Study|New cancer therapy|0|||
129898766|NCT00567879|467590031|FG002|Overall Study|New cancer therapy|1|||
129838236|NCT02586012|467373223|FG003|Overall Study|study terminated|1|||
129838237|NCT02586012|467373224|FG004|Overall Study|study terminated|1|||
129838238|NCT02586012|467373225|FG005|Overall Study|study terminated|0|||
129838239|NCT03277846|467373226|FG000|Overall Study|Inpatient stay too brief|12|||
129898767|NCT00567879|467590032|FG003|Overall Study|New cancer therapy|0|||
129898768|NCT00567879|467590033|FG004|Overall Study|New cancer therapy|0|||
129838240|NCT03277846|467373227|FG001|Overall Study|Inpatient stay too brief|11|||
129838241|NCT04013191|467373228|FG000|Overall Study|Adverse Event|1|||
129838242|NCT04013191|467373229|FG001|Overall Study|Adverse Event|0|||
129838243|NCT01275066|467373238|FG000|Overall Study|Withdrawal by Subject|0|||
129838244|NCT01275066|467373239|FG001|Overall Study|Withdrawal by Subject|0|||
129838245|NCT01275066|467373240|FG002|Overall Study|Withdrawal by Subject|1|||
129838246|NCT01275066|467373238|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
129838247|NCT01275066|467373239|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
129838248|NCT01275066|467373240|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
129838249|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
129838250|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
129838251|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
129838252|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
129838253|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
129838254|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
129838255|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
129838256|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
129838257|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
129838258|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
129838259|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
129838260|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
129838261|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
129898769|NCT00567879|467590034|FG005|Overall Study|New cancer therapy|0|||
129898770|NCT00567879|467590029|FG000|Overall Study|Disease progression|5|||
129898771|NCT00567879|467590030|FG001|Overall Study|Disease progression|7|||
129898772|NCT00567879|467590031|FG002|Overall Study|Disease progression|15|||
129898773|NCT00567879|467590032|FG003|Overall Study|Disease progression|5|||
129898774|NCT00567879|467590033|FG004|Overall Study|Disease progression|11|||
129898775|NCT00567879|467590034|FG005|Overall Study|Disease progression|3|||
129838262|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
129898776|NCT00470626|467590035|FG000|Overall Study|Lost to Follow-up|10|||
129838263|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
129898777|NCT00470626|467590035|FG000|Overall Study|Withdrawal by Subject|7|||
129898778|NCT00777556|467590036|FG000|Overall Study|Inappropriate self-selection|34|||
129838264|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
129838265|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
129838266|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
129898779|NCT00777556|467590036|FG000|Overall Study|Dispensed but did not use product|12|||
129898780|NCT00777556|467590036|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
129898781|NCT01729819|467590041|FG000|Overall Study|Adverse Event|2|||
129898782|NCT01729819|467590042|FG001|Overall Study|Adverse Event|4|||
129898783|NCT01729819|467590041|FG000|Overall Study|Lack of Efficacy|1|||
129447295|NCT01970488|465937504|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
129447296|NCT01970488|465937505|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
129447297|NCT01970488|465937506|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
129447298|NCT01970488|465937507|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
129447299|NCT00851682|465937510|FG000|Overall Study|screen failure|5|||
129447300|NCT00851682|465937511|FG001|Overall Study|screen failure|0|||
129447301|NCT04060563|465937512|FG000|Overall Study|Lost to Follow-up|1|||
129447302|NCT04060563|465937513|FG001|Overall Study|Lost to Follow-up|1|||
129447303|NCT04060563|465937512|FG000|Overall Study|Physician Decision|0|||
129447304|NCT04060563|465937513|FG001|Overall Study|Physician Decision|1|||
129447305|NCT00760669|465937514|FG000|Overall Study|Not assessed for overall improvement|18|||
129447306|NCT00760669|465937514|FG000|Overall Study|Participants missing efficacy assessment|6|||
129447307|NCT00760669|465937514|FG000|Overall Study|Participants with overlapping cases|1|||
129447308|NCT00760669|465937514|FG000|Overall Study|Took drug before entering in contract|5|||
129447309|NCT01572675|465937515|FG000|Overall Study|End of prescribed treatment|140|||
129447310|NCT01572675|465937516|FG001|Overall Study|End of prescribed treatment|118|||
129447311|NCT01572675|465937515|FG000|Overall Study|Recovery|16|||
129447312|NCT01572675|465937516|FG001|Overall Study|Recovery|23|||
129447313|NCT01572675|465937515|FG000|Overall Study|Lack of Efficacy|31|||
129447314|NCT01572675|465937516|FG001|Overall Study|Lack of Efficacy|31|||
129447315|NCT01572675|465937515|FG000|Overall Study|Intolerance|6|||
129447316|NCT01572675|465937516|FG001|Overall Study|Intolerance|5|||
129447317|NCT01572675|465937515|FG000|Overall Study|Improved symptoms|8|||
129447318|NCT01572675|465937516|FG001|Overall Study|Improved symptoms|2|||
129447319|NCT01572675|465937515|FG000|Overall Study|Surgical intervention|3|||
129447320|NCT01572675|465937516|FG001|Overall Study|Surgical intervention|6|||
129447321|NCT01572675|465937515|FG000|Overall Study|Withdrawal by Subject|5|||
129447322|NCT01572675|465937516|FG001|Overall Study|Withdrawal by Subject|1|||
129447323|NCT01572675|465937515|FG000|Overall Study|Physician Decision|2|||
129447324|NCT01572675|465937516|FG001|Overall Study|Physician Decision|2|||
129447325|NCT01572675|465937515|FG000|Overall Study|Death unrelated to coxibs|1|||
129447326|NCT01572675|465937516|FG001|Overall Study|Death unrelated to coxibs|1|||
129447327|NCT01572675|465937515|FG000|Overall Study|Other disease detected|1|||
129447328|NCT01572675|465937516|FG001|Overall Study|Other disease detected|1|||
129447329|NCT01572675|465937515|FG000|Overall Study|Unknown reason|1|||
129447330|NCT01572675|465937516|FG001|Overall Study|Unknown reason|1|||
129447331|NCT01572675|465937515|FG000|Overall Study|Rheumatologist new evaluation|0|||
129447332|NCT01572675|465937516|FG001|Overall Study|Rheumatologist new evaluation|1|||
129447333|NCT01572675|465937515|FG000|Overall Study|Missing data|1|||
129447334|NCT01572675|465937516|FG001|Overall Study|Missing data|4|||
129447335|NCT01572675|465937515|FG000|Overall Study|Lost to Follow-up|22|||
129447336|NCT01572675|465937516|FG001|Overall Study|Lost to Follow-up|27|||
129447337|NCT02921269|465937517|FG000|Overall Study|Did not complete DLT period|1|||
129447338|NCT02003014|465937527|FG000|Overall Study|Case report forms uncollected|9|||
129447339|NCT02003014|465937527|FG000|Overall Study|Treatment started after contract period|1|||
129447340|NCT02003014|465937527|FG000|Overall Study|Patient did not visit the study site|5|||
129447341|NCT02003014|465937527|FG000|Overall Study|Investigator's transfer|4|||
129447342|NCT01660451|465937528|FG000|Overall Study|Protocol Violation|0|||
129447343|NCT01660451|465937529|FG001|Overall Study|Protocol Violation|1|||
129838267|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
129838268|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
129838269|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
129838270|NCT00934544|467373246|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
129838271|NCT00934544|467373247|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
129838272|NCT00934544|467373248|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
129838273|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
129838274|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
129898784|NCT01729819|467590042|FG001|Overall Study|Lack of Efficacy|0|||
129898785|NCT01729819|467590041|FG000|Overall Study|Lost to Follow-up|2|||
129898786|NCT01729819|467590042|FG001|Overall Study|Lost to Follow-up|0|||
129447344|NCT01660451|465937530|FG002|Overall Study|Protocol Violation|1|||
129447345|NCT01660451|465937528|FG000|Overall Study|AE not associated with clinical disease progression|13|||
129447346|NCT01660451|465937529|FG001|Overall Study|AE not associated with clinical disease progression|10|||
129447347|NCT01660451|465937530|FG002|Overall Study|AE not associated with clinical disease progression|40|||
129447348|NCT01660451|465937528|FG000|Overall Study|AE associated with clinical disease progression|1|||
129447349|NCT01660451|465937529|FG001|Overall Study|AE associated with clinical disease progression|3|||
129447350|NCT01660451|465937530|FG002|Overall Study|AE associated with clinical disease progression|11|||
129447351|NCT01660451|465937528|FG000|Overall Study|Sponsor Decision|0|||
129447352|NCT01660451|465937529|FG001|Overall Study|Sponsor Decision|0|||
129447353|NCT01660451|465937530|FG002|Overall Study|Sponsor Decision|1|||
129447354|NCT01660451|465937528|FG000|Overall Study|Protocol Deviation|0|||
129447355|NCT01660451|465937529|FG001|Overall Study|Protocol Deviation|0|||
129447356|NCT01660451|465937530|FG002|Overall Study|Protocol Deviation|1|||
129838275|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
129447357|NCT01660451|465937528|FG000|Overall Study|Physician Decision|1|||
129447358|NCT01660451|465937529|FG001|Overall Study|Physician Decision|2|||
129447359|NCT01660451|465937530|FG002|Overall Study|Physician Decision|5|||
129447360|NCT01660451|465937528|FG000|Overall Study|Withdrawal by Subject|1|||
129447361|NCT01660451|465937529|FG001|Overall Study|Withdrawal by Subject|1|||
129447362|NCT01660451|465937530|FG002|Overall Study|Withdrawal by Subject|20|||
129447363|NCT01660451|465937528|FG000|Overall Study|Trial closure.|0|||
129447364|NCT01660451|465937529|FG001|Overall Study|Trial closure.|0|||
129447365|NCT01660451|465937530|FG002|Overall Study|Trial closure.|1|||
129447366|NCT01660451|465937528|FG000|Overall Study|Switching to other therapy|0|||
129447367|NCT01660451|465937529|FG001|Overall Study|Switching to other therapy|1|||
129447368|NCT01660451|465937530|FG002|Overall Study|Switching to other therapy|1|||
129447369|NCT01660451|465937528|FG000|Overall Study|Progressive disease - clinical progression|4|||
129447370|NCT01660451|465937529|FG001|Overall Study|Progressive disease - clinical progression|10|||
129447371|NCT01660451|465937530|FG002|Overall Study|Progressive disease - clinical progression|9|||
129447372|NCT01660451|465937528|FG000|Overall Study|Progressive disease - radiological progression|12|||
129447373|NCT01660451|465937529|FG001|Overall Study|Progressive disease - radiological progression|23|||
129447374|NCT01660451|465937530|FG002|Overall Study|Progressive disease - radiological progression|50|||
129447375|NCT01660451|465937528|FG000|Overall Study|Death|1|||
129447376|NCT01660451|465937529|FG001|Overall Study|Death|0|||
129447377|NCT01660451|465937530|FG002|Overall Study|Death|1|||
129447378|NCT01660451|465937528|FG000|Overall Study|Other|0|||
129838276|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
129838277|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
129838278|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
129838279|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
129838280|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
129838281|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
129838282|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
129838283|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
129838284|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
129838285|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
129838286|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
129838287|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
129838288|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
129838289|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
129838290|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
129838291|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
129838292|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
129838293|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
129838294|NCT00934544|467373246|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
129838295|NCT00934544|467373247|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
129838296|NCT00934544|467373248|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
129838297|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
129838298|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
129838299|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
129838300|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
129838301|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
129838302|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
129838303|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
129838304|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
129838305|NCT04033003|467373250|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
129838306|NCT04033003|467373251|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
129838307|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
129838308|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
129838309|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
129838310|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
129838311|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
129838312|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
129838313|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
129447379|NCT01660451|465937529|FG001|Overall Study|Other|0|||
129447380|NCT01660451|465937530|FG002|Overall Study|Other|1|||
129447381|NCT02281357|465937531|FG000|Overall Study|Adverse Event|2|||
129447382|NCT02281357|465937532|FG001|Overall Study|Adverse Event|1|||
129447383|NCT02281357|465937531|FG000|Overall Study|Lost to Follow-up|1|||
129447384|NCT02281357|465937532|FG001|Overall Study|Lost to Follow-up|0|||
129838314|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
129838315|NCT04033003|467373250|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
129838316|NCT04033003|467373251|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
129838317|NCT04033003|467373250|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
129838318|NCT04033003|467373251|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
129838319|NCT04033003|467373250|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
129838320|NCT04033003|467373251|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
129838321|NCT04033003|467373250|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
129838322|NCT04033003|467373251|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
129838323|NCT02487394|467373252|FG000|Phase 1|Withdrawal by Subject|0|||
129838324|NCT02487394|467373253|FG001|Phase 1|Withdrawal by Subject|1|||
129838325|NCT00782210|467373254|FG000|Overall Study|Adverse Event|21|||
129838326|NCT00782210|467373255|FG001|Overall Study|Adverse Event|17|||
129838327|NCT00782210|467373256|FG002|Overall Study|Adverse Event|16|||
129838328|NCT00782210|467373254|FG000|Overall Study|Lost to Follow-up|2|||
129838329|NCT00782210|467373255|FG001|Overall Study|Lost to Follow-up|1|||
129838330|NCT00782210|467373256|FG002|Overall Study|Lost to Follow-up|2|||
129838331|NCT00782210|467373254|FG000|Overall Study|Withdrawal by Subject|11|||
129838332|NCT00782210|467373255|FG001|Overall Study|Withdrawal by Subject|8|||
129838333|NCT00782210|467373256|FG002|Overall Study|Withdrawal by Subject|11|||
129838334|NCT00782210|467373254|FG000|Overall Study|Non compliance with protocol|0|||
129838335|NCT00782210|467373255|FG001|Overall Study|Non compliance with protocol|3|||
129838336|NCT00782210|467373256|FG002|Overall Study|Non compliance with protocol|2|||
129838337|NCT00782210|467373254|FG000|Overall Study|Lack of Efficacy|13|||
129838338|NCT00782210|467373255|FG001|Overall Study|Lack of Efficacy|4|||
129838339|NCT00782210|467373256|FG002|Overall Study|Lack of Efficacy|1|||
129838340|NCT00782210|467373254|FG000|Overall Study|Other reason not described above|3|||
129838341|NCT00782210|467373255|FG001|Overall Study|Other reason not described above|2|||
129838342|NCT00782210|467373256|FG002|Overall Study|Other reason not described above|3|||
129838343|NCT00735371|467373257|FG000|Overall Study|Adverse Event|3|||
129838344|NCT00735371|467373258|FG001|Overall Study|Adverse Event|3|||
129838345|NCT00735371|467373259|FG002|Overall Study|Adverse Event|4|||
129838346|NCT00735371|467373260|FG003|Overall Study|Adverse Event|1|||
129838347|NCT00735371|467373257|FG000|Overall Study|Protocol Violation|2|||
129838348|NCT00735371|467373258|FG001|Overall Study|Protocol Violation|2|||
129838349|NCT00735371|467373259|FG002|Overall Study|Protocol Violation|0|||
129838350|NCT00735371|467373260|FG003|Overall Study|Protocol Violation|3|||
129838351|NCT00735371|467373257|FG000|Overall Study|Withdrawal by Subject|0|||
129838352|NCT00735371|467373258|FG001|Overall Study|Withdrawal by Subject|2|||
129838353|NCT00735371|467373259|FG002|Overall Study|Withdrawal by Subject|2|||
129838354|NCT00735371|467373260|FG003|Overall Study|Withdrawal by Subject|0|||
129838355|NCT00735371|467373257|FG000|Overall Study|Lost to Follow-up|1|||
129838356|NCT00735371|467373258|FG001|Overall Study|Lost to Follow-up|1|||
129838357|NCT00735371|467373259|FG002|Overall Study|Lost to Follow-up|3|||
129838358|NCT00735371|467373260|FG003|Overall Study|Lost to Follow-up|1|||
129838359|NCT00735371|467373257|FG000|Overall Study|Lack of Efficacy|4|||
129838360|NCT00735371|467373258|FG001|Overall Study|Lack of Efficacy|2|||
129838361|NCT00735371|467373259|FG002|Overall Study|Lack of Efficacy|0|||
129838362|NCT00735371|467373260|FG003|Overall Study|Lack of Efficacy|4|||
129838363|NCT00735371|467373257|FG000|Overall Study|Sponsor Decision|3|||
129838364|NCT00735371|467373258|FG001|Overall Study|Sponsor Decision|1|||
129838365|NCT00735371|467373259|FG002|Overall Study|Sponsor Decision|0|||
129838366|NCT00735371|467373260|FG003|Overall Study|Sponsor Decision|1|||
129838367|NCT00735371|467373257|FG000|Overall Study|Protocol Violation|0|||
129838368|NCT00735371|467373258|FG001|Overall Study|Protocol Violation|1|||
129838369|NCT00735371|467373259|FG002|Overall Study|Protocol Violation|2|||
129838370|NCT00735371|467373260|FG003|Overall Study|Protocol Violation|0|||
129838371|NCT00735371|467373257|FG000|Overall Study|Prior Vyvanse Exposure|1|||
129838372|NCT00735371|467373258|FG001|Overall Study|Prior Vyvanse Exposure|1|||
129838373|NCT00735371|467373259|FG002|Overall Study|Prior Vyvanse Exposure|0|||
129838374|NCT00735371|467373260|FG003|Overall Study|Prior Vyvanse Exposure|0|||
129838375|NCT00735371|467373257|FG000|Overall Study|Exclusion criteria|1|||
129838376|NCT00735371|467373258|FG001|Overall Study|Exclusion criteria|0|||
129838377|NCT00735371|467373259|FG002|Overall Study|Exclusion criteria|0|||
129838378|NCT00735371|467373260|FG003|Overall Study|Exclusion criteria|0|||
129838379|NCT00994448|467373261|FG000|Overall Study|Adverse Event|1|||
129838380|NCT00994448|467373262|FG001|Overall Study|Adverse Event|0|||
129838381|NCT00994448|467373261|FG000|Overall Study|Lost to Follow-up|5|||
129838382|NCT00994448|467373262|FG001|Overall Study|Lost to Follow-up|1|||
129838383|NCT00994448|467373261|FG000|Overall Study|Withdrawal by Subject|1|||
129838384|NCT00994448|467373262|FG001|Overall Study|Withdrawal by Subject|1|||
129838385|NCT00994448|467373261|FG000|Overall Study|Physician Decision|1|||
129838386|NCT00994448|467373262|FG001|Overall Study|Physician Decision|0|||
129838387|NCT00436748|467373267|FG000|Overall Study|Ineligibility Determined|1|||
129838388|NCT00436748|467373268|FG001|Overall Study|Ineligibility Determined|1|||
129838389|NCT00436748|467373267|FG000|Overall Study|Adverse Event|0|||
129838390|NCT00436748|467373268|FG001|Overall Study|Adverse Event|2|||
129838391|NCT00436748|467373267|FG000|Overall Study|Consent Withdrawn|1|||
129447385|NCT02281357|465937531|FG000|Overall Study|Withdrawal by Subject|4|||
129447386|NCT02281357|465937532|FG001|Overall Study|Withdrawal by Subject|3|||
129447387|NCT03007979|465937535|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
129447388|NCT00482703|465937536|FG000|Overall Study|Poor compliance|1|||
129447389|NCT00482703|465937537|FG001|Overall Study|Poor compliance|0|||
129447390|NCT00729378|465939020|FG000|Baseline|Did not complete study measurements|72|||
129447391|NCT00729378|465939021|FG001|Baseline|Did not complete study measurements|33|||
129447392|NCT00729378|465939020|FG000|Baseline|Withdrawal by Subject|66|||
129447393|NCT00729378|465939021|FG001|Baseline|Withdrawal by Subject|59|||
129447394|NCT00729378|465939020|FG000|12-months|Lost to Follow-up|100|||
129447395|NCT00729378|465939021|FG001|12-months|Lost to Follow-up|65|||
129447396|NCT00729378|465939020|FG000|24-months|Lost to Follow-up|72|||
129447397|NCT00729378|465939021|FG001|24-months|Lost to Follow-up|51|||
129447398|NCT00729378|465939020|FG000|36-months|Lost to Follow-up|15|||
129447399|NCT00729378|465939021|FG001|36-months|Lost to Follow-up|6|||
129447400|NCT02246582|465939024|FG000|Overall Study|Withdrawal by Subject|3|||
129447401|NCT02246582|465939025|FG001|Overall Study|Withdrawal by Subject|4|||
129447402|NCT02060383|465939026|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
129447403|NCT02060383|465939027|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
129447404|NCT02060383|465939028|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
129447405|NCT02060383|465939029|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
129447406|NCT02060383|465939030|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
129447407|NCT02060383|465939026|FG000|Core Phase|Adverse Event|2|||
129447408|NCT02060383|465939027|FG001|Core Phase|Adverse Event|0|||
129447409|NCT02060383|465939028|FG002|Core Phase|Adverse Event|0|||
129447410|NCT02060383|465939029|FG003|Core Phase|Adverse Event|2|||
129447411|NCT02060383|465939030|FG004|Core Phase|Adverse Event|6|||
129447412|NCT02060383|465939026|FG000|Core Phase|Administrative problems|0|||
129447413|NCT02060383|465939027|FG001|Core Phase|Administrative problems|1|||
129447414|NCT02060383|465939028|FG002|Core Phase|Administrative problems|0|||
129447415|NCT02060383|465939029|FG003|Core Phase|Administrative problems|0|||
129447416|NCT02060383|465939030|FG004|Core Phase|Administrative problems|0|||
129447417|NCT02060383|465939026|FG000|Core Phase|Protocol Violation|0|||
129447418|NCT02060383|465939027|FG001|Core Phase|Protocol Violation|0|||
129447419|NCT02060383|465939028|FG002|Core Phase|Protocol Violation|0|||
129447420|NCT02060383|465939029|FG003|Core Phase|Protocol Violation|1|||
129447421|NCT02060383|465939030|FG004|Core Phase|Protocol Violation|0|||
129447422|NCT02060383|465939026|FG000|Core Phase|Withdrawal by Subject|0|||
129838392|NCT00436748|467373268|FG001|Overall Study|Consent Withdrawn|4|||
129838393|NCT00436748|467373267|FG000|Overall Study|Administrative Decision|1|||
129838394|NCT00436748|467373268|FG001|Overall Study|Administrative Decision|0|||
129838395|NCT00436748|467373267|FG000|Overall Study|Lost to Follow-up|0|||
129838396|NCT00436748|467373268|FG001|Overall Study|Lost to Follow-up|1|||
129838397|NCT00436748|467373267|FG000|Overall Study|Protocol-specified Criteria|5|||
129838398|NCT00436748|467373268|FG001|Overall Study|Protocol-specified Criteria|4|||
129838399|NCT00436748|467373267|FG000|Overall Study|Other|3|||
129838400|NCT00436748|467373268|FG001|Overall Study|Other|0|||
129838401|NCT01610791|467373269|FG000|Overall Study|Lost to Follow-up|7|||
129838402|NCT01610791|467373269|FG000|Overall Study|Adverse Event|6|||
129838403|NCT01610791|467373269|FG000|Overall Study|Physician Decision|1|||
129838404|NCT01610791|467373269|FG000|Overall Study|Adverse event and Investigator decision|1|||
129838405|NCT01610791|467373269|FG000|Overall Study|Death|1|||
129838406|NCT01610791|467373269|FG000|Overall Study|Not determined|5|||
129838407|NCT00850200|467373272|FG000|Overall Study|Physician Decision|2|||
129838408|NCT00850200|467373272|FG000|Overall Study|Did not recieve treatment|2|||
129838409|NCT00850200|467373272|FG000|Overall Study|Withdrawal by Subject|1|||
129838410|NCT02711800|467373273|FG000|Overall Study|Lost to Follow-up|1|||
129838411|NCT02711800|467373273|FG000|Overall Study|Withdrawal by Subject|1|||
129838412|NCT04164901|467373277|FG000|Overall Study|Withdrawal by Subject|4|||
129838413|NCT04164901|467373278|FG001|Overall Study|Withdrawal by Subject|4|||
129838414|NCT05040152|467373283|FG000|Overall Study|Withdrawal by Subject|5|||
129838415|NCT05040152|467373284|FG001|Overall Study|Withdrawal by Subject|0|||
129838416|NCT05040152|467373283|FG000|Overall Study|Lost to Follow-up|0|||
129838417|NCT05040152|467373284|FG001|Overall Study|Lost to Follow-up|2|||
129838418|NCT02046148|467373292|FG000|Overall Study|Lost to Follow-up|1|||
129838419|NCT02046148|467373293|FG001|Overall Study|Lost to Follow-up|1|||
129838420|NCT02046148|467373292|FG000|Overall Study|Withdrawal by Subject|0|||
129838421|NCT02046148|467373293|FG001|Overall Study|Withdrawal by Subject|2|||
129838422|NCT00314574|467373294|FG000|Overall Study|Death|3|||
129447423|NCT02060383|465939027|FG001|Core Phase|Withdrawal by Subject|0|||
129447424|NCT02060383|465939028|FG002|Core Phase|Withdrawal by Subject|0|||
129447425|NCT02060383|465939029|FG003|Core Phase|Withdrawal by Subject|4|||
129447426|NCT02060383|465939030|FG004|Core Phase|Withdrawal by Subject|2|||
129838423|NCT00314574|467373295|FG001|Overall Study|Death|0|||
129838424|NCT00314574|467373294|FG000|Overall Study|Adverse Event|11|||
129447427|NCT02060383|465939026|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
129447428|NCT02060383|465939027|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
129838425|NCT00314574|467373295|FG001|Overall Study|Adverse Event|16|||
129838426|NCT00314574|467373294|FG000|Overall Study|Lost to Follow-up|19|||
129838427|NCT00314574|467373295|FG001|Overall Study|Lost to Follow-up|25|||
129838428|NCT00314574|467373294|FG000|Overall Study|Withdrawal by Subject|33|||
129838429|NCT00314574|467373295|FG001|Overall Study|Withdrawal by Subject|22|||
129838430|NCT00314574|467373294|FG000|Overall Study|Physician Decision|22|||
129838431|NCT00314574|467373295|FG001|Overall Study|Physician Decision|15|||
129838432|NCT00314574|467373294|FG000|Overall Study|Pregnancy|6|||
129838433|NCT00314574|467373295|FG001|Overall Study|Pregnancy|4|||
129838434|NCT00314574|467373294|FG000|Overall Study|Data unknown at database lock|0|||
129838435|NCT00314574|467373295|FG001|Overall Study|Data unknown at database lock|1|||
129838436|NCT00449956|467373296|FG000|Overall Study|Adverse Event|7|||
129838437|NCT00449956|467373297|FG001|Overall Study|Adverse Event|1|||
129838438|NCT00449956|467373298|FG002|Overall Study|Adverse Event|6|||
129838439|NCT00449956|467373296|FG000|Overall Study|Lack of Efficacy|0|||
129838440|NCT00449956|467373297|FG001|Overall Study|Lack of Efficacy|0|||
129838441|NCT00449956|467373298|FG002|Overall Study|Lack of Efficacy|1|||
129838442|NCT00449956|467373296|FG000|Overall Study|Protocol Violation|1|||
129838443|NCT00449956|467373297|FG001|Overall Study|Protocol Violation|1|||
129838444|NCT00449956|467373298|FG002|Overall Study|Protocol Violation|1|||
129838445|NCT00449956|467373296|FG000|Overall Study|Withdrawal by Subject|0|||
129838446|NCT00449956|467373297|FG001|Overall Study|Withdrawal by Subject|1|||
129838447|NCT00449956|467373298|FG002|Overall Study|Withdrawal by Subject|0|||
129898787|NCT01729819|467590041|FG000|Overall Study|Other reason|1|||
129898788|NCT01729819|467590042|FG001|Overall Study|Other reason|0|||
129898789|NCT01729819|467590041|FG000|Overall Study|Protocol Violation|0|||
129898790|NCT01729819|467590042|FG001|Overall Study|Protocol Violation|1|||
129898791|NCT01729819|467590041|FG000|Overall Study|Withdrawal by Subject|0|||
129898792|NCT01729819|467590042|FG001|Overall Study|Withdrawal by Subject|2|||
129898793|NCT03646669|467590043|FG000|Overall Study|Withdrawal by Subject|5|||
129898794|NCT03646669|467590044|FG001|Overall Study|Withdrawal by Subject|0|||
129898795|NCT03439124|467590049|FG000|Overall Study|Adverse Event|2|||
129898796|NCT03439124|467590050|FG001|Overall Study|Adverse Event|0|||
129898797|NCT03439124|467590049|FG000|Overall Study|Lost to Follow-up|1|||
129898798|NCT03439124|467590050|FG001|Overall Study|Lost to Follow-up|0|||
129898799|NCT03439124|467590049|FG000|Overall Study|Other reasons|1|||
129898800|NCT03439124|467590050|FG001|Overall Study|Other reasons|0|||
129898801|NCT01451814|467590051|FG000|Overall Study|Withdrawal by Subject|1|||
129898802|NCT01451814|467590052|FG001|Overall Study|Withdrawal by Subject|1|||
129898803|NCT01451814|467590051|FG000|Overall Study|Lost to Follow-up|5|||
129898804|NCT01451814|467590052|FG001|Overall Study|Lost to Follow-up|4|||
129898805|NCT02049866|467590053|FG000|Overall Study|Withdrawal by Subject|1|||
129898806|NCT01117480|467590054|FG000|Overall Study|Protocol Violation|8|||
129898807|NCT01117480|467590054|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
129898808|NCT02955069|467590056|FG000|Overall Study|Adverse Event|7|||
129898809|NCT02955069|467590057|FG001|Overall Study|Adverse Event|2|||
129898810|NCT02955069|467590056|FG000|Overall Study|Death|7|||
129898811|NCT02955069|467590057|FG001|Overall Study|Death|3|||
129898812|NCT02955069|467590056|FG000|Overall Study|Physician Decision|10|||
129898813|NCT02955069|467590057|FG001|Overall Study|Physician Decision|2|||
129898814|NCT02955069|467590056|FG000|Overall Study|Progressive disease|64|||
129898815|NCT02955069|467590057|FG001|Overall Study|Progressive disease|13|||
129898816|NCT02955069|467590056|FG000|Overall Study|Study terminated by sponsor|4|||
129898817|NCT02955069|467590057|FG001|Overall Study|Study terminated by sponsor|0|||
129898818|NCT02955069|467590056|FG000|Overall Study|Subject/Guardian decision|3|||
129898819|NCT02955069|467590057|FG001|Overall Study|Subject/Guardian decision|1|||
129898820|NCT00943605|467590059|FG000|Overall Study|Study termination|30|||
129898821|NCT00943605|467590060|FG001|Overall Study|Study termination|30|||
129838448|NCT00449956|467373296|FG000|Overall Study|Physician Decision|2|||
129838449|NCT00449956|467373297|FG001|Overall Study|Physician Decision|1|||
129898822|NCT04148937|467590063|FG000|Overall Study|Withdrawal by Subject|0|||
129447429|NCT02060383|465939028|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
129838450|NCT00449956|467373298|FG002|Overall Study|Physician Decision|1|||
129838451|NCT02086110|467373299|FG000|Overall Study|Withdrawal by Subject|1|||
129838452|NCT02086110|467373300|FG001|Overall Study|Withdrawal by Subject|1|||
129838453|NCT00235872|467373305|FG000|Overall Study|Adverse Event|34|||
129838454|NCT00235872|467373305|FG000|Overall Study|Death|1|||
129838455|NCT00235872|467373305|FG000|Overall Study|Lost to Follow-up|1|||
129838456|NCT00235872|467373305|FG000|Overall Study|Withdrawal by Subject|50|||
129838457|NCT00235872|467373305|FG000|Overall Study|Administrative reason|61|||
129838458|NCT02272413|467373306|FG000|Randomized Through Treatment Start|Not treated|3|||
129838459|NCT02272413|467373307|FG001|Randomized Through Treatment Start|Not treated|5|||
129838460|NCT02272413|467373306|FG000|Pre-switch Period|Adverse Event|38|||
129838461|NCT02272413|467373307|FG001|Pre-switch Period|Adverse Event|37|||
129898823|NCT04148937|467590064|FG001|Overall Study|Withdrawal by Subject|0|||
129898824|NCT04148937|467590065|FG002|Overall Study|Withdrawal by Subject|0|||
129898825|NCT04148937|467590066|FG003|Overall Study|Withdrawal by Subject|1|||
129898826|NCT04148937|467590067|FG004|Overall Study|Withdrawal by Subject|0|||
129898827|NCT04148937|467590068|FG005|Overall Study|Withdrawal by Subject|1|||
129838462|NCT02272413|467373306|FG000|Pre-switch Period|Death|26|||
129838463|NCT02272413|467373307|FG001|Pre-switch Period|Death|26|||
129838464|NCT02272413|467373306|FG000|Pre-switch Period|Withdrawal by Subject|27|||
129838465|NCT02272413|467373307|FG001|Pre-switch Period|Withdrawal by Subject|15|||
129838466|NCT02272413|467373306|FG000|Pre-switch Period|Physician Decision|6|||
129838467|NCT02272413|467373307|FG001|Pre-switch Period|Physician Decision|18|||
129838468|NCT02272413|467373306|FG000|Pre-switch Period|Progressive disease|185|||
129838469|NCT02272413|467373307|FG001|Pre-switch Period|Progressive disease|173|||
129838470|NCT02272413|467373306|FG000|Pre-switch Period|Lost to Follow-up|0|||
129838471|NCT02272413|467373307|FG001|Pre-switch Period|Lost to Follow-up|2|||
129838472|NCT02272413|467373306|FG000|Pre-switch Period|Protocol Violation|1|||
129838473|NCT02272413|467373307|FG001|Pre-switch Period|Protocol Violation|0|||
129838474|NCT02272413|467373306|FG000|Pre-switch Period|Other than listed|10|||
129838475|NCT02272413|467373307|FG001|Pre-switch Period|Other than listed|11|||
129838476|NCT02272413|467373306|FG000|Post-switch Period|Adverse Event|4|||
129838477|NCT02272413|467373307|FG001|Post-switch Period|Adverse Event|4|||
129838478|NCT02272413|467373306|FG000|Post-switch Period|Death|3|||
129838479|NCT02272413|467373307|FG001|Post-switch Period|Death|2|||
129838480|NCT02272413|467373306|FG000|Post-switch Period|Withdrawal by Subject|1|||
129838481|NCT02272413|467373307|FG001|Post-switch Period|Withdrawal by Subject|2|||
129838482|NCT02272413|467373306|FG000|Post-switch Period|Physician Decision|1|||
129838483|NCT02272413|467373307|FG001|Post-switch Period|Physician Decision|1|||
129838484|NCT02272413|467373306|FG000|Post-switch Period|Progressive disease|21|||
129838485|NCT02272413|467373307|FG001|Post-switch Period|Progressive disease|21|||
129838486|NCT02272413|467373306|FG000|Post-switch Period|Study terminated by sponsor|8|||
129838487|NCT02272413|467373307|FG001|Post-switch Period|Study terminated by sponsor|11|||
129838488|NCT02272413|467373306|FG000|Post-switch Period|Other than listed|4|||
129838489|NCT02272413|467373307|FG001|Post-switch Period|Other than listed|5|||
129838490|NCT03144180|467373316|FG000|Overall Study|STAT Delivery|1|||
129838491|NCT03144180|467373317|FG001|Overall Study|STAT Delivery|1|||
129838492|NCT03144180|467373316|FG000|Overall Study|Provider forgot to fill out forms|1|||
129838493|NCT03144180|467373317|FG001|Overall Study|Provider forgot to fill out forms|3|||
129838494|NCT03144180|467373316|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
129838495|NCT03144180|467373317|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
129838496|NCT03144180|467373316|FG000|Overall Study|Scrub tech removed tube cap|0|||
129838497|NCT03144180|467373317|FG001|Overall Study|Scrub tech removed tube cap|1|||
129838498|NCT02308735|467373318|FG000|Overall Study|Physician Decision|2|||
129838499|NCT02308735|467373319|FG001|Overall Study|Physician Decision|0|||
129898828|NCT04148937|467590069|FG006|Overall Study|Withdrawal by Subject|1|||
129898829|NCT04148937|467590070|FG007|Overall Study|Withdrawal by Subject|0|||
129898830|NCT04148937|467590063|FG000|Overall Study|Lost to Follow-up|0|||
129898831|NCT04148937|467590064|FG001|Overall Study|Lost to Follow-up|0|||
129898832|NCT04148937|467590065|FG002|Overall Study|Lost to Follow-up|1|||
129898833|NCT04148937|467590066|FG003|Overall Study|Lost to Follow-up|0|||
129898834|NCT04148937|467590067|FG004|Overall Study|Lost to Follow-up|0|||
129898835|NCT04148937|467590068|FG005|Overall Study|Lost to Follow-up|2|||
129898836|NCT04148937|467590069|FG006|Overall Study|Lost to Follow-up|0|||
129898837|NCT04148937|467590070|FG007|Overall Study|Lost to Follow-up|0|||
129898838|NCT03107611|467590072|FG000|Overall Study|Adverse Event|1|||
129898839|NCT03107611|467590073|FG001|Overall Study|Adverse Event|0|||
129898840|NCT03107611|467590074|FG002|Overall Study|Adverse Event|2|||
129838500|NCT02308735|467373320|FG002|Overall Study|Physician Decision|0|||
129838501|NCT02308735|467373321|FG003|Overall Study|Physician Decision|2|||
129838502|NCT00606892|467373322|FG000|First Intervention|Protocol Violation|1|||
129838503|NCT00606892|467373323|FG001|First Intervention|Protocol Violation|4|||
129838504|NCT00794196|467373324|FG000|Overall Study|Lost to Follow-up|5|||
129838505|NCT00794196|467373325|FG001|Overall Study|Lost to Follow-up|23|||
129838506|NCT00850395|467373331|FG000|Overall Study|Death|1|||
129838507|NCT00850395|467373331|FG000|Overall Study|Adverse Event|1|||
129898841|NCT03107611|467590072|FG000|Overall Study|Lost to Follow-up|3|||
129898842|NCT03107611|467590073|FG001|Overall Study|Lost to Follow-up|3|||
129898843|NCT03107611|467590074|FG002|Overall Study|Lost to Follow-up|3|||
129898844|NCT03107611|467590072|FG000|Overall Study|Protocol Violation|0|||
129838508|NCT00850395|467373331|FG000|Overall Study|Insufficient clinical response|3|||
129838509|NCT00850395|467373331|FG000|Overall Study|Other|5|||
129838510|NCT02376166|467373332|FG000|Overall Study|Adverse Event|1|||
129838511|NCT02376166|467373332|FG000|Overall Study|Discontinued metformin early|2|||
129838512|NCT00842348|467373334|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
129838513|NCT00842348|467373335|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
129838514|NCT00842348|467373334|FG000|Study 729|Disease progression/death|19|||
129838515|NCT00842348|467373335|FG001|Study 729|Disease progression/death|30|||
129838516|NCT00842348|467373334|FG000|Study 729|Adverse Event|1|||
129838517|NCT00842348|467373335|FG001|Study 729|Adverse Event|1|||
129838518|NCT00842348|467373334|FG000|Study 729|Protocol Violation|1|||
129838519|NCT00842348|467373335|FG001|Study 729|Protocol Violation|1|||
129838520|NCT00842348|467373334|FG000|Study 729|Withdrawal by Subject|2|||
129838521|NCT00842348|467373335|FG001|Study 729|Withdrawal by Subject|4|||
129838522|NCT00842348|467373334|FG000|Study 729|Due to Sponsor stopping the study|1|||
129838523|NCT00842348|467373335|FG001|Study 729|Due to Sponsor stopping the study|1|||
129838524|NCT00842348|467373334|FG000|Study 729|Due to non-availability of IP|0|||
129838525|NCT00842348|467373335|FG001|Study 729|Due to non-availability of IP|1|||
129838526|NCT00842348|467373334|FG000|Study 729|Sponsor's decision|1|||
129838527|NCT00842348|467373335|FG001|Study 729|Sponsor's decision|0|||
129838528|NCT00842348|467373334|FG000|Study 729|Surgical resection|1|||
129838529|NCT00842348|467373335|FG001|Study 729|Surgical resection|0|||
129838530|NCT01524627|467373338|FG000|Overall Study|Physician Decision|0|||
129838531|NCT01524627|467373339|FG001|Overall Study|Physician Decision|1|||
129838532|NCT01524627|467373338|FG000|Overall Study|Lost to Follow-up|1|||
129838533|NCT01524627|467373339|FG001|Overall Study|Lost to Follow-up|1|||
129838534|NCT02388737|467375280|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
129838535|NCT02388737|467375281|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
129838536|NCT02388737|467375282|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
129838537|NCT02388737|467375280|FG000|Overall Study|Major Protocol Deviation|18|||
129838538|NCT02388737|467375281|FG001|Overall Study|Major Protocol Deviation|25|||
129838539|NCT02388737|467375282|FG002|Overall Study|Major Protocol Deviation|22|||
129838540|NCT02388737|467375280|FG000|Overall Study|Lost to Follow-up|5|||
129838541|NCT02388737|467375281|FG001|Overall Study|Lost to Follow-up|1|||
129838542|NCT02388737|467375282|FG002|Overall Study|Lost to Follow-up|4|||
129838543|NCT02388737|467375280|FG000|Overall Study|Voluntary Withdrawal|10|||
129838544|NCT02388737|467375281|FG001|Overall Study|Voluntary Withdrawal|18|||
129838545|NCT02388737|467375282|FG002|Overall Study|Voluntary Withdrawal|17|||
129838546|NCT02388737|467375280|FG000|Overall Study|Lack of Efficacy|3|||
129838547|NCT02388737|467375281|FG001|Overall Study|Lack of Efficacy|0|||
129838548|NCT02388737|467375282|FG002|Overall Study|Lack of Efficacy|3|||
129838549|NCT02388737|467375280|FG000|Overall Study|Reason Not Specified|5|||
129838550|NCT02388737|467375281|FG001|Overall Study|Reason Not Specified|5|||
129838551|NCT02388737|467375282|FG002|Overall Study|Reason Not Specified|4|||
129838552|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
129838553|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
129838554|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
129838555|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
129838556|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
129838557|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
129838558|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
129838559|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
129838560|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
129838561|NCT03252522|467375283|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
129838562|NCT03252522|467375284|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
129838563|NCT03252522|467375285|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
129838564|NCT03252522|467375283|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
129838565|NCT03252522|467375284|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
129838566|NCT03252522|467375285|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
129838567|NCT03252522|467375283|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
129838568|NCT03252522|467375284|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
129838569|NCT03252522|467375285|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
129838570|NCT03252522|467375283|FG000|Phase 2: Open Label|Adverse Event|0|||
129838571|NCT03252522|467375284|FG001|Phase 2: Open Label|Adverse Event|0|||
129838572|NCT03252522|467375285|FG002|Phase 2: Open Label|Adverse Event|2|||
129838573|NCT03252522|467375283|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
129838574|NCT03252522|467375284|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
129838575|NCT03252522|467375285|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
129838576|NCT03299842|467375287|FG000|Overall Study|Caregiver withdrew consent|2|||
129838577|NCT03299842|467375287|FG000|Overall Study|Child would not keep the watch on|3|||
129838578|NCT01344369|467375288|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
129838579|NCT01344369|467375289|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
129838580|NCT01344369|467375288|FG000|Washout of 28 Days|Physician Decision|0|||
129838581|NCT01344369|467375289|FG001|Washout of 28 Days|Physician Decision|1|||
129838582|NCT01344369|467375288|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
129838583|NCT01344369|467375289|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
129838584|NCT01454726|467375295|FG000|Overall Study|Withdrawal by Subject|0|||
129838585|NCT01454726|467375296|FG001|Overall Study|Withdrawal by Subject|1|||
129838586|NCT01886833|467375297|FG000|Overall Study|IgA not available from both periods|204|||
129838587|NCT03848845|467375298|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
129838588|NCT03848845|467375299|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
129838589|NCT03848845|467375300|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
129838590|NCT03848845|467375301|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
129838591|NCT03848845|467375298|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
129838592|NCT03848845|467375299|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
129838593|NCT03848845|467375300|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
129838594|NCT03848845|467375301|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
129838595|NCT03848845|467375298|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
129838596|NCT03848845|467375299|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
129838597|NCT03848845|467375300|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
129838598|NCT03848845|467375301|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
129838599|NCT03848845|467375298|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129838600|NCT03848845|467375299|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129838601|NCT03848845|467375300|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
129838602|NCT03848845|467375301|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
129838603|NCT02223767|467375307|FG000|Overall Study|Withdrawal by Subject|4|||
129838604|NCT02223767|467375308|FG001|Overall Study|Withdrawal by Subject|4|||
129838605|NCT02342704|467375309|FG000|Overall Study|Physician Decision|0|||
129838606|NCT02342704|467375310|FG001|Overall Study|Physician Decision|3|||
129838607|NCT02342704|467375309|FG000|Overall Study|Sponsor Termination|49|||
129838608|NCT02342704|467375310|FG001|Overall Study|Sponsor Termination|43|||
129838609|NCT02342704|467375309|FG000|Overall Study|Other|0|||
129838610|NCT02342704|467375310|FG001|Overall Study|Other|1|||
129838611|NCT02342704|467375309|FG000|Overall Study|Withdrawal by Subject|1|||
129838612|NCT02342704|467375310|FG001|Overall Study|Withdrawal by Subject|0|||
129838613|NCT02342704|467375309|FG000|Overall Study|Lost to Follow-up|2|||
129838614|NCT02342704|467375310|FG001|Overall Study|Lost to Follow-up|1|||
129838615|NCT02342704|467375309|FG000|Overall Study|Adverse Event|1|||
129838616|NCT02342704|467375310|FG001|Overall Study|Adverse Event|3|||
129838617|NCT02347527|467375311|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
129838618|NCT02347527|467375312|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
129838619|NCT02347527|467375313|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
129838620|NCT02347527|467375314|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
129838621|NCT02347527|467375311|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
129838622|NCT02347527|467375312|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
129838623|NCT02347527|467375313|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
129838624|NCT02347527|467375314|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
129838625|NCT02347527|467375311|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
129838626|NCT02347527|467375312|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
129838627|NCT02347527|467375313|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
129838628|NCT02347527|467375314|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
129838629|NCT02347527|467375311|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
129838630|NCT02347527|467375312|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
129838631|NCT02347527|467375313|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
129838632|NCT02347527|467375314|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
129838633|NCT02347527|467375311|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
129838634|NCT02347527|467375312|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
129838635|NCT02347527|467375313|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
129838636|NCT02347527|467375314|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
129838637|NCT00302003|467375316|FG000|Overall Study|Lack of Efficacy|62|||
129838638|NCT00302003|467375316|FG000|Overall Study|Lost to Follow-up|1|||
129838639|NCT00302003|467375316|FG000|Overall Study|Physician Decision|2|||
129838640|NCT00302003|467375316|FG000|Overall Study|Withdrawal by Subject|5|||
129838641|NCT00302003|467375316|FG000|Overall Study|Ineligible|9|||
129838642|NCT00302003|467375316|FG000|Overall Study|Protocol Violation|1|||
129447430|NCT02060383|465939029|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
129447431|NCT02060383|465939030|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
129447432|NCT02060383|465939026|FG000|Extension Phase|Adverse Event|1|||
129447433|NCT02060383|465939027|FG001|Extension Phase|Adverse Event|1|||
129447434|NCT02060383|465939028|FG002|Extension Phase|Adverse Event|2|||
129447435|NCT02060383|465939029|FG003|Extension Phase|Adverse Event|0|||
129447436|NCT02060383|465939030|FG004|Extension Phase|Adverse Event|1|||
129447437|NCT02060383|465939026|FG000|Extension Phase|Withdrawal by Subject|0|||
129447438|NCT02060383|465939027|FG001|Extension Phase|Withdrawal by Subject|1|||
129447439|NCT02060383|465939028|FG002|Extension Phase|Withdrawal by Subject|0|||
129447440|NCT02060383|465939029|FG003|Extension Phase|Withdrawal by Subject|0|||
129447441|NCT02060383|465939030|FG004|Extension Phase|Withdrawal by Subject|2|||
129447442|NCT02060383|465939026|FG000|Extension Phase|Administrative problems|1|||
129447443|NCT02060383|465939027|FG001|Extension Phase|Administrative problems|0|||
129447444|NCT02060383|465939028|FG002|Extension Phase|Administrative problems|0|||
129447445|NCT02060383|465939029|FG003|Extension Phase|Administrative problems|0|||
129447446|NCT02060383|465939030|FG004|Extension Phase|Administrative problems|0|||
129447447|NCT02060383|465939026|FG000|Extension Phase|Death|0|||
129447448|NCT02060383|465939027|FG001|Extension Phase|Death|0|||
129447449|NCT02060383|465939028|FG002|Extension Phase|Death|1|||
129447450|NCT02060383|465939029|FG003|Extension Phase|Death|0|||
129838643|NCT00283439|467375317|FG000|Overall Study|Adverse Event|0|||
129838644|NCT00283439|467375318|FG001|Overall Study|Adverse Event|0|||
129838645|NCT00283439|467375319|FG002|Overall Study|Adverse Event|0|||
129838646|NCT00283439|467375320|FG003|Overall Study|Adverse Event|1|||
129838647|NCT00283439|467375317|FG000|Overall Study|Death|0|||
129838648|NCT00283439|467375318|FG001|Overall Study|Death|0|||
129838649|NCT00283439|467375319|FG002|Overall Study|Death|1|||
129838650|NCT00283439|467375320|FG003|Overall Study|Death|0|||
129838651|NCT00283439|467375317|FG000|Overall Study|Disease progression|0|||
129838652|NCT00283439|467375318|FG001|Overall Study|Disease progression|1|||
129838653|NCT00283439|467375319|FG002|Overall Study|Disease progression|0|||
129838654|NCT00283439|467375320|FG003|Overall Study|Disease progression|0|||
129447451|NCT02060383|465939030|FG004|Extension Phase|Death|1|||
129447452|NCT02060383|465939026|FG000|Extension Phase|Protocol Violation|0|||
129838655|NCT00283439|467375317|FG000|Overall Study|Requirement for alternative therapy|1|||
129838656|NCT00283439|467375318|FG001|Overall Study|Requirement for alternative therapy|2|||
129838657|NCT00283439|467375319|FG002|Overall Study|Requirement for alternative therapy|5|||
129838658|NCT00283439|467375320|FG003|Overall Study|Requirement for alternative therapy|2|||
129838659|NCT00283439|467375317|FG000|Overall Study|Stem cell transplant|6|||
129838660|NCT00283439|467375318|FG001|Overall Study|Stem cell transplant|6|||
129838661|NCT00283439|467375319|FG002|Overall Study|Stem cell transplant|4|||
129838662|NCT00283439|467375320|FG003|Overall Study|Stem cell transplant|3|||
129838663|NCT00283439|467375317|FG000|Overall Study|Treatment discontinued|0|||
129838664|NCT00283439|467375318|FG001|Overall Study|Treatment discontinued|2|||
129838665|NCT00283439|467375319|FG002|Overall Study|Treatment discontinued|1|||
129838666|NCT00283439|467375320|FG003|Overall Study|Treatment discontinued|3|||
129838667|NCT00283439|467375317|FG000|Overall Study|Other|1|||
129838668|NCT00283439|467375318|FG001|Overall Study|Other|0|||
129838669|NCT00283439|467375319|FG002|Overall Study|Other|0|||
129838670|NCT00283439|467375320|FG003|Overall Study|Other|0|||
129838671|NCT02042924|467375321|FG000|Overall Study|Early Death|1|||
129838672|NCT01632891|467375322|FG000|Overall Study|Lost to Follow-up|0|||
129838673|NCT01632891|467375323|FG001|Overall Study|Lost to Follow-up|1|||
129838674|NCT01632891|467375322|FG000|Overall Study|Withdrawal by Subject|1|||
129838675|NCT01632891|467375323|FG001|Overall Study|Withdrawal by Subject|0|||
129838676|NCT02919670|467375324|FG000|Overall Study|Only 17 participants met compliance|43|||
129838677|NCT02919670|467375325|FG001|Overall Study|Only 17 participants met compliance|39|||
129838678|NCT00240071|467375326|FG000|Overall Study|Withdrawal by Subject|3|||
129838679|NCT01466270|467375327|FG000|Overall Study|Withdrawal by Subject|4|||
129838680|NCT01466270|467375328|FG001|Overall Study|Withdrawal by Subject|1|||
129838681|NCT01466270|467375327|FG000|Overall Study|Physician Decision|1|||
129838682|NCT01466270|467375328|FG001|Overall Study|Physician Decision|0|||
129838683|NCT01466270|467375327|FG000|Overall Study|Lost to Follow-up|1|||
129838684|NCT01466270|467375328|FG001|Overall Study|Lost to Follow-up|3|||
129838685|NCT01466270|467375327|FG000|Overall Study|Progression|1|||
129447453|NCT02060383|465939027|FG001|Extension Phase|Protocol Violation|0|||
129447454|NCT02060383|465939028|FG002|Extension Phase|Protocol Violation|0|||
129447455|NCT02060383|465939029|FG003|Extension Phase|Protocol Violation|0|||
129447456|NCT02060383|465939030|FG004|Extension Phase|Protocol Violation|1|||
129838686|NCT01466270|467375328|FG001|Overall Study|Progression|0|||
129838687|NCT01466270|467375327|FG000|Overall Study|Toxicity|4|||
129838688|NCT01466270|467375328|FG001|Overall Study|Toxicity|1|||
129838689|NCT01466270|467375327|FG000|Overall Study|Multiple|1|||
129838690|NCT01466270|467375328|FG001|Overall Study|Multiple|1|||
129838691|NCT04206293|467375333|FG000|Overall Study|Consent withdrawal|1|||
129838692|NCT01454934|467375336|FG000|Overall Study|Clinical progression|28|||
129838693|NCT01454934|467375337|FG001|Overall Study|Clinical progression|25|||
129838694|NCT01454934|467375336|FG000|Overall Study|Other|6|||
129838695|NCT01454934|467375337|FG001|Overall Study|Other|17|||
129838696|NCT01454934|467375336|FG000|Overall Study|Adverse Event|28|||
129838697|NCT01454934|467375337|FG001|Overall Study|Adverse Event|24|||
129838698|NCT01454934|467375336|FG000|Overall Study|Withdrawn consent|2|||
129838699|NCT01454934|467375337|FG001|Overall Study|Withdrawn consent|5|||
129838700|NCT01454934|467375336|FG000|Overall Study|Withdrawal by Subject|11|||
129838701|NCT01454934|467375337|FG001|Overall Study|Withdrawal by Subject|15|||
129838702|NCT01454934|467375336|FG000|Overall Study|Disease progression|194|||
129838703|NCT01454934|467375337|FG001|Overall Study|Disease progression|181|||
129838704|NCT01454934|467375336|FG000|Overall Study|Lost to Follow-up|0|||
129838705|NCT01454934|467375337|FG001|Overall Study|Lost to Follow-up|1|||
129838706|NCT01454934|467375336|FG000|Overall Study|Not treated|1|||
129838707|NCT01454934|467375337|FG001|Overall Study|Not treated|2|||
129838708|NCT00430092|467375340|FG000|Overall Study|Adverse Event|0|||
129838709|NCT00430092|467375341|FG001|Overall Study|Adverse Event|0|||
129838710|NCT00430092|467375342|FG002|Overall Study|Adverse Event|1|||
129838711|NCT00430092|467375340|FG000|Overall Study|Lack of Efficacy|5|||
129838712|NCT00430092|467375341|FG001|Overall Study|Lack of Efficacy|2|||
129838713|NCT00430092|467375342|FG002|Overall Study|Lack of Efficacy|54|||
129838714|NCT00430092|467375340|FG000|Overall Study|Lost to Follow-up|1|||
129838715|NCT00430092|467375341|FG001|Overall Study|Lost to Follow-up|0|||
129838716|NCT00430092|467375342|FG002|Overall Study|Lost to Follow-up|0|||
129838717|NCT00430092|467375340|FG000|Overall Study|Protocol Violation|0|||
129838718|NCT00430092|467375341|FG001|Overall Study|Protocol Violation|1|||
129838719|NCT00430092|467375342|FG002|Overall Study|Protocol Violation|1|||
129838720|NCT00430092|467375340|FG000|Overall Study|Withdrawal by Subject|0|||
129838721|NCT00430092|467375341|FG001|Overall Study|Withdrawal by Subject|1|||
129838722|NCT00430092|467375342|FG002|Overall Study|Withdrawal by Subject|1|||
129838723|NCT00706966|467375347|FG000|Overall Study|Adverse Event|1|||
129838724|NCT02884089|467375355|FG000|Period 1|Dosing error|2|||
129838725|NCT02884089|467375356|FG001|Period 1|Dosing error|2|||
129838726|NCT02884089|467375357|FG002|Period 1|Dosing error|0|||
129838727|NCT02884089|467375358|FG003|Period 1|Dosing error|0|||
129838728|NCT02884089|467375355|FG000|Washout Period 1|Lost to Follow-up|0|||
129838729|NCT02884089|467375356|FG001|Washout Period 1|Lost to Follow-up|1|||
129838730|NCT02884089|467375357|FG002|Washout Period 1|Lost to Follow-up|0|||
129838731|NCT02884089|467375358|FG003|Washout Period 1|Lost to Follow-up|1|||
129838732|NCT02884089|467375355|FG000|Washout Period 1|Withdrawal by Subject|0|||
129838733|NCT02884089|467375356|FG001|Washout Period 1|Withdrawal by Subject|1|||
129838734|NCT02884089|467375357|FG002|Washout Period 1|Withdrawal by Subject|0|||
129838735|NCT02884089|467375358|FG003|Washout Period 1|Withdrawal by Subject|0|||
129838736|NCT02884089|467375355|FG000|Period 2|Adverse Event|1|||
129838737|NCT02884089|467375356|FG001|Period 2|Adverse Event|0|||
129838738|NCT02884089|467375357|FG002|Period 2|Adverse Event|0|||
129838739|NCT02884089|467375358|FG003|Period 2|Adverse Event|0|||
129838740|NCT02884089|467375355|FG000|Period 3|Withdrawal by Subject|0|||
129838741|NCT02884089|467375356|FG001|Period 3|Withdrawal by Subject|0|||
129838742|NCT02884089|467375357|FG002|Period 3|Withdrawal by Subject|1|||
129838743|NCT02884089|467375358|FG003|Period 3|Withdrawal by Subject|0|||
129838744|NCT02884089|467375355|FG000|Washout Period 3|Withdrawal by Subject|0|||
129838745|NCT02884089|467375356|FG001|Washout Period 3|Withdrawal by Subject|0|||
129838746|NCT02884089|467375357|FG002|Washout Period 3|Withdrawal by Subject|1|||
129838747|NCT02884089|467375358|FG003|Washout Period 3|Withdrawal by Subject|0|||
129838748|NCT02884089|467375355|FG000|Washout Period 3|Lost to Follow-up|0|||
129838749|NCT02884089|467375356|FG001|Washout Period 3|Lost to Follow-up|0|||
129838750|NCT02884089|467375357|FG002|Washout Period 3|Lost to Follow-up|0|||
129838751|NCT02884089|467375358|FG003|Washout Period 3|Lost to Follow-up|1|||
129838752|NCT02884089|467375355|FG000|Period 4|Withdrawal by Subject|0|||
129838753|NCT02884089|467375356|FG001|Period 4|Withdrawal by Subject|1|||
129838754|NCT02884089|467375357|FG002|Period 4|Withdrawal by Subject|0|||
129838755|NCT02884089|467375358|FG003|Period 4|Withdrawal by Subject|0|||
129838756|NCT02884089|467375355|FG000|Period 4|Lost to Follow-up|1|||
129838757|NCT02884089|467375356|FG001|Period 4|Lost to Follow-up|0|||
129838758|NCT02884089|467375357|FG002|Period 4|Lost to Follow-up|0|||
129838759|NCT02884089|467375358|FG003|Period 4|Lost to Follow-up|0|||
129838760|NCT02884089|467375355|FG000|Follow-up Visit|Withdrawal by Subject|1|||
129838761|NCT02884089|467375356|FG001|Follow-up Visit|Withdrawal by Subject|0|||
129838762|NCT02884089|467375357|FG002|Follow-up Visit|Withdrawal by Subject|0|||
129838763|NCT02884089|467375358|FG003|Follow-up Visit|Withdrawal by Subject|1|||
129838764|NCT01631474|467375359|FG000|Overall Study|Lost to Follow-up|8|||
129838765|NCT01631474|467375360|FG001|Overall Study|Lost to Follow-up|5|||
129838766|NCT01631474|467375361|FG002|Overall Study|Lost to Follow-up|7|||
129838767|NCT01631474|467375362|FG003|Overall Study|Lost to Follow-up|5|||
129838768|NCT01631474|467375363|FG004|Overall Study|Lost to Follow-up|5|||
129838769|NCT01631474|467375359|FG000|Overall Study|Withdrawal by Subject|4|||
129838770|NCT01631474|467375360|FG001|Overall Study|Withdrawal by Subject|4|||
129838771|NCT01631474|467375361|FG002|Overall Study|Withdrawal by Subject|2|||
129838772|NCT01631474|467375362|FG003|Overall Study|Withdrawal by Subject|6|||
129838773|NCT01631474|467375363|FG004|Overall Study|Withdrawal by Subject|5|||
129838774|NCT01631474|467375359|FG000|Overall Study|Lack of Efficacy|2|||
129838775|NCT01631474|467375360|FG001|Overall Study|Lack of Efficacy|2|||
129838776|NCT01631474|467375361|FG002|Overall Study|Lack of Efficacy|0|||
129838777|NCT01631474|467375362|FG003|Overall Study|Lack of Efficacy|0|||
129838778|NCT01631474|467375363|FG004|Overall Study|Lack of Efficacy|2|||
129838779|NCT01631474|467375359|FG000|Overall Study|Noncompliance with Study Drug|0|||
129838780|NCT01631474|467375360|FG001|Overall Study|Noncompliance with Study Drug|0|||
129838781|NCT01631474|467375361|FG002|Overall Study|Noncompliance with Study Drug|0|||
129838782|NCT01631474|467375362|FG003|Overall Study|Noncompliance with Study Drug|0|||
129838783|NCT01631474|467375363|FG004|Overall Study|Noncompliance with Study Drug|1|||
129838784|NCT01631474|467375359|FG000|Overall Study|Adverse Event|0|||
129838785|NCT01631474|467375360|FG001|Overall Study|Adverse Event|1|||
129838786|NCT01631474|467375361|FG002|Overall Study|Adverse Event|0|||
129838787|NCT01631474|467375362|FG003|Overall Study|Adverse Event|0|||
129838788|NCT01631474|467375363|FG004|Overall Study|Adverse Event|0|||
129838789|NCT02624284|467375364|FG000|Overall Study|Withdrawal by Subject|3|||
129838790|NCT02624284|467375365|FG001|Overall Study|Withdrawal by Subject|6|||
129838791|NCT02624284|467375366|FG002|Overall Study|Withdrawal by Subject|3|||
129838792|NCT02624284|467375364|FG000|Overall Study|Protocol Violation|9|||
129838793|NCT02624284|467375365|FG001|Overall Study|Protocol Violation|10|||
129838794|NCT02624284|467375366|FG002|Overall Study|Protocol Violation|7|||
129838795|NCT02624284|467375364|FG000|Overall Study|Revealed exclusionary condition|2|||
129838796|NCT02624284|467375365|FG001|Overall Study|Revealed exclusionary condition|2|||
129838797|NCT02624284|467375366|FG002|Overall Study|Revealed exclusionary condition|0|||
129838798|NCT02624284|467375364|FG000|Overall Study|Adverse Event|0|||
129838799|NCT02624284|467375365|FG001|Overall Study|Adverse Event|0|||
129838800|NCT02624284|467375366|FG002|Overall Study|Adverse Event|1|||
129838801|NCT01641367|467375377|FG000|Cohorts|Death|18|||
129838802|NCT01641367|467375378|FG001|Cohorts|Death|1|||
129838803|NCT01641367|467375379|FG002|Cohorts|Death|2|||
129838804|NCT01641367|467375380|FG003|Cohorts|Death|0|||
129838805|NCT01641367|467375381|FG004|Cohorts|Death|1|||
129838806|NCT01641367|467375382|FG005|Cohorts|Death|1|||
129838807|NCT01641367|467375383|FG006|Cohorts|Death|0|||
129838808|NCT01641367|467375384|FG007|Cohorts|Death|0|||
129838809|NCT01641367|467375377|FG000|Cohorts|Lost to Follow-up|16|||
129838810|NCT01641367|467375378|FG001|Cohorts|Lost to Follow-up|0|||
129838811|NCT01641367|467375379|FG002|Cohorts|Lost to Follow-up|2|||
129838812|NCT01641367|467375380|FG003|Cohorts|Lost to Follow-up|0|||
129838813|NCT01641367|467375381|FG004|Cohorts|Lost to Follow-up|2|||
129838814|NCT01641367|467375382|FG005|Cohorts|Lost to Follow-up|0|||
129838815|NCT01641367|467375383|FG006|Cohorts|Lost to Follow-up|0|||
129838816|NCT01641367|467375384|FG007|Cohorts|Lost to Follow-up|0|||
129838817|NCT01641367|467375377|FG000|Randomized Adherence Intervention|Death|0|||
129447457|NCT04479436|465939035|FG000|Overall Study|Progressive disease|26|||
129447458|NCT04479436|465939036|FG001|Overall Study|Progressive disease|1|||
129447459|NCT04479436|465939035|FG000|Overall Study|Adverse Event|6|||
129838818|NCT01641367|467375378|FG001|Randomized Adherence Intervention|Death|0|||
129838819|NCT01641367|467375379|FG002|Randomized Adherence Intervention|Death|0|||
129838820|NCT01641367|467375380|FG003|Randomized Adherence Intervention|Death|0|||
129838821|NCT01641367|467375381|FG004|Randomized Adherence Intervention|Death|0|||
129838822|NCT01641367|467375382|FG005|Randomized Adherence Intervention|Death|0|||
129838823|NCT01641367|467375383|FG006|Randomized Adherence Intervention|Death|11|||
129838824|NCT01641367|467375384|FG007|Randomized Adherence Intervention|Death|12|||
129838825|NCT01641367|467375377|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838826|NCT01641367|467375378|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838827|NCT01641367|467375379|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
129898845|NCT03107611|467590073|FG001|Overall Study|Protocol Violation|0|||
129838828|NCT01641367|467375380|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838829|NCT01641367|467375381|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
129838830|NCT01641367|467375382|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
129447460|NCT04479436|465939036|FG001|Overall Study|Adverse Event|0|||
129838831|NCT01641367|467375383|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
129838832|NCT01641367|467375384|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
129838833|NCT00654381|467375389|FG000|1st Stage|Adverse Event|3|||
129838834|NCT00654381|467375390|FG001|1st Stage|Adverse Event|3|||
129838835|NCT00654381|467375391|FG002|1st Stage|Adverse Event|3|||
129838836|NCT00654381|467375392|FG003|1st Stage|Adverse Event|3|||
129838837|NCT00654381|467375393|FG004|1st Stage|Adverse Event|2|||
129838838|NCT00654381|467375394|FG005|1st Stage|Adverse Event|1|||
129838839|NCT00654381|467375389|FG000|1st Stage|Withdrawal by Subject|0|||
129838840|NCT00654381|467375390|FG001|1st Stage|Withdrawal by Subject|0|||
129838841|NCT00654381|467375391|FG002|1st Stage|Withdrawal by Subject|0|||
129838842|NCT00654381|467375392|FG003|1st Stage|Withdrawal by Subject|1|||
129838843|NCT00654381|467375393|FG004|1st Stage|Withdrawal by Subject|0|||
129838844|NCT00654381|467375394|FG005|1st Stage|Withdrawal by Subject|1|||
129838845|NCT00654381|467375389|FG000|1st Stage|Investigator's decision|0|||
129838846|NCT00654381|467375390|FG001|1st Stage|Investigator's decision|0|||
129838847|NCT00654381|467375391|FG002|1st Stage|Investigator's decision|0|||
129838848|NCT00654381|467375392|FG003|1st Stage|Investigator's decision|1|||
129838849|NCT00654381|467375393|FG004|1st Stage|Investigator's decision|0|||
129838850|NCT00654381|467375394|FG005|1st Stage|Investigator's decision|0|||
129838851|NCT00654381|467375389|FG000|2nd Stage|Adverse Event|2|||
129838852|NCT00654381|467375390|FG001|2nd Stage|Adverse Event|0|||
129838853|NCT00654381|467375391|FG002|2nd Stage|Adverse Event|2|||
129838854|NCT00654381|467375392|FG003|2nd Stage|Adverse Event|3|||
129838855|NCT00654381|467375393|FG004|2nd Stage|Adverse Event|7|||
129838856|NCT00654381|467375394|FG005|2nd Stage|Adverse Event|2|||
129838857|NCT00654381|467375389|FG000|2nd Stage|Withdrawal by Subject|0|||
129838858|NCT00654381|467375390|FG001|2nd Stage|Withdrawal by Subject|0|||
129838859|NCT00654381|467375391|FG002|2nd Stage|Withdrawal by Subject|0|||
129838860|NCT00654381|467375392|FG003|2nd Stage|Withdrawal by Subject|0|||
129838861|NCT00654381|467375393|FG004|2nd Stage|Withdrawal by Subject|1|||
129838862|NCT00654381|467375394|FG005|2nd Stage|Withdrawal by Subject|1|||
129838863|NCT00654381|467375389|FG000|2nd Stage|Investigator's decision|0|||
129838864|NCT00654381|467375390|FG001|2nd Stage|Investigator's decision|0|||
129838865|NCT00654381|467375391|FG002|2nd Stage|Investigator's decision|1|||
129838866|NCT00654381|467375392|FG003|2nd Stage|Investigator's decision|1|||
129838867|NCT00654381|467375393|FG004|2nd Stage|Investigator's decision|0|||
129838868|NCT00654381|467375394|FG005|2nd Stage|Investigator's decision|0|||
129838869|NCT00654381|467375389|FG000|Extension Stage|Adverse Event|1|||
129838870|NCT00654381|467375390|FG001|Extension Stage|Adverse Event|2|||
129838871|NCT00654381|467375391|FG002|Extension Stage|Adverse Event|9|||
129838872|NCT00654381|467375392|FG003|Extension Stage|Adverse Event|7|||
129838873|NCT00654381|467375393|FG004|Extension Stage|Adverse Event|1|||
129838874|NCT00654381|467375394|FG005|Extension Stage|Adverse Event|1|||
129838875|NCT00654381|467375389|FG000|Extension Stage|Protocol Violation|0|||
129838876|NCT00654381|467375390|FG001|Extension Stage|Protocol Violation|0|||
129838877|NCT00654381|467375391|FG002|Extension Stage|Protocol Violation|0|||
129838878|NCT00654381|467375392|FG003|Extension Stage|Protocol Violation|1|||
129838879|NCT00654381|467375393|FG004|Extension Stage|Protocol Violation|0|||
129838880|NCT00654381|467375394|FG005|Extension Stage|Protocol Violation|0|||
129838881|NCT00654381|467375389|FG000|Extension Stage|Lack of Efficacy|0|||
129838882|NCT00654381|467375390|FG001|Extension Stage|Lack of Efficacy|0|||
129838883|NCT00654381|467375391|FG002|Extension Stage|Lack of Efficacy|1|||
129838884|NCT00654381|467375392|FG003|Extension Stage|Lack of Efficacy|0|||
129838885|NCT00654381|467375393|FG004|Extension Stage|Lack of Efficacy|0|||
129838886|NCT00654381|467375394|FG005|Extension Stage|Lack of Efficacy|0|||
129838887|NCT00654381|467375389|FG000|Extension Stage|Withdrawal by Subject|0|||
129838888|NCT00654381|467375390|FG001|Extension Stage|Withdrawal by Subject|0|||
129838889|NCT00654381|467375391|FG002|Extension Stage|Withdrawal by Subject|1|||
129838890|NCT00654381|467375392|FG003|Extension Stage|Withdrawal by Subject|1|||
129838891|NCT00654381|467375393|FG004|Extension Stage|Withdrawal by Subject|1|||
129838892|NCT00654381|467375394|FG005|Extension Stage|Withdrawal by Subject|1|||
129838893|NCT00654381|467375389|FG000|Extension Stage|Closure of the trial site|0|||
129838894|NCT00654381|467375390|FG001|Extension Stage|Closure of the trial site|0|||
129838895|NCT00654381|467375391|FG002|Extension Stage|Closure of the trial site|0|||
129838896|NCT00654381|467375392|FG003|Extension Stage|Closure of the trial site|0|||
129838897|NCT00654381|467375393|FG004|Extension Stage|Closure of the trial site|1|||
129838898|NCT00654381|467375394|FG005|Extension Stage|Closure of the trial site|1|||
129838899|NCT00826267|467375397|FG000|Overall Study|Other Adverse Event|1|||
129838900|NCT00826267|467375398|FG001|Overall Study|Other Adverse Event|0|||
129838901|NCT00826267|467375399|FG002|Overall Study|Other Adverse Event|0|||
129838902|NCT01675882|467375412|FG000|Overall Study|Adverse Event|0|||
129838903|NCT01675882|467375413|FG001|Overall Study|Adverse Event|2|||
129838904|NCT01675882|467375414|FG002|Overall Study|Adverse Event|1|||
129838905|NCT01675882|467375415|FG003|Overall Study|Adverse Event|0|||
129838906|NCT01675882|467375412|FG000|Overall Study|Participant unwilling to continue|2|||
129838907|NCT01675882|467375413|FG001|Overall Study|Participant unwilling to continue|4|||
129838908|NCT01675882|467375414|FG002|Overall Study|Participant unwilling to continue|2|||
129838909|NCT01675882|467375415|FG003|Overall Study|Participant unwilling to continue|1|||
129838910|NCT01675882|467375412|FG000|Overall Study|Lost to Follow-up|0|||
129838911|NCT01675882|467375413|FG001|Overall Study|Lost to Follow-up|1|||
129898846|NCT03107611|467590074|FG002|Overall Study|Protocol Violation|1|||
129838912|NCT01675882|467375414|FG002|Overall Study|Lost to Follow-up|0|||
129838913|NCT01675882|467375415|FG003|Overall Study|Lost to Follow-up|0|||
129838914|NCT01675882|467375412|FG000|Overall Study|Non-compliance|0|||
129838915|NCT01675882|467375413|FG001|Overall Study|Non-compliance|0|||
129838916|NCT01675882|467375414|FG002|Overall Study|Non-compliance|0|||
129838917|NCT01675882|467375415|FG003|Overall Study|Non-compliance|1|||
129838918|NCT04116710|467375425|FG000|Overall Study|Death|4|||
129838919|NCT04116710|467375426|FG001|Overall Study|Death|6|||
129838920|NCT04116710|467375427|FG002|Overall Study|Death|3|||
129838921|NCT04116710|467375428|FG003|Overall Study|Death|1|||
129838922|NCT04116710|467375425|FG000|Overall Study|Withdrawal by Subject|0|||
129838923|NCT04116710|467375426|FG001|Overall Study|Withdrawal by Subject|0|||
129838924|NCT04116710|467375427|FG002|Overall Study|Withdrawal by Subject|0|||
129838925|NCT04116710|467375428|FG003|Overall Study|Withdrawal by Subject|1|||
129838926|NCT00582933|467375429|FG000|Overall Study|Physician Decision|3|||
129838927|NCT00696137|467375431|FG000|Overall Study|Withdrawal by Subject|2|||
129838928|NCT00785486|467375435|FG000|Midazolam Alone|Withdrawal by Subject|1|||
129838929|NCT01640366|467375439|FG000|Overall Study|Withdrawal by Subject|1|||
129838930|NCT01640366|467375439|FG000|Overall Study|Protocol Violation|16|||
129898847|NCT03107611|467590072|FG000|Overall Study|Withdrawal by Subject|1|||
129838931|NCT01640366|467375439|FG000|Overall Study|Lost to Follow-up|5|||
129838932|NCT01116232|467375442|FG000|Overall Study|Progressive diease|4|||
129838933|NCT02357940|467375445|FG000|Overall Study|Adverse Event|0|||
129838934|NCT02357940|467375446|FG001|Overall Study|Adverse Event|1|||
129838935|NCT02357940|467375445|FG000|Overall Study|Investigator's judgement|0|||
129838936|NCT02357940|467375446|FG001|Overall Study|Investigator's judgement|1|||
129838937|NCT02275481|467375447|FG000|Overall Study|Death|2|||
129838938|NCT02275481|467375448|FG001|Overall Study|Death|1|||
129838939|NCT02275481|467375447|FG000|Overall Study|Lost to Follow-up|2|||
129838940|NCT02275481|467375448|FG001|Overall Study|Lost to Follow-up|0|||
129838941|NCT02275481|467375447|FG000|Overall Study|Withdrawal by Subject|3|||
129838942|NCT02275481|467375448|FG001|Overall Study|Withdrawal by Subject|0|||
129838943|NCT02275481|467375447|FG000|Overall Study|all other reasons combined|2|||
129838944|NCT02275481|467375448|FG001|Overall Study|all other reasons combined|1|||
129838945|NCT02275481|467375447|FG000|Overall Study|Physician Decision|0|||
129838946|NCT02275481|467375448|FG001|Overall Study|Physician Decision|1|||
129838947|NCT03274986|467375449|FG000|Overall Study|Withdrawal by Subject|0|||
129838948|NCT03274986|467375450|FG001|Overall Study|Withdrawal by Subject|1|||
129838949|NCT03274986|467375449|FG000|Overall Study|Lost to Follow-up|0|||
129838950|NCT03274986|467375450|FG001|Overall Study|Lost to Follow-up|1|||
129838951|NCT00344773|467375459|FG000|Overall Study|Adverse Event|2|||
129838952|NCT00344773|467375459|FG000|Overall Study|Objective Disease Progression|16|||
129838953|NCT00344773|467375459|FG000|Overall Study|Withdrawal by Subject|1|||
129838954|NCT00344773|467375459|FG000|Overall Study|Not Eligible for the study|2|||
129838955|NCT00714259|467375461|FG000|Overall Study|Death|2|||
129838956|NCT02141074|467375462|FG000|Pre-prophylaxis|Adverse Event|3|||
129838957|NCT02141074|467375463|FG001|Pre-prophylaxis|Adverse Event|0|||
129838958|NCT02141074|467375462|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
129838959|NCT02141074|467375463|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
129838960|NCT02141074|467375462|FG000|Prophylaxis|Adverse Event|0|||
129838961|NCT02141074|467375463|FG001|Prophylaxis|Adverse Event|4|||
129838962|NCT02141074|467375462|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
129838963|NCT02141074|467375463|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
129838964|NCT02141074|467375462|FG000|Prophylaxis|Withdrawal by Subject|0|||
129838965|NCT02141074|467375463|FG001|Prophylaxis|Withdrawal by Subject|1|||
129838966|NCT01336738|467377461|FG000|Overall Study|Adverse Event|0|||
129838967|NCT01336738|467377462|FG001|Overall Study|Adverse Event|3|||
129838968|NCT01336738|467377463|FG002|Overall Study|Adverse Event|2|||
129838969|NCT01336738|467377464|FG003|Overall Study|Adverse Event|1|||
129838970|NCT01336738|467377465|FG004|Overall Study|Adverse Event|3|||
129838971|NCT01336738|467377461|FG000|Overall Study|Lost to Follow-up|2|||
129838972|NCT01336738|467377462|FG001|Overall Study|Lost to Follow-up|1|||
129838973|NCT01336738|467377463|FG002|Overall Study|Lost to Follow-up|2|||
129838974|NCT01336738|467377464|FG003|Overall Study|Lost to Follow-up|2|||
129838975|NCT01336738|467377465|FG004|Overall Study|Lost to Follow-up|2|||
129838976|NCT01336738|467377461|FG000|Overall Study|Did not meet entrance criteria|0|||
129838977|NCT01336738|467377462|FG001|Overall Study|Did not meet entrance criteria|1|||
129838978|NCT01336738|467377463|FG002|Overall Study|Did not meet entrance criteria|0|||
129838979|NCT01336738|467377464|FG003|Overall Study|Did not meet entrance criteria|0|||
129838980|NCT01336738|467377465|FG004|Overall Study|Did not meet entrance criteria|0|||
129838981|NCT01336738|467377461|FG000|Overall Study|Protocol Violation|0|||
129838982|NCT01336738|467377462|FG001|Overall Study|Protocol Violation|1|||
129838983|NCT01336738|467377463|FG002|Overall Study|Protocol Violation|0|||
129838984|NCT01336738|467377464|FG003|Overall Study|Protocol Violation|0|||
129898848|NCT03107611|467590073|FG001|Overall Study|Withdrawal by Subject|0|||
129898849|NCT03107611|467590074|FG002|Overall Study|Withdrawal by Subject|1|||
129898850|NCT03107611|467590072|FG000|Overall Study|Worsening signs/symptoms|2|||
129898851|NCT03107611|467590073|FG001|Overall Study|Worsening signs/symptoms|1|||
129898852|NCT03107611|467590074|FG002|Overall Study|Worsening signs/symptoms|2|||
129898853|NCT01720446|467590075|FG000|Overall Study|Lost to Follow-up|12|||
129898854|NCT01720446|467590076|FG001|Overall Study|Lost to Follow-up|6|||
129898855|NCT01720446|467590077|FG002|Overall Study|Lost to Follow-up|16|||
129838985|NCT01336738|467377465|FG004|Overall Study|Protocol Violation|0|||
129838986|NCT01336738|467377461|FG000|Overall Study|Withdrawal by Subject|2|||
129838987|NCT01336738|467377462|FG001|Overall Study|Withdrawal by Subject|0|||
129838988|NCT01336738|467377463|FG002|Overall Study|Withdrawal by Subject|2|||
129838989|NCT01336738|467377464|FG003|Overall Study|Withdrawal by Subject|1|||
129838990|NCT01336738|467377465|FG004|Overall Study|Withdrawal by Subject|1|||
129838991|NCT01336738|467377461|FG000|Overall Study|Other|3|||
129838992|NCT01336738|467377462|FG001|Overall Study|Other|3|||
129838993|NCT01336738|467377463|FG002|Overall Study|Other|2|||
129838994|NCT01336738|467377464|FG003|Overall Study|Other|3|||
129838995|NCT01336738|467377465|FG004|Overall Study|Other|4|||
129838996|NCT03003520|467377466|FG000|Overall Study|Adverse Event|9|||
129838997|NCT03003520|467377467|FG001|Overall Study|Adverse Event|0|||
129838998|NCT03003520|467377466|FG000|Overall Study|Death|1|||
129898856|NCT01720446|467590078|FG003|Overall Study|Lost to Follow-up|16|||
129898857|NCT01720446|467590075|FG000|Overall Study|Withdrawal by Subject|2|||
129898858|NCT01720446|467590076|FG001|Overall Study|Withdrawal by Subject|5|||
129898859|NCT01720446|467590077|FG002|Overall Study|Withdrawal by Subject|4|||
129898860|NCT01720446|467590078|FG003|Overall Study|Withdrawal by Subject|4|||
129898861|NCT04464421|467590079|FG000|Overall Study|Lost to Follow-up|2|||
129898862|NCT04464421|467590080|FG001|Overall Study|Lost to Follow-up|2|||
129898863|NCT01956669|467590081|FG000|Overall Study|Disease Progression|12|||
129898864|NCT01956669|467590082|FG001|Overall Study|Disease Progression|7|||
129898865|NCT01956669|467590083|FG002|Overall Study|Disease Progression|7|||
129898866|NCT01956669|467590084|FG003|Overall Study|Disease Progression|8|||
129898867|NCT01956669|467590085|FG004|Overall Study|Disease Progression|4|||
129898868|NCT01956669|467590086|FG005|Overall Study|Disease Progression|3|||
129898869|NCT01956669|467590087|FG006|Overall Study|Disease Progression|5|||
129898870|NCT01956669|467590081|FG000|Overall Study|Adverse Event|0|||
129898871|NCT01956669|467590082|FG001|Overall Study|Adverse Event|2|||
129898872|NCT01956669|467590083|FG002|Overall Study|Adverse Event|2|||
129898873|NCT01956669|467590084|FG003|Overall Study|Adverse Event|1|||
129898874|NCT01956669|467590085|FG004|Overall Study|Adverse Event|0|||
129898875|NCT01956669|467590086|FG005|Overall Study|Adverse Event|0|||
129898876|NCT01956669|467590087|FG006|Overall Study|Adverse Event|0|||
129898877|NCT01956669|467590081|FG000|Overall Study|Physician Decision|0|||
129898878|NCT01956669|467590082|FG001|Overall Study|Physician Decision|2|||
129898879|NCT01956669|467590083|FG002|Overall Study|Physician Decision|0|||
129898880|NCT01956669|467590084|FG003|Overall Study|Physician Decision|0|||
129898881|NCT01956669|467590085|FG004|Overall Study|Physician Decision|0|||
129898882|NCT01956669|467590086|FG005|Overall Study|Physician Decision|1|||
129898883|NCT01956669|467590087|FG006|Overall Study|Physician Decision|0|||
129898884|NCT01956669|467590081|FG000|Overall Study|Withdrawal by Subject|0|||
129898885|NCT01956669|467590082|FG001|Overall Study|Withdrawal by Subject|0|||
129898886|NCT01956669|467590083|FG002|Overall Study|Withdrawal by Subject|1|||
129898887|NCT01956669|467590084|FG003|Overall Study|Withdrawal by Subject|1|||
129898888|NCT01956669|467590085|FG004|Overall Study|Withdrawal by Subject|0|||
129898889|NCT01956669|467590086|FG005|Overall Study|Withdrawal by Subject|0|||
129898890|NCT01956669|467590087|FG006|Overall Study|Withdrawal by Subject|1|||
129898891|NCT01072357|467590090|FG000|Overall Study|Lost to Follow-up|0|||
129898892|NCT01072357|467590091|FG001|Overall Study|Lost to Follow-up|1|||
129898893|NCT02131324|467590092|FG000|Overall Study|Withdrawal by Subject|1|||
129898894|NCT02131324|467590093|FG001|Overall Study|Withdrawal by Subject|2|||
129898895|NCT02131324|467590092|FG000|Overall Study|Lost to Follow-up|1|||
129898896|NCT02131324|467590093|FG001|Overall Study|Lost to Follow-up|1|||
129898897|NCT00891618|467590094|FG000|Overall Study|Withdrawal by Subject|1|||
129898898|NCT01693614|467590095|FG000|Overall Study|Adverse Event|7|||
129447461|NCT04479436|465939035|FG000|Overall Study|Withdrawal by Subject|5|||
129447462|NCT04479436|465939036|FG001|Overall Study|Withdrawal by Subject|0|||
129838999|NCT03003520|467377467|FG001|Overall Study|Death|0|||
129839000|NCT03003520|467377466|FG000|Overall Study|Other reasons|4|||
129839001|NCT03003520|467377467|FG001|Overall Study|Other reasons|0|||
129839002|NCT03003520|467377466|FG000|Overall Study|Withdrawal by Subject|6|||
129839003|NCT03003520|467377467|FG001|Overall Study|Withdrawal by Subject|0|||
129839004|NCT03003520|467377466|FG000|Overall Study|Progressive disease|9|||
129839005|NCT03003520|467377467|FG001|Overall Study|Progressive disease|1|||
129839006|NCT01920932|467377469|FG000|Overall Study|Death|1|||
129839007|NCT01920932|467377469|FG000|Overall Study|Withdrawal of consent|1|||
129839008|NCT01816139|467377470|FG000|Overall Study|Adverse Event|6|||
129839009|NCT01816139|467377471|FG001|Overall Study|Adverse Event|8|||
129839010|NCT01816139|467377470|FG000|Overall Study|Lack of Efficacy|1|||
129839011|NCT01816139|467377471|FG001|Overall Study|Lack of Efficacy|2|||
129839012|NCT01816139|467377470|FG000|Overall Study|Lost to Follow-up|5|||
129839013|NCT01816139|467377471|FG001|Overall Study|Lost to Follow-up|3|||
129839014|NCT01816139|467377470|FG000|Overall Study|Withdrew Consent|6|||
129839015|NCT01816139|467377471|FG001|Overall Study|Withdrew Consent|4|||
129839016|NCT01816139|467377470|FG000|Overall Study|Protocol Violation|6|||
129839017|NCT01816139|467377471|FG001|Overall Study|Protocol Violation|3|||
129839018|NCT01816139|467377470|FG000|Overall Study|Reason not Specified|4|||
129839019|NCT01816139|467377471|FG001|Overall Study|Reason not Specified|2|||
129898899|NCT01693614|467590096|FG001|Overall Study|Adverse Event|11|||
129447463|NCT04479436|465939035|FG000|Overall Study|Clinical progression|1|||
129839020|NCT03240575|467377474|FG000|Overall Study|Adverse Event|0|||
129839021|NCT03240575|467377475|FG001|Overall Study|Adverse Event|2|||
129839022|NCT03240575|467377476|FG002|Overall Study|Adverse Event|0|||
129839023|NCT03240575|467377477|FG003|Overall Study|Adverse Event|1|||
129898900|NCT01693614|467590097|FG002|Overall Study|Adverse Event|5|||
129898901|NCT01693614|467590095|FG000|Overall Study|Disease progression|11|||
129898902|NCT01693614|467590096|FG001|Overall Study|Disease progression|8|||
129898903|NCT01693614|467590097|FG002|Overall Study|Disease progression|7|||
129898904|NCT01693614|467590095|FG000|Overall Study|Protocol Violation|5|||
129898905|NCT01693614|467590096|FG001|Overall Study|Protocol Violation|2|||
129898906|NCT01693614|467590097|FG002|Overall Study|Protocol Violation|1|||
129898907|NCT01693614|467590095|FG000|Overall Study|Death|1|||
129898908|NCT01693614|467590096|FG001|Overall Study|Death|0|||
129447464|NCT04479436|465939036|FG001|Overall Study|Clinical progression|0|||
129447465|NCT04479436|465939035|FG000|Overall Study|Physician Decision|1|||
129447466|NCT04479436|465939036|FG001|Overall Study|Physician Decision|0|||
129447467|NCT00791258|465939039|FG000|Overall Study|Adverse Event|87|||
129447468|NCT00791258|465939039|FG000|Overall Study|Lost to Follow-up|18|||
129447469|NCT00791258|465939039|FG000|Overall Study|Protocol Violation|109|||
129447470|NCT00791258|465939039|FG000|Overall Study|Withdrawal by Subject|40|||
129447471|NCT00791258|465939039|FG000|Overall Study|Did not take medication for >3 days|1|||
129447472|NCT00791258|465939039|FG000|Overall Study|subject left area|2|||
129447473|NCT00791258|465939039|FG000|Overall Study|non-compliance|3|||
129447474|NCT00791258|465939039|FG000|Overall Study|Subject incarcerated|1|||
129447475|NCT00791258|465939039|FG000|Overall Study|Subject required restricted medication|1|||
129447476|NCT00791258|465939039|FG000|Overall Study|Lack of Efficacy|1|||
129447477|NCT00058552|465939040|FG000|Overall Study|Died prior to receiving treatment|4|||
129447478|NCT00058552|465939041|FG001|Overall Study|Died prior to receiving treatment|2|||
129447479|NCT00058552|465939040|FG000|Overall Study|Disease progression|52|||
129447480|NCT00058552|465939041|FG001|Overall Study|Disease progression|44|||
129447481|NCT00058552|465939040|FG000|Overall Study|Adverse Event|4|||
129447482|NCT00058552|465939041|FG001|Overall Study|Adverse Event|2|||
129447483|NCT00058552|465939040|FG000|Overall Study|Withdrawal by Subject|3|||
129447484|NCT00058552|465939041|FG001|Overall Study|Withdrawal by Subject|5|||
129447485|NCT00058552|465939040|FG000|Overall Study|Physician Decision|2|||
129447486|NCT00058552|465939041|FG001|Overall Study|Physician Decision|5|||
129447487|NCT00058552|465939040|FG000|Overall Study|Clinical disease progression|0|||
129447488|NCT00058552|465939041|FG001|Overall Study|Clinical disease progression|4|||
129447489|NCT02319668|465939042|FG000|Overall Study|Other (Not specified)|0|||
129447490|NCT02319668|465939043|FG001|Overall Study|Other (Not specified)|2|||
129447491|NCT01372150|465939044|FG000|Overall Study|Lack of Efficacy|3|||
129447492|NCT01372150|465939045|FG001|Overall Study|Lack of Efficacy|0|||
129447493|NCT01372150|465939046|FG002|Overall Study|Lack of Efficacy|1|||
129447494|NCT01372150|465939044|FG000|Overall Study|Lost to Follow-up|4|||
129447495|NCT01372150|465939045|FG001|Overall Study|Lost to Follow-up|5|||
129447496|NCT01372150|465939046|FG002|Overall Study|Lost to Follow-up|6|||
129447497|NCT01372150|465939044|FG000|Overall Study|Protocol Violation|1|||
129447498|NCT01372150|465939045|FG001|Overall Study|Protocol Violation|0|||
129447499|NCT01372150|465939046|FG002|Overall Study|Protocol Violation|3|||
129447500|NCT01372150|465939044|FG000|Overall Study|Withdrawal by Subject|2|||
129447501|NCT01372150|465939045|FG001|Overall Study|Withdrawal by Subject|7|||
129447502|NCT01372150|465939046|FG002|Overall Study|Withdrawal by Subject|2|||
129447503|NCT01372150|465939044|FG000|Overall Study|Other|1|||
129447504|NCT01372150|465939045|FG001|Overall Study|Other|0|||
129447505|NCT01372150|465939046|FG002|Overall Study|Other|2|||
129447506|NCT01372150|465939044|FG000|Overall Study|Adverse Event|2|||
129447507|NCT01372150|465939045|FG001|Overall Study|Adverse Event|1|||
129447508|NCT01372150|465939046|FG002|Overall Study|Adverse Event|2|||
129447509|NCT01372150|465939044|FG000|Overall Study|Randomized but not treated|0|||
129447510|NCT01372150|465939045|FG001|Overall Study|Randomized but not treated|1|||
129447511|NCT01372150|465939046|FG002|Overall Study|Randomized but not treated|0|||
129447512|NCT02316340|465939049|FG000|First Progression|Clinical progression|2|||
129447513|NCT02316340|465939050|FG001|First Progression|Clinical progression|1|||
129447514|NCT02316340|465939049|FG000|First Progression|Withdrawal by Subject|1|||
129447515|NCT02316340|465939050|FG001|First Progression|Withdrawal by Subject|0|||
129447516|NCT01986920|465939051|FG000|A- 101 25%|Withdrawal by Subject|1|||
129447517|NCT01986920|465939052|FG001|A- 101 25%|Withdrawal by Subject|0|||
129447518|NCT01986920|465939053|FG002|A- 101 25%|Withdrawal by Subject|0|||
129447519|NCT01986920|465939054|FG003|A- 101 25%|Withdrawal by Subject|0|||
129447520|NCT01986920|465939051|FG000|A-101 32.5%|Withdrawal by Subject|0|||
129839024|NCT03240575|467377474|FG000|Overall Study|Withdrawal by Subject|2|||
129839025|NCT03240575|467377475|FG001|Overall Study|Withdrawal by Subject|11|||
129839026|NCT03240575|467377476|FG002|Overall Study|Withdrawal by Subject|0|||
129839027|NCT03240575|467377477|FG003|Overall Study|Withdrawal by Subject|1|||
129839028|NCT03240575|467377474|FG000|Overall Study|Other|0|||
129839029|NCT03240575|467377475|FG001|Overall Study|Other|1|||
129839030|NCT03240575|467377476|FG002|Overall Study|Other|0|||
129839031|NCT03240575|467377477|FG003|Overall Study|Other|0|||
129898909|NCT01693614|467590097|FG002|Overall Study|Death|0|||
129898910|NCT01693614|467590095|FG000|Overall Study|Physician Decision|1|||
129898911|NCT01693614|467590096|FG001|Overall Study|Physician Decision|1|||
129898912|NCT01693614|467590097|FG002|Overall Study|Physician Decision|4|||
129898913|NCT01693614|467590095|FG000|Overall Study|Withdrawal by subject/guardian|0|||
129898914|NCT01693614|467590096|FG001|Overall Study|Withdrawal by subject/guardian|0|||
129898915|NCT01693614|467590097|FG002|Overall Study|Withdrawal by subject/guardian|2|||
129898916|NCT01693614|467590095|FG000|Overall Study|Withdrawal by Subject|1|||
129898917|NCT01693614|467590096|FG001|Overall Study|Withdrawal by Subject|0|||
129898918|NCT01693614|467590097|FG002|Overall Study|Withdrawal by Subject|5|||
129898919|NCT00420316|467590098|FG000|Overall Study|Withdrawal by Subject|0|||
129898920|NCT00420316|467590099|FG001|Overall Study|Withdrawal by Subject|1|||
129898921|NCT00420316|467590098|FG000|Overall Study|Lost to Follow-up|12|||
129898922|NCT00420316|467590099|FG001|Overall Study|Lost to Follow-up|8|||
129898923|NCT01196988|467590100|FG000|Overall Study|Adverse Event|1|||
129898924|NCT01196988|467590101|FG001|Overall Study|Adverse Event|2|||
129898925|NCT01196988|467590102|FG002|Overall Study|Adverse Event|0|||
129898926|NCT01196988|467590103|FG003|Overall Study|Adverse Event|0|||
129898927|NCT01196988|467590100|FG000|Overall Study|Withdrawal by Subject|5|||
129898928|NCT01196988|467590101|FG001|Overall Study|Withdrawal by Subject|1|||
129898929|NCT01196988|467590102|FG002|Overall Study|Withdrawal by Subject|4|||
129898930|NCT01196988|467590103|FG003|Overall Study|Withdrawal by Subject|0|||
129898931|NCT01196988|467590100|FG000|Overall Study|Lost to Follow-up|16|||
129898932|NCT01196988|467590101|FG001|Overall Study|Lost to Follow-up|29|||
129898933|NCT01196988|467590102|FG002|Overall Study|Lost to Follow-up|21|||
129898934|NCT01196988|467590103|FG003|Overall Study|Lost to Follow-up|1|||
129898935|NCT01196988|467590100|FG000|Overall Study|Other|2|||
129898936|NCT01196988|467590101|FG001|Overall Study|Other|0|||
129898937|NCT01196988|467590102|FG002|Overall Study|Other|0|||
129898938|NCT01196988|467590103|FG003|Overall Study|Other|0|||
129898939|NCT05419557|467590104|FG000|Overall Study|Lost to Follow-up|11|||
129898940|NCT05419557|467590105|FG001|Overall Study|Lost to Follow-up|4|||
129898941|NCT01313182|467590107|FG000|Overall Study|Protocol Violation|66|||
129898942|NCT01313182|467590108|FG001|Overall Study|Protocol Violation|92|||
129898943|NCT01695317|467590109|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
129898944|NCT01695317|467590110|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
129898945|NCT01695317|467590109|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
129898946|NCT01695317|467590110|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
129898947|NCT00464672|467590111|FG000|Overall Study|withdrawal of consent|0|||
129898948|NCT00464672|467590112|FG001|Overall Study|withdrawal of consent|0|||
129898949|NCT00464672|467590113|FG002|Overall Study|withdrawal of consent|0|||
129898950|NCT00464672|467590114|FG003|Overall Study|withdrawal of consent|1|||
129898951|NCT00464672|467590115|FG004|Overall Study|withdrawal of consent|9|||
129898952|NCT00464672|467590116|FG005|Overall Study|withdrawal of consent|4|||
129898953|NCT00464672|467590111|FG000|Overall Study|Lost to Follow-up|25|||
129898954|NCT00464672|467590112|FG001|Overall Study|Lost to Follow-up|10|||
129898955|NCT00464672|467590113|FG002|Overall Study|Lost to Follow-up|0|||
129898956|NCT00464672|467590114|FG003|Overall Study|Lost to Follow-up|0|||
129898957|NCT00464672|467590115|FG004|Overall Study|Lost to Follow-up|1|||
129898958|NCT00464672|467590116|FG005|Overall Study|Lost to Follow-up|0|||
129898959|NCT00957229|467590118|FG000|Study Start|Adverse Event|0|||
129898960|NCT00957229|467590119|FG001|Study Start|Adverse Event|3|||
129898961|NCT00957229|467590118|FG000|Study Start|Disease Progression|1|||
129898962|NCT00957229|467590119|FG001|Study Start|Disease Progression|0|||
129898963|NCT00957229|467590118|FG000|Reallocated to or Continued Vismodegib|Death|1|||
129898964|NCT00957229|467590119|FG001|Reallocated to or Continued Vismodegib|Death|1|||
129898965|NCT00957229|467590118|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
129839032|NCT00697346|467377478|FG000|Overall Study|Adverse Event|4|||
129839033|NCT00697346|467377479|FG001|Overall Study|Adverse Event|5|||
129898966|NCT00957229|467590119|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
129898967|NCT00606580|467590120|FG000|Overall Study|Lost to Follow-up|1|||
129898968|NCT00606580|467590121|FG001|Overall Study|Lost to Follow-up|1|||
129898969|NCT00606580|467590122|FG002|Overall Study|Lost to Follow-up|4|||
129898970|NCT00606580|467590120|FG000|Overall Study|Clinical failures|1|||
129898971|NCT00606580|467590121|FG001|Overall Study|Clinical failures|0|||
129839034|NCT00697346|467377480|FG002|Overall Study|Adverse Event|0|||
129898972|NCT00606580|467590122|FG002|Overall Study|Clinical failures|12|||
129898973|NCT00606580|467590120|FG000|Overall Study|Withdrawal by investigator|0|||
129898974|NCT00606580|467590121|FG001|Overall Study|Withdrawal by investigator|1|||
129898975|NCT00606580|467590122|FG002|Overall Study|Withdrawal by investigator|6|||
129898976|NCT00606580|467590120|FG000|Overall Study|Withdrawal by Subject|0|||
129898977|NCT00606580|467590121|FG001|Overall Study|Withdrawal by Subject|1|||
129898978|NCT00606580|467590122|FG002|Overall Study|Withdrawal by Subject|0|||
129898979|NCT00927823|467590125|FG000|Continuous Dosing Period|Death|0|||
129839035|NCT00697346|467377478|FG000|Overall Study|Progressive Disease|19|||
129839036|NCT00697346|467377479|FG001|Overall Study|Progressive Disease|18|||
129447521|NCT01986920|465939052|FG001|A-101 32.5%|Withdrawal by Subject|1|||
129447522|NCT01986920|465939053|FG002|A-101 32.5%|Withdrawal by Subject|0|||
129839037|NCT00697346|467377480|FG002|Overall Study|Progressive Disease|0|||
129839038|NCT00697346|467377478|FG000|Overall Study|Symptomatic Deterioration|0|||
129839039|NCT00697346|467377479|FG001|Overall Study|Symptomatic Deterioration|1|||
129839040|NCT00697346|467377480|FG002|Overall Study|Symptomatic Deterioration|0|||
129839041|NCT00697346|467377478|FG000|Overall Study|Withdrawal by Subject|2|||
129839042|NCT00697346|467377479|FG001|Overall Study|Withdrawal by Subject|2|||
129839043|NCT00697346|467377480|FG002|Overall Study|Withdrawal by Subject|0|||
129839044|NCT00697346|467377478|FG000|Overall Study|Reason not Specified|3|||
129839045|NCT00697346|467377479|FG001|Overall Study|Reason not Specified|0|||
129839046|NCT00697346|467377480|FG002|Overall Study|Reason not Specified|1|||
129839047|NCT03643562|467377482|FG000|Overall Study|Adverse Event|1|||
129898980|NCT00927823|467590126|FG001|Continuous Dosing Period|Death|0|||
129898981|NCT00927823|467590127|FG002|Continuous Dosing Period|Death|6|||
129447523|NCT01986920|465939054|FG003|A-101 32.5%|Withdrawal by Subject|0|||
129839048|NCT03643562|467377483|FG001|Overall Study|Adverse Event|0|||
129447524|NCT01986920|465939051|FG000|A-101 40%|Withdrawal by Subject|0|||
129447525|NCT01986920|465939052|FG001|A-101 40%|Withdrawal by Subject|0|||
129447526|NCT01986920|465939053|FG002|A-101 40%|Withdrawal by Subject|1|||
129447527|NCT01986920|465939054|FG003|A-101 40%|Withdrawal by Subject|0|||
129447528|NCT01986920|465939051|FG000|Placebo|Withdrawal by Subject|0|||
129447529|NCT01986920|465939052|FG001|Placebo|Withdrawal by Subject|0|||
129447530|NCT01986920|465939053|FG002|Placebo|Withdrawal by Subject|0|||
129447531|NCT01986920|465939054|FG003|Placebo|Withdrawal by Subject|1|||
129447532|NCT03781323|465939055|FG000|Overall Study|Withdrawal by Subject|1|||
129447533|NCT01338415|465939056|FG000|Core + Extension|Adverse Event|8|||
129447534|NCT01338415|465939057|FG001|Core + Extension|Adverse Event|6|||
129447535|NCT01338415|465939058|FG002|Core + Extension|Adverse Event|0|||
129447536|NCT01338415|465939056|FG000|Core + Extension|Withdrawal by Subject|1|||
129447537|NCT01338415|465939057|FG001|Core + Extension|Withdrawal by Subject|1|||
129447538|NCT01338415|465939058|FG002|Core + Extension|Withdrawal by Subject|0|||
129447539|NCT01338415|465939056|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
129447540|NCT01338415|465939057|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
129447541|NCT01338415|465939058|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
129447542|NCT01338415|465939056|FG000|Core + Extension|Other (administrative reason)|1|||
129447543|NCT01338415|465939057|FG001|Core + Extension|Other (administrative reason)|0|||
129447544|NCT01338415|465939058|FG002|Core + Extension|Other (administrative reason)|0|||
129447545|NCT01338415|465939056|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
129447546|NCT01338415|465939057|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
129447547|NCT01338415|465939058|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
129447548|NCT01338415|465939056|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
129447549|NCT01338415|465939057|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
129447550|NCT01338415|465939058|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
129447551|NCT01338415|465939056|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
129447552|NCT01338415|465939057|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
129447553|NCT01338415|465939058|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
129447554|NCT01338415|465939056|FG000|Exceptional Use Treatment Period|Death|0|||
129447555|NCT01338415|465939057|FG001|Exceptional Use Treatment Period|Death|0|||
129839049|NCT03643562|467377482|FG000|Overall Study|Lack of Efficacy|0|||
129898982|NCT00927823|467590128|FG003|Continuous Dosing Period|Death|0|||
129898983|NCT00927823|467590125|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
129898984|NCT00927823|467590126|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
129447556|NCT01338415|465939058|FG002|Exceptional Use Treatment Period|Death|1|||
129447557|NCT05215262|465939061|FG000|Overall Study|Lost to Follow-up|12|||
129447558|NCT05215262|465939062|FG001|Overall Study|Lost to Follow-up|0|||
129839050|NCT03643562|467377483|FG001|Overall Study|Lack of Efficacy|1|||
129839051|NCT03643562|467377482|FG000|Overall Study|Physician Decision|0|||
129839052|NCT03643562|467377483|FG001|Overall Study|Physician Decision|1|||
129839053|NCT03643562|467377482|FG000|Overall Study|Study Terminated by Sponsor|2|||
129898985|NCT00927823|467590127|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
129898986|NCT00927823|467590128|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
129898987|NCT00927823|467590125|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
129447559|NCT04880447|465939063|FG000|Overall Study|No vaccination information|1|||
129447560|NCT04880447|465939063|FG000|Overall Study|No adverse event information (missing information)|1|||
129447561|NCT04880447|465939063|FG000|Overall Study|Disease not covered in this study|35|||
129447562|NCT00718549|465939068|FG000|Induction Phase|Disease Progression|1|||
129447563|NCT00718549|465939069|FG001|Induction Phase|Disease Progression|0|||
129447564|NCT00718549|465939070|FG002|Induction Phase|Disease Progression|0|||
129447565|NCT00718549|465939068|FG000|Induction Phase|Eligibility Criteria Violation|2|||
129447566|NCT00718549|465939069|FG001|Induction Phase|Eligibility Criteria Violation|0|||
129447567|NCT00718549|465939070|FG002|Induction Phase|Eligibility Criteria Violation|0|||
129447568|NCT00718549|465939068|FG000|Induction Phase|Early Termination - No Additional Info|59|||
129447569|NCT00718549|465939069|FG001|Induction Phase|Early Termination - No Additional Info|0|||
129447570|NCT00718549|465939070|FG002|Induction Phase|Early Termination - No Additional Info|0|||
129447571|NCT00718549|465939068|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
129447572|NCT00718549|465939069|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
129447573|NCT00718549|465939070|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
129447574|NCT00718549|465939068|FG000|Maintenance/ Observation Phase|Death|0|||
129447575|NCT00718549|465939069|FG001|Maintenance/ Observation Phase|Death|1|||
129447576|NCT00718549|465939070|FG002|Maintenance/ Observation Phase|Death|2|||
129447577|NCT00718549|465939068|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
129447578|NCT00718549|465939069|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
129447579|NCT00718549|465939070|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
129447580|NCT00718549|465939068|FG000|Maintenance/ Observation Phase|Progression|0|||
129447581|NCT00718549|465939069|FG001|Maintenance/ Observation Phase|Progression|5|||
129447582|NCT00718549|465939070|FG002|Maintenance/ Observation Phase|Progression|14|||
129447583|NCT00718549|465939068|FG000|Maintenance/ Observation Phase|Relapse|0|||
129447584|NCT00718549|465939069|FG001|Maintenance/ Observation Phase|Relapse|3|||
129447585|NCT00718549|465939070|FG002|Maintenance/ Observation Phase|Relapse|2|||
129447586|NCT01353508|465939071|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
129447587|NCT01353508|465939072|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
129447588|NCT01353508|465939073|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
129447589|NCT01353508|465939074|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
129447590|NCT01353508|465939071|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
129447591|NCT01353508|465939072|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
129447592|NCT01353508|465939073|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
129447593|NCT01353508|465939074|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
129447594|NCT00239226|465939079|FG000|Overall Study|permAF during stabilization period|0|||
129447595|NCT00239226|465939080|FG001|Overall Study|permAF during stabilization period|0|||
129447596|NCT00239226|465939081|FG002|Overall Study|permAF during stabilization period|0|||
129447597|NCT00239226|465939082|FG003|Overall Study|permAF during stabilization period|3|||
129447598|NCT00239226|465939079|FG000|Overall Study|Lost to Follow-up|1|||
129447599|NCT00239226|465939080|FG001|Overall Study|Lost to Follow-up|0|||
129447600|NCT00239226|465939081|FG002|Overall Study|Lost to Follow-up|1|||
129447601|NCT00239226|465939082|FG003|Overall Study|Lost to Follow-up|0|||
129447602|NCT00646906|465939084|FG000|Crossover Period 1|Withdrawal by Subject|1|||
129447603|NCT00646906|465939085|FG001|Crossover Period 1|Withdrawal by Subject|0|||
129447604|NCT00646906|465939086|FG002|Crossover Period 1|Withdrawal by Subject|0|||
129447605|NCT00646906|465939087|FG003|Crossover Period 1|Withdrawal by Subject|0|||
129447606|NCT00646906|465939088|FG004|Crossover Period 1|Withdrawal by Subject|0|||
129447607|NCT00646906|465939089|FG005|Crossover Period 1|Withdrawal by Subject|1|||
129447608|NCT00646906|465939090|FG006|Crossover Period 1|Withdrawal by Subject|0|||
129447609|NCT00646906|465939084|FG000|Crossover Period 2|Withdrawal by Subject|0|||
129447610|NCT00646906|465939085|FG001|Crossover Period 2|Withdrawal by Subject|1|||
129447611|NCT00646906|465939086|FG002|Crossover Period 2|Withdrawal by Subject|2|||
129447612|NCT00646906|465939087|FG003|Crossover Period 2|Withdrawal by Subject|1|||
129839054|NCT03643562|467377483|FG001|Overall Study|Study Terminated by Sponsor|10|||
129839055|NCT03643562|467377482|FG000|Overall Study|Withdrawal by Subject|2|||
129839056|NCT03643562|467377483|FG001|Overall Study|Withdrawal by Subject|2|||
129839057|NCT03643562|467377482|FG000|Overall Study|Other than specified|3|||
129839058|NCT03643562|467377483|FG001|Overall Study|Other than specified|2|||
129839059|NCT01982253|467377486|FG000|Overall Study|Withdrawal by Subject|1|||
129839060|NCT01982253|467377487|FG001|Overall Study|Withdrawal by Subject|0|||
129839061|NCT01982253|467377488|FG002|Overall Study|Withdrawal by Subject|0|||
129839062|NCT01982253|467377486|FG000|Overall Study|Study terminated by sponsor|1|||
129447613|NCT00646906|465939088|FG004|Crossover Period 2|Withdrawal by Subject|0|||
129447614|NCT00646906|465939089|FG005|Crossover Period 2|Withdrawal by Subject|0|||
129447615|NCT00646906|465939090|FG006|Crossover Period 2|Withdrawal by Subject|0|||
129447616|NCT00646906|465939084|FG000|Crossover Period 2|Physician Decision|0|||
129447617|NCT00646906|465939085|FG001|Crossover Period 2|Physician Decision|0|||
129447618|NCT00646906|465939086|FG002|Crossover Period 2|Physician Decision|0|||
129839063|NCT01982253|467377487|FG001|Overall Study|Study terminated by sponsor|4|||
129839064|NCT01982253|467377488|FG002|Overall Study|Study terminated by sponsor|4|||
129447619|NCT00646906|465939087|FG003|Crossover Period 2|Physician Decision|0|||
129447620|NCT00646906|465939088|FG004|Crossover Period 2|Physician Decision|0|||
129447621|NCT00646906|465939089|FG005|Crossover Period 2|Physician Decision|0|||
129447622|NCT00646906|465939090|FG006|Crossover Period 2|Physician Decision|1|||
129447623|NCT02486653|465939091|FG000|Overall Study|Withdrawal by Subject|1|||
129447624|NCT02486653|465939092|FG001|Overall Study|Withdrawal by Subject|3|||
129447625|NCT02486653|465939091|FG000|Overall Study|Protocol Violation|1|||
129447626|NCT02486653|465939092|FG001|Overall Study|Protocol Violation|0|||
129447627|NCT02486653|465939091|FG000|Overall Study|surgery cancelled|4|||
129447628|NCT02486653|465939092|FG001|Overall Study|surgery cancelled|1|||
129447629|NCT01177384|465939094|FG000|Overall Study|Adverse Event|6|||
129447630|NCT01177384|465939095|FG001|Overall Study|Adverse Event|4|||
129447631|NCT01177384|465939094|FG000|Overall Study|Lack of Efficacy|0|||
129447632|NCT01177384|465939095|FG001|Overall Study|Lack of Efficacy|1|||
129447633|NCT01177384|465939094|FG000|Overall Study|Lost to Follow-up|3|||
129447634|NCT01177384|465939095|FG001|Overall Study|Lost to Follow-up|4|||
129447635|NCT01177384|465939094|FG000|Overall Study|Physician Decision|0|||
129447636|NCT01177384|465939095|FG001|Overall Study|Physician Decision|3|||
129447637|NCT01177384|465939094|FG000|Overall Study|Protocol Violation|0|||
129447638|NCT01177384|465939095|FG001|Overall Study|Protocol Violation|2|||
129447639|NCT01177384|465939094|FG000|Overall Study|Withdrawal by Subject|5|||
129447640|NCT01177384|465939095|FG001|Overall Study|Withdrawal by Subject|12|||
129447641|NCT01849497|465939096|FG000|Overall Study|Withdrawal by Subject|1|||
129447642|NCT01849497|465939097|FG001|Overall Study|Withdrawal by Subject|2|||
129447643|NCT01849497|465939096|FG000|Overall Study|Sponsor Decision|0|||
129447644|NCT01849497|465939097|FG001|Overall Study|Sponsor Decision|1|||
129447645|NCT01849497|465939096|FG000|Overall Study|Lost to Follow-up|0|||
129447646|NCT01849497|465939097|FG001|Overall Study|Lost to Follow-up|1|||
129447647|NCT01514136|465939098|FG000|Test Period 1; Test A|Protocol Violation|1|||
129447648|NCT01514136|465939099|FG001|Test Period 1; Test A|Protocol Violation|0|||
129447649|NCT01514136|465939100|FG002|Test Period 1; Test A|Protocol Violation|0|||
129447650|NCT01514136|465939101|FG003|Test Period 1; Test A|Protocol Violation|0|||
129447651|NCT01514136|465939102|FG004|Test Period 1; Test A|Protocol Violation|0|||
129447652|NCT01514136|465939103|FG005|Test Period 1; Test A|Protocol Violation|0|||
129447653|NCT01514136|465939104|FG006|Test Period 1; Test A|Protocol Violation|0|||
129447654|NCT01514136|465939105|FG007|Test Period 1; Test A|Protocol Violation|0|||
129447655|NCT01514136|465939098|FG000|Test Period 1; Test A|Break from study holiday|2|||
129447656|NCT01514136|465939099|FG001|Test Period 1; Test A|Break from study holiday|0|||
129447657|NCT01514136|465939100|FG002|Test Period 1; Test A|Break from study holiday|0|||
129447658|NCT01514136|465939101|FG003|Test Period 1; Test A|Break from study holiday|0|||
129447659|NCT01514136|465939102|FG004|Test Period 1; Test A|Break from study holiday|0|||
129447660|NCT01514136|465939103|FG005|Test Period 1; Test A|Break from study holiday|0|||
129447661|NCT01514136|465939104|FG006|Test Period 1; Test A|Break from study holiday|0|||
129447662|NCT01514136|465939105|FG007|Test Period 1; Test A|Break from study holiday|0|||
129447663|NCT01514136|465939098|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
129447664|NCT01514136|465939099|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
129447665|NCT01514136|465939100|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
129447666|NCT01514136|465939101|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
129447667|NCT01514136|465939102|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
129447668|NCT01514136|465939103|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
129447669|NCT01514136|465939104|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
129447670|NCT01514136|465939105|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
129447671|NCT01514136|465939098|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
129447672|NCT01514136|465939099|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
129447673|NCT01514136|465939100|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
129447674|NCT01514136|465939101|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
129447675|NCT01514136|465939102|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
129447676|NCT01514136|465939103|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
129839065|NCT00913744|467377490|FG000|Overall Study|Adverse Event|2|||
129839066|NCT00913744|467377491|FG001|Overall Study|Adverse Event|0|||
129839067|NCT00913744|467377490|FG000|Overall Study|Withdrawal by Subject|2|||
129839068|NCT00913744|467377491|FG001|Overall Study|Withdrawal by Subject|1|||
129839069|NCT00913744|467377490|FG000|Overall Study|Death|1|||
129839070|NCT00913744|467377491|FG001|Overall Study|Death|0|||
129839071|NCT02945410|467377492|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839072|NCT02945410|467377493|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
129447677|NCT01514136|465939104|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
129898988|NCT00927823|467590126|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
129447678|NCT01514136|465939105|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
129447679|NCT01514136|465939098|FG000|Test Period 2; Test A*|Adverse Event|0|||
129447680|NCT01514136|465939099|FG001|Test Period 2; Test A*|Adverse Event|0|||
129447681|NCT01514136|465939100|FG002|Test Period 2; Test A*|Adverse Event|0|||
129839073|NCT02945410|467377494|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839074|NCT02945410|467377495|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129447682|NCT01514136|465939101|FG003|Test Period 2; Test A*|Adverse Event|0|||
129447683|NCT01514136|465939102|FG004|Test Period 2; Test A*|Adverse Event|1|||
129447684|NCT01514136|465939103|FG005|Test Period 2; Test A*|Adverse Event|0|||
129447685|NCT01514136|465939104|FG006|Test Period 2; Test A*|Adverse Event|0|||
129447686|NCT01514136|465939105|FG007|Test Period 2; Test A*|Adverse Event|0|||
129447687|NCT01514136|465939098|FG000|Test Period 2; Test A*|Holiday|0|||
129447688|NCT01514136|465939099|FG001|Test Period 2; Test A*|Holiday|0|||
129447689|NCT01514136|465939100|FG002|Test Period 2; Test A*|Holiday|0|||
129447690|NCT01514136|465939101|FG003|Test Period 2; Test A*|Holiday|0|||
129447691|NCT01514136|465939102|FG004|Test Period 2; Test A*|Holiday|1|||
129447692|NCT01514136|465939103|FG005|Test Period 2; Test A*|Holiday|0|||
129447693|NCT01514136|465939104|FG006|Test Period 2; Test A*|Holiday|0|||
129447694|NCT01514136|465939105|FG007|Test Period 2; Test A*|Holiday|0|||
129447695|NCT01514136|465939098|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447696|NCT01514136|465939099|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447697|NCT01514136|465939100|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447698|NCT01514136|465939101|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447699|NCT01514136|465939102|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447700|NCT01514136|465939103|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
129447701|NCT01514136|465939104|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447702|NCT01514136|465939105|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
129447703|NCT01514136|465939098|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
129447704|NCT01514136|465939099|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
129447705|NCT01514136|465939100|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
129447706|NCT01514136|465939101|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
129447707|NCT01514136|465939102|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
129447708|NCT01514136|465939103|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
129839075|NCT02945410|467377496|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839076|NCT02945410|467377497|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
129839077|NCT02945410|467377492|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
129839078|NCT02945410|467377493|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
129839079|NCT02945410|467377494|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
129839080|NCT02945410|467377495|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
129839081|NCT02945410|467377496|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
129839082|NCT02945410|467377497|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
129839083|NCT02945410|467377492|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839084|NCT02945410|467377493|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839085|NCT02945410|467377494|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
129839086|NCT02945410|467377495|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839087|NCT02945410|467377496|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
129839088|NCT02945410|467377497|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
129839089|NCT02118428|467377504|FG000|Overall Study|Physician Decision|0|||
129839090|NCT02118428|467377505|FG001|Overall Study|Physician Decision|1|||
129839091|NCT02118428|467377506|FG002|Overall Study|Physician Decision|0|||
129839092|NCT02118428|467377504|FG000|Overall Study|Withdrawal by Subject|2|||
129839093|NCT02118428|467377505|FG001|Overall Study|Withdrawal by Subject|2|||
129839094|NCT02118428|467377506|FG002|Overall Study|Withdrawal by Subject|0|||
129839095|NCT02118428|467377504|FG000|Overall Study|Death|7|||
129839096|NCT02118428|467377505|FG001|Overall Study|Death|5|||
129839097|NCT02118428|467377506|FG002|Overall Study|Death|0|||
129839098|NCT02118428|467377504|FG000|Overall Study|Lost to Follow-up|3|||
129839099|NCT02118428|467377505|FG001|Overall Study|Lost to Follow-up|1|||
129839100|NCT02118428|467377506|FG002|Overall Study|Lost to Follow-up|0|||
129839101|NCT02118428|467377504|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
129839102|NCT02118428|467377505|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
129839103|NCT02118428|467377506|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
129839104|NCT03100825|467377507|FG000|Overall Study|Participant/Guardian Decision|7|||
129839105|NCT03100825|467377507|FG000|Overall Study|Physician Decision|1|||
129839106|NCT00048542|467377516|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129839107|NCT00048542|467377517|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
129839108|NCT00048542|467377518|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
129839109|NCT00048542|467377519|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129839110|NCT00048542|467377520|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129839111|NCT00048542|467377521|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
129839112|NCT00048542|467377522|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
129447709|NCT01514136|465939104|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
129447710|NCT01514136|465939105|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
129447711|NCT01514136|465939098|FG000|Test Period 2; Test C*|holiday|0|||
129839113|NCT00048542|467377523|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
129839114|NCT00048542|467377516|FG000|Double-Blind Phase|Protocol Violation|0|||
129839115|NCT00048542|467377517|FG001|Double-Blind Phase|Protocol Violation|0|||
129839116|NCT00048542|467377518|FG002|Double-Blind Phase|Protocol Violation|1|||
129839117|NCT00048542|467377519|FG003|Double-Blind Phase|Protocol Violation|0|||
129839118|NCT00048542|467377520|FG004|Double-Blind Phase|Protocol Violation|0|||
129839119|NCT00048542|467377521|FG005|Double-Blind Phase|Protocol Violation|0|||
129839120|NCT00048542|467377522|FG006|Double-Blind Phase|Protocol Violation|0|||
129839121|NCT00048542|467377523|FG007|Double-Blind Phase|Protocol Violation|0|||
129839122|NCT00048542|467377516|FG000|Double-Blind Phase|Sponsor request or decision|2|||
129839123|NCT00048542|467377517|FG001|Double-Blind Phase|Sponsor request or decision|0|||
129839124|NCT00048542|467377518|FG002|Double-Blind Phase|Sponsor request or decision|0|||
129839125|NCT00048542|467377519|FG003|Double-Blind Phase|Sponsor request or decision|0|||
129839126|NCT00048542|467377520|FG004|Double-Blind Phase|Sponsor request or decision|0|||
129839127|NCT00048542|467377521|FG005|Double-Blind Phase|Sponsor request or decision|0|||
129839128|NCT00048542|467377522|FG006|Double-Blind Phase|Sponsor request or decision|0|||
129447712|NCT01514136|465939099|FG001|Test Period 2; Test C*|holiday|0|||
129447713|NCT01514136|465939100|FG002|Test Period 2; Test C*|holiday|0|||
129839129|NCT00048542|467377523|FG007|Double-Blind Phase|Sponsor request or decision|0|||
129839130|NCT00048542|467377516|FG000|Double-Blind Phase|Randomized in error|1|||
129839131|NCT00048542|467377517|FG001|Double-Blind Phase|Randomized in error|0|||
129839132|NCT00048542|467377518|FG002|Double-Blind Phase|Randomized in error|0|||
129839133|NCT00048542|467377519|FG003|Double-Blind Phase|Randomized in error|0|||
129839134|NCT00048542|467377520|FG004|Double-Blind Phase|Randomized in error|0|||
129839135|NCT00048542|467377521|FG005|Double-Blind Phase|Randomized in error|0|||
129839136|NCT00048542|467377522|FG006|Double-Blind Phase|Randomized in error|0|||
129839137|NCT00048542|467377523|FG007|Double-Blind Phase|Randomized in error|0|||
129839138|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839139|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839140|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839141|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839142|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
129839143|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
129839144|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839145|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
129839146|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839147|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839148|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839149|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839150|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839151|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
129839152|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839153|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
129839154|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839155|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839156|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129447714|NCT01514136|465939101|FG003|Test Period 2; Test C*|holiday|0|||
129447715|NCT01514136|465939102|FG004|Test Period 2; Test C*|holiday|0|||
129447716|NCT01514136|465939103|FG005|Test Period 2; Test C*|holiday|0|||
129447717|NCT01514136|465939104|FG006|Test Period 2; Test C*|holiday|1|||
129447718|NCT01514136|465939105|FG007|Test Period 2; Test C*|holiday|0|||
129447719|NCT01514136|465939098|FG000|Test Period 2; Test C*|Protocol Violation|0|||
129447720|NCT01514136|465939099|FG001|Test Period 2; Test C*|Protocol Violation|0|||
129447721|NCT01514136|465939100|FG002|Test Period 2; Test C*|Protocol Violation|0|||
129447722|NCT01514136|465939101|FG003|Test Period 2; Test C*|Protocol Violation|0|||
129447723|NCT01514136|465939102|FG004|Test Period 2; Test C*|Protocol Violation|0|||
129447724|NCT01514136|465939103|FG005|Test Period 2; Test C*|Protocol Violation|0|||
129447725|NCT01514136|465939104|FG006|Test Period 2; Test C*|Protocol Violation|1|||
129447726|NCT01514136|465939105|FG007|Test Period 2; Test C*|Protocol Violation|0|||
129447727|NCT02941926|465939106|FG000|Core Phase|Progressive disease|1109|||
129447728|NCT02941926|465939106|FG000|Core Phase|Adverse Event|504|||
129447729|NCT02941926|465939106|FG000|Core Phase|Subject/guardian decision|127|||
129447730|NCT02941926|465939106|FG000|Core Phase|Physician Decision|112|||
129447731|NCT02941926|465939106|FG000|Core Phase|Death|46|||
129447732|NCT02941926|465939106|FG000|Core Phase|Protocol deviation|34|||
129447733|NCT02941926|465939106|FG000|Core Phase|Lost to Follow-up|8|||
129447734|NCT02941926|465939106|FG000|Core Phase|Technical problems|5|||
129447735|NCT02941926|465939106|FG000|Extension Phase|Physician Decision|155|||
129447736|NCT02941926|465939106|FG000|Extension Phase|Progressive disease|115|||
129447737|NCT02941926|465939106|FG000|Extension Phase|Adverse Event|13|||
129447738|NCT02941926|465939106|FG000|Extension Phase|Subject/Guardian decision|12|||
129447739|NCT02941926|465939106|FG000|Extension Phase|Death|6|||
129447740|NCT02729740|465939107|FG000|Overall Study|Early Termination|130|||
129447741|NCT02729740|465939107|FG000|Overall Study|Other|1|||
129447742|NCT00307333|465939108|FG000|Overall Study|Lost to Follow-up|11|||
129447743|NCT00307333|465939109|FG001|Overall Study|Lost to Follow-up|3|||
129447744|NCT00698932|465939113|FG000|Overall Study|Adverse Event|0|||
129447745|NCT00698932|465939114|FG001|Overall Study|Adverse Event|2|||
129447746|NCT00698932|465939113|FG000|Overall Study|Incorrect enrollment|0|||
129447747|NCT00698932|465939114|FG001|Overall Study|Incorrect enrollment|2|||
129447748|NCT00698932|465939113|FG000|Overall Study|Study specific discontinuation criteria|3|||
129447749|NCT00698932|465939114|FG001|Overall Study|Study specific discontinuation criteria|4|||
129898989|NCT00927823|467590127|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
129898990|NCT00927823|467590128|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
129898991|NCT00927823|467590125|FG000|Continuous Dosing Period|Other|1|||
129898992|NCT00927823|467590126|FG001|Continuous Dosing Period|Other|2|||
129898993|NCT00927823|467590127|FG002|Continuous Dosing Period|Other|9|||
129898994|NCT00927823|467590128|FG003|Continuous Dosing Period|Other|3|||
129898995|NCT00828672|467590129|FG000|Study Treatment|Lost to Follow-up|1|||
129898996|NCT00828672|467590130|FG001|Study Treatment|Lost to Follow-up|0|||
129898997|NCT00828672|467590129|FG000|Study Treatment|Adverse Event|0|||
129898998|NCT00828672|467590130|FG001|Study Treatment|Adverse Event|1|||
129898999|NCT00828672|467590129|FG000|Study Treatment|Complete response, no surgery|1|||
129899000|NCT00828672|467590130|FG001|Study Treatment|Complete response, no surgery|1|||
129447750|NCT00698932|465939113|FG000|Overall Study|Withdrawal by Subject|11|||
129447751|NCT00698932|465939114|FG001|Overall Study|Withdrawal by Subject|23|||
129447752|NCT00698932|465939113|FG000|Overall Study|Lost to Follow-up|6|||
129447753|NCT00698932|465939114|FG001|Overall Study|Lost to Follow-up|1|||
129839157|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839158|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
129839159|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
129839160|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839161|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
129839162|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
129839163|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
129839164|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
129839165|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
129839166|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
129839167|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
129839168|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
129839169|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
129899001|NCT00828672|467590129|FG000|Post-surgery (<30 Days)|No central review materials|0|||
129899002|NCT00828672|467590130|FG001|Post-surgery (<30 Days)|No central review materials|1|||
129447754|NCT00698932|465939113|FG000|Overall Study|Severe non-compliance to protocol|1|||
129447755|NCT00698932|465939114|FG001|Overall Study|Severe non-compliance to protocol|2|||
129447756|NCT00698932|465939113|FG000|Overall Study|Safety reasons|0|||
129447757|NCT00698932|465939114|FG001|Overall Study|Safety reasons|2|||
129447758|NCT00698932|465939113|FG000|Overall Study|Death|1|||
129447759|NCT00698932|465939114|FG001|Overall Study|Death|0|||
129447760|NCT00601705|465939115|FG000|Overall Study|Withdrawal by Subject|1|||
129447761|NCT03044249|465939122|FG000|Overall Study|Adverse Event|4|||
129839170|NCT00048542|467377516|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839171|NCT00048542|467377517|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839172|NCT00048542|467377518|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839173|NCT00048542|467377519|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839174|NCT00048542|467377520|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
129839175|NCT00048542|467377521|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
129839176|NCT00048542|467377522|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839177|NCT00048542|467377523|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
129839178|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839179|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839180|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839181|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839182|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839183|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
129839184|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
129839185|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
129839186|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839187|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839188|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839189|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839190|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839191|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
129839192|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
129899003|NCT01250002|467590138|FG000|Overall Study|Change to open surgical procedure|4|||
129899004|NCT01250002|467590139|FG001|Overall Study|Change to open surgical procedure|3|||
129899005|NCT04044664|467590144|FG000|Stage 1|Adverse Event|3|||
129899006|NCT04044664|467590145|FG001|Stage 1|Adverse Event|3|||
129899007|NCT04044664|467590146|FG002|Stage 1|Adverse Event|1|||
129899008|NCT04044664|467590144|FG000|Stage 1|Lost to Follow-up|3|||
129899009|NCT04044664|467590145|FG001|Stage 1|Lost to Follow-up|2|||
129899010|NCT04044664|467590146|FG002|Stage 1|Lost to Follow-up|2|||
129899011|NCT04044664|467590144|FG000|Stage 1|Withdrawal by Subject|9|||
129899012|NCT04044664|467590145|FG001|Stage 1|Withdrawal by Subject|1|||
129899013|NCT04044664|467590146|FG002|Stage 1|Withdrawal by Subject|0|||
129899014|NCT04044664|467590144|FG000|Stage 1|noncompliance, personal reason|2|||
129899015|NCT04044664|467590145|FG001|Stage 1|noncompliance, personal reason|0|||
129899016|NCT04044664|467590146|FG002|Stage 1|noncompliance, personal reason|0|||
129899017|NCT04044664|467590144|FG000|Stage 1|randomization error|0|||
129899018|NCT04044664|467590145|FG001|Stage 1|randomization error|1|||
129899019|NCT04044664|467590146|FG002|Stage 1|randomization error|0|||
129899020|NCT04044664|467590144|FG000|Stage 2|Adverse Event|2|||
129899021|NCT04044664|467590145|FG001|Stage 2|Adverse Event|0|||
129899022|NCT04044664|467590146|FG002|Stage 2|Adverse Event|0|||
129899023|NCT04044664|467590144|FG000|Stage 2|Lost to Follow-up|3|||
129899024|NCT04044664|467590145|FG001|Stage 2|Lost to Follow-up|2|||
129899025|NCT04044664|467590146|FG002|Stage 2|Lost to Follow-up|1|||
129899026|NCT04044664|467590144|FG000|Stage 2|Withdrawal by Subject|3|||
129899027|NCT04044664|467590145|FG001|Stage 2|Withdrawal by Subject|0|||
129899028|NCT04044664|467590146|FG002|Stage 2|Withdrawal by Subject|0|||
129899029|NCT04044664|467590144|FG000|Stage 2|protocol deviation|1|||
129899030|NCT04044664|467590145|FG001|Stage 2|protocol deviation|0|||
129899031|NCT04044664|467590146|FG002|Stage 2|protocol deviation|0|||
129899032|NCT00001575|467590150|FG000|Overall Study|Screening failures-Ph I portion|22|||
129899033|NCT00001575|467590150|FG000|Overall Study|Withdrawn/deaths|23|||
129899034|NCT00290732|467590157|FG000|Overall Study|Inability to instill drug intraductally.|0|||
129899035|NCT00290732|467590158|FG001|Overall Study|Inability to instill drug intraductally.|1|||
129899036|NCT00290732|467590159|FG002|Overall Study|Inability to instill drug intraductally.|1|||
129899037|NCT00290732|467590160|FG003|Overall Study|Inability to instill drug intraductally.|0|||
129899038|NCT00290732|467590161|FG004|Overall Study|Inability to instill drug intraductally.|0|||
129899039|NCT00542386|467590162|FG000|Overall Study|Adverse Event|1|||
129899040|NCT00542386|467590163|FG001|Overall Study|Adverse Event|7|||
129899041|NCT00542386|467590164|FG002|Overall Study|Adverse Event|7|||
129899042|NCT00542386|467590165|FG003|Overall Study|Adverse Event|8|||
129839193|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
129839194|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839195|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839196|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839197|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839198|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839199|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
129839200|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
129839201|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
129839202|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839203|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839204|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839205|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839206|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839207|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
129839208|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
129839209|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
129839210|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839211|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839212|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839213|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839214|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839215|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
129839216|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
129899043|NCT00542386|467590166|FG004|Overall Study|Adverse Event|13|||
129899044|NCT00542386|467590167|FG005|Overall Study|Adverse Event|4|||
129899045|NCT00542386|467590162|FG000|Overall Study|Death|0|||
129899046|NCT00542386|467590163|FG001|Overall Study|Death|0|||
129899047|NCT00542386|467590164|FG002|Overall Study|Death|1|||
129899048|NCT00542386|467590165|FG003|Overall Study|Death|2|||
129899049|NCT00542386|467590166|FG004|Overall Study|Death|1|||
129899050|NCT00542386|467590167|FG005|Overall Study|Death|2|||
129899051|NCT00542386|467590162|FG000|Overall Study|Lack of Efficacy|32|||
129899052|NCT00542386|467590163|FG001|Overall Study|Lack of Efficacy|12|||
129839217|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
129839218|NCT00048542|467377516|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839219|NCT00048542|467377517|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839220|NCT00048542|467377518|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839221|NCT00048542|467377519|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839222|NCT00048542|467377520|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839223|NCT00048542|467377521|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
129839224|NCT00048542|467377522|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
129839225|NCT00048542|467377523|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
129839226|NCT00578175|467377524|FG000|Overall Study|Adverse Event|0|||
129839227|NCT00578175|467377525|FG001|Overall Study|Adverse Event|1|||
129839228|NCT00578175|467377526|FG002|Overall Study|Adverse Event|1|||
129839229|NCT00578175|467377524|FG000|Overall Study|Other reasons|70|||
129839230|NCT00578175|467377525|FG001|Overall Study|Other reasons|42|||
129839231|NCT00578175|467377526|FG002|Overall Study|Other reasons|23|||
129839232|NCT01869192|467377527|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
129839233|NCT01869192|467377528|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
129839234|NCT01869192|467377527|FG000|Postoperative Chemotherapy|Physician Decision|0|||
129839235|NCT01869192|467377528|FG001|Postoperative Chemotherapy|Physician Decision|2|||
129839236|NCT02126969|467377533|FG000|Overall Study|Withdrawal by Subject|1|||
129839237|NCT02126969|467377534|FG001|Overall Study|Withdrawal by Subject|2|||
129839238|NCT00423891|467377535|FG000|Enrolled|Withdrawal by Subject|0|||
129839239|NCT00423891|467377536|FG001|Enrolled|Withdrawal by Subject|0|||
129839240|NCT00423891|467377537|FG002|Enrolled|Withdrawal by Subject|1|||
129839241|NCT00423891|467377535|FG000|Enrolled|Lost to Follow-up|0|||
129839242|NCT00423891|467377536|FG001|Enrolled|Lost to Follow-up|0|||
129839243|NCT00423891|467377537|FG002|Enrolled|Lost to Follow-up|1|||
129839244|NCT00423891|467377535|FG000|Enrolled|No longer met criteria|11|||
129839245|NCT00423891|467377536|FG001|Enrolled|No longer met criteria|2|||
129839246|NCT00423891|467377537|FG002|Enrolled|No longer met criteria|1|||
129839247|NCT00423891|467377535|FG000|Treatment|Withdrawal by Subject|1|||
129839248|NCT00423891|467377536|FG001|Treatment|Withdrawal by Subject|0|||
129839249|NCT00423891|467377537|FG002|Treatment|Withdrawal by Subject|0|||
129839250|NCT00423891|467377535|FG000|Treatment|Lost to Follow-up|1|||
129839251|NCT00423891|467377536|FG001|Treatment|Lost to Follow-up|0|||
129839252|NCT00423891|467377537|FG002|Treatment|Lost to Follow-up|0|||
129839253|NCT00423891|467377535|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
129839254|NCT00423891|467377536|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
129839255|NCT00423891|467377537|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
129839256|NCT00423891|467377535|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
129839257|NCT00423891|467377536|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
129839258|NCT00423891|467377537|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
129839259|NCT00414661|467377538|FG000|Overall Study|Death|2|||
129839260|NCT00414661|467377539|FG001|Overall Study|Death|5|||
129839261|NCT00414661|467377540|FG002|Overall Study|Death|0|||
129839262|NCT00414661|467377541|FG003|Overall Study|Death|0|||
129839263|NCT00414661|467377538|FG000|Overall Study|Lost to Follow-up|1|||
129839264|NCT00414661|467377539|FG001|Overall Study|Lost to Follow-up|4|||
129839265|NCT00414661|467377540|FG002|Overall Study|Lost to Follow-up|0|||
129839266|NCT00414661|467377541|FG003|Overall Study|Lost to Follow-up|1|||
129839267|NCT00414661|467377538|FG000|Overall Study|Withdrawal by Subject|5|||
129839268|NCT00414661|467377539|FG001|Overall Study|Withdrawal by Subject|2|||
129899053|NCT00542386|467590164|FG002|Overall Study|Lack of Efficacy|10|||
129899054|NCT00542386|467590165|FG003|Overall Study|Lack of Efficacy|13|||
129839269|NCT00414661|467377540|FG002|Overall Study|Withdrawal by Subject|2|||
129839270|NCT00414661|467377541|FG003|Overall Study|Withdrawal by Subject|2|||
129899055|NCT00542386|467590166|FG004|Overall Study|Lack of Efficacy|7|||
129899056|NCT00542386|467590167|FG005|Overall Study|Lack of Efficacy|31|||
129899057|NCT00542386|467590162|FG000|Overall Study|Physician Decision|1|||
129899058|NCT00542386|467590163|FG001|Overall Study|Physician Decision|0|||
129899059|NCT00542386|467590164|FG002|Overall Study|Physician Decision|0|||
129899060|NCT00542386|467590165|FG003|Overall Study|Physician Decision|1|||
129899061|NCT00542386|467590166|FG004|Overall Study|Physician Decision|0|||
129899062|NCT00542386|467590167|FG005|Overall Study|Physician Decision|0|||
129899063|NCT00542386|467590162|FG000|Overall Study|Protocol Violation|0|||
129899064|NCT00542386|467590163|FG001|Overall Study|Protocol Violation|0|||
129899065|NCT00542386|467590164|FG002|Overall Study|Protocol Violation|1|||
129899066|NCT00542386|467590165|FG003|Overall Study|Protocol Violation|0|||
129899067|NCT00542386|467590166|FG004|Overall Study|Protocol Violation|0|||
129899068|NCT00542386|467590167|FG005|Overall Study|Protocol Violation|4|||
129899069|NCT00542386|467590162|FG000|Overall Study|Withdrawal by Subject|5|||
129899070|NCT00542386|467590163|FG001|Overall Study|Withdrawal by Subject|8|||
129899071|NCT00542386|467590164|FG002|Overall Study|Withdrawal by Subject|10|||
129899072|NCT00542386|467590165|FG003|Overall Study|Withdrawal by Subject|11|||
129899073|NCT00542386|467590166|FG004|Overall Study|Withdrawal by Subject|15|||
129899074|NCT00542386|467590167|FG005|Overall Study|Withdrawal by Subject|7|||
129839271|NCT00414661|467377538|FG000|Overall Study|Other|6|||
129839272|NCT00414661|467377539|FG001|Overall Study|Other|3|||
129839273|NCT00414661|467377540|FG002|Overall Study|Other|0|||
129839274|NCT00414661|467377541|FG003|Overall Study|Other|0|||
129839275|NCT00357370|467377542|FG000|Cohort 2|Lack of Efficacy|0|||
129839276|NCT00357370|467377543|FG001|Cohort 2|Lack of Efficacy|2|||
129839277|NCT00357370|467377544|FG002|Cohort 2|Lack of Efficacy|1|||
129839278|NCT00357370|467377542|FG000|Cohort 2|Adverse Event|1|||
129839279|NCT00357370|467377543|FG001|Cohort 2|Adverse Event|1|||
129839280|NCT00357370|467377544|FG002|Cohort 2|Adverse Event|1|||
129839281|NCT00357370|467377542|FG000|Cohort 2|Lost to Follow-up|0|||
129839282|NCT00357370|467377543|FG001|Cohort 2|Lost to Follow-up|1|||
129839283|NCT00357370|467377544|FG002|Cohort 2|Lost to Follow-up|0|||
129839284|NCT00357370|467377542|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
129839285|NCT00357370|467377543|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
129839286|NCT00357370|467377544|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
129839287|NCT00357370|467377542|FG000|Cohort 2|Withdrawal by Subject|0|||
129839288|NCT00357370|467377543|FG001|Cohort 2|Withdrawal by Subject|2|||
129839289|NCT00357370|467377544|FG002|Cohort 2|Withdrawal by Subject|0|||
129839290|NCT01143090|467377545|FG000|Overall Study|Lack of Efficacy|2|||
129839291|NCT01143090|467377545|FG000|Overall Study|Adverse Event|17|||
129839292|NCT01143090|467377545|FG000|Overall Study|Lost to Follow-up|9|||
129839293|NCT01143090|467377545|FG000|Overall Study|Protocol Violation|2|||
129839294|NCT01143090|467377545|FG000|Overall Study|Withdrawal by Subject|18|||
129839295|NCT01143090|467377545|FG000|Overall Study|Non-compliance with study drug|1|||
129839296|NCT01143090|467377545|FG000|Overall Study|Failure to meet eligibility criteria|1|||
129839297|NCT01143090|467377545|FG000|Overall Study|Administrative|1|||
129839298|NCT01232296|467377546|FG000|Overall Study|Adverse Event|24|||
129839299|NCT01232296|467377547|FG001|Overall Study|Adverse Event|12|||
129839300|NCT01232296|467377546|FG000|Overall Study|Physician Decision|1|||
129839301|NCT01232296|467377547|FG001|Overall Study|Physician Decision|1|||
129839302|NCT01232296|467377546|FG000|Overall Study|Progressive disease|43|||
129839303|NCT01232296|467377547|FG001|Overall Study|Progressive disease|61|||
129839304|NCT01232296|467377546|FG000|Overall Study|Study terminated by sponsor|0|||
129839305|NCT01232296|467377547|FG001|Overall Study|Study terminated by sponsor|1|||
129839306|NCT01232296|467377546|FG000|Overall Study|Technical problems|3|||
129839307|NCT01232296|467377547|FG001|Overall Study|Technical problems|0|||
129839308|NCT01232296|467377546|FG000|Overall Study|Subject/guardian decision|10|||
129839309|NCT01232296|467377547|FG001|Overall Study|Subject/guardian decision|2|||
129839310|NCT01232296|467377546|FG000|Overall Study|Death|1|||
129839311|NCT01232296|467377547|FG001|Overall Study|Death|6|||
129839312|NCT00727714|467377550|FG000|Overall Study|Lost to Follow-up|2|||
129839313|NCT00937547|467377551|FG000|Overall Study|misdiagnosis|1|||
129839314|NCT00937547|467377552|FG001|Overall Study|misdiagnosis|6|||
129839315|NCT00937547|467377553|FG002|Overall Study|misdiagnosis|7|||
129839316|NCT00325234|467377554|FG000|Overall Study|Adverse Event|10|||
129839317|NCT00325234|467377555|FG001|Overall Study|Adverse Event|7|||
129899075|NCT00542386|467590162|FG000|Overall Study|Other Reasons|4|||
129899076|NCT00542386|467590163|FG001|Overall Study|Other Reasons|1|||
129839318|NCT00325234|467377554|FG000|Overall Study|Death due to Study Disease|1|||
129839319|NCT00325234|467377555|FG001|Overall Study|Death due to Study Disease|0|||
129839320|NCT00325234|467377554|FG000|Overall Study|Entry Criteria Not Met|1|||
129839321|NCT00325234|467377555|FG001|Overall Study|Entry Criteria Not Met|2|||
129839322|NCT00325234|467377554|FG000|Overall Study|Subject Decision|6|||
129839323|NCT00325234|467377555|FG001|Overall Study|Subject Decision|8|||
129839324|NCT00325234|467377554|FG000|Overall Study|Physician Decision|17|||
129839325|NCT00325234|467377555|FG001|Overall Study|Physician Decision|12|||
129839326|NCT00325234|467377554|FG000|Overall Study|Progressive Disease|34|||
129899077|NCT00542386|467590164|FG002|Overall Study|Other Reasons|4|||
129839327|NCT00325234|467377555|FG001|Overall Study|Progressive Disease|37|||
129899078|NCT00542386|467590165|FG003|Overall Study|Other Reasons|3|||
129447762|NCT03044249|465939123|FG001|Overall Study|Adverse Event|9|||
129447763|NCT03044249|465939122|FG000|Overall Study|Lost to Follow-up|1|||
129447764|NCT03044249|465939123|FG001|Overall Study|Lost to Follow-up|0|||
129447765|NCT03044249|465939122|FG000|Overall Study|Non-compliance with Study Drug|1|||
129447766|NCT03044249|465939123|FG001|Overall Study|Non-compliance with Study Drug|0|||
129447767|NCT03044249|465939122|FG000|Overall Study|Study Terminated by Sponsor|2|||
129447768|NCT03044249|465939123|FG001|Overall Study|Study Terminated by Sponsor|0|||
129447769|NCT03044249|465939122|FG000|Overall Study|Withdrawal by Subject|2|||
129447770|NCT03044249|465939123|FG001|Overall Study|Withdrawal by Subject|5|||
129447771|NCT02101021|465939124|FG000|Overall Study|Death|4|||
129447772|NCT02101021|465939125|FG001|Overall Study|Death|3|||
129447773|NCT02101021|465939126|FG002|Overall Study|Death|6|||
129447774|NCT02101021|465939127|FG003|Overall Study|Death|0|||
129447775|NCT02101021|465939128|FG004|Overall Study|Death|3|||
129447776|NCT02101021|465939124|FG000|Overall Study|Withdrew Consent from study|1|||
129447777|NCT02101021|465939125|FG001|Overall Study|Withdrew Consent from study|1|||
129447778|NCT02101021|465939126|FG002|Overall Study|Withdrew Consent from study|0|||
129447779|NCT02101021|465939127|FG003|Overall Study|Withdrew Consent from study|2|||
129447780|NCT02101021|465939128|FG004|Overall Study|Withdrew Consent from study|0|||
129839328|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
129839329|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
129839330|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
129839331|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
129839332|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
129839333|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
129839334|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
129839335|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
129839336|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
129839337|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
129839338|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
129839339|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
129839340|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
129839341|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
129839342|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
129839343|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
129839344|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
129839345|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
129839346|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Death|0|||
129839347|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Death|0|||
129839348|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Death|1|||
129839349|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Death|0|||
129839350|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Death|0|||
129839351|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Death|0|||
129839352|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Death|0|||
129839353|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Death|0|||
129839354|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Death|0|||
129839355|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
129839356|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
129839357|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
129899079|NCT00542386|467590166|FG004|Overall Study|Other Reasons|4|||
129899080|NCT00542386|467590167|FG005|Overall Study|Other Reasons|2|||
129899081|NCT01549652|467590168|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
129447781|NCT02101021|465939124|FG000|Overall Study|Lost to Follow-up|1|||
129447782|NCT02101021|465939125|FG001|Overall Study|Lost to Follow-up|0|||
129447783|NCT02101021|465939126|FG002|Overall Study|Lost to Follow-up|0|||
129447784|NCT02101021|465939127|FG003|Overall Study|Lost to Follow-up|0|||
129447785|NCT02101021|465939128|FG004|Overall Study|Lost to Follow-up|0|||
129447786|NCT02101021|465939124|FG000|Overall Study|Study Terminated by Sponsor|1|||
129447787|NCT02101021|465939125|FG001|Overall Study|Study Terminated by Sponsor|0|||
129447788|NCT02101021|465939126|FG002|Overall Study|Study Terminated by Sponsor|1|||
129447789|NCT02101021|465939127|FG003|Overall Study|Study Terminated by Sponsor|1|||
129447790|NCT02101021|465939128|FG004|Overall Study|Study Terminated by Sponsor|1|||
129447791|NCT01621542|465939129|FG000|Overall Study|Adverse Event|0|||
129447792|NCT01621542|465939130|FG001|Overall Study|Adverse Event|0|||
129447793|NCT01621542|465939131|FG002|Overall Study|Adverse Event|1|||
129447794|NCT01621542|465939132|FG003|Overall Study|Adverse Event|3|||
129447795|NCT01621542|465939133|FG004|Overall Study|Adverse Event|0|||
129447796|NCT01621542|465939134|FG005|Overall Study|Adverse Event|0|||
129447797|NCT01621542|465939129|FG000|Overall Study|Death|0|||
129447798|NCT01621542|465939130|FG001|Overall Study|Death|1|||
129447799|NCT01621542|465939131|FG002|Overall Study|Death|0|||
129447800|NCT01621542|465939132|FG003|Overall Study|Death|0|||
129447801|NCT01621542|465939133|FG004|Overall Study|Death|0|||
129447802|NCT01621542|465939134|FG005|Overall Study|Death|0|||
129447803|NCT01621542|465939129|FG000|Overall Study|Physician Decision|1|||
129447804|NCT01621542|465939130|FG001|Overall Study|Physician Decision|0|||
129447805|NCT01621542|465939131|FG002|Overall Study|Physician Decision|1|||
129447806|NCT01621542|465939132|FG003|Overall Study|Physician Decision|13|||
129447807|NCT01621542|465939133|FG004|Overall Study|Physician Decision|3|||
129447808|NCT01621542|465939134|FG005|Overall Study|Physician Decision|1|||
129447809|NCT01621542|465939129|FG000|Overall Study|Withdrawal by Subject|2|||
129447810|NCT01621542|465939130|FG001|Overall Study|Withdrawal by Subject|0|||
129447811|NCT01621542|465939131|FG002|Overall Study|Withdrawal by Subject|1|||
129447812|NCT01621542|465939132|FG003|Overall Study|Withdrawal by Subject|3|||
129447813|NCT01621542|465939133|FG004|Overall Study|Withdrawal by Subject|3|||
129447814|NCT01621542|465939134|FG005|Overall Study|Withdrawal by Subject|3|||
129839358|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129447815|NCT01621542|465939129|FG000|Overall Study|progression/treatment failure|2|||
129839359|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839360|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839361|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129447816|NCT01621542|465939130|FG001|Overall Study|progression/treatment failure|4|||
129447817|NCT01621542|465939131|FG002|Overall Study|progression/treatment failure|3|||
129447818|NCT01621542|465939132|FG003|Overall Study|progression/treatment failure|7|||
129447819|NCT01621542|465939133|FG004|Overall Study|progression/treatment failure|3|||
129447820|NCT01621542|465939134|FG005|Overall Study|progression/treatment failure|5|||
129447821|NCT01621542|465939129|FG000|Overall Study|Protocol Violation|0|||
129447822|NCT01621542|465939130|FG001|Overall Study|Protocol Violation|0|||
129447823|NCT01621542|465939131|FG002|Overall Study|Protocol Violation|0|||
129447824|NCT01621542|465939132|FG003|Overall Study|Protocol Violation|1|||
129447825|NCT01621542|465939133|FG004|Overall Study|Protocol Violation|0|||
129447826|NCT01621542|465939134|FG005|Overall Study|Protocol Violation|0|||
129447827|NCT01621542|465939129|FG000|Overall Study|study stopped by sponsor|0|||
129447828|NCT01621542|465939130|FG001|Overall Study|study stopped by sponsor|0|||
129447829|NCT01621542|465939131|FG002|Overall Study|study stopped by sponsor|0|||
129447830|NCT01621542|465939132|FG003|Overall Study|study stopped by sponsor|1|||
129447831|NCT01621542|465939133|FG004|Overall Study|study stopped by sponsor|0|||
129447832|NCT01621542|465939134|FG005|Overall Study|study stopped by sponsor|0|||
129447833|NCT01368042|465939135|FG000|Overall Study|Death|14|||
129447834|NCT01368042|465939135|FG000|Overall Study|Protocol Violation|11|||
129447835|NCT01368042|465939135|FG000|Overall Study|Lost to Follow-up|4|||
129447836|NCT01368042|465939135|FG000|Overall Study|Transplanted|1|||
129447837|NCT00955279|465939136|FG000|Overall Study|Other|0|||
129447838|NCT00955279|465939137|FG001|Overall Study|Other|0|||
129447839|NCT00955279|465939138|FG002|Overall Study|Other|3|||
129447840|NCT00955279|465939136|FG000|Overall Study|Death|1|||
129447841|NCT00955279|465939137|FG001|Overall Study|Death|1|||
129447842|NCT00955279|465939138|FG002|Overall Study|Death|1|||
129447843|NCT00955279|465939136|FG000|Overall Study|Lost to Follow-up|0|||
129447844|NCT00955279|465939137|FG001|Overall Study|Lost to Follow-up|3|||
129447845|NCT00955279|465939138|FG002|Overall Study|Lost to Follow-up|1|||
129839362|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839363|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
129839364|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
129839365|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
129839366|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
129839367|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839368|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839369|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839370|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839371|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839372|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
129839373|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
129839374|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
129839375|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
129839376|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
129839377|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
129839378|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
129839379|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
129839380|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
129839381|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
129839382|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
129839383|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
129839384|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
129839385|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
129839386|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
129839387|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
129839388|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
129839389|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
129839390|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
129839391|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
129839392|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
129839393|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
129839394|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129899082|NCT01549652|467590169|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
129899083|NCT01549652|467590170|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
129899084|NCT01549652|467590171|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
129899085|NCT01549652|467590168|FG000|Overall Study|Study Drug Titration Failure|5|||
129899086|NCT01549652|467590169|FG001|Overall Study|Study Drug Titration Failure|6|||
129899087|NCT01549652|467590170|FG002|Overall Study|Study Drug Titration Failure|0|||
129899088|NCT01549652|467590171|FG003|Overall Study|Study Drug Titration Failure|0|||
129839395|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129447846|NCT00955279|465939136|FG000|Overall Study|Withdrawal by Subject|2|||
129447847|NCT00955279|465939137|FG001|Overall Study|Withdrawal by Subject|0|||
129447848|NCT00955279|465939138|FG002|Overall Study|Withdrawal by Subject|3|||
129447849|NCT02632721|465939140|FG000|Overall Study|Adverse Event|0|||
129447850|NCT02632721|465939141|FG001|Overall Study|Adverse Event|0|||
129447851|NCT02632721|465939142|FG002|Overall Study|Adverse Event|2|||
129447852|NCT02632721|465939143|FG003|Overall Study|Adverse Event|5|||
129839396|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839397|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839398|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839399|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
129839400|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839401|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
129839402|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839403|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839404|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839405|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839406|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129899089|NCT01549652|467590168|FG000|Overall Study|Withdrawal Effect|0|||
129899090|NCT01549652|467590169|FG001|Overall Study|Withdrawal Effect|2|||
129899091|NCT01549652|467590170|FG002|Overall Study|Withdrawal Effect|0|||
129839407|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839408|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
129839409|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
129839410|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
129839411|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
129839412|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
129839413|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
129839414|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
129839415|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
129839416|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
129839417|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
129839418|NCT00404352|467377556|FG000|Double Blind (up to 24 Month)|Other|0|||
129839419|NCT00404352|467377557|FG001|Double Blind (up to 24 Month)|Other|1|||
129839420|NCT00404352|467377558|FG002|Double Blind (up to 24 Month)|Other|0|||
129839421|NCT00404352|467377559|FG003|Double Blind (up to 24 Month)|Other|0|||
129839422|NCT00404352|467377560|FG004|Double Blind (up to 24 Month)|Other|0|||
129839423|NCT00404352|467377561|FG005|Double Blind (up to 24 Month)|Other|0|||
129839424|NCT00404352|467377562|FG006|Double Blind (up to 24 Month)|Other|0|||
129839425|NCT00404352|467377563|FG007|Double Blind (up to 24 Month)|Other|0|||
129839426|NCT00404352|467377564|FG008|Double Blind (up to 24 Month)|Other|0|||
129839427|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
129839428|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
129839429|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
129839430|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
129839431|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
129839432|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
129839433|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
129839434|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
129839435|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
129839436|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
129839437|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
129839438|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
129839439|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
129839440|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
129839441|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
129839442|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
129839443|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
129839444|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
129839445|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839446|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839447|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839448|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839449|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
129839450|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839451|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839452|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839453|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
129839454|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839455|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839456|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839457|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839458|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839459|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
129839460|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839461|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839462|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
129839463|NCT00404352|467377556|FG000|Open Label (up to 24 Month)|Disease progression|0|||
129839464|NCT00404352|467377557|FG001|Open Label (up to 24 Month)|Disease progression|0|||
129839465|NCT00404352|467377558|FG002|Open Label (up to 24 Month)|Disease progression|0|||
129839466|NCT00404352|467377559|FG003|Open Label (up to 24 Month)|Disease progression|1|||
129839467|NCT00404352|467377560|FG004|Open Label (up to 24 Month)|Disease progression|0|||
129839468|NCT00404352|467377561|FG005|Open Label (up to 24 Month)|Disease progression|0|||
129839469|NCT00404352|467377562|FG006|Open Label (up to 24 Month)|Disease progression|0|||
129839470|NCT00404352|467377563|FG007|Open Label (up to 24 Month)|Disease progression|0|||
129839471|NCT00404352|467377564|FG008|Open Label (up to 24 Month)|Disease progression|0|||
129839472|NCT00404352|467377556|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839473|NCT00404352|467377557|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839474|NCT00404352|467377558|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839475|NCT00404352|467377559|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839476|NCT00404352|467377560|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839477|NCT00404352|467377561|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839478|NCT00404352|467377562|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
129839479|NCT00404352|467377563|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
129839480|NCT00404352|467377564|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
129839481|NCT00404352|467377556|FG000|Open Label Extension (up to 36 Months)|Other|0|||
129839482|NCT00404352|467377557|FG001|Open Label Extension (up to 36 Months)|Other|0|||
129839483|NCT00404352|467377558|FG002|Open Label Extension (up to 36 Months)|Other|0|||
129839484|NCT00404352|467377559|FG003|Open Label Extension (up to 36 Months)|Other|0|||
129839485|NCT00404352|467377560|FG004|Open Label Extension (up to 36 Months)|Other|0|||
129839486|NCT00404352|467377561|FG005|Open Label Extension (up to 36 Months)|Other|0|||
129839487|NCT00404352|467377562|FG006|Open Label Extension (up to 36 Months)|Other|0|||
129839488|NCT00404352|467377563|FG007|Open Label Extension (up to 36 Months)|Other|0|||
129839489|NCT00404352|467377564|FG008|Open Label Extension (up to 36 Months)|Other|2|||
129839490|NCT04370691|467377565|FG000|Overall Study|Pending visit|48|||
129839491|NCT04370691|467377565|FG000|Overall Study|Have Not Reached Lower Window|15|||
129839492|NCT04370691|467377565|FG000|Overall Study|Termination|14|||
129839493|NCT04370691|467377565|FG000|Overall Study|Missed or Overdue|10|||
129839494|NCT00486265|467377566|FG000|Overall Study|Adverse Event|1|||
129839495|NCT00486265|467377566|FG000|Overall Study|Lack of Efficacy|8|||
129839496|NCT04225923|467377570|FG000|Overall Study|Protocol Violation|1|||
129839497|NCT04225923|467377571|FG001|Overall Study|Protocol Violation|0|||
129839498|NCT04225923|467377572|FG002|Overall Study|Protocol Violation|1|||
129839499|NCT04225923|467377570|FG000|Overall Study|Withdrawal by Subject|4|||
129839500|NCT04225923|467377571|FG001|Overall Study|Withdrawal by Subject|1|||
129839501|NCT04225923|467377572|FG002|Overall Study|Withdrawal by Subject|3|||
129839502|NCT04225923|467377570|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
129839503|NCT04225923|467377571|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
129839504|NCT04225923|467377572|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
129839505|NCT00855309|467377573|FG000|Overall Study|patient never recieved drug|1|||
129839506|NCT00855309|467377574|FG001|Overall Study|patient never recieved drug|0|||
129447853|NCT02632721|465939144|FG004|Overall Study|Adverse Event|3|||
129447854|NCT02632721|465939140|FG000|Overall Study|Dose limiting toxicity|0|||
129447855|NCT02632721|465939141|FG001|Overall Study|Dose limiting toxicity|0|||
129447856|NCT02632721|465939142|FG002|Overall Study|Dose limiting toxicity|0|||
129447857|NCT02632721|465939143|FG003|Overall Study|Dose limiting toxicity|1|||
129447858|NCT02632721|465939144|FG004|Overall Study|Dose limiting toxicity|0|||
129447859|NCT02632721|465939140|FG000|Overall Study|Progressive disease|3|||
129447860|NCT02632721|465939141|FG001|Overall Study|Progressive disease|0|||
129839507|NCT01417481|467377575|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129839508|NCT01417481|467377576|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
129839509|NCT00829296|467377577|FG000|Overall Study|Adverse Event|5|||
129839510|NCT00829296|467377578|FG001|Overall Study|Adverse Event|4|||
129839511|NCT03029624|467377579|FG000|Overall Study|Adverse Event|1|||
129839512|NCT03029624|467377579|FG000|Overall Study|Withdrawal by Subject|1|||
129839513|NCT03029624|467377579|FG000|Overall Study|Lack of Efficacy|1|||
129839514|NCT03029624|467377579|FG000|Overall Study|MRI need|2|||
129839515|NCT01077960|467377583|FG000|Overall Study|Adverse Event|6|||
129839516|NCT01077960|467377583|FG000|Overall Study|Protocol Violation|3|||
129839517|NCT01077960|467377583|FG000|Overall Study|Lost to Follow-up|5|||
129839518|NCT01077960|467377583|FG000|Overall Study|Subject decision|1|||
129839519|NCT01077960|467377583|FG000|Overall Study|Reason unspecified|1|||
129839520|NCT03837899|467377584|FG000|Overall Study|Death|6|||
129839521|NCT03837899|467377585|FG001|Overall Study|Death|8|||
129839522|NCT03837899|467377586|FG002|Overall Study|Death|3|||
129839523|NCT03837899|467377587|FG003|Overall Study|Death|7|||
129839524|NCT03837899|467377588|FG004|Overall Study|Death|8|||
129839525|NCT03837899|467377589|FG005|Overall Study|Death|7|||
129839526|NCT03837899|467377584|FG000|Overall Study|Moved to post-trial access program|0|||
129839527|NCT03837899|467377585|FG001|Overall Study|Moved to post-trial access program|1|||
129839528|NCT03837899|467377586|FG002|Overall Study|Moved to post-trial access program|0|||
129839529|NCT03837899|467377587|FG003|Overall Study|Moved to post-trial access program|0|||
129839530|NCT03837899|467377588|FG004|Overall Study|Moved to post-trial access program|0|||
129839531|NCT03837899|467377589|FG005|Overall Study|Moved to post-trial access program|0|||
129839532|NCT03837899|467377584|FG000|Overall Study|Other|0|||
129839533|NCT03837899|467377585|FG001|Overall Study|Other|0|||
129839534|NCT03837899|467377586|FG002|Overall Study|Other|0|||
129839535|NCT03837899|467377587|FG003|Overall Study|Other|0|||
129839536|NCT03837899|467377588|FG004|Overall Study|Other|0|||
129839537|NCT03837899|467377589|FG005|Overall Study|Other|2|||
129839538|NCT03837899|467377584|FG000|Overall Study|Lost to Follow-up|0|||
129839539|NCT03837899|467377585|FG001|Overall Study|Lost to Follow-up|1|||
129839540|NCT03837899|467377586|FG002|Overall Study|Lost to Follow-up|0|||
129839541|NCT03837899|467377587|FG003|Overall Study|Lost to Follow-up|0|||
129839542|NCT03837899|467377588|FG004|Overall Study|Lost to Follow-up|0|||
129839543|NCT03837899|467377589|FG005|Overall Study|Lost to Follow-up|0|||
129839544|NCT03837899|467377584|FG000|Overall Study|Withdrawal by Subject|0|||
129839545|NCT03837899|467377585|FG001|Overall Study|Withdrawal by Subject|0|||
129839546|NCT03837899|467377586|FG002|Overall Study|Withdrawal by Subject|0|||
129839547|NCT03837899|467377587|FG003|Overall Study|Withdrawal by Subject|1|||
129839548|NCT03837899|467377588|FG004|Overall Study|Withdrawal by Subject|0|||
129839549|NCT03837899|467377589|FG005|Overall Study|Withdrawal by Subject|0|||
129839550|NCT03837899|467377584|FG000|Overall Study|Study specific discontinuation criteria|0|||
129839551|NCT03837899|467377585|FG001|Overall Study|Study specific discontinuation criteria|1|||
129839552|NCT03837899|467377586|FG002|Overall Study|Study specific discontinuation criteria|0|||
129839553|NCT03837899|467377587|FG003|Overall Study|Study specific discontinuation criteria|0|||
129839554|NCT03837899|467377588|FG004|Overall Study|Study specific discontinuation criteria|3|||
129839555|NCT03837899|467377589|FG005|Overall Study|Study specific discontinuation criteria|1|||
129839556|NCT01371656|467377590|FG000|Overall Study|Death|7|||
129839557|NCT01371656|467377591|FG001|Overall Study|Death|4|||
129839558|NCT01371656|467377590|FG000|Overall Study|Physician Decision|46|||
129839559|NCT01371656|467377591|FG001|Overall Study|Physician Decision|7|||
129839560|NCT01371656|467377590|FG000|Overall Study|Withdrawal by Subject|7|||
129839561|NCT01371656|467377591|FG001|Overall Study|Withdrawal by Subject|0|||
129839562|NCT01371656|467377590|FG000|Overall Study|Ineligible|4|||
129839563|NCT01371656|467377591|FG001|Overall Study|Ineligible|3|||
129839564|NCT01465464|467377592|FG000|Overall Study|Adverse Event|96|||
129839565|NCT01465464|467377593|FG001|Overall Study|Adverse Event|49|||
129839566|NCT01465464|467377592|FG000|Overall Study|Lack of Efficacy|139|||
129839567|NCT01465464|467377593|FG001|Overall Study|Lack of Efficacy|190|||
129839568|NCT01465464|467377592|FG000|Overall Study|Physician Decision|13|||
129839569|NCT01465464|467377593|FG001|Overall Study|Physician Decision|5|||
129447861|NCT02632721|465939142|FG002|Overall Study|Progressive disease|4|||
129447862|NCT02632721|465939143|FG003|Overall Study|Progressive disease|6|||
129447863|NCT02632721|465939144|FG004|Overall Study|Progressive disease|5|||
129839570|NCT01465464|467377592|FG000|Overall Study|Protocol Violation|1|||
129839571|NCT01465464|467377593|FG001|Overall Study|Protocol Violation|1|||
129839572|NCT01465464|467377592|FG000|Overall Study|Withdrawal by Subject|46|||
129839573|NCT01465464|467377593|FG001|Overall Study|Withdrawal by Subject|30|||
129899092|NCT01549652|467590171|FG003|Overall Study|Withdrawal Effect|0|||
129899093|NCT01549652|467590168|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
129447864|NCT02632721|465939140|FG000|Overall Study|Refused to continue taking trial medication|0|||
129447865|NCT02632721|465939141|FG001|Overall Study|Refused to continue taking trial medication|1|||
129447866|NCT02632721|465939142|FG002|Overall Study|Refused to continue taking trial medication|1|||
129447867|NCT02632721|465939143|FG003|Overall Study|Refused to continue taking trial medication|1|||
129447868|NCT02632721|465939144|FG004|Overall Study|Refused to continue taking trial medication|2|||
129447869|NCT02632721|465939140|FG000|Overall Study|Inadequate clinical condition|0|||
129447870|NCT02632721|465939141|FG001|Overall Study|Inadequate clinical condition|0|||
129447871|NCT02632721|465939142|FG002|Overall Study|Inadequate clinical condition|0|||
129447872|NCT02632721|465939143|FG003|Overall Study|Inadequate clinical condition|0|||
129447873|NCT02632721|465939144|FG004|Overall Study|Inadequate clinical condition|1|||
129447874|NCT02632721|465939140|FG000|Overall Study|No meet eligibility|0|||
129447875|NCT02632721|465939141|FG001|Overall Study|No meet eligibility|0|||
129447876|NCT02632721|465939142|FG002|Overall Study|No meet eligibility|0|||
129447877|NCT02632721|465939143|FG003|Overall Study|No meet eligibility|0|||
129447878|NCT02632721|465939144|FG004|Overall Study|No meet eligibility|1|||
129447879|NCT02632721|465939140|FG000|Overall Study|Allergic reaction|0|||
129447880|NCT02632721|465939141|FG001|Overall Study|Allergic reaction|0|||
129447881|NCT02632721|465939142|FG002|Overall Study|Allergic reaction|0|||
129447882|NCT02632721|465939143|FG003|Overall Study|Allergic reaction|1|||
129447883|NCT02632721|465939144|FG004|Overall Study|Allergic reaction|0|||
129447884|NCT02632721|465939140|FG000|Overall Study|Receiving Decitabine locally|0|||
129447885|NCT02632721|465939141|FG001|Overall Study|Receiving Decitabine locally|0|||
129447886|NCT02632721|465939142|FG002|Overall Study|Receiving Decitabine locally|1|||
129447887|NCT02632721|465939143|FG003|Overall Study|Receiving Decitabine locally|0|||
129447888|NCT02632721|465939144|FG004|Overall Study|Receiving Decitabine locally|0|||
129447889|NCT02632721|465939140|FG000|Overall Study|No benefit from study treatment|1|||
129447890|NCT02632721|465939141|FG001|Overall Study|No benefit from study treatment|1|||
129447891|NCT02632721|465939142|FG002|Overall Study|No benefit from study treatment|0|||
129447892|NCT02632721|465939143|FG003|Overall Study|No benefit from study treatment|0|||
129447893|NCT02632721|465939144|FG004|Overall Study|No benefit from study treatment|1|||
129447894|NCT02632721|465939140|FG000|Overall Study|Patient wish for other treatment|0|||
129447895|NCT02632721|465939141|FG001|Overall Study|Patient wish for other treatment|1|||
129839574|NCT01465464|467377592|FG000|Overall Study|Other|9|||
129839575|NCT01465464|467377593|FG001|Overall Study|Other|3|||
129839576|NCT01465464|467377592|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
129839577|NCT01465464|467377593|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
129899094|NCT01549652|467590169|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
129839578|NCT01554618|467377594|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
129839579|NCT01554618|467377595|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
129839580|NCT01554618|467377594|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
129839581|NCT01554618|467377595|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
129839582|NCT01554618|467377594|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
129839583|NCT01554618|467377595|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
129839584|NCT01554618|467377594|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
129839585|NCT01554618|467377595|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
129839586|NCT01554618|467377594|FG000|Open-Label Extension Period|Physician Decision|0|||
129839587|NCT01554618|467377595|FG001|Open-Label Extension Period|Physician Decision|1|||
129839588|NCT01554618|467377594|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
129839589|NCT01554618|467377595|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
129839590|NCT02244580|467377597|FG000|Overall Study|No cancer tissues available|241|||
129839591|NCT04011410|467377598|FG000|Overall Study|Withdrawal by Subject|1|||
129839592|NCT00291668|467377604|FG000|Overall Study|Lack of Efficacy|1|||
129839593|NCT00291668|467377605|FG001|Overall Study|Lack of Efficacy|0|||
129839594|NCT00291668|467377606|FG002|Overall Study|Lack of Efficacy|0|||
129839595|NCT00291668|467377604|FG000|Overall Study|SAE, non-fatal|1|||
129839596|NCT00291668|467377605|FG001|Overall Study|SAE, non-fatal|1|||
129839597|NCT00291668|467377606|FG002|Overall Study|SAE, non-fatal|1|||
129839598|NCT00291668|467377604|FG000|Overall Study|AE, non-serious non-fatal|1|||
129839599|NCT00291668|467377605|FG001|Overall Study|AE, non-serious non-fatal|0|||
129839600|NCT00291668|467377606|FG002|Overall Study|AE, non-serious non-fatal|0|||
129839601|NCT00291668|467377604|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
129839602|NCT00291668|467377605|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129839603|NCT00291668|467377606|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
129447896|NCT02632721|465939142|FG002|Overall Study|Patient wish for other treatment|0|||
129447897|NCT02632721|465939143|FG003|Overall Study|Patient wish for other treatment|0|||
129839604|NCT00313612|467377609|FG000|Overall Study|Patient never received treatment|0|||
129839605|NCT00313612|467377610|FG001|Overall Study|Patient never received treatment|1|||
129839606|NCT00451035|467377611|FG000|Overall Study|Disease progression|11|||
129447898|NCT02632721|465939144|FG004|Overall Study|Patient wish for other treatment|0|||
129447899|NCT02632721|465939140|FG000|Overall Study|Relapsed Pneumonia|0|||
129899095|NCT01549652|467590170|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
129899096|NCT01549652|467590171|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
129899097|NCT01549652|467590168|FG000|Overall Study|Problem with Infusion|1|||
129899098|NCT01549652|467590169|FG001|Overall Study|Problem with Infusion|0|||
129899099|NCT01549652|467590170|FG002|Overall Study|Problem with Infusion|0|||
129899100|NCT01549652|467590171|FG003|Overall Study|Problem with Infusion|0|||
129899101|NCT01549652|467590168|FG000|Overall Study|Titration Non-Compliance|1|||
129899102|NCT01549652|467590169|FG001|Overall Study|Titration Non-Compliance|3|||
129899103|NCT01549652|467590170|FG002|Overall Study|Titration Non-Compliance|4|||
129899104|NCT01549652|467590171|FG003|Overall Study|Titration Non-Compliance|5|||
129899105|NCT01549652|467590168|FG000|Overall Study|Titration Side Effects|0|||
129899106|NCT01549652|467590169|FG001|Overall Study|Titration Side Effects|0|||
129899107|NCT01549652|467590170|FG002|Overall Study|Titration Side Effects|6|||
129899108|NCT01549652|467590171|FG003|Overall Study|Titration Side Effects|3|||
129899109|NCT01549652|467590168|FG000|Overall Study|Withdrawal by Subject|0|||
129899110|NCT01549652|467590169|FG001|Overall Study|Withdrawal by Subject|0|||
129899111|NCT01549652|467590170|FG002|Overall Study|Withdrawal by Subject|5|||
129899112|NCT01549652|467590171|FG003|Overall Study|Withdrawal by Subject|3|||
129899113|NCT00988637|467590183|FG000|Overall Study|Lost to Follow-up|2|||
129899114|NCT00988637|467590184|FG001|Overall Study|Lost to Follow-up|1|||
129899115|NCT00988637|467590183|FG000|Overall Study|Withdrawal by Subject|1|||
129899116|NCT00988637|467590184|FG001|Overall Study|Withdrawal by Subject|1|||
129899117|NCT00988637|467590183|FG000|Overall Study|non-compliance with study drug|0|||
129899118|NCT00988637|467590184|FG001|Overall Study|non-compliance with study drug|1|||
129899119|NCT03593070|467590185|FG000|Overall Study|administrative withdrawal|1|||
129899120|NCT03593070|467590186|FG001|Overall Study|administrative withdrawal|1|||
129899121|NCT01582945|467590187|FG000|Overall Study|Intolerable side-effects|1|||
129899122|NCT01582945|467590187|FG000|Overall Study|Scheduling conflicts|1|||
129899123|NCT02197234|467590188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
129899124|NCT02197234|467590188|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
129899125|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
129899126|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
129899127|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
129899128|NCT02197234|467590188|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
129839607|NCT00451035|467377611|FG000|Overall Study|Death|3|||
129839608|NCT00451035|467377611|FG000|Overall Study|New anti-neoplastic therapy|3|||
129839609|NCT01393405|467377614|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
129839610|NCT01393405|467377615|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
129839611|NCT01393405|467377616|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
129839612|NCT01393405|467377614|FG000|Induction Period (week1-16)|Adverse Event|16|||
129839613|NCT01393405|467377615|FG001|Induction Period (week1-16)|Adverse Event|0|||
129839614|NCT01393405|467377616|FG002|Induction Period (week1-16)|Adverse Event|0|||
129899129|NCT01543685|467590189|FG000|Overall Study|Lack of Efficacy|1|||
129899130|NCT01543685|467590190|FG001|Overall Study|Lack of Efficacy|2|||
129899131|NCT01543685|467590191|FG002|Overall Study|Lack of Efficacy|2|||
129839615|NCT01393405|467377614|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
129839616|NCT01393405|467377615|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
129839617|NCT01393405|467377616|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
129839618|NCT01393405|467377614|FG000|Maintenance Period Week|Lack of Efficacy|0|||
129839619|NCT01393405|467377615|FG001|Maintenance Period Week|Lack of Efficacy|22|||
129839620|NCT01393405|467377616|FG002|Maintenance Period Week|Lack of Efficacy|22|||
129839621|NCT01393405|467377614|FG000|Maintenance Period Week|Adverse Event|0|||
129839622|NCT01393405|467377615|FG001|Maintenance Period Week|Adverse Event|5|||
129839623|NCT01393405|467377616|FG002|Maintenance Period Week|Adverse Event|2|||
129839624|NCT01393405|467377614|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
129447900|NCT02632721|465939141|FG001|Overall Study|Relapsed Pneumonia|0|||
129839625|NCT01393405|467377615|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
129899132|NCT01543685|467590192|FG003|Overall Study|Lack of Efficacy|0|||
129899133|NCT01543685|467590193|FG004|Overall Study|Lack of Efficacy|2|||
129899134|NCT01543685|467590189|FG000|Overall Study|Adverse Event|2|||
129447901|NCT02632721|465939142|FG002|Overall Study|Relapsed Pneumonia|0|||
129839626|NCT01393405|467377616|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
129839627|NCT01393405|467377614|FG000|Maintenance Period Week|Lost to Follow-up|0|||
129899135|NCT01543685|467590190|FG001|Overall Study|Adverse Event|1|||
129899136|NCT01543685|467590191|FG002|Overall Study|Adverse Event|0|||
129447902|NCT02632721|465939143|FG003|Overall Study|Relapsed Pneumonia|0|||
129839628|NCT01393405|467377615|FG001|Maintenance Period Week|Lost to Follow-up|1|||
129839629|NCT01393405|467377616|FG002|Maintenance Period Week|Lost to Follow-up|0|||
129839630|NCT03350503|467377620|FG000|Overall Study|Adverse Event|5|||
129899137|NCT01543685|467590192|FG003|Overall Study|Adverse Event|0|||
129899138|NCT01543685|467590193|FG004|Overall Study|Adverse Event|2|||
129899139|NCT02163915|467590194|FG000|Overall Study|Withdrawal by Subject|2|||
129899140|NCT02163915|467590195|FG001|Overall Study|Withdrawal by Subject|0|||
129899141|NCT02163915|467590196|FG002|Overall Study|Withdrawal by Subject|2|||
129839631|NCT03350503|467377620|FG000|Overall Study|Withdrawal by Subject|5|||
129839632|NCT03350503|467377620|FG000|Overall Study|Continuation impossible due to move|4|||
129839633|NCT03350503|467377620|FG000|Overall Study|Physician Decision|3|||
129839634|NCT04536727|467377621|FG000|Overall Study|Lost to Follow-up|1|||
129839635|NCT04536727|467377622|FG001|Overall Study|Lost to Follow-up|1|||
129839636|NCT04536727|467377621|FG000|Overall Study|Death|0|||
129839637|NCT04536727|467377622|FG001|Overall Study|Death|1|||
129839638|NCT01399593|467377623|FG000|Overall Study|Physician Decision|1|||
129839639|NCT01399593|467377624|FG001|Overall Study|Physician Decision|0|||
129839640|NCT01399593|467377623|FG000|Overall Study|Adverse Event|1|||
129839641|NCT01399593|467377624|FG001|Overall Study|Adverse Event|0|||
129839642|NCT01399593|467377623|FG000|Overall Study|Death|1|||
129839643|NCT01399593|467377624|FG001|Overall Study|Death|1|||
129839644|NCT01399593|467377623|FG000|Overall Study|Transplantectomy|0|||
129839645|NCT01399593|467377624|FG001|Overall Study|Transplantectomy|1|||
129839646|NCT05627518|467377625|FG000|Treatment Period 1|Adverse Event|0|||
129839647|NCT05627518|467377626|FG001|Treatment Period 1|Adverse Event|0|||
129839648|NCT05627518|467377627|FG002|Treatment Period 1|Adverse Event|1|||
129839649|NCT05627518|467377628|FG003|Treatment Period 1|Adverse Event|0|||
129839650|NCT05627518|467377629|FG004|Treatment Period 1|Adverse Event|0|||
129839651|NCT05627518|467377630|FG005|Treatment Period 1|Adverse Event|0|||
129839652|NCT05627518|467377631|FG006|Treatment Period 1|Adverse Event|0|||
129839653|NCT05627518|467377632|FG007|Treatment Period 1|Adverse Event|1|||
129839654|NCT05627518|467377625|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129839655|NCT05627518|467377626|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129839656|NCT05627518|467377627|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129839657|NCT05627518|467377628|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129839658|NCT05627518|467377629|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129839659|NCT05627518|467377630|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129839660|NCT05627518|467377631|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129839661|NCT05627518|467377632|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129839662|NCT05627518|467377625|FG000|Treatment Period 1|Protocol Violation|0|||
129839663|NCT05627518|467377626|FG001|Treatment Period 1|Protocol Violation|0|||
129839664|NCT05627518|467377627|FG002|Treatment Period 1|Protocol Violation|0|||
129839665|NCT05627518|467377628|FG003|Treatment Period 1|Protocol Violation|0|||
129839666|NCT05627518|467377629|FG004|Treatment Period 1|Protocol Violation|0|||
129839667|NCT05627518|467377630|FG005|Treatment Period 1|Protocol Violation|0|||
129839668|NCT05627518|467377631|FG006|Treatment Period 1|Protocol Violation|6|||
129839669|NCT05627518|467377632|FG007|Treatment Period 1|Protocol Violation|6|||
129839670|NCT05627518|467377625|FG000|Treatment Period 2|Adverse Event|1|||
129839671|NCT05627518|467377626|FG001|Treatment Period 2|Adverse Event|0|||
129839672|NCT05627518|467377627|FG002|Treatment Period 2|Adverse Event|0|||
129839673|NCT05627518|467377628|FG003|Treatment Period 2|Adverse Event|0|||
129839674|NCT05627518|467377629|FG004|Treatment Period 2|Adverse Event|0|||
129839675|NCT05627518|467377630|FG005|Treatment Period 2|Adverse Event|0|||
129839676|NCT05627518|467377631|FG006|Treatment Period 2|Adverse Event|0|||
129839677|NCT05627518|467377632|FG007|Treatment Period 2|Adverse Event|0|||
129839678|NCT05627518|467377625|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129839679|NCT05627518|467377626|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129839680|NCT05627518|467377627|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129839681|NCT05627518|467377628|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129839682|NCT05627518|467377629|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129839683|NCT05627518|467377630|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129839684|NCT05627518|467377631|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129899142|NCT02163915|467590197|FG003|Overall Study|Withdrawal by Subject|2|||
129899143|NCT02163915|467590198|FG004|Overall Study|Withdrawal by Subject|2|||
129899144|NCT02163915|467590194|FG000|Overall Study|Study termination|1|||
129899145|NCT02163915|467590195|FG001|Overall Study|Study termination|0|||
129899146|NCT02163915|467590196|FG002|Overall Study|Study termination|0|||
129899147|NCT02163915|467590197|FG003|Overall Study|Study termination|0|||
129899148|NCT02163915|467590198|FG004|Overall Study|Study termination|2|||
129899149|NCT02163915|467590194|FG000|Overall Study|Physician Decision|0|||
129899150|NCT02163915|467590195|FG001|Overall Study|Physician Decision|0|||
129899151|NCT02163915|467590196|FG002|Overall Study|Physician Decision|0|||
129899152|NCT02163915|467590197|FG003|Overall Study|Physician Decision|1|||
129899153|NCT02163915|467590198|FG004|Overall Study|Physician Decision|0|||
129447903|NCT02632721|465939144|FG004|Overall Study|Relapsed Pneumonia|1|||
129447904|NCT02632721|465939140|FG000|Overall Study|Therapy refractory AML|0|||
129839685|NCT05627518|467377632|FG007|Treatment Period 2|Withdrawal by Subject|0|||
129839686|NCT00403273|467379006|FG000|Overall Study|Lost to Follow-up|3|||
129839687|NCT00403273|467379007|FG001|Overall Study|Lost to Follow-up|2|||
129839688|NCT00403273|467379006|FG000|Overall Study|Physician Decision|0|||
129839689|NCT00403273|467379007|FG001|Overall Study|Physician Decision|1|||
129839690|NCT00403273|467379006|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
129839691|NCT00403273|467379007|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
129839692|NCT00574405|467379009|FG000|Overall Study|Withdrawal by Subject|3|||
129839693|NCT00574405|467379010|FG001|Overall Study|Withdrawal by Subject|2|||
129839694|NCT01332149|467379012|FG000|Overall Study|Adverse Event|11|||
129839695|NCT01332149|467379013|FG001|Overall Study|Adverse Event|9|||
129839696|NCT01332149|467379012|FG000|Overall Study|Other unspecified|5|||
129839697|NCT01332149|467379013|FG001|Overall Study|Other unspecified|7|||
129839698|NCT01332149|467379012|FG000|Overall Study|Protocol Violation|1|||
129839699|NCT01332149|467379013|FG001|Overall Study|Protocol Violation|3|||
129839700|NCT01332149|467379012|FG000|Overall Study|Withdrawal by Subject|4|||
129839701|NCT01332149|467379013|FG001|Overall Study|Withdrawal by Subject|5|||
129839702|NCT01332149|467379012|FG000|Overall Study|Lost to Follow-up|1|||
129839703|NCT01332149|467379013|FG001|Overall Study|Lost to Follow-up|1|||
129839704|NCT01332149|467379012|FG000|Overall Study|Insufficient clinical response|4|||
129839705|NCT01332149|467379013|FG001|Overall Study|Insufficient clinical response|7|||
129839706|NCT01332149|467379012|FG000|Overall Study|Did not meet entrance criteria|3|||
129839707|NCT01332149|467379013|FG001|Overall Study|Did not meet entrance criteria|4|||
129839708|NCT01332149|467379012|FG000|Overall Study|Randomized but not treated|1|||
129839709|NCT01332149|467379013|FG001|Overall Study|Randomized but not treated|2|||
129839710|NCT02565381|467379014|FG000|Overall Study|Lost to Follow-up|1|||
129839711|NCT02565381|467379015|FG001|Overall Study|Lost to Follow-up|0|||
129839712|NCT02565381|467379016|FG002|Overall Study|Lost to Follow-up|1|||
129839713|NCT04615949|467379019|FG000|Overall Study|Withdrawal by Subject|2|||
129839714|NCT04615949|467379020|FG001|Overall Study|Withdrawal by Subject|4|||
129839715|NCT04615949|467379019|FG000|Overall Study|Lost to Follow-up|2|||
129839716|NCT04615949|467379020|FG001|Overall Study|Lost to Follow-up|2|||
129839717|NCT04615949|467379019|FG000|Overall Study|Death|0|||
129839718|NCT04615949|467379020|FG001|Overall Study|Death|2|||
129839719|NCT05084053|467379021|FG000|Epoch 1: Up to 6 Months|Withdrawal by Subject|1|||
129839720|NCT05084053|467379022|FG001|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
129839721|NCT05084053|467379023|FG002|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
129839722|NCT05084053|467379024|FG003|Epoch 1: Up to 6 Months|Withdrawal by Subject|0|||
129839723|NCT05084053|467379021|FG000|Epoch 1: Up to 6 Months|Physician Decision|1|||
129839724|NCT05084053|467379022|FG001|Epoch 1: Up to 6 Months|Physician Decision|0|||
129839725|NCT05084053|467379023|FG002|Epoch 1: Up to 6 Months|Physician Decision|0|||
129839726|NCT05084053|467379024|FG003|Epoch 1: Up to 6 Months|Physician Decision|0|||
129839727|NCT05084053|467379021|FG000|Epoch 2: Up to 6 Months|Physician Decision|0|||
129839728|NCT05084053|467379022|FG001|Epoch 2: Up to 6 Months|Physician Decision|0|||
129839729|NCT05084053|467379023|FG002|Epoch 2: Up to 6 Months|Physician Decision|1|||
129839730|NCT05084053|467379024|FG003|Epoch 2: Up to 6 Months|Physician Decision|0|||
129839731|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Adverse Event|2|||
129839732|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Adverse Event|3|||
129839733|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Adverse Event|4|||
129839734|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Adverse Event|4|||
129839735|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
129899154|NCT02931396|467590199|FG000|Overall Study|Lost to Follow-up|3|||
129899155|NCT02931396|467590200|FG001|Overall Study|Lost to Follow-up|0|||
129899156|NCT02931396|467590199|FG000|Overall Study|Withdrawal by Subject|2|||
129447905|NCT02632721|465939141|FG001|Overall Study|Therapy refractory AML|0|||
129447906|NCT02632721|465939142|FG002|Overall Study|Therapy refractory AML|0|||
129447907|NCT02632721|465939143|FG003|Overall Study|Therapy refractory AML|0|||
129447908|NCT02632721|465939144|FG004|Overall Study|Therapy refractory AML|1|||
129447909|NCT02632721|465939140|FG000|Overall Study|Increase of white blood cell count|0|||
129447910|NCT02632721|465939141|FG001|Overall Study|Increase of white blood cell count|0|||
129447911|NCT02632721|465939142|FG002|Overall Study|Increase of white blood cell count|0|||
129447912|NCT02632721|465939143|FG003|Overall Study|Increase of white blood cell count|0|||
129447913|NCT02632721|465939144|FG004|Overall Study|Increase of white blood cell count|1|||
129447914|NCT02632721|465939140|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
129447915|NCT02632721|465939141|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
129447916|NCT02632721|465939142|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
129447917|NCT02632721|465939143|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
129447918|NCT02632721|465939144|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
129447919|NCT00544648|465939147|FG000|Overall Study|Withdrawal by Subject|1|||
129447920|NCT00544648|465939148|FG001|Overall Study|Withdrawal by Subject|0|||
129447921|NCT00544648|465939147|FG000|Overall Study|Adverse Event|1|||
129839736|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
129839737|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
129839738|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
129839739|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
129839740|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
129839741|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
129839742|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
129839743|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
129839744|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
129839745|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
129839746|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
129839747|NCT00071812|467379025|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
129839748|NCT00071812|467379026|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
129839749|NCT00071812|467379027|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
129839750|NCT00071812|467379028|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
129839751|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
129839752|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
129839753|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
129839754|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
129839755|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129839756|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129839757|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129839758|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
129839759|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129839760|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129839761|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129839762|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
129839763|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129839764|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129839765|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129839766|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
129839767|NCT00071812|467379025|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129839768|NCT00071812|467379026|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129839769|NCT00071812|467379027|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
129839770|NCT00071812|467379028|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
129839771|NCT02554656|467379029|FG000|Overall Study|Protocol Violation|3|||
129839772|NCT00749463|467379034|FG000|Overall Study|Adverse Event|0|||
129839773|NCT00749463|467379035|FG001|Overall Study|Adverse Event|4|||
129839774|NCT00749463|467379036|FG002|Overall Study|Adverse Event|1|||
129839775|NCT00749463|467379034|FG000|Overall Study|Withdrawal by Subject|1|||
129839776|NCT00749463|467379035|FG001|Overall Study|Withdrawal by Subject|0|||
129839777|NCT00749463|467379036|FG002|Overall Study|Withdrawal by Subject|0|||
129839778|NCT00805935|467379041|FG000|Overall Study|Stimulation Failure|1|||
129447922|NCT00544648|465939148|FG001|Overall Study|Adverse Event|1|||
129447923|NCT00544648|465939147|FG000|Overall Study|progression of disease|1|||
129447924|NCT00544648|465939148|FG001|Overall Study|progression of disease|0|||
129447925|NCT02663271|465939149|FG000|Overall Study|Withdrawal by Subject|5|||
129839779|NCT00805935|467379042|FG001|Overall Study|Stimulation Failure|5|||
129839780|NCT00805935|467379043|FG002|Overall Study|Stimulation Failure|2|||
129839781|NCT00805935|467379044|FG003|Overall Study|Stimulation Failure|2|||
129839782|NCT00805935|467379041|FG000|Overall Study|Cycle cancelled|0|||
129899157|NCT02931396|467590200|FG001|Overall Study|Withdrawal by Subject|0|||
129899158|NCT03895034|467591767|FG000|Overall Study|Lost to Follow-up|2|||
129839783|NCT00805935|467379042|FG001|Overall Study|Cycle cancelled|0|||
129839784|NCT00805935|467379043|FG002|Overall Study|Cycle cancelled|2|||
129839785|NCT00805935|467379044|FG003|Overall Study|Cycle cancelled|0|||
129899159|NCT03784963|467591768|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
129899160|NCT03784963|467591769|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
129899161|NCT03784963|467591770|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
129839786|NCT00805935|467379041|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
129839787|NCT00805935|467379042|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
129839788|NCT00805935|467379043|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
129839789|NCT00805935|467379044|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
129839790|NCT00805935|467379041|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
129839791|NCT00805935|467379042|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
129839792|NCT00805935|467379043|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
129839793|NCT00805935|467379044|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
129839794|NCT00805935|467379041|FG000|Overall Study|Lost to Follow-up|1|||
129839795|NCT00805935|467379042|FG001|Overall Study|Lost to Follow-up|0|||
129839796|NCT00805935|467379043|FG002|Overall Study|Lost to Follow-up|0|||
129839797|NCT00805935|467379044|FG003|Overall Study|Lost to Follow-up|0|||
129899162|NCT03784963|467591771|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
129899163|NCT00157014|467591772|FG000|Overall Study|Death|4|||
129899164|NCT00157014|467591773|FG001|Overall Study|Death|2|||
129899165|NCT00157014|467591774|FG002|Overall Study|Death|1|||
129899166|NCT00157014|467591775|FG003|Overall Study|Death|1|||
129899167|NCT00157014|467591772|FG000|Overall Study|Physician Decision|0|||
129899168|NCT00157014|467591773|FG001|Overall Study|Physician Decision|1|||
129899169|NCT00157014|467591774|FG002|Overall Study|Physician Decision|0|||
129899170|NCT00157014|467591775|FG003|Overall Study|Physician Decision|0|||
129899171|NCT00157014|467591772|FG000|Overall Study|Medications withdrawn on family request|0|||
129899172|NCT00157014|467591773|FG001|Overall Study|Medications withdrawn on family request|1|||
129899173|NCT00157014|467591774|FG002|Overall Study|Medications withdrawn on family request|0|||
129839798|NCT00805935|467379041|FG000|Overall Study|No positive serum pregnancy|8|||
129839799|NCT00805935|467379042|FG001|Overall Study|No positive serum pregnancy|7|||
129839800|NCT00805935|467379043|FG002|Overall Study|No positive serum pregnancy|6|||
129839801|NCT00805935|467379044|FG003|Overall Study|No positive serum pregnancy|5|||
129839802|NCT00805935|467379041|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129839803|NCT00805935|467379042|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129839804|NCT00805935|467379043|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129839805|NCT00805935|467379044|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
129839806|NCT00805935|467379041|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
129839807|NCT00805935|467379042|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
129839808|NCT00805935|467379043|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
129839809|NCT00805935|467379044|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
129839810|NCT00805935|467379041|FG000|Overall Study|Biochemical pregnancy|0|||
129839811|NCT00805935|467379042|FG001|Overall Study|Biochemical pregnancy|1|||
129839812|NCT00805935|467379043|FG002|Overall Study|Biochemical pregnancy|0|||
129839813|NCT00805935|467379044|FG003|Overall Study|Biochemical pregnancy|0|||
129839814|NCT00805935|467379041|FG000|Overall Study|Chemical pregnancy|0|||
129839815|NCT00805935|467379042|FG001|Overall Study|Chemical pregnancy|5|||
129839816|NCT00805935|467379043|FG002|Overall Study|Chemical pregnancy|3|||
129839817|NCT00805935|467379044|FG003|Overall Study|Chemical pregnancy|2|||
129839818|NCT00805935|467379041|FG000|Overall Study|Ectopic pregnancy|0|||
129839819|NCT00805935|467379042|FG001|Overall Study|Ectopic pregnancy|0|||
129839820|NCT00805935|467379043|FG002|Overall Study|Ectopic pregnancy|1|||
129839821|NCT00805935|467379044|FG003|Overall Study|Ectopic pregnancy|0|||
129839822|NCT00805935|467379041|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
129839823|NCT00805935|467379042|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
129839824|NCT00805935|467379043|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
129839825|NCT00805935|467379044|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
129839826|NCT01539226|467379045|FG000|Overall Study|Withdrawal by Subject|24|||
129839827|NCT01539226|467379046|FG001|Overall Study|Withdrawal by Subject|54|||
129839828|NCT01539226|467379045|FG000|Overall Study|Lost to Follow-up|20|||
129839829|NCT01539226|467379046|FG001|Overall Study|Lost to Follow-up|54|||
129839830|NCT01539226|467379045|FG000|Overall Study|Death|1|||
129839831|NCT01539226|467379046|FG001|Overall Study|Death|2|||
129839832|NCT01539226|467379045|FG000|Overall Study|Adverse Event|2|||
129839833|NCT01539226|467379046|FG001|Overall Study|Adverse Event|0|||
129839834|NCT01539226|467379045|FG000|Overall Study|Pregnancy|13|||
129839835|NCT01539226|467379046|FG001|Overall Study|Pregnancy|29|||
129839836|NCT01539226|467379045|FG000|Overall Study|inappropriate enrollment|0|||
129839837|NCT01539226|467379046|FG001|Overall Study|inappropriate enrollment|1|||
129839838|NCT01539226|467379045|FG000|Overall Study|Multiple Reasons|3|||
129839839|NCT01539226|467379046|FG001|Overall Study|Multiple Reasons|1|||
129839840|NCT01539226|467379045|FG000|Overall Study|not HIV seroconversion-related|93|||
129447926|NCT02663271|465939149|FG000|Overall Study|Lack of Efficacy|1|||
129447927|NCT04166383|465939156|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
129447928|NCT04166383|465939156|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
129447929|NCT04166383|465939156|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
129447930|NCT03346057|465939158|FG000|Overall Study|Death|1|||
129447931|NCT03346057|465939159|FG001|Overall Study|Death|2|||
129447932|NCT03346057|465939160|FG002|Overall Study|Death|0|||
129839841|NCT01539226|467379046|FG001|Overall Study|not HIV seroconversion-related|176|||
129899174|NCT00157014|467591775|FG003|Overall Study|Medications withdrawn on family request|0|||
129447933|NCT03346057|465939161|FG003|Overall Study|Death|0|||
129447934|NCT03346057|465939158|FG000|Overall Study|Lost to Follow-up|0|||
129447935|NCT03346057|465939159|FG001|Overall Study|Lost to Follow-up|2|||
129447936|NCT03346057|465939160|FG002|Overall Study|Lost to Follow-up|1|||
129447937|NCT03346057|465939161|FG003|Overall Study|Lost to Follow-up|0|||
129447938|NCT03346057|465939158|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
129447939|NCT03346057|465939159|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
129447940|NCT03346057|465939160|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
129447941|NCT03346057|465939161|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
129447942|NCT03346057|465939158|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
129447943|NCT03346057|465939159|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
129447944|NCT03346057|465939160|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
129447945|NCT03346057|465939161|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
129447946|NCT03346057|465939158|FG000|Overall Study|Physician Decision|3|||
129447947|NCT03346057|465939159|FG001|Overall Study|Physician Decision|2|||
129447948|NCT03346057|465939160|FG002|Overall Study|Physician Decision|0|||
129447949|NCT03346057|465939161|FG003|Overall Study|Physician Decision|2|||
129447950|NCT03346057|465939158|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
129447951|NCT03346057|465939159|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
129447952|NCT03346057|465939160|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
129447953|NCT03346057|465939161|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
129447954|NCT03346057|465939158|FG000|Overall Study|Withdrawal by Subject|1|||
129447955|NCT03346057|465939159|FG001|Overall Study|Withdrawal by Subject|0|||
129447956|NCT03346057|465939160|FG002|Overall Study|Withdrawal by Subject|0|||
129447957|NCT03346057|465939161|FG003|Overall Study|Withdrawal by Subject|0|||
129447958|NCT03044886|465939162|FG000|Overall Study|Lost to Follow-up|15|||
129447959|NCT03044886|465939163|FG001|Overall Study|Lost to Follow-up|10|||
129447960|NCT03044886|465939164|FG002|Overall Study|Lost to Follow-up|12|||
129447961|NCT02456662|465939166|FG000|Overall Study|Lost to Follow-up|2|||
129447962|NCT02456662|465939167|FG001|Overall Study|Lost to Follow-up|1|||
129447963|NCT00504153|465939168|FG000|Overall Study|Withdrawal by Subject|1|||
129447964|NCT00504153|465939168|FG000|Overall Study|Adverse Event|4|||
129447965|NCT00504153|465939168|FG000|Overall Study|Death|1|||
129447966|NCT00074581|465939170|FG000|Overall Study|Death|15|||
129839842|NCT01539226|467379045|FG000|Overall Study|HIV seroconversion-related|55|||
129839843|NCT01539226|467379046|FG001|Overall Study|HIV seroconversion-related|80|||
129839844|NCT01539226|467379045|FG000|Overall Study|Non-compliance|6|||
129839845|NCT01539226|467379046|FG001|Overall Study|Non-compliance|8|||
129839846|NCT05288556|467379054|FG000|Overall Study|Protocol Violation|1|||
129839847|NCT05288556|467379054|FG000|Overall Study|Withdrawal by Subject|1|||
129839848|NCT02775344|467379055|FG000|Overall Study|No ovarian cyst identified|3|||
129839849|NCT02775344|467379056|FG001|Overall Study|No ovarian cyst identified|2|||
129839850|NCT04627064|467379057|FG000|Overall Study|Progressive disease|8|||
129839851|NCT04627064|467379058|FG001|Overall Study|Progressive disease|0|||
129839852|NCT04627064|467379057|FG000|Overall Study|Withdrawal by Subject|2|||
129839853|NCT04627064|467379058|FG001|Overall Study|Withdrawal by Subject|0|||
129839854|NCT04627064|467379057|FG000|Overall Study|Physician Decision|1|||
129839855|NCT04627064|467379058|FG001|Overall Study|Physician Decision|0|||
129839856|NCT01800916|467379059|FG000|Test Period 1 (1 Week)|Convex product user|0|||
129839857|NCT01800916|467379060|FG001|Test Period 1 (1 Week)|Convex product user|0|||
129839858|NCT01800916|467379061|FG002|Test Period 1 (1 Week)|Convex product user|0|||
129839859|NCT01800916|467379062|FG003|Test Period 1 (1 Week)|Convex product user|1|||
129899175|NCT00157014|467591772|FG000|Overall Study|Patient withdrawn by investigator|1|||
129447967|NCT00074581|465939171|FG001|Overall Study|Death|16|||
129447968|NCT00074581|465939170|FG000|Overall Study|Withdrawal by Subject|50|||
129447969|NCT00074581|465939171|FG001|Overall Study|Withdrawal by Subject|49|||
129447970|NCT00074581|465939170|FG000|Overall Study|Unable to adhere to visit schedule|13|||
129839860|NCT01800916|467379063|FG004|Test Period 1 (1 Week)|Convex product user|0|||
129839861|NCT01800916|467379064|FG005|Test Period 1 (1 Week)|Convex product user|0|||
129839862|NCT01800916|467379065|FG006|Test Period 1 (1 Week)|Convex product user|0|||
129839863|NCT01800916|467379066|FG007|Test Period 1 (1 Week)|Convex product user|0|||
129839864|NCT01800916|467379067|FG008|Test Period 1 (1 Week)|Convex product user|0|||
129447971|NCT00074581|465939171|FG001|Overall Study|Unable to adhere to visit schedule|14|||
129447972|NCT00074581|465939170|FG000|Overall Study|Relocated|14|||
129447973|NCT00074581|465939171|FG001|Overall Study|Relocated|9|||
129839865|NCT01800916|467379059|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
129839866|NCT01800916|467379060|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
129839867|NCT01800916|467379061|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
129839868|NCT01800916|467379062|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
129839869|NCT01800916|467379063|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
129839870|NCT01800916|467379064|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
129839871|NCT01800916|467379065|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
129839872|NCT01800916|467379066|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
129839873|NCT01800916|467379067|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
129839874|NCT01234467|467379070|FG000|Overall Study|Adverse Event|3|||
129839875|NCT01234467|467379070|FG000|Overall Study|Death|2|||
129839876|NCT01234467|467379070|FG000|Overall Study|Withdrawal by Subject|2|||
129839877|NCT01234467|467379070|FG000|Overall Study|Disease Progression|2|||
129839878|NCT01234467|467379070|FG000|Overall Study|Clinical deterioration|1|||
129839879|NCT01234467|467379070|FG000|Overall Study|Physician Decision|1|||
129839880|NCT01234467|467379070|FG000|Overall Study|Other complicating disease (stroke)|1|||
129839881|NCT00559962|467379073|FG000|Overall Study|Adverse Event|1|||
129839882|NCT00559962|467379074|FG001|Overall Study|Adverse Event|7|||
129839883|NCT00559962|467379075|FG002|Overall Study|Adverse Event|8|||
129839884|NCT00559962|467379076|FG003|Overall Study|Adverse Event|5|||
129839885|NCT00559962|467379077|FG004|Overall Study|Adverse Event|11|||
129839886|NCT00559962|467379078|FG005|Overall Study|Adverse Event|4|||
129839887|NCT00559962|467379079|FG006|Overall Study|Adverse Event|4|||
129839888|NCT00559962|467379080|FG007|Overall Study|Adverse Event|2|||
129839889|NCT00559962|467379073|FG000|Overall Study|Lost to Follow-up|0|||
129839890|NCT00559962|467379074|FG001|Overall Study|Lost to Follow-up|1|||
129839891|NCT00559962|467379075|FG002|Overall Study|Lost to Follow-up|0|||
129839892|NCT00559962|467379076|FG003|Overall Study|Lost to Follow-up|0|||
129839893|NCT00559962|467379077|FG004|Overall Study|Lost to Follow-up|0|||
129839894|NCT00559962|467379078|FG005|Overall Study|Lost to Follow-up|0|||
129839895|NCT00559962|467379079|FG006|Overall Study|Lost to Follow-up|0|||
129839896|NCT00559962|467379080|FG007|Overall Study|Lost to Follow-up|0|||
129839897|NCT00559962|467379073|FG000|Overall Study|Withdrawal by Subject|1|||
129839898|NCT00559962|467379074|FG001|Overall Study|Withdrawal by Subject|1|||
129839899|NCT00559962|467379075|FG002|Overall Study|Withdrawal by Subject|2|||
129839900|NCT00559962|467379076|FG003|Overall Study|Withdrawal by Subject|0|||
129839901|NCT00559962|467379077|FG004|Overall Study|Withdrawal by Subject|3|||
129839902|NCT00559962|467379078|FG005|Overall Study|Withdrawal by Subject|1|||
129839903|NCT00559962|467379079|FG006|Overall Study|Withdrawal by Subject|0|||
129839904|NCT00559962|467379080|FG007|Overall Study|Withdrawal by Subject|2|||
129839905|NCT00559962|467379073|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
129839906|NCT00559962|467379074|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
129839907|NCT00559962|467379075|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
129839908|NCT00559962|467379076|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
129839909|NCT00559962|467379077|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
129839910|NCT00559962|467379078|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
129839911|NCT00559962|467379079|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
129839912|NCT00559962|467379080|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
129839913|NCT01461096|467379081|FG000|Overall Study|Death|3|||
129839914|NCT01461096|467379082|FG001|Overall Study|Death|6|||
129839915|NCT01461096|467379081|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129839916|NCT01461096|467379082|FG001|Overall Study|Severe debilitation, unable to continue|1|||
129839917|NCT01461096|467379081|FG000|Overall Study|Subj not able to get to clinic|15|||
129839918|NCT01461096|467379082|FG001|Overall Study|Subj not able to get to clinic|13|||
129839919|NCT01461096|467379081|FG000|Overall Study|Site is closing|27|||
129839920|NCT01461096|467379082|FG001|Overall Study|Site is closing|30|||
129839921|NCT01461096|467379081|FG000|Overall Study|Withdrawal by Subject|5|||
129839922|NCT01461096|467379082|FG001|Overall Study|Withdrawal by Subject|3|||
129839923|NCT01461096|467379081|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
129839924|NCT01461096|467379082|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
129839925|NCT01461096|467379081|FG000|Overall Study|Lost to Follow-up|8|||
129839926|NCT01461096|467379082|FG001|Overall Study|Lost to Follow-up|4|||
129839927|NCT01452412|467379088|FG000|Overall Study|Withdrawal by Subject|15|||
129839928|NCT01452412|467379089|FG001|Overall Study|Withdrawal by Subject|11|||
129839929|NCT01452412|467379088|FG000|Overall Study|Adverse Event|4|||
129839930|NCT01452412|467379089|FG001|Overall Study|Adverse Event|3|||
129839931|NCT01452412|467379088|FG000|Overall Study|Lost to Follow-up|5|||
129839932|NCT01452412|467379089|FG001|Overall Study|Lost to Follow-up|3|||
129839933|NCT01452412|467379088|FG000|Overall Study|Death|1|||
129839934|NCT01452412|467379089|FG001|Overall Study|Death|0|||
129839935|NCT01452412|467379088|FG000|Overall Study|Initiated dialysis|1|||
129839936|NCT01452412|467379089|FG001|Overall Study|Initiated dialysis|0|||
129839937|NCT01452412|467379088|FG000|Overall Study|Other|2|||
129839938|NCT01452412|467379089|FG001|Overall Study|Other|0|||
129839939|NCT03047135|467379090|FG000|Overall Study|Still being treated|3|||
129839940|NCT03013543|467379091|FG000|Overall Study|Withdrawal by Subject|0|||
129839941|NCT03013543|467379092|FG001|Overall Study|Withdrawal by Subject|2|||
129839942|NCT03013543|467379093|FG002|Overall Study|Withdrawal by Subject|0|||
129447974|NCT00074581|465939170|FG000|Overall Study|Were withdrawn by investigator|5|||
129447975|NCT00074581|465939171|FG001|Overall Study|Were withdrawn by investigator|2|||
129447976|NCT00074581|465939170|FG000|Overall Study|Lost to Follow-up|16|||
129447977|NCT00074581|465939171|FG001|Overall Study|Lost to Follow-up|11|||
129447978|NCT00074581|465939170|FG000|Overall Study|Ended relationship w. index participant|117|||
129447979|NCT00074581|465939171|FG001|Overall Study|Ended relationship w. index participant|106|||
129447980|NCT00074581|465939170|FG000|Overall Study|Other|14|||
129447981|NCT00074581|465939171|FG001|Overall Study|Other|19|||
129447982|NCT02322229|465939174|FG000|Overall Study|Physician Decision|2|||
129447983|NCT00705432|465939177|FG000|Treatment Period|Adverse Event|45|||
129447984|NCT00705432|465939178|FG001|Treatment Period|Adverse Event|37|||
129447985|NCT00705432|465939179|FG002|Treatment Period|Adverse Event|51|||
129447986|NCT00705432|465939180|FG003|Treatment Period|Adverse Event|12|||
129447987|NCT00705432|465939181|FG004|Treatment Period|Adverse Event|8|||
129447988|NCT00705432|465939182|FG005|Treatment Period|Adverse Event|9|||
129447989|NCT00705432|465939177|FG000|Treatment Period|Treatment failure|92|||
129447990|NCT00705432|465939178|FG001|Treatment Period|Treatment failure|42|||
129447991|NCT00705432|465939179|FG002|Treatment Period|Treatment failure|33|||
129447992|NCT00705432|465939180|FG003|Treatment Period|Treatment failure|25|||
129447993|NCT00705432|465939181|FG004|Treatment Period|Treatment failure|13|||
129447994|NCT00705432|465939182|FG005|Treatment Period|Treatment failure|14|||
129447995|NCT00705432|465939177|FG000|Treatment Period|Non medical reason|26|||
129447996|NCT00705432|465939178|FG001|Treatment Period|Non medical reason|32|||
129447997|NCT00705432|465939179|FG002|Treatment Period|Non medical reason|37|||
129447998|NCT00705432|465939180|FG003|Treatment Period|Non medical reason|4|||
129447999|NCT00705432|465939181|FG004|Treatment Period|Non medical reason|7|||
129448000|NCT00705432|465939182|FG005|Treatment Period|Non medical reason|7|||
129448001|NCT00705432|465939177|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
129448002|NCT00705432|465939178|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
129448003|NCT00705432|465939179|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
129448004|NCT00705432|465939180|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
129448005|NCT00705432|465939181|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
129448006|NCT00705432|465939182|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
129448007|NCT00705432|465939177|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
129448008|NCT00705432|465939178|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
129448009|NCT00705432|465939179|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
129448010|NCT00705432|465939180|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
129448011|NCT00705432|465939181|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
129448012|NCT00705432|465939182|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
129448013|NCT04411628|465939183|FG000|Overall Study|Withdrawal by Subject|1|||
129448014|NCT04411628|465939184|FG001|Overall Study|Withdrawal by Subject|1|||
129448015|NCT04411628|465939185|FG002|Overall Study|Withdrawal by Subject|2|||
129448016|NCT04411628|465939186|FG003|Overall Study|Withdrawal by Subject|0|||
129448017|NCT04411628|465939183|FG000|Overall Study|Lost to Follow-up|0|||
129448018|NCT04411628|465939184|FG001|Overall Study|Lost to Follow-up|1|||
129448019|NCT04411628|465939185|FG002|Overall Study|Lost to Follow-up|0|||
129448020|NCT04411628|465939186|FG003|Overall Study|Lost to Follow-up|0|||
129448021|NCT00521053|465939187|FG000|Observation Phase|Disease Progression|55|||
129448022|NCT00521053|465939187|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
129448023|NCT00521053|465939187|FG000|Observation Phase|Death|2|||
129448024|NCT00521053|465939187|FG000|Observation Phase|Adverse Event|1|||
129448025|NCT00521053|465939187|FG000|Observation Phase|Other non-study melanoma treatment|1|||
129448026|NCT00521053|465939187|FG000|Observation Phase|Physician Decision|1|||
129448027|NCT00732251|465939188|FG000|Overall Study|Lost to Follow-up|3|||
129448028|NCT00732251|465939188|FG000|Overall Study|Withdrawal by Subject|3|||
129448029|NCT00732251|465939188|FG000|Overall Study|Early Term due to Site Closure|1|||
129448030|NCT01034540|465939189|FG000|Overall Study|Adverse Event|0|||
129448031|NCT01034540|465939190|FG001|Overall Study|Adverse Event|1|||
129448032|NCT03519867|465939195|FG000|Overall Study|Adverse Event|1|||
129448033|NCT03519867|465939196|FG001|Overall Study|Adverse Event|1|||
129448034|NCT03519867|465939197|FG002|Overall Study|Adverse Event|0|||
129448035|NCT03519867|465939198|FG003|Overall Study|Adverse Event|0|||
129448036|NCT03519867|465939199|FG004|Overall Study|Adverse Event|0|||
129448037|NCT03519867|465939200|FG005|Overall Study|Adverse Event|0|||
129448038|NCT03519867|465939201|FG006|Overall Study|Adverse Event|0|||
129899176|NCT00157014|467591773|FG001|Overall Study|Patient withdrawn by investigator|0|||
129899177|NCT00157014|467591774|FG002|Overall Study|Patient withdrawn by investigator|0|||
129448039|NCT03519867|465939202|FG007|Overall Study|Adverse Event|0|||
129448040|NCT03519867|465939203|FG008|Overall Study|Adverse Event|0|||
129448041|NCT03519867|465939204|FG009|Overall Study|Adverse Event|0|||
129448042|NCT03519867|465939195|FG000|Overall Study|Protocol Violation|0|||
129899178|NCT00157014|467591775|FG003|Overall Study|Patient withdrawn by investigator|0|||
129448043|NCT03519867|465939196|FG001|Overall Study|Protocol Violation|0|||
129448044|NCT03519867|465939197|FG002|Overall Study|Protocol Violation|0|||
129448045|NCT03519867|465939198|FG003|Overall Study|Protocol Violation|0|||
129899179|NCT00157014|467591772|FG000|Overall Study|Patient unable to return in nursing home|1|||
129899180|NCT00157014|467591773|FG001|Overall Study|Patient unable to return in nursing home|0|||
129899181|NCT00157014|467591774|FG002|Overall Study|Patient unable to return in nursing home|0|||
129899182|NCT00157014|467591775|FG003|Overall Study|Patient unable to return in nursing home|0|||
129899183|NCT00157014|467591772|FG000|Overall Study|Patient would not receive transplant|0|||
129899184|NCT00157014|467591773|FG001|Overall Study|Patient would not receive transplant|1|||
129899185|NCT00157014|467591774|FG002|Overall Study|Patient would not receive transplant|0|||
129899186|NCT00157014|467591775|FG003|Overall Study|Patient would not receive transplant|0|||
129899187|NCT00157014|467591772|FG000|Overall Study|Withdrawal by Subject|1|||
129899188|NCT00157014|467591773|FG001|Overall Study|Withdrawal by Subject|0|||
129899189|NCT00157014|467591774|FG002|Overall Study|Withdrawal by Subject|0|||
129899190|NCT00157014|467591775|FG003|Overall Study|Withdrawal by Subject|0|||
129899191|NCT01362491|467591776|FG000|Overall Study|Ineligible|1|||
129899192|NCT01362491|467591777|FG001|Overall Study|Ineligible|0|||
129899193|NCT01362491|467591778|FG002|Overall Study|Ineligible|0|||
129899194|NCT03181958|467591779|FG000|Overall Study|Lost to Follow-up|17|||
129899195|NCT03181958|467591780|FG001|Overall Study|Lost to Follow-up|21|||
129899196|NCT03181958|467591781|FG002|Overall Study|Lost to Follow-up|15|||
129899197|NCT01257503|467591782|FG000|Overall Study|Lost to Follow-up|7|||
129899198|NCT01257503|467591783|FG001|Overall Study|Lost to Follow-up|10|||
129899199|NCT01257503|467591782|FG000|Overall Study|Over 5 years old at enrollment|0|||
129899200|NCT01257503|467591783|FG001|Overall Study|Over 5 years old at enrollment|1|||
129899201|NCT01257503|467591782|FG000|Overall Study|strep culture positive at enrollment|1|||
129899202|NCT01257503|467591783|FG001|Overall Study|strep culture positive at enrollment|0|||
129899203|NCT02987543|467591786|FG000|Overall Study|Ongoing study at data cut off|49|||
129899204|NCT02987543|467591787|FG001|Overall Study|Ongoing study at data cut off|21|||
129899205|NCT02987543|467591788|FG002|Overall Study|Ongoing study at data cut off|19|||
129899206|NCT02987543|467591789|FG003|Overall Study|Ongoing study at data cut off|12|||
129899207|NCT02987543|467591786|FG000|Overall Study|Death|88|||
129899208|NCT02987543|467591787|FG001|Overall Study|Death|54|||
129899209|NCT02987543|467591788|FG002|Overall Study|Death|67|||
129899210|NCT02987543|467591789|FG003|Overall Study|Death|28|||
129899211|NCT02987543|467591786|FG000|Overall Study|Lost to Follow-up|3|||
129899212|NCT02987543|467591787|FG001|Overall Study|Lost to Follow-up|0|||
129899213|NCT02987543|467591788|FG002|Overall Study|Lost to Follow-up|1|||
129899214|NCT02987543|467591789|FG003|Overall Study|Lost to Follow-up|0|||
129899215|NCT02987543|467591786|FG000|Overall Study|Screen failure|0|||
129899216|NCT02987543|467591787|FG001|Overall Study|Screen failure|0|||
129899217|NCT02987543|467591788|FG002|Overall Study|Screen failure|0|||
129899218|NCT02987543|467591789|FG003|Overall Study|Screen failure|1|||
129899219|NCT02987543|467591786|FG000|Overall Study|Withdrawal by Subject|21|||
129899220|NCT02987543|467591787|FG001|Overall Study|Withdrawal by Subject|7|||
129899221|NCT02987543|467591788|FG002|Overall Study|Withdrawal by Subject|7|||
129899222|NCT02987543|467591789|FG003|Overall Study|Withdrawal by Subject|6|||
129899223|NCT02987543|467591786|FG000|Overall Study|Study terminated by sponsor|1|||
129899224|NCT02987543|467591787|FG001|Overall Study|Study terminated by sponsor|0|||
129899225|NCT02987543|467591788|FG002|Overall Study|Study terminated by sponsor|0|||
129899226|NCT02987543|467591789|FG003|Overall Study|Study terminated by sponsor|0|||
129899227|NCT02987543|467591786|FG000|Overall Study|Investigator decision|0|||
129899228|NCT02987543|467591787|FG001|Overall Study|Investigator decision|1|||
129899229|NCT02987543|467591788|FG002|Overall Study|Investigator decision|0|||
129899230|NCT02987543|467591789|FG003|Overall Study|Investigator decision|0|||
129899231|NCT02987543|467591786|FG000|Overall Study|Disease progression|0|||
129899232|NCT02987543|467591787|FG001|Overall Study|Disease progression|0|||
129899233|NCT02987543|467591788|FG002|Overall Study|Disease progression|0|||
129899234|NCT02987543|467591789|FG003|Overall Study|Disease progression|1|||
129899235|NCT01977612|467591792|FG000|Overall Study|Lost to Follow-up|1|||
129899236|NCT01977612|467591793|FG001|Overall Study|Lost to Follow-up|1|||
129899237|NCT01883492|467591795|FG000|Overall Study|Lost to Follow-up|3|||
129899238|NCT01883492|467591796|FG001|Overall Study|Lost to Follow-up|4|||
129899239|NCT01883492|467591795|FG000|Overall Study|Surgery on contra-lateral hip|0|||
129899240|NCT01883492|467591796|FG001|Overall Study|Surgery on contra-lateral hip|1|||
129899241|NCT01883492|467591795|FG000|Overall Study|Poor X-ray quality|7|||
129899242|NCT01883492|467591796|FG001|Overall Study|Poor X-ray quality|4|||
129899243|NCT01883492|467591795|FG000|Overall Study|Withdrawal by Subject|1|||
129899244|NCT01883492|467591796|FG001|Overall Study|Withdrawal by Subject|0|||
129899245|NCT01883492|467591795|FG000|Overall Study|inappropriate implant used|1|||
129899246|NCT01883492|467591796|FG001|Overall Study|inappropriate implant used|1|||
129899247|NCT01883492|467591795|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
129899248|NCT01883492|467591796|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
129899249|NCT01259102|467591797|FG000|Overall Study|Adverse Event|1|||
129899250|NCT01259102|467591798|FG001|Overall Study|Adverse Event|0|||
129899251|NCT01259102|467591799|FG002|Overall Study|Adverse Event|1|||
129899252|NCT01259102|467591800|FG003|Overall Study|Adverse Event|1|||
129899253|NCT01259102|467591801|FG004|Overall Study|Adverse Event|0|||
129899254|NCT01259102|467591797|FG000|Overall Study|Other|0|||
129899255|NCT01259102|467591798|FG001|Overall Study|Other|0|||
129899256|NCT01259102|467591799|FG002|Overall Study|Other|1|||
129899257|NCT01259102|467591800|FG003|Overall Study|Other|1|||
129899258|NCT01259102|467591801|FG004|Overall Study|Other|1|||
129899259|NCT01876511|467591803|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
129899260|NCT01876511|467591804|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
129899261|NCT01876511|467591805|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
129899262|NCT01876511|467591803|FG000|Overall Study|Death (unrelated)|3|||
129899263|NCT01876511|467591804|FG001|Overall Study|Death (unrelated)|0|||
129899264|NCT01876511|467591805|FG002|Overall Study|Death (unrelated)|2|||
129899265|NCT01876511|467591803|FG000|Overall Study|Drug-related Toxicity|5|||
129899266|NCT01876511|467591804|FG001|Overall Study|Drug-related Toxicity|1|||
129899267|NCT01876511|467591805|FG002|Overall Study|Drug-related Toxicity|6|||
129899268|NCT01876511|467591803|FG000|Overall Study|Patient Decision|3|||
129899269|NCT01876511|467591804|FG001|Overall Study|Patient Decision|0|||
129899270|NCT01876511|467591805|FG002|Overall Study|Patient Decision|6|||
129899271|NCT01876511|467591803|FG000|Overall Study|Physician Decision|1|||
129899272|NCT01876511|467591804|FG001|Overall Study|Physician Decision|0|||
129899273|NCT01876511|467591805|FG002|Overall Study|Physician Decision|1|||
129899274|NCT01048788|467591806|FG000|Overall Study|Adverse Event|5|||
129899275|NCT01048788|467591807|FG001|Overall Study|Adverse Event|1|||
129899276|NCT01048788|467591808|FG002|Overall Study|Adverse Event|1|||
129899277|NCT01048788|467591806|FG000|Overall Study|Lack of Efficacy|0|||
129899278|NCT01048788|467591807|FG001|Overall Study|Lack of Efficacy|0|||
129899279|NCT01048788|467591808|FG002|Overall Study|Lack of Efficacy|1|||
129899280|NCT01048788|467591806|FG000|Overall Study|Withdrawal by Subject|0|||
129899281|NCT01048788|467591807|FG001|Overall Study|Withdrawal by Subject|1|||
129899282|NCT01048788|467591808|FG002|Overall Study|Withdrawal by Subject|0|||
129899283|NCT01233050|467591809|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
129899284|NCT01233050|467591810|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
129899285|NCT01064817|467591811|FG000|Study Completion|Physician Decision|1|||
129899286|NCT01064817|467591812|FG001|Study Completion|Physician Decision|0|||
129899287|NCT01064817|467591811|FG000|Study Completion|Withdrawal by Subject|1|||
129899288|NCT01064817|467591812|FG001|Study Completion|Withdrawal by Subject|0|||
129899289|NCT00920686|467591813|FG000|Overall Study|Lost to Follow-up|2|||
129899290|NCT00920686|467591814|FG001|Overall Study|Lost to Follow-up|3|||
129899291|NCT00920686|467591815|FG002|Overall Study|Lost to Follow-up|1|||
129899292|NCT00920686|467591813|FG000|Overall Study|Study drug dosing criteria not met|17|||
129899293|NCT00920686|467591814|FG001|Overall Study|Study drug dosing criteria not met|19|||
129899294|NCT00920686|467591815|FG002|Overall Study|Study drug dosing criteria not met|12|||
129899295|NCT00868192|467591816|FG000|Overall Study|Ineligible|4|||
129899296|NCT04304534|467591817|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
129899297|NCT04304534|467591818|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
129899298|NCT04304534|467591819|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
129899299|NCT04304534|467591820|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
129899300|NCT04304534|467591817|FG000|Overall Study|Non-Compliance with study drug|0|||
129899301|NCT04304534|467591818|FG001|Overall Study|Non-Compliance with study drug|1|||
129899302|NCT04304534|467591819|FG002|Overall Study|Non-Compliance with study drug|1|||
129839943|NCT03013543|467379094|FG003|Overall Study|Withdrawal by Subject|5|||
129839944|NCT03013543|467379095|FG004|Overall Study|Withdrawal by Subject|6|||
129839945|NCT03013543|467379096|FG005|Overall Study|Withdrawal by Subject|2|||
129839946|NCT03013543|467379097|FG006|Overall Study|Withdrawal by Subject|3|||
129839947|NCT03013543|467379098|FG007|Overall Study|Withdrawal by Subject|1|||
129839948|NCT03013543|467379099|FG008|Overall Study|Withdrawal by Subject|0|||
129839949|NCT03013543|467379100|FG009|Overall Study|Withdrawal by Subject|4|||
129839950|NCT03013543|467379091|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129839951|NCT03013543|467379092|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
129839952|NCT03013543|467379093|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
129839953|NCT03013543|467379094|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
129839954|NCT03013543|467379095|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
129839955|NCT03013543|467379096|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
129839956|NCT03013543|467379097|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
129839957|NCT03013543|467379098|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
129899303|NCT04304534|467591820|FG003|Overall Study|Non-Compliance with study drug|1|||
129899304|NCT04304534|467591817|FG000|Overall Study|Lost to Follow-up|0|||
129899305|NCT04304534|467591818|FG001|Overall Study|Lost to Follow-up|1|||
129899306|NCT04304534|467591819|FG002|Overall Study|Lost to Follow-up|2|||
129899307|NCT04304534|467591820|FG003|Overall Study|Lost to Follow-up|3|||
129899308|NCT04304534|467591817|FG000|Overall Study|Unspecific|4|||
129899309|NCT04304534|467591818|FG001|Overall Study|Unspecific|2|||
129899310|NCT04304534|467591819|FG002|Overall Study|Unspecific|2|||
129899311|NCT04304534|467591820|FG003|Overall Study|Unspecific|2|||
129899312|NCT04304534|467591817|FG000|Overall Study|Technical Problems|2|||
129899313|NCT04304534|467591818|FG001|Overall Study|Technical Problems|2|||
129448046|NCT03519867|465939199|FG004|Overall Study|Protocol Violation|0|||
129448047|NCT03519867|465939200|FG005|Overall Study|Protocol Violation|1|||
129448048|NCT03519867|465939201|FG006|Overall Study|Protocol Violation|0|||
129448049|NCT03519867|465939202|FG007|Overall Study|Protocol Violation|0|||
129448050|NCT03519867|465939203|FG008|Overall Study|Protocol Violation|0|||
129448051|NCT03519867|465939204|FG009|Overall Study|Protocol Violation|0|||
129448052|NCT03519867|465939195|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448053|NCT03519867|465939196|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448054|NCT03519867|465939197|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448055|NCT03519867|465939198|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448056|NCT03519867|465939199|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448057|NCT03519867|465939200|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448058|NCT03519867|465939201|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
129448059|NCT03519867|465939202|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448060|NCT03519867|465939203|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448061|NCT03519867|465939204|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
129448062|NCT03519867|465939195|FG000|Overall Study|Admin. of other reversal agent|1|||
129448063|NCT03519867|465939196|FG001|Overall Study|Admin. of other reversal agent|1|||
129448064|NCT03519867|465939197|FG002|Overall Study|Admin. of other reversal agent|0|||
129448065|NCT03519867|465939198|FG003|Overall Study|Admin. of other reversal agent|0|||
129448066|NCT03519867|465939199|FG004|Overall Study|Admin. of other reversal agent|0|||
129448067|NCT03519867|465939200|FG005|Overall Study|Admin. of other reversal agent|1|||
129448068|NCT03519867|465939201|FG006|Overall Study|Admin. of other reversal agent|0|||
129448069|NCT03519867|465939202|FG007|Overall Study|Admin. of other reversal agent|0|||
129448070|NCT03519867|465939203|FG008|Overall Study|Admin. of other reversal agent|0|||
129448071|NCT03519867|465939204|FG009|Overall Study|Admin. of other reversal agent|0|||
129448072|NCT03519867|465939195|FG000|Overall Study|Reason not provided|1|||
129448073|NCT03519867|465939196|FG001|Overall Study|Reason not provided|1|||
129448074|NCT03519867|465939197|FG002|Overall Study|Reason not provided|1|||
129448075|NCT03519867|465939198|FG003|Overall Study|Reason not provided|1|||
129839958|NCT03013543|467379099|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
129839959|NCT03013543|467379100|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
129839960|NCT03013543|467379091|FG000|Overall Study|Other|0|||
129839961|NCT03013543|467379092|FG001|Overall Study|Other|0|||
129839962|NCT03013543|467379093|FG002|Overall Study|Other|2|||
129839963|NCT03013543|467379094|FG003|Overall Study|Other|0|||
129839964|NCT03013543|467379095|FG004|Overall Study|Other|2|||
129839965|NCT03013543|467379096|FG005|Overall Study|Other|0|||
129839966|NCT03013543|467379097|FG006|Overall Study|Other|0|||
129839967|NCT03013543|467379098|FG007|Overall Study|Other|0|||
129839968|NCT03013543|467379099|FG008|Overall Study|Other|1|||
129839969|NCT03013543|467379100|FG009|Overall Study|Other|0|||
129839970|NCT03013543|467379091|FG000|Overall Study|Adverse Event|0|||
129839971|NCT03013543|467379092|FG001|Overall Study|Adverse Event|0|||
129839972|NCT03013543|467379093|FG002|Overall Study|Adverse Event|0|||
129839973|NCT03013543|467379094|FG003|Overall Study|Adverse Event|3|||
129839974|NCT03013543|467379095|FG004|Overall Study|Adverse Event|2|||
129839975|NCT03013543|467379096|FG005|Overall Study|Adverse Event|1|||
129839976|NCT03013543|467379097|FG006|Overall Study|Adverse Event|3|||
129839977|NCT03013543|467379098|FG007|Overall Study|Adverse Event|8|||
129839978|NCT03013543|467379099|FG008|Overall Study|Adverse Event|0|||
129839979|NCT03013543|467379100|FG009|Overall Study|Adverse Event|2|||
129839980|NCT03013543|467379091|FG000|Overall Study|Death|0|||
129839981|NCT03013543|467379092|FG001|Overall Study|Death|0|||
129839982|NCT03013543|467379093|FG002|Overall Study|Death|0|||
129839983|NCT03013543|467379094|FG003|Overall Study|Death|1|||
129839984|NCT03013543|467379095|FG004|Overall Study|Death|0|||
129839985|NCT03013543|467379096|FG005|Overall Study|Death|0|||
129839986|NCT03013543|467379097|FG006|Overall Study|Death|0|||
129839987|NCT03013543|467379098|FG007|Overall Study|Death|0|||
129839988|NCT03013543|467379099|FG008|Overall Study|Death|0|||
129839989|NCT03013543|467379100|FG009|Overall Study|Death|0|||
129839990|NCT03013543|467379091|FG000|Overall Study|Lack of Efficacy|0|||
129839991|NCT03013543|467379092|FG001|Overall Study|Lack of Efficacy|0|||
129839992|NCT03013543|467379093|FG002|Overall Study|Lack of Efficacy|0|||
129839993|NCT03013543|467379094|FG003|Overall Study|Lack of Efficacy|1|||
129839994|NCT03013543|467379095|FG004|Overall Study|Lack of Efficacy|0|||
129839995|NCT03013543|467379096|FG005|Overall Study|Lack of Efficacy|0|||
129448076|NCT03519867|465939199|FG004|Overall Study|Reason not provided|0|||
129448077|NCT03519867|465939200|FG005|Overall Study|Reason not provided|1|||
129839996|NCT03013543|467379097|FG006|Overall Study|Lack of Efficacy|0|||
129839997|NCT03013543|467379098|FG007|Overall Study|Lack of Efficacy|0|||
129448078|NCT03519867|465939201|FG006|Overall Study|Reason not provided|0|||
129448079|NCT03519867|465939202|FG007|Overall Study|Reason not provided|1|||
129839998|NCT03013543|467379099|FG008|Overall Study|Lack of Efficacy|0|||
129839999|NCT03013543|467379100|FG009|Overall Study|Lack of Efficacy|0|||
129840000|NCT03013543|467379091|FG000|Overall Study|Lost to Follow-up|0|||
129840001|NCT03013543|467379092|FG001|Overall Study|Lost to Follow-up|0|||
129840002|NCT03013543|467379093|FG002|Overall Study|Lost to Follow-up|0|||
129840003|NCT03013543|467379094|FG003|Overall Study|Lost to Follow-up|1|||
129840004|NCT03013543|467379095|FG004|Overall Study|Lost to Follow-up|0|||
129840005|NCT03013543|467379096|FG005|Overall Study|Lost to Follow-up|0|||
129840006|NCT03013543|467379097|FG006|Overall Study|Lost to Follow-up|1|||
129840007|NCT03013543|467379098|FG007|Overall Study|Lost to Follow-up|0|||
129840008|NCT03013543|467379099|FG008|Overall Study|Lost to Follow-up|0|||
129840009|NCT03013543|467379100|FG009|Overall Study|Lost to Follow-up|2|||
129840010|NCT03013543|467379091|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129840011|NCT03013543|467379092|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129840012|NCT03013543|467379093|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129840013|NCT03013543|467379094|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129840014|NCT03013543|467379095|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129840015|NCT03013543|467379096|FG005|Overall Study|Non-Compliance With Study Drug|0|||
129840016|NCT03013543|467379097|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129840017|NCT03013543|467379098|FG007|Overall Study|Non-Compliance With Study Drug|0|||
129840018|NCT03013543|467379099|FG008|Overall Study|Non-Compliance With Study Drug|1|||
129840019|NCT03013543|467379100|FG009|Overall Study|Non-Compliance With Study Drug|0|||
129840020|NCT03013543|467379091|FG000|Overall Study|Physician Decision|0|||
129840021|NCT03013543|467379092|FG001|Overall Study|Physician Decision|0|||
129840022|NCT03013543|467379093|FG002|Overall Study|Physician Decision|0|||
129840023|NCT03013543|467379094|FG003|Overall Study|Physician Decision|0|||
129840024|NCT03013543|467379095|FG004|Overall Study|Physician Decision|1|||
129840025|NCT03013543|467379096|FG005|Overall Study|Physician Decision|0|||
129840026|NCT03013543|467379097|FG006|Overall Study|Physician Decision|0|||
129840027|NCT03013543|467379098|FG007|Overall Study|Physician Decision|0|||
129840028|NCT03013543|467379099|FG008|Overall Study|Physician Decision|0|||
129840029|NCT03013543|467379100|FG009|Overall Study|Physician Decision|0|||
129840030|NCT03013543|467379091|FG000|Overall Study|Protocol Violation|0|||
129840031|NCT03013543|467379092|FG001|Overall Study|Protocol Violation|0|||
129840032|NCT03013543|467379093|FG002|Overall Study|Protocol Violation|0|||
129840033|NCT03013543|467379094|FG003|Overall Study|Protocol Violation|0|||
129840034|NCT03013543|467379095|FG004|Overall Study|Protocol Violation|0|||
129840035|NCT03013543|467379096|FG005|Overall Study|Protocol Violation|0|||
129840036|NCT03013543|467379097|FG006|Overall Study|Protocol Violation|0|||
129840037|NCT03013543|467379098|FG007|Overall Study|Protocol Violation|0|||
129840038|NCT03013543|467379099|FG008|Overall Study|Protocol Violation|0|||
129840039|NCT03013543|467379100|FG009|Overall Study|Protocol Violation|1|||
129840040|NCT01537783|467379107|FG000|Overall Study|Lost to Follow-up|11|||
129840041|NCT01537783|467379108|FG001|Overall Study|Lost to Follow-up|2|||
129840042|NCT02722928|467379111|FG000|Overall Study|Standard CT was not as required per prot|5|||
129840043|NCT02722928|467379112|FG001|Overall Study|Standard CT was not as required per prot|13|||
129840044|NCT02722928|467379111|FG000|Overall Study|Required Intraoperative MRI|5|||
129840045|NCT02722928|467379112|FG001|Overall Study|Required Intraoperative MRI|7|||
129840046|NCT01838642|467379113|FG000|Overall Study|Died on study|1|||
129840047|NCT01398956|467379114|FG000|Overall Study|Withdrawal by Subject|4|||
129840048|NCT01398956|467379114|FG000|Overall Study|AE, non-serious non-fatal|4|||
129840049|NCT01398956|467379114|FG000|Overall Study|Withdrawal Criteria No.3|1|||
129840050|NCT01398956|467379114|FG000|Overall Study|Subject moved a long distance|1|||
129840051|NCT01557400|467379115|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
129840052|NCT01557400|467379115|FG000|Overall Study|Adverse Event|3|||
129840053|NCT01557400|467379115|FG000|Overall Study|Lost to Follow-up|5|||
129840054|NCT01557400|467379115|FG000|Overall Study|Withdrawal by Subject|9|||
129840055|NCT02281552|467379118|FG000|Overall Study|Medication error|1|||
129840056|NCT02281552|467379119|FG001|Overall Study|Medication error|0|||
129840057|NCT02281552|467379118|FG000|Overall Study|Insufficient clinical response|0|||
129840058|NCT02281552|467379119|FG001|Overall Study|Insufficient clinical response|1|||
129840059|NCT02281552|467379118|FG000|Overall Study|Adverse Event|3|||
129840060|NCT02281552|467379119|FG001|Overall Study|Adverse Event|9|||
129840061|NCT01224639|467379120|FG000|Overall Study|Withdrawal by Subject|0|||
129840062|NCT01224639|467379121|FG001|Overall Study|Withdrawal by Subject|0|||
129840063|NCT01224639|467379122|FG002|Overall Study|Withdrawal by Subject|0|||
129840064|NCT01224639|467379123|FG003|Overall Study|Withdrawal by Subject|0|||
129840065|NCT01224639|467379124|FG004|Overall Study|Withdrawal by Subject|2|||
129840066|NCT01224639|467379125|FG005|Overall Study|Withdrawal by Subject|0|||
129840067|NCT01224639|467379126|FG006|Overall Study|Withdrawal by Subject|1|||
129840068|NCT01224639|467379127|FG007|Overall Study|Withdrawal by Subject|1|||
129840069|NCT01224639|467379120|FG000|Overall Study|Adverse Event|0|||
129840070|NCT01224639|467379121|FG001|Overall Study|Adverse Event|0|||
129840071|NCT01224639|467379122|FG002|Overall Study|Adverse Event|0|||
129840072|NCT01224639|467379123|FG003|Overall Study|Adverse Event|0|||
129840073|NCT01224639|467379124|FG004|Overall Study|Adverse Event|0|||
129840074|NCT01224639|467379125|FG005|Overall Study|Adverse Event|0|||
129840075|NCT01224639|467379126|FG006|Overall Study|Adverse Event|0|||
129840076|NCT01224639|467379127|FG007|Overall Study|Adverse Event|1|||
129840077|NCT03465878|467379128|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
129840078|NCT03465878|467379129|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
129840079|NCT03465878|467379130|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
129840080|NCT03465878|467379131|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
129840081|NCT03465878|467379128|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
129840082|NCT03465878|467379129|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
129840083|NCT03465878|467379130|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
129840084|NCT03465878|467379131|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
129840085|NCT03465878|467379128|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
129840086|NCT03465878|467379129|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
129840087|NCT03465878|467379130|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
129840088|NCT03465878|467379131|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
129840089|NCT04656132|467379132|FG000|Overall Study|Lost to Follow-up|4|||
129840090|NCT04656132|467379132|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
129840091|NCT04365699|467379133|FG000|Overall Study|Death|2|||
129840092|NCT04365699|467379134|FG001|Overall Study|Death|5|||
129840093|NCT04365699|467379135|FG002|Overall Study|Death|15|||
129840094|NCT02540954|467379136|FG000|Overall Study|Physician Decision|3|||
129840095|NCT02540954|467379137|FG001|Overall Study|Physician Decision|1|||
129840096|NCT02540954|467379136|FG000|Overall Study|Withdrawal by Subject|6|||
129840097|NCT02540954|467379137|FG001|Overall Study|Withdrawal by Subject|5|||
129840098|NCT02540954|467379136|FG000|Overall Study|Lost to Follow-up|1|||
129840099|NCT02540954|467379137|FG001|Overall Study|Lost to Follow-up|1|||
129840100|NCT02540954|467379136|FG000|Overall Study|Adverse Event|4|||
129840101|NCT02540954|467379137|FG001|Overall Study|Adverse Event|2|||
129840102|NCT02540954|467379136|FG000|Overall Study|Death|0|||
129840103|NCT02540954|467379137|FG001|Overall Study|Death|3|||
129840104|NCT02540954|467379136|FG000|Overall Study|Treatment failure|1|||
129840105|NCT02540954|467379137|FG001|Overall Study|Treatment failure|0|||
129840106|NCT02540954|467379136|FG000|Overall Study|Other reason|4|||
129840107|NCT02540954|467379137|FG001|Overall Study|Other reason|2|||
129840108|NCT00834912|467379140|FG000|Treatment Period 1|Adverse Event|0|||
129840109|NCT00834912|467379141|FG001|Treatment Period 1|Adverse Event|1|||
129840110|NCT00834912|467379142|FG002|Treatment Period 1|Adverse Event|0|||
129840111|NCT00834912|467379143|FG003|Treatment Period 1|Adverse Event|1|||
129840112|NCT00834912|467379144|FG004|Treatment Period 1|Adverse Event|0|||
129840113|NCT00834912|467379145|FG005|Treatment Period 1|Adverse Event|0|||
129840114|NCT00834912|467379140|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129840115|NCT00834912|467379141|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129840116|NCT00834912|467379142|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129840117|NCT00834912|467379143|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129840118|NCT00834912|467379144|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129840119|NCT00834912|467379145|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129840120|NCT03829046|467379146|FG000|Overall Study|Withdrawal by Subject|1|||
129840121|NCT03829046|467379147|FG001|Overall Study|Withdrawal by Subject|0|||
129840122|NCT00244712|467379150|FG000|Overall Study|Adverse Event|20|||
129840123|NCT00244712|467379151|FG001|Overall Study|Adverse Event|21|||
129840124|NCT00244712|467379150|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
129840125|NCT00244712|467379151|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
129840126|NCT00244712|467379150|FG000|Overall Study|Lack of Compliance|10|||
129840127|NCT00244712|467379151|FG001|Overall Study|Lack of Compliance|11|||
129840128|NCT00244712|467379150|FG000|Overall Study|Lost to Follow-up|45|||
129840129|NCT00244712|467379151|FG001|Overall Study|Lost to Follow-up|52|||
129840130|NCT00244712|467379150|FG000|Overall Study|Withdrawal by Subject|13|||
129840131|NCT00244712|467379151|FG001|Overall Study|Withdrawal by Subject|23|||
129840132|NCT00244712|467379150|FG000|Overall Study|Protocol Violation, disease progression|13|||
129840133|NCT00244712|467379151|FG001|Overall Study|Protocol Violation, disease progression|11|||
129840134|NCT00500370|467379162|FG000|Overall Study|Adverse Event|9|||
129840135|NCT00500370|467379163|FG001|Overall Study|Adverse Event|3|||
129840136|NCT00500370|467379162|FG000|Overall Study|Lost to Follow-up|10|||
129840137|NCT00500370|467379163|FG001|Overall Study|Lost to Follow-up|10|||
129840138|NCT00500370|467379162|FG000|Overall Study|Protocol Violation|2|||
129840139|NCT00500370|467379163|FG001|Overall Study|Protocol Violation|4|||
129840140|NCT00500370|467379162|FG000|Overall Study|Sponsor Decision|2|||
129840141|NCT00500370|467379163|FG001|Overall Study|Sponsor Decision|0|||
129840142|NCT00500370|467379162|FG000|Overall Study|Subject Decision|10|||
129840143|NCT00500370|467379163|FG001|Overall Study|Subject Decision|17|||
129840144|NCT04804813|467379164|FG000|Overall Study|Protocol Violation|2|||
129840145|NCT04804813|467379165|FG001|Overall Study|Protocol Violation|0|||
129840146|NCT04804813|467379164|FG000|Overall Study|Withdrawal by Subject|1|||
129840147|NCT04804813|467379165|FG001|Overall Study|Withdrawal by Subject|0|||
129840148|NCT02777125|467379168|FG000|Overall Study|Consent form violation|14|||
129840149|NCT02777125|467379169|FG001|Overall Study|Consent form violation|12|||
129840150|NCT02777125|467379168|FG000|Overall Study|Assent form violation|21|||
129448080|NCT03519867|465939203|FG008|Overall Study|Reason not provided|1|||
129448081|NCT03519867|465939204|FG009|Overall Study|Reason not provided|0|||
129448082|NCT01252810|465939205|FG000|Overall Study|Withdrawal by Subject|4|||
129448083|NCT01252810|465939206|FG001|Overall Study|Withdrawal by Subject|1|||
129448084|NCT01252810|465939205|FG000|Overall Study|Lost to Follow-up|0|||
129448085|NCT01252810|465939206|FG001|Overall Study|Lost to Follow-up|1|||
129448086|NCT01252810|465939205|FG000|Overall Study|Physician Decision|2|||
129448087|NCT01252810|465939206|FG001|Overall Study|Physician Decision|1|||
129448088|NCT01252810|465939205|FG000|Overall Study|Various reasons|8|||
129448089|NCT01252810|465939206|FG001|Overall Study|Various reasons|0|||
129448090|NCT01428661|465939208|FG000|Double-Masked Phase|Protocol Violation|9|||
129448091|NCT01428661|465939209|FG001|Double-Masked Phase|Protocol Violation|4|||
129448092|NCT01428661|465939210|FG002|Double-Masked Phase|Protocol Violation|0|||
129448093|NCT01428661|465939208|FG000|Double-Masked Phase|Adverse Event|13|||
129448094|NCT01428661|465939209|FG001|Double-Masked Phase|Adverse Event|4|||
129448095|NCT01428661|465939210|FG002|Double-Masked Phase|Adverse Event|0|||
129448096|NCT01428661|465939208|FG000|Double-Masked Phase|Lost to Follow-up|14|||
129840151|NCT02777125|467379169|FG001|Overall Study|Assent form violation|23|||
129840152|NCT02777125|467379168|FG000|Overall Study|Protocol Violation|8|||
129840153|NCT02777125|467379169|FG001|Overall Study|Protocol Violation|12|||
129840154|NCT06023394|467379170|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
129840155|NCT06023394|467379171|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
129840156|NCT06023394|467379170|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
129448097|NCT01428661|465939209|FG001|Double-Masked Phase|Lost to Follow-up|14|||
129448098|NCT01428661|465939210|FG002|Double-Masked Phase|Lost to Follow-up|0|||
129448099|NCT01428661|465939208|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
129448100|NCT01428661|465939209|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
129448101|NCT01428661|465939210|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
129899314|NCT04304534|467591819|FG002|Overall Study|Technical Problems|3|||
129899315|NCT04304534|467591820|FG003|Overall Study|Technical Problems|4|||
129899316|NCT04304534|467591817|FG000|Overall Study|Death|7|||
129899317|NCT04304534|467591818|FG001|Overall Study|Death|2|||
129899318|NCT04304534|467591819|FG002|Overall Study|Death|4|||
129899319|NCT04304534|467591820|FG003|Overall Study|Death|3|||
129899320|NCT04304534|467591817|FG000|Overall Study|Withdrawal by Subject|7|||
129899321|NCT04304534|467591818|FG001|Overall Study|Withdrawal by Subject|2|||
129899322|NCT04304534|467591819|FG002|Overall Study|Withdrawal by Subject|7|||
129899323|NCT04304534|467591820|FG003|Overall Study|Withdrawal by Subject|4|||
129899324|NCT04304534|467591817|FG000|Overall Study|Physician Decision|4|||
129899325|NCT04304534|467591818|FG001|Overall Study|Physician Decision|9|||
129899326|NCT04304534|467591819|FG002|Overall Study|Physician Decision|9|||
129899327|NCT04304534|467591820|FG003|Overall Study|Physician Decision|5|||
129899328|NCT04304534|467591817|FG000|Overall Study|Subject Decision|34|||
129899329|NCT04304534|467591818|FG001|Overall Study|Subject Decision|25|||
129899330|NCT04304534|467591819|FG002|Overall Study|Subject Decision|25|||
129899331|NCT04304534|467591820|FG003|Overall Study|Subject Decision|26|||
129899332|NCT04304534|467591817|FG000|Overall Study|Adverse Event|35|||
129899333|NCT04304534|467591818|FG001|Overall Study|Adverse Event|40|||
129899334|NCT04304534|467591819|FG002|Overall Study|Adverse Event|39|||
129899335|NCT04304534|467591820|FG003|Overall Study|Adverse Event|44|||
129899336|NCT04580303|467591821|FG000|Overall Study|Adverse Event|0|||
129899337|NCT04580303|467591822|FG001|Overall Study|Adverse Event|1|||
129899338|NCT04580303|467591823|FG002|Overall Study|Adverse Event|0|||
129899339|NCT04580303|467591824|FG003|Overall Study|Adverse Event|0|||
129899340|NCT04580303|467591821|FG000|Overall Study|Withdrawal by Subject|0|||
129840157|NCT06023394|467379171|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
129840158|NCT06023394|467379170|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
129840159|NCT06023394|467379171|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
129840160|NCT06023394|467379170|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
129840161|NCT06023394|467379171|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
129840162|NCT01581593|467380712|FG000|Overall Study|Withdrawal by Subject|1|||
129840163|NCT02970968|467380713|FG000|Overall Study|Withdrawal by Subject|3|||
129840164|NCT02970968|467380714|FG001|Overall Study|Withdrawal by Subject|3|||
129840165|NCT02970968|467380713|FG000|Overall Study|Adverse Event|1|||
129840166|NCT02970968|467380714|FG001|Overall Study|Adverse Event|2|||
129840167|NCT02970968|467380713|FG000|Overall Study|Lost to Follow-up|1|||
129840168|NCT02970968|467380714|FG001|Overall Study|Lost to Follow-up|1|||
129840169|NCT02970968|467380713|FG000|Overall Study|Non-Compliance|0|||
129840170|NCT02970968|467380714|FG001|Overall Study|Non-Compliance|1|||
129840171|NCT04127786|467380719|FG000|Primary Series|Adverse Event|1|||
129840172|NCT04127786|467380720|FG001|Primary Series|Adverse Event|0|||
129840173|NCT04127786|467380721|FG002|Primary Series|Adverse Event|0|||
129840174|NCT04127786|467380722|FG003|Primary Series|Adverse Event|1|||
129840175|NCT04127786|467380723|FG004|Primary Series|Adverse Event|0|||
129840176|NCT04127786|467380724|FG005|Primary Series|Adverse Event|1|||
129840177|NCT04127786|467380719|FG000|Primary Series|Protocol Violation|5|||
129840178|NCT04127786|467380720|FG001|Primary Series|Protocol Violation|3|||
129840179|NCT04127786|467380721|FG002|Primary Series|Protocol Violation|4|||
129840180|NCT04127786|467380722|FG003|Primary Series|Protocol Violation|3|||
129840181|NCT04127786|467380723|FG004|Primary Series|Protocol Violation|2|||
129840182|NCT04127786|467380724|FG005|Primary Series|Protocol Violation|0|||
129840183|NCT04127786|467380719|FG000|Primary Series|Withdrawal by Subject|0|||
129840184|NCT04127786|467380720|FG001|Primary Series|Withdrawal by Subject|0|||
129840185|NCT04127786|467380721|FG002|Primary Series|Withdrawal by Subject|0|||
129840186|NCT04127786|467380722|FG003|Primary Series|Withdrawal by Subject|1|||
129840187|NCT04127786|467380723|FG004|Primary Series|Withdrawal by Subject|0|||
129840188|NCT04127786|467380724|FG005|Primary Series|Withdrawal by Subject|0|||
129840189|NCT04127786|467380719|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
129840190|NCT04127786|467380720|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
129840191|NCT04127786|467380721|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
129840192|NCT04127786|467380722|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
129840193|NCT04127786|467380723|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
129840194|NCT04127786|467380724|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
129899341|NCT04580303|467591822|FG001|Overall Study|Withdrawal by Subject|0|||
129899342|NCT04580303|467591823|FG002|Overall Study|Withdrawal by Subject|1|||
129899343|NCT04580303|467591824|FG003|Overall Study|Withdrawal by Subject|0|||
129899344|NCT02299635|467591826|FG000|Overall Study|Adverse Event|2|||
129899345|NCT02299635|467591826|FG000|Overall Study|Death|1|||
129448102|NCT01428661|465939208|FG000|Double-Masked Phase|Lack of Efficacy|2|||
129899346|NCT02299635|467591826|FG000|Overall Study|Global deterioration of health status|1|||
129899347|NCT02299635|467591826|FG000|Overall Study|Objective progression or relapse|10|||
129840195|NCT04127786|467380719|FG000|Booster Phase|Withdrawal by Subject|2|||
129840196|NCT04127786|467380720|FG001|Booster Phase|Withdrawal by Subject|0|||
129840197|NCT04127786|467380721|FG002|Booster Phase|Withdrawal by Subject|0|||
129448103|NCT01428661|465939209|FG001|Double-Masked Phase|Lack of Efficacy|1|||
129448104|NCT01428661|465939210|FG002|Double-Masked Phase|Lack of Efficacy|0|||
129448105|NCT01428661|465939208|FG000|Double-Masked Phase|*Various|1|||
129448106|NCT01428661|465939209|FG001|Double-Masked Phase|*Various|6|||
129448107|NCT01428661|465939210|FG002|Double-Masked Phase|*Various|0|||
129448108|NCT01428661|465939208|FG000|Open Label Extension|Protocol Violation|0|||
129448109|NCT01428661|465939209|FG001|Open Label Extension|Protocol Violation|0|||
129448110|NCT01428661|465939210|FG002|Open Label Extension|Protocol Violation|9|||
129448111|NCT01428661|465939208|FG000|Open Label Extension|Adverse Event|0|||
129448112|NCT01428661|465939209|FG001|Open Label Extension|Adverse Event|0|||
129448113|NCT01428661|465939210|FG002|Open Label Extension|Adverse Event|15|||
129448114|NCT01428661|465939208|FG000|Open Label Extension|Lost to Follow-up|0|||
129448115|NCT01428661|465939209|FG001|Open Label Extension|Lost to Follow-up|0|||
129448116|NCT01428661|465939210|FG002|Open Label Extension|Lost to Follow-up|38|||
129448117|NCT01428661|465939208|FG000|Open Label Extension|Withdrawal by Subject|0|||
129448118|NCT01428661|465939209|FG001|Open Label Extension|Withdrawal by Subject|0|||
129448119|NCT01428661|465939210|FG002|Open Label Extension|Withdrawal by Subject|49|||
129448120|NCT01428661|465939208|FG000|Open Label Extension|Lack of Efficacy|0|||
129448121|NCT01428661|465939209|FG001|Open Label Extension|Lack of Efficacy|0|||
129448122|NCT01428661|465939210|FG002|Open Label Extension|Lack of Efficacy|24|||
129448123|NCT01428661|465939208|FG000|Open Label Extension|**Various|0|||
129448124|NCT01428661|465939209|FG001|Open Label Extension|**Various|0|||
129448125|NCT01428661|465939210|FG002|Open Label Extension|**Various|185|||
129448126|NCT00761306|465941465|FG000|Overall Study|Adverse Event|5|||
129448127|NCT00761306|465941465|FG000|Overall Study|Lack of Efficacy|4|||
129448128|NCT00761306|465941465|FG000|Overall Study|Protocol Violation|2|||
129448129|NCT00761306|465941465|FG000|Overall Study|Withdrawal of Consent|3|||
129448130|NCT00761306|465941465|FG000|Overall Study|Lost to Follow-up|1|||
129448131|NCT00761306|465941465|FG000|Overall Study|Administrative or Other Reasons|5|||
129448132|NCT05162027|465941466|FG000|Overall Study|Adverse Event|1|||
129448133|NCT05162027|465941467|FG001|Overall Study|Adverse Event|0|||
129448134|NCT03335163|465941468|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
129448135|NCT03335163|465941468|FG000|Overall Study|Withdrawal by Subject|18|||
129448136|NCT03713034|465941469|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
129448137|NCT03713034|465941470|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
129448138|NCT02982239|465941473|FG000|Overall Study|Lost to Follow-up|3|||
129448139|NCT02982239|465941474|FG001|Overall Study|Lost to Follow-up|2|||
129448140|NCT02767323|465941478|FG000|Overall Study|Withdrawal by Subject|17|||
129448141|NCT02767323|465941479|FG001|Overall Study|Withdrawal by Subject|5|||
129448142|NCT02767323|465941480|FG002|Overall Study|Withdrawal by Subject|13|||
129448143|NCT02767323|465941481|FG003|Overall Study|Withdrawal by Subject|0|||
129448144|NCT02767323|465941478|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
129448145|NCT02767323|465941479|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
129448146|NCT02767323|465941480|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
129448147|NCT02767323|465941481|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
129448148|NCT01526551|465941486|FG000|Overall Study|Lack of returned parental consent form|424|||
129448149|NCT02606461|465941487|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
129448150|NCT02606461|465941488|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
129448151|NCT02606461|465941489|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
129448152|NCT02606461|465941490|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
129448153|NCT02606461|465941491|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
129448154|NCT02606461|465941492|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
129448155|NCT02092350|465941493|FG000|Overall Study|Adverse Event|0|||
129448156|NCT02092350|465941494|FG001|Overall Study|Adverse Event|3|||
129448157|NCT02092350|465941493|FG000|Overall Study|Death|2|||
129448158|NCT02092350|465941494|FG001|Overall Study|Death|5|||
129448159|NCT02092350|465941493|FG000|Overall Study|Lost to Follow-up|3|||
129448160|NCT02092350|465941494|FG001|Overall Study|Lost to Follow-up|1|||
129448161|NCT02092350|465941493|FG000|Overall Study|Protocol Violation|1|||
129448162|NCT02092350|465941494|FG001|Overall Study|Protocol Violation|0|||
129448163|NCT02092350|465941493|FG000|Overall Study|Physician Decision|1|||
129448164|NCT02092350|465941494|FG001|Overall Study|Physician Decision|1|||
129448165|NCT02092350|465941493|FG000|Overall Study|Screen Failure|1|||
129448166|NCT02092350|465941494|FG001|Overall Study|Screen Failure|0|||
129448167|NCT02092350|465941493|FG000|Overall Study|Withdrawal by Subject|2|||
129448168|NCT02092350|465941494|FG001|Overall Study|Withdrawal by Subject|2|||
129448169|NCT02448225|465941495|FG000|Overall Study|Withdrawal by Subject|1|||
129448170|NCT02448225|465941495|FG000|Overall Study|Did not get FSPG scan|18|||
129448171|NCT02448225|465941495|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
129448172|NCT04422990|465941501|FG000|Overall Study|Withdrawal by Subject|0|||
129448173|NCT04422990|465941502|FG001|Overall Study|Withdrawal by Subject|1|||
129448174|NCT04422990|465941501|FG000|Overall Study|Travel|3|||
129448175|NCT04422990|465941502|FG001|Overall Study|Travel|0|||
129840198|NCT04127786|467380722|FG003|Booster Phase|Withdrawal by Subject|0|||
129840199|NCT04127786|467380723|FG004|Booster Phase|Withdrawal by Subject|0|||
129840200|NCT04127786|467380724|FG005|Booster Phase|Withdrawal by Subject|0|||
129840201|NCT03568942|467380725|FG000|Overall Study|Family emergency|1|||
129840202|NCT03568942|467380725|FG000|Overall Study|Lost to Follow-up|1|||
129840203|NCT01945489|467380726|FG000|Cycle 1|Adverse Event|2|||
129840204|NCT01945489|467380727|FG001|Cycle 1|Adverse Event|0|||
129840205|NCT01945489|467380726|FG000|Cycle 1|Lost to Follow-up|4|||
129840206|NCT01945489|467380727|FG001|Cycle 1|Lost to Follow-up|0|||
129840207|NCT01945489|467380726|FG000|Cycle 1|Personal Reasons|4|||
129840208|NCT01945489|467380727|FG001|Cycle 1|Personal Reasons|2|||
129840209|NCT01945489|467380726|FG000|Cycle 1|Protocol Violation|0|||
129840210|NCT01945489|467380727|FG001|Cycle 1|Protocol Violation|1|||
129840211|NCT01945489|467380726|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
129840212|NCT01945489|467380727|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
129840213|NCT01945489|467380726|FG000|Cycle 2|Adverse Event|1|||
129840214|NCT01945489|467380727|FG001|Cycle 2|Adverse Event|0|||
129840215|NCT01945489|467380726|FG000|Cycle 2|Lost to Follow-up|0|||
129840216|NCT01945489|467380727|FG001|Cycle 2|Lost to Follow-up|1|||
129840217|NCT00358527|467380728|FG000|Overall Study|Adverse Event|4|||
129840218|NCT00358527|467380729|FG001|Overall Study|Adverse Event|0|||
129840219|NCT00358527|467380728|FG000|Overall Study|Withdrawal by Subject|1|||
129840220|NCT00358527|467380729|FG001|Overall Study|Withdrawal by Subject|1|||
129840221|NCT00358527|467380728|FG000|Overall Study|Non-compliance with protocol|6|||
129840222|NCT00358527|467380729|FG001|Overall Study|Non-compliance with protocol|1|||
129840223|NCT00358527|467380728|FG000|Overall Study|Administrative|2|||
129840224|NCT00358527|467380729|FG001|Overall Study|Administrative|1|||
129840225|NCT04144166|467380730|FG000|Overall Study|Discharged before study start|1|||
129840226|NCT04144166|467380730|FG000|Overall Study|Pregnancy|1|||
129840227|NCT04144166|467380730|FG000|Overall Study|Nail polish could not be removed from finger|1|||
129840228|NCT03569371|467380731|FG000|Overall Study|Lack of Efficacy|1|||
129840229|NCT03569371|467380731|FG000|Overall Study|Lost to Follow-up|1|||
129840230|NCT03569371|467380731|FG000|Overall Study|Adverse Event|1|||
129840231|NCT04145895|467380732|FG000|Overall Study|Physician Decision|2|||
129840232|NCT04145895|467380733|FG001|Overall Study|Physician Decision|0|||
129840233|NCT04145895|467380732|FG000|Overall Study|Withdrawal by Subject|0|||
129840234|NCT04145895|467380733|FG001|Overall Study|Withdrawal by Subject|2|||
129840235|NCT01236755|467380734|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
129840236|NCT01236755|467380734|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
129840237|NCT01236755|467380734|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
129840238|NCT01236755|467380734|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
129840239|NCT04904185|467380735|FG000|Overall Study|Expansion failure|1|||
129840240|NCT04904185|467380736|FG001|Overall Study|Expansion failure|0|||
129840241|NCT04904185|467380735|FG000|Overall Study|Late response on prior treatment|1|||
129840242|NCT04904185|467380736|FG001|Overall Study|Late response on prior treatment|0|||
129840243|NCT02433834|467380740|FG000|Overall Study|Protocol-specified criteria|7|||
129840244|NCT02433834|467380740|FG000|Overall Study|Protocol Violation|3|||
129840245|NCT02433834|467380740|FG000|Overall Study|Lost to Follow-up|6|||
129840246|NCT02433834|467380740|FG000|Overall Study|Withdrawal by Subject|14|||
129840247|NCT02433834|467380740|FG000|Overall Study|Adverse Event|6|||
129840248|NCT02433834|467380740|FG000|Overall Study|Physician Decision|1|||
129840249|NCT02643251|467380741|FG000|Overall Study|Adverse Event|3|||
129840250|NCT02643251|467380742|FG001|Overall Study|Adverse Event|1|||
129840251|NCT02643251|467380741|FG000|Overall Study|Withdrawal by Subject|2|||
129840252|NCT02643251|467380742|FG001|Overall Study|Withdrawal by Subject|0|||
129840253|NCT02643251|467380741|FG000|Overall Study|Lost to Follow-up|4|||
129840254|NCT02643251|467380742|FG001|Overall Study|Lost to Follow-up|1|||
129899348|NCT02299635|467591826|FG000|Overall Study|Withdrawal by Subject|2|||
129840255|NCT02643251|467380741|FG000|Overall Study|Protocol Violation|1|||
129840256|NCT02643251|467380742|FG001|Overall Study|Protocol Violation|0|||
129840257|NCT02643251|467380741|FG000|Overall Study|PI Decision to terminate patient|1|||
129840258|NCT02643251|467380742|FG001|Overall Study|PI Decision to terminate patient|0|||
129840259|NCT00333229|467380743|FG000|Overall Study|Lack of Efficacy|0|||
129840260|NCT00333229|467380744|FG001|Overall Study|Lack of Efficacy|1|||
129840261|NCT00348556|467380747|FG000|Overall Study|Adverse Event|1|||
129840262|NCT01944059|467380748|FG000|Overall Study|Lost to Follow-up|1|||
129840263|NCT01944059|467380748|FG000|Overall Study|Physician Decision|3|||
129840264|NCT01944059|467380748|FG000|Overall Study|Withdrawal by Subject|1|||
129840265|NCT01944059|467380748|FG000|Overall Study|Adverse Event|2|||
129840266|NCT02365636|467380749|FG000|Overall Study|Adverse Event|3|||
129840267|NCT02365636|467380750|FG001|Overall Study|Adverse Event|3|||
129840268|NCT02365636|467380751|FG002|Overall Study|Adverse Event|2|||
129840269|NCT02365636|467380749|FG000|Overall Study|Protocol Violation|1|||
129840270|NCT02365636|467380750|FG001|Overall Study|Protocol Violation|4|||
129840271|NCT02365636|467380751|FG002|Overall Study|Protocol Violation|0|||
129840272|NCT02365636|467380749|FG000|Overall Study|Lost to Follow-up|0|||
129840273|NCT02365636|467380750|FG001|Overall Study|Lost to Follow-up|0|||
129840274|NCT02365636|467380751|FG002|Overall Study|Lost to Follow-up|1|||
129840275|NCT02365636|467380749|FG000|Overall Study|Other|2|||
129840276|NCT02365636|467380750|FG001|Overall Study|Other|0|||
129840277|NCT02365636|467380751|FG002|Overall Study|Other|0|||
129840278|NCT00463060|467380754|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
129840279|NCT00463060|467380754|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
129840280|NCT01802775|467380757|FG000|Overall Study|Death|0|||
129840281|NCT01802775|467380758|FG001|Overall Study|Death|3|||
129840282|NCT01802775|467380757|FG000|Overall Study|Reason not provided|0|||
129840283|NCT01802775|467380758|FG001|Overall Study|Reason not provided|1|||
129840284|NCT01802775|467380757|FG000|Overall Study|Physician Decision|1|||
129840285|NCT01802775|467380758|FG001|Overall Study|Physician Decision|0|||
129840286|NCT01802775|467380757|FG000|Overall Study|Adverse Event|1|||
129840287|NCT01802775|467380758|FG001|Overall Study|Adverse Event|1|||
129840288|NCT01802775|467380757|FG000|Overall Study|Withdrawal by Subject|3|||
129840289|NCT01802775|467380758|FG001|Overall Study|Withdrawal by Subject|5|||
129840290|NCT01802775|467380757|FG000|Overall Study|Lost to Follow-up|1|||
129840291|NCT01802775|467380758|FG001|Overall Study|Lost to Follow-up|2|||
129840292|NCT01067352|467380763|FG000|Overall Study|Withdrawal by Subject|1|||
129840293|NCT01067352|467380764|FG001|Overall Study|Withdrawal by Subject|2|||
129840294|NCT01067352|467380765|FG002|Overall Study|Withdrawal by Subject|1|||
129840295|NCT01067352|467380763|FG000|Overall Study|Physician Decision|0|||
129840296|NCT01067352|467380764|FG001|Overall Study|Physician Decision|1|||
129840297|NCT01067352|467380765|FG002|Overall Study|Physician Decision|0|||
129840298|NCT01096784|467380766|FG000|Overall Study|Withdrawal by Subject|2|||
129840299|NCT01096784|467380767|FG001|Overall Study|Withdrawal by Subject|1|||
129840300|NCT01096784|467380766|FG000|Overall Study|Adverse Event|11|||
129840301|NCT01096784|467380767|FG001|Overall Study|Adverse Event|9|||
129840302|NCT01096784|467380766|FG000|Overall Study|Protocol Deviation|2|||
129840303|NCT01096784|467380767|FG001|Overall Study|Protocol Deviation|2|||
129840304|NCT01096784|467380766|FG000|Overall Study|Administrative Decision|0|||
129840305|NCT01096784|467380767|FG001|Overall Study|Administrative Decision|1|||
129840306|NCT01096784|467380766|FG000|Overall Study|Other Unspecified|0|||
129840307|NCT01096784|467380767|FG001|Overall Study|Other Unspecified|1|||
129840308|NCT05923229|467380768|FG000|Overall Study|Withdrawal by Subject|3|||
129840309|NCT05923229|467380769|FG001|Overall Study|Withdrawal by Subject|0|||
129840310|NCT05923229|467380768|FG000|Overall Study|Health related|2|||
129840311|NCT05923229|467380769|FG001|Overall Study|Health related|1|||
129840312|NCT03064126|467380770|FG000|Overall Study|Death|40|||
129840313|NCT03064126|467380771|FG001|Overall Study|Death|16|||
129840314|NCT03064126|467380772|FG002|Overall Study|Death|4|||
129840315|NCT03064126|467380773|FG003|Overall Study|Death|2|||
129840316|NCT03064126|467380770|FG000|Overall Study|Withdrawal by Subject|17|||
129840317|NCT03064126|467380771|FG001|Overall Study|Withdrawal by Subject|9|||
129840318|NCT03064126|467380772|FG002|Overall Study|Withdrawal by Subject|0|||
129840319|NCT03064126|467380773|FG003|Overall Study|Withdrawal by Subject|2|||
129840320|NCT03064126|467380770|FG000|Overall Study|Lost to Follow-up|7|||
129840321|NCT03064126|467380771|FG001|Overall Study|Lost to Follow-up|3|||
129840322|NCT03064126|467380772|FG002|Overall Study|Lost to Follow-up|0|||
129840323|NCT03064126|467380773|FG003|Overall Study|Lost to Follow-up|0|||
129840324|NCT03064126|467380770|FG000|Overall Study|Adverse Event|2|||
129840325|NCT03064126|467380771|FG001|Overall Study|Adverse Event|0|||
129448176|NCT00433914|465941505|FG000|Overall Study|Withdrawal by Subject|0|||
129448177|NCT00433914|465941506|FG001|Overall Study|Withdrawal by Subject|2|||
129448178|NCT00433914|465941505|FG000|Overall Study|Lost to Follow-up|0|||
129448179|NCT00433914|465941506|FG001|Overall Study|Lost to Follow-up|1|||
129448180|NCT02844920|465941507|FG000|Overall Study|Lost to Follow-up|2|||
129448181|NCT00800436|465941518|FG000|Overall Study|Withdrawal by Subject|0|||
129448182|NCT00800436|465941519|FG001|Overall Study|Withdrawal by Subject|0|||
129448183|NCT00800436|465941520|FG002|Overall Study|Withdrawal by Subject|1|||
129448184|NCT00800436|465941521|FG003|Overall Study|Withdrawal by Subject|1|||
129840326|NCT03064126|467380772|FG002|Overall Study|Adverse Event|0|||
129840327|NCT03064126|467380773|FG003|Overall Study|Adverse Event|0|||
129840328|NCT03064126|467380770|FG000|Overall Study|Physician Decision|3|||
129840329|NCT03064126|467380771|FG001|Overall Study|Physician Decision|0|||
129840330|NCT03064126|467380772|FG002|Overall Study|Physician Decision|0|||
129840331|NCT03064126|467380773|FG003|Overall Study|Physician Decision|0|||
129840332|NCT03064126|467380770|FG000|Overall Study|Other reason for early termination|3|||
129840333|NCT03064126|467380771|FG001|Overall Study|Other reason for early termination|2|||
129840334|NCT03064126|467380772|FG002|Overall Study|Other reason for early termination|0|||
129840335|NCT03064126|467380773|FG003|Overall Study|Other reason for early termination|0|||
129840336|NCT03064126|467380770|FG000|Overall Study|Missed Visit|3|||
129840337|NCT03064126|467380771|FG001|Overall Study|Missed Visit|1|||
129840338|NCT03064126|467380772|FG002|Overall Study|Missed Visit|0|||
129840339|NCT03064126|467380773|FG003|Overall Study|Missed Visit|0|||
129840340|NCT02465528|467380774|FG000|Overall Study|Progressive disease|0|||
129840341|NCT02465528|467380775|FG001|Overall Study|Progressive disease|2|||
129840342|NCT02465528|467380776|FG002|Overall Study|Progressive disease|9|||
129840343|NCT02465528|467380777|FG003|Overall Study|Progressive disease|4|||
129840344|NCT02465528|467380774|FG000|Overall Study|Study terminated by sponsor|1|||
129840345|NCT02465528|467380775|FG001|Overall Study|Study terminated by sponsor|2|||
129840346|NCT02465528|467380776|FG002|Overall Study|Study terminated by sponsor|0|||
129840347|NCT02465528|467380777|FG003|Overall Study|Study terminated by sponsor|0|||
129840348|NCT02465528|467380774|FG000|Overall Study|Withdrawal by Subject|0|||
129840349|NCT02465528|467380775|FG001|Overall Study|Withdrawal by Subject|0|||
129840350|NCT02465528|467380776|FG002|Overall Study|Withdrawal by Subject|2|||
129840351|NCT02465528|467380777|FG003|Overall Study|Withdrawal by Subject|0|||
129840352|NCT02465528|467380774|FG000|Overall Study|Adverse Event|0|||
129840353|NCT02465528|467380775|FG001|Overall Study|Adverse Event|0|||
129840354|NCT02465528|467380776|FG002|Overall Study|Adverse Event|0|||
129840355|NCT02465528|467380777|FG003|Overall Study|Adverse Event|1|||
129840356|NCT02465528|467380774|FG000|Overall Study|Physician Decision|0|||
129840357|NCT02465528|467380775|FG001|Overall Study|Physician Decision|0|||
129840358|NCT02465528|467380776|FG002|Overall Study|Physician Decision|1|||
129840359|NCT02465528|467380777|FG003|Overall Study|Physician Decision|0|||
129840360|NCT00846742|467380780|FG000|Overall Study|Withdrawal by Subject|1|||
129840361|NCT03795610|467380782|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
129840362|NCT03795610|467380782|FG000|Overall Study|Withdrawal by Subject|1|||
129840363|NCT03795610|467380782|FG000|Overall Study|Screen Failure (Unknown)|1|||
129840364|NCT03909165|467380787|FG000|Overall Study|Physician Decision|0|||
129840365|NCT03909165|467380788|FG001|Overall Study|Physician Decision|1|||
129840366|NCT03909165|467380789|FG002|Overall Study|Physician Decision|0|||
129840367|NCT03909165|467380790|FG003|Overall Study|Physician Decision|0|||
129840368|NCT03909165|467380791|FG004|Overall Study|Physician Decision|0|||
129840369|NCT03909165|467380787|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129840370|NCT03909165|467380788|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129840371|NCT03909165|467380789|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129840372|NCT03909165|467380790|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129840373|NCT03909165|467380791|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129840374|NCT03909165|467380787|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129840375|NCT03909165|467380788|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
129840376|NCT03909165|467380789|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
129840377|NCT03909165|467380790|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
129840378|NCT03909165|467380791|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
129840379|NCT03909165|467380787|FG000|Overall Study|Previous Drug Exposure|0|||
129840380|NCT03909165|467380788|FG001|Overall Study|Previous Drug Exposure|0|||
129840381|NCT03909165|467380789|FG002|Overall Study|Previous Drug Exposure|1|||
129840382|NCT03909165|467380790|FG003|Overall Study|Previous Drug Exposure|0|||
129840383|NCT03909165|467380791|FG004|Overall Study|Previous Drug Exposure|0|||
129840384|NCT03909165|467380787|FG000|Overall Study|Early Discharge|1|||
129840385|NCT03909165|467380788|FG001|Overall Study|Early Discharge|0|||
129840386|NCT03909165|467380789|FG002|Overall Study|Early Discharge|0|||
129840387|NCT03909165|467380790|FG003|Overall Study|Early Discharge|0|||
129840388|NCT03909165|467380791|FG004|Overall Study|Early Discharge|0|||
129840389|NCT01533246|467380793|FG000|Overall Study|Adverse Event|1|||
129840390|NCT01533246|467380793|FG000|Overall Study|Withdrawal by Subject|1|||
129840391|NCT03491150|467380794|FG000|Overall Study|Adverse Event|1|||
129840392|NCT03491150|467380795|FG001|Overall Study|Adverse Event|0|||
129840393|NCT03491150|467380794|FG000|Overall Study|Study Terminated by Sponsor|74|||
129840394|NCT03491150|467380795|FG001|Overall Study|Study Terminated by Sponsor|70|||
129840395|NCT03491150|467380794|FG000|Overall Study|Other|0|||
129840396|NCT03491150|467380795|FG001|Overall Study|Other|1|||
129840397|NCT03491150|467380794|FG000|Overall Study|Withdrawal by Subject|1|||
129840398|NCT03491150|467380795|FG001|Overall Study|Withdrawal by Subject|2|||
129840399|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
129840400|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840401|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840402|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840403|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840404|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840405|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
129840406|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
129840407|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840408|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840409|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840410|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840411|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840412|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
129840413|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
129840414|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840415|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840416|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840417|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840418|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840419|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
129840420|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
129840421|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840422|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840423|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840424|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840425|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840426|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
129840427|NCT01479621|467380796|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
129840428|NCT01479621|467380797|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840429|NCT01479621|467380798|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840430|NCT01479621|467380799|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840431|NCT01479621|467380800|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840432|NCT01479621|467380801|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840433|NCT01479621|467380802|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
129840434|NCT01479621|467380796|FG000|Treatment Period|Adverse Event|0|||
129840435|NCT01479621|467380797|FG001|Treatment Period|Adverse Event|0|||
129840436|NCT01479621|467380798|FG002|Treatment Period|Adverse Event|0|||
129840437|NCT01479621|467380799|FG003|Treatment Period|Adverse Event|0|||
129840438|NCT01479621|467380800|FG004|Treatment Period|Adverse Event|1|||
129840439|NCT01479621|467380801|FG005|Treatment Period|Adverse Event|2|||
129840440|NCT01479621|467380802|FG006|Treatment Period|Adverse Event|2|||
129840441|NCT01479621|467380796|FG000|Treatment Period|Withdrawal by Subject|0|||
129899349|NCT02299635|467591826|FG000|Overall Study|Other|3|||
129899350|NCT01456936|467591830|FG000|Overall Study|Other reason|41|||
129899351|NCT01456936|467591831|FG001|Overall Study|Other reason|30|||
129899352|NCT01456936|467591832|FG002|Overall Study|Other reason|36|||
129899353|NCT01456936|467591833|FG003|Overall Study|Other reason|33|||
129899354|NCT01456936|467591830|FG000|Overall Study|No longer meets eligibility criteria|4|||
129899355|NCT01456936|467591831|FG001|Overall Study|No longer meets eligibility criteria|8|||
129899356|NCT01456936|467591832|FG002|Overall Study|No longer meets eligibility criteria|6|||
129899357|NCT01456936|467591833|FG003|Overall Study|No longer meets eligibility criteria|5|||
129899358|NCT01456936|467591830|FG000|Overall Study|Protocol Violation|4|||
129899359|NCT01456936|467591831|FG001|Overall Study|Protocol Violation|2|||
129899360|NCT01456936|467591832|FG002|Overall Study|Protocol Violation|5|||
129899361|NCT01456936|467591833|FG003|Overall Study|Protocol Violation|5|||
129899362|NCT01456936|467591830|FG000|Overall Study|Pregnancy|1|||
129899363|NCT01456936|467591831|FG001|Overall Study|Pregnancy|0|||
129899364|NCT01456936|467591832|FG002|Overall Study|Pregnancy|0|||
129899365|NCT01456936|467591833|FG003|Overall Study|Pregnancy|1|||
129899366|NCT01456936|467591830|FG000|Overall Study|Insufficient clinical response|4|||
129899367|NCT01456936|467591831|FG001|Overall Study|Insufficient clinical response|4|||
129899368|NCT01456936|467591832|FG002|Overall Study|Insufficient clinical response|14|||
129899369|NCT01456936|467591833|FG003|Overall Study|Insufficient clinical response|13|||
129899370|NCT01456936|467591830|FG000|Overall Study|No longer willing to participate|195|||
129899371|NCT01456936|467591831|FG001|Overall Study|No longer willing to participate|218|||
129899372|NCT01456936|467591832|FG002|Overall Study|No longer willing to participate|224|||
129899373|NCT01456936|467591833|FG003|Overall Study|No longer willing to participate|248|||
129899374|NCT01456936|467591830|FG000|Overall Study|Lost to Follow-up|135|||
129899375|NCT01456936|467591831|FG001|Overall Study|Lost to Follow-up|126|||
129899376|NCT01456936|467591832|FG002|Overall Study|Lost to Follow-up|144|||
129899377|NCT01456936|467591833|FG003|Overall Study|Lost to Follow-up|127|||
129899378|NCT01456936|467591830|FG000|Overall Study|Medication error|0|||
129899379|NCT01456936|467591831|FG001|Overall Study|Medication error|1|||
129899380|NCT01456936|467591832|FG002|Overall Study|Medication error|0|||
129899381|NCT01456936|467591833|FG003|Overall Study|Medication error|1|||
129899382|NCT01456936|467591830|FG000|Overall Study|Adverse event (study drug)|25|||
129899383|NCT01456936|467591831|FG001|Overall Study|Adverse event (study drug)|21|||
129899384|NCT01456936|467591832|FG002|Overall Study|Adverse event (study drug)|26|||
129899385|NCT01456936|467591833|FG003|Overall Study|Adverse event (study drug)|17|||
129899386|NCT01456936|467591830|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
129899387|NCT01456936|467591831|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
129899388|NCT01456936|467591832|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
129899389|NCT01456936|467591833|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
129899390|NCT01456936|467591830|FG000|Overall Study|Death|0|||
129899391|NCT01456936|467591831|FG001|Overall Study|Death|3|||
129899392|NCT01456936|467591832|FG002|Overall Study|Death|1|||
129899393|NCT01456936|467591833|FG003|Overall Study|Death|3|||
129899394|NCT01456936|467591830|FG000|Overall Study|Randomized but not treated|21|||
129899395|NCT01456936|467591831|FG001|Overall Study|Randomized but not treated|28|||
129899396|NCT01456936|467591832|FG002|Overall Study|Randomized but not treated|16|||
129899397|NCT01456936|467591833|FG003|Overall Study|Randomized but not treated|21|||
129899398|NCT01710514|467591834|FG000|Overall Study|Adverse Event|6|||
129899399|NCT01710514|467591835|FG001|Overall Study|Adverse Event|7|||
129899400|NCT01710514|467591834|FG000|Overall Study|Withdrawal by Subject|1|||
129899401|NCT01710514|467591835|FG001|Overall Study|Withdrawal by Subject|0|||
129899402|NCT02750709|467591839|FG000|Treatment Period 1|Adverse Event|0|||
129899403|NCT02750709|467591840|FG001|Treatment Period 1|Adverse Event|0|||
129899404|NCT02750709|467591841|FG002|Treatment Period 1|Adverse Event|0|||
129899405|NCT02750709|467591842|FG003|Treatment Period 1|Adverse Event|0|||
129899406|NCT02750709|467591843|FG004|Treatment Period 1|Adverse Event|0|||
129448185|NCT00800436|465941522|FG004|Overall Study|Withdrawal by Subject|0|||
129448186|NCT00800436|465941523|FG005|Overall Study|Withdrawal by Subject|0|||
129448187|NCT00800436|465941524|FG006|Overall Study|Withdrawal by Subject|0|||
129899407|NCT02750709|467591844|FG005|Treatment Period 1|Adverse Event|1|||
129899408|NCT02595398|467591846|FG000|Overall Study|Non-compliance|1|||
129899409|NCT02595398|467591847|FG001|Overall Study|Non-compliance|0|||
129899410|NCT02595398|467591846|FG000|Overall Study|Withdrawal by Subject|2|||
129899411|NCT02595398|467591847|FG001|Overall Study|Withdrawal by Subject|1|||
129899412|NCT02595398|467591846|FG000|Overall Study|Lost to Follow-up|1|||
129899413|NCT02595398|467591847|FG001|Overall Study|Lost to Follow-up|0|||
129899414|NCT00197015|467591848|FG000|Overall Study|Adverse Event|3|||
129899415|NCT00197015|467591849|FG001|Overall Study|Adverse Event|0|||
129899416|NCT00197015|467591850|FG002|Overall Study|Adverse Event|1|||
129899417|NCT00197015|467591848|FG000|Overall Study|Protocol Violation|0|||
129899418|NCT00197015|467591849|FG001|Overall Study|Protocol Violation|3|||
129899419|NCT00197015|467591850|FG002|Overall Study|Protocol Violation|3|||
129899420|NCT00197015|467591848|FG000|Overall Study|Withdrawal by Subject|17|||
129899421|NCT00197015|467591849|FG001|Overall Study|Withdrawal by Subject|37|||
129448188|NCT00766090|465941525|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129840442|NCT01479621|467380797|FG001|Treatment Period|Withdrawal by Subject|4|||
129840443|NCT01479621|467380798|FG002|Treatment Period|Withdrawal by Subject|2|||
129840444|NCT01479621|467380799|FG003|Treatment Period|Withdrawal by Subject|2|||
129840445|NCT01479621|467380800|FG004|Treatment Period|Withdrawal by Subject|5|||
129840446|NCT01479621|467380801|FG005|Treatment Period|Withdrawal by Subject|5|||
129840447|NCT01479621|467380802|FG006|Treatment Period|Withdrawal by Subject|1|||
129840448|NCT01479621|467380796|FG000|Treatment Period|Physician Decision|0|||
129840449|NCT01479621|467380797|FG001|Treatment Period|Physician Decision|0|||
129840450|NCT01479621|467380798|FG002|Treatment Period|Physician Decision|0|||
129840451|NCT01479621|467380799|FG003|Treatment Period|Physician Decision|0|||
129840452|NCT01479621|467380800|FG004|Treatment Period|Physician Decision|1|||
129840453|NCT01479621|467380801|FG005|Treatment Period|Physician Decision|1|||
129840454|NCT01479621|467380802|FG006|Treatment Period|Physician Decision|0|||
129840455|NCT01479621|467380796|FG000|Treatment Period|Non-compliance to study drug|0|||
129840456|NCT01479621|467380797|FG001|Treatment Period|Non-compliance to study drug|1|||
129840457|NCT01479621|467380798|FG002|Treatment Period|Non-compliance to study drug|0|||
129840458|NCT01479621|467380799|FG003|Treatment Period|Non-compliance to study drug|0|||
129840459|NCT01479621|467380800|FG004|Treatment Period|Non-compliance to study drug|0|||
129840460|NCT01479621|467380801|FG005|Treatment Period|Non-compliance to study drug|0|||
129840461|NCT01479621|467380802|FG006|Treatment Period|Non-compliance to study drug|1|||
129840462|NCT01479621|467380796|FG000|Treatment Period|Protocol Violation|0|||
129840463|NCT01479621|467380797|FG001|Treatment Period|Protocol Violation|9|||
129840464|NCT01479621|467380798|FG002|Treatment Period|Protocol Violation|6|||
129840465|NCT01479621|467380799|FG003|Treatment Period|Protocol Violation|5|||
129840466|NCT01479621|467380800|FG004|Treatment Period|Protocol Violation|2|||
129840467|NCT01479621|467380801|FG005|Treatment Period|Protocol Violation|10|||
129840468|NCT01479621|467380802|FG006|Treatment Period|Protocol Violation|6|||
129840469|NCT01479621|467380796|FG000|Treatment Period|Pregnancy|0|||
129840470|NCT01479621|467380797|FG001|Treatment Period|Pregnancy|0|||
129840471|NCT01479621|467380798|FG002|Treatment Period|Pregnancy|2|||
129840472|NCT01479621|467380799|FG003|Treatment Period|Pregnancy|0|||
129840473|NCT01479621|467380800|FG004|Treatment Period|Pregnancy|0|||
129840474|NCT01479621|467380801|FG005|Treatment Period|Pregnancy|0|||
129840475|NCT01479621|467380802|FG006|Treatment Period|Pregnancy|0|||
129840476|NCT01479621|467380796|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
129840477|NCT01479621|467380797|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
129840478|NCT01479621|467380798|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
129840479|NCT01479621|467380799|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
129840480|NCT01479621|467380800|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
129840481|NCT01479621|467380801|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
129840482|NCT01479621|467380802|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
129840483|NCT01479621|467380796|FG000|Treatment Period|Lost to Follow-up|0|||
129840484|NCT01479621|467380797|FG001|Treatment Period|Lost to Follow-up|0|||
129840485|NCT01479621|467380798|FG002|Treatment Period|Lost to Follow-up|1|||
129840486|NCT01479621|467380799|FG003|Treatment Period|Lost to Follow-up|0|||
129840487|NCT01479621|467380800|FG004|Treatment Period|Lost to Follow-up|2|||
129840488|NCT01479621|467380801|FG005|Treatment Period|Lost to Follow-up|2|||
129840489|NCT01479621|467380802|FG006|Treatment Period|Lost to Follow-up|1|||
129840490|NCT01479621|467380796|FG000|Treatment Period|Met stopping criteria|0|||
129840491|NCT01479621|467380797|FG001|Treatment Period|Met stopping criteria|8|||
129840492|NCT01479621|467380798|FG002|Treatment Period|Met stopping criteria|7|||
129840493|NCT01479621|467380799|FG003|Treatment Period|Met stopping criteria|4|||
129840494|NCT01479621|467380800|FG004|Treatment Period|Met stopping criteria|9|||
129840495|NCT01479621|467380801|FG005|Treatment Period|Met stopping criteria|20|||
129840496|NCT01479621|467380802|FG006|Treatment Period|Met stopping criteria|6|||
129840497|NCT00677807|467380816|FG000|Overall Study|Adverse Event|4|||
129840498|NCT00677807|467380817|FG001|Overall Study|Adverse Event|1|||
129840499|NCT00677807|467380818|FG002|Overall Study|Adverse Event|6|||
129840500|NCT00677807|467380816|FG000|Overall Study|Lack of Efficacy|0|||
129840501|NCT00677807|467380817|FG001|Overall Study|Lack of Efficacy|0|||
129840502|NCT00677807|467380818|FG002|Overall Study|Lack of Efficacy|2|||
129840503|NCT00677807|467380816|FG000|Overall Study|Participant no longer needs study drug|0|||
129840504|NCT00677807|467380817|FG001|Overall Study|Participant no longer needs study drug|0|||
129840505|NCT00677807|467380818|FG002|Overall Study|Participant no longer needs study drug|1|||
129840506|NCT00677807|467380816|FG000|Overall Study|Withdrawal by Subject|10|||
129840507|NCT00677807|467380817|FG001|Overall Study|Withdrawal by Subject|3|||
129840508|NCT00677807|467380818|FG002|Overall Study|Withdrawal by Subject|6|||
129840509|NCT00677807|467380816|FG000|Overall Study|Lost to Follow-up|2|||
129840510|NCT00677807|467380817|FG001|Overall Study|Lost to Follow-up|2|||
129840511|NCT00677807|467380818|FG002|Overall Study|Lost to Follow-up|2|||
129840512|NCT00677807|467380816|FG000|Overall Study|Administrative problems|1|||
129840513|NCT00677807|467380817|FG001|Overall Study|Administrative problems|1|||
129840514|NCT00677807|467380818|FG002|Overall Study|Administrative problems|2|||
129840515|NCT00677807|467380816|FG000|Overall Study|Death|0|||
129840516|NCT00677807|467380817|FG001|Overall Study|Death|1|||
129840517|NCT00677807|467380818|FG002|Overall Study|Death|1|||
129840518|NCT00677807|467380816|FG000|Overall Study|Protocol Deviation|1|||
129840519|NCT00677807|467380817|FG001|Overall Study|Protocol Deviation|3|||
129840520|NCT00677807|467380818|FG002|Overall Study|Protocol Deviation|0|||
129840521|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
129840522|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
129840523|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
129840524|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129840525|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129840526|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129840527|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840528|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840529|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
129840530|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840531|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840532|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
129840533|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
129840534|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
129840535|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
129840536|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129840537|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129840538|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129840539|NCT04019041|467380819|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840540|NCT04019041|467380820|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840541|NCT04019041|467380821|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
129840542|NCT04019041|467380822|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840543|NCT04019041|467380823|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840544|NCT04019041|467380824|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
129840545|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129840546|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129840547|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129840548|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
129840549|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
129840550|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
129840551|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840552|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840553|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129899422|NCT00197015|467591850|FG002|Overall Study|Withdrawal by Subject|34|||
129899423|NCT00197015|467591848|FG000|Overall Study|Lost to Follow-up|28|||
129899424|NCT00197015|467591849|FG001|Overall Study|Lost to Follow-up|46|||
129840554|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
129840555|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840556|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
129840557|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840558|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840559|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840560|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840561|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
129840562|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
129840563|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129840564|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129840565|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129840566|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
129840567|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
129840568|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
129840569|NCT04019041|467380819|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840570|NCT04019041|467380820|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840571|NCT04019041|467380821|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840572|NCT04019041|467380822|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129840573|NCT04019041|467380823|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
129840574|NCT04019041|467380824|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
129840575|NCT03925727|467380825|FG000|Overall Study|Adverse Event|4|||
129840576|NCT03925727|467380826|FG001|Overall Study|Adverse Event|0|||
129840577|NCT03925727|467380827|FG002|Overall Study|Adverse Event|3|||
129840578|NCT03925727|467380825|FG000|Overall Study|Protocol Violation|1|||
129840579|NCT03925727|467380826|FG001|Overall Study|Protocol Violation|2|||
129840580|NCT03925727|467380827|FG002|Overall Study|Protocol Violation|2|||
129840581|NCT03925727|467380825|FG000|Overall Study|Withdrawal by Subject|3|||
129840582|NCT03925727|467380826|FG001|Overall Study|Withdrawal by Subject|2|||
129840583|NCT03925727|467380827|FG002|Overall Study|Withdrawal by Subject|4|||
129840584|NCT03925727|467380825|FG000|Overall Study|Administrative Reasons|3|||
129840585|NCT03925727|467380826|FG001|Overall Study|Administrative Reasons|1|||
129840586|NCT03925727|467380827|FG002|Overall Study|Administrative Reasons|2|||
129840587|NCT03925727|467380825|FG000|Overall Study|Randomized in error or Disqualified|8|||
129840588|NCT03925727|467380826|FG001|Overall Study|Randomized in error or Disqualified|1|||
129840589|NCT03925727|467380827|FG002|Overall Study|Randomized in error or Disqualified|7|||
129840590|NCT01393743|467380828|FG000|Core Study|Adverse Event|5|||
129840591|NCT01393743|467380829|FG001|Core Study|Adverse Event|9|||
129840592|NCT01393743|467380830|FG002|Core Study|Adverse Event|0|||
129840593|NCT01393743|467380828|FG000|Core Study|Lost to Follow-up|1|||
129840594|NCT01393743|467380829|FG001|Core Study|Lost to Follow-up|1|||
129840595|NCT01393743|467380830|FG002|Core Study|Lost to Follow-up|0|||
129840596|NCT01393743|467380828|FG000|Core Study|Participant's Choice|2|||
129840597|NCT01393743|467380829|FG001|Core Study|Participant's Choice|3|||
129840598|NCT01393743|467380830|FG002|Core Study|Participant's Choice|0|||
129840599|NCT01393743|467380828|FG000|Core Study|Inadequate therapeutic effect|2|||
129840600|NCT01393743|467380829|FG001|Core Study|Inadequate therapeutic effect|0|||
129840601|NCT01393743|467380830|FG002|Core Study|Inadequate therapeutic effect|0|||
129840602|NCT01393743|467380828|FG000|Extension Phase|Adverse Event|0|||
129840603|NCT01393743|467380829|FG001|Extension Phase|Adverse Event|0|||
129840604|NCT01393743|467380830|FG002|Extension Phase|Adverse Event|12|||
129840605|NCT01393743|467380828|FG000|Extension Phase|Lost to Follow-up|0|||
129840606|NCT01393743|467380829|FG001|Extension Phase|Lost to Follow-up|0|||
129840607|NCT01393743|467380830|FG002|Extension Phase|Lost to Follow-up|2|||
129840608|NCT01393743|467380828|FG000|Extension Phase|Participant choice|0|||
129840609|NCT01393743|467380829|FG001|Extension Phase|Participant choice|0|||
129840610|NCT01393743|467380830|FG002|Extension Phase|Participant choice|16|||
129840611|NCT01393743|467380828|FG000|Extension Phase|Inadequate therapeutic effect|0|||
129840612|NCT01393743|467380829|FG001|Extension Phase|Inadequate therapeutic effect|0|||
129840613|NCT01393743|467380830|FG002|Extension Phase|Inadequate therapeutic effect|7|||
129840614|NCT01393743|467380828|FG000|Extension Phase|Withdrawal by Subject|0|||
129840615|NCT01393743|467380829|FG001|Extension Phase|Withdrawal by Subject|0|||
129840616|NCT01393743|467380830|FG002|Extension Phase|Withdrawal by Subject|8|||
129840617|NCT01393743|467380828|FG000|Extension Phase|Pregnancy|0|||
129840618|NCT01393743|467380829|FG001|Extension Phase|Pregnancy|0|||
129840619|NCT01393743|467380830|FG002|Extension Phase|Pregnancy|1|||
129840620|NCT01393743|467380828|FG000|Extension Phase|Other|0|||
129840621|NCT01393743|467380829|FG001|Extension Phase|Other|0|||
129840622|NCT01393743|467380830|FG002|Extension Phase|Other|14|||
129899425|NCT00197015|467591850|FG002|Overall Study|Lost to Follow-up|37|||
129899426|NCT00197015|467591848|FG000|Overall Study|Other|2|||
129840623|NCT00314366|467380831|FG000|Overall Study|not treated due to patient medical condi|1|||
129840624|NCT00314366|467380832|FG001|Overall Study|not treated due to patient medical condi|0|||
129840625|NCT02321462|467380836|FG000|Overall Study|Withdrawal by Subject|5|||
129840626|NCT02321462|467380837|FG001|Overall Study|Withdrawal by Subject|2|||
129840627|NCT02321462|467380836|FG000|Overall Study|Subject withdrawn before any treatment|1|||
129840628|NCT02321462|467380837|FG001|Overall Study|Subject withdrawn before any treatment|1|||
129840629|NCT01574352|467380850|FG000|Overall Study|Withdrawal by Subject|6|||
129840630|NCT01574352|467380851|FG001|Overall Study|Withdrawal by Subject|13|||
129840631|NCT01574352|467380850|FG000|Overall Study|Injury in non-camp related sport|1|||
129840632|NCT01574352|467380851|FG001|Overall Study|Injury in non-camp related sport|0|||
129840633|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
129840634|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
129840635|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
129840636|NCT01282424|467380852|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
129840637|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
129840638|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
129840639|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
129840640|NCT01282424|467380852|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
129840641|NCT02283788|467380858|FG000|Overall Study|Adverse Event|1|||
129840642|NCT02283788|467380859|FG001|Overall Study|Adverse Event|3|||
129840643|NCT02283788|467380860|FG002|Overall Study|Adverse Event|5|||
129840644|NCT02283788|467380861|FG003|Overall Study|Adverse Event|1|||
129840645|NCT02283788|467380858|FG000|Overall Study|Withdrawal by Subject|0|||
129840646|NCT02283788|467380859|FG001|Overall Study|Withdrawal by Subject|1|||
129840647|NCT02283788|467380860|FG002|Overall Study|Withdrawal by Subject|0|||
129840648|NCT02283788|467380861|FG003|Overall Study|Withdrawal by Subject|1|||
129840649|NCT01083433|467382680|FG000|Overall Study|Lost to Follow-up|2|||
129840650|NCT01083433|467382681|FG001|Overall Study|Lost to Follow-up|1|||
129840651|NCT01083433|467382682|FG002|Overall Study|Lost to Follow-up|1|||
129840652|NCT01083433|467382680|FG000|Overall Study|Withdrawal by Subject|0|||
129840653|NCT01083433|467382681|FG001|Overall Study|Withdrawal by Subject|5|||
129840654|NCT01083433|467382682|FG002|Overall Study|Withdrawal by Subject|3|||
129840655|NCT01083433|467382680|FG000|Overall Study|Pregnancy|0|||
129840656|NCT01083433|467382681|FG001|Overall Study|Pregnancy|0|||
129840657|NCT01083433|467382682|FG002|Overall Study|Pregnancy|1|||
129840658|NCT04982029|467382683|FG000|Overall Study|Lost to Follow-up|2|||
129840659|NCT04982029|467382684|FG001|Overall Study|Lost to Follow-up|3|||
129840660|NCT05458856|467382685|FG000|Overall Study|Withdrawal by Subject|5|||
129840661|NCT05458856|467382685|FG000|Overall Study|Death|4|||
129840662|NCT05458856|467382685|FG000|Overall Study|Protocol Deviation|3|||
129840663|NCT05458856|467382685|FG000|Overall Study|Physician Decision|1|||
129840664|NCT05168475|467382686|FG000|Period 1|Protocol Violation|1|||
129840665|NCT05168475|467382686|FG000|Period 1|IMP shortage|2|||
129840666|NCT05168475|467382686|FG000|Period 1|Not randomised|2|||
129840667|NCT05168475|467382686|FG000|Period 2|IMP shortage|1|||
129840668|NCT01589822|467382687|FG000|Overall Study|Withdrawal by Subject|1|||
129840669|NCT01589822|467382688|FG001|Overall Study|Withdrawal by Subject|2|||
129840670|NCT01589822|467382689|FG002|Overall Study|Withdrawal by Subject|0|||
129840671|NCT01589822|467382687|FG000|Overall Study|Death|1|||
129840672|NCT01589822|467382688|FG001|Overall Study|Death|0|||
129840673|NCT01589822|467382689|FG002|Overall Study|Death|0|||
129840674|NCT01589822|467382687|FG000|Overall Study|Missed 90 day visit|2|||
129840675|NCT01589822|467382688|FG001|Overall Study|Missed 90 day visit|1|||
129840676|NCT01589822|467382689|FG002|Overall Study|Missed 90 day visit|1|||
129840677|NCT01140477|467382690|FG000|Overall Study|Lost to Follow-up|4|||
129840678|NCT01140477|467382691|FG001|Overall Study|Lost to Follow-up|0|||
129840679|NCT01140477|467382690|FG000|Overall Study|Withdrawal by Subject|1|||
129840680|NCT01140477|467382691|FG001|Overall Study|Withdrawal by Subject|4|||
129840681|NCT01140477|467382690|FG000|Overall Study|Surgical complication preventing implant|2|||
129840682|NCT01140477|467382691|FG001|Overall Study|Surgical complication preventing implant|0|||
129840683|NCT01140477|467382690|FG000|Overall Study|Death|1|||
129840684|NCT01140477|467382691|FG001|Overall Study|Death|1|||
129840685|NCT01140477|467382690|FG000|Overall Study|Subject explanted|0|||
129840686|NCT01140477|467382691|FG001|Overall Study|Subject explanted|1|||
129840687|NCT00773175|467382692|FG000|Overall Study|Adverse Event|2|||
129840688|NCT00773175|467382693|FG001|Overall Study|Adverse Event|0|||
129840689|NCT00773175|467382692|FG000|Overall Study|Consent Withdrawn|0|||
129840690|NCT00773175|467382693|FG001|Overall Study|Consent Withdrawn|2|||
129840691|NCT01904604|467382700|FG000|Overall Study|Withdrew before receiving dosing|0|||
129840692|NCT01904604|467382701|FG001|Overall Study|Withdrew before receiving dosing|1|||
129840693|NCT01904604|467382702|FG002|Overall Study|Withdrew before receiving dosing|0|||
129840694|NCT01904604|467382700|FG000|Overall Study|Non-compliance|1|||
129840695|NCT01904604|467382701|FG001|Overall Study|Non-compliance|0|||
129840696|NCT01904604|467382702|FG002|Overall Study|Non-compliance|0|||
129840697|NCT01904604|467382700|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
129840698|NCT01904604|467382701|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
129899427|NCT00197015|467591849|FG001|Overall Study|Other|3|||
129840699|NCT01904604|467382702|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
129840700|NCT01904604|467382700|FG000|Overall Study|Patch site reactions|1|||
129840701|NCT01904604|467382701|FG001|Overall Study|Patch site reactions|1|||
129840702|NCT01904604|467382702|FG002|Overall Study|Patch site reactions|0|||
129840703|NCT01904604|467382700|FG000|Overall Study|Increased syncope|0|||
129840704|NCT01904604|467382701|FG001|Overall Study|Increased syncope|1|||
129840705|NCT01904604|467382702|FG002|Overall Study|Increased syncope|0|||
129840706|NCT01904604|467382700|FG000|Overall Study|Unrelated illness|0|||
129840707|NCT01904604|467382701|FG001|Overall Study|Unrelated illness|1|||
129448189|NCT00766090|465941526|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448190|NCT00766090|465941527|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448191|NCT00766090|465941528|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448192|NCT00766090|465941529|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448193|NCT00766090|465941530|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448194|NCT00766090|465941531|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448195|NCT00766090|465941532|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448196|NCT00766090|465941533|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
129448197|NCT00766090|465941534|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448198|NCT00766090|465941535|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448199|NCT00766090|465941536|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129448200|NCT00766090|465941525|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
129448201|NCT00766090|465941526|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448202|NCT00766090|465941527|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448203|NCT00766090|465941528|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448204|NCT00766090|465941529|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448205|NCT00766090|465941530|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448206|NCT00766090|465941531|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448207|NCT00766090|465941532|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448208|NCT00766090|465941533|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448209|NCT00766090|465941534|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448210|NCT00766090|465941535|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448211|NCT00766090|465941536|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
129448212|NCT00766090|465941525|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129448213|NCT00766090|465941526|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448214|NCT00766090|465941527|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448215|NCT00766090|465941528|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129448216|NCT00766090|465941529|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448217|NCT00766090|465941530|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448218|NCT00766090|465941531|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448219|NCT00766090|465941532|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129840708|NCT01904604|467382702|FG002|Overall Study|Unrelated illness|0|||
129840709|NCT01904604|467382700|FG000|Overall Study|Passed Week 52 OFC|1|||
129840710|NCT01904604|467382701|FG001|Overall Study|Passed Week 52 OFC|0|||
129840711|NCT01904604|467382702|FG002|Overall Study|Passed Week 52 OFC|0|||
129840712|NCT01904604|467382700|FG000|Overall Study|Withdrawal by Subject|1|||
129840713|NCT01904604|467382701|FG001|Overall Study|Withdrawal by Subject|2|||
129840714|NCT01904604|467382702|FG002|Overall Study|Withdrawal by Subject|0|||
129840715|NCT01904604|467382700|FG000|Overall Study|Participant Relocated|1|||
129840716|NCT01904604|467382701|FG001|Overall Study|Participant Relocated|1|||
129840717|NCT01904604|467382702|FG002|Overall Study|Participant Relocated|1|||
129840718|NCT01904604|467382700|FG000|Overall Study|Lost to Follow-up|0|||
129840719|NCT01904604|467382701|FG001|Overall Study|Lost to Follow-up|0|||
129840720|NCT01904604|467382702|FG002|Overall Study|Lost to Follow-up|1|||
129840721|NCT01481116|467382707|FG000|Overall Study|Adverse Event|26|||
129840722|NCT01481116|467382708|FG001|Overall Study|Adverse Event|26|||
129840723|NCT01481116|467382709|FG002|Overall Study|Adverse Event|42|||
129840724|NCT01481116|467382707|FG000|Overall Study|Major Protocol Deviation|3|||
129840725|NCT01481116|467382708|FG001|Overall Study|Major Protocol Deviation|7|||
129840726|NCT01481116|467382709|FG002|Overall Study|Major Protocol Deviation|1|||
129840727|NCT01481116|467382707|FG000|Overall Study|Lost to Follow-up|8|||
129840728|NCT01481116|467382708|FG001|Overall Study|Lost to Follow-up|12|||
129840729|NCT01481116|467382709|FG002|Overall Study|Lost to Follow-up|11|||
129840730|NCT01481116|467382707|FG000|Overall Study|Withdrawal by Subject|37|||
129840731|NCT01481116|467382708|FG001|Overall Study|Withdrawal by Subject|33|||
129840732|NCT01481116|467382709|FG002|Overall Study|Withdrawal by Subject|37|||
129840733|NCT01481116|467382707|FG000|Overall Study|Study Termination|730|||
129840734|NCT01481116|467382708|FG001|Overall Study|Study Termination|729|||
129840735|NCT01481116|467382709|FG002|Overall Study|Study Termination|713|||
129840736|NCT01481116|467382707|FG000|Overall Study|Pregnancy|0|||
129840737|NCT01481116|467382708|FG001|Overall Study|Pregnancy|0|||
129840738|NCT01481116|467382709|FG002|Overall Study|Pregnancy|1|||
129840739|NCT01481116|467382707|FG000|Overall Study|Lack of Efficacy|3|||
129840740|NCT01481116|467382708|FG001|Overall Study|Lack of Efficacy|3|||
129840741|NCT01481116|467382709|FG002|Overall Study|Lack of Efficacy|1|||
129840742|NCT01481116|467382707|FG000|Overall Study|Contraindications|1|||
129840743|NCT01481116|467382708|FG001|Overall Study|Contraindications|1|||
129840744|NCT01481116|467382709|FG002|Overall Study|Contraindications|0|||
129840745|NCT01481116|467382707|FG000|Overall Study|Other|1|||
129840746|NCT01481116|467382708|FG001|Overall Study|Other|1|||
129840747|NCT01481116|467382709|FG002|Overall Study|Other|0|||
129840748|NCT01481116|467382707|FG000|Overall Study|Participant Started Taking Glipizide|1|||
129840749|NCT01481116|467382708|FG001|Overall Study|Participant Started Taking Glipizide|0|||
129840750|NCT01481116|467382709|FG002|Overall Study|Participant Started Taking Glipizide|0|||
129899428|NCT00197015|467591850|FG002|Overall Study|Other|2|||
129899429|NCT02982213|467591853|FG000|Overall Study|Did not complete follow up questionnaire|5|||
129899430|NCT02982213|467591854|FG001|Overall Study|Did not complete follow up questionnaire|1|||
129899431|NCT01972152|467591855|FG000|First Treatment Visit|Lost to Follow-up|0|||
129899432|NCT01972152|467591856|FG001|First Treatment Visit|Lost to Follow-up|1|||
129899433|NCT01972152|467591857|FG002|First Treatment Visit|Lost to Follow-up|0|||
129899434|NCT01972152|467591858|FG003|First Treatment Visit|Lost to Follow-up|0|||
129899435|NCT01972152|467591859|FG004|First Treatment Visit|Lost to Follow-up|0|||
129899436|NCT01972152|467591860|FG005|First Treatment Visit|Lost to Follow-up|0|||
129899437|NCT01972152|467591855|FG000|Second Treatment Visit|Protocol Violation|0|||
129899438|NCT01972152|467591856|FG001|Second Treatment Visit|Protocol Violation|1|||
129899439|NCT01972152|467591857|FG002|Second Treatment Visit|Protocol Violation|0|||
129899440|NCT01972152|467591858|FG003|Second Treatment Visit|Protocol Violation|0|||
129899441|NCT01972152|467591859|FG004|Second Treatment Visit|Protocol Violation|0|||
129899442|NCT01972152|467591860|FG005|Second Treatment Visit|Protocol Violation|0|||
129899443|NCT02512042|467591861|FG000|Overall Study|Adverse Event|0|||
129899444|NCT02512042|467591862|FG001|Overall Study|Adverse Event|4|||
129899445|NCT02512042|467591861|FG000|Overall Study|Withdrawal by Subject|6|||
129899446|NCT02512042|467591862|FG001|Overall Study|Withdrawal by Subject|6|||
129899447|NCT02512042|467591861|FG000|Overall Study|Non-compliance with study drug|1|||
129899448|NCT02512042|467591862|FG001|Overall Study|Non-compliance with study drug|2|||
129899449|NCT02512042|467591861|FG000|Overall Study|Lost to Follow-up|5|||
129899450|NCT02512042|467591862|FG001|Overall Study|Lost to Follow-up|2|||
129899451|NCT02512042|467591861|FG000|Overall Study|Other|11|||
129899452|NCT02512042|467591862|FG001|Overall Study|Other|11|||
129899453|NCT01194258|467591863|FG000|Titration Period|Withdrawal by Subject|6|||
129899454|NCT01194258|467591864|FG001|Titration Period|Withdrawal by Subject|0|||
129899455|NCT01194258|467591865|FG002|Titration Period|Withdrawal by Subject|0|||
129899456|NCT01194258|467591866|FG003|Titration Period|Withdrawal by Subject|0|||
129899457|NCT01194258|467591867|FG004|Titration Period|Withdrawal by Subject|0|||
129899458|NCT01194258|467591863|FG000|Titration Period|Lost to Follow-up|2|||
129899459|NCT01194258|467591864|FG001|Titration Period|Lost to Follow-up|0|||
129899460|NCT01194258|467591865|FG002|Titration Period|Lost to Follow-up|0|||
129899461|NCT01194258|467591866|FG003|Titration Period|Lost to Follow-up|0|||
129899462|NCT01194258|467591867|FG004|Titration Period|Lost to Follow-up|0|||
129899463|NCT01194258|467591863|FG000|Titration Period|Titration failure|3|||
129899464|NCT01194258|467591864|FG001|Titration Period|Titration failure|0|||
129899465|NCT01194258|467591865|FG002|Titration Period|Titration failure|0|||
129899466|NCT01194258|467591866|FG003|Titration Period|Titration failure|0|||
129899467|NCT01194258|467591867|FG004|Titration Period|Titration failure|0|||
129899468|NCT01194258|467591863|FG000|Period 1 (12 Weeks)|Death|0|||
129899469|NCT01194258|467591864|FG001|Period 1 (12 Weeks)|Death|0|||
129899470|NCT01194258|467591865|FG002|Period 1 (12 Weeks)|Death|0|||
129899471|NCT01194258|467591866|FG003|Period 1 (12 Weeks)|Death|0|||
129899472|NCT01194258|467591867|FG004|Period 1 (12 Weeks)|Death|1|||
129899473|NCT01194258|467591863|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899474|NCT01194258|467591864|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899475|NCT01194258|467591865|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899476|NCT01194258|467591866|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
129899477|NCT01194258|467591867|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
129899478|NCT01194258|467591863|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
129899479|NCT01194258|467591864|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
129899480|NCT01194258|467591865|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
129899481|NCT01194258|467591866|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
129899482|NCT01194258|467591867|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
129899483|NCT01194258|467591863|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129899484|NCT01194258|467591864|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129899485|NCT01194258|467591865|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129899486|NCT01194258|467591866|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129899487|NCT01194258|467591867|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129899488|NCT01253226|467591868|FG000|Overall Study|Adverse Event|0|||
129899489|NCT01253226|467591869|FG001|Overall Study|Adverse Event|0|||
129899490|NCT01253226|467591870|FG002|Overall Study|Adverse Event|1|||
129899491|NCT01253226|467591871|FG003|Overall Study|Adverse Event|0|||
129899492|NCT01253226|467591872|FG004|Overall Study|Adverse Event|0|||
129899493|NCT01253226|467591868|FG000|Overall Study|Death|0|||
129899494|NCT01253226|467591869|FG001|Overall Study|Death|1|||
129899495|NCT01253226|467591870|FG002|Overall Study|Death|0|||
129899496|NCT01253226|467591871|FG003|Overall Study|Death|0|||
129899497|NCT01253226|467591872|FG004|Overall Study|Death|0|||
129899498|NCT01253226|467591868|FG000|Overall Study|Physician Decision|0|||
129899499|NCT01253226|467591869|FG001|Overall Study|Physician Decision|0|||
129899500|NCT01253226|467591870|FG002|Overall Study|Physician Decision|0|||
129899501|NCT01253226|467591871|FG003|Overall Study|Physician Decision|0|||
129899502|NCT01253226|467591872|FG004|Overall Study|Physician Decision|2|||
129899503|NCT01253226|467591868|FG000|Overall Study|Withdrawal by Subject|0|||
129899504|NCT01253226|467591869|FG001|Overall Study|Withdrawal by Subject|0|||
129899505|NCT01253226|467591870|FG002|Overall Study|Withdrawal by Subject|0|||
129840751|NCT01481116|467382707|FG000|Overall Study|Participant Moved Out of Area|2|||
129840752|NCT01481116|467382708|FG001|Overall Study|Participant Moved Out of Area|0|||
129840753|NCT01481116|467382709|FG002|Overall Study|Participant Moved Out of Area|1|||
129840754|NCT01481116|467382707|FG000|Overall Study|Participant Moved Out of Country|1|||
129840755|NCT01481116|467382708|FG001|Overall Study|Participant Moved Out of Country|0|||
129840756|NCT01481116|467382709|FG002|Overall Study|Participant Moved Out of Country|1|||
129840757|NCT01481116|467382707|FG000|Overall Study|Investigator Decision|3|||
129840758|NCT01481116|467382708|FG001|Overall Study|Investigator Decision|2|||
129840759|NCT01481116|467382709|FG002|Overall Study|Investigator Decision|1|||
129840760|NCT01481116|467382707|FG000|Overall Study|Sponsor Decision|0|||
129840761|NCT01481116|467382708|FG001|Overall Study|Sponsor Decision|1|||
129840762|NCT01481116|467382709|FG002|Overall Study|Sponsor Decision|3|||
129840763|NCT01481116|467382707|FG000|Overall Study|Non-Compliant With Study Drug|0|||
129840764|NCT01481116|467382708|FG001|Overall Study|Non-Compliant With Study Drug|1|||
129840765|NCT01481116|467382709|FG002|Overall Study|Non-Compliant With Study Drug|1|||
129840766|NCT01481116|467382707|FG000|Overall Study|Investigator's Discretion|2|||
129840767|NCT01481116|467382708|FG001|Overall Study|Investigator's Discretion|0|||
129840768|NCT01481116|467382709|FG002|Overall Study|Investigator's Discretion|0|||
129840769|NCT01481116|467382707|FG000|Overall Study|Death|2|||
129840770|NCT01481116|467382708|FG001|Overall Study|Death|1|||
129840771|NCT01481116|467382709|FG002|Overall Study|Death|0|||
129840772|NCT01481116|467382707|FG000|Overall Study|Hypoglycemic Event|4|||
129840773|NCT01481116|467382708|FG001|Overall Study|Hypoglycemic Event|0|||
129840774|NCT01481116|467382709|FG002|Overall Study|Hypoglycemic Event|0|||
129840775|NCT01782313|467382727|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
129840776|NCT01782313|467382727|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
129840777|NCT01782313|467382727|FG000|Treated Cycle 3|Progressive Disease|21|||
129840778|NCT01782313|467382727|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
129840779|NCT01782313|467382727|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
129840780|NCT01782313|467382727|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
129840781|NCT01782313|467382727|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
129840782|NCT01782313|467382727|FG000|Survival Follow up|Lost to Follow-up|1|||
129840783|NCT04476017|467382731|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
129840784|NCT04476017|467382732|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
129840785|NCT02704364|467382733|FG000|Overall Study|Adverse Event|1|||
129840786|NCT02704364|467382734|FG001|Overall Study|Adverse Event|1|||
129840787|NCT02704364|467382735|FG002|Overall Study|Adverse Event|0|||
129840788|NCT02704364|467382733|FG000|Overall Study|Noncompliance with study drug|1|||
129840789|NCT02704364|467382734|FG001|Overall Study|Noncompliance with study drug|1|||
129840790|NCT02704364|467382735|FG002|Overall Study|Noncompliance with study drug|0|||
129840791|NCT02704364|467382733|FG000|Overall Study|Other|0|||
129840792|NCT02704364|467382734|FG001|Overall Study|Other|1|||
129840793|NCT02704364|467382735|FG002|Overall Study|Other|1|||
129840794|NCT02975934|467382736|FG000|Treatment Phase|Never initiated study drug|0|||
129840795|NCT02975934|467382737|FG001|Treatment Phase|Never initiated study drug|5|||
129840796|NCT02975934|467382738|FG002|Treatment Phase|Never initiated study drug|0|||
129840797|NCT03362502|467382739|FG000|Overall Study|Death|0|||
129840798|NCT03362502|467382740|FG001|Overall Study|Death|0|||
129840799|NCT03362502|467382741|FG002|Overall Study|Death|1|||
129840800|NCT02075840|467382742|FG000|Overall Study|Withdrawal by Subject|13|||
129840801|NCT02075840|467382743|FG001|Overall Study|Withdrawal by Subject|22|||
129840802|NCT02075840|467382742|FG000|Overall Study|Reason not specified|1|||
129840803|NCT02075840|467382743|FG001|Overall Study|Reason not specified|0|||
129840804|NCT02075840|467382742|FG000|Overall Study|Adverse Event|0|||
129840805|NCT02075840|467382743|FG001|Overall Study|Adverse Event|2|||
129840806|NCT02075840|467382742|FG000|Overall Study|Death|35|||
129840807|NCT02075840|467382743|FG001|Overall Study|Death|40|||
129840808|NCT02075840|467382742|FG000|Overall Study|Lost to Follow-up|3|||
129840809|NCT02075840|467382743|FG001|Overall Study|Lost to Follow-up|2|||
129840810|NCT02075840|467382742|FG000|Overall Study|Physician Decision|1|||
129840811|NCT02075840|467382743|FG001|Overall Study|Physician Decision|3|||
129840812|NCT02075840|467382742|FG000|Overall Study|Ongoing at CCOD|99|||
129840813|NCT02075840|467382743|FG001|Overall Study|Ongoing at CCOD|82|||
129840814|NCT04098458|467382748|FG000|Overall Study|Death|1|||
129840815|NCT04098458|467382748|FG000|Overall Study|did not meet study inclusion criteria|3|||
129840816|NCT00006489|467382751|FG000|Overall Study|Adverse Event|3|||
129840817|NCT00006489|467382752|FG001|Overall Study|Adverse Event|2|||
129840818|NCT00006489|467382753|FG002|Overall Study|Adverse Event|4|||
129840819|NCT00006489|467382754|FG003|Overall Study|Adverse Event|3|||
129840820|NCT00006489|467382751|FG000|Overall Study|Withdrawal by Subject|10|||
129840821|NCT00006489|467382752|FG001|Overall Study|Withdrawal by Subject|9|||
129840822|NCT00006489|467382753|FG002|Overall Study|Withdrawal by Subject|9|||
129840823|NCT00006489|467382754|FG003|Overall Study|Withdrawal by Subject|6|||
129840824|NCT00006489|467382751|FG000|Overall Study|Scheduling Conflict|0|||
129840825|NCT00006489|467382752|FG001|Overall Study|Scheduling Conflict|3|||
129840826|NCT00006489|467382753|FG002|Overall Study|Scheduling Conflict|2|||
129840827|NCT00006489|467382754|FG003|Overall Study|Scheduling Conflict|1|||
129840828|NCT00006489|467382751|FG000|Overall Study|Death|0|||
129840829|NCT00006489|467382752|FG001|Overall Study|Death|0|||
129840830|NCT00006489|467382753|FG002|Overall Study|Death|0|||
129840831|NCT00006489|467382754|FG003|Overall Study|Death|1|||
129840832|NCT05179421|467382765|FG000|First Infusion Day|Adverse Event|1|||
129840833|NCT05179421|467382766|FG001|First Infusion Day|Adverse Event|0|||
129840834|NCT04889625|467382767|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
129840835|NCT04889625|467382768|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
129840836|NCT04889625|467382767|FG000|Period 1|Subject out of window|0|||
129840837|NCT04889625|467382768|FG001|Period 1|Subject out of window|1|||
129840838|NCT04889625|467382767|FG000|Period 1|Wrong add power dispensed|0|||
129840839|NCT04889625|467382768|FG001|Period 1|Wrong add power dispensed|1|||
129840840|NCT04889625|467382767|FG000|Period 1|Discontinued due to fitting guide error|1|||
129840841|NCT04889625|467382768|FG001|Period 1|Discontinued due to fitting guide error|1|||
129840842|NCT04889625|467382767|FG000|Period 2|Test article no longer available|1|||
129840843|NCT04889625|467382768|FG001|Period 2|Test article no longer available|0|||
129448220|NCT00766090|465941533|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448221|NCT00766090|465941534|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448222|NCT00766090|465941535|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448223|NCT00766090|465941536|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129448224|NCT00766090|465941525|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448225|NCT00766090|465941526|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448226|NCT00766090|465941527|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
129448227|NCT00766090|465941528|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448228|NCT00766090|465941529|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448229|NCT00766090|465941530|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448230|NCT00766090|465941531|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448231|NCT00766090|465941532|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448232|NCT00766090|465941533|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448233|NCT00766090|465941534|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448234|NCT00766090|465941535|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448235|NCT00766090|465941536|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
129448236|NCT00766090|465941525|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448237|NCT00766090|465941526|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448238|NCT00766090|465941527|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448239|NCT00766090|465941528|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448240|NCT00766090|465941529|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
129448241|NCT00766090|465941530|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448242|NCT00766090|465941531|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448243|NCT00766090|465941532|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448244|NCT00766090|465941533|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448245|NCT00766090|465941534|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448246|NCT00766090|465941535|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448247|NCT00766090|465941536|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129448248|NCT00766090|465941525|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448249|NCT00766090|465941526|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448250|NCT00766090|465941527|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
129448251|NCT00766090|465941528|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448252|NCT00766090|465941529|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448253|NCT00766090|465941530|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448254|NCT00766090|465941531|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448255|NCT00766090|465941532|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448256|NCT00766090|465941533|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448257|NCT00766090|465941534|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448258|NCT00766090|465941535|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448259|NCT00766090|465941536|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
129448260|NCT00766090|465941525|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
129448261|NCT00766090|465941526|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
129448262|NCT00766090|465941527|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
129448263|NCT00766090|465941528|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
129448264|NCT00766090|465941529|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
129448265|NCT00766090|465941530|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
129448266|NCT00766090|465941531|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
129448267|NCT00766090|465941532|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
129448268|NCT00766090|465941533|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
129448269|NCT00766090|465941534|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
129448270|NCT00766090|465941535|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
129448271|NCT00766090|465941536|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
129448272|NCT00766090|465941525|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448273|NCT00766090|465941526|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448274|NCT00766090|465941527|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448275|NCT00766090|465941528|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448276|NCT00766090|465941529|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448277|NCT00766090|465941530|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
129448278|NCT00766090|465941531|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448279|NCT00766090|465941532|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448280|NCT00766090|465941533|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448281|NCT00766090|465941534|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448282|NCT00766090|465941535|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448283|NCT00766090|465941536|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
129448284|NCT00766090|465941525|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448285|NCT00766090|465941526|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
129448286|NCT00766090|465941527|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448287|NCT00766090|465941528|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
129448288|NCT00766090|465941529|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448289|NCT00766090|465941530|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448290|NCT00766090|465941531|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448291|NCT00766090|465941532|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448292|NCT00766090|465941533|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448293|NCT00766090|465941534|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448294|NCT00766090|465941535|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
129448295|NCT00766090|465941536|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
129448296|NCT00766090|465941525|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448297|NCT00766090|465941526|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448298|NCT00766090|465941527|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448299|NCT00766090|465941528|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448300|NCT00766090|465941529|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
129448301|NCT00766090|465941530|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448302|NCT00766090|465941531|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448303|NCT00766090|465941532|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448304|NCT00766090|465941533|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448305|NCT00766090|465941534|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448306|NCT00766090|465941535|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448307|NCT00766090|465941536|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
129448308|NCT01106027|465941543|FG000|Overall Study|Lost graft early, discontinued|1|||
129448309|NCT02871778|465941544|FG000|Part A: Treatment Period 1|Adverse Event|1|||
129448310|NCT02871778|465941545|FG001|Part A: Treatment Period 1|Adverse Event|1|||
129448311|NCT02871778|465941546|FG002|Part A: Treatment Period 1|Adverse Event|1|||
129448312|NCT02871778|465941547|FG003|Part A: Treatment Period 1|Adverse Event|0|||
129448313|NCT02871778|465941548|FG004|Part A: Treatment Period 1|Adverse Event|0|||
129448314|NCT02871778|465941549|FG005|Part A: Treatment Period 1|Adverse Event|0|||
129448315|NCT02871778|465941550|FG006|Part A: Treatment Period 1|Adverse Event|0|||
129448316|NCT02871778|465941551|FG007|Part A: Treatment Period 1|Adverse Event|0|||
129448317|NCT02871778|465941544|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
129448318|NCT02871778|465941545|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
129448319|NCT02871778|465941546|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
129448320|NCT02871778|465941547|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
129448321|NCT02871778|465941548|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
129448322|NCT02871778|465941549|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
129448323|NCT02871778|465941550|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
129448324|NCT02871778|465941551|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
129840844|NCT04889625|467382767|FG000|Period 2|Incorrect lens dispensed|1|||
129840845|NCT04889625|467382768|FG001|Period 2|Incorrect lens dispensed|0|||
129840846|NCT04889625|467382767|FG000|Period 2|Wrong add power dispensed|0|||
129840847|NCT04889625|467382768|FG001|Period 2|Wrong add power dispensed|1|||
129840848|NCT03746522|467382778|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
129840849|NCT03746522|467382779|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
129840850|NCT03746522|467382780|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
129840851|NCT03746522|467382778|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
129840852|NCT03746522|467382779|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
129840853|NCT03746522|467382780|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
129840854|NCT03746522|467382778|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
129840855|NCT03746522|467382779|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
129840856|NCT03746522|467382780|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
129840857|NCT03746522|467382778|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
129840858|NCT03746522|467382779|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
129840859|NCT03746522|467382780|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
129840860|NCT03746522|467382778|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
129840861|NCT03746522|467382779|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
129840862|NCT03746522|467382780|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
129840863|NCT00323414|467382783|FG000|Overall Study|Withdrawal by Subject|0|||
129840864|NCT00323414|467382784|FG001|Overall Study|Withdrawal by Subject|1|||
129840865|NCT02552316|467382786|FG000|Overall Study|Withdrawal by Subject|1|||
129840866|NCT02552316|467382786|FG000|Overall Study|Withdrawal due to non-compliance|1|||
129840867|NCT02659020|467382787|FG000|Overall Study|Adverse Event|0|||
129840868|NCT02659020|467382788|FG001|Overall Study|Adverse Event|0|||
129840869|NCT02659020|467382789|FG002|Overall Study|Adverse Event|0|||
129840870|NCT02659020|467382790|FG003|Overall Study|Adverse Event|2|||
129840871|NCT02659020|467382791|FG004|Overall Study|Adverse Event|0|||
129840872|NCT02659020|467382792|FG005|Overall Study|Adverse Event|0|||
129448325|NCT02871778|465941544|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129840873|NCT02659020|467382793|FG006|Overall Study|Adverse Event|2|||
129840874|NCT02659020|467382787|FG000|Overall Study|Lost to Follow-up|1|||
129840875|NCT02659020|467382788|FG001|Overall Study|Lost to Follow-up|2|||
129840876|NCT02659020|467382789|FG002|Overall Study|Lost to Follow-up|1|||
129840877|NCT02659020|467382790|FG003|Overall Study|Lost to Follow-up|6|||
129448326|NCT02871778|465941545|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129448327|NCT02871778|465941546|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
129448328|NCT02871778|465941547|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129448329|NCT02871778|465941548|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129448330|NCT02871778|465941549|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129448331|NCT02871778|465941550|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129448332|NCT02871778|465941551|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
129448333|NCT02871778|465941544|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448334|NCT02871778|465941545|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448335|NCT02871778|465941546|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
129448336|NCT02871778|465941547|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448337|NCT02871778|465941548|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448338|NCT02871778|465941549|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448339|NCT02871778|465941550|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448340|NCT02871778|465941551|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
129448341|NCT02871778|465941544|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
129448342|NCT02871778|465941545|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
129448343|NCT02871778|465941546|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
129448344|NCT02871778|465941547|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
129448345|NCT02871778|465941548|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
129840878|NCT02659020|467382791|FG004|Overall Study|Lost to Follow-up|1|||
129448346|NCT02871778|465941549|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
129448347|NCT02871778|465941550|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
129448348|NCT02871778|465941551|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
129448349|NCT02871778|465941544|FG000|Part A: Treatment Period 2|Adverse Event|2|||
129448350|NCT02871778|465941545|FG001|Part A: Treatment Period 2|Adverse Event|2|||
129448351|NCT02871778|465941546|FG002|Part A: Treatment Period 2|Adverse Event|0|||
129448352|NCT02871778|465941547|FG003|Part A: Treatment Period 2|Adverse Event|0|||
129448353|NCT02871778|465941548|FG004|Part A: Treatment Period 2|Adverse Event|0|||
129448354|NCT02871778|465941549|FG005|Part A: Treatment Period 2|Adverse Event|0|||
129448355|NCT02871778|465941550|FG006|Part A: Treatment Period 2|Adverse Event|0|||
129448356|NCT02871778|465941551|FG007|Part A: Treatment Period 2|Adverse Event|0|||
129448357|NCT02871778|465941544|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448358|NCT02871778|465941545|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448359|NCT02871778|465941546|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448360|NCT02871778|465941547|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
129448361|NCT02871778|465941548|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448362|NCT02871778|465941549|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448363|NCT02871778|465941550|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448364|NCT02871778|465941551|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
129448365|NCT02871778|465941544|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
129448366|NCT02871778|465941545|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
129448367|NCT02871778|465941546|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
129448368|NCT02871778|465941547|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
129448369|NCT02871778|465941548|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
129448370|NCT02871778|465941549|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
129448371|NCT02871778|465941550|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
129448372|NCT02871778|465941551|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
129448373|NCT02871778|465941544|FG000|Part B: Treatment Period 3|Adverse Event|0|||
129448374|NCT02871778|465941545|FG001|Part B: Treatment Period 3|Adverse Event|0|||
129448375|NCT02871778|465941546|FG002|Part B: Treatment Period 3|Adverse Event|0|||
129448376|NCT02871778|465941547|FG003|Part B: Treatment Period 3|Adverse Event|0|||
129448377|NCT02871778|465941548|FG004|Part B: Treatment Period 3|Adverse Event|1|||
129448378|NCT02871778|465941549|FG005|Part B: Treatment Period 3|Adverse Event|1|||
129448379|NCT02871778|465941550|FG006|Part B: Treatment Period 3|Adverse Event|1|||
129448380|NCT02871778|465941551|FG007|Part B: Treatment Period 3|Adverse Event|0|||
129448381|NCT02653300|465941553|FG000|Overall Study|Withdrawal by Subject|2|||
129448382|NCT02170779|465941573|FG000|Overall Study|Withdrawal by Subject|1|||
129448383|NCT02170779|465941574|FG001|Overall Study|Withdrawal by Subject|0|||
129448384|NCT02170779|465941573|FG000|Overall Study|Lost to Follow-up|0|||
129448385|NCT02170779|465941574|FG001|Overall Study|Lost to Follow-up|1|||
129448386|NCT00369785|465941575|FG000|Overall Study|Physician Decision|3|||
129448387|NCT00369785|465941576|FG001|Overall Study|Physician Decision|2|||
129448388|NCT00369785|465941575|FG000|Overall Study|Death|1|||
129448389|NCT00369785|465941576|FG001|Overall Study|Death|2|||
129448390|NCT00369785|465941575|FG000|Overall Study|Withdrawal by Subject|7|||
129448391|NCT00369785|465941576|FG001|Overall Study|Withdrawal by Subject|6|||
129448392|NCT00369785|465941575|FG000|Overall Study|Toxicity|6|||
129448393|NCT00369785|465941576|FG001|Overall Study|Toxicity|4|||
129448394|NCT00369785|465941575|FG000|Overall Study|Never started|0|||
129840879|NCT02659020|467382792|FG005|Overall Study|Lost to Follow-up|5|||
129840880|NCT02659020|467382793|FG006|Overall Study|Lost to Follow-up|0|||
129448395|NCT00369785|465941576|FG001|Overall Study|Never started|2|||
129448396|NCT00369785|465941575|FG000|Overall Study|Progression|4|||
129448397|NCT00369785|465941576|FG001|Overall Study|Progression|4|||
129448398|NCT00369785|465941575|FG000|Overall Study|Multiple reasons|6|||
129448399|NCT00369785|465941576|FG001|Overall Study|Multiple reasons|5|||
129448400|NCT00800683|465941577|FG000|Overall Study|Adverse Event|11|||
129448401|NCT00800683|465941578|FG001|Overall Study|Adverse Event|8|||
129448402|NCT00800683|465941577|FG000|Overall Study|Lost to Follow-up|3|||
129448403|NCT00800683|465941578|FG001|Overall Study|Lost to Follow-up|1|||
129448404|NCT00800683|465941577|FG000|Overall Study|Withdrawal by Subject|1|||
129448405|NCT00800683|465941578|FG001|Overall Study|Withdrawal by Subject|7|||
129448406|NCT00800683|465941577|FG000|Overall Study|Lack of Efficacy|1|||
129448407|NCT00800683|465941578|FG001|Overall Study|Lack of Efficacy|1|||
129448408|NCT00800683|465941577|FG000|Overall Study|Other|1|||
129448409|NCT00800683|465941578|FG001|Overall Study|Other|2|||
129448410|NCT04556136|465941586|FG000|Overall Study|Lost to Follow-up|6|||
129448411|NCT04556136|465941587|FG001|Overall Study|Lost to Follow-up|6|||
129448412|NCT04556136|465941586|FG000|Overall Study|Physician Decision|2|||
129448413|NCT04556136|465941587|FG001|Overall Study|Physician Decision|1|||
129448414|NCT04556136|465941586|FG000|Overall Study|Withdrawal by Subject|2|||
129448415|NCT04556136|465941587|FG001|Overall Study|Withdrawal by Subject|1|||
129448416|NCT02678416|465941588|FG000|Part 1|Withdrawal by Subject|1|||
129448417|NCT02678416|465941588|FG000|Part 2|Adverse Event|2|||
129448418|NCT02678416|465941588|FG000|Part 2|Withdrawal by Subject|1|||
129448419|NCT01848353|465941589|FG000|Phase 1|Withdrawal by Subject|3|||
129448420|NCT01848353|465941590|FG001|Phase 1|Withdrawal by Subject|1|||
129448421|NCT01848353|465941591|FG002|Phase 1|Withdrawal by Subject|0|||
129448422|NCT01848353|465941592|FG003|Phase 1|Withdrawal by Subject|0|||
129448423|NCT01848353|465941589|FG000|Phase 2|Withdrawal by Subject|3|||
129448424|NCT01848353|465941590|FG001|Phase 2|Withdrawal by Subject|2|||
129448425|NCT01848353|465941591|FG002|Phase 2|Withdrawal by Subject|0|||
129448426|NCT01848353|465941592|FG003|Phase 2|Withdrawal by Subject|0|||
129448427|NCT01848353|465941589|FG000|Phase 3|Withdrawal by Subject|1|||
129448428|NCT01848353|465941590|FG001|Phase 3|Withdrawal by Subject|1|||
129448429|NCT01848353|465941591|FG002|Phase 3|Withdrawal by Subject|0|||
129448430|NCT01848353|465941592|FG003|Phase 3|Withdrawal by Subject|0|||
129448431|NCT00935272|465941593|FG000|Overall Study|Lost to Follow-up|10|||
129448432|NCT00935272|465941594|FG001|Overall Study|Lost to Follow-up|3|||
129448433|NCT00935272|465941593|FG000|Overall Study|Withdrawal by Subject|8|||
129448434|NCT00935272|465941594|FG001|Overall Study|Withdrawal by Subject|2|||
129448435|NCT00935272|465941593|FG000|Overall Study|Physician Decision|1|||
129448436|NCT00935272|465941594|FG001|Overall Study|Physician Decision|0|||
129448437|NCT00935272|465941593|FG000|Overall Study|Protocol Violation|0|||
129448438|NCT00935272|465941594|FG001|Overall Study|Protocol Violation|1|||
129448439|NCT03492554|465941604|FG000|Overall Study|Protocol Violation|0|||
129448440|NCT03492554|465941605|FG001|Overall Study|Protocol Violation|14|||
129448441|NCT01478360|465941608|FG000|Overall Study|Lost to Follow-up|1|||
129448442|NCT01478360|465941609|FG001|Overall Study|Lost to Follow-up|0|||
129448443|NCT01478360|465941608|FG000|Overall Study|Adverse Event|0|||
129448444|NCT01478360|465941609|FG001|Overall Study|Adverse Event|1|||
129448445|NCT01478360|465941608|FG000|Overall Study|Administrative problems|1|||
129448446|NCT01478360|465941609|FG001|Overall Study|Administrative problems|2|||
129448447|NCT02289352|465941610|FG000|Overall Study|Withdrawal by Subject|1|||
129448448|NCT02289352|465941611|FG001|Overall Study|Withdrawal by Subject|1|||
129448449|NCT02289352|465941612|FG002|Overall Study|Withdrawal by Subject|0|||
129448450|NCT04340557|465941613|FG000|Overall Study|Transferred to ICU and/or death|1|||
129448451|NCT04340557|465941614|FG001|Overall Study|Transferred to ICU and/or death|2|||
129448452|NCT01221727|465941615|FG000|Overall Study|Physician Decision|2|||
129448453|NCT01221727|465941616|FG001|Overall Study|Physician Decision|0|||
129448454|NCT01221727|465941615|FG000|Overall Study|Withdrawal by Subject|1|||
129448455|NCT01221727|465941616|FG001|Overall Study|Withdrawal by Subject|1|||
129448456|NCT00529451|465941644|FG000|Overall Study|Subject withdrew consent|16|||
129448457|NCT00529451|465941645|FG001|Overall Study|Subject withdrew consent|21|||
129448458|NCT00529451|465941646|FG002|Overall Study|Subject withdrew consent|13|||
129448459|NCT00529451|465941647|FG003|Overall Study|Subject withdrew consent|12|||
129448460|NCT00529451|465941644|FG000|Overall Study|Adverse Event|9|||
129448461|NCT00529451|465941645|FG001|Overall Study|Adverse Event|16|||
129448462|NCT00529451|465941646|FG002|Overall Study|Adverse Event|14|||
129448463|NCT00529451|465941647|FG003|Overall Study|Adverse Event|8|||
129840881|NCT02659020|467382787|FG000|Overall Study|Physician Decision|0|||
129840882|NCT02659020|467382788|FG001|Overall Study|Physician Decision|0|||
129448464|NCT00529451|465941644|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
129448465|NCT00529451|465941645|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
129448466|NCT00529451|465941646|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
129448467|NCT00529451|465941647|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
129448468|NCT00529451|465941644|FG000|Overall Study|Lost to Follow-up|4|||
129448469|NCT00529451|465941645|FG001|Overall Study|Lost to Follow-up|7|||
129448470|NCT00529451|465941646|FG002|Overall Study|Lost to Follow-up|4|||
129840883|NCT02659020|467382789|FG002|Overall Study|Physician Decision|0|||
129840884|NCT02659020|467382790|FG003|Overall Study|Physician Decision|1|||
129840885|NCT02659020|467382791|FG004|Overall Study|Physician Decision|1|||
129840886|NCT02659020|467382792|FG005|Overall Study|Physician Decision|0|||
129840887|NCT02659020|467382793|FG006|Overall Study|Physician Decision|1|||
129840888|NCT02659020|467382787|FG000|Overall Study|Withdrawal by Subject|2|||
129840889|NCT02659020|467382788|FG001|Overall Study|Withdrawal by Subject|1|||
129840890|NCT02659020|467382789|FG002|Overall Study|Withdrawal by Subject|0|||
129840891|NCT02659020|467382790|FG003|Overall Study|Withdrawal by Subject|3|||
129840892|NCT02659020|467382791|FG004|Overall Study|Withdrawal by Subject|3|||
129840893|NCT02659020|467382792|FG005|Overall Study|Withdrawal by Subject|6|||
129840894|NCT02659020|467382793|FG006|Overall Study|Withdrawal by Subject|3|||
129840895|NCT02659020|467382787|FG000|Overall Study|Progressive Disease|0|||
129840896|NCT02659020|467382788|FG001|Overall Study|Progressive Disease|0|||
129840897|NCT02659020|467382789|FG002|Overall Study|Progressive Disease|0|||
129840898|NCT02659020|467382790|FG003|Overall Study|Progressive Disease|4|||
129840899|NCT02659020|467382791|FG004|Overall Study|Progressive Disease|1|||
129840900|NCT02659020|467382792|FG005|Overall Study|Progressive Disease|0|||
129840901|NCT02659020|467382793|FG006|Overall Study|Progressive Disease|2|||
129840902|NCT04382911|467382794|FG000|Overall Study|unable to be imaged prior to surgery|2|||
129840903|NCT01585766|467382798|FG000|Overall Study|Withdrawal by Subject|0|||
129840904|NCT01585766|467382799|FG001|Overall Study|Withdrawal by Subject|1|||
129840905|NCT01585766|467382800|FG002|Overall Study|Withdrawal by Subject|1|||
129840906|NCT01585766|467382801|FG003|Overall Study|Withdrawal by Subject|0|||
129840907|NCT01585766|467382802|FG004|Overall Study|Withdrawal by Subject|0|||
129840908|NCT01585766|467382803|FG005|Overall Study|Withdrawal by Subject|0|||
129840909|NCT01585766|467382798|FG000|Overall Study|Death|0|||
129840910|NCT01585766|467382799|FG001|Overall Study|Death|1|||
129840911|NCT01585766|467382800|FG002|Overall Study|Death|0|||
129840912|NCT01585766|467382801|FG003|Overall Study|Death|0|||
129840913|NCT01585766|467382802|FG004|Overall Study|Death|0|||
129840914|NCT01585766|467382803|FG005|Overall Study|Death|0|||
129840915|NCT01585766|467382798|FG000|Overall Study|Physician Decision|0|||
129840916|NCT01585766|467382799|FG001|Overall Study|Physician Decision|0|||
129840917|NCT01585766|467382800|FG002|Overall Study|Physician Decision|1|||
129840918|NCT01585766|467382801|FG003|Overall Study|Physician Decision|0|||
129840919|NCT01585766|467382802|FG004|Overall Study|Physician Decision|0|||
129840920|NCT01585766|467382803|FG005|Overall Study|Physician Decision|0|||
129840921|NCT01120210|467382804|FG000|MAIN INFUSION|Adverse Event|1|||
129840922|NCT01120210|467382805|FG001|MAIN INFUSION|Adverse Event|0|||
129840923|NCT01120210|467382804|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
129840924|NCT01120210|467382805|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
129840925|NCT00477672|467382818|FG000|Overall Study|Adverse Event|3|||
129840926|NCT00477672|467382819|FG001|Overall Study|Adverse Event|5|||
129840927|NCT00477672|467382820|FG002|Overall Study|Adverse Event|6|||
129840928|NCT00477672|467382818|FG000|Overall Study|Death|0|||
129840929|NCT00477672|467382819|FG001|Overall Study|Death|1|||
129840930|NCT00477672|467382820|FG002|Overall Study|Death|0|||
129840931|NCT00477672|467382818|FG000|Overall Study|Disease progression|0|||
129840932|NCT00477672|467382819|FG001|Overall Study|Disease progression|1|||
129840933|NCT00477672|467382820|FG002|Overall Study|Disease progression|0|||
129840934|NCT00477672|467382818|FG000|Overall Study|Physician Decision|1|||
129840935|NCT00477672|467382819|FG001|Overall Study|Physician Decision|0|||
129840936|NCT00477672|467382820|FG002|Overall Study|Physician Decision|0|||
129840937|NCT00477672|467382818|FG000|Overall Study|Protocol noncompliance|0|||
129448471|NCT00529451|465941647|FG003|Overall Study|Lost to Follow-up|4|||
129448472|NCT00529451|465941644|FG000|Overall Study|Protocol deviation|1|||
129448473|NCT00529451|465941645|FG001|Overall Study|Protocol deviation|1|||
129448474|NCT00529451|465941646|FG002|Overall Study|Protocol deviation|4|||
129448475|NCT00529451|465941647|FG003|Overall Study|Protocol deviation|1|||
129448476|NCT00529451|465941644|FG000|Overall Study|Administrative problems|1|||
129448477|NCT00529451|465941645|FG001|Overall Study|Administrative problems|1|||
129448478|NCT00529451|465941646|FG002|Overall Study|Administrative problems|0|||
129448479|NCT00529451|465941647|FG003|Overall Study|Administrative problems|2|||
129448480|NCT00911625|465941648|FG000|Overall Study|Lost to Follow-up|7|||
129448481|NCT00911625|465941649|FG001|Overall Study|Lost to Follow-up|0|||
129448482|NCT01289821|465941652|FG000|Treatment Period|Withdrawal by Subject|1|||
129448483|NCT01289821|465941652|FG000|Treatment Period|Physician Decision|3|||
129448484|NCT01289821|465941652|FG000|Treatment Period|Adverse Event|4|||
129448485|NCT01289821|465941652|FG000|Treatment Period|Radiological Progression|43|||
129448486|NCT01289821|465941652|FG000|Treatment Period|Clinical Progression|2|||
129448487|NCT01289821|465941652|FG000|Treatment Period|Therapeutic procedure required|1|||
129448488|NCT01289821|465941652|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
129840938|NCT00477672|467382819|FG001|Overall Study|Protocol noncompliance|2|||
129840939|NCT00477672|467382820|FG002|Overall Study|Protocol noncompliance|0|||
129840940|NCT00477672|467382818|FG000|Overall Study|Consent withdrawn|2|||
129840941|NCT00477672|467382819|FG001|Overall Study|Consent withdrawn|5|||
129840942|NCT00477672|467382820|FG002|Overall Study|Consent withdrawn|10|||
129840943|NCT00477672|467382818|FG000|Overall Study|Discretion of Sponsor|1|||
129840944|NCT00477672|467382819|FG001|Overall Study|Discretion of Sponsor|2|||
129840945|NCT00477672|467382820|FG002|Overall Study|Discretion of Sponsor|0|||
129840946|NCT03571516|467382821|FG000|Overall Study|Severe diarrhea|1|||
129840947|NCT03571516|467382822|FG001|Overall Study|Severe diarrhea|0|||
129840948|NCT03571516|467382821|FG000|Overall Study|Withdrawal by Subject|0|||
129840949|NCT03571516|467382822|FG001|Overall Study|Withdrawal by Subject|1|||
129840950|NCT03044197|467382825|FG000|Overall Study|Withdrawal by Subject|3|||
129840951|NCT03044197|467382826|FG001|Overall Study|Withdrawal by Subject|1|||
129840952|NCT00989833|467382831|FG000|Overall Study|Lost to Follow-up|0|||
129840953|NCT00989833|467382832|FG001|Overall Study|Lost to Follow-up|1|||
129840954|NCT00989833|467382833|FG002|Overall Study|Lost to Follow-up|0|||
129448489|NCT01289821|465941652|FG000|Safety Follow-up Period|Protocol Violation|3|||
129448490|NCT01289821|465941652|FG000|Safety Follow-up Period|Unspecified reason|1|||
129448491|NCT01289821|465941652|FG000|Survival Follow-up Period|Protocol Violation|1|||
129840955|NCT00989833|467382831|FG000|Overall Study|Protocol Violation|1|||
129840956|NCT00989833|467382832|FG001|Overall Study|Protocol Violation|2|||
129448492|NCT01289821|465941652|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
129448493|NCT01289821|465941652|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
129448494|NCT00590044|465941656|FG000|Overall Study|Withdrawal by Subject|2|||
129448495|NCT00590044|465941657|FG001|Overall Study|Withdrawal by Subject|2|||
129448496|NCT00590044|465941656|FG000|Overall Study|wrong insulin arm assigned|1|||
129448497|NCT00590044|465941657|FG001|Overall Study|wrong insulin arm assigned|0|||
129448498|NCT00590044|465941656|FG000|Overall Study|Protocol Violation|1|||
129448499|NCT00590044|465941657|FG001|Overall Study|Protocol Violation|0|||
129448500|NCT01010633|465941663|FG000|Overall Study|Adverse Event|1|||
129448501|NCT01010633|465941664|FG001|Overall Study|Adverse Event|1|||
129448502|NCT01010633|465941663|FG000|Overall Study|Protocol Violation|1|||
129899506|NCT01253226|467591871|FG003|Overall Study|Withdrawal by Subject|1|||
129899507|NCT01253226|467591872|FG004|Overall Study|Withdrawal by Subject|0|||
129899508|NCT03310983|467591873|FG000|Overall Study|Lost to Follow-up|15|||
129899509|NCT03310983|467591874|FG001|Overall Study|Lost to Follow-up|17|||
129448503|NCT01010633|465941664|FG001|Overall Study|Protocol Violation|2|||
129448504|NCT01010633|465941663|FG000|Overall Study|Withdrawal by Subject|2|||
129840957|NCT00989833|467382833|FG002|Overall Study|Protocol Violation|1|||
129840958|NCT00989833|467382831|FG000|Overall Study|Withdrawal by Subject|0|||
129840959|NCT00989833|467382832|FG001|Overall Study|Withdrawal by Subject|0|||
129840960|NCT00989833|467382833|FG002|Overall Study|Withdrawal by Subject|1|||
129840961|NCT00989833|467382831|FG000|Overall Study|Incorrectly randomized|1|||
129840962|NCT00989833|467382832|FG001|Overall Study|Incorrectly randomized|0|||
129840963|NCT00989833|467382833|FG002|Overall Study|Incorrectly randomized|0|||
129840964|NCT02469610|467382834|FG000|Overall Study|Death|1|||
129840965|NCT02469610|467382835|FG001|Overall Study|Death|0|||
129840966|NCT02469610|467382834|FG000|Overall Study|Lost to Follow-up|1|||
129840967|NCT02469610|467382835|FG001|Overall Study|Lost to Follow-up|0|||
129840968|NCT02469610|467382834|FG000|Overall Study|exclusion criteria|2|||
129840969|NCT02469610|467382835|FG001|Overall Study|exclusion criteria|1|||
129840970|NCT01806896|467382836|FG000|Overall Study|Adverse Event|2|||
129840971|NCT01806896|467382837|FG001|Overall Study|Adverse Event|0|||
129840972|NCT01806896|467382836|FG000|Overall Study|Other|1|||
129840973|NCT01806896|467382837|FG001|Overall Study|Other|0|||
129840974|NCT02434770|467382838|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
129840975|NCT02434770|467382839|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
129840976|NCT02434770|467382840|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
129840977|NCT02434770|467382838|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
129840978|NCT02434770|467382839|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
129840979|NCT02434770|467382840|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
129840980|NCT02434770|467382838|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
129840981|NCT02434770|467382839|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
129840982|NCT02434770|467382840|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
129840983|NCT02434770|467382838|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
129840984|NCT02434770|467382839|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
129840985|NCT02434770|467382840|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
129840986|NCT02434770|467382838|FG000|Week 1 to Week 18|Death|1|||
129840987|NCT02434770|467382839|FG001|Week 1 to Week 18|Death|0|||
129840988|NCT02434770|467382840|FG002|Week 1 to Week 18|Death|0|||
129840989|NCT02434770|467382838|FG000|Week 18 to Week|Lost to Follow-up|2|||
129840990|NCT02434770|467382839|FG001|Week 18 to Week|Lost to Follow-up|2|||
129840991|NCT02434770|467382840|FG002|Week 18 to Week|Lost to Follow-up|1|||
129840992|NCT02434770|467382838|FG000|Week 18 to Week|Withdrawal by Subject|0|||
129840993|NCT02434770|467382839|FG001|Week 18 to Week|Withdrawal by Subject|0|||
129840994|NCT02434770|467382840|FG002|Week 18 to Week|Withdrawal by Subject|2|||
129840995|NCT02434770|467382838|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
129840996|NCT02434770|467382839|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
129840997|NCT02434770|467382840|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
129840998|NCT00245765|467382841|FG000|Overall Study|Adverse Event|1|||
129840999|NCT00245765|467382842|FG001|Overall Study|Adverse Event|1|||
129841000|NCT00245765|467382843|FG002|Overall Study|Adverse Event|0|||
129841001|NCT00245765|467382841|FG000|Overall Study|Lack of Efficacy|14|||
129841002|NCT00245765|467382842|FG001|Overall Study|Lack of Efficacy|7|||
129841003|NCT00245765|467382843|FG002|Overall Study|Lack of Efficacy|0|||
129841004|NCT00245765|467382841|FG000|Overall Study|Lost to Follow-up|1|||
129841005|NCT00245765|467382842|FG001|Overall Study|Lost to Follow-up|2|||
129841006|NCT00245765|467382843|FG002|Overall Study|Lost to Follow-up|0|||
129841007|NCT00245765|467382841|FG000|Overall Study|Withdrawal by Subject|1|||
129841008|NCT00245765|467382842|FG001|Overall Study|Withdrawal by Subject|0|||
129841009|NCT00245765|467382843|FG002|Overall Study|Withdrawal by Subject|3|||
129841010|NCT00245765|467382841|FG000|Overall Study|Other reason|2|||
129841011|NCT00245765|467382842|FG001|Overall Study|Other reason|0|||
129841012|NCT00245765|467382843|FG002|Overall Study|Other reason|1|||
129841013|NCT00245765|467382841|FG000|Overall Study|Other|13|||
129899510|NCT01656304|467591880|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
129448505|NCT01010633|465941664|FG001|Overall Study|Withdrawal by Subject|1|||
129448506|NCT01010633|465941663|FG000|Overall Study|Investigator decision|0|||
129841014|NCT00245765|467382842|FG001|Overall Study|Other|4|||
129841015|NCT00245765|467382843|FG002|Overall Study|Other|4|||
129448507|NCT01010633|465941664|FG001|Overall Study|Investigator decision|1|||
129448508|NCT02463071|465941665|FG000|Overall Study|Adverse Event|3|||
129448509|NCT02463071|465941666|FG001|Overall Study|Adverse Event|5|||
129448510|NCT02463071|465941667|FG002|Overall Study|Adverse Event|1|||
129448511|NCT02463071|465941665|FG000|Overall Study|Death|1|||
129448512|NCT02463071|465941666|FG001|Overall Study|Death|0|||
129448513|NCT02463071|465941667|FG002|Overall Study|Death|0|||
129448514|NCT02463071|465941665|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
129448515|NCT02463071|465941666|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129448516|NCT02463071|465941667|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129448517|NCT02463071|465941665|FG000|Overall Study|Reason not specified|7|||
129448518|NCT02463071|465941666|FG001|Overall Study|Reason not specified|9|||
129448519|NCT02463071|465941667|FG002|Overall Study|Reason not specified|4|||
129448520|NCT02463071|465941665|FG000|Overall Study|Protocol Violation|0|||
129448521|NCT02463071|465941666|FG001|Overall Study|Protocol Violation|2|||
129448522|NCT02463071|465941667|FG002|Overall Study|Protocol Violation|0|||
129448523|NCT02463071|465941665|FG000|Overall Study|Lost to Follow-up|0|||
129448524|NCT02463071|465941666|FG001|Overall Study|Lost to Follow-up|0|||
129448525|NCT02463071|465941667|FG002|Overall Study|Lost to Follow-up|1|||
129448526|NCT01245387|465941668|FG000|Overall Study|Lost to Follow-up|106|||
129448527|NCT01245387|465941668|FG000|Overall Study|Lack of Efficacy|195|||
129448528|NCT01245387|465941668|FG000|Overall Study|Adverse Event|9|||
129448529|NCT01245387|465941668|FG000|Overall Study|Death|3|||
129448530|NCT01245387|465941668|FG000|Overall Study|Other|131|||
129448531|NCT01245387|465941668|FG000|Overall Study|Missing discontinuation status|369|||
129448532|NCT00757003|465941669|FG000|Overall Study|Death|33|||
129448533|NCT00757003|465941669|FG000|Overall Study|Lost to Follow-up|9|||
129448534|NCT00757003|465941669|FG000|Overall Study|Withdrawal by Subject|4|||
129448535|NCT00757003|465941669|FG000|Overall Study|Surgically explanted|2|||
129448536|NCT00757003|465941669|FG000|Overall Study|Not implanted|1|||
129448537|NCT02146599|465941685|FG000|Overall Study|Failed to meet inclusion criteria|5|||
129448538|NCT03061175|465941689|FG000|Baseline|Participant was deemed ineligible|1|||
129448539|NCT03061175|465941690|FG001|Baseline|Participant was deemed ineligible|0|||
129448540|NCT03061175|465941689|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
129448541|NCT03061175|465941690|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
129448542|NCT03061175|465941689|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
129448543|NCT03061175|465941690|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
129448544|NCT03061175|465941689|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
129448545|NCT03061175|465941690|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
129448546|NCT02243865|465941691|FG000|Overall Study|Protocol Violation|1|||
129448547|NCT02243865|465941692|FG001|Overall Study|Protocol Violation|3|||
129448548|NCT02243865|465941691|FG000|Overall Study|Lost to Follow-up|1|||
129448549|NCT02243865|465941692|FG001|Overall Study|Lost to Follow-up|1|||
129448550|NCT02243865|465941691|FG000|Overall Study|Withdrawal by Subject|1|||
129448551|NCT02243865|465941692|FG001|Overall Study|Withdrawal by Subject|0|||
129448552|NCT02243865|465941691|FG000|Overall Study|Adverse Event|1|||
129448553|NCT02243865|465941692|FG001|Overall Study|Adverse Event|1|||
129448554|NCT01235793|465941696|FG000|Overall Study|Death|6|||
129448555|NCT01159912|465941697|FG000|Overall Study|Adverse Event|2|||
129448556|NCT01159912|465941698|FG001|Overall Study|Adverse Event|2|||
129448557|NCT01159912|465941699|FG002|Overall Study|Adverse Event|3|||
129448558|NCT01159912|465941697|FG000|Overall Study|Lack of Efficacy|23|||
129448559|NCT01159912|465941698|FG001|Overall Study|Lack of Efficacy|15|||
129448560|NCT01159912|465941699|FG002|Overall Study|Lack of Efficacy|14|||
129448561|NCT01159912|465941697|FG000|Overall Study|Protocol Violation|1|||
129448562|NCT01159912|465941698|FG001|Overall Study|Protocol Violation|2|||
129448563|NCT01159912|465941699|FG002|Overall Study|Protocol Violation|3|||
129448564|NCT01159912|465941697|FG000|Overall Study|Lost to Follow-up|4|||
129448565|NCT01159912|465941698|FG001|Overall Study|Lost to Follow-up|0|||
129448566|NCT01159912|465941699|FG002|Overall Study|Lost to Follow-up|0|||
129448567|NCT01159912|465941697|FG000|Overall Study|Physician Decision|0|||
129448568|NCT01159912|465941698|FG001|Overall Study|Physician Decision|0|||
129448569|NCT01159912|465941699|FG002|Overall Study|Physician Decision|3|||
129448570|NCT01159912|465941697|FG000|Overall Study|Withdrawal by Subject|10|||
129448571|NCT01159912|465941698|FG001|Overall Study|Withdrawal by Subject|3|||
129448572|NCT01159912|465941699|FG002|Overall Study|Withdrawal by Subject|3|||
129448573|NCT04376827|465941707|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
129841016|NCT00660348|467382844|FG000|Overall Study|Withdrawal by Subject|1|||
129841017|NCT00660348|467382845|FG001|Overall Study|Withdrawal by Subject|0|||
129841018|NCT03316872|467382849|FG000|Overall Study|Death|1|||
129448574|NCT04376827|465941708|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
129448575|NCT04376827|465941707|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
129448576|NCT04376827|465941708|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
129448577|NCT04376827|465941707|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
129448578|NCT04376827|465941708|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
129841019|NCT04074317|467382853|FG000|Third Period|Withdrawal by Subject|0|||
129841020|NCT04074317|467382854|FG001|Third Period|Withdrawal by Subject|0|||
129841021|NCT04074317|467382855|FG002|Third Period|Withdrawal by Subject|0|||
129899511|NCT01155869|467591881|FG000|Overall Study|Lost to Follow-up|3|||
129899512|NCT01155869|467591882|FG001|Overall Study|Lost to Follow-up|1|||
129899513|NCT02824432|467591883|FG000|Overall Study|Major Protocol Deviation|1|||
129899514|NCT02824432|467591884|FG001|Overall Study|Major Protocol Deviation|0|||
129899515|NCT05826431|467591886|FG000|Overall Study|Withdrawal by Subject|1|||
129899516|NCT04771273|467591887|FG000|Dose Escalation Period|Not treated with trial medication|0|||
129899517|NCT04771273|467591888|FG001|Dose Escalation Period|Not treated with trial medication|1|||
129899518|NCT04771273|467591889|FG002|Dose Escalation Period|Not treated with trial medication|1|||
129899519|NCT04771273|467591890|FG003|Dose Escalation Period|Not treated with trial medication|0|||
129899520|NCT04771273|467591887|FG000|Dose Escalation Period|Other reasons than listed|2|||
129899521|NCT04771273|467591888|FG001|Dose Escalation Period|Other reasons than listed|0|||
129899522|NCT04771273|467591889|FG002|Dose Escalation Period|Other reasons than listed|2|||
129899523|NCT04771273|467591890|FG003|Dose Escalation Period|Other reasons than listed|1|||
129899524|NCT04771273|467591887|FG000|Dose Escalation Period|Protocol Violation|0|||
129899525|NCT04771273|467591888|FG001|Dose Escalation Period|Protocol Violation|0|||
129899526|NCT04771273|467591889|FG002|Dose Escalation Period|Protocol Violation|3|||
129899527|NCT04771273|467591890|FG003|Dose Escalation Period|Protocol Violation|1|||
129899528|NCT04771273|467591887|FG000|Dose Escalation Period|Burden of study procedures|1|||
129899529|NCT04771273|467591888|FG001|Dose Escalation Period|Burden of study procedures|0|||
129899530|NCT04771273|467591889|FG002|Dose Escalation Period|Burden of study procedures|0|||
129899531|NCT04771273|467591890|FG003|Dose Escalation Period|Burden of study procedures|0|||
129841022|NCT04074317|467382856|FG003|Third Period|Withdrawal by Subject|1|||
129841023|NCT04074317|467382857|FG004|Third Period|Withdrawal by Subject|0|||
129841024|NCT04074317|467382858|FG005|Third Period|Withdrawal by Subject|0|||
129841025|NCT00355238|467385025|FG000|Overall Study|Adverse event unrelated to study drug|2|||
129841026|NCT00355238|467385026|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129841027|NCT00355238|467385027|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129841028|NCT00355238|467385028|FG003|Overall Study|Adverse event unrelated to study drug|1|||
129841029|NCT00355238|467385025|FG000|Overall Study|Death|1|||
129841030|NCT00355238|467385026|FG001|Overall Study|Death|0|||
129841031|NCT00355238|467385027|FG002|Overall Study|Death|0|||
129841032|NCT00355238|467385028|FG003|Overall Study|Death|0|||
129841033|NCT00355238|467385025|FG000|Overall Study|Disease progression|37|||
129841034|NCT00355238|467385026|FG001|Overall Study|Disease progression|36|||
129841035|NCT00355238|467385027|FG002|Overall Study|Disease progression|16|||
129841036|NCT00355238|467385028|FG003|Overall Study|Disease progression|11|||
129841037|NCT00355238|467385025|FG000|Overall Study|Study drug toxicity|11|||
129841038|NCT00355238|467385026|FG001|Overall Study|Study drug toxicity|7|||
129841039|NCT00355238|467385027|FG002|Overall Study|Study drug toxicity|5|||
129841040|NCT00355238|467385028|FG003|Overall Study|Study drug toxicity|2|||
129841041|NCT00355238|467385025|FG000|Overall Study|Participant withdrew consent|3|||
129841042|NCT00355238|467385026|FG001|Overall Study|Participant withdrew consent|1|||
129841043|NCT00355238|467385027|FG002|Overall Study|Participant withdrew consent|0|||
129841044|NCT00355238|467385028|FG003|Overall Study|Participant withdrew consent|0|||
129841045|NCT00355238|467385025|FG000|Overall Study|Participant request to discontinue study treatment|1|||
129841046|NCT00355238|467385026|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129841047|NCT00355238|467385027|FG002|Overall Study|Participant request to discontinue study treatment|1|||
129841048|NCT00355238|467385028|FG003|Overall Study|Participant request to discontinue study treatment|0|||
129841049|NCT01956110|467385029|FG000|Overall Study|Protocol Violation|25|||
129841050|NCT01956110|467385030|FG001|Overall Study|Protocol Violation|11|||
129841051|NCT01956110|467385029|FG000|Overall Study|Adverse Event|9|||
129841052|NCT01956110|467385030|FG001|Overall Study|Adverse Event|10|||
129841053|NCT01956110|467385029|FG000|Overall Study|Personal reasons|1|||
129841054|NCT01956110|467385030|FG001|Overall Study|Personal reasons|1|||
129841055|NCT00910715|467385037|FG000|Overall Study|Lost to Follow-up|22|||
129841056|NCT00910715|467385038|FG001|Overall Study|Lost to Follow-up|26|||
129841057|NCT00910715|467385039|FG002|Overall Study|Lost to Follow-up|0|||
129841058|NCT01467076|467385040|FG000|Overall Study|Lost to Follow-up|1|||
129841059|NCT01467076|467385041|FG001|Overall Study|Lost to Follow-up|0|||
129841060|NCT01467076|467385042|FG002|Overall Study|Lost to Follow-up|0|||
129841061|NCT03761628|467385044|FG000|Overall Study|Withdrawal by Subject|3|||
129899532|NCT04771273|467591887|FG000|Dose Escalation Period|Change of residence|0|||
129841062|NCT03761628|467385044|FG000|Overall Study|Physician Decision|1|||
129841063|NCT03761628|467385044|FG000|Overall Study|Pregnancy|1|||
129841064|NCT03761628|467385044|FG000|Overall Study|Lost to Follow-up|1|||
129841065|NCT05358821|467385047|FG000|Overall Study|Withdrawal by Subject|0|||
129841066|NCT05358821|467385048|FG001|Overall Study|Withdrawal by Subject|1|||
129841067|NCT05358821|467385049|FG002|Overall Study|Withdrawal by Subject|0|||
129841068|NCT05358821|467385047|FG000|Overall Study|Withdrawal of Consent|0|||
129841069|NCT05358821|467385048|FG001|Overall Study|Withdrawal of Consent|0|||
129899533|NCT04771273|467591888|FG001|Dose Escalation Period|Change of residence|0|||
129899534|NCT04771273|467591889|FG002|Dose Escalation Period|Change of residence|0|||
129841070|NCT05358821|467385049|FG002|Overall Study|Withdrawal of Consent|1|||
129841071|NCT04649151|467385050|FG000|Overall Study|Pregnancy|0|||
129899535|NCT04771273|467591890|FG003|Dose Escalation Period|Change of residence|1|||
129899536|NCT04771273|467591887|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
129841072|NCT04649151|467385051|FG001|Overall Study|Pregnancy|0|||
129841073|NCT04649151|467385052|FG002|Overall Study|Pregnancy|0|||
129841074|NCT04649151|467385053|FG003|Overall Study|Pregnancy|0|||
129841075|NCT04649151|467385054|FG004|Overall Study|Pregnancy|3|||
129841076|NCT04649151|467385050|FG000|Overall Study|Physician Decision|10|||
129841077|NCT04649151|467385051|FG001|Overall Study|Physician Decision|0|||
129841078|NCT04649151|467385052|FG002|Overall Study|Physician Decision|0|||
129841079|NCT04649151|467385053|FG003|Overall Study|Physician Decision|1|||
129841080|NCT04649151|467385054|FG004|Overall Study|Physician Decision|1|||
129841081|NCT04649151|467385050|FG000|Overall Study|Protocol Deviation|25|||
129841082|NCT04649151|467385051|FG001|Overall Study|Protocol Deviation|3|||
129841083|NCT04649151|467385052|FG002|Overall Study|Protocol Deviation|0|||
129841084|NCT04649151|467385053|FG003|Overall Study|Protocol Deviation|0|||
129841085|NCT04649151|467385054|FG004|Overall Study|Protocol Deviation|0|||
129841086|NCT04649151|467385050|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
129841087|NCT04649151|467385051|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
129841088|NCT04649151|467385052|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
129841089|NCT04649151|467385053|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
129841090|NCT04649151|467385054|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
129841091|NCT04649151|467385050|FG000|Overall Study|Withdrawal by Subject|370|||
129841092|NCT04649151|467385051|FG001|Overall Study|Withdrawal by Subject|113|||
129841093|NCT04649151|467385052|FG002|Overall Study|Withdrawal by Subject|2|||
129841094|NCT04649151|467385053|FG003|Overall Study|Withdrawal by Subject|7|||
129841095|NCT04649151|467385054|FG004|Overall Study|Withdrawal by Subject|15|||
129841096|NCT04649151|467385050|FG000|Overall Study|Adverse Event|1|||
129841097|NCT04649151|467385051|FG001|Overall Study|Adverse Event|0|||
129841098|NCT04649151|467385052|FG002|Overall Study|Adverse Event|0|||
129841099|NCT04649151|467385053|FG003|Overall Study|Adverse Event|0|||
129841100|NCT04649151|467385054|FG004|Overall Study|Adverse Event|0|||
129841101|NCT04649151|467385050|FG000|Overall Study|Lost to Follow-up|256|||
129841102|NCT04649151|467385051|FG001|Overall Study|Lost to Follow-up|29|||
129841103|NCT04649151|467385052|FG002|Overall Study|Lost to Follow-up|10|||
129841104|NCT04649151|467385053|FG003|Overall Study|Lost to Follow-up|3|||
129841105|NCT04649151|467385054|FG004|Overall Study|Lost to Follow-up|6|||
129841106|NCT04649151|467385050|FG000|Overall Study|Other than specified|59|||
129841107|NCT04649151|467385051|FG001|Overall Study|Other than specified|294|||
129841108|NCT04649151|467385052|FG002|Overall Study|Other than specified|0|||
129841109|NCT04649151|467385053|FG003|Overall Study|Other than specified|0|||
129841110|NCT04649151|467385054|FG004|Overall Study|Other than specified|4|||
129841111|NCT04649151|467385050|FG000|Overall Study|Death|0|||
129841112|NCT04649151|467385051|FG001|Overall Study|Death|0|||
129841113|NCT04649151|467385052|FG002|Overall Study|Death|0|||
129841114|NCT04649151|467385053|FG003|Overall Study|Death|0|||
129841115|NCT04649151|467385054|FG004|Overall Study|Death|1|||
129841116|NCT03752619|467385055|FG000|Overall Study|Lost to Follow-up|2|||
129841117|NCT03752619|467385056|FG001|Overall Study|Lost to Follow-up|1|||
129841118|NCT03752619|467385055|FG000|Overall Study|Withdrawal by Subject|1|||
129841119|NCT03752619|467385056|FG001|Overall Study|Withdrawal by Subject|1|||
129841120|NCT03752619|467385055|FG000|Overall Study|Adverse Event|0|||
129841121|NCT03752619|467385056|FG001|Overall Study|Adverse Event|1|||
129841122|NCT03907683|467385057|FG000|Overall Study|Pregnancy|1|||
129841123|NCT03907683|467385057|FG000|Overall Study|Withdrawal by Subject|1|||
129841124|NCT03400332|467385058|FG000|Pre-Treatment|Other reasons|0|||
129841125|NCT03400332|467385059|FG001|Pre-Treatment|Other reasons|0|||
129841126|NCT03400332|467385060|FG002|Pre-Treatment|Other reasons|0|||
129841127|NCT03400332|467385061|FG003|Pre-Treatment|Other reasons|0|||
129841128|NCT03400332|467385062|FG004|Pre-Treatment|Other reasons|0|||
129841129|NCT03400332|467385063|FG005|Pre-Treatment|Other reasons|0|||
129841130|NCT03400332|467385064|FG006|Pre-Treatment|Other reasons|0|||
129841131|NCT03400332|467385065|FG007|Pre-Treatment|Other reasons|0|||
129899537|NCT04771273|467591888|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
129448579|NCT04376827|465941707|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
129841132|NCT03400332|467385066|FG008|Pre-Treatment|Other reasons|1|||
129841133|NCT03400332|467385058|FG000|Pre-Treatment|No longer met study criteria|0|||
129841134|NCT03400332|467385059|FG001|Pre-Treatment|No longer met study criteria|0|||
129841135|NCT03400332|467385060|FG002|Pre-Treatment|No longer met study criteria|0|||
129841136|NCT03400332|467385061|FG003|Pre-Treatment|No longer met study criteria|0|||
129841137|NCT03400332|467385062|FG004|Pre-Treatment|No longer met study criteria|0|||
129841138|NCT03400332|467385063|FG005|Pre-Treatment|No longer met study criteria|0|||
129841139|NCT03400332|467385064|FG006|Pre-Treatment|No longer met study criteria|0|||
129841140|NCT03400332|467385065|FG007|Pre-Treatment|No longer met study criteria|0|||
129841141|NCT03400332|467385066|FG008|Pre-Treatment|No longer met study criteria|1|||
129841142|NCT03400332|467385058|FG000|Pre-Treatment|Withdrawal by Subject|0|||
129841143|NCT03400332|467385059|FG001|Pre-Treatment|Withdrawal by Subject|0|||
129841144|NCT03400332|467385060|FG002|Pre-Treatment|Withdrawal by Subject|0|||
129841145|NCT03400332|467385061|FG003|Pre-Treatment|Withdrawal by Subject|0|||
129841146|NCT03400332|467385062|FG004|Pre-Treatment|Withdrawal by Subject|0|||
129841147|NCT03400332|467385063|FG005|Pre-Treatment|Withdrawal by Subject|0|||
129448580|NCT04376827|465941708|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
129841148|NCT03400332|467385064|FG006|Pre-Treatment|Withdrawal by Subject|0|||
129841149|NCT03400332|467385065|FG007|Pre-Treatment|Withdrawal by Subject|0|||
129841150|NCT03400332|467385066|FG008|Pre-Treatment|Withdrawal by Subject|1|||
129841151|NCT03400332|467385058|FG000|Treatment|Participant withdrew consent|2|||
129841152|NCT03400332|467385059|FG001|Treatment|Participant withdrew consent|2|||
129841153|NCT03400332|467385060|FG002|Treatment|Participant withdrew consent|0|||
129841154|NCT03400332|467385061|FG003|Treatment|Participant withdrew consent|0|||
129841155|NCT03400332|467385062|FG004|Treatment|Participant withdrew consent|3|||
129841156|NCT03400332|467385063|FG005|Treatment|Participant withdrew consent|3|||
129841157|NCT03400332|467385064|FG006|Treatment|Participant withdrew consent|1|||
129841158|NCT03400332|467385065|FG007|Treatment|Participant withdrew consent|1|||
129841159|NCT03400332|467385066|FG008|Treatment|Participant withdrew consent|1|||
129841160|NCT03400332|467385058|FG000|Treatment|Other reasons|0|||
129841161|NCT03400332|467385059|FG001|Treatment|Other reasons|1|||
129841162|NCT03400332|467385060|FG002|Treatment|Other reasons|1|||
129841163|NCT03400332|467385061|FG003|Treatment|Other reasons|0|||
129841164|NCT03400332|467385062|FG004|Treatment|Other reasons|3|||
129841165|NCT03400332|467385063|FG005|Treatment|Other reasons|1|||
129841166|NCT03400332|467385064|FG006|Treatment|Other reasons|2|||
129841167|NCT03400332|467385065|FG007|Treatment|Other reasons|0|||
129841168|NCT03400332|467385066|FG008|Treatment|Other reasons|1|||
129841169|NCT03400332|467385058|FG000|Treatment|Lost to Follow-up|0|||
129841170|NCT03400332|467385059|FG001|Treatment|Lost to Follow-up|1|||
129841171|NCT03400332|467385060|FG002|Treatment|Lost to Follow-up|0|||
129841172|NCT03400332|467385061|FG003|Treatment|Lost to Follow-up|0|||
129841173|NCT03400332|467385062|FG004|Treatment|Lost to Follow-up|0|||
129841174|NCT03400332|467385063|FG005|Treatment|Lost to Follow-up|0|||
129841175|NCT03400332|467385064|FG006|Treatment|Lost to Follow-up|0|||
129841176|NCT03400332|467385065|FG007|Treatment|Lost to Follow-up|0|||
129841177|NCT03400332|467385066|FG008|Treatment|Lost to Follow-up|0|||
129841178|NCT03400332|467385058|FG000|Treatment|Death|3|||
129841179|NCT03400332|467385059|FG001|Treatment|Death|1|||
129841180|NCT03400332|467385060|FG002|Treatment|Death|2|||
129841181|NCT03400332|467385061|FG003|Treatment|Death|3|||
129841182|NCT03400332|467385062|FG004|Treatment|Death|6|||
129841183|NCT03400332|467385063|FG005|Treatment|Death|2|||
129841184|NCT03400332|467385064|FG006|Treatment|Death|1|||
129841185|NCT03400332|467385065|FG007|Treatment|Death|3|||
129841186|NCT03400332|467385066|FG008|Treatment|Death|6|||
129841187|NCT03901963|467385067|FG000|Overall Study|Lost to Follow-up|1|||
129841188|NCT03901963|467385068|FG001|Overall Study|Lost to Follow-up|1|||
129841189|NCT03901963|467385067|FG000|Overall Study|Physician Decision|1|||
129841190|NCT03901963|467385068|FG001|Overall Study|Physician Decision|2|||
129841191|NCT03901963|467385067|FG000|Overall Study|Protocol Violation|1|||
129841192|NCT03901963|467385068|FG001|Overall Study|Protocol Violation|1|||
129841193|NCT03901963|467385067|FG000|Overall Study|Withdrawal by Subject|4|||
129841194|NCT03901963|467385068|FG001|Overall Study|Withdrawal by Subject|11|||
129841195|NCT03901963|467385067|FG000|Overall Study|Ongoing|84|||
129841196|NCT03901963|467385068|FG001|Overall Study|Ongoing|73|||
129841197|NCT03901963|467385067|FG000|Overall Study|Randomized but not treated|3|||
129841198|NCT03901963|467385068|FG001|Overall Study|Randomized but not treated|3|||
129841199|NCT02018458|467385075|FG000|Overall Study|Death|4|||
129841200|NCT04033159|467385099|FG000|Washout Period|Physician Decision|0|||
129841201|NCT04033159|467385100|FG001|Washout Period|Physician Decision|1|||
129841202|NCT04033159|467385101|FG002|Washout Period|Physician Decision|0|||
129841203|NCT04033159|467385099|FG000|Washout Period|Study terminated by Sponsor|0|||
129841204|NCT04033159|467385100|FG001|Washout Period|Study terminated by Sponsor|7|||
129841205|NCT04033159|467385101|FG002|Washout Period|Study terminated by Sponsor|0|||
129841206|NCT04033159|467385099|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
129841207|NCT04033159|467385100|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
129841208|NCT04033159|467385101|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
129841209|NCT00116558|467385102|FG000|Overall Study|Death|11|||
129841210|NCT00116558|467385103|FG001|Overall Study|Death|5|||
129841211|NCT00116558|467385104|FG002|Overall Study|Death|3|||
129841212|NCT00116558|467385102|FG000|Overall Study|Withdrawal by Subject|17|||
129841213|NCT00116558|467385103|FG001|Overall Study|Withdrawal by Subject|3|||
129841214|NCT00116558|467385104|FG002|Overall Study|Withdrawal by Subject|12|||
129841215|NCT00116558|467385102|FG000|Overall Study|disease progression|3|||
129841216|NCT00116558|467385103|FG001|Overall Study|disease progression|7|||
129841217|NCT00116558|467385104|FG002|Overall Study|disease progression|18|||
129841218|NCT02027844|467385105|FG000|Overall Study|Withdrawal by Subject|3|||
129841219|NCT02027844|467385106|FG001|Overall Study|Withdrawal by Subject|2|||
129841220|NCT02027844|467385107|FG002|Overall Study|Withdrawal by Subject|1|||
129841221|NCT02027844|467385105|FG000|Overall Study|Lost to Follow-up|0|||
129841222|NCT02027844|467385106|FG001|Overall Study|Lost to Follow-up|2|||
129841223|NCT02027844|467385107|FG002|Overall Study|Lost to Follow-up|1|||
129841224|NCT02027844|467385105|FG000|Overall Study|Protocol Violation|0|||
129841225|NCT02027844|467385106|FG001|Overall Study|Protocol Violation|2|||
129841226|NCT02027844|467385107|FG002|Overall Study|Protocol Violation|0|||
129841227|NCT02027844|467385105|FG000|Overall Study|Incomlete data|2|||
129841228|NCT02027844|467385106|FG001|Overall Study|Incomlete data|0|||
129841229|NCT02027844|467385107|FG002|Overall Study|Incomlete data|0|||
129841230|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
129841231|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
129841232|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Graft loss|1|||
129841233|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Graft loss|2|||
129841234|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Death|5|||
129841235|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Death|3|||
129841236|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
129841237|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
129841238|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
129841239|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
129841240|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
129841241|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
129841242|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
129841243|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
129841244|NCT00378014|467385108|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
129448581|NCT04376827|465941707|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
129448582|NCT04376827|465941708|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
129448583|NCT02229539|465943401|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
129448584|NCT02229539|465943402|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
129448585|NCT02229539|465943403|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
129448586|NCT02229539|465943401|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
129448587|NCT02229539|465943402|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
129448588|NCT02229539|465943403|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
129448589|NCT02229539|465943401|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
129448590|NCT02229539|465943402|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
129448591|NCT02229539|465943403|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
129448592|NCT02229539|465943401|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
129448593|NCT02229539|465943402|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
129448594|NCT02229539|465943403|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
129448595|NCT02229539|465943401|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
129448596|NCT02229539|465943402|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
129448597|NCT02229539|465943403|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
129448598|NCT02229539|465943401|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
129448599|NCT02229539|465943402|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
129448600|NCT02229539|465943403|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
129448601|NCT00880555|465943410|FG000|Overall Study|Physician Decision|0|||
129448602|NCT00880555|465943411|FG001|Overall Study|Physician Decision|8|||
129448603|NCT00880555|465943412|FG002|Overall Study|Physician Decision|0|||
129448604|NCT00880555|465943413|FG003|Overall Study|Physician Decision|2|||
129448605|NCT00880555|465943414|FG004|Overall Study|Physician Decision|1|||
129448606|NCT00880555|465943415|FG005|Overall Study|Physician Decision|0|||
129448607|NCT00880555|465943410|FG000|Overall Study|Withdrawal by Subject|1|||
129448608|NCT00880555|465943411|FG001|Overall Study|Withdrawal by Subject|1|||
129448609|NCT00880555|465943412|FG002|Overall Study|Withdrawal by Subject|0|||
129448610|NCT00880555|465943413|FG003|Overall Study|Withdrawal by Subject|0|||
129448611|NCT00880555|465943414|FG004|Overall Study|Withdrawal by Subject|0|||
129448612|NCT00880555|465943415|FG005|Overall Study|Withdrawal by Subject|0|||
129448613|NCT00880555|465943410|FG000|Overall Study|Lack of resources (hired rater)|9|||
129448614|NCT00880555|465943411|FG001|Overall Study|Lack of resources (hired rater)|7|||
129448615|NCT00880555|465943412|FG002|Overall Study|Lack of resources (hired rater)|5|||
129448616|NCT00880555|465943413|FG003|Overall Study|Lack of resources (hired rater)|0|||
129448617|NCT00880555|465943414|FG004|Overall Study|Lack of resources (hired rater)|0|||
129448618|NCT00880555|465943415|FG005|Overall Study|Lack of resources (hired rater)|0|||
129448619|NCT00880555|465943410|FG000|Overall Study|Death|0|||
129448620|NCT00880555|465943411|FG001|Overall Study|Death|0|||
129448621|NCT00880555|465943412|FG002|Overall Study|Death|0|||
129448622|NCT00880555|465943413|FG003|Overall Study|Death|0|||
129448623|NCT00880555|465943414|FG004|Overall Study|Death|0|||
129448624|NCT00880555|465943415|FG005|Overall Study|Death|1|||
129448625|NCT00880555|465943410|FG000|Overall Study|Lost to Follow-up|0|||
129448626|NCT00880555|465943411|FG001|Overall Study|Lost to Follow-up|1|||
129448627|NCT00880555|465943412|FG002|Overall Study|Lost to Follow-up|0|||
129448628|NCT00880555|465943413|FG003|Overall Study|Lost to Follow-up|0|||
129448629|NCT00880555|465943414|FG004|Overall Study|Lost to Follow-up|0|||
129448630|NCT00880555|465943415|FG005|Overall Study|Lost to Follow-up|0|||
129448631|NCT02982590|465943417|FG000|Overall Study|Lost to Follow-up|0|||
129448632|NCT02982590|465943418|FG001|Overall Study|Lost to Follow-up|1|||
129448633|NCT02982590|465943417|FG000|Overall Study|Death|4|||
129448634|NCT02982590|465943418|FG001|Overall Study|Death|0|||
129448635|NCT01480284|465943425|FG000|Overall Study|Withdrawal by Subject|2|||
129899538|NCT04771273|467591889|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
129899539|NCT04771273|467591890|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
129899540|NCT04771273|467591887|FG000|Dose Escalation Period|Adverse Event|8|||
129899541|NCT04771273|467591888|FG001|Dose Escalation Period|Adverse Event|9|||
129899542|NCT04771273|467591889|FG002|Dose Escalation Period|Adverse Event|12|||
129899543|NCT04771273|467591890|FG003|Dose Escalation Period|Adverse Event|2|||
129899544|NCT04771273|467591887|FG000|Maintenance Period|Other than listed|4|||
129899545|NCT04771273|467591888|FG001|Maintenance Period|Other than listed|2|||
129899546|NCT04771273|467591889|FG002|Maintenance Period|Other than listed|0|||
129448636|NCT01480284|465943426|FG001|Overall Study|Withdrawal by Subject|0|||
129448637|NCT01480284|465943425|FG000|Overall Study|Adverse Event|1|||
129448638|NCT01480284|465943426|FG001|Overall Study|Adverse Event|0|||
129448639|NCT01480284|465943425|FG000|Overall Study|Study closed/terminated|3|||
129448640|NCT01480284|465943426|FG001|Overall Study|Study closed/terminated|0|||
129448641|NCT01480284|465943425|FG000|Overall Study|Lost to Follow-up|1|||
129448642|NCT01480284|465943426|FG001|Overall Study|Lost to Follow-up|0|||
129448643|NCT01480284|465943425|FG000|Overall Study|Physician Decision|1|||
129899547|NCT04771273|467591890|FG003|Maintenance Period|Other than listed|3|||
129899548|NCT04771273|467591887|FG000|Maintenance Period|Burden of study procedures|1|||
129899549|NCT04771273|467591888|FG001|Maintenance Period|Burden of study procedures|0|||
129899550|NCT04771273|467591889|FG002|Maintenance Period|Burden of study procedures|0|||
129899551|NCT04771273|467591890|FG003|Maintenance Period|Burden of study procedures|0|||
129899552|NCT04771273|467591887|FG000|Maintenance Period|Change of residence|0|||
129899553|NCT04771273|467591888|FG001|Maintenance Period|Change of residence|1|||
129899554|NCT04771273|467591889|FG002|Maintenance Period|Change of residence|3|||
129899555|NCT04771273|467591890|FG003|Maintenance Period|Change of residence|0|||
129899556|NCT04771273|467591887|FG000|Maintenance Period|Perceived lack of efficacy|0|||
129899557|NCT04771273|467591888|FG001|Maintenance Period|Perceived lack of efficacy|0|||
129899558|NCT04771273|467591889|FG002|Maintenance Period|Perceived lack of efficacy|0|||
129899559|NCT04771273|467591890|FG003|Maintenance Period|Perceived lack of efficacy|1|||
129899560|NCT04771273|467591887|FG000|Maintenance Period|Adverse Event|4|||
129899561|NCT04771273|467591888|FG001|Maintenance Period|Adverse Event|5|||
129899562|NCT04771273|467591889|FG002|Maintenance Period|Adverse Event|5|||
129899563|NCT04771273|467591890|FG003|Maintenance Period|Adverse Event|0|||
129899564|NCT02465359|467591891|FG000|Overall Study|Lack of Efficacy|1|||
129899565|NCT02465359|467591891|FG000|Overall Study|Withdrawal by Subject|1|||
129899566|NCT02465359|467591891|FG000|Overall Study|Adverse Event|1|||
129899567|NCT01304147|467591892|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
129899568|NCT01304147|467591893|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
129899569|NCT01244828|467591894|FG000|Overall Study|Adverse Event|37|||
129899570|NCT01244828|467591894|FG000|Overall Study|Withdrawal by Subject|31|||
129899571|NCT01244828|467591894|FG000|Overall Study|Lack of Efficacy|7|||
129899572|NCT01244828|467591894|FG000|Overall Study|Lost to Follow-up|2|||
129899573|NCT01244828|467591894|FG000|Overall Study|Other reason (not specified)|1|||
129899574|NCT01278862|467591895|FG000|Overall Study|Lost to Follow-up|1|||
129899575|NCT01278862|467591896|FG001|Overall Study|Lost to Follow-up|1|||
129899576|NCT00603447|467591898|FG000|Overall Study|Adverse Event|0|||
129899577|NCT00603447|467591899|FG001|Overall Study|Adverse Event|1|||
129899578|NCT00603447|467591900|FG002|Overall Study|Adverse Event|1|||
129899579|NCT00603447|467591901|FG003|Overall Study|Adverse Event|2|||
129899580|NCT00603447|467591902|FG004|Overall Study|Adverse Event|1|||
129899581|NCT00603447|467591903|FG005|Overall Study|Adverse Event|2|||
129899582|NCT00603447|467591904|FG006|Overall Study|Adverse Event|10|||
129899583|NCT00603447|467591898|FG000|Overall Study|Other|0|||
129899584|NCT00603447|467591899|FG001|Overall Study|Other|0|||
129899585|NCT00603447|467591900|FG002|Overall Study|Other|1|||
129899586|NCT00603447|467591901|FG003|Overall Study|Other|0|||
129899587|NCT00603447|467591902|FG004|Overall Study|Other|3|||
129899588|NCT00603447|467591903|FG005|Overall Study|Other|0|||
129899589|NCT00603447|467591904|FG006|Overall Study|Other|13|||
129899590|NCT00603447|467591898|FG000|Overall Study|Withdrew Consent|0|||
129899591|NCT00603447|467591899|FG001|Overall Study|Withdrew Consent|2|||
129899592|NCT00603447|467591900|FG002|Overall Study|Withdrew Consent|0|||
129899593|NCT00603447|467591901|FG003|Overall Study|Withdrew Consent|0|||
129899594|NCT00603447|467591902|FG004|Overall Study|Withdrew Consent|1|||
129899595|NCT00603447|467591903|FG005|Overall Study|Withdrew Consent|0|||
129899596|NCT00603447|467591904|FG006|Overall Study|Withdrew Consent|1|||
129899597|NCT05233085|467591905|FG000|Overall Study|Adverse Event|1|||
129899598|NCT05233085|467591906|FG001|Overall Study|Adverse Event|0|||
129899599|NCT05233085|467591907|FG002|Overall Study|Adverse Event|0|||
129899600|NCT05233085|467591908|FG003|Overall Study|Adverse Event|0|||
129899601|NCT00798265|467591909|FG000|Overall Study|Lost to Follow-up|1|||
129899602|NCT00798265|467591910|FG001|Overall Study|Lost to Follow-up|10|||
129899603|NCT00798265|467591909|FG000|Overall Study|Study closing|7|||
129899604|NCT00798265|467591910|FG001|Overall Study|Study closing|6|||
129899605|NCT00798265|467591909|FG000|Overall Study|Withdrawal by Subject|0|||
129899606|NCT00798265|467591910|FG001|Overall Study|Withdrawal by Subject|1|||
129899607|NCT00798265|467591909|FG000|Overall Study|Screen failure|0|||
129899608|NCT00798265|467591910|FG001|Overall Study|Screen failure|1|||
129899609|NCT01838200|467591913|FG000|Overall Study|Adverse Event|0|||
129899610|NCT01838200|467591914|FG001|Overall Study|Adverse Event|2|||
129899611|NCT01838200|467591913|FG000|Overall Study|Progressive disease|3|||
129899612|NCT01838200|467591914|FG001|Overall Study|Progressive disease|0|||
129899613|NCT02738840|467593704|FG000|Overall Study|MRI Scan not Performed|5|||
129899614|NCT02738840|467593704|FG000|Overall Study|Lost to Follow-up|1|||
129899615|NCT02738840|467593704|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
129899616|NCT02738840|467593704|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
129899617|NCT01311648|467593706|FG000|Main Study|Protocol Violation|0|||
129899618|NCT01311648|467593707|FG001|Main Study|Protocol Violation|1|||
129899619|NCT01311648|467593706|FG000|Main Study|Adverse Event|0|||
129899620|NCT01311648|467593707|FG001|Main Study|Adverse Event|1|||
129899621|NCT01311648|467593706|FG000|Main Study|Inhibitor management|0|||
129899622|NCT01311648|467593707|FG001|Main Study|Inhibitor management|17|||
129899623|NCT01311648|467593706|FG000|Main Study|Withdrawal by Subject|0|||
129899624|NCT01311648|467593707|FG001|Main Study|Withdrawal by Subject|2|||
129899625|NCT01311648|467593706|FG000|Extension Study|Physician Decision|0|||
129899626|NCT01311648|467593707|FG001|Extension Study|Physician Decision|1|||
129899627|NCT01311648|467593706|FG000|Extension Study|ITI therapy with marketed product|0|||
129899628|NCT01311648|467593707|FG001|Extension Study|ITI therapy with marketed product|1|||
129899629|NCT01311648|467593706|FG000|Extension Study|Incorrect visit planning|0|||
129899630|NCT01311648|467593707|FG001|Extension Study|Incorrect visit planning|1|||
129899631|NCT01311648|467593706|FG000|Extension Study|Family's decision|0|||
129899632|NCT01311648|467593707|FG001|Extension Study|Family's decision|1|||
129899633|NCT01311648|467593706|FG000|Extension Study|Failure of ITI therapy|0|||
129899634|NCT01311648|467593707|FG001|Extension Study|Failure of ITI therapy|3|||
129899635|NCT01311648|467593706|FG000|Extension Study|Long travel|0|||
129899636|NCT01311648|467593707|FG001|Extension Study|Long travel|1|||
129899637|NCT01311648|467593706|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
129899638|NCT01311648|467593707|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
129899639|NCT01311648|467593706|FG000|Extension Study|Withdrawal by Subject|0|||
129899640|NCT01311648|467593707|FG001|Extension Study|Withdrawal by Subject|1|||
129899641|NCT01311648|467593706|FG000|Extension Study|Inhibitor management|0|||
129899642|NCT01311648|467593707|FG001|Extension Study|Inhibitor management|2|||
129899643|NCT04057196|467593708|FG000|Overall Study|Withdrawal by Subject|3|||
129899644|NCT04057196|467593708|FG000|Overall Study|Death|3|||
129899645|NCT02466516|467593710|FG000|Overall Study|Adverse Event|1|||
129899646|NCT02466516|467593711|FG001|Overall Study|Adverse Event|1|||
129899647|NCT02466516|467593712|FG002|Overall Study|Adverse Event|0|||
129899648|NCT02466516|467593713|FG003|Overall Study|Adverse Event|0|||
129899649|NCT02466516|467593714|FG004|Overall Study|Adverse Event|0|||
129899650|NCT02466516|467593710|FG000|Overall Study|Withdrew Consent|1|||
129899651|NCT02466516|467593711|FG001|Overall Study|Withdrew Consent|0|||
129899652|NCT02466516|467593712|FG002|Overall Study|Withdrew Consent|0|||
129899653|NCT02466516|467593713|FG003|Overall Study|Withdrew Consent|0|||
129899654|NCT02466516|467593714|FG004|Overall Study|Withdrew Consent|0|||
129899655|NCT02466516|467593710|FG000|Overall Study|Lost to Follow-up|2|||
129899656|NCT02466516|467593711|FG001|Overall Study|Lost to Follow-up|0|||
129899657|NCT02466516|467593712|FG002|Overall Study|Lost to Follow-up|1|||
129899658|NCT02466516|467593713|FG003|Overall Study|Lost to Follow-up|0|||
129899659|NCT02466516|467593714|FG004|Overall Study|Lost to Follow-up|0|||
129899660|NCT03712930|467593715|FG000|Overall Study|Death|7|||
129899661|NCT03712930|467593715|FG000|Overall Study|Physician Decision|1|||
129899662|NCT03712930|467593715|FG000|Overall Study|Study Terminated by Sponsor|3|||
129899663|NCT03712930|467593715|FG000|Overall Study|Progressive Disease|2|||
129899664|NCT00739102|467593720|FG000|Overall Study|Death|5|||
129899665|NCT00739102|467593720|FG000|Overall Study|Withdrawal by Subject|10|||
129899666|NCT01331824|467593721|FG000|Overall Study|Adverse Event|2|||
129899667|NCT01331824|467593721|FG000|Overall Study|Death|1|||
129899668|NCT01331824|467593721|FG000|Overall Study|Disease Progression|9|||
129899669|NCT01331824|467593721|FG000|Overall Study|Withdrawal by Subject|1|||
129899670|NCT01091454|467593722|FG000|Overall Study|Ineligible|1|||
129899671|NCT01510912|467593725|FG000|Overall Study|Adverse Event|99|||
129899672|NCT01510912|467593725|FG000|Overall Study|Lack of Efficacy|12|||
129899673|NCT01510912|467593725|FG000|Overall Study|Non-compliance with trial drug|23|||
129899674|NCT01510912|467593725|FG000|Overall Study|Withdrawal by Subject|49|||
129899675|NCT01510912|467593725|FG000|Overall Study|Physician Decision|1|||
129899676|NCT01510912|467593725|FG000|Overall Study|Protocol Violation|27|||
129899677|NCT01510912|467593725|FG000|Overall Study|Lost to Follow-up|26|||
129899678|NCT01510912|467593725|FG000|Overall Study|Other, including joint replacement|5|||
129899679|NCT03179787|467593726|FG000|Overall Study|Lost to Follow-up|15|||
129899680|NCT03179787|467593726|FG000|Overall Study|Case report failures|2|||
129899681|NCT03179787|467593726|FG000|Overall Study|Treatment not administered|1|||
129899682|NCT02030028|467593727|FG000|Overall Study|Withdrawal by Subject|4|||
129899683|NCT02030028|467593727|FG000|Overall Study|lack of transportation|1|||
129899684|NCT02380742|467593729|FG000|Overall Study|Withdrawal by Subject|1|||
129899685|NCT02380742|467593730|FG001|Overall Study|Withdrawal by Subject|0|||
129899686|NCT02930343|467593732|FG000|Overall Study|Lost to Follow-up|9|||
129899687|NCT02930343|467593733|FG001|Overall Study|Lost to Follow-up|7|||
129899688|NCT01280591|467593736|FG000|Overall Study|Withdrawal by Subject|0|||
129899689|NCT01280591|467593737|FG001|Overall Study|Withdrawal by Subject|0|||
129899690|NCT01280591|467593738|FG002|Overall Study|Withdrawal by Subject|0|||
129899691|NCT01280591|467593739|FG003|Overall Study|Withdrawal by Subject|2|||
129899692|NCT01280591|467593736|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
129899693|NCT01280591|467593737|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
129899694|NCT01280591|467593738|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
129899695|NCT01280591|467593739|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
129899696|NCT01803646|467593745|FG000|Overall Study|Protocol Violation|1|||
129899697|NCT01803646|467593746|FG001|Overall Study|Protocol Violation|0|||
129899698|NCT01803646|467593745|FG000|Overall Study|Adverse Event|1|||
129899699|NCT01803646|467593746|FG001|Overall Study|Adverse Event|1|||
129899700|NCT01803646|467593745|FG000|Overall Study|Withdrawal by Subject|9|||
129899701|NCT01803646|467593746|FG001|Overall Study|Withdrawal by Subject|6|||
129899702|NCT01803646|467593745|FG000|Overall Study|Randomization error|1|||
129899703|NCT01803646|467593746|FG001|Overall Study|Randomization error|2|||
129899704|NCT01803646|467593745|FG000|Overall Study|Lost to Follow-up|5|||
129899705|NCT01803646|467593746|FG001|Overall Study|Lost to Follow-up|1|||
129899706|NCT01131494|467593747|FG000|Overall Study|Withdrawal by Subject|2|||
129899707|NCT01368406|467593752|FG000|Overall Study|Lost to Follow-up|8|||
129899708|NCT01368406|467593753|FG001|Overall Study|Lost to Follow-up|4|||
129899709|NCT01368406|467593752|FG000|Overall Study|Withdrawal by Subject|8|||
129899710|NCT01368406|467593753|FG001|Overall Study|Withdrawal by Subject|4|||
129899711|NCT01368406|467593752|FG000|Overall Study|relapse of the disease|3|||
129899712|NCT01368406|467593753|FG001|Overall Study|relapse of the disease|2|||
129899713|NCT01368406|467593752|FG000|Overall Study|started working|2|||
129899714|NCT01368406|467593753|FG001|Overall Study|started working|3|||
129899715|NCT01466881|467593759|FG000|Overall Study|Ineligible|5|||
129899716|NCT01466881|467593759|FG000|Overall Study|Adverse Event|6|||
129899717|NCT01466881|467593759|FG000|Overall Study|Progression/relapse|20|||
129899718|NCT01466881|467593759|FG000|Overall Study|Death|4|||
129899719|NCT01466881|467593759|FG000|Overall Study|Other reason not protocol specified|5|||
129899720|NCT03670602|467593763|FG000|Overall Study|Lost to Follow-up|1|||
129899721|NCT03670602|467593764|FG001|Overall Study|Lost to Follow-up|0|||
129899722|NCT03670602|467593763|FG000|Overall Study|Withdrawal by Subject|0|||
129899723|NCT03670602|467593764|FG001|Overall Study|Withdrawal by Subject|3|||
129899724|NCT00906698|467593765|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899725|NCT00906698|467593766|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
129899726|NCT00906698|467593767|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899727|NCT00906698|467593768|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899728|NCT00906698|467593769|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
129899729|NCT00906698|467593770|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
129899730|NCT00906698|467593765|FG000|Overall Study|Adverse Event|0|||
129899731|NCT00906698|467593766|FG001|Overall Study|Adverse Event|0|||
129899732|NCT00906698|467593767|FG002|Overall Study|Adverse Event|2|||
129899733|NCT00906698|467593768|FG003|Overall Study|Adverse Event|0|||
129899734|NCT00906698|467593769|FG004|Overall Study|Adverse Event|4|||
129899735|NCT00906698|467593770|FG005|Overall Study|Adverse Event|1|||
129899736|NCT00906698|467593765|FG000|Overall Study|Disease progression|3|||
129899737|NCT00906698|467593766|FG001|Overall Study|Disease progression|12|||
129899738|NCT00906698|467593767|FG002|Overall Study|Disease progression|4|||
129899739|NCT00906698|467593768|FG003|Overall Study|Disease progression|4|||
129899740|NCT00906698|467593769|FG004|Overall Study|Disease progression|12|||
129899741|NCT00906698|467593770|FG005|Overall Study|Disease progression|4|||
129899742|NCT00906698|467593765|FG000|Overall Study|Withdrawal by Subject|0|||
129899743|NCT00906698|467593766|FG001|Overall Study|Withdrawal by Subject|0|||
129899744|NCT00906698|467593767|FG002|Overall Study|Withdrawal by Subject|0|||
129899745|NCT00906698|467593768|FG003|Overall Study|Withdrawal by Subject|0|||
129899746|NCT00906698|467593769|FG004|Overall Study|Withdrawal by Subject|1|||
129899747|NCT00906698|467593770|FG005|Overall Study|Withdrawal by Subject|0|||
129899748|NCT00906698|467593765|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
129899749|NCT00906698|467593766|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
129899750|NCT00906698|467593767|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
129899751|NCT00906698|467593768|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
129899752|NCT00906698|467593769|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
129899753|NCT00906698|467593770|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
129899754|NCT03095508|467593771|FG000|Overall Study|Adverse Event|0|||
129899755|NCT03095508|467593772|FG001|Overall Study|Adverse Event|1|||
129899756|NCT02846415|467593773|FG000|Overall Study|Lost to Follow-up|2|||
129899757|NCT02846415|467593774|FG001|Overall Study|Lost to Follow-up|0|||
129899758|NCT02846415|467593773|FG000|Overall Study|Withdrawal by Subject|1|||
129899759|NCT02846415|467593774|FG001|Overall Study|Withdrawal by Subject|1|||
129899760|NCT03383887|467593775|FG000|Overall Study|Lost to Follow-up|0|||
129899761|NCT03383887|467593776|FG001|Overall Study|Lost to Follow-up|1|||
129899762|NCT00831792|467593777|FG000|Overall Study|Not Eligible|3|||
129899763|NCT00831792|467593777|FG000|Overall Study|Adverse Event|1|||
129899764|NCT00831792|467593777|FG000|Overall Study|Death|1|||
129899765|NCT00831792|467593777|FG000|Overall Study|Lack of Efficacy|1|||
129899766|NCT02469064|467593782|FG000|Overall Study|Request not to receive intervention.|1|||
129899767|NCT02469064|467593783|FG001|Overall Study|Request not to receive intervention.|3|||
129899768|NCT00678795|467593784|FG000|Overall Study|Adverse Event|7|||
129899769|NCT00678795|467593785|FG001|Overall Study|Adverse Event|3|||
129899770|NCT00678795|467593784|FG000|Overall Study|Withdrawal by Subject|3|||
129899771|NCT00678795|467593785|FG001|Overall Study|Withdrawal by Subject|0|||
129899772|NCT00678795|467593784|FG000|Overall Study|Protocol Violation|0|||
129899773|NCT00678795|467593785|FG001|Overall Study|Protocol Violation|1|||
129899774|NCT00678795|467593784|FG000|Overall Study|Lost to Follow-up|0|||
129899775|NCT00678795|467593785|FG001|Overall Study|Lost to Follow-up|1|||
129899776|NCT00678795|467593784|FG000|Overall Study|Lack of Efficacy|1|||
129899777|NCT00678795|467593785|FG001|Overall Study|Lack of Efficacy|1|||
129899778|NCT00404079|467593786|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
129899779|NCT00404079|467593787|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
129899780|NCT01120275|467593788|FG000|Overall Study|Adverse Event|3|||
129899781|NCT01120275|467593788|FG000|Overall Study|Progression|27|||
129899782|NCT01120275|467593788|FG000|Overall Study|Ineligible|3|||
129899783|NCT01120275|467593788|FG000|Overall Study|Withdrawal by Subject|1|||
129899784|NCT01120275|467593788|FG000|Overall Study|Refusal|1|||
129899785|NCT01120275|467593788|FG000|Overall Study|Not specific|1|||
129899786|NCT00880906|467593789|FG000|Overall Study|Lost to Follow-up|0|||
129899787|NCT00880906|467593790|FG001|Overall Study|Lost to Follow-up|1|||
129899788|NCT00880906|467593789|FG000|Overall Study|Did not meet criteria following patholog|12|||
129899789|NCT00880906|467593790|FG001|Overall Study|Did not meet criteria following patholog|6|||
129899790|NCT00559949|467593793|FG000|Overall Study|Progressive Disease during cycle 1|1|||
129899791|NCT00559949|467593793|FG000|Overall Study|Adverse Event|1|||
129899792|NCT00559949|467593793|FG000|Overall Study|Withdrawal by Subject|4|||
129899793|NCT00559949|467593793|FG000|Overall Study|No disease evaluation per protocol|1|||
129899794|NCT01235949|467593796|FG000|Primary Phase|Migrated/moved from study area|1|||
129899795|NCT01235949|467593797|FG001|Primary Phase|Migrated/moved from study area|1|||
129899796|NCT01235949|467593798|FG002|Primary Phase|Migrated/moved from study area|0|||
129899797|NCT01235949|467593799|FG003|Primary Phase|Migrated/moved from study area|0|||
129899798|NCT01235949|467593800|FG004|Primary Phase|Migrated/moved from study area|1|||
129899799|NCT01235949|467593801|FG005|Primary Phase|Migrated/moved from study area|2|||
129899800|NCT01235949|467593802|FG006|Primary Phase|Migrated/moved from study area|0|||
129899801|NCT01235949|467593803|FG007|Primary Phase|Migrated/moved from study area|0|||
129899802|NCT01235949|467593804|FG008|Primary Phase|Migrated/moved from study area|0|||
129899803|NCT01235949|467593805|FG009|Primary Phase|Migrated/moved from study area|0|||
129899804|NCT01235949|467593806|FG010|Primary Phase|Migrated/moved from study area|0|||
129899805|NCT01235949|467593807|FG011|Primary Phase|Migrated/moved from study area|0|||
129899806|NCT01235949|467593808|FG012|Primary Phase|Migrated/moved from study area|0|||
129899807|NCT01235949|467593809|FG013|Primary Phase|Migrated/moved from study area|0|||
129899808|NCT01235949|467593810|FG014|Primary Phase|Migrated/moved from study area|0|||
129899809|NCT01235949|467593811|FG015|Primary Phase|Migrated/moved from study area|0|||
129899810|NCT01235949|467593812|FG016|Primary Phase|Migrated/moved from study area|0|||
129899811|NCT01235949|467593813|FG017|Primary Phase|Migrated/moved from study area|0|||
129899812|NCT01235949|467593796|FG000|Primary Phase|Adverse Event|0|||
129899813|NCT01235949|467593797|FG001|Primary Phase|Adverse Event|0|||
129899814|NCT01235949|467593798|FG002|Primary Phase|Adverse Event|0|||
129899815|NCT01235949|467593799|FG003|Primary Phase|Adverse Event|1|||
129899816|NCT01235949|467593800|FG004|Primary Phase|Adverse Event|0|||
129899817|NCT01235949|467593801|FG005|Primary Phase|Adverse Event|0|||
129899818|NCT01235949|467593802|FG006|Primary Phase|Adverse Event|0|||
129899819|NCT01235949|467593803|FG007|Primary Phase|Adverse Event|0|||
129899820|NCT01235949|467593804|FG008|Primary Phase|Adverse Event|0|||
129899821|NCT01235949|467593805|FG009|Primary Phase|Adverse Event|0|||
129899822|NCT01235949|467593806|FG010|Primary Phase|Adverse Event|0|||
129899823|NCT01235949|467593807|FG011|Primary Phase|Adverse Event|0|||
129899824|NCT01235949|467593808|FG012|Primary Phase|Adverse Event|0|||
129899825|NCT01235949|467593809|FG013|Primary Phase|Adverse Event|0|||
129899826|NCT01235949|467593810|FG014|Primary Phase|Adverse Event|0|||
129899827|NCT01235949|467593811|FG015|Primary Phase|Adverse Event|0|||
129899828|NCT01235949|467593812|FG016|Primary Phase|Adverse Event|0|||
129899829|NCT01235949|467593813|FG017|Primary Phase|Adverse Event|0|||
129899830|NCT01235949|467593796|FG000|Primary Phase|Withdrawal by Subject|3|||
129899831|NCT01235949|467593797|FG001|Primary Phase|Withdrawal by Subject|2|||
129899832|NCT01235949|467593798|FG002|Primary Phase|Withdrawal by Subject|2|||
129899833|NCT01235949|467593799|FG003|Primary Phase|Withdrawal by Subject|0|||
129899834|NCT01235949|467593800|FG004|Primary Phase|Withdrawal by Subject|0|||
129899835|NCT01235949|467593801|FG005|Primary Phase|Withdrawal by Subject|3|||
129448644|NCT01480284|465943426|FG001|Overall Study|Physician Decision|0|||
129899836|NCT01235949|467593802|FG006|Primary Phase|Withdrawal by Subject|0|||
129899837|NCT01235949|467593803|FG007|Primary Phase|Withdrawal by Subject|0|||
129899838|NCT01235949|467593804|FG008|Primary Phase|Withdrawal by Subject|0|||
129899839|NCT01235949|467593805|FG009|Primary Phase|Withdrawal by Subject|0|||
129899840|NCT01235949|467593806|FG010|Primary Phase|Withdrawal by Subject|0|||
129899841|NCT01235949|467593807|FG011|Primary Phase|Withdrawal by Subject|0|||
129899842|NCT01235949|467593808|FG012|Primary Phase|Withdrawal by Subject|0|||
129899843|NCT01235949|467593809|FG013|Primary Phase|Withdrawal by Subject|0|||
129899844|NCT01235949|467593810|FG014|Primary Phase|Withdrawal by Subject|0|||
129899845|NCT01235949|467593811|FG015|Primary Phase|Withdrawal by Subject|0|||
129899846|NCT01235949|467593812|FG016|Primary Phase|Withdrawal by Subject|0|||
129899847|NCT01235949|467593813|FG017|Primary Phase|Withdrawal by Subject|0|||
129899848|NCT01235949|467593796|FG000|Primary Phase|Lost to Follow-up|0|||
129899849|NCT01235949|467593797|FG001|Primary Phase|Lost to Follow-up|0|||
129899850|NCT01235949|467593798|FG002|Primary Phase|Lost to Follow-up|1|||
129899851|NCT01235949|467593799|FG003|Primary Phase|Lost to Follow-up|1|||
129899852|NCT01235949|467593800|FG004|Primary Phase|Lost to Follow-up|0|||
129899853|NCT01235949|467593801|FG005|Primary Phase|Lost to Follow-up|2|||
129899854|NCT01235949|467593802|FG006|Primary Phase|Lost to Follow-up|0|||
129899855|NCT01235949|467593803|FG007|Primary Phase|Lost to Follow-up|0|||
129899856|NCT01235949|467593804|FG008|Primary Phase|Lost to Follow-up|0|||
129899857|NCT01235949|467593805|FG009|Primary Phase|Lost to Follow-up|0|||
129899858|NCT01235949|467593806|FG010|Primary Phase|Lost to Follow-up|0|||
129899859|NCT01235949|467593807|FG011|Primary Phase|Lost to Follow-up|0|||
129899860|NCT01235949|467593808|FG012|Primary Phase|Lost to Follow-up|0|||
129899861|NCT01235949|467593809|FG013|Primary Phase|Lost to Follow-up|0|||
129899862|NCT01235949|467593810|FG014|Primary Phase|Lost to Follow-up|0|||
129899863|NCT01235949|467593811|FG015|Primary Phase|Lost to Follow-up|0|||
129899864|NCT01235949|467593812|FG016|Primary Phase|Lost to Follow-up|0|||
129899865|NCT01235949|467593813|FG017|Primary Phase|Lost to Follow-up|0|||
129899866|NCT01235949|467593796|FG000|Booster Phase|Migrated/moved from study area|0|||
129899867|NCT01235949|467593797|FG001|Booster Phase|Migrated/moved from study area|0|||
129899868|NCT01235949|467593798|FG002|Booster Phase|Migrated/moved from study area|0|||
129899869|NCT01235949|467593799|FG003|Booster Phase|Migrated/moved from study area|0|||
129899870|NCT01235949|467593800|FG004|Booster Phase|Migrated/moved from study area|0|||
129899871|NCT01235949|467593801|FG005|Booster Phase|Migrated/moved from study area|0|||
129899872|NCT01235949|467593802|FG006|Booster Phase|Migrated/moved from study area|0|||
129899873|NCT01235949|467593803|FG007|Booster Phase|Migrated/moved from study area|0|||
129899874|NCT01235949|467593804|FG008|Booster Phase|Migrated/moved from study area|0|||
129899875|NCT01235949|467593805|FG009|Booster Phase|Migrated/moved from study area|0|||
129899876|NCT01235949|467593806|FG010|Booster Phase|Migrated/moved from study area|0|||
129899877|NCT01235949|467593807|FG011|Booster Phase|Migrated/moved from study area|1|||
129899878|NCT01235949|467593808|FG012|Booster Phase|Migrated/moved from study area|1|||
129899879|NCT01235949|467593809|FG013|Booster Phase|Migrated/moved from study area|0|||
129899880|NCT01235949|467593810|FG014|Booster Phase|Migrated/moved from study area|0|||
129899881|NCT01235949|467593811|FG015|Booster Phase|Migrated/moved from study area|0|||
129899882|NCT01235949|467593812|FG016|Booster Phase|Migrated/moved from study area|0|||
129899883|NCT01235949|467593813|FG017|Booster Phase|Migrated/moved from study area|1|||
129899884|NCT01235949|467593796|FG000|Booster Phase|Adverse Event|0|||
129899885|NCT01235949|467593797|FG001|Booster Phase|Adverse Event|0|||
129899886|NCT01235949|467593798|FG002|Booster Phase|Adverse Event|0|||
129899887|NCT01235949|467593799|FG003|Booster Phase|Adverse Event|0|||
129899888|NCT01235949|467593800|FG004|Booster Phase|Adverse Event|0|||
129899889|NCT01235949|467593801|FG005|Booster Phase|Adverse Event|0|||
129899890|NCT01235949|467593802|FG006|Booster Phase|Adverse Event|0|||
129899891|NCT01235949|467593803|FG007|Booster Phase|Adverse Event|0|||
129899892|NCT01235949|467593804|FG008|Booster Phase|Adverse Event|0|||
129899893|NCT01235949|467593805|FG009|Booster Phase|Adverse Event|0|||
129899894|NCT01235949|467593806|FG010|Booster Phase|Adverse Event|0|||
129899895|NCT01235949|467593807|FG011|Booster Phase|Adverse Event|0|||
129899896|NCT01235949|467593808|FG012|Booster Phase|Adverse Event|0|||
129899897|NCT01235949|467593809|FG013|Booster Phase|Adverse Event|0|||
129899898|NCT01235949|467593810|FG014|Booster Phase|Adverse Event|0|||
129899899|NCT01235949|467593811|FG015|Booster Phase|Adverse Event|1|||
129899900|NCT01235949|467593812|FG016|Booster Phase|Adverse Event|0|||
129899901|NCT01235949|467593813|FG017|Booster Phase|Adverse Event|0|||
129899902|NCT01235949|467593796|FG000|Booster Phase|Withdrawal by Subject|0|||
129899903|NCT01235949|467593797|FG001|Booster Phase|Withdrawal by Subject|0|||
129899904|NCT01235949|467593798|FG002|Booster Phase|Withdrawal by Subject|0|||
129899905|NCT01235949|467593799|FG003|Booster Phase|Withdrawal by Subject|0|||
129899906|NCT01235949|467593800|FG004|Booster Phase|Withdrawal by Subject|0|||
129899907|NCT01235949|467593801|FG005|Booster Phase|Withdrawal by Subject|0|||
129899908|NCT01235949|467593802|FG006|Booster Phase|Withdrawal by Subject|0|||
129899909|NCT01235949|467593803|FG007|Booster Phase|Withdrawal by Subject|1|||
129899910|NCT01235949|467593804|FG008|Booster Phase|Withdrawal by Subject|1|||
129899911|NCT01235949|467593805|FG009|Booster Phase|Withdrawal by Subject|0|||
129899912|NCT01235949|467593806|FG010|Booster Phase|Withdrawal by Subject|1|||
129899913|NCT01235949|467593807|FG011|Booster Phase|Withdrawal by Subject|1|||
129448645|NCT01641237|465943428|FG000|Period II|Withdrawal by Subject|1|||
129448646|NCT01641237|465943429|FG001|Period II|Withdrawal by Subject|0|||
129448647|NCT01641237|465943430|FG002|Period II|Withdrawal by Subject|0|||
129448648|NCT01641237|465943431|FG003|Period II|Withdrawal by Subject|0|||
129448649|NCT01641237|465943428|FG000|Period III|Lost to Follow-up|1|||
129448650|NCT01641237|465943429|FG001|Period III|Lost to Follow-up|0|||
129448651|NCT01641237|465943430|FG002|Period III|Lost to Follow-up|0|||
129448652|NCT01641237|465943431|FG003|Period III|Lost to Follow-up|0|||
129448653|NCT02716675|465943443|FG000|Overall Study|Death|2|||
129448654|NCT02716675|465943444|FG001|Overall Study|Death|3|||
129448655|NCT02716675|465943445|FG002|Overall Study|Death|0|||
129448656|NCT02716675|465943443|FG000|Overall Study|Physician Decision|2|||
129448657|NCT02716675|465943444|FG001|Overall Study|Physician Decision|1|||
129448658|NCT02716675|465943445|FG002|Overall Study|Physician Decision|1|||
129448659|NCT02716675|465943443|FG000|Overall Study|Lost to Follow-up|100|||
129448660|NCT02716675|465943444|FG001|Overall Study|Lost to Follow-up|87|||
129448661|NCT02716675|465943445|FG002|Overall Study|Lost to Follow-up|99|||
129448662|NCT02716675|465943443|FG000|Overall Study|Withdrawal by Subject|22|||
129448663|NCT02716675|465943444|FG001|Overall Study|Withdrawal by Subject|25|||
129448664|NCT02716675|465943445|FG002|Overall Study|Withdrawal by Subject|20|||
129448665|NCT02716675|465943443|FG000|Overall Study|Protocol Violation|0|||
129448666|NCT02716675|465943444|FG001|Overall Study|Protocol Violation|3|||
129448667|NCT02716675|465943445|FG002|Overall Study|Protocol Violation|1|||
129448668|NCT02716675|465943443|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
129448669|NCT02716675|465943444|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
129448670|NCT02716675|465943445|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
129448671|NCT02716675|465943443|FG000|Overall Study|Other|38|||
129448672|NCT02716675|465943444|FG001|Overall Study|Other|47|||
129448673|NCT02716675|465943445|FG002|Overall Study|Other|48|||
129448674|NCT00709111|465943446|FG000|Overall Study|Withdrawal by Subject|1|||
129448675|NCT00709111|465943446|FG000|Overall Study|Unable to attend clinic visits|1|||
129448676|NCT03593850|465943453|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
129448677|NCT03593850|465943454|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
129448678|NCT01735279|465943455|FG000|Overall Study|Lost to Follow-up|11|||
129448679|NCT01735279|465943456|FG001|Overall Study|Lost to Follow-up|8|||
129448680|NCT01195090|465943461|FG000|Overall Study|Adverse Event|1|||
129448681|NCT01195090|465943462|FG001|Overall Study|Adverse Event|2|||
129448682|NCT01195090|465943461|FG000|Overall Study|Lost to Follow-up|2|||
129448683|NCT01195090|465943462|FG001|Overall Study|Lost to Follow-up|2|||
129448684|NCT01195090|465943461|FG000|Overall Study|Protocol Violation|3|||
129448685|NCT01195090|465943462|FG001|Overall Study|Protocol Violation|4|||
129448686|NCT05111041|465943463|FG000|Overall Study|Lost to Follow-up|6|||
129448687|NCT05111041|465943464|FG001|Overall Study|Lost to Follow-up|7|||
129448688|NCT05111041|465943463|FG000|Overall Study|Withdrawal by Subject|1|||
129448689|NCT05111041|465943464|FG001|Overall Study|Withdrawal by Subject|0|||
129448690|NCT01205230|465943465|FG000|Overall Study|Adverse Event|4|||
129448691|NCT01205230|465943466|FG001|Overall Study|Adverse Event|0|||
129448692|NCT01205230|465943465|FG000|Overall Study|Physician Decision|1|||
129448693|NCT01205230|465943466|FG001|Overall Study|Physician Decision|0|||
129448694|NCT00922480|465943467|FG000|Main Study|Protocol Violation|3|||
129448695|NCT00922480|465943468|FG001|Main Study|Protocol Violation|6|||
129448696|NCT00922480|465943467|FG000|Main Study|Adverse Event|6|||
129448697|NCT00922480|465943468|FG001|Main Study|Adverse Event|7|||
129448698|NCT00922480|465943467|FG000|Main Study|Lack of Efficacy|3|||
129448699|NCT00922480|465943468|FG001|Main Study|Lack of Efficacy|0|||
129448700|NCT00922480|465943467|FG000|Main Study|Withdrawal by Subject|20|||
129448701|NCT00922480|465943468|FG001|Main Study|Withdrawal by Subject|15|||
129448702|NCT00922480|465943467|FG000|Main Study|Lost to Follow-up|5|||
129448703|NCT00922480|465943468|FG001|Main Study|Lost to Follow-up|0|||
129448704|NCT00922480|465943467|FG000|Main Study|Physician Decision|0|||
129841245|NCT00378014|467385109|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
129841246|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
129841247|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
129448705|NCT00922480|465943468|FG001|Main Study|Physician Decision|1|||
129448706|NCT00922480|465943467|FG000|Extension Study|Protocol Violation|3|||
129448707|NCT00922480|465943468|FG001|Extension Study|Protocol Violation|0|||
129448708|NCT00922480|465943467|FG000|Extension Study|Adverse Event|1|||
129448709|NCT00922480|465943468|FG001|Extension Study|Adverse Event|1|||
129448710|NCT00922480|465943467|FG000|Extension Study|Withdrawal by Subject|1|||
129448711|NCT00922480|465943468|FG001|Extension Study|Withdrawal by Subject|1|||
129448712|NCT00922480|465943467|FG000|Extension Study|Others|0|||
129448713|NCT00922480|465943468|FG001|Extension Study|Others|1|||
129448714|NCT04784897|465943469|FG000|Overall Study|Death|4|||
129448715|NCT04784897|465943470|FG001|Overall Study|Death|2|||
129448716|NCT04784897|465943471|FG002|Overall Study|Death|1|||
129448717|NCT04784897|465943469|FG000|Overall Study|Withdrawal by Subject|0|||
129448718|NCT04784897|465943470|FG001|Overall Study|Withdrawal by Subject|0|||
129448719|NCT04784897|465943471|FG002|Overall Study|Withdrawal by Subject|1|||
129899914|NCT01235949|467593808|FG012|Booster Phase|Withdrawal by Subject|2|||
129899915|NCT01235949|467593809|FG013|Booster Phase|Withdrawal by Subject|0|||
129899916|NCT01235949|467593810|FG014|Booster Phase|Withdrawal by Subject|2|||
129899917|NCT01235949|467593811|FG015|Booster Phase|Withdrawal by Subject|0|||
129899918|NCT01235949|467593812|FG016|Booster Phase|Withdrawal by Subject|0|||
129899919|NCT01235949|467593813|FG017|Booster Phase|Withdrawal by Subject|0|||
129899920|NCT01235949|467593796|FG000|Booster Phase|Lost to Follow-up|0|||
129899921|NCT01235949|467593797|FG001|Booster Phase|Lost to Follow-up|0|||
129899922|NCT01235949|467593798|FG002|Booster Phase|Lost to Follow-up|0|||
129899923|NCT01235949|467593799|FG003|Booster Phase|Lost to Follow-up|0|||
129899924|NCT01235949|467593800|FG004|Booster Phase|Lost to Follow-up|0|||
129899925|NCT01235949|467593801|FG005|Booster Phase|Lost to Follow-up|0|||
129899926|NCT01235949|467593802|FG006|Booster Phase|Lost to Follow-up|0|||
129899927|NCT01235949|467593803|FG007|Booster Phase|Lost to Follow-up|0|||
129899928|NCT01235949|467593804|FG008|Booster Phase|Lost to Follow-up|1|||
129899929|NCT01235949|467593805|FG009|Booster Phase|Lost to Follow-up|1|||
129899930|NCT01235949|467593806|FG010|Booster Phase|Lost to Follow-up|1|||
129899931|NCT01235949|467593807|FG011|Booster Phase|Lost to Follow-up|1|||
129899932|NCT01235949|467593808|FG012|Booster Phase|Lost to Follow-up|0|||
129899933|NCT01235949|467593809|FG013|Booster Phase|Lost to Follow-up|0|||
129899934|NCT01235949|467593810|FG014|Booster Phase|Lost to Follow-up|0|||
129899935|NCT01235949|467593811|FG015|Booster Phase|Lost to Follow-up|0|||
129899936|NCT01235949|467593812|FG016|Booster Phase|Lost to Follow-up|0|||
129899937|NCT01235949|467593813|FG017|Booster Phase|Lost to Follow-up|1|||
129899938|NCT00383188|467593814|FG000|Overall Study|Adverse Event|4|||
129899939|NCT00383188|467593815|FG001|Overall Study|Adverse Event|7|||
129899940|NCT00383188|467593816|FG002|Overall Study|Adverse Event|9|||
129899941|NCT00383188|467593817|FG003|Overall Study|Adverse Event|8|||
129899942|NCT00383188|467593818|FG004|Overall Study|Adverse Event|8|||
129899943|NCT00383188|467593814|FG000|Overall Study|Lack of Efficacy|9|||
129899944|NCT00383188|467593815|FG001|Overall Study|Lack of Efficacy|3|||
129899945|NCT00383188|467593816|FG002|Overall Study|Lack of Efficacy|3|||
129899946|NCT00383188|467593817|FG003|Overall Study|Lack of Efficacy|2|||
129899947|NCT00383188|467593818|FG004|Overall Study|Lack of Efficacy|6|||
129899948|NCT00383188|467593814|FG000|Overall Study|Other|3|||
129899949|NCT00383188|467593815|FG001|Overall Study|Other|1|||
129899950|NCT00383188|467593816|FG002|Overall Study|Other|0|||
129899951|NCT00383188|467593817|FG003|Overall Study|Other|2|||
129899952|NCT00383188|467593818|FG004|Overall Study|Other|6|||
129899953|NCT00383188|467593814|FG000|Overall Study|No longer willing to participate|1|||
129899954|NCT00383188|467593815|FG001|Overall Study|No longer willing to participate|0|||
129899955|NCT00383188|467593816|FG002|Overall Study|No longer willing to participate|1|||
129899956|NCT00383188|467593817|FG003|Overall Study|No longer willing to participate|0|||
129899957|NCT00383188|467593818|FG004|Overall Study|No longer willing to participate|2|||
129899958|NCT00383188|467593814|FG000|Overall Study|Lost to Follow-up|0|||
129899959|NCT00383188|467593815|FG001|Overall Study|Lost to Follow-up|0|||
129899960|NCT00383188|467593816|FG002|Overall Study|Lost to Follow-up|0|||
129899961|NCT00383188|467593817|FG003|Overall Study|Lost to Follow-up|0|||
129899962|NCT00383188|467593818|FG004|Overall Study|Lost to Follow-up|1|||
129899963|NCT02341625|467593823|FG000|Overall Study|Disease Progression|2|||
129899964|NCT02341625|467593824|FG001|Overall Study|Disease Progression|2|||
129899965|NCT02341625|467593825|FG002|Overall Study|Disease Progression|3|||
129899966|NCT02341625|467593826|FG003|Overall Study|Disease Progression|6|||
129899967|NCT02341625|467593827|FG004|Overall Study|Disease Progression|7|||
129899968|NCT02341625|467593828|FG005|Overall Study|Disease Progression|7|||
129899969|NCT02341625|467593829|FG006|Overall Study|Disease Progression|28|||
129899970|NCT02341625|467593830|FG007|Overall Study|Disease Progression|5|||
129899971|NCT02341625|467593831|FG008|Overall Study|Disease Progression|4|||
129899972|NCT02341625|467593832|FG009|Overall Study|Disease Progression|19|||
129899973|NCT02341625|467593823|FG000|Overall Study|Study Drug Toxicity|0|||
129899974|NCT02341625|467593824|FG001|Overall Study|Study Drug Toxicity|0|||
129899975|NCT02341625|467593825|FG002|Overall Study|Study Drug Toxicity|0|||
129899976|NCT02341625|467593826|FG003|Overall Study|Study Drug Toxicity|1|||
129899977|NCT02341625|467593827|FG004|Overall Study|Study Drug Toxicity|0|||
129899978|NCT02341625|467593828|FG005|Overall Study|Study Drug Toxicity|3|||
129899979|NCT02341625|467593829|FG006|Overall Study|Study Drug Toxicity|10|||
129899980|NCT02341625|467593830|FG007|Overall Study|Study Drug Toxicity|0|||
129899981|NCT02341625|467593831|FG008|Overall Study|Study Drug Toxicity|0|||
129899982|NCT02341625|467593832|FG009|Overall Study|Study Drug Toxicity|3|||
129899983|NCT02341625|467593823|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899984|NCT02341625|467593824|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899985|NCT02341625|467593825|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899986|NCT02341625|467593826|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899987|NCT02341625|467593827|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899988|NCT02341625|467593828|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129899989|NCT02341625|467593829|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129899990|NCT02341625|467593830|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
129841248|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Death|1|||
129841249|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Death|2|||
129841250|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
129841251|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
129841252|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
129841253|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
129841254|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
129841255|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
129841256|NCT00378014|467385108|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
129841257|NCT00378014|467385109|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
129841258|NCT00354172|467385110|FG000|Overall Study|Did not receive transplant|1|||
129841259|NCT02287896|467385116|FG000|Second Injection Visit|Withdrawal by Subject|0|||
129841260|NCT02287896|467385117|FG001|Second Injection Visit|Withdrawal by Subject|1|||
129841261|NCT01639040|467385119|FG000|Overall Study|Adverse Event|1|||
129841262|NCT01639040|467385120|FG001|Overall Study|Adverse Event|0|||
129841263|NCT03473743|467385121|FG000|Overall Study|Withdrawal by Subject|0|||
129841264|NCT03473743|467385122|FG001|Overall Study|Withdrawal by Subject|0|||
129841265|NCT03473743|467385123|FG002|Overall Study|Withdrawal by Subject|0|||
129841266|NCT03473743|467385124|FG003|Overall Study|Withdrawal by Subject|0|||
129841267|NCT03473743|467385125|FG004|Overall Study|Withdrawal by Subject|0|||
129841268|NCT03473743|467385126|FG005|Overall Study|Withdrawal by Subject|0|||
129841269|NCT03473743|467385127|FG006|Overall Study|Withdrawal by Subject|0|||
129841270|NCT03473743|467385128|FG007|Overall Study|Withdrawal by Subject|3|||
129841271|NCT03473743|467385121|FG000|Overall Study|Other|0|||
129841272|NCT03473743|467385122|FG001|Overall Study|Other|0|||
129841273|NCT03473743|467385123|FG002|Overall Study|Other|0|||
129841274|NCT03473743|467385124|FG003|Overall Study|Other|1|||
129841275|NCT03473743|467385125|FG004|Overall Study|Other|0|||
129841276|NCT03473743|467385126|FG005|Overall Study|Other|0|||
129841277|NCT03473743|467385127|FG006|Overall Study|Other|0|||
129841278|NCT03473743|467385128|FG007|Overall Study|Other|0|||
129841279|NCT03473743|467385121|FG000|Overall Study|Ongoing|0|||
129841280|NCT03473743|467385122|FG001|Overall Study|Ongoing|0|||
129841281|NCT03473743|467385123|FG002|Overall Study|Ongoing|6|||
129841282|NCT03473743|467385124|FG003|Overall Study|Ongoing|8|||
129841283|NCT03473743|467385125|FG004|Overall Study|Ongoing|1|||
129841284|NCT03473743|467385126|FG005|Overall Study|Ongoing|1|||
129841285|NCT03473743|467385127|FG006|Overall Study|Ongoing|22|||
129841286|NCT03473743|467385128|FG007|Overall Study|Ongoing|24|||
129841287|NCT03473743|467385121|FG000|Overall Study|Randomized but not treated|0|||
129841288|NCT03473743|467385122|FG001|Overall Study|Randomized but not treated|0|||
129841289|NCT03473743|467385123|FG002|Overall Study|Randomized but not treated|0|||
129841290|NCT03473743|467385124|FG003|Overall Study|Randomized but not treated|0|||
129841291|NCT03473743|467385125|FG004|Overall Study|Randomized but not treated|0|||
129841292|NCT03473743|467385126|FG005|Overall Study|Randomized but not treated|0|||
129841293|NCT03473743|467385127|FG006|Overall Study|Randomized but not treated|1|||
129841294|NCT03473743|467385128|FG007|Overall Study|Randomized but not treated|1|||
129841295|NCT02052739|467385131|FG000|Overall Study|Withdrew due to Adverse Event|3|||
129841296|NCT02052739|467385132|FG001|Overall Study|Withdrew due to Adverse Event|0|||
129841297|NCT02052739|467385131|FG000|Overall Study|Participant Died|2|||
129841298|NCT02052739|467385132|FG001|Overall Study|Participant Died|1|||
129841299|NCT02043015|467385135|FG000|Overall Study|Lost to Follow-up|4|||
129841300|NCT02043015|467385135|FG000|Overall Study|Withdrawal by Subject|4|||
129841301|NCT02043015|467385135|FG000|Overall Study|Removed once target enrollment reached|15|||
129841302|NCT02043015|467385135|FG000|Overall Study|Participant moved away from study city|4|||
129841303|NCT02043015|467385135|FG000|Overall Study|Incarceration|1|||
129841304|NCT05619692|467385136|FG000|Overall Study|Adverse Event|2|||
129841305|NCT05619692|467385137|FG001|Overall Study|Adverse Event|2|||
129841306|NCT05619692|467385136|FG000|Overall Study|Withdrawal by Participant|3|||
129841307|NCT05619692|467385137|FG001|Overall Study|Withdrawal by Participant|4|||
129841308|NCT05619692|467385136|FG000|Overall Study|Lost to Follow-up|2|||
129841309|NCT05619692|467385137|FG001|Overall Study|Lost to Follow-up|1|||
129841310|NCT05619692|467385136|FG000|Overall Study|Randomized but not treated|1|||
129841311|NCT05619692|467385137|FG001|Overall Study|Randomized but not treated|3|||
129841312|NCT05267054|467385139|FG000|Overall Study|Death|13|||
129899991|NCT02341625|467593831|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129841313|NCT05267054|467385140|FG001|Overall Study|Death|14|||
129841314|NCT05267054|467385139|FG000|Overall Study|Study Ended by Sponsor|9|||
129841315|NCT05267054|467385140|FG001|Overall Study|Study Ended by Sponsor|13|||
129841316|NCT05267054|467385139|FG000|Overall Study|Lost to Follow-up|1|||
129841317|NCT05267054|467385140|FG001|Overall Study|Lost to Follow-up|1|||
129841318|NCT05267054|467385139|FG000|Overall Study|Withdrawal by Subject|1|||
129841319|NCT05267054|467385140|FG001|Overall Study|Withdrawal by Subject|1|||
129448720|NCT04667377|465943472|FG000|Dose Escalation Period|Other not specified below|3|||
129841320|NCT04049760|467385141|FG000|Overall Study|Withdrawal by Subject|1|||
129841321|NCT02457598|467385142|FG000|Overall Study|Progressive Disease|2|||
129841322|NCT02457598|467385143|FG001|Overall Study|Progressive Disease|2|||
129899992|NCT02341625|467593832|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
129899993|NCT02341625|467593823|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899994|NCT02341625|467593824|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899995|NCT02341625|467593825|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899996|NCT02341625|467593826|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899997|NCT02341625|467593827|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899998|NCT02341625|467593828|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129899999|NCT02341625|467593829|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
129900000|NCT02341625|467593830|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
129900001|NCT02341625|467593831|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129900002|NCT02341625|467593832|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
129900003|NCT02341625|467593823|FG000|Overall Study|Participant Withdrew Consent|0|||
129900004|NCT02341625|467593824|FG001|Overall Study|Participant Withdrew Consent|0|||
129900005|NCT02341625|467593825|FG002|Overall Study|Participant Withdrew Consent|0|||
129900006|NCT02341625|467593826|FG003|Overall Study|Participant Withdrew Consent|1|||
129900007|NCT02341625|467593827|FG004|Overall Study|Participant Withdrew Consent|0|||
129900008|NCT02341625|467593828|FG005|Overall Study|Participant Withdrew Consent|0|||
129900009|NCT02341625|467593829|FG006|Overall Study|Participant Withdrew Consent|0|||
129900010|NCT02341625|467593830|FG007|Overall Study|Participant Withdrew Consent|0|||
129900011|NCT02341625|467593831|FG008|Overall Study|Participant Withdrew Consent|0|||
129900012|NCT02341625|467593832|FG009|Overall Study|Participant Withdrew Consent|0|||
129900013|NCT02341625|467593823|FG000|Overall Study|Completed Treatment as per Protocol|0|||
129900014|NCT02341625|467593824|FG001|Overall Study|Completed Treatment as per Protocol|0|||
129900015|NCT02341625|467593825|FG002|Overall Study|Completed Treatment as per Protocol|0|||
129900016|NCT02341625|467593826|FG003|Overall Study|Completed Treatment as per Protocol|0|||
129900017|NCT02341625|467593827|FG004|Overall Study|Completed Treatment as per Protocol|0|||
129900018|NCT02341625|467593828|FG005|Overall Study|Completed Treatment as per Protocol|0|||
129900019|NCT02341625|467593829|FG006|Overall Study|Completed Treatment as per Protocol|0|||
129900020|NCT02341625|467593830|FG007|Overall Study|Completed Treatment as per Protocol|0|||
129900021|NCT02341625|467593831|FG008|Overall Study|Completed Treatment as per Protocol|0|||
129900022|NCT02341625|467593832|FG009|Overall Study|Completed Treatment as per Protocol|1|||
129900023|NCT02341625|467593823|FG000|Overall Study|Other Reasons|0|||
129900024|NCT02341625|467593824|FG001|Overall Study|Other Reasons|0|||
129900025|NCT02341625|467593825|FG002|Overall Study|Other Reasons|0|||
129900026|NCT02341625|467593826|FG003|Overall Study|Other Reasons|0|||
129900027|NCT02341625|467593827|FG004|Overall Study|Other Reasons|1|||
129900028|NCT02341625|467593828|FG005|Overall Study|Other Reasons|0|||
129900029|NCT02341625|467593829|FG006|Overall Study|Other Reasons|5|||
129900030|NCT02341625|467593830|FG007|Overall Study|Other Reasons|0|||
129900031|NCT02341625|467593831|FG008|Overall Study|Other Reasons|0|||
129900032|NCT02341625|467593832|FG009|Overall Study|Other Reasons|2|||
129900033|NCT02341625|467593823|FG000|Overall Study|Not Reported|0|||
129900034|NCT02341625|467593824|FG001|Overall Study|Not Reported|0|||
129900035|NCT02341625|467593825|FG002|Overall Study|Not Reported|0|||
129900036|NCT02341625|467593826|FG003|Overall Study|Not Reported|0|||
129900037|NCT02341625|467593827|FG004|Overall Study|Not Reported|0|||
129900038|NCT02341625|467593828|FG005|Overall Study|Not Reported|0|||
129900039|NCT02341625|467593829|FG006|Overall Study|Not Reported|0|||
129900040|NCT02341625|467593830|FG007|Overall Study|Not Reported|0|||
129900041|NCT02341625|467593831|FG008|Overall Study|Not Reported|0|||
129900042|NCT02341625|467593832|FG009|Overall Study|Not Reported|3|||
129900043|NCT01726023|467593834|FG000|Overall Study|Death|1|||
129900044|NCT01726023|467593835|FG001|Overall Study|Death|1|||
129900045|NCT01726023|467593834|FG000|Overall Study|Lost to Follow-up|5|||
129900046|NCT01726023|467593835|FG001|Overall Study|Lost to Follow-up|10|||
129900047|NCT01726023|467593834|FG000|Overall Study|Other Eligibility criteria|7|||
129900048|NCT01726023|467593835|FG001|Overall Study|Other Eligibility criteria|7|||
129900049|NCT01726023|467593834|FG000|Overall Study|Withdrawal by Subject|16|||
129900050|NCT01726023|467593835|FG001|Overall Study|Withdrawal by Subject|8|||
129900051|NCT04858425|467593839|FG000|Overall Study|Adverse Event|2|||
129900052|NCT04858425|467593840|FG001|Overall Study|Adverse Event|2|||
129900053|NCT04858425|467593839|FG000|Overall Study|Withdrawal by Subject|3|||
129900054|NCT04858425|467593840|FG001|Overall Study|Withdrawal by Subject|1|||
129900055|NCT04858425|467593839|FG000|Overall Study|Lost to Follow-up|4|||
129900056|NCT04858425|467593840|FG001|Overall Study|Lost to Follow-up|2|||
129900057|NCT04858425|467593839|FG000|Overall Study|Lost to Follow-up|1|||
129900058|NCT04858425|467593840|FG001|Overall Study|Lost to Follow-up|0|||
129900059|NCT04536077|467593842|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
129900060|NCT04536077|467593843|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
129900061|NCT04536077|467593842|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
129900062|NCT04536077|467593843|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
129900063|NCT02698241|467593849|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
129900064|NCT02698241|467593849|FG000|Overall Study|Screening not met|7|||
129900065|NCT02698241|467593849|FG000|Overall Study|Withdrawal by Subject|7|||
129900066|NCT02698241|467593849|FG000|Overall Study|Physician Decision|2|||
129900067|NCT02698241|467593849|FG000|Overall Study|Subject underwent system modification|2|||
129900068|NCT02698241|467593849|FG000|Overall Study|Lost to Follow-up|3|||
129900069|NCT02698241|467593849|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
129900070|NCT02698241|467593849|FG000|Overall Study|geographic and licensing issue|1|||
129900071|NCT02698241|467593849|FG000|Overall Study|Death|2|||
129900072|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
129900073|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
129900074|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Progressive disease|6|||
129900075|NCT00906282|467593852|FG000|Preoperative Chemotherapy|Toxicity|1|||
129900076|NCT02540213|467593853|FG000|Overall Study|Death/adverse event|18|||
129900077|NCT02540213|467593853|FG000|Overall Study|Administrative reasons|3|||
129900078|NCT02540213|467593853|FG000|Overall Study|Kidney transplant|3|||
129900079|NCT02540213|467593853|FG000|Overall Study|Lack of Efficacy|6|||
129900080|NCT02540213|467593853|FG000|Overall Study|Consent withdrawn|7|||
129900081|NCT02540213|467593853|FG000|Overall Study|Enrolled but not treated|2|||
129900082|NCT00290706|467593860|FG000|Overall Study|Withdrawal by Subject|2|||
129900083|NCT00290706|467593861|FG001|Overall Study|Withdrawal by Subject|0|||
129900084|NCT00290706|467593862|FG002|Overall Study|Withdrawal by Subject|0|||
129900085|NCT00290706|467593863|FG003|Overall Study|Withdrawal by Subject|0|||
129900086|NCT00290706|467593860|FG000|Overall Study|Progressive Disease|3|||
129900087|NCT00290706|467593861|FG001|Overall Study|Progressive Disease|5|||
129900088|NCT00290706|467593862|FG002|Overall Study|Progressive Disease|4|||
129900089|NCT00290706|467593863|FG003|Overall Study|Progressive Disease|10|||
129900090|NCT00290706|467593860|FG000|Overall Study|Adverse Event|0|||
129900091|NCT00290706|467593861|FG001|Overall Study|Adverse Event|1|||
129900092|NCT00290706|467593862|FG002|Overall Study|Adverse Event|2|||
129900093|NCT00290706|467593863|FG003|Overall Study|Adverse Event|0|||
129900094|NCT00290706|467593860|FG000|Overall Study|Receive auto transplant or radiation|0|||
129900095|NCT00290706|467593861|FG001|Overall Study|Receive auto transplant or radiation|0|||
129900096|NCT00290706|467593862|FG002|Overall Study|Receive auto transplant or radiation|0|||
129900097|NCT00290706|467593863|FG003|Overall Study|Receive auto transplant or radiation|1|||
129900098|NCT00290706|467593860|FG000|Overall Study|Physician Decision|0|||
129900099|NCT00290706|467593861|FG001|Overall Study|Physician Decision|0|||
129900100|NCT00290706|467593862|FG002|Overall Study|Physician Decision|0|||
129900101|NCT00290706|467593863|FG003|Overall Study|Physician Decision|1|||
129900102|NCT02952261|467593866|FG000|Overall Study|Withdrawal by Subject|4|||
129900103|NCT02952261|467593867|FG001|Overall Study|Withdrawal by Subject|5|||
129900104|NCT02952261|467593866|FG000|Overall Study|Protocol Violation|1|||
129900105|NCT02952261|467593867|FG001|Overall Study|Protocol Violation|0|||
129900106|NCT02960659|467594986|FG000|Overall Study|Withdrawal by Subject|1|||
129900107|NCT02960659|467594987|FG001|Overall Study|Withdrawal by Subject|0|||
129900108|NCT02960659|467594986|FG000|Overall Study|Poor compliance|0|||
129900109|NCT02960659|467594987|FG001|Overall Study|Poor compliance|1|||
129900110|NCT01645111|467594989|FG000|Overall Study|Did not require Clevidipine|15|||
129900111|NCT03068468|467594993|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
129900112|NCT03068468|467594994|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
129900113|NCT03068468|467594995|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
129900114|NCT03068468|467594996|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
129900115|NCT03068468|467594993|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
129900116|NCT03068468|467594994|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
129900117|NCT03068468|467594995|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
129900118|NCT03068468|467594996|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
129900119|NCT03068468|467594993|FG000|Placebo-Controlled Period|Adverse Event|16|||
129900120|NCT03068468|467594994|FG001|Placebo-Controlled Period|Adverse Event|21|||
129900121|NCT03068468|467594995|FG002|Placebo-Controlled Period|Adverse Event|0|||
129900122|NCT03068468|467594996|FG003|Placebo-Controlled Period|Adverse Event|0|||
129900123|NCT03068468|467594993|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
129900124|NCT03068468|467594994|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
129900125|NCT03068468|467594995|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
129900126|NCT03068468|467594996|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
129900127|NCT03068468|467594993|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129900128|NCT03068468|467594994|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
129900129|NCT03068468|467594995|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129900130|NCT03068468|467594996|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129900131|NCT03068468|467594993|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
129900132|NCT03068468|467594994|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
129900133|NCT03068468|467594995|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
129900134|NCT03068468|467594996|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
129900135|NCT03068468|467594993|FG000|Placebo-Controlled Period|Death|0|||
129900136|NCT03068468|467594994|FG001|Placebo-Controlled Period|Death|1|||
129900137|NCT03068468|467594995|FG002|Placebo-Controlled Period|Death|0|||
129900138|NCT03068468|467594996|FG003|Placebo-Controlled Period|Death|0|||
129900139|NCT03068468|467594993|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
129900140|NCT03068468|467594994|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
129900141|NCT03068468|467594995|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
129900142|NCT03068468|467594996|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
129900143|NCT03068468|467594993|FG000|Open-Label Extension Period|Adverse Event|0|||
129900144|NCT03068468|467594994|FG001|Open-Label Extension Period|Adverse Event|0|||
129900145|NCT03068468|467594995|FG002|Open-Label Extension Period|Adverse Event|13|||
129900146|NCT03068468|467594996|FG003|Open-Label Extension Period|Adverse Event|17|||
129900147|NCT03068468|467594993|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
129900148|NCT03068468|467594994|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
129900149|NCT03068468|467594995|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
129900150|NCT03068468|467594996|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
129900151|NCT03068468|467594993|FG000|Open-Label Extension Period|Death|0|||
129900152|NCT03068468|467594994|FG001|Open-Label Extension Period|Death|0|||
129900153|NCT03068468|467594995|FG002|Open-Label Extension Period|Death|0|||
129900154|NCT03068468|467594996|FG003|Open-Label Extension Period|Death|1|||
129900155|NCT03068468|467594993|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
129900156|NCT03068468|467594994|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
129900157|NCT03068468|467594995|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
129900158|NCT03068468|467594996|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
129900159|NCT03068468|467594993|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
129900160|NCT03068468|467594994|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
129900161|NCT03068468|467594995|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
129900162|NCT03068468|467594996|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
129900163|NCT03068468|467594993|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
129900164|NCT03068468|467594994|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
129900165|NCT03068468|467594995|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
129900166|NCT03068468|467594996|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
129900167|NCT03068468|467594993|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
129900168|NCT03068468|467594994|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
129900169|NCT03068468|467594995|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
129900170|NCT03068468|467594996|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
129900171|NCT03068468|467594993|FG000|Open-Label Extension Period|Reason not Specified|0|||
129900172|NCT03068468|467594994|FG001|Open-Label Extension Period|Reason not Specified|0|||
129900173|NCT03068468|467594995|FG002|Open-Label Extension Period|Reason not Specified|1|||
129900174|NCT03068468|467594996|FG003|Open-Label Extension Period|Reason not Specified|4|||
129900175|NCT01062126|467594998|FG000|Overall Study|Death|209|||
129900176|NCT01062126|467594998|FG000|Overall Study|All Withdrawals|324|||
129900177|NCT00646451|467594999|FG000|Overall Study|Adverse Event|3|||
129900178|NCT00646451|467595000|FG001|Overall Study|Adverse Event|0|||
129900179|NCT00646451|467594999|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
129900180|NCT00646451|467595000|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
129900181|NCT01249092|467595004|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
129900182|NCT01249092|467595004|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
129900183|NCT00486759|467595005|FG000|Treatment|Adverse event/intercurrent illness|86|||
129900184|NCT00486759|467595006|FG001|Treatment|Adverse event/intercurrent illness|39|||
129900185|NCT00486759|467595005|FG000|Treatment|Insufficient therapeutic response|37|||
129900186|NCT00486759|467595006|FG001|Treatment|Insufficient therapeutic response|39|||
129900187|NCT00486759|467595005|FG000|Treatment|Death|17|||
129900188|NCT00486759|467595006|FG001|Treatment|Death|10|||
129900189|NCT00486759|467595005|FG000|Treatment|Withdrew consent|15|||
129900190|NCT00486759|467595006|FG001|Treatment|Withdrew consent|12|||
129900191|NCT00486759|467595005|FG000|Treatment|Administrative/reason not specified|17|||
129900192|NCT00486759|467595006|FG001|Treatment|Administrative/reason not specified|21|||
129900193|NCT00486759|467595005|FG000|Treatment|Refused treatment|10|||
129900194|NCT00486759|467595006|FG001|Treatment|Refused treatment|7|||
129900195|NCT00486759|467595005|FG000|Treatment|Violation of selection criteria at entry|3|||
129900196|NCT00486759|467595006|FG001|Treatment|Violation of selection criteria at entry|3|||
129900197|NCT00486759|467595005|FG000|Treatment|Other protocol violation|1|||
129900198|NCT00486759|467595006|FG001|Treatment|Other protocol violation|5|||
129900199|NCT00486759|467595005|FG000|Treatment|Failure to return|1|||
129900200|NCT00486759|467595006|FG001|Treatment|Failure to return|1|||
129900201|NCT00486759|467595005|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
129448721|NCT04667377|465943473|FG001|Dose Escalation Period|Other not specified below|3|||
129448722|NCT04667377|465943474|FG002|Dose Escalation Period|Other not specified below|2|||
129448723|NCT04667377|465943475|FG003|Dose Escalation Period|Other not specified below|1|||
129448724|NCT04667377|465943476|FG004|Dose Escalation Period|Other not specified below|3|||
129448725|NCT04667377|465943472|FG000|Dose Escalation Period|Protocol Violation|2|||
129448726|NCT04667377|465943473|FG001|Dose Escalation Period|Protocol Violation|2|||
129448727|NCT04667377|465943474|FG002|Dose Escalation Period|Protocol Violation|0|||
129448728|NCT04667377|465943475|FG003|Dose Escalation Period|Protocol Violation|2|||
129448729|NCT04667377|465943476|FG004|Dose Escalation Period|Protocol Violation|1|||
129448730|NCT04667377|465943472|FG000|Dose Escalation Period|Burden of study procedures|2|||
129448731|NCT04667377|465943473|FG001|Dose Escalation Period|Burden of study procedures|1|||
129448732|NCT04667377|465943474|FG002|Dose Escalation Period|Burden of study procedures|1|||
129448733|NCT04667377|465943475|FG003|Dose Escalation Period|Burden of study procedures|1|||
129448734|NCT04667377|465943476|FG004|Dose Escalation Period|Burden of study procedures|5|||
129448735|NCT04667377|465943472|FG000|Dose Escalation Period|Change of residence|0|||
129448736|NCT04667377|465943473|FG001|Dose Escalation Period|Change of residence|0|||
129448737|NCT04667377|465943474|FG002|Dose Escalation Period|Change of residence|1|||
129448738|NCT04667377|465943475|FG003|Dose Escalation Period|Change of residence|0|||
129448739|NCT04667377|465943476|FG004|Dose Escalation Period|Change of residence|0|||
129448740|NCT04667377|465943472|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
129448741|NCT04667377|465943473|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
129448742|NCT04667377|465943474|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
129448743|NCT04667377|465943475|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
129448744|NCT04667377|465943476|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
129448745|NCT04667377|465943472|FG000|Dose Escalation Period|Adverse Event|9|||
129448746|NCT04667377|465943473|FG001|Dose Escalation Period|Adverse Event|10|||
129448747|NCT04667377|465943474|FG002|Dose Escalation Period|Adverse Event|12|||
129448748|NCT04667377|465943475|FG003|Dose Escalation Period|Adverse Event|17|||
129448749|NCT04667377|465943476|FG004|Dose Escalation Period|Adverse Event|3|||
129448750|NCT04667377|465943472|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
129448751|NCT04667377|465943473|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
129448752|NCT04667377|465943474|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
129448753|NCT04667377|465943475|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
129448754|NCT04667377|465943476|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
129448755|NCT04667377|465943472|FG000|Dose Escalation Period|Not treated|1|||
129448756|NCT04667377|465943473|FG001|Dose Escalation Period|Not treated|0|||
129448757|NCT04667377|465943474|FG002|Dose Escalation Period|Not treated|0|||
129448758|NCT04667377|465943475|FG003|Dose Escalation Period|Not treated|0|||
129448759|NCT04667377|465943476|FG004|Dose Escalation Period|Not treated|0|||
129448760|NCT04667377|465943472|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
129448761|NCT04667377|465943473|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
129448762|NCT04667377|465943474|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
129448763|NCT04667377|465943475|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
129448764|NCT04667377|465943476|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
129448765|NCT04667377|465943472|FG000|Dose Escalation Period|Lost to Follow-up|0|||
129448766|NCT04667377|465943473|FG001|Dose Escalation Period|Lost to Follow-up|1|||
129448767|NCT04667377|465943474|FG002|Dose Escalation Period|Lost to Follow-up|0|||
129448768|NCT04667377|465943475|FG003|Dose Escalation Period|Lost to Follow-up|0|||
129448769|NCT04667377|465943476|FG004|Dose Escalation Period|Lost to Follow-up|0|||
129448770|NCT04667377|465943472|FG000|Maintenance Period|Perceived lack of efficacy|0|||
129448771|NCT04667377|465943473|FG001|Maintenance Period|Perceived lack of efficacy|2|||
129448772|NCT04667377|465943474|FG002|Maintenance Period|Perceived lack of efficacy|1|||
129448773|NCT04667377|465943475|FG003|Maintenance Period|Perceived lack of efficacy|0|||
129448774|NCT04667377|465943476|FG004|Maintenance Period|Perceived lack of efficacy|1|||
129448775|NCT04667377|465943472|FG000|Maintenance Period|Adverse Event|2|||
129448776|NCT04667377|465943473|FG001|Maintenance Period|Adverse Event|8|||
129448777|NCT04667377|465943474|FG002|Maintenance Period|Adverse Event|5|||
129448778|NCT04667377|465943475|FG003|Maintenance Period|Adverse Event|4|||
129448779|NCT04667377|465943476|FG004|Maintenance Period|Adverse Event|1|||
129448780|NCT04667377|465943472|FG000|Maintenance Period|Adverse event: COVID infection|0|||
129448781|NCT04667377|465943473|FG001|Maintenance Period|Adverse event: COVID infection|1|||
129448782|NCT04667377|465943474|FG002|Maintenance Period|Adverse event: COVID infection|0|||
129448783|NCT04667377|465943475|FG003|Maintenance Period|Adverse event: COVID infection|0|||
129448784|NCT04667377|465943476|FG004|Maintenance Period|Adverse event: COVID infection|0|||
129448785|NCT04667377|465943472|FG000|Maintenance Period|COVID-related|0|||
129448786|NCT04667377|465943473|FG001|Maintenance Period|COVID-related|0|||
129448787|NCT04667377|465943474|FG002|Maintenance Period|COVID-related|1|||
129448788|NCT04667377|465943475|FG003|Maintenance Period|COVID-related|1|||
129448789|NCT04667377|465943476|FG004|Maintenance Period|COVID-related|0|||
129448790|NCT04667377|465943472|FG000|Maintenance Period|Protocol Violation|1|||
129448791|NCT04667377|465943473|FG001|Maintenance Period|Protocol Violation|0|||
129448792|NCT04667377|465943474|FG002|Maintenance Period|Protocol Violation|0|||
129448793|NCT04667377|465943475|FG003|Maintenance Period|Protocol Violation|0|||
129841323|NCT02457598|467385144|FG002|Overall Study|Progressive Disease|1|||
129841324|NCT02457598|467385145|FG003|Overall Study|Progressive Disease|11|||
129841325|NCT02457598|467385146|FG004|Overall Study|Progressive Disease|7|||
129841326|NCT02457598|467385147|FG005|Overall Study|Progressive Disease|3|||
129841327|NCT02457598|467385148|FG006|Overall Study|Progressive Disease|2|||
129841328|NCT02457598|467385149|FG007|Overall Study|Progressive Disease|1|||
129841329|NCT02457598|467385150|FG008|Overall Study|Progressive Disease|1|||
129841330|NCT02457598|467385151|FG009|Overall Study|Progressive Disease|2|||
129841331|NCT02457598|467385152|FG010|Overall Study|Progressive Disease|45|||
129841332|NCT02457598|467385153|FG011|Overall Study|Progressive Disease|6|||
129841333|NCT02457598|467385154|FG012|Overall Study|Progressive Disease|2|||
129841334|NCT02457598|467385155|FG013|Overall Study|Progressive Disease|2|||
129841335|NCT02457598|467385156|FG014|Overall Study|Progressive Disease|10|||
129841336|NCT02457598|467385157|FG015|Overall Study|Progressive Disease|1|||
129841337|NCT02457598|467385158|FG016|Overall Study|Progressive Disease|1|||
129841338|NCT02457598|467385142|FG000|Overall Study|Investigator's Discretion|0|||
129841339|NCT02457598|467385143|FG001|Overall Study|Investigator's Discretion|2|||
129841340|NCT02457598|467385144|FG002|Overall Study|Investigator's Discretion|2|||
129841341|NCT02457598|467385145|FG003|Overall Study|Investigator's Discretion|2|||
129841342|NCT02457598|467385146|FG004|Overall Study|Investigator's Discretion|0|||
129841343|NCT02457598|467385147|FG005|Overall Study|Investigator's Discretion|0|||
129841344|NCT02457598|467385148|FG006|Overall Study|Investigator's Discretion|0|||
129841345|NCT02457598|467385149|FG007|Overall Study|Investigator's Discretion|1|||
129841346|NCT02457598|467385150|FG008|Overall Study|Investigator's Discretion|2|||
129841347|NCT02457598|467385151|FG009|Overall Study|Investigator's Discretion|0|||
129841348|NCT02457598|467385152|FG010|Overall Study|Investigator's Discretion|10|||
129841349|NCT02457598|467385153|FG011|Overall Study|Investigator's Discretion|2|||
129841350|NCT02457598|467385154|FG012|Overall Study|Investigator's Discretion|2|||
129841351|NCT02457598|467385155|FG013|Overall Study|Investigator's Discretion|1|||
129841352|NCT02457598|467385156|FG014|Overall Study|Investigator's Discretion|5|||
129841353|NCT02457598|467385157|FG015|Overall Study|Investigator's Discretion|0|||
129841354|NCT02457598|467385158|FG016|Overall Study|Investigator's Discretion|0|||
129841355|NCT02457598|467385142|FG000|Overall Study|Study Terminated by Sponsor|0|||
129841356|NCT02457598|467385143|FG001|Overall Study|Study Terminated by Sponsor|1|||
129841357|NCT02457598|467385144|FG002|Overall Study|Study Terminated by Sponsor|0|||
129841358|NCT02457598|467385145|FG003|Overall Study|Study Terminated by Sponsor|4|||
129841359|NCT02457598|467385146|FG004|Overall Study|Study Terminated by Sponsor|1|||
129841360|NCT02457598|467385147|FG005|Overall Study|Study Terminated by Sponsor|0|||
129841361|NCT02457598|467385148|FG006|Overall Study|Study Terminated by Sponsor|1|||
129841362|NCT02457598|467385149|FG007|Overall Study|Study Terminated by Sponsor|0|||
129841363|NCT02457598|467385150|FG008|Overall Study|Study Terminated by Sponsor|0|||
129841364|NCT02457598|467385151|FG009|Overall Study|Study Terminated by Sponsor|0|||
129841365|NCT02457598|467385152|FG010|Overall Study|Study Terminated by Sponsor|4|||
129841366|NCT02457598|467385153|FG011|Overall Study|Study Terminated by Sponsor|0|||
129841367|NCT02457598|467385154|FG012|Overall Study|Study Terminated by Sponsor|1|||
129841368|NCT02457598|467385155|FG013|Overall Study|Study Terminated by Sponsor|0|||
129841369|NCT02457598|467385156|FG014|Overall Study|Study Terminated by Sponsor|8|||
129841370|NCT02457598|467385157|FG015|Overall Study|Study Terminated by Sponsor|1|||
129841371|NCT02457598|467385158|FG016|Overall Study|Study Terminated by Sponsor|0|||
129841372|NCT02457598|467385142|FG000|Overall Study|Adverse Event|0|||
129841373|NCT02457598|467385143|FG001|Overall Study|Adverse Event|1|||
129841374|NCT02457598|467385144|FG002|Overall Study|Adverse Event|1|||
129841375|NCT02457598|467385145|FG003|Overall Study|Adverse Event|4|||
129841376|NCT02457598|467385146|FG004|Overall Study|Adverse Event|1|||
129841377|NCT02457598|467385147|FG005|Overall Study|Adverse Event|0|||
129841378|NCT02457598|467385148|FG006|Overall Study|Adverse Event|0|||
129841379|NCT02457598|467385149|FG007|Overall Study|Adverse Event|1|||
129841380|NCT02457598|467385150|FG008|Overall Study|Adverse Event|0|||
129841381|NCT02457598|467385151|FG009|Overall Study|Adverse Event|1|||
129841382|NCT02457598|467385152|FG010|Overall Study|Adverse Event|6|||
129841383|NCT02457598|467385153|FG011|Overall Study|Adverse Event|0|||
129841384|NCT02457598|467385154|FG012|Overall Study|Adverse Event|0|||
129841385|NCT02457598|467385155|FG013|Overall Study|Adverse Event|1|||
129841386|NCT02457598|467385156|FG014|Overall Study|Adverse Event|2|||
129841387|NCT02457598|467385157|FG015|Overall Study|Adverse Event|0|||
129841388|NCT02457598|467385158|FG016|Overall Study|Adverse Event|0|||
129841389|NCT02457598|467385142|FG000|Overall Study|Death|0|||
129841390|NCT02457598|467385143|FG001|Overall Study|Death|0|||
129841391|NCT02457598|467385144|FG002|Overall Study|Death|0|||
129841392|NCT02457598|467385145|FG003|Overall Study|Death|3|||
129841393|NCT02457598|467385146|FG004|Overall Study|Death|0|||
129841394|NCT02457598|467385147|FG005|Overall Study|Death|1|||
129841395|NCT02457598|467385148|FG006|Overall Study|Death|0|||
129841396|NCT02457598|467385149|FG007|Overall Study|Death|0|||
129841397|NCT02457598|467385150|FG008|Overall Study|Death|0|||
129841398|NCT02457598|467385151|FG009|Overall Study|Death|0|||
129841399|NCT02457598|467385152|FG010|Overall Study|Death|3|||
129841400|NCT02457598|467385153|FG011|Overall Study|Death|0|||
129841401|NCT02457598|467385154|FG012|Overall Study|Death|0|||
129841402|NCT02457598|467385155|FG013|Overall Study|Death|1|||
129841403|NCT02457598|467385156|FG014|Overall Study|Death|2|||
129841404|NCT02457598|467385157|FG015|Overall Study|Death|0|||
129841405|NCT02457598|467385158|FG016|Overall Study|Death|1|||
129841406|NCT02457598|467385142|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841407|NCT02457598|467385143|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
129841408|NCT02457598|467385144|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841409|NCT02457598|467385145|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841410|NCT02457598|467385146|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841411|NCT02457598|467385147|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841412|NCT02457598|467385148|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841413|NCT02457598|467385149|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841414|NCT02457598|467385150|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841415|NCT02457598|467385151|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841416|NCT02457598|467385152|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
129841417|NCT02457598|467385153|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
129900202|NCT00486759|467595006|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
129900203|NCT00486759|467595005|FG000|Safety Follow-up|Death|40|||
129900204|NCT00486759|467595006|FG001|Safety Follow-up|Death|29|||
129900205|NCT00486759|467595005|FG000|Safety Follow-up|Withdrew consent|32|||
129900206|NCT00486759|467595006|FG001|Safety Follow-up|Withdrew consent|23|||
129900207|NCT00486759|467595005|FG000|Safety Follow-up|Failure to return|9|||
129900208|NCT00486759|467595006|FG001|Safety Follow-up|Failure to return|6|||
129900209|NCT00486759|467595005|FG000|Safety Follow-up|Administrative/not specified|8|||
129900210|NCT00486759|467595006|FG001|Safety Follow-up|Administrative/not specified|6|||
129900211|NCT00486759|467595005|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
129900212|NCT00486759|467595006|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
129900213|NCT00486759|467595005|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
129900214|NCT00486759|467595006|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
129900215|NCT01185522|467595007|FG000|Overall Study|Lack of Efficacy|28|||
129900216|NCT01185522|467595007|FG000|Overall Study|Lost to Follow-up|19|||
129900217|NCT01185522|467595007|FG000|Overall Study|Withdrawal by Subject|10|||
129900218|NCT01185522|467595007|FG000|Overall Study|Poor tolerance|39|||
129900219|NCT01185522|467595007|FG000|Overall Study|Other reasons|12|||
129900220|NCT00109967|467595008|FG000|Overall Study|Cancel Prior to Treatment|2|||
129900221|NCT00109967|467595009|FG001|Overall Study|Cancel Prior to Treatment|0|||
129900222|NCT00109967|467595008|FG000|Overall Study|Adverse Event|12|||
129900223|NCT00109967|467595009|FG001|Overall Study|Adverse Event|1|||
129900224|NCT00109967|467595008|FG000|Overall Study|Withdrawal by Subject|5|||
129900225|NCT00109967|467595009|FG001|Overall Study|Withdrawal by Subject|0|||
129900226|NCT00109967|467595008|FG000|Overall Study|Physician Decision|1|||
129900227|NCT00109967|467595009|FG001|Overall Study|Physician Decision|3|||
129900228|NCT00109967|467595008|FG000|Overall Study|Death|0|||
129900229|NCT00109967|467595009|FG001|Overall Study|Death|2|||
129900230|NCT03357341|467595016|FG000|Overall Study|Withdrawal by Subject|3|||
129900231|NCT03357341|467595017|FG001|Overall Study|Withdrawal by Subject|6|||
129900232|NCT03357341|467595016|FG000|Overall Study|Lost to Follow-up|4|||
129900233|NCT03357341|467595017|FG001|Overall Study|Lost to Follow-up|5|||
129900234|NCT03357341|467595016|FG000|Overall Study|Death|0|||
129900235|NCT03357341|467595017|FG001|Overall Study|Death|1|||
129900236|NCT00918957|467595018|FG000|Overall Study|Adverse Event|2|||
129900237|NCT00918957|467595019|FG001|Overall Study|Adverse Event|0|||
129900238|NCT00918957|467595018|FG000|Overall Study|Withdrawal by Subject|1|||
129900239|NCT00918957|467595019|FG001|Overall Study|Withdrawal by Subject|0|||
129900240|NCT00543725|467595020|FG000|Overall Study|Adverse Event|18|||
129900241|NCT00543725|467595021|FG001|Overall Study|Adverse Event|27|||
129900242|NCT00543725|467595020|FG000|Overall Study|Sponsor's Decision|0|||
129900243|NCT00543725|467595021|FG001|Overall Study|Sponsor's Decision|1|||
129900244|NCT00543725|467595020|FG000|Overall Study|Subject Non-Compliant|4|||
129900245|NCT00543725|467595021|FG001|Overall Study|Subject Non-Compliant|4|||
129900246|NCT00543725|467595020|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
129900247|NCT00543725|467595021|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
129900248|NCT00543725|467595020|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
129900249|NCT00543725|467595021|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
129900250|NCT00543725|467595020|FG000|Overall Study|Protocol Violation|0|||
129900251|NCT00543725|467595021|FG001|Overall Study|Protocol Violation|1|||
129900252|NCT00543725|467595020|FG000|Overall Study|Withdrawal by Subject|4|||
129900253|NCT00543725|467595021|FG001|Overall Study|Withdrawal by Subject|13|||
129900254|NCT00543725|467595020|FG000|Overall Study|Lost to Follow-up|15|||
129900255|NCT00543725|467595021|FG001|Overall Study|Lost to Follow-up|11|||
129900256|NCT00543725|467595020|FG000|Overall Study|Other|3|||
129900257|NCT00543725|467595021|FG001|Overall Study|Other|3|||
129900258|NCT01242085|467595023|FG000|Overall Study|Withdrawal by Subject|4|||
129900259|NCT01242085|467595024|FG001|Overall Study|Withdrawal by Subject|2|||
129900260|NCT01242085|467595025|FG002|Overall Study|Withdrawal by Subject|0|||
129900261|NCT01242085|467595023|FG000|Overall Study|medically unable to have surgery|4|||
129900262|NCT01242085|467595024|FG001|Overall Study|medically unable to have surgery|5|||
129900263|NCT01242085|467595025|FG002|Overall Study|medically unable to have surgery|0|||
129900264|NCT01178762|467595026|FG000|Overall Study|Lost to Follow-up|15|||
129900265|NCT01651949|467595032|FG000|Overall Study|Unknown status|4|||
129900266|NCT01651949|467595033|FG001|Overall Study|Unknown status|4|||
129900267|NCT01651949|467595034|FG002|Overall Study|Unknown status|0|||
129448794|NCT04667377|465943476|FG004|Maintenance Period|Protocol Violation|1|||
129900268|NCT01651949|467595032|FG000|Overall Study|Lost to Follow-up|30|||
129900269|NCT01651949|467595033|FG001|Overall Study|Lost to Follow-up|56|||
129900270|NCT01651949|467595034|FG002|Overall Study|Lost to Follow-up|20|||
129900271|NCT01651949|467595032|FG000|Overall Study|Protocol Violation|0|||
129900272|NCT01651949|467595033|FG001|Overall Study|Protocol Violation|2|||
129900273|NCT01651949|467595034|FG002|Overall Study|Protocol Violation|1|||
129900274|NCT01651949|467595032|FG000|Overall Study|Physician Decision|0|||
129900275|NCT01651949|467595033|FG001|Overall Study|Physician Decision|2|||
129900276|NCT01651949|467595034|FG002|Overall Study|Physician Decision|0|||
129900277|NCT01651949|467595032|FG000|Overall Study|Adverse Event|0|||
129841418|NCT02457598|467385154|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841419|NCT02457598|467385155|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
129841420|NCT02457598|467385156|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841421|NCT02457598|467385157|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841422|NCT02457598|467385158|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
129841423|NCT02457598|467385142|FG000|Overall Study|Withdrew Consent|0|||
129841424|NCT02457598|467385143|FG001|Overall Study|Withdrew Consent|0|||
129841425|NCT02457598|467385144|FG002|Overall Study|Withdrew Consent|0|||
129841426|NCT02457598|467385145|FG003|Overall Study|Withdrew Consent|0|||
129841427|NCT02457598|467385146|FG004|Overall Study|Withdrew Consent|0|||
129841428|NCT02457598|467385147|FG005|Overall Study|Withdrew Consent|0|||
129841429|NCT02457598|467385148|FG006|Overall Study|Withdrew Consent|0|||
129841430|NCT02457598|467385149|FG007|Overall Study|Withdrew Consent|2|||
129841431|NCT02457598|467385150|FG008|Overall Study|Withdrew Consent|0|||
129841432|NCT02457598|467385151|FG009|Overall Study|Withdrew Consent|0|||
129448795|NCT04667377|465943472|FG000|Maintenance Period|Burden of study procedures|1|||
129841433|NCT02457598|467385152|FG010|Overall Study|Withdrew Consent|3|||
129841434|NCT02457598|467385153|FG011|Overall Study|Withdrew Consent|0|||
129841435|NCT02457598|467385154|FG012|Overall Study|Withdrew Consent|0|||
129841436|NCT02457598|467385155|FG013|Overall Study|Withdrew Consent|1|||
129841437|NCT02457598|467385156|FG014|Overall Study|Withdrew Consent|0|||
129841438|NCT02457598|467385157|FG015|Overall Study|Withdrew Consent|0|||
129841439|NCT02457598|467385158|FG016|Overall Study|Withdrew Consent|0|||
129841440|NCT02457598|467385142|FG000|Overall Study|Unacceptable Toxicity|0|||
129841441|NCT02457598|467385143|FG001|Overall Study|Unacceptable Toxicity|0|||
129841442|NCT02457598|467385144|FG002|Overall Study|Unacceptable Toxicity|0|||
129841443|NCT02457598|467385145|FG003|Overall Study|Unacceptable Toxicity|0|||
129841444|NCT02457598|467385146|FG004|Overall Study|Unacceptable Toxicity|0|||
129841445|NCT02457598|467385147|FG005|Overall Study|Unacceptable Toxicity|0|||
129841446|NCT02457598|467385148|FG006|Overall Study|Unacceptable Toxicity|0|||
129841447|NCT02457598|467385149|FG007|Overall Study|Unacceptable Toxicity|0|||
129841448|NCT02457598|467385150|FG008|Overall Study|Unacceptable Toxicity|0|||
129841449|NCT02457598|467385151|FG009|Overall Study|Unacceptable Toxicity|0|||
129841450|NCT02457598|467385152|FG010|Overall Study|Unacceptable Toxicity|1|||
129841451|NCT02457598|467385153|FG011|Overall Study|Unacceptable Toxicity|0|||
129841452|NCT02457598|467385154|FG012|Overall Study|Unacceptable Toxicity|1|||
129841453|NCT02457598|467385155|FG013|Overall Study|Unacceptable Toxicity|1|||
129841454|NCT02457598|467385156|FG014|Overall Study|Unacceptable Toxicity|1|||
129841455|NCT02457598|467385157|FG015|Overall Study|Unacceptable Toxicity|0|||
129841456|NCT02457598|467385158|FG016|Overall Study|Unacceptable Toxicity|0|||
129841457|NCT02457598|467385142|FG000|Overall Study|Intercurrent Illness|0|||
129841458|NCT02457598|467385143|FG001|Overall Study|Intercurrent Illness|0|||
129841459|NCT02457598|467385144|FG002|Overall Study|Intercurrent Illness|0|||
129841460|NCT02457598|467385145|FG003|Overall Study|Intercurrent Illness|0|||
129841461|NCT02457598|467385146|FG004|Overall Study|Intercurrent Illness|0|||
129841462|NCT02457598|467385147|FG005|Overall Study|Intercurrent Illness|0|||
129841463|NCT02457598|467385148|FG006|Overall Study|Intercurrent Illness|0|||
129841464|NCT02457598|467385149|FG007|Overall Study|Intercurrent Illness|0|||
129841465|NCT02457598|467385150|FG008|Overall Study|Intercurrent Illness|0|||
129841466|NCT02457598|467385151|FG009|Overall Study|Intercurrent Illness|0|||
129841467|NCT02457598|467385152|FG010|Overall Study|Intercurrent Illness|1|||
129841468|NCT02457598|467385153|FG011|Overall Study|Intercurrent Illness|0|||
129841469|NCT02457598|467385154|FG012|Overall Study|Intercurrent Illness|0|||
129841470|NCT02457598|467385155|FG013|Overall Study|Intercurrent Illness|0|||
129841471|NCT02457598|467385156|FG014|Overall Study|Intercurrent Illness|0|||
129841472|NCT02457598|467385157|FG015|Overall Study|Intercurrent Illness|0|||
129841473|NCT02457598|467385158|FG016|Overall Study|Intercurrent Illness|0|||
129841474|NCT02457598|467385142|FG000|Overall Study|Protocol Violation|0|||
129841475|NCT02457598|467385143|FG001|Overall Study|Protocol Violation|0|||
129841476|NCT02457598|467385144|FG002|Overall Study|Protocol Violation|0|||
129841477|NCT02457598|467385145|FG003|Overall Study|Protocol Violation|0|||
129841478|NCT02457598|467385146|FG004|Overall Study|Protocol Violation|0|||
129841479|NCT02457598|467385147|FG005|Overall Study|Protocol Violation|0|||
129841480|NCT02457598|467385148|FG006|Overall Study|Protocol Violation|0|||
129841481|NCT02457598|467385149|FG007|Overall Study|Protocol Violation|0|||
129841482|NCT02457598|467385150|FG008|Overall Study|Protocol Violation|0|||
129841483|NCT02457598|467385151|FG009|Overall Study|Protocol Violation|0|||
129841484|NCT02457598|467385152|FG010|Overall Study|Protocol Violation|1|||
129841485|NCT02457598|467385153|FG011|Overall Study|Protocol Violation|0|||
129841486|NCT02457598|467385154|FG012|Overall Study|Protocol Violation|0|||
129841487|NCT02457598|467385155|FG013|Overall Study|Protocol Violation|0|||
129841488|NCT02457598|467385156|FG014|Overall Study|Protocol Violation|0|||
129841489|NCT02457598|467385157|FG015|Overall Study|Protocol Violation|0|||
129841490|NCT02457598|467385158|FG016|Overall Study|Protocol Violation|0|||
129841491|NCT01403974|467385159|FG000|Overall Study|Progressive disease according to RECIST|3|||
129841492|NCT01403974|467385160|FG001|Overall Study|Progressive disease according to RECIST|3|||
129841493|NCT01403974|467385161|FG002|Overall Study|Progressive disease according to RECIST|2|||
129841494|NCT01403974|467385162|FG003|Overall Study|Progressive disease according to RECIST|3|||
129841495|NCT01403974|467385163|FG004|Overall Study|Progressive disease according to RECIST|3|||
129841496|NCT01403974|467385164|FG005|Overall Study|Progressive disease according to RECIST|2|||
129841497|NCT01403974|467385165|FG006|Overall Study|Progressive disease according to RECIST|3|||
129841498|NCT01403974|467385166|FG007|Overall Study|Progressive disease according to RECIST|2|||
129841499|NCT01403974|467385167|FG008|Overall Study|Progressive disease according to RECIST|6|||
129841500|NCT01403974|467385168|FG009|Overall Study|Progressive disease according to RECIST|2|||
129841501|NCT01403974|467385169|FG010|Overall Study|Progressive disease according to RECIST|3|||
129841502|NCT01403974|467385170|FG011|Overall Study|Progressive disease according to RECIST|2|||
129841503|NCT01403974|467385171|FG012|Overall Study|Progressive disease according to RECIST|2|||
129841504|NCT01403974|467385172|FG013|Overall Study|Progressive disease according to RECIST|3|||
129841505|NCT01403974|467385173|FG014|Overall Study|Progressive disease according to RECIST|1|||
129900278|NCT01651949|467595033|FG001|Overall Study|Adverse Event|2|||
129900279|NCT01651949|467595034|FG002|Overall Study|Adverse Event|1|||
129900280|NCT01651949|467595032|FG000|Overall Study|Screen failure|2|||
129900281|NCT01651949|467595033|FG001|Overall Study|Screen failure|2|||
129900282|NCT01651949|467595034|FG002|Overall Study|Screen failure|0|||
129900283|NCT01651949|467595032|FG000|Overall Study|Withdrawal by Subject|17|||
129900284|NCT01651949|467595033|FG001|Overall Study|Withdrawal by Subject|18|||
129900285|NCT01651949|467595034|FG002|Overall Study|Withdrawal by Subject|9|||
129900286|NCT01806714|467595037|FG000|Overall Study|No functioning phone number|200|||
129900287|NCT01806714|467595038|FG001|Overall Study|No functioning phone number|170|||
129900288|NCT02155829|467595039|FG000|Overall Study|Adverse Event|1|||
129900289|NCT02155829|467595040|FG001|Overall Study|Adverse Event|0|||
129900290|NCT02155829|467595039|FG000|Overall Study|Withdrawal by Subject|3|||
129900291|NCT02155829|467595040|FG001|Overall Study|Withdrawal by Subject|3|||
129900292|NCT02155829|467595039|FG000|Overall Study|Protocol Violation|2|||
129900293|NCT02155829|467595040|FG001|Overall Study|Protocol Violation|0|||
129900294|NCT01585038|467595041|FG000|Overall Study|Adverse Event|2|||
129900295|NCT01585038|467595042|FG001|Overall Study|Adverse Event|2|||
129900296|NCT04107805|467595045|FG000|Overall Study|Adverse Event|0|||
129900297|NCT04107805|467595046|FG001|Overall Study|Adverse Event|0|||
129900298|NCT04107805|467595047|FG002|Overall Study|Adverse Event|0|||
129900299|NCT04107805|467595048|FG003|Overall Study|Adverse Event|1|||
129900300|NCT04107805|467595049|FG004|Overall Study|Adverse Event|0|||
129900301|NCT04107805|467595050|FG005|Overall Study|Adverse Event|1|||
129900302|NCT04107805|467595051|FG006|Overall Study|Adverse Event|0|||
129900303|NCT04107805|467595052|FG007|Overall Study|Adverse Event|0|||
129900304|NCT04107805|467595053|FG008|Overall Study|Adverse Event|1|||
129900305|NCT02596035|467595062|FG000|Overall Study|Disease Progression|64|||
129900306|NCT02596035|467595063|FG001|Overall Study|Disease Progression|32|||
129900307|NCT02596035|467595064|FG002|Overall Study|Disease Progression|1|||
129900308|NCT02596035|467595062|FG000|Overall Study|study drug toxicity|12|||
129900309|NCT02596035|467595063|FG001|Overall Study|study drug toxicity|3|||
129900310|NCT02596035|467595064|FG002|Overall Study|study drug toxicity|0|||
129900311|NCT02596035|467595062|FG000|Overall Study|AE unrelated to study drug|5|||
129900312|NCT02596035|467595063|FG001|Overall Study|AE unrelated to study drug|2|||
129900313|NCT02596035|467595064|FG002|Overall Study|AE unrelated to study drug|0|||
129900314|NCT02596035|467595062|FG000|Overall Study|participant request to discontinue study treatment|2|||
129900315|NCT02596035|467595063|FG001|Overall Study|participant request to discontinue study treatment|0|||
129900316|NCT02596035|467595064|FG002|Overall Study|participant request to discontinue study treatment|0|||
129900317|NCT02596035|467595062|FG000|Overall Study|participant withdrew consent|2|||
129900318|NCT02596035|467595063|FG001|Overall Study|participant withdrew consent|2|||
129900319|NCT02596035|467595064|FG002|Overall Study|participant withdrew consent|0|||
129900320|NCT02596035|467595062|FG000|Overall Study|Poor/Non Comlpiance|0|||
129900321|NCT02596035|467595063|FG001|Overall Study|Poor/Non Comlpiance|1|||
129900322|NCT02596035|467595064|FG002|Overall Study|Poor/Non Comlpiance|0|||
129900323|NCT02596035|467595062|FG000|Overall Study|participant no longer meets study criteria|1|||
129900324|NCT02596035|467595063|FG001|Overall Study|participant no longer meets study criteria|0|||
129900325|NCT02596035|467595064|FG002|Overall Study|participant no longer meets study criteria|0|||
129900326|NCT02596035|467595062|FG000|Overall Study|other reasons|11|||
129900327|NCT02596035|467595063|FG001|Overall Study|other reasons|4|||
129900328|NCT02596035|467595064|FG002|Overall Study|other reasons|0|||
129900329|NCT00414648|467595065|FG000|Overall Study|Adverse Event|5|||
129841506|NCT01403974|467385174|FG015|Overall Study|Progressive disease according to RECIST|8|||
129841507|NCT01403974|467385159|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
129841508|NCT01403974|467385160|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
129841509|NCT01403974|467385161|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
129841510|NCT01403974|467385162|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
129841511|NCT01403974|467385163|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
129841512|NCT01403974|467385164|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
129841513|NCT01403974|467385165|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
129841514|NCT01403974|467385166|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
129841515|NCT01403974|467385167|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
129841516|NCT01403974|467385168|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
129900330|NCT00414648|467595066|FG001|Overall Study|Adverse Event|5|||
129900331|NCT00414648|467595065|FG000|Overall Study|Death|0|||
129900332|NCT00414648|467595066|FG001|Overall Study|Death|1|||
129900333|NCT00414648|467595065|FG000|Overall Study|Lack of Efficacy|0|||
129900334|NCT00414648|467595066|FG001|Overall Study|Lack of Efficacy|2|||
129841517|NCT01403974|467385169|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
129841518|NCT01403974|467385170|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
129841519|NCT01403974|467385171|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
129841520|NCT01403974|467385172|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
129841521|NCT01403974|467385173|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
129841522|NCT01403974|467385174|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
129841523|NCT01403974|467385159|FG000|Overall Study|Refused to continue study medication|0|||
129841524|NCT01403974|467385160|FG001|Overall Study|Refused to continue study medication|0|||
129841525|NCT01403974|467385161|FG002|Overall Study|Refused to continue study medication|0|||
129841526|NCT01403974|467385162|FG003|Overall Study|Refused to continue study medication|0|||
129841527|NCT01403974|467385163|FG004|Overall Study|Refused to continue study medication|0|||
129841528|NCT01403974|467385164|FG005|Overall Study|Refused to continue study medication|1|||
129841529|NCT01403974|467385165|FG006|Overall Study|Refused to continue study medication|0|||
129841530|NCT01403974|467385166|FG007|Overall Study|Refused to continue study medication|0|||
129841531|NCT01403974|467385167|FG008|Overall Study|Refused to continue study medication|1|||
129841532|NCT01403974|467385168|FG009|Overall Study|Refused to continue study medication|0|||
129841533|NCT01403974|467385169|FG010|Overall Study|Refused to continue study medication|1|||
129841534|NCT01403974|467385170|FG011|Overall Study|Refused to continue study medication|0|||
129841535|NCT01403974|467385171|FG012|Overall Study|Refused to continue study medication|0|||
129841536|NCT01403974|467385172|FG013|Overall Study|Refused to continue study medication|0|||
129841537|NCT01403974|467385173|FG014|Overall Study|Refused to continue study medication|0|||
129841538|NCT01403974|467385174|FG015|Overall Study|Refused to continue study medication|4|||
129841539|NCT01403974|467385159|FG000|Overall Study|Adverse Event|0|||
129841540|NCT01403974|467385160|FG001|Overall Study|Adverse Event|0|||
129841541|NCT01403974|467385161|FG002|Overall Study|Adverse Event|1|||
129841542|NCT01403974|467385162|FG003|Overall Study|Adverse Event|0|||
129841543|NCT01403974|467385163|FG004|Overall Study|Adverse Event|0|||
129841544|NCT01403974|467385164|FG005|Overall Study|Adverse Event|0|||
129841545|NCT01403974|467385165|FG006|Overall Study|Adverse Event|0|||
129841546|NCT01403974|467385166|FG007|Overall Study|Adverse Event|1|||
129841547|NCT01403974|467385167|FG008|Overall Study|Adverse Event|0|||
129841548|NCT01403974|467385168|FG009|Overall Study|Adverse Event|0|||
129841549|NCT01403974|467385169|FG010|Overall Study|Adverse Event|0|||
129841550|NCT01403974|467385170|FG011|Overall Study|Adverse Event|0|||
129841551|NCT01403974|467385171|FG012|Overall Study|Adverse Event|1|||
129841552|NCT01403974|467385172|FG013|Overall Study|Adverse Event|0|||
129841553|NCT01403974|467385173|FG014|Overall Study|Adverse Event|0|||
129841554|NCT01403974|467385174|FG015|Overall Study|Adverse Event|0|||
129841555|NCT01403974|467385159|FG000|Overall Study|Other than specified|0|||
129841556|NCT01403974|467385160|FG001|Overall Study|Other than specified|0|||
129841557|NCT01403974|467385161|FG002|Overall Study|Other than specified|0|||
129841558|NCT01403974|467385162|FG003|Overall Study|Other than specified|0|||
129841559|NCT01403974|467385163|FG004|Overall Study|Other than specified|0|||
129841560|NCT01403974|467385164|FG005|Overall Study|Other than specified|0|||
129841561|NCT01403974|467385165|FG006|Overall Study|Other than specified|0|||
129841562|NCT01403974|467385166|FG007|Overall Study|Other than specified|0|||
129841563|NCT01403974|467385167|FG008|Overall Study|Other than specified|0|||
129841564|NCT01403974|467385168|FG009|Overall Study|Other than specified|1|||
129841565|NCT01403974|467385169|FG010|Overall Study|Other than specified|0|||
129841566|NCT01403974|467385170|FG011|Overall Study|Other than specified|1|||
129841567|NCT01403974|467385171|FG012|Overall Study|Other than specified|0|||
129841568|NCT01403974|467385172|FG013|Overall Study|Other than specified|0|||
129841569|NCT01403974|467385173|FG014|Overall Study|Other than specified|0|||
129841570|NCT01403974|467385174|FG015|Overall Study|Other than specified|0|||
129841571|NCT01526889|467385175|FG000|Treatment Period|Adverse Event|2|||
129841572|NCT01526889|467385176|FG001|Treatment Period|Adverse Event|0|||
129841573|NCT01526889|467385175|FG000|Treatment Extension Period|Administrative problems|1|||
129841574|NCT01526889|467385176|FG001|Treatment Extension Period|Administrative problems|0|||
129841575|NCT00974571|467385179|FG000|Overall Study|Adverse Event|31|||
129841576|NCT00974571|467385180|FG001|Overall Study|Adverse Event|4|||
129841577|NCT00974571|467385181|FG002|Overall Study|Adverse Event|27|||
129841578|NCT00974571|467385179|FG000|Overall Study|Lack of Efficacy|3|||
129841579|NCT00974571|467385180|FG001|Overall Study|Lack of Efficacy|2|||
129841580|NCT00974571|467385181|FG002|Overall Study|Lack of Efficacy|9|||
129841581|NCT00974571|467385179|FG000|Overall Study|Lost to Follow-up|2|||
129841582|NCT00974571|467385180|FG001|Overall Study|Lost to Follow-up|1|||
129841583|NCT00974571|467385181|FG002|Overall Study|Lost to Follow-up|2|||
129841584|NCT00974571|467385179|FG000|Overall Study|Protocol Violation|13|||
129841585|NCT00974571|467385180|FG001|Overall Study|Protocol Violation|4|||
129841586|NCT00974571|467385181|FG002|Overall Study|Protocol Violation|18|||
129841587|NCT00974571|467385179|FG000|Overall Study|Withdrawal by Subject|14|||
129841588|NCT00974571|467385180|FG001|Overall Study|Withdrawal by Subject|5|||
129841589|NCT00974571|467385181|FG002|Overall Study|Withdrawal by Subject|16|||
129841590|NCT00974571|467385179|FG000|Overall Study|Patient Moved|1|||
129448796|NCT04667377|465943473|FG001|Maintenance Period|Burden of study procedures|2|||
129448797|NCT04667377|465943474|FG002|Maintenance Period|Burden of study procedures|0|||
129448798|NCT04667377|465943475|FG003|Maintenance Period|Burden of study procedures|1|||
129448799|NCT04667377|465943476|FG004|Maintenance Period|Burden of study procedures|0|||
129448800|NCT04667377|465943472|FG000|Maintenance Period|Change of residence|0|||
129448801|NCT04667377|465943473|FG001|Maintenance Period|Change of residence|1|||
129900335|NCT00414648|467595065|FG000|Overall Study|Withdrawal by Subject|0|||
129900336|NCT00414648|467595066|FG001|Overall Study|Withdrawal by Subject|1|||
129900337|NCT04173572|467595069|FG000|Overall Study|Withdrawal by Subject|1|||
129900338|NCT04173572|467595070|FG001|Overall Study|Withdrawal by Subject|5|||
129900339|NCT04173572|467595069|FG000|Overall Study|Lost to Follow-up|3|||
129900340|NCT04173572|467595070|FG001|Overall Study|Lost to Follow-up|1|||
129900341|NCT00835380|467595075|FG000|Overall Study|Withdrawal by Subject|2|||
129900342|NCT03247543|467595076|FG000|Overall Study|Adverse Event|3|||
129900343|NCT03247543|467595077|FG001|Overall Study|Adverse Event|6|||
129900344|NCT03247543|467595078|FG002|Overall Study|Adverse Event|4|||
129900345|NCT03247543|467595076|FG000|Overall Study|Lost to Follow-up|10|||
129900346|NCT03247543|467595077|FG001|Overall Study|Lost to Follow-up|7|||
129900347|NCT03247543|467595078|FG002|Overall Study|Lost to Follow-up|8|||
129900348|NCT03247543|467595076|FG000|Overall Study|Consent withdrawn by caregiver|2|||
129900349|NCT03247543|467595077|FG001|Overall Study|Consent withdrawn by caregiver|2|||
129900350|NCT03247543|467595078|FG002|Overall Study|Consent withdrawn by caregiver|9|||
129900351|NCT03247543|467595076|FG000|Overall Study|Withdrawal by Subject|0|||
129900352|NCT03247543|467595077|FG001|Overall Study|Withdrawal by Subject|0|||
129900353|NCT03247543|467595078|FG002|Overall Study|Withdrawal by Subject|1|||
129900354|NCT03247543|467595076|FG000|Overall Study|Failure to Follow study procedures|1|||
129900355|NCT03247543|467595077|FG001|Overall Study|Failure to Follow study procedures|3|||
129900356|NCT03247543|467595078|FG002|Overall Study|Failure to Follow study procedures|1|||
129900357|NCT03247543|467595076|FG000|Overall Study|Lack of Efficacy|1|||
129900358|NCT03247543|467595077|FG001|Overall Study|Lack of Efficacy|0|||
129900359|NCT03247543|467595078|FG002|Overall Study|Lack of Efficacy|0|||
129900360|NCT03247543|467595076|FG000|Overall Study|Non-compliance with study visits|0|||
129900361|NCT03247543|467595077|FG001|Overall Study|Non-compliance with study visits|1|||
129900362|NCT03247543|467595078|FG002|Overall Study|Non-compliance with study visits|0|||
129900363|NCT02059980|467595081|FG000|Overall Study|Lost to Follow-up|2|||
129900364|NCT02059980|467595082|FG001|Overall Study|Lost to Follow-up|1|||
129900365|NCT01104415|467595083|FG000|Core Phase|Consent withdrawn by subjects|1|||
129900366|NCT01104415|467595084|FG001|Core Phase|Consent withdrawn by subjects|0|||
129900367|NCT01104415|467595083|FG000|Extension Period|Progressive disease|0|||
129900368|NCT01104415|467595084|FG001|Extension Period|Progressive disease|4|||
129900369|NCT01104415|467595083|FG000|Extension Period|Death|0|||
129900370|NCT01104415|467595084|FG001|Extension Period|Death|1|||
129900371|NCT01104415|467595083|FG000|Extension Period|Physician Decision|0|||
129900372|NCT01104415|467595084|FG001|Extension Period|Physician Decision|1|||
129900373|NCT01104415|467595083|FG000|Extension Period|Transition to Study LX1606.302|0|||
129900374|NCT01104415|467595084|FG001|Extension Period|Transition to Study LX1606.302|4|||
129900375|NCT01104415|467595083|FG000|Extension Period|Heart surgery/feeling miserable|0|||
129900376|NCT01104415|467595084|FG001|Extension Period|Heart surgery/feeling miserable|1|||
129900377|NCT01839877|467595087|FG000|Overall Study|Protocol Violation|1|||
129900378|NCT03098030|467595088|FG000|Overall Study|Death|10|||
129900379|NCT03098030|467595089|FG001|Overall Study|Death|156|||
129900380|NCT03098030|467595090|FG002|Overall Study|Death|156|||
129900381|NCT03098030|467595091|FG003|Overall Study|Death|82|||
129900382|NCT03098030|467595088|FG000|Overall Study|Withdrawal by Subject|0|||
129900383|NCT03098030|467595089|FG001|Overall Study|Withdrawal by Subject|7|||
129900384|NCT03098030|467595090|FG002|Overall Study|Withdrawal by Subject|8|||
129900385|NCT03098030|467595091|FG003|Overall Study|Withdrawal by Subject|2|||
129900386|NCT03098030|467595088|FG000|Overall Study|Lost to Follow-up|0|||
129900387|NCT03098030|467595089|FG001|Overall Study|Lost to Follow-up|0|||
129900388|NCT03098030|467595090|FG002|Overall Study|Lost to Follow-up|2|||
129448802|NCT04667377|465943474|FG002|Maintenance Period|Change of residence|0|||
129448803|NCT04667377|465943475|FG003|Maintenance Period|Change of residence|0|||
129900389|NCT03098030|467595091|FG003|Overall Study|Lost to Follow-up|1|||
129900390|NCT03643211|467595092|FG000|Overall Study|Contract violation/deficiency|12|||
129900391|NCT03643211|467595092|FG000|Overall Study|Invalid registration|3|||
129900392|NCT03643211|467595092|FG000|Overall Study|No treatment information|2|||
129900393|NCT03643211|467595092|FG000|Overall Study|No adverse event information - No revisit|4|||
129900394|NCT03368001|467595093|FG000|Allocation|Lost to Pretest|16|||
129900395|NCT03368001|467595094|FG001|Allocation|Lost to Pretest|25|||
129900396|NCT03368001|467595093|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
129900397|NCT03368001|467595094|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
129900398|NCT03368001|467595093|FG000|Posttest|Lost to Posttest|7|||
129900399|NCT03368001|467595094|FG001|Posttest|Lost to Posttest|11|||
129900400|NCT03368001|467595093|FG000|Posttest|Discontinued Intervention|6|||
129900401|NCT03368001|467595094|FG001|Posttest|Discontinued Intervention|19|||
129900402|NCT03368001|467595093|FG000|Follow-up|Lost to Follow-up|6|||
129841591|NCT00974571|467385180|FG001|Overall Study|Patient Moved|0|||
129841592|NCT00974571|467385181|FG002|Overall Study|Patient Moved|1|||
129841593|NCT00974571|467385179|FG000|Overall Study|Other|4|||
129841594|NCT00974571|467385180|FG001|Overall Study|Other|0|||
129841595|NCT00974571|467385181|FG002|Overall Study|Other|10|||
129841596|NCT01494610|467385198|FG000|Period 1|Withdrawal by Subject|1|||
129841597|NCT01494610|467385199|FG001|Period 1|Withdrawal by Subject|1|||
129841598|NCT01494610|467385198|FG000|Period 3|Adverse Event|1|||
129841599|NCT01494610|467385199|FG001|Period 3|Adverse Event|0|||
129841600|NCT01494610|467385198|FG000|Period 3|Withdrawal by Subject|1|||
129841601|NCT01494610|467385199|FG001|Period 3|Withdrawal by Subject|0|||
129841602|NCT01494610|467385198|FG000|Period 4|Protocol Violation|1|||
129841603|NCT01494610|467385199|FG001|Period 4|Protocol Violation|0|||
129841604|NCT04334460|467385200|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
129841605|NCT04334460|467385201|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
129841606|NCT04334460|467385200|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
129841607|NCT04334460|467385201|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
129841608|NCT02385799|467385202|FG000|Overall Study|Lost to Follow-up|1|||
129841609|NCT02385799|467385203|FG001|Overall Study|Lost to Follow-up|2|||
129841610|NCT02385799|467385202|FG000|Overall Study|Adverse Event|4|||
129841611|NCT02385799|467385203|FG001|Overall Study|Adverse Event|2|||
129841612|NCT02385799|467385202|FG000|Overall Study|Withdrawal by Subject|0|||
129841613|NCT02385799|467385203|FG001|Overall Study|Withdrawal by Subject|4|||
129841614|NCT00547703|467385206|FG000|Overall Study|Lost to Follow-up|1|||
129841615|NCT00547703|467385207|FG001|Overall Study|Lost to Follow-up|0|||
129841616|NCT03995953|467385210|FG000|Overall Study|Death|3|||
129841617|NCT03995953|467385211|FG001|Overall Study|Death|0|||
129841618|NCT03995953|467385212|FG002|Overall Study|Death|3|||
129900403|NCT03368001|467595094|FG001|Follow-up|Lost to Follow-up|3|||
129900404|NCT00554801|467595095|FG000|Overall Study|left area before completion|5|||
129900405|NCT00554801|467595096|FG001|Overall Study|left area before completion|0|||
129900406|NCT00554801|467595095|FG000|Overall Study|Withdrawal by Subject|14|||
129900407|NCT00554801|467595096|FG001|Overall Study|Withdrawal by Subject|0|||
129900408|NCT04436120|467595097|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900409|NCT04436120|467595098|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900410|NCT04436120|467595099|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900411|NCT04436120|467595100|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
129900412|NCT04436120|467595101|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900413|NCT04436120|467595102|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
129900414|NCT04436120|467595103|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
129900415|NCT02357784|467595104|FG000|Overall Study|Withdrawal by Subject|1|||
129900416|NCT04776213|467595106|FG000|Overall Study|Other|1|||
129900417|NCT04776213|467595106|FG000|Overall Study|Withdrawal by Subject|7|||
129900418|NCT04776213|467595106|FG000|Overall Study|Protocol Violation|1|||
129900419|NCT04776213|467595106|FG000|Overall Study|Lost to Follow-up|2|||
129900420|NCT01838551|467595107|FG000|Overall Study|Adverse Event|16|||
129900421|NCT01838551|467595107|FG000|Overall Study|Death|1|||
129900422|NCT01838551|467595107|FG000|Overall Study|Lack of Efficacy|10|||
129448804|NCT04667377|465943476|FG004|Maintenance Period|Change of residence|1|||
129448805|NCT04667377|465943472|FG000|Maintenance Period|Missing|1|||
129448806|NCT04667377|465943473|FG001|Maintenance Period|Missing|0|||
129448807|NCT04667377|465943474|FG002|Maintenance Period|Missing|0|||
129448808|NCT04667377|465943475|FG003|Maintenance Period|Missing|0|||
129448809|NCT04667377|465943476|FG004|Maintenance Period|Missing|0|||
129448810|NCT04667377|465943472|FG000|Maintenance Period|Other than listed above|2|||
129448811|NCT04667377|465943473|FG001|Maintenance Period|Other than listed above|0|||
129448812|NCT04667377|465943474|FG002|Maintenance Period|Other than listed above|3|||
129448813|NCT04667377|465943475|FG003|Maintenance Period|Other than listed above|2|||
129448814|NCT04667377|465943476|FG004|Maintenance Period|Other than listed above|6|||
129448815|NCT04667377|465943472|FG000|Maintenance Period|Withdrawal by Subject|0|||
129448816|NCT04667377|465943473|FG001|Maintenance Period|Withdrawal by Subject|1|||
129448817|NCT04667377|465943474|FG002|Maintenance Period|Withdrawal by Subject|0|||
129448818|NCT04667377|465943475|FG003|Maintenance Period|Withdrawal by Subject|0|||
129448819|NCT04667377|465943476|FG004|Maintenance Period|Withdrawal by Subject|0|||
129448820|NCT04667377|465943472|FG000|Maintenance Period|Lost to Follow-up|1|||
129448821|NCT04667377|465943473|FG001|Maintenance Period|Lost to Follow-up|0|||
129448822|NCT04667377|465943474|FG002|Maintenance Period|Lost to Follow-up|1|||
129448823|NCT04667377|465943475|FG003|Maintenance Period|Lost to Follow-up|0|||
129448824|NCT04667377|465943476|FG004|Maintenance Period|Lost to Follow-up|1|||
129448825|NCT01011439|465943477|FG000|Overall Study|Death|37|||
129448826|NCT01011439|465943477|FG000|Overall Study|Lost to Follow-up|4|||
129448827|NCT01011439|465943477|FG000|Overall Study|Withdrawal by Subject|1|||
129448828|NCT01011439|465943477|FG000|Overall Study|Sponsor's decision|15|||
129448829|NCT02428855|465943478|FG000|Overall Study|Withdrawal by Subject|2|||
129448830|NCT02066311|465943479|FG000|Overall Study|Adverse Event|4|||
129448831|NCT02066311|465943479|FG000|Overall Study|Withdrawal by Subject|1|||
129448832|NCT03198520|465943484|FG000|Overall Study|Physician Decision|2|||
129448833|NCT03198520|465943484|FG000|Overall Study|Protocol Violation|2|||
129448834|NCT03198520|465943484|FG000|Overall Study|Withdrawal by Subject|1|||
129448835|NCT03198520|465943484|FG000|Overall Study|Study Ended|1|||
129448836|NCT01670539|465943485|FG000|Overall Study|Death|3|||
129448837|NCT01670539|465943486|FG001|Overall Study|Death|5|||
129448838|NCT01670539|465943485|FG000|Overall Study|Withdrawal by Subject|3|||
129448839|NCT01670539|465943486|FG001|Overall Study|Withdrawal by Subject|0|||
129448840|NCT00536809|465943487|FG000|Phase II|Adverse Event|1|||
129448841|NCT00536809|465943487|FG000|Phase II|Referred for surgical resection|1|||
129448842|NCT01303965|465943488|FG000|Overall Study|Adverse Event|1|||
129841619|NCT03995953|467385213|FG003|Overall Study|Death|0|||
129841620|NCT03995953|467385214|FG004|Overall Study|Death|3|||
129841621|NCT03995953|467385215|FG005|Overall Study|Death|0|||
129841622|NCT03995953|467385216|FG006|Overall Study|Death|0|||
129841623|NCT03995953|467385217|FG007|Overall Study|Death|0|||
129841624|NCT03995953|467385218|FG008|Overall Study|Death|1|||
129841625|NCT03995953|467385219|FG009|Overall Study|Death|0|||
129841626|NCT03995953|467385220|FG010|Overall Study|Death|0|||
129841627|NCT03995953|467385221|FG011|Overall Study|Death|0|||
129841628|NCT03995953|467385210|FG000|Overall Study|Lost to Follow-up|6|||
129841629|NCT03995953|467385211|FG001|Overall Study|Lost to Follow-up|54|||
129841630|NCT03995953|467385212|FG002|Overall Study|Lost to Follow-up|3|||
129841631|NCT03995953|467385213|FG003|Overall Study|Lost to Follow-up|32|||
129841632|NCT03995953|467385214|FG004|Overall Study|Lost to Follow-up|5|||
129841633|NCT03995953|467385215|FG005|Overall Study|Lost to Follow-up|44|||
129841634|NCT03995953|467385216|FG006|Overall Study|Lost to Follow-up|0|||
129900423|NCT01838551|467595107|FG000|Overall Study|Physician Decision|4|||
129900424|NCT01838551|467595107|FG000|Overall Study|Withdrawal by Subject|10|||
129900425|NCT01838551|467595107|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
129900426|NCT02289560|467595108|FG000|Overall Study|Lost to Follow-up|6|||
129841635|NCT03995953|467385217|FG007|Overall Study|Lost to Follow-up|31|||
129841636|NCT03995953|467385218|FG008|Overall Study|Lost to Follow-up|8|||
129448843|NCT01303965|465943489|FG001|Overall Study|Adverse Event|1|||
129448844|NCT01303965|465943488|FG000|Overall Study|Death|0|||
129448845|NCT01303965|465943489|FG001|Overall Study|Death|3|||
129448846|NCT01303965|465943488|FG000|Overall Study|Withdrawal by Subject|1|||
129448847|NCT01303965|465943489|FG001|Overall Study|Withdrawal by Subject|0|||
129448848|NCT01303965|465943488|FG000|Overall Study|Disease Progression|1|||
129448849|NCT01303965|465943489|FG001|Overall Study|Disease Progression|6|||
129448850|NCT01490814|465943495|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
129448851|NCT01490814|465943496|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
129841637|NCT03995953|467385219|FG009|Overall Study|Lost to Follow-up|36|||
129448852|NCT01490814|465943495|FG000|Overall Study|Physician Decision|1|||
129448853|NCT01490814|465943496|FG001|Overall Study|Physician Decision|0|||
129841638|NCT03995953|467385220|FG010|Overall Study|Lost to Follow-up|5|||
129448854|NCT01490814|465943495|FG000|Overall Study|Withdrawal by Subject|0|||
129841639|NCT03995953|467385221|FG011|Overall Study|Lost to Follow-up|41|||
129841640|NCT03995953|467385210|FG000|Overall Study|Withdrawal by Subject|4|||
129841641|NCT03995953|467385211|FG001|Overall Study|Withdrawal by Subject|0|||
129841642|NCT03995953|467385212|FG002|Overall Study|Withdrawal by Subject|1|||
129841643|NCT03995953|467385213|FG003|Overall Study|Withdrawal by Subject|0|||
129841644|NCT03995953|467385214|FG004|Overall Study|Withdrawal by Subject|1|||
129841645|NCT03995953|467385215|FG005|Overall Study|Withdrawal by Subject|0|||
129841646|NCT03995953|467385216|FG006|Overall Study|Withdrawal by Subject|1|||
129448855|NCT01490814|465943496|FG001|Overall Study|Withdrawal by Subject|5|||
129448856|NCT03024970|465943500|FG000|First Intervention|Adverse Event|1|||
129448857|NCT03024970|465943501|FG001|First Intervention|Adverse Event|0|||
129448858|NCT03024970|465943500|FG000|Second Intervention|Lost to Follow-up|1|||
129448859|NCT03024970|465943501|FG001|Second Intervention|Lost to Follow-up|0|||
129448860|NCT00773136|465943504|FG000|Overall Study|Physician Decision|2|||
129900427|NCT02289560|467595108|FG000|Overall Study|Alternative Treatment|4|||
129900428|NCT02289560|467595108|FG000|Overall Study|Inadequate Treatment|2|||
129900429|NCT02289560|467595108|FG000|Overall Study|Withdrawal by Subject|23|||
129900430|NCT01981356|467595111|FG000|Overall Study|Lost to Follow-up|4|||
129900431|NCT01981356|467595112|FG001|Overall Study|Lost to Follow-up|1|||
129900432|NCT01981356|467595111|FG000|Overall Study|Withdrawal by Subject|1|||
129900433|NCT01981356|467595112|FG001|Overall Study|Withdrawal by Subject|1|||
129900434|NCT01981356|467595111|FG000|Overall Study|Protocol Violation|2|||
129900435|NCT01981356|467595112|FG001|Overall Study|Protocol Violation|0|||
129900436|NCT02685033|467595113|FG000|Overall Study|Withdrawal of Consent|0|||
129900437|NCT02685033|467595114|FG001|Overall Study|Withdrawal of Consent|1|||
129900438|NCT02685033|467595113|FG000|Overall Study|Lost to Follow-up|2|||
129900439|NCT02685033|467595114|FG001|Overall Study|Lost to Follow-up|1|||
129900440|NCT02685033|467595113|FG000|Overall Study|Adverse Event|1|||
129900441|NCT02685033|467595114|FG001|Overall Study|Adverse Event|0|||
129900442|NCT02013037|467595115|FG000|Overall Study|Death|6|||
129900443|NCT02013037|467595115|FG000|Overall Study|Withdrawal by Subject|1|||
129900444|NCT02013037|467595115|FG000|Overall Study|Awaiting Transplantation|7|||
129900445|NCT02013037|467595115|FG000|Overall Study|Transplanted without DSA|2|||
129900446|NCT03227757|467597081|FG000|Overall Study|Death|25|||
129900447|NCT03227757|467597081|FG000|Overall Study|Withdrawal|10|||
129900448|NCT03227757|467597081|FG000|Overall Study|Missed visits|1|||
129900449|NCT03227757|467597081|FG000|Overall Study|Lost to Follow-up|2|||
129900450|NCT03140176|467597084|FG000|Overall Study|Reason missing|23|||
129900451|NCT03140176|467597084|FG000|Overall Study|Death|33|||
129900452|NCT03140176|467597084|FG000|Overall Study|Disease progression|1|||
129900453|NCT03140176|467597084|FG000|Overall Study|Physician Decision|1|||
129900454|NCT03140176|467597084|FG000|Overall Study|Withdrawal by Subject|1|||
129900455|NCT03140176|467597084|FG000|Overall Study|Lost to Follow-up|15|||
129900456|NCT00954707|467597088|FG000|Overall Study|Death|34|||
129900457|NCT00954707|467597088|FG000|Overall Study|Withdrawal by Subject|100|||
129900458|NCT00954707|467597088|FG000|Overall Study|Lost to Follow-up|33|||
129900459|NCT02001623|467597089|FG000|Overall Study|Disease Progression|2|||
129900460|NCT02001623|467597090|FG001|Overall Study|Disease Progression|2|||
129900461|NCT02001623|467597091|FG002|Overall Study|Disease Progression|3|||
129900462|NCT02001623|467597092|FG003|Overall Study|Disease Progression|2|||
129900463|NCT02001623|467597093|FG004|Overall Study|Disease Progression|3|||
129448861|NCT00888381|465943509|FG000|Overall Study|Lost to Follow-up|0|||
129448862|NCT00888381|465943510|FG001|Overall Study|Lost to Follow-up|1|||
129448863|NCT00097773|465943511|FG000|Overall Study|Lost to Follow-up|2|||
129448864|NCT00097773|465943512|FG001|Overall Study|Lost to Follow-up|2|||
129448865|NCT00097773|465943513|FG002|Overall Study|Lost to Follow-up|0|||
129841647|NCT03995953|467385217|FG007|Overall Study|Withdrawal by Subject|0|||
129841648|NCT03995953|467385218|FG008|Overall Study|Withdrawal by Subject|3|||
129841649|NCT03995953|467385219|FG009|Overall Study|Withdrawal by Subject|0|||
129841650|NCT03995953|467385220|FG010|Overall Study|Withdrawal by Subject|3|||
129841651|NCT03995953|467385221|FG011|Overall Study|Withdrawal by Subject|0|||
129841652|NCT03995953|467385210|FG000|Overall Study|Health Issues|0|||
129841653|NCT03995953|467385211|FG001|Overall Study|Health Issues|0|||
129841654|NCT03995953|467385212|FG002|Overall Study|Health Issues|0|||
129841655|NCT03995953|467385213|FG003|Overall Study|Health Issues|0|||
129841656|NCT03995953|467385214|FG004|Overall Study|Health Issues|1|||
129841657|NCT03995953|467385215|FG005|Overall Study|Health Issues|0|||
129841658|NCT03995953|467385216|FG006|Overall Study|Health Issues|0|||
129841659|NCT03995953|467385217|FG007|Overall Study|Health Issues|0|||
129841660|NCT03995953|467385218|FG008|Overall Study|Health Issues|4|||
129841661|NCT03995953|467385219|FG009|Overall Study|Health Issues|0|||
129841662|NCT03995953|467385220|FG010|Overall Study|Health Issues|0|||
129841663|NCT03995953|467385221|FG011|Overall Study|Health Issues|0|||
129841664|NCT03995953|467385210|FG000|Overall Study|Relocated|11|||
129900464|NCT02001623|467597094|FG005|Overall Study|Disease Progression|2|||
129900465|NCT02001623|467597095|FG006|Overall Study|Disease Progression|3|||
129900466|NCT02001623|467597096|FG007|Overall Study|Disease Progression|3|||
129841665|NCT03995953|467385211|FG001|Overall Study|Relocated|0|||
129900467|NCT02001623|467597097|FG008|Overall Study|Disease Progression|7|||
129900468|NCT02001623|467597098|FG009|Overall Study|Disease Progression|40|||
129900469|NCT02001623|467597099|FG010|Overall Study|Disease Progression|5|||
129900470|NCT02001623|467597100|FG011|Overall Study|Disease Progression|9|||
129900471|NCT02001623|467597101|FG012|Overall Study|Disease Progression|9|||
129841666|NCT03995953|467385212|FG002|Overall Study|Relocated|16|||
129841667|NCT03995953|467385213|FG003|Overall Study|Relocated|0|||
129841668|NCT03995953|467385214|FG004|Overall Study|Relocated|14|||
129841669|NCT03995953|467385215|FG005|Overall Study|Relocated|0|||
129841670|NCT03995953|467385216|FG006|Overall Study|Relocated|16|||
129841671|NCT03995953|467385217|FG007|Overall Study|Relocated|0|||
129841672|NCT03995953|467385218|FG008|Overall Study|Relocated|14|||
129841673|NCT03995953|467385219|FG009|Overall Study|Relocated|0|||
129841674|NCT03995953|467385220|FG010|Overall Study|Relocated|15|||
129841675|NCT03995953|467385221|FG011|Overall Study|Relocated|0|||
129841676|NCT02130765|467385222|FG000|Overall Study|Did not receive treatment|4|||
129841677|NCT02130765|467385223|FG001|Overall Study|Did not receive treatment|0|||
129841678|NCT02130765|467385224|FG002|Overall Study|Did not receive treatment|0|||
129841679|NCT02130765|467385225|FG003|Overall Study|Did not receive treatment|0|||
129841680|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
129841681|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
129841682|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
129841683|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
129841684|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
129841685|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
129841686|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
129841687|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129841688|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129841689|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
129841690|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
129841691|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
129841692|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
129841693|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
129841694|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
129841695|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841696|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
129841697|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841698|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841699|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
129841700|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
129841701|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
129841702|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
129841703|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
129841704|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
129841705|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841706|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
129841707|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841708|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841709|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
129841710|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
129841711|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841712|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841713|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841714|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
129841715|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
129841716|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841717|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841718|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841719|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
129841720|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
129841721|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841722|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841723|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841724|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
129841725|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841726|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
129841727|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841728|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841729|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
129841730|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
129841731|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129841732|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129841733|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129841734|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
129900472|NCT02001623|467597102|FG013|Overall Study|Disease Progression|20|||
129841735|NCT04951622|467385235|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841736|NCT04951622|467385236|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
129841737|NCT04951622|467385237|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841738|NCT04951622|467385238|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841739|NCT04951622|467385239|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
129841740|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129841741|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129841742|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
129841743|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
129900473|NCT02001623|467597103|FG014|Overall Study|Disease Progression|9|||
129900474|NCT02001623|467597089|FG000|Overall Study|Physician Decision|0|||
129900475|NCT02001623|467597090|FG001|Overall Study|Physician Decision|0|||
129900476|NCT02001623|467597091|FG002|Overall Study|Physician Decision|0|||
129900477|NCT02001623|467597092|FG003|Overall Study|Physician Decision|0|||
129900478|NCT02001623|467597093|FG004|Overall Study|Physician Decision|0|||
129900479|NCT02001623|467597094|FG005|Overall Study|Physician Decision|0|||
129900480|NCT02001623|467597095|FG006|Overall Study|Physician Decision|0|||
129900481|NCT02001623|467597096|FG007|Overall Study|Physician Decision|0|||
129900482|NCT02001623|467597097|FG008|Overall Study|Physician Decision|3|||
129900483|NCT02001623|467597098|FG009|Overall Study|Physician Decision|2|||
129900484|NCT02001623|467597099|FG010|Overall Study|Physician Decision|3|||
129900485|NCT02001623|467597100|FG011|Overall Study|Physician Decision|3|||
129900486|NCT02001623|467597101|FG012|Overall Study|Physician Decision|1|||
129900487|NCT02001623|467597102|FG013|Overall Study|Physician Decision|2|||
129900488|NCT02001623|467597103|FG014|Overall Study|Physician Decision|1|||
129900489|NCT02001623|467597089|FG000|Overall Study|Death|0|||
129900490|NCT02001623|467597090|FG001|Overall Study|Death|1|||
129900491|NCT02001623|467597091|FG002|Overall Study|Death|0|||
129900492|NCT02001623|467597092|FG003|Overall Study|Death|0|||
129900493|NCT02001623|467597093|FG004|Overall Study|Death|0|||
129900494|NCT02001623|467597094|FG005|Overall Study|Death|0|||
129900495|NCT02001623|467597095|FG006|Overall Study|Death|0|||
129900496|NCT02001623|467597096|FG007|Overall Study|Death|0|||
129900497|NCT02001623|467597097|FG008|Overall Study|Death|0|||
129900498|NCT02001623|467597098|FG009|Overall Study|Death|0|||
129900499|NCT02001623|467597099|FG010|Overall Study|Death|0|||
129900500|NCT02001623|467597100|FG011|Overall Study|Death|0|||
129900501|NCT02001623|467597101|FG012|Overall Study|Death|0|||
129900502|NCT02001623|467597102|FG013|Overall Study|Death|0|||
129900503|NCT02001623|467597103|FG014|Overall Study|Death|0|||
129900504|NCT02001623|467597089|FG000|Overall Study|Adverse Event|0|||
129900505|NCT02001623|467597090|FG001|Overall Study|Adverse Event|0|||
129900506|NCT02001623|467597091|FG002|Overall Study|Adverse Event|0|||
129900507|NCT02001623|467597092|FG003|Overall Study|Adverse Event|0|||
129900508|NCT02001623|467597093|FG004|Overall Study|Adverse Event|0|||
129900509|NCT02001623|467597094|FG005|Overall Study|Adverse Event|1|||
129900510|NCT02001623|467597095|FG006|Overall Study|Adverse Event|0|||
129900511|NCT02001623|467597096|FG007|Overall Study|Adverse Event|3|||
129900512|NCT02001623|467597097|FG008|Overall Study|Adverse Event|4|||
129900513|NCT02001623|467597098|FG009|Overall Study|Adverse Event|6|||
129900514|NCT02001623|467597099|FG010|Overall Study|Adverse Event|4|||
129900515|NCT02001623|467597100|FG011|Overall Study|Adverse Event|0|||
129900516|NCT02001623|467597101|FG012|Overall Study|Adverse Event|3|||
129900517|NCT02001623|467597102|FG013|Overall Study|Adverse Event|5|||
129900518|NCT02001623|467597103|FG014|Overall Study|Adverse Event|6|||
129900519|NCT02001623|467597089|FG000|Overall Study|Other - Miscellaneous|0|||
129900520|NCT02001623|467597090|FG001|Overall Study|Other - Miscellaneous|0|||
129900521|NCT02001623|467597091|FG002|Overall Study|Other - Miscellaneous|0|||
129900522|NCT02001623|467597092|FG003|Overall Study|Other - Miscellaneous|0|||
129900523|NCT02001623|467597093|FG004|Overall Study|Other - Miscellaneous|0|||
129900524|NCT02001623|467597094|FG005|Overall Study|Other - Miscellaneous|0|||
129900525|NCT02001623|467597095|FG006|Overall Study|Other - Miscellaneous|0|||
129900526|NCT02001623|467597096|FG007|Overall Study|Other - Miscellaneous|0|||
129900527|NCT02001623|467597097|FG008|Overall Study|Other - Miscellaneous|0|||
129900528|NCT02001623|467597098|FG009|Overall Study|Other - Miscellaneous|1|||
129448866|NCT00097773|465943514|FG003|Overall Study|Lost to Follow-up|1|||
129900529|NCT02001623|467597099|FG010|Overall Study|Other - Miscellaneous|0|||
129900530|NCT02001623|467597100|FG011|Overall Study|Other - Miscellaneous|0|||
129900531|NCT02001623|467597101|FG012|Overall Study|Other - Miscellaneous|0|||
129900532|NCT02001623|467597102|FG013|Overall Study|Other - Miscellaneous|1|||
129900533|NCT02001623|467597103|FG014|Overall Study|Other - Miscellaneous|0|||
129900534|NCT02001623|467597089|FG000|Overall Study|Withdrawal by Subject|1|||
129900535|NCT02001623|467597090|FG001|Overall Study|Withdrawal by Subject|0|||
129900536|NCT02001623|467597091|FG002|Overall Study|Withdrawal by Subject|0|||
129900537|NCT02001623|467597092|FG003|Overall Study|Withdrawal by Subject|0|||
129900538|NCT02001623|467597093|FG004|Overall Study|Withdrawal by Subject|0|||
129900539|NCT02001623|467597094|FG005|Overall Study|Withdrawal by Subject|0|||
129900540|NCT02001623|467597095|FG006|Overall Study|Withdrawal by Subject|0|||
129900541|NCT02001623|467597096|FG007|Overall Study|Withdrawal by Subject|0|||
129900542|NCT02001623|467597097|FG008|Overall Study|Withdrawal by Subject|1|||
129900543|NCT02001623|467597098|FG009|Overall Study|Withdrawal by Subject|3|||
129900544|NCT02001623|467597099|FG010|Overall Study|Withdrawal by Subject|2|||
129900545|NCT02001623|467597100|FG011|Overall Study|Withdrawal by Subject|2|||
129900546|NCT02001623|467597101|FG012|Overall Study|Withdrawal by Subject|1|||
129900547|NCT02001623|467597102|FG013|Overall Study|Withdrawal by Subject|5|||
129900548|NCT02001623|467597103|FG014|Overall Study|Withdrawal by Subject|2|||
129900549|NCT02001623|467597089|FG000|Overall Study|Lost to Follow-up|0|||
129900550|NCT02001623|467597090|FG001|Overall Study|Lost to Follow-up|0|||
129900551|NCT02001623|467597091|FG002|Overall Study|Lost to Follow-up|0|||
129900552|NCT02001623|467597092|FG003|Overall Study|Lost to Follow-up|0|||
129900553|NCT02001623|467597093|FG004|Overall Study|Lost to Follow-up|0|||
129900554|NCT02001623|467597094|FG005|Overall Study|Lost to Follow-up|0|||
129900555|NCT02001623|467597095|FG006|Overall Study|Lost to Follow-up|0|||
129900556|NCT02001623|467597096|FG007|Overall Study|Lost to Follow-up|0|||
129900557|NCT02001623|467597097|FG008|Overall Study|Lost to Follow-up|0|||
129900558|NCT02001623|467597098|FG009|Overall Study|Lost to Follow-up|1|||
129900559|NCT02001623|467597099|FG010|Overall Study|Lost to Follow-up|0|||
129900560|NCT02001623|467597100|FG011|Overall Study|Lost to Follow-up|0|||
129900561|NCT02001623|467597101|FG012|Overall Study|Lost to Follow-up|0|||
129900562|NCT02001623|467597102|FG013|Overall Study|Lost to Follow-up|0|||
129900563|NCT02001623|467597103|FG014|Overall Study|Lost to Follow-up|0|||
129900564|NCT02001623|467597089|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
129900565|NCT02001623|467597090|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
129900566|NCT02001623|467597091|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
129900567|NCT02001623|467597092|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
129900568|NCT02001623|467597093|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
129900569|NCT02001623|467597094|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
129900570|NCT02001623|467597095|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
129900571|NCT02001623|467597096|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
129900572|NCT02001623|467597097|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
129900573|NCT02001623|467597098|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
129900574|NCT02001623|467597099|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
129900575|NCT02001623|467597100|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
129900576|NCT02001623|467597101|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
129900577|NCT02001623|467597102|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
129900578|NCT02001623|467597103|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
129900579|NCT02001623|467597089|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
129900580|NCT02001623|467597090|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
129900581|NCT02001623|467597091|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
129900582|NCT02001623|467597092|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
129900583|NCT02001623|467597093|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
129900584|NCT02001623|467597094|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
129900585|NCT02001623|467597095|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
129900586|NCT02001623|467597096|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
129900587|NCT02001623|467597097|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
129900588|NCT02001623|467597098|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
129900589|NCT02001623|467597099|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
129900590|NCT02001623|467597100|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
129900591|NCT02001623|467597101|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
129900592|NCT02001623|467597102|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
129900593|NCT02001623|467597103|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
129900594|NCT00309452|467597104|FG000|Overall Study|Withdrawal by Subject|3|||
129900595|NCT00309452|467597105|FG001|Overall Study|Withdrawal by Subject|0|||
129900596|NCT00771667|467597106|FG000|Induction Phase|Adverse Event|5|||
129900597|NCT00771667|467597107|FG001|Induction Phase|Adverse Event|2|||
129900598|NCT00771667|467597108|FG002|Induction Phase|Adverse Event|4|||
129900599|NCT00771667|467597109|FG003|Induction Phase|Adverse Event|1|||
129900600|NCT00771667|467597110|FG004|Induction Phase|Adverse Event|0|||
129900601|NCT00771667|467597111|FG005|Induction Phase|Adverse Event|0|||
129900602|NCT00771667|467597112|FG006|Induction Phase|Adverse Event|0|||
129900603|NCT00771667|467597113|FG007|Induction Phase|Adverse Event|0|||
129900604|NCT00771667|467597114|FG008|Induction Phase|Adverse Event|0|||
129900605|NCT00771667|467597115|FG009|Induction Phase|Adverse Event|0|||
129900606|NCT00771667|467597106|FG000|Induction Phase|Lack of Efficacy|9|||
129900607|NCT00771667|467597107|FG001|Induction Phase|Lack of Efficacy|2|||
129841744|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
129841745|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
129841746|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
129841747|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
129841748|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
129841749|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
129841750|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
129841751|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
129841752|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
129841753|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
129841754|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
129841755|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
129841756|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
129841757|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
129841758|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
129841759|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
129841760|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841761|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841762|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
129841763|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841764|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
129841765|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
129841766|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
129841767|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
129841768|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
129841769|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
129841770|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
129841771|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
129841772|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
129841773|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
129841774|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
129841775|NCT04951622|467385235|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841776|NCT04951622|467385236|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841777|NCT04951622|467385237|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841778|NCT04951622|467385238|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
129841779|NCT04951622|467385239|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
129841780|NCT01455012|467385244|FG000|Overall Study|Adverse Event|0|||
129841781|NCT01455012|467385245|FG001|Overall Study|Adverse Event|2|||
129841782|NCT01455012|467385244|FG000|Overall Study|Lack of Efficacy|6|||
129841783|NCT01455012|467385245|FG001|Overall Study|Lack of Efficacy|1|||
129841784|NCT01455012|467385244|FG000|Overall Study|Withdrawal by Subject|3|||
129841785|NCT01455012|467385245|FG001|Overall Study|Withdrawal by Subject|1|||
129841786|NCT01455012|467385244|FG000|Overall Study|Unknown reason|2|||
129841787|NCT01455012|467385245|FG001|Overall Study|Unknown reason|0|||
129841788|NCT01215227|467385246|FG000|Overall Study|Adverse Event|11|||
129841789|NCT01215227|467385247|FG001|Overall Study|Adverse Event|11|||
129841790|NCT01215227|467385248|FG002|Overall Study|Adverse Event|4|||
129841791|NCT01215227|467385249|FG003|Overall Study|Adverse Event|8|||
129841792|NCT01215227|467385250|FG004|Overall Study|Adverse Event|7|||
129841793|NCT01215227|467385251|FG005|Overall Study|Adverse Event|6|||
129841794|NCT01215227|467385246|FG000|Overall Study|Treatment Failure|8|||
129841795|NCT01215227|467385247|FG001|Overall Study|Treatment Failure|4|||
129841796|NCT01215227|467385248|FG002|Overall Study|Treatment Failure|1|||
129841797|NCT01215227|467385249|FG003|Overall Study|Treatment Failure|5|||
129841798|NCT01215227|467385250|FG004|Overall Study|Treatment Failure|1|||
129841799|NCT01215227|467385251|FG005|Overall Study|Treatment Failure|1|||
129841800|NCT01215227|467385246|FG000|Overall Study|Lost to Follow-up|1|||
129841801|NCT01215227|467385247|FG001|Overall Study|Lost to Follow-up|4|||
129841802|NCT01215227|467385248|FG002|Overall Study|Lost to Follow-up|1|||
129841803|NCT01215227|467385249|FG003|Overall Study|Lost to Follow-up|1|||
129841804|NCT01215227|467385250|FG004|Overall Study|Lost to Follow-up|1|||
129841805|NCT01215227|467385251|FG005|Overall Study|Lost to Follow-up|2|||
129841806|NCT01215227|467385246|FG000|Overall Study|Subject Withdrew Consent|16|||
129841807|NCT01215227|467385247|FG001|Overall Study|Subject Withdrew Consent|20|||
129841808|NCT01215227|467385248|FG002|Overall Study|Subject Withdrew Consent|7|||
129841809|NCT01215227|467385249|FG003|Overall Study|Subject Withdrew Consent|10|||
129900608|NCT00771667|467597108|FG002|Induction Phase|Lack of Efficacy|4|||
129900609|NCT00771667|467597109|FG003|Induction Phase|Lack of Efficacy|3|||
129900610|NCT00771667|467597110|FG004|Induction Phase|Lack of Efficacy|0|||
129900611|NCT00771667|467597111|FG005|Induction Phase|Lack of Efficacy|0|||
129900612|NCT00771667|467597112|FG006|Induction Phase|Lack of Efficacy|0|||
129900613|NCT00771667|467597113|FG007|Induction Phase|Lack of Efficacy|0|||
129900614|NCT00771667|467597114|FG008|Induction Phase|Lack of Efficacy|0|||
129900615|NCT00771667|467597115|FG009|Induction Phase|Lack of Efficacy|0|||
129900616|NCT00771667|467597106|FG000|Induction Phase|Lost to Follow-up|1|||
129900617|NCT00771667|467597107|FG001|Induction Phase|Lost to Follow-up|0|||
129900618|NCT00771667|467597108|FG002|Induction Phase|Lost to Follow-up|1|||
129900619|NCT00771667|467597109|FG003|Induction Phase|Lost to Follow-up|0|||
129900620|NCT00771667|467597110|FG004|Induction Phase|Lost to Follow-up|0|||
129900621|NCT00771667|467597111|FG005|Induction Phase|Lost to Follow-up|0|||
129900622|NCT00771667|467597112|FG006|Induction Phase|Lost to Follow-up|0|||
129900623|NCT00771667|467597113|FG007|Induction Phase|Lost to Follow-up|0|||
129900624|NCT00771667|467597114|FG008|Induction Phase|Lost to Follow-up|0|||
129900625|NCT00771667|467597115|FG009|Induction Phase|Lost to Follow-up|0|||
129900626|NCT00771667|467597106|FG000|Induction Phase|Other|4|||
129900627|NCT00771667|467597107|FG001|Induction Phase|Other|6|||
129900628|NCT00771667|467597108|FG002|Induction Phase|Other|3|||
129900629|NCT00771667|467597109|FG003|Induction Phase|Other|4|||
129900630|NCT00771667|467597110|FG004|Induction Phase|Other|0|||
129900631|NCT00771667|467597111|FG005|Induction Phase|Other|0|||
129900632|NCT00771667|467597112|FG006|Induction Phase|Other|0|||
129900633|NCT00771667|467597113|FG007|Induction Phase|Other|0|||
129900634|NCT00771667|467597114|FG008|Induction Phase|Other|0|||
129900635|NCT00771667|467597115|FG009|Induction Phase|Other|0|||
129900636|NCT00771667|467597106|FG000|Maintenance Phase|Adverse Event|0|||
129900637|NCT00771667|467597107|FG001|Maintenance Phase|Adverse Event|0|||
129900638|NCT00771667|467597108|FG002|Maintenance Phase|Adverse Event|0|||
129900639|NCT00771667|467597109|FG003|Maintenance Phase|Adverse Event|0|||
129900640|NCT00771667|467597110|FG004|Maintenance Phase|Adverse Event|1|||
129900641|NCT00771667|467597111|FG005|Maintenance Phase|Adverse Event|3|||
129900642|NCT00771667|467597112|FG006|Maintenance Phase|Adverse Event|5|||
129900643|NCT00771667|467597113|FG007|Maintenance Phase|Adverse Event|1|||
129900644|NCT00771667|467597114|FG008|Maintenance Phase|Adverse Event|8|||
129900645|NCT00771667|467597115|FG009|Maintenance Phase|Adverse Event|7|||
129900646|NCT00771667|467597106|FG000|Maintenance Phase|Lack of Efficacy|0|||
129900647|NCT00771667|467597107|FG001|Maintenance Phase|Lack of Efficacy|0|||
129841810|NCT01215227|467385250|FG004|Overall Study|Subject Withdrew Consent|11|||
129841811|NCT01215227|467385251|FG005|Overall Study|Subject Withdrew Consent|8|||
129841812|NCT01215227|467385246|FG000|Overall Study|Non-Compliance With Protocol|2|||
129841813|NCT01215227|467385247|FG001|Overall Study|Non-Compliance With Protocol|6|||
129841814|NCT01215227|467385248|FG002|Overall Study|Non-Compliance With Protocol|1|||
129841815|NCT01215227|467385249|FG003|Overall Study|Non-Compliance With Protocol|0|||
129841816|NCT01215227|467385250|FG004|Overall Study|Non-Compliance With Protocol|0|||
129841817|NCT01215227|467385251|FG005|Overall Study|Non-Compliance With Protocol|0|||
129841818|NCT01215227|467385246|FG000|Overall Study|Administrative|83|||
129841819|NCT01215227|467385247|FG001|Overall Study|Administrative|73|||
129841820|NCT01215227|467385248|FG002|Overall Study|Administrative|42|||
129841821|NCT01215227|467385249|FG003|Overall Study|Administrative|24|||
129841822|NCT01215227|467385250|FG004|Overall Study|Administrative|28|||
129841823|NCT01215227|467385251|FG005|Overall Study|Administrative|40|||
129841824|NCT01215227|467385246|FG000|Overall Study|Missing Status|0|||
129841825|NCT01215227|467385247|FG001|Overall Study|Missing Status|1|||
129841826|NCT01215227|467385248|FG002|Overall Study|Missing Status|0|||
129841827|NCT01215227|467385249|FG003|Overall Study|Missing Status|0|||
129841828|NCT01215227|467385250|FG004|Overall Study|Missing Status|0|||
129841829|NCT01215227|467385251|FG005|Overall Study|Missing Status|0|||
129841830|NCT01215227|467385246|FG000|Overall Study|Randomized but not treated|0|||
129841831|NCT01215227|467385247|FG001|Overall Study|Randomized but not treated|0|||
129841832|NCT01215227|467385248|FG002|Overall Study|Randomized but not treated|1|||
129841833|NCT01215227|467385249|FG003|Overall Study|Randomized but not treated|1|||
129841834|NCT01215227|467385250|FG004|Overall Study|Randomized but not treated|0|||
129841835|NCT01215227|467385251|FG005|Overall Study|Randomized but not treated|1|||
129841836|NCT02253810|467385252|FG000|Overall Study|Withdrawal by Subject|2|||
129841837|NCT02253810|467385253|FG001|Overall Study|Withdrawal by Subject|1|||
129900648|NCT00771667|467597108|FG002|Maintenance Phase|Lack of Efficacy|0|||
129900649|NCT00771667|467597109|FG003|Maintenance Phase|Lack of Efficacy|0|||
129900650|NCT00771667|467597110|FG004|Maintenance Phase|Lack of Efficacy|1|||
129900651|NCT00771667|467597111|FG005|Maintenance Phase|Lack of Efficacy|3|||
129900652|NCT00771667|467597112|FG006|Maintenance Phase|Lack of Efficacy|3|||
129841838|NCT02253810|467385252|FG000|Overall Study|Unknown concomitant procedure|3|||
129900653|NCT00771667|467597113|FG007|Maintenance Phase|Lack of Efficacy|2|||
129900654|NCT00771667|467597114|FG008|Maintenance Phase|Lack of Efficacy|11|||
129900655|NCT00771667|467597115|FG009|Maintenance Phase|Lack of Efficacy|7|||
129900656|NCT00771667|467597106|FG000|Maintenance Phase|Other|0|||
129900657|NCT00771667|467597107|FG001|Maintenance Phase|Other|0|||
129900658|NCT00771667|467597108|FG002|Maintenance Phase|Other|0|||
129841839|NCT02253810|467385253|FG001|Overall Study|Unknown concomitant procedure|2|||
129841840|NCT01434290|467385254|FG000|Overall Study|Protocol Violation|6|||
129841841|NCT01434290|467385255|FG001|Overall Study|Protocol Violation|3|||
129841842|NCT01434290|467385254|FG000|Overall Study|No protocol treatment|2|||
129841843|NCT01434290|467385255|FG001|Overall Study|No protocol treatment|4|||
129841844|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
129841845|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
129841846|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
129841847|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
129841848|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
129841849|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
129841850|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
129841851|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
129841852|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
129841853|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
129841854|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
129841855|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
129841856|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
129841857|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
129900659|NCT00771667|467597109|FG003|Maintenance Phase|Other|0|||
129841858|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
129841859|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
129841860|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
129841861|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
129841862|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
129900660|NCT00771667|467597110|FG004|Maintenance Phase|Other|0|||
129900661|NCT00771667|467597111|FG005|Maintenance Phase|Other|1|||
129900662|NCT00771667|467597112|FG006|Maintenance Phase|Other|2|||
129841863|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
129841864|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Other|3|||
129841865|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Other|0|||
129841866|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Other|2|||
129841867|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Other|2|||
129900663|NCT00771667|467597113|FG007|Maintenance Phase|Other|2|||
129900664|NCT00771667|467597114|FG008|Maintenance Phase|Other|3|||
129448867|NCT00097773|465943511|FG000|Overall Study|Physician Decision|2|||
129841868|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Other|7|||
129841869|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841870|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841871|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841872|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
129841873|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841874|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841875|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841876|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841877|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841878|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
129841879|NCT00213148|467385257|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
129841880|NCT00213148|467385258|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
129841881|NCT00213148|467385259|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
129841882|NCT00213148|467385260|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
129841883|NCT00213148|467385261|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
129841884|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
129841885|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
129841886|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
129841887|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
129841888|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
129841889|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
129841890|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
129841891|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
129841892|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
129841893|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
129841894|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Other|2|||
129841895|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Other|1|||
129841896|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Other|2|||
129841897|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Other|8|||
129841898|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Other|7|||
129841899|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841900|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
129841901|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841902|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841903|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
129841904|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
129841905|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841906|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841907|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841908|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
129841909|NCT00213148|467385257|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
129841910|NCT00213148|467385258|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
129841911|NCT00213148|467385259|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
129841912|NCT00213148|467385260|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
129841913|NCT00213148|467385261|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
129841914|NCT00213148|467385257|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
129841915|NCT00213148|467385258|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
129841916|NCT00213148|467385259|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
129841917|NCT00213148|467385260|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
129841918|NCT00213148|467385261|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
129841919|NCT00213148|467385257|FG000|Cycle 3 (1 Month)|Other|0|||
129841920|NCT00213148|467385258|FG001|Cycle 3 (1 Month)|Other|0|||
129841921|NCT00213148|467385259|FG002|Cycle 3 (1 Month)|Other|1|||
129841922|NCT00213148|467385260|FG003|Cycle 3 (1 Month)|Other|1|||
129841923|NCT00213148|467385261|FG004|Cycle 3 (1 Month)|Other|0|||
129841924|NCT00558103|467385262|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
129841925|NCT00558103|467385263|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
129841926|NCT00558103|467385264|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
129841927|NCT00558103|467385265|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
129841928|NCT00558103|467385266|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
129841929|NCT00558103|467385267|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
129841930|NCT00558103|467385262|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
129841931|NCT00558103|467385263|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
129841932|NCT00558103|467385264|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
129841933|NCT00558103|467385265|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
129841934|NCT00558103|467385266|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
129841935|NCT00558103|467385267|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
129841936|NCT00558103|467385262|FG000|Randomized Treatment Phase|Disease Progression|1|||
129841937|NCT00558103|467385263|FG001|Randomized Treatment Phase|Disease Progression|0|||
129841938|NCT00558103|467385264|FG002|Randomized Treatment Phase|Disease Progression|1|||
129841939|NCT00558103|467385265|FG003|Randomized Treatment Phase|Disease Progression|0|||
129841940|NCT00558103|467385266|FG004|Randomized Treatment Phase|Disease Progression|0|||
129841941|NCT00558103|467385267|FG005|Randomized Treatment Phase|Disease Progression|0|||
129841942|NCT00558103|467385262|FG000|Randomized Treatment Phase|Adverse Event|0|||
129841943|NCT00558103|467385263|FG001|Randomized Treatment Phase|Adverse Event|0|||
129841944|NCT00558103|467385264|FG002|Randomized Treatment Phase|Adverse Event|0|||
129841945|NCT00558103|467385265|FG003|Randomized Treatment Phase|Adverse Event|1|||
129841946|NCT00558103|467385266|FG004|Randomized Treatment Phase|Adverse Event|1|||
129841947|NCT00558103|467385267|FG005|Randomized Treatment Phase|Adverse Event|0|||
129841948|NCT00558103|467385262|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
129448868|NCT00097773|465943512|FG001|Overall Study|Physician Decision|2|||
129448869|NCT00097773|465943513|FG002|Overall Study|Physician Decision|3|||
129448870|NCT00097773|465943514|FG003|Overall Study|Physician Decision|1|||
129448871|NCT00097773|465943511|FG000|Overall Study|Withdrawal by Subject|3|||
129448872|NCT00097773|465943512|FG001|Overall Study|Withdrawal by Subject|3|||
129448873|NCT00097773|465943513|FG002|Overall Study|Withdrawal by Subject|3|||
129448874|NCT00097773|465943514|FG003|Overall Study|Withdrawal by Subject|1|||
129448875|NCT00097773|465943511|FG000|Overall Study|Adverse Event|0|||
129448876|NCT00097773|465943512|FG001|Overall Study|Adverse Event|1|||
129448877|NCT00097773|465943513|FG002|Overall Study|Adverse Event|0|||
129448878|NCT00097773|465943514|FG003|Overall Study|Adverse Event|0|||
129448879|NCT00097773|465943511|FG000|Overall Study|Other|1|||
129448880|NCT00097773|465943512|FG001|Overall Study|Other|0|||
129448881|NCT00097773|465943513|FG002|Overall Study|Other|2|||
129448882|NCT00097773|465943514|FG003|Overall Study|Other|0|||
129448883|NCT00003702|465943515|FG000|Overall Study|Ineligible cell types|2|||
129448884|NCT00003702|465943516|FG001|Overall Study|Ineligible cell types|2|||
129448885|NCT00003702|465943515|FG000|Overall Study|Did not meet criteria for persistence|8|||
129448886|NCT00003702|465943516|FG001|Overall Study|Did not meet criteria for persistence|5|||
129448887|NCT00003702|465943515|FG000|Overall Study|WHO score > 6|2|||
129448888|NCT00003702|465943516|FG001|Overall Study|WHO score > 6|1|||
129448889|NCT00003702|465943515|FG000|Overall Study|Inadequate documentation of disease|1|||
129448890|NCT00003702|465943516|FG001|Overall Study|Inadequate documentation of disease|3|||
129448891|NCT01009034|465943517|FG000|Overall Study|Lost to Follow-up|2|||
129448892|NCT01009034|465943517|FG000|Overall Study|Withdrawal by Subject|2|||
129448893|NCT01494350|465943518|FG000|Overall Study|Worsening of lesion|1|||
129448894|NCT02054325|465943520|FG000|Overall Study|Lost to Follow-up|8|||
129448895|NCT02054325|465943521|FG001|Overall Study|Lost to Follow-up|5|||
129448896|NCT00617604|465943522|FG000|Overall Study|Death|2|||
129448897|NCT00617604|465943523|FG001|Overall Study|Death|1|||
129448898|NCT00617604|465943522|FG000|Overall Study|Lost to Follow-up|1|||
129448899|NCT00617604|465943523|FG001|Overall Study|Lost to Follow-up|0|||
129448900|NCT00617604|465943522|FG000|Overall Study|Miscellaneous Reasons|8|||
129448901|NCT00617604|465943523|FG001|Overall Study|Miscellaneous Reasons|10|||
129448902|NCT00617604|465943522|FG000|Overall Study|Withdrawal by Subject|4|||
129448903|NCT00617604|465943523|FG001|Overall Study|Withdrawal by Subject|6|||
129448904|NCT00617604|465943522|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
129448905|NCT00617604|465943523|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
129448906|NCT03250832|465943524|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
129448907|NCT03250832|465943525|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
129448908|NCT03250832|465943526|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
129448909|NCT03250832|465943527|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
129448910|NCT03250832|465943528|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
129448911|NCT03250832|465943529|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
129448912|NCT03250832|465943530|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
129448913|NCT03250832|465943531|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
129448914|NCT03250832|465943532|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
129448915|NCT03250832|465943533|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
129448916|NCT03250832|465943534|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
129448917|NCT03250832|465943535|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
129448918|NCT03250832|465943524|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
129448919|NCT03250832|465943525|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
129900665|NCT00771667|467597115|FG009|Maintenance Phase|Other|3|||
129900666|NCT00628862|467597116|FG000|Overall Study|Adverse Event|6|||
129900667|NCT00628862|467597117|FG001|Overall Study|Adverse Event|8|||
129900668|NCT00628862|467597118|FG002|Overall Study|Adverse Event|10|||
129900669|NCT00628862|467597116|FG000|Overall Study|Withdrawal by Subject|4|||
129900670|NCT00628862|467597117|FG001|Overall Study|Withdrawal by Subject|6|||
129900671|NCT00628862|467597118|FG002|Overall Study|Withdrawal by Subject|11|||
129900672|NCT00628862|467597116|FG000|Overall Study|Lost to Follow-up|0|||
129900673|NCT00628862|467597117|FG001|Overall Study|Lost to Follow-up|2|||
129448920|NCT03250832|465943526|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
129448921|NCT03250832|465943527|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
129448922|NCT03250832|465943528|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
129448923|NCT03250832|465943529|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
129448924|NCT03250832|465943530|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
129448925|NCT03250832|465943531|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
129448926|NCT03250832|465943532|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
129448927|NCT03250832|465943533|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
129448928|NCT03250832|465943534|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
129448929|NCT03250832|465943535|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
129900674|NCT00628862|467597118|FG002|Overall Study|Lost to Follow-up|1|||
129900675|NCT00628862|467597116|FG000|Overall Study|Protocol Violation|1|||
129900676|NCT00628862|467597117|FG001|Overall Study|Protocol Violation|0|||
129448930|NCT03250832|465943524|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448931|NCT03250832|465943525|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448932|NCT03250832|465943526|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
129448933|NCT03250832|465943527|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448934|NCT03250832|465943528|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448935|NCT03250832|465943529|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448936|NCT03250832|465943530|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448937|NCT03250832|465943531|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448938|NCT03250832|465943532|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448939|NCT03250832|465943533|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448940|NCT03250832|465943534|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448941|NCT03250832|465943535|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
129448942|NCT03250832|465943524|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448943|NCT03250832|465943525|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448944|NCT03250832|465943526|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448945|NCT03250832|465943527|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448946|NCT03250832|465943528|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448947|NCT03250832|465943529|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448948|NCT03250832|465943530|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448949|NCT03250832|465943531|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
129448950|NCT03250832|465943532|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448951|NCT03250832|465943533|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448952|NCT03250832|465943534|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448953|NCT03250832|465943535|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
129448954|NCT03250832|465943524|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448955|NCT03250832|465943525|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448956|NCT03250832|465943526|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448957|NCT03250832|465943527|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448958|NCT03250832|465943528|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448959|NCT03250832|465943529|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448960|NCT03250832|465943530|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448961|NCT03250832|465943531|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
129448962|NCT03250832|465943532|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448963|NCT03250832|465943533|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448964|NCT03250832|465943534|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448965|NCT03250832|465943535|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
129448966|NCT03250832|465943524|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448967|NCT03250832|465943525|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448968|NCT03250832|465943526|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448969|NCT03250832|465943527|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448970|NCT03250832|465943528|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448971|NCT03250832|465943529|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448972|NCT03250832|465943530|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448973|NCT03250832|465943531|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
129448974|NCT03250832|465943532|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448975|NCT03250832|465943533|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448976|NCT03250832|465943534|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448977|NCT03250832|465943535|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
129448978|NCT03250832|465943524|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129900677|NCT00628862|467597118|FG002|Overall Study|Protocol Violation|0|||
129900678|NCT00628862|467597116|FG000|Overall Study|COPD Exacerbation|0|||
129900679|NCT00628862|467597117|FG001|Overall Study|COPD Exacerbation|1|||
129900680|NCT00628862|467597118|FG002|Overall Study|COPD Exacerbation|0|||
129900681|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Adverse Event|1|||
129900682|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
129900683|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
129900684|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
129900685|NCT01063036|467597119|FG000|Participants Treated With Study Drug|Pregnancy|1|||
129900686|NCT01063036|467597119|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
129900687|NCT01063036|467597119|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
129900688|NCT01063036|467597119|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
129448979|NCT03250832|465943525|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448980|NCT03250832|465943526|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129900689|NCT02715258|467597120|FG000|Overall Study|Withdrawal by Subject|6|||
129900690|NCT02715258|467597121|FG001|Overall Study|Withdrawal by Subject|1|||
129900691|NCT02715258|467597120|FG000|Overall Study|Lost to Follow-up|7|||
129900692|NCT02715258|467597121|FG001|Overall Study|Lost to Follow-up|1|||
129448981|NCT03250832|465943527|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448982|NCT03250832|465943528|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448983|NCT03250832|465943529|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448984|NCT03250832|465943530|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448985|NCT03250832|465943531|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
129448986|NCT03250832|465943532|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448987|NCT03250832|465943533|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448988|NCT03250832|465943534|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448989|NCT03250832|465943535|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
129448990|NCT03250832|465943524|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448991|NCT03250832|465943525|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448992|NCT03250832|465943526|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448993|NCT03250832|465943527|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448994|NCT03250832|465943528|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448995|NCT03250832|465943529|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448996|NCT03250832|465943530|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448997|NCT03250832|465943531|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
129448998|NCT03250832|465943532|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
129448999|NCT03250832|465943533|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
129449000|NCT03250832|465943534|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
129449001|NCT03250832|465943535|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
129449002|NCT03250832|465943524|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449003|NCT03250832|465943525|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449004|NCT03250832|465943526|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449005|NCT03250832|465943527|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449006|NCT03250832|465943528|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449007|NCT03250832|465943529|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449008|NCT03250832|465943530|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449009|NCT03250832|465943531|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449010|NCT03250832|465943532|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
129449011|NCT03250832|465943533|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
129449012|NCT03250832|465943534|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449013|NCT03250832|465943535|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
129449014|NCT03250832|465943524|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449015|NCT03250832|465943525|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449016|NCT03250832|465943526|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449017|NCT03250832|465943527|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449018|NCT03250832|465943528|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449019|NCT03250832|465943529|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129841949|NCT00558103|467385263|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
129841950|NCT00558103|467385264|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
129841951|NCT00558103|467385265|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
129841952|NCT00558103|467385266|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
129841953|NCT00558103|467385267|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
129841954|NCT00558103|467385262|FG000|Monotherapy Extension Phase|Disease Progression|0|||
129841955|NCT00558103|467385263|FG001|Monotherapy Extension Phase|Disease Progression|0|||
129841956|NCT00558103|467385264|FG002|Monotherapy Extension Phase|Disease Progression|0|||
129841957|NCT00558103|467385265|FG003|Monotherapy Extension Phase|Disease Progression|0|||
129841958|NCT00558103|467385266|FG004|Monotherapy Extension Phase|Disease Progression|0|||
129841959|NCT00558103|467385267|FG005|Monotherapy Extension Phase|Disease Progression|8|||
129841960|NCT03548584|467387429|FG000|Overall Study|Lost to Follow-up|0|||
129841961|NCT03548584|467387430|FG001|Overall Study|Lost to Follow-up|0|||
129841962|NCT03548584|467387431|FG002|Overall Study|Lost to Follow-up|1|||
129841963|NCT03548584|467387429|FG000|Overall Study|Adverse Event|1|||
129841964|NCT03548584|467387430|FG001|Overall Study|Adverse Event|11|||
129841965|NCT03548584|467387431|FG002|Overall Study|Adverse Event|5|||
129841966|NCT03548584|467387429|FG000|Overall Study|Site Terminated by Sponsor|1|||
129841967|NCT03548584|467387430|FG001|Overall Study|Site Terminated by Sponsor|3|||
129841968|NCT03548584|467387431|FG002|Overall Study|Site Terminated by Sponsor|2|||
129841969|NCT03548584|467387429|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
129841970|NCT03548584|467387430|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
129449020|NCT03250832|465943530|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449021|NCT03250832|465943531|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129449022|NCT03250832|465943532|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
129449023|NCT03250832|465943533|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
129449024|NCT03250832|465943534|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129841971|NCT03548584|467387431|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
129841972|NCT03548584|467387429|FG000|Overall Study|Lack of Efficacy|0|||
129841973|NCT03548584|467387430|FG001|Overall Study|Lack of Efficacy|1|||
129841974|NCT03548584|467387431|FG002|Overall Study|Lack of Efficacy|0|||
129841975|NCT03548584|467387429|FG000|Overall Study|Non-compliance with Study Drug|0|||
129841976|NCT03548584|467387430|FG001|Overall Study|Non-compliance with Study Drug|1|||
129841977|NCT03548584|467387431|FG002|Overall Study|Non-compliance with Study Drug|0|||
129841978|NCT03548584|467387429|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
129841979|NCT03548584|467387430|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
129841980|NCT03548584|467387431|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
129841981|NCT01101841|467387436|FG000|Overall Study|Adverse Event|15|||
129841982|NCT01101841|467387437|FG001|Overall Study|Adverse Event|15|||
129841983|NCT01101841|467387436|FG000|Overall Study|Lost to Follow-up|9|||
129841984|NCT01101841|467387437|FG001|Overall Study|Lost to Follow-up|3|||
129841985|NCT01101841|467387436|FG000|Overall Study|Withdrawal by Subject|21|||
129841986|NCT01101841|467387437|FG001|Overall Study|Withdrawal by Subject|40|||
129841987|NCT01101841|467387436|FG000|Overall Study|Protocol Violation|1|||
129841988|NCT01101841|467387437|FG001|Overall Study|Protocol Violation|1|||
129841989|NCT01101841|467387436|FG000|Overall Study|Physician Decision|0|||
129841990|NCT01101841|467387437|FG001|Overall Study|Physician Decision|2|||
129841991|NCT01101841|467387436|FG000|Overall Study|Lack of Efficacy|0|||
129841992|NCT01101841|467387437|FG001|Overall Study|Lack of Efficacy|2|||
129841993|NCT01101841|467387436|FG000|Overall Study|Other|0|||
129841994|NCT01101841|467387437|FG001|Overall Study|Other|1|||
129841995|NCT01101841|467387436|FG000|Overall Study|Suicidality Tracking Scale|3|||
129841996|NCT01101841|467387437|FG001|Overall Study|Suicidality Tracking Scale|1|||
129841997|NCT01101841|467387436|FG000|Overall Study|Eligibility Criteria|1|||
129841998|NCT01101841|467387437|FG001|Overall Study|Eligibility Criteria|2|||
129841999|NCT00653224|467387442|FG000|Overall Study|Adverse Event|2|||
129842000|NCT00653224|467387443|FG001|Overall Study|Adverse Event|1|||
129842001|NCT00653224|467387442|FG000|Overall Study|Lack of Efficacy|1|||
129842002|NCT00653224|467387443|FG001|Overall Study|Lack of Efficacy|2|||
129842003|NCT00653224|467387442|FG000|Overall Study|Loss of efficacy|1|||
129842004|NCT00653224|467387443|FG001|Overall Study|Loss of efficacy|0|||
129842005|NCT00653224|467387442|FG000|Overall Study|Lost to Follow-up|1|||
129842006|NCT00653224|467387443|FG001|Overall Study|Lost to Follow-up|0|||
129842007|NCT00653224|467387442|FG000|Overall Study|Other|2|||
129842008|NCT00653224|467387443|FG001|Overall Study|Other|4|||
129842009|NCT03633396|467387448|FG000|Overall Study|Withdrawal by Subject|4|||
129842010|NCT03633396|467387449|FG001|Overall Study|Withdrawal by Subject|4|||
129842011|NCT03633396|467387448|FG000|Overall Study|Adverse Event|1|||
129842012|NCT03633396|467387449|FG001|Overall Study|Adverse Event|1|||
129842013|NCT03633396|467387448|FG000|Overall Study|Lack of Efficacy|1|||
129842014|NCT03633396|467387449|FG001|Overall Study|Lack of Efficacy|0|||
129842015|NCT03633396|467387448|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
129842016|NCT03633396|467387449|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
129842017|NCT01012817|467387450|FG000|Overall Study|Withdrawal by Subject|0|||
129842018|NCT01012817|467387451|FG001|Overall Study|Withdrawal by Subject|0|||
129842019|NCT01012817|467387452|FG002|Overall Study|Withdrawal by Subject|0|||
129842020|NCT01012817|467387453|FG003|Overall Study|Withdrawal by Subject|1|||
129842021|NCT01012817|467387454|FG004|Overall Study|Withdrawal by Subject|0|||
129842022|NCT01012817|467387455|FG005|Overall Study|Withdrawal by Subject|0|||
129842023|NCT01012817|467387456|FG006|Overall Study|Withdrawal by Subject|0|||
129842024|NCT01012817|467387457|FG007|Overall Study|Withdrawal by Subject|1|||
129842025|NCT01012817|467387458|FG008|Overall Study|Withdrawal by Subject|0|||
129842026|NCT01012817|467387459|FG009|Overall Study|Withdrawal by Subject|0|||
129842027|NCT01012817|467387460|FG010|Overall Study|Withdrawal by Subject|1|||
129842028|NCT01012817|467387461|FG011|Overall Study|Withdrawal by Subject|1|||
129842029|NCT01012817|467387462|FG012|Overall Study|Withdrawal by Subject|0|||
129842030|NCT01012817|467387463|FG013|Overall Study|Withdrawal by Subject|1|||
129842031|NCT01012817|467387450|FG000|Overall Study|Adverse Event|0|||
129842032|NCT01012817|467387451|FG001|Overall Study|Adverse Event|0|||
129842033|NCT01012817|467387452|FG002|Overall Study|Adverse Event|0|||
129842034|NCT01012817|467387453|FG003|Overall Study|Adverse Event|0|||
129842035|NCT01012817|467387454|FG004|Overall Study|Adverse Event|0|||
129842036|NCT01012817|467387455|FG005|Overall Study|Adverse Event|1|||
129842037|NCT01012817|467387456|FG006|Overall Study|Adverse Event|0|||
129842038|NCT01012817|467387457|FG007|Overall Study|Adverse Event|0|||
129842039|NCT01012817|467387458|FG008|Overall Study|Adverse Event|0|||
129842040|NCT01012817|467387459|FG009|Overall Study|Adverse Event|0|||
129842041|NCT01012817|467387460|FG010|Overall Study|Adverse Event|1|||
129842042|NCT01012817|467387461|FG011|Overall Study|Adverse Event|0|||
129842043|NCT01012817|467387462|FG012|Overall Study|Adverse Event|0|||
129842044|NCT01012817|467387463|FG013|Overall Study|Adverse Event|1|||
129842045|NCT03756558|467387464|FG000|Overall Study|Death|1|||
129842046|NCT03756558|467387464|FG000|Overall Study|Lost to Follow-up|2|||
129842047|NCT03756558|467387464|FG000|Overall Study|Withdrawal by Subject|2|||
129842048|NCT05308901|467387465|FG000|Overall Study|Death|6|||
129842049|NCT00978731|467387466|FG000|Overall Study|Death|4|||
129842050|NCT00978731|467387467|FG001|Overall Study|Death|1|||
129842051|NCT00978731|467387468|FG002|Overall Study|Death|1|||
129842052|NCT00978731|467387469|FG003|Overall Study|Death|0|||
129842053|NCT00978731|467387466|FG000|Overall Study|Lost to Follow-up|0|||
129842054|NCT00978731|467387467|FG001|Overall Study|Lost to Follow-up|0|||
129842055|NCT00978731|467387468|FG002|Overall Study|Lost to Follow-up|0|||
129842056|NCT00978731|467387469|FG003|Overall Study|Lost to Follow-up|1|||
129842057|NCT00978731|467387466|FG000|Overall Study|Adverse Event|5|||
129842058|NCT00978731|467387467|FG001|Overall Study|Adverse Event|2|||
129842059|NCT00978731|467387468|FG002|Overall Study|Adverse Event|0|||
129842060|NCT00978731|467387469|FG003|Overall Study|Adverse Event|0|||
129842061|NCT00978731|467387466|FG000|Overall Study|Participant's request|1|||
129842062|NCT00978731|467387467|FG001|Overall Study|Participant's request|0|||
129842063|NCT00978731|467387468|FG002|Overall Study|Participant's request|0|||
129842064|NCT00978731|467387469|FG003|Overall Study|Participant's request|0|||
129842065|NCT00978731|467387466|FG000|Overall Study|Administrative reason|3|||
129842066|NCT00978731|467387467|FG001|Overall Study|Administrative reason|3|||
129842067|NCT00978731|467387468|FG002|Overall Study|Administrative reason|1|||
129842068|NCT00978731|467387469|FG003|Overall Study|Administrative reason|0|||
129842069|NCT00978731|467387466|FG000|Overall Study|Deterioration without progression|0|||
129842070|NCT00978731|467387467|FG001|Overall Study|Deterioration without progression|1|||
129842071|NCT00978731|467387468|FG002|Overall Study|Deterioration without progression|0|||
129842072|NCT00978731|467387469|FG003|Overall Study|Deterioration without progression|0|||
129842073|NCT00978731|467387466|FG000|Overall Study|Disease progression/relapse|5|||
129842074|NCT00978731|467387467|FG001|Overall Study|Disease progression/relapse|4|||
129842075|NCT00978731|467387468|FG002|Overall Study|Disease progression/relapse|2|||
129842076|NCT00978731|467387469|FG003|Overall Study|Disease progression/relapse|2|||
129842077|NCT00978731|467387466|FG000|Overall Study|Study closure|3|||
129842078|NCT00978731|467387467|FG001|Overall Study|Study closure|4|||
129842079|NCT00978731|467387468|FG002|Overall Study|Study closure|1|||
129842080|NCT00978731|467387469|FG003|Overall Study|Study closure|1|||
129842081|NCT00978731|467387466|FG000|Overall Study|No response|1|||
129842082|NCT00978731|467387467|FG001|Overall Study|No response|0|||
129842083|NCT00978731|467387468|FG002|Overall Study|No response|0|||
129842084|NCT00978731|467387469|FG003|Overall Study|No response|0|||
129842085|NCT01896895|467387472|FG000|Double-blind MP|Physician Decision|0|||
129842086|NCT01896895|467387473|FG001|Double-blind MP|Physician Decision|0|||
129842087|NCT01896895|467387474|FG002|Double-blind MP|Physician Decision|1|||
129842088|NCT01896895|467387475|FG003|Double-blind MP|Physician Decision|0|||
129842089|NCT01896895|467387472|FG000|Double-blind MP|Withdrawal by Subject|0|||
129842090|NCT01896895|467387473|FG001|Double-blind MP|Withdrawal by Subject|2|||
129842091|NCT01896895|467387474|FG002|Double-blind MP|Withdrawal by Subject|1|||
129842092|NCT01896895|467387475|FG003|Double-blind MP|Withdrawal by Subject|0|||
129842093|NCT01896895|467387472|FG000|Double-blind MP|Lost to Follow-up|1|||
129842094|NCT01896895|467387473|FG001|Double-blind MP|Lost to Follow-up|0|||
129842095|NCT01896895|467387474|FG002|Double-blind MP|Lost to Follow-up|1|||
129842096|NCT01896895|467387475|FG003|Double-blind MP|Lost to Follow-up|0|||
129842097|NCT00293384|467387476|FG000|Overall Study|Non-compliance|2|||
129842098|NCT00293384|467387476|FG000|Overall Study|Missed dosage/study drug|1|||
129842099|NCT00293384|467387476|FG000|Overall Study|Ineligible|2|||
129842100|NCT04482179|467387477|FG000|Overall Study|Death|1|||
129842101|NCT04482179|467387478|FG001|Overall Study|Death|0|||
129842102|NCT04482179|467387477|FG000|Overall Study|Withdrawal by Subject|1|||
129842103|NCT04482179|467387478|FG001|Overall Study|Withdrawal by Subject|0|||
129842104|NCT00145509|467387479|FG000|Overall Study|Adverse Event|10|||
129842105|NCT00145509|467387480|FG001|Overall Study|Adverse Event|3|||
129842106|NCT00145509|467387479|FG000|Overall Study|Lack of Efficacy|3|||
129842107|NCT00145509|467387480|FG001|Overall Study|Lack of Efficacy|1|||
129842108|NCT00145509|467387479|FG000|Overall Study|Lost to Follow-up|5|||
129842109|NCT00145509|467387480|FG001|Overall Study|Lost to Follow-up|9|||
129842110|NCT00145509|467387479|FG000|Overall Study|Withdrew Consent|2|||
129842111|NCT00145509|467387480|FG001|Overall Study|Withdrew Consent|7|||
129842112|NCT00145509|467387479|FG000|Overall Study|Reason not provided|2|||
129842113|NCT00145509|467387480|FG001|Overall Study|Reason not provided|1|||
129842114|NCT00419562|467387481|FG000|Overall Study|Lost to Follow-up|12|||
129842115|NCT00419562|467387482|FG001|Overall Study|Lost to Follow-up|13|||
129842116|NCT00419562|467387481|FG000|Overall Study|Withdrawal by Subject|20|||
129842117|NCT00419562|467387482|FG001|Overall Study|Withdrawal by Subject|18|||
129842118|NCT00419562|467387481|FG000|Overall Study|Participant Institutionalized|1|||
129842119|NCT00419562|467387482|FG001|Overall Study|Participant Institutionalized|0|||
129842120|NCT02789176|467387483|FG000|Overall Study|Death|0|||
129842121|NCT02789176|467387484|FG001|Overall Study|Death|0|||
129842122|NCT02789176|467387485|FG002|Overall Study|Death|3|||
129842123|NCT02789176|467387486|FG003|Overall Study|Death|0|||
129842124|NCT02789176|467387483|FG000|Overall Study|Withdrawal by Subject|0|||
129842125|NCT02789176|467387484|FG001|Overall Study|Withdrawal by Subject|0|||
129842126|NCT02789176|467387485|FG002|Overall Study|Withdrawal by Subject|1|||
129842127|NCT02789176|467387486|FG003|Overall Study|Withdrawal by Subject|0|||
129842128|NCT02789176|467387483|FG000|Overall Study|Lost to Follow-up|8|||
129842129|NCT02789176|467387484|FG001|Overall Study|Lost to Follow-up|2|||
129842130|NCT02789176|467387485|FG002|Overall Study|Lost to Follow-up|6|||
129842131|NCT02789176|467387486|FG003|Overall Study|Lost to Follow-up|1|||
129842132|NCT00640510|467387487|FG000|Overall Study|Lack of Efficacy|0|||
129842133|NCT00640510|467387488|FG001|Overall Study|Lack of Efficacy|1|||
129842134|NCT00640510|467387487|FG000|Overall Study|Protocol Violation|1|||
129842135|NCT00640510|467387488|FG001|Overall Study|Protocol Violation|0|||
129449025|NCT03250832|465943535|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
129842136|NCT00640510|467387487|FG000|Overall Study|Physician Decision|0|||
129842137|NCT00640510|467387488|FG001|Overall Study|Physician Decision|1|||
129842138|NCT00596011|467387489|FG000|Overall Study|Withdrawal by Subject|2|||
129842139|NCT00596011|467387490|FG001|Overall Study|Withdrawal by Subject|3|||
129842140|NCT00596011|467387489|FG000|Overall Study|Adverse Event|11|||
129842141|NCT00596011|467387490|FG001|Overall Study|Adverse Event|7|||
129842142|NCT00192075|467387491|FG000|Overall Study|Disease Progression|23|||
129842143|NCT00192075|467387492|FG001|Overall Study|Disease Progression|6|||
129842144|NCT00192075|467387491|FG000|Overall Study|Adverse Event|1|||
129842145|NCT00192075|467387492|FG001|Overall Study|Adverse Event|3|||
129842146|NCT00192075|467387491|FG000|Overall Study|Death|0|||
129842147|NCT00192075|467387492|FG001|Overall Study|Death|1|||
129842148|NCT00192075|467387491|FG000|Overall Study|Lack of Efficacy|0|||
129842149|NCT00192075|467387492|FG001|Overall Study|Lack of Efficacy|0|||
129842150|NCT00192075|467387491|FG000|Overall Study|Physician Decision|3|||
129842151|NCT00192075|467387492|FG001|Overall Study|Physician Decision|0|||
129842152|NCT00192075|467387491|FG000|Overall Study|Withdrawal by Subject|5|||
129842153|NCT00192075|467387492|FG001|Overall Study|Withdrawal by Subject|5|||
129842154|NCT00192075|467387491|FG000|Overall Study|Patient Non-Compliance|0|||
129842155|NCT00192075|467387492|FG001|Overall Study|Patient Non-Compliance|1|||
129842156|NCT00192075|467387491|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
129842157|NCT00192075|467387492|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
129842158|NCT00192075|467387491|FG000|Overall Study|Other|5|||
129842159|NCT00192075|467387492|FG001|Overall Study|Other|2|||
129842160|NCT03325166|467387493|FG000|Overall Study|Adverse Event|1|||
129842161|NCT01400841|467387495|FG000|Initial Study Phase (6 Months)|Death|1|||
129842162|NCT01400841|467387495|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
129842163|NCT00770120|467387498|FG000|Overall Study|Progression|31|||
129842164|NCT00770120|467387498|FG000|Overall Study|Adverse Event|11|||
129842165|NCT00770120|467387498|FG000|Overall Study|Not Protocol Specified|11|||
129842166|NCT00770120|467387498|FG000|Overall Study|Death|3|||
129842167|NCT00770120|467387498|FG000|Overall Study|Withdrawal by Subject|2|||
129842168|NCT00770120|467387498|FG000|Overall Study|Ineligible|1|||
129842169|NCT00770120|467387498|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
129842170|NCT00770120|467387498|FG000|Overall Study|Reason under Review|1|||
129842171|NCT02583256|467387499|FG000|Overall Study|Withdrawal by Subject|0|||
129842172|NCT02583256|467387500|FG001|Overall Study|Withdrawal by Subject|1|||
129900693|NCT02715258|467597120|FG000|Overall Study|Terminated by Sponsor|0|||
129842173|NCT02583256|467387501|FG002|Overall Study|Withdrawal by Subject|1|||
129842174|NCT02583256|467387502|FG003|Overall Study|Withdrawal by Subject|0|||
129842175|NCT02583256|467387499|FG000|Overall Study|Lost to Follow-up|1|||
129842176|NCT02583256|467387500|FG001|Overall Study|Lost to Follow-up|1|||
129842177|NCT02583256|467387501|FG002|Overall Study|Lost to Follow-up|0|||
129842178|NCT02583256|467387502|FG003|Overall Study|Lost to Follow-up|1|||
129842179|NCT02583256|467387499|FG000|Overall Study|Administrative/Other|2|||
129842180|NCT02583256|467387500|FG001|Overall Study|Administrative/Other|0|||
129449026|NCT03250832|465943524|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129900694|NCT02715258|467597121|FG001|Overall Study|Terminated by Sponsor|1|||
129900695|NCT02715258|467597120|FG000|Overall Study|Death|0|||
129900696|NCT02715258|467597121|FG001|Overall Study|Death|1|||
129900697|NCT02715258|467597120|FG000|Overall Study|Subject non-compliant|1|||
129900698|NCT02715258|467597121|FG001|Overall Study|Subject non-compliant|1|||
129900699|NCT02715258|467597120|FG000|Overall Study|GCP violation|2|||
129900700|NCT02715258|467597121|FG001|Overall Study|GCP violation|1|||
129900701|NCT02814643|467597122|FG000|Overall Study|Lost to Follow-up|0|||
129900702|NCT02814643|467597123|FG001|Overall Study|Lost to Follow-up|1|||
129900703|NCT02814643|467597122|FG000|Overall Study|Withdrawal by Subject|1|||
129900704|NCT02814643|467597123|FG001|Overall Study|Withdrawal by Subject|2|||
129900705|NCT02263508|467597124|FG000|Overall Study|Withdrawal by Subject|1|||
129900706|NCT02263508|467597125|FG001|Overall Study|Withdrawal by Subject|23|||
129900707|NCT02263508|467597126|FG002|Overall Study|Withdrawal by Subject|17|||
129900708|NCT02263508|467597124|FG000|Overall Study|Sponsor Decision|12|||
129900709|NCT02263508|467597125|FG001|Overall Study|Sponsor Decision|165|||
129900710|NCT02263508|467597126|FG002|Overall Study|Sponsor Decision|182|||
129900711|NCT02263508|467597124|FG000|Overall Study|Lost to Follow-up|2|||
129900712|NCT02263508|467597125|FG001|Overall Study|Lost to Follow-up|7|||
129900713|NCT02263508|467597126|FG002|Overall Study|Lost to Follow-up|7|||
129900714|NCT02263508|467597124|FG000|Overall Study|Death|6|||
129900715|NCT02263508|467597125|FG001|Overall Study|Death|151|||
129900716|NCT02263508|467597126|FG002|Overall Study|Death|140|||
129900717|NCT03265210|467597129|FG000|Overall Study|Withdrawal by Subject|7|||
129900718|NCT03265210|467597130|FG001|Overall Study|Withdrawal by Subject|9|||
129900719|NCT03265210|467597129|FG000|Overall Study|Lost to Follow-up|2|||
129900720|NCT03265210|467597130|FG001|Overall Study|Lost to Follow-up|0|||
129900721|NCT03265210|467597129|FG000|Overall Study|Physician Decision|2|||
129900722|NCT03265210|467597130|FG001|Overall Study|Physician Decision|0|||
129900723|NCT03265210|467597129|FG000|Overall Study|Adverse Event|1|||
129900724|NCT03265210|467597130|FG001|Overall Study|Adverse Event|0|||
129900725|NCT00686517|467597131|FG000|Treatment|Serious Adverse Event|1|||
129900726|NCT00686517|467597132|FG001|Treatment|Serious Adverse Event|2|||
129900727|NCT00686517|467597133|FG002|Treatment|Serious Adverse Event|1|||
129900728|NCT00686517|467597131|FG000|Treatment|Adverse Event|2|||
129900729|NCT00686517|467597132|FG001|Treatment|Adverse Event|0|||
129900730|NCT00686517|467597133|FG002|Treatment|Adverse Event|0|||
129900731|NCT00686517|467597131|FG000|Treatment|Poor Protocol Compliance|1|||
129900732|NCT00686517|467597132|FG001|Treatment|Poor Protocol Compliance|0|||
129900733|NCT00686517|467597133|FG002|Treatment|Poor Protocol Compliance|0|||
129900734|NCT00686517|467597131|FG000|Treatment|Protocol Violation|2|||
129900735|NCT00686517|467597132|FG001|Treatment|Protocol Violation|1|||
129900736|NCT00686517|467597133|FG002|Treatment|Protocol Violation|0|||
129900737|NCT02281318|467597134|FG000|Overall Study|Adverse Event|2|||
129900738|NCT02281318|467597135|FG001|Overall Study|Adverse Event|2|||
129900739|NCT02281318|467597134|FG000|Overall Study|Lack of Efficacy|2|||
129900740|NCT02281318|467597135|FG001|Overall Study|Lack of Efficacy|0|||
129900741|NCT02281318|467597134|FG000|Overall Study|Lost to Follow-up|2|||
129900742|NCT02281318|467597135|FG001|Overall Study|Lost to Follow-up|1|||
129900743|NCT02281318|467597134|FG000|Overall Study|Physician Decision|2|||
129900744|NCT02281318|467597135|FG001|Overall Study|Physician Decision|0|||
129900745|NCT02281318|467597134|FG000|Overall Study|Withdrawal by Subject|6|||
129900746|NCT02281318|467597135|FG001|Overall Study|Withdrawal by Subject|2|||
129900747|NCT02614560|467597138|FG000|Overall Study|Death|6|||
129900748|NCT02614560|467597139|FG001|Overall Study|Death|2|||
129900749|NCT00703911|467597142|FG000|Overall Study|Death|1|||
129900750|NCT00703911|467597142|FG000|Overall Study|Physician Decision|6|||
129900751|NCT00703911|467597142|FG000|Overall Study|Lost to Follow-up|1|||
129900752|NCT00703911|467597142|FG000|Overall Study|Withdrawal by Subject|2|||
129900753|NCT05193318|467597145|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
129900754|NCT05193318|467597145|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
129900755|NCT00798096|467597146|FG000|Overall Study|Ongoing|2|||
129900756|NCT01833065|467597147|FG000|Overall Study|Adverse Event|6|||
129900757|NCT01833065|467597148|FG001|Overall Study|Adverse Event|1|||
129900758|NCT01833065|467597149|FG002|Overall Study|Adverse Event|0|||
129900759|NCT01833065|467597150|FG003|Overall Study|Adverse Event|2|||
129900760|NCT01833065|467597151|FG004|Overall Study|Adverse Event|3|||
129900761|NCT01833065|467597147|FG000|Overall Study|Protocol Violation|1|||
129900762|NCT01833065|467597148|FG001|Overall Study|Protocol Violation|0|||
129900763|NCT01833065|467597149|FG002|Overall Study|Protocol Violation|0|||
129900764|NCT01833065|467597150|FG003|Overall Study|Protocol Violation|0|||
129900765|NCT01833065|467597151|FG004|Overall Study|Protocol Violation|2|||
129900766|NCT01833065|467597147|FG000|Overall Study|Lost to Follow-up|1|||
129900767|NCT01833065|467597148|FG001|Overall Study|Lost to Follow-up|0|||
129900768|NCT01833065|467597149|FG002|Overall Study|Lost to Follow-up|0|||
129900769|NCT01833065|467597150|FG003|Overall Study|Lost to Follow-up|0|||
129900770|NCT01833065|467597151|FG004|Overall Study|Lost to Follow-up|3|||
129900771|NCT01833065|467597147|FG000|Overall Study|Withdrawal by Subject|6|||
129900772|NCT01833065|467597148|FG001|Overall Study|Withdrawal by Subject|2|||
129449027|NCT03250832|465943525|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129842181|NCT02583256|467387501|FG002|Overall Study|Administrative/Other|1|||
129842182|NCT02583256|467387502|FG003|Overall Study|Administrative/Other|2|||
129842183|NCT02506816|467387511|FG000|Overall Study|Adverse Event|3|||
129842184|NCT03364049|467387512|FG000|Overall Study|Death|6|||
129842185|NCT03364049|467387513|FG001|Overall Study|Death|4|||
129842186|NCT03364049|467387514|FG002|Overall Study|Death|5|||
129842187|NCT03364049|467387515|FG003|Overall Study|Death|14|||
129842188|NCT03364049|467387512|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
129842189|NCT03364049|467387513|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
129842190|NCT03364049|467387514|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
129842191|NCT03364049|467387515|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
129842192|NCT03364049|467387512|FG000|Overall Study|Withdrawal by Subject|0|||
129842193|NCT03364049|467387513|FG001|Overall Study|Withdrawal by Subject|1|||
129842194|NCT03364049|467387514|FG002|Overall Study|Withdrawal by Subject|1|||
129449028|NCT03250832|465943526|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449029|NCT03250832|465943527|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449030|NCT03250832|465943528|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449031|NCT03250832|465943529|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449032|NCT03250832|465943530|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449033|NCT03250832|465943531|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449034|NCT03250832|465943532|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
129449035|NCT03250832|465943533|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
129449036|NCT03250832|465943534|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449037|NCT03250832|465943535|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
129449038|NCT03250832|465943524|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449039|NCT03250832|465943525|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449040|NCT03250832|465943526|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449041|NCT03250832|465943527|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449042|NCT03250832|465943528|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449043|NCT03250832|465943529|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449044|NCT03250832|465943530|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449045|NCT03250832|465943531|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449046|NCT03250832|465943532|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129842195|NCT03364049|467387515|FG003|Overall Study|Withdrawal by Subject|1|||
129842196|NCT00418691|467387516|FG000|Overall Study|Lost to Follow-up|1|||
129842197|NCT00418691|467387517|FG001|Overall Study|Lost to Follow-up|2|||
129842198|NCT00418691|467387518|FG002|Overall Study|Lost to Follow-up|3|||
129842199|NCT00418691|467387516|FG000|Overall Study|Started new medication voiding entry|0|||
129842200|NCT00418691|467387517|FG001|Overall Study|Started new medication voiding entry|0|||
129842201|NCT00418691|467387518|FG002|Overall Study|Started new medication voiding entry|1|||
129842202|NCT00418691|467387516|FG000|Overall Study|Progressive Disease|1|||
129842203|NCT00418691|467387517|FG001|Overall Study|Progressive Disease|0|||
129842204|NCT00418691|467387518|FG002|Overall Study|Progressive Disease|1|||
129842205|NCT02103478|467387519|FG000|Overall Study|Adverse Event|0|||
129842206|NCT02103478|467387520|FG001|Overall Study|Adverse Event|0|||
129842207|NCT02103478|467387521|FG002|Overall Study|Adverse Event|1|||
129842208|NCT02103478|467387522|FG003|Overall Study|Adverse Event|1|||
129842209|NCT02103478|467387523|FG004|Overall Study|Adverse Event|2|||
129842210|NCT02103478|467387524|FG005|Overall Study|Adverse Event|1|||
129842211|NCT02103478|467387525|FG006|Overall Study|Adverse Event|0|||
129842212|NCT02103478|467387526|FG007|Overall Study|Adverse Event|0|||
129842213|NCT02103478|467387527|FG008|Overall Study|Adverse Event|0|||
129842214|NCT02103478|467387519|FG000|Overall Study|Death|2|||
129842215|NCT02103478|467387520|FG001|Overall Study|Death|2|||
129842216|NCT02103478|467387521|FG002|Overall Study|Death|1|||
129842217|NCT02103478|467387522|FG003|Overall Study|Death|1|||
129842218|NCT02103478|467387523|FG004|Overall Study|Death|5|||
129842219|NCT02103478|467387524|FG005|Overall Study|Death|15|||
129842220|NCT02103478|467387525|FG006|Overall Study|Death|14|||
129842221|NCT02103478|467387526|FG007|Overall Study|Death|10|||
129842222|NCT02103478|467387527|FG008|Overall Study|Death|11|||
129842223|NCT02103478|467387519|FG000|Overall Study|Progressive Disease|2|||
129842224|NCT02103478|467387520|FG001|Overall Study|Progressive Disease|1|||
129842225|NCT02103478|467387521|FG002|Overall Study|Progressive Disease|2|||
129842226|NCT02103478|467387522|FG003|Overall Study|Progressive Disease|0|||
129842227|NCT02103478|467387523|FG004|Overall Study|Progressive Disease|9|||
129842228|NCT02103478|467387524|FG005|Overall Study|Progressive Disease|1|||
129842229|NCT02103478|467387525|FG006|Overall Study|Progressive Disease|2|||
129842230|NCT02103478|467387526|FG007|Overall Study|Progressive Disease|0|||
129842231|NCT02103478|467387527|FG008|Overall Study|Progressive Disease|1|||
129842232|NCT02103478|467387519|FG000|Overall Study|Withdrawal by Subject|2|||
129842233|NCT02103478|467387520|FG001|Overall Study|Withdrawal by Subject|0|||
129842234|NCT02103478|467387521|FG002|Overall Study|Withdrawal by Subject|0|||
129842235|NCT02103478|467387522|FG003|Overall Study|Withdrawal by Subject|4|||
129842236|NCT02103478|467387523|FG004|Overall Study|Withdrawal by Subject|0|||
129842237|NCT02103478|467387524|FG005|Overall Study|Withdrawal by Subject|0|||
129842238|NCT02103478|467387525|FG006|Overall Study|Withdrawal by Subject|1|||
129842239|NCT02103478|467387526|FG007|Overall Study|Withdrawal by Subject|1|||
129842240|NCT02103478|467387527|FG008|Overall Study|Withdrawal by Subject|0|||
129842241|NCT02103478|467387519|FG000|Overall Study|Lost to Follow-up|0|||
129842242|NCT02103478|467387520|FG001|Overall Study|Lost to Follow-up|0|||
129842243|NCT02103478|467387521|FG002|Overall Study|Lost to Follow-up|0|||
129842244|NCT02103478|467387522|FG003|Overall Study|Lost to Follow-up|0|||
129842245|NCT02103478|467387523|FG004|Overall Study|Lost to Follow-up|0|||
129842246|NCT02103478|467387524|FG005|Overall Study|Lost to Follow-up|0|||
129842247|NCT02103478|467387525|FG006|Overall Study|Lost to Follow-up|0|||
129842248|NCT02103478|467387526|FG007|Overall Study|Lost to Follow-up|1|||
129842249|NCT02103478|467387527|FG008|Overall Study|Lost to Follow-up|0|||
129842250|NCT02103478|467387519|FG000|Overall Study|Other|1|||
129842251|NCT02103478|467387520|FG001|Overall Study|Other|3|||
129842252|NCT02103478|467387521|FG002|Overall Study|Other|2|||
129842253|NCT02103478|467387522|FG003|Overall Study|Other|0|||
129842254|NCT02103478|467387523|FG004|Overall Study|Other|3|||
129842255|NCT02103478|467387524|FG005|Overall Study|Other|8|||
129842256|NCT02103478|467387525|FG006|Overall Study|Other|8|||
129842257|NCT02103478|467387526|FG007|Overall Study|Other|4|||
129842258|NCT02103478|467387527|FG008|Overall Study|Other|2|||
129842259|NCT04182100|467387528|FG000|Overall Study|Adverse Event|1|||
129842260|NCT04182100|467387528|FG000|Overall Study|Withdrawal by Subject|1|||
129842261|NCT04988295|467387529|FG000|Overall Study|Withdrawal by Subject|9|||
129842262|NCT04988295|467387530|FG001|Overall Study|Withdrawal by Subject|29|||
129842263|NCT04988295|467387531|FG002|Overall Study|Withdrawal by Subject|6|||
129842264|NCT04988295|467387532|FG003|Overall Study|Withdrawal by Subject|0|||
129842265|NCT04988295|467387529|FG000|Overall Study|Lost to Follow-up|1|||
129842266|NCT04988295|467387530|FG001|Overall Study|Lost to Follow-up|0|||
129842267|NCT04988295|467387531|FG002|Overall Study|Lost to Follow-up|0|||
129842268|NCT04988295|467387532|FG003|Overall Study|Lost to Follow-up|0|||
129842269|NCT04988295|467387529|FG000|Overall Study|Study participation ongoing|186|||
129842270|NCT04988295|467387530|FG001|Overall Study|Study participation ongoing|169|||
129842271|NCT04988295|467387531|FG002|Overall Study|Study participation ongoing|99|||
129842272|NCT04988295|467387532|FG003|Overall Study|Study participation ongoing|119|||
129842273|NCT00433654|467387533|FG000|Overall Study|Death|4|||
129842274|NCT00433654|467387534|FG001|Overall Study|Death|0|||
129842275|NCT00433654|467387533|FG000|Overall Study|Missed visit|6|||
129842276|NCT00433654|467387534|FG001|Overall Study|Missed visit|3|||
129842277|NCT00433654|467387533|FG000|Overall Study|Subject not yet due for visit|4|||
129842278|NCT00433654|467387534|FG001|Overall Study|Subject not yet due for visit|0|||
129842279|NCT00433654|467387533|FG000|Overall Study|Withdrawal by Subject|1|||
129842280|NCT00433654|467387534|FG001|Overall Study|Withdrawal by Subject|2|||
129842281|NCT03762083|467387535|FG000|Overall Study|Withdrawal by Subject|2|||
129842282|NCT03762083|467387535|FG000|Overall Study|Physician Decision|1|||
129842283|NCT04108208|467387536|FG000|Overall Study|Withdrawal by Subject|2|||
129842284|NCT04108208|467387537|FG001|Overall Study|Withdrawal by Subject|6|||
129842285|NCT04108208|467387536|FG000|Overall Study|other-ongoing|20|||
129842286|NCT04108208|467387537|FG001|Overall Study|other-ongoing|40|||
129842287|NCT04108208|467387536|FG000|Overall Study|Death|1|||
129842288|NCT04108208|467387537|FG001|Overall Study|Death|4|||
129842289|NCT04108208|467387536|FG000|Overall Study|Lost to Follow-up|2|||
129842290|NCT04108208|467387537|FG001|Overall Study|Lost to Follow-up|0|||
129842291|NCT02948842|467387539|FG000|Overall Study|Withdrawal by Subject|4|||
129842292|NCT02350309|467387541|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
129900773|NCT01833065|467597149|FG002|Overall Study|Withdrawal by Subject|4|||
129900774|NCT01833065|467597150|FG003|Overall Study|Withdrawal by Subject|3|||
129900775|NCT01833065|467597151|FG004|Overall Study|Withdrawal by Subject|11|||
129900776|NCT01833065|467597147|FG000|Overall Study|Subject's substantial non-compliance|0|||
129900777|NCT01833065|467597148|FG001|Overall Study|Subject's substantial non-compliance|1|||
129842293|NCT02350309|467387542|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842294|NCT02350309|467387543|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
129842295|NCT02350309|467387544|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842296|NCT02350309|467387545|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842297|NCT02350309|467387546|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
129842298|NCT02350309|467387541|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842299|NCT02350309|467387542|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842300|NCT02350309|467387543|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842301|NCT02350309|467387544|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842302|NCT02350309|467387545|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
129842303|NCT02350309|467387546|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
129449047|NCT03250832|465943533|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449048|NCT03250832|465943534|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
129449049|NCT03250832|465943535|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
129449050|NCT02303704|465943536|FG000|Overall Study|Protocol Violation|5|||
129449051|NCT02303704|465943537|FG001|Overall Study|Protocol Violation|9|||
129449052|NCT00397033|465943542|FG000|Overall Study|Adverse Event|7|||
129449053|NCT00397033|465943543|FG001|Overall Study|Adverse Event|10|||
129449054|NCT00397033|465943544|FG002|Overall Study|Adverse Event|4|||
129449055|NCT00397033|465943542|FG000|Overall Study|Lack of Efficacy|22|||
129449056|NCT00397033|465943543|FG001|Overall Study|Lack of Efficacy|12|||
129449057|NCT00397033|465943544|FG002|Overall Study|Lack of Efficacy|9|||
129449058|NCT00397033|465943542|FG000|Overall Study|Lost to Follow-up|3|||
129449059|NCT00397033|465943543|FG001|Overall Study|Lost to Follow-up|3|||
129449060|NCT00397033|465943544|FG002|Overall Study|Lost to Follow-up|3|||
129449061|NCT00397033|465943542|FG000|Overall Study|Withdrawal by Subject|12|||
129449062|NCT00397033|465943543|FG001|Overall Study|Withdrawal by Subject|7|||
129449063|NCT00397033|465943544|FG002|Overall Study|Withdrawal by Subject|5|||
129449064|NCT00397033|465943542|FG000|Overall Study|Other|0|||
129449065|NCT00397033|465943543|FG001|Overall Study|Other|5|||
129449066|NCT00397033|465943544|FG002|Overall Study|Other|2|||
129449067|NCT01984164|465943545|FG000|Overall Study|Withdrawal by Subject|4|||
129449068|NCT01984164|465943546|FG001|Overall Study|Withdrawal by Subject|3|||
129449069|NCT01984164|465943545|FG000|Overall Study|Adverse Event|5|||
129449070|NCT01984164|465943546|FG001|Overall Study|Adverse Event|19|||
129449071|NCT01984164|465943545|FG000|Overall Study|Lost to Follow-up|1|||
129449072|NCT01984164|465943546|FG001|Overall Study|Lost to Follow-up|3|||
129449073|NCT05293743|465943547|FG000|Overall Study|Withdrawal by Subject|1|||
129449074|NCT05293743|465943548|FG001|Overall Study|Withdrawal by Subject|0|||
129449075|NCT00667823|465943549|FG000|Overall Study|Lost to Follow-up|5|||
129449076|NCT00667823|465943549|FG000|Overall Study|Adverse Event|7|||
129449077|NCT00667823|465943549|FG000|Overall Study|Death|182|||
129449078|NCT00667823|465943549|FG000|Overall Study|Withdrawal by Subject|12|||
129449079|NCT00667823|465943549|FG000|Overall Study|Other|8|||
129449080|NCT00667823|465943549|FG000|Overall Study|Missing (completion page missing)|2|||
129449081|NCT00583024|465943550|FG000|Overall Study|Lost to Follow-up|4|||
129449082|NCT00682448|465945530|FG000|Overall Study|Adverse Event|1|||
129449083|NCT00682448|465945531|FG001|Overall Study|Adverse Event|2|||
129449084|NCT00682448|465945530|FG000|Overall Study|Lack of Efficacy|1|||
129449085|NCT00682448|465945531|FG001|Overall Study|Lack of Efficacy|0|||
129449086|NCT00682448|465945530|FG000|Overall Study|Lost to Follow-up|1|||
129449087|NCT00682448|465945531|FG001|Overall Study|Lost to Follow-up|3|||
129449088|NCT00682448|465945530|FG000|Overall Study|Pregnancy|0|||
129449089|NCT00682448|465945531|FG001|Overall Study|Pregnancy|1|||
129449090|NCT00682448|465945530|FG000|Overall Study|Withdrawal by Subject|2|||
129449091|NCT00682448|465945531|FG001|Overall Study|Withdrawal by Subject|0|||
129449092|NCT00257166|465945535|FG000|Overall Study|Adverse Event|18|||
129449093|NCT00257166|465945536|FG001|Overall Study|Adverse Event|13|||
129449094|NCT00257166|465945535|FG000|Overall Study|Laboratory abnormality|1|||
129449095|NCT00257166|465945536|FG001|Overall Study|Laboratory abnormality|0|||
129449096|NCT00257166|465945535|FG000|Overall Study|Lost to Follow-up|8|||
129449097|NCT00257166|465945536|FG001|Overall Study|Lost to Follow-up|1|||
129449098|NCT00257166|465945535|FG000|Overall Study|Withdrawal by Subject|9|||
129449099|NCT00257166|465945536|FG001|Overall Study|Withdrawal by Subject|2|||
129449100|NCT00257166|465945535|FG000|Overall Study|Other|16|||
129449101|NCT00257166|465945536|FG001|Overall Study|Other|21|||
129449102|NCT00257166|465945535|FG000|Overall Study|Randomized, but not treated|1|||
129449103|NCT00257166|465945536|FG001|Overall Study|Randomized, but not treated|0|||
129842304|NCT01256710|467387547|FG000|Overall Study|Death|449|||
129842305|NCT01256710|467387547|FG000|Overall Study|System Explant|67|||
129842306|NCT01256710|467387547|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
129842307|NCT01256710|467387547|FG000|Overall Study|Lost to Follow-up|67|||
129842308|NCT01256710|467387547|FG000|Overall Study|Withdrawal by Subject|29|||
129842309|NCT01256710|467387547|FG000|Overall Study|Physician Decision|9|||
129842310|NCT01256710|467387547|FG000|Overall Study|Subject Noncompliance|2|||
129449104|NCT02737852|465945539|FG000|Overall Study|Withdrawal by Subject|2|||
129449105|NCT04050670|465945542|FG000|Period 3|Physician Decision|0|||
129449106|NCT04050670|465945543|FG001|Period 3|Physician Decision|1|||
129449107|NCT04050670|465945544|FG002|Period 3|Physician Decision|0|||
129449108|NCT00525044|465945551|FG000|Overall Study|Lost to Follow-up|0|||
129449109|NCT00525044|465945552|FG001|Overall Study|Lost to Follow-up|1|||
129449110|NCT02553265|465945554|FG000|Enrollment|Death|0|||
129449111|NCT02553265|465945555|FG001|Enrollment|Death|0|||
129449112|NCT02553265|465945556|FG002|Enrollment|Death|1|||
129449113|NCT02553265|465945554|FG000|First Intervention (28 Days)|Adverse Event|1|||
129449114|NCT02553265|465945555|FG001|First Intervention (28 Days)|Adverse Event|0|||
129449115|NCT02553265|465945556|FG002|First Intervention (28 Days)|Adverse Event|0|||
129449116|NCT02553265|465945554|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
129449117|NCT02553265|465945555|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
129842311|NCT01256710|467387547|FG000|Overall Study|Study Terminated by Sponsor|273|||
129842312|NCT00058825|467387548|FG000|Overall Study|Relapse|9|||
129842313|NCT00058825|467387548|FG000|Overall Study|Progressive Disease|5|||
129842314|NCT00058825|467387548|FG000|Overall Study|Graft Failure|5|||
129842315|NCT00058825|467387548|FG000|Overall Study|Death|3|||
129842316|NCT01205165|467387549|FG000|Overall Study|Lost to Follow-up|2|||
129842317|NCT02942017|467387550|FG000|Overall Study|Adverse Event|0|||
129842318|NCT02942017|467387551|FG001|Overall Study|Adverse Event|1|||
129842319|NCT02942017|467387550|FG000|Overall Study|Withdrawal by Subject|0|||
129842320|NCT02942017|467387551|FG001|Overall Study|Withdrawal by Subject|1|||
129842321|NCT02942017|467387550|FG000|Overall Study|Lost to Follow-up|1|||
129842322|NCT02942017|467387551|FG001|Overall Study|Lost to Follow-up|1|||
129842323|NCT02942017|467387550|FG000|Overall Study|Randomized but not dosed|1|||
129842324|NCT02942017|467387551|FG001|Overall Study|Randomized but not dosed|3|||
129842325|NCT04399161|467387552|FG000|Overall Study|Withdrawal by Subject|1|||
129842326|NCT04399161|467387553|FG001|Overall Study|Withdrawal by Subject|0|||
129842327|NCT04399161|467387554|FG002|Overall Study|Withdrawal by Subject|2|||
129842328|NCT04399161|467387552|FG000|Overall Study|Protocol Violation|1|||
129842329|NCT04399161|467387553|FG001|Overall Study|Protocol Violation|2|||
129842330|NCT04399161|467387554|FG002|Overall Study|Protocol Violation|0|||
129842331|NCT01736696|467387557|FG000|Overall Study|Withdrawal by Subject|0|||
129842332|NCT01736696|467387558|FG001|Overall Study|Withdrawal by Subject|0|||
129842333|NCT01736696|467387559|FG002|Overall Study|Withdrawal by Subject|1|||
129842334|NCT01736696|467387560|FG003|Overall Study|Withdrawal by Subject|0|||
129842335|NCT01736696|467387561|FG004|Overall Study|Withdrawal by Subject|0|||
129842336|NCT01736696|467387562|FG005|Overall Study|Withdrawal by Subject|0|||
129842337|NCT01736696|467387563|FG006|Overall Study|Withdrawal by Subject|0|||
129842338|NCT00838565|467387564|FG000|Overall Study|Withdrawal by Subject|0|||
129842339|NCT00838565|467387565|FG001|Overall Study|Withdrawal by Subject|0|||
129842340|NCT00838565|467387566|FG002|Overall Study|Withdrawal by Subject|1|||
129842341|NCT00838565|467387567|FG003|Overall Study|Withdrawal by Subject|0|||
129842342|NCT00838565|467387568|FG004|Overall Study|Withdrawal by Subject|0|||
129842343|NCT00838565|467387569|FG005|Overall Study|Withdrawal by Subject|2|||
129842344|NCT00838565|467387564|FG000|Overall Study|Other|0|||
129842345|NCT00838565|467387565|FG001|Overall Study|Other|2|||
129842346|NCT00838565|467387566|FG002|Overall Study|Other|0|||
129842347|NCT00838565|467387567|FG003|Overall Study|Other|0|||
129842348|NCT00838565|467387568|FG004|Overall Study|Other|0|||
129842349|NCT00838565|467387569|FG005|Overall Study|Other|0|||
129842350|NCT00838565|467387564|FG000|Overall Study|Randomized but not Treated|0|||
129842351|NCT00838565|467387565|FG001|Overall Study|Randomized but not Treated|1|||
129842352|NCT00838565|467387566|FG002|Overall Study|Randomized but not Treated|0|||
129842353|NCT00838565|467387567|FG003|Overall Study|Randomized but not Treated|0|||
129842354|NCT00838565|467387568|FG004|Overall Study|Randomized but not Treated|0|||
129842355|NCT00838565|467387569|FG005|Overall Study|Randomized but not Treated|0|||
129842356|NCT02114879|467387570|FG000|Overall Study|Withdrawal by Subject|9|||
129842357|NCT02114879|467387571|FG001|Overall Study|Withdrawal by Subject|5|||
129842358|NCT02114879|467387570|FG000|Overall Study|Death|6|||
129842359|NCT02114879|467387571|FG001|Overall Study|Death|11|||
129842360|NCT02114879|467387570|FG000|Overall Study|Lost to Follow-up|4|||
129842361|NCT02114879|467387571|FG001|Overall Study|Lost to Follow-up|6|||
129842362|NCT02114879|467387570|FG000|Overall Study|Physician Decision|0|||
129842363|NCT02114879|467387571|FG001|Overall Study|Physician Decision|2|||
129842364|NCT00458484|467387572|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
129842365|NCT00458484|467387573|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
129842366|NCT00458484|467387574|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
129842367|NCT00458484|467387575|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
129842368|NCT00458484|467387576|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
129842369|NCT00458484|467387577|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
129842370|NCT00458484|467387578|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
129842371|NCT05059600|467387579|FG000|Overall Study|Enrolled but not Treated|10|||
129842372|NCT04538664|467387580|FG000|Overall Study|Withdrawal by Subject|5|||
129842373|NCT04538664|467387581|FG001|Overall Study|Withdrawal by Subject|9|||
129842374|NCT04538664|467387580|FG000|Overall Study|Lost to Follow-up|2|||
129842375|NCT04538664|467387581|FG001|Overall Study|Lost to Follow-up|1|||
129842376|NCT04538664|467387580|FG000|Overall Study|Ongoing|106|||
129842377|NCT04538664|467387581|FG001|Overall Study|Ongoing|115|||
129842378|NCT04552587|467387582|FG000|Overall Study|Lost to Follow-up|4|||
129842379|NCT03400033|467387585|FG000|Overall Study|Withdrawal by Subject|1|||
129842380|NCT03400033|467387586|FG001|Overall Study|Withdrawal by Subject|2|||
129842381|NCT02741115|467387592|FG000|Overall Study|Adverse Event|1|||
129842382|NCT02741115|467387593|FG001|Overall Study|Adverse Event|0|||
129842383|NCT02741115|467387592|FG000|Overall Study|Lost to Follow-up|7|||
129842384|NCT02741115|467387593|FG001|Overall Study|Lost to Follow-up|4|||
129842385|NCT02741115|467387592|FG000|Overall Study|Withdrawal by Subject|4|||
129842386|NCT02741115|467387593|FG001|Overall Study|Withdrawal by Subject|2|||
129842387|NCT06425458|467387594|FG000|Overall Study|Removed by study team|2|||
129842388|NCT06425458|467387594|FG000|Overall Study|Lost to Follow-up|5|||
129842389|NCT00445328|467387595|FG000|Overall Study|Death|0|||
129842390|NCT00445328|467387596|FG001|Overall Study|Death|1|||
129842391|NCT00445328|467387595|FG000|Overall Study|Adverse Event|0|||
129842392|NCT00445328|467387596|FG001|Overall Study|Adverse Event|3|||
129842393|NCT00445328|467387595|FG000|Overall Study|Other|0|||
129842394|NCT00445328|467387596|FG001|Overall Study|Other|2|||
129842395|NCT00445328|467387595|FG000|Overall Study|Withdrawal by Subject|2|||
129842396|NCT00445328|467387596|FG001|Overall Study|Withdrawal by Subject|0|||
129842397|NCT00445328|467387595|FG000|Overall Study|Protocol Violation|1|||
129842398|NCT00445328|467387596|FG001|Overall Study|Protocol Violation|0|||
129842399|NCT02782949|467387600|FG000|Overall Study|Protocol Violation|1|||
129842400|NCT02782949|467387601|FG001|Overall Study|Protocol Violation|0|||
129842401|NCT02782949|467387600|FG000|Overall Study|Withdrawal by Subject|0|||
129842402|NCT02782949|467387601|FG001|Overall Study|Withdrawal by Subject|1|||
129842403|NCT01433263|467388724|FG000|Overall Study|Adverse Event|3|||
129842404|NCT01433263|467388725|FG001|Overall Study|Adverse Event|1|||
129842405|NCT01433263|467388724|FG000|Overall Study|Death|5|||
129842406|NCT01433263|467388725|FG001|Overall Study|Death|3|||
129842407|NCT01433263|467388724|FG000|Overall Study|Lost to Follow-up|0|||
129842408|NCT01433263|467388725|FG001|Overall Study|Lost to Follow-up|1|||
129842409|NCT01433263|467388724|FG000|Overall Study|Protocol Deviation|1|||
129842410|NCT01433263|467388725|FG001|Overall Study|Protocol Deviation|0|||
129842411|NCT01433263|467388724|FG000|Overall Study|Withdrawal by Subject|10|||
129842412|NCT01433263|467388725|FG001|Overall Study|Withdrawal by Subject|7|||
129842413|NCT04709237|467388726|FG000|Overall Study|Lost to Follow-up|1|||
129842414|NCT04709237|467388727|FG001|Overall Study|Lost to Follow-up|0|||
129842415|NCT04709237|467388728|FG002|Overall Study|Lost to Follow-up|0|||
129842416|NCT01302964|467388730|FG000|Overall Study|Adverse Event|1|||
129842417|NCT01302964|467388731|FG001|Overall Study|Adverse Event|0|||
129842418|NCT02489318|467388732|FG000|Randomized|Withdrawal by Subject|0|||
129842419|NCT02489318|467388733|FG001|Randomized|Withdrawal by Subject|1|||
129842420|NCT02489318|467388732|FG000|Treated|Adverse Event|19|||
129842421|NCT02489318|467388733|FG001|Treated|Adverse Event|62|||
129842422|NCT02489318|467388732|FG000|Treated|Death|13|||
129842423|NCT02489318|467388733|FG001|Treated|Death|11|||
129842424|NCT02489318|467388732|FG000|Treated|Physician Decision|4|||
129842425|NCT02489318|467388733|FG001|Treated|Physician Decision|6|||
129842426|NCT02489318|467388732|FG000|Treated|Protocol Violation|1|||
129842427|NCT02489318|467388733|FG001|Treated|Protocol Violation|2|||
129842428|NCT02489318|467388732|FG000|Treated|Withdrawal by Subject|37|||
129842429|NCT02489318|467388733|FG001|Treated|Withdrawal by Subject|36|||
129842430|NCT02489318|467388732|FG000|Treated|Other: Progressive Disease|245|||
129842431|NCT02489318|467388733|FG001|Treated|Other: Progressive Disease|138|||
129842432|NCT02489318|467388732|FG000|Treated|Other|0|||
129842433|NCT02489318|467388733|FG001|Treated|Other|2|||
129842434|NCT02489318|467388732|FG000|Treated|Ongoing|0|||
129842435|NCT02489318|467388733|FG001|Treated|Ongoing|267|||
129842436|NCT05723770|467388734|FG000|Overall Study|Lost to Follow-up|4|||
129842437|NCT05723770|467388734|FG000|Overall Study|Withdrawal by Subject|2|||
129842438|NCT01171898|467388735|FG000|Overall Study|Death|0|||
129842439|NCT01171898|467388736|FG001|Overall Study|Death|0|||
129842440|NCT01171898|467388737|FG002|Overall Study|Death|2|||
129842441|NCT01171898|467388738|FG003|Overall Study|Death|0|||
129842442|NCT01171898|467388735|FG000|Overall Study|Lost to Follow-up|0|||
129842443|NCT01171898|467388736|FG001|Overall Study|Lost to Follow-up|1|||
129842444|NCT01171898|467388737|FG002|Overall Study|Lost to Follow-up|1|||
129842445|NCT01171898|467388738|FG003|Overall Study|Lost to Follow-up|1|||
129842446|NCT01171898|467388735|FG000|Overall Study|Withdrawal by Subject|1|||
129842447|NCT01171898|467388736|FG001|Overall Study|Withdrawal by Subject|4|||
129842448|NCT01171898|467388737|FG002|Overall Study|Withdrawal by Subject|6|||
129842449|NCT01171898|467388738|FG003|Overall Study|Withdrawal by Subject|3|||
129842450|NCT01171898|467388735|FG000|Overall Study|Terminated by Sponsor|1|||
129842451|NCT01171898|467388736|FG001|Overall Study|Terminated by Sponsor|0|||
129842452|NCT01171898|467388737|FG002|Overall Study|Terminated by Sponsor|0|||
129842453|NCT01171898|467388738|FG003|Overall Study|Terminated by Sponsor|0|||
129842454|NCT01171898|467388735|FG000|Overall Study|Ongoing|1|||
129842455|NCT01171898|467388736|FG001|Overall Study|Ongoing|9|||
129842456|NCT01171898|467388737|FG002|Overall Study|Ongoing|3|||
129842457|NCT01171898|467388738|FG003|Overall Study|Ongoing|0|||
129842458|NCT01171898|467388735|FG000|Overall Study|Other|1|||
129842459|NCT01171898|467388736|FG001|Overall Study|Other|5|||
129842460|NCT01171898|467388737|FG002|Overall Study|Other|0|||
129842461|NCT01171898|467388738|FG003|Overall Study|Other|2|||
129842462|NCT01359592|467388742|FG000|Initial Registration|Adverse Event|1|||
129842463|NCT01359592|467388743|FG001|Initial Registration|Adverse Event|0|||
129842464|NCT01359592|467388744|FG002|Initial Registration|Adverse Event|0|||
129842465|NCT01359592|467388745|FG003|Initial Registration|Adverse Event|0|||
129842466|NCT01359592|467388742|FG000|Initial Registration|Death|1|||
129842467|NCT01359592|467388743|FG001|Initial Registration|Death|0|||
129842468|NCT01359592|467388744|FG002|Initial Registration|Death|0|||
129842469|NCT01359592|467388745|FG003|Initial Registration|Death|0|||
129842470|NCT01359592|467388742|FG000|Initial Registration|Other reason not protocol specified|1|||
129900778|NCT01833065|467597149|FG002|Overall Study|Subject's substantial non-compliance|0|||
129900779|NCT01833065|467597150|FG003|Overall Study|Subject's substantial non-compliance|0|||
129900780|NCT01833065|467597151|FG004|Overall Study|Subject's substantial non-compliance|0|||
129900781|NCT01833065|467597147|FG000|Overall Study|Trial terminated by sponsor|8|||
129900782|NCT01833065|467597148|FG001|Overall Study|Trial terminated by sponsor|8|||
129900783|NCT01833065|467597149|FG002|Overall Study|Trial terminated by sponsor|7|||
129900784|NCT01833065|467597150|FG003|Overall Study|Trial terminated by sponsor|3|||
129900785|NCT01833065|467597151|FG004|Overall Study|Trial terminated by sponsor|13|||
129900786|NCT01833065|467597147|FG000|Overall Study|Others|2|||
129900787|NCT01833065|467597148|FG001|Overall Study|Others|1|||
129900788|NCT01833065|467597149|FG002|Overall Study|Others|1|||
129900789|NCT01833065|467597150|FG003|Overall Study|Others|1|||
129900790|NCT01833065|467597151|FG004|Overall Study|Others|4|||
129900791|NCT03201809|467597155|FG000|Overall Study|Lost to Follow-up|2|||
129900792|NCT03201809|467597156|FG001|Overall Study|Lost to Follow-up|0|||
129900793|NCT00246012|467597158|FG000|Overall Study|Adverse Event|0|||
129900794|NCT00246012|467597159|FG001|Overall Study|Adverse Event|0|||
129842471|NCT01359592|467388743|FG001|Initial Registration|Other reason not protocol specified|0|||
129842472|NCT01359592|467388744|FG002|Initial Registration|Other reason not protocol specified|0|||
129842473|NCT01359592|467388745|FG003|Initial Registration|Other reason not protocol specified|0|||
129842474|NCT01359592|467388742|FG000|Initial Registration|Ineligible|26|||
129842475|NCT01359592|467388743|FG001|Initial Registration|Ineligible|0|||
129842476|NCT01359592|467388744|FG002|Initial Registration|Ineligible|0|||
129842477|NCT01359592|467388745|FG003|Initial Registration|Ineligible|0|||
129842478|NCT01359592|467388742|FG000|PET-Directed Therapy|Adverse Event|0|||
129842479|NCT01359592|467388743|FG001|PET-Directed Therapy|Adverse Event|0|||
129842480|NCT01359592|467388744|FG002|PET-Directed Therapy|Adverse Event|1|||
129842481|NCT01359592|467388745|FG003|PET-Directed Therapy|Adverse Event|0|||
129842482|NCT01359592|467388742|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129842483|NCT01359592|467388743|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129842484|NCT01359592|467388744|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
129842485|NCT01359592|467388745|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
129842486|NCT01359592|467388742|FG000|PET-Directed Therapy|Ineligible|0|||
129842487|NCT01359592|467388743|FG001|PET-Directed Therapy|Ineligible|0|||
129842488|NCT01359592|467388744|FG002|PET-Directed Therapy|Ineligible|24|||
129842489|NCT01359592|467388745|FG003|PET-Directed Therapy|Ineligible|0|||
129842490|NCT00779675|467388755|FG000|Treatment Period|Adverse Event|87|||
129842491|NCT00779675|467388755|FG000|Treatment Period|Treatment Failure|80|||
129842492|NCT00779675|467388755|FG000|Treatment Period|Transferred to Another Study|38|||
129842493|NCT00779675|467388755|FG000|Treatment Period|Lost to Follow-up|23|||
129842494|NCT00779675|467388755|FG000|Treatment Period|Withdrawal by Subject|46|||
129842495|NCT00779675|467388755|FG000|Treatment Period|Protocol Violation|54|||
129842496|NCT00779675|467388755|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
129842497|NCT00779675|467388755|FG000|Treatment Period|Administrative|3|||
129842498|NCT00779675|467388755|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
129842499|NCT00779675|467388755|FG000|Extended Treatment Period|Protocol Violation|13|||
129842500|NCT00779675|467388755|FG000|Extended Treatment Period|Adverse Event|6|||
129842501|NCT00779675|467388755|FG000|Extended Treatment Period|Treatment Failure|11|||
129842502|NCT00779675|467388755|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
129842503|NCT00779675|467388755|FG000|Extended Treatment Period|Lost to Follow-up|6|||
129842504|NCT00749775|467388758|FG000|Overall Study|Protocol Violation|24|||
129842505|NCT00749775|467388758|FG000|Overall Study|Lost to Follow-up|36|||
129842506|NCT00749775|467388758|FG000|Overall Study|No visit after first day of treatment|44|||
129842507|NCT00749775|467388758|FG000|Overall Study|No drug administration|3|||
129842508|NCT04300296|467388759|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
129842509|NCT04300296|467388760|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842510|NCT04300296|467388761|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842511|NCT04300296|467388762|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842512|NCT04300296|467388763|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842513|NCT04300296|467388764|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
129842514|NCT04300296|467388759|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842515|NCT04300296|467388760|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842516|NCT04300296|467388761|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842517|NCT04300296|467388762|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129842518|NCT04300296|467388763|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
129842519|NCT04300296|467388764|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
129900795|NCT00246012|467597160|FG002|Overall Study|Adverse Event|0|||
129900796|NCT00246012|467597161|FG003|Overall Study|Adverse Event|0|||
129900797|NCT00246012|467597162|FG004|Overall Study|Adverse Event|0|||
129900798|NCT00246012|467597163|FG005|Overall Study|Adverse Event|1|||
129900799|NCT00246012|467597164|FG006|Overall Study|Adverse Event|0|||
129900800|NCT00246012|467597165|FG007|Overall Study|Adverse Event|0|||
129900801|NCT00246012|467597166|FG008|Overall Study|Adverse Event|2|||
129842520|NCT04300296|467388759|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
129842521|NCT04300296|467388760|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
129842522|NCT04300296|467388761|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129842523|NCT04300296|467388762|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129842524|NCT04300296|467388763|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
129842525|NCT04300296|467388764|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
129842526|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
129842527|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129842528|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
129842529|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129842530|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
129842531|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
129842532|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
129842533|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129842534|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
129842535|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129842536|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
129842537|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
129842538|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842539|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
129842540|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842541|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842542|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842543|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
129842544|NCT04300296|467388759|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
129842545|NCT04300296|467388760|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
129842546|NCT04300296|467388761|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
129842547|NCT04300296|467388762|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
129842548|NCT04300296|467388763|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
129842549|NCT04300296|467388764|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
129842550|NCT01633944|467388765|FG000|Open-label Titration Phase|Adverse Event|109|||
129842551|NCT01633944|467388766|FG001|Open-label Titration Phase|Adverse Event|0|||
129842552|NCT01633944|467388767|FG002|Open-label Titration Phase|Adverse Event|0|||
129842553|NCT01633944|467388765|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
129842554|NCT01633944|467388766|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
129842555|NCT01633944|467388767|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
129842556|NCT01633944|467388765|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
129842557|NCT01633944|467388766|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
129842558|NCT01633944|467388767|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
129842559|NCT01633944|467388765|FG000|Open-label Titration Phase|Protocol Violation|24|||
129842560|NCT01633944|467388766|FG001|Open-label Titration Phase|Protocol Violation|0|||
129842561|NCT01633944|467388767|FG002|Open-label Titration Phase|Protocol Violation|0|||
129842562|NCT01633944|467388765|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
129842563|NCT01633944|467388766|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
129842564|NCT01633944|467388767|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
129842565|NCT01633944|467388765|FG000|Open-label Titration Phase|Other|68|||
129842566|NCT01633944|467388766|FG001|Open-label Titration Phase|Other|0|||
129842567|NCT01633944|467388767|FG002|Open-label Titration Phase|Other|0|||
129842568|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Adverse Event|0|||
129842569|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Adverse Event|13|||
129842570|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Adverse Event|7|||
129842571|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
129842572|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
129842573|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
129842574|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
129842575|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
129842576|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
129842577|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
129842578|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
129842579|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
129842580|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129842581|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
129842582|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
129842583|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
129842584|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
129842585|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
129900802|NCT00246012|467597158|FG000|Overall Study|Withdrawal by Subject|0|||
129449118|NCT02553265|465945556|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
129900803|NCT00246012|467597159|FG001|Overall Study|Withdrawal by Subject|0|||
129449119|NCT02553265|465945554|FG000|Second Intervention (28 Days)|Adverse Event|1|||
129449120|NCT02553265|465945555|FG001|Second Intervention (28 Days)|Adverse Event|0|||
129449121|NCT02553265|465945556|FG002|Second Intervention (28 Days)|Adverse Event|0|||
129449122|NCT02553265|465945554|FG000|Third Intervention (28 Days)|Adverse Event|1|||
129449123|NCT02553265|465945555|FG001|Third Intervention (28 Days)|Adverse Event|0|||
129449124|NCT02553265|465945556|FG002|Third Intervention (28 Days)|Adverse Event|0|||
129449125|NCT02553265|465945554|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
129449126|NCT02553265|465945555|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
129449127|NCT02553265|465945556|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
129449128|NCT04042740|465945559|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
129449129|NCT04042740|465945559|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
129449130|NCT01168973|465945560|FG000|Overall Study|Progressive Disease|341|||
129449131|NCT01168973|465945561|FG001|Overall Study|Progressive Disease|429|||
129449132|NCT01168973|465945560|FG000|Overall Study|Adverse Event|94|||
129900804|NCT00246012|467597160|FG002|Overall Study|Withdrawal by Subject|0|||
129900805|NCT00246012|467597161|FG003|Overall Study|Withdrawal by Subject|0|||
129900806|NCT00246012|467597162|FG004|Overall Study|Withdrawal by Subject|0|||
129900807|NCT00246012|467597163|FG005|Overall Study|Withdrawal by Subject|1|||
129900808|NCT00246012|467597164|FG006|Overall Study|Withdrawal by Subject|0|||
129900809|NCT00246012|467597165|FG007|Overall Study|Withdrawal by Subject|0|||
129900810|NCT00246012|467597166|FG008|Overall Study|Withdrawal by Subject|0|||
129900811|NCT00246012|467597158|FG000|Overall Study|Disease progression|3|||
129900812|NCT00246012|467597159|FG001|Overall Study|Disease progression|1|||
129900813|NCT00246012|467597160|FG002|Overall Study|Disease progression|2|||
129900814|NCT00246012|467597161|FG003|Overall Study|Disease progression|3|||
129900815|NCT00246012|467597162|FG004|Overall Study|Disease progression|3|||
129900816|NCT00246012|467597163|FG005|Overall Study|Disease progression|25|||
129900817|NCT00246012|467597164|FG006|Overall Study|Disease progression|30|||
129900818|NCT00246012|467597165|FG007|Overall Study|Disease progression|27|||
129900819|NCT00246012|467597166|FG008|Overall Study|Disease progression|26|||
129900820|NCT00246012|467597158|FG000|Overall Study|Other|0|||
129900821|NCT00246012|467597159|FG001|Overall Study|Other|0|||
129900822|NCT00246012|467597160|FG002|Overall Study|Other|0|||
129900823|NCT00246012|467597161|FG003|Overall Study|Other|0|||
129900824|NCT00246012|467597162|FG004|Overall Study|Other|0|||
129900825|NCT00246012|467597163|FG005|Overall Study|Other|0|||
129900826|NCT00246012|467597164|FG006|Overall Study|Other|0|||
129900827|NCT00246012|467597165|FG007|Overall Study|Other|1|||
129900828|NCT00246012|467597166|FG008|Overall Study|Other|0|||
129900829|NCT00246012|467597158|FG000|Overall Study|Randomly assigned but not treated|0|||
129900830|NCT00246012|467597159|FG001|Overall Study|Randomly assigned but not treated|0|||
129900831|NCT00246012|467597160|FG002|Overall Study|Randomly assigned but not treated|0|||
129900832|NCT00246012|467597161|FG003|Overall Study|Randomly assigned but not treated|0|||
129900833|NCT00246012|467597162|FG004|Overall Study|Randomly assigned but not treated|0|||
129842586|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
129842587|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
129842588|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
129842589|NCT01633944|467388765|FG000|Double-blind Treatment Phase|Other|0|||
129842590|NCT01633944|467388766|FG001|Double-blind Treatment Phase|Other|7|||
129842591|NCT01633944|467388767|FG002|Double-blind Treatment Phase|Other|0|||
129842592|NCT00701129|467388768|FG000|Overall Study|Death|2|||
129842593|NCT02412631|467388769|FG000|Overall Study|Adverse Event|1|||
129842594|NCT02412631|467388770|FG001|Overall Study|Adverse Event|2|||
129842595|NCT02412631|467388769|FG000|Overall Study|Lost to Follow-up|5|||
129842596|NCT02412631|467388770|FG001|Overall Study|Lost to Follow-up|9|||
129842597|NCT02412631|467388769|FG000|Overall Study|Withdrawal by Subject|9|||
129842598|NCT02412631|467388770|FG001|Overall Study|Withdrawal by Subject|3|||
129842599|NCT02412631|467388769|FG000|Overall Study|Early stop by FDA|5|||
129842600|NCT02412631|467388770|FG001|Overall Study|Early stop by FDA|2|||
129842601|NCT02412631|467388769|FG000|Overall Study|Unspecified reason|6|||
129842602|NCT02412631|467388770|FG001|Overall Study|Unspecified reason|8|||
129900834|NCT00246012|467597163|FG005|Overall Study|Randomly assigned but not treated|1|||
129900835|NCT00246012|467597164|FG006|Overall Study|Randomly assigned but not treated|1|||
129449133|NCT01168973|465945561|FG001|Overall Study|Adverse Event|55|||
129842603|NCT00958776|467388771|FG000|Overall Study|Adverse Event|0|||
129900836|NCT00246012|467597165|FG007|Overall Study|Randomly assigned but not treated|0|||
129900837|NCT00246012|467597166|FG008|Overall Study|Randomly assigned but not treated|0|||
129900838|NCT02377362|467597167|FG000|Part A Second Treatment|Protocol Violation|0|||
129900839|NCT02377362|467597168|FG001|Part A Second Treatment|Protocol Violation|0|||
129842604|NCT00958776|467388772|FG001|Overall Study|Adverse Event|1|||
129842605|NCT00958776|467388771|FG000|Overall Study|Physician Decision|1|||
129842606|NCT00958776|467388772|FG001|Overall Study|Physician Decision|0|||
129842607|NCT00958776|467388771|FG000|Overall Study|Lost to Follow-up|2|||
129842608|NCT00958776|467388772|FG001|Overall Study|Lost to Follow-up|6|||
129900840|NCT02377362|467597169|FG002|Part A Second Treatment|Protocol Violation|0|||
129900841|NCT02377362|467597170|FG003|Part A Second Treatment|Protocol Violation|0|||
129900842|NCT02377362|467597171|FG004|Part A Second Treatment|Protocol Violation|1|||
129900843|NCT02377362|467597172|FG005|Part A Second Treatment|Protocol Violation|0|||
129900844|NCT02377362|467597173|FG006|Part A Second Treatment|Protocol Violation|0|||
129900845|NCT02377362|467597174|FG007|Part A Second Treatment|Protocol Violation|0|||
129900846|NCT02377362|467597175|FG008|Part A Second Treatment|Protocol Violation|0|||
129900847|NCT02377362|467597176|FG009|Part A Second Treatment|Protocol Violation|0|||
129900848|NCT02377362|467597177|FG010|Part A Second Treatment|Protocol Violation|0|||
129900849|NCT02377362|467597178|FG011|Part A Second Treatment|Protocol Violation|0|||
129900850|NCT02377362|467597179|FG012|Part A Second Treatment|Protocol Violation|0|||
129900851|NCT02377362|467597167|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900852|NCT02377362|467597168|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900853|NCT02377362|467597169|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900854|NCT02377362|467597170|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
129900855|NCT02377362|467597171|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
129900856|NCT02377362|467597172|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
129900857|NCT02377362|467597173|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900858|NCT02377362|467597174|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900859|NCT02377362|467597175|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900860|NCT02377362|467597176|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900861|NCT02377362|467597177|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900862|NCT02377362|467597178|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900863|NCT02377362|467597179|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
129900864|NCT02377362|467597167|FG000|Part B Overall|Protocol Violation|0|||
129900865|NCT02377362|467597168|FG001|Part B Overall|Protocol Violation|0|||
129900866|NCT02377362|467597169|FG002|Part B Overall|Protocol Violation|0|||
129900867|NCT02377362|467597170|FG003|Part B Overall|Protocol Violation|0|||
129900868|NCT02377362|467597171|FG004|Part B Overall|Protocol Violation|0|||
129900869|NCT02377362|467597172|FG005|Part B Overall|Protocol Violation|0|||
129900870|NCT02377362|467597173|FG006|Part B Overall|Protocol Violation|0|||
129900871|NCT02377362|467597174|FG007|Part B Overall|Protocol Violation|0|||
129900872|NCT02377362|467597175|FG008|Part B Overall|Protocol Violation|0|||
129900873|NCT02377362|467597176|FG009|Part B Overall|Protocol Violation|1|||
129900874|NCT02377362|467597177|FG010|Part B Overall|Protocol Violation|0|||
129900875|NCT02377362|467597178|FG011|Part B Overall|Protocol Violation|0|||
129900876|NCT02377362|467597179|FG012|Part B Overall|Protocol Violation|0|||
129900877|NCT02377362|467597167|FG000|Part B Overall|Adverse Event|0|||
129900878|NCT02377362|467597168|FG001|Part B Overall|Adverse Event|0|||
129900879|NCT02377362|467597169|FG002|Part B Overall|Adverse Event|0|||
129900880|NCT02377362|467597170|FG003|Part B Overall|Adverse Event|0|||
129900881|NCT02377362|467597171|FG004|Part B Overall|Adverse Event|0|||
129900882|NCT02377362|467597172|FG005|Part B Overall|Adverse Event|0|||
129900883|NCT02377362|467597173|FG006|Part B Overall|Adverse Event|1|||
129900884|NCT02377362|467597174|FG007|Part B Overall|Adverse Event|1|||
129900885|NCT02377362|467597175|FG008|Part B Overall|Adverse Event|0|||
129900886|NCT02377362|467597176|FG009|Part B Overall|Adverse Event|0|||
129900887|NCT02377362|467597177|FG010|Part B Overall|Adverse Event|0|||
129900888|NCT02377362|467597178|FG011|Part B Overall|Adverse Event|0|||
129900889|NCT02377362|467597179|FG012|Part B Overall|Adverse Event|0|||
129900890|NCT02377362|467597167|FG000|Part B Overall|Withdrawal by Subject|0|||
129900891|NCT02377362|467597168|FG001|Part B Overall|Withdrawal by Subject|0|||
129900892|NCT02377362|467597169|FG002|Part B Overall|Withdrawal by Subject|0|||
129900893|NCT02377362|467597170|FG003|Part B Overall|Withdrawal by Subject|0|||
129900894|NCT02377362|467597171|FG004|Part B Overall|Withdrawal by Subject|0|||
129900895|NCT02377362|467597172|FG005|Part B Overall|Withdrawal by Subject|0|||
129900896|NCT02377362|467597173|FG006|Part B Overall|Withdrawal by Subject|1|||
129900897|NCT02377362|467597174|FG007|Part B Overall|Withdrawal by Subject|0|||
129900898|NCT02377362|467597175|FG008|Part B Overall|Withdrawal by Subject|0|||
129900899|NCT02377362|467597176|FG009|Part B Overall|Withdrawal by Subject|0|||
129900900|NCT02377362|467597177|FG010|Part B Overall|Withdrawal by Subject|0|||
129900901|NCT02377362|467597178|FG011|Part B Overall|Withdrawal by Subject|1|||
129900902|NCT02377362|467597179|FG012|Part B Overall|Withdrawal by Subject|0|||
129900903|NCT04889664|467597180|FG000|Screen|Lost to Follow-up|1|||
129900904|NCT04889664|467597180|FG000|Screen|Failed to meet screening criteria|1|||
129900905|NCT04889664|467597180|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
129900906|NCT02322216|467597181|FG000|Overall Study|Adverse Event|1|||
129900907|NCT02322216|467597182|FG001|Overall Study|Adverse Event|0|||
129900908|NCT02322216|467597181|FG000|Overall Study|Withdrawal by Subject|1|||
129900909|NCT02322216|467597182|FG001|Overall Study|Withdrawal by Subject|4|||
129900910|NCT01191086|467597194|FG000|Overall Study|Adverse Event|20|||
129900911|NCT01191086|467597194|FG000|Overall Study|Lack of Efficacy|10|||
129900912|NCT01191086|467597194|FG000|Overall Study|Lost to Follow-up|4|||
129900913|NCT01191086|467597194|FG000|Overall Study|Physician Decision|2|||
129900914|NCT01191086|467597194|FG000|Overall Study|Withdrawal by Subject|24|||
129900915|NCT01191086|467597194|FG000|Overall Study|Discontinuation criterion met|1|||
129900916|NCT01191086|467597194|FG000|Overall Study|Other|1|||
129449134|NCT01168973|465945560|FG000|Overall Study|Withdrawal by Subject|90|||
129449135|NCT01168973|465945561|FG001|Overall Study|Withdrawal by Subject|53|||
129449136|NCT01168973|465945560|FG000|Overall Study|Death|42|||
129449137|NCT01168973|465945561|FG001|Overall Study|Death|45|||
129449138|NCT01168973|465945560|FG000|Overall Study|Physician Decision|37|||
129449139|NCT01168973|465945561|FG001|Overall Study|Physician Decision|19|||
129449140|NCT01168973|465945560|FG000|Overall Study|Sponsor Decision|2|||
129449141|NCT01168973|465945561|FG001|Overall Study|Sponsor Decision|1|||
129449142|NCT01168973|465945560|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
129449143|NCT01168973|465945561|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
129449144|NCT02230254|465945562|FG000|Overall Study|Lost to Follow-up|3|||
129449145|NCT02023242|465945563|FG000|Overall Study|Lost to Follow-up|3|||
129449146|NCT02023242|465945564|FG001|Overall Study|Lost to Follow-up|1|||
129449147|NCT02023242|465945563|FG000|Overall Study|Death|0|||
129449148|NCT02023242|465945564|FG001|Overall Study|Death|1|||
129449149|NCT00388505|465945568|FG000|Overall Study|Adverse Event or Death|43|||
129449150|NCT00388505|465945569|FG001|Overall Study|Adverse Event or Death|17|||
129449151|NCT00388505|465945568|FG000|Overall Study|Withdrawal by Subject|24|||
129449152|NCT00388505|465945569|FG001|Overall Study|Withdrawal by Subject|9|||
129449153|NCT00388505|465945568|FG000|Overall Study|Lost to Follow-up|5|||
129449154|NCT00388505|465945569|FG001|Overall Study|Lost to Follow-up|3|||
129449155|NCT00388505|465945568|FG000|Overall Study|Inappropriate Enrollment|0|||
129449156|NCT00388505|465945569|FG001|Overall Study|Inappropriate Enrollment|1|||
129449157|NCT00388505|465945568|FG000|Overall Study|Administrative Reason|1|||
129449158|NCT00388505|465945569|FG001|Overall Study|Administrative Reason|0|||
129449159|NCT00388505|465945568|FG000|Overall Study|Protocol Violation|6|||
129449160|NCT00388505|465945569|FG001|Overall Study|Protocol Violation|5|||
129449161|NCT00388505|465945568|FG000|Overall Study|Unable to classify|4|||
129449162|NCT00388505|465945569|FG001|Overall Study|Unable to classify|3|||
129449163|NCT04854434|465945574|FG000|Overall Study|Death|1|||
129449164|NCT04854434|465945575|FG001|Overall Study|Death|3|||
129449165|NCT04854434|465945576|FG002|Overall Study|Death|4|||
129449166|NCT04854434|465945574|FG000|Overall Study|Study Terminated by Sponsor|2|||
129449167|NCT04854434|465945575|FG001|Overall Study|Study Terminated by Sponsor|0|||
129449168|NCT04854434|465945576|FG002|Overall Study|Study Terminated by Sponsor|0|||
129449169|NCT04854434|465945574|FG000|Overall Study|Other|1|||
129449170|NCT04854434|465945575|FG001|Overall Study|Other|1|||
129449171|NCT04854434|465945576|FG002|Overall Study|Other|0|||
129449172|NCT02667275|465945577|FG000|Overall Study|Protocol Violation|11|||
129449173|NCT02667275|465945578|FG001|Overall Study|Protocol Violation|7|||
129449174|NCT02667275|465945577|FG000|Overall Study|Lost to Follow-up|0|||
129449175|NCT02667275|465945578|FG001|Overall Study|Lost to Follow-up|2|||
129449176|NCT02667275|465945577|FG000|Overall Study|Withdrawal by Subject|0|||
129449177|NCT02667275|465945578|FG001|Overall Study|Withdrawal by Subject|5|||
129449178|NCT02667275|465945577|FG000|Overall Study|Discontinued early without completing|0|||
129449179|NCT02667275|465945578|FG001|Overall Study|Discontinued early without completing|1|||
129449180|NCT01274715|465945579|FG000|Overall Study|Lost to Follow-up|1|||
129449181|NCT01274715|465945579|FG000|Overall Study|After consent, met exclusion criteria.|1|||
129900917|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Other|4|||
129900918|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Other|0|||
129900919|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
129900920|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
129900921|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
129900922|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
129900923|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
129900924|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
129900925|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
129449182|NCT01274715|465945579|FG000|Overall Study|After consent, met exclusion criteria.|1|||
129449183|NCT01274715|465945579|FG000|Overall Study|After consent, met exclusion criteria.|1|||
129449184|NCT02285920|465945581|FG000|Overall Study|Kidney transplantation|2|||
129900926|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
129900927|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
129449185|NCT02285920|465945582|FG001|Overall Study|Kidney transplantation|2|||
129449186|NCT02285920|465945583|FG002|Overall Study|Kidney transplantation|2|||
129449187|NCT02285920|465945584|FG003|Overall Study|Kidney transplantation|0|||
129449188|NCT02285920|465945581|FG000|Overall Study|Change to peritoneal dialysis|0|||
129449189|NCT02285920|465945582|FG001|Overall Study|Change to peritoneal dialysis|0|||
129449190|NCT02285920|465945583|FG002|Overall Study|Change to peritoneal dialysis|1|||
129449191|NCT02285920|465945584|FG003|Overall Study|Change to peritoneal dialysis|0|||
129449192|NCT02285920|465945581|FG000|Overall Study|Transfer to non-participating unit|0|||
129449193|NCT02285920|465945582|FG001|Overall Study|Transfer to non-participating unit|1|||
129449194|NCT02285920|465945583|FG002|Overall Study|Transfer to non-participating unit|0|||
129449195|NCT02285920|465945584|FG003|Overall Study|Transfer to non-participating unit|0|||
129449196|NCT02285920|465945581|FG000|Overall Study|Dialysis discontinuation|0|||
129449197|NCT02285920|465945582|FG001|Overall Study|Dialysis discontinuation|1|||
129842609|NCT00958776|467388771|FG000|Overall Study|Withdrawal by Subject|7|||
129842610|NCT00958776|467388772|FG001|Overall Study|Withdrawal by Subject|16|||
129842611|NCT00958776|467388771|FG000|Overall Study|Protocol Violation|1|||
129842612|NCT00958776|467388772|FG001|Overall Study|Protocol Violation|1|||
129842613|NCT00958776|467388771|FG000|Overall Study|Death|2|||
129842614|NCT00958776|467388772|FG001|Overall Study|Death|1|||
129842615|NCT00958776|467388771|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
129842616|NCT00958776|467388772|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
129842617|NCT00958776|467388771|FG000|Overall Study|Missing|1|||
129842618|NCT00958776|467388772|FG001|Overall Study|Missing|1|||
129842619|NCT00480636|467388773|FG000|Overall Study|Death|12|||
129842620|NCT00480636|467388773|FG000|Overall Study|Lost to Follow-up|4|||
129842621|NCT00480636|467388773|FG000|Overall Study|Other|2|||
129842622|NCT00480636|467388773|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
129842623|NCT00326911|467388776|FG000|Overall Study|Hospitalization prior to treatment|0|||
129842624|NCT00326911|467388777|FG001|Overall Study|Hospitalization prior to treatment|1|||
129842625|NCT00326911|467388776|FG000|Overall Study|Physician decision prior to treatment|1|||
129842626|NCT00326911|467388777|FG001|Overall Study|Physician decision prior to treatment|0|||
129842627|NCT00326911|467388776|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
129842628|NCT00326911|467388777|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
129842629|NCT04537806|467388781|FG000|Overall Study|Randomized but not treated|1|||
129842630|NCT04537806|467388782|FG001|Overall Study|Randomized but not treated|0|||
129842631|NCT04537806|467388781|FG000|Overall Study|Adverse Event|1|||
129842632|NCT04537806|467388782|FG001|Overall Study|Adverse Event|1|||
129842633|NCT03019627|467388783|FG000|Overall Study|Adverse Event|8|||
129842634|NCT03019627|467388784|FG001|Overall Study|Adverse Event|0|||
129842635|NCT03019627|467388783|FG000|Overall Study|Unrelated to adverse event|1|||
129842636|NCT03019627|467388784|FG001|Overall Study|Unrelated to adverse event|3|||
129842637|NCT03019627|467388783|FG000|Overall Study|Lost to Follow-up|2|||
129842638|NCT03019627|467388784|FG001|Overall Study|Lost to Follow-up|1|||
129842639|NCT03019627|467388783|FG000|Overall Study|not compliance|2|||
129842640|NCT03019627|467388784|FG001|Overall Study|not compliance|2|||
129842641|NCT03019627|467388783|FG000|Overall Study|Other|2|||
129842642|NCT03019627|467388784|FG001|Overall Study|Other|2|||
129842643|NCT02953821|467388785|FG000|Overall Study|Adverse Event|0|||
129842644|NCT02953821|467388786|FG001|Overall Study|Adverse Event|4|||
129842645|NCT02953821|467388785|FG000|Overall Study|Death|1|||
129842646|NCT02953821|467388786|FG001|Overall Study|Death|0|||
129842647|NCT02953821|467388785|FG000|Overall Study|Progressive Disease|5|||
129842648|NCT02953821|467388786|FG001|Overall Study|Progressive Disease|1|||
129842649|NCT02953821|467388785|FG000|Overall Study|Lost to Follow-up|2|||
129842650|NCT02953821|467388786|FG001|Overall Study|Lost to Follow-up|0|||
129842651|NCT02953821|467388785|FG000|Overall Study|Physician Decision|1|||
129842652|NCT02953821|467388786|FG001|Overall Study|Physician Decision|1|||
129842653|NCT02953821|467388785|FG000|Overall Study|Withdrawal by Subject|3|||
129842654|NCT02953821|467388786|FG001|Overall Study|Withdrawal by Subject|3|||
129842655|NCT02953821|467388785|FG000|Overall Study|Change of address|0|||
129842656|NCT02953821|467388786|FG001|Overall Study|Change of address|1|||
129842657|NCT02953821|467388785|FG000|Overall Study|Lack of Efficacy|1|||
129842658|NCT02953821|467388786|FG001|Overall Study|Lack of Efficacy|0|||
129842659|NCT02953821|467388785|FG000|Overall Study|Out of state for indeterminate time|0|||
129842660|NCT02953821|467388786|FG001|Overall Study|Out of state for indeterminate time|1|||
129842661|NCT02953821|467388785|FG000|Overall Study|No improvement|0|||
129842662|NCT02953821|467388786|FG001|Overall Study|No improvement|1|||
129842663|NCT02953821|467388785|FG000|Overall Study|Refused follow-up visit|2|||
129842664|NCT02953821|467388786|FG001|Overall Study|Refused follow-up visit|1|||
129842665|NCT03219333|467388787|FG000|Overall Study|Withdrawal by Subject|9|||
129842666|NCT03219333|467388788|FG001|Overall Study|Withdrawal by Subject|4|||
129842667|NCT03219333|467388787|FG000|Overall Study|Lost to Follow-up|1|||
129842668|NCT03219333|467388788|FG001|Overall Study|Lost to Follow-up|1|||
129842669|NCT03219333|467388787|FG000|Overall Study|Death|104|||
129842670|NCT03219333|467388788|FG001|Overall Study|Death|72|||
129842671|NCT03219333|467388787|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
129842672|NCT03219333|467388788|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
129842673|NCT03219333|467388787|FG000|Overall Study|Other|2|||
129842674|NCT03219333|467388788|FG001|Overall Study|Other|2|||
129842675|NCT01470469|467388789|FG000|Overall Study|Withdrawal by Subject|4|||
129842676|NCT01470469|467388790|FG001|Overall Study|Withdrawal by Subject|6|||
129842677|NCT01470469|467388789|FG000|Overall Study|Lack of Efficacy|1|||
129842678|NCT01470469|467388790|FG001|Overall Study|Lack of Efficacy|7|||
129842679|NCT01470469|467388789|FG000|Overall Study|Adverse Event|0|||
129842680|NCT01470469|467388790|FG001|Overall Study|Adverse Event|7|||
129842681|NCT01470469|467388789|FG000|Overall Study|Lost to Follow-up|2|||
129842682|NCT01470469|467388790|FG001|Overall Study|Lost to Follow-up|2|||
129842683|NCT01470469|467388789|FG000|Overall Study|Protocol Violation|1|||
129842684|NCT01470469|467388790|FG001|Overall Study|Protocol Violation|1|||
129842685|NCT01470469|467388789|FG000|Overall Study|Other|2|||
129842686|NCT01470469|467388790|FG001|Overall Study|Other|1|||
129842687|NCT04083976|467388791|FG000|Overall Study|Lost to Follow-up|3|||
129842688|NCT04083976|467388792|FG001|Overall Study|Lost to Follow-up|0|||
129842689|NCT04083976|467388793|FG002|Overall Study|Lost to Follow-up|0|||
129842690|NCT04083976|467388794|FG003|Overall Study|Lost to Follow-up|1|||
129842691|NCT04083976|467388791|FG000|Overall Study|Withdrawal by Subject|16|||
129842692|NCT04083976|467388792|FG001|Overall Study|Withdrawal by Subject|1|||
129842693|NCT04083976|467388793|FG002|Overall Study|Withdrawal by Subject|9|||
129842694|NCT04083976|467388794|FG003|Overall Study|Withdrawal by Subject|0|||
129842695|NCT04083976|467388791|FG000|Overall Study|Sponsor Decision|14|||
129842696|NCT04083976|467388792|FG001|Overall Study|Sponsor Decision|0|||
129842697|NCT04083976|467388793|FG002|Overall Study|Sponsor Decision|0|||
129842698|NCT04083976|467388794|FG003|Overall Study|Sponsor Decision|7|||
129842699|NCT04083976|467388791|FG000|Overall Study|Other|1|||
129842700|NCT04083976|467388792|FG001|Overall Study|Other|0|||
129842701|NCT04083976|467388793|FG002|Overall Study|Other|1|||
129842702|NCT04083976|467388794|FG003|Overall Study|Other|0|||
129842703|NCT02504372|467388795|FG000|Overall Study|Death|136|||
129842704|NCT02504372|467388796|FG001|Overall Study|Death|154|||
129842705|NCT02504372|467388795|FG000|Overall Study|Lost to Follow-up|0|||
129842706|NCT02504372|467388796|FG001|Overall Study|Lost to Follow-up|2|||
129842707|NCT02504372|467388795|FG000|Overall Study|Withdrawal of consent|25|||
129842708|NCT02504372|467388796|FG001|Overall Study|Withdrawal of consent|16|||
129842709|NCT02504372|467388795|FG000|Overall Study|Participants ongoing|429|||
129842710|NCT02504372|467388796|FG001|Overall Study|Participants ongoing|415|||
129842711|NCT03748641|467388804|FG000|Overall Study|Ongoing|155|||
129842712|NCT03748641|467388805|FG001|Overall Study|Ongoing|148|||
129842713|NCT03748641|467388806|FG002|Overall Study|Ongoing|66|||
129842714|NCT03748641|467388807|FG003|Overall Study|Ongoing|79|||
129842715|NCT03748641|467388808|FG004|Overall Study|Ongoing|84|||
129842716|NCT03748641|467388804|FG000|Overall Study|Death|54|||
129842717|NCT03748641|467388805|FG001|Overall Study|Death|59|||
129842718|NCT03748641|467388806|FG002|Overall Study|Death|51|||
129842719|NCT03748641|467388807|FG003|Overall Study|Death|42|||
129842720|NCT03748641|467388808|FG004|Overall Study|Death|9|||
129842721|NCT03748641|467388804|FG000|Overall Study|Lost to Follow-up|0|||
129842722|NCT03748641|467388805|FG001|Overall Study|Lost to Follow-up|2|||
129842723|NCT03748641|467388806|FG002|Overall Study|Lost to Follow-up|1|||
129842724|NCT03748641|467388807|FG003|Overall Study|Lost to Follow-up|0|||
129842725|NCT03748641|467388808|FG004|Overall Study|Lost to Follow-up|0|||
129842726|NCT03748641|467388804|FG000|Overall Study|Withdrawal by Subject|3|||
129842727|NCT03748641|467388805|FG001|Overall Study|Withdrawal by Subject|2|||
129842728|NCT03748641|467388806|FG002|Overall Study|Withdrawal by Subject|5|||
129842729|NCT03748641|467388807|FG003|Overall Study|Withdrawal by Subject|3|||
129842730|NCT03748641|467388808|FG004|Overall Study|Withdrawal by Subject|2|||
129842731|NCT04397263|467388809|FG000|Overall Study|Withdrawal by Subject|2|||
129842732|NCT01428193|467388810|FG000|Overall Study|Physician Decision|1|||
129842733|NCT01428193|467388810|FG000|Overall Study|Elevated screening liver enzymes|1|||
129842734|NCT04697628|467388811|FG000|Overall Study|Withdrawal by Subject|17|||
129842735|NCT04697628|467388812|FG001|Overall Study|Withdrawal by Subject|23|||
129842736|NCT04697628|467388811|FG000|Overall Study|Lost to Follow-up|0|||
129842737|NCT04697628|467388812|FG001|Overall Study|Lost to Follow-up|4|||
129842738|NCT04697628|467388811|FG000|Overall Study|On-going in study|122|||
129842739|NCT04697628|467388812|FG001|Overall Study|On-going in study|91|||
129842740|NCT02703636|467388813|FG000|Overall Study|Adverse Event|14|||
129842741|NCT02703636|467388813|FG000|Overall Study|Study stopped by sponsor|1|||
129842742|NCT02703636|467388813|FG000|Overall Study|Withdrawal by Subject|1|||
129842743|NCT00393939|467388814|FG000|Overall Study|Protocol Violation|1|||
129842744|NCT00393939|467388815|FG001|Overall Study|Protocol Violation|1|||
129842745|NCT00393939|467388814|FG000|Overall Study|Lost to Follow-up|2|||
129842746|NCT00393939|467388815|FG001|Overall Study|Lost to Follow-up|4|||
129842747|NCT00393939|467388814|FG000|Overall Study|Death|10|||
129842748|NCT00393939|467388815|FG001|Overall Study|Death|4|||
129842749|NCT00393939|467388814|FG000|Overall Study|Sponsor|5|||
129842750|NCT00393939|467388815|FG001|Overall Study|Sponsor|13|||
129842751|NCT00393939|467388814|FG000|Overall Study|Objective progression or relapse|239|||
129842752|NCT00393939|467388815|FG001|Overall Study|Objective progression or relapse|223|||
129842753|NCT00393939|467388814|FG000|Overall Study|Withdrawal by Subject|2|||
129842754|NCT00393939|467388815|FG001|Overall Study|Withdrawal by Subject|7|||
129842755|NCT00393939|467388814|FG000|Overall Study|Other|37|||
129842756|NCT00393939|467388815|FG001|Overall Study|Other|45|||
129842757|NCT03778931|467388816|FG000|Overall Study|Withdrawal by Subject|12|||
129842758|NCT03778931|467388817|FG001|Overall Study|Withdrawal by Subject|25|||
129900928|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
129900929|NCT00853827|467597195|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
129900930|NCT00853827|467597196|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
129900931|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
129900932|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
129900933|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
129900934|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
129900935|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
129900936|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
129900937|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
129900938|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
129900939|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
129900940|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
129900941|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
129900942|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
129900943|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
129900944|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
129900945|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
129900946|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
129900947|NCT00853827|467597195|FG000|Double Blind Period (103 Weeks)|Death|1|||
129900948|NCT00853827|467597196|FG001|Double Blind Period (103 Weeks)|Death|6|||
129900949|NCT02046616|467597202|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
129900950|NCT02046616|467597202|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
129900951|NCT02046616|467597202|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
129900952|NCT02046616|467597202|FG000|24-Week Treatment Period|Physician Decision|3|||
129900953|NCT02046616|467597202|FG000|24-Week Treatment Period|Other|1|||
129900954|NCT02046616|467597202|FG000|8-Week FU Period|Lost to Follow-up|1|||
129900955|NCT02736799|467597203|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
129900956|NCT02736799|467597204|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
129900957|NCT02736799|467597205|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
129900958|NCT02736799|467597206|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
129900959|NCT01833832|467597208|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
129900960|NCT01156116|467597210|FG000|Overall Study|Withdrawal by Subject|3|||
129900961|NCT01156116|467597211|FG001|Overall Study|Withdrawal by Subject|1|||
129900962|NCT01156116|467597210|FG000|Overall Study|CPAP intolerance|2|||
129900963|NCT01156116|467597211|FG001|Overall Study|CPAP intolerance|0|||
129900964|NCT00344019|467597212|FG000|Overall Study|did not meet final inclusion criteria|0|||
129900965|NCT00344019|467597213|FG001|Overall Study|did not meet final inclusion criteria|0|||
129900966|NCT00344019|467597214|FG002|Overall Study|did not meet final inclusion criteria|74|||
129900967|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
129900968|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
129900969|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
129900970|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
129900971|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
129900972|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
129900973|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
129900974|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
129900975|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
129900976|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
129900977|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
129900978|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
129900979|NCT02057718|467597215|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
129842759|NCT03778931|467388816|FG000|Overall Study|Physician Decision|1|||
129842760|NCT03778931|467388817|FG001|Overall Study|Physician Decision|3|||
129842761|NCT03778931|467388816|FG000|Overall Study|Participant Noncompliance|1|||
129842762|NCT03778931|467388817|FG001|Overall Study|Participant Noncompliance|1|||
129842763|NCT03778931|467388816|FG000|Overall Study|Lost to Follow-up|4|||
129842764|NCT03778931|467388817|FG001|Overall Study|Lost to Follow-up|1|||
129842765|NCT03778931|467388816|FG000|Overall Study|Death|69|||
129842766|NCT03778931|467388817|FG001|Overall Study|Death|79|||
129842767|NCT00006184|467388818|FG000|Overall Study|Death|1|||
129842768|NCT00006184|467388819|FG001|Overall Study|Death|0|||
129842769|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
129900980|NCT02057718|467597216|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
129842770|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
129842771|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
129842772|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
129449198|NCT02285920|465945583|FG002|Overall Study|Dialysis discontinuation|0|||
129449199|NCT02285920|465945584|FG003|Overall Study|Dialysis discontinuation|0|||
129449200|NCT02285920|465945581|FG000|Overall Study|Death|2|||
129449201|NCT02285920|465945582|FG001|Overall Study|Death|0|||
129449202|NCT02285920|465945583|FG002|Overall Study|Death|2|||
129449203|NCT02285920|465945584|FG003|Overall Study|Death|1|||
129449204|NCT02357134|465945585|FG000|Overall Study|Lost to Follow-up|1|||
129449205|NCT02357134|465945586|FG001|Overall Study|Lost to Follow-up|0|||
129842773|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
129900981|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
129900982|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
129900983|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
129900984|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
129900985|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
129900986|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
129900987|NCT02057718|467597215|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
129900988|NCT02057718|467597216|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
129900989|NCT01191788|467597217|FG000|Overall Study|Lost to Follow-up|21|||
129900990|NCT01191788|467597218|FG001|Overall Study|Lost to Follow-up|22|||
129900991|NCT05046132|467597220|FG000|Overall Study|Adverse Event|4|||
129900992|NCT05046132|467597221|FG001|Overall Study|Adverse Event|0|||
129900993|NCT05046132|467597222|FG002|Overall Study|Adverse Event|0|||
129900994|NCT05046132|467597220|FG000|Overall Study|Withdrawal by Subject|3|||
129900995|NCT05046132|467597221|FG001|Overall Study|Withdrawal by Subject|0|||
129900996|NCT05046132|467597222|FG002|Overall Study|Withdrawal by Subject|0|||
129900997|NCT05046132|467597220|FG000|Overall Study|Positive Covid19 Result.|0|||
129900998|NCT05046132|467597221|FG001|Overall Study|Positive Covid19 Result.|1|||
129900999|NCT05046132|467597222|FG002|Overall Study|Positive Covid19 Result.|0|||
129901000|NCT01959412|467597223|FG000|Overall Study|Protocol deviation|1|||
129901001|NCT01959412|467597224|FG001|Overall Study|Protocol deviation|1|||
129901002|NCT01959412|467597225|FG002|Overall Study|Protocol deviation|0|||
129901003|NCT01959412|467597226|FG003|Overall Study|Protocol deviation|1|||
129901004|NCT01959412|467597227|FG004|Overall Study|Protocol deviation|3|||
129901005|NCT01959412|467597228|FG005|Overall Study|Protocol deviation|0|||
129901006|NCT01959412|467597223|FG000|Overall Study|Adverse Event|0|||
129901007|NCT01959412|467597224|FG001|Overall Study|Adverse Event|0|||
129842774|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
129842775|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
129842776|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
129842777|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
129842778|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
129842779|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
129842780|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
129842781|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
129842782|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
129842783|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
129842784|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
129842785|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
129842786|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
129842787|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
129842788|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
129842789|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
129842790|NCT02161718|467388824|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
129842791|NCT02161718|467388825|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
129842792|NCT02161718|467388826|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
129842793|NCT02161718|467388824|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
129842794|NCT02161718|467388825|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
129842795|NCT02161718|467388826|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
129842796|NCT02161718|467388824|FG000|Post- Randomization Period|Lost to Follow-up|0|||
129842797|NCT02161718|467388825|FG001|Post- Randomization Period|Lost to Follow-up|9|||
129901008|NCT01959412|467597225|FG002|Overall Study|Adverse Event|0|||
129901009|NCT01959412|467597226|FG003|Overall Study|Adverse Event|1|||
129901010|NCT01959412|467597227|FG004|Overall Study|Adverse Event|0|||
129901011|NCT01959412|467597228|FG005|Overall Study|Adverse Event|0|||
129901012|NCT00509769|467597231|FG000|Overall Study|Progressive disease|77|||
129901013|NCT00509769|467597231|FG000|Overall Study|Adverse Event|4|||
129901014|NCT00509769|467597231|FG000|Overall Study|Patient's decision|1|||
129901015|NCT00509769|467597231|FG000|Overall Study|Physician Decision|8|||
129901016|NCT00509769|467597231|FG000|Overall Study|Use of prohibited therapies during study|1|||
129901017|NCT00754936|467597232|FG000|Overall Study|Lost to Follow-up|3|||
129449206|NCT02357134|465945587|FG002|Overall Study|Lost to Follow-up|0|||
129449207|NCT02357134|465945588|FG003|Overall Study|Lost to Follow-up|0|||
129449208|NCT01301456|465945589|FG000|Stage 1|Withdrawal by Subject|0|||
129449209|NCT01301456|465945590|FG001|Stage 1|Withdrawal by Subject|0|||
129449210|NCT01301456|465945591|FG002|Stage 1|Withdrawal by Subject|1|||
129449211|NCT01301456|465945592|FG003|Stage 1|Withdrawal by Subject|0|||
129449212|NCT01301456|465945593|FG004|Stage 1|Withdrawal by Subject|1|||
129449213|NCT01301456|465945594|FG005|Stage 1|Withdrawal by Subject|0|||
129449214|NCT01301456|465945595|FG006|Stage 1|Withdrawal by Subject|0|||
129449215|NCT01301456|465945596|FG007|Stage 1|Withdrawal by Subject|0|||
129449216|NCT01301456|465945597|FG008|Stage 1|Withdrawal by Subject|0|||
129449217|NCT01301456|465945598|FG009|Stage 1|Withdrawal by Subject|0|||
129449218|NCT01301456|465945599|FG010|Stage 1|Withdrawal by Subject|0|||
129449219|NCT01301456|465945600|FG011|Stage 1|Withdrawal by Subject|0|||
129449220|NCT01301456|465945589|FG000|Stage 1|Randomized but not treated|0|||
129449221|NCT01301456|465945590|FG001|Stage 1|Randomized but not treated|0|||
129449222|NCT01301456|465945591|FG002|Stage 1|Randomized but not treated|0|||
129449223|NCT01301456|465945592|FG003|Stage 1|Randomized but not treated|0|||
129449224|NCT01301456|465945593|FG004|Stage 1|Randomized but not treated|0|||
129449225|NCT01301456|465945594|FG005|Stage 1|Randomized but not treated|0|||
129449226|NCT01301456|465945595|FG006|Stage 1|Randomized but not treated|1|||
129449227|NCT01301456|465945596|FG007|Stage 1|Randomized but not treated|0|||
129449228|NCT01301456|465945597|FG008|Stage 1|Randomized but not treated|0|||
129449229|NCT01301456|465945598|FG009|Stage 1|Randomized but not treated|0|||
129449230|NCT01301456|465945599|FG010|Stage 1|Randomized but not treated|0|||
129449231|NCT01301456|465945600|FG011|Stage 1|Randomized but not treated|0|||
129449232|NCT01301456|465945589|FG000|Stage 2|Adverse Event|0|||
129449233|NCT01301456|465945590|FG001|Stage 2|Adverse Event|0|||
129449234|NCT01301456|465945591|FG002|Stage 2|Adverse Event|0|||
129449235|NCT01301456|465945592|FG003|Stage 2|Adverse Event|0|||
129449236|NCT01301456|465945593|FG004|Stage 2|Adverse Event|0|||
129449237|NCT01301456|465945594|FG005|Stage 2|Adverse Event|0|||
129449238|NCT01301456|465945595|FG006|Stage 2|Adverse Event|0|||
129449239|NCT01301456|465945596|FG007|Stage 2|Adverse Event|0|||
129449240|NCT01301456|465945597|FG008|Stage 2|Adverse Event|0|||
129449241|NCT01301456|465945598|FG009|Stage 2|Adverse Event|0|||
129449242|NCT01301456|465945599|FG010|Stage 2|Adverse Event|1|||
129449243|NCT01301456|465945600|FG011|Stage 2|Adverse Event|0|||
129449244|NCT00915772|465945601|FG000|Overall Study|Adverse Event|12|||
129449245|NCT00915772|465945602|FG001|Overall Study|Adverse Event|13|||
129449246|NCT00915772|465945603|FG002|Overall Study|Adverse Event|11|||
129449247|NCT00915772|465945601|FG000|Overall Study|Protocol Violation|4|||
129842798|NCT02161718|467388826|FG002|Post- Randomization Period|Lost to Follow-up|15|||
129842799|NCT02161718|467388824|FG000|Post- Randomization Period|Adverse Event|0|||
129842800|NCT02161718|467388825|FG001|Post- Randomization Period|Adverse Event|9|||
129842801|NCT02161718|467388826|FG002|Post- Randomization Period|Adverse Event|10|||
129842802|NCT02161718|467388824|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
129842803|NCT02161718|467388825|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
129842804|NCT02161718|467388826|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
129842805|NCT02161718|467388824|FG000|Post- Randomization Period|Physician Decision|0|||
129842806|NCT02161718|467388825|FG001|Post- Randomization Period|Physician Decision|2|||
129842807|NCT02161718|467388826|FG002|Post- Randomization Period|Physician Decision|4|||
129842808|NCT02161718|467388824|FG000|Post- Randomization Period|Protocol Violation|0|||
129842809|NCT02161718|467388825|FG001|Post- Randomization Period|Protocol Violation|2|||
129842810|NCT02161718|467388826|FG002|Post- Randomization Period|Protocol Violation|3|||
129842811|NCT02161718|467388824|FG000|Post- Randomization Period|Lack of Efficacy|0|||
129842812|NCT02161718|467388825|FG001|Post- Randomization Period|Lack of Efficacy|0|||
129842813|NCT02161718|467388826|FG002|Post- Randomization Period|Lack of Efficacy|1|||
129842814|NCT02161718|467388824|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
129842815|NCT02161718|467388825|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
129842816|NCT02161718|467388826|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
129842817|NCT02161718|467388824|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
129842818|NCT02161718|467388825|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
129842819|NCT02161718|467388826|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
129842820|NCT02161718|467388824|FG000|Post- Randomization Period|Relocation|0|||
129842821|NCT02161718|467388825|FG001|Post- Randomization Period|Relocation|3|||
129842822|NCT02161718|467388826|FG002|Post- Randomization Period|Relocation|0|||
129842823|NCT00376168|467388832|FG000|Overall Study|Adverse Event|1|||
129842824|NCT00376168|467388833|FG001|Overall Study|Adverse Event|1|||
129449248|NCT00915772|465945602|FG001|Overall Study|Protocol Violation|1|||
129449249|NCT00915772|465945603|FG002|Overall Study|Protocol Violation|2|||
129449250|NCT00915772|465945601|FG000|Overall Study|Lost to Follow-up|1|||
129449251|NCT00915772|465945602|FG001|Overall Study|Lost to Follow-up|2|||
129449252|NCT00915772|465945603|FG002|Overall Study|Lost to Follow-up|2|||
129449253|NCT00915772|465945601|FG000|Overall Study|Lack of Efficacy|9|||
129449254|NCT00915772|465945602|FG001|Overall Study|Lack of Efficacy|15|||
129842825|NCT00376168|467388832|FG000|Overall Study|Pregnancy|1|||
129449255|NCT00915772|465945603|FG002|Overall Study|Lack of Efficacy|3|||
129449256|NCT00915772|465945601|FG000|Overall Study|Refused to continue trial medication|6|||
129842826|NCT00376168|467388833|FG001|Overall Study|Pregnancy|0|||
129842827|NCT04181827|467388834|FG000|Overall Study|Ongoing|124|||
129842828|NCT04181827|467388835|FG001|Overall Study|Ongoing|157|||
129842829|NCT04181827|467388834|FG000|Overall Study|Death|82|||
129842830|NCT04181827|467388835|FG001|Overall Study|Death|50|||
129842831|NCT04181827|467388834|FG000|Overall Study|Lost to Follow-up|0|||
129842832|NCT04181827|467388835|FG001|Overall Study|Lost to Follow-up|1|||
129842833|NCT04181827|467388834|FG000|Overall Study|Withdrawal by Subject|5|||
129842834|NCT04181827|467388835|FG001|Overall Study|Withdrawal by Subject|0|||
129901018|NCT00754936|467597232|FG000|Overall Study|Physician Decision|1|||
129901019|NCT00754936|467597232|FG000|Overall Study|Withdrawal by Subject|2|||
129901020|NCT00754936|467597232|FG000|Overall Study|Side Effects|3|||
129901021|NCT00754936|467597232|FG000|Overall Study|Inter-current medical events|3|||
129901022|NCT00604721|467597238|FG000|Overall Study|Physician Decision|1|||
129901023|NCT00604721|467597238|FG000|Overall Study|Withdrawal by Subject|1|||
129901024|NCT01144182|467597243|FG000|Overall Study|Death|5|||
129901025|NCT01144182|467597244|FG001|Overall Study|Death|6|||
129901026|NCT01144182|467597243|FG000|Overall Study|Withdrawal by Subject|3|||
129901027|NCT01144182|467597244|FG001|Overall Study|Withdrawal by Subject|6|||
129901028|NCT01144182|467597243|FG000|Overall Study|Lost to Follow-up|9|||
129901029|NCT01144182|467597244|FG001|Overall Study|Lost to Follow-up|9|||
129901030|NCT02317016|467597245|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
129901031|NCT02317016|467597245|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
129901032|NCT02317016|467597245|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
129901033|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
129901034|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
129901035|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
129901036|NCT02317016|467597245|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
129901037|NCT00536380|467597246|FG000|Overall Study|Adverse Event|0|||
129901038|NCT00536380|467597247|FG001|Overall Study|Adverse Event|2|||
129901039|NCT00536380|467597248|FG002|Overall Study|Adverse Event|2|||
129842835|NCT05091528|467388836|FG000|Overall Study|Study Termination by Sponsor|0|||
129842836|NCT05091528|467388837|FG001|Overall Study|Study Termination by Sponsor|1|||
129842837|NCT05091528|467388838|FG002|Overall Study|Study Termination by Sponsor|0|||
129842838|NCT05091528|467388839|FG003|Overall Study|Study Termination by Sponsor|1|||
129842839|NCT01857063|467388840|FG000|Period 1 (7 Days)|Adverse Event|0|||
129842840|NCT01857063|467388841|FG001|Period 1 (7 Days)|Adverse Event|1|||
129842841|NCT01857063|467388840|FG000|Period 1 (7 Days)|Physician Decision|1|||
129842842|NCT01857063|467388841|FG001|Period 1 (7 Days)|Physician Decision|0|||
129842843|NCT01857063|467388840|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
129842844|NCT01857063|467388841|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
129842845|NCT01857063|467388840|FG000|Period 2 (7 Days)|Adverse Event|2|||
129842846|NCT01857063|467388841|FG001|Period 2 (7 Days)|Adverse Event|1|||
129842847|NCT01857063|467388840|FG000|Period 2 (7 Days)|Physician Decision|1|||
129842848|NCT01857063|467388841|FG001|Period 2 (7 Days)|Physician Decision|1|||
129842849|NCT01857063|467388840|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
129842850|NCT01857063|467388841|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
129842851|NCT02448875|467388842|FG000|Overall Study|Adverse Event|2|||
129842852|NCT02448875|467388843|FG001|Overall Study|Adverse Event|1|||
129842853|NCT02448875|467388844|FG002|Overall Study|Adverse Event|0|||
129842854|NCT02448875|467388842|FG000|Overall Study|Lost to Follow-up|1|||
129842855|NCT02448875|467388843|FG001|Overall Study|Lost to Follow-up|0|||
129842856|NCT02448875|467388844|FG002|Overall Study|Lost to Follow-up|0|||
129842857|NCT02448875|467388842|FG000|Overall Study|Investigator Decision|3|||
129842858|NCT02448875|467388843|FG001|Overall Study|Investigator Decision|0|||
129901040|NCT00536380|467597246|FG000|Overall Study|Lost to Follow-up|0|||
129842859|NCT02448875|467388844|FG002|Overall Study|Investigator Decision|1|||
129842860|NCT02448875|467388842|FG000|Overall Study|Withdrawal by Subject|1|||
129842861|NCT02448875|467388843|FG001|Overall Study|Withdrawal by Subject|0|||
129842862|NCT02448875|467388844|FG002|Overall Study|Withdrawal by Subject|0|||
129842863|NCT00689481|467388845|FG000|Overall Study|Adverse Event|7|||
129842864|NCT00689481|467388846|FG001|Overall Study|Adverse Event|1|||
129842865|NCT00689481|467388845|FG000|Overall Study|Lost to Follow-up|4|||
129842866|NCT00689481|467388846|FG001|Overall Study|Lost to Follow-up|3|||
129842867|NCT00689481|467388845|FG000|Overall Study|Lack of Efficacy|4|||
129842868|NCT00689481|467388846|FG001|Overall Study|Lack of Efficacy|3|||
129842869|NCT00689481|467388845|FG000|Overall Study|Non-compliance with study treatment|1|||
129901041|NCT00536380|467597247|FG001|Overall Study|Lost to Follow-up|0|||
129842870|NCT00689481|467388846|FG001|Overall Study|Non-compliance with study treatment|1|||
129842871|NCT00689481|467388845|FG000|Overall Study|Withdrawal by Subject|8|||
129901042|NCT00536380|467597248|FG002|Overall Study|Lost to Follow-up|1|||
129901043|NCT00536380|467597246|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
129901044|NCT00536380|467597247|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
129842872|NCT00689481|467388846|FG001|Overall Study|Withdrawal by Subject|4|||
129842873|NCT00689481|467388845|FG000|Overall Study|Excluded medication started during study|0|||
129842874|NCT00689481|467388846|FG001|Overall Study|Excluded medication started during study|1|||
129842875|NCT00689481|467388845|FG000|Overall Study|Subject early term, left on vacation|0|||
129842876|NCT00689481|467388846|FG001|Overall Study|Subject early term, left on vacation|1|||
129842877|NCT00316199|467388847|FG000|Overall Study|Adverse Event|2|||
129901045|NCT00536380|467597248|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
129901046|NCT00536380|467597246|FG000|Overall Study|Withdrawal related to study drug|7|||
129901047|NCT00536380|467597247|FG001|Overall Study|Withdrawal related to study drug|5|||
129842878|NCT00316199|467388847|FG000|Overall Study|Death|8|||
129842879|NCT00316199|467388847|FG000|Overall Study|Lost to Follow-up|2|||
129842880|NCT00590954|467388848|FG000|Overall Study|Inevaluable|2|||
129842881|NCT02821962|467390151|FG000|Overall Study|Lost to Follow-up|2|||
129842882|NCT02821962|467390152|FG001|Overall Study|Lost to Follow-up|0|||
129901048|NCT00536380|467597248|FG002|Overall Study|Withdrawal related to study drug|2|||
129901049|NCT00536380|467597246|FG000|Overall Study|Noncompliance with protocol|3|||
129901050|NCT00536380|467597247|FG001|Overall Study|Noncompliance with protocol|2|||
129901051|NCT00536380|467597248|FG002|Overall Study|Noncompliance with protocol|2|||
129842883|NCT00723606|467390155|FG000|Overall Study|Adverse Event|2|||
129842884|NCT00723606|467390156|FG001|Overall Study|Adverse Event|5|||
129842885|NCT00723606|467390155|FG000|Overall Study|Other|2|||
129842886|NCT00723606|467390156|FG001|Overall Study|Other|0|||
129842887|NCT00723606|467390155|FG000|Overall Study|Withdrawal by Subject|0|||
129842888|NCT00723606|467390156|FG001|Overall Study|Withdrawal by Subject|2|||
129842889|NCT00976898|467390157|FG000|Overall Study|Protocol Violation|1|||
129901052|NCT00536380|467597246|FG000|Overall Study|Did not meet protocol eligibility|0|||
129901053|NCT00536380|467597247|FG001|Overall Study|Did not meet protocol eligibility|0|||
129901054|NCT00536380|467597248|FG002|Overall Study|Did not meet protocol eligibility|1|||
129901055|NCT00536380|467597246|FG000|Overall Study|Administrative|0|||
129901056|NCT00536380|467597247|FG001|Overall Study|Administrative|0|||
129901057|NCT00536380|467597248|FG002|Overall Study|Administrative|1|||
129901058|NCT01768676|467597253|FG000|Overall Study|Adverse Event|3|||
129901059|NCT01768676|467597254|FG001|Overall Study|Adverse Event|3|||
129901060|NCT01768676|467597253|FG000|Overall Study|Lost to Follow-up|13|||
129901061|NCT01768676|467597254|FG001|Overall Study|Lost to Follow-up|16|||
129901062|NCT01768676|467597253|FG000|Overall Study|Protocol Violation|1|||
129901063|NCT01768676|467597254|FG001|Overall Study|Protocol Violation|1|||
129901064|NCT01768676|467597253|FG000|Overall Study|Physician Decision|4|||
129901065|NCT01768676|467597254|FG001|Overall Study|Physician Decision|1|||
129901066|NCT01768676|467597253|FG000|Overall Study|Withdrawal by Subject|3|||
129901067|NCT01768676|467597254|FG001|Overall Study|Withdrawal by Subject|10|||
129901068|NCT03395353|467597256|FG000|Overall Study|Adverse Event|20|||
129901069|NCT03395353|467597256|FG000|Overall Study|Protocol Violation|1|||
129842890|NCT00976898|467390157|FG000|Overall Study|Adverse Event|1|||
129842891|NCT00976898|467390157|FG000|Overall Study|Physician Decision|1|||
129842892|NCT00976898|467390157|FG000|Overall Study|Liver Transplant|1|||
129842893|NCT00976898|467390157|FG000|Overall Study|Progressive Disease|1|||
129842894|NCT05107128|467390158|FG000|Overall Study|Adverse Event|2|||
129842895|NCT05107128|467390159|FG001|Overall Study|Adverse Event|0|||
129842896|NCT05107128|467390158|FG000|Overall Study|Withdrawal by Subject|3|||
129842897|NCT05107128|467390159|FG001|Overall Study|Withdrawal by Subject|3|||
129842898|NCT05107128|467390158|FG000|Overall Study|Withdrawal of Consent|0|||
129842899|NCT05107128|467390159|FG001|Overall Study|Withdrawal of Consent|1|||
129842900|NCT05107128|467390158|FG000|Overall Study|Reason Not Specified|2|||
129901070|NCT03395353|467597256|FG000|Overall Study|Lack of Efficacy|3|||
129901071|NCT03395353|467597256|FG000|Overall Study|Withdrawal by Subject|24|||
129901072|NCT03395353|467597256|FG000|Overall Study|Discontinued visit|1|||
129901073|NCT03395353|467597256|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
129901074|NCT03395353|467597256|FG000|Overall Study|Physician Decision|4|||
129901075|NCT03395353|467597256|FG000|Overall Study|Early termination of overall study|33|||
129842901|NCT05107128|467390159|FG001|Overall Study|Reason Not Specified|0|||
129901076|NCT01196429|467597257|FG000|Overall Study|Ineligible - inadequate pathology|1|||
129901077|NCT01196429|467597258|FG001|Overall Study|Ineligible - inadequate pathology|0|||
129901078|NCT01196429|467597257|FG000|Overall Study|Ineligible - wrong cell type|1|||
129901079|NCT01196429|467597258|FG001|Overall Study|Ineligible - wrong cell type|0|||
129842902|NCT05459129|467390160|FG000|Overall Study|Death|1|||
129842903|NCT05459129|467390161|FG001|Overall Study|Death|0|||
129842904|NCT05459129|467390160|FG000|Overall Study|Study Terminated By Sponsor|5|||
129842905|NCT05459129|467390161|FG001|Overall Study|Study Terminated By Sponsor|6|||
129842906|NCT04530552|467390163|FG000|Overall Study|Physician Decision|0|||
129842907|NCT04530552|467390164|FG001|Overall Study|Physician Decision|1|||
129842908|NCT04530552|467390163|FG000|Overall Study|Withdrawal by Subject|0|||
129842909|NCT04530552|467390164|FG001|Overall Study|Withdrawal by Subject|1|||
129842910|NCT04530552|467390163|FG000|Overall Study|Adverse Event|0|||
129842911|NCT04530552|467390164|FG001|Overall Study|Adverse Event|1|||
129842912|NCT04530552|467390163|FG000|Overall Study|No surgery|0|||
129842913|NCT04530552|467390164|FG001|Overall Study|No surgery|1|||
129842914|NCT06034496|467390165|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
129842915|NCT06034496|467390166|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
129842916|NCT06034496|467390165|FG000|Overall Study|Withdrawal by Subject|5|||
129842917|NCT06034496|467390166|FG001|Overall Study|Withdrawal by Subject|4|||
129842918|NCT03277261|467390173|FG000|Overall Study|Adverse Event|17|||
129842919|NCT03277261|467390174|FG001|Overall Study|Adverse Event|1|||
129842920|NCT03277261|467390173|FG000|Overall Study|Participant Withdrawal of Consent|6|||
129842921|NCT03277261|467390174|FG001|Overall Study|Participant Withdrawal of Consent|15|||
129842922|NCT03277261|467390173|FG000|Overall Study|Investigator / Sponsor Decision|4|||
129842923|NCT03277261|467390174|FG001|Overall Study|Investigator / Sponsor Decision|2|||
129842924|NCT03277261|467390173|FG000|Overall Study|Pregnancy|2|||
129842925|NCT03277261|467390174|FG001|Overall Study|Pregnancy|0|||
129842926|NCT03277261|467390173|FG000|Overall Study|Lost to Follow-up|2|||
129842927|NCT03277261|467390174|FG001|Overall Study|Lost to Follow-up|2|||
129842928|NCT03277261|467390173|FG000|Overall Study|Lack of Efficacy|2|||
129842929|NCT03277261|467390174|FG001|Overall Study|Lack of Efficacy|2|||
129842930|NCT03277261|467390173|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
129842931|NCT03277261|467390174|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
129842932|NCT02365597|467390178|FG000|Overall Study|Lost to Follow-up|0|||
129842933|NCT02365597|467390179|FG001|Overall Study|Lost to Follow-up|1|||
129842934|NCT02365597|467390180|FG002|Overall Study|Lost to Follow-up|0|||
129842935|NCT02365597|467390181|FG003|Overall Study|Lost to Follow-up|1|||
129842936|NCT02365597|467390178|FG000|Overall Study|Withdrawal by Subject|1|||
129842937|NCT02365597|467390179|FG001|Overall Study|Withdrawal by Subject|8|||
129842938|NCT02365597|467390180|FG002|Overall Study|Withdrawal by Subject|5|||
129842939|NCT02365597|467390181|FG003|Overall Study|Withdrawal by Subject|1|||
129842940|NCT02365597|467390178|FG000|Overall Study|Sponsor's decision|1|||
129842941|NCT02365597|467390179|FG001|Overall Study|Sponsor's decision|3|||
129842942|NCT02365597|467390180|FG002|Overall Study|Sponsor's decision|13|||
129842943|NCT02365597|467390181|FG003|Overall Study|Sponsor's decision|0|||
129842944|NCT02365597|467390178|FG000|Overall Study|Other|0|||
129842945|NCT02365597|467390179|FG001|Overall Study|Other|4|||
129842946|NCT02365597|467390180|FG002|Overall Study|Other|0|||
129842947|NCT02365597|467390181|FG003|Overall Study|Other|0|||
129842948|NCT02365597|467390178|FG000|Overall Study|Enrolled but not treated|0|||
129842949|NCT02365597|467390179|FG001|Overall Study|Enrolled but not treated|1|||
129842950|NCT02365597|467390180|FG002|Overall Study|Enrolled but not treated|1|||
129842951|NCT02365597|467390181|FG003|Overall Study|Enrolled but not treated|0|||
129842952|NCT02365597|467390178|FG000|Overall Study|Ongoing|0|||
129842953|NCT02365597|467390179|FG001|Overall Study|Ongoing|0|||
129842954|NCT02365597|467390180|FG002|Overall Study|Ongoing|0|||
129842955|NCT02365597|467390181|FG003|Overall Study|Ongoing|17|||
129842956|NCT00499603|467390182|FG000|Overall Study|Adverse Event|0|||
129842957|NCT00499603|467390183|FG001|Overall Study|Adverse Event|1|||
129842958|NCT03323099|467390184|FG000|Overall Study|Withdrawal by Subject|6|||
129842959|NCT03323099|467390185|FG001|Overall Study|Withdrawal by Subject|12|||
129842960|NCT03323099|467390184|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
129842961|NCT03323099|467390185|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
129842962|NCT05132127|467390188|FG000|Overall Study|Adverse Event|1|||
129842963|NCT05220397|467390189|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842964|NCT05220397|467390190|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842965|NCT05220397|467390191|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
129842966|NCT05220397|467390192|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842967|NCT05220397|467390193|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
129842968|NCT03604692|467390196|FG000|Overall Study|Investigator's Decision|0|||
129842969|NCT03604692|467390197|FG001|Overall Study|Investigator's Decision|0|||
129842970|NCT03604692|467390198|FG002|Overall Study|Investigator's Decision|0|||
129842971|NCT03604692|467390199|FG003|Overall Study|Investigator's Decision|1|||
129842972|NCT03604692|467390200|FG004|Overall Study|Investigator's Decision|0|||
129842973|NCT03604692|467390201|FG005|Overall Study|Investigator's Decision|7|||
129842974|NCT03604692|467390196|FG000|Overall Study|Withdrawal by Subject|0|||
129842975|NCT03604692|467390197|FG001|Overall Study|Withdrawal by Subject|0|||
129842976|NCT03604692|467390198|FG002|Overall Study|Withdrawal by Subject|0|||
129842977|NCT03604692|467390199|FG003|Overall Study|Withdrawal by Subject|0|||
129842978|NCT03604692|467390200|FG004|Overall Study|Withdrawal by Subject|0|||
129842979|NCT03604692|467390201|FG005|Overall Study|Withdrawal by Subject|2|||
129842980|NCT03604692|467390196|FG000|Overall Study|Progressive Disease|1|||
129842981|NCT03604692|467390197|FG001|Overall Study|Progressive Disease|0|||
129842982|NCT03604692|467390198|FG002|Overall Study|Progressive Disease|1|||
129842983|NCT03604692|467390199|FG003|Overall Study|Progressive Disease|0|||
129842984|NCT03604692|467390200|FG004|Overall Study|Progressive Disease|3|||
129842985|NCT03604692|467390201|FG005|Overall Study|Progressive Disease|4|||
129842986|NCT03604692|467390196|FG000|Overall Study|Difficulty Coming into Site|0|||
129842987|NCT03604692|467390197|FG001|Overall Study|Difficulty Coming into Site|0|||
129842988|NCT03604692|467390198|FG002|Overall Study|Difficulty Coming into Site|0|||
129842989|NCT03604692|467390199|FG003|Overall Study|Difficulty Coming into Site|0|||
129842990|NCT03604692|467390200|FG004|Overall Study|Difficulty Coming into Site|0|||
129842991|NCT03604692|467390201|FG005|Overall Study|Difficulty Coming into Site|1|||
129842992|NCT03604692|467390196|FG000|Overall Study|Death|0|||
129842993|NCT03604692|467390197|FG001|Overall Study|Death|0|||
129842994|NCT03604692|467390198|FG002|Overall Study|Death|1|||
129842995|NCT03604692|467390199|FG003|Overall Study|Death|0|||
129842996|NCT03604692|467390200|FG004|Overall Study|Death|0|||
129842997|NCT03604692|467390201|FG005|Overall Study|Death|0|||
129842998|NCT03604692|467390196|FG000|Overall Study|Drug Intolerance|0|||
129842999|NCT03604692|467390197|FG001|Overall Study|Drug Intolerance|0|||
129843000|NCT03604692|467390198|FG002|Overall Study|Drug Intolerance|0|||
129843001|NCT03604692|467390199|FG003|Overall Study|Drug Intolerance|1|||
129843002|NCT03604692|467390200|FG004|Overall Study|Drug Intolerance|0|||
129843003|NCT03604692|467390201|FG005|Overall Study|Drug Intolerance|0|||
129843004|NCT03604692|467390196|FG000|Overall Study|Noncompliance with follow-up visit|0|||
129843005|NCT03604692|467390197|FG001|Overall Study|Noncompliance with follow-up visit|0|||
129843006|NCT03604692|467390198|FG002|Overall Study|Noncompliance with follow-up visit|0|||
129843007|NCT03604692|467390199|FG003|Overall Study|Noncompliance with follow-up visit|1|||
129843008|NCT03604692|467390200|FG004|Overall Study|Noncompliance with follow-up visit|0|||
129843009|NCT03604692|467390201|FG005|Overall Study|Noncompliance with follow-up visit|0|||
129843010|NCT03604692|467390196|FG000|Overall Study|Not Treated|0|||
129843011|NCT03604692|467390197|FG001|Overall Study|Not Treated|0|||
129843012|NCT03604692|467390198|FG002|Overall Study|Not Treated|0|||
129843013|NCT03604692|467390199|FG003|Overall Study|Not Treated|0|||
129843014|NCT03604692|467390200|FG004|Overall Study|Not Treated|1|||
129843015|NCT03604692|467390201|FG005|Overall Study|Not Treated|0|||
129843016|NCT01946204|467390202|FG000|Overall Study|Death|38|||
129843017|NCT01946204|467390203|FG001|Overall Study|Death|59|||
129843018|NCT01946204|467390202|FG000|Overall Study|Withdrawal by Subject|37|||
129843019|NCT01946204|467390203|FG001|Overall Study|Withdrawal by Subject|50|||
129843020|NCT01946204|467390202|FG000|Overall Study|Lost to Follow-up|3|||
129843021|NCT01946204|467390203|FG001|Overall Study|Lost to Follow-up|7|||
129843022|NCT01946204|467390202|FG000|Overall Study|Ongoing|316|||
129843023|NCT01946204|467390203|FG001|Overall Study|Ongoing|687|||
129843024|NCT01946204|467390202|FG000|Overall Study|Other|7|||
129843025|NCT01946204|467390203|FG001|Overall Study|Other|3|||
129843026|NCT03466411|467390204|FG000|Overall Study|Lost to Follow-up|0|||
129843027|NCT03466411|467390205|FG001|Overall Study|Lost to Follow-up|1|||
129843028|NCT03466411|467390206|FG002|Overall Study|Lost to Follow-up|1|||
129843029|NCT03466411|467390207|FG003|Overall Study|Lost to Follow-up|0|||
129843030|NCT03466411|467390208|FG004|Overall Study|Lost to Follow-up|0|||
129843031|NCT03466411|467390209|FG005|Overall Study|Lost to Follow-up|0|||
129843032|NCT03466411|467390210|FG006|Overall Study|Lost to Follow-up|1|||
129843033|NCT03466411|467390211|FG007|Overall Study|Lost to Follow-up|1|||
129843034|NCT03466411|467390212|FG008|Overall Study|Lost to Follow-up|0|||
129843035|NCT03466411|467390213|FG009|Overall Study|Lost to Follow-up|1|||
129843036|NCT03466411|467390214|FG010|Overall Study|Lost to Follow-up|1|||
129843037|NCT03466411|467390215|FG011|Overall Study|Lost to Follow-up|1|||
129843038|NCT03466411|467390216|FG012|Overall Study|Lost to Follow-up|0|||
129843039|NCT03466411|467390204|FG000|Overall Study|Withdrawal by Subject|14|||
129843040|NCT03466411|467390205|FG001|Overall Study|Withdrawal by Subject|7|||
129843041|NCT03466411|467390206|FG002|Overall Study|Withdrawal by Subject|8|||
129843042|NCT03466411|467390207|FG003|Overall Study|Withdrawal by Subject|4|||
129843043|NCT03466411|467390208|FG004|Overall Study|Withdrawal by Subject|6|||
129843044|NCT03466411|467390209|FG005|Overall Study|Withdrawal by Subject|3|||
129843045|NCT03466411|467390210|FG006|Overall Study|Withdrawal by Subject|6|||
129843046|NCT03466411|467390211|FG007|Overall Study|Withdrawal by Subject|9|||
129843047|NCT03466411|467390212|FG008|Overall Study|Withdrawal by Subject|6|||
129843048|NCT03466411|467390213|FG009|Overall Study|Withdrawal by Subject|11|||
129843049|NCT03466411|467390214|FG010|Overall Study|Withdrawal by Subject|14|||
129843050|NCT03466411|467390215|FG011|Overall Study|Withdrawal by Subject|12|||
129843051|NCT03466411|467390216|FG012|Overall Study|Withdrawal by Subject|7|||
129843052|NCT03466411|467390204|FG000|Overall Study|Other|1|||
129843053|NCT03466411|467390205|FG001|Overall Study|Other|1|||
129843054|NCT03466411|467390206|FG002|Overall Study|Other|0|||
129843055|NCT03466411|467390207|FG003|Overall Study|Other|1|||
129843056|NCT03466411|467390208|FG004|Overall Study|Other|2|||
129843057|NCT03466411|467390209|FG005|Overall Study|Other|0|||
129843058|NCT03466411|467390210|FG006|Overall Study|Other|0|||
129843059|NCT03466411|467390211|FG007|Overall Study|Other|0|||
129843060|NCT03466411|467390212|FG008|Overall Study|Other|0|||
129843061|NCT03466411|467390213|FG009|Overall Study|Other|1|||
129843062|NCT03466411|467390214|FG010|Overall Study|Other|2|||
129843063|NCT03466411|467390215|FG011|Overall Study|Other|0|||
129843064|NCT03466411|467390216|FG012|Overall Study|Other|0|||
129843065|NCT03466411|467390204|FG000|Overall Study|Randomized but not Treated|0|||
129843066|NCT03466411|467390205|FG001|Overall Study|Randomized but not Treated|0|||
129843067|NCT03466411|467390206|FG002|Overall Study|Randomized but not Treated|0|||
129843068|NCT03466411|467390207|FG003|Overall Study|Randomized but not Treated|0|||
129843069|NCT03466411|467390208|FG004|Overall Study|Randomized but not Treated|0|||
129843070|NCT03466411|467390209|FG005|Overall Study|Randomized but not Treated|0|||
129843071|NCT03466411|467390210|FG006|Overall Study|Randomized but not Treated|1|||
129843072|NCT03466411|467390211|FG007|Overall Study|Randomized but not Treated|0|||
129843073|NCT03466411|467390212|FG008|Overall Study|Randomized but not Treated|0|||
129843074|NCT03466411|467390213|FG009|Overall Study|Randomized but not Treated|0|||
129843075|NCT03466411|467390214|FG010|Overall Study|Randomized but not Treated|0|||
129843076|NCT03466411|467390215|FG011|Overall Study|Randomized but not Treated|0|||
129843077|NCT03466411|467390216|FG012|Overall Study|Randomized but not Treated|0|||
129843078|NCT04115358|467390219|FG000|Overall Study|exfoliation|0|||
129843079|NCT04115358|467390220|FG001|Overall Study|exfoliation|0|||
129843080|NCT04115358|467390221|FG002|Overall Study|exfoliation|1|||
129843081|NCT02681302|467390224|FG000|Overall Study|Withdrawal by Subject|1|||
129843082|NCT02681302|467390225|FG001|Overall Study|Withdrawal by Subject|1|||
129843083|NCT02681302|467390226|FG002|Overall Study|Withdrawal by Subject|0|||
129843084|NCT02681302|467390227|FG003|Overall Study|Withdrawal by Subject|0|||
129843085|NCT02681302|467390228|FG004|Overall Study|Withdrawal by Subject|1|||
129843086|NCT02681302|467390229|FG005|Overall Study|Withdrawal by Subject|0|||
129843087|NCT02681302|467390224|FG000|Overall Study|Screen Failure|2|||
129843088|NCT02681302|467390225|FG001|Overall Study|Screen Failure|4|||
129843089|NCT02681302|467390226|FG002|Overall Study|Screen Failure|2|||
129843090|NCT02681302|467390227|FG003|Overall Study|Screen Failure|0|||
129843091|NCT02681302|467390228|FG004|Overall Study|Screen Failure|1|||
129843092|NCT02681302|467390229|FG005|Overall Study|Screen Failure|1|||
129843093|NCT02681302|467390224|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843094|NCT02681302|467390225|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843095|NCT02681302|467390226|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843096|NCT02681302|467390227|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843097|NCT02681302|467390228|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
129843098|NCT02681302|467390229|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
129843099|NCT02115282|467390230|FG000|Overall Study|Disease progression during treatment|216|||
129843100|NCT02115282|467390231|FG001|Overall Study|Disease progression during treatment|229|||
129843101|NCT02115282|467390230|FG000|Overall Study|Adverse Event|49|||
129843102|NCT02115282|467390231|FG001|Overall Study|Adverse Event|23|||
129843103|NCT02115282|467390230|FG000|Overall Study|Death|1|||
129843104|NCT02115282|467390231|FG001|Overall Study|Death|3|||
129843105|NCT02115282|467390230|FG000|Overall Study|Alternative therapy|1|||
129843106|NCT02115282|467390231|FG001|Overall Study|Alternative therapy|1|||
129843107|NCT02115282|467390230|FG000|Overall Study|Complicating disease|0|||
129843108|NCT02115282|467390231|FG001|Overall Study|Complicating disease|3|||
129843109|NCT02115282|467390230|FG000|Overall Study|Withdrawal by Subject|12|||
129843110|NCT02115282|467390231|FG001|Overall Study|Withdrawal by Subject|10|||
129843111|NCT02115282|467390230|FG000|Overall Study|Symptomatic progression/deterioration|7|||
129843112|NCT02115282|467390231|FG001|Overall Study|Symptomatic progression/deterioration|18|||
129843113|NCT02115282|467390230|FG000|Overall Study|Non-compliance|5|||
129843114|NCT02115282|467390231|FG001|Overall Study|Non-compliance|1|||
129843115|NCT02115282|467390230|FG000|Overall Study|Protocol Violation|2|||
129843116|NCT02115282|467390231|FG001|Overall Study|Protocol Violation|2|||
129843117|NCT02115282|467390230|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
129843118|NCT02115282|467390231|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
129843119|NCT02115282|467390230|FG000|Overall Study|Not start protocol therapy|9|||
129843120|NCT02115282|467390231|FG001|Overall Study|Not start protocol therapy|10|||
129843121|NCT02152995|467390234|FG000|Overall Study|Withdrawal by Subject|1|||
129843122|NCT02152995|467390235|FG001|Overall Study|Withdrawal by Subject|0|||
129843123|NCT00480779|467390237|FG000|Overall Study|Other|2|||
129843124|NCT00480779|467390238|FG001|Overall Study|Other|0|||
129843125|NCT00480779|467390237|FG000|Overall Study|Job and Health-related|0|||
129843126|NCT00480779|467390238|FG001|Overall Study|Job and Health-related|3|||
129843127|NCT04907032|467390239|FG000|Overall Study|Withdrawal by Subject|7|||
129843128|NCT04907032|467390240|FG001|Overall Study|Withdrawal by Subject|1|||
129843129|NCT00613509|467390241|FG000|Cycle 1|Adverse Event|2|||
129843130|NCT00613509|467390242|FG001|Cycle 1|Adverse Event|1|||
129843131|NCT00613509|467390241|FG000|Cycle 1|Disease Progression|2|||
129843132|NCT00613509|467390242|FG001|Cycle 1|Disease Progression|6|||
129843133|NCT00613509|467390241|FG000|Cycle 1|Unacceptable Toxicity|1|||
129843134|NCT00613509|467390242|FG001|Cycle 1|Unacceptable Toxicity|0|||
129843135|NCT00613509|467390241|FG000|Cycle 1|Other administrative reason|0|||
129843136|NCT00613509|467390242|FG001|Cycle 1|Other administrative reason|1|||
129843137|NCT01723228|467390258|FG000|Overall Study|Adverse Event|2|||
129843138|NCT01723228|467390259|FG001|Overall Study|Adverse Event|6|||
129843139|NCT01723228|467390258|FG000|Overall Study|Withdrawal by Subject|2|||
129843140|NCT01723228|467390259|FG001|Overall Study|Withdrawal by Subject|1|||
129843141|NCT01723228|467390258|FG000|Overall Study|Protocol Violation|0|||
129843142|NCT01723228|467390259|FG001|Overall Study|Protocol Violation|2|||
129843143|NCT01723228|467390258|FG000|Overall Study|Lost to Follow-up|2|||
129843144|NCT01723228|467390259|FG001|Overall Study|Lost to Follow-up|1|||
129843145|NCT01723228|467390258|FG000|Overall Study|Other|2|||
129843146|NCT01723228|467390259|FG001|Overall Study|Other|1|||
129843147|NCT01451424|467390262|FG000|Overall Study|Withdrawal by Subject|1|||
129843148|NCT01451424|467390263|FG001|Overall Study|Withdrawal by Subject|1|||
129843149|NCT01451424|467390264|FG002|Overall Study|Withdrawal by Subject|0|||
129843150|NCT01451424|467390265|FG003|Overall Study|Withdrawal by Subject|2|||
129843151|NCT01451424|467390262|FG000|Overall Study|Lost to Follow-up|0|||
129843152|NCT01451424|467390263|FG001|Overall Study|Lost to Follow-up|1|||
129843153|NCT01451424|467390264|FG002|Overall Study|Lost to Follow-up|0|||
129843154|NCT01451424|467390265|FG003|Overall Study|Lost to Follow-up|1|||
129843155|NCT01451424|467390262|FG000|Overall Study|Physician Decision|0|||
129843156|NCT01451424|467390263|FG001|Overall Study|Physician Decision|0|||
129843157|NCT01451424|467390264|FG002|Overall Study|Physician Decision|1|||
129843158|NCT01451424|467390265|FG003|Overall Study|Physician Decision|1|||
129843159|NCT01451424|467390262|FG000|Overall Study|Adverse Event|0|||
129843160|NCT01451424|467390263|FG001|Overall Study|Adverse Event|0|||
129843161|NCT01451424|467390264|FG002|Overall Study|Adverse Event|0|||
129843162|NCT01451424|467390265|FG003|Overall Study|Adverse Event|1|||
129843163|NCT00528528|467390267|FG000|Overall Study|Lost to Follow-up|0|||
129843164|NCT00528528|467390268|FG001|Overall Study|Lost to Follow-up|0|||
129843165|NCT00528528|467390269|FG002|Overall Study|Lost to Follow-up|1|||
129843166|NCT00528528|467390270|FG003|Overall Study|Lost to Follow-up|1|||
129843167|NCT00528528|467390267|FG000|Overall Study|Ineligible to continue the trial|0|||
129843168|NCT00528528|467390268|FG001|Overall Study|Ineligible to continue the trial|0|||
129843169|NCT00528528|467390269|FG002|Overall Study|Ineligible to continue the trial|0|||
129843170|NCT00528528|467390270|FG003|Overall Study|Ineligible to continue the trial|1|||
129843171|NCT00528528|467390267|FG000|Overall Study|Other|0|||
129843172|NCT00528528|467390268|FG001|Overall Study|Other|1|||
129843173|NCT00528528|467390269|FG002|Overall Study|Other|0|||
129843174|NCT00528528|467390270|FG003|Overall Study|Other|0|||
129843175|NCT00528528|467390267|FG000|Overall Study|Withdrawal by Subject|3|||
129843176|NCT00528528|467390268|FG001|Overall Study|Withdrawal by Subject|2|||
129843177|NCT00528528|467390269|FG002|Overall Study|Withdrawal by Subject|1|||
129843178|NCT00528528|467390270|FG003|Overall Study|Withdrawal by Subject|1|||
129843179|NCT00528528|467390267|FG000|Overall Study|Ongoing participant|0|||
129843180|NCT00528528|467390268|FG001|Overall Study|Ongoing participant|0|||
129843181|NCT00528528|467390269|FG002|Overall Study|Ongoing participant|1|||
129843182|NCT00528528|467390270|FG003|Overall Study|Ongoing participant|0|||
129843183|NCT04325828|467390271|FG000|Overall Study|Ongoing|26|||
129843184|NCT03508219|467390272|FG000|Overall Study|Death|2|||
129843185|NCT03508219|467390272|FG000|Overall Study|Withdrawal by Subject|1|||
129843186|NCT03508219|467390272|FG000|Overall Study|Lost to Follow-up|4|||
129843187|NCT03508219|467390272|FG000|Overall Study|Missed visit|2|||
129843188|NCT03945981|467390273|FG000|Overall Study|Lost to Follow-up|12|||
129843189|NCT03945981|467390273|FG000|Overall Study|Physician Decision|4|||
129843190|NCT03945981|467390273|FG000|Overall Study|Withdrawal by Subject|6|||
129843191|NCT03945981|467390273|FG000|Overall Study|Protocol Violation|1|||
129843192|NCT04466891|467390274|FG000|Overall Study|Death|60|||
129843193|NCT04466891|467390275|FG001|Overall Study|Death|6|||
129843194|NCT04466891|467390274|FG000|Overall Study|Withdrawal by Subject|8|||
129843195|NCT04466891|467390275|FG001|Overall Study|Withdrawal by Subject|1|||
129843196|NCT04466891|467390274|FG000|Overall Study|Study terminated by sponsor|5|||
129843197|NCT04466891|467390275|FG001|Overall Study|Study terminated by sponsor|0|||
129843198|NCT04466891|467390274|FG000|Overall Study|Lost to Follow-up|2|||
129843199|NCT04466891|467390275|FG001|Overall Study|Lost to Follow-up|0|||
129843200|NCT04466891|467390274|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
129843201|NCT04466891|467390275|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
129843202|NCT03091192|467390276|FG000|Overall Study|Study terminated by sponsor|21|||
129843203|NCT03091192|467390277|FG001|Overall Study|Study terminated by sponsor|14|||
129843204|NCT03091192|467390276|FG000|Overall Study|Death|9|||
129843205|NCT03091192|467390277|FG001|Overall Study|Death|13|||
129843206|NCT03091192|467390276|FG000|Overall Study|Withdrawal by Subject|2|||
129843207|NCT03091192|467390277|FG001|Overall Study|Withdrawal by Subject|0|||
129843208|NCT03091192|467390276|FG000|Overall Study|Lost to Follow-up|1|||
129843209|NCT03091192|467390277|FG001|Overall Study|Lost to Follow-up|0|||
129843210|NCT04487080|467390280|FG000|Overall Study|Withdrawal by Subject|19|||
129843211|NCT04487080|467390281|FG001|Overall Study|Withdrawal by Subject|18|||
129843212|NCT04487080|467390282|FG002|Overall Study|Withdrawal by Subject|13|||
129449257|NCT00915772|465945602|FG001|Overall Study|Refused to continue trial medication|8|||
129449258|NCT00915772|465945603|FG002|Overall Study|Refused to continue trial medication|4|||
129449259|NCT00915772|465945601|FG000|Overall Study|Any other reason|4|||
129449260|NCT00915772|465945602|FG001|Overall Study|Any other reason|7|||
129449261|NCT00915772|465945603|FG002|Overall Study|Any other reason|7|||
129449262|NCT03583450|465945604|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
129449263|NCT03583450|465945605|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
129901080|NCT01196429|467597257|FG000|Overall Study|Refused - Never Treated|1|||
129901081|NCT01196429|467597258|FG001|Overall Study|Refused - Never Treated|0|||
129901082|NCT02486588|467597259|FG000|Overall Study|Randomized in error- ineligible|738|||
129901083|NCT02486588|467597260|FG001|Overall Study|Randomized in error- ineligible|750|||
129901084|NCT02486588|467597261|FG002|Overall Study|Randomized in error- ineligible|755|||
129449264|NCT03374995|465945606|FG000|Overall Study|Withdrawal by Subject|0|||
129449265|NCT03374995|465945607|FG001|Overall Study|Withdrawal by Subject|1|||
129449266|NCT01383096|465945608|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
129449267|NCT01383096|465945609|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
129449268|NCT01383096|465945610|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
129449269|NCT01383096|465945608|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
129449270|NCT01383096|465945609|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
129449271|NCT01383096|465945610|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
129449272|NCT01383096|465945608|FG000|Third Intervention (8 Days)|Elevated AST|0|||
129449273|NCT01383096|465945609|FG001|Third Intervention (8 Days)|Elevated AST|1|||
129449274|NCT01383096|465945610|FG002|Third Intervention (8 Days)|Elevated AST|0|||
129449275|NCT01383096|465945608|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
129449276|NCT01383096|465945609|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
129449277|NCT01383096|465945610|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
129449278|NCT01383096|465945608|FG000|Third Intervention (8 Days)|Adverse Event|1|||
129449279|NCT01383096|465945609|FG001|Third Intervention (8 Days)|Adverse Event|0|||
129449280|NCT01383096|465945610|FG002|Third Intervention (8 Days)|Adverse Event|0|||
129449281|NCT01383096|465945608|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
129449282|NCT01383096|465945609|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
129449283|NCT01383096|465945610|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
129449284|NCT01383096|465945608|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
129449285|NCT01383096|465945609|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
129449286|NCT01383096|465945610|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
129449287|NCT01383096|465945608|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
129449288|NCT01383096|465945609|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
129449289|NCT01383096|465945610|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
129449290|NCT01383096|465945608|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
129449291|NCT01383096|465945609|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
129449292|NCT01383096|465945610|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
129449293|NCT01383096|465945608|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
129449294|NCT01383096|465945609|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
129449295|NCT01383096|465945610|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
129449296|NCT01383096|465945608|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
129449297|NCT01383096|465945609|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
129449298|NCT01383096|465945610|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
129449299|NCT01211535|465945611|FG000|Overall Study|Adverse Event|0|||
129449300|NCT01211535|465945612|FG001|Overall Study|Adverse Event|1|||
129449301|NCT01380730|465945615|FG000|Overall Study|Death|0|||
129449302|NCT01380730|465945616|FG001|Overall Study|Death|0|||
129449303|NCT01380730|465945617|FG002|Overall Study|Death|0|||
129449304|NCT01380730|465945618|FG003|Overall Study|Death|0|||
129449305|NCT01380730|465945619|FG004|Overall Study|Death|1|||
129449306|NCT01380730|465945620|FG005|Overall Study|Death|0|||
129901085|NCT02486588|467597262|FG003|Overall Study|Randomized in error- ineligible|738|||
129901086|NCT02486588|467597263|FG004|Overall Study|Randomized in error- ineligible|746|||
129901087|NCT02486588|467597264|FG005|Overall Study|Randomized in error- ineligible|746|||
129901088|NCT04248829|467597265|FG000|Overall Study|Disease progression|44|||
129901089|NCT04248829|467597266|FG001|Overall Study|Disease progression|109|||
129449307|NCT01380730|465945621|FG006|Overall Study|Death|0|||
129449308|NCT01380730|465945622|FG007|Overall Study|Death|0|||
129901090|NCT04248829|467597265|FG000|Overall Study|Adverse Event|19|||
129901091|NCT04248829|467597266|FG001|Overall Study|Adverse Event|18|||
129449309|NCT00467779|465945623|FG000|Stage 1|Adverse Event|1|||
129449310|NCT00467779|465945624|FG001|Stage 1|Adverse Event|0|||
129449311|NCT00467779|465945625|FG002|Stage 1|Adverse Event|0|||
129449312|NCT00467779|465945626|FG003|Stage 1|Adverse Event|0|||
129449313|NCT00467779|465945627|FG004|Stage 1|Adverse Event|0|||
129449314|NCT00467779|465945628|FG005|Stage 1|Adverse Event|1|||
129449315|NCT00467779|465945629|FG006|Stage 1|Adverse Event|2|||
129449316|NCT00467779|465945630|FG007|Stage 1|Adverse Event|1|||
129843213|NCT04487080|467390280|FG000|Overall Study|Lost to Follow-up|3|||
129843214|NCT04487080|467390281|FG001|Overall Study|Lost to Follow-up|1|||
129843215|NCT04487080|467390282|FG002|Overall Study|Lost to Follow-up|0|||
129843216|NCT04487080|467390280|FG000|Overall Study|Ongoing|313|||
129843217|NCT04487080|467390281|FG001|Overall Study|Ongoing|297|||
129843218|NCT04487080|467390282|FG002|Overall Study|Ongoing|149|||
129843219|NCT05645432|467390283|FG000|Overall Study|Withdrawal by Subject|1|||
129843220|NCT03195478|467390284|FG000|Overall Study|Disease Progression|5|||
129843221|NCT03195478|467390285|FG001|Overall Study|Disease Progression|4|||
129843222|NCT03195478|467390286|FG002|Overall Study|Disease Progression|6|||
129843223|NCT03195478|467390287|FG003|Overall Study|Disease Progression|1|||
129843224|NCT03195478|467390284|FG000|Overall Study|Study Drug Toxicity|2|||
129843225|NCT03195478|467390285|FG001|Overall Study|Study Drug Toxicity|0|||
129843226|NCT03195478|467390286|FG002|Overall Study|Study Drug Toxicity|0|||
129843227|NCT03195478|467390287|FG003|Overall Study|Study Drug Toxicity|1|||
129843228|NCT03195478|467390284|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
129843229|NCT03195478|467390285|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
129843230|NCT03195478|467390286|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
129843231|NCT03195478|467390287|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
129843232|NCT03195478|467390284|FG000|Overall Study|Participant Withdrew Consent|1|||
129843233|NCT03195478|467390285|FG001|Overall Study|Participant Withdrew Consent|0|||
129843234|NCT03195478|467390286|FG002|Overall Study|Participant Withdrew Consent|0|||
129843235|NCT03195478|467390287|FG003|Overall Study|Participant Withdrew Consent|0|||
129843236|NCT03195478|467390284|FG000|Overall Study|Maximum Clinical benefit|0|||
129843237|NCT03195478|467390285|FG001|Overall Study|Maximum Clinical benefit|0|||
129843238|NCT03195478|467390286|FG002|Overall Study|Maximum Clinical benefit|1|||
129843239|NCT03195478|467390287|FG003|Overall Study|Maximum Clinical benefit|0|||
129843240|NCT03195478|467390284|FG000|Overall Study|Other Reasons|0|||
129843241|NCT03195478|467390285|FG001|Overall Study|Other Reasons|0|||
129843242|NCT03195478|467390286|FG002|Overall Study|Other Reasons|1|||
129843243|NCT03195478|467390287|FG003|Overall Study|Other Reasons|0|||
129843244|NCT03890367|467390288|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129843245|NCT03890367|467390289|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129843246|NCT03890367|467390290|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129843247|NCT03890367|467390288|FG000|Overall Study|Protocol deviation|2|||
129843248|NCT03890367|467390289|FG001|Overall Study|Protocol deviation|2|||
129843249|NCT03890367|467390290|FG002|Overall Study|Protocol deviation|1|||
129843250|NCT03890367|467390288|FG000|Overall Study|Lost to Follow-up|1|||
129843251|NCT03890367|467390289|FG001|Overall Study|Lost to Follow-up|1|||
129843252|NCT03890367|467390290|FG002|Overall Study|Lost to Follow-up|0|||
129843253|NCT03370341|467391928|FG000|Overall Study|Lost to Follow-up|0|||
129843254|NCT03370341|467391929|FG001|Overall Study|Lost to Follow-up|1|||
129843255|NCT01707004|467391932|FG000|Overall Study|Physician Decision|3|||
129843256|NCT00533949|467391933|FG000|Overall Study|Protocol Violation|12|||
129843257|NCT00533949|467391934|FG001|Overall Study|Protocol Violation|12|||
129843258|NCT00533949|467391935|FG002|Overall Study|Protocol Violation|9|||
129843259|NCT00533949|467391936|FG003|Overall Study|Protocol Violation|9|||
129843260|NCT00533949|467391933|FG000|Overall Study|Withdrawal by Subject|3|||
129843261|NCT00533949|467391934|FG001|Overall Study|Withdrawal by Subject|2|||
129843262|NCT00533949|467391935|FG002|Overall Study|Withdrawal by Subject|1|||
129843263|NCT00533949|467391936|FG003|Overall Study|Withdrawal by Subject|1|||
129843264|NCT00727194|467391937|FG000|Screening Period|Low QMG scores|0|||
129843265|NCT00727194|467391938|FG001|Screening Period|Low QMG scores|0|||
129843266|NCT00727194|467391939|FG002|Screening Period|Low QMG scores|6|||
129843267|NCT00727194|467391937|FG000|Screening Period|Lacked AChR antibodies|0|||
129843268|NCT00727194|467391938|FG001|Screening Period|Lacked AChR antibodies|0|||
129843269|NCT00727194|467391939|FG002|Screening Period|Lacked AChR antibodies|5|||
129843270|NCT00727194|467391937|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
129843271|NCT00727194|467391938|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
129843272|NCT00727194|467391939|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
129843273|NCT00727194|467391937|FG000|Screening Period|Severe infections|0|||
129843274|NCT00727194|467391938|FG001|Screening Period|Severe infections|0|||
129843275|NCT00727194|467391939|FG002|Screening Period|Severe infections|2|||
129843276|NCT00727194|467391937|FG000|Screening Period|History of thymoma|0|||
129843277|NCT00727194|467391938|FG001|Screening Period|History of thymoma|0|||
129843278|NCT00727194|467391939|FG002|Screening Period|History of thymoma|1|||
129843279|NCT00727194|467391937|FG000|Treatment Period 2|Lack of Efficacy|0|||
129843280|NCT00727194|467391938|FG001|Treatment Period 2|Lack of Efficacy|1|||
129843281|NCT00727194|467391939|FG002|Treatment Period 2|Lack of Efficacy|0|||
129843282|NCT04269161|467391945|FG000|Overall Study|Change of modality and no longer eligible|3|||
129843283|NCT04269161|467391946|FG001|Overall Study|Change of modality and no longer eligible|3|||
129843284|NCT04269161|467391945|FG000|Overall Study|Required procedure outside of NICU|1|||
129843285|NCT04269161|467391946|FG001|Overall Study|Required procedure outside of NICU|0|||
129843286|NCT04269161|467391945|FG000|Overall Study|Equipment issue|1|||
129843287|NCT04269161|467391946|FG001|Overall Study|Equipment issue|1|||
129843288|NCT01677195|467391947|FG000|Overall Study|Lost to Follow-up|14|||
129901092|NCT04248829|467597265|FG000|Overall Study|Withdrawal by Subject|11|||
129901093|NCT04248829|467597266|FG001|Overall Study|Withdrawal by Subject|2|||
129901094|NCT04248829|467597265|FG000|Overall Study|Lost to Follow-up|0|||
129901095|NCT04248829|467597266|FG001|Overall Study|Lost to Follow-up|1|||
129901096|NCT04248829|467597265|FG000|Overall Study|Death|12|||
129901097|NCT04248829|467597266|FG001|Overall Study|Death|14|||
129901098|NCT04248829|467597265|FG000|Overall Study|Physician Decision|2|||
129901099|NCT04248829|467597266|FG001|Overall Study|Physician Decision|4|||
129901100|NCT04248829|467597265|FG000|Overall Study|Any reason not specifically recorded|0|||
129901101|NCT04248829|467597266|FG001|Overall Study|Any reason not specifically recorded|2|||
129901102|NCT02132702|467597267|FG000|Overall Study|Protocol Violation|2|||
129901103|NCT02132702|467597267|FG000|Overall Study|Adverse Event|3|||
129901104|NCT02132702|467597267|FG000|Overall Study|Withdrawal by Subject|3|||
129901105|NCT03354390|467597268|FG000|Level 1|Death|2|||
129901106|NCT03354390|467597269|FG001|Level 1|Death|0|||
129901107|NCT03354390|467597270|FG002|Level 1|Death|0|||
129901108|NCT03354390|467597271|FG003|Level 1|Death|0|||
129901109|NCT03354390|467597268|FG000|Level 1|Physician Decision|1|||
129901110|NCT03354390|467597269|FG001|Level 1|Physician Decision|0|||
129901111|NCT03354390|467597270|FG002|Level 1|Physician Decision|0|||
129901112|NCT03354390|467597271|FG003|Level 1|Physician Decision|0|||
129901113|NCT03354390|467597268|FG000|Level 2|Physician Decision|0|||
129901114|NCT03354390|467597269|FG001|Level 2|Physician Decision|2|||
129901115|NCT03354390|467597270|FG002|Level 2|Physician Decision|0|||
129901116|NCT03354390|467597271|FG003|Level 2|Physician Decision|0|||
129901117|NCT03354390|467597268|FG000|Level 2|Lack of Efficacy|0|||
129901118|NCT03354390|467597269|FG001|Level 2|Lack of Efficacy|1|||
129901119|NCT03354390|467597270|FG002|Level 2|Lack of Efficacy|0|||
129901120|NCT03354390|467597271|FG003|Level 2|Lack of Efficacy|0|||
129901121|NCT03354390|467597268|FG000|Level 2|Lost to Follow-up|0|||
129901122|NCT03354390|467597269|FG001|Level 2|Lost to Follow-up|1|||
129901123|NCT03354390|467597270|FG002|Level 2|Lost to Follow-up|0|||
129901124|NCT03354390|467597271|FG003|Level 2|Lost to Follow-up|0|||
129901125|NCT03354390|467597268|FG000|Level 3|Death|0|||
129901126|NCT03354390|467597269|FG001|Level 3|Death|0|||
129901127|NCT03354390|467597270|FG002|Level 3|Death|1|||
129901128|NCT03354390|467597271|FG003|Level 3|Death|0|||
129901129|NCT03354390|467597268|FG000|Level 3|Physician Decision|0|||
129901130|NCT03354390|467597269|FG001|Level 3|Physician Decision|0|||
129901131|NCT03354390|467597270|FG002|Level 3|Physician Decision|2|||
129901132|NCT03354390|467597271|FG003|Level 3|Physician Decision|0|||
129901133|NCT03354390|467597268|FG000|Level 4|Death|0|||
129901134|NCT03354390|467597269|FG001|Level 4|Death|0|||
129901135|NCT03354390|467597270|FG002|Level 4|Death|0|||
129901136|NCT03354390|467597271|FG003|Level 4|Death|3|||
129901137|NCT01066923|467597272|FG000|Overall Study|Withdrawal by Subject|3|||
129901138|NCT01066923|467597273|FG001|Overall Study|Withdrawal by Subject|3|||
129901139|NCT01066923|467597274|FG002|Overall Study|Withdrawal by Subject|8|||
129901140|NCT01066923|467597275|FG003|Overall Study|Withdrawal by Subject|8|||
129979660|NCT00403767|467889417|FG000|Overall Study|Study terminated by sponsor|82|||
129979661|NCT00403767|467889418|FG001|Overall Study|Study terminated by sponsor|69|||
129979662|NCT00403767|467889417|FG000|Overall Study|Missing/incomplete data|1|||
129979663|NCT00403767|467889418|FG001|Overall Study|Missing/incomplete data|1|||
129979664|NCT01696955|467889419|FG000|Main Study|Protocol Violation|1|||
129979665|NCT01696955|467889420|FG001|Main Study|Protocol Violation|0|||
129979666|NCT01696955|467889419|FG000|Main Study|Withdrawal by Subject|1|||
129979667|NCT01696955|467889420|FG001|Main Study|Withdrawal by Subject|1|||
129979668|NCT03192475|467889421|FG000|Overall Study|Death|0|||
129979669|NCT03192475|467889422|FG001|Overall Study|Death|1|||
129979670|NCT03192475|467889421|FG000|Overall Study|Lost to Follow-up|13|||
129979671|NCT03192475|467889422|FG001|Overall Study|Lost to Follow-up|8|||
129449317|NCT00467779|465945631|FG008|Stage 1|Adverse Event|0|||
129449318|NCT00467779|465945632|FG009|Stage 1|Adverse Event|0|||
129449319|NCT00467779|465945633|FG010|Stage 1|Adverse Event|0|||
129449320|NCT00467779|465945634|FG011|Stage 1|Adverse Event|0|||
129449321|NCT00467779|465945635|FG012|Stage 1|Adverse Event|0|||
129979672|NCT03653208|467889425|FG000|Overall Study|Withdrawal by Subject|0|||
129979673|NCT03653208|467889426|FG001|Overall Study|Withdrawal by Subject|0|||
129979674|NCT03653208|467889427|FG002|Overall Study|Withdrawal by Subject|0|||
129979675|NCT03653208|467889428|FG003|Overall Study|Withdrawal by Subject|0|||
129979676|NCT03653208|467889429|FG004|Overall Study|Withdrawal by Subject|1|||
129979677|NCT03653208|467889430|FG005|Overall Study|Withdrawal by Subject|0|||
129449322|NCT00467779|465945636|FG013|Stage 1|Adverse Event|0|||
129449323|NCT00467779|465945637|FG014|Stage 1|Adverse Event|0|||
129979678|NCT03653208|467889431|FG006|Overall Study|Withdrawal by Subject|0|||
129979679|NCT03653208|467889432|FG007|Overall Study|Withdrawal by Subject|1|||
129979680|NCT03653208|467889433|FG008|Overall Study|Withdrawal by Subject|1|||
129979681|NCT00436605|467889434|FG000|Overall Study|Protocol Violation|3|||
129979682|NCT03752970|467889435|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
129979683|NCT03752970|467889436|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
129979684|NCT03752970|467889437|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
129449324|NCT00467779|465945623|FG000|Stage 1|Disease Progression|2|||
129901141|NCT01144468|467598776|FG000|Overall Study|Lost to Follow-up|4|||
129901142|NCT01144468|467598777|FG001|Overall Study|Lost to Follow-up|7|||
129901143|NCT01144468|467598776|FG000|Overall Study|Adverse Event|3|||
129901144|NCT01144468|467598777|FG001|Overall Study|Adverse Event|2|||
129901145|NCT01144468|467598776|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
129901146|NCT01144468|467598777|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
129901147|NCT01875250|467598778|FG000|Overall Study|Adverse Event|2|||
129901148|NCT01875250|467598779|FG001|Overall Study|Adverse Event|0|||
129901149|NCT00149630|467598785|FG000|Overall Study|Incarceration|2|||
129901150|NCT00149630|467598786|FG001|Overall Study|Incarceration|0|||
129901151|NCT00149630|467598785|FG000|Overall Study|Treatment Programs|4|||
129901152|NCT00149630|467598786|FG001|Overall Study|Treatment Programs|5|||
129901153|NCT00149630|467598785|FG000|Overall Study|Adverse Event|2|||
129901154|NCT00149630|467598786|FG001|Overall Study|Adverse Event|0|||
129901155|NCT05298111|467598788|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
129901156|NCT05298111|467598789|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
129901157|NCT02689349|467598790|FG000|Overall Study|Not implanted|4|||
129901158|NCT02689349|467598791|FG001|Overall Study|Not implanted|0|||
129901159|NCT02689349|467598790|FG000|Overall Study|Withdrawal by Subject|9|||
129901160|NCT02689349|467598791|FG001|Overall Study|Withdrawal by Subject|0|||
129901161|NCT03518112|467598792|FG000|Overall Study|Withdrawal by Subject|1|||
129901162|NCT01546155|467598793|FG000|Overall Study|could not tolerate long scan duration|3|||
129901163|NCT00377455|467598794|FG000|Overall Study|Withdrawal by Subject|1|||
129901164|NCT02034916|467598797|FG000|Overall Study|Death|39|||
129901165|NCT02034916|467598798|FG001|Overall Study|Death|28|||
129901166|NCT02034916|467598797|FG000|Overall Study|Withdrawal by Subject|2|||
129901167|NCT02034916|467598798|FG001|Overall Study|Withdrawal by Subject|1|||
129901168|NCT02034916|467598797|FG000|Overall Study|Lost to Follow-up|4|||
129901169|NCT02034916|467598798|FG001|Overall Study|Lost to Follow-up|1|||
129901170|NCT02034916|467598797|FG000|Overall Study|Study terminated by sponsor|4|||
129901171|NCT02034916|467598798|FG001|Overall Study|Study terminated by sponsor|5|||
129901172|NCT01616654|467598803|FG000|Overall Study|Lack of Efficacy|1|||
129901173|NCT01616654|467598804|FG001|Overall Study|Lack of Efficacy|0|||
129901174|NCT01616654|467598805|FG002|Overall Study|Lack of Efficacy|0|||
129901175|NCT01616654|467598806|FG003|Overall Study|Lack of Efficacy|0|||
129901176|NCT01616654|467598807|FG004|Overall Study|Lack of Efficacy|1|||
129901177|NCT01616654|467598803|FG000|Overall Study|Adverse Event|0|||
129901178|NCT01616654|467598804|FG001|Overall Study|Adverse Event|1|||
129901179|NCT01616654|467598805|FG002|Overall Study|Adverse Event|2|||
129901180|NCT01616654|467598806|FG003|Overall Study|Adverse Event|1|||
129901181|NCT01616654|467598807|FG004|Overall Study|Adverse Event|0|||
129901182|NCT01616654|467598803|FG000|Overall Study|Withdrawal by Subject|2|||
129901183|NCT01616654|467598804|FG001|Overall Study|Withdrawal by Subject|2|||
129901184|NCT01616654|467598805|FG002|Overall Study|Withdrawal by Subject|3|||
129901185|NCT01616654|467598806|FG003|Overall Study|Withdrawal by Subject|1|||
129901186|NCT01616654|467598807|FG004|Overall Study|Withdrawal by Subject|5|||
129901187|NCT01616654|467598803|FG000|Overall Study|Protocol Violation|0|||
129901188|NCT01616654|467598804|FG001|Overall Study|Protocol Violation|5|||
129901189|NCT01616654|467598805|FG002|Overall Study|Protocol Violation|2|||
129901190|NCT01616654|467598806|FG003|Overall Study|Protocol Violation|4|||
129901191|NCT01616654|467598807|FG004|Overall Study|Protocol Violation|4|||
129901192|NCT01616654|467598803|FG000|Overall Study|Lost to Follow-up|1|||
129901193|NCT01616654|467598804|FG001|Overall Study|Lost to Follow-up|0|||
129901194|NCT01616654|467598805|FG002|Overall Study|Lost to Follow-up|3|||
129901195|NCT01616654|467598806|FG003|Overall Study|Lost to Follow-up|2|||
129901196|NCT01616654|467598807|FG004|Overall Study|Lost to Follow-up|1|||
129901197|NCT01616654|467598803|FG000|Overall Study|Pregnancy|1|||
129901198|NCT01616654|467598804|FG001|Overall Study|Pregnancy|0|||
129901199|NCT01616654|467598805|FG002|Overall Study|Pregnancy|0|||
129901200|NCT01616654|467598806|FG003|Overall Study|Pregnancy|0|||
129901201|NCT01616654|467598807|FG004|Overall Study|Pregnancy|1|||
129901202|NCT02057692|467598811|FG000|Overall Study|Adverse Event|1|||
129901203|NCT02057692|467598812|FG001|Overall Study|Adverse Event|0|||
129901204|NCT02057692|467598813|FG002|Overall Study|Adverse Event|0|||
129901205|NCT02057692|467598814|FG003|Overall Study|Adverse Event|0|||
129901206|NCT02057692|467598811|FG000|Overall Study|Lost to Follow-up|0|||
129901207|NCT02057692|467598812|FG001|Overall Study|Lost to Follow-up|0|||
129901208|NCT02057692|467598813|FG002|Overall Study|Lost to Follow-up|0|||
129901209|NCT02057692|467598814|FG003|Overall Study|Lost to Follow-up|1|||
129901210|NCT02174562|467598815|FG000|Overall Study|Withdrawal by Subject|7|||
129901211|NCT02174562|467598816|FG001|Overall Study|Withdrawal by Subject|2|||
129901212|NCT02174562|467598815|FG000|Overall Study|Death|2|||
129901213|NCT02174562|467598816|FG001|Overall Study|Death|0|||
129901214|NCT02174562|467598815|FG000|Overall Study|Lost to Follow-up|0|||
129901215|NCT02174562|467598816|FG001|Overall Study|Lost to Follow-up|3|||
129901216|NCT00864682|467598817|FG000|Overall Study|Protocol Violation|2|||
129901217|NCT00864682|467598818|FG001|Overall Study|Protocol Violation|1|||
129901218|NCT00864682|467598819|FG002|Overall Study|Protocol Violation|2|||
129901219|NCT00545844|467598820|FG000|Overall Study|Lost to Follow-up|9|||
129843289|NCT01677195|467391948|FG001|Overall Study|Lost to Follow-up|22|||
129843290|NCT01677195|467391949|FG002|Overall Study|Lost to Follow-up|22|||
129843291|NCT01677195|467391947|FG000|Overall Study|Withdrawal by Subject|1|||
129843292|NCT01677195|467391948|FG001|Overall Study|Withdrawal by Subject|0|||
129843293|NCT01677195|467391949|FG002|Overall Study|Withdrawal by Subject|1|||
129843294|NCT01677195|467391947|FG000|Overall Study|Adverse Event|6|||
129843295|NCT01677195|467391948|FG001|Overall Study|Adverse Event|4|||
129843296|NCT01677195|467391949|FG002|Overall Study|Adverse Event|1|||
129843297|NCT01677195|467391947|FG000|Overall Study|Physician Decision|1|||
129843298|NCT01677195|467391948|FG001|Overall Study|Physician Decision|2|||
129843299|NCT01677195|467391949|FG002|Overall Study|Physician Decision|2|||
129843300|NCT01677195|467391947|FG000|Overall Study|Pregnancy|0|||
129843301|NCT01677195|467391948|FG001|Overall Study|Pregnancy|1|||
129843302|NCT01677195|467391949|FG002|Overall Study|Pregnancy|0|||
129843303|NCT01677195|467391947|FG000|Overall Study|Protocol Violation|7|||
129843304|NCT01677195|467391948|FG001|Overall Study|Protocol Violation|3|||
129843305|NCT01677195|467391949|FG002|Overall Study|Protocol Violation|4|||
129843306|NCT02143414|467391951|FG000|Induction|Adverse Event|1|||
129843307|NCT02143414|467391952|FG001|Induction|Adverse Event|2|||
129843308|NCT02143414|467391951|FG000|Induction|Death|1|||
129843309|NCT02143414|467391952|FG001|Induction|Death|2|||
129843310|NCT02143414|467391951|FG000|Induction|Patient refusal|1|||
129843311|NCT02143414|467391952|FG001|Induction|Patient refusal|1|||
129843312|NCT02143414|467391951|FG000|Induction|Refractory|1|||
129843313|NCT02143414|467391952|FG001|Induction|Refractory|0|||
129843314|NCT02143414|467391951|FG000|Induction|Began alternative treatment|1|||
129843315|NCT02143414|467391952|FG001|Induction|Began alternative treatment|0|||
129843316|NCT02143414|467391951|FG000|Induction|Ineligible for postremission|5|||
129843317|NCT02143414|467391952|FG001|Induction|Ineligible for postremission|1|||
129843318|NCT02143414|467391951|FG000|Post-remission|Adverse Event|0|||
129843319|NCT02143414|467391952|FG001|Post-remission|Adverse Event|2|||
129843320|NCT02143414|467391951|FG000|Post-remission|Disease progression/relapse|5|||
129843321|NCT02143414|467391952|FG001|Post-remission|Disease progression/relapse|0|||
129843322|NCT02143414|467391951|FG000|Maintenance|Adverse Event|4|||
129843323|NCT02143414|467391952|FG001|Maintenance|Adverse Event|6|||
129843324|NCT02143414|467391951|FG000|Maintenance|Disease progression/relapse|3|||
129843325|NCT02143414|467391952|FG001|Maintenance|Disease progression/relapse|2|||
129843326|NCT02143414|467391951|FG000|Maintenance|Patient refusal|2|||
129843327|NCT02143414|467391952|FG001|Maintenance|Patient refusal|1|||
129843328|NCT02143414|467391951|FG000|Maintenance|Physician Decision|1|||
129843329|NCT02143414|467391952|FG001|Maintenance|Physician Decision|0|||
129843330|NCT02143414|467391951|FG000|Maintenance|Death|0|||
129843331|NCT02143414|467391952|FG001|Maintenance|Death|1|||
129843332|NCT02143414|467391951|FG000|Maintenance|On protocol treatment|0|||
129843333|NCT02143414|467391952|FG001|Maintenance|On protocol treatment|6|||
129843334|NCT00634647|467391956|FG000|Overall Study|death on study|3|||
129843335|NCT00634647|467391956|FG000|Overall Study|refused further treatment|3|||
129843336|NCT00634647|467391956|FG000|Overall Study|declined to participate before treatment|1|||
129843337|NCT02984020|467391957|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
129843338|NCT02984020|467391957|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
129843339|NCT02984020|467391957|FG000|Overall Study|Other significant protocol violation|2|||
129843340|NCT00646204|467391960|FG000|Overall Study|Adverse Event|3|||
129843341|NCT00646204|467391961|FG001|Overall Study|Adverse Event|0|||
129843342|NCT00646204|467391960|FG000|Overall Study|Withdrawal by Subject|1|||
129843343|NCT00646204|467391961|FG001|Overall Study|Withdrawal by Subject|0|||
129843344|NCT03107988|467391965|FG000|Overall Study|Adverse Event|0|||
129843345|NCT03107988|467391966|FG001|Overall Study|Adverse Event|0|||
129843346|NCT03107988|467391967|FG002|Overall Study|Adverse Event|0|||
129843347|NCT03107988|467391968|FG003|Overall Study|Adverse Event|1|||
129843348|NCT03107988|467391969|FG004|Overall Study|Adverse Event|0|||
129843349|NCT03107988|467391970|FG005|Overall Study|Adverse Event|1|||
129843350|NCT03107988|467391971|FG006|Overall Study|Adverse Event|0|||
129843351|NCT03107988|467391972|FG007|Overall Study|Adverse Event|1|||
129843352|NCT03107988|467391973|FG008|Overall Study|Adverse Event|0|||
129843353|NCT03107988|467391974|FG009|Overall Study|Adverse Event|0|||
129843354|NCT03107988|467391975|FG010|Overall Study|Adverse Event|0|||
129843355|NCT03107988|467391976|FG011|Overall Study|Adverse Event|0|||
129843356|NCT03107988|467391977|FG012|Overall Study|Adverse Event|0|||
129843357|NCT03107988|467391965|FG000|Overall Study|Disease Progression or Relapse|1|||
129901220|NCT00545844|467598820|FG000|Overall Study|Protocol Violation|1|||
129843358|NCT03107988|467391966|FG001|Overall Study|Disease Progression or Relapse|2|||
129901221|NCT00545844|467598820|FG000|Overall Study|Withdrawal by Subject|2|||
129843359|NCT03107988|467391967|FG002|Overall Study|Disease Progression or Relapse|2|||
129843360|NCT03107988|467391968|FG003|Overall Study|Disease Progression or Relapse|5|||
129843361|NCT03107988|467391969|FG004|Overall Study|Disease Progression or Relapse|1|||
129843362|NCT03107988|467391970|FG005|Overall Study|Disease Progression or Relapse|1|||
129843363|NCT03107988|467391971|FG006|Overall Study|Disease Progression or Relapse|0|||
129843364|NCT03107988|467391972|FG007|Overall Study|Disease Progression or Relapse|0|||
129901222|NCT00957658|467598821|FG000|Overall Study|Death|1|||
129901223|NCT00957658|467598821|FG000|Overall Study|Lost to Follow-up|4|||
129901224|NCT00957658|467598821|FG000|Overall Study|Withdrawal by Subject|12|||
129901225|NCT00957658|467598821|FG000|Overall Study|Revision|1|||
129901226|NCT00957658|467598821|FG000|Overall Study|Incomplete 2 yr data|28|||
129901227|NCT00957658|467598821|FG000|Overall Study|Site termination|10|||
129901228|NCT00957658|467598821|FG000|Overall Study|unwilling/unable to return|2|||
129901229|NCT00957658|467598821|FG000|Overall Study|surgery cancelled|2|||
129901230|NCT00957658|467598821|FG000|Overall Study|Protocol Violation|5|||
129901231|NCT00975806|467598823|FG000|Overall Study|Adverse Event|2|||
129901232|NCT00975806|467598824|FG001|Overall Study|Adverse Event|1|||
129901233|NCT00975806|467598825|FG002|Overall Study|Adverse Event|2|||
129901234|NCT00975806|467598823|FG000|Overall Study|Disease Progression|1|||
129901235|NCT00975806|467598824|FG001|Overall Study|Disease Progression|5|||
129901236|NCT00975806|467598825|FG002|Overall Study|Disease Progression|1|||
129901237|NCT00975806|467598823|FG000|Overall Study|Withdrawal by Subject|1|||
129901238|NCT00975806|467598824|FG001|Overall Study|Withdrawal by Subject|0|||
129901239|NCT00975806|467598825|FG002|Overall Study|Withdrawal by Subject|0|||
129901240|NCT00975806|467598823|FG000|Overall Study|Death|0|||
129901241|NCT00975806|467598824|FG001|Overall Study|Death|1|||
129901242|NCT00975806|467598825|FG002|Overall Study|Death|0|||
129901243|NCT00975806|467598823|FG000|Overall Study|Physician decision and disease related|1|||
129901244|NCT00975806|467598824|FG001|Overall Study|Physician decision and disease related|0|||
129901245|NCT00975806|467598825|FG002|Overall Study|Physician decision and disease related|1|||
129901246|NCT00094809|467598826|FG000|Overall Study|Protocol deviation|2|||
129901247|NCT00094809|467598827|FG001|Overall Study|Protocol deviation|2|||
129901248|NCT00094809|467598826|FG000|Overall Study|Noncompliance|1|||
129901249|NCT00094809|467598827|FG001|Overall Study|Noncompliance|0|||
129901250|NCT00094809|467598826|FG000|Overall Study|Adverse Event|3|||
129901251|NCT00094809|467598827|FG001|Overall Study|Adverse Event|1|||
129901252|NCT00094809|467598826|FG000|Overall Study|Withdrawal by Subject|8|||
129901253|NCT00094809|467598827|FG001|Overall Study|Withdrawal by Subject|9|||
129901254|NCT00094809|467598826|FG000|Overall Study|Disease progression|3|||
129901255|NCT00094809|467598827|FG001|Overall Study|Disease progression|3|||
129901256|NCT00094809|467598826|FG000|Overall Study|Physician Decision|3|||
129901257|NCT00094809|467598827|FG001|Overall Study|Physician Decision|5|||
129901258|NCT00094809|467598826|FG000|Overall Study|Lost to Follow-up|6|||
129901259|NCT00094809|467598827|FG001|Overall Study|Lost to Follow-up|6|||
129901260|NCT00094809|467598826|FG000|Overall Study|Death|19|||
129901261|NCT00094809|467598827|FG001|Overall Study|Death|25|||
129901262|NCT00094809|467598826|FG000|Overall Study|Protocol-specified criteria|1|||
129901263|NCT00094809|467598827|FG001|Overall Study|Protocol-specified criteria|1|||
129901264|NCT00094809|467598826|FG000|Overall Study|Other|2|||
129901265|NCT00094809|467598827|FG001|Overall Study|Other|4|||
129901266|NCT00094809|467598826|FG000|Overall Study|Informed consent signed after treatment|1|||
129901267|NCT00094809|467598827|FG001|Overall Study|Informed consent signed after treatment|0|||
129901268|NCT00094809|467598826|FG000|Overall Study|Study drug not received|2|||
129901269|NCT00094809|467598827|FG001|Overall Study|Study drug not received|8|||
129901270|NCT00094809|467598826|FG000|Overall Study|Other|1|||
129901271|NCT00094809|467598827|FG001|Overall Study|Other|1|||
129901272|NCT00771849|467598829|FG000|Overall Study|Lost to Follow-up|1|||
129901273|NCT00771849|467598830|FG001|Overall Study|Lost to Follow-up|2|||
129901274|NCT00771849|467598829|FG000|Overall Study|Withdrawal by Subject|1|||
129901275|NCT00771849|467598830|FG001|Overall Study|Withdrawal by Subject|1|||
129901276|NCT00771849|467598829|FG000|Overall Study|Not vaccinated|0|||
129901277|NCT00771849|467598830|FG001|Overall Study|Not vaccinated|1|||
129901278|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Death|1|||
129901279|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Death|1|||
129901280|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Death|0|||
129843365|NCT03107988|467391973|FG008|Overall Study|Disease Progression or Relapse|0|||
129843366|NCT03107988|467391974|FG009|Overall Study|Disease Progression or Relapse|1|||
129843367|NCT03107988|467391975|FG010|Overall Study|Disease Progression or Relapse|4|||
129843368|NCT03107988|467391976|FG011|Overall Study|Disease Progression or Relapse|0|||
129843369|NCT03107988|467391977|FG012|Overall Study|Disease Progression or Relapse|0|||
129843370|NCT03107988|467391965|FG000|Overall Study|Ineligible|0|||
129843371|NCT03107988|467391966|FG001|Overall Study|Ineligible|0|||
129843372|NCT03107988|467391967|FG002|Overall Study|Ineligible|0|||
129901281|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Death|0|||
129901282|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Death|0|||
129843373|NCT03107988|467391968|FG003|Overall Study|Ineligible|0|||
129901283|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
129901284|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
129901285|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
129901286|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
129901287|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
129843374|NCT03107988|467391969|FG004|Overall Study|Ineligible|0|||
129901288|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Physician Decision|0|||
129901289|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Physician Decision|0|||
129843375|NCT03107988|467391970|FG005|Overall Study|Ineligible|0|||
129843376|NCT03107988|467391971|FG006|Overall Study|Ineligible|0|||
129843377|NCT03107988|467391972|FG007|Overall Study|Ineligible|0|||
129843378|NCT03107988|467391973|FG008|Overall Study|Ineligible|1|||
129843379|NCT03107988|467391974|FG009|Overall Study|Ineligible|0|||
129843380|NCT03107988|467391975|FG010|Overall Study|Ineligible|0|||
129843381|NCT03107988|467391976|FG011|Overall Study|Ineligible|0|||
129843382|NCT03107988|467391977|FG012|Overall Study|Ineligible|0|||
129843383|NCT02610192|467391979|FG000|Overall Study|Received other treatment|8|||
129843384|NCT02610192|467391979|FG000|Overall Study|Physician Decision|1|||
129843385|NCT00503841|467391980|FG000|Overall Study|All screen failures|44|||
129843386|NCT00326612|467391981|FG000|Overall Study|They did not have a seizure requiring tx|129|||
129843387|NCT00326612|467391982|FG001|Overall Study|They did not have a seizure requiring tx|137|||
129843388|NCT00548808|467391984|FG000|Overall Study|Lost to Follow-up|9|||
129843389|NCT00548808|467391985|FG001|Overall Study|Lost to Follow-up|3|||
129843390|NCT00548808|467391984|FG000|Overall Study|Protocol Violation|8|||
129843391|NCT00548808|467391985|FG001|Overall Study|Protocol Violation|8|||
129843392|NCT00548808|467391984|FG000|Overall Study|Withdrawal by Subject|8|||
129843393|NCT00548808|467391985|FG001|Overall Study|Withdrawal by Subject|4|||
129843394|NCT00548808|467391984|FG000|Overall Study|Physician Decision|6|||
129843395|NCT00548808|467391985|FG001|Overall Study|Physician Decision|3|||
129843396|NCT00548808|467391984|FG000|Overall Study|Adverse Event|4|||
129843397|NCT00548808|467391985|FG001|Overall Study|Adverse Event|5|||
129843398|NCT00548808|467391984|FG000|Overall Study|Death|2|||
129843399|NCT00548808|467391985|FG001|Overall Study|Death|0|||
129843400|NCT00548808|467391984|FG000|Overall Study|Entry Criteria Not Met|2|||
129843401|NCT00548808|467391985|FG001|Overall Study|Entry Criteria Not Met|2|||
129843402|NCT00548808|467391984|FG000|Overall Study|Lack of Efficacy|2|||
129843403|NCT00548808|467391985|FG001|Overall Study|Lack of Efficacy|0|||
129843404|NCT00548808|467391984|FG000|Overall Study|Sponsor Decision|1|||
129843405|NCT00548808|467391985|FG001|Overall Study|Sponsor Decision|1|||
129843406|NCT02177266|467391986|FG000|Overall Study|Adverse Event|0|||
129843407|NCT02177266|467391987|FG001|Overall Study|Adverse Event|1|||
129843408|NCT02177266|467391986|FG000|Overall Study|Withdrawal by Subject|1|||
129843409|NCT02177266|467391987|FG001|Overall Study|Withdrawal by Subject|0|||
129843410|NCT00546715|467391989|FG000|Overall Study|Withdrawal by Subject|0|||
129843411|NCT00546715|467391990|FG001|Overall Study|Withdrawal by Subject|1|||
129843412|NCT00546715|467391991|FG002|Overall Study|Withdrawal by Subject|0|||
129843413|NCT00546715|467391992|FG003|Overall Study|Withdrawal by Subject|0|||
129843414|NCT02331446|467391993|FG000|Overall Study|Lost to Follow-up|2|||
129843415|NCT02331446|467391994|FG001|Overall Study|Lost to Follow-up|1|||
129843416|NCT02331446|467391995|FG002|Overall Study|Lost to Follow-up|0|||
129843417|NCT02331446|467391996|FG003|Overall Study|Lost to Follow-up|1|||
129843418|NCT02331446|467391993|FG000|Overall Study|Personal Problem|2|||
129843419|NCT02331446|467391994|FG001|Overall Study|Personal Problem|0|||
129843420|NCT02331446|467391995|FG002|Overall Study|Personal Problem|0|||
129843421|NCT02331446|467391996|FG003|Overall Study|Personal Problem|0|||
129843422|NCT02331446|467391993|FG000|Overall Study|Disease|0|||
129843423|NCT02331446|467391994|FG001|Overall Study|Disease|2|||
129843424|NCT02331446|467391995|FG002|Overall Study|Disease|2|||
129843425|NCT02331446|467391996|FG003|Overall Study|Disease|1|||
129843426|NCT02331446|467391993|FG000|Overall Study|Physician Decision|0|||
129843427|NCT02331446|467391994|FG001|Overall Study|Physician Decision|1|||
129843428|NCT02331446|467391995|FG002|Overall Study|Physician Decision|0|||
129843429|NCT02331446|467391996|FG003|Overall Study|Physician Decision|1|||
129843430|NCT02331446|467391993|FG000|Overall Study|Lost before baseline analysis|0|||
129843431|NCT02331446|467391994|FG001|Overall Study|Lost before baseline analysis|1|||
129843432|NCT02331446|467391995|FG002|Overall Study|Lost before baseline analysis|1|||
129843433|NCT02331446|467391996|FG003|Overall Study|Lost before baseline analysis|0|||
129843434|NCT03670810|467392005|FG000|Main Study|Adverse Event|37|||
129843435|NCT03670810|467392006|FG001|Main Study|Adverse Event|38|||
129843436|NCT03670810|467392007|FG002|Main Study|Adverse Event|3|||
129843437|NCT03670810|467392008|FG003|Main Study|Adverse Event|4|||
129843438|NCT03670810|467392009|FG004|Main Study|Adverse Event|4|||
129843439|NCT03670810|467392010|FG005|Main Study|Adverse Event|5|||
129843440|NCT03670810|467392011|FG006|Main Study|Adverse Event|0|||
129843441|NCT03670810|467392012|FG007|Main Study|Adverse Event|0|||
129843442|NCT03670810|467392013|FG008|Main Study|Adverse Event|0|||
129843443|NCT03670810|467392005|FG000|Main Study|Lack of Efficacy|8|||
129843444|NCT03670810|467392006|FG001|Main Study|Lack of Efficacy|9|||
129843445|NCT03670810|467392007|FG002|Main Study|Lack of Efficacy|3|||
129843446|NCT03670810|467392008|FG003|Main Study|Lack of Efficacy|4|||
129843447|NCT03670810|467392009|FG004|Main Study|Lack of Efficacy|0|||
129843448|NCT03670810|467392010|FG005|Main Study|Lack of Efficacy|0|||
129843449|NCT03670810|467392011|FG006|Main Study|Lack of Efficacy|0|||
129843450|NCT03670810|467392012|FG007|Main Study|Lack of Efficacy|0|||
129843451|NCT03670810|467392013|FG008|Main Study|Lack of Efficacy|0|||
129843452|NCT03670810|467392005|FG000|Main Study|Lost to Follow-up|9|||
129843453|NCT03670810|467392006|FG001|Main Study|Lost to Follow-up|7|||
129843454|NCT03670810|467392007|FG002|Main Study|Lost to Follow-up|4|||
129843455|NCT03670810|467392008|FG003|Main Study|Lost to Follow-up|6|||
129449325|NCT00467779|465945624|FG001|Stage 1|Disease Progression|2|||
129449326|NCT00467779|465945625|FG002|Stage 1|Disease Progression|2|||
129449327|NCT00467779|465945626|FG003|Stage 1|Disease Progression|3|||
129449328|NCT00467779|465945627|FG004|Stage 1|Disease Progression|2|||
129449329|NCT00467779|465945628|FG005|Stage 1|Disease Progression|2|||
129449330|NCT00467779|465945629|FG006|Stage 1|Disease Progression|4|||
129449331|NCT00467779|465945630|FG007|Stage 1|Disease Progression|5|||
129449332|NCT00467779|465945631|FG008|Stage 1|Disease Progression|0|||
129449333|NCT00467779|465945632|FG009|Stage 1|Disease Progression|0|||
129449334|NCT00467779|465945633|FG010|Stage 1|Disease Progression|0|||
129449335|NCT00467779|465945634|FG011|Stage 1|Disease Progression|0|||
129449336|NCT00467779|465945635|FG012|Stage 1|Disease Progression|0|||
129449337|NCT00467779|465945636|FG013|Stage 1|Disease Progression|0|||
129449338|NCT00467779|465945637|FG014|Stage 1|Disease Progression|0|||
129449339|NCT00467779|465945623|FG000|Stage 1|Unspecified Reason|1|||
129449340|NCT00467779|465945624|FG001|Stage 1|Unspecified Reason|0|||
129449341|NCT00467779|465945625|FG002|Stage 1|Unspecified Reason|1|||
129449342|NCT00467779|465945626|FG003|Stage 1|Unspecified Reason|0|||
129449343|NCT00467779|465945627|FG004|Stage 1|Unspecified Reason|1|||
129449344|NCT00467779|465945628|FG005|Stage 1|Unspecified Reason|2|||
129449345|NCT00467779|465945629|FG006|Stage 1|Unspecified Reason|0|||
129449346|NCT00467779|465945630|FG007|Stage 1|Unspecified Reason|0|||
129449347|NCT00467779|465945631|FG008|Stage 1|Unspecified Reason|0|||
129449348|NCT00467779|465945632|FG009|Stage 1|Unspecified Reason|0|||
129449349|NCT00467779|465945633|FG010|Stage 1|Unspecified Reason|0|||
129449350|NCT00467779|465945634|FG011|Stage 1|Unspecified Reason|0|||
129449351|NCT00467779|465945635|FG012|Stage 1|Unspecified Reason|0|||
129449352|NCT00467779|465945636|FG013|Stage 1|Unspecified Reason|0|||
129449353|NCT00467779|465945637|FG014|Stage 1|Unspecified Reason|0|||
129449354|NCT00467779|465945623|FG000|Stage 1|Physician Decision|0|||
129449355|NCT00467779|465945624|FG001|Stage 1|Physician Decision|1|||
129449356|NCT00467779|465945625|FG002|Stage 1|Physician Decision|0|||
129449357|NCT00467779|465945626|FG003|Stage 1|Physician Decision|0|||
129449358|NCT00467779|465945627|FG004|Stage 1|Physician Decision|0|||
129449359|NCT00467779|465945628|FG005|Stage 1|Physician Decision|0|||
129449360|NCT00467779|465945629|FG006|Stage 1|Physician Decision|0|||
129449361|NCT00467779|465945630|FG007|Stage 1|Physician Decision|0|||
129449362|NCT00467779|465945631|FG008|Stage 1|Physician Decision|0|||
129449363|NCT00467779|465945632|FG009|Stage 1|Physician Decision|0|||
129449364|NCT00467779|465945633|FG010|Stage 1|Physician Decision|0|||
129449365|NCT00467779|465945634|FG011|Stage 1|Physician Decision|0|||
129449366|NCT00467779|465945635|FG012|Stage 1|Physician Decision|0|||
129449367|NCT00467779|465945636|FG013|Stage 1|Physician Decision|0|||
129449368|NCT00467779|465945637|FG014|Stage 1|Physician Decision|0|||
129449369|NCT00467779|465945623|FG000|Stage 1|Withdrawal by Subject|0|||
129449370|NCT00467779|465945624|FG001|Stage 1|Withdrawal by Subject|0|||
129449371|NCT00467779|465945625|FG002|Stage 1|Withdrawal by Subject|0|||
129449372|NCT00467779|465945626|FG003|Stage 1|Withdrawal by Subject|0|||
129449373|NCT00467779|465945627|FG004|Stage 1|Withdrawal by Subject|0|||
129449374|NCT00467779|465945628|FG005|Stage 1|Withdrawal by Subject|0|||
129449375|NCT00467779|465945629|FG006|Stage 1|Withdrawal by Subject|1|||
129449376|NCT00467779|465945630|FG007|Stage 1|Withdrawal by Subject|1|||
129449377|NCT00467779|465945631|FG008|Stage 1|Withdrawal by Subject|0|||
129449378|NCT00467779|465945632|FG009|Stage 1|Withdrawal by Subject|0|||
129449379|NCT00467779|465945633|FG010|Stage 1|Withdrawal by Subject|0|||
129449380|NCT00467779|465945634|FG011|Stage 1|Withdrawal by Subject|0|||
129449381|NCT00467779|465945635|FG012|Stage 1|Withdrawal by Subject|0|||
129449382|NCT00467779|465945636|FG013|Stage 1|Withdrawal by Subject|0|||
129449383|NCT00467779|465945637|FG014|Stage 1|Withdrawal by Subject|0|||
129449384|NCT00467779|465945623|FG000|Stage 1A|Adverse Event|0|||
129449385|NCT00467779|465945624|FG001|Stage 1A|Adverse Event|0|||
129449386|NCT00467779|465945625|FG002|Stage 1A|Adverse Event|0|||
129449387|NCT00467779|465945626|FG003|Stage 1A|Adverse Event|0|||
129449388|NCT00467779|465945627|FG004|Stage 1A|Adverse Event|0|||
129449389|NCT00467779|465945628|FG005|Stage 1A|Adverse Event|0|||
129449390|NCT00467779|465945629|FG006|Stage 1A|Adverse Event|0|||
129449391|NCT00467779|465945630|FG007|Stage 1A|Adverse Event|0|||
129449392|NCT00467779|465945631|FG008|Stage 1A|Adverse Event|0|||
129449393|NCT00467779|465945632|FG009|Stage 1A|Adverse Event|0|||
129449394|NCT00467779|465945633|FG010|Stage 1A|Adverse Event|0|||
129449395|NCT00467779|465945634|FG011|Stage 1A|Adverse Event|0|||
129449396|NCT00467779|465945635|FG012|Stage 1A|Adverse Event|1|||
129449397|NCT00467779|465945636|FG013|Stage 1A|Adverse Event|0|||
129449398|NCT00467779|465945637|FG014|Stage 1A|Adverse Event|0|||
129449399|NCT00467779|465945623|FG000|Stage 1A|Death|0|||
129449400|NCT00467779|465945624|FG001|Stage 1A|Death|0|||
129449401|NCT00467779|465945625|FG002|Stage 1A|Death|0|||
129449402|NCT00467779|465945626|FG003|Stage 1A|Death|0|||
129449403|NCT00467779|465945627|FG004|Stage 1A|Death|0|||
129449404|NCT00467779|465945628|FG005|Stage 1A|Death|0|||
129449405|NCT00467779|465945629|FG006|Stage 1A|Death|0|||
129449406|NCT00467779|465945630|FG007|Stage 1A|Death|0|||
129449407|NCT00467779|465945631|FG008|Stage 1A|Death|0|||
129901290|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Physician Decision|0|||
129449408|NCT00467779|465945632|FG009|Stage 1A|Death|0|||
129449409|NCT00467779|465945633|FG010|Stage 1A|Death|0|||
129449410|NCT00467779|465945634|FG011|Stage 1A|Death|1|||
129449411|NCT00467779|465945635|FG012|Stage 1A|Death|1|||
129449412|NCT00467779|465945636|FG013|Stage 1A|Death|0|||
129449413|NCT00467779|465945637|FG014|Stage 1A|Death|0|||
129449414|NCT00467779|465945623|FG000|Stage 1A|Disease Progression|0|||
129449415|NCT00467779|465945624|FG001|Stage 1A|Disease Progression|0|||
129449416|NCT00467779|465945625|FG002|Stage 1A|Disease Progression|0|||
129449417|NCT00467779|465945626|FG003|Stage 1A|Disease Progression|0|||
129449418|NCT00467779|465945627|FG004|Stage 1A|Disease Progression|0|||
129449419|NCT00467779|465945628|FG005|Stage 1A|Disease Progression|0|||
129449420|NCT00467779|465945629|FG006|Stage 1A|Disease Progression|0|||
129449421|NCT00467779|465945630|FG007|Stage 1A|Disease Progression|0|||
129449422|NCT00467779|465945631|FG008|Stage 1A|Disease Progression|0|||
129449423|NCT00467779|465945632|FG009|Stage 1A|Disease Progression|2|||
129449424|NCT00467779|465945633|FG010|Stage 1A|Disease Progression|2|||
129449425|NCT00467779|465945634|FG011|Stage 1A|Disease Progression|5|||
129449426|NCT00467779|465945635|FG012|Stage 1A|Disease Progression|2|||
129449427|NCT00467779|465945636|FG013|Stage 1A|Disease Progression|0|||
129449428|NCT00467779|465945637|FG014|Stage 1A|Disease Progression|0|||
129449429|NCT00467779|465945623|FG000|Stage 1A|Physician Decision|0|||
129449430|NCT00467779|465945624|FG001|Stage 1A|Physician Decision|0|||
129449431|NCT00467779|465945625|FG002|Stage 1A|Physician Decision|0|||
129449432|NCT00467779|465945626|FG003|Stage 1A|Physician Decision|0|||
129449433|NCT00467779|465945627|FG004|Stage 1A|Physician Decision|0|||
129449434|NCT00467779|465945628|FG005|Stage 1A|Physician Decision|0|||
129449435|NCT00467779|465945629|FG006|Stage 1A|Physician Decision|0|||
129449436|NCT00467779|465945630|FG007|Stage 1A|Physician Decision|0|||
129449437|NCT00467779|465945631|FG008|Stage 1A|Physician Decision|0|||
129843456|NCT03670810|467392009|FG004|Main Study|Lost to Follow-up|1|||
129843457|NCT03670810|467392010|FG005|Main Study|Lost to Follow-up|0|||
129843458|NCT03670810|467392011|FG006|Main Study|Lost to Follow-up|0|||
129843459|NCT03670810|467392012|FG007|Main Study|Lost to Follow-up|0|||
129843460|NCT03670810|467392013|FG008|Main Study|Lost to Follow-up|0|||
129843461|NCT03670810|467392005|FG000|Main Study|Non-compliance with Study Drug|0|||
129843462|NCT03670810|467392006|FG001|Main Study|Non-compliance with Study Drug|2|||
129843463|NCT03670810|467392007|FG002|Main Study|Non-compliance with Study Drug|3|||
129843464|NCT03670810|467392008|FG003|Main Study|Non-compliance with Study Drug|0|||
129843465|NCT03670810|467392009|FG004|Main Study|Non-compliance with Study Drug|0|||
129843466|NCT03670810|467392010|FG005|Main Study|Non-compliance with Study Drug|0|||
129843467|NCT03670810|467392011|FG006|Main Study|Non-compliance with Study Drug|0|||
129843468|NCT03670810|467392012|FG007|Main Study|Non-compliance with Study Drug|1|||
129843469|NCT03670810|467392013|FG008|Main Study|Non-compliance with Study Drug|0|||
129843470|NCT03670810|467392005|FG000|Main Study|Physician Decision|3|||
129843471|NCT03670810|467392006|FG001|Main Study|Physician Decision|0|||
129843472|NCT03670810|467392007|FG002|Main Study|Physician Decision|1|||
129843473|NCT03670810|467392008|FG003|Main Study|Physician Decision|0|||
129843474|NCT03670810|467392009|FG004|Main Study|Physician Decision|0|||
129843475|NCT03670810|467392010|FG005|Main Study|Physician Decision|0|||
129843476|NCT03670810|467392011|FG006|Main Study|Physician Decision|1|||
129843477|NCT03670810|467392012|FG007|Main Study|Physician Decision|1|||
129843478|NCT03670810|467392013|FG008|Main Study|Physician Decision|0|||
129843479|NCT03670810|467392005|FG000|Main Study|Pregnancy|1|||
129843480|NCT03670810|467392006|FG001|Main Study|Pregnancy|2|||
129843481|NCT03670810|467392007|FG002|Main Study|Pregnancy|0|||
129843482|NCT03670810|467392008|FG003|Main Study|Pregnancy|0|||
129843483|NCT03670810|467392009|FG004|Main Study|Pregnancy|0|||
129843484|NCT03670810|467392010|FG005|Main Study|Pregnancy|0|||
129843485|NCT03670810|467392011|FG006|Main Study|Pregnancy|0|||
129901291|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Physician Decision|0|||
129901292|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Physician Decision|1|||
129449438|NCT00467779|465945632|FG009|Stage 1A|Physician Decision|1|||
129449439|NCT00467779|465945633|FG010|Stage 1A|Physician Decision|0|||
129449440|NCT00467779|465945634|FG011|Stage 1A|Physician Decision|0|||
129449441|NCT00467779|465945635|FG012|Stage 1A|Physician Decision|0|||
129843486|NCT03670810|467392012|FG007|Main Study|Pregnancy|0|||
129843487|NCT03670810|467392013|FG008|Main Study|Pregnancy|0|||
129843488|NCT03670810|467392005|FG000|Main Study|Protocol Deviation|2|||
129843489|NCT03670810|467392006|FG001|Main Study|Protocol Deviation|12|||
129449442|NCT00467779|465945636|FG013|Stage 1A|Physician Decision|0|||
129449443|NCT00467779|465945637|FG014|Stage 1A|Physician Decision|0|||
129449444|NCT00467779|465945623|FG000|Stage 1A|Withdrawal by Subject|0|||
129449445|NCT00467779|465945624|FG001|Stage 1A|Withdrawal by Subject|0|||
129449446|NCT00467779|465945625|FG002|Stage 1A|Withdrawal by Subject|0|||
129449447|NCT00467779|465945626|FG003|Stage 1A|Withdrawal by Subject|0|||
129449448|NCT00467779|465945627|FG004|Stage 1A|Withdrawal by Subject|0|||
129843490|NCT03670810|467392007|FG002|Main Study|Protocol Deviation|8|||
129843491|NCT03670810|467392008|FG003|Main Study|Protocol Deviation|4|||
129843492|NCT03670810|467392009|FG004|Main Study|Protocol Deviation|0|||
129843493|NCT03670810|467392010|FG005|Main Study|Protocol Deviation|0|||
129843494|NCT03670810|467392011|FG006|Main Study|Protocol Deviation|0|||
129843495|NCT03670810|467392012|FG007|Main Study|Protocol Deviation|0|||
129843496|NCT03670810|467392013|FG008|Main Study|Protocol Deviation|0|||
129843497|NCT03670810|467392005|FG000|Main Study|Withdrawal by Subject|21|||
129843498|NCT03670810|467392006|FG001|Main Study|Withdrawal by Subject|21|||
129843499|NCT03670810|467392007|FG002|Main Study|Withdrawal by Subject|8|||
129843500|NCT03670810|467392008|FG003|Main Study|Withdrawal by Subject|9|||
129843501|NCT03670810|467392009|FG004|Main Study|Withdrawal by Subject|5|||
129843502|NCT03670810|467392010|FG005|Main Study|Withdrawal by Subject|2|||
129843503|NCT03670810|467392011|FG006|Main Study|Withdrawal by Subject|1|||
129843504|NCT03670810|467392012|FG007|Main Study|Withdrawal by Subject|1|||
129843505|NCT03670810|467392013|FG008|Main Study|Withdrawal by Subject|0|||
129843506|NCT03670810|467392005|FG000|Main Study|Participant did not want to take the three other treatments|1|||
129843507|NCT03670810|467392006|FG001|Main Study|Participant did not want to take the three other treatments|0|||
129843508|NCT03670810|467392007|FG002|Main Study|Participant did not want to take the three other treatments|0|||
129843509|NCT03670810|467392008|FG003|Main Study|Participant did not want to take the three other treatments|0|||
129843510|NCT03670810|467392009|FG004|Main Study|Participant did not want to take the three other treatments|0|||
129843511|NCT03670810|467392010|FG005|Main Study|Participant did not want to take the three other treatments|0|||
129843512|NCT03670810|467392011|FG006|Main Study|Participant did not want to take the three other treatments|0|||
129843513|NCT03670810|467392012|FG007|Main Study|Participant did not want to take the three other treatments|0|||
129843514|NCT03670810|467392013|FG008|Main Study|Participant did not want to take the three other treatments|0|||
129843515|NCT03670810|467392005|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843516|NCT03670810|467392006|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
129843517|NCT03670810|467392007|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843518|NCT03670810|467392008|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843519|NCT03670810|467392009|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843520|NCT03670810|467392010|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843521|NCT03670810|467392011|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843522|NCT03670810|467392012|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843523|NCT03670810|467392013|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
129843524|NCT03670810|467392005|FG000|Main Study|Travel and Coronavirus issues|0|||
129843525|NCT03670810|467392006|FG001|Main Study|Travel and Coronavirus issues|0|||
129843526|NCT03670810|467392007|FG002|Main Study|Travel and Coronavirus issues|0|||
129843527|NCT03670810|467392008|FG003|Main Study|Travel and Coronavirus issues|1|||
129843528|NCT03670810|467392009|FG004|Main Study|Travel and Coronavirus issues|0|||
129843529|NCT03670810|467392010|FG005|Main Study|Travel and Coronavirus issues|0|||
129843530|NCT03670810|467392011|FG006|Main Study|Travel and Coronavirus issues|0|||
129843531|NCT03670810|467392012|FG007|Main Study|Travel and Coronavirus issues|0|||
129843532|NCT03670810|467392013|FG008|Main Study|Travel and Coronavirus issues|0|||
129843533|NCT03670810|467392005|FG000|Open Label Extension|Protocol Deviation|0|||
129843534|NCT03670810|467392006|FG001|Open Label Extension|Protocol Deviation|0|||
129843535|NCT03670810|467392007|FG002|Open Label Extension|Protocol Deviation|0|||
129843536|NCT03670810|467392008|FG003|Open Label Extension|Protocol Deviation|0|||
129843537|NCT03670810|467392009|FG004|Open Label Extension|Protocol Deviation|0|||
129843538|NCT03670810|467392010|FG005|Open Label Extension|Protocol Deviation|0|||
129843539|NCT03670810|467392011|FG006|Open Label Extension|Protocol Deviation|0|||
129843540|NCT03670810|467392012|FG007|Open Label Extension|Protocol Deviation|0|||
129843541|NCT03670810|467392013|FG008|Open Label Extension|Protocol Deviation|5|||
129843542|NCT03670810|467392005|FG000|Open Label Extension|Death|0|||
129843543|NCT03670810|467392006|FG001|Open Label Extension|Death|0|||
129843544|NCT03670810|467392007|FG002|Open Label Extension|Death|0|||
129449449|NCT00467779|465945628|FG005|Stage 1A|Withdrawal by Subject|0|||
129843545|NCT03670810|467392008|FG003|Open Label Extension|Death|0|||
129843546|NCT03670810|467392009|FG004|Open Label Extension|Death|0|||
129843547|NCT03670810|467392010|FG005|Open Label Extension|Death|0|||
129843548|NCT03670810|467392011|FG006|Open Label Extension|Death|0|||
129843549|NCT03670810|467392012|FG007|Open Label Extension|Death|0|||
129843550|NCT03670810|467392013|FG008|Open Label Extension|Death|1|||
129843551|NCT03670810|467392005|FG000|Open Label Extension|COVID-19|0|||
129843552|NCT03670810|467392006|FG001|Open Label Extension|COVID-19|0|||
129843553|NCT03670810|467392007|FG002|Open Label Extension|COVID-19|0|||
129843554|NCT03670810|467392008|FG003|Open Label Extension|COVID-19|0|||
129843555|NCT03670810|467392009|FG004|Open Label Extension|COVID-19|0|||
129843556|NCT03670810|467392010|FG005|Open Label Extension|COVID-19|0|||
129843557|NCT03670810|467392011|FG006|Open Label Extension|COVID-19|0|||
129843558|NCT03670810|467392012|FG007|Open Label Extension|COVID-19|0|||
129843559|NCT03670810|467392013|FG008|Open Label Extension|COVID-19|1|||
129843560|NCT03670810|467392005|FG000|Open Label Extension|Lack of Efficacy|0|||
129843561|NCT03670810|467392006|FG001|Open Label Extension|Lack of Efficacy|0|||
129843562|NCT03670810|467392007|FG002|Open Label Extension|Lack of Efficacy|0|||
129843563|NCT03670810|467392008|FG003|Open Label Extension|Lack of Efficacy|0|||
129843564|NCT03670810|467392009|FG004|Open Label Extension|Lack of Efficacy|0|||
129843565|NCT03670810|467392010|FG005|Open Label Extension|Lack of Efficacy|0|||
129843566|NCT03670810|467392011|FG006|Open Label Extension|Lack of Efficacy|0|||
129843567|NCT03670810|467392012|FG007|Open Label Extension|Lack of Efficacy|0|||
129843568|NCT03670810|467392013|FG008|Open Label Extension|Lack of Efficacy|39|||
129843569|NCT03670810|467392005|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
129843570|NCT03670810|467392006|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
129843571|NCT03670810|467392007|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
129843572|NCT03670810|467392008|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
129843573|NCT03670810|467392009|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
129843574|NCT03670810|467392010|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
129843575|NCT03670810|467392011|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
129843576|NCT03670810|467392012|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
129843577|NCT03670810|467392013|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
129843578|NCT03670810|467392005|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843579|NCT03670810|467392006|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843580|NCT03670810|467392007|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843581|NCT03670810|467392008|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843582|NCT03670810|467392009|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843583|NCT03670810|467392010|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843584|NCT03670810|467392011|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843585|NCT03670810|467392012|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
129843586|NCT03670810|467392013|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
129843587|NCT03670810|467392005|FG000|Open Label Extension|Withdrawal by Subject|0|||
129843588|NCT03670810|467392006|FG001|Open Label Extension|Withdrawal by Subject|0|||
129843589|NCT03670810|467392007|FG002|Open Label Extension|Withdrawal by Subject|0|||
129843590|NCT03670810|467392008|FG003|Open Label Extension|Withdrawal by Subject|0|||
129843591|NCT03670810|467392009|FG004|Open Label Extension|Withdrawal by Subject|0|||
129843592|NCT03670810|467392010|FG005|Open Label Extension|Withdrawal by Subject|0|||
129843593|NCT03670810|467392011|FG006|Open Label Extension|Withdrawal by Subject|0|||
129843594|NCT03670810|467392012|FG007|Open Label Extension|Withdrawal by Subject|0|||
129843595|NCT03670810|467392013|FG008|Open Label Extension|Withdrawal by Subject|46|||
129843596|NCT03670810|467392005|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843597|NCT03670810|467392006|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843598|NCT03670810|467392007|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843599|NCT03670810|467392008|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843600|NCT03670810|467392009|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843601|NCT03670810|467392010|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843602|NCT03670810|467392011|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843603|NCT03670810|467392012|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
129843604|NCT03670810|467392013|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
129843605|NCT03670810|467392005|FG000|Open Label Extension|Physician Decision|0|||
129843606|NCT03670810|467392006|FG001|Open Label Extension|Physician Decision|0|||
129843607|NCT03670810|467392007|FG002|Open Label Extension|Physician Decision|0|||
129843608|NCT03670810|467392008|FG003|Open Label Extension|Physician Decision|0|||
129843609|NCT03670810|467392009|FG004|Open Label Extension|Physician Decision|0|||
129843610|NCT03670810|467392010|FG005|Open Label Extension|Physician Decision|0|||
129843611|NCT03670810|467392011|FG006|Open Label Extension|Physician Decision|0|||
129843612|NCT03670810|467392012|FG007|Open Label Extension|Physician Decision|0|||
129449450|NCT00467779|465945629|FG006|Stage 1A|Withdrawal by Subject|0|||
129449451|NCT00467779|465945630|FG007|Stage 1A|Withdrawal by Subject|0|||
129449452|NCT00467779|465945631|FG008|Stage 1A|Withdrawal by Subject|0|||
129449453|NCT00467779|465945632|FG009|Stage 1A|Withdrawal by Subject|0|||
129449454|NCT00467779|465945633|FG010|Stage 1A|Withdrawal by Subject|1|||
129449455|NCT00467779|465945634|FG011|Stage 1A|Withdrawal by Subject|1|||
129449456|NCT00467779|465945635|FG012|Stage 1A|Withdrawal by Subject|1|||
129449457|NCT00467779|465945636|FG013|Stage 1A|Withdrawal by Subject|0|||
129449458|NCT00467779|465945637|FG014|Stage 1A|Withdrawal by Subject|0|||
129449459|NCT00467779|465945623|FG000|Stage 1A|Unspecified Reason|0|||
129449460|NCT00467779|465945624|FG001|Stage 1A|Unspecified Reason|0|||
129449461|NCT00467779|465945625|FG002|Stage 1A|Unspecified Reason|0|||
129449462|NCT00467779|465945626|FG003|Stage 1A|Unspecified Reason|0|||
129449463|NCT00467779|465945627|FG004|Stage 1A|Unspecified Reason|0|||
129449464|NCT00467779|465945628|FG005|Stage 1A|Unspecified Reason|0|||
129449465|NCT00467779|465945629|FG006|Stage 1A|Unspecified Reason|0|||
129449466|NCT00467779|465945630|FG007|Stage 1A|Unspecified Reason|0|||
129449467|NCT00467779|465945631|FG008|Stage 1A|Unspecified Reason|0|||
129449468|NCT00467779|465945632|FG009|Stage 1A|Unspecified Reason|0|||
129449469|NCT00467779|465945633|FG010|Stage 1A|Unspecified Reason|0|||
129449470|NCT00467779|465945634|FG011|Stage 1A|Unspecified Reason|1|||
129449471|NCT00467779|465945635|FG012|Stage 1A|Unspecified Reason|1|||
129449472|NCT00467779|465945636|FG013|Stage 1A|Unspecified Reason|0|||
129449473|NCT00467779|465945637|FG014|Stage 1A|Unspecified Reason|0|||
129449474|NCT00467779|465945623|FG000|Stage 2|Adverse Event|0|||
129449475|NCT00467779|465945624|FG001|Stage 2|Adverse Event|0|||
129449476|NCT00467779|465945625|FG002|Stage 2|Adverse Event|0|||
129449477|NCT00467779|465945626|FG003|Stage 2|Adverse Event|0|||
129449478|NCT00467779|465945627|FG004|Stage 2|Adverse Event|0|||
129449479|NCT00467779|465945628|FG005|Stage 2|Adverse Event|0|||
129449480|NCT00467779|465945629|FG006|Stage 2|Adverse Event|0|||
129449481|NCT00467779|465945630|FG007|Stage 2|Adverse Event|0|||
129449482|NCT00467779|465945631|FG008|Stage 2|Adverse Event|1|||
129901293|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
129449483|NCT00467779|465945632|FG009|Stage 2|Adverse Event|0|||
129449484|NCT00467779|465945633|FG010|Stage 2|Adverse Event|0|||
129449485|NCT00467779|465945634|FG011|Stage 2|Adverse Event|0|||
129843613|NCT03670810|467392013|FG008|Open Label Extension|Physician Decision|2|||
129843614|NCT03670810|467392005|FG000|Open Label Extension|Non-compliance with study drug|0|||
129843615|NCT03670810|467392006|FG001|Open Label Extension|Non-compliance with study drug|0|||
129843616|NCT03670810|467392007|FG002|Open Label Extension|Non-compliance with study drug|0|||
129843617|NCT03670810|467392008|FG003|Open Label Extension|Non-compliance with study drug|0|||
129843618|NCT03670810|467392009|FG004|Open Label Extension|Non-compliance with study drug|0|||
129843619|NCT03670810|467392010|FG005|Open Label Extension|Non-compliance with study drug|0|||
129843620|NCT03670810|467392011|FG006|Open Label Extension|Non-compliance with study drug|0|||
129843621|NCT03670810|467392012|FG007|Open Label Extension|Non-compliance with study drug|0|||
129843622|NCT03670810|467392013|FG008|Open Label Extension|Non-compliance with study drug|5|||
129843623|NCT03670810|467392005|FG000|Open Label Extension|Pregnancy|0|||
129843624|NCT03670810|467392006|FG001|Open Label Extension|Pregnancy|0|||
129843625|NCT03670810|467392007|FG002|Open Label Extension|Pregnancy|0|||
129843626|NCT03670810|467392008|FG003|Open Label Extension|Pregnancy|0|||
129843627|NCT03670810|467392009|FG004|Open Label Extension|Pregnancy|0|||
129843628|NCT03670810|467392010|FG005|Open Label Extension|Pregnancy|0|||
129843629|NCT03670810|467392011|FG006|Open Label Extension|Pregnancy|0|||
129843630|NCT03670810|467392012|FG007|Open Label Extension|Pregnancy|0|||
129843631|NCT03670810|467392013|FG008|Open Label Extension|Pregnancy|3|||
129843632|NCT03670810|467392005|FG000|Open Label Extension|Adverse Event|0|||
129843633|NCT03670810|467392006|FG001|Open Label Extension|Adverse Event|0|||
129843634|NCT03670810|467392007|FG002|Open Label Extension|Adverse Event|0|||
129843635|NCT03670810|467392008|FG003|Open Label Extension|Adverse Event|0|||
129843636|NCT03670810|467392009|FG004|Open Label Extension|Adverse Event|0|||
129843637|NCT03670810|467392010|FG005|Open Label Extension|Adverse Event|0|||
129843638|NCT03670810|467392011|FG006|Open Label Extension|Adverse Event|0|||
129843639|NCT03670810|467392012|FG007|Open Label Extension|Adverse Event|0|||
129901294|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
129449486|NCT00467779|465945635|FG012|Stage 2|Adverse Event|0|||
129449487|NCT00467779|465945636|FG013|Stage 2|Adverse Event|0|||
129449488|NCT00467779|465945637|FG014|Stage 2|Adverse Event|0|||
129449489|NCT00467779|465945623|FG000|Stage 2|Death|0|||
129449490|NCT00467779|465945624|FG001|Stage 2|Death|0|||
129449491|NCT00467779|465945625|FG002|Stage 2|Death|0|||
129449492|NCT00467779|465945626|FG003|Stage 2|Death|0|||
129843640|NCT03670810|467392013|FG008|Open Label Extension|Adverse Event|24|||
129843641|NCT03670810|467392005|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
129843642|NCT03670810|467392006|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
129449493|NCT00467779|465945627|FG004|Stage 2|Death|0|||
129449494|NCT00467779|465945628|FG005|Stage 2|Death|0|||
129449495|NCT00467779|465945629|FG006|Stage 2|Death|0|||
129449496|NCT00467779|465945630|FG007|Stage 2|Death|0|||
129901295|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
129901296|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
129901297|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
129901298|NCT02503202|467598833|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
129901299|NCT02503202|467598834|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
129901300|NCT02503202|467598835|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
129901301|NCT02503202|467598836|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
129901302|NCT02503202|467598837|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
129901303|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
129901304|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
129901305|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
129901306|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
129901307|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
129901308|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Death|1|||
129901309|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Death|0|||
129901310|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Death|0|||
129901311|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Death|0|||
129901312|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Death|0|||
129901313|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
129901314|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
129901315|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
129901316|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
129901317|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
129901318|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Physician Decision|1|||
129901319|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Physician Decision|0|||
129901320|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Physician Decision|1|||
129901321|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Physician Decision|3|||
129901322|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Physician Decision|0|||
129901323|NCT02503202|467598833|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
129901324|NCT02503202|467598834|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
129901325|NCT02503202|467598835|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
129901326|NCT02503202|467598836|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
129901327|NCT02503202|467598837|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
129901328|NCT00608907|467598840|FG000|Overall Study|Adverse Event|6|||
129901329|NCT00608907|467598841|FG001|Overall Study|Adverse Event|0|||
129901330|NCT00608907|467598842|FG002|Overall Study|Adverse Event|1|||
129901331|NCT00608907|467598840|FG000|Overall Study|Death|1|||
129901332|NCT00608907|467598841|FG001|Overall Study|Death|0|||
129901333|NCT00608907|467598842|FG002|Overall Study|Death|0|||
129901334|NCT00608907|467598840|FG000|Overall Study|Withdrawal by Subject|4|||
129901335|NCT00608907|467598841|FG001|Overall Study|Withdrawal by Subject|0|||
129901336|NCT00608907|467598842|FG002|Overall Study|Withdrawal by Subject|0|||
129901337|NCT00608907|467598840|FG000|Overall Study|Progressive Disease|1|||
129901338|NCT00608907|467598841|FG001|Overall Study|Progressive Disease|0|||
129901339|NCT00608907|467598842|FG002|Overall Study|Progressive Disease|0|||
129901340|NCT00906035|467598846|FG000|Overall Study|Withdrawal by Subject|2|||
129901341|NCT00906035|467598847|FG001|Overall Study|Withdrawal by Subject|3|||
129901342|NCT00906035|467598848|FG002|Overall Study|Withdrawal by Subject|0|||
129901343|NCT03058991|467598851|FG000|Overall Study|Lost to Follow-up|17|||
129901344|NCT03058991|467598852|FG001|Overall Study|Lost to Follow-up|12|||
129901345|NCT03058991|467598853|FG002|Overall Study|Lost to Follow-up|12|||
129901346|NCT03058991|467598851|FG000|Overall Study|Withdrawal by Subject|1|||
129901347|NCT03058991|467598852|FG001|Overall Study|Withdrawal by Subject|0|||
129901348|NCT03058991|467598853|FG002|Overall Study|Withdrawal by Subject|0|||
129901349|NCT00130637|467598854|FG000|Overall Study|Adverse Event|2|||
129901350|NCT00130637|467598854|FG000|Overall Study|Withdrawal by Subject|1|||
129901351|NCT01460342|467598856|FG000|Overall Study|Adverse Event|5|||
129901352|NCT01460342|467598857|FG001|Overall Study|Adverse Event|4|||
129901353|NCT01460342|467598856|FG000|Overall Study|Lost to Follow-up|1|||
129901354|NCT01460342|467598857|FG001|Overall Study|Lost to Follow-up|2|||
129901355|NCT01460342|467598856|FG000|Overall Study|Protocol Violation|0|||
129901356|NCT01460342|467598857|FG001|Overall Study|Protocol Violation|1|||
129901357|NCT01460342|467598856|FG000|Overall Study|Withdrawal by Subject|3|||
129901358|NCT01460342|467598857|FG001|Overall Study|Withdrawal by Subject|4|||
129901359|NCT01460342|467598856|FG000|Overall Study|Physician Decision|1|||
129901360|NCT01460342|467598857|FG001|Overall Study|Physician Decision|3|||
129901361|NCT01460342|467598856|FG000|Overall Study|Lack of Efficacy|1|||
129901362|NCT01460342|467598857|FG001|Overall Study|Lack of Efficacy|0|||
129901363|NCT01689519|467598858|FG000|Intent to Treat|Death|157|||
129901364|NCT01689519|467598859|FG001|Intent to Treat|Death|167|||
129901365|NCT01689519|467598858|FG000|Intent to Treat|Lost to Follow-up|4|||
129901366|NCT01689519|467598859|FG001|Intent to Treat|Lost to Follow-up|8|||
129901367|NCT01689519|467598858|FG000|Intent to Treat|Other|2|||
129901368|NCT01689519|467598859|FG001|Intent to Treat|Other|4|||
129901369|NCT01689519|467598858|FG000|Intent to Treat|Physician Decision|4|||
129901370|NCT01689519|467598859|FG001|Intent to Treat|Physician Decision|1|||
129901371|NCT01689519|467598858|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
129449497|NCT00467779|465945631|FG008|Stage 2|Death|1|||
129449498|NCT00467779|465945632|FG009|Stage 2|Death|0|||
129449499|NCT00467779|465945633|FG010|Stage 2|Death|0|||
129449500|NCT00467779|465945634|FG011|Stage 2|Death|0|||
129449501|NCT00467779|465945635|FG012|Stage 2|Death|0|||
129449502|NCT00467779|465945636|FG013|Stage 2|Death|0|||
129449503|NCT00467779|465945637|FG014|Stage 2|Death|0|||
129449504|NCT00467779|465945623|FG000|Stage 2|Disease Progression|0|||
129449505|NCT00467779|465945624|FG001|Stage 2|Disease Progression|0|||
129449506|NCT00467779|465945625|FG002|Stage 2|Disease Progression|0|||
129449507|NCT00467779|465945626|FG003|Stage 2|Disease Progression|0|||
129901372|NCT01689519|467598859|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
129901373|NCT01689519|467598858|FG000|Intent to Treat|Withdrawal by Subject|21|||
129901374|NCT01689519|467598859|FG001|Intent to Treat|Withdrawal by Subject|20|||
129901375|NCT01689519|467598858|FG000|Safety Population|Death|158|||
129901376|NCT01689519|467598859|FG001|Safety Population|Death|165|||
129901377|NCT01689519|467598858|FG000|Safety Population|Lost to Follow-up|4|||
129901378|NCT01689519|467598859|FG001|Safety Population|Lost to Follow-up|8|||
129901379|NCT01689519|467598858|FG000|Safety Population|Other|2|||
129901380|NCT01689519|467598859|FG001|Safety Population|Other|4|||
129901381|NCT01689519|467598858|FG000|Safety Population|Physician Decision|4|||
129901382|NCT01689519|467598859|FG001|Safety Population|Physician Decision|1|||
129901383|NCT01689519|467598858|FG000|Safety Population|Study Terminated By Sponsor|60|||
129901384|NCT01689519|467598859|FG001|Safety Population|Study Terminated By Sponsor|47|||
129901385|NCT01689519|467598858|FG000|Safety Population|Withdrawal by Subject|20|||
129901386|NCT01689519|467598859|FG001|Safety Population|Withdrawal by Subject|20|||
129901387|NCT03525119|467598863|FG000|Overall Study|Adverse Event|0|||
129901388|NCT03525119|467598864|FG001|Overall Study|Adverse Event|1|||
129901389|NCT03525119|467598865|FG002|Overall Study|Adverse Event|0|||
129901390|NCT03525119|467598863|FG000|Overall Study|Lost to Follow-up|32|||
129901391|NCT03525119|467598864|FG001|Overall Study|Lost to Follow-up|33|||
129901392|NCT03525119|467598865|FG002|Overall Study|Lost to Follow-up|37|||
129901393|NCT03525119|467598863|FG000|Overall Study|Withdrawal by Subject|5|||
129901394|NCT03525119|467598864|FG001|Overall Study|Withdrawal by Subject|4|||
129901395|NCT03525119|467598865|FG002|Overall Study|Withdrawal by Subject|2|||
129901396|NCT03525119|467598863|FG000|Overall Study|Reason not Specified|2|||
129901397|NCT03525119|467598864|FG001|Overall Study|Reason not Specified|1|||
129901398|NCT03525119|467598865|FG002|Overall Study|Reason not Specified|2|||
129449508|NCT00467779|465945627|FG004|Stage 2|Disease Progression|0|||
129449509|NCT00467779|465945628|FG005|Stage 2|Disease Progression|0|||
129449510|NCT00467779|465945629|FG006|Stage 2|Disease Progression|0|||
129843643|NCT03670810|467392007|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
129843644|NCT03670810|467392008|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
129843645|NCT03670810|467392009|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
129843646|NCT03670810|467392010|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
129843647|NCT03670810|467392011|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
129843648|NCT03670810|467392012|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
129843649|NCT03670810|467392013|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
129843650|NCT03670810|467392005|FG000|Open Label Extension|Lost to Follow-up|0|||
129843651|NCT03670810|467392006|FG001|Open Label Extension|Lost to Follow-up|0|||
129843652|NCT03670810|467392007|FG002|Open Label Extension|Lost to Follow-up|0|||
129843653|NCT03670810|467392008|FG003|Open Label Extension|Lost to Follow-up|0|||
129843654|NCT03670810|467392009|FG004|Open Label Extension|Lost to Follow-up|0|||
129843655|NCT03670810|467392010|FG005|Open Label Extension|Lost to Follow-up|0|||
129843656|NCT03670810|467392011|FG006|Open Label Extension|Lost to Follow-up|0|||
129843657|NCT03670810|467392012|FG007|Open Label Extension|Lost to Follow-up|0|||
129843658|NCT03670810|467392013|FG008|Open Label Extension|Lost to Follow-up|23|||
129843659|NCT02644967|467392015|FG000|Overall Study|Death|26|||
129843660|NCT02644967|467392015|FG000|Overall Study|Physician Decision|1|||
129843661|NCT02644967|467392015|FG000|Overall Study|Withdrawal by Subject|2|||
129843662|NCT02644967|467392015|FG000|Overall Study|Protocol Violation|1|||
129843663|NCT02644967|467392015|FG000|Overall Study|Progressive Disease|1|||
129843664|NCT02644967|467392015|FG000|Overall Study|Study Terminated by Sponsor|4|||
129843665|NCT01502644|467392016|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
129449511|NCT00467779|465945630|FG007|Stage 2|Disease Progression|0|||
129449512|NCT00467779|465945631|FG008|Stage 2|Disease Progression|16|||
129449513|NCT00467779|465945632|FG009|Stage 2|Disease Progression|0|||
129449514|NCT00467779|465945633|FG010|Stage 2|Disease Progression|0|||
129449515|NCT00467779|465945634|FG011|Stage 2|Disease Progression|0|||
129843666|NCT01502644|467392017|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
129901399|NCT03525119|467598863|FG000|Overall Study|Randomized but not Vaccinated|1|||
129901400|NCT03525119|467598864|FG001|Overall Study|Randomized but not Vaccinated|0|||
129901401|NCT03525119|467598865|FG002|Overall Study|Randomized but not Vaccinated|2|||
129901402|NCT01713530|467598866|FG000|Overall Study|Adverse Event|0|||
129449516|NCT00467779|465945635|FG012|Stage 2|Disease Progression|0|||
129449517|NCT00467779|465945636|FG013|Stage 2|Disease Progression|0|||
129901403|NCT01713530|467598867|FG001|Overall Study|Adverse Event|5|||
129843667|NCT01502644|467392018|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
129843668|NCT01502644|467392019|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
129843669|NCT01502644|467392016|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
129843670|NCT01502644|467392017|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129843671|NCT01502644|467392018|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129843672|NCT01502644|467392019|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
129843673|NCT01502644|467392016|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
129843674|NCT01502644|467392017|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129843675|NCT01502644|467392018|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129843676|NCT01502644|467392019|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
129843677|NCT01502644|467392016|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
129843678|NCT01502644|467392017|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
129843679|NCT01502644|467392018|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
129843680|NCT01502644|467392019|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
129843681|NCT01502644|467392016|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
129843682|NCT01502644|467392017|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
129843683|NCT01502644|467392018|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
129843684|NCT01502644|467392019|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
129843685|NCT01552226|467392020|FG000|Overall Study|Withdrawal by Subject|4|||
129843686|NCT01552226|467392021|FG001|Overall Study|Withdrawal by Subject|4|||
129843687|NCT00637195|467392022|FG000|Overall Study|Lost to Follow-up|1|||
129843688|NCT00637195|467392023|FG001|Overall Study|Lost to Follow-up|0|||
129843689|NCT00637195|467392022|FG000|Overall Study|Other|2|||
129843690|NCT00637195|467392023|FG001|Overall Study|Other|0|||
129843691|NCT00637195|467392022|FG000|Overall Study|Withdrawal by Subject|0|||
129843692|NCT00637195|467392023|FG001|Overall Study|Withdrawal by Subject|1|||
129843693|NCT02388997|467392024|FG000|Overall Study|Adverse Event|1|||
129843694|NCT02388997|467392025|FG001|Overall Study|Adverse Event|2|||
129843695|NCT02388997|467392024|FG000|Overall Study|Withdrawal by Subject|2|||
129843696|NCT02388997|467392025|FG001|Overall Study|Withdrawal by Subject|1|||
129843697|NCT02388997|467392024|FG000|Overall Study|Lung function exclusion criteria|0|||
129843698|NCT02388997|467392025|FG001|Overall Study|Lung function exclusion criteria|2|||
129843699|NCT02388997|467392024|FG000|Overall Study|Tested positive for virus during run-in|0|||
129843700|NCT02388997|467392025|FG001|Overall Study|Tested positive for virus during run-in|1|||
129843701|NCT01110915|467392026|FG000|Overall Study|Death|2|||
129843702|NCT01110915|467392027|FG001|Overall Study|Death|1|||
129843703|NCT01110915|467392026|FG000|Overall Study|Lost to Follow-up|1|||
129843704|NCT01110915|467392027|FG001|Overall Study|Lost to Follow-up|0|||
129843705|NCT01110915|467392026|FG000|Overall Study|Withdrawal by Subject|7|||
129843706|NCT01110915|467392027|FG001|Overall Study|Withdrawal by Subject|1|||
129843707|NCT00207142|467392028|FG000|Induction Phase|Adverse Event|9|||
129843708|NCT00207142|467392029|FG001|Induction Phase|Adverse Event|0|||
129843709|NCT00207142|467392030|FG002|Induction Phase|Adverse Event|0|||
129843710|NCT00207142|467392031|FG003|Induction Phase|Adverse Event|0|||
129843711|NCT00207142|467392028|FG000|Induction Phase|Death|1|||
129843712|NCT00207142|467392029|FG001|Induction Phase|Death|0|||
129843713|NCT00207142|467392030|FG002|Induction Phase|Death|0|||
129901404|NCT01713530|467598866|FG000|Overall Study|Withdrawal criteria|21|||
129843714|NCT00207142|467392031|FG003|Induction Phase|Death|0|||
129843715|NCT00207142|467392028|FG000|Induction Phase|Lack of Efficacy|1|||
129843716|NCT00207142|467392029|FG001|Induction Phase|Lack of Efficacy|0|||
129843717|NCT00207142|467392030|FG002|Induction Phase|Lack of Efficacy|0|||
129843718|NCT00207142|467392031|FG003|Induction Phase|Lack of Efficacy|0|||
129843719|NCT00207142|467392028|FG000|Induction Phase|Lost to Follow-up|5|||
129843720|NCT00207142|467392029|FG001|Induction Phase|Lost to Follow-up|0|||
129843721|NCT00207142|467392030|FG002|Induction Phase|Lost to Follow-up|0|||
129843722|NCT00207142|467392031|FG003|Induction Phase|Lost to Follow-up|0|||
129843723|NCT00207142|467392028|FG000|Induction Phase|Physician Decision|2|||
129843724|NCT00207142|467392029|FG001|Induction Phase|Physician Decision|0|||
129843725|NCT00207142|467392030|FG002|Induction Phase|Physician Decision|0|||
129843726|NCT00207142|467392031|FG003|Induction Phase|Physician Decision|0|||
129843727|NCT00207142|467392028|FG000|Induction Phase|Poor/noncompliance|2|||
129843728|NCT00207142|467392029|FG001|Induction Phase|Poor/noncompliance|0|||
129843729|NCT00207142|467392030|FG002|Induction Phase|Poor/noncompliance|0|||
129843730|NCT00207142|467392031|FG003|Induction Phase|Poor/noncompliance|0|||
129843731|NCT00207142|467392028|FG000|Induction Phase|Pregnancy|1|||
129843732|NCT00207142|467392029|FG001|Induction Phase|Pregnancy|0|||
129843733|NCT00207142|467392030|FG002|Induction Phase|Pregnancy|0|||
129843734|NCT00207142|467392031|FG003|Induction Phase|Pregnancy|0|||
129843735|NCT00207142|467392028|FG000|Induction Phase|Subject no longer meets study criteria|3|||
129843736|NCT00207142|467392029|FG001|Induction Phase|Subject no longer meets study criteria|0|||
129843737|NCT00207142|467392030|FG002|Induction Phase|Subject no longer meets study criteria|0|||
129901405|NCT01713530|467598867|FG001|Overall Study|Withdrawal criteria|12|||
129843738|NCT00207142|467392031|FG003|Induction Phase|Subject no longer meets study criteria|0|||
129843739|NCT00207142|467392028|FG000|Induction Phase|Withdrawal by Subject|4|||
129843740|NCT00207142|467392029|FG001|Induction Phase|Withdrawal by Subject|0|||
129843741|NCT00207142|467392030|FG002|Induction Phase|Withdrawal by Subject|0|||
129843742|NCT00207142|467392031|FG003|Induction Phase|Withdrawal by Subject|0|||
129843743|NCT00207142|467392028|FG000|Induction Phase|Incarceration|1|||
129843744|NCT00207142|467392029|FG001|Induction Phase|Incarceration|0|||
129843745|NCT00207142|467392030|FG002|Induction Phase|Incarceration|0|||
129843746|NCT00207142|467392031|FG003|Induction Phase|Incarceration|0|||
129843747|NCT00207142|467392028|FG000|Induction Phase|Missing lab data|1|||
129843748|NCT00207142|467392029|FG001|Induction Phase|Missing lab data|0|||
129843749|NCT00207142|467392030|FG002|Induction Phase|Missing lab data|0|||
129843750|NCT00207142|467392031|FG003|Induction Phase|Missing lab data|0|||
129843751|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
129843752|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
129843753|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
129843754|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
129843755|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
129843756|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
129843757|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
129843758|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
129843759|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
129843760|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
129843761|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
129843762|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
129843763|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
129843764|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
129843765|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
129843766|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
129843767|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
129843768|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
129843769|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
129843770|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
129843771|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
129843772|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
129843773|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
129843774|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
129843775|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
129843776|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
129843777|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
129843778|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
129843779|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Death|0|||
129843780|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Death|0|||
129843781|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Death|0|||
129843782|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Death|1|||
129843783|NCT00207142|467392028|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
129843784|NCT00207142|467392029|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
129843785|NCT00207142|467392030|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
129843786|NCT00207142|467392031|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
129843787|NCT02375672|467392032|FG000|Overall Study|remain on follow up|20|||
129843788|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843789|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
129843790|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
129843791|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
129843792|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843793|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843794|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843795|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843796|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843797|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843798|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843799|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843800|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843801|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843802|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843803|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843804|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843805|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843806|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129449518|NCT00467779|465945637|FG014|Stage 2|Disease Progression|0|||
129449519|NCT00467779|465945623|FG000|Stage 2|Unspecified Reason|0|||
129449520|NCT00467779|465945624|FG001|Stage 2|Unspecified Reason|0|||
129449521|NCT00467779|465945625|FG002|Stage 2|Unspecified Reason|0|||
129449522|NCT00467779|465945626|FG003|Stage 2|Unspecified Reason|0|||
129449523|NCT00467779|465945627|FG004|Stage 2|Unspecified Reason|0|||
129449524|NCT00467779|465945628|FG005|Stage 2|Unspecified Reason|0|||
129449525|NCT00467779|465945629|FG006|Stage 2|Unspecified Reason|0|||
129449526|NCT00467779|465945630|FG007|Stage 2|Unspecified Reason|0|||
129449527|NCT00467779|465945631|FG008|Stage 2|Unspecified Reason|3|||
129449528|NCT00467779|465945632|FG009|Stage 2|Unspecified Reason|0|||
129449529|NCT00467779|465945633|FG010|Stage 2|Unspecified Reason|0|||
129449530|NCT00467779|465945634|FG011|Stage 2|Unspecified Reason|0|||
129449531|NCT00467779|465945635|FG012|Stage 2|Unspecified Reason|0|||
129449532|NCT00467779|465945636|FG013|Stage 2|Unspecified Reason|0|||
129449533|NCT00467779|465945637|FG014|Stage 2|Unspecified Reason|0|||
129449534|NCT00467779|465945623|FG000|Stage 2A|Adverse Event|0|||
129449535|NCT00467779|465945624|FG001|Stage 2A|Adverse Event|0|||
129449536|NCT00467779|465945625|FG002|Stage 2A|Adverse Event|0|||
129449537|NCT00467779|465945626|FG003|Stage 2A|Adverse Event|0|||
129449538|NCT00467779|465945627|FG004|Stage 2A|Adverse Event|0|||
129449539|NCT00467779|465945628|FG005|Stage 2A|Adverse Event|0|||
129449540|NCT00467779|465945629|FG006|Stage 2A|Adverse Event|0|||
129449541|NCT00467779|465945630|FG007|Stage 2A|Adverse Event|0|||
129449542|NCT00467779|465945631|FG008|Stage 2A|Adverse Event|0|||
129449543|NCT00467779|465945632|FG009|Stage 2A|Adverse Event|0|||
129449544|NCT00467779|465945633|FG010|Stage 2A|Adverse Event|0|||
129449545|NCT00467779|465945634|FG011|Stage 2A|Adverse Event|0|||
129449546|NCT00467779|465945635|FG012|Stage 2A|Adverse Event|0|||
129449547|NCT00467779|465945636|FG013|Stage 2A|Adverse Event|2|||
129449548|NCT00467779|465945637|FG014|Stage 2A|Adverse Event|0|||
129449549|NCT00467779|465945623|FG000|Stage 2A|Death|0|||
129449550|NCT00467779|465945624|FG001|Stage 2A|Death|0|||
129449551|NCT00467779|465945625|FG002|Stage 2A|Death|0|||
129449552|NCT00467779|465945626|FG003|Stage 2A|Death|0|||
129449553|NCT00467779|465945627|FG004|Stage 2A|Death|0|||
129449554|NCT00467779|465945628|FG005|Stage 2A|Death|0|||
129449555|NCT00467779|465945629|FG006|Stage 2A|Death|0|||
129449556|NCT00467779|465945630|FG007|Stage 2A|Death|0|||
129449557|NCT00467779|465945631|FG008|Stage 2A|Death|0|||
129449558|NCT00467779|465945632|FG009|Stage 2A|Death|0|||
129449559|NCT00467779|465945633|FG010|Stage 2A|Death|0|||
129449560|NCT00467779|465945634|FG011|Stage 2A|Death|0|||
129843807|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843808|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843809|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843810|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843811|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
129843812|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843813|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
129843814|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843815|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129901406|NCT01713530|467598866|FG000|Overall Study|Unclassified|4|||
129901407|NCT01713530|467598867|FG001|Overall Study|Unclassified|2|||
129901408|NCT01186848|467598868|FG000|Overall Study|Lost to Follow-up|4|||
129901409|NCT01186848|467598868|FG000|Overall Study|Withdrawal by Subject|2|||
129449561|NCT00467779|465945635|FG012|Stage 2A|Death|0|||
129449562|NCT00467779|465945636|FG013|Stage 2A|Death|1|||
129449563|NCT00467779|465945637|FG014|Stage 2A|Death|0|||
129901410|NCT01186848|467598868|FG000|Overall Study|Adverse Event|2|||
129901411|NCT02148133|467598881|FG000|Overall Study|Investigator discretion|1|||
129449564|NCT00467779|465945623|FG000|Stage 2A|Disease Progression|0|||
129449565|NCT00467779|465945624|FG001|Stage 2A|Disease Progression|0|||
129449566|NCT00467779|465945625|FG002|Stage 2A|Disease Progression|0|||
129449567|NCT00467779|465945626|FG003|Stage 2A|Disease Progression|0|||
129449568|NCT00467779|465945627|FG004|Stage 2A|Disease Progression|0|||
129449569|NCT00467779|465945628|FG005|Stage 2A|Disease Progression|0|||
129449570|NCT00467779|465945629|FG006|Stage 2A|Disease Progression|0|||
129449571|NCT00467779|465945630|FG007|Stage 2A|Disease Progression|0|||
129449572|NCT00467779|465945631|FG008|Stage 2A|Disease Progression|0|||
129449573|NCT00467779|465945632|FG009|Stage 2A|Disease Progression|0|||
129449574|NCT00467779|465945633|FG010|Stage 2A|Disease Progression|0|||
129449575|NCT00467779|465945634|FG011|Stage 2A|Disease Progression|0|||
129449576|NCT00467779|465945635|FG012|Stage 2A|Disease Progression|0|||
129449577|NCT00467779|465945636|FG013|Stage 2A|Disease Progression|10|||
129449578|NCT00467779|465945637|FG014|Stage 2A|Disease Progression|0|||
129449579|NCT00467779|465945623|FG000|Stage 2A|Unspecified Reason|0|||
129449580|NCT00467779|465945624|FG001|Stage 2A|Unspecified Reason|0|||
129449581|NCT00467779|465945625|FG002|Stage 2A|Unspecified Reason|0|||
129449582|NCT00467779|465945626|FG003|Stage 2A|Unspecified Reason|0|||
129843816|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843817|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843818|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843819|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843820|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843821|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843822|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843823|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843824|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843825|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843826|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843827|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843828|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843829|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843830|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843831|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843832|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843833|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843834|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843835|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
129843836|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843837|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
129843838|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843839|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843840|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843841|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843842|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843843|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843844|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843845|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843846|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843847|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843848|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843849|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843850|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843851|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843852|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843853|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843854|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843855|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843856|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843857|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843858|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843859|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
129843860|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
129843861|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
129843862|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
129843863|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
129843864|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843865|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843866|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843867|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843868|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843869|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843870|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843871|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843872|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843873|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843874|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843875|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843876|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843877|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843878|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843879|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843880|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843881|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843882|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843883|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
129843884|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
129843885|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
129843886|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
129901412|NCT02148133|467598881|FG000|Overall Study|Lack of Efficacy|1|||
129901413|NCT02148133|467598881|FG000|Overall Study|Protocol deviation|1|||
129843887|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
129843888|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843889|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843890|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843891|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843892|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843893|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843894|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843895|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843896|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843897|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843898|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843899|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843900|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843901|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843902|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843903|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843904|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843905|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843906|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843907|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
129843908|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843909|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
129843910|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843911|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
129843912|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843913|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843914|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843915|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843916|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843917|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843918|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843919|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843920|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843921|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843922|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843923|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843924|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843925|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843926|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843927|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843928|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843929|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843930|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843931|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
129843932|NCT02346240|467392034|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843933|NCT02346240|467392035|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843934|NCT02346240|467392036|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
129843935|NCT02346240|467392037|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843936|NCT02346240|467392038|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843937|NCT02346240|467392039|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843938|NCT02346240|467392040|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843939|NCT02346240|467392041|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843940|NCT02346240|467392042|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843941|NCT02346240|467392043|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843942|NCT02346240|467392044|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843943|NCT02346240|467392045|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129901414|NCT02148133|467598881|FG000|Overall Study|Protocol-defined stopping criteria|2|||
129901415|NCT00079183|467598882|FG000|Overall Study|Withdrawal by Subject|4|||
129843944|NCT02346240|467392046|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129901416|NCT00079183|467598882|FG000|Overall Study|Study medication non-compliance|2|||
129901417|NCT00079183|467598882|FG000|Overall Study|Specimen collection non-compliance|1|||
129449583|NCT00467779|465945627|FG004|Stage 2A|Unspecified Reason|0|||
129449584|NCT00467779|465945628|FG005|Stage 2A|Unspecified Reason|0|||
129449585|NCT00467779|465945629|FG006|Stage 2A|Unspecified Reason|0|||
129449586|NCT00467779|465945630|FG007|Stage 2A|Unspecified Reason|0|||
129449587|NCT00467779|465945631|FG008|Stage 2A|Unspecified Reason|0|||
129449588|NCT00467779|465945632|FG009|Stage 2A|Unspecified Reason|0|||
129843945|NCT02346240|467392047|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843946|NCT02346240|467392048|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843947|NCT02346240|467392049|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843948|NCT02346240|467392050|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843949|NCT02346240|467392051|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843950|NCT02346240|467392052|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843951|NCT02346240|467392053|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843952|NCT02346240|467392054|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843953|NCT02346240|467392055|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843954|NCT02346240|467392056|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843955|NCT02346240|467392057|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
129843956|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843957|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843958|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843959|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843960|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843961|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843962|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843963|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129843964|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129843965|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843966|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843967|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843968|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843969|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129843970|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
129843971|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
129843972|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
129843973|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843974|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843975|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843976|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843977|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843978|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843979|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
129843980|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843981|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843982|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843983|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843984|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843985|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843986|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843987|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843988|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843989|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843990|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843991|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843992|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843993|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
129843994|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843995|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
129901418|NCT00619645|467598883|FG000|Overall Study|Adverse Event|1|||
129449589|NCT00467779|465945633|FG010|Stage 2A|Unspecified Reason|0|||
129449590|NCT00467779|465945634|FG011|Stage 2A|Unspecified Reason|0|||
129843996|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843997|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843998|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129843999|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844000|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844001|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129901419|NCT04364269|467598884|FG000|Overall Study|Adverse Event|1|||
129844002|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844003|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
129844004|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844005|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844006|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844007|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844008|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844009|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844010|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844011|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844012|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844013|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844014|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844015|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844016|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844017|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844018|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
129844019|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844020|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844021|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844022|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844023|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844024|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844025|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844026|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844027|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
129844028|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844029|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844030|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844031|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844032|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844033|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844034|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844035|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844036|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844037|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844038|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844039|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
129844040|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844041|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
129844042|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
129844043|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
129844044|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
129844045|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844046|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844047|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844048|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844049|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844050|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844051|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
129844052|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844053|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844054|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129901420|NCT04364269|467598885|FG001|Overall Study|Adverse Event|0|||
129844055|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844056|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844057|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844058|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844059|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844060|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844061|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844062|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844063|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129901421|NCT04364269|467598886|FG002|Overall Study|Adverse Event|0|||
129901422|NCT04364269|467598884|FG000|Overall Study|Withdrawal by Subject|0|||
129901423|NCT04364269|467598885|FG001|Overall Study|Withdrawal by Subject|1|||
129901424|NCT04364269|467598886|FG002|Overall Study|Withdrawal by Subject|0|||
129901425|NCT00371566|467598887|FG000|Treatment Phase|Withdrawal by Subject|0|||
129901426|NCT00371566|467598888|FG001|Treatment Phase|Withdrawal by Subject|1|||
129901427|NCT00371566|467598887|FG000|Treatment Phase|Adverse Event|0|||
129901428|NCT00371566|467598888|FG001|Treatment Phase|Adverse Event|1|||
129901429|NCT00371566|467598887|FG000|Treatment Phase|Protocol Violation|0|||
129901430|NCT00371566|467598888|FG001|Treatment Phase|Protocol Violation|1|||
129901431|NCT00371566|467598887|FG000|Chemoradiation Phase|Physician Decision|2|||
129901432|NCT00371566|467598888|FG001|Chemoradiation Phase|Physician Decision|0|||
129901433|NCT00371566|467598887|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
129844064|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844065|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
129844066|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
129844067|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
129844068|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
129844069|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844070|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844071|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844072|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844073|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844074|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844075|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
129844076|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844077|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844078|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844079|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844080|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844081|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844082|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
129844083|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844084|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844085|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844086|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844087|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844088|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844089|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844090|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844091|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844092|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844093|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844094|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844095|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844096|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844097|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844098|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844099|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
129844100|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844101|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844102|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844103|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844104|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844105|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844106|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844107|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844108|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129901434|NCT00371566|467598888|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
129901435|NCT00371566|467598887|FG000|Chemoradiation Phase|Non compliant|0|||
129901436|NCT00371566|467598888|FG001|Chemoradiation Phase|Non compliant|1|||
129901437|NCT00371566|467598887|FG000|Chemoradiation Phase|Progressive Disease|1|||
129901438|NCT00371566|467598888|FG001|Chemoradiation Phase|Progressive Disease|1|||
129901439|NCT00371566|467598887|FG000|Chemoradiation Phase|Death|2|||
129901440|NCT00371566|467598888|FG001|Chemoradiation Phase|Death|0|||
129901441|NCT00371566|467598887|FG000|Follow Up Phase|Death|0|||
129901442|NCT00371566|467598888|FG001|Follow Up Phase|Death|5|||
129901443|NCT00371566|467598887|FG000|Follow Up Phase|Disease progression|1|||
129844109|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844110|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844111|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129844112|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129901444|NCT00371566|467598888|FG001|Follow Up Phase|Disease progression|0|||
129901445|NCT00371566|467598887|FG000|Follow Up Phase|Withdrawal by Subject|0|||
129901446|NCT00371566|467598888|FG001|Follow Up Phase|Withdrawal by Subject|1|||
129901447|NCT00371566|467598887|FG000|Follow Up Phase|Physician Decision|1|||
129901448|NCT00371566|467598888|FG001|Follow Up Phase|Physician Decision|1|||
129901449|NCT00371566|467598887|FG000|Follow Up Phase|Lost to Follow-up|1|||
129901450|NCT00371566|467598888|FG001|Follow Up Phase|Lost to Follow-up|0|||
129901451|NCT00972504|467598889|FG000|Overall Study|Adverse Event|2|||
129901452|NCT00972504|467598889|FG000|Overall Study|Investigator discretion|1|||
129901453|NCT04246762|467598890|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
129901454|NCT00597519|467598891|FG000|Overall Study|Death|1|||
129901455|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
129901456|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
129901457|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
129901458|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
129901459|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
129901460|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
129901461|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
129901462|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
129901463|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
129901464|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
129901465|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
129901466|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
129901467|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Death|7|||
129901468|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Death|4|||
129901469|NCT00410124|467598892|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
129901470|NCT00410124|467598893|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
129901471|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
129901472|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
129901473|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
129901474|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
129901475|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
129844113|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129844114|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
129844115|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844116|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844117|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844118|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844119|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844120|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844121|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844122|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844123|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
129844124|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844125|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129901476|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
129901477|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
129901478|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
129901479|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
129901480|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
129901481|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
129901482|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
129901483|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
129901484|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
129901485|NCT00410124|467598892|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
129901486|NCT00410124|467598893|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
129901487|NCT01227707|467598894|FG000|Overall Study|Adverse Event|10|||
129901488|NCT01227707|467598894|FG000|Overall Study|Progression of disease|3|||
129901489|NCT01227707|467598894|FG000|Overall Study|Withdrawal by Subject|1|||
129901490|NCT01227707|467598894|FG000|Overall Study|Patient non-compliance|3|||
129901491|NCT01227707|467598894|FG000|Overall Study|Medical decision|6|||
129901492|NCT01227707|467598894|FG000|Overall Study|Death|1|||
129901493|NCT05484726|467598897|FG000|Overall Study|Protocol Violation|3|||
129901494|NCT05484726|467598898|FG001|Overall Study|Protocol Violation|3|||
129901495|NCT05484726|467598897|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
129901496|NCT05484726|467598898|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
129901497|NCT05484726|467598897|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
129901498|NCT05484726|467598898|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
129901499|NCT05484726|467598897|FG000|Overall Study|continued need of mechanical ventilation|2|||
129901500|NCT05484726|467598898|FG001|Overall Study|continued need of mechanical ventilation|3|||
129901501|NCT05484726|467598897|FG000|Overall Study|Withdrawal by Subject|2|||
129844126|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844127|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844128|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844129|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844130|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844131|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844132|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844133|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
129844134|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844135|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844136|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844137|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844138|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844139|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844140|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844141|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844142|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844143|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844144|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844145|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844146|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844147|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
129844148|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844149|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844150|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844151|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844152|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844153|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844154|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844155|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844156|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844157|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844158|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
129844159|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844160|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844161|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844162|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844163|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844164|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844165|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844166|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844167|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129901502|NCT05484726|467598898|FG001|Overall Study|Withdrawal by Subject|3|||
129901503|NCT05484726|467598897|FG000|Overall Study|IVH (G III & IV)|2|||
129901504|NCT05484726|467598898|FG001|Overall Study|IVH (G III & IV)|1|||
129901505|NCT05484726|467598897|FG000|Overall Study|NEC (stage II & III)|2|||
129901506|NCT05484726|467598898|FG001|Overall Study|NEC (stage II & III)|3|||
129844168|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844169|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844170|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844171|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
129844172|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844173|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844174|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844175|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844176|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844177|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844178|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844179|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844180|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844181|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844182|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844183|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844184|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844185|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844186|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
129844187|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844188|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844189|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844190|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844191|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844192|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844193|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844194|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844195|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
129844196|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844197|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844198|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844199|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844200|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844201|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844202|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844203|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844204|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844205|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844206|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844207|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844208|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844209|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844210|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
129844211|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844212|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844213|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844214|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844215|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844216|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844217|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844218|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844219|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
129844220|NCT02346240|467392034|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844221|NCT02346240|467392035|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844222|NCT02346240|467392036|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844223|NCT02346240|467392037|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844224|NCT02346240|467392038|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844225|NCT02346240|467392039|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844226|NCT02346240|467392040|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844227|NCT02346240|467392041|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844228|NCT02346240|467392042|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844229|NCT02346240|467392043|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844230|NCT02346240|467392044|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844231|NCT02346240|467392045|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844232|NCT02346240|467392046|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844233|NCT02346240|467392047|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844234|NCT02346240|467392048|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
129844235|NCT02346240|467392049|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844236|NCT02346240|467392050|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844237|NCT02346240|467392051|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844238|NCT02346240|467392052|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844239|NCT02346240|467392053|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844240|NCT02346240|467392054|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844241|NCT02346240|467392055|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844242|NCT02346240|467392056|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844243|NCT02346240|467392057|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
129844244|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844245|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844246|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844247|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844248|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844249|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844250|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844251|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844252|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844253|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844254|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844255|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844256|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844257|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844258|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844259|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844260|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
129844261|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
129844262|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
129844263|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
129844264|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129844265|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
129844266|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129844267|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
129844268|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844269|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844270|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844271|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844272|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844273|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844274|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844275|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844276|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844277|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844278|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844279|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844280|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844281|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844282|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844283|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844284|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844285|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844286|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
129844287|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
129844288|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844289|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
129844290|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844291|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
129844292|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844293|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844294|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844295|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844296|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844297|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844298|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844299|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844300|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844301|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844302|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844303|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844304|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844305|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844306|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844307|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844308|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844309|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844310|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129844311|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844312|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844313|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
129844314|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844315|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
129844316|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844317|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844318|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844319|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844320|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844321|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844322|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844323|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844324|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844325|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844326|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844327|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844328|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844329|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844330|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844331|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844332|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844333|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844334|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844335|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844336|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844337|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
129844338|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844339|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
129844340|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844341|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844342|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844343|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844344|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844345|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844346|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844347|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844348|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844349|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844350|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844351|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844352|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844353|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844354|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844355|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844356|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844357|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
129844358|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
129844359|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
129844360|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
129844361|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129844362|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129844363|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
129844364|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844365|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844366|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844367|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844368|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844369|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844370|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844371|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844372|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844373|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844374|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844375|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844376|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844377|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844378|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844379|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844380|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844381|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844382|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
129844383|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129844384|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
129844385|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
129844386|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129844387|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
129844388|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844389|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844390|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844391|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844392|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844393|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844394|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844395|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844396|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844397|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844398|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844399|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844400|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844401|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844402|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844403|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844404|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844405|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844406|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
129844407|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844408|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
129844409|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
129844410|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
129844411|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
129844412|NCT02346240|467392034|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844413|NCT02346240|467392035|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844414|NCT02346240|467392036|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844415|NCT02346240|467392037|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844416|NCT02346240|467392038|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844417|NCT02346240|467392039|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844418|NCT02346240|467392040|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844419|NCT02346240|467392041|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844420|NCT02346240|467392042|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844421|NCT02346240|467392043|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844422|NCT02346240|467392044|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844423|NCT02346240|467392045|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844424|NCT02346240|467392046|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844425|NCT02346240|467392047|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844426|NCT02346240|467392048|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844427|NCT02346240|467392049|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844428|NCT02346240|467392050|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844429|NCT02346240|467392051|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844430|NCT02346240|467392052|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
129844431|NCT02346240|467392053|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844432|NCT02346240|467392054|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844433|NCT02346240|467392055|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844434|NCT02346240|467392056|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844435|NCT02346240|467392057|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
129844436|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844437|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844438|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
129844439|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844440|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844441|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
129844442|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
129844443|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
129844444|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
129844445|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
129844446|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129844447|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
129844448|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
129844449|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
129844450|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
129844451|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844452|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844453|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844454|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844455|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844456|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
129844457|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129844458|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844459|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129844460|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844461|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844462|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
129844463|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129844464|NCT01573624|467392058|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
129844465|NCT01573624|467392059|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
129844466|NCT01573624|467392060|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844467|NCT01573624|467392061|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844468|NCT01573624|467392062|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
129844469|NCT01573624|467392063|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844470|NCT01573624|467392064|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
129844471|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844472|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129901507|NCT01093534|467598901|FG000|Overall Study|Adverse Event|2|||
129901508|NCT01093534|467598902|FG001|Overall Study|Adverse Event|5|||
129901509|NCT01093534|467598903|FG002|Overall Study|Adverse Event|2|||
129844473|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844474|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844475|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844476|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
129844477|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
129844478|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844479|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
129844480|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844481|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
129844482|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844483|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
129844484|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
129844485|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
129844486|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844487|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
129844488|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
129844489|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844490|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844491|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
129844492|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844493|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844494|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844495|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844496|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844497|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
129844498|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
129844499|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844500|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844501|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844502|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
129844503|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844504|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
129844505|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
129844506|NCT01573624|467392058|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844507|NCT01573624|467392059|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844508|NCT01573624|467392060|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844509|NCT01573624|467392061|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844510|NCT01573624|467392062|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844511|NCT01573624|467392063|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844512|NCT01573624|467392064|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844513|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
129844514|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
129844515|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
129844516|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
129844517|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
129844518|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
129901510|NCT01093534|467598901|FG000|Overall Study|Lack of Efficacy|2|||
129901511|NCT01093534|467598902|FG001|Overall Study|Lack of Efficacy|1|||
129901512|NCT01093534|467598903|FG002|Overall Study|Lack of Efficacy|1|||
129901513|NCT01093534|467598901|FG000|Overall Study|Withdrawal by Subject|5|||
129901514|NCT01093534|467598902|FG001|Overall Study|Withdrawal by Subject|7|||
129901515|NCT01093534|467598903|FG002|Overall Study|Withdrawal by Subject|2|||
129901516|NCT01093534|467598901|FG000|Overall Study|Other|1|||
129844519|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
129844520|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844521|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
129844522|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844523|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844524|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129844525|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
129844526|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
129901517|NCT01093534|467598902|FG001|Overall Study|Other|3|||
129901518|NCT01093534|467598903|FG002|Overall Study|Other|4|||
129901519|NCT01837641|467598910|FG000|Overall Study|Sponsor decision|1|||
129901520|NCT01837641|467598911|FG001|Overall Study|Sponsor decision|0|||
129901521|NCT01837641|467598912|FG002|Overall Study|Sponsor decision|0|||
129901522|NCT01837641|467598913|FG003|Overall Study|Sponsor decision|0|||
129901523|NCT01837641|467598914|FG004|Overall Study|Sponsor decision|0|||
129901524|NCT01837641|467598915|FG005|Overall Study|Sponsor decision|1|||
129901525|NCT01837641|467598916|FG006|Overall Study|Sponsor decision|0|||
129901526|NCT01837641|467598917|FG007|Overall Study|Sponsor decision|0|||
129901527|NCT01837641|467598910|FG000|Overall Study|Adverse Event|0|||
129901528|NCT01837641|467598911|FG001|Overall Study|Adverse Event|0|||
129901529|NCT01837641|467598912|FG002|Overall Study|Adverse Event|0|||
129901530|NCT01837641|467598913|FG003|Overall Study|Adverse Event|0|||
129901531|NCT01837641|467598914|FG004|Overall Study|Adverse Event|0|||
129901532|NCT01837641|467598915|FG005|Overall Study|Adverse Event|1|||
129901533|NCT01837641|467598916|FG006|Overall Study|Adverse Event|0|||
129901534|NCT01837641|467598917|FG007|Overall Study|Adverse Event|0|||
129901535|NCT01837641|467598910|FG000|Overall Study|Withdrawal by Subject|0|||
129901536|NCT01837641|467598911|FG001|Overall Study|Withdrawal by Subject|0|||
129901537|NCT01837641|467598912|FG002|Overall Study|Withdrawal by Subject|0|||
129901538|NCT01837641|467598913|FG003|Overall Study|Withdrawal by Subject|0|||
129901539|NCT01837641|467598914|FG004|Overall Study|Withdrawal by Subject|1|||
129901540|NCT01837641|467598915|FG005|Overall Study|Withdrawal by Subject|0|||
129901541|NCT01837641|467598916|FG006|Overall Study|Withdrawal by Subject|1|||
129901542|NCT01837641|467598917|FG007|Overall Study|Withdrawal by Subject|0|||
129901543|NCT01769391|467598922|FG000|Overall Study|Death|10|||
129901544|NCT01769391|467598923|FG001|Overall Study|Death|1|||
129901545|NCT01769391|467598922|FG000|Overall Study|Adverse Event|0|||
129901546|NCT01769391|467598923|FG001|Overall Study|Adverse Event|3|||
129901547|NCT01769391|467598922|FG000|Overall Study|Progressive Disease|1|||
129901548|NCT01769391|467598923|FG001|Overall Study|Progressive Disease|2|||
129901549|NCT01769391|467598922|FG000|Overall Study|Withdrawal by Subject|4|||
129901550|NCT01769391|467598923|FG001|Overall Study|Withdrawal by Subject|3|||
129901551|NCT01769391|467598922|FG000|Overall Study|Investigator Decision|2|||
129901552|NCT01769391|467598923|FG001|Overall Study|Investigator Decision|0|||
129901553|NCT02351180|467598926|FG000|Overall Study|Withdrawal by Subject|1|||
129901554|NCT02351180|467598927|FG001|Overall Study|Withdrawal by Subject|0|||
129901555|NCT01123083|467598928|FG000|Overall Study|Investigator recommendation|1|||
129449591|NCT00467779|465945635|FG012|Stage 2A|Unspecified Reason|0|||
129449592|NCT00467779|465945636|FG013|Stage 2A|Unspecified Reason|7|||
129449593|NCT00467779|465945637|FG014|Stage 2A|Unspecified Reason|0|||
129844527|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
129844528|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844529|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844530|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844531|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844532|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844533|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
129844534|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844535|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129844536|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129844537|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844538|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844539|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129844540|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129844541|NCT01573624|467392058|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
129844542|NCT01573624|467392059|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844543|NCT01573624|467392060|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844544|NCT01573624|467392061|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844545|NCT01573624|467392062|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844546|NCT01573624|467392063|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844547|NCT01573624|467392064|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
129844548|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
129901556|NCT01123083|467598929|FG001|Overall Study|Investigator recommendation|1|||
129901557|NCT01123083|467598928|FG000|Overall Study|Administrative reasons|0|||
129901558|NCT01123083|467598929|FG001|Overall Study|Administrative reasons|4|||
129901559|NCT01123083|467598928|FG000|Overall Study|Lost to Follow-up|2|||
129901560|NCT01123083|467598929|FG001|Overall Study|Lost to Follow-up|6|||
129901561|NCT01123083|467598928|FG000|Overall Study|Adverse Event|1|||
129901562|NCT01123083|467598929|FG001|Overall Study|Adverse Event|0|||
129901563|NCT01123083|467598928|FG000|Overall Study|Withdrew for another reason not covered|0|||
129449594|NCT00467779|465945623|FG000|Stage 2A|Withdrawal by Subject|0|||
129449595|NCT00467779|465945624|FG001|Stage 2A|Withdrawal by Subject|0|||
129844549|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844550|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844551|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844552|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844553|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
129844554|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
129844555|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
129844556|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844557|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844558|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844559|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844560|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
129844561|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
129844562|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844563|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
129844564|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844565|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844566|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844567|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844568|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
129844569|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844570|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
129844571|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844572|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844573|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844574|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844575|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
129844576|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844577|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844578|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844579|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844580|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
129844581|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129844582|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
129844583|NCT01573624|467392058|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844584|NCT01573624|467392059|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844585|NCT01573624|467392060|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844586|NCT01573624|467392061|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844587|NCT01573624|467392062|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844588|NCT01573624|467392063|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
129844589|NCT01573624|467392064|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
129844590|NCT01573624|467392058|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
129844591|NCT01573624|467392059|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129844592|NCT01573624|467392060|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129844593|NCT01573624|467392061|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
129844594|NCT01573624|467392062|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
129844595|NCT01573624|467392063|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
129844596|NCT01573624|467392064|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
129844597|NCT01573624|467392058|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844598|NCT01573624|467392059|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
129844599|NCT01573624|467392060|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844600|NCT01573624|467392061|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844601|NCT01573624|467392062|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844602|NCT01573624|467392063|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
129844603|NCT01573624|467392064|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
129844604|NCT01573624|467392058|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
129844605|NCT01573624|467392059|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844606|NCT01573624|467392060|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844607|NCT01573624|467392061|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844608|NCT01573624|467392062|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844609|NCT01573624|467392063|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129844610|NCT01573624|467392064|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
129901564|NCT01123083|467598929|FG001|Overall Study|Withdrew for another reason not covered|1|||
129901565|NCT01123083|467598928|FG000|Overall Study|Participant/legal representative request|7|||
129901566|NCT01123083|467598929|FG001|Overall Study|Participant/legal representative request|3|||
129901567|NCT01751724|467598930|FG000|Overall Study|extubated bef.start assigned treatment|1|||
129901568|NCT01751724|467598931|FG001|Overall Study|extubated bef.start assigned treatment|0|||
129901569|NCT01751724|467598930|FG000|Overall Study|withdrawn by parent|0|||
129901570|NCT01751724|467598931|FG001|Overall Study|withdrawn by parent|2|||
129901571|NCT00605033|467598932|FG000|Overall Study|Adverse Event|2|||
129901572|NCT00605033|467598933|FG001|Overall Study|Adverse Event|2|||
129901573|NCT00605033|467598932|FG000|Overall Study|Lost to Follow-up|1|||
129901574|NCT00605033|467598933|FG001|Overall Study|Lost to Follow-up|1|||
129901575|NCT00605033|467598932|FG000|Overall Study|Withdrawal by Subject|3|||
129901576|NCT00605033|467598933|FG001|Overall Study|Withdrawal by Subject|4|||
129901577|NCT00605033|467598932|FG000|Overall Study|Protocol Violation|1|||
129901578|NCT00605033|467598933|FG001|Overall Study|Protocol Violation|1|||
129901579|NCT03121950|467598935|FG000|Overall Study|Withdrawal by Subject|11|||
129901580|NCT03121950|467598936|FG001|Overall Study|Withdrawal by Subject|2|||
129901581|NCT01867580|467598937|FG000|Overall Study|Withdrawal by Subject|2|||
129901582|NCT01867580|467598938|FG001|Overall Study|Withdrawal by Subject|3|||
129901583|NCT01867580|467598937|FG000|Overall Study|Physician Decision|17|||
129901584|NCT01867580|467598938|FG001|Overall Study|Physician Decision|12|||
129901585|NCT01867580|467598937|FG000|Overall Study|Lost to Follow-up|3|||
129901586|NCT01867580|467598938|FG001|Overall Study|Lost to Follow-up|5|||
129901587|NCT01867580|467598937|FG000|Overall Study|Sponsor terminated study|1|||
129901588|NCT01867580|467598938|FG001|Overall Study|Sponsor terminated study|0|||
129901589|NCT01867580|467598937|FG000|Overall Study|Missed follow-up assessment|2|||
129901590|NCT01867580|467598938|FG001|Overall Study|Missed follow-up assessment|1|||
129901591|NCT01867580|467598937|FG000|Overall Study|Interruption to therapy|3|||
129901592|NCT01867580|467598938|FG001|Overall Study|Interruption to therapy|0|||
129901593|NCT01867580|467598937|FG000|Overall Study|Osteomyelitis|0|||
129901594|NCT01867580|467598938|FG001|Overall Study|Osteomyelitis|1|||
129901595|NCT01867580|467598937|FG000|Overall Study|Continuation of therapy|0|||
129901596|NCT01867580|467598938|FG001|Overall Study|Continuation of therapy|1|||
129901597|NCT01867580|467598937|FG000|Overall Study|Wound recurrence|0|||
129901598|NCT01867580|467598938|FG001|Overall Study|Wound recurrence|1|||
129901599|NCT03141788|467598939|FG000|Overall Study|Lost to Follow-up|1|||
129901600|NCT03141788|467598939|FG000|Overall Study|Protocol Violation|3|||
129901601|NCT03141788|467598939|FG000|Overall Study|Withdrawal by Subject|4|||
129901602|NCT01025843|467600519|FG000|Washout 4|Withdrawal by Subject|0|||
129901603|NCT01025843|467600520|FG001|Washout 4|Withdrawal by Subject|0|||
129901604|NCT01025843|467600521|FG002|Washout 4|Withdrawal by Subject|1|||
129901605|NCT01025843|467600522|FG003|Washout 4|Withdrawal by Subject|1|||
129901606|NCT01025843|467600523|FG004|Washout 4|Withdrawal by Subject|0|||
129901607|NCT01025843|467600524|FG005|Washout 4|Withdrawal by Subject|0|||
129901608|NCT01025843|467600525|FG006|Washout 4|Withdrawal by Subject|0|||
129901609|NCT01025843|467600526|FG007|Washout 4|Withdrawal by Subject|0|||
129901610|NCT01025843|467600527|FG008|Washout 4|Withdrawal by Subject|0|||
129901611|NCT01025843|467600528|FG009|Washout 4|Withdrawal by Subject|0|||
129901612|NCT01897233|467600531|FG000|Part B (24 Weeks)|Adverse Event|1|||
129901613|NCT01897233|467600531|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
129901614|NCT01897233|467600531|FG000|Part B (24 Weeks)|Physician Decision|1|||
129901615|NCT01281813|467600540|FG000|Overall Study|Adverse Event|0|||
129901616|NCT01281813|467600541|FG001|Overall Study|Adverse Event|0|||
129901617|NCT01281813|467600542|FG002|Overall Study|Adverse Event|10|||
129901618|NCT01281813|467600540|FG000|Overall Study|Lost to Follow-up|0|||
129901619|NCT01281813|467600541|FG001|Overall Study|Lost to Follow-up|0|||
129901620|NCT01281813|467600542|FG002|Overall Study|Lost to Follow-up|31|||
129901621|NCT01281813|467600540|FG000|Overall Study|Withdrawal by Subject|0|||
129901622|NCT01281813|467600541|FG001|Overall Study|Withdrawal by Subject|0|||
129901623|NCT01281813|467600542|FG002|Overall Study|Withdrawal by Subject|13|||
129901624|NCT01281813|467600540|FG000|Overall Study|Subject Non-Compliant|0|||
129901625|NCT01281813|467600541|FG001|Overall Study|Subject Non-Compliant|0|||
129901626|NCT01281813|467600542|FG002|Overall Study|Subject Non-Compliant|6|||
129901627|NCT01281813|467600540|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
129901628|NCT01281813|467600541|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
129901629|NCT01281813|467600542|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
129901630|NCT01281813|467600540|FG000|Overall Study|Sponsor's Decision|4|||
129901631|NCT01281813|467600541|FG001|Overall Study|Sponsor's Decision|3|||
129901632|NCT01281813|467600542|FG002|Overall Study|Sponsor's Decision|7|||
129901633|NCT01281813|467600540|FG000|Overall Study|Switched to Commercially Available Medication|0|||
129901634|NCT01281813|467600541|FG001|Overall Study|Switched to Commercially Available Medication|0|||
129901635|NCT01281813|467600542|FG002|Overall Study|Switched to Commercially Available Medication|26|||
129901636|NCT01281813|467600540|FG000|Overall Study|Other|0|||
129901637|NCT01281813|467600541|FG001|Overall Study|Other|1|||
129901638|NCT01281813|467600542|FG002|Overall Study|Other|39|||
129901639|NCT03546907|467600543|FG000|Overall Study|Lack of Efficacy|1|||
129844611|NCT01573624|467392058|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844612|NCT01573624|467392059|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844613|NCT01573624|467392060|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844614|NCT01573624|467392061|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844615|NCT01573624|467392062|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
129844616|NCT01573624|467392063|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
129844617|NCT01573624|467392064|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
129844618|NCT01573624|467392058|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
129844619|NCT01573624|467392059|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844620|NCT01573624|467392060|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844621|NCT01573624|467392061|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844622|NCT01573624|467392062|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844623|NCT01573624|467392063|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844624|NCT01573624|467392064|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
129844625|NCT03306264|467392065|FG000|Overall Study|Death|33|||
129844626|NCT03306264|467392066|FG001|Overall Study|Death|25|||
129844627|NCT03306264|467392067|FG002|Overall Study|Death|34|||
129844628|NCT03306264|467392068|FG003|Overall Study|Death|34|||
129901640|NCT03546907|467600544|FG001|Overall Study|Lack of Efficacy|1|||
129901641|NCT03546907|467600543|FG000|Overall Study|Withdrawal by Subject|8|||
129901642|NCT03546907|467600544|FG001|Overall Study|Withdrawal by Subject|9|||
129901643|NCT03546907|467600543|FG000|Overall Study|Adverse events (AEs)|7|||
129901644|NCT03546907|467600544|FG001|Overall Study|Adverse events (AEs)|10|||
129901645|NCT03546907|467600543|FG000|Overall Study|Other-unspecified|1|||
129901646|NCT03546907|467600544|FG001|Overall Study|Other-unspecified|1|||
129901647|NCT02810080|467600551|FG000|Overall Study|Adverse Event|3|||
129901648|NCT02810080|467600552|FG001|Overall Study|Adverse Event|0|||
129901649|NCT02810080|467600551|FG000|Overall Study|Death|0|||
129901650|NCT02810080|467600552|FG001|Overall Study|Death|2|||
129901651|NCT02810080|467600551|FG000|Overall Study|Physician Decision|4|||
129901652|NCT02810080|467600552|FG001|Overall Study|Physician Decision|0|||
129901653|NCT02810080|467600551|FG000|Overall Study|Withdrawal by Subject|0|||
129901654|NCT02810080|467600552|FG001|Overall Study|Withdrawal by Subject|2|||
129901655|NCT03808883|467600556|FG000|Overall Study|Withdrawal by Subject|2|||
129901656|NCT03808883|467600557|FG001|Overall Study|Withdrawal by Subject|0|||
129901657|NCT03808883|467600556|FG000|Overall Study|Did not complete pre test or post test survey|4|||
129901658|NCT03808883|467600557|FG001|Overall Study|Did not complete pre test or post test survey|3|||
129901659|NCT00158054|467600559|FG000|Overall Study|Refused to continue|3|||
129901660|NCT00158054|467600560|FG001|Overall Study|Refused to continue|0|||
129901661|NCT00158054|467600559|FG000|Overall Study|Unavailable for follow up|7|||
129901662|NCT00158054|467600560|FG001|Overall Study|Unavailable for follow up|3|||
129901663|NCT00855465|467600563|FG000|Treatment Period|Adverse Event|4|||
129901664|NCT00855465|467600564|FG001|Treatment Period|Adverse Event|2|||
129901665|NCT00855465|467600563|FG000|Treatment Period|Death|2|||
129901666|NCT00855465|467600564|FG001|Treatment Period|Death|2|||
129901667|NCT00855465|467600563|FG000|Treatment Period|Lack of Efficacy|2|||
129901668|NCT00855465|467600564|FG001|Treatment Period|Lack of Efficacy|1|||
129901669|NCT00855465|467600563|FG000|Treatment Period|Non-compliance|1|||
129901670|NCT00855465|467600564|FG001|Treatment Period|Non-compliance|0|||
129901671|NCT00855465|467600563|FG000|Treatment Period|Protocol Violation|2|||
129901672|NCT00855465|467600564|FG001|Treatment Period|Protocol Violation|0|||
129901673|NCT00855465|467600563|FG000|Treatment Period|Withdrawal by Subject|2|||
129901674|NCT00855465|467600564|FG001|Treatment Period|Withdrawal by Subject|0|||
129901675|NCT00855465|467600563|FG000|Treatment Period|Not treated|1|||
129901676|NCT00855465|467600564|FG001|Treatment Period|Not treated|0|||
129901677|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Adverse Event|0|||
129901678|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Adverse Event|1|||
129901679|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Death|0|||
129901680|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Death|1|||
129901681|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
129901682|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
129901683|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
129844629|NCT03306264|467392065|FG000|Overall Study|Complete Consent Withdrawal|4|||
129901684|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
129901685|NCT00855465|467600563|FG000|Follow-up Period (FUP)|Missing|1|||
129901686|NCT00855465|467600564|FG001|Follow-up Period (FUP)|Missing|0|||
129901687|NCT04567888|467600578|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
129901688|NCT04567888|467600579|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
129901689|NCT04567888|467600578|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
129901690|NCT04567888|467600579|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
129901691|NCT04567888|467600578|FG000|Overall Study|Reported Unusual Birth Year|2|||
129901692|NCT04567888|467600579|FG001|Overall Study|Reported Unusual Birth Year|3|||
129901693|NCT04567888|467600578|FG000|Overall Study|Duplicate Responses|0|||
129901694|NCT04567888|467600579|FG001|Overall Study|Duplicate Responses|1|||
129901695|NCT02371746|467600580|FG000|Overall Study|Consent withdrawn|0|||
129901696|NCT02371746|467600581|FG001|Overall Study|Consent withdrawn|0|||
129844630|NCT03306264|467392066|FG001|Overall Study|Complete Consent Withdrawal|4|||
129844631|NCT03306264|467392067|FG002|Overall Study|Complete Consent Withdrawal|1|||
129844632|NCT03306264|467392068|FG003|Overall Study|Complete Consent Withdrawal|8|||
129844633|NCT03306264|467392065|FG000|Overall Study|Lost to Follow-up|1|||
129844634|NCT03306264|467392066|FG001|Overall Study|Lost to Follow-up|0|||
129844635|NCT03306264|467392067|FG002|Overall Study|Lost to Follow-up|1|||
129844636|NCT03306264|467392068|FG003|Overall Study|Lost to Follow-up|0|||
129844637|NCT03306264|467392065|FG000|Overall Study|Rollover to ASTX727-06|10|||
129844638|NCT03306264|467392066|FG001|Overall Study|Rollover to ASTX727-06|18|||
129844639|NCT03306264|467392067|FG002|Overall Study|Rollover to ASTX727-06|4|||
129844640|NCT03306264|467392068|FG003|Overall Study|Rollover to ASTX727-06|2|||
129844641|NCT03306264|467392065|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
129844642|NCT03306264|467392066|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
129844643|NCT03306264|467392067|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
129844644|NCT03306264|467392068|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
129844645|NCT02257736|467392072|FG000|Overall Study|Progressive disease|365|||
129844646|NCT02257736|467392073|FG001|Overall Study|Progressive disease|327|||
129844647|NCT02257736|467392072|FG000|Overall Study|Adverse Event|45|||
129844648|NCT02257736|467392073|FG001|Overall Study|Adverse Event|56|||
129844649|NCT02257736|467392072|FG000|Overall Study|Withdrawal by Subject|21|||
129844650|NCT02257736|467392073|FG001|Overall Study|Withdrawal by Subject|38|||
129844651|NCT02257736|467392072|FG000|Overall Study|Death|11|||
129844652|NCT02257736|467392073|FG001|Overall Study|Death|6|||
129844653|NCT02257736|467392072|FG000|Overall Study|Physician Decision|5|||
129844654|NCT02257736|467392073|FG001|Overall Study|Physician Decision|9|||
129844655|NCT02257736|467392072|FG000|Overall Study|Non-Compliance with study drug|1|||
129844656|NCT02257736|467392073|FG001|Overall Study|Non-Compliance with study drug|2|||
129844657|NCT02257736|467392072|FG000|Overall Study|Protocol Violation|1|||
129844658|NCT02257736|467392073|FG001|Overall Study|Protocol Violation|0|||
129844659|NCT02257736|467392072|FG000|Overall Study|Other|1|||
129844660|NCT02257736|467392073|FG001|Overall Study|Other|7|||
129844661|NCT02257736|467392072|FG000|Overall Study|Randomized, not treated|1|||
129844662|NCT02257736|467392073|FG001|Overall Study|Randomized, not treated|2|||
129844663|NCT00308711|467392076|FG000|Overall Study|Withdrawal by Subject|1|||
129844664|NCT00308711|467392077|FG001|Overall Study|Withdrawal by Subject|0|||
129844665|NCT00308711|467392078|FG002|Overall Study|Withdrawal by Subject|1|||
129844666|NCT00308711|467392076|FG000|Overall Study|Protocol Violation|0|||
129844667|NCT00308711|467392077|FG001|Overall Study|Protocol Violation|1|||
129844668|NCT00308711|467392078|FG002|Overall Study|Protocol Violation|1|||
129844669|NCT00308711|467392076|FG000|Overall Study|Lost to Follow-up|0|||
129844670|NCT00308711|467392077|FG001|Overall Study|Lost to Follow-up|1|||
129844671|NCT00308711|467392078|FG002|Overall Study|Lost to Follow-up|0|||
129844672|NCT00308711|467392076|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
129844673|NCT00308711|467392077|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
129844674|NCT00308711|467392078|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
129844675|NCT00308711|467392076|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
129844676|NCT00308711|467392077|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
129844677|NCT00308711|467392078|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
129844678|NCT02167256|467392079|FG000|Overall Study|Adverse Event|13|||
129844679|NCT02167256|467392080|FG001|Overall Study|Adverse Event|6|||
129844680|NCT02167256|467392079|FG000|Overall Study|Withdrawal by Subject|4|||
129844681|NCT02167256|467392080|FG001|Overall Study|Withdrawal by Subject|4|||
129844682|NCT02167256|467392079|FG000|Overall Study|non-compliance|3|||
129844683|NCT02167256|467392080|FG001|Overall Study|non-compliance|0|||
129844684|NCT02167256|467392079|FG000|Overall Study|Study partner unable to participate|1|||
129844685|NCT02167256|467392080|FG001|Overall Study|Study partner unable to participate|0|||
129844686|NCT01420081|467392081|FG000|Overall Study|Death|1|||
129844687|NCT01420081|467392082|FG001|Overall Study|Death|0|||
129901697|NCT02371746|467600582|FG002|Overall Study|Consent withdrawn|0|||
129901698|NCT02371746|467600583|FG003|Overall Study|Consent withdrawn|0|||
129901699|NCT02371746|467600584|FG004|Overall Study|Consent withdrawn|0|||
129901700|NCT02371746|467600585|FG005|Overall Study|Consent withdrawn|0|||
129844688|NCT01420081|467392083|FG002|Overall Study|Death|8|||
129844689|NCT01420081|467392084|FG003|Overall Study|Death|0|||
129844690|NCT01420081|467392085|FG004|Overall Study|Death|7|||
129844691|NCT01420081|467392086|FG005|Overall Study|Death|12|||
129844692|NCT01420081|467392087|FG006|Overall Study|Death|0|||
129844693|NCT01420081|467392088|FG007|Overall Study|Death|1|||
129844694|NCT01420081|467392089|FG008|Overall Study|Death|1|||
129844695|NCT01420081|467392081|FG000|Overall Study|Lost to Follow-up|0|||
129844696|NCT01420081|467392082|FG001|Overall Study|Lost to Follow-up|0|||
129844697|NCT01420081|467392083|FG002|Overall Study|Lost to Follow-up|0|||
129844698|NCT01420081|467392084|FG003|Overall Study|Lost to Follow-up|0|||
129844699|NCT01420081|467392085|FG004|Overall Study|Lost to Follow-up|1|||
129844700|NCT01420081|467392086|FG005|Overall Study|Lost to Follow-up|1|||
129844701|NCT01420081|467392087|FG006|Overall Study|Lost to Follow-up|0|||
129901701|NCT02371746|467600586|FG006|Overall Study|Consent withdrawn|1|||
129844702|NCT01420081|467392088|FG007|Overall Study|Lost to Follow-up|0|||
129844703|NCT01420081|467392089|FG008|Overall Study|Lost to Follow-up|0|||
129844704|NCT01420081|467392081|FG000|Overall Study|Study Terminated by Sponsor|2|||
129844705|NCT01420081|467392082|FG001|Overall Study|Study Terminated by Sponsor|1|||
129844706|NCT01420081|467392083|FG002|Overall Study|Study Terminated by Sponsor|1|||
129844707|NCT01420081|467392084|FG003|Overall Study|Study Terminated by Sponsor|3|||
129844708|NCT01420081|467392085|FG004|Overall Study|Study Terminated by Sponsor|11|||
129844709|NCT01420081|467392086|FG005|Overall Study|Study Terminated by Sponsor|7|||
129844710|NCT01420081|467392087|FG006|Overall Study|Study Terminated by Sponsor|3|||
129844711|NCT01420081|467392088|FG007|Overall Study|Study Terminated by Sponsor|2|||
129844712|NCT01420081|467392089|FG008|Overall Study|Study Terminated by Sponsor|2|||
129844713|NCT01420081|467392081|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
129844714|NCT01420081|467392082|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
129844715|NCT01420081|467392083|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
129844716|NCT01420081|467392084|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
129844717|NCT01420081|467392085|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
129844718|NCT01420081|467392086|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
129844719|NCT01420081|467392087|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
129844720|NCT01420081|467392088|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
129844721|NCT01420081|467392089|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
129844722|NCT01420081|467392081|FG000|Overall Study|Other Reasons|0|||
129844723|NCT01420081|467392082|FG001|Overall Study|Other Reasons|0|||
129844724|NCT01420081|467392083|FG002|Overall Study|Other Reasons|1|||
129844725|NCT01420081|467392084|FG003|Overall Study|Other Reasons|0|||
129844726|NCT01420081|467392085|FG004|Overall Study|Other Reasons|0|||
129844727|NCT01420081|467392086|FG005|Overall Study|Other Reasons|0|||
129844728|NCT01420081|467392087|FG006|Overall Study|Other Reasons|0|||
129844729|NCT01420081|467392088|FG007|Overall Study|Other Reasons|0|||
129844730|NCT01420081|467392089|FG008|Overall Study|Other Reasons|0|||
129844731|NCT03431350|467392092|FG000|Overall Study|ONGOING|0|||
129844732|NCT03431350|467392093|FG001|Overall Study|ONGOING|0|||
129844733|NCT03431350|467392094|FG002|Overall Study|ONGOING|2|||
129844734|NCT03431350|467392095|FG003|Overall Study|ONGOING|0|||
129844735|NCT03431350|467392096|FG004|Overall Study|ONGOING|1|||
129844736|NCT03431350|467392097|FG005|Overall Study|ONGOING|3|||
129844737|NCT03431350|467392098|FG006|Overall Study|ONGOING|0|||
129844738|NCT03431350|467392099|FG007|Overall Study|ONGOING|1|||
129844739|NCT03431350|467392100|FG008|Overall Study|ONGOING|3|||
129844740|NCT03431350|467392101|FG009|Overall Study|ONGOING|4|||
129844741|NCT03431350|467392102|FG010|Overall Study|ONGOING|2|||
129844742|NCT03431350|467392103|FG011|Overall Study|ONGOING|1|||
129844743|NCT03431350|467392092|FG000|Overall Study|Death|6|||
129844744|NCT03431350|467392093|FG001|Overall Study|Death|5|||
129844745|NCT03431350|467392094|FG002|Overall Study|Death|18|||
129844746|NCT03431350|467392095|FG003|Overall Study|Death|7|||
129844747|NCT03431350|467392096|FG004|Overall Study|Death|4|||
129844748|NCT03431350|467392097|FG005|Overall Study|Death|3|||
129844749|NCT03431350|467392098|FG006|Overall Study|Death|2|||
129844750|NCT03431350|467392099|FG007|Overall Study|Death|0|||
129844751|NCT03431350|467392100|FG008|Overall Study|Death|0|||
129844752|NCT03431350|467392101|FG009|Overall Study|Death|0|||
129844753|NCT03431350|467392102|FG010|Overall Study|Death|4|||
129844754|NCT03431350|467392103|FG011|Overall Study|Death|0|||
129844755|NCT03431350|467392092|FG000|Overall Study|Lost to Follow-up|0|||
129844756|NCT03431350|467392093|FG001|Overall Study|Lost to Follow-up|1|||
129844757|NCT03431350|467392094|FG002|Overall Study|Lost to Follow-up|0|||
129844758|NCT03431350|467392095|FG003|Overall Study|Lost to Follow-up|0|||
129844759|NCT03431350|467392096|FG004|Overall Study|Lost to Follow-up|0|||
129844760|NCT03431350|467392097|FG005|Overall Study|Lost to Follow-up|0|||
129844761|NCT03431350|467392098|FG006|Overall Study|Lost to Follow-up|0|||
129844762|NCT03431350|467392099|FG007|Overall Study|Lost to Follow-up|0|||
129844763|NCT03431350|467392100|FG008|Overall Study|Lost to Follow-up|0|||
129844764|NCT03431350|467392101|FG009|Overall Study|Lost to Follow-up|0|||
129844765|NCT03431350|467392102|FG010|Overall Study|Lost to Follow-up|0|||
129844766|NCT03431350|467392103|FG011|Overall Study|Lost to Follow-up|0|||
129844767|NCT03431350|467392092|FG000|Overall Study|Withdrawal by Subject|0|||
129844768|NCT03431350|467392093|FG001|Overall Study|Withdrawal by Subject|0|||
129844769|NCT03431350|467392094|FG002|Overall Study|Withdrawal by Subject|0|||
129844770|NCT03431350|467392095|FG003|Overall Study|Withdrawal by Subject|1|||
129844771|NCT03431350|467392096|FG004|Overall Study|Withdrawal by Subject|1|||
129844772|NCT03431350|467392097|FG005|Overall Study|Withdrawal by Subject|1|||
129844773|NCT03431350|467392098|FG006|Overall Study|Withdrawal by Subject|0|||
129844774|NCT03431350|467392099|FG007|Overall Study|Withdrawal by Subject|0|||
129844775|NCT03431350|467392100|FG008|Overall Study|Withdrawal by Subject|0|||
129844776|NCT03431350|467392101|FG009|Overall Study|Withdrawal by Subject|2|||
129844777|NCT03431350|467392102|FG010|Overall Study|Withdrawal by Subject|0|||
129844778|NCT03431350|467392103|FG011|Overall Study|Withdrawal by Subject|1|||
129844779|NCT03431350|467392092|FG000|Overall Study|Other|0|||
129844780|NCT03431350|467392093|FG001|Overall Study|Other|0|||
129844781|NCT03431350|467392094|FG002|Overall Study|Other|1|||
129901702|NCT00436644|467600588|FG000|Overall Study|Adverse Event|2|||
129901703|NCT00436644|467600588|FG000|Overall Study|Death|1|||
129901704|NCT01490580|467600589|FG000|Overall Study|Parents withdrew consent|0|||
129901705|NCT01490580|467600590|FG001|Overall Study|Parents withdrew consent|2|||
129901706|NCT00878722|467600591|FG000|Overall Study|Progressive disease|3|||
129901707|NCT00878722|467600592|FG001|Overall Study|Progressive disease|3|||
129901708|NCT00878722|467600593|FG002|Overall Study|Progressive disease|3|||
129901709|NCT00878722|467600594|FG003|Overall Study|Progressive disease|7|||
129901710|NCT00878722|467600595|FG004|Overall Study|Progressive disease|7|||
129901711|NCT00878722|467600596|FG005|Overall Study|Progressive disease|1|||
129901712|NCT00878722|467600597|FG006|Overall Study|Progressive disease|4|||
129901713|NCT00878722|467600598|FG007|Overall Study|Progressive disease|3|||
129901714|NCT00878722|467600591|FG000|Overall Study|Death|0|||
129901715|NCT00878722|467600592|FG001|Overall Study|Death|0|||
129901716|NCT00878722|467600593|FG002|Overall Study|Death|0|||
129901717|NCT00878722|467600594|FG003|Overall Study|Death|1|||
129901718|NCT00878722|467600595|FG004|Overall Study|Death|0|||
129901719|NCT00878722|467600596|FG005|Overall Study|Death|1|||
129901720|NCT00878722|467600597|FG006|Overall Study|Death|0|||
129901721|NCT00878722|467600598|FG007|Overall Study|Death|2|||
129901722|NCT00878722|467600591|FG000|Overall Study|Adverse Event|0|||
129901723|NCT00878722|467600592|FG001|Overall Study|Adverse Event|0|||
129901724|NCT00878722|467600593|FG002|Overall Study|Adverse Event|0|||
129901725|NCT00878722|467600594|FG003|Overall Study|Adverse Event|0|||
129901726|NCT00878722|467600595|FG004|Overall Study|Adverse Event|0|||
129901727|NCT00878722|467600596|FG005|Overall Study|Adverse Event|0|||
129901728|NCT00878722|467600597|FG006|Overall Study|Adverse Event|2|||
129901729|NCT00878722|467600598|FG007|Overall Study|Adverse Event|0|||
129901730|NCT00878722|467600591|FG000|Overall Study|Withdrawal by Subject|0|||
129901731|NCT00878722|467600592|FG001|Overall Study|Withdrawal by Subject|0|||
129901732|NCT00878722|467600593|FG002|Overall Study|Withdrawal by Subject|0|||
129901733|NCT00878722|467600594|FG003|Overall Study|Withdrawal by Subject|0|||
129901734|NCT00878722|467600595|FG004|Overall Study|Withdrawal by Subject|0|||
129901735|NCT00878722|467600596|FG005|Overall Study|Withdrawal by Subject|0|||
129901736|NCT00878722|467600597|FG006|Overall Study|Withdrawal by Subject|0|||
129901737|NCT00878722|467600598|FG007|Overall Study|Withdrawal by Subject|2|||
129901738|NCT00878722|467600591|FG000|Overall Study|Relapse|0|||
129901739|NCT00878722|467600592|FG001|Overall Study|Relapse|0|||
129901740|NCT00878722|467600593|FG002|Overall Study|Relapse|0|||
129901741|NCT00878722|467600594|FG003|Overall Study|Relapse|1|||
129901742|NCT00878722|467600595|FG004|Overall Study|Relapse|0|||
129901743|NCT00878722|467600596|FG005|Overall Study|Relapse|0|||
129901744|NCT00878722|467600597|FG006|Overall Study|Relapse|0|||
129901745|NCT00878722|467600598|FG007|Overall Study|Relapse|0|||
129901746|NCT02873754|467600599|FG000|Overall Study|Lost to Follow-up|5|||
129901747|NCT02873754|467600599|FG000|Overall Study|Couldn't complete study procedures|1|||
129901748|NCT02807493|467600604|FG000|Overall Study|Adverse Event|5|||
129901749|NCT02807493|467600605|FG001|Overall Study|Adverse Event|2|||
129901750|NCT02807493|467600604|FG000|Overall Study|Lost to Follow-up|6|||
129901751|NCT02807493|467600605|FG001|Overall Study|Lost to Follow-up|0|||
129901752|NCT02807493|467600604|FG000|Overall Study|Physician Decision|4|||
129901753|NCT02807493|467600605|FG001|Overall Study|Physician Decision|1|||
129844782|NCT03431350|467392095|FG003|Overall Study|Other|3|||
129844783|NCT03431350|467392096|FG004|Overall Study|Other|2|||
129844784|NCT03431350|467392097|FG005|Overall Study|Other|2|||
129844785|NCT03431350|467392098|FG006|Overall Study|Other|4|||
129844786|NCT03431350|467392099|FG007|Overall Study|Other|0|||
129844787|NCT03431350|467392100|FG008|Overall Study|Other|14|||
129844788|NCT03431350|467392101|FG009|Overall Study|Other|11|||
129844789|NCT03431350|467392102|FG010|Overall Study|Other|11|||
129844790|NCT03431350|467392103|FG011|Overall Study|Other|15|||
129844791|NCT00414388|467392104|FG000|Overall Study|Adverse Event|1|||
129844792|NCT03591575|467392106|FG000|Overall Study|Adverse Event|2|||
129844793|NCT03591575|467392107|FG001|Overall Study|Adverse Event|0|||
129844794|NCT03591575|467392106|FG000|Overall Study|Withdrawal by Subject|4|||
129844795|NCT03591575|467392107|FG001|Overall Study|Withdrawal by Subject|1|||
129844796|NCT00218543|467392108|FG000|Overall Study|Lost to Follow-up|8|||
129844797|NCT00218543|467392108|FG000|Overall Study|relocated|1|||
129844798|NCT00218543|467392108|FG000|Overall Study|Withdrawal by Subject|1|||
129844799|NCT00218543|467392108|FG000|Overall Study|Physician Decision|3|||
129844800|NCT00218543|467392108|FG000|Overall Study|Adverse Event|2|||
129844801|NCT01864291|467392109|FG000|Overall Study|need for revision surgery|2|||
129844802|NCT01387607|467392110|FG000|Overall Study|Adverse Event|23|||
129844803|NCT01387607|467392111|FG001|Overall Study|Adverse Event|11|||
129844804|NCT01387607|467392110|FG000|Overall Study|Lack of Efficacy|8|||
129844805|NCT01387607|467392111|FG001|Overall Study|Lack of Efficacy|6|||
129844806|NCT01387607|467392110|FG000|Overall Study|Lost to Follow-up|2|||
129844807|NCT01387607|467392111|FG001|Overall Study|Lost to Follow-up|1|||
129844808|NCT01387607|467392110|FG000|Overall Study|No longer meets eligibility criteria|0|||
129844809|NCT01387607|467392111|FG001|Overall Study|No longer meets eligibility criteria|1|||
129844810|NCT01387607|467392110|FG000|Overall Study|Protocol Violation|1|||
129844811|NCT01387607|467392111|FG001|Overall Study|Protocol Violation|5|||
129844812|NCT01387607|467392110|FG000|Overall Study|Withdrawal by Subject|13|||
129844813|NCT01387607|467392111|FG001|Overall Study|Withdrawal by Subject|14|||
129844814|NCT01387607|467392110|FG000|Overall Study|Other|1|||
129844815|NCT01387607|467392111|FG001|Overall Study|Other|1|||
129844816|NCT01387607|467392110|FG000|Overall Study|Randomized, not treated|3|||
129844817|NCT01387607|467392111|FG001|Overall Study|Randomized, not treated|6|||
129844818|NCT03080961|467392112|FG000|Overall Study|Withdrawal by Subject|3|||
129844819|NCT04602624|467392117|FG000|Overall Study|Protocol Deviation|1|||
129844820|NCT04602624|467392117|FG000|Overall Study|Withdrawal by Participant|1|||
129844821|NCT04084769|467392118|FG000|Overall Study|Protocol Violation|1|||
129844822|NCT04084769|467392119|FG001|Overall Study|Protocol Violation|3|||
129844823|NCT04084769|467392120|FG002|Overall Study|Protocol Violation|0|||
129844824|NCT04084769|467392121|FG003|Overall Study|Protocol Violation|1|||
129844825|NCT04084769|467392118|FG000|Overall Study|Withdrawal by Subject|0|||
129844826|NCT04084769|467392119|FG001|Overall Study|Withdrawal by Subject|1|||
129844827|NCT04084769|467392120|FG002|Overall Study|Withdrawal by Subject|0|||
129844828|NCT04084769|467392121|FG003|Overall Study|Withdrawal by Subject|0|||
129844829|NCT04084769|467392118|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129901754|NCT02807493|467600604|FG000|Overall Study|Protocol Violation|7|||
129844830|NCT04084769|467392119|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129844831|NCT04084769|467392120|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129844832|NCT04084769|467392121|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129844833|NCT04084769|467392118|FG000|Overall Study|Lost to Follow-up|2|||
129844834|NCT04084769|467392119|FG001|Overall Study|Lost to Follow-up|0|||
129844835|NCT04084769|467392120|FG002|Overall Study|Lost to Follow-up|0|||
129844836|NCT04084769|467392121|FG003|Overall Study|Lost to Follow-up|0|||
129844837|NCT03390504|467392122|FG000|Overall Study|Lost to Follow-up|2|||
129844838|NCT03390504|467392123|FG001|Overall Study|Lost to Follow-up|4|||
129844839|NCT03390504|467392124|FG002|Overall Study|Lost to Follow-up|0|||
129844840|NCT03390504|467392125|FG003|Overall Study|Lost to Follow-up|1|||
129844841|NCT03390504|467392122|FG000|Overall Study|Withdrawal by Subject|3|||
129844842|NCT03390504|467392123|FG001|Overall Study|Withdrawal by Subject|15|||
129844843|NCT03390504|467392124|FG002|Overall Study|Withdrawal by Subject|5|||
129844844|NCT03390504|467392125|FG003|Overall Study|Withdrawal by Subject|2|||
129901755|NCT02807493|467600605|FG001|Overall Study|Protocol Violation|0|||
129901756|NCT02807493|467600604|FG000|Overall Study|Withdrawal by Subject|17|||
129901757|NCT02807493|467600605|FG001|Overall Study|Withdrawal by Subject|10|||
129901758|NCT02807493|467600604|FG000|Overall Study|Other withdrawal|17|||
129901759|NCT02807493|467600605|FG001|Overall Study|Other withdrawal|0|||
129901760|NCT02807493|467600604|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
129901761|NCT02807493|467600605|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
129901762|NCT03612804|467600607|FG000|Overall Study|Death|0|||
129901763|NCT03612804|467600608|FG001|Overall Study|Death|7|||
129844845|NCT03390504|467392122|FG000|Overall Study|Other|1|||
129844846|NCT03390504|467392123|FG001|Overall Study|Other|2|||
129844847|NCT03390504|467392124|FG002|Overall Study|Other|2|||
129844848|NCT03390504|467392125|FG003|Overall Study|Other|6|||
129844849|NCT03665038|467392128|FG000|Overall Study|Lost to Follow-up|0|||
129844850|NCT03665038|467392129|FG001|Overall Study|Lost to Follow-up|0|||
129844851|NCT03665038|467392130|FG002|Overall Study|Lost to Follow-up|1|||
129844852|NCT04579679|467392131|FG000|Overall Study|New Antitumor Therapy|6|||
129844853|NCT04579679|467392132|FG001|Overall Study|New Antitumor Therapy|4|||
129901764|NCT03612804|467600609|FG002|Overall Study|Death|0|||
129901765|NCT03612804|467600610|FG003|Overall Study|Death|8|||
129901766|NCT03612804|467600607|FG000|Overall Study|Medication copay coverage issues|0|||
129844854|NCT04579679|467392133|FG002|Overall Study|New Antitumor Therapy|7|||
129844855|NCT04579679|467392134|FG003|Overall Study|New Antitumor Therapy|0|||
129844856|NCT04579679|467392131|FG000|Overall Study|Withdrawal of Consent|1|||
129844857|NCT04579679|467392132|FG001|Overall Study|Withdrawal of Consent|1|||
129844858|NCT04579679|467392133|FG002|Overall Study|Withdrawal of Consent|2|||
129844859|NCT04579679|467392134|FG003|Overall Study|Withdrawal of Consent|4|||
129844860|NCT04579679|467392131|FG000|Overall Study|Death|2|||
129844861|NCT04579679|467392132|FG001|Overall Study|Death|2|||
129844862|NCT04579679|467392133|FG002|Overall Study|Death|2|||
129844863|NCT04579679|467392134|FG003|Overall Study|Death|0|||
129844864|NCT04579679|467392131|FG000|Overall Study|Adverse Event|0|||
129844865|NCT04579679|467392132|FG001|Overall Study|Adverse Event|4|||
129844866|NCT04579679|467392133|FG002|Overall Study|Adverse Event|0|||
129844867|NCT04579679|467392134|FG003|Overall Study|Adverse Event|0|||
129844868|NCT04579679|467392131|FG000|Overall Study|Disease Progression|9|||
129844869|NCT04579679|467392132|FG001|Overall Study|Disease Progression|13|||
129844870|NCT04579679|467392133|FG002|Overall Study|Disease Progression|7|||
129844871|NCT04579679|467392134|FG003|Overall Study|Disease Progression|0|||
129844872|NCT04579679|467392131|FG000|Overall Study|Physician Decision|0|||
129901767|NCT03612804|467600608|FG001|Overall Study|Medication copay coverage issues|0|||
129844873|NCT04579679|467392132|FG001|Overall Study|Physician Decision|0|||
129844874|NCT04579679|467392133|FG002|Overall Study|Physician Decision|1|||
129844875|NCT04579679|467392134|FG003|Overall Study|Physician Decision|0|||
129844876|NCT04579679|467392131|FG000|Overall Study|Study Terminated by Sponsor|2|||
129844877|NCT04579679|467392132|FG001|Overall Study|Study Terminated by Sponsor|7|||
129844878|NCT04579679|467392133|FG002|Overall Study|Study Terminated by Sponsor|1|||
129844879|NCT04579679|467392134|FG003|Overall Study|Study Terminated by Sponsor|0|||
129844880|NCT04346615|467393353|FG000|Overall Study|Lost to Follow-up|0|||
129844881|NCT04346615|467393354|FG001|Overall Study|Lost to Follow-up|2|||
129844882|NCT04346615|467393353|FG000|Overall Study|Withdrawal by Subject|1|||
129844883|NCT04346615|467393354|FG001|Overall Study|Withdrawal by Subject|0|||
129844884|NCT04346615|467393353|FG000|Overall Study|Death|5|||
129844885|NCT04346615|467393354|FG001|Overall Study|Death|1|||
129844886|NCT04346615|467393353|FG000|Overall Study|Other|0|||
129844887|NCT04346615|467393354|FG001|Overall Study|Other|2|||
129844888|NCT04346615|467393353|FG000|Overall Study|Randomized not treated|1|||
129844889|NCT04346615|467393354|FG001|Overall Study|Randomized not treated|0|||
129844890|NCT04368429|467393355|FG000|Overall Study|Adverse Event|1|||
129844891|NCT04368429|467393356|FG001|Overall Study|Adverse Event|0|||
129844892|NCT02472756|467393357|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
129844893|NCT02472756|467393357|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
129844894|NCT02472756|467393357|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
129844895|NCT02472756|467393357|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
129844896|NCT02472756|467393357|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
129844897|NCT00110266|467393359|FG000|Overall Study|Adverse Event|27|||
129844898|NCT00110266|467393359|FG000|Overall Study|Abnormal laboratory value|15|||
129844899|NCT00110266|467393359|FG000|Overall Study|Withdrawal by Subject|16|||
129844900|NCT00110266|467393359|FG000|Overall Study|Death|17|||
129844901|NCT00110266|467393359|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129844902|NCT00110266|467393359|FG000|Overall Study|Participant condition no longer requires study drug|1|||
129844903|NCT02896400|467393360|FG000|1 Month Follow-up|Lost to Follow-up|7|||
129844904|NCT02896400|467393361|FG001|1 Month Follow-up|Lost to Follow-up|7|||
129844905|NCT02896400|467393362|FG002|1 Month Follow-up|Lost to Follow-up|5|||
129844906|NCT02896400|467393363|FG003|1 Month Follow-up|Lost to Follow-up|8|||
129844907|NCT02896400|467393364|FG004|1 Month Follow-up|Lost to Follow-up|9|||
129844908|NCT02896400|467393365|FG005|1 Month Follow-up|Lost to Follow-up|6|||
129844909|NCT02896400|467393366|FG006|1 Month Follow-up|Lost to Follow-up|5|||
129844910|NCT02896400|467393367|FG007|1 Month Follow-up|Lost to Follow-up|6|||
129844911|NCT02896400|467393368|FG008|1 Month Follow-up|Lost to Follow-up|4|||
129844912|NCT02896400|467393369|FG009|1 Month Follow-up|Lost to Follow-up|7|||
129844913|NCT02896400|467393370|FG010|1 Month Follow-up|Lost to Follow-up|5|||
129844914|NCT02896400|467393371|FG011|1 Month Follow-up|Lost to Follow-up|5|||
129844915|NCT02896400|467393372|FG012|1 Month Follow-up|Lost to Follow-up|3|||
129844916|NCT02896400|467393373|FG013|1 Month Follow-up|Lost to Follow-up|4|||
129844917|NCT02896400|467393374|FG014|1 Month Follow-up|Lost to Follow-up|1|||
129844918|NCT02896400|467393375|FG015|1 Month Follow-up|Lost to Follow-up|2|||
129844919|NCT02896400|467393360|FG000|1 Month Follow-up|Death|0|||
129844920|NCT02896400|467393361|FG001|1 Month Follow-up|Death|0|||
129844921|NCT02896400|467393362|FG002|1 Month Follow-up|Death|0|||
129844922|NCT02896400|467393363|FG003|1 Month Follow-up|Death|0|||
129844923|NCT02896400|467393364|FG004|1 Month Follow-up|Death|0|||
129844924|NCT02896400|467393365|FG005|1 Month Follow-up|Death|0|||
129844925|NCT02896400|467393366|FG006|1 Month Follow-up|Death|0|||
129844926|NCT02896400|467393367|FG007|1 Month Follow-up|Death|0|||
129844927|NCT02896400|467393368|FG008|1 Month Follow-up|Death|0|||
129844928|NCT02896400|467393369|FG009|1 Month Follow-up|Death|0|||
129844929|NCT02896400|467393370|FG010|1 Month Follow-up|Death|0|||
129844930|NCT02896400|467393371|FG011|1 Month Follow-up|Death|0|||
129844931|NCT02896400|467393372|FG012|1 Month Follow-up|Death|0|||
129844932|NCT02896400|467393373|FG013|1 Month Follow-up|Death|0|||
129844933|NCT02896400|467393374|FG014|1 Month Follow-up|Death|0|||
129844934|NCT02896400|467393375|FG015|1 Month Follow-up|Death|1|||
129844935|NCT02896400|467393360|FG000|3 Month Follow-up|Lost to Follow-up|6|||
129844936|NCT02896400|467393361|FG001|3 Month Follow-up|Lost to Follow-up|3|||
129844937|NCT02896400|467393362|FG002|3 Month Follow-up|Lost to Follow-up|6|||
129844938|NCT02896400|467393363|FG003|3 Month Follow-up|Lost to Follow-up|11|||
129844939|NCT02896400|467393364|FG004|3 Month Follow-up|Lost to Follow-up|12|||
129844940|NCT02896400|467393365|FG005|3 Month Follow-up|Lost to Follow-up|6|||
129844941|NCT02896400|467393366|FG006|3 Month Follow-up|Lost to Follow-up|4|||
129844942|NCT02896400|467393367|FG007|3 Month Follow-up|Lost to Follow-up|3|||
129844943|NCT02896400|467393368|FG008|3 Month Follow-up|Lost to Follow-up|6|||
129844944|NCT02896400|467393369|FG009|3 Month Follow-up|Lost to Follow-up|5|||
129844945|NCT02896400|467393370|FG010|3 Month Follow-up|Lost to Follow-up|6|||
129844946|NCT02896400|467393371|FG011|3 Month Follow-up|Lost to Follow-up|6|||
129844947|NCT02896400|467393372|FG012|3 Month Follow-up|Lost to Follow-up|3|||
129844948|NCT02896400|467393373|FG013|3 Month Follow-up|Lost to Follow-up|5|||
129844949|NCT02896400|467393374|FG014|3 Month Follow-up|Lost to Follow-up|3|||
129844950|NCT02896400|467393375|FG015|3 Month Follow-up|Lost to Follow-up|2|||
129844951|NCT02896400|467393360|FG000|3 Month Follow-up|Death|0|||
129844952|NCT02896400|467393361|FG001|3 Month Follow-up|Death|0|||
129844953|NCT02896400|467393362|FG002|3 Month Follow-up|Death|0|||
129844954|NCT02896400|467393363|FG003|3 Month Follow-up|Death|0|||
129844955|NCT02896400|467393364|FG004|3 Month Follow-up|Death|0|||
129844956|NCT02896400|467393365|FG005|3 Month Follow-up|Death|0|||
129844957|NCT02896400|467393366|FG006|3 Month Follow-up|Death|0|||
129844958|NCT02896400|467393367|FG007|3 Month Follow-up|Death|0|||
129844959|NCT02896400|467393368|FG008|3 Month Follow-up|Death|0|||
129844960|NCT02896400|467393369|FG009|3 Month Follow-up|Death|0|||
129844961|NCT02896400|467393370|FG010|3 Month Follow-up|Death|0|||
129844962|NCT02896400|467393371|FG011|3 Month Follow-up|Death|0|||
129844963|NCT02896400|467393372|FG012|3 Month Follow-up|Death|0|||
129844964|NCT02896400|467393373|FG013|3 Month Follow-up|Death|1|||
129844965|NCT02896400|467393374|FG014|3 Month Follow-up|Death|1|||
129844966|NCT02896400|467393375|FG015|3 Month Follow-up|Death|0|||
129844967|NCT02896400|467393360|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844968|NCT02896400|467393361|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844969|NCT02896400|467393362|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844970|NCT02896400|467393363|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844971|NCT02896400|467393364|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844972|NCT02896400|467393365|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844973|NCT02896400|467393366|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
129844974|NCT02896400|467393367|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
129844975|NCT02896400|467393368|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844976|NCT02896400|467393369|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844977|NCT02896400|467393370|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844978|NCT02896400|467393371|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844979|NCT02896400|467393372|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844980|NCT02896400|467393373|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
129844981|NCT02896400|467393374|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
129844982|NCT02896400|467393375|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
129844983|NCT02896400|467393360|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
129844984|NCT02896400|467393361|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844985|NCT02896400|467393362|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
129844986|NCT02896400|467393363|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
129844987|NCT02896400|467393364|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
129844988|NCT02896400|467393365|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844989|NCT02896400|467393366|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844990|NCT02896400|467393367|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
129844991|NCT02896400|467393368|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
129844992|NCT02896400|467393369|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
129844993|NCT02896400|467393370|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
129844994|NCT02896400|467393371|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
129844995|NCT02896400|467393372|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
129844996|NCT02896400|467393373|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
129844997|NCT02896400|467393374|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
129844998|NCT02896400|467393375|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
129844999|NCT01700179|467393377|FG000|Overall Study|Physician Decision|2|||
129845000|NCT00679341|467393378|FG000|Overall Study|Disease progression|42|||
129845001|NCT00679341|467393379|FG001|Overall Study|Disease progression|36|||
129845002|NCT00679341|467393378|FG000|Overall Study|Adverse Event|5|||
129845003|NCT00679341|467393379|FG001|Overall Study|Adverse Event|6|||
129845004|NCT00679341|467393378|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
129845005|NCT00679341|467393379|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
129845006|NCT00679341|467393378|FG000|Overall Study|Death|1|||
129845007|NCT00679341|467393379|FG001|Overall Study|Death|1|||
129845008|NCT00679341|467393378|FG000|Overall Study|Other|1|||
129845009|NCT00679341|467393379|FG001|Overall Study|Other|0|||
129845010|NCT00679341|467393378|FG000|Overall Study|Physician Decision|1|||
129845011|NCT00679341|467393379|FG001|Overall Study|Physician Decision|0|||
129845012|NCT00679341|467393378|FG000|Overall Study|Not treated|0|||
129845013|NCT00679341|467393379|FG001|Overall Study|Not treated|2|||
129845014|NCT00679341|467393378|FG000|Overall Study|Physician/patient decision to withdraw|0|||
129845015|NCT00679341|467393379|FG001|Overall Study|Physician/patient decision to withdraw|6|||
129845016|NCT00667342|467393380|FG000|Overall Study|Protocol Violation|1|||
129845017|NCT00667342|467393381|FG001|Overall Study|Protocol Violation|0|||
129845018|NCT00667342|467393382|FG002|Overall Study|Protocol Violation|0|||
129845019|NCT00667342|467393380|FG000|Overall Study|Withdrawal by Subject|1|||
129845020|NCT00667342|467393381|FG001|Overall Study|Withdrawal by Subject|0|||
129845021|NCT00667342|467393382|FG002|Overall Study|Withdrawal by Subject|0|||
129845022|NCT00667342|467393380|FG000|Overall Study|Physician Decision|3|||
129845023|NCT00667342|467393381|FG001|Overall Study|Physician Decision|0|||
129845024|NCT00667342|467393382|FG002|Overall Study|Physician Decision|0|||
129845025|NCT00667342|467393380|FG000|Overall Study|Relapse or tumor progression|9|||
129845026|NCT00667342|467393381|FG001|Overall Study|Relapse or tumor progression|0|||
129845027|NCT00667342|467393382|FG002|Overall Study|Relapse or tumor progression|7|||
129901768|NCT03612804|467600609|FG002|Overall Study|Medication copay coverage issues|0|||
129901769|NCT03612804|467600610|FG003|Overall Study|Medication copay coverage issues|17|||
129901770|NCT03612804|467600607|FG000|Overall Study|Not current smoker at time of screening|0|||
129901771|NCT03612804|467600608|FG001|Overall Study|Not current smoker at time of screening|1|||
129845028|NCT00667342|467393380|FG000|Overall Study|Adverse Event|0|||
129845029|NCT00667342|467393381|FG001|Overall Study|Adverse Event|0|||
129845030|NCT00667342|467393382|FG002|Overall Study|Adverse Event|1|||
129845031|NCT00667342|467393380|FG000|Overall Study|Ineligible|0|||
129845032|NCT00667342|467393381|FG001|Overall Study|Ineligible|0|||
129845033|NCT00667342|467393382|FG002|Overall Study|Ineligible|1|||
129845034|NCT01207778|467393383|FG000|Overall Study|Lost to Follow-up|0|||
129845035|NCT01207778|467393384|FG001|Overall Study|Lost to Follow-up|3|||
129845036|NCT01207778|467393385|FG002|Overall Study|Lost to Follow-up|3|||
129845037|NCT01440322|467393388|FG000|Overall Study|Discomfort|2|||
129845038|NCT01440322|467393389|FG001|Overall Study|Discomfort|0|||
129845039|NCT01440322|467393388|FG000|Overall Study|Biomicroscopy|1|||
129845040|NCT01440322|467393389|FG001|Overall Study|Biomicroscopy|0|||
129845041|NCT01440322|467393388|FG000|Overall Study|Symptoms and Problems|1|||
129845042|NCT01440322|467393389|FG001|Overall Study|Symptoms and Problems|0|||
129845043|NCT01440322|467393388|FG000|Overall Study|Unacceptable Subjective Vision|1|||
129845044|NCT01440322|467393389|FG001|Overall Study|Unacceptable Subjective Vision|0|||
129845045|NCT01440322|467393388|FG000|Overall Study|Other Product Related|1|||
129845046|NCT01440322|467393389|FG001|Overall Study|Other Product Related|0|||
129845047|NCT01440322|467393388|FG000|Overall Study|Unrelated Medical Problem|0|||
129845048|NCT01440322|467393389|FG001|Overall Study|Unrelated Medical Problem|1|||
129845049|NCT01440322|467393388|FG000|Overall Study|Other Non-Product Related|1|||
129845050|NCT01440322|467393389|FG001|Overall Study|Other Non-Product Related|0|||
129845051|NCT05044234|467393391|FG000|Overall Study|Lost to Follow-up|2|||
129845052|NCT05044234|467393392|FG001|Overall Study|Lost to Follow-up|1|||
129845053|NCT05044234|467393393|FG002|Overall Study|Lost to Follow-up|1|||
129845054|NCT05044234|467393394|FG003|Overall Study|Lost to Follow-up|2|||
129845055|NCT05044234|467393391|FG000|Overall Study|Withdrawal by Subject|6|||
129845056|NCT05044234|467393392|FG001|Overall Study|Withdrawal by Subject|4|||
129845057|NCT05044234|467393393|FG002|Overall Study|Withdrawal by Subject|5|||
129845058|NCT05044234|467393394|FG003|Overall Study|Withdrawal by Subject|8|||
129845059|NCT05044234|467393391|FG000|Overall Study|Study terminated by Sponsor|21|||
129845060|NCT05044234|467393392|FG001|Overall Study|Study terminated by Sponsor|21|||
129845061|NCT05044234|467393393|FG002|Overall Study|Study terminated by Sponsor|20|||
129845062|NCT05044234|467393394|FG003|Overall Study|Study terminated by Sponsor|14|||
129845063|NCT05044234|467393391|FG000|Overall Study|Other, not specified|0|||
129845064|NCT05044234|467393392|FG001|Overall Study|Other, not specified|0|||
129845065|NCT05044234|467393393|FG002|Overall Study|Other, not specified|1|||
129901772|NCT03612804|467600609|FG002|Overall Study|Not current smoker at time of screening|0|||
129901773|NCT03612804|467600610|FG003|Overall Study|Not current smoker at time of screening|3|||
129901774|NCT03612804|467600607|FG000|Overall Study|Non-veteran status|0|||
129901775|NCT03612804|467600608|FG001|Overall Study|Non-veteran status|1|||
129901776|NCT03612804|467600609|FG002|Overall Study|Non-veteran status|0|||
129901777|NCT03612804|467600610|FG003|Overall Study|Non-veteran status|0|||
129901778|NCT03612804|467600607|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
129901779|NCT03612804|467600608|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
129901780|NCT03612804|467600609|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
129901781|NCT03612804|467600610|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
129845066|NCT05044234|467393394|FG003|Overall Study|Other, not specified|2|||
129845067|NCT05044234|467393391|FG000|Overall Study|Delayed data entry|0|||
129845068|NCT05044234|467393392|FG001|Overall Study|Delayed data entry|0|||
129845069|NCT05044234|467393393|FG002|Overall Study|Delayed data entry|0|||
129845070|NCT05044234|467393394|FG003|Overall Study|Delayed data entry|1|||
129845071|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Adverse Event|9|||
129845072|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Adverse Event|2|||
129845073|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
129845074|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
129845075|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
129845076|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
129845077|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Physician Decision|1|||
129845078|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Physician Decision|1|||
129845079|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Pregnancy|2|||
129845080|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Pregnancy|0|||
129845081|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
129845082|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
129845083|NCT02896127|467393395|FG000|COMPLETED WEEK 52|Technical problems|1|||
129845084|NCT02896127|467393396|FG001|COMPLETED WEEK 52|Technical problems|0|||
129845085|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
129845086|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
129845087|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
129845088|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
129845089|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
129845090|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
129845091|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
129845092|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
129845093|NCT02896127|467393395|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
129845094|NCT02896127|467393396|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
129845095|NCT00279708|467393397|FG000|Overall Study|Withdrawal by Subject|2|||
129845096|NCT00279708|467393398|FG001|Overall Study|Withdrawal by Subject|3|||
129845097|NCT00279708|467393397|FG000|Overall Study|Adverse Event|1|||
129845098|NCT00279708|467393398|FG001|Overall Study|Adverse Event|1|||
129845099|NCT03354429|467393399|FG000|Overall Study|Withdrawal by Subject|8|||
129845100|NCT03354429|467393400|FG001|Overall Study|Withdrawal by Subject|7|||
129845101|NCT03354429|467393399|FG000|Overall Study|Lost to Follow-up|1|||
129845102|NCT03354429|467393400|FG001|Overall Study|Lost to Follow-up|0|||
129845103|NCT02488629|467393401|FG000|Overall Study|Lack of Efficacy|3|||
129845104|NCT02488629|467393402|FG001|Overall Study|Lack of Efficacy|1|||
129845105|NCT02488629|467393403|FG002|Overall Study|Lack of Efficacy|0|||
129845106|NCT02488629|467393404|FG003|Overall Study|Lack of Efficacy|0|||
129845107|NCT02488629|467393401|FG000|Overall Study|Withdrawal by Subject|0|||
129845108|NCT02488629|467393402|FG001|Overall Study|Withdrawal by Subject|1|||
129845109|NCT02488629|467393403|FG002|Overall Study|Withdrawal by Subject|0|||
129845110|NCT02488629|467393404|FG003|Overall Study|Withdrawal by Subject|0|||
129845111|NCT02940691|467393405|FG000|Overall Study|Lost to Follow-up|5|||
129845112|NCT02940691|467393405|FG000|Overall Study|Incarceration|1|||
129845113|NCT03912233|467393406|FG000|Overall Study|Adverse Event|1|||
129845114|NCT03912233|467393407|FG001|Overall Study|Adverse Event|0|||
129845115|NCT03912233|467393408|FG002|Overall Study|Adverse Event|0|||
129845116|NCT03912233|467393409|FG003|Overall Study|Adverse Event|0|||
129845117|NCT03912233|467393410|FG004|Overall Study|Adverse Event|0|||
129845118|NCT03912233|467393411|FG005|Overall Study|Adverse Event|0|||
129845119|NCT03912233|467393406|FG000|Overall Study|Physician Decision|1|||
129845120|NCT03912233|467393407|FG001|Overall Study|Physician Decision|0|||
129845121|NCT03912233|467393408|FG002|Overall Study|Physician Decision|0|||
129845122|NCT03912233|467393409|FG003|Overall Study|Physician Decision|0|||
129845123|NCT03912233|467393410|FG004|Overall Study|Physician Decision|0|||
129845124|NCT03912233|467393411|FG005|Overall Study|Physician Decision|0|||
129845125|NCT03912233|467393406|FG000|Overall Study|Other|0|||
129845126|NCT03912233|467393407|FG001|Overall Study|Other|0|||
129845127|NCT03912233|467393408|FG002|Overall Study|Other|0|||
129845128|NCT03912233|467393409|FG003|Overall Study|Other|0|||
129845129|NCT03912233|467393410|FG004|Overall Study|Other|7|||
129845130|NCT03912233|467393411|FG005|Overall Study|Other|12|||
129845131|NCT00654628|467393412|FG000|6-week Active Treatment Period|Adverse Event|9|||
129845132|NCT00654628|467393412|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
129845133|NCT00654628|467393412|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
129845134|NCT00654628|467393412|FG000|6-week Active Treatment Period|Out of window period|1|||
129845135|NCT00654628|467393412|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
129845136|NCT00654628|467393412|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
129845137|NCT00953329|467393417|FG000|Overall Study|Lack of Efficacy|1|||
129845138|NCT02477020|467393420|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
129845139|NCT02477020|467393421|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
129845140|NCT02477020|467393420|FG000|Overall Study|Voluntary Withdrawal|7|||
129845141|NCT02477020|467393421|FG001|Overall Study|Voluntary Withdrawal|16|||
129845142|NCT02477020|467393420|FG000|Overall Study|Reason not Specified|3|||
129845143|NCT02477020|467393421|FG001|Overall Study|Reason not Specified|1|||
129845144|NCT02477020|467393420|FG000|Overall Study|Lack of Efficacy|14|||
129845145|NCT02477020|467393421|FG001|Overall Study|Lack of Efficacy|5|||
129845146|NCT01465802|467393423|FG000|Overall Study|Study terminated by sponsor|1|||
129845147|NCT01465802|467393424|FG001|Overall Study|Study terminated by sponsor|0|||
129845148|NCT01465802|467393425|FG002|Overall Study|Study terminated by sponsor|0|||
129845149|NCT01465802|467393426|FG003|Overall Study|Study terminated by sponsor|1|||
129845150|NCT01465802|467393427|FG004|Overall Study|Study terminated by sponsor|7|||
129845151|NCT01465802|467393423|FG000|Overall Study|Withdrawal by Subject|7|||
129845152|NCT01465802|467393424|FG001|Overall Study|Withdrawal by Subject|7|||
129845153|NCT01465802|467393425|FG002|Overall Study|Withdrawal by Subject|0|||
129845154|NCT01465802|467393426|FG003|Overall Study|Withdrawal by Subject|8|||
129845155|NCT01465802|467393427|FG004|Overall Study|Withdrawal by Subject|1|||
129845156|NCT01465802|467393423|FG000|Overall Study|Lost to Follow-up|1|||
129901782|NCT03612804|467600607|FG000|Overall Study|Provider retired from VA|0|||
129901783|NCT03612804|467600608|FG001|Overall Study|Provider retired from VA|0|||
129901784|NCT03612804|467600609|FG002|Overall Study|Provider retired from VA|2|||
129901785|NCT03612804|467600610|FG003|Overall Study|Provider retired from VA|0|||
129901786|NCT03612804|467600607|FG000|Overall Study|Withdrawal by Subject|0|||
129901787|NCT03612804|467600608|FG001|Overall Study|Withdrawal by Subject|0|||
129901788|NCT03612804|467600609|FG002|Overall Study|Withdrawal by Subject|7|||
129901789|NCT03612804|467600610|FG003|Overall Study|Withdrawal by Subject|0|||
129901790|NCT03612804|467600607|FG000|Overall Study|Provider involved with study activities|1|||
129901791|NCT03612804|467600608|FG001|Overall Study|Provider involved with study activities|0|||
129901792|NCT03612804|467600609|FG002|Overall Study|Provider involved with study activities|0|||
129901793|NCT03612804|467600610|FG003|Overall Study|Provider involved with study activities|0|||
129901794|NCT00741988|467600618|FG000|Overall Study|Adverse Event|2|||
129901795|NCT00741988|467600619|FG001|Overall Study|Adverse Event|4|||
129901796|NCT00741988|467600618|FG000|Overall Study|Lack of Efficacy|2|||
129901797|NCT00741988|467600619|FG001|Overall Study|Lack of Efficacy|0|||
129901798|NCT00811057|467600620|FG000|Overall Study|Protocol Violation|5|||
129901799|NCT00811057|467600621|FG001|Overall Study|Protocol Violation|10|||
129901800|NCT00811057|467600622|FG002|Overall Study|Protocol Violation|10|||
129901801|NCT00768651|467600627|FG000|Overall Study|Withdrawal by Subject|1|||
129901802|NCT02104765|467600628|FG000|Overall Study|Lost to Follow-up|0|||
129901803|NCT02104765|467600629|FG001|Overall Study|Lost to Follow-up|0|||
129901804|NCT02104765|467600630|FG002|Overall Study|Lost to Follow-up|1|||
129901805|NCT02104765|467600631|FG003|Overall Study|Lost to Follow-up|0|||
129901806|NCT02104765|467600632|FG004|Overall Study|Lost to Follow-up|0|||
129901807|NCT02104765|467600633|FG005|Overall Study|Lost to Follow-up|0|||
129901808|NCT02104765|467600634|FG006|Overall Study|Lost to Follow-up|0|||
129901809|NCT02104765|467600628|FG000|Overall Study|Withdrawal by Subject|0|||
129901810|NCT02104765|467600629|FG001|Overall Study|Withdrawal by Subject|0|||
129901811|NCT02104765|467600630|FG002|Overall Study|Withdrawal by Subject|0|||
129901812|NCT02104765|467600631|FG003|Overall Study|Withdrawal by Subject|1|||
129901813|NCT02104765|467600632|FG004|Overall Study|Withdrawal by Subject|1|||
129901814|NCT02104765|467600633|FG005|Overall Study|Withdrawal by Subject|0|||
129901815|NCT02104765|467600634|FG006|Overall Study|Withdrawal by Subject|1|||
129901816|NCT00995709|467600639|FG000|Overall Study|Adverse Event|4|||
129901817|NCT00995709|467600640|FG001|Overall Study|Adverse Event|2|||
129901818|NCT00995709|467600641|FG002|Overall Study|Adverse Event|0|||
129901819|NCT00995709|467600639|FG000|Overall Study|Lack of Efficacy|0|||
129901820|NCT00995709|467600640|FG001|Overall Study|Lack of Efficacy|1|||
129901821|NCT00995709|467600641|FG002|Overall Study|Lack of Efficacy|4|||
129901822|NCT00995709|467600639|FG000|Overall Study|Withdrawal by Subject|0|||
129901823|NCT00995709|467600640|FG001|Overall Study|Withdrawal by Subject|4|||
129901824|NCT00995709|467600641|FG002|Overall Study|Withdrawal by Subject|1|||
129901825|NCT00995709|467600639|FG000|Overall Study|Lost to Follow-up|1|||
129901826|NCT00995709|467600640|FG001|Overall Study|Lost to Follow-up|0|||
129901827|NCT00995709|467600641|FG002|Overall Study|Lost to Follow-up|0|||
129901828|NCT00995709|467600639|FG000|Overall Study|Death|0|||
129901829|NCT00995709|467600640|FG001|Overall Study|Death|1|||
129901830|NCT00995709|467600641|FG002|Overall Study|Death|0|||
129901831|NCT00995709|467600639|FG000|Overall Study|Protocol Violation|2|||
129901832|NCT00995709|467600640|FG001|Overall Study|Protocol Violation|1|||
129901833|NCT00995709|467600641|FG002|Overall Study|Protocol Violation|0|||
129901834|NCT01697319|467600642|FG000|Primary Phase|Withdrawal by Subject|1|||
129901835|NCT01697319|467600642|FG000|Extension Phase|Terminated by Sponsor|15|||
129901836|NCT04222959|467600643|FG000|Overall Study|Lost to Follow-up|76|||
129901837|NCT04222959|467600644|FG001|Overall Study|Lost to Follow-up|28|||
129901838|NCT03008915|467600645|FG000|Treatment 1|Withdrawal by Subject|0|||
129901839|NCT03008915|467600646|FG001|Treatment 1|Withdrawal by Subject|1|||
129901840|NCT00712166|467600649|FG000|Overall Study|Noncompliance|0|||
129901841|NCT00712166|467600650|FG001|Overall Study|Noncompliance|1|||
129901842|NCT01773122|467600651|FG000|Overall Study|Due to amended age eligibility criteria|3|||
129901843|NCT01773122|467600652|FG001|Overall Study|Due to amended age eligibility criteria|1|||
129901844|NCT01773122|467600653|FG002|Overall Study|Due to amended age eligibility criteria|0|||
129901845|NCT01773122|467600654|FG003|Overall Study|Due to amended age eligibility criteria|1|||
129901846|NCT01264718|467600655|FG000|Overall Study|Lost to Follow-up|3|||
129901847|NCT01264718|467600656|FG001|Overall Study|Lost to Follow-up|2|||
129901848|NCT01264718|467600655|FG000|Overall Study|Withdrawal by Subject|9|||
129901849|NCT01264718|467600656|FG001|Overall Study|Withdrawal by Subject|15|||
129901850|NCT01264718|467600655|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
129901851|NCT01264718|467600656|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
129901852|NCT03386929|467600659|FG000|Overall Study|Death|0|||
129901853|NCT03386929|467600660|FG001|Overall Study|Death|0|||
129901854|NCT03386929|467600661|FG002|Overall Study|Death|1|||
129901855|NCT03386929|467600659|FG000|Overall Study|Withdrawal by Subject|0|||
129901856|NCT03386929|467600660|FG001|Overall Study|Withdrawal by Subject|1|||
129901857|NCT03386929|467600661|FG002|Overall Study|Withdrawal by Subject|0|||
129901858|NCT03386929|467600659|FG000|Overall Study|Physician Decision|0|||
129901859|NCT03386929|467600660|FG001|Overall Study|Physician Decision|0|||
129901860|NCT03386929|467600661|FG002|Overall Study|Physician Decision|1|||
129901861|NCT03386929|467600659|FG000|Overall Study|Progression|4|||
129901862|NCT03386929|467600660|FG001|Overall Study|Progression|4|||
129901863|NCT03386929|467600661|FG002|Overall Study|Progression|0|||
129901864|NCT03386929|467600659|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
129901865|NCT03386929|467600660|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
129901866|NCT03386929|467600661|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
129901867|NCT03386929|467600659|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
129901868|NCT03386929|467600660|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
129901869|NCT03386929|467600661|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
129901870|NCT03264456|467600668|FG000|Overall Study|Withdrawal by Subject|3|||
129901871|NCT03264456|467600668|FG000|Overall Study|Lost to Follow-up|1|||
129901872|NCT03538054|467600669|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
129901873|NCT03538054|467600669|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
129901874|NCT03538054|467600669|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
129901875|NCT03254394|467600670|FG000|Overall Study|Withdrawal by Subject|0|||
129901876|NCT03254394|467600671|FG001|Overall Study|Withdrawal by Subject|2|||
129901877|NCT00387465|467600678|FG000|Overall Study|Withdrawal by Subject|0|||
129901878|NCT00387465|467600679|FG001|Overall Study|Withdrawal by Subject|1|||
129901879|NCT00387465|467600680|FG002|Overall Study|Withdrawal by Subject|0|||
129901880|NCT03418324|467600681|FG000|Overall Study|Death|0|||
129901881|NCT03418324|467600682|FG001|Overall Study|Death|1|||
129901882|NCT03418324|467600681|FG000|Overall Study|Physician Decision|1|||
129901883|NCT03418324|467600682|FG001|Overall Study|Physician Decision|1|||
129901884|NCT04257058|467602208|FG000|Overall Study|Lost to Follow-up|31|||
129901885|NCT00661778|467602218|FG000|Overall Study|Disease Progression|23|||
129901886|NCT00661778|467602218|FG000|Overall Study|Adverse Event|18|||
129901887|NCT00661778|467602218|FG000|Overall Study|Reason not Specified|6|||
129901888|NCT00661778|467602218|FG000|Overall Study|Protocol Violation|2|||
129901889|NCT00661778|467602218|FG000|Overall Study|Withdrawal of Consent|1|||
129901890|NCT00487578|467602222|FG000|Overall Study|Adverse Event|1|||
129901891|NCT00487578|467602223|FG001|Overall Study|Adverse Event|2|||
129901892|NCT00487578|467602222|FG000|Overall Study|Lack of Efficacy|0|||
129901893|NCT00487578|467602223|FG001|Overall Study|Lack of Efficacy|1|||
129901894|NCT00487578|467602222|FG000|Overall Study|Lost to Follow-up|0|||
129901895|NCT00487578|467602223|FG001|Overall Study|Lost to Follow-up|1|||
129901896|NCT02525796|467602228|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
129901897|NCT02525796|467602229|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
129901898|NCT02525796|467602230|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
129901899|NCT02525796|467602228|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
129901900|NCT02525796|467602229|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
129901901|NCT02525796|467602230|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
129901902|NCT02525796|467602228|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
129901903|NCT02525796|467602229|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
129901904|NCT02525796|467602230|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
129901905|NCT02525796|467602228|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
129901906|NCT02525796|467602229|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
129901907|NCT02525796|467602230|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
129901908|NCT02525796|467602228|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
129901909|NCT02525796|467602229|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
129901910|NCT02525796|467602230|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
129901911|NCT01499134|467602231|FG000|Overall Study|Withdrawal by Subject|0|||
129901912|NCT01499134|467602232|FG001|Overall Study|Withdrawal by Subject|1|||
129901913|NCT01198275|467602233|FG000|Overall Study|Adverse Event|2|||
129901914|NCT01198275|467602234|FG001|Overall Study|Adverse Event|3|||
129901915|NCT01198275|467602233|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
129901916|NCT01198275|467602234|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
129901917|NCT02385669|467602238|FG000|Overall Study|Adverse Event|2|||
129901918|NCT00970307|467602239|FG000|Overall Study|Serious Adverse Event|1|||
129901919|NCT00970307|467602240|FG001|Overall Study|Serious Adverse Event|0|||
129901920|NCT00970307|467602241|FG002|Overall Study|Serious Adverse Event|0|||
129901921|NCT00970307|467602239|FG000|Overall Study|Withdrawal by Subject|2|||
129901922|NCT00970307|467602240|FG001|Overall Study|Withdrawal by Subject|3|||
129901923|NCT00970307|467602241|FG002|Overall Study|Withdrawal by Subject|2|||
129901924|NCT05257798|467602242|FG000|Follow-up Phase|Lost to Follow-up|1|||
129901925|NCT05257798|467602243|FG001|Follow-up Phase|Lost to Follow-up|0|||
129901926|NCT04033432|467602246|FG000|Overall Study|Progressive Disease|8|||
129901927|NCT04033432|467602246|FG000|Overall Study|Adverse Event|4|||
129901928|NCT04033432|467602246|FG000|Overall Study|Death|1|||
129901929|NCT00393848|467602247|FG000|Overall Study|Surgical schedule|0|||
129901930|NCT00393848|467602248|FG001|Overall Study|Surgical schedule|0|||
129901931|NCT00393848|467602249|FG002|Overall Study|Surgical schedule|0|||
129901932|NCT00393848|467602250|FG003|Overall Study|Surgical schedule|1|||
129901933|NCT00393848|467602247|FG000|Overall Study|Personal reasons|0|||
129901934|NCT00393848|467602248|FG001|Overall Study|Personal reasons|0|||
129901935|NCT00393848|467602249|FG002|Overall Study|Personal reasons|2|||
129901936|NCT00393848|467602250|FG003|Overall Study|Personal reasons|0|||
129901937|NCT02192606|467602256|FG000|Overall Study|surgery type was changed|1|||
129901938|NCT02192606|467602257|FG001|Overall Study|surgery type was changed|1|||
129901939|NCT02192606|467602256|FG000|Overall Study|Physician Decision|1|||
129901940|NCT02192606|467602257|FG001|Overall Study|Physician Decision|2|||
129901941|NCT02192606|467602256|FG000|Overall Study|3D equipment rep unable to join|0|||
129901942|NCT02192606|467602257|FG001|Overall Study|3D equipment rep unable to join|1|||
129901943|NCT01458210|467602258|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
129901944|NCT01458210|467602258|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
129901945|NCT01458210|467602258|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
129901946|NCT01458210|467602258|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
129901947|NCT03923491|467602259|FG000|Overall Study|Lost to Follow-up|5|||
129901948|NCT03923491|467602260|FG001|Overall Study|Lost to Follow-up|8|||
129901949|NCT03923491|467602259|FG000|Overall Study|Withdrawal by Subject|4|||
129901950|NCT03923491|467602260|FG001|Overall Study|Withdrawal by Subject|6|||
129901951|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
129901952|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
129901953|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
129901954|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
129901955|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
129901956|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
129901957|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
129901958|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
129901959|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
129901960|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
129901961|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
129901962|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
129901963|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
129901964|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
129901965|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
129901966|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
129901967|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
129901968|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
129901969|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
129901970|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
129901971|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
129901972|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
129901973|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
129901974|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
129901975|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
129901976|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
129901977|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
129901978|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
129901979|NCT00241644|467602264|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
129901980|NCT00241644|467602265|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
129901981|NCT00241644|467602266|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
129901982|NCT00241644|467602267|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
129901983|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
129901984|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
129901985|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
129901986|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
129901987|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
129901988|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
129901989|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
129901990|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
129901991|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
129901992|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
129901993|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
129901994|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
129901995|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
129901996|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
129901997|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
129845157|NCT01465802|467393424|FG001|Overall Study|Lost to Follow-up|1|||
129845158|NCT01465802|467393425|FG002|Overall Study|Lost to Follow-up|0|||
129845159|NCT01465802|467393426|FG003|Overall Study|Lost to Follow-up|0|||
129845160|NCT01465802|467393427|FG004|Overall Study|Lost to Follow-up|0|||
129845161|NCT01465802|467393423|FG000|Overall Study|Reason not specified|9|||
129845162|NCT01465802|467393424|FG001|Overall Study|Reason not specified|4|||
129845163|NCT01465802|467393425|FG002|Overall Study|Reason not specified|0|||
129845164|NCT01465802|467393426|FG003|Overall Study|Reason not specified|10|||
129845165|NCT01465802|467393427|FG004|Overall Study|Reason not specified|2|||
129845166|NCT01465802|467393423|FG000|Overall Study|Death|15|||
129845167|NCT01465802|467393424|FG001|Overall Study|Death|12|||
129845168|NCT01465802|467393425|FG002|Overall Study|Death|0|||
129845169|NCT01465802|467393426|FG003|Overall Study|Death|10|||
129845170|NCT01465802|467393427|FG004|Overall Study|Death|2|||
129845171|NCT01340976|467393428|FG000|Overall Study|Physician Decision|2|||
129845172|NCT01340976|467393429|FG001|Overall Study|Physician Decision|0|||
129845173|NCT01340976|467393430|FG002|Overall Study|Physician Decision|1|||
129845174|NCT01340976|467393431|FG003|Overall Study|Physician Decision|1|||
129845175|NCT01340976|467393432|FG004|Overall Study|Physician Decision|1|||
129845176|NCT01340976|467393433|FG005|Overall Study|Physician Decision|0|||
129845177|NCT01340976|467393428|FG000|Overall Study|Death|0|||
129845178|NCT01340976|467393429|FG001|Overall Study|Death|1|||
129845179|NCT01340976|467393430|FG002|Overall Study|Death|0|||
129845180|NCT01340976|467393431|FG003|Overall Study|Death|0|||
129845181|NCT01340976|467393432|FG004|Overall Study|Death|0|||
129845182|NCT01340976|467393433|FG005|Overall Study|Death|0|||
129845183|NCT01340976|467393428|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
129901998|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
129901999|NCT00241644|467602264|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
129902000|NCT00241644|467602265|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
129902001|NCT00241644|467602266|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
129902002|NCT00241644|467602267|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
129902003|NCT01027286|467602268|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
129902004|NCT01027286|467602269|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
129902005|NCT01027286|467602268|FG000|Overall Study|Lost to Follow-up|0|||
129902006|NCT01027286|467602269|FG001|Overall Study|Lost to Follow-up|1|||
129902007|NCT01563354|467602274|FG000|Core Phase|Adverse Event|5|||
129902008|NCT01563354|467602275|FG001|Core Phase|Adverse Event|15|||
129902009|NCT01563354|467602276|FG002|Core Phase|Adverse Event|13|||
129902010|NCT01563354|467602274|FG000|Core Phase|Withdrawal by Subject|1|||
129902011|NCT01563354|467602275|FG001|Core Phase|Withdrawal by Subject|0|||
129902012|NCT01563354|467602276|FG002|Core Phase|Withdrawal by Subject|3|||
129902013|NCT01563354|467602274|FG000|Core Phase|Lost to Follow-up|1|||
129902014|NCT01563354|467602275|FG001|Core Phase|Lost to Follow-up|0|||
129902015|NCT01563354|467602276|FG002|Core Phase|Lost to Follow-up|0|||
129902016|NCT01563354|467602274|FG000|Core Phase|Death|1|||
129902017|NCT01563354|467602275|FG001|Core Phase|Death|5|||
129902018|NCT01563354|467602276|FG002|Core Phase|Death|2|||
129902019|NCT01563354|467602274|FG000|Core Phase|Diseasse progression|18|||
129902020|NCT01563354|467602275|FG001|Core Phase|Diseasse progression|7|||
129902021|NCT01563354|467602276|FG002|Core Phase|Diseasse progression|8|||
129902022|NCT01563354|467602274|FG000|Core Phase|Protocol deviation|2|||
129902023|NCT01563354|467602275|FG001|Core Phase|Protocol deviation|0|||
129902024|NCT01563354|467602276|FG002|Core Phase|Protocol deviation|0|||
129902025|NCT01563354|467602274|FG000|Core Phase|PI decision - did not enter extension|0|||
129902026|NCT01563354|467602275|FG001|Core Phase|PI decision - did not enter extension|1|||
129902027|NCT01563354|467602276|FG002|Core Phase|PI decision - did not enter extension|0|||
129902028|NCT01563354|467602274|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
129902029|NCT01563354|467602275|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
129902030|NCT01563354|467602276|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
129902031|NCT01563354|467602274|FG000|Extension Phase|Adverse Event|0|||
129902032|NCT01563354|467602275|FG001|Extension Phase|Adverse Event|3|||
129902033|NCT01563354|467602276|FG002|Extension Phase|Adverse Event|2|||
129902034|NCT01563354|467602274|FG000|Extension Phase|Withdrawal by Subject|0|||
129902035|NCT01563354|467602275|FG001|Extension Phase|Withdrawal by Subject|1|||
129902036|NCT01563354|467602276|FG002|Extension Phase|Withdrawal by Subject|0|||
129902037|NCT01563354|467602274|FG000|Extension Phase|Administration problems|3|||
129902038|NCT01563354|467602275|FG001|Extension Phase|Administration problems|2|||
129902039|NCT01563354|467602276|FG002|Extension Phase|Administration problems|3|||
129902040|NCT01563354|467602274|FG000|Extension Phase|Disease progression|9|||
129902041|NCT01563354|467602275|FG001|Extension Phase|Disease progression|8|||
129902042|NCT01563354|467602276|FG002|Extension Phase|Disease progression|10|||
129845184|NCT01340976|467393429|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845185|NCT01340976|467393430|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129902043|NCT01565928|467602277|FG000|Overall Study|Adverse Event|3|||
129902044|NCT01565928|467602277|FG000|Overall Study|Other|3|||
129902045|NCT01565928|467602277|FG000|Overall Study|Progressive Disease|13|||
129902046|NCT01565928|467602277|FG000|Overall Study|Withdrawal by Subject|1|||
129902047|NCT01565928|467602277|FG000|Overall Study|Death|2|||
129902048|NCT01119950|467602278|FG000|Overall Study|Adverse Event|25|||
129902049|NCT01119950|467602278|FG000|Overall Study|Withdrawal by Subject|9|||
129902050|NCT01119950|467602278|FG000|Overall Study|Protocol Violation|5|||
129902051|NCT01119950|467602278|FG000|Overall Study|Lost to Follow-up|4|||
129902052|NCT01119950|467602278|FG000|Overall Study|Administrative|2|||
129902053|NCT01119950|467602278|FG000|Overall Study|Abnormal lab value|1|||
129902054|NCT01119950|467602278|FG000|Overall Study|Death|1|||
129902055|NCT01988233|467602283|FG000|Overall Study|Lost to Follow-up|64|||
129902056|NCT01988233|467602284|FG001|Overall Study|Lost to Follow-up|51|||
129902057|NCT03621761|467602289|FG000|Overall Study|Lost to Follow-up|1|||
129902058|NCT03621761|467602290|FG001|Overall Study|Lost to Follow-up|1|||
129902059|NCT03621761|467602291|FG002|Overall Study|Lost to Follow-up|2|||
129902060|NCT03621761|467602289|FG000|Overall Study|Withdrawal by Subject|2|||
129902061|NCT03621761|467602290|FG001|Overall Study|Withdrawal by Subject|1|||
129902062|NCT03621761|467602291|FG002|Overall Study|Withdrawal by Subject|1|||
129902063|NCT03621761|467602289|FG000|Overall Study|Became Ineligible|0|||
129902064|NCT03621761|467602290|FG001|Overall Study|Became Ineligible|2|||
129902065|NCT03621761|467602291|FG002|Overall Study|Became Ineligible|0|||
129902066|NCT00217672|467602292|FG000|Allocation|Ineligible|2|||
129902067|NCT00217672|467602293|FG001|Allocation|Ineligible|0|||
129902068|NCT00217672|467602292|FG000|Treatment|disease progression|33|||
129902069|NCT00217672|467602293|FG001|Treatment|disease progression|4|||
129902070|NCT00217672|467602292|FG000|Treatment|Adverse Event|18|||
129902071|NCT00217672|467602293|FG001|Treatment|Adverse Event|2|||
129902072|NCT00217672|467602292|FG000|Treatment|reqd treatment not permitted by protocol|6|||
129902073|NCT00217672|467602293|FG001|Treatment|reqd treatment not permitted by protocol|0|||
129902074|NCT00217672|467602292|FG000|Treatment|Physician Decision|6|||
129902075|NCT00217672|467602293|FG001|Treatment|Physician Decision|0|||
129902076|NCT00217672|467602292|FG000|Treatment|insurance issues|1|||
129902077|NCT00217672|467602293|FG001|Treatment|insurance issues|1|||
129902078|NCT00217672|467602292|FG000|Treatment|Death|2|||
129902079|NCT00217672|467602293|FG001|Treatment|Death|0|||
129902080|NCT00217672|467602292|FG000|Treatment|secondary malignancy|1|||
129902081|NCT00217672|467602293|FG001|Treatment|secondary malignancy|0|||
129902082|NCT00217672|467602292|FG000|Follow-up|Withdrawal by Subject|4|||
129902083|NCT00217672|467602293|FG001|Follow-up|Withdrawal by Subject|0|||
129902084|NCT00217672|467602292|FG000|Follow-up|Lost to Follow-up|1|||
129902085|NCT00217672|467602293|FG001|Follow-up|Lost to Follow-up|0|||
129902086|NCT01050569|467602294|FG000|Overall Study|Lost to Follow-up|20|||
129902087|NCT01050569|467602295|FG001|Overall Study|Lost to Follow-up|14|||
129902088|NCT01050569|467602296|FG002|Overall Study|Lost to Follow-up|16|||
129902089|NCT01050569|467602294|FG000|Overall Study|Withdrawal by Subject|9|||
129902090|NCT01050569|467602295|FG001|Overall Study|Withdrawal by Subject|3|||
129902091|NCT01050569|467602296|FG002|Overall Study|Withdrawal by Subject|11|||
129902092|NCT01050569|467602294|FG000|Overall Study|Lack of Efficacy|5|||
129902093|NCT01050569|467602295|FG001|Overall Study|Lack of Efficacy|4|||
129902094|NCT01050569|467602296|FG002|Overall Study|Lack of Efficacy|3|||
129902095|NCT01050569|467602294|FG000|Overall Study|Adverse Event|1|||
129902096|NCT01050569|467602295|FG001|Overall Study|Adverse Event|0|||
129902097|NCT01050569|467602296|FG002|Overall Study|Adverse Event|0|||
129902098|NCT01050569|467602294|FG000|Overall Study|Physician Decision|3|||
129902099|NCT01050569|467602295|FG001|Overall Study|Physician Decision|3|||
129902100|NCT01050569|467602296|FG002|Overall Study|Physician Decision|3|||
129902101|NCT01591616|467602301|FG000|Overall Study|Withdrawal by Subject|1|||
129902102|NCT00758602|467602302|FG000|Overall Study|Adverse Event|11|||
129902103|NCT00758602|467602303|FG001|Overall Study|Adverse Event|10|||
129902104|NCT00758602|467602302|FG000|Overall Study|Lost to Follow-up|4|||
129902105|NCT00758602|467602303|FG001|Overall Study|Lost to Follow-up|3|||
129902106|NCT00758602|467602302|FG000|Overall Study|Withdrawal by Subject|1|||
129902107|NCT00758602|467602303|FG001|Overall Study|Withdrawal by Subject|3|||
129902108|NCT00758602|467602302|FG000|Overall Study|Protocol Violation|0|||
129902109|NCT00758602|467602303|FG001|Overall Study|Protocol Violation|2|||
129902110|NCT00758602|467602302|FG000|Overall Study|Death|0|||
129902111|NCT00758602|467602303|FG001|Overall Study|Death|1|||
129902112|NCT00758602|467602302|FG000|Overall Study|Reason not specified|3|||
129902113|NCT00758602|467602303|FG001|Overall Study|Reason not specified|3|||
129902114|NCT03939819|467602304|FG000|Overall Study|Death|2|||
129902115|NCT03939819|467602305|FG001|Overall Study|Death|0|||
129902116|NCT01183780|467602306|FG000|Overall Study|Withdrawal by Subject|25|||
129902117|NCT01183780|467602307|FG001|Overall Study|Withdrawal by Subject|14|||
129902118|NCT01183780|467602306|FG000|Overall Study|Lost to Follow-up|6|||
129902119|NCT01183780|467602307|FG001|Overall Study|Lost to Follow-up|11|||
129902120|NCT04379713|467602308|FG000|Overall Study|Adverse Event|2|||
129902121|NCT04379713|467602309|FG001|Overall Study|Adverse Event|0|||
129902122|NCT04379713|467602308|FG000|Overall Study|Physician Decision|2|||
129902123|NCT04379713|467602309|FG001|Overall Study|Physician Decision|1|||
129902124|NCT04379713|467602308|FG000|Overall Study|Protocol Violation|11|||
129902125|NCT04379713|467602309|FG001|Overall Study|Protocol Violation|6|||
129902126|NCT04379713|467602308|FG000|Overall Study|No longer met eligibility criteria|14|||
129902127|NCT04379713|467602309|FG001|Overall Study|No longer met eligibility criteria|11|||
129902128|NCT04379713|467602308|FG000|Overall Study|Withdrawal by parent/guardian|36|||
129902129|NCT04379713|467602309|FG001|Overall Study|Withdrawal by parent/guardian|15|||
129902130|NCT04379713|467602308|FG000|Overall Study|Lost to Follow-up|31|||
129902131|NCT04379713|467602309|FG001|Overall Study|Lost to Follow-up|21|||
129902132|NCT02613364|467602310|FG000|Overall Study|Other|19|||
129902133|NCT02613364|467602311|FG001|Overall Study|Other|29|||
129902134|NCT02613364|467602312|FG002|Overall Study|Other|17|||
129902135|NCT02613364|467602310|FG000|Overall Study|Too time consuming|21|||
129902136|NCT02613364|467602311|FG001|Overall Study|Too time consuming|26|||
129902137|NCT02613364|467602312|FG002|Overall Study|Too time consuming|26|||
129902138|NCT02613364|467602310|FG000|Overall Study|Withdrawal by Subject|13|||
129902139|NCT02613364|467602311|FG001|Overall Study|Withdrawal by Subject|18|||
129902140|NCT02613364|467602312|FG002|Overall Study|Withdrawal by Subject|17|||
129902141|NCT02613364|467602310|FG000|Overall Study|Medical|12|||
129902142|NCT02613364|467602311|FG001|Overall Study|Medical|13|||
129902143|NCT02613364|467602312|FG002|Overall Study|Medical|9|||
129902144|NCT02613364|467602310|FG000|Overall Study|Disliked Study Procedure|1|||
129902145|NCT02613364|467602311|FG001|Overall Study|Disliked Study Procedure|1|||
129902146|NCT02613364|467602312|FG002|Overall Study|Disliked Study Procedure|4|||
129902147|NCT02613364|467602310|FG000|Overall Study|Disliked Intervention|0|||
129902148|NCT02613364|467602311|FG001|Overall Study|Disliked Intervention|3|||
129902149|NCT02613364|467602312|FG002|Overall Study|Disliked Intervention|3|||
129902150|NCT00082810|467602320|FG000|Overall Study|Adverse Event|3|||
129902151|NCT00082810|467602320|FG000|Overall Study|Progressive disease|24|||
129845186|NCT01340976|467393431|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845187|NCT01340976|467393432|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845188|NCT01340976|467393433|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
129845189|NCT01340976|467393428|FG000|Overall Study|Withdrawal by Subject|0|||
129845190|NCT01340976|467393429|FG001|Overall Study|Withdrawal by Subject|0|||
129845191|NCT01340976|467393430|FG002|Overall Study|Withdrawal by Subject|0|||
129845192|NCT01340976|467393431|FG003|Overall Study|Withdrawal by Subject|1|||
129845193|NCT01340976|467393432|FG004|Overall Study|Withdrawal by Subject|1|||
129845194|NCT01340976|467393433|FG005|Overall Study|Withdrawal by Subject|0|||
129845195|NCT01340976|467393428|FG000|Overall Study|Other anemia treatment|1|||
129845196|NCT01340976|467393429|FG001|Overall Study|Other anemia treatment|0|||
129845197|NCT01340976|467393430|FG002|Overall Study|Other anemia treatment|2|||
129845198|NCT01340976|467393431|FG003|Overall Study|Other anemia treatment|1|||
129845199|NCT01340976|467393432|FG004|Overall Study|Other anemia treatment|0|||
129845200|NCT01340976|467393433|FG005|Overall Study|Other anemia treatment|1|||
129845201|NCT01340976|467393428|FG000|Overall Study|Adverse Event|0|||
129845202|NCT01340976|467393429|FG001|Overall Study|Adverse Event|1|||
129845203|NCT01340976|467393430|FG002|Overall Study|Adverse Event|0|||
129845204|NCT01340976|467393431|FG003|Overall Study|Adverse Event|0|||
129845205|NCT01340976|467393432|FG004|Overall Study|Adverse Event|0|||
129845206|NCT01340976|467393433|FG005|Overall Study|Adverse Event|0|||
129845207|NCT01358981|467393434|FG000|Period 1|Withdrawal by Subject|0|||
129845208|NCT01358981|467393435|FG001|Period 1|Withdrawal by Subject|0|||
129845209|NCT01358981|467393436|FG002|Period 1|Withdrawal by Subject|0|||
129845210|NCT01358981|467393437|FG003|Period 1|Withdrawal by Subject|1|||
129845211|NCT01358981|467393438|FG004|Period 1|Withdrawal by Subject|0|||
129845212|NCT01358981|467393439|FG005|Period 1|Withdrawal by Subject|0|||
129845213|NCT01358981|467393440|FG006|Period 1|Withdrawal by Subject|0|||
129845214|NCT03417141|467393449|FG000|Overall Study|Withdrawal by Subject|1|||
129845215|NCT03417141|467393449|FG000|Overall Study|Protocol Violation|3|||
129845216|NCT03706690|467393450|FG000|Overall Study|Withdrawal by Subject|8|||
129845217|NCT03706690|467393451|FG001|Overall Study|Withdrawal by Subject|8|||
129845218|NCT03706690|467393450|FG000|Overall Study|Death|143|||
129845219|NCT03706690|467393451|FG001|Overall Study|Death|75|||
129845220|NCT03706690|467393450|FG000|Overall Study|Ongoing at DCO|121|||
129845221|NCT03706690|467393451|FG001|Overall Study|Ongoing at DCO|52|||
129845222|NCT02098109|467393452|FG000|Overall Study|Protocol Violation|3|||
129845223|NCT02098109|467393453|FG001|Overall Study|Protocol Violation|0|||
129845224|NCT01822132|467393454|FG000|Overall Study|Lost to Follow-up|4|||
129845225|NCT01822132|467393455|FG001|Overall Study|Lost to Follow-up|2|||
129845226|NCT02519712|467393458|FG000|Overall Study|Disease Relapse|1|||
129845227|NCT02519712|467393458|FG000|Overall Study|Disease Progression|1|||
129845228|NCT02519712|467393458|FG000|Overall Study|Accruals are donors|2|||
129845229|NCT01247090|467393461|FG000|Overall Study|Physician Decision|1|||
129845230|NCT01247090|467393462|FG001|Overall Study|Physician Decision|0|||
129845231|NCT01247090|467393463|FG002|Overall Study|Physician Decision|0|||
129845232|NCT01247090|467393461|FG000|Overall Study|Withdrawal by Subject|0|||
129902152|NCT00082810|467602320|FG000|Overall Study|Withdrawal by Subject|4|||
129902153|NCT05052983|467602326|FG000|Overall Study|Lack of Efficacy|3|||
129902154|NCT05052983|467602327|FG001|Overall Study|Lack of Efficacy|12|||
129902155|NCT05052983|467602326|FG000|Overall Study|Adverse Event|1|||
129845233|NCT01247090|467393462|FG001|Overall Study|Withdrawal by Subject|1|||
129902156|NCT05052983|467602327|FG001|Overall Study|Adverse Event|0|||
129902157|NCT03425643|467602328|FG000|Overall Study|Withdrawal by Subject|10|||
129902158|NCT03425643|467602329|FG001|Overall Study|Withdrawal by Subject|12|||
129902159|NCT03425643|467602328|FG000|Overall Study|Lost to Follow-up|2|||
129902160|NCT03425643|467602329|FG001|Overall Study|Lost to Follow-up|0|||
129902161|NCT03425643|467602328|FG000|Overall Study|Death|109|||
129902162|NCT03425643|467602329|FG001|Overall Study|Death|141|||
129902163|NCT03425643|467602328|FG000|Overall Study|Ongoing in study|276|||
129902164|NCT03425643|467602329|FG001|Overall Study|Ongoing in study|247|||
129902165|NCT04133363|467602330|FG000|Overall Study|Lost to Follow-up|2|||
129902166|NCT04133363|467602331|FG001|Overall Study|Lost to Follow-up|1|||
129902167|NCT04133363|467602332|FG002|Overall Study|Lost to Follow-up|4|||
129902168|NCT00849147|467602336|FG000|Overall Study|Withdrawal by Subject|1|||
129845234|NCT01247090|467393463|FG002|Overall Study|Withdrawal by Subject|0|||
129845235|NCT00006916|467393465|FG000|Overall Study|Device not inserted|4|||
129845236|NCT00006916|467393465|FG000|Overall Study|Complication of device insertion|1|||
129845237|NCT03385239|467393470|FG000|Overall Study|Voluntary Withdrawal|2|||
129845238|NCT03385239|467393471|FG001|Overall Study|Voluntary Withdrawal|3|||
129845239|NCT03385239|467393472|FG002|Overall Study|Voluntary Withdrawal|2|||
129845240|NCT03385239|467393473|FG003|Overall Study|Voluntary Withdrawal|3|||
129845241|NCT03385239|467393474|FG004|Overall Study|Voluntary Withdrawal|0|||
129845242|NCT03385239|467393470|FG000|Overall Study|Adverse Event|0|||
129845243|NCT03385239|467393471|FG001|Overall Study|Adverse Event|0|||
129845244|NCT03385239|467393472|FG002|Overall Study|Adverse Event|1|||
129845245|NCT03385239|467393473|FG003|Overall Study|Adverse Event|0|||
129845246|NCT03385239|467393474|FG004|Overall Study|Adverse Event|0|||
129845247|NCT03385239|467393470|FG000|Overall Study|Other|0|||
129845248|NCT03385239|467393471|FG001|Overall Study|Other|0|||
129845249|NCT03385239|467393472|FG002|Overall Study|Other|0|||
129845250|NCT03385239|467393473|FG003|Overall Study|Other|1|||
129845251|NCT03385239|467393474|FG004|Overall Study|Other|0|||
129845252|NCT01574703|467393475|FG000|Overall Study|Adverse Event|0|||
129845253|NCT01574703|467393476|FG001|Overall Study|Adverse Event|2|||
129845254|NCT01574703|467393477|FG002|Overall Study|Adverse Event|1|||
129845255|NCT01574703|467393478|FG003|Overall Study|Adverse Event|1|||
129845256|NCT01574703|467393475|FG000|Overall Study|Protocol Violation|0|||
129902169|NCT00849147|467602336|FG000|Overall Study|Protocol Violation|2|||
129902170|NCT00849147|467602336|FG000|Overall Study|Disease Relapse/Progression|2|||
129902171|NCT04199728|467604056|FG000|Overall Study|Adverse Event|1|||
129902172|NCT04199728|467604057|FG001|Overall Study|Adverse Event|0|||
129902173|NCT04199728|467604056|FG000|Overall Study|Withdrawal by Subject|8|||
129902174|NCT04199728|467604057|FG001|Overall Study|Withdrawal by Subject|3|||
129902175|NCT04199728|467604056|FG000|Overall Study|Screen fail after consent|0|||
129902176|NCT04199728|467604057|FG001|Overall Study|Screen fail after consent|1|||
129902177|NCT04199728|467604056|FG000|Overall Study|Early withdraw criteria met|0|||
129902178|NCT04199728|467604057|FG001|Overall Study|Early withdraw criteria met|1|||
129902179|NCT04199728|467604056|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
129902180|NCT04199728|467604057|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
129902181|NCT00482729|467604058|FG000|Overall Study|Adverse Event|29|||
129902182|NCT00482729|467604059|FG001|Overall Study|Adverse Event|33|||
129902183|NCT00482729|467604058|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
129902184|NCT00482729|467604059|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
129902185|NCT00482729|467604058|FG000|Overall Study|Hyperglycemia Criteria|7|||
129902186|NCT00482729|467604059|FG001|Overall Study|Hyperglycemia Criteria|5|||
129902187|NCT00482729|467604058|FG000|Overall Study|Lack of Efficacy|4|||
129902188|NCT00482729|467604059|FG001|Overall Study|Lack of Efficacy|16|||
129902189|NCT00482729|467604058|FG000|Overall Study|Lost to Follow-up|86|||
129902190|NCT00482729|467604059|FG001|Overall Study|Lost to Follow-up|66|||
129902191|NCT00482729|467604058|FG000|Overall Study|Physician Decision|10|||
129902192|NCT00482729|467604059|FG001|Overall Study|Physician Decision|7|||
129902193|NCT00482729|467604058|FG000|Overall Study|Pregnancy|4|||
129902194|NCT00482729|467604059|FG001|Overall Study|Pregnancy|2|||
129902195|NCT00482729|467604058|FG000|Overall Study|Protocol Violation|10|||
129902196|NCT00482729|467604059|FG001|Overall Study|Protocol Violation|18|||
129902197|NCT00482729|467604058|FG000|Overall Study|Withdrawal by Subject|67|||
129902198|NCT00482729|467604059|FG001|Overall Study|Withdrawal by Subject|69|||
129902199|NCT01070888|467604062|FG000|First Intervention (14 Days)|Adverse Event|0|||
129902200|NCT01070888|467604063|FG001|First Intervention (14 Days)|Adverse Event|1|||
129902201|NCT01070888|467604062|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
129902202|NCT01070888|467604063|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
129902203|NCT01070888|467604062|FG000|Washout (14 Days)|Physician Decision|1|||
129902204|NCT01070888|467604063|FG001|Washout (14 Days)|Physician Decision|0|||
129902205|NCT02577523|467604064|FG000|Overall Study|Adverse Event|1|||
129902206|NCT02577523|467604065|FG001|Overall Study|Adverse Event|1|||
129845257|NCT01574703|467393476|FG001|Overall Study|Protocol Violation|0|||
129902207|NCT02577523|467604064|FG000|Overall Study|Lack of Efficacy|1|||
129902208|NCT02577523|467604065|FG001|Overall Study|Lack of Efficacy|1|||
129845258|NCT01574703|467393477|FG002|Overall Study|Protocol Violation|0|||
129902209|NCT02577523|467604064|FG000|Overall Study|Withdrawal by Subject|1|||
129902210|NCT02577523|467604065|FG001|Overall Study|Withdrawal by Subject|0|||
129902211|NCT02631148|467604066|FG000|Overall Study|8 were ineligible|8|||
129902212|NCT02631148|467604067|FG001|Overall Study|8 were ineligible|0|||
129902213|NCT02631148|467604066|FG000|Overall Study|Withdrawal by Subject|1|||
129902214|NCT02631148|467604067|FG001|Overall Study|Withdrawal by Subject|0|||
129902215|NCT02631148|467604066|FG000|Overall Study|PAH not available to study participant|1|||
129902216|NCT02631148|467604067|FG001|Overall Study|PAH not available to study participant|0|||
129902217|NCT00955825|467604069|FG000|Overall Study|Adverse Event|15|||
129902218|NCT00955825|467604070|FG001|Overall Study|Adverse Event|2|||
129902219|NCT00955825|467604069|FG000|Overall Study|Withdrawal by Subject|4|||
129902220|NCT00955825|467604070|FG001|Overall Study|Withdrawal by Subject|6|||
129902221|NCT00955825|467604069|FG000|Overall Study|Any other reason not above-mentioned|7|||
129902222|NCT00955825|467604070|FG001|Overall Study|Any other reason not above-mentioned|9|||
129902223|NCT02488980|467604071|FG000|Overall Study|Protocol Violation|2|||
129902224|NCT02488980|467604072|FG001|Overall Study|Protocol Violation|2|||
129902225|NCT02488980|467604073|FG002|Overall Study|Protocol Violation|2|||
129902226|NCT00150176|467604074|FG000|Overall Study|Adverse Event|16|||
129902227|NCT00150176|467604075|FG001|Overall Study|Adverse Event|53|||
129902228|NCT00150176|467604074|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
129902229|NCT00150176|467604075|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
129902230|NCT00150176|467604074|FG000|Overall Study|Withdrawal by Subject|19|||
129902231|NCT00150176|467604075|FG001|Overall Study|Withdrawal by Subject|12|||
129902232|NCT00150176|467604074|FG000|Overall Study|Lost to Follow-up|3|||
129902233|NCT00150176|467604075|FG001|Overall Study|Lost to Follow-up|3|||
129902234|NCT00150176|467604074|FG000|Overall Study|OTHER|11|||
129902235|NCT00150176|467604075|FG001|Overall Study|OTHER|13|||
129902236|NCT02082158|467604077|FG000|Overall Study|Withdrawal by Subject|0|||
129902237|NCT02082158|467604078|FG001|Overall Study|Withdrawal by Subject|0|||
129902238|NCT02082158|467604079|FG002|Overall Study|Withdrawal by Subject|0|||
129902239|NCT02082158|467604080|FG003|Overall Study|Withdrawal by Subject|0|||
129902240|NCT02082158|467604081|FG004|Overall Study|Withdrawal by Subject|1|||
129902241|NCT02082158|467604082|FG005|Overall Study|Withdrawal by Subject|0|||
129902242|NCT02082158|467604077|FG000|Overall Study|Failed Fit-testing|8|||
129902243|NCT02082158|467604078|FG001|Overall Study|Failed Fit-testing|8|||
129902244|NCT02082158|467604079|FG002|Overall Study|Failed Fit-testing|14|||
129902245|NCT02082158|467604080|FG003|Overall Study|Failed Fit-testing|4|||
129902246|NCT02082158|467604081|FG004|Overall Study|Failed Fit-testing|3|||
129902247|NCT02082158|467604082|FG005|Overall Study|Failed Fit-testing|7|||
129902248|NCT00738699|467604083|FG000|Overall Study|Withdrawal by Subject|5|||
129902249|NCT00738699|467604084|FG001|Overall Study|Withdrawal by Subject|0|||
129902250|NCT00738699|467604083|FG000|Overall Study|Lost to Follow-up|1|||
129902251|NCT00738699|467604084|FG001|Overall Study|Lost to Follow-up|0|||
129902252|NCT00738699|467604083|FG000|Overall Study|Death|144|||
129902253|NCT00738699|467604084|FG001|Overall Study|Death|68|||
129902254|NCT00738699|467604083|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
129902255|NCT00738699|467604084|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
129902256|NCT00738699|467604083|FG000|Overall Study|Other|2|||
129902257|NCT00738699|467604084|FG001|Overall Study|Other|0|||
129902258|NCT00549848|467604089|FG000|Overall Study|Death|1|||
129902259|NCT00549848|467604090|FG001|Overall Study|Death|4|||
129902260|NCT00549848|467604091|FG002|Overall Study|Death|13|||
129902261|NCT00549848|467604089|FG000|Overall Study|Physician Decision|0|||
129902262|NCT00549848|467604090|FG001|Overall Study|Physician Decision|0|||
129902263|NCT00549848|467604091|FG002|Overall Study|Physician Decision|4|||
129902264|NCT00549848|467604089|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
129902265|NCT00549848|467604090|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
129902266|NCT00549848|467604091|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
129902267|NCT00549848|467604089|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
129902268|NCT00549848|467604090|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
129902269|NCT00549848|467604091|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
129902270|NCT00549848|467604089|FG000|Overall Study|Participant/Family Withdraw|2|||
129902271|NCT00549848|467604090|FG001|Overall Study|Participant/Family Withdraw|3|||
129902272|NCT00549848|467604091|FG002|Overall Study|Participant/Family Withdraw|5|||
129902273|NCT00549848|467604089|FG000|Overall Study|Second Malignancy|1|||
129902274|NCT00549848|467604090|FG001|Overall Study|Second Malignancy|0|||
129902275|NCT00549848|467604091|FG002|Overall Study|Second Malignancy|0|||
129902276|NCT00549848|467604089|FG000|Overall Study|Transplant|3|||
129902277|NCT00549848|467604090|FG001|Overall Study|Transplant|3|||
129902278|NCT00549848|467604091|FG002|Overall Study|Transplant|18|||
129902279|NCT00549848|467604089|FG000|Overall Study|Unacceptable Toxicity|1|||
129902280|NCT00549848|467604090|FG001|Overall Study|Unacceptable Toxicity|6|||
129902281|NCT00549848|467604091|FG002|Overall Study|Unacceptable Toxicity|6|||
129902282|NCT03262935|467604092|FG000|Overall Study|Withdrawal by Subject|6|||
129902283|NCT03262935|467604093|FG001|Overall Study|Withdrawal by Subject|7|||
129902284|NCT03262935|467604092|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
129902285|NCT03262935|467604093|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
129902286|NCT03262935|467604092|FG000|Overall Study|Death|181|||
129902287|NCT03262935|467604093|FG001|Overall Study|Death|94|||
129902288|NCT03262935|467604092|FG000|Overall Study|Lost to Follow-up|9|||
129902289|NCT03262935|467604093|FG001|Overall Study|Lost to Follow-up|4|||
129902290|NCT03262935|467604092|FG000|Overall Study|Other reason|5|||
129845259|NCT01574703|467393478|FG003|Overall Study|Protocol Violation|1|||
129845260|NCT01574703|467393475|FG000|Overall Study|Unspecified Reason|27|||
129845261|NCT01574703|467393476|FG001|Overall Study|Unspecified Reason|15|||
129845262|NCT01574703|467393477|FG002|Overall Study|Unspecified Reason|20|||
129845263|NCT01574703|467393478|FG003|Overall Study|Unspecified Reason|16|||
129845264|NCT01574703|467393475|FG000|Overall Study|Withdrawal by Subject|53|||
129845265|NCT01574703|467393476|FG001|Overall Study|Withdrawal by Subject|52|||
129845266|NCT01574703|467393477|FG002|Overall Study|Withdrawal by Subject|36|||
129845267|NCT01574703|467393478|FG003|Overall Study|Withdrawal by Subject|61|||
129845268|NCT01574703|467393475|FG000|Overall Study|Met Withdrawal Criteria|0|||
129845269|NCT01574703|467393476|FG001|Overall Study|Met Withdrawal Criteria|1|||
129845270|NCT01574703|467393477|FG002|Overall Study|Met Withdrawal Criteria|1|||
129845271|NCT01574703|467393478|FG003|Overall Study|Met Withdrawal Criteria|0|||
129845272|NCT01574703|467393475|FG000|Overall Study|Lost to Follow-up|43|||
129845273|NCT01574703|467393476|FG001|Overall Study|Lost to Follow-up|41|||
129845274|NCT01574703|467393477|FG002|Overall Study|Lost to Follow-up|46|||
129845275|NCT01574703|467393478|FG003|Overall Study|Lost to Follow-up|35|||
129845276|NCT01574703|467393475|FG000|Overall Study|Death|2|||
129845277|NCT01574703|467393476|FG001|Overall Study|Death|1|||
129845278|NCT01574703|467393477|FG002|Overall Study|Death|1|||
129845279|NCT01574703|467393478|FG003|Overall Study|Death|0|||
129845280|NCT01524770|467393479|FG000|First Intervention|Withdrawal by Subject|1|||
129845281|NCT01524770|467393480|FG001|First Intervention|Withdrawal by Subject|0|||
129845282|NCT01524770|467393479|FG000|First Intervention|Adverse Event|1|||
129845283|NCT01524770|467393480|FG001|First Intervention|Adverse Event|1|||
129845284|NCT01524770|467393479|FG000|First Intervention|Protocol Violation|1|||
129845285|NCT01524770|467393480|FG001|First Intervention|Protocol Violation|0|||
129845286|NCT03467425|467393482|FG000|Overall Study|Adverse Event|9|||
129845287|NCT03467425|467393483|FG001|Overall Study|Adverse Event|9|||
129845288|NCT03467425|467393482|FG000|Overall Study|Lack of Efficacy|3|||
129845289|NCT03467425|467393483|FG001|Overall Study|Lack of Efficacy|1|||
129845290|NCT03467425|467393482|FG000|Overall Study|Protocol Violation|0|||
129845291|NCT03467425|467393483|FG001|Overall Study|Protocol Violation|1|||
129845292|NCT03467425|467393482|FG000|Overall Study|Lost to Follow-up|18|||
129845293|NCT03467425|467393483|FG001|Overall Study|Lost to Follow-up|25|||
129845294|NCT03467425|467393482|FG000|Overall Study|Physician Decision|2|||
129845295|NCT03467425|467393483|FG001|Overall Study|Physician Decision|1|||
129845296|NCT03467425|467393482|FG000|Overall Study|Withdrawal by Subject|15|||
129845297|NCT03467425|467393483|FG001|Overall Study|Withdrawal by Subject|17|||
129845298|NCT02318693|467393484|FG000|Overall Study|Protocol Violation|0|||
129845299|NCT02318693|467393485|FG001|Overall Study|Protocol Violation|1|||
129845300|NCT01282216|467393486|FG000|Overall Study|Graft failure|0|||
129845301|NCT01282216|467393487|FG001|Overall Study|Graft failure|0|||
129845302|NCT01282216|467393488|FG002|Overall Study|Graft failure|3|||
129845303|NCT01282216|467393489|FG003|Overall Study|Graft failure|2|||
129845304|NCT01282216|467393486|FG000|Overall Study|Physician Decision|0|||
129845305|NCT01282216|467393487|FG001|Overall Study|Physician Decision|0|||
129845306|NCT01282216|467393488|FG002|Overall Study|Physician Decision|11|||
129845307|NCT01282216|467393489|FG003|Overall Study|Physician Decision|0|||
129845308|NCT01282216|467393486|FG000|Overall Study|Relapse|0|||
129845309|NCT01282216|467393487|FG001|Overall Study|Relapse|0|||
129845310|NCT01282216|467393488|FG002|Overall Study|Relapse|17|||
129845311|NCT01282216|467393489|FG003|Overall Study|Relapse|6|||
129845312|NCT01282216|467393486|FG000|Overall Study|Death|0|||
129845313|NCT01282216|467393487|FG001|Overall Study|Death|0|||
129845314|NCT01282216|467393488|FG002|Overall Study|Death|2|||
129845315|NCT01282216|467393489|FG003|Overall Study|Death|0|||
129845316|NCT03492177|467393494|FG000|Overall Study|Adverse Event|1|||
129902291|NCT03262935|467604093|FG001|Overall Study|Other reason|0|||
129902292|NCT00419094|467604094|FG000|Overall Study|Adverse Event|3|||
129902293|NCT00419094|467604095|FG001|Overall Study|Adverse Event|7|||
129902294|NCT00419094|467604094|FG000|Overall Study|Lack of Efficacy|1|||
129902295|NCT00419094|467604095|FG001|Overall Study|Lack of Efficacy|0|||
129845317|NCT03492177|467393495|FG001|Overall Study|Adverse Event|0|||
129902296|NCT00419094|467604094|FG000|Overall Study|Lost to Follow-up|0|||
129902297|NCT00419094|467604095|FG001|Overall Study|Lost to Follow-up|2|||
129902298|NCT00419094|467604094|FG000|Overall Study|Protocol Violation|1|||
129902299|NCT00419094|467604095|FG001|Overall Study|Protocol Violation|14|||
129845318|NCT03492177|467393496|FG002|Overall Study|Adverse Event|0|||
129845319|NCT03492177|467393494|FG000|Overall Study|Death|3|||
129845320|NCT03492177|467393495|FG001|Overall Study|Death|0|||
129845321|NCT03492177|467393496|FG002|Overall Study|Death|3|||
129845322|NCT03492177|467393494|FG000|Overall Study|Lack of Efficacy|1|||
129845323|NCT03492177|467393495|FG001|Overall Study|Lack of Efficacy|2|||
129845324|NCT03492177|467393496|FG002|Overall Study|Lack of Efficacy|0|||
129902300|NCT00419094|467604094|FG000|Overall Study|Withdrawal of consent|1|||
129845325|NCT03492177|467393494|FG000|Overall Study|Other|1|||
129845326|NCT03492177|467393495|FG001|Overall Study|Other|0|||
129845327|NCT03492177|467393496|FG002|Overall Study|Other|0|||
129845328|NCT03492177|467393494|FG000|Overall Study|Ongoing|16|||
129845329|NCT03492177|467393495|FG001|Overall Study|Ongoing|19|||
129845330|NCT03492177|467393496|FG002|Overall Study|Ongoing|17|||
129845331|NCT04745689|467393497|FG000|Overall Study|Death|9|||
129845332|NCT04745689|467393498|FG001|Overall Study|Death|6|||
129845333|NCT04745689|467393497|FG000|Overall Study|Lost to Follow-up|1|||
129845334|NCT04745689|467393498|FG001|Overall Study|Lost to Follow-up|0|||
129845335|NCT04745689|467393497|FG000|Overall Study|Withdrawal by Subject|2|||
129845336|NCT04745689|467393498|FG001|Overall Study|Withdrawal by Subject|0|||
129845337|NCT04745689|467393497|FG000|Overall Study|Study terminated by sponsor|10|||
129845338|NCT04745689|467393498|FG001|Overall Study|Study terminated by sponsor|3|||
129902301|NCT00419094|467604095|FG001|Overall Study|Withdrawal of consent|5|||
129902302|NCT00419094|467604094|FG000|Overall Study|Other: Error determining exit criteria|1|||
129902303|NCT00419094|467604095|FG001|Overall Study|Other: Error determining exit criteria|0|||
129902304|NCT00419094|467604094|FG000|Overall Study|Other: Patient non-compliant|0|||
129902305|NCT00419094|467604095|FG001|Overall Study|Other: Patient non-compliant|1|||
129902306|NCT00419094|467604094|FG000|Overall Study|Other: No contact for extended period|0|||
129902307|NCT00419094|467604095|FG001|Overall Study|Other: No contact for extended period|1|||
129902308|NCT01811706|467604096|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
129902309|NCT01811706|467604097|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
129902310|NCT02224924|467604098|FG000|Overall Study|Withdrawal by Subject|7|||
129902311|NCT02224924|467604099|FG001|Overall Study|Withdrawal by Subject|6|||
129902312|NCT02224924|467604098|FG000|Overall Study|Biopsy cancelled|20|||
129902313|NCT02224924|467604099|FG001|Overall Study|Biopsy cancelled|14|||
129902314|NCT02224924|467604098|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
129902315|NCT02224924|467604099|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
129902316|NCT02224924|467604098|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
129902317|NCT02224924|467604099|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
129902318|NCT03020745|467604100|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902319|NCT03020745|467604101|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902320|NCT03020745|467604102|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902321|NCT03020745|467604103|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902322|NCT03020745|467604104|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902323|NCT03020745|467604105|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902324|NCT03020745|467604106|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902325|NCT03020745|467604107|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902326|NCT03020745|467604108|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
129902327|NCT03020745|467604109|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
129902328|NCT03020745|467604100|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902329|NCT03020745|467604101|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902330|NCT03020745|467604102|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902331|NCT03020745|467604103|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902332|NCT03020745|467604104|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902333|NCT03020745|467604105|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902334|NCT03020745|467604106|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902335|NCT03020745|467604107|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
129902336|NCT03020745|467604108|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902337|NCT03020745|467604109|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
129902338|NCT03020745|467604100|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902339|NCT03020745|467604101|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902340|NCT03020745|467604102|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902341|NCT03020745|467604103|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902342|NCT03020745|467604104|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902343|NCT03020745|467604105|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
129902344|NCT03020745|467604106|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902345|NCT03020745|467604107|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902346|NCT03020745|467604108|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
129902347|NCT03020745|467604109|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
129902348|NCT03020745|467604100|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902349|NCT03020745|467604101|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902350|NCT03020745|467604102|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902351|NCT03020745|467604103|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902352|NCT03020745|467604104|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902353|NCT03020745|467604105|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902354|NCT03020745|467604106|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902355|NCT03020745|467604107|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129902356|NCT03020745|467604108|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
129902357|NCT03020745|467604109|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
129845339|NCT03285646|467395166|FG000|Overall Study|Adverse Event|1|||
129845340|NCT03285646|467395167|FG001|Overall Study|Adverse Event|0|||
129845341|NCT03285646|467395166|FG000|Overall Study|Withdrawal by Subject|10|||
129845342|NCT03285646|467395167|FG001|Overall Study|Withdrawal by Subject|2|||
129845343|NCT03285646|467395166|FG000|Overall Study|Lost to Follow-up|2|||
129845344|NCT03285646|467395167|FG001|Overall Study|Lost to Follow-up|1|||
129845345|NCT03285646|467395166|FG000|Overall Study|Investigator/Sponsor Decision|0|||
129845346|NCT03285646|467395167|FG001|Overall Study|Investigator/Sponsor Decision|1|||
129845347|NCT01344057|467395168|FG000|Overall Study|Premature Withdrawal|1|||
129845348|NCT00306592|467395169|FG000|Overall Study|Adverse Event|8|||
129845349|NCT00306592|467395170|FG001|Overall Study|Adverse Event|15|||
129845350|NCT00306592|467395169|FG000|Overall Study|Lost to Follow-up|1|||
129845351|NCT00306592|467395170|FG001|Overall Study|Lost to Follow-up|0|||
129845352|NCT00306592|467395169|FG000|Overall Study|Noncompliance|0|||
129845353|NCT00306592|467395170|FG001|Overall Study|Noncompliance|2|||
129845354|NCT00306592|467395169|FG000|Overall Study|Persistent Antibodies|6|||
129845355|NCT00306592|467395170|FG001|Overall Study|Persistent Antibodies|3|||
129845356|NCT00306592|467395169|FG000|Overall Study|Voluntary|10|||
129845357|NCT00306592|467395170|FG001|Overall Study|Voluntary|6|||
129845358|NCT00306592|467395169|FG000|Overall Study|Other|5|||
129845359|NCT00306592|467395170|FG001|Overall Study|Other|10|||
129845360|NCT00306592|467395169|FG000|Overall Study|Other|1|||
129845361|NCT00306592|467395170|FG001|Overall Study|Other|2|||
129845362|NCT00306592|467395169|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
129845363|NCT00306592|467395170|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
129845364|NCT02566759|467395171|FG000|All Parts|Withdrawal by Subject|0|||
129845365|NCT02566759|467395172|FG001|All Parts|Withdrawal by Subject|1|||
129845366|NCT02566759|467395173|FG002|All Parts|Withdrawal by Subject|0|||
129845367|NCT02566759|467395174|FG003|All Parts|Withdrawal by Subject|0|||
129845368|NCT02566759|467395175|FG004|All Parts|Withdrawal by Subject|0|||
129845369|NCT02566759|467395176|FG005|All Parts|Withdrawal by Subject|0|||
129845370|NCT02566759|467395177|FG006|All Parts|Withdrawal by Subject|0|||
129845371|NCT02566759|467395178|FG007|All Parts|Withdrawal by Subject|0|||
129845372|NCT02566759|467395179|FG008|All Parts|Withdrawal by Subject|0|||
129845373|NCT02566759|467395180|FG009|All Parts|Withdrawal by Subject|0|||
129845374|NCT02566759|467395181|FG010|All Parts|Withdrawal by Subject|0|||
129845375|NCT02566759|467395182|FG011|All Parts|Withdrawal by Subject|0|||
129845376|NCT02566759|467395183|FG012|All Parts|Withdrawal by Subject|0|||
129845377|NCT02566759|467395184|FG013|All Parts|Withdrawal by Subject|0|||
129845378|NCT02566759|467395185|FG014|All Parts|Withdrawal by Subject|0|||
129845379|NCT02566759|467395186|FG015|All Parts|Withdrawal by Subject|0|||
129845380|NCT02566759|467395187|FG016|All Parts|Withdrawal by Subject|0|||
129845381|NCT02566759|467395171|FG000|All Parts|Adverse Event|0|||
129845382|NCT02566759|467395172|FG001|All Parts|Adverse Event|0|||
129845383|NCT02566759|467395173|FG002|All Parts|Adverse Event|0|||
129845384|NCT02566759|467395174|FG003|All Parts|Adverse Event|0|||
129845385|NCT02566759|467395175|FG004|All Parts|Adverse Event|0|||
129845386|NCT02566759|467395176|FG005|All Parts|Adverse Event|0|||
129845387|NCT02566759|467395177|FG006|All Parts|Adverse Event|0|||
129845388|NCT02566759|467395178|FG007|All Parts|Adverse Event|0|||
129845389|NCT02566759|467395179|FG008|All Parts|Adverse Event|0|||
129845390|NCT02566759|467395180|FG009|All Parts|Adverse Event|0|||
129845391|NCT02566759|467395181|FG010|All Parts|Adverse Event|0|||
129845392|NCT02566759|467395182|FG011|All Parts|Adverse Event|0|||
129845393|NCT02566759|467395183|FG012|All Parts|Adverse Event|1|||
129845394|NCT02566759|467395184|FG013|All Parts|Adverse Event|3|||
129845395|NCT02566759|467395185|FG014|All Parts|Adverse Event|0|||
129845396|NCT02566759|467395186|FG015|All Parts|Adverse Event|0|||
129845397|NCT02566759|467395187|FG016|All Parts|Adverse Event|0|||
129845398|NCT02566759|467395171|FG000|All Parts|Other|0|||
129845399|NCT02566759|467395172|FG001|All Parts|Other|0|||
129845400|NCT02566759|467395173|FG002|All Parts|Other|0|||
129845401|NCT02566759|467395174|FG003|All Parts|Other|0|||
129845402|NCT02566759|467395175|FG004|All Parts|Other|0|||
129845403|NCT02566759|467395176|FG005|All Parts|Other|0|||
129845404|NCT02566759|467395177|FG006|All Parts|Other|0|||
129845405|NCT02566759|467395178|FG007|All Parts|Other|0|||
129845406|NCT02566759|467395179|FG008|All Parts|Other|0|||
129845407|NCT02566759|467395180|FG009|All Parts|Other|0|||
129845408|NCT02566759|467395181|FG010|All Parts|Other|0|||
129845409|NCT02566759|467395182|FG011|All Parts|Other|0|||
129845410|NCT02566759|467395183|FG012|All Parts|Other|0|||
129845411|NCT02566759|467395184|FG013|All Parts|Other|2|||
129845412|NCT02566759|467395185|FG014|All Parts|Other|0|||
129845413|NCT02566759|467395186|FG015|All Parts|Other|0|||
129845414|NCT02566759|467395187|FG016|All Parts|Other|0|||
129845415|NCT02566759|467395171|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845416|NCT02566759|467395172|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845417|NCT02566759|467395173|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845418|NCT02566759|467395174|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845419|NCT02566759|467395175|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845420|NCT02566759|467395176|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845421|NCT02566759|467395177|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129902358|NCT00753012|467604114|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
129902359|NCT00753012|467604115|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
129902360|NCT00753012|467604114|FG000|Overall Study|Adverse Event|2|||
129902361|NCT00753012|467604115|FG001|Overall Study|Adverse Event|0|||
129902362|NCT00753012|467604114|FG000|Overall Study|Withdrawal by Subject|0|||
129902363|NCT00753012|467604115|FG001|Overall Study|Withdrawal by Subject|1|||
129902364|NCT00753012|467604114|FG000|Overall Study|Lost to Follow-up|4|||
129902365|NCT00753012|467604115|FG001|Overall Study|Lost to Follow-up|0|||
129902366|NCT00753012|467604114|FG000|Overall Study|Confounded endpoint data|1|||
129902367|NCT00753012|467604115|FG001|Overall Study|Confounded endpoint data|0|||
129902368|NCT00943735|467604118|FG000|Overall Study|Adverse Event|12|||
129902369|NCT00943735|467604118|FG000|Overall Study|Withdrawal by Subject|8|||
129902370|NCT00943735|467604118|FG000|Overall Study|Death|1|||
129902371|NCT00943735|467604118|FG000|Overall Study|Other|8|||
129902372|NCT00943735|467604118|FG000|Overall Study|Other|3|||
129902373|NCT03804918|467604119|FG000|Overall Study|Participant did not use the app|1|||
129902374|NCT01329328|467604120|FG000|Overall Study|Withdrawal by Subject|2|||
129902375|NCT01329328|467604121|FG001|Overall Study|Withdrawal by Subject|4|||
129902376|NCT01329328|467604122|FG002|Overall Study|Withdrawal by Subject|3|||
129902377|NCT04842604|467604125|FG000|Overall Study|Death|1|||
129902378|NCT04842604|467604126|FG001|Overall Study|Death|0|||
129902379|NCT04842604|467604125|FG000|Overall Study|Other|4|||
129902380|NCT04842604|467604126|FG001|Overall Study|Other|4|||
129902381|NCT04842604|467604125|FG000|Overall Study|Randomized but not treated|1|||
129902382|NCT04842604|467604126|FG001|Overall Study|Randomized but not treated|0|||
129902383|NCT01193153|467604127|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
129845422|NCT02566759|467395178|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845423|NCT02566759|467395179|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845424|NCT02566759|467395180|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845425|NCT02566759|467395181|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845426|NCT02566759|467395182|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845427|NCT02566759|467395183|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845428|NCT02566759|467395184|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845429|NCT02566759|467395185|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845430|NCT02566759|467395186|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
129845431|NCT02566759|467395187|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
129845432|NCT01126541|467395188|FG000|Overall Study|Adverse Event|0|||
129845433|NCT01126541|467395189|FG001|Overall Study|Adverse Event|2|||
129845434|NCT01126541|467395190|FG002|Overall Study|Adverse Event|4|||
129845435|NCT01126541|467395188|FG000|Overall Study|Death|0|||
129845436|NCT01126541|467395189|FG001|Overall Study|Death|1|||
129845437|NCT01126541|467395190|FG002|Overall Study|Death|0|||
129845438|NCT01126541|467395188|FG000|Overall Study|Lack of Efficacy|6|||
129845439|NCT01126541|467395189|FG001|Overall Study|Lack of Efficacy|1|||
129845440|NCT01126541|467395190|FG002|Overall Study|Lack of Efficacy|11|||
129845441|NCT01126541|467395188|FG000|Overall Study|Lost to Follow-up|1|||
129845442|NCT01126541|467395189|FG001|Overall Study|Lost to Follow-up|2|||
129845443|NCT01126541|467395190|FG002|Overall Study|Lost to Follow-up|2|||
129845444|NCT01126541|467395188|FG000|Overall Study|Withdrawal by Subject|2|||
129845445|NCT01126541|467395189|FG001|Overall Study|Withdrawal by Subject|5|||
129845446|NCT01126541|467395190|FG002|Overall Study|Withdrawal by Subject|6|||
129845447|NCT01126541|467395188|FG000|Overall Study|Protocol Violation|0|||
129845448|NCT01126541|467395189|FG001|Overall Study|Protocol Violation|0|||
129845449|NCT01126541|467395190|FG002|Overall Study|Protocol Violation|1|||
129845450|NCT01126541|467395188|FG000|Overall Study|Administrative reason or other|1|||
129845451|NCT01126541|467395189|FG001|Overall Study|Administrative reason or other|1|||
129845452|NCT01126541|467395190|FG002|Overall Study|Administrative reason or other|2|||
129845453|NCT01532687|467395191|FG000|Overall Study|Death|2|||
129845454|NCT01532687|467395192|FG001|Overall Study|Death|0|||
129845455|NCT01532687|467395191|FG000|Overall Study|Adverse Event|6|||
129845456|NCT01532687|467395192|FG001|Overall Study|Adverse Event|1|||
129845457|NCT01532687|467395191|FG000|Overall Study|Withdrawal by Subject|1|||
129902384|NCT01193153|467604128|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
129902385|NCT01193153|467604127|FG000|Open-label Lead in Period|Pregnancy|1|||
129902386|NCT01193153|467604128|FG001|Open-label Lead in Period|Pregnancy|0|||
129902387|NCT01193153|467604127|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
129902388|NCT01193153|467604128|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
129845458|NCT01532687|467395192|FG001|Overall Study|Withdrawal by Subject|0|||
129845459|NCT01532687|467395191|FG000|Overall Study|Physician Decision|2|||
129845460|NCT01532687|467395192|FG001|Overall Study|Physician Decision|1|||
129845461|NCT01532687|467395191|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
129845462|NCT01532687|467395192|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
129845463|NCT03160703|467395193|FG000|Overall Study|Withdrawal by Subject|0|||
129845464|NCT03160703|467395194|FG001|Overall Study|Withdrawal by Subject|0|||
129902389|NCT01193153|467604127|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
129902390|NCT01193153|467604128|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
129845465|NCT03160703|467395195|FG002|Overall Study|Withdrawal by Subject|0|||
129845466|NCT03160703|467395196|FG003|Overall Study|Withdrawal by Subject|1|||
129845467|NCT00226941|467395197|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
129845468|NCT00226941|467395198|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
129845469|NCT00226941|467395199|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
129845470|NCT00226941|467395200|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
129845471|NCT00226941|467395197|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
129845472|NCT00226941|467395198|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
129845473|NCT00226941|467395199|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
129845474|NCT00226941|467395200|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
129845475|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
129845476|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
129845477|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
129845478|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
129845479|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
129845480|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
129845481|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
129845482|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
129845483|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
129845484|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
129845485|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
129845486|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
129845487|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
129845488|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
129845489|NCT03732638|467395201|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
129845490|NCT03732638|467395202|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
129845491|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
129845492|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
129845493|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
129845494|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
129845495|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
129845496|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
129845497|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
129845498|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
129845499|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
129845500|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
129845501|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
129845502|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
129845503|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
129845504|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
129845505|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
129845506|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
129845507|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
129845508|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
129845509|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
129845510|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
129845511|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
129845512|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
129845513|NCT03732638|467395201|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
129845514|NCT03732638|467395202|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
129845515|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
129845516|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
129845517|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
129845518|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
129845519|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
129845520|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
129845521|NCT03732638|467395201|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
129845522|NCT03732638|467395202|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
129845523|NCT03728582|467395203|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
129845524|NCT03728582|467395204|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
129845525|NCT03728582|467395203|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
129845526|NCT03728582|467395204|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
129845527|NCT01034397|467395205|FG000|Overall Study|Lack of compliance|0|||
129845528|NCT01034397|467395206|FG001|Overall Study|Lack of compliance|1|||
129845529|NCT01034397|467395205|FG000|Overall Study|Lack of Efficacy|3|||
129845530|NCT01034397|467395206|FG001|Overall Study|Lack of Efficacy|0|||
129845531|NCT01034397|467395205|FG000|Overall Study|Adverse Event|4|||
129845532|NCT01034397|467395206|FG001|Overall Study|Adverse Event|0|||
129902391|NCT01193153|467604127|FG000|Open-label Lead in Period|Other|14|||
129902392|NCT01193153|467604128|FG001|Open-label Lead in Period|Other|0|||
129845533|NCT01034397|467395205|FG000|Overall Study|Other|0|||
129845534|NCT01034397|467395206|FG001|Overall Study|Other|1|||
129845535|NCT01018264|467395207|FG000|Overall Study|Withdrawal by Subject|1|||
129845536|NCT01018264|467395208|FG001|Overall Study|Withdrawal by Subject|0|||
129845537|NCT01018264|467395207|FG000|Overall Study|Lost to Follow-up|0|||
129845538|NCT01018264|467395208|FG001|Overall Study|Lost to Follow-up|1|||
129845539|NCT01785524|467395209|FG000|Overall Study|Withdrawal by Subject|2|||
129845540|NCT01785524|467395210|FG001|Overall Study|Withdrawal by Subject|2|||
129845541|NCT00767676|467395215|FG000|Overall Study|Investigator error|54|||
129845542|NCT00617240|467395216|FG000|Overall Study|Lack of Efficacy|1|||
129845543|NCT00617240|467395217|FG001|Overall Study|Lack of Efficacy|0|||
129845544|NCT01611259|467395218|FG000|Overall Study|Physician Decision|1|||
129845545|NCT01611259|467395218|FG000|Overall Study|Lack of Efficacy|2|||
129845546|NCT01611259|467395218|FG000|Overall Study|Adverse Event|4|||
129845547|NCT01611259|467395218|FG000|Overall Study|Withdrawal by Subject|7|||
129845548|NCT04936685|467395219|FG000|Overall Study|Protocol Violation|1|||
129845549|NCT04936685|467395220|FG001|Overall Study|Protocol Violation|0|||
129845550|NCT03969212|467395223|FG000|Overall Study|Adverse Event|1|||
129845551|NCT03969212|467395224|FG001|Overall Study|Adverse Event|0|||
129845552|NCT03969212|467395225|FG002|Overall Study|Adverse Event|0|||
129845553|NCT03969212|467395226|FG003|Overall Study|Adverse Event|0|||
129845554|NCT03969212|467395223|FG000|Overall Study|Lost to Follow-up|2|||
129845555|NCT03969212|467395224|FG001|Overall Study|Lost to Follow-up|2|||
129845556|NCT03969212|467395225|FG002|Overall Study|Lost to Follow-up|2|||
129845557|NCT03969212|467395226|FG003|Overall Study|Lost to Follow-up|2|||
129845558|NCT03969212|467395223|FG000|Overall Study|Protocol Violation|0|||
129845559|NCT03969212|467395224|FG001|Overall Study|Protocol Violation|0|||
129845560|NCT03969212|467395225|FG002|Overall Study|Protocol Violation|0|||
129845561|NCT03969212|467395226|FG003|Overall Study|Protocol Violation|1|||
129845562|NCT03969212|467395223|FG000|Overall Study|Withdrawal by Subject|7|||
129845563|NCT03969212|467395224|FG001|Overall Study|Withdrawal by Subject|13|||
129845564|NCT03969212|467395225|FG002|Overall Study|Withdrawal by Subject|5|||
129845565|NCT03969212|467395226|FG003|Overall Study|Withdrawal by Subject|11|||
129845566|NCT03969212|467395223|FG000|Overall Study|Physician Decision|0|||
129845567|NCT03969212|467395224|FG001|Overall Study|Physician Decision|0|||
129845568|NCT03969212|467395225|FG002|Overall Study|Physician Decision|1|||
129845569|NCT03969212|467395226|FG003|Overall Study|Physician Decision|0|||
129845570|NCT03969212|467395223|FG000|Overall Study|Reason not Specified|22|||
129845571|NCT03969212|467395224|FG001|Overall Study|Reason not Specified|23|||
129845572|NCT03969212|467395225|FG002|Overall Study|Reason not Specified|28|||
129845573|NCT03969212|467395226|FG003|Overall Study|Reason not Specified|26|||
129845574|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
129845575|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
129845576|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
129845577|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
129845578|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
129845579|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
129845580|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
129845581|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
129845582|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
129845583|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
129845584|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
129845585|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
129845586|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
129845587|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
129845588|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
129845589|NCT00280566|467395229|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
129902393|NCT01193153|467604127|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
129902394|NCT01193153|467604128|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
129902395|NCT01193153|467604127|FG000|Open-label Lead in Period|Adverse Event|41|||
129902396|NCT01193153|467604128|FG001|Open-label Lead in Period|Adverse Event|0|||
129845590|NCT00280566|467395230|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
129845591|NCT00280566|467395231|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
129845592|NCT00280566|467395229|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
129845593|NCT00280566|467395230|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
129845594|NCT00280566|467395231|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
129845595|NCT00280566|467395229|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
129845596|NCT00280566|467395230|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
129845597|NCT00280566|467395231|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
129845598|NCT00280566|467395229|FG000|Period 2 Double Blind|Adverse Event|0|||
129845599|NCT00280566|467395230|FG001|Period 2 Double Blind|Adverse Event|11|||
129845600|NCT00280566|467395231|FG002|Period 2 Double Blind|Adverse Event|15|||
129902397|NCT01193153|467604127|FG000|Open-label Lead in Period|Death|1|||
129902398|NCT01193153|467604128|FG001|Open-label Lead in Period|Death|0|||
129845601|NCT00280566|467395229|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
129845602|NCT00280566|467395230|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
129845603|NCT00280566|467395231|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
129845604|NCT00280566|467395229|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
129845605|NCT00280566|467395230|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
129845606|NCT00280566|467395231|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
129845607|NCT00280566|467395229|FG000|Period 2 Double Blind|miscellaneous|0|||
129845608|NCT00280566|467395230|FG001|Period 2 Double Blind|miscellaneous|10|||
129845609|NCT00280566|467395231|FG002|Period 2 Double Blind|miscellaneous|5|||
129845610|NCT00353366|467395232|FG000|Overall Study|Adverse Event|8|||
129845611|NCT00353366|467395232|FG000|Overall Study|Protocol Violation|12|||
129845612|NCT00353366|467395232|FG000|Overall Study|Withdrawal by Subject|12|||
129845613|NCT00353366|467395232|FG000|Overall Study|Lost to Follow-up|92|||
129845614|NCT00353366|467395232|FG000|Overall Study|Other|19|||
129845615|NCT01302392|467395235|FG000|Overall Study|Lost to Follow-up|1|||
129845616|NCT01302392|467395236|FG001|Overall Study|Lost to Follow-up|0|||
129845617|NCT01302392|467395235|FG000|Overall Study|Withdrawal by Subject|6|||
129845618|NCT01302392|467395236|FG001|Overall Study|Withdrawal by Subject|1|||
129845619|NCT00259857|467395237|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
129845620|NCT00259857|467395238|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
129845621|NCT00259857|467395237|FG000|24 Months Treatment|Lost to Follow-up|0|||
129845622|NCT00259857|467395238|FG001|24 Months Treatment|Lost to Follow-up|3|||
129845623|NCT01813019|467395243|FG000|Overall Study|Adverse Event|0|||
129845624|NCT01813019|467395244|FG001|Overall Study|Adverse Event|3|||
129845625|NCT01813019|467395243|FG000|Overall Study|Withdrawal by Subject|3|||
129845626|NCT01813019|467395244|FG001|Overall Study|Withdrawal by Subject|2|||
129845627|NCT01813019|467395243|FG000|Overall Study|administrative problems|2|||
129845628|NCT01813019|467395244|FG001|Overall Study|administrative problems|0|||
129845629|NCT01813019|467395243|FG000|Overall Study|Protocol Deviation|2|||
129845630|NCT01813019|467395244|FG001|Overall Study|Protocol Deviation|1|||
129845631|NCT03025828|467395249|FG000|Overall Study|Lost to Follow-up|1|||
129845632|NCT01020019|467395250|FG000|Overall Study|Lost to Follow-up|21|||
129845633|NCT01020019|467395251|FG001|Overall Study|Lost to Follow-up|18|||
129845634|NCT01020019|467395250|FG000|Overall Study|Adverse Event|1|||
129845635|NCT01020019|467395251|FG001|Overall Study|Adverse Event|5|||
129845636|NCT01020019|467395250|FG000|Overall Study|not interested in treatment|4|||
129845637|NCT01020019|467395251|FG001|Overall Study|not interested in treatment|4|||
129902399|NCT01193153|467604127|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
129902400|NCT01193153|467604128|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
129845638|NCT01020019|467395250|FG000|Overall Study|moving|0|||
129845639|NCT01020019|467395251|FG001|Overall Study|moving|2|||
129845640|NCT04958109|467395252|FG000|Overall Study|Withdrawal by Subject|0|||
129902401|NCT01193153|467604127|FG000|Open-label Stabilization Period|Adverse Event|9|||
129902402|NCT01193153|467604128|FG001|Open-label Stabilization Period|Adverse Event|0|||
129902403|NCT01193153|467604127|FG000|Open-label Stabilization Period|Death|2|||
129902404|NCT01193153|467604128|FG001|Open-label Stabilization Period|Death|0|||
129902405|NCT01193153|467604127|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
129902406|NCT01193153|467604128|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
129902407|NCT01193153|467604127|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
129902408|NCT01193153|467604128|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
129902409|NCT01193153|467604127|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
129902410|NCT01193153|467604128|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
129845641|NCT04958109|467395253|FG001|Overall Study|Withdrawal by Subject|1|||
129845642|NCT04958109|467395252|FG000|Overall Study|Lost to Follow-up|0|||
129845643|NCT04958109|467395253|FG001|Overall Study|Lost to Follow-up|1|||
129845644|NCT02214121|467395254|FG000|Part A|Patient decision|2|||
129845645|NCT02214121|467395255|FG001|Part A|Patient decision|0|||
129845646|NCT02214121|467395256|FG002|Part A|Patient decision|0|||
129845647|NCT02214121|467395254|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
129845648|NCT02214121|467395255|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
129845649|NCT02214121|467395256|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
129845650|NCT02214121|467395254|FG000|Part A|Other|1|||
129845651|NCT02214121|467395255|FG001|Part A|Other|0|||
129845652|NCT02214121|467395256|FG002|Part A|Other|0|||
129845653|NCT02214121|467395254|FG000|Part B|Patient decision|0|||
129902411|NCT01193153|467604127|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
129845654|NCT02214121|467395255|FG001|Part B|Patient decision|1|||
129845655|NCT02214121|467395256|FG002|Part B|Patient decision|0|||
129845656|NCT02214121|467395254|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
129845657|NCT02214121|467395255|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
129845658|NCT02214121|467395256|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
129845659|NCT02214121|467395254|FG000|Part B|Lost to Follow-up|0|||
129902412|NCT01193153|467604128|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
129845660|NCT02214121|467395255|FG001|Part B|Lost to Follow-up|0|||
129845661|NCT02214121|467395256|FG002|Part B|Lost to Follow-up|1|||
129902413|NCT01193153|467604127|FG000|Open-label Stabilization Period|Other|8|||
129902414|NCT01193153|467604128|FG001|Open-label Stabilization Period|Other|0|||
129845662|NCT00715793|467395257|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
129845663|NCT00715793|467395258|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
129845664|NCT00715793|467395257|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
129845665|NCT00715793|467395258|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
129845666|NCT01559311|467395259|FG000|Overall Study|Protocol Violation|0|||
129845667|NCT01559311|467395260|FG001|Overall Study|Protocol Violation|0|||
129845668|NCT01559311|467395261|FG002|Overall Study|Protocol Violation|2|||
129845669|NCT01559311|467395259|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
129845670|NCT01559311|467395260|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
129845671|NCT01559311|467395261|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
129845672|NCT01559311|467395259|FG000|Overall Study|Withdrawal by Subject|2|||
129845673|NCT01559311|467395260|FG001|Overall Study|Withdrawal by Subject|1|||
129845674|NCT01559311|467395261|FG002|Overall Study|Withdrawal by Subject|0|||
129845675|NCT01559311|467395259|FG000|Overall Study|Death|0|||
129845676|NCT01559311|467395260|FG001|Overall Study|Death|2|||
129845677|NCT01559311|467395261|FG002|Overall Study|Death|3|||
129845678|NCT01559311|467395259|FG000|Overall Study|Lost to Follow-up|0|||
129845679|NCT01559311|467395260|FG001|Overall Study|Lost to Follow-up|3|||
129845680|NCT01559311|467395261|FG002|Overall Study|Lost to Follow-up|2|||
129845681|NCT01559311|467395259|FG000|Overall Study|Adverse Event|0|||
129845682|NCT01559311|467395260|FG001|Overall Study|Adverse Event|0|||
129845683|NCT01559311|467395261|FG002|Overall Study|Adverse Event|1|||
129845684|NCT01849588|467395262|FG000|Overall Study|Lack of Efficacy|3|||
129845685|NCT02143843|467395264|FG000|Overall Study|Adverse Event|8|||
129845686|NCT02143843|467395264|FG000|Overall Study|Lack of Efficacy|2|||
129845687|NCT02143843|467395264|FG000|Overall Study|Withdrawal by Subject|2|||
129845688|NCT01462357|467395268|FG000|Overall Study|Death|0|||
129845689|NCT01462357|467395269|FG001|Overall Study|Death|0|||
129845690|NCT01462357|467395270|FG002|Overall Study|Death|1|||
129845691|NCT01462357|467395268|FG000|Overall Study|Withdrawal by Subject|3|||
129845692|NCT01462357|467395269|FG001|Overall Study|Withdrawal by Subject|11|||
129845693|NCT01462357|467395270|FG002|Overall Study|Withdrawal by Subject|3|||
129845694|NCT01462357|467395268|FG000|Overall Study|Migrated/moved from study area|2|||
129845695|NCT01462357|467395269|FG001|Overall Study|Migrated/moved from study area|3|||
129845696|NCT01462357|467395270|FG002|Overall Study|Migrated/moved from study area|1|||
129845697|NCT01462357|467395268|FG000|Overall Study|Lost to Follow-up|3|||
129845698|NCT01462357|467395269|FG001|Overall Study|Lost to Follow-up|5|||
129845699|NCT01462357|467395270|FG002|Overall Study|Lost to Follow-up|7|||
129845700|NCT01482767|467395272|FG000|Overall Study|Death|1|||
129845701|NCT01482767|467395273|FG001|Overall Study|Death|1|||
129845702|NCT01482767|467395272|FG000|Overall Study|Withdrawal by Subject|7|||
129845703|NCT01482767|467395273|FG001|Overall Study|Withdrawal by Subject|5|||
129845704|NCT01482767|467395272|FG000|Overall Study|Lost to Follow-up|12|||
129845705|NCT01482767|467395273|FG001|Overall Study|Lost to Follow-up|6|||
129845706|NCT01482767|467395272|FG000|Overall Study|Adverse Event|0|||
129845707|NCT01482767|467395273|FG001|Overall Study|Adverse Event|3|||
129845708|NCT01482767|467395272|FG000|Overall Study|Site closure|22|||
129845709|NCT01482767|467395273|FG001|Overall Study|Site closure|14|||
129845710|NCT01482767|467395272|FG000|Overall Study|Non-adherence to study requirements|4|||
129845711|NCT01482767|467395273|FG001|Overall Study|Non-adherence to study requirements|7|||
129845712|NCT01482767|467395272|FG000|Overall Study|Alternate HCV treatment|7|||
129845713|NCT01482767|467395273|FG001|Overall Study|Alternate HCV treatment|8|||
129845714|NCT01482767|467395272|FG000|Overall Study|Ineligible|0|||
129845715|NCT01482767|467395273|FG001|Overall Study|Ineligible|5|||
129845716|NCT01482767|467395272|FG000|Overall Study|Nurse error|1|||
129845717|NCT01482767|467395273|FG001|Overall Study|Nurse error|0|||
129845718|NCT00025883|467395274|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
129845719|NCT00025883|467395274|FG000|Overall Study|no baseline data|1|||
129845720|NCT00025883|467395274|FG000|Overall Study|Death|1|||
129845721|NCT00025883|467395274|FG000|Overall Study|Adverse Event|1|||
129845722|NCT00025883|467395274|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
129845723|NCT02908529|467395276|FG000|Overall Study|Lost to Follow-up|0|||
129845724|NCT02908529|467395277|FG001|Overall Study|Lost to Follow-up|2|||
129845725|NCT02553421|467395278|FG000|Overall Study|Lost to Follow-up|21|||
129845726|NCT02553421|467395279|FG001|Overall Study|Lost to Follow-up|1|||
129845727|NCT02553421|467395278|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
129845728|NCT02553421|467395279|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
129845729|NCT02553421|467395278|FG000|Overall Study|Improper Device Placement|3|||
129845730|NCT02553421|467395279|FG001|Overall Study|Improper Device Placement|0|||
129845731|NCT04197713|467395282|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
129845732|NCT04197713|467395283|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
129845733|NCT05569954|467395284|FG000|Overall Study|Lost to Follow-up|3|||
129845734|NCT05569954|467395285|FG001|Overall Study|Lost to Follow-up|4|||
129845735|NCT05569954|467395284|FG000|Overall Study|Protocol Violation|1|||
129845736|NCT05569954|467395285|FG001|Overall Study|Protocol Violation|2|||
129845737|NCT05569954|467395284|FG000|Overall Study|Withdrawal by Subject|4|||
129845738|NCT05569954|467395285|FG001|Overall Study|Withdrawal by Subject|2|||
129902415|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Other|2|||
129902416|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Other|3|||
129902417|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
129902418|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
129902419|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Death|2|||
129902420|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Death|0|||
129902421|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
129902422|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
129902423|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
129902424|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
129902425|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
129902426|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
129902427|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
129902428|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
129902429|NCT01193153|467604127|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
129902430|NCT01193153|467604128|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
129902431|NCT01648140|467604129|FG000|Overall Study|Physician Decision|1|||
129902432|NCT01648140|467604130|FG001|Overall Study|Physician Decision|0|||
129902433|NCT01648140|467604131|FG002|Overall Study|Physician Decision|0|||
129902434|NCT01648140|467604132|FG003|Overall Study|Physician Decision|0|||
129449596|NCT00467779|465945625|FG002|Stage 2A|Withdrawal by Subject|0|||
129449597|NCT00467779|465945626|FG003|Stage 2A|Withdrawal by Subject|0|||
129449598|NCT00467779|465945627|FG004|Stage 2A|Withdrawal by Subject|0|||
129449599|NCT00467779|465945628|FG005|Stage 2A|Withdrawal by Subject|0|||
129449600|NCT00467779|465945629|FG006|Stage 2A|Withdrawal by Subject|0|||
129845739|NCT01660412|467395286|FG000|Overall Study|Protocol Violation|0|||
129845740|NCT01660412|467395287|FG001|Overall Study|Protocol Violation|3|||
129845741|NCT03013491|467395288|FG000|Main Study|Death|2|||
129902435|NCT01648140|467604129|FG000|Overall Study|Lack of Efficacy|4|||
129902436|NCT01648140|467604130|FG001|Overall Study|Lack of Efficacy|7|||
129902437|NCT01648140|467604131|FG002|Overall Study|Lack of Efficacy|1|||
129902438|NCT01648140|467604132|FG003|Overall Study|Lack of Efficacy|0|||
129902439|NCT01648140|467604129|FG000|Overall Study|Adverse Event|3|||
129902440|NCT01648140|467604130|FG001|Overall Study|Adverse Event|1|||
129902441|NCT01648140|467604131|FG002|Overall Study|Adverse Event|2|||
129902442|NCT01648140|467604132|FG003|Overall Study|Adverse Event|0|||
129902443|NCT01648140|467604129|FG000|Overall Study|Withdrawal by Subject|2|||
129902444|NCT01648140|467604130|FG001|Overall Study|Withdrawal by Subject|3|||
129845742|NCT03013491|467395289|FG001|Main Study|Death|2|||
129845743|NCT03013491|467395290|FG002|Main Study|Death|5|||
129845744|NCT03013491|467395291|FG003|Main Study|Death|3|||
129845745|NCT03013491|467395292|FG004|Main Study|Death|9|||
129845746|NCT03013491|467395293|FG005|Main Study|Death|12|||
129845747|NCT03013491|467395294|FG006|Main Study|Death|3|||
129845748|NCT03013491|467395295|FG007|Main Study|Death|5|||
129845749|NCT03013491|467395296|FG008|Main Study|Death|1|||
129845750|NCT03013491|467395297|FG009|Main Study|Death|2|||
129845751|NCT03013491|467395298|FG010|Main Study|Death|4|||
129845752|NCT03013491|467395299|FG011|Main Study|Death|1|||
129845753|NCT03013491|467395300|FG012|Main Study|Death|1|||
129845754|NCT03013491|467395301|FG013|Main Study|Death|4|||
129845755|NCT03013491|467395302|FG014|Main Study|Death|0|||
129845756|NCT03013491|467395303|FG015|Main Study|Death|3|||
129845757|NCT03013491|467395304|FG016|Main Study|Death|5|||
129845758|NCT03013491|467395305|FG017|Main Study|Death|1|||
129845759|NCT03013491|467395306|FG018|Main Study|Death|47|||
129845760|NCT03013491|467395288|FG000|Main Study|Lost to Follow-up|0|||
129845761|NCT03013491|467395289|FG001|Main Study|Lost to Follow-up|0|||
129845762|NCT03013491|467395290|FG002|Main Study|Lost to Follow-up|1|||
129845763|NCT03013491|467395291|FG003|Main Study|Lost to Follow-up|0|||
129845764|NCT03013491|467395292|FG004|Main Study|Lost to Follow-up|1|||
129845765|NCT03013491|467395293|FG005|Main Study|Lost to Follow-up|0|||
129902445|NCT01648140|467604131|FG002|Overall Study|Withdrawal by Subject|3|||
129902446|NCT01648140|467604132|FG003|Overall Study|Withdrawal by Subject|2|||
129902447|NCT01648140|467604129|FG000|Overall Study|Lost to Follow-up|2|||
129902448|NCT01648140|467604130|FG001|Overall Study|Lost to Follow-up|1|||
129902449|NCT01648140|467604131|FG002|Overall Study|Lost to Follow-up|2|||
129902450|NCT01648140|467604132|FG003|Overall Study|Lost to Follow-up|0|||
129902451|NCT00716144|467604137|FG000|Overall Study|Withdrawal by Subject|4|||
129902452|NCT00716144|467604138|FG001|Overall Study|Withdrawal by Subject|2|||
129902453|NCT00716144|467604139|FG002|Overall Study|Withdrawal by Subject|6|||
129449601|NCT00467779|465945630|FG007|Stage 2A|Withdrawal by Subject|0|||
129845766|NCT03013491|467395294|FG006|Main Study|Lost to Follow-up|0|||
129845767|NCT03013491|467395295|FG007|Main Study|Lost to Follow-up|0|||
129845768|NCT03013491|467395296|FG008|Main Study|Lost to Follow-up|0|||
129845769|NCT03013491|467395297|FG009|Main Study|Lost to Follow-up|0|||
129845770|NCT03013491|467395298|FG010|Main Study|Lost to Follow-up|0|||
129845771|NCT03013491|467395299|FG011|Main Study|Lost to Follow-up|0|||
129845772|NCT03013491|467395300|FG012|Main Study|Lost to Follow-up|0|||
129845773|NCT03013491|467395301|FG013|Main Study|Lost to Follow-up|0|||
129845774|NCT03013491|467395302|FG014|Main Study|Lost to Follow-up|0|||
129845775|NCT03013491|467395303|FG015|Main Study|Lost to Follow-up|0|||
129845776|NCT03013491|467395304|FG016|Main Study|Lost to Follow-up|0|||
129845777|NCT03013491|467395305|FG017|Main Study|Lost to Follow-up|0|||
129845778|NCT03013491|467395306|FG018|Main Study|Lost to Follow-up|3|||
129845779|NCT03013491|467395288|FG000|Main Study|Termination of the study by Sponsor|0|||
129845780|NCT03013491|467395289|FG001|Main Study|Termination of the study by Sponsor|0|||
129845781|NCT03013491|467395290|FG002|Main Study|Termination of the study by Sponsor|2|||
129845782|NCT03013491|467395291|FG003|Main Study|Termination of the study by Sponsor|0|||
129845783|NCT03013491|467395292|FG004|Main Study|Termination of the study by Sponsor|1|||
129845784|NCT03013491|467395293|FG005|Main Study|Termination of the study by Sponsor|2|||
129845785|NCT03013491|467395294|FG006|Main Study|Termination of the study by Sponsor|0|||
129845786|NCT03013491|467395295|FG007|Main Study|Termination of the study by Sponsor|0|||
129845787|NCT03013491|467395296|FG008|Main Study|Termination of the study by Sponsor|1|||
129845788|NCT03013491|467395297|FG009|Main Study|Termination of the study by Sponsor|1|||
129845789|NCT03013491|467395298|FG010|Main Study|Termination of the study by Sponsor|1|||
129845790|NCT03013491|467395299|FG011|Main Study|Termination of the study by Sponsor|2|||
129845791|NCT03013491|467395300|FG012|Main Study|Termination of the study by Sponsor|0|||
129845792|NCT03013491|467395301|FG013|Main Study|Termination of the study by Sponsor|0|||
129845793|NCT03013491|467395302|FG014|Main Study|Termination of the study by Sponsor|0|||
129845794|NCT03013491|467395303|FG015|Main Study|Termination of the study by Sponsor|0|||
129845795|NCT03013491|467395304|FG016|Main Study|Termination of the study by Sponsor|0|||
129845796|NCT03013491|467395305|FG017|Main Study|Termination of the study by Sponsor|1|||
129845797|NCT03013491|467395306|FG018|Main Study|Termination of the study by Sponsor|13|||
129845798|NCT03013491|467395288|FG000|Main Study|Withdrawal by Subject|0|||
129845799|NCT03013491|467395289|FG001|Main Study|Withdrawal by Subject|0|||
129845800|NCT03013491|467395290|FG002|Main Study|Withdrawal by Subject|0|||
129845801|NCT03013491|467395291|FG003|Main Study|Withdrawal by Subject|4|||
129845802|NCT03013491|467395292|FG004|Main Study|Withdrawal by Subject|2|||
129845803|NCT03013491|467395293|FG005|Main Study|Withdrawal by Subject|1|||
129845804|NCT03013491|467395294|FG006|Main Study|Withdrawal by Subject|0|||
129845805|NCT03013491|467395295|FG007|Main Study|Withdrawal by Subject|0|||
129845806|NCT03013491|467395296|FG008|Main Study|Withdrawal by Subject|0|||
129845807|NCT03013491|467395297|FG009|Main Study|Withdrawal by Subject|0|||
129845808|NCT03013491|467395298|FG010|Main Study|Withdrawal by Subject|1|||
129845809|NCT03013491|467395299|FG011|Main Study|Withdrawal by Subject|2|||
129845810|NCT03013491|467395300|FG012|Main Study|Withdrawal by Subject|0|||
129845811|NCT03013491|467395301|FG013|Main Study|Withdrawal by Subject|2|||
129845812|NCT03013491|467395302|FG014|Main Study|Withdrawal by Subject|0|||
129845813|NCT03013491|467395303|FG015|Main Study|Withdrawal by Subject|0|||
129845814|NCT03013491|467395304|FG016|Main Study|Withdrawal by Subject|0|||
129845815|NCT03013491|467395305|FG017|Main Study|Withdrawal by Subject|0|||
129845816|NCT03013491|467395306|FG018|Main Study|Withdrawal by Subject|18|||
129845817|NCT03013491|467395288|FG000|Main Study|Disease progression|0|||
129845818|NCT03013491|467395289|FG001|Main Study|Disease progression|0|||
129845819|NCT03013491|467395290|FG002|Main Study|Disease progression|0|||
129845820|NCT03013491|467395291|FG003|Main Study|Disease progression|1|||
129845821|NCT03013491|467395292|FG004|Main Study|Disease progression|0|||
129845822|NCT03013491|467395293|FG005|Main Study|Disease progression|0|||
129845823|NCT03013491|467395294|FG006|Main Study|Disease progression|0|||
129845824|NCT03013491|467395295|FG007|Main Study|Disease progression|0|||
129845825|NCT03013491|467395296|FG008|Main Study|Disease progression|1|||
129845826|NCT03013491|467395297|FG009|Main Study|Disease progression|0|||
129845827|NCT03013491|467395298|FG010|Main Study|Disease progression|1|||
129845828|NCT03013491|467395299|FG011|Main Study|Disease progression|0|||
129845829|NCT03013491|467395300|FG012|Main Study|Disease progression|0|||
129845830|NCT03013491|467395301|FG013|Main Study|Disease progression|0|||
129845831|NCT03013491|467395302|FG014|Main Study|Disease progression|0|||
129845832|NCT03013491|467395303|FG015|Main Study|Disease progression|0|||
129845833|NCT03013491|467395304|FG016|Main Study|Disease progression|0|||
129845834|NCT03013491|467395305|FG017|Main Study|Disease progression|0|||
129845835|NCT03013491|467395306|FG018|Main Study|Disease progression|4|||
129845836|NCT03013491|467395288|FG000|Main Study|Symptomatic deterioration|0|||
129845837|NCT03013491|467395289|FG001|Main Study|Symptomatic deterioration|0|||
129845838|NCT03013491|467395290|FG002|Main Study|Symptomatic deterioration|0|||
129845839|NCT03013491|467395291|FG003|Main Study|Symptomatic deterioration|0|||
129845840|NCT03013491|467395292|FG004|Main Study|Symptomatic deterioration|0|||
129845841|NCT03013491|467395293|FG005|Main Study|Symptomatic deterioration|1|||
129845842|NCT03013491|467395294|FG006|Main Study|Symptomatic deterioration|0|||
129845843|NCT03013491|467395295|FG007|Main Study|Symptomatic deterioration|0|||
129845844|NCT03013491|467395296|FG008|Main Study|Symptomatic deterioration|0|||
129845845|NCT03013491|467395297|FG009|Main Study|Symptomatic deterioration|0|||
129845846|NCT03013491|467395298|FG010|Main Study|Symptomatic deterioration|0|||
129845847|NCT03013491|467395299|FG011|Main Study|Symptomatic deterioration|0|||
129845848|NCT03013491|467395300|FG012|Main Study|Symptomatic deterioration|0|||
129845849|NCT03013491|467395301|FG013|Main Study|Symptomatic deterioration|0|||
129845850|NCT03013491|467395302|FG014|Main Study|Symptomatic deterioration|0|||
129845851|NCT03013491|467395303|FG015|Main Study|Symptomatic deterioration|0|||
129845852|NCT03013491|467395304|FG016|Main Study|Symptomatic deterioration|0|||
129845853|NCT03013491|467395305|FG017|Main Study|Symptomatic deterioration|0|||
129845854|NCT03013491|467395306|FG018|Main Study|Symptomatic deterioration|0|||
129845855|NCT03013491|467395288|FG000|Main Study|Protocol version 8.0 approval|0|||
129845856|NCT03013491|467395289|FG001|Main Study|Protocol version 8.0 approval|0|||
129845857|NCT03013491|467395290|FG002|Main Study|Protocol version 8.0 approval|0|||
129845858|NCT03013491|467395291|FG003|Main Study|Protocol version 8.0 approval|0|||
129845859|NCT03013491|467395292|FG004|Main Study|Protocol version 8.0 approval|0|||
129845860|NCT03013491|467395293|FG005|Main Study|Protocol version 8.0 approval|0|||
129845861|NCT03013491|467395294|FG006|Main Study|Protocol version 8.0 approval|0|||
129845862|NCT03013491|467395295|FG007|Main Study|Protocol version 8.0 approval|0|||
129845863|NCT03013491|467395296|FG008|Main Study|Protocol version 8.0 approval|0|||
129845864|NCT03013491|467395297|FG009|Main Study|Protocol version 8.0 approval|0|||
129845865|NCT03013491|467395298|FG010|Main Study|Protocol version 8.0 approval|1|||
129845866|NCT03013491|467395299|FG011|Main Study|Protocol version 8.0 approval|0|||
129845867|NCT03013491|467395300|FG012|Main Study|Protocol version 8.0 approval|0|||
129845868|NCT03013491|467395301|FG013|Main Study|Protocol version 8.0 approval|0|||
129845869|NCT03013491|467395302|FG014|Main Study|Protocol version 8.0 approval|0|||
129845870|NCT03013491|467395303|FG015|Main Study|Protocol version 8.0 approval|0|||
129902454|NCT00716144|467604140|FG003|Overall Study|Withdrawal by Subject|6|||
129845871|NCT03013491|467395304|FG016|Main Study|Protocol version 8.0 approval|0|||
129845872|NCT03013491|467395305|FG017|Main Study|Protocol version 8.0 approval|0|||
129845873|NCT03013491|467395306|FG018|Main Study|Protocol version 8.0 approval|0|||
129845874|NCT03013491|467395288|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
129845875|NCT03013491|467395289|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
129845876|NCT03013491|467395290|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
129845877|NCT03013491|467395291|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
129845878|NCT03013491|467395292|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
129845879|NCT03013491|467395293|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
129845880|NCT03013491|467395294|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
129845881|NCT03013491|467395295|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
129845882|NCT03013491|467395296|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
129845883|NCT03013491|467395297|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
129845884|NCT03013491|467395298|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
129845885|NCT03013491|467395299|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
129845886|NCT03013491|467395300|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
129845887|NCT03013491|467395301|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
129845888|NCT03013491|467395302|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
129845889|NCT03013491|467395303|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
129845890|NCT03013491|467395304|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
129845891|NCT03013491|467395305|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
129902455|NCT00716144|467604137|FG000|Overall Study|Lost to Follow-up|2|||
129902456|NCT00716144|467604138|FG001|Overall Study|Lost to Follow-up|2|||
129902457|NCT00716144|467604139|FG002|Overall Study|Lost to Follow-up|1|||
129902458|NCT00716144|467604140|FG003|Overall Study|Lost to Follow-up|2|||
129902459|NCT00716144|467604137|FG000|Overall Study|Adverse Event|0|||
129902460|NCT00716144|467604138|FG001|Overall Study|Adverse Event|0|||
129902461|NCT00716144|467604139|FG002|Overall Study|Adverse Event|0|||
129902462|NCT00716144|467604140|FG003|Overall Study|Adverse Event|2|||
129902463|NCT00716144|467604137|FG000|Overall Study|Non-compliance|1|||
129902464|NCT00716144|467604138|FG001|Overall Study|Non-compliance|0|||
129902465|NCT00716144|467604139|FG002|Overall Study|Non-compliance|0|||
129902466|NCT00716144|467604140|FG003|Overall Study|Non-compliance|0|||
129845892|NCT03013491|467395306|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
129845893|NCT03013491|467395288|FG000|Main Study|Start of new anticancer therapy|0|||
129845894|NCT03013491|467395289|FG001|Main Study|Start of new anticancer therapy|0|||
129845895|NCT03013491|467395290|FG002|Main Study|Start of new anticancer therapy|0|||
129845896|NCT03013491|467395291|FG003|Main Study|Start of new anticancer therapy|0|||
129845897|NCT03013491|467395292|FG004|Main Study|Start of new anticancer therapy|0|||
129902467|NCT00716144|467604137|FG000|Overall Study|Protocol Violation|2|||
129902468|NCT00716144|467604138|FG001|Overall Study|Protocol Violation|0|||
129902469|NCT00716144|467604139|FG002|Overall Study|Protocol Violation|1|||
129902470|NCT00716144|467604140|FG003|Overall Study|Protocol Violation|0|||
129902471|NCT00716144|467604137|FG000|Overall Study|Physician Decision|0|||
129902472|NCT00716144|467604138|FG001|Overall Study|Physician Decision|1|||
129902473|NCT00716144|467604139|FG002|Overall Study|Physician Decision|2|||
129902474|NCT00716144|467604140|FG003|Overall Study|Physician Decision|2|||
129902475|NCT00716144|467604137|FG000|Overall Study|Intercurrent illness|0|||
129902476|NCT00716144|467604138|FG001|Overall Study|Intercurrent illness|0|||
129902477|NCT00716144|467604139|FG002|Overall Study|Intercurrent illness|1|||
129902478|NCT00716144|467604140|FG003|Overall Study|Intercurrent illness|0|||
129902479|NCT00716144|467604137|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
129902480|NCT00716144|467604138|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
129902481|NCT00716144|467604139|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
129902482|NCT00716144|467604140|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
129845898|NCT03013491|467395293|FG005|Main Study|Start of new anticancer therapy|0|||
129845899|NCT03013491|467395294|FG006|Main Study|Start of new anticancer therapy|0|||
129845900|NCT03013491|467395295|FG007|Main Study|Start of new anticancer therapy|0|||
129845901|NCT03013491|467395296|FG008|Main Study|Start of new anticancer therapy|0|||
129845902|NCT03013491|467395297|FG009|Main Study|Start of new anticancer therapy|0|||
129845903|NCT03013491|467395298|FG010|Main Study|Start of new anticancer therapy|0|||
129845904|NCT03013491|467395299|FG011|Main Study|Start of new anticancer therapy|0|||
129845905|NCT03013491|467395300|FG012|Main Study|Start of new anticancer therapy|0|||
129845906|NCT03013491|467395301|FG013|Main Study|Start of new anticancer therapy|0|||
129845907|NCT03013491|467395302|FG014|Main Study|Start of new anticancer therapy|0|||
129845908|NCT03013491|467395303|FG015|Main Study|Start of new anticancer therapy|0|||
129845909|NCT03013491|467395304|FG016|Main Study|Start of new anticancer therapy|0|||
129845910|NCT03013491|467395305|FG017|Main Study|Start of new anticancer therapy|0|||
129845911|NCT03013491|467395306|FG018|Main Study|Start of new anticancer therapy|2|||
129845912|NCT03013491|467395288|FG000|Long-term Extension|Disease progression|0|||
129845913|NCT03013491|467395289|FG001|Long-term Extension|Disease progression|0|||
129845914|NCT03013491|467395290|FG002|Long-term Extension|Disease progression|0|||
129845915|NCT03013491|467395291|FG003|Long-term Extension|Disease progression|1|||
129845916|NCT03013491|467395292|FG004|Long-term Extension|Disease progression|0|||
129845917|NCT03013491|467395293|FG005|Long-term Extension|Disease progression|0|||
129845918|NCT03013491|467395294|FG006|Long-term Extension|Disease progression|0|||
129845919|NCT03013491|467395295|FG007|Long-term Extension|Disease progression|0|||
129845920|NCT03013491|467395296|FG008|Long-term Extension|Disease progression|0|||
129845921|NCT03013491|467395297|FG009|Long-term Extension|Disease progression|0|||
129845922|NCT03013491|467395298|FG010|Long-term Extension|Disease progression|0|||
129845923|NCT03013491|467395299|FG011|Long-term Extension|Disease progression|0|||
129845924|NCT03013491|467395300|FG012|Long-term Extension|Disease progression|0|||
129845925|NCT03013491|467395301|FG013|Long-term Extension|Disease progression|0|||
129845926|NCT03013491|467395302|FG014|Long-term Extension|Disease progression|0|||
129902483|NCT00716144|467604137|FG000|Overall Study|Adverse event: left foot pain|0|||
129902484|NCT00716144|467604138|FG001|Overall Study|Adverse event: left foot pain|1|||
129902485|NCT00716144|467604139|FG002|Overall Study|Adverse event: left foot pain|0|||
129902486|NCT00716144|467604140|FG003|Overall Study|Adverse event: left foot pain|0|||
129902487|NCT00716144|467604137|FG000|Overall Study|Clinical Depression|0|||
129902488|NCT00716144|467604138|FG001|Overall Study|Clinical Depression|1|||
129902489|NCT00716144|467604139|FG002|Overall Study|Clinical Depression|0|||
129902490|NCT00716144|467604140|FG003|Overall Study|Clinical Depression|0|||
129902491|NCT02950558|467604141|FG000|Overall Study|Lost to Follow-up|2|||
129902492|NCT02950558|467604142|FG001|Overall Study|Lost to Follow-up|0|||
129902493|NCT01321606|467604145|FG000|Overall Study|Lost to Follow-up|0|||
129902494|NCT01321606|467604146|FG001|Overall Study|Lost to Follow-up|0|||
129902495|NCT01321606|467604147|FG002|Overall Study|Lost to Follow-up|0|||
129902496|NCT01321606|467604148|FG003|Overall Study|Lost to Follow-up|1|||
129902497|NCT00756730|467604153|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
129902498|NCT00756730|467604154|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
129902499|NCT00756730|467604153|FG000|Overall Study|persistent low-level viremmia|0|||
129902500|NCT00756730|467604154|FG001|Overall Study|persistent low-level viremmia|1|||
129902501|NCT01161498|467604156|FG000|Overall Study|Disease Progression|0|||
129902502|NCT01161498|467604157|FG001|Overall Study|Disease Progression|1|||
129902503|NCT05686421|467604158|FG000|Overall Study|Screen failure|22|||
129902504|NCT05686421|467604159|FG001|Overall Study|Screen failure|0|||
129902505|NCT05686421|467604160|FG002|Overall Study|Screen failure|0|||
129902506|NCT05686421|467604161|FG003|Overall Study|Screen failure|0|||
129902507|NCT00367055|467604165|FG000|Overall Study|Adverse Event|6|||
129902508|NCT00367055|467604166|FG001|Overall Study|Adverse Event|3|||
129845927|NCT03013491|467395303|FG015|Long-term Extension|Disease progression|0|||
129845928|NCT03013491|467395304|FG016|Long-term Extension|Disease progression|0|||
129845929|NCT03013491|467395305|FG017|Long-term Extension|Disease progression|0|||
129845930|NCT03013491|467395306|FG018|Long-term Extension|Disease progression|1|||
129845931|NCT03013491|467395288|FG000|Long-term Extension|Withdrawal by Subject|0|||
129902509|NCT00367055|467604165|FG000|Overall Study|Patient's Willing|3|||
129845932|NCT03013491|467395289|FG001|Long-term Extension|Withdrawal by Subject|0|||
129902510|NCT00367055|467604166|FG001|Overall Study|Patient's Willing|2|||
129902511|NCT00367055|467604165|FG000|Overall Study|Lack of Efficacy|1|||
129902512|NCT00367055|467604166|FG001|Overall Study|Lack of Efficacy|2|||
129902513|NCT00367055|467604165|FG000|Overall Study|Lost to Follow-up|1|||
129902514|NCT00367055|467604166|FG001|Overall Study|Lost to Follow-up|1|||
129902515|NCT00367055|467604165|FG000|Overall Study|Protocol Violation|0|||
129902516|NCT00367055|467604166|FG001|Overall Study|Protocol Violation|1|||
129902517|NCT00367055|467604165|FG000|Overall Study|Stopping Criterion Met|0|||
129902518|NCT00367055|467604166|FG001|Overall Study|Stopping Criterion Met|1|||
129902519|NCT00367055|467604165|FG000|Overall Study|Participant Living too Far from Hospital|0|||
129902520|NCT00367055|467604166|FG001|Overall Study|Participant Living too Far from Hospital|1|||
129845933|NCT03013491|467395290|FG002|Long-term Extension|Withdrawal by Subject|0|||
129845934|NCT03013491|467395291|FG003|Long-term Extension|Withdrawal by Subject|0|||
129845935|NCT03013491|467395292|FG004|Long-term Extension|Withdrawal by Subject|0|||
129845936|NCT03013491|467395293|FG005|Long-term Extension|Withdrawal by Subject|0|||
129845937|NCT03013491|467395294|FG006|Long-term Extension|Withdrawal by Subject|0|||
129845938|NCT03013491|467395295|FG007|Long-term Extension|Withdrawal by Subject|1|||
129845939|NCT03013491|467395296|FG008|Long-term Extension|Withdrawal by Subject|0|||
129845940|NCT03013491|467395297|FG009|Long-term Extension|Withdrawal by Subject|0|||
129845941|NCT03013491|467395298|FG010|Long-term Extension|Withdrawal by Subject|0|||
129845942|NCT03013491|467395299|FG011|Long-term Extension|Withdrawal by Subject|0|||
129845943|NCT03013491|467395300|FG012|Long-term Extension|Withdrawal by Subject|0|||
129845944|NCT03013491|467395301|FG013|Long-term Extension|Withdrawal by Subject|0|||
129845945|NCT03013491|467395302|FG014|Long-term Extension|Withdrawal by Subject|0|||
129845946|NCT03013491|467395303|FG015|Long-term Extension|Withdrawal by Subject|0|||
129845947|NCT03013491|467395304|FG016|Long-term Extension|Withdrawal by Subject|0|||
129845948|NCT03013491|467395305|FG017|Long-term Extension|Withdrawal by Subject|0|||
129845949|NCT03013491|467395306|FG018|Long-term Extension|Withdrawal by Subject|0|||
129845950|NCT03013491|467395288|FG000|Long-term Extension|Adverse Event|0|||
129845951|NCT03013491|467395289|FG001|Long-term Extension|Adverse Event|0|||
129845952|NCT03013491|467395290|FG002|Long-term Extension|Adverse Event|0|||
129845953|NCT03013491|467395291|FG003|Long-term Extension|Adverse Event|0|||
129845954|NCT03013491|467395292|FG004|Long-term Extension|Adverse Event|0|||
129845955|NCT03013491|467395293|FG005|Long-term Extension|Adverse Event|0|||
129845956|NCT03013491|467395294|FG006|Long-term Extension|Adverse Event|0|||
129845957|NCT03013491|467395295|FG007|Long-term Extension|Adverse Event|0|||
129845958|NCT03013491|467395296|FG008|Long-term Extension|Adverse Event|0|||
129845959|NCT03013491|467395297|FG009|Long-term Extension|Adverse Event|0|||
129845960|NCT03013491|467395298|FG010|Long-term Extension|Adverse Event|0|||
129902521|NCT02517307|467604181|FG000|Overall Study|Withdrawal by Subject|1|||
129902522|NCT02517307|467604182|FG001|Overall Study|Withdrawal by Subject|0|||
129902523|NCT02517307|467604183|FG002|Overall Study|Withdrawal by Subject|1|||
129902524|NCT02517307|467604184|FG003|Overall Study|Withdrawal by Subject|0|||
129902525|NCT02517307|467604181|FG000|Overall Study|Protocol Violation|0|||
129902526|NCT02517307|467604182|FG001|Overall Study|Protocol Violation|0|||
129902527|NCT02517307|467604183|FG002|Overall Study|Protocol Violation|1|||
129902528|NCT02517307|467604184|FG003|Overall Study|Protocol Violation|1|||
129902529|NCT00823979|467604185|FG000|Overall Study|Lack of Efficacy|13|||
129902530|NCT00823979|467604186|FG001|Overall Study|Lack of Efficacy|16|||
129902531|NCT00823979|467604187|FG002|Overall Study|Lack of Efficacy|9|||
129902532|NCT00823979|467604185|FG000|Overall Study|Lost to Follow-up|2|||
129902533|NCT00823979|467604186|FG001|Overall Study|Lost to Follow-up|1|||
129902534|NCT00823979|467604187|FG002|Overall Study|Lost to Follow-up|0|||
129902535|NCT00823979|467604185|FG000|Overall Study|Withdrawal by Subject|2|||
129902536|NCT00823979|467604186|FG001|Overall Study|Withdrawal by Subject|3|||
129902537|NCT00823979|467604187|FG002|Overall Study|Withdrawal by Subject|2|||
129902538|NCT00823979|467604185|FG000|Overall Study|Protocol Violation|1|||
129902539|NCT00823979|467604186|FG001|Overall Study|Protocol Violation|1|||
129902540|NCT00823979|467604187|FG002|Overall Study|Protocol Violation|0|||
129902541|NCT00823979|467604185|FG000|Overall Study|Pregnancy|0|||
129902542|NCT00823979|467604186|FG001|Overall Study|Pregnancy|1|||
129902543|NCT00823979|467604187|FG002|Overall Study|Pregnancy|0|||
129902544|NCT00823979|467604185|FG000|Overall Study|Adverse Event|0|||
129902545|NCT00823979|467604186|FG001|Overall Study|Adverse Event|2|||
129902546|NCT00823979|467604187|FG002|Overall Study|Adverse Event|4|||
129902547|NCT00823979|467604185|FG000|Overall Study|Other|2|||
129902548|NCT00823979|467604186|FG001|Overall Study|Other|0|||
129902549|NCT00823979|467604187|FG002|Overall Study|Other|1|||
129902550|NCT00823979|467604185|FG000|Overall Study|Randomized but not Treated|4|||
129902551|NCT00823979|467604186|FG001|Overall Study|Randomized but not Treated|3|||
129902552|NCT00823979|467604187|FG002|Overall Study|Randomized but not Treated|1|||
129902553|NCT00823979|467604185|FG000|Overall Study|Study Terminated by Sponsor|5|||
129902554|NCT00823979|467604186|FG001|Overall Study|Study Terminated by Sponsor|5|||
129902555|NCT00823979|467604187|FG002|Overall Study|Study Terminated by Sponsor|7|||
129902556|NCT02781584|467604188|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
129902557|NCT02781584|467604189|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
129902558|NCT02781584|467604190|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
129845961|NCT03013491|467395299|FG011|Long-term Extension|Adverse Event|0|||
129845962|NCT03013491|467395300|FG012|Long-term Extension|Adverse Event|0|||
129845963|NCT03013491|467395301|FG013|Long-term Extension|Adverse Event|0|||
129845964|NCT03013491|467395302|FG014|Long-term Extension|Adverse Event|0|||
129845965|NCT03013491|467395303|FG015|Long-term Extension|Adverse Event|0|||
129902559|NCT02781584|467604191|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
129902560|NCT02781584|467604192|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
129902561|NCT02781584|467604193|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
129902562|NCT02781584|467604194|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
129902563|NCT02781584|467604195|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
129902564|NCT02781584|467604196|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
129902565|NCT02781584|467604197|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
129902566|NCT02781584|467604198|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
129902567|NCT02781584|467604199|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
129902568|NCT02781584|467604200|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
129902569|NCT02781584|467604188|FG000|Pre-treatment Phase|Adverse Event|0|||
129902570|NCT02781584|467604189|FG001|Pre-treatment Phase|Adverse Event|0|||
129902571|NCT02781584|467604190|FG002|Pre-treatment Phase|Adverse Event|0|||
129902572|NCT02781584|467604191|FG003|Pre-treatment Phase|Adverse Event|0|||
129902573|NCT02781584|467604192|FG004|Pre-treatment Phase|Adverse Event|0|||
129902574|NCT02781584|467604193|FG005|Pre-treatment Phase|Adverse Event|0|||
129902575|NCT02781584|467604194|FG006|Pre-treatment Phase|Adverse Event|0|||
129902576|NCT02781584|467604195|FG007|Pre-treatment Phase|Adverse Event|0|||
129902577|NCT02781584|467604196|FG008|Pre-treatment Phase|Adverse Event|0|||
129902578|NCT02781584|467604197|FG009|Pre-treatment Phase|Adverse Event|0|||
129902579|NCT02781584|467604198|FG010|Pre-treatment Phase|Adverse Event|0|||
129902580|NCT02781584|467604199|FG011|Pre-treatment Phase|Adverse Event|1|||
129902581|NCT02781584|467604200|FG012|Pre-treatment Phase|Adverse Event|0|||
129902582|NCT02781584|467604188|FG000|Treatment Phase|Withdrew Consent|0|||
129902583|NCT02781584|467604189|FG001|Treatment Phase|Withdrew Consent|0|||
129902584|NCT02781584|467604190|FG002|Treatment Phase|Withdrew Consent|0|||
129902585|NCT02781584|467604191|FG003|Treatment Phase|Withdrew Consent|0|||
129902586|NCT02781584|467604192|FG004|Treatment Phase|Withdrew Consent|0|||
129902587|NCT02781584|467604193|FG005|Treatment Phase|Withdrew Consent|1|||
129902588|NCT02781584|467604194|FG006|Treatment Phase|Withdrew Consent|0|||
129902589|NCT02781584|467604195|FG007|Treatment Phase|Withdrew Consent|0|||
129902590|NCT02781584|467604196|FG008|Treatment Phase|Withdrew Consent|0|||
129902591|NCT02781584|467604197|FG009|Treatment Phase|Withdrew Consent|0|||
129902592|NCT02781584|467604198|FG010|Treatment Phase|Withdrew Consent|1|||
129902593|NCT02781584|467604199|FG011|Treatment Phase|Withdrew Consent|2|||
129902594|NCT02781584|467604200|FG012|Treatment Phase|Withdrew Consent|0|||
129902595|NCT02781584|467604188|FG000|Treatment Phase|Adverse Event|0|||
129902596|NCT02781584|467604189|FG001|Treatment Phase|Adverse Event|0|||
129902597|NCT02781584|467604190|FG002|Treatment Phase|Adverse Event|0|||
129902598|NCT02781584|467604191|FG003|Treatment Phase|Adverse Event|0|||
129902599|NCT02781584|467604192|FG004|Treatment Phase|Adverse Event|0|||
129902600|NCT02781584|467604193|FG005|Treatment Phase|Adverse Event|0|||
129902601|NCT02781584|467604194|FG006|Treatment Phase|Adverse Event|0|||
129902602|NCT02781584|467604195|FG007|Treatment Phase|Adverse Event|1|||
129902603|NCT02781584|467604196|FG008|Treatment Phase|Adverse Event|0|||
129902604|NCT02781584|467604197|FG009|Treatment Phase|Adverse Event|0|||
129902605|NCT02781584|467604198|FG010|Treatment Phase|Adverse Event|0|||
129902606|NCT02781584|467604199|FG011|Treatment Phase|Adverse Event|0|||
129902607|NCT02781584|467604200|FG012|Treatment Phase|Adverse Event|0|||
129902608|NCT00038103|467604205|FG000|Overall Study|Adverse Event|5|||
129902609|NCT00038103|467604206|FG001|Overall Study|Adverse Event|6|||
129902610|NCT00038103|467604205|FG000|Overall Study|Lack of Efficacy|48|||
129902611|NCT00038103|467604206|FG001|Overall Study|Lack of Efficacy|41|||
129902612|NCT00038103|467604205|FG000|Overall Study|Withdrawal by Subject|0|||
129902613|NCT00038103|467604206|FG001|Overall Study|Withdrawal by Subject|3|||
129902614|NCT00038103|467604205|FG000|Overall Study|Lost to Follow-up|0|||
129902615|NCT00038103|467604206|FG001|Overall Study|Lost to Follow-up|3|||
129902616|NCT00038103|467604205|FG000|Overall Study|Protocol Violation|0|||
129902617|NCT00038103|467604206|FG001|Overall Study|Protocol Violation|2|||
129902618|NCT00038103|467604205|FG000|Overall Study|Sponsor Decision|0|||
129902619|NCT00038103|467604206|FG001|Overall Study|Sponsor Decision|1|||
129902620|NCT00038103|467604205|FG000|Overall Study|Randomized/never treated|2|||
129902621|NCT00038103|467604206|FG001|Overall Study|Randomized/never treated|0|||
129902622|NCT00208767|467604209|FG000|Overall Study|Adverse Event|9|||
129902623|NCT00208767|467604210|FG001|Overall Study|Adverse Event|1|||
129902624|NCT00208767|467604209|FG000|Overall Study|Withdrawal by Subject|14|||
129902625|NCT00208767|467604210|FG001|Overall Study|Withdrawal by Subject|3|||
129902626|NCT00208767|467604209|FG000|Overall Study|Death|1|||
129902627|NCT00208767|467604210|FG001|Overall Study|Death|0|||
129902628|NCT00208767|467604209|FG000|Overall Study|Lost to Follow-up|3|||
129902629|NCT00208767|467604210|FG001|Overall Study|Lost to Follow-up|3|||
129902630|NCT03545984|467604211|FG000|Overall Study|CSF cases not present during rotation|11|||
129902631|NCT03545984|467604212|FG001|Overall Study|CSF cases not present during rotation|9|||
129902632|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
129902633|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
129902634|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
129902635|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902636|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902637|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129845966|NCT03013491|467395304|FG016|Long-term Extension|Adverse Event|0|||
129845967|NCT03013491|467395305|FG017|Long-term Extension|Adverse Event|0|||
129845968|NCT03013491|467395306|FG018|Long-term Extension|Adverse Event|1|||
129845969|NCT03013491|467395288|FG000|Long-term Extension|Death|0|||
129845970|NCT03013491|467395289|FG001|Long-term Extension|Death|0|||
129845971|NCT03013491|467395290|FG002|Long-term Extension|Death|0|||
129845972|NCT03013491|467395291|FG003|Long-term Extension|Death|0|||
129845973|NCT03013491|467395292|FG004|Long-term Extension|Death|0|||
129845974|NCT03013491|467395293|FG005|Long-term Extension|Death|0|||
129845975|NCT03013491|467395294|FG006|Long-term Extension|Death|0|||
129845976|NCT03013491|467395295|FG007|Long-term Extension|Death|0|||
129845977|NCT03013491|467395296|FG008|Long-term Extension|Death|0|||
129845978|NCT03013491|467395297|FG009|Long-term Extension|Death|0|||
129845979|NCT03013491|467395298|FG010|Long-term Extension|Death|0|||
129845980|NCT03013491|467395299|FG011|Long-term Extension|Death|0|||
129845981|NCT03013491|467395300|FG012|Long-term Extension|Death|0|||
129845982|NCT03013491|467395301|FG013|Long-term Extension|Death|0|||
129845983|NCT03013491|467395302|FG014|Long-term Extension|Death|0|||
129845984|NCT03013491|467395303|FG015|Long-term Extension|Death|0|||
129845985|NCT03013491|467395304|FG016|Long-term Extension|Death|0|||
129845986|NCT03013491|467395305|FG017|Long-term Extension|Death|0|||
129845987|NCT03013491|467395306|FG018|Long-term Extension|Death|1|||
129845988|NCT03238911|467395309|FG000|Overall Study|Withdrawal by Subject|1|||
129845989|NCT03238911|467395310|FG001|Overall Study|Withdrawal by Subject|2|||
129845990|NCT03238911|467395309|FG000|Overall Study|Lost to Follow-up|2|||
129845991|NCT03238911|467395310|FG001|Overall Study|Lost to Follow-up|1|||
129845992|NCT02239536|467395311|FG000|Overall Study|Non-neoplastic polyp|23|||
129845993|NCT02239536|467395312|FG001|Overall Study|Non-neoplastic polyp|17|||
129845994|NCT01038778|467395316|FG000|Overall Study|Withdrawal by Subject|0|||
129845995|NCT01038778|467395317|FG001|Overall Study|Withdrawal by Subject|2|||
129845996|NCT01038778|467395318|FG002|Overall Study|Withdrawal by Subject|3|||
129845997|NCT04740034|467395319|FG000|Overall Study|Death|0|||
129845998|NCT04740034|467395320|FG001|Overall Study|Death|1|||
129845999|NCT04740034|467395321|FG002|Overall Study|Death|2|||
129846000|NCT04740034|467395322|FG003|Overall Study|Death|3|||
129846001|NCT04740034|467395323|FG004|Overall Study|Death|4|||
129846002|NCT04740034|467395324|FG005|Overall Study|Death|4|||
129846003|NCT04740034|467395325|FG006|Overall Study|Death|2|||
129846004|NCT04740034|467395326|FG007|Overall Study|Death|2|||
129846005|NCT04740034|467395327|FG008|Overall Study|Death|2|||
129902638|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902639|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902640|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129902641|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
129902642|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
129902643|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
129902644|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902645|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902646|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902647|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902648|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902649|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129902650|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
129902651|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
129902652|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
129902653|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902654|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902655|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902656|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902657|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902658|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129902659|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
129902660|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902661|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
129846006|NCT04740034|467395328|FG009|Overall Study|Death|4|||
129846007|NCT04740034|467395329|FG010|Overall Study|Death|0|||
129846008|NCT04740034|467395319|FG000|Overall Study|Lost to Follow-up|0|||
129846009|NCT04740034|467395320|FG001|Overall Study|Lost to Follow-up|0|||
129846010|NCT04740034|467395321|FG002|Overall Study|Lost to Follow-up|0|||
129846011|NCT04740034|467395322|FG003|Overall Study|Lost to Follow-up|1|||
129846012|NCT04740034|467395323|FG004|Overall Study|Lost to Follow-up|2|||
129846013|NCT04740034|467395324|FG005|Overall Study|Lost to Follow-up|2|||
129846014|NCT04740034|467395325|FG006|Overall Study|Lost to Follow-up|0|||
129846015|NCT04740034|467395326|FG007|Overall Study|Lost to Follow-up|0|||
129846016|NCT04740034|467395327|FG008|Overall Study|Lost to Follow-up|0|||
129846017|NCT04740034|467395328|FG009|Overall Study|Lost to Follow-up|1|||
129902662|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902663|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902664|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902665|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902666|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902667|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129902668|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129902669|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129902670|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
129902671|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902672|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902673|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902674|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902675|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902676|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129902677|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902678|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129902679|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129902680|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902681|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902682|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902683|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902684|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902685|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129902686|NCT01212757|467604214|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
129902687|NCT01212757|467604215|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
129902688|NCT01212757|467604216|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902689|NCT01212757|467604217|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902690|NCT01212757|467604218|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902691|NCT01212757|467604219|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902692|NCT01212757|467604220|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902693|NCT01212757|467604221|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902694|NCT01212757|467604222|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129902695|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902696|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
129902697|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
129902698|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
129902699|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902700|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
129902701|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902702|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902703|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
129902704|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902705|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
129902706|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
129902707|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
129902708|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902709|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
129902710|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902711|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902712|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
129902713|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902714|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902715|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
129902716|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902717|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902718|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902719|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902720|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902721|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
129902722|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902723|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
129902724|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
129902725|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
129846018|NCT04740034|467395329|FG010|Overall Study|Lost to Follow-up|0|||
129846019|NCT04740034|467395319|FG000|Overall Study|Withdrawal by Subject|1|||
129846020|NCT04740034|467395320|FG001|Overall Study|Withdrawal by Subject|0|||
129846021|NCT04740034|467395321|FG002|Overall Study|Withdrawal by Subject|0|||
129846022|NCT04740034|467395322|FG003|Overall Study|Withdrawal by Subject|0|||
129846023|NCT04740034|467395323|FG004|Overall Study|Withdrawal by Subject|0|||
129846024|NCT04740034|467395324|FG005|Overall Study|Withdrawal by Subject|0|||
129846025|NCT04740034|467395325|FG006|Overall Study|Withdrawal by Subject|0|||
129846026|NCT04740034|467395326|FG007|Overall Study|Withdrawal by Subject|1|||
129846027|NCT04740034|467395327|FG008|Overall Study|Withdrawal by Subject|0|||
129846028|NCT04740034|467395328|FG009|Overall Study|Withdrawal by Subject|1|||
129846029|NCT04740034|467395329|FG010|Overall Study|Withdrawal by Subject|0|||
129846030|NCT04740034|467395319|FG000|Overall Study|Decision by sponsor|0|||
129846031|NCT04740034|467395320|FG001|Overall Study|Decision by sponsor|0|||
129846032|NCT04740034|467395321|FG002|Overall Study|Decision by sponsor|1|||
129846033|NCT04740034|467395322|FG003|Overall Study|Decision by sponsor|0|||
129846034|NCT04740034|467395323|FG004|Overall Study|Decision by sponsor|0|||
129846035|NCT04740034|467395324|FG005|Overall Study|Decision by sponsor|0|||
129846036|NCT04740034|467395325|FG006|Overall Study|Decision by sponsor|1|||
129846037|NCT04740034|467395326|FG007|Overall Study|Decision by sponsor|2|||
129846038|NCT04740034|467395327|FG008|Overall Study|Decision by sponsor|1|||
129846039|NCT04740034|467395328|FG009|Overall Study|Decision by sponsor|1|||
129846040|NCT04740034|467395329|FG010|Overall Study|Decision by sponsor|2|||
129846041|NCT04524403|467396922|FG000|Overall Study|Withdrawal by Subject|10|||
129846042|NCT04524403|467396923|FG001|Overall Study|Withdrawal by Subject|3|||
129846043|NCT04524403|467396924|FG002|Overall Study|Withdrawal by Subject|8|||
129846044|NCT04524403|467396922|FG000|Overall Study|Lost to Follow-up|3|||
129846045|NCT04524403|467396923|FG001|Overall Study|Lost to Follow-up|4|||
129846046|NCT04524403|467396924|FG002|Overall Study|Lost to Follow-up|3|||
129846047|NCT04524403|467396922|FG000|Overall Study|Adverse Event|3|||
129846048|NCT04524403|467396923|FG001|Overall Study|Adverse Event|1|||
129846049|NCT04524403|467396924|FG002|Overall Study|Adverse Event|4|||
129846050|NCT04524403|467396922|FG000|Overall Study|Non-compliant with study drug|1|||
129846051|NCT04524403|467396923|FG001|Overall Study|Non-compliant with study drug|2|||
129846052|NCT04524403|467396924|FG002|Overall Study|Non-compliant with study drug|3|||
129846053|NCT04524403|467396922|FG000|Overall Study|Moved|0|||
129846054|NCT04524403|467396923|FG001|Overall Study|Moved|1|||
129846055|NCT04524403|467396924|FG002|Overall Study|Moved|0|||
129846056|NCT02649972|467396932|FG000|Overall Study|Not treated|1|||
129846057|NCT03394391|467396933|FG000|Overall Study|Lost to Follow-up|1|||
129846058|NCT03394391|467396934|FG001|Overall Study|Lost to Follow-up|2|||
129846059|NCT00519649|467396935|FG000|Overall Study|Withdrawal by Subject|1|||
129846060|NCT04879745|467396936|FG000|Overall Study|Lost to Follow-up|4|||
129846061|NCT04879745|467396937|FG001|Overall Study|Lost to Follow-up|1|||
129846062|NCT03592641|467396940|FG000|Overall Study|Withdrawal by Subject|1|||
129846063|NCT00436280|467396941|FG000|Period 1: Induction|Adverse Event|8|||
129846064|NCT00436280|467396941|FG000|Period 1: Induction|Progressive Disease|12|||
129846065|NCT00436280|467396941|FG000|Period 1: Induction|Stable Disease|6|||
129846066|NCT00436280|467396941|FG000|Period 1: Induction|Withdrawal by Subject|1|||
129846067|NCT00436280|467396941|FG000|Period 1: Induction|Death|1|||
129846068|NCT00436280|467396941|FG000|Period 2: Consolidation|Adverse Event|1|||
129846069|NCT00436280|467396941|FG000|Period 2: Consolidation|Progressive Disease|10|||
129846070|NCT00436280|467396941|FG000|Period 2: Consolidation|Stable Disease|1|||
129846071|NCT00436280|467396941|FG000|Period 2: Consolidation|Physician Decision|2|||
129846072|NCT00436280|467396941|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
129846073|NCT00436280|467396941|FG000|Period 2: Consolidation|Death|1|||
129846074|NCT00436280|467396941|FG000|Period 3: Maintenance|Adverse Event|6|||
129846075|NCT00436280|467396941|FG000|Period 3: Maintenance|Progressive Disease|12|||
129846076|NCT01049919|467396944|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
129846077|NCT01049919|467396945|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
129846078|NCT01049919|467396944|FG000|Overall Study|Withdrawal by Subject|5|||
129846079|NCT01049919|467396945|FG001|Overall Study|Withdrawal by Subject|0|||
129846080|NCT01049919|467396944|FG000|Overall Study|Lost to Follow-up|6|||
129846081|NCT01049919|467396945|FG001|Overall Study|Lost to Follow-up|1|||
129846082|NCT01049919|467396944|FG000|Overall Study|Physician Decision|2|||
129846083|NCT01049919|467396945|FG001|Overall Study|Physician Decision|0|||
129846084|NCT01049919|467396944|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
129846085|NCT01049919|467396945|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
129846086|NCT01049919|467396944|FG000|Overall Study|Early study termination by sponsor.|2|||
129846087|NCT01049919|467396945|FG001|Overall Study|Early study termination by sponsor.|0|||
129846088|NCT01513291|467396950|FG000|Treatment Period|Adverse Event|8|||
129846089|NCT01513291|467396951|FG001|Treatment Period|Adverse Event|4|||
129846090|NCT01513291|467396952|FG002|Treatment Period|Adverse Event|0|||
129846091|NCT01513291|467396953|FG003|Treatment Period|Adverse Event|0|||
129846092|NCT01513291|467396954|FG004|Treatment Period|Adverse Event|0|||
129846093|NCT01513291|467396950|FG000|Treatment Period|Lack of Efficacy|3|||
129846094|NCT01513291|467396951|FG001|Treatment Period|Lack of Efficacy|0|||
129846095|NCT01513291|467396952|FG002|Treatment Period|Lack of Efficacy|0|||
129846096|NCT01513291|467396953|FG003|Treatment Period|Lack of Efficacy|0|||
129846097|NCT01513291|467396954|FG004|Treatment Period|Lack of Efficacy|0|||
129846098|NCT01513291|467396950|FG000|Treatment Period|Lost to Follow-up|2|||
129846099|NCT01513291|467396951|FG001|Treatment Period|Lost to Follow-up|3|||
129846100|NCT01513291|467396952|FG002|Treatment Period|Lost to Follow-up|0|||
129846101|NCT01513291|467396953|FG003|Treatment Period|Lost to Follow-up|0|||
129846102|NCT01513291|467396954|FG004|Treatment Period|Lost to Follow-up|0|||
129846103|NCT01513291|467396950|FG000|Treatment Period|Physician Decision|1|||
129846104|NCT01513291|467396951|FG001|Treatment Period|Physician Decision|0|||
129846105|NCT01513291|467396952|FG002|Treatment Period|Physician Decision|0|||
129846106|NCT01513291|467396953|FG003|Treatment Period|Physician Decision|0|||
129846107|NCT01513291|467396954|FG004|Treatment Period|Physician Decision|0|||
129846108|NCT01513291|467396950|FG000|Treatment Period|Protocol Violation|1|||
129846109|NCT01513291|467396951|FG001|Treatment Period|Protocol Violation|2|||
129846110|NCT01513291|467396952|FG002|Treatment Period|Protocol Violation|0|||
129846111|NCT01513291|467396953|FG003|Treatment Period|Protocol Violation|0|||
129846112|NCT01513291|467396954|FG004|Treatment Period|Protocol Violation|0|||
129846113|NCT01513291|467396950|FG000|Treatment Period|Withdrawal by Subject|8|||
129846114|NCT01513291|467396951|FG001|Treatment Period|Withdrawal by Subject|5|||
129846115|NCT01513291|467396952|FG002|Treatment Period|Withdrawal by Subject|0|||
129846116|NCT01513291|467396953|FG003|Treatment Period|Withdrawal by Subject|0|||
129846117|NCT01513291|467396954|FG004|Treatment Period|Withdrawal by Subject|0|||
129846118|NCT01513291|467396950|FG000|Treatment Period|Randomized not treated|0|||
129846119|NCT01513291|467396951|FG001|Treatment Period|Randomized not treated|2|||
129846120|NCT01513291|467396952|FG002|Treatment Period|Randomized not treated|0|||
129846121|NCT01513291|467396953|FG003|Treatment Period|Randomized not treated|0|||
129846122|NCT01513291|467396954|FG004|Treatment Period|Randomized not treated|0|||
129846123|NCT01513291|467396950|FG000|Run-out Period|Lost to Follow-up|0|||
129846124|NCT01513291|467396951|FG001|Run-out Period|Lost to Follow-up|0|||
129846125|NCT01513291|467396952|FG002|Run-out Period|Lost to Follow-up|0|||
129846126|NCT01513291|467396953|FG003|Run-out Period|Lost to Follow-up|1|||
129846127|NCT01513291|467396954|FG004|Run-out Period|Lost to Follow-up|0|||
129846128|NCT01513291|467396950|FG000|Run-out Period|Withdrawal by Subject|0|||
129846129|NCT01513291|467396951|FG001|Run-out Period|Withdrawal by Subject|0|||
129846130|NCT01513291|467396952|FG002|Run-out Period|Withdrawal by Subject|0|||
129846131|NCT01513291|467396953|FG003|Run-out Period|Withdrawal by Subject|1|||
129846132|NCT01513291|467396954|FG004|Run-out Period|Withdrawal by Subject|0|||
129846133|NCT03217136|467396955|FG000|Overall Study|Lost to Follow-up|2|||
129846134|NCT03217136|467396956|FG001|Overall Study|Lost to Follow-up|1|||
129846135|NCT03217136|467396955|FG000|Overall Study|Site Randomized Participant in Error|0|||
129846136|NCT03217136|467396956|FG001|Overall Study|Site Randomized Participant in Error|1|||
129846137|NCT03217136|467396955|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
129846138|NCT03217136|467396956|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
129846139|NCT03217136|467396955|FG000|Overall Study|Dispensing Error|1|||
129846140|NCT03217136|467396956|FG001|Overall Study|Dispensing Error|0|||
129846141|NCT03217136|467396955|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129846142|NCT03217136|467396956|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129846143|NCT03192150|467396957|FG000|Overall Study|Adverse Event|14|||
129846144|NCT03192150|467396958|FG001|Overall Study|Adverse Event|12|||
129846145|NCT03192150|467396957|FG000|Overall Study|Lack of Efficacy|23|||
129846146|NCT03192150|467396958|FG001|Overall Study|Lack of Efficacy|30|||
129846147|NCT03192150|467396957|FG000|Overall Study|Lost to Follow-up|1|||
129846148|NCT03192150|467396958|FG001|Overall Study|Lost to Follow-up|1|||
129846149|NCT03192150|467396957|FG000|Overall Study|Withdrawal by Subject|4|||
129846150|NCT03192150|467396958|FG001|Overall Study|Withdrawal by Subject|2|||
129846151|NCT03192150|467396957|FG000|Overall Study|Protocol Violation|5|||
129846152|NCT03192150|467396958|FG001|Overall Study|Protocol Violation|2|||
129846153|NCT03192150|467396957|FG000|Overall Study|Surgery Canceled|6|||
129846154|NCT03192150|467396958|FG001|Overall Study|Surgery Canceled|2|||
129846155|NCT03192150|467396957|FG000|Overall Study|Other-Various Administrative Reasons|2|||
129846156|NCT03192150|467396958|FG001|Overall Study|Other-Various Administrative Reasons|5|||
129846157|NCT02579616|467396959|FG000|Overall Study|Participants did not receive treatment|3|||
129846158|NCT00482391|467396960|FG000|Overall Study|Withdrawal by Subject|1|||
129846159|NCT00482391|467396960|FG000|Overall Study|Adverse Event|1|||
129846160|NCT00482391|467396960|FG000|Overall Study|Death|1|||
129846161|NCT01448850|467396961|FG000|Overall Study|Death|3|||
129846162|NCT01448850|467396962|FG001|Overall Study|Death|6|||
129846163|NCT01448850|467396961|FG000|Overall Study|Withdrawal by Subject|13|||
129846164|NCT01448850|467396962|FG001|Overall Study|Withdrawal by Subject|21|||
129846165|NCT01448850|467396961|FG000|Overall Study|Lost to Follow-up|3|||
129846166|NCT01448850|467396962|FG001|Overall Study|Lost to Follow-up|1|||
129846167|NCT01448850|467396961|FG000|Overall Study|Other|15|||
129846168|NCT01448850|467396962|FG001|Overall Study|Other|12|||
129846169|NCT02939404|467396965|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
129902726|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
129902727|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
129902728|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902729|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902730|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
129902731|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902732|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
129902733|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902734|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902735|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
129902736|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902737|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902738|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902739|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
129902740|NCT01212757|467604214|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902741|NCT01212757|467604215|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
129902742|NCT01212757|467604216|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
129902743|NCT01212757|467604217|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902744|NCT01212757|467604218|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902745|NCT01212757|467604219|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902746|NCT01212757|467604220|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902747|NCT01212757|467604221|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902748|NCT01212757|467604222|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
129902749|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902750|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902751|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902752|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902753|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902754|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902755|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902756|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
129902757|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
129902758|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902759|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
129902760|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
129902761|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902762|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902763|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902764|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
129902765|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
129902766|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
129902767|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902768|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
129902769|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
129902770|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902771|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902772|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902773|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902774|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
129902775|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
129902776|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902777|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
129902778|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
129902779|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902780|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902781|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902782|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129902783|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
129902784|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
129902785|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902786|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902787|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
129902788|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902789|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902790|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902791|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902792|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902793|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
129902794|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902795|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
129902796|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
129902797|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902798|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902799|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902800|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902801|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
129902802|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
129902803|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902804|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
129902805|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
129902806|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902807|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902808|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902809|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
129902810|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
129902811|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
129902812|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902813|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902814|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
129902815|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902816|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902817|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902818|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902819|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902820|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
129902821|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902822|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
129902823|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129902824|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902825|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902826|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902827|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129902828|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129902829|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129902830|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902831|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902832|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902833|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902834|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902835|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902836|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902837|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
129902838|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
129902839|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902840|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
129902841|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902842|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902843|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902844|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129846170|NCT02939404|467396966|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
129846171|NCT02939404|467396965|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
129846172|NCT02939404|467396966|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
129846173|NCT06640829|467396976|FG000|Overall Study|Withdrawal by Subject|1|||
129846174|NCT06640829|467396976|FG000|Overall Study|Lost to Follow-up|1|||
129846175|NCT01350128|467396986|FG000|Overall Study|Withdrawal by Subject|3|||
129846176|NCT01350128|467396986|FG000|Overall Study|Protocol discontinuation criteria|8|||
129846177|NCT01350128|467396986|FG000|Overall Study|Physician Decision|1|||
129846178|NCT01350128|467396986|FG000|Overall Study|Lost to Follow-up|2|||
129846179|NCT00261716|467396988|FG000|Overall Study|Withdrawal by Subject|6|||
129846180|NCT00261716|467396989|FG001|Overall Study|Withdrawal by Subject|8|||
129846181|NCT00261716|467396988|FG000|Overall Study|Lost to Follow-up|0|||
129846182|NCT00261716|467396989|FG001|Overall Study|Lost to Follow-up|2|||
129846183|NCT01147653|467396990|FG000|Year 2|Withdrawal by Subject|2|||
129846184|NCT01147653|467396991|FG001|Year 2|Withdrawal by Subject|3|||
129846185|NCT01109316|467396992|FG000|Study Period 1|Adverse Event|0|||
129846186|NCT01109316|467396993|FG001|Study Period 1|Adverse Event|0|||
129902845|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902846|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902847|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
129902848|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902849|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902850|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
129902851|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902852|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902853|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902854|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902855|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
129902856|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
129902857|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902858|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
129902859|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902860|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902861|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902862|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902863|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902864|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
129902865|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
129902866|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902867|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
129902868|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
129902869|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902870|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902871|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902872|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
129902873|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
129902874|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
129902875|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902876|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
129902877|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
129902878|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902879|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902880|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902881|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
129902882|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
129902883|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
129902884|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902885|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
129902886|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
129902887|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129846187|NCT01109316|467396994|FG002|Study Period 1|Adverse Event|1|||
129846188|NCT01109316|467396995|FG003|Study Period 1|Adverse Event|0|||
129846189|NCT01109316|467396996|FG004|Study Period 1|Adverse Event|0|||
129846190|NCT01109316|467396997|FG005|Study Period 1|Adverse Event|0|||
129846191|NCT01109316|467396992|FG000|Study Period 1|Lost to Follow-up|0|||
129846192|NCT01109316|467396993|FG001|Study Period 1|Lost to Follow-up|0|||
129846193|NCT01109316|467396994|FG002|Study Period 1|Lost to Follow-up|1|||
129846194|NCT01109316|467396995|FG003|Study Period 1|Lost to Follow-up|1|||
129846195|NCT01109316|467396996|FG004|Study Period 1|Lost to Follow-up|0|||
129846196|NCT01109316|467396997|FG005|Study Period 1|Lost to Follow-up|0|||
129846197|NCT01109316|467396992|FG000|Study Period 1|Withdrawal by Subject|0|||
129846198|NCT01109316|467396993|FG001|Study Period 1|Withdrawal by Subject|0|||
129846199|NCT01109316|467396994|FG002|Study Period 1|Withdrawal by Subject|1|||
129846200|NCT01109316|467396995|FG003|Study Period 1|Withdrawal by Subject|0|||
129846201|NCT01109316|467396996|FG004|Study Period 1|Withdrawal by Subject|2|||
129846202|NCT01109316|467396997|FG005|Study Period 1|Withdrawal by Subject|0|||
129846203|NCT01109316|467396992|FG000|Study Period 1|Sponsor Decision|0|||
129846204|NCT01109316|467396993|FG001|Study Period 1|Sponsor Decision|0|||
129846205|NCT01109316|467396994|FG002|Study Period 1|Sponsor Decision|0|||
129846206|NCT01109316|467396995|FG003|Study Period 1|Sponsor Decision|0|||
129846207|NCT01109316|467396996|FG004|Study Period 1|Sponsor Decision|0|||
129846208|NCT01109316|467396997|FG005|Study Period 1|Sponsor Decision|2|||
129846209|NCT01109316|467396992|FG000|Study Period 2|Entry Criteria Not Met|0|||
129846210|NCT01109316|467396993|FG001|Study Period 2|Entry Criteria Not Met|1|||
129846211|NCT01109316|467396994|FG002|Study Period 2|Entry Criteria Not Met|0|||
129846212|NCT01109316|467396995|FG003|Study Period 2|Entry Criteria Not Met|0|||
129846213|NCT01109316|467396996|FG004|Study Period 2|Entry Criteria Not Met|0|||
129846214|NCT01109316|467396997|FG005|Study Period 2|Entry Criteria Not Met|0|||
129846215|NCT01109316|467396992|FG000|Study Period 2|Physician Decision|0|||
129846216|NCT01109316|467396993|FG001|Study Period 2|Physician Decision|0|||
129902888|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902889|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902890|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129902891|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
129902892|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
129902893|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
129902894|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
129449602|NCT00467779|465945631|FG008|Stage 2A|Withdrawal by Subject|0|||
129449603|NCT00467779|465945632|FG009|Stage 2A|Withdrawal by Subject|0|||
129449604|NCT00467779|465945633|FG010|Stage 2A|Withdrawal by Subject|0|||
129449605|NCT00467779|465945634|FG011|Stage 2A|Withdrawal by Subject|0|||
129846217|NCT01109316|467396994|FG002|Study Period 2|Physician Decision|0|||
129846218|NCT01109316|467396995|FG003|Study Period 2|Physician Decision|1|||
129902895|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
129902896|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
129902897|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
129902898|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
129902899|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
129902900|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
129902901|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
129902902|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902903|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902904|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902905|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902906|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902907|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902908|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902909|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
129902910|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
129902911|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902912|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
129902913|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
129902914|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902915|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902916|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902917|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129902918|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129902919|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129902920|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902921|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
129902922|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
129902923|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902924|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902925|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902926|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902927|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
129902928|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
129902929|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902930|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
129902931|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
129902932|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902933|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902934|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902935|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
129902936|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
129846219|NCT01109316|467396996|FG004|Study Period 2|Physician Decision|0|||
129846220|NCT01109316|467396997|FG005|Study Period 2|Physician Decision|0|||
129846221|NCT01109316|467396992|FG000|Study Period 2|Protocol Violation|1|||
129846222|NCT01109316|467396993|FG001|Study Period 2|Protocol Violation|0|||
129846223|NCT01109316|467396994|FG002|Study Period 2|Protocol Violation|0|||
129846224|NCT01109316|467396995|FG003|Study Period 2|Protocol Violation|0|||
129902937|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
129902938|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902939|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
129902940|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902941|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902942|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902943|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129449606|NCT00467779|465945635|FG012|Stage 2A|Withdrawal by Subject|0|||
129846225|NCT01109316|467396996|FG004|Study Period 2|Protocol Violation|0|||
129846226|NCT01109316|467396997|FG005|Study Period 2|Protocol Violation|0|||
129846227|NCT01109316|467396992|FG000|Study Period 2|Withdrawal by Subject|0|||
129846228|NCT01109316|467396993|FG001|Study Period 2|Withdrawal by Subject|0|||
129846229|NCT01109316|467396994|FG002|Study Period 2|Withdrawal by Subject|1|||
129846230|NCT01109316|467396995|FG003|Study Period 2|Withdrawal by Subject|0|||
129846231|NCT01109316|467396996|FG004|Study Period 2|Withdrawal by Subject|0|||
129846232|NCT01109316|467396997|FG005|Study Period 2|Withdrawal by Subject|1|||
129846233|NCT01109316|467396992|FG000|Study Period 3|Lost to Follow-up|0|||
129846234|NCT01109316|467396993|FG001|Study Period 3|Lost to Follow-up|0|||
129846235|NCT01109316|467396994|FG002|Study Period 3|Lost to Follow-up|0|||
129902944|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902945|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902946|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
129902947|NCT01212757|467604214|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902948|NCT01212757|467604215|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
129902949|NCT01212757|467604216|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
129902950|NCT01212757|467604217|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902951|NCT01212757|467604218|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902952|NCT01212757|467604219|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902953|NCT01212757|467604220|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902954|NCT01212757|467604221|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902955|NCT01212757|467604222|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
129902956|NCT02812966|467604223|FG000|Overall Study|Death|1|||
129902957|NCT02812966|467604224|FG001|Overall Study|Death|0|||
129902958|NCT05147233|467606290|FG000|Overall Study|Adverse Event|0|||
129902959|NCT05147233|467606291|FG001|Overall Study|Adverse Event|1|||
129902960|NCT05147233|467606290|FG000|Overall Study|Lost to Follow-up|1|||
129902961|NCT05147233|467606291|FG001|Overall Study|Lost to Follow-up|1|||
129902962|NCT05147233|467606290|FG000|Overall Study|Protocol Violation|0|||
129902963|NCT05147233|467606291|FG001|Overall Study|Protocol Violation|1|||
129846236|NCT01109316|467396995|FG003|Study Period 3|Lost to Follow-up|0|||
129846237|NCT01109316|467396996|FG004|Study Period 3|Lost to Follow-up|1|||
129846238|NCT01109316|467396997|FG005|Study Period 3|Lost to Follow-up|0|||
129846239|NCT01109316|467396992|FG000|Study Period 3|Withdrawal by Subject|1|||
129846240|NCT01109316|467396993|FG001|Study Period 3|Withdrawal by Subject|0|||
129846241|NCT01109316|467396994|FG002|Study Period 3|Withdrawal by Subject|0|||
129846242|NCT01109316|467396995|FG003|Study Period 3|Withdrawal by Subject|0|||
129846243|NCT01109316|467396996|FG004|Study Period 3|Withdrawal by Subject|1|||
129846244|NCT01109316|467396997|FG005|Study Period 3|Withdrawal by Subject|0|||
129846245|NCT00670228|467396998|FG000|Overall Study|Adverse Event|1|||
129846246|NCT00670228|467396999|FG001|Overall Study|Adverse Event|0|||
129846247|NCT00670228|467396998|FG000|Overall Study|Death or MACE|0|||
129846248|NCT00670228|467396999|FG001|Overall Study|Death or MACE|1|||
129846249|NCT00670228|467396998|FG000|Overall Study|Not treated|2|||
129846250|NCT00670228|467396999|FG001|Overall Study|Not treated|2|||
129846251|NCT00670228|467396998|FG000|Overall Study|Not meeting the selection criteria|2|||
129846252|NCT00670228|467396999|FG001|Overall Study|Not meeting the selection criteria|0|||
129846253|NCT00094653|467397012|FG000|Overall Study|Death|306|||
129846254|NCT00094653|467397013|FG001|Overall Study|Death|100|||
129846255|NCT00094653|467397014|FG002|Overall Study|Death|119|||
129846256|NCT00094653|467397012|FG000|Overall Study|Subject Withdrew Consent|10|||
129846257|NCT00094653|467397013|FG001|Overall Study|Subject Withdrew Consent|2|||
129846258|NCT00094653|467397014|FG002|Overall Study|Subject Withdrew Consent|3|||
129846259|NCT00094653|467397012|FG000|Overall Study|Other|2|||
129846260|NCT00094653|467397013|FG001|Overall Study|Other|2|||
129846261|NCT00094653|467397014|FG002|Overall Study|Other|2|||
129846262|NCT00094653|467397012|FG000|Overall Study|Lost to Follow-up|3|||
129846263|NCT00094653|467397013|FG001|Overall Study|Lost to Follow-up|2|||
129846264|NCT00094653|467397014|FG002|Overall Study|Lost to Follow-up|1|||
129846265|NCT00094653|467397012|FG000|Overall Study|Protocol Violation|0|||
129846266|NCT00094653|467397013|FG001|Overall Study|Protocol Violation|0|||
129846267|NCT00094653|467397014|FG002|Overall Study|Protocol Violation|1|||
129846268|NCT03921411|467397015|FG000|Overall Study|Withdrawal by Subject|1|||
129846269|NCT03921411|467397015|FG000|Overall Study|Protocol Deviation|2|||
129846270|NCT03921411|467397015|FG000|Overall Study|Enrolled, but never treated|2|||
129846271|NCT01541826|467397018|FG000|Overall Study|Lost to Follow-up|2|||
129846272|NCT01541826|467397019|FG001|Overall Study|Lost to Follow-up|3|||
129846273|NCT01541826|467397020|FG002|Overall Study|Lost to Follow-up|0|||
129846274|NCT01541826|467397018|FG000|Overall Study|Withdrawal by Subject|2|||
129846275|NCT01541826|467397019|FG001|Overall Study|Withdrawal by Subject|0|||
129846276|NCT01541826|467397020|FG002|Overall Study|Withdrawal by Subject|0|||
129846277|NCT01365273|467397023|FG000|Overall Study|Lost to Follow-up|1|||
129846278|NCT01365273|467397024|FG001|Overall Study|Lost to Follow-up|0|||
129846279|NCT01365273|467397023|FG000|Overall Study|Protocol Violation|0|||
129846280|NCT01365273|467397024|FG001|Overall Study|Protocol Violation|1|||
129846281|NCT01365273|467397023|FG000|Overall Study|Physician Decision|1|||
129846282|NCT01365273|467397024|FG001|Overall Study|Physician Decision|0|||
129846283|NCT00854581|467397027|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
129846284|NCT00854581|467397027|FG000|Induction (Up to Day 21)|Death|1|||
129846285|NCT00854581|467397027|FG000|Induction (Up to Day 21)|Physician Decision|1|||
129846286|NCT00854581|467397027|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
129846287|NCT01339390|467397028|FG000|Overall Study|Death|32|||
129846288|NCT01339390|467397029|FG001|Overall Study|Death|29|||
129846289|NCT01339390|467397028|FG000|Overall Study|Lost to Follow-up|125|||
129846290|NCT01339390|467397029|FG001|Overall Study|Lost to Follow-up|127|||
129846291|NCT04847674|467397030|FG000|Overall Study|Withdrawal by Subject|0|||
129846292|NCT04847674|467397031|FG001|Overall Study|Withdrawal by Subject|1|||
129846293|NCT04847674|467397032|FG002|Overall Study|Withdrawal by Subject|0|||
129846294|NCT04847674|467397030|FG000|Overall Study|Lost to Follow-up|0|||
129846295|NCT04847674|467397031|FG001|Overall Study|Lost to Follow-up|0|||
129846296|NCT04847674|467397032|FG002|Overall Study|Lost to Follow-up|2|||
129846297|NCT04847674|467397030|FG000|Overall Study|Other than specified|21|||
129846298|NCT04847674|467397031|FG001|Overall Study|Other than specified|20|||
129846299|NCT04847674|467397032|FG002|Overall Study|Other than specified|20|||
129846300|NCT03254134|467397034|FG000|Overall Study|Not eligible patients|599|||
129846301|NCT03254134|467397035|FG001|Overall Study|Not eligible patients|3630|||
129846302|NCT02563028|467397036|FG000|Overall Study|Lack of equipment|1|||
129846303|NCT02563028|467397036|FG000|Overall Study|Unable to elicit VEP post induction|1|||
129846304|NCT00378703|467397037|FG000|Overall Study|Disease progression|59|||
129846305|NCT00378703|467397038|FG001|Overall Study|Disease progression|43|||
129846306|NCT00378703|467397039|FG002|Overall Study|Disease progression|48|||
129846307|NCT00378703|467397040|FG003|Overall Study|Disease progression|49|||
129846308|NCT00378703|467397037|FG000|Overall Study|Adverse Event|11|||
129846309|NCT00378703|467397038|FG001|Overall Study|Adverse Event|17|||
129846310|NCT00378703|467397039|FG002|Overall Study|Adverse Event|20|||
129846311|NCT00378703|467397040|FG003|Overall Study|Adverse Event|18|||
129846312|NCT00378703|467397037|FG000|Overall Study|Death|2|||
129846313|NCT00378703|467397038|FG001|Overall Study|Death|2|||
129846314|NCT00378703|467397039|FG002|Overall Study|Death|4|||
129846315|NCT00378703|467397040|FG003|Overall Study|Death|3|||
129846316|NCT00378703|467397037|FG000|Overall Study|Withdrawal by Subject|4|||
129846317|NCT00378703|467397038|FG001|Overall Study|Withdrawal by Subject|8|||
129846318|NCT00378703|467397039|FG002|Overall Study|Withdrawal by Subject|5|||
129846319|NCT00378703|467397040|FG003|Overall Study|Withdrawal by Subject|7|||
129846320|NCT00378703|467397037|FG000|Overall Study|Physician Decision|1|||
129846321|NCT00378703|467397038|FG001|Overall Study|Physician Decision|4|||
129846322|NCT00378703|467397039|FG002|Overall Study|Physician Decision|1|||
129846323|NCT00378703|467397040|FG003|Overall Study|Physician Decision|0|||
129846324|NCT00378703|467397037|FG000|Overall Study|Alternative therapy|4|||
129846325|NCT00378703|467397038|FG001|Overall Study|Alternative therapy|2|||
129846326|NCT00378703|467397039|FG002|Overall Study|Alternative therapy|0|||
129846327|NCT00378703|467397040|FG003|Overall Study|Alternative therapy|0|||
129846328|NCT00378703|467397037|FG000|Overall Study|Other complicated disease|0|||
129846329|NCT00378703|467397038|FG001|Overall Study|Other complicated disease|2|||
129846330|NCT00378703|467397039|FG002|Overall Study|Other complicated disease|2|||
129846331|NCT00378703|467397040|FG003|Overall Study|Other complicated disease|0|||
129846332|NCT00378703|467397037|FG000|Overall Study|Symptomatic deterioration|0|||
129846333|NCT00378703|467397038|FG001|Overall Study|Symptomatic deterioration|1|||
129846334|NCT00378703|467397039|FG002|Overall Study|Symptomatic deterioration|0|||
129846335|NCT00378703|467397040|FG003|Overall Study|Symptomatic deterioration|2|||
129846336|NCT00378703|467397037|FG000|Overall Study|Surgery|1|||
129846337|NCT00378703|467397038|FG001|Overall Study|Surgery|0|||
129846338|NCT00378703|467397039|FG002|Overall Study|Surgery|0|||
129846339|NCT00378703|467397040|FG003|Overall Study|Surgery|1|||
129846340|NCT00378703|467397037|FG000|Overall Study|Joint decision of physician and patient|1|||
129846341|NCT00378703|467397038|FG001|Overall Study|Joint decision of physician and patient|0|||
129846342|NCT00378703|467397039|FG002|Overall Study|Joint decision of physician and patient|0|||
129846343|NCT00378703|467397040|FG003|Overall Study|Joint decision of physician and patient|0|||
129846344|NCT00378703|467397037|FG000|Overall Study|Adverse events and progressive disease|0|||
129846345|NCT00378703|467397038|FG001|Overall Study|Adverse events and progressive disease|0|||
129846346|NCT00378703|467397039|FG002|Overall Study|Adverse events and progressive disease|0|||
129846347|NCT00378703|467397040|FG003|Overall Study|Adverse events and progressive disease|1|||
129846348|NCT00378703|467397037|FG000|Overall Study|Relocation|0|||
129846349|NCT00378703|467397038|FG001|Overall Study|Relocation|0|||
129846350|NCT00378703|467397039|FG002|Overall Study|Relocation|1|||
129846351|NCT00378703|467397040|FG003|Overall Study|Relocation|0|||
129846352|NCT00378703|467397037|FG000|Overall Study|Ineligible|4|||
129846353|NCT00378703|467397038|FG001|Overall Study|Ineligible|7|||
129846354|NCT00378703|467397039|FG002|Overall Study|Ineligible|7|||
129846355|NCT00378703|467397040|FG003|Overall Study|Ineligible|7|||
129846356|NCT00378703|467397037|FG000|Overall Study|Never started treatment|1|||
129846357|NCT00378703|467397038|FG001|Overall Study|Never started treatment|4|||
129846358|NCT00378703|467397039|FG002|Overall Study|Never started treatment|0|||
129846359|NCT00378703|467397040|FG003|Overall Study|Never started treatment|0|||
129846360|NCT00378703|467397037|FG000|Overall Study|Other|1|||
129846361|NCT00378703|467397038|FG001|Overall Study|Other|1|||
129846362|NCT00378703|467397039|FG002|Overall Study|Other|2|||
129846363|NCT00378703|467397040|FG003|Overall Study|Other|3|||
129846364|NCT04292730|467397047|FG000|Overall Study|Lost to Follow-up|8|||
129846365|NCT04292730|467397048|FG001|Overall Study|Lost to Follow-up|12|||
129846366|NCT04292730|467397049|FG002|Overall Study|Lost to Follow-up|12|||
129846367|NCT04292730|467397050|FG003|Overall Study|Lost to Follow-up|48|||
129846368|NCT04292730|467397047|FG000|Overall Study|Death|2|||
129846369|NCT04292730|467397048|FG001|Overall Study|Death|2|||
129846370|NCT04292730|467397049|FG002|Overall Study|Death|4|||
129846371|NCT04292730|467397050|FG003|Overall Study|Death|12|||
129846372|NCT04292730|467397047|FG000|Overall Study|Withdrew Consent|2|||
129846373|NCT04292730|467397048|FG001|Overall Study|Withdrew Consent|2|||
129846374|NCT04292730|467397049|FG002|Overall Study|Withdrew Consent|5|||
129846375|NCT04292730|467397050|FG003|Overall Study|Withdrew Consent|6|||
129846376|NCT04292730|467397047|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129846377|NCT04292730|467397048|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129846378|NCT04292730|467397049|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129846379|NCT04292730|467397050|FG003|Overall Study|Non-Compliance with Study Drug|0|||
129846380|NCT04292730|467397047|FG000|Overall Study|Protocol Violation|0|||
129846381|NCT04292730|467397048|FG001|Overall Study|Protocol Violation|0|||
129846382|NCT04292730|467397049|FG002|Overall Study|Protocol Violation|1|||
129846383|NCT04292730|467397050|FG003|Overall Study|Protocol Violation|0|||
129846384|NCT04292730|467397047|FG000|Overall Study|Randomized but not Treated|8|||
129846385|NCT04292730|467397048|FG001|Overall Study|Randomized but not Treated|4|||
129846386|NCT04292730|467397049|FG002|Overall Study|Randomized but not Treated|0|||
129846387|NCT04292730|467397050|FG003|Overall Study|Randomized but not Treated|14|||
129846388|NCT01527292|467397051|FG000|Overall Study|Physician Decision|0|||
129846389|NCT01527292|467397052|FG001|Overall Study|Physician Decision|3|||
129846390|NCT00806546|467397053|FG000|Overall Study|Enrolled, not treated|35|||
129846391|NCT00806546|467397053|FG000|Overall Study|Lost to Follow-up|32|||
129846392|NCT00806546|467397053|FG000|Overall Study|Adverse Event|74|||
129846393|NCT00806546|467397053|FG000|Overall Study|Withdrawal by Subject|75|||
129846394|NCT00806546|467397053|FG000|Overall Study|Protocol Violation|49|||
129846395|NCT00806546|467397053|FG000|Overall Study|Various|42|||
129846396|NCT02751983|467397054|FG000|Treatment|Stopped ACT, but Remained in study|2|||
129846397|NCT02751983|467397055|FG001|Treatment|Stopped ACT, but Remained in study|0|||
129846398|NCT02751983|467397054|FG000|Treatment|Discharged prior to beginning ACT|2|||
129846399|NCT02751983|467397055|FG001|Treatment|Discharged prior to beginning ACT|0|||
129846400|NCT02751983|467397054|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
129846401|NCT02751983|467397055|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
129846402|NCT02751983|467397054|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
129846403|NCT02751983|467397055|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
129846404|NCT02751983|467397054|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
129846405|NCT02751983|467397055|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
129846406|NCT00096044|467397056|FG000|Overall Study|Withdrawal by Subject|9|||
129846407|NCT00096044|467397056|FG000|Overall Study|Adverse Event|21|||
129846408|NCT00096044|467397056|FG000|Overall Study|Disease Progression|4|||
129846409|NCT03139916|467397057|FG000|Overall Study|Withdrawal by Subject|2|||
129846410|NCT03139916|467397057|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
129846411|NCT00813358|467397058|FG000|Overall Study|Death|32|||
129846412|NCT00813358|467397058|FG000|Overall Study|Lost to Follow-up|12|||
129846413|NCT00813358|467397058|FG000|Overall Study|other endpoints|5|||
129846414|NCT00813358|467397058|FG000|Overall Study|Withdrawal by Subject|20|||
129846415|NCT00004031|467397059|FG000|Overall Study|Adverse Event|5|||
129846416|NCT00004031|467397060|FG001|Overall Study|Adverse Event|0|||
129846417|NCT00004031|467397059|FG000|Overall Study|Refusal unrelated to adverse events|2|||
129846418|NCT00004031|467397060|FG001|Overall Study|Refusal unrelated to adverse events|11|||
129846419|NCT00004031|467397059|FG000|Overall Study|Progression/relapse|9|||
129846420|NCT00004031|467397060|FG001|Overall Study|Progression/relapse|4|||
129846421|NCT00004031|467397059|FG000|Overall Study|Death|3|||
129846422|NCT00004031|467397060|FG001|Overall Study|Death|1|||
129846423|NCT00004031|467397059|FG000|Overall Study|Other- not protocol specified|3|||
129846424|NCT00004031|467397060|FG001|Overall Study|Other- not protocol specified|3|||
129846425|NCT00004031|467397059|FG000|Overall Study|Reason under review|3|||
129846426|NCT00004031|467397060|FG001|Overall Study|Reason under review|2|||
129846427|NCT03851016|467397063|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129846428|NCT03851016|467397064|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
129846429|NCT00586469|467397065|FG000|Overall Study|Adverse Event|0|||
129846430|NCT00586469|467397066|FG001|Overall Study|Adverse Event|1|||
129846431|NCT03337724|467397073|FG000|Overall Study|Reason not Specified|12|||
129846432|NCT03337724|467397074|FG001|Overall Study|Reason not Specified|21|||
129846433|NCT03337724|467397075|FG002|Overall Study|Reason not Specified|9|||
129846434|NCT03337724|467397076|FG003|Overall Study|Reason not Specified|9|||
129846435|NCT03337724|467397077|FG004|Overall Study|Reason not Specified|29|||
129846436|NCT03337724|467397073|FG000|Overall Study|Withdrawal by Subject|13|||
129846437|NCT03337724|467397074|FG001|Overall Study|Withdrawal by Subject|15|||
129846438|NCT03337724|467397075|FG002|Overall Study|Withdrawal by Subject|4|||
129846439|NCT03337724|467397076|FG003|Overall Study|Withdrawal by Subject|15|||
129902964|NCT05147233|467606290|FG000|Overall Study|Withdrawal by Subject|2|||
129902965|NCT05147233|467606291|FG001|Overall Study|Withdrawal by Subject|1|||
129902966|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Adverse Event|1|||
129902967|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Adverse Event|0|||
129902968|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Adverse Event|0|||
129846440|NCT03337724|467397077|FG004|Overall Study|Withdrawal by Subject|6|||
129846441|NCT03337724|467397073|FG000|Overall Study|Protocol Deviation|0|||
129846442|NCT03337724|467397074|FG001|Overall Study|Protocol Deviation|1|||
129846443|NCT03337724|467397075|FG002|Overall Study|Protocol Deviation|1|||
129846444|NCT03337724|467397076|FG003|Overall Study|Protocol Deviation|1|||
129846445|NCT03337724|467397077|FG004|Overall Study|Protocol Deviation|0|||
129846446|NCT03337724|467397073|FG000|Overall Study|Adverse Event|1|||
129846447|NCT03337724|467397074|FG001|Overall Study|Adverse Event|1|||
129846448|NCT03337724|467397075|FG002|Overall Study|Adverse Event|0|||
129846449|NCT03337724|467397076|FG003|Overall Study|Adverse Event|1|||
129846450|NCT03337724|467397077|FG004|Overall Study|Adverse Event|0|||
129846451|NCT03337724|467397073|FG000|Overall Study|Death|40|||
129846452|NCT03337724|467397074|FG001|Overall Study|Death|89|||
129846453|NCT03337724|467397075|FG002|Overall Study|Death|43|||
129846454|NCT03337724|467397076|FG003|Overall Study|Death|76|||
129846455|NCT03337724|467397077|FG004|Overall Study|Death|50|||
129846456|NCT03337724|467397073|FG000|Overall Study|Lost to Follow-up|5|||
129846457|NCT03337724|467397074|FG001|Overall Study|Lost to Follow-up|5|||
129846458|NCT03337724|467397075|FG002|Overall Study|Lost to Follow-up|4|||
129846459|NCT03337724|467397076|FG003|Overall Study|Lost to Follow-up|7|||
129846460|NCT03337724|467397077|FG004|Overall Study|Lost to Follow-up|4|||
129846461|NCT03337724|467397073|FG000|Overall Study|Physician Decision|16|||
129846462|NCT03337724|467397074|FG001|Overall Study|Physician Decision|34|||
129846463|NCT03337724|467397075|FG002|Overall Study|Physician Decision|14|||
129846464|NCT03337724|467397076|FG003|Overall Study|Physician Decision|34|||
129846465|NCT03337724|467397077|FG004|Overall Study|Physician Decision|13|||
129846466|NCT03337724|467397073|FG000|Overall Study|Progressive Disease|0|||
129846467|NCT03337724|467397074|FG001|Overall Study|Progressive Disease|2|||
129846468|NCT03337724|467397075|FG002|Overall Study|Progressive Disease|1|||
129846469|NCT03337724|467397076|FG003|Overall Study|Progressive Disease|2|||
129846470|NCT03337724|467397077|FG004|Overall Study|Progressive Disease|0|||
129846471|NCT03337724|467397073|FG000|Overall Study|Symptomatic Deterioration|0|||
129846472|NCT03337724|467397074|FG001|Overall Study|Symptomatic Deterioration|0|||
129846473|NCT03337724|467397075|FG002|Overall Study|Symptomatic Deterioration|0|||
129846474|NCT03337724|467397076|FG003|Overall Study|Symptomatic Deterioration|1|||
129846475|NCT03337724|467397077|FG004|Overall Study|Symptomatic Deterioration|0|||
129846476|NCT03551210|467397079|FG000|Overall Study|Adverse Event|5|||
129846477|NCT03551210|467397080|FG001|Overall Study|Adverse Event|6|||
129846478|NCT03551210|467397079|FG000|Overall Study|Withdrawal by Subject|1|||
129846479|NCT03551210|467397080|FG001|Overall Study|Withdrawal by Subject|7|||
129846480|NCT03551210|467397079|FG000|Overall Study|Needed in other antibiotic treatment|2|||
129846481|NCT03551210|467397080|FG001|Overall Study|Needed in other antibiotic treatment|5|||
129846482|NCT03551210|467397079|FG000|Overall Study|Lost to Follow-up|1|||
129902969|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
129846483|NCT03551210|467397080|FG001|Overall Study|Lost to Follow-up|1|||
129902970|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
129902971|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
129902972|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
129902973|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
129902974|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
129902975|NCT04517864|467606294|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
129902976|NCT04517864|467606295|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
129902977|NCT04517864|467606296|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
129902978|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Adverse Event|1|||
129902979|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Adverse Event|0|||
129902980|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Adverse Event|0|||
129902981|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
129902982|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
129902983|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
129846484|NCT03551210|467397079|FG000|Overall Study|Absence of visit 4 and 5|1|||
129846485|NCT03551210|467397080|FG001|Overall Study|Absence of visit 4 and 5|0|||
129846486|NCT03551210|467397079|FG000|Overall Study|No drug for dispensing|0|||
129846487|NCT03551210|467397080|FG001|Overall Study|No drug for dispensing|1|||
129846488|NCT03265119|467397081|FG000|Overall Study|Adverse Event|2|||
129846489|NCT03265119|467397082|FG001|Overall Study|Adverse Event|1|||
129846490|NCT03265119|467397081|FG000|Overall Study|Lack of Efficacy|3|||
129846491|NCT03265119|467397082|FG001|Overall Study|Lack of Efficacy|0|||
129846492|NCT03265119|467397081|FG000|Overall Study|Protocol Violation|1|||
129846493|NCT03265119|467397082|FG001|Overall Study|Protocol Violation|2|||
129846494|NCT03265119|467397081|FG000|Overall Study|Withdrawal by Subject|2|||
129846495|NCT03265119|467397082|FG001|Overall Study|Withdrawal by Subject|4|||
129846496|NCT03265119|467397081|FG000|Overall Study|Lost to Follow-up|1|||
129902984|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
129902985|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
129902986|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
129902987|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Physician Decision|1|||
129902988|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Physician Decision|0|||
129902989|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Physician Decision|0|||
129902990|NCT04517864|467606294|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
129902991|NCT04517864|467606295|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
129902992|NCT04517864|467606296|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
129902993|NCT04517864|467606294|FG000|Extension Phase|Adverse Event|0|||
129902994|NCT04517864|467606295|FG001|Extension Phase|Adverse Event|0|||
129902995|NCT04517864|467606296|FG002|Extension Phase|Adverse Event|1|||
129902996|NCT04517864|467606294|FG000|Extension Phase|Lack of Efficacy|0|||
129902997|NCT04517864|467606295|FG001|Extension Phase|Lack of Efficacy|0|||
129902998|NCT04517864|467606296|FG002|Extension Phase|Lack of Efficacy|2|||
129902999|NCT04517864|467606294|FG000|Extension Phase|Study Terminated By Sponsor|0|||
129903000|NCT04517864|467606295|FG001|Extension Phase|Study Terminated By Sponsor|0|||
129903001|NCT04517864|467606296|FG002|Extension Phase|Study Terminated By Sponsor|32|||
129903002|NCT04517864|467606294|FG000|Extension Phase|Withdrawal by Subject|0|||
129903003|NCT04517864|467606295|FG001|Extension Phase|Withdrawal by Subject|0|||
129903004|NCT04517864|467606296|FG002|Extension Phase|Withdrawal by Subject|3|||
129903005|NCT04517864|467606294|FG000|Extension Phase|Approved Drug Available for Indication|0|||
129903006|NCT04517864|467606295|FG001|Extension Phase|Approved Drug Available for Indication|0|||
129903007|NCT04517864|467606296|FG002|Extension Phase|Approved Drug Available for Indication|7|||
129903008|NCT04722003|467606297|FG000|Overall Study|Lost to Follow-up|2|||
129903009|NCT04722003|467606298|FG001|Overall Study|Lost to Follow-up|0|||
129903010|NCT04722003|467606297|FG000|Overall Study|Physician Decision|1|||
129903011|NCT04722003|467606298|FG001|Overall Study|Physician Decision|0|||
129903012|NCT04860258|467606305|FG000|Overall Study|Withdrawal by Subject|0|||
129903013|NCT04860258|467606306|FG001|Overall Study|Withdrawal by Subject|0|||
129903014|NCT04860258|467606307|FG002|Overall Study|Withdrawal by Subject|4|||
129903015|NCT04860258|467606308|FG003|Overall Study|Withdrawal by Subject|1|||
129903016|NCT04860258|467606309|FG004|Overall Study|Withdrawal by Subject|4|||
129903017|NCT04860258|467606310|FG005|Overall Study|Withdrawal by Subject|1|||
129903018|NCT04860258|467606311|FG006|Overall Study|Withdrawal by Subject|0|||
129903019|NCT00726999|467606314|FG000|Overall Study|Physician Decision|0|||
129903020|NCT00726999|467606315|FG001|Overall Study|Physician Decision|1|||
129846497|NCT03265119|467397082|FG001|Overall Study|Lost to Follow-up|0|||
129846498|NCT03265119|467397081|FG000|Overall Study|Lack of Compliance|1|||
129846499|NCT03265119|467397082|FG001|Overall Study|Lack of Compliance|0|||
129846500|NCT00991302|467398489|FG000|Overall Study|Death|0|||
129846501|NCT00991302|467398490|FG001|Overall Study|Death|1|||
129846502|NCT00991302|467398489|FG000|Overall Study|Lost to Follow-up|14|||
129846503|NCT00991302|467398490|FG001|Overall Study|Lost to Follow-up|12|||
129846504|NCT03085927|467398491|FG000|Overall Study|Withdrawal by Subject|1|||
129846505|NCT03085927|467398492|FG001|Overall Study|Withdrawal by Subject|4|||
129903021|NCT00726999|467606314|FG000|Overall Study|Withdrawal by Subject|2|||
129903022|NCT00726999|467606315|FG001|Overall Study|Withdrawal by Subject|0|||
129903023|NCT00726999|467606314|FG000|Overall Study|Protocol Violation|1|||
129903024|NCT00726999|467606315|FG001|Overall Study|Protocol Violation|0|||
129903025|NCT00391846|467606316|FG000|Overall Study|Adverse Event|4|||
129903026|NCT00391846|467606317|FG001|Overall Study|Adverse Event|1|||
129903027|NCT00391846|467606316|FG000|Overall Study|Did not meet the required elig. crit|2|||
129903028|NCT00391846|467606317|FG001|Overall Study|Did not meet the required elig. crit|2|||
129903029|NCT00391846|467606316|FG000|Overall Study|Withdrawal by Subject|2|||
129903030|NCT00391846|467606317|FG001|Overall Study|Withdrawal by Subject|3|||
129903031|NCT00391846|467606316|FG000|Overall Study|Developed study specific DC criteria|0|||
129903032|NCT00391846|467606317|FG001|Overall Study|Developed study specific DC criteria|1|||
129903033|NCT03823300|467606321|FG000|Overall Study|Withdrawal by Subject|16|||
129903034|NCT03823300|467606322|FG001|Overall Study|Withdrawal by Subject|22|||
129903035|NCT03823300|467606321|FG000|Overall Study|Death|10|||
129903036|NCT03823300|467606322|FG001|Overall Study|Death|14|||
129903037|NCT03823300|467606321|FG000|Overall Study|Adverse Event|3|||
129903038|NCT03823300|467606322|FG001|Overall Study|Adverse Event|5|||
129903039|NCT03823300|467606321|FG000|Overall Study|Physician Decision|1|||
129903040|NCT03823300|467606322|FG001|Overall Study|Physician Decision|7|||
129903041|NCT03823300|467606321|FG000|Overall Study|Lost to Follow-up|1|||
129903042|NCT03823300|467606322|FG001|Overall Study|Lost to Follow-up|3|||
129903043|NCT03823300|467606321|FG000|Overall Study|Protocol Violation|1|||
129903044|NCT03823300|467606322|FG001|Overall Study|Protocol Violation|1|||
129903045|NCT03823300|467606321|FG000|Overall Study|Lack of Efficacy|1|||
129903046|NCT03823300|467606322|FG001|Overall Study|Lack of Efficacy|1|||
129903047|NCT03823300|467606321|FG000|Overall Study|Not Eligible|0|||
129846506|NCT03085927|467398491|FG000|Overall Study|Lost to Follow-up|3|||
129846507|NCT03085927|467398492|FG001|Overall Study|Lost to Follow-up|1|||
129846508|NCT03085927|467398491|FG000|Overall Study|Death|1|||
129846509|NCT03085927|467398492|FG001|Overall Study|Death|0|||
129846510|NCT03085927|467398491|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
129846511|NCT03085927|467398492|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
129846512|NCT03085927|467398491|FG000|Overall Study|Dyad Became Ineligible|0|||
129846513|NCT03085927|467398492|FG001|Overall Study|Dyad Became Ineligible|1|||
129846514|NCT02349711|467398494|FG000|Overall Study|Withdrawal by Subject|2|||
129903048|NCT03823300|467606322|FG001|Overall Study|Not Eligible|1|||
129903049|NCT03823300|467606321|FG000|Overall Study|Other|1|||
129903050|NCT03823300|467606322|FG001|Overall Study|Other|0|||
129903051|NCT00964366|467606323|FG000|Overall Study|Did not qualify at Day 1|1|||
129903052|NCT00964366|467606324|FG001|Overall Study|Did not qualify at Day 1|0|||
129903053|NCT00964366|467606323|FG000|Overall Study|Withdrawal by Subject|0|||
129903054|NCT00964366|467606324|FG001|Overall Study|Withdrawal by Subject|1|||
129903055|NCT01370694|467606325|FG000|Overall Study|Switched to rituximab|4|||
129903056|NCT01370694|467606325|FG000|Overall Study|Progressive disease|2|||
129903057|NCT02393716|467606326|FG000|Overall Study|Death|29|||
129903058|NCT02393716|467606326|FG000|Overall Study|Withdrawal by Subject|8|||
129903059|NCT02393716|467606326|FG000|Overall Study|Device Explanted|8|||
129903060|NCT02393716|467606326|FG000|Overall Study|Missed visit|16|||
129903061|NCT02957539|467606327|FG000|Baseline to Week 16|Lost to Follow-up|8|||
129903062|NCT02957539|467606328|FG001|Baseline to Week 16|Lost to Follow-up|10|||
129903063|NCT02957539|467606329|FG002|Baseline to Week 16|Lost to Follow-up|16|||
129903064|NCT02957539|467606327|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
129903065|NCT02957539|467606328|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
129903066|NCT02957539|467606329|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
129903067|NCT02957539|467606327|FG000|Week 16 to 32|Withdrawal by Subject|3|||
129903068|NCT02957539|467606328|FG001|Week 16 to 32|Withdrawal by Subject|3|||
129903069|NCT02957539|467606329|FG002|Week 16 to 32|Withdrawal by Subject|1|||
129903070|NCT02957539|467606327|FG000|Week 16 to 32|Lost to Follow-up|8|||
129903071|NCT02957539|467606328|FG001|Week 16 to 32|Lost to Follow-up|7|||
129903072|NCT02957539|467606329|FG002|Week 16 to 32|Lost to Follow-up|5|||
129903073|NCT02957539|467606327|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
129903074|NCT02957539|467606328|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
129903075|NCT02957539|467606329|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
129903076|NCT02957539|467606327|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
129903077|NCT02957539|467606328|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
129903078|NCT02957539|467606329|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
129903079|NCT01909336|467606334|FG000|Overall Study|Lost to Follow-up|4|||
129903080|NCT01909336|467606335|FG001|Overall Study|Lost to Follow-up|2|||
129903081|NCT01909336|467606336|FG002|Overall Study|Lost to Follow-up|2|||
129903082|NCT01909336|467606334|FG000|Overall Study|Physician Decision|0|||
129903083|NCT01909336|467606335|FG001|Overall Study|Physician Decision|1|||
129903084|NCT01909336|467606336|FG002|Overall Study|Physician Decision|1|||
129903085|NCT01157182|467606337|FG000|Washout of 28 Days|Adverse Event|2|||
129903086|NCT01157182|467606338|FG001|Washout of 28 Days|Adverse Event|0|||
129903087|NCT03743246|467606339|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
129903088|NCT03743246|467606340|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
129903089|NCT03743246|467606341|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
129903090|NCT03743246|467606342|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
129903091|NCT03743246|467606339|FG000|Pre-Treatment Period|Death|0|||
129903092|NCT03743246|467606340|FG001|Pre-Treatment Period|Death|1|||
129903093|NCT03743246|467606341|FG002|Pre-Treatment Period|Death|0|||
129903094|NCT03743246|467606342|FG003|Pre-Treatment Period|Death|1|||
129903095|NCT03743246|467606339|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
129903096|NCT03743246|467606340|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
129903097|NCT03743246|467606341|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
129903098|NCT03743246|467606342|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
129903099|NCT03743246|467606339|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
129903100|NCT03743246|467606340|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
129903101|NCT03743246|467606341|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
129903102|NCT03743246|467606342|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
129903103|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
129903104|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
129903105|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
129903106|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
129903107|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
129903108|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
129846515|NCT02349711|467398495|FG001|Overall Study|Withdrawal by Subject|1|||
129846516|NCT02349711|467398494|FG000|Overall Study|Lost to Follow-up|1|||
129846517|NCT02349711|467398495|FG001|Overall Study|Lost to Follow-up|1|||
129846518|NCT00194012|467398496|FG000|Randomized Phase|Lack of Efficacy|8|||
129846519|NCT00194012|467398497|FG001|Randomized Phase|Lack of Efficacy|18|||
129846520|NCT00194012|467398496|FG000|Randomized Phase|Study nonadherence|2|||
129846521|NCT00194012|467398497|FG001|Randomized Phase|Study nonadherence|1|||
129903109|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
129903110|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
129903111|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
129903112|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
129903113|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
129903114|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
129903115|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
129903116|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
129903117|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
129903118|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
129846522|NCT00194012|467398496|FG000|Randomized Phase|Withdrawal by Subject|3|||
129846523|NCT00194012|467398497|FG001|Randomized Phase|Withdrawal by Subject|3|||
129846524|NCT00194012|467398496|FG000|Randomized Phase|Adverse Event|2|||
129846525|NCT00194012|467398497|FG001|Randomized Phase|Adverse Event|1|||
129846526|NCT00194012|467398496|FG000|Randomized Phase|Participant reported having a rash|1|||
129846527|NCT00194012|467398497|FG001|Randomized Phase|Participant reported having a rash|0|||
129846528|NCT00194012|467398496|FG000|Randomized Phase|Emesis and enuresis|0|||
129846529|NCT00194012|467398497|FG001|Randomized Phase|Emesis and enuresis|1|||
129846530|NCT00194012|467398496|FG000|Randomized Phase|Oral/nasal twitching|0|||
129846531|NCT00194012|467398497|FG001|Randomized Phase|Oral/nasal twitching|1|||
129846532|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Weight Gain|1|||
129846533|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Weight Gain|0|||
129846534|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
129846535|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
129846536|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
129846537|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
129846538|NCT00194012|467398496|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
129846539|NCT00194012|467398497|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
129846540|NCT01513317|467398503|FG000|Overall Study|Withdrawal by Subject|15|||
129846541|NCT01513317|467398504|FG001|Overall Study|Withdrawal by Subject|4|||
129846542|NCT01513317|467398503|FG000|Overall Study|Death|1|||
129846543|NCT01513317|467398504|FG001|Overall Study|Death|1|||
129846544|NCT01513317|467398503|FG000|Overall Study|Study terminated by sponsor|18|||
129846545|NCT01513317|467398504|FG001|Overall Study|Study terminated by sponsor|18|||
129846546|NCT01513317|467398503|FG000|Overall Study|Other|0|||
129846547|NCT01513317|467398504|FG001|Overall Study|Other|1|||
129846548|NCT02564198|467398505|FG000|Overall Study|Withdrawal by Subject|2|||
129846549|NCT02564198|467398506|FG001|Overall Study|Withdrawal by Subject|4|||
129846550|NCT02564198|467398507|FG002|Overall Study|Withdrawal by Subject|0|||
129846551|NCT02564198|467398505|FG000|Overall Study|Adverse Event|0|||
129846552|NCT02564198|467398506|FG001|Overall Study|Adverse Event|1|||
129846553|NCT02564198|467398507|FG002|Overall Study|Adverse Event|0|||
129846554|NCT02200042|467398508|FG000|Overall Study|Withdrawal by Subject|0|||
129846555|NCT02200042|467398509|FG001|Overall Study|Withdrawal by Subject|1|||
129846556|NCT02097134|467398510|FG000|Overall Study|Physician Decision|4|||
129846557|NCT02097134|467398510|FG000|Overall Study|Non-Protocol Therapy|1|||
129846558|NCT02097134|467398510|FG000|Overall Study|Progressive Disease|3|||
129846559|NCT02097134|467398510|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
129846560|NCT00298896|467398515|FG000|Overall Study|Death|3|||
129846561|NCT00298896|467398515|FG000|Overall Study|Physician Decision|2|||
129846562|NCT00298896|467398515|FG000|Overall Study|Intercurrent Illness|1|||
129846563|NCT00298896|467398515|FG000|Overall Study|Disease Progression|41|||
129846564|NCT00298896|467398515|FG000|Overall Study|Withdrawal by Subject|2|||
129846565|NCT00298896|467398515|FG000|Overall Study|Assigned to treatment in error|1|||
129846566|NCT02652624|467398518|FG000|Randomized Phase|Pregnancy|3|||
129846567|NCT02652624|467398519|FG001|Randomized Phase|Pregnancy|1|||
129846568|NCT02652624|467398518|FG000|Randomized Phase|Investigator's Discretion|0|||
129846569|NCT02652624|467398519|FG001|Randomized Phase|Investigator's Discretion|2|||
129846570|NCT02652624|467398518|FG000|Randomized Phase|Death|0|||
129846571|NCT02652624|467398519|FG001|Randomized Phase|Death|1|||
129846572|NCT02652624|467398518|FG000|Randomized Phase|Lost to Follow-up|0|||
129846573|NCT02652624|467398519|FG001|Randomized Phase|Lost to Follow-up|1|||
129846574|NCT02652624|467398518|FG000|Extension Phase|Lost to Follow-up|3|||
129846575|NCT02652624|467398519|FG001|Extension Phase|Lost to Follow-up|1|||
129846576|NCT02652624|467398518|FG000|Extension Phase|Pregnancy|1|||
129846577|NCT02652624|467398519|FG001|Extension Phase|Pregnancy|1|||
129846578|NCT02652624|467398518|FG000|Extension Phase|Adverse Event|0|||
129903119|NCT03743246|467606339|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
129846579|NCT02652624|467398519|FG001|Extension Phase|Adverse Event|1|||
129846580|NCT02652624|467398518|FG000|Extension Phase|Withdrew Consent|0|||
129846581|NCT02652624|467398519|FG001|Extension Phase|Withdrew Consent|1|||
129903120|NCT03743246|467606340|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
129846582|NCT01023659|467398520|FG000|Overall Study|Lost to Follow-up|73|||
129846583|NCT01023659|467398521|FG001|Overall Study|Lost to Follow-up|228|||
129846584|NCT01023659|467398522|FG002|Overall Study|Lost to Follow-up|99|||
129846585|NCT00912405|467398525|FG000|Overall Study|Lost to Follow-up|5|||
129903121|NCT03743246|467606341|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
129903122|NCT03743246|467606342|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
129903123|NCT01596504|467606343|FG000|Overall Study|Participant's Private Reason|0|||
129903124|NCT01596504|467606344|FG001|Overall Study|Participant's Private Reason|1|||
129903125|NCT01596504|467606345|FG002|Overall Study|Participant's Private Reason|0|||
129903126|NCT01596504|467606343|FG000|Overall Study|Adverse Event|1|||
129903127|NCT01596504|467606344|FG001|Overall Study|Adverse Event|2|||
129903128|NCT01596504|467606345|FG002|Overall Study|Adverse Event|1|||
129903129|NCT01596504|467606343|FG000|Overall Study|Withdrawal by Subject|1|||
129903130|NCT01596504|467606344|FG001|Overall Study|Withdrawal by Subject|0|||
129903131|NCT01596504|467606345|FG002|Overall Study|Withdrawal by Subject|0|||
129903132|NCT01901276|467606346|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
129903133|NCT01901276|467606347|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
129903134|NCT02026258|467606348|FG000|Randomized|Did not start treatment|2|||
129903135|NCT02026258|467606349|FG001|Randomized|Did not start treatment|1|||
129903136|NCT02026258|467606348|FG000|Randomized|Change in treatment plan|1|||
129903137|NCT02026258|467606349|FG001|Randomized|Change in treatment plan|0|||
129903138|NCT02026258|467606348|FG000|Randomized|Presence of periodontal disease|1|||
129903139|NCT02026258|467606349|FG001|Randomized|Presence of periodontal disease|1|||
129903140|NCT02026258|467606348|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
129903141|NCT02026258|467606349|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
129903142|NCT02026258|467606348|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
129903143|NCT02026258|467606349|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
129903144|NCT00530842|467606350|FG000|Overall Study|Adverse Event|10|||
129903145|NCT00530842|467606351|FG001|Overall Study|Adverse Event|6|||
129903146|NCT00530842|467606350|FG000|Overall Study|Lack of Efficacy|2|||
129903147|NCT00530842|467606351|FG001|Overall Study|Lack of Efficacy|1|||
129903148|NCT00530842|467606350|FG000|Overall Study|Lost to Follow-up|0|||
129903149|NCT00530842|467606351|FG001|Overall Study|Lost to Follow-up|4|||
129903150|NCT00530842|467606350|FG000|Overall Study|Protocol Violation|3|||
129903151|NCT00530842|467606351|FG001|Overall Study|Protocol Violation|2|||
129903152|NCT00530842|467606350|FG000|Overall Study|Withdrawal by Subject|4|||
129903153|NCT00530842|467606351|FG001|Overall Study|Withdrawal by Subject|5|||
129903154|NCT00530842|467606350|FG000|Overall Study|Individual different reasons|4|||
129903155|NCT00530842|467606351|FG001|Overall Study|Individual different reasons|3|||
129903156|NCT00530842|467606350|FG000|Period 1|Adverse Event|7|||
129903157|NCT00530842|467606351|FG001|Period 1|Adverse Event|3|||
129903158|NCT00530842|467606350|FG000|Period 1|Lack of Efficacy|1|||
129903159|NCT00530842|467606351|FG001|Period 1|Lack of Efficacy|1|||
129903160|NCT00530842|467606350|FG000|Period 1|Protocol Violation|2|||
129903161|NCT00530842|467606351|FG001|Period 1|Protocol Violation|1|||
129903162|NCT00530842|467606350|FG000|Period 1|Withdrawal by Subject|2|||
129903163|NCT00530842|467606351|FG001|Period 1|Withdrawal by Subject|3|||
129903164|NCT00530842|467606350|FG000|Period 1|Individual different reasons|2|||
129903165|NCT00530842|467606351|FG001|Period 1|Individual different reasons|3|||
129903166|NCT00530842|467606350|FG000|Period 2|Adverse Event|3|||
129903167|NCT00530842|467606351|FG001|Period 2|Adverse Event|3|||
129846586|NCT01434823|467398526|FG000|Overall Study|Incomplete data in medical record|4|||
129846587|NCT01434823|467398527|FG001|Overall Study|Incomplete data in medical record|7|||
129846588|NCT00501540|467398528|FG000|Overall Study|Death|5|||
129846589|NCT01797536|467398529|FG000|Overall Study|Adverse Event|0|||
129846590|NCT01797536|467398530|FG001|Overall Study|Adverse Event|1|||
129846591|NCT01797536|467398531|FG002|Overall Study|Adverse Event|0|||
129846592|NCT01797536|467398532|FG003|Overall Study|Adverse Event|0|||
129846593|NCT00120042|467398533|FG000|Overall Study|all completed protocl|0|||
129846594|NCT00120042|467398534|FG001|Overall Study|all completed protocl|0|||
129846595|NCT00120042|467398535|FG002|Overall Study|all completed protocl|0|||
129846596|NCT02984995|467398537|FG000|Overall Study|Required stem cell transplant|13|||
129846597|NCT02984995|467398538|FG001|Overall Study|Required stem cell transplant|2|||
129846598|NCT02984995|467398537|FG000|Overall Study|Progressive disease|11|||
129846599|NCT02984995|467398538|FG001|Overall Study|Progressive disease|1|||
129846600|NCT02984995|467398537|FG000|Overall Study|Adverse Event|1|||
129846601|NCT02984995|467398538|FG001|Overall Study|Adverse Event|0|||
129846602|NCT04304001|467398543|FG000|Overall Study|Lost to Follow-up|13|||
129846603|NCT04304001|467398544|FG001|Overall Study|Lost to Follow-up|9|||
129846604|NCT02664038|467398548|FG000|13 Week|Lost to Follow-up|7|||
129903168|NCT00530842|467606350|FG000|Period 2|Lack of Efficacy|1|||
129903169|NCT00530842|467606351|FG001|Period 2|Lack of Efficacy|0|||
129903170|NCT00530842|467606350|FG000|Period 2|Lost to Follow-up|0|||
129903171|NCT00530842|467606351|FG001|Period 2|Lost to Follow-up|4|||
129903172|NCT00530842|467606350|FG000|Period 2|Protocol Violation|1|||
129903173|NCT00530842|467606351|FG001|Period 2|Protocol Violation|0|||
129903174|NCT00530842|467606350|FG000|Period 2|Withdrawal by Subject|1|||
129903175|NCT00530842|467606351|FG001|Period 2|Withdrawal by Subject|2|||
129903176|NCT00530842|467606350|FG000|Period 2|Individual different reasons|2|||
129903177|NCT00530842|467606351|FG001|Period 2|Individual different reasons|0|||
129903178|NCT00949975|467606352|FG000|Overall Study|Voluntary discontinuation|6|||
129846605|NCT02664038|467398549|FG001|13 Week|Lost to Follow-up|14|||
129846606|NCT02664038|467398548|FG000|13 Week|Withdrawal by Subject|1|||
129846607|NCT02664038|467398549|FG001|13 Week|Withdrawal by Subject|0|||
129846608|NCT02664038|467398548|FG000|26 Week|Lost to Follow-up|5|||
129846609|NCT02664038|467398549|FG001|26 Week|Lost to Follow-up|4|||
129846610|NCT02606136|467398554|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
129846611|NCT02606136|467398554|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
129846612|NCT02606136|467398554|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
129846613|NCT02606136|467398554|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
129846614|NCT03296696|467398555|FG000|Overall Study|Started Other Antitumor Therapy|1|||
129846615|NCT03296696|467398556|FG001|Overall Study|Started Other Antitumor Therapy|2|||
129846616|NCT03296696|467398557|FG002|Overall Study|Started Other Antitumor Therapy|1|||
129846617|NCT03296696|467398558|FG003|Overall Study|Started Other Antitumor Therapy|2|||
129846618|NCT03296696|467398559|FG004|Overall Study|Started Other Antitumor Therapy|1|||
129846619|NCT03296696|467398560|FG005|Overall Study|Started Other Antitumor Therapy|1|||
129846620|NCT03296696|467398561|FG006|Overall Study|Started Other Antitumor Therapy|2|||
129846621|NCT03296696|467398562|FG007|Overall Study|Started Other Antitumor Therapy|3|||
129846622|NCT03296696|467398563|FG008|Overall Study|Started Other Antitumor Therapy|1|||
129846623|NCT03296696|467398564|FG009|Overall Study|Started Other Antitumor Therapy|0|||
129846624|NCT03296696|467398555|FG000|Overall Study|Death|0|||
129846625|NCT03296696|467398556|FG001|Overall Study|Death|1|||
129846626|NCT03296696|467398557|FG002|Overall Study|Death|1|||
129846627|NCT03296696|467398558|FG003|Overall Study|Death|2|||
129846628|NCT03296696|467398559|FG004|Overall Study|Death|2|||
129846629|NCT03296696|467398560|FG005|Overall Study|Death|3|||
129846630|NCT03296696|467398561|FG006|Overall Study|Death|1|||
129846631|NCT03296696|467398562|FG007|Overall Study|Death|2|||
129846632|NCT03296696|467398563|FG008|Overall Study|Death|0|||
129846633|NCT03296696|467398564|FG009|Overall Study|Death|0|||
129846634|NCT03296696|467398555|FG000|Overall Study|Withdrawal by Subject|0|||
129846635|NCT03296696|467398556|FG001|Overall Study|Withdrawal by Subject|0|||
129846636|NCT03296696|467398557|FG002|Overall Study|Withdrawal by Subject|1|||
129846637|NCT03296696|467398558|FG003|Overall Study|Withdrawal by Subject|0|||
129846638|NCT03296696|467398559|FG004|Overall Study|Withdrawal by Subject|1|||
129846639|NCT03296696|467398560|FG005|Overall Study|Withdrawal by Subject|0|||
129846640|NCT03296696|467398561|FG006|Overall Study|Withdrawal by Subject|0|||
129846641|NCT03296696|467398562|FG007|Overall Study|Withdrawal by Subject|0|||
129846642|NCT03296696|467398563|FG008|Overall Study|Withdrawal by Subject|0|||
129846643|NCT03296696|467398564|FG009|Overall Study|Withdrawal by Subject|1|||
129846644|NCT02075437|467398569|FG000|Overall Study|Withdrawal by Subject|5|||
129846645|NCT02075437|467398569|FG000|Overall Study|Lost to Follow-up|1|||
129846646|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
129846647|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
129846648|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
129846649|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
129846650|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
129846651|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
129846652|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
129846653|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
129846654|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
129846655|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
129846656|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
129846657|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
129846658|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
129846659|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
129846660|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
129846661|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
129846662|NCT02047110|467398570|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
129846663|NCT02047110|467398571|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
129846664|NCT02047110|467398572|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
129846665|NCT02047110|467398573|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
129846666|NCT02047110|467398570|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
129846667|NCT02047110|467398571|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
129846668|NCT02047110|467398572|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
129846669|NCT02047110|467398573|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
129846670|NCT02047110|467398570|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
129846671|NCT02047110|467398571|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
129846672|NCT02047110|467398572|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
129846673|NCT02047110|467398573|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
129846674|NCT02047110|467398570|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
129846675|NCT02047110|467398571|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
129846676|NCT02047110|467398572|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
129846677|NCT02047110|467398573|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
129846678|NCT02047110|467398570|FG000|Escape Treatment Period|Adverse Event|1|||
129846679|NCT02047110|467398571|FG001|Escape Treatment Period|Adverse Event|2|||
129846680|NCT02047110|467398572|FG002|Escape Treatment Period|Adverse Event|2|||
129846681|NCT02047110|467398573|FG003|Escape Treatment Period|Adverse Event|0|||
129846682|NCT02047110|467398570|FG000|Escape Treatment Period|Other than specified|1|||
129846683|NCT02047110|467398571|FG001|Escape Treatment Period|Other than specified|2|||
129846684|NCT02047110|467398572|FG002|Escape Treatment Period|Other than specified|0|||
129846685|NCT02047110|467398573|FG003|Escape Treatment Period|Other than specified|1|||
129846686|NCT02047110|467398570|FG000|OLE Treatment Period|Other than specified|0|||
129846687|NCT02047110|467398571|FG001|OLE Treatment Period|Other than specified|0|||
129846688|NCT02047110|467398572|FG002|OLE Treatment Period|Other than specified|1|||
129846689|NCT02047110|467398573|FG003|OLE Treatment Period|Other than specified|0|||
129846690|NCT04439240|467398574|FG000|Overall Study|Ineligible|2|||
129846691|NCT04439240|467398574|FG000|Overall Study|Never started treatment|2|||
129846692|NCT04439240|467398574|FG000|Overall Study|Adverse Event|12|||
129846693|NCT04439240|467398574|FG000|Overall Study|Death|2|||
129846694|NCT04439240|467398574|FG000|Overall Study|Disease progression|25|||
129846695|NCT04439240|467398574|FG000|Overall Study|Other diseases|2|||
129846696|NCT04439240|467398574|FG000|Overall Study|Withdrawal by Subject|3|||
129846697|NCT04439240|467398574|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
129846698|NCT04439240|467398574|FG000|Overall Study|Symptomatic decline|1|||
129846699|NCT04439240|467398574|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
129846700|NCT04439240|467398574|FG000|Overall Study|Clinical progression|1|||
129846701|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Adverse Event|41|||
129846702|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Adverse Event|24|||
129846703|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
129846704|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
129846705|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
129846706|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
129846707|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Physician Decision|0|||
129846708|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Physician Decision|6|||
129846709|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
129846710|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
129846711|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
129846712|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
129846713|NCT00673452|467398575|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
129846714|NCT00673452|467398576|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
129846715|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
129846716|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
129846717|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
129846718|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
129846719|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
129846720|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
129846721|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
129846722|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
129846723|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
129846724|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
129846725|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
129846726|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
129846727|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
129846728|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
129846729|NCT00673452|467398575|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
129846730|NCT00673452|467398576|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
129846731|NCT00813124|467398577|FG000|Overall Study|Death|2|||
129846732|NCT00813124|467398577|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
129846733|NCT00813124|467398577|FG000|Overall Study|Withdrawal by Subject|1|||
129846734|NCT00079274|467398582|FG000|Overall Study|Withdrawal by Subject|111|||
129846735|NCT00079274|467398583|FG001|Overall Study|Withdrawal by Subject|10|||
129846736|NCT00079274|467398584|FG002|Overall Study|Withdrawal by Subject|12|||
129846737|NCT00079274|467398585|FG003|Overall Study|Withdrawal by Subject|163|||
129846738|NCT00079274|467398586|FG004|Overall Study|Withdrawal by Subject|7|||
129846739|NCT00079274|467398587|FG005|Overall Study|Withdrawal by Subject|8|||
129846740|NCT00079274|467398588|FG006|Overall Study|Withdrawal by Subject|0|||
129846741|NCT00079274|467398582|FG000|Overall Study|Adverse Event|130|||
129846742|NCT00079274|467398583|FG001|Overall Study|Adverse Event|8|||
129846743|NCT00079274|467398584|FG002|Overall Study|Adverse Event|8|||
129846744|NCT00079274|467398585|FG003|Overall Study|Adverse Event|184|||
129846745|NCT00079274|467398586|FG004|Overall Study|Adverse Event|7|||
129903179|NCT00949975|467606353|FG001|Overall Study|Voluntary discontinuation|5|||
129903180|NCT00949975|467606354|FG002|Overall Study|Voluntary discontinuation|3|||
129903181|NCT00949975|467606355|FG003|Overall Study|Voluntary discontinuation|6|||
129846746|NCT00079274|467398587|FG005|Overall Study|Adverse Event|8|||
129846747|NCT00079274|467398588|FG006|Overall Study|Adverse Event|0|||
129846748|NCT00079274|467398582|FG000|Overall Study|Recurrence|21|||
129846749|NCT00079274|467398583|FG001|Overall Study|Recurrence|0|||
129846750|NCT00079274|467398584|FG002|Overall Study|Recurrence|1|||
129846751|NCT00079274|467398585|FG003|Overall Study|Recurrence|15|||
129846752|NCT00079274|467398586|FG004|Overall Study|Recurrence|0|||
129846753|NCT00079274|467398587|FG005|Overall Study|Recurrence|2|||
129846754|NCT00079274|467398588|FG006|Overall Study|Recurrence|0|||
129846755|NCT00079274|467398582|FG000|Overall Study|Alternate Treatment|6|||
129846756|NCT00079274|467398583|FG001|Overall Study|Alternate Treatment|1|||
129846757|NCT00079274|467398584|FG002|Overall Study|Alternate Treatment|0|||
129846758|NCT00079274|467398585|FG003|Overall Study|Alternate Treatment|3|||
129846759|NCT00079274|467398586|FG004|Overall Study|Alternate Treatment|0|||
129903182|NCT00949975|467606352|FG000|Overall Study|Adverse Event|11|||
129903183|NCT00949975|467606353|FG001|Overall Study|Adverse Event|11|||
129903184|NCT00949975|467606354|FG002|Overall Study|Adverse Event|10|||
129903185|NCT00949975|467606355|FG003|Overall Study|Adverse Event|10|||
129903186|NCT00949975|467606352|FG000|Overall Study|Safety reason|0|||
129903187|NCT00949975|467606353|FG001|Overall Study|Safety reason|1|||
129903188|NCT00949975|467606354|FG002|Overall Study|Safety reason|0|||
129903189|NCT00949975|467606355|FG003|Overall Study|Safety reason|0|||
129903190|NCT00949975|467606352|FG000|Overall Study|Study-specific criteria|0|||
129903191|NCT00949975|467606353|FG001|Overall Study|Study-specific criteria|1|||
129903192|NCT00949975|467606354|FG002|Overall Study|Study-specific criteria|1|||
129903193|NCT00949975|467606355|FG003|Overall Study|Study-specific criteria|0|||
129903194|NCT00949975|467606352|FG000|Overall Study|Incorrect enrolment|5|||
129903195|NCT00949975|467606353|FG001|Overall Study|Incorrect enrolment|10|||
129903196|NCT00949975|467606354|FG002|Overall Study|Incorrect enrolment|4|||
129903197|NCT00949975|467606355|FG003|Overall Study|Incorrect enrolment|7|||
129903198|NCT00949975|467606352|FG000|Overall Study|Severe non-compliance|3|||
129903199|NCT00949975|467606353|FG001|Overall Study|Severe non-compliance|1|||
129903200|NCT00949975|467606354|FG002|Overall Study|Severe non-compliance|0|||
129903201|NCT00949975|467606355|FG003|Overall Study|Severe non-compliance|2|||
129903202|NCT00949975|467606352|FG000|Overall Study|Lost to Follow-up|1|||
129903203|NCT00949975|467606353|FG001|Overall Study|Lost to Follow-up|0|||
129903204|NCT00949975|467606354|FG002|Overall Study|Lost to Follow-up|1|||
129903205|NCT00949975|467606355|FG003|Overall Study|Lost to Follow-up|3|||
129903206|NCT00949975|467606352|FG000|Overall Study|Other|1|||
129903207|NCT00949975|467606353|FG001|Overall Study|Other|0|||
129903208|NCT00949975|467606354|FG002|Overall Study|Other|0|||
129903209|NCT00949975|467606355|FG003|Overall Study|Other|0|||
129903210|NCT04347954|467606356|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
129903211|NCT04347954|467606357|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
129903212|NCT04347954|467606358|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
129903213|NCT04347954|467606356|FG000|Overall Study|Lost to Follow-up|0|||
129903214|NCT04347954|467606357|FG001|Overall Study|Lost to Follow-up|1|||
129903215|NCT04347954|467606358|FG002|Overall Study|Lost to Follow-up|0|||
129903216|NCT02534350|467606359|FG000|Overall Study|Randomized But Not Treated|1|||
129903217|NCT02534350|467606360|FG001|Overall Study|Randomized But Not Treated|0|||
129903218|NCT02534350|467606359|FG000|Overall Study|Protocol Violation|1|||
129903219|NCT02534350|467606360|FG001|Overall Study|Protocol Violation|0|||
129903220|NCT02534350|467606359|FG000|Overall Study|Withdrew Consent|2|||
129903221|NCT02534350|467606360|FG001|Overall Study|Withdrew Consent|0|||
129903222|NCT03257813|467606376|FG000|Overall Study|Protocol Violation|6|||
129903223|NCT03257813|467606377|FG001|Overall Study|Protocol Violation|3|||
129903224|NCT02878330|467606378|FG000|Overall Study|Death|3|||
129903225|NCT02878330|467606379|FG001|Overall Study|Death|2|||
129903226|NCT02878330|467606378|FG000|Overall Study|Lost to Follow-up|11|||
129903227|NCT02878330|467606379|FG001|Overall Study|Lost to Follow-up|26|||
129903228|NCT02878330|467606378|FG000|Overall Study|Withdrawal by Subject|11|||
129846760|NCT00079274|467398587|FG005|Overall Study|Alternate Treatment|0|||
129846761|NCT00079274|467398588|FG006|Overall Study|Alternate Treatment|0|||
129846762|NCT00079274|467398582|FG000|Overall Study|Other Medical Problems|6|||
129903229|NCT02878330|467606379|FG001|Overall Study|Withdrawal by Subject|21|||
129903230|NCT02878330|467606378|FG000|Overall Study|Other|4|||
129903231|NCT02878330|467606379|FG001|Overall Study|Other|7|||
129903232|NCT05641311|467606384|FG000|Dosing Period 1|Adverse Event|1|||
129903233|NCT05641311|467606385|FG001|Dosing Period 1|Adverse Event|0|||
129903234|NCT00909363|467606386|FG000|Overall Study|Withdrawal by Subject|1|||
129903235|NCT00909363|467606387|FG001|Overall Study|Withdrawal by Subject|0|||
129903236|NCT00909363|467606388|FG002|Overall Study|Withdrawal by Subject|0|||
129903237|NCT00909363|467606386|FG000|Overall Study|Lack of Efficacy|1|||
129903238|NCT00909363|467606387|FG001|Overall Study|Lack of Efficacy|0|||
129903239|NCT00909363|467606388|FG002|Overall Study|Lack of Efficacy|0|||
129903240|NCT00922207|467606391|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
129903241|NCT00922207|467606392|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
129846763|NCT00079274|467398583|FG001|Overall Study|Other Medical Problems|1|||
129846764|NCT00079274|467398584|FG002|Overall Study|Other Medical Problems|0|||
129846765|NCT00079274|467398585|FG003|Overall Study|Other Medical Problems|7|||
129846766|NCT00079274|467398586|FG004|Overall Study|Other Medical Problems|0|||
129846767|NCT00079274|467398587|FG005|Overall Study|Other Medical Problems|0|||
129846768|NCT00079274|467398588|FG006|Overall Study|Other Medical Problems|0|||
129846769|NCT00079274|467398582|FG000|Overall Study|Death|4|||
129846770|NCT00079274|467398583|FG001|Overall Study|Death|0|||
129846771|NCT00079274|467398584|FG002|Overall Study|Death|1|||
129846772|NCT00079274|467398585|FG003|Overall Study|Death|15|||
129846773|NCT00079274|467398586|FG004|Overall Study|Death|0|||
129846774|NCT00079274|467398587|FG005|Overall Study|Death|0|||
129846775|NCT00079274|467398588|FG006|Overall Study|Death|0|||
129846776|NCT00079274|467398582|FG000|Overall Study|Cytogenetic resistance|0|||
129846777|NCT00079274|467398583|FG001|Overall Study|Cytogenetic resistance|0|||
129846778|NCT00079274|467398584|FG002|Overall Study|Cytogenetic resistance|0|||
129846779|NCT00079274|467398585|FG003|Overall Study|Cytogenetic resistance|2|||
129846780|NCT00079274|467398586|FG004|Overall Study|Cytogenetic resistance|0|||
129846781|NCT00079274|467398587|FG005|Overall Study|Cytogenetic resistance|0|||
129846782|NCT00079274|467398588|FG006|Overall Study|Cytogenetic resistance|0|||
129846783|NCT00079274|467398582|FG000|Overall Study|Other|43|||
129846784|NCT00079274|467398583|FG001|Overall Study|Other|7|||
129846785|NCT00079274|467398584|FG002|Overall Study|Other|5|||
129846786|NCT00079274|467398585|FG003|Overall Study|Other|55|||
129846787|NCT00079274|467398586|FG004|Overall Study|Other|1|||
129846788|NCT00079274|467398587|FG005|Overall Study|Other|2|||
129846789|NCT00079274|467398588|FG006|Overall Study|Other|0|||
129846790|NCT02075320|467398589|FG000|Overall Study|Withdrawal by Subject|2|||
129846791|NCT03773757|467398591|FG000|Overall Study|Withdrawal by Subject|2|||
129846792|NCT03773757|467398592|FG001|Overall Study|Withdrawal by Subject|4|||
129846793|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
129846794|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
129846795|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
129846796|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
129846797|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
129846798|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
129846799|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
129846800|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
129846801|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
129846802|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
129846803|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
129846804|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
129846805|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
129846806|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
129846807|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
129846808|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
129846809|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
129903242|NCT00922207|467606393|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
129903243|NCT00922207|467606391|FG000|Overall Study|Insufficient Therapeutic Response|0|||
129903244|NCT00922207|467606392|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129903245|NCT00922207|467606393|FG002|Overall Study|Insufficient Therapeutic Response|1|||
129903246|NCT00922207|467606391|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129903247|NCT00922207|467606392|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129903248|NCT00922207|467606393|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
129903249|NCT00922207|467606391|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
129903250|NCT00922207|467606392|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129903251|NCT00922207|467606393|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129903252|NCT00922207|467606391|FG000|Overall Study|Withdrew Consent|2|||
129903253|NCT00922207|467606392|FG001|Overall Study|Withdrew Consent|5|||
129903254|NCT00922207|467606393|FG002|Overall Study|Withdrew Consent|2|||
129903255|NCT00922207|467606391|FG000|Overall Study|Abnormality of Laboratory Test|0|||
129903256|NCT00922207|467606392|FG001|Overall Study|Abnormality of Laboratory Test|1|||
129903257|NCT00922207|467606393|FG002|Overall Study|Abnormality of Laboratory Test|1|||
129903258|NCT00319436|467606397|FG000|Overall Study|Withdrawal by Subject|6|||
129903259|NCT00319436|467606398|FG001|Overall Study|Withdrawal by Subject|7|||
129903260|NCT02194933|467606409|FG000|Overall Study|Lost to Follow-up|1|||
129903261|NCT02194933|467606410|FG001|Overall Study|Lost to Follow-up|2|||
129903262|NCT02194933|467606409|FG000|Overall Study|Participant met withdrawal criteria|1|||
129846810|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
129846811|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
129846812|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
129846813|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
129903263|NCT02194933|467606410|FG001|Overall Study|Participant met withdrawal criteria|3|||
129903264|NCT02194933|467606409|FG000|Overall Study|Withdrawal by Subject|0|||
129846814|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
129846815|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
129846816|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
129846817|NCT04542070|467398593|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
129846818|NCT04542070|467398594|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
129846819|NCT04542070|467398595|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
129846820|NCT04542070|467398596|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
129846821|NCT04542070|467398593|FG000|Maintenance + Extension Period|Adverse Event|10|||
129846822|NCT04542070|467398594|FG001|Maintenance + Extension Period|Adverse Event|2|||
129846823|NCT04542070|467398595|FG002|Maintenance + Extension Period|Adverse Event|0|||
129846824|NCT04542070|467398596|FG003|Maintenance + Extension Period|Adverse Event|0|||
129846825|NCT04542070|467398593|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
129846826|NCT04542070|467398594|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
129846827|NCT04542070|467398595|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
129846828|NCT04542070|467398596|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
129846829|NCT04542070|467398593|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
129846830|NCT04542070|467398594|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
129846831|NCT04542070|467398595|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
129846832|NCT04542070|467398596|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
129846833|NCT04542070|467398593|FG000|Maintenance + Extension Period|Physician Decision|1|||
129846834|NCT04542070|467398594|FG001|Maintenance + Extension Period|Physician Decision|1|||
129846835|NCT04542070|467398595|FG002|Maintenance + Extension Period|Physician Decision|0|||
129846836|NCT04542070|467398596|FG003|Maintenance + Extension Period|Physician Decision|0|||
129846837|NCT04542070|467398593|FG000|Maintenance + Extension Period|Protocol Violation|2|||
129846838|NCT04542070|467398594|FG001|Maintenance + Extension Period|Protocol Violation|5|||
129846839|NCT04542070|467398595|FG002|Maintenance + Extension Period|Protocol Violation|0|||
129846840|NCT04542070|467398596|FG003|Maintenance + Extension Period|Protocol Violation|0|||
129846841|NCT04542070|467398593|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
129846842|NCT04542070|467398594|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
129846843|NCT04542070|467398595|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
129846844|NCT04542070|467398596|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
129846845|NCT04542070|467398593|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
129846846|NCT04542070|467398594|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
129846847|NCT04542070|467398595|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
129846848|NCT04542070|467398596|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
129846849|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
129846850|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
129846851|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
129846852|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
129846853|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
129846854|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
129846855|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
129846856|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
129846857|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
129846858|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
129846859|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
129846860|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
129846861|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
129846862|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
129846863|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
129846864|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
129846865|NCT04542070|467398593|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
129846866|NCT04542070|467398594|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
129846867|NCT04542070|467398595|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
129846868|NCT04542070|467398596|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
129846869|NCT03049813|467398598|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
129846870|NCT03049813|467398599|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
129846871|NCT03049813|467398600|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
129846872|NCT03049813|467398601|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
129846873|NCT03049813|467398598|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
129846874|NCT03049813|467398599|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
129846875|NCT03049813|467398600|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
129846876|NCT03049813|467398601|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
129846877|NCT03049813|467398598|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
129903265|NCT02194933|467606410|FG001|Overall Study|Withdrawal by Subject|2|||
129846878|NCT03049813|467398599|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
129846879|NCT03049813|467398600|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
129846880|NCT03049813|467398601|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
129846881|NCT03049813|467398598|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
129846882|NCT03049813|467398599|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
129846883|NCT03049813|467398600|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
129846884|NCT03049813|467398601|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
129846885|NCT00550836|467398602|FG000|Overall Study|Withdrawal by Subject|3|||
129846886|NCT00550836|467398603|FG001|Overall Study|Withdrawal by Subject|9|||
129846887|NCT03120013|467398604|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129846888|NCT03120013|467398605|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129846889|NCT02705820|467398606|FG000|Overall Study|Death|2|||
129846890|NCT02705820|467398606|FG000|Overall Study|Disease Progression|34|||
129846891|NCT02705820|467398606|FG000|Overall Study|Clinical Deterioration|3|||
129846892|NCT02702401|467398607|FG000|Overall Study|Death|242|||
129846893|NCT02702401|467398608|FG001|Overall Study|Death|125|||
129846894|NCT02702401|467398607|FG000|Overall Study|Withdrawal by Subject|15|||
129846895|NCT02702401|467398608|FG001|Overall Study|Withdrawal by Subject|5|||
129846896|NCT02702401|467398607|FG000|Overall Study|Sponsor Decision|19|||
129903266|NCT02194933|467606409|FG000|Overall Study|Lack of Efficacy|1|||
129846897|NCT02702401|467398608|FG001|Overall Study|Sponsor Decision|3|||
129846898|NCT02702401|467398607|FG000|Overall Study|Physician Decision|1|||
129846899|NCT02702401|467398608|FG001|Overall Study|Physician Decision|2|||
129846900|NCT02702401|467398607|FG000|Overall Study|Lost to Follow-up|1|||
129846901|NCT02702401|467398608|FG001|Overall Study|Lost to Follow-up|0|||
129903267|NCT02194933|467606410|FG001|Overall Study|Lack of Efficacy|2|||
129903268|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
129903269|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
129903270|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
129903271|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
129903272|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
129903273|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
129846902|NCT01856543|467398613|FG000|Overall Study|Treatment discontinued|6|||
129846903|NCT01856543|467398614|FG001|Overall Study|Treatment discontinued|3|||
129846904|NCT01856543|467398613|FG000|Overall Study|Withdrawn before start|7|||
129846905|NCT01856543|467398614|FG001|Overall Study|Withdrawn before start|3|||
129846906|NCT02457325|467398619|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
129846907|NCT02457325|467398620|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
129846908|NCT01541930|467398621|FG000|Overall Study|Withdrawal by Subject|1|||
129846909|NCT04187196|467398622|FG000|Overall Study|Screen Failure|2|||
129846910|NCT04187196|467398623|FG001|Overall Study|Screen Failure|0|||
129846911|NCT01957475|467398626|FG000|Test Period 1|Withdrawal by Subject|1|||
129846912|NCT01957475|467398627|FG001|Test Period 1|Withdrawal by Subject|0|||
129846913|NCT01957475|467398626|FG000|Test Period 1|Other|1|||
129846914|NCT01957475|467398627|FG001|Test Period 1|Other|0|||
129846915|NCT01957475|467398626|FG000|Test Period 1|Lack of Efficacy|0|||
129846916|NCT01957475|467398627|FG001|Test Period 1|Lack of Efficacy|1|||
129846917|NCT01957475|467398626|FG000|Test Period 2|Adverse Event|1|||
129846918|NCT01957475|467398627|FG001|Test Period 2|Adverse Event|0|||
129846919|NCT04587193|467398628|FG000|Overall Study|Screen failure after consent|3|||
129846920|NCT04587193|467398629|FG001|Overall Study|Screen failure after consent|0|||
129846921|NCT04587193|467398628|FG000|Overall Study|Device broke during study|3|||
129846922|NCT04587193|467398629|FG001|Overall Study|Device broke during study|2|||
129846923|NCT01552772|467398630|FG000|Overall Study|Lost to Follow-up|2|||
129846924|NCT01552772|467398630|FG000|Overall Study|Adverse Event|1|||
129846925|NCT01552772|467398630|FG000|Overall Study|Protocol Deviation|1|||
129846926|NCT02920983|467398633|FG000|Dispense 1|Unacceptable Lens Fit|0|||
129846927|NCT02920983|467398634|FG001|Dispense 1|Unacceptable Lens Fit|0|||
129903274|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
129846928|NCT02920983|467398635|FG002|Dispense 1|Unacceptable Lens Fit|0|||
129846929|NCT02920983|467398636|FG003|Dispense 1|Unacceptable Lens Fit|0|||
129846930|NCT02920983|467398637|FG004|Dispense 1|Unacceptable Lens Fit|1|||
129903275|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
129903276|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
129846931|NCT02920983|467398638|FG005|Dispense 1|Unacceptable Lens Fit|0|||
129846932|NCT02920983|467398633|FG000|Dispense 2|Unscceptable lens fit|1|||
129846933|NCT02920983|467398634|FG001|Dispense 2|Unscceptable lens fit|0|||
129846934|NCT02920983|467398635|FG002|Dispense 2|Unscceptable lens fit|0|||
129846935|NCT02920983|467398636|FG003|Dispense 2|Unscceptable lens fit|0|||
129903277|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
129846936|NCT02920983|467398637|FG004|Dispense 2|Unscceptable lens fit|1|||
129846937|NCT02920983|467398638|FG005|Dispense 2|Unscceptable lens fit|0|||
129846938|NCT02920983|467398633|FG000|Dispense 3|Unacceptable Lens Fit|1|||
129846939|NCT02920983|467398634|FG001|Dispense 3|Unacceptable Lens Fit|1|||
129846940|NCT02920983|467398635|FG002|Dispense 3|Unacceptable Lens Fit|0|||
129846941|NCT02920983|467398636|FG003|Dispense 3|Unacceptable Lens Fit|0|||
129846942|NCT02920983|467398637|FG004|Dispense 3|Unacceptable Lens Fit|1|||
129846943|NCT02920983|467398638|FG005|Dispense 3|Unacceptable Lens Fit|0|||
129846944|NCT03878134|467398639|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
129846945|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
129846946|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
129846947|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
129846948|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Death|1|||
129903278|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
129903279|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
129903280|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
129903281|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
129903282|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
129903283|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
129903284|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
129903285|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903286|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903287|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903288|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903289|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
129903290|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
129903291|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
129903292|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
129903293|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
129903294|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
129903295|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
129903296|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
129903297|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
129903298|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
129903299|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
129903300|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
129903301|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903302|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
129903303|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
129903304|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
129903305|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903306|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903307|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903308|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903309|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903310|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903311|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
129903312|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903313|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903314|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903315|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903316|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
129903317|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903318|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903319|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903320|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903321|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903322|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
129903323|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
129903324|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903325|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903326|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903327|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903328|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903329|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903330|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903331|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903332|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903333|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
129903334|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
129903335|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
129903336|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
129903337|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
129846949|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Death|0|||
129846950|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Death|0|||
129846951|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
129846952|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
129846953|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
129846954|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
129846955|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
129846956|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
129846957|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
129846958|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
129846959|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
129846960|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
129846961|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
129846962|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
129846963|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
129846964|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
129846965|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
129846966|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
129846967|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
129846968|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
129846969|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
129846970|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
129846971|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
129846972|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
129846973|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
129846974|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
129846975|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
129846976|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
129846977|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
129846978|NCT03655236|467398642|FG000|Subject Disposition in Part 1 Period|Other|0|||
129846979|NCT03655236|467398643|FG001|Subject Disposition in Part 1 Period|Other|2|||
129846980|NCT03655236|467398644|FG002|Subject Disposition in Part 1 Period|Other|2|||
129846981|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
129846982|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
129846983|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
129846984|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
129846985|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
129846986|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
129846987|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
129846988|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
129846989|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
129846990|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
129846991|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
129846992|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
129846993|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
129846994|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
129846995|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
129846996|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
129846997|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
129846998|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
129846999|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
129847000|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
129847001|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
129847002|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
129847003|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
129847004|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
129847005|NCT03655236|467398642|FG000|Subject Disposition in Part 2 Period|Other|1|||
129847006|NCT03655236|467398643|FG001|Subject Disposition in Part 2 Period|Other|0|||
129903338|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
129903339|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
129449607|NCT00467779|465945636|FG013|Stage 2A|Withdrawal by Subject|1|||
129449608|NCT00467779|465945637|FG014|Stage 2A|Withdrawal by Subject|0|||
129449609|NCT00467779|465945623|FG000|Stage 3|Adverse Event|0|||
129449610|NCT00467779|465945624|FG001|Stage 3|Adverse Event|0|||
129903340|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
129903341|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
129903342|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
129903343|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
129903344|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
129903345|NCT02914522|467606411|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903346|NCT02914522|467606412|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
129903347|NCT02914522|467606413|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903348|NCT02914522|467606414|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903349|NCT02914522|467606415|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
129903350|NCT02914522|467606416|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
129903351|NCT02914522|467606417|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903352|NCT02914522|467606418|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903353|NCT02914522|467606419|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903354|NCT02914522|467606420|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129449611|NCT00467779|465945625|FG002|Stage 3|Adverse Event|0|||
129903355|NCT02914522|467606421|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
129903356|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903357|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903358|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903359|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903360|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903361|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
129903362|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
129449612|NCT00467779|465945626|FG003|Stage 3|Adverse Event|0|||
129847007|NCT03655236|467398644|FG002|Subject Disposition in Part 2 Period|Other|0|||
129847008|NCT01709318|467400328|FG000|Overall Study|Adverse Event|3|||
129903363|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
129903364|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
129903365|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
129903366|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
129903367|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903368|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903369|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903370|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903371|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903372|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
129903373|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
129903374|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
129903375|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
129903376|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
129903377|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
129903378|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903379|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903380|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903381|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129847009|NCT01709318|467400329|FG001|Overall Study|Adverse Event|4|||
129847010|NCT01709318|467400330|FG002|Overall Study|Adverse Event|2|||
129847011|NCT01709318|467400331|FG003|Overall Study|Adverse Event|2|||
129847012|NCT01709318|467400332|FG004|Overall Study|Adverse Event|0|||
129847013|NCT01709318|467400333|FG005|Overall Study|Adverse Event|1|||
129847014|NCT01709318|467400334|FG006|Overall Study|Adverse Event|2|||
129847015|NCT01709318|467400328|FG000|Overall Study|Lost to Follow-up|2|||
129847016|NCT01709318|467400329|FG001|Overall Study|Lost to Follow-up|0|||
129847017|NCT01709318|467400330|FG002|Overall Study|Lost to Follow-up|0|||
129847018|NCT01709318|467400331|FG003|Overall Study|Lost to Follow-up|0|||
129847019|NCT01709318|467400332|FG004|Overall Study|Lost to Follow-up|1|||
129903382|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903383|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903384|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
129903385|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
129903386|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
129449613|NCT00467779|465945627|FG004|Stage 3|Adverse Event|0|||
129847020|NCT01709318|467400333|FG005|Overall Study|Lost to Follow-up|1|||
129847021|NCT01709318|467400334|FG006|Overall Study|Lost to Follow-up|1|||
129847022|NCT01709318|467400328|FG000|Overall Study|Non-compliance with Study Drug|0|||
129449614|NCT00467779|465945628|FG005|Stage 3|Adverse Event|0|||
129847023|NCT01709318|467400329|FG001|Overall Study|Non-compliance with Study Drug|2|||
129847024|NCT01709318|467400330|FG002|Overall Study|Non-compliance with Study Drug|1|||
129847025|NCT01709318|467400331|FG003|Overall Study|Non-compliance with Study Drug|1|||
129847026|NCT01709318|467400332|FG004|Overall Study|Non-compliance with Study Drug|0|||
129847027|NCT01709318|467400333|FG005|Overall Study|Non-compliance with Study Drug|0|||
129847028|NCT01709318|467400334|FG006|Overall Study|Non-compliance with Study Drug|2|||
129847029|NCT01709318|467400328|FG000|Overall Study|Physician Decision|0|||
129847030|NCT01709318|467400329|FG001|Overall Study|Physician Decision|0|||
129847031|NCT01709318|467400330|FG002|Overall Study|Physician Decision|0|||
129847032|NCT01709318|467400331|FG003|Overall Study|Physician Decision|0|||
129847033|NCT01709318|467400332|FG004|Overall Study|Physician Decision|0|||
129847034|NCT01709318|467400333|FG005|Overall Study|Physician Decision|0|||
129847035|NCT01709318|467400334|FG006|Overall Study|Physician Decision|1|||
129847036|NCT01709318|467400328|FG000|Overall Study|Pregnancy|0|||
129847037|NCT01709318|467400329|FG001|Overall Study|Pregnancy|0|||
129847038|NCT01709318|467400330|FG002|Overall Study|Pregnancy|0|||
129847039|NCT01709318|467400331|FG003|Overall Study|Pregnancy|0|||
129847040|NCT01709318|467400332|FG004|Overall Study|Pregnancy|1|||
129847041|NCT01709318|467400333|FG005|Overall Study|Pregnancy|0|||
129847042|NCT01709318|467400334|FG006|Overall Study|Pregnancy|0|||
129847043|NCT01709318|467400328|FG000|Overall Study|Protocol Violation|0|||
129847044|NCT01709318|467400329|FG001|Overall Study|Protocol Violation|0|||
129847045|NCT01709318|467400330|FG002|Overall Study|Protocol Violation|0|||
129847046|NCT01709318|467400331|FG003|Overall Study|Protocol Violation|0|||
129847047|NCT01709318|467400332|FG004|Overall Study|Protocol Violation|2|||
129847048|NCT01709318|467400333|FG005|Overall Study|Protocol Violation|0|||
129847049|NCT01709318|467400334|FG006|Overall Study|Protocol Violation|1|||
129847050|NCT01709318|467400328|FG000|Overall Study|Technical Problems|1|||
129847051|NCT01709318|467400329|FG001|Overall Study|Technical Problems|0|||
129847052|NCT01709318|467400330|FG002|Overall Study|Technical Problems|0|||
129847053|NCT01709318|467400331|FG003|Overall Study|Technical Problems|0|||
129847054|NCT01709318|467400332|FG004|Overall Study|Technical Problems|0|||
129847055|NCT01709318|467400333|FG005|Overall Study|Technical Problems|0|||
129847056|NCT01709318|467400334|FG006|Overall Study|Technical Problems|0|||
129847057|NCT01709318|467400328|FG000|Overall Study|Withdrawal by Subject|3|||
129847058|NCT01709318|467400329|FG001|Overall Study|Withdrawal by Subject|0|||
129847059|NCT01709318|467400330|FG002|Overall Study|Withdrawal by Subject|3|||
129847060|NCT01709318|467400331|FG003|Overall Study|Withdrawal by Subject|3|||
129847061|NCT01709318|467400332|FG004|Overall Study|Withdrawal by Subject|0|||
129847062|NCT01709318|467400333|FG005|Overall Study|Withdrawal by Subject|2|||
129847063|NCT01709318|467400334|FG006|Overall Study|Withdrawal by Subject|4|||
129847064|NCT01709318|467400328|FG000|Overall Study|Other Protocol Specified Criteria|0|||
129847065|NCT01709318|467400329|FG001|Overall Study|Other Protocol Specified Criteria|1|||
129847066|NCT01709318|467400330|FG002|Overall Study|Other Protocol Specified Criteria|0|||
129847067|NCT01709318|467400331|FG003|Overall Study|Other Protocol Specified Criteria|0|||
129847068|NCT01709318|467400332|FG004|Overall Study|Other Protocol Specified Criteria|0|||
129847069|NCT01709318|467400333|FG005|Overall Study|Other Protocol Specified Criteria|0|||
129847070|NCT01709318|467400334|FG006|Overall Study|Other Protocol Specified Criteria|0|||
129903387|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
129903388|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
129903389|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903390|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903391|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903392|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903393|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903394|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
129903395|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
129903396|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
129903397|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
129903398|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
129903399|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
129903400|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
129903401|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
129903402|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
129903403|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
129847071|NCT02383758|467400335|FG000|Overall Study|Withdrawal by Subject|0|||
129847072|NCT02383758|467400336|FG001|Overall Study|Withdrawal by Subject|2|||
129847073|NCT00600821|467400339|FG000|Overall Study|Death|45|||
129847074|NCT00600821|467400340|FG001|Overall Study|Death|46|||
129847075|NCT00600821|467400339|FG000|Overall Study|Lost to Follow-up|2|||
129847076|NCT00600821|467400340|FG001|Overall Study|Lost to Follow-up|2|||
129847077|NCT00600821|467400339|FG000|Overall Study|Withdrawal by Subject|1|||
129847078|NCT00600821|467400340|FG001|Overall Study|Withdrawal by Subject|1|||
129847079|NCT00600821|467400339|FG000|Overall Study|Terminated by sponsor|8|||
129847080|NCT00600821|467400340|FG001|Overall Study|Terminated by sponsor|6|||
129847081|NCT00600821|467400339|FG000|Overall Study|Objective progression or relapse|0|||
129847082|NCT00600821|467400340|FG001|Overall Study|Objective progression or relapse|1|||
129847083|NCT00600821|467400339|FG000|Overall Study|Randomized but not treated|0|||
129847084|NCT00600821|467400340|FG001|Overall Study|Randomized but not treated|1|||
129847085|NCT00600821|467400339|FG000|Overall Study|Other|2|||
129847086|NCT00600821|467400340|FG001|Overall Study|Other|3|||
129847087|NCT04101526|467400350|FG000|Overall Study|Did not complete all sleep diary entries|0|||
129847088|NCT04101526|467400351|FG001|Overall Study|Did not complete all sleep diary entries|1|||
129903404|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
129903405|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
129903406|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
129903407|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
129903408|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
129903409|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
129903410|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
129903411|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903412|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903413|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903414|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903415|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903416|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903417|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903418|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
129903419|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
129903420|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903421|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
129903422|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903423|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903424|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903425|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903426|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903427|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903428|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903429|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903430|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
129903431|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
129903432|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
129903433|NCT02914522|467606411|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903434|NCT02914522|467606412|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903435|NCT02914522|467606413|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903436|NCT02914522|467606414|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903437|NCT02914522|467606415|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903438|NCT02914522|467606416|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903439|NCT02914522|467606417|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129847089|NCT00424372|467400352|FG000|Overall Study|Death|1|||
129847090|NCT00424372|467400352|FG000|Overall Study|Adverse Event|18|||
129847091|NCT00424372|467400352|FG000|Overall Study|Lack of Efficacy|6|||
129847092|NCT00424372|467400352|FG000|Overall Study|Withdrawal by Subject|4|||
129847093|NCT00424372|467400352|FG000|Overall Study|Protocol Violation|1|||
129847094|NCT00424372|467400352|FG000|Overall Study|Health deterioration|1|||
129847095|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847096|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
129847097|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847098|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847099|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847100|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
129847101|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
129847102|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
129847103|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
129847104|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129847105|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129847106|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129847107|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
129847108|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847109|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847110|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847111|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847112|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
129847113|NCT04622254|467400353|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847114|NCT04622254|467400354|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
129847115|NCT04622254|467400355|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
129847116|NCT04622254|467400356|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847117|NCT04622254|467400357|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847118|NCT04622254|467400358|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129847119|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847120|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847121|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847122|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
129847123|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847124|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129847125|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847126|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847127|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847128|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
129847129|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129847130|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
129847131|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847132|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847133|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847134|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
129847135|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847136|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129847137|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847138|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847139|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847140|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
129847141|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847142|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129847143|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129847144|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129847145|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129847146|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
129847147|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
129847148|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
129847149|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129847150|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129847151|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129847152|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
129847153|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
129847154|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
129847155|NCT04622254|467400353|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
129847156|NCT04622254|467400354|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
129847157|NCT04622254|467400355|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
129847158|NCT04622254|467400356|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
129847159|NCT04622254|467400357|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
129847160|NCT04622254|467400358|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
129847161|NCT00098839|467400361|FG000|Overall Study|Adverse Event|5|||
129847162|NCT00098839|467400362|FG001|Overall Study|Adverse Event|2|||
129847163|NCT00098839|467400361|FG000|Overall Study|Death|1|||
129847164|NCT00098839|467400362|FG001|Overall Study|Death|2|||
129847165|NCT00098839|467400361|FG000|Overall Study|Physician Decision|4|||
129847166|NCT00098839|467400362|FG001|Overall Study|Physician Decision|14|||
129847167|NCT00098839|467400361|FG000|Overall Study|Withdrawal by Subject|1|||
129847168|NCT00098839|467400362|FG001|Overall Study|Withdrawal by Subject|0|||
129847169|NCT00098839|467400361|FG000|Overall Study|Refusal of further protocol therapy|3|||
129847170|NCT00098839|467400362|FG001|Overall Study|Refusal of further protocol therapy|1|||
129847171|NCT00098839|467400361|FG000|Overall Study|Relapse|6|||
129847172|NCT00098839|467400362|FG001|Overall Study|Relapse|3|||
129847173|NCT00098839|467400361|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
129847174|NCT00098839|467400362|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
129847175|NCT00098839|467400361|FG000|Overall Study|Ineligible|2|||
129847176|NCT00098839|467400362|FG001|Overall Study|Ineligible|0|||
129847177|NCT03228680|467400364|FG000|Overall Study|Adverse Event|13|||
129847178|NCT03228680|467400365|FG001|Overall Study|Adverse Event|18|||
129847179|NCT03228680|467400364|FG000|Overall Study|Randomization failure|0|||
129847180|NCT03228680|467400365|FG001|Overall Study|Randomization failure|1|||
129847181|NCT03228680|467400364|FG000|Overall Study|Withdrawal by Subject|1|||
129847182|NCT03228680|467400365|FG001|Overall Study|Withdrawal by Subject|0|||
129847183|NCT03228680|467400364|FG000|Overall Study|Other|9|||
129847184|NCT03228680|467400365|FG001|Overall Study|Other|16|||
129847185|NCT02167035|467400366|FG000|Overall Study|Adverse Event|2|||
129847186|NCT02167035|467400367|FG001|Overall Study|Adverse Event|2|||
129847187|NCT02167035|467400366|FG000|Overall Study|Lost to Follow-up|3|||
129847188|NCT02167035|467400367|FG001|Overall Study|Lost to Follow-up|3|||
129847189|NCT02167035|467400366|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
129847190|NCT02167035|467400367|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
129847191|NCT02148003|467400368|FG000|Overall Study|Failed inclusion criteria|1|||
129847192|NCT02148003|467400369|FG001|Overall Study|Failed inclusion criteria|0|||
129847193|NCT02148003|467400368|FG000|Overall Study|Met exclusion criteria|0|||
129847194|NCT02148003|467400369|FG001|Overall Study|Met exclusion criteria|1|||
129847195|NCT02148003|467400368|FG000|Overall Study|Withdrawal by Subject|0|||
129847196|NCT02148003|467400369|FG001|Overall Study|Withdrawal by Subject|1|||
129847197|NCT02489981|467400370|FG000|Overall Study|Adverse Event|21|||
129847198|NCT02489981|467400370|FG000|Overall Study|Insufficient effectiveness|16|||
129847199|NCT02489981|467400370|FG000|Overall Study|Improved|31|||
129847200|NCT02489981|467400370|FG000|Overall Study|Lost to Follow-up|31|||
129847201|NCT02489981|467400370|FG000|Overall Study|Other than listed|28|||
129847202|NCT00796861|467400371|FG000|Overall Study|Withdrawal by Subject|2|||
129847203|NCT00796861|467400371|FG000|Overall Study|Death|2|||
129847204|NCT03852316|467400374|FG000|Overall Study|Protocol Violation|1|||
129847205|NCT03852316|467400374|FG000|Overall Study|Withdrawal by Subject|2|||
129847206|NCT03852316|467400374|FG000|Overall Study|Enrolled but Device not Utilized|1|||
129847207|NCT01263873|467400375|FG000|Overall Study|One provider unable to complete numbers|1|||
129847208|NCT01263873|467400376|FG001|Overall Study|One provider unable to complete numbers|1|||
129847209|NCT00047463|467400377|FG000|Overall Study|Withdrawal by Subject|0|||
129847210|NCT00047463|467400378|FG001|Overall Study|Withdrawal by Subject|3|||
129847211|NCT01401530|467400380|FG000|Overall Study|Disease Progression|1|||
129847212|NCT01401530|467400381|FG001|Overall Study|Disease Progression|2|||
129847213|NCT01401530|467400382|FG002|Overall Study|Disease Progression|1|||
129847214|NCT01401530|467400380|FG000|Overall Study|Adverse Event|1|||
129847215|NCT01401530|467400381|FG001|Overall Study|Adverse Event|1|||
129847216|NCT01401530|467400382|FG002|Overall Study|Adverse Event|1|||
129847217|NCT01401530|467400380|FG000|Overall Study|Participant Choice|1|||
129847218|NCT01401530|467400381|FG001|Overall Study|Participant Choice|2|||
129847219|NCT01401530|467400382|FG002|Overall Study|Participant Choice|1|||
129847220|NCT01401530|467400380|FG000|Overall Study|Physician Decision|0|||
129847221|NCT01401530|467400381|FG001|Overall Study|Physician Decision|1|||
129847222|NCT01401530|467400382|FG002|Overall Study|Physician Decision|0|||
129847223|NCT04694131|467400389|FG000|Overall Study|Withdrawal by Subject|7|||
129847224|NCT04694131|467400389|FG000|Overall Study|Screen Failure|1|||
129847225|NCT04694131|467400389|FG000|Overall Study|High stimulation threshold|3|||
129847226|NCT04456699|467400390|FG000|Overall Study|Death|48|||
129847227|NCT04456699|467400391|FG001|Overall Study|Death|50|||
129847228|NCT04456699|467400392|FG002|Overall Study|Death|52|||
129847229|NCT04456699|467400390|FG000|Overall Study|Physician Decision|0|||
129847230|NCT04456699|467400391|FG001|Overall Study|Physician Decision|0|||
129847231|NCT04456699|467400392|FG002|Overall Study|Physician Decision|2|||
129847232|NCT04456699|467400390|FG000|Overall Study|Sponsor Decision|55|||
129847233|NCT04456699|467400391|FG001|Overall Study|Sponsor Decision|61|||
129847234|NCT04456699|467400392|FG002|Overall Study|Sponsor Decision|50|||
129847235|NCT04456699|467400390|FG000|Overall Study|Withdrawal by Subject|8|||
129847236|NCT04456699|467400391|FG001|Overall Study|Withdrawal by Subject|4|||
129847237|NCT04456699|467400392|FG002|Overall Study|Withdrawal by Subject|5|||
129847238|NCT04112810|467400393|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
129847239|NCT01859715|467400398|FG000|Overall Study|No 2nd VAS|16|||
129847240|NCT01859715|467400399|FG001|Overall Study|No 2nd VAS|8|||
129847241|NCT01859715|467400400|FG002|Overall Study|No 2nd VAS|23|||
129847242|NCT01252290|467400401|FG000|Overall Study|Withdrawal by Subject|1|||
129847243|NCT00086580|467400402|FG000|Treatment Period|Disease progression|9|||
129847244|NCT00086580|467400403|FG001|Treatment Period|Disease progression|8|||
129847245|NCT00086580|467400402|FG000|Treatment Period|Unable to comply with protocol|3|||
129847246|NCT00086580|467400403|FG001|Treatment Period|Unable to comply with protocol|1|||
129847247|NCT00086580|467400402|FG000|Treatment Period|Withdrawal by Subject|7|||
129847248|NCT00086580|467400403|FG001|Treatment Period|Withdrawal by Subject|8|||
129847249|NCT00086580|467400402|FG000|Treatment Period|Physician Decision|13|||
129847250|NCT00086580|467400403|FG001|Treatment Period|Physician Decision|7|||
129847251|NCT00086580|467400402|FG000|Treatment Period|AE - not treatment related|7|||
129847252|NCT00086580|467400403|FG001|Treatment Period|AE - not treatment related|7|||
129847253|NCT00086580|467400402|FG000|Treatment Period|Toxicity - treatment related|15|||
129847254|NCT00086580|467400403|FG001|Treatment Period|Toxicity - treatment related|15|||
129847255|NCT00086580|467400402|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
129847256|NCT00086580|467400403|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
129847257|NCT00086580|467400402|FG000|Treatment Period|Death|5|||
129847258|NCT00086580|467400403|FG001|Treatment Period|Death|7|||
129847259|NCT00086580|467400402|FG000|Treatment Period|Other|5|||
129847260|NCT00086580|467400403|FG001|Treatment Period|Other|3|||
129847261|NCT00086580|467400402|FG000|Follow-up Period|Disease progression|72|||
129847262|NCT00086580|467400403|FG001|Follow-up Period|Disease progression|99|||
129847263|NCT00086580|467400402|FG000|Follow-up Period|Unable to comply with protocol|5|||
129847264|NCT00086580|467400403|FG001|Follow-up Period|Unable to comply with protocol|0|||
129847265|NCT00086580|467400402|FG000|Follow-up Period|Withdrawal by Subject|6|||
129847266|NCT00086580|467400403|FG001|Follow-up Period|Withdrawal by Subject|6|||
129847267|NCT00086580|467400402|FG000|Follow-up Period|Physician Decision|0|||
129847268|NCT00086580|467400403|FG001|Follow-up Period|Physician Decision|1|||
129847269|NCT00086580|467400402|FG000|Follow-up Period|AE - not related|1|||
129847270|NCT00086580|467400403|FG001|Follow-up Period|AE - not related|0|||
129847271|NCT00086580|467400402|FG000|Follow-up Period|Death|13|||
129847272|NCT00086580|467400403|FG001|Follow-up Period|Death|7|||
129847273|NCT00086580|467400402|FG000|Follow-up Period|Other|7|||
129847274|NCT00086580|467400403|FG001|Follow-up Period|Other|6|||
129847275|NCT00086580|467400402|FG000|Observation Period|Unable to comply with protocol|1|||
129847276|NCT00086580|467400403|FG001|Observation Period|Unable to comply with protocol|1|||
129847277|NCT00086580|467400402|FG000|Observation Period|Withdrawal by Subject|4|||
129847278|NCT00086580|467400403|FG001|Observation Period|Withdrawal by Subject|2|||
129847279|NCT00086580|467400402|FG000|Observation Period|Death|33|||
129847280|NCT00086580|467400403|FG001|Observation Period|Death|55|||
129979685|NCT03752970|467889435|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
129847281|NCT00086580|467400402|FG000|Observation Period|Other|8|||
129847282|NCT00086580|467400403|FG001|Observation Period|Other|7|||
129847283|NCT01000051|467400407|FG000|Overall Study|Withdrawal by Subject|1|||
129847284|NCT01000051|467400408|FG001|Overall Study|Withdrawal by Subject|1|||
129847285|NCT01000051|467400407|FG000|Overall Study|Disease Progression|1|||
129847286|NCT01000051|467400408|FG001|Overall Study|Disease Progression|0|||
129847287|NCT01000051|467400407|FG000|Overall Study|Serious noncompliance|1|||
129847288|NCT01000051|467400408|FG001|Overall Study|Serious noncompliance|0|||
129847289|NCT02247349|467400409|FG000|Overall Study|Disease Progression|7|||
129847290|NCT02247349|467400410|FG001|Overall Study|Disease Progression|4|||
129847291|NCT02247349|467400411|FG002|Overall Study|Disease Progression|26|||
129847292|NCT02247349|467400412|FG003|Overall Study|Disease Progression|31|||
129847293|NCT02247349|467400413|FG004|Overall Study|Disease Progression|16|||
129847294|NCT02247349|467400414|FG005|Overall Study|Disease Progression|6|||
129847295|NCT02247349|467400409|FG000|Overall Study|Study drug toxicity|0|||
129847296|NCT02247349|467400410|FG001|Overall Study|Study drug toxicity|1|||
129847297|NCT02247349|467400411|FG002|Overall Study|Study drug toxicity|1|||
129847298|NCT02247349|467400412|FG003|Overall Study|Study drug toxicity|1|||
129847299|NCT02247349|467400413|FG004|Overall Study|Study drug toxicity|2|||
129847300|NCT02247349|467400414|FG005|Overall Study|Study drug toxicity|2|||
129847301|NCT02247349|467400409|FG000|Overall Study|Death|0|||
129847302|NCT02247349|467400410|FG001|Overall Study|Death|0|||
129847303|NCT02247349|467400411|FG002|Overall Study|Death|0|||
129847304|NCT02247349|467400412|FG003|Overall Study|Death|1|||
129847305|NCT02247349|467400413|FG004|Overall Study|Death|0|||
129847306|NCT02247349|467400414|FG005|Overall Study|Death|0|||
129847307|NCT02247349|467400409|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
129847308|NCT02247349|467400410|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
129847309|NCT02247349|467400411|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
129847310|NCT02247349|467400412|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
129847311|NCT02247349|467400413|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
129847312|NCT02247349|467400414|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
129847313|NCT02247349|467400409|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129847314|NCT02247349|467400410|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129847315|NCT02247349|467400411|FG002|Overall Study|Participant request to discontinue study treatment|1|||
129847316|NCT02247349|467400412|FG003|Overall Study|Participant request to discontinue study treatment|2|||
129847317|NCT02247349|467400413|FG004|Overall Study|Participant request to discontinue study treatment|1|||
129847318|NCT02247349|467400414|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129847319|NCT02247349|467400409|FG000|Overall Study|Withdrawal by Subject|0|||
129847320|NCT02247349|467400410|FG001|Overall Study|Withdrawal by Subject|1|||
129847321|NCT02247349|467400411|FG002|Overall Study|Withdrawal by Subject|0|||
129847322|NCT02247349|467400412|FG003|Overall Study|Withdrawal by Subject|0|||
129847323|NCT02247349|467400413|FG004|Overall Study|Withdrawal by Subject|0|||
129847324|NCT02247349|467400414|FG005|Overall Study|Withdrawal by Subject|0|||
129847325|NCT02247349|467400409|FG000|Overall Study|Administrative reason by sponsor|0|||
129847326|NCT02247349|467400410|FG001|Overall Study|Administrative reason by sponsor|0|||
129847327|NCT02247349|467400411|FG002|Overall Study|Administrative reason by sponsor|0|||
129847328|NCT02247349|467400412|FG003|Overall Study|Administrative reason by sponsor|0|||
129847329|NCT02247349|467400413|FG004|Overall Study|Administrative reason by sponsor|1|||
129847330|NCT02247349|467400414|FG005|Overall Study|Administrative reason by sponsor|0|||
129847331|NCT02247349|467400409|FG000|Overall Study|Other reasons|0|||
129847332|NCT02247349|467400410|FG001|Overall Study|Other reasons|0|||
129847333|NCT02247349|467400411|FG002|Overall Study|Other reasons|1|||
129847334|NCT02247349|467400412|FG003|Overall Study|Other reasons|0|||
129847335|NCT02247349|467400413|FG004|Overall Study|Other reasons|0|||
129903440|NCT02914522|467606418|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903441|NCT02914522|467606419|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903442|NCT02914522|467606420|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
129903443|NCT02914522|467606421|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
129903444|NCT03383146|467606422|FG000|Overall Study|Screen Failure|1|||
129847336|NCT02247349|467400414|FG005|Overall Study|Other reasons|0|||
129847337|NCT01959581|467400415|FG000|Overall Study|Lost to Follow-up|5|||
129847338|NCT00179413|467400417|FG000|Overall Study|Adverse Event|38|||
129847339|NCT00179413|467400418|FG001|Overall Study|Adverse Event|20|||
129847340|NCT00179413|467400417|FG000|Overall Study|Withdrawal by Subject|87|||
129847341|NCT00179413|467400418|FG001|Overall Study|Withdrawal by Subject|95|||
129847342|NCT01458171|467400421|FG000|Overall Study|Adverse Event|1|||
129847343|NCT01696032|467400422|FG000|Overall Study|Withdrawal by Subject|0|||
129847344|NCT01696032|467400423|FG001|Overall Study|Withdrawal by Subject|0|||
129847345|NCT01696032|467400424|FG002|Overall Study|Withdrawal by Subject|1|||
129847346|NCT01696032|467400425|FG003|Overall Study|Withdrawal by Subject|2|||
129847347|NCT01696032|467400422|FG000|Overall Study|Death|14|||
129847348|NCT01696032|467400423|FG001|Overall Study|Death|4|||
129847349|NCT01696032|467400424|FG002|Overall Study|Death|43|||
129847350|NCT01696032|467400425|FG003|Overall Study|Death|18|||
129847351|NCT01696032|467400422|FG000|Overall Study|Lost to Follow-up|0|||
129847352|NCT01696032|467400423|FG001|Overall Study|Lost to Follow-up|1|||
129847353|NCT01696032|467400424|FG002|Overall Study|Lost to Follow-up|0|||
129847354|NCT01696032|467400425|FG003|Overall Study|Lost to Follow-up|0|||
129847355|NCT01696032|467400422|FG000|Overall Study|Database lock|0|||
129847356|NCT01696032|467400423|FG001|Overall Study|Database lock|1|||
129847357|NCT01696032|467400424|FG002|Overall Study|Database lock|7|||
129847358|NCT01696032|467400425|FG003|Overall Study|Database lock|2|||
129847359|NCT02203591|467400429|FG000|Overall Study|Did not meet treatment day baseline|147|||
129847360|NCT02203591|467400430|FG001|Overall Study|Did not meet treatment day baseline|141|||
129847361|NCT02203591|467400431|FG002|Overall Study|Did not meet treatment day baseline|150|||
129847362|NCT02203591|467400432|FG003|Overall Study|Did not meet treatment day baseline|45|||
129847363|NCT02203591|467400433|FG004|Overall Study|Did not meet treatment day baseline|33|||
129847364|NCT02203591|467400434|FG005|Overall Study|Did not meet treatment day baseline|35|||
129847365|NCT02203591|467400435|FG006|Overall Study|Did not meet treatment day baseline|29|||
129847366|NCT02203591|467400436|FG007|Overall Study|Did not meet treatment day baseline|12|||
129847367|NCT02203591|467400429|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
129847368|NCT02203591|467400430|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
129847369|NCT02203591|467400431|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
129847370|NCT02203591|467400432|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
129847371|NCT02203591|467400433|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
129847372|NCT02203591|467400434|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
129847373|NCT02203591|467400435|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
129847374|NCT02203591|467400436|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
129847375|NCT00515827|467400439|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
129847376|NCT00515827|467400440|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
129847377|NCT00515827|467400439|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
129847378|NCT00515827|467400440|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
129847379|NCT05402995|467400443|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
129847380|NCT05402995|467400444|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
129847381|NCT05402995|467400445|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
129847382|NCT05402995|467400446|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
129847383|NCT01009099|467400447|FG000|Overall Study|Lost to Follow-up|1|||
129903445|NCT03383146|467606423|FG001|Overall Study|Screen Failure|0|||
129903446|NCT03383146|467606422|FG000|Overall Study|Adverse Event|6|||
129903447|NCT03383146|467606423|FG001|Overall Study|Adverse Event|18|||
129903448|NCT03383146|467606422|FG000|Overall Study|Lack of Efficacy|0|||
129903449|NCT03383146|467606423|FG001|Overall Study|Lack of Efficacy|3|||
129903450|NCT03383146|467606422|FG000|Overall Study|Withdrawal by Subject|20|||
129903451|NCT03383146|467606423|FG001|Overall Study|Withdrawal by Subject|36|||
129903452|NCT03383146|467606422|FG000|Overall Study|Lost to Follow-up|5|||
129903453|NCT03383146|467606423|FG001|Overall Study|Lost to Follow-up|15|||
129847384|NCT01009099|467400448|FG001|Overall Study|Lost to Follow-up|0|||
129847385|NCT01009099|467400447|FG000|Overall Study|Physician Decision|3|||
129847386|NCT01009099|467400448|FG001|Overall Study|Physician Decision|2|||
129847387|NCT01009099|467400447|FG000|Overall Study|Withdrawal by Subject|1|||
129847388|NCT01009099|467400448|FG001|Overall Study|Withdrawal by Subject|1|||
129847389|NCT01009099|467400447|FG000|Overall Study|Death|0|||
129903454|NCT03383146|467606422|FG000|Overall Study|Death|0|||
129903455|NCT03383146|467606423|FG001|Overall Study|Death|2|||
129903456|NCT03383146|467606422|FG000|Overall Study|Physician Decision|0|||
129847390|NCT01009099|467400448|FG001|Overall Study|Death|1|||
129847391|NCT02501096|467400460|FG000|Overall Study|Lost to Follow-up|0|||
129847392|NCT02501096|467400461|FG001|Overall Study|Lost to Follow-up|0|||
129847393|NCT02501096|467400462|FG002|Overall Study|Lost to Follow-up|0|||
129847394|NCT02501096|467400463|FG003|Overall Study|Lost to Follow-up|0|||
129847395|NCT02501096|467400464|FG004|Overall Study|Lost to Follow-up|1|||
129847396|NCT02501096|467400465|FG005|Overall Study|Lost to Follow-up|1|||
129847397|NCT02501096|467400466|FG006|Overall Study|Lost to Follow-up|3|||
129847398|NCT02501096|467400467|FG007|Overall Study|Lost to Follow-up|0|||
129847399|NCT02501096|467400468|FG008|Overall Study|Lost to Follow-up|0|||
129847400|NCT02501096|467400460|FG000|Overall Study|Withdrawal by Subject|1|||
129847401|NCT02501096|467400461|FG001|Overall Study|Withdrawal by Subject|0|||
129847402|NCT02501096|467400462|FG002|Overall Study|Withdrawal by Subject|7|||
129847403|NCT02501096|467400463|FG003|Overall Study|Withdrawal by Subject|13|||
129847404|NCT02501096|467400464|FG004|Overall Study|Withdrawal by Subject|2|||
129847405|NCT02501096|467400465|FG005|Overall Study|Withdrawal by Subject|2|||
129847406|NCT02501096|467400466|FG006|Overall Study|Withdrawal by Subject|2|||
129847407|NCT02501096|467400467|FG007|Overall Study|Withdrawal by Subject|3|||
129847408|NCT02501096|467400468|FG008|Overall Study|Withdrawal by Subject|0|||
129847409|NCT02501096|467400460|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
129847410|NCT02501096|467400461|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
129847411|NCT02501096|467400462|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
129847412|NCT02501096|467400463|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
129847413|NCT02501096|467400464|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
129847414|NCT02501096|467400465|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
129847415|NCT02501096|467400466|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
129847416|NCT02501096|467400467|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
129847417|NCT02501096|467400468|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
129847418|NCT02501096|467400460|FG000|Overall Study|Death|1|||
129847419|NCT02501096|467400461|FG001|Overall Study|Death|1|||
129847420|NCT02501096|467400462|FG002|Overall Study|Death|88|||
129847421|NCT02501096|467400463|FG003|Overall Study|Death|74|||
129847422|NCT02501096|467400464|FG004|Overall Study|Death|15|||
129847423|NCT02501096|467400465|FG005|Overall Study|Death|16|||
129847424|NCT02501096|467400466|FG006|Overall Study|Death|15|||
129847425|NCT02501096|467400467|FG007|Overall Study|Death|16|||
129847426|NCT02501096|467400468|FG008|Overall Study|Death|1|||
129847427|NCT00512096|467400472|FG000|Overall Study|Adverse Event|2|||
129847428|NCT00512096|467400472|FG000|Overall Study|Withdrawal by Subject|2|||
129847429|NCT00512096|467400472|FG000|Overall Study|Lack of Efficacy|3|||
129847430|NCT01069289|467400473|FG000|Overall Study|Withdrawal by Subject|15|||
129847431|NCT01069289|467400474|FG001|Overall Study|Withdrawal by Subject|26|||
129847432|NCT01069289|467400473|FG000|Overall Study|Adverse Event|21|||
129847433|NCT01069289|467400474|FG001|Overall Study|Adverse Event|28|||
129847434|NCT01069289|467400473|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129847435|NCT01069289|467400474|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129847436|NCT01069289|467400473|FG000|Overall Study|Severe non-compliance to protocol|3|||
129847437|NCT01069289|467400474|FG001|Overall Study|Severe non-compliance to protocol|2|||
129847438|NCT01069289|467400473|FG000|Overall Study|Due to deteriorating health condition|1|||
129847439|NCT01069289|467400474|FG001|Overall Study|Due to deteriorating health condition|0|||
129847440|NCT02696096|467400475|FG000|Overall Study|ruled out at screening|1|||
129847441|NCT02696096|467400475|FG000|Overall Study|did not attend second fMRI|1|||
129847442|NCT02047604|467400476|FG000|Overall Study|Withdrawal by Subject|0|||
129847443|NCT02047604|467400477|FG001|Overall Study|Withdrawal by Subject|0|||
129847444|NCT02047604|467400478|FG002|Overall Study|Withdrawal by Subject|0|||
129847445|NCT02047604|467400479|FG003|Overall Study|Withdrawal by Subject|0|||
129847446|NCT02047604|467400480|FG004|Overall Study|Withdrawal by Subject|1|||
129847447|NCT02047604|467400481|FG005|Overall Study|Withdrawal by Subject|1|||
129847448|NCT00773097|467400482|FG000|Overall Study|Withdrawal by Subject|1|||
129847449|NCT00773097|467400482|FG000|Overall Study|Physician Decision|6|||
129847450|NCT01755416|467400484|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
129847451|NCT01755416|467400485|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
129847452|NCT02742103|467402290|FG000|Overall Study|Protocol Violation|1|||
129847453|NCT02742103|467402291|FG001|Overall Study|Protocol Violation|0|||
129847454|NCT02742103|467402290|FG000|Overall Study|Death|2|||
129847455|NCT02742103|467402291|FG001|Overall Study|Death|2|||
129847456|NCT02742103|467402290|FG000|Overall Study|Adverse Event|1|||
129847457|NCT02742103|467402291|FG001|Overall Study|Adverse Event|0|||
129847458|NCT02742103|467402290|FG000|Overall Study|Moved to another town|0|||
129847459|NCT02742103|467402291|FG001|Overall Study|Moved to another town|1|||
129847460|NCT02742103|467402290|FG000|Overall Study|Withdrawal by Subject|5|||
129847461|NCT02742103|467402291|FG001|Overall Study|Withdrawal by Subject|2|||
129847462|NCT03042312|467402292|FG000|Overall Study|Administrative Reason|1|||
129847463|NCT03042312|467402293|FG001|Overall Study|Administrative Reason|1|||
129847464|NCT03042312|467402292|FG000|Overall Study|Adverse Event|0|||
129847465|NCT03042312|467402293|FG001|Overall Study|Adverse Event|1|||
129847466|NCT03042312|467402292|FG000|Overall Study|Lost to Follow-up|1|||
129847467|NCT03042312|467402293|FG001|Overall Study|Lost to Follow-up|3|||
129847468|NCT03042312|467402292|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
129847469|NCT03042312|467402293|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
129847470|NCT03042312|467402292|FG000|Overall Study|Withdrawal by Subject|4|||
129847471|NCT03042312|467402293|FG001|Overall Study|Withdrawal by Subject|5|||
129847472|NCT00646958|467402296|FG000|Overall Study|Lack of Efficacy|1|||
129847473|NCT00646958|467402297|FG001|Overall Study|Lack of Efficacy|0|||
129847474|NCT00646958|467402298|FG002|Overall Study|Lack of Efficacy|0|||
129847475|NCT00646958|467402296|FG000|Overall Study|Adverse Event|4|||
129847476|NCT00646958|467402297|FG001|Overall Study|Adverse Event|0|||
129847477|NCT00646958|467402298|FG002|Overall Study|Adverse Event|0|||
129847478|NCT00646958|467402296|FG000|Overall Study|Lost to Follow-up|1|||
129847479|NCT00646958|467402297|FG001|Overall Study|Lost to Follow-up|5|||
129847480|NCT00646958|467402298|FG002|Overall Study|Lost to Follow-up|7|||
129847481|NCT00646958|467402296|FG000|Overall Study|Protocol Violation|1|||
129847482|NCT00646958|467402297|FG001|Overall Study|Protocol Violation|1|||
129847483|NCT00646958|467402298|FG002|Overall Study|Protocol Violation|0|||
129847484|NCT00646958|467402296|FG000|Overall Study|Abnormal screening lab tests|1|||
129847485|NCT00646958|467402297|FG001|Overall Study|Abnormal screening lab tests|1|||
129847486|NCT00646958|467402298|FG002|Overall Study|Abnormal screening lab tests|0|||
129847487|NCT00646958|467402296|FG000|Overall Study|Withdrawal by Subject|1|||
129847488|NCT00646958|467402297|FG001|Overall Study|Withdrawal by Subject|2|||
129847489|NCT00646958|467402298|FG002|Overall Study|Withdrawal by Subject|0|||
129847490|NCT00646958|467402296|FG000|Overall Study|Did not receive study drug|2|||
129847491|NCT00646958|467402297|FG001|Overall Study|Did not receive study drug|0|||
129847492|NCT00646958|467402298|FG002|Overall Study|Did not receive study drug|2|||
129847493|NCT02573324|467402300|FG000|Overall Study|Withdrawal by Subject|26|||
129847494|NCT02573324|467402301|FG001|Overall Study|Withdrawal by Subject|23|||
129847495|NCT02573324|467402302|FG002|Overall Study|Withdrawal by Subject|3|||
129847496|NCT02573324|467402300|FG000|Overall Study|Lost to Follow-up|4|||
129847497|NCT02573324|467402301|FG001|Overall Study|Lost to Follow-up|5|||
129847498|NCT02573324|467402302|FG002|Overall Study|Lost to Follow-up|0|||
129847499|NCT02573324|467402300|FG000|Overall Study|Study Terminated by Sponsor|107|||
129847500|NCT02573324|467402301|FG001|Overall Study|Study Terminated by Sponsor|89|||
129847501|NCT02573324|467402302|FG002|Overall Study|Study Terminated by Sponsor|2|||
129847502|NCT02573324|467402300|FG000|Overall Study|Death|182|||
129847503|NCT02573324|467402301|FG001|Overall Study|Death|200|||
129847504|NCT02573324|467402302|FG002|Overall Study|Death|1|||
129847505|NCT02573324|467402300|FG000|Overall Study|Other, Not Specified|20|||
129847506|NCT02573324|467402301|FG001|Overall Study|Other, Not Specified|27|||
129847507|NCT02573324|467402302|FG002|Overall Study|Other, Not Specified|0|||
129847508|NCT02573324|467402300|FG000|Overall Study|Unknown Reason|2|||
129847509|NCT02573324|467402301|FG001|Overall Study|Unknown Reason|0|||
129847510|NCT02573324|467402302|FG002|Overall Study|Unknown Reason|0|||
129847511|NCT01105533|467402303|FG000|Overall Study|Death|0|||
129847512|NCT01105533|467402304|FG001|Overall Study|Death|0|||
129847513|NCT01105533|467402305|FG002|Overall Study|Death|0|||
129847514|NCT01105533|467402306|FG003|Overall Study|Death|0|||
129847515|NCT01105533|467402307|FG004|Overall Study|Death|1|||
129847516|NCT01105533|467402308|FG005|Overall Study|Death|0|||
129847517|NCT01105533|467402309|FG006|Overall Study|Death|0|||
129847518|NCT01105533|467402310|FG007|Overall Study|Death|0|||
129847519|NCT01105533|467402311|FG008|Overall Study|Death|0|||
129847520|NCT01105533|467402303|FG000|Overall Study|Lack of Efficacy|1|||
129847521|NCT01105533|467402304|FG001|Overall Study|Lack of Efficacy|1|||
129847522|NCT01105533|467402305|FG002|Overall Study|Lack of Efficacy|3|||
129847523|NCT01105533|467402306|FG003|Overall Study|Lack of Efficacy|3|||
129847524|NCT01105533|467402307|FG004|Overall Study|Lack of Efficacy|4|||
129847525|NCT01105533|467402308|FG005|Overall Study|Lack of Efficacy|5|||
129847526|NCT01105533|467402309|FG006|Overall Study|Lack of Efficacy|3|||
129847527|NCT01105533|467402310|FG007|Overall Study|Lack of Efficacy|2|||
129847528|NCT01105533|467402311|FG008|Overall Study|Lack of Efficacy|9|||
129847529|NCT01105533|467402303|FG000|Overall Study|Adverse Event|0|||
129847530|NCT01105533|467402304|FG001|Overall Study|Adverse Event|0|||
129847531|NCT01105533|467402305|FG002|Overall Study|Adverse Event|0|||
129847532|NCT01105533|467402306|FG003|Overall Study|Adverse Event|0|||
129847533|NCT01105533|467402307|FG004|Overall Study|Adverse Event|1|||
129847534|NCT01105533|467402308|FG005|Overall Study|Adverse Event|2|||
129847535|NCT01105533|467402309|FG006|Overall Study|Adverse Event|2|||
129847536|NCT01105533|467402310|FG007|Overall Study|Adverse Event|0|||
129847537|NCT01105533|467402311|FG008|Overall Study|Adverse Event|1|||
129847538|NCT01105533|467402303|FG000|Overall Study|Other|0|||
129847539|NCT01105533|467402304|FG001|Overall Study|Other|0|||
129847540|NCT01105533|467402305|FG002|Overall Study|Other|0|||
129847541|NCT01105533|467402306|FG003|Overall Study|Other|0|||
129847542|NCT01105533|467402307|FG004|Overall Study|Other|1|||
129847543|NCT01105533|467402308|FG005|Overall Study|Other|0|||
129847544|NCT01105533|467402309|FG006|Overall Study|Other|3|||
129847545|NCT01105533|467402310|FG007|Overall Study|Other|1|||
129847546|NCT01105533|467402311|FG008|Overall Study|Other|2|||
129847547|NCT01105533|467402303|FG000|Overall Study|Physician Decision|0|||
129847548|NCT01105533|467402304|FG001|Overall Study|Physician Decision|0|||
129847549|NCT01105533|467402305|FG002|Overall Study|Physician Decision|0|||
129847550|NCT01105533|467402306|FG003|Overall Study|Physician Decision|0|||
129847551|NCT01105533|467402307|FG004|Overall Study|Physician Decision|0|||
129847552|NCT01105533|467402308|FG005|Overall Study|Physician Decision|0|||
129847553|NCT01105533|467402309|FG006|Overall Study|Physician Decision|0|||
129847554|NCT01105533|467402310|FG007|Overall Study|Physician Decision|1|||
129847555|NCT01105533|467402311|FG008|Overall Study|Physician Decision|0|||
129847556|NCT02096835|467402313|FG000|Overall Study|Withdrawal by Subject|1|||
129847557|NCT02096835|467402314|FG001|Overall Study|Withdrawal by Subject|0|||
129847558|NCT02096835|467402315|FG002|Overall Study|Withdrawal by Subject|0|||
129847559|NCT02096835|467402313|FG000|Overall Study|converted to open procedures|1|||
129847560|NCT02096835|467402314|FG001|Overall Study|converted to open procedures|0|||
129847561|NCT02096835|467402315|FG002|Overall Study|converted to open procedures|0|||
129847562|NCT02096835|467402313|FG000|Overall Study|Lost to Follow-up|1|||
129847563|NCT02096835|467402314|FG001|Overall Study|Lost to Follow-up|0|||
129847564|NCT02096835|467402315|FG002|Overall Study|Lost to Follow-up|1|||
129847565|NCT03892889|467402316|FG000|Overall Study|Adverse Event|17|||
129847566|NCT03892889|467402316|FG000|Overall Study|Lack of Efficacy|1|||
129847567|NCT03892889|467402316|FG000|Overall Study|Lost to Follow-up|46|||
129847568|NCT03892889|467402316|FG000|Overall Study|Non-compliance with study drug|22|||
129847569|NCT03892889|467402316|FG000|Overall Study|Pregnancy|1|||
129847570|NCT03892889|467402316|FG000|Overall Study|Protocol Deviation|3|||
129847571|NCT03892889|467402316|FG000|Overall Study|Withdrawal by Subject|50|||
129847572|NCT03892889|467402316|FG000|Overall Study|Withdrawal by Caregiver|1|||
129847573|NCT03892889|467402316|FG000|Overall Study|Study Terminated by Sponsor|50|||
129847574|NCT03892889|467402316|FG000|Overall Study|Physician Decision|8|||
129847575|NCT03892889|467402316|FG000|Overall Study|Reason not Specified|5|||
129847576|NCT04260191|467402317|FG000|Overall Study|Decision by Sponsor|0|||
129847577|NCT04260191|467402318|FG001|Overall Study|Decision by Sponsor|1|||
129847578|NCT04260191|467402319|FG002|Overall Study|Decision by Sponsor|0|||
129847579|NCT04260191|467402317|FG000|Overall Study|Withdrawal by Subject|1|||
129847580|NCT04260191|467402318|FG001|Overall Study|Withdrawal by Subject|0|||
129847581|NCT04260191|467402319|FG002|Overall Study|Withdrawal by Subject|3|||
129847582|NCT04260191|467402317|FG000|Overall Study|Death|4|||
129847583|NCT04260191|467402318|FG001|Overall Study|Death|3|||
129847584|NCT04260191|467402319|FG002|Overall Study|Death|2|||
129847585|NCT00023673|467402322|FG000|Overall Study|Ineligible / no protocol treatment|0|||
129847586|NCT00023673|467402323|FG001|Overall Study|Ineligible / no protocol treatment|0|||
129847587|NCT00023673|467402324|FG002|Overall Study|Ineligible / no protocol treatment|0|||
129847588|NCT00023673|467402325|FG003|Overall Study|Ineligible / no protocol treatment|1|||
129847589|NCT00023673|467402322|FG000|Overall Study|Patient withdrew consent|0|||
129847590|NCT00023673|467402323|FG001|Overall Study|Patient withdrew consent|0|||
129847591|NCT00023673|467402324|FG002|Overall Study|Patient withdrew consent|0|||
129847592|NCT00023673|467402325|FG003|Overall Study|Patient withdrew consent|1|||
129847593|NCT02453594|467402326|FG000|Overall Study|Protocol Violation|0|||
129847594|NCT02453594|467402327|FG001|Overall Study|Protocol Violation|0|||
129847595|NCT02453594|467402328|FG002|Overall Study|Protocol Violation|1|||
129847596|NCT02453594|467402326|FG000|Overall Study|Cohort Was Closed|17|||
129847597|NCT02453594|467402327|FG001|Overall Study|Cohort Was Closed|21|||
129847598|NCT02453594|467402328|FG002|Overall Study|Cohort Was Closed|14|||
129847599|NCT02453594|467402326|FG000|Overall Study|Death|20|||
129847600|NCT02453594|467402327|FG001|Overall Study|Death|24|||
129847601|NCT02453594|467402328|FG002|Overall Study|Death|16|||
129847602|NCT02453594|467402326|FG000|Overall Study|Lost to Follow-up|6|||
129847603|NCT02453594|467402327|FG001|Overall Study|Lost to Follow-up|14|||
129847604|NCT02453594|467402328|FG002|Overall Study|Lost to Follow-up|2|||
129847605|NCT02453594|467402326|FG000|Overall Study|Physician Decision|2|||
129847606|NCT02453594|467402327|FG001|Overall Study|Physician Decision|4|||
129847607|NCT02453594|467402328|FG002|Overall Study|Physician Decision|0|||
129847608|NCT02453594|467402326|FG000|Overall Study|Site Terminated by Sponsor|1|||
129847609|NCT02453594|467402327|FG001|Overall Study|Site Terminated by Sponsor|0|||
129847610|NCT02453594|467402328|FG002|Overall Study|Site Terminated by Sponsor|1|||
129903457|NCT03383146|467606423|FG001|Overall Study|Physician Decision|1|||
129847611|NCT02453594|467402326|FG000|Overall Study|Transitioned to Extension Study|16|||
129847612|NCT02453594|467402327|FG001|Overall Study|Transitioned to Extension Study|9|||
129847613|NCT02453594|467402328|FG002|Overall Study|Transitioned to Extension Study|16|||
129847614|NCT02453594|467402326|FG000|Overall Study|Withdrawal by Subject|7|||
129847615|NCT02453594|467402327|FG001|Overall Study|Withdrawal by Subject|9|||
129847616|NCT02453594|467402328|FG002|Overall Study|Withdrawal by Subject|11|||
129847617|NCT02086591|467402329|FG000|Overall Study|Adverse Event|1|||
129847618|NCT02086591|467402329|FG000|Overall Study|Withdrawal by Subject|1|||
129847619|NCT02086591|467402329|FG000|Overall Study|protocol terminated|3|||
129847620|NCT02660359|467402330|FG000|Overall Study|Protocol Deviation|0|||
129847621|NCT02660359|467402331|FG001|Overall Study|Protocol Deviation|0|||
129847622|NCT02660359|467402332|FG002|Overall Study|Protocol Deviation|1|||
129847623|NCT02660359|467402330|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
129847624|NCT02660359|467402331|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
129847625|NCT02660359|467402332|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
129847626|NCT02660359|467402330|FG000|Overall Study|Lack of Efficacy|1|||
129847627|NCT02660359|467402331|FG001|Overall Study|Lack of Efficacy|1|||
129847628|NCT02660359|467402332|FG002|Overall Study|Lack of Efficacy|1|||
129847629|NCT02660359|467402330|FG000|Overall Study|Adverse Event|0|||
129847630|NCT02660359|467402331|FG001|Overall Study|Adverse Event|1|||
129847631|NCT02660359|467402332|FG002|Overall Study|Adverse Event|0|||
129847632|NCT02660359|467402330|FG000|Overall Study|Other|2|||
129847633|NCT02660359|467402331|FG001|Overall Study|Other|1|||
129847634|NCT02660359|467402332|FG002|Overall Study|Other|3|||
129847635|NCT02660359|467402330|FG000|Overall Study|Withdrawal by Subject|7|||
129847636|NCT02660359|467402331|FG001|Overall Study|Withdrawal by Subject|5|||
129847637|NCT02660359|467402332|FG002|Overall Study|Withdrawal by Subject|8|||
129847638|NCT02660359|467402330|FG000|Overall Study|Lost to Follow-up|3|||
129847639|NCT02660359|467402331|FG001|Overall Study|Lost to Follow-up|3|||
129847640|NCT02660359|467402332|FG002|Overall Study|Lost to Follow-up|0|||
129847641|NCT03348904|467402334|FG000|Overall Study|Administrative reason by the sponsor|0|||
129847642|NCT03348904|467402335|FG001|Overall Study|Administrative reason by the sponsor|1|||
129847643|NCT03348904|467402336|FG002|Overall Study|Administrative reason by the sponsor|0|||
129847644|NCT04086472|467402337|FG000|Overall Study|Lost to Follow-up|1|||
129847645|NCT04086472|467402338|FG001|Overall Study|Lost to Follow-up|0|||
129847646|NCT04086472|467402339|FG002|Overall Study|Lost to Follow-up|0|||
129847647|NCT04086472|467402340|FG003|Overall Study|Lost to Follow-up|0|||
129847648|NCT04086472|467402341|FG004|Overall Study|Lost to Follow-up|1|||
129847649|NCT04086472|467402337|FG000|Overall Study|Physician Decision|0|||
129847650|NCT04086472|467402338|FG001|Overall Study|Physician Decision|1|||
129847651|NCT04086472|467402339|FG002|Overall Study|Physician Decision|1|||
129847652|NCT04086472|467402340|FG003|Overall Study|Physician Decision|0|||
129847653|NCT04086472|467402341|FG004|Overall Study|Physician Decision|0|||
129847654|NCT04086472|467402337|FG000|Overall Study|Withdrawal by Subject|1|||
129847655|NCT04086472|467402338|FG001|Overall Study|Withdrawal by Subject|1|||
129847656|NCT04086472|467402339|FG002|Overall Study|Withdrawal by Subject|1|||
129847657|NCT04086472|467402340|FG003|Overall Study|Withdrawal by Subject|0|||
129847658|NCT04086472|467402341|FG004|Overall Study|Withdrawal by Subject|0|||
129847659|NCT04086472|467402337|FG000|Overall Study|Various reasons|2|||
129847660|NCT04086472|467402338|FG001|Overall Study|Various reasons|0|||
129847661|NCT04086472|467402339|FG002|Overall Study|Various reasons|0|||
129847662|NCT04086472|467402340|FG003|Overall Study|Various reasons|3|||
129847663|NCT04086472|467402341|FG004|Overall Study|Various reasons|1|||
129847664|NCT00048724|467402347|FG000|Overall Study|Adverse Event|53|||
129847665|NCT00048724|467402348|FG001|Overall Study|Adverse Event|12|||
129847666|NCT00048724|467402347|FG000|Overall Study|Withdrawal by Subject|34|||
129847667|NCT00048724|467402348|FG001|Overall Study|Withdrawal by Subject|54|||
129847668|NCT00048724|467402347|FG000|Overall Study|Lost to Follow-up|5|||
129903458|NCT03383146|467606422|FG000|Overall Study|Protocol Deviation|1|||
129903459|NCT03383146|467606423|FG001|Overall Study|Protocol Deviation|8|||
129903460|NCT03383146|467606422|FG000|Overall Study|Study Terminated by the Sponsor|48|||
129903461|NCT03383146|467606423|FG001|Overall Study|Study Terminated by the Sponsor|95|||
129903462|NCT03383146|467606422|FG000|Overall Study|Reason not Specified|4|||
129903463|NCT03383146|467606423|FG001|Overall Study|Reason not Specified|6|||
129903464|NCT00639002|467606426|FG000|Overall Study|Death|1|||
129903465|NCT00639002|467606426|FG000|Overall Study|Adverse Event|1|||
129903466|NCT00639002|467606426|FG000|Overall Study|Protocol Violation|1|||
129903467|NCT00639002|467606426|FG000|Overall Study|Disease progression|3|||
129903468|NCT00639002|467606426|FG000|Overall Study|Physician Decision|6|||
129903469|NCT00639002|467606426|FG000|Overall Study|Lack of Efficacy|1|||
129903470|NCT05382104|467606427|FG000|Period 2 (2 Days)|Adverse Event|0|||
129903471|NCT05382104|467606428|FG001|Period 2 (2 Days)|Adverse Event|1|||
129903472|NCT05382104|467606429|FG002|Period 2 (2 Days)|Adverse Event|0|||
129903473|NCT05382104|467606430|FG003|Period 2 (2 Days)|Adverse Event|0|||
129847669|NCT00048724|467402348|FG001|Overall Study|Lost to Follow-up|5|||
129847670|NCT00048724|467402347|FG000|Overall Study|Protocol-defined Clinical Event|17|||
129903474|NCT05382104|467606431|FG004|Period 2 (2 Days)|Adverse Event|0|||
129903475|NCT05382104|467606432|FG005|Period 2 (2 Days)|Adverse Event|0|||
129903476|NCT00940992|467606440|FG000|Overall Study|Adverse Event|2|||
129903477|NCT00940992|467606441|FG001|Overall Study|Adverse Event|0|||
129903478|NCT00940992|467606442|FG002|Overall Study|Adverse Event|1|||
129903479|NCT00940992|467606440|FG000|Overall Study|subject request|2|||
129903480|NCT00940992|467606441|FG001|Overall Study|subject request|1|||
129847671|NCT00048724|467402348|FG001|Overall Study|Protocol-defined Clinical Event|32|||
129847672|NCT00048724|467402347|FG000|Overall Study|Noncompliance With Protocol|4|||
129847673|NCT00048724|467402348|FG001|Overall Study|Noncompliance With Protocol|12|||
129847674|NCT00048724|467402347|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
129847675|NCT00048724|467402348|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
129847676|NCT00048724|467402347|FG000|Overall Study|Administrative|1|||
129847677|NCT00048724|467402348|FG001|Overall Study|Administrative|1|||
129847678|NCT00844545|467402349|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
129847679|NCT00844545|467402349|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
129847680|NCT00844545|467402349|FG000|Extension Treatment Period|Adverse Event|2|||
129847681|NCT00844545|467402349|FG000|Post Treatment Period|Withdrawal by Subject|1|||
129847682|NCT02039427|467402350|FG000|Overall Study|Duration of surgery > 3h|1|||
129847683|NCT02039427|467402351|FG001|Overall Study|Duration of surgery > 3h|1|||
129847684|NCT02039427|467402352|FG002|Overall Study|Duration of surgery > 3h|0|||
129847685|NCT02039427|467402353|FG003|Overall Study|Duration of surgery > 3h|0|||
129847686|NCT02039427|467402350|FG000|Overall Study|Withdrawal on concent|0|||
129847687|NCT02039427|467402351|FG001|Overall Study|Withdrawal on concent|0|||
129847688|NCT02039427|467402352|FG002|Overall Study|Withdrawal on concent|0|||
129847689|NCT02039427|467402353|FG003|Overall Study|Withdrawal on concent|1|||
129847690|NCT02039427|467402350|FG000|Overall Study|Cancellation of surgery|0|||
129847691|NCT02039427|467402351|FG001|Overall Study|Cancellation of surgery|0|||
129847692|NCT02039427|467402352|FG002|Overall Study|Cancellation of surgery|1|||
129847693|NCT02039427|467402353|FG003|Overall Study|Cancellation of surgery|0|||
129847694|NCT02039427|467402350|FG000|Overall Study|Loss of follow - up|1|||
129847695|NCT02039427|467402351|FG001|Overall Study|Loss of follow - up|0|||
129847696|NCT02039427|467402352|FG002|Overall Study|Loss of follow - up|2|||
129847697|NCT02039427|467402353|FG003|Overall Study|Loss of follow - up|4|||
129847698|NCT02039427|467402350|FG000|Overall Study|Steroid Use|1|||
129847699|NCT02039427|467402351|FG001|Overall Study|Steroid Use|0|||
129847700|NCT02039427|467402352|FG002|Overall Study|Steroid Use|0|||
129847701|NCT02039427|467402353|FG003|Overall Study|Steroid Use|0|||
129847702|NCT01743092|467402354|FG000|Overall Study|Lost to Follow-up|14|||
129847703|NCT01743092|467402355|FG001|Overall Study|Lost to Follow-up|15|||
129847704|NCT03586869|467402361|FG000|Overall Study|Progressive Disease|3|||
129847705|NCT00403455|467402362|FG000|Overall Study|Withdrawal by Subject|1|||
129847706|NCT00087568|467402371|FG000|Overall Study|Adverse Event|4|||
129847707|NCT00087568|467402372|FG001|Overall Study|Adverse Event|0|||
129847708|NCT00087568|467402371|FG000|Overall Study|Withdrawal by Subject|1|||
129847709|NCT00087568|467402372|FG001|Overall Study|Withdrawal by Subject|1|||
129847710|NCT00087568|467402371|FG000|Overall Study|Lost to Follow-up|1|||
129847711|NCT00087568|467402372|FG001|Overall Study|Lost to Follow-up|0|||
129847712|NCT00087568|467402371|FG000|Overall Study|Lack of Efficacy|24|||
129847713|NCT00087568|467402372|FG001|Overall Study|Lack of Efficacy|1|||
129847714|NCT04394351|467402373|FG000|Part A (16 Weeks)|Adverse Event|1|||
129847715|NCT04394351|467402374|FG001|Part A (16 Weeks)|Adverse Event|0|||
129847716|NCT04394351|467402375|FG002|Part A (16 Weeks)|Adverse Event|0|||
129847717|NCT04394351|467402376|FG003|Part A (16 Weeks)|Adverse Event|0|||
129847718|NCT04394351|467402377|FG004|Part A (16 Weeks)|Adverse Event|0|||
129847719|NCT04394351|467402378|FG005|Part A (16 Weeks)|Adverse Event|0|||
129847720|NCT04394351|467402379|FG006|Part A (16 Weeks)|Adverse Event|0|||
129847721|NCT04394351|467402380|FG007|Part A (16 Weeks)|Adverse Event|0|||
129847722|NCT04394351|467402373|FG000|Part A (16 Weeks)|Physician Decision|0|||
129847723|NCT04394351|467402374|FG001|Part A (16 Weeks)|Physician Decision|1|||
129847724|NCT04394351|467402375|FG002|Part A (16 Weeks)|Physician Decision|0|||
129847725|NCT04394351|467402376|FG003|Part A (16 Weeks)|Physician Decision|0|||
129847726|NCT04394351|467402377|FG004|Part A (16 Weeks)|Physician Decision|0|||
129847727|NCT04394351|467402378|FG005|Part A (16 Weeks)|Physician Decision|0|||
129847728|NCT04394351|467402379|FG006|Part A (16 Weeks)|Physician Decision|0|||
129847729|NCT04394351|467402380|FG007|Part A (16 Weeks)|Physician Decision|0|||
129847730|NCT04394351|467402373|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847731|NCT04394351|467402374|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
129847732|NCT04394351|467402375|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847733|NCT04394351|467402376|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847734|NCT04394351|467402377|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847735|NCT04394351|467402378|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847736|NCT04394351|467402379|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847737|NCT04394351|467402380|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
129847738|NCT04394351|467402373|FG000|Part B (36 Weeks)|Adverse Event|0|||
129847739|NCT04394351|467402374|FG001|Part B (36 Weeks)|Adverse Event|0|||
129847740|NCT04394351|467402375|FG002|Part B (36 Weeks)|Adverse Event|0|||
129847741|NCT04394351|467402376|FG003|Part B (36 Weeks)|Adverse Event|0|||
129847742|NCT04394351|467402377|FG004|Part B (36 Weeks)|Adverse Event|0|||
129847743|NCT04394351|467402378|FG005|Part B (36 Weeks)|Adverse Event|0|||
129847744|NCT04394351|467402379|FG006|Part B (36 Weeks)|Adverse Event|1|||
129847745|NCT04394351|467402380|FG007|Part B (36 Weeks)|Adverse Event|0|||
129847746|NCT04354831|467402385|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
129847747|NCT04354831|467402386|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
129847748|NCT02732847|467402387|FG000|Overall Study|some filled early|42|||
129847749|NCT02732847|467402388|FG001|Overall Study|some filled early|42|||
129847750|NCT01430585|467402393|FG000|Overall Study|Death|1|||
129847751|NCT01430585|467402393|FG000|Overall Study|Objective Progression or Relapse|3|||
129847752|NCT01430585|467402393|FG000|Overall Study|Study Terminated by Sponsor|3|||
129847753|NCT01430585|467402393|FG000|Overall Study|Other|7|||
129847754|NCT02357576|467402394|FG000|Treatment Period|Withdrawal by Subject|0|||
129847755|NCT02357576|467402395|FG001|Treatment Period|Withdrawal by Subject|1|||
129847756|NCT02357576|467402394|FG000|Treatment Period|Physician Decision|0|||
129847757|NCT02357576|467402395|FG001|Treatment Period|Physician Decision|1|||
129847758|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
129847759|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
129847760|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
129847761|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
129847762|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
129847763|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
129847764|NCT02357576|467402394|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
129847765|NCT02357576|467402395|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
129847766|NCT00699699|467402398|FG000|Overall Study|Adverse Event|36|||
129847767|NCT00699699|467402398|FG000|Overall Study|Individual different reasons|21|||
129847768|NCT01632800|467402401|FG000|Overall Study|Subject did not fit in apparatus|1|||
129847769|NCT00057746|467402405|FG000|Overall Study|Withdrawal by Subject|0|||
129847770|NCT00057746|467402406|FG001|Overall Study|Withdrawal by Subject|0|||
129847771|NCT00057746|467402407|FG002|Overall Study|Withdrawal by Subject|1|||
129449615|NCT00467779|465945629|FG006|Stage 3|Adverse Event|0|||
129449616|NCT00467779|465945630|FG007|Stage 3|Adverse Event|0|||
129449617|NCT00467779|465945631|FG008|Stage 3|Adverse Event|0|||
129449618|NCT00467779|465945632|FG009|Stage 3|Adverse Event|0|||
129449619|NCT00467779|465945633|FG010|Stage 3|Adverse Event|0|||
129449620|NCT00467779|465945634|FG011|Stage 3|Adverse Event|0|||
129449621|NCT00467779|465945635|FG012|Stage 3|Adverse Event|0|||
129449622|NCT00467779|465945636|FG013|Stage 3|Adverse Event|0|||
129847772|NCT01469065|467402414|FG000|Overall Study|Lack of Efficacy|0|||
129847773|NCT01469065|467402415|FG001|Overall Study|Lack of Efficacy|0|||
129847774|NCT01469065|467402416|FG002|Overall Study|Lack of Efficacy|0|||
129847775|NCT01469065|467402417|FG003|Overall Study|Lack of Efficacy|0|||
129847776|NCT01469065|467402418|FG004|Overall Study|Lack of Efficacy|1|||
129847777|NCT01469065|467402414|FG000|Overall Study|Other|0|||
129847778|NCT01469065|467402415|FG001|Overall Study|Other|1|||
129847779|NCT01469065|467402416|FG002|Overall Study|Other|0|||
129847780|NCT01469065|467402417|FG003|Overall Study|Other|0|||
129847781|NCT01469065|467402418|FG004|Overall Study|Other|0|||
129847782|NCT03075644|467402419|FG000|Overall Study|Withdrawal by Subject|1|||
129847783|NCT03075644|467402420|FG001|Overall Study|Withdrawal by Subject|1|||
129847784|NCT00578565|467402421|FG000|Overall Study|Adverse Event|3|||
129847785|NCT01192152|467402422|FG000|Period 1|left prematurely (while on treatment B)|0|||
129847786|NCT01192152|467402423|FG001|Period 1|left prematurely (while on treatment B)|1|||
129847787|NCT01192152|467402422|FG000|Period 3|family emergency|1|||
129847788|NCT01192152|467402423|FG001|Period 3|family emergency|0|||
129847789|NCT05013905|467402424|FG000|Overall Study|Adverse Event|1|||
129847790|NCT05013905|467402424|FG000|Overall Study|Lack of Efficacy|1|||
129847791|NCT03286140|467402426|FG000|Overall Study|Withdrawal by Subject|10|||
129847792|NCT03286140|467402427|FG001|Overall Study|Withdrawal by Subject|5|||
129847793|NCT03286140|467402426|FG000|Overall Study|Lost to Follow-up|5|||
129847794|NCT03286140|467402427|FG001|Overall Study|Lost to Follow-up|10|||
129847795|NCT03286140|467402426|FG000|Overall Study|Failure to comply|0|||
129847796|NCT03286140|467402427|FG001|Overall Study|Failure to comply|1|||
129847797|NCT04666259|467402428|FG000|Treatment Phase|Physician Decision|9|||
129847798|NCT04666259|467402429|FG001|Treatment Phase|Physician Decision|3|||
129847799|NCT04666259|467402430|FG002|Treatment Phase|Physician Decision|3|||
129847800|NCT04666259|467402428|FG000|Treatment Phase|Adverse Event|3|||
129847801|NCT04666259|467402429|FG001|Treatment Phase|Adverse Event|1|||
129847802|NCT04666259|467402430|FG002|Treatment Phase|Adverse Event|0|||
129847803|NCT04666259|467402428|FG000|Treatment Phase|Subject decision|1|||
129903481|NCT00940992|467606442|FG002|Overall Study|subject request|0|||
129903482|NCT00940992|467606440|FG000|Overall Study|Lost to Follow-up|0|||
129903483|NCT00940992|467606441|FG001|Overall Study|Lost to Follow-up|1|||
129903484|NCT00940992|467606442|FG002|Overall Study|Lost to Follow-up|1|||
129903485|NCT03210402|467606443|FG000|Overall Study|Withdrawal by Subject|0|||
129903486|NCT03210402|467606444|FG001|Overall Study|Withdrawal by Subject|1|||
129903487|NCT03586544|467606447|FG000|First Intervention|Adverse Event|0|||
129903488|NCT03586544|467606448|FG001|First Intervention|Adverse Event|1|||
129903489|NCT03586544|467606447|FG000|Second Intervention|Withdrawal by Subject|0|||
129449623|NCT00467779|465945637|FG014|Stage 3|Adverse Event|2|||
129847804|NCT04666259|467402429|FG001|Treatment Phase|Subject decision|2|||
129847805|NCT04666259|467402430|FG002|Treatment Phase|Subject decision|0|||
129847806|NCT04666259|467402428|FG000|Treatment Phase|Progressive disease|0|||
129847807|NCT04666259|467402429|FG001|Treatment Phase|Progressive disease|1|||
129847808|NCT04666259|467402430|FG002|Treatment Phase|Progressive disease|0|||
129847809|NCT04666259|467402428|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
129903490|NCT03586544|467606448|FG001|Second Intervention|Withdrawal by Subject|1|||
129449624|NCT00467779|465945623|FG000|Stage 3|Death|0|||
129449625|NCT00467779|465945624|FG001|Stage 3|Death|0|||
129449626|NCT00467779|465945625|FG002|Stage 3|Death|0|||
129847810|NCT04666259|467402429|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
129847811|NCT04666259|467402430|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
129847812|NCT04666259|467402428|FG000|Safety Follow-up Phase|Physician Decision|2|||
129847813|NCT04666259|467402429|FG001|Safety Follow-up Phase|Physician Decision|0|||
129847814|NCT04666259|467402430|FG002|Safety Follow-up Phase|Physician Decision|0|||
129847815|NCT04666259|467402428|FG000|Safety Follow-up Phase|Subject decision|1|||
129847816|NCT04666259|467402429|FG001|Safety Follow-up Phase|Subject decision|0|||
129847817|NCT04666259|467402430|FG002|Safety Follow-up Phase|Subject decision|0|||
129847818|NCT04666259|467402428|FG000|Safety Follow-up Phase|Death|0|||
129847819|NCT04666259|467402429|FG001|Safety Follow-up Phase|Death|1|||
129847820|NCT04666259|467402430|FG002|Safety Follow-up Phase|Death|0|||
129847821|NCT01565291|467402431|FG000|Overall Study|Withdrawal by Subject|1|||
129847822|NCT01565291|467402432|FG001|Overall Study|Withdrawal by Subject|0|||
129847823|NCT02188485|467402437|FG000|Overall Study|Withdrawal by Subject|2|||
129847824|NCT02188485|467402438|FG001|Overall Study|Withdrawal by Subject|1|||
129847825|NCT02188485|467402437|FG000|Overall Study|PI withdrew, lack of capacity|0|||
129847826|NCT02188485|467402438|FG001|Overall Study|PI withdrew, lack of capacity|2|||
129847827|NCT03149237|467402441|FG000|Overall Study|Withdrawal by Subject|4|||
129847828|NCT03149237|467402442|FG001|Overall Study|Withdrawal by Subject|5|||
129847829|NCT01466192|467402443|FG000|Overall Study|Physician Decision|1|||
129847830|NCT01466192|467402443|FG000|Overall Study|Withdrawal by Subject|3|||
129847831|NCT01227512|467402446|FG000|Overall Study|Physician Decision|6|||
129847832|NCT01227512|467402447|FG001|Overall Study|Physician Decision|6|||
129847833|NCT01227512|467402446|FG000|Overall Study|Adverse Event|4|||
129847834|NCT01227512|467402447|FG001|Overall Study|Adverse Event|3|||
129847835|NCT01227512|467402446|FG000|Overall Study|Withdrawal by Subject|3|||
129847836|NCT01227512|467402447|FG001|Overall Study|Withdrawal by Subject|0|||
129847837|NCT01227512|467402446|FG000|Overall Study|Participant met withdrawal criteria|0|||
129847838|NCT01227512|467402447|FG001|Overall Study|Participant met withdrawal criteria|1|||
129847839|NCT04055116|467402448|FG000|First Intervention|Physician Decision|2|||
129847840|NCT04055116|467402449|FG001|First Intervention|Physician Decision|7|||
129847841|NCT02774681|467402456|FG000|Treatment on Study|Progressive Disease|7|||
129847842|NCT02774681|467402456|FG000|Follow-Up for 3 Years|Death|11|||
129847843|NCT02774681|467402456|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
129847844|NCT04497987|467402457|FG000|Overall Study|Adverse Event|1|||
129847845|NCT04497987|467402458|FG001|Overall Study|Adverse Event|0|||
129847846|NCT04497987|467402457|FG000|Overall Study|Death|21|||
129847847|NCT04497987|467402458|FG001|Overall Study|Death|13|||
129847848|NCT04497987|467402457|FG000|Overall Study|Lost to Follow-up|19|||
129847849|NCT04497987|467402458|FG001|Overall Study|Lost to Follow-up|17|||
129847850|NCT04497987|467402457|FG000|Overall Study|Other - as reported by the investigator|22|||
129847851|NCT04497987|467402458|FG001|Overall Study|Other - as reported by the investigator|16|||
129847852|NCT04497987|467402457|FG000|Overall Study|Physician Decision|1|||
129847853|NCT04497987|467402458|FG001|Overall Study|Physician Decision|0|||
129847854|NCT04497987|467402457|FG000|Overall Study|Withdrawal by Subject|35|||
129847855|NCT04497987|467402458|FG001|Overall Study|Withdrawal by Subject|21|||
129847856|NCT00298038|467402459|FG000|Overall Study|Lost to Follow-up|0|||
129847857|NCT00298038|467402460|FG001|Overall Study|Lost to Follow-up|1|||
129847858|NCT00298038|467402459|FG000|Overall Study|Liver Transplant|0|||
129847859|NCT00298038|467402460|FG001|Overall Study|Liver Transplant|1|||
129847860|NCT00298038|467402459|FG000|Overall Study|Protocol Violation|1|||
129847861|NCT00298038|467402460|FG001|Overall Study|Protocol Violation|3|||
129847862|NCT00298038|467402459|FG000|Overall Study|Death|6|||
129847863|NCT00298038|467402460|FG001|Overall Study|Death|3|||
129847864|NCT00298038|467402459|FG000|Overall Study|Withdrawal by Subject|6|||
129847865|NCT00298038|467402460|FG001|Overall Study|Withdrawal by Subject|9|||
129847866|NCT00298038|467402459|FG000|Overall Study|Adverse Event|8|||
129847867|NCT00298038|467402460|FG001|Overall Study|Adverse Event|7|||
129847868|NCT00298038|467402459|FG000|Overall Study|Breakthrough overt HE episode|28|||
129847869|NCT00298038|467402460|FG001|Overall Study|Breakthrough overt HE episode|69|||
129847870|NCT00298038|467402459|FG000|Overall Study|Noncompliance|1|||
129847871|NCT00298038|467402460|FG001|Overall Study|Noncompliance|0|||
129847872|NCT00298038|467402459|FG000|Overall Study|Cocaine Abuse|1|||
129847873|NCT00298038|467402460|FG001|Overall Study|Cocaine Abuse|0|||
129847874|NCT00298038|467402459|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
129847875|NCT00298038|467402460|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
129847876|NCT02707640|467402461|FG000|Overall Study|Adverse Event|4|||
129847877|NCT02707640|467402462|FG001|Overall Study|Adverse Event|2|||
129847878|NCT02707640|467402461|FG000|Overall Study|Death|1|||
129847879|NCT02707640|467402462|FG001|Overall Study|Death|2|||
129847880|NCT02707640|467402461|FG000|Overall Study|Physician Decision|2|||
129847881|NCT02707640|467402462|FG001|Overall Study|Physician Decision|0|||
129847882|NCT02707640|467402461|FG000|Overall Study|Withdrawal by Subject|0|||
129847883|NCT02707640|467402462|FG001|Overall Study|Withdrawal by Subject|1|||
129847884|NCT02707640|467402461|FG000|Overall Study|Participant's Personal Decision|1|||
129847885|NCT02707640|467402462|FG001|Overall Study|Participant's Personal Decision|2|||
129847886|NCT02707640|467402461|FG000|Overall Study|Sponsor Discretion|1|||
129847887|NCT02707640|467402462|FG001|Overall Study|Sponsor Discretion|0|||
129847888|NCT02517905|467402463|FG000|Overall Study|Lost to Follow-up|4|||
129847889|NCT02517905|467402464|FG001|Overall Study|Lost to Follow-up|0|||
129847890|NCT02517905|467402463|FG000|Overall Study|Withdrawal by Subject|4|||
129847891|NCT02517905|467402464|FG001|Overall Study|Withdrawal by Subject|0|||
129847892|NCT02517905|467402463|FG000|Overall Study|Screen failure|2|||
129847893|NCT02517905|467402464|FG001|Overall Study|Screen failure|2|||
129847894|NCT01607905|467404311|FG000|Overall Study|Withdrawal by participant|7|||
129847895|NCT01607905|467404312|FG001|Overall Study|Withdrawal by participant|2|||
129847896|NCT01607905|467404313|FG002|Overall Study|Withdrawal by participant|4|||
129903491|NCT03523091|467606449|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
129903492|NCT03523091|467606450|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
129903493|NCT03523091|467606449|FG000|Overall Study|Withdrawal by Subject|0|||
129903494|NCT03523091|467606450|FG001|Overall Study|Withdrawal by Subject|3|||
129903495|NCT03523091|467606449|FG000|Overall Study|Increase Botox dose|0|||
129847897|NCT01607905|467404314|FG003|Overall Study|Withdrawal by participant|6|||
129847898|NCT01607905|467404315|FG004|Overall Study|Withdrawal by participant|0|||
129847899|NCT01607905|467404316|FG005|Overall Study|Withdrawal by participant|4|||
129847900|NCT01607905|467404317|FG006|Overall Study|Withdrawal by participant|12|||
129847901|NCT01607905|467404311|FG000|Overall Study|Incidence or severity of AEs|5|||
129847902|NCT01607905|467404312|FG001|Overall Study|Incidence or severity of AEs|1|||
129847903|NCT01607905|467404313|FG002|Overall Study|Incidence or severity of AEs|1|||
129847904|NCT01607905|467404314|FG003|Overall Study|Incidence or severity of AEs|3|||
129847905|NCT01607905|467404315|FG004|Overall Study|Incidence or severity of AEs|0|||
129847906|NCT01607905|467404316|FG005|Overall Study|Incidence or severity of AEs|2|||
129847907|NCT01607905|467404317|FG006|Overall Study|Incidence or severity of AEs|8|||
129847908|NCT01607905|467404311|FG000|Overall Study|Disease progression|44|||
129847909|NCT01607905|467404312|FG001|Overall Study|Disease progression|16|||
129847910|NCT01607905|467404313|FG002|Overall Study|Disease progression|15|||
129847911|NCT01607905|467404314|FG003|Overall Study|Disease progression|11|||
129847912|NCT01607905|467404315|FG004|Overall Study|Disease progression|6|||
129847913|NCT01607905|467404316|FG005|Overall Study|Disease progression|7|||
129847914|NCT01607905|467404317|FG006|Overall Study|Disease progression|21|||
129847915|NCT01607905|467404311|FG000|Overall Study|Non-compliance with study procedures|0|||
129847916|NCT01607905|467404312|FG001|Overall Study|Non-compliance with study procedures|0|||
129847917|NCT01607905|467404313|FG002|Overall Study|Non-compliance with study procedures|0|||
129847918|NCT01607905|467404314|FG003|Overall Study|Non-compliance with study procedures|0|||
129847919|NCT01607905|467404315|FG004|Overall Study|Non-compliance with study procedures|0|||
129847920|NCT01607905|467404316|FG005|Overall Study|Non-compliance with study procedures|0|||
129847921|NCT01607905|467404317|FG006|Overall Study|Non-compliance with study procedures|1|||
129847922|NCT01607905|467404311|FG000|Overall Study|Death|1|||
129847923|NCT01607905|467404312|FG001|Overall Study|Death|1|||
129847924|NCT01607905|467404313|FG002|Overall Study|Death|1|||
129847925|NCT01607905|467404314|FG003|Overall Study|Death|1|||
129847926|NCT01607905|467404315|FG004|Overall Study|Death|0|||
129847927|NCT01607905|467404316|FG005|Overall Study|Death|0|||
129847928|NCT01607905|467404317|FG006|Overall Study|Death|3|||
129847929|NCT01607905|467404311|FG000|Overall Study|Other treatments become available|1|||
129847930|NCT01607905|467404312|FG001|Overall Study|Other treatments become available|0|||
129847931|NCT01607905|467404313|FG002|Overall Study|Other treatments become available|0|||
129847932|NCT01607905|467404314|FG003|Overall Study|Other treatments become available|0|||
129847933|NCT01607905|467404315|FG004|Overall Study|Other treatments become available|0|||
129847934|NCT01607905|467404316|FG005|Overall Study|Other treatments become available|0|||
129847935|NCT01607905|467404317|FG006|Overall Study|Other treatments become available|1|||
129847936|NCT01607905|467404311|FG000|Overall Study|Investigator discretion|0|||
129847937|NCT01607905|467404312|FG001|Overall Study|Investigator discretion|0|||
129847938|NCT01607905|467404313|FG002|Overall Study|Investigator discretion|0|||
129847939|NCT01607905|467404314|FG003|Overall Study|Investigator discretion|0|||
129847940|NCT01607905|467404315|FG004|Overall Study|Investigator discretion|0|||
129903496|NCT03523091|467606450|FG001|Overall Study|Increase Botox dose|1|||
129903497|NCT03863834|467606456|FG000|Overall Study|Lost to Follow-up|3|||
129903498|NCT02685488|467606457|FG000|Overall Study|Withdrawal by Subject|0|||
129903499|NCT02685488|467606458|FG001|Overall Study|Withdrawal by Subject|1|||
129903500|NCT05019729|467606459|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903501|NCT05019729|467606460|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903502|NCT05019729|467606461|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129847941|NCT01607905|467404316|FG005|Overall Study|Investigator discretion|1|||
129847942|NCT01607905|467404317|FG006|Overall Study|Investigator discretion|0|||
129847943|NCT01607905|467404311|FG000|Overall Study|Other|1|||
129847944|NCT01607905|467404312|FG001|Overall Study|Other|0|||
129847945|NCT01607905|467404313|FG002|Overall Study|Other|0|||
129847946|NCT01607905|467404314|FG003|Overall Study|Other|0|||
129847947|NCT01607905|467404315|FG004|Overall Study|Other|0|||
129847948|NCT01607905|467404316|FG005|Overall Study|Other|0|||
129847949|NCT01607905|467404317|FG006|Overall Study|Other|1|||
129847950|NCT01607905|467404311|FG000|Overall Study|Randomized but not treated|1|||
129847951|NCT01607905|467404312|FG001|Overall Study|Randomized but not treated|0|||
129847952|NCT01607905|467404313|FG002|Overall Study|Randomized but not treated|0|||
129847953|NCT01607905|467404314|FG003|Overall Study|Randomized but not treated|0|||
129847954|NCT01607905|467404315|FG004|Overall Study|Randomized but not treated|1|||
129847955|NCT01607905|467404316|FG005|Overall Study|Randomized but not treated|1|||
129847956|NCT01607905|467404317|FG006|Overall Study|Randomized but not treated|0|||
129847957|NCT00659646|467404320|FG000|Overall Study|Protocol Violation|12|||
129847958|NCT00659646|467404321|FG001|Overall Study|Protocol Violation|8|||
129847959|NCT00659646|467404320|FG000|Overall Study|Adverse Event|1|||
129847960|NCT00659646|467404321|FG001|Overall Study|Adverse Event|0|||
129847961|NCT00659646|467404320|FG000|Overall Study|Lost to Follow-up|1|||
129847962|NCT00659646|467404321|FG001|Overall Study|Lost to Follow-up|0|||
129847963|NCT00659646|467404320|FG000|Overall Study|protocol noncompliance after randomized|1|||
129847964|NCT00659646|467404321|FG001|Overall Study|protocol noncompliance after randomized|0|||
129847965|NCT02212730|467404327|FG000|Overall Study|Tumor not of the required cell histology|1|||
129847966|NCT02212730|467404328|FG001|Overall Study|Tumor not of the required cell histology|0|||
129847967|NCT02212730|467404327|FG000|Overall Study|Withdrawal by Subject|1|||
129847968|NCT02212730|467404328|FG001|Overall Study|Withdrawal by Subject|0|||
129847969|NCT02212730|467404327|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
129847970|NCT02212730|467404328|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
129847971|NCT02932891|467404329|FG000|Overall Study|Lost to Follow-up|2|||
129847972|NCT02932891|467404329|FG000|Overall Study|HPA Suppress|2|||
129847973|NCT00451282|467404330|FG000|Overall Study|Lost to Follow-up|6|||
129847974|NCT00451282|467404331|FG001|Overall Study|Lost to Follow-up|5|||
129847975|NCT00577122|467404332|FG000|Overall Study|Adverse Event|0|||
129847976|NCT00577122|467404333|FG001|Overall Study|Adverse Event|2|||
129847977|NCT00577122|467404332|FG000|Overall Study|Progression, relapse during active trt|6|||
129847978|NCT00577122|467404333|FG001|Overall Study|Progression, relapse during active trt|8|||
129847979|NCT00577122|467404332|FG000|Overall Study|Prog, refract disease during active trt|8|||
129847980|NCT00577122|467404333|FG001|Overall Study|Prog, refract disease during active trt|5|||
129847981|NCT00577122|467404332|FG000|Overall Study|Alternative Therapy|0|||
129847982|NCT00577122|467404333|FG001|Overall Study|Alternative Therapy|1|||
129847983|NCT04532112|467404342|FG000|Overall Study|Adverse Event|3|||
129847984|NCT04532112|467404343|FG001|Overall Study|Adverse Event|0|||
129847985|NCT00529386|467404344|FG000|Overall Study|Lost to Follow-up|1|||
129847986|NCT02738775|467404345|FG000|Overall Study|Withdrawal by Subject|0|||
129847987|NCT02738775|467404346|FG001|Overall Study|Withdrawal by Subject|1|||
129847988|NCT02738775|467404347|FG002|Overall Study|Withdrawal by Subject|0|||
129847989|NCT02738775|467404348|FG003|Overall Study|Withdrawal by Subject|0|||
129847990|NCT02738775|467404349|FG004|Overall Study|Withdrawal by Subject|0|||
129847991|NCT02738775|467404350|FG005|Overall Study|Withdrawal by Subject|0|||
129847992|NCT02738775|467404345|FG000|Overall Study|Adverse Event|0|||
129847993|NCT02738775|467404346|FG001|Overall Study|Adverse Event|0|||
129847994|NCT02738775|467404347|FG002|Overall Study|Adverse Event|0|||
129847995|NCT02738775|467404348|FG003|Overall Study|Adverse Event|1|||
129847996|NCT02738775|467404349|FG004|Overall Study|Adverse Event|0|||
129847997|NCT02738775|467404350|FG005|Overall Study|Adverse Event|0|||
129847998|NCT02738775|467404345|FG000|Overall Study|Pregnancy|0|||
129847999|NCT02738775|467404346|FG001|Overall Study|Pregnancy|1|||
129848000|NCT02738775|467404347|FG002|Overall Study|Pregnancy|0|||
129848001|NCT02738775|467404348|FG003|Overall Study|Pregnancy|0|||
129848002|NCT02738775|467404349|FG004|Overall Study|Pregnancy|0|||
129848003|NCT02738775|467404350|FG005|Overall Study|Pregnancy|0|||
129848004|NCT02738775|467404345|FG000|Overall Study|Missing|0|||
129848005|NCT02738775|467404346|FG001|Overall Study|Missing|0|||
129848006|NCT02738775|467404347|FG002|Overall Study|Missing|0|||
129848007|NCT02738775|467404348|FG003|Overall Study|Missing|0|||
129848008|NCT02738775|467404349|FG004|Overall Study|Missing|0|||
129848009|NCT02738775|467404350|FG005|Overall Study|Missing|1|||
129848010|NCT02992899|467404351|FG000|Overall Study|Withdrawal by Subject|1|||
129848011|NCT02992899|467404352|FG001|Overall Study|Withdrawal by Subject|0|||
129848012|NCT02992899|467404351|FG000|Overall Study|Lost to Follow-up|1|||
129848013|NCT02992899|467404352|FG001|Overall Study|Lost to Follow-up|3|||
129848014|NCT02370888|467404353|FG000|Overall Study|disease progression|2|||
129848015|NCT02370888|467404353|FG000|Overall Study|did not meet chimerism criteria|6|||
129848016|NCT04574362|467404354|FG000|Overall Study|Other|0|||
129848017|NCT04574362|467404355|FG001|Overall Study|Other|5|||
129848018|NCT04574362|467404354|FG000|Overall Study|COVID-19|0|||
129848019|NCT04574362|467404355|FG001|Overall Study|COVID-19|1|||
129848020|NCT04574362|467404354|FG000|Overall Study|Adverse Event|1|||
129848021|NCT04574362|467404355|FG001|Overall Study|Adverse Event|1|||
129848022|NCT04574362|467404354|FG000|Overall Study|Withdrawal by Subject|2|||
129848023|NCT04574362|467404355|FG001|Overall Study|Withdrawal by Subject|4|||
129848024|NCT04574362|467404354|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
129848025|NCT04574362|467404355|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
129848026|NCT04574362|467404354|FG000|Overall Study|Participant refused to come to the hospital|1|||
129848027|NCT04574362|467404355|FG001|Overall Study|Participant refused to come to the hospital|0|||
129848028|NCT04574362|467404354|FG000|Overall Study|Participant refused the visit|1|||
129848029|NCT04574362|467404355|FG001|Overall Study|Participant refused the visit|0|||
129848030|NCT04574362|467404354|FG000|Overall Study|Participant quit early because of business trip|1|||
129848031|NCT04574362|467404355|FG001|Overall Study|Participant quit early because of business trip|0|||
129848032|NCT01060384|467404356|FG000|Overall Study|Withdrawal by Subject|0|||
129848033|NCT01060384|467404357|FG001|Overall Study|Withdrawal by Subject|1|||
129848034|NCT01060384|467404358|FG002|Overall Study|Withdrawal by Subject|0|||
129848035|NCT01060384|467404359|FG003|Overall Study|Withdrawal by Subject|0|||
129848036|NCT01060384|467404360|FG004|Overall Study|Withdrawal by Subject|0|||
129848037|NCT01060384|467404356|FG000|Overall Study|Death|0|||
129848038|NCT01060384|467404357|FG001|Overall Study|Death|0|||
129848039|NCT01060384|467404358|FG002|Overall Study|Death|0|||
129848040|NCT01060384|467404359|FG003|Overall Study|Death|0|||
129848041|NCT01060384|467404360|FG004|Overall Study|Death|1|||
129848042|NCT01060384|467404356|FG000|Overall Study|Intercurrent illness|0|||
129848043|NCT01060384|467404357|FG001|Overall Study|Intercurrent illness|0|||
129848044|NCT01060384|467404358|FG002|Overall Study|Intercurrent illness|0|||
129848045|NCT01060384|467404359|FG003|Overall Study|Intercurrent illness|0|||
129848046|NCT01060384|467404360|FG004|Overall Study|Intercurrent illness|1|||
129848047|NCT00812929|467404363|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
129848048|NCT00812929|467404364|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
129848049|NCT00812929|467404365|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
129848050|NCT00812929|467404366|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
129848051|NCT00812929|467404367|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
129848052|NCT00812929|467404368|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
129848053|NCT00812929|467404369|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
129848054|NCT00812929|467404370|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
129848055|NCT00812929|467404371|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
129848056|NCT00812929|467404372|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
129848057|NCT00812929|467404363|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
129848058|NCT00812929|467404364|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
129848059|NCT00812929|467404365|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
129848060|NCT00812929|467404366|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
129848061|NCT00812929|467404367|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
129848062|NCT00812929|467404368|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
129848063|NCT00812929|467404369|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
129848064|NCT00812929|467404370|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
129848065|NCT00812929|467404371|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
129848066|NCT00812929|467404372|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
129848067|NCT00812929|467404363|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
129848068|NCT00812929|467404364|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
129848069|NCT00812929|467404365|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
129848070|NCT00812929|467404366|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
129848071|NCT00812929|467404367|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
129848072|NCT00812929|467404368|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
129848073|NCT00812929|467404369|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
129848074|NCT00812929|467404370|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
129848075|NCT00812929|467404371|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
129848076|NCT00812929|467404372|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
129848077|NCT00211081|467404374|FG000|Overall Study|Withdrawal by Subject|2|||
129848078|NCT01332305|467404375|FG000|Overall Study|Adverse Event|1|||
129848079|NCT01332305|467404376|FG001|Overall Study|Adverse Event|4|||
129848080|NCT01332305|467404377|FG002|Overall Study|Adverse Event|6|||
129848081|NCT01332305|467404378|FG003|Overall Study|Adverse Event|3|||
129848082|NCT01332305|467404379|FG004|Overall Study|Adverse Event|5|||
129848083|NCT01332305|467404375|FG000|Overall Study|Withdrawal by Subject|6|||
129848084|NCT01332305|467404376|FG001|Overall Study|Withdrawal by Subject|5|||
129848085|NCT01332305|467404377|FG002|Overall Study|Withdrawal by Subject|4|||
129848086|NCT01332305|467404378|FG003|Overall Study|Withdrawal by Subject|1|||
129848087|NCT01332305|467404379|FG004|Overall Study|Withdrawal by Subject|0|||
129848088|NCT01332305|467404375|FG000|Overall Study|Lost to Follow-up|0|||
129848089|NCT01332305|467404376|FG001|Overall Study|Lost to Follow-up|2|||
129848090|NCT01332305|467404377|FG002|Overall Study|Lost to Follow-up|3|||
129848091|NCT01332305|467404378|FG003|Overall Study|Lost to Follow-up|2|||
129848092|NCT01332305|467404379|FG004|Overall Study|Lost to Follow-up|3|||
129848093|NCT01332305|467404375|FG000|Overall Study|Protocol Violation|1|||
129848094|NCT01332305|467404376|FG001|Overall Study|Protocol Violation|2|||
129848095|NCT01332305|467404377|FG002|Overall Study|Protocol Violation|1|||
129848096|NCT01332305|467404378|FG003|Overall Study|Protocol Violation|0|||
129848097|NCT01332305|467404379|FG004|Overall Study|Protocol Violation|3|||
129848098|NCT01332305|467404375|FG000|Overall Study|Withdrawal by Sponsor|1|||
129848099|NCT01332305|467404376|FG001|Overall Study|Withdrawal by Sponsor|0|||
129848100|NCT01332305|467404377|FG002|Overall Study|Withdrawal by Sponsor|0|||
129848101|NCT01332305|467404378|FG003|Overall Study|Withdrawal by Sponsor|1|||
129848102|NCT01332305|467404379|FG004|Overall Study|Withdrawal by Sponsor|1|||
129848103|NCT01332305|467404375|FG000|Overall Study|Treatment Failure|1|||
129848104|NCT01332305|467404376|FG001|Overall Study|Treatment Failure|1|||
129848105|NCT01332305|467404377|FG002|Overall Study|Treatment Failure|0|||
129848106|NCT01332305|467404378|FG003|Overall Study|Treatment Failure|0|||
129848107|NCT01332305|467404379|FG004|Overall Study|Treatment Failure|0|||
129848108|NCT01332305|467404375|FG000|Overall Study|Physician Decision|0|||
129848109|NCT01332305|467404376|FG001|Overall Study|Physician Decision|0|||
129848110|NCT01332305|467404377|FG002|Overall Study|Physician Decision|0|||
129848111|NCT01332305|467404378|FG003|Overall Study|Physician Decision|1|||
129848112|NCT01332305|467404379|FG004|Overall Study|Physician Decision|0|||
129848113|NCT01600040|467404380|FG000|Overall Study|Withdrawal by Subject|1|||
129848114|NCT04027686|467404381|FG000|Overall Study|Lost to Follow-up|2|||
129848115|NCT04027686|467404382|FG001|Overall Study|Lost to Follow-up|0|||
129848116|NCT04027686|467404381|FG000|Overall Study|Withdrawal by Subject|0|||
129848117|NCT04027686|467404382|FG001|Overall Study|Withdrawal by Subject|1|||
129848118|NCT03755765|467404388|FG000|Overall Study|Withdrawal by Subject|2|||
129848119|NCT03755765|467404389|FG001|Overall Study|Withdrawal by Subject|4|||
129848120|NCT03755765|467404390|FG002|Overall Study|Withdrawal by Subject|4|||
129848121|NCT02104557|467404391|FG000|Overall Study|Adverse Event|24|||
129848122|NCT02104557|467404391|FG000|Overall Study|Lost to Follow-up|34|||
129848123|NCT02104557|467404391|FG000|Overall Study|Violated the usage and dosage|14|||
129848124|NCT02104557|467404391|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
129848125|NCT02104557|467404391|FG000|Overall Study|Administered Sayana prior to the contract|1|||
129848126|NCT02104557|467404391|FG000|Overall Study|Other|17|||
129848127|NCT02104557|467404391|FG000|Overall Study|Change to other contraception methods|5|||
129848128|NCT02104557|467404391|FG000|Overall Study|Discontinuation due to no pain|1|||
129848129|NCT02104557|467404391|FG000|Overall Study|Withdrawal consent|2|||
129848130|NCT02104557|467404391|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
129848131|NCT02104557|467404391|FG000|Overall Study|Discontinuation of contraception|9|||
129848132|NCT00111228|467404395|FG000|Overall Study|Withdrawal by Subject|5|||
129848133|NCT00111228|467404396|FG001|Overall Study|Withdrawal by Subject|1|||
129848134|NCT00111228|467404397|FG002|Overall Study|Withdrawal by Subject|0|||
129848135|NCT00678691|467404398|FG000|Overall Study|Adverse Event|6|||
129848136|NCT00678691|467404399|FG001|Overall Study|Adverse Event|4|||
129848137|NCT02178475|467404406|FG000|Overall Study|Withdrawal by Subject|7|||
129848138|NCT02178475|467404406|FG000|Overall Study|Lost to Follow-up|10|||
129848139|NCT02178475|467404406|FG000|Overall Study|Death|13|||
129848140|NCT02178475|467404406|FG000|Overall Study|Protocol-specified Criteria|99|||
129848141|NCT00779766|467404407|FG000|Month 24|Serious Adverse Event|2|||
129848142|NCT00779766|467404408|FG001|Month 24|Serious Adverse Event|3|||
129848143|NCT00779766|467404407|FG000|Month 24|Adverse Event|3|||
129848144|NCT00779766|467404408|FG001|Month 24|Adverse Event|3|||
129848145|NCT00779766|467404407|FG000|Month 24|Protocol Violation|3|||
129903503|NCT05019729|467606462|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903504|NCT05019729|467606463|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
129903505|NCT05019729|467606464|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
129903506|NCT00361283|467606473|FG000|Overall Study|Lost to Follow-up|27|||
129903507|NCT01049503|467608307|FG000|Overall Study|Lost to Follow-up|11|||
129903508|NCT01049503|467608308|FG001|Overall Study|Lost to Follow-up|12|||
129903509|NCT01049503|467608309|FG002|Overall Study|Lost to Follow-up|24|||
129848146|NCT00779766|467404408|FG001|Month 24|Protocol Violation|1|||
129848147|NCT00779766|467404407|FG000|Month 24|Withdrawal by Subject|159|||
129848148|NCT00779766|467404408|FG001|Month 24|Withdrawal by Subject|127|||
129848149|NCT00779766|467404407|FG000|Month 24|Migrated/moved from study area|138|||
129848150|NCT00779766|467404408|FG001|Month 24|Migrated/moved from study area|162|||
129903510|NCT01049503|467608310|FG003|Overall Study|Lost to Follow-up|26|||
129848151|NCT00779766|467404407|FG000|Month 24|Lost to Follow-up|9|||
129848152|NCT00779766|467404408|FG001|Month 24|Lost to Follow-up|9|||
129848153|NCT00779766|467404407|FG000|Month 24|Other|18|||
129848154|NCT00779766|467404408|FG001|Month 24|Other|27|||
129848155|NCT00779766|467404407|FG000|Month 48|Withdrawal by Subject|68|||
129848156|NCT00779766|467404408|FG001|Month 48|Withdrawal by Subject|63|||
129848157|NCT00779766|467404407|FG000|Month 48|Migrated/moved from study area|76|||
129848158|NCT00779766|467404408|FG001|Month 48|Migrated/moved from study area|75|||
129848159|NCT00779766|467404407|FG000|Month 48|Lost to Follow-up|29|||
129848160|NCT00779766|467404408|FG001|Month 48|Lost to Follow-up|30|||
129848161|NCT00779766|467404407|FG000|Month 48|Other|1|||
129848162|NCT00779766|467404408|FG001|Month 48|Other|0|||
129848163|NCT00779766|467404407|FG000|Month 72|Withdrawal by Subject|55|||
129848164|NCT00779766|467404408|FG001|Month 72|Withdrawal by Subject|71|||
129848165|NCT00779766|467404407|FG000|Month 72|Migrated/moved from study area|124|||
129848166|NCT00779766|467404408|FG001|Month 72|Migrated/moved from study area|109|||
129848167|NCT00779766|467404407|FG000|Month 72|Lost to Follow-up|6|||
129848168|NCT00779766|467404408|FG001|Month 72|Lost to Follow-up|8|||
129848169|NCT00779766|467404407|FG000|Month 72|Other|0|||
129848170|NCT00779766|467404408|FG001|Month 72|Other|1|||
129848171|NCT01412424|467404411|FG000|Core Treatment Period|Treatment Failure|24|||
129848172|NCT01412424|467404411|FG000|Core Treatment Period|Adverse Event|21|||
129848173|NCT01412424|467404411|FG000|Core Treatment Period|Patient Request|5|||
129848174|NCT01412424|467404411|FG000|Core Treatment Period|Lost to Follow-up|2|||
129848175|NCT01412424|467404411|FG000|Core Treatment Period|Sponsor Request|1|||
129848176|NCT01412424|467404411|FG000|Extension Treatment Period|Adverse Event|2|||
129848177|NCT01412424|467404411|FG000|Extension Treatment Period|Treatment Failure|2|||
129848178|NCT01412424|467404411|FG000|Extension Treatment Period|Patient Request|2|||
129848179|NCT01274637|467404412|FG000|Overall Study|Withdrawal by Subject|0|||
129848180|NCT01274637|467404413|FG001|Overall Study|Withdrawal by Subject|1|||
129848181|NCT01274637|467404412|FG000|Overall Study|Lost to Follow-up|0|||
129848182|NCT01274637|467404413|FG001|Overall Study|Lost to Follow-up|1|||
129848183|NCT00414050|467404421|FG000|Overall Study|Adverse Event|1|||
129848184|NCT00414050|467404422|FG001|Overall Study|Adverse Event|1|||
129848185|NCT00414050|467404423|FG002|Overall Study|Adverse Event|1|||
129848186|NCT00414050|467404424|FG003|Overall Study|Adverse Event|1|||
129848187|NCT00414050|467404421|FG000|Overall Study|Lost to Follow-up|2|||
129848188|NCT00414050|467404422|FG001|Overall Study|Lost to Follow-up|2|||
129848189|NCT00414050|467404423|FG002|Overall Study|Lost to Follow-up|1|||
129848190|NCT00414050|467404424|FG003|Overall Study|Lost to Follow-up|1|||
129848191|NCT00414050|467404421|FG000|Overall Study|Withdrawal by Subject|5|||
129848192|NCT00414050|467404422|FG001|Overall Study|Withdrawal by Subject|3|||
129848193|NCT00414050|467404423|FG002|Overall Study|Withdrawal by Subject|2|||
129848194|NCT00414050|467404424|FG003|Overall Study|Withdrawal by Subject|4|||
129848195|NCT00414050|467404421|FG000|Overall Study|Subject discontinued for other reason|1|||
129848196|NCT00414050|467404422|FG001|Overall Study|Subject discontinued for other reason|2|||
129848197|NCT00414050|467404423|FG002|Overall Study|Subject discontinued for other reason|2|||
129848198|NCT00414050|467404424|FG003|Overall Study|Subject discontinued for other reason|1|||
129848199|NCT00414050|467404421|FG000|Overall Study|Subject Moved|0|||
129848200|NCT00414050|467404422|FG001|Overall Study|Subject Moved|0|||
129848201|NCT00414050|467404423|FG002|Overall Study|Subject Moved|0|||
129848202|NCT00414050|467404424|FG003|Overall Study|Subject Moved|1|||
129848203|NCT00720876|467404425|FG000|Overall Study|found to be ineligible after starting tx|2|||
129848204|NCT03495908|467404427|FG000|Overall Study|Withdrawal by Subject|3|||
129848205|NCT03495908|467404428|FG001|Overall Study|Withdrawal by Subject|1|||
129848206|NCT03495908|467404427|FG000|Overall Study|Lost to Follow-up|1|||
129848207|NCT03495908|467404428|FG001|Overall Study|Lost to Follow-up|4|||
129848208|NCT03495908|467404427|FG000|Overall Study|Adverse Event|0|||
129848209|NCT03495908|467404428|FG001|Overall Study|Adverse Event|2|||
129848210|NCT03495908|467404427|FG000|Overall Study|Death|1|||
129848211|NCT03495908|467404428|FG001|Overall Study|Death|0|||
129848212|NCT03495908|467404427|FG000|Overall Study|Physician Decision|5|||
129848213|NCT03495908|467404428|FG001|Overall Study|Physician Decision|4|||
129848214|NCT03495908|467404427|FG000|Overall Study|No documented reason|0|||
129848215|NCT03495908|467404428|FG001|Overall Study|No documented reason|2|||
129848216|NCT03511560|467404433|FG000|Overall Study|Death|0|||
129848217|NCT03511560|467404434|FG001|Overall Study|Death|1|||
129848218|NCT03511560|467404433|FG000|Overall Study|Adverse Event|0|||
129848219|NCT03511560|467404434|FG001|Overall Study|Adverse Event|2|||
129848220|NCT03511560|467404433|FG000|Overall Study|Transplant cancelled|0|||
129848221|NCT03511560|467404434|FG001|Overall Study|Transplant cancelled|1|||
129848222|NCT03511560|467404433|FG000|Overall Study|Patient switched to another drug|1|||
129848223|NCT03511560|467404434|FG001|Overall Study|Patient switched to another drug|0|||
129848224|NCT02985736|467404439|FG000|Overall Study|Lost to Follow-up|3|||
129848225|NCT00382733|467404440|FG000|Overall Study|Withdrawal by Subject|0|||
129848226|NCT00382733|467404441|FG001|Overall Study|Withdrawal by Subject|1|||
129848227|NCT00382733|467404442|FG002|Overall Study|Withdrawal by Subject|0|||
129848228|NCT00382733|467404443|FG003|Overall Study|Withdrawal by Subject|0|||
129848229|NCT00382733|467404444|FG004|Overall Study|Withdrawal by Subject|0|||
129848230|NCT00439140|467404447|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
129848231|NCT00439140|467404448|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
129848232|NCT00439140|467404449|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
129848233|NCT00439140|467404447|FG000|Treatment Cycle 1|Personal reasons|0|||
129848234|NCT00439140|467404448|FG001|Treatment Cycle 1|Personal reasons|2|||
129848235|NCT00439140|467404449|FG002|Treatment Cycle 1|Personal reasons|0|||
129848236|NCT00439140|467404447|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
129848237|NCT00439140|467404448|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
129848238|NCT00439140|467404449|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
129848239|NCT00439140|467404447|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
129848240|NCT00439140|467404448|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
129848241|NCT00439140|467404449|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
129848242|NCT00439140|467404447|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
129848243|NCT00439140|467404448|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
129848244|NCT00439140|467404449|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
129848245|NCT01193556|467404450|FG000|Overall Study|Study termination|26|||
129848246|NCT01193556|467404451|FG001|Overall Study|Study termination|25|||
129848247|NCT01752933|467404452|FG000|Treatment|Disease Progression|3|||
129848248|NCT01752933|467404453|FG001|Treatment|Disease Progression|29|||
129848249|NCT01752933|467404452|FG000|Treatment|Withdrawal by Subject|0|||
129848250|NCT01752933|467404453|FG001|Treatment|Withdrawal by Subject|5|||
129848251|NCT01752933|467404452|FG000|Treatment|Adverse Event|1|||
129848252|NCT01752933|467404453|FG001|Treatment|Adverse Event|4|||
129848253|NCT01752933|467404452|FG000|Treatment|Physician Decision|0|||
129848254|NCT01752933|467404453|FG001|Treatment|Physician Decision|3|||
129848255|NCT01752933|467404452|FG000|Treatment|Death|0|||
129848256|NCT01752933|467404453|FG001|Treatment|Death|2|||
129848257|NCT01752933|467404452|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
129848258|NCT01752933|467404453|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
129848259|NCT01752933|467404452|FG000|Treatment|Patient noncompliant|0|||
129848260|NCT01752933|467404453|FG001|Treatment|Patient noncompliant|1|||
129848261|NCT01752933|467404452|FG000|Treatment|Patient unable to travel to appointments|0|||
129848262|NCT01752933|467404453|FG001|Treatment|Patient unable to travel to appointments|1|||
129848263|NCT01752933|467404452|FG000|Overall Study and Follow-up|Death|4|||
129848264|NCT01752933|467404453|FG001|Overall Study and Follow-up|Death|34|||
129848265|NCT01752933|467404452|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
129848266|NCT01752933|467404453|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
129848267|NCT01752933|467404452|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
129848268|NCT01752933|467404453|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
129848269|NCT01752933|467404452|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
129848270|NCT01752933|467404453|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
129848271|NCT00835406|467404454|FG000|Period: First Intervention|Adverse Event|0|||
129848272|NCT00835406|467404455|FG001|Period: First Intervention|Adverse Event|1|||
129848273|NCT00835406|467404454|FG000|Period: First Intervention|Withdrawal by Subject|2|||
129848274|NCT00835406|467404455|FG001|Period: First Intervention|Withdrawal by Subject|0|||
129848275|NCT00835406|467404454|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
129848276|NCT00835406|467404455|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
129848277|NCT00799617|467404456|FG000|Main Testosterone Trial|Randomized in error|1|||
129848278|NCT00799617|467404457|FG001|Main Testosterone Trial|Randomized in error|1|||
129848279|NCT00799617|467404456|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
129848280|NCT00799617|467404457|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
129848281|NCT00799617|467404456|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
129848282|NCT00799617|467404457|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
129848283|NCT00799617|467404456|FG000|Sexual Funtion Trial|No Baseline Data|4|||
129848284|NCT00799617|467404457|FG001|Sexual Funtion Trial|No Baseline Data|7|||
129848285|NCT00799617|467404456|FG000|Physical Function Trial|Lost to Follow-up|6|||
129848286|NCT00799617|467404457|FG001|Physical Function Trial|Lost to Follow-up|11|||
129848287|NCT00799617|467404456|FG000|Vitality Trial|Lost to Follow-up|7|||
129848288|NCT00799617|467404457|FG001|Vitality Trial|Lost to Follow-up|22|||
129848289|NCT00799617|467404456|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
129848290|NCT00799617|467404457|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
129848291|NCT00799617|467404456|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
129848292|NCT00799617|467404457|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
129848293|NCT00799617|467404456|FG000|Bone Trial|Month 12 scan not available|6|||
129848294|NCT00799617|467404457|FG001|Bone Trial|Month 12 scan not available|16|||
129848295|NCT00799617|467404456|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
129848296|NCT00799617|467404457|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
129848297|NCT00799617|467404456|FG000|Anemia Trial|Withdrawal by Subject|3|||
129848298|NCT00799617|467404457|FG001|Anemia Trial|Withdrawal by Subject|3|||
129848299|NCT04545515|467404458|FG000|Overall Study|Adverse Event|1|||
129848300|NCT04545515|467404458|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
129848301|NCT04545515|467404458|FG000|Overall Study|Commercial drug is available for participant|7|||
129848302|NCT00958880|467404459|FG000|Overall Study|Lost to Follow-up|2|||
129848303|NCT00958880|467404460|FG001|Overall Study|Lost to Follow-up|2|||
129848304|NCT01848990|467404461|FG000|Overall Study|Adverse Event|6|||
129848305|NCT01848990|467404462|FG001|Overall Study|Adverse Event|2|||
129848306|NCT01848990|467404463|FG002|Overall Study|Adverse Event|0|||
129848307|NCT01848990|467404461|FG000|Overall Study|Lost to Follow-up|6|||
129848308|NCT01848990|467404462|FG001|Overall Study|Lost to Follow-up|2|||
129848309|NCT01848990|467404463|FG002|Overall Study|Lost to Follow-up|2|||
129848310|NCT01848990|467404461|FG000|Overall Study|Protocol Violation|1|||
129848311|NCT01848990|467404462|FG001|Overall Study|Protocol Violation|1|||
129848312|NCT01848990|467404463|FG002|Overall Study|Protocol Violation|0|||
129848313|NCT01848990|467404461|FG000|Overall Study|Withdrawal by Subject|29|||
129848314|NCT01848990|467404462|FG001|Overall Study|Withdrawal by Subject|10|||
129848315|NCT01848990|467404463|FG002|Overall Study|Withdrawal by Subject|11|||
129848316|NCT01848990|467404461|FG000|Overall Study|Physician Decision|1|||
129848317|NCT01848990|467404462|FG001|Overall Study|Physician Decision|1|||
129848318|NCT01848990|467404463|FG002|Overall Study|Physician Decision|0|||
129848319|NCT01848990|467404461|FG000|Overall Study|Non Compliance|1|||
129848320|NCT01848990|467404462|FG001|Overall Study|Non Compliance|0|||
129848321|NCT01848990|467404463|FG002|Overall Study|Non Compliance|0|||
129848322|NCT01848990|467404461|FG000|Overall Study|Death|1|||
129848323|NCT01848990|467404462|FG001|Overall Study|Death|0|||
129848324|NCT01848990|467404463|FG002|Overall Study|Death|1|||
129848325|NCT01848990|467404461|FG000|Overall Study|Other|1|||
129848326|NCT01848990|467404462|FG001|Overall Study|Other|4|||
129848327|NCT01848990|467404463|FG002|Overall Study|Other|2|||
129848328|NCT01712984|467404466|FG000|Overall Study|Adverse Event|0|||
129848329|NCT01712984|467404467|FG001|Overall Study|Adverse Event|0|||
129848330|NCT01712984|467404468|FG002|Overall Study|Adverse Event|1|||
129848331|NCT01712984|467404466|FG000|Overall Study|Protocol Violation|2|||
129848332|NCT01712984|467404467|FG001|Overall Study|Protocol Violation|0|||
129848333|NCT01712984|467404468|FG002|Overall Study|Protocol Violation|1|||
129848334|NCT01712984|467404466|FG000|Overall Study|Lost to Follow-up|8|||
129848335|NCT01712984|467404467|FG001|Overall Study|Lost to Follow-up|10|||
129848336|NCT01712984|467404468|FG002|Overall Study|Lost to Follow-up|1|||
129848337|NCT01712984|467404466|FG000|Overall Study|Withdrawal by Subject|6|||
129848338|NCT01712984|467404467|FG001|Overall Study|Withdrawal by Subject|6|||
129848339|NCT01712984|467404468|FG002|Overall Study|Withdrawal by Subject|7|||
129848340|NCT00678561|467404473|FG000|Overall Study|Adverse Event|0|||
129848341|NCT00678561|467404474|FG001|Overall Study|Adverse Event|1|||
129848342|NCT00678561|467404475|FG002|Overall Study|Adverse Event|1|||
129848343|NCT00678561|467404476|FG003|Overall Study|Adverse Event|0|||
129848344|NCT00678561|467404477|FG004|Overall Study|Adverse Event|1|||
129848345|NCT00678561|467404478|FG005|Overall Study|Adverse Event|0|||
129848346|NCT00678561|467404479|FG006|Overall Study|Adverse Event|0|||
129848347|NCT00678561|467404480|FG007|Overall Study|Adverse Event|0|||
129848348|NCT00678561|467404473|FG000|Overall Study|Protocol Violation|0|||
129848349|NCT00678561|467404474|FG001|Overall Study|Protocol Violation|0|||
129848350|NCT00678561|467404475|FG002|Overall Study|Protocol Violation|0|||
129848351|NCT00678561|467404476|FG003|Overall Study|Protocol Violation|0|||
129848352|NCT00678561|467404477|FG004|Overall Study|Protocol Violation|1|||
129848353|NCT00678561|467404478|FG005|Overall Study|Protocol Violation|1|||
129848354|NCT00678561|467404479|FG006|Overall Study|Protocol Violation|0|||
129848355|NCT00678561|467404480|FG007|Overall Study|Protocol Violation|0|||
129848356|NCT00678561|467404473|FG000|Overall Study|Withdrawal by Subject|0|||
129848357|NCT00678561|467404474|FG001|Overall Study|Withdrawal by Subject|0|||
129848358|NCT00678561|467404475|FG002|Overall Study|Withdrawal by Subject|0|||
129848359|NCT00678561|467404476|FG003|Overall Study|Withdrawal by Subject|0|||
129848360|NCT00678561|467404477|FG004|Overall Study|Withdrawal by Subject|0|||
129848361|NCT00678561|467404478|FG005|Overall Study|Withdrawal by Subject|0|||
129848362|NCT00678561|467404479|FG006|Overall Study|Withdrawal by Subject|0|||
129848363|NCT00678561|467404480|FG007|Overall Study|Withdrawal by Subject|1|||
129848364|NCT00437034|467404481|FG000|Overall Study|Adverse Event|1|||
129848365|NCT00437034|467404481|FG000|Overall Study|Disease progression during treatment|5|||
129848366|NCT02556710|467406757|FG000|Overall Study|Surgical treatment|3|||
129848367|NCT02556710|467406758|FG001|Overall Study|Surgical treatment|0|||
129848368|NCT02556710|467406757|FG000|Overall Study|Required proscribed pain medication|2|||
129848369|NCT02556710|467406758|FG001|Overall Study|Required proscribed pain medication|1|||
129848370|NCT02556710|467406757|FG000|Overall Study|Lack of Efficacy|1|||
129848371|NCT02556710|467406758|FG001|Overall Study|Lack of Efficacy|0|||
129848372|NCT02556710|467406757|FG000|Overall Study|Worsening osteoarthritis|1|||
129848373|NCT02556710|467406758|FG001|Overall Study|Worsening osteoarthritis|0|||
129848374|NCT02556710|467406757|FG000|Overall Study|Moved out of state|1|||
129848375|NCT02556710|467406758|FG001|Overall Study|Moved out of state|0|||
129848376|NCT02556710|467406757|FG000|Overall Study|Missing reason|3|||
129848377|NCT02556710|467406758|FG001|Overall Study|Missing reason|1|||
129848378|NCT02556710|467406757|FG000|Overall Study|Pain as lack of efficacy|0|||
129848379|NCT02556710|467406758|FG001|Overall Study|Pain as lack of efficacy|4|||
129848380|NCT04258839|467406761|FG000|Overall Study|Adverse Event|2|||
129848381|NCT04258839|467406762|FG001|Overall Study|Adverse Event|4|||
129848382|NCT04258839|467406761|FG000|Overall Study|Lack of Efficacy|0|||
129848383|NCT04258839|467406762|FG001|Overall Study|Lack of Efficacy|2|||
129848384|NCT04258839|467406761|FG000|Overall Study|Lost to Follow-up|2|||
129848385|NCT04258839|467406762|FG001|Overall Study|Lost to Follow-up|0|||
129848386|NCT04258839|467406761|FG000|Overall Study|Withdrawal by Subject|1|||
129848387|NCT04258839|467406762|FG001|Overall Study|Withdrawal by Subject|2|||
129848388|NCT04258839|467406761|FG000|Overall Study|Withdrawal by Caregiver|5|||
129848389|NCT04258839|467406762|FG001|Overall Study|Withdrawal by Caregiver|6|||
129848390|NCT04258839|467406761|FG000|Overall Study|Reason not Specified|0|||
129848391|NCT04258839|467406762|FG001|Overall Study|Reason not Specified|1|||
129848392|NCT01519518|467406763|FG000|Overall Study|Consent not available|7|||
129848393|NCT01519518|467406764|FG001|Overall Study|Consent not available|10|||
129848394|NCT01312909|467406766|FG000|Overall Study|Randomized but not treated|1|||
129848395|NCT01312909|467406767|FG001|Overall Study|Randomized but not treated|3|||
129848396|NCT01312909|467406768|FG002|Overall Study|Randomized but not treated|1|||
129848397|NCT01312909|467406766|FG000|Overall Study|Adverse Event|1|||
129848398|NCT01312909|467406767|FG001|Overall Study|Adverse Event|0|||
129848399|NCT01312909|467406768|FG002|Overall Study|Adverse Event|3|||
129848400|NCT01312909|467406766|FG000|Overall Study|Protocol Violation|2|||
129848401|NCT01312909|467406767|FG001|Overall Study|Protocol Violation|0|||
129848402|NCT01312909|467406768|FG002|Overall Study|Protocol Violation|2|||
129848403|NCT01312909|467406766|FG000|Overall Study|Other|9|||
129848404|NCT01312909|467406767|FG001|Overall Study|Other|6|||
129848405|NCT01312909|467406768|FG002|Overall Study|Other|11|||
129848406|NCT01312909|467406766|FG000|Overall Study|Withdrawal by Subject|8|||
129848407|NCT01312909|467406767|FG001|Overall Study|Withdrawal by Subject|10|||
129848408|NCT01312909|467406768|FG002|Overall Study|Withdrawal by Subject|7|||
129848409|NCT01312909|467406766|FG000|Overall Study|Lost to Follow-up|21|||
129848410|NCT01312909|467406767|FG001|Overall Study|Lost to Follow-up|17|||
129848411|NCT01312909|467406768|FG002|Overall Study|Lost to Follow-up|20|||
129848412|NCT01312909|467406766|FG000|Overall Study|Insufficient clinical response|0|||
129848413|NCT01312909|467406767|FG001|Overall Study|Insufficient clinical response|0|||
129848414|NCT01312909|467406768|FG002|Overall Study|Insufficient clinical response|1|||
129848415|NCT01312909|467406766|FG000|Overall Study|Entrance criteria not met|0|||
129848416|NCT01312909|467406767|FG001|Overall Study|Entrance criteria not met|0|||
129848417|NCT01312909|467406768|FG002|Overall Study|Entrance criteria not met|2|||
129848418|NCT00938431|467406772|FG000|Overall Study|Adverse Event|5|||
129848419|NCT00938431|467406773|FG001|Overall Study|Adverse Event|8|||
129848420|NCT00938431|467406774|FG002|Overall Study|Adverse Event|6|||
129848421|NCT00938431|467406772|FG000|Overall Study|Lack of Efficacy|0|||
129848422|NCT00938431|467406773|FG001|Overall Study|Lack of Efficacy|1|||
129848423|NCT00938431|467406774|FG002|Overall Study|Lack of Efficacy|0|||
129848424|NCT00938431|467406772|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
129848425|NCT00938431|467406773|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
129848426|NCT00938431|467406774|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
129848427|NCT00938431|467406772|FG000|Overall Study|Dosing compliance issue|0|||
129848428|NCT00938431|467406773|FG001|Overall Study|Dosing compliance issue|0|||
129848429|NCT00938431|467406774|FG002|Overall Study|Dosing compliance issue|1|||
129848430|NCT00938431|467406772|FG000|Overall Study|Reached maximum dose early|0|||
129848431|NCT00938431|467406773|FG001|Overall Study|Reached maximum dose early|0|||
129848432|NCT00938431|467406774|FG002|Overall Study|Reached maximum dose early|1|||
129848433|NCT01529645|467406775|FG000|Overall Study|Lost to Follow-up|0|||
129848434|NCT01529645|467406776|FG001|Overall Study|Lost to Follow-up|1|||
129848435|NCT01529645|467406777|FG002|Overall Study|Lost to Follow-up|1|||
129848436|NCT01529645|467406778|FG003|Overall Study|Lost to Follow-up|1|||
129848437|NCT01529645|467406779|FG004|Overall Study|Lost to Follow-up|1|||
129848438|NCT01529645|467406780|FG005|Overall Study|Lost to Follow-up|0|||
129848439|NCT01529645|467406781|FG006|Overall Study|Lost to Follow-up|2|||
129848440|NCT01529645|467406782|FG007|Overall Study|Lost to Follow-up|0|||
129848441|NCT01529645|467406783|FG008|Overall Study|Lost to Follow-up|1|||
129848442|NCT01529645|467406784|FG009|Overall Study|Lost to Follow-up|0|||
129848443|NCT01529645|467406775|FG000|Overall Study|SAE - Premature contractions|0|||
129848444|NCT01529645|467406776|FG001|Overall Study|SAE - Premature contractions|0|||
129848445|NCT01529645|467406777|FG002|Overall Study|SAE - Premature contractions|1|||
129848446|NCT01529645|467406778|FG003|Overall Study|SAE - Premature contractions|0|||
129848447|NCT01529645|467406779|FG004|Overall Study|SAE - Premature contractions|0|||
129848448|NCT01529645|467406780|FG005|Overall Study|SAE - Premature contractions|0|||
129848449|NCT01529645|467406781|FG006|Overall Study|SAE - Premature contractions|0|||
129848450|NCT01529645|467406782|FG007|Overall Study|SAE - Premature contractions|0|||
129848451|NCT01529645|467406783|FG008|Overall Study|SAE - Premature contractions|0|||
129848452|NCT01529645|467406784|FG009|Overall Study|SAE - Premature contractions|0|||
129848453|NCT01529645|467406775|FG000|Overall Study|Withdrawal by Subject|2|||
129848454|NCT01529645|467406776|FG001|Overall Study|Withdrawal by Subject|0|||
129848455|NCT01529645|467406777|FG002|Overall Study|Withdrawal by Subject|0|||
129848456|NCT01529645|467406778|FG003|Overall Study|Withdrawal by Subject|1|||
129848457|NCT01529645|467406779|FG004|Overall Study|Withdrawal by Subject|1|||
129848458|NCT01529645|467406780|FG005|Overall Study|Withdrawal by Subject|1|||
129848459|NCT01529645|467406781|FG006|Overall Study|Withdrawal by Subject|0|||
129848460|NCT01529645|467406782|FG007|Overall Study|Withdrawal by Subject|0|||
129848461|NCT01529645|467406783|FG008|Overall Study|Withdrawal by Subject|0|||
129848462|NCT01529645|467406784|FG009|Overall Study|Withdrawal by Subject|0|||
129848463|NCT01774903|467406785|FG000|Overall Study|Adverse Event|7|||
129848464|NCT01774903|467406785|FG000|Overall Study|Withdrawal by Subject|2|||
129848465|NCT01774903|467406785|FG000|Overall Study|Lack of Efficacy|1|||
129848466|NCT01774903|467406785|FG000|Overall Study|Ineligible to continue the trial|1|||
129848467|NCT01602315|467406786|FG000|Overall Study|Protocol Violation|0|||
129848468|NCT01602315|467406787|FG001|Overall Study|Protocol Violation|0|||
129848469|NCT01602315|467406788|FG002|Overall Study|Protocol Violation|0|||
129848470|NCT01602315|467406789|FG003|Overall Study|Protocol Violation|0|||
129848471|NCT01602315|467406790|FG004|Overall Study|Protocol Violation|0|||
129848472|NCT01602315|467406791|FG005|Overall Study|Protocol Violation|1|||
129848473|NCT01602315|467406792|FG006|Overall Study|Protocol Violation|0|||
129848474|NCT01602315|467406786|FG000|Overall Study|Physician Decision|2|||
129848475|NCT01602315|467406787|FG001|Overall Study|Physician Decision|0|||
129848476|NCT01602315|467406788|FG002|Overall Study|Physician Decision|0|||
129848477|NCT01602315|467406789|FG003|Overall Study|Physician Decision|0|||
129848478|NCT01602315|467406790|FG004|Overall Study|Physician Decision|2|||
129848479|NCT01602315|467406791|FG005|Overall Study|Physician Decision|1|||
129848480|NCT01602315|467406792|FG006|Overall Study|Physician Decision|1|||
129848481|NCT01602315|467406786|FG000|Overall Study|Disease progression|6|||
129848482|NCT01602315|467406787|FG001|Overall Study|Disease progression|3|||
129848483|NCT01602315|467406788|FG002|Overall Study|Disease progression|10|||
129848484|NCT01602315|467406789|FG003|Overall Study|Disease progression|1|||
129848485|NCT01602315|467406790|FG004|Overall Study|Disease progression|41|||
129848486|NCT01602315|467406791|FG005|Overall Study|Disease progression|12|||
129848487|NCT01602315|467406792|FG006|Overall Study|Disease progression|15|||
129848488|NCT01602315|467406786|FG000|Overall Study|Death|1|||
129848489|NCT01602315|467406787|FG001|Overall Study|Death|1|||
129848490|NCT01602315|467406788|FG002|Overall Study|Death|1|||
129848491|NCT01602315|467406789|FG003|Overall Study|Death|1|||
129848492|NCT01602315|467406790|FG004|Overall Study|Death|7|||
129848493|NCT01602315|467406791|FG005|Overall Study|Death|2|||
129848494|NCT01602315|467406792|FG006|Overall Study|Death|2|||
129848495|NCT01602315|467406786|FG000|Overall Study|Withdrawal by Subject|2|||
129848496|NCT01602315|467406787|FG001|Overall Study|Withdrawal by Subject|0|||
129848497|NCT01602315|467406788|FG002|Overall Study|Withdrawal by Subject|2|||
129848498|NCT01602315|467406789|FG003|Overall Study|Withdrawal by Subject|0|||
129848499|NCT01602315|467406790|FG004|Overall Study|Withdrawal by Subject|6|||
129848500|NCT01602315|467406791|FG005|Overall Study|Withdrawal by Subject|0|||
129848501|NCT01602315|467406792|FG006|Overall Study|Withdrawal by Subject|1|||
129848502|NCT01602315|467406786|FG000|Overall Study|Adverse Event|5|||
129848503|NCT01602315|467406787|FG001|Overall Study|Adverse Event|1|||
129848504|NCT01602315|467406788|FG002|Overall Study|Adverse Event|5|||
129848505|NCT01602315|467406789|FG003|Overall Study|Adverse Event|4|||
129848506|NCT01602315|467406790|FG004|Overall Study|Adverse Event|15|||
129848507|NCT01602315|467406791|FG005|Overall Study|Adverse Event|3|||
129848508|NCT01602315|467406792|FG006|Overall Study|Adverse Event|9|||
129848509|NCT01602315|467406786|FG000|Overall Study|Subject/guardian decision|0|||
129848510|NCT01602315|467406787|FG001|Overall Study|Subject/guardian decision|0|||
129848511|NCT01602315|467406788|FG002|Overall Study|Subject/guardian decision|0|||
129848512|NCT01602315|467406789|FG003|Overall Study|Subject/guardian decision|0|||
129848513|NCT01602315|467406790|FG004|Overall Study|Subject/guardian decision|0|||
129848514|NCT01602315|467406791|FG005|Overall Study|Subject/guardian decision|0|||
129848515|NCT01602315|467406792|FG006|Overall Study|Subject/guardian decision|1|||
129848516|NCT01602315|467406786|FG000|Overall Study|Cross-over patients to combo treatment|0|||
129848517|NCT01602315|467406787|FG001|Overall Study|Cross-over patients to combo treatment|0|||
129848518|NCT01602315|467406788|FG002|Overall Study|Cross-over patients to combo treatment|0|||
129848519|NCT01602315|467406789|FG003|Overall Study|Cross-over patients to combo treatment|0|||
129848520|NCT01602315|467406790|FG004|Overall Study|Cross-over patients to combo treatment|0|||
129848521|NCT01602315|467406791|FG005|Overall Study|Cross-over patients to combo treatment|16|||
129848522|NCT01602315|467406792|FG006|Overall Study|Cross-over patients to combo treatment|0|||
129848523|NCT02880371|467406793|FG000|Phase 1b|Lost to Follow-up|1|||
129848524|NCT02880371|467406794|FG001|Phase 1b|Lost to Follow-up|0|||
129848525|NCT02880371|467406795|FG002|Phase 1b|Lost to Follow-up|0|||
129848526|NCT02880371|467406796|FG003|Phase 1b|Lost to Follow-up|0|||
129848527|NCT02880371|467406797|FG004|Phase 1b|Lost to Follow-up|0|||
129848528|NCT02880371|467406798|FG005|Phase 1b|Lost to Follow-up|0|||
129848529|NCT02880371|467406799|FG006|Phase 1b|Lost to Follow-up|0|||
129848530|NCT02880371|467406800|FG007|Phase 1b|Lost to Follow-up|0|||
129848531|NCT02880371|467406793|FG000|Phase 1b|Participants terminated by Sponsor|1|||
129848532|NCT02880371|467406794|FG001|Phase 1b|Participants terminated by Sponsor|0|||
129848533|NCT02880371|467406795|FG002|Phase 1b|Participants terminated by Sponsor|0|||
129848534|NCT02880371|467406796|FG003|Phase 1b|Participants terminated by Sponsor|0|||
129848535|NCT02880371|467406797|FG004|Phase 1b|Participants terminated by Sponsor|0|||
129848536|NCT02880371|467406798|FG005|Phase 1b|Participants terminated by Sponsor|0|||
129848537|NCT02880371|467406799|FG006|Phase 1b|Participants terminated by Sponsor|0|||
129848538|NCT02880371|467406800|FG007|Phase 1b|Participants terminated by Sponsor|0|||
129848539|NCT02880371|467406793|FG000|Phase 1b|Withdrawal by Subject|0|||
129848540|NCT02880371|467406794|FG001|Phase 1b|Withdrawal by Subject|0|||
129848541|NCT02880371|467406795|FG002|Phase 1b|Withdrawal by Subject|1|||
129848542|NCT02880371|467406796|FG003|Phase 1b|Withdrawal by Subject|0|||
129848543|NCT02880371|467406797|FG004|Phase 1b|Withdrawal by Subject|0|||
129848544|NCT02880371|467406798|FG005|Phase 1b|Withdrawal by Subject|0|||
129848545|NCT02880371|467406799|FG006|Phase 1b|Withdrawal by Subject|0|||
129848546|NCT02880371|467406800|FG007|Phase 1b|Withdrawal by Subject|0|||
129848547|NCT02880371|467406793|FG000|Phase 1b|Death|4|||
129848548|NCT02880371|467406794|FG001|Phase 1b|Death|6|||
129848549|NCT02880371|467406795|FG002|Phase 1b|Death|5|||
129848550|NCT02880371|467406796|FG003|Phase 1b|Death|1|||
129848551|NCT02880371|467406797|FG004|Phase 1b|Death|0|||
129848552|NCT02880371|467406798|FG005|Phase 1b|Death|0|||
129848553|NCT02880371|467406799|FG006|Phase 1b|Death|0|||
129848554|NCT02880371|467406800|FG007|Phase 1b|Death|0|||
129848555|NCT02880371|467406793|FG000|Phase 1b|Enrolled but not Treated|0|||
129848556|NCT02880371|467406794|FG001|Phase 1b|Enrolled but not Treated|1|||
129848557|NCT02880371|467406795|FG002|Phase 1b|Enrolled but not Treated|0|||
129848558|NCT02880371|467406796|FG003|Phase 1b|Enrolled but not Treated|0|||
129848559|NCT02880371|467406797|FG004|Phase 1b|Enrolled but not Treated|0|||
129848560|NCT02880371|467406798|FG005|Phase 1b|Enrolled but not Treated|0|||
129848561|NCT02880371|467406799|FG006|Phase 1b|Enrolled but not Treated|0|||
129848562|NCT02880371|467406800|FG007|Phase 1b|Enrolled but not Treated|0|||
129848563|NCT02880371|467406793|FG000|Phase 2|Enrolled but not Treated|0|||
129848564|NCT02880371|467406794|FG001|Phase 2|Enrolled but not Treated|0|||
129848565|NCT02880371|467406795|FG002|Phase 2|Enrolled but not Treated|0|||
129848566|NCT02880371|467406796|FG003|Phase 2|Enrolled but not Treated|0|||
129848567|NCT02880371|467406797|FG004|Phase 2|Enrolled but not Treated|0|||
129848568|NCT02880371|467406798|FG005|Phase 2|Enrolled but not Treated|1|||
129848569|NCT02880371|467406799|FG006|Phase 2|Enrolled but not Treated|1|||
129848570|NCT02880371|467406800|FG007|Phase 2|Enrolled but not Treated|0|||
129848571|NCT02880371|467406793|FG000|Phase 2|Other|0|||
129848572|NCT02880371|467406794|FG001|Phase 2|Other|0|||
129848573|NCT02880371|467406795|FG002|Phase 2|Other|0|||
129848574|NCT02880371|467406796|FG003|Phase 2|Other|0|||
129848575|NCT02880371|467406797|FG004|Phase 2|Other|0|||
129848576|NCT02880371|467406798|FG005|Phase 2|Other|1|||
129848577|NCT02880371|467406799|FG006|Phase 2|Other|2|||
129848578|NCT02880371|467406800|FG007|Phase 2|Other|1|||
129848579|NCT02880371|467406793|FG000|Phase 2|Participants terminated by Sponsor|0|||
129848580|NCT02880371|467406794|FG001|Phase 2|Participants terminated by Sponsor|0|||
129848581|NCT02880371|467406795|FG002|Phase 2|Participants terminated by Sponsor|0|||
129848582|NCT02880371|467406796|FG003|Phase 2|Participants terminated by Sponsor|0|||
129848583|NCT02880371|467406797|FG004|Phase 2|Participants terminated by Sponsor|1|||
129848584|NCT02880371|467406798|FG005|Phase 2|Participants terminated by Sponsor|6|||
129848585|NCT02880371|467406799|FG006|Phase 2|Participants terminated by Sponsor|1|||
129848586|NCT02880371|467406800|FG007|Phase 2|Participants terminated by Sponsor|5|||
129848587|NCT02880371|467406793|FG000|Phase 2|Death|0|||
129848588|NCT02880371|467406794|FG001|Phase 2|Death|0|||
129848589|NCT02880371|467406795|FG002|Phase 2|Death|0|||
129848590|NCT02880371|467406796|FG003|Phase 2|Death|0|||
129848591|NCT02880371|467406797|FG004|Phase 2|Death|1|||
129848592|NCT02880371|467406798|FG005|Phase 2|Death|10|||
129848593|NCT02880371|467406799|FG006|Phase 2|Death|20|||
129848594|NCT02880371|467406800|FG007|Phase 2|Death|5|||
129848595|NCT02880371|467406793|FG000|Phase 2|Lost to Follow-up|0|||
129848596|NCT02880371|467406794|FG001|Phase 2|Lost to Follow-up|0|||
129848597|NCT02880371|467406795|FG002|Phase 2|Lost to Follow-up|0|||
129848598|NCT02880371|467406796|FG003|Phase 2|Lost to Follow-up|0|||
129848599|NCT02880371|467406797|FG004|Phase 2|Lost to Follow-up|0|||
129848600|NCT02880371|467406798|FG005|Phase 2|Lost to Follow-up|0|||
129848601|NCT02880371|467406799|FG006|Phase 2|Lost to Follow-up|3|||
129848602|NCT02880371|467406800|FG007|Phase 2|Lost to Follow-up|0|||
129848603|NCT02880371|467406793|FG000|Phase 2|Withdrawal by Subject|0|||
129848604|NCT02880371|467406794|FG001|Phase 2|Withdrawal by Subject|0|||
129848605|NCT02880371|467406795|FG002|Phase 2|Withdrawal by Subject|0|||
129848606|NCT02880371|467406796|FG003|Phase 2|Withdrawal by Subject|0|||
129848607|NCT02880371|467406797|FG004|Phase 2|Withdrawal by Subject|0|||
129848608|NCT02880371|467406798|FG005|Phase 2|Withdrawal by Subject|1|||
129848609|NCT02880371|467406799|FG006|Phase 2|Withdrawal by Subject|1|||
129848610|NCT02880371|467406800|FG007|Phase 2|Withdrawal by Subject|0|||
129848611|NCT02880371|467406793|FG000|Phase 2|End of Study page not completed by error|0|||
129848612|NCT02880371|467406794|FG001|Phase 2|End of Study page not completed by error|0|||
129848613|NCT02880371|467406795|FG002|Phase 2|End of Study page not completed by error|0|||
129848614|NCT02880371|467406796|FG003|Phase 2|End of Study page not completed by error|0|||
129848615|NCT02880371|467406797|FG004|Phase 2|End of Study page not completed by error|0|||
129848616|NCT02880371|467406798|FG005|Phase 2|End of Study page not completed by error|1|||
129848617|NCT02880371|467406799|FG006|Phase 2|End of Study page not completed by error|0|||
129848618|NCT02880371|467406800|FG007|Phase 2|End of Study page not completed by error|0|||
129848619|NCT01777997|467406803|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
129848620|NCT01777997|467406803|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
129848621|NCT01777997|467406803|FG000|Weeks 48 to 72/96 on ART|Death|1|||
129848622|NCT01777997|467406803|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
129848623|NCT00440271|467406812|FG000|Overall Study|Protocol Violation|1|||
129848624|NCT00440271|467406813|FG001|Overall Study|Protocol Violation|1|||
129848625|NCT00440271|467406812|FG000|Overall Study|Adverse Event|0|||
129848626|NCT00440271|467406813|FG001|Overall Study|Adverse Event|1|||
129848627|NCT00440271|467406812|FG000|Overall Study|Lost to Follow-up|1|||
129848628|NCT00440271|467406813|FG001|Overall Study|Lost to Follow-up|0|||
129848629|NCT00440271|467406812|FG000|Overall Study|Withdrawal by Subject|0|||
129848630|NCT00440271|467406813|FG001|Overall Study|Withdrawal by Subject|2|||
129848631|NCT00440271|467406812|FG000|Overall Study|Lack of Efficacy|0|||
129848632|NCT00440271|467406813|FG001|Overall Study|Lack of Efficacy|1|||
129848633|NCT00440271|467406812|FG000|Overall Study|Due to closure of trial|8|||
129848634|NCT00440271|467406813|FG001|Overall Study|Due to closure of trial|10|||
129848635|NCT00440271|467406812|FG000|Overall Study|Other|2|||
129848636|NCT00440271|467406813|FG001|Overall Study|Other|0|||
129848637|NCT00723801|467406814|FG000|Overall Study|Lost to Follow-up|1|||
129848638|NCT00723801|467406815|FG001|Overall Study|Lost to Follow-up|2|||
129848639|NCT00723801|467406814|FG000|Overall Study|Protocol Violation|2|||
129848640|NCT00723801|467406815|FG001|Overall Study|Protocol Violation|1|||
129848641|NCT01565993|467406823|FG000|Overall Study|Physician Decision|0|||
129848642|NCT01565993|467406824|FG001|Overall Study|Physician Decision|3|||
129848643|NCT01824303|467406825|FG000|Randomized Study|Withdrawal by Subject|1|||
129848644|NCT01824303|467406826|FG001|Randomized Study|Withdrawal by Subject|1|||
129848645|NCT01824303|467406825|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
129848646|NCT01824303|467406826|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
129848647|NCT02809976|467406827|FG000|Overall Study|Lost to Follow-up|1|||
129848648|NCT02809976|467406827|FG000|Overall Study|Withdrawal by Subject|1|||
129848649|NCT00113516|467406828|FG000|Part 1|Adverse Event|6|||
129848650|NCT00113516|467406829|FG001|Part 1|Adverse Event|0|||
129848651|NCT00113516|467406828|FG000|Part 1|Death|3|||
129848652|NCT00113516|467406829|FG001|Part 1|Death|0|||
129848653|NCT00113516|467406828|FG000|Part 1|Other|3|||
129848654|NCT00113516|467406829|FG001|Part 1|Other|0|||
129848655|NCT00113516|467406828|FG000|Part 1|Withdrawal by Subject|2|||
129848656|NCT00113516|467406829|FG001|Part 1|Withdrawal by Subject|0|||
129848657|NCT00113516|467406828|FG000|Part 1|Lack of Efficacy|2|||
129848658|NCT00113516|467406829|FG001|Part 1|Lack of Efficacy|0|||
129848659|NCT00113516|467406828|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
129848660|NCT00113516|467406829|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
129848661|NCT00113516|467406828|FG000|Part 1|Laboratory Abnormality|1|||
129848662|NCT00113516|467406829|FG001|Part 1|Laboratory Abnormality|0|||
129848663|NCT00113516|467406828|FG000|Part 1|Ongoing|1|||
129848664|NCT00113516|467406829|FG001|Part 1|Ongoing|0|||
129848665|NCT00113516|467406828|FG000|Part 1|Missing|65|||
129848666|NCT00113516|467406829|FG001|Part 1|Missing|0|||
129848667|NCT00113516|467406828|FG000|Part 2|Adverse Event|0|||
129848668|NCT00113516|467406829|FG001|Part 2|Adverse Event|16|||
129848669|NCT00113516|467406828|FG000|Part 2|Death|0|||
129848670|NCT00113516|467406829|FG001|Part 2|Death|5|||
129903511|NCT01049503|467608311|FG004|Overall Study|Lost to Follow-up|27|||
129903512|NCT01049503|467608312|FG005|Overall Study|Lost to Follow-up|8|||
129903513|NCT00726596|467608313|FG000|Overall Study|Adverse Event|2|||
129903514|NCT00726596|467608314|FG001|Overall Study|Adverse Event|1|||
129903515|NCT00726596|467608313|FG000|Overall Study|Withdrawal by Subject|3|||
129903516|NCT00726596|467608314|FG001|Overall Study|Withdrawal by Subject|3|||
129903517|NCT02974634|467608315|FG000|Overall Study|Advanced disease|12|||
129903518|NCT02974634|467608316|FG001|Overall Study|Advanced disease|3|||
129903519|NCT02974634|467608315|FG000|Overall Study|Noncompliance|3|||
129903520|NCT02974634|467608316|FG001|Overall Study|Noncompliance|7|||
129903521|NCT02974634|467608315|FG000|Overall Study|intervention technology related issues|5|||
129903522|NCT02974634|467608316|FG001|Overall Study|intervention technology related issues|0|||
129848671|NCT00113516|467406828|FG000|Part 2|Lack of Efficacy|0|||
129848672|NCT00113516|467406829|FG001|Part 2|Lack of Efficacy|37|||
129848673|NCT00113516|467406828|FG000|Part 2|Withdrawal by Subject|0|||
129848674|NCT00113516|467406829|FG001|Part 2|Withdrawal by Subject|3|||
129848675|NCT00113516|467406828|FG000|Part 2|Other|0|||
129848676|NCT00113516|467406829|FG001|Part 2|Other|3|||
129848677|NCT00113516|467406828|FG000|Part 2|Laboratory Abnormality|0|||
129848678|NCT00113516|467406829|FG001|Part 2|Laboratory Abnormality|1|||
129848679|NCT00113516|467406828|FG000|Part 2|Ongoing|0|||
129848680|NCT00113516|467406829|FG001|Part 2|Ongoing|1|||
129848681|NCT00642304|467406830|FG000|Overall Study|Adverse Event|1|||
129848682|NCT00642304|467406830|FG000|Overall Study|Death|1|||
129848683|NCT00642304|467406830|FG000|Overall Study|Blood transfusion|2|||
129848684|NCT00642304|467406830|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
129848685|NCT00642304|467406830|FG000|Overall Study|Transplantation|1|||
129848686|NCT00812812|467406831|FG000|Overall Study|Adverse Event|2|||
129848687|NCT00812812|467406832|FG001|Overall Study|Adverse Event|1|||
129848688|NCT00812812|467406831|FG000|Overall Study|Lack of Efficacy|1|||
129848689|NCT00812812|467406832|FG001|Overall Study|Lack of Efficacy|0|||
129848690|NCT00812812|467406831|FG000|Overall Study|Lost to Follow-up|0|||
129903523|NCT02974634|467608315|FG000|Overall Study|Death|8|||
129903524|NCT02974634|467608316|FG001|Overall Study|Death|11|||
129848691|NCT00812812|467406832|FG001|Overall Study|Lost to Follow-up|1|||
129848692|NCT00812812|467406831|FG000|Overall Study|Withdrawal by Subject|0|||
129848693|NCT00812812|467406832|FG001|Overall Study|Withdrawal by Subject|2|||
129848694|NCT02863354|467406836|FG000|Year 1|Lost to Follow-up|1|||
129848695|NCT02863354|467406837|FG001|Year 1|Lost to Follow-up|1|||
129979686|NCT03752970|467889436|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
129848696|NCT02863354|467406836|FG000|Year 1|Withdrawal by Subject|3|||
129848697|NCT02863354|467406837|FG001|Year 1|Withdrawal by Subject|0|||
129848698|NCT02863354|467406836|FG000|Year 1|Death|0|||
129848699|NCT02863354|467406837|FG001|Year 1|Death|1|||
129848700|NCT02863354|467406836|FG000|Year 2|Lost to Follow-up|2|||
129848701|NCT02863354|467406837|FG001|Year 2|Lost to Follow-up|2|||
129848702|NCT03235024|467406838|FG000|Overall Study|Adverse Event|2|||
129848703|NCT03235024|467406839|FG001|Overall Study|Adverse Event|2|||
129848704|NCT03235024|467406838|FG000|Overall Study|Death|1|||
129848705|NCT03235024|467406839|FG001|Overall Study|Death|0|||
129848706|NCT03235024|467406838|FG000|Overall Study|Lost to Follow-up|2|||
129848707|NCT03235024|467406839|FG001|Overall Study|Lost to Follow-up|5|||
129848708|NCT03235024|467406838|FG000|Overall Study|Protocol Violation|1|||
129848709|NCT03235024|467406839|FG001|Overall Study|Protocol Violation|0|||
129848710|NCT03235024|467406838|FG000|Overall Study|Withdrawal by Subject|0|||
129848711|NCT03235024|467406839|FG001|Overall Study|Withdrawal by Subject|3|||
129848712|NCT00705575|467406840|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129848713|NCT00705575|467406841|FG001|Overall Study|Abnormal laboratory value(s)|3|||
129848714|NCT00705575|467406840|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129848715|NCT00705575|467406841|FG001|Overall Study|Abnormal test procedure result(s)|12|||
129848716|NCT00705575|467406840|FG000|Overall Study|Adverse Event|11|||
129848717|NCT00705575|467406841|FG001|Overall Study|Adverse Event|15|||
129848718|NCT00705575|467406840|FG000|Overall Study|Lost to Follow-up|3|||
129848719|NCT00705575|467406841|FG001|Overall Study|Lost to Follow-up|4|||
129848720|NCT00705575|467406840|FG000|Overall Study|Protocol Violation|2|||
129848721|NCT00705575|467406841|FG001|Overall Study|Protocol Violation|2|||
129848722|NCT00705575|467406840|FG000|Overall Study|Withdrawal by Subject|5|||
129848723|NCT00705575|467406841|FG001|Overall Study|Withdrawal by Subject|10|||
129848724|NCT03304379|467406842|FG000|Overall Study|Protocol Violation|8|||
129848725|NCT03304379|467406843|FG001|Overall Study|Protocol Violation|10|||
129848726|NCT03304379|467406844|FG002|Overall Study|Protocol Violation|5|||
129848727|NCT03304379|467406845|FG003|Overall Study|Protocol Violation|0|||
129848728|NCT03304379|467406846|FG004|Overall Study|Protocol Violation|2|||
129848729|NCT03304379|467406842|FG000|Overall Study|Adverse Event|4|||
129848730|NCT03304379|467406843|FG001|Overall Study|Adverse Event|20|||
129848731|NCT03304379|467406844|FG002|Overall Study|Adverse Event|17|||
129848732|NCT03304379|467406845|FG003|Overall Study|Adverse Event|1|||
129848733|NCT03304379|467406846|FG004|Overall Study|Adverse Event|0|||
129848734|NCT03304379|467406842|FG000|Overall Study|Lack of Efficacy|17|||
129848735|NCT03304379|467406843|FG001|Overall Study|Lack of Efficacy|16|||
129848736|NCT03304379|467406844|FG002|Overall Study|Lack of Efficacy|20|||
129848737|NCT03304379|467406845|FG003|Overall Study|Lack of Efficacy|0|||
129848738|NCT03304379|467406846|FG004|Overall Study|Lack of Efficacy|0|||
129848739|NCT03304379|467406842|FG000|Overall Study|Physician Decision|6|||
129848740|NCT03304379|467406843|FG001|Overall Study|Physician Decision|10|||
129848741|NCT03304379|467406844|FG002|Overall Study|Physician Decision|6|||
129848742|NCT03304379|467406845|FG003|Overall Study|Physician Decision|9|||
129848743|NCT03304379|467406846|FG004|Overall Study|Physician Decision|10|||
129848744|NCT03304379|467406842|FG000|Overall Study|Withdrawal by Subject|26|||
129848745|NCT03304379|467406843|FG001|Overall Study|Withdrawal by Subject|58|||
129848746|NCT03304379|467406844|FG002|Overall Study|Withdrawal by Subject|66|||
129848747|NCT03304379|467406845|FG003|Overall Study|Withdrawal by Subject|3|||
129848748|NCT03304379|467406846|FG004|Overall Study|Withdrawal by Subject|5|||
129848749|NCT03304379|467406842|FG000|Overall Study|Lost to Follow-up|8|||
129848750|NCT03304379|467406843|FG001|Overall Study|Lost to Follow-up|24|||
129848751|NCT03304379|467406844|FG002|Overall Study|Lost to Follow-up|35|||
129848752|NCT03304379|467406845|FG003|Overall Study|Lost to Follow-up|4|||
129848753|NCT03304379|467406846|FG004|Overall Study|Lost to Follow-up|0|||
129848754|NCT03304379|467406842|FG000|Overall Study|Death|1|||
129848755|NCT03304379|467406843|FG001|Overall Study|Death|2|||
129848756|NCT03304379|467406844|FG002|Overall Study|Death|0|||
129848757|NCT03304379|467406845|FG003|Overall Study|Death|0|||
129848758|NCT03304379|467406846|FG004|Overall Study|Death|0|||
129848759|NCT03304379|467406842|FG000|Overall Study|Other|0|||
129848760|NCT03304379|467406843|FG001|Overall Study|Other|1|||
129848761|NCT03304379|467406844|FG002|Overall Study|Other|0|||
129848762|NCT03304379|467406845|FG003|Overall Study|Other|0|||
129848763|NCT03304379|467406846|FG004|Overall Study|Other|0|||
129903525|NCT02962674|467608325|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
129903526|NCT00364286|467608326|FG000|Overall Study|Withdrawal by Subject|1|||
129848764|NCT00684424|467406858|FG000|Overall Study|Adverse Event|1|||
129848765|NCT00684424|467406858|FG000|Overall Study|Lost to Follow-up|2|||
129848766|NCT00684424|467406858|FG000|Overall Study|Other|2|||
129848767|NCT02410811|467406859|FG000|Overall Study|Withdrawal by Subject|0|||
129848768|NCT02410811|467406860|FG001|Overall Study|Withdrawal by Subject|0|||
129449627|NCT00467779|465945626|FG003|Stage 3|Death|0|||
129848769|NCT02410811|467406861|FG002|Overall Study|Withdrawal by Subject|1|||
129848770|NCT02410811|467406862|FG003|Overall Study|Withdrawal by Subject|0|||
129848771|NCT02550652|467406868|FG000|Overall Study|Death|1|||
129848772|NCT02550652|467406869|FG001|Overall Study|Death|4|||
129848773|NCT02550652|467406868|FG000|Overall Study|Lack of Efficacy|1|||
129848774|NCT02550652|467406869|FG001|Overall Study|Lack of Efficacy|0|||
129848775|NCT02550652|467406868|FG000|Overall Study|Withdrawal by Subject|4|||
129848776|NCT02550652|467406869|FG001|Overall Study|Withdrawal by Subject|7|||
129848777|NCT02550652|467406868|FG000|Overall Study|Post Trial Access|1|||
129903527|NCT00364286|467608326|FG000|Overall Study|Adverse Event|2|||
129903528|NCT01134562|467608327|FG000|Overall Study|Adverse Event|0|||
129903529|NCT01134562|467608328|FG001|Overall Study|Adverse Event|1|||
129903530|NCT01134562|467608329|FG002|Overall Study|Adverse Event|0|||
129903531|NCT01134562|467608330|FG003|Overall Study|Adverse Event|0|||
129903532|NCT01134562|467608331|FG004|Overall Study|Adverse Event|0|||
129903533|NCT00357396|467608332|FG000|Overall Study|Adverse Event|1|||
129903534|NCT00357396|467608333|FG001|Overall Study|Adverse Event|0|||
129903535|NCT02496702|467608334|FG000|Overall Study|Lost to Follow-up|8|||
129903536|NCT02496702|467608335|FG001|Overall Study|Lost to Follow-up|6|||
129903537|NCT02496702|467608334|FG000|Overall Study|Only partially tested|0|||
129903538|NCT02496702|467608335|FG001|Overall Study|Only partially tested|2|||
129903539|NCT01227278|467608338|FG000|Overall Study|Withdrawal by Subject|4|||
129903540|NCT01227278|467608339|FG001|Overall Study|Withdrawal by Subject|4|||
129903541|NCT01227278|467608338|FG000|Overall Study|Death|0|||
129903542|NCT01227278|467608339|FG001|Overall Study|Death|2|||
129903543|NCT01227278|467608338|FG000|Overall Study|Other|1|||
129903544|NCT01227278|467608339|FG001|Overall Study|Other|2|||
129903545|NCT04035668|467608340|FG000|Overall Study|Adverse Event|3|||
129903546|NCT04035668|467608341|FG001|Overall Study|Adverse Event|4|||
129903547|NCT04035668|467608342|FG002|Overall Study|Adverse Event|2|||
129903548|NCT04035668|467608340|FG000|Overall Study|Lost to Follow-up|0|||
129903549|NCT04035668|467608341|FG001|Overall Study|Lost to Follow-up|1|||
129903550|NCT04035668|467608342|FG002|Overall Study|Lost to Follow-up|0|||
129903551|NCT04035668|467608340|FG000|Overall Study|Physician Decision|2|||
129903552|NCT04035668|467608341|FG001|Overall Study|Physician Decision|1|||
129903553|NCT04035668|467608342|FG002|Overall Study|Physician Decision|1|||
129903554|NCT04035668|467608340|FG000|Overall Study|Subject Decision|2|||
129903555|NCT04035668|467608341|FG001|Overall Study|Subject Decision|2|||
129903556|NCT04035668|467608342|FG002|Overall Study|Subject Decision|0|||
129903557|NCT02320123|467608343|FG000|Overall Study|Lost to Follow-up|4|||
129903558|NCT02320123|467608344|FG001|Overall Study|Lost to Follow-up|6|||
129903559|NCT02320123|467608343|FG000|Overall Study|Death|6|||
129903560|NCT02320123|467608344|FG001|Overall Study|Death|5|||
129903561|NCT00516386|467608355|FG000|Overall Study|not interested in the study|4|||
129903562|NCT00516386|467608355|FG000|Overall Study|Lost to Follow-up|2|||
129903563|NCT01376089|467608360|FG000|Overall Study|Patient received no contrast media|3|||
129903564|NCT01376089|467608361|FG001|Overall Study|Patient received no contrast media|4|||
129903565|NCT03287622|467608364|FG000|Overall Study|Withdrawal by Subject|1|||
129903566|NCT03287622|467608365|FG001|Overall Study|Withdrawal by Subject|0|||
129903567|NCT03287622|467608364|FG000|Overall Study|Lost to Follow-up|27|||
129903568|NCT03287622|467608365|FG001|Overall Study|Lost to Follow-up|15|||
129903569|NCT03287622|467608364|FG000|Overall Study|No prescripion after surgery|28|||
129903570|NCT03287622|467608365|FG001|Overall Study|No prescripion after surgery|31|||
129903571|NCT03287622|467608364|FG000|Overall Study|prolonged Length of stay|2|||
129903572|NCT03287622|467608365|FG001|Overall Study|prolonged Length of stay|0|||
129903573|NCT03287622|467608364|FG000|Overall Study|surgery related|0|||
129903574|NCT03287622|467608365|FG001|Overall Study|surgery related|2|||
129903575|NCT01786564|467608368|FG000|Overall Study|Lost to Follow-up|47|||
129903576|NCT01786564|467608368|FG000|Overall Study|Ineligible|17|||
129903577|NCT02506257|467608369|FG000|Overall Study|Adverse Event|0|||
129903578|NCT02506257|467608370|FG001|Overall Study|Adverse Event|2|||
129903579|NCT02506257|467608371|FG002|Overall Study|Adverse Event|3|||
129903580|NCT02506257|467608372|FG003|Overall Study|Adverse Event|0|||
129903581|NCT02506257|467608369|FG000|Overall Study|Protocol Violation|0|||
129903582|NCT02506257|467608370|FG001|Overall Study|Protocol Violation|0|||
129903583|NCT02506257|467608371|FG002|Overall Study|Protocol Violation|1|||
129903584|NCT02506257|467608372|FG003|Overall Study|Protocol Violation|0|||
129903585|NCT00139737|467608380|FG000|Overall Study|Withdrawal by Subject|190|||
129903586|NCT00139737|467608380|FG000|Overall Study|Adverse Event|58|||
129903587|NCT00139737|467608380|FG000|Overall Study|Lack of Efficacy|40|||
129903588|NCT00139737|467608380|FG000|Overall Study|Lost to Follow-up|8|||
129903589|NCT00139737|467608380|FG000|Overall Study|Death|3|||
129903590|NCT00139737|467608380|FG000|Overall Study|Laboratory Abnormality|2|||
129903591|NCT00139737|467608380|FG000|Overall Study|Protocol Violation|18|||
129903592|NCT00139737|467608380|FG000|Overall Study|Withdrew During Screening Phase|8|||
129903593|NCT00139737|467608380|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129903594|NCT00139737|467608380|FG000|Overall Study|Screened, Not Treated|13|||
129903595|NCT03781336|467608381|FG000|Overall Study|Withdrawal by Subject|2|||
129903596|NCT03781336|467608382|FG001|Overall Study|Withdrawal by Subject|2|||
129903597|NCT03460756|467608383|FG000|Overall Study|Adverse Event|0|||
129903598|NCT03460756|467608384|FG001|Overall Study|Adverse Event|0|||
129903599|NCT03460756|467608385|FG002|Overall Study|Adverse Event|0|||
129903600|NCT03460756|467608386|FG003|Overall Study|Adverse Event|1|||
129903601|NCT03460756|467608383|FG000|Overall Study|Lack of Efficacy|0|||
129903602|NCT03460756|467608384|FG001|Overall Study|Lack of Efficacy|0|||
129903603|NCT03460756|467608385|FG002|Overall Study|Lack of Efficacy|0|||
129903604|NCT03460756|467608386|FG003|Overall Study|Lack of Efficacy|2|||
129903605|NCT03460756|467608383|FG000|Overall Study|Lost to Follow-up|0|||
129903606|NCT03460756|467608384|FG001|Overall Study|Lost to Follow-up|1|||
129903607|NCT03460756|467608385|FG002|Overall Study|Lost to Follow-up|2|||
129903608|NCT03460756|467608386|FG003|Overall Study|Lost to Follow-up|1|||
129903609|NCT03460756|467608383|FG000|Overall Study|Pregnancy|0|||
129903610|NCT03460756|467608384|FG001|Overall Study|Pregnancy|0|||
129903611|NCT03460756|467608385|FG002|Overall Study|Pregnancy|0|||
129903612|NCT03460756|467608386|FG003|Overall Study|Pregnancy|1|||
129903613|NCT03460756|467608383|FG000|Overall Study|Protocol Violation|0|||
129903614|NCT03460756|467608384|FG001|Overall Study|Protocol Violation|0|||
129903615|NCT03460756|467608385|FG002|Overall Study|Protocol Violation|0|||
129903616|NCT03460756|467608386|FG003|Overall Study|Protocol Violation|1|||
129903617|NCT03460756|467608383|FG000|Overall Study|Withdrawal by Subject|0|||
129903618|NCT03460756|467608384|FG001|Overall Study|Withdrawal by Subject|4|||
129903619|NCT03460756|467608385|FG002|Overall Study|Withdrawal by Subject|7|||
129903620|NCT03460756|467608386|FG003|Overall Study|Withdrawal by Subject|3|||
129903621|NCT03987451|467608387|FG000|Overall Study|Lost to Follow-up|1|||
129903622|NCT03987451|467608388|FG001|Overall Study|Lost to Follow-up|0|||
129903623|NCT03987451|467608387|FG000|Overall Study|Withdrawal by Subject|1|||
129903624|NCT03987451|467608388|FG001|Overall Study|Withdrawal by Subject|1|||
129903625|NCT02441036|467608390|FG000|Overall Study|No tissue resected|0|||
129903626|NCT02441036|467608391|FG001|Overall Study|No tissue resected|1|||
129903627|NCT02441036|467608392|FG002|Overall Study|No tissue resected|0|||
129903628|NCT02441036|467608393|FG003|Overall Study|No tissue resected|1|||
129903629|NCT02441036|467608394|FG004|Overall Study|No tissue resected|0|||
129903630|NCT00612586|467608395|FG000|Overall Study|Adverse Event|6|||
129903631|NCT00612586|467608396|FG001|Overall Study|Adverse Event|2|||
129903632|NCT00612586|467608395|FG000|Overall Study|Death|1|||
129903633|NCT00612586|467608396|FG001|Overall Study|Death|0|||
129903634|NCT00612586|467608395|FG000|Overall Study|Entry Criteria Not Met|0|||
129848778|NCT02550652|467406869|FG001|Overall Study|Post Trial Access|0|||
129848779|NCT02550652|467406868|FG000|Overall Study|Lost to Follow-up|1|||
129848780|NCT02550652|467406869|FG001|Overall Study|Lost to Follow-up|3|||
129848781|NCT02550652|467406868|FG000|Overall Study|Physician Decision|0|||
129848782|NCT02550652|467406869|FG001|Overall Study|Physician Decision|2|||
129848783|NCT02550652|467406868|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
129848784|NCT02550652|467406869|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
129848785|NCT01706250|467406870|FG000|Overall Study|Lost to Follow-up|2|||
129848786|NCT02486406|467406871|FG000|Overall Study|Withdrew consent|1|||
129848787|NCT02486406|467406872|FG001|Overall Study|Withdrew consent|0|||
129848788|NCT02486406|467406873|FG002|Overall Study|Withdrew consent|0|||
129848789|NCT02486406|467406874|FG003|Overall Study|Withdrew consent|1|||
129848790|NCT02486406|467406871|FG000|Overall Study|Lost to Follow-up|1|||
129848791|NCT02486406|467406872|FG001|Overall Study|Lost to Follow-up|3|||
129848792|NCT02486406|467406873|FG002|Overall Study|Lost to Follow-up|1|||
129848793|NCT02486406|467406874|FG003|Overall Study|Lost to Follow-up|3|||
129848794|NCT02486406|467406871|FG000|Overall Study|Other, not specified|0|||
129848795|NCT02486406|467406872|FG001|Overall Study|Other, not specified|0|||
129848796|NCT02486406|467406873|FG002|Overall Study|Other, not specified|1|||
129848797|NCT02486406|467406874|FG003|Overall Study|Other, not specified|0|||
129848798|NCT01826825|467406875|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
129848799|NCT01826825|467406876|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
129848800|NCT01858194|467406877|FG000|Overall Study|Total Artificial Heart Implant|0|||
129848801|NCT01858194|467406878|FG001|Overall Study|Total Artificial Heart Implant|1|||
129848802|NCT01858194|467406877|FG000|Overall Study|Lost to Follow-up|0|||
129848803|NCT01858194|467406878|FG001|Overall Study|Lost to Follow-up|1|||
129848804|NCT03181542|467406882|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
129848805|NCT03181542|467406883|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
129848806|NCT01071512|467406884|FG000|Overall Study|Adverse Event|1|||
129848807|NCT01071512|467406884|FG000|Overall Study|Development of antibodies to drug|2|||
129848808|NCT01071512|467406884|FG000|Overall Study|positive anti-JC virus antibody test|2|||
129848809|NCT02460224|467406895|FG000|Overall Study|Adverse Event|0|||
129848810|NCT02460224|467406896|FG001|Overall Study|Adverse Event|0|||
129848811|NCT02460224|467406897|FG002|Overall Study|Adverse Event|0|||
129903635|NCT00612586|467608396|FG001|Overall Study|Entry Criteria Not Met|2|||
129903636|NCT00612586|467608395|FG000|Overall Study|Withdrawal by Subject|7|||
129903637|NCT00612586|467608396|FG001|Overall Study|Withdrawal by Subject|9|||
129903638|NCT00612586|467608395|FG000|Overall Study|Physician Decision|1|||
129903639|NCT00612586|467608396|FG001|Overall Study|Physician Decision|2|||
129903640|NCT00612586|467608395|FG000|Overall Study|Sponsor Decision|1|||
129903641|NCT00612586|467608396|FG001|Overall Study|Sponsor Decision|1|||
129903642|NCT00612586|467608395|FG000|Overall Study|Progressive Disease|26|||
129903643|NCT00612586|467608396|FG001|Overall Study|Progressive Disease|24|||
129903644|NCT00612586|467608395|FG000|Overall Study|Randomized and Not Treated|1|||
129903645|NCT00612586|467608396|FG001|Overall Study|Randomized and Not Treated|1|||
129903646|NCT01069341|467608397|FG000|Overall Study|Lost to Follow-up|1|||
129848812|NCT02460224|467406898|FG003|Overall Study|Adverse Event|0|||
129848813|NCT02460224|467406899|FG004|Overall Study|Adverse Event|0|||
129848814|NCT02460224|467406900|FG005|Overall Study|Adverse Event|0|||
129848815|NCT02460224|467406901|FG006|Overall Study|Adverse Event|1|||
129848816|NCT02460224|467406902|FG007|Overall Study|Adverse Event|0|||
129848817|NCT02460224|467406903|FG008|Overall Study|Adverse Event|0|||
129848818|NCT02460224|467406904|FG009|Overall Study|Adverse Event|0|||
129848819|NCT02460224|467406905|FG010|Overall Study|Adverse Event|0|||
129848820|NCT02460224|467406906|FG011|Overall Study|Adverse Event|0|||
129848821|NCT02460224|467406907|FG012|Overall Study|Adverse Event|1|||
129848822|NCT02460224|467406908|FG013|Overall Study|Adverse Event|0|||
129848823|NCT02460224|467406909|FG014|Overall Study|Adverse Event|0|||
129848824|NCT02460224|467406910|FG015|Overall Study|Adverse Event|0|||
129848825|NCT02460224|467406911|FG016|Overall Study|Adverse Event|1|||
129848826|NCT02460224|467406912|FG017|Overall Study|Adverse Event|0|||
129848827|NCT02460224|467406913|FG018|Overall Study|Adverse Event|1|||
129848828|NCT02460224|467406914|FG019|Overall Study|Adverse Event|0|||
129848829|NCT02460224|467406915|FG020|Overall Study|Adverse Event|1|||
129848830|NCT02460224|467406916|FG021|Overall Study|Adverse Event|1|||
129848831|NCT02460224|467406917|FG022|Overall Study|Adverse Event|1|||
129848832|NCT02460224|467406918|FG023|Overall Study|Adverse Event|0|||
129848833|NCT02460224|467406919|FG024|Overall Study|Adverse Event|0|||
129848834|NCT02460224|467406920|FG025|Overall Study|Adverse Event|0|||
129848835|NCT02460224|467406921|FG026|Overall Study|Adverse Event|11|||
129848836|NCT02460224|467406922|FG027|Overall Study|Adverse Event|1|||
129848837|NCT02460224|467406923|FG028|Overall Study|Adverse Event|6|||
129848838|NCT02460224|467406895|FG000|Overall Study|Death|0|||
129848839|NCT02460224|467406896|FG001|Overall Study|Death|0|||
129848840|NCT02460224|467406897|FG002|Overall Study|Death|0|||
129848841|NCT02460224|467406898|FG003|Overall Study|Death|0|||
129848842|NCT02460224|467406899|FG004|Overall Study|Death|0|||
129848843|NCT02460224|467406900|FG005|Overall Study|Death|2|||
129848844|NCT02460224|467406901|FG006|Overall Study|Death|1|||
129848845|NCT02460224|467406902|FG007|Overall Study|Death|0|||
129848846|NCT02460224|467406903|FG008|Overall Study|Death|0|||
129848847|NCT02460224|467406904|FG009|Overall Study|Death|1|||
129848848|NCT02460224|467406905|FG010|Overall Study|Death|0|||
129848849|NCT02460224|467406906|FG011|Overall Study|Death|0|||
129848850|NCT02460224|467406907|FG012|Overall Study|Death|0|||
129848851|NCT02460224|467406908|FG013|Overall Study|Death|1|||
129848852|NCT02460224|467406909|FG014|Overall Study|Death|0|||
129848853|NCT02460224|467406910|FG015|Overall Study|Death|0|||
129848854|NCT02460224|467406911|FG016|Overall Study|Death|2|||
129848855|NCT02460224|467406912|FG017|Overall Study|Death|1|||
129848856|NCT02460224|467406913|FG018|Overall Study|Death|0|||
129848857|NCT02460224|467406914|FG019|Overall Study|Death|2|||
129848858|NCT02460224|467406915|FG020|Overall Study|Death|0|||
129848859|NCT02460224|467406916|FG021|Overall Study|Death|0|||
129848860|NCT02460224|467406917|FG022|Overall Study|Death|0|||
129848861|NCT02460224|467406918|FG023|Overall Study|Death|0|||
129848862|NCT02460224|467406919|FG024|Overall Study|Death|1|||
129848863|NCT02460224|467406920|FG025|Overall Study|Death|1|||
129848864|NCT02460224|467406921|FG026|Overall Study|Death|5|||
129848865|NCT02460224|467406922|FG027|Overall Study|Death|0|||
129848866|NCT02460224|467406923|FG028|Overall Study|Death|1|||
129848867|NCT02460224|467406895|FG000|Overall Study|Lost to Follow-up|0|||
129848868|NCT02460224|467406896|FG001|Overall Study|Lost to Follow-up|0|||
129848869|NCT02460224|467406897|FG002|Overall Study|Lost to Follow-up|0|||
129848870|NCT02460224|467406898|FG003|Overall Study|Lost to Follow-up|0|||
129848871|NCT02460224|467406899|FG004|Overall Study|Lost to Follow-up|0|||
129848872|NCT02460224|467406900|FG005|Overall Study|Lost to Follow-up|0|||
129848873|NCT02460224|467406901|FG006|Overall Study|Lost to Follow-up|0|||
129848874|NCT02460224|467406902|FG007|Overall Study|Lost to Follow-up|0|||
129848875|NCT02460224|467406903|FG008|Overall Study|Lost to Follow-up|0|||
129848876|NCT02460224|467406904|FG009|Overall Study|Lost to Follow-up|0|||
129848877|NCT02460224|467406905|FG010|Overall Study|Lost to Follow-up|0|||
129848878|NCT02460224|467406906|FG011|Overall Study|Lost to Follow-up|0|||
129848879|NCT02460224|467406907|FG012|Overall Study|Lost to Follow-up|0|||
129848880|NCT02460224|467406908|FG013|Overall Study|Lost to Follow-up|0|||
129848881|NCT02460224|467406909|FG014|Overall Study|Lost to Follow-up|0|||
129848882|NCT02460224|467406910|FG015|Overall Study|Lost to Follow-up|0|||
129848883|NCT02460224|467406911|FG016|Overall Study|Lost to Follow-up|0|||
129848884|NCT02460224|467406912|FG017|Overall Study|Lost to Follow-up|0|||
129848885|NCT02460224|467406913|FG018|Overall Study|Lost to Follow-up|0|||
129848886|NCT02460224|467406914|FG019|Overall Study|Lost to Follow-up|0|||
129848887|NCT02460224|467406915|FG020|Overall Study|Lost to Follow-up|0|||
129848888|NCT02460224|467406916|FG021|Overall Study|Lost to Follow-up|0|||
129848889|NCT02460224|467406917|FG022|Overall Study|Lost to Follow-up|1|||
129848890|NCT02460224|467406918|FG023|Overall Study|Lost to Follow-up|0|||
129848891|NCT02460224|467406919|FG024|Overall Study|Lost to Follow-up|0|||
129848892|NCT02460224|467406920|FG025|Overall Study|Lost to Follow-up|0|||
129848893|NCT02460224|467406921|FG026|Overall Study|Lost to Follow-up|0|||
129848894|NCT02460224|467406922|FG027|Overall Study|Lost to Follow-up|0|||
129848895|NCT02460224|467406923|FG028|Overall Study|Lost to Follow-up|0|||
129848896|NCT02460224|467406895|FG000|Overall Study|Physician Decision|0|||
129848897|NCT02460224|467406896|FG001|Overall Study|Physician Decision|1|||
129848898|NCT02460224|467406897|FG002|Overall Study|Physician Decision|0|||
129848899|NCT02460224|467406898|FG003|Overall Study|Physician Decision|0|||
129848900|NCT02460224|467406899|FG004|Overall Study|Physician Decision|1|||
129848901|NCT02460224|467406900|FG005|Overall Study|Physician Decision|0|||
129848902|NCT02460224|467406901|FG006|Overall Study|Physician Decision|0|||
129848903|NCT02460224|467406902|FG007|Overall Study|Physician Decision|1|||
129848904|NCT02460224|467406903|FG008|Overall Study|Physician Decision|0|||
129848905|NCT02460224|467406904|FG009|Overall Study|Physician Decision|0|||
129848906|NCT02460224|467406905|FG010|Overall Study|Physician Decision|0|||
129848907|NCT02460224|467406906|FG011|Overall Study|Physician Decision|1|||
129848908|NCT02460224|467406907|FG012|Overall Study|Physician Decision|0|||
129848909|NCT02460224|467406908|FG013|Overall Study|Physician Decision|1|||
129848910|NCT02460224|467406909|FG014|Overall Study|Physician Decision|0|||
129848911|NCT02460224|467406910|FG015|Overall Study|Physician Decision|0|||
129848912|NCT02460224|467406911|FG016|Overall Study|Physician Decision|2|||
129848913|NCT02460224|467406912|FG017|Overall Study|Physician Decision|1|||
129848914|NCT02460224|467406913|FG018|Overall Study|Physician Decision|1|||
129848915|NCT02460224|467406914|FG019|Overall Study|Physician Decision|2|||
129848916|NCT02460224|467406915|FG020|Overall Study|Physician Decision|1|||
129848917|NCT02460224|467406916|FG021|Overall Study|Physician Decision|1|||
129848918|NCT02460224|467406917|FG022|Overall Study|Physician Decision|0|||
129848919|NCT02460224|467406918|FG023|Overall Study|Physician Decision|0|||
129848920|NCT02460224|467406919|FG024|Overall Study|Physician Decision|1|||
129848921|NCT02460224|467406920|FG025|Overall Study|Physician Decision|0|||
129848922|NCT02460224|467406921|FG026|Overall Study|Physician Decision|14|||
129848923|NCT02460224|467406922|FG027|Overall Study|Physician Decision|1|||
129848924|NCT02460224|467406923|FG028|Overall Study|Physician Decision|6|||
129848925|NCT02460224|467406895|FG000|Overall Study|Progressive disease|15|||
129848926|NCT02460224|467406896|FG001|Overall Study|Progressive disease|11|||
129848927|NCT02460224|467406897|FG002|Overall Study|Progressive disease|5|||
129848928|NCT02460224|467406898|FG003|Overall Study|Progressive disease|6|||
129848929|NCT02460224|467406899|FG004|Overall Study|Progressive disease|3|||
129848930|NCT02460224|467406900|FG005|Overall Study|Progressive disease|26|||
129848931|NCT02460224|467406901|FG006|Overall Study|Progressive disease|28|||
129848932|NCT02460224|467406902|FG007|Overall Study|Progressive disease|4|||
129848933|NCT02460224|467406903|FG008|Overall Study|Progressive disease|5|||
129848934|NCT02460224|467406904|FG009|Overall Study|Progressive disease|9|||
129848935|NCT02460224|467406905|FG010|Overall Study|Progressive disease|5|||
129848936|NCT02460224|467406906|FG011|Overall Study|Progressive disease|4|||
129848937|NCT02460224|467406907|FG012|Overall Study|Progressive disease|5|||
129848938|NCT02460224|467406908|FG013|Overall Study|Progressive disease|4|||
129848939|NCT02460224|467406909|FG014|Overall Study|Progressive disease|5|||
129848940|NCT02460224|467406910|FG015|Overall Study|Progressive disease|5|||
129848941|NCT02460224|467406911|FG016|Overall Study|Progressive disease|15|||
129848942|NCT02460224|467406912|FG017|Overall Study|Progressive disease|3|||
129848943|NCT02460224|467406913|FG018|Overall Study|Progressive disease|8|||
129848944|NCT02460224|467406914|FG019|Overall Study|Progressive disease|3|||
129848945|NCT02460224|467406915|FG020|Overall Study|Progressive disease|4|||
129848946|NCT02460224|467406916|FG021|Overall Study|Progressive disease|9|||
129848947|NCT02460224|467406917|FG022|Overall Study|Progressive disease|4|||
129848948|NCT02460224|467406918|FG023|Overall Study|Progressive disease|11|||
129848949|NCT02460224|467406919|FG024|Overall Study|Progressive disease|4|||
129848950|NCT02460224|467406920|FG025|Overall Study|Progressive disease|5|||
129848951|NCT02460224|467406921|FG026|Overall Study|Progressive disease|85|||
129848952|NCT02460224|467406922|FG027|Overall Study|Progressive disease|17|||
129848953|NCT02460224|467406923|FG028|Overall Study|Progressive disease|77|||
129848954|NCT02460224|467406895|FG000|Overall Study|Subject/guardian decision|2|||
129848955|NCT02460224|467406896|FG001|Overall Study|Subject/guardian decision|0|||
129848956|NCT02460224|467406897|FG002|Overall Study|Subject/guardian decision|1|||
129848957|NCT02460224|467406898|FG003|Overall Study|Subject/guardian decision|0|||
129848958|NCT02460224|467406899|FG004|Overall Study|Subject/guardian decision|2|||
129848959|NCT02460224|467406900|FG005|Overall Study|Subject/guardian decision|2|||
129848960|NCT02460224|467406901|FG006|Overall Study|Subject/guardian decision|0|||
129848961|NCT02460224|467406902|FG007|Overall Study|Subject/guardian decision|0|||
129848962|NCT02460224|467406903|FG008|Overall Study|Subject/guardian decision|1|||
129848963|NCT02460224|467406904|FG009|Overall Study|Subject/guardian decision|1|||
129848964|NCT02460224|467406905|FG010|Overall Study|Subject/guardian decision|0|||
129848965|NCT02460224|467406906|FG011|Overall Study|Subject/guardian decision|1|||
129848966|NCT02460224|467406907|FG012|Overall Study|Subject/guardian decision|0|||
129848967|NCT02460224|467406908|FG013|Overall Study|Subject/guardian decision|0|||
129848968|NCT02460224|467406909|FG014|Overall Study|Subject/guardian decision|0|||
129848969|NCT02460224|467406910|FG015|Overall Study|Subject/guardian decision|1|||
129848970|NCT02460224|467406911|FG016|Overall Study|Subject/guardian decision|0|||
129848971|NCT02460224|467406912|FG017|Overall Study|Subject/guardian decision|1|||
129848972|NCT02460224|467406913|FG018|Overall Study|Subject/guardian decision|2|||
129848973|NCT02460224|467406914|FG019|Overall Study|Subject/guardian decision|0|||
129848974|NCT02460224|467406915|FG020|Overall Study|Subject/guardian decision|0|||
129848975|NCT02460224|467406916|FG021|Overall Study|Subject/guardian decision|1|||
129903647|NCT01802632|467608398|FG000|Overall Study|Death|28|||
129848976|NCT02460224|467406917|FG022|Overall Study|Subject/guardian decision|0|||
129848977|NCT02460224|467406918|FG023|Overall Study|Subject/guardian decision|0|||
129848978|NCT02460224|467406919|FG024|Overall Study|Subject/guardian decision|0|||
129848979|NCT02460224|467406920|FG025|Overall Study|Subject/guardian decision|0|||
129848980|NCT02460224|467406921|FG026|Overall Study|Subject/guardian decision|6|||
129848981|NCT02460224|467406922|FG027|Overall Study|Subject/guardian decision|2|||
129848982|NCT02460224|467406923|FG028|Overall Study|Subject/guardian decision|3|||
129848983|NCT00853658|467406924|FG000|Overall Study|Death|713|||
129848984|NCT00853658|467406925|FG001|Overall Study|Death|768|||
129848985|NCT00853658|467406926|FG002|Overall Study|Death|753|||
129848986|NCT00853658|467406924|FG000|Overall Study|Lost to Follow-up|11|||
129848987|NCT00853658|467406925|FG001|Overall Study|Lost to Follow-up|6|||
129848988|NCT00853658|467406926|FG002|Overall Study|Lost to Follow-up|11|||
129848989|NCT00853658|467406924|FG000|Overall Study|H.A. Request|26|||
129848990|NCT00853658|467406925|FG001|Overall Study|H.A. Request|23|||
129848991|NCT00853658|467406926|FG002|Overall Study|H.A. Request|19|||
129848992|NCT00853658|467406924|FG000|Overall Study|IRB request|0|||
129848993|NCT00853658|467406925|FG001|Overall Study|IRB request|0|||
129848994|NCT00853658|467406926|FG002|Overall Study|IRB request|2|||
129848995|NCT00853658|467406924|FG000|Overall Study|Vital Status known (alive) at study end|2|||
129848996|NCT00853658|467406925|FG001|Overall Study|Vital Status known (alive) at study end|3|||
129848997|NCT00853658|467406926|FG002|Overall Study|Vital Status known (alive) at study end|3|||
129848998|NCT00853658|467406924|FG000|Overall Study|Vital Status unknown at study end|1|||
129848999|NCT00853658|467406925|FG001|Overall Study|Vital Status unknown at study end|1|||
129849000|NCT00853658|467406926|FG002|Overall Study|Vital Status unknown at study end|0|||
129849001|NCT00853658|467406924|FG000|Overall Study|Vital Status at study end N/A|8|||
129849002|NCT00853658|467406925|FG001|Overall Study|Vital Status at study end N/A|10|||
129849003|NCT00853658|467406926|FG002|Overall Study|Vital Status at study end N/A|10|||
129849004|NCT00853658|467406924|FG000|Overall Study|Patient's request|21|||
129849005|NCT00853658|467406925|FG001|Overall Study|Patient's request|17|||
129849006|NCT00853658|467406926|FG002|Overall Study|Patient's request|11|||
129849007|NCT00853658|467406924|FG000|Overall Study|Missing study completion information|5|||
129849008|NCT00853658|467406925|FG001|Overall Study|Missing study completion information|4|||
129849009|NCT00853658|467406926|FG002|Overall Study|Missing study completion information|6|||
129849010|NCT03146650|467406928|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
129849011|NCT03146650|467406928|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
129849012|NCT03146650|467406928|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
129849013|NCT03146650|467406928|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
129849014|NCT03146650|467406928|FG000|2 Year Follow-up|Death|11|||
129849015|NCT03146650|467406928|FG000|2 Year Follow-up|Still in follow-up|7|||
129849016|NCT03146650|467406928|FG000|2 Year Follow-up|Lost to Follow-up|1|||
129849017|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
129849018|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
129849019|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
129849020|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
129849021|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
129849022|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
129849023|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
129849024|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
129849025|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
129849026|NCT00983814|467406931|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
129849027|NCT00983814|467406932|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
129849028|NCT00983814|467406933|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
129849029|NCT00983814|467406931|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
129849030|NCT00983814|467406932|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
129849031|NCT00983814|467406933|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
129849032|NCT03333486|467406934|FG000|Overall Study|Withdrawal by Subject|1|||
129849033|NCT03333486|467406934|FG000|Overall Study|Lost to Follow-up|1|||
129849034|NCT01976845|467406937|FG000|Overall Study|Physician Decision|8|||
129849035|NCT01976845|467406938|FG001|Overall Study|Physician Decision|8|||
129903648|NCT01802632|467608399|FG001|Overall Study|Death|1|||
129849036|NCT01976845|467406939|FG002|Overall Study|Physician Decision|3|||
129849037|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
129849038|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
129903649|NCT01802632|467608400|FG002|Overall Study|Death|38|||
129903650|NCT01802632|467608401|FG003|Overall Study|Death|0|||
129849039|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
129849040|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
129849041|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
129849042|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
129903651|NCT01802632|467608402|FG004|Overall Study|Death|2|||
129903652|NCT01802632|467608403|FG005|Overall Study|Death|0|||
129449628|NCT00467779|465945627|FG004|Stage 3|Death|0|||
129849043|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
129903653|NCT01802632|467608398|FG000|Overall Study|Withdrawal by Subject|4|||
129903654|NCT01802632|467608399|FG001|Overall Study|Withdrawal by Subject|2|||
129903655|NCT01802632|467608400|FG002|Overall Study|Withdrawal by Subject|7|||
129903656|NCT01802632|467608401|FG003|Overall Study|Withdrawal by Subject|3|||
129903657|NCT01802632|467608402|FG004|Overall Study|Withdrawal by Subject|0|||
129903658|NCT01802632|467608403|FG005|Overall Study|Withdrawal by Subject|1|||
129903659|NCT01802632|467608398|FG000|Overall Study|Objective Disease Progression|1|||
129903660|NCT01802632|467608399|FG001|Overall Study|Objective Disease Progression|12|||
129903661|NCT01802632|467608400|FG002|Overall Study|Objective Disease Progression|104|||
129903662|NCT01802632|467608401|FG003|Overall Study|Objective Disease Progression|6|||
129903663|NCT01802632|467608402|FG004|Overall Study|Objective Disease Progression|4|||
129903664|NCT01802632|467608403|FG005|Overall Study|Objective Disease Progression|4|||
129903665|NCT01802632|467608398|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
129903666|NCT01802632|467608399|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
129903667|NCT01802632|467608400|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
129903668|NCT01802632|467608401|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
129903669|NCT01802632|467608402|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
129903670|NCT01802632|467608403|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
129903671|NCT01802632|467608398|FG000|Overall Study|Other (not specified)|0|||
129903672|NCT01802632|467608399|FG001|Overall Study|Other (not specified)|0|||
129903673|NCT01802632|467608400|FG002|Overall Study|Other (not specified)|7|||
129903674|NCT01802632|467608401|FG003|Overall Study|Other (not specified)|1|||
129903675|NCT01802632|467608402|FG004|Overall Study|Other (not specified)|0|||
129903676|NCT01802632|467608403|FG005|Overall Study|Other (not specified)|1|||
129903677|NCT02880241|467608404|FG000|Overall Study|Lack of Efficacy|1|||
129903678|NCT02880241|467608405|FG001|Overall Study|Lack of Efficacy|0|||
129903679|NCT02880241|467608406|FG002|Overall Study|Lack of Efficacy|0|||
129903680|NCT02880241|467608407|FG003|Overall Study|Lack of Efficacy|0|||
129903681|NCT02880241|467608408|FG004|Overall Study|Lack of Efficacy|0|||
129903682|NCT02880241|467608409|FG005|Overall Study|Lack of Efficacy|0|||
129903683|NCT02705586|467608410|FG000|Overall Study|Health Issues|2|||
129903684|NCT02705586|467608410|FG000|Overall Study|Transportation Difficulties|5|||
129903685|NCT02705586|467608410|FG000|Overall Study|Vacation/Planned Absence|1|||
129903686|NCT02045836|467608414|FG000|Overall Study|Adverse Event|4|||
129849044|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
129849045|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
129849046|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
129849047|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
129849048|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
129849049|NCT03246529|467406941|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
129849050|NCT03246529|467406942|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
129849051|NCT03246529|467406943|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
129849052|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
129849053|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
129849054|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
129849055|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
129849056|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
129849057|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
129849058|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
129849059|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
129849060|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
129849061|NCT03246529|467406941|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
129849062|NCT03246529|467406942|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
129849063|NCT03246529|467406943|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
129849064|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
129849065|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849066|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849067|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849068|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849069|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129849070|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
129903687|NCT02045836|467608415|FG001|Overall Study|Adverse Event|4|||
129903688|NCT02045836|467608414|FG000|Overall Study|Withdrawal by Subject|1|||
129903689|NCT02045836|467608415|FG001|Overall Study|Withdrawal by Subject|1|||
129903690|NCT02045836|467608414|FG000|Overall Study|Lost to Follow-up|4|||
129903691|NCT02045836|467608415|FG001|Overall Study|Lost to Follow-up|7|||
129903692|NCT02045836|467608414|FG000|Overall Study|Migrated from study area|0|||
129849071|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129903693|NCT02045836|467608415|FG001|Overall Study|Migrated from study area|2|||
129903694|NCT03920215|467608418|FG000|Overall Study|Lost to Follow-up|1|||
129903695|NCT03920215|467608419|FG001|Overall Study|Lost to Follow-up|2|||
129903696|NCT03920215|467608420|FG002|Overall Study|Lost to Follow-up|0|||
129903697|NCT03920215|467608421|FG003|Overall Study|Lost to Follow-up|0|||
129903698|NCT03920215|467608418|FG000|Overall Study|Death|0|||
129903699|NCT03920215|467608419|FG001|Overall Study|Death|0|||
129903700|NCT03920215|467608420|FG002|Overall Study|Death|0|||
129903701|NCT03920215|467608421|FG003|Overall Study|Death|1|||
129903702|NCT02000817|467608422|FG000|Overall Study|Withdrawal by Subject|2|||
129903703|NCT02000817|467608423|FG001|Overall Study|Withdrawal by Subject|0|||
129903704|NCT02000817|467608424|FG002|Overall Study|Withdrawal by Subject|0|||
129903705|NCT02000817|467608425|FG003|Overall Study|Withdrawal by Subject|0|||
129903706|NCT02000817|467608422|FG000|Overall Study|Adverse Event|0|||
129903707|NCT02000817|467608423|FG001|Overall Study|Adverse Event|1|||
129903708|NCT02000817|467608424|FG002|Overall Study|Adverse Event|0|||
129903709|NCT02000817|467608425|FG003|Overall Study|Adverse Event|0|||
129903710|NCT02000817|467608422|FG000|Overall Study|Lost to Follow-up|0|||
129903711|NCT02000817|467608423|FG001|Overall Study|Lost to Follow-up|0|||
129903712|NCT02000817|467608424|FG002|Overall Study|Lost to Follow-up|1|||
129903713|NCT02000817|467608425|FG003|Overall Study|Lost to Follow-up|0|||
129903714|NCT00177216|467608426|FG000|Overall Study|Withdrawal by Subject|6|||
129903715|NCT00177216|467608427|FG001|Overall Study|Withdrawal by Subject|3|||
129903716|NCT00177216|467608428|FG002|Overall Study|Withdrawal by Subject|1|||
129903717|NCT02459899|467608429|FG000|Overall Study|Adverse Event|1|||
129903718|NCT02459899|467608430|FG001|Overall Study|Adverse Event|1|||
129903719|NCT02459899|467608431|FG002|Overall Study|Adverse Event|0|||
129903720|NCT02459899|467608432|FG003|Overall Study|Adverse Event|0|||
129903721|NCT02459899|467608429|FG000|Overall Study|Lost to Follow-up|1|||
129903722|NCT02459899|467608430|FG001|Overall Study|Lost to Follow-up|2|||
129903723|NCT02459899|467608431|FG002|Overall Study|Lost to Follow-up|0|||
129903724|NCT02459899|467608432|FG003|Overall Study|Lost to Follow-up|1|||
129903725|NCT02459899|467608429|FG000|Overall Study|Non-compliance with the treatment|0|||
129903726|NCT02459899|467608430|FG001|Overall Study|Non-compliance with the treatment|0|||
129903727|NCT02459899|467608431|FG002|Overall Study|Non-compliance with the treatment|0|||
129903728|NCT02459899|467608432|FG003|Overall Study|Non-compliance with the treatment|1|||
129903729|NCT02459899|467608429|FG000|Overall Study|Withdrawal by Subject|1|||
129903730|NCT02459899|467608430|FG001|Overall Study|Withdrawal by Subject|3|||
129903731|NCT02459899|467608431|FG002|Overall Study|Withdrawal by Subject|0|||
129903732|NCT02459899|467608432|FG003|Overall Study|Withdrawal by Subject|0|||
129903733|NCT02739035|467608435|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
129903734|NCT02739035|467608436|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
129903735|NCT02739035|467608435|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
129903736|NCT02739035|467608436|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
129903737|NCT02739035|467608435|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
129903738|NCT02739035|467608436|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
129903739|NCT02739035|467608435|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
129903740|NCT02739035|467608436|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
129903741|NCT02770248|467608437|FG000|Overall Study|Adverse Event|0|||
129903742|NCT02770248|467608438|FG001|Overall Study|Adverse Event|1|||
129903743|NCT02770248|467608437|FG000|Overall Study|Randomized in error, prior to treatment|0|||
129903744|NCT02770248|467608438|FG001|Overall Study|Randomized in error, prior to treatment|1|||
129903745|NCT03768206|467608441|FG000|Overall Study|Lost to Follow-up|2|||
129903746|NCT03768206|467608442|FG001|Overall Study|Lost to Follow-up|1|||
129903747|NCT03768206|467608441|FG000|Overall Study|Withdrawal by Subject|0|||
129903748|NCT03768206|467608442|FG001|Overall Study|Withdrawal by Subject|1|||
129903749|NCT02551055|467608445|FG000|Overall Study|Death|2|||
129903750|NCT02551055|467608446|FG001|Overall Study|Death|4|||
129903751|NCT02551055|467608447|FG002|Overall Study|Death|2|||
129903752|NCT02551055|467608448|FG003|Overall Study|Death|2|||
129903753|NCT02551055|467608449|FG004|Overall Study|Death|2|||
129903754|NCT02551055|467608450|FG005|Overall Study|Death|1|||
129903755|NCT02551055|467608451|FG006|Overall Study|Death|2|||
129903756|NCT02551055|467608452|FG007|Overall Study|Death|0|||
129903757|NCT02551055|467608445|FG000|Overall Study|Study Terminated by Sponsor|1|||
129903758|NCT02551055|467608446|FG001|Overall Study|Study Terminated by Sponsor|1|||
129903759|NCT02551055|467608447|FG002|Overall Study|Study Terminated by Sponsor|0|||
129903760|NCT02551055|467608448|FG003|Overall Study|Study Terminated by Sponsor|2|||
129903761|NCT02551055|467608449|FG004|Overall Study|Study Terminated by Sponsor|2|||
129903762|NCT02551055|467608450|FG005|Overall Study|Study Terminated by Sponsor|0|||
129903763|NCT02551055|467608451|FG006|Overall Study|Study Terminated by Sponsor|0|||
129903764|NCT02551055|467608452|FG007|Overall Study|Study Terminated by Sponsor|0|||
129903765|NCT02551055|467608445|FG000|Overall Study|Withdrawal by Subject|1|||
129903766|NCT02551055|467608446|FG001|Overall Study|Withdrawal by Subject|1|||
129903767|NCT02551055|467608447|FG002|Overall Study|Withdrawal by Subject|0|||
129903768|NCT02551055|467608448|FG003|Overall Study|Withdrawal by Subject|1|||
129903769|NCT02551055|467608449|FG004|Overall Study|Withdrawal by Subject|2|||
129903770|NCT02551055|467608450|FG005|Overall Study|Withdrawal by Subject|0|||
129849072|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849073|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849074|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849075|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129849076|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
129849077|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849078|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849079|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849080|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849081|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129849082|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
129849083|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849084|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849085|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849086|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849087|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129849088|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
129849089|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849090|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849091|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849092|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849093|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129849094|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
129849095|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849096|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849097|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849098|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849099|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
129849100|NCT02139644|467408729|FG000|Run-In Period (Pre-assignment)|Other|6|||
129849101|NCT02139644|467408730|FG001|Run-In Period (Pre-assignment)|Other|0|||
129849102|NCT02139644|467408731|FG002|Run-In Period (Pre-assignment)|Other|0|||
129849103|NCT02139644|467408732|FG003|Run-In Period (Pre-assignment)|Other|0|||
129849104|NCT02139644|467408733|FG004|Run-In Period (Pre-assignment)|Other|0|||
129849105|NCT02139644|467408734|FG005|Run-In Period (Pre-assignment)|Other|0|||
129849106|NCT02139644|467408729|FG000|Treatment Period|Adverse Event|0|||
129849107|NCT02139644|467408730|FG001|Treatment Period|Adverse Event|0|||
129849108|NCT02139644|467408731|FG002|Treatment Period|Adverse Event|3|||
129849109|NCT02139644|467408732|FG003|Treatment Period|Adverse Event|2|||
129849110|NCT02139644|467408733|FG004|Treatment Period|Adverse Event|1|||
129849111|NCT02139644|467408734|FG005|Treatment Period|Adverse Event|6|||
129849112|NCT02139644|467408729|FG000|Treatment Period|Withdrawal by Subject|0|||
129849113|NCT02139644|467408730|FG001|Treatment Period|Withdrawal by Subject|0|||
129849114|NCT02139644|467408731|FG002|Treatment Period|Withdrawal by Subject|2|||
129849115|NCT02139644|467408732|FG003|Treatment Period|Withdrawal by Subject|2|||
129849116|NCT02139644|467408733|FG004|Treatment Period|Withdrawal by Subject|3|||
129849117|NCT02139644|467408734|FG005|Treatment Period|Withdrawal by Subject|2|||
129849118|NCT02139644|467408729|FG000|Treatment Period|Non-compliance|0|||
129849119|NCT02139644|467408730|FG001|Treatment Period|Non-compliance|0|||
129849120|NCT02139644|467408731|FG002|Treatment Period|Non-compliance|0|||
129849121|NCT02139644|467408732|FG003|Treatment Period|Non-compliance|1|||
129849122|NCT02139644|467408733|FG004|Treatment Period|Non-compliance|0|||
129849123|NCT02139644|467408734|FG005|Treatment Period|Non-compliance|0|||
129849124|NCT02139644|467408729|FG000|Treatment Period|Protocol Violation|0|||
129849125|NCT02139644|467408730|FG001|Treatment Period|Protocol Violation|0|||
129849126|NCT02139644|467408731|FG002|Treatment Period|Protocol Violation|0|||
129849127|NCT02139644|467408732|FG003|Treatment Period|Protocol Violation|1|||
129849128|NCT02139644|467408733|FG004|Treatment Period|Protocol Violation|1|||
129849129|NCT02139644|467408734|FG005|Treatment Period|Protocol Violation|1|||
129849130|NCT02139644|467408729|FG000|Treatment Period|Disease progression|0|||
129849131|NCT02139644|467408730|FG001|Treatment Period|Disease progression|0|||
129849132|NCT02139644|467408731|FG002|Treatment Period|Disease progression|0|||
129849133|NCT02139644|467408732|FG003|Treatment Period|Disease progression|1|||
129849134|NCT02139644|467408733|FG004|Treatment Period|Disease progression|1|||
129849135|NCT02139644|467408734|FG005|Treatment Period|Disease progression|2|||
129849136|NCT02139644|467408729|FG000|Treatment Period|Lost to Follow-up|0|||
129849137|NCT02139644|467408730|FG001|Treatment Period|Lost to Follow-up|0|||
129849138|NCT02139644|467408731|FG002|Treatment Period|Lost to Follow-up|1|||
129849139|NCT02139644|467408732|FG003|Treatment Period|Lost to Follow-up|1|||
129849140|NCT02139644|467408733|FG004|Treatment Period|Lost to Follow-up|1|||
129849141|NCT02139644|467408734|FG005|Treatment Period|Lost to Follow-up|1|||
129849142|NCT02139644|467408729|FG000|Treatment Period|Lack of Efficacy|0|||
129849143|NCT02139644|467408730|FG001|Treatment Period|Lack of Efficacy|0|||
129849144|NCT02139644|467408731|FG002|Treatment Period|Lack of Efficacy|1|||
129849145|NCT02139644|467408732|FG003|Treatment Period|Lack of Efficacy|0|||
129849146|NCT02139644|467408733|FG004|Treatment Period|Lack of Efficacy|1|||
129849147|NCT02139644|467408734|FG005|Treatment Period|Lack of Efficacy|4|||
129849148|NCT02139644|467408729|FG000|Treatment Period|Other|0|||
129849149|NCT02139644|467408730|FG001|Treatment Period|Other|3|||
129849150|NCT02139644|467408731|FG002|Treatment Period|Other|1|||
129849151|NCT02139644|467408732|FG003|Treatment Period|Other|1|||
129849152|NCT02139644|467408733|FG004|Treatment Period|Other|0|||
129849153|NCT02139644|467408734|FG005|Treatment Period|Other|1|||
129849154|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Adverse Event|4|||
129849155|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Adverse Event|1|||
129849156|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Adverse Event|1|||
129849157|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
129849158|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
129849159|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
129849160|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Pregnancy|3|||
129849161|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Pregnancy|0|||
129849162|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Pregnancy|0|||
129849163|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
129849164|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
129849165|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
129849166|NCT03328897|467408739|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
129849167|NCT03328897|467408740|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
129849168|NCT03328897|467408741|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
129849169|NCT03328897|467408739|FG000|Follow-up Epoch|Adverse Event|4|||
129849170|NCT03328897|467408740|FG001|Follow-up Epoch|Adverse Event|0|||
129849171|NCT03328897|467408741|FG002|Follow-up Epoch|Adverse Event|1|||
129849172|NCT03328897|467408739|FG000|Follow-up Epoch|Lack of Efficacy|1|||
129849173|NCT03328897|467408740|FG001|Follow-up Epoch|Lack of Efficacy|1|||
129849174|NCT03328897|467408741|FG002|Follow-up Epoch|Lack of Efficacy|1|||
129849175|NCT03328897|467408739|FG000|Follow-up Epoch|Lost to Follow-up|0|||
129849176|NCT03328897|467408740|FG001|Follow-up Epoch|Lost to Follow-up|1|||
129849177|NCT03328897|467408741|FG002|Follow-up Epoch|Lost to Follow-up|0|||
129849178|NCT03328897|467408739|FG000|Follow-up Epoch|Pregnancy|1|||
129849179|NCT03328897|467408740|FG001|Follow-up Epoch|Pregnancy|0|||
129849180|NCT03328897|467408741|FG002|Follow-up Epoch|Pregnancy|0|||
129849181|NCT03328897|467408739|FG000|Follow-up Epoch|Patient/guardian decision|2|||
129849182|NCT03328897|467408740|FG001|Follow-up Epoch|Patient/guardian decision|1|||
129849183|NCT03328897|467408741|FG002|Follow-up Epoch|Patient/guardian decision|0|||
129849184|NCT02602288|467408742|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
129849185|NCT02602288|467408743|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
129849186|NCT02602288|467408742|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
129849187|NCT02602288|467408743|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
129849188|NCT02602288|467408742|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
129849189|NCT02602288|467408743|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
129849190|NCT02602288|467408742|FG000|12 Month Follow-up|Lost to Follow-up|0|||
129849191|NCT02602288|467408743|FG001|12 Month Follow-up|Lost to Follow-up|4|||
129849192|NCT02602288|467408742|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
129849193|NCT02602288|467408743|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
129849194|NCT01310413|467408744|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
129849195|NCT01310413|467408745|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
129849196|NCT01310413|467408746|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
129849197|NCT01310413|467408747|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
129849198|NCT01310413|467408748|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
129849199|NCT01310413|467408749|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
129849200|NCT01310413|467408750|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
129849201|NCT01310413|467408744|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
129849202|NCT01310413|467408745|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
129849203|NCT01310413|467408746|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
129849204|NCT01310413|467408747|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
129849205|NCT01310413|467408748|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
129849206|NCT01310413|467408749|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
129849207|NCT01310413|467408750|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
129849208|NCT01310413|467408744|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
129849209|NCT01310413|467408745|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
129849210|NCT01310413|467408746|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
129849211|NCT01310413|467408747|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
129849212|NCT01310413|467408748|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
129849213|NCT01310413|467408749|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
129849214|NCT01310413|467408750|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
129849215|NCT01310413|467408744|FG000|Day 0 to Day 385|Other|1|||
129849216|NCT01310413|467408745|FG001|Day 0 to Day 385|Other|0|||
129849217|NCT01310413|467408746|FG002|Day 0 to Day 385|Other|3|||
129849218|NCT01310413|467408747|FG003|Day 0 to Day 385|Other|0|||
129849219|NCT01310413|467408748|FG004|Day 0 to Day 385|Other|0|||
129903771|NCT02551055|467608451|FG006|Overall Study|Withdrawal by Subject|0|||
129903772|NCT02551055|467608452|FG007|Overall Study|Withdrawal by Subject|0|||
129903773|NCT02551055|467608445|FG000|Overall Study|Reason not specified|0|||
129903774|NCT02551055|467608446|FG001|Overall Study|Reason not specified|0|||
129903775|NCT02551055|467608447|FG002|Overall Study|Reason not specified|0|||
129903776|NCT02551055|467608448|FG003|Overall Study|Reason not specified|0|||
129903777|NCT02551055|467608449|FG004|Overall Study|Reason not specified|1|||
129903778|NCT02551055|467608450|FG005|Overall Study|Reason not specified|0|||
129903779|NCT02551055|467608451|FG006|Overall Study|Reason not specified|1|||
129903780|NCT02551055|467608452|FG007|Overall Study|Reason not specified|0|||
129903781|NCT00430300|467608453|FG000|Overall Study|Adverse Event|0|||
129903782|NCT00430300|467608454|FG001|Overall Study|Adverse Event|2|||
129903783|NCT00430300|467608455|FG002|Overall Study|Adverse Event|1|||
129903784|NCT00430300|467608456|FG003|Overall Study|Adverse Event|1|||
129903785|NCT00430300|467608453|FG000|Overall Study|Withdrawal by Subject|1|||
129903786|NCT00430300|467608454|FG001|Overall Study|Withdrawal by Subject|0|||
129903787|NCT00430300|467608455|FG002|Overall Study|Withdrawal by Subject|5|||
129903788|NCT00430300|467608456|FG003|Overall Study|Withdrawal by Subject|0|||
129903789|NCT00430300|467608453|FG000|Overall Study|Laboratory abnormality|1|||
129903790|NCT00430300|467608454|FG001|Overall Study|Laboratory abnormality|0|||
129903791|NCT00430300|467608455|FG002|Overall Study|Laboratory abnormality|0|||
129903792|NCT00430300|467608456|FG003|Overall Study|Laboratory abnormality|0|||
129903793|NCT00430300|467608453|FG000|Overall Study|Other|0|||
129903794|NCT00430300|467608454|FG001|Overall Study|Other|0|||
129903795|NCT00430300|467608455|FG002|Overall Study|Other|0|||
129903796|NCT00430300|467608456|FG003|Overall Study|Other|1|||
129903797|NCT02754479|467608460|FG000|Overall Study|Lost to Follow-up|1|||
129903798|NCT01063517|467608465|FG000|Overall Study|Consent withdrawal|1|||
129903799|NCT01063517|467608466|FG001|Overall Study|Consent withdrawal|0|||
129903800|NCT01063517|467608465|FG000|Overall Study|Study reached data cut-off|19|||
129903801|NCT01063517|467608466|FG001|Overall Study|Study reached data cut-off|7|||
129903802|NCT01063517|467608465|FG000|Overall Study|Lost to Follow-up|4|||
129903803|NCT01063517|467608466|FG001|Overall Study|Lost to Follow-up|3|||
129903804|NCT01063517|467608465|FG000|Overall Study|Withdrawal by Subject|1|||
129903805|NCT01063517|467608466|FG001|Overall Study|Withdrawal by Subject|2|||
129903806|NCT01063517|467608465|FG000|Overall Study|Death|33|||
129903807|NCT01063517|467608466|FG001|Overall Study|Death|48|||
129903808|NCT02041104|467608467|FG000|Overall Study|Lost to Follow-up|1|||
129903809|NCT02041104|467608468|FG001|Overall Study|Lost to Follow-up|4|||
129903810|NCT02041104|467608467|FG000|Overall Study|discomfort during OGTT|0|||
129903811|NCT02041104|467608468|FG001|Overall Study|discomfort during OGTT|3|||
129903812|NCT00617201|467608471|FG000|Overall Study|Lost to Follow-up|9|||
129903813|NCT00617201|467608472|FG001|Overall Study|Lost to Follow-up|13|||
129903814|NCT00546871|467608473|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
129903815|NCT00546871|467608474|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
129903816|NCT00546871|467608473|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
129903817|NCT00546871|467608474|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
129903818|NCT00546871|467608473|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
129903819|NCT00546871|467608474|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
129903820|NCT00546871|467608473|FG000|Study Extension Period|Protocol Violation|1|||
129903821|NCT00546871|467608474|FG001|Study Extension Period|Protocol Violation|0|||
129903822|NCT00546871|467608473|FG000|Study Extension Period|Withdrawal by Subject|0|||
129903823|NCT00546871|467608474|FG001|Study Extension Period|Withdrawal by Subject|1|||
129903824|NCT01713946|467608475|FG000|Overall Study|Death|0|||
129903825|NCT01713946|467608476|FG001|Overall Study|Death|2|||
129903826|NCT01713946|467608477|FG002|Overall Study|Death|2|||
129903827|NCT01713946|467608475|FG000|Overall Study|Adverse Event|19|||
129903828|NCT01713946|467608476|FG001|Overall Study|Adverse Event|14|||
129903829|NCT01713946|467608477|FG002|Overall Study|Adverse Event|13|||
129903830|NCT01713946|467608475|FG000|Overall Study|Withdrawal by Subject|12|||
129903831|NCT01713946|467608476|FG001|Overall Study|Withdrawal by Subject|12|||
129903832|NCT01713946|467608477|FG002|Overall Study|Withdrawal by Subject|8|||
129903833|NCT01713946|467608475|FG000|Overall Study|Lack of Efficacy|8|||
129903834|NCT01713946|467608476|FG001|Overall Study|Lack of Efficacy|8|||
129903835|NCT01713946|467608477|FG002|Overall Study|Lack of Efficacy|14|||
129903836|NCT01713946|467608475|FG000|Overall Study|Protocol Violation|2|||
129903837|NCT01713946|467608476|FG001|Overall Study|Protocol Violation|4|||
129903838|NCT01713946|467608477|FG002|Overall Study|Protocol Violation|1|||
129903839|NCT01713946|467608475|FG000|Overall Study|Lost to Follow-up|0|||
129903840|NCT01713946|467608476|FG001|Overall Study|Lost to Follow-up|0|||
129903841|NCT01713946|467608477|FG002|Overall Study|Lost to Follow-up|1|||
129903842|NCT01713946|467608475|FG000|Overall Study|Administrative problems|1|||
129903843|NCT01713946|467608476|FG001|Overall Study|Administrative problems|0|||
129903844|NCT01713946|467608477|FG002|Overall Study|Administrative problems|0|||
129903845|NCT01713946|467608475|FG000|Overall Study|Did not continue in Ext|0|||
129903846|NCT01713946|467608476|FG001|Overall Study|Did not continue in Ext|3|||
129903847|NCT01713946|467608477|FG002|Overall Study|Did not continue in Ext|0|||
129903848|NCT01713946|467608475|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
129903849|NCT01713946|467608476|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
129903850|NCT01713946|467608477|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
129903851|NCT01713946|467608475|FG000|Overall Study|Patients never switched to everolimus|0|||
129903852|NCT01713946|467608476|FG001|Overall Study|Patients never switched to everolimus|0|||
129903853|NCT01713946|467608477|FG002|Overall Study|Patients never switched to everolimus|5|||
129903854|NCT03183518|467608478|FG000|Overall Study|Other (Not specified)|2|||
129903855|NCT03183518|467608478|FG000|Overall Study|Other (Withdrawal of consent)|1|||
129903856|NCT04493242|467608481|FG000|Overall Study|Death|10|||
129903857|NCT04493242|467608482|FG001|Overall Study|Death|14|||
129903858|NCT04493242|467608483|FG002|Overall Study|Death|16|||
129903859|NCT04493242|467608481|FG000|Overall Study|Lost to Follow-up|1|||
129903860|NCT04493242|467608482|FG001|Overall Study|Lost to Follow-up|1|||
129903861|NCT04493242|467608483|FG002|Overall Study|Lost to Follow-up|0|||
129903862|NCT04493242|467608481|FG000|Overall Study|Withdrawal by Subject|1|||
129903863|NCT04493242|467608482|FG001|Overall Study|Withdrawal by Subject|0|||
129903864|NCT04493242|467608483|FG002|Overall Study|Withdrawal by Subject|0|||
129903865|NCT04493242|467608481|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
129903866|NCT04493242|467608482|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
129903867|NCT04493242|467608483|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
129903868|NCT04493242|467608481|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
129903869|NCT04493242|467608482|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
129903870|NCT04493242|467608483|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
129903871|NCT04513522|467610902|FG000|Overall Study|Other reasons|1|||
129903872|NCT04513522|467610902|FG000|Overall Study|Adverse event unrelated to study drug|9|||
129903873|NCT04513522|467610902|FG000|Overall Study|Study drug toxicity|14|||
129903874|NCT04513522|467610902|FG000|Overall Study|Disease progression|39|||
129903875|NCT04513522|467610902|FG000|Overall Study|Participants withdrew consent|2|||
129903876|NCT00589667|467610903|FG000|Overall Study|Adverse Event|2|||
129903877|NCT00589667|467610903|FG000|Overall Study|Withdrawal by Subject|1|||
129903878|NCT03538041|467610906|FG000|12-Week Treatment Period|Adverse Event|1|||
129903879|NCT03538041|467610907|FG001|12-Week Treatment Period|Adverse Event|1|||
129903880|NCT03538041|467610906|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
129903881|NCT03538041|467610907|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
129903882|NCT03538041|467610906|FG000|Treatment Extension Period|Adverse Event|4|||
129903883|NCT03538041|467610907|FG001|Treatment Extension Period|Adverse Event|1|||
129903884|NCT03538041|467610906|FG000|Treatment Extension Period|Physician Decision|1|||
129903885|NCT03538041|467610907|FG001|Treatment Extension Period|Physician Decision|1|||
129903886|NCT03538041|467610906|FG000|Treatment Extension Period|Lack of Efficacy|1|||
129903887|NCT03538041|467610907|FG001|Treatment Extension Period|Lack of Efficacy|4|||
129903888|NCT03538041|467610906|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
129903889|NCT03538041|467610907|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
129903890|NCT03538041|467610906|FG000|Treatment Extension Period|Death|0|||
129903891|NCT03538041|467610907|FG001|Treatment Extension Period|Death|1|||
129903892|NCT01266265|467610908|FG000|Overall Study|Death|95|||
129903893|NCT01266265|467610909|FG001|Overall Study|Death|73|||
129903894|NCT01266265|467610908|FG000|Overall Study|Lost to Follow-up|23|||
129903895|NCT01266265|467610909|FG001|Overall Study|Lost to Follow-up|28|||
129903896|NCT01266265|467610908|FG000|Overall Study|Withdrawal by Subject|13|||
129903897|NCT01266265|467610909|FG001|Overall Study|Withdrawal by Subject|11|||
129903898|NCT01266265|467610908|FG000|Overall Study|Respiratory-related adverse event|2|||
129903899|NCT01266265|467610909|FG001|Overall Study|Respiratory-related adverse event|1|||
129903900|NCT01266265|467610908|FG000|Overall Study|Transferred care to another provider|22|||
129903901|NCT01266265|467610909|FG001|Overall Study|Transferred care to another provider|28|||
129903902|NCT01266265|467610908|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
129903903|NCT01266265|467610909|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
129903904|NCT01266265|467610908|FG000|Overall Study|Enrolled in another clinical study|15|||
129849220|NCT01310413|467408749|FG005|Day 0 to Day 385|Other|0|||
129849221|NCT01310413|467408750|FG006|Day 0 to Day 385|Other|0|||
129849222|NCT01310413|467408744|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849223|NCT01310413|467408745|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849224|NCT01310413|467408746|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849225|NCT01310413|467408747|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849226|NCT01310413|467408748|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849227|NCT01310413|467408749|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
129849228|NCT01310413|467408750|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
129849229|NCT01310413|467408744|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
129903905|NCT01266265|467610909|FG001|Overall Study|Enrolled in another clinical study|26|||
129903906|NCT01266265|467610908|FG000|Overall Study|Non-compliance|8|||
129849230|NCT01310413|467408745|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
129849231|NCT01310413|467408746|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
129849232|NCT01310413|467408747|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
129849233|NCT01310413|467408748|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
129849234|NCT01310413|467408749|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
129849235|NCT01310413|467408750|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
129849236|NCT00941733|467408751|FG000|Overall Study|Death|24|||
129849237|NCT00941733|467408752|FG001|Overall Study|Death|10|||
129849238|NCT00941733|467408751|FG000|Overall Study|Withdrawal by Subject|14|||
129849239|NCT00941733|467408752|FG001|Overall Study|Withdrawal by Subject|6|||
129849240|NCT00941733|467408751|FG000|Overall Study|Adverse Event|20|||
129849241|NCT00941733|467408752|FG001|Overall Study|Adverse Event|4|||
129849242|NCT00941733|467408751|FG000|Overall Study|Lost to Follow-up|1|||
129849243|NCT00941733|467408752|FG001|Overall Study|Lost to Follow-up|2|||
129849244|NCT00941733|467408751|FG000|Overall Study|Protocol Violation|15|||
129849245|NCT00941733|467408752|FG001|Overall Study|Protocol Violation|6|||
129849246|NCT00612066|467408755|FG000|Overall Study|Adverse Event|1|||
129849247|NCT00630877|467408756|FG000|Overall Study|Adverse Event|11|||
129849248|NCT00630877|467408757|FG001|Overall Study|Adverse Event|8|||
129849249|NCT00630877|467408758|FG002|Overall Study|Adverse Event|7|||
129849250|NCT00630877|467408756|FG000|Overall Study|Withdrawal by Subject|3|||
129849251|NCT00630877|467408757|FG001|Overall Study|Withdrawal by Subject|4|||
129849252|NCT00630877|467408758|FG002|Overall Study|Withdrawal by Subject|0|||
129849253|NCT00630877|467408756|FG000|Overall Study|Lost to Follow-up|2|||
129849254|NCT00630877|467408757|FG001|Overall Study|Lost to Follow-up|0|||
129849255|NCT00630877|467408758|FG002|Overall Study|Lost to Follow-up|0|||
129903907|NCT01266265|467610909|FG001|Overall Study|Non-compliance|5|||
129903908|NCT01266265|467610908|FG000|Overall Study|Lung transplant|6|||
129903909|NCT01266265|467610909|FG001|Overall Study|Lung transplant|5|||
129903910|NCT01266265|467610908|FG000|Overall Study|Site closed early|4|||
129903911|NCT01266265|467610909|FG001|Overall Study|Site closed early|3|||
129903912|NCT01266265|467610908|FG000|Overall Study|Clinical worsening|1|||
129903913|NCT01266265|467610909|FG001|Overall Study|Clinical worsening|1|||
129903914|NCT01580293|467610912|FG000|Part A_Main Trial|Adverse Event|0|||
129903915|NCT01580293|467610913|FG001|Part A_Main Trial|Adverse Event|2|||
129903916|NCT01580293|467610914|FG002|Part A_Main Trial|Adverse Event|0|||
129903917|NCT01580293|467610912|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
129903918|NCT01580293|467610913|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
129903919|NCT01580293|467610914|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
129903920|NCT01580293|467610912|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
129849256|NCT00630877|467408756|FG000|Overall Study|Noncompliance|2|||
129849257|NCT00630877|467408757|FG001|Overall Study|Noncompliance|3|||
129849258|NCT00630877|467408758|FG002|Overall Study|Noncompliance|1|||
129849259|NCT00630877|467408756|FG000|Overall Study|Protocol violation|1|||
129849260|NCT00630877|467408757|FG001|Overall Study|Protocol violation|0|||
129849261|NCT00630877|467408758|FG002|Overall Study|Protocol violation|1|||
129849262|NCT00630877|467408756|FG000|Overall Study|Personal reasons|0|||
129849263|NCT00630877|467408757|FG001|Overall Study|Personal reasons|0|||
129903921|NCT01580293|467610913|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
129903922|NCT01580293|467610914|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
129849264|NCT00630877|467408758|FG002|Overall Study|Personal reasons|1|||
129849265|NCT01643473|467408759|FG000|Overall Study|Lost to Follow-up|1|||
129849266|NCT01643473|467408760|FG001|Overall Study|Lost to Follow-up|0|||
129849267|NCT02033889|467408762|FG000|Overall Study|Adverse Event|3|||
129849268|NCT02033889|467408763|FG001|Overall Study|Adverse Event|1|||
129849269|NCT02033889|467408764|FG002|Overall Study|Adverse Event|3|||
129849270|NCT02033889|467408762|FG000|Overall Study|Death|3|||
129849271|NCT02033889|467408763|FG001|Overall Study|Death|1|||
129849272|NCT02033889|467408764|FG002|Overall Study|Death|2|||
129849273|NCT02033889|467408762|FG000|Overall Study|Excluded Medication|1|||
129849274|NCT02033889|467408763|FG001|Overall Study|Excluded Medication|1|||
129849275|NCT02033889|467408764|FG002|Overall Study|Excluded Medication|0|||
129849276|NCT02033889|467408762|FG000|Overall Study|Lost to Follow-up|8|||
129849277|NCT02033889|467408763|FG001|Overall Study|Lost to Follow-up|5|||
129903923|NCT01580293|467610912|FG000|Part A_Extension|Adverse Event|0|||
129903924|NCT01580293|467610913|FG001|Part A_Extension|Adverse Event|2|||
129903925|NCT01580293|467610914|FG002|Part A_Extension|Adverse Event|0|||
129849278|NCT02033889|467408764|FG002|Overall Study|Lost to Follow-up|6|||
129849279|NCT02033889|467408762|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129849280|NCT02033889|467408763|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129849281|NCT02033889|467408764|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129849282|NCT02033889|467408762|FG000|Overall Study|Physician Decision|0|||
129849283|NCT02033889|467408763|FG001|Overall Study|Physician Decision|1|||
129849284|NCT02033889|467408764|FG002|Overall Study|Physician Decision|1|||
129903926|NCT01580293|467610912|FG000|Part A_Extension|Withdrawal by Subject|0|||
129849285|NCT02033889|467408762|FG000|Overall Study|Participant moved|0|||
129849286|NCT02033889|467408763|FG001|Overall Study|Participant moved|1|||
129849287|NCT02033889|467408764|FG002|Overall Study|Participant moved|0|||
129849288|NCT02033889|467408762|FG000|Overall Study|Withdrawal by Subject|18|||
129849289|NCT02033889|467408763|FG001|Overall Study|Withdrawal by Subject|10|||
129903927|NCT01580293|467610913|FG001|Part A_Extension|Withdrawal by Subject|3|||
129849290|NCT02033889|467408764|FG002|Overall Study|Withdrawal by Subject|13|||
129849291|NCT01913041|467408765|FG000|Overall Study|Protocol Violation|35|||
129849292|NCT01913041|467408765|FG000|Overall Study|Withdrawal by Subject|3|||
129849293|NCT01913041|467408765|FG000|Overall Study|Physician Decision|1|||
129849294|NCT01265953|467408767|FG000|Overall Study|Non compliance|5|||
129849295|NCT01265953|467408768|FG001|Overall Study|Non compliance|3|||
129903928|NCT01580293|467610914|FG002|Part A_Extension|Withdrawal by Subject|0|||
129903929|NCT01580293|467610912|FG000|Part A_Extension|Lost to Follow-up|0|||
129903930|NCT01580293|467610913|FG001|Part A_Extension|Lost to Follow-up|1|||
129903931|NCT01580293|467610914|FG002|Part A_Extension|Lost to Follow-up|0|||
129903932|NCT01580293|467610912|FG000|Part A_Extension|Other Reason|0|||
129903933|NCT01580293|467610913|FG001|Part A_Extension|Other Reason|1|||
129903934|NCT01580293|467610914|FG002|Part A_Extension|Other Reason|0|||
129903935|NCT01580293|467610912|FG000|Part A_Extension|Completed Japan only|0|||
129903936|NCT01580293|467610913|FG001|Part A_Extension|Completed Japan only|5|||
129903937|NCT01580293|467610914|FG002|Part A_Extension|Completed Japan only|0|||
129903938|NCT01580293|467610912|FG000|Part B|Withdrawal by Subject|0|||
129903939|NCT01580293|467610913|FG001|Part B|Withdrawal by Subject|0|||
129903940|NCT01580293|467610914|FG002|Part B|Withdrawal by Subject|1|||
129903941|NCT01580293|467610912|FG000|Part B|Other reason|0|||
129903942|NCT01580293|467610913|FG001|Part B|Other reason|0|||
129903943|NCT01580293|467610914|FG002|Part B|Other reason|1|||
129903944|NCT00028769|467610915|FG000|Overall Study|Adverse Event|2|||
129903945|NCT00028769|467610915|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
129903946|NCT00028769|467610915|FG000|Overall Study|Progression or Death|31|||
129903947|NCT00028769|467610915|FG000|Overall Study|Other - Not Protocol Specified|1|||
129903948|NCT00028769|467610915|FG000|Overall Study|Ineligible|5|||
129903949|NCT00028769|467610915|FG000|Overall Study|Not Analyzable|1|||
129903950|NCT00768664|467610918|FG000|Overall Study|Death|57|||
129903951|NCT00768664|467610918|FG000|Overall Study|Lost to Follow-up|2|||
129903952|NCT00768664|467610918|FG000|Overall Study|Other|9|||
129903953|NCT00768664|467610918|FG000|Overall Study|Participant refused|1|||
129903954|NCT00708032|467610919|FG000|Overall Study|Adverse Event|0|||
129903955|NCT00708032|467610920|FG001|Overall Study|Adverse Event|2|||
129903956|NCT00708032|467610919|FG000|Overall Study|Lost to Follow-up|1|||
129903957|NCT00708032|467610920|FG001|Overall Study|Lost to Follow-up|2|||
129903958|NCT00708032|467610919|FG000|Overall Study|Pregnancy|0|||
129903959|NCT00708032|467610920|FG001|Overall Study|Pregnancy|1|||
129903960|NCT00708032|467610919|FG000|Overall Study|Poor vision|0|||
129903961|NCT00708032|467610920|FG001|Overall Study|Poor vision|6|||
129903962|NCT00708032|467610919|FG000|Overall Study|Visit out of range at month 12|4|||
129903963|NCT00708032|467610920|FG001|Overall Study|Visit out of range at month 12|1|||
129903964|NCT00708032|467610919|FG000|Overall Study|Did not meet protocol criteria|1|||
129903965|NCT00708032|467610920|FG001|Overall Study|Did not meet protocol criteria|2|||
129849296|NCT01610700|467408770|FG000|Overall Study|Adverse Event|3|||
129849297|NCT01610700|467408771|FG001|Overall Study|Adverse Event|1|||
129849298|NCT01610700|467408770|FG000|Overall Study|Withdrawal by Subject|0|||
129849299|NCT01610700|467408771|FG001|Overall Study|Withdrawal by Subject|1|||
129849300|NCT01610700|467408770|FG000|Overall Study|subject took one dose of street cannabis|0|||
129849301|NCT01610700|467408771|FG001|Overall Study|subject took one dose of street cannabis|1|||
129849302|NCT02648698|467408772|FG000|Overall Study|Protocol Violation|1|||
129849303|NCT02648698|467408773|FG001|Overall Study|Protocol Violation|5|||
129849304|NCT01640301|467408774|FG000|Overall Study|Death|0|||
129849305|NCT01640301|467408775|FG001|Overall Study|Death|8|||
129849306|NCT02391948|467408780|FG000|6-month Assessment|Death|0|||
129849307|NCT02391948|467408781|FG001|6-month Assessment|Death|0|||
129849308|NCT02391948|467408782|FG002|6-month Assessment|Death|0|||
129849309|NCT02391948|467408783|FG003|6-month Assessment|Death|0|||
129849310|NCT02391948|467408784|FG004|6-month Assessment|Death|1|||
129849311|NCT02391948|467408780|FG000|6-month Assessment|Withdrawal by Subject|0|||
129849312|NCT02391948|467408781|FG001|6-month Assessment|Withdrawal by Subject|0|||
129849313|NCT02391948|467408782|FG002|6-month Assessment|Withdrawal by Subject|1|||
129903966|NCT00708032|467610919|FG000|Overall Study|Protocol Violation|4|||
129903967|NCT00708032|467610920|FG001|Overall Study|Protocol Violation|1|||
129903968|NCT00708032|467610919|FG000|Overall Study|Withdrawal by Subject|0|||
129903969|NCT00708032|467610920|FG001|Overall Study|Withdrawal by Subject|1|||
129849314|NCT02391948|467408783|FG003|6-month Assessment|Withdrawal by Subject|2|||
129849315|NCT02391948|467408784|FG004|6-month Assessment|Withdrawal by Subject|0|||
129849316|NCT02391948|467408780|FG000|6-month Assessment|Lost to Follow-up|4|||
129849317|NCT02391948|467408781|FG001|6-month Assessment|Lost to Follow-up|5|||
129849318|NCT02391948|467408782|FG002|6-month Assessment|Lost to Follow-up|2|||
129849319|NCT02391948|467408783|FG003|6-month Assessment|Lost to Follow-up|3|||
129849320|NCT02391948|467408784|FG004|6-month Assessment|Lost to Follow-up|1|||
129849321|NCT02391948|467408780|FG000|6-month Assessment|Medical issue/illness|1|||
129903970|NCT01400776|467610921|FG000|Overall Study|Adverse Event|7|||
129903971|NCT01400776|467610922|FG001|Overall Study|Adverse Event|2|||
129903972|NCT01400776|467610923|FG002|Overall Study|Adverse Event|9|||
129903973|NCT01400776|467610924|FG003|Overall Study|Adverse Event|2|||
129903974|NCT01400776|467610921|FG000|Overall Study|Lost to Follow-up|1|||
129903975|NCT01400776|467610922|FG001|Overall Study|Lost to Follow-up|0|||
129903976|NCT01400776|467610923|FG002|Overall Study|Lost to Follow-up|4|||
129903977|NCT01400776|467610924|FG003|Overall Study|Lost to Follow-up|1|||
129903978|NCT01400776|467610921|FG000|Overall Study|Withdrew Consent|4|||
129903979|NCT01400776|467610922|FG001|Overall Study|Withdrew Consent|2|||
129903980|NCT01400776|467610923|FG002|Overall Study|Withdrew Consent|6|||
129903981|NCT01400776|467610924|FG003|Overall Study|Withdrew Consent|1|||
129903982|NCT01400776|467610921|FG000|Overall Study|Protocol Deviation|6|||
129903983|NCT01400776|467610922|FG001|Overall Study|Protocol Deviation|1|||
129903984|NCT01400776|467610923|FG002|Overall Study|Protocol Deviation|5|||
129903985|NCT01400776|467610924|FG003|Overall Study|Protocol Deviation|2|||
129903986|NCT01400776|467610921|FG000|Overall Study|Reason not Specified|3|||
129903987|NCT01400776|467610922|FG001|Overall Study|Reason not Specified|0|||
129903988|NCT01400776|467610923|FG002|Overall Study|Reason not Specified|4|||
129903989|NCT01400776|467610924|FG003|Overall Study|Reason not Specified|3|||
129903990|NCT00423098|467610925|FG000|Overall Study|Adverse Event|1|||
129903991|NCT00423098|467610926|FG001|Overall Study|Adverse Event|2|||
129903992|NCT00423098|467610925|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129903993|NCT00423098|467610926|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129903994|NCT00423098|467610925|FG000|Overall Study|Administrative problems|0|||
129903995|NCT00423098|467610926|FG001|Overall Study|Administrative problems|1|||
129903996|NCT00423098|467610925|FG000|Overall Study|Death|2|||
129903997|NCT00423098|467610926|FG001|Overall Study|Death|0|||
129903998|NCT04480827|467610928|FG000|Overall Study|Adverse Event|0|||
129903999|NCT04480827|467610929|FG001|Overall Study|Adverse Event|0|||
129904000|NCT04480827|467610930|FG002|Overall Study|Adverse Event|0|||
129904001|NCT04480827|467610931|FG003|Overall Study|Adverse Event|0|||
129904002|NCT04480827|467610932|FG004|Overall Study|Adverse Event|0|||
129904003|NCT04480827|467610933|FG005|Overall Study|Adverse Event|1|||
129904004|NCT04480827|467610934|FG006|Overall Study|Adverse Event|0|||
129904005|NCT00941655|467610935|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
129904006|NCT00941655|467610936|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
129904007|NCT00941655|467610935|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
129904008|NCT00941655|467610936|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
129904009|NCT00941655|467610935|FG000|Overall Study|progressed while on chemo|0|||
129904010|NCT00941655|467610936|FG001|Overall Study|progressed while on chemo|2|||
129904011|NCT00941655|467610935|FG000|Overall Study|refused further treatment|0|||
129904012|NCT00941655|467610936|FG001|Overall Study|refused further treatment|1|||
129904013|NCT00941655|467610935|FG000|Overall Study|withdrew consent|0|||
129904014|NCT00941655|467610936|FG001|Overall Study|withdrew consent|1|||
129904015|NCT00941655|467610935|FG000|Overall Study|non-compliant|0|||
129904016|NCT00941655|467610936|FG001|Overall Study|non-compliant|1|||
129904017|NCT02477670|467610942|FG000|Stage 1|Adverse Event|2|||
129904018|NCT02477670|467610943|FG001|Stage 1|Adverse Event|7|||
129904019|NCT02477670|467610944|FG002|Stage 1|Adverse Event|0|||
129904020|NCT02477670|467610945|FG003|Stage 1|Adverse Event|0|||
129904021|NCT02477670|467610946|FG004|Stage 1|Adverse Event|0|||
129904022|NCT02477670|467610947|FG005|Stage 1|Adverse Event|0|||
129904023|NCT02477670|467610948|FG006|Stage 1|Adverse Event|0|||
129904024|NCT02477670|467610942|FG000|Stage 1|Lost to Follow-up|0|||
129904025|NCT02477670|467610943|FG001|Stage 1|Lost to Follow-up|2|||
129904026|NCT02477670|467610944|FG002|Stage 1|Lost to Follow-up|0|||
129904027|NCT02477670|467610945|FG003|Stage 1|Lost to Follow-up|0|||
129904028|NCT02477670|467610946|FG004|Stage 1|Lost to Follow-up|0|||
129904029|NCT02477670|467610947|FG005|Stage 1|Lost to Follow-up|0|||
129904030|NCT02477670|467610948|FG006|Stage 1|Lost to Follow-up|0|||
129904031|NCT02477670|467610942|FG000|Stage 1|Withdrawal by Subject|1|||
129904032|NCT02477670|467610943|FG001|Stage 1|Withdrawal by Subject|2|||
129904033|NCT02477670|467610944|FG002|Stage 1|Withdrawal by Subject|0|||
129904034|NCT02477670|467610945|FG003|Stage 1|Withdrawal by Subject|0|||
129904035|NCT02477670|467610946|FG004|Stage 1|Withdrawal by Subject|0|||
129904036|NCT02477670|467610947|FG005|Stage 1|Withdrawal by Subject|0|||
129904037|NCT02477670|467610948|FG006|Stage 1|Withdrawal by Subject|0|||
129904038|NCT02477670|467610942|FG000|Stage 1|Non-compliance with Study Drug|1|||
129904039|NCT02477670|467610943|FG001|Stage 1|Non-compliance with Study Drug|2|||
129904040|NCT02477670|467610944|FG002|Stage 1|Non-compliance with Study Drug|0|||
129904041|NCT02477670|467610945|FG003|Stage 1|Non-compliance with Study Drug|0|||
129904042|NCT02477670|467610946|FG004|Stage 1|Non-compliance with Study Drug|0|||
129904043|NCT02477670|467610947|FG005|Stage 1|Non-compliance with Study Drug|0|||
129904044|NCT02477670|467610948|FG006|Stage 1|Non-compliance with Study Drug|0|||
129904045|NCT02477670|467610942|FG000|Stage 2|Adverse Event|0|||
129904046|NCT02477670|467610943|FG001|Stage 2|Adverse Event|0|||
129904047|NCT02477670|467610944|FG002|Stage 2|Adverse Event|1|||
129904048|NCT02477670|467610945|FG003|Stage 2|Adverse Event|0|||
129904049|NCT02477670|467610946|FG004|Stage 2|Adverse Event|0|||
129904050|NCT02477670|467610947|FG005|Stage 2|Adverse Event|0|||
129904051|NCT02477670|467610948|FG006|Stage 2|Adverse Event|0|||
129904052|NCT02477670|467610942|FG000|Stage 2|Antipsychotic Medication Changed|0|||
129904053|NCT02477670|467610943|FG001|Stage 2|Antipsychotic Medication Changed|0|||
129849322|NCT02391948|467408781|FG001|6-month Assessment|Medical issue/illness|1|||
129849323|NCT02391948|467408782|FG002|6-month Assessment|Medical issue/illness|0|||
129849324|NCT02391948|467408783|FG003|6-month Assessment|Medical issue/illness|0|||
129849325|NCT02391948|467408784|FG004|6-month Assessment|Medical issue/illness|0|||
129904054|NCT02477670|467610944|FG002|Stage 2|Antipsychotic Medication Changed|1|||
129904055|NCT02477670|467610945|FG003|Stage 2|Antipsychotic Medication Changed|0|||
129904056|NCT02477670|467610946|FG004|Stage 2|Antipsychotic Medication Changed|0|||
129904057|NCT02477670|467610947|FG005|Stage 2|Antipsychotic Medication Changed|0|||
129904058|NCT02477670|467610948|FG006|Stage 2|Antipsychotic Medication Changed|0|||
129904059|NCT02477670|467610942|FG000|Stage 2|Withdrawal by Subject|0|||
129904060|NCT02477670|467610943|FG001|Stage 2|Withdrawal by Subject|0|||
129904061|NCT02477670|467610944|FG002|Stage 2|Withdrawal by Subject|0|||
129904062|NCT02477670|467610945|FG003|Stage 2|Withdrawal by Subject|1|||
129904063|NCT02477670|467610946|FG004|Stage 2|Withdrawal by Subject|0|||
129904064|NCT02477670|467610947|FG005|Stage 2|Withdrawal by Subject|0|||
129904065|NCT02477670|467610948|FG006|Stage 2|Withdrawal by Subject|0|||
129904066|NCT00446550|467610950|FG000|Overall Study|Adverse Event|1|||
129904067|NCT00446550|467610951|FG001|Overall Study|Adverse Event|0|||
129904068|NCT02937831|467610952|FG000|Overall Study|Protocol Violation|4|||
129904069|NCT02983617|467610955|FG000|Overall Study|Adverse Event|0|||
129904070|NCT02983617|467610956|FG001|Overall Study|Adverse Event|7|||
129904071|NCT02983617|467610955|FG000|Overall Study|Death|0|||
129904072|NCT02983617|467610956|FG001|Overall Study|Death|1|||
129904073|NCT02983617|467610955|FG000|Overall Study|Investigator's Discretion|0|||
129904074|NCT02983617|467610956|FG001|Overall Study|Investigator's Discretion|1|||
129904075|NCT02027558|467610957|FG000|Overall Study|Death|0|||
129904076|NCT02027558|467610958|FG001|Overall Study|Death|1|||
129904077|NCT02027558|467610957|FG000|Overall Study|Withdrawal by Subject|2|||
129904078|NCT02027558|467610958|FG001|Overall Study|Withdrawal by Subject|0|||
129904079|NCT02027558|467610957|FG000|Overall Study|Lost to Follow-up|4|||
129904080|NCT02027558|467610958|FG001|Overall Study|Lost to Follow-up|1|||
129904081|NCT02027558|467610957|FG000|Overall Study|Refused assessment|3|||
129904082|NCT02027558|467610958|FG001|Overall Study|Refused assessment|0|||
129849326|NCT02391948|467408780|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
129849327|NCT02391948|467408781|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
129849328|NCT02391948|467408782|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
129849329|NCT02391948|467408783|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
129849330|NCT02391948|467408784|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
129849331|NCT02391948|467408780|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
129849332|NCT02391948|467408781|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
129849333|NCT02391948|467408782|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
129849334|NCT02391948|467408783|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
129849335|NCT02391948|467408784|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
129849336|NCT02391948|467408780|FG000|12-month Assessment|Death|0|||
129849337|NCT02391948|467408781|FG001|12-month Assessment|Death|0|||
129849338|NCT02391948|467408782|FG002|12-month Assessment|Death|0|||
129849339|NCT02391948|467408783|FG003|12-month Assessment|Death|1|||
129849340|NCT02391948|467408784|FG004|12-month Assessment|Death|0|||
129849341|NCT02391948|467408780|FG000|12-month Assessment|Withdrawal by Subject|1|||
129849342|NCT02391948|467408781|FG001|12-month Assessment|Withdrawal by Subject|0|||
129849343|NCT02391948|467408782|FG002|12-month Assessment|Withdrawal by Subject|0|||
129849344|NCT02391948|467408783|FG003|12-month Assessment|Withdrawal by Subject|1|||
129849345|NCT02391948|467408784|FG004|12-month Assessment|Withdrawal by Subject|0|||
129849346|NCT02391948|467408780|FG000|12-month Assessment|Lost to Follow-up|5|||
129849347|NCT02391948|467408781|FG001|12-month Assessment|Lost to Follow-up|4|||
129849348|NCT02391948|467408782|FG002|12-month Assessment|Lost to Follow-up|4|||
129849349|NCT02391948|467408783|FG003|12-month Assessment|Lost to Follow-up|4|||
129849350|NCT02391948|467408784|FG004|12-month Assessment|Lost to Follow-up|5|||
129849351|NCT02391948|467408780|FG000|12-month Assessment|Medical issue/illness|0|||
129849352|NCT02391948|467408781|FG001|12-month Assessment|Medical issue/illness|1|||
129904083|NCT03720210|467610959|FG000|Overall Study|Lost to Follow-up|1|||
129904084|NCT00114244|467610960|FG000|Overall Study|Adverse Event|2|||
129904085|NCT00114244|467610961|FG001|Overall Study|Adverse Event|5|||
129904086|NCT00114244|467610960|FG000|Overall Study|Withdrawal by Subject|0|||
129904087|NCT00114244|467610961|FG001|Overall Study|Withdrawal by Subject|2|||
129904088|NCT02698891|467610962|FG000|Overall Study|Withdrawal by Subject|2|||
129904089|NCT02698891|467610962|FG000|Overall Study|deemed ineligible|1|||
129849353|NCT02391948|467408782|FG002|12-month Assessment|Medical issue/illness|0|||
129849354|NCT02391948|467408783|FG003|12-month Assessment|Medical issue/illness|1|||
129849355|NCT02391948|467408784|FG004|12-month Assessment|Medical issue/illness|0|||
129849356|NCT02391948|467408780|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
129849357|NCT02391948|467408781|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
129849358|NCT02391948|467408782|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
129904090|NCT02698891|467610962|FG000|Overall Study|Adverse Event|9|||
129904091|NCT00711958|467610963|FG000|Overall Study|Withdrawal by Subject|6|||
129849359|NCT02391948|467408783|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
129849360|NCT02391948|467408784|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
129849361|NCT02391948|467408780|FG000|18-month Assessment|Death|0|||
129849362|NCT02391948|467408781|FG001|18-month Assessment|Death|0|||
129849363|NCT02391948|467408782|FG002|18-month Assessment|Death|0|||
129849364|NCT02391948|467408783|FG003|18-month Assessment|Death|1|||
129849365|NCT02391948|467408784|FG004|18-month Assessment|Death|1|||
129849366|NCT02391948|467408780|FG000|18-month Assessment|Withdrawal by Subject|1|||
129849367|NCT02391948|467408781|FG001|18-month Assessment|Withdrawal by Subject|0|||
129849368|NCT02391948|467408782|FG002|18-month Assessment|Withdrawal by Subject|0|||
129849369|NCT02391948|467408783|FG003|18-month Assessment|Withdrawal by Subject|1|||
129849370|NCT02391948|467408784|FG004|18-month Assessment|Withdrawal by Subject|0|||
129849371|NCT02391948|467408780|FG000|18-month Assessment|Lost to Follow-up|2|||
129849372|NCT02391948|467408781|FG001|18-month Assessment|Lost to Follow-up|6|||
129849373|NCT02391948|467408782|FG002|18-month Assessment|Lost to Follow-up|2|||
129849374|NCT02391948|467408783|FG003|18-month Assessment|Lost to Follow-up|2|||
129849375|NCT02391948|467408784|FG004|18-month Assessment|Lost to Follow-up|3|||
129849376|NCT02391948|467408780|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
129849377|NCT02391948|467408781|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
129849378|NCT02391948|467408782|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
129849379|NCT02391948|467408783|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
129849380|NCT02391948|467408784|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
129849381|NCT02391948|467408780|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
129849382|NCT02391948|467408781|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
129849383|NCT02391948|467408782|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
129849384|NCT02391948|467408783|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
129849385|NCT02391948|467408784|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
129849386|NCT02391948|467408780|FG000|24-month Assessment|Death|0|||
129849387|NCT02391948|467408781|FG001|24-month Assessment|Death|0|||
129849388|NCT02391948|467408782|FG002|24-month Assessment|Death|0|||
129849389|NCT02391948|467408783|FG003|24-month Assessment|Death|0|||
129849390|NCT02391948|467408784|FG004|24-month Assessment|Death|1|||
129849391|NCT02391948|467408780|FG000|24-month Assessment|Withdrawal by Subject|1|||
129849392|NCT02391948|467408781|FG001|24-month Assessment|Withdrawal by Subject|1|||
129849393|NCT02391948|467408782|FG002|24-month Assessment|Withdrawal by Subject|0|||
129849394|NCT02391948|467408783|FG003|24-month Assessment|Withdrawal by Subject|0|||
129849395|NCT02391948|467408784|FG004|24-month Assessment|Withdrawal by Subject|1|||
129849396|NCT02391948|467408780|FG000|24-month Assessment|Lost to Follow-up|5|||
129849397|NCT02391948|467408781|FG001|24-month Assessment|Lost to Follow-up|4|||
129849398|NCT02391948|467408782|FG002|24-month Assessment|Lost to Follow-up|0|||
129904092|NCT00711958|467610964|FG001|Overall Study|Withdrawal by Subject|8|||
129904093|NCT00711958|467610963|FG000|Overall Study|Lack of Efficacy|3|||
129904094|NCT00711958|467610964|FG001|Overall Study|Lack of Efficacy|1|||
129904095|NCT00711958|467610963|FG000|Overall Study|Clinical deterioration|1|||
129904096|NCT00711958|467610964|FG001|Overall Study|Clinical deterioration|0|||
129904097|NCT00711958|467610963|FG000|Overall Study|Adverse Event|9|||
129904098|NCT00711958|467610964|FG001|Overall Study|Adverse Event|7|||
129904099|NCT00711958|467610963|FG000|Overall Study|Protocol Violation|1|||
129904100|NCT00711958|467610964|FG001|Overall Study|Protocol Violation|0|||
129904101|NCT00711958|467610963|FG000|Overall Study|Lost to Follow-up|2|||
129904102|NCT00711958|467610964|FG001|Overall Study|Lost to Follow-up|2|||
129904103|NCT00711958|467610963|FG000|Overall Study|Death|10|||
129904104|NCT00711958|467610964|FG001|Overall Study|Death|5|||
129904105|NCT00711958|467610963|FG000|Overall Study|Progression of disease|1|||
129904106|NCT00711958|467610964|FG001|Overall Study|Progression of disease|0|||
129904107|NCT01111526|467610965|FG000|Overall Study|GVHD Disease Progression|0|||
129904108|NCT01111526|467610966|FG001|Overall Study|GVHD Disease Progression|1|||
129849399|NCT02391948|467408783|FG003|24-month Assessment|Lost to Follow-up|0|||
129849400|NCT02391948|467408784|FG004|24-month Assessment|Lost to Follow-up|0|||
129849401|NCT02391948|467408780|FG000|24-month Assessment|Medical issue/illness|0|||
129904109|NCT01111526|467610967|FG002|Overall Study|GVHD Disease Progression|2|||
129904110|NCT04424641|467610968|FG000|Overall Study|Death|1|||
129904111|NCT04424641|467610969|FG001|Overall Study|Death|2|||
129904112|NCT04424641|467610970|FG002|Overall Study|Death|3|||
129904113|NCT04424641|467610971|FG003|Overall Study|Death|0|||
129904114|NCT04424641|467610972|FG004|Overall Study|Death|3|||
129849402|NCT02391948|467408781|FG001|24-month Assessment|Medical issue/illness|0|||
129849403|NCT02391948|467408782|FG002|24-month Assessment|Medical issue/illness|1|||
129849404|NCT02391948|467408783|FG003|24-month Assessment|Medical issue/illness|0|||
129849405|NCT02391948|467408784|FG004|24-month Assessment|Medical issue/illness|0|||
129849406|NCT02391948|467408780|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
129849407|NCT02391948|467408781|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
129849408|NCT02391948|467408782|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
129904115|NCT04424641|467610973|FG005|Overall Study|Death|0|||
129904116|NCT04424641|467610974|FG006|Overall Study|Death|1|||
129849409|NCT02391948|467408783|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
129849410|NCT02391948|467408784|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
129849411|NCT01639001|467408785|FG000|Overall Study|Refused further follow-up|9|||
129849412|NCT01639001|467408786|FG001|Overall Study|Refused further follow-up|12|||
129849413|NCT01639001|467408785|FG000|Overall Study|Lost to Follow-up|3|||
129849414|NCT01639001|467408786|FG001|Overall Study|Lost to Follow-up|0|||
129849415|NCT01639001|467408785|FG000|Overall Study|Death|62|||
129849416|NCT01639001|467408786|FG001|Overall Study|Death|61|||
129849417|NCT01639001|467408785|FG000|Overall Study|Randomized but not treated|0|||
129849418|NCT01639001|467408786|FG001|Overall Study|Randomized but not treated|2|||
129849419|NCT01639001|467408785|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
129849420|NCT01639001|467408786|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
129849421|NCT01969838|467408787|FG000|Double-blind Phase|Adverse Event|10|||
129849422|NCT01969838|467408788|FG001|Double-blind Phase|Adverse Event|4|||
129849423|NCT01969838|467408789|FG002|Double-blind Phase|Adverse Event|0|||
129849424|NCT01969838|467408790|FG003|Double-blind Phase|Adverse Event|0|||
129849425|NCT01969838|467408787|FG000|Double-blind Phase|Death|5|||
129849426|NCT01969838|467408788|FG001|Double-blind Phase|Death|2|||
129849427|NCT01969838|467408789|FG002|Double-blind Phase|Death|0|||
129849428|NCT01969838|467408790|FG003|Double-blind Phase|Death|0|||
129849429|NCT01969838|467408787|FG000|Double-blind Phase|Physician Decision|5|||
129849430|NCT01969838|467408788|FG001|Double-blind Phase|Physician Decision|1|||
129849431|NCT01969838|467408789|FG002|Double-blind Phase|Physician Decision|0|||
129849432|NCT01969838|467408790|FG003|Double-blind Phase|Physician Decision|0|||
129849433|NCT01969838|467408787|FG000|Double-blind Phase|Subject Decision|4|||
129849434|NCT01969838|467408788|FG001|Double-blind Phase|Subject Decision|2|||
129849435|NCT01969838|467408789|FG002|Double-blind Phase|Subject Decision|0|||
129849436|NCT01969838|467408790|FG003|Double-blind Phase|Subject Decision|0|||
129849437|NCT01969838|467408787|FG000|Double-blind Phase|Disease Progression|2|||
129849438|NCT01969838|467408788|FG001|Double-blind Phase|Disease Progression|0|||
129849439|NCT01969838|467408789|FG002|Double-blind Phase|Disease Progression|0|||
129849440|NCT01969838|467408790|FG003|Double-blind Phase|Disease Progression|0|||
129849441|NCT01969838|467408787|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
129849442|NCT01969838|467408788|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
129849443|NCT01969838|467408789|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
129849444|NCT01969838|467408790|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
129849445|NCT01969838|467408787|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
129849446|NCT01969838|467408788|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
129849447|NCT01969838|467408789|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
129849448|NCT01969838|467408790|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
129849449|NCT01969838|467408787|FG000|Open-label Phase|Adverse Event|0|||
129849450|NCT01969838|467408788|FG001|Open-label Phase|Adverse Event|0|||
129849451|NCT01969838|467408789|FG002|Open-label Phase|Adverse Event|37|||
129849452|NCT01969838|467408790|FG003|Open-label Phase|Adverse Event|49|||
129849453|NCT01969838|467408787|FG000|Open-label Phase|Disease Progression|0|||
129849454|NCT01969838|467408788|FG001|Open-label Phase|Disease Progression|0|||
129849455|NCT01969838|467408789|FG002|Open-label Phase|Disease Progression|26|||
129849456|NCT01969838|467408790|FG003|Open-label Phase|Disease Progression|27|||
129849457|NCT01969838|467408787|FG000|Open-label Phase|Lack of Efficacy|0|||
129849458|NCT01969838|467408788|FG001|Open-label Phase|Lack of Efficacy|0|||
129849459|NCT01969838|467408789|FG002|Open-label Phase|Lack of Efficacy|17|||
129849460|NCT01969838|467408790|FG003|Open-label Phase|Lack of Efficacy|19|||
129849461|NCT01969838|467408787|FG000|Open-label Phase|Subject Decision|0|||
129849462|NCT01969838|467408788|FG001|Open-label Phase|Subject Decision|0|||
129849463|NCT01969838|467408789|FG002|Open-label Phase|Subject Decision|14|||
129849464|NCT01969838|467408790|FG003|Open-label Phase|Subject Decision|15|||
129849465|NCT01969838|467408787|FG000|Open-label Phase|Death|0|||
129849466|NCT01969838|467408788|FG001|Open-label Phase|Death|0|||
129849467|NCT01969838|467408789|FG002|Open-label Phase|Death|13|||
129849468|NCT01969838|467408790|FG003|Open-label Phase|Death|11|||
129849469|NCT01969838|467408787|FG000|Open-label Phase|Physician Decision|0|||
129849470|NCT01969838|467408788|FG001|Open-label Phase|Physician Decision|0|||
129849471|NCT01969838|467408789|FG002|Open-label Phase|Physician Decision|9|||
129849472|NCT01969838|467408790|FG003|Open-label Phase|Physician Decision|14|||
129849473|NCT01969838|467408787|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
129849474|NCT01969838|467408788|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
129849475|NCT01969838|467408789|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
129849476|NCT01969838|467408790|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
129849477|NCT02944578|467408793|FG000|Overall Study|Physician Decision|1|||
129849478|NCT02944578|467408794|FG001|Overall Study|Physician Decision|0|||
129849479|NCT00807092|467408795|FG000|Overall Study|Adverse Event|0|||
129849480|NCT00807092|467408796|FG001|Overall Study|Adverse Event|1|||
129849481|NCT00807092|467408795|FG000|Overall Study|Protocol Violation|0|||
129849482|NCT00807092|467408796|FG001|Overall Study|Protocol Violation|2|||
129904117|NCT04424641|467610975|FG007|Overall Study|Death|2|||
129849483|NCT00807092|467408795|FG000|Overall Study|Withdrawal by Subject|1|||
129849484|NCT00807092|467408796|FG001|Overall Study|Withdrawal by Subject|0|||
129849485|NCT00807092|467408795|FG000|Overall Study|CGMS data collection failed|0|||
129849486|NCT00807092|467408796|FG001|Overall Study|CGMS data collection failed|1|||
129849487|NCT04116229|467408797|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
129849488|NCT04116229|467408798|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
129849489|NCT04116229|467408797|FG000|Overall Study|Scheduling not possible.|0|||
129849490|NCT04116229|467408798|FG001|Overall Study|Scheduling not possible.|1|||
129849491|NCT02170727|467408807|FG000|Overall Study|Lost to Follow-up|1|||
129849492|NCT02170727|467408808|FG001|Overall Study|Lost to Follow-up|0|||
129849493|NCT02170727|467408807|FG000|Overall Study|Withdrawal by Subject|2|||
129849494|NCT02170727|467408808|FG001|Overall Study|Withdrawal by Subject|0|||
129849495|NCT01599650|467408809|FG000|Overall Study|Administrative issue|1|||
129849496|NCT01599650|467408810|FG001|Overall Study|Administrative issue|0|||
129849497|NCT01599650|467408811|FG002|Overall Study|Administrative issue|1|||
129849498|NCT01599650|467408809|FG000|Overall Study|Physician Decision|2|||
129849499|NCT01599650|467408810|FG001|Overall Study|Physician Decision|0|||
129849500|NCT01599650|467408811|FG002|Overall Study|Physician Decision|7|||
129849501|NCT01599650|467408809|FG000|Overall Study|Protocol Violation|0|||
129849502|NCT01599650|467408810|FG001|Overall Study|Protocol Violation|3|||
129849503|NCT01599650|467408811|FG002|Overall Study|Protocol Violation|0|||
129849504|NCT01599650|467408809|FG000|Overall Study|Death|2|||
129849505|NCT01599650|467408810|FG001|Overall Study|Death|1|||
129849506|NCT01599650|467408811|FG002|Overall Study|Death|2|||
129849507|NCT01599650|467408809|FG000|Overall Study|Lost to Follow-up|3|||
129849508|NCT01599650|467408810|FG001|Overall Study|Lost to Follow-up|3|||
129849509|NCT01599650|467408811|FG002|Overall Study|Lost to Follow-up|3|||
129849510|NCT01599650|467408809|FG000|Overall Study|Withdrawal by Subject|11|||
129849511|NCT01599650|467408810|FG001|Overall Study|Withdrawal by Subject|11|||
129849512|NCT01599650|467408811|FG002|Overall Study|Withdrawal by Subject|10|||
129849513|NCT01599650|467408809|FG000|Overall Study|Adverse Event|3|||
129849514|NCT01599650|467408810|FG001|Overall Study|Adverse Event|8|||
129849515|NCT01599650|467408811|FG002|Overall Study|Adverse Event|4|||
129849516|NCT00179647|467408819|FG000|Overall Study|Adverse Event|294|||
129849517|NCT00179647|467408819|FG000|Overall Study|Lack of Efficacy|478|||
129849518|NCT00179647|467408819|FG000|Overall Study|Withdrawal by Subject|83|||
129849519|NCT00179647|467408819|FG000|Overall Study|Lost to Follow-up|4|||
129849520|NCT00179647|467408819|FG000|Overall Study|Death|94|||
129849521|NCT00179647|467408819|FG000|Overall Study|Other|960|||
129849522|NCT04154631|467408820|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
129849523|NCT04154631|467408821|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
129849524|NCT02138214|467408824|FG000|Overall Study|Withdrawal by Subject|0|||
129849525|NCT02138214|467408825|FG001|Overall Study|Withdrawal by Subject|1|||
129849526|NCT02138214|467408826|FG002|Overall Study|Withdrawal by Subject|0|||
129849527|NCT02138214|467408824|FG000|Overall Study|Lost to Follow-up|0|||
129849528|NCT02138214|467408825|FG001|Overall Study|Lost to Follow-up|2|||
129849529|NCT02138214|467408826|FG002|Overall Study|Lost to Follow-up|4|||
129849530|NCT02138214|467408824|FG000|Overall Study|Screen Failure|0|||
129849531|NCT02138214|467408825|FG001|Overall Study|Screen Failure|1|||
129849532|NCT02138214|467408826|FG002|Overall Study|Screen Failure|0|||
129849533|NCT02185768|467408827|FG000|Overall Study|Patients were not treated|2|||
129849534|NCT02158039|467408834|FG000|Overall Study|Withdrawal by Subject|1|||
129849535|NCT02158039|467408834|FG000|Overall Study|Screen Failure|9|||
129849536|NCT02127307|467408841|FG000|Overall Study|Protocol Violation|36|||
129849537|NCT02127307|467408841|FG000|Overall Study|Lost to Follow-up|2|||
129849538|NCT02127307|467408841|FG000|Overall Study|Death|101|||
129849539|NCT02127307|467408841|FG000|Overall Study|Other than specified above|169|||
129849540|NCT03509948|467408842|FG000|Overall Study|Protocol Violation|0|||
129849541|NCT03509948|467408843|FG001|Overall Study|Protocol Violation|1|||
129849542|NCT03221257|467408844|FG000|Overall Study|Lost to Follow-up|0|||
129849543|NCT03221257|467408845|FG001|Overall Study|Lost to Follow-up|1|||
129849544|NCT03221257|467408844|FG000|Overall Study|Withdrawal by Subject|1|||
129849545|NCT03221257|467408845|FG001|Overall Study|Withdrawal by Subject|1|||
129849546|NCT01334866|467408849|FG000|Overall Study|Withdrawal by Subject|10|||
129849547|NCT01334866|467408849|FG000|Overall Study|Lost to Follow-up|3|||
129849548|NCT01334866|467408849|FG000|Overall Study|Physician Decision|3|||
129849549|NCT01334866|467408849|FG000|Overall Study|medically necessary prior to procedure|2|||
129849550|NCT01334866|467408849|FG000|Overall Study|medically necessary post-procedure|1|||
129849551|NCT02755831|467408858|FG000|Overall Study|Lost to Follow-up|3|||
129849552|NCT02755831|467408859|FG001|Overall Study|Lost to Follow-up|3|||
129849553|NCT02296112|467408860|FG000|Overall Study|Disease progression|7|||
129849554|NCT02296112|467408860|FG000|Overall Study|Toxicity|1|||
129849555|NCT02296112|467408860|FG000|Overall Study|Began an alternate therapy|1|||
129849556|NCT02442830|467408861|FG000|Overall Study|Technical Failure|0|||
129849557|NCT02442830|467408862|FG001|Overall Study|Technical Failure|1|||
129849558|NCT00183872|467408863|FG000|Overall Study|Death|3|||
129849559|NCT00183872|467408863|FG000|Overall Study|Adverse Event|9|||
129849560|NCT00183872|467408863|FG000|Overall Study|Withdrawal by Subject|2|||
129849561|NCT00183872|467408863|FG000|Overall Study|Drug delayed more than 28 days|2|||
129849562|NCT01720069|467408864|FG000|Overall Study|Could not use e-diary correctly|0|||
129849563|NCT01720069|467408865|FG001|Overall Study|Could not use e-diary correctly|1|||
129849564|NCT01720069|467408866|FG002|Overall Study|Could not use e-diary correctly|1|||
129849565|NCT01720069|467408864|FG000|Overall Study|Randomised without baseline values|0|||
129849566|NCT01720069|467408865|FG001|Overall Study|Randomised without baseline values|0|||
129849567|NCT01720069|467408866|FG002|Overall Study|Randomised without baseline values|1|||
129849568|NCT01720069|467408864|FG000|Overall Study|Adverse Event|0|||
129849569|NCT01720069|467408865|FG001|Overall Study|Adverse Event|0|||
129849570|NCT01720069|467408866|FG002|Overall Study|Adverse Event|1|||
129849571|NCT01720069|467408864|FG000|Overall Study|Lack of Efficacy|0|||
129849572|NCT01720069|467408865|FG001|Overall Study|Lack of Efficacy|4|||
129849573|NCT01720069|467408866|FG002|Overall Study|Lack of Efficacy|0|||
129849574|NCT01720069|467408864|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
129849575|NCT01720069|467408865|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
129849576|NCT01720069|467408866|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
129849577|NCT01720069|467408864|FG000|Overall Study|Withdrawal by Subject|0|||
129849578|NCT01720069|467408865|FG001|Overall Study|Withdrawal by Subject|2|||
129849579|NCT01720069|467408866|FG002|Overall Study|Withdrawal by Subject|1|||
129849580|NCT01720069|467408864|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
129849581|NCT01720069|467408865|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
129849582|NCT01720069|467408866|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
129849583|NCT01720069|467408864|FG000|Overall Study|Non-compliance on using e-diary|0|||
129849584|NCT01720069|467408865|FG001|Overall Study|Non-compliance on using e-diary|0|||
129849585|NCT01720069|467408866|FG002|Overall Study|Non-compliance on using e-diary|1|||
129849586|NCT01720069|467408864|FG000|Overall Study|Lost to Follow-up|0|||
129849587|NCT01720069|467408865|FG001|Overall Study|Lost to Follow-up|0|||
129849588|NCT01720069|467408866|FG002|Overall Study|Lost to Follow-up|1|||
129849589|NCT00508742|467408867|FG000|Period 1: Infant Series|Adverse Event|5|||
129849590|NCT00508742|467408868|FG001|Period 1: Infant Series|Adverse Event|4|||
129849591|NCT00508742|467408867|FG000|Period 1: Infant Series|Protocol Violation|1|||
129849592|NCT00508742|467408868|FG001|Period 1: Infant Series|Protocol Violation|0|||
129849593|NCT00508742|467408867|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
129849594|NCT00508742|467408868|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
129849595|NCT00508742|467408867|FG000|Period 1: Infant Series|Physician Decision|1|||
129849596|NCT00508742|467408868|FG001|Period 1: Infant Series|Physician Decision|0|||
129849597|NCT00508742|467408867|FG000|Period 1: Infant Series|Other|4|||
129849598|NCT00508742|467408868|FG001|Period 1: Infant Series|Other|1|||
129849599|NCT00508742|467408867|FG000|Period 2: After Infant Series|Adverse Event|2|||
129849600|NCT00508742|467408868|FG001|Period 2: After Infant Series|Adverse Event|6|||
129849601|NCT00508742|467408867|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
129849602|NCT00508742|467408868|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
129849603|NCT00508742|467408867|FG000|Period 2: After Infant Series|Protocol Violation|1|||
129849604|NCT00508742|467408868|FG001|Period 2: After Infant Series|Protocol Violation|0|||
129849605|NCT00508742|467408867|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
129849606|NCT00508742|467408868|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
129849607|NCT00508742|467408867|FG000|Period 2: After Infant Series|Failed to Return|1|||
129849608|NCT00508742|467408868|FG001|Period 2: After Infant Series|Failed to Return|0|||
129849609|NCT00508742|467408867|FG000|Period 2: After Infant Series|Other|2|||
129849610|NCT00508742|467408868|FG001|Period 2: After Infant Series|Other|1|||
129849611|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Adverse Event|1|||
129849612|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Adverse Event|0|||
129849613|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
129849614|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
129904118|NCT04424641|467610968|FG000|Overall Study|Sponsor decision|0|||
129904119|NCT04424641|467610969|FG001|Overall Study|Sponsor decision|2|||
129904120|NCT04424641|467610970|FG002|Overall Study|Sponsor decision|3|||
129904121|NCT04424641|467610971|FG003|Overall Study|Sponsor decision|7|||
129849615|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
129849616|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
129849617|NCT00508742|467408867|FG000|Period 3: Toddler Dose|Other|5|||
129849618|NCT00508742|467408868|FG001|Period 3: Toddler Dose|Other|4|||
129849619|NCT04568122|467408869|FG000|Overall Study|Lost to Follow-up|48|||
129849620|NCT04568122|467408870|FG001|Overall Study|Lost to Follow-up|44|||
129849621|NCT04568122|467408871|FG002|Overall Study|Lost to Follow-up|4|||
129849622|NCT04568122|467408872|FG003|Overall Study|Lost to Follow-up|0|||
129849623|NCT04568122|467408873|FG004|Overall Study|Lost to Follow-up|0|||
129849624|NCT00700011|467408879|FG000|Overall Study|Death|0|||
129849625|NCT00700011|467408880|FG001|Overall Study|Death|1|||
129849626|NCT02797262|467408881|FG000|Overall Study|Withdrawal by Subject|5|||
129849627|NCT02797262|467408882|FG001|Overall Study|Withdrawal by Subject|1|||
129849628|NCT02797262|467408881|FG000|Overall Study|Lost to Follow-up|10|||
129849629|NCT02797262|467408882|FG001|Overall Study|Lost to Follow-up|7|||
129849630|NCT02797262|467408881|FG000|Overall Study|Death|1|||
129904122|NCT04424641|467610972|FG004|Overall Study|Sponsor decision|2|||
129849631|NCT02797262|467408882|FG001|Overall Study|Death|2|||
129849632|NCT02797262|467408881|FG000|Overall Study|Adverse Event|1|||
129849633|NCT02797262|467408882|FG001|Overall Study|Adverse Event|0|||
129849634|NCT02797262|467408881|FG000|Overall Study|COVID-19|2|||
129849635|NCT02797262|467408882|FG001|Overall Study|COVID-19|1|||
129849636|NCT02797262|467408881|FG000|Overall Study|Out-of-country|1|||
129849637|NCT02797262|467408882|FG001|Overall Study|Out-of-country|0|||
129849638|NCT01209624|467408883|FG000|Overall Study|Death|2|||
129849639|NCT01209624|467408883|FG000|Overall Study|Adverse Event|13|||
129849640|NCT01209624|467408883|FG000|Overall Study|Lack of Efficacy|17|||
129849641|NCT01209624|467408883|FG000|Overall Study|Lost to Follow-up|290|||
129849642|NCT01209624|467408883|FG000|Overall Study|Other|4|||
129849643|NCT06748040|467408888|FG000|Overall Study|Death|3|||
129849644|NCT06748040|467408889|FG001|Overall Study|Death|4|||
129849645|NCT06748040|467408888|FG000|Overall Study|Lost to Follow-up|134|||
129849646|NCT06748040|467408889|FG001|Overall Study|Lost to Follow-up|132|||
129849647|NCT06748040|467408888|FG000|Overall Study|Withdrawal by Subject|3|||
129849648|NCT06748040|467408889|FG001|Overall Study|Withdrawal by Subject|5|||
129849649|NCT01818336|467410605|FG000|Overall Study|Declined retest visit|0|||
129849650|NCT01818336|467410606|FG001|Overall Study|Declined retest visit|11|||
129849651|NCT01818336|467410605|FG000|Overall Study|Lost to Follow-up|0|||
129849652|NCT01818336|467410606|FG001|Overall Study|Lost to Follow-up|1|||
129849653|NCT00827372|467410611|FG000|Overall Study|Adverse Event|5|||
129849654|NCT00827372|467410611|FG000|Overall Study|Lack of Efficacy|3|||
129849655|NCT02293005|467410612|FG000|Overall Study|Adverse Event|2|||
129849656|NCT02293005|467410612|FG000|Overall Study|Death|4|||
129849657|NCT02293005|467410612|FG000|Overall Study|Lost to Follow-up|1|||
129849658|NCT02293005|467410612|FG000|Overall Study|Withdrawal by Subject|2|||
129849659|NCT02293005|467410612|FG000|Overall Study|Progression|17|||
129849660|NCT00608829|467410614|FG000|Overall Study|Death|6|||
129849661|NCT00608829|467410614|FG000|Overall Study|Withdrawal by Subject|4|||
129849662|NCT00608829|467410614|FG000|Overall Study|Subject refuses to follow up or return.|5|||
129849663|NCT02564471|467410617|FG000|Overall Study|Adverse Event|1|||
129849664|NCT02564471|467410618|FG001|Overall Study|Adverse Event|0|||
129849665|NCT02564471|467410619|FG002|Overall Study|Adverse Event|0|||
129849666|NCT02564471|467410620|FG003|Overall Study|Adverse Event|0|||
129849667|NCT02564471|467410617|FG000|Overall Study|Withdrawal by Subject|2|||
129849668|NCT02564471|467410618|FG001|Overall Study|Withdrawal by Subject|1|||
129849669|NCT02564471|467410619|FG002|Overall Study|Withdrawal by Subject|3|||
129849670|NCT02564471|467410620|FG003|Overall Study|Withdrawal by Subject|0|||
129849671|NCT02564471|467410617|FG000|Overall Study|Lost to Follow-up|0|||
129849672|NCT02564471|467410618|FG001|Overall Study|Lost to Follow-up|2|||
129849673|NCT02564471|467410619|FG002|Overall Study|Lost to Follow-up|0|||
129849674|NCT02564471|467410620|FG003|Overall Study|Lost to Follow-up|0|||
129849675|NCT02805257|467410621|FG000|Overall Study|Lost to Follow-up|7|||
129849676|NCT02805257|467410622|FG001|Overall Study|Lost to Follow-up|6|||
129849677|NCT02805257|467410621|FG000|Overall Study|Death|0|||
129849678|NCT02805257|467410622|FG001|Overall Study|Death|1|||
129849679|NCT02766608|467410626|FG000|Overall Study|Adverse Event|27|||
129849680|NCT02766608|467410627|FG001|Overall Study|Adverse Event|22|||
129849681|NCT02766608|467410628|FG002|Overall Study|Adverse Event|17|||
129849682|NCT02766608|467410629|FG003|Overall Study|Adverse Event|13|||
129849683|NCT02766608|467410630|FG004|Overall Study|Adverse Event|12|||
129849684|NCT02766608|467410626|FG000|Overall Study|Withdrawal by Subject|21|||
129849685|NCT02766608|467410627|FG001|Overall Study|Withdrawal by Subject|20|||
129849686|NCT02766608|467410628|FG002|Overall Study|Withdrawal by Subject|24|||
129849687|NCT02766608|467410629|FG003|Overall Study|Withdrawal by Subject|13|||
129849688|NCT02766608|467410630|FG004|Overall Study|Withdrawal by Subject|10|||
129849689|NCT02766608|467410626|FG000|Overall Study|Lack of Efficacy|16|||
129849690|NCT02766608|467410627|FG001|Overall Study|Lack of Efficacy|15|||
129849691|NCT02766608|467410628|FG002|Overall Study|Lack of Efficacy|32|||
129849692|NCT02766608|467410629|FG003|Overall Study|Lack of Efficacy|8|||
129849693|NCT02766608|467410630|FG004|Overall Study|Lack of Efficacy|2|||
129849694|NCT02766608|467410626|FG000|Overall Study|Lost to Follow-up|6|||
129849695|NCT02766608|467410627|FG001|Overall Study|Lost to Follow-up|3|||
129849696|NCT02766608|467410628|FG002|Overall Study|Lost to Follow-up|5|||
129849697|NCT02766608|467410629|FG003|Overall Study|Lost to Follow-up|2|||
129849698|NCT02766608|467410630|FG004|Overall Study|Lost to Follow-up|2|||
129849699|NCT02766608|467410626|FG000|Overall Study|Physician Decision|3|||
129849700|NCT02766608|467410627|FG001|Overall Study|Physician Decision|2|||
129849701|NCT02766608|467410628|FG002|Overall Study|Physician Decision|3|||
129849702|NCT02766608|467410629|FG003|Overall Study|Physician Decision|1|||
129849703|NCT02766608|467410630|FG004|Overall Study|Physician Decision|2|||
129849704|NCT02766608|467410626|FG000|Overall Study|Protocol disc criteria|3|||
129849705|NCT02766608|467410627|FG001|Overall Study|Protocol disc criteria|3|||
129849706|NCT02766608|467410628|FG002|Overall Study|Protocol disc criteria|4|||
129849707|NCT02766608|467410629|FG003|Overall Study|Protocol disc criteria|0|||
129849708|NCT02766608|467410630|FG004|Overall Study|Protocol disc criteria|0|||
129849709|NCT02766608|467410626|FG000|Overall Study|Protocol Violation|0|||
129849710|NCT02766608|467410627|FG001|Overall Study|Protocol Violation|4|||
129849711|NCT02766608|467410628|FG002|Overall Study|Protocol Violation|4|||
129849712|NCT02766608|467410629|FG003|Overall Study|Protocol Violation|0|||
129849713|NCT02766608|467410630|FG004|Overall Study|Protocol Violation|1|||
129849714|NCT02766608|467410626|FG000|Overall Study|Administrative Reasons|3|||
129849715|NCT02766608|467410627|FG001|Overall Study|Administrative Reasons|1|||
129849716|NCT02766608|467410628|FG002|Overall Study|Administrative Reasons|1|||
129849717|NCT02766608|467410629|FG003|Overall Study|Administrative Reasons|0|||
129849718|NCT02766608|467410630|FG004|Overall Study|Administrative Reasons|0|||
129849719|NCT02343458|467410634|FG000|Overall Study|Adverse Event|15|||
129849720|NCT02343458|467410635|FG001|Overall Study|Adverse Event|14|||
129849721|NCT02343458|467410636|FG002|Overall Study|Adverse Event|15|||
129849722|NCT02343458|467410637|FG003|Overall Study|Adverse Event|3|||
129849723|NCT02343458|467410634|FG000|Overall Study|Lack of Efficacy|3|||
129849724|NCT02343458|467410635|FG001|Overall Study|Lack of Efficacy|8|||
129849725|NCT02343458|467410636|FG002|Overall Study|Lack of Efficacy|4|||
129849726|NCT02343458|467410637|FG003|Overall Study|Lack of Efficacy|8|||
129849727|NCT02343458|467410634|FG000|Overall Study|Withdrawal by Subject|18|||
129849728|NCT02343458|467410635|FG001|Overall Study|Withdrawal by Subject|17|||
129849729|NCT02343458|467410636|FG002|Overall Study|Withdrawal by Subject|23|||
129849730|NCT02343458|467410637|FG003|Overall Study|Withdrawal by Subject|14|||
129849731|NCT02343458|467410634|FG000|Overall Study|Physician Decision|1|||
129849732|NCT02343458|467410635|FG001|Overall Study|Physician Decision|4|||
129849733|NCT02343458|467410636|FG002|Overall Study|Physician Decision|2|||
129849734|NCT02343458|467410637|FG003|Overall Study|Physician Decision|2|||
129849735|NCT02343458|467410634|FG000|Overall Study|Lost to Follow-up|5|||
129849736|NCT02343458|467410635|FG001|Overall Study|Lost to Follow-up|5|||
129849737|NCT02343458|467410636|FG002|Overall Study|Lost to Follow-up|3|||
129849738|NCT02343458|467410637|FG003|Overall Study|Lost to Follow-up|1|||
129849739|NCT02343458|467410634|FG000|Overall Study|Protocol Violation|2|||
129849740|NCT02343458|467410635|FG001|Overall Study|Protocol Violation|5|||
129849741|NCT02343458|467410636|FG002|Overall Study|Protocol Violation|2|||
129849742|NCT02343458|467410637|FG003|Overall Study|Protocol Violation|2|||
129849743|NCT02343458|467410634|FG000|Overall Study|Protocol Specified Criteria|17|||
129849744|NCT02343458|467410635|FG001|Overall Study|Protocol Specified Criteria|13|||
129849745|NCT02343458|467410636|FG002|Overall Study|Protocol Specified Criteria|14|||
129849746|NCT02343458|467410637|FG003|Overall Study|Protocol Specified Criteria|8|||
129849747|NCT02080091|467410638|FG000|Overall Study|Study Terminated|22|||
129849748|NCT02080091|467410638|FG000|Overall Study|Death|1|||
129849749|NCT02080091|467410638|FG000|Overall Study|Withdrawal by Subject|1|||
129849750|NCT02080091|467410638|FG000|Overall Study|Other|1|||
129849751|NCT02886572|467410640|FG000|Overall Study|Death|8|||
129849752|NCT00408993|467410641|FG000|Overall Study|Adverse Event|15|||
129849753|NCT00408993|467410642|FG001|Overall Study|Adverse Event|4|||
129849754|NCT00408993|467410641|FG000|Overall Study|Protocol Violation|1|||
129849755|NCT00408993|467410642|FG001|Overall Study|Protocol Violation|6|||
129849756|NCT00408993|467410641|FG000|Overall Study|Lack of Efficacy|1|||
129849757|NCT00408993|467410642|FG001|Overall Study|Lack of Efficacy|4|||
129849758|NCT00408993|467410641|FG000|Overall Study|Withdrawal by Subject|2|||
129849759|NCT00408993|467410642|FG001|Overall Study|Withdrawal by Subject|3|||
129849760|NCT03738865|467410643|FG000|Overall Study|Withdrawal by Subject|3|||
129849761|NCT03738865|467410644|FG001|Overall Study|Withdrawal by Subject|3|||
129849762|NCT03738865|467410643|FG000|Overall Study|Adverse Event|2|||
129849763|NCT03738865|467410644|FG001|Overall Study|Adverse Event|0|||
129849764|NCT03738865|467410643|FG000|Overall Study|Physician Decision|0|||
129849765|NCT03738865|467410644|FG001|Overall Study|Physician Decision|1|||
129849766|NCT00961259|467410645|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
129849767|NCT00961259|467410646|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
129849768|NCT00961259|467410647|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
129849769|NCT01324024|467410648|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
129849770|NCT01324024|467410649|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129849771|NCT02691455|467410650|FG000|Overall Study|Withdrawal by Subject|1|||
129849772|NCT02691455|467410651|FG001|Overall Study|Withdrawal by Subject|2|||
129849773|NCT02691455|467410650|FG000|Overall Study|Lost to Follow-up|15|||
129849774|NCT02691455|467410651|FG001|Overall Study|Lost to Follow-up|15|||
129849775|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129849776|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
129849777|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
129849778|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
129849779|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
129849780|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
129849781|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129849782|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
129849783|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129849784|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129849785|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
129849786|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129849787|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
129849788|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
129849789|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
129849790|NCT01257204|467410652|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
129849791|NCT01257204|467410653|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
129849792|NCT01257204|467410654|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
129849793|NCT01257204|467410652|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
129849794|NCT01257204|467410653|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
129849795|NCT01257204|467410654|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
129849796|NCT01257204|467410652|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
129849797|NCT01257204|467410653|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
129849798|NCT01257204|467410654|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
129849799|NCT01257204|467410652|FG000|Follow-up Period (up to Week 48)|Other|0|||
129849800|NCT01257204|467410653|FG001|Follow-up Period (up to Week 48)|Other|0|||
129849801|NCT01257204|467410654|FG002|Follow-up Period (up to Week 48)|Other|5|||
129849802|NCT01276327|467410658|FG000|Overall Study|Adverse Event|1|||
129849803|NCT01276327|467410659|FG001|Overall Study|Adverse Event|3|||
129849804|NCT01276327|467410658|FG000|Overall Study|Withdrawal by Subject|1|||
129849805|NCT01276327|467410659|FG001|Overall Study|Withdrawal by Subject|0|||
129849806|NCT01794949|467410660|FG000|Overall Study|Lost to Follow-up|1|||
129849807|NCT01794949|467410661|FG001|Overall Study|Lost to Follow-up|0|||
129849808|NCT03766646|467410663|FG000|Overall Study|Withdrawal by Subject|1|||
129849809|NCT03766646|467410664|FG001|Overall Study|Withdrawal by Subject|0|||
129849810|NCT03766646|467410663|FG000|Overall Study|Protocol Violation|0|||
129849811|NCT03766646|467410664|FG001|Overall Study|Protocol Violation|3|||
129849812|NCT04713748|467410674|FG000|Overall Study|Not enough kits allocated|35|||
129849813|NCT02802345|467410681|FG000|Overall Study|Not Treated|0|||
129849814|NCT02802345|467410682|FG001|Overall Study|Not Treated|1|||
129849815|NCT02802345|467410681|FG000|Overall Study|Adverse Event|28|||
129849816|NCT02802345|467410682|FG001|Overall Study|Adverse Event|20|||
129849817|NCT02802345|467410681|FG000|Overall Study|Withdrawal by Subject|3|||
129849818|NCT02802345|467410682|FG001|Overall Study|Withdrawal by Subject|3|||
129849819|NCT02802345|467410681|FG000|Overall Study|Protocol Violation|0|||
129849820|NCT02802345|467410682|FG001|Overall Study|Protocol Violation|1|||
129849821|NCT02802345|467410681|FG000|Overall Study|Other than listed|1|||
129849822|NCT02802345|467410682|FG001|Overall Study|Other than listed|5|||
129849823|NCT05857527|467410685|FG000|Overall Study|Withdrawal by Subject|0|||
129849824|NCT05857527|467410686|FG001|Overall Study|Withdrawal by Subject|1|||
129849825|NCT02799082|467410689|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
129849826|NCT02799082|467410690|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
129849827|NCT02799082|467410689|FG000|Overall Study|Protocol Violation|0|||
129849828|NCT02799082|467410690|FG001|Overall Study|Protocol Violation|1|||
129849829|NCT01748994|467410695|FG000|Overall Study|Lost to Follow-up|8|||
129849830|NCT01748994|467410696|FG001|Overall Study|Lost to Follow-up|6|||
129849831|NCT02520531|467410699|FG000|Overall Study|Revision of study device components|2|||
129849832|NCT02520531|467410700|FG001|Overall Study|Revision of study device components|2|||
129849833|NCT02520531|467410699|FG000|Overall Study|Death|1|||
129849834|NCT02520531|467410700|FG001|Overall Study|Death|2|||
129849835|NCT02520531|467410699|FG000|Overall Study|Lost to Follow-up|1|||
129849836|NCT02520531|467410700|FG001|Overall Study|Lost to Follow-up|1|||
129849837|NCT02520531|467410699|FG000|Overall Study|Meet exclusion criterion|0|||
129849838|NCT02520531|467410700|FG001|Overall Study|Meet exclusion criterion|1|||
129849839|NCT02520531|467410699|FG000|Overall Study|Withdrawal by Subject|1|||
129849840|NCT02520531|467410700|FG001|Overall Study|Withdrawal by Subject|0|||
129849841|NCT02520531|467410699|FG000|Overall Study|Not study device|1|||
129849842|NCT02520531|467410700|FG001|Overall Study|Not study device|0|||
129849843|NCT01723904|467410702|FG000|Overall Study|Noncompliant|3|||
129849844|NCT01723904|467410702|FG000|Overall Study|Adverse Event|5|||
129849845|NCT01723904|467410702|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
129849846|NCT03251924|467410703|FG000|Overall Study|Disease Progression|6|||
129849847|NCT03251924|467410704|FG001|Overall Study|Disease Progression|6|||
129849848|NCT03251924|467410705|FG002|Overall Study|Disease Progression|7|||
129849849|NCT03251924|467410706|FG003|Overall Study|Disease Progression|8|||
129849850|NCT03251924|467410707|FG004|Overall Study|Disease Progression|8|||
129849851|NCT03251924|467410708|FG005|Overall Study|Disease Progression|7|||
129849852|NCT03251924|467410709|FG006|Overall Study|Disease Progression|6|||
129849853|NCT03251924|467410710|FG007|Overall Study|Disease Progression|10|||
129849854|NCT03251924|467410711|FG008|Overall Study|Disease Progression|6|||
129849855|NCT03251924|467410703|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
129849856|NCT03251924|467410704|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
129849857|NCT03251924|467410705|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
129849858|NCT03251924|467410706|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
129849859|NCT03251924|467410707|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
129849860|NCT03251924|467410708|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
129904123|NCT04424641|467610973|FG005|Overall Study|Sponsor decision|2|||
129904124|NCT04424641|467610974|FG006|Overall Study|Sponsor decision|3|||
129904125|NCT04424641|467610975|FG007|Overall Study|Sponsor decision|4|||
129904126|NCT04424641|467610968|FG000|Overall Study|Withdrawal by Subject|0|||
129849861|NCT03251924|467410709|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
129849862|NCT03251924|467410710|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
129849863|NCT03251924|467410711|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
129849864|NCT03251924|467410703|FG000|Overall Study|Death|0|||
129849865|NCT03251924|467410704|FG001|Overall Study|Death|1|||
129849866|NCT03251924|467410705|FG002|Overall Study|Death|0|||
129849867|NCT03251924|467410706|FG003|Overall Study|Death|1|||
129849868|NCT03251924|467410707|FG004|Overall Study|Death|1|||
129849869|NCT03251924|467410708|FG005|Overall Study|Death|1|||
129849870|NCT03251924|467410709|FG006|Overall Study|Death|0|||
129849871|NCT03251924|467410710|FG007|Overall Study|Death|0|||
129849872|NCT03251924|467410711|FG008|Overall Study|Death|0|||
129849873|NCT03251924|467410703|FG000|Overall Study|Study Drug Toxicity|0|||
129849874|NCT03251924|467410704|FG001|Overall Study|Study Drug Toxicity|0|||
129849875|NCT03251924|467410705|FG002|Overall Study|Study Drug Toxicity|0|||
129849876|NCT03251924|467410706|FG003|Overall Study|Study Drug Toxicity|1|||
129849877|NCT03251924|467410707|FG004|Overall Study|Study Drug Toxicity|0|||
129849878|NCT03251924|467410708|FG005|Overall Study|Study Drug Toxicity|0|||
129849879|NCT03251924|467410709|FG006|Overall Study|Study Drug Toxicity|0|||
129849880|NCT03251924|467410710|FG007|Overall Study|Study Drug Toxicity|0|||
129849881|NCT03251924|467410711|FG008|Overall Study|Study Drug Toxicity|1|||
129849882|NCT03251924|467410703|FG000|Overall Study|Other Reasons|0|||
129849883|NCT03251924|467410704|FG001|Overall Study|Other Reasons|0|||
129849884|NCT03251924|467410705|FG002|Overall Study|Other Reasons|0|||
129849885|NCT03251924|467410706|FG003|Overall Study|Other Reasons|0|||
129849886|NCT03251924|467410707|FG004|Overall Study|Other Reasons|0|||
129849887|NCT03251924|467410708|FG005|Overall Study|Other Reasons|0|||
129849888|NCT03251924|467410709|FG006|Overall Study|Other Reasons|0|||
129849889|NCT03251924|467410710|FG007|Overall Study|Other Reasons|0|||
129849890|NCT03251924|467410711|FG008|Overall Study|Other Reasons|1|||
129849891|NCT03251924|467410703|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129849892|NCT03251924|467410704|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129849893|NCT03251924|467410705|FG002|Overall Study|Participant request to discontinue study treatment|0|||
129849894|NCT03251924|467410706|FG003|Overall Study|Participant request to discontinue study treatment|0|||
129849895|NCT03251924|467410707|FG004|Overall Study|Participant request to discontinue study treatment|0|||
129849896|NCT03251924|467410708|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129849897|NCT03251924|467410709|FG006|Overall Study|Participant request to discontinue study treatment|0|||
129849898|NCT03251924|467410710|FG007|Overall Study|Participant request to discontinue study treatment|1|||
129849899|NCT03251924|467410711|FG008|Overall Study|Participant request to discontinue study treatment|0|||
129849900|NCT02617589|467410720|FG000|Randomization|Request to Discontinue Study Treatment|1|||
129849901|NCT02617589|467410721|FG001|Randomization|Request to Discontinue Study Treatment|3|||
129849902|NCT02617589|467410720|FG000|Randomization|Participant Withdrew Consent|1|||
129849903|NCT02617589|467410721|FG001|Randomization|Participant Withdrew Consent|2|||
129849904|NCT02617589|467410720|FG000|Treatment|Other Reasons|3|||
129849905|NCT02617589|467410721|FG001|Treatment|Other Reasons|3|||
129849906|NCT02617589|467410720|FG000|Treatment|Poor/Non Compliance|1|||
129849907|NCT02617589|467410721|FG001|Treatment|Poor/Non Compliance|1|||
129849908|NCT02617589|467410720|FG000|Treatment|Maximum Clinical Benefit|0|||
129849909|NCT02617589|467410721|FG001|Treatment|Maximum Clinical Benefit|2|||
129904127|NCT04424641|467610969|FG001|Overall Study|Withdrawal by Subject|0|||
129904128|NCT04424641|467610970|FG002|Overall Study|Withdrawal by Subject|0|||
129849910|NCT02617589|467410720|FG000|Treatment|Participant Withdrew Consent|2|||
129849911|NCT02617589|467410721|FG001|Treatment|Participant Withdrew Consent|6|||
129849912|NCT02617589|467410720|FG000|Treatment|Participant Request to Discontinue|12|||
129849913|NCT02617589|467410721|FG001|Treatment|Participant Request to Discontinue|21|||
129849914|NCT02617589|467410720|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
129849915|NCT02617589|467410721|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
129849916|NCT02617589|467410720|FG000|Treatment|Death|1|||
129849917|NCT02617589|467410721|FG001|Treatment|Death|1|||
129904129|NCT04424641|467610971|FG003|Overall Study|Withdrawal by Subject|0|||
129849918|NCT02617589|467410720|FG000|Treatment|Study Drug Toxicity|27|||
129849919|NCT02617589|467410721|FG001|Treatment|Study Drug Toxicity|20|||
129849920|NCT02617589|467410720|FG000|Treatment|Disease Progression|216|||
129849921|NCT02617589|467410721|FG001|Treatment|Disease Progression|136|||
129849922|NCT01649856|467410722|FG000|Overall Study|Withdrawal by Subject|14|||
129849923|NCT01649856|467410723|FG001|Overall Study|Withdrawal by Subject|14|||
129849924|NCT01649856|467410722|FG000|Overall Study|Protocol Violation|4|||
129849925|NCT01649856|467410723|FG001|Overall Study|Protocol Violation|4|||
129849926|NCT01649856|467410722|FG000|Overall Study|Treatment Failure|1|||
129849927|NCT01649856|467410723|FG001|Overall Study|Treatment Failure|1|||
129849928|NCT01649856|467410722|FG000|Overall Study|Death|69|||
129849929|NCT01649856|467410723|FG001|Overall Study|Death|34|||
129904130|NCT04424641|467610972|FG004|Overall Study|Withdrawal by Subject|1|||
129904131|NCT04424641|467610973|FG005|Overall Study|Withdrawal by Subject|0|||
129904132|NCT04424641|467610974|FG006|Overall Study|Withdrawal by Subject|0|||
129904133|NCT04424641|467610975|FG007|Overall Study|Withdrawal by Subject|0|||
129904134|NCT04424641|467610968|FG000|Overall Study|Other|0|||
129904135|NCT04424641|467610969|FG001|Overall Study|Other|0|||
129904136|NCT04424641|467610970|FG002|Overall Study|Other|1|||
129904137|NCT04424641|467610971|FG003|Overall Study|Other|0|||
129904138|NCT04424641|467610972|FG004|Overall Study|Other|0|||
129904139|NCT04424641|467610973|FG005|Overall Study|Other|0|||
129904140|NCT04424641|467610974|FG006|Overall Study|Other|0|||
129904141|NCT04424641|467610975|FG007|Overall Study|Other|0|||
129904142|NCT01613716|467610982|FG000|Overall Study|screen failures|3|||
129904143|NCT01613716|467610982|FG000|Overall Study|Lost to Follow-up|4|||
129904144|NCT01171625|467610983|FG000|Overall Study|On-Protocol|67|||
129904145|NCT01171625|467610983|FG000|Overall Study|Death|38|||
129904146|NCT01171625|467610983|FG000|Overall Study|Withdrawal by Subject|31|||
129904147|NCT01171625|467610983|FG000|Overall Study|Explanted|10|||
129904148|NCT01171625|467610983|FG000|Overall Study|Lost to Follow-up|5|||
129904149|NCT01171625|467610983|FG000|Overall Study|Patient received valve-in-valve|3|||
129904150|NCT01171625|467610983|FG000|Overall Study|Other|1|||
129904151|NCT01171625|467610983|FG000|Overall Study|Consented but did not receive device|25|||
129904152|NCT05174013|467610984|FG000|Overall Study|Lost to Follow-up|0|||
129904153|NCT05174013|467610985|FG001|Overall Study|Lost to Follow-up|0|||
129904154|NCT05174013|467610986|FG002|Overall Study|Lost to Follow-up|0|||
129904155|NCT05174013|467610987|FG003|Overall Study|Lost to Follow-up|1|||
129904156|NCT05174013|467610988|FG004|Overall Study|Lost to Follow-up|0|||
129904157|NCT05174013|467610989|FG005|Overall Study|Lost to Follow-up|0|||
129904158|NCT05174013|467610984|FG000|Overall Study|Withdrawal by Subject|0|||
129904159|NCT05174013|467610985|FG001|Overall Study|Withdrawal by Subject|0|||
129904160|NCT05174013|467610986|FG002|Overall Study|Withdrawal by Subject|1|||
129904161|NCT05174013|467610987|FG003|Overall Study|Withdrawal by Subject|0|||
129904162|NCT05174013|467610988|FG004|Overall Study|Withdrawal by Subject|0|||
129904163|NCT05174013|467610989|FG005|Overall Study|Withdrawal by Subject|0|||
129904164|NCT01930045|467610990|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904165|NCT01930045|467610991|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904166|NCT01930045|467610992|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904167|NCT01930045|467610993|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904168|NCT01930045|467610994|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
129904169|NCT01930045|467610995|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
129904170|NCT01930045|467610990|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
129904171|NCT01930045|467610991|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
129904172|NCT01930045|467610992|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
129904173|NCT01930045|467610993|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
129904174|NCT01930045|467610994|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
129904175|NCT01930045|467610995|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
129904176|NCT01924767|467610996|FG000|Overall Study|Adverse Event|1|||
129904177|NCT01924767|467610997|FG001|Overall Study|Adverse Event|0|||
129904178|NCT01924767|467610998|FG002|Overall Study|Adverse Event|1|||
129904179|NCT01924767|467610999|FG003|Overall Study|Adverse Event|0|||
129904180|NCT01924767|467611000|FG004|Overall Study|Adverse Event|0|||
129904181|NCT01194154|467611003|FG000|Overall Study|Adverse Event|12|||
129904182|NCT01194154|467611004|FG001|Overall Study|Adverse Event|7|||
129904183|NCT01194154|467611003|FG000|Overall Study|Lost to Follow-up|2|||
129904184|NCT01194154|467611004|FG001|Overall Study|Lost to Follow-up|3|||
129904185|NCT01194154|467611003|FG000|Overall Study|Protocol Violation|0|||
129904186|NCT01194154|467611004|FG001|Overall Study|Protocol Violation|1|||
129904187|NCT01194154|467611003|FG000|Overall Study|Withdrawal by Subject|5|||
129904188|NCT01194154|467611004|FG001|Overall Study|Withdrawal by Subject|6|||
129904189|NCT01194154|467611003|FG000|Overall Study|Blood pressure increase|5|||
129904190|NCT01194154|467611004|FG001|Overall Study|Blood pressure increase|3|||
129904191|NCT01194154|467611003|FG000|Overall Study|Hemoglobin decrease|0|||
129904192|NCT01194154|467611004|FG001|Overall Study|Hemoglobin decrease|1|||
129904193|NCT01194154|467611003|FG000|Overall Study|Hemoglobin increase|12|||
129904194|NCT01194154|467611004|FG001|Overall Study|Hemoglobin increase|3|||
129904195|NCT01194154|467611003|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
129904196|NCT01194154|467611004|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
129904197|NCT01194154|467611003|FG000|Overall Study|Treatment with prohibited medication|4|||
129904198|NCT01194154|467611004|FG001|Overall Study|Treatment with prohibited medication|5|||
129904199|NCT01194154|467611003|FG000|Overall Study|Other|4|||
129904200|NCT01194154|467611004|FG001|Overall Study|Other|0|||
129904201|NCT01194154|467611003|FG000|Overall Study|Did not receive study medication|2|||
129904202|NCT01194154|467611004|FG001|Overall Study|Did not receive study medication|4|||
129904203|NCT02314117|467611005|FG000|Overall Study|Lost to Follow-up|9|||
129904204|NCT02314117|467611006|FG001|Overall Study|Lost to Follow-up|14|||
129904205|NCT02314117|467611005|FG000|Overall Study|Withdrawal by Subject|3|||
129904206|NCT02314117|467611006|FG001|Overall Study|Withdrawal by Subject|2|||
129904207|NCT00880048|467611010|FG000|Overall Study|Adverse Event|2|||
129904208|NCT00880048|467611011|FG001|Overall Study|Adverse Event|3|||
129849930|NCT01649856|467410722|FG000|Overall Study|Stable or Progressed Disease|5|||
129849931|NCT01649856|467410723|FG001|Overall Study|Stable or Progressed Disease|3|||
129849932|NCT01649856|467410722|FG000|Overall Study|Lost to Follow-up|20|||
129849933|NCT01649856|467410723|FG001|Overall Study|Lost to Follow-up|16|||
129849934|NCT01649856|467410722|FG000|Overall Study|Lack of Compliance|6|||
129849935|NCT01649856|467410723|FG001|Overall Study|Lack of Compliance|1|||
129849936|NCT01649856|467410722|FG000|Overall Study|Other|20|||
129849937|NCT01649856|467410723|FG001|Overall Study|Other|5|||
129849938|NCT00622635|467410724|FG000|Treatment Period 1|Adverse Event|0|||
129849939|NCT00622635|467410725|FG001|Treatment Period 1|Adverse Event|0|||
129849940|NCT00622635|467410726|FG002|Treatment Period 1|Adverse Event|1|||
129849941|NCT00622635|467410727|FG003|Treatment Period 1|Adverse Event|0|||
129849942|NCT00622635|467410728|FG004|Treatment Period 1|Adverse Event|0|||
129849943|NCT00622635|467410729|FG005|Treatment Period 1|Adverse Event|0|||
129849944|NCT00622635|467410724|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129849945|NCT00622635|467410725|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129849946|NCT00622635|467410726|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129849947|NCT00622635|467410727|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129849948|NCT00622635|467410728|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129849949|NCT00622635|467410729|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129849950|NCT00622635|467410724|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849951|NCT00622635|467410725|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849952|NCT00622635|467410726|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849953|NCT00622635|467410727|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849954|NCT00622635|467410728|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
129849955|NCT00622635|467410729|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
129849956|NCT00622635|467410724|FG000|Treatment Period 2|Adverse Event|1|||
129849957|NCT00622635|467410725|FG001|Treatment Period 2|Adverse Event|0|||
129849958|NCT00622635|467410726|FG002|Treatment Period 2|Adverse Event|0|||
129849959|NCT00622635|467410727|FG003|Treatment Period 2|Adverse Event|0|||
129849960|NCT00622635|467410728|FG004|Treatment Period 2|Adverse Event|0|||
129849961|NCT00622635|467410729|FG005|Treatment Period 2|Adverse Event|0|||
129849962|NCT00622635|467410724|FG000|Treatment Period 3|Adverse Event|0|||
129849963|NCT00622635|467410725|FG001|Treatment Period 3|Adverse Event|0|||
129849964|NCT00622635|467410726|FG002|Treatment Period 3|Adverse Event|0|||
129849965|NCT00622635|467410727|FG003|Treatment Period 3|Adverse Event|2|||
129849966|NCT00622635|467410728|FG004|Treatment Period 3|Adverse Event|0|||
129849967|NCT00622635|467410729|FG005|Treatment Period 3|Adverse Event|0|||
129849968|NCT00622635|467410724|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129849969|NCT00622635|467410725|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129849970|NCT00622635|467410726|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129849971|NCT00622635|467410727|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129849972|NCT00622635|467410728|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129849973|NCT00622635|467410729|FG005|Treatment Period 3|Withdrawal by Subject|0|||
129849974|NCT03027466|467410734|FG000|Overall Study|Opting out of the app|1869|||
129849975|NCT03027466|467410735|FG001|Overall Study|Opting out of the app|1819|||
129849976|NCT03027466|467410736|FG002|Overall Study|Opting out of the app|1743|||
129849977|NCT03027466|467410737|FG003|Overall Study|Opting out of the app|1821|||
129849978|NCT03062891|467410747|FG000|Overall Study|Withdrawal by Subject|2|||
129849979|NCT03062891|467410748|FG001|Overall Study|Withdrawal by Subject|0|||
129849980|NCT03062891|467410747|FG000|Overall Study|Lost to Follow-up|50|||
129849981|NCT03062891|467410748|FG001|Overall Study|Lost to Follow-up|38|||
129849982|NCT01687166|467410749|FG000|Overall Study|Attempt subject|2|||
129849983|NCT01687166|467410750|FG001|Overall Study|Attempt subject|3|||
129849984|NCT01687166|467410751|FG002|Overall Study|Attempt subject|2|||
129849985|NCT01687166|467410752|FG003|Overall Study|Attempt subject|0|||
129849986|NCT01687166|467410749|FG000|Overall Study|Did not meet eligibility criteria|4|||
129849987|NCT01687166|467410750|FG001|Overall Study|Did not meet eligibility criteria|6|||
129849988|NCT01687166|467410751|FG002|Overall Study|Did not meet eligibility criteria|1|||
129849989|NCT01687166|467410752|FG003|Overall Study|Did not meet eligibility criteria|1|||
129849990|NCT01687166|467410749|FG000|Overall Study|Adverse Event|2|||
129849991|NCT01687166|467410750|FG001|Overall Study|Adverse Event|1|||
129849992|NCT01687166|467410751|FG002|Overall Study|Adverse Event|0|||
129849993|NCT01687166|467410752|FG003|Overall Study|Adverse Event|0|||
129849994|NCT01687166|467410749|FG000|Overall Study|Physician Decision|3|||
129849995|NCT01687166|467410750|FG001|Overall Study|Physician Decision|2|||
129849996|NCT01687166|467410751|FG002|Overall Study|Physician Decision|1|||
129849997|NCT01687166|467410752|FG003|Overall Study|Physician Decision|0|||
129849998|NCT01687166|467410749|FG000|Overall Study|Withdrawal by Subject|11|||
129904209|NCT00880048|467611012|FG002|Overall Study|Adverse Event|5|||
129849999|NCT01687166|467410750|FG001|Overall Study|Withdrawal by Subject|4|||
129850000|NCT01687166|467410751|FG002|Overall Study|Withdrawal by Subject|3|||
129850001|NCT01687166|467410752|FG003|Overall Study|Withdrawal by Subject|0|||
129850002|NCT01687166|467410749|FG000|Overall Study|Lost to Follow-up|2|||
129850003|NCT01687166|467410750|FG001|Overall Study|Lost to Follow-up|5|||
129850004|NCT01687166|467410751|FG002|Overall Study|Lost to Follow-up|1|||
129850005|NCT01687166|467410752|FG003|Overall Study|Lost to Follow-up|0|||
129904210|NCT00880048|467611010|FG000|Overall Study|Lack of Efficacy|1|||
129904211|NCT00880048|467611011|FG001|Overall Study|Lack of Efficacy|2|||
129904212|NCT00880048|467611012|FG002|Overall Study|Lack of Efficacy|2|||
129904213|NCT00880048|467611010|FG000|Overall Study|Protocol Violation|4|||
129904214|NCT00880048|467611011|FG001|Overall Study|Protocol Violation|6|||
129904215|NCT00880048|467611012|FG002|Overall Study|Protocol Violation|5|||
129904216|NCT00880048|467611010|FG000|Overall Study|Lost to Follow-up|6|||
129904217|NCT00880048|467611011|FG001|Overall Study|Lost to Follow-up|6|||
129904218|NCT00880048|467611012|FG002|Overall Study|Lost to Follow-up|5|||
129904219|NCT00880048|467611010|FG000|Overall Study|Physician Decision|1|||
129904220|NCT00880048|467611011|FG001|Overall Study|Physician Decision|1|||
129904221|NCT00880048|467611012|FG002|Overall Study|Physician Decision|7|||
129904222|NCT00880048|467611010|FG000|Overall Study|Withdrawal by Subject|5|||
129904223|NCT00880048|467611011|FG001|Overall Study|Withdrawal by Subject|8|||
129904224|NCT00880048|467611012|FG002|Overall Study|Withdrawal by Subject|5|||
129904225|NCT00880048|467611010|FG000|Overall Study|Study closed/terminated|9|||
129904226|NCT00880048|467611011|FG001|Overall Study|Study closed/terminated|7|||
129904227|NCT00880048|467611012|FG002|Overall Study|Study closed/terminated|6|||
129904228|NCT02954848|467611017|FG000|Overall Study|Randomized but Not Treated|0|||
129904229|NCT02954848|467611018|FG001|Overall Study|Randomized but Not Treated|1|||
129904230|NCT02954848|467611017|FG000|Overall Study|Adverse Event|2|||
129904231|NCT02954848|467611018|FG001|Overall Study|Adverse Event|3|||
129904232|NCT02954848|467611017|FG000|Overall Study|Withdrawal by Participant|0|||
129904233|NCT02954848|467611018|FG001|Overall Study|Withdrawal by Participant|1|||
129904234|NCT01184508|467611019|FG000|Overall Study|Adverse Event|4|||
129904235|NCT01184508|467611020|FG001|Overall Study|Adverse Event|6|||
129904236|NCT01184508|467611019|FG000|Overall Study|Lack of Efficacy|1|||
129904237|NCT01184508|467611020|FG001|Overall Study|Lack of Efficacy|1|||
129904238|NCT01184508|467611019|FG000|Overall Study|Lost to Follow-up|1|||
129904239|NCT01184508|467611020|FG001|Overall Study|Lost to Follow-up|1|||
129904240|NCT01184508|467611019|FG000|Overall Study|Physician Decision|1|||
129904241|NCT01184508|467611020|FG001|Overall Study|Physician Decision|0|||
129904242|NCT01184508|467611019|FG000|Overall Study|Protocol Violation|3|||
129904243|NCT01184508|467611020|FG001|Overall Study|Protocol Violation|1|||
129904244|NCT01184508|467611019|FG000|Overall Study|Sponsor Decision|5|||
129904245|NCT01184508|467611020|FG001|Overall Study|Sponsor Decision|2|||
129904246|NCT01184508|467611019|FG000|Overall Study|Withdrawal by Subject|1|||
129904247|NCT01184508|467611020|FG001|Overall Study|Withdrawal by Subject|3|||
129904248|NCT01184508|467611019|FG000|Overall Study|Randomized, Not Treated|0|||
129904249|NCT01184508|467611020|FG001|Overall Study|Randomized, Not Treated|1|||
129904250|NCT02798835|467611026|FG000|Overall Study|Protocol Violation|0|||
129904251|NCT02798835|467611027|FG001|Overall Study|Protocol Violation|0|||
129904252|NCT02798835|467611028|FG002|Overall Study|Protocol Violation|3|||
129904253|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
129904254|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
129904255|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
129904256|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
129904257|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
129904258|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
129904259|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
129904260|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
129904261|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
129904262|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904263|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904264|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904265|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
129904266|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
129904267|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
129904268|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904269|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904270|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
129904271|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904272|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904273|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904274|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904275|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904276|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904277|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904278|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
129904279|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
129904280|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
129904281|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
129904282|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
129904283|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
129904284|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
129904285|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
129904286|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
129904287|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
129904288|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904289|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904290|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904291|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
129904292|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904293|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
129904294|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
129904295|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129850006|NCT01687166|467410749|FG000|Overall Study|Equipment/Device Availability|0|||
129850007|NCT01687166|467410750|FG001|Overall Study|Equipment/Device Availability|1|||
129850008|NCT01687166|467410751|FG002|Overall Study|Equipment/Device Availability|0|||
129850009|NCT01687166|467410752|FG003|Overall Study|Equipment/Device Availability|0|||
129850010|NCT01687166|467410749|FG000|Overall Study|Death|1|||
129850011|NCT01687166|467410750|FG001|Overall Study|Death|1|||
129904296|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
129904297|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904298|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904299|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904300|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904301|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904302|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904303|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904304|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
129904305|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904306|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
129904307|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904308|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904309|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
129904310|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904311|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904312|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904313|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
129904314|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904315|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129850012|NCT01687166|467410751|FG002|Overall Study|Death|0|||
129850013|NCT01687166|467410752|FG003|Overall Study|Death|0|||
129850014|NCT01687166|467410749|FG000|Overall Study|Protocol Violation|1|||
129850015|NCT01687166|467410750|FG001|Overall Study|Protocol Violation|1|||
129850016|NCT01687166|467410751|FG002|Overall Study|Protocol Violation|1|||
129850017|NCT01687166|467410752|FG003|Overall Study|Protocol Violation|0|||
129850018|NCT01687166|467410749|FG000|Overall Study|Subject moved out of state|0|||
129850019|NCT01687166|467410750|FG001|Overall Study|Subject moved out of state|1|||
129850020|NCT01687166|467410751|FG002|Overall Study|Subject moved out of state|0|||
129850021|NCT01687166|467410752|FG003|Overall Study|Subject moved out of state|0|||
129850022|NCT01687166|467410749|FG000|Overall Study|Patient unable to be compliant|1|||
129850023|NCT01687166|467410750|FG001|Overall Study|Patient unable to be compliant|0|||
129850024|NCT01687166|467410751|FG002|Overall Study|Patient unable to be compliant|0|||
129850025|NCT01687166|467410752|FG003|Overall Study|Patient unable to be compliant|0|||
129850026|NCT01687166|467410749|FG000|Overall Study|Physician choice to use different device|1|||
129850027|NCT01687166|467410750|FG001|Overall Study|Physician choice to use different device|2|||
129850028|NCT01687166|467410751|FG002|Overall Study|Physician choice to use different device|4|||
129850029|NCT01687166|467410752|FG003|Overall Study|Physician choice to use different device|0|||
129850030|NCT01687166|467410749|FG000|Overall Study|Insurance|0|||
129850031|NCT01687166|467410750|FG001|Overall Study|Insurance|0|||
129850032|NCT01687166|467410751|FG002|Overall Study|Insurance|1|||
129850033|NCT01687166|467410752|FG003|Overall Study|Insurance|1|||
129904316|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904317|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
129904318|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
129850034|NCT01516879|467410753|FG000|Overall Study|Withdrawal by Subject|9|||
129904319|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129850035|NCT01516879|467410754|FG001|Overall Study|Withdrawal by Subject|11|||
129850036|NCT01516879|467410753|FG000|Overall Study|Death|0|||
129850037|NCT01516879|467410754|FG001|Overall Study|Death|2|||
129850038|NCT01516879|467410753|FG000|Overall Study|Lost to Follow-up|2|||
129850039|NCT01516879|467410754|FG001|Overall Study|Lost to Follow-up|11|||
129850040|NCT01516879|467410753|FG000|Overall Study|Other|5|||
129850041|NCT01516879|467410754|FG001|Overall Study|Other|10|||
129850042|NCT01600586|467410755|FG000|Overall Study|Physician Decision|3|||
129850043|NCT01600586|467410756|FG001|Overall Study|Physician Decision|3|||
129850044|NCT01898793|467410757|FG000|Overall Study|Death|2|||
129850045|NCT01898793|467410758|FG001|Overall Study|Death|1|||
129850046|NCT01898793|467410759|FG002|Overall Study|Death|4|||
129850047|NCT01898793|467410760|FG003|Overall Study|Death|0|||
129850048|NCT01898793|467410761|FG004|Overall Study|Death|0|||
129850049|NCT01898793|467410762|FG005|Overall Study|Death|0|||
129850050|NCT01898793|467410763|FG006|Overall Study|Death|0|||
129850051|NCT00931307|467410764|FG000|Overall Study|Lack of Efficacy|12|||
129850052|NCT00931307|467410764|FG000|Overall Study|Biomicroscopy|1|||
129850053|NCT02447991|467410767|FG000|Overall Study|Withdrawn by subject - no data|0|||
129850054|NCT02447991|467410768|FG001|Overall Study|Withdrawn by subject - no data|2|||
129850055|NCT02447991|467410767|FG000|Overall Study|Withdrawn by Subject - with data|4|||
129850056|NCT02447991|467410768|FG001|Overall Study|Withdrawn by Subject - with data|4|||
129850057|NCT02447991|467410767|FG000|Overall Study|Lost to Follow-up - no data|3|||
129850058|NCT02447991|467410768|FG001|Overall Study|Lost to Follow-up - no data|6|||
129850059|NCT02447991|467410767|FG000|Overall Study|Lost to follow-up - with data|0|||
129850060|NCT02447991|467410768|FG001|Overall Study|Lost to follow-up - with data|3|||
129850061|NCT02447991|467410767|FG000|Overall Study|End of study - no treatment results|3|||
129850062|NCT02447991|467410768|FG001|Overall Study|End of study - no treatment results|6|||
129850063|NCT02447991|467410767|FG000|Overall Study|End of study - partial treatment results|0|||
129850064|NCT02447991|467410768|FG001|Overall Study|End of study - partial treatment results|9|||
129850065|NCT00459134|467410769|FG000|Overall Study|Physician Decision|1|||
129850066|NCT00459134|467410770|FG001|Overall Study|Physician Decision|1|||
129850067|NCT00459134|467410769|FG000|Overall Study|Withdrawal by Subject|8|||
129850068|NCT00459134|467410770|FG001|Overall Study|Withdrawal by Subject|7|||
129850069|NCT00459134|467410769|FG000|Overall Study|Lost to Follow-up|6|||
129850070|NCT00459134|467410770|FG001|Overall Study|Lost to Follow-up|7|||
129850071|NCT00459134|467410769|FG000|Overall Study|Surgery|1|||
129850072|NCT00459134|467410770|FG001|Overall Study|Surgery|2|||
129850073|NCT00459134|467410769|FG000|Overall Study|Toxicity|4|||
129850074|NCT00459134|467410770|FG001|Overall Study|Toxicity|5|||
129850075|NCT00459134|467410769|FG000|Overall Study|Progression|1|||
129850076|NCT00459134|467410770|FG001|Overall Study|Progression|0|||
129850077|NCT00459134|467410769|FG000|Overall Study|Multiple Reasons|2|||
129850078|NCT00459134|467410770|FG001|Overall Study|Multiple Reasons|3|||
129850079|NCT00829621|467410771|FG000|Overall Study|Death|1|||
129850080|NCT00829621|467410772|FG001|Overall Study|Death|0|||
129850081|NCT00829621|467410771|FG000|Overall Study|Lost to Follow-up|3|||
129850082|NCT00829621|467410772|FG001|Overall Study|Lost to Follow-up|4|||
129850083|NCT00774995|467410773|FG000|Overall Study|Protocol Violation|0|||
129850084|NCT00774995|467410774|FG001|Overall Study|Protocol Violation|0|||
129850085|NCT00774995|467410775|FG002|Overall Study|Protocol Violation|1|||
129850086|NCT00774995|467410776|FG003|Overall Study|Protocol Violation|0|||
129850087|NCT00441337|467410780|FG000|Overall Study|Disease Progression|6|||
129850088|NCT00441337|467410781|FG001|Overall Study|Disease Progression|6|||
129850089|NCT00441337|467410782|FG002|Overall Study|Disease Progression|4|||
129850090|NCT00441337|467410783|FG003|Overall Study|Disease Progression|18|||
129850091|NCT00441337|467410780|FG000|Overall Study|Lost to Follow-up|0|||
129850092|NCT00441337|467410781|FG001|Overall Study|Lost to Follow-up|0|||
129850093|NCT00441337|467410782|FG002|Overall Study|Lost to Follow-up|0|||
129850094|NCT00441337|467410783|FG003|Overall Study|Lost to Follow-up|1|||
129850095|NCT00441337|467410780|FG000|Overall Study|Sponsor Decision|0|||
129850096|NCT00441337|467410781|FG001|Overall Study|Sponsor Decision|0|||
129850097|NCT00441337|467410782|FG002|Overall Study|Sponsor Decision|1|||
129850098|NCT00441337|467410783|FG003|Overall Study|Sponsor Decision|2|||
129850099|NCT00441337|467410780|FG000|Overall Study|Did not meet inclusion criteria|0|||
129850100|NCT00441337|467410781|FG001|Overall Study|Did not meet inclusion criteria|0|||
129850101|NCT00441337|467410782|FG002|Overall Study|Did not meet inclusion criteria|1|||
129850102|NCT00441337|467410783|FG003|Overall Study|Did not meet inclusion criteria|0|||
129850103|NCT02066298|467412338|FG000|Overall Study|Lost to Follow-up|3|||
129850104|NCT02066298|467412339|FG001|Overall Study|Lost to Follow-up|2|||
129850105|NCT02066298|467412340|FG002|Overall Study|Lost to Follow-up|3|||
129850106|NCT02066298|467412341|FG003|Overall Study|Lost to Follow-up|2|||
129850107|NCT02066298|467412342|FG004|Overall Study|Lost to Follow-up|3|||
129850108|NCT02066298|467412343|FG005|Overall Study|Lost to Follow-up|4|||
129904320|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129850109|NCT02066298|467412338|FG000|Overall Study|Withdrawal by Subject|6|||
129850110|NCT02066298|467412339|FG001|Overall Study|Withdrawal by Subject|6|||
129850111|NCT02066298|467412340|FG002|Overall Study|Withdrawal by Subject|6|||
129850112|NCT02066298|467412341|FG003|Overall Study|Withdrawal by Subject|4|||
129850113|NCT02066298|467412342|FG004|Overall Study|Withdrawal by Subject|5|||
129850114|NCT02066298|467412343|FG005|Overall Study|Withdrawal by Subject|8|||
129850115|NCT02066298|467412338|FG000|Overall Study|Physician Decision|0|||
129850116|NCT02066298|467412339|FG001|Overall Study|Physician Decision|0|||
129904321|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129850117|NCT02066298|467412340|FG002|Overall Study|Physician Decision|1|||
129904322|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904323|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
129904324|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
129904325|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
129904326|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904327|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904328|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904329|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904330|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
129904331|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
129904332|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
129904333|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
129904334|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
129904335|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
129904336|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
129904337|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
129904338|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
129904339|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
129904340|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904341|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904342|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904343|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
129904344|NCT04707313|467611039|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904345|NCT04707313|467611040|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904346|NCT04707313|467611041|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
129904347|NCT04707313|467611042|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904348|NCT04707313|467611043|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904349|NCT04707313|467611044|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904350|NCT04707313|467611045|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904351|NCT04707313|467611046|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
129904352|NCT04707313|467611047|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904353|NCT04707313|467611048|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904354|NCT04707313|467611049|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904355|NCT04707313|467611050|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904356|NCT04707313|467611051|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
129904357|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904358|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904359|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904360|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904361|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904362|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904363|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904364|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904365|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904366|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
129904367|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
129904368|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
129904369|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
129904370|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904371|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904372|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904373|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904374|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904375|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904376|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904377|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904378|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904379|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
129904380|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
129904381|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
129904382|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
129904383|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904384|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904385|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904386|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904387|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904388|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904389|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129850118|NCT02066298|467412341|FG003|Overall Study|Physician Decision|0|||
129850119|NCT02066298|467412342|FG004|Overall Study|Physician Decision|1|||
129850120|NCT02066298|467412343|FG005|Overall Study|Physician Decision|0|||
129850121|NCT03143829|467412344|FG000|Overall Study|Withdrawal by Subject|2|||
129850122|NCT03143829|467412345|FG001|Overall Study|Withdrawal by Subject|5|||
129850123|NCT03143829|467412344|FG000|Overall Study|Lost to Follow-up|0|||
129850124|NCT03143829|467412345|FG001|Overall Study|Lost to Follow-up|2|||
129850125|NCT03143829|467412344|FG000|Overall Study|Death|1|||
129850126|NCT03143829|467412345|FG001|Overall Study|Death|1|||
129850127|NCT03143829|467412344|FG000|Overall Study|changed treatment, no longer eligible|2|||
129850128|NCT03143829|467412345|FG001|Overall Study|changed treatment, no longer eligible|2|||
129850129|NCT00672477|467412346|FG000|Overall Study|Adverse Event|10|||
129850130|NCT00672477|467412347|FG001|Overall Study|Adverse Event|7|||
129850131|NCT00672477|467412346|FG000|Overall Study|Death|7|||
129850132|NCT00672477|467412347|FG001|Overall Study|Death|11|||
129850133|NCT00672477|467412346|FG000|Overall Study|Physician Decision|2|||
129850134|NCT00672477|467412347|FG001|Overall Study|Physician Decision|0|||
129850135|NCT00672477|467412346|FG000|Overall Study|Protocol Violation|1|||
129850136|NCT00672477|467412347|FG001|Overall Study|Protocol Violation|1|||
129850137|NCT00672477|467412346|FG000|Overall Study|Withdrawal by Subject|5|||
129850138|NCT00672477|467412347|FG001|Overall Study|Withdrawal by Subject|3|||
129850139|NCT00672477|467412346|FG000|Overall Study|Lack of Efficacy|1|||
129850140|NCT00672477|467412347|FG001|Overall Study|Lack of Efficacy|1|||
129850141|NCT00672477|467412346|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
129850142|NCT00672477|467412347|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
129850143|NCT02348489|467412350|FG000|Overall Study|Death|336|||
129850144|NCT02348489|467412351|FG001|Overall Study|Death|335|||
129850145|NCT02348489|467412350|FG000|Overall Study|Withdrawal by Subject|14|||
129850146|NCT02348489|467412351|FG001|Overall Study|Withdrawal by Subject|27|||
129850147|NCT02348489|467412350|FG000|Overall Study|Lost to Follow-up|3|||
129850148|NCT02348489|467412351|FG001|Overall Study|Lost to Follow-up|5|||
129850149|NCT02866682|467412352|FG000|Overall Study|Death|0|||
129850150|NCT02866682|467412353|FG001|Overall Study|Death|1|||
129850151|NCT02866682|467412352|FG000|Overall Study|Lost to Follow-up|0|||
129850152|NCT02866682|467412353|FG001|Overall Study|Lost to Follow-up|4|||
129850153|NCT02866682|467412352|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
129850154|NCT02866682|467412353|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
129850155|NCT02866682|467412352|FG000|Overall Study|Other|0|||
129850156|NCT02866682|467412353|FG001|Overall Study|Other|1|||
129850157|NCT01750268|467412355|FG000|Overall Study|Lost to Follow-up|0|||
129850158|NCT01750268|467412356|FG001|Overall Study|Lost to Follow-up|2|||
129850159|NCT01750268|467412355|FG000|Overall Study|Physician Decision|0|||
129850160|NCT01750268|467412356|FG001|Overall Study|Physician Decision|3|||
129850161|NCT01750268|467412355|FG000|Overall Study|Withdrawal by Subject|2|||
129850162|NCT01750268|467412356|FG001|Overall Study|Withdrawal by Subject|0|||
129850163|NCT03087591|467412359|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
129850164|NCT03087591|467412359|FG000|Overall Study|Withdrawal by Subject|1|||
129850165|NCT02621606|467412362|FG000|Overall Study|Withdrawal by Subject|0|||
129850166|NCT02621606|467412363|FG001|Overall Study|Withdrawal by Subject|1|||
129850167|NCT02621606|467412364|FG002|Overall Study|Withdrawal by Subject|0|||
129850168|NCT00274716|467412365|FG000|Phase A|Other non-reported reason|4|||
129850169|NCT00274716|467412366|FG001|Phase A|Other non-reported reason|2|||
129850170|NCT00274716|467412367|FG002|Phase A|Other non-reported reason|1|||
129850171|NCT00274716|467412368|FG003|Phase A|Other non-reported reason|2|||
129850172|NCT00274716|467412369|FG004|Phase A|Other non-reported reason|0|||
129850173|NCT00274716|467412370|FG005|Phase A|Other non-reported reason|1|||
129850174|NCT00274716|467412365|FG000|Phase A|Participant moved|0|||
129850175|NCT00274716|467412366|FG001|Phase A|Participant moved|0|||
129850176|NCT00274716|467412367|FG002|Phase A|Participant moved|1|||
129850177|NCT00274716|467412368|FG003|Phase A|Participant moved|0|||
129850178|NCT00274716|467412369|FG004|Phase A|Participant moved|0|||
129850179|NCT00274716|467412370|FG005|Phase A|Participant moved|1|||
129850180|NCT00274716|467412365|FG000|Phase A|Site Terminated|0|||
129850181|NCT00274716|467412366|FG001|Phase A|Site Terminated|0|||
129850182|NCT00274716|467412367|FG002|Phase A|Site Terminated|0|||
129850183|NCT00274716|467412368|FG003|Phase A|Site Terminated|1|||
129850184|NCT00274716|467412369|FG004|Phase A|Site Terminated|0|||
129850185|NCT00274716|467412370|FG005|Phase A|Site Terminated|0|||
129850186|NCT00274716|467412365|FG000|Phase A|Protocol Violation|1|||
129850187|NCT00274716|467412366|FG001|Phase A|Protocol Violation|0|||
129850188|NCT00274716|467412367|FG002|Phase A|Protocol Violation|0|||
129850189|NCT00274716|467412368|FG003|Phase A|Protocol Violation|1|||
129850190|NCT00274716|467412369|FG004|Phase A|Protocol Violation|0|||
129850191|NCT00274716|467412370|FG005|Phase A|Protocol Violation|0|||
129850192|NCT00274716|467412365|FG000|Phase A|Met criteria for discontinuation|1|||
129850193|NCT00274716|467412366|FG001|Phase A|Met criteria for discontinuation|1|||
129850194|NCT00274716|467412367|FG002|Phase A|Met criteria for discontinuation|0|||
129850195|NCT00274716|467412368|FG003|Phase A|Met criteria for discontinuation|0|||
129850196|NCT00274716|467412369|FG004|Phase A|Met criteria for discontinuation|0|||
129850197|NCT00274716|467412370|FG005|Phase A|Met criteria for discontinuation|0|||
129904390|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904391|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
129904392|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
129904393|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
129904394|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
129904395|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
129904396|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904397|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904398|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904399|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904400|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904401|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904402|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904403|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904404|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904405|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904406|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
129904407|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
129904408|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
129904409|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904410|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904411|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904412|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904413|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904414|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904415|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904416|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904417|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904418|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
129904419|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
129904420|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904421|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
129904422|NCT04707313|467611039|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904423|NCT04707313|467611040|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904424|NCT04707313|467611041|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904425|NCT04707313|467611042|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904426|NCT04707313|467611043|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904427|NCT04707313|467611044|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904428|NCT04707313|467611045|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904429|NCT04707313|467611046|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904430|NCT04707313|467611047|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
129904431|NCT04707313|467611048|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
129904432|NCT04707313|467611049|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
129904433|NCT04707313|467611050|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
129904434|NCT04707313|467611051|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
129904435|NCT00324038|467611055|FG000|Overall Study|Adverse Event|38|||
129904436|NCT00324038|467611056|FG001|Overall Study|Adverse Event|23|||
129904437|NCT00324038|467611055|FG000|Overall Study|Lack of Efficacy|5|||
129904438|NCT00324038|467611056|FG001|Overall Study|Lack of Efficacy|13|||
129904439|NCT00324038|467611055|FG000|Overall Study|Lost to Follow-up|0|||
129904440|NCT00324038|467611056|FG001|Overall Study|Lost to Follow-up|2|||
129904441|NCT00324038|467611055|FG000|Overall Study|Other|6|||
129904442|NCT00324038|467611056|FG001|Overall Study|Other|13|||
129904443|NCT03070483|467611057|FG000|Overall Study|Lost to Follow-up|2|||
129904444|NCT01585558|467611059|FG000|Overall Study|Withdrawal by Subject|4|||
129904445|NCT01585558|467611060|FG001|Overall Study|Withdrawal by Subject|5|||
129904446|NCT01585558|467611061|FG002|Overall Study|Withdrawal by Subject|8|||
129904447|NCT01585558|467611059|FG000|Overall Study|Lost to Follow-up|2|||
129904448|NCT01585558|467611060|FG001|Overall Study|Lost to Follow-up|0|||
129904449|NCT01585558|467611061|FG002|Overall Study|Lost to Follow-up|3|||
129904450|NCT01585558|467611059|FG000|Overall Study|Adverse Event|3|||
129904451|NCT01585558|467611060|FG001|Overall Study|Adverse Event|4|||
129904452|NCT01585558|467611061|FG002|Overall Study|Adverse Event|1|||
129904453|NCT01585558|467611059|FG000|Overall Study|Protocol Violation|4|||
129904454|NCT01585558|467611060|FG001|Overall Study|Protocol Violation|3|||
129904455|NCT01585558|467611061|FG002|Overall Study|Protocol Violation|2|||
129904456|NCT01585558|467611059|FG000|Overall Study|Lack of Efficacy|0|||
129904457|NCT01585558|467611060|FG001|Overall Study|Lack of Efficacy|0|||
129904458|NCT01585558|467611061|FG002|Overall Study|Lack of Efficacy|1|||
129904459|NCT00841035|467611062|FG000|Phase 1 Overall Study|Physician Decision|13|||
129904460|NCT01390402|467611077|FG000|Overall Study|Death|1|||
129904461|NCT01390402|467611077|FG000|Overall Study|Disease Progression|4|||
129904462|NCT02694978|467612832|FG000|Overall Study|Adverse Event|10|||
129904463|NCT02694978|467612833|FG001|Overall Study|Adverse Event|9|||
129904464|NCT02694978|467612832|FG000|Overall Study|Withdrawal by Subject|22|||
129904465|NCT02694978|467612833|FG001|Overall Study|Withdrawal by Subject|19|||
129904466|NCT02694978|467612832|FG000|Overall Study|Lost to Follow-up|14|||
129904467|NCT02694978|467612833|FG001|Overall Study|Lost to Follow-up|17|||
129904468|NCT02694978|467612832|FG000|Overall Study|Death|4|||
129904469|NCT02694978|467612833|FG001|Overall Study|Death|1|||
129904470|NCT02694978|467612832|FG000|Overall Study|Other-Decision of Participant|6|||
129904471|NCT02694978|467612833|FG001|Overall Study|Other-Decision of Participant|1|||
129904472|NCT02694978|467612832|FG000|Overall Study|Other-Investigator's decision|1|||
129904473|NCT02694978|467612833|FG001|Overall Study|Other-Investigator's decision|0|||
129904474|NCT02694978|467612832|FG000|Overall Study|Other-Unable to be reached|0|||
129904475|NCT02694978|467612833|FG001|Overall Study|Other-Unable to be reached|1|||
129904476|NCT02694978|467612832|FG000|Overall Study|Other-Protocol noncompliant|2|||
129904477|NCT02694978|467612833|FG001|Overall Study|Other-Protocol noncompliant|1|||
129904478|NCT02694978|467612832|FG000|Overall Study|Other-Personal reasons|3|||
129904479|NCT02694978|467612833|FG001|Overall Study|Other-Personal reasons|3|||
129904480|NCT02694978|467612832|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
129904481|NCT02694978|467612833|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
129904482|NCT00818454|467612834|FG000|Treatment Period 1|Adverse Event|0|||
129904483|NCT00818454|467612835|FG001|Treatment Period 1|Adverse Event|1|||
129904484|NCT00818454|467612836|FG002|Treatment Period 1|Adverse Event|0|||
129904485|NCT00818454|467612837|FG003|Treatment Period 1|Adverse Event|0|||
129904486|NCT00818454|467612834|FG000|Treatment Period 1|Other|3|||
129904487|NCT00818454|467612835|FG001|Treatment Period 1|Other|0|||
129904488|NCT00818454|467612836|FG002|Treatment Period 1|Other|0|||
129904489|NCT00818454|467612837|FG003|Treatment Period 1|Other|0|||
129904490|NCT00818454|467612834|FG000|Washout Period of 1 Week|Adverse Event|1|||
129904491|NCT00818454|467612835|FG001|Washout Period of 1 Week|Adverse Event|1|||
129904492|NCT00818454|467612836|FG002|Washout Period of 1 Week|Adverse Event|0|||
129904493|NCT00818454|467612837|FG003|Washout Period of 1 Week|Adverse Event|0|||
129904494|NCT00818454|467612834|FG000|Washout Period of 1 Week|Protocol Violation|2|||
129904495|NCT00818454|467612835|FG001|Washout Period of 1 Week|Protocol Violation|0|||
129904496|NCT00818454|467612836|FG002|Washout Period of 1 Week|Protocol Violation|0|||
129904497|NCT00818454|467612837|FG003|Washout Period of 1 Week|Protocol Violation|0|||
129904498|NCT00818454|467612834|FG000|Washout Period of 1 Week|Other|1|||
129904499|NCT00818454|467612835|FG001|Washout Period of 1 Week|Other|2|||
129904500|NCT00818454|467612836|FG002|Washout Period of 1 Week|Other|0|||
129904501|NCT00818454|467612837|FG003|Washout Period of 1 Week|Other|0|||
129904502|NCT00818454|467612834|FG000|Treatment Period 2|Other|2|||
129904503|NCT00818454|467612835|FG001|Treatment Period 2|Other|1|||
129904504|NCT00818454|467612836|FG002|Treatment Period 2|Other|0|||
129904505|NCT00818454|467612837|FG003|Treatment Period 2|Other|0|||
129904506|NCT00818454|467612834|FG000|Treatment Period 3|Adverse Event|0|||
129904507|NCT00818454|467612835|FG001|Treatment Period 3|Adverse Event|0|||
129904508|NCT00818454|467612836|FG002|Treatment Period 3|Adverse Event|0|||
129904509|NCT00818454|467612837|FG003|Treatment Period 3|Adverse Event|1|||
129904510|NCT02296424|467612839|FG000|Part 1|New therapy for study indication|0|||
129904511|NCT02296424|467612840|FG001|Part 1|New therapy for study indication|1|||
129904512|NCT02296424|467612841|FG002|Part 1|New therapy for study indication|0|||
129904513|NCT02296424|467612842|FG003|Part 1|New therapy for study indication|0|||
129904514|NCT02296424|467612839|FG000|Part 1|Protocol Violation|0|||
129904515|NCT02296424|467612840|FG001|Part 1|Protocol Violation|1|||
129904516|NCT02296424|467612841|FG002|Part 1|Protocol Violation|0|||
129904517|NCT02296424|467612842|FG003|Part 1|Protocol Violation|0|||
129904518|NCT02296424|467612839|FG000|Part 1|Withdrawal by Subject|0|||
129904519|NCT02296424|467612840|FG001|Part 1|Withdrawal by Subject|2|||
129904520|NCT02296424|467612841|FG002|Part 1|Withdrawal by Subject|0|||
129904521|NCT02296424|467612842|FG003|Part 1|Withdrawal by Subject|0|||
129904522|NCT02296424|467612839|FG000|Part 1|Study terminated by sponsor|0|||
129904523|NCT02296424|467612840|FG001|Part 1|Study terminated by sponsor|1|||
129904524|NCT02296424|467612841|FG002|Part 1|Study terminated by sponsor|0|||
129904525|NCT02296424|467612842|FG003|Part 1|Study terminated by sponsor|0|||
129904526|NCT02296424|467612839|FG000|Part 1|Adverse Event|2|||
129904527|NCT02296424|467612840|FG001|Part 1|Adverse Event|11|||
129904528|NCT02296424|467612841|FG002|Part 1|Adverse Event|0|||
129904529|NCT02296424|467612842|FG003|Part 1|Adverse Event|0|||
129904530|NCT02296424|467612839|FG000|Part 1|Lack of Efficacy|5|||
129904531|NCT02296424|467612840|FG001|Part 1|Lack of Efficacy|17|||
129904532|NCT02296424|467612841|FG002|Part 1|Lack of Efficacy|0|||
129904533|NCT02296424|467612842|FG003|Part 1|Lack of Efficacy|0|||
129904534|NCT02296424|467612839|FG000|Part 1|16 directly started part II|16|||
129904535|NCT02296424|467612840|FG001|Part 1|16 directly started part II|0|||
129904536|NCT02296424|467612841|FG002|Part 1|16 directly started part II|0|||
129904537|NCT02296424|467612842|FG003|Part 1|16 directly started part II|0|||
129904538|NCT02296424|467612839|FG000|Part 2|Lack of Efficacy|0|||
129904539|NCT02296424|467612840|FG001|Part 2|Lack of Efficacy|0|||
129904540|NCT02296424|467612841|FG002|Part 2|Lack of Efficacy|1|||
129904541|NCT02296424|467612842|FG003|Part 2|Lack of Efficacy|0|||
129904542|NCT02296424|467612839|FG000|Part 2|Adverse Event|0|||
129904543|NCT02296424|467612840|FG001|Part 2|Adverse Event|0|||
129904544|NCT02296424|467612841|FG002|Part 2|Adverse Event|1|||
129904545|NCT02296424|467612842|FG003|Part 2|Adverse Event|0|||
129904546|NCT02296424|467612839|FG000|Part 2|Lost to Follow-up|0|||
129904547|NCT02296424|467612840|FG001|Part 2|Lost to Follow-up|0|||
129904548|NCT02296424|467612841|FG002|Part 2|Lost to Follow-up|1|||
129904549|NCT02296424|467612842|FG003|Part 2|Lost to Follow-up|0|||
129904550|NCT00743444|467612843|FG000|First Intervention|Catheter placement problems|0|||
129904551|NCT00743444|467612844|FG001|First Intervention|Catheter placement problems|1|||
129904552|NCT00743444|467612843|FG000|Washout Period|Adverse Event|0|||
129904553|NCT00743444|467612844|FG001|Washout Period|Adverse Event|1|||
129904554|NCT00807144|467612847|FG000|Overall Study|Lost to Follow-up|0|||
129904555|NCT00807144|467612848|FG001|Overall Study|Lost to Follow-up|1|||
129904556|NCT00854906|467612851|FG000|Overall Study|One person had no ocular history|1|||
129904557|NCT00814346|467612852|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
129904558|NCT00814346|467612853|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
129904559|NCT00814346|467612852|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
129904560|NCT00814346|467612853|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
129904561|NCT00814346|467612852|FG000|Open Phase (17 Months)|Adverse Event|5|||
129904562|NCT00814346|467612853|FG001|Open Phase (17 Months)|Adverse Event|0|||
129904563|NCT00814346|467612852|FG000|Open Phase (17 Months)|Consent|2|||
129904564|NCT00814346|467612853|FG001|Open Phase (17 Months)|Consent|0|||
129904565|NCT00814346|467612852|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
129904566|NCT00814346|467612853|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
129904567|NCT00814346|467612852|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
129904568|NCT00814346|467612853|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
129904569|NCT03622580|467612854|FG000|Overall Study|Death|16|||
129904570|NCT03622580|467612855|FG001|Overall Study|Death|21|||
129904571|NCT03622580|467612856|FG002|Overall Study|Death|13|||
129904572|NCT03622580|467612854|FG000|Overall Study|Adverse Event|6|||
129904573|NCT03622580|467612855|FG001|Overall Study|Adverse Event|6|||
129904574|NCT03622580|467612856|FG002|Overall Study|Adverse Event|5|||
129904575|NCT03622580|467612854|FG000|Overall Study|Withdrawal by Subject|12|||
129904576|NCT03622580|467612855|FG001|Overall Study|Withdrawal by Subject|7|||
129904577|NCT03622580|467612856|FG002|Overall Study|Withdrawal by Subject|19|||
129904578|NCT03622580|467612854|FG000|Overall Study|Lost to Follow-up|12|||
129904579|NCT03622580|467612855|FG001|Overall Study|Lost to Follow-up|9|||
129904580|NCT03622580|467612856|FG002|Overall Study|Lost to Follow-up|9|||
129904581|NCT03622580|467612854|FG000|Overall Study|Protocol Violation|1|||
129904582|NCT03622580|467612855|FG001|Overall Study|Protocol Violation|0|||
129904583|NCT03622580|467612856|FG002|Overall Study|Protocol Violation|1|||
129904584|NCT03622580|467612854|FG000|Overall Study|Physician Decision|3|||
129904585|NCT03622580|467612855|FG001|Overall Study|Physician Decision|0|||
129904586|NCT03622580|467612856|FG002|Overall Study|Physician Decision|1|||
129904587|NCT03622580|467612854|FG000|Overall Study|Pregnancy|0|||
129904588|NCT03622580|467612855|FG001|Overall Study|Pregnancy|1|||
129904589|NCT03622580|467612856|FG002|Overall Study|Pregnancy|0|||
129904590|NCT03622580|467612854|FG000|Overall Study|Lack of Efficacy|0|||
129904591|NCT03622580|467612855|FG001|Overall Study|Lack of Efficacy|0|||
129904592|NCT03622580|467612856|FG002|Overall Study|Lack of Efficacy|1|||
129904593|NCT03622580|467612854|FG000|Overall Study|Other|2|||
129904594|NCT03622580|467612855|FG001|Overall Study|Other|0|||
129904595|NCT03622580|467612856|FG002|Overall Study|Other|3|||
129850198|NCT00274716|467412365|FG000|Phase A|Withdrawal by Subject|2|||
129850199|NCT00274716|467412366|FG001|Phase A|Withdrawal by Subject|2|||
129850200|NCT00274716|467412367|FG002|Phase A|Withdrawal by Subject|1|||
129850201|NCT00274716|467412368|FG003|Phase A|Withdrawal by Subject|3|||
129850202|NCT00274716|467412369|FG004|Phase A|Withdrawal by Subject|0|||
129850203|NCT00274716|467412370|FG005|Phase A|Withdrawal by Subject|1|||
129850204|NCT00274716|467412365|FG000|Phase A|Adverse Event|2|||
129850205|NCT00274716|467412366|FG001|Phase A|Adverse Event|3|||
129850206|NCT00274716|467412367|FG002|Phase A|Adverse Event|3|||
129850207|NCT00274716|467412368|FG003|Phase A|Adverse Event|0|||
129850208|NCT00274716|467412369|FG004|Phase A|Adverse Event|2|||
129850209|NCT00274716|467412370|FG005|Phase A|Adverse Event|0|||
129850210|NCT00274716|467412365|FG000|Phase A|Completed but did not enter Phase B|1|||
129850211|NCT00274716|467412366|FG001|Phase A|Completed but did not enter Phase B|2|||
129850212|NCT00274716|467412367|FG002|Phase A|Completed but did not enter Phase B|2|||
129904596|NCT02613871|467612859|FG000|Overall Study|Death|2|||
129904597|NCT02613871|467612859|FG000|Overall Study|Withdrew Consent|1|||
129850213|NCT00274716|467412368|FG003|Phase A|Completed but did not enter Phase B|2|||
129850214|NCT00274716|467412369|FG004|Phase A|Completed but did not enter Phase B|1|||
129850215|NCT00274716|467412370|FG005|Phase A|Completed but did not enter Phase B|1|||
129850216|NCT00274716|467412365|FG000|Phase B|Adverse Event|0|||
129904598|NCT00507689|467612860|FG000|Pre-Randomization Period|Adverse Event|1|||
129904599|NCT00507689|467612861|FG001|Pre-Randomization Period|Adverse Event|0|||
129904600|NCT00507689|467612860|FG000|Pre-Randomization Period|Physician Decision|1|||
129904601|NCT00507689|467612861|FG001|Pre-Randomization Period|Physician Decision|0|||
129904602|NCT00507689|467612860|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
129904603|NCT00507689|467612861|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
129904604|NCT00507689|467612860|FG000|Randomized Period|Adverse Event|1|||
129904605|NCT00507689|467612861|FG001|Randomized Period|Adverse Event|1|||
129904606|NCT00507689|467612860|FG000|Randomized Period|Withdrawal by Subject|0|||
129904607|NCT00507689|467612861|FG001|Randomized Period|Withdrawal by Subject|1|||
129904608|NCT00494442|467612862|FG000|Overall Study|Death|1|||
129850217|NCT00274716|467412366|FG001|Phase B|Adverse Event|0|||
129850218|NCT00274716|467412367|FG002|Phase B|Adverse Event|2|||
129850219|NCT00274716|467412368|FG003|Phase B|Adverse Event|0|||
129850220|NCT00274716|467412369|FG004|Phase B|Adverse Event|0|||
129850221|NCT00274716|467412370|FG005|Phase B|Adverse Event|1|||
129850222|NCT00274716|467412365|FG000|Phase B|Protocol Violation|0|||
129850223|NCT00274716|467412366|FG001|Phase B|Protocol Violation|2|||
129850224|NCT00274716|467412367|FG002|Phase B|Protocol Violation|0|||
129850225|NCT00274716|467412368|FG003|Phase B|Protocol Violation|0|||
129850226|NCT00274716|467412369|FG004|Phase B|Protocol Violation|0|||
129850227|NCT00274716|467412370|FG005|Phase B|Protocol Violation|0|||
129850228|NCT00274716|467412365|FG000|Phase B|Withdrawal by Subject|0|||
129850229|NCT00274716|467412366|FG001|Phase B|Withdrawal by Subject|1|||
129850230|NCT00274716|467412367|FG002|Phase B|Withdrawal by Subject|0|||
129850231|NCT00274716|467412368|FG003|Phase B|Withdrawal by Subject|0|||
129850232|NCT00274716|467412369|FG004|Phase B|Withdrawal by Subject|0|||
129850233|NCT00274716|467412370|FG005|Phase B|Withdrawal by Subject|0|||
129850234|NCT00274716|467412365|FG000|Phase B|Participant moved|1|||
129850235|NCT00274716|467412366|FG001|Phase B|Participant moved|0|||
129850236|NCT00274716|467412367|FG002|Phase B|Participant moved|0|||
129850237|NCT00274716|467412368|FG003|Phase B|Participant moved|0|||
129850238|NCT00274716|467412369|FG004|Phase B|Participant moved|0|||
129850239|NCT00274716|467412370|FG005|Phase B|Participant moved|0|||
129850240|NCT00274716|467412365|FG000|Phase B|Other non-reported reason|0|||
129850241|NCT00274716|467412366|FG001|Phase B|Other non-reported reason|0|||
129850242|NCT00274716|467412367|FG002|Phase B|Other non-reported reason|1|||
129850243|NCT00274716|467412368|FG003|Phase B|Other non-reported reason|1|||
129850244|NCT00274716|467412369|FG004|Phase B|Other non-reported reason|0|||
129850245|NCT00274716|467412370|FG005|Phase B|Other non-reported reason|0|||
129850246|NCT00274716|467412365|FG000|Phase B|Lost to Follow-up|0|||
129850247|NCT00274716|467412366|FG001|Phase B|Lost to Follow-up|1|||
129850248|NCT00274716|467412367|FG002|Phase B|Lost to Follow-up|0|||
129850249|NCT00274716|467412368|FG003|Phase B|Lost to Follow-up|0|||
129850250|NCT00274716|467412369|FG004|Phase B|Lost to Follow-up|0|||
129850251|NCT00274716|467412370|FG005|Phase B|Lost to Follow-up|0|||
129850252|NCT00982319|467412373|FG000|Overall Study|Surgery date change|1|||
129850253|NCT00982319|467412374|FG001|Overall Study|Surgery date change|0|||
129850254|NCT00982319|467412373|FG000|Overall Study|Preop values out of acceptable range|1|||
129850255|NCT00982319|467412374|FG001|Overall Study|Preop values out of acceptable range|1|||
129850256|NCT00982319|467412373|FG000|Overall Study|Pregnancy|0|||
129850257|NCT00982319|467412374|FG001|Overall Study|Pregnancy|1|||
129850258|NCT01252251|467412375|FG000|Overall Study|Withdrawal by Subject|1|||
129850259|NCT01923181|467412376|FG000|Overall Study|Protocol Violation|2|||
129850260|NCT01923181|467412377|FG001|Overall Study|Protocol Violation|2|||
129850261|NCT01923181|467412378|FG002|Overall Study|Protocol Violation|0|||
129850262|NCT01923181|467412379|FG003|Overall Study|Protocol Violation|2|||
129850263|NCT01923181|467412380|FG004|Overall Study|Protocol Violation|2|||
129850264|NCT01923181|467412381|FG005|Overall Study|Protocol Violation|1|||
129850265|NCT01923181|467412382|FG006|Overall Study|Protocol Violation|1|||
129850266|NCT01923181|467412383|FG007|Overall Study|Protocol Violation|2|||
129850267|NCT01923181|467412384|FG008|Overall Study|Protocol Violation|1|||
129850268|NCT01923181|467412376|FG000|Overall Study|Withdrawal by Subject|0|||
129850269|NCT01923181|467412377|FG001|Overall Study|Withdrawal by Subject|1|||
129850270|NCT01923181|467412378|FG002|Overall Study|Withdrawal by Subject|0|||
129850271|NCT01923181|467412379|FG003|Overall Study|Withdrawal by Subject|1|||
129904609|NCT00494442|467612863|FG001|Overall Study|Death|1|||
129904610|NCT00494442|467612862|FG000|Overall Study|Lack of Efficacy|16|||
129904611|NCT00494442|467612863|FG001|Overall Study|Lack of Efficacy|10|||
129850272|NCT01923181|467412380|FG004|Overall Study|Withdrawal by Subject|4|||
129850273|NCT01923181|467412381|FG005|Overall Study|Withdrawal by Subject|2|||
129850274|NCT01923181|467412382|FG006|Overall Study|Withdrawal by Subject|4|||
129850275|NCT01923181|467412383|FG007|Overall Study|Withdrawal by Subject|3|||
129850276|NCT01923181|467412384|FG008|Overall Study|Withdrawal by Subject|1|||
129850277|NCT01923181|467412376|FG000|Overall Study|Other|1|||
129850278|NCT01923181|467412377|FG001|Overall Study|Other|0|||
129850279|NCT01923181|467412378|FG002|Overall Study|Other|0|||
129850280|NCT01923181|467412379|FG003|Overall Study|Other|1|||
129850281|NCT01923181|467412380|FG004|Overall Study|Other|0|||
129850282|NCT01923181|467412381|FG005|Overall Study|Other|0|||
129850283|NCT01923181|467412382|FG006|Overall Study|Other|0|||
129850284|NCT01923181|467412383|FG007|Overall Study|Other|0|||
129850285|NCT01923181|467412384|FG008|Overall Study|Other|0|||
129850286|NCT01923181|467412376|FG000|Overall Study|Lost to Follow-up|0|||
129904612|NCT00494442|467612862|FG000|Overall Study|Adverse Event|0|||
129904613|NCT00494442|467612863|FG001|Overall Study|Adverse Event|2|||
129904614|NCT00494442|467612862|FG000|Overall Study|Physician Decision|0|||
129904615|NCT00494442|467612863|FG001|Overall Study|Physician Decision|1|||
129904616|NCT00494442|467612862|FG000|Overall Study|Non-compliance|0|||
129904617|NCT00494442|467612863|FG001|Overall Study|Non-compliance|1|||
129904618|NCT00494442|467612862|FG000|Overall Study|Intercurrent illness|0|||
129904619|NCT00494442|467612863|FG001|Overall Study|Intercurrent illness|1|||
129850287|NCT01923181|467412377|FG001|Overall Study|Lost to Follow-up|3|||
129850288|NCT01923181|467412378|FG002|Overall Study|Lost to Follow-up|2|||
129850289|NCT01923181|467412379|FG003|Overall Study|Lost to Follow-up|1|||
129850290|NCT01923181|467412380|FG004|Overall Study|Lost to Follow-up|2|||
129850291|NCT01923181|467412381|FG005|Overall Study|Lost to Follow-up|1|||
129850292|NCT01923181|467412382|FG006|Overall Study|Lost to Follow-up|3|||
129850293|NCT01923181|467412383|FG007|Overall Study|Lost to Follow-up|3|||
129850294|NCT01923181|467412384|FG008|Overall Study|Lost to Follow-up|1|||
129850295|NCT01863446|467412385|FG000|Overall Study|Withdrawal by Subject|1|||
129850296|NCT01863446|467412386|FG001|Overall Study|Withdrawal by Subject|0|||
129850297|NCT01863446|467412387|FG002|Overall Study|Withdrawal by Subject|1|||
129850298|NCT01863446|467412388|FG003|Overall Study|Withdrawal by Subject|2|||
129850299|NCT01863446|467412385|FG000|Overall Study|Physician Decision|0|||
129850300|NCT01863446|467412386|FG001|Overall Study|Physician Decision|0|||
129850301|NCT01863446|467412387|FG002|Overall Study|Physician Decision|1|||
129850302|NCT01863446|467412388|FG003|Overall Study|Physician Decision|0|||
129850303|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
129850304|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
129850305|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
129850306|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Death|1|||
129850307|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
129850308|NCT02840877|467412389|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
129850309|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
129850310|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Treatment failure|1|||
129850311|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
129850312|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
129850313|NCT02840877|467412389|FG000|12 Weeks to 6 Months|Death|1|||
129850314|NCT02840877|467412389|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
129850315|NCT02840877|467412389|FG000|6 Months to 18 Months|Treatment failure|7|||
129850316|NCT02840877|467412389|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
129850317|NCT02840877|467412389|FG000|6 Months to 18 Months|Moved/transferred out|6|||
129850318|NCT02840877|467412389|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
129850319|NCT02840877|467412389|FG000|6 Months to 18 Months|Death|4|||
129850320|NCT02840877|467412389|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
129850321|NCT02840877|467412389|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
129850322|NCT02840877|467412389|FG000|6 Months to 18 Months|Still in study.|14|||
129850323|NCT02252081|467412392|FG000|Overall Study|Withdrawal by Subject|2|||
129850324|NCT02252081|467412393|FG001|Overall Study|Withdrawal by Subject|1|||
129850325|NCT02252081|467412392|FG000|Overall Study|Adverse Event|4|||
129850326|NCT02252081|467412393|FG001|Overall Study|Adverse Event|1|||
129850327|NCT02252081|467412392|FG000|Overall Study|non compliance & others|0|||
129850328|NCT02252081|467412393|FG001|Overall Study|non compliance & others|2|||
129850329|NCT03003676|467412398|FG000|Overall Study|Lack of Efficacy|5|||
129850330|NCT03003676|467412399|FG001|Overall Study|Lack of Efficacy|7|||
129850331|NCT03003676|467412398|FG000|Overall Study|Withdrawal by Subject|0|||
129850332|NCT03003676|467412399|FG001|Overall Study|Withdrawal by Subject|1|||
129850333|NCT03003676|467412398|FG000|Overall Study|Hepatitis B infection|1|||
129850334|NCT03003676|467412399|FG001|Overall Study|Hepatitis B infection|0|||
129850335|NCT00530023|467412410|FG000|Overall Study|Withdrawal by Subject|0|||
129850336|NCT00530023|467412411|FG001|Overall Study|Withdrawal by Subject|1|||
129850337|NCT03224468|467412421|FG000|Overall Study|Did not obtain MM card|53|||
129850338|NCT03224468|467412422|FG001|Overall Study|Did not obtain MM card|0|||
129850339|NCT03224468|467412421|FG000|Overall Study|Lost to Follow-up|4|||
129850340|NCT03224468|467412422|FG001|Overall Study|Lost to Follow-up|11|||
129904620|NCT00486330|467612864|FG000|Overall Study|Adverse Event|2|||
129904621|NCT00831415|467612865|FG000|Overall Study|Adverse Event|14|||
129850341|NCT03224468|467412421|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
129850342|NCT03224468|467412422|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
129850343|NCT02461589|467412423|FG000|Overall Study|Withdrawal by Subject|5|||
129850344|NCT02461589|467412424|FG001|Overall Study|Withdrawal by Subject|1|||
129850345|NCT02461589|467412425|FG002|Overall Study|Withdrawal by Subject|3|||
129850346|NCT02461589|467412426|FG003|Overall Study|Withdrawal by Subject|2|||
129850347|NCT02461589|467412427|FG004|Overall Study|Withdrawal by Subject|1|||
129850348|NCT02461589|467412428|FG005|Overall Study|Withdrawal by Subject|2|||
129850349|NCT02461589|467412429|FG006|Overall Study|Withdrawal by Subject|1|||
129850350|NCT02461589|467412430|FG007|Overall Study|Withdrawal by Subject|3|||
129850351|NCT02461589|467412431|FG008|Overall Study|Withdrawal by Subject|3|||
129904622|NCT00831415|467612865|FG000|Overall Study|Failed to return|3|||
129904623|NCT00831415|467612865|FG000|Overall Study|Physician Decision|6|||
129904624|NCT00831415|467612865|FG000|Overall Study|Lost to Follow-up|9|||
129904625|NCT00831415|467612865|FG000|Overall Study|Protocol Violation|3|||
129904626|NCT00831415|467612865|FG000|Overall Study|Withdrawal by Subject|35|||
129904627|NCT00831415|467612865|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
129904628|NCT00831415|467612865|FG000|Overall Study|Death|1|||
129904629|NCT01290224|467612866|FG000|Overall Study|Adverse Event|1|||
129904630|NCT01290224|467612866|FG000|Overall Study|Refused Further Treatment|4|||
129904631|NCT01241292|467612867|FG000|Overall Study|Administrative Reason by Sponsor|1|||
129904632|NCT01241292|467612868|FG001|Overall Study|Administrative Reason by Sponsor|0|||
129904633|NCT01241292|467612867|FG000|Overall Study|Disease Progression|2|||
129904634|NCT01241292|467612868|FG001|Overall Study|Disease Progression|0|||
129904635|NCT01241292|467612867|FG000|Overall Study|Study Drug Toxicity|0|||
129904636|NCT01241292|467612868|FG001|Overall Study|Study Drug Toxicity|1|||
129904637|NCT01241292|467612867|FG000|Overall Study|Participant Discontinued Treatment|0|||
129904638|NCT01241292|467612868|FG001|Overall Study|Participant Discontinued Treatment|2|||
129904639|NCT03861767|467612873|FG000|Overall Study|Withdrawal by Subject|2|||
129904640|NCT03861767|467612874|FG001|Overall Study|Withdrawal by Subject|1|||
129904641|NCT03861767|467612875|FG002|Overall Study|Withdrawal by Subject|0|||
129904642|NCT03861767|467612876|FG003|Overall Study|Withdrawal by Subject|5|||
129904643|NCT03861767|467612877|FG004|Overall Study|Withdrawal by Subject|2|||
129904644|NCT03861767|467612878|FG005|Overall Study|Withdrawal by Subject|1|||
129904645|NCT03861767|467612879|FG006|Overall Study|Withdrawal by Subject|3|||
129904646|NCT03861767|467612880|FG007|Overall Study|Withdrawal by Subject|1|||
129904647|NCT03861767|467612881|FG008|Overall Study|Withdrawal by Subject|0|||
129904648|NCT03861767|467612882|FG009|Overall Study|Withdrawal by Subject|5|||
129904649|NCT00346333|467612883|FG000|Overall Study|Death|1|||
129904650|NCT00346333|467612884|FG001|Overall Study|Death|0|||
129904651|NCT00346333|467612883|FG000|Overall Study|unwilling or unable to continue|4|||
129904652|NCT00346333|467612884|FG001|Overall Study|unwilling or unable to continue|8|||
129904653|NCT00813904|467612885|FG000|Overall Study|Death|1|||
129904654|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
129904655|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
129904656|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
129904657|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
129904658|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
129904659|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
129904660|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
129904661|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
129904662|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
129904663|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
129904664|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
129904665|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
129904666|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
129904667|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
129904668|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
129904669|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
129850352|NCT02461589|467412432|FG009|Overall Study|Withdrawal by Subject|1|||
129850353|NCT02461589|467412423|FG000|Overall Study|Lost to Follow-up|0|||
129850354|NCT02461589|467412424|FG001|Overall Study|Lost to Follow-up|0|||
129850355|NCT02461589|467412425|FG002|Overall Study|Lost to Follow-up|2|||
129850356|NCT02461589|467412426|FG003|Overall Study|Lost to Follow-up|3|||
129850357|NCT02461589|467412427|FG004|Overall Study|Lost to Follow-up|1|||
129850358|NCT02461589|467412428|FG005|Overall Study|Lost to Follow-up|1|||
129850359|NCT02461589|467412429|FG006|Overall Study|Lost to Follow-up|3|||
129850360|NCT02461589|467412430|FG007|Overall Study|Lost to Follow-up|1|||
129850361|NCT02461589|467412431|FG008|Overall Study|Lost to Follow-up|3|||
129850362|NCT02461589|467412432|FG009|Overall Study|Lost to Follow-up|1|||
129850363|NCT02461589|467412423|FG000|Overall Study|Death|0|||
129850364|NCT02461589|467412424|FG001|Overall Study|Death|0|||
129850365|NCT02461589|467412425|FG002|Overall Study|Death|0|||
129850366|NCT02461589|467412426|FG003|Overall Study|Death|0|||
129850367|NCT02461589|467412427|FG004|Overall Study|Death|0|||
129850368|NCT02461589|467412428|FG005|Overall Study|Death|0|||
129850369|NCT02461589|467412429|FG006|Overall Study|Death|0|||
129904670|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
129904671|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
129904672|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
129904673|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
129850370|NCT02461589|467412430|FG007|Overall Study|Death|1|||
129850371|NCT02461589|467412431|FG008|Overall Study|Death|0|||
129850372|NCT02461589|467412432|FG009|Overall Study|Death|0|||
129850373|NCT02461589|467412423|FG000|Overall Study|Unclassified|0|||
129850374|NCT02461589|467412424|FG001|Overall Study|Unclassified|0|||
129850375|NCT02461589|467412425|FG002|Overall Study|Unclassified|0|||
129850376|NCT02461589|467412426|FG003|Overall Study|Unclassified|0|||
129850377|NCT02461589|467412427|FG004|Overall Study|Unclassified|0|||
129850378|NCT02461589|467412428|FG005|Overall Study|Unclassified|0|||
129850379|NCT02461589|467412429|FG006|Overall Study|Unclassified|1|||
129850380|NCT02461589|467412430|FG007|Overall Study|Unclassified|0|||
129850381|NCT02461589|467412431|FG008|Overall Study|Unclassified|0|||
129850382|NCT02461589|467412432|FG009|Overall Study|Unclassified|2|||
129850383|NCT02461589|467412423|FG000|Overall Study|Missing follow-up information|1|||
129850384|NCT02461589|467412424|FG001|Overall Study|Missing follow-up information|1|||
129850385|NCT02461589|467412425|FG002|Overall Study|Missing follow-up information|0|||
129850386|NCT02461589|467412426|FG003|Overall Study|Missing follow-up information|0|||
129850387|NCT02461589|467412427|FG004|Overall Study|Missing follow-up information|0|||
129850388|NCT02461589|467412428|FG005|Overall Study|Missing follow-up information|0|||
129850389|NCT02461589|467412429|FG006|Overall Study|Missing follow-up information|1|||
129850390|NCT02461589|467412430|FG007|Overall Study|Missing follow-up information|0|||
129850391|NCT02461589|467412431|FG008|Overall Study|Missing follow-up information|0|||
129850392|NCT02461589|467412432|FG009|Overall Study|Missing follow-up information|0|||
129850393|NCT02461589|467412423|FG000|Overall Study|Withdrawal from trial before exposure|0|||
129850394|NCT02461589|467412424|FG001|Overall Study|Withdrawal from trial before exposure|0|||
129850395|NCT02461589|467412425|FG002|Overall Study|Withdrawal from trial before exposure|0|||
129850396|NCT02461589|467412426|FG003|Overall Study|Withdrawal from trial before exposure|0|||
129850397|NCT02461589|467412427|FG004|Overall Study|Withdrawal from trial before exposure|0|||
129850398|NCT02461589|467412428|FG005|Overall Study|Withdrawal from trial before exposure|0|||
129850399|NCT02461589|467412429|FG006|Overall Study|Withdrawal from trial before exposure|0|||
129850400|NCT02461589|467412430|FG007|Overall Study|Withdrawal from trial before exposure|0|||
129850401|NCT02461589|467412431|FG008|Overall Study|Withdrawal from trial before exposure|0|||
129850402|NCT02461589|467412432|FG009|Overall Study|Withdrawal from trial before exposure|1|||
129850403|NCT04067141|467412433|FG000|First Intervention|Withdrawal by Subject|0|||
129850404|NCT04067141|467412434|FG001|First Intervention|Withdrawal by Subject|1|||
129850405|NCT04067141|467412433|FG000|Second Intervention|Adverse Event|0|||
129850406|NCT04067141|467412434|FG001|Second Intervention|Adverse Event|2|||
129850407|NCT01038921|467412435|FG000|Overall Study|Withdrawal by Subject|1|||
129850408|NCT01038921|467412436|FG001|Overall Study|Withdrawal by Subject|0|||
129850409|NCT01038921|467412435|FG000|Overall Study|Physician Decision|1|||
129850410|NCT01038921|467412436|FG001|Overall Study|Physician Decision|0|||
129850411|NCT01978119|467412437|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
129850412|NCT01978119|467412438|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
129850413|NCT01978119|467412437|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
129850414|NCT01978119|467412438|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129850415|NCT01978119|467412437|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129850416|NCT01978119|467412438|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
129850417|NCT03295201|467412439|FG000|Overall Study|Lost to Follow-up|1|||
129850418|NCT03295201|467412440|FG001|Overall Study|Lost to Follow-up|1|||
129850419|NCT03295201|467412439|FG000|Overall Study|Hospital admission|0|||
129850420|NCT03295201|467412440|FG001|Overall Study|Hospital admission|1|||
129850421|NCT00733824|467412441|FG000|Phase I|Withdrawal by Subject|1|||
129850422|NCT00733824|467412442|FG001|Phase I|Withdrawal by Subject|0|||
129850423|NCT00733824|467412443|FG002|Phase I|Withdrawal by Subject|0|||
129850424|NCT00733824|467412444|FG003|Phase I|Withdrawal by Subject|0|||
129850425|NCT00733824|467412445|FG004|Phase I|Withdrawal by Subject|0|||
129850426|NCT01243944|467412446|FG000|Overall Study|Adverse Event|15|||
129850427|NCT01243944|467412447|FG001|Overall Study|Adverse Event|13|||
129850428|NCT01243944|467412446|FG000|Overall Study|Lost to Follow-up|2|||
129850429|NCT01243944|467412447|FG001|Overall Study|Lost to Follow-up|1|||
129850430|NCT01243944|467412446|FG000|Overall Study|Physician Decision|2|||
129850431|NCT01243944|467412447|FG001|Overall Study|Physician Decision|7|||
129850432|NCT01243944|467412446|FG000|Overall Study|Disease progression|12|||
129850433|NCT01243944|467412447|FG001|Overall Study|Disease progression|11|||
129850434|NCT01243944|467412446|FG000|Overall Study|Protocol deviation|1|||
129850435|NCT01243944|467412447|FG001|Overall Study|Protocol deviation|1|||
129850436|NCT01243944|467412446|FG000|Overall Study|Participant decision|10|||
129850437|NCT01243944|467412447|FG001|Overall Study|Participant decision|15|||
129850438|NCT01243944|467412446|FG000|Overall Study|Death|2|||
129850439|NCT01243944|467412447|FG001|Overall Study|Death|3|||
129850440|NCT01243944|467412446|FG000|Overall Study|Non-compliance with study treatment|1|||
129850441|NCT01243944|467412447|FG001|Overall Study|Non-compliance with study treatment|0|||
129850442|NCT01410110|467412448|FG000|Overall Study|Withdrawal by Subject|4|||
129850443|NCT01410110|467412449|FG001|Overall Study|Withdrawal by Subject|2|||
129850444|NCT01416805|467412450|FG000|Overall Study|Lost to Follow-up|4|||
129850445|NCT01416805|467412451|FG001|Overall Study|Lost to Follow-up|4|||
129850446|NCT04632940|467412455|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
129850447|NCT04632940|467412456|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
129850448|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
129850449|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
129850450|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
129850451|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
129850452|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
129850453|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
129850454|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
129850455|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
129850456|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
129850457|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
129850458|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Other than specified|0|||
129850459|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Other than specified|1|||
129850460|NCT04632940|467412455|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
129850461|NCT04632940|467412456|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
129850462|NCT00153101|467412461|FG000|Overall Study|Lost to Follow-up|14|||
129850463|NCT00153101|467412462|FG001|Overall Study|Lost to Follow-up|14|||
129850464|NCT00153101|467412463|FG002|Overall Study|Lost to Follow-up|12|||
129850465|NCT00153101|467412464|FG003|Overall Study|Lost to Follow-up|5|||
129850466|NCT00153101|467412465|FG004|Overall Study|Lost to Follow-up|5|||
129850467|NCT00153101|467412461|FG000|Overall Study|Withdrawal by Subject|3|||
129850468|NCT00153101|467412462|FG001|Overall Study|Withdrawal by Subject|4|||
129850469|NCT00153101|467412463|FG002|Overall Study|Withdrawal by Subject|3|||
129850470|NCT00153101|467412464|FG003|Overall Study|Withdrawal by Subject|3|||
129850471|NCT00153101|467412465|FG004|Overall Study|Withdrawal by Subject|5|||
129850472|NCT02610140|467412466|FG000|Randomization and Treatment Period|Radiological progression|23|||
129850473|NCT02610140|467412467|FG001|Randomization and Treatment Period|Radiological progression|15|||
129850474|NCT02610140|467412466|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
129850475|NCT02610140|467412467|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
129850476|NCT02610140|467412466|FG000|Randomization and Treatment Period|Protocol Violation|1|||
129850477|NCT02610140|467412467|FG001|Randomization and Treatment Period|Protocol Violation|0|||
129850478|NCT02610140|467412466|FG000|Randomization and Treatment Period|Physician Decision|0|||
129850479|NCT02610140|467412467|FG001|Randomization and Treatment Period|Physician Decision|1|||
129850480|NCT02610140|467412466|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
129850481|NCT02610140|467412467|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
129850482|NCT02610140|467412466|FG000|Randomization and Treatment Period|Death|7|||
129850483|NCT02610140|467412467|FG001|Randomization and Treatment Period|Death|1|||
129850484|NCT02610140|467412466|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
129850485|NCT02610140|467412467|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
129850486|NCT02610140|467412466|FG000|Randomization and Treatment Period|Adverse Event|44|||
129850487|NCT02610140|467412467|FG001|Randomization and Treatment Period|Adverse Event|13|||
129850488|NCT02610140|467412466|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
129850489|NCT02610140|467412467|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
129850490|NCT02610140|467412466|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
129850491|NCT02610140|467412467|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
129850492|NCT02610140|467412466|FG000|Randomization and Treatment Period|Not treated|3|||
129850493|NCT02610140|467412467|FG001|Randomization and Treatment Period|Not treated|10|||
129850494|NCT02610140|467412466|FG000|Safety Follow-up|Other|0|||
129850495|NCT02610140|467412467|FG001|Safety Follow-up|Other|2|||
129850496|NCT02610140|467412466|FG000|Safety Follow-up|Lost to Follow-up|1|||
129850497|NCT02610140|467412467|FG001|Safety Follow-up|Lost to Follow-up|0|||
129850498|NCT02610140|467412466|FG000|Safety Follow-up|No follow-up|5|||
129850499|NCT02610140|467412467|FG001|Safety Follow-up|No follow-up|3|||
129850500|NCT02610140|467412466|FG000|Safety Follow-up|Death|12|||
129850501|NCT02610140|467412467|FG001|Safety Follow-up|Death|2|||
129850502|NCT02610140|467412466|FG000|Safety Follow-up|Deterioration of general conditions|15|||
129850503|NCT02610140|467412467|FG001|Safety Follow-up|Deterioration of general conditions|5|||
129850504|NCT02610140|467412466|FG000|Safety Follow-up|Withdrawal by Subject|12|||
129904674|NCT01087762|467612886|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
129850505|NCT02610140|467412467|FG001|Safety Follow-up|Withdrawal by Subject|12|||
129850506|NCT02610140|467412466|FG000|Active Follow-up|Progressive disease - radiological|30|||
129850507|NCT02610140|467412467|FG001|Active Follow-up|Progressive disease - radiological|22|||
129850508|NCT02610140|467412466|FG000|Active Follow-up|Death|8|||
129850509|NCT02610140|467412467|FG001|Active Follow-up|Death|1|||
129850510|NCT02610140|467412466|FG000|Active Follow-up|Withdrawal by Subject|4|||
129850511|NCT02610140|467412467|FG001|Active Follow-up|Withdrawal by Subject|0|||
129850512|NCT02610140|467412466|FG000|Active Follow-up|Progressive disease - clinical|1|||
129850513|NCT02610140|467412467|FG001|Active Follow-up|Progressive disease - clinical|2|||
129850514|NCT02610140|467412466|FG000|Active Follow-up|Deterioration of general conditions|1|||
129850515|NCT02610140|467412467|FG001|Active Follow-up|Deterioration of general conditions|0|||
129850516|NCT02610140|467412466|FG000|Active Follow-up|Ongoing but not completed|4|||
129850517|NCT02610140|467412467|FG001|Active Follow-up|Ongoing but not completed|1|||
129850518|NCT02610140|467412466|FG000|Long-term Follow-up|Death|86|||
129850519|NCT02610140|467412467|FG001|Long-term Follow-up|Death|44|||
129850520|NCT02610140|467412466|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
129850521|NCT02610140|467412467|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
129850522|NCT02610140|467412466|FG000|Long-term Follow-up|Lost to Follow-up|1|||
129850523|NCT02610140|467412467|FG001|Long-term Follow-up|Lost to Follow-up|2|||
129850524|NCT02610140|467412466|FG000|Long-term Follow-up|Ongoing but not completed|30|||
129850525|NCT02610140|467412467|FG001|Long-term Follow-up|Ongoing but not completed|17|||
129850526|NCT03169153|467412468|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129850527|NCT03169153|467412469|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
129850528|NCT03169153|467412468|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
129850529|NCT03169153|467412469|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
129850530|NCT03169153|467412468|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
129850531|NCT03169153|467412469|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
129850532|NCT03169153|467412468|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
129850533|NCT03169153|467412469|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
129850534|NCT00887341|467412470|FG000|Overall Study|Refused treatment|1|||
129850535|NCT00887341|467412471|FG001|Overall Study|Refused treatment|0|||
129850536|NCT00887341|467412470|FG000|Overall Study|Withdrawal by Subject|1|||
129850537|NCT00887341|467412471|FG001|Overall Study|Withdrawal by Subject|1|||
129850538|NCT00887341|467412470|FG000|Overall Study|Adverse Event|0|||
129850539|NCT00887341|467412471|FG001|Overall Study|Adverse Event|1|||
129850540|NCT00887341|467412470|FG000|Overall Study|Lost to Follow-up|0|||
129850541|NCT00887341|467412471|FG001|Overall Study|Lost to Follow-up|1|||
129850542|NCT01591681|467412474|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
129850543|NCT01591681|467412474|FG000|Overall Study|Failed to use system during run-in|1|||
129850544|NCT00281840|467412477|FG000|Overall Study|Adverse Event|12|||
129850545|NCT00281840|467412477|FG000|Overall Study|Physician Decision|6|||
129850546|NCT00281840|467412477|FG000|Overall Study|Withdrawal by Subject|3|||
129850547|NCT00281840|467412477|FG000|Overall Study|Disease Progression|2|||
129850548|NCT00281840|467412477|FG000|Overall Study|exceed maximum delay in treatment|1|||
129850549|NCT00281840|467412477|FG000|Overall Study|Complicating Disease|1|||
129850550|NCT01079234|467412480|FG000|Main: Week 0 to 26|Adverse Event|5|||
129850551|NCT01079234|467412481|FG001|Main: Week 0 to 26|Adverse Event|4|||
129850552|NCT01079234|467412482|FG002|Main: Week 0 to 26|Adverse Event|1|||
129850553|NCT01079234|467412483|FG003|Main: Week 0 to 26|Adverse Event|0|||
129850554|NCT01079234|467412480|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
129850555|NCT01079234|467412481|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
129850556|NCT01079234|467412482|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
129850557|NCT01079234|467412483|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
129850558|NCT01079234|467412480|FG000|Main: Week 0 to 26|Protocol Violation|6|||
129850559|NCT01079234|467412481|FG001|Main: Week 0 to 26|Protocol Violation|2|||
129850560|NCT01079234|467412482|FG002|Main: Week 0 to 26|Protocol Violation|4|||
129850561|NCT01079234|467412483|FG003|Main: Week 0 to 26|Protocol Violation|0|||
129850562|NCT01079234|467412480|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
129850563|NCT01079234|467412481|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
129850564|NCT01079234|467412482|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
129850565|NCT01079234|467412483|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
129850566|NCT01079234|467412480|FG000|Main: Week 0 to 26|Unclassified|7|||
129850567|NCT01079234|467412481|FG001|Main: Week 0 to 26|Unclassified|13|||
129850568|NCT01079234|467412482|FG002|Main: Week 0 to 26|Unclassified|4|||
129850569|NCT01079234|467412483|FG003|Main: Week 0 to 26|Unclassified|0|||
129850570|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Adverse Event|0|||
129850571|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Adverse Event|0|||
129850572|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Adverse Event|1|||
129850573|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Adverse Event|0|||
129850574|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
129904675|NCT01087762|467612887|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
129850575|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
129850576|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
129850577|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
129850578|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
129850579|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
129850580|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
129850581|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
129850582|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
129850583|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
129850584|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
129850585|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
129850586|NCT01079234|467412480|FG000|Extension: Week 27 to 52|Unclassified|0|||
129850587|NCT01079234|467412481|FG001|Extension: Week 27 to 52|Unclassified|0|||
129850588|NCT01079234|467412482|FG002|Extension: Week 27 to 52|Unclassified|4|||
129850589|NCT01079234|467412483|FG003|Extension: Week 27 to 52|Unclassified|7|||
129850590|NCT01312961|467412490|FG000|Overall Study|Adverse Event|3|||
129850591|NCT01312961|467412491|FG001|Overall Study|Adverse Event|3|||
129850592|NCT01312961|467412490|FG000|Overall Study|Lack of Efficacy|11|||
129850593|NCT01312961|467412491|FG001|Overall Study|Lack of Efficacy|1|||
129850594|NCT01312961|467412490|FG000|Overall Study|Poor compliance to protocol|1|||
129850595|NCT01312961|467412491|FG001|Overall Study|Poor compliance to protocol|0|||
129850596|NCT01312961|467412490|FG000|Overall Study|Other than specified above|2|||
129850597|NCT01312961|467412491|FG001|Overall Study|Other than specified above|3|||
129850598|NCT04278417|467412492|FG000|Overall Study|Withdrawal by Subject|20|||
129850599|NCT04278417|467412493|FG001|Overall Study|Withdrawal by Subject|20|||
129850600|NCT04278417|467412492|FG000|Overall Study|Progressive disease|0|||
129850601|NCT04278417|467412493|FG001|Overall Study|Progressive disease|2|||
129850602|NCT04278417|467412492|FG000|Overall Study|Physician Decision|4|||
129850603|NCT04278417|467412493|FG001|Overall Study|Physician Decision|6|||
129850604|NCT04278417|467412492|FG000|Overall Study|Lost to Follow-up|11|||
129850605|NCT04278417|467412493|FG001|Overall Study|Lost to Follow-up|13|||
129850606|NCT04278417|467412492|FG000|Overall Study|Death|8|||
129850607|NCT04278417|467412493|FG001|Overall Study|Death|9|||
129850608|NCT04278417|467412492|FG000|Overall Study|Adverse Event|3|||
129850609|NCT04278417|467412493|FG001|Overall Study|Adverse Event|5|||
129850610|NCT00205712|467412495|FG000|Overall Study|Lost to Follow-up|0|||
129850611|NCT00205712|467412496|FG001|Overall Study|Lost to Follow-up|1|||
129850612|NCT01652716|467412506|FG000|Overall Study|Loss of glucose control|1|||
129850613|NCT01652716|467412507|FG001|Overall Study|Loss of glucose control|0|||
129850614|NCT01652716|467412506|FG000|Overall Study|Administrative|0|||
129850615|NCT01652716|467412507|FG001|Overall Study|Administrative|2|||
129850616|NCT01652716|467412506|FG000|Overall Study|Investigator decision|1|||
129850617|NCT01652716|467412507|FG001|Overall Study|Investigator decision|4|||
129850618|NCT01652716|467412506|FG000|Overall Study|Lost to Follow-up|12|||
129850619|NCT01652716|467412507|FG001|Overall Study|Lost to Follow-up|11|||
129850620|NCT01652716|467412506|FG000|Overall Study|Protocol Violation|2|||
129850621|NCT01652716|467412507|FG001|Overall Study|Protocol Violation|1|||
129850622|NCT01652716|467412506|FG000|Overall Study|Adverse Event|7|||
129850623|NCT01652716|467412507|FG001|Overall Study|Adverse Event|10|||
129850624|NCT01652716|467412506|FG000|Overall Study|Withdrawal by Subject|33|||
129850625|NCT01652716|467412507|FG001|Overall Study|Withdrawal by Subject|18|||
129850626|NCT01337297|467412508|FG000|Overall Study|They entered to single anodal tDCS|4|||
129850627|NCT01337297|467412509|FG001|Overall Study|They entered to single anodal tDCS|3|||
129850628|NCT01337297|467412508|FG000|Overall Study|Lost to Follow-up|1|||
129850629|NCT01337297|467412509|FG001|Overall Study|Lost to Follow-up|3|||
129850630|NCT02778204|467412510|FG000|Overall Study|Adverse Event|1|||
129850631|NCT02778204|467412511|FG001|Overall Study|Adverse Event|0|||
129850632|NCT02778204|467412512|FG002|Overall Study|Adverse Event|0|||
129850633|NCT02778204|467412513|FG003|Overall Study|Adverse Event|0|||
129850634|NCT02778204|467412510|FG000|Overall Study|Withdrawal by Subject|0|||
129850635|NCT02778204|467412511|FG001|Overall Study|Withdrawal by Subject|0|||
129850636|NCT02778204|467412512|FG002|Overall Study|Withdrawal by Subject|1|||
129850637|NCT02778204|467412513|FG003|Overall Study|Withdrawal by Subject|2|||
129850638|NCT02778204|467412510|FG000|Overall Study|Lost to Follow-up|1|||
129850639|NCT02778204|467412511|FG001|Overall Study|Lost to Follow-up|0|||
129850640|NCT02778204|467412512|FG002|Overall Study|Lost to Follow-up|2|||
129850641|NCT02778204|467412513|FG003|Overall Study|Lost to Follow-up|1|||
129850642|NCT02778204|467412510|FG000|Overall Study|Protocol Violation|0|||
129850643|NCT02778204|467412511|FG001|Overall Study|Protocol Violation|0|||
129850644|NCT02778204|467412512|FG002|Overall Study|Protocol Violation|1|||
129850645|NCT02778204|467412513|FG003|Overall Study|Protocol Violation|0|||
129850646|NCT02778204|467412510|FG000|Overall Study|Eligibility Violation|0|||
129850647|NCT02778204|467412511|FG001|Overall Study|Eligibility Violation|0|||
129850648|NCT02778204|467412512|FG002|Overall Study|Eligibility Violation|0|||
129850649|NCT02778204|467412513|FG003|Overall Study|Eligibility Violation|1|||
129850650|NCT03964454|467412519|FG000|Overall Study|Lost to Follow-up|13|||
129850651|NCT03964454|467412520|FG001|Overall Study|Lost to Follow-up|7|||
129850652|NCT03964454|467412519|FG000|Overall Study|Withdrawal by Subject|4|||
129850653|NCT03964454|467412520|FG001|Overall Study|Withdrawal by Subject|11|||
129850654|NCT00201006|467414586|FG000|Overall Study|Withdrawal by Subject|7|||
129850655|NCT00201006|467414587|FG001|Overall Study|Withdrawal by Subject|2|||
129850656|NCT00201006|467414588|FG002|Overall Study|Withdrawal by Subject|3|||
129850657|NCT00201006|467414586|FG000|Overall Study|Adverse Event|1|||
129850658|NCT00201006|467414587|FG001|Overall Study|Adverse Event|0|||
129850659|NCT00201006|467414588|FG002|Overall Study|Adverse Event|1|||
129850660|NCT01694706|467414590|FG000|Overall Study|Adverse Event|0|||
129850661|NCT01694706|467414591|FG001|Overall Study|Adverse Event|1|||
129850662|NCT01694706|467414592|FG002|Overall Study|Adverse Event|0|||
129850663|NCT01694706|467414590|FG000|Overall Study|other reason not defined above|1|||
129850664|NCT01694706|467414591|FG001|Overall Study|other reason not defined above|0|||
129850665|NCT01694706|467414592|FG002|Overall Study|other reason not defined above|0|||
129850666|NCT00975975|467414593|FG000|Overall Study|Death|6|||
129850667|NCT02057757|467414600|FG000|Overall Study|Withdrawal by Subject|3|||
129850668|NCT02057757|467414601|FG001|Overall Study|Withdrawal by Subject|5|||
129850669|NCT02057757|467414600|FG000|Overall Study|Death|2|||
129850670|NCT02057757|467414601|FG001|Overall Study|Death|0|||
129850671|NCT02057757|467414600|FG000|Overall Study|Lost to Follow-up|8|||
129850672|NCT02057757|467414601|FG001|Overall Study|Lost to Follow-up|3|||
129850673|NCT02057757|467414600|FG000|Overall Study|Non-compliance|1|||
129850674|NCT02057757|467414601|FG001|Overall Study|Non-compliance|0|||
129850675|NCT03614793|467414602|FG000|Overall Study|Lost to Follow-up|1|||
129850676|NCT03614793|467414603|FG001|Overall Study|Lost to Follow-up|2|||
129850677|NCT03614793|467414602|FG000|Overall Study|Lack of Efficacy|0|||
129850678|NCT03614793|467414603|FG001|Overall Study|Lack of Efficacy|5|||
129850679|NCT03614793|467414602|FG000|Overall Study|Withdrawal by Subject|0|||
129850680|NCT03614793|467414603|FG001|Overall Study|Withdrawal by Subject|1|||
129850681|NCT03614793|467414602|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
129850682|NCT03614793|467414603|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
129850683|NCT02082522|467414604|FG000|Overall Study|Sponsor termination|5|||
129850684|NCT02082522|467414605|FG001|Overall Study|Sponsor termination|3|||
129850685|NCT02082522|467414604|FG000|Overall Study|Withdrawal by Subject|2|||
129850686|NCT02082522|467414605|FG001|Overall Study|Withdrawal by Subject|4|||
129850687|NCT02082522|467414604|FG000|Overall Study|Death|1|||
129850688|NCT02082522|467414605|FG001|Overall Study|Death|0|||
129850689|NCT02082522|467414604|FG000|Overall Study|Lost to Follow-up|1|||
129850690|NCT02082522|467414605|FG001|Overall Study|Lost to Follow-up|0|||
129850691|NCT02082522|467414604|FG000|Overall Study|Physician Decision|3|||
129850692|NCT02082522|467414605|FG001|Overall Study|Physician Decision|1|||
129850693|NCT02082522|467414604|FG000|Overall Study|Disease progression|2|||
129850694|NCT02082522|467414605|FG001|Overall Study|Disease progression|2|||
129850695|NCT02082522|467414604|FG000|Overall Study|Chemotherapy change|1|||
129850696|NCT02082522|467414605|FG001|Overall Study|Chemotherapy change|3|||
129850697|NCT00456092|467414606|FG000|Extension Phase|Grade 2 or Greater AE|2|||
129850698|NCT00456092|467414607|FG001|Extension Phase|Grade 2 or Greater AE|2|||
129850699|NCT00456092|467414608|FG002|Extension Phase|Grade 2 or Greater AE|0|||
129850700|NCT00456092|467414609|FG003|Extension Phase|Grade 2 or Greater AE|0|||
129850701|NCT00456092|467414610|FG004|Extension Phase|Grade 2 or Greater AE|2|||
129850702|NCT00456092|467414606|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
129850703|NCT00456092|467414607|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
129850704|NCT00456092|467414608|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
129850705|NCT00456092|467414609|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
129850706|NCT00456092|467414610|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
129850707|NCT00456092|467414606|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
129850708|NCT00456092|467414607|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
129850709|NCT00456092|467414608|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
129850710|NCT00456092|467414609|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
129850711|NCT00456092|467414610|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
129850712|NCT00456092|467414606|FG000|Extension Phase|Withdrew Consent|2|||
129850713|NCT00456092|467414607|FG001|Extension Phase|Withdrew Consent|0|||
129850714|NCT00456092|467414608|FG002|Extension Phase|Withdrew Consent|0|||
129850715|NCT00456092|467414609|FG003|Extension Phase|Withdrew Consent|0|||
129850716|NCT00456092|467414610|FG004|Extension Phase|Withdrew Consent|0|||
129850717|NCT00456092|467414606|FG000|Extension Phase|Lost to Follow-up|1|||
129850718|NCT00456092|467414607|FG001|Extension Phase|Lost to Follow-up|1|||
129850719|NCT00456092|467414608|FG002|Extension Phase|Lost to Follow-up|0|||
129850720|NCT00456092|467414609|FG003|Extension Phase|Lost to Follow-up|0|||
129850721|NCT00456092|467414610|FG004|Extension Phase|Lost to Follow-up|1|||
129850722|NCT00456092|467414606|FG000|Extension Phase|Other|2|||
129850723|NCT00456092|467414607|FG001|Extension Phase|Other|0|||
129850724|NCT00456092|467414608|FG002|Extension Phase|Other|0|||
129850725|NCT00456092|467414609|FG003|Extension Phase|Other|1|||
129850726|NCT00456092|467414610|FG004|Extension Phase|Other|1|||
129850727|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
129850728|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
129850729|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
129850730|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
129850731|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
129850732|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
129850733|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
129850734|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
129850735|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
129850736|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
129850737|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
129850738|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850739|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850740|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850741|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
129850742|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
129850743|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
129850744|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
129850745|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
129850746|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
129850747|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
129850748|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
129850749|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
129850750|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
129850751|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
129850752|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
129850753|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
129850754|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
129850755|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
129850756|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
129850757|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
129850758|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
129850759|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
129850760|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
129850761|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
129850762|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129850763|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129850764|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
129850765|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129850766|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
129850767|NCT00456092|467414606|FG000|Treatment Phase (12 Weeks)|Other|1|||
129850768|NCT00456092|467414607|FG001|Treatment Phase (12 Weeks)|Other|0|||
129850769|NCT00456092|467414608|FG002|Treatment Phase (12 Weeks)|Other|1|||
129850770|NCT00456092|467414609|FG003|Treatment Phase (12 Weeks)|Other|0|||
129850771|NCT00456092|467414610|FG004|Treatment Phase (12 Weeks)|Other|0|||
129850772|NCT01168999|467414611|FG000|Overall Study|Lost to Follow-up|2|||
129850773|NCT01168999|467414612|FG001|Overall Study|Lost to Follow-up|1|||
129850774|NCT01168999|467414613|FG002|Overall Study|Lost to Follow-up|0|||
129850775|NCT01168999|467414614|FG003|Overall Study|Lost to Follow-up|0|||
129850776|NCT03603964|467414615|FG000|Overall Study|Death|9|||
129850777|NCT03603964|467414615|FG000|Overall Study|Withdrawal by participant|7|||
129850778|NCT03603964|467414615|FG000|Overall Study|Study terminated by Sponsor|19|||
129850779|NCT04317586|467414616|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
129850780|NCT04317586|467414616|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
129850781|NCT00563797|467414617|FG000|Overall Study|Lost to Follow-up|7|||
129850782|NCT00563797|467414618|FG001|Overall Study|Lost to Follow-up|2|||
129850783|NCT04327934|467414619|FG000|Overall Study|Did not qualify|7|||
129850784|NCT04327934|467414620|FG001|Overall Study|Did not qualify|4|||
129850785|NCT04327934|467414619|FG000|Overall Study|Physician Decision|0|||
129850786|NCT04327934|467414620|FG001|Overall Study|Physician Decision|1|||
129850787|NCT03095417|467414625|FG000|Overall Study|missed|1|||
129850788|NCT03095417|467414626|FG001|Overall Study|missed|2|||
129850789|NCT03095417|467414627|FG002|Overall Study|missed|0|||
129850790|NCT03095417|467414628|FG003|Overall Study|missed|1|||
129850791|NCT03095417|467414625|FG000|Overall Study|Lost to Follow-up|2|||
129850792|NCT03095417|467414626|FG001|Overall Study|Lost to Follow-up|2|||
129850793|NCT03095417|467414627|FG002|Overall Study|Lost to Follow-up|1|||
129850794|NCT03095417|467414628|FG003|Overall Study|Lost to Follow-up|0|||
129850795|NCT03095417|467414625|FG000|Overall Study|refusal|0|||
129850796|NCT03095417|467414626|FG001|Overall Study|refusal|1|||
129850797|NCT03095417|467414627|FG002|Overall Study|refusal|0|||
129850798|NCT03095417|467414628|FG003|Overall Study|refusal|1|||
129850799|NCT03095417|467414625|FG000|Overall Study|Withdrawal by Subject|8|||
129850800|NCT03095417|467414626|FG001|Overall Study|Withdrawal by Subject|2|||
129850801|NCT03095417|467414627|FG002|Overall Study|Withdrawal by Subject|5|||
129850802|NCT03095417|467414628|FG003|Overall Study|Withdrawal by Subject|4|||
129850803|NCT03095417|467414625|FG000|Overall Study|Physician Decision|1|||
129850804|NCT03095417|467414626|FG001|Overall Study|Physician Decision|2|||
129850805|NCT03095417|467414627|FG002|Overall Study|Physician Decision|2|||
129850806|NCT03095417|467414628|FG003|Overall Study|Physician Decision|2|||
129850807|NCT03095417|467414625|FG000|Overall Study|Death|1|||
129850808|NCT03095417|467414626|FG001|Overall Study|Death|2|||
129850809|NCT03095417|467414627|FG002|Overall Study|Death|1|||
129850810|NCT03095417|467414628|FG003|Overall Study|Death|3|||
129850811|NCT01490060|467414629|FG000|Cycle 1|Change of Treatment|0|||
129850812|NCT01490060|467414630|FG001|Cycle 1|Change of Treatment|1|||
129850813|NCT01490060|467414631|FG002|Cycle 1|Change of Treatment|1|||
129850814|NCT01490060|467414632|FG003|Cycle 1|Change of Treatment|1|||
129850815|NCT01490060|467414629|FG000|Cycle 1|Insurance Denied|0|||
129850816|NCT01490060|467414630|FG001|Cycle 1|Insurance Denied|0|||
129850817|NCT01490060|467414631|FG002|Cycle 1|Insurance Denied|2|||
129850818|NCT01490060|467414632|FG003|Cycle 1|Insurance Denied|0|||
129850819|NCT01490060|467414629|FG000|Cycle 1|Withdrawal by Subject|0|||
129850820|NCT01490060|467414630|FG001|Cycle 1|Withdrawal by Subject|0|||
129850821|NCT01490060|467414631|FG002|Cycle 1|Withdrawal by Subject|0|||
129850822|NCT01490060|467414632|FG003|Cycle 1|Withdrawal by Subject|1|||
129850823|NCT01490060|467414629|FG000|Cycle 1|Treatment at Another Facility|0|||
129850824|NCT01490060|467414630|FG001|Cycle 1|Treatment at Another Facility|0|||
129850825|NCT01490060|467414631|FG002|Cycle 1|Treatment at Another Facility|0|||
129850826|NCT01490060|467414632|FG003|Cycle 1|Treatment at Another Facility|1|||
129850827|NCT01490060|467414629|FG000|Cycle 2|Change of Treatment|1|||
129850828|NCT01490060|467414630|FG001|Cycle 2|Change of Treatment|1|||
129850829|NCT01490060|467414631|FG002|Cycle 2|Change of Treatment|0|||
129850830|NCT01490060|467414632|FG003|Cycle 2|Change of Treatment|0|||
129850831|NCT01490060|467414629|FG000|Cycle 2|Non-Compliance|0|||
129850832|NCT01490060|467414630|FG001|Cycle 2|Non-Compliance|0|||
129850833|NCT01490060|467414631|FG002|Cycle 2|Non-Compliance|1|||
129850834|NCT01490060|467414632|FG003|Cycle 2|Non-Compliance|0|||
129850835|NCT01490060|467414629|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
129850836|NCT01490060|467414630|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
129850837|NCT01490060|467414631|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
129850838|NCT01490060|467414632|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
129850839|NCT01877421|467414633|FG000|Phase 2|Lost to Follow-up|0|||
129850840|NCT01877421|467414634|FG001|Phase 2|Lost to Follow-up|0|||
129850841|NCT01877421|467414635|FG002|Phase 2|Lost to Follow-up|0|||
129850842|NCT01877421|467414636|FG003|Phase 2|Lost to Follow-up|0|||
129850843|NCT01877421|467414637|FG004|Phase 2|Lost to Follow-up|0|||
129850844|NCT01877421|467414638|FG005|Phase 2|Lost to Follow-up|0|||
129850845|NCT01877421|467414639|FG006|Phase 2|Lost to Follow-up|1|||
129850846|NCT01877421|467414640|FG007|Phase 2|Lost to Follow-up|0|||
129850847|NCT01877421|467414641|FG008|Phase 2|Lost to Follow-up|0|||
129850848|NCT01877421|467414642|FG009|Phase 2|Lost to Follow-up|0|||
129850849|NCT01877421|467414643|FG010|Phase 2|Lost to Follow-up|0|||
129850850|NCT01877421|467414644|FG011|Phase 2|Lost to Follow-up|0|||
129850851|NCT01877421|467414645|FG012|Phase 2|Lost to Follow-up|0|||
129850852|NCT01877421|467414646|FG013|Phase 2|Lost to Follow-up|0|||
129850853|NCT01877421|467414647|FG014|Phase 2|Lost to Follow-up|0|||
129850854|NCT01877421|467414648|FG015|Phase 2|Lost to Follow-up|0|||
129850855|NCT01877421|467414649|FG016|Phase 2|Lost to Follow-up|0|||
129850856|NCT01877421|467414650|FG017|Phase 2|Lost to Follow-up|0|||
129850857|NCT01877421|467414633|FG000|Phase 2|Withdrawal by Subject|0|||
129850858|NCT01877421|467414634|FG001|Phase 2|Withdrawal by Subject|0|||
129850859|NCT01877421|467414635|FG002|Phase 2|Withdrawal by Subject|0|||
129850860|NCT01877421|467414636|FG003|Phase 2|Withdrawal by Subject|0|||
129850861|NCT01877421|467414637|FG004|Phase 2|Withdrawal by Subject|0|||
129850862|NCT01877421|467414638|FG005|Phase 2|Withdrawal by Subject|0|||
129850863|NCT01877421|467414639|FG006|Phase 2|Withdrawal by Subject|0|||
129850864|NCT01877421|467414640|FG007|Phase 2|Withdrawal by Subject|0|||
129850865|NCT01877421|467414641|FG008|Phase 2|Withdrawal by Subject|1|||
129850866|NCT01877421|467414642|FG009|Phase 2|Withdrawal by Subject|0|||
129850867|NCT01877421|467414643|FG010|Phase 2|Withdrawal by Subject|1|||
129850868|NCT01877421|467414644|FG011|Phase 2|Withdrawal by Subject|0|||
129850869|NCT01877421|467414645|FG012|Phase 2|Withdrawal by Subject|1|||
129850870|NCT01877421|467414646|FG013|Phase 2|Withdrawal by Subject|0|||
129850871|NCT01877421|467414647|FG014|Phase 2|Withdrawal by Subject|0|||
129850872|NCT01877421|467414648|FG015|Phase 2|Withdrawal by Subject|1|||
129850873|NCT01877421|467414649|FG016|Phase 2|Withdrawal by Subject|0|||
129850874|NCT01877421|467414650|FG017|Phase 2|Withdrawal by Subject|0|||
129850875|NCT01877421|467414633|FG000|Phase 2|Protocol Violation|0|||
129850876|NCT01877421|467414634|FG001|Phase 2|Protocol Violation|0|||
129850877|NCT01877421|467414635|FG002|Phase 2|Protocol Violation|0|||
129850878|NCT01877421|467414636|FG003|Phase 2|Protocol Violation|0|||
129850879|NCT01877421|467414637|FG004|Phase 2|Protocol Violation|0|||
129850880|NCT01877421|467414638|FG005|Phase 2|Protocol Violation|0|||
129850881|NCT01877421|467414639|FG006|Phase 2|Protocol Violation|0|||
129850882|NCT01877421|467414640|FG007|Phase 2|Protocol Violation|0|||
129850883|NCT01877421|467414641|FG008|Phase 2|Protocol Violation|0|||
129850884|NCT01877421|467414642|FG009|Phase 2|Protocol Violation|0|||
129850885|NCT01877421|467414643|FG010|Phase 2|Protocol Violation|1|||
129850886|NCT01877421|467414644|FG011|Phase 2|Protocol Violation|0|||
129850887|NCT01877421|467414645|FG012|Phase 2|Protocol Violation|0|||
129850888|NCT01877421|467414646|FG013|Phase 2|Protocol Violation|0|||
129850889|NCT01877421|467414647|FG014|Phase 2|Protocol Violation|0|||
129850890|NCT01877421|467414648|FG015|Phase 2|Protocol Violation|0|||
129850891|NCT01877421|467414649|FG016|Phase 2|Protocol Violation|0|||
129850892|NCT01877421|467414650|FG017|Phase 2|Protocol Violation|0|||
129850893|NCT01047683|467414651|FG000|Overall Study|Adverse Event|3|||
129850894|NCT01047683|467414652|FG001|Overall Study|Adverse Event|1|||
129850895|NCT01047683|467414653|FG002|Overall Study|Adverse Event|0|||
129850896|NCT01047683|467414651|FG000|Overall Study|Withdrew Consent|1|||
129850897|NCT01047683|467414652|FG001|Overall Study|Withdrew Consent|4|||
129850898|NCT01047683|467414653|FG002|Overall Study|Withdrew Consent|2|||
129850899|NCT01047683|467414651|FG000|Overall Study|Lost to Follow-up|0|||
129904676|NCT01087762|467612888|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
129904677|NCT01087762|467612889|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
129904678|NCT01087762|467612890|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
129904679|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
129904680|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
129904681|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
129904682|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
129904683|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
129904684|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
129904685|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
129904686|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
129904687|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
129904688|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
129904689|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
129904690|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
129904691|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
129904692|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
129904693|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
129904694|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
129904695|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
129904696|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
129904697|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
129904698|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
129904699|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
129904700|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
129904701|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
129904702|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
129904703|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
129904704|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
129904705|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
129904706|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
129904707|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
129904708|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
129904709|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
129904710|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
129904711|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
129904712|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
129904713|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
129904714|NCT01087762|467612886|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
129904715|NCT01087762|467612887|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
129904716|NCT01087762|467612888|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
129904717|NCT01087762|467612889|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
129904718|NCT01087762|467612890|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
129904719|NCT01405924|467612893|FG000|Overall Study|Protocol Violation|8|||
129904720|NCT01405924|467612893|FG000|Overall Study|Missing/Incomplete Data|2|||
129904721|NCT03184558|467612894|FG000|Overall Study|Withdrawal by Subject|2|||
129904722|NCT03184558|467612894|FG000|Overall Study|Death|16|||
129904723|NCT03184558|467612894|FG000|Overall Study|Lost to Follow-up|2|||
129904724|NCT03184558|467612894|FG000|Overall Study|Other|9|||
129904725|NCT00723450|467612902|FG000|Open-Label Phase|Adverse Event|26|||
129904726|NCT00723450|467612903|FG001|Open-Label Phase|Adverse Event|0|||
129904727|NCT00723450|467612904|FG002|Open-Label Phase|Adverse Event|0|||
129904728|NCT00723450|467612902|FG000|Open-Label Phase|Lack of Efficacy|18|||
129904729|NCT00723450|467612903|FG001|Open-Label Phase|Lack of Efficacy|0|||
129904730|NCT00723450|467612904|FG002|Open-Label Phase|Lack of Efficacy|0|||
129904731|NCT00723450|467612902|FG000|Open-Label Phase|Protocol Violation|35|||
129904732|NCT00723450|467612903|FG001|Open-Label Phase|Protocol Violation|0|||
129904733|NCT00723450|467612904|FG002|Open-Label Phase|Protocol Violation|0|||
129904734|NCT00723450|467612902|FG000|Open-Label Phase|Lost to Follow-up|7|||
129904735|NCT00723450|467612903|FG001|Open-Label Phase|Lost to Follow-up|0|||
129904736|NCT00723450|467612904|FG002|Open-Label Phase|Lost to Follow-up|0|||
129904737|NCT00723450|467612902|FG000|Open-Label Phase|Physician Decision|2|||
129904738|NCT00723450|467612903|FG001|Open-Label Phase|Physician Decision|0|||
129904739|NCT00723450|467612904|FG002|Open-Label Phase|Physician Decision|0|||
129904740|NCT00723450|467612902|FG000|Open-Label Phase|Withdrawal by Subject|37|||
129904741|NCT00723450|467612903|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129904742|NCT00723450|467612904|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129904743|NCT00723450|467612902|FG000|Randomized Phase|Adverse Event|0|||
129904744|NCT00723450|467612903|FG001|Randomized Phase|Adverse Event|26|||
129904745|NCT00723450|467612904|FG002|Randomized Phase|Adverse Event|17|||
129904746|NCT00723450|467612902|FG000|Randomized Phase|Lack of Efficacy|0|||
129850900|NCT01047683|467414652|FG001|Overall Study|Lost to Follow-up|1|||
129850901|NCT01047683|467414653|FG002|Overall Study|Lost to Follow-up|0|||
129850902|NCT01047683|467414651|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
129850903|NCT01047683|467414652|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
129850904|NCT01047683|467414653|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
129850905|NCT03698773|467414655|FG000|Overall Study|Lost to Follow-up|2|||
129850906|NCT03698773|467414656|FG001|Overall Study|Lost to Follow-up|1|||
129850907|NCT00908960|467414657|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
129850908|NCT00908960|467414658|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
129850909|NCT00908960|467414659|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
129850910|NCT05074433|467414660|FG000|Overall Study|Adverse Event|0|||
129850911|NCT05074433|467414661|FG001|Overall Study|Adverse Event|2|||
129850912|NCT05074433|467414662|FG002|Overall Study|Adverse Event|0|||
129850913|NCT05074433|467414663|FG003|Overall Study|Adverse Event|1|||
129850914|NCT05074433|467414660|FG000|Overall Study|Sponsor Request|0|||
129850915|NCT05074433|467414661|FG001|Overall Study|Sponsor Request|1|||
129850916|NCT05074433|467414662|FG002|Overall Study|Sponsor Request|1|||
129850917|NCT05074433|467414663|FG003|Overall Study|Sponsor Request|0|||
129850918|NCT05074433|467414660|FG000|Overall Study|Death|1|||
129850919|NCT05074433|467414661|FG001|Overall Study|Death|0|||
129850920|NCT05074433|467414662|FG002|Overall Study|Death|0|||
129850921|NCT05074433|467414663|FG003|Overall Study|Death|0|||
129850922|NCT05074433|467414660|FG000|Overall Study|Lost to Follow-up|0|||
129850923|NCT05074433|467414661|FG001|Overall Study|Lost to Follow-up|0|||
129850924|NCT05074433|467414662|FG002|Overall Study|Lost to Follow-up|2|||
129850925|NCT05074433|467414663|FG003|Overall Study|Lost to Follow-up|0|||
129850926|NCT05074433|467414660|FG000|Overall Study|Subject Decision|8|||
129850927|NCT05074433|467414661|FG001|Overall Study|Subject Decision|6|||
129850928|NCT05074433|467414662|FG002|Overall Study|Subject Decision|4|||
129850929|NCT05074433|467414663|FG003|Overall Study|Subject Decision|5|||
129850930|NCT01158924|467414665|FG000|Overall Study|Withdrawal by Subject|1|||
129850931|NCT01158924|467414666|FG001|Overall Study|Withdrawal by Subject|2|||
129850932|NCT01158924|467414665|FG000|Overall Study|Lost to Follow-up|0|||
129850933|NCT01158924|467414666|FG001|Overall Study|Lost to Follow-up|1|||
129850934|NCT03795922|467414667|FG000|Overall Study|Adverse Event|2|||
129850935|NCT03795922|467414668|FG001|Overall Study|Adverse Event|1|||
129850936|NCT03795922|467414667|FG000|Overall Study|Withdrawal by Subject|5|||
129850937|NCT03795922|467414668|FG001|Overall Study|Withdrawal by Subject|13|||
129850938|NCT03795922|467414667|FG000|Overall Study|Lost to Follow-up|2|||
129850939|NCT03795922|467414668|FG001|Overall Study|Lost to Follow-up|3|||
129850940|NCT03795922|467414667|FG000|Overall Study|Pregnancy|0|||
129850941|NCT03795922|467414668|FG001|Overall Study|Pregnancy|1|||
129850942|NCT03795922|467414667|FG000|Overall Study|Physician Decision|1|||
129850943|NCT03795922|467414668|FG001|Overall Study|Physician Decision|2|||
129850944|NCT03795922|467414667|FG000|Overall Study|Protocol Violation|0|||
129850945|NCT03795922|467414668|FG001|Overall Study|Protocol Violation|1|||
129850946|NCT03795922|467414667|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
129850947|NCT03795922|467414668|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
129850948|NCT00724451|467414672|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
129850949|NCT00724451|467414672|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
129850950|NCT00724451|467414672|FG000|Overall Study|Not Eligible for Treatment|431|||
129850951|NCT00724451|467414672|FG000|Overall Study|Participant Refused Treatment|89|||
129850952|NCT00724451|467414672|FG000|Overall Study|Never Started Treatment|89|||
129850953|NCT00724451|467414672|FG000|Overall Study|Unknown; No Data Sources Available|9|||
129850954|NCT00724451|467414672|FG000|Overall Study|Physician Decision|116|||
129850955|NCT00724451|467414672|FG000|Overall Study|Withdrawal by Subject|45|||
129850956|NCT00724451|467414672|FG000|Overall Study|Investigator + Participant Decision|13|||
129850957|NCT01260922|467414674|FG000|First Intervention|Withdrawal by Subject|0|||
129850958|NCT01260922|467414675|FG001|First Intervention|Withdrawal by Subject|1|||
129850959|NCT01260922|467414674|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
129850960|NCT01260922|467414675|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
129850961|NCT01260922|467414674|FG000|Second Intervention|Emesis|0|||
129850962|NCT01260922|467414675|FG001|Second Intervention|Emesis|2|||
129850963|NCT02822794|467414680|FG000|Overall Study|Withdrew Consent|1|||
129850964|NCT02822794|467414681|FG001|Overall Study|Withdrew Consent|0|||
129850965|NCT03732248|467414682|FG000|Overall Study|Withdrawal by Subject|1|||
129850966|NCT03732248|467414683|FG001|Overall Study|Withdrawal by Subject|0|||
129850967|NCT01525082|467414688|FG000|Overall Study|Death|1|||
129850968|NCT02480621|467414689|FG000|Randomization|Withdrawal by Subject|1|||
129850969|NCT02480621|467414690|FG001|Randomization|Withdrawal by Subject|0|||
129850970|NCT02480621|467414689|FG000|Randomization|Surgeon did not give intervention|0|||
129850971|NCT02480621|467414690|FG001|Randomization|Surgeon did not give intervention|1|||
129850972|NCT02480621|467414689|FG000|Follow Up|Lost to Follow-up|4|||
129449629|NCT00467779|465945628|FG005|Stage 3|Death|0|||
129850973|NCT02480621|467414690|FG001|Follow Up|Lost to Follow-up|2|||
129850974|NCT03056690|467414691|FG000|Overall Study|Adverse Event|3|||
129850975|NCT03056690|467414692|FG001|Overall Study|Adverse Event|2|||
129850976|NCT03056690|467414691|FG000|Overall Study|Lack of Efficacy|1|||
129850977|NCT03056690|467414692|FG001|Overall Study|Lack of Efficacy|2|||
129850978|NCT03056690|467414691|FG000|Overall Study|Lost to Follow-up|3|||
129850979|NCT03056690|467414692|FG001|Overall Study|Lost to Follow-up|2|||
129850980|NCT03056690|467414691|FG000|Overall Study|Protocol Violation|2|||
129850981|NCT03056690|467414692|FG001|Overall Study|Protocol Violation|2|||
129850982|NCT03056690|467414691|FG000|Overall Study|Withdrawal by Subject|3|||
129850983|NCT03056690|467414692|FG001|Overall Study|Withdrawal by Subject|6|||
129850984|NCT03056690|467414691|FG000|Overall Study|Non-compliance with Study Drug|1|||
129850985|NCT03056690|467414692|FG001|Overall Study|Non-compliance with Study Drug|0|||
129850986|NCT03056690|467414691|FG000|Overall Study|Miscellaneous|1|||
129850987|NCT03056690|467414692|FG001|Overall Study|Miscellaneous|2|||
129850988|NCT02141516|467414699|FG000|Overall Study|Adverse Event|0|||
129850989|NCT02141516|467414700|FG001|Overall Study|Adverse Event|1|||
129850990|NCT02141516|467414701|FG002|Overall Study|Adverse Event|0|||
129850991|NCT02141516|467414699|FG000|Overall Study|Lost to Follow-up|0|||
129850992|NCT02141516|467414700|FG001|Overall Study|Lost to Follow-up|1|||
129850993|NCT02141516|467414701|FG002|Overall Study|Lost to Follow-up|0|||
129850994|NCT02141516|467414699|FG000|Overall Study|Other|0|||
129850995|NCT02141516|467414700|FG001|Overall Study|Other|3|||
129850996|NCT02141516|467414701|FG002|Overall Study|Other|0|||
129850997|NCT01440946|467414702|FG000|Overall Study|Lost to Follow-up|1|||
129850998|NCT01440946|467414703|FG001|Overall Study|Lost to Follow-up|1|||
129850999|NCT01440946|467414702|FG000|Overall Study|Physician Decision|1|||
129851000|NCT01440946|467414703|FG001|Overall Study|Physician Decision|0|||
129851001|NCT00235989|467414710|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851002|NCT00235989|467414711|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851003|NCT00235989|467414712|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851004|NCT00235989|467414713|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851005|NCT00235989|467414714|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
129851006|NCT00235989|467414715|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
129851007|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
129851008|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
129851009|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
129851010|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
129851011|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
129851012|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
129851013|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
129851014|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851015|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
129851016|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851017|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851018|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
129851019|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
129851020|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
129851021|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
129851022|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
129851023|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
129851024|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
129851025|NCT00235989|467414710|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
129851026|NCT00235989|467414711|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
129851027|NCT00235989|467414712|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
129851028|NCT00235989|467414713|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
129851029|NCT00235989|467414714|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
129851030|NCT00235989|467414715|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
129851031|NCT00983580|467414716|FG000|Overall Study|Cancel Prior to treatment|1|||
129851032|NCT00983580|467414717|FG001|Overall Study|Cancel Prior to treatment|3|||
129851033|NCT00983580|467414716|FG000|Overall Study|Protocol Violation|1|||
129851034|NCT00983580|467414717|FG001|Overall Study|Protocol Violation|1|||
129851035|NCT00983580|467414716|FG000|Overall Study|Ineligible|3|||
129851036|NCT00983580|467414717|FG001|Overall Study|Ineligible|0|||
129851037|NCT02316717|467414720|FG000|Overall Study|Adverse Event|2|||
129851038|NCT02316717|467414721|FG001|Overall Study|Adverse Event|2|||
129851039|NCT02316717|467414722|FG002|Overall Study|Adverse Event|0|||
129851040|NCT02316717|467414720|FG000|Overall Study|Lost to Follow-up|1|||
129851041|NCT02316717|467414721|FG001|Overall Study|Lost to Follow-up|2|||
129851042|NCT02316717|467414722|FG002|Overall Study|Lost to Follow-up|1|||
129851043|NCT02316717|467414720|FG000|Overall Study|Non compliance|3|||
129851044|NCT02316717|467414721|FG001|Overall Study|Non compliance|1|||
129851045|NCT02316717|467414722|FG002|Overall Study|Non compliance|0|||
129851046|NCT02316717|467414720|FG000|Overall Study|Protocol Violation|2|||
129851047|NCT02316717|467414721|FG001|Overall Study|Protocol Violation|0|||
129851048|NCT02316717|467414722|FG002|Overall Study|Protocol Violation|0|||
129851049|NCT02316717|467414720|FG000|Overall Study|Withdrawal by Subject|2|||
129851050|NCT02316717|467414721|FG001|Overall Study|Withdrawal by Subject|1|||
129904747|NCT00723450|467612903|FG001|Randomized Phase|Lack of Efficacy|11|||
129851051|NCT02316717|467414722|FG002|Overall Study|Withdrawal by Subject|1|||
129851052|NCT02316717|467414720|FG000|Overall Study|Death|0|||
129851053|NCT02316717|467414721|FG001|Overall Study|Death|0|||
129851054|NCT02316717|467414722|FG002|Overall Study|Death|1|||
129851055|NCT02316717|467414720|FG000|Overall Study|Physician Decision|0|||
129851056|NCT02316717|467414721|FG001|Overall Study|Physician Decision|1|||
129851057|NCT02316717|467414722|FG002|Overall Study|Physician Decision|0|||
129851058|NCT02316717|467414720|FG000|Overall Study|TBC|1|||
129851059|NCT02316717|467414721|FG001|Overall Study|TBC|0|||
129851060|NCT02316717|467414722|FG002|Overall Study|TBC|0|||
129851061|NCT01072201|467414723|FG000|Overall Study|Lost to Follow-up|0|||
129851062|NCT01072201|467414724|FG001|Overall Study|Lost to Follow-up|1|||
129851063|NCT02052466|467414725|FG000|Overall Study|Withdrawal by Subject|1|||
129851064|NCT02052466|467414725|FG000|Overall Study|Acromial fracture|1|||
129851065|NCT00360334|467414726|FG000|Overall Study|Adverse Event|7|||
129851066|NCT00360334|467414727|FG001|Overall Study|Adverse Event|4|||
129851067|NCT00360334|467414726|FG000|Overall Study|Protocol Violation|1|||
129851068|NCT00360334|467414727|FG001|Overall Study|Protocol Violation|1|||
129851069|NCT00360334|467414726|FG000|Overall Study|Physician Decision|2|||
129851070|NCT00360334|467414727|FG001|Overall Study|Physician Decision|3|||
129851071|NCT00360334|467414726|FG000|Overall Study|Lack of Efficacy|0|||
129851072|NCT00360334|467414727|FG001|Overall Study|Lack of Efficacy|1|||
129851073|NCT00360334|467414726|FG000|Overall Study|Entry criterion not met|1|||
129851074|NCT00360334|467414727|FG001|Overall Study|Entry criterion not met|2|||
129851075|NCT00360334|467414726|FG000|Overall Study|Subject decision|8|||
129851076|NCT00360334|467414727|FG001|Overall Study|Subject decision|2|||
129851077|NCT00595582|467414728|FG000|Overall Study|Pilot study that PI terminated|2|||
129851078|NCT00595582|467414728|FG000|Overall Study|Lost to Follow-up|1|||
129851079|NCT00595582|467414728|FG000|Overall Study|Adverse Event|2|||
129851080|NCT00595582|467414728|FG000|Overall Study|Physician Decision|5|||
129851081|NCT01978184|467414730|FG000|Overall Study|Progressive disease|5|||
129851082|NCT01978184|467414731|FG001|Overall Study|Progressive disease|5|||
129851083|NCT01978184|467414730|FG000|Overall Study|Other than PDA|2|||
129851084|NCT01978184|467414731|FG001|Overall Study|Other than PDA|2|||
129851085|NCT01978184|467414730|FG000|Overall Study|Physician Decision|0|||
129851086|NCT01978184|467414731|FG001|Overall Study|Physician Decision|3|||
129851087|NCT01978184|467414730|FG000|Overall Study|Noncompliance|1|||
129851088|NCT01978184|467414731|FG001|Overall Study|Noncompliance|2|||
129851089|NCT01978184|467414730|FG000|Overall Study|Death|1|||
129851090|NCT01978184|467414731|FG001|Overall Study|Death|0|||
129851091|NCT01978184|467414730|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
129851092|NCT01978184|467414731|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
129851093|NCT00965848|467414740|FG000|Overall Study|Protocol Violation|3|||
129851094|NCT00965848|467414741|FG001|Overall Study|Protocol Violation|0|||
129851095|NCT00965848|467414742|FG002|Overall Study|Protocol Violation|1|||
129851096|NCT00965848|467414740|FG000|Overall Study|Death|11|||
129851097|NCT00965848|467414741|FG001|Overall Study|Death|1|||
129851098|NCT00965848|467414742|FG002|Overall Study|Death|5|||
129851099|NCT00965848|467414740|FG000|Overall Study|Lost to Follow-up|0|||
129851100|NCT00965848|467414741|FG001|Overall Study|Lost to Follow-up|0|||
129851101|NCT00965848|467414742|FG002|Overall Study|Lost to Follow-up|1|||
129851102|NCT00965848|467414740|FG000|Overall Study|Withdrawal by Subject|1|||
129851103|NCT00965848|467414741|FG001|Overall Study|Withdrawal by Subject|0|||
129851104|NCT00965848|467414742|FG002|Overall Study|Withdrawal by Subject|0|||
129851105|NCT00965848|467414740|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
129851106|NCT00965848|467414741|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
129851107|NCT00965848|467414742|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
129851108|NCT00965848|467414740|FG000|Overall Study|Not Clinically Evaluable|7|||
129851109|NCT00965848|467414741|FG001|Overall Study|Not Clinically Evaluable|1|||
129851110|NCT00965848|467414742|FG002|Overall Study|Not Clinically Evaluable|1|||
129851111|NCT00965848|467414740|FG000|Overall Study|Other|5|||
129851112|NCT00965848|467414741|FG001|Overall Study|Other|0|||
129851113|NCT00965848|467414742|FG002|Overall Study|Other|1|||
129851114|NCT01328002|467414744|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
129851115|NCT01328002|467414745|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
129851116|NCT01328002|467414744|FG000|Open-Label Period|Adverse Event|8|||
129851117|NCT01328002|467414745|FG001|Open-Label Period|Adverse Event|0|||
129851118|NCT01328002|467414744|FG000|Open-Label Period|Lack of Efficacy|3|||
129851119|NCT01328002|467414745|FG001|Open-Label Period|Lack of Efficacy|0|||
129851120|NCT01328002|467414744|FG000|Open-Label Period|Protocol Violation|2|||
129851121|NCT01328002|467414745|FG001|Open-Label Period|Protocol Violation|0|||
129851122|NCT01328002|467414744|FG000|Open-Label Period|Withdrawal by Subject|9|||
129851123|NCT01328002|467414745|FG001|Open-Label Period|Withdrawal by Subject|0|||
129851124|NCT01328002|467414744|FG000|Open-Label Period|Lost to Follow-up|6|||
129851125|NCT01328002|467414745|FG001|Open-Label Period|Lost to Follow-up|0|||
129851126|NCT01328002|467414744|FG000|Open-Label Period|Other Reason|2|||
129851127|NCT01328002|467414745|FG001|Open-Label Period|Other Reason|0|||
129851128|NCT01328002|467414744|FG000|Double-Blind Period|Adverse Event|1|||
129851129|NCT01328002|467414745|FG001|Double-Blind Period|Adverse Event|0|||
129904748|NCT00723450|467612904|FG002|Randomized Phase|Lack of Efficacy|11|||
129851130|NCT01328002|467414744|FG000|Double-Blind Period|Lack of Efficacy|1|||
129851131|NCT01328002|467414745|FG001|Double-Blind Period|Lack of Efficacy|0|||
129851132|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
129851133|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
129851134|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
129851135|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
129851136|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
129851137|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
129851138|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
129851139|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
129851140|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
129851141|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
129851142|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
129851143|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
129851144|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
129851145|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
129851146|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
129851147|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
129851148|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
129851149|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
129851150|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
129851151|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
129851152|NCT00813761|467414746|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
129851153|NCT00813761|467414747|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
129851154|NCT00813761|467414748|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
129851155|NCT00813761|467414749|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
129851156|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
129851157|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
129851158|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
129851159|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
129851160|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
129851161|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
129851162|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
129851163|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
129851164|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
129851165|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
129851166|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
129851167|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
129851168|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
129851169|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
129851170|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
129851171|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
129851172|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
129851173|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
129851174|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
129851175|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
129851176|NCT00813761|467414746|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
129851177|NCT00813761|467414747|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
129851178|NCT00813761|467414748|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
129851179|NCT00813761|467414749|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
129851180|NCT01208233|467414751|FG000|Overall Study|Adverse Event|0|||
129851181|NCT01208233|467414752|FG001|Overall Study|Adverse Event|1|||
129851182|NCT01208233|467414753|FG002|Overall Study|Adverse Event|2|||
129851183|NCT01208233|467414754|FG003|Overall Study|Adverse Event|0|||
129851184|NCT01208233|467414755|FG004|Overall Study|Adverse Event|3|||
129851185|NCT01208233|467414756|FG005|Overall Study|Adverse Event|5|||
129851186|NCT01208233|467414751|FG000|Overall Study|Death|0|||
129851187|NCT01208233|467414752|FG001|Overall Study|Death|0|||
129851188|NCT01208233|467414753|FG002|Overall Study|Death|0|||
129851189|NCT01208233|467414754|FG003|Overall Study|Death|0|||
129851190|NCT01208233|467414755|FG004|Overall Study|Death|3|||
129851191|NCT01208233|467414756|FG005|Overall Study|Death|5|||
129851192|NCT01208233|467414751|FG000|Overall Study|Did not meet entrance criteria|2|||
129851193|NCT01208233|467414752|FG001|Overall Study|Did not meet entrance criteria|1|||
129851194|NCT01208233|467414753|FG002|Overall Study|Did not meet entrance criteria|1|||
129851195|NCT01208233|467414754|FG003|Overall Study|Did not meet entrance criteria|0|||
129851196|NCT01208233|467414755|FG004|Overall Study|Did not meet entrance criteria|1|||
129851197|NCT01208233|467414756|FG005|Overall Study|Did not meet entrance criteria|0|||
129851198|NCT01208233|467414751|FG000|Overall Study|Medication error without adverse event|0|||
129851199|NCT01208233|467414752|FG001|Overall Study|Medication error without adverse event|0|||
129851200|NCT01208233|467414753|FG002|Overall Study|Medication error without adverse event|0|||
129851201|NCT01208233|467414754|FG003|Overall Study|Medication error without adverse event|0|||
129904749|NCT00723450|467612902|FG000|Randomized Phase|Protocol Violation|0|||
129904750|NCT00723450|467612903|FG001|Randomized Phase|Protocol Violation|9|||
129904751|NCT00723450|467612904|FG002|Randomized Phase|Protocol Violation|13|||
129904752|NCT00723450|467612902|FG000|Randomized Phase|Lost to Follow-up|0|||
129904753|NCT00723450|467612903|FG001|Randomized Phase|Lost to Follow-up|2|||
129904754|NCT00723450|467612904|FG002|Randomized Phase|Lost to Follow-up|3|||
129904755|NCT00723450|467612902|FG000|Randomized Phase|Physician Decision|0|||
129904756|NCT00723450|467612903|FG001|Randomized Phase|Physician Decision|3|||
129904757|NCT00723450|467612904|FG002|Randomized Phase|Physician Decision|1|||
129904758|NCT00723450|467612902|FG000|Randomized Phase|Withdrawal by Subject|0|||
129904759|NCT00723450|467612903|FG001|Randomized Phase|Withdrawal by Subject|14|||
129904760|NCT00723450|467612904|FG002|Randomized Phase|Withdrawal by Subject|22|||
129904761|NCT00770965|467612905|FG000|Safety Set|Withdrawal by Subject|0|||
129904762|NCT00770965|467612906|FG001|Safety Set|Withdrawal by Subject|0|||
129904763|NCT00770965|467612907|FG002|Safety Set|Withdrawal by Subject|0|||
129904764|NCT00770965|467612908|FG003|Safety Set|Withdrawal by Subject|1|||
129904765|NCT00770965|467612905|FG000|Safety Set|Protocol deviation|0|||
129904766|NCT00770965|467612906|FG001|Safety Set|Protocol deviation|0|||
129904767|NCT00770965|467612907|FG002|Safety Set|Protocol deviation|1|||
129904768|NCT00770965|467612908|FG003|Safety Set|Protocol deviation|0|||
129904769|NCT00770965|467612905|FG000|Excluded Set|Administrative problems|14|||
129904770|NCT00770965|467612906|FG001|Excluded Set|Administrative problems|12|||
129904771|NCT00770965|467612907|FG002|Excluded Set|Administrative problems|12|||
129904772|NCT00770965|467612908|FG003|Excluded Set|Administrative problems|10|||
129904773|NCT00770965|467612905|FG000|Excluded Set|Withdrawal by Subject|1|||
129904774|NCT00770965|467612906|FG001|Excluded Set|Withdrawal by Subject|1|||
129904775|NCT00770965|467612907|FG002|Excluded Set|Withdrawal by Subject|2|||
129904776|NCT00770965|467612908|FG003|Excluded Set|Withdrawal by Subject|3|||
129904777|NCT03192046|467612910|FG000|Overall Study|Withdrawal by Subject|1|||
129904778|NCT03192046|467612911|FG001|Overall Study|Withdrawal by Subject|1|||
129904779|NCT00762606|467612912|FG000|Overall Study|Lost to Follow-up|18|||
129904780|NCT00762606|467612913|FG001|Overall Study|Lost to Follow-up|13|||
129904781|NCT01505881|467612914|FG000|Overall Study|Adverse Event|0|||
129904782|NCT01505881|467612915|FG001|Overall Study|Adverse Event|1|||
129904783|NCT01505881|467612914|FG000|Overall Study|Lost to Follow-up|2|||
129904784|NCT01505881|467612915|FG001|Overall Study|Lost to Follow-up|0|||
129904785|NCT01505881|467612914|FG000|Overall Study|Withdrawal by Subject|2|||
129904786|NCT01505881|467612915|FG001|Overall Study|Withdrawal by Subject|0|||
129904787|NCT00842257|467612916|FG000|Overall Study|Adverse Event|1|||
129904788|NCT00395018|467612917|FG000|On-Treatment|Death|4|||
129904789|NCT00395018|467612917|FG000|On-Treatment|Other Reason|2|||
129904790|NCT00395018|467612917|FG000|On-Treatment|Poor/non-compliance|2|||
129904791|NCT00395018|467612917|FG000|On-Treatment|Subject no longer meets study criteria|2|||
129904792|NCT00395018|467612917|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
129904793|NCT00395018|467612917|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
129851202|NCT01208233|467414755|FG004|Overall Study|Medication error without adverse event|0|||
129851203|NCT01208233|467414756|FG005|Overall Study|Medication error without adverse event|1|||
129851204|NCT01208233|467414751|FG000|Overall Study|Study terminated by sponsor|0|||
129851205|NCT01208233|467414752|FG001|Overall Study|Study terminated by sponsor|0|||
129851206|NCT01208233|467414753|FG002|Overall Study|Study terminated by sponsor|0|||
129851207|NCT01208233|467414754|FG003|Overall Study|Study terminated by sponsor|0|||
129851208|NCT01208233|467414755|FG004|Overall Study|Study terminated by sponsor|10|||
129851209|NCT01208233|467414756|FG005|Overall Study|Study terminated by sponsor|7|||
129851210|NCT01208233|467414751|FG000|Overall Study|Protocol Violation|0|||
129851211|NCT01208233|467414752|FG001|Overall Study|Protocol Violation|0|||
129851212|NCT01208233|467414753|FG002|Overall Study|Protocol Violation|0|||
129851213|NCT01208233|467414754|FG003|Overall Study|Protocol Violation|0|||
129904794|NCT00395018|467612917|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
129904795|NCT04439799|467612918|FG000|Overall Study|Lost to Follow-up|6|||
129904796|NCT04439799|467612919|FG001|Overall Study|Lost to Follow-up|6|||
129904797|NCT04439799|467612918|FG000|Overall Study|Withdrawal by Subject|2|||
129904798|NCT04439799|467612919|FG001|Overall Study|Withdrawal by Subject|6|||
129904799|NCT04439799|467612918|FG000|Overall Study|Adverse Event|2|||
129904800|NCT04439799|467612919|FG001|Overall Study|Adverse Event|5|||
129904801|NCT01391130|467612927|FG000|Overall Study|Withdrawal by Subject|3|||
129904802|NCT01391130|467612928|FG001|Overall Study|Withdrawal by Subject|2|||
129904803|NCT01391130|467612927|FG000|Overall Study|Physician Decision|2|||
129904804|NCT01391130|467612928|FG001|Overall Study|Physician Decision|3|||
129904805|NCT01391130|467612927|FG000|Overall Study|Did not Receive Drug|1|||
129851214|NCT01208233|467414755|FG004|Overall Study|Protocol Violation|3|||
129851215|NCT01208233|467414756|FG005|Overall Study|Protocol Violation|0|||
129904806|NCT01391130|467612928|FG001|Overall Study|Did not Receive Drug|1|||
129904807|NCT03478696|467612929|FG000|Overall Study|Adverse Event|1|||
129904808|NCT03478696|467612930|FG001|Overall Study|Adverse Event|5|||
129904809|NCT03478696|467612929|FG000|Overall Study|Lost to Follow-up|1|||
129904810|NCT03478696|467612930|FG001|Overall Study|Lost to Follow-up|0|||
129904811|NCT03478696|467612929|FG000|Overall Study|Physician Decision|6|||
129904812|NCT03478696|467612930|FG001|Overall Study|Physician Decision|3|||
129904813|NCT03478696|467612929|FG000|Overall Study|Withdrawal by Subject|9|||
129904814|NCT03478696|467612930|FG001|Overall Study|Withdrawal by Subject|4|||
129904815|NCT03615924|467612931|FG000|Overall Study|Withdrawal by Subject|2|||
129904816|NCT03615924|467612932|FG001|Overall Study|Withdrawal by Subject|5|||
129904817|NCT03615924|467612931|FG000|Overall Study|Death|3|||
129904818|NCT03615924|467612932|FG001|Overall Study|Death|1|||
129904819|NCT03615924|467612931|FG000|Overall Study|Lost to Follow-up|1|||
129904820|NCT03615924|467612932|FG001|Overall Study|Lost to Follow-up|0|||
129904821|NCT03615924|467612931|FG000|Overall Study|Randomized in error|1|||
129904822|NCT03615924|467612932|FG001|Overall Study|Randomized in error|0|||
129904823|NCT03615924|467612931|FG000|Overall Study|Study termination by Sponsor|94|||
129904824|NCT03615924|467612932|FG001|Overall Study|Study termination by Sponsor|86|||
129904825|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
129904826|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
129904827|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
129904828|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
129904829|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
129904830|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
129904831|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
129904832|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
129904833|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
129904834|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
129904835|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
129904836|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
129904837|NCT00790790|467612944|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
129904838|NCT00790790|467612945|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
129904839|NCT00790790|467612946|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
129904840|NCT02808338|467612947|FG000|Screening|Screen Failure|10|||
129904841|NCT02808338|467612947|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
129904842|NCT02808338|467612947|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
129904843|NCT00057837|467612948|FG000|Overall Study|Progression/relapse|12|||
129904844|NCT00057837|467612949|FG001|Overall Study|Progression/relapse|14|||
129904845|NCT00057837|467612948|FG000|Overall Study|Adverse Event|2|||
129904846|NCT00057837|467612949|FG001|Overall Study|Adverse Event|12|||
129904847|NCT00057837|467612948|FG000|Overall Study|Death|5|||
129904848|NCT00057837|467612949|FG001|Overall Study|Death|4|||
129904849|NCT00057837|467612948|FG000|Overall Study|Withdrawal by Subject|5|||
129904850|NCT00057837|467612949|FG001|Overall Study|Withdrawal by Subject|3|||
129904851|NCT00057837|467612948|FG000|Overall Study|Alternative therapy|0|||
129904852|NCT00057837|467612949|FG001|Overall Study|Alternative therapy|1|||
129904853|NCT00057837|467612948|FG000|Overall Study|Other complicating disease|2|||
129904854|NCT00057837|467612949|FG001|Overall Study|Other complicating disease|1|||
129904855|NCT00057837|467612948|FG000|Overall Study|Physician Decision|1|||
129904856|NCT00057837|467612949|FG001|Overall Study|Physician Decision|0|||
129904857|NCT00057837|467612948|FG000|Overall Study|Ineligible|3|||
129904858|NCT00057837|467612949|FG001|Overall Study|Ineligible|3|||
129904859|NCT00057837|467612948|FG000|Overall Study|Never started treatment|1|||
129904860|NCT00057837|467612949|FG001|Overall Study|Never started treatment|1|||
129904861|NCT02537522|467612950|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
129904862|NCT02537522|467612951|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
129904863|NCT02537522|467612952|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
129904864|NCT02537522|467612953|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
129904865|NCT02537522|467612950|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
129904866|NCT02537522|467612951|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
129904867|NCT02537522|467612952|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
129904868|NCT02537522|467612953|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
129904869|NCT02537522|467612950|FG000|Phase I - Contralateral|incorrect randomization|0|||
129904870|NCT02537522|467612951|FG001|Phase I - Contralateral|incorrect randomization|1|||
129904871|NCT02537522|467612952|FG002|Phase I - Contralateral|incorrect randomization|0|||
129904872|NCT02537522|467612953|FG003|Phase I - Contralateral|incorrect randomization|0|||
129904873|NCT02537522|467612950|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
129904874|NCT02537522|467612951|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
129904875|NCT02537522|467612952|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
129904876|NCT02537522|467612953|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
129904877|NCT02537522|467612950|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
129904878|NCT02537522|467612951|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
129904879|NCT02537522|467612952|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
129904880|NCT02537522|467612953|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
129904881|NCT02570711|467612955|FG000|Overall Study|Death|1|||
129904882|NCT02570711|467612956|FG001|Overall Study|Death|0|||
129904883|NCT02570711|467612955|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
129904884|NCT02570711|467612956|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
129904885|NCT02547922|467612957|FG000|Overall Study|Withdrawal by Subject|9|||
129904886|NCT02547922|467612958|FG001|Overall Study|Withdrawal by Subject|6|||
129904887|NCT02547922|467612959|FG002|Overall Study|Withdrawal by Subject|10|||
129904888|NCT02547922|467612957|FG000|Overall Study|Adverse Event|3|||
129904889|NCT02547922|467612958|FG001|Overall Study|Adverse Event|1|||
129904890|NCT02547922|467612959|FG002|Overall Study|Adverse Event|2|||
129904891|NCT02547922|467612957|FG000|Overall Study|Lost to Follow-up|1|||
129904892|NCT02547922|467612958|FG001|Overall Study|Lost to Follow-up|0|||
129904893|NCT02547922|467612959|FG002|Overall Study|Lost to Follow-up|0|||
129904894|NCT02547922|467612957|FG000|Overall Study|Lack of Efficacy|5|||
129904895|NCT02547922|467612958|FG001|Overall Study|Lack of Efficacy|7|||
129904896|NCT02547922|467612959|FG002|Overall Study|Lack of Efficacy|4|||
129904897|NCT02547922|467612957|FG000|Overall Study|Death|1|||
129904898|NCT02547922|467612958|FG001|Overall Study|Death|0|||
129904899|NCT02547922|467612959|FG002|Overall Study|Death|0|||
129904900|NCT02547922|467612957|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
129904901|NCT02547922|467612958|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
129904902|NCT02547922|467612959|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
129904903|NCT02547922|467612957|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
129904904|NCT02547922|467612958|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
129904905|NCT02547922|467612959|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
129904906|NCT02547922|467612957|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
129904907|NCT02547922|467612958|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
129904908|NCT02547922|467612959|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
129904909|NCT02547922|467612957|FG000|Overall Study|Physician Decision|2|||
129904910|NCT02547922|467612958|FG001|Overall Study|Physician Decision|1|||
129904911|NCT02547922|467612959|FG002|Overall Study|Physician Decision|2|||
129904912|NCT02547922|467612957|FG000|Overall Study|Patients did not receive IP|1|||
129904913|NCT02547922|467612958|FG001|Overall Study|Patients did not receive IP|1|||
129904914|NCT02547922|467612959|FG002|Overall Study|Patients did not receive IP|0|||
129904915|NCT01317420|467612965|FG000|Overall Study|Progressive disease according to RECIST|2|||
129904916|NCT01317420|467612966|FG001|Overall Study|Progressive disease according to RECIST|3|||
129904917|NCT01317420|467612967|FG002|Overall Study|Progressive disease according to RECIST|3|||
129904918|NCT01317420|467612968|FG003|Overall Study|Progressive disease according to RECIST|3|||
129904919|NCT01317420|467612969|FG004|Overall Study|Progressive disease according to RECIST|3|||
129904920|NCT01317420|467612970|FG005|Overall Study|Progressive disease according to RECIST|3|||
129904921|NCT01317420|467612971|FG006|Overall Study|Progressive disease according to RECIST|3|||
129904922|NCT01317420|467612972|FG007|Overall Study|Progressive disease according to RECIST|3|||
129904923|NCT01317420|467612973|FG008|Overall Study|Progressive disease according to RECIST|3|||
129904924|NCT01317420|467612974|FG009|Overall Study|Progressive disease according to RECIST|2|||
129904925|NCT01317420|467612975|FG010|Overall Study|Progressive disease according to RECIST|3|||
129904926|NCT01317420|467612976|FG011|Overall Study|Progressive disease according to RECIST|11|||
129904927|NCT01317420|467612977|FG012|Overall Study|Progressive disease according to RECIST|16|||
129904928|NCT01317420|467612965|FG000|Overall Study|Other adverse event|1|||
129904929|NCT01317420|467612966|FG001|Overall Study|Other adverse event|0|||
129904930|NCT01317420|467612967|FG002|Overall Study|Other adverse event|0|||
129904931|NCT01317420|467612968|FG003|Overall Study|Other adverse event|0|||
129904932|NCT01317420|467612969|FG004|Overall Study|Other adverse event|0|||
129904933|NCT01317420|467612970|FG005|Overall Study|Other adverse event|0|||
129904934|NCT01317420|467612971|FG006|Overall Study|Other adverse event|0|||
129904935|NCT01317420|467612972|FG007|Overall Study|Other adverse event|0|||
129904936|NCT01317420|467612973|FG008|Overall Study|Other adverse event|0|||
129904937|NCT01317420|467612974|FG009|Overall Study|Other adverse event|0|||
129904938|NCT01317420|467612975|FG010|Overall Study|Other adverse event|0|||
129904939|NCT01317420|467612976|FG011|Overall Study|Other adverse event|0|||
129904940|NCT01317420|467612977|FG012|Overall Study|Other adverse event|2|||
129904941|NCT01317420|467612965|FG000|Overall Study|Non-compliant with protocol|0|||
129904942|NCT01317420|467612966|FG001|Overall Study|Non-compliant with protocol|0|||
129904943|NCT01317420|467612967|FG002|Overall Study|Non-compliant with protocol|0|||
129904944|NCT01317420|467612968|FG003|Overall Study|Non-compliant with protocol|0|||
129904945|NCT01317420|467612969|FG004|Overall Study|Non-compliant with protocol|0|||
129904946|NCT01317420|467612970|FG005|Overall Study|Non-compliant with protocol|0|||
129904947|NCT01317420|467612971|FG006|Overall Study|Non-compliant with protocol|0|||
129904948|NCT01317420|467612972|FG007|Overall Study|Non-compliant with protocol|0|||
129904949|NCT01317420|467612973|FG008|Overall Study|Non-compliant with protocol|0|||
129904950|NCT01317420|467612974|FG009|Overall Study|Non-compliant with protocol|0|||
129904951|NCT01317420|467612975|FG010|Overall Study|Non-compliant with protocol|0|||
129904952|NCT01317420|467612976|FG011|Overall Study|Non-compliant with protocol|0|||
129904953|NCT01317420|467612977|FG012|Overall Study|Non-compliant with protocol|1|||
129904954|NCT01317420|467612965|FG000|Overall Study|Refused to cont. taking trial medication|0|||
129904955|NCT01317420|467612966|FG001|Overall Study|Refused to cont. taking trial medication|0|||
129904956|NCT01317420|467612967|FG002|Overall Study|Refused to cont. taking trial medication|0|||
129904957|NCT01317420|467612968|FG003|Overall Study|Refused to cont. taking trial medication|0|||
129904958|NCT01317420|467612969|FG004|Overall Study|Refused to cont. taking trial medication|0|||
129904959|NCT01317420|467612970|FG005|Overall Study|Refused to cont. taking trial medication|0|||
129904960|NCT01317420|467612971|FG006|Overall Study|Refused to cont. taking trial medication|0|||
129904961|NCT01317420|467612972|FG007|Overall Study|Refused to cont. taking trial medication|0|||
129904962|NCT01317420|467612973|FG008|Overall Study|Refused to cont. taking trial medication|0|||
129904963|NCT01317420|467612974|FG009|Overall Study|Refused to cont. taking trial medication|0|||
129904964|NCT01317420|467612975|FG010|Overall Study|Refused to cont. taking trial medication|0|||
129904965|NCT01317420|467612976|FG011|Overall Study|Refused to cont. taking trial medication|0|||
129904966|NCT01317420|467612977|FG012|Overall Study|Refused to cont. taking trial medication|1|||
129904967|NCT01317420|467612965|FG000|Overall Study|Reason other than those specified|0|||
129904968|NCT01317420|467612966|FG001|Overall Study|Reason other than those specified|0|||
129904969|NCT01317420|467612967|FG002|Overall Study|Reason other than those specified|0|||
129904970|NCT01317420|467612968|FG003|Overall Study|Reason other than those specified|0|||
129904971|NCT01317420|467612969|FG004|Overall Study|Reason other than those specified|0|||
129904972|NCT01317420|467612970|FG005|Overall Study|Reason other than those specified|0|||
129904973|NCT01317420|467612971|FG006|Overall Study|Reason other than those specified|0|||
129904974|NCT01317420|467612972|FG007|Overall Study|Reason other than those specified|0|||
129904975|NCT01317420|467612973|FG008|Overall Study|Reason other than those specified|0|||
129904976|NCT01317420|467612974|FG009|Overall Study|Reason other than those specified|1|||
129904977|NCT01317420|467612975|FG010|Overall Study|Reason other than those specified|0|||
129904978|NCT01317420|467612976|FG011|Overall Study|Reason other than those specified|0|||
129904979|NCT01317420|467612977|FG012|Overall Study|Reason other than those specified|0|||
129904980|NCT00102063|467612979|FG000|Overall Study|Lack of Efficacy|5|||
129851216|NCT01208233|467414751|FG000|Overall Study|Other|2|||
129851217|NCT01208233|467414752|FG001|Overall Study|Other|1|||
129851218|NCT01208233|467414753|FG002|Overall Study|Other|0|||
129851219|NCT01208233|467414754|FG003|Overall Study|Other|0|||
129851220|NCT01208233|467414755|FG004|Overall Study|Other|0|||
129851221|NCT01208233|467414756|FG005|Overall Study|Other|1|||
129851222|NCT01208233|467414751|FG000|Overall Study|Withdrawal by Subject|1|||
129851223|NCT01208233|467414752|FG001|Overall Study|Withdrawal by Subject|0|||
129851224|NCT01208233|467414753|FG002|Overall Study|Withdrawal by Subject|1|||
129851225|NCT01208233|467414754|FG003|Overall Study|Withdrawal by Subject|1|||
129851226|NCT01208233|467414755|FG004|Overall Study|Withdrawal by Subject|4|||
129851227|NCT01208233|467414756|FG005|Overall Study|Withdrawal by Subject|2|||
129851228|NCT01181895|467414757|FG000|Overall Study|Adverse Event|3|||
129851229|NCT01181895|467414758|FG001|Overall Study|Adverse Event|1|||
129851230|NCT01181895|467414759|FG002|Overall Study|Adverse Event|1|||
129851231|NCT01181895|467414757|FG000|Overall Study|Lack of Efficacy|8|||
129851232|NCT01181895|467414758|FG001|Overall Study|Lack of Efficacy|9|||
129851233|NCT01181895|467414759|FG002|Overall Study|Lack of Efficacy|9|||
129851234|NCT01181895|467414757|FG000|Overall Study|Protocol Violation|2|||
129851235|NCT01181895|467414758|FG001|Overall Study|Protocol Violation|1|||
129851236|NCT01181895|467414759|FG002|Overall Study|Protocol Violation|0|||
129851237|NCT01181895|467414757|FG000|Overall Study|Lost to Follow-up|0|||
129851238|NCT01181895|467414758|FG001|Overall Study|Lost to Follow-up|1|||
129851239|NCT01181895|467414759|FG002|Overall Study|Lost to Follow-up|2|||
129851240|NCT01181895|467414757|FG000|Overall Study|Investigator Discretion|1|||
129851241|NCT01181895|467414758|FG001|Overall Study|Investigator Discretion|2|||
129851242|NCT01181895|467414759|FG002|Overall Study|Investigator Discretion|1|||
129851243|NCT01181895|467414757|FG000|Overall Study|Withdrawal by Subject|3|||
129851244|NCT01181895|467414758|FG001|Overall Study|Withdrawal by Subject|0|||
129851245|NCT01181895|467414759|FG002|Overall Study|Withdrawal by Subject|5|||
129851246|NCT00555438|467414764|FG000|10 Days Post-operative|Death|4|||
129851247|NCT00555438|467414764|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
129851248|NCT01114516|467414768|FG000|Overall Study|Lost to Follow-up|2|||
129851249|NCT01114516|467414769|FG001|Overall Study|Lost to Follow-up|1|||
129851250|NCT00061048|467414770|FG000|Overall Study|Adverse Event|2|||
129851251|NCT00061048|467414770|FG000|Overall Study|disease progression|20|||
129851252|NCT01431508|467414771|FG000|Overall Study|Lack of Efficacy|1|||
129851253|NCT01431508|467414771|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
129851254|NCT00129259|467414772|FG000|Overall Study|Lost to Follow-up|1|||
129851255|NCT00129259|467414773|FG001|Overall Study|Lost to Follow-up|1|||
129851256|NCT00129259|467414772|FG000|Overall Study|Withdrawal by Subject|2|||
129851257|NCT00129259|467414773|FG001|Overall Study|Withdrawal by Subject|1|||
129851258|NCT00129259|467414772|FG000|Overall Study|Only available minimal phone assessments|0|||
129851259|NCT00129259|467414773|FG001|Overall Study|Only available minimal phone assessments|1|||
129851260|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851261|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851262|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851263|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129904981|NCT00102063|467612980|FG001|Overall Study|Lack of Efficacy|1|||
129904982|NCT00102063|467612981|FG002|Overall Study|Lack of Efficacy|1|||
129904983|NCT00102063|467612979|FG000|Overall Study|Adverse Event|7|||
129851264|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851265|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851266|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851267|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851268|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851269|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851270|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851271|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
129851272|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851273|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851274|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851275|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
129851276|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851277|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
129851278|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
129851279|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
129851280|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
129851281|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
129851282|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
129851283|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
129851284|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
129851285|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
129851286|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
129851287|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
129851288|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851289|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851290|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851291|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
129851292|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851293|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851294|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851295|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851296|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851297|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
129851298|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
129851299|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851300|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851301|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
129851302|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
129851303|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
129851304|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851305|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129904984|NCT00102063|467612980|FG001|Overall Study|Adverse Event|4|||
129904985|NCT00102063|467612981|FG002|Overall Study|Adverse Event|2|||
129904986|NCT00102063|467612979|FG000|Overall Study|Withdrawal by Subject|4|||
129851306|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851307|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
129851308|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851309|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851310|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851311|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851312|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851313|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
129851314|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851315|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851316|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851317|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851318|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129904987|NCT00102063|467612980|FG001|Overall Study|Withdrawal by Subject|12|||
129851319|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
129851320|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851321|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851322|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851323|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
129851324|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851325|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851326|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851327|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851328|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851329|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
129851330|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851331|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851332|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851333|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851334|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851335|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851336|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851337|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851338|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851339|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
129851340|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851341|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851342|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851343|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851344|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851345|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851346|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851347|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851348|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
129851349|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851350|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851351|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851352|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851353|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851354|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851355|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
129851356|NCT01609556|467414778|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
129851357|NCT01609556|467414779|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851358|NCT01609556|467414780|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851359|NCT01609556|467414781|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851360|NCT01609556|467414782|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851361|NCT01609556|467414783|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
129851362|NCT01609556|467414784|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851363|NCT01609556|467414785|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851364|NCT01609556|467414786|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851365|NCT01609556|467414787|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851366|NCT01609556|467414788|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
129851367|NCT01609556|467414789|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851368|NCT01609556|467414790|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851369|NCT01609556|467414791|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851370|NCT01609556|467414792|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851371|NCT01609556|467414793|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
129851372|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851373|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851374|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851375|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851376|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851377|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851378|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851379|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851380|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851381|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851382|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129904988|NCT00102063|467612981|FG002|Overall Study|Withdrawal by Subject|5|||
129904989|NCT00102063|467612979|FG000|Overall Study|Lost to Follow-up|0|||
129904990|NCT00102063|467612980|FG001|Overall Study|Lost to Follow-up|0|||
129904991|NCT00102063|467612981|FG002|Overall Study|Lost to Follow-up|1|||
129904992|NCT00102063|467612979|FG000|Overall Study|Protocol Violation|0|||
129904993|NCT00102063|467612980|FG001|Overall Study|Protocol Violation|1|||
129851383|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
129851384|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
129851385|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
129851386|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
129851387|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
129851388|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851389|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851390|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851391|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851392|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851393|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851394|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851395|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851396|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851397|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851398|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851399|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
129851400|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
129851401|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
129851402|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
129851403|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
129851404|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851405|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851406|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851407|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851408|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851409|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851410|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851411|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851412|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851413|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851414|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851415|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
129851416|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
129851417|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
129851418|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
129851419|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
129851420|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851421|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851422|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851423|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851424|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851425|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851426|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851427|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851428|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851429|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851430|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851431|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851432|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
129851433|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851434|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851435|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
129851436|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851437|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851438|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851439|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851440|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851441|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129904994|NCT00102063|467612981|FG002|Overall Study|Protocol Violation|1|||
129904995|NCT01493778|467612982|FG000|Overall Study|Withdrawal by Subject|8|||
129904996|NCT05082025|467612983|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
129904997|NCT00857649|467612984|FG000|Overall Study|Adverse Event|15|||
129904998|NCT00857649|467612985|FG001|Overall Study|Adverse Event|10|||
129904999|NCT00857649|467612984|FG000|Overall Study|Non-compliance|1|||
129905000|NCT00857649|467612985|FG001|Overall Study|Non-compliance|1|||
129905001|NCT00857649|467612984|FG000|Overall Study|Protocol Violation|2|||
129905002|NCT00857649|467612985|FG001|Overall Study|Protocol Violation|2|||
129905003|NCT00857649|467612984|FG000|Overall Study|Withdrawal of Consent|10|||
129905004|NCT00857649|467612985|FG001|Overall Study|Withdrawal of Consent|7|||
129905005|NCT00857649|467612984|FG000|Overall Study|Nursing Home Placement|2|||
129905006|NCT00857649|467612985|FG001|Overall Study|Nursing Home Placement|9|||
129905007|NCT00857649|467612984|FG000|Overall Study|Other Reasons|1|||
129905008|NCT00857649|467612985|FG001|Overall Study|Other Reasons|3|||
129905009|NCT05190419|467612986|FG000|Overall Study|Lack of Efficacy|8|||
129905010|NCT05190419|467612987|FG001|Overall Study|Lack of Efficacy|0|||
129905011|NCT05190419|467612988|FG002|Overall Study|Lack of Efficacy|1|||
129905012|NCT05190419|467612989|FG003|Overall Study|Lack of Efficacy|0|||
129905013|NCT05190419|467612986|FG000|Overall Study|Withdrawal by Subject|7|||
129905014|NCT05190419|467612987|FG001|Overall Study|Withdrawal by Subject|1|||
129905015|NCT05190419|467612988|FG002|Overall Study|Withdrawal by Subject|2|||
129905016|NCT05190419|467612989|FG003|Overall Study|Withdrawal by Subject|2|||
129905017|NCT05190419|467612986|FG000|Overall Study|Adverse Event|2|||
129905018|NCT05190419|467612987|FG001|Overall Study|Adverse Event|10|||
129905019|NCT05190419|467612988|FG002|Overall Study|Adverse Event|11|||
129905020|NCT05190419|467612989|FG003|Overall Study|Adverse Event|21|||
129905021|NCT05190419|467612986|FG000|Overall Study|Lost to Follow-up|1|||
129905022|NCT05190419|467612987|FG001|Overall Study|Lost to Follow-up|2|||
129905023|NCT05190419|467612988|FG002|Overall Study|Lost to Follow-up|3|||
129905024|NCT05190419|467612989|FG003|Overall Study|Lost to Follow-up|1|||
129905025|NCT05190419|467612986|FG000|Overall Study|Other|1|||
129905026|NCT05190419|467612987|FG001|Overall Study|Other|1|||
129905027|NCT05190419|467612988|FG002|Overall Study|Other|0|||
129905028|NCT05190419|467612989|FG003|Overall Study|Other|3|||
129905029|NCT00094575|467612990|FG000|Overall Study|Death|146|||
129905030|NCT00094575|467612991|FG001|Overall Study|Death|146|||
129905031|NCT00961636|467612993|FG000|Overall Study|Adverse Event|35|||
129905032|NCT00961636|467612994|FG001|Overall Study|Adverse Event|54|||
129905033|NCT00961636|467612995|FG002|Overall Study|Adverse Event|13|||
129905034|NCT00961636|467612993|FG000|Overall Study|Flushing Symptoms|29|||
129905035|NCT00961636|467612994|FG001|Overall Study|Flushing Symptoms|46|||
129905036|NCT00961636|467612995|FG002|Overall Study|Flushing Symptoms|3|||
129905037|NCT00961636|467612993|FG000|Overall Study|Lost to Follow-up|2|||
129905038|NCT00961636|467612994|FG001|Overall Study|Lost to Follow-up|3|||
129905039|NCT00961636|467612995|FG002|Overall Study|Lost to Follow-up|1|||
129905040|NCT00961636|467612993|FG000|Overall Study|Physician Decision|3|||
129905041|NCT00961636|467612994|FG001|Overall Study|Physician Decision|1|||
129905042|NCT00961636|467612995|FG002|Overall Study|Physician Decision|1|||
129905043|NCT00961636|467612993|FG000|Overall Study|Protocol Violation|9|||
129905044|NCT00961636|467612994|FG001|Overall Study|Protocol Violation|5|||
129905045|NCT00961636|467612995|FG002|Overall Study|Protocol Violation|1|||
129905046|NCT00961636|467612993|FG000|Overall Study|Withdrawal by Subject|29|||
129905047|NCT00961636|467612994|FG001|Overall Study|Withdrawal by Subject|22|||
129905048|NCT00961636|467612995|FG002|Overall Study|Withdrawal by Subject|13|||
129905049|NCT03762668|467614878|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
129905050|NCT03762668|467614879|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
129905051|NCT01393119|467614880|FG000|Overall Study|Adverse Event|1|||
129905052|NCT01393119|467614881|FG001|Overall Study|Adverse Event|1|||
129905053|NCT01393119|467614882|FG002|Overall Study|Adverse Event|0|||
129905054|NCT01393119|467614883|FG003|Overall Study|Adverse Event|1|||
129905055|NCT01393119|467614880|FG000|Overall Study|Withdrawal by Subject|0|||
129905056|NCT01393119|467614881|FG001|Overall Study|Withdrawal by Subject|1|||
129905057|NCT01393119|467614882|FG002|Overall Study|Withdrawal by Subject|1|||
129905058|NCT01393119|467614883|FG003|Overall Study|Withdrawal by Subject|0|||
129905059|NCT01393119|467614880|FG000|Overall Study|Lack of Efficacy|1|||
129905060|NCT01393119|467614881|FG001|Overall Study|Lack of Efficacy|0|||
129905061|NCT01393119|467614882|FG002|Overall Study|Lack of Efficacy|2|||
129905062|NCT01393119|467614883|FG003|Overall Study|Lack of Efficacy|1|||
129905063|NCT01393119|467614880|FG000|Overall Study|Protocol Violation|0|||
129905064|NCT01393119|467614881|FG001|Overall Study|Protocol Violation|0|||
129905065|NCT01393119|467614882|FG002|Overall Study|Protocol Violation|1|||
129905066|NCT01393119|467614883|FG003|Overall Study|Protocol Violation|0|||
129905067|NCT01393119|467614880|FG000|Overall Study|Death|0|||
129905068|NCT01393119|467614881|FG001|Overall Study|Death|0|||
129905069|NCT01393119|467614882|FG002|Overall Study|Death|0|||
129905070|NCT01393119|467614883|FG003|Overall Study|Death|1|||
129905071|NCT01393119|467614880|FG000|Overall Study|Randomized but Not treated|1|||
129905072|NCT01393119|467614881|FG001|Overall Study|Randomized but Not treated|0|||
129905073|NCT01393119|467614882|FG002|Overall Study|Randomized but Not treated|1|||
129905074|NCT01393119|467614883|FG003|Overall Study|Randomized but Not treated|1|||
129905075|NCT01393119|467614880|FG000|Overall Study|Sponsor Termination of Study|11|||
129905076|NCT01393119|467614881|FG001|Overall Study|Sponsor Termination of Study|12|||
129905077|NCT01393119|467614882|FG002|Overall Study|Sponsor Termination of Study|9|||
129905078|NCT01393119|467614883|FG003|Overall Study|Sponsor Termination of Study|12|||
129905079|NCT00465816|467614885|FG000|Overall Study|Lost to Follow-up|0|||
129905080|NCT00465816|467614886|FG001|Overall Study|Lost to Follow-up|0|||
129905081|NCT00465816|467614887|FG002|Overall Study|Lost to Follow-up|2|||
129905082|NCT00004124|467614888|FG000|Overall Study|Received no protocol therapy|12|||
129905083|NCT00004124|467614889|FG001|Overall Study|Received no protocol therapy|20|||
129905084|NCT01759264|467614890|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
129905085|NCT01759264|467614890|FG000|Overall Study|Adverse Event|1|||
129905086|NCT01759264|467614890|FG000|Overall Study|Other|2|||
129905087|NCT01759264|467614890|FG000|Overall Study|Lost to Follow-up|2|||
129905088|NCT01759264|467614890|FG000|Overall Study|Withdrawal by Subject|3|||
129905089|NCT01759264|467614890|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
129905090|NCT02383472|467614891|FG000|Overall Study|Withdrawal by Subject|1|||
129905091|NCT02383472|467614892|FG001|Overall Study|Withdrawal by Subject|1|||
129905092|NCT02013830|467614893|FG000|Overall Study|Adverse Event|3|||
129905093|NCT02013830|467614893|FG000|Overall Study|Death|1|||
129905094|NCT02013830|467614893|FG000|Overall Study|Insufficient therapeutic response|25|||
129905095|NCT02013830|467614893|FG000|Overall Study|Refused treatment|1|||
129905096|NCT00186186|467614899|FG000|Overall Study|Lack of Efficacy|3|||
129905097|NCT00186186|467614899|FG000|Overall Study|Withdrawal by Subject|3|||
129905098|NCT00186186|467614899|FG000|Overall Study|Not reported as to reason|2|||
129905099|NCT01337635|467614900|FG000|Overall Study|Lost to Follow-up|0|||
129905100|NCT01337635|467614901|FG001|Overall Study|Lost to Follow-up|1|||
129905101|NCT02567656|467614904|FG000|Overall Study|Premature discontinuation due to PD|1|||
129905102|NCT02567656|467614905|FG001|Overall Study|Premature discontinuation due to PD|1|||
129905103|NCT02567656|467614906|FG002|Overall Study|Premature discontinuation due to PD|2|||
129905104|NCT02567656|467614907|FG003|Overall Study|Premature discontinuation due to PD|0|||
129905105|NCT02567656|467614908|FG004|Overall Study|Premature discontinuation due to PD|0|||
129905106|NCT02567656|467614909|FG005|Overall Study|Premature discontinuation due to PD|0|||
129905107|NCT01307267|467614910|FG000|Overall Study|Death|4|||
129905108|NCT01307267|467614911|FG001|Overall Study|Death|3|||
129905109|NCT01307267|467614912|FG002|Overall Study|Death|5|||
129905110|NCT01307267|467614913|FG003|Overall Study|Death|3|||
129905111|NCT01307267|467614914|FG004|Overall Study|Death|1|||
129905112|NCT01307267|467614915|FG005|Overall Study|Death|26|||
129905113|NCT01307267|467614916|FG006|Overall Study|Death|2|||
129905114|NCT01307267|467614917|FG007|Overall Study|Death|2|||
129905115|NCT01307267|467614918|FG008|Overall Study|Death|21|||
129905116|NCT01307267|467614919|FG009|Overall Study|Death|2|||
129905117|NCT01307267|467614920|FG010|Overall Study|Death|3|||
129905118|NCT01307267|467614921|FG011|Overall Study|Death|9|||
129905119|NCT01307267|467614922|FG012|Overall Study|Death|0|||
129905120|NCT01307267|467614923|FG013|Overall Study|Death|0|||
129905121|NCT01307267|467614924|FG014|Overall Study|Death|0|||
129905122|NCT01307267|467614925|FG015|Overall Study|Death|0|||
129905123|NCT01307267|467614926|FG016|Overall Study|Death|1|||
129905124|NCT01307267|467614927|FG017|Overall Study|Death|1|||
129905125|NCT01307267|467614928|FG018|Overall Study|Death|2|||
129905126|NCT01307267|467614929|FG019|Overall Study|Death|8|||
129905127|NCT01307267|467614930|FG020|Overall Study|Death|1|||
129905128|NCT01307267|467614931|FG021|Overall Study|Death|2|||
129905129|NCT01307267|467614932|FG022|Overall Study|Death|2|||
129905130|NCT01307267|467614910|FG000|Overall Study|Lost to Follow-up|0|||
129905131|NCT01307267|467614911|FG001|Overall Study|Lost to Follow-up|0|||
129905132|NCT01307267|467614912|FG002|Overall Study|Lost to Follow-up|0|||
129905133|NCT01307267|467614913|FG003|Overall Study|Lost to Follow-up|0|||
129905134|NCT01307267|467614914|FG004|Overall Study|Lost to Follow-up|0|||
129905135|NCT01307267|467614915|FG005|Overall Study|Lost to Follow-up|7|||
129905136|NCT01307267|467614916|FG006|Overall Study|Lost to Follow-up|0|||
129905137|NCT01307267|467614917|FG007|Overall Study|Lost to Follow-up|0|||
129905138|NCT01307267|467614918|FG008|Overall Study|Lost to Follow-up|1|||
129905139|NCT01307267|467614919|FG009|Overall Study|Lost to Follow-up|2|||
129905140|NCT01307267|467614920|FG010|Overall Study|Lost to Follow-up|1|||
129905141|NCT01307267|467614921|FG011|Overall Study|Lost to Follow-up|0|||
129905142|NCT01307267|467614922|FG012|Overall Study|Lost to Follow-up|0|||
129905143|NCT01307267|467614923|FG013|Overall Study|Lost to Follow-up|0|||
129905144|NCT01307267|467614924|FG014|Overall Study|Lost to Follow-up|0|||
129905145|NCT01307267|467614925|FG015|Overall Study|Lost to Follow-up|0|||
129905146|NCT01307267|467614926|FG016|Overall Study|Lost to Follow-up|0|||
129905147|NCT01307267|467614927|FG017|Overall Study|Lost to Follow-up|0|||
129905148|NCT01307267|467614928|FG018|Overall Study|Lost to Follow-up|0|||
129905149|NCT01307267|467614929|FG019|Overall Study|Lost to Follow-up|2|||
129905150|NCT01307267|467614930|FG020|Overall Study|Lost to Follow-up|0|||
129905151|NCT01307267|467614931|FG021|Overall Study|Lost to Follow-up|0|||
129905152|NCT01307267|467614932|FG022|Overall Study|Lost to Follow-up|0|||
129851442|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851443|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851444|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851445|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851446|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851447|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
129851448|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
129851449|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
129851450|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
129851451|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
129851452|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851453|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851454|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851455|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851456|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851457|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851458|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851459|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851460|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851461|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851462|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851463|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851464|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851465|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851466|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
129851467|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
129851468|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851469|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851470|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851471|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851472|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851473|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851474|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851475|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851476|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851477|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851478|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851479|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851480|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
129851481|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
129851482|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
129851483|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
129851484|NCT01609556|467414778|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851485|NCT01609556|467414779|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851486|NCT01609556|467414780|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851487|NCT01609556|467414781|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851488|NCT01609556|467414782|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851489|NCT01609556|467414783|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851490|NCT01609556|467414784|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851491|NCT01609556|467414785|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851492|NCT01609556|467414786|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851493|NCT01609556|467414787|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851494|NCT01609556|467414788|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851495|NCT01609556|467414789|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129905153|NCT01307267|467614910|FG000|Overall Study|Withdrawal by Subject|0|||
129905154|NCT01307267|467614911|FG001|Overall Study|Withdrawal by Subject|0|||
129851496|NCT01609556|467414790|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
129851497|NCT01609556|467414791|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851498|NCT01609556|467414792|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851499|NCT01609556|467414793|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
129851500|NCT00023452|467414794|FG000|Overall Study|Ineligible for Study|163|||
129851501|NCT00023452|467414795|FG001|Overall Study|Ineligible for Study|159|||
129851502|NCT00023452|467414794|FG000|Overall Study|Out of Window|129|||
129851503|NCT00023452|467414795|FG001|Overall Study|Out of Window|69|||
129851504|NCT00023452|467414794|FG000|Overall Study|Death|2|||
129851505|NCT00023452|467414795|FG001|Overall Study|Death|0|||
129851506|NCT00023452|467414794|FG000|Overall Study|Withdrawal by Subject|66|||
129851507|NCT00023452|467414795|FG001|Overall Study|Withdrawal by Subject|54|||
129851508|NCT00023452|467414794|FG000|Overall Study|Adverse Event|139|||
129905155|NCT01307267|467614912|FG002|Overall Study|Withdrawal by Subject|0|||
129905156|NCT01307267|467614913|FG003|Overall Study|Withdrawal by Subject|0|||
129905157|NCT01307267|467614914|FG004|Overall Study|Withdrawal by Subject|0|||
129905158|NCT01307267|467614915|FG005|Overall Study|Withdrawal by Subject|1|||
129905159|NCT01307267|467614916|FG006|Overall Study|Withdrawal by Subject|0|||
129905160|NCT01307267|467614917|FG007|Overall Study|Withdrawal by Subject|1|||
129905161|NCT01307267|467614918|FG008|Overall Study|Withdrawal by Subject|5|||
129905162|NCT01307267|467614919|FG009|Overall Study|Withdrawal by Subject|1|||
129905163|NCT01307267|467614920|FG010|Overall Study|Withdrawal by Subject|1|||
129905164|NCT01307267|467614921|FG011|Overall Study|Withdrawal by Subject|1|||
129905165|NCT01307267|467614922|FG012|Overall Study|Withdrawal by Subject|0|||
129905166|NCT01307267|467614923|FG013|Overall Study|Withdrawal by Subject|0|||
129905167|NCT01307267|467614924|FG014|Overall Study|Withdrawal by Subject|0|||
129905168|NCT01307267|467614925|FG015|Overall Study|Withdrawal by Subject|0|||
129905169|NCT01307267|467614926|FG016|Overall Study|Withdrawal by Subject|0|||
129905170|NCT01307267|467614927|FG017|Overall Study|Withdrawal by Subject|0|||
129905171|NCT01307267|467614928|FG018|Overall Study|Withdrawal by Subject|0|||
129905172|NCT01307267|467614929|FG019|Overall Study|Withdrawal by Subject|3|||
129905173|NCT01307267|467614930|FG020|Overall Study|Withdrawal by Subject|0|||
129905174|NCT01307267|467614931|FG021|Overall Study|Withdrawal by Subject|0|||
129905175|NCT01307267|467614932|FG022|Overall Study|Withdrawal by Subject|0|||
129905176|NCT01307267|467614910|FG000|Overall Study|Other|0|||
129905177|NCT01307267|467614911|FG001|Overall Study|Other|0|||
129905178|NCT01307267|467614912|FG002|Overall Study|Other|0|||
129905179|NCT01307267|467614913|FG003|Overall Study|Other|0|||
129905180|NCT01307267|467614914|FG004|Overall Study|Other|0|||
129905181|NCT01307267|467614915|FG005|Overall Study|Other|7|||
129905182|NCT01307267|467614916|FG006|Overall Study|Other|0|||
129905183|NCT01307267|467614917|FG007|Overall Study|Other|1|||
129905184|NCT01307267|467614918|FG008|Overall Study|Other|3|||
129905185|NCT01307267|467614919|FG009|Overall Study|Other|0|||
129905186|NCT01307267|467614920|FG010|Overall Study|Other|1|||
129905187|NCT01307267|467614921|FG011|Overall Study|Other|1|||
129905188|NCT01307267|467614922|FG012|Overall Study|Other|1|||
129905189|NCT01307267|467614923|FG013|Overall Study|Other|0|||
129905190|NCT01307267|467614924|FG014|Overall Study|Other|2|||
129905191|NCT01307267|467614925|FG015|Overall Study|Other|1|||
129905192|NCT01307267|467614926|FG016|Overall Study|Other|0|||
129905193|NCT01307267|467614927|FG017|Overall Study|Other|0|||
129905194|NCT01307267|467614928|FG018|Overall Study|Other|0|||
129905195|NCT01307267|467614929|FG019|Overall Study|Other|19|||
129905196|NCT01307267|467614930|FG020|Overall Study|Other|2|||
129905197|NCT01307267|467614931|FG021|Overall Study|Other|3|||
129905198|NCT01307267|467614932|FG022|Overall Study|Other|2|||
129905199|NCT04956575|467614933|FG000|Overall Study|Death|1|||
129905200|NCT04956575|467614934|FG001|Overall Study|Death|0|||
129905201|NCT04956575|467614935|FG002|Overall Study|Death|0|||
129905202|NCT04956575|467614936|FG003|Overall Study|Death|0|||
129905203|NCT04956575|467614937|FG004|Overall Study|Death|0|||
129905204|NCT04956575|467614938|FG005|Overall Study|Death|0|||
129905205|NCT04956575|467614939|FG006|Overall Study|Death|0|||
129905206|NCT04956575|467614940|FG007|Overall Study|Death|1|||
129905207|NCT04956575|467614941|FG008|Overall Study|Death|0|||
129905208|NCT04956575|467614942|FG009|Overall Study|Death|1|||
129905209|NCT04956575|467614943|FG010|Overall Study|Death|0|||
129905210|NCT04956575|467614944|FG011|Overall Study|Death|0|||
129905211|NCT04956575|467614933|FG000|Overall Study|Lost to Follow-up|3|||
129905212|NCT04956575|467614934|FG001|Overall Study|Lost to Follow-up|4|||
129905213|NCT04956575|467614935|FG002|Overall Study|Lost to Follow-up|2|||
129905214|NCT04956575|467614936|FG003|Overall Study|Lost to Follow-up|3|||
129905215|NCT04956575|467614937|FG004|Overall Study|Lost to Follow-up|1|||
129905216|NCT04956575|467614938|FG005|Overall Study|Lost to Follow-up|10|||
129905217|NCT04956575|467614939|FG006|Overall Study|Lost to Follow-up|11|||
129905218|NCT04956575|467614940|FG007|Overall Study|Lost to Follow-up|7|||
129905219|NCT04956575|467614941|FG008|Overall Study|Lost to Follow-up|4|||
129905220|NCT04956575|467614942|FG009|Overall Study|Lost to Follow-up|2|||
129905221|NCT04956575|467614943|FG010|Overall Study|Lost to Follow-up|3|||
129905222|NCT04956575|467614944|FG011|Overall Study|Lost to Follow-up|8|||
129905223|NCT04956575|467614933|FG000|Overall Study|Withdrawal by Subject|1|||
129905224|NCT04956575|467614934|FG001|Overall Study|Withdrawal by Subject|2|||
129905225|NCT04956575|467614935|FG002|Overall Study|Withdrawal by Subject|1|||
129905226|NCT04956575|467614936|FG003|Overall Study|Withdrawal by Subject|4|||
129905227|NCT04956575|467614937|FG004|Overall Study|Withdrawal by Subject|2|||
129905228|NCT04956575|467614938|FG005|Overall Study|Withdrawal by Subject|8|||
129905229|NCT04956575|467614939|FG006|Overall Study|Withdrawal by Subject|5|||
129905230|NCT04956575|467614940|FG007|Overall Study|Withdrawal by Subject|1|||
129905231|NCT04956575|467614941|FG008|Overall Study|Withdrawal by Subject|1|||
129905232|NCT04956575|467614942|FG009|Overall Study|Withdrawal by Subject|0|||
129905233|NCT04956575|467614943|FG010|Overall Study|Withdrawal by Subject|3|||
129905234|NCT04956575|467614944|FG011|Overall Study|Withdrawal by Subject|1|||
129905235|NCT03593876|467614945|FG000|Overall Study|Withdrawal by Subject|1|||
129905236|NCT03593876|467614945|FG000|Overall Study|Discharged home before intervention completion|2|||
129905237|NCT05136443|467614956|FG000|Overall Study|Lost to Follow-up|2|||
129905238|NCT05136443|467614956|FG000|Overall Study|Adverse Event|2|||
129905239|NCT03034915|467614967|FG000|Overall Study|Adverse Event|29|||
129905240|NCT03034915|467614968|FG001|Overall Study|Adverse Event|32|||
129905241|NCT03034915|467614969|FG002|Overall Study|Adverse Event|22|||
129905242|NCT03034915|467614967|FG000|Overall Study|Lost to Follow-up|5|||
129905243|NCT03034915|467614968|FG001|Overall Study|Lost to Follow-up|13|||
129905244|NCT03034915|467614969|FG002|Overall Study|Lost to Follow-up|3|||
129905245|NCT03034915|467614967|FG000|Overall Study|Withdrawal by Subject|29|||
129905246|NCT03034915|467614968|FG001|Overall Study|Withdrawal by Subject|46|||
129905247|NCT03034915|467614969|FG002|Overall Study|Withdrawal by Subject|41|||
129905248|NCT03034915|467614967|FG000|Overall Study|Protocol Deviation|2|||
129905249|NCT03034915|467614968|FG001|Overall Study|Protocol Deviation|14|||
129905250|NCT03034915|467614969|FG002|Overall Study|Protocol Deviation|7|||
129905251|NCT03034915|467614967|FG000|Overall Study|Lack of Efficacy|8|||
129905252|NCT03034915|467614968|FG001|Overall Study|Lack of Efficacy|16|||
129905253|NCT03034915|467614969|FG002|Overall Study|Lack of Efficacy|18|||
129905254|NCT03034915|467614967|FG000|Overall Study|Site closed|2|||
129905255|NCT03034915|467614968|FG001|Overall Study|Site closed|2|||
129905256|NCT03034915|467614969|FG002|Overall Study|Site closed|4|||
129905257|NCT03034915|467614967|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
129905258|NCT03034915|467614968|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
129905259|NCT03034915|467614969|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
129905260|NCT03034915|467614967|FG000|Overall Study|Physician Decision|1|||
129905261|NCT03034915|467614968|FG001|Overall Study|Physician Decision|5|||
129905262|NCT03034915|467614969|FG002|Overall Study|Physician Decision|2|||
129905263|NCT00424762|467614975|FG000|Overall Study|Withdrawal by Subject|18|||
129905264|NCT00424762|467614976|FG001|Overall Study|Withdrawal by Subject|19|||
129905265|NCT00424762|467614975|FG000|Overall Study|Lost to Follow-up|2|||
129905266|NCT00424762|467614976|FG001|Overall Study|Lost to Follow-up|3|||
129905267|NCT01147341|467614979|FG000|Double Blind Period|Lack of Efficacy|1|||
129905268|NCT01147341|467614980|FG001|Double Blind Period|Lack of Efficacy|1|||
129905269|NCT01147341|467614979|FG000|Double Blind Period|Withdrawal by Subject|0|||
129905270|NCT01147341|467614980|FG001|Double Blind Period|Withdrawal by Subject|1|||
129905271|NCT01147341|467614979|FG000|Open Label Period|Lack of Efficacy|3|||
129905272|NCT01147341|467614980|FG001|Open Label Period|Lack of Efficacy|0|||
129905273|NCT01147341|467614979|FG000|Open Label Period|Subject moved|1|||
129905274|NCT01147341|467614980|FG001|Open Label Period|Subject moved|0|||
129905275|NCT00367991|467614981|FG000|Overall Study|Withdrawal by Subject|1|||
129905276|NCT00367991|467614982|FG001|Overall Study|Withdrawal by Subject|1|||
129905277|NCT00367991|467614981|FG000|Overall Study|Adverse Event|1|||
129905278|NCT00367991|467614982|FG001|Overall Study|Adverse Event|1|||
129905279|NCT03024606|467614985|FG000|Overall Study|Withdrawal by Subject|9|||
129905280|NCT03024606|467614986|FG001|Overall Study|Withdrawal by Subject|10|||
129905281|NCT01968226|467614987|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
129905282|NCT04975308|467614994|FG000|Overall Study|Withdrawal by Subject|6|||
129905283|NCT04975308|467614995|FG001|Overall Study|Withdrawal by Subject|16|||
129905284|NCT04975308|467614996|FG002|Overall Study|Withdrawal by Subject|6|||
129905285|NCT04975308|467614994|FG000|Overall Study|Physician Decision|0|||
129905286|NCT04975308|467614995|FG001|Overall Study|Physician Decision|3|||
129905287|NCT04975308|467614996|FG002|Overall Study|Physician Decision|1|||
129905288|NCT04975308|467614994|FG000|Overall Study|Adverse Event|10|||
129905289|NCT04975308|467614995|FG001|Overall Study|Adverse Event|1|||
129905290|NCT04975308|467614996|FG002|Overall Study|Adverse Event|12|||
129905291|NCT04975308|467614994|FG000|Overall Study|On study treatment (Ongoing)|65|||
129905292|NCT04975308|467614995|FG001|Overall Study|On study treatment (Ongoing)|43|||
129905293|NCT04975308|467614996|FG002|Overall Study|On study treatment (Ongoing)|75|||
129905294|NCT04975308|467614994|FG000|Overall Study|Protocol Deviation|4|||
129905295|NCT04975308|467614995|FG001|Overall Study|Protocol Deviation|3|||
129905296|NCT04975308|467614996|FG002|Overall Study|Protocol Deviation|2|||
129905297|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
129905298|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905299|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905300|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905301|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
129905302|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
129905303|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905304|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905305|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905306|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
129905307|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
129905308|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905309|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905310|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905311|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
129905312|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
129905313|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905314|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905315|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905316|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
129905317|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
129905318|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905319|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905320|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905321|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
129905322|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
129905323|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905324|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905325|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905326|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
129905327|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
129905328|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905329|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905330|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905331|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
129905332|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
129905333|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905334|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905335|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905336|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
129905337|NCT02709655|467614997|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
129905338|NCT02709655|467614998|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905339|NCT02709655|467614999|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905340|NCT02709655|467615000|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905341|NCT02709655|467615001|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
129905342|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
129905343|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
129905344|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
129905345|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
129905346|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
129905347|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
129905348|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
129905349|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
129905350|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
129905351|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
129905352|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
129905353|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
129905354|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
129905355|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
129905356|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
129905357|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905358|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
129905359|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905360|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905361|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
129905362|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
129905363|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
129905364|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
129905365|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
129905366|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
129905367|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
129905368|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
129905369|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
129905370|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
129905371|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
129905372|NCT02709655|467614997|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
129905373|NCT02709655|467614998|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
129905374|NCT02709655|467614999|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
129905375|NCT02709655|467615000|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
129905376|NCT02709655|467615001|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
129905377|NCT04210180|467615002|FG000|Overall Study|Withdrawal by Subject|2|||
129905378|NCT01179334|467615003|FG000|Treatment Period|Adverse Event|1|||
129905379|NCT01179334|467615004|FG001|Treatment Period|Adverse Event|0|||
129905380|NCT01179334|467615003|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
129905381|NCT01179334|467615004|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
129905382|NCT01179334|467615003|FG000|Long-term Extension (LTE) Period|Death|3|||
129905383|NCT01179334|467615004|FG001|Long-term Extension (LTE) Period|Death|0|||
129905384|NCT01179334|467615003|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
129905385|NCT01179334|467615004|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
129905386|NCT00919763|467615005|FG000|Overall Study|Adverse Event|7|||
129905387|NCT00919763|467615006|FG001|Overall Study|Adverse Event|1|||
129905388|NCT00919763|467615005|FG000|Overall Study|Lost to Follow-up|1|||
129905389|NCT00919763|467615006|FG001|Overall Study|Lost to Follow-up|0|||
129905390|NCT00919763|467615005|FG000|Overall Study|Protocol Violation|1|||
129905391|NCT00919763|467615006|FG001|Overall Study|Protocol Violation|1|||
129905392|NCT00919763|467615005|FG000|Overall Study|Withdrawal by Subject|3|||
129905393|NCT00919763|467615006|FG001|Overall Study|Withdrawal by Subject|1|||
129905394|NCT00919763|467615005|FG000|Overall Study|Non-compliance|0|||
129905395|NCT00919763|467615006|FG001|Overall Study|Non-compliance|1|||
129905396|NCT05323734|467615012|FG000|Overall Study|Adverse Event|5|||
129905397|NCT05323734|467615013|FG001|Overall Study|Adverse Event|2|||
129905398|NCT05323734|467615012|FG000|Overall Study|Physician Decision|1|||
129905399|NCT05323734|467615013|FG001|Overall Study|Physician Decision|0|||
129905400|NCT05323734|467615012|FG000|Overall Study|Lack of Efficacy|1|||
129905401|NCT05323734|467615013|FG001|Overall Study|Lack of Efficacy|2|||
129905402|NCT05323734|467615012|FG000|Overall Study|Withdrawal by Subject|2|||
129905403|NCT05323734|467615013|FG001|Overall Study|Withdrawal by Subject|0|||
129905404|NCT05323734|467615012|FG000|Overall Study|Participant Withdrawn Due|0|||
129905405|NCT05323734|467615013|FG001|Overall Study|Participant Withdrawn Due|1|||
129905406|NCT03603717|467615016|FG000|Overall Study|Lost to Follow-up|20|||
129905407|NCT03603717|467615017|FG001|Overall Study|Lost to Follow-up|20|||
129905408|NCT03603717|467615016|FG000|Overall Study|Withdrawal by Subject|16|||
129905409|NCT03603717|467615017|FG001|Overall Study|Withdrawal by Subject|10|||
129905410|NCT00732381|467615018|FG000|Overall Study|Adverse Event|1|||
129905411|NCT00732381|467615019|FG001|Overall Study|Adverse Event|0|||
129905412|NCT00732381|467615018|FG000|Overall Study|Treatment Failure|1|||
129905413|NCT00732381|467615019|FG001|Overall Study|Treatment Failure|1|||
129905414|NCT01350804|467615022|FG000|Core Study|Withdrawal by Subject|11|||
129905415|NCT01350804|467615023|FG001|Core Study|Withdrawal by Subject|17|||
129905416|NCT01350804|467615024|FG002|Core Study|Withdrawal by Subject|16|||
129905417|NCT01350804|467615025|FG003|Core Study|Withdrawal by Subject|7|||
129905418|NCT01350804|467615022|FG000|Core Study|Study terminated by Sponsor|0|||
129905419|NCT01350804|467615023|FG001|Core Study|Study terminated by Sponsor|0|||
129905420|NCT01350804|467615024|FG002|Core Study|Study terminated by Sponsor|0|||
129905421|NCT01350804|467615025|FG003|Core Study|Study terminated by Sponsor|2|||
129905422|NCT01350804|467615022|FG000|Core Study|Protocol deviation|1|||
129905423|NCT01350804|467615023|FG001|Core Study|Protocol deviation|0|||
129905424|NCT01350804|467615024|FG002|Core Study|Protocol deviation|1|||
129905425|NCT01350804|467615025|FG003|Core Study|Protocol deviation|0|||
129905426|NCT01350804|467615022|FG000|Core Study|Physician Decision|1|||
129905427|NCT01350804|467615023|FG001|Core Study|Physician Decision|0|||
129905428|NCT01350804|467615024|FG002|Core Study|Physician Decision|1|||
129905429|NCT01350804|467615025|FG003|Core Study|Physician Decision|3|||
129905430|NCT01350804|467615022|FG000|Core Study|Lost to Follow-up|3|||
129905431|NCT01350804|467615023|FG001|Core Study|Lost to Follow-up|0|||
129905432|NCT01350804|467615024|FG002|Core Study|Lost to Follow-up|2|||
129905433|NCT01350804|467615025|FG003|Core Study|Lost to Follow-up|1|||
129905434|NCT01350804|467615022|FG000|Core Study|Lack of Efficacy|16|||
129905435|NCT01350804|467615023|FG001|Core Study|Lack of Efficacy|19|||
129905436|NCT01350804|467615024|FG002|Core Study|Lack of Efficacy|18|||
129905437|NCT01350804|467615025|FG003|Core Study|Lack of Efficacy|5|||
129905438|NCT01350804|467615022|FG000|Core Study|Death|1|||
129905439|NCT01350804|467615023|FG001|Core Study|Death|1|||
129905440|NCT01350804|467615024|FG002|Core Study|Death|1|||
129905441|NCT01350804|467615025|FG003|Core Study|Death|0|||
129905442|NCT01350804|467615022|FG000|Core Study|Adverse Event|8|||
129905443|NCT01350804|467615023|FG001|Core Study|Adverse Event|10|||
129905444|NCT01350804|467615024|FG002|Core Study|Adverse Event|8|||
129905445|NCT01350804|467615025|FG003|Core Study|Adverse Event|8|||
129905446|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
129449630|NCT00467779|465945629|FG006|Stage 3|Death|0|||
129905447|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
129905448|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
129905449|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
129905450|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
129905451|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
129905452|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
129851509|NCT00023452|467414795|FG001|Overall Study|Adverse Event|196|||
129851510|NCT00023452|467414794|FG000|Overall Study|Lost to Follow-up|293|||
129851511|NCT00023452|467414795|FG001|Overall Study|Lost to Follow-up|60|||
129851512|NCT00023452|467414794|FG000|Overall Study|Physician Decision|49|||
129851513|NCT00023452|467414795|FG001|Overall Study|Physician Decision|21|||
129851514|NCT00023452|467414794|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
129851515|NCT00023452|467414795|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
129851516|NCT00023452|467414794|FG000|Overall Study|Pregnant|53|||
129851517|NCT00023452|467414795|FG001|Overall Study|Pregnant|20|||
129851518|NCT00023452|467414794|FG000|Overall Study|Other|204|||
129851519|NCT00023452|467414795|FG001|Overall Study|Other|69|||
129851520|NCT05789875|467414796|FG000|Overall Study|Lost to Follow-up|6|||
129851521|NCT01076400|467416526|FG000|Overall Study|Adverse Event|2|||
129851522|NCT01076400|467416527|FG001|Overall Study|Adverse Event|0|||
129851523|NCT01076400|467416528|FG002|Overall Study|Adverse Event|0|||
129851524|NCT01076400|467416526|FG000|Overall Study|Progressive Disease|5|||
129851525|NCT01076400|467416527|FG001|Overall Study|Progressive Disease|0|||
129851526|NCT01076400|467416528|FG002|Overall Study|Progressive Disease|0|||
129851527|NCT03019536|467416530|FG000|Overall Study|Withdrawal by Subject|1|||
129851528|NCT03019536|467416531|FG001|Overall Study|Withdrawal by Subject|1|||
129851529|NCT03019536|467416532|FG002|Overall Study|Withdrawal by Subject|0|||
129851530|NCT03019536|467416530|FG000|Overall Study|Adverse Event|0|||
129851531|NCT03019536|467416531|FG001|Overall Study|Adverse Event|0|||
129851532|NCT03019536|467416532|FG002|Overall Study|Adverse Event|2|||
129851533|NCT01043874|467416533|FG000|Overall Study|Adverse Event|3|||
129851534|NCT01043874|467416533|FG000|Overall Study|Withdrawal by Subject|1|||
129851535|NCT01043874|467416533|FG000|Overall Study|Lack of Efficacy|1|||
129851536|NCT01043874|467416533|FG000|Overall Study|Administrative Problems|1|||
129851537|NCT00182689|467416541|FG000|Overall Study|Adverse Event|8|||
129851538|NCT00182689|467416542|FG001|Overall Study|Adverse Event|11|||
129851539|NCT00182689|467416541|FG000|Overall Study|Withdrawal by Subject|2|||
129851540|NCT00182689|467416542|FG001|Overall Study|Withdrawal by Subject|2|||
129851541|NCT00182689|467416541|FG000|Overall Study|Progression|27|||
129851542|NCT00182689|467416542|FG001|Overall Study|Progression|29|||
129851543|NCT00182689|467416541|FG000|Overall Study|Death|1|||
129851544|NCT00182689|467416542|FG001|Overall Study|Death|0|||
129851545|NCT00182689|467416541|FG000|Overall Study|not protocol specified|0|||
129851546|NCT00182689|467416542|FG001|Overall Study|not protocol specified|3|||
129851547|NCT00182689|467416541|FG000|Overall Study|Ineligible|1|||
129851548|NCT00182689|467416542|FG001|Overall Study|Ineligible|4|||
129851549|NCT00182689|467416541|FG000|Overall Study|Never received treatment|1|||
129851550|NCT00182689|467416542|FG001|Overall Study|Never received treatment|0|||
129851551|NCT03422003|467416543|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
129851552|NCT03422003|467416544|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
129851553|NCT03422003|467416543|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
129851554|NCT03422003|467416544|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
129851555|NCT01040871|467416549|FG000|Overall Study|Adverse Event|6|||
129851556|NCT01040871|467416550|FG001|Overall Study|Adverse Event|2|||
129851557|NCT01040871|467416549|FG000|Overall Study|Withdrawal by Subject|2|||
129851558|NCT01040871|467416550|FG001|Overall Study|Withdrawal by Subject|0|||
129851559|NCT01040871|467416549|FG000|Overall Study|Death|1|||
129851560|NCT01040871|467416550|FG001|Overall Study|Death|3|||
129851561|NCT01040871|467416549|FG000|Overall Study|Lack of Efficacy|1|||
129851562|NCT01040871|467416550|FG001|Overall Study|Lack of Efficacy|1|||
129905453|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
129851563|NCT01040871|467416549|FG000|Overall Study|drug supply issue|1|||
129851564|NCT01040871|467416550|FG001|Overall Study|drug supply issue|0|||
129851565|NCT01040871|467416549|FG000|Overall Study|Randomized and Not Treated|2|||
129851566|NCT01040871|467416550|FG001|Overall Study|Randomized and Not Treated|1|||
129851567|NCT02696850|467416555|FG000|Overall Study|Withdrawal by Subject|3|||
129851568|NCT02696850|467416556|FG001|Overall Study|Withdrawal by Subject|3|||
129851569|NCT02696850|467416555|FG000|Overall Study|Lost to Follow-up|8|||
129851570|NCT02696850|467416556|FG001|Overall Study|Lost to Follow-up|5|||
129851571|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
129851572|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
129851573|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
129851574|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
129851575|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Death|235|||
129851576|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Death|167|||
129851577|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Death|1|||
129851578|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Death|0|||
129851579|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
129851580|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
129851581|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
129851582|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
129905454|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
129905455|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
129851583|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
129851584|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
129851585|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
129851586|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
129851587|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Other|1|||
129851588|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Other|2|||
129851589|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Other|0|||
129851590|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Other|0|||
129851591|NCT00673049|467416557|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
129851592|NCT00673049|467416558|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
129851593|NCT00673049|467416559|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
129851594|NCT00673049|467416560|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
129851595|NCT00673049|467416557|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
129851596|NCT00673049|467416558|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
129851597|NCT00673049|467416559|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
129851598|NCT00673049|467416560|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
129851599|NCT00673049|467416557|FG000|After Progression on Erlotinib|Death|0|||
129851600|NCT00673049|467416558|FG001|After Progression on Erlotinib|Death|0|||
129851601|NCT00673049|467416559|FG002|After Progression on Erlotinib|Death|0|||
129851602|NCT00673049|467416560|FG003|After Progression on Erlotinib|Death|71|||
129851603|NCT00673049|467416557|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
129851604|NCT00673049|467416558|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
129851605|NCT00673049|467416559|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
129851606|NCT00673049|467416560|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
129851607|NCT00673049|467416557|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
129851608|NCT00673049|467416558|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
129851609|NCT00673049|467416559|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
129851610|NCT00673049|467416560|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
129851611|NCT00673049|467416557|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
129851612|NCT00673049|467416558|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
129851613|NCT00673049|467416559|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
129851614|NCT00673049|467416560|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
129851615|NCT01175824|467416561|FG000|Overall Study|Adverse Event|2|||
129851616|NCT01175824|467416562|FG001|Overall Study|Adverse Event|1|||
129851617|NCT01175824|467416561|FG000|Overall Study|Lack of Efficacy|2|||
129851618|NCT01175824|467416562|FG001|Overall Study|Lack of Efficacy|0|||
129851619|NCT01175824|467416561|FG000|Overall Study|Lost to Follow-up|0|||
129851620|NCT01175824|467416562|FG001|Overall Study|Lost to Follow-up|1|||
129851621|NCT01175824|467416561|FG000|Overall Study|Physician Decision|0|||
129851622|NCT01175824|467416562|FG001|Overall Study|Physician Decision|4|||
129851623|NCT01175824|467416561|FG000|Overall Study|Protocol Violation|2|||
129851624|NCT01175824|467416562|FG001|Overall Study|Protocol Violation|5|||
129851625|NCT01175824|467416561|FG000|Overall Study|Withdrawal by Subject|3|||
129851626|NCT01175824|467416562|FG001|Overall Study|Withdrawal by Subject|7|||
129851627|NCT01175824|467416561|FG000|Overall Study|Sponsor Decision|1|||
129851628|NCT01175824|467416562|FG001|Overall Study|Sponsor Decision|0|||
129851629|NCT01175824|467416561|FG000|Overall Study|Entry Criteria Not Met|6|||
129851630|NCT01175824|467416562|FG001|Overall Study|Entry Criteria Not Met|4|||
129905456|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
129905457|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
129905458|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
129905459|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
129905460|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
129905461|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
129905462|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
129905463|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
129905464|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
129905465|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
129905466|NCT01350804|467615022|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
129905467|NCT01350804|467615023|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
129905468|NCT01350804|467615024|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
129851631|NCT00924950|467416563|FG000|Overall Study|Lost to Follow-up|2|||
129851632|NCT04193202|467416564|FG000|Overall Study|Adverse Event|2|||
129851633|NCT04193202|467416565|FG001|Overall Study|Adverse Event|1|||
129851634|NCT04193202|467416564|FG000|Overall Study|Death|0|||
129851635|NCT04193202|467416565|FG001|Overall Study|Death|1|||
129851636|NCT04193202|467416564|FG000|Overall Study|Physician Decision|1|||
129851637|NCT04193202|467416565|FG001|Overall Study|Physician Decision|1|||
129851638|NCT04193202|467416564|FG000|Overall Study|Protocol Violation|2|||
129851639|NCT04193202|467416565|FG001|Overall Study|Protocol Violation|2|||
129851640|NCT04193202|467416564|FG000|Overall Study|Withdrawal by Subject|11|||
129851641|NCT04193202|467416565|FG001|Overall Study|Withdrawal by Subject|5|||
129851642|NCT02979535|467416566|FG000|Overall Study|Non compliance with the protocol|78|||
129851643|NCT02979535|467416567|FG001|Overall Study|Non compliance with the protocol|82|||
129851644|NCT02979535|467416566|FG000|Overall Study|Consent withdrawn by participant|11|||
129851645|NCT02979535|467416567|FG001|Overall Study|Consent withdrawn by participant|18|||
129851646|NCT02979535|467416566|FG000|Overall Study|Lost to Follow-up|6|||
129851647|NCT02979535|467416567|FG001|Overall Study|Lost to Follow-up|1|||
129851648|NCT02530619|467416571|FG000|Registered for Study|Withdrawal by Subject|2|||
129851649|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
129851650|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
129851651|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
129851652|NCT02530619|467416571|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
129851653|NCT02530619|467416571|FG000|Follow-up Period (6 Months)|Death|4|||
129851654|NCT02530619|467416571|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
129851655|NCT02530619|467416571|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
129851656|NCT01163682|467416572|FG000|Overall Study|Lost to Follow-up|6|||
129851657|NCT01163682|467416573|FG001|Overall Study|Lost to Follow-up|9|||
129851658|NCT00359762|467416574|FG000|Period II|Adverse Event|17|||
129851659|NCT00359762|467416575|FG001|Period II|Adverse Event|0|||
129851660|NCT00359762|467416576|FG002|Period II|Adverse Event|0|||
129851661|NCT00359762|467416577|FG003|Period II|Adverse Event|0|||
129851662|NCT00359762|467416578|FG004|Period II|Adverse Event|49|||
129851663|NCT00359762|467416574|FG000|Period II|Protocol Violation|18|||
129851664|NCT00359762|467416575|FG001|Period II|Protocol Violation|0|||
129851665|NCT00359762|467416576|FG002|Period II|Protocol Violation|0|||
129851666|NCT00359762|467416577|FG003|Period II|Protocol Violation|0|||
129851667|NCT00359762|467416578|FG004|Period II|Protocol Violation|11|||
129905469|NCT01350804|467615025|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
129905470|NCT02299336|467615026|FG000|Overall Study|Withdrawal by Subject|11|||
129905471|NCT02299336|467615026|FG000|Overall Study|Adverse Event|1|||
129905472|NCT02299336|467615026|FG000|Overall Study|Death|1|||
129905473|NCT02299336|467615026|FG000|Overall Study|Lost to Follow-up|1|||
129905474|NCT02106442|467615028|FG000|Overall Study|Case Report Forms Uncollected|7|||
129905475|NCT02106442|467615028|FG000|Overall Study|Protocol Deviation|30|||
129905476|NCT00573833|467615029|FG000|Overall Study|Not Treated|2|||
129905477|NCT05328297|467616339|FG000|Overall Study|Adverse Event|5|||
129905478|NCT05328297|467616340|FG001|Overall Study|Adverse Event|7|||
129905479|NCT05328297|467616339|FG000|Overall Study|Withdrawal by Subject|4|||
129905480|NCT05328297|467616340|FG001|Overall Study|Withdrawal by Subject|3|||
129905481|NCT05328297|467616339|FG000|Overall Study|Lack of Efficacy|1|||
129905482|NCT05328297|467616340|FG001|Overall Study|Lack of Efficacy|0|||
129905483|NCT05328297|467616339|FG000|Overall Study|Lost to Follow-up|1|||
129905484|NCT05328297|467616340|FG001|Overall Study|Lost to Follow-up|0|||
129905485|NCT05328297|467616339|FG000|Overall Study|Protocol Violation|1|||
129905486|NCT05328297|467616340|FG001|Overall Study|Protocol Violation|0|||
129905487|NCT05328297|467616339|FG000|Overall Study|Randomized but not treated|1|||
129905488|NCT05328297|467616340|FG001|Overall Study|Randomized but not treated|1|||
129905489|NCT03544515|467616350|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
129905490|NCT03544515|467616351|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
129905491|NCT03544515|467616350|FG000|Overall Study|Lost to Follow-up|2|||
129905492|NCT03544515|467616351|FG001|Overall Study|Lost to Follow-up|0|||
129905493|NCT03175172|467616352|FG000|Overall Study|Death|3|||
129851668|NCT00359762|467416574|FG000|Period II|Physician Decision|17|||
129851669|NCT00359762|467416575|FG001|Period II|Physician Decision|0|||
129905494|NCT03175172|467616352|FG000|Overall Study|Withdrawal by Subject|3|||
129905495|NCT03175172|467616352|FG000|Overall Study|Lost to Follow-up|1|||
129905496|NCT03175172|467616352|FG000|Overall Study|Study Terminated by Sponsor|3|||
129905497|NCT01662336|467616353|FG000|Overall Study|Adverse Event|1|||
129905498|NCT01662336|467616353|FG000|Overall Study|No longer on LPV/r|30|||
129905499|NCT01662336|467616353|FG000|Overall Study|Other|29|||
129905500|NCT01662336|467616353|FG000|Overall Study|Withdrawal by Subject|6|||
129905501|NCT04668339|467616354|FG000|Overall Study|Physician Decision|1|||
129905502|NCT04668339|467616355|FG001|Overall Study|Physician Decision|0|||
129905503|NCT04668339|467616356|FG002|Overall Study|Physician Decision|1|||
129905504|NCT04668339|467616357|FG003|Overall Study|Physician Decision|1|||
129905505|NCT04668339|467616354|FG000|Overall Study|Lost to Follow-up|14|||
129851670|NCT00359762|467416576|FG002|Period II|Physician Decision|0|||
129851671|NCT00359762|467416577|FG003|Period II|Physician Decision|0|||
129851672|NCT00359762|467416578|FG004|Period II|Physician Decision|23|||
129851673|NCT00359762|467416574|FG000|Period II|Death|2|||
129851674|NCT00359762|467416575|FG001|Period II|Death|0|||
129851675|NCT00359762|467416576|FG002|Period II|Death|0|||
129851676|NCT00359762|467416577|FG003|Period II|Death|0|||
129851677|NCT00359762|467416578|FG004|Period II|Death|4|||
129905506|NCT04668339|467616355|FG001|Overall Study|Lost to Follow-up|12|||
129905507|NCT04668339|467616356|FG002|Overall Study|Lost to Follow-up|8|||
129905508|NCT04668339|467616357|FG003|Overall Study|Lost to Follow-up|5|||
129905509|NCT04668339|467616354|FG000|Overall Study|Adverse Event|0|||
129905510|NCT04668339|467616355|FG001|Overall Study|Adverse Event|0|||
129905511|NCT04668339|467616356|FG002|Overall Study|Adverse Event|1|||
129905512|NCT04668339|467616357|FG003|Overall Study|Adverse Event|0|||
129905513|NCT04668339|467616354|FG000|Overall Study|Other than specified|3|||
129905514|NCT04668339|467616355|FG001|Overall Study|Other than specified|0|||
129905515|NCT04668339|467616356|FG002|Overall Study|Other than specified|1|||
129905516|NCT04668339|467616357|FG003|Overall Study|Other than specified|0|||
129905517|NCT04668339|467616354|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
129905518|NCT04668339|467616355|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
129905519|NCT04668339|467616356|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
129905520|NCT04668339|467616357|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
129905521|NCT04668339|467616354|FG000|Overall Study|Vaccine not Administered|0|||
129905522|NCT04668339|467616355|FG001|Overall Study|Vaccine not Administered|0|||
129905523|NCT04668339|467616356|FG002|Overall Study|Vaccine not Administered|1|||
129905524|NCT04668339|467616357|FG003|Overall Study|Vaccine not Administered|0|||
129905525|NCT04668339|467616354|FG000|Overall Study|Protocol Violation|18|||
129905526|NCT04668339|467616355|FG001|Overall Study|Protocol Violation|23|||
129905527|NCT04668339|467616356|FG002|Overall Study|Protocol Violation|12|||
129905528|NCT04668339|467616357|FG003|Overall Study|Protocol Violation|20|||
129905529|NCT04668339|467616354|FG000|Overall Study|Withdrawal by Subject|45|||
129905530|NCT04668339|467616355|FG001|Overall Study|Withdrawal by Subject|46|||
129905531|NCT04668339|467616356|FG002|Overall Study|Withdrawal by Subject|46|||
129905532|NCT04668339|467616357|FG003|Overall Study|Withdrawal by Subject|27|||
129905533|NCT04668339|467616354|FG000|Overall Study|Study Terminated by Sponsor|59|||
129905534|NCT04668339|467616355|FG001|Overall Study|Study Terminated by Sponsor|59|||
129905535|NCT04668339|467616356|FG002|Overall Study|Study Terminated by Sponsor|71|||
129905536|NCT04668339|467616357|FG003|Overall Study|Study Terminated by Sponsor|1|||
129905537|NCT03622593|467616361|FG000|Overall Study|Withdrawal by Subject|11|||
129905538|NCT03622593|467616362|FG001|Overall Study|Withdrawal by Subject|9|||
129905539|NCT03622593|467616363|FG002|Overall Study|Withdrawal by Subject|13|||
129905540|NCT03622593|467616361|FG000|Overall Study|Death|12|||
129905541|NCT03622593|467616362|FG001|Overall Study|Death|9|||
129905542|NCT03622593|467616363|FG002|Overall Study|Death|10|||
129905543|NCT03622593|467616361|FG000|Overall Study|Lost to Follow-up|11|||
129905544|NCT03622593|467616362|FG001|Overall Study|Lost to Follow-up|5|||
129905545|NCT03622593|467616363|FG002|Overall Study|Lost to Follow-up|8|||
129905546|NCT03622593|467616361|FG000|Overall Study|Adverse Event|4|||
129905547|NCT03622593|467616362|FG001|Overall Study|Adverse Event|5|||
129905548|NCT03622593|467616363|FG002|Overall Study|Adverse Event|6|||
129905549|NCT03622593|467616361|FG000|Overall Study|Physician Decision|2|||
129905550|NCT03622593|467616362|FG001|Overall Study|Physician Decision|1|||
129905551|NCT03622593|467616363|FG002|Overall Study|Physician Decision|6|||
129905552|NCT03622593|467616361|FG000|Overall Study|Other|2|||
129905553|NCT03622593|467616362|FG001|Overall Study|Other|2|||
129905554|NCT03622593|467616363|FG002|Overall Study|Other|3|||
129905555|NCT03622593|467616361|FG000|Overall Study|Protocol Violation|0|||
129905556|NCT03622593|467616362|FG001|Overall Study|Protocol Violation|0|||
129905557|NCT03622593|467616363|FG002|Overall Study|Protocol Violation|1|||
129905558|NCT03622593|467616361|FG000|Overall Study|Pregnancy|0|||
129905559|NCT03622593|467616362|FG001|Overall Study|Pregnancy|0|||
129905560|NCT03622593|467616363|FG002|Overall Study|Pregnancy|1|||
129905561|NCT00178399|467616364|FG000|Overall Study|Physician Decision|4|||
129905562|NCT00178399|467616364|FG000|Overall Study|Withdrawal by Subject|8|||
129905563|NCT00178399|467616364|FG000|Overall Study|Lost to Follow-up|1|||
129905564|NCT02544152|467616365|FG000|Overall Study|Adverse Event|0|||
129905565|NCT02544152|467616366|FG001|Overall Study|Adverse Event|4|||
129905566|NCT02544152|467616365|FG000|Overall Study|Withdrawal by Subject|0|||
129905567|NCT02544152|467616366|FG001|Overall Study|Withdrawal by Subject|3|||
129905568|NCT02544152|467616365|FG000|Overall Study|Other|1|||
129905569|NCT02544152|467616366|FG001|Overall Study|Other|0|||
129905570|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
129905571|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
129905572|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
129905573|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
129905574|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
129905575|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
129905576|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
129905577|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
129905578|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
129905579|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
129905580|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
129905581|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
129905582|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
129905583|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
129905584|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
129905585|NCT00516321|467616369|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
129905586|NCT00516321|467616370|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
129905587|NCT00516321|467616371|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
129905588|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
129905589|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
129905590|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
129905591|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
129905592|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
129905593|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
129905594|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
129905595|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
129905596|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
129905597|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
129905598|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
129905599|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
129905600|NCT00516321|467616369|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
129905601|NCT00516321|467616370|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
129905602|NCT00516321|467616371|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
129905603|NCT02015546|467616373|FG000|Overall Study|Withdrawal by Subject|1|||
129905604|NCT02015546|467616374|FG001|Overall Study|Withdrawal by Subject|1|||
129905605|NCT02015546|467616375|FG002|Overall Study|Withdrawal by Subject|1|||
129905606|NCT02015546|467616373|FG000|Overall Study|Screem Failure|2|||
129905607|NCT02015546|467616374|FG001|Overall Study|Screem Failure|1|||
129905608|NCT02015546|467616375|FG002|Overall Study|Screem Failure|3|||
129905609|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Adverse Event|5|||
129905610|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Adverse Event|0|||
129905611|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Adverse Event|0|||
129905612|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
129905613|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
129905614|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
129905615|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
129905616|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
129905617|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
129905618|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
129905619|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
129905620|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
129905621|NCT01426269|467616378|FG000|Period 1: 12 Weeks|Pregnancy|1|||
129905622|NCT01426269|467616379|FG001|Period 1: 12 Weeks|Pregnancy|0|||
129905623|NCT01426269|467616380|FG002|Period 1: 12 Weeks|Pregnancy|0|||
129905624|NCT01426269|467616378|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
129905625|NCT01426269|467616379|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
129905626|NCT01426269|467616380|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
129905627|NCT01426269|467616378|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
129905628|NCT01426269|467616379|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
129905629|NCT01426269|467616380|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
129905630|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Adverse Event|0|||
129905631|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Adverse Event|1|||
129905632|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Adverse Event|2|||
129905633|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
129905634|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
129905635|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
129905636|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
129905637|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
129905638|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
129905639|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
129905640|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
129905641|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
129905642|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Site closed|0|||
129905643|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Site closed|6|||
129905644|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Site closed|5|||
129905645|NCT01426269|467616378|FG000|Period 2: 40 Weeks|Relapsed|0|||
129905646|NCT01426269|467616379|FG001|Period 2: 40 Weeks|Relapsed|9|||
129905647|NCT01426269|467616380|FG002|Period 2: 40 Weeks|Relapsed|18|||
129905648|NCT00463788|467616381|FG000|Overall Study|Progressive Disease|86|||
129905649|NCT00463788|467616382|FG001|Overall Study|Progressive Disease|42|||
129905650|NCT00463788|467616381|FG000|Overall Study|Adverse Event|6|||
129905651|NCT00463788|467616382|FG001|Overall Study|Adverse Event|2|||
129905652|NCT00463788|467616381|FG000|Overall Study|Withdrawal by Subject|6|||
129851678|NCT00359762|467416574|FG000|Period II|Lack of Efficacy|11|||
129851679|NCT00359762|467416575|FG001|Period II|Lack of Efficacy|0|||
129851680|NCT00359762|467416576|FG002|Period II|Lack of Efficacy|0|||
129851681|NCT00359762|467416577|FG003|Period II|Lack of Efficacy|0|||
129851682|NCT00359762|467416578|FG004|Period II|Lack of Efficacy|8|||
129851683|NCT00359762|467416574|FG000|Period II|Lost to follow up|5|||
129851684|NCT00359762|467416575|FG001|Period II|Lost to follow up|0|||
129851685|NCT00359762|467416576|FG002|Period II|Lost to follow up|0|||
129851686|NCT00359762|467416577|FG003|Period II|Lost to follow up|0|||
129851687|NCT00359762|467416578|FG004|Period II|Lost to follow up|5|||
129851688|NCT00359762|467416574|FG000|Period II|Entry Criteria Not Met|8|||
129851689|NCT00359762|467416575|FG001|Period II|Entry Criteria Not Met|0|||
129851690|NCT00359762|467416576|FG002|Period II|Entry Criteria Not Met|0|||
129851691|NCT00359762|467416577|FG003|Period II|Entry Criteria Not Met|0|||
129851692|NCT00359762|467416578|FG004|Period II|Entry Criteria Not Met|4|||
129851693|NCT00359762|467416574|FG000|Period II|Subject Decision|50|||
129851694|NCT00359762|467416575|FG001|Period II|Subject Decision|0|||
129851695|NCT00359762|467416576|FG002|Period II|Subject Decision|0|||
129851696|NCT00359762|467416577|FG003|Period II|Subject Decision|0|||
129851697|NCT00359762|467416578|FG004|Period II|Subject Decision|70|||
129851698|NCT00359762|467416574|FG000|Period III|Protocol Violation|0|||
129851699|NCT00359762|467416575|FG001|Period III|Protocol Violation|5|||
129851700|NCT00359762|467416576|FG002|Period III|Protocol Violation|3|||
129851701|NCT00359762|467416577|FG003|Period III|Protocol Violation|8|||
129851702|NCT00359762|467416578|FG004|Period III|Protocol Violation|0|||
129851703|NCT00359762|467416574|FG000|Period III|Adverse Event|0|||
129851704|NCT00359762|467416575|FG001|Period III|Adverse Event|3|||
129851705|NCT00359762|467416576|FG002|Period III|Adverse Event|4|||
129851706|NCT00359762|467416577|FG003|Period III|Adverse Event|10|||
129851707|NCT00359762|467416578|FG004|Period III|Adverse Event|0|||
129851708|NCT00359762|467416574|FG000|Period III|Physician Decision|0|||
129851709|NCT00359762|467416575|FG001|Period III|Physician Decision|5|||
129851710|NCT00359762|467416576|FG002|Period III|Physician Decision|9|||
129851711|NCT00359762|467416577|FG003|Period III|Physician Decision|15|||
129851712|NCT00359762|467416578|FG004|Period III|Physician Decision|0|||
129851713|NCT00359762|467416574|FG000|Period III|Lack of Efficacy|0|||
129851714|NCT00359762|467416575|FG001|Period III|Lack of Efficacy|7|||
129851715|NCT00359762|467416576|FG002|Period III|Lack of Efficacy|5|||
129851716|NCT00359762|467416577|FG003|Period III|Lack of Efficacy|9|||
129851717|NCT00359762|467416578|FG004|Period III|Lack of Efficacy|0|||
129851718|NCT00359762|467416574|FG000|Period III|Lost to follow up|0|||
129851719|NCT00359762|467416575|FG001|Period III|Lost to follow up|1|||
129851720|NCT00359762|467416576|FG002|Period III|Lost to follow up|1|||
129851721|NCT00359762|467416577|FG003|Period III|Lost to follow up|2|||
129851722|NCT00359762|467416578|FG004|Period III|Lost to follow up|0|||
129851723|NCT00359762|467416574|FG000|Period III|Entry Criteria Not Met|0|||
129851724|NCT00359762|467416575|FG001|Period III|Entry Criteria Not Met|1|||
129851725|NCT00359762|467416576|FG002|Period III|Entry Criteria Not Met|0|||
129851726|NCT00359762|467416577|FG003|Period III|Entry Criteria Not Met|1|||
129851727|NCT00359762|467416578|FG004|Period III|Entry Criteria Not Met|0|||
129851728|NCT00359762|467416574|FG000|Period III|Subject Decision|0|||
129851729|NCT00359762|467416575|FG001|Period III|Subject Decision|7|||
129851730|NCT00359762|467416576|FG002|Period III|Subject Decision|8|||
129851731|NCT00359762|467416577|FG003|Period III|Subject Decision|20|||
129851732|NCT00359762|467416578|FG004|Period III|Subject Decision|0|||
129851733|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
129851734|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
129851735|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
129851736|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851737|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851738|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851739|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851740|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851741|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129851742|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
129851743|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
129851744|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
129851745|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851746|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851747|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851748|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851749|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851750|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129851751|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851752|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
129851753|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
129851754|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851755|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851756|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851757|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851758|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851759|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129851760|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
129851761|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
129851762|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
129851763|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851764|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851765|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851766|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851767|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851768|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129851769|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851770|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
129851771|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851772|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851773|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851774|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851775|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851776|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851777|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
129851778|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
129851779|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851780|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851781|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851782|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851783|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851784|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851785|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851786|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129851787|NCT01172938|467416582|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851788|NCT01172938|467416583|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
129851789|NCT01172938|467416584|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
129851790|NCT01172938|467416585|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851791|NCT01172938|467416586|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851792|NCT01172938|467416587|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851793|NCT01172938|467416588|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851794|NCT01172938|467416589|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851795|NCT01172938|467416590|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
129851796|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851797|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
129851798|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
129851799|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
129851800|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
129851801|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
129851802|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851803|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851804|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
129851805|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851806|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
129851807|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
129851808|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
129851809|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
129851810|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
129851811|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851812|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851813|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
129851814|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129905653|NCT00463788|467616382|FG001|Overall Study|Withdrawal by Subject|2|||
129905654|NCT00463788|467616381|FG000|Overall Study|Death|4|||
129905655|NCT00463788|467616382|FG001|Overall Study|Death|3|||
129851815|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851816|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
129851817|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851818|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851819|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851820|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851821|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851822|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
129851823|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
129851824|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
129851825|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
129851826|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
129851827|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
129851828|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
129851829|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
129851830|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
129851831|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
129851832|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851833|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
129851834|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
129851835|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
129851836|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851837|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851838|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851839|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851840|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
129851841|NCT01172938|467416582|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851842|NCT01172938|467416583|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851843|NCT01172938|467416584|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851844|NCT01172938|467416585|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851845|NCT01172938|467416586|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851846|NCT01172938|467416587|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
129851847|NCT01172938|467416588|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
129851848|NCT01172938|467416589|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851849|NCT01172938|467416590|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
129851850|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851851|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
129851852|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
129851853|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851854|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851855|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851856|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
129851857|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
129851858|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
129851859|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851860|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
129851861|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
129851862|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851863|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851864|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851865|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851866|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
129851867|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
129851868|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851869|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851870|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
129851871|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851872|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851873|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851874|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129905656|NCT00463788|467616381|FG000|Overall Study|Symptomatic Deterioration|2|||
129905657|NCT00463788|467616382|FG001|Overall Study|Symptomatic Deterioration|3|||
129905658|NCT00463788|467616381|FG000|Overall Study|Lost to Follow-up|1|||
129905659|NCT00463788|467616382|FG001|Overall Study|Lost to Follow-up|0|||
129905660|NCT00463788|467616381|FG000|Overall Study|Protocol Violation|0|||
129905661|NCT00463788|467616382|FG001|Overall Study|Protocol Violation|1|||
129905662|NCT00463788|467616381|FG000|Overall Study|Other|3|||
129905663|NCT00463788|467616382|FG001|Overall Study|Other|0|||
129905664|NCT00463788|467616381|FG000|Overall Study|Randomized but not treated|1|||
129905665|NCT00463788|467616382|FG001|Overall Study|Randomized but not treated|1|||
129905666|NCT00360698|467616383|FG000|Run-In|Physician Decision|0|||
129905667|NCT00360698|467616384|FG001|Run-In|Physician Decision|1|||
129905668|NCT00360698|467616383|FG000|Run-In|Withdrawal by Subject|0|||
129905669|NCT00360698|467616384|FG001|Run-In|Withdrawal by Subject|2|||
129905670|NCT00360698|467616383|FG000|Run-In|Non compliance with treatment procedure|0|||
129905671|NCT00360698|467616384|FG001|Run-In|Non compliance with treatment procedure|1|||
129905672|NCT00360698|467616383|FG000|Run-In|Sponsor request|0|||
129905673|NCT00360698|467616384|FG001|Run-In|Sponsor request|2|||
129905674|NCT00360698|467616383|FG000|Run-In|Patient did not meet inclusion criteria|0|||
129905675|NCT00360698|467616384|FG001|Run-In|Patient did not meet inclusion criteria|1|||
129905676|NCT00360698|467616383|FG000|Run-In|Patient personal reasons|0|||
129905677|NCT00360698|467616384|FG001|Run-In|Patient personal reasons|2|||
129905678|NCT00360698|467616383|FG000|Run-In|Need of insulin with meals|0|||
129905679|NCT00360698|467616384|FG001|Run-In|Need of insulin with meals|1|||
129905680|NCT00360698|467616383|FG000|Treatment Period|Non compliance with treatment procedure|1|||
129905681|NCT00360698|467616384|FG001|Treatment Period|Non compliance with treatment procedure|0|||
129905682|NCT00360698|467616383|FG000|Treatment Period|Early termination by error|0|||
129905683|NCT00360698|467616384|FG001|Treatment Period|Early termination by error|1|||
129905684|NCT00712335|467616389|FG000|Overall Study|Withdrawal by Subject|0|||
129905685|NCT00712335|467616390|FG001|Overall Study|Withdrawal by Subject|7|||
129905686|NCT00712335|467616391|FG002|Overall Study|Withdrawal by Subject|2|||
129905687|NCT00712335|467616392|FG003|Overall Study|Withdrawal by Subject|3|||
129905688|NCT00712335|467616393|FG004|Overall Study|Withdrawal by Subject|0|||
129905689|NCT00712335|467616389|FG000|Overall Study|Lost to Follow-up|2|||
129905690|NCT00712335|467616390|FG001|Overall Study|Lost to Follow-up|5|||
129905691|NCT00712335|467616391|FG002|Overall Study|Lost to Follow-up|0|||
129905692|NCT00712335|467616392|FG003|Overall Study|Lost to Follow-up|1|||
129905693|NCT00712335|467616393|FG004|Overall Study|Lost to Follow-up|0|||
129905694|NCT00712335|467616389|FG000|Overall Study|Protocol Violation|1|||
129905695|NCT00712335|467616390|FG001|Overall Study|Protocol Violation|2|||
129905696|NCT00712335|467616391|FG002|Overall Study|Protocol Violation|1|||
129905697|NCT00712335|467616392|FG003|Overall Study|Protocol Violation|0|||
129905698|NCT00712335|467616393|FG004|Overall Study|Protocol Violation|0|||
129905699|NCT00712335|467616389|FG000|Overall Study|Lack of Efficacy|0|||
129905700|NCT00712335|467616390|FG001|Overall Study|Lack of Efficacy|0|||
129905701|NCT00712335|467616391|FG002|Overall Study|Lack of Efficacy|1|||
129449631|NCT00467779|465945630|FG007|Stage 3|Death|0|||
129449632|NCT00467779|465945631|FG008|Stage 3|Death|0|||
129905702|NCT00712335|467616392|FG003|Overall Study|Lack of Efficacy|1|||
129905703|NCT00712335|467616393|FG004|Overall Study|Lack of Efficacy|0|||
129905704|NCT00712335|467616389|FG000|Overall Study|Other Reason|0|||
129905705|NCT00712335|467616390|FG001|Overall Study|Other Reason|3|||
129905706|NCT00712335|467616391|FG002|Overall Study|Other Reason|1|||
129905707|NCT00712335|467616392|FG003|Overall Study|Other Reason|0|||
129905708|NCT00712335|467616393|FG004|Overall Study|Other Reason|0|||
129905709|NCT03401112|467616394|FG000|Overall Study|Adverse Event|1|||
129905710|NCT03401112|467616395|FG001|Overall Study|Adverse Event|2|||
129905711|NCT03401112|467616396|FG002|Overall Study|Adverse Event|3|||
129905712|NCT03401112|467616397|FG003|Overall Study|Adverse Event|2|||
129905713|NCT03401112|467616398|FG004|Overall Study|Adverse Event|0|||
129905714|NCT03401112|467616394|FG000|Overall Study|Lost to Follow-up|1|||
129905715|NCT03401112|467616395|FG001|Overall Study|Lost to Follow-up|0|||
129905716|NCT03401112|467616396|FG002|Overall Study|Lost to Follow-up|0|||
129905717|NCT03401112|467616397|FG003|Overall Study|Lost to Follow-up|0|||
129905718|NCT03401112|467616398|FG004|Overall Study|Lost to Follow-up|0|||
129905719|NCT03401112|467616394|FG000|Overall Study|Noncompliance|1|||
129905720|NCT03401112|467616395|FG001|Overall Study|Noncompliance|2|||
129905721|NCT03401112|467616396|FG002|Overall Study|Noncompliance|3|||
129905722|NCT03401112|467616397|FG003|Overall Study|Noncompliance|0|||
129905723|NCT03401112|467616398|FG004|Overall Study|Noncompliance|0|||
129905724|NCT03401112|467616394|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
129905725|NCT03401112|467616395|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
129905726|NCT03401112|467616396|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
129905727|NCT03401112|467616397|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
129905728|NCT03401112|467616398|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
129905729|NCT03401112|467616394|FG000|Overall Study|Withdrawal by Subject|0|||
129449633|NCT00467779|465945632|FG009|Stage 3|Death|0|||
129449634|NCT00467779|465945633|FG010|Stage 3|Death|0|||
129449635|NCT00467779|465945634|FG011|Stage 3|Death|0|||
129905730|NCT03401112|467616395|FG001|Overall Study|Withdrawal by Subject|3|||
129905731|NCT03401112|467616396|FG002|Overall Study|Withdrawal by Subject|2|||
129905732|NCT03401112|467616397|FG003|Overall Study|Withdrawal by Subject|1|||
129905733|NCT03401112|467616398|FG004|Overall Study|Withdrawal by Subject|0|||
129905734|NCT03401112|467616394|FG000|Overall Study|Physician Decision|0|||
129905735|NCT03401112|467616395|FG001|Overall Study|Physician Decision|0|||
129905736|NCT03401112|467616396|FG002|Overall Study|Physician Decision|0|||
129905737|NCT03401112|467616397|FG003|Overall Study|Physician Decision|2|||
129905738|NCT03401112|467616398|FG004|Overall Study|Physician Decision|0|||
129905739|NCT03401112|467616394|FG000|Overall Study|Study was Terminated by Sponsor|0|||
129905740|NCT03401112|467616395|FG001|Overall Study|Study was Terminated by Sponsor|0|||
129905741|NCT03401112|467616396|FG002|Overall Study|Study was Terminated by Sponsor|0|||
129905742|NCT03401112|467616397|FG003|Overall Study|Study was Terminated by Sponsor|1|||
129905743|NCT03401112|467616398|FG004|Overall Study|Study was Terminated by Sponsor|0|||
129905744|NCT03401112|467616394|FG000|Overall Study|Day 1 Assessment not Done|1|||
129905745|NCT03401112|467616395|FG001|Overall Study|Day 1 Assessment not Done|0|||
129905746|NCT03401112|467616396|FG002|Overall Study|Day 1 Assessment not Done|0|||
129905747|NCT03401112|467616397|FG003|Overall Study|Day 1 Assessment not Done|0|||
129905748|NCT03401112|467616398|FG004|Overall Study|Day 1 Assessment not Done|0|||
129905749|NCT03401112|467616394|FG000|Overall Study|Not Dosed|0|||
129905750|NCT03401112|467616395|FG001|Overall Study|Not Dosed|0|||
129905751|NCT03401112|467616396|FG002|Overall Study|Not Dosed|1|||
129905752|NCT03401112|467616397|FG003|Overall Study|Not Dosed|0|||
129905753|NCT03401112|467616398|FG004|Overall Study|Not Dosed|0|||
129905754|NCT03401112|467616394|FG000|Overall Study|Missed Clinical Visit|0|||
129905755|NCT03401112|467616395|FG001|Overall Study|Missed Clinical Visit|0|||
129905756|NCT03401112|467616396|FG002|Overall Study|Missed Clinical Visit|1|||
129905757|NCT03401112|467616397|FG003|Overall Study|Missed Clinical Visit|0|||
129905758|NCT03401112|467616398|FG004|Overall Study|Missed Clinical Visit|0|||
129905759|NCT03401112|467616394|FG000|Overall Study|Missed Doses|0|||
129905760|NCT03401112|467616395|FG001|Overall Study|Missed Doses|0|||
129905761|NCT03401112|467616396|FG002|Overall Study|Missed Doses|1|||
129905762|NCT03401112|467616397|FG003|Overall Study|Missed Doses|0|||
129905763|NCT03401112|467616398|FG004|Overall Study|Missed Doses|0|||
129905764|NCT03194958|467616399|FG000|Overall Study|Death|0|||
129851875|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851876|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
129851877|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851878|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
129851879|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
129851880|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851881|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851882|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851883|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
129851884|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
129851885|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
129851886|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851887|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851888|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
129851889|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851890|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851891|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851892|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851893|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851894|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
129851895|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851896|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
129851897|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
129851898|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851899|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851900|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851901|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851902|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
129851903|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
129851904|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851905|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
129905765|NCT03194958|467616400|FG001|Overall Study|Death|1|||
129905766|NCT03194958|467616401|FG002|Overall Study|Death|1|||
129905767|NCT03194958|467616402|FG003|Overall Study|Death|1|||
129905768|NCT03194958|467616399|FG000|Overall Study|Withdrawal by Subject|24|||
129905769|NCT03194958|467616400|FG001|Overall Study|Withdrawal by Subject|27|||
129905770|NCT03194958|467616401|FG002|Overall Study|Withdrawal by Subject|7|||
129905771|NCT03194958|467616402|FG003|Overall Study|Withdrawal by Subject|22|||
129905772|NCT03194958|467616399|FG000|Overall Study|Lost to Follow-up|168|||
129905773|NCT03194958|467616400|FG001|Overall Study|Lost to Follow-up|196|||
129905774|NCT03194958|467616401|FG002|Overall Study|Lost to Follow-up|174|||
129905775|NCT03194958|467616402|FG003|Overall Study|Lost to Follow-up|186|||
129905776|NCT01202955|467616404|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
129905777|NCT01202955|467616405|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
129905778|NCT00256243|467616409|FG000|Overall Study|Lost to Follow-up|2|||
129905779|NCT00256243|467616409|FG000|Overall Study|Death|7|||
129905780|NCT00256243|467616409|FG000|Overall Study|Not treated|1|||
129905781|NCT00258895|467616410|FG000|Overall Study|Lost to Follow-up|3|||
129905782|NCT00258895|467616411|FG001|Overall Study|Lost to Follow-up|1|||
129905783|NCT00258895|467616410|FG000|Overall Study|Protocol Violation|6|||
129905784|NCT00258895|467616411|FG001|Overall Study|Protocol Violation|2|||
129905785|NCT00258895|467616410|FG000|Overall Study|Withdrawal by Subject|1|||
129905786|NCT00258895|467616411|FG001|Overall Study|Withdrawal by Subject|0|||
129905787|NCT00547118|467616412|FG000|Overall Study|Did not qualify prior to starting drug|1|||
129905788|NCT00547118|467616413|FG001|Overall Study|Did not qualify prior to starting drug|1|||
129905789|NCT00547118|467616412|FG000|Overall Study|Study suspended|7|||
129905790|NCT00547118|467616413|FG001|Overall Study|Study suspended|8|||
129905791|NCT02248480|467616414|FG000|Overall Study|Lack of Efficacy|4|||
129905792|NCT02248480|467616415|FG001|Overall Study|Lack of Efficacy|6|||
129905793|NCT02248480|467616414|FG000|Overall Study|Adverse Event|11|||
129905794|NCT02248480|467616415|FG001|Overall Study|Adverse Event|2|||
129905795|NCT02248480|467616414|FG000|Overall Study|Withdrawal by Subject|2|||
129905796|NCT02248480|467616415|FG001|Overall Study|Withdrawal by Subject|4|||
129905797|NCT02248480|467616414|FG000|Overall Study|Entry Criteria Not Met|0|||
129905798|NCT02248480|467616415|FG001|Overall Study|Entry Criteria Not Met|1|||
129905799|NCT02248480|467616414|FG000|Overall Study|Other:Physician Decision|0|||
129905800|NCT02248480|467616415|FG001|Overall Study|Other:Physician Decision|1|||
129905801|NCT01595321|467616416|FG000|Overall Study|Adverse Event|1|||
129905802|NCT01595321|467616417|FG001|Overall Study|Adverse Event|1|||
129905803|NCT01595321|467616418|FG002|Overall Study|Adverse Event|1|||
129905804|NCT01595321|467616416|FG000|Overall Study|Lack of Efficacy|0|||
129905805|NCT01595321|467616417|FG001|Overall Study|Lack of Efficacy|0|||
129905806|NCT01595321|467616418|FG002|Overall Study|Lack of Efficacy|4|||
129905807|NCT04504916|467616419|FG000|Overall Study|Study terminated|7|||
129905808|NCT04504916|467616420|FG001|Overall Study|Study terminated|8|||
129905809|NCT04504916|467616419|FG000|Overall Study|Death|54|||
129905810|NCT04504916|467616420|FG001|Overall Study|Death|18|||
129905811|NCT04504916|467616419|FG000|Overall Study|Lost to Follow-up|1|||
129905812|NCT04504916|467616420|FG001|Overall Study|Lost to Follow-up|1|||
129905813|NCT04504916|467616419|FG000|Overall Study|Withdrawal by Subject|8|||
129905814|NCT04504916|467616420|FG001|Overall Study|Withdrawal by Subject|4|||
129905815|NCT04504916|467616419|FG000|Overall Study|Did not agree to follow-up|0|||
129905816|NCT04504916|467616420|FG001|Overall Study|Did not agree to follow-up|1|||
129905817|NCT00834834|467616422|FG000|Overall Study|Withdrawal by Subject|4|||
129905818|NCT00834834|467616423|FG001|Overall Study|Withdrawal by Subject|3|||
129905819|NCT00539292|467616424|FG000|Overall Study|Physician Decision|1|||
129905820|NCT00539292|467616425|FG001|Overall Study|Physician Decision|0|||
129905821|NCT00630786|467616426|FG000|Overall Study|Physician Decision|0|||
129905822|NCT00630786|467616427|FG001|Overall Study|Physician Decision|0|||
129905823|NCT00630786|467616428|FG002|Overall Study|Physician Decision|1|||
129905824|NCT00630786|467616426|FG000|Overall Study|Withdrawal by Subject|0|||
129851906|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851907|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851908|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851909|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851910|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851911|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
129851912|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
129851913|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851914|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
129851915|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851916|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129905825|NCT00630786|467616427|FG001|Overall Study|Withdrawal by Subject|1|||
129905826|NCT00630786|467616428|FG002|Overall Study|Withdrawal by Subject|1|||
129905827|NCT00630786|467616426|FG000|Overall Study|Lost to Follow-up|0|||
129905828|NCT00630786|467616427|FG001|Overall Study|Lost to Follow-up|1|||
129905829|NCT00630786|467616428|FG002|Overall Study|Lost to Follow-up|0|||
129905830|NCT00630786|467616426|FG000|Overall Study|Other|1|||
129905831|NCT00630786|467616427|FG001|Overall Study|Other|0|||
129905832|NCT00630786|467616428|FG002|Overall Study|Other|0|||
129905833|NCT02020616|467616430|FG000|Overall Study|Adverse Event|0|||
129905834|NCT02020616|467616431|FG001|Overall Study|Adverse Event|0|||
129905835|NCT02020616|467616432|FG002|Overall Study|Adverse Event|0|||
129851917|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851918|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851919|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851920|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851921|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
129851922|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851923|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851924|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851925|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851926|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851927|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851928|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851929|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
129851930|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
129851931|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851932|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
129851933|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
129851934|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851935|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851936|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851937|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
129851938|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
129851939|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
129851940|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851941|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
129851942|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
129851943|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851944|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851945|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851946|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
129851947|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
129851948|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
129851949|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851950|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851951|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851952|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851953|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851954|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851955|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851956|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
129851957|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
129851958|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851959|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
129851960|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851961|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851962|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851963|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851964|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851965|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851966|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
129851967|NCT01172938|467416582|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851968|NCT01172938|467416583|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851969|NCT01172938|467416584|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
129851970|NCT01172938|467416585|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851971|NCT01172938|467416586|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851972|NCT01172938|467416587|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851973|NCT01172938|467416588|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851974|NCT01172938|467416589|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851975|NCT01172938|467416590|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
129851976|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851977|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
129851978|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
129851979|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851980|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851981|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851982|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851983|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
129851984|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
129851985|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851986|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
129851987|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
129851988|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851989|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851990|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851991|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
129851992|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
129851993|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
129851994|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129851995|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
129851996|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
129851997|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129851998|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129851999|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129852000|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
129852001|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
129852002|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
129852003|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852004|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852005|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
129852006|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852007|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852008|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852009|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852010|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
129852011|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
129852012|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852013|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852014|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852015|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852016|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852017|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852018|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852019|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
129852020|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
129852021|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852022|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852023|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
129852024|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852025|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852026|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852027|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
129852028|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
129852029|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
129852030|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852031|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852032|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
129852033|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852034|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852035|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852036|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852037|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852038|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
129852039|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852040|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
129852041|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852042|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852043|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852044|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852045|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129905836|NCT02020616|467616433|FG003|Overall Study|Adverse Event|0|||
129852046|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
129852047|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
129852048|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852049|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
129852050|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
129852051|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852052|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852053|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852054|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852055|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
129852056|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
129852057|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852058|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852059|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
129852060|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852061|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852062|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852063|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852064|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852065|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
129852066|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852067|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852068|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
129852069|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852070|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852071|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852072|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852073|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852074|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
129852075|NCT01172938|467416582|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852076|NCT01172938|467416583|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852077|NCT01172938|467416584|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852078|NCT01172938|467416585|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852079|NCT01172938|467416586|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852080|NCT01172938|467416587|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852081|NCT01172938|467416588|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852082|NCT01172938|467416589|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
129852083|NCT01172938|467416590|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
129852084|NCT00003498|467416591|FG000|Overall Study|Not evaluable.|4|||
129852085|NCT05282004|467416595|FG000|Overall Study|Adverse Event|2|||
129852086|NCT00889421|467416596|FG000|Overall Study|Lack of Efficacy|3|||
129852087|NCT01958918|467416597|FG000|Overall Study|Death|1|||
129852088|NCT01958918|467416598|FG001|Overall Study|Death|3|||
129852089|NCT01958918|467416597|FG000|Overall Study|Lost to Follow-up|4|||
129852090|NCT01958918|467416598|FG001|Overall Study|Lost to Follow-up|7|||
129852091|NCT01958918|467416597|FG000|Overall Study|Withdrawal by Subject|13|||
129852092|NCT01958918|467416598|FG001|Overall Study|Withdrawal by Subject|8|||
129852093|NCT01958918|467416597|FG000|Overall Study|Lack of Efficacy|13|||
129852094|NCT01958918|467416598|FG001|Overall Study|Lack of Efficacy|10|||
129852095|NCT01958918|467416597|FG000|Overall Study|Adverse Event|12|||
129852096|NCT01958918|467416598|FG001|Overall Study|Adverse Event|12|||
129852097|NCT01958918|467416597|FG000|Overall Study|administrative problems|0|||
129852098|NCT01958918|467416598|FG001|Overall Study|administrative problems|2|||
129852099|NCT02013765|467416602|FG000|Overall Study|Trial was terminated by sponsor|1|||
129852100|NCT00659269|467416603|FG000|Overall Study|Physician Decision|1|||
129852101|NCT00659269|467416604|FG001|Overall Study|Physician Decision|1|||
129852102|NCT01158222|467416605|FG000|Overall Study|Not eligible for intermediate phase|17|||
129852103|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852104|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852105|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852106|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852107|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
129852108|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
129852109|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
129852110|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129852111|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129852112|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129852113|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
129852114|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
129905837|NCT02020616|467616434|FG004|Overall Study|Adverse Event|0|||
129905838|NCT02020616|467616435|FG005|Overall Study|Adverse Event|1|||
129905839|NCT02020616|467616436|FG006|Overall Study|Adverse Event|1|||
129905840|NCT02020616|467616430|FG000|Overall Study|Physician Decision|0|||
129905841|NCT02020616|467616431|FG001|Overall Study|Physician Decision|0|||
129905842|NCT02020616|467616432|FG002|Overall Study|Physician Decision|0|||
129905843|NCT02020616|467616433|FG003|Overall Study|Physician Decision|0|||
129905844|NCT02020616|467616434|FG004|Overall Study|Physician Decision|0|||
129905845|NCT02020616|467616435|FG005|Overall Study|Physician Decision|1|||
129905846|NCT02020616|467616436|FG006|Overall Study|Physician Decision|2|||
129905847|NCT02020616|467616430|FG000|Overall Study|Withdrawal by Subject|0|||
129905848|NCT02020616|467616431|FG001|Overall Study|Withdrawal by Subject|0|||
129905849|NCT02020616|467616432|FG002|Overall Study|Withdrawal by Subject|1|||
129905850|NCT02020616|467616433|FG003|Overall Study|Withdrawal by Subject|0|||
129905851|NCT02020616|467616434|FG004|Overall Study|Withdrawal by Subject|0|||
129905852|NCT02020616|467616435|FG005|Overall Study|Withdrawal by Subject|1|||
129905853|NCT02020616|467616436|FG006|Overall Study|Withdrawal by Subject|1|||
129905854|NCT02020616|467616430|FG000|Overall Study|Lost to Follow-up|0|||
129905855|NCT02020616|467616431|FG001|Overall Study|Lost to Follow-up|1|||
129852115|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852116|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
129852117|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
129852118|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852119|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852120|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
129852121|NCT00718042|467416606|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852122|NCT00718042|467416607|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
129852123|NCT00718042|467416608|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852124|NCT00718042|467416609|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852125|NCT00718042|467416610|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852126|NCT00718042|467416611|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
129852127|NCT00718042|467416606|FG000|Donor Follow-up|Lost to Follow-up|13|||
129852128|NCT00718042|467416607|FG001|Donor Follow-up|Lost to Follow-up|0|||
129852129|NCT00718042|467416608|FG002|Donor Follow-up|Lost to Follow-up|0|||
129852130|NCT00718042|467416609|FG003|Donor Follow-up|Lost to Follow-up|0|||
129852131|NCT00718042|467416610|FG004|Donor Follow-up|Lost to Follow-up|19|||
129852132|NCT00718042|467416611|FG005|Donor Follow-up|Lost to Follow-up|0|||
129852133|NCT02443298|467416612|FG000|Overall Study|Adverse Event|3|||
129852134|NCT02443298|467416613|FG001|Overall Study|Adverse Event|3|||
129852135|NCT02443298|467416612|FG000|Overall Study|Withdrawal by Subject|1|||
129852136|NCT02443298|467416613|FG001|Overall Study|Withdrawal by Subject|2|||
129852137|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
129852138|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
129852139|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
129852140|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
129852141|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
129852142|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
129852143|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
129852144|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
129852145|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
129852146|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
129852147|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
129852148|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
129852149|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
129852150|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
129905856|NCT02020616|467616432|FG002|Overall Study|Lost to Follow-up|0|||
129905857|NCT02020616|467616433|FG003|Overall Study|Lost to Follow-up|1|||
129905858|NCT02020616|467616434|FG004|Overall Study|Lost to Follow-up|1|||
129905859|NCT02020616|467616435|FG005|Overall Study|Lost to Follow-up|1|||
129905860|NCT02020616|467616436|FG006|Overall Study|Lost to Follow-up|0|||
129905861|NCT02020616|467616430|FG000|Overall Study|Early Termination Criteria Met|0|||
129905862|NCT02020616|467616431|FG001|Overall Study|Early Termination Criteria Met|0|||
129905863|NCT02020616|467616432|FG002|Overall Study|Early Termination Criteria Met|1|||
129852151|NCT02464969|467416614|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
129905864|NCT02020616|467616433|FG003|Overall Study|Early Termination Criteria Met|0|||
129905865|NCT02020616|467616434|FG004|Overall Study|Early Termination Criteria Met|0|||
129905866|NCT02020616|467616435|FG005|Overall Study|Early Termination Criteria Met|1|||
129905867|NCT02020616|467616436|FG006|Overall Study|Early Termination Criteria Met|0|||
129852152|NCT02464969|467416615|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
129852153|NCT02464969|467416614|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
129905868|NCT02020616|467616430|FG000|Overall Study|Randomized in Error|0|||
129905869|NCT02020616|467616431|FG001|Overall Study|Randomized in Error|0|||
129905870|NCT02020616|467616432|FG002|Overall Study|Randomized in Error|0|||
129905871|NCT02020616|467616433|FG003|Overall Study|Randomized in Error|1|||
129852154|NCT02464969|467416615|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
129852155|NCT02464969|467416614|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
129852156|NCT02464969|467416615|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
129852157|NCT02464969|467416614|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
129852158|NCT02464969|467416615|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
129852159|NCT02399085|467416620|FG000|Overall Study|Adverse Event|16|||
129852160|NCT02399085|467416620|FG000|Overall Study|Death|2|||
129852161|NCT02399085|467416620|FG000|Overall Study|Withdrawal by Subject|8|||
129852162|NCT02399085|467416620|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
129852163|NCT02399085|467416620|FG000|Overall Study|Physician Decision|5|||
129852164|NCT00833924|467416621|FG000|Overall Study|Death|21|||
129852165|NCT00833924|467416621|FG000|Overall Study|Conversion|2|||
129852166|NCT00833924|467416621|FG000|Overall Study|Lost to Follow-up|2|||
129852167|NCT00833924|467416621|FG000|Overall Study|Withdrawal by Subject|13|||
129852168|NCT00833924|467416621|FG000|Overall Study|In study follow-up|71|||
129852169|NCT01975389|467416624|FG000|Overall Study|Adverse Event|10|||
129852170|NCT01975389|467416625|FG001|Overall Study|Adverse Event|6|||
129852171|NCT01975389|467416624|FG000|Overall Study|Death|61|||
129852172|NCT01975389|467416625|FG001|Overall Study|Death|54|||
129852173|NCT01975389|467416624|FG000|Overall Study|Lost to Follow-up|81|||
129852174|NCT01975389|467416625|FG001|Overall Study|Lost to Follow-up|86|||
129852175|NCT01975389|467416624|FG000|Overall Study|Withdrawal by Subject|90|||
129852176|NCT01975389|467416625|FG001|Overall Study|Withdrawal by Subject|76|||
129852177|NCT01975389|467416624|FG000|Overall Study|Other|6|||
129852178|NCT01975389|467416625|FG001|Overall Study|Other|9|||
129852179|NCT01975389|467416624|FG000|Overall Study|Randomized, not treated|4|||
129852180|NCT01975389|467416625|FG001|Overall Study|Randomized, not treated|5|||
129852181|NCT00298831|467416630|FG000|Overall Study|Adverse Event|1|||
129852182|NCT00298831|467416630|FG000|Overall Study|Lost to Follow-up|3|||
129852183|NCT00298831|467416630|FG000|Overall Study|Withdrawal by Subject|1|||
129852184|NCT00298831|467416630|FG000|Overall Study|Participants did not receive treatment|27|||
129852185|NCT00691210|467416631|FG000|Overall Study|Progression of Disease|0|||
129852186|NCT00691210|467416632|FG001|Overall Study|Progression of Disease|0|||
129852187|NCT00691210|467416633|FG002|Overall Study|Progression of Disease|0|||
129852188|NCT00691210|467416634|FG003|Overall Study|Progression of Disease|2|||
129852189|NCT00691210|467416635|FG004|Overall Study|Progression of Disease|0|||
129852190|NCT00691210|467416636|FG005|Overall Study|Progression of Disease|0|||
129852191|NCT00691210|467416637|FG006|Overall Study|Progression of Disease|0|||
129852192|NCT00691210|467416638|FG007|Overall Study|Progression of Disease|0|||
129852193|NCT00691210|467416631|FG000|Overall Study|Lack of Efficacy|0|||
129852194|NCT00691210|467416632|FG001|Overall Study|Lack of Efficacy|0|||
129852195|NCT00691210|467416633|FG002|Overall Study|Lack of Efficacy|0|||
129852196|NCT00691210|467416634|FG003|Overall Study|Lack of Efficacy|1|||
129852197|NCT00691210|467416635|FG004|Overall Study|Lack of Efficacy|0|||
129852198|NCT00691210|467416636|FG005|Overall Study|Lack of Efficacy|1|||
129852199|NCT00691210|467416637|FG006|Overall Study|Lack of Efficacy|0|||
129852200|NCT00691210|467416638|FG007|Overall Study|Lack of Efficacy|0|||
129852201|NCT01306617|467416640|FG000|Overall Study|Adverse Event|1|||
129852202|NCT01306617|467416641|FG001|Overall Study|Adverse Event|0|||
129852203|NCT01306617|467416642|FG002|Overall Study|Adverse Event|0|||
129852204|NCT01306617|467416640|FG000|Overall Study|Virologic Failure|0|||
129852205|NCT01306617|467416641|FG001|Overall Study|Virologic Failure|0|||
129852206|NCT01306617|467416642|FG002|Overall Study|Virologic Failure|5|||
129852207|NCT01306617|467416640|FG000|Overall Study|Non-compliance|0|||
129852208|NCT01306617|467416641|FG001|Overall Study|Non-compliance|1|||
129852209|NCT01306617|467416642|FG002|Overall Study|Non-compliance|0|||
129852210|NCT04028388|467416652|FG000|Overall Study|Evaluations missing|3|||
129852211|NCT04028388|467416653|FG001|Overall Study|Evaluations missing|6|||
129852212|NCT04028388|467416652|FG000|Overall Study|Not started|2|||
129852213|NCT04028388|467416653|FG001|Overall Study|Not started|0|||
129852214|NCT01994395|467416654|FG000|Overall Study|Withdrawal by Subject|1|||
129852215|NCT01994395|467416655|FG001|Overall Study|Withdrawal by Subject|2|||
129852216|NCT01940705|467416657|FG000|Overall Study|Lost to Follow-up|1|||
129852217|NCT01940705|467416658|FG001|Overall Study|Lost to Follow-up|3|||
129852218|NCT01940705|467416659|FG002|Overall Study|Lost to Follow-up|2|||
129852219|NCT01940705|467416660|FG003|Overall Study|Lost to Follow-up|2|||
129852220|NCT01940705|467416657|FG000|Overall Study|Withdrawal by Subject|2|||
129852221|NCT01940705|467416658|FG001|Overall Study|Withdrawal by Subject|2|||
129852222|NCT01940705|467416659|FG002|Overall Study|Withdrawal by Subject|3|||
129852223|NCT01940705|467416660|FG003|Overall Study|Withdrawal by Subject|2|||
129852224|NCT01940705|467416657|FG000|Overall Study|Intervention not given|0|||
129852225|NCT01940705|467416658|FG001|Overall Study|Intervention not given|3|||
129852226|NCT01940705|467416659|FG002|Overall Study|Intervention not given|3|||
129852227|NCT01940705|467416660|FG003|Overall Study|Intervention not given|0|||
129852228|NCT01940705|467416657|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
129852229|NCT01940705|467416658|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
129852230|NCT01940705|467416659|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
129905872|NCT02020616|467616434|FG004|Overall Study|Randomized in Error|0|||
129852231|NCT01940705|467416660|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
129852232|NCT03779841|467416663|FG000|Randomized Population|Did Not Receive Treatment|3|||
129852233|NCT03779841|467416664|FG001|Randomized Population|Did Not Receive Treatment|1|||
129852234|NCT03779841|467416665|FG002|Randomized Population|Did Not Receive Treatment|0|||
129852235|NCT03779841|467416663|FG000|Treated (Safety) Population|Adverse Event|1|||
129852236|NCT03779841|467416664|FG001|Treated (Safety) Population|Adverse Event|1|||
129852237|NCT03779841|467416665|FG002|Treated (Safety) Population|Adverse Event|0|||
129852238|NCT03779841|467416663|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
129852239|NCT03779841|467416664|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
129852240|NCT03779841|467416665|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
129852241|NCT03779841|467416663|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
129852242|NCT03779841|467416664|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
129852243|NCT03779841|467416665|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
129852244|NCT03779841|467416663|FG000|Treated (Safety) Population|Death|1|||
129852245|NCT03779841|467416664|FG001|Treated (Safety) Population|Death|0|||
129852246|NCT03779841|467416665|FG002|Treated (Safety) Population|Death|2|||
129852247|NCT01632579|467416666|FG000|Washout Period|Adverse Event|1|||
129852248|NCT01632579|467416667|FG001|Washout Period|Adverse Event|0|||
129852249|NCT01632579|467416668|FG002|Washout Period|Adverse Event|0|||
129852250|NCT01632579|467416669|FG003|Washout Period|Adverse Event|0|||
129852251|NCT01632579|467416670|FG004|Washout Period|Adverse Event|0|||
129852252|NCT01632579|467416671|FG005|Washout Period|Adverse Event|0|||
129852253|NCT01632579|467416672|FG006|Washout Period|Adverse Event|0|||
129852254|NCT01632579|467416673|FG007|Washout Period|Adverse Event|0|||
129852255|NCT01632579|467416674|FG008|Washout Period|Adverse Event|0|||
129852256|NCT01632579|467416666|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
129852257|NCT01632579|467416667|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
129852258|NCT01632579|467416668|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
129852259|NCT01632579|467416669|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
129852260|NCT01632579|467416670|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
129852261|NCT01632579|467416671|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
129852262|NCT01632579|467416672|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
129852263|NCT01632579|467416673|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
129852264|NCT01632579|467416674|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
129852265|NCT02788175|467416675|FG000|Overall Study|Protocol Violation|3|||
129852266|NCT02788175|467416675|FG000|Overall Study|Withdrawal by Subject|4|||
129852267|NCT02788175|467416675|FG000|Overall Study|Ineligible prior to study agent|6|||
129852268|NCT00162136|467416676|FG000|Overall Study|Adverse Event|1|||
129852269|NCT00162136|467416676|FG000|Overall Study|Death|1|||
129852270|NCT00162136|467416676|FG000|Overall Study|Disease Progression/Relapse|23|||
129852271|NCT00162136|467416676|FG000|Overall Study|Investigator Request|5|||
129852272|NCT00162136|467416676|FG000|Overall Study|Study Drug Toxicity|4|||
129852273|NCT00162136|467416676|FG000|Overall Study|Withdrawal by Subject|1|||
129852274|NCT03930745|467416677|FG000|Overall Study|Lost to Follow-up|10|||
129852275|NCT03930745|467416678|FG001|Overall Study|Lost to Follow-up|5|||
129852276|NCT03930745|467416677|FG000|Overall Study|Withdrawal by Subject|1|||
129852277|NCT03930745|467416678|FG001|Overall Study|Withdrawal by Subject|2|||
129852278|NCT03930745|467416677|FG000|Overall Study|Protocol Violation|2|||
129852279|NCT03930745|467416678|FG001|Overall Study|Protocol Violation|2|||
129852280|NCT03930745|467416677|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
129852281|NCT03930745|467416678|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
129852282|NCT03930745|467416677|FG000|Overall Study|Adverse Event|0|||
129852283|NCT03930745|467416678|FG001|Overall Study|Adverse Event|1|||
129852284|NCT03930745|467416677|FG000|Overall Study|Pregnancy|0|||
129852285|NCT03930745|467416678|FG001|Overall Study|Pregnancy|1|||
129852286|NCT03483623|467416683|FG000|Overall Study|43 complete sets achieved|1|||
129852287|NCT02770391|467416684|FG000|Overall Study|Lost to Follow-up|2|||
129852288|NCT02770391|467416684|FG000|Overall Study|Withdrawal by Subject|1|||
129852289|NCT02770391|467416684|FG000|Overall Study|Surgery delayed unevaluable|2|||
129852290|NCT02770391|467416684|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
129852291|NCT00612313|467416690|FG000|Overall Study|Withdrawal by Subject|6|||
129852292|NCT00612313|467416691|FG001|Overall Study|Withdrawal by Subject|9|||
129852293|NCT00612313|467416690|FG000|Overall Study|Lost to Follow-up|11|||
129852294|NCT00612313|467416691|FG001|Overall Study|Lost to Follow-up|4|||
129852295|NCT03403634|467416704|FG000|Overall Study|Disease progression|3|||
129852296|NCT03403634|467416704|FG000|Overall Study|Did not meet eligibility criteria|4|||
129852297|NCT01337089|467418492|FG000|Overall Study|Adverse Event|237|||
129852298|NCT01337089|467418492|FG000|Overall Study|Withdrawal by Subject|129|||
129852299|NCT01337089|467418492|FG000|Overall Study|Withdrawal by Investigator|33|||
129852300|NCT01337089|467418492|FG000|Overall Study|Met Withdrawal Criteria|3|||
129852301|NCT01337089|467418492|FG000|Overall Study|Lost to Follow-up|2|||
129852302|NCT01627249|467418495|FG000|Overall Study|Death|3|||
129852303|NCT01627249|467418496|FG001|Overall Study|Death|5|||
129852304|NCT01627249|467418497|FG002|Overall Study|Death|3|||
129852305|NCT01627249|467418495|FG000|Overall Study|Withdrawal by Subject|12|||
129905873|NCT02020616|467616435|FG005|Overall Study|Randomized in Error|0|||
129852306|NCT01627249|467418496|FG001|Overall Study|Withdrawal by Subject|6|||
129852307|NCT01627249|467418497|FG002|Overall Study|Withdrawal by Subject|9|||
129852308|NCT01627249|467418495|FG000|Overall Study|Missed Visit|1|||
129852309|NCT01627249|467418496|FG001|Overall Study|Missed Visit|1|||
129852310|NCT01627249|467418497|FG002|Overall Study|Missed Visit|0|||
129852311|NCT00966940|467418499|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
129852312|NCT00966940|467418500|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
129852313|NCT00966940|467418499|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
129852314|NCT00966940|467418500|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
129852315|NCT03455855|467418501|FG000|Overall Study|Lost to Follow-up|4|||
129852316|NCT03455855|467418502|FG001|Overall Study|Lost to Follow-up|2|||
129852317|NCT04820673|467418503|FG000|Overall Study|Adverse Event|6|||
129852318|NCT04820673|467418503|FG000|Overall Study|Due to Lack of Effectiveness|1|||
129852319|NCT04820673|467418503|FG000|Overall Study|Pregnancy|1|||
129852320|NCT04820673|467418503|FG000|Overall Study|Voluntary Withdrawal|20|||
129852321|NCT04820673|467418503|FG000|Overall Study|Lost to Follow-up|10|||
129852322|NCT00767000|467418507|FG000|54-week Study|Adverse Event|4|||
129852323|NCT00767000|467418508|FG001|54-week Study|Adverse Event|6|||
129852324|NCT00767000|467418509|FG002|54-week Study|Adverse Event|6|||
129852325|NCT00767000|467418510|FG003|54-week Study|Adverse Event|8|||
129852326|NCT00767000|467418511|FG004|54-week Study|Adverse Event|4|||
129852327|NCT00767000|467418507|FG000|54-week Study|Creaninine/creatinine clearance|2|||
129852328|NCT00767000|467418508|FG001|54-week Study|Creaninine/creatinine clearance|1|||
129852329|NCT00767000|467418509|FG002|54-week Study|Creaninine/creatinine clearance|2|||
129852330|NCT00767000|467418510|FG003|54-week Study|Creaninine/creatinine clearance|2|||
129852331|NCT00767000|467418511|FG004|54-week Study|Creaninine/creatinine clearance|4|||
129852332|NCT00767000|467418507|FG000|54-week Study|Hyperglycemia|0|||
129852333|NCT00767000|467418508|FG001|54-week Study|Hyperglycemia|0|||
129852334|NCT00767000|467418509|FG002|54-week Study|Hyperglycemia|1|||
129852335|NCT00767000|467418510|FG003|54-week Study|Hyperglycemia|0|||
129852336|NCT00767000|467418511|FG004|54-week Study|Hyperglycemia|1|||
129852337|NCT00767000|467418507|FG000|54-week Study|Hypoglycemia|0|||
129852338|NCT00767000|467418508|FG001|54-week Study|Hypoglycemia|1|||
129852339|NCT00767000|467418509|FG002|54-week Study|Hypoglycemia|0|||
129852340|NCT00767000|467418510|FG003|54-week Study|Hypoglycemia|0|||
129852341|NCT00767000|467418511|FG004|54-week Study|Hypoglycemia|0|||
129852342|NCT00767000|467418507|FG000|54-week Study|Interruption of study medication|0|||
129852343|NCT00767000|467418508|FG001|54-week Study|Interruption of study medication|0|||
129852344|NCT00767000|467418509|FG002|54-week Study|Interruption of study medication|1|||
129852345|NCT00767000|467418510|FG003|54-week Study|Interruption of study medication|0|||
129852346|NCT00767000|467418511|FG004|54-week Study|Interruption of study medication|0|||
129852347|NCT00767000|467418507|FG000|54-week Study|Lack of Efficacy|2|||
129852348|NCT00767000|467418508|FG001|54-week Study|Lack of Efficacy|0|||
129852349|NCT00767000|467418509|FG002|54-week Study|Lack of Efficacy|1|||
129852350|NCT00767000|467418510|FG003|54-week Study|Lack of Efficacy|0|||
129852351|NCT00767000|467418511|FG004|54-week Study|Lack of Efficacy|5|||
129852352|NCT00767000|467418507|FG000|54-week Study|Lost to Follow-up|4|||
129852353|NCT00767000|467418508|FG001|54-week Study|Lost to Follow-up|0|||
129852354|NCT00767000|467418509|FG002|54-week Study|Lost to Follow-up|1|||
129852355|NCT00767000|467418510|FG003|54-week Study|Lost to Follow-up|4|||
129852356|NCT00767000|467418511|FG004|54-week Study|Lost to Follow-up|2|||
129852357|NCT00767000|467418507|FG000|54-week Study|Physician Decision|4|||
129852358|NCT00767000|467418508|FG001|54-week Study|Physician Decision|0|||
129852359|NCT00767000|467418509|FG002|54-week Study|Physician Decision|1|||
129852360|NCT00767000|467418510|FG003|54-week Study|Physician Decision|1|||
129852361|NCT00767000|467418511|FG004|54-week Study|Physician Decision|1|||
129852362|NCT00767000|467418507|FG000|54-week Study|Progressive disease|0|||
129852363|NCT00767000|467418508|FG001|54-week Study|Progressive disease|0|||
129852364|NCT00767000|467418509|FG002|54-week Study|Progressive disease|1|||
129852365|NCT00767000|467418510|FG003|54-week Study|Progressive disease|0|||
129852366|NCT00767000|467418511|FG004|54-week Study|Progressive disease|0|||
129852367|NCT00767000|467418507|FG000|54-week Study|Protocol Violation|0|||
129852368|NCT00767000|467418508|FG001|54-week Study|Protocol Violation|0|||
129852369|NCT00767000|467418509|FG002|54-week Study|Protocol Violation|1|||
129852370|NCT00767000|467418510|FG003|54-week Study|Protocol Violation|2|||
129852371|NCT00767000|467418511|FG004|54-week Study|Protocol Violation|0|||
129852372|NCT00767000|467418507|FG000|54-week Study|Withdrawal by Subject|2|||
129852373|NCT00767000|467418508|FG001|54-week Study|Withdrawal by Subject|3|||
129852374|NCT00767000|467418509|FG002|54-week Study|Withdrawal by Subject|5|||
129852375|NCT00767000|467418510|FG003|54-week Study|Withdrawal by Subject|11|||
129852376|NCT00767000|467418511|FG004|54-week Study|Withdrawal by Subject|13|||
129852377|NCT00767000|467418507|FG000|54-week Study|Study terminated by sponsor|90|||
129852378|NCT00767000|467418508|FG001|54-week Study|Study terminated by sponsor|102|||
129852379|NCT00767000|467418509|FG002|54-week Study|Study terminated by sponsor|89|||
129852380|NCT00767000|467418510|FG003|54-week Study|Study terminated by sponsor|196|||
129905874|NCT02020616|467616436|FG006|Overall Study|Randomized in Error|0|||
129905875|NCT02020616|467616430|FG000|Overall Study|Lack of Efficacy|0|||
129449636|NCT00467779|465945635|FG012|Stage 3|Death|0|||
129449637|NCT00467779|465945636|FG013|Stage 3|Death|0|||
129449638|NCT00467779|465945637|FG014|Stage 3|Death|1|||
129449639|NCT00467779|465945623|FG000|Stage 3|Disease Progression|0|||
129852381|NCT00767000|467418511|FG004|54-week Study|Study terminated by sponsor|194|||
129852382|NCT00767000|467418507|FG000|54-week Study|Reason not reported|0|||
129852383|NCT00767000|467418508|FG001|54-week Study|Reason not reported|0|||
129852384|NCT00767000|467418509|FG002|54-week Study|Reason not reported|0|||
129852385|NCT00767000|467418510|FG003|54-week Study|Reason not reported|1|||
129852386|NCT00767000|467418511|FG004|54-week Study|Reason not reported|0|||
129852387|NCT00767000|467418507|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
129852388|NCT00767000|467418508|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
129852389|NCT00767000|467418509|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
129852390|NCT00767000|467418510|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
129852391|NCT00767000|467418511|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
129852392|NCT02039505|467418513|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
129852393|NCT02039505|467418514|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
129852394|NCT02039505|467418515|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
129852395|NCT02039505|467418516|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852396|NCT02039505|467418517|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852397|NCT02039505|467418518|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852398|NCT02039505|467418519|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
129852399|NCT02039505|467418513|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
129852400|NCT02039505|467418514|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
129852401|NCT02039505|467418515|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
129852402|NCT02039505|467418516|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852403|NCT02039505|467418517|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852404|NCT02039505|467418518|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852405|NCT02039505|467418519|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
129852406|NCT02039505|467418513|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
129852407|NCT02039505|467418514|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852408|NCT02039505|467418515|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852409|NCT02039505|467418516|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852410|NCT02039505|467418517|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852411|NCT02039505|467418518|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852412|NCT02039505|467418519|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
129852413|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852414|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852415|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852416|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
129852417|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
129852418|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
129852419|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
129852420|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852421|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852422|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852423|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
129852424|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
129852425|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
129852426|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
129852427|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852428|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852429|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852430|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
129852431|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
129852432|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
129852433|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
129852434|NCT02039505|467418513|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852435|NCT02039505|467418514|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852436|NCT02039505|467418515|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852437|NCT02039505|467418516|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
129852438|NCT02039505|467418517|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852439|NCT02039505|467418518|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129852440|NCT02039505|467418519|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
129449640|NCT00467779|465945624|FG001|Stage 3|Disease Progression|0|||
129905876|NCT02020616|467616431|FG001|Overall Study|Lack of Efficacy|0|||
129905877|NCT02020616|467616432|FG002|Overall Study|Lack of Efficacy|0|||
129905878|NCT02020616|467616433|FG003|Overall Study|Lack of Efficacy|0|||
129905879|NCT02020616|467616434|FG004|Overall Study|Lack of Efficacy|1|||
129905880|NCT02020616|467616435|FG005|Overall Study|Lack of Efficacy|0|||
129905881|NCT02020616|467616436|FG006|Overall Study|Lack of Efficacy|0|||
129905882|NCT02031471|467616439|FG000|24 Week Treatment Period|Adverse Event|6|||
129905883|NCT02031471|467616439|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
129905884|NCT02031471|467616439|FG000|24 Week Treatment Period|Protocol Violation|1|||
129905885|NCT02031471|467616439|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
129905886|NCT02031471|467616439|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
129905887|NCT02031471|467616439|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
129905888|NCT02031471|467616439|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
129905889|NCT00658996|467616441|FG000|First Intervention|Positive slit lamp finding|1|||
129905890|NCT00658996|467616442|FG001|First Intervention|Positive slit lamp finding|0|||
129905891|NCT00658996|467616441|FG000|First Intervention|Lack of lenses|0|||
129905892|NCT00658996|467616442|FG001|First Intervention|Lack of lenses|1|||
129905893|NCT00658996|467616441|FG000|Crossover Period|Physician Decision|1|||
129905894|NCT00658996|467616442|FG001|Crossover Period|Physician Decision|0|||
129905895|NCT00658996|467616441|FG000|Crossover Period|Ineligible|1|||
129905896|NCT00658996|467616442|FG001|Crossover Period|Ineligible|1|||
129905897|NCT00658996|467616441|FG000|Second Intervention|Developed a stye on upper lid|1|||
129905898|NCT00658996|467616442|FG001|Second Intervention|Developed a stye on upper lid|0|||
129905899|NCT00658996|467616441|FG000|Second Intervention|Positive slit lamp finding|0|||
129905900|NCT00658996|467616442|FG001|Second Intervention|Positive slit lamp finding|1|||
129905901|NCT00997386|467616443|FG000|Overall Study|Death|7|||
129905902|NCT01579916|467616445|FG000|Overall Study|Lost to Follow-up|6|||
129905903|NCT01579916|467616446|FG001|Overall Study|Lost to Follow-up|1|||
129905904|NCT01579916|467616445|FG000|Overall Study|Withdrawal by Subject|1|||
129905905|NCT01579916|467616446|FG001|Overall Study|Withdrawal by Subject|1|||
129905906|NCT01579916|467616445|FG000|Overall Study|Death|1|||
129905907|NCT01579916|467616446|FG001|Overall Study|Death|0|||
129905908|NCT02994654|467616448|FG000|Overall Study|Lost to Follow-up|1|||
129905909|NCT03351075|467617530|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
129905910|NCT03351075|467617531|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
129905911|NCT03351075|467617530|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
129905912|NCT03351075|467617531|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
129852441|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852442|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852443|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852444|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852445|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852446|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
129852447|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
129852448|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852449|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852450|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852451|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852452|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852453|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
129852454|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
129852455|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129905913|NCT03351075|467617530|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
129905914|NCT03351075|467617531|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
129905915|NCT03351075|467617530|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
129905916|NCT03351075|467617531|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
129905917|NCT03169244|467617534|FG000|Overall Study|Lost to Follow-up|1|||
129905918|NCT03169244|467617535|FG001|Overall Study|Lost to Follow-up|2|||
129905919|NCT03169244|467617534|FG000|Overall Study|Adverse Event|1|||
129905920|NCT03169244|467617535|FG001|Overall Study|Adverse Event|0|||
129905921|NCT03169244|467617534|FG000|Overall Study|Withdrawal by Subject|2|||
129905922|NCT03169244|467617535|FG001|Overall Study|Withdrawal by Subject|2|||
129905923|NCT03169244|467617534|FG000|Overall Study|Physician Decision|1|||
129905924|NCT03169244|467617535|FG001|Overall Study|Physician Decision|0|||
129852456|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852457|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852458|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852459|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852460|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
129852461|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
129852462|NCT02039505|467418513|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852463|NCT02039505|467418514|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852464|NCT02039505|467418515|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852465|NCT02039505|467418516|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852466|NCT02039505|467418517|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852467|NCT02039505|467418518|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
129852468|NCT02039505|467418519|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
129852469|NCT00097591|467418520|FG000|Overall Study|Withdrawal of consent|342|||
129852470|NCT00097591|467418521|FG001|Overall Study|Withdrawal of consent|323|||
129852471|NCT00097591|467418520|FG000|Overall Study|Less than 6 months on study drug|9|||
129852472|NCT00097591|467418521|FG001|Overall Study|Less than 6 months on study drug|7|||
129852473|NCT00097591|467418520|FG000|Overall Study|Unable to attend termination visit|53|||
129852474|NCT00097591|467418521|FG001|Overall Study|Unable to attend termination visit|51|||
129852475|NCT00097591|467418520|FG000|Overall Study|Lost to follow up|6|||
129852476|NCT00097591|467418521|FG001|Overall Study|Lost to follow up|10|||
129852477|NCT00097591|467418520|FG000|Overall Study|Other|0|||
129852478|NCT00097591|467418521|FG001|Overall Study|Other|3|||
129852479|NCT00009737|467418523|FG000|Overall Study|Adverse Event|112|||
129852480|NCT00009737|467418524|FG001|Overall Study|Adverse Event|75|||
129852481|NCT00009737|467418523|FG000|Overall Study|Death|4|||
129852482|NCT00009737|467418524|FG001|Overall Study|Death|6|||
129852483|NCT00009737|467418523|FG000|Overall Study|Lack of Efficacy|17|||
129852484|NCT00009737|467418524|FG001|Overall Study|Lack of Efficacy|15|||
129852485|NCT00009737|467418523|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
129852486|NCT00009737|467418524|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
129852487|NCT00009737|467418523|FG000|Overall Study|Other Protocol Violation|1|||
129852488|NCT00009737|467418524|FG001|Overall Study|Other Protocol Violation|0|||
129852489|NCT00009737|467418523|FG000|Overall Study|Refused Treatment|15|||
129852490|NCT00009737|467418524|FG001|Overall Study|Refused Treatment|16|||
129852491|NCT00009737|467418523|FG000|Overall Study|Lost to Follow-up|1|||
129852492|NCT00009737|467418524|FG001|Overall Study|Lost to Follow-up|1|||
129852493|NCT00009737|467418523|FG000|Overall Study|Administrative/Other Reasons|7|||
129852494|NCT00009737|467418524|FG001|Overall Study|Administrative/Other Reasons|1|||
129852495|NCT04808609|467418533|FG000|Overall Study|Lost to Follow-up|0|||
129852496|NCT04808609|467418534|FG001|Overall Study|Lost to Follow-up|2|||
129852497|NCT04808609|467418533|FG000|Overall Study|Administrative Withdrawal|0|||
129852498|NCT04808609|467418534|FG001|Overall Study|Administrative Withdrawal|1|||
129852499|NCT01993719|467418536|FG000|First Drug Administration|Not treated|1|||
129852500|NCT01993719|467418537|FG001|First Drug Administration|Not treated|0|||
129852501|NCT01993719|467418538|FG002|First Drug Administration|Not treated|0|||
129852502|NCT01993719|467418539|FG003|First Drug Administration|Not treated|0|||
129852503|NCT01993719|467418540|FG004|First Drug Administration|Not treated|0|||
129852504|NCT04382326|467418546|FG000|Overall Study|Adverse Event, not serious|1|||
129852505|NCT04382326|467418547|FG001|Overall Study|Adverse Event, not serious|2|||
129852506|NCT04382326|467418546|FG000|Overall Study|Other|1|||
129852507|NCT04382326|467418547|FG001|Overall Study|Other|0|||
129852508|NCT04382326|467418546|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
129852509|NCT04382326|467418547|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
129852510|NCT04382326|467418546|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
129852511|NCT04382326|467418547|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
129852512|NCT04382326|467418546|FG000|Overall Study|Protocol Violation|29|||
129852513|NCT04382326|467418547|FG001|Overall Study|Protocol Violation|23|||
129852514|NCT04382326|467418546|FG000|Overall Study|Physician Decision|0|||
129852515|NCT04382326|467418547|FG001|Overall Study|Physician Decision|1|||
129852516|NCT04382326|467418546|FG000|Overall Study|Lost to Follow-up|48|||
129852517|NCT04382326|467418547|FG001|Overall Study|Lost to Follow-up|63|||
129852518|NCT04382326|467418546|FG000|Overall Study|Adverse Event, non-fatal|1|||
129852519|NCT04382326|467418547|FG001|Overall Study|Adverse Event, non-fatal|1|||
129852520|NCT01557946|467418550|FG000|Overall Study|Adverse Event|3|||
129852521|NCT01557946|467418551|FG001|Overall Study|Adverse Event|0|||
129852522|NCT02352493|467418553|FG000|Overall Study|Pregnancy|0|||
129852523|NCT02352493|467418554|FG001|Overall Study|Pregnancy|0|||
129852524|NCT02352493|467418555|FG002|Overall Study|Pregnancy|0|||
129852525|NCT02352493|467418556|FG003|Overall Study|Pregnancy|0|||
129852526|NCT02352493|467418557|FG004|Overall Study|Pregnancy|0|||
129852527|NCT02352493|467418558|FG005|Overall Study|Pregnancy|0|||
129852528|NCT02352493|467418559|FG006|Overall Study|Pregnancy|1|||
129852529|NCT02352493|467418560|FG007|Overall Study|Pregnancy|0|||
129852530|NCT02352493|467418561|FG008|Overall Study|Pregnancy|1|||
129852531|NCT02352493|467418562|FG009|Overall Study|Pregnancy|0|||
129852532|NCT02352493|467418563|FG010|Overall Study|Pregnancy|0|||
129852533|NCT02352493|467418564|FG011|Overall Study|Pregnancy|0|||
129852534|NCT02352493|467418565|FG012|Overall Study|Pregnancy|0|||
129852535|NCT02352493|467418566|FG013|Overall Study|Pregnancy|0|||
129852536|NCT02352493|467418567|FG014|Overall Study|Pregnancy|0|||
129852537|NCT02352493|467418568|FG015|Overall Study|Pregnancy|0|||
129852538|NCT02352493|467418569|FG016|Overall Study|Pregnancy|0|||
129852539|NCT02352493|467418570|FG017|Overall Study|Pregnancy|0|||
129852540|NCT02352493|467418553|FG000|Overall Study|Withdrawal by Subject|0|||
129852541|NCT02352493|467418554|FG001|Overall Study|Withdrawal by Subject|0|||
129852542|NCT02352493|467418555|FG002|Overall Study|Withdrawal by Subject|0|||
129852543|NCT02352493|467418556|FG003|Overall Study|Withdrawal by Subject|0|||
129852544|NCT02352493|467418557|FG004|Overall Study|Withdrawal by Subject|0|||
129852545|NCT02352493|467418558|FG005|Overall Study|Withdrawal by Subject|0|||
129852546|NCT02352493|467418559|FG006|Overall Study|Withdrawal by Subject|0|||
129852547|NCT02352493|467418560|FG007|Overall Study|Withdrawal by Subject|0|||
129852548|NCT02352493|467418561|FG008|Overall Study|Withdrawal by Subject|1|||
129852549|NCT02352493|467418562|FG009|Overall Study|Withdrawal by Subject|0|||
129852550|NCT02352493|467418563|FG010|Overall Study|Withdrawal by Subject|0|||
129852551|NCT02352493|467418564|FG011|Overall Study|Withdrawal by Subject|0|||
129852552|NCT02352493|467418565|FG012|Overall Study|Withdrawal by Subject|0|||
129852553|NCT02352493|467418566|FG013|Overall Study|Withdrawal by Subject|0|||
129852554|NCT02352493|467418567|FG014|Overall Study|Withdrawal by Subject|1|||
129852555|NCT02352493|467418568|FG015|Overall Study|Withdrawal by Subject|0|||
129852556|NCT02352493|467418569|FG016|Overall Study|Withdrawal by Subject|0|||
129852557|NCT02352493|467418570|FG017|Overall Study|Withdrawal by Subject|0|||
129852558|NCT02352493|467418553|FG000|Overall Study|Lost to Follow-up|0|||
129852559|NCT02352493|467418554|FG001|Overall Study|Lost to Follow-up|0|||
129852560|NCT02352493|467418555|FG002|Overall Study|Lost to Follow-up|0|||
129852561|NCT02352493|467418556|FG003|Overall Study|Lost to Follow-up|0|||
129852562|NCT02352493|467418557|FG004|Overall Study|Lost to Follow-up|0|||
129852563|NCT02352493|467418558|FG005|Overall Study|Lost to Follow-up|0|||
129852564|NCT02352493|467418559|FG006|Overall Study|Lost to Follow-up|0|||
129852565|NCT02352493|467418560|FG007|Overall Study|Lost to Follow-up|0|||
129852566|NCT02352493|467418561|FG008|Overall Study|Lost to Follow-up|0|||
129852567|NCT02352493|467418562|FG009|Overall Study|Lost to Follow-up|1|||
129852568|NCT02352493|467418563|FG010|Overall Study|Lost to Follow-up|0|||
129852569|NCT02352493|467418564|FG011|Overall Study|Lost to Follow-up|0|||
129852570|NCT02352493|467418565|FG012|Overall Study|Lost to Follow-up|1|||
129852571|NCT02352493|467418566|FG013|Overall Study|Lost to Follow-up|2|||
129852572|NCT02352493|467418567|FG014|Overall Study|Lost to Follow-up|0|||
129852573|NCT02352493|467418568|FG015|Overall Study|Lost to Follow-up|0|||
129852574|NCT02352493|467418569|FG016|Overall Study|Lost to Follow-up|0|||
129852575|NCT02352493|467418570|FG017|Overall Study|Lost to Follow-up|0|||
129852576|NCT01465334|467418571|FG000|Overall Study|Disease Progression|1|||
129852577|NCT01465334|467418572|FG001|Overall Study|Disease Progression|0|||
129852578|NCT01465334|467418571|FG000|Overall Study|Adverse Event|1|||
129852579|NCT01465334|467418572|FG001|Overall Study|Adverse Event|0|||
129852580|NCT01465334|467418571|FG000|Overall Study|Richter's transformation|0|||
129852581|NCT01465334|467418572|FG001|Overall Study|Richter's transformation|3|||
129852582|NCT01465334|467418571|FG000|Overall Study|Refractory Disease|0|||
129852583|NCT01465334|467418572|FG001|Overall Study|Refractory Disease|3|||
129852584|NCT00572572|467418573|FG000|Overall Study|Withdrawal by Subject|3|||
129852585|NCT00572572|467418574|FG001|Overall Study|Withdrawal by Subject|6|||
129852586|NCT01831089|467418575|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
129852587|NCT01831089|467418576|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
129852588|NCT01831089|467418577|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
129852589|NCT01831089|467418578|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
129852590|NCT01831089|467418579|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
129852591|NCT01831089|467418580|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
129852592|NCT01831089|467418575|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
129852593|NCT01831089|467418576|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
129852594|NCT01831089|467418577|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
129852595|NCT01831089|467418578|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
129852596|NCT01831089|467418579|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
129852597|NCT01831089|467418580|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
129852598|NCT01831089|467418575|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852599|NCT01831089|467418576|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
129852600|NCT01831089|467418577|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852601|NCT01831089|467418578|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852602|NCT01831089|467418579|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852603|NCT01831089|467418580|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
129852604|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
129852605|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
129905925|NCT04603924|467617536|FG000|Overall Study|Not Dosed|2|||
129905926|NCT04603924|467617537|FG001|Overall Study|Not Dosed|1|||
129905927|NCT04603924|467617536|FG000|Overall Study|Withdrawal by Subject|6|||
129905928|NCT04603924|467617537|FG001|Overall Study|Withdrawal by Subject|6|||
129905929|NCT04603924|467617536|FG000|Overall Study|Adverse Event|2|||
129905930|NCT04603924|467617537|FG001|Overall Study|Adverse Event|2|||
129905931|NCT02139046|467617540|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
129905932|NCT02139046|467617541|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
129905933|NCT02139046|467617542|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
129905934|NCT02139046|467617543|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
129905935|NCT02139046|467617544|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
129905936|NCT02139046|467617540|FG000|Overall Study|Major Protocol Deviation|9|||
129905937|NCT02139046|467617541|FG001|Overall Study|Major Protocol Deviation|10|||
129905938|NCT02139046|467617542|FG002|Overall Study|Major Protocol Deviation|16|||
129905939|NCT02139046|467617543|FG003|Overall Study|Major Protocol Deviation|12|||
129905940|NCT02139046|467617544|FG004|Overall Study|Major Protocol Deviation|6|||
129905941|NCT02139046|467617540|FG000|Overall Study|Lost to Follow-up|13|||
129905942|NCT02139046|467617541|FG001|Overall Study|Lost to Follow-up|16|||
129905943|NCT02139046|467617542|FG002|Overall Study|Lost to Follow-up|16|||
129905944|NCT02139046|467617543|FG003|Overall Study|Lost to Follow-up|18|||
129905945|NCT02139046|467617544|FG004|Overall Study|Lost to Follow-up|13|||
129905946|NCT02139046|467617540|FG000|Overall Study|Voluntary Withdrawal|20|||
129905947|NCT02139046|467617541|FG001|Overall Study|Voluntary Withdrawal|8|||
129905948|NCT02139046|467617542|FG002|Overall Study|Voluntary Withdrawal|10|||
129905949|NCT02139046|467617543|FG003|Overall Study|Voluntary Withdrawal|15|||
129905950|NCT02139046|467617544|FG004|Overall Study|Voluntary Withdrawal|16|||
129905951|NCT02139046|467617540|FG000|Overall Study|Lack of Efficacy|0|||
129905952|NCT02139046|467617541|FG001|Overall Study|Lack of Efficacy|1|||
129905953|NCT02139046|467617542|FG002|Overall Study|Lack of Efficacy|2|||
129852606|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
129852607|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
129852608|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
129852609|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
129852610|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852611|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852612|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
129852613|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852614|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852615|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
129852616|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
129852617|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
129852618|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
129852619|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
129852620|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
129852621|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
129852622|NCT01831089|467418575|FG000|Cohort III: Dose Level 3|Global end of study|0|||
129852623|NCT01831089|467418576|FG001|Cohort III: Dose Level 3|Global end of study|0|||
129852624|NCT01831089|467418577|FG002|Cohort III: Dose Level 3|Global end of study|1|||
129852625|NCT01831089|467418578|FG003|Cohort III: Dose Level 3|Global end of study|0|||
129852626|NCT01831089|467418579|FG004|Cohort III: Dose Level 3|Global end of study|0|||
129852627|NCT01831089|467418580|FG005|Cohort III: Dose Level 3|Global end of study|0|||
129852628|NCT01831089|467418575|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
129852629|NCT01831089|467418576|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
129852630|NCT01831089|467418577|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
129852631|NCT01831089|467418578|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
129852632|NCT01831089|467418579|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
129852633|NCT01831089|467418580|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
129852634|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
129852635|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
129852636|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
129905954|NCT02139046|467617543|FG003|Overall Study|Lack of Efficacy|1|||
129905955|NCT02139046|467617544|FG004|Overall Study|Lack of Efficacy|2|||
129905956|NCT02139046|467617540|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
129905957|NCT02139046|467617541|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
129905958|NCT02139046|467617542|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
129905959|NCT02139046|467617543|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
129905960|NCT02139046|467617544|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
129905961|NCT02139046|467617540|FG000|Overall Study|Other Miscellaneous Reasons|10|||
129905962|NCT02139046|467617541|FG001|Overall Study|Other Miscellaneous Reasons|9|||
129905963|NCT02139046|467617542|FG002|Overall Study|Other Miscellaneous Reasons|4|||
129905964|NCT02139046|467617543|FG003|Overall Study|Other Miscellaneous Reasons|9|||
129905965|NCT02139046|467617544|FG004|Overall Study|Other Miscellaneous Reasons|12|||
129905966|NCT03557008|467617545|FG000|Overall Study|Withdrawal by Subject|2|||
129905967|NCT03557008|467617546|FG001|Overall Study|Withdrawal by Subject|2|||
129852637|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
129852638|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
129852639|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
129852640|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852641|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852642|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852643|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852644|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
129852645|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
129852646|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Death|0|||
129852647|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Death|0|||
129852648|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Death|0|||
129852649|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Death|0|||
129852650|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Death|1|||
129852651|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Death|0|||
129852652|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Global end of study|0|||
129852653|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Global end of study|0|||
129852654|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Global end of study|0|||
129852655|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Global end of study|0|||
129852656|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Global end of study|2|||
129852657|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Global end of study|0|||
129852658|NCT01831089|467418575|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852659|NCT01831089|467418576|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852660|NCT01831089|467418577|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852661|NCT01831089|467418578|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852662|NCT01831089|467418579|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
129852663|NCT01831089|467418580|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
129852664|NCT01831089|467418575|FG000|Cohort B: Arm B|Progressive disease|0|||
129852665|NCT01831089|467418576|FG001|Cohort B: Arm B|Progressive disease|0|||
129852666|NCT01831089|467418577|FG002|Cohort B: Arm B|Progressive disease|0|||
129852667|NCT01831089|467418578|FG003|Cohort B: Arm B|Progressive disease|0|||
129852668|NCT01831089|467418579|FG004|Cohort B: Arm B|Progressive disease|0|||
129852669|NCT01831089|467418580|FG005|Cohort B: Arm B|Progressive disease|8|||
129852670|NCT01831089|467418575|FG000|Cohort B: Arm B|Physician Decision|0|||
129852671|NCT01831089|467418576|FG001|Cohort B: Arm B|Physician Decision|0|||
129852672|NCT01831089|467418577|FG002|Cohort B: Arm B|Physician Decision|0|||
129852673|NCT01831089|467418578|FG003|Cohort B: Arm B|Physician Decision|0|||
129852674|NCT01831089|467418579|FG004|Cohort B: Arm B|Physician Decision|0|||
129852675|NCT01831089|467418580|FG005|Cohort B: Arm B|Physician Decision|2|||
129852676|NCT01831089|467418575|FG000|Cohort B: Arm B|Never treated|0|||
129852677|NCT01831089|467418576|FG001|Cohort B: Arm B|Never treated|0|||
129852678|NCT01831089|467418577|FG002|Cohort B: Arm B|Never treated|0|||
129852679|NCT01831089|467418578|FG003|Cohort B: Arm B|Never treated|0|||
129852680|NCT01831089|467418579|FG004|Cohort B: Arm B|Never treated|0|||
129852681|NCT01831089|467418580|FG005|Cohort B: Arm B|Never treated|2|||
129852682|NCT01831089|467418575|FG000|Cohort B: Arm B|Adverse Event|0|||
129852683|NCT01831089|467418576|FG001|Cohort B: Arm B|Adverse Event|0|||
129852684|NCT01831089|467418577|FG002|Cohort B: Arm B|Adverse Event|0|||
129852685|NCT01831089|467418578|FG003|Cohort B: Arm B|Adverse Event|0|||
129852686|NCT01831089|467418579|FG004|Cohort B: Arm B|Adverse Event|0|||
129852687|NCT01831089|467418580|FG005|Cohort B: Arm B|Adverse Event|1|||
129852688|NCT01831089|467418575|FG000|Cohort B: Arm B|Global end of study|0|||
129852689|NCT01831089|467418576|FG001|Cohort B: Arm B|Global end of study|0|||
129852690|NCT01831089|467418577|FG002|Cohort B: Arm B|Global end of study|0|||
129852691|NCT01831089|467418578|FG003|Cohort B: Arm B|Global end of study|0|||
129852692|NCT01831089|467418579|FG004|Cohort B: Arm B|Global end of study|0|||
129852693|NCT01831089|467418580|FG005|Cohort B: Arm B|Global end of study|1|||
129852694|NCT02114892|467418586|FG000|Overall Study|Lost to Follow-up|1|||
129852695|NCT02114892|467418587|FG001|Overall Study|Lost to Follow-up|2|||
129852696|NCT03525834|467418590|FG000|Overall Study|Progressive disease|1|||
129852697|NCT01751568|467418595|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
129852698|NCT01751568|467418596|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
129852699|NCT01751568|467418597|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
129852700|NCT02660944|467418606|FG000|Overall Study|Adverse Event|3|||
129852701|NCT02660944|467418607|FG001|Overall Study|Adverse Event|4|||
129852702|NCT02660944|467418606|FG000|Overall Study|Physician Decision|3|||
129852703|NCT02660944|467418607|FG001|Overall Study|Physician Decision|1|||
129852704|NCT02660944|467418606|FG000|Overall Study|Withdrawal by Subject|5|||
129852705|NCT02660944|467418607|FG001|Overall Study|Withdrawal by Subject|3|||
129852706|NCT02660944|467418606|FG000|Overall Study|Lost to Follow-up|4|||
129852707|NCT02660944|467418607|FG001|Overall Study|Lost to Follow-up|1|||
129852708|NCT02660944|467418606|FG000|Overall Study|Subject schedule|0|||
129852709|NCT02660944|467418607|FG001|Overall Study|Subject schedule|1|||
129852710|NCT02660944|467418606|FG000|Overall Study|Exclusion criteria met|2|||
129852711|NCT02660944|467418607|FG001|Overall Study|Exclusion criteria met|0|||
129852712|NCT03586999|467418608|FG000|Overall Study|Lack of Efficacy|2|||
129852713|NCT04096560|467418609|FG000|Overall Study|Reason not Specified|1|||
129852714|NCT04096560|467418610|FG001|Overall Study|Reason not Specified|0|||
129852715|NCT04096560|467418611|FG002|Overall Study|Reason not Specified|0|||
129852716|NCT04096560|467418612|FG003|Overall Study|Reason not Specified|0|||
129852717|NCT04096560|467418613|FG004|Overall Study|Reason not Specified|1|||
129852718|NCT04096560|467418614|FG005|Overall Study|Reason not Specified|1|||
129852719|NCT04096560|467418615|FG006|Overall Study|Reason not Specified|1|||
129852720|NCT04096560|467418616|FG007|Overall Study|Reason not Specified|0|||
129852721|NCT04096560|467418609|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852722|NCT04096560|467418610|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852723|NCT04096560|467418611|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852724|NCT04096560|467418612|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852725|NCT04096560|467418613|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852726|NCT04096560|467418614|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
129852727|NCT04096560|467418615|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
129852728|NCT04096560|467418616|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
129852729|NCT04096560|467418609|FG000|Overall Study|Study Terminated by Sponsor|0|||
129852730|NCT04096560|467418610|FG001|Overall Study|Study Terminated by Sponsor|0|||
129852731|NCT04096560|467418611|FG002|Overall Study|Study Terminated by Sponsor|0|||
129852732|NCT04096560|467418612|FG003|Overall Study|Study Terminated by Sponsor|5|||
129852733|NCT04096560|467418613|FG004|Overall Study|Study Terminated by Sponsor|6|||
129852734|NCT04096560|467418614|FG005|Overall Study|Study Terminated by Sponsor|4|||
129852735|NCT04096560|467418615|FG006|Overall Study|Study Terminated by Sponsor|6|||
129852736|NCT04096560|467418616|FG007|Overall Study|Study Terminated by Sponsor|1|||
129852737|NCT04096560|467418609|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852738|NCT04096560|467418610|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852739|NCT04096560|467418611|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852740|NCT04096560|467418612|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852741|NCT04096560|467418613|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852742|NCT04096560|467418614|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852743|NCT04096560|467418615|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
129852744|NCT04096560|467418616|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
129852745|NCT01485861|467418617|FG000|Phase Ib|Death|1|||
129852746|NCT01485861|467418618|FG001|Phase Ib|Death|0|||
129852747|NCT01485861|467418619|FG002|Phase Ib|Death|0|||
129852748|NCT01485861|467418620|FG003|Phase Ib|Death|0|||
129852749|NCT01485861|467418621|FG004|Phase Ib|Death|0|||
129852750|NCT01485861|467418622|FG005|Phase Ib|Death|0|||
129852751|NCT01485861|467418617|FG000|Phase Ib|Physician Decision|1|||
129852752|NCT01485861|467418618|FG001|Phase Ib|Physician Decision|1|||
129852753|NCT01485861|467418619|FG002|Phase Ib|Physician Decision|0|||
129852754|NCT01485861|467418620|FG003|Phase Ib|Physician Decision|0|||
129852755|NCT01485861|467418621|FG004|Phase Ib|Physician Decision|0|||
129852756|NCT01485861|467418622|FG005|Phase Ib|Physician Decision|0|||
129852757|NCT01485861|467418617|FG000|Phase Ib|Adverse Event|0|||
129852758|NCT01485861|467418618|FG001|Phase Ib|Adverse Event|4|||
129852759|NCT01485861|467418619|FG002|Phase Ib|Adverse Event|0|||
129852760|NCT01485861|467418620|FG003|Phase Ib|Adverse Event|0|||
129852761|NCT01485861|467418621|FG004|Phase Ib|Adverse Event|0|||
129852762|NCT01485861|467418622|FG005|Phase Ib|Adverse Event|0|||
129852763|NCT01485861|467418617|FG000|Phase Ib|Progression of disease|5|||
129852764|NCT01485861|467418618|FG001|Phase Ib|Progression of disease|0|||
129852765|NCT01485861|467418619|FG002|Phase Ib|Progression of disease|0|||
129852766|NCT01485861|467418620|FG003|Phase Ib|Progression of disease|0|||
129852767|NCT01485861|467418621|FG004|Phase Ib|Progression of disease|0|||
129852768|NCT01485861|467418622|FG005|Phase Ib|Progression of disease|0|||
129852769|NCT01485861|467418617|FG000|Phase Ib|Other|3|||
129852770|NCT01485861|467418618|FG001|Phase Ib|Other|0|||
129852771|NCT01485861|467418619|FG002|Phase Ib|Other|0|||
129852772|NCT01485861|467418620|FG003|Phase Ib|Other|0|||
129852773|NCT01485861|467418621|FG004|Phase Ib|Other|0|||
129852774|NCT01485861|467418622|FG005|Phase Ib|Other|0|||
129852775|NCT01485861|467418617|FG000|Phase Ib|Withdrawal by Subject|4|||
129852776|NCT01485861|467418618|FG001|Phase Ib|Withdrawal by Subject|1|||
129852777|NCT01485861|467418619|FG002|Phase Ib|Withdrawal by Subject|0|||
129852778|NCT01485861|467418620|FG003|Phase Ib|Withdrawal by Subject|0|||
129852779|NCT01485861|467418621|FG004|Phase Ib|Withdrawal by Subject|0|||
129852780|NCT01485861|467418622|FG005|Phase Ib|Withdrawal by Subject|0|||
129852781|NCT01485861|467418617|FG000|Phase II|Death|0|||
129852782|NCT01485861|467418618|FG001|Phase II|Death|0|||
129852783|NCT01485861|467418619|FG002|Phase II|Death|67|||
129852784|NCT01485861|467418620|FG003|Phase II|Death|71|||
129852785|NCT01485861|467418621|FG004|Phase II|Death|68|||
129852786|NCT01485861|467418622|FG005|Phase II|Death|0|||
129905968|NCT03557008|467617545|FG000|Overall Study|Early termination from study|3|||
129905969|NCT03557008|467617546|FG001|Overall Study|Early termination from study|1|||
129905970|NCT01113931|467617548|FG000|Overall Study|Adverse Event|2|||
129905971|NCT01113931|467617549|FG001|Overall Study|Adverse Event|2|||
129905972|NCT01113931|467617548|FG000|Overall Study|Physician Decision|0|||
129905973|NCT01113931|467617549|FG001|Overall Study|Physician Decision|2|||
129905974|NCT01113931|467617548|FG000|Overall Study|Lost to Follow-up|12|||
129905975|NCT01113931|467617549|FG001|Overall Study|Lost to Follow-up|9|||
129905976|NCT01113931|467617548|FG000|Overall Study|Various|2|||
129905977|NCT01113931|467617549|FG001|Overall Study|Various|4|||
129905978|NCT01113931|467617548|FG000|Overall Study|Withdrawal by Subject|3|||
129905979|NCT01113931|467617549|FG001|Overall Study|Withdrawal by Subject|0|||
129905980|NCT03959241|467617551|FG000|Overall Study|Withdrawal by Subject|7|||
129905981|NCT03959241|467617552|FG001|Overall Study|Withdrawal by Subject|8|||
129905982|NCT03959241|467617551|FG000|Overall Study|Lost to Follow-up|1|||
129905983|NCT03959241|467617552|FG001|Overall Study|Lost to Follow-up|0|||
129905984|NCT03959241|467617551|FG000|Overall Study|Move to Hospice Care|1|||
129905985|NCT03959241|467617552|FG001|Overall Study|Move to Hospice Care|0|||
129905986|NCT03959241|467617551|FG000|Overall Study|Screen Failure|1|||
129905987|NCT03959241|467617552|FG001|Overall Study|Screen Failure|0|||
129905988|NCT03959241|467617551|FG000|Overall Study|Disease Relapse|0|||
129905989|NCT03959241|467617552|FG001|Overall Study|Disease Relapse|1|||
129905990|NCT03959241|467617551|FG000|Overall Study|Off Study|1|||
129905991|NCT03959241|467617552|FG001|Overall Study|Off Study|0|||
129905992|NCT00346151|467617553|FG000|Overall Study|Withdrawal by Subject|3|||
129905993|NCT00545077|467617561|FG000|Overall Study|Treatment not received|5|||
129905994|NCT00545077|467617562|FG001|Overall Study|Treatment not received|1|||
129905995|NCT00545077|467617561|FG000|Overall Study|Disease Progression|131|||
129905996|NCT00545077|467617562|FG001|Overall Study|Disease Progression|98|||
129905997|NCT00545077|467617561|FG000|Overall Study|Withdrawal by Subject|3|||
129905998|NCT00545077|467617562|FG001|Overall Study|Withdrawal by Subject|14|||
129905999|NCT00545077|467617561|FG000|Overall Study|Physician Decision|6|||
129906000|NCT00545077|467617562|FG001|Overall Study|Physician Decision|3|||
129906001|NCT00545077|467617561|FG000|Overall Study|Lost to Follow-up|2|||
129906002|NCT00545077|467617562|FG001|Overall Study|Lost to Follow-up|0|||
129906003|NCT00545077|467617561|FG000|Overall Study|Protocol Violation|1|||
129906004|NCT00545077|467617562|FG001|Overall Study|Protocol Violation|0|||
129906005|NCT00545077|467617561|FG000|Overall Study|Adverse Event|0|||
129906006|NCT00545077|467617562|FG001|Overall Study|Adverse Event|31|||
129906007|NCT00545077|467617561|FG000|Overall Study|Death|0|||
129906008|NCT00545077|467617562|FG001|Overall Study|Death|8|||
129906009|NCT02202499|467617563|FG000|Overall Study|Cancer diagnosis|0|||
129906010|NCT02202499|467617564|FG001|Overall Study|Cancer diagnosis|0|||
129906011|NCT02202499|467617565|FG002|Overall Study|Cancer diagnosis|1|||
129906012|NCT02202499|467617563|FG000|Overall Study|Moved from area|0|||
129906013|NCT02202499|467617564|FG001|Overall Study|Moved from area|0|||
129906014|NCT02202499|467617565|FG002|Overall Study|Moved from area|1|||
129906015|NCT02202499|467617563|FG000|Overall Study|Declined before randomization|1|||
129906016|NCT02202499|467617564|FG001|Overall Study|Declined before randomization|0|||
129906017|NCT02202499|467617565|FG002|Overall Study|Declined before randomization|0|||
129906018|NCT02202499|467617563|FG000|Overall Study|Auto accident|1|||
129906019|NCT02202499|467617564|FG001|Overall Study|Auto accident|0|||
129906020|NCT02202499|467617565|FG002|Overall Study|Auto accident|0|||
129906021|NCT00535145|467617567|FG000|Phase I|Adverse Event|3|||
129906022|NCT00535145|467617567|FG000|Phase I|Lost to Follow-up|7|||
129906023|NCT00535145|467617567|FG000|Phase I|Withdrawal by Subject|6|||
129906024|NCT00535145|467617567|FG000|Phase I|(eligibility)|8|||
129906025|NCT00535145|467617567|FG000|Phase I|(protocol violation)|1|||
129906026|NCT00535145|467617567|FG000|Phase I|(PI decision)|1|||
129906027|NCT00535145|467617567|FG000|Phase I|(diagnosis)|3|||
129906028|NCT00535145|467617567|FG000|Phase II|Adverse Event|2|||
129906029|NCT00535145|467617567|FG000|Phase II|Lack of Efficacy|1|||
129906030|NCT00535145|467617567|FG000|Phase II|Lost to Follow-up|5|||
129906031|NCT00535145|467617567|FG000|Phase II|Withdrawal by Subject|5|||
129906032|NCT00535145|467617567|FG000|Phase II|Subject non-compliance|2|||
129906033|NCT03260140|467617568|FG000|Overall Study|Death|4|||
129906034|NCT03260140|467617569|FG001|Overall Study|Death|1|||
129906035|NCT03260140|467617568|FG000|Overall Study|Withdrawal by Subject|1|||
129906036|NCT03260140|467617569|FG001|Overall Study|Withdrawal by Subject|4|||
129906037|NCT01692938|467617573|FG000|Overall Study|Protocol Deviation|1|||
129906038|NCT01692938|467617574|FG001|Overall Study|Protocol Deviation|1|||
129906039|NCT01692938|467617573|FG000|Overall Study|Study completed prior to site completion|3|||
129906040|NCT01692938|467617574|FG001|Overall Study|Study completed prior to site completion|3|||
129906041|NCT02423291|467617576|FG000|Overall Study|Lack of Efficacy|14|||
129906042|NCT02423291|467617576|FG000|Overall Study|Adverse Event|1|||
129906043|NCT05283395|467617578|FG000|Overall Study|Adverse Event|4|||
129906044|NCT05283395|467617579|FG001|Overall Study|Adverse Event|4|||
129906045|NCT05283395|467617580|FG002|Overall Study|Adverse Event|0|||
129906046|NCT05283395|467617578|FG000|Overall Study|Patient Lost to Follow-Up|0|||
129906047|NCT05283395|467617579|FG001|Overall Study|Patient Lost to Follow-Up|0|||
129906048|NCT05283395|467617580|FG002|Overall Study|Patient Lost to Follow-Up|1|||
129906049|NCT05283395|467617578|FG000|Overall Study|Patient Withdrawal|2|||
129906050|NCT05283395|467617579|FG001|Overall Study|Patient Withdrawal|4|||
129906051|NCT05283395|467617580|FG002|Overall Study|Patient Withdrawal|2|||
129906052|NCT05283395|467617578|FG000|Overall Study|Investigator Decision|1|||
129906053|NCT05283395|467617579|FG001|Overall Study|Investigator Decision|0|||
129906054|NCT05283395|467617580|FG002|Overall Study|Investigator Decision|1|||
129906055|NCT05283395|467617578|FG000|Overall Study|Enrolled in error|0|||
129906056|NCT05283395|467617579|FG001|Overall Study|Enrolled in error|0|||
129906057|NCT05283395|467617580|FG002|Overall Study|Enrolled in error|1|||
129906058|NCT00424645|467617584|FG000|Overall Study|Death|1|||
129906059|NCT00424645|467617585|FG001|Overall Study|Death|0|||
129906060|NCT00959946|467617588|FG000|Overall Study|Adverse Event|0|||
129906061|NCT00959946|467617589|FG001|Overall Study|Adverse Event|0|||
129906062|NCT00959946|467617590|FG002|Overall Study|Adverse Event|2|||
129906063|NCT00959946|467617591|FG003|Overall Study|Adverse Event|1|||
129906064|NCT00959946|467617592|FG004|Overall Study|Adverse Event|0|||
129906065|NCT00959946|467617593|FG005|Overall Study|Adverse Event|1|||
129906066|NCT00959946|467617594|FG006|Overall Study|Adverse Event|0|||
129906067|NCT00959946|467617595|FG007|Overall Study|Adverse Event|0|||
129906068|NCT00959946|467617588|FG000|Overall Study|Death|0|||
129906069|NCT00959946|467617589|FG001|Overall Study|Death|0|||
129906070|NCT00959946|467617590|FG002|Overall Study|Death|0|||
129906071|NCT00959946|467617591|FG003|Overall Study|Death|0|||
129906072|NCT00959946|467617592|FG004|Overall Study|Death|0|||
129906073|NCT00959946|467617593|FG005|Overall Study|Death|1|||
129906074|NCT00959946|467617594|FG006|Overall Study|Death|0|||
129906075|NCT00959946|467617595|FG007|Overall Study|Death|0|||
129906076|NCT00959946|467617588|FG000|Overall Study|Disease Progression|2|||
129906077|NCT00959946|467617589|FG001|Overall Study|Disease Progression|4|||
129906078|NCT00959946|467617590|FG002|Overall Study|Disease Progression|2|||
129906079|NCT00959946|467617591|FG003|Overall Study|Disease Progression|4|||
129906080|NCT00959946|467617592|FG004|Overall Study|Disease Progression|4|||
129906081|NCT00959946|467617593|FG005|Overall Study|Disease Progression|6|||
129906082|NCT00959946|467617594|FG006|Overall Study|Disease Progression|2|||
129906083|NCT00959946|467617595|FG007|Overall Study|Disease Progression|2|||
129906084|NCT00959946|467617588|FG000|Overall Study|Withdrawal by Subject|0|||
129906085|NCT00959946|467617589|FG001|Overall Study|Withdrawal by Subject|0|||
129906086|NCT00959946|467617590|FG002|Overall Study|Withdrawal by Subject|0|||
129906087|NCT00959946|467617591|FG003|Overall Study|Withdrawal by Subject|0|||
129906088|NCT00959946|467617592|FG004|Overall Study|Withdrawal by Subject|0|||
129906089|NCT00959946|467617593|FG005|Overall Study|Withdrawal by Subject|1|||
129906090|NCT00959946|467617594|FG006|Overall Study|Withdrawal by Subject|0|||
129906091|NCT00959946|467617595|FG007|Overall Study|Withdrawal by Subject|0|||
129906092|NCT02115139|467617598|FG000|Overall Study|Protocol Violation|1|||
129906093|NCT02115139|467617598|FG000|Overall Study|treatment discontinuation|6|||
129906094|NCT01909778|467617599|FG000|Overall Study|failed screening|1|||
129906095|NCT02471755|467617601|FG000|Overall Study|Withdrawal by Subject|1|||
129906096|NCT02471755|467617602|FG001|Overall Study|Withdrawal by Subject|0|||
129906097|NCT02471755|467617601|FG000|Overall Study|Lost to Follow-up|0|||
129906098|NCT02471755|467617602|FG001|Overall Study|Lost to Follow-up|1|||
129906099|NCT04740164|467617603|FG000|Overall Study|Lack of Efficacy|4|||
129906100|NCT04740164|467617604|FG001|Overall Study|Lack of Efficacy|0|||
129906101|NCT04740164|467617603|FG000|Overall Study|Physician Decision|3|||
129906102|NCT04740164|467617604|FG001|Overall Study|Physician Decision|3|||
129906103|NCT04177394|467617605|FG000|Overall Study|Death|16|||
129906104|NCT04177394|467617605|FG000|Overall Study|Withdrawal by Subject|19|||
129906105|NCT04177394|467617605|FG000|Overall Study|Missed visits|61|||
129906106|NCT04177394|467617605|FG000|Overall Study|Expected Visits|15|||
129906107|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
129906108|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
129906109|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
129906110|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906111|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906112|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906113|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906114|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906115|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906116|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906117|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906118|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
129906119|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
129906120|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
129906121|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
129906122|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
129906123|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
129906124|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
129906125|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
129906126|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
129906127|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
129906128|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
129906129|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
129906130|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
129906131|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
129906132|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906133|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906134|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906135|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906136|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906137|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906138|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906139|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906140|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906141|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906142|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
129906143|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906144|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906145|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
129906146|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906147|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906148|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906149|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906150|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906151|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906152|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906153|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906154|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
129906155|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
129906156|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
129906157|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
129906158|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
129852787|NCT01485861|467418617|FG000|Phase II|Progression of Disease|0|||
129852788|NCT01485861|467418618|FG001|Phase II|Progression of Disease|0|||
129852789|NCT01485861|467418619|FG002|Phase II|Progression of Disease|1|||
129852790|NCT01485861|467418620|FG003|Phase II|Progression of Disease|0|||
129852791|NCT01485861|467418621|FG004|Phase II|Progression of Disease|0|||
129852792|NCT01485861|467418622|FG005|Phase II|Progression of Disease|0|||
129852793|NCT01485861|467418617|FG000|Phase II|Other|0|||
129852794|NCT01485861|467418618|FG001|Phase II|Other|0|||
129852795|NCT01485861|467418619|FG002|Phase II|Other|0|||
129852796|NCT01485861|467418620|FG003|Phase II|Other|1|||
129852797|NCT01485861|467418621|FG004|Phase II|Other|0|||
129852798|NCT01485861|467418622|FG005|Phase II|Other|0|||
129852799|NCT01485861|467418617|FG000|Phase II|Withdrawal by Subject|0|||
129852800|NCT01485861|467418618|FG001|Phase II|Withdrawal by Subject|0|||
129852801|NCT01485861|467418619|FG002|Phase II|Withdrawal by Subject|6|||
129852802|NCT01485861|467418620|FG003|Phase II|Withdrawal by Subject|3|||
129852803|NCT01485861|467418621|FG004|Phase II|Withdrawal by Subject|4|||
129852804|NCT01485861|467418622|FG005|Phase II|Withdrawal by Subject|0|||
129852805|NCT01485861|467418617|FG000|Phase II|Lost to Follow-up|0|||
129852806|NCT01485861|467418618|FG001|Phase II|Lost to Follow-up|0|||
129852807|NCT01485861|467418619|FG002|Phase II|Lost to Follow-up|2|||
129852808|NCT01485861|467418620|FG003|Phase II|Lost to Follow-up|3|||
129852809|NCT01485861|467418621|FG004|Phase II|Lost to Follow-up|5|||
129852810|NCT01485861|467418622|FG005|Phase II|Lost to Follow-up|0|||
129852811|NCT01485861|467418617|FG000|Phase II|Study Ended|0|||
129852812|NCT01485861|467418618|FG001|Phase II|Study Ended|0|||
129852813|NCT01485861|467418619|FG002|Phase II|Study Ended|7|||
129906159|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906160|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906161|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129852814|NCT01485861|467418620|FG003|Phase II|Study Ended|8|||
129852815|NCT01485861|467418621|FG004|Phase II|Study Ended|6|||
129852816|NCT01485861|467418622|FG005|Phase II|Study Ended|0|||
129852817|NCT01485861|467418617|FG000|Safety Phase|Death|0|||
129852818|NCT01485861|467418618|FG001|Safety Phase|Death|0|||
129852819|NCT01485861|467418619|FG002|Safety Phase|Death|0|||
129852820|NCT01485861|467418620|FG003|Safety Phase|Death|0|||
129852821|NCT01485861|467418621|FG004|Safety Phase|Death|0|||
129852822|NCT01485861|467418622|FG005|Safety Phase|Death|2|||
129906162|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906163|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906164|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906165|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906166|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
129906167|NCT05061693|467617606|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
129906168|NCT05061693|467617607|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
129906169|NCT05061693|467617608|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
129906170|NCT05061693|467617609|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
129906171|NCT05061693|467617610|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906172|NCT05061693|467617611|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906173|NCT05061693|467617612|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906174|NCT05061693|467617613|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906175|NCT05061693|467617614|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906176|NCT05061693|467617615|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906177|NCT05061693|467617616|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906178|NCT05061693|467617617|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
129906179|NCT05061693|467617606|FG000|24-week Extension Period|Adverse Event|0|||
129906180|NCT05061693|467617607|FG001|24-week Extension Period|Adverse Event|0|||
129906181|NCT05061693|467617608|FG002|24-week Extension Period|Adverse Event|0|||
129906182|NCT05061693|467617609|FG003|24-week Extension Period|Adverse Event|0|||
129906183|NCT05061693|467617610|FG004|24-week Extension Period|Adverse Event|0|||
129906184|NCT05061693|467617611|FG005|24-week Extension Period|Adverse Event|0|||
129906185|NCT05061693|467617612|FG006|24-week Extension Period|Adverse Event|0|||
129906186|NCT05061693|467617613|FG007|24-week Extension Period|Adverse Event|2|||
129906187|NCT05061693|467617614|FG008|24-week Extension Period|Adverse Event|2|||
129906188|NCT05061693|467617615|FG009|24-week Extension Period|Adverse Event|0|||
129906189|NCT05061693|467617616|FG010|24-week Extension Period|Adverse Event|1|||
129906190|NCT05061693|467617617|FG011|24-week Extension Period|Adverse Event|3|||
129906191|NCT05061693|467617606|FG000|24-week Extension Period|Lack of Efficacy|0|||
129906192|NCT05061693|467617607|FG001|24-week Extension Period|Lack of Efficacy|0|||
129906193|NCT05061693|467617608|FG002|24-week Extension Period|Lack of Efficacy|0|||
129906194|NCT05061693|467617609|FG003|24-week Extension Period|Lack of Efficacy|0|||
129906195|NCT05061693|467617610|FG004|24-week Extension Period|Lack of Efficacy|0|||
129906196|NCT05061693|467617611|FG005|24-week Extension Period|Lack of Efficacy|0|||
129906197|NCT05061693|467617612|FG006|24-week Extension Period|Lack of Efficacy|0|||
129906198|NCT05061693|467617613|FG007|24-week Extension Period|Lack of Efficacy|0|||
129906199|NCT05061693|467617614|FG008|24-week Extension Period|Lack of Efficacy|0|||
129906200|NCT05061693|467617615|FG009|24-week Extension Period|Lack of Efficacy|0|||
129906201|NCT05061693|467617616|FG010|24-week Extension Period|Lack of Efficacy|2|||
129906202|NCT05061693|467617617|FG011|24-week Extension Period|Lack of Efficacy|0|||
129906203|NCT05061693|467617606|FG000|24-week Extension Period|Lost to Follow-up|0|||
129906204|NCT05061693|467617607|FG001|24-week Extension Period|Lost to Follow-up|0|||
129906205|NCT05061693|467617608|FG002|24-week Extension Period|Lost to Follow-up|0|||
129906206|NCT05061693|467617609|FG003|24-week Extension Period|Lost to Follow-up|0|||
129906207|NCT05061693|467617610|FG004|24-week Extension Period|Lost to Follow-up|0|||
129906208|NCT05061693|467617611|FG005|24-week Extension Period|Lost to Follow-up|0|||
129906209|NCT05061693|467617612|FG006|24-week Extension Period|Lost to Follow-up|1|||
129906210|NCT05061693|467617613|FG007|24-week Extension Period|Lost to Follow-up|0|||
129906211|NCT05061693|467617614|FG008|24-week Extension Period|Lost to Follow-up|1|||
129906212|NCT05061693|467617615|FG009|24-week Extension Period|Lost to Follow-up|1|||
129906213|NCT05061693|467617616|FG010|24-week Extension Period|Lost to Follow-up|0|||
129906214|NCT05061693|467617617|FG011|24-week Extension Period|Lost to Follow-up|0|||
129906215|NCT05061693|467617606|FG000|24-week Extension Period|Withdrawal by Subject|0|||
129906216|NCT05061693|467617607|FG001|24-week Extension Period|Withdrawal by Subject|0|||
129906217|NCT05061693|467617608|FG002|24-week Extension Period|Withdrawal by Subject|0|||
129906218|NCT05061693|467617609|FG003|24-week Extension Period|Withdrawal by Subject|0|||
129906219|NCT05061693|467617610|FG004|24-week Extension Period|Withdrawal by Subject|0|||
129906220|NCT05061693|467617611|FG005|24-week Extension Period|Withdrawal by Subject|0|||
129906221|NCT05061693|467617612|FG006|24-week Extension Period|Withdrawal by Subject|0|||
129906222|NCT05061693|467617613|FG007|24-week Extension Period|Withdrawal by Subject|0|||
129906223|NCT05061693|467617614|FG008|24-week Extension Period|Withdrawal by Subject|1|||
129906224|NCT05061693|467617615|FG009|24-week Extension Period|Withdrawal by Subject|2|||
129906225|NCT05061693|467617616|FG010|24-week Extension Period|Withdrawal by Subject|2|||
129906226|NCT05061693|467617617|FG011|24-week Extension Period|Withdrawal by Subject|1|||
129906227|NCT05061693|467617606|FG000|24-week Extension Period|Sponsor Decision|0|||
129906228|NCT05061693|467617607|FG001|24-week Extension Period|Sponsor Decision|0|||
129906229|NCT05061693|467617608|FG002|24-week Extension Period|Sponsor Decision|0|||
129906230|NCT05061693|467617609|FG003|24-week Extension Period|Sponsor Decision|0|||
129906231|NCT05061693|467617610|FG004|24-week Extension Period|Sponsor Decision|0|||
129906232|NCT05061693|467617611|FG005|24-week Extension Period|Sponsor Decision|0|||
129906233|NCT05061693|467617612|FG006|24-week Extension Period|Sponsor Decision|0|||
129906234|NCT05061693|467617613|FG007|24-week Extension Period|Sponsor Decision|1|||
129906235|NCT05061693|467617614|FG008|24-week Extension Period|Sponsor Decision|0|||
129906236|NCT05061693|467617615|FG009|24-week Extension Period|Sponsor Decision|0|||
129906237|NCT05061693|467617616|FG010|24-week Extension Period|Sponsor Decision|0|||
129906238|NCT05061693|467617617|FG011|24-week Extension Period|Sponsor Decision|0|||
129906239|NCT05061693|467617606|FG000|24-week Extension Period|Site Closure|0|||
129906240|NCT05061693|467617607|FG001|24-week Extension Period|Site Closure|0|||
129906241|NCT05061693|467617608|FG002|24-week Extension Period|Site Closure|0|||
129906242|NCT05061693|467617609|FG003|24-week Extension Period|Site Closure|0|||
129906243|NCT05061693|467617610|FG004|24-week Extension Period|Site Closure|0|||
129906244|NCT05061693|467617611|FG005|24-week Extension Period|Site Closure|0|||
129906245|NCT05061693|467617612|FG006|24-week Extension Period|Site Closure|0|||
129906246|NCT05061693|467617613|FG007|24-week Extension Period|Site Closure|0|||
129906247|NCT05061693|467617614|FG008|24-week Extension Period|Site Closure|1|||
129906248|NCT05061693|467617615|FG009|24-week Extension Period|Site Closure|0|||
129906249|NCT05061693|467617616|FG010|24-week Extension Period|Site Closure|0|||
129906250|NCT05061693|467617617|FG011|24-week Extension Period|Site Closure|1|||
129906251|NCT01152190|467617618|FG000|Overall Study|Adverse Event|2|||
129906252|NCT01152190|467617619|FG001|Overall Study|Adverse Event|4|||
129906253|NCT01152190|467617618|FG000|Overall Study|Death|1|||
129906254|NCT01152190|467617619|FG001|Overall Study|Death|0|||
129906255|NCT01152190|467617618|FG000|Overall Study|Protocol Violation|1|||
129906256|NCT01152190|467617619|FG001|Overall Study|Protocol Violation|1|||
129906257|NCT01152190|467617618|FG000|Overall Study|Withdrawal by Subject|1|||
129906258|NCT01152190|467617619|FG001|Overall Study|Withdrawal by Subject|3|||
129906259|NCT03823911|467617620|FG000|Overall Study|Lost to Follow-up|1|||
129906260|NCT03823911|467617621|FG001|Overall Study|Lost to Follow-up|5|||
129906261|NCT03823911|467617622|FG002|Overall Study|Lost to Follow-up|2|||
129906262|NCT03823911|467617620|FG000|Overall Study|Did not meet eligibility criteria|13|||
129906263|NCT03823911|467617621|FG001|Overall Study|Did not meet eligibility criteria|7|||
129906264|NCT03823911|467617622|FG002|Overall Study|Did not meet eligibility criteria|4|||
129906265|NCT03823911|467617620|FG000|Overall Study|Death|0|||
129906266|NCT03823911|467617621|FG001|Overall Study|Death|1|||
129906267|NCT03823911|467617622|FG002|Overall Study|Death|0|||
129906268|NCT00373529|467617625|FG000|Overall Study|Physician Decision|19|||
129906269|NCT00373529|467617625|FG000|Overall Study|Withdrawal by Subject|7|||
129906270|NCT00373529|467617625|FG000|Overall Study|Adverse Event|7|||
129906271|NCT00373529|467617625|FG000|Overall Study|Treatment failure|36|||
129906272|NCT00373529|467617625|FG000|Overall Study|Disease recurrence|10|||
129906273|NCT00373529|467617625|FG000|Overall Study|Death|16|||
129906274|NCT00373529|467617625|FG000|Overall Study|Need for treatment prohibited by study|1|||
129906275|NCT00373529|467617625|FG000|Overall Study|Other|8|||
129906276|NCT00373529|467617625|FG000|Overall Study|Failed independent confirmation of AML|3|||
129906277|NCT00373529|467617625|FG000|Overall Study|Consent violation|1|||
129906278|NCT00442117|467617626|FG000|Overall Study|Adverse Event|3|||
129852823|NCT01485861|467418617|FG000|Safety Phase|Adverse Event|0|||
129852824|NCT01485861|467418618|FG001|Safety Phase|Adverse Event|0|||
129852825|NCT01485861|467418619|FG002|Safety Phase|Adverse Event|0|||
129852826|NCT01485861|467418620|FG003|Safety Phase|Adverse Event|0|||
129852827|NCT01485861|467418621|FG004|Safety Phase|Adverse Event|0|||
129852828|NCT01485861|467418622|FG005|Safety Phase|Adverse Event|1|||
129852829|NCT01485861|467418617|FG000|Safety Phase|Other|0|||
129852830|NCT01485861|467418618|FG001|Safety Phase|Other|0|||
129852831|NCT01485861|467418619|FG002|Safety Phase|Other|0|||
129852832|NCT01485861|467418620|FG003|Safety Phase|Other|0|||
129852833|NCT01485861|467418621|FG004|Safety Phase|Other|0|||
129852834|NCT01485861|467418622|FG005|Safety Phase|Other|5|||
129852835|NCT01485861|467418617|FG000|Safety Phase|Progression of Disease|0|||
129852836|NCT01485861|467418618|FG001|Safety Phase|Progression of Disease|0|||
129852837|NCT01485861|467418619|FG002|Safety Phase|Progression of Disease|0|||
129852838|NCT01485861|467418620|FG003|Safety Phase|Progression of Disease|0|||
129852839|NCT01485861|467418621|FG004|Safety Phase|Progression of Disease|0|||
129852840|NCT01485861|467418622|FG005|Safety Phase|Progression of Disease|9|||
129852841|NCT01485861|467418617|FG000|Safety Phase|Withdrawal by Subject|0|||
129906279|NCT00442117|467617627|FG001|Overall Study|Adverse Event|2|||
129906280|NCT00442117|467617626|FG000|Overall Study|Lack of Efficacy|2|||
129906281|NCT00442117|467617627|FG001|Overall Study|Lack of Efficacy|6|||
129906282|NCT00442117|467617626|FG000|Overall Study|Lost to Follow-up|1|||
129906283|NCT00442117|467617627|FG001|Overall Study|Lost to Follow-up|2|||
129906284|NCT00442117|467617626|FG000|Overall Study|Withdrawal by Subject|2|||
129906285|NCT00442117|467617627|FG001|Overall Study|Withdrawal by Subject|2|||
129852842|NCT01485861|467418618|FG001|Safety Phase|Withdrawal by Subject|0|||
129852843|NCT01485861|467418619|FG002|Safety Phase|Withdrawal by Subject|0|||
129852844|NCT01485861|467418620|FG003|Safety Phase|Withdrawal by Subject|0|||
129852845|NCT01485861|467418621|FG004|Safety Phase|Withdrawal by Subject|0|||
129852846|NCT01485861|467418622|FG005|Safety Phase|Withdrawal by Subject|6|||
129852847|NCT01485861|467418617|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852848|NCT01485861|467418618|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852849|NCT01485861|467418619|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852850|NCT01485861|467418620|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852851|NCT01485861|467418621|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
129852852|NCT01485861|467418622|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
129852853|NCT03653429|467418623|FG000|Overall Study|Physician Decision|4|||
129852854|NCT03653429|467418624|FG001|Overall Study|Physician Decision|10|||
129852855|NCT03321981|467418630|FG000|Overall Study|Progressive Disease (PD)|15|||
129852856|NCT03321981|467418631|FG001|Overall Study|Progressive Disease (PD)|30|||
129852857|NCT03321981|467418632|FG002|Overall Study|Progressive Disease (PD)|47|||
129852858|NCT03321981|467418630|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
129852859|NCT03321981|467418631|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
129852860|NCT03321981|467418632|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
129852861|NCT03321981|467418630|FG000|Overall Study|Adverse Event|0|||
129852862|NCT03321981|467418631|FG001|Overall Study|Adverse Event|0|||
129852863|NCT03321981|467418632|FG002|Overall Study|Adverse Event|2|||
129852864|NCT03321981|467418630|FG000|Overall Study|symptomatic deterioration|0|||
129852865|NCT03321981|467418631|FG001|Overall Study|symptomatic deterioration|1|||
129852866|NCT03321981|467418632|FG002|Overall Study|symptomatic deterioration|1|||
129852867|NCT03321981|467418630|FG000|Overall Study|Lack of compliance|0|||
129852868|NCT03321981|467418631|FG001|Overall Study|Lack of compliance|1|||
129852869|NCT03321981|467418632|FG002|Overall Study|Lack of compliance|0|||
129852870|NCT03321981|467418630|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
129852871|NCT03321981|467418631|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
129852872|NCT03321981|467418632|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
129852873|NCT03321981|467418630|FG000|Overall Study|Death|0|||
129852874|NCT03321981|467418631|FG001|Overall Study|Death|1|||
129852875|NCT03321981|467418632|FG002|Overall Study|Death|0|||
129852876|NCT03321981|467418630|FG000|Overall Study|Subject withdrawal of investigational product|0|||
129852877|NCT03321981|467418631|FG001|Overall Study|Subject withdrawal of investigational product|1|||
129852878|NCT03321981|467418632|FG002|Overall Study|Subject withdrawal of investigational product|0|||
129852879|NCT03321981|467418630|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
129852880|NCT03321981|467418631|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
129852881|NCT03321981|467418632|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
129852882|NCT03321981|467418630|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
129852883|NCT03321981|467418631|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
129852884|NCT03321981|467418632|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
129852885|NCT05061446|467418634|FG000|Overall Study|Adverse Event|2|||
129852886|NCT05061446|467418635|FG001|Overall Study|Adverse Event|0|||
129852887|NCT05061446|467418636|FG002|Overall Study|Adverse Event|0|||
129852888|NCT05061446|467418634|FG000|Overall Study|Participant no longer available due to personal reason|0|||
129852889|NCT05061446|467418635|FG001|Overall Study|Participant no longer available due to personal reason|1|||
129852890|NCT05061446|467418636|FG002|Overall Study|Participant no longer available due to personal reason|0|||
129852891|NCT03880578|467418637|FG000|Overall Study|Withdrawal by Subject|0|||
129852892|NCT03880578|467418638|FG001|Overall Study|Withdrawal by Subject|3|||
129852893|NCT03880578|467418639|FG002|Overall Study|Withdrawal by Subject|1|||
129852894|NCT03880578|467418637|FG000|Overall Study|Death|0|||
129852895|NCT03880578|467418638|FG001|Overall Study|Death|1|||
129852896|NCT03880578|467418639|FG002|Overall Study|Death|0|||
129852897|NCT02543346|467418640|FG000|Second Priming Visit|Withdrawal by Subject|0|||
129852898|NCT02543346|467418641|FG001|Second Priming Visit|Withdrawal by Subject|2|||
129852899|NCT02543346|467418642|FG002|Second Priming Visit|Withdrawal by Subject|2|||
129852900|NCT02543346|467418643|FG003|Second Priming Visit|Withdrawal by Subject|2|||
129852901|NCT02543346|467418640|FG000|Second Priming Visit|Adverse Event|1|||
129852902|NCT02543346|467418641|FG001|Second Priming Visit|Adverse Event|0|||
129852903|NCT02543346|467418642|FG002|Second Priming Visit|Adverse Event|0|||
129852904|NCT02543346|467418643|FG003|Second Priming Visit|Adverse Event|0|||
129852905|NCT01767116|467418644|FG000|Overall Study|Lost to Follow-up|2|||
129852906|NCT01767116|467418645|FG001|Overall Study|Lost to Follow-up|2|||
129852907|NCT00861341|467418646|FG000|Overall Study|Withdrawal by Subject|2|||
129852908|NCT03299192|467418647|FG000|Overall Study|Fell before classes started|1|||
129852909|NCT03299192|467418648|FG001|Overall Study|Fell before classes started|0|||
129852910|NCT03299192|467418649|FG002|Overall Study|Fell before classes started|0|||
129852911|NCT03299192|467418647|FG000|Overall Study|Other|0|||
129852912|NCT03299192|467418648|FG001|Overall Study|Other|2|||
129852913|NCT03299192|467418649|FG002|Overall Study|Other|1|||
129852914|NCT04122443|467418654|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
129852915|NCT04122443|467418655|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
129852916|NCT04122443|467418656|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
129852917|NCT04122443|467418654|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
129852918|NCT04122443|467418655|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
129852919|NCT04122443|467418656|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
129852920|NCT01916304|467418657|FG000|Overall Study|Screening failure|17|||
129852921|NCT03149328|467418659|FG000|Overall Study|Withdrawal by Subject|30|||
129852922|NCT03149328|467418660|FG001|Overall Study|Withdrawal by Subject|26|||
129852923|NCT03149328|467418659|FG000|Overall Study|Changed Dialysis Modality|18|||
129852924|NCT03149328|467418660|FG001|Overall Study|Changed Dialysis Modality|1|||
129852925|NCT03149328|467418659|FG000|Overall Study|Transplant|9|||
129852926|NCT03149328|467418660|FG001|Overall Study|Transplant|1|||
129852927|NCT03149328|467418659|FG000|Overall Study|Lost to Follow-up|25|||
129852928|NCT03149328|467418660|FG001|Overall Study|Lost to Follow-up|16|||
129852929|NCT03149328|467418659|FG000|Overall Study|Left Study Site|1|||
129852930|NCT03149328|467418660|FG001|Overall Study|Left Study Site|2|||
129852931|NCT03149328|467418659|FG000|Overall Study|Language Barrier|1|||
129852932|NCT03149328|467418660|FG001|Overall Study|Language Barrier|0|||
129852933|NCT02758236|467418661|FG000|Overall Study|Investigator discretion|43|||
129852934|NCT00818441|467418662|FG000|Overall Study|Death|69|||
129852935|NCT00818441|467418663|FG001|Overall Study|Death|26|||
129852936|NCT00818441|467418662|FG000|Overall Study|Other|5|||
129852937|NCT00818441|467418663|FG001|Overall Study|Other|0|||
129852938|NCT00818441|467418662|FG000|Overall Study|Lost to Follow-up|2|||
129852939|NCT00818441|467418663|FG001|Overall Study|Lost to Follow-up|1|||
129852940|NCT00818441|467418662|FG000|Overall Study|Withdrawal by Subject|2|||
129852941|NCT00818441|467418663|FG001|Overall Study|Withdrawal by Subject|0|||
129852942|NCT00818441|467418662|FG000|Overall Study|Adverse Event|0|||
129852943|NCT00818441|467418663|FG001|Overall Study|Adverse Event|1|||
129852944|NCT00818441|467418662|FG000|Overall Study|Study terminated by sponsor|11|||
129852945|NCT00818441|467418663|FG001|Overall Study|Study terminated by sponsor|2|||
129852946|NCT03136068|467420351|FG000|Overall Study|Lost to Follow-up|1|||
129852947|NCT03136068|467420352|FG001|Overall Study|Lost to Follow-up|1|||
129852948|NCT03136068|467420351|FG000|Overall Study|Protocol Violation|1|||
129852949|NCT03136068|467420352|FG001|Overall Study|Protocol Violation|0|||
129852950|NCT00432380|467420358|FG000|Overall Study|Migrated/moved from study area|3|||
129852951|NCT00432380|467420359|FG001|Overall Study|Migrated/moved from study area|4|||
129852952|NCT00432380|467420360|FG002|Overall Study|Migrated/moved from study area|1|||
129852953|NCT00432380|467420358|FG000|Overall Study|Adverse Event|1|||
129852954|NCT00432380|467420359|FG001|Overall Study|Adverse Event|0|||
129852955|NCT00432380|467420360|FG002|Overall Study|Adverse Event|0|||
129852956|NCT02044510|467420361|FG000|Overall Study|Adverse Event|1|||
129852957|NCT02044510|467420362|FG001|Overall Study|Adverse Event|2|||
129852958|NCT00581945|467420365|FG000|Overall Study|Adverse Event|4|||
129852959|NCT00581945|467420366|FG001|Overall Study|Adverse Event|4|||
129852960|NCT00581945|467420365|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129852961|NCT00581945|467420366|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129852962|NCT00581945|467420365|FG000|Overall Study|Withdrawal by Subject|2|||
129852963|NCT00581945|467420366|FG001|Overall Study|Withdrawal by Subject|6|||
129852964|NCT00581945|467420365|FG000|Overall Study|Death|1|||
129852965|NCT00581945|467420366|FG001|Overall Study|Death|0|||
129852966|NCT01933334|467420370|FG000|Overall Study|Adverse Event|5|||
129852967|NCT01933334|467420371|FG001|Overall Study|Adverse Event|1|||
129852968|NCT01933334|467420370|FG000|Overall Study|Withdrawal by Subject|0|||
129852969|NCT01933334|467420371|FG001|Overall Study|Withdrawal by Subject|1|||
129852970|NCT02032901|467420372|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
129852971|NCT02032901|467420373|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
129852972|NCT02032901|467420372|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
129852973|NCT02032901|467420373|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
129852974|NCT00633984|467420374|FG000|Overall Study|Lost to Follow-up|0|||
129852975|NCT00633984|467420375|FG001|Overall Study|Lost to Follow-up|6|||
129852976|NCT00633984|467420374|FG000|Overall Study|Withdrawal by Subject|8|||
129852977|NCT00633984|467420375|FG001|Overall Study|Withdrawal by Subject|7|||
129852978|NCT00633984|467420374|FG000|Overall Study|Hospitalized|1|||
129852979|NCT00633984|467420375|FG001|Overall Study|Hospitalized|0|||
129852980|NCT02496884|467420376|FG000|Overall Study|Counted twice as enrolled|2|||
129852981|NCT02496884|467420377|FG001|Overall Study|Counted twice as enrolled|0|||
129852982|NCT02496884|467420378|FG002|Overall Study|Counted twice as enrolled|0|||
129852983|NCT02496884|467420379|FG003|Overall Study|Counted twice as enrolled|0|||
129852984|NCT02496884|467420376|FG000|Overall Study|Withdrawal by Subject|0|||
129852985|NCT02496884|467420377|FG001|Overall Study|Withdrawal by Subject|3|||
129852986|NCT02496884|467420378|FG002|Overall Study|Withdrawal by Subject|0|||
129852987|NCT02496884|467420379|FG003|Overall Study|Withdrawal by Subject|0|||
129852988|NCT01033747|467420380|FG000|Overall Study|Adverse Event|9|||
129852989|NCT01033747|467420381|FG001|Overall Study|Adverse Event|4|||
129906286|NCT00442117|467617626|FG000|Overall Study|Major Deviation|25|||
129906287|NCT00442117|467617627|FG001|Overall Study|Major Deviation|20|||
129906288|NCT00442117|467617626|FG000|Overall Study|Non compliance with protocol|3|||
129906289|NCT00442117|467617627|FG001|Overall Study|Non compliance with protocol|5|||
129906290|NCT00442117|467617626|FG000|Overall Study|Met Withdrawal Criteria|2|||
129906291|NCT00442117|467617627|FG001|Overall Study|Met Withdrawal Criteria|1|||
129906292|NCT04009577|467617633|FG000|Core Study|Adverse Event|1|||
129906293|NCT04009577|467617634|FG001|Core Study|Adverse Event|0|||
129906294|NCT04009577|467617635|FG002|Core Study|Adverse Event|2|||
129906295|NCT04009577|467617636|FG003|Core Study|Adverse Event|4|||
129906296|NCT04009577|467617633|FG000|Core Study|Withdrawal by Subject|0|||
129906297|NCT04009577|467617634|FG001|Core Study|Withdrawal by Subject|0|||
129906298|NCT04009577|467617635|FG002|Core Study|Withdrawal by Subject|2|||
129906299|NCT04009577|467617636|FG003|Core Study|Withdrawal by Subject|0|||
129906300|NCT04009577|467617633|FG000|Core Study|Other|0|||
129906301|NCT04009577|467617634|FG001|Core Study|Other|0|||
129906302|NCT04009577|467617635|FG002|Core Study|Other|0|||
129906303|NCT04009577|467617636|FG003|Core Study|Other|1|||
129906304|NCT04009577|467617633|FG000|Extension Phase|Adverse Event|0|||
129906305|NCT04009577|467617634|FG001|Extension Phase|Adverse Event|0|||
129906306|NCT04009577|467617635|FG002|Extension Phase|Adverse Event|0|||
129906307|NCT04009577|467617636|FG003|Extension Phase|Adverse Event|1|||
129906308|NCT04009577|467617633|FG000|Extension Phase|Inadequate therapeutic effect|0|||
129906309|NCT04009577|467617634|FG001|Extension Phase|Inadequate therapeutic effect|0|||
129906310|NCT04009577|467617635|FG002|Extension Phase|Inadequate therapeutic effect|1|||
129906311|NCT04009577|467617636|FG003|Extension Phase|Inadequate therapeutic effect|0|||
129906312|NCT04009577|467617633|FG000|Extension Phase|Withdrawal by Subject|0|||
129906313|NCT04009577|467617634|FG001|Extension Phase|Withdrawal by Subject|0|||
129906314|NCT04009577|467617635|FG002|Extension Phase|Withdrawal by Subject|1|||
129906315|NCT04009577|467617636|FG003|Extension Phase|Withdrawal by Subject|0|||
129906316|NCT04009577|467617633|FG000|Extension Phase|Not Treated|0|||
129906317|NCT04009577|467617634|FG001|Extension Phase|Not Treated|0|||
129906318|NCT04009577|467617635|FG002|Extension Phase|Not Treated|2|||
129906319|NCT04009577|467617636|FG003|Extension Phase|Not Treated|0|||
129906320|NCT01810263|467617654|FG000|Overall Study|Lost to Follow-up|8|||
129906321|NCT01810263|467617655|FG001|Overall Study|Lost to Follow-up|7|||
129906322|NCT00688519|467617656|FG000|Overall Study|Adverse Event|2|||
129906323|NCT00688519|467617657|FG001|Overall Study|Adverse Event|3|||
129906324|NCT00688519|467617656|FG000|Overall Study|Lost to Follow-up|3|||
129906325|NCT00688519|467617657|FG001|Overall Study|Lost to Follow-up|3|||
129906326|NCT00688519|467617656|FG000|Overall Study|Lack of Efficacy|3|||
129906327|NCT00688519|467617657|FG001|Overall Study|Lack of Efficacy|1|||
129906328|NCT00688519|467617656|FG000|Overall Study|Withdrawal by Subject|7|||
129906329|NCT00688519|467617657|FG001|Overall Study|Withdrawal by Subject|6|||
129906330|NCT00688519|467617656|FG000|Overall Study|Prohibited medication|1|||
129906331|NCT00688519|467617657|FG001|Overall Study|Prohibited medication|0|||
129906332|NCT00688519|467617656|FG000|Overall Study|Non-compliance|0|||
129906333|NCT00688519|467617657|FG001|Overall Study|Non-compliance|1|||
129906334|NCT00688519|467617656|FG000|Overall Study|Subject moved out of state|1|||
129906335|NCT00688519|467617657|FG001|Overall Study|Subject moved out of state|0|||
129906336|NCT00688519|467617656|FG000|Overall Study|Investigator decision|1|||
129906337|NCT00688519|467617657|FG001|Overall Study|Investigator decision|0|||
129906338|NCT00688519|467617656|FG000|Overall Study|Subject moved out of area|1|||
129906339|NCT00688519|467617657|FG001|Overall Study|Subject moved out of area|0|||
129906340|NCT00688519|467617656|FG000|Overall Study|Pregnancy|0|||
129906341|NCT00688519|467617657|FG001|Overall Study|Pregnancy|1|||
129906342|NCT01353963|467617658|FG000|Overall Study|Adverse Event|2|||
129906343|NCT00493649|467619106|FG000|Overall Study|Adverse Event|44|||
129906344|NCT00493649|467619106|FG000|Overall Study|Patient Request|21|||
129906345|NCT00493649|467619106|FG000|Overall Study|Investigator Request|2|||
129906346|NCT00493649|467619106|FG000|Overall Study|Disease Progression|1|||
129906347|NCT00493649|467619106|FG000|Overall Study|Lost to Follow-up|1|||
129906348|NCT00493649|467619106|FG000|Overall Study|Other|13|||
129906349|NCT05219253|467619107|FG000|Overall Study|Withdrawal by Subject|1|||
129906350|NCT05219253|467619108|FG001|Overall Study|Withdrawal by Subject|2|||
129906351|NCT03086369|467619109|FG000|Overall Study|Lost to Follow-up|1|||
129906352|NCT03086369|467619110|FG001|Overall Study|Lost to Follow-up|0|||
129906353|NCT03086369|467619111|FG002|Overall Study|Lost to Follow-up|0|||
129906354|NCT03086369|467619112|FG003|Overall Study|Lost to Follow-up|2|||
129906355|NCT03086369|467619113|FG004|Overall Study|Lost to Follow-up|1|||
129906356|NCT03086369|467619109|FG000|Overall Study|Physician Decision|0|||
129906357|NCT03086369|467619110|FG001|Overall Study|Physician Decision|0|||
129906358|NCT03086369|467619111|FG002|Overall Study|Physician Decision|0|||
129906359|NCT03086369|467619112|FG003|Overall Study|Physician Decision|1|||
129906360|NCT03086369|467619113|FG004|Overall Study|Physician Decision|2|||
129906361|NCT03086369|467619109|FG000|Overall Study|Withdrawal by Subject|0|||
129906362|NCT03086369|467619110|FG001|Overall Study|Withdrawal by Subject|0|||
129906363|NCT03086369|467619111|FG002|Overall Study|Withdrawal by Subject|0|||
129906364|NCT03086369|467619112|FG003|Overall Study|Withdrawal by Subject|5|||
129906365|NCT03086369|467619113|FG004|Overall Study|Withdrawal by Subject|3|||
129906366|NCT03086369|467619109|FG000|Overall Study|Progressive Disease|0|||
129449641|NCT00467779|465945625|FG002|Stage 3|Disease Progression|0|||
129449642|NCT00467779|465945626|FG003|Stage 3|Disease Progression|0|||
129449643|NCT00467779|465945627|FG004|Stage 3|Disease Progression|0|||
129449644|NCT00467779|465945628|FG005|Stage 3|Disease Progression|0|||
129449645|NCT00467779|465945629|FG006|Stage 3|Disease Progression|0|||
129449646|NCT00467779|465945630|FG007|Stage 3|Disease Progression|0|||
129449647|NCT00467779|465945631|FG008|Stage 3|Disease Progression|0|||
129449648|NCT00467779|465945632|FG009|Stage 3|Disease Progression|0|||
129449649|NCT00467779|465945633|FG010|Stage 3|Disease Progression|0|||
129449650|NCT00467779|465945634|FG011|Stage 3|Disease Progression|0|||
129449651|NCT00467779|465945635|FG012|Stage 3|Disease Progression|0|||
129449652|NCT00467779|465945636|FG013|Stage 3|Disease Progression|0|||
129852990|NCT01033747|467420380|FG000|Overall Study|Abnormal Laboratory Value|1|||
129852991|NCT01033747|467420381|FG001|Overall Study|Abnormal Laboratory Value|0|||
129852992|NCT01033747|467420380|FG000|Overall Study|Abnormal test procedure|0|||
129852993|NCT01033747|467420381|FG001|Overall Study|Abnormal test procedure|1|||
129852994|NCT01033747|467420380|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
129852995|NCT01033747|467420381|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129852996|NCT01033747|467420380|FG000|Overall Study|Protocol Violation|1|||
129852997|NCT01033747|467420381|FG001|Overall Study|Protocol Violation|0|||
129852998|NCT01033747|467420380|FG000|Overall Study|Withdrawal by Subject|9|||
129852999|NCT01033747|467420381|FG001|Overall Study|Withdrawal by Subject|6|||
129853000|NCT01033747|467420380|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
129853001|NCT01033747|467420381|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
129853002|NCT01033747|467420380|FG000|Overall Study|Stopped at end of Extension 1|2|||
129853003|NCT01033747|467420381|FG001|Overall Study|Stopped at end of Extension 1|0|||
129853004|NCT02956629|467420382|FG000|Overall Study|Adverse Event|0|||
129853005|NCT02956629|467420383|FG001|Overall Study|Adverse Event|0|||
129853006|NCT02956629|467420384|FG002|Overall Study|Adverse Event|1|||
129853007|NCT02956629|467420385|FG003|Overall Study|Adverse Event|0|||
129853008|NCT02956629|467420386|FG004|Overall Study|Adverse Event|0|||
129853009|NCT02956629|467420387|FG005|Overall Study|Adverse Event|0|||
129853010|NCT02956629|467420382|FG000|Overall Study|Lost to Follow-up|2|||
129853011|NCT02956629|467420383|FG001|Overall Study|Lost to Follow-up|5|||
129853012|NCT02956629|467420384|FG002|Overall Study|Lost to Follow-up|3|||
129853013|NCT02956629|467420385|FG003|Overall Study|Lost to Follow-up|1|||
129853014|NCT02956629|467420386|FG004|Overall Study|Lost to Follow-up|0|||
129853015|NCT02956629|467420387|FG005|Overall Study|Lost to Follow-up|1|||
129853016|NCT02956629|467420382|FG000|Overall Study|Withdrawal by Subject|3|||
129853017|NCT02956629|467420383|FG001|Overall Study|Withdrawal by Subject|1|||
129853018|NCT02956629|467420384|FG002|Overall Study|Withdrawal by Subject|0|||
129853019|NCT02956629|467420385|FG003|Overall Study|Withdrawal by Subject|0|||
129853020|NCT02956629|467420386|FG004|Overall Study|Withdrawal by Subject|0|||
129853021|NCT02956629|467420387|FG005|Overall Study|Withdrawal by Subject|0|||
129853022|NCT01931839|467420392|FG000|Overall Study|Death|0|||
129853023|NCT01931839|467420393|FG001|Overall Study|Death|1|||
129853024|NCT01931839|467420394|FG002|Overall Study|Death|2|||
129853025|NCT01931839|467420395|FG003|Overall Study|Death|0|||
129853026|NCT01931839|467420396|FG004|Overall Study|Death|0|||
129853027|NCT01931839|467420397|FG005|Overall Study|Death|0|||
129853028|NCT01931839|467420398|FG006|Overall Study|Death|0|||
129853029|NCT01931839|467420392|FG000|Overall Study|Physician Decision|1|||
129853030|NCT01931839|467420393|FG001|Overall Study|Physician Decision|0|||
129853031|NCT01931839|467420394|FG002|Overall Study|Physician Decision|1|||
129853032|NCT01931839|467420395|FG003|Overall Study|Physician Decision|0|||
129853033|NCT01931839|467420396|FG004|Overall Study|Physician Decision|0|||
129853034|NCT01931839|467420397|FG005|Overall Study|Physician Decision|0|||
129853035|NCT01931839|467420398|FG006|Overall Study|Physician Decision|1|||
129853036|NCT01931839|467420392|FG000|Overall Study|Withdrawal of consent|0|||
129853037|NCT01931839|467420393|FG001|Overall Study|Withdrawal of consent|0|||
129853038|NCT01931839|467420394|FG002|Overall Study|Withdrawal of consent|0|||
129853039|NCT01931839|467420395|FG003|Overall Study|Withdrawal of consent|0|||
129853040|NCT01931839|467420396|FG004|Overall Study|Withdrawal of consent|1|||
129853041|NCT01931839|467420397|FG005|Overall Study|Withdrawal of consent|0|||
129853042|NCT01931839|467420398|FG006|Overall Study|Withdrawal of consent|0|||
129853043|NCT01931839|467420392|FG000|Overall Study|Adverse Event|9|||
129853044|NCT01931839|467420393|FG001|Overall Study|Adverse Event|4|||
129853045|NCT01931839|467420394|FG002|Overall Study|Adverse Event|1|||
129853046|NCT01931839|467420395|FG003|Overall Study|Adverse Event|3|||
129853047|NCT01931839|467420396|FG004|Overall Study|Adverse Event|0|||
129853048|NCT01931839|467420397|FG005|Overall Study|Adverse Event|0|||
129853049|NCT01931839|467420398|FG006|Overall Study|Adverse Event|1|||
129853050|NCT01931839|467420392|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
129853051|NCT01931839|467420393|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
129853052|NCT01931839|467420394|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
129853053|NCT01931839|467420395|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
129449653|NCT00467779|465945637|FG014|Stage 3|Disease Progression|9|||
129853054|NCT01931839|467420396|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
129906367|NCT03086369|467619110|FG001|Overall Study|Progressive Disease|0|||
129906368|NCT03086369|467619111|FG002|Overall Study|Progressive Disease|0|||
129906369|NCT03086369|467619112|FG003|Overall Study|Progressive Disease|1|||
129906370|NCT03086369|467619113|FG004|Overall Study|Progressive Disease|1|||
129906371|NCT01765543|467619117|FG000|Overall Study|Death|1|||
129906372|NCT01765543|467619117|FG000|Overall Study|Withdrawal by Subject|2|||
129906373|NCT01424397|467619118|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906374|NCT01424397|467619119|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906375|NCT01424397|467619120|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
129906376|NCT01424397|467619121|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906377|NCT01424397|467619122|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906378|NCT01424397|467619123|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906379|NCT01424397|467619124|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906380|NCT01424397|467619125|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906381|NCT01424397|467619126|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906382|NCT01424397|467619127|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906383|NCT01424397|467619128|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906384|NCT01424397|467619129|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
129906385|NCT05876949|467619130|FG000|Overall Study|Withdrawal by Subject|1|||
129906386|NCT05876949|467619131|FG001|Overall Study|Withdrawal by Subject|3|||
129906387|NCT05876949|467619130|FG000|Overall Study|Physician Decision|0|||
129906388|NCT05876949|467619131|FG001|Overall Study|Physician Decision|2|||
129906389|NCT05876949|467619130|FG000|Overall Study|Death|0|||
129906390|NCT05876949|467619131|FG001|Overall Study|Death|1|||
129906391|NCT03644849|467619132|FG000|Overall Study|Lost to Follow-up|1|||
129906392|NCT03644849|467619133|FG001|Overall Study|Lost to Follow-up|3|||
129906393|NCT00071799|467619134|FG000|Overall Study|Adverse Event|19|||
129906394|NCT00071799|467619135|FG001|Overall Study|Adverse Event|10|||
129906395|NCT00071799|467619134|FG000|Overall Study|Protocol Violation|1|||
129906396|NCT00071799|467619135|FG001|Overall Study|Protocol Violation|7|||
129906397|NCT00071799|467619134|FG000|Overall Study|Lost to Follow-up|1|||
129906398|NCT00071799|467619135|FG001|Overall Study|Lost to Follow-up|1|||
129906399|NCT00071799|467619134|FG000|Overall Study|Withdrawal by Subject|15|||
129906400|NCT00071799|467619135|FG001|Overall Study|Withdrawal by Subject|37|||
129906401|NCT00071799|467619134|FG000|Overall Study|Physician Decision|0|||
129906402|NCT00071799|467619135|FG001|Overall Study|Physician Decision|2|||
129906403|NCT00071799|467619134|FG000|Overall Study|Lack of Efficacy|11|||
129906404|NCT00071799|467619135|FG001|Overall Study|Lack of Efficacy|18|||
129906405|NCT00071799|467619134|FG000|Overall Study|Disease Progression|23|||
129906406|NCT00071799|467619135|FG001|Overall Study|Disease Progression|20|||
129906407|NCT00071799|467619134|FG000|Overall Study|Different Central+Local Pathology Review|0|||
129906408|NCT00071799|467619135|FG001|Overall Study|Different Central+Local Pathology Review|1|||
129906409|NCT00071799|467619134|FG000|Overall Study|Not Documented|0|||
129853055|NCT01931839|467420397|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
129853056|NCT01931839|467420398|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
129853057|NCT01931839|467420392|FG000|Overall Study|Other non-compliance|15|||
129853058|NCT01931839|467420393|FG001|Overall Study|Other non-compliance|9|||
129853059|NCT01931839|467420394|FG002|Overall Study|Other non-compliance|12|||
129853060|NCT01931839|467420395|FG003|Overall Study|Other non-compliance|3|||
129853061|NCT01931839|467420396|FG004|Overall Study|Other non-compliance|0|||
129853062|NCT01931839|467420397|FG005|Overall Study|Other non-compliance|3|||
129853063|NCT01931839|467420398|FG006|Overall Study|Other non-compliance|0|||
129853064|NCT01931839|467420392|FG000|Overall Study|Lost to Follow-up|1|||
129853065|NCT01931839|467420393|FG001|Overall Study|Lost to Follow-up|2|||
129853066|NCT01931839|467420394|FG002|Overall Study|Lost to Follow-up|4|||
129853067|NCT01931839|467420395|FG003|Overall Study|Lost to Follow-up|5|||
129853068|NCT01931839|467420396|FG004|Overall Study|Lost to Follow-up|0|||
129853069|NCT01931839|467420397|FG005|Overall Study|Lost to Follow-up|0|||
129853070|NCT01931839|467420398|FG006|Overall Study|Lost to Follow-up|0|||
129853071|NCT01931839|467420392|FG000|Overall Study|Other|4|||
129853072|NCT01931839|467420393|FG001|Overall Study|Other|2|||
129853073|NCT01931839|467420394|FG002|Overall Study|Other|6|||
129853074|NCT01931839|467420395|FG003|Overall Study|Other|0|||
129853075|NCT01931839|467420396|FG004|Overall Study|Other|0|||
129853076|NCT01931839|467420397|FG005|Overall Study|Other|0|||
129853077|NCT01931839|467420398|FG006|Overall Study|Other|0|||
129853078|NCT01762761|467420399|FG000|Overall Study|Adverse Event|15|||
129853079|NCT01762761|467420400|FG001|Overall Study|Adverse Event|17|||
129853080|NCT01762761|467420399|FG000|Overall Study|Lack of Efficacy|9|||
129853081|NCT01762761|467420400|FG001|Overall Study|Lack of Efficacy|25|||
129906410|NCT00071799|467619135|FG001|Overall Study|Not Documented|2|||
129906411|NCT01177670|467619136|FG000|Overall Study|Study Terminated|115|||
129906412|NCT01177670|467619136|FG000|Overall Study|Physician Decision|50|||
129906413|NCT01177670|467619136|FG000|Overall Study|Withdrawal by Subject|4|||
129906414|NCT01145885|467619139|FG000|Overall Study|Progressive Disease|7|||
129906415|NCT03691428|467619140|FG000|Overall Study|Withdrawal by Subject|6|||
129906416|NCT03691428|467619141|FG001|Overall Study|Withdrawal by Subject|8|||
129906417|NCT02527148|467619142|FG000|Overall Study|Did not receive study intervention|1|||
129906418|NCT02527148|467619143|FG001|Overall Study|Did not receive study intervention|0|||
129906419|NCT01140048|467619144|FG000|Overall Study|Physician Decision|1|||
129906420|NCT01140048|467619144|FG000|Overall Study|Withdrawal by Subject|13|||
129906421|NCT01140048|467619144|FG000|Overall Study|Lost to Follow-up|31|||
129906422|NCT01831791|467619145|FG000|Overall Study|Withdrawal by Subject|10|||
129906423|NCT00494780|467619146|FG000|Overall Study|Adverse Event|1|||
129906424|NCT00494780|467619147|FG001|Overall Study|Adverse Event|0|||
129906425|NCT00494780|467619146|FG000|Overall Study|Withdrew before Dosed|0|||
129906426|NCT00494780|467619147|FG001|Overall Study|Withdrew before Dosed|1|||
129906427|NCT00494780|467619146|FG000|Overall Study|Progression of Study Disease|7|||
129906428|NCT00494780|467619147|FG001|Overall Study|Progression of Study Disease|8|||
129906429|NCT00494780|467619146|FG000|Overall Study|New Treatment|2|||
129906430|NCT00494780|467619147|FG001|Overall Study|New Treatment|2|||
129906431|NCT00494780|467619146|FG000|Overall Study|Non-compliance|1|||
129906432|NCT00494780|467619147|FG001|Overall Study|Non-compliance|0|||
129906433|NCT00494780|467619146|FG000|Overall Study|Residual Tumour Mass|0|||
129906434|NCT00494780|467619147|FG001|Overall Study|Residual Tumour Mass|1|||
129906435|NCT00494780|467619146|FG000|Overall Study|Insurance Issues|0|||
129906436|NCT00494780|467619147|FG001|Overall Study|Insurance Issues|1|||
129906437|NCT01254019|467619148|FG000|Overall Study|Adverse Event|0|||
129906438|NCT01254019|467619149|FG001|Overall Study|Adverse Event|2|||
129906439|NCT01254019|467619148|FG000|Overall Study|Protocol Violation|1|||
129906440|NCT01254019|467619149|FG001|Overall Study|Protocol Violation|0|||
129906441|NCT01254019|467619148|FG000|Overall Study|Withdrawal by Subject|0|||
129906442|NCT01254019|467619149|FG001|Overall Study|Withdrawal by Subject|2|||
129906443|NCT03061474|467619150|FG000|Overall Study|Adverse Event|2|||
129906444|NCT03061474|467619151|FG001|Overall Study|Adverse Event|0|||
129906445|NCT03061474|467619150|FG000|Overall Study|Safety Risk|0|||
129906446|NCT03061474|467619151|FG001|Overall Study|Safety Risk|1|||
129906447|NCT03061474|467619150|FG000|Overall Study|Participant unwilling or unable to participate|0|||
129906448|NCT03061474|467619151|FG001|Overall Study|Participant unwilling or unable to participate|2|||
129906449|NCT03061474|467619150|FG000|Overall Study|Lost to Follow-up|0|||
129906450|NCT03061474|467619151|FG001|Overall Study|Lost to Follow-up|1|||
129906451|NCT02888080|467619152|FG000|Overall Study|Subject / Guardian decision|1|||
129906452|NCT02888080|467619153|FG001|Overall Study|Subject / Guardian decision|3|||
129906453|NCT02888080|467619152|FG000|Overall Study|New Therapy for study indication|1|||
129906454|NCT02888080|467619153|FG001|Overall Study|New Therapy for study indication|0|||
129906455|NCT02888080|467619152|FG000|Overall Study|Lack of Efficacy|0|||
129906456|NCT02888080|467619153|FG001|Overall Study|Lack of Efficacy|1|||
129906457|NCT02888080|467619152|FG000|Overall Study|Adverse Event|0|||
129906458|NCT02888080|467619153|FG001|Overall Study|Adverse Event|1|||
129906459|NCT00845832|467619154|FG000|Treatment Period|Adverse Event|0|||
129906460|NCT00845832|467619155|FG001|Treatment Period|Adverse Event|2|||
129906461|NCT00845832|467619156|FG002|Treatment Period|Adverse Event|0|||
129906462|NCT00845832|467619154|FG000|Treatment Period|Protocol Violation|1|||
129906463|NCT00845832|467619155|FG001|Treatment Period|Protocol Violation|1|||
129906464|NCT00845832|467619156|FG002|Treatment Period|Protocol Violation|0|||
129906465|NCT00845832|467619154|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
129906466|NCT00845832|467619155|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
129906467|NCT00845832|467619156|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
129906468|NCT00845832|467619154|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
129906469|NCT00845832|467619155|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
129906470|NCT00845832|467619156|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
129906471|NCT00189202|467619161|FG000|Overall Study|Physician Decision|5|||
129906472|NCT00980330|467619162|FG000|Overall Study|Adverse Event|0|||
129906473|NCT00980330|467619163|FG001|Overall Study|Adverse Event|0|||
129906474|NCT00980330|467619164|FG002|Overall Study|Adverse Event|0|||
129906475|NCT00980330|467619165|FG003|Overall Study|Adverse Event|1|||
129906476|NCT00980330|467619166|FG004|Overall Study|Adverse Event|0|||
129906477|NCT00980330|467619167|FG005|Overall Study|Adverse Event|0|||
129906478|NCT00980330|467619168|FG006|Overall Study|Adverse Event|0|||
129906479|NCT00980330|467619162|FG000|Overall Study|Lost to Follow-up|1|||
129906480|NCT00980330|467619163|FG001|Overall Study|Lost to Follow-up|1|||
129906481|NCT00980330|467619164|FG002|Overall Study|Lost to Follow-up|4|||
129906482|NCT00980330|467619165|FG003|Overall Study|Lost to Follow-up|2|||
129906483|NCT00980330|467619166|FG004|Overall Study|Lost to Follow-up|1|||
129906484|NCT00980330|467619167|FG005|Overall Study|Lost to Follow-up|1|||
129906485|NCT00980330|467619168|FG006|Overall Study|Lost to Follow-up|2|||
129906486|NCT00980330|467619162|FG000|Overall Study|Withdrawal by Subject|2|||
129906487|NCT00980330|467619163|FG001|Overall Study|Withdrawal by Subject|4|||
129906488|NCT00980330|467619164|FG002|Overall Study|Withdrawal by Subject|4|||
129906489|NCT00980330|467619165|FG003|Overall Study|Withdrawal by Subject|1|||
129906490|NCT00980330|467619166|FG004|Overall Study|Withdrawal by Subject|3|||
129906491|NCT00980330|467619167|FG005|Overall Study|Withdrawal by Subject|2|||
129906492|NCT00980330|467619168|FG006|Overall Study|Withdrawal by Subject|5|||
129906493|NCT00980330|467619162|FG000|Overall Study|(not specified)|2|||
129906494|NCT00980330|467619163|FG001|Overall Study|(not specified)|0|||
129906495|NCT00980330|467619164|FG002|Overall Study|(not specified)|0|||
129906496|NCT00980330|467619165|FG003|Overall Study|(not specified)|1|||
129853082|NCT01762761|467420399|FG000|Overall Study|Protocol Violation|1|||
129853083|NCT01762761|467420400|FG001|Overall Study|Protocol Violation|1|||
129853084|NCT01762761|467420399|FG000|Overall Study|Study closed/terminated|0|||
129853085|NCT01762761|467420400|FG001|Overall Study|Study closed/terminated|2|||
129853086|NCT01762761|467420399|FG000|Overall Study|Lost to Follow-up|3|||
129853087|NCT01762761|467420400|FG001|Overall Study|Lost to Follow-up|6|||
129853088|NCT01762761|467420399|FG000|Overall Study|Physician Decision|4|||
129853089|NCT01762761|467420400|FG001|Overall Study|Physician Decision|6|||
129853090|NCT01762761|467420399|FG000|Overall Study|Withdrawal by Subject|7|||
129853091|NCT01762761|467420400|FG001|Overall Study|Withdrawal by Subject|8|||
129853092|NCT01925183|467420401|FG000|Overall Study|Adverse Event|1|||
129853093|NCT01925183|467420402|FG001|Overall Study|Adverse Event|0|||
129853094|NCT01046110|467420403|FG000|Overall Study|Adverse Event|9|||
129853095|NCT01046110|467420404|FG001|Overall Study|Adverse Event|2|||
129853096|NCT01046110|467420403|FG000|Overall Study|Lack of Efficacy|0|||
129853097|NCT01046110|467420404|FG001|Overall Study|Lack of Efficacy|1|||
129853098|NCT01046110|467420403|FG000|Overall Study|Protocol Violation|7|||
129853099|NCT01046110|467420404|FG001|Overall Study|Protocol Violation|12|||
129853100|NCT01046110|467420403|FG000|Overall Study|Withdrawal Criteria|3|||
129853101|NCT01046110|467420404|FG001|Overall Study|Withdrawal Criteria|5|||
129853102|NCT01046110|467420403|FG000|Overall Study|Unclassified|36|||
129853103|NCT01046110|467420404|FG001|Overall Study|Unclassified|35|||
129853104|NCT00575588|467420411|FG000|Overall Study|Adverse Event|11|||
129853105|NCT00575588|467420412|FG001|Overall Study|Adverse Event|13|||
129853106|NCT00575588|467420411|FG000|Overall Study|Withdrawal by Subject|27|||
129853107|NCT00575588|467420412|FG001|Overall Study|Withdrawal by Subject|31|||
129853108|NCT00575588|467420411|FG000|Overall Study|Lost to Follow-up|1|||
129853109|NCT00575588|467420412|FG001|Overall Study|Lost to Follow-up|3|||
129853110|NCT00575588|467420411|FG000|Overall Study|Death|4|||
129853111|NCT00575588|467420412|FG001|Overall Study|Death|2|||
129853112|NCT00575588|467420411|FG000|Overall Study|Incorrect enrollment|8|||
129853113|NCT00575588|467420412|FG001|Overall Study|Incorrect enrollment|4|||
129853114|NCT00575588|467420411|FG000|Overall Study|Study specific discontinuation criteria|203|||
129853115|NCT00575588|467420412|FG001|Overall Study|Study specific discontinuation criteria|218|||
129853116|NCT00575588|467420411|FG000|Overall Study|Severe non-compliance to protocol|5|||
129853117|NCT00575588|467420412|FG001|Overall Study|Severe non-compliance to protocol|7|||
129853118|NCT00575588|467420411|FG000|Overall Study|Safety reasons|2|||
129853119|NCT00575588|467420412|FG001|Overall Study|Safety reasons|1|||
129853120|NCT00575588|467420411|FG000|Overall Study|Elevated triglyceride|1|||
129853121|NCT00575588|467420412|FG001|Overall Study|Elevated triglyceride|0|||
129853122|NCT00575588|467420411|FG000|Overall Study|Patient moved|1|||
129853123|NCT00575588|467420412|FG001|Overall Study|Patient moved|3|||
129853124|NCT00575588|467420411|FG000|Overall Study|Impossible to determine HbA1c|0|||
129853125|NCT00575588|467420412|FG001|Overall Study|Impossible to determine HbA1c|1|||
129853126|NCT00614939|467420413|FG000|Overall Study|Withdrawal by Subject|10|||
129853127|NCT00614939|467420414|FG001|Overall Study|Withdrawal by Subject|17|||
129853128|NCT00614939|467420413|FG000|Overall Study|Study specific discontinuation criteris|13|||
129853129|NCT00614939|467420414|FG001|Overall Study|Study specific discontinuation criteris|16|||
129853130|NCT00614939|467420413|FG000|Overall Study|Adverse Event|2|||
129853131|NCT00614939|467420414|FG001|Overall Study|Adverse Event|5|||
129853132|NCT00614939|467420413|FG000|Overall Study|Incorrect enrollment|1|||
129853133|NCT00614939|467420414|FG001|Overall Study|Incorrect enrollment|2|||
129853134|NCT00614939|467420413|FG000|Overall Study|Death|4|||
129853135|NCT00614939|467420414|FG001|Overall Study|Death|3|||
129853136|NCT00614939|467420413|FG000|Overall Study|Poor/non-compliance|4|||
129853137|NCT00614939|467420414|FG001|Overall Study|Poor/non-compliance|0|||
129853138|NCT00614939|467420413|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
129853139|NCT00614939|467420414|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
129853140|NCT00840970|467420415|FG000|Overall Study|Adverse Event|0|||
129853141|NCT00840970|467420416|FG001|Overall Study|Adverse Event|0|||
129853142|NCT00840970|467420417|FG002|Overall Study|Adverse Event|1|||
129853143|NCT00504829|467420418|FG000|Overall Study|Protocol Violation|6|||
129853144|NCT00504829|467420419|FG001|Overall Study|Protocol Violation|4|||
129853145|NCT00504829|467420420|FG002|Overall Study|Protocol Violation|10|||
129853146|NCT01854827|467420421|FG000|Overall Study|Death|1|||
129853147|NCT02571452|467420422|FG000|Overall Study Treatment|Protocol Violation|0|||
129853148|NCT02571452|467420423|FG001|Overall Study Treatment|Protocol Violation|1|||
129853149|NCT02571452|467420422|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
129853150|NCT02571452|467420423|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
129853151|NCT02571452|467420422|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
129853152|NCT02571452|467420423|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
129906497|NCT00980330|467619166|FG004|Overall Study|(not specified)|1|||
129853153|NCT00534352|467420424|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
129853154|NCT00534352|467420424|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
129853155|NCT00534352|467420424|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
129853156|NCT00534352|467420424|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
129906498|NCT00980330|467619167|FG005|Overall Study|(not specified)|1|||
129906499|NCT00980330|467619168|FG006|Overall Study|(not specified)|0|||
129906500|NCT00666276|467619171|FG000|Overall Study|Protocol Violation|34|||
129906501|NCT00665444|467619174|FG000|Overall Study|Physician Decision|1|||
129906502|NCT00665444|467619174|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
129906503|NCT03299816|467619175|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
129906504|NCT03299816|467619176|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
129906505|NCT03299816|467619175|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
129906506|NCT03299816|467619176|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
129906507|NCT03299816|467619175|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
129906508|NCT03299816|467619176|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
129906509|NCT03520413|467619177|FG000|Overall Study|Lost to Follow-up|1|||
129906510|NCT03520413|467619178|FG001|Overall Study|Lost to Follow-up|1|||
129906511|NCT03520413|467619177|FG000|Overall Study|Withdrawal by Subject|1|||
129906512|NCT03520413|467619178|FG001|Overall Study|Withdrawal by Subject|2|||
129906513|NCT03520413|467619177|FG000|Overall Study|Death|0|||
129906514|NCT03520413|467619178|FG001|Overall Study|Death|1|||
129906515|NCT03520413|467619177|FG000|Overall Study|Physician Decision|3|||
129906516|NCT03520413|467619178|FG001|Overall Study|Physician Decision|3|||
129906517|NCT03520413|467619177|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
129906518|NCT03520413|467619178|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
129906519|NCT00869323|467619183|FG000|Maintenance Therapy|concurrent illness|1|||
129906520|NCT01135511|467619191|FG000|Overall Study|Adverse Event|0|||
129906521|NCT01135511|467619192|FG001|Overall Study|Adverse Event|1|||
129906522|NCT01135511|467619193|FG002|Overall Study|Adverse Event|2|||
129906523|NCT01135511|467619194|FG003|Overall Study|Adverse Event|0|||
129906524|NCT01135511|467619195|FG004|Overall Study|Adverse Event|0|||
129906525|NCT01135511|467619196|FG005|Overall Study|Adverse Event|1|||
129906526|NCT01135511|467619197|FG006|Overall Study|Adverse Event|0|||
129906527|NCT01135511|467619198|FG007|Overall Study|Adverse Event|1|||
129906528|NCT01135511|467619199|FG008|Overall Study|Adverse Event|0|||
129906529|NCT01135511|467619191|FG000|Overall Study|Lack of Efficacy|0|||
129906530|NCT01135511|467619192|FG001|Overall Study|Lack of Efficacy|1|||
129906531|NCT01135511|467619193|FG002|Overall Study|Lack of Efficacy|1|||
129906532|NCT01135511|467619194|FG003|Overall Study|Lack of Efficacy|2|||
129906533|NCT01135511|467619195|FG004|Overall Study|Lack of Efficacy|0|||
129906534|NCT01135511|467619196|FG005|Overall Study|Lack of Efficacy|0|||
129906535|NCT01135511|467619197|FG006|Overall Study|Lack of Efficacy|0|||
129906536|NCT01135511|467619198|FG007|Overall Study|Lack of Efficacy|0|||
129906537|NCT01135511|467619199|FG008|Overall Study|Lack of Efficacy|0|||
129906538|NCT01135511|467619191|FG000|Overall Study|Protocol Violation|0|||
129906539|NCT01135511|467619192|FG001|Overall Study|Protocol Violation|0|||
129906540|NCT01135511|467619193|FG002|Overall Study|Protocol Violation|3|||
129906541|NCT01135511|467619194|FG003|Overall Study|Protocol Violation|0|||
129906542|NCT01135511|467619195|FG004|Overall Study|Protocol Violation|0|||
129906543|NCT01135511|467619196|FG005|Overall Study|Protocol Violation|0|||
129906544|NCT01135511|467619197|FG006|Overall Study|Protocol Violation|0|||
129906545|NCT01135511|467619198|FG007|Overall Study|Protocol Violation|0|||
129906546|NCT01135511|467619199|FG008|Overall Study|Protocol Violation|0|||
129906547|NCT01135511|467619191|FG000|Overall Study|Pregnancy|0|||
129906548|NCT01135511|467619192|FG001|Overall Study|Pregnancy|0|||
129906549|NCT01135511|467619193|FG002|Overall Study|Pregnancy|0|||
129906550|NCT01135511|467619194|FG003|Overall Study|Pregnancy|1|||
129906551|NCT01135511|467619195|FG004|Overall Study|Pregnancy|0|||
129906552|NCT01135511|467619196|FG005|Overall Study|Pregnancy|0|||
129906553|NCT01135511|467619197|FG006|Overall Study|Pregnancy|0|||
129906554|NCT01135511|467619198|FG007|Overall Study|Pregnancy|0|||
129906555|NCT01135511|467619199|FG008|Overall Study|Pregnancy|0|||
129906556|NCT01135511|467619191|FG000|Overall Study|could not visit the clinic|0|||
129906557|NCT01135511|467619192|FG001|Overall Study|could not visit the clinic|1|||
129906558|NCT01135511|467619193|FG002|Overall Study|could not visit the clinic|2|||
129906559|NCT01135511|467619194|FG003|Overall Study|could not visit the clinic|0|||
129906560|NCT01135511|467619195|FG004|Overall Study|could not visit the clinic|0|||
129906561|NCT01135511|467619196|FG005|Overall Study|could not visit the clinic|0|||
129906562|NCT01135511|467619197|FG006|Overall Study|could not visit the clinic|0|||
129906563|NCT01135511|467619198|FG007|Overall Study|could not visit the clinic|0|||
129906564|NCT01135511|467619199|FG008|Overall Study|could not visit the clinic|0|||
129906565|NCT01135511|467619191|FG000|Overall Study|noncompliance with study drug taken|0|||
129906566|NCT01135511|467619192|FG001|Overall Study|noncompliance with study drug taken|0|||
129906567|NCT01135511|467619193|FG002|Overall Study|noncompliance with study drug taken|0|||
129906568|NCT01135511|467619194|FG003|Overall Study|noncompliance with study drug taken|0|||
129906569|NCT01135511|467619195|FG004|Overall Study|noncompliance with study drug taken|1|||
129906570|NCT01135511|467619196|FG005|Overall Study|noncompliance with study drug taken|0|||
129906571|NCT01135511|467619197|FG006|Overall Study|noncompliance with study drug taken|0|||
129906572|NCT01135511|467619198|FG007|Overall Study|noncompliance with study drug taken|0|||
129906573|NCT01135511|467619199|FG008|Overall Study|noncompliance with study drug taken|0|||
129906574|NCT01135511|467619191|FG000|Overall Study|Withdrawal by Subject|0|||
129906575|NCT01135511|467619192|FG001|Overall Study|Withdrawal by Subject|0|||
129906576|NCT01135511|467619193|FG002|Overall Study|Withdrawal by Subject|0|||
129906577|NCT01135511|467619194|FG003|Overall Study|Withdrawal by Subject|0|||
129906578|NCT01135511|467619195|FG004|Overall Study|Withdrawal by Subject|0|||
129906579|NCT01135511|467619196|FG005|Overall Study|Withdrawal by Subject|0|||
129906580|NCT01135511|467619197|FG006|Overall Study|Withdrawal by Subject|1|||
129906581|NCT01135511|467619198|FG007|Overall Study|Withdrawal by Subject|0|||
129906582|NCT01135511|467619199|FG008|Overall Study|Withdrawal by Subject|1|||
129906583|NCT04054635|467619200|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
129906584|NCT04054635|467619201|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
129906585|NCT04054635|467619202|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
129906586|NCT04054635|467619200|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
129906587|NCT04054635|467619201|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
129906588|NCT04054635|467619202|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
129906589|NCT00891930|467619203|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
129906590|NCT00891930|467619203|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
129906591|NCT00891930|467619203|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
129906592|NCT00891930|467619203|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
129906593|NCT00891930|467619203|FG000|Part 2 Panitumumab + AMG479|Death|30|||
129906594|NCT00638963|467619204|FG000|Overall Study|Withdrawal by Subject|1|||
129906595|NCT00638963|467619205|FG001|Overall Study|Withdrawal by Subject|0|||
129853157|NCT00534352|467420424|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
129853158|NCT00534352|467420424|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
129853159|NCT01229436|467420425|FG000|Overall Study|Withdrawal by Subject|2|||
129853160|NCT01229436|467420425|FG000|Overall Study|Lost to Follow-up|3|||
129853161|NCT04788147|467420426|FG000|Overall Study|Screen Failure|3|||
129853162|NCT04788147|467420427|FG001|Overall Study|Screen Failure|10|||
129853163|NCT04788147|467420426|FG000|Overall Study|Incomplete RMRS image session|2|||
129853164|NCT04788147|467420427|FG001|Overall Study|Incomplete RMRS image session|0|||
129853165|NCT02266381|467420430|FG000|Overall Study|Physician Decision|3|||
129853166|NCT02266381|467420431|FG001|Overall Study|Physician Decision|5|||
129853167|NCT02266381|467420432|FG002|Overall Study|Physician Decision|4|||
129853168|NCT05101252|467420435|FG000|Overall Study|Unsatisfactory Test Article|1|||
129853169|NCT05101252|467420436|FG001|Overall Study|Unsatisfactory Test Article|0|||
129853170|NCT05101252|467420435|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
129853171|NCT05101252|467420436|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
129853172|NCT05101252|467420435|FG000|Overall Study|Withdrew Consent during study|0|||
129853173|NCT05101252|467420436|FG001|Overall Study|Withdrew Consent during study|1|||
129853174|NCT05101252|467420435|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
129853175|NCT05101252|467420436|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
129853176|NCT04796610|467420437|FG000|Overall Study|Withdrawal by Subject|1|||
129853177|NCT04796610|467420438|FG001|Overall Study|Withdrawal by Subject|0|||
129853178|NCT04796610|467420439|FG002|Overall Study|Withdrawal by Subject|0|||
129853179|NCT04796610|467420440|FG003|Overall Study|Withdrawal by Subject|0|||
129853180|NCT04796610|467420437|FG000|Overall Study|Lost to Follow-up|2|||
129853181|NCT04796610|467420438|FG001|Overall Study|Lost to Follow-up|0|||
129853182|NCT04796610|467420439|FG002|Overall Study|Lost to Follow-up|1|||
129853183|NCT04796610|467420440|FG003|Overall Study|Lost to Follow-up|1|||
129853184|NCT02401672|467420441|FG000|Overall Study|Withdrawal by Subject|1|||
129853185|NCT02401672|467420442|FG001|Overall Study|Withdrawal by Subject|3|||
129853186|NCT00701051|467420443|FG000|Screening|Failed Screening|40|||
129853187|NCT00701051|467420444|FG001|Screening|Failed Screening|0|||
129853188|NCT00701051|467420445|FG002|Screening|Failed Screening|0|||
129853189|NCT00701051|467420443|FG000|Screening|Time conflicts|19|||
129853190|NCT00701051|467420444|FG001|Screening|Time conflicts|0|||
129853191|NCT00701051|467420445|FG002|Screening|Time conflicts|0|||
129853192|NCT00701051|467420443|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
129853193|NCT00701051|467420444|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
129853194|NCT00701051|467420445|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
129853195|NCT02059148|467420446|FG000|Treatment 1|Protocol Violation|0|||
129853196|NCT02059148|467420447|FG001|Treatment 1|Protocol Violation|0|||
129853197|NCT02059148|467420448|FG002|Treatment 1|Protocol Violation|0|||
129853198|NCT02059148|467420449|FG003|Treatment 1|Protocol Violation|0|||
129853199|NCT02059148|467420450|FG004|Treatment 1|Protocol Violation|0|||
129906596|NCT05001945|467619208|FG000|Overall Study|Adverse Event|0|||
129906597|NCT05001945|467619209|FG001|Overall Study|Adverse Event|0|||
129853200|NCT02059148|467420451|FG005|Treatment 1|Protocol Violation|1|||
129906598|NCT05001945|467619210|FG002|Overall Study|Adverse Event|0|||
129906599|NCT05001945|467619211|FG003|Overall Study|Adverse Event|1|||
129853201|NCT01731171|467420470|FG000|Overall Study|Withdrawal by Subject|4|||
129853202|NCT01731171|467420471|FG001|Overall Study|Withdrawal by Subject|1|||
129853203|NCT01731171|467420470|FG000|Overall Study|Lost to Follow-up|3|||
129853204|NCT01731171|467420471|FG001|Overall Study|Lost to Follow-up|2|||
129853205|NCT01731171|467420470|FG000|Overall Study|Moved out of Area|0|||
129906600|NCT05001945|467619212|FG004|Overall Study|Adverse Event|0|||
129906601|NCT05001945|467619213|FG005|Overall Study|Adverse Event|0|||
129906602|NCT05001945|467619214|FG006|Overall Study|Adverse Event|0|||
129853206|NCT01731171|467420471|FG001|Overall Study|Moved out of Area|2|||
129853207|NCT01731171|467420470|FG000|Overall Study|Terminated for Lack of Adherence|0|||
129853208|NCT01731171|467420471|FG001|Overall Study|Terminated for Lack of Adherence|1|||
129853209|NCT01731171|467420470|FG000|Overall Study|Terminated for Safety Reasons|0|||
129853210|NCT01731171|467420471|FG001|Overall Study|Terminated for Safety Reasons|1|||
129853211|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
129853212|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
129853213|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
129853214|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
129906603|NCT05001945|467619215|FG007|Overall Study|Adverse Event|0|||
129906604|NCT05001945|467619208|FG000|Overall Study|Lost to Follow-up|0|||
129906605|NCT05001945|467619209|FG001|Overall Study|Lost to Follow-up|1|||
129906606|NCT05001945|467619210|FG002|Overall Study|Lost to Follow-up|1|||
129906607|NCT05001945|467619211|FG003|Overall Study|Lost to Follow-up|2|||
129906608|NCT05001945|467619212|FG004|Overall Study|Lost to Follow-up|0|||
129906609|NCT05001945|467619213|FG005|Overall Study|Lost to Follow-up|1|||
129906610|NCT05001945|467619214|FG006|Overall Study|Lost to Follow-up|0|||
129906611|NCT05001945|467619215|FG007|Overall Study|Lost to Follow-up|0|||
129906612|NCT05001945|467619208|FG000|Overall Study|Protocol Violation|1|||
129906613|NCT05001945|467619209|FG001|Overall Study|Protocol Violation|0|||
129906614|NCT05001945|467619210|FG002|Overall Study|Protocol Violation|1|||
129906615|NCT05001945|467619211|FG003|Overall Study|Protocol Violation|1|||
129906616|NCT05001945|467619212|FG004|Overall Study|Protocol Violation|0|||
129906617|NCT05001945|467619213|FG005|Overall Study|Protocol Violation|1|||
129906618|NCT05001945|467619214|FG006|Overall Study|Protocol Violation|0|||
129906619|NCT05001945|467619215|FG007|Overall Study|Protocol Violation|0|||
129906620|NCT05001945|467619208|FG000|Overall Study|Withdrawal by Subject|0|||
129906621|NCT05001945|467619209|FG001|Overall Study|Withdrawal by Subject|0|||
129906622|NCT05001945|467619210|FG002|Overall Study|Withdrawal by Subject|0|||
129906623|NCT05001945|467619211|FG003|Overall Study|Withdrawal by Subject|1|||
129906624|NCT05001945|467619212|FG004|Overall Study|Withdrawal by Subject|1|||
129906625|NCT05001945|467619213|FG005|Overall Study|Withdrawal by Subject|1|||
129906626|NCT05001945|467619214|FG006|Overall Study|Withdrawal by Subject|0|||
129906627|NCT05001945|467619215|FG007|Overall Study|Withdrawal by Subject|1|||
129906628|NCT05001945|467619208|FG000|Overall Study|Not specified by Investigator|0|||
129906629|NCT05001945|467619209|FG001|Overall Study|Not specified by Investigator|3|||
129906630|NCT05001945|467619210|FG002|Overall Study|Not specified by Investigator|0|||
129906631|NCT05001945|467619211|FG003|Overall Study|Not specified by Investigator|0|||
129906632|NCT05001945|467619212|FG004|Overall Study|Not specified by Investigator|1|||
129906633|NCT05001945|467619213|FG005|Overall Study|Not specified by Investigator|0|||
129906634|NCT05001945|467619214|FG006|Overall Study|Not specified by Investigator|0|||
129906635|NCT05001945|467619215|FG007|Overall Study|Not specified by Investigator|0|||
129906636|NCT02425111|467619216|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
129906637|NCT02425111|467619216|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
129906638|NCT02425111|467619216|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
129906639|NCT02425111|467619216|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
129906640|NCT02425111|467619216|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
129906641|NCT02425111|467619216|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
129906642|NCT01444417|467619217|FG000|Overall Study|Ineligibility Determined|0|||
129906643|NCT01444417|467619218|FG001|Overall Study|Ineligibility Determined|1|||
129906644|NCT01444417|467619217|FG000|Overall Study|Withdrawal by Subject|2|||
129906645|NCT01444417|467619218|FG001|Overall Study|Withdrawal by Subject|0|||
129906646|NCT00305695|467619219|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
129906647|NCT00305695|467619220|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
129906648|NCT00305695|467619219|FG000|Overall Study|Did not have baseline scan|1|||
129906649|NCT00305695|467619220|FG001|Overall Study|Did not have baseline scan|1|||
129906650|NCT00206375|467619221|FG000|Overall Study|Lost to Follow-up|1|||
129906651|NCT00206375|467619222|FG001|Overall Study|Lost to Follow-up|0|||
129853215|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
129853216|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
129853217|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
129906652|NCT00206375|467619223|FG002|Overall Study|Lost to Follow-up|0|||
129853218|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
129853219|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
129906653|NCT00206375|467619221|FG000|Overall Study|Withdrawal by Subject|2|||
129906654|NCT00206375|467619222|FG001|Overall Study|Withdrawal by Subject|1|||
129906655|NCT00206375|467619223|FG002|Overall Study|Withdrawal by Subject|3|||
129906656|NCT00206375|467619221|FG000|Overall Study|Study terminated due to lack of funds|0|||
129906657|NCT00206375|467619222|FG001|Overall Study|Study terminated due to lack of funds|1|||
129906658|NCT00206375|467619223|FG002|Overall Study|Study terminated due to lack of funds|1|||
129906659|NCT01121549|467619224|FG000|Overall Study|Adverse Event|10|||
129906660|NCT01121549|467619224|FG000|Overall Study|Lack of Efficacy|11|||
129853220|NCT00403546|467420474|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
129853221|NCT00403546|467420475|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
129853222|NCT00403546|467420476|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
129853223|NCT00403546|467420474|FG000|Screening Phase|Screening Failure|22|||
129853224|NCT00403546|467420475|FG001|Screening Phase|Screening Failure|0|||
129853225|NCT00403546|467420476|FG002|Screening Phase|Screening Failure|0|||
129853226|NCT00403546|467420474|FG000|Screening Phase|Adverse Event|1|||
129853227|NCT00403546|467420475|FG001|Screening Phase|Adverse Event|0|||
129853228|NCT00403546|467420476|FG002|Screening Phase|Adverse Event|0|||
129853229|NCT00403546|467420474|FG000|Screening Phase|Terminated Prior to Randomization|5|||
129853230|NCT00403546|467420475|FG001|Screening Phase|Terminated Prior to Randomization|0|||
129853231|NCT00403546|467420476|FG002|Screening Phase|Terminated Prior to Randomization|0|||
129853232|NCT00403546|467420474|FG000|Randomized Trial|Early Terminations|0|||
129853233|NCT00403546|467420475|FG001|Randomized Trial|Early Terminations|17|||
129853234|NCT00403546|467420476|FG002|Randomized Trial|Early Terminations|16|||
129853235|NCT02673697|467420477|FG000|Overall Study|Adverse Event|2|||
129853236|NCT02673697|467420478|FG001|Overall Study|Adverse Event|0|||
129853237|NCT02673697|467420477|FG000|Overall Study|Death|32|||
129853238|NCT02673697|467420478|FG001|Overall Study|Death|24|||
129853239|NCT02673697|467420477|FG000|Overall Study|Lost to Follow-up|5|||
129853240|NCT02673697|467420478|FG001|Overall Study|Lost to Follow-up|2|||
129853241|NCT02673697|467420477|FG000|Overall Study|Physician Decision|2|||
129853242|NCT02673697|467420478|FG001|Overall Study|Physician Decision|1|||
129853243|NCT02673697|467420477|FG000|Overall Study|Withdrawal by Subject|10|||
129853244|NCT02673697|467420478|FG001|Overall Study|Withdrawal by Subject|7|||
129853245|NCT02673697|467420477|FG000|Overall Study|Change subj medical status|1|||
129853246|NCT02673697|467420478|FG001|Overall Study|Change subj medical status|2|||
129853247|NCT02673697|467420477|FG000|Overall Study|Explant|10|||
129853248|NCT02673697|467420478|FG001|Overall Study|Explant|5|||
129853249|NCT02673697|467420477|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
129853250|NCT02673697|467420478|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
129853251|NCT00437489|467420479|FG000|Overall Study|Study terminated by sponsor|23|||
129853252|NCT00437489|467420480|FG001|Overall Study|Study terminated by sponsor|21|||
129853253|NCT00437489|467420479|FG000|Overall Study|Lost to Follow-up|0|||
129853254|NCT00437489|467420480|FG001|Overall Study|Lost to Follow-up|1|||
129853255|NCT03893448|467420486|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
129853256|NCT03893448|467420487|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
129853257|NCT03893448|467420486|FG000|Overall Study|Physician Decision|8|||
129853258|NCT03893448|467420487|FG001|Overall Study|Physician Decision|14|||
129853259|NCT03893448|467420486|FG000|Overall Study|Lost to Follow-up|34|||
129853260|NCT03893448|467420487|FG001|Overall Study|Lost to Follow-up|27|||
129853261|NCT03893448|467420486|FG000|Overall Study|Death|1|||
129853262|NCT03893448|467420487|FG001|Overall Study|Death|0|||
129853263|NCT02604589|467420490|FG000|Overall Study|catheter dislodgement|0|||
129853264|NCT02604589|467420491|FG001|Overall Study|catheter dislodgement|0|||
129853265|NCT02604589|467420492|FG002|Overall Study|catheter dislodgement|1|||
129853266|NCT00793910|467420493|FG000|Overall Study|discarded study pills|0|||
129853267|NCT00793910|467420494|FG001|Overall Study|discarded study pills|1|||
129853268|NCT00793910|467420493|FG000|Overall Study|did not pick up medications|1|||
129853269|NCT00793910|467420494|FG001|Overall Study|did not pick up medications|1|||
129853270|NCT00793910|467420493|FG000|Overall Study|ineligible based on entry criteria|2|||
129853271|NCT00793910|467420494|FG001|Overall Study|ineligible based on entry criteria|3|||
129853272|NCT00793910|467420493|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
129853273|NCT00793910|467420494|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
129906661|NCT01121549|467619224|FG000|Overall Study|Lost to Follow-up|12|||
129906662|NCT01121549|467619224|FG000|Overall Study|Did not meet entrance criteria|9|||
129906663|NCT01121549|467619224|FG000|Overall Study|Study terminated by sponsor|197|||
129906664|NCT01121549|467619224|FG000|Overall Study|Pregnancy|1|||
129906665|NCT01121549|467619224|FG000|Overall Study|Protocol Violation|33|||
129906666|NCT01121549|467619224|FG000|Overall Study|Withdrawal by Subject|16|||
129906667|NCT01121549|467619224|FG000|Overall Study|Other|58|||
129906668|NCT04789408|467619225|FG000|Overall Study|Death|4|||
129449654|NCT00467779|465945623|FG000|Stage 3|Unspecified Reason|0|||
129449655|NCT00467779|465945624|FG001|Stage 3|Unspecified Reason|0|||
129853274|NCT00793910|467420493|FG000|Overall Study|Withdrawal by Subject|0|||
129853275|NCT00793910|467420494|FG001|Overall Study|Withdrawal by Subject|1|||
129853276|NCT01700946|467420495|FG000|Overall Study|Lost to Follow-up|1|||
129853277|NCT01700946|467420496|FG001|Overall Study|Lost to Follow-up|0|||
129853278|NCT01700946|467420495|FG000|Overall Study|Physician Decision|7|||
129853279|NCT01700946|467420496|FG001|Overall Study|Physician Decision|12|||
129853280|NCT01700946|467420495|FG000|Overall Study|Withdrawal by Subject|0|||
129853281|NCT01700946|467420496|FG001|Overall Study|Withdrawal by Subject|2|||
129853282|NCT01700946|467420495|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
129853283|NCT01700946|467420496|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
129853284|NCT01700946|467420495|FG000|Overall Study|Relapse|2|||
129906669|NCT04789408|467619226|FG001|Overall Study|Death|3|||
129906670|NCT04789408|467619227|FG002|Overall Study|Death|6|||
129906671|NCT04789408|467619225|FG000|Overall Study|Did not meet eligibility criteria|1|||
129906672|NCT04789408|467619226|FG001|Overall Study|Did not meet eligibility criteria|0|||
129906673|NCT04789408|467619227|FG002|Overall Study|Did not meet eligibility criteria|0|||
129906674|NCT04789408|467619225|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
129906675|NCT04789408|467619226|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
129906676|NCT04789408|467619227|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
129906677|NCT01420549|467619228|FG000|Overall Study|Adverse Event|1|||
129906678|NCT01420549|467619229|FG001|Overall Study|Adverse Event|1|||
129906679|NCT01420549|467619228|FG000|Overall Study|Lost to Follow-up|2|||
129906680|NCT01420549|467619229|FG001|Overall Study|Lost to Follow-up|2|||
129906681|NCT01420549|467619228|FG000|Overall Study|Protocol Violation|0|||
129906682|NCT01420549|467619229|FG001|Overall Study|Protocol Violation|1|||
129906683|NCT01420549|467619228|FG000|Overall Study|Non-adherence to medication|4|||
129906684|NCT01420549|467619229|FG001|Overall Study|Non-adherence to medication|1|||
129906685|NCT02755805|467620624|FG000|Overall Study|Lost to Follow-up|1|||
129906686|NCT02755805|467620625|FG001|Overall Study|Lost to Follow-up|2|||
129906687|NCT02755805|467620624|FG000|Overall Study|Refused assessments|1|||
129906688|NCT02755805|467620625|FG001|Overall Study|Refused assessments|0|||
129906689|NCT02755805|467620624|FG000|Overall Study|Withdrawal by Subject|0|||
129906690|NCT02755805|467620625|FG001|Overall Study|Withdrawal by Subject|2|||
129906691|NCT02252042|467620629|FG000|Overall Study|Adverse Event|9|||
129906692|NCT02252042|467620630|FG001|Overall Study|Adverse Event|6|||
129906693|NCT02252042|467620629|FG000|Overall Study|Death|209|||
129906694|NCT02252042|467620630|FG001|Overall Study|Death|217|||
129906695|NCT02252042|467620629|FG000|Overall Study|Physician Decision|0|||
129906696|NCT02252042|467620630|FG001|Overall Study|Physician Decision|2|||
129906697|NCT02252042|467620629|FG000|Overall Study|Transferred to Extension Study|7|||
129906698|NCT02252042|467620630|FG001|Overall Study|Transferred to Extension Study|1|||
129906699|NCT02252042|467620629|FG000|Overall Study|Did Not Continue on Extension Study|7|||
129906700|NCT02252042|467620630|FG001|Overall Study|Did Not Continue on Extension Study|2|||
129906701|NCT02252042|467620629|FG000|Overall Study|Withdrawal by Subject|15|||
129906702|NCT02252042|467620630|FG001|Overall Study|Withdrawal by Subject|20|||
129906703|NCT02593149|467620631|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
129906704|NCT02593149|467620632|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
129906705|NCT02593149|467620631|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
129906706|NCT02593149|467620632|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
129906707|NCT00979992|467620634|FG000|Overall Study|Ineligible - inadequate pathology|1|||
129906708|NCT00979992|467620634|FG000|Overall Study|Ineligible - wrong cell type|2|||
129906709|NCT00979992|467620634|FG000|Overall Study|Refused - Never Treated|2|||
129906710|NCT04532528|467620638|FG000|Overall Study|Adverse Event|12|||
129906711|NCT04532528|467620639|FG001|Overall Study|Adverse Event|17|||
129906712|NCT04532528|467620638|FG000|Overall Study|Withdrawal of consent|16|||
129906713|NCT04532528|467620639|FG001|Overall Study|Withdrawal of consent|17|||
129906714|NCT04532528|467620638|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
129906715|NCT04532528|467620639|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
129906716|NCT04532528|467620638|FG000|Overall Study|Lost to Follow-up|69|||
129906717|NCT04532528|467620639|FG001|Overall Study|Lost to Follow-up|68|||
129906718|NCT04532528|467620638|FG000|Overall Study|Administrative problems|12|||
129906719|NCT04532528|467620639|FG001|Overall Study|Administrative problems|14|||
129906720|NCT04532528|467620638|FG000|Overall Study|Death|3|||
129906721|NCT04532528|467620639|FG001|Overall Study|Death|3|||
129906722|NCT04532528|467620638|FG000|Overall Study|Other|38|||
129906723|NCT04532528|467620639|FG001|Overall Study|Other|46|||
129906724|NCT01636687|467620640|FG000|Induction Period|Withdrawal by Subject|1|||
129906725|NCT01636687|467620641|FG001|Induction Period|Withdrawal by Subject|0|||
129906726|NCT01636687|467620642|FG002|Induction Period|Withdrawal by Subject|0|||
129906727|NCT01636687|467620643|FG003|Induction Period|Withdrawal by Subject|0|||
129906728|NCT01636687|467620644|FG004|Induction Period|Withdrawal by Subject|0|||
129906729|NCT01636687|467620640|FG000|Induction Period|Adverse Event|1|||
129906730|NCT01636687|467620641|FG001|Induction Period|Adverse Event|0|||
129906731|NCT01636687|467620642|FG002|Induction Period|Adverse Event|0|||
129906732|NCT01636687|467620643|FG003|Induction Period|Adverse Event|0|||
129906733|NCT01636687|467620644|FG004|Induction Period|Adverse Event|1|||
129906734|NCT01636687|467620640|FG000|Induction Period|Lack of Efficacy|0|||
129906735|NCT01636687|467620641|FG001|Induction Period|Lack of Efficacy|0|||
129906736|NCT01636687|467620642|FG002|Induction Period|Lack of Efficacy|0|||
129906737|NCT01636687|467620643|FG003|Induction Period|Lack of Efficacy|0|||
129906738|NCT01636687|467620644|FG004|Induction Period|Lack of Efficacy|1|||
129906739|NCT01636687|467620640|FG000|Induction Period|Physician Decision|1|||
129906740|NCT01636687|467620641|FG001|Induction Period|Physician Decision|0|||
129906741|NCT01636687|467620642|FG002|Induction Period|Physician Decision|0|||
129906742|NCT01636687|467620643|FG003|Induction Period|Physician Decision|0|||
129906743|NCT01636687|467620644|FG004|Induction Period|Physician Decision|0|||
129906744|NCT01636687|467620640|FG000|Maintenance Period|Withdrawal by Subject|2|||
129906745|NCT01636687|467620641|FG001|Maintenance Period|Withdrawal by Subject|0|||
129906746|NCT01636687|467620642|FG002|Maintenance Period|Withdrawal by Subject|2|||
129906747|NCT01636687|467620643|FG003|Maintenance Period|Withdrawal by Subject|0|||
129906748|NCT01636687|467620644|FG004|Maintenance Period|Withdrawal by Subject|0|||
129906749|NCT01636687|467620640|FG000|Maintenance Period|Adverse Event|1|||
129906750|NCT01636687|467620641|FG001|Maintenance Period|Adverse Event|0|||
129906751|NCT01636687|467620642|FG002|Maintenance Period|Adverse Event|0|||
129906752|NCT01636687|467620643|FG003|Maintenance Period|Adverse Event|0|||
129906753|NCT01636687|467620644|FG004|Maintenance Period|Adverse Event|0|||
129906754|NCT01636687|467620640|FG000|Maintenance Period|Lack of Efficacy|4|||
129906755|NCT01636687|467620641|FG001|Maintenance Period|Lack of Efficacy|1|||
129906756|NCT01636687|467620642|FG002|Maintenance Period|Lack of Efficacy|0|||
129906757|NCT01636687|467620643|FG003|Maintenance Period|Lack of Efficacy|0|||
129906758|NCT01636687|467620644|FG004|Maintenance Period|Lack of Efficacy|0|||
129906759|NCT01636687|467620640|FG000|Maintenance Period|Lost to Follow-up|1|||
129906760|NCT01636687|467620641|FG001|Maintenance Period|Lost to Follow-up|1|||
129906761|NCT01636687|467620642|FG002|Maintenance Period|Lost to Follow-up|0|||
129906762|NCT01636687|467620643|FG003|Maintenance Period|Lost to Follow-up|0|||
129906763|NCT01636687|467620644|FG004|Maintenance Period|Lost to Follow-up|1|||
129906764|NCT01636687|467620640|FG000|Maintenance Period|Physician Decision|0|||
129906765|NCT01636687|467620641|FG001|Maintenance Period|Physician Decision|0|||
129906766|NCT01636687|467620642|FG002|Maintenance Period|Physician Decision|0|||
129906767|NCT01636687|467620643|FG003|Maintenance Period|Physician Decision|0|||
129853285|NCT01700946|467420496|FG001|Overall Study|Relapse|1|||
129853286|NCT01700946|467420495|FG000|Overall Study|Unacceptable toxicity|1|||
129853287|NCT01700946|467420496|FG001|Overall Study|Unacceptable toxicity|0|||
129853288|NCT04934670|467420504|FG000|Overall Study|Death|4|||
129853289|NCT04934670|467420505|FG001|Overall Study|Death|0|||
129853290|NCT04934670|467420504|FG000|Overall Study|Lost to Follow-up|1|||
129853291|NCT04934670|467420505|FG001|Overall Study|Lost to Follow-up|4|||
129853292|NCT00817089|467420506|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
129853293|NCT00817089|467420507|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
129853294|NCT00817089|467420508|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
129853295|NCT00817089|467420509|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
129853296|NCT00817089|467420506|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
129853297|NCT00817089|467420507|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
129853298|NCT00817089|467420508|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
129853299|NCT00817089|467420509|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
129853300|NCT03783923|467420510|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
129853301|NCT03783923|467420511|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
129853302|NCT03783923|467420510|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
129853303|NCT03783923|467420511|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
129853304|NCT03783923|467420510|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
129853305|NCT03783923|467420511|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
129853306|NCT03783923|467420510|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
129853307|NCT03783923|467420511|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
129853308|NCT03783923|467420510|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
129853309|NCT03783923|467420511|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
129853310|NCT01592708|467420512|FG000|Overall Study|Protocol Violation|3|||
129853311|NCT01592708|467420513|FG001|Overall Study|Protocol Violation|0|||
129853312|NCT01785602|467420517|FG000|Overall Study|Withdrawal by Subject|2|||
129853313|NCT01785602|467420518|FG001|Overall Study|Withdrawal by Subject|0|||
129853314|NCT01785602|467420517|FG000|Overall Study|Lost to Follow-up|1|||
129853315|NCT01785602|467420518|FG001|Overall Study|Lost to Follow-up|1|||
129853316|NCT01785602|467420517|FG000|Overall Study|Adverse Event|3|||
129853317|NCT01785602|467420518|FG001|Overall Study|Adverse Event|5|||
129853318|NCT01785602|467420517|FG000|Overall Study|Administrative problems|7|||
129853319|NCT01785602|467420518|FG001|Overall Study|Administrative problems|3|||
129853320|NCT02041429|467420520|FG000|Overall Study|Progressive Disease|2|||
129853321|NCT02041429|467420521|FG001|Overall Study|Progressive Disease|2|||
129853322|NCT02041429|467420522|FG002|Overall Study|Progressive Disease|3|||
129853323|NCT02041429|467420523|FG003|Overall Study|Progressive Disease|2|||
129853324|NCT02041429|467420520|FG000|Overall Study|Toxicity|0|||
129853325|NCT02041429|467420521|FG001|Overall Study|Toxicity|1|||
129853326|NCT02041429|467420522|FG002|Overall Study|Toxicity|4|||
129853327|NCT02041429|467420523|FG003|Overall Study|Toxicity|2|||
129853328|NCT02041429|467420520|FG000|Overall Study|Withdrawal by Subject|0|||
129853329|NCT02041429|467420521|FG001|Overall Study|Withdrawal by Subject|1|||
129906768|NCT01636687|467620644|FG004|Maintenance Period|Physician Decision|1|||
129906769|NCT01636687|467620640|FG000|Extension Period|technical problems|0|||
129853330|NCT02041429|467420522|FG002|Overall Study|Withdrawal by Subject|0|||
129853331|NCT02041429|467420523|FG003|Overall Study|Withdrawal by Subject|0|||
129853332|NCT02041429|467420520|FG000|Overall Study|On Maintenance Therapy|1|||
129853333|NCT02041429|467420521|FG001|Overall Study|On Maintenance Therapy|0|||
129853334|NCT02041429|467420522|FG002|Overall Study|On Maintenance Therapy|0|||
129853335|NCT02041429|467420523|FG003|Overall Study|On Maintenance Therapy|2|||
129853336|NCT00101101|467420524|FG000|Overall Study|never received vaccine|20|||
129853337|NCT01418209|467420525|FG000|Overall Study|Withdrawal by Subject|1|||
129853338|NCT01418209|467420526|FG001|Overall Study|Withdrawal by Subject|0|||
129853339|NCT01418209|467420527|FG002|Overall Study|Withdrawal by Subject|1|||
129853340|NCT01418209|467420525|FG000|Overall Study|Did not provide hot flash diary data|1|||
129853341|NCT01418209|467420526|FG001|Overall Study|Did not provide hot flash diary data|3|||
129853342|NCT01418209|467420527|FG002|Overall Study|Did not provide hot flash diary data|3|||
129853343|NCT01603875|467420529|FG000|Overall Study|Preexisting rabies antibody|3|||
129853344|NCT01603875|467420530|FG001|Overall Study|Preexisting rabies antibody|4|||
129853345|NCT01603875|467420531|FG002|Overall Study|Preexisting rabies antibody|3|||
129853346|NCT01603875|467420529|FG000|Overall Study|Lost to Follow-up|4|||
129853347|NCT01603875|467420530|FG001|Overall Study|Lost to Follow-up|3|||
129853348|NCT01603875|467420531|FG002|Overall Study|Lost to Follow-up|6|||
129853349|NCT01603875|467420529|FG000|Overall Study|Protocol Violation|0|||
129853350|NCT01603875|467420530|FG001|Overall Study|Protocol Violation|1|||
129853351|NCT01603875|467420531|FG002|Overall Study|Protocol Violation|0|||
129853352|NCT01971346|467420532|FG000|Overall Study|Protocol Violation|3|||
129853353|NCT01971346|467420532|FG000|Overall Study|Lost to Follow-up|2|||
129853354|NCT01971346|467420532|FG000|Overall Study|Withdrawal by Subject|2|||
129853355|NCT01971346|467420532|FG000|Overall Study|Physician Decision|1|||
129853356|NCT02460198|467420536|FG000|Overall Study|Adverse Event|1|||
129853357|NCT02460198|467420537|FG001|Overall Study|Adverse Event|3|||
129853358|NCT02460198|467420536|FG000|Overall Study|Death|36|||
129853359|NCT02460198|467420537|FG001|Overall Study|Death|28|||
129853360|NCT02460198|467420536|FG000|Overall Study|Lost to Follow-up|1|||
129853361|NCT02460198|467420537|FG001|Overall Study|Lost to Follow-up|1|||
129853362|NCT02460198|467420536|FG000|Overall Study|Transferred to Extension Study|15|||
129853363|NCT02460198|467420537|FG001|Overall Study|Transferred to Extension Study|15|||
129853364|NCT02460198|467420536|FG000|Overall Study|Withdrawal by Subject|2|||
129853365|NCT02460198|467420537|FG001|Overall Study|Withdrawal by Subject|4|||
129853366|NCT02460198|467420536|FG000|Overall Study|Site Terminated By Sponsor|0|||
129853367|NCT02460198|467420537|FG001|Overall Study|Site Terminated By Sponsor|1|||
129853368|NCT02460198|467420536|FG000|Overall Study|Did Not Continue on Extension Study|6|||
129853369|NCT02460198|467420537|FG001|Overall Study|Did Not Continue on Extension Study|11|||
129853370|NCT04382612|467420538|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
129853371|NCT04666441|467420539|FG000|Overall Study|Lost to Follow-up|1|||
129853372|NCT04666441|467420540|FG001|Overall Study|Lost to Follow-up|4|||
129853373|NCT04666441|467420541|FG002|Overall Study|Lost to Follow-up|1|||
129853374|NCT04666441|467420542|FG003|Overall Study|Lost to Follow-up|3|||
129853375|NCT04666441|467420543|FG004|Overall Study|Lost to Follow-up|0|||
129853376|NCT04666441|467420544|FG005|Overall Study|Lost to Follow-up|2|||
129853377|NCT04666441|467420545|FG006|Overall Study|Lost to Follow-up|2|||
129853378|NCT04666441|467420546|FG007|Overall Study|Lost to Follow-up|2|||
129853379|NCT04666441|467420539|FG000|Overall Study|Subject Decision|1|||
129853380|NCT04666441|467420540|FG001|Overall Study|Subject Decision|1|||
129853381|NCT04666441|467420541|FG002|Overall Study|Subject Decision|3|||
129853382|NCT04666441|467420542|FG003|Overall Study|Subject Decision|1|||
129853383|NCT04666441|467420543|FG004|Overall Study|Subject Decision|0|||
129853384|NCT04666441|467420544|FG005|Overall Study|Subject Decision|1|||
129853385|NCT04666441|467420545|FG006|Overall Study|Subject Decision|3|||
129853386|NCT04666441|467420546|FG007|Overall Study|Subject Decision|2|||
129853387|NCT03285477|467420547|FG000|Treatment and Response Assessment Period|Death|1|||
129853388|NCT03285477|467420548|FG001|Treatment and Response Assessment Period|Death|0|||
129853389|NCT03285477|467420547|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
129853390|NCT03285477|467420548|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
129853391|NCT03285477|467420547|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
129853392|NCT03285477|467420548|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
129853393|NCT03285477|467420547|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
129853394|NCT03285477|467420548|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
129853395|NCT03285477|467420547|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
129853396|NCT03285477|467420548|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
129853397|NCT01071395|467422474|FG000|Overall Study|Withdrawal by Subject|2|||
129853398|NCT01071395|467422475|FG001|Overall Study|Withdrawal by Subject|1|||
129853399|NCT01071395|467422474|FG000|Overall Study|Adverse Event|3|||
129853400|NCT01071395|467422475|FG001|Overall Study|Adverse Event|1|||
129853401|NCT01539291|467422476|FG000|Study GS-US-312-0116|Adverse Event|9|||
129853402|NCT01539291|467422477|FG001|Study GS-US-312-0116|Adverse Event|0|||
129853403|NCT01539291|467422478|FG002|Study GS-US-312-0116|Adverse Event|0|||
129853404|NCT01539291|467422479|FG003|Study GS-US-312-0116|Adverse Event|0|||
129853405|NCT01539291|467422476|FG000|Study GS-US-312-0116|Physician Decision|1|||
129853406|NCT01539291|467422477|FG001|Study GS-US-312-0116|Physician Decision|0|||
129853407|NCT01539291|467422478|FG002|Study GS-US-312-0116|Physician Decision|0|||
129853408|NCT01539291|467422479|FG003|Study GS-US-312-0116|Physician Decision|0|||
129853409|NCT01539291|467422476|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
129853410|NCT01539291|467422477|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
129853411|NCT01539291|467422478|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
129853412|NCT01539291|467422479|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
129906770|NCT01636687|467620641|FG001|Extension Period|technical problems|1|||
129906771|NCT01636687|467620642|FG002|Extension Period|technical problems|2|||
129906772|NCT01636687|467620643|FG003|Extension Period|technical problems|1|||
129906773|NCT01636687|467620644|FG004|Extension Period|technical problems|0|||
129906774|NCT01636687|467620640|FG000|Extension Period|Adverse Event|4|||
129906775|NCT01636687|467620641|FG001|Extension Period|Adverse Event|3|||
129906776|NCT01636687|467620642|FG002|Extension Period|Adverse Event|2|||
129906777|NCT01636687|467620643|FG003|Extension Period|Adverse Event|1|||
129906778|NCT01636687|467620644|FG004|Extension Period|Adverse Event|0|||
129906779|NCT01636687|467620640|FG000|Extension Period|Lack of Efficacy|7|||
129906780|NCT01636687|467620641|FG001|Extension Period|Lack of Efficacy|0|||
129906781|NCT01636687|467620642|FG002|Extension Period|Lack of Efficacy|2|||
129906782|NCT01636687|467620643|FG003|Extension Period|Lack of Efficacy|1|||
129906783|NCT01636687|467620644|FG004|Extension Period|Lack of Efficacy|0|||
129906784|NCT01636687|467620640|FG000|Extension Period|Lost to Follow-up|1|||
129906785|NCT01636687|467620641|FG001|Extension Period|Lost to Follow-up|0|||
129906786|NCT01636687|467620642|FG002|Extension Period|Lost to Follow-up|1|||
129906787|NCT01636687|467620643|FG003|Extension Period|Lost to Follow-up|0|||
129906788|NCT01636687|467620644|FG004|Extension Period|Lost to Follow-up|0|||
129906789|NCT01636687|467620640|FG000|Extension Period|Physician Decision|1|||
129906790|NCT01636687|467620641|FG001|Extension Period|Physician Decision|0|||
129906791|NCT01636687|467620642|FG002|Extension Period|Physician Decision|0|||
129906792|NCT01636687|467620643|FG003|Extension Period|Physician Decision|1|||
129906793|NCT01636687|467620644|FG004|Extension Period|Physician Decision|0|||
129906794|NCT01636687|467620640|FG000|Extension Period|study terminated by sponsor|33|||
129906795|NCT01636687|467620641|FG001|Extension Period|study terminated by sponsor|50|||
129906796|NCT01636687|467620642|FG002|Extension Period|study terminated by sponsor|17|||
129906797|NCT01636687|467620643|FG003|Extension Period|study terminated by sponsor|23|||
129906798|NCT01636687|467620644|FG004|Extension Period|study terminated by sponsor|0|||
129906799|NCT01636687|467620640|FG000|Extension Period|Withdrawal by Subject|1|||
129906800|NCT01636687|467620641|FG001|Extension Period|Withdrawal by Subject|0|||
129906801|NCT01636687|467620642|FG002|Extension Period|Withdrawal by Subject|1|||
129906802|NCT01636687|467620643|FG003|Extension Period|Withdrawal by Subject|1|||
129906803|NCT01636687|467620644|FG004|Extension Period|Withdrawal by Subject|0|||
129906804|NCT01636687|467620640|FG000|Follow-up Period|Withdrawal by Subject|1|||
129906805|NCT01636687|467620641|FG001|Follow-up Period|Withdrawal by Subject|0|||
129906806|NCT01636687|467620642|FG002|Follow-up Period|Withdrawal by Subject|0|||
129906807|NCT01636687|467620643|FG003|Follow-up Period|Withdrawal by Subject|0|||
129906808|NCT01636687|467620644|FG004|Follow-up Period|Withdrawal by Subject|1|||
129906809|NCT01460290|467620652|FG000|Overall Study|Adverse Event|3|||
129906810|NCT01460290|467620652|FG000|Overall Study|Elevated liver function|1|||
129906811|NCT01039688|467620657|FG000|Overall Study|Adverse Event|38|||
129906812|NCT01039688|467620658|FG001|Overall Study|Adverse Event|39|||
129906813|NCT01039688|467620659|FG002|Overall Study|Adverse Event|24|||
129906814|NCT01039688|467620657|FG000|Overall Study|Lack of Efficacy|20|||
129906815|NCT01039688|467620658|FG001|Overall Study|Lack of Efficacy|11|||
129906816|NCT01039688|467620659|FG002|Overall Study|Lack of Efficacy|26|||
129906817|NCT01039688|467620657|FG000|Overall Study|Lost to Follow-up|11|||
129906818|NCT01039688|467620658|FG001|Overall Study|Lost to Follow-up|9|||
129906819|NCT01039688|467620659|FG002|Overall Study|Lost to Follow-up|5|||
129906820|NCT01039688|467620657|FG000|Overall Study|Other|13|||
129906821|NCT01039688|467620658|FG001|Overall Study|Other|25|||
129906822|NCT01039688|467620659|FG002|Overall Study|Other|12|||
129906823|NCT01039688|467620657|FG000|Overall Study|Withdrawal by Subject|23|||
129906824|NCT01039688|467620658|FG001|Overall Study|Withdrawal by Subject|27|||
129906825|NCT01039688|467620659|FG002|Overall Study|Withdrawal by Subject|13|||
129906826|NCT01039688|467620657|FG000|Overall Study|Death|2|||
129906827|NCT01039688|467620658|FG001|Overall Study|Death|0|||
129906828|NCT01039688|467620659|FG002|Overall Study|Death|0|||
129906829|NCT00668863|467620660|FG000|Overall Study|Objective Progression or Relapse|42|||
129906830|NCT00668863|467620660|FG000|Overall Study|Adverse Event|13|||
129906831|NCT00668863|467620660|FG000|Overall Study|Study Terminated by Sponsor|8|||
129906832|NCT00668863|467620660|FG000|Overall Study|Global Deterioration of Health Status|4|||
129906833|NCT00668863|467620660|FG000|Overall Study|Withdrawal by Subject|1|||
129906834|NCT00668863|467620660|FG000|Overall Study|Surgery|1|||
129906835|NCT00668863|467620660|FG000|Overall Study|Subject's work scheduling problem|1|||
129906836|NCT00668863|467620660|FG000|Overall Study|Physician Decision|1|||
129906837|NCT02448446|467620665|FG000|Overall Study|Withdrawal by Subject|1|||
129906838|NCT02448446|467620666|FG001|Overall Study|Withdrawal by Subject|0|||
129906839|NCT02755116|467620672|FG000|Overall Study|surgery converted to open, pt admitted|3|||
129906840|NCT02755116|467620673|FG001|Overall Study|surgery converted to open, pt admitted|1|||
129906841|NCT01124734|467620677|FG000|Overall Study|Disease progression|13|||
129906842|NCT01124734|467620677|FG000|Overall Study|Adverse Event|1|||
129906843|NCT01124734|467620677|FG000|Overall Study|Withdrawal by Subject|1|||
129906844|NCT01124734|467620677|FG000|Overall Study|Elected for alternative treatment|2|||
129906845|NCT02214160|467620679|FG000|Overall Study|Withdrawal by Subject|1|||
129906846|NCT02214160|467620680|FG001|Overall Study|Withdrawal by Subject|0|||
129853413|NCT01539291|467422476|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
129853414|NCT01539291|467422477|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
129853415|NCT01539291|467422478|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
129853416|NCT01539291|467422479|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
129853417|NCT01539291|467422476|FG000|Study GS-US-312-0116|Other|1|||
129853418|NCT01539291|467422477|FG001|Study GS-US-312-0116|Other|0|||
129853419|NCT01539291|467422478|FG002|Study GS-US-312-0116|Other|0|||
129853420|NCT01539291|467422479|FG003|Study GS-US-312-0116|Other|0|||
129853421|NCT01539291|467422476|FG000|Study GS-US-312-0117|Adverse Event|22|||
129853422|NCT01539291|467422477|FG001|Study GS-US-312-0117|Adverse Event|1|||
129853423|NCT01539291|467422478|FG002|Study GS-US-312-0117|Adverse Event|9|||
129853424|NCT01539291|467422479|FG003|Study GS-US-312-0117|Adverse Event|12|||
129853425|NCT01539291|467422476|FG000|Study GS-US-312-0117|Physician Decision|9|||
129853426|NCT01539291|467422477|FG001|Study GS-US-312-0117|Physician Decision|0|||
129853427|NCT01539291|467422478|FG002|Study GS-US-312-0117|Physician Decision|6|||
129853428|NCT01539291|467422479|FG003|Study GS-US-312-0117|Physician Decision|4|||
129853429|NCT01539291|467422476|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
129853430|NCT01539291|467422477|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
129853431|NCT01539291|467422478|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
129853432|NCT01539291|467422479|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
129853433|NCT01539291|467422476|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
129853434|NCT01539291|467422477|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
129853435|NCT01539291|467422478|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
129853436|NCT01539291|467422479|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
129853437|NCT01539291|467422476|FG000|Study GS-US-312-0117|Other|2|||
129853438|NCT01539291|467422477|FG001|Study GS-US-312-0117|Other|1|||
129853439|NCT01539291|467422478|FG002|Study GS-US-312-0117|Other|1|||
129853440|NCT01539291|467422479|FG003|Study GS-US-312-0117|Other|1|||
129853441|NCT02627677|467422480|FG000|Overall Study|Adverse event (not progressive disease)|1|||
129853442|NCT02627677|467422481|FG001|Overall Study|Adverse event (not progressive disease)|4|||
129853443|NCT02627677|467422482|FG002|Overall Study|Adverse event (not progressive disease)|1|||
129853444|NCT02627677|467422480|FG000|Overall Study|Progressive disease|1|||
129853445|NCT02627677|467422481|FG001|Overall Study|Progressive disease|3|||
129853446|NCT02627677|467422482|FG002|Overall Study|Progressive disease|0|||
129853447|NCT02627677|467422480|FG000|Overall Study|Lack of Efficacy|1|||
129853448|NCT02627677|467422481|FG001|Overall Study|Lack of Efficacy|2|||
129853449|NCT02627677|467422482|FG002|Overall Study|Lack of Efficacy|0|||
129853450|NCT02627677|467422480|FG000|Overall Study|Lost to Follow-up|0|||
129853451|NCT02627677|467422481|FG001|Overall Study|Lost to Follow-up|0|||
129853452|NCT02627677|467422482|FG002|Overall Study|Lost to Follow-up|1|||
129853453|NCT02627677|467422480|FG000|Overall Study|Pregnancy|0|||
129853454|NCT02627677|467422481|FG001|Overall Study|Pregnancy|1|||
129853455|NCT02627677|467422482|FG002|Overall Study|Pregnancy|0|||
129853456|NCT02627677|467422480|FG000|Overall Study|Study Terminated by Sponsor|5|||
129853457|NCT02627677|467422481|FG001|Overall Study|Study Terminated by Sponsor|10|||
129853458|NCT02627677|467422482|FG002|Overall Study|Study Terminated by Sponsor|6|||
129853459|NCT02627677|467422480|FG000|Overall Study|Physician Decision|0|||
129853460|NCT02627677|467422481|FG001|Overall Study|Physician Decision|0|||
129853461|NCT02627677|467422482|FG002|Overall Study|Physician Decision|2|||
129853462|NCT02627677|467422480|FG000|Overall Study|Withdrawal by Subject|2|||
129853463|NCT02627677|467422481|FG001|Overall Study|Withdrawal by Subject|1|||
129853464|NCT02627677|467422482|FG002|Overall Study|Withdrawal by Subject|1|||
129853465|NCT02627677|467422480|FG000|Overall Study|Reason not Specified|0|||
129853466|NCT02627677|467422481|FG001|Overall Study|Reason not Specified|0|||
129853467|NCT02627677|467422482|FG002|Overall Study|Reason not Specified|1|||
129853468|NCT02627677|467422480|FG000|Overall Study|Randomized but not Treated|1|||
129853469|NCT02627677|467422481|FG001|Overall Study|Randomized but not Treated|0|||
129853470|NCT02627677|467422482|FG002|Overall Study|Randomized but not Treated|0|||
129853471|NCT00587587|467422487|FG000|Overall Study|Lost to Follow-up|6|||
129853472|NCT00587587|467422488|FG001|Overall Study|Lost to Follow-up|1|||
129853473|NCT01075321|467422493|FG000|Overall Study|Withdrawal by Subject|0|||
129853474|NCT01075321|467422494|FG001|Overall Study|Withdrawal by Subject|0|||
129853475|NCT01075321|467422495|FG002|Overall Study|Withdrawal by Subject|1|||
129853476|NCT01075321|467422496|FG003|Overall Study|Withdrawal by Subject|1|||
129853477|NCT01075321|467422493|FG000|Overall Study|Protocol Violation|0|||
129853478|NCT01075321|467422494|FG001|Overall Study|Protocol Violation|0|||
129853479|NCT01075321|467422495|FG002|Overall Study|Protocol Violation|1|||
129853480|NCT01075321|467422496|FG003|Overall Study|Protocol Violation|0|||
129853481|NCT01075321|467422493|FG000|Overall Study|Treatment Incomplete due to progression|1|||
129853482|NCT01075321|467422494|FG001|Overall Study|Treatment Incomplete due to progression|0|||
129853483|NCT01075321|467422495|FG002|Overall Study|Treatment Incomplete due to progression|0|||
129853484|NCT01075321|467422496|FG003|Overall Study|Treatment Incomplete due to progression|0|||
129853485|NCT01075321|467422493|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
129853486|NCT01075321|467422494|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
129853487|NCT01075321|467422495|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
129853488|NCT01075321|467422496|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
129853489|NCT01722331|467422497|FG000|Part 1|Adverse Event|5|||
129853490|NCT01722331|467422498|FG001|Part 1|Adverse Event|0|||
129853491|NCT01722331|467422499|FG002|Part 1|Adverse Event|0|||
129853492|NCT01722331|467422500|FG003|Part 1|Adverse Event|0|||
129853493|NCT01722331|467422501|FG004|Part 1|Adverse Event|0|||
129853494|NCT01722331|467422502|FG005|Part 1|Adverse Event|0|||
129853495|NCT01722331|467422503|FG006|Part 1|Adverse Event|0|||
129853496|NCT01722331|467422497|FG000|Part 1|Lack of Efficacy|0|||
129853497|NCT01722331|467422498|FG001|Part 1|Lack of Efficacy|0|||
129853498|NCT01722331|467422499|FG002|Part 1|Lack of Efficacy|1|||
129853499|NCT01722331|467422500|FG003|Part 1|Lack of Efficacy|0|||
129853500|NCT01722331|467422501|FG004|Part 1|Lack of Efficacy|2|||
129853501|NCT01722331|467422502|FG005|Part 1|Lack of Efficacy|0|||
129853502|NCT01722331|467422503|FG006|Part 1|Lack of Efficacy|0|||
129853503|NCT01722331|467422497|FG000|Part 1|Lost to Follow-up|1|||
129853504|NCT01722331|467422498|FG001|Part 1|Lost to Follow-up|0|||
129853505|NCT01722331|467422499|FG002|Part 1|Lost to Follow-up|2|||
129853506|NCT01722331|467422500|FG003|Part 1|Lost to Follow-up|0|||
129853507|NCT01722331|467422501|FG004|Part 1|Lost to Follow-up|1|||
129853508|NCT01722331|467422502|FG005|Part 1|Lost to Follow-up|0|||
129853509|NCT01722331|467422503|FG006|Part 1|Lost to Follow-up|0|||
129853510|NCT01722331|467422497|FG000|Part 1|Physician Decision|0|||
129853511|NCT01722331|467422498|FG001|Part 1|Physician Decision|0|||
129853512|NCT01722331|467422499|FG002|Part 1|Physician Decision|3|||
129853513|NCT01722331|467422500|FG003|Part 1|Physician Decision|0|||
129853514|NCT01722331|467422501|FG004|Part 1|Physician Decision|1|||
129853515|NCT01722331|467422502|FG005|Part 1|Physician Decision|0|||
129853516|NCT01722331|467422503|FG006|Part 1|Physician Decision|0|||
129853517|NCT01722331|467422497|FG000|Part 1|Pregnancy|1|||
129853518|NCT01722331|467422498|FG001|Part 1|Pregnancy|0|||
129853519|NCT01722331|467422499|FG002|Part 1|Pregnancy|0|||
129853520|NCT01722331|467422500|FG003|Part 1|Pregnancy|0|||
129853521|NCT01722331|467422501|FG004|Part 1|Pregnancy|0|||
129853522|NCT01722331|467422502|FG005|Part 1|Pregnancy|0|||
129853523|NCT01722331|467422503|FG006|Part 1|Pregnancy|0|||
129853524|NCT01722331|467422497|FG000|Part 1|Progressive Disease|0|||
129853525|NCT01722331|467422498|FG001|Part 1|Progressive Disease|0|||
129853526|NCT01722331|467422499|FG002|Part 1|Progressive Disease|0|||
129853527|NCT01722331|467422500|FG003|Part 1|Progressive Disease|0|||
129853528|NCT01722331|467422501|FG004|Part 1|Progressive Disease|1|||
129853529|NCT01722331|467422502|FG005|Part 1|Progressive Disease|0|||
129853530|NCT01722331|467422503|FG006|Part 1|Progressive Disease|0|||
129853531|NCT01722331|467422497|FG000|Part 1|Protocol Violation|1|||
129853532|NCT01722331|467422498|FG001|Part 1|Protocol Violation|0|||
129853533|NCT01722331|467422499|FG002|Part 1|Protocol Violation|0|||
129853534|NCT01722331|467422500|FG003|Part 1|Protocol Violation|0|||
129853535|NCT01722331|467422501|FG004|Part 1|Protocol Violation|1|||
129853536|NCT01722331|467422502|FG005|Part 1|Protocol Violation|0|||
129853537|NCT01722331|467422503|FG006|Part 1|Protocol Violation|0|||
129853538|NCT01722331|467422497|FG000|Part 1|Withdrawal by Subject|2|||
129853539|NCT01722331|467422498|FG001|Part 1|Withdrawal by Subject|0|||
129853540|NCT01722331|467422499|FG002|Part 1|Withdrawal by Subject|3|||
129853541|NCT01722331|467422500|FG003|Part 1|Withdrawal by Subject|0|||
129853542|NCT01722331|467422501|FG004|Part 1|Withdrawal by Subject|3|||
129853543|NCT01722331|467422502|FG005|Part 1|Withdrawal by Subject|0|||
129853544|NCT01722331|467422503|FG006|Part 1|Withdrawal by Subject|0|||
129853545|NCT01722331|467422497|FG000|Part 2|Adverse Event|3|||
129853546|NCT01722331|467422498|FG001|Part 2|Adverse Event|0|||
129853547|NCT01722331|467422499|FG002|Part 2|Adverse Event|0|||
129853548|NCT01722331|467422500|FG003|Part 2|Adverse Event|0|||
129853549|NCT01722331|467422501|FG004|Part 2|Adverse Event|0|||
129853550|NCT01722331|467422502|FG005|Part 2|Adverse Event|1|||
129853551|NCT01722331|467422503|FG006|Part 2|Adverse Event|0|||
129853552|NCT01722331|467422497|FG000|Part 2|Lack of Efficacy|3|||
129853553|NCT01722331|467422498|FG001|Part 2|Lack of Efficacy|0|||
129853554|NCT01722331|467422499|FG002|Part 2|Lack of Efficacy|11|||
129853555|NCT01722331|467422500|FG003|Part 2|Lack of Efficacy|0|||
129853556|NCT01722331|467422501|FG004|Part 2|Lack of Efficacy|0|||
129853557|NCT01722331|467422502|FG005|Part 2|Lack of Efficacy|3|||
129853558|NCT01722331|467422503|FG006|Part 2|Lack of Efficacy|3|||
129853559|NCT01722331|467422497|FG000|Part 2|Lost to Follow-up|0|||
129853560|NCT01722331|467422498|FG001|Part 2|Lost to Follow-up|0|||
129853561|NCT01722331|467422499|FG002|Part 2|Lost to Follow-up|3|||
129853562|NCT01722331|467422500|FG003|Part 2|Lost to Follow-up|0|||
129853563|NCT01722331|467422501|FG004|Part 2|Lost to Follow-up|0|||
129853564|NCT01722331|467422502|FG005|Part 2|Lost to Follow-up|1|||
129853565|NCT01722331|467422503|FG006|Part 2|Lost to Follow-up|1|||
129853566|NCT01722331|467422497|FG000|Part 2|Non-Compliance with Study Drug|1|||
129853567|NCT01722331|467422498|FG001|Part 2|Non-Compliance with Study Drug|0|||
129853568|NCT01722331|467422499|FG002|Part 2|Non-Compliance with Study Drug|1|||
129853569|NCT01722331|467422500|FG003|Part 2|Non-Compliance with Study Drug|0|||
129853570|NCT01722331|467422501|FG004|Part 2|Non-Compliance with Study Drug|0|||
129853571|NCT01722331|467422502|FG005|Part 2|Non-Compliance with Study Drug|0|||
129853572|NCT01722331|467422503|FG006|Part 2|Non-Compliance with Study Drug|0|||
129853573|NCT01722331|467422497|FG000|Part 2|Physician Decision|0|||
129906847|NCT02214160|467620681|FG002|Overall Study|Withdrawal by Subject|6|||
129906848|NCT02214160|467620679|FG000|Overall Study|Death|2|||
129906849|NCT02214160|467620680|FG001|Overall Study|Death|2|||
129906850|NCT02214160|467620681|FG002|Overall Study|Death|1|||
129906851|NCT02214160|467620679|FG000|Overall Study|Subject Non-Compliance|0|||
129906852|NCT02214160|467620680|FG001|Overall Study|Subject Non-Compliance|3|||
129906853|NCT02214160|467620681|FG002|Overall Study|Subject Non-Compliance|1|||
129906854|NCT02214160|467620679|FG000|Overall Study|Adverse Event|0|||
129906855|NCT02214160|467620680|FG001|Overall Study|Adverse Event|1|||
129906856|NCT02214160|467620681|FG002|Overall Study|Adverse Event|1|||
129906857|NCT02214160|467620679|FG000|Overall Study|Sponsor Decision|0|||
129906858|NCT02214160|467620680|FG001|Overall Study|Sponsor Decision|2|||
129906859|NCT02214160|467620681|FG002|Overall Study|Sponsor Decision|0|||
129906860|NCT02214160|467620679|FG000|Overall Study|Protocol Violation|1|||
129906861|NCT02214160|467620680|FG001|Overall Study|Protocol Violation|0|||
129906862|NCT02214160|467620681|FG002|Overall Study|Protocol Violation|0|||
129906863|NCT02214160|467620679|FG000|Overall Study|Physician Decision|0|||
129906864|NCT02214160|467620680|FG001|Overall Study|Physician Decision|0|||
129906865|NCT02214160|467620681|FG002|Overall Study|Physician Decision|1|||
129906866|NCT02423798|467620682|FG000|Overall Study|Withdrawal by Subject|3|||
129906867|NCT01063972|467620683|FG000|Overall Study|Death|12|||
129906868|NCT01063972|467620684|FG001|Overall Study|Death|11|||
129906869|NCT01063972|467620683|FG000|Overall Study|Incarcerated|2|||
129906870|NCT01063972|467620684|FG001|Overall Study|Incarcerated|1|||
129906871|NCT03475316|467620686|FG000|6 Month Intervention|Adverse Event|2|||
129906872|NCT03475316|467620687|FG001|6 Month Intervention|Adverse Event|1|||
129906873|NCT03475316|467620686|FG000|6 Month Intervention|Withdrawal by Subject|2|||
129906874|NCT03475316|467620687|FG001|6 Month Intervention|Withdrawal by Subject|0|||
129906875|NCT03475316|467620686|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
129906876|NCT03475316|467620687|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
129906877|NCT03475316|467620686|FG000|9 Months|Study stopped due to COVID pandemic|3|||
129906878|NCT03475316|467620687|FG001|9 Months|Study stopped due to COVID pandemic|4|||
129906879|NCT02555215|467620690|FG000|Overall Study|Other|1|||
129906880|NCT02555215|467620690|FG000|Overall Study|Investigator Decision|2|||
129906881|NCT00468052|467620691|FG000|Overall Study|Protocol Violation|7|||
129906882|NCT00468052|467620692|FG001|Overall Study|Protocol Violation|8|||
129906883|NCT00457743|467620695|FG000|Overall Study|Adverse Event|0|||
129906884|NCT00457743|467620696|FG001|Overall Study|Adverse Event|4|||
129906885|NCT00457743|467620697|FG002|Overall Study|Adverse Event|0|||
129906886|NCT00457743|467620695|FG000|Overall Study|Lack of Efficacy|3|||
129906887|NCT00457743|467620696|FG001|Overall Study|Lack of Efficacy|23|||
129906888|NCT00457743|467620697|FG002|Overall Study|Lack of Efficacy|3|||
129906889|NCT00566527|467620698|FG000|Overall Study|Reason not provided|3|||
129906890|NCT00566527|467620699|FG001|Overall Study|Reason not provided|11|||
129906891|NCT00566527|467620700|FG002|Overall Study|Reason not provided|10|||
129906892|NCT00566527|467620698|FG000|Overall Study|Adverse Event|2|||
129906893|NCT00566527|467620699|FG001|Overall Study|Adverse Event|0|||
129906894|NCT00566527|467620700|FG002|Overall Study|Adverse Event|1|||
129906895|NCT00566527|467620698|FG000|Overall Study|Physician Decision|3|||
129906896|NCT00566527|467620699|FG001|Overall Study|Physician Decision|8|||
129906897|NCT00566527|467620700|FG002|Overall Study|Physician Decision|20|||
129906898|NCT00566527|467620698|FG000|Overall Study|Lost to Follow-up|3|||
129906899|NCT00566527|467620699|FG001|Overall Study|Lost to Follow-up|4|||
129906900|NCT00566527|467620700|FG002|Overall Study|Lost to Follow-up|4|||
129906901|NCT00566527|467620698|FG000|Overall Study|Withdrawal by Subject|6|||
129906902|NCT00566527|467620699|FG001|Overall Study|Withdrawal by Subject|43|||
129906903|NCT00566527|467620700|FG002|Overall Study|Withdrawal by Subject|43|||
129906904|NCT00356265|467620701|FG000|Overall Study|Withdrawal by Subject|0|||
129906905|NCT00356265|467620702|FG001|Overall Study|Withdrawal by Subject|0|||
129906906|NCT00356265|467620703|FG002|Overall Study|Withdrawal by Subject|1|||
129906907|NCT01837966|467620704|FG000|Overall Study|Withdrawal by Subject|2|||
129906908|NCT01837966|467620705|FG001|Overall Study|Withdrawal by Subject|1|||
129906909|NCT00159783|467620709|FG000|Overall Study|Adverse Event|5|||
129906910|NCT00159783|467620710|FG001|Overall Study|Adverse Event|7|||
129906911|NCT00159783|467620711|FG002|Overall Study|Adverse Event|9|||
129906912|NCT00159783|467620709|FG000|Overall Study|Lack of Efficacy|1|||
129906913|NCT00159783|467620710|FG001|Overall Study|Lack of Efficacy|2|||
129906914|NCT00159783|467620711|FG002|Overall Study|Lack of Efficacy|3|||
129906915|NCT00159783|467620709|FG000|Overall Study|Withdrawal by Subject|7|||
129906916|NCT00159783|467620710|FG001|Overall Study|Withdrawal by Subject|11|||
129906917|NCT00159783|467620711|FG002|Overall Study|Withdrawal by Subject|12|||
129906918|NCT00159783|467620709|FG000|Overall Study|Lost to Follow-up|6|||
129906919|NCT00159783|467620710|FG001|Overall Study|Lost to Follow-up|5|||
129906920|NCT00159783|467620711|FG002|Overall Study|Lost to Follow-up|11|||
129906921|NCT00159783|467620709|FG000|Overall Study|Other|0|||
129906922|NCT00159783|467620710|FG001|Overall Study|Other|2|||
129906923|NCT00159783|467620711|FG002|Overall Study|Other|4|||
129906924|NCT02928224|467620712|FG000|Overall Study|Lost to Follow-up|1|||
129906925|NCT02928224|467620713|FG001|Overall Study|Lost to Follow-up|1|||
129906926|NCT02928224|467620714|FG002|Overall Study|Lost to Follow-up|3|||
129906927|NCT02928224|467620715|FG003|Overall Study|Lost to Follow-up|0|||
129906928|NCT02928224|467620712|FG000|Overall Study|Death|30|||
129906929|NCT02928224|467620713|FG001|Overall Study|Death|209|||
129906930|NCT02928224|467620714|FG002|Overall Study|Death|193|||
129906931|NCT02928224|467620715|FG003|Overall Study|Death|198|||
129906932|NCT02928224|467620712|FG000|Overall Study|Withdrawal by Subject|0|||
129906933|NCT02928224|467620713|FG001|Overall Study|Withdrawal by Subject|3|||
129906934|NCT02928224|467620714|FG002|Overall Study|Withdrawal by Subject|7|||
129906935|NCT02928224|467620715|FG003|Overall Study|Withdrawal by Subject|20|||
129906936|NCT02928224|467620712|FG000|Overall Study|Study participation terminated by sponsor|3|||
129906937|NCT02928224|467620713|FG001|Overall Study|Study participation terminated by sponsor|8|||
129906938|NCT02928224|467620714|FG002|Overall Study|Study participation terminated by sponsor|12|||
129906939|NCT02928224|467620715|FG003|Overall Study|Study participation terminated by sponsor|3|||
129906940|NCT02928224|467620712|FG000|Overall Study|Other|3|||
129906941|NCT02928224|467620713|FG001|Overall Study|Other|3|||
129906942|NCT02928224|467620714|FG002|Overall Study|Other|5|||
129906943|NCT02928224|467620715|FG003|Overall Study|Other|0|||
129906944|NCT01278394|467620718|FG000|Overall Study|Lost to Follow-up|1|||
129906945|NCT01236560|467620719|FG000|Overall Study|Adverse Event|0|||
129906946|NCT01236560|467620720|FG001|Overall Study|Adverse Event|2|||
129906947|NCT01236560|467620721|FG002|Overall Study|Adverse Event|1|||
129906948|NCT01236560|467620722|FG003|Overall Study|Adverse Event|3|||
129906949|NCT01236560|467620723|FG004|Overall Study|Adverse Event|0|||
129906950|NCT01236560|467620724|FG005|Overall Study|Adverse Event|0|||
129906951|NCT01236560|467620719|FG000|Overall Study|Death|0|||
129906952|NCT01236560|467620720|FG001|Overall Study|Death|1|||
129906953|NCT01236560|467620721|FG002|Overall Study|Death|0|||
129906954|NCT01236560|467620722|FG003|Overall Study|Death|1|||
129906955|NCT01236560|467620723|FG004|Overall Study|Death|0|||
129906956|NCT01236560|467620724|FG005|Overall Study|Death|0|||
129906957|NCT01236560|467620719|FG000|Overall Study|Lost to Follow-up|0|||
129853574|NCT01722331|467422498|FG001|Part 2|Physician Decision|0|||
129853575|NCT01722331|467422499|FG002|Part 2|Physician Decision|2|||
129853576|NCT01722331|467422500|FG003|Part 2|Physician Decision|0|||
129853577|NCT01722331|467422501|FG004|Part 2|Physician Decision|0|||
129853578|NCT01722331|467422502|FG005|Part 2|Physician Decision|0|||
129853579|NCT01722331|467422503|FG006|Part 2|Physician Decision|0|||
129853580|NCT01722331|467422497|FG000|Part 2|Pregnancy|0|||
129853581|NCT01722331|467422498|FG001|Part 2|Pregnancy|0|||
129853582|NCT01722331|467422499|FG002|Part 2|Pregnancy|0|||
129853583|NCT01722331|467422500|FG003|Part 2|Pregnancy|0|||
129853584|NCT01722331|467422501|FG004|Part 2|Pregnancy|0|||
129853585|NCT01722331|467422502|FG005|Part 2|Pregnancy|1|||
129853586|NCT01722331|467422503|FG006|Part 2|Pregnancy|0|||
129853587|NCT01722331|467422497|FG000|Part 2|Progressive Disease|0|||
129853588|NCT01722331|467422498|FG001|Part 2|Progressive Disease|0|||
129853589|NCT01722331|467422499|FG002|Part 2|Progressive Disease|1|||
129853590|NCT01722331|467422500|FG003|Part 2|Progressive Disease|0|||
129853591|NCT01722331|467422501|FG004|Part 2|Progressive Disease|0|||
129853592|NCT01722331|467422502|FG005|Part 2|Progressive Disease|0|||
129853593|NCT01722331|467422503|FG006|Part 2|Progressive Disease|0|||
129853594|NCT01722331|467422497|FG000|Part 2|Protocol Violation|1|||
129853595|NCT01722331|467422498|FG001|Part 2|Protocol Violation|0|||
129853596|NCT01722331|467422499|FG002|Part 2|Protocol Violation|0|||
129853597|NCT01722331|467422500|FG003|Part 2|Protocol Violation|0|||
129853598|NCT01722331|467422501|FG004|Part 2|Protocol Violation|0|||
129906958|NCT01236560|467620720|FG001|Overall Study|Lost to Follow-up|1|||
129906959|NCT01236560|467620721|FG002|Overall Study|Lost to Follow-up|1|||
129906960|NCT01236560|467620722|FG003|Overall Study|Lost to Follow-up|0|||
129906961|NCT01236560|467620723|FG004|Overall Study|Lost to Follow-up|0|||
129906962|NCT01236560|467620724|FG005|Overall Study|Lost to Follow-up|0|||
129906963|NCT01236560|467620719|FG000|Overall Study|Physician Decision|0|||
129906964|NCT01236560|467620720|FG001|Overall Study|Physician Decision|1|||
129906965|NCT01236560|467620721|FG002|Overall Study|Physician Decision|8|||
129906966|NCT01236560|467620722|FG003|Overall Study|Physician Decision|0|||
129906967|NCT01236560|467620723|FG004|Overall Study|Physician Decision|0|||
129853599|NCT01722331|467422502|FG005|Part 2|Protocol Violation|0|||
129906968|NCT01236560|467620724|FG005|Overall Study|Physician Decision|0|||
129906969|NCT01236560|467620719|FG000|Overall Study|Withdrawal by Subject|0|||
129906970|NCT01236560|467620720|FG001|Overall Study|Withdrawal by Subject|0|||
129906971|NCT01236560|467620721|FG002|Overall Study|Withdrawal by Subject|1|||
129906972|NCT01236560|467620722|FG003|Overall Study|Withdrawal by Subject|2|||
129853600|NCT01722331|467422503|FG006|Part 2|Protocol Violation|0|||
129853601|NCT01722331|467422497|FG000|Part 2|Withdrawal by Subject|5|||
129853602|NCT01722331|467422498|FG001|Part 2|Withdrawal by Subject|0|||
129853603|NCT01722331|467422499|FG002|Part 2|Withdrawal by Subject|3|||
129853604|NCT01722331|467422500|FG003|Part 2|Withdrawal by Subject|0|||
129853605|NCT01722331|467422501|FG004|Part 2|Withdrawal by Subject|0|||
129853606|NCT01722331|467422502|FG005|Part 2|Withdrawal by Subject|2|||
129853607|NCT01722331|467422503|FG006|Part 2|Withdrawal by Subject|2|||
129906973|NCT01236560|467620723|FG004|Overall Study|Withdrawal by Subject|0|||
129906974|NCT01236560|467620724|FG005|Overall Study|Withdrawal by Subject|0|||
129906975|NCT01236560|467620719|FG000|Overall Study|Progressive disease|5|||
129906976|NCT01236560|467620720|FG001|Overall Study|Progressive disease|19|||
129906977|NCT01236560|467620721|FG002|Overall Study|Progressive disease|9|||
129906978|NCT01236560|467620722|FG003|Overall Study|Progressive disease|16|||
129906979|NCT01236560|467620723|FG004|Overall Study|Progressive disease|0|||
129906980|NCT01236560|467620724|FG005|Overall Study|Progressive disease|0|||
129906981|NCT00468910|467620725|FG000|Overall Study|Lost to Follow-up|2|||
129906982|NCT00468910|467620726|FG001|Overall Study|Lost to Follow-up|1|||
129906983|NCT00468910|467620725|FG000|Overall Study|Withdrawal by Subject|2|||
129906984|NCT00468910|467620726|FG001|Overall Study|Withdrawal by Subject|1|||
129906985|NCT00468910|467620725|FG000|Overall Study|Medical Contraindication|0|||
129906986|NCT00468910|467620726|FG001|Overall Study|Medical Contraindication|1|||
129906987|NCT00457691|467620728|FG000|Overall Study|Adverse Event|4|||
129906988|NCT00457691|467620729|FG001|Overall Study|Adverse Event|1|||
129906989|NCT00457691|467620728|FG000|Overall Study|Death|163|||
129906990|NCT00457691|467620729|FG001|Overall Study|Death|148|||
129906991|NCT00457691|467620728|FG000|Overall Study|Protocol Violation|1|||
129906992|NCT00457691|467620729|FG001|Overall Study|Protocol Violation|3|||
129906993|NCT00457691|467620728|FG000|Overall Study|Lost to Follow-up|23|||
129906994|NCT00457691|467620729|FG001|Overall Study|Lost to Follow-up|14|||
129906995|NCT00457691|467620728|FG000|Overall Study|Study terminated by Sponsor|1|||
129906996|NCT00457691|467620729|FG001|Overall Study|Study terminated by Sponsor|1|||
129906997|NCT00457691|467620728|FG000|Overall Study|Subject refused (reason other than AE)|14|||
129906998|NCT00457691|467620729|FG001|Overall Study|Subject refused (reason other than AE)|19|||
129906999|NCT00457691|467620728|FG000|Overall Study|Disease progression, study terminated|180|||
129907000|NCT00457691|467620729|FG001|Overall Study|Disease progression, study terminated|196|||
129907001|NCT02079844|467620730|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
129907002|NCT02079844|467620731|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
129907003|NCT02079844|467620732|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
129907004|NCT02079844|467620730|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
129907005|NCT02079844|467620731|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
129907006|NCT02079844|467620732|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
129907007|NCT01823536|467622443|FG000|Overall Study|Lost to Follow-up|1|||
129907008|NCT01823536|467622444|FG001|Overall Study|Lost to Follow-up|0|||
129907009|NCT01823536|467622445|FG002|Overall Study|Lost to Follow-up|0|||
129907010|NCT01823536|467622446|FG003|Overall Study|Lost to Follow-up|1|||
129907011|NCT01823536|467622447|FG004|Overall Study|Lost to Follow-up|1|||
129907012|NCT01823536|467622448|FG005|Overall Study|Lost to Follow-up|0|||
129907013|NCT01823536|467622443|FG000|Overall Study|Protocol Violation|0|||
129907014|NCT01823536|467622444|FG001|Overall Study|Protocol Violation|1|||
129907015|NCT01823536|467622445|FG002|Overall Study|Protocol Violation|0|||
129907016|NCT01823536|467622446|FG003|Overall Study|Protocol Violation|0|||
129907017|NCT01823536|467622447|FG004|Overall Study|Protocol Violation|0|||
129907018|NCT01823536|467622448|FG005|Overall Study|Protocol Violation|0|||
129907019|NCT01823536|467622443|FG000|Overall Study|Withdrawal by Subject|1|||
129907020|NCT01823536|467622444|FG001|Overall Study|Withdrawal by Subject|1|||
129907021|NCT01823536|467622445|FG002|Overall Study|Withdrawal by Subject|0|||
129907022|NCT01823536|467622446|FG003|Overall Study|Withdrawal by Subject|0|||
129907023|NCT01823536|467622447|FG004|Overall Study|Withdrawal by Subject|0|||
129907024|NCT01823536|467622448|FG005|Overall Study|Withdrawal by Subject|0|||
129907025|NCT01823536|467622443|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907026|NCT01823536|467622444|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907027|NCT01823536|467622445|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
129907028|NCT01823536|467622446|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907029|NCT01823536|467622447|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907030|NCT01823536|467622448|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
129907031|NCT01823536|467622443|FG000|Overall Study|Met exclusion criterion No 6|0|||
129907032|NCT01823536|467622444|FG001|Overall Study|Met exclusion criterion No 6|0|||
129907033|NCT01823536|467622445|FG002|Overall Study|Met exclusion criterion No 6|0|||
129907034|NCT01823536|467622446|FG003|Overall Study|Met exclusion criterion No 6|1|||
129907035|NCT01823536|467622447|FG004|Overall Study|Met exclusion criterion No 6|0|||
129907036|NCT01823536|467622448|FG005|Overall Study|Met exclusion criterion No 6|0|||
129907037|NCT01823536|467622443|FG000|Overall Study|Subject moved out of the state|0|||
129907038|NCT01823536|467622444|FG001|Overall Study|Subject moved out of the state|0|||
129907039|NCT01823536|467622445|FG002|Overall Study|Subject moved out of the state|0|||
129907040|NCT01823536|467622446|FG003|Overall Study|Subject moved out of the state|0|||
129907041|NCT01823536|467622447|FG004|Overall Study|Subject moved out of the state|1|||
129907042|NCT01823536|467622448|FG005|Overall Study|Subject moved out of the state|0|||
129907043|NCT03648762|467622449|FG000|Overall Study|Lost to Follow-up|1|||
129907044|NCT03648762|467622450|FG001|Overall Study|Lost to Follow-up|2|||
129907045|NCT03648762|467622451|FG002|Overall Study|Lost to Follow-up|0|||
129907046|NCT03648762|467622449|FG000|Overall Study|Withdrawal by Subject|5|||
129907047|NCT03648762|467622450|FG001|Overall Study|Withdrawal by Subject|2|||
129907048|NCT03648762|467622451|FG002|Overall Study|Withdrawal by Subject|1|||
129449656|NCT00467779|465945625|FG002|Stage 3|Unspecified Reason|0|||
129907049|NCT00002842|467622461|FG000|Overall Study|ineligible for surgical resection|27|||
129907050|NCT02564744|467622462|FG000|Overall Study|Investigator decision|0|||
129907051|NCT02564744|467622463|FG001|Overall Study|Investigator decision|0|||
129907052|NCT02564744|467622464|FG002|Overall Study|Investigator decision|0|||
129907053|NCT02564744|467622465|FG003|Overall Study|Investigator decision|0|||
129907054|NCT02564744|467622466|FG004|Overall Study|Investigator decision|1|||
129907055|NCT02564744|467622462|FG000|Overall Study|Death|10|||
129907056|NCT02564744|467622463|FG001|Overall Study|Death|5|||
129907057|NCT02564744|467622464|FG002|Overall Study|Death|4|||
129907058|NCT02564744|467622465|FG003|Overall Study|Death|16|||
129907059|NCT02564744|467622466|FG004|Overall Study|Death|16|||
129907060|NCT02564744|467622462|FG000|Overall Study|End of study Page Missing|0|||
129907061|NCT02564744|467622463|FG001|Overall Study|End of study Page Missing|0|||
129907062|NCT02564744|467622464|FG002|Overall Study|End of study Page Missing|3|||
129907063|NCT02564744|467622465|FG003|Overall Study|End of study Page Missing|3|||
129907064|NCT02564744|467622466|FG004|Overall Study|End of study Page Missing|0|||
129907065|NCT02564744|467622462|FG000|Overall Study|Subject Withdrew Consent|1|||
129907066|NCT02564744|467622463|FG001|Overall Study|Subject Withdrew Consent|1|||
129907067|NCT02564744|467622464|FG002|Overall Study|Subject Withdrew Consent|1|||
129907068|NCT02564744|467622465|FG003|Overall Study|Subject Withdrew Consent|0|||
129907069|NCT02564744|467622466|FG004|Overall Study|Subject Withdrew Consent|2|||
129907070|NCT02564744|467622462|FG000|Overall Study|Lost to Follow-up|0|||
129907071|NCT02564744|467622463|FG001|Overall Study|Lost to Follow-up|1|||
129907072|NCT02564744|467622464|FG002|Overall Study|Lost to Follow-up|0|||
129907073|NCT02564744|467622465|FG003|Overall Study|Lost to Follow-up|0|||
129907074|NCT02564744|467622466|FG004|Overall Study|Lost to Follow-up|1|||
129907075|NCT02564744|467622462|FG000|Overall Study|Reason not specified|1|||
129907076|NCT02564744|467622463|FG001|Overall Study|Reason not specified|0|||
129907077|NCT02564744|467622464|FG002|Overall Study|Reason not specified|0|||
129907078|NCT02564744|467622465|FG003|Overall Study|Reason not specified|0|||
129907079|NCT02564744|467622466|FG004|Overall Study|Reason not specified|0|||
129907080|NCT00508924|467622467|FG000|Overall Study|Protocol Violation|0|||
129907081|NCT00508924|467622468|FG001|Overall Study|Protocol Violation|0|||
129907082|NCT00508924|467622469|FG002|Overall Study|Protocol Violation|1|||
129907083|NCT00508924|467622470|FG003|Overall Study|Protocol Violation|1|||
129907084|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
129907085|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
129907086|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
129907087|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
129907088|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
129907089|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
129907090|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
129907091|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
129907092|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
129907093|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
129907094|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
129907095|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
129907096|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
129907097|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
129907098|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
129907099|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
129907100|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
129907101|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
129907102|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
129907103|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
129907104|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
129907105|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
129907106|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
129907107|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
129907108|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
129907109|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
129907110|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
129907111|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
129907112|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
129907113|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
129907114|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
129907115|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
129907116|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
129907117|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
129907118|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
129907119|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
129907120|NCT03593213|467622472|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
129907121|NCT03593213|467622473|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
129907122|NCT03593213|467622474|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
129907123|NCT03593213|467622475|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
129907124|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
129907125|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
129907126|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
129907127|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
129907128|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
129907129|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
129853608|NCT01722331|467422497|FG000|Part 2|Other Protocol Specified Criteria|6|||
129853609|NCT01722331|467422498|FG001|Part 2|Other Protocol Specified Criteria|0|||
129853610|NCT01722331|467422499|FG002|Part 2|Other Protocol Specified Criteria|10|||
129853611|NCT01722331|467422500|FG003|Part 2|Other Protocol Specified Criteria|0|||
129853612|NCT01722331|467422501|FG004|Part 2|Other Protocol Specified Criteria|0|||
129853613|NCT01722331|467422502|FG005|Part 2|Other Protocol Specified Criteria|2|||
129853614|NCT01722331|467422503|FG006|Part 2|Other Protocol Specified Criteria|1|||
129853615|NCT01722331|467422497|FG000|Part 3|Adverse Event|2|||
129853616|NCT01722331|467422498|FG001|Part 3|Adverse Event|2|||
129853617|NCT01722331|467422499|FG002|Part 3|Adverse Event|0|||
129853618|NCT01722331|467422500|FG003|Part 3|Adverse Event|1|||
129853619|NCT01722331|467422501|FG004|Part 3|Adverse Event|0|||
129853620|NCT01722331|467422502|FG005|Part 3|Adverse Event|0|||
129853621|NCT01722331|467422503|FG006|Part 3|Adverse Event|0|||
129853622|NCT01722331|467422497|FG000|Part 3|Death|1|||
129853623|NCT01722331|467422498|FG001|Part 3|Death|0|||
129853624|NCT01722331|467422499|FG002|Part 3|Death|0|||
129853625|NCT01722331|467422500|FG003|Part 3|Death|0|||
129853626|NCT01722331|467422501|FG004|Part 3|Death|0|||
129853627|NCT01722331|467422502|FG005|Part 3|Death|0|||
129853628|NCT01722331|467422503|FG006|Part 3|Death|0|||
129853629|NCT01722331|467422497|FG000|Part 3|Lack of Efficacy|1|||
129853630|NCT01722331|467422498|FG001|Part 3|Lack of Efficacy|0|||
129853631|NCT01722331|467422499|FG002|Part 3|Lack of Efficacy|0|||
129853632|NCT01722331|467422500|FG003|Part 3|Lack of Efficacy|0|||
129853633|NCT01722331|467422501|FG004|Part 3|Lack of Efficacy|0|||
129853634|NCT01722331|467422502|FG005|Part 3|Lack of Efficacy|0|||
129853635|NCT01722331|467422503|FG006|Part 3|Lack of Efficacy|0|||
129853636|NCT01722331|467422497|FG000|Part 3|Lost to Follow-up|3|||
129853637|NCT01722331|467422498|FG001|Part 3|Lost to Follow-up|4|||
129853638|NCT01722331|467422499|FG002|Part 3|Lost to Follow-up|0|||
129853639|NCT01722331|467422500|FG003|Part 3|Lost to Follow-up|0|||
129853640|NCT01722331|467422501|FG004|Part 3|Lost to Follow-up|0|||
129853641|NCT01722331|467422502|FG005|Part 3|Lost to Follow-up|1|||
129853642|NCT01722331|467422503|FG006|Part 3|Lost to Follow-up|0|||
129853643|NCT01722331|467422497|FG000|Part 3|Non-Compliance with Study Drug|0|||
129853644|NCT01722331|467422498|FG001|Part 3|Non-Compliance with Study Drug|1|||
129853645|NCT01722331|467422499|FG002|Part 3|Non-Compliance with Study Drug|0|||
129853646|NCT01722331|467422500|FG003|Part 3|Non-Compliance with Study Drug|0|||
129853647|NCT01722331|467422501|FG004|Part 3|Non-Compliance with Study Drug|0|||
129853648|NCT01722331|467422502|FG005|Part 3|Non-Compliance with Study Drug|0|||
129853649|NCT01722331|467422503|FG006|Part 3|Non-Compliance with Study Drug|0|||
129853650|NCT01722331|467422497|FG000|Part 3|Physician Decision|1|||
129853651|NCT01722331|467422498|FG001|Part 3|Physician Decision|1|||
129853652|NCT01722331|467422499|FG002|Part 3|Physician Decision|0|||
129853653|NCT01722331|467422500|FG003|Part 3|Physician Decision|0|||
129853654|NCT01722331|467422501|FG004|Part 3|Physician Decision|0|||
129853655|NCT01722331|467422502|FG005|Part 3|Physician Decision|0|||
129853656|NCT01722331|467422503|FG006|Part 3|Physician Decision|1|||
129853657|NCT01722331|467422497|FG000|Part 3|Protocol Violation|2|||
129853658|NCT01722331|467422498|FG001|Part 3|Protocol Violation|1|||
129853659|NCT01722331|467422499|FG002|Part 3|Protocol Violation|0|||
129853660|NCT01722331|467422500|FG003|Part 3|Protocol Violation|0|||
129853661|NCT01722331|467422501|FG004|Part 3|Protocol Violation|0|||
129853662|NCT01722331|467422502|FG005|Part 3|Protocol Violation|0|||
129853663|NCT01722331|467422503|FG006|Part 3|Protocol Violation|0|||
129853664|NCT01722331|467422497|FG000|Part 3|Withdrawal by Subject|4|||
129853665|NCT01722331|467422498|FG001|Part 3|Withdrawal by Subject|7|||
129853666|NCT01722331|467422499|FG002|Part 3|Withdrawal by Subject|0|||
129853667|NCT01722331|467422500|FG003|Part 3|Withdrawal by Subject|0|||
129449657|NCT00467779|465945626|FG003|Stage 3|Unspecified Reason|0|||
129853668|NCT01722331|467422501|FG004|Part 3|Withdrawal by Subject|0|||
129853669|NCT01722331|467422502|FG005|Part 3|Withdrawal by Subject|2|||
129853670|NCT01722331|467422503|FG006|Part 3|Withdrawal by Subject|1|||
129853671|NCT01722331|467422497|FG000|Part 3|Other Protocol Specified Criteria|1|||
129853672|NCT01722331|467422498|FG001|Part 3|Other Protocol Specified Criteria|1|||
129853673|NCT01722331|467422499|FG002|Part 3|Other Protocol Specified Criteria|0|||
129853674|NCT01722331|467422500|FG003|Part 3|Other Protocol Specified Criteria|0|||
129853675|NCT01722331|467422501|FG004|Part 3|Other Protocol Specified Criteria|0|||
129853676|NCT01722331|467422502|FG005|Part 3|Other Protocol Specified Criteria|0|||
129853677|NCT01722331|467422503|FG006|Part 3|Other Protocol Specified Criteria|0|||
129853678|NCT00262834|467422504|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
129853679|NCT00262834|467422505|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
129853680|NCT00003457|467422508|FG000|Overall Study|Not evaluable|9|||
129853681|NCT02525133|467422514|FG000|Overall Study|Adverse Event|0|||
129853682|NCT02525133|467422515|FG001|Overall Study|Adverse Event|1|||
129853683|NCT02525133|467422514|FG000|Overall Study|Death|0|||
129853684|NCT02525133|467422515|FG001|Overall Study|Death|1|||
129853685|NCT02525133|467422514|FG000|Overall Study|did not meet randomization criteria|1|||
129853686|NCT02525133|467422515|FG001|Overall Study|did not meet randomization criteria|0|||
129853687|NCT02525133|467422514|FG000|Overall Study|Lost to Follow-up|5|||
129853688|NCT02525133|467422515|FG001|Overall Study|Lost to Follow-up|1|||
129853689|NCT02525133|467422514|FG000|Overall Study|randomized not enrolled|3|||
129853690|NCT02525133|467422515|FG001|Overall Study|randomized not enrolled|0|||
129853691|NCT02525133|467422514|FG000|Overall Study|Withdrawal by Subject|1|||
129853692|NCT02525133|467422515|FG001|Overall Study|Withdrawal by Subject|0|||
129853693|NCT01075074|467422516|FG000|Overall Study|Surgeon changed to open incisional case|1|||
129853694|NCT01075074|467422517|FG001|Overall Study|Surgeon changed to open incisional case|2|||
129853695|NCT01075074|467422518|FG002|Overall Study|Surgeon changed to open incisional case|2|||
129853696|NCT01054729|467422519|FG000|Overall Study|Randomized but Not Treated|0|||
129853697|NCT01054729|467422520|FG001|Overall Study|Randomized but Not Treated|1|||
129853698|NCT01054729|467422521|FG002|Overall Study|Randomized but Not Treated|0|||
129853699|NCT01054729|467422522|FG003|Overall Study|Randomized but Not Treated|0|||
129853700|NCT01054729|467422519|FG000|Overall Study|Adverse Event|1|||
129853701|NCT01054729|467422520|FG001|Overall Study|Adverse Event|1|||
129853702|NCT01054729|467422521|FG002|Overall Study|Adverse Event|2|||
129853703|NCT01054729|467422522|FG003|Overall Study|Adverse Event|1|||
129853704|NCT01054729|467422519|FG000|Overall Study|Withdrawal by Subject|1|||
129853705|NCT01054729|467422520|FG001|Overall Study|Withdrawal by Subject|0|||
129853706|NCT01054729|467422521|FG002|Overall Study|Withdrawal by Subject|1|||
129853707|NCT01054729|467422522|FG003|Overall Study|Withdrawal by Subject|0|||
129853708|NCT01054729|467422519|FG000|Overall Study|Lost to Follow-up|0|||
129853709|NCT01054729|467422520|FG001|Overall Study|Lost to Follow-up|1|||
129853710|NCT01054729|467422521|FG002|Overall Study|Lost to Follow-up|0|||
129853711|NCT01054729|467422522|FG003|Overall Study|Lost to Follow-up|0|||
129853712|NCT01054729|467422519|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
129853713|NCT01054729|467422520|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
129853714|NCT01054729|467422521|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
129853715|NCT01054729|467422522|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
129853716|NCT01054729|467422519|FG000|Overall Study|Non-responder|1|||
129853717|NCT01054729|467422520|FG001|Overall Study|Non-responder|0|||
129853718|NCT01054729|467422521|FG002|Overall Study|Non-responder|1|||
129853719|NCT01054729|467422522|FG003|Overall Study|Non-responder|1|||
129853720|NCT01054729|467422519|FG000|Overall Study|PEG/RBV Non-responder|1|||
129853721|NCT01054729|467422520|FG001|Overall Study|PEG/RBV Non-responder|0|||
129853722|NCT01054729|467422521|FG002|Overall Study|PEG/RBV Non-responder|1|||
129853723|NCT01054729|467422522|FG003|Overall Study|PEG/RBV Non-responder|0|||
129853724|NCT01054729|467422519|FG000|Overall Study|Personal/Obligations|0|||
129853725|NCT01054729|467422520|FG001|Overall Study|Personal/Obligations|1|||
129853726|NCT01054729|467422521|FG002|Overall Study|Personal/Obligations|0|||
129853727|NCT01054729|467422522|FG003|Overall Study|Personal/Obligations|0|||
129853728|NCT01054729|467422519|FG000|Overall Study|Subject moved|0|||
129853729|NCT01054729|467422520|FG001|Overall Study|Subject moved|0|||
129853730|NCT01054729|467422521|FG002|Overall Study|Subject moved|1|||
129853731|NCT01054729|467422522|FG003|Overall Study|Subject moved|0|||
129853732|NCT01054729|467422519|FG000|Overall Study|Lack of Efficacy|0|||
129853733|NCT01054729|467422520|FG001|Overall Study|Lack of Efficacy|0|||
129853734|NCT01054729|467422521|FG002|Overall Study|Lack of Efficacy|0|||
129853735|NCT01054729|467422522|FG003|Overall Study|Lack of Efficacy|1|||
129853736|NCT04265755|467422523|FG000|Overall Study|Withdrawal by Subject|39|||
129853737|NCT04265755|467422523|FG000|Overall Study|Decision by sponsor|2|||
129853738|NCT04265755|467422523|FG000|Overall Study|Lost to Follow-up|11|||
129853739|NCT04265755|467422523|FG000|Overall Study|Death|1|||
129853740|NCT01575561|467422524|FG000|Overall Study|Adverse Event|9|||
129853741|NCT01575561|467422524|FG000|Overall Study|Lack of Efficacy|8|||
129853742|NCT01575561|467422524|FG000|Overall Study|Lost to Follow-up|6|||
129449658|NCT00467779|465945627|FG004|Stage 3|Unspecified Reason|0|||
129853743|NCT01575561|467422524|FG000|Overall Study|Protocol Violation|4|||
129853744|NCT01575561|467422524|FG000|Overall Study|Withdrawal by Subject|11|||
129853745|NCT01575561|467422524|FG000|Overall Study|administration|1|||
129853746|NCT01992536|467422525|FG000|Overall Study|Administrative Reason|0|||
129853747|NCT01992536|467422526|FG001|Overall Study|Administrative Reason|0|||
129853748|NCT01992536|467422527|FG002|Overall Study|Administrative Reason|0|||
129853749|NCT01992536|467422528|FG003|Overall Study|Administrative Reason|0|||
129907130|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
129907131|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
129907132|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
129907133|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
129907134|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
129907135|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
129907136|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
129907137|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
129907138|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
129907139|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
129907140|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
129907141|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
129907142|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
129907143|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
129907144|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
129907145|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
129907146|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
129907147|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
129907148|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
129907149|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
129907150|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
129907151|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
129907152|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
129907153|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
129907154|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
129907155|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
129907156|NCT03593213|467622472|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
129907157|NCT03593213|467622473|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
129907158|NCT03593213|467622474|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
129907159|NCT03593213|467622475|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
129907160|NCT02594735|467622482|FG000|Overall Study|Adverse Event|1|||
129907161|NCT03844269|467622486|FG000|Overall Study|Withdrawal pre-intervention|1|||
129907162|NCT03844269|467622486|FG000|Overall Study|Did not complete the intervention|2|||
129907163|NCT00101010|467622490|FG000|Overall Study|Physician Decision|1|||
129907164|NCT02969863|467622491|FG000|Overall Study|Physician Decision|1|||
129907165|NCT02969863|467622492|FG001|Overall Study|Physician Decision|0|||
129907166|NCT02969863|467622493|FG002|Overall Study|Physician Decision|0|||
129907167|NCT02969863|467622494|FG003|Overall Study|Physician Decision|0|||
129907168|NCT02969863|467622495|FG004|Overall Study|Physician Decision|0|||
129907169|NCT02969863|467622496|FG005|Overall Study|Physician Decision|0|||
129907170|NCT03737240|467622497|FG000|Overall Study|Lost to Follow-up|16|||
129907171|NCT03737240|467622498|FG001|Overall Study|Lost to Follow-up|15|||
129907172|NCT01254188|467622499|FG000|Overall Study|Disease Progression|6|||
129907173|NCT01254188|467622499|FG000|Overall Study|Protocol Violation|6|||
129907174|NCT01254188|467622499|FG000|Overall Study|Pregnancy|2|||
129907175|NCT01254188|467622499|FG000|Overall Study|Death|4|||
129907176|NCT01254188|467622499|FG000|Overall Study|Lost to Follow-up|5|||
129907177|NCT01254188|467622499|FG000|Overall Study|Withdrawal by Subject|7|||
129907178|NCT01254188|467622499|FG000|Overall Study|Adverse Event|43|||
129907179|NCT01254188|467622499|FG000|Overall Study|per investigator discretion|20|||
129907180|NCT02957136|467622509|FG000|Overall Study|Withdrawal by Subject|2|||
129907181|NCT02957136|467622510|FG001|Overall Study|Withdrawal by Subject|1|||
129907182|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
129907183|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
129907184|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
129907185|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
129907186|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
129907187|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
129907188|NCT02200770|467622511|FG000|Randomized-controlled Period (RCP)|Other|1|||
129907189|NCT02200770|467622512|FG001|Randomized-controlled Period (RCP)|Other|2|||
129907190|NCT02200770|467622511|FG000|Open-label Period (OLP)|Adverse Event|1|||
129907191|NCT02200770|467622512|FG001|Open-label Period (OLP)|Adverse Event|2|||
129907192|NCT02200770|467622511|FG000|Open-label Period (OLP)|Death|1|||
129907193|NCT02200770|467622512|FG001|Open-label Period (OLP)|Death|2|||
129907194|NCT02200770|467622511|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
129907195|NCT02200770|467622512|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
129907196|NCT02200770|467622511|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
129907197|NCT02200770|467622512|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
129853750|NCT01992536|467422529|FG004|Overall Study|Administrative Reason|0|||
129853751|NCT01992536|467422530|FG005|Overall Study|Administrative Reason|0|||
129853752|NCT01992536|467422531|FG006|Overall Study|Administrative Reason|7|||
129853753|NCT01992536|467422532|FG007|Overall Study|Administrative Reason|0|||
129853754|NCT01992536|467422533|FG008|Overall Study|Administrative Reason|0|||
129853755|NCT01992536|467422534|FG009|Overall Study|Administrative Reason|0|||
129853756|NCT01992536|467422525|FG000|Overall Study|Lost to Follow-up|4|||
129853757|NCT01992536|467422526|FG001|Overall Study|Lost to Follow-up|2|||
129853758|NCT01992536|467422527|FG002|Overall Study|Lost to Follow-up|1|||
129853759|NCT01992536|467422528|FG003|Overall Study|Lost to Follow-up|0|||
129853760|NCT01992536|467422529|FG004|Overall Study|Lost to Follow-up|0|||
129853761|NCT01992536|467422530|FG005|Overall Study|Lost to Follow-up|1|||
129853762|NCT01992536|467422531|FG006|Overall Study|Lost to Follow-up|0|||
129853763|NCT01992536|467422532|FG007|Overall Study|Lost to Follow-up|0|||
129853764|NCT01992536|467422533|FG008|Overall Study|Lost to Follow-up|1|||
129853765|NCT01992536|467422534|FG009|Overall Study|Lost to Follow-up|1|||
129853766|NCT01992536|467422525|FG000|Overall Study|Withdrawal by Subject|0|||
129853767|NCT01992536|467422526|FG001|Overall Study|Withdrawal by Subject|1|||
129853768|NCT01992536|467422527|FG002|Overall Study|Withdrawal by Subject|0|||
129853769|NCT01992536|467422528|FG003|Overall Study|Withdrawal by Subject|2|||
129853770|NCT01992536|467422529|FG004|Overall Study|Withdrawal by Subject|0|||
129853771|NCT01992536|467422530|FG005|Overall Study|Withdrawal by Subject|0|||
129853772|NCT01992536|467422531|FG006|Overall Study|Withdrawal by Subject|0|||
129853773|NCT01992536|467422532|FG007|Overall Study|Withdrawal by Subject|0|||
129853774|NCT01992536|467422533|FG008|Overall Study|Withdrawal by Subject|0|||
129853775|NCT01992536|467422534|FG009|Overall Study|Withdrawal by Subject|0|||
129853776|NCT00406029|467422544|FG000|Overall Study|Adverse Event|12|||
129853777|NCT00406029|467422545|FG001|Overall Study|Adverse Event|2|||
129853778|NCT00406029|467422546|FG002|Overall Study|Adverse Event|5|||
129853779|NCT00406029|467422547|FG003|Overall Study|Adverse Event|10|||
129853780|NCT00406029|467422548|FG004|Overall Study|Adverse Event|7|||
129853781|NCT00406029|467422544|FG000|Overall Study|Withdrawal by Subject|3|||
129853782|NCT00406029|467422545|FG001|Overall Study|Withdrawal by Subject|4|||
129853783|NCT00406029|467422546|FG002|Overall Study|Withdrawal by Subject|2|||
129853784|NCT00406029|467422547|FG003|Overall Study|Withdrawal by Subject|2|||
129853785|NCT00406029|467422548|FG004|Overall Study|Withdrawal by Subject|0|||
129853786|NCT00406029|467422544|FG000|Overall Study|Protocol Violation|1|||
129853787|NCT00406029|467422545|FG001|Overall Study|Protocol Violation|2|||
129853788|NCT00406029|467422546|FG002|Overall Study|Protocol Violation|0|||
129853789|NCT00406029|467422547|FG003|Overall Study|Protocol Violation|2|||
129853790|NCT00406029|467422548|FG004|Overall Study|Protocol Violation|0|||
129853791|NCT00406029|467422544|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853792|NCT00406029|467422545|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853793|NCT00406029|467422546|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
129853794|NCT00406029|467422547|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853795|NCT00406029|467422548|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
129853796|NCT00406029|467422544|FG000|Overall Study|Randomized in Error|0|||
129853797|NCT00406029|467422545|FG001|Overall Study|Randomized in Error|0|||
129853798|NCT00406029|467422546|FG002|Overall Study|Randomized in Error|2|||
129853799|NCT00406029|467422547|FG003|Overall Study|Randomized in Error|3|||
129853800|NCT00406029|467422548|FG004|Overall Study|Randomized in Error|1|||
129853801|NCT01709227|467422550|FG000|Overall Study|Physician Decision|1|||
129853802|NCT01709227|467422551|FG001|Overall Study|Physician Decision|0|||
129853803|NCT01709227|467422550|FG000|Overall Study|Pleural Peritoneal communication|0|||
129853804|NCT01709227|467422551|FG001|Overall Study|Pleural Peritoneal communication|9|||
129853805|NCT03669081|467422554|FG000|Overall Study|Data could not be validated|1|||
129853806|NCT03669081|467422555|FG001|Overall Study|Data could not be validated|1|||
129853807|NCT00389324|467422556|FG000|Run-In Phase|Adverse Event|1|||
129853808|NCT00389324|467422556|FG000|Run-In Phase|Lost to Follow-up|1|||
129853809|NCT00389324|467422556|FG000|Run-In Phase|Withdrawal by Subject|1|||
129853810|NCT00389324|467422556|FG000|Subcutaneous Phase|Adverse Event|2|||
129853811|NCT00389324|467422556|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
129853812|NCT00389324|467422556|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
129853813|NCT00389324|467422556|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
129853814|NCT02317575|467422557|FG000|Period 1|Difficulty with venous cannulation|0|||
129853815|NCT02317575|467422558|FG001|Period 1|Difficulty with venous cannulation|1|||
129853816|NCT02317575|467422559|FG002|Period 1|Difficulty with venous cannulation|0|||
129853817|NCT02317575|467422560|FG003|Period 1|Difficulty with venous cannulation|0|||
129853818|NCT02317575|467422561|FG004|Period 1|Difficulty with venous cannulation|0|||
129853819|NCT02317575|467422557|FG000|Period 1|Withdrawal by Subject|1|||
129853820|NCT02317575|467422558|FG001|Period 1|Withdrawal by Subject|0|||
129853821|NCT02317575|467422559|FG002|Period 1|Withdrawal by Subject|0|||
129853822|NCT02317575|467422560|FG003|Period 1|Withdrawal by Subject|0|||
129853823|NCT02317575|467422561|FG004|Period 1|Withdrawal by Subject|0|||
129853824|NCT02843568|467422562|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
129907198|NCT02200770|467622511|FG000|Open-label Period (OLP)|Other|6|||
129907199|NCT02200770|467622512|FG001|Open-label Period (OLP)|Other|15|||
129907200|NCT01264679|467622513|FG000|Overall Study|Participation in Another Clinical Trial|1|||
129907201|NCT01264679|467622513|FG000|Overall Study|Physician Decision|1|||
129907202|NCT01264679|467622513|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
129907203|NCT01264679|467622513|FG000|Overall Study|Withdrawal by Subject|1|||
129907204|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
129907205|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
129907206|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
129907207|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
129907208|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129907209|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
129907210|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
129907211|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
129907212|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
129907213|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
129907214|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907215|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907216|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907217|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907218|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907219|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
129907220|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907221|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
129907222|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907223|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907224|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907225|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907226|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907227|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
129907228|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
129907229|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
129907230|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
129907231|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
129907232|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
129907233|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
129907234|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
129907235|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
129907236|NCT03482011|467622514|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
129907237|NCT03482011|467622515|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
129907238|NCT03482011|467622516|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907239|NCT03482011|467622517|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907240|NCT03482011|467622518|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907241|NCT03482011|467622519|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907242|NCT03482011|467622520|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907243|NCT03482011|467622521|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129907244|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907245|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907246|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907247|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907248|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
129907249|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
129907250|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
129907251|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
129907252|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129907253|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129907254|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
129907255|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
129907256|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
129907257|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
129907258|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
129907259|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
129907260|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907261|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907262|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907263|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129907264|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
129907265|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129449659|NCT00467779|465945628|FG005|Stage 3|Unspecified Reason|0|||
129449660|NCT00467779|465945629|FG006|Stage 3|Unspecified Reason|0|||
129449661|NCT00467779|465945630|FG007|Stage 3|Unspecified Reason|0|||
129449662|NCT00467779|465945631|FG008|Stage 3|Unspecified Reason|0|||
129449663|NCT00467779|465945632|FG009|Stage 3|Unspecified Reason|0|||
129853825|NCT02843568|467422563|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
129853826|NCT02843568|467422562|FG000|Overall Study|Death|3|||
129853827|NCT02843568|467422563|FG001|Overall Study|Death|3|||
129853828|NCT02843568|467422562|FG000|Overall Study|Withdrawal by Subject|1|||
129853829|NCT02843568|467422563|FG001|Overall Study|Withdrawal by Subject|1|||
129853830|NCT02843568|467422562|FG000|Overall Study|Lost to Follow-up|2|||
129853831|NCT02843568|467422563|FG001|Overall Study|Lost to Follow-up|0|||
129853832|NCT04079933|467422566|FG000|Overall Study|Withdrawal by Subject|3|||
129853833|NCT04079933|467422567|FG001|Overall Study|Withdrawal by Subject|4|||
129853834|NCT04079933|467422566|FG000|Overall Study|Lost to Follow-up|0|||
129853835|NCT04079933|467422567|FG001|Overall Study|Lost to Follow-up|1|||
129853836|NCT01459796|467422568|FG000|Overall Study|Non compliance with protocol|2|||
129853837|NCT01459796|467422569|FG001|Overall Study|Non compliance with protocol|4|||
129853838|NCT01459796|467422568|FG000|Overall Study|Adverse Event|5|||
129853839|NCT01459796|467422569|FG001|Overall Study|Adverse Event|5|||
129853840|NCT01459796|467422568|FG000|Overall Study|Withdrawal by Subject|6|||
129853841|NCT01459796|467422569|FG001|Overall Study|Withdrawal by Subject|3|||
129853842|NCT01459796|467422568|FG000|Overall Study|Lost to Follow-up|5|||
129853843|NCT01459796|467422569|FG001|Overall Study|Lost to Follow-up|4|||
129853844|NCT01459796|467422568|FG000|Overall Study|Reason unspecified|1|||
129853845|NCT01459796|467422569|FG001|Overall Study|Reason unspecified|2|||
129853846|NCT01459796|467422568|FG000|Overall Study|Decision by the sponsor|75|||
129853847|NCT01459796|467422569|FG001|Overall Study|Decision by the sponsor|108|||
129853848|NCT00345579|467422570|FG000|Overall Study|Adverse Event|9|||
129853849|NCT00345579|467422571|FG001|Overall Study|Adverse Event|6|||
129853850|NCT00345579|467422570|FG000|Overall Study|Protocol Violation|14|||
129853851|NCT00345579|467422571|FG001|Overall Study|Protocol Violation|5|||
129853852|NCT00345579|467422570|FG000|Overall Study|Withdrawal by Subject|50|||
129853853|NCT00345579|467422571|FG001|Overall Study|Withdrawal by Subject|17|||
129853854|NCT00345579|467422570|FG000|Overall Study|Lost to Follow-up|82|||
129853855|NCT00345579|467422571|FG001|Overall Study|Lost to Follow-up|36|||
129853856|NCT00345579|467422570|FG000|Overall Study|Other|9|||
129853857|NCT00345579|467422571|FG001|Overall Study|Other|1|||
129853858|NCT00413413|467422572|FG000|Single-Blind|Adverse Event|0|||
129853859|NCT00413413|467422573|FG001|Single-Blind|Adverse Event|9|||
129853860|NCT00413413|467422574|FG002|Single-Blind|Adverse Event|0|||
129853861|NCT00413413|467422572|FG000|Single-Blind|Lack of Efficacy|0|||
129853862|NCT00413413|467422573|FG001|Single-Blind|Lack of Efficacy|5|||
129853863|NCT00413413|467422574|FG002|Single-Blind|Lack of Efficacy|0|||
129853864|NCT00413413|467422572|FG000|Single-Blind|Subject no longer requires study drug|0|||
129853865|NCT00413413|467422573|FG001|Single-Blind|Subject no longer requires study drug|151|||
129853866|NCT00413413|467422574|FG002|Single-Blind|Subject no longer requires study drug|0|||
129853867|NCT00413413|467422572|FG000|Single-Blind|Protocol Violation|0|||
129853868|NCT00413413|467422573|FG001|Single-Blind|Protocol Violation|16|||
129853869|NCT00413413|467422574|FG002|Single-Blind|Protocol Violation|0|||
129853870|NCT00413413|467422572|FG000|Single-Blind|Withdrawal by Subject|0|||
129853871|NCT00413413|467422573|FG001|Single-Blind|Withdrawal by Subject|27|||
129853872|NCT00413413|467422574|FG002|Single-Blind|Withdrawal by Subject|0|||
129853873|NCT00413413|467422572|FG000|Single-Blind|Lost to Follow-up|0|||
129853874|NCT00413413|467422573|FG001|Single-Blind|Lost to Follow-up|8|||
129853875|NCT00413413|467422574|FG002|Single-Blind|Lost to Follow-up|0|||
129853876|NCT00413413|467422572|FG000|Double-Blind|Adverse Event|6|||
129853877|NCT00413413|467422573|FG001|Double-Blind|Adverse Event|0|||
129853878|NCT00413413|467422574|FG002|Double-Blind|Adverse Event|5|||
129853879|NCT00413413|467422572|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
129853880|NCT00413413|467422573|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
129853881|NCT00413413|467422574|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
129853882|NCT00413413|467422572|FG000|Double-Blind|Protocol deviation|1|||
129853883|NCT00413413|467422573|FG001|Double-Blind|Protocol deviation|2|||
129853884|NCT00413413|467422574|FG002|Double-Blind|Protocol deviation|1|||
129853885|NCT00413413|467422572|FG000|Double-Blind|Subject withdrew consent|4|||
129853886|NCT00413413|467422573|FG001|Double-Blind|Subject withdrew consent|6|||
129853887|NCT00413413|467422574|FG002|Double-Blind|Subject withdrew consent|9|||
129853888|NCT00413413|467422572|FG000|Double-Blind|Lost to Follow-up|3|||
129853889|NCT00413413|467422573|FG001|Double-Blind|Lost to Follow-up|4|||
129853890|NCT00413413|467422574|FG002|Double-Blind|Lost to Follow-up|2|||
129853891|NCT03207750|467422575|FG000|Overall Study|Adverse Event|3|||
129907266|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
129853892|NCT03207750|467422576|FG001|Overall Study|Adverse Event|2|||
129853893|NCT03207750|467422575|FG000|Overall Study|Lost to Follow-up|21|||
129853894|NCT03207750|467422576|FG001|Overall Study|Lost to Follow-up|29|||
129853895|NCT03207750|467422575|FG000|Overall Study|Protocol Violation|0|||
129853896|NCT03207750|467422576|FG001|Overall Study|Protocol Violation|1|||
129853897|NCT03207750|467422575|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
129853898|NCT03207750|467422576|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
129853899|NCT03207750|467422575|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
129853900|NCT03207750|467422576|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
129907267|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
129907268|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907269|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907270|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907271|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907272|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
129907273|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907274|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907275|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
129907276|NCT03482011|467622514|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129907277|NCT03482011|467622515|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129907278|NCT03482011|467622516|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
129907279|NCT03482011|467622517|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
129907280|NCT03482011|467622518|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129907281|NCT03482011|467622519|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
129907282|NCT03482011|467622520|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129907283|NCT03482011|467622521|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
129907284|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907285|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907286|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907287|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
129907288|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129907289|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
129907290|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
129907291|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
129907292|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907293|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907294|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907295|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
129853901|NCT03207750|467422575|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
129853902|NCT03207750|467422576|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
129853903|NCT03207750|467422575|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
129853904|NCT03207750|467422576|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
129853905|NCT03207750|467422575|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
129853906|NCT03207750|467422576|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
129853907|NCT03634579|467422581|FG000|Overall Study|study termination|9|||
129853908|NCT04111497|467422589|FG000|Overall Study|relapse of primary disease|1|||
129853909|NCT04111497|467422589|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
129853910|NCT03321019|467422590|FG000|Overall Study|Withdrawal by Subject|0|||
129853911|NCT03321019|467422591|FG001|Overall Study|Withdrawal by Subject|6|||
129853912|NCT03321019|467422590|FG000|Overall Study|Lost to Follow-up|0|||
129853913|NCT03321019|467422591|FG001|Overall Study|Lost to Follow-up|22|||
129853914|NCT01578551|467422594|FG000|Overall Study|Adverse Event|1|||
129853915|NCT01578551|467422595|FG001|Overall Study|Adverse Event|0|||
129853916|NCT00766415|467422596|FG000|Overall Study|Withdrawal by Subject|0|||
129853917|NCT00766415|467422597|FG001|Overall Study|Withdrawal by Subject|1|||
129853918|NCT01312467|467422598|FG000|Overall Study|Adverse Event|4|||
129853919|NCT01312467|467422598|FG000|Overall Study|Lost to Follow-up|1|||
129853920|NCT01312467|467422598|FG000|Overall Study|Withdrawal by Subject|2|||
129853921|NCT01312467|467422598|FG000|Overall Study|Deported to country of origin|1|||
129853922|NCT01312467|467422598|FG000|Overall Study|Another medical condition|1|||
129853923|NCT01312467|467422598|FG000|Overall Study|Ineligible|4|||
129853924|NCT02752048|467422601|FG000|Overall Study|Withdrawal by Subject|0|||
129853925|NCT02752048|467422602|FG001|Overall Study|Withdrawal by Subject|0|||
129853926|NCT02752048|467422603|FG002|Overall Study|Withdrawal by Subject|3|||
129853927|NCT00132769|467422604|FG000|Overall Study|Withdrawal by Subject|1|||
129853928|NCT00132769|467422605|FG001|Overall Study|Withdrawal by Subject|3|||
129853929|NCT00132769|467422604|FG000|Overall Study|Lack of Efficacy|7|||
129853930|NCT00132769|467422605|FG001|Overall Study|Lack of Efficacy|6|||
129853931|NCT00132769|467422604|FG000|Overall Study|Adverse Event|2|||
129853932|NCT00132769|467422605|FG001|Overall Study|Adverse Event|1|||
129853933|NCT00132769|467422604|FG000|Overall Study|Protocol Violation|1|||
129853934|NCT00132769|467422605|FG001|Overall Study|Protocol Violation|1|||
129853935|NCT04452344|467422606|FG000|Overall Study|Withdrawal by Subject|3|||
129907296|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907297|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
129907298|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
129853936|NCT04452344|467422607|FG001|Overall Study|Withdrawal by Subject|6|||
129853937|NCT04452344|467422606|FG000|Overall Study|Adverse Event|1|||
129853938|NCT04452344|467422607|FG001|Overall Study|Adverse Event|2|||
129853939|NCT04452344|467422606|FG000|Overall Study|Lost to Follow-up|2|||
129853940|NCT04452344|467422607|FG001|Overall Study|Lost to Follow-up|2|||
129853941|NCT04452344|467422606|FG000|Overall Study|No Post-Op Visit|6|||
129853942|NCT04452344|467422607|FG001|Overall Study|No Post-Op Visit|7|||
129853943|NCT04095858|467422613|FG000|Overall Study|Death|1|||
129853944|NCT04095858|467422614|FG001|Overall Study|Death|0|||
129853945|NCT04095858|467422613|FG000|Overall Study|Study terminated by Sponsor|2|||
129853946|NCT04095858|467422614|FG001|Overall Study|Study terminated by Sponsor|4|||
129853947|NCT01344460|467422615|FG000|Overall Study|Withdrawal by Subject|1|||
129853948|NCT01344460|467422615|FG000|Overall Study|Lost to Follow-up|2|||
129853949|NCT00560833|467422616|FG000|Overall Study|Adverse Event|16|||
129853950|NCT00560833|467422617|FG001|Overall Study|Adverse Event|10|||
129853951|NCT00560833|467422618|FG002|Overall Study|Adverse Event|25|||
129853952|NCT00560833|467422619|FG003|Overall Study|Adverse Event|23|||
129853953|NCT00560833|467422620|FG004|Overall Study|Adverse Event|35|||
129853954|NCT00560833|467422616|FG000|Overall Study|Lost to Follow-up|0|||
129853955|NCT00560833|467422617|FG001|Overall Study|Lost to Follow-up|0|||
129853956|NCT00560833|467422618|FG002|Overall Study|Lost to Follow-up|1|||
129853957|NCT00560833|467422619|FG003|Overall Study|Lost to Follow-up|0|||
129853958|NCT00560833|467422620|FG004|Overall Study|Lost to Follow-up|0|||
129853959|NCT00560833|467422616|FG000|Overall Study|Lack of Efficacy|22|||
129853960|NCT00560833|467422617|FG001|Overall Study|Lack of Efficacy|9|||
129853961|NCT00560833|467422618|FG002|Overall Study|Lack of Efficacy|6|||
129853962|NCT00560833|467422619|FG003|Overall Study|Lack of Efficacy|4|||
129853963|NCT00560833|467422620|FG004|Overall Study|Lack of Efficacy|4|||
129853964|NCT00560833|467422616|FG000|Overall Study|Participant uncooperative|5|||
129853965|NCT00560833|467422617|FG001|Overall Study|Participant uncooperative|5|||
129853966|NCT00560833|467422618|FG002|Overall Study|Participant uncooperative|4|||
129853967|NCT00560833|467422619|FG003|Overall Study|Participant uncooperative|4|||
129853968|NCT00560833|467422620|FG004|Overall Study|Participant uncooperative|2|||
129853969|NCT00560833|467422616|FG000|Overall Study|Other|1|||
129853970|NCT00560833|467422617|FG001|Overall Study|Other|1|||
129853971|NCT00560833|467422618|FG002|Overall Study|Other|3|||
129853972|NCT00560833|467422619|FG003|Overall Study|Other|0|||
129853973|NCT00560833|467422620|FG004|Overall Study|Other|0|||
129853974|NCT00560833|467422616|FG000|Overall Study|Never received drug|0|||
129853975|NCT00560833|467422617|FG001|Overall Study|Never received drug|1|||
129853976|NCT00560833|467422618|FG002|Overall Study|Never received drug|0|||
129853977|NCT00560833|467422619|FG003|Overall Study|Never received drug|0|||
129853978|NCT00560833|467422620|FG004|Overall Study|Never received drug|1|||
129853979|NCT00898677|467422623|FG000|Overall Study|Adverse Event|0|||
129853980|NCT00898677|467422624|FG001|Overall Study|Adverse Event|0|||
129853981|NCT00898677|467422625|FG002|Overall Study|Adverse Event|1|||
129853982|NCT00898677|467422626|FG003|Overall Study|Adverse Event|0|||
129853983|NCT00898677|467422623|FG000|Overall Study|Lost to Follow-up|0|||
129853984|NCT00898677|467422624|FG001|Overall Study|Lost to Follow-up|0|||
129853985|NCT00898677|467422625|FG002|Overall Study|Lost to Follow-up|2|||
129853986|NCT00898677|467422626|FG003|Overall Study|Lost to Follow-up|0|||
129853987|NCT00898677|467422623|FG000|Overall Study|Protocol Violation|1|||
129853988|NCT00898677|467422624|FG001|Overall Study|Protocol Violation|1|||
129853989|NCT00898677|467422625|FG002|Overall Study|Protocol Violation|2|||
129853990|NCT00898677|467422626|FG003|Overall Study|Protocol Violation|0|||
129853991|NCT00898677|467422623|FG000|Overall Study|Withdrawal by Subject|0|||
129853992|NCT00898677|467422624|FG001|Overall Study|Withdrawal by Subject|0|||
129853993|NCT00898677|467422625|FG002|Overall Study|Withdrawal by Subject|0|||
129853994|NCT00898677|467422626|FG003|Overall Study|Withdrawal by Subject|1|||
129853995|NCT00898677|467422623|FG000|Overall Study|Not Treated: Adverse Event|0|||
129853996|NCT00898677|467422624|FG001|Overall Study|Not Treated: Adverse Event|2|||
129853997|NCT00898677|467422625|FG002|Overall Study|Not Treated: Adverse Event|1|||
129853998|NCT00898677|467422626|FG003|Overall Study|Not Treated: Adverse Event|0|||
129853999|NCT00898677|467422623|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
129854000|NCT00898677|467422624|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
129854001|NCT00898677|467422625|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
129854002|NCT00898677|467422626|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
129854003|NCT00898677|467422623|FG000|Overall Study|Not Treated: Pregnancy|0|||
129854004|NCT00898677|467422624|FG001|Overall Study|Not Treated: Pregnancy|0|||
129854005|NCT00898677|467422625|FG002|Overall Study|Not Treated: Pregnancy|1|||
129854006|NCT00898677|467422626|FG003|Overall Study|Not Treated: Pregnancy|0|||
129854007|NCT00898677|467422623|FG000|Overall Study|Not Treated: Protocol Violation|2|||
129449664|NCT00467779|465945633|FG010|Stage 3|Unspecified Reason|0|||
129854008|NCT00898677|467422624|FG001|Overall Study|Not Treated: Protocol Violation|0|||
129854009|NCT00898677|467422625|FG002|Overall Study|Not Treated: Protocol Violation|2|||
129854010|NCT00898677|467422626|FG003|Overall Study|Not Treated: Protocol Violation|0|||
129854011|NCT00898677|467422623|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
129854012|NCT00898677|467422624|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
129854013|NCT00898677|467422625|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
129854014|NCT00898677|467422626|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
129854015|NCT00898677|467422623|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
129449665|NCT00467779|465945634|FG011|Stage 3|Unspecified Reason|0|||
129854016|NCT00898677|467422624|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
129854017|NCT00898677|467422625|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
129854018|NCT00898677|467422626|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
129854019|NCT00898677|467422623|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
129854020|NCT00898677|467422624|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
129854021|NCT00898677|467422625|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
129854022|NCT00898677|467422626|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
129854023|NCT00898677|467422623|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
129854024|NCT00898677|467422624|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
129854025|NCT00898677|467422625|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
129854026|NCT00898677|467422626|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
129854027|NCT00898677|467422623|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
129854028|NCT00898677|467422624|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
129854029|NCT00898677|467422625|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
129854030|NCT00898677|467422626|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
129854031|NCT00898677|467422623|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
129854032|NCT00898677|467422624|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
129854033|NCT00898677|467422625|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
129854034|NCT00898677|467422626|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
129854035|NCT00898677|467422623|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
129854036|NCT00898677|467422624|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
129854037|NCT00898677|467422625|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
129854038|NCT00898677|467422626|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
129854039|NCT02199691|467422627|FG000|Overall Study|Protocol Violation|3|||
129854040|NCT02199691|467422628|FG001|Overall Study|Protocol Violation|3|||
129854041|NCT02199691|467422629|FG002|Overall Study|Protocol Violation|6|||
129854042|NCT02199691|467422630|FG003|Overall Study|Protocol Violation|7|||
129854043|NCT02199691|467422627|FG000|Overall Study|Withdrawal by Subject|5|||
129854044|NCT02199691|467422628|FG001|Overall Study|Withdrawal by Subject|3|||
129854045|NCT02199691|467422629|FG002|Overall Study|Withdrawal by Subject|12|||
129854046|NCT02199691|467422630|FG003|Overall Study|Withdrawal by Subject|13|||
129854047|NCT02199691|467422627|FG000|Overall Study|Lost to Follow-up|2|||
129854048|NCT02199691|467422628|FG001|Overall Study|Lost to Follow-up|1|||
129854049|NCT02199691|467422629|FG002|Overall Study|Lost to Follow-up|9|||
129854050|NCT02199691|467422630|FG003|Overall Study|Lost to Follow-up|10|||
129854051|NCT00836875|467422633|FG000|Overall Study|Death|3|||
129854052|NCT00836875|467422634|FG001|Overall Study|Death|2|||
129854053|NCT00836875|467422633|FG000|Overall Study|Withdrawal by Subject|0|||
129854054|NCT00836875|467422634|FG001|Overall Study|Withdrawal by Subject|1|||
129854055|NCT03823651|467422636|FG000|Overall Study|Death|5|||
129854056|NCT03823651|467422637|FG001|Overall Study|Death|0|||
129854057|NCT03823651|467422636|FG000|Overall Study|Physician Decision|1|||
129854058|NCT03823651|467422637|FG001|Overall Study|Physician Decision|0|||
129854059|NCT03823651|467422636|FG000|Overall Study|Caregiver to patient who died|0|||
129854060|NCT03823651|467422637|FG001|Overall Study|Caregiver to patient who died|5|||
129854061|NCT03823651|467422636|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
129854062|NCT03823651|467422637|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
129854063|NCT00428610|467422638|FG000|Overall Study|Death Due to Adverse Event|3|||
129854064|NCT00428610|467422639|FG001|Overall Study|Death Due to Adverse Event|0|||
129854065|NCT00428610|467422640|FG002|Overall Study|Death Due to Adverse Event|5|||
129854066|NCT00428610|467422638|FG000|Overall Study|Death Due to Progressive Disease|0|||
129854067|NCT00428610|467422639|FG001|Overall Study|Death Due to Progressive Disease|0|||
129854068|NCT00428610|467422640|FG002|Overall Study|Death Due to Progressive Disease|2|||
129854069|NCT00428610|467422638|FG000|Overall Study|Adverse Event|2|||
129854070|NCT00428610|467422639|FG001|Overall Study|Adverse Event|3|||
129854071|NCT00428610|467422640|FG002|Overall Study|Adverse Event|2|||
129854072|NCT00428610|467422638|FG000|Overall Study|Investigator Decision|2|||
129854073|NCT00428610|467422639|FG001|Overall Study|Investigator Decision|1|||
129854074|NCT00428610|467422640|FG002|Overall Study|Investigator Decision|1|||
129854075|NCT00428610|467422638|FG000|Overall Study|Progressive Disease|42|||
129854076|NCT00428610|467422639|FG001|Overall Study|Progressive Disease|14|||
129854077|NCT00428610|467422640|FG002|Overall Study|Progressive Disease|22|||
129854078|NCT00428610|467422638|FG000|Overall Study|Withdrawal by Subject|4|||
129449666|NCT00467779|465945635|FG012|Stage 3|Unspecified Reason|0|||
129854079|NCT00428610|467422639|FG001|Overall Study|Withdrawal by Subject|0|||
129854080|NCT00428610|467422640|FG002|Overall Study|Withdrawal by Subject|0|||
129854081|NCT05350449|467422641|FG000|Overall Study|Withdrawal by Subject|4|||
129854082|NCT05350449|467422642|FG001|Overall Study|Withdrawal by Subject|8|||
129854083|NCT02239510|467424797|FG000|Overall Study|Lost to Follow-up|2|||
129854084|NCT02239510|467424798|FG001|Overall Study|Lost to Follow-up|1|||
129854085|NCT03859323|467424801|FG000|Overall Study|Lost to Follow-up|0|||
129854086|NCT03859323|467424802|FG001|Overall Study|Lost to Follow-up|0|||
129854087|NCT03859323|467424803|FG002|Overall Study|Lost to Follow-up|0|||
129854088|NCT03859323|467424804|FG003|Overall Study|Lost to Follow-up|0|||
129854089|NCT03859323|467424805|FG004|Overall Study|Lost to Follow-up|0|||
129854090|NCT03859323|467424806|FG005|Overall Study|Lost to Follow-up|0|||
129907299|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
129907300|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907301|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907302|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
129907303|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
129907304|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907305|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907306|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
129907307|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
129907308|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907309|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907310|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907311|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907312|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907313|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907314|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
129907315|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
129907316|NCT03482011|467622514|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907317|NCT03482011|467622515|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907318|NCT03482011|467622516|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907319|NCT03482011|467622517|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907320|NCT03482011|467622518|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907321|NCT03482011|467622519|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907322|NCT03482011|467622520|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129907323|NCT03482011|467622521|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
129907324|NCT01595061|467622525|FG000|Overall Study|Never Treated|3|||
129907325|NCT01595061|467622525|FG000|Overall Study|Inadequate Pathology|1|||
129907326|NCT00529789|467622526|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
129907327|NCT00529789|467622526|FG000|Study Period II/III|Adverse Event|3|||
129907328|NCT00529789|467622526|FG000|Study Period II/III|Lack of Efficacy|2|||
129907329|NCT00529789|467622526|FG000|Study Period II/III|Withdrawal by Subject|1|||
129907330|NCT00529789|467622526|FG000|Study Period II/III|Protocol Violation|3|||
129907331|NCT00529789|467622526|FG000|Study Period II/III|Physician Decision|3|||
129907332|NCT00529789|467622526|FG000|Study Period II/III|Lost to Follow-up|3|||
129907333|NCT00529789|467622526|FG000|Study Period IV|Parent/Caregiver Decision|1|||
129907334|NCT00529789|467622526|FG000|Study Period IV|Adverse Event|1|||
129907335|NCT00529789|467622526|FG000|Study Period IV|Lack of Efficacy|1|||
129907336|NCT00529789|467622526|FG000|Study Period IV|Lost to Follow-up|3|||
129907337|NCT01430611|467622527|FG000|Overall Study|Adverse Event|0|||
129907338|NCT01430611|467622528|FG001|Overall Study|Adverse Event|1|||
129907339|NCT01430611|467622527|FG000|Overall Study|Protocol Violation|1|||
129907340|NCT01430611|467622528|FG001|Overall Study|Protocol Violation|0|||
129907341|NCT01430611|467622527|FG000|Overall Study|Lost to Follow-up|1|||
129907342|NCT01430611|467622528|FG001|Overall Study|Lost to Follow-up|0|||
129907343|NCT01430611|467622527|FG000|Overall Study|Withdrawal by Subject|15|||
129907344|NCT01430611|467622528|FG001|Overall Study|Withdrawal by Subject|14|||
129907345|NCT00960141|467622529|FG000|Overall Study|Adverse Event|4|||
129907346|NCT00960141|467622530|FG001|Overall Study|Adverse Event|8|||
129907347|NCT00960141|467622531|FG002|Overall Study|Adverse Event|2|||
129907348|NCT00960141|467622529|FG000|Overall Study|Lack of Efficacy|3|||
129907349|NCT00960141|467622530|FG001|Overall Study|Lack of Efficacy|4|||
129907350|NCT00960141|467622531|FG002|Overall Study|Lack of Efficacy|2|||
129907351|NCT00960141|467622529|FG000|Overall Study|Lost to Follow-up|1|||
129907352|NCT00960141|467622530|FG001|Overall Study|Lost to Follow-up|0|||
129907353|NCT00960141|467622531|FG002|Overall Study|Lost to Follow-up|0|||
129907354|NCT00960141|467622529|FG000|Overall Study|Protocol Violation|1|||
129907355|NCT00960141|467622530|FG001|Overall Study|Protocol Violation|3|||
129907356|NCT00960141|467622531|FG002|Overall Study|Protocol Violation|2|||
129907357|NCT00960141|467622529|FG000|Overall Study|Withdrawal by Subject|1|||
129907358|NCT00960141|467622530|FG001|Overall Study|Withdrawal by Subject|2|||
129907359|NCT00960141|467622531|FG002|Overall Study|Withdrawal by Subject|1|||
129907360|NCT02538107|467622532|FG000|Overall Study|Did not receive any Mircera dose|11|||
129907361|NCT02538107|467622532|FG000|Overall Study|Missing|5|||
129907362|NCT02538107|467622532|FG000|Overall Study|Necessity of dialysis|20|||
129907363|NCT02538107|467622532|FG000|Overall Study|Administration of other ESA|11|||
129907364|NCT02538107|467622532|FG000|Overall Study|No further treatment necessary|18|||
129907365|NCT02538107|467622532|FG000|Overall Study|Withdrawal by Subject|17|||
129907366|NCT02538107|467622532|FG000|Overall Study|Death|4|||
129907367|NCT02538107|467622532|FG000|Overall Study|Administrative reason|5|||
129907368|NCT02538107|467622532|FG000|Overall Study|Adverse Event|4|||
129907369|NCT02538107|467622532|FG000|Overall Study|Surgery|1|||
129907370|NCT02538107|467622532|FG000|Overall Study|Other|7|||
129907371|NCT02538107|467622532|FG000|Overall Study|Not recorded|7|||
129907372|NCT01576484|467622533|FG000|Overall Study|Adverse Event|1|||
129907373|NCT01576484|467622534|FG001|Overall Study|Adverse Event|1|||
129907374|NCT01576484|467622533|FG000|Overall Study|Protocol Violation|0|||
129854091|NCT03859323|467424807|FG006|Overall Study|Lost to Follow-up|1|||
129854092|NCT03859323|467424808|FG007|Overall Study|Lost to Follow-up|0|||
129854093|NCT03859323|467424809|FG008|Overall Study|Lost to Follow-up|0|||
129854094|NCT03859323|467424810|FG009|Overall Study|Lost to Follow-up|0|||
129854095|NCT03859323|467424811|FG010|Overall Study|Lost to Follow-up|0|||
129854096|NCT03859323|467424812|FG011|Overall Study|Lost to Follow-up|0|||
129854097|NCT03859323|467424813|FG012|Overall Study|Lost to Follow-up|0|||
129854098|NCT03859323|467424801|FG000|Overall Study|Withdrawal by Subject|0|||
129854099|NCT03859323|467424802|FG001|Overall Study|Withdrawal by Subject|0|||
129854100|NCT03859323|467424803|FG002|Overall Study|Withdrawal by Subject|1|||
129854101|NCT03859323|467424804|FG003|Overall Study|Withdrawal by Subject|0|||
129854102|NCT03859323|467424805|FG004|Overall Study|Withdrawal by Subject|0|||
129854103|NCT03859323|467424806|FG005|Overall Study|Withdrawal by Subject|1|||
129854104|NCT03859323|467424807|FG006|Overall Study|Withdrawal by Subject|0|||
129854105|NCT03859323|467424808|FG007|Overall Study|Withdrawal by Subject|0|||
129854106|NCT03859323|467424809|FG008|Overall Study|Withdrawal by Subject|0|||
129854107|NCT03859323|467424810|FG009|Overall Study|Withdrawal by Subject|1|||
129854108|NCT03859323|467424811|FG010|Overall Study|Withdrawal by Subject|1|||
129854109|NCT03859323|467424812|FG011|Overall Study|Withdrawal by Subject|2|||
129854110|NCT03859323|467424813|FG012|Overall Study|Withdrawal by Subject|1|||
129854111|NCT03859323|467424801|FG000|Overall Study|Pregnancy|0|||
129854112|NCT03859323|467424802|FG001|Overall Study|Pregnancy|0|||
129854113|NCT03859323|467424803|FG002|Overall Study|Pregnancy|0|||
129854114|NCT03859323|467424804|FG003|Overall Study|Pregnancy|0|||
129854115|NCT03859323|467424805|FG004|Overall Study|Pregnancy|0|||
129854116|NCT03859323|467424806|FG005|Overall Study|Pregnancy|0|||
129854117|NCT03859323|467424807|FG006|Overall Study|Pregnancy|0|||
129854118|NCT03859323|467424808|FG007|Overall Study|Pregnancy|0|||
129854119|NCT03859323|467424809|FG008|Overall Study|Pregnancy|0|||
129854120|NCT03859323|467424810|FG009|Overall Study|Pregnancy|1|||
129854121|NCT03859323|467424811|FG010|Overall Study|Pregnancy|0|||
129854122|NCT03859323|467424812|FG011|Overall Study|Pregnancy|0|||
129854123|NCT03859323|467424813|FG012|Overall Study|Pregnancy|0|||
129854124|NCT03794089|467424816|FG000|Overall Study|Lost to Follow-up|4|||
129854125|NCT03794089|467424817|FG001|Overall Study|Lost to Follow-up|1|||
129854126|NCT03794089|467424816|FG000|Overall Study|Withdrawal by Subject|2|||
129854127|NCT03794089|467424817|FG001|Overall Study|Withdrawal by Subject|0|||
129854128|NCT03985423|467424818|FG000|Overall Study|Adverse Event|1|||
129854129|NCT03985423|467424818|FG000|Overall Study|Death|2|||
129854130|NCT03985423|467424818|FG000|Overall Study|Physician Decision|1|||
129854131|NCT03985423|467424818|FG000|Overall Study|Withdrawal by Subject|2|||
129854132|NCT03985423|467424818|FG000|Overall Study|Lack of insurance and citizenship|1|||
129854133|NCT01045447|467424827|FG000|Overall Study|Adverse Event|0|||
129854134|NCT01045447|467424828|FG001|Overall Study|Adverse Event|1|||
129854135|NCT01045447|467424827|FG000|Overall Study|Lack of Efficacy|3|||
129854136|NCT01045447|467424828|FG001|Overall Study|Lack of Efficacy|1|||
129854137|NCT01045447|467424827|FG000|Overall Study|Protocol Violation|6|||
129854138|NCT01045447|467424828|FG001|Overall Study|Protocol Violation|3|||
129854139|NCT01045447|467424827|FG000|Overall Study|Withdrawal Criteria|10|||
129854140|NCT01045447|467424828|FG001|Overall Study|Withdrawal Criteria|10|||
129854141|NCT01045447|467424827|FG000|Overall Study|Unclassified|17|||
129854142|NCT01045447|467424828|FG001|Overall Study|Unclassified|13|||
129854143|NCT00129987|467424830|FG000|1st Educational Session|Withdrawal by Subject|141|||
129854144|NCT00129987|467424831|FG001|1st Educational Session|Withdrawal by Subject|109|||
129854145|NCT00129987|467424830|FG000|1 Year|Withdrawal by Subject|32|||
129854146|NCT00129987|467424831|FG001|1 Year|Withdrawal by Subject|21|||
129854147|NCT00116805|467424835|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
129854148|NCT00116805|467424836|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
129854149|NCT00116805|467424835|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
129854150|NCT00116805|467424836|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
129854151|NCT00116805|467424835|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
129854152|NCT00116805|467424836|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
129854153|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
129854154|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
129854155|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
129854156|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
129854157|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
129854158|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
129854159|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
129854160|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
129854161|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
129854162|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
129854163|NCT00116805|467424835|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
129854164|NCT00116805|467424836|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
129854165|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
129907375|NCT01576484|467622534|FG001|Overall Study|Protocol Violation|2|||
129854166|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
129854167|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
129854168|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
129854169|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
129854170|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
129854171|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
129854172|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
129854173|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
129854174|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
129854175|NCT00116805|467424835|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
129854176|NCT00116805|467424836|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
129854177|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
129854178|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
129854179|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
129854180|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
129854181|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
129854182|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
129854183|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
129854184|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
129854185|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
129854186|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
129854187|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
129854188|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
129854189|NCT00116805|467424835|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
129854190|NCT00116805|467424836|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
129854191|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
129854192|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
129854193|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
129854194|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
129854195|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
129854196|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
129854197|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
129854198|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
129854199|NCT00116805|467424835|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
129854200|NCT00116805|467424836|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
129854201|NCT00116805|467424835|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
129854202|NCT00116805|467424836|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
129854203|NCT00116805|467424835|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
129854204|NCT00116805|467424836|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
129854205|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
129854206|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
129854207|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
129854208|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
129854209|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
129854210|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
129854211|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
129854212|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
129854213|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
129854214|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
129854215|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
129854216|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
129854217|NCT00116805|467424835|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
129854218|NCT00116805|467424836|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
129854219|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
129854220|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
129854221|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
129854222|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
129854223|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
129854224|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
129854225|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
129854226|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
129854227|NCT00116805|467424835|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
129854228|NCT00116805|467424836|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
129907376|NCT01576484|467622533|FG000|Overall Study|Sponsor Decision|2|||
129907377|NCT01576484|467622534|FG001|Overall Study|Sponsor Decision|8|||
129907378|NCT01576484|467622533|FG000|Overall Study|Withdrawal by Subject|0|||
129907379|NCT01576484|467622534|FG001|Overall Study|Withdrawal by Subject|3|||
129907380|NCT01576484|467622533|FG000|Overall Study|Other|2|||
129907381|NCT01576484|467622534|FG001|Overall Study|Other|5|||
129907382|NCT01792830|467622538|FG000|Overall Study|Withdrawal by Subject|22|||
129907383|NCT01792830|467622539|FG001|Overall Study|Withdrawal by Subject|0|||
129907384|NCT01792830|467622540|FG002|Overall Study|Withdrawal by Subject|0|||
129907385|NCT01792830|467622541|FG003|Overall Study|Withdrawal by Subject|2|||
129907386|NCT01792830|467622542|FG004|Overall Study|Withdrawal by Subject|1|||
129907387|NCT01792830|467622543|FG005|Overall Study|Withdrawal by Subject|1|||
129907388|NCT01792830|467622544|FG006|Overall Study|Withdrawal by Subject|1|||
129907389|NCT01792830|467622545|FG007|Overall Study|Withdrawal by Subject|1|||
129907390|NCT01792830|467622546|FG008|Overall Study|Withdrawal by Subject|7|||
129907391|NCT01792830|467622547|FG009|Overall Study|Withdrawal by Subject|0|||
129907392|NCT01792830|467622548|FG010|Overall Study|Withdrawal by Subject|2|||
129907393|NCT01792830|467622538|FG000|Overall Study|Death|3|||
129907394|NCT01792830|467622539|FG001|Overall Study|Death|0|||
129907395|NCT01792830|467622540|FG002|Overall Study|Death|0|||
129907396|NCT01792830|467622541|FG003|Overall Study|Death|1|||
129907397|NCT01792830|467622542|FG004|Overall Study|Death|0|||
129907398|NCT01792830|467622543|FG005|Overall Study|Death|0|||
129907399|NCT01792830|467622544|FG006|Overall Study|Death|1|||
129907400|NCT01792830|467622545|FG007|Overall Study|Death|0|||
129907401|NCT01792830|467622546|FG008|Overall Study|Death|1|||
129907402|NCT01792830|467622547|FG009|Overall Study|Death|0|||
129907403|NCT01792830|467622548|FG010|Overall Study|Death|1|||
129907404|NCT01792830|467622538|FG000|Overall Study|Adverse Event|0|||
129907405|NCT01792830|467622539|FG001|Overall Study|Adverse Event|0|||
129907406|NCT01792830|467622540|FG002|Overall Study|Adverse Event|0|||
129907407|NCT01792830|467622541|FG003|Overall Study|Adverse Event|0|||
129907408|NCT01792830|467622542|FG004|Overall Study|Adverse Event|0|||
129907409|NCT01792830|467622543|FG005|Overall Study|Adverse Event|0|||
129907410|NCT01792830|467622544|FG006|Overall Study|Adverse Event|0|||
129907411|NCT01792830|467622545|FG007|Overall Study|Adverse Event|0|||
129907412|NCT01792830|467622546|FG008|Overall Study|Adverse Event|1|||
129907413|NCT01792830|467622547|FG009|Overall Study|Adverse Event|0|||
129907414|NCT01792830|467622548|FG010|Overall Study|Adverse Event|0|||
129907415|NCT01943799|467622564|FG000|Overall Study|Lost to Follow-up|0|||
129907416|NCT01943799|467622565|FG001|Overall Study|Lost to Follow-up|1|||
129907417|NCT01943799|467622566|FG002|Overall Study|Lost to Follow-up|1|||
129907418|NCT01943799|467622567|FG003|Overall Study|Lost to Follow-up|0|||
129907419|NCT01943799|467622564|FG000|Overall Study|Protocol Violation|1|||
129907420|NCT01943799|467622565|FG001|Overall Study|Protocol Violation|0|||
129907421|NCT01943799|467622566|FG002|Overall Study|Protocol Violation|0|||
129907422|NCT01943799|467622567|FG003|Overall Study|Protocol Violation|0|||
129907423|NCT01943799|467622564|FG000|Overall Study|Withdrawal by Subject|4|||
129907424|NCT01943799|467622565|FG001|Overall Study|Withdrawal by Subject|2|||
129907425|NCT01943799|467622566|FG002|Overall Study|Withdrawal by Subject|1|||
129907426|NCT01943799|467622567|FG003|Overall Study|Withdrawal by Subject|0|||
129907427|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
129907428|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
129907429|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
129907430|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
129907431|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
129907432|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
129907433|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
129907434|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
129907435|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
129907436|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
129907437|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
129907438|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
129907439|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
129907440|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
129907441|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
129907442|NCT00958633|467622572|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
129907443|NCT00958633|467622573|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
129907444|NCT00958633|467622574|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
129907445|NCT00958633|467622572|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
129907446|NCT00958633|467622573|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
129449667|NCT00467779|465945636|FG013|Stage 3|Unspecified Reason|0|||
129907447|NCT00958633|467622574|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
129907448|NCT03144674|467622583|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
129907449|NCT03144674|467622584|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
129907450|NCT03144674|467622585|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
129907451|NCT03144674|467622586|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
129907452|NCT03144674|467622583|FG000|Overall Study|Death|3|||
129907453|NCT03144674|467622584|FG001|Overall Study|Death|2|||
129907454|NCT03144674|467622585|FG002|Overall Study|Death|6|||
129907455|NCT03144674|467622586|FG003|Overall Study|Death|24|||
129907456|NCT03144674|467622583|FG000|Overall Study|Lost to Follow-up|0|||
129907457|NCT03144674|467622584|FG001|Overall Study|Lost to Follow-up|1|||
129907458|NCT03144674|467622585|FG002|Overall Study|Lost to Follow-up|0|||
129907459|NCT03144674|467622586|FG003|Overall Study|Lost to Follow-up|4|||
129907460|NCT03144674|467622583|FG000|Overall Study|Withdrawal by Participant|0|||
129907461|NCT03144674|467622584|FG001|Overall Study|Withdrawal by Participant|0|||
129907462|NCT03144674|467622585|FG002|Overall Study|Withdrawal by Participant|2|||
129907463|NCT03144674|467622586|FG003|Overall Study|Withdrawal by Participant|6|||
129907464|NCT03144674|467622583|FG000|Overall Study|Discharged from the Trust|0|||
129907465|NCT03144674|467622584|FG001|Overall Study|Discharged from the Trust|0|||
129907466|NCT03144674|467622585|FG002|Overall Study|Discharged from the Trust|1|||
129907467|NCT03144674|467622586|FG003|Overall Study|Discharged from the Trust|0|||
129907468|NCT03144674|467622583|FG000|Overall Study|Exclusion Criteria Met|0|||
129907469|NCT03144674|467622584|FG001|Overall Study|Exclusion Criteria Met|0|||
129907470|NCT03144674|467622585|FG002|Overall Study|Exclusion Criteria Met|1|||
129907471|NCT03144674|467622586|FG003|Overall Study|Exclusion Criteria Met|0|||
129907472|NCT03144674|467622583|FG000|Overall Study|Changed Physicians|0|||
129907473|NCT03144674|467622584|FG001|Overall Study|Changed Physicians|0|||
129907474|NCT03144674|467622585|FG002|Overall Study|Changed Physicians|0|||
129907475|NCT03144674|467622586|FG003|Overall Study|Changed Physicians|1|||
129907476|NCT03144674|467622583|FG000|Overall Study|Removed for Safety|0|||
129907477|NCT03144674|467622584|FG001|Overall Study|Removed for Safety|0|||
129907478|NCT03144674|467622585|FG002|Overall Study|Removed for Safety|0|||
129907479|NCT03144674|467622586|FG003|Overall Study|Removed for Safety|1|||
129907480|NCT03144674|467622583|FG000|Overall Study|Site Closed|0|||
129907481|NCT03144674|467622584|FG001|Overall Study|Site Closed|0|||
129907482|NCT03144674|467622585|FG002|Overall Study|Site Closed|0|||
129907483|NCT03144674|467622586|FG003|Overall Study|Site Closed|1|||
129907484|NCT03144674|467622583|FG000|Overall Study|Histological Criteria Not Met|0|||
129907485|NCT03144674|467622584|FG001|Overall Study|Histological Criteria Not Met|0|||
129907486|NCT03144674|467622585|FG002|Overall Study|Histological Criteria Not Met|0|||
129907487|NCT03144674|467622586|FG003|Overall Study|Histological Criteria Not Met|1|||
129907488|NCT03144674|467622583|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
129907489|NCT03144674|467622584|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
129907490|NCT03144674|467622585|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
129907491|NCT03144674|467622586|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
129907492|NCT03144674|467622583|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
129907493|NCT03144674|467622584|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
129907494|NCT03144674|467622585|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
129907495|NCT03144674|467622586|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
129907496|NCT01373346|467622590|FG000|Overall Study|Death|1|||
129907497|NCT01198028|467622592|FG000|Overall Study|Adverse Event|5|||
129907498|NCT01198028|467622592|FG000|Overall Study|Death|3|||
129907499|NCT01198028|467622592|FG000|Overall Study|Physician Decision|2|||
129907500|NCT01395758|467622593|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
129907501|NCT01395758|467622594|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129907502|NCT01395758|467622595|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129907503|NCT00433199|467622596|FG000|Double-Blind Period|Adverse Event|0|||
129907504|NCT00433199|467622597|FG001|Double-Blind Period|Adverse Event|25|||
129907505|NCT00433199|467622596|FG000|Double-Blind Period|Lack of Efficacy|0|||
129907506|NCT00433199|467622597|FG001|Double-Blind Period|Lack of Efficacy|2|||
129907507|NCT00433199|467622596|FG000|Double-Blind Period|Lost to Follow-up|2|||
129907508|NCT00433199|467622597|FG001|Double-Blind Period|Lost to Follow-up|5|||
129907509|NCT00433199|467622596|FG000|Double-Blind Period|Withdrawal by Subject|8|||
129907510|NCT00433199|467622597|FG001|Double-Blind Period|Withdrawal by Subject|19|||
129907511|NCT00433199|467622596|FG000|Double-Blind Period|Protocol Violation|1|||
129907512|NCT00433199|467622597|FG001|Double-Blind Period|Protocol Violation|10|||
129907513|NCT00433199|467622596|FG000|Double-Blind Period|Administrative|1|||
129907514|NCT00433199|467622597|FG001|Double-Blind Period|Administrative|5|||
129907515|NCT00433199|467622596|FG000|Open-Label Period|Adverse Event|0|||
129907516|NCT00433199|467622597|FG001|Open-Label Period|Adverse Event|19|||
129907517|NCT00433199|467622596|FG000|Open-Label Period|Lack of Efficacy|0|||
129907518|NCT00433199|467622597|FG001|Open-Label Period|Lack of Efficacy|2|||
129907519|NCT00433199|467622596|FG000|Open-Label Period|Lost to Follow-up|0|||
129907520|NCT00433199|467622597|FG001|Open-Label Period|Lost to Follow-up|3|||
129907521|NCT00433199|467622596|FG000|Open-Label Period|Withdrawal by Subject|0|||
129907522|NCT00433199|467622597|FG001|Open-Label Period|Withdrawal by Subject|7|||
129907523|NCT00433199|467622596|FG000|Open-Label Period|Protocol Violation|0|||
129907524|NCT00433199|467622597|FG001|Open-Label Period|Protocol Violation|2|||
129907525|NCT00433199|467622596|FG000|Open-Label Period|Administrative|0|||
129907526|NCT00433199|467622597|FG001|Open-Label Period|Administrative|1|||
129907527|NCT00357097|467622600|FG000|Overall Study|Did not meet inclusion criteria|5|||
129907528|NCT00357097|467622601|FG001|Overall Study|Did not meet inclusion criteria|3|||
129907529|NCT00357097|467622600|FG000|Overall Study|Adverse Event|34|||
129907530|NCT00357097|467622601|FG001|Overall Study|Adverse Event|6|||
129907531|NCT00357097|467622600|FG000|Overall Study|Withdrawal by Subject|8|||
129907532|NCT00357097|467622601|FG001|Overall Study|Withdrawal by Subject|7|||
129907533|NCT00357097|467622600|FG000|Overall Study|Non-compliance|1|||
129907534|NCT00357097|467622601|FG001|Overall Study|Non-compliance|2|||
129907535|NCT00357097|467622600|FG000|Overall Study|Lack of Efficacy|2|||
129907536|NCT00357097|467622601|FG001|Overall Study|Lack of Efficacy|8|||
129907537|NCT00357097|467622600|FG000|Overall Study|Met Exclusion Criteria|3|||
129907538|NCT00357097|467622601|FG001|Overall Study|Met Exclusion Criteria|1|||
129907539|NCT00357097|467622600|FG000|Overall Study|Other|1|||
129907540|NCT00357097|467622601|FG001|Overall Study|Other|1|||
129907541|NCT00357097|467622600|FG000|Overall Study|Increase of RLS Symptoms|0|||
129907542|NCT00357097|467622601|FG001|Overall Study|Increase of RLS Symptoms|1|||
129907543|NCT00794118|467622602|FG000|Overall Study|Lost to Follow-up|16|||
129907544|NCT00794118|467622602|FG000|Overall Study|Withdrawal by Subject|9|||
129907545|NCT00794118|467622602|FG000|Overall Study|Changed hospital center|2|||
129907546|NCT04305405|467622603|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129907547|NCT04305405|467622604|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129907548|NCT03887650|467622606|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
129907549|NCT03887650|467622607|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
129907550|NCT03887650|467622606|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
129907551|NCT03887650|467622607|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
129907552|NCT03887650|467622606|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
129907553|NCT03887650|467622607|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
129907554|NCT01170962|467622608|FG000|Treatment Period|Lack of Efficacy|96|||
129907555|NCT01170962|467622609|FG001|Treatment Period|Lack of Efficacy|91|||
129907556|NCT01170962|467622610|FG002|Treatment Period|Lack of Efficacy|7|||
129907557|NCT01170962|467622608|FG000|Treatment Period|Adverse Event|11|||
129907558|NCT01170962|467622609|FG001|Treatment Period|Adverse Event|12|||
129907559|NCT01170962|467622610|FG002|Treatment Period|Adverse Event|3|||
129907560|NCT01170962|467622608|FG000|Treatment Period|Withdrawal by Subject|2|||
129907561|NCT01170962|467622609|FG001|Treatment Period|Withdrawal by Subject|1|||
129907562|NCT01170962|467622610|FG002|Treatment Period|Withdrawal by Subject|0|||
129907563|NCT01170962|467622608|FG000|Treatment Period|Lost to Follow-up|1|||
129907564|NCT01170962|467622609|FG001|Treatment Period|Lost to Follow-up|1|||
129907565|NCT01170962|467622610|FG002|Treatment Period|Lost to Follow-up|1|||
129907566|NCT01170962|467622608|FG000|Treatment Period|Participant no longer meets criteria|0|||
129907567|NCT01170962|467622609|FG001|Treatment Period|Participant no longer meets criteria|1|||
129907568|NCT01170962|467622610|FG002|Treatment Period|Participant no longer meets criteria|0|||
129907569|NCT01170962|467622608|FG000|Treatment Period|Request to discontinue treatment|7|||
129907570|NCT01170962|467622609|FG001|Treatment Period|Request to discontinue treatment|3|||
129907571|NCT01170962|467622610|FG002|Treatment Period|Request to discontinue treatment|1|||
129907572|NCT01170962|467622608|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
129907573|NCT01170962|467622609|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
129907574|NCT01170962|467622610|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
129907575|NCT01170962|467622608|FG000|Follow up Period|Withdrawal by Subject|14|||
129907576|NCT01170962|467622609|FG001|Follow up Period|Withdrawal by Subject|10|||
129854229|NCT00116805|467424835|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
129854230|NCT00116805|467424836|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
129854231|NCT00116805|467424835|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
129854232|NCT00116805|467424836|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
129854233|NCT00116805|467424835|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
129854234|NCT00116805|467424836|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
129854235|NCT00116805|467424835|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
129854236|NCT00116805|467424836|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
129854237|NCT01782131|467424837|FG000|Overall Study|Death|93|||
129854238|NCT01782131|467424838|FG001|Overall Study|Death|96|||
129854239|NCT01782131|467424837|FG000|Overall Study|Lost to Follow-up|1|||
129854240|NCT01782131|467424838|FG001|Overall Study|Lost to Follow-up|3|||
129854241|NCT01782131|467424837|FG000|Overall Study|Withdrawal by Subject|10|||
129854242|NCT01782131|467424838|FG001|Overall Study|Withdrawal by Subject|10|||
129854243|NCT01782131|467424837|FG000|Overall Study|Randomized but not treated|5|||
129907577|NCT01170962|467622610|FG002|Follow up Period|Withdrawal by Subject|2|||
129907578|NCT01170962|467622608|FG000|Follow up Period|Lost to Follow-up|13|||
129907579|NCT01170962|467622609|FG001|Follow up Period|Lost to Follow-up|8|||
129907580|NCT01170962|467622610|FG002|Follow up Period|Lost to Follow-up|1|||
129907581|NCT01170962|467622608|FG000|Follow up Period|Death|2|||
129907582|NCT01170962|467622609|FG001|Follow up Period|Death|2|||
129907583|NCT01170962|467622610|FG002|Follow up Period|Death|0|||
129854244|NCT01782131|467424838|FG001|Overall Study|Randomized but not treated|5|||
129854245|NCT01782131|467424837|FG000|Overall Study|Reason not provided|0|||
129854246|NCT01782131|467424838|FG001|Overall Study|Reason not provided|1|||
129854247|NCT00796718|467424839|FG000|Overall Study|Adverse Event|2|||
129854248|NCT00796718|467424839|FG000|Overall Study|Exclusion Criteria|1|||
129854249|NCT00796718|467424839|FG000|Overall Study|Lost to Follow-up|5|||
129854250|NCT00796718|467424839|FG000|Overall Study|Withdrawal by Informed Consent|1|||
129854251|NCT03266588|467424840|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
129854252|NCT03266588|467424841|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
129854253|NCT03266588|467424842|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
129854254|NCT03266588|467424840|FG000|Observational Period|Withdrawal by Subject|44|||
129854255|NCT03266588|467424841|FG001|Observational Period|Withdrawal by Subject|22|||
129907584|NCT01170962|467622608|FG000|Follow up Period|Others|10|||
129907585|NCT01170962|467622609|FG001|Follow up Period|Others|7|||
129907586|NCT01170962|467622610|FG002|Follow up Period|Others|3|||
129907587|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
129907588|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
129907589|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
129907590|NCT03368664|467622616|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
129907591|NCT00837616|467622617|FG000|Overall Study|Withdrawal by Subject|0|||
129907592|NCT00837616|467622618|FG001|Overall Study|Withdrawal by Subject|1|||
129907593|NCT01597258|467622624|FG000|Overall Study|No Drug Administration|1|||
129907594|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
129907595|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
129907596|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
129907597|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
129907598|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
129907599|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
129907600|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
129907601|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
129907602|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
129907603|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
129907604|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
129907605|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
129907606|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
129907607|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
129907608|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
129907609|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
129907610|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
129907611|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
129907612|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
129907613|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
129907614|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
129907615|NCT00304031|467624237|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
129907616|NCT00304031|467624238|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
129907617|NCT00304031|467624239|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
129907618|NCT00304031|467624237|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
129907619|NCT00304031|467624238|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
129907620|NCT00304031|467624239|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
129907621|NCT00925899|467624240|FG000|Part 1|Death|1|||
129907622|NCT00925899|467624241|FG001|Part 1|Death|2|||
129907623|NCT00925899|467624240|FG000|Part 1|Withdrawal by Subject|10|||
129907624|NCT00925899|467624241|FG001|Part 1|Withdrawal by Subject|9|||
129907625|NCT00683696|467624242|FG000|Overall Study|Withdrawn due to study closure|337|||
129907626|NCT00683696|467624243|FG001|Overall Study|Withdrawn due to study closure|338|||
129907627|NCT00683696|467624242|FG000|Overall Study|Withdrawn prior to study closure|13|||
129907628|NCT00683696|467624243|FG001|Overall Study|Withdrawn prior to study closure|28|||
129907629|NCT00683696|467624242|FG000|Overall Study|Lost to Follow-up|5|||
129907630|NCT00683696|467624243|FG001|Overall Study|Lost to Follow-up|6|||
129907631|NCT00683696|467624242|FG000|Overall Study|Vital status follow-up only|3|||
129449668|NCT00467779|465945637|FG014|Stage 3|Unspecified Reason|5|||
129854256|NCT03266588|467424842|FG002|Observational Period|Withdrawal by Subject|13|||
129854257|NCT03266588|467424840|FG000|Observational Period|Non-compliance|18|||
129854258|NCT03266588|467424841|FG001|Observational Period|Non-compliance|12|||
129854259|NCT03266588|467424842|FG002|Observational Period|Non-compliance|10|||
129449669|NCT00041080|465945640|FG000|Overall Study|Adverse Event|21|||
129854260|NCT03266588|467424840|FG000|Observational Period|Lost to Follow-up|8|||
129854261|NCT03266588|467424841|FG001|Observational Period|Lost to Follow-up|12|||
129854262|NCT03266588|467424842|FG002|Observational Period|Lost to Follow-up|4|||
129907632|NCT00683696|467624243|FG001|Overall Study|Vital status follow-up only|3|||
129907633|NCT00683696|467624242|FG000|Overall Study|Death|46|||
129907634|NCT00683696|467624243|FG001|Overall Study|Death|30|||
129907635|NCT02396316|467624244|FG000|Overall Study|Physician Decision|1|||
129907636|NCT02396316|467624245|FG001|Overall Study|Physician Decision|0|||
129907637|NCT02396316|467624244|FG000|Overall Study|Progressive disease|6|||
129907638|NCT02396316|467624245|FG001|Overall Study|Progressive disease|3|||
129907639|NCT02396316|467624244|FG000|Overall Study|Protocol Violation|0|||
129907640|NCT02396316|467624245|FG001|Overall Study|Protocol Violation|1|||
129907641|NCT02396316|467624244|FG000|Overall Study|Treatment unblinded|0|||
129907642|NCT02396316|467624245|FG001|Overall Study|Treatment unblinded|1|||
129907643|NCT01875848|467624249|FG000|Overall Study|Withdrawal by Subject|2|||
129907644|NCT01875848|467624250|FG001|Overall Study|Withdrawal by Subject|0|||
129907645|NCT02189252|467624251|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
129907646|NCT02189252|467624252|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
129907647|NCT02189252|467624253|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
129907648|NCT02189252|467624254|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
129907649|NCT02189252|467624251|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
129907650|NCT02189252|467624252|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
129907651|NCT02189252|467624253|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
129907652|NCT02189252|467624254|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
129907653|NCT00840177|467624255|FG000|Overall Study|Adverse Event|5|||
129907654|NCT00840177|467624256|FG001|Overall Study|Adverse Event|1|||
129907655|NCT00840177|467624257|FG002|Overall Study|Adverse Event|1|||
129907656|NCT00840177|467624255|FG000|Overall Study|Refusal unrelated to adverse events|1|||
129907657|NCT00840177|467624256|FG001|Overall Study|Refusal unrelated to adverse events|0|||
129907658|NCT00840177|467624257|FG002|Overall Study|Refusal unrelated to adverse events|1|||
129907659|NCT00840177|467624255|FG000|Overall Study|Progression/relapse|2|||
129907660|NCT00840177|467624256|FG001|Overall Study|Progression/relapse|0|||
129907661|NCT00840177|467624257|FG002|Overall Study|Progression/relapse|0|||
129907662|NCT00840177|467624255|FG000|Overall Study|Death|4|||
129907663|NCT00840177|467624256|FG001|Overall Study|Death|5|||
129907664|NCT00840177|467624257|FG002|Overall Study|Death|5|||
129907665|NCT00840177|467624255|FG000|Overall Study|not protocol specified|6|||
129907666|NCT00840177|467624256|FG001|Overall Study|not protocol specified|3|||
129907667|NCT00840177|467624257|FG002|Overall Study|not protocol specified|0|||
129907668|NCT00840177|467624255|FG000|Overall Study|Ineligible|0|||
129907669|NCT00840177|467624256|FG001|Overall Study|Ineligible|0|||
129907670|NCT00840177|467624257|FG002|Overall Study|Ineligible|3|||
129907671|NCT00840177|467624255|FG000|Overall Study|Did not start treatment|0|||
129907672|NCT00840177|467624256|FG001|Overall Study|Did not start treatment|0|||
129907673|NCT00840177|467624257|FG002|Overall Study|Did not start treatment|1|||
129907674|NCT01391832|467624258|FG000|Overall Study|Withdrawal by Subject|21|||
129907675|NCT01391832|467624259|FG001|Overall Study|Withdrawal by Subject|22|||
129907676|NCT01391832|467624258|FG000|Overall Study|Lost to Follow-up|0|||
129907677|NCT01391832|467624259|FG001|Overall Study|Lost to Follow-up|1|||
129907678|NCT03345901|467624265|FG000|Overall Study|The study was terminated|18|||
129907679|NCT00566735|467624266|FG000|Overall Study|Withdrawal by Subject|0|||
129907680|NCT00566735|467624267|FG001|Overall Study|Withdrawal by Subject|1|||
129907681|NCT00566735|467624266|FG000|Overall Study|Refused neuropsychological testing|2|||
129907682|NCT00566735|467624267|FG001|Overall Study|Refused neuropsychological testing|5|||
129907683|NCT00566735|467624266|FG000|Overall Study|Switched into a manic episode|0|||
129907684|NCT00566735|467624267|FG001|Overall Study|Switched into a manic episode|1|||
129907685|NCT00722046|467624268|FG000|Overall Study|Adverse Event|0|||
129907686|NCT00722046|467624269|FG001|Overall Study|Adverse Event|1|||
129907687|NCT00722046|467624270|FG002|Overall Study|Adverse Event|2|||
129907688|NCT00722046|467624271|FG003|Overall Study|Adverse Event|1|||
129907689|NCT00722046|467624272|FG004|Overall Study|Adverse Event|2|||
129907690|NCT00722046|467624273|FG005|Overall Study|Adverse Event|1|||
129907691|NCT00722046|467624274|FG006|Overall Study|Adverse Event|0|||
129907692|NCT00722046|467624268|FG000|Overall Study|Death|0|||
129907693|NCT00722046|467624269|FG001|Overall Study|Death|1|||
129907694|NCT00722046|467624270|FG002|Overall Study|Death|0|||
129907695|NCT00722046|467624271|FG003|Overall Study|Death|0|||
129907696|NCT00722046|467624272|FG004|Overall Study|Death|0|||
129907697|NCT00722046|467624273|FG005|Overall Study|Death|0|||
129907698|NCT00722046|467624274|FG006|Overall Study|Death|2|||
129907699|NCT00722046|467624268|FG000|Overall Study|Protocol Violation|1|||
129907700|NCT00722046|467624269|FG001|Overall Study|Protocol Violation|0|||
129907701|NCT00722046|467624270|FG002|Overall Study|Protocol Violation|0|||
129907702|NCT00722046|467624271|FG003|Overall Study|Protocol Violation|0|||
129907703|NCT00722046|467624272|FG004|Overall Study|Protocol Violation|0|||
129907704|NCT00722046|467624273|FG005|Overall Study|Protocol Violation|1|||
129907705|NCT00722046|467624274|FG006|Overall Study|Protocol Violation|0|||
129907706|NCT00722046|467624268|FG000|Overall Study|Withdrawal by Subject|3|||
129907707|NCT00722046|467624269|FG001|Overall Study|Withdrawal by Subject|3|||
129907708|NCT00722046|467624270|FG002|Overall Study|Withdrawal by Subject|4|||
129907709|NCT00722046|467624271|FG003|Overall Study|Withdrawal by Subject|4|||
129907710|NCT00722046|467624272|FG004|Overall Study|Withdrawal by Subject|4|||
129907711|NCT00722046|467624273|FG005|Overall Study|Withdrawal by Subject|7|||
129907712|NCT00722046|467624274|FG006|Overall Study|Withdrawal by Subject|3|||
129907713|NCT00722046|467624268|FG000|Overall Study|Randomized, but not treated|1|||
129907714|NCT00722046|467624269|FG001|Overall Study|Randomized, but not treated|1|||
129907715|NCT00722046|467624270|FG002|Overall Study|Randomized, but not treated|0|||
129907716|NCT00722046|467624271|FG003|Overall Study|Randomized, but not treated|2|||
129907717|NCT00722046|467624272|FG004|Overall Study|Randomized, but not treated|0|||
129907718|NCT00722046|467624273|FG005|Overall Study|Randomized, but not treated|0|||
129907719|NCT00722046|467624274|FG006|Overall Study|Randomized, but not treated|0|||
129907720|NCT00722046|467624268|FG000|Overall Study|Other|0|||
129907721|NCT00722046|467624269|FG001|Overall Study|Other|0|||
129854263|NCT03266588|467424840|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
129854264|NCT03266588|467424841|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
129854265|NCT03266588|467424842|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
129854266|NCT03266588|467424840|FG000|Observational Period|Protocol Deviation|1|||
129854267|NCT03266588|467424841|FG001|Observational Period|Protocol Deviation|0|||
129854268|NCT03266588|467424842|FG002|Observational Period|Protocol Deviation|0|||
129854269|NCT03266588|467424840|FG000|Observational Period|Other Reasons|3|||
129854270|NCT03266588|467424841|FG001|Observational Period|Other Reasons|0|||
129854271|NCT03266588|467424842|FG002|Observational Period|Other Reasons|1|||
129854272|NCT03266588|467424840|FG000|Long-term Treatment Period|Adverse Event|33|||
129854273|NCT03266588|467424841|FG001|Long-term Treatment Period|Adverse Event|17|||
129854274|NCT03266588|467424842|FG002|Long-term Treatment Period|Adverse Event|8|||
129854275|NCT03266588|467424840|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
129854276|NCT03266588|467424841|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
129854277|NCT03266588|467424842|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
129854278|NCT03266588|467424840|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
129854279|NCT03266588|467424841|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
129854280|NCT03266588|467424842|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
129854281|NCT03266588|467424840|FG000|Long-term Treatment Period|Non-Compliance|126|||
129854282|NCT03266588|467424841|FG001|Long-term Treatment Period|Non-Compliance|57|||
129854283|NCT03266588|467424842|FG002|Long-term Treatment Period|Non-Compliance|7|||
129854284|NCT03266588|467424840|FG000|Long-term Treatment Period|Pregnancy|11|||
129854285|NCT03266588|467424841|FG001|Long-term Treatment Period|Pregnancy|5|||
129854286|NCT03266588|467424842|FG002|Long-term Treatment Period|Pregnancy|0|||
129854287|NCT03266588|467424840|FG000|Long-term Treatment Period|Protocol Deviation|17|||
129854288|NCT03266588|467424841|FG001|Long-term Treatment Period|Protocol Deviation|10|||
129854289|NCT03266588|467424842|FG002|Long-term Treatment Period|Protocol Deviation|4|||
129854290|NCT03266588|467424840|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
129854291|NCT03266588|467424841|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
129854292|NCT03266588|467424842|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
129854293|NCT03266588|467424840|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
129854294|NCT03266588|467424841|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
129854295|NCT03266588|467424842|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
129854296|NCT03266588|467424840|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
129854297|NCT03266588|467424841|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
129854298|NCT03266588|467424842|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
129854299|NCT03266588|467424840|FG000|Long-term Treatment Period|Other Reasons|5|||
129854300|NCT03266588|467424841|FG001|Long-term Treatment Period|Other Reasons|0|||
129854301|NCT03266588|467424842|FG002|Long-term Treatment Period|Other Reasons|0|||
129854302|NCT03266588|467424840|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
129854303|NCT03266588|467424841|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
129854304|NCT03266588|467424842|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
129854305|NCT00317772|467424843|FG000|Overall Study|Adverse Event|0|||
129854306|NCT00317772|467424844|FG001|Overall Study|Adverse Event|0|||
129854307|NCT00317772|467424845|FG002|Overall Study|Adverse Event|0|||
129854308|NCT00317772|467424846|FG003|Overall Study|Adverse Event|2|||
129854309|NCT00317772|467424843|FG000|Overall Study|Disease Progression|2|||
129854310|NCT00317772|467424844|FG001|Overall Study|Disease Progression|2|||
129854311|NCT00317772|467424845|FG002|Overall Study|Disease Progression|1|||
129907722|NCT00722046|467624270|FG002|Overall Study|Other|1|||
129907723|NCT00722046|467624271|FG003|Overall Study|Other|1|||
129907724|NCT00722046|467624272|FG004|Overall Study|Other|3|||
129907725|NCT00722046|467624273|FG005|Overall Study|Other|2|||
129907726|NCT00722046|467624274|FG006|Overall Study|Other|1|||
129854312|NCT00317772|467424846|FG003|Overall Study|Disease Progression|7|||
129854313|NCT01073618|467424847|FG000|Overall Study|Death|208|||
129854314|NCT01073618|467424847|FG000|Overall Study|Adverse Event|19|||
129854315|NCT01073618|467424847|FG000|Overall Study|Other|80|||
129854316|NCT00982020|467424848|FG000|Overall Study|Adverse Event|19|||
129854317|NCT00982020|467424849|FG001|Overall Study|Adverse Event|15|||
129854318|NCT00982020|467424848|FG000|Overall Study|Withdrawal by Subject|11|||
129854319|NCT00982020|467424849|FG001|Overall Study|Withdrawal by Subject|14|||
129907727|NCT00925587|467624276|FG000|Overall Study|Protocol Specified Criteria|6|||
129854320|NCT00982020|467424848|FG000|Overall Study|Lost to Follow-up|5|||
129854321|NCT00982020|467424849|FG001|Overall Study|Lost to Follow-up|11|||
129854322|NCT00982020|467424848|FG000|Overall Study|Lack of Efficacy|10|||
129854323|NCT00982020|467424849|FG001|Overall Study|Lack of Efficacy|4|||
129854324|NCT00982020|467424848|FG000|Overall Study|Parent/Caregiver Decision|5|||
129854325|NCT00982020|467424849|FG001|Overall Study|Parent/Caregiver Decision|5|||
129854326|NCT00982020|467424848|FG000|Overall Study|Treatment Non-compliance|3|||
129854327|NCT00982020|467424849|FG001|Overall Study|Treatment Non-compliance|6|||
129854328|NCT00982020|467424848|FG000|Overall Study|Physician Decision|2|||
129854329|NCT00982020|467424849|FG001|Overall Study|Physician Decision|5|||
129854330|NCT00982020|467424848|FG000|Overall Study|Entry Criteria Not Met|2|||
129854331|NCT00982020|467424849|FG001|Overall Study|Entry Criteria Not Met|1|||
129854332|NCT00982020|467424848|FG000|Overall Study|Protocol Violation|0|||
129854333|NCT00982020|467424849|FG001|Overall Study|Protocol Violation|2|||
129854334|NCT00982020|467424848|FG000|Overall Study|Clinical Relapse|0|||
129854335|NCT00982020|467424849|FG001|Overall Study|Clinical Relapse|1|||
129854336|NCT00466193|467424850|FG000|Overall Study|Adverse Event|0|||
129854337|NCT00466193|467424851|FG001|Overall Study|Adverse Event|1|||
129854338|NCT00466193|467424850|FG000|Overall Study|Lost to Follow-up|2|||
129854339|NCT00466193|467424851|FG001|Overall Study|Lost to Follow-up|4|||
129854340|NCT00466193|467424850|FG000|Overall Study|Physician Decision|1|||
129854341|NCT00466193|467424851|FG001|Overall Study|Physician Decision|0|||
129854342|NCT00466193|467424850|FG000|Overall Study|Protocol Violation|1|||
129854343|NCT00466193|467424851|FG001|Overall Study|Protocol Violation|1|||
129854344|NCT00466193|467424850|FG000|Overall Study|Withdrawal by Subject|7|||
129854345|NCT00466193|467424851|FG001|Overall Study|Withdrawal by Subject|2|||
129854346|NCT00466193|467424850|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
129854347|NCT00466193|467424851|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
129854348|NCT02246998|467424852|FG000|Overall Study|Adverse Event|0|||
129854349|NCT02246998|467424853|FG001|Overall Study|Adverse Event|1|||
129854350|NCT02246998|467424854|FG002|Overall Study|Adverse Event|1|||
129854351|NCT02246998|467424855|FG003|Overall Study|Adverse Event|0|||
129854352|NCT02246998|467424852|FG000|Overall Study|Lost to Follow-up|1|||
129854353|NCT02246998|467424853|FG001|Overall Study|Lost to Follow-up|0|||
129854354|NCT02246998|467424854|FG002|Overall Study|Lost to Follow-up|0|||
129854355|NCT02246998|467424855|FG003|Overall Study|Lost to Follow-up|1|||
129854356|NCT02246998|467424852|FG000|Overall Study|Randomized but Never Dosed|1|||
129854357|NCT02246998|467424853|FG001|Overall Study|Randomized but Never Dosed|2|||
129854358|NCT02246998|467424854|FG002|Overall Study|Randomized but Never Dosed|2|||
129854359|NCT02246998|467424855|FG003|Overall Study|Randomized but Never Dosed|1|||
129854360|NCT01343082|467424856|FG000|The run-in Period|Not meeting criteria|3|||
129854361|NCT01343082|467424857|FG001|The run-in Period|Not meeting criteria|4|||
129854362|NCT01343082|467424858|FG002|The run-in Period|Not meeting criteria|5|||
129854363|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
129854364|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
129854365|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
129854366|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
129854367|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
129854368|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
129854369|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
129854370|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
129854371|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
129854372|NCT01343082|467424856|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
129854373|NCT01343082|467424857|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
129854374|NCT01343082|467424858|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
129854375|NCT01854554|467424859|FG000|Overall Study|Denial of Insurance Coverage|12|||
129854376|NCT01854554|467424860|FG001|Overall Study|Denial of Insurance Coverage|0|||
129854377|NCT01854554|467424859|FG000|Overall Study|Decided to get treatment locally|1|||
129854378|NCT01854554|467424860|FG001|Overall Study|Decided to get treatment locally|5|||
129854379|NCT01854554|467424859|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
129854380|NCT01854554|467424860|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
129854381|NCT01854554|467424859|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129854382|NCT01854554|467424860|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
129854383|NCT01854554|467424859|FG000|Overall Study|Progression|0|||
129854384|NCT01854554|467424860|FG001|Overall Study|Progression|1|||
129854385|NCT01854554|467424859|FG000|Overall Study|Lost to Follow-up|0|||
129854386|NCT01854554|467424860|FG001|Overall Study|Lost to Follow-up|1|||
129854387|NCT02819726|467424861|FG000|Part A (All Participants)|Lost to Follow-up|0|||
129854388|NCT02819726|467424862|FG001|Part A (All Participants)|Lost to Follow-up|1|||
129854389|NCT02819726|467424863|FG002|Part A (All Participants)|Lost to Follow-up|0|||
129854390|NCT02819726|467424864|FG003|Part A (All Participants)|Lost to Follow-up|0|||
129854391|NCT02819726|467424861|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
129854392|NCT02819726|467424862|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
129854393|NCT02819726|467424863|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
129907728|NCT00925587|467624277|FG001|Overall Study|Protocol Specified Criteria|6|||
129907729|NCT00925587|467624276|FG000|Overall Study|Physician Decision|4|||
129907730|NCT00925587|467624277|FG001|Overall Study|Physician Decision|1|||
129907731|NCT00925587|467624276|FG000|Overall Study|Protocol Violation|6|||
129907732|NCT00925587|467624277|FG001|Overall Study|Protocol Violation|4|||
129907733|NCT00925587|467624276|FG000|Overall Study|Withdrawal by Subject|9|||
129907734|NCT00925587|467624277|FG001|Overall Study|Withdrawal by Subject|6|||
129907735|NCT00925587|467624276|FG000|Overall Study|Death|5|||
129907736|NCT00925587|467624277|FG001|Overall Study|Death|5|||
129907737|NCT00925587|467624276|FG000|Overall Study|Adverse Event|6|||
129907738|NCT00925587|467624277|FG001|Overall Study|Adverse Event|2|||
129907739|NCT00925587|467624276|FG000|Overall Study|Lost to Follow-up|0|||
129907740|NCT00925587|467624277|FG001|Overall Study|Lost to Follow-up|1|||
129907741|NCT00686855|467624285|FG000|Overall Study|Lost to Follow-up|1|||
129907742|NCT00686855|467624286|FG001|Overall Study|Lost to Follow-up|0|||
129907743|NCT00686855|467624285|FG000|Overall Study|Progressive GVHD|0|||
129907744|NCT00686855|467624286|FG001|Overall Study|Progressive GVHD|1|||
129854394|NCT02819726|467424864|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
129854395|NCT02819726|467424861|FG000|Part A (All Participants)|Protocol non-compliance|3|||
129854396|NCT02819726|467424862|FG001|Part A (All Participants)|Protocol non-compliance|4|||
129854397|NCT02819726|467424863|FG002|Part A (All Participants)|Protocol non-compliance|5|||
129854398|NCT02819726|467424864|FG003|Part A (All Participants)|Protocol non-compliance|0|||
129854399|NCT02819726|467424861|FG000|Part B (All Participants)|Lost to Follow-up|1|||
129854400|NCT02819726|467424862|FG001|Part B (All Participants)|Lost to Follow-up|1|||
129854401|NCT02819726|467424863|FG002|Part B (All Participants)|Lost to Follow-up|2|||
129854402|NCT02819726|467424864|FG003|Part B (All Participants)|Lost to Follow-up|2|||
129854403|NCT02819726|467424861|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
129854404|NCT02819726|467424862|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
129854405|NCT02819726|467424863|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
129854406|NCT02819726|467424864|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
129854407|NCT02819726|467424861|FG000|Part B (All Participants)|Protocol non-compliance|0|||
129854408|NCT02819726|467424862|FG001|Part B (All Participants)|Protocol non-compliance|0|||
129854409|NCT02819726|467424863|FG002|Part B (All Participants)|Protocol non-compliance|1|||
129854410|NCT02819726|467424864|FG003|Part B (All Participants)|Protocol non-compliance|0|||
129854411|NCT02613481|467424865|FG000|Overall Study|Lost to Follow-up|7|||
129854412|NCT02613481|467424865|FG000|Overall Study|Withdrawal by Subject|2|||
129854413|NCT00844194|467424866|FG000|Overall Study|Adverse Event|17|||
129854414|NCT00844194|467424867|FG001|Overall Study|Adverse Event|5|||
129854415|NCT00844194|467424866|FG000|Overall Study|Protocol Violation|1|||
129854416|NCT00844194|467424867|FG001|Overall Study|Protocol Violation|1|||
129854417|NCT00844194|467424866|FG000|Overall Study|Lost to Follow-up|1|||
129854418|NCT00844194|467424867|FG001|Overall Study|Lost to Follow-up|1|||
129854419|NCT00844194|467424866|FG000|Overall Study|Withdrawal by Subject|2|||
129854420|NCT00844194|467424867|FG001|Overall Study|Withdrawal by Subject|1|||
129854421|NCT00844194|467424866|FG000|Overall Study|Lack of Efficacy|3|||
129854422|NCT00844194|467424867|FG001|Overall Study|Lack of Efficacy|0|||
129854423|NCT00844194|467424866|FG000|Overall Study|Other reason (not specified)|1|||
129854424|NCT00844194|467424867|FG001|Overall Study|Other reason (not specified)|0|||
129854425|NCT02647658|467424868|FG000|Overall Study|Consent refusal|15|||
129854426|NCT02647658|467424869|FG001|Overall Study|Consent refusal|24|||
129854427|NCT00803023|467424870|FG000|Overall Study|Adverse Event|5|||
129854428|NCT00803023|467424871|FG001|Overall Study|Adverse Event|4|||
129854429|NCT00803023|467424872|FG002|Overall Study|Adverse Event|8|||
129854430|NCT00803023|467424873|FG003|Overall Study|Adverse Event|6|||
129854431|NCT00803023|467424870|FG000|Overall Study|Withdrawal by Subject|0|||
129854432|NCT00803023|467424871|FG001|Overall Study|Withdrawal by Subject|2|||
129854433|NCT00803023|467424872|FG002|Overall Study|Withdrawal by Subject|0|||
129854434|NCT00803023|467424873|FG003|Overall Study|Withdrawal by Subject|0|||
129854435|NCT00803023|467424870|FG000|Overall Study|Lost to Follow-up|0|||
129854436|NCT00803023|467424871|FG001|Overall Study|Lost to Follow-up|1|||
129854437|NCT00803023|467424872|FG002|Overall Study|Lost to Follow-up|2|||
129854438|NCT00803023|467424873|FG003|Overall Study|Lost to Follow-up|1|||
129854439|NCT00803023|467424870|FG000|Overall Study|Lack of Efficacy|0|||
129854440|NCT00803023|467424871|FG001|Overall Study|Lack of Efficacy|1|||
129854441|NCT00803023|467424872|FG002|Overall Study|Lack of Efficacy|1|||
129854442|NCT00803023|467424873|FG003|Overall Study|Lack of Efficacy|1|||
129854443|NCT01542528|467424874|FG000|Overall Study|Lost to Follow-up|2|||
129854444|NCT01542528|467424875|FG001|Overall Study|Lost to Follow-up|1|||
129854445|NCT01542528|467424874|FG000|Overall Study|Physician Decision|1|||
129854446|NCT01542528|467424875|FG001|Overall Study|Physician Decision|0|||
129854447|NCT01542528|467424874|FG000|Overall Study|Withdrawal by Subject|9|||
129854448|NCT01542528|467424875|FG001|Overall Study|Withdrawal by Subject|6|||
129854449|NCT01921348|467424881|FG000|Overall Study|Withdrawal by Subject|1|||
129854450|NCT01921348|467424882|FG001|Overall Study|Withdrawal by Subject|0|||
129907745|NCT02731755|467624292|FG000|First Intervention|Withdrawal by Subject|0|||
129907746|NCT02731755|467624293|FG001|First Intervention|Withdrawal by Subject|2|||
129907747|NCT01460446|467624294|FG000|Overall Study|Non-compliance|2|||
129907748|NCT01460446|467624295|FG001|Overall Study|Non-compliance|9|||
129907749|NCT01460446|467624294|FG000|Overall Study|Consent Withdrawn|0|||
129907750|NCT01460446|467624295|FG001|Overall Study|Consent Withdrawn|4|||
129907751|NCT01460446|467624294|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
129907752|NCT01460446|467624295|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
129907753|NCT01460446|467624294|FG000|Overall Study|Surgery/Illness|1|||
129907754|NCT01460446|467624295|FG001|Overall Study|Surgery/Illness|1|||
129907755|NCT01460446|467624294|FG000|Overall Study|Pregnancy|1|||
129907756|NCT01460446|467624295|FG001|Overall Study|Pregnancy|0|||
129907757|NCT01460446|467624294|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
129907758|NCT01460446|467624295|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
129907759|NCT04218110|467624296|FG000|Overall Study|Withdrawal by Subject|0|||
129907760|NCT04218110|467624297|FG001|Overall Study|Withdrawal by Subject|0|||
129907761|NCT04218110|467624298|FG002|Overall Study|Withdrawal by Subject|0|||
129907762|NCT04218110|467624299|FG003|Overall Study|Withdrawal by Subject|1|||
129907763|NCT00799396|467624300|FG000|Clopidogrel Treatment|Adverse Event|6|||
129907764|NCT00799396|467624300|FG000|Clopidogrel Treatment|Physician Decision|5|||
129907765|NCT00799396|467624300|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
129907766|NCT00799396|467624300|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
129907767|NCT00799396|467624300|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
129907768|NCT01318382|467624302|FG000|Overall Study|Physician Decision|2|||
129907769|NCT01318382|467624302|FG000|Overall Study|Device Malfunction|10|||
129907770|NCT01318382|467624302|FG000|Overall Study|Protocol Violation|1|||
129907771|NCT01867216|467624303|FG000|Overall Study|Withdrawal by Subject|2|||
129907772|NCT01867216|467624304|FG001|Overall Study|Withdrawal by Subject|0|||
129907773|NCT01867216|467624305|FG002|Overall Study|Withdrawal by Subject|0|||
129907774|NCT01867216|467624306|FG003|Overall Study|Withdrawal by Subject|0|||
129907775|NCT01867216|467624307|FG004|Overall Study|Withdrawal by Subject|1|||
129907776|NCT01867216|467624308|FG005|Overall Study|Withdrawal by Subject|0|||
129907777|NCT01867216|467624309|FG006|Overall Study|Withdrawal by Subject|1|||
129907778|NCT01867216|467624303|FG000|Overall Study|Physician Decision|1|||
129907779|NCT01867216|467624304|FG001|Overall Study|Physician Decision|0|||
129907780|NCT01867216|467624305|FG002|Overall Study|Physician Decision|0|||
129907781|NCT01867216|467624306|FG003|Overall Study|Physician Decision|0|||
129907782|NCT01867216|467624307|FG004|Overall Study|Physician Decision|0|||
129907783|NCT01867216|467624308|FG005|Overall Study|Physician Decision|0|||
129907784|NCT01867216|467624309|FG006|Overall Study|Physician Decision|0|||
129907785|NCT01867216|467624303|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
129907786|NCT01867216|467624304|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907787|NCT01867216|467624305|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907788|NCT01867216|467624306|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907789|NCT01867216|467624307|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907790|NCT01867216|467624308|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907791|NCT01867216|467624309|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
129907792|NCT01599104|467624312|FG000|Overall Study|Withdrawal by Subject|1|||
129907793|NCT01599104|467624313|FG001|Overall Study|Withdrawal by Subject|1|||
129907794|NCT01599104|467624314|FG002|Overall Study|Withdrawal by Subject|2|||
129907795|NCT01599104|467624312|FG000|Overall Study|Technical Problems|1|||
129907796|NCT01599104|467624313|FG001|Overall Study|Technical Problems|0|||
129907797|NCT01599104|467624314|FG002|Overall Study|Technical Problems|0|||
129907798|NCT01599104|467624312|FG000|Overall Study|Physician Decision|3|||
129907799|NCT01599104|467624313|FG001|Overall Study|Physician Decision|2|||
129907800|NCT01599104|467624314|FG002|Overall Study|Physician Decision|2|||
129907801|NCT01599104|467624312|FG000|Overall Study|Non-compliance with study treatment|0|||
129907802|NCT01599104|467624313|FG001|Overall Study|Non-compliance with study treatment|1|||
129907803|NCT01599104|467624314|FG002|Overall Study|Non-compliance with study treatment|0|||
129907804|NCT01599104|467624312|FG000|Overall Study|Lack of Efficacy|4|||
129907805|NCT01599104|467624313|FG001|Overall Study|Lack of Efficacy|4|||
129907806|NCT01599104|467624314|FG002|Overall Study|Lack of Efficacy|10|||
129907807|NCT01599104|467624312|FG000|Overall Study|Adverse Event|7|||
129907808|NCT01599104|467624313|FG001|Overall Study|Adverse Event|6|||
129907809|NCT01599104|467624314|FG002|Overall Study|Adverse Event|12|||
129907810|NCT00714714|467624315|FG000|Overall Study|Adverse Event|1|||
129907811|NCT02271854|467624322|FG000|Overall Study|Withdrawal by Subject|2|||
129907812|NCT02271854|467624322|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
129907813|NCT02271854|467624322|FG000|Overall Study|Lost to Follow-up|1|||
129907814|NCT01308567|467624327|FG000|Overall Study|Lost to Follow-up|2|||
129907815|NCT01308567|467624328|FG001|Overall Study|Lost to Follow-up|4|||
129907816|NCT01308567|467624329|FG002|Overall Study|Lost to Follow-up|4|||
129907817|NCT00542789|467624330|FG000|Overall Study|Adverse Event|18|||
129907818|NCT00542789|467624331|FG001|Overall Study|Adverse Event|17|||
129907819|NCT00542789|467624330|FG000|Overall Study|Withdrawal by Subject|7|||
129907820|NCT00542789|467624331|FG001|Overall Study|Withdrawal by Subject|3|||
129907821|NCT00542789|467624330|FG000|Overall Study|Protocol Violation|8|||
129907822|NCT00542789|467624331|FG001|Overall Study|Protocol Violation|1|||
129907823|NCT00542789|467624330|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
129854451|NCT01921348|467424881|FG000|Overall Study|Lost to Follow-up|0|||
129854452|NCT01921348|467424882|FG001|Overall Study|Lost to Follow-up|2|||
129854453|NCT00795600|467424888|FG000|Overall Study|Adverse Event|1|||
129854454|NCT00795600|467424889|FG001|Overall Study|Adverse Event|1|||
129854455|NCT00795600|467424888|FG000|Overall Study|Protocol Violation|1|||
129854456|NCT00795600|467424889|FG001|Overall Study|Protocol Violation|2|||
129854457|NCT00795600|467424888|FG000|Overall Study|Withdrawal by Subject|1|||
129854458|NCT00795600|467424889|FG001|Overall Study|Withdrawal by Subject|0|||
129854459|NCT00795600|467424888|FG000|Overall Study|Unclassified|1|||
129854460|NCT00795600|467424889|FG001|Overall Study|Unclassified|1|||
129854461|NCT03936244|467424890|FG000|Overall Study|Lost to Follow-up|5|||
129854462|NCT03936244|467424891|FG001|Overall Study|Lost to Follow-up|1|||
129854463|NCT03936244|467424890|FG000|Overall Study|Physician Decision|7|||
129854464|NCT03936244|467424891|FG001|Overall Study|Physician Decision|3|||
129854465|NCT01114646|467424892|FG000|Overall Study|Withdrawal by Subject|3|||
129854466|NCT01114646|467424893|FG001|Overall Study|Withdrawal by Subject|2|||
129854467|NCT01248884|467424898|FG000|Overall Study|Withdrawal by Subject|1|||
129854468|NCT01248884|467424899|FG001|Overall Study|Withdrawal by Subject|3|||
129854469|NCT01248884|467424900|FG002|Overall Study|Withdrawal by Subject|1|||
129854470|NCT01248884|467424898|FG000|Overall Study|Adverse Event|1|||
129854471|NCT01248884|467424899|FG001|Overall Study|Adverse Event|0|||
129854472|NCT01248884|467424900|FG002|Overall Study|Adverse Event|0|||
129854473|NCT02511431|467424901|FG000|Treatment|Lost to Follow-up|0|||
129854474|NCT02511431|467424902|FG001|Treatment|Lost to Follow-up|0|||
129854475|NCT02511431|467424903|FG002|Treatment|Lost to Follow-up|1|||
129854476|NCT02511431|467424904|FG003|Treatment|Lost to Follow-up|0|||
129854477|NCT02511431|467424905|FG004|Treatment|Lost to Follow-up|0|||
129854478|NCT02511431|467424906|FG005|Treatment|Lost to Follow-up|1|||
129854479|NCT01430130|467424911|FG000|Overall Study|Lost to Follow-up|1|||
129854480|NCT01430130|467424911|FG000|Overall Study|Infection on Control Side of Incision|1|||
129854481|NCT02828111|467424915|FG000|Overall Study|Withdrawal by Subject|0|||
129854482|NCT02828111|467424916|FG001|Overall Study|Withdrawal by Subject|0|||
129854483|NCT02828111|467424917|FG002|Overall Study|Withdrawal by Subject|2|||
129854484|NCT02828111|467424918|FG003|Overall Study|Withdrawal by Subject|0|||
129854485|NCT02828111|467424919|FG004|Overall Study|Withdrawal by Subject|0|||
129854486|NCT02828111|467424915|FG000|Overall Study|Lost to Follow-up|0|||
129854487|NCT02828111|467424916|FG001|Overall Study|Lost to Follow-up|0|||
129854488|NCT02828111|467424917|FG002|Overall Study|Lost to Follow-up|0|||
129854489|NCT02828111|467424918|FG003|Overall Study|Lost to Follow-up|1|||
129854490|NCT02828111|467424919|FG004|Overall Study|Lost to Follow-up|1|||
129854491|NCT02667912|467424922|FG000|Overall Study|Death|3|||
129854492|NCT02667912|467424923|FG001|Overall Study|Death|1|||
129854493|NCT02667912|467424922|FG000|Overall Study|Withdrawal by Subject|1|||
129854494|NCT02667912|467424923|FG001|Overall Study|Withdrawal by Subject|2|||
129854495|NCT02667912|467424922|FG000|Overall Study|Withdrawal by Subject|1|||
129854496|NCT02667912|467424923|FG001|Overall Study|Withdrawal by Subject|0|||
129854497|NCT04443218|467424924|FG000|Overall Study|Exited study for other reasons|9|||
129854498|NCT04443218|467424924|FG000|Overall Study|Withdrawal by Subject|1|||
129854499|NCT04443218|467424924|FG000|Overall Study|Lost to Follow-up|4|||
129854500|NCT04443218|467424924|FG000|Overall Study|Death|19|||
129854501|NCT00022516|467424941|FG000|Overall Study|Adverse Event|0|||
129854502|NCT00022516|467424942|FG001|Overall Study|Adverse Event|59|||
129854503|NCT00022516|467424941|FG000|Overall Study|Lack of Efficacy|0|||
129854504|NCT00022516|467424942|FG001|Overall Study|Lack of Efficacy|27|||
129854505|NCT00022516|467424941|FG000|Overall Study|Physician Decision|0|||
129854506|NCT00022516|467424942|FG001|Overall Study|Physician Decision|1|||
129854507|NCT00022516|467424941|FG000|Overall Study|Protocol Violation|1|||
129854508|NCT00022516|467424942|FG001|Overall Study|Protocol Violation|3|||
129854509|NCT00022516|467424941|FG000|Overall Study|Withdrawal by Subject|2|||
129854510|NCT00022516|467424942|FG001|Overall Study|Withdrawal by Subject|113|||
129854511|NCT00022516|467424941|FG000|Overall Study|Incomplete documentation|0|||
129854512|NCT00022516|467424942|FG001|Overall Study|Incomplete documentation|27|||
129854513|NCT02207829|467424948|FG000|Overall Study|Adverse Event|10|||
129854514|NCT02207829|467424949|FG001|Overall Study|Adverse Event|9|||
129854515|NCT02207829|467424948|FG000|Overall Study|Lack of Efficacy|7|||
129854516|NCT02207829|467424949|FG001|Overall Study|Lack of Efficacy|5|||
129854517|NCT02207829|467424948|FG000|Overall Study|Lost to Follow-up|2|||
129854518|NCT02207829|467424949|FG001|Overall Study|Lost to Follow-up|2|||
129854519|NCT02207829|467424948|FG000|Overall Study|Protocol deviation|5|||
129854520|NCT02207829|467424949|FG001|Overall Study|Protocol deviation|4|||
129854521|NCT02207829|467424948|FG000|Overall Study|Withdrew consent|18|||
129854522|NCT02207829|467424949|FG001|Overall Study|Withdrew consent|14|||
129854523|NCT00766376|467424950|FG000|Overall Study|Withdrawal by Subject|27|||
129854524|NCT01800903|467424951|FG000|Second Test Period|unable to catheterise|1|||
129854525|NCT01800903|467424952|FG001|Second Test Period|unable to catheterise|0|||
129854526|NCT01800903|467424953|FG002|Second Test Period|unable to catheterise|0|||
129854527|NCT01800903|467424954|FG003|Second Test Period|unable to catheterise|0|||
129854528|NCT01800903|467424955|FG004|Second Test Period|unable to catheterise|0|||
129854529|NCT01800903|467424956|FG005|Second Test Period|unable to catheterise|0|||
129907824|NCT00542789|467624331|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
129907825|NCT03454529|467624341|FG000|Overall Study|Did not receive treatment|6|||
129907826|NCT03454529|467624341|FG000|Overall Study|Received < 80% doses|1|||
129907827|NCT01582100|467624345|FG000|Overall Study|Adverse Event|1|||
129907828|NCT01582100|467624345|FG000|Overall Study|Withdrawal by Subject|1|||
129907829|NCT01040689|467624348|FG000|Overall Study|Adverse Event|0|||
129907830|NCT01040689|467624349|FG001|Overall Study|Adverse Event|0|||
129907831|NCT01040689|467624350|FG002|Overall Study|Adverse Event|2|||
129907832|NCT01040689|467624351|FG003|Overall Study|Adverse Event|4|||
129907833|NCT01040689|467624348|FG000|Overall Study|Lack of Efficacy|0|||
129907834|NCT01040689|467624349|FG001|Overall Study|Lack of Efficacy|0|||
129907835|NCT01040689|467624350|FG002|Overall Study|Lack of Efficacy|1|||
129907836|NCT01040689|467624351|FG003|Overall Study|Lack of Efficacy|0|||
129907837|NCT01040689|467624348|FG000|Overall Study|Lost to Follow-up|1|||
129907838|NCT01040689|467624349|FG001|Overall Study|Lost to Follow-up|0|||
129907839|NCT01040689|467624350|FG002|Overall Study|Lost to Follow-up|0|||
129907840|NCT01040689|467624351|FG003|Overall Study|Lost to Follow-up|0|||
129907841|NCT01040689|467624348|FG000|Overall Study|Withdrawal by Subject|2|||
129907842|NCT01040689|467624349|FG001|Overall Study|Withdrawal by Subject|1|||
129907843|NCT01040689|467624350|FG002|Overall Study|Withdrawal by Subject|1|||
129907844|NCT01040689|467624351|FG003|Overall Study|Withdrawal by Subject|0|||
129907845|NCT01040689|467624348|FG000|Overall Study|Other reasons not listed above|0|||
129907846|NCT01040689|467624349|FG001|Overall Study|Other reasons not listed above|1|||
129907847|NCT01040689|467624350|FG002|Overall Study|Other reasons not listed above|0|||
129907848|NCT01040689|467624351|FG003|Overall Study|Other reasons not listed above|0|||
129907849|NCT01185561|467624352|FG000|Overall Study|Lost to Follow-up|0|||
129907850|NCT01185561|467624353|FG001|Overall Study|Lost to Follow-up|4|||
129907851|NCT01185561|467624352|FG000|Overall Study|Withdrawal by Subject|2|||
129907852|NCT01185561|467624353|FG001|Overall Study|Withdrawal by Subject|8|||
129907853|NCT02616900|467624354|FG000|Overall Study|Lack of Efficacy|7|||
129907854|NCT02616900|467624354|FG000|Overall Study|Lost to Follow-up|2|||
129907855|NCT02616900|467624354|FG000|Overall Study|Protocol Violation|5|||
129907856|NCT02616900|467624354|FG000|Overall Study|Withdrawal by Subject|3|||
129907857|NCT02616900|467624354|FG000|Overall Study|Incomplete data|6|||
129907858|NCT02499159|467624355|FG000|Randomization|Protocol Violation|1|||
129907859|NCT02499159|467624356|FG001|Randomization|Protocol Violation|1|||
129907860|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
129907861|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
129907862|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
129907863|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
129907864|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
129907865|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
129907866|NCT02499159|467624355|FG000|30-Day Follow-Up Phone Call|Other|1|||
129907867|NCT02499159|467624356|FG001|30-Day Follow-Up Phone Call|Other|0|||
129907868|NCT01190007|467624357|FG000|Overall Study|Withdrawal by Subject|4|||
129907869|NCT01190007|467624357|FG000|Overall Study|Adverse Event|8|||
129907870|NCT01190007|467624357|FG000|Overall Study|Difficulty of visit for complications|1|||
129907871|NCT01190007|467624357|FG000|Overall Study|Participant was arrested|1|||
129907872|NCT00585533|467624358|FG000|Overall Study|objective or symptomatic progression|9|||
129907873|NCT01369498|467624359|FG000|Overall Study|Lack of Efficacy|9|||
129907874|NCT01369498|467624360|FG001|Overall Study|Lack of Efficacy|9|||
129907875|NCT01369498|467624361|FG002|Overall Study|Lack of Efficacy|1|||
129907876|NCT01369498|467624362|FG003|Overall Study|Lack of Efficacy|3|||
129907877|NCT01369498|467624359|FG000|Overall Study|Adverse Event|1|||
129907878|NCT01369498|467624360|FG001|Overall Study|Adverse Event|2|||
129907879|NCT01369498|467624361|FG002|Overall Study|Adverse Event|0|||
129907880|NCT01369498|467624362|FG003|Overall Study|Adverse Event|1|||
129907881|NCT01369498|467624359|FG000|Overall Study|Withdrawal of Consent|0|||
129907882|NCT01369498|467624360|FG001|Overall Study|Withdrawal of Consent|1|||
129907883|NCT01369498|467624361|FG002|Overall Study|Withdrawal of Consent|1|||
129907884|NCT01369498|467624362|FG003|Overall Study|Withdrawal of Consent|1|||
129907885|NCT01369498|467624359|FG000|Overall Study|Death|0|||
129907886|NCT01369498|467624360|FG001|Overall Study|Death|0|||
129907887|NCT01369498|467624361|FG002|Overall Study|Death|1|||
129907888|NCT01369498|467624362|FG003|Overall Study|Death|0|||
129907889|NCT01369498|467624359|FG000|Overall Study|Investigator's Discretion|1|||
129907890|NCT01369498|467624360|FG001|Overall Study|Investigator's Discretion|0|||
129907891|NCT01369498|467624361|FG002|Overall Study|Investigator's Discretion|1|||
129907892|NCT01369498|467624362|FG003|Overall Study|Investigator's Discretion|3|||
129907893|NCT01369498|467624359|FG000|Overall Study|Unknown Reason|1|||
129907894|NCT01369498|467624360|FG001|Overall Study|Unknown Reason|0|||
129907895|NCT01369498|467624361|FG002|Overall Study|Unknown Reason|11|||
129907896|NCT01369498|467624362|FG003|Overall Study|Unknown Reason|6|||
129907897|NCT01369498|467624359|FG000|Overall Study|Disease Progression|0|||
129907898|NCT01369498|467624360|FG001|Overall Study|Disease Progression|0|||
129907899|NCT01369498|467624361|FG002|Overall Study|Disease Progression|0|||
129907900|NCT01369498|467624362|FG003|Overall Study|Disease Progression|1|||
129854530|NCT03283670|467424963|FG000|Placebo Gas|Withdrawal by Subject|2|||
129854531|NCT03283670|467424963|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
129854532|NCT03283670|467424963|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
129854533|NCT00852397|467424964|FG000|Overall Study|Adverse Event|4|||
129854534|NCT00852397|467424965|FG001|Overall Study|Adverse Event|6|||
129854535|NCT00852397|467424966|FG002|Overall Study|Adverse Event|4|||
129854536|NCT00852397|467424964|FG000|Overall Study|Death|0|||
129854537|NCT00852397|467424965|FG001|Overall Study|Death|0|||
129854538|NCT00852397|467424966|FG002|Overall Study|Death|1|||
129854539|NCT00852397|467424964|FG000|Overall Study|Withdrawal by Subject|4|||
129854540|NCT00852397|467424965|FG001|Overall Study|Withdrawal by Subject|1|||
129854541|NCT00852397|467424966|FG002|Overall Study|Withdrawal by Subject|2|||
129854542|NCT00852397|467424964|FG000|Overall Study|Study terminated by sponsor|2|||
129854543|NCT00852397|467424965|FG001|Overall Study|Study terminated by sponsor|1|||
129854544|NCT00852397|467424966|FG002|Overall Study|Study terminated by sponsor|6|||
129854545|NCT00852397|467424964|FG000|Overall Study|Difficulty in study site visit|1|||
129854546|NCT00852397|467424965|FG001|Overall Study|Difficulty in study site visit|0|||
129854547|NCT00852397|467424966|FG002|Overall Study|Difficulty in study site visit|0|||
129854548|NCT00852397|467424964|FG000|Overall Study|Protocol Violation|0|||
129854549|NCT00852397|467424965|FG001|Overall Study|Protocol Violation|0|||
129854550|NCT00852397|467424966|FG002|Overall Study|Protocol Violation|1|||
129854551|NCT01850004|467424970|FG000|Overall Study|Poor/Non-compliance|1|||
129854552|NCT01850004|467424970|FG000|Overall Study|Participant Withdrew Consent|9|||
129854553|NCT01850004|467424970|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
129854554|NCT01850004|467424970|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
129854555|NCT01850004|467424970|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
129854556|NCT01850004|467424970|FG000|Overall Study|Other Reasons|2|||
129854557|NCT01850004|467424970|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
129854558|NCT01850004|467424970|FG000|Overall Study|Maximum Clinical Benefit|4|||
129854559|NCT01404312|467426779|FG000|Overall Study|Death|21|||
129854560|NCT01404312|467426780|FG001|Overall Study|Death|27|||
129854561|NCT01404312|467426779|FG000|Overall Study|Withdrawal by Subject|15|||
129854562|NCT01404312|467426780|FG001|Overall Study|Withdrawal by Subject|18|||
129854563|NCT01404312|467426779|FG000|Overall Study|Participant Unable to get to clinic|93|||
129854564|NCT01404312|467426780|FG001|Overall Study|Participant Unable to get to clinic|103|||
129854565|NCT01404312|467426779|FG000|Overall Study|Lost to Follow-up|115|||
129854566|NCT01404312|467426780|FG001|Overall Study|Lost to Follow-up|111|||
129854567|NCT01404312|467426779|FG000|Overall Study|Site closed|22|||
129854568|NCT01404312|467426780|FG001|Overall Study|Site closed|21|||
129854569|NCT01404312|467426779|FG000|Overall Study|Participant not willing to adhere to req|31|||
129854570|NCT01404312|467426780|FG001|Overall Study|Participant not willing to adhere to req|29|||
129854571|NCT01404312|467426779|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129854572|NCT01404312|467426780|FG001|Overall Study|Severe debilitation, unable to continue|2|||
129854573|NCT04419493|467426781|FG000|Wash-out After Period 1|Adverse Event|1|||
129854574|NCT04419493|467426782|FG001|Wash-out After Period 1|Adverse Event|2|||
129854575|NCT04419493|467426783|FG002|Wash-out After Period 1|Adverse Event|1|||
129854576|NCT04419493|467426784|FG003|Wash-out After Period 1|Adverse Event|0|||
129854577|NCT00524134|467426785|FG000|Overall Study|Withdrawal by Subject|1|||
129854578|NCT00524134|467426785|FG000|Overall Study|Physician Decision|1|||
129854579|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
129854580|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
129854581|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
129854582|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
129854583|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
129854584|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
129854585|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Death|1|||
129854586|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Death|0|||
129854587|NCT02554773|467426790|FG000|Original Dose Regimen (SAS 1)|Other|4|||
129854588|NCT02554773|467426791|FG001|Original Dose Regimen (SAS 1)|Other|0|||
129854589|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
129854590|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
129854591|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
129854592|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
129854593|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
129854594|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
129854595|NCT02554773|467426790|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
129854596|NCT02554773|467426791|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
129854597|NCT04831736|467426792|FG000|Overall Study|Withdrawal by Subject|0|||
129854598|NCT04831736|467426793|FG001|Overall Study|Withdrawal by Subject|1|||
129907901|NCT05082935|467624366|FG000|Overall Study|Lost to Follow-up|549|||
129907902|NCT05082935|467624367|FG001|Overall Study|Lost to Follow-up|631|||
129907903|NCT05082935|467624366|FG000|Overall Study|Withdrawal by Subject|27|||
129907904|NCT05082935|467624367|FG001|Overall Study|Withdrawal by Subject|58|||
129907905|NCT00439569|467624368|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
129907906|NCT00439569|467624368|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
129907907|NCT00439569|467624368|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
129907908|NCT01510717|467624369|FG000|Overall Study|Adverse Event|1|||
129907909|NCT01510717|467624370|FG001|Overall Study|Adverse Event|2|||
129907910|NCT01510717|467624369|FG000|Overall Study|Death|1|||
129907911|NCT01510717|467624370|FG001|Overall Study|Death|0|||
129907912|NCT01510717|467624369|FG000|Overall Study|Lost to Follow-up|0|||
129907913|NCT01510717|467624370|FG001|Overall Study|Lost to Follow-up|1|||
129907914|NCT01510717|467624369|FG000|Overall Study|Withdrawal by Subject|0|||
129907915|NCT01510717|467624370|FG001|Overall Study|Withdrawal by Subject|2|||
129907916|NCT02204982|467624371|FG000|Overall Study|Patient ineligible-medical monitor|1|||
129907917|NCT02204982|467624372|FG001|Overall Study|Patient ineligible-medical monitor|0|||
129907918|NCT02204982|467624371|FG000|Overall Study|Withdrawal by Subject|1|||
129907919|NCT02204982|467624372|FG001|Overall Study|Withdrawal by Subject|0|||
129907920|NCT02204982|467624371|FG000|Overall Study|Adverse Event|1|||
129907921|NCT02204982|467624372|FG001|Overall Study|Adverse Event|0|||
129907922|NCT02204982|467624371|FG000|Overall Study|Adverse Event and Investigator decision|1|||
129907923|NCT02204982|467624372|FG001|Overall Study|Adverse Event and Investigator decision|0|||
129907924|NCT02204982|467624371|FG000|Overall Study|Physician Decision|0|||
129907925|NCT02204982|467624372|FG001|Overall Study|Physician Decision|2|||
129907926|NCT02204982|467624371|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
129907927|NCT02204982|467624372|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
129907928|NCT02204982|467624371|FG000|Overall Study|Termination of Study bySponsor|0|||
129907929|NCT02204982|467624372|FG001|Overall Study|Termination of Study bySponsor|1|||
129907930|NCT04594759|467624373|FG000|Overall Study|Lost to Follow-up|3|||
129907931|NCT00529659|467624374|FG000|Overall Study|Adverse Event|8|||
129907932|NCT00529659|467624375|FG001|Overall Study|Adverse Event|7|||
129907933|NCT00529659|467624374|FG000|Overall Study|Lost to Follow-up|0|||
129907934|NCT00529659|467624375|FG001|Overall Study|Lost to Follow-up|2|||
129907935|NCT00529659|467624374|FG000|Overall Study|Physician Decision|0|||
129907936|NCT00529659|467624375|FG001|Overall Study|Physician Decision|2|||
129907937|NCT00529659|467624374|FG000|Overall Study|Protocol Violation|2|||
129907938|NCT00529659|467624375|FG001|Overall Study|Protocol Violation|6|||
129907939|NCT00529659|467624374|FG000|Overall Study|Withdrawal by Subject|1|||
129907940|NCT00529659|467624375|FG001|Overall Study|Withdrawal by Subject|6|||
129907941|NCT01199705|467624378|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
129907942|NCT01415349|467624379|FG000|Treatment Period 1|Adverse Event|0|||
129907943|NCT01415349|467624380|FG001|Treatment Period 1|Adverse Event|1|||
129907944|NCT01415349|467624379|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129907945|NCT01415349|467624380|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129907946|NCT03473340|467624381|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
129907947|NCT03473340|467624382|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
129907948|NCT03473340|467624381|FG000|Overall Study|Withdrawal by Subject|1|||
129907949|NCT03473340|467624382|FG001|Overall Study|Withdrawal by Subject|0|||
129907950|NCT03473340|467624381|FG000|Overall Study|Lost to Follow-up|1|||
129907951|NCT03473340|467624382|FG001|Overall Study|Lost to Follow-up|2|||
129907952|NCT01616459|467624383|FG000|Overall Study|Adverse Event|1|||
129907953|NCT01616459|467624384|FG001|Overall Study|Adverse Event|1|||
129907954|NCT01616459|467624385|FG002|Overall Study|Adverse Event|2|||
129907955|NCT01616459|467624386|FG003|Overall Study|Adverse Event|0|||
129907956|NCT01616459|467624383|FG000|Overall Study|Lost to Follow-up|1|||
129907957|NCT01616459|467624384|FG001|Overall Study|Lost to Follow-up|11|||
129907958|NCT01616459|467624385|FG002|Overall Study|Lost to Follow-up|3|||
129907959|NCT01616459|467624386|FG003|Overall Study|Lost to Follow-up|2|||
129907960|NCT01616459|467624383|FG000|Overall Study|Protocol Violation|0|||
129907961|NCT01616459|467624384|FG001|Overall Study|Protocol Violation|0|||
129907962|NCT01616459|467624385|FG002|Overall Study|Protocol Violation|0|||
129907963|NCT01616459|467624386|FG003|Overall Study|Protocol Violation|2|||
129907964|NCT01616459|467624383|FG000|Overall Study|Withdrawal by Subject|2|||
129907965|NCT01616459|467624384|FG001|Overall Study|Withdrawal by Subject|4|||
129907966|NCT01616459|467624385|FG002|Overall Study|Withdrawal by Subject|4|||
129907967|NCT01616459|467624386|FG003|Overall Study|Withdrawal by Subject|4|||
129907968|NCT01616459|467624383|FG000|Overall Study|Other reason|0|||
129907969|NCT01616459|467624384|FG001|Overall Study|Other reason|1|||
129907970|NCT01616459|467624385|FG002|Overall Study|Other reason|1|||
129907971|NCT01616459|467624386|FG003|Overall Study|Other reason|0|||
129907972|NCT03394885|467624388|FG000|Overall Study|Adverse Event|4|||
129907973|NCT03394885|467624388|FG000|Overall Study|Lack of Efficacy|1|||
129907974|NCT03394885|467624388|FG000|Overall Study|Physician Decision|1|||
129907975|NCT03394885|467624388|FG000|Overall Study|Withdrawal by Subject|8|||
129907976|NCT03394885|467624388|FG000|Overall Study|Alternative Therapy|1|||
129907977|NCT04980755|467624392|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
129907978|NCT04980755|467624392|FG000|Body Reprogramming Courses|Work commitment|2|||
129907979|NCT04980755|467624392|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
129907980|NCT04980755|467624392|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
129907981|NCT04250883|467625868|FG000|Overall Study|Lost to Follow-up|1|||
129907982|NCT04250883|467625869|FG001|Overall Study|Lost to Follow-up|0|||
129907983|NCT01188655|467625871|FG000|Overall Study|Lack of Efficacy|1|||
129907984|NCT01188655|467625871|FG000|Overall Study|Lost to Follow-up|1|||
129907985|NCT01188655|467625871|FG000|Overall Study|Other|11|||
129907986|NCT00089544|467625872|FG000|Overall Study|Ineligible|1|||
129907987|NCT00089544|467625873|FG001|Overall Study|Ineligible|0|||
129907988|NCT02407249|467625878|FG000|Overall Study|Did not complete 12-month follow-up|13|||
129907989|NCT02407249|467625878|FG000|Overall Study|Not treated|13|||
129907990|NCT04425629|467625879|FG000|Overall Study|Adverse Event|0|||
129907991|NCT04425629|467625880|FG001|Overall Study|Adverse Event|0|||
129907992|NCT04425629|467625881|FG002|Overall Study|Adverse Event|0|||
129907993|NCT04425629|467625882|FG003|Overall Study|Adverse Event|0|||
129907994|NCT04425629|467625883|FG004|Overall Study|Adverse Event|1|||
129907995|NCT04425629|467625884|FG005|Overall Study|Adverse Event|0|||
129907996|NCT04425629|467625885|FG006|Overall Study|Adverse Event|0|||
129907997|NCT04425629|467625886|FG007|Overall Study|Adverse Event|0|||
129907998|NCT04425629|467625887|FG008|Overall Study|Adverse Event|0|||
129907999|NCT04425629|467625888|FG009|Overall Study|Adverse Event|3|||
129908000|NCT04425629|467625889|FG010|Overall Study|Adverse Event|2|||
129908001|NCT04425629|467625890|FG011|Overall Study|Adverse Event|1|||
129908002|NCT04425629|467625891|FG012|Overall Study|Adverse Event|1|||
129908003|NCT04425629|467625892|FG013|Overall Study|Adverse Event|0|||
129908004|NCT04425629|467625893|FG014|Overall Study|Adverse Event|0|||
129908005|NCT04425629|467625894|FG015|Overall Study|Adverse Event|0|||
129908006|NCT04425629|467625895|FG016|Overall Study|Adverse Event|0|||
129908007|NCT04425629|467625896|FG017|Overall Study|Adverse Event|0|||
129908008|NCT04425629|467625897|FG018|Overall Study|Adverse Event|0|||
129908009|NCT04425629|467625879|FG000|Overall Study|Lost to Follow-up|1|||
129908010|NCT04425629|467625880|FG001|Overall Study|Lost to Follow-up|3|||
129908011|NCT04425629|467625881|FG002|Overall Study|Lost to Follow-up|1|||
129908012|NCT04425629|467625882|FG003|Overall Study|Lost to Follow-up|7|||
129908013|NCT04425629|467625883|FG004|Overall Study|Lost to Follow-up|1|||
129908014|NCT04425629|467625884|FG005|Overall Study|Lost to Follow-up|2|||
129908015|NCT04425629|467625885|FG006|Overall Study|Lost to Follow-up|1|||
129908016|NCT04425629|467625886|FG007|Overall Study|Lost to Follow-up|0|||
129908017|NCT04425629|467625887|FG008|Overall Study|Lost to Follow-up|1|||
129908018|NCT04425629|467625888|FG009|Overall Study|Lost to Follow-up|64|||
129908019|NCT04425629|467625889|FG010|Overall Study|Lost to Follow-up|70|||
129908020|NCT04425629|467625890|FG011|Overall Study|Lost to Follow-up|98|||
129908021|NCT04425629|467625891|FG012|Overall Study|Lost to Follow-up|30|||
129908022|NCT04425629|467625892|FG013|Overall Study|Lost to Follow-up|0|||
129908023|NCT04425629|467625893|FG014|Overall Study|Lost to Follow-up|5|||
129908024|NCT04425629|467625894|FG015|Overall Study|Lost to Follow-up|4|||
129908025|NCT04425629|467625895|FG016|Overall Study|Lost to Follow-up|0|||
129908026|NCT04425629|467625896|FG017|Overall Study|Lost to Follow-up|3|||
129908027|NCT04425629|467625897|FG018|Overall Study|Lost to Follow-up|1|||
129908028|NCT04425629|467625879|FG000|Overall Study|Subject Decision|0|||
129908029|NCT04425629|467625880|FG001|Overall Study|Subject Decision|2|||
129908030|NCT04425629|467625881|FG002|Overall Study|Subject Decision|1|||
129908031|NCT04425629|467625882|FG003|Overall Study|Subject Decision|3|||
129908032|NCT04425629|467625883|FG004|Overall Study|Subject Decision|6|||
129908033|NCT04425629|467625884|FG005|Overall Study|Subject Decision|6|||
129908034|NCT04425629|467625885|FG006|Overall Study|Subject Decision|3|||
129908035|NCT04425629|467625886|FG007|Overall Study|Subject Decision|3|||
129908036|NCT04425629|467625887|FG008|Overall Study|Subject Decision|1|||
129908037|NCT04425629|467625888|FG009|Overall Study|Subject Decision|70|||
129908038|NCT04425629|467625889|FG010|Overall Study|Subject Decision|95|||
129908039|NCT04425629|467625890|FG011|Overall Study|Subject Decision|124|||
129908040|NCT04425629|467625891|FG012|Overall Study|Subject Decision|25|||
129908041|NCT04425629|467625892|FG013|Overall Study|Subject Decision|0|||
129908042|NCT04425629|467625893|FG014|Overall Study|Subject Decision|1|||
129908043|NCT04425629|467625894|FG015|Overall Study|Subject Decision|4|||
129908044|NCT04425629|467625895|FG016|Overall Study|Subject Decision|1|||
129908045|NCT04425629|467625896|FG017|Overall Study|Subject Decision|0|||
129908046|NCT04425629|467625897|FG018|Overall Study|Subject Decision|2|||
129908047|NCT04425629|467625879|FG000|Overall Study|Death|0|||
129908048|NCT04425629|467625880|FG001|Overall Study|Death|0|||
129908049|NCT04425629|467625881|FG002|Overall Study|Death|0|||
129908050|NCT04425629|467625882|FG003|Overall Study|Death|0|||
129908051|NCT04425629|467625883|FG004|Overall Study|Death|0|||
129908052|NCT04425629|467625884|FG005|Overall Study|Death|0|||
129908053|NCT04425629|467625885|FG006|Overall Study|Death|0|||
129908054|NCT04425629|467625886|FG007|Overall Study|Death|0|||
129908055|NCT04425629|467625887|FG008|Overall Study|Death|0|||
129908056|NCT04425629|467625888|FG009|Overall Study|Death|11|||
129908057|NCT04425629|467625889|FG010|Overall Study|Death|2|||
129908058|NCT04425629|467625890|FG011|Overall Study|Death|4|||
129908059|NCT04425629|467625891|FG012|Overall Study|Death|0|||
129908060|NCT04425629|467625892|FG013|Overall Study|Death|0|||
129908061|NCT04425629|467625893|FG014|Overall Study|Death|0|||
129908062|NCT04425629|467625894|FG015|Overall Study|Death|0|||
129854599|NCT01666002|467426796|FG000|Overall Study|Lost to Follow-up|5|||
129854600|NCT01666002|467426797|FG001|Overall Study|Lost to Follow-up|0|||
129908063|NCT04425629|467625895|FG016|Overall Study|Death|0|||
129908064|NCT04425629|467625896|FG017|Overall Study|Death|0|||
129908065|NCT04425629|467625897|FG018|Overall Study|Death|0|||
129908066|NCT04425629|467625879|FG000|Overall Study|Sponsor Request|0|||
129908067|NCT04425629|467625880|FG001|Overall Study|Sponsor Request|0|||
129908068|NCT04425629|467625881|FG002|Overall Study|Sponsor Request|0|||
129908069|NCT04425629|467625882|FG003|Overall Study|Sponsor Request|2|||
129908070|NCT04425629|467625883|FG004|Overall Study|Sponsor Request|2|||
129908071|NCT04425629|467625884|FG005|Overall Study|Sponsor Request|2|||
129908072|NCT04425629|467625885|FG006|Overall Study|Sponsor Request|1|||
129908073|NCT04425629|467625886|FG007|Overall Study|Sponsor Request|0|||
129908074|NCT04425629|467625887|FG008|Overall Study|Sponsor Request|0|||
129908075|NCT04425629|467625888|FG009|Overall Study|Sponsor Request|9|||
129908076|NCT04425629|467625889|FG010|Overall Study|Sponsor Request|9|||
129908077|NCT04425629|467625890|FG011|Overall Study|Sponsor Request|10|||
129908078|NCT04425629|467625891|FG012|Overall Study|Sponsor Request|8|||
129908079|NCT04425629|467625892|FG013|Overall Study|Sponsor Request|0|||
129908080|NCT04425629|467625893|FG014|Overall Study|Sponsor Request|0|||
129908081|NCT04425629|467625894|FG015|Overall Study|Sponsor Request|1|||
129908082|NCT04425629|467625895|FG016|Overall Study|Sponsor Request|0|||
129908083|NCT04425629|467625896|FG017|Overall Study|Sponsor Request|0|||
129908084|NCT04425629|467625897|FG018|Overall Study|Sponsor Request|0|||
129908085|NCT04425629|467625879|FG000|Overall Study|Physician Decision|0|||
129908086|NCT04425629|467625880|FG001|Overall Study|Physician Decision|0|||
129908087|NCT04425629|467625881|FG002|Overall Study|Physician Decision|0|||
129908088|NCT04425629|467625882|FG003|Overall Study|Physician Decision|0|||
129908089|NCT04425629|467625883|FG004|Overall Study|Physician Decision|0|||
129908090|NCT04425629|467625884|FG005|Overall Study|Physician Decision|0|||
129908091|NCT04425629|467625885|FG006|Overall Study|Physician Decision|0|||
129908092|NCT04425629|467625886|FG007|Overall Study|Physician Decision|0|||
129908093|NCT04425629|467625887|FG008|Overall Study|Physician Decision|0|||
129908094|NCT04425629|467625888|FG009|Overall Study|Physician Decision|4|||
129908095|NCT04425629|467625889|FG010|Overall Study|Physician Decision|3|||
129908096|NCT04425629|467625890|FG011|Overall Study|Physician Decision|5|||
129908097|NCT04425629|467625891|FG012|Overall Study|Physician Decision|1|||
129908098|NCT04425629|467625892|FG013|Overall Study|Physician Decision|0|||
129908099|NCT04425629|467625893|FG014|Overall Study|Physician Decision|0|||
129908100|NCT04425629|467625894|FG015|Overall Study|Physician Decision|1|||
129908101|NCT04425629|467625895|FG016|Overall Study|Physician Decision|0|||
129908102|NCT04425629|467625896|FG017|Overall Study|Physician Decision|0|||
129908103|NCT04425629|467625897|FG018|Overall Study|Physician Decision|0|||
129854601|NCT01233817|467426798|FG000|Overall Study|Lost to Follow-up|1|||
129854602|NCT01233817|467426798|FG000|Overall Study|Withdrawal by Subject|2|||
129854603|NCT02159482|467426799|FG000|Overall Study|Withdrawal by Subject|2|||
129854604|NCT02159482|467426799|FG000|Overall Study|Physician Decision|3|||
129854605|NCT04479618|467426800|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
129854606|NCT04479618|467426801|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
129854607|NCT04479618|467426802|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
129854608|NCT04479618|467426800|FG000|Overall Study|Lack of Efficacy|1|||
129854609|NCT04479618|467426801|FG001|Overall Study|Lack of Efficacy|0|||
129854610|NCT04479618|467426802|FG002|Overall Study|Lack of Efficacy|0|||
129854611|NCT04479618|467426800|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
129854612|NCT04479618|467426801|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
129854613|NCT04479618|467426802|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
129854614|NCT04479618|467426800|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
129854615|NCT04479618|467426801|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
129908104|NCT04425629|467625879|FG000|Overall Study|Lack of Efficacy|0|||
129908105|NCT04425629|467625880|FG001|Overall Study|Lack of Efficacy|0|||
129908106|NCT04425629|467625881|FG002|Overall Study|Lack of Efficacy|0|||
129854616|NCT04479618|467426802|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
129854617|NCT04479618|467426800|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
129908107|NCT04425629|467625882|FG003|Overall Study|Lack of Efficacy|0|||
129908108|NCT04425629|467625883|FG004|Overall Study|Lack of Efficacy|0|||
129908109|NCT04425629|467625884|FG005|Overall Study|Lack of Efficacy|0|||
129908110|NCT04425629|467625885|FG006|Overall Study|Lack of Efficacy|0|||
129908111|NCT04425629|467625886|FG007|Overall Study|Lack of Efficacy|0|||
129908112|NCT04425629|467625887|FG008|Overall Study|Lack of Efficacy|0|||
129908113|NCT04425629|467625888|FG009|Overall Study|Lack of Efficacy|0|||
129908114|NCT04425629|467625889|FG010|Overall Study|Lack of Efficacy|1|||
129908115|NCT04425629|467625890|FG011|Overall Study|Lack of Efficacy|0|||
129908116|NCT04425629|467625891|FG012|Overall Study|Lack of Efficacy|0|||
129908117|NCT04425629|467625892|FG013|Overall Study|Lack of Efficacy|0|||
129908118|NCT04425629|467625893|FG014|Overall Study|Lack of Efficacy|0|||
129908119|NCT04425629|467625894|FG015|Overall Study|Lack of Efficacy|0|||
129908120|NCT04425629|467625895|FG016|Overall Study|Lack of Efficacy|0|||
129908121|NCT04425629|467625896|FG017|Overall Study|Lack of Efficacy|0|||
129908122|NCT04425629|467625897|FG018|Overall Study|Lack of Efficacy|0|||
129908123|NCT00610649|467625898|FG000|Overall Study|Adverse Event|1|||
129908124|NCT00610649|467625899|FG001|Overall Study|Adverse Event|0|||
129908125|NCT00610649|467625900|FG002|Overall Study|Adverse Event|0|||
129908126|NCT00610649|467625901|FG003|Overall Study|Adverse Event|0|||
129908127|NCT00610649|467625902|FG004|Overall Study|Adverse Event|0|||
129908128|NCT00610649|467625903|FG005|Overall Study|Adverse Event|0|||
129908129|NCT00610649|467625904|FG006|Overall Study|Adverse Event|0|||
129908130|NCT00610649|467625905|FG007|Overall Study|Adverse Event|0|||
129908131|NCT00610649|467625906|FG008|Overall Study|Adverse Event|0|||
129908132|NCT00610649|467625907|FG009|Overall Study|Adverse Event|0|||
129908133|NCT00610649|467625908|FG010|Overall Study|Adverse Event|1|||
129908134|NCT00610649|467625898|FG000|Overall Study|Family Emergency|0|||
129908135|NCT00610649|467625899|FG001|Overall Study|Family Emergency|1|||
129908136|NCT00610649|467625900|FG002|Overall Study|Family Emergency|0|||
129908137|NCT00610649|467625901|FG003|Overall Study|Family Emergency|0|||
129908138|NCT00610649|467625902|FG004|Overall Study|Family Emergency|0|||
129908139|NCT00610649|467625903|FG005|Overall Study|Family Emergency|0|||
129908140|NCT00610649|467625904|FG006|Overall Study|Family Emergency|0|||
129908141|NCT00610649|467625905|FG007|Overall Study|Family Emergency|0|||
129908142|NCT00610649|467625906|FG008|Overall Study|Family Emergency|0|||
129908143|NCT00610649|467625907|FG009|Overall Study|Family Emergency|0|||
129908144|NCT00610649|467625908|FG010|Overall Study|Family Emergency|0|||
129908145|NCT00610649|467625898|FG000|Overall Study|Withdrawal by Subject|0|||
129908146|NCT00610649|467625899|FG001|Overall Study|Withdrawal by Subject|0|||
129908147|NCT00610649|467625900|FG002|Overall Study|Withdrawal by Subject|0|||
129908148|NCT00610649|467625901|FG003|Overall Study|Withdrawal by Subject|0|||
129908149|NCT00610649|467625902|FG004|Overall Study|Withdrawal by Subject|0|||
129908150|NCT00610649|467625903|FG005|Overall Study|Withdrawal by Subject|0|||
129908151|NCT00610649|467625904|FG006|Overall Study|Withdrawal by Subject|0|||
129908152|NCT00610649|467625905|FG007|Overall Study|Withdrawal by Subject|0|||
129908153|NCT00610649|467625906|FG008|Overall Study|Withdrawal by Subject|0|||
129908154|NCT00610649|467625907|FG009|Overall Study|Withdrawal by Subject|1|||
129908155|NCT00610649|467625908|FG010|Overall Study|Withdrawal by Subject|0|||
129908156|NCT00414544|467625911|FG000|Overall Study|Lost to Follow-up|14|||
129908157|NCT01149369|467625912|FG000|Overall Study|Adverse Event|6|||
129908158|NCT01149369|467625913|FG001|Overall Study|Adverse Event|3|||
129908159|NCT01078116|467625918|FG000|Overall Study|Lost to Follow-up|17|||
129908160|NCT01078116|467625918|FG000|Overall Study|Adverse Event|5|||
129908161|NCT01078116|467625918|FG000|Overall Study|Withdrawal by Subject|8|||
129908162|NCT01078116|467625918|FG000|Overall Study|Lack of effectiveness|15|||
129908163|NCT01078116|467625918|FG000|Overall Study|Case report form not completed|3|||
129908164|NCT02601820|467625919|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
129908165|NCT02601820|467625919|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
129908166|NCT02601820|467625919|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
129908167|NCT02601820|467625919|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
129908168|NCT02242487|467625920|FG000|Overall Study|Adverse Event|13|||
129908169|NCT02242487|467625921|FG001|Overall Study|Adverse Event|15|||
129908170|NCT02242487|467625920|FG000|Overall Study|Lack of Efficacy|4|||
129908171|NCT02242487|467625921|FG001|Overall Study|Lack of Efficacy|6|||
129908172|NCT02242487|467625920|FG000|Overall Study|Protocol Violation|2|||
129908173|NCT02242487|467625921|FG001|Overall Study|Protocol Violation|0|||
129908174|NCT02242487|467625920|FG000|Overall Study|Lost to Follow-up|2|||
129908175|NCT02242487|467625921|FG001|Overall Study|Lost to Follow-up|1|||
129908176|NCT02242487|467625920|FG000|Overall Study|Other - Miscellaneous|4|||
129908177|NCT02242487|467625921|FG001|Overall Study|Other - Miscellaneous|6|||
129908178|NCT02242487|467625920|FG000|Overall Study|Withdrawal by Subject|37|||
129908179|NCT02242487|467625921|FG001|Overall Study|Withdrawal by Subject|19|||
129908180|NCT01599793|467625922|FG000|Overall Study|Adverse Event|2|||
129908181|NCT00869258|467625929|FG000|Overall Study|Physician Decision|1|||
129908182|NCT00636207|467625930|FG000|Overall Study|Adverse Event|1|||
129908183|NCT00636207|467625931|FG001|Overall Study|Adverse Event|0|||
129908184|NCT00636207|467625932|FG002|Overall Study|Adverse Event|0|||
129908185|NCT00636207|467625933|FG003|Overall Study|Adverse Event|0|||
129908186|NCT00636207|467625934|FG004|Overall Study|Adverse Event|0|||
129908187|NCT00636207|467625935|FG005|Overall Study|Adverse Event|0|||
129854618|NCT04479618|467426801|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
129854619|NCT04479618|467426802|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
129854620|NCT04479618|467426800|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
129854621|NCT04479618|467426801|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
129854622|NCT04479618|467426802|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
129854623|NCT01202773|467426803|FG000|Overall Study|Adverse Event|4|||
129854624|NCT01202773|467426804|FG001|Overall Study|Adverse Event|5|||
129854625|NCT01202773|467426805|FG002|Overall Study|Adverse Event|5|||
129854626|NCT01202773|467426803|FG000|Overall Study|Lack of Efficacy|5|||
129854627|NCT01202773|467426804|FG001|Overall Study|Lack of Efficacy|4|||
129854628|NCT01202773|467426805|FG002|Overall Study|Lack of Efficacy|9|||
129854629|NCT01202773|467426803|FG000|Overall Study|Entry Criteria Not Met|2|||
129854630|NCT01202773|467426804|FG001|Overall Study|Entry Criteria Not Met|0|||
129854631|NCT01202773|467426805|FG002|Overall Study|Entry Criteria Not Met|1|||
129854632|NCT01202773|467426803|FG000|Overall Study|Lost to Follow-up|1|||
129854633|NCT01202773|467426804|FG001|Overall Study|Lost to Follow-up|2|||
129854634|NCT01202773|467426805|FG002|Overall Study|Lost to Follow-up|2|||
129854635|NCT01202773|467426803|FG000|Overall Study|Withdrawal by Subject|13|||
129854636|NCT01202773|467426804|FG001|Overall Study|Withdrawal by Subject|6|||
129854637|NCT01202773|467426805|FG002|Overall Study|Withdrawal by Subject|5|||
129854638|NCT01202773|467426803|FG000|Overall Study|Physician Decision|2|||
129854639|NCT01202773|467426804|FG001|Overall Study|Physician Decision|0|||
129854640|NCT01202773|467426805|FG002|Overall Study|Physician Decision|0|||
129854641|NCT01202773|467426803|FG000|Overall Study|Protocol Violation|11|||
129854642|NCT01202773|467426804|FG001|Overall Study|Protocol Violation|6|||
129854643|NCT01202773|467426805|FG002|Overall Study|Protocol Violation|10|||
129854644|NCT01202773|467426803|FG000|Overall Study|Sponsor Decision|19|||
129854645|NCT01202773|467426804|FG001|Overall Study|Sponsor Decision|20|||
129854646|NCT01202773|467426805|FG002|Overall Study|Sponsor Decision|23|||
129854647|NCT00462384|467426813|FG000|Overall Study|Adverse Event|2|||
129854648|NCT00462384|467426813|FG000|Overall Study|Death|2|||
129854649|NCT00462384|467426813|FG000|Overall Study|Withdrawal by Subject|1|||
129854650|NCT00462384|467426813|FG000|Overall Study|Other|4|||
129854651|NCT00346034|467426814|FG000|Overall Study|Adverse Event|34|||
129854652|NCT00346034|467426814|FG000|Overall Study|Lack of Efficacy|8|||
129854653|NCT00346034|467426814|FG000|Overall Study|Withdrawal by Subject|13|||
129854654|NCT00346034|467426814|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
129854655|NCT00346034|467426814|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
129854656|NCT01255358|467426815|FG000|Overall Study|Adverse Event|2|||
129854657|NCT01255358|467426815|FG000|Overall Study|Protocol Violation|2|||
129854658|NCT00797667|467426816|FG000|Overall Study|Lack of Efficacy|0|||
129854659|NCT00797667|467426817|FG001|Overall Study|Lack of Efficacy|1|||
129854660|NCT00797667|467426818|FG002|Overall Study|Lack of Efficacy|0|||
129854661|NCT00797667|467426816|FG000|Overall Study|Lost to Follow-up|8|||
129854662|NCT00797667|467426817|FG001|Overall Study|Lost to Follow-up|12|||
129854663|NCT00797667|467426818|FG002|Overall Study|Lost to Follow-up|2|||
129854664|NCT00797667|467426816|FG000|Overall Study|Physician Decision|3|||
129854665|NCT00797667|467426817|FG001|Overall Study|Physician Decision|1|||
129854666|NCT00797667|467426818|FG002|Overall Study|Physician Decision|0|||
129854667|NCT00797667|467426816|FG000|Overall Study|Pregnancy|2|||
129854668|NCT00797667|467426817|FG001|Overall Study|Pregnancy|0|||
129854669|NCT00797667|467426818|FG002|Overall Study|Pregnancy|0|||
129854670|NCT00797667|467426816|FG000|Overall Study|Protocol Violation|2|||
129854671|NCT00797667|467426817|FG001|Overall Study|Protocol Violation|7|||
129854672|NCT00797667|467426818|FG002|Overall Study|Protocol Violation|0|||
129854673|NCT00797667|467426816|FG000|Overall Study|Study Terminated by Sponsor|217|||
129854674|NCT00797667|467426817|FG001|Overall Study|Study Terminated by Sponsor|216|||
129854675|NCT00797667|467426818|FG002|Overall Study|Study Terminated by Sponsor|115|||
129854676|NCT00797667|467426816|FG000|Overall Study|Withdrawal by Subject|9|||
129854677|NCT00797667|467426817|FG001|Overall Study|Withdrawal by Subject|14|||
129854678|NCT00797667|467426818|FG002|Overall Study|Withdrawal by Subject|2|||
129854679|NCT00797667|467426816|FG000|Overall Study|Adverse Event|19|||
129854680|NCT00797667|467426817|FG001|Overall Study|Adverse Event|8|||
129854681|NCT00797667|467426818|FG002|Overall Study|Adverse Event|8|||
129854682|NCT01986829|467426819|FG000|Overall Study|Death|1|||
129854683|NCT02504866|467426820|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
129854684|NCT02504866|467426821|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
129854685|NCT02504866|467426822|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
129854686|NCT03231371|467426823|FG000|Overall Study|Withdrawal by Subject|1|||
129854687|NCT03231371|467426823|FG000|Overall Study|chose or were ineligible to have MRI|12|||
129854688|NCT01732835|467426826|FG000|6-month Primary Endpoint|Did not receive device|19|||
129854689|NCT01732835|467426826|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
129854690|NCT01732835|467426826|FG000|6-month Primary Endpoint|Adverse Event|3|||
129854691|NCT01732835|467426826|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
129908188|NCT00636207|467625936|FG006|Overall Study|Adverse Event|0|||
129908189|NCT00636207|467625930|FG000|Overall Study|Withdrawal by Subject|0|||
129908190|NCT00636207|467625931|FG001|Overall Study|Withdrawal by Subject|1|||
129908191|NCT00636207|467625932|FG002|Overall Study|Withdrawal by Subject|0|||
129908192|NCT00636207|467625933|FG003|Overall Study|Withdrawal by Subject|0|||
129908193|NCT00636207|467625934|FG004|Overall Study|Withdrawal by Subject|1|||
129908194|NCT00636207|467625935|FG005|Overall Study|Withdrawal by Subject|0|||
129908195|NCT00636207|467625936|FG006|Overall Study|Withdrawal by Subject|0|||
129908196|NCT01641198|467625937|FG000|After 12 Months of Function|Lost to Follow-up|3|||
129908197|NCT01641198|467625938|FG001|After 12 Months of Function|Lost to Follow-up|2|||
129908198|NCT01641198|467625939|FG002|After 12 Months of Function|Lost to Follow-up|2|||
129908199|NCT01641198|467625937|FG000|After 12 Months of Function|Protocol Violation|1|||
129908200|NCT01641198|467625938|FG001|After 12 Months of Function|Protocol Violation|0|||
129908201|NCT01641198|467625939|FG002|After 12 Months of Function|Protocol Violation|0|||
129908202|NCT01641198|467625937|FG000|After 12 Months of Function|Adverse Event|0|||
129908203|NCT01641198|467625938|FG001|After 12 Months of Function|Adverse Event|1|||
129908204|NCT01641198|467625939|FG002|After 12 Months of Function|Adverse Event|0|||
129908205|NCT01641198|467625937|FG000|After 24 Months of Function|Lost to Follow-up|4|||
129908206|NCT01641198|467625938|FG001|After 24 Months of Function|Lost to Follow-up|9|||
129908207|NCT01641198|467625939|FG002|After 24 Months of Function|Lost to Follow-up|6|||
129908208|NCT01641198|467625937|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
129908209|NCT01641198|467625938|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
129908210|NCT01641198|467625939|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
129908211|NCT01641198|467625937|FG000|At 15-20 Years of Function|Death|1|||
129908212|NCT01641198|467625938|FG001|At 15-20 Years of Function|Death|0|||
129908213|NCT01641198|467625939|FG002|At 15-20 Years of Function|Death|1|||
129908214|NCT02529995|467625941|FG000|Part A|Ongoing Study at Data Cut-off|14|||
129908215|NCT02529995|467625942|FG001|Part A|Ongoing Study at Data Cut-off|16|||
129908216|NCT02529995|467625941|FG000|Part A|Discontinued Study|1|||
129908217|NCT02529995|467625942|FG001|Part A|Discontinued Study|0|||
129908218|NCT02529995|467625941|FG000|Part B|Ongoing Study at Data Cut-off|0|||
129908219|NCT02529995|467625942|FG001|Part B|Ongoing Study at Data Cut-off|7|||
129908220|NCT02529995|467625941|FG000|Part B|Discontinued Study|6|||
129908221|NCT02529995|467625942|FG001|Part B|Discontinued Study|5|||
129908222|NCT01075217|467625945|FG000|Overall Study|Adverse Event|1|||
129908223|NCT01075217|467625946|FG001|Overall Study|Adverse Event|1|||
129908224|NCT01075217|467625945|FG000|Overall Study|Physician Decision|1|||
129908225|NCT01075217|467625946|FG001|Overall Study|Physician Decision|0|||
129908226|NCT00364013|467625947|FG000|Overall Study|Ineligibility determined|4|||
129908227|NCT00364013|467625948|FG001|Overall Study|Ineligibility determined|2|||
129908228|NCT00364013|467625947|FG000|Overall Study|Adverse Event|4|||
129908229|NCT00364013|467625948|FG001|Overall Study|Adverse Event|3|||
129908230|NCT00364013|467625947|FG000|Overall Study|Withdrawal by Subject|13|||
129908231|NCT00364013|467625948|FG001|Overall Study|Withdrawal by Subject|18|||
129908232|NCT00364013|467625947|FG000|Overall Study|Physician Decision|3|||
129908233|NCT00364013|467625948|FG001|Overall Study|Physician Decision|3|||
129908234|NCT00364013|467625947|FG000|Overall Study|Lost to Follow-up|10|||
129908235|NCT00364013|467625948|FG001|Overall Study|Lost to Follow-up|3|||
129908236|NCT00364013|467625947|FG000|Overall Study|Protocol-specified criteria|6|||
129908237|NCT00364013|467625948|FG001|Overall Study|Protocol-specified criteria|6|||
129908238|NCT00364013|467625947|FG000|Overall Study|Other|41|||
129908239|NCT00364013|467625948|FG001|Overall Study|Other|47|||
129908240|NCT00364013|467625947|FG000|Overall Study|Ongoing|20|||
129908241|NCT00364013|467625948|FG001|Overall Study|Ongoing|13|||
129908242|NCT01943916|467625949|FG000|Overall Study|Technically invalid images|10|||
129908243|NCT01943916|467625949|FG000|Overall Study|Enrollment Failure|23|||
129908244|NCT01943916|467625949|FG000|Overall Study|Pilot Phase exclusion|100|||
129908245|NCT01943916|467625949|FG000|Overall Study|Quality Assurance Reader Fail|130|||
129908246|NCT01943916|467625949|FG000|Overall Study|Technical Failure|39|||
129908247|NCT01943916|467625949|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
129908248|NCT01943916|467625949|FG000|Overall Study|No Truth Panel Review|38|||
129908249|NCT01943916|467625949|FG000|Overall Study|Protocol Deviation|1|||
129908250|NCT05274217|467625950|FG000|Overall Study|Study terminated.|11|||
129908251|NCT05274217|467625951|FG001|Overall Study|Study terminated.|0|||
129908252|NCT03811574|467625954|FG000|Overall Study|Withdrawal by Subject|2|||
129908253|NCT03811574|467625955|FG001|Overall Study|Withdrawal by Subject|4|||
129908254|NCT03811574|467625956|FG002|Overall Study|Withdrawal by Subject|0|||
129908255|NCT01832480|467625957|FG000|Overall Study|Lost to Follow-up|33|||
129908256|NCT01832480|467625958|FG001|Overall Study|Lost to Follow-up|30|||
129908257|NCT01832480|467625957|FG000|Overall Study|Withdrawal by Subject|0|||
129908258|NCT01832480|467625958|FG001|Overall Study|Withdrawal by Subject|2|||
129908259|NCT01832480|467625957|FG000|Overall Study|post randomization ineligible|8|||
129908260|NCT01832480|467625958|FG001|Overall Study|post randomization ineligible|10|||
129908261|NCT05609032|467625959|FG000|Overall Study|Lost to Follow-up|3|||
129908262|NCT05609032|467625960|FG001|Overall Study|Lost to Follow-up|1|||
129908263|NCT05609032|467625959|FG000|Overall Study|Withdrawal by Subject|1|||
129908264|NCT05609032|467625960|FG001|Overall Study|Withdrawal by Subject|0|||
129908265|NCT02261467|467625961|FG000|Overall Study|Enrolled in Error|1|||
129908266|NCT02261467|467625962|FG001|Overall Study|Enrolled in Error|0|||
129908267|NCT02261467|467625961|FG000|Overall Study|Protocol Violation|0|||
129908268|NCT02261467|467625962|FG001|Overall Study|Protocol Violation|1|||
129908269|NCT02261467|467625961|FG000|Overall Study|Personal Reasons|17|||
129908270|NCT02261467|467625962|FG001|Overall Study|Personal Reasons|22|||
129908271|NCT02261467|467625961|FG000|Overall Study|Lost to Follow-up|2|||
129908272|NCT02261467|467625962|FG001|Overall Study|Lost to Follow-up|13|||
129908273|NCT02261467|467625961|FG000|Overall Study|Adverse Event|1|||
129908274|NCT02261467|467625962|FG001|Overall Study|Adverse Event|1|||
129908275|NCT02674750|467625968|FG000|Overall Study|Death|4|||
129908276|NCT02674750|467625969|FG001|Overall Study|Death|5|||
129908277|NCT02674750|467625970|FG002|Overall Study|Death|8|||
129908278|NCT02674750|467625968|FG000|Overall Study|Lost to Follow-up|0|||
129908279|NCT02674750|467625969|FG001|Overall Study|Lost to Follow-up|8|||
129908280|NCT02674750|467625970|FG002|Overall Study|Lost to Follow-up|0|||
129908281|NCT02674750|467625968|FG000|Overall Study|Lack of Efficacy|1|||
129908282|NCT02674750|467625969|FG001|Overall Study|Lack of Efficacy|17|||
129908283|NCT02674750|467625970|FG002|Overall Study|Lack of Efficacy|3|||
129908284|NCT02674750|467625968|FG000|Overall Study|Withdrawal by Subject|0|||
129908285|NCT02674750|467625969|FG001|Overall Study|Withdrawal by Subject|7|||
129908286|NCT02674750|467625970|FG002|Overall Study|Withdrawal by Subject|1|||
129908287|NCT02674750|467625968|FG000|Overall Study|Other|0|||
129908288|NCT02674750|467625969|FG001|Overall Study|Other|8|||
129908289|NCT02674750|467625970|FG002|Overall Study|Other|0|||
129908290|NCT01685606|467625973|FG000|Overall Study|Withdrawal by Subject|1|||
129908291|NCT01787760|467625974|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
129908292|NCT01787760|467625975|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
129908293|NCT01787760|467625976|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
129908294|NCT01787760|467625974|FG000|Overall Study|Decompensated on left exotropia|0|||
129908295|NCT01787760|467625975|FG001|Overall Study|Decompensated on left exotropia|0|||
129908296|NCT01787760|467625976|FG002|Overall Study|Decompensated on left exotropia|1|||
129908297|NCT01787760|467625974|FG000|Overall Study|Dryness|0|||
129908298|NCT01787760|467625975|FG001|Overall Study|Dryness|1|||
129908299|NCT01787760|467625976|FG002|Overall Study|Dryness|0|||
129908300|NCT01787760|467625974|FG000|Overall Study|Relocation|1|||
129908301|NCT01787760|467625975|FG001|Overall Study|Relocation|1|||
129908302|NCT01787760|467625976|FG002|Overall Study|Relocation|0|||
129908303|NCT01787760|467625974|FG000|Overall Study|Lens discomfort|3|||
129854692|NCT01732835|467426826|FG000|2-year Extended Follow-up|Adverse Event|3|||
129854693|NCT01732835|467426826|FG000|2-year Extended Follow-up|Death|1|||
129854694|NCT02493361|467426827|FG000|Overall Study|Withdrawal by Subject|3|||
129854695|NCT02334748|467426828|FG000|Overall Study|Adverse Event|1|||
129854696|NCT02334748|467426828|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
129854697|NCT02334748|467426828|FG000|Overall Study|Patient no longer required study drug|2|||
129854698|NCT02334748|467426828|FG000|Overall Study|Lack of Efficacy|4|||
129854699|NCT03067441|467426829|FG000|Overall Study|Withdrawal by Subject|16|||
129854700|NCT03067441|467426830|FG001|Overall Study|Withdrawal by Subject|34|||
129854701|NCT03067441|467426829|FG000|Overall Study|Lost to Follow-up|7|||
129854702|NCT03067441|467426830|FG001|Overall Study|Lost to Follow-up|5|||
129854703|NCT03067441|467426829|FG000|Overall Study|Adverse Event|7|||
129854704|NCT03067441|467426830|FG001|Overall Study|Adverse Event|14|||
129854705|NCT03067441|467426829|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
129854706|NCT03067441|467426830|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
129854707|NCT03067441|467426829|FG000|Overall Study|Physician Decision|1|||
129854708|NCT03067441|467426830|FG001|Overall Study|Physician Decision|3|||
129854709|NCT03067441|467426829|FG000|Overall Study|Other|1|||
129854710|NCT03067441|467426830|FG001|Overall Study|Other|1|||
129854711|NCT02056301|467426834|FG000|Overall Study|Protocol Violation|1|||
129854712|NCT02056301|467426835|FG001|Overall Study|Protocol Violation|2|||
129854713|NCT02056301|467426834|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
129854714|NCT02056301|467426835|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
129908304|NCT01787760|467625975|FG001|Overall Study|Lens discomfort|0|||
129908305|NCT01787760|467625976|FG002|Overall Study|Lens discomfort|0|||
129908306|NCT01787760|467625974|FG000|Overall Study|Lens handling difficulty|1|||
129854715|NCT02056301|467426834|FG000|Overall Study|Withdrawal by Subject|0|||
129854716|NCT02056301|467426835|FG001|Overall Study|Withdrawal by Subject|1|||
129854717|NCT02056301|467426834|FG000|Overall Study|Issues with epidural|0|||
129908307|NCT01787760|467625975|FG001|Overall Study|Lens handling difficulty|2|||
129908308|NCT01787760|467625976|FG002|Overall Study|Lens handling difficulty|0|||
129908309|NCT01787760|467625974|FG000|Overall Study|Protocol Violation|6|||
129908310|NCT01787760|467625975|FG001|Overall Study|Protocol Violation|0|||
129908311|NCT01787760|467625976|FG002|Overall Study|Protocol Violation|1|||
129908312|NCT01787760|467625974|FG000|Overall Study|Withdrawal by Subject|5|||
129854718|NCT02056301|467426835|FG001|Overall Study|Issues with epidural|3|||
129854719|NCT02209324|467426839|FG000|Overall Study|Adverse Event|2|||
129854720|NCT02209324|467426839|FG000|Overall Study|Lack of Efficacy|1|||
129854721|NCT02209324|467426839|FG000|Overall Study|Lost to Follow-up|1|||
129854722|NCT02209324|467426839|FG000|Overall Study|Physician Decision|3|||
129854723|NCT02209324|467426839|FG000|Overall Study|Protocol Violation|14|||
129854724|NCT02209324|467426839|FG000|Overall Study|Withdrawal by Subject|8|||
129854725|NCT02209324|467426839|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
129854726|NCT02209324|467426839|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
129854727|NCT02209324|467426839|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
129854728|NCT03433456|467426840|FG000|Overall Study|Death|1|||
129854729|NCT03433456|467426841|FG001|Overall Study|Death|1|||
129854730|NCT03433456|467426840|FG000|Overall Study|Lost to Follow-up|14|||
129854731|NCT03433456|467426841|FG001|Overall Study|Lost to Follow-up|11|||
129854732|NCT03433456|467426840|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
129854733|NCT03433456|467426841|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
129854734|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
129854735|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
129854736|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
129854737|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
129854738|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
129854739|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
129854740|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
129854741|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
129854742|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Other|0|||
129854743|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Other|1|||
129854744|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Other|0|||
129854745|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Other|0|||
129854746|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
129854747|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
129854748|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
129854749|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
129854750|NCT05799495|467426842|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
129854751|NCT05799495|467426843|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
129854752|NCT05799495|467426844|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
129854753|NCT05799495|467426845|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
129854754|NCT05799495|467426842|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129854755|NCT05799495|467426843|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129854756|NCT05799495|467426844|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
129854757|NCT05799495|467426845|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
129854758|NCT03105362|467426846|FG000|Overall Study|Withdrawal by Subject|1|||
129854759|NCT03105362|467426846|FG000|Overall Study|Lost to Follow-up|1|||
129854760|NCT01198600|467426847|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
129854761|NCT01198600|467426848|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
129854762|NCT01198600|467426849|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
129854763|NCT01198600|467426850|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
129854764|NCT01198600|467426847|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
129854765|NCT01198600|467426848|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
129854766|NCT01198600|467426849|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
129854767|NCT01198600|467426850|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
129854768|NCT01198600|467426847|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
129854769|NCT01198600|467426848|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
129854770|NCT01198600|467426849|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
129854771|NCT01198600|467426850|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
129854772|NCT01198600|467426847|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
129854773|NCT01198600|467426848|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
129854774|NCT01198600|467426849|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
129854775|NCT01198600|467426850|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
129854776|NCT01198600|467426847|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
129854777|NCT01198600|467426848|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
129854778|NCT01198600|467426849|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
129854779|NCT01198600|467426850|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
129854780|NCT01198600|467426847|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
129854781|NCT01198600|467426848|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
129854782|NCT01198600|467426849|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
129854783|NCT01198600|467426850|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
129854784|NCT01198600|467426847|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
129854785|NCT01198600|467426848|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
129854786|NCT01198600|467426849|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
129854787|NCT01198600|467426850|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
129908313|NCT01787760|467625975|FG001|Overall Study|Withdrawal by Subject|1|||
129908314|NCT01787760|467625976|FG002|Overall Study|Withdrawal by Subject|2|||
129908315|NCT01787760|467625974|FG000|Overall Study|Lost to Follow-up|1|||
129908316|NCT01787760|467625975|FG001|Overall Study|Lost to Follow-up|0|||
129908317|NCT01787760|467625976|FG002|Overall Study|Lost to Follow-up|1|||
129908318|NCT01787760|467625974|FG000|Overall Study|Stroke|1|||
129908319|NCT01787760|467625975|FG001|Overall Study|Stroke|0|||
129908320|NCT01787760|467625976|FG002|Overall Study|Stroke|0|||
129908321|NCT01787760|467625974|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
129908322|NCT01787760|467625975|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
129908323|NCT01787760|467625976|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
129908324|NCT01787760|467625974|FG000|Overall Study|Unsatisfactory physiological response|2|||
129908325|NCT01787760|467625975|FG001|Overall Study|Unsatisfactory physiological response|4|||
129908326|NCT01787760|467625976|FG002|Overall Study|Unsatisfactory physiological response|0|||
129908327|NCT01787760|467625974|FG000|Overall Study|Unsatisfactory visual response|1|||
129908328|NCT01787760|467625975|FG001|Overall Study|Unsatisfactory visual response|1|||
129908329|NCT01787760|467625976|FG002|Overall Study|Unsatisfactory visual response|0|||
129908330|NCT01787760|467625974|FG000|Overall Study|Near vision blur|1|||
129908331|NCT01787760|467625975|FG001|Overall Study|Near vision blur|0|||
129908332|NCT01787760|467625976|FG002|Overall Study|Near vision blur|0|||
129908333|NCT03512756|467625977|FG000|Part 1|Death|23|||
129908334|NCT03512756|467625978|FG001|Part 1|Death|18|||
129908335|NCT03512756|467625979|FG002|Part 1|Death|0|||
129908336|NCT03512756|467625980|FG003|Part 1|Death|0|||
129908337|NCT03512756|467625977|FG000|Part 1|Lost to Follow-up|0|||
129908338|NCT03512756|467625978|FG001|Part 1|Lost to Follow-up|3|||
129908339|NCT03512756|467625979|FG002|Part 1|Lost to Follow-up|0|||
129908340|NCT03512756|467625980|FG003|Part 1|Lost to Follow-up|0|||
129908341|NCT03512756|467625977|FG000|Part 1|Physician Decision|0|||
129908342|NCT03512756|467625978|FG001|Part 1|Physician Decision|1|||
129908343|NCT03512756|467625979|FG002|Part 1|Physician Decision|0|||
129908344|NCT03512756|467625980|FG003|Part 1|Physician Decision|0|||
129908345|NCT03512756|467625977|FG000|Part 1|Withdrawal by Subject|2|||
129908346|NCT03512756|467625978|FG001|Part 1|Withdrawal by Subject|2|||
129908347|NCT03512756|467625979|FG002|Part 1|Withdrawal by Subject|0|||
129908348|NCT03512756|467625980|FG003|Part 1|Withdrawal by Subject|0|||
129908349|NCT03512756|467625977|FG000|Part 2|Death|0|||
129908350|NCT03512756|467625978|FG001|Part 2|Death|0|||
129908351|NCT03512756|467625979|FG002|Part 2|Death|32|||
129908352|NCT03512756|467625980|FG003|Part 2|Death|21|||
129854788|NCT03694548|467426851|FG000|Part A Survey|Protocol Violation|3|||
129854789|NCT03694548|467426852|FG001|Part A Survey|Protocol Violation|3|||
129854790|NCT03694548|467426853|FG002|Part A Survey|Protocol Violation|0|||
129854791|NCT03694548|467426851|FG000|Part B Yoga Program|Protocol Violation|0|||
129854792|NCT03694548|467426852|FG001|Part B Yoga Program|Protocol Violation|0|||
129854793|NCT03694548|467426853|FG002|Part B Yoga Program|Protocol Violation|3|||
129854794|NCT03694548|467426851|FG000|Part B Yoga Program|Did not attend intervention|0|||
129854795|NCT03694548|467426852|FG001|Part B Yoga Program|Did not attend intervention|0|||
129854796|NCT03694548|467426853|FG002|Part B Yoga Program|Did not attend intervention|8|||
129854797|NCT04177108|467426854|FG000|Overall Study|Withdrawal by Subject|4|||
129854798|NCT04177108|467426855|FG001|Overall Study|Withdrawal by Subject|8|||
129854799|NCT04177108|467426856|FG002|Overall Study|Withdrawal by Subject|9|||
129854800|NCT04177108|467426857|FG003|Overall Study|Withdrawal by Subject|11|||
129854801|NCT04177108|467426858|FG004|Overall Study|Withdrawal by Subject|13|||
129854802|NCT04177108|467426854|FG000|Overall Study|Physician Decision|23|||
129854803|NCT04177108|467426855|FG001|Overall Study|Physician Decision|15|||
129854804|NCT04177108|467426856|FG002|Overall Study|Physician Decision|18|||
129854805|NCT04177108|467426857|FG003|Overall Study|Physician Decision|29|||
129854806|NCT04177108|467426858|FG004|Overall Study|Physician Decision|23|||
129854807|NCT04177108|467426854|FG000|Overall Study|Reason Not Specified|0|||
129854808|NCT04177108|467426855|FG001|Overall Study|Reason Not Specified|1|||
129854809|NCT04177108|467426856|FG002|Overall Study|Reason Not Specified|0|||
129854810|NCT04177108|467426857|FG003|Overall Study|Reason Not Specified|0|||
129854811|NCT04177108|467426858|FG004|Overall Study|Reason Not Specified|2|||
129854812|NCT04177108|467426854|FG000|Overall Study|Lost to Follow-up|0|||
129854813|NCT04177108|467426855|FG001|Overall Study|Lost to Follow-up|0|||
129908353|NCT03512756|467625977|FG000|Part 2|Lost to Follow-up|0|||
129908354|NCT03512756|467625978|FG001|Part 2|Lost to Follow-up|0|||
129908355|NCT03512756|467625979|FG002|Part 2|Lost to Follow-up|1|||
129908356|NCT03512756|467625980|FG003|Part 2|Lost to Follow-up|0|||
129908357|NCT03512756|467625977|FG000|Part 2|Physician Decision|0|||
129908358|NCT03512756|467625978|FG001|Part 2|Physician Decision|0|||
129908359|NCT03512756|467625979|FG002|Part 2|Physician Decision|2|||
129908360|NCT03512756|467625980|FG003|Part 2|Physician Decision|4|||
129854814|NCT04177108|467426856|FG002|Overall Study|Lost to Follow-up|1|||
129908361|NCT03512756|467625977|FG000|Part 2|Study Terminated by Sponsor|0|||
129908362|NCT03512756|467625978|FG001|Part 2|Study Terminated by Sponsor|0|||
129854815|NCT04177108|467426857|FG003|Overall Study|Lost to Follow-up|1|||
129854816|NCT04177108|467426858|FG004|Overall Study|Lost to Follow-up|1|||
129854817|NCT04177108|467426854|FG000|Overall Study|Death|16|||
129854818|NCT04177108|467426855|FG001|Overall Study|Death|19|||
129854819|NCT04177108|467426856|FG002|Overall Study|Death|13|||
129854820|NCT04177108|467426857|FG003|Overall Study|Death|17|||
129854821|NCT04177108|467426858|FG004|Overall Study|Death|18|||
129854822|NCT04496258|467426862|FG000|Overall Study|Withdrawal by Subject|2|||
129854823|NCT04496258|467426863|FG001|Overall Study|Withdrawal by Subject|1|||
129854824|NCT01669343|467426865|FG000|Part A: All Patients|Withdrawal by Subject|7|||
129854825|NCT01669343|467426865|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
129854826|NCT01669343|467426865|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
129854827|NCT01669343|467426865|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
129854828|NCT01669343|467426865|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
129854829|NCT04433767|467426867|FG000|Overall Study|Adverse Event|1|||
129854830|NCT02371369|467426868|FG000|Part 1|Physician Decision|0|||
129854831|NCT02371369|467426869|FG001|Part 1|Physician Decision|3|||
129854832|NCT02371369|467426868|FG000|Part 1|Adverse Event|8|||
129854833|NCT02371369|467426869|FG001|Part 1|Adverse Event|0|||
129854834|NCT02371369|467426868|FG000|Part 1|Withdrawal by Subject|1|||
129854835|NCT02371369|467426869|FG001|Part 1|Withdrawal by Subject|6|||
129854836|NCT02371369|467426868|FG000|Part 1|Disease progression|0|||
129854837|NCT02371369|467426869|FG001|Part 1|Disease progression|1|||
129854838|NCT02371369|467426868|FG000|Part 1|Protocol Violation|0|||
129854839|NCT02371369|467426869|FG001|Part 1|Protocol Violation|1|||
129854840|NCT02371369|467426868|FG000|Part 2|Adverse Event|6|||
129854841|NCT02371369|467426869|FG001|Part 2|Adverse Event|5|||
129854842|NCT02371369|467426868|FG000|Part 2|Withdrawal by Subject|16|||
129854843|NCT02371369|467426869|FG001|Part 2|Withdrawal by Subject|6|||
129854844|NCT02371369|467426868|FG000|Part 2|Investigator decision|1|||
129854845|NCT02371369|467426869|FG001|Part 2|Investigator decision|2|||
129854846|NCT02371369|467426868|FG000|Part 2|Death|0|||
129854847|NCT02371369|467426869|FG001|Part 2|Death|1|||
129854848|NCT02371369|467426868|FG000|Part 2|Disease progression|1|||
129854849|NCT02371369|467426869|FG001|Part 2|Disease progression|0|||
129854850|NCT02371369|467426868|FG000|Part 2|Subject Noncompliance|1|||
129854851|NCT02371369|467426869|FG001|Part 2|Subject Noncompliance|0|||
129854852|NCT02371369|467426868|FG000|Part 2|Lost to Follow-up|1|||
129854853|NCT02371369|467426869|FG001|Part 2|Lost to Follow-up|1|||
129854854|NCT02371369|467426868|FG000|Part 2|Subject transitioned to commercial supply|6|||
129854855|NCT02371369|467426869|FG001|Part 2|Subject transitioned to commercial supply|4|||
129854856|NCT02371369|467426868|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
129854857|NCT02371369|467426869|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
129854858|NCT02371369|467426868|FG000|Part 2|Surgical resection of tumor|1|||
129854859|NCT02371369|467426869|FG001|Part 2|Surgical resection of tumor|1|||
129854860|NCT02371369|467426868|FG000|Part 2|Other|0|||
129854861|NCT02371369|467426869|FG001|Part 2|Other|1|||
129854862|NCT00439777|467426870|FG000|Treatment Period|Death|29|||
129854863|NCT00439777|467426871|FG001|Treatment Period|Death|21|||
129854864|NCT00439777|467426870|FG000|Treatment Period|Study terminated by sponsor|125|||
129854865|NCT00439777|467426871|FG001|Treatment Period|Study terminated by sponsor|132|||
129854866|NCT00439777|467426870|FG000|Treatment Period|Site closed by investigator|0|||
129854867|NCT00439777|467426871|FG001|Treatment Period|Site closed by investigator|1|||
129854868|NCT00439777|467426870|FG000|Treatment Period|Did not take study treatment|7|||
129854869|NCT00439777|467426871|FG001|Treatment Period|Did not take study treatment|8|||
129854870|NCT00439777|467426870|FG000|Treatment Period|Adverse Event|111|||
129854871|NCT00439777|467426871|FG001|Treatment Period|Adverse Event|92|||
129854872|NCT00439777|467426870|FG000|Treatment Period|Protocol Violation|23|||
129854873|NCT00439777|467426871|FG001|Treatment Period|Protocol Violation|30|||
129854874|NCT00439777|467426870|FG000|Treatment Period|Withdrawal by Subject|66|||
129854875|NCT00439777|467426871|FG001|Treatment Period|Withdrawal by Subject|118|||
129854876|NCT00439777|467426870|FG000|Treatment Period|Lack of Efficacy|1|||
129854877|NCT00439777|467426871|FG001|Treatment Period|Lack of Efficacy|4|||
129854878|NCT00439777|467426870|FG000|Treatment Period|Lost to Follow-up|8|||
129854879|NCT00439777|467426871|FG001|Treatment Period|Lost to Follow-up|10|||
129854880|NCT00439777|467426870|FG000|Treatment Period|Protocol driven decision point|1|||
129908363|NCT03512756|467625979|FG002|Part 2|Study Terminated by Sponsor|2|||
129854881|NCT00439777|467426871|FG001|Treatment Period|Protocol driven decision point|3|||
129854882|NCT00439777|467426870|FG000|Treatment Period|Physician Decision|7|||
129908364|NCT03512756|467625980|FG003|Part 2|Study Terminated by Sponsor|6|||
129908365|NCT03512756|467625977|FG000|Part 2|Protocol Violation|0|||
129854883|NCT00439777|467426871|FG001|Treatment Period|Physician Decision|18|||
129854884|NCT00439777|467426870|FG000|Treatment Period|Clinical endpoint reached|26|||
129854885|NCT00439777|467426871|FG001|Treatment Period|Clinical endpoint reached|13|||
129854886|NCT00439777|467426870|FG000|Treatment Period|Technical problems|3|||
129854887|NCT00439777|467426871|FG001|Treatment Period|Technical problems|1|||
129908366|NCT03512756|467625978|FG001|Part 2|Protocol Violation|0|||
129908367|NCT03512756|467625979|FG002|Part 2|Protocol Violation|1|||
129908368|NCT03512756|467625980|FG003|Part 2|Protocol Violation|0|||
129908369|NCT03512756|467625977|FG000|Part 2|Withdrawal by Subject|0|||
129908370|NCT03512756|467625978|FG001|Part 2|Withdrawal by Subject|0|||
129908371|NCT03512756|467625979|FG002|Part 2|Withdrawal by Subject|3|||
129908372|NCT03512756|467625980|FG003|Part 2|Withdrawal by Subject|9|||
129908373|NCT00736853|467625981|FG000|Open-Label Period|Physician Decision|2|||
129908374|NCT00736853|467625982|FG001|Open-Label Period|Physician Decision|0|||
129908375|NCT00736853|467625983|FG002|Open-Label Period|Physician Decision|0|||
129908376|NCT00736853|467625981|FG000|Open-Label Period|Adverse Event|31|||
129908377|NCT00736853|467625982|FG001|Open-Label Period|Adverse Event|0|||
129908378|NCT00736853|467625983|FG002|Open-Label Period|Adverse Event|0|||
129908379|NCT00736853|467625981|FG000|Open-Label Period|Withdrawal by Subject|16|||
129908380|NCT00736853|467625982|FG001|Open-Label Period|Withdrawal by Subject|0|||
129908381|NCT00736853|467625983|FG002|Open-Label Period|Withdrawal by Subject|0|||
129908382|NCT00736853|467625981|FG000|Open-Label Period|Started but not treated|42|||
129908383|NCT00736853|467625982|FG001|Open-Label Period|Started but not treated|0|||
129908384|NCT00736853|467625983|FG002|Open-Label Period|Started but not treated|0|||
129908385|NCT00736853|467625981|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
129908386|NCT00736853|467625982|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
129908387|NCT00736853|467625983|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
129908388|NCT00736853|467625981|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
129908389|NCT00736853|467625982|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
129908390|NCT00736853|467625983|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
129908391|NCT00736853|467625981|FG000|Double-Blind Period|Lack of Efficacy|0|||
129908392|NCT00736853|467625982|FG001|Double-Blind Period|Lack of Efficacy|19|||
129908393|NCT00736853|467625983|FG002|Double-Blind Period|Lack of Efficacy|42|||
129908394|NCT00736853|467625981|FG000|Double-Blind Period|Adverse Event|0|||
129908395|NCT00736853|467625982|FG001|Double-Blind Period|Adverse Event|3|||
129908396|NCT00736853|467625983|FG002|Double-Blind Period|Adverse Event|2|||
129908397|NCT00736853|467625981|FG000|Double-Blind Period|Withdrawal by Subject|0|||
129908398|NCT00736853|467625982|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129908399|NCT00736853|467625983|FG002|Double-Blind Period|Withdrawal by Subject|4|||
129908400|NCT00736853|467625981|FG000|Double-Blind Period|Ineligible to participate the study|0|||
129908401|NCT00736853|467625982|FG001|Double-Blind Period|Ineligible to participate the study|1|||
129908402|NCT00736853|467625983|FG002|Double-Blind Period|Ineligible to participate the study|0|||
129908403|NCT00801983|467625990|FG000|Period 1|Lost to Follow-up|2|||
129908404|NCT00801983|467625991|FG001|Period 1|Lost to Follow-up|0|||
129908405|NCT00801983|467625990|FG000|Period 1|Withdrawal by Subject|2|||
129908406|NCT00801983|467625991|FG001|Period 1|Withdrawal by Subject|8|||
129908407|NCT00801983|467625990|FG000|Period 2|Withdrawal by Subject|2|||
129908408|NCT00801983|467625991|FG001|Period 2|Withdrawal by Subject|1|||
129908409|NCT05135000|467625996|FG000|Overall Study|Adverse Event|2|||
129908410|NCT05135000|467625997|FG001|Overall Study|Adverse Event|0|||
129908411|NCT05135000|467625996|FG000|Overall Study|Lost to Follow-up|1|||
129908412|NCT05135000|467625997|FG001|Overall Study|Lost to Follow-up|0|||
129908413|NCT05135000|467625996|FG000|Overall Study|Study Terminated by Sponsor|6|||
129908414|NCT05135000|467625997|FG001|Overall Study|Study Terminated by Sponsor|3|||
129908415|NCT03215927|467627584|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
129908416|NCT03215927|467627585|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
129908417|NCT03215927|467627584|FG000|Open Label Extension|Adverse Event|1|||
129908418|NCT03215927|467627585|FG001|Open Label Extension|Adverse Event|0|||
129908419|NCT03215927|467627584|FG000|Open Label Extension|Lack of Efficacy|1|||
129908420|NCT03215927|467627585|FG001|Open Label Extension|Lack of Efficacy|0|||
129908421|NCT03215927|467627584|FG000|Open Label Extension|Death|0|||
129908422|NCT03215927|467627585|FG001|Open Label Extension|Death|1|||
129908423|NCT03889925|467627586|FG000|Overall Study|Lost to Follow-up|11|||
129908424|NCT03889925|467627587|FG001|Overall Study|Lost to Follow-up|10|||
129908425|NCT03073941|467627588|FG000|Overall Study|Received non-study device intraoperatively|0|||
129908426|NCT03073941|467627589|FG001|Overall Study|Received non-study device intraoperatively|2|||
129908427|NCT03073941|467627588|FG000|Overall Study|Death|1|||
129908428|NCT03073941|467627589|FG001|Overall Study|Death|0|||
129908429|NCT03073941|467627588|FG000|Overall Study|Withdrawal by Subject|1|||
129908430|NCT03073941|467627589|FG001|Overall Study|Withdrawal by Subject|3|||
129908431|NCT03073941|467627588|FG000|Overall Study|Lost to Follow-up|5|||
129908432|NCT03073941|467627589|FG001|Overall Study|Lost to Follow-up|4|||
129908433|NCT03073941|467627588|FG000|Overall Study|Adverse Event|4|||
129908434|NCT03073941|467627589|FG001|Overall Study|Adverse Event|2|||
129908435|NCT03073941|467627588|FG000|Overall Study|Met an exclusion criterion|0|||
129908436|NCT03073941|467627589|FG001|Overall Study|Met an exclusion criterion|1|||
129908437|NCT04252586|467627591|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129908438|NCT04252586|467627591|FG000|Overall Study|Adverse Event|1|||
129908439|NCT04252586|467627591|FG000|Overall Study|Death|2|||
129908440|NCT04252586|467627591|FG000|Overall Study|Study terminated by sponsor|4|||
129908441|NCT04252586|467627591|FG000|Overall Study|Sponsor request|10|||
129908442|NCT04252586|467627591|FG000|Overall Study|Did not complete treatment period|1|||
129854888|NCT00439777|467426870|FG000|Treatment Period|Participant convenience|12|||
129854889|NCT00439777|467426871|FG001|Treatment Period|Participant convenience|8|||
129854890|NCT00439777|467426870|FG000|Observational Period|Protocol Violation|0|||
129854891|NCT00439777|467426871|FG001|Observational Period|Protocol Violation|2|||
129854892|NCT00439777|467426870|FG000|Observational Period|Withdrawal by Subject|9|||
129854893|NCT00439777|467426871|FG001|Observational Period|Withdrawal by Subject|5|||
129854894|NCT00439777|467426870|FG000|Observational Period|Lost to Follow-up|1|||
129854895|NCT00439777|467426871|FG001|Observational Period|Lost to Follow-up|11|||
129854896|NCT00439777|467426870|FG000|Observational Period|Death|27|||
129854897|NCT00439777|467426871|FG001|Observational Period|Death|20|||
129854898|NCT00439777|467426870|FG000|Observational Period|Study terminated by sponsor|3|||
129854899|NCT00439777|467426871|FG001|Observational Period|Study terminated by sponsor|1|||
129854900|NCT00439777|467426870|FG000|Observational Period|Protocol driven decision point|0|||
129854901|NCT00439777|467426871|FG001|Observational Period|Protocol driven decision point|1|||
129854902|NCT00439777|467426870|FG000|Observational Period|Lack of Efficacy|1|||
129854903|NCT00439777|467426871|FG001|Observational Period|Lack of Efficacy|0|||
129854904|NCT00439777|467426870|FG000|Observational Period|Technical problems|0|||
129854905|NCT00439777|467426871|FG001|Observational Period|Technical problems|1|||
129854906|NCT03855189|467426872|FG000|Overall Study|Adverse Event|5|||
129854907|NCT03855189|467426873|FG001|Overall Study|Adverse Event|2|||
129854908|NCT03855189|467426874|FG002|Overall Study|Adverse Event|4|||
129854909|NCT03855189|467426872|FG000|Overall Study|Treatment Failure|1|||
129854910|NCT03855189|467426873|FG001|Overall Study|Treatment Failure|1|||
129854911|NCT03855189|467426874|FG002|Overall Study|Treatment Failure|2|||
129854912|NCT03855189|467426872|FG000|Overall Study|Noncompliance with Protocol|0|||
129854913|NCT03855189|467426873|FG001|Overall Study|Noncompliance with Protocol|1|||
129854914|NCT03855189|467426874|FG002|Overall Study|Noncompliance with Protocol|0|||
129854915|NCT03855189|467426872|FG000|Overall Study|Did Not Return|4|||
129854916|NCT03855189|467426873|FG001|Overall Study|Did Not Return|3|||
129854917|NCT03855189|467426874|FG002|Overall Study|Did Not Return|0|||
129854918|NCT01143259|467426875|FG000|Overall Study|Withdrawal by Subject|3|||
129854919|NCT01143259|467426876|FG001|Overall Study|Withdrawal by Subject|2|||
129854920|NCT01143259|467426875|FG000|Overall Study|Protocol Violation|13|||
129854921|NCT01143259|467426876|FG001|Overall Study|Protocol Violation|9|||
129854922|NCT01143259|467426875|FG000|Overall Study|Screen Failure|7|||
129854923|NCT01143259|467426876|FG001|Overall Study|Screen Failure|9|||
129854924|NCT00099983|467426877|FG000|Overall Study|Lost to Follow-up|2|||
129854925|NCT00099983|467426878|FG001|Overall Study|Lost to Follow-up|3|||
129854926|NCT00099983|467426877|FG000|Overall Study|Missing Source Documents|14|||
129854927|NCT00099983|467426878|FG001|Overall Study|Missing Source Documents|15|||
129854928|NCT00099983|467426877|FG000|Overall Study|Withdrawal by Subject|3|||
129854929|NCT00099983|467426878|FG001|Overall Study|Withdrawal by Subject|2|||
129854930|NCT00099983|467426877|FG000|Overall Study|Adverse Event|1|||
129854931|NCT00099983|467426878|FG001|Overall Study|Adverse Event|1|||
129854932|NCT00099983|467426877|FG000|Overall Study|Lack of Efficacy|0|||
129854933|NCT00099983|467426878|FG001|Overall Study|Lack of Efficacy|1|||
129854934|NCT00099983|467426877|FG000|Overall Study|Unable to return for appointments|1|||
129854935|NCT00099983|467426878|FG001|Overall Study|Unable to return for appointments|1|||
129854936|NCT00099983|467426877|FG000|Overall Study|Moved|1|||
129854937|NCT00099983|467426878|FG001|Overall Study|Moved|0|||
129854938|NCT00099983|467426877|FG000|Overall Study|Other psychiatric problem|1|||
129854939|NCT00099983|467426878|FG001|Overall Study|Other psychiatric problem|0|||
129854940|NCT00099983|467426877|FG000|Overall Study|Incarcerated|0|||
129854941|NCT00099983|467426878|FG001|Overall Study|Incarcerated|1|||
129854942|NCT00099983|467426877|FG000|Overall Study|Intolerant of burden of visits|0|||
129854943|NCT00099983|467426878|FG001|Overall Study|Intolerant of burden of visits|1|||
129854944|NCT00099983|467426877|FG000|Overall Study|Other issue|1|||
129854945|NCT00099983|467426878|FG001|Overall Study|Other issue|0|||
129854946|NCT02641080|467426879|FG000|Overall Study|Physician Decision|2|||
129854947|NCT02641080|467426880|FG001|Overall Study|Physician Decision|0|||
129854948|NCT02641080|467426879|FG000|Overall Study|Withdrawal by Subject|0|||
129854949|NCT02641080|467426880|FG001|Overall Study|Withdrawal by Subject|1|||
129854950|NCT02641080|467426879|FG000|Overall Study|Rehab Center denied use of pumps|0|||
129854951|NCT02641080|467426880|FG001|Overall Study|Rehab Center denied use of pumps|3|||
129854952|NCT02641080|467426879|FG000|Overall Study|Lost to Follow-up|0|||
129854953|NCT02641080|467426880|FG001|Overall Study|Lost to Follow-up|3|||
129854954|NCT00803634|467426881|FG000|Overall Study|Withdrew Consent|1|||
129854955|NCT00803634|467426882|FG001|Overall Study|Withdrew Consent|0|||
129854956|NCT00803634|467426881|FG000|Overall Study|Lost to Follow-up|2|||
129854957|NCT00803634|467426882|FG001|Overall Study|Lost to Follow-up|3|||
129854958|NCT00803634|467426881|FG000|Overall Study|Death|3|||
129854959|NCT00803634|467426882|FG001|Overall Study|Death|2|||
129854960|NCT03864900|467426887|FG000|Overall Study|Withdrawal by Subject|1|||
129854961|NCT03864900|467426888|FG001|Overall Study|Withdrawal by Subject|1|||
129854962|NCT03864900|467426887|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
129908443|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Death|186|||
129854963|NCT03864900|467426888|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
129854964|NCT00759109|467426890|FG000|Overall Study|Adverse Event|17|||
129854965|NCT00759109|467426891|FG001|Overall Study|Adverse Event|12|||
129854966|NCT00759109|467426890|FG000|Overall Study|Inability to comply|1|||
129854967|NCT00759109|467426891|FG001|Overall Study|Inability to comply|1|||
129854968|NCT00759109|467426890|FG000|Overall Study|Withdrawal by Subject|9|||
129854969|NCT00759109|467426891|FG001|Overall Study|Withdrawal by Subject|5|||
129854970|NCT00759109|467426890|FG000|Overall Study|Death|4|||
129854971|NCT00759109|467426891|FG001|Overall Study|Death|3|||
129854972|NCT00759109|467426890|FG000|Overall Study|Lost to Follow-up|4|||
129854973|NCT00759109|467426891|FG001|Overall Study|Lost to Follow-up|6|||
129854974|NCT00759109|467426890|FG000|Overall Study|Started new therapy|2|||
129854975|NCT00759109|467426891|FG001|Overall Study|Started new therapy|6|||
129854976|NCT00759109|467426890|FG000|Overall Study|HCV RNA negative|1|||
129854977|NCT00759109|467426891|FG001|Overall Study|HCV RNA negative|0|||
129854978|NCT00759109|467426890|FG000|Overall Study|Participant moved to a different city|0|||
129854979|NCT00759109|467426891|FG001|Overall Study|Participant moved to a different city|1|||
129854980|NCT00759109|467426890|FG000|Overall Study|Participant had a liver transplant|0|||
129854981|NCT00759109|467426891|FG001|Overall Study|Participant had a liver transplant|1|||
129854982|NCT00759109|467426890|FG000|Overall Study|Lost during study|1|||
129854983|NCT00759109|467426891|FG001|Overall Study|Lost during study|0|||
129854984|NCT03165045|467426892|FG000|Visit 1|No registration after visit 1|9|||
129854985|NCT03165045|467426892|FG000|Visit 1|No treatment documented|10|||
129854986|NCT03165045|467426892|FG000|Visit 1|No visit 1|10|||
129854987|NCT03165045|467426892|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
129854988|NCT03165045|467426892|FG000|Visit 2|No available total CCQ score at all|29|||
129854989|NCT03165045|467426892|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
129854990|NCT03238001|467426893|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
129854991|NCT03238001|467426893|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
129854992|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
129854993|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
129854994|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
129854995|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
129854996|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
129854997|NCT03238001|467426893|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
129854998|NCT01827904|467426894|FG000|Main Study|Withdrawal by Subject|1|||
129854999|NCT01827904|467426895|FG001|Main Study|Withdrawal by Subject|0|||
129855000|NCT01827904|467426896|FG002|Main Study|Withdrawal by Subject|0|||
129855001|NCT01827904|467426894|FG000|Main Study|Adverse Event|1|||
129855002|NCT01827904|467426895|FG001|Main Study|Adverse Event|0|||
129855003|NCT01827904|467426896|FG002|Main Study|Adverse Event|0|||
129855004|NCT01827904|467426894|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
129855005|NCT01827904|467426895|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
129855006|NCT01827904|467426896|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
129855007|NCT01827904|467426894|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
129855008|NCT01827904|467426895|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
129855009|NCT01827904|467426896|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
129855010|NCT01827904|467426894|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
129855011|NCT01827904|467426895|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
129855012|NCT01827904|467426896|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
129855013|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
129855014|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
129855015|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
129855016|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
129855017|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
129855018|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
129855019|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
129855020|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
129855021|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
129855022|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
129855023|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
129855024|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
129855025|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Physician Decision|1|||
129855026|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Physician Decision|0|||
129855027|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Physician Decision|0|||
129855028|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
129855029|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
129855030|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
129855031|NCT01827904|467426894|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
129855032|NCT01827904|467426895|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
129855033|NCT01827904|467426896|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
129855034|NCT01866709|467426903|FG000|Overall Study|Adverse Event|1|||
129855035|NCT01866709|467426904|FG001|Overall Study|Adverse Event|0|||
129908444|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Death|222|||
129908445|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Death|0|||
129908446|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
129908447|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
129908448|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
129908449|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
129908450|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
129908451|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
129908452|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
129908453|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
129908454|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
129908455|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Adverse Event|83|||
129908456|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Adverse Event|100|||
129908457|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Adverse Event|0|||
129908458|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Other|70|||
129908459|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Other|75|||
129908460|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Other|0|||
129908461|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
129908462|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
129908463|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
129908464|NCT00232180|467627592|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
129908465|NCT00232180|467627593|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
129908466|NCT00232180|467627594|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
129908467|NCT00232180|467627592|FG000|Open Label Phase|Death|0|||
129908468|NCT00232180|467627593|FG001|Open Label Phase|Death|0|||
129908469|NCT00232180|467627594|FG002|Open Label Phase|Death|48|||
129908470|NCT00232180|467627592|FG000|Open Label Phase|Lost to Follow-up|0|||
129908471|NCT00232180|467627593|FG001|Open Label Phase|Lost to Follow-up|0|||
129908472|NCT00232180|467627594|FG002|Open Label Phase|Lost to Follow-up|5|||
129908473|NCT00232180|467627592|FG000|Open Label Phase|Protocol Violation|0|||
129908474|NCT00232180|467627593|FG001|Open Label Phase|Protocol Violation|0|||
129908475|NCT00232180|467627594|FG002|Open Label Phase|Protocol Violation|3|||
129908476|NCT00232180|467627592|FG000|Open Label Phase|Study terminated by sponsor|0|||
129908477|NCT00232180|467627593|FG001|Open Label Phase|Study terminated by sponsor|0|||
129908478|NCT00232180|467627594|FG002|Open Label Phase|Study terminated by sponsor|3|||
129908479|NCT00232180|467627592|FG000|Open Label Phase|Withdrawal by Subject|0|||
129908480|NCT00232180|467627593|FG001|Open Label Phase|Withdrawal by Subject|0|||
129908481|NCT00232180|467627594|FG002|Open Label Phase|Withdrawal by Subject|37|||
129908482|NCT00232180|467627592|FG000|Open Label Phase|Other|0|||
129908483|NCT00232180|467627593|FG001|Open Label Phase|Other|0|||
129908484|NCT00232180|467627594|FG002|Open Label Phase|Other|16|||
129908485|NCT00232180|467627592|FG000|Open Label Phase|Adverse Event|0|||
129908486|NCT00232180|467627593|FG001|Open Label Phase|Adverse Event|0|||
129908487|NCT00232180|467627594|FG002|Open Label Phase|Adverse Event|25|||
129908488|NCT00232180|467627592|FG000|Open Label Phase|Laboratory abnormality|0|||
129908489|NCT00232180|467627593|FG001|Open Label Phase|Laboratory abnormality|0|||
129908490|NCT00232180|467627594|FG002|Open Label Phase|Laboratory abnormality|10|||
129908491|NCT00232180|467627592|FG000|Open Label Phase|Randomized but not treated|0|||
129908492|NCT00232180|467627593|FG001|Open Label Phase|Randomized but not treated|0|||
129908493|NCT00232180|467627594|FG002|Open Label Phase|Randomized but not treated|1|||
129908494|NCT03452189|467627595|FG000|First Intervention (3 Months)|Adverse Event|1|||
129908495|NCT03452189|467627596|FG001|First Intervention (3 Months)|Adverse Event|0|||
129908496|NCT03452189|467627595|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
129908497|NCT03452189|467627596|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
129908498|NCT01571596|467627599|FG000|Overall Study|Adverse Event|2|||
129908499|NCT01571596|467627600|FG001|Overall Study|Adverse Event|0|||
129908500|NCT01571596|467627601|FG002|Overall Study|Adverse Event|0|||
129908501|NCT01571596|467627599|FG000|Overall Study|Study Terminated by the Sponsor|0|||
129908502|NCT01571596|467627600|FG001|Overall Study|Study Terminated by the Sponsor|1|||
129908503|NCT01571596|467627601|FG002|Overall Study|Study Terminated by the Sponsor|1|||
129908504|NCT04512482|467627605|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
129908505|NCT04512482|467627606|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
129908506|NCT00446459|467627607|FG000|8 Months|Protocol Violation|12|||
129908507|NCT00446459|467627607|FG000|12 Months|Protocol Violation|4|||
129908508|NCT00446459|467627607|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
129908509|NCT00391898|467627622|FG000|Overall Study|Adverse Event|3|||
129908510|NCT00391898|467627623|FG001|Overall Study|Adverse Event|0|||
129908511|NCT00391898|467627622|FG000|Overall Study|Other|8|||
129908512|NCT00391898|467627623|FG001|Overall Study|Other|10|||
129908513|NCT02918279|467627626|FG000|Overall Study|Lost to Follow-up|3|||
129908514|NCT02918279|467627627|FG001|Overall Study|Lost to Follow-up|6|||
129908515|NCT02918279|467627626|FG000|Overall Study|Withdrawal by Subject|5|||
129908516|NCT02918279|467627627|FG001|Overall Study|Withdrawal by Subject|15|||
129908517|NCT02918279|467627626|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129908518|NCT02918279|467627627|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129855036|NCT03791398|467426905|FG000|Overall Study|Progression of Disease Under Study|2|||
129855037|NCT03791398|467426906|FG001|Overall Study|Progression of Disease Under Study|0|||
129855038|NCT03791398|467426907|FG002|Overall Study|Progression of Disease Under Study|0|||
129855039|NCT03191903|467426908|FG000|Overall Study|Withdrawal by Subject|6|||
129855040|NCT03191903|467426909|FG001|Overall Study|Withdrawal by Subject|5|||
129855041|NCT03191903|467426910|FG002|Overall Study|Withdrawal by Subject|4|||
129855042|NCT03191903|467426908|FG000|Overall Study|Adverse Event|1|||
129855043|NCT03191903|467426909|FG001|Overall Study|Adverse Event|0|||
129855044|NCT03191903|467426910|FG002|Overall Study|Adverse Event|0|||
129855045|NCT00503685|467426911|FG000|Overall Study|Adverse Event|0|||
129855046|NCT00503685|467426912|FG001|Overall Study|Adverse Event|0|||
129855047|NCT00503685|467426913|FG002|Overall Study|Adverse Event|2|||
129855048|NCT00503685|467426911|FG000|Overall Study|Withdrawal by Subject|0|||
129855049|NCT00503685|467426912|FG001|Overall Study|Withdrawal by Subject|1|||
129855050|NCT00503685|467426913|FG002|Overall Study|Withdrawal by Subject|0|||
129855051|NCT00503685|467426911|FG000|Overall Study|Protocol Violation|0|||
129855052|NCT00503685|467426912|FG001|Overall Study|Protocol Violation|1|||
129855053|NCT00503685|467426913|FG002|Overall Study|Protocol Violation|0|||
129855054|NCT00503685|467426911|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129855055|NCT00503685|467426912|FG001|Overall Study|Eligibility Criteria Not Met|1|||
129855056|NCT00503685|467426913|FG002|Overall Study|Eligibility Criteria Not Met|0|||
129855057|NCT01110239|467426916|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
129855058|NCT01110239|467426917|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
129855059|NCT01110239|467426918|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
129855060|NCT01110239|467426919|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
129855061|NCT01110239|467426916|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
129855062|NCT01110239|467426917|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
129855063|NCT01110239|467426918|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
129855064|NCT01110239|467426919|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
129855065|NCT00080223|467426922|FG000|Overall Study|Adverse Event|23|||
129855066|NCT00080223|467426922|FG000|Overall Study|Death|21|||
129855067|NCT00080223|467426922|FG000|Overall Study|Withdrawal by Subject|13|||
129855068|NCT00080223|467426922|FG000|Overall Study|Lung Transplantation|9|||
129855069|NCT00080223|467426922|FG000|Overall Study|Non-compliance With Study Treatment|7|||
129855070|NCT00080223|467426922|FG000|Overall Study|Participant unwilling to continue|2|||
129855071|NCT00080223|467426922|FG000|Overall Study|Physician Decision|1|||
129855072|NCT04369469|467426923|FG000|Overall Study|Lost to Follow-up|2|||
129855073|NCT04369469|467426924|FG001|Overall Study|Lost to Follow-up|4|||
129855074|NCT04369469|467426923|FG000|Overall Study|Physician Decision|2|||
129855075|NCT04369469|467426924|FG001|Overall Study|Physician Decision|1|||
129855076|NCT04369469|467426923|FG000|Overall Study|Withdrawal by Subject|2|||
129855077|NCT04369469|467426924|FG001|Overall Study|Withdrawal by Subject|3|||
129855078|NCT04369469|467426923|FG000|Overall Study|Adverse Event|1|||
129855079|NCT04369469|467426924|FG001|Overall Study|Adverse Event|0|||
129855080|NCT04369469|467426923|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
129855081|NCT04369469|467426924|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
129855082|NCT04369469|467426923|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
129855083|NCT04369469|467426924|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
129855084|NCT04369469|467426923|FG000|Overall Study|Unable to Provide Consent|0|||
129855085|NCT04369469|467426924|FG001|Overall Study|Unable to Provide Consent|1|||
129855086|NCT05204134|467426925|FG000|Overall Study|Withdrawal by Subject|3|||
129855087|NCT05204134|467426925|FG000|Overall Study|Physician Decision|1|||
129855088|NCT03099382|467426928|FG000|Overall Study|Protocol Violation|2|||
129855089|NCT03099382|467426929|FG001|Overall Study|Protocol Violation|3|||
129855090|NCT00499369|467426930|FG000|Overall Study|Adverse Event|2|||
129855091|NCT00499369|467426931|FG001|Overall Study|Adverse Event|2|||
129855092|NCT00499369|467426932|FG002|Overall Study|Adverse Event|3|||
129855093|NCT00499369|467426933|FG003|Overall Study|Adverse Event|1|||
129855094|NCT00499369|467426934|FG004|Overall Study|Adverse Event|2|||
129908519|NCT02918279|467627626|FG000|Overall Study|Other|3|||
129908520|NCT02918279|467627627|FG001|Overall Study|Other|1|||
129855095|NCT00499369|467426930|FG000|Overall Study|Withdrawal by Subject|0|||
129908521|NCT00309907|467627628|FG000|Overall Study|Death|4|||
129855096|NCT00499369|467426931|FG001|Overall Study|Withdrawal by Subject|1|||
129855097|NCT00499369|467426932|FG002|Overall Study|Withdrawal by Subject|1|||
129855098|NCT00499369|467426933|FG003|Overall Study|Withdrawal by Subject|0|||
129855099|NCT00499369|467426934|FG004|Overall Study|Withdrawal by Subject|0|||
129855100|NCT00499369|467426930|FG000|Overall Study|Progression|10|||
129855101|NCT00499369|467426931|FG001|Overall Study|Progression|12|||
129855102|NCT00499369|467426932|FG002|Overall Study|Progression|9|||
129855103|NCT00499369|467426933|FG003|Overall Study|Progression|6|||
129855104|NCT00499369|467426934|FG004|Overall Study|Progression|10|||
129855105|NCT00499369|467426930|FG000|Overall Study|Death|0|||
129855106|NCT00499369|467426931|FG001|Overall Study|Death|1|||
129855107|NCT00499369|467426932|FG002|Overall Study|Death|0|||
129908522|NCT00309907|467627628|FG000|Overall Study|Physician Decision|1|||
129908523|NCT00309907|467627628|FG000|Overall Study|Ineligible|11|||
129908524|NCT00309907|467627628|FG000|Overall Study|Major infectious event|4|||
129855108|NCT00499369|467426933|FG003|Overall Study|Death|0|||
129855109|NCT00499369|467426934|FG004|Overall Study|Death|0|||
129855110|NCT00499369|467426930|FG000|Overall Study|Not protocol specified|2|||
129855111|NCT00499369|467426931|FG001|Overall Study|Not protocol specified|0|||
129855112|NCT00499369|467426932|FG002|Overall Study|Not protocol specified|3|||
129855113|NCT00499369|467426933|FG003|Overall Study|Not protocol specified|1|||
129855114|NCT00499369|467426934|FG004|Overall Study|Not protocol specified|0|||
129855115|NCT00499369|467426930|FG000|Overall Study|Ineligible|2|||
129855116|NCT00499369|467426931|FG001|Overall Study|Ineligible|2|||
129855117|NCT00499369|467426932|FG002|Overall Study|Ineligible|1|||
129855118|NCT00499369|467426933|FG003|Overall Study|Ineligible|1|||
129855119|NCT00499369|467426934|FG004|Overall Study|Ineligible|0|||
129855120|NCT01802411|467426935|FG000|Overall Study|Death|2|||
129855121|NCT01802411|467426936|FG001|Overall Study|Death|1|||
129855122|NCT01802411|467426935|FG000|Overall Study|Adverse Event|2|||
129855123|NCT01802411|467426936|FG001|Overall Study|Adverse Event|7|||
129855124|NCT01802411|467426935|FG000|Overall Study|Lack of Efficacy|8|||
129855125|NCT01802411|467426936|FG001|Overall Study|Lack of Efficacy|10|||
129855126|NCT01802411|467426935|FG000|Overall Study|Withdrawal by Subject|0|||
129855127|NCT01802411|467426936|FG001|Overall Study|Withdrawal by Subject|2|||
129855128|NCT01802411|467426935|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
129855129|NCT01802411|467426936|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
129855130|NCT01802411|467426935|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
129855131|NCT01802411|467426936|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
129855132|NCT01802411|467426935|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
129855133|NCT01802411|467426936|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
129855134|NCT01059617|467426939|FG000|Overall Study|Other|7|||
129855135|NCT01059617|467426940|FG001|Overall Study|Other|1|||
129855136|NCT01059617|467426941|FG002|Overall Study|Other|8|||
129855137|NCT01059617|467426942|FG003|Overall Study|Other|6|||
129855138|NCT03864614|467426947|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
129855139|NCT03864614|467426948|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
129855140|NCT03864614|467426949|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
129855141|NCT03864614|467426950|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
129855142|NCT03864614|467426947|FG000|Overall Study|Withdrawal by Subject|72|||
129855143|NCT03864614|467426948|FG001|Overall Study|Withdrawal by Subject|100|||
129855144|NCT03864614|467426949|FG002|Overall Study|Withdrawal by Subject|1|||
129855145|NCT03864614|467426950|FG003|Overall Study|Withdrawal by Subject|21|||
129855146|NCT03864614|467426947|FG000|Overall Study|Lost to Follow-up|45|||
129855147|NCT03864614|467426948|FG001|Overall Study|Lost to Follow-up|54|||
129855148|NCT03864614|467426949|FG002|Overall Study|Lost to Follow-up|0|||
129855149|NCT03864614|467426950|FG003|Overall Study|Lost to Follow-up|9|||
129855150|NCT03864614|467426947|FG000|Overall Study|Adverse Event|42|||
129449670|NCT00041080|465945641|FG001|Overall Study|Adverse Event|1|||
129855151|NCT03864614|467426948|FG001|Overall Study|Adverse Event|30|||
129855152|NCT03864614|467426949|FG002|Overall Study|Adverse Event|1|||
129855153|NCT03864614|467426950|FG003|Overall Study|Adverse Event|9|||
129855154|NCT03864614|467426947|FG000|Overall Study|Protocol Deviation|6|||
129855155|NCT03864614|467426948|FG001|Overall Study|Protocol Deviation|26|||
129855156|NCT03864614|467426949|FG002|Overall Study|Protocol Deviation|0|||
129855157|NCT03864614|467426950|FG003|Overall Study|Protocol Deviation|1|||
129855158|NCT03864614|467426947|FG000|Overall Study|Physician Decision|7|||
129855159|NCT03864614|467426948|FG001|Overall Study|Physician Decision|10|||
129855160|NCT03864614|467426949|FG002|Overall Study|Physician Decision|1|||
129855161|NCT03864614|467426950|FG003|Overall Study|Physician Decision|5|||
129855162|NCT03864614|467426947|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
129855163|NCT03864614|467426948|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
129908525|NCT01068743|467627629|FG000|Period 3|Adverse Event|0|||
129908526|NCT01068743|467627630|FG001|Period 3|Adverse Event|1|||
129908527|NCT01068743|467627631|FG002|Period 3|Adverse Event|0|||
129908528|NCT01068743|467627632|FG003|Period 3|Adverse Event|0|||
129908529|NCT02507752|467627633|FG000|Overall Study|Adverse Event|1|||
129908530|NCT02507752|467627633|FG000|Overall Study|Protocol Violation|6|||
129908531|NCT02507752|467627633|FG000|Overall Study|Lost to Follow-up|7|||
129908532|NCT02507752|467627633|FG000|Overall Study|Infusion reaction at first infusion|1|||
129908533|NCT02507752|467627633|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
129908534|NCT02507752|467627633|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
129908535|NCT01236001|467627635|FG000|Overall Study|Adverse Event|5|||
129908536|NCT01236001|467627636|FG001|Overall Study|Adverse Event|14|||
129908537|NCT01236001|467627635|FG000|Overall Study|Lack of Efficacy|6|||
129908538|NCT01236001|467627636|FG001|Overall Study|Lack of Efficacy|6|||
129908539|NCT01236001|467627635|FG000|Overall Study|Lost to Follow-up|6|||
129908540|NCT01236001|467627636|FG001|Overall Study|Lost to Follow-up|1|||
129908541|NCT01236001|467627635|FG000|Overall Study|Incompliance|1|||
129908542|NCT01236001|467627636|FG001|Overall Study|Incompliance|0|||
129908543|NCT01236001|467627635|FG000|Overall Study|Planned Visit After End of Study|0|||
129908544|NCT01236001|467627636|FG001|Overall Study|Planned Visit After End of Study|1|||
129908545|NCT02528188|467627646|FG000|Overall Study|Adverse Event|23|||
129908546|NCT02528188|467627647|FG001|Overall Study|Adverse Event|22|||
129908547|NCT02528188|467627648|FG002|Overall Study|Adverse Event|8|||
129908548|NCT02528188|467627646|FG000|Overall Study|Protocol Violation|4|||
129908549|NCT02528188|467627647|FG001|Overall Study|Protocol Violation|6|||
129908550|NCT02528188|467627648|FG002|Overall Study|Protocol Violation|4|||
129908551|NCT02528188|467627646|FG000|Overall Study|Lack of Efficacy|19|||
129908552|NCT02528188|467627647|FG001|Overall Study|Lack of Efficacy|21|||
129908553|NCT02528188|467627648|FG002|Overall Study|Lack of Efficacy|22|||
129908554|NCT02528188|467627646|FG000|Overall Study|Withdrawal by Subject|97|||
129908555|NCT02528188|467627647|FG001|Overall Study|Withdrawal by Subject|104|||
129908556|NCT02528188|467627648|FG002|Overall Study|Withdrawal by Subject|100|||
129908557|NCT02528188|467627646|FG000|Overall Study|Lost to Follow-up|25|||
129908558|NCT02528188|467627647|FG001|Overall Study|Lost to Follow-up|21|||
129908559|NCT02528188|467627648|FG002|Overall Study|Lost to Follow-up|31|||
129908560|NCT02528188|467627646|FG000|Overall Study|Death|4|||
129908561|NCT02528188|467627647|FG001|Overall Study|Death|4|||
129908562|NCT02528188|467627648|FG002|Overall Study|Death|0|||
129908563|NCT02528188|467627646|FG000|Overall Study|Other|89|||
129908564|NCT02528188|467627647|FG001|Overall Study|Other|91|||
129908565|NCT02528188|467627648|FG002|Overall Study|Other|74|||
129908566|NCT02528188|467627646|FG000|Overall Study|Randomized but not treated|6|||
129908567|NCT02528188|467627647|FG001|Overall Study|Randomized but not treated|7|||
129908568|NCT02528188|467627648|FG002|Overall Study|Randomized but not treated|12|||
129908569|NCT00933400|467627649|FG000|Overall Study|Withdrawal by Subject|21|||
129908570|NCT00933400|467627650|FG001|Overall Study|Withdrawal by Subject|1|||
129908571|NCT01041417|467627653|FG000|Overall Study|Adverse Event|5|||
129908572|NCT01041417|467627654|FG001|Overall Study|Adverse Event|2|||
129908573|NCT01041417|467627653|FG000|Overall Study|Lost to Follow-up|1|||
129908574|NCT01041417|467627654|FG001|Overall Study|Lost to Follow-up|1|||
129908575|NCT01041417|467627653|FG000|Overall Study|Death|1|||
129908576|NCT01041417|467627654|FG001|Overall Study|Death|0|||
129908577|NCT02299375|467627657|FG000|Overall Study|Adverse Event, serious fatal|1|||
129908578|NCT02299375|467627658|FG001|Overall Study|Adverse Event, serious fatal|3|||
129908579|NCT02299375|467627657|FG000|Overall Study|Adverse Event, non-fatal|8|||
129908580|NCT02299375|467627658|FG001|Overall Study|Adverse Event, non-fatal|9|||
129908581|NCT02299375|467627657|FG000|Overall Study|Lack of Efficacy|1|||
129908582|NCT02299375|467627658|FG001|Overall Study|Lack of Efficacy|3|||
129908583|NCT02299375|467627657|FG000|Overall Study|Protocol Violation|1|||
129908584|NCT02299375|467627658|FG001|Overall Study|Protocol Violation|3|||
129908585|NCT02299375|467627657|FG000|Overall Study|Other: Met stopping criteria|1|||
129908586|NCT02299375|467627658|FG001|Overall Study|Other: Met stopping criteria|0|||
129908587|NCT02299375|467627657|FG000|Overall Study|Other: Study closed/terminated|66|||
129908588|NCT02299375|467627658|FG001|Overall Study|Other: Study closed/terminated|55|||
129908589|NCT02299375|467627657|FG000|Overall Study|Lost to Follow-up|0|||
129908590|NCT02299375|467627658|FG001|Overall Study|Lost to Follow-up|2|||
129908591|NCT02299375|467627657|FG000|Overall Study|Physician Decision|1|||
129908592|NCT02299375|467627658|FG001|Overall Study|Physician Decision|1|||
129908593|NCT02299375|467627657|FG000|Overall Study|Withdrawal by Subject|1|||
129908594|NCT02299375|467627658|FG001|Overall Study|Withdrawal by Subject|4|||
129908595|NCT00704184|467627659|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
129908596|NCT00704184|467627660|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
129908597|NCT00704184|467627661|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
129449671|NCT00041080|465945640|FG000|Overall Study|Withdrawal by Subject|6|||
129449672|NCT00041080|465945641|FG001|Overall Study|Withdrawal by Subject|6|||
129855164|NCT03864614|467426949|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
129855165|NCT03864614|467426950|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
129855166|NCT03864614|467426947|FG000|Overall Study|Sponsor Decision|1|||
129855167|NCT03864614|467426948|FG001|Overall Study|Sponsor Decision|2|||
129855168|NCT03864614|467426949|FG002|Overall Study|Sponsor Decision|0|||
129855169|NCT03864614|467426950|FG003|Overall Study|Sponsor Decision|0|||
129855170|NCT03864614|467426947|FG000|Overall Study|Pregnancy|0|||
129855171|NCT03864614|467426948|FG001|Overall Study|Pregnancy|1|||
129855172|NCT03864614|467426949|FG002|Overall Study|Pregnancy|0|||
129855173|NCT03864614|467426950|FG003|Overall Study|Pregnancy|0|||
129855174|NCT03864614|467426947|FG000|Overall Study|Other|7|||
129855175|NCT03864614|467426948|FG001|Overall Study|Other|9|||
129855176|NCT03864614|467426949|FG002|Overall Study|Other|1|||
129855177|NCT03864614|467426950|FG003|Overall Study|Other|4|||
129855178|NCT03864614|467426947|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
129855179|NCT03864614|467426948|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
129855180|NCT03864614|467426949|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
129855181|NCT03864614|467426950|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
129855182|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
129855183|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
129855184|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
129855185|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
129855186|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Adverse Event|5|||
129855187|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Adverse Event|3|||
129855188|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Adverse Event|4|||
129855189|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Adverse Event|10|||
129855190|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
129855191|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
129855192|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
129855193|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
129855194|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
129855195|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
129855196|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
129855197|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
129855198|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Pregnancy|5|||
129855199|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Pregnancy|0|||
129855200|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Pregnancy|3|||
129855201|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Pregnancy|2|||
129855202|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Non-compliance|1|||
129855203|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Non-compliance|4|||
129855204|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Non-compliance|0|||
129855205|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Non-compliance|3|||
129855206|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Other|0|||
129855207|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Other|3|||
129855208|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Other|3|||
129855209|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Other|1|||
129855210|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
129855211|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
129855212|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
129855213|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
129855214|NCT01760954|467428734|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
129855215|NCT01760954|467428735|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
129855216|NCT01760954|467428736|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
129855217|NCT01760954|467428737|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
129855218|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
129855219|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
129855220|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
129855221|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
129855222|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
129855223|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
129449673|NCT00041080|465945640|FG000|Overall Study|Concommitant Illness/Other|1|||
129449674|NCT00041080|465945641|FG001|Overall Study|Concommitant Illness/Other|2|||
129855224|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
129855225|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
129855226|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
129855227|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
129855228|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
129855229|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
129908598|NCT00704184|467627662|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
129908599|NCT00704184|467627663|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
129908600|NCT00704184|467627659|FG000|Open-Label Treatment|Adverse Event|0|||
129908601|NCT00704184|467627660|FG001|Open-Label Treatment|Adverse Event|0|||
129908602|NCT00704184|467627661|FG002|Open-Label Treatment|Adverse Event|2|||
129908603|NCT00704184|467627662|FG003|Open-Label Treatment|Adverse Event|0|||
129908604|NCT00704184|467627663|FG004|Open-Label Treatment|Adverse Event|1|||
129908605|NCT00704184|467627659|FG000|Open-Label Treatment|Lack of Efficacy|0|||
129908606|NCT00704184|467627660|FG001|Open-Label Treatment|Lack of Efficacy|2|||
129908607|NCT00704184|467627661|FG002|Open-Label Treatment|Lack of Efficacy|2|||
129908608|NCT00704184|467627662|FG003|Open-Label Treatment|Lack of Efficacy|2|||
129908609|NCT00704184|467627663|FG004|Open-Label Treatment|Lack of Efficacy|1|||
129908610|NCT00704184|467627659|FG000|Open-Label Treatment|Physician Decision|0|||
129908611|NCT00704184|467627660|FG001|Open-Label Treatment|Physician Decision|0|||
129908612|NCT00704184|467627661|FG002|Open-Label Treatment|Physician Decision|0|||
129908613|NCT00704184|467627662|FG003|Open-Label Treatment|Physician Decision|0|||
129908614|NCT00704184|467627663|FG004|Open-Label Treatment|Physician Decision|1|||
129908615|NCT00704184|467627659|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
129908616|NCT00704184|467627660|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
129908617|NCT00704184|467627661|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
129908618|NCT00704184|467627662|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
129908619|NCT00704184|467627663|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
129908620|NCT00716859|467627664|FG000|Overall Study|Adverse Event|4|||
129908621|NCT00716859|467627665|FG001|Overall Study|Adverse Event|1|||
129908622|NCT00716859|467627664|FG000|Overall Study|Lack of Efficacy|3|||
129908623|NCT00716859|467627665|FG001|Overall Study|Lack of Efficacy|0|||
129908624|NCT00716859|467627664|FG000|Overall Study|Withdrawal by Subject|1|||
129908625|NCT00716859|467627665|FG001|Overall Study|Withdrawal by Subject|3|||
129908626|NCT00716859|467627664|FG000|Overall Study|Not treated|1|||
129908627|NCT00716859|467627665|FG001|Overall Study|Not treated|1|||
129908628|NCT01764464|467627666|FG000|First Intervention|Withdrawal by Subject|1|||
129908629|NCT01764464|467627667|FG001|First Intervention|Withdrawal by Subject|0|||
129908630|NCT01764464|467627666|FG000|First Intervention|Lost to Follow-up|1|||
129908631|NCT01764464|467627667|FG001|First Intervention|Lost to Follow-up|0|||
129908632|NCT01764464|467627666|FG000|First Intervention|Adverse Event|0|||
129908633|NCT01764464|467627667|FG001|First Intervention|Adverse Event|2|||
129908634|NCT01764464|467627666|FG000|First Intervention|did not receive study drug|0|||
129908635|NCT01764464|467627667|FG001|First Intervention|did not receive study drug|1|||
129908636|NCT01764464|467627666|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
129908637|NCT01764464|467627667|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
129908638|NCT02918071|467627679|FG000|Overall Study|Withdrawal by Subject|2|||
129908639|NCT02918071|467627679|FG000|Overall Study|Lost to Follow-up|1|||
129908640|NCT00203411|467627681|FG000|Follow-up|Progressive Disease|4|||
129908641|NCT01212991|467627682|FG000|Double-blind|Lost to Follow-up|8|||
129908642|NCT01212991|467627683|FG001|Double-blind|Lost to Follow-up|4|||
129908643|NCT01212991|467627684|FG002|Double-blind|Lost to Follow-up|0|||
129908644|NCT01212991|467627682|FG000|Double-blind|Death|699|||
129908645|NCT01212991|467627683|FG001|Double-blind|Death|550|||
129908646|NCT01212991|467627684|FG002|Double-blind|Death|0|||
129908647|NCT01212991|467627682|FG000|Double-blind|Withdrawal by Subject|16|||
129908648|NCT01212991|467627683|FG001|Double-blind|Withdrawal by Subject|19|||
129908649|NCT01212991|467627684|FG002|Double-blind|Withdrawal by Subject|0|||
129908650|NCT01212991|467627682|FG000|Double-blind|Other|7|||
129908651|NCT01212991|467627683|FG001|Double-blind|Other|0|||
129908652|NCT01212991|467627684|FG002|Double-blind|Other|0|||
129908653|NCT01212991|467627682|FG000|Double-blind|Sponsor decision|142|||
129908654|NCT01212991|467627683|FG001|Double-blind|Sponsor decision|38|||
129908655|NCT01212991|467627684|FG002|Double-blind|Sponsor decision|0|||
129908656|NCT01212991|467627682|FG000|Open-label|Death|0|||
129908657|NCT01212991|467627683|FG001|Open-label|Death|0|||
129908658|NCT01212991|467627684|FG002|Open-label|Death|166|||
129908659|NCT01212991|467627682|FG000|Open-label|Lost to Follow-up|0|||
129908660|NCT01212991|467627683|FG001|Open-label|Lost to Follow-up|0|||
129908661|NCT01212991|467627684|FG002|Open-label|Lost to Follow-up|5|||
129908662|NCT01212991|467627682|FG000|Open-label|Withdrawal by Subject|0|||
129908663|NCT01212991|467627683|FG001|Open-label|Withdrawal by Subject|0|||
129908664|NCT01212991|467627684|FG002|Open-label|Withdrawal by Subject|7|||
129908665|NCT01212991|467627682|FG000|Open-label|Sponsor decision|0|||
129908666|NCT01212991|467627683|FG001|Open-label|Sponsor decision|0|||
129908667|NCT01212991|467627684|FG002|Open-label|Sponsor decision|53|||
129908668|NCT01212991|467627682|FG000|Open-label|Other|0|||
129908669|NCT01212991|467627683|FG001|Open-label|Other|0|||
129908670|NCT01212991|467627684|FG002|Open-label|Other|3|||
129908671|NCT01170026|467628752|FG000|Overall Study|Lost to Follow-up|4|||
129908672|NCT01170026|467628753|FG001|Overall Study|Lost to Follow-up|2|||
129908673|NCT04623008|467628754|FG000|Baseline to T2|Withdrawal by Subject|4|||
129908674|NCT04623008|467628755|FG001|Baseline to T2|Withdrawal by Subject|2|||
129908675|NCT04623008|467628754|FG000|Baseline to T3|Withdrawal by Subject|4|||
129908676|NCT04623008|467628755|FG001|Baseline to T3|Withdrawal by Subject|2|||
129855230|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
129855231|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
129855232|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
129855233|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
129855234|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
129855235|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
129855236|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
129855237|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
129855238|NCT01760954|467428734|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
129855239|NCT01760954|467428735|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
129855240|NCT01760954|467428736|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
129855241|NCT01760954|467428737|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
129855242|NCT03320070|467428738|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
129855243|NCT03320070|467428739|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
129855244|NCT03320070|467428738|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
129855245|NCT03320070|467428739|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
129855246|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
129855247|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
129855248|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
129855249|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
129855250|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
129855251|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
129855252|NCT03320070|467428738|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
129855253|NCT03320070|467428739|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
129855254|NCT00353704|467428756|FG000|Overall Study|Protocol Violation|3|||
129855255|NCT00353704|467428757|FG001|Overall Study|Protocol Violation|1|||
129855256|NCT02473614|467428758|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
129855257|NCT02473614|467428759|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
129855258|NCT01154166|467428760|FG000|Overall Study|Adverse Event|14|||
129855259|NCT01154166|467428761|FG001|Overall Study|Adverse Event|9|||
129855260|NCT01154166|467428760|FG000|Overall Study|Lost to Follow-up|1|||
129855261|NCT01154166|467428761|FG001|Overall Study|Lost to Follow-up|1|||
129855262|NCT01154166|467428760|FG000|Overall Study|Protocol Violation|4|||
129855263|NCT01154166|467428761|FG001|Overall Study|Protocol Violation|1|||
129855264|NCT01154166|467428760|FG000|Overall Study|Withdrawal by Subject|10|||
129855265|NCT01154166|467428761|FG001|Overall Study|Withdrawal by Subject|1|||
129855266|NCT01154166|467428760|FG000|Overall Study|Lack of Efficacy|3|||
129855267|NCT01154166|467428761|FG001|Overall Study|Lack of Efficacy|0|||
129855268|NCT01154166|467428760|FG000|Overall Study|Disease Progression|1|||
129855269|NCT01154166|467428761|FG001|Overall Study|Disease Progression|0|||
129855270|NCT01154166|467428760|FG000|Overall Study|Poor Compliance|1|||
129855271|NCT01154166|467428761|FG001|Overall Study|Poor Compliance|0|||
129855272|NCT01375049|467428762|FG000|Overall Study|Adverse Event|2|||
129855273|NCT01375049|467428762|FG000|Overall Study|Lost to Follow-up|1|||
129855274|NCT01375049|467428762|FG000|Overall Study|Withdrawal by Subject|2|||
129855275|NCT01375049|467428762|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
129855276|NCT04121962|467428765|FG000|Overall Study|Lost to Follow-up|42|||
129855277|NCT04121962|467428766|FG001|Overall Study|Lost to Follow-up|39|||
129855278|NCT01175382|467428767|FG000|Overall Study|Lost to Follow-up|4|||
129855279|NCT01175382|467428768|FG001|Overall Study|Lost to Follow-up|3|||
129855280|NCT01175382|467428769|FG002|Overall Study|Lost to Follow-up|1|||
129855281|NCT01175382|467428767|FG000|Overall Study|Physician Decision|0|||
129855282|NCT01175382|467428768|FG001|Overall Study|Physician Decision|1|||
129855283|NCT01175382|467428769|FG002|Overall Study|Physician Decision|0|||
129855284|NCT01175382|467428767|FG000|Overall Study|Withdrawal by Subject|0|||
129855285|NCT01175382|467428768|FG001|Overall Study|Withdrawal by Subject|0|||
129855286|NCT01175382|467428769|FG002|Overall Study|Withdrawal by Subject|1|||
129855287|NCT01175382|467428767|FG000|Overall Study|No longer having problem|1|||
129855288|NCT01175382|467428768|FG001|Overall Study|No longer having problem|0|||
129855289|NCT01175382|467428769|FG002|Overall Study|No longer having problem|1|||
129855290|NCT01175382|467428767|FG000|Overall Study|Unable/unwilling to attend visits|3|||
129855291|NCT01175382|467428768|FG001|Overall Study|Unable/unwilling to attend visits|1|||
129855292|NCT01175382|467428769|FG002|Overall Study|Unable/unwilling to attend visits|2|||
129855293|NCT01175382|467428767|FG000|Overall Study|Unwilling to follow protocol|0|||
129855294|NCT01175382|467428768|FG001|Overall Study|Unwilling to follow protocol|1|||
129855295|NCT01175382|467428769|FG002|Overall Study|Unwilling to follow protocol|0|||
129855296|NCT01175382|467428767|FG000|Overall Study|Unable to tolerate study meds|0|||
129855297|NCT01175382|467428768|FG001|Overall Study|Unable to tolerate study meds|1|||
129855298|NCT01175382|467428769|FG002|Overall Study|Unable to tolerate study meds|1|||
129855299|NCT00774787|467428770|FG000|Overall Study|Lost to Follow-up|1|||
129855300|NCT02019719|467428771|FG000|Overall Study|Adverse Event|1|||
129855301|NCT02019719|467428772|FG001|Overall Study|Adverse Event|0|||
129855302|NCT02019719|467428773|FG002|Overall Study|Adverse Event|0|||
129855303|NCT02019719|467428774|FG003|Overall Study|Adverse Event|1|||
129855304|NCT02019719|467428775|FG004|Overall Study|Adverse Event|1|||
129855305|NCT02019719|467428771|FG000|Overall Study|Protocol Violation|1|||
129855306|NCT02019719|467428772|FG001|Overall Study|Protocol Violation|1|||
129855307|NCT02019719|467428773|FG002|Overall Study|Protocol Violation|0|||
129855308|NCT02019719|467428774|FG003|Overall Study|Protocol Violation|0|||
129855309|NCT02019719|467428775|FG004|Overall Study|Protocol Violation|0|||
129855310|NCT02019719|467428771|FG000|Overall Study|Protocol defined stopping criteria|2|||
129855311|NCT02019719|467428772|FG001|Overall Study|Protocol defined stopping criteria|0|||
129855312|NCT02019719|467428773|FG002|Overall Study|Protocol defined stopping criteria|0|||
129855313|NCT02019719|467428774|FG003|Overall Study|Protocol defined stopping criteria|1|||
129855314|NCT02019719|467428775|FG004|Overall Study|Protocol defined stopping criteria|1|||
129855315|NCT02019719|467428771|FG000|Overall Study|Physician Decision|2|||
129855316|NCT02019719|467428772|FG001|Overall Study|Physician Decision|0|||
129855317|NCT02019719|467428773|FG002|Overall Study|Physician Decision|0|||
129855318|NCT02019719|467428774|FG003|Overall Study|Physician Decision|0|||
129855319|NCT02019719|467428775|FG004|Overall Study|Physician Decision|0|||
129855320|NCT02731131|467428779|FG000|Overall Study|Psychiatric Disorder|0|||
129855321|NCT02731131|467428780|FG001|Overall Study|Psychiatric Disorder|1|||
129855322|NCT02731131|467428779|FG000|Overall Study|Refused Therapy|0|||
129855323|NCT02731131|467428780|FG001|Overall Study|Refused Therapy|1|||
129855324|NCT02348216|467428785|FG000|Overall Study|Death|5|||
129855325|NCT02348216|467428786|FG001|Overall Study|Death|53|||
129855326|NCT02348216|467428787|FG002|Overall Study|Death|11|||
129855327|NCT02348216|467428788|FG003|Overall Study|Death|20|||
129855328|NCT02348216|467428789|FG004|Overall Study|Death|16|||
129855329|NCT02348216|467428790|FG005|Overall Study|Death|32|||
129855330|NCT02348216|467428791|FG006|Overall Study|Death|17|||
129855331|NCT02348216|467428785|FG000|Overall Study|Full consent withdrawal|0|||
129855332|NCT02348216|467428786|FG001|Overall Study|Full consent withdrawal|0|||
129855333|NCT02348216|467428787|FG002|Overall Study|Full consent withdrawal|0|||
129855334|NCT02348216|467428788|FG003|Overall Study|Full consent withdrawal|1|||
129855335|NCT02348216|467428789|FG004|Overall Study|Full consent withdrawal|3|||
129855336|NCT02348216|467428790|FG005|Overall Study|Full consent withdrawal|0|||
129855337|NCT02348216|467428791|FG006|Overall Study|Full consent withdrawal|3|||
129855338|NCT02348216|467428785|FG000|Overall Study|Lost to Follow-up|0|||
129855339|NCT02348216|467428786|FG001|Overall Study|Lost to Follow-up|5|||
129855340|NCT02348216|467428787|FG002|Overall Study|Lost to Follow-up|2|||
129855341|NCT02348216|467428788|FG003|Overall Study|Lost to Follow-up|0|||
129855342|NCT02348216|467428789|FG004|Overall Study|Lost to Follow-up|1|||
129855343|NCT02348216|467428790|FG005|Overall Study|Lost to Follow-up|1|||
129855344|NCT02348216|467428791|FG006|Overall Study|Lost to Follow-up|1|||
129855345|NCT02348216|467428785|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
129855346|NCT02348216|467428786|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
129855347|NCT02348216|467428787|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
129855348|NCT02348216|467428788|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
129855349|NCT02348216|467428789|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
129855350|NCT02348216|467428790|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
129855351|NCT02348216|467428791|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
129855352|NCT02348216|467428785|FG000|Overall Study|Reason not specified|2|||
129855353|NCT02348216|467428786|FG001|Overall Study|Reason not specified|19|||
129855354|NCT02348216|467428787|FG002|Overall Study|Reason not specified|11|||
129855355|NCT02348216|467428788|FG003|Overall Study|Reason not specified|17|||
129855356|NCT02348216|467428789|FG004|Overall Study|Reason not specified|21|||
129855357|NCT02348216|467428790|FG005|Overall Study|Reason not specified|17|||
129855358|NCT02348216|467428791|FG006|Overall Study|Reason not specified|19|||
129855359|NCT01055639|467428792|FG000|Overall Study|Adverse Event|0|||
129855360|NCT01055639|467428793|FG001|Overall Study|Adverse Event|1|||
129855361|NCT01055639|467428792|FG000|Overall Study|Lack of Efficacy|0|||
129855362|NCT01055639|467428793|FG001|Overall Study|Lack of Efficacy|1|||
129855363|NCT01055639|467428792|FG000|Overall Study|Lost to Follow-up|8|||
129855364|NCT01055639|467428793|FG001|Overall Study|Lost to Follow-up|11|||
129855365|NCT01055639|467428792|FG000|Overall Study|Protocol Violation|5|||
129855366|NCT01055639|467428793|FG001|Overall Study|Protocol Violation|5|||
129855367|NCT01055639|467428792|FG000|Overall Study|Withdrawal by Subject|8|||
129855368|NCT01055639|467428793|FG001|Overall Study|Withdrawal by Subject|11|||
129855369|NCT00562159|467428794|FG000|Overall Study|Adverse Event|11|||
129855370|NCT00562159|467428795|FG001|Overall Study|Adverse Event|8|||
129855371|NCT00562159|467428794|FG000|Overall Study|Lost to Follow-up|5|||
129855372|NCT00562159|467428795|FG001|Overall Study|Lost to Follow-up|4|||
129855373|NCT00562159|467428794|FG000|Overall Study|Withdrawal by Subject|9|||
129855374|NCT00562159|467428795|FG001|Overall Study|Withdrawal by Subject|8|||
129855375|NCT00562159|467428794|FG000|Overall Study|Protocol Violation|12|||
129855376|NCT00562159|467428795|FG001|Overall Study|Protocol Violation|12|||
129855377|NCT00562159|467428794|FG000|Overall Study|Did not meet protocol eligibility|1|||
129855378|NCT00562159|467428795|FG001|Overall Study|Did not meet protocol eligibility|1|||
129855379|NCT00765245|467428796|FG000|Overall Study|disease progression|3|||
129855380|NCT00765245|467428797|FG001|Overall Study|disease progression|2|||
129855381|NCT00765245|467428796|FG000|Overall Study|Withdrawal by Subject|3|||
129855382|NCT00765245|467428797|FG001|Overall Study|Withdrawal by Subject|0|||
129855383|NCT00765245|467428796|FG000|Overall Study|Adverse Event|5|||
129855384|NCT00765245|467428797|FG001|Overall Study|Adverse Event|0|||
129855385|NCT00765245|467428796|FG000|Overall Study|Physician Decision|1|||
129855386|NCT00765245|467428797|FG001|Overall Study|Physician Decision|0|||
129855387|NCT00765245|467428796|FG000|Overall Study|Death|1|||
129855388|NCT00765245|467428797|FG001|Overall Study|Death|0|||
129855389|NCT02546544|467428798|FG000|Overall Study|Disease Progression|14|||
129855390|NCT02546544|467428798|FG000|Overall Study|Adverse Event|1|||
129855391|NCT02546544|467428798|FG000|Overall Study|Withdrawal by Subject|1|||
129855392|NCT02223390|467428799|FG000|Overall Study|Lost to Follow-up|9|||
129855393|NCT02223390|467428800|FG001|Overall Study|Lost to Follow-up|4|||
129855394|NCT02548962|467428802|FG000|Overall Study|Withdrawal by Subject|1|||
129855395|NCT02548962|467428803|FG001|Overall Study|Withdrawal by Subject|0|||
129855396|NCT01197950|467428804|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
129855397|NCT01197950|467428805|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
129855398|NCT01197950|467428806|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
129855399|NCT04137380|467428812|FG000|Overall Study|Physician Decision|0|||
129855400|NCT04137380|467428813|FG001|Overall Study|Physician Decision|0|||
129855401|NCT04137380|467428814|FG002|Overall Study|Physician Decision|0|||
129855402|NCT04137380|467428815|FG003|Overall Study|Physician Decision|1|||
129855403|NCT04137380|467428816|FG004|Overall Study|Physician Decision|0|||
129855404|NCT04137380|467428817|FG005|Overall Study|Physician Decision|0|||
129855405|NCT04137380|467428818|FG006|Overall Study|Physician Decision|0|||
129855406|NCT03465540|467428824|FG000|Overall Study|Withdrawal by Subject|0|||
129855407|NCT03465540|467428825|FG001|Overall Study|Withdrawal by Subject|0|||
129855408|NCT03465540|467428826|FG002|Overall Study|Withdrawal by Subject|1|||
129855409|NCT03465540|467428827|FG003|Overall Study|Withdrawal by Subject|1|||
129855410|NCT03465540|467428828|FG004|Overall Study|Withdrawal by Subject|1|||
129855411|NCT03465540|467428829|FG005|Overall Study|Withdrawal by Subject|0|||
129855412|NCT03465540|467428824|FG000|Overall Study|Lost to Follow-up|0|||
129855413|NCT03465540|467428825|FG001|Overall Study|Lost to Follow-up|1|||
129855414|NCT03465540|467428826|FG002|Overall Study|Lost to Follow-up|0|||
129855415|NCT03465540|467428827|FG003|Overall Study|Lost to Follow-up|0|||
129855416|NCT03465540|467428828|FG004|Overall Study|Lost to Follow-up|1|||
129855417|NCT03465540|467428829|FG005|Overall Study|Lost to Follow-up|0|||
129855418|NCT03465540|467428824|FG000|Overall Study|Death|1|||
129855419|NCT03465540|467428825|FG001|Overall Study|Death|1|||
129855420|NCT03465540|467428826|FG002|Overall Study|Death|0|||
129855421|NCT03465540|467428827|FG003|Overall Study|Death|2|||
129855422|NCT03465540|467428828|FG004|Overall Study|Death|0|||
129855423|NCT03465540|467428829|FG005|Overall Study|Death|2|||
129855424|NCT03465540|467428824|FG000|Overall Study|Protocol specified criteria|0|||
129855425|NCT03465540|467428825|FG001|Overall Study|Protocol specified criteria|2|||
129855426|NCT03465540|467428826|FG002|Overall Study|Protocol specified criteria|2|||
129855427|NCT03465540|467428827|FG003|Overall Study|Protocol specified criteria|0|||
129855428|NCT03465540|467428828|FG004|Overall Study|Protocol specified criteria|2|||
129855429|NCT03465540|467428829|FG005|Overall Study|Protocol specified criteria|0|||
129855430|NCT00736996|467428830|FG000|Overall Study|Lost to Follow-up|1|||
129855431|NCT00736996|467428831|FG001|Overall Study|Lost to Follow-up|9|||
129855432|NCT00736996|467428832|FG002|Overall Study|Lost to Follow-up|2|||
129855433|NCT02844946|467428833|FG000|Overall Study|Lost to Follow-up|7|||
129855434|NCT02844946|467428834|FG001|Overall Study|Lost to Follow-up|0|||
129855435|NCT02806986|467428835|FG000|Treatment Stage 1|Adverse Event|1|||
129855436|NCT02806986|467428835|FG000|Treatment Stage 2|Adverse Event|3|||
129855437|NCT02806986|467428835|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
129855438|NCT04000165|467428836|FG000|Overall Study|Physician Decision|1|||
129855439|NCT04000165|467428836|FG000|Overall Study|Withdrawal by Subject|1|||
129855440|NCT01753193|467428837|FG000|Overall Study|Withdrawal by Subject|23|||
129855441|NCT01753193|467428837|FG000|Overall Study|Lost to Follow-up|6|||
129855442|NCT01753193|467428837|FG000|Overall Study|Death|1|||
129855443|NCT01753193|467428837|FG000|Overall Study|Other|16|||
129855444|NCT01131312|467428838|FG000|Overall Study|Lost to Follow-up|425|||
129908677|NCT03785782|467628756|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
129908678|NCT03785782|467628757|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
129908679|NCT03785782|467628756|FG000|Overall Study|Withdrawal by Subject|1|||
129908680|NCT03785782|467628757|FG001|Overall Study|Withdrawal by Subject|1|||
129908681|NCT03785782|467628756|FG000|Overall Study|insufficient image quality.|3|||
129908682|NCT03785782|467628757|FG001|Overall Study|insufficient image quality.|0|||
129908683|NCT03779048|467628758|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
129908684|NCT03779048|467628759|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
129908685|NCT03779048|467628760|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
129908686|NCT03779048|467628758|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
129908687|NCT03779048|467628759|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
129908688|NCT03779048|467628760|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
129908689|NCT03779048|467628758|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
129908690|NCT03779048|467628759|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
129908691|NCT03779048|467628760|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
129908692|NCT05777785|467628761|FG000|Overall Study|Withdrawal by Subject|5|||
129908693|NCT05777785|467628761|FG000|Overall Study|Lost to Follow-up|1|||
129908694|NCT04588259|467628763|FG000|Run-in Period|Run-in failure|0|||
129908695|NCT04588259|467628764|FG001|Run-in Period|Run-in failure|23|||
129908696|NCT04588259|467628763|FG000|Run-in Period|Withdrawn before randomisation|0|||
129908697|NCT04588259|467628764|FG001|Run-in Period|Withdrawn before randomisation|8|||
129908698|NCT04588259|467628763|FG000|Treatment Period|Withdrawal by Subject|6|||
129908699|NCT04588259|467628764|FG001|Treatment Period|Withdrawal by Subject|6|||
129908700|NCT02763319|467628768|FG000|Overall Study|Adverse Event|12|||
129908701|NCT02763319|467628769|FG001|Overall Study|Adverse Event|3|||
129908702|NCT02763319|467628768|FG000|Overall Study|Death|123|||
129908703|NCT02763319|467628769|FG001|Overall Study|Death|123|||
129908704|NCT02763319|467628768|FG000|Overall Study|Lost to Follow-up|6|||
129908705|NCT02763319|467628769|FG001|Overall Study|Lost to Follow-up|7|||
129908706|NCT02763319|467628768|FG000|Overall Study|Noncompliance with Study Drug|2|||
129908707|NCT02763319|467628769|FG001|Overall Study|Noncompliance with Study Drug|0|||
129908708|NCT02763319|467628768|FG000|Overall Study|"Captured as Other in Database"|29|||
129908709|NCT02763319|467628769|FG001|Overall Study|"Captured as Other in Database"|34|||
129908710|NCT02763319|467628768|FG000|Overall Study|Physician Decision|1|||
129908711|NCT02763319|467628769|FG001|Overall Study|Physician Decision|7|||
129908712|NCT02763319|467628768|FG000|Overall Study|Progressive Disease|24|||
129908713|NCT02763319|467628769|FG001|Overall Study|Progressive Disease|27|||
129908714|NCT02763319|467628768|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
129908715|NCT02763319|467628769|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
129908716|NCT02763319|467628768|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
129908717|NCT02763319|467628769|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
129908718|NCT02763319|467628768|FG000|Overall Study|Withdrawal by Subject|26|||
129908719|NCT02763319|467628769|FG001|Overall Study|Withdrawal by Subject|25|||
129908720|NCT01622868|467628773|FG000|Overall Study|Protocol Violation|7|||
129908721|NCT01622868|467628774|FG001|Overall Study|Protocol Violation|0|||
129908722|NCT00244855|467628779|FG000|Overall Study|Withdrawal by Subject|0|||
129908723|NCT00244855|467628780|FG001|Overall Study|Withdrawal by Subject|1|||
129908724|NCT04530747|467628783|FG000|Overall Study|Withdrawal by Subject|1|||
129908725|NCT04530747|467628784|FG001|Overall Study|Withdrawal by Subject|0|||
129908726|NCT03292913|467628785|FG000|Overall Study|Death|9|||
129908727|NCT03292913|467628786|FG001|Overall Study|Death|3|||
129908728|NCT03292913|467628785|FG000|Overall Study|Lost to Follow-up|49|||
129908729|NCT03292913|467628786|FG001|Overall Study|Lost to Follow-up|49|||
129908730|NCT03292913|467628785|FG000|Overall Study|Withdrawal by Subject|2|||
129908731|NCT03292913|467628786|FG001|Overall Study|Withdrawal by Subject|0|||
129908732|NCT03292913|467628785|FG000|Overall Study|Clinic closed due to COVID|22|||
129908733|NCT03292913|467628786|FG001|Overall Study|Clinic closed due to COVID|36|||
129908734|NCT03950622|467628787|FG000|Overall Study|Withdrawal by Subject|1|||
129908735|NCT03950622|467628788|FG001|Overall Study|Withdrawal by Subject|0|||
129908736|NCT03950622|467628787|FG000|Overall Study|Protocol Deviation|0|||
129908737|NCT03950622|467628788|FG001|Overall Study|Protocol Deviation|1|||
129855445|NCT01131312|467428839|FG001|Overall Study|Lost to Follow-up|229|||
129855446|NCT01131312|467428840|FG002|Overall Study|Lost to Follow-up|351|||
129855447|NCT00781326|467428844|FG000|Phase I|Adverse Event|1|||
129855448|NCT00781326|467428844|FG000|Phase I|Withdrawal by Subject|1|||
129855449|NCT00781326|467428844|FG000|Phase I|Physician Decision|2|||
129855450|NCT00096941|467428845|FG000|Overall Study|disease progression|3|||
129855451|NCT01343056|467428846|FG000|Overall Study|Lost to Follow-up|7|||
129855452|NCT01343056|467428847|FG001|Overall Study|Lost to Follow-up|5|||
129855453|NCT01343056|467428848|FG002|Overall Study|Lost to Follow-up|3|||
129855454|NCT01343056|467428849|FG003|Overall Study|Lost to Follow-up|9|||
129855455|NCT03029208|467428850|FG000|Overall Study|Withdrawal by Subject|2|||
129855456|NCT03029208|467428851|FG001|Overall Study|Withdrawal by Subject|3|||
129855457|NCT03029208|467428850|FG000|Overall Study|Lost to Follow-up|0|||
129855458|NCT03029208|467428851|FG001|Overall Study|Lost to Follow-up|1|||
129855459|NCT01046643|467428852|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
129855460|NCT01046643|467428853|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
129855461|NCT01046643|467428854|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
129855462|NCT01046643|467428855|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
129855463|NCT00305058|467428861|FG000|Overall Study|Participant too young|1|||
129855464|NCT00305058|467428862|FG001|Overall Study|Participant too young|0|||
129855465|NCT00305058|467428861|FG000|Overall Study|Missing data collection instrument|3|||
129855466|NCT00305058|467428862|FG001|Overall Study|Missing data collection instrument|2|||
129855467|NCT00305058|467428861|FG000|Overall Study|Missing outcome data|3|||
129855468|NCT00305058|467428862|FG001|Overall Study|Missing outcome data|2|||
129855469|NCT04102501|467428863|FG000|Overall Study|Withdrawal by Subject|7|||
129855470|NCT04102501|467428864|FG001|Overall Study|Withdrawal by Subject|9|||
129855471|NCT04102501|467428863|FG000|Overall Study|Adverse Event|1|||
129855472|NCT04102501|467428864|FG001|Overall Study|Adverse Event|3|||
129855473|NCT01427712|467428865|FG000|Overall Study|Transfer to a different hospital|2|||
129855474|NCT01427712|467428865|FG000|Overall Study|Lost to Follow-up|1|||
129855475|NCT01427712|467428865|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
129855476|NCT01427712|467428865|FG000|Overall Study|Failure to visit|1|||
129855477|NCT04798586|467428866|FG000|Overall Study|Death|2|||
129855478|NCT00968617|467428867|FG000|Overall Study|Study terminated by sponsor|6|||
129855479|NCT00661492|467428877|FG000|Overall Study|Adverse Event|16|||
129855480|NCT00661492|467428878|FG001|Overall Study|Adverse Event|13|||
129855481|NCT00661492|467428877|FG000|Overall Study|Disease Progression|44|||
129855482|NCT00661492|467428878|FG001|Overall Study|Disease Progression|14|||
129855483|NCT00661492|467428877|FG000|Overall Study|Patient Request|6|||
129855484|NCT00661492|467428878|FG001|Overall Study|Patient Request|1|||
129855485|NCT00661492|467428877|FG000|Overall Study|Investigator Request|1|||
129855486|NCT00661492|467428878|FG001|Overall Study|Investigator Request|0|||
129855487|NCT00661492|467428877|FG000|Overall Study|Lost to Follow-up|0|||
129855488|NCT00661492|467428878|FG001|Overall Study|Lost to Follow-up|1|||
129855489|NCT00661492|467428877|FG000|Overall Study|Other|1|||
129855490|NCT00661492|467428878|FG001|Overall Study|Other|0|||
129855491|NCT01024387|467428879|FG000|Overall Study|Radiographic Progression|29|||
129855492|NCT01024387|467428879|FG000|Overall Study|Symptomatic Progression|10|||
129855493|NCT01024387|467428879|FG000|Overall Study|Physician Decision|5|||
129855494|NCT01024387|467428879|FG000|Overall Study|Withdrawal by Subject|5|||
129855495|NCT01024387|467428879|FG000|Overall Study|Death|2|||
129855496|NCT01024387|467428879|FG000|Overall Study|Prolonged Treatment Delay|1|||
129855497|NCT01024387|467428879|FG000|Overall Study|Adverse Event|3|||
129855498|NCT01024387|467428879|FG000|Overall Study|Other|5|||
129855499|NCT04307186|467428880|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
129855500|NCT04307186|467428880|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
129855501|NCT04307186|467428880|FG000|Washout 3-14 Days|Progressive disease|1|||
129855502|NCT04307186|467428880|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
129855503|NCT04307186|467428880|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
129855504|NCT00927927|467428889|FG000|Overall Study|Withdrawal by Subject|0|||
129855505|NCT00927927|467428890|FG001|Overall Study|Withdrawal by Subject|0|||
129855506|NCT00927927|467428891|FG002|Overall Study|Withdrawal by Subject|0|||
129855507|NCT00927927|467428892|FG003|Overall Study|Withdrawal by Subject|0|||
129855508|NCT00927927|467428893|FG004|Overall Study|Withdrawal by Subject|0|||
129855509|NCT00927927|467428894|FG005|Overall Study|Withdrawal by Subject|0|||
129855510|NCT00927927|467428895|FG006|Overall Study|Withdrawal by Subject|0|||
129855511|NCT00927927|467428896|FG007|Overall Study|Withdrawal by Subject|2|||
129855512|NCT00927927|467428897|FG008|Overall Study|Withdrawal by Subject|0|||
129855513|NCT00927927|467428898|FG009|Overall Study|Withdrawal by Subject|0|||
129855514|NCT00927927|467428899|FG010|Overall Study|Withdrawal by Subject|0|||
129855515|NCT00927927|467428900|FG011|Overall Study|Withdrawal by Subject|2|||
129855516|NCT00927927|467428901|FG012|Overall Study|Withdrawal by Subject|0|||
129855517|NCT00927927|467428902|FG013|Overall Study|Withdrawal by Subject|0|||
129855518|NCT00927927|467428903|FG014|Overall Study|Withdrawal by Subject|0|||
129855519|NCT03135522|467428910|FG000|Overall Study|Adverse Event|1|||
129855520|NCT03135522|467428911|FG001|Overall Study|Adverse Event|0|||
129855521|NCT02838017|467428913|FG000|Overall Study|Lost to Follow-up|14|||
129908738|NCT03950622|467628787|FG000|Overall Study|Physician Decision|1|||
129908739|NCT03950622|467628788|FG001|Overall Study|Physician Decision|0|||
129908740|NCT03950622|467628787|FG000|Overall Study|Lost to Follow-up|5|||
129908741|NCT03950622|467628788|FG001|Overall Study|Lost to Follow-up|5|||
129908742|NCT03950622|467628787|FG000|Overall Study|Death|1|||
129908743|NCT03950622|467628788|FG001|Overall Study|Death|1|||
129908744|NCT01546753|467628791|FG000|Overall Study|anxiety|1|||
129908745|NCT01546753|467628792|FG001|Overall Study|anxiety|1|||
129908746|NCT01546753|467628791|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
129908747|NCT01546753|467628792|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
129908748|NCT00939510|467628793|FG000|Overall Study|Withdrawal by Subject|1|||
129908749|NCT05782231|467628809|FG000|Overall Study|Withdrawal by Subject|1|||
129908750|NCT03830866|467628812|FG000|Overall Study|Death|90|||
129908751|NCT03830866|467628813|FG001|Overall Study|Death|111|||
129908752|NCT03830866|467628812|FG000|Overall Study|Lost to Follow-up|7|||
129908753|NCT03830866|467628813|FG001|Overall Study|Lost to Follow-up|7|||
129908754|NCT03830866|467628812|FG000|Overall Study|Withdrawal by Subject|19|||
129908755|NCT03830866|467628813|FG001|Overall Study|Withdrawal by Subject|16|||
129908756|NCT03830866|467628812|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
129908757|NCT03830866|467628813|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
129908758|NCT03830866|467628812|FG000|Overall Study|Other|1|||
129908759|NCT03830866|467628813|FG001|Overall Study|Other|1|||
129908760|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
129908761|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
129908762|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
129908763|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
129908764|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
129908765|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
129908766|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
129908767|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
129908768|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
129855522|NCT02838017|467428914|FG001|Overall Study|Lost to Follow-up|11|||
129855523|NCT02120924|467428915|FG000|Overall Study|Lack of Efficacy|1|||
129855524|NCT02120924|467428916|FG001|Overall Study|Lack of Efficacy|2|||
129855525|NCT02120924|467428917|FG002|Overall Study|Lack of Efficacy|3|||
129855526|NCT02120924|467428915|FG000|Overall Study|Adverse Event|0|||
129855527|NCT02120924|467428916|FG001|Overall Study|Adverse Event|1|||
129855528|NCT02120924|467428917|FG002|Overall Study|Adverse Event|3|||
129855529|NCT02120924|467428915|FG000|Overall Study|Withdrawal by Subject|16|||
129855530|NCT02120924|467428916|FG001|Overall Study|Withdrawal by Subject|20|||
129855531|NCT02120924|467428917|FG002|Overall Study|Withdrawal by Subject|8|||
129855532|NCT02120924|467428915|FG000|Overall Study|Lost to Follow-up|14|||
129855533|NCT02120924|467428916|FG001|Overall Study|Lost to Follow-up|14|||
129855534|NCT02120924|467428917|FG002|Overall Study|Lost to Follow-up|11|||
129855535|NCT02120924|467428915|FG000|Overall Study|Pregnancy|2|||
129855536|NCT02120924|467428916|FG001|Overall Study|Pregnancy|0|||
129855537|NCT02120924|467428917|FG002|Overall Study|Pregnancy|0|||
129855538|NCT02120924|467428915|FG000|Overall Study|Protocol Violation|3|||
129855539|NCT02120924|467428916|FG001|Overall Study|Protocol Violation|7|||
129855540|NCT02120924|467428917|FG002|Overall Study|Protocol Violation|2|||
129855541|NCT02120924|467428915|FG000|Overall Study|Physician Decision|0|||
129908769|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
129908770|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
129908771|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
129855542|NCT02120924|467428916|FG001|Overall Study|Physician Decision|1|||
129855543|NCT02120924|467428917|FG002|Overall Study|Physician Decision|1|||
129908772|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
129908773|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
129855544|NCT02120924|467428915|FG000|Overall Study|Death|1|||
129855545|NCT02120924|467428916|FG001|Overall Study|Death|0|||
129855546|NCT02120924|467428917|FG002|Overall Study|Death|0|||
129855547|NCT02120924|467428915|FG000|Overall Study|Compliance with IP|5|||
129908774|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
129908775|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
129908776|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
129908777|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
129908778|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
129908779|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
129908780|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
129908781|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
129908782|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
129908783|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
129908784|NCT00311363|467628814|FG000|24-Week Single-Blind Treatment Period|Death|1|||
129908785|NCT00311363|467628815|FG001|24-Week Single-Blind Treatment Period|Death|0|||
129908786|NCT00311363|467628816|FG002|24-Week Single-Blind Treatment Period|Death|0|||
129908787|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
129908788|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
129908789|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
129908790|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
129855548|NCT02120924|467428916|FG001|Overall Study|Compliance with IP|1|||
129855549|NCT02120924|467428917|FG002|Overall Study|Compliance with IP|1|||
129855550|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
129855551|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
129855552|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
129855553|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
129855554|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
129855555|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
129855556|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
129855557|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
129855558|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
129855559|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
129855560|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
129855561|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
129855562|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
129855563|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
129855564|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
129855565|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
129855566|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
129855567|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
129855568|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
129855569|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
129855570|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
129855571|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
129855572|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
129855573|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
129855574|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
129855575|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
129855576|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
129855577|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
129855578|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
129855579|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
129855580|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
129855581|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
129855582|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
129855583|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
129855584|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
129855585|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
129855586|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
129855587|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
129855588|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
129855589|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
129855590|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
129855591|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
129855592|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
129855593|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
129908791|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
129908792|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129855594|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
129855595|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
129855596|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
129855597|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
129855598|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
129855599|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
129855600|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
129855601|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
129855602|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
129855603|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
129855604|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
129855605|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
129855606|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
129855607|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
129855608|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
129855609|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
129855610|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
129855611|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
129855612|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
129855613|NCT01884350|467428918|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
129855614|NCT01884350|467428919|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
129855615|NCT01884350|467428920|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
129855616|NCT02345512|467428921|FG000|Overall Study|Adverse Event|1|||
129855617|NCT02345512|467428921|FG000|Overall Study|Withdrawal by Subject|1|||
129855618|NCT01968434|467428924|FG000|Overall Study|Lost to Follow-up|3|||
129855619|NCT01968434|467428925|FG001|Overall Study|Lost to Follow-up|6|||
129855620|NCT00074282|467430665|FG000|Step 1|Adverse Event|32|||
129855621|NCT00074282|467430666|FG001|Step 1|Adverse Event|0|||
129855622|NCT00074282|467430667|FG002|Step 1|Adverse Event|0|||
129855623|NCT00074282|467430665|FG000|Step 1|Death|6|||
129855624|NCT00074282|467430666|FG001|Step 1|Death|0|||
129855625|NCT00074282|467430667|FG002|Step 1|Death|0|||
129855626|NCT00074282|467430665|FG000|Step 1|Withdrawal by Subject|7|||
129855627|NCT00074282|467430666|FG001|Step 1|Withdrawal by Subject|0|||
129855628|NCT00074282|467430667|FG002|Step 1|Withdrawal by Subject|0|||
129855629|NCT00074282|467430665|FG000|Step 1|Disease progression|2|||
129855630|NCT00074282|467430666|FG001|Step 1|Disease progression|0|||
129855631|NCT00074282|467430667|FG002|Step 1|Disease progression|0|||
129855632|NCT00074282|467430665|FG000|Step 1|Alternative therapy|2|||
129855633|NCT00074282|467430666|FG001|Step 1|Alternative therapy|0|||
129855634|NCT00074282|467430667|FG002|Step 1|Alternative therapy|0|||
129855635|NCT00074282|467430665|FG000|Step 1|Other complicating disease|2|||
129855636|NCT00074282|467430666|FG001|Step 1|Other complicating disease|0|||
129855637|NCT00074282|467430667|FG002|Step 1|Other complicating disease|0|||
129855638|NCT00074282|467430665|FG000|Step 1|Physician Decision|1|||
129855639|NCT00074282|467430666|FG001|Step 1|Physician Decision|0|||
129855640|NCT00074282|467430667|FG002|Step 1|Physician Decision|0|||
129855641|NCT00074282|467430665|FG000|Step 1|Ineligible|4|||
129855642|NCT00074282|467430666|FG001|Step 1|Ineligible|0|||
129855643|NCT00074282|467430667|FG002|Step 1|Ineligible|0|||
129855644|NCT00074282|467430665|FG000|Step 1|Never started treatment|2|||
129855645|NCT00074282|467430666|FG001|Step 1|Never started treatment|0|||
129855646|NCT00074282|467430667|FG002|Step 1|Never started treatment|0|||
129855647|NCT00074282|467430665|FG000|Step 2|Adverse Event|0|||
129855648|NCT00074282|467430666|FG001|Step 2|Adverse Event|2|||
129855649|NCT00074282|467430667|FG002|Step 2|Adverse Event|12|||
129855650|NCT00074282|467430665|FG000|Step 2|Disease progression|0|||
129855651|NCT00074282|467430666|FG001|Step 2|Disease progression|0|||
129855652|NCT00074282|467430667|FG002|Step 2|Disease progression|5|||
129855653|NCT00074282|467430665|FG000|Step 2|Death|0|||
129855654|NCT00074282|467430666|FG001|Step 2|Death|0|||
129855655|NCT00074282|467430667|FG002|Step 2|Death|3|||
129855656|NCT00074282|467430665|FG000|Step 2|Withdrawal by Subject|0|||
129855657|NCT00074282|467430666|FG001|Step 2|Withdrawal by Subject|0|||
129855658|NCT00074282|467430667|FG002|Step 2|Withdrawal by Subject|2|||
129855659|NCT00074282|467430665|FG000|Step 2|Physician Decision|0|||
129855660|NCT00074282|467430666|FG001|Step 2|Physician Decision|0|||
129855661|NCT00074282|467430667|FG002|Step 2|Physician Decision|1|||
129855662|NCT00074282|467430665|FG000|Step 2|Ineligible|0|||
129855663|NCT00074282|467430666|FG001|Step 2|Ineligible|0|||
129855664|NCT00074282|467430667|FG002|Step 2|Ineligible|1|||
129855665|NCT00464542|467430668|FG000|Pre-treatment|Withdrawal by Subject|2|||
129855666|NCT01773226|467430670|FG000|Overall Study|Withdrawal by Subject|1|||
129855667|NCT02055352|467430675|FG000|Overall Study|Adverse Event|0|||
129855668|NCT02055352|467430676|FG001|Overall Study|Adverse Event|1|||
129855669|NCT02055352|467430675|FG000|Overall Study|Non-eligible|0|||
129855670|NCT02055352|467430676|FG001|Overall Study|Non-eligible|1|||
129855671|NCT02055352|467430675|FG000|Overall Study|Poor compliance|1|||
129855672|NCT02055352|467430676|FG001|Overall Study|Poor compliance|1|||
129855673|NCT02055352|467430675|FG000|Overall Study|Death|1|||
129855674|NCT02055352|467430676|FG001|Overall Study|Death|2|||
129855675|NCT02055352|467430675|FG000|Overall Study|Patient decision|1|||
129855676|NCT02055352|467430676|FG001|Overall Study|Patient decision|1|||
129855677|NCT02055352|467430675|FG000|Overall Study|Use of prohibited treatment|0|||
129855678|NCT02055352|467430676|FG001|Overall Study|Use of prohibited treatment|3|||
129855679|NCT02055352|467430675|FG000|Overall Study|AE, study drug would be detrimental|1|||
129855680|NCT02055352|467430676|FG001|Overall Study|AE, study drug would be detrimental|3|||
129855681|NCT02055352|467430675|FG000|Overall Study|Withdrawal of informed consent|1|||
129855682|NCT02055352|467430676|FG001|Overall Study|Withdrawal of informed consent|0|||
129855683|NCT02055352|467430675|FG000|Overall Study|Reason unknown|1|||
129855684|NCT02055352|467430676|FG001|Overall Study|Reason unknown|5|||
129855685|NCT00489970|467430683|FG000|Persistence Year 9|Lost to Follow-up|2|||
129855686|NCT00489970|467430684|FG001|Persistence Year 9|Lost to Follow-up|2|||
129855687|NCT00489970|467430685|FG002|Persistence Year 9|Lost to Follow-up|3|||
129855688|NCT00489970|467430683|FG000|Persistence Year 9|Other|1|||
129855689|NCT00489970|467430684|FG001|Persistence Year 9|Other|0|||
129855690|NCT00489970|467430685|FG002|Persistence Year 9|Other|2|||
129855691|NCT02707055|467430692|FG000|Phase 1|Withdrawal by Subject|1|||
129855692|NCT02707055|467430693|FG001|Phase 1|Withdrawal by Subject|2|||
129855693|NCT02707055|467430692|FG000|Phase 1|Physician Decision|0|||
129855694|NCT02707055|467430693|FG001|Phase 1|Physician Decision|1|||
129855695|NCT02707055|467430692|FG000|Phase 2|Adverse Event|1|||
129855696|NCT02707055|467430693|FG001|Phase 2|Adverse Event|2|||
129855697|NCT03564496|467430694|FG000|Overall Study|Withdrawal by Subject|1|||
129855698|NCT03564496|467430695|FG001|Overall Study|Withdrawal by Subject|1|||
129855699|NCT03564496|467430696|FG002|Overall Study|Withdrawal by Subject|0|||
129855700|NCT03564496|467430694|FG000|Overall Study|Screen failure|0|||
129855701|NCT03564496|467430695|FG001|Overall Study|Screen failure|3|||
129855702|NCT03564496|467430696|FG002|Overall Study|Screen failure|0|||
129855703|NCT01159938|467430697|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855704|NCT01159938|467430698|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855705|NCT01159938|467430699|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
129855706|NCT01159938|467430700|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855707|NCT01159938|467430701|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
129855708|NCT02318329|467430702|FG000|Overall Study|Progressive Disease|2|||
129855709|NCT02318329|467430703|FG001|Overall Study|Progressive Disease|3|||
129855710|NCT02318329|467430704|FG002|Overall Study|Progressive Disease|2|||
129855711|NCT02318329|467430705|FG003|Overall Study|Progressive Disease|3|||
129855712|NCT02318329|467430706|FG004|Overall Study|Progressive Disease|3|||
129855713|NCT02318329|467430707|FG005|Overall Study|Progressive Disease|3|||
129855714|NCT02318329|467430708|FG006|Overall Study|Progressive Disease|1|||
129855715|NCT02318329|467430709|FG007|Overall Study|Progressive Disease|1|||
129855716|NCT02318329|467430710|FG008|Overall Study|Progressive Disease|5|||
129855717|NCT02318329|467430711|FG009|Overall Study|Progressive Disease|39|||
129855718|NCT02318329|467430702|FG000|Overall Study|Death|0|||
129855719|NCT02318329|467430703|FG001|Overall Study|Death|0|||
129855720|NCT02318329|467430704|FG002|Overall Study|Death|0|||
129855721|NCT02318329|467430705|FG003|Overall Study|Death|0|||
129855722|NCT02318329|467430706|FG004|Overall Study|Death|0|||
129855723|NCT02318329|467430707|FG005|Overall Study|Death|0|||
129855724|NCT02318329|467430708|FG006|Overall Study|Death|0|||
129855725|NCT02318329|467430709|FG007|Overall Study|Death|0|||
129855726|NCT02318329|467430710|FG008|Overall Study|Death|0|||
129855727|NCT02318329|467430711|FG009|Overall Study|Death|5|||
129855728|NCT02318329|467430702|FG000|Overall Study|Lost to Follow-up|0|||
129855729|NCT02318329|467430703|FG001|Overall Study|Lost to Follow-up|0|||
129855730|NCT02318329|467430704|FG002|Overall Study|Lost to Follow-up|0|||
129855731|NCT02318329|467430705|FG003|Overall Study|Lost to Follow-up|0|||
129855732|NCT02318329|467430706|FG004|Overall Study|Lost to Follow-up|0|||
129855733|NCT02318329|467430707|FG005|Overall Study|Lost to Follow-up|0|||
129855734|NCT02318329|467430708|FG006|Overall Study|Lost to Follow-up|0|||
129855735|NCT02318329|467430709|FG007|Overall Study|Lost to Follow-up|0|||
129855736|NCT02318329|467430710|FG008|Overall Study|Lost to Follow-up|0|||
129855737|NCT02318329|467430711|FG009|Overall Study|Lost to Follow-up|1|||
129855738|NCT02318329|467430702|FG000|Overall Study|Withdrawal by Subject|0|||
129855739|NCT02318329|467430703|FG001|Overall Study|Withdrawal by Subject|0|||
129855740|NCT02318329|467430704|FG002|Overall Study|Withdrawal by Subject|0|||
129855741|NCT02318329|467430705|FG003|Overall Study|Withdrawal by Subject|0|||
129855742|NCT02318329|467430706|FG004|Overall Study|Withdrawal by Subject|0|||
129855743|NCT02318329|467430707|FG005|Overall Study|Withdrawal by Subject|0|||
129855744|NCT02318329|467430708|FG006|Overall Study|Withdrawal by Subject|0|||
129855745|NCT02318329|467430709|FG007|Overall Study|Withdrawal by Subject|0|||
129855746|NCT02318329|467430710|FG008|Overall Study|Withdrawal by Subject|0|||
129855747|NCT02318329|467430711|FG009|Overall Study|Withdrawal by Subject|6|||
129855748|NCT02318329|467430702|FG000|Overall Study|Other|1|||
129908793|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
129908794|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
129908795|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
129908796|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
129908797|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
129855749|NCT02318329|467430703|FG001|Overall Study|Other|1|||
129855750|NCT02318329|467430704|FG002|Overall Study|Other|1|||
129855751|NCT02318329|467430705|FG003|Overall Study|Other|0|||
129908798|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
129908799|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
129908800|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
129908801|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
129908802|NCT00311363|467628814|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
129908803|NCT00311363|467628815|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
129908804|NCT00311363|467628816|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
129908805|NCT00510887|467628818|FG000|Overall Study|Lost to Follow-up|1|||
129908806|NCT03485950|467628823|FG000|Overall Study|Adverse Event|1|||
129908807|NCT03485950|467628824|FG001|Overall Study|Adverse Event|0|||
129908808|NCT03485950|467628823|FG000|Overall Study|Death|3|||
129908809|NCT03485950|467628824|FG001|Overall Study|Death|2|||
129908810|NCT03485950|467628823|FG000|Overall Study|Withdrawal by Subject|3|||
129908811|NCT03485950|467628824|FG001|Overall Study|Withdrawal by Subject|0|||
129908812|NCT00988858|467628826|FG000|Overall Study|Adverse Event|7|||
129908813|NCT00988858|467628826|FG000|Overall Study|Death|1|||
129908814|NCT00988858|467628826|FG000|Overall Study|Physician Decision|1|||
129908815|NCT00988858|467628826|FG000|Overall Study|Sponsor Decision|1|||
129908816|NCT05510245|467628833|FG000|Overall Study|Withdrawal by Subject|1|||
129908817|NCT05510245|467628834|FG001|Overall Study|Withdrawal by Subject|0|||
129908818|NCT05510245|467628835|FG002|Overall Study|Withdrawal by Subject|0|||
129908819|NCT01759771|467628843|FG000|Overall Study|Withdrawal by Subject|1|||
129908820|NCT01759771|467628844|FG001|Overall Study|Withdrawal by Subject|1|||
129908821|NCT03942042|467628845|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
129908822|NCT03942042|467628846|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
129908823|NCT03942042|467628845|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
129908824|NCT03942042|467628846|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
129908825|NCT00411216|467628848|FG000|Overall Study|Ten participants were entered into the c|0|||
129908826|NCT00411216|467628849|FG001|Overall Study|Ten participants were entered into the c|2|||
129908827|NCT01251354|467628851|FG000|Overall Study|Adverse Event|1|||
129908828|NCT01251354|467628851|FG000|Overall Study|Investigator's Decision|1|||
129908829|NCT01251354|467628851|FG000|Overall Study|Disease Progression|4|||
129908830|NCT05094141|467628852|FG000|Overall Study|Death|0|||
129908831|NCT05094141|467628853|FG001|Overall Study|Death|0|||
129908832|NCT05094141|467628854|FG002|Overall Study|Death|1|||
129908833|NCT05094141|467628852|FG000|Overall Study|Withdrawal by Subject|0|||
129908834|NCT05094141|467628853|FG001|Overall Study|Withdrawal by Subject|0|||
129908835|NCT05094141|467628854|FG002|Overall Study|Withdrawal by Subject|1|||
129908836|NCT05094141|467628852|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
129908837|NCT05094141|467628853|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
129908838|NCT05094141|467628854|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
129908839|NCT05094141|467628852|FG000|Overall Study|Did not participate in randomization|0|||
129908840|NCT05094141|467628853|FG001|Overall Study|Did not participate in randomization|0|||
129908841|NCT05094141|467628854|FG002|Overall Study|Did not participate in randomization|33|||
129908842|NCT04411056|467630834|FG000|Overall Study|surgery cancelled|1|||
129908843|NCT04411056|467630835|FG001|Overall Study|surgery cancelled|0|||
129855752|NCT02318329|467430706|FG004|Overall Study|Other|0|||
129855753|NCT02318329|467430707|FG005|Overall Study|Other|0|||
129855754|NCT02318329|467430708|FG006|Overall Study|Other|0|||
129855755|NCT02318329|467430709|FG007|Overall Study|Other|0|||
129855756|NCT02318329|467430710|FG008|Overall Study|Other|1|||
129855757|NCT02318329|467430711|FG009|Overall Study|Other|1|||
129855758|NCT00086346|467430712|FG000|Randomization|Did not receive test article|4|||
129855759|NCT00086346|467430713|FG001|Randomization|Did not receive test article|4|||
129855760|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Adverse Event|94|||
129855761|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Adverse Event|11|||
129855762|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
129908844|NCT04411056|467630834|FG000|Overall Study|Equipment problem during intubation|0|||
129908845|NCT04411056|467630835|FG001|Overall Study|Equipment problem during intubation|1|||
129908846|NCT03122886|467630838|FG000|Overall Study|Withdrawal by Subject|1|||
129908847|NCT03122886|467630839|FG001|Overall Study|Withdrawal by Subject|2|||
129908848|NCT05985044|467630840|FG000|Overall Study|Death|6|||
129908849|NCT05985044|467630840|FG000|Overall Study|Lost to Follow-up|4|||
129908850|NCT05985044|467630840|FG000|Overall Study|Incapacitation|3|||
129908851|NCT05985044|467630840|FG000|Overall Study|Withdrawal by Subject|2|||
129855763|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
129855764|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
129855765|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
129855766|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
129855767|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
129855768|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
129855769|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
129855770|NCT00086346|467430712|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
129855771|NCT00086346|467430713|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
129855772|NCT04495374|467430714|FG000|Overall Study|Protocol Violation|2|||
129855773|NCT04495374|467430715|FG001|Overall Study|Protocol Violation|1|||
129855774|NCT01303627|467430716|FG000|Overall Study|the failure while performing URS|0|||
129855775|NCT01303627|467430717|FG001|Overall Study|the failure while performing URS|1|||
129855776|NCT02416791|467430719|FG000|6 Months|Lost to Follow-up|0|||
129855777|NCT02416791|467430720|FG001|6 Months|Lost to Follow-up|0|||
129855778|NCT02416791|467430721|FG002|6 Months|Lost to Follow-up|1|||
129855779|NCT01054820|467430722|FG000|Overall Study|Withdrawal by Subject|2|||
129855780|NCT00996996|467430724|FG000|Overall Study|Progressive Disease|10|||
129855781|NCT00996996|467430724|FG000|Overall Study|Non-compliance|8|||
129855782|NCT00996996|467430724|FG000|Overall Study|Lost to Follow-up|9|||
129855783|NCT00996996|467430724|FG000|Overall Study|Death|5|||
129855784|NCT00996996|467430724|FG000|Overall Study|Did Not Receive Study Medications|1|||
129855785|NCT04535037|467430727|FG000|Overall Study|Protocol Violation|1|||
129855786|NCT04535037|467430728|FG001|Overall Study|Protocol Violation|0|||
129855787|NCT04535037|467430727|FG000|Overall Study|Withdrawal by Subject|8|||
129855788|NCT04535037|467430728|FG001|Overall Study|Withdrawal by Subject|9|||
129855789|NCT04535037|467430727|FG000|Overall Study|Migrated / moved from the study area|1|||
129855790|NCT04535037|467430728|FG001|Overall Study|Migrated / moved from the study area|4|||
129855791|NCT04535037|467430727|FG000|Overall Study|Other|2|||
129855792|NCT04535037|467430728|FG001|Overall Study|Other|5|||
129855793|NCT02031276|467430729|FG000|Period 1 Double-blind IV|Adverse Event|6|||
129855794|NCT02031276|467430730|FG001|Period 1 Double-blind IV|Adverse Event|5|||
129855795|NCT02031276|467430731|FG002|Period 1 Double-blind IV|Adverse Event|1|||
129855796|NCT02031276|467430729|FG000|Period 1 Double-blind IV|Other|0|||
129855797|NCT02031276|467430730|FG001|Period 1 Double-blind IV|Other|1|||
129855798|NCT02031276|467430731|FG002|Period 1 Double-blind IV|Other|0|||
129855799|NCT02031276|467430729|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
129855800|NCT02031276|467430730|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
129855801|NCT02031276|467430731|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
129855802|NCT02031276|467430729|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
129855803|NCT02031276|467430730|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
129855804|NCT02031276|467430731|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
129855805|NCT02031276|467430729|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
129855806|NCT02031276|467430730|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
129855807|NCT02031276|467430731|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
129855808|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
129855809|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
129855810|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
129855811|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
129855812|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
129855813|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
129855814|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
129855815|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
129855816|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
129855817|NCT02031276|467430729|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
129855818|NCT02031276|467430730|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
129855819|NCT02031276|467430731|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
129855820|NCT01148810|467430732|FG000|Overall Study|Adverse Event|0|||
129855821|NCT01148810|467430733|FG001|Overall Study|Adverse Event|2|||
129855822|NCT01148810|467430732|FG000|Overall Study|Lack of Efficacy|0|||
129855823|NCT01148810|467430733|FG001|Overall Study|Lack of Efficacy|1|||
129855824|NCT01148810|467430732|FG000|Overall Study|Withdrawal by Subject|0|||
129855825|NCT01148810|467430733|FG001|Overall Study|Withdrawal by Subject|2|||
129855826|NCT01148810|467430732|FG000|Overall Study|Protocol Violation|1|||
129855827|NCT01148810|467430733|FG001|Overall Study|Protocol Violation|0|||
129855828|NCT02417246|467430740|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
129855829|NCT02417246|467430741|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
129908852|NCT02279095|467630843|FG000|Overall Study|Non-Compliance|1|||
129908853|NCT02279095|467630843|FG000|Overall Study|Withdrawal by Subject|8|||
129855830|NCT02417246|467430740|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
129855831|NCT02417246|467430741|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
129855832|NCT02417246|467430740|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
129855833|NCT02417246|467430741|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
129855834|NCT02417246|467430740|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
129855835|NCT02417246|467430741|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
129855836|NCT01181921|467430745|FG000|Overall Study|Lost to Follow-up|1|||
129855837|NCT04408469|467430746|FG000|Overall Study|Lost to Follow-up|6|||
129855838|NCT04408469|467430747|FG001|Overall Study|Lost to Follow-up|9|||
129855839|NCT04408469|467430746|FG000|Overall Study|Withdrawal by Subject|6|||
129855840|NCT04408469|467430747|FG001|Overall Study|Withdrawal by Subject|1|||
129855841|NCT04408469|467430746|FG000|Overall Study|Dismissal due to ineligibility|0|||
129855842|NCT04408469|467430747|FG001|Overall Study|Dismissal due to ineligibility|1|||
129855843|NCT04321460|467430748|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
129855844|NCT04321460|467430749|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
129855845|NCT02162810|467430752|FG000|Overall Study|Protocol Violation|1|||
129855846|NCT02162810|467430753|FG001|Overall Study|Protocol Violation|0|||
129855847|NCT02162810|467430752|FG000|Overall Study|patients did not report compliance|4|||
129855848|NCT02162810|467430753|FG001|Overall Study|patients did not report compliance|1|||
129855849|NCT01308749|467430758|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
129855850|NCT01308749|467430759|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
129855851|NCT01308749|467430758|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
129855852|NCT01308749|467430759|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
129855853|NCT01308749|467430758|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
129855854|NCT01308749|467430759|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
129855855|NCT02519504|467430760|FG000|Overall Study|Protocol Violation|6|||
129855856|NCT02519504|467430761|FG001|Overall Study|Protocol Violation|5|||
129855857|NCT02519504|467430760|FG000|Overall Study|Ineligible for direct testing|12|||
129855858|NCT02519504|467430761|FG001|Overall Study|Ineligible for direct testing|12|||
129855859|NCT02519504|467430760|FG000|Overall Study|Did not participate in direct testing|95|||
129855860|NCT02519504|467430761|FG001|Overall Study|Did not participate in direct testing|86|||
129855861|NCT04726709|467430762|FG000|Overall Study|Withdrawal by Subject|2|||
129855862|NCT04726709|467430763|FG001|Overall Study|Withdrawal by Subject|2|||
129855863|NCT02553330|467430764|FG000|Overall Study|Study Terminated by Sponsor|2|||
129855864|NCT02553330|467430765|FG001|Overall Study|Study Terminated by Sponsor|13|||
129855865|NCT02553330|467430766|FG002|Overall Study|Study Terminated by Sponsor|12|||
129855866|NCT02553330|467430764|FG000|Overall Study|Withdrawal by Subject|3|||
129855867|NCT02553330|467430765|FG001|Overall Study|Withdrawal by Subject|19|||
129855868|NCT02553330|467430766|FG002|Overall Study|Withdrawal by Subject|21|||
129855869|NCT02553330|467430764|FG000|Overall Study|Other|0|||
129855870|NCT02553330|467430765|FG001|Overall Study|Other|1|||
129855871|NCT02553330|467430766|FG002|Overall Study|Other|0|||
129855872|NCT02553330|467430764|FG000|Overall Study|Non compliance to study treatment|0|||
129855873|NCT02553330|467430765|FG001|Overall Study|Non compliance to study treatment|1|||
129855874|NCT02553330|467430766|FG002|Overall Study|Non compliance to study treatment|0|||
129855875|NCT02553330|467430764|FG000|Overall Study|Adverse Event|0|||
129855876|NCT02553330|467430765|FG001|Overall Study|Adverse Event|1|||
129855877|NCT02553330|467430766|FG002|Overall Study|Adverse Event|0|||
129855878|NCT02553330|467430764|FG000|Overall Study|Lost to Follow-up|0|||
129855879|NCT02553330|467430765|FG001|Overall Study|Lost to Follow-up|4|||
129855880|NCT02553330|467430766|FG002|Overall Study|Lost to Follow-up|4|||
129855881|NCT03551938|467430770|FG000|3-Month Follow Up|Lost to Follow-up|39|||
129855882|NCT03551938|467430771|FG001|3-Month Follow Up|Lost to Follow-up|38|||
129855883|NCT03551938|467430770|FG000|6-Month Follow Up|Lost to Follow-up|46|||
129855884|NCT03551938|467430771|FG001|6-Month Follow Up|Lost to Follow-up|42|||
129855885|NCT03551938|467430770|FG000|9-Month Follow Up|Lost to Follow-up|44|||
129855886|NCT03551938|467430771|FG001|9-Month Follow Up|Lost to Follow-up|43|||
129855887|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Adverse Event|3|||
129855888|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Adverse Event|2|||
129855889|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Adverse Event|0|||
129855890|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Adverse Event|0|||
129855891|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Adverse Event|0|||
129855892|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Adverse Event|0|||
129855893|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Adverse Event|0|||
129855894|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
129855895|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
129855896|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855897|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855898|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855899|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855900|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
129855901|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Physician Decision|1|||
129855902|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Physician Decision|0|||
129855903|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Physician Decision|0|||
129855904|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Physician Decision|0|||
129855905|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Physician Decision|0|||
129908854|NCT02279095|467630843|FG000|Overall Study|Adverse Event|2|||
129908855|NCT02279095|467630843|FG000|Overall Study|Other|7|||
129908856|NCT02279095|467630843|FG000|Overall Study|Lost to Follow-up|1|||
129908857|NCT02767765|467630844|FG000|Overall Study|Adverse Event|4|||
129908858|NCT02767765|467630844|FG000|Overall Study|Death|1|||
129908859|NCT02767765|467630844|FG000|Overall Study|Insufficient response|1|||
129908860|NCT02767765|467630844|FG000|Overall Study|Lost to Follow-up|2|||
129908861|NCT02767765|467630844|FG000|Overall Study|Investigator decision|1|||
129855906|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Physician Decision|0|||
129855907|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Physician Decision|0|||
129855908|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
129855909|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
129855910|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855911|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855912|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855913|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855914|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
129855915|NCT02265705|467430772|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855916|NCT02265705|467430773|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
129855917|NCT02265705|467430774|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855918|NCT02265705|467430775|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855919|NCT02265705|467430776|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855920|NCT02265705|467430777|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855921|NCT02265705|467430778|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
129855922|NCT02265705|467430772|FG000|Rescue Period|Withdrawal by Subject|0|||
129855923|NCT02265705|467430773|FG001|Rescue Period|Withdrawal by Subject|0|||
129855924|NCT02265705|467430774|FG002|Rescue Period|Withdrawal by Subject|1|||
129855925|NCT02265705|467430775|FG003|Rescue Period|Withdrawal by Subject|0|||
129855926|NCT02265705|467430776|FG004|Rescue Period|Withdrawal by Subject|0|||
129855927|NCT02265705|467430777|FG005|Rescue Period|Withdrawal by Subject|0|||
129855928|NCT02265705|467430778|FG006|Rescue Period|Withdrawal by Subject|0|||
129855929|NCT02265705|467430772|FG000|Rescue Period|Death|0|||
129855930|NCT02265705|467430773|FG001|Rescue Period|Death|0|||
129855931|NCT02265705|467430774|FG002|Rescue Period|Death|1|||
129855932|NCT02265705|467430775|FG003|Rescue Period|Death|0|||
129855933|NCT02265705|467430776|FG004|Rescue Period|Death|0|||
129855934|NCT02265705|467430777|FG005|Rescue Period|Death|0|||
129855935|NCT02265705|467430778|FG006|Rescue Period|Death|0|||
129855936|NCT02265705|467430772|FG000|Rescue Period|Lack of Efficacy|0|||
129855937|NCT02265705|467430773|FG001|Rescue Period|Lack of Efficacy|0|||
129855938|NCT02265705|467430774|FG002|Rescue Period|Lack of Efficacy|1|||
129855939|NCT02265705|467430775|FG003|Rescue Period|Lack of Efficacy|0|||
129855940|NCT02265705|467430776|FG004|Rescue Period|Lack of Efficacy|0|||
129855941|NCT02265705|467430777|FG005|Rescue Period|Lack of Efficacy|0|||
129855942|NCT02265705|467430778|FG006|Rescue Period|Lack of Efficacy|0|||
129855943|NCT02265705|467430772|FG000|Open Label Period|Adverse Event|0|||
129855944|NCT02265705|467430773|FG001|Open Label Period|Adverse Event|0|||
129855945|NCT02265705|467430774|FG002|Open Label Period|Adverse Event|0|||
129855946|NCT02265705|467430775|FG003|Open Label Period|Adverse Event|2|||
129855947|NCT02265705|467430776|FG004|Open Label Period|Adverse Event|2|||
129855948|NCT02265705|467430777|FG005|Open Label Period|Adverse Event|0|||
129855949|NCT02265705|467430778|FG006|Open Label Period|Adverse Event|0|||
129855950|NCT02265705|467430772|FG000|Open Label Period|Physician Decision|0|||
129855951|NCT02265705|467430773|FG001|Open Label Period|Physician Decision|0|||
129855952|NCT02265705|467430774|FG002|Open Label Period|Physician Decision|0|||
129855953|NCT02265705|467430775|FG003|Open Label Period|Physician Decision|0|||
129855954|NCT02265705|467430776|FG004|Open Label Period|Physician Decision|1|||
129855955|NCT02265705|467430777|FG005|Open Label Period|Physician Decision|0|||
129855956|NCT02265705|467430778|FG006|Open Label Period|Physician Decision|0|||
129855957|NCT02265705|467430772|FG000|Open Label Period|Withdrawal by Subject|0|||
129855958|NCT02265705|467430773|FG001|Open Label Period|Withdrawal by Subject|0|||
129855959|NCT02265705|467430774|FG002|Open Label Period|Withdrawal by Subject|0|||
129855960|NCT02265705|467430775|FG003|Open Label Period|Withdrawal by Subject|0|||
129855961|NCT02265705|467430776|FG004|Open Label Period|Withdrawal by Subject|2|||
129855962|NCT02265705|467430777|FG005|Open Label Period|Withdrawal by Subject|0|||
129855963|NCT02265705|467430778|FG006|Open Label Period|Withdrawal by Subject|0|||
129855964|NCT02265705|467430772|FG000|Follow-up Period|Sponsor Decision|0|||
129855965|NCT02265705|467430773|FG001|Follow-up Period|Sponsor Decision|0|||
129855966|NCT02265705|467430774|FG002|Follow-up Period|Sponsor Decision|0|||
129855967|NCT02265705|467430775|FG003|Follow-up Period|Sponsor Decision|0|||
129855968|NCT02265705|467430776|FG004|Follow-up Period|Sponsor Decision|0|||
129855969|NCT02265705|467430777|FG005|Follow-up Period|Sponsor Decision|1|||
129855970|NCT02265705|467430778|FG006|Follow-up Period|Sponsor Decision|6|||
129908862|NCT02767765|467630844|FG000|Overall Study|Non-Compliance|1|||
129855971|NCT02265705|467430772|FG000|Follow-up Period|Adverse Event|0|||
129855972|NCT02265705|467430773|FG001|Follow-up Period|Adverse Event|0|||
129855973|NCT02265705|467430774|FG002|Follow-up Period|Adverse Event|0|||
129855974|NCT02265705|467430775|FG003|Follow-up Period|Adverse Event|0|||
129855975|NCT02265705|467430776|FG004|Follow-up Period|Adverse Event|0|||
129855976|NCT02265705|467430777|FG005|Follow-up Period|Adverse Event|0|||
129855977|NCT02265705|467430778|FG006|Follow-up Period|Adverse Event|3|||
129855978|NCT02265705|467430772|FG000|Follow-up Period|Physician Decision|0|||
129855979|NCT02265705|467430773|FG001|Follow-up Period|Physician Decision|0|||
129855980|NCT02265705|467430774|FG002|Follow-up Period|Physician Decision|0|||
129855981|NCT02265705|467430775|FG003|Follow-up Period|Physician Decision|0|||
129855982|NCT02265705|467430776|FG004|Follow-up Period|Physician Decision|0|||
129855983|NCT02265705|467430777|FG005|Follow-up Period|Physician Decision|0|||
129855984|NCT02265705|467430778|FG006|Follow-up Period|Physician Decision|1|||
129855985|NCT02265705|467430772|FG000|Follow-up Period|Withdrawal by Subject|0|||
129855986|NCT02265705|467430773|FG001|Follow-up Period|Withdrawal by Subject|0|||
129855987|NCT02265705|467430774|FG002|Follow-up Period|Withdrawal by Subject|0|||
129855988|NCT02265705|467430775|FG003|Follow-up Period|Withdrawal by Subject|0|||
129855989|NCT02265705|467430776|FG004|Follow-up Period|Withdrawal by Subject|0|||
129855990|NCT02265705|467430777|FG005|Follow-up Period|Withdrawal by Subject|0|||
129855991|NCT02265705|467430778|FG006|Follow-up Period|Withdrawal by Subject|1|||
129855992|NCT00779246|467430779|FG000|Overall Study|Missing sufficient data for analysis|33|||
129855993|NCT00779246|467430780|FG001|Overall Study|Missing sufficient data for analysis|53|||
129855994|NCT02079805|467430781|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129855995|NCT02079805|467430782|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129449675|NCT00041080|465945640|FG000|Overall Study|Did not start therapy|1|||
129449676|NCT00041080|465945641|FG001|Overall Study|Did not start therapy|1|||
129449677|NCT00041080|465945640|FG000|Overall Study|Ineligible|1|||
129449678|NCT00041080|465945641|FG001|Overall Study|Ineligible|0|||
129449679|NCT04353596|465945644|FG000|Overall Study|Protocol Violation|4|||
129449680|NCT04353596|465945645|FG001|Overall Study|Protocol Violation|4|||
129449681|NCT04353596|465945644|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
129449682|NCT04353596|465945645|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
129449683|NCT05418673|465945646|FG000|Overall Study|Study Terminated by Sponsor|2|||
129449684|NCT05418673|465945647|FG001|Overall Study|Study Terminated by Sponsor|4|||
129449685|NCT05418673|465945646|FG000|Overall Study|Lost to Follow-up|1|||
129449686|NCT05418673|465945647|FG001|Overall Study|Lost to Follow-up|0|||
129449687|NCT02665052|465945650|FG000|Overall Study|Lost to Follow-up|1|||
129855996|NCT02079805|467430781|FG000|Overall Study|Voluntary Withdrawal|0|||
129855997|NCT02079805|467430782|FG001|Overall Study|Voluntary Withdrawal|1|||
129855998|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
129855999|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
129856000|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
129856001|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
129856002|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
129856003|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
129856004|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
129856005|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
129856006|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
129856007|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
129856008|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
129856009|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
129856010|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
129856011|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129856012|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129856013|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
129856014|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
129856015|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
129856016|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
129856017|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
129856018|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
129856019|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
129856020|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
129856021|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
129449688|NCT02665052|465945651|FG001|Overall Study|Lost to Follow-up|0|||
129449689|NCT02665052|465945652|FG002|Overall Study|Lost to Follow-up|0|||
129449690|NCT02665052|465945653|FG003|Overall Study|Lost to Follow-up|0|||
129449691|NCT02665052|465945650|FG000|Overall Study|Withdrawal by Subject|1|||
129856022|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
129856023|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
129856024|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
129856025|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
129449692|NCT02665052|465945651|FG001|Overall Study|Withdrawal by Subject|1|||
129449693|NCT02665052|465945652|FG002|Overall Study|Withdrawal by Subject|0|||
129856026|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
129856027|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
129856028|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
129856029|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
129856030|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
129856031|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129856032|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
129856033|NCT00383435|467430783|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
129856034|NCT00383435|467430784|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
129856035|NCT00383435|467430785|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
129856036|NCT00383435|467430786|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
129856037|NCT00383435|467430787|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
129856038|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
129856039|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
129856040|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
129856041|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
129856042|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
129856043|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856044|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856045|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856046|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129856047|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
129856048|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
129856049|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
129856050|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
129856051|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
129856052|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
129856053|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
129856054|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
129856055|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
129856056|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
129856057|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
129856058|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129856059|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
129856060|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
129856061|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
129856062|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129856063|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
129856064|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129856065|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129856066|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129856067|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
129856068|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129856069|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129856070|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129856071|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129856072|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129856073|NCT00383435|467430783|FG000|26-Week Treatment Safety Extension|Administrative|1|||
129856074|NCT00383435|467430784|FG001|26-Week Treatment Safety Extension|Administrative|1|||
129856075|NCT00383435|467430785|FG002|26-Week Treatment Safety Extension|Administrative|0|||
129856076|NCT00383435|467430786|FG003|26-Week Treatment Safety Extension|Administrative|1|||
129856077|NCT00383435|467430787|FG004|26-Week Treatment Safety Extension|Administrative|0|||
129856078|NCT02682264|467430788|FG000|Overall Study|Withdrawal by Subject|56|||
129856079|NCT02682264|467430789|FG001|Overall Study|Withdrawal by Subject|45|||
129856080|NCT02682264|467430788|FG000|Overall Study|Lost to Follow-up|49|||
129856081|NCT02682264|467430789|FG001|Overall Study|Lost to Follow-up|41|||
129856082|NCT02682264|467430788|FG000|Overall Study|Lack of Efficacy|14|||
129856083|NCT02682264|467430789|FG001|Overall Study|Lack of Efficacy|16|||
129856084|NCT02682264|467430788|FG000|Overall Study|Withdrawal by Parent|6|||
129856085|NCT02682264|467430789|FG001|Overall Study|Withdrawal by Parent|7|||
129856086|NCT02682264|467430788|FG000|Overall Study|Adverse Event|9|||
129856087|NCT02682264|467430789|FG001|Overall Study|Adverse Event|0|||
129856088|NCT02682264|467430788|FG000|Overall Study|Noncompliance with study drug|1|||
129856089|NCT02682264|467430789|FG001|Overall Study|Noncompliance with study drug|4|||
129908863|NCT02767765|467630844|FG000|Overall Study|Withdrawal by Subject|1|||
129908864|NCT01951170|467630846|FG000|Overall Study|Investigator decision|1|||
129908865|NCT00077675|467630855|FG000|Overall Study|Adverse Event|1|||
129908866|NCT00077675|467630856|FG001|Overall Study|Adverse Event|2|||
129908867|NCT00077675|467630855|FG000|Overall Study|Lost to Follow-up|6|||
129908868|NCT00077675|467630856|FG001|Overall Study|Lost to Follow-up|3|||
129908869|NCT00077675|467630855|FG000|Overall Study|Withdrawal by Subject|1|||
129908870|NCT00077675|467630856|FG001|Overall Study|Withdrawal by Subject|0|||
129856090|NCT02682264|467430788|FG000|Overall Study|Pregnancy|1|||
129856091|NCT02682264|467430789|FG001|Overall Study|Pregnancy|2|||
129856092|NCT02682264|467430788|FG000|Overall Study|Recovery|1|||
129856093|NCT02682264|467430789|FG001|Overall Study|Recovery|2|||
129856094|NCT02682264|467430788|FG000|Overall Study|Progressive Disease|1|||
129856095|NCT02682264|467430789|FG001|Overall Study|Progressive Disease|0|||
129856096|NCT02682264|467430788|FG000|Overall Study|Technical Problems|0|||
129856097|NCT02682264|467430789|FG001|Overall Study|Technical Problems|1|||
129856098|NCT02682264|467430788|FG000|Overall Study|Moved abroad and unable to continue|0|||
129856099|NCT02682264|467430789|FG001|Overall Study|Moved abroad and unable to continue|3|||
129856100|NCT02682264|467430788|FG000|Overall Study|Stopped test article application|0|||
129856101|NCT02682264|467430789|FG001|Overall Study|Stopped test article application|1|||
129856102|NCT03447769|467430790|FG000|Overall Study|Progressive disease|138|||
129856103|NCT03447769|467430791|FG001|Overall Study|Progressive disease|148|||
129856104|NCT03447769|467430790|FG000|Overall Study|Study terminated by Sponsor|60|||
129856105|NCT03447769|467430791|FG001|Overall Study|Study terminated by Sponsor|44|||
129856106|NCT03447769|467430790|FG000|Overall Study|Adverse Event|34|||
129856107|NCT03447769|467430791|FG001|Overall Study|Adverse Event|31|||
129856108|NCT03447769|467430790|FG000|Overall Study|Patient decision|27|||
129856109|NCT03447769|467430791|FG001|Overall Study|Patient decision|27|||
129856110|NCT03447769|467430790|FG000|Overall Study|Protocol deviation|4|||
129856111|NCT03447769|467430791|FG001|Overall Study|Protocol deviation|6|||
129856112|NCT03447769|467430790|FG000|Overall Study|Death|2|||
129856113|NCT03447769|467430791|FG001|Overall Study|Death|7|||
129856114|NCT03447769|467430790|FG000|Overall Study|Technical problems|1|||
129856115|NCT03447769|467430791|FG001|Overall Study|Technical problems|0|||
129856116|NCT03447769|467430790|FG000|Overall Study|Lost to Follow-up|0|||
129856117|NCT03447769|467430791|FG001|Overall Study|Lost to Follow-up|1|||
129856118|NCT03447769|467430790|FG000|Overall Study|Physician Decision|13|||
129856119|NCT03447769|467430791|FG001|Overall Study|Physician Decision|5|||
129856120|NCT01343407|467430793|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
129856121|NCT01343407|467430794|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
129856122|NCT01343407|467430795|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
129856123|NCT01343407|467430796|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
129856124|NCT01343407|467430797|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
129856125|NCT01343407|467430798|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
129856126|NCT01343407|467430793|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856127|NCT01343407|467430794|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856128|NCT01343407|467430795|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
129856129|NCT01343407|467430796|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856130|NCT01343407|467430797|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856131|NCT01343407|467430798|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
129856132|NCT03950739|467430799|FG000|Treatment Phase|Adverse Event|2|||
129856133|NCT03950739|467430799|FG000|Optional Extension Phase|Death|1|||
129856134|NCT03950739|467430799|FG000|Optional Extension Phase|Progressive Disease|5|||
129856135|NCT03950739|467430799|FG000|Optional Extension Phase|Adverse Event|7|||
129856136|NCT03950739|467430799|FG000|Optional Extension Phase|Lost to Follow-up|2|||
129856137|NCT03950739|467430799|FG000|Optional Extension Phase|Site Closure|2|||
129856138|NCT03950739|467430799|FG000|Optional Extension Phase|Pregnancy|1|||
129856139|NCT03264989|467430803|FG000|Overall Study|Lost to Follow-up|1|||
129856140|NCT03264989|467430804|FG001|Overall Study|Lost to Follow-up|0|||
129856141|NCT03264989|467430803|FG000|Overall Study|New Therapy for study Indication|1|||
129856142|NCT03264989|467430804|FG001|Overall Study|New Therapy for study Indication|0|||
129856143|NCT03264989|467430803|FG000|Overall Study|Protocol Violation|0|||
129856144|NCT03264989|467430804|FG001|Overall Study|Protocol Violation|1|||
129856145|NCT03264989|467430803|FG000|Overall Study|Patient decision|13|||
129856146|NCT03264989|467430804|FG001|Overall Study|Patient decision|0|||
129856147|NCT03264989|467430803|FG000|Overall Study|Physician Decision|6|||
129856148|NCT03264989|467430804|FG001|Overall Study|Physician Decision|4|||
129908871|NCT00077675|467630855|FG000|Overall Study|Other|0|||
129908872|NCT00077675|467630856|FG001|Overall Study|Other|1|||
129856149|NCT03264989|467430803|FG000|Overall Study|Adverse Event|2|||
129856150|NCT03264989|467430804|FG001|Overall Study|Adverse Event|1|||
129856151|NCT03264989|467430803|FG000|Overall Study|Death|1|||
129856152|NCT03264989|467430804|FG001|Overall Study|Death|1|||
129856153|NCT03264989|467430803|FG000|Overall Study|Pregnancy|2|||
129856154|NCT03264989|467430804|FG001|Overall Study|Pregnancy|0|||
129856155|NCT03264989|467430803|FG000|Overall Study|End of Study|19|||
129856156|NCT03264989|467430804|FG001|Overall Study|End of Study|5|||
129856157|NCT01775137|467430810|FG000|Overall Study|Death|1|||
129856158|NCT01775137|467430810|FG000|Overall Study|Protocol deviation|2|||
129856159|NCT01775137|467430810|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129856160|NCT01775137|467430810|FG000|Overall Study|Adverse Event|1|||
129856161|NCT01775137|467430810|FG000|Overall Study|Withdrawal by participants|5|||
129856162|NCT00096135|467430817|FG000|Overall Study|Physician Decision|20|||
129856163|NCT00096135|467430818|FG001|Overall Study|Physician Decision|4|||
129856164|NCT00096135|467430817|FG000|Overall Study|Refusal of further protocol therapy|4|||
129856165|NCT00096135|467430818|FG001|Overall Study|Refusal of further protocol therapy|1|||
129856166|NCT00096135|467430817|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
129856167|NCT00096135|467430818|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
129856168|NCT00096135|467430817|FG000|Overall Study|Other, specify|15|||
129856169|NCT00096135|467430818|FG001|Overall Study|Other, specify|3|||
129856170|NCT00096135|467430817|FG000|Overall Study|Ineligible|2|||
129856171|NCT00096135|467430818|FG001|Overall Study|Ineligible|0|||
129856172|NCT00874029|467430820|FG000|Overall Study|Withdrawal by Subject|10|||
129856173|NCT00874029|467430820|FG000|Overall Study|Pregnancy|4|||
129856174|NCT00874029|467430820|FG000|Overall Study|Physician Decision|1|||
129856175|NCT00874029|467430820|FG000|Overall Study|Adverse Event|1|||
129856176|NCT00874029|467430820|FG000|Overall Study|Lost to Follow-up|5|||
129856177|NCT00856583|467430821|FG000|Overall Study|Lack of Efficacy|389|||
129856178|NCT00856583|467430822|FG001|Overall Study|Lack of Efficacy|377|||
129856179|NCT00856583|467430821|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
129856180|NCT00856583|467430822|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
129856181|NCT00856583|467430821|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
129856182|NCT00856583|467430822|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
129856183|NCT00856583|467430821|FG000|Overall Study|Non-compliance|305|||
129856184|NCT00856583|467430822|FG001|Overall Study|Non-compliance|262|||
129856185|NCT00856583|467430821|FG000|Overall Study|Withdrawal by Subject|1092|||
129856186|NCT00856583|467430822|FG001|Overall Study|Withdrawal by Subject|919|||
129856187|NCT00856583|467430821|FG000|Overall Study|Physician Decision|59|||
129856188|NCT00856583|467430822|FG001|Overall Study|Physician Decision|82|||
129856189|NCT00856583|467430821|FG000|Overall Study|Pregnancy|14|||
129856190|NCT00856583|467430822|FG001|Overall Study|Pregnancy|5|||
129856191|NCT00856583|467430821|FG000|Overall Study|Other|92|||
129856192|NCT00856583|467430822|FG001|Overall Study|Other|104|||
129856193|NCT00856583|467430821|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
129856194|NCT00856583|467430822|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
129856195|NCT00499889|467430829|FG000|Overall Study|Infection prior to treatment|1|||
129856196|NCT01898195|467430833|FG000|Smoking Abstinence|Did not have good measurements|35|||
129856197|NCT01898195|467430834|FG001|Smoking Abstinence|Did not have good measurements|38|||
129856198|NCT01898195|467430835|FG002|Smoking Abstinence|Did not have good measurements|36|||
129856199|NCT04401579|467433036|FG000|Overall Study|Death|23|||
129856200|NCT04401579|467433037|FG001|Overall Study|Death|36|||
129856201|NCT04401579|467433036|FG000|Overall Study|Lost to Follow-up|40|||
129856202|NCT04401579|467433037|FG001|Overall Study|Lost to Follow-up|41|||
129856203|NCT04401579|467433036|FG000|Overall Study|Withdrawal by Subject|8|||
129856204|NCT04401579|467433037|FG001|Overall Study|Withdrawal by Subject|16|||
129856205|NCT04401579|467433036|FG000|Overall Study|Physician Decision|1|||
129856206|NCT04401579|467433037|FG001|Overall Study|Physician Decision|2|||
129856207|NCT04401579|467433036|FG000|Overall Study|Became ineligible after enrollment|1|||
129856208|NCT04401579|467433037|FG001|Overall Study|Became ineligible after enrollment|1|||
129856209|NCT04401579|467433036|FG000|Overall Study|Enrolled but treatment not administered|7|||
129856210|NCT04401579|467433037|FG001|Overall Study|Enrolled but treatment not administered|9|||
129856211|NCT04401579|467433036|FG000|Overall Study|Adverse Event|2|||
129856212|NCT04401579|467433037|FG001|Overall Study|Adverse Event|1|||
129856213|NCT04401579|467433036|FG000|Overall Study|Scheduling error|1|||
129856214|NCT04401579|467433037|FG001|Overall Study|Scheduling error|2|||
129856215|NCT04401579|467433036|FG000|Overall Study|Transferred to another hospital|1|||
129856216|NCT04401579|467433037|FG001|Overall Study|Transferred to another hospital|2|||
129856217|NCT03521635|467433038|FG000|Overall Study|Adverse Event|1|||
129856218|NCT03521635|467433039|FG001|Overall Study|Adverse Event|1|||
129856219|NCT03521635|467433038|FG000|Overall Study|Refused to complete study visit|1|||
129856220|NCT03521635|467433039|FG001|Overall Study|Refused to complete study visit|0|||
129856221|NCT03521635|467433038|FG000|Overall Study|Refused to continue trial medication|2|||
129856222|NCT03521635|467433039|FG001|Overall Study|Refused to continue trial medication|2|||
129856223|NCT03521635|467433038|FG000|Overall Study|Lost to Follow-up|0|||
129856224|NCT03521635|467433039|FG001|Overall Study|Lost to Follow-up|1|||
129856225|NCT03521635|467433038|FG000|Overall Study|Meet exclusion criteria|0|||
129856226|NCT03521635|467433039|FG001|Overall Study|Meet exclusion criteria|1|||
129856227|NCT03521635|467433038|FG000|Overall Study|Patient not taken study medicine|0|||
129856228|NCT03521635|467433039|FG001|Overall Study|Patient not taken study medicine|1|||
129856229|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Adverse Event|5|||
129856230|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Adverse Event|8|||
129856231|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Adverse Event|4|||
129856232|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Adverse Event|8|||
129856233|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
129856234|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
129856235|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
129856236|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
129856237|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
129856238|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
129856239|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
129856240|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
129856241|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Physician Decision|1|||
129856242|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Physician Decision|0|||
129856243|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Physician Decision|0|||
129856244|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Physician Decision|0|||
129856245|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
129856246|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
129856247|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
129856248|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
129856249|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Pregnancy|0|||
129856250|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Pregnancy|1|||
129856251|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Pregnancy|0|||
129856252|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Pregnancy|0|||
129856253|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
129856254|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
129856255|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
129856256|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
129856257|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Death|0|||
129856258|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Death|1|||
129856259|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Death|0|||
129856260|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Death|0|||
129856261|NCT00071487|467433043|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
129856262|NCT00071487|467433044|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
129856263|NCT00071487|467433045|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
129856264|NCT00071487|467433046|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
129856265|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
129856266|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
129856267|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
129856268|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
129856269|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129856270|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129856271|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
129856272|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
129856273|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129856274|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129856275|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
129856276|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
129856277|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
129856278|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
129856279|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
129856280|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
129856281|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129856282|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129856283|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
129856284|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
129856285|NCT00071487|467433043|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129856286|NCT00071487|467433044|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129856287|NCT00071487|467433045|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
129856288|NCT00071487|467433046|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
129856289|NCT01227889|467433047|FG000|Randomized Phase (RP)|Adverse Event|13|||
129856290|NCT01227889|467433048|FG001|Randomized Phase (RP)|Adverse Event|0|||
129856291|NCT01227889|467433047|FG000|Randomized Phase (RP)|Physician Decision|13|||
129856292|NCT01227889|467433048|FG001|Randomized Phase (RP)|Physician Decision|5|||
129856293|NCT01227889|467433047|FG000|Randomized Phase (RP)|Progressive Disease|135|||
129856294|NCT01227889|467433048|FG001|Randomized Phase (RP)|Progressive Disease|52|||
129856295|NCT01227889|467433047|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
129856296|NCT01227889|467433048|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
129856297|NCT01227889|467433047|FG000|Randomized Phase (RP)|Missing|1|||
129856298|NCT01227889|467433048|FG001|Randomized Phase (RP)|Missing|3|||
129856299|NCT01227889|467433047|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
129908873|NCT00077675|467630855|FG000|Overall Study|Never received study treatment|3|||
129908874|NCT00077675|467630856|FG001|Overall Study|Never received study treatment|3|||
129908875|NCT02675244|467630857|FG000|Overall Study|Death|9|||
129908876|NCT02675244|467630858|FG001|Overall Study|Death|6|||
129908877|NCT02675244|467630857|FG000|Overall Study|Withdrawal by Subject|3|||
129908878|NCT02675244|467630858|FG001|Overall Study|Withdrawal by Subject|6|||
129908879|NCT02675244|467630857|FG000|Overall Study|Lost to Follow-up|1|||
129908880|NCT02675244|467630858|FG001|Overall Study|Lost to Follow-up|1|||
129856300|NCT01227889|467433048|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
129856301|NCT01227889|467433047|FG000|Crossover Phase|Adverse Event|0|||
129856302|NCT01227889|467433048|FG001|Crossover Phase|Adverse Event|1|||
129856303|NCT01227889|467433047|FG000|Crossover Phase|Physician Decision|0|||
129856304|NCT01227889|467433048|FG001|Crossover Phase|Physician Decision|3|||
129856305|NCT01227889|467433047|FG000|Crossover Phase|Progressive Disease|0|||
129856306|NCT01227889|467433048|FG001|Crossover Phase|Progressive Disease|31|||
129856307|NCT01227889|467433047|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
129856308|NCT01227889|467433048|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
129856309|NCT01227889|467433047|FG000|Crossover Phase|Withdrawal by Subject|0|||
129856310|NCT01227889|467433048|FG001|Crossover Phase|Withdrawal by Subject|1|||
129856311|NCT03268811|467433049|FG000|Overall Study|Adverse Event|0|||
129856312|NCT03268811|467433050|FG001|Overall Study|Adverse Event|1|||
129856313|NCT04827212|467433055|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
129856314|NCT04827212|467433056|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
129856315|NCT04827212|467433055|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
129856316|NCT04827212|467433056|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
129856317|NCT03434119|467433063|FG000|Overall Study|Randomized but not treated|1|||
129856318|NCT03434119|467433064|FG001|Overall Study|Randomized but not treated|0|||
129856319|NCT03434119|467433063|FG000|Overall Study|Adverse Event|1|||
129856320|NCT03434119|467433064|FG001|Overall Study|Adverse Event|0|||
129856321|NCT03434119|467433063|FG000|Overall Study|Poor Compliance to Protocol|0|||
129856322|NCT03434119|467433064|FG001|Overall Study|Poor Compliance to Protocol|1|||
129856323|NCT03434119|467433063|FG000|Overall Study|Study Terminated by Sponsor|91|||
129856324|NCT03434119|467433064|FG001|Overall Study|Study Terminated by Sponsor|102|||
129856325|NCT03434119|467433063|FG000|Overall Study|Withdrawal by Subject|7|||
129856326|NCT03434119|467433064|FG001|Overall Study|Withdrawal by Subject|5|||
129856327|NCT03434119|467433063|FG000|Overall Study|Other than specified|7|||
129856328|NCT03434119|467433064|FG001|Overall Study|Other than specified|5|||
129856329|NCT03579459|467433066|FG000|Overall Study|Adverse Event|7|||
129856330|NCT03579459|467433067|FG001|Overall Study|Adverse Event|6|||
129856331|NCT03579459|467433068|FG002|Overall Study|Adverse Event|2|||
129856332|NCT03579459|467433069|FG003|Overall Study|Adverse Event|6|||
129856333|NCT03579459|467433066|FG000|Overall Study|Death|1|||
129856334|NCT03579459|467433067|FG001|Overall Study|Death|0|||
129856335|NCT03579459|467433068|FG002|Overall Study|Death|1|||
129856336|NCT03579459|467433069|FG003|Overall Study|Death|2|||
129856337|NCT03579459|467433066|FG000|Overall Study|Lost to Follow-up|6|||
129856338|NCT03579459|467433067|FG001|Overall Study|Lost to Follow-up|2|||
129856339|NCT03579459|467433068|FG002|Overall Study|Lost to Follow-up|4|||
129856340|NCT03579459|467433069|FG003|Overall Study|Lost to Follow-up|1|||
129856341|NCT03579459|467433066|FG000|Overall Study|Physician Decision|0|||
129856342|NCT03579459|467433067|FG001|Overall Study|Physician Decision|1|||
129856343|NCT03579459|467433068|FG002|Overall Study|Physician Decision|0|||
129856344|NCT03579459|467433069|FG003|Overall Study|Physician Decision|1|||
129856345|NCT03579459|467433066|FG000|Overall Study|Protocol Violation|1|||
129856346|NCT03579459|467433067|FG001|Overall Study|Protocol Violation|2|||
129856347|NCT03579459|467433068|FG002|Overall Study|Protocol Violation|3|||
129856348|NCT03579459|467433069|FG003|Overall Study|Protocol Violation|5|||
129856349|NCT03579459|467433066|FG000|Overall Study|Withdrawal by Subject|12|||
129856350|NCT03579459|467433067|FG001|Overall Study|Withdrawal by Subject|8|||
129856351|NCT03579459|467433068|FG002|Overall Study|Withdrawal by Subject|11|||
129856352|NCT03579459|467433069|FG003|Overall Study|Withdrawal by Subject|8|||
129856353|NCT03579459|467433066|FG000|Overall Study|Medication error without associated adverse event|2|||
129856354|NCT03579459|467433067|FG001|Overall Study|Medication error without associated adverse event|1|||
129856355|NCT03579459|467433068|FG002|Overall Study|Medication error without associated adverse event|1|||
129856356|NCT03579459|467433069|FG003|Overall Study|Medication error without associated adverse event|0|||
129908881|NCT02675244|467630857|FG000|Overall Study|Ongoing at 2 Years|190|||
129856357|NCT03579459|467433066|FG000|Overall Study|Other|0|||
129856358|NCT03579459|467433067|FG001|Overall Study|Other|1|||
129856359|NCT03579459|467433068|FG002|Overall Study|Other|1|||
129856360|NCT03579459|467433069|FG003|Overall Study|Other|0|||
129856361|NCT03579459|467433066|FG000|Overall Study|Randomized not vaccinated|0|||
129856362|NCT03579459|467433067|FG001|Overall Study|Randomized not vaccinated|2|||
129856363|NCT03579459|467433068|FG002|Overall Study|Randomized not vaccinated|0|||
129856364|NCT03579459|467433069|FG003|Overall Study|Randomized not vaccinated|1|||
129856365|NCT00148343|467433072|FG000|Overall Study|Withdrawal by Subject|12|||
129856366|NCT00148343|467433073|FG001|Overall Study|Withdrawal by Subject|7|||
129908882|NCT02675244|467630858|FG001|Overall Study|Ongoing at 2 Years|185|||
129908883|NCT02706717|467630859|FG000|Overall Study|Withdrawal by Subject|1|||
129908884|NCT02706717|467630860|FG001|Overall Study|Withdrawal by Subject|8|||
129908885|NCT02706717|467630859|FG000|Overall Study|Lost to Follow-up|0|||
129908886|NCT02706717|467630860|FG001|Overall Study|Lost to Follow-up|1|||
129908887|NCT02706717|467630859|FG000|Overall Study|Physician Decision|0|||
129908888|NCT02706717|467630860|FG001|Overall Study|Physician Decision|1|||
129908889|NCT02706717|467630859|FG000|Overall Study|Death|0|||
129908890|NCT02706717|467630860|FG001|Overall Study|Death|1|||
129908891|NCT00293293|467630863|FG000|Overall Study|Withdrawal by Subject|1|||
129908892|NCT00293293|467630864|FG001|Overall Study|Withdrawal by Subject|1|||
129908893|NCT00293293|467630863|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
129908894|NCT00293293|467630864|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
129908895|NCT00293293|467630863|FG000|Overall Study|Patient discontinued chemotherapy|0|||
129908896|NCT00293293|467630864|FG001|Overall Study|Patient discontinued chemotherapy|1|||
129908897|NCT02512965|467630867|FG000|Overall Study|Withdrawal by Subject|0|||
129908898|NCT02512965|467630868|FG001|Overall Study|Withdrawal by Subject|4|||
129908899|NCT00835770|467630869|FG000|Overall Study|MS Relapse|17|||
129908900|NCT00835770|467630870|FG001|Overall Study|MS Relapse|23|||
129908901|NCT00835770|467630869|FG000|Overall Study|MS Progression|14|||
129908902|NCT00835770|467630870|FG001|Overall Study|MS Progression|9|||
129908903|NCT00835770|467630869|FG000|Overall Study|Adverse Event|113|||
129908904|NCT00835770|467630870|FG001|Overall Study|Adverse Event|124|||
129908905|NCT00835770|467630869|FG000|Overall Study|Lost to Follow-up|22|||
129908906|NCT00835770|467630870|FG001|Overall Study|Lost to Follow-up|19|||
129908907|NCT00835770|467630869|FG000|Overall Study|Consent Withdrawn|144|||
129908908|NCT00835770|467630870|FG001|Overall Study|Consent Withdrawn|156|||
129908909|NCT00835770|467630869|FG000|Overall Study|Investigator Decision|42|||
129908910|NCT00835770|467630870|FG001|Overall Study|Investigator Decision|42|||
129908911|NCT00835770|467630869|FG000|Overall Study|Participant Non-Compliance|11|||
129908912|NCT00835770|467630870|FG001|Overall Study|Participant Non-Compliance|9|||
129908913|NCT00835770|467630869|FG000|Overall Study|Death|4|||
129908914|NCT00835770|467630870|FG001|Overall Study|Death|6|||
129908915|NCT00835770|467630869|FG000|Overall Study|Other|115|||
129908916|NCT00835770|467630870|FG001|Overall Study|Other|104|||
129908917|NCT00835770|467630869|FG000|Overall Study|Other|2|||
129908918|NCT00835770|467630870|FG001|Overall Study|Other|1|||
129908919|NCT01185782|467630871|FG000|Overall Study|Adverse Event|0|||
129908920|NCT01185782|467630872|FG001|Overall Study|Adverse Event|1|||
129908921|NCT01185782|467630871|FG000|Overall Study|Protocol Violation|1|||
129908922|NCT01185782|467630872|FG001|Overall Study|Protocol Violation|0|||
129908923|NCT01185782|467630871|FG000|Overall Study|Poor Response to Treatment|3|||
129908924|NCT01185782|467630872|FG001|Overall Study|Poor Response to Treatment|1|||
129908925|NCT01185782|467630871|FG000|Overall Study|Other|2|||
129908926|NCT01185782|467630872|FG001|Overall Study|Other|5|||
129908927|NCT01185782|467630871|FG000|Overall Study|Randomized but not treated|0|||
129908928|NCT01185782|467630872|FG001|Overall Study|Randomized but not treated|4|||
129908929|NCT02988817|467630877|FG000|Overall Study|Withdrawal by Subject|1|||
129908930|NCT02988817|467630878|FG001|Overall Study|Withdrawal by Subject|0|||
129908931|NCT02988817|467630879|FG002|Overall Study|Withdrawal by Subject|0|||
129908932|NCT02988817|467630880|FG003|Overall Study|Withdrawal by Subject|1|||
129908933|NCT02988817|467630881|FG004|Overall Study|Withdrawal by Subject|3|||
129908934|NCT02988817|467630882|FG005|Overall Study|Withdrawal by Subject|1|||
129908935|NCT02988817|467630883|FG006|Overall Study|Withdrawal by Subject|2|||
129908936|NCT02988817|467630884|FG007|Overall Study|Withdrawal by Subject|1|||
129908937|NCT02988817|467630885|FG008|Overall Study|Withdrawal by Subject|1|||
129908938|NCT02988817|467630886|FG009|Overall Study|Withdrawal by Subject|1|||
129908939|NCT02988817|467630887|FG010|Overall Study|Withdrawal by Subject|1|||
129908940|NCT02988817|467630888|FG011|Overall Study|Withdrawal by Subject|12|||
129908941|NCT02988817|467630889|FG012|Overall Study|Withdrawal by Subject|6|||
129908942|NCT02988817|467630890|FG013|Overall Study|Withdrawal by Subject|6|||
129908943|NCT02988817|467630891|FG014|Overall Study|Withdrawal by Subject|4|||
129908944|NCT02988817|467630892|FG015|Overall Study|Withdrawal by Subject|5|||
129908945|NCT02988817|467630893|FG016|Overall Study|Withdrawal by Subject|4|||
129908946|NCT02988817|467630894|FG017|Overall Study|Withdrawal by Subject|11|||
129908947|NCT02988817|467630895|FG018|Overall Study|Withdrawal by Subject|4|||
129908948|NCT02988817|467630896|FG019|Overall Study|Withdrawal by Subject|2|||
129908949|NCT02988817|467630877|FG000|Overall Study|Death|0|||
129908950|NCT02988817|467630878|FG001|Overall Study|Death|1|||
129908951|NCT02988817|467630879|FG002|Overall Study|Death|3|||
129908952|NCT02988817|467630880|FG003|Overall Study|Death|1|||
129908953|NCT02988817|467630881|FG004|Overall Study|Death|6|||
129908954|NCT02988817|467630882|FG005|Overall Study|Death|10|||
129908955|NCT02988817|467630883|FG006|Overall Study|Death|1|||
129908956|NCT02988817|467630884|FG007|Overall Study|Death|2|||
129908957|NCT02988817|467630885|FG008|Overall Study|Death|1|||
129908958|NCT02988817|467630886|FG009|Overall Study|Death|5|||
129908959|NCT02988817|467630887|FG010|Overall Study|Death|1|||
129908960|NCT02988817|467630888|FG011|Overall Study|Death|8|||
129908961|NCT02988817|467630889|FG012|Overall Study|Death|9|||
129908962|NCT02988817|467630890|FG013|Overall Study|Death|17|||
129908963|NCT02988817|467630891|FG014|Overall Study|Death|18|||
129908964|NCT02988817|467630892|FG015|Overall Study|Death|30|||
129908965|NCT02988817|467630893|FG016|Overall Study|Death|17|||
129908966|NCT02988817|467630894|FG017|Overall Study|Death|38|||
129908967|NCT02988817|467630895|FG018|Overall Study|Death|14|||
129908968|NCT02988817|467630896|FG019|Overall Study|Death|16|||
129908969|NCT02988817|467630877|FG000|Overall Study|Other|0|||
129908970|NCT02988817|467630878|FG001|Overall Study|Other|0|||
129908971|NCT02988817|467630879|FG002|Overall Study|Other|0|||
129908972|NCT02988817|467630880|FG003|Overall Study|Other|1|||
129908973|NCT02988817|467630881|FG004|Overall Study|Other|1|||
129908974|NCT02988817|467630882|FG005|Overall Study|Other|0|||
129908975|NCT02988817|467630883|FG006|Overall Study|Other|0|||
129908976|NCT02988817|467630884|FG007|Overall Study|Other|0|||
129908977|NCT02988817|467630885|FG008|Overall Study|Other|0|||
129908978|NCT02988817|467630886|FG009|Overall Study|Other|0|||
129908979|NCT02988817|467630887|FG010|Overall Study|Other|0|||
129908980|NCT02988817|467630888|FG011|Overall Study|Other|0|||
129908981|NCT02988817|467630889|FG012|Overall Study|Other|0|||
129908982|NCT02988817|467630890|FG013|Overall Study|Other|0|||
129908983|NCT02988817|467630891|FG014|Overall Study|Other|0|||
129908984|NCT02988817|467630892|FG015|Overall Study|Other|1|||
129908985|NCT02988817|467630893|FG016|Overall Study|Other|0|||
129908986|NCT02988817|467630894|FG017|Overall Study|Other|0|||
129908987|NCT02988817|467630895|FG018|Overall Study|Other|0|||
129908988|NCT02988817|467630896|FG019|Overall Study|Other|0|||
129908989|NCT02988817|467630877|FG000|Overall Study|Lost to Follow-up|0|||
129908990|NCT02988817|467630878|FG001|Overall Study|Lost to Follow-up|0|||
129908991|NCT02988817|467630879|FG002|Overall Study|Lost to Follow-up|0|||
129908992|NCT02988817|467630880|FG003|Overall Study|Lost to Follow-up|0|||
129908993|NCT02988817|467630881|FG004|Overall Study|Lost to Follow-up|0|||
129908994|NCT02988817|467630882|FG005|Overall Study|Lost to Follow-up|0|||
129908995|NCT02988817|467630883|FG006|Overall Study|Lost to Follow-up|0|||
129908996|NCT02988817|467630884|FG007|Overall Study|Lost to Follow-up|0|||
129908997|NCT02988817|467630885|FG008|Overall Study|Lost to Follow-up|1|||
129908998|NCT02988817|467630886|FG009|Overall Study|Lost to Follow-up|0|||
129908999|NCT02988817|467630887|FG010|Overall Study|Lost to Follow-up|1|||
129909000|NCT02988817|467630888|FG011|Overall Study|Lost to Follow-up|1|||
129909001|NCT02988817|467630889|FG012|Overall Study|Lost to Follow-up|0|||
129909002|NCT02988817|467630890|FG013|Overall Study|Lost to Follow-up|0|||
129909003|NCT02988817|467630891|FG014|Overall Study|Lost to Follow-up|1|||
129909004|NCT02988817|467630892|FG015|Overall Study|Lost to Follow-up|1|||
129909005|NCT02988817|467630893|FG016|Overall Study|Lost to Follow-up|2|||
129909006|NCT02988817|467630894|FG017|Overall Study|Lost to Follow-up|3|||
129909007|NCT02988817|467630895|FG018|Overall Study|Lost to Follow-up|0|||
129909008|NCT02988817|467630896|FG019|Overall Study|Lost to Follow-up|0|||
129909009|NCT02988817|467630877|FG000|Overall Study|Sponsor decision|0|||
129909010|NCT02988817|467630878|FG001|Overall Study|Sponsor decision|0|||
129909011|NCT02988817|467630879|FG002|Overall Study|Sponsor decision|0|||
129909012|NCT02988817|467630880|FG003|Overall Study|Sponsor decision|0|||
129909013|NCT02988817|467630881|FG004|Overall Study|Sponsor decision|0|||
129909014|NCT02988817|467630882|FG005|Overall Study|Sponsor decision|0|||
129909015|NCT02988817|467630883|FG006|Overall Study|Sponsor decision|0|||
129909016|NCT02988817|467630884|FG007|Overall Study|Sponsor decision|0|||
129909017|NCT02988817|467630885|FG008|Overall Study|Sponsor decision|0|||
129909018|NCT02988817|467630886|FG009|Overall Study|Sponsor decision|0|||
129909019|NCT02988817|467630887|FG010|Overall Study|Sponsor decision|0|||
129909020|NCT02988817|467630888|FG011|Overall Study|Sponsor decision|1|||
129909021|NCT02988817|467630889|FG012|Overall Study|Sponsor decision|1|||
129909022|NCT02988817|467630890|FG013|Overall Study|Sponsor decision|2|||
129909023|NCT02988817|467630891|FG014|Overall Study|Sponsor decision|2|||
129909024|NCT02988817|467630892|FG015|Overall Study|Sponsor decision|6|||
129909025|NCT02988817|467630893|FG016|Overall Study|Sponsor decision|2|||
129909026|NCT02988817|467630894|FG017|Overall Study|Sponsor decision|3|||
129909027|NCT02988817|467630895|FG018|Overall Study|Sponsor decision|2|||
129909028|NCT02988817|467630896|FG019|Overall Study|Sponsor decision|7|||
129909029|NCT02988817|467630877|FG000|Overall Study|Physician Decision|0|||
129909030|NCT02988817|467630878|FG001|Overall Study|Physician Decision|0|||
129909031|NCT02988817|467630879|FG002|Overall Study|Physician Decision|0|||
129909032|NCT02988817|467630880|FG003|Overall Study|Physician Decision|0|||
129909033|NCT02988817|467630881|FG004|Overall Study|Physician Decision|0|||
129909034|NCT02988817|467630882|FG005|Overall Study|Physician Decision|0|||
129909035|NCT02988817|467630883|FG006|Overall Study|Physician Decision|0|||
129909036|NCT02988817|467630884|FG007|Overall Study|Physician Decision|0|||
129909037|NCT02988817|467630885|FG008|Overall Study|Physician Decision|0|||
129909038|NCT02988817|467630886|FG009|Overall Study|Physician Decision|0|||
129909039|NCT02988817|467630887|FG010|Overall Study|Physician Decision|0|||
129909040|NCT02988817|467630888|FG011|Overall Study|Physician Decision|0|||
129909041|NCT02988817|467630889|FG012|Overall Study|Physician Decision|0|||
129909042|NCT02988817|467630890|FG013|Overall Study|Physician Decision|0|||
129909043|NCT02988817|467630891|FG014|Overall Study|Physician Decision|0|||
129909044|NCT02988817|467630892|FG015|Overall Study|Physician Decision|1|||
129856367|NCT00148343|467433072|FG000|Overall Study|Physician Decision|3|||
129856368|NCT00148343|467433073|FG001|Overall Study|Physician Decision|4|||
129856369|NCT02528214|467433082|FG000|Overall Study|Protocol Violation|0|||
129856370|NCT02528214|467433083|FG001|Overall Study|Protocol Violation|1|||
129856371|NCT02528214|467433082|FG000|Overall Study|Adverse Event|0|||
129856372|NCT02528214|467433083|FG001|Overall Study|Adverse Event|1|||
129856373|NCT02528214|467433082|FG000|Overall Study|Other than specified above|0|||
129856374|NCT02528214|467433083|FG001|Overall Study|Other than specified above|1|||
129856375|NCT00941603|467433087|FG000|Overall Study|Adverse Event|10|||
129856376|NCT00941603|467433088|FG001|Overall Study|Adverse Event|15|||
129856377|NCT00941603|467433089|FG002|Overall Study|Adverse Event|5|||
129856378|NCT00941603|467433090|FG003|Overall Study|Adverse Event|1|||
129856379|NCT00941603|467433091|FG004|Overall Study|Adverse Event|4|||
129856380|NCT00941603|467433092|FG005|Overall Study|Adverse Event|0|||
129856381|NCT00941603|467433087|FG000|Overall Study|Lost to Follow-up|0|||
129856382|NCT00941603|467433088|FG001|Overall Study|Lost to Follow-up|0|||
129856383|NCT00941603|467433089|FG002|Overall Study|Lost to Follow-up|0|||
129856384|NCT00941603|467433090|FG003|Overall Study|Lost to Follow-up|1|||
129856385|NCT00941603|467433091|FG004|Overall Study|Lost to Follow-up|0|||
129856386|NCT00941603|467433092|FG005|Overall Study|Lost to Follow-up|2|||
129856387|NCT00941603|467433087|FG000|Overall Study|Withdrawal by Subject|0|||
129856388|NCT00941603|467433088|FG001|Overall Study|Withdrawal by Subject|0|||
129856389|NCT00941603|467433089|FG002|Overall Study|Withdrawal by Subject|0|||
129856390|NCT00941603|467433090|FG003|Overall Study|Withdrawal by Subject|2|||
129856391|NCT00941603|467433091|FG004|Overall Study|Withdrawal by Subject|0|||
129856392|NCT00941603|467433092|FG005|Overall Study|Withdrawal by Subject|1|||
129856393|NCT00941603|467433087|FG000|Overall Study|Protocol Violation|0|||
129856394|NCT00941603|467433088|FG001|Overall Study|Protocol Violation|1|||
129856395|NCT00941603|467433089|FG002|Overall Study|Protocol Violation|0|||
129856396|NCT00941603|467433090|FG003|Overall Study|Protocol Violation|0|||
129856397|NCT00941603|467433091|FG004|Overall Study|Protocol Violation|0|||
129856398|NCT00941603|467433092|FG005|Overall Study|Protocol Violation|0|||
129856399|NCT00941603|467433087|FG000|Overall Study|Did not meet protocol eligibility|1|||
129856400|NCT00941603|467433088|FG001|Overall Study|Did not meet protocol eligibility|0|||
129856401|NCT00941603|467433089|FG002|Overall Study|Did not meet protocol eligibility|0|||
129856402|NCT00941603|467433090|FG003|Overall Study|Did not meet protocol eligibility|0|||
129856403|NCT00941603|467433091|FG004|Overall Study|Did not meet protocol eligibility|0|||
129856404|NCT00941603|467433092|FG005|Overall Study|Did not meet protocol eligibility|0|||
129856405|NCT00407537|467433093|FG000|Overall Study|Death|5|||
129856406|NCT00407537|467433094|FG001|Overall Study|Death|2|||
129856407|NCT00407537|467433093|FG000|Overall Study|Adverse Event|36|||
129856408|NCT00407537|467433094|FG001|Overall Study|Adverse Event|0|||
129856409|NCT00407537|467433093|FG000|Overall Study|Lost to Follow-up|12|||
129856410|NCT00407537|467433094|FG001|Overall Study|Lost to Follow-up|19|||
129856411|NCT00407537|467433093|FG000|Overall Study|Other|6|||
129856412|NCT00407537|467433094|FG001|Overall Study|Other|7|||
129856413|NCT00407537|467433093|FG000|Overall Study|Withdrawal by Subject|34|||
129856414|NCT00407537|467433094|FG001|Overall Study|Withdrawal by Subject|16|||
129856415|NCT02014116|467433096|FG000|Overall Study|Progressive Disease|3|||
129856416|NCT02014116|467433097|FG001|Overall Study|Progressive Disease|4|||
129856417|NCT02014116|467433098|FG002|Overall Study|Progressive Disease|2|||
129856418|NCT02014116|467433099|FG003|Overall Study|Progressive Disease|6|||
129856419|NCT02014116|467433100|FG004|Overall Study|Progressive Disease|1|||
129856420|NCT02014116|467433101|FG005|Overall Study|Progressive Disease|13|||
129856421|NCT02014116|467433102|FG006|Overall Study|Progressive Disease|1|||
129856422|NCT02014116|467433103|FG007|Overall Study|Progressive Disease|3|||
129856423|NCT02014116|467433104|FG008|Overall Study|Progressive Disease|7|||
129856424|NCT02014116|467433096|FG000|Overall Study|Adverse Event|0|||
129856425|NCT02014116|467433097|FG001|Overall Study|Adverse Event|0|||
129856426|NCT02014116|467433098|FG002|Overall Study|Adverse Event|0|||
129856427|NCT02014116|467433099|FG003|Overall Study|Adverse Event|0|||
129856428|NCT02014116|467433100|FG004|Overall Study|Adverse Event|1|||
129856429|NCT02014116|467433101|FG005|Overall Study|Adverse Event|0|||
129856430|NCT02014116|467433102|FG006|Overall Study|Adverse Event|0|||
129856431|NCT02014116|467433103|FG007|Overall Study|Adverse Event|1|||
129856432|NCT02014116|467433104|FG008|Overall Study|Adverse Event|0|||
129856433|NCT02014116|467433096|FG000|Overall Study|Lost to Follow-up|0|||
129856434|NCT02014116|467433097|FG001|Overall Study|Lost to Follow-up|0|||
129856435|NCT02014116|467433098|FG002|Overall Study|Lost to Follow-up|0|||
129856436|NCT02014116|467433099|FG003|Overall Study|Lost to Follow-up|0|||
129856437|NCT02014116|467433100|FG004|Overall Study|Lost to Follow-up|0|||
129856438|NCT02014116|467433101|FG005|Overall Study|Lost to Follow-up|1|||
129856439|NCT02014116|467433102|FG006|Overall Study|Lost to Follow-up|0|||
129856440|NCT02014116|467433103|FG007|Overall Study|Lost to Follow-up|0|||
129856441|NCT02014116|467433104|FG008|Overall Study|Lost to Follow-up|1|||
129856442|NCT02014116|467433096|FG000|Overall Study|Death|0|||
129856443|NCT02014116|467433097|FG001|Overall Study|Death|0|||
129856444|NCT02014116|467433098|FG002|Overall Study|Death|0|||
129856445|NCT02014116|467433099|FG003|Overall Study|Death|0|||
129856446|NCT02014116|467433100|FG004|Overall Study|Death|0|||
129856447|NCT02014116|467433101|FG005|Overall Study|Death|0|||
129856448|NCT02014116|467433102|FG006|Overall Study|Death|0|||
129856449|NCT02014116|467433103|FG007|Overall Study|Death|1|||
129856450|NCT02014116|467433104|FG008|Overall Study|Death|1|||
129856451|NCT02014116|467433096|FG000|Overall Study|Withdrawal by Subject|0|||
129856452|NCT02014116|467433097|FG001|Overall Study|Withdrawal by Subject|0|||
129856453|NCT02014116|467433098|FG002|Overall Study|Withdrawal by Subject|1|||
129856454|NCT02014116|467433099|FG003|Overall Study|Withdrawal by Subject|1|||
129856455|NCT02014116|467433100|FG004|Overall Study|Withdrawal by Subject|0|||
129856456|NCT02014116|467433101|FG005|Overall Study|Withdrawal by Subject|1|||
129856457|NCT02014116|467433102|FG006|Overall Study|Withdrawal by Subject|0|||
129856458|NCT02014116|467433103|FG007|Overall Study|Withdrawal by Subject|0|||
129856459|NCT02014116|467433104|FG008|Overall Study|Withdrawal by Subject|0|||
129856460|NCT02014116|467433096|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
129856461|NCT02014116|467433097|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
129856462|NCT02014116|467433098|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
129856463|NCT02014116|467433099|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
129856464|NCT02014116|467433100|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
129856465|NCT02014116|467433101|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
129856466|NCT02014116|467433102|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
129856467|NCT02014116|467433103|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
129856468|NCT02014116|467433104|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
129856469|NCT02014116|467433096|FG000|Overall Study|Physician Decision|0|||
129856470|NCT02014116|467433097|FG001|Overall Study|Physician Decision|0|||
129856471|NCT02014116|467433098|FG002|Overall Study|Physician Decision|0|||
129856472|NCT02014116|467433099|FG003|Overall Study|Physician Decision|0|||
129856473|NCT02014116|467433100|FG004|Overall Study|Physician Decision|0|||
129856474|NCT02014116|467433101|FG005|Overall Study|Physician Decision|0|||
129856475|NCT02014116|467433102|FG006|Overall Study|Physician Decision|0|||
129856476|NCT02014116|467433103|FG007|Overall Study|Physician Decision|0|||
129856477|NCT02014116|467433104|FG008|Overall Study|Physician Decision|1|||
129856478|NCT00583557|467433105|FG000|Overall Study|Withdrawal by Subject|18|||
129856479|NCT00583557|467433105|FG000|Overall Study|Adverse Event|9|||
129856480|NCT00583557|467433105|FG000|Overall Study|Lack of Efficacy|31|||
129856481|NCT00583557|467433105|FG000|Overall Study|Lack of Compliance|5|||
129856482|NCT00583557|467433105|FG000|Overall Study|Other|5|||
129856483|NCT00583557|467433105|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
129856484|NCT02347761|467433106|FG000|All Collected|Death|1|||
129856485|NCT02347761|467433107|FG001|All Collected|Death|0|||
129856486|NCT02347761|467433108|FG002|All Collected|Death|0|||
129856487|NCT02347761|467433106|FG000|All Collected|Lost to Follow-up|3|||
129856488|NCT02347761|467433107|FG001|All Collected|Lost to Follow-up|2|||
129856489|NCT02347761|467433108|FG002|All Collected|Lost to Follow-up|3|||
129856490|NCT02347761|467433106|FG000|All Collected|Withdrawal by Subject|11|||
129856491|NCT02347761|467433107|FG001|All Collected|Withdrawal by Subject|11|||
129856492|NCT02347761|467433108|FG002|All Collected|Withdrawal by Subject|22|||
129856493|NCT02347761|467433106|FG000|All Collected|invetigator disretion|2|||
129856494|NCT02347761|467433107|FG001|All Collected|invetigator disretion|0|||
129856495|NCT02347761|467433108|FG002|All Collected|invetigator disretion|0|||
129856496|NCT02347761|467433106|FG000|All Collected|instillation site pain|0|||
129856497|NCT02347761|467433107|FG001|All Collected|instillation site pain|0|||
129856498|NCT02347761|467433108|FG002|All Collected|instillation site pain|1|||
129856499|NCT02347761|467433106|FG000|All Collected|exacerbation of COPD|0|||
129856500|NCT02347761|467433107|FG001|All Collected|exacerbation of COPD|0|||
129856501|NCT02347761|467433108|FG002|All Collected|exacerbation of COPD|1|||
129856502|NCT02347761|467433106|FG000|All Collected|moved/travel|0|||
129856503|NCT02347761|467433107|FG001|All Collected|moved/travel|1|||
129856504|NCT02347761|467433108|FG002|All Collected|moved/travel|0|||
129856505|NCT02347761|467433106|FG000|On Study Treatment|Lack of Efficacy|2|||
129856506|NCT02347761|467433107|FG001|On Study Treatment|Lack of Efficacy|3|||
129856507|NCT02347761|467433108|FG002|On Study Treatment|Lack of Efficacy|4|||
129856508|NCT02347761|467433106|FG000|On Study Treatment|non-compliance with study medication|0|||
129856509|NCT02347761|467433107|FG001|On Study Treatment|non-compliance with study medication|0|||
129856510|NCT02347761|467433108|FG002|On Study Treatment|non-compliance with study medication|2|||
129856511|NCT02347761|467433106|FG000|On Study Treatment|Withdrawal by Subject|7|||
129856512|NCT02347761|467433107|FG001|On Study Treatment|Withdrawal by Subject|3|||
129856513|NCT02347761|467433108|FG002|On Study Treatment|Withdrawal by Subject|5|||
129856514|NCT02347761|467433106|FG000|On Study Treatment|move/travel|2|||
129856515|NCT02347761|467433107|FG001|On Study Treatment|move/travel|6|||
129856516|NCT02347761|467433108|FG002|On Study Treatment|move/travel|5|||
129856517|NCT02347761|467433106|FG000|On Study Treatment|dissastisfaction with device|2|||
129856518|NCT02347761|467433107|FG001|On Study Treatment|dissastisfaction with device|1|||
129856519|NCT02347761|467433108|FG002|On Study Treatment|dissastisfaction with device|4|||
129856520|NCT02347761|467433106|FG000|On Study Treatment|Lost to Follow-up|2|||
129909045|NCT02988817|467630893|FG016|Overall Study|Physician Decision|0|||
129909046|NCT02988817|467630894|FG017|Overall Study|Physician Decision|0|||
129909047|NCT02988817|467630895|FG018|Overall Study|Physician Decision|1|||
129909048|NCT02988817|467630896|FG019|Overall Study|Physician Decision|1|||
129909049|NCT00529516|467630897|FG000|Overall Study|Adverse Event|2|||
129909050|NCT00529516|467630898|FG001|Overall Study|Adverse Event|1|||
129909051|NCT00529516|467630899|FG002|Overall Study|Adverse Event|0|||
129909052|NCT00529516|467630897|FG000|Overall Study|Withdrawal by Subject|1|||
129909053|NCT00529516|467630898|FG001|Overall Study|Withdrawal by Subject|1|||
129909054|NCT00529516|467630899|FG002|Overall Study|Withdrawal by Subject|0|||
129909055|NCT00529516|467630897|FG000|Overall Study|Lost to Follow-up|0|||
129909056|NCT00529516|467630898|FG001|Overall Study|Lost to Follow-up|0|||
129909057|NCT00529516|467630899|FG002|Overall Study|Lost to Follow-up|1|||
129909058|NCT03752151|467630900|FG000|Overall Study|Withdrawal by Subject|1|||
129909059|NCT03752151|467630900|FG000|Overall Study|Protocol Violation|1|||
129909060|NCT01839331|467630901|FG000|Overall Study|Early Termination|3|||
129909061|NCT01839331|467630902|FG001|Overall Study|Early Termination|0|||
129909062|NCT01839331|467630903|FG002|Overall Study|Early Termination|1|||
129909063|NCT01839331|467630904|FG003|Overall Study|Early Termination|2|||
129909064|NCT01839331|467630901|FG000|Overall Study|Protocol Violation|1|||
129909065|NCT01839331|467630902|FG001|Overall Study|Protocol Violation|6|||
129909066|NCT01839331|467630903|FG002|Overall Study|Protocol Violation|4|||
129909067|NCT01839331|467630904|FG003|Overall Study|Protocol Violation|3|||
129909068|NCT04056624|467630905|FG000|Overall Study|Withdrawal by Subject|0|||
129909069|NCT04056624|467630906|FG001|Overall Study|Withdrawal by Subject|0|||
129909070|NCT04056624|467630907|FG002|Overall Study|Withdrawal by Subject|1|||
129909071|NCT04056624|467630905|FG000|Overall Study|Protocol Violation|1|||
129909072|NCT04056624|467630906|FG001|Overall Study|Protocol Violation|2|||
129909073|NCT04056624|467630907|FG002|Overall Study|Protocol Violation|0|||
129909074|NCT03051165|467630912|FG000|Overall Study|Withdrawal by Subject|1|||
129909075|NCT03051165|467630912|FG000|Overall Study|Early termination of study|12|||
129909076|NCT02092116|467630914|FG000|Overall Study|Withdrawal by Subject|0|||
129909077|NCT02092116|467630915|FG001|Overall Study|Withdrawal by Subject|3|||
129909078|NCT02092116|467630914|FG000|Overall Study|Adverse Event|0|||
129909079|NCT02092116|467630915|FG001|Overall Study|Adverse Event|1|||
129909080|NCT03074331|467630916|FG000|Overall Study|Enrolled but Not Treated|1|||
129909081|NCT03074331|467630916|FG000|Overall Study|Lost to Follow-up|5|||
129909082|NCT03074331|467630916|FG000|Overall Study|Withdrew Consent|1|||
129909083|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
129909084|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
129909085|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909086|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909087|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909088|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
129909089|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
129909090|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
129909091|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909092|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909093|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909094|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909095|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
129909096|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
129909097|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909098|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
129909099|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909100|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909101|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909102|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909103|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909104|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
129909105|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
129909106|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
129909107|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909108|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
129909109|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909110|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909111|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909112|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909113|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909114|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
129909115|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909116|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909117|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909118|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
129909119|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
129856521|NCT02347761|467433107|FG001|On Study Treatment|Lost to Follow-up|1|||
129856522|NCT02347761|467433108|FG002|On Study Treatment|Lost to Follow-up|1|||
129856523|NCT02347761|467433106|FG000|On Study Treatment|investigator discretion|2|||
129856524|NCT02347761|467433107|FG001|On Study Treatment|investigator discretion|0|||
129856525|NCT02347761|467433108|FG002|On Study Treatment|investigator discretion|0|||
129856526|NCT02347761|467433106|FG000|On Study Treatment|durg not working|0|||
129856527|NCT02347761|467433107|FG001|On Study Treatment|durg not working|1|||
129856528|NCT02347761|467433108|FG002|On Study Treatment|durg not working|1|||
129856529|NCT02347761|467433106|FG000|On Study Treatment|Adverse Event|10|||
129856530|NCT02347761|467433107|FG001|On Study Treatment|Adverse Event|8|||
129856531|NCT02347761|467433108|FG002|On Study Treatment|Adverse Event|20|||
129856532|NCT03879798|467433109|FG000|Overall Study|Adverse Event|0|||
129856533|NCT03879798|467433110|FG001|Overall Study|Adverse Event|0|||
129856534|NCT03879798|467433111|FG002|Overall Study|Adverse Event|0|||
129856535|NCT03879798|467433112|FG003|Overall Study|Adverse Event|0|||
129856536|NCT03879798|467433113|FG004|Overall Study|Adverse Event|0|||
129856537|NCT03879798|467433114|FG005|Overall Study|Adverse Event|1|||
129856538|NCT03879798|467433109|FG000|Overall Study|Lack of Efficacy|0|||
129856539|NCT03879798|467433110|FG001|Overall Study|Lack of Efficacy|0|||
129856540|NCT03879798|467433111|FG002|Overall Study|Lack of Efficacy|0|||
129856541|NCT03879798|467433112|FG003|Overall Study|Lack of Efficacy|0|||
129856542|NCT03879798|467433113|FG004|Overall Study|Lack of Efficacy|0|||
129856543|NCT03879798|467433114|FG005|Overall Study|Lack of Efficacy|1|||
129856544|NCT03879798|467433109|FG000|Overall Study|Withdrawal by Subject|0|||
129856545|NCT03879798|467433110|FG001|Overall Study|Withdrawal by Subject|0|||
129856546|NCT03879798|467433111|FG002|Overall Study|Withdrawal by Subject|0|||
129856547|NCT03879798|467433112|FG003|Overall Study|Withdrawal by Subject|0|||
129856548|NCT03879798|467433113|FG004|Overall Study|Withdrawal by Subject|0|||
129856549|NCT03879798|467433114|FG005|Overall Study|Withdrawal by Subject|1|||
129856550|NCT03625570|467433115|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
129856551|NCT03625570|467433116|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
129856552|NCT03625570|467433115|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
129856553|NCT03625570|467433116|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
129856554|NCT03625570|467433115|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
129856555|NCT03625570|467433116|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
129856556|NCT01040130|467433122|FG000|Overall Study|Adverse Event|1|||
129856557|NCT01040130|467433123|FG001|Overall Study|Adverse Event|1|||
129856558|NCT01040130|467433124|FG002|Overall Study|Adverse Event|0|||
129856559|NCT01040130|467433125|FG003|Overall Study|Adverse Event|5|||
129856560|NCT01040130|467433126|FG004|Overall Study|Adverse Event|0|||
129856561|NCT01040130|467433127|FG005|Overall Study|Adverse Event|3|||
129856562|NCT01040130|467433122|FG000|Overall Study|Protocol Violation|0|||
129856563|NCT01040130|467433123|FG001|Overall Study|Protocol Violation|0|||
129856564|NCT01040130|467433124|FG002|Overall Study|Protocol Violation|2|||
129856565|NCT01040130|467433125|FG003|Overall Study|Protocol Violation|0|||
129856566|NCT01040130|467433126|FG004|Overall Study|Protocol Violation|0|||
129856567|NCT01040130|467433127|FG005|Overall Study|Protocol Violation|0|||
129856568|NCT01040130|467433122|FG000|Overall Study|Withdrawal by Subject|0|||
129856569|NCT01040130|467433123|FG001|Overall Study|Withdrawal by Subject|2|||
129856570|NCT01040130|467433124|FG002|Overall Study|Withdrawal by Subject|0|||
129856571|NCT01040130|467433125|FG003|Overall Study|Withdrawal by Subject|0|||
129856572|NCT01040130|467433126|FG004|Overall Study|Withdrawal by Subject|0|||
129856573|NCT01040130|467433127|FG005|Overall Study|Withdrawal by Subject|1|||
129856574|NCT01040130|467433122|FG000|Overall Study|Other reasons not listed above|2|||
129856575|NCT01040130|467433123|FG001|Overall Study|Other reasons not listed above|0|||
129856576|NCT01040130|467433124|FG002|Overall Study|Other reasons not listed above|0|||
129856577|NCT01040130|467433125|FG003|Overall Study|Other reasons not listed above|0|||
129856578|NCT01040130|467433126|FG004|Overall Study|Other reasons not listed above|0|||
129856579|NCT01040130|467433127|FG005|Overall Study|Other reasons not listed above|0|||
129856580|NCT01310036|467433130|FG000|Overall Study|Administrative/other|10|||
129856581|NCT01310036|467433130|FG000|Overall Study|Withdrew Consent|11|||
129856582|NCT01310036|467433130|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
129856583|NCT01310036|467433130|FG000|Overall Study|Progression of Disease|164|||
129856584|NCT01310036|467433130|FG000|Overall Study|Death|1|||
129856585|NCT01310036|467433130|FG000|Overall Study|Adverse event or intercurrent illness|12|||
129856586|NCT00553267|467433131|FG000|Overall Study|Adverse Event|8|||
129856587|NCT00553267|467433132|FG001|Overall Study|Adverse Event|10|||
129856588|NCT00553267|467433133|FG002|Overall Study|Adverse Event|5|||
129856589|NCT00553267|467433131|FG000|Overall Study|Non compliant with protocol|3|||
129856590|NCT00553267|467433132|FG001|Overall Study|Non compliant with protocol|3|||
129856591|NCT00553267|467433133|FG002|Overall Study|Non compliant with protocol|2|||
129856592|NCT00553267|467433131|FG000|Overall Study|Lost to Follow-up|0|||
129909120|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909121|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909122|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
129909123|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909124|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909125|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909126|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
129909127|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909128|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909129|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909130|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
129909131|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909132|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
129909133|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909134|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909135|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
129909136|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
129909137|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
129909138|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
129909139|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
129909140|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909141|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909142|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909143|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909144|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
129909145|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909146|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
129909147|NCT03903822|467630920|FG000|Treatment Phase (6 Weeks)|Other|2|||
129909148|NCT03903822|467630921|FG001|Treatment Phase (6 Weeks)|Other|1|||
129909149|NCT03903822|467630922|FG002|Treatment Phase (6 Weeks)|Other|0|||
129909150|NCT03903822|467630923|FG003|Treatment Phase (6 Weeks)|Other|0|||
129909151|NCT03903822|467630924|FG004|Treatment Phase (6 Weeks)|Other|1|||
129909152|NCT03903822|467630925|FG005|Treatment Phase (6 Weeks)|Other|1|||
129909153|NCT03903822|467630926|FG006|Treatment Phase (6 Weeks)|Other|0|||
129909154|NCT03903822|467630927|FG007|Treatment Phase (6 Weeks)|Other|0|||
129909155|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
129909156|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
129909157|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
129909158|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
129909159|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
129909160|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
129909161|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
129856593|NCT00553267|467433132|FG001|Overall Study|Lost to Follow-up|0|||
129856594|NCT00553267|467433133|FG002|Overall Study|Lost to Follow-up|1|||
129856595|NCT00553267|467433131|FG000|Overall Study|Consent withdrawn|2|||
129856596|NCT00553267|467433132|FG001|Overall Study|Consent withdrawn|3|||
129856597|NCT00553267|467433133|FG002|Overall Study|Consent withdrawn|1|||
129856598|NCT00553267|467433131|FG000|Overall Study|Specified category|1|||
129856599|NCT00553267|467433132|FG001|Overall Study|Specified category|2|||
129856600|NCT00553267|467433133|FG002|Overall Study|Specified category|1|||
129856601|NCT01175668|467433134|FG000|Overall Study|Withdrawal by Subject|2|||
129856602|NCT01175668|467433135|FG001|Overall Study|Withdrawal by Subject|0|||
129856603|NCT02328326|467433139|FG000|Overall Study|Withdrawal by Subject|10|||
129856604|NCT02328326|467433140|FG001|Overall Study|Withdrawal by Subject|3|||
129856605|NCT02328326|467433139|FG000|Overall Study|Death|2|||
129856606|NCT02328326|467433140|FG001|Overall Study|Death|1|||
129856607|NCT02328326|467433139|FG000|Overall Study|Lost to Follow-up|10|||
129856608|NCT02328326|467433140|FG001|Overall Study|Lost to Follow-up|4|||
129856609|NCT02937545|467433149|FG000|Overall Study|Withdrawal by Subject|1|||
129856610|NCT02937545|467433150|FG001|Overall Study|Withdrawal by Subject|2|||
129856611|NCT02937545|467433151|FG002|Overall Study|Withdrawal by Subject|6|||
129856612|NCT02937545|467433152|FG003|Overall Study|Withdrawal by Subject|7|||
129856613|NCT02937545|467433149|FG000|Overall Study|Lost to Follow-up|1|||
129856614|NCT02937545|467433150|FG001|Overall Study|Lost to Follow-up|0|||
129856615|NCT02937545|467433151|FG002|Overall Study|Lost to Follow-up|0|||
129856616|NCT02937545|467433152|FG003|Overall Study|Lost to Follow-up|0|||
129856617|NCT01985126|467433157|FG000|Overall Study|Death|15|||
129856618|NCT01985126|467433158|FG001|Overall Study|Death|69|||
129856619|NCT01985126|467433157|FG000|Overall Study|Lost to Follow-up|0|||
129856620|NCT01985126|467433158|FG001|Overall Study|Lost to Follow-up|8|||
129856621|NCT01985126|467433157|FG000|Overall Study|Study Terminated By Sponsor|1|||
129909162|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
129909163|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909164|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909165|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129856622|NCT01985126|467433158|FG001|Overall Study|Study Terminated By Sponsor|22|||
129856623|NCT01985126|467433157|FG000|Overall Study|Withdrawal by Subject|2|||
129856624|NCT01985126|467433158|FG001|Overall Study|Withdrawal by Subject|7|||
129856625|NCT00784043|467433166|FG000|Overall Study|Withdrawal by Subject|8|||
129856626|NCT00784043|467433167|FG001|Overall Study|Withdrawal by Subject|5|||
129856627|NCT00784043|467433166|FG000|Overall Study|Protocol Terminated|23|||
129856628|NCT00784043|467433167|FG001|Overall Study|Protocol Terminated|1|||
129856629|NCT01618838|467433168|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
129856630|NCT03965052|467433171|FG000|Overall Study|Protocol Violation|1|||
129856631|NCT03965052|467433172|FG001|Overall Study|Protocol Violation|0|||
129856632|NCT00142909|467433176|FG000|Randomization|Various Reasons|7|||
129856633|NCT00142909|467433177|FG001|Randomization|Various Reasons|10|||
129856634|NCT00142909|467433176|FG000|Medications Begin|Protocol Violation|2|||
129856635|NCT00142909|467433177|FG001|Medications Begin|Protocol Violation|0|||
129856636|NCT00142909|467433176|FG000|Medications Begin|Withdrawal by Subject|5|||
129856637|NCT00142909|467433177|FG001|Medications Begin|Withdrawal by Subject|3|||
129856638|NCT00142909|467433176|FG000|Medications Begin|Withdrawal by Subject|2|||
129856639|NCT00142909|467433177|FG001|Medications Begin|Withdrawal by Subject|0|||
129856640|NCT00345397|467433178|FG000|Overall Study|Death|1|||
129856641|NCT01870843|467433179|FG000|Overall Study|Adverse Event|10|||
129856642|NCT01870843|467433179|FG000|Overall Study|Lost to Follow-up|24|||
129856643|NCT01870843|467433179|FG000|Overall Study|Death|1|||
129856644|NCT01870843|467433179|FG000|Overall Study|Withdrawal by Subject|18|||
129856645|NCT01910519|467433180|FG000|Overall Study|Withdrawal by Subject|2|||
129856646|NCT01910519|467433181|FG001|Overall Study|Withdrawal by Subject|0|||
129856647|NCT01910519|467433180|FG000|Overall Study|Adverse Event|2|||
129856648|NCT01910519|467433181|FG001|Overall Study|Adverse Event|0|||
129856649|NCT04266028|467433184|FG000|Overall Study|Adverse Event|0|||
129856650|NCT04266028|467433185|FG001|Overall Study|Adverse Event|0|||
129856651|NCT04266028|467433186|FG002|Overall Study|Adverse Event|1|||
129856652|NCT04266028|467433187|FG003|Overall Study|Adverse Event|0|||
129856653|NCT04266028|467433188|FG004|Overall Study|Adverse Event|1|||
129856654|NCT04266028|467433189|FG005|Overall Study|Adverse Event|0|||
129856655|NCT04266028|467433190|FG006|Overall Study|Adverse Event|2|||
129856656|NCT04266028|467433191|FG007|Overall Study|Adverse Event|0|||
129856657|NCT04266028|467433184|FG000|Overall Study|temporary halt of the study|0|||
129856658|NCT04266028|467433185|FG001|Overall Study|temporary halt of the study|0|||
129856659|NCT04266028|467433186|FG002|Overall Study|temporary halt of the study|0|||
129856660|NCT04266028|467433187|FG003|Overall Study|temporary halt of the study|0|||
129856661|NCT04266028|467433188|FG004|Overall Study|temporary halt of the study|0|||
129856662|NCT04266028|467433189|FG005|Overall Study|temporary halt of the study|0|||
129856663|NCT04266028|467433190|FG006|Overall Study|temporary halt of the study|2|||
129856664|NCT04266028|467433191|FG007|Overall Study|temporary halt of the study|1|||
129856665|NCT04266028|467433184|FG000|Overall Study|Onset of birch pollen season|0|||
129856666|NCT04266028|467433185|FG001|Overall Study|Onset of birch pollen season|0|||
129856667|NCT04266028|467433186|FG002|Overall Study|Onset of birch pollen season|0|||
129856668|NCT04266028|467433187|FG003|Overall Study|Onset of birch pollen season|0|||
129856669|NCT04266028|467433188|FG004|Overall Study|Onset of birch pollen season|1|||
129856670|NCT04266028|467433189|FG005|Overall Study|Onset of birch pollen season|0|||
129856671|NCT04266028|467433190|FG006|Overall Study|Onset of birch pollen season|0|||
129856672|NCT04266028|467433191|FG007|Overall Study|Onset of birch pollen season|0|||
129856673|NCT03021187|467433194|FG000|Overall Study|Death|0|||
129856674|NCT03021187|467433195|FG001|Overall Study|Death|0|||
129856675|NCT03021187|467433196|FG002|Overall Study|Death|3|||
129856676|NCT03021187|467433197|FG003|Overall Study|Death|0|||
129856677|NCT03021187|467433194|FG000|Overall Study|Withdrawal by Subject|0|||
129856678|NCT03021187|467433195|FG001|Overall Study|Withdrawal by Subject|6|||
129856679|NCT03021187|467433196|FG002|Overall Study|Withdrawal by Subject|2|||
129856680|NCT03021187|467433197|FG003|Overall Study|Withdrawal by Subject|5|||
129856681|NCT03021187|467433194|FG000|Overall Study|Lost to Follow-up|10|||
129856682|NCT03021187|467433195|FG001|Overall Study|Lost to Follow-up|3|||
129856683|NCT03021187|467433196|FG002|Overall Study|Lost to Follow-up|1|||
129856684|NCT03021187|467433197|FG003|Overall Study|Lost to Follow-up|4|||
129856685|NCT01664078|467433198|FG000|Overall Study|Death|9|||
129856686|NCT01664078|467433198|FG000|Overall Study|Withdrawal by Subject|4|||
129856687|NCT01664078|467433198|FG000|Overall Study|Lost to Follow-up|2|||
129856688|NCT01664078|467433198|FG000|Overall Study|missed 5 year visit|1|||
129856689|NCT01664078|467433198|FG000|Overall Study|Other|53|||
129856690|NCT03351049|467433201|FG000|Overall Study|Withdrawal|26|||
129856691|NCT03351049|467433202|FG001|Overall Study|Withdrawal|22|||
129856692|NCT02720484|467433211|FG000|Treatment on Study|Adverse Event|1|||
129856693|NCT02720484|467433211|FG000|Treatment on Study|Withdrawal by Subject|1|||
129856694|NCT02720484|467433211|FG000|Treatment on Study|Progressive Disease|4|||
129856695|NCT02720484|467433211|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
129856696|NCT02720484|467433211|FG000|Follow Up for 2 Years|Death|3|||
129856697|NCT02720484|467433211|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
129856698|NCT05070897|467433214|FG000|Overall Study|Protocol Violation|123|||
129856699|NCT05070897|467433215|FG001|Overall Study|Protocol Violation|68|||
129909166|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909167|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
129856700|NCT01617629|467433216|FG000|Overall Study|Death|2|||
129856701|NCT01617629|467433216|FG000|Overall Study|Investigator's Clinical Judgement|1|||
129856702|NCT01617629|467433216|FG000|Overall Study|Reason Not Specified|1|||
129856703|NCT01617629|467433216|FG000|Overall Study|Participant Withdrew Consent|2|||
129856704|NCT01663636|467433217|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
129856705|NCT01663636|467433218|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
129856706|NCT03832946|467433219|FG000|Overall Study|Adverse Event|3|||
129856707|NCT03832946|467433220|FG001|Overall Study|Adverse Event|1|||
129856708|NCT03832946|467433219|FG000|Overall Study|Lost to Follow-up|1|||
129856709|NCT03832946|467433220|FG001|Overall Study|Lost to Follow-up|0|||
129856710|NCT03832946|467433219|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
129856711|NCT03832946|467433220|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
129856712|NCT03832946|467433219|FG000|Overall Study|Lack of Efficacy|1|||
129856713|NCT03832946|467433220|FG001|Overall Study|Lack of Efficacy|0|||
129856714|NCT03832946|467433219|FG000|Overall Study|Withdrawal by Subject|12|||
129856715|NCT03832946|467433220|FG001|Overall Study|Withdrawal by Subject|9|||
129856716|NCT02863991|467433221|FG000|Overall Study|Death|0|||
129856717|NCT02863991|467433222|FG001|Overall Study|Death|3|||
129856718|NCT02863991|467433221|FG000|Overall Study|Lack of Efficacy|0|||
129856719|NCT02863991|467433222|FG001|Overall Study|Lack of Efficacy|1|||
129856720|NCT02863991|467433221|FG000|Overall Study|Study Terminated|2|||
129856721|NCT02863991|467433222|FG001|Overall Study|Study Terminated|8|||
129856722|NCT02663817|467433223|FG000|Overall Study|Screen failure|2|||
129856723|NCT01438541|467433226|FG000|Overall Study|Physician Decision|1|||
129856724|NCT01438541|467433226|FG000|Overall Study|Withdrawal by Subject|1|||
129856725|NCT01438541|467433226|FG000|Overall Study|discharge from the hospital|5|||
129856726|NCT00136955|467435224|FG000|Overall Study|Adverse Event|8|||
129856727|NCT00136955|467435224|FG000|Overall Study|Lost to Follow-up|1|||
129856728|NCT00136955|467435224|FG000|Overall Study|Withdrawal by Subject|2|||
129856729|NCT00136955|467435224|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
129856730|NCT04450264|467435225|FG000|Overall Study|Incomplete survey|13|||
129856731|NCT04450264|467435226|FG001|Overall Study|Incomplete survey|19|||
129856732|NCT05349617|467435227|FG000|Overall Study|Death|1|||
129856733|NCT05349617|467435228|FG001|Overall Study|Death|1|||
129856734|NCT05349617|467435227|FG000|Overall Study|Lost to Follow-up|3|||
129856735|NCT05349617|467435228|FG001|Overall Study|Lost to Follow-up|8|||
129856736|NCT05349617|467435227|FG000|Overall Study|Withdrawal by Subject|2|||
129856737|NCT05349617|467435228|FG001|Overall Study|Withdrawal by Subject|10|||
129856738|NCT00987467|467435229|FG000|Overall Study|Lost to Follow-up|2|||
129856739|NCT00512135|467435230|FG000|Overall Study|Not Treated|5|||
129856740|NCT00512135|467435230|FG000|Overall Study|Lack of Efficacy|2|||
129856741|NCT00512135|467435230|FG000|Overall Study|Adverse Event|6|||
129856742|NCT00512135|467435230|FG000|Overall Study|Withdrawal by Subject|22|||
129856743|NCT00512135|467435230|FG000|Overall Study|Lost to Follow-up|27|||
129856744|NCT00512135|467435230|FG000|Overall Study|Other|22|||
129856745|NCT02646423|467435231|FG000|Overall Study|Adverse Event|5|||
129856746|NCT02646423|467435232|FG001|Overall Study|Adverse Event|7|||
129856747|NCT02646423|467435231|FG000|Overall Study|Ineligible|2|||
129856748|NCT02646423|467435232|FG001|Overall Study|Ineligible|1|||
129856749|NCT00377819|467435233|FG000|Overall Study|Adverse Event|2|||
129856750|NCT00377819|467435234|FG001|Overall Study|Adverse Event|3|||
129856751|NCT00377819|467435233|FG000|Overall Study|Withdrawal by Subject|10|||
129909168|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129856752|NCT00377819|467435234|FG001|Overall Study|Withdrawal by Subject|4|||
129856753|NCT00377819|467435233|FG000|Overall Study|Death|0|||
129856754|NCT00377819|467435234|FG001|Overall Study|Death|1|||
129856755|NCT00377819|467435233|FG000|Overall Study|Lost to Follow-up|0|||
129856756|NCT00377819|467435234|FG001|Overall Study|Lost to Follow-up|1|||
129856757|NCT00377819|467435233|FG000|Overall Study|Protocol Violation|1|||
129856758|NCT00377819|467435234|FG001|Overall Study|Protocol Violation|1|||
129856759|NCT02807948|467435235|FG000|Overall Study|Physician Decision|1|||
129856760|NCT02807948|467435236|FG001|Overall Study|Physician Decision|0|||
129856761|NCT03727750|467435237|FG000|Overall Study|Death|45|||
129856762|NCT03727750|467435237|FG000|Overall Study|Withdrawal by Subject|2|||
129856763|NCT03727750|467435237|FG000|Overall Study|Lost to Follow-up|1|||
129856764|NCT03727750|467435237|FG000|Overall Study|Other|1|||
129856765|NCT00760929|467435241|FG000|Overall Study|Adverse Event|2|||
129856766|NCT00760929|467435242|FG001|Overall Study|Adverse Event|0|||
129856767|NCT00760929|467435243|FG002|Overall Study|Adverse Event|6|||
129856768|NCT00760929|467435244|FG003|Overall Study|Adverse Event|10|||
129856769|NCT00760929|467435241|FG000|Overall Study|Lack of Efficacy|0|||
129856770|NCT00760929|467435242|FG001|Overall Study|Lack of Efficacy|2|||
129856771|NCT00760929|467435243|FG002|Overall Study|Lack of Efficacy|1|||
129856772|NCT00760929|467435244|FG003|Overall Study|Lack of Efficacy|0|||
129856773|NCT00760929|467435241|FG000|Overall Study|Withdrawal by Subject|1|||
129856774|NCT00760929|467435242|FG001|Overall Study|Withdrawal by Subject|0|||
129449694|NCT02665052|465945653|FG003|Overall Study|Withdrawal by Subject|5|||
129856775|NCT00760929|467435243|FG002|Overall Study|Withdrawal by Subject|9|||
129856776|NCT00760929|467435244|FG003|Overall Study|Withdrawal by Subject|1|||
129856777|NCT00760929|467435241|FG000|Overall Study|Lost to Follow-up|0|||
129856778|NCT00760929|467435242|FG001|Overall Study|Lost to Follow-up|0|||
129856779|NCT00760929|467435243|FG002|Overall Study|Lost to Follow-up|1|||
129856780|NCT00760929|467435244|FG003|Overall Study|Lost to Follow-up|0|||
129856781|NCT00760929|467435241|FG000|Overall Study|Progression of Disease|21|||
129856782|NCT00760929|467435242|FG001|Overall Study|Progression of Disease|26|||
129856783|NCT00760929|467435243|FG002|Overall Study|Progression of Disease|38|||
129856784|NCT00760929|467435244|FG003|Overall Study|Progression of Disease|42|||
129856785|NCT00760929|467435241|FG000|Overall Study|Other|2|||
129856786|NCT00760929|467435242|FG001|Overall Study|Other|0|||
129856787|NCT00760929|467435243|FG002|Overall Study|Other|2|||
129856788|NCT00760929|467435244|FG003|Overall Study|Other|1|||
129856789|NCT00760929|467435241|FG000|Overall Study|Death|0|||
129856790|NCT00760929|467435242|FG001|Overall Study|Death|0|||
129856791|NCT00760929|467435243|FG002|Overall Study|Death|1|||
129856792|NCT00760929|467435244|FG003|Overall Study|Death|0|||
129856793|NCT00760929|467435241|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129856794|NCT00760929|467435242|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
129856795|NCT00760929|467435243|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
129856796|NCT00760929|467435244|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
129856797|NCT04360824|467435246|FG000|Overall Study|Withdrawal by Subject|2|||
129856798|NCT04360824|467435247|FG001|Overall Study|Withdrawal by Subject|1|||
129856799|NCT04360824|467435246|FG000|Overall Study|Did not receive assigned treatment|1|||
129856800|NCT04360824|467435247|FG001|Overall Study|Did not receive assigned treatment|3|||
129856801|NCT00304070|467435248|FG000|Overall Study|Death|0|||
129856802|NCT00304070|467435249|FG001|Overall Study|Death|0|||
129856803|NCT00304070|467435250|FG002|Overall Study|Death|3|||
129856804|NCT00304070|467435248|FG000|Overall Study|Lost to Follow-up|0|||
129856805|NCT00304070|467435249|FG001|Overall Study|Lost to Follow-up|0|||
129856806|NCT00304070|467435250|FG002|Overall Study|Lost to Follow-up|1|||
129856807|NCT00304070|467435248|FG000|Overall Study|Physician Decision|0|||
129856808|NCT00304070|467435249|FG001|Overall Study|Physician Decision|0|||
129856809|NCT00304070|467435250|FG002|Overall Study|Physician Decision|3|||
129856810|NCT00304070|467435248|FG000|Overall Study|Withdrawal by Subject|0|||
129856811|NCT00304070|467435249|FG001|Overall Study|Withdrawal by Subject|0|||
129856812|NCT00304070|467435250|FG002|Overall Study|Withdrawal by Subject|1|||
129856813|NCT00304070|467435248|FG000|Overall Study|Progressive Disease|3|||
129856814|NCT00304070|467435249|FG001|Overall Study|Progressive Disease|7|||
129856815|NCT00304070|467435250|FG002|Overall Study|Progressive Disease|4|||
129856816|NCT00320216|467435251|FG000|Overall Study|Adverse Event|0|||
129856817|NCT00320216|467435252|FG001|Overall Study|Adverse Event|6|||
129856818|NCT00320216|467435253|FG002|Overall Study|Adverse Event|0|||
129856819|NCT00320216|467435254|FG003|Overall Study|Adverse Event|2|||
129856820|NCT00320216|467435255|FG004|Overall Study|Adverse Event|2|||
129856821|NCT00320216|467435251|FG000|Overall Study|Lack of Efficacy|6|||
129856822|NCT00320216|467435252|FG001|Overall Study|Lack of Efficacy|2|||
129856823|NCT00320216|467435253|FG002|Overall Study|Lack of Efficacy|1|||
129856824|NCT00320216|467435254|FG003|Overall Study|Lack of Efficacy|0|||
129856825|NCT00320216|467435255|FG004|Overall Study|Lack of Efficacy|1|||
129856826|NCT00320216|467435251|FG000|Overall Study|Lost to Follow-up|3|||
129856827|NCT00320216|467435252|FG001|Overall Study|Lost to Follow-up|0|||
129856828|NCT00320216|467435253|FG002|Overall Study|Lost to Follow-up|0|||
129856829|NCT00320216|467435254|FG003|Overall Study|Lost to Follow-up|0|||
129856830|NCT00320216|467435255|FG004|Overall Study|Lost to Follow-up|0|||
129856831|NCT00320216|467435251|FG000|Overall Study|Other|7|||
129856832|NCT00320216|467435252|FG001|Overall Study|Other|2|||
129856833|NCT00320216|467435253|FG002|Overall Study|Other|5|||
129856834|NCT00320216|467435254|FG003|Overall Study|Other|1|||
129856835|NCT00320216|467435255|FG004|Overall Study|Other|3|||
129856836|NCT00377676|467435256|FG000|Overall Study|Adverse Event|498|||
129856837|NCT00377676|467435257|FG001|Overall Study|Adverse Event|107|||
129856838|NCT00377676|467435256|FG000|Overall Study|Protocol Violation|33|||
129856839|NCT00377676|467435257|FG001|Overall Study|Protocol Violation|27|||
129856840|NCT00377676|467435256|FG000|Overall Study|Death|5|||
129856841|NCT00377676|467435257|FG001|Overall Study|Death|2|||
129856842|NCT00377676|467435256|FG000|Overall Study|Withdrawal by Subject|187|||
129449695|NCT02665052|465945650|FG000|Overall Study|Adverse Event|1|||
129856843|NCT00377676|467435257|FG001|Overall Study|Withdrawal by Subject|72|||
129856844|NCT00377676|467435256|FG000|Overall Study|Lost to Follow-up|120|||
129856845|NCT00377676|467435257|FG001|Overall Study|Lost to Follow-up|56|||
129856846|NCT00377676|467435256|FG000|Overall Study|Other|118|||
129856847|NCT00377676|467435257|FG001|Overall Study|Other|58|||
129856848|NCT05348681|467435262|FG000|Overall Study|Study terminated by Sponsor|8|||
129856849|NCT05348681|467435263|FG001|Overall Study|Study terminated by Sponsor|3|||
129856850|NCT05348681|467435262|FG000|Overall Study|Withdrawal by Subject|1|||
129856851|NCT05348681|467435263|FG001|Overall Study|Withdrawal by Subject|1|||
129856852|NCT05348681|467435262|FG000|Overall Study|Lost to Follow-up|1|||
129909169|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909170|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
129909171|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
129909172|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909173|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909174|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909175|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909176|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
129909177|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
129909178|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
129909179|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909180|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909181|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909182|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
129909183|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
129909184|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909185|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909186|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
129909187|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909188|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
129909189|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
129909190|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909191|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909192|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
129909193|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
129909194|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
129909195|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909196|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909197|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909198|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909199|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909200|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
129909201|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909202|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
129909203|NCT03903822|467630920|FG000|Follow up Phase (4 Weeks)|Other|1|||
129909204|NCT03903822|467630921|FG001|Follow up Phase (4 Weeks)|Other|1|||
129909205|NCT03903822|467630922|FG002|Follow up Phase (4 Weeks)|Other|0|||
129909206|NCT03903822|467630923|FG003|Follow up Phase (4 Weeks)|Other|0|||
129909207|NCT03903822|467630924|FG004|Follow up Phase (4 Weeks)|Other|0|||
129909208|NCT03903822|467630925|FG005|Follow up Phase (4 Weeks)|Other|0|||
129909209|NCT03903822|467630926|FG006|Follow up Phase (4 Weeks)|Other|0|||
129909210|NCT03903822|467630927|FG007|Follow up Phase (4 Weeks)|Other|0|||
129909211|NCT00546754|467630930|FG000|Overall Study|Serious Adverse Event|1|||
129909212|NCT00546754|467630931|FG001|Overall Study|Serious Adverse Event|1|||
129909213|NCT00546754|467630930|FG000|Overall Study|Adverse Event|11|||
129909214|NCT00546754|467630931|FG001|Overall Study|Adverse Event|16|||
129909215|NCT00546754|467630930|FG000|Overall Study|Lack of Efficacy|1|||
129909216|NCT00546754|467630931|FG001|Overall Study|Lack of Efficacy|1|||
129856853|NCT05348681|467435263|FG001|Overall Study|Lost to Follow-up|1|||
129856854|NCT05348681|467435262|FG000|Overall Study|Adverse Event|1|||
129856855|NCT05348681|467435263|FG001|Overall Study|Adverse Event|0|||
129856856|NCT05348681|467435262|FG000|Overall Study|Other|2|||
129856857|NCT05348681|467435263|FG001|Overall Study|Other|1|||
129856858|NCT00782340|467435264|FG000|Open Label Titration|Adverse Event|12|||
129856859|NCT00782340|467435265|FG001|Open Label Titration|Adverse Event|0|||
129856860|NCT00782340|467435266|FG002|Open Label Titration|Adverse Event|0|||
129909217|NCT00546754|467630930|FG000|Overall Study|Lost to Follow-up|9|||
129909218|NCT00546754|467630931|FG001|Overall Study|Lost to Follow-up|15|||
129909219|NCT00546754|467630930|FG000|Overall Study|Protocol Violation|3|||
129909220|NCT00546754|467630931|FG001|Overall Study|Protocol Violation|0|||
129909221|NCT00546754|467630930|FG000|Overall Study|Withdrawal by Subject|6|||
129909222|NCT00546754|467630931|FG001|Overall Study|Withdrawal by Subject|7|||
129909223|NCT00546754|467630930|FG000|Overall Study|Dyspnea|1|||
129909224|NCT00546754|467630931|FG001|Overall Study|Dyspnea|0|||
129856861|NCT00782340|467435264|FG000|Open Label Titration|Treatment failure|50|||
129856862|NCT00782340|467435265|FG001|Open Label Titration|Treatment failure|0|||
129856863|NCT00782340|467435266|FG002|Open Label Titration|Treatment failure|0|||
129856864|NCT00782340|467435264|FG000|Open Label Titration|Protocol Violation|5|||
129909225|NCT00546754|467630930|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
129909226|NCT00546754|467630931|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
129909227|NCT00546754|467630930|FG000|Overall Study|Hip Replacement|1|||
129856865|NCT00782340|467435265|FG001|Open Label Titration|Protocol Violation|0|||
129856866|NCT00782340|467435266|FG002|Open Label Titration|Protocol Violation|0|||
129909228|NCT00546754|467630931|FG001|Overall Study|Hip Replacement|0|||
129909229|NCT00546754|467630930|FG000|Overall Study|Suicide|1|||
129909230|NCT00546754|467630931|FG001|Overall Study|Suicide|0|||
129909231|NCT00546754|467630930|FG000|Overall Study|Missing Cooperation|1|||
129909232|NCT00546754|467630931|FG001|Overall Study|Missing Cooperation|0|||
129909233|NCT00546754|467630930|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
129909234|NCT00546754|467630931|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
129909235|NCT00546754|467630930|FG000|Overall Study|Patient's Decision|0|||
129909236|NCT00546754|467630931|FG001|Overall Study|Patient's Decision|1|||
129909237|NCT00546754|467630930|FG000|Overall Study|Missing|14|||
129909238|NCT00546754|467630931|FG001|Overall Study|Missing|7|||
129909239|NCT03733119|467630932|FG000|Overall Study|Physician Decision|2|||
129909240|NCT03733119|467630933|FG001|Overall Study|Physician Decision|1|||
129909241|NCT03733119|467630932|FG000|Overall Study|ineligible to treat per protocol|0|||
129909242|NCT03733119|467630933|FG001|Overall Study|ineligible to treat per protocol|1|||
129909243|NCT03764475|467630939|FG000|Overall Study|Adverse Event|11|||
129909244|NCT03764475|467630940|FG001|Overall Study|Adverse Event|2|||
129909245|NCT03764475|467630939|FG000|Overall Study|Lost to Follow-up|24|||
129909246|NCT03764475|467630940|FG001|Overall Study|Lost to Follow-up|10|||
129909247|NCT03764475|467630939|FG000|Overall Study|Withdrawal by Subject|26|||
129909248|NCT03764475|467630940|FG001|Overall Study|Withdrawal by Subject|10|||
129909249|NCT03764475|467630939|FG000|Overall Study|Lack of Efficacy|3|||
129909250|NCT03764475|467630940|FG001|Overall Study|Lack of Efficacy|0|||
129909251|NCT03764475|467630939|FG000|Overall Study|COVID-19 Disruption|2|||
129909252|NCT03764475|467630940|FG001|Overall Study|COVID-19 Disruption|0|||
129909253|NCT00390299|467630941|FG000|Overall Study|Cancellation|1|||
129909254|NCT00390299|467630942|FG001|Overall Study|Cancellation|0|||
129909255|NCT00390299|467630943|FG002|Overall Study|Cancellation|0|||
129909256|NCT00390299|467630944|FG003|Overall Study|Cancellation|0|||
129909257|NCT00390299|467630945|FG004|Overall Study|Cancellation|0|||
129909258|NCT00970359|467630946|FG000|Overall Study|Not Treated|4|||
129909259|NCT01565148|467630947|FG000|Overall Study|Withdrawal by Subject|1|||
129909260|NCT01565148|467630948|FG001|Overall Study|Withdrawal by Subject|1|||
129909261|NCT01565148|467630949|FG002|Overall Study|Withdrawal by Subject|1|||
129909262|NCT01565148|467630950|FG003|Overall Study|Withdrawal by Subject|2|||
129909263|NCT01565148|467630947|FG000|Overall Study|Lost to Follow-up|4|||
129909264|NCT01565148|467630948|FG001|Overall Study|Lost to Follow-up|4|||
129909265|NCT01565148|467630949|FG002|Overall Study|Lost to Follow-up|0|||
129909266|NCT01565148|467630950|FG003|Overall Study|Lost to Follow-up|3|||
129909267|NCT01565148|467630947|FG000|Overall Study|Rescue Therapy|8|||
129909268|NCT01565148|467630948|FG001|Overall Study|Rescue Therapy|5|||
129909269|NCT01565148|467630949|FG002|Overall Study|Rescue Therapy|5|||
129909270|NCT01565148|467630950|FG003|Overall Study|Rescue Therapy|8|||
129909271|NCT01565148|467630947|FG000|Overall Study|Death|0|||
129909272|NCT01565148|467630948|FG001|Overall Study|Death|0|||
129909273|NCT01565148|467630949|FG002|Overall Study|Death|1|||
129909274|NCT01565148|467630950|FG003|Overall Study|Death|0|||
129909275|NCT01565148|467630947|FG000|Overall Study|Physician Decision|2|||
129909276|NCT01565148|467630948|FG001|Overall Study|Physician Decision|5|||
129909277|NCT01565148|467630949|FG002|Overall Study|Physician Decision|0|||
129909278|NCT01565148|467630950|FG003|Overall Study|Physician Decision|0|||
129909279|NCT01061671|467630951|FG000|Overall Study|Withdrawal by Subject|16|||
129909280|NCT01061671|467630952|FG001|Overall Study|Withdrawal by Subject|20|||
129909281|NCT01061671|467630951|FG000|Overall Study|Lost to Follow-up|3|||
129909282|NCT01061671|467630952|FG001|Overall Study|Lost to Follow-up|5|||
129909283|NCT01061671|467630951|FG000|Overall Study|Death|28|||
129909284|NCT01061671|467630952|FG001|Overall Study|Death|30|||
129909285|NCT05368831|467630953|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
129909286|NCT01692730|467630961|FG000|Overall Study|Lost to Follow-up|225|||
129909287|NCT01692730|467630962|FG001|Overall Study|Lost to Follow-up|227|||
129909288|NCT01199575|467630963|FG000|Overall Study|Withdrawal by Subject|5|||
129909289|NCT01849055|467630964|FG000|Overall Study|Withdrawal by Subject|0|||
129909290|NCT01849055|467630965|FG001|Overall Study|Withdrawal by Subject|0|||
129909291|NCT01849055|467630966|FG002|Overall Study|Withdrawal by Subject|1|||
129909292|NCT01849055|467630967|FG003|Overall Study|Withdrawal by Subject|0|||
129909293|NCT01849055|467630968|FG004|Overall Study|Withdrawal by Subject|0|||
129909294|NCT01849055|467630969|FG005|Overall Study|Withdrawal by Subject|0|||
129909295|NCT01239316|467630974|FG000|Overall Study|Progression/Relapse|11|||
129909296|NCT01239316|467630974|FG000|Overall Study|Adverse Event|1|||
129909297|NCT00223795|467630975|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
129909298|NCT00223795|467630976|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
129909299|NCT00223795|467630975|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
129909300|NCT00223795|467630976|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
129909301|NCT02139943|467630977|FG000|Overall Study|Adverse Event|0|||
129909302|NCT02139943|467630978|FG001|Overall Study|Adverse Event|1|||
129909303|NCT02139943|467630979|FG002|Overall Study|Adverse Event|2|||
129909304|NCT02139943|467630977|FG000|Overall Study|Lost to Follow-up|3|||
129856867|NCT00782340|467435264|FG000|Open Label Titration|Withdrawal by Subject|5|||
129856868|NCT00782340|467435265|FG001|Open Label Titration|Withdrawal by Subject|0|||
129856869|NCT00782340|467435266|FG002|Open Label Titration|Withdrawal by Subject|0|||
129856870|NCT00782340|467435264|FG000|Open Label Titration|Enrollment capped|16|||
129856871|NCT00782340|467435265|FG001|Open Label Titration|Enrollment capped|0|||
129856872|NCT00782340|467435266|FG002|Open Label Titration|Enrollment capped|0|||
129856873|NCT00782340|467435264|FG000|Open Label Titration|Did not meet responder criteria|2|||
129856874|NCT00782340|467435265|FG001|Open Label Titration|Did not meet responder criteria|0|||
129856875|NCT00782340|467435266|FG002|Open Label Titration|Did not meet responder criteria|0|||
129856876|NCT00782340|467435264|FG000|Open Label Titration|Lost to Follow-up|5|||
129856877|NCT00782340|467435265|FG001|Open Label Titration|Lost to Follow-up|0|||
129856878|NCT00782340|467435266|FG002|Open Label Titration|Lost to Follow-up|0|||
129856879|NCT00782340|467435264|FG000|Open Label Titration|Randomized in error|6|||
129856880|NCT00782340|467435265|FG001|Open Label Titration|Randomized in error|0|||
129856881|NCT00782340|467435266|FG002|Open Label Titration|Randomized in error|0|||
129856882|NCT01568047|467435272|FG000|Overall Study|Ineligibility|1|||
129856883|NCT01568047|467435273|FG001|Overall Study|Ineligibility|0|||
129856884|NCT01568047|467435274|FG002|Overall Study|Ineligibility|0|||
129856885|NCT01568047|467435275|FG003|Overall Study|Ineligibility|0|||
129856886|NCT01568047|467435272|FG000|Overall Study|Withdrawal by Subject|0|||
129856887|NCT01568047|467435273|FG001|Overall Study|Withdrawal by Subject|1|||
129856888|NCT01568047|467435274|FG002|Overall Study|Withdrawal by Subject|0|||
129856889|NCT01568047|467435275|FG003|Overall Study|Withdrawal by Subject|0|||
129856890|NCT01568047|467435272|FG000|Overall Study|Adverse Event|0|||
129856891|NCT01568047|467435273|FG001|Overall Study|Adverse Event|0|||
129856892|NCT01568047|467435274|FG002|Overall Study|Adverse Event|1|||
129856893|NCT01568047|467435275|FG003|Overall Study|Adverse Event|1|||
129856894|NCT03359096|467435276|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
129856895|NCT03359096|467435277|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
129856896|NCT03359096|467435276|FG000|First Intervention (4 Weeks)|Death|1|||
129856897|NCT03359096|467435277|FG001|First Intervention (4 Weeks)|Death|0|||
129856898|NCT03359096|467435276|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
129856899|NCT03359096|467435277|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
129856900|NCT01944046|467435278|FG000|Randomized to DB|Adverse Event|5|||
129856901|NCT01944046|467435279|FG001|Randomized to DB|Adverse Event|2|||
129856902|NCT01944046|467435278|FG000|Randomized to DB|Clinical Worsening|3|||
129856903|NCT01944046|467435279|FG001|Randomized to DB|Clinical Worsening|2|||
129856904|NCT01944046|467435278|FG000|Randomized to DB|Lost to Follow-up|3|||
129856905|NCT01944046|467435279|FG001|Randomized to DB|Lost to Follow-up|3|||
129856906|NCT01944046|467435278|FG000|Randomized to DB|Withdrawal by Subject|2|||
129856907|NCT01944046|467435279|FG001|Randomized to DB|Withdrawal by Subject|4|||
129856908|NCT01944046|467435278|FG000|Randomized to DB|Physician Decision|1|||
129856909|NCT01944046|467435279|FG001|Randomized to DB|Physician Decision|2|||
129856910|NCT01944046|467435278|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
129856911|NCT01944046|467435279|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
129856912|NCT01944046|467435278|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
129856913|NCT01944046|467435279|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
129856914|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
129856915|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
129856916|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Adverse Event|6|||
129856917|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Adverse Event|1|||
129856918|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
129856919|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
129856920|NCT01944046|467435278|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
129856921|NCT01944046|467435279|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
129856922|NCT02007577|467435281|FG000|Overall Study|Adverse Event|1|||
129856923|NCT02007577|467435282|FG001|Overall Study|Adverse Event|0|||
129856924|NCT02007577|467435281|FG000|Overall Study|Withdrawal by Subject|0|||
129856925|NCT02007577|467435282|FG001|Overall Study|Withdrawal by Subject|1|||
129856926|NCT02504294|467435283|FG000|Overall Study|Adverse Event|15|||
129856927|NCT02504294|467435284|FG001|Overall Study|Adverse Event|12|||
129856928|NCT02504294|467435283|FG000|Overall Study|Withdrawal by Subject|7|||
129856929|NCT02504294|467435284|FG001|Overall Study|Withdrawal by Subject|1|||
129856930|NCT02504294|467435283|FG000|Overall Study|Protocol Violation|27|||
129856931|NCT02504294|467435284|FG001|Overall Study|Protocol Violation|26|||
129856932|NCT02504294|467435283|FG000|Overall Study|Physician Decision|1|||
129856933|NCT02504294|467435284|FG001|Overall Study|Physician Decision|2|||
129856934|NCT02504294|467435283|FG000|Overall Study|Lost to Follow-up|6|||
129856935|NCT02504294|467435284|FG001|Overall Study|Lost to Follow-up|7|||
129856936|NCT01953926|467435285|FG000|Overall Study|Withdrawal by Subject|23|||
129856937|NCT01953926|467435286|FG001|Overall Study|Withdrawal by Subject|3|||
129856938|NCT01953926|467435287|FG002|Overall Study|Withdrawal by Subject|3|||
129856939|NCT01953926|467435288|FG003|Overall Study|Withdrawal by Subject|5|||
129856940|NCT01953926|467435289|FG004|Overall Study|Withdrawal by Subject|6|||
129909305|NCT02139943|467630978|FG001|Overall Study|Lost to Follow-up|2|||
129909306|NCT02139943|467630979|FG002|Overall Study|Lost to Follow-up|2|||
129909307|NCT02139943|467630977|FG000|Overall Study|Withdrawal by Subject|4|||
129909308|NCT02139943|467630978|FG001|Overall Study|Withdrawal by Subject|3|||
129909309|NCT02139943|467630979|FG002|Overall Study|Withdrawal by Subject|0|||
129909310|NCT02139943|467630977|FG000|Overall Study|Other|0|||
129909311|NCT02139943|467630978|FG001|Overall Study|Other|0|||
129909312|NCT02139943|467630979|FG002|Overall Study|Other|1|||
129909313|NCT02139943|467630977|FG000|Overall Study|Participant wishes to discontinue|2|||
129909314|NCT02139943|467630978|FG001|Overall Study|Participant wishes to discontinue|0|||
129909315|NCT02139943|467630979|FG002|Overall Study|Participant wishes to discontinue|0|||
129909316|NCT02139943|467630977|FG000|Overall Study|Participant in Poor Compliance|1|||
129909317|NCT02139943|467630978|FG001|Overall Study|Participant in Poor Compliance|0|||
129909318|NCT02139943|467630979|FG002|Overall Study|Participant in Poor Compliance|1|||
129909319|NCT02139943|467630977|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
129909320|NCT02139943|467630978|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
129909321|NCT02139943|467630979|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
129909322|NCT03750968|467630982|FG000|Overall Study|Adverse Event|2|||
129909323|NCT03750968|467630983|FG001|Overall Study|Adverse Event|0|||
129909324|NCT03750968|467630982|FG000|Overall Study|Lost to Follow-up|1|||
129909325|NCT03750968|467630983|FG001|Overall Study|Lost to Follow-up|3|||
129909326|NCT00088413|467630985|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
129909327|NCT00088413|467630986|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
129909328|NCT00088413|467630987|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
129909329|NCT00088413|467630988|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
129909330|NCT00088413|467630985|FG000|Overall Study|Adverse Events/Side Effects|0|||
129909331|NCT00088413|467630986|FG001|Overall Study|Adverse Events/Side Effects|1|||
129909332|NCT00088413|467630987|FG002|Overall Study|Adverse Events/Side Effects|1|||
129909333|NCT00088413|467630988|FG003|Overall Study|Adverse Events/Side Effects|0|||
129909334|NCT00088413|467630985|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
129909335|NCT00088413|467630986|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
129909336|NCT00088413|467630987|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
129909337|NCT00088413|467630988|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
129909338|NCT00088413|467630985|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
129909339|NCT00088413|467630986|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
129909340|NCT00088413|467630987|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
129909341|NCT00088413|467630988|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
129909342|NCT00088413|467630985|FG000|Overall Study|Death|0|||
129909343|NCT00088413|467630986|FG001|Overall Study|Death|1|||
129909344|NCT00088413|467630987|FG002|Overall Study|Death|0|||
129909345|NCT00088413|467630988|FG003|Overall Study|Death|0|||
129909346|NCT00088413|467630985|FG000|Overall Study|Progressive disease|9|||
129909347|NCT00088413|467630986|FG001|Overall Study|Progressive disease|11|||
129909348|NCT00088413|467630987|FG002|Overall Study|Progressive disease|8|||
129909349|NCT00088413|467630988|FG003|Overall Study|Progressive disease|14|||
129909350|NCT00088413|467630985|FG000|Overall Study|Other|0|||
129909351|NCT00088413|467630986|FG001|Overall Study|Other|1|||
129909352|NCT00088413|467630987|FG002|Overall Study|Other|0|||
129909353|NCT00088413|467630988|FG003|Overall Study|Other|0|||
129909354|NCT00088413|467630985|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
129909355|NCT00088413|467630986|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
129856941|NCT01953926|467435290|FG005|Overall Study|Withdrawal by Subject|0|||
129856942|NCT01953926|467435291|FG006|Overall Study|Withdrawal by Subject|1|||
129856943|NCT01953926|467435285|FG000|Overall Study|Physician Decision|1|||
129856944|NCT01953926|467435286|FG001|Overall Study|Physician Decision|0|||
129856945|NCT01953926|467435287|FG002|Overall Study|Physician Decision|0|||
129856946|NCT01953926|467435288|FG003|Overall Study|Physician Decision|0|||
129856947|NCT01953926|467435289|FG004|Overall Study|Physician Decision|2|||
129909356|NCT00088413|467630987|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
129909357|NCT00088413|467630988|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
129909358|NCT00632424|467630991|FG000|Overall Study|Disease Progression|17|||
129909359|NCT00632424|467630991|FG000|Overall Study|Study Drug Toxicity|1|||
129856948|NCT01953926|467435290|FG005|Overall Study|Physician Decision|0|||
129909360|NCT02531113|467630992|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
129856949|NCT01953926|467435291|FG006|Overall Study|Physician Decision|0|||
129909361|NCT02531113|467630992|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
129856950|NCT01953926|467435285|FG000|Overall Study|Lost to Follow-up|18|||
129909362|NCT02531113|467630992|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
129909363|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
129909364|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
129909365|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
129909366|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
129909367|NCT02531113|467630992|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
129909368|NCT03807778|467630993|FG000|Overall Study|Adverse Event|0|||
129909369|NCT03807778|467630994|FG001|Overall Study|Adverse Event|0|||
129909370|NCT03807778|467630995|FG002|Overall Study|Adverse Event|3|||
129909371|NCT03807778|467630996|FG003|Overall Study|Adverse Event|5|||
129909372|NCT03807778|467630993|FG000|Overall Study|Progressive Disease|4|||
129909373|NCT03807778|467630994|FG001|Overall Study|Progressive Disease|2|||
129909374|NCT03807778|467630995|FG002|Overall Study|Progressive Disease|8|||
129909375|NCT03807778|467630996|FG003|Overall Study|Progressive Disease|15|||
129909376|NCT03807778|467630993|FG000|Overall Study|Symptomatic Deterioration|0|||
129909377|NCT03807778|467630994|FG001|Overall Study|Symptomatic Deterioration|1|||
129909378|NCT03807778|467630995|FG002|Overall Study|Symptomatic Deterioration|0|||
129909379|NCT03807778|467630996|FG003|Overall Study|Symptomatic Deterioration|1|||
129909380|NCT03807778|467630993|FG000|Overall Study|Withdrawal by Subject|0|||
129909381|NCT03807778|467630994|FG001|Overall Study|Withdrawal by Subject|1|||
129909382|NCT03807778|467630995|FG002|Overall Study|Withdrawal by Subject|0|||
129909383|NCT03807778|467630996|FG003|Overall Study|Withdrawal by Subject|1|||
129909384|NCT03807778|467630993|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
129909385|NCT03807778|467630994|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
129909386|NCT03807778|467630995|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
129909387|NCT03807778|467630996|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
129909388|NCT03422276|467632291|FG000|Overall Study|Withdrawal by Subject|21|||
129909389|NCT03422276|467632292|FG001|Overall Study|Withdrawal by Subject|25|||
129909390|NCT03422276|467632293|FG002|Overall Study|Withdrawal by Subject|14|||
129909391|NCT03422276|467632294|FG003|Overall Study|Withdrawal by Subject|16|||
129909392|NCT03422276|467632291|FG000|Overall Study|Death|14|||
129909393|NCT03422276|467632292|FG001|Overall Study|Death|21|||
129909394|NCT03422276|467632293|FG002|Overall Study|Death|3|||
129909395|NCT03422276|467632294|FG003|Overall Study|Death|1|||
129909396|NCT03422276|467632291|FG000|Overall Study|Discontinued, ineligible|4|||
129909397|NCT03422276|467632292|FG001|Overall Study|Discontinued, ineligible|3|||
129909398|NCT03422276|467632293|FG002|Overall Study|Discontinued, ineligible|0|||
129909399|NCT03422276|467632294|FG003|Overall Study|Discontinued, ineligible|0|||
129909400|NCT03422276|467632291|FG000|Overall Study|Lost to Follow-up|15|||
129909401|NCT03422276|467632292|FG001|Overall Study|Lost to Follow-up|8|||
129909402|NCT03422276|467632293|FG002|Overall Study|Lost to Follow-up|13|||
129909403|NCT03422276|467632294|FG003|Overall Study|Lost to Follow-up|4|||
129909404|NCT03422276|467632291|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
129909405|NCT03422276|467632292|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
129909406|NCT03422276|467632293|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
129909407|NCT03422276|467632294|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
129909408|NCT03422276|467632291|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
129909409|NCT03422276|467632292|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
129909410|NCT03422276|467632293|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
129909411|NCT03422276|467632294|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
129909412|NCT03422276|467632291|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
129909413|NCT03422276|467632292|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
129909414|NCT03422276|467632293|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
129909415|NCT03422276|467632294|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
129909416|NCT03422276|467632291|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
129909417|NCT03422276|467632292|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
129909418|NCT03422276|467632293|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
129909419|NCT03422276|467632294|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
129909420|NCT03422276|467632291|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
129909421|NCT03422276|467632292|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
129909422|NCT03422276|467632293|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
129909423|NCT03422276|467632294|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
129909424|NCT05938413|467632295|FG000|Overall Study|Lost to Follow-up|1|||
129909425|NCT05938413|467632296|FG001|Overall Study|Lost to Follow-up|7|||
129909426|NCT05938413|467632295|FG000|Overall Study|Withdrawal by Subject|1|||
129909427|NCT05938413|467632296|FG001|Overall Study|Withdrawal by Subject|1|||
129909428|NCT05644444|467632301|FG000|Tolerance Phase|Adverse Event|0|||
129909429|NCT05644444|467632302|FG001|Tolerance Phase|Adverse Event|2|||
129909430|NCT05644444|467632301|FG000|Treatment Phase|Adverse Event|0|||
129909431|NCT05644444|467632302|FG001|Treatment Phase|Adverse Event|2|||
129909432|NCT04817670|467632303|FG000|Overall Study|Withdrawal by Subject|1|||
129909433|NCT04817670|467632304|FG001|Overall Study|Withdrawal by Subject|0|||
129909434|NCT04817670|467632305|FG002|Overall Study|Withdrawal by Subject|0|||
129909435|NCT04817670|467632306|FG003|Overall Study|Withdrawal by Subject|0|||
129909436|NCT04817670|467632307|FG004|Overall Study|Withdrawal by Subject|0|||
129909437|NCT04817670|467632303|FG000|Overall Study|Lost to Follow-up|0|||
129909438|NCT04817670|467632304|FG001|Overall Study|Lost to Follow-up|0|||
129909439|NCT04817670|467632305|FG002|Overall Study|Lost to Follow-up|1|||
129909440|NCT04817670|467632306|FG003|Overall Study|Lost to Follow-up|0|||
129909441|NCT04817670|467632307|FG004|Overall Study|Lost to Follow-up|0|||
129909442|NCT03312907|467632308|FG000|Overall Study|Adverse Event|1|||
129909443|NCT03312907|467632309|FG001|Overall Study|Adverse Event|6|||
129909444|NCT03312907|467632310|FG002|Overall Study|Adverse Event|1|||
129909445|NCT03312907|467632308|FG000|Overall Study|Protocol Violation|2|||
129909446|NCT03312907|467632309|FG001|Overall Study|Protocol Violation|3|||
129909447|NCT03312907|467632310|FG002|Overall Study|Protocol Violation|4|||
129909448|NCT03312907|467632308|FG000|Overall Study|Lost to Follow-up|2|||
129909449|NCT03312907|467632309|FG001|Overall Study|Lost to Follow-up|3|||
129909450|NCT03312907|467632310|FG002|Overall Study|Lost to Follow-up|2|||
129856951|NCT01953926|467435286|FG001|Overall Study|Lost to Follow-up|3|||
129909451|NCT03312907|467632308|FG000|Overall Study|Physician Decision|3|||
129909452|NCT03312907|467632309|FG001|Overall Study|Physician Decision|4|||
129909453|NCT03312907|467632310|FG002|Overall Study|Physician Decision|2|||
129909454|NCT03312907|467632308|FG000|Overall Study|Withdrawal by Subject|9|||
129909455|NCT03312907|467632309|FG001|Overall Study|Withdrawal by Subject|14|||
129909456|NCT03312907|467632310|FG002|Overall Study|Withdrawal by Subject|10|||
129909457|NCT04723394|467632328|FG000|Overall Study|Adverse Event|0|||
129909458|NCT04723394|467632329|FG001|Overall Study|Adverse Event|3|||
129909459|NCT04723394|467632328|FG000|Overall Study|Death|8|||
129909460|NCT04723394|467632329|FG001|Overall Study|Death|8|||
129909461|NCT04723394|467632328|FG000|Overall Study|Lost to Follow-up|20|||
129856952|NCT01953926|467435287|FG002|Overall Study|Lost to Follow-up|0|||
129856953|NCT01953926|467435288|FG003|Overall Study|Lost to Follow-up|5|||
129856954|NCT01953926|467435289|FG004|Overall Study|Lost to Follow-up|3|||
129856955|NCT01953926|467435290|FG005|Overall Study|Lost to Follow-up|0|||
129856956|NCT01953926|467435291|FG006|Overall Study|Lost to Follow-up|0|||
129856957|NCT01953926|467435285|FG000|Overall Study|Protocol Violation|1|||
129856958|NCT01953926|467435286|FG001|Overall Study|Protocol Violation|0|||
129856959|NCT01953926|467435287|FG002|Overall Study|Protocol Violation|0|||
129856960|NCT01953926|467435288|FG003|Overall Study|Protocol Violation|0|||
129856961|NCT01953926|467435289|FG004|Overall Study|Protocol Violation|0|||
129856962|NCT01953926|467435290|FG005|Overall Study|Protocol Violation|0|||
129856963|NCT01953926|467435291|FG006|Overall Study|Protocol Violation|0|||
129856964|NCT01953926|467435285|FG000|Overall Study|Other, Disease progression|2|||
129856965|NCT01953926|467435286|FG001|Overall Study|Other, Disease progression|1|||
129856966|NCT01953926|467435287|FG002|Overall Study|Other, Disease progression|0|||
129856967|NCT01953926|467435288|FG003|Overall Study|Other, Disease progression|0|||
129856968|NCT01953926|467435289|FG004|Overall Study|Other, Disease progression|1|||
129856969|NCT01953926|467435290|FG005|Overall Study|Other, Disease progression|0|||
129856970|NCT01953926|467435291|FG006|Overall Study|Other, Disease progression|0|||
129856971|NCT01953926|467435285|FG000|Overall Study|Discontinuation of study by sponsor|41|||
129856972|NCT01953926|467435286|FG001|Overall Study|Discontinuation of study by sponsor|7|||
129856973|NCT01953926|467435287|FG002|Overall Study|Discontinuation of study by sponsor|5|||
129856974|NCT01953926|467435288|FG003|Overall Study|Discontinuation of study by sponsor|12|||
129856975|NCT01953926|467435289|FG004|Overall Study|Discontinuation of study by sponsor|46|||
129856976|NCT01953926|467435290|FG005|Overall Study|Discontinuation of study by sponsor|5|||
129856977|NCT01953926|467435291|FG006|Overall Study|Discontinuation of study by sponsor|6|||
129856978|NCT01953926|467435285|FG000|Overall Study|Not Treated|1|||
129856979|NCT01953926|467435286|FG001|Overall Study|Not Treated|0|||
129856980|NCT01953926|467435287|FG002|Overall Study|Not Treated|1|||
129909462|NCT04723394|467632329|FG001|Overall Study|Lost to Follow-up|17|||
129909463|NCT04723394|467632328|FG000|Overall Study|Physician Decision|1|||
129909464|NCT04723394|467632329|FG001|Overall Study|Physician Decision|0|||
129856981|NCT01953926|467435288|FG003|Overall Study|Not Treated|0|||
129856982|NCT01953926|467435289|FG004|Overall Study|Not Treated|0|||
129856983|NCT01953926|467435290|FG005|Overall Study|Not Treated|0|||
129856984|NCT01953926|467435291|FG006|Overall Study|Not Treated|0|||
129856985|NCT02338362|467435292|FG000|Overall Study|Withdrawal by Subject|1|||
129856986|NCT02338362|467435293|FG001|Overall Study|Withdrawal by Subject|1|||
129856987|NCT03585244|467435298|FG000|Overall Study|Withdrawal by Subject|15|||
129909465|NCT04723394|467632328|FG000|Overall Study|Withdrawal by Subject|20|||
129909466|NCT04723394|467632329|FG001|Overall Study|Withdrawal by Subject|34|||
129909467|NCT04723394|467632328|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
129909468|NCT04723394|467632329|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
129909469|NCT00774397|467632330|FG000|Overall Study|Adverse Event|1|||
129909470|NCT00774397|467632331|FG001|Overall Study|Adverse Event|3|||
129856988|NCT06281548|467435300|FG000|Overall Study|Lost to Follow-up|3|||
129856989|NCT03538626|467435302|FG000|Overall Study|Withdrawal by Subject|0|||
129856990|NCT03538626|467435303|FG001|Overall Study|Withdrawal by Subject|1|||
129856991|NCT03538626|467435304|FG002|Overall Study|Withdrawal by Subject|0|||
129856992|NCT03538626|467435305|FG003|Overall Study|Withdrawal by Subject|0|||
129856993|NCT03538626|467435306|FG004|Overall Study|Withdrawal by Subject|0|||
129856994|NCT03538626|467435307|FG005|Overall Study|Withdrawal by Subject|0|||
129856995|NCT03538626|467435308|FG006|Overall Study|Withdrawal by Subject|0|||
129856996|NCT03538626|467435309|FG007|Overall Study|Withdrawal by Subject|0|||
129856997|NCT03538626|467435302|FG000|Overall Study|Lost to Follow-up|0|||
129856998|NCT03538626|467435303|FG001|Overall Study|Lost to Follow-up|0|||
129856999|NCT03538626|467435304|FG002|Overall Study|Lost to Follow-up|0|||
129857000|NCT03538626|467435305|FG003|Overall Study|Lost to Follow-up|0|||
129857001|NCT03538626|467435306|FG004|Overall Study|Lost to Follow-up|0|||
129857002|NCT03538626|467435307|FG005|Overall Study|Lost to Follow-up|0|||
129857003|NCT03538626|467435308|FG006|Overall Study|Lost to Follow-up|1|||
129857004|NCT03538626|467435309|FG007|Overall Study|Lost to Follow-up|0|||
129857005|NCT00288587|467435310|FG000|Overall Study|Death|4|||
129857006|NCT00288587|467435311|FG001|Overall Study|Death|4|||
129857007|NCT00288587|467435310|FG000|Overall Study|Transplant|0|||
129857008|NCT00288587|467435311|FG001|Overall Study|Transplant|3|||
129857009|NCT00288587|467435310|FG000|Overall Study|Adverse Event|0|||
129857010|NCT00288587|467435311|FG001|Overall Study|Adverse Event|1|||
129857011|NCT00288587|467435310|FG000|Overall Study|Physician Decision|0|||
129857012|NCT00288587|467435311|FG001|Overall Study|Physician Decision|2|||
129857013|NCT00288587|467435310|FG000|Overall Study|Severe Aortic Stenosis|1|||
129857014|NCT00288587|467435311|FG001|Overall Study|Severe Aortic Stenosis|0|||
129857015|NCT01434602|467435316|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857016|NCT01434602|467435317|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
129857017|NCT01434602|467435318|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857018|NCT01434602|467435319|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857019|NCT01434602|467435320|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
129857020|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857021|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857022|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857023|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
129857024|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
129857025|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857026|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857027|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857028|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
129857029|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
129857030|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857031|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857032|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857033|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
129857034|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
129857035|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857036|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857037|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857038|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
129857039|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
129857040|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857041|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857042|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857043|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
129857044|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
129857045|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857046|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857047|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857048|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
129857049|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
129857050|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
129857051|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
129857052|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
129857053|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
129857054|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
129857055|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857056|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857057|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857058|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
129857059|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
129857060|NCT01434602|467435316|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857061|NCT01434602|467435317|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857062|NCT01434602|467435318|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857063|NCT01434602|467435319|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
129857064|NCT01434602|467435320|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
129857065|NCT01764945|467435326|FG000|Overall Study|Adverse Event|0|||
129857066|NCT01764945|467435327|FG001|Overall Study|Adverse Event|1|||
129857067|NCT01764945|467435328|FG002|Overall Study|Adverse Event|0|||
129857068|NCT01764945|467435329|FG003|Overall Study|Adverse Event|0|||
129857069|NCT01764945|467435330|FG004|Overall Study|Adverse Event|0|||
129857070|NCT01764945|467435331|FG005|Overall Study|Adverse Event|0|||
129857071|NCT01764945|467435332|FG006|Overall Study|Adverse Event|1|||
129857072|NCT01764945|467435333|FG007|Overall Study|Adverse Event|0|||
129857073|NCT05077267|467435335|FG000|Treatment Period|Lost to Follow-up|0|||
129857074|NCT05077267|467435336|FG001|Treatment Period|Lost to Follow-up|1|||
129857075|NCT05077267|467435337|FG002|Treatment Period|Lost to Follow-up|0|||
129857076|NCT05077267|467435335|FG000|Treatment Period|Withdrawal by Subject|0|||
129857077|NCT05077267|467435336|FG001|Treatment Period|Withdrawal by Subject|1|||
129857078|NCT05077267|467435337|FG002|Treatment Period|Withdrawal by Subject|0|||
129857079|NCT05077267|467435335|FG000|Follow-up Period|Lost to Follow-up|0|||
129857080|NCT05077267|467435336|FG001|Follow-up Period|Lost to Follow-up|5|||
129857081|NCT05077267|467435337|FG002|Follow-up Period|Lost to Follow-up|7|||
129857082|NCT05077267|467435335|FG000|Follow-up Period|Withdrawal by Subject|0|||
129857083|NCT05077267|467435336|FG001|Follow-up Period|Withdrawal by Subject|2|||
129857084|NCT05077267|467435337|FG002|Follow-up Period|Withdrawal by Subject|5|||
129857085|NCT05077267|467435335|FG000|Follow-up Period|Study terminated by sponsor|0|||
129857086|NCT05077267|467435336|FG001|Follow-up Period|Study terminated by sponsor|27|||
129857087|NCT05077267|467435337|FG002|Follow-up Period|Study terminated by sponsor|23|||
129857088|NCT05077267|467435335|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
129857089|NCT05077267|467435336|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
129857090|NCT05077267|467435337|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
129857091|NCT05077267|467435335|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
129857092|NCT05077267|467435336|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
129857093|NCT05077267|467435337|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
129857094|NCT02911948|467435338|FG000|Overall Study|Protocol Violation|0|||
129857095|NCT02911948|467435339|FG001|Overall Study|Protocol Violation|1|||
129857096|NCT02911948|467435338|FG000|Overall Study|Withdrawal by Subject|0|||
129857097|NCT02911948|467435339|FG001|Overall Study|Withdrawal by Subject|2|||
129857098|NCT02911948|467435338|FG000|Overall Study|Lack of Efficacy|0|||
129857099|NCT02911948|467435339|FG001|Overall Study|Lack of Efficacy|1|||
129857100|NCT02911948|467435338|FG000|Overall Study|Unclassified|0|||
129857101|NCT02911948|467435339|FG001|Overall Study|Unclassified|3|||
129857102|NCT00586105|467435340|FG000|Overall Study|Adverse Event|4|||
129857103|NCT00586105|467435340|FG000|Overall Study|Death|2|||
129857104|NCT00586105|467435340|FG000|Overall Study|Protocol Violation|1|||
129857105|NCT00586105|467435340|FG000|Overall Study|Withdrawal by Subject|3|||
129857106|NCT00586105|467435340|FG000|Overall Study|Disease progression|19|||
129857107|NCT00586105|467435340|FG000|Overall Study|Switched to commercial drug|9|||
129857108|NCT00586105|467435340|FG000|Overall Study|Reason not reported|1|||
129857109|NCT03835533|467435343|FG000|Overall Study|Death|5|||
129857110|NCT03835533|467435344|FG001|Overall Study|Death|10|||
129857111|NCT03835533|467435345|FG002|Overall Study|Death|9|||
129857112|NCT03835533|467435343|FG000|Overall Study|Withdrawal by Subject|2|||
129857113|NCT03835533|467435344|FG001|Overall Study|Withdrawal by Subject|2|||
129857114|NCT03835533|467435345|FG002|Overall Study|Withdrawal by Subject|2|||
129857115|NCT03835533|467435343|FG000|Overall Study|Lost to Follow-up|1|||
129857116|NCT03835533|467435344|FG001|Overall Study|Lost to Follow-up|0|||
129857117|NCT03835533|467435345|FG002|Overall Study|Lost to Follow-up|0|||
129857118|NCT01136291|467435346|FG000|Overall Study|Lost to Follow-up|1|||
129857119|NCT01136291|467435347|FG001|Overall Study|Lost to Follow-up|1|||
129857120|NCT02308033|467435355|FG000|Overall Study|Normal Gram stain at Baseline|13|||
129857121|NCT02308033|467435356|FG001|Overall Study|Normal Gram stain at Baseline|10|||
129857122|NCT02308033|467435355|FG000|Overall Study|Positive for STD at Baseline|7|||
129857123|NCT02308033|467435356|FG001|Overall Study|Positive for STD at Baseline|4|||
129857124|NCT02308033|467435355|FG000|Overall Study|Lost to Follow-up|6|||
129909471|NCT00774397|467632332|FG002|Overall Study|Adverse Event|16|||
129909472|NCT00774397|467632333|FG003|Overall Study|Adverse Event|8|||
129909473|NCT00774397|467632334|FG004|Overall Study|Adverse Event|8|||
129909474|NCT00774397|467632335|FG005|Overall Study|Adverse Event|3|||
129909475|NCT00774397|467632336|FG006|Overall Study|Adverse Event|16|||
129909476|NCT00774397|467632330|FG000|Overall Study|Lack of Efficacy|11|||
129909477|NCT00774397|467632331|FG001|Overall Study|Lack of Efficacy|4|||
129909478|NCT00774397|467632332|FG002|Overall Study|Lack of Efficacy|5|||
129909479|NCT00774397|467632333|FG003|Overall Study|Lack of Efficacy|3|||
129909480|NCT00774397|467632334|FG004|Overall Study|Lack of Efficacy|27|||
129909481|NCT00774397|467632335|FG005|Overall Study|Lack of Efficacy|15|||
129909482|NCT00774397|467632336|FG006|Overall Study|Lack of Efficacy|9|||
129909483|NCT00774397|467632330|FG000|Overall Study|Protocol Violation|0|||
129909484|NCT00774397|467632331|FG001|Overall Study|Protocol Violation|1|||
129909485|NCT00774397|467632332|FG002|Overall Study|Protocol Violation|3|||
129909486|NCT00774397|467632333|FG003|Overall Study|Protocol Violation|1|||
129909487|NCT00774397|467632334|FG004|Overall Study|Protocol Violation|2|||
129909488|NCT00774397|467632335|FG005|Overall Study|Protocol Violation|1|||
129909489|NCT00774397|467632336|FG006|Overall Study|Protocol Violation|0|||
129909490|NCT00774397|467632330|FG000|Overall Study|Lost to Follow-up|0|||
129909491|NCT00774397|467632331|FG001|Overall Study|Lost to Follow-up|1|||
129909492|NCT00774397|467632332|FG002|Overall Study|Lost to Follow-up|1|||
129909493|NCT00774397|467632333|FG003|Overall Study|Lost to Follow-up|1|||
129909494|NCT00774397|467632334|FG004|Overall Study|Lost to Follow-up|0|||
129909495|NCT00774397|467632335|FG005|Overall Study|Lost to Follow-up|1|||
129909496|NCT00774397|467632336|FG006|Overall Study|Lost to Follow-up|0|||
129857125|NCT02308033|467435356|FG001|Overall Study|Lost to Follow-up|5|||
129857126|NCT01337245|467435357|FG000|Overall Study|Lost to Follow-up|1|||
129857127|NCT00364858|467435362|FG000|Overall Study|Adverse Event|1|||
129857128|NCT00364858|467435363|FG001|Overall Study|Adverse Event|5|||
129857129|NCT00364858|467435362|FG000|Overall Study|Withdrawal by Subject|1|||
129857130|NCT00364858|467435363|FG001|Overall Study|Withdrawal by Subject|1|||
129857131|NCT00364858|467435362|FG000|Overall Study|Pregnancy|1|||
129857132|NCT00364858|467435363|FG001|Overall Study|Pregnancy|1|||
129857133|NCT00364858|467435362|FG000|Overall Study|Clinical failure|2|||
129857134|NCT00364858|467435363|FG001|Overall Study|Clinical failure|13|||
129857135|NCT00364858|467435362|FG000|Overall Study|Discontinuation at baseline|1|||
129857136|NCT00364858|467435363|FG001|Overall Study|Discontinuation at baseline|0|||
129857137|NCT00364858|467435362|FG000|Overall Study|Non-compliant|1|||
129857138|NCT00364858|467435363|FG001|Overall Study|Non-compliant|0|||
129857139|NCT00364858|467435362|FG000|Overall Study|Return to Q2 regimen|0|||
129857140|NCT00364858|467435363|FG001|Overall Study|Return to Q2 regimen|1|||
129857141|NCT00364858|467435362|FG000|Overall Study|Clinical baseline issue|0|||
129857142|NCT00364858|467435363|FG001|Overall Study|Clinical baseline issue|1|||
129857143|NCT01307501|467435364|FG000|Overall Study|Treatment Failure|1|||
129857144|NCT01307501|467435364|FG000|Overall Study|Death|20|||
129857145|NCT01307501|467435364|FG000|Overall Study|Lost to Follow-up|1|||
129857146|NCT01307501|467435364|FG000|Overall Study|Starting Hospice|1|||
129857147|NCT00558285|467435365|FG000|Overall Study|Adverse Event|1|||
129857148|NCT00558285|467435366|FG001|Overall Study|Adverse Event|1|||
129857149|NCT00558285|467435367|FG002|Overall Study|Adverse Event|4|||
129857150|NCT00558285|467435368|FG003|Overall Study|Adverse Event|1|||
129857151|NCT00558285|467435369|FG004|Overall Study|Adverse Event|2|||
129857152|NCT00558285|467435365|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129857153|NCT00558285|467435366|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129857154|NCT00558285|467435367|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129909497|NCT00774397|467632330|FG000|Overall Study|Refused to continue trial medication|1|||
129909498|NCT00774397|467632331|FG001|Overall Study|Refused to continue trial medication|3|||
129909499|NCT00774397|467632332|FG002|Overall Study|Refused to continue trial medication|2|||
129909500|NCT00774397|467632333|FG003|Overall Study|Refused to continue trial medication|2|||
129909501|NCT00774397|467632334|FG004|Overall Study|Refused to continue trial medication|6|||
129857155|NCT00558285|467435368|FG003|Overall Study|Abnormal test procedure result(s)|0|||
129857156|NCT00558285|467435369|FG004|Overall Study|Abnormal test procedure result(s)|0|||
129857157|NCT00558285|467435365|FG000|Overall Study|Subject withdrew consent|2|||
129857158|NCT00558285|467435366|FG001|Overall Study|Subject withdrew consent|0|||
129857159|NCT00558285|467435367|FG002|Overall Study|Subject withdrew consent|1|||
129857160|NCT00558285|467435368|FG003|Overall Study|Subject withdrew consent|1|||
129857161|NCT00558285|467435369|FG004|Overall Study|Subject withdrew consent|1|||
129857162|NCT00558285|467435365|FG000|Overall Study|Lost to Follow-up|1|||
129909502|NCT00774397|467632335|FG005|Overall Study|Refused to continue trial medication|2|||
129857163|NCT00558285|467435366|FG001|Overall Study|Lost to Follow-up|1|||
129909503|NCT00774397|467632336|FG006|Overall Study|Refused to continue trial medication|3|||
129909504|NCT00774397|467632330|FG000|Overall Study|Not treated|0|||
129909505|NCT00774397|467632331|FG001|Overall Study|Not treated|0|||
129909506|NCT00774397|467632332|FG002|Overall Study|Not treated|0|||
129909507|NCT00774397|467632333|FG003|Overall Study|Not treated|0|||
129909508|NCT00774397|467632334|FG004|Overall Study|Not treated|1|||
129909509|NCT00774397|467632335|FG005|Overall Study|Not treated|0|||
129857164|NCT00558285|467435367|FG002|Overall Study|Lost to Follow-up|0|||
129857165|NCT00558285|467435368|FG003|Overall Study|Lost to Follow-up|0|||
129857166|NCT00558285|467435369|FG004|Overall Study|Lost to Follow-up|0|||
129857167|NCT00558285|467435365|FG000|Overall Study|Administrative problems|0|||
129857168|NCT00558285|467435366|FG001|Overall Study|Administrative problems|0|||
129857169|NCT00558285|467435367|FG002|Overall Study|Administrative problems|0|||
129857170|NCT00558285|467435368|FG003|Overall Study|Administrative problems|1|||
129857171|NCT00558285|467435369|FG004|Overall Study|Administrative problems|1|||
129857172|NCT00558285|467435365|FG000|Overall Study|Protocol deviation|1|||
129857173|NCT00558285|467435366|FG001|Overall Study|Protocol deviation|1|||
129857174|NCT00558285|467435367|FG002|Overall Study|Protocol deviation|0|||
129857175|NCT00558285|467435368|FG003|Overall Study|Protocol deviation|1|||
129857176|NCT00558285|467435369|FG004|Overall Study|Protocol deviation|0|||
129857177|NCT02730819|467435370|FG000|Overall Study|Lost to Follow-up|9|||
129857178|NCT02121847|467435371|FG000|Overall Study|Administrative Reasons|1|||
129857179|NCT02121847|467435371|FG000|Overall Study|Adverse Event|2|||
129857180|NCT01660906|467435373|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
129857181|NCT03478891|467435374|FG000|Overall Study|Enrolled, but product never administered|0|||
129857182|NCT03478891|467435375|FG001|Overall Study|Enrolled, but product never administered|0|||
129857183|NCT03478891|467435376|FG002|Overall Study|Enrolled, but product never administered|1|||
129857184|NCT03478891|467435374|FG000|Overall Study|Moved from area|0|||
129857185|NCT03478891|467435375|FG001|Overall Study|Moved from area|0|||
129857186|NCT03478891|467435376|FG002|Overall Study|Moved from area|1|||
129857187|NCT03478891|467435374|FG000|Overall Study|Lost to Follow-up|1|||
129857188|NCT03478891|467435375|FG001|Overall Study|Lost to Follow-up|0|||
129857189|NCT03478891|467435376|FG002|Overall Study|Lost to Follow-up|1|||
129857190|NCT00809757|467435378|FG000|Overall Study|Adverse Event|2|||
129857191|NCT00809757|467435379|FG001|Overall Study|Adverse Event|3|||
129857192|NCT00809757|467435380|FG002|Overall Study|Adverse Event|3|||
129857193|NCT00809757|467435378|FG000|Overall Study|Lost to Follow-up|0|||
129857194|NCT00809757|467435379|FG001|Overall Study|Lost to Follow-up|0|||
129857195|NCT00809757|467435380|FG002|Overall Study|Lost to Follow-up|1|||
129857196|NCT00809757|467435378|FG000|Overall Study|Protocol Violation|1|||
129857197|NCT00809757|467435379|FG001|Overall Study|Protocol Violation|1|||
129857198|NCT00809757|467435380|FG002|Overall Study|Protocol Violation|1|||
129857199|NCT00809757|467435378|FG000|Overall Study|Withdrawal by Subject|2|||
129857200|NCT00809757|467435379|FG001|Overall Study|Withdrawal by Subject|1|||
129857201|NCT00809757|467435380|FG002|Overall Study|Withdrawal by Subject|3|||
129857202|NCT00809757|467435378|FG000|Overall Study|Subject Uncooperative|1|||
129857203|NCT00809757|467435379|FG001|Overall Study|Subject Uncooperative|0|||
129857204|NCT00809757|467435380|FG002|Overall Study|Subject Uncooperative|2|||
129857205|NCT00809757|467435378|FG000|Overall Study|Noncompliance with Medication|0|||
129857206|NCT00809757|467435379|FG001|Overall Study|Noncompliance with Medication|0|||
129857207|NCT00809757|467435380|FG002|Overall Study|Noncompliance with Medication|1|||
129857208|NCT00253864|467435381|FG000|Overall Study|Lost to Follow-up|5|||
129857209|NCT00253864|467435382|FG001|Overall Study|Lost to Follow-up|8|||
129857210|NCT01410448|467435386|FG000|Overall Study|No conversion to everolimus|0|||
129857211|NCT01410448|467435387|FG001|Overall Study|No conversion to everolimus|24|||
129857212|NCT01410448|467435386|FG000|Overall Study|Graft loss|4|||
129857213|NCT01410448|467435387|FG001|Overall Study|Graft loss|1|||
129857214|NCT01410448|467435386|FG000|Overall Study|Administrative issues|2|||
129857215|NCT01410448|467435387|FG001|Overall Study|Administrative issues|1|||
129857216|NCT01410448|467435386|FG000|Overall Study|Lost to Follow-up|1|||
129857217|NCT01410448|467435387|FG001|Overall Study|Lost to Follow-up|0|||
129857218|NCT01410448|467435386|FG000|Overall Study|Withdrawal by Subject|3|||
129857219|NCT01410448|467435387|FG001|Overall Study|Withdrawal by Subject|2|||
129857220|NCT01410448|467435386|FG000|Overall Study|Protocol Violation|0|||
129857221|NCT01410448|467435387|FG001|Overall Study|Protocol Violation|4|||
129857222|NCT01410448|467435386|FG000|Overall Study|Death|2|||
129857223|NCT01410448|467435387|FG001|Overall Study|Death|3|||
129857224|NCT00360529|467435388|FG000|Overall Study|Adverse Event|10|||
129857225|NCT00360529|467435389|FG001|Overall Study|Adverse Event|23|||
129857226|NCT00360529|467435390|FG002|Overall Study|Adverse Event|33|||
129857227|NCT00360529|467435388|FG000|Overall Study|Protocol Violation|3|||
129857228|NCT00360529|467435389|FG001|Overall Study|Protocol Violation|3|||
129857229|NCT00360529|467435390|FG002|Overall Study|Protocol Violation|11|||
129857230|NCT00360529|467435388|FG000|Overall Study|Lost to Follow-up|14|||
129857231|NCT00360529|467435389|FG001|Overall Study|Lost to Follow-up|10|||
129857232|NCT00360529|467435390|FG002|Overall Study|Lost to Follow-up|13|||
129857233|NCT00360529|467435388|FG000|Overall Study|Withdrawal by Subject|22|||
129857234|NCT00360529|467435389|FG001|Overall Study|Withdrawal by Subject|14|||
129857235|NCT00360529|467435390|FG002|Overall Study|Withdrawal by Subject|18|||
129909510|NCT00774397|467632336|FG006|Overall Study|Not treated|1|||
129857236|NCT00360529|467435388|FG000|Overall Study|Lack of Efficacy|8|||
129857237|NCT00360529|467435389|FG001|Overall Study|Lack of Efficacy|6|||
129857238|NCT00360529|467435390|FG002|Overall Study|Lack of Efficacy|5|||
129857239|NCT00360529|467435388|FG000|Overall Study|Reason discontinued not explained above|4|||
129857240|NCT00360529|467435389|FG001|Overall Study|Reason discontinued not explained above|9|||
129857241|NCT00360529|467435390|FG002|Overall Study|Reason discontinued not explained above|11|||
129857242|NCT03712917|467435391|FG000|Overall Study|Pregnancy|0|||
129857243|NCT03712917|467435392|FG001|Overall Study|Pregnancy|0|||
129857244|NCT03712917|467435393|FG002|Overall Study|Pregnancy|1|||
129857245|NCT03712917|467435391|FG000|Overall Study|Adverse Event|0|||
129857246|NCT03712917|467435392|FG001|Overall Study|Adverse Event|4|||
129857247|NCT03712917|467435393|FG002|Overall Study|Adverse Event|3|||
129857248|NCT03712917|467435391|FG000|Overall Study|Lost to Follow-up|9|||
129857249|NCT03712917|467435392|FG001|Overall Study|Lost to Follow-up|4|||
129857250|NCT03712917|467435393|FG002|Overall Study|Lost to Follow-up|5|||
129857251|NCT01218438|467435394|FG000|Epoch 1|Physician Decision|2|||
129857252|NCT01218438|467435394|FG000|Epoch 1|Adverse Event|1|||
129857253|NCT01218438|467435394|FG000|Epoch 3|Withdrawal by Subject|3|||
129857254|NCT01218438|467435394|FG000|Epoch 3|Adverse Event|1|||
129857255|NCT01218438|467435394|FG000|Epoch 4|Physician Decision|1|||
129857256|NCT01218438|467435394|FG000|Epoch 4|Withdrawal by Subject|2|||
129857257|NCT02091167|467435396|FG000|Overall Study|Lost to Follow-up|0|||
129857258|NCT02091167|467435397|FG001|Overall Study|Lost to Follow-up|2|||
129857259|NCT03096782|467435398|FG000|Overall Study|Death|1|||
129857260|NCT03096782|467435398|FG000|Overall Study|Participant Relapsed|1|||
129857261|NCT03662750|467435399|FG000|Overall Study|Withdrawal by Subject|1|||
129857262|NCT00932893|467435406|FG000|Overall Study|Death|115|||
129857263|NCT00932893|467435407|FG001|Overall Study|Death|24|||
129857264|NCT00932893|467435406|FG000|Overall Study|Lost to Follow-up|8|||
129857265|NCT00932893|467435407|FG001|Overall Study|Lost to Follow-up|0|||
129857266|NCT00932893|467435406|FG000|Overall Study|Withdrawal by Subject|5|||
129857267|NCT00932893|467435407|FG001|Overall Study|Withdrawal by Subject|2|||
129857268|NCT00932893|467435406|FG000|Overall Study|Other|5|||
129857269|NCT00932893|467435407|FG001|Overall Study|Other|144|||
129857270|NCT00993447|467437012|FG000|Overall Study|Withdrawal by Subject|23|||
129857271|NCT00993447|467437013|FG001|Overall Study|Withdrawal by Subject|8|||
129857272|NCT00993447|467437012|FG000|Overall Study|Protocol Violation|12|||
129857273|NCT00993447|467437013|FG001|Overall Study|Protocol Violation|8|||
129857274|NCT00993447|467437012|FG000|Overall Study|Lost to Follow-up|1|||
129857275|NCT00993447|467437013|FG001|Overall Study|Lost to Follow-up|3|||
129857276|NCT00993447|467437012|FG000|Overall Study|Adverse Event|1|||
129857277|NCT00993447|467437013|FG001|Overall Study|Adverse Event|0|||
129857278|NCT00970502|467437015|FG000|Overall Study|Withdrawal by Subject|1|||
129857279|NCT03811912|467437016|FG000|Overall Study|Withdrew Consent|4|||
129857280|NCT03811912|467437017|FG001|Overall Study|Withdrew Consent|2|||
129857281|NCT01438411|467437018|FG000|Overall Study|Adverse Event|8|||
129857282|NCT01438411|467437018|FG000|Overall Study|Lost to Follow-up|1|||
129857283|NCT01438411|467437018|FG000|Overall Study|Lack of Efficacy|1|||
129857284|NCT01438411|467437018|FG000|Overall Study|Withdrawal by Subject|3|||
129857285|NCT01863680|467437019|FG000|Overall Study|Adverse Event|17|||
129857286|NCT01863680|467437019|FG000|Overall Study|Risk of OHSS|17|||
129857287|NCT01863680|467437019|FG000|Overall Study|Spontaneous pregnancy|2|||
129857288|NCT01863680|467437019|FG000|Overall Study|Withdrawal by Subject|1|||
129857289|NCT01863680|467437019|FG000|Overall Study|Did not undergo IVF/ET|14|||
129857290|NCT01863680|467437019|FG000|Overall Study|Other|6|||
129857291|NCT00618514|467437020|FG000|Overall Study|Lost to Follow-up|11|||
129857292|NCT00618514|467437021|FG001|Overall Study|Lost to Follow-up|12|||
129857293|NCT00618514|467437022|FG002|Overall Study|Lost to Follow-up|4|||
129857294|NCT00566228|467437023|FG000|Overall Study|Withdrawal by Subject|1|||
129857295|NCT00566228|467437024|FG001|Overall Study|Withdrawal by Subject|0|||
129857296|NCT00566228|467437023|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
129857297|NCT00566228|467437024|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
129857298|NCT00566228|467437023|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
129857299|NCT00566228|467437024|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
129857300|NCT00566228|467437023|FG000|Overall Study|progressed before infusion could occur|0|||
129857301|NCT00566228|467437024|FG001|Overall Study|progressed before infusion could occur|1|||
129857302|NCT02053350|467437025|FG000|Overall Study|Withdrawal by Subject|1|||
129857303|NCT02053350|467437025|FG000|Overall Study|Adverse Event|4|||
129857304|NCT02244944|467437026|FG000|Overall Study|Withdrawal by Subject|1|||
129857305|NCT02244944|467437026|FG000|Overall Study|Study Terminated|1|||
129857306|NCT02367911|467437031|FG000|Overall Study|Withdrawal by Subject|3|||
129857307|NCT02367911|467437032|FG001|Overall Study|Withdrawal by Subject|2|||
129857308|NCT02367911|467437031|FG000|Overall Study|Lost to Follow-up|2|||
129857309|NCT02367911|467437032|FG001|Overall Study|Lost to Follow-up|2|||
129857310|NCT00902304|467437033|FG000|Overall Study|Adverse Event|4|||
129857311|NCT00902304|467437034|FG001|Overall Study|Adverse Event|10|||
129857312|NCT00902304|467437035|FG002|Overall Study|Adverse Event|25|||
129857313|NCT00902304|467437033|FG000|Overall Study|Investigator discretion|3|||
129857314|NCT00902304|467437034|FG001|Overall Study|Investigator discretion|5|||
129857315|NCT00902304|467437035|FG002|Overall Study|Investigator discretion|13|||
129857316|NCT00902304|467437033|FG000|Overall Study|Lost to Follow-up|7|||
129857317|NCT00902304|467437034|FG001|Overall Study|Lost to Follow-up|7|||
129857318|NCT00902304|467437035|FG002|Overall Study|Lost to Follow-up|7|||
129857319|NCT00902304|467437033|FG000|Overall Study|Protocol Violation|9|||
129909511|NCT00774397|467632330|FG000|Overall Study|Other than those stated above|1|||
129909512|NCT00774397|467632331|FG001|Overall Study|Other than those stated above|1|||
129909513|NCT00774397|467632332|FG002|Overall Study|Other than those stated above|3|||
129909514|NCT00774397|467632333|FG003|Overall Study|Other than those stated above|2|||
129909515|NCT00774397|467632334|FG004|Overall Study|Other than those stated above|2|||
129909516|NCT00774397|467632335|FG005|Overall Study|Other than those stated above|0|||
129909517|NCT00774397|467632336|FG006|Overall Study|Other than those stated above|1|||
129909518|NCT02765100|467632340|FG000|Overall Study|subject found ineligible after baseline|1|||
129857320|NCT00902304|467437034|FG001|Overall Study|Protocol Violation|18|||
129857321|NCT00902304|467437035|FG002|Overall Study|Protocol Violation|20|||
129857322|NCT00902304|467437033|FG000|Overall Study|Withdrawal by Subject|32|||
129857323|NCT00902304|467437034|FG001|Overall Study|Withdrawal by Subject|22|||
129857324|NCT00902304|467437035|FG002|Overall Study|Withdrawal by Subject|43|||
129857325|NCT00902304|467437033|FG000|Overall Study|includes pregnancy|3|||
129857326|NCT00902304|467437034|FG001|Overall Study|includes pregnancy|9|||
129857327|NCT00902304|467437035|FG002|Overall Study|includes pregnancy|2|||
129857328|NCT04579757|467437036|FG000|Overall Study|Adverse Event|0|||
129857329|NCT04579757|467437037|FG001|Overall Study|Adverse Event|0|||
129857330|NCT04579757|467437038|FG002|Overall Study|Adverse Event|0|||
129857331|NCT04579757|467437039|FG003|Overall Study|Adverse Event|2|||
129857332|NCT04579757|467437040|FG004|Overall Study|Adverse Event|1|||
129857333|NCT04579757|467437041|FG005|Overall Study|Adverse Event|1|||
129857334|NCT04579757|467437042|FG006|Overall Study|Adverse Event|0|||
129857335|NCT04579757|467437043|FG007|Overall Study|Adverse Event|0|||
129857336|NCT04579757|467437044|FG008|Overall Study|Adverse Event|0|||
129857337|NCT04579757|467437036|FG000|Overall Study|Death|4|||
129857338|NCT04579757|467437037|FG001|Overall Study|Death|1|||
129857339|NCT04579757|467437038|FG002|Overall Study|Death|14|||
129857340|NCT04579757|467437039|FG003|Overall Study|Death|3|||
129857341|NCT04579757|467437040|FG004|Overall Study|Death|2|||
129857342|NCT04579757|467437041|FG005|Overall Study|Death|7|||
129857343|NCT04579757|467437042|FG006|Overall Study|Death|0|||
129857344|NCT04579757|467437043|FG007|Overall Study|Death|1|||
129857345|NCT04579757|467437044|FG008|Overall Study|Death|3|||
129857346|NCT04579757|467437036|FG000|Overall Study|Physician Decision|0|||
129857347|NCT04579757|467437037|FG001|Overall Study|Physician Decision|0|||
129857348|NCT04579757|467437038|FG002|Overall Study|Physician Decision|0|||
129857349|NCT04579757|467437039|FG003|Overall Study|Physician Decision|2|||
129857350|NCT04579757|467437040|FG004|Overall Study|Physician Decision|1|||
129857351|NCT04579757|467437041|FG005|Overall Study|Physician Decision|1|||
129857352|NCT04579757|467437042|FG006|Overall Study|Physician Decision|1|||
129857353|NCT04579757|467437043|FG007|Overall Study|Physician Decision|0|||
129857354|NCT04579757|467437044|FG008|Overall Study|Physician Decision|0|||
129857355|NCT04579757|467437036|FG000|Overall Study|Study Terminated By Sponsor|0|||
129857356|NCT04579757|467437037|FG001|Overall Study|Study Terminated By Sponsor|0|||
129857357|NCT04579757|467437038|FG002|Overall Study|Study Terminated By Sponsor|0|||
129857358|NCT04579757|467437039|FG003|Overall Study|Study Terminated By Sponsor|0|||
129857359|NCT04579757|467437040|FG004|Overall Study|Study Terminated By Sponsor|2|||
129857360|NCT04579757|467437041|FG005|Overall Study|Study Terminated By Sponsor|0|||
129857361|NCT04579757|467437042|FG006|Overall Study|Study Terminated By Sponsor|0|||
129857362|NCT04579757|467437043|FG007|Overall Study|Study Terminated By Sponsor|2|||
129857363|NCT04579757|467437044|FG008|Overall Study|Study Terminated By Sponsor|0|||
129857364|NCT04579757|467437036|FG000|Overall Study|Withdrawal by Subject|1|||
129857365|NCT04579757|467437037|FG001|Overall Study|Withdrawal by Subject|1|||
129857366|NCT04579757|467437038|FG002|Overall Study|Withdrawal by Subject|0|||
129857367|NCT04579757|467437039|FG003|Overall Study|Withdrawal by Subject|0|||
129857368|NCT04579757|467437040|FG004|Overall Study|Withdrawal by Subject|2|||
129857369|NCT04579757|467437041|FG005|Overall Study|Withdrawal by Subject|1|||
129909519|NCT02765100|467632341|FG001|Overall Study|subject found ineligible after baseline|1|||
129857370|NCT04579757|467437042|FG006|Overall Study|Withdrawal by Subject|0|||
129857371|NCT04579757|467437043|FG007|Overall Study|Withdrawal by Subject|3|||
129857372|NCT04579757|467437044|FG008|Overall Study|Withdrawal by Subject|0|||
129857373|NCT04579757|467437036|FG000|Overall Study|Radiological or Clinical PD|1|||
129909520|NCT02765100|467632340|FG000|Overall Study|Lost to Follow-up|0|||
129909521|NCT02765100|467632341|FG001|Overall Study|Lost to Follow-up|1|||
129857374|NCT04579757|467437037|FG001|Overall Study|Radiological or Clinical PD|4|||
129857375|NCT04579757|467437038|FG002|Overall Study|Radiological or Clinical PD|1|||
129857376|NCT04579757|467437039|FG003|Overall Study|Radiological or Clinical PD|3|||
129857377|NCT04579757|467437040|FG004|Overall Study|Radiological or Clinical PD|9|||
129857378|NCT04579757|467437041|FG005|Overall Study|Radiological or Clinical PD|4|||
129857379|NCT04579757|467437042|FG006|Overall Study|Radiological or Clinical PD|2|||
129857380|NCT04579757|467437043|FG007|Overall Study|Radiological or Clinical PD|2|||
129857381|NCT04579757|467437044|FG008|Overall Study|Radiological or Clinical PD|0|||
129857382|NCT04579757|467437036|FG000|Overall Study|Start of New Therapy|0|||
129857383|NCT04579757|467437037|FG001|Overall Study|Start of New Therapy|0|||
129857384|NCT04579757|467437038|FG002|Overall Study|Start of New Therapy|0|||
129857385|NCT04579757|467437039|FG003|Overall Study|Start of New Therapy|0|||
129857386|NCT04579757|467437040|FG004|Overall Study|Start of New Therapy|2|||
129857387|NCT04579757|467437041|FG005|Overall Study|Start of New Therapy|1|||
129857388|NCT04579757|467437042|FG006|Overall Study|Start of New Therapy|0|||
129857389|NCT04579757|467437043|FG007|Overall Study|Start of New Therapy|0|||
129857390|NCT04579757|467437044|FG008|Overall Study|Start of New Therapy|0|||
129857391|NCT05706506|467437045|FG000|Overall Study|Adverse Event|1|||
129857392|NCT05706506|467437045|FG000|Overall Study|Withdrawal by Subject|4|||
129857393|NCT05706506|467437045|FG000|Overall Study|Lost to Follow-up|2|||
129857394|NCT05706506|467437045|FG000|Overall Study|Inadvertent Enrolment|12|||
129857395|NCT05706506|467437045|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
129857396|NCT05706506|467437045|FG000|Overall Study|Participant Moved Out of State|1|||
129857397|NCT05732454|467437046|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
129857398|NCT05732454|467437047|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
129857399|NCT05732454|467437046|FG000|Part 1: DB Period|Adverse Event|1|||
129857400|NCT05732454|467437047|FG001|Part 1: DB Period|Adverse Event|0|||
129857401|NCT05732454|467437046|FG000|Part 1: DB Period|Lost to Follow-up|1|||
129857402|NCT05732454|467437047|FG001|Part 1: DB Period|Lost to Follow-up|0|||
129857403|NCT05732454|467437046|FG000|Part 1: DB Period|Protocol Violation|0|||
129857404|NCT05732454|467437047|FG001|Part 1: DB Period|Protocol Violation|1|||
129857405|NCT05732454|467437046|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
129857406|NCT05732454|467437047|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
129857407|NCT05732454|467437046|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
129857408|NCT05732454|467437047|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
129857409|NCT05732454|467437046|FG000|Part 1: OLE Period|Adverse Event|0|||
129857410|NCT05732454|467437047|FG001|Part 1: OLE Period|Adverse Event|1|||
129857411|NCT05732454|467437046|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
129857412|NCT05732454|467437047|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
129857413|NCT01153633|467437048|FG000|Overall Study|Protocol Violation|1|||
129857414|NCT01153633|467437049|FG001|Overall Study|Protocol Violation|1|||
129857415|NCT01153633|467437048|FG000|Overall Study|Therapeutic failure|3|||
129857416|NCT01153633|467437049|FG001|Overall Study|Therapeutic failure|3|||
129857417|NCT00384085|467437050|FG000|Overall Study|Adverse Event|5|||
129857418|NCT00384085|467437051|FG001|Overall Study|Adverse Event|5|||
129857419|NCT00384085|467437052|FG002|Overall Study|Adverse Event|4|||
129857420|NCT00384085|467437050|FG000|Overall Study|Lack of Efficacy|0|||
129857421|NCT00384085|467437051|FG001|Overall Study|Lack of Efficacy|3|||
129857422|NCT00384085|467437052|FG002|Overall Study|Lack of Efficacy|2|||
129857423|NCT00384085|467437050|FG000|Overall Study|No longer Requires Study Treatment|1|||
129857424|NCT00384085|467437051|FG001|Overall Study|No longer Requires Study Treatment|0|||
129857425|NCT00384085|467437052|FG002|Overall Study|No longer Requires Study Treatment|1|||
129857426|NCT00384085|467437050|FG000|Overall Study|Protocol Violation|2|||
129857427|NCT00384085|467437051|FG001|Overall Study|Protocol Violation|2|||
129857428|NCT00384085|467437052|FG002|Overall Study|Protocol Violation|2|||
129857429|NCT00384085|467437050|FG000|Overall Study|Lost to Follow-up|9|||
129857430|NCT00384085|467437051|FG001|Overall Study|Lost to Follow-up|9|||
129857431|NCT00384085|467437052|FG002|Overall Study|Lost to Follow-up|10|||
129857432|NCT00384085|467437050|FG000|Overall Study|Progressive Disease|0|||
129857433|NCT00384085|467437051|FG001|Overall Study|Progressive Disease|1|||
129857434|NCT00384085|467437052|FG002|Overall Study|Progressive Disease|0|||
129857435|NCT00384085|467437050|FG000|Overall Study|Withdrawal by Subject|14|||
129857436|NCT00384085|467437051|FG001|Overall Study|Withdrawal by Subject|19|||
129857437|NCT00384085|467437052|FG002|Overall Study|Withdrawal by Subject|29|||
129857438|NCT00384085|467437050|FG000|Overall Study|Patient non-compliant|4|||
129857439|NCT00384085|467437051|FG001|Overall Study|Patient non-compliant|4|||
129857440|NCT00384085|467437052|FG002|Overall Study|Patient non-compliant|5|||
129857441|NCT00384085|467437050|FG000|Overall Study|Physician Decision|1|||
129857442|NCT00384085|467437051|FG001|Overall Study|Physician Decision|0|||
129857443|NCT00384085|467437052|FG002|Overall Study|Physician Decision|0|||
129857444|NCT00384085|467437050|FG000|Overall Study|Loss of site personnel|1|||
129857445|NCT00384085|467437051|FG001|Overall Study|Loss of site personnel|0|||
129857446|NCT00384085|467437052|FG002|Overall Study|Loss of site personnel|1|||
129857447|NCT00384085|467437050|FG000|Overall Study|Sponsor decision|1|||
129857448|NCT00384085|467437051|FG001|Overall Study|Sponsor decision|2|||
129857449|NCT00384085|467437052|FG002|Overall Study|Sponsor decision|1|||
129857450|NCT00384085|467437050|FG000|Overall Study|Patient moved|1|||
129857451|NCT00384085|467437051|FG001|Overall Study|Patient moved|0|||
129857452|NCT00384085|467437052|FG002|Overall Study|Patient moved|1|||
129857453|NCT00384085|467437050|FG000|Overall Study|Patient required surgery|0|||
129857454|NCT00384085|467437051|FG001|Overall Study|Patient required surgery|1|||
129857455|NCT00384085|467437052|FG002|Overall Study|Patient required surgery|0|||
129857456|NCT03725982|467437055|FG000|First Intervention|Withdrawal by Subject|0|||
129857457|NCT03725982|467437056|FG001|First Intervention|Withdrawal by Subject|1|||
129857458|NCT03725982|467437055|FG000|First Intervention|Physician Decision|1|||
129857459|NCT03725982|467437056|FG001|First Intervention|Physician Decision|1|||
129857460|NCT00352365|467437059|FG000|Induction Therapy|Adverse Event|7|||
129857461|NCT00352365|467437059|FG000|Induction Therapy|Progression/Relapse|8|||
129857462|NCT00352365|467437059|FG000|Induction Therapy|Death|7|||
129909522|NCT02652442|467632342|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
129909523|NCT00106080|467632348|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
129909524|NCT00106080|467632349|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
129909525|NCT03740009|467632350|FG000|Overall Study|Physician Decision|9|||
129909526|NCT03740009|467632350|FG000|Overall Study|Lost to Follow-up|1|||
129909527|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
129909528|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
129909529|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
129909530|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
129909531|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
129909532|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
129909533|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
129909534|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
129909535|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
129909536|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
129909537|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
129909538|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
129909539|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
129909540|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
129909541|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
129909542|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
129909543|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
129909544|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
129909545|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
129909546|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
129909547|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
129909548|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
129909549|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
129909550|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
129909551|NCT01061151|467632351|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
129909552|NCT01061151|467632352|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
129909553|NCT01061151|467632353|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
129449696|NCT02665052|465945651|FG001|Overall Study|Adverse Event|1|||
129857463|NCT00352365|467437059|FG000|Induction Therapy|Not protocol specified|1|||
129857464|NCT00352365|467437059|FG000|Induction Therapy|Not eligible|3|||
129857465|NCT00352365|467437059|FG000|Induction Therapy|Death before starting protocol therapy|1|||
129857466|NCT00352365|467437059|FG000|Maintenance Therapy|Progression/Relapse|3|||
129857467|NCT00352365|467437059|FG000|Maintenance Therapy|Death|2|||
129857468|NCT00352365|467437059|FG000|Maintenance Therapy|Not protocol specified|3|||
129857469|NCT00352365|467437059|FG000|Maintenance Therapy|Not eligible|4|||
129857470|NCT04743908|467437060|FG000|Overall Study|Death|1|||
129857471|NCT04743908|467437061|FG001|Overall Study|Death|0|||
129857472|NCT04743908|467437060|FG000|Overall Study|Lost to Follow-up|181|||
129857473|NCT04743908|467437061|FG001|Overall Study|Lost to Follow-up|180|||
129857474|NCT04743908|467437060|FG000|Overall Study|Withdrawal by Subject|1|||
129857475|NCT04743908|467437061|FG001|Overall Study|Withdrawal by Subject|2|||
129857476|NCT04837482|467437062|FG000|Period 2|Withdrawal by Subject|0|||
129857477|NCT04837482|467437063|FG001|Period 2|Withdrawal by Subject|1|||
129857478|NCT00328510|467437064|FG000|Overall Study|Gag disorder, could not use frame|4|||
129857479|NCT00328510|467437065|FG001|Overall Study|Gag disorder, could not use frame|0|||
129857480|NCT00328510|467437064|FG000|Overall Study|Dentition problems, could not use frame|1|||
129857481|NCT00328510|467437065|FG001|Overall Study|Dentition problems, could not use frame|0|||
129857482|NCT00328510|467437064|FG000|Overall Study|Withdrawal by Subject|4|||
129857483|NCT00328510|467437065|FG001|Overall Study|Withdrawal by Subject|2|||
129857484|NCT00328510|467437064|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
129857485|NCT00328510|467437065|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
129857486|NCT00328510|467437064|FG000|Overall Study|Treatment changed to a single fraction|1|||
129857487|NCT00328510|467437065|FG001|Overall Study|Treatment changed to a single fraction|1|||
129857488|NCT02624804|467437071|FG000|Overall Study|Screen Failure|5|||
129857489|NCT03073603|467437077|FG000|Overall Study|Noncompliance|3|||
129857490|NCT03073603|467437078|FG001|Overall Study|Noncompliance|1|||
129857491|NCT03073603|467437077|FG000|Overall Study|Adverse Event|5|||
129857492|NCT03073603|467437078|FG001|Overall Study|Adverse Event|3|||
129857493|NCT03073603|467437077|FG000|Overall Study|Physician Decision|1|||
129857494|NCT03073603|467437078|FG001|Overall Study|Physician Decision|2|||
129857495|NCT03073603|467437077|FG000|Overall Study|Required treatment not allowed by protocol|1|||
129857496|NCT03073603|467437078|FG001|Overall Study|Required treatment not allowed by protocol|0|||
129857497|NCT03073603|467437077|FG000|Overall Study|Financial or insurance-related|8|||
129857498|NCT03073603|467437078|FG001|Overall Study|Financial or insurance-related|0|||
129857499|NCT03073603|467437077|FG000|Overall Study|Withdrawal by Subject|0|||
129909554|NCT01061151|467632354|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
129909555|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
129857500|NCT03073603|467437078|FG001|Overall Study|Withdrawal by Subject|1|||
129857501|NCT03073603|467437077|FG000|Overall Study|Discontinued DMT|4|||
129909556|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
129909557|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
129909558|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
129909559|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
129909560|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
129909561|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
129909562|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
129909563|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
129909564|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
129909565|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
129909566|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
129909567|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
129909568|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
129909569|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
129909570|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
129909571|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
129909572|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
129909573|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
129909574|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
129909575|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
129909576|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
129857502|NCT03073603|467437078|FG001|Overall Study|Discontinued DMT|0|||
129857503|NCT03073603|467437077|FG000|Overall Study|Restarted DMT|0|||
129857504|NCT03073603|467437078|FG001|Overall Study|Restarted DMT|1|||
129857505|NCT04757649|467437082|FG000|Overall Study|Withdrawal by Subject|1|||
129857506|NCT04757649|467437082|FG000|Overall Study|Adverse Event|1|||
129857507|NCT01286779|467437083|FG000|Overall Study|Withdrawal by Subject|9|||
129857508|NCT01286779|467437083|FG000|Overall Study|Protocol Violation|5|||
129857509|NCT01286779|467437083|FG000|Overall Study|Physician Decision|2|||
129857510|NCT01286779|467437083|FG000|Overall Study|Participant had scheduled surgery|1|||
129857511|NCT01286779|467437083|FG000|Overall Study|Participant moved to another country|1|||
129857512|NCT01286779|467437083|FG000|Overall Study|Discontinued by sponsor|1|||
129857513|NCT01659021|467437086|FG000|Main Study|Adverse Event|2|||
129857514|NCT01659021|467437087|FG001|Main Study|Adverse Event|3|||
129857515|NCT01659021|467437086|FG000|Main Study|Lost to Follow-up|1|||
129857516|NCT01659021|467437087|FG001|Main Study|Lost to Follow-up|0|||
129857517|NCT01659021|467437086|FG000|Main Study|Unknown Reasons|2|||
129857518|NCT01659021|467437087|FG001|Main Study|Unknown Reasons|1|||
129857519|NCT01659021|467437086|FG000|Main Study|Physician Decision|34|||
129857520|NCT01659021|467437087|FG001|Main Study|Physician Decision|16|||
129857521|NCT01659021|467437086|FG000|Main Study|Withdrawal by Subject|19|||
129857522|NCT01659021|467437087|FG001|Main Study|Withdrawal by Subject|16|||
129857523|NCT01659021|467437086|FG000|Main Study|Study Terminated by Sponsor|16|||
129857524|NCT01659021|467437087|FG001|Main Study|Study Terminated by Sponsor|1|||
129857525|NCT01659021|467437086|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
129857526|NCT01659021|467437087|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
129857527|NCT01659021|467437086|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
129857528|NCT01659021|467437087|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
129857529|NCT02896855|467437090|FG000|Overall Study|Death|50|||
129909577|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
129909578|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
129909579|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
129857530|NCT02896855|467437091|FG001|Overall Study|Death|40|||
129857531|NCT02896855|467437090|FG000|Overall Study|Lost to Follow-up|15|||
129857532|NCT02896855|467437091|FG001|Overall Study|Lost to Follow-up|9|||
129857533|NCT02896855|467437090|FG000|Overall Study|Withdrawal by Subject|7|||
129857534|NCT02896855|467437091|FG001|Overall Study|Withdrawal by Subject|4|||
129857535|NCT02508311|467437092|FG000|Overall Study|Withdrawal by Subject|1|||
129857536|NCT02508311|467437093|FG001|Overall Study|Withdrawal by Subject|0|||
129857537|NCT01205685|467437094|FG000|Overall Study|Disease Progression|10|||
129857538|NCT01205685|467437094|FG000|Overall Study|Withdrawal by Subject|1|||
129857539|NCT02169674|467437095|FG000|Overall Study|Withdrawal by Subject|2|||
129857540|NCT02169674|467437096|FG001|Overall Study|Withdrawal by Subject|1|||
129857541|NCT02169674|467437095|FG000|Overall Study|Seroprotected|30|||
129857542|NCT02169674|467437096|FG001|Overall Study|Seroprotected|76|||
129857543|NCT02169674|467437095|FG000|Overall Study|Lost to Follow-up|0|||
129857544|NCT02169674|467437096|FG001|Overall Study|Lost to Follow-up|1|||
129909580|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
129909581|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
129909582|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
129909583|NCT01061151|467632351|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
129909584|NCT01061151|467632352|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
129909585|NCT01061151|467632353|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
129909586|NCT01061151|467632354|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
129909587|NCT03531840|467632359|FG000|Overall Study|Death on study|3|||
129909588|NCT03531840|467632360|FG001|Overall Study|Death on study|2|||
129909589|NCT03531840|467632361|FG002|Overall Study|Death on study|1|||
129909590|NCT03531840|467632362|FG003|Overall Study|Death on study|2|||
129909591|NCT03531840|467632359|FG000|Overall Study|Death during follow up|2|||
129909592|NCT03531840|467632360|FG001|Overall Study|Death during follow up|3|||
129857545|NCT03058679|467437102|FG000|Baseline to Week 6|Lost to Follow-up|3|||
129857546|NCT03058679|467437103|FG001|Baseline to Week 6|Lost to Follow-up|2|||
129857547|NCT03058679|467437102|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
129857548|NCT03058679|467437103|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
129857549|NCT03058679|467437102|FG000|Baseline to Week 6|Adverse Event|6|||
129857550|NCT03058679|467437103|FG001|Baseline to Week 6|Adverse Event|6|||
129857551|NCT03058679|467437102|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
129857552|NCT03058679|467437103|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
129857553|NCT03058679|467437102|FG000|Baseline to Week 6|Difficulty following the diet|0|||
129857554|NCT03058679|467437103|FG001|Baseline to Week 6|Difficulty following the diet|2|||
129857555|NCT03058679|467437102|FG000|Baseline to Week 6|Physician Decision|1|||
129857556|NCT03058679|467437103|FG001|Baseline to Week 6|Physician Decision|0|||
129857557|NCT03058679|467437102|FG000|Week 6 to Week 12|Change in medication|5|||
129857558|NCT03058679|467437103|FG001|Week 6 to Week 12|Change in medication|7|||
129857559|NCT03058679|467437102|FG000|Week 6 to Week 12|Adverse Event|4|||
129857560|NCT03058679|467437103|FG001|Week 6 to Week 12|Adverse Event|3|||
129857561|NCT03058679|467437102|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
129857562|NCT03058679|467437103|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
129857563|NCT03058679|467437102|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
129857564|NCT03058679|467437103|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
129857565|NCT00574080|467437104|FG000|Overall Study|Death|10|||
129857566|NCT00574080|467437105|FG001|Overall Study|Death|10|||
129857567|NCT00599326|467437106|FG000|Overall Study|Lost to Follow-up|1|||
129857568|NCT00599326|467437106|FG000|Overall Study|Noncompliant|1|||
129857569|NCT00784810|467437109|FG000|Overall Study|Adverse Event|32|||
129857570|NCT00784810|467437110|FG001|Overall Study|Adverse Event|20|||
129857571|NCT00784810|467437109|FG000|Overall Study|Lack of Efficacy|14|||
129857572|NCT00784810|467437110|FG001|Overall Study|Lack of Efficacy|11|||
129857573|NCT00784810|467437109|FG000|Overall Study|Withdrawal by Subject|11|||
129857574|NCT00784810|467437110|FG001|Overall Study|Withdrawal by Subject|9|||
129857575|NCT00784810|467437109|FG000|Overall Study|Administrative|5|||
129857576|NCT00784810|467437110|FG001|Overall Study|Administrative|8|||
129857577|NCT00784810|467437109|FG000|Overall Study|Lost to Follow-up|1|||
129857578|NCT00784810|467437110|FG001|Overall Study|Lost to Follow-up|1|||
129857579|NCT02862106|467437111|FG000|Overall Study|Adverse Event|4|||
129857580|NCT02862106|467437112|FG001|Overall Study|Adverse Event|0|||
129857581|NCT02862106|467437111|FG000|Overall Study|Protocol Violation|16|||
129857582|NCT02862106|467437112|FG001|Overall Study|Protocol Violation|1|||
129857583|NCT02862106|467437111|FG000|Overall Study|Lost to Follow-up|15|||
129857584|NCT02862106|467437112|FG001|Overall Study|Lost to Follow-up|5|||
129857585|NCT02862106|467437111|FG000|Overall Study|Withdrawal by Subject|2|||
129857586|NCT02862106|467437112|FG001|Overall Study|Withdrawal by Subject|0|||
129909593|NCT03531840|467632361|FG002|Overall Study|Death during follow up|4|||
129857587|NCT02862106|467437111|FG000|Overall Study|Subjects moved to other city|1|||
129857588|NCT02862106|467437112|FG001|Overall Study|Subjects moved to other city|0|||
129857589|NCT00563784|467437115|FG000|Overall Study|Withdrawal by Subject|2|||
129857590|NCT00563784|467437115|FG000|Overall Study|Screen Failures|20|||
129857591|NCT01380327|467437116|FG000|Overall Study|Lost to Follow-up|0|||
129857592|NCT01380327|467437117|FG001|Overall Study|Lost to Follow-up|1|||
129857593|NCT01380327|467437118|FG002|Overall Study|Lost to Follow-up|1|||
129857594|NCT01380327|467437116|FG000|Overall Study|Protocol Violation|3|||
129857595|NCT01380327|467437117|FG001|Overall Study|Protocol Violation|2|||
129857596|NCT01380327|467437118|FG002|Overall Study|Protocol Violation|3|||
129857597|NCT01380327|467437116|FG000|Overall Study|Withdrawal by Subject|0|||
129857598|NCT01380327|467437117|FG001|Overall Study|Withdrawal by Subject|0|||
129857599|NCT01380327|467437118|FG002|Overall Study|Withdrawal by Subject|1|||
129857600|NCT01380327|467437116|FG000|Overall Study|Housing situation precluded ability to k|0|||
129857601|NCT01380327|467437117|FG001|Overall Study|Housing situation precluded ability to k|0|||
129857602|NCT01380327|467437118|FG002|Overall Study|Housing situation precluded ability to k|1|||
129909594|NCT03531840|467632362|FG003|Overall Study|Death during follow up|1|||
129909595|NCT00761605|467632364|FG000|Overall Study|Adverse Event|26|||
129857603|NCT01380327|467437116|FG000|Overall Study|Questionable onset of epilepsy|0|||
129909596|NCT00761605|467632364|FG000|Overall Study|Death|2|||
129909597|NCT00761605|467632364|FG000|Overall Study|Lack of Efficacy|26|||
129909598|NCT00761605|467632364|FG000|Overall Study|Lost to Follow-up|29|||
129909599|NCT00761605|467632364|FG000|Overall Study|Withdrawal by Subject|37|||
129909600|NCT00761605|467632364|FG000|Overall Study|Other|21|||
129909601|NCT02267824|467632365|FG000|Overall Study|Pregnancy|1|||
129909602|NCT02267824|467632366|FG001|Overall Study|Pregnancy|1|||
129909603|NCT02267824|467632365|FG000|Overall Study|Lost to Follow-up|4|||
129909604|NCT02267824|467632366|FG001|Overall Study|Lost to Follow-up|0|||
129909605|NCT02267824|467632365|FG000|Overall Study|Protocol Violation|3|||
129909606|NCT02267824|467632366|FG001|Overall Study|Protocol Violation|0|||
129909607|NCT02267824|467632365|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
129909608|NCT02267824|467632366|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
129909609|NCT03451721|467632367|FG000|Overall Study|Death|1|||
129909610|NCT01985334|467632368|FG000|Overall Study|Administrative problems|1|||
129909611|NCT01985334|467632369|FG001|Overall Study|Administrative problems|1|||
129909612|NCT01985334|467632370|FG002|Overall Study|Administrative problems|0|||
129909613|NCT01985334|467632371|FG003|Overall Study|Administrative problems|2|||
129909614|NCT01985334|467632372|FG004|Overall Study|Administrative problems|0|||
129909615|NCT01985334|467632373|FG005|Overall Study|Administrative problems|1|||
129909616|NCT01985334|467632374|FG006|Overall Study|Administrative problems|1|||
129909617|NCT01985334|467632375|FG007|Overall Study|Administrative problems|3|||
129909618|NCT01985334|467632368|FG000|Overall Study|Death|1|||
129909619|NCT01985334|467632369|FG001|Overall Study|Death|0|||
129909620|NCT01985334|467632370|FG002|Overall Study|Death|0|||
129909621|NCT01985334|467632371|FG003|Overall Study|Death|3|||
129909622|NCT01985334|467632372|FG004|Overall Study|Death|0|||
129909623|NCT01985334|467632373|FG005|Overall Study|Death|0|||
129909624|NCT01985334|467632374|FG006|Overall Study|Death|1|||
129909625|NCT01985334|467632375|FG007|Overall Study|Death|2|||
129909626|NCT01985334|467632368|FG000|Overall Study|Worsening of disease|0|||
129909627|NCT01985334|467632369|FG001|Overall Study|Worsening of disease|0|||
129909628|NCT01985334|467632370|FG002|Overall Study|Worsening of disease|0|||
129909629|NCT01985334|467632371|FG003|Overall Study|Worsening of disease|1|||
129909630|NCT01985334|467632372|FG004|Overall Study|Worsening of disease|0|||
129909631|NCT01985334|467632373|FG005|Overall Study|Worsening of disease|3|||
129909632|NCT01985334|467632374|FG006|Overall Study|Worsening of disease|0|||
129909633|NCT01985334|467632375|FG007|Overall Study|Worsening of disease|1|||
129909634|NCT01985334|467632368|FG000|Overall Study|Other|2|||
129909635|NCT01985334|467632369|FG001|Overall Study|Other|9|||
129909636|NCT01985334|467632370|FG002|Overall Study|Other|7|||
129909637|NCT01985334|467632371|FG003|Overall Study|Other|17|||
129909638|NCT01985334|467632372|FG004|Overall Study|Other|4|||
129909639|NCT01985334|467632373|FG005|Overall Study|Other|8|||
129909640|NCT01985334|467632374|FG006|Overall Study|Other|4|||
129909641|NCT01985334|467632375|FG007|Overall Study|Other|7|||
129909642|NCT01985334|467632368|FG000|Overall Study|Protocol deviation|6|||
129909643|NCT01985334|467632369|FG001|Overall Study|Protocol deviation|31|||
129909644|NCT01985334|467632370|FG002|Overall Study|Protocol deviation|25|||
129909645|NCT01985334|467632371|FG003|Overall Study|Protocol deviation|84|||
129909646|NCT01985334|467632372|FG004|Overall Study|Protocol deviation|17|||
129909647|NCT01985334|467632373|FG005|Overall Study|Protocol deviation|47|||
129909648|NCT01985334|467632374|FG006|Overall Study|Protocol deviation|15|||
129909649|NCT01985334|467632375|FG007|Overall Study|Protocol deviation|42|||
129909650|NCT01985334|467632368|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
129909651|NCT01985334|467632369|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
129909652|NCT01985334|467632370|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
129909653|NCT01985334|467632371|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
129909654|NCT01985334|467632372|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
129909655|NCT01985334|467632373|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
129909656|NCT01985334|467632374|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
129909657|NCT01985334|467632375|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
129909658|NCT01985334|467632368|FG000|Overall Study|Subject withdrawal of consent|3|||
129909659|NCT01985334|467632369|FG001|Overall Study|Subject withdrawal of consent|6|||
129909660|NCT01985334|467632370|FG002|Overall Study|Subject withdrawal of consent|2|||
129909661|NCT01985334|467632371|FG003|Overall Study|Subject withdrawal of consent|28|||
129909662|NCT01985334|467632372|FG004|Overall Study|Subject withdrawal of consent|4|||
129909663|NCT01985334|467632373|FG005|Overall Study|Subject withdrawal of consent|19|||
129909664|NCT01985334|467632374|FG006|Overall Study|Subject withdrawal of consent|0|||
129909665|NCT01985334|467632375|FG007|Overall Study|Subject withdrawal of consent|20|||
129909666|NCT01985334|467632368|FG000|Overall Study|Adverse Event|0|||
129909667|NCT01985334|467632369|FG001|Overall Study|Adverse Event|8|||
129909668|NCT01985334|467632370|FG002|Overall Study|Adverse Event|2|||
129909669|NCT01985334|467632371|FG003|Overall Study|Adverse Event|26|||
129909670|NCT01985334|467632372|FG004|Overall Study|Adverse Event|3|||
129909671|NCT01985334|467632373|FG005|Overall Study|Adverse Event|18|||
129909672|NCT01985334|467632374|FG006|Overall Study|Adverse Event|3|||
129909673|NCT01985334|467632375|FG007|Overall Study|Adverse Event|15|||
129909674|NCT01985334|467632368|FG000|Overall Study|Other|4|||
129909675|NCT01985334|467632369|FG001|Overall Study|Other|2|||
129909676|NCT01985334|467632370|FG002|Overall Study|Other|3|||
129909677|NCT01985334|467632371|FG003|Overall Study|Other|10|||
129909678|NCT01985334|467632372|FG004|Overall Study|Other|1|||
129909679|NCT01985334|467632373|FG005|Overall Study|Other|6|||
129909680|NCT01985334|467632374|FG006|Overall Study|Other|2|||
129909681|NCT01985334|467632375|FG007|Overall Study|Other|2|||
129909682|NCT01985334|467632368|FG000|Overall Study|Medication non-compliance|0|||
129909683|NCT01985334|467632369|FG001|Overall Study|Medication non-compliance|4|||
129909684|NCT01985334|467632370|FG002|Overall Study|Medication non-compliance|1|||
129909685|NCT01985334|467632371|FG003|Overall Study|Medication non-compliance|6|||
129909686|NCT01985334|467632372|FG004|Overall Study|Medication non-compliance|2|||
129909687|NCT01985334|467632373|FG005|Overall Study|Medication non-compliance|3|||
129909688|NCT01985334|467632374|FG006|Overall Study|Medication non-compliance|1|||
129909689|NCT01985334|467632375|FG007|Overall Study|Medication non-compliance|3|||
129909690|NCT01985334|467632368|FG000|Overall Study|Use of prohibited treatment|1|||
129909691|NCT01985334|467632369|FG001|Overall Study|Use of prohibited treatment|4|||
129909692|NCT01985334|467632370|FG002|Overall Study|Use of prohibited treatment|1|||
129909693|NCT01985334|467632371|FG003|Overall Study|Use of prohibited treatment|2|||
129909694|NCT01985334|467632372|FG004|Overall Study|Use of prohibited treatment|1|||
129909695|NCT01985334|467632373|FG005|Overall Study|Use of prohibited treatment|6|||
129909696|NCT01985334|467632374|FG006|Overall Study|Use of prohibited treatment|2|||
129909697|NCT01985334|467632375|FG007|Overall Study|Use of prohibited treatment|0|||
129909698|NCT01985334|467632368|FG000|Overall Study|Investigator decision|0|||
129909699|NCT01985334|467632369|FG001|Overall Study|Investigator decision|3|||
129909700|NCT01985334|467632370|FG002|Overall Study|Investigator decision|0|||
129909701|NCT01985334|467632371|FG003|Overall Study|Investigator decision|7|||
129857604|NCT01380327|467437117|FG001|Overall Study|Questionable onset of epilepsy|0|||
129857605|NCT01380327|467437118|FG002|Overall Study|Questionable onset of epilepsy|1|||
129857606|NCT03646513|467437122|FG000|Overall Study|Premature study termination|4|||
129857607|NCT01660763|467437126|FG000|Overall Study|Lack of Efficacy|45|||
129857608|NCT01660763|467437127|FG001|Overall Study|Lack of Efficacy|50|||
129857609|NCT01660763|467437126|FG000|Overall Study|Adverse Event|22|||
129857610|NCT01660763|467437127|FG001|Overall Study|Adverse Event|7|||
129857611|NCT01660763|467437126|FG000|Overall Study|Protocol Violation|1|||
129857612|NCT01660763|467437127|FG001|Overall Study|Protocol Violation|0|||
129857613|NCT01660763|467437126|FG000|Overall Study|Withdrawal by Subject|4|||
129857614|NCT01660763|467437127|FG001|Overall Study|Withdrawal by Subject|0|||
129857615|NCT01660763|467437126|FG000|Overall Study|Patient ready for early discharge|28|||
129857616|NCT01660763|467437127|FG001|Overall Study|Patient ready for early discharge|4|||
129857617|NCT03325712|467437128|FG000|Overall Study|Protocol Violation|0|||
129857618|NCT03325712|467437129|FG001|Overall Study|Protocol Violation|0|||
129857619|NCT03325712|467437130|FG002|Overall Study|Protocol Violation|0|||
129857620|NCT03325712|467437131|FG003|Overall Study|Protocol Violation|0|||
129857621|NCT03325712|467437132|FG004|Overall Study|Protocol Violation|1|||
129857622|NCT03325712|467437133|FG005|Overall Study|Protocol Violation|0|||
129857623|NCT03325712|467437134|FG006|Overall Study|Protocol Violation|0|||
129857624|NCT03325712|467437135|FG007|Overall Study|Protocol Violation|0|||
129857625|NCT03325712|467437128|FG000|Overall Study|Adverse Event|0|||
129857626|NCT03325712|467437129|FG001|Overall Study|Adverse Event|0|||
129857627|NCT03325712|467437130|FG002|Overall Study|Adverse Event|0|||
129857628|NCT03325712|467437131|FG003|Overall Study|Adverse Event|0|||
129857629|NCT03325712|467437132|FG004|Overall Study|Adverse Event|1|||
129857630|NCT03325712|467437133|FG005|Overall Study|Adverse Event|0|||
129857631|NCT03325712|467437134|FG006|Overall Study|Adverse Event|0|||
129857632|NCT03325712|467437135|FG007|Overall Study|Adverse Event|0|||
129857633|NCT02265237|467437137|FG000|As Treated (Overall Study)|Adverse Event|1|||
129857634|NCT02265237|467437138|FG001|As Treated (Overall Study)|Adverse Event|1|||
129857635|NCT02265237|467437139|FG002|As Treated (Overall Study)|Adverse Event|0|||
129857636|NCT02265237|467437140|FG003|As Treated (Overall Study)|Adverse Event|0|||
129857637|NCT02265237|467437137|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
129857638|NCT02265237|467437138|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
129857639|NCT02265237|467437139|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
129857640|NCT02265237|467437140|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
129909702|NCT01985334|467632372|FG004|Overall Study|Investigator decision|1|||
129909703|NCT01985334|467632373|FG005|Overall Study|Investigator decision|1|||
129909704|NCT01985334|467632374|FG006|Overall Study|Investigator decision|0|||
129909705|NCT01985334|467632375|FG007|Overall Study|Investigator decision|4|||
129857641|NCT02265237|467437137|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
129857642|NCT02265237|467437138|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
129857643|NCT02265237|467437139|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
129857644|NCT02265237|467437140|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
129909706|NCT01985334|467632368|FG000|Overall Study|Lost to Follow-up|0|||
129909707|NCT01985334|467632369|FG001|Overall Study|Lost to Follow-up|2|||
129909708|NCT01985334|467632370|FG002|Overall Study|Lost to Follow-up|0|||
129857645|NCT02265237|467437137|FG000|As Treated (Overall Study)|Other|2|||
129857646|NCT02265237|467437138|FG001|As Treated (Overall Study)|Other|0|||
129857647|NCT02265237|467437139|FG002|As Treated (Overall Study)|Other|3|||
129857648|NCT02265237|467437140|FG003|As Treated (Overall Study)|Other|1|||
129857649|NCT01178853|467437141|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
129857650|NCT01178853|467437142|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
129857651|NCT01178853|467437141|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
129857652|NCT01178853|467437142|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
129857653|NCT01178853|467437141|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
129857654|NCT01178853|467437142|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
129857655|NCT01178853|467437141|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
129857656|NCT01178853|467437142|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
129857657|NCT01178853|467437141|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
129857658|NCT01178853|467437142|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
129857659|NCT03550313|467437143|FG000|Overall Study|Adverse Event|0|||
129857660|NCT03550313|467437144|FG001|Overall Study|Adverse Event|1|||
129857661|NCT03550313|467437145|FG002|Overall Study|Adverse Event|0|||
129857662|NCT03550313|467437143|FG000|Overall Study|Lost to Follow-up|5|||
129857663|NCT03550313|467437144|FG001|Overall Study|Lost to Follow-up|7|||
129857664|NCT03550313|467437145|FG002|Overall Study|Lost to Follow-up|12|||
129857665|NCT03550313|467437143|FG000|Overall Study|Study terminated by sponsor|44|||
129857666|NCT03550313|467437144|FG001|Overall Study|Study terminated by sponsor|37|||
129857667|NCT03550313|467437145|FG002|Overall Study|Study terminated by sponsor|48|||
129857668|NCT03550313|467437143|FG000|Overall Study|No longer met eligibility criteria|3|||
129857669|NCT03550313|467437144|FG001|Overall Study|No longer met eligibility criteria|5|||
129857670|NCT03550313|467437145|FG002|Overall Study|No longer met eligibility criteria|6|||
129857671|NCT03550313|467437143|FG000|Overall Study|Withdrawal by parent/guardian|20|||
129857672|NCT03550313|467437144|FG001|Overall Study|Withdrawal by parent/guardian|18|||
129857673|NCT03550313|467437145|FG002|Overall Study|Withdrawal by parent/guardian|26|||
129857674|NCT03550313|467437143|FG000|Overall Study|Other|4|||
129857675|NCT03550313|467437144|FG001|Overall Study|Other|2|||
129857676|NCT03550313|467437145|FG002|Overall Study|Other|2|||
129857677|NCT03550313|467437143|FG000|Overall Study|Randomized but not vaccinated|3|||
129857678|NCT03550313|467437144|FG001|Overall Study|Randomized but not vaccinated|23|||
129857679|NCT03550313|467437145|FG002|Overall Study|Randomized but not vaccinated|2|||
129857680|NCT03550313|467437143|FG000|Overall Study|Sites terminated due to quality issues|18|||
129857681|NCT03550313|467437144|FG001|Overall Study|Sites terminated due to quality issues|17|||
129857682|NCT03550313|467437145|FG002|Overall Study|Sites terminated due to quality issues|18|||
129857683|NCT00380068|467437147|FG000|Overall Study|Adverse Event|40|||
129857684|NCT00380068|467437147|FG000|Overall Study|Withdrawal by Subject|10|||
129857685|NCT00380068|467437147|FG000|Overall Study|Not compliant|6|||
129857686|NCT00380068|467437147|FG000|Overall Study|Lost to Follow-up|1|||
129857687|NCT00380068|467437147|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
129857688|NCT00380068|467437147|FG000|Overall Study|Lung transplant|3|||
129857689|NCT00380068|467437147|FG000|Overall Study|Physician Decision|2|||
129857690|NCT00380068|467437147|FG000|Overall Study|Partipant moved away|1|||
129857691|NCT00380068|467437147|FG000|Overall Study|Lack of Efficacy|5|||
129857692|NCT01297062|467437148|FG000|Overall Study|Adverse Event|2|||
129857693|NCT01297062|467437149|FG001|Overall Study|Adverse Event|0|||
129857694|NCT01297062|467437150|FG002|Overall Study|Adverse Event|1|||
129857695|NCT01297062|467437151|FG003|Overall Study|Adverse Event|0|||
129857696|NCT01297062|467437152|FG004|Overall Study|Adverse Event|0|||
129857697|NCT01297062|467437153|FG005|Overall Study|Adverse Event|0|||
129857698|NCT01297062|467437154|FG006|Overall Study|Adverse Event|0|||
129857699|NCT01297062|467437148|FG000|Overall Study|Physician Decision|1|||
129857700|NCT01297062|467437149|FG001|Overall Study|Physician Decision|0|||
129857701|NCT01297062|467437150|FG002|Overall Study|Physician Decision|1|||
129857702|NCT01297062|467437151|FG003|Overall Study|Physician Decision|0|||
129857703|NCT01297062|467437152|FG004|Overall Study|Physician Decision|0|||
129857704|NCT01297062|467437153|FG005|Overall Study|Physician Decision|0|||
129857705|NCT01297062|467437154|FG006|Overall Study|Physician Decision|6|||
129857706|NCT01297062|467437148|FG000|Overall Study|Protocol Violation|0|||
129857707|NCT01297062|467437149|FG001|Overall Study|Protocol Violation|0|||
129857708|NCT01297062|467437150|FG002|Overall Study|Protocol Violation|0|||
129857709|NCT01297062|467437151|FG003|Overall Study|Protocol Violation|0|||
129857710|NCT01297062|467437152|FG004|Overall Study|Protocol Violation|1|||
129857711|NCT01297062|467437153|FG005|Overall Study|Protocol Violation|0|||
129857712|NCT01297062|467437154|FG006|Overall Study|Protocol Violation|0|||
129857713|NCT01297062|467437148|FG000|Overall Study|Subject Decision|1|||
129857714|NCT01297062|467437149|FG001|Overall Study|Subject Decision|1|||
129857715|NCT01297062|467437150|FG002|Overall Study|Subject Decision|0|||
129857716|NCT01297062|467437151|FG003|Overall Study|Subject Decision|1|||
129857717|NCT01297062|467437152|FG004|Overall Study|Subject Decision|1|||
129857718|NCT01297062|467437153|FG005|Overall Study|Subject Decision|1|||
129857719|NCT01297062|467437154|FG006|Overall Study|Subject Decision|2|||
129857720|NCT04964089|467437155|FG000|Overall Study|Adverse Event|8|||
129909709|NCT01985334|467632371|FG003|Overall Study|Lost to Follow-up|3|||
129909710|NCT01985334|467632372|FG004|Overall Study|Lost to Follow-up|1|||
129909711|NCT01985334|467632373|FG005|Overall Study|Lost to Follow-up|4|||
129909712|NCT01985334|467632374|FG006|Overall Study|Lost to Follow-up|0|||
129909713|NCT01985334|467632375|FG007|Overall Study|Lost to Follow-up|3|||
129909714|NCT01290341|467632376|FG000|Overall Study|Protocol Violation|7|||
129909715|NCT01290341|467632377|FG001|Overall Study|Protocol Violation|3|||
129909716|NCT01290341|467632376|FG000|Overall Study|Adverse Event|1|||
129909717|NCT01290341|467632377|FG001|Overall Study|Adverse Event|0|||
129909718|NCT01290341|467632376|FG000|Overall Study|Lost to Follow-up|21|||
129909719|NCT01290341|467632377|FG001|Overall Study|Lost to Follow-up|10|||
129909720|NCT01290341|467632376|FG000|Overall Study|Withdrawal by Subject|19|||
129909721|NCT01290341|467632377|FG001|Overall Study|Withdrawal by Subject|5|||
129909722|NCT01290341|467632376|FG000|Overall Study|Negative baseline culture and others|44|||
129909723|NCT01290341|467632377|FG001|Overall Study|Negative baseline culture and others|11|||
129909724|NCT01102231|467632382|FG000|Overall Study|Protocol Violation|3|||
129909725|NCT01102231|467632382|FG000|Overall Study|Lack of Efficacy|2|||
129909726|NCT01102231|467632382|FG000|Overall Study|Death|2|||
129909727|NCT01102231|467632382|FG000|Overall Study|Adverse Event|3|||
129909728|NCT01102231|467632382|FG000|Overall Study|Withdrawal by Subject|1|||
129909729|NCT01102231|467632382|FG000|Overall Study|Did not received the treatment|4|||
129909730|NCT02568683|467632385|FG000|Overall Study|Death|0|||
129909731|NCT02568683|467632386|FG001|Overall Study|Death|2|||
129909732|NCT02568683|467632385|FG000|Overall Study|Withdrew Consent|1|||
129909733|NCT02568683|467632386|FG001|Overall Study|Withdrew Consent|0|||
129909734|NCT02568683|467632385|FG000|Overall Study|Study Terminated By Sponsor|5|||
129909735|NCT02568683|467632386|FG001|Overall Study|Study Terminated By Sponsor|2|||
129909736|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
129909737|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909738|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909739|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909740|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
129909741|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
129909742|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909743|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909744|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909745|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
129909746|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
129909747|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909748|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909749|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909750|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
129909751|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
129909752|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909753|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909754|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909755|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
129909756|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
129909757|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909758|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909759|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909760|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
129909761|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
129909762|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909763|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909764|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909765|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
129909766|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
129909767|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909768|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909769|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909770|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
129909771|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
129909772|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129909773|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129909774|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129857721|NCT04964089|467437156|FG001|Overall Study|Adverse Event|6|||
129857722|NCT04964089|467437155|FG000|Overall Study|Non-compliance with study schedule|1|||
129857723|NCT04964089|467437156|FG001|Overall Study|Non-compliance with study schedule|0|||
129857724|NCT04964089|467437155|FG000|Overall Study|Withdrawal by Subject|6|||
129857725|NCT04964089|467437156|FG001|Overall Study|Withdrawal by Subject|5|||
129857726|NCT04964089|467437155|FG000|Overall Study|Lost to Follow-up|1|||
129857727|NCT04964089|467437156|FG001|Overall Study|Lost to Follow-up|1|||
129857728|NCT04964089|467437155|FG000|Overall Study|Progressive disease|4|||
129857729|NCT04964089|467437156|FG001|Overall Study|Progressive disease|0|||
129857730|NCT04964089|467437155|FG000|Overall Study|Physician Decision|1|||
129857731|NCT04964089|467437156|FG001|Overall Study|Physician Decision|0|||
129857732|NCT04964089|467437155|FG000|Overall Study|Participant did not want to continue study treatment|1|||
129857733|NCT04964089|467437156|FG001|Overall Study|Participant did not want to continue study treatment|0|||
129857734|NCT04964089|467437155|FG000|Overall Study|Participant moved to different state|1|||
129857735|NCT04964089|467437156|FG001|Overall Study|Participant moved to different state|0|||
129857736|NCT04964089|467437155|FG000|Overall Study|Participant decided to discontinue|0|||
129857737|NCT04964089|467437156|FG001|Overall Study|Participant decided to discontinue|1|||
129857738|NCT01165281|467437162|FG000|Overall Study|Adverse Event|12|||
129857739|NCT01165281|467437163|FG001|Overall Study|Adverse Event|14|||
129857740|NCT01165281|467437162|FG000|Overall Study|Death|3|||
129857741|NCT01165281|467437163|FG001|Overall Study|Death|4|||
129857742|NCT01165281|467437162|FG000|Overall Study|Lack of Efficacy|4|||
129857743|NCT01165281|467437163|FG001|Overall Study|Lack of Efficacy|1|||
129857744|NCT01165281|467437162|FG000|Overall Study|Lost to Follow-up|0|||
129857745|NCT01165281|467437163|FG001|Overall Study|Lost to Follow-up|1|||
129857746|NCT01165281|467437162|FG000|Overall Study|Physician Decision|8|||
129857747|NCT01165281|467437163|FG001|Overall Study|Physician Decision|1|||
129857748|NCT01165281|467437162|FG000|Overall Study|Protocol Violation|6|||
129857749|NCT01165281|467437163|FG001|Overall Study|Protocol Violation|5|||
129857750|NCT01165281|467437162|FG000|Overall Study|Withdrawal by Subject|8|||
129857751|NCT01165281|467437163|FG001|Overall Study|Withdrawal by Subject|7|||
129857752|NCT01165281|467437162|FG000|Overall Study|Noncompliance with Study Drug|1|||
129857753|NCT01165281|467437163|FG001|Overall Study|Noncompliance with Study Drug|4|||
129857754|NCT01165281|467437162|FG000|Overall Study|Progressive Disease|10|||
129857755|NCT01165281|467437163|FG001|Overall Study|Progressive Disease|14|||
129857756|NCT01165281|467437162|FG000|Overall Study|Other|6|||
129857757|NCT01165281|467437163|FG001|Overall Study|Other|0|||
129857758|NCT00363766|467437168|FG000|Overall Study|Progressive Disease|15|||
129857759|NCT00363766|467437169|FG001|Overall Study|Progressive Disease|9|||
129857760|NCT00363766|467437168|FG000|Overall Study|Adverse Event|10|||
129857761|NCT00363766|467437169|FG001|Overall Study|Adverse Event|2|||
129857762|NCT00363766|467437168|FG000|Overall Study|Disease Related Death|1|||
129857763|NCT00363766|467437169|FG001|Overall Study|Disease Related Death|3|||
129857764|NCT00363766|467437168|FG000|Overall Study|Not Disease Related Death|3|||
129857765|NCT00363766|467437169|FG001|Overall Study|Not Disease Related Death|4|||
129857766|NCT00363766|467437168|FG000|Overall Study|Withdrawal by Subject|2|||
129857767|NCT00363766|467437169|FG001|Overall Study|Withdrawal by Subject|0|||
129857768|NCT00363766|467437168|FG000|Overall Study|Physician Decision|1|||
129857769|NCT00363766|467437169|FG001|Overall Study|Physician Decision|2|||
129857770|NCT02005471|467437170|FG000|Main Study|Adverse Event|0|||
129857771|NCT02005471|467437171|FG001|Main Study|Adverse Event|1|||
129857772|NCT02005471|467437172|FG002|Main Study|Adverse Event|0|||
129857773|NCT02005471|467437173|FG003|Main Study|Adverse Event|0|||
129857774|NCT02005471|467437170|FG000|Main Study|Death|83|||
129857775|NCT02005471|467437171|FG001|Main Study|Death|52|||
129857776|NCT02005471|467437172|FG002|Main Study|Death|0|||
129857777|NCT02005471|467437173|FG003|Main Study|Death|0|||
129857778|NCT02005471|467437170|FG000|Main Study|Lost to Follow-up|4|||
129857779|NCT02005471|467437171|FG001|Main Study|Lost to Follow-up|5|||
129857780|NCT02005471|467437172|FG002|Main Study|Lost to Follow-up|0|||
129857781|NCT02005471|467437173|FG003|Main Study|Lost to Follow-up|0|||
129857782|NCT02005471|467437170|FG000|Main Study|Physician Decision|3|||
129857783|NCT02005471|467437171|FG001|Main Study|Physician Decision|1|||
129857784|NCT02005471|467437172|FG002|Main Study|Physician Decision|0|||
129857785|NCT02005471|467437173|FG003|Main Study|Physician Decision|0|||
129857786|NCT02005471|467437170|FG000|Main Study|Withdrawal by Subject|26|||
129857787|NCT02005471|467437171|FG001|Main Study|Withdrawal by Subject|11|||
129857788|NCT02005471|467437172|FG002|Main Study|Withdrawal by Subject|0|||
129857789|NCT02005471|467437173|FG003|Main Study|Withdrawal by Subject|0|||
129857790|NCT02005471|467437170|FG000|Main Study|Reason not Specified|0|||
129857791|NCT02005471|467437171|FG001|Main Study|Reason not Specified|6|||
129857792|NCT02005471|467437172|FG002|Main Study|Reason not Specified|0|||
129449697|NCT02665052|465945652|FG002|Overall Study|Adverse Event|0|||
129857793|NCT02005471|467437173|FG003|Main Study|Reason not Specified|0|||
129857794|NCT02005471|467437170|FG000|Main Study|Randomized but not Dosed|8|||
129857795|NCT02005471|467437171|FG001|Main Study|Randomized but not Dosed|0|||
129857796|NCT02005471|467437172|FG002|Main Study|Randomized but not Dosed|0|||
129857797|NCT02005471|467437173|FG003|Main Study|Randomized but not Dosed|0|||
129857798|NCT02005471|467437170|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
129857799|NCT02005471|467437171|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
129857800|NCT02005471|467437172|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
129857801|NCT02005471|467437173|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
129857802|NCT02005471|467437170|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
129857803|NCT02005471|467437171|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
129857804|NCT02005471|467437172|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
129857805|NCT02005471|467437173|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
129857806|NCT02005471|467437170|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
129857807|NCT02005471|467437171|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
129857808|NCT02005471|467437172|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
129857809|NCT02005471|467437173|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
129857810|NCT00627705|467437174|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
129857811|NCT00627705|467437175|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
129857812|NCT00627705|467437174|FG000|Overall Study|Adverse Event|1|||
129857813|NCT00627705|467437175|FG001|Overall Study|Adverse Event|0|||
129857814|NCT00627705|467437174|FG000|Overall Study|Withdrawal by Subject|0|||
129857815|NCT00627705|467437175|FG001|Overall Study|Withdrawal by Subject|2|||
129857816|NCT00627705|467437174|FG000|Overall Study|Lost to Follow-up|0|||
129857817|NCT00627705|467437175|FG001|Overall Study|Lost to Follow-up|1|||
129857818|NCT04295564|467439387|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
129857819|NCT04295564|467439388|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
129857820|NCT01682460|467439389|FG000|Overall Study|Withdrawal by Subject|2|||
129857821|NCT01682460|467439389|FG000|Overall Study|Did not meet inclusion criteria|2|||
129857822|NCT00724282|467439390|FG000|Overall Study|Withdrawal by Subject|3|||
129857823|NCT00724282|467439390|FG000|Overall Study|Physician Decision|1|||
129857824|NCT01159691|467439393|FG000|Overall Study|Lost to Follow-up|2|||
129857825|NCT01159691|467439393|FG000|Overall Study|Unknown reasons|1|||
129857826|NCT01159691|467439393|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
129857827|NCT01159691|467439393|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
129857828|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
129857829|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
129857830|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
129857831|NCT01159691|467439393|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
129857832|NCT01928719|467439394|FG000|Overall Study|Lost to Follow-up|26|||
129857833|NCT01928719|467439395|FG001|Overall Study|Lost to Follow-up|11|||
129857834|NCT01928719|467439394|FG000|Overall Study|Withdrawal by Subject|22|||
129857835|NCT01928719|467439395|FG001|Overall Study|Withdrawal by Subject|7|||
129857836|NCT01928719|467439394|FG000|Overall Study|Protocol Violation|3|||
129857837|NCT01928719|467439395|FG001|Overall Study|Protocol Violation|1|||
129857838|NCT01928719|467439394|FG000|Overall Study|Adverse Event|1|||
129857839|NCT01928719|467439395|FG001|Overall Study|Adverse Event|0|||
129857840|NCT02105116|467439396|FG000|Overall Study|not eligible for step 2 of trial|5|||
129857841|NCT02105116|467439396|FG000|Overall Study|Death|1|||
129857842|NCT00773968|467439397|FG000|Overall Study|Adverse Event|2|||
129857843|NCT00773968|467439397|FG000|Overall Study|Death|1|||
129857844|NCT00773968|467439397|FG000|Overall Study|Failure to Return|2|||
129857845|NCT00773968|467439397|FG000|Overall Study|Lack of Efficacy|3|||
129857846|NCT00773968|467439397|FG000|Overall Study|Protocol Violation|1|||
129857847|NCT00773968|467439397|FG000|Overall Study|Withdrawal by Subject|11|||
129857848|NCT00773968|467439397|FG000|Overall Study|Screen Failure|17|||
129857849|NCT00773968|467439397|FG000|Overall Study|Other|8|||
129857850|NCT00263666|467439398|FG000|Overall Study|Adverse Event|6|||
129857851|NCT00263666|467439399|FG001|Overall Study|Adverse Event|8|||
129857852|NCT00263666|467439398|FG000|Overall Study|Lost to Follow-up|1|||
129857853|NCT00263666|467439399|FG001|Overall Study|Lost to Follow-up|2|||
129857854|NCT00263666|467439398|FG000|Overall Study|Withdrawal by Subject|0|||
129857855|NCT00263666|467439399|FG001|Overall Study|Withdrawal by Subject|1|||
129857856|NCT02492100|467439400|FG000|Overall Study|Death|1|||
129857857|NCT02332720|467439401|FG000|Part A and Part B|Lost to Follow-up|1|||
129857858|NCT02332720|467439402|FG001|Part A and Part B|Lost to Follow-up|0|||
129857859|NCT02332720|467439403|FG002|Part A and Part B|Lost to Follow-up|0|||
129857860|NCT02332720|467439404|FG003|Part A and Part B|Lost to Follow-up|0|||
129857861|NCT02332720|467439405|FG004|Part A and Part B|Lost to Follow-up|0|||
129857862|NCT02332720|467439406|FG005|Part A and Part B|Lost to Follow-up|2|||
129857863|NCT02332720|467439407|FG006|Part A and Part B|Lost to Follow-up|1|||
129857864|NCT02332720|467439408|FG007|Part A and Part B|Lost to Follow-up|1|||
129857865|NCT02332720|467439409|FG008|Part A and Part B|Lost to Follow-up|0|||
129857866|NCT02332720|467439410|FG009|Part A and Part B|Lost to Follow-up|0|||
129857867|NCT02332720|467439411|FG010|Part A and Part B|Lost to Follow-up|0|||
129857868|NCT02332720|467439412|FG011|Part A and Part B|Lost to Follow-up|0|||
129857869|NCT02332720|467439413|FG012|Part A and Part B|Lost to Follow-up|0|||
129857870|NCT02332720|467439414|FG013|Part A and Part B|Lost to Follow-up|0|||
129857871|NCT02332720|467439415|FG014|Part A and Part B|Lost to Follow-up|0|||
129857872|NCT02332720|467439416|FG015|Part A and Part B|Lost to Follow-up|1|||
129857873|NCT02332720|467439417|FG016|Part A and Part B|Lost to Follow-up|0|||
129857874|NCT02332720|467439418|FG017|Part A and Part B|Lost to Follow-up|0|||
129857875|NCT02332720|467439419|FG018|Part A and Part B|Lost to Follow-up|0|||
129857876|NCT02332720|467439420|FG019|Part A and Part B|Lost to Follow-up|0|||
129857877|NCT02332720|467439421|FG020|Part A and Part B|Lost to Follow-up|0|||
129857878|NCT02332720|467439422|FG021|Part A and Part B|Lost to Follow-up|0|||
129857879|NCT02332720|467439423|FG022|Part A and Part B|Lost to Follow-up|0|||
129857880|NCT02332720|467439401|FG000|Part A and Part B|Adverse Event|0|||
129857881|NCT02332720|467439402|FG001|Part A and Part B|Adverse Event|0|||
129857882|NCT02332720|467439403|FG002|Part A and Part B|Adverse Event|0|||
129857883|NCT02332720|467439404|FG003|Part A and Part B|Adverse Event|0|||
129857884|NCT02332720|467439405|FG004|Part A and Part B|Adverse Event|0|||
129857885|NCT02332720|467439406|FG005|Part A and Part B|Adverse Event|0|||
129857886|NCT02332720|467439407|FG006|Part A and Part B|Adverse Event|0|||
129857887|NCT02332720|467439408|FG007|Part A and Part B|Adverse Event|0|||
129857888|NCT02332720|467439409|FG008|Part A and Part B|Adverse Event|0|||
129857889|NCT02332720|467439410|FG009|Part A and Part B|Adverse Event|0|||
129857890|NCT02332720|467439411|FG010|Part A and Part B|Adverse Event|0|||
129857891|NCT02332720|467439412|FG011|Part A and Part B|Adverse Event|0|||
129857892|NCT02332720|467439413|FG012|Part A and Part B|Adverse Event|0|||
129857893|NCT02332720|467439414|FG013|Part A and Part B|Adverse Event|0|||
129857894|NCT02332720|467439415|FG014|Part A and Part B|Adverse Event|0|||
129857895|NCT02332720|467439416|FG015|Part A and Part B|Adverse Event|0|||
129857896|NCT02332720|467439417|FG016|Part A and Part B|Adverse Event|0|||
129857897|NCT02332720|467439418|FG017|Part A and Part B|Adverse Event|1|||
129857898|NCT02332720|467439419|FG018|Part A and Part B|Adverse Event|0|||
129857899|NCT02332720|467439420|FG019|Part A and Part B|Adverse Event|0|||
129857900|NCT02332720|467439421|FG020|Part A and Part B|Adverse Event|0|||
129857901|NCT02332720|467439422|FG021|Part A and Part B|Adverse Event|0|||
129857902|NCT02332720|467439423|FG022|Part A and Part B|Adverse Event|0|||
129857903|NCT02332720|467439401|FG000|Part A and Part B|Physician Decision|0|||
129857904|NCT02332720|467439402|FG001|Part A and Part B|Physician Decision|0|||
129857905|NCT02332720|467439403|FG002|Part A and Part B|Physician Decision|0|||
129857906|NCT02332720|467439404|FG003|Part A and Part B|Physician Decision|0|||
129857907|NCT02332720|467439405|FG004|Part A and Part B|Physician Decision|0|||
129857908|NCT02332720|467439406|FG005|Part A and Part B|Physician Decision|0|||
129857909|NCT02332720|467439407|FG006|Part A and Part B|Physician Decision|0|||
129857910|NCT02332720|467439408|FG007|Part A and Part B|Physician Decision|0|||
129857911|NCT02332720|467439409|FG008|Part A and Part B|Physician Decision|0|||
129857912|NCT02332720|467439410|FG009|Part A and Part B|Physician Decision|0|||
129857913|NCT02332720|467439411|FG010|Part A and Part B|Physician Decision|0|||
129857914|NCT02332720|467439412|FG011|Part A and Part B|Physician Decision|0|||
129857915|NCT02332720|467439413|FG012|Part A and Part B|Physician Decision|0|||
129857916|NCT02332720|467439414|FG013|Part A and Part B|Physician Decision|0|||
129857917|NCT02332720|467439415|FG014|Part A and Part B|Physician Decision|0|||
129857918|NCT02332720|467439416|FG015|Part A and Part B|Physician Decision|0|||
129857919|NCT02332720|467439417|FG016|Part A and Part B|Physician Decision|0|||
129857920|NCT02332720|467439418|FG017|Part A and Part B|Physician Decision|0|||
129857921|NCT02332720|467439419|FG018|Part A and Part B|Physician Decision|1|||
129857922|NCT02332720|467439420|FG019|Part A and Part B|Physician Decision|0|||
129857923|NCT02332720|467439421|FG020|Part A and Part B|Physician Decision|0|||
129857924|NCT02332720|467439422|FG021|Part A and Part B|Physician Decision|0|||
129857925|NCT02332720|467439423|FG022|Part A and Part B|Physician Decision|0|||
129857926|NCT02332720|467439401|FG000|Part A and Part B|Withdrawal by Subject|0|||
129857927|NCT02332720|467439402|FG001|Part A and Part B|Withdrawal by Subject|0|||
129857928|NCT02332720|467439403|FG002|Part A and Part B|Withdrawal by Subject|0|||
129857929|NCT02332720|467439404|FG003|Part A and Part B|Withdrawal by Subject|0|||
129857930|NCT02332720|467439405|FG004|Part A and Part B|Withdrawal by Subject|0|||
129857931|NCT02332720|467439406|FG005|Part A and Part B|Withdrawal by Subject|1|||
129857932|NCT02332720|467439407|FG006|Part A and Part B|Withdrawal by Subject|0|||
129857933|NCT02332720|467439408|FG007|Part A and Part B|Withdrawal by Subject|0|||
129857934|NCT02332720|467439409|FG008|Part A and Part B|Withdrawal by Subject|0|||
129857935|NCT02332720|467439410|FG009|Part A and Part B|Withdrawal by Subject|0|||
129857936|NCT02332720|467439411|FG010|Part A and Part B|Withdrawal by Subject|0|||
129857937|NCT02332720|467439412|FG011|Part A and Part B|Withdrawal by Subject|0|||
129857938|NCT02332720|467439413|FG012|Part A and Part B|Withdrawal by Subject|0|||
129857939|NCT02332720|467439414|FG013|Part A and Part B|Withdrawal by Subject|0|||
129857940|NCT02332720|467439415|FG014|Part A and Part B|Withdrawal by Subject|0|||
129857941|NCT02332720|467439416|FG015|Part A and Part B|Withdrawal by Subject|0|||
129857942|NCT02332720|467439417|FG016|Part A and Part B|Withdrawal by Subject|0|||
129857943|NCT02332720|467439418|FG017|Part A and Part B|Withdrawal by Subject|0|||
129857944|NCT02332720|467439419|FG018|Part A and Part B|Withdrawal by Subject|0|||
129857945|NCT02332720|467439420|FG019|Part A and Part B|Withdrawal by Subject|1|||
129857946|NCT02332720|467439421|FG020|Part A and Part B|Withdrawal by Subject|0|||
129857947|NCT02332720|467439422|FG021|Part A and Part B|Withdrawal by Subject|0|||
129857948|NCT02332720|467439423|FG022|Part A and Part B|Withdrawal by Subject|0|||
129857949|NCT03832010|467439424|FG000|Overall Study|Withdrawal by Subject|2|||
129857950|NCT03832010|467439425|FG001|Overall Study|Withdrawal by Subject|1|||
129857951|NCT03832010|467439426|FG002|Overall Study|Withdrawal by Subject|0|||
129857952|NCT03832010|467439424|FG000|Overall Study|Lost to Follow-up|2|||
129857953|NCT03832010|467439425|FG001|Overall Study|Lost to Follow-up|1|||
129857954|NCT03832010|467439426|FG002|Overall Study|Lost to Follow-up|1|||
129857955|NCT03240588|467439428|FG000|Overall Study|Death|3|||
129857956|NCT03240588|467439429|FG001|Overall Study|Death|0|||
129857957|NCT03240588|467439430|FG002|Overall Study|Death|0|||
129857958|NCT03240588|467439428|FG000|Overall Study|Adverse Event|5|||
129857959|NCT03240588|467439429|FG001|Overall Study|Adverse Event|4|||
129857960|NCT03240588|467439430|FG002|Overall Study|Adverse Event|0|||
129857961|NCT03240588|467439428|FG000|Overall Study|Lost to Follow-up|9|||
129857962|NCT03240588|467439429|FG001|Overall Study|Lost to Follow-up|4|||
129857963|NCT03240588|467439430|FG002|Overall Study|Lost to Follow-up|0|||
129857964|NCT03240588|467439428|FG000|Overall Study|Physician Decision|3|||
129857965|NCT03240588|467439429|FG001|Overall Study|Physician Decision|2|||
129857966|NCT03240588|467439430|FG002|Overall Study|Physician Decision|0|||
129857967|NCT03240588|467439428|FG000|Overall Study|Did not meet eligibility criteria|0|||
129857968|NCT03240588|467439429|FG001|Overall Study|Did not meet eligibility criteria|6|||
129857969|NCT03240588|467439430|FG002|Overall Study|Did not meet eligibility criteria|0|||
129857970|NCT03240588|467439428|FG000|Overall Study|No longer meets protocol criteria|12|||
129857971|NCT03240588|467439429|FG001|Overall Study|No longer meets protocol criteria|7|||
129857972|NCT03240588|467439430|FG002|Overall Study|No longer meets protocol criteria|0|||
129857973|NCT03240588|467439428|FG000|Overall Study|Withdrawal by Subject|60|||
129857974|NCT03240588|467439429|FG001|Overall Study|Withdrawal by Subject|52|||
129857975|NCT03240588|467439430|FG002|Overall Study|Withdrawal by Subject|7|||
129857976|NCT03240588|467439428|FG000|Overall Study|Other, additional details not available.|0|||
129857977|NCT03240588|467439429|FG001|Overall Study|Other, additional details not available.|12|||
129857978|NCT03240588|467439430|FG002|Overall Study|Other, additional details not available.|1|||
129857979|NCT03240588|467439428|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
129857980|NCT03240588|467439429|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
129857981|NCT03240588|467439430|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
129857982|NCT03240588|467439428|FG000|Overall Study|Closure of study|55|||
129857983|NCT03240588|467439429|FG001|Overall Study|Closure of study|3|||
129857984|NCT03240588|467439430|FG002|Overall Study|Closure of study|0|||
129857985|NCT03240588|467439428|FG000|Overall Study|Subject non-compliance|23|||
129857986|NCT03240588|467439429|FG001|Overall Study|Subject non-compliance|2|||
129857987|NCT03240588|467439430|FG002|Overall Study|Subject non-compliance|1|||
129857988|NCT03240588|467439428|FG000|Overall Study|Device Deficiency|1|||
129857989|NCT03240588|467439429|FG001|Overall Study|Device Deficiency|0|||
129857990|NCT03240588|467439430|FG002|Overall Study|Device Deficiency|0|||
129857991|NCT03240588|467439428|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
129857992|NCT03240588|467439429|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
129857993|NCT03240588|467439430|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
129857994|NCT03422250|467439431|FG000|Intervention|Adverse Event|0|||
129857995|NCT03422250|467439432|FG001|Intervention|Adverse Event|1|||
129857996|NCT03422250|467439433|FG002|Intervention|Adverse Event|0|||
129857997|NCT03422250|467439434|FG003|Intervention|Adverse Event|1|||
129857998|NCT03422250|467439431|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
129857999|NCT03422250|467439432|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
129909775|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
129909776|NCT02409667|467632403|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
129909777|NCT02409667|467632404|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129909778|NCT02409667|467632405|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129909779|NCT02409667|467632406|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129858000|NCT03422250|467439433|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
129909780|NCT02409667|467632407|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
129909781|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
129909782|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
129858001|NCT03422250|467439434|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
129858002|NCT03422250|467439431|FG000|Follow-up|Withdrawal by Subject|0|||
129858003|NCT03422250|467439432|FG001|Follow-up|Withdrawal by Subject|0|||
129858004|NCT03422250|467439433|FG002|Follow-up|Withdrawal by Subject|0|||
129858005|NCT03422250|467439434|FG003|Follow-up|Withdrawal by Subject|1|||
129858006|NCT03422250|467439431|FG000|Follow-up|Adverse Event|0|||
129858007|NCT03422250|467439432|FG001|Follow-up|Adverse Event|0|||
129858008|NCT03422250|467439433|FG002|Follow-up|Adverse Event|0|||
129858009|NCT03422250|467439434|FG003|Follow-up|Adverse Event|1|||
129858010|NCT02091726|467439437|FG000|Overall Study|Lost to Follow-up|6|||
129858011|NCT00467870|467439438|FG000|Overall Study|Adverse Event|13|||
129858012|NCT00467870|467439439|FG001|Overall Study|Adverse Event|9|||
129858013|NCT00467870|467439440|FG002|Overall Study|Adverse Event|1|||
129858014|NCT00467870|467439441|FG003|Overall Study|Adverse Event|15|||
129858015|NCT00467870|467439442|FG004|Overall Study|Adverse Event|15|||
129858016|NCT00467870|467439443|FG005|Overall Study|Adverse Event|1|||
129858017|NCT00467870|467439438|FG000|Overall Study|Protocol Violation|2|||
129858018|NCT00467870|467439439|FG001|Overall Study|Protocol Violation|1|||
129858019|NCT00467870|467439440|FG002|Overall Study|Protocol Violation|1|||
129858020|NCT00467870|467439441|FG003|Overall Study|Protocol Violation|2|||
129858021|NCT00467870|467439442|FG004|Overall Study|Protocol Violation|0|||
129858022|NCT00467870|467439443|FG005|Overall Study|Protocol Violation|0|||
129858023|NCT00467870|467439438|FG000|Overall Study|Withdrawal by Subject|14|||
129858024|NCT00467870|467439439|FG001|Overall Study|Withdrawal by Subject|21|||
129858025|NCT00467870|467439440|FG002|Overall Study|Withdrawal by Subject|0|||
129858026|NCT00467870|467439441|FG003|Overall Study|Withdrawal by Subject|9|||
129858027|NCT00467870|467439442|FG004|Overall Study|Withdrawal by Subject|10|||
129858028|NCT00467870|467439443|FG005|Overall Study|Withdrawal by Subject|1|||
129858029|NCT00467870|467439438|FG000|Overall Study|Lost to Follow-up|5|||
129858030|NCT00467870|467439439|FG001|Overall Study|Lost to Follow-up|3|||
129858031|NCT00467870|467439440|FG002|Overall Study|Lost to Follow-up|1|||
129858032|NCT00467870|467439441|FG003|Overall Study|Lost to Follow-up|1|||
129858033|NCT00467870|467439442|FG004|Overall Study|Lost to Follow-up|3|||
129858034|NCT00467870|467439443|FG005|Overall Study|Lost to Follow-up|0|||
129858035|NCT00467870|467439438|FG000|Overall Study|Subject Non-compliance|3|||
129858036|NCT00467870|467439439|FG001|Overall Study|Subject Non-compliance|4|||
129858037|NCT00467870|467439440|FG002|Overall Study|Subject Non-compliance|0|||
129858038|NCT00467870|467439441|FG003|Overall Study|Subject Non-compliance|1|||
129858039|NCT00467870|467439442|FG004|Overall Study|Subject Non-compliance|5|||
129858040|NCT00467870|467439443|FG005|Overall Study|Subject Non-compliance|0|||
129858041|NCT00467870|467439438|FG000|Overall Study|Other/Unknown|8|||
129858042|NCT00467870|467439439|FG001|Overall Study|Other/Unknown|5|||
129858043|NCT00467870|467439440|FG002|Overall Study|Other/Unknown|1|||
129858044|NCT00467870|467439441|FG003|Overall Study|Other/Unknown|5|||
129858045|NCT00467870|467439442|FG004|Overall Study|Other/Unknown|4|||
129858046|NCT00467870|467439443|FG005|Overall Study|Other/Unknown|0|||
129858047|NCT00321919|467439444|FG000|Overall Study|Adverse Event|17|||
129858048|NCT00321919|467439445|FG001|Overall Study|Adverse Event|10|||
129858049|NCT00321919|467439444|FG000|Overall Study|Death|21|||
129858050|NCT00321919|467439445|FG001|Overall Study|Death|17|||
129858051|NCT00321919|467439444|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129858052|NCT00321919|467439445|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129858053|NCT00321919|467439444|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129858054|NCT00321919|467439445|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129858055|NCT00321919|467439444|FG000|Overall Study|Refused Treatment|23|||
129858056|NCT00321919|467439445|FG001|Overall Study|Refused Treatment|14|||
129858057|NCT00321919|467439444|FG000|Overall Study|Other Protocol Violation|2|||
129858058|NCT00321919|467439445|FG001|Overall Study|Other Protocol Violation|3|||
129858059|NCT00321919|467439444|FG000|Overall Study|Failure to Return|3|||
129858060|NCT00321919|467439445|FG001|Overall Study|Failure to Return|1|||
129858061|NCT00321919|467439444|FG000|Overall Study|Other withdrawal reason|7|||
129858062|NCT00321919|467439445|FG001|Overall Study|Other withdrawal reason|6|||
129858063|NCT02261363|467439446|FG000|Overall Study|Lost to Follow-up|21|||
129858064|NCT01517802|467439447|FG000|Overall Study|Death|1|||
129858065|NCT02590354|467439448|FG000|Phase 1|Active hepatitis B or C infection|1|||
129858066|NCT02590354|467439448|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
129858067|NCT02590354|467439448|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
129858068|NCT02590354|467439448|FG000|Phase 1|Subject does not want to participate|20|||
129858069|NCT02590354|467439448|FG000|Phase 1|Lost to Follow-up|1|||
129858070|NCT02590354|467439448|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
129858071|NCT02099838|467439449|FG000|Overall Study|Death|1|||
129858072|NCT02099838|467439450|FG001|Overall Study|Death|0|||
129858073|NCT02099838|467439449|FG000|Overall Study|Lost to Follow-up|3|||
129858074|NCT02099838|467439450|FG001|Overall Study|Lost to Follow-up|1|||
129858075|NCT02099838|467439449|FG000|Overall Study|Withdrawal by Subject|0|||
129858076|NCT02099838|467439450|FG001|Overall Study|Withdrawal by Subject|1|||
129858077|NCT02301143|467439451|FG000|Induction Period|Enrolled But Not Treated|1|||
129858078|NCT02301143|467439452|FG001|Induction Period|Enrolled But Not Treated|0|||
129858079|NCT02301143|467439451|FG000|Induction Period|Death|1|||
129858080|NCT02301143|467439452|FG001|Induction Period|Death|0|||
129858081|NCT02301143|467439451|FG000|Induction Period|Adverse Event|22|||
129858082|NCT02301143|467439452|FG001|Induction Period|Adverse Event|0|||
129858083|NCT02301143|467439451|FG000|Induction Period|Progressive Disease|8|||
129858084|NCT02301143|467439452|FG001|Induction Period|Progressive Disease|0|||
129858085|NCT02301143|467439451|FG000|Induction Period|Withdrawal by Subject|3|||
129858086|NCT02301143|467439452|FG001|Induction Period|Withdrawal by Subject|0|||
129909783|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
129909784|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
129909785|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
129909786|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909787|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909788|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909789|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
129909790|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
129909791|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
129909792|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
129909793|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
129909794|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
129909795|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
129909796|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
129909797|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
129909798|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
129909799|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
129909800|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
129909801|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
129909802|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
129909803|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
129909804|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
129909805|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
129909806|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
129909807|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
129909808|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
129909809|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
129909810|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
129909811|NCT02409667|467632403|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909812|NCT02409667|467632404|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909813|NCT02409667|467632405|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
129909814|NCT02409667|467632406|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909815|NCT02409667|467632407|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
129909816|NCT03482635|467632410|FG000|Overall Study|Lack of Efficacy|0|||
129909817|NCT03482635|467632411|FG001|Overall Study|Lack of Efficacy|0|||
129909818|NCT03482635|467632412|FG002|Overall Study|Lack of Efficacy|1|||
129909819|NCT03482635|467632413|FG003|Overall Study|Lack of Efficacy|3|||
129909820|NCT03482635|467632410|FG000|Overall Study|Adverse Event|2|||
129909821|NCT03482635|467632411|FG001|Overall Study|Adverse Event|2|||
129909822|NCT03482635|467632412|FG002|Overall Study|Adverse Event|0|||
129909823|NCT03482635|467632413|FG003|Overall Study|Adverse Event|3|||
129909824|NCT03482635|467632410|FG000|Overall Study|Withdrawal by Subject|2|||
129909825|NCT03482635|467632411|FG001|Overall Study|Withdrawal by Subject|1|||
129909826|NCT03482635|467632412|FG002|Overall Study|Withdrawal by Subject|0|||
129909827|NCT03482635|467632413|FG003|Overall Study|Withdrawal by Subject|1|||
129909828|NCT03482635|467632410|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
129909829|NCT03482635|467632411|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
129909830|NCT03482635|467632412|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
129909831|NCT03482635|467632413|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
129909832|NCT03482635|467632410|FG000|Overall Study|Not treated|0|||
129909833|NCT03482635|467632411|FG001|Overall Study|Not treated|0|||
129909834|NCT03482635|467632412|FG002|Overall Study|Not treated|0|||
129909835|NCT03482635|467632413|FG003|Overall Study|Not treated|1|||
129449698|NCT02665052|465945653|FG003|Overall Study|Adverse Event|0|||
129449699|NCT00823823|465945654|FG000|Overall Study|Lost to Follow-up|3|||
129909836|NCT03237481|467633701|FG000|Overall Study|Lost to Follow-up|1|||
129909837|NCT03237481|467633702|FG001|Overall Study|Lost to Follow-up|0|||
129909838|NCT03237481|467633703|FG002|Overall Study|Lost to Follow-up|0|||
129909839|NCT03237481|467633701|FG000|Overall Study|Protocol Violation|1|||
129909840|NCT03237481|467633702|FG001|Overall Study|Protocol Violation|0|||
129909841|NCT03237481|467633703|FG002|Overall Study|Protocol Violation|0|||
129909842|NCT03237481|467633701|FG000|Overall Study|Withdrawal by Subject|3|||
129909843|NCT03237481|467633702|FG001|Overall Study|Withdrawal by Subject|2|||
129909844|NCT03237481|467633703|FG002|Overall Study|Withdrawal by Subject|1|||
129909845|NCT03936660|467633704|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
129909846|NCT03936660|467633705|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
129909847|NCT03112174|467633706|FG000|Overall Study|Withdrawal by Subject|3|||
129909848|NCT03112174|467633707|FG001|Overall Study|Withdrawal by Subject|0|||
129449700|NCT00823823|465945655|FG001|Overall Study|Lost to Follow-up|1|||
129909849|NCT03112174|467633708|FG002|Overall Study|Withdrawal by Subject|11|||
129858087|NCT02301143|467439451|FG000|Induction Period|Noncompliance with Study Drug|1|||
129858088|NCT02301143|467439452|FG001|Induction Period|Noncompliance with Study Drug|0|||
129858089|NCT02301143|467439451|FG000|Induction Period|Physician Decision|4|||
129858090|NCT02301143|467439452|FG001|Induction Period|Physician Decision|0|||
129858091|NCT02301143|467439451|FG000|Induction Period|Symptomatic Deterioration|2|||
129858092|NCT02301143|467439452|FG001|Induction Period|Symptomatic Deterioration|0|||
129858093|NCT02301143|467439451|FG000|Induction Period|Protocol Violation|2|||
129858094|NCT02301143|467439452|FG001|Induction Period|Protocol Violation|0|||
129858095|NCT02301143|467439451|FG000|Induction Period|Other|1|||
129858096|NCT02301143|467439452|FG001|Induction Period|Other|0|||
129858097|NCT02301143|467439451|FG000|Investigator's Choice|Adverse Event|0|||
129858098|NCT02301143|467439452|FG001|Investigator's Choice|Adverse Event|3|||
129858099|NCT02301143|467439451|FG000|Investigator's Choice|Progressive Disease|0|||
129858100|NCT02301143|467439452|FG001|Investigator's Choice|Progressive Disease|3|||
129858101|NCT02301143|467439451|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
129858102|NCT02301143|467439452|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
129858103|NCT02301143|467439451|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
129858104|NCT02301143|467439452|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
129858105|NCT02301143|467439451|FG000|Investigator's Choice|Other|0|||
129858106|NCT02301143|467439452|FG001|Investigator's Choice|Other|1|||
129858107|NCT02301143|467439451|FG000|Investigator's Choice|Unresectable Surgery|0|||
129858108|NCT02301143|467439452|FG001|Investigator's Choice|Unresectable Surgery|1|||
129858109|NCT02536508|467439455|FG000|Overall Study|Withdrawal by Subject|18|||
129858110|NCT02536508|467439456|FG001|Overall Study|Withdrawal by Subject|13|||
129858111|NCT02536508|467439457|FG002|Overall Study|Withdrawal by Subject|7|||
129858112|NCT02536508|467439455|FG000|Overall Study|Adverse Event|14|||
129858113|NCT02536508|467439456|FG001|Overall Study|Adverse Event|13|||
129858114|NCT02536508|467439457|FG002|Overall Study|Adverse Event|6|||
129858115|NCT02536508|467439455|FG000|Overall Study|Lost to Follow-up|12|||
129858116|NCT02536508|467439456|FG001|Overall Study|Lost to Follow-up|4|||
129858117|NCT02536508|467439457|FG002|Overall Study|Lost to Follow-up|0|||
129858118|NCT02536508|467439455|FG000|Overall Study|Lack of Efficacy|3|||
129858119|NCT02536508|467439456|FG001|Overall Study|Lack of Efficacy|5|||
129858120|NCT02536508|467439457|FG002|Overall Study|Lack of Efficacy|4|||
129858121|NCT02536508|467439455|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
129858122|NCT02536508|467439456|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
129858123|NCT02536508|467439457|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
129858124|NCT02536508|467439455|FG000|Overall Study|Physician Decision|0|||
129858125|NCT02536508|467439456|FG001|Overall Study|Physician Decision|4|||
129858126|NCT02536508|467439457|FG002|Overall Study|Physician Decision|2|||
129858127|NCT02536508|467439455|FG000|Overall Study|Major Protocol Deviation|2|||
129858128|NCT02536508|467439456|FG001|Overall Study|Major Protocol Deviation|2|||
129858129|NCT02536508|467439457|FG002|Overall Study|Major Protocol Deviation|2|||
129858130|NCT02536508|467439455|FG000|Overall Study|Administrative Reasons|0|||
129858131|NCT02536508|467439456|FG001|Overall Study|Administrative Reasons|1|||
129858132|NCT02536508|467439457|FG002|Overall Study|Administrative Reasons|0|||
129858133|NCT00823719|467439460|FG000|Overall Study|Adverse Event|1|||
129858134|NCT00823719|467439461|FG001|Overall Study|Adverse Event|2|||
129858135|NCT00823719|467439460|FG000|Overall Study|Physician Decision|1|||
129858136|NCT00823719|467439461|FG001|Overall Study|Physician Decision|4|||
129858137|NCT00823719|467439460|FG000|Overall Study|Withdrawal by Subject|0|||
129858138|NCT00823719|467439461|FG001|Overall Study|Withdrawal by Subject|1|||
129858139|NCT00823719|467439460|FG000|Overall Study|Disease Progression|4|||
129858140|NCT00823719|467439461|FG001|Overall Study|Disease Progression|4|||
129858141|NCT02219932|467439469|FG000|Overall Study|Other|5|||
129858142|NCT02219932|467439470|FG001|Overall Study|Other|11|||
129858143|NCT02219932|467439469|FG000|Overall Study|Death|1|||
129858144|NCT02219932|467439470|FG001|Overall Study|Death|1|||
129858145|NCT02219932|467439469|FG000|Overall Study|Investigator Decision|0|||
129858146|NCT02219932|467439470|FG001|Overall Study|Investigator Decision|1|||
129858147|NCT02219932|467439469|FG000|Overall Study|Consent Withdrawn|11|||
129858148|NCT02219932|467439470|FG001|Overall Study|Consent Withdrawn|7|||
129858149|NCT02219932|467439469|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
129858150|NCT02219932|467439470|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
129858151|NCT02219932|467439469|FG000|Overall Study|Protocol Violation|10|||
129858152|NCT02219932|467439470|FG001|Overall Study|Protocol Violation|6|||
129858153|NCT02219932|467439469|FG000|Overall Study|Pregnancy|1|||
129858154|NCT02219932|467439470|FG001|Overall Study|Pregnancy|0|||
129858155|NCT02219932|467439469|FG000|Overall Study|Lost to Follow-up|4|||
129858156|NCT02219932|467439470|FG001|Overall Study|Lost to Follow-up|2|||
129858157|NCT02219932|467439469|FG000|Overall Study|Adverse Event|23|||
129858158|NCT02219932|467439470|FG001|Overall Study|Adverse Event|21|||
129858159|NCT00093145|467439471|FG000|Overall Study|Unacceptable Toxicity Only|2|||
129858160|NCT00093145|467439471|FG000|Overall Study|Physician Decision|5|||
129858161|NCT00093145|467439471|FG000|Overall Study|Withdrawal by Subject|9|||
129858162|NCT00093145|467439471|FG000|Overall Study|Other|1|||
129858163|NCT04389840|467439472|FG000|Overall Study|Adverse Event|0|||
129909850|NCT03112174|467633709|FG003|Overall Study|Withdrawal by Subject|9|||
129909851|NCT03112174|467633710|FG004|Overall Study|Withdrawal by Subject|7|||
129909852|NCT03112174|467633706|FG000|Overall Study|Lost to Follow-up|1|||
129909853|NCT03112174|467633707|FG001|Overall Study|Lost to Follow-up|1|||
129909854|NCT03112174|467633708|FG002|Overall Study|Lost to Follow-up|2|||
129909855|NCT03112174|467633709|FG003|Overall Study|Lost to Follow-up|3|||
129909856|NCT03112174|467633710|FG004|Overall Study|Lost to Follow-up|2|||
129909857|NCT03112174|467633706|FG000|Overall Study|Death|8|||
129909858|NCT03112174|467633707|FG001|Overall Study|Death|3|||
129909859|NCT03112174|467633708|FG002|Overall Study|Death|67|||
129909860|NCT03112174|467633709|FG003|Overall Study|Death|73|||
129909861|NCT03112174|467633710|FG004|Overall Study|Death|18|||
129909862|NCT03112174|467633706|FG000|Overall Study|Other, Not Specified|1|||
129909863|NCT03112174|467633707|FG001|Overall Study|Other, Not Specified|0|||
129909864|NCT03112174|467633708|FG002|Overall Study|Other, Not Specified|1|||
129909865|NCT03112174|467633709|FG003|Overall Study|Other, Not Specified|2|||
129909866|NCT03112174|467633710|FG004|Overall Study|Other, Not Specified|0|||
129909867|NCT04259450|467633713|FG000|Overall Study|Adverse event/ Toxicity|0|||
129909868|NCT04259450|467633714|FG001|Overall Study|Adverse event/ Toxicity|3|||
129909869|NCT04259450|467633715|FG002|Overall Study|Adverse event/ Toxicity|0|||
129909870|NCT04259450|467633716|FG003|Overall Study|Adverse event/ Toxicity|1|||
129909871|NCT04259450|467633717|FG004|Overall Study|Adverse event/ Toxicity|0|||
129909872|NCT04259450|467633718|FG005|Overall Study|Adverse event/ Toxicity|0|||
129909873|NCT04259450|467633719|FG006|Overall Study|Adverse event/ Toxicity|0|||
129909874|NCT04259450|467633720|FG007|Overall Study|Adverse event/ Toxicity|1|||
129909875|NCT04259450|467633721|FG008|Overall Study|Adverse event/ Toxicity|0|||
129909876|NCT04259450|467633722|FG009|Overall Study|Adverse event/ Toxicity|3|||
129909877|NCT04259450|467633713|FG000|Overall Study|Disease progression|2|||
129909878|NCT04259450|467633714|FG001|Overall Study|Disease progression|3|||
129909879|NCT04259450|467633715|FG002|Overall Study|Disease progression|4|||
129909880|NCT04259450|467633716|FG003|Overall Study|Disease progression|4|||
129909881|NCT04259450|467633717|FG004|Overall Study|Disease progression|6|||
129909882|NCT04259450|467633718|FG005|Overall Study|Disease progression|6|||
129909883|NCT04259450|467633719|FG006|Overall Study|Disease progression|6|||
129909884|NCT04259450|467633720|FG007|Overall Study|Disease progression|15|||
129909885|NCT04259450|467633721|FG008|Overall Study|Disease progression|6|||
129909886|NCT04259450|467633722|FG009|Overall Study|Disease progression|18|||
129909887|NCT04259450|467633713|FG000|Overall Study|Death|0|||
129909888|NCT04259450|467633714|FG001|Overall Study|Death|0|||
129909889|NCT04259450|467633715|FG002|Overall Study|Death|0|||
129909890|NCT04259450|467633716|FG003|Overall Study|Death|0|||
129909891|NCT04259450|467633717|FG004|Overall Study|Death|0|||
129909892|NCT04259450|467633718|FG005|Overall Study|Death|0|||
129909893|NCT04259450|467633719|FG006|Overall Study|Death|0|||
129909894|NCT04259450|467633720|FG007|Overall Study|Death|1|||
129909895|NCT04259450|467633721|FG008|Overall Study|Death|1|||
129909896|NCT04259450|467633722|FG009|Overall Study|Death|0|||
129909897|NCT04259450|467633713|FG000|Overall Study|Withdrawal by Subject|0|||
129909898|NCT04259450|467633714|FG001|Overall Study|Withdrawal by Subject|0|||
129909899|NCT04259450|467633715|FG002|Overall Study|Withdrawal by Subject|0|||
129909900|NCT04259450|467633716|FG003|Overall Study|Withdrawal by Subject|0|||
129909901|NCT04259450|467633717|FG004|Overall Study|Withdrawal by Subject|0|||
129858164|NCT04389840|467439473|FG001|Overall Study|Adverse Event|0|||
129858165|NCT04389840|467439474|FG002|Overall Study|Adverse Event|0|||
129858166|NCT04389840|467439475|FG003|Overall Study|Adverse Event|1|||
129858167|NCT04389840|467439476|FG004|Overall Study|Adverse Event|0|||
129858168|NCT04389840|467439477|FG005|Overall Study|Adverse Event|0|||
129858169|NCT04389840|467439472|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
129858170|NCT04389840|467439473|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
129858171|NCT04389840|467439474|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
129858172|NCT04389840|467439475|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
129858173|NCT04389840|467439476|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
129858174|NCT04389840|467439477|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
129909902|NCT04259450|467633718|FG005|Overall Study|Withdrawal by Subject|0|||
129909903|NCT04259450|467633719|FG006|Overall Study|Withdrawal by Subject|0|||
129909904|NCT04259450|467633720|FG007|Overall Study|Withdrawal by Subject|1|||
129909905|NCT04259450|467633721|FG008|Overall Study|Withdrawal by Subject|0|||
129909906|NCT04259450|467633722|FG009|Overall Study|Withdrawal by Subject|0|||
129909907|NCT04259450|467633713|FG000|Overall Study|Other than listed|0|||
129909908|NCT04259450|467633714|FG001|Overall Study|Other than listed|0|||
129909909|NCT04259450|467633715|FG002|Overall Study|Other than listed|0|||
129909910|NCT04259450|467633716|FG003|Overall Study|Other than listed|0|||
129909911|NCT04259450|467633717|FG004|Overall Study|Other than listed|0|||
129909912|NCT04259450|467633718|FG005|Overall Study|Other than listed|0|||
129909913|NCT04259450|467633719|FG006|Overall Study|Other than listed|0|||
129909914|NCT04259450|467633720|FG007|Overall Study|Other than listed|1|||
129909915|NCT04259450|467633721|FG008|Overall Study|Other than listed|1|||
129909916|NCT04259450|467633722|FG009|Overall Study|Other than listed|2|||
129858175|NCT04389840|467439472|FG000|Overall Study|Death|0|||
129858176|NCT04389840|467439473|FG001|Overall Study|Death|1|||
129858177|NCT04389840|467439474|FG002|Overall Study|Death|0|||
129858178|NCT04389840|467439475|FG003|Overall Study|Death|0|||
129858179|NCT04389840|467439476|FG004|Overall Study|Death|0|||
129858180|NCT04389840|467439477|FG005|Overall Study|Death|0|||
129858181|NCT02252211|467439478|FG000|Overall Study|Adverse Event|0|||
129858182|NCT02252211|467439479|FG001|Overall Study|Adverse Event|1|||
129858183|NCT02252211|467439480|FG002|Overall Study|Adverse Event|0|||
129858184|NCT02252211|467439478|FG000|Overall Study|Progressive disease|3|||
129858185|NCT02252211|467439479|FG001|Overall Study|Progressive disease|2|||
129858186|NCT02252211|467439480|FG002|Overall Study|Progressive disease|0|||
129858187|NCT02252211|467439478|FG000|Overall Study|Withdrawal by Subject|1|||
129858188|NCT02252211|467439479|FG001|Overall Study|Withdrawal by Subject|0|||
129858189|NCT02252211|467439480|FG002|Overall Study|Withdrawal by Subject|0|||
129858190|NCT02252211|467439478|FG000|Overall Study|Serious Adverse Event During Screening|1|||
129858191|NCT02252211|467439479|FG001|Overall Study|Serious Adverse Event During Screening|0|||
129858192|NCT02252211|467439480|FG002|Overall Study|Serious Adverse Event During Screening|1|||
129858193|NCT00968669|467439481|FG000|Overall Study|Lost to Follow-up|5|||
129858194|NCT00968669|467439482|FG001|Overall Study|Lost to Follow-up|2|||
129858195|NCT00968669|467439483|FG002|Overall Study|Lost to Follow-up|1|||
129858196|NCT00968669|467439484|FG003|Overall Study|Lost to Follow-up|4|||
129858197|NCT00968669|467439481|FG000|Overall Study|Withdrawal by Subject|9|||
129858198|NCT00968669|467439482|FG001|Overall Study|Withdrawal by Subject|7|||
129858199|NCT00968669|467439483|FG002|Overall Study|Withdrawal by Subject|5|||
129858200|NCT00968669|467439484|FG003|Overall Study|Withdrawal by Subject|3|||
129858201|NCT00968669|467439481|FG000|Overall Study|Pregnancy|0|||
129858202|NCT00968669|467439482|FG001|Overall Study|Pregnancy|0|||
129858203|NCT00968669|467439483|FG002|Overall Study|Pregnancy|2|||
129858204|NCT00968669|467439484|FG003|Overall Study|Pregnancy|0|||
129858205|NCT00968669|467439481|FG000|Overall Study|AE|1|||
129858206|NCT00968669|467439482|FG001|Overall Study|AE|0|||
129858207|NCT00968669|467439483|FG002|Overall Study|AE|0|||
129858208|NCT00968669|467439484|FG003|Overall Study|AE|0|||
129858209|NCT00968669|467439481|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
129858210|NCT00968669|467439482|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
129858211|NCT00968669|467439483|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
129858212|NCT00968669|467439484|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
129858213|NCT00968669|467439481|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
129858214|NCT00968669|467439482|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
129858215|NCT00968669|467439483|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
129858216|NCT00968669|467439484|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
129858217|NCT00968669|467439481|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
129858218|NCT00968669|467439482|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
129858219|NCT00968669|467439483|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
129858220|NCT00968669|467439484|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
129858221|NCT00968669|467439481|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
129858222|NCT00968669|467439482|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
129858223|NCT00968669|467439483|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
129858224|NCT00968669|467439484|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
129858225|NCT00968669|467439481|FG000|Overall Study|EARLY WITHDRAWAL|0|||
129858226|NCT00968669|467439482|FG001|Overall Study|EARLY WITHDRAWAL|1|||
129858227|NCT00968669|467439483|FG002|Overall Study|EARLY WITHDRAWAL|0|||
129858228|NCT00968669|467439484|FG003|Overall Study|EARLY WITHDRAWAL|0|||
129858229|NCT00968669|467439481|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
129858230|NCT00968669|467439482|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
129858231|NCT00968669|467439483|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
129858232|NCT00968669|467439484|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
129858233|NCT00968669|467439481|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
129858234|NCT00968669|467439482|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
129858235|NCT00968669|467439483|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
129858236|NCT00968669|467439484|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
129858237|NCT00968669|467439481|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
129858238|NCT00968669|467439482|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
129858239|NCT00968669|467439483|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
129858240|NCT00968669|467439484|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
129858241|NCT00968669|467439481|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
129858242|NCT00968669|467439482|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
129449701|NCT00823823|465945654|FG000|Overall Study|Protocol Violation|5|||
129858243|NCT00968669|467439483|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
129858244|NCT00968669|467439484|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
129858245|NCT00968669|467439481|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
129858246|NCT00968669|467439482|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
129909917|NCT01534494|467633723|FG000|Overall Study|Withdrawal by Subject|1|||
129909918|NCT02724592|467633724|FG000|Overall Study|Lost to Follow-up|4|||
129909919|NCT02724592|467633725|FG001|Overall Study|Lost to Follow-up|1|||
129909920|NCT02584829|467633726|FG000|Overall Study|Physician Decision|1|||
129909921|NCT02584829|467633727|FG001|Overall Study|Physician Decision|0|||
129909922|NCT02584829|467633726|FG000|Overall Study|Withdrawal by Subject|0|||
129909923|NCT02584829|467633727|FG001|Overall Study|Withdrawal by Subject|1|||
129909924|NCT02584829|467633726|FG000|Overall Study|Progressive Disease|0|||
129909925|NCT02584829|467633727|FG001|Overall Study|Progressive Disease|3|||
129909926|NCT00434304|467633733|FG000|Overall Study|Adverse Event|14|||
129909927|NCT00434304|467633733|FG000|Overall Study|Lack of Efficacy|2|||
129909928|NCT00434304|467633733|FG000|Overall Study|Withdrawal by Subject|4|||
129909929|NCT05262738|467633734|FG000|Overall Study|Withdrawal by Subject|1|||
129909930|NCT05262738|467633735|FG001|Overall Study|Withdrawal by Subject|0|||
129909931|NCT02374463|467633736|FG000|Overall Study|Withdrawal by Subject|3|||
129909932|NCT02374463|467633737|FG001|Overall Study|Withdrawal by Subject|3|||
129909933|NCT01939899|467633744|FG000|Lead-in Dose Finding Phase|Death|0|||
129909934|NCT01939899|467633745|FG001|Lead-in Dose Finding Phase|Death|3|||
129909935|NCT01939899|467633746|FG002|Lead-in Dose Finding Phase|Death|1|||
129909936|NCT01939899|467633747|FG003|Lead-in Dose Finding Phase|Death|0|||
129909937|NCT01939899|467633748|FG004|Lead-in Dose Finding Phase|Death|0|||
129909938|NCT01939899|467633744|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
129909939|NCT01939899|467633745|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
129858247|NCT00968669|467439483|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
129858248|NCT00968669|467439484|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
129858249|NCT00968669|467439481|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
129858250|NCT00968669|467439482|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
129858251|NCT00968669|467439483|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
129858252|NCT00968669|467439484|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
129858253|NCT00968669|467439481|FG000|Overall Study|SPONSOR DECISION|0|||
129858254|NCT00968669|467439482|FG001|Overall Study|SPONSOR DECISION|1|||
129858255|NCT00968669|467439483|FG002|Overall Study|SPONSOR DECISION|0|||
129858256|NCT00968669|467439484|FG003|Overall Study|SPONSOR DECISION|0|||
129858257|NCT00968669|467439481|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
129858258|NCT00968669|467439482|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
129858259|NCT00968669|467439483|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
129858260|NCT00968669|467439484|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
129858261|NCT00968669|467439481|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
129858262|NCT00968669|467439482|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
129858263|NCT00968669|467439483|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
129858264|NCT00968669|467439484|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
129858265|NCT00968669|467439481|FG000|Overall Study|SUBJECT INCARCERATED|0|||
129858266|NCT00968669|467439482|FG001|Overall Study|SUBJECT INCARCERATED|1|||
129858267|NCT00968669|467439483|FG002|Overall Study|SUBJECT INCARCERATED|0|||
129858268|NCT00968669|467439484|FG003|Overall Study|SUBJECT INCARCERATED|0|||
129858269|NCT00968669|467439481|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
129858270|NCT00968669|467439482|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
129858271|NCT00968669|467439483|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
129858272|NCT00968669|467439484|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
129858273|NCT00968669|467439481|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
129858274|NCT00968669|467439482|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
129858275|NCT00968669|467439483|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
129858276|NCT00968669|467439484|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
129858277|NCT00144339|467439485|FG000|Overall Study|Adverse Event|746|||
129858278|NCT00144339|467439486|FG001|Overall Study|Adverse Event|627|||
129858279|NCT00144339|467439485|FG000|Overall Study|Protocol Violation|75|||
129858280|NCT00144339|467439486|FG001|Overall Study|Protocol Violation|48|||
129858281|NCT00144339|467439485|FG000|Overall Study|Withdrawal by Subject|403|||
129858282|NCT00144339|467439486|FG001|Overall Study|Withdrawal by Subject|300|||
129858283|NCT00144339|467439485|FG000|Overall Study|Lost to Follow-up|76|||
129858284|NCT00144339|467439486|FG001|Overall Study|Lost to Follow-up|64|||
129909940|NCT01939899|467633746|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
129858285|NCT00144339|467439485|FG000|Overall Study|Other|58|||
129858286|NCT00144339|467439486|FG001|Overall Study|Other|60|||
129858287|NCT01109992|467439487|FG000|Overall Study|Withdrawal by Subject|0|||
129858288|NCT01109992|467439488|FG001|Overall Study|Withdrawal by Subject|1|||
129858289|NCT01109992|467439487|FG000|Overall Study|Movement during rest scan.|0|||
129858290|NCT01109992|467439488|FG001|Overall Study|Movement during rest scan.|1|||
129858291|NCT00690755|467439489|FG000|Overall Study|Physician Decision|2|||
129909941|NCT01939899|467633747|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
129909942|NCT01939899|467633748|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
129909943|NCT01939899|467633744|FG000|Lead-in Dose Finding Phase|Other|0|||
129909944|NCT01939899|467633745|FG001|Lead-in Dose Finding Phase|Other|0|||
129909945|NCT01939899|467633746|FG002|Lead-in Dose Finding Phase|Other|1|||
129858292|NCT00690755|467439490|FG001|Overall Study|Physician Decision|0|||
129858293|NCT00690755|467439491|FG002|Overall Study|Physician Decision|46|||
129858294|NCT00690755|467439492|FG003|Overall Study|Physician Decision|5|||
129858295|NCT00690755|467439493|FG004|Overall Study|Physician Decision|0|||
129858296|NCT00690755|467439494|FG005|Overall Study|Physician Decision|4|||
129858297|NCT00690755|467439495|FG006|Overall Study|Physician Decision|0|||
129858298|NCT02952924|467439496|FG000|Overall Study|Protocol Violation|0|||
129858299|NCT02952924|467439497|FG001|Overall Study|Protocol Violation|0|||
129858300|NCT02952924|467439498|FG002|Overall Study|Protocol Violation|0|||
129858301|NCT02952924|467439499|FG003|Overall Study|Protocol Violation|0|||
129858302|NCT02952924|467439500|FG004|Overall Study|Protocol Violation|0|||
129858303|NCT02952924|467439501|FG005|Overall Study|Protocol Violation|0|||
129858304|NCT02952924|467439502|FG006|Overall Study|Protocol Violation|0|||
129858305|NCT02952924|467439503|FG007|Overall Study|Protocol Violation|0|||
129858306|NCT02952924|467439504|FG008|Overall Study|Protocol Violation|0|||
129858307|NCT02952924|467439505|FG009|Overall Study|Protocol Violation|0|||
129858308|NCT02952924|467439506|FG010|Overall Study|Protocol Violation|0|||
129858309|NCT02952924|467439507|FG011|Overall Study|Protocol Violation|0|||
129858310|NCT02952924|467439508|FG012|Overall Study|Protocol Violation|0|||
129858311|NCT02952924|467439509|FG013|Overall Study|Protocol Violation|0|||
129858312|NCT02952924|467439510|FG014|Overall Study|Protocol Violation|0|||
129858313|NCT02952924|467439511|FG015|Overall Study|Protocol Violation|0|||
129858314|NCT02952924|467439512|FG016|Overall Study|Protocol Violation|0|||
129858315|NCT02952924|467439513|FG017|Overall Study|Protocol Violation|0|||
129858316|NCT02952924|467439514|FG018|Overall Study|Protocol Violation|0|||
129858317|NCT02952924|467439515|FG019|Overall Study|Protocol Violation|1|||
129858318|NCT02952924|467439516|FG020|Overall Study|Protocol Violation|0|||
129858319|NCT02952924|467439517|FG021|Overall Study|Protocol Violation|0|||
129858320|NCT02952924|467439496|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
129858321|NCT02952924|467439497|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
129858322|NCT02952924|467439498|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
129858323|NCT02952924|467439499|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
129858324|NCT02952924|467439500|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
129858325|NCT02952924|467439501|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
129858326|NCT02952924|467439502|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
129858327|NCT02952924|467439503|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
129858328|NCT02952924|467439504|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
129858329|NCT02952924|467439505|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
129858330|NCT02952924|467439506|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
129858331|NCT02952924|467439507|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
129858332|NCT02952924|467439508|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
129858333|NCT02952924|467439509|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
129858334|NCT02952924|467439510|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
129858335|NCT02952924|467439511|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
129858336|NCT02952924|467439512|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
129858337|NCT02952924|467439513|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
129858338|NCT02952924|467439514|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
129858339|NCT02952924|467439515|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
129858340|NCT02952924|467439516|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
129858341|NCT02952924|467439517|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
129858342|NCT02952924|467439496|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858343|NCT02952924|467439497|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858344|NCT02952924|467439498|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858345|NCT02952924|467439499|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858346|NCT02952924|467439500|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858347|NCT02952924|467439501|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858348|NCT02952924|467439502|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858349|NCT02952924|467439503|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858350|NCT02952924|467439504|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858351|NCT02952924|467439505|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858352|NCT02952924|467439506|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858353|NCT02952924|467439507|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858354|NCT02952924|467439508|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858355|NCT02952924|467439509|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858356|NCT02952924|467439510|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
129909946|NCT01939899|467633747|FG003|Lead-in Dose Finding Phase|Other|0|||
129858357|NCT02952924|467439511|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858358|NCT02952924|467439512|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858359|NCT02952924|467439513|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858360|NCT02952924|467439514|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858361|NCT02952924|467439515|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858362|NCT02952924|467439516|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
129858363|NCT02952924|467439517|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
129858364|NCT02952924|467439496|FG000|Overall Study|Noncompliance with study drug|0|||
129858365|NCT02952924|467439497|FG001|Overall Study|Noncompliance with study drug|0|||
129858366|NCT02952924|467439498|FG002|Overall Study|Noncompliance with study drug|0|||
129858367|NCT02952924|467439499|FG003|Overall Study|Noncompliance with study drug|0|||
129858368|NCT02952924|467439500|FG004|Overall Study|Noncompliance with study drug|0|||
129858369|NCT02952924|467439501|FG005|Overall Study|Noncompliance with study drug|0|||
129858370|NCT02952924|467439502|FG006|Overall Study|Noncompliance with study drug|0|||
129858371|NCT02952924|467439503|FG007|Overall Study|Noncompliance with study drug|0|||
129858372|NCT02952924|467439504|FG008|Overall Study|Noncompliance with study drug|0|||
129858373|NCT02952924|467439505|FG009|Overall Study|Noncompliance with study drug|0|||
129858374|NCT02952924|467439506|FG010|Overall Study|Noncompliance with study drug|0|||
129858375|NCT02952924|467439507|FG011|Overall Study|Noncompliance with study drug|0|||
129858376|NCT02952924|467439508|FG012|Overall Study|Noncompliance with study drug|0|||
129858377|NCT02952924|467439509|FG013|Overall Study|Noncompliance with study drug|0|||
129858378|NCT02952924|467439510|FG014|Overall Study|Noncompliance with study drug|0|||
129858379|NCT02952924|467439511|FG015|Overall Study|Noncompliance with study drug|0|||
129858380|NCT02952924|467439512|FG016|Overall Study|Noncompliance with study drug|0|||
129858381|NCT02952924|467439513|FG017|Overall Study|Noncompliance with study drug|0|||
129858382|NCT02952924|467439514|FG018|Overall Study|Noncompliance with study drug|0|||
129858383|NCT02952924|467439515|FG019|Overall Study|Noncompliance with study drug|0|||
129858384|NCT02952924|467439516|FG020|Overall Study|Noncompliance with study drug|0|||
129858385|NCT02952924|467439517|FG021|Overall Study|Noncompliance with study drug|1|||
129858386|NCT02105948|467439522|FG000|Overall Study|Adverse Event|10|||
129858387|NCT02105948|467439523|FG001|Overall Study|Adverse Event|7|||
129858388|NCT02105948|467439524|FG002|Overall Study|Adverse Event|11|||
129858389|NCT02105948|467439525|FG003|Overall Study|Adverse Event|11|||
129858390|NCT02105948|467439522|FG000|Overall Study|Lack of Efficacy|0|||
129858391|NCT02105948|467439523|FG001|Overall Study|Lack of Efficacy|1|||
129858392|NCT02105948|467439524|FG002|Overall Study|Lack of Efficacy|3|||
129858393|NCT02105948|467439525|FG003|Overall Study|Lack of Efficacy|2|||
129858394|NCT02105948|467439522|FG000|Overall Study|Lost to Follow-up|0|||
129858395|NCT02105948|467439523|FG001|Overall Study|Lost to Follow-up|0|||
129858396|NCT02105948|467439524|FG002|Overall Study|Lost to Follow-up|2|||
129858397|NCT02105948|467439525|FG003|Overall Study|Lost to Follow-up|1|||
129858398|NCT02105948|467439522|FG000|Overall Study|Physician Decision|2|||
129858399|NCT02105948|467439523|FG001|Overall Study|Physician Decision|2|||
129858400|NCT02105948|467439524|FG002|Overall Study|Physician Decision|2|||
129858401|NCT02105948|467439525|FG003|Overall Study|Physician Decision|2|||
129858402|NCT02105948|467439522|FG000|Overall Study|Withdrawal by Subject|15|||
129858403|NCT02105948|467439523|FG001|Overall Study|Withdrawal by Subject|10|||
129858404|NCT02105948|467439524|FG002|Overall Study|Withdrawal by Subject|10|||
129858405|NCT02105948|467439525|FG003|Overall Study|Withdrawal by Subject|11|||
129858406|NCT01934218|467439527|FG000|Double-blind Phase|Adverse Event|8|||
129858407|NCT01934218|467439528|FG001|Double-blind Phase|Adverse Event|8|||
129858408|NCT01934218|467439527|FG000|Double-blind Phase|Lack of Efficacy|6|||
129858409|NCT01934218|467439528|FG001|Double-blind Phase|Lack of Efficacy|7|||
129858410|NCT01934218|467439527|FG000|Double-blind Phase|Lost to Follow-up|7|||
129858411|NCT01934218|467439528|FG001|Double-blind Phase|Lost to Follow-up|14|||
129858412|NCT01934218|467439527|FG000|Double-blind Phase|Physician Decision|1|||
129858413|NCT01934218|467439528|FG001|Double-blind Phase|Physician Decision|2|||
129858414|NCT01934218|467439527|FG000|Double-blind Phase|Protocol Violation|4|||
129858415|NCT01934218|467439528|FG001|Double-blind Phase|Protocol Violation|0|||
129909947|NCT01939899|467633748|FG004|Lead-in Dose Finding Phase|Other|0|||
129858416|NCT01934218|467439527|FG000|Double-blind Phase|Withdrawal by Subject|16|||
129858417|NCT01934218|467439528|FG001|Double-blind Phase|Withdrawal by Subject|13|||
129858418|NCT01934218|467439527|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
129858419|NCT01934218|467439528|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
129858420|NCT01934218|467439527|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
129858421|NCT01934218|467439528|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
129858422|NCT01934218|467439527|FG000|Open-Label Phase|Adverse Event|2|||
129858423|NCT01934218|467439528|FG001|Open-Label Phase|Adverse Event|4|||
129858424|NCT01934218|467439527|FG000|Open-Label Phase|Lack of Efficacy|1|||
129858425|NCT01934218|467439528|FG001|Open-Label Phase|Lack of Efficacy|4|||
129909948|NCT01939899|467633744|FG000|Phase 2|Withdrawal by Subject|0|||
129858426|NCT01934218|467439527|FG000|Open-Label Phase|Lost to Follow-up|4|||
129909949|NCT01939899|467633745|FG001|Phase 2|Withdrawal by Subject|0|||
129909950|NCT01939899|467633746|FG002|Phase 2|Withdrawal by Subject|0|||
129909951|NCT01939899|467633747|FG003|Phase 2|Withdrawal by Subject|2|||
129909952|NCT01939899|467633748|FG004|Phase 2|Withdrawal by Subject|0|||
129909953|NCT01939899|467633744|FG000|Phase 2|Disease Progression|0|||
129909954|NCT01939899|467633745|FG001|Phase 2|Disease Progression|0|||
129909955|NCT01939899|467633746|FG002|Phase 2|Disease Progression|0|||
129909956|NCT01939899|467633747|FG003|Phase 2|Disease Progression|9|||
129909957|NCT01939899|467633748|FG004|Phase 2|Disease Progression|1|||
129909958|NCT00585052|467633749|FG000|Overall Study|Withdrawal by Subject|1|||
129909959|NCT00858117|467633750|FG000|Treatment on Study|Adverse Event|2|||
129909960|NCT00858117|467633750|FG000|Follow up for 5 Years|Death|4|||
129909961|NCT00858117|467633750|FG000|Follow up for 5 Years|No further data collected for study|9|||
129909962|NCT04425863|467633752|FG000|Overall Study|Death|0|||
129909963|NCT04425863|467633753|FG001|Overall Study|Death|0|||
129909964|NCT04425863|467633754|FG002|Overall Study|Death|1|||
129909965|NCT00277355|467633757|FG000|Overall Study|Withdrawal by Subject|3|||
129909966|NCT00277355|467633758|FG001|Overall Study|Withdrawal by Subject|3|||
129909967|NCT00277355|467633757|FG000|Overall Study|Lost to Follow-up|2|||
129909968|NCT00277355|467633758|FG001|Overall Study|Lost to Follow-up|2|||
129909969|NCT00277355|467633757|FG000|Overall Study|Adverse Event|5|||
129909970|NCT00277355|467633758|FG001|Overall Study|Adverse Event|0|||
129909971|NCT00277355|467633757|FG000|Overall Study|Death|3|||
129909972|NCT00277355|467633758|FG001|Overall Study|Death|0|||
129909973|NCT00277355|467633757|FG000|Overall Study|Physician Decision|1|||
129909974|NCT00277355|467633758|FG001|Overall Study|Physician Decision|0|||
129909975|NCT05489484|467633764|FG000|Overall Study|withdrawn|1|||
129909976|NCT00444600|467633767|FG000|Overall Study|Death|7|||
129909977|NCT00444600|467633768|FG001|Overall Study|Death|5|||
129909978|NCT00444600|467633769|FG002|Overall Study|Death|3|||
129909979|NCT00444600|467633770|FG003|Overall Study|Death|2|||
129909980|NCT00444600|467633767|FG000|Overall Study|Dropped|11|||
129909981|NCT00444600|467633768|FG001|Overall Study|Dropped|11|||
129909982|NCT00444600|467633769|FG002|Overall Study|Dropped|7|||
129909983|NCT00444600|467633770|FG003|Overall Study|Dropped|7|||
129909984|NCT00444600|467633767|FG000|Overall Study|Missed visit|1|||
129909985|NCT00444600|467633768|FG001|Overall Study|Missed visit|0|||
129909986|NCT00444600|467633769|FG002|Overall Study|Missed visit|0|||
129909987|NCT00444600|467633770|FG003|Overall Study|Missed visit|1|||
129909988|NCT05132478|467633771|FG000|Overall Study|did not complete survey after consent|1|||
129909989|NCT05132478|467633772|FG001|Overall Study|did not complete survey after consent|1|||
129909990|NCT05132478|467633771|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
129909991|NCT05132478|467633772|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
129909992|NCT02549170|467633773|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
129909993|NCT02549170|467633774|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
129909994|NCT02549170|467633775|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
129909995|NCT02549170|467633776|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
129909996|NCT02549170|467633777|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
129909997|NCT02549170|467633773|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
129909998|NCT02549170|467633774|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
129909999|NCT02549170|467633775|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
129910000|NCT02549170|467633776|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
129910001|NCT02549170|467633777|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
129910002|NCT02549170|467633773|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
129910003|NCT02549170|467633774|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
129910004|NCT02549170|467633775|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
129910005|NCT02549170|467633776|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
129910006|NCT02549170|467633777|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
129910007|NCT01414738|467633778|FG000|Overall Study|Death|26|||
129910008|NCT01414738|467633778|FG000|Overall Study|Refused testing|5|||
129910009|NCT01414738|467633778|FG000|Overall Study|Lost to Follow-up|2|||
129910010|NCT01414738|467633778|FG000|Overall Study|Refused, disease progression|8|||
129910011|NCT01414738|467633778|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
129910012|NCT00703820|467633782|FG000|Overall Study|Adverse Event|12|||
129910013|NCT00703820|467633783|FG001|Overall Study|Adverse Event|17|||
129910014|NCT00703820|467633782|FG000|Overall Study|Death|5|||
129910015|NCT00703820|467633783|FG001|Overall Study|Death|0|||
129910016|NCT00703820|467633782|FG000|Overall Study|Lack of Efficacy|11|||
129910017|NCT00703820|467633783|FG001|Overall Study|Lack of Efficacy|11|||
129910018|NCT00703820|467633782|FG000|Overall Study|Received non-protocol therapy|1|||
129910019|NCT00703820|467633783|FG001|Overall Study|Received non-protocol therapy|0|||
129910020|NCT00703820|467633782|FG000|Overall Study|Physician Decision|4|||
129910021|NCT00703820|467633783|FG001|Overall Study|Physician Decision|5|||
129910022|NCT00703820|467633782|FG000|Overall Study|Withdrawal by Subject|2|||
129910023|NCT00703820|467633783|FG001|Overall Study|Withdrawal by Subject|1|||
129910024|NCT00914589|467633786|FG000|Overall Study|Adverse Event|1|||
129910025|NCT00914589|467633787|FG001|Overall Study|Adverse Event|0|||
129910026|NCT00914589|467633788|FG002|Overall Study|Adverse Event|1|||
129910027|NCT00914589|467633786|FG000|Overall Study|Protocol Violation|8|||
129910028|NCT00914589|467633787|FG001|Overall Study|Protocol Violation|6|||
129910029|NCT00914589|467633788|FG002|Overall Study|Protocol Violation|3|||
129910030|NCT00914589|467633786|FG000|Overall Study|unclassified|16|||
129910031|NCT00914589|467633787|FG001|Overall Study|unclassified|9|||
129910032|NCT00914589|467633788|FG002|Overall Study|unclassified|7|||
129910033|NCT00914589|467633786|FG000|Overall Study|Death|0|||
129910034|NCT00914589|467633787|FG001|Overall Study|Death|1|||
129910035|NCT00914589|467633788|FG002|Overall Study|Death|1|||
129910036|NCT03036813|467633789|FG000|Overall Study|Adverse Event|6|||
129910037|NCT03036813|467633790|FG001|Overall Study|Adverse Event|11|||
129910038|NCT03036813|467633791|FG002|Overall Study|Adverse Event|6|||
129910039|NCT03036813|467633789|FG000|Overall Study|Withdrawal by Subject|12|||
129910040|NCT03036813|467633790|FG001|Overall Study|Withdrawal by Subject|6|||
129910041|NCT03036813|467633791|FG002|Overall Study|Withdrawal by Subject|10|||
129910042|NCT03036813|467633789|FG000|Overall Study|Lost to Follow-up|1|||
129910043|NCT03036813|467633790|FG001|Overall Study|Lost to Follow-up|1|||
129910044|NCT03036813|467633791|FG002|Overall Study|Lost to Follow-up|0|||
129910045|NCT03036813|467633789|FG000|Overall Study|Physician Decision|2|||
129910046|NCT03036813|467633790|FG001|Overall Study|Physician Decision|1|||
129910047|NCT03036813|467633791|FG002|Overall Study|Physician Decision|1|||
129910048|NCT03036813|467633789|FG000|Overall Study|Non-Compliance|1|||
129910049|NCT03036813|467633790|FG001|Overall Study|Non-Compliance|5|||
129910050|NCT03036813|467633791|FG002|Overall Study|Non-Compliance|3|||
129910051|NCT03036813|467633789|FG000|Overall Study|Pregnancy|0|||
129910052|NCT03036813|467633790|FG001|Overall Study|Pregnancy|0|||
129910053|NCT03036813|467633791|FG002|Overall Study|Pregnancy|1|||
129910054|NCT03036813|467633789|FG000|Overall Study|Other|0|||
129910055|NCT03036813|467633790|FG001|Overall Study|Other|3|||
129910056|NCT03036813|467633791|FG002|Overall Study|Other|5|||
129910057|NCT00529100|467633794|FG000|Overall Study|Adverse Event|0|||
129910058|NCT00529100|467633795|FG001|Overall Study|Adverse Event|5|||
129910059|NCT00529100|467633794|FG000|Overall Study|Protocol Violation|0|||
129910060|NCT00529100|467633795|FG001|Overall Study|Protocol Violation|1|||
129910061|NCT00529100|467633794|FG000|Overall Study|Progressive Disease|0|||
129910062|NCT00529100|467633795|FG001|Overall Study|Progressive Disease|1|||
129910063|NCT00529100|467633794|FG000|Overall Study|Withdrawal by Subject|0|||
129910064|NCT00529100|467633795|FG001|Overall Study|Withdrawal by Subject|1|||
129910065|NCT00529100|467633794|FG000|Overall Study|Participant Ineligibility|0|||
129910066|NCT00529100|467633795|FG001|Overall Study|Participant Ineligibility|1|||
129910067|NCT00807937|467633797|FG000|Overall Study|Adverse Event|12|||
129910068|NCT00807937|467633798|FG001|Overall Study|Adverse Event|12|||
129910069|NCT00807937|467633799|FG002|Overall Study|Adverse Event|5|||
129910070|NCT00807937|467633800|FG003|Overall Study|Adverse Event|4|||
129910071|NCT00807937|467633797|FG000|Overall Study|Protocol Violation|4|||
129910072|NCT00807937|467633798|FG001|Overall Study|Protocol Violation|5|||
129910073|NCT00807937|467633799|FG002|Overall Study|Protocol Violation|3|||
129910074|NCT00807937|467633800|FG003|Overall Study|Protocol Violation|3|||
129910075|NCT00807937|467633797|FG000|Overall Study|Withdrawal by Subject|5|||
129910076|NCT00807937|467633798|FG001|Overall Study|Withdrawal by Subject|4|||
129910077|NCT00807937|467633799|FG002|Overall Study|Withdrawal by Subject|1|||
129910078|NCT00807937|467633800|FG003|Overall Study|Withdrawal by Subject|4|||
129910079|NCT00807937|467633797|FG000|Overall Study|Lost to Follow-up|4|||
129910080|NCT00807937|467633798|FG001|Overall Study|Lost to Follow-up|0|||
129910081|NCT00807937|467633799|FG002|Overall Study|Lost to Follow-up|2|||
129910082|NCT00807937|467633800|FG003|Overall Study|Lost to Follow-up|1|||
129910083|NCT00807937|467633797|FG000|Overall Study|Lack of Efficacy|0|||
129910084|NCT00807937|467633798|FG001|Overall Study|Lack of Efficacy|0|||
129910085|NCT00807937|467633799|FG002|Overall Study|Lack of Efficacy|1|||
129910086|NCT00807937|467633800|FG003|Overall Study|Lack of Efficacy|2|||
129910087|NCT00807937|467633797|FG000|Overall Study|Intake of prohibited medicine|0|||
129910088|NCT00807937|467633798|FG001|Overall Study|Intake of prohibited medicine|0|||
129910089|NCT00807937|467633799|FG002|Overall Study|Intake of prohibited medicine|2|||
129910090|NCT00807937|467633800|FG003|Overall Study|Intake of prohibited medicine|0|||
129910091|NCT00807937|467633797|FG000|Overall Study|All other reasons (not provided)|2|||
129910092|NCT00807937|467633798|FG001|Overall Study|All other reasons (not provided)|4|||
129910093|NCT00807937|467633799|FG002|Overall Study|All other reasons (not provided)|0|||
129910094|NCT00807937|467633800|FG003|Overall Study|All other reasons (not provided)|1|||
129910095|NCT04629950|467633801|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
129910096|NCT04629950|467633802|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
129910097|NCT04629950|467633803|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
129910098|NCT04629950|467633804|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
129910099|NCT04629950|467633801|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
129858427|NCT01934218|467439528|FG001|Open-Label Phase|Lost to Follow-up|2|||
129858428|NCT01934218|467439527|FG000|Open-Label Phase|Physician Decision|1|||
129858429|NCT01934218|467439528|FG001|Open-Label Phase|Physician Decision|0|||
129858430|NCT01934218|467439527|FG000|Open-Label Phase|Protocol Violation|1|||
129858431|NCT01934218|467439528|FG001|Open-Label Phase|Protocol Violation|0|||
129858432|NCT01934218|467439527|FG000|Open-Label Phase|Withdrawal by Subject|13|||
129858433|NCT01934218|467439528|FG001|Open-Label Phase|Withdrawal by Subject|11|||
129858434|NCT01934218|467439527|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
129858435|NCT01934218|467439528|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
129858436|NCT01934218|467439527|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
129858437|NCT01934218|467439528|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
129858438|NCT02232893|467439529|FG000|Overall Study|Withdrawal by Subject|4|||
129858439|NCT02232893|467439530|FG001|Overall Study|Withdrawal by Subject|1|||
129858440|NCT02232893|467439529|FG000|Overall Study|Adverse Event|0|||
129858441|NCT02232893|467439530|FG001|Overall Study|Adverse Event|1|||
129858442|NCT02232893|467439529|FG000|Overall Study|Sponsor request early termination|0|||
129858443|NCT02232893|467439530|FG001|Overall Study|Sponsor request early termination|1|||
129858444|NCT02232893|467439529|FG000|Overall Study|Developed exclusion criteria|0|||
129858445|NCT02232893|467439530|FG001|Overall Study|Developed exclusion criteria|1|||
129858446|NCT02232893|467439529|FG000|Overall Study|Other|0|||
129858447|NCT02232893|467439530|FG001|Overall Study|Other|3|||
129858448|NCT01587651|467439534|FG000|Overall Study|Adverse Event|0|||
129858449|NCT01587651|467439535|FG001|Overall Study|Adverse Event|1|||
129858450|NCT01587651|467439536|FG002|Overall Study|Adverse Event|0|||
129858451|NCT01587651|467439534|FG000|Overall Study|Protocol Violation|0|||
129858452|NCT01587651|467439535|FG001|Overall Study|Protocol Violation|1|||
129858453|NCT01587651|467439536|FG002|Overall Study|Protocol Violation|1|||
129858454|NCT01587651|467439534|FG000|Overall Study|Withdrawal by Subject|0|||
129858455|NCT01587651|467439535|FG001|Overall Study|Withdrawal by Subject|1|||
129858456|NCT01587651|467439536|FG002|Overall Study|Withdrawal by Subject|0|||
129858457|NCT03867734|467439537|FG000|Overall Study|Lost to Follow-up|2|||
129858458|NCT04323436|467439543|FG000|Overall Study|Adverse Event|7|||
129858459|NCT04323436|467439544|FG001|Overall Study|Adverse Event|0|||
129858460|NCT04323436|467439545|FG002|Overall Study|Adverse Event|0|||
129858461|NCT04323436|467439543|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
129858462|NCT04323436|467439544|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
129858463|NCT04323436|467439545|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
129858464|NCT04323436|467439543|FG000|Overall Study|Death|1|||
129858465|NCT04323436|467439544|FG001|Overall Study|Death|0|||
129858466|NCT04323436|467439545|FG002|Overall Study|Death|0|||
129858467|NCT04323436|467439543|FG000|Overall Study|Physician Decision|2|||
129858468|NCT04323436|467439544|FG001|Overall Study|Physician Decision|0|||
129858469|NCT04323436|467439545|FG002|Overall Study|Physician Decision|0|||
129858470|NCT04323436|467439543|FG000|Overall Study|Progressive disease|10|||
129858471|NCT04323436|467439544|FG001|Overall Study|Progressive disease|0|||
129858472|NCT04323436|467439545|FG002|Overall Study|Progressive disease|0|||
129858473|NCT04323436|467439543|FG000|Overall Study|Subject decision|3|||
129858474|NCT04323436|467439544|FG001|Overall Study|Subject decision|0|||
129858475|NCT04323436|467439545|FG002|Overall Study|Subject decision|0|||
129858476|NCT00839072|467439547|FG000|First Intervention Period|Withdrawal by Subject|1|||
129858477|NCT00839072|467439548|FG001|First Intervention Period|Withdrawal by Subject|0|||
129858478|NCT00839072|467439547|FG000|First Intervention Period|Adverse Event|1|||
129858479|NCT00839072|467439548|FG001|First Intervention Period|Adverse Event|1|||
129858480|NCT00839072|467439547|FG000|Second Intervention Period|Withdrawal by Subject|1|||
129858481|NCT00839072|467439548|FG001|Second Intervention Period|Withdrawal by Subject|0|||
129858482|NCT01458574|467439549|FG000|Overall Study|Adverse Event|5|||
129858483|NCT01458574|467439550|FG001|Overall Study|Adverse Event|9|||
129858484|NCT01458574|467439551|FG002|Overall Study|Adverse Event|7|||
129858485|NCT01458574|467439549|FG000|Overall Study|Lack of Efficacy|70|||
129858486|NCT01458574|467439550|FG001|Overall Study|Lack of Efficacy|53|||
129858487|NCT01458574|467439551|FG002|Overall Study|Lack of Efficacy|132|||
129858488|NCT01458574|467439549|FG000|Overall Study|Lost to Follow-up|3|||
129858489|NCT01458574|467439550|FG001|Overall Study|Lost to Follow-up|2|||
129858490|NCT01458574|467439551|FG002|Overall Study|Lost to Follow-up|1|||
129858491|NCT01458574|467439549|FG000|Overall Study|Pregnancy|1|||
129858492|NCT01458574|467439550|FG001|Overall Study|Pregnancy|1|||
129858493|NCT01458574|467439551|FG002|Overall Study|Pregnancy|0|||
129858494|NCT01458574|467439549|FG000|Overall Study|Protocol Violation|0|||
129858495|NCT01458574|467439550|FG001|Overall Study|Protocol Violation|1|||
129858496|NCT01458574|467439551|FG002|Overall Study|Protocol Violation|0|||
129858497|NCT01458574|467439549|FG000|Overall Study|Withdrawal by Subject|6|||
129858498|NCT01458574|467439550|FG001|Overall Study|Withdrawal by Subject|3|||
129858499|NCT01458574|467439551|FG002|Overall Study|Withdrawal by Subject|5|||
129858500|NCT01458574|467439549|FG000|Overall Study|Other|2|||
129858501|NCT01458574|467439550|FG001|Overall Study|Other|1|||
129858502|NCT01458574|467439551|FG002|Overall Study|Other|0|||
129858503|NCT01458574|467439549|FG000|Overall Study|Randomized but not treated|0|||
129858504|NCT01458574|467439550|FG001|Overall Study|Randomized but not treated|1|||
129858505|NCT01458574|467439551|FG002|Overall Study|Randomized but not treated|0|||
129858506|NCT02125786|467439552|FG000|Overall Study|Still in Follow-up|3|||
129858507|NCT02125786|467439552|FG000|Overall Study|Screen Failure|2|||
129858508|NCT02125786|467439552|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
129858509|NCT02125786|467439552|FG000|Overall Study|Progressive Disease|44|||
129858510|NCT02125786|467439552|FG000|Overall Study|Death|8|||
129858511|NCT01682837|467439553|FG000|Baseline|Withdrawal by Subject|5|||
129858512|NCT04782323|467439556|FG000|Overall Study|Death|1|||
129858513|NCT04782323|467439557|FG001|Overall Study|Death|0|||
129858514|NCT04782323|467439558|FG002|Overall Study|Death|0|||
129858515|NCT04782323|467439559|FG003|Overall Study|Death|0|||
129858516|NCT04782323|467439560|FG004|Overall Study|Death|1|||
129858517|NCT04782323|467439561|FG005|Overall Study|Death|1|||
129858518|NCT04782323|467439562|FG006|Overall Study|Death|1|||
129858519|NCT04782323|467439563|FG007|Overall Study|Death|0|||
129858520|NCT04782323|467439556|FG000|Overall Study|Withdrawal by Subject|0|||
129858521|NCT04782323|467439557|FG001|Overall Study|Withdrawal by Subject|0|||
129858522|NCT04782323|467439558|FG002|Overall Study|Withdrawal by Subject|1|||
129858523|NCT04782323|467439559|FG003|Overall Study|Withdrawal by Subject|0|||
129858524|NCT04782323|467439560|FG004|Overall Study|Withdrawal by Subject|0|||
129858525|NCT04782323|467439561|FG005|Overall Study|Withdrawal by Subject|1|||
129858526|NCT04782323|467439562|FG006|Overall Study|Withdrawal by Subject|0|||
129858527|NCT04782323|467439563|FG007|Overall Study|Withdrawal by Subject|1|||
129858528|NCT04782323|467439556|FG000|Overall Study|Lost to Follow-up|0|||
129858529|NCT04782323|467439557|FG001|Overall Study|Lost to Follow-up|1|||
129858530|NCT04782323|467439558|FG002|Overall Study|Lost to Follow-up|1|||
129858531|NCT04782323|467439559|FG003|Overall Study|Lost to Follow-up|0|||
129858532|NCT04782323|467439560|FG004|Overall Study|Lost to Follow-up|0|||
129858533|NCT04782323|467439561|FG005|Overall Study|Lost to Follow-up|1|||
129858534|NCT04782323|467439562|FG006|Overall Study|Lost to Follow-up|1|||
129858535|NCT04782323|467439563|FG007|Overall Study|Lost to Follow-up|2|||
129858536|NCT04782323|467439556|FG000|Overall Study|randomization in error|1|||
129858537|NCT04782323|467439557|FG001|Overall Study|randomization in error|0|||
129858538|NCT04782323|467439558|FG002|Overall Study|randomization in error|0|||
129858539|NCT04782323|467439559|FG003|Overall Study|randomization in error|0|||
129858540|NCT04782323|467439560|FG004|Overall Study|randomization in error|0|||
129858541|NCT04782323|467439561|FG005|Overall Study|randomization in error|0|||
129858542|NCT04782323|467439562|FG006|Overall Study|randomization in error|0|||
129858543|NCT04782323|467439563|FG007|Overall Study|randomization in error|0|||
129858544|NCT03832192|467439568|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
129858545|NCT03832192|467439569|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
129858546|NCT03738150|467439570|FG000|Base Study|Withdrawal by Subject|1|||
129858547|NCT03738150|467439570|FG000|Extension Study|Withdrawal by Subject|1|||
129858548|NCT00724971|467439573|FG000|Overall Study|Adverse Event|5|||
129858549|NCT00724971|467439573|FG000|Overall Study|Withdrawal by Subject|1|||
129858550|NCT01692197|467439574|FG000|Overall Study|Failed Screening|3|||
129858551|NCT03086447|467439576|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129858552|NCT03086447|467439577|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
129858553|NCT03086447|467439576|FG000|Overall Study|Lost Lens|2|||
129858554|NCT03086447|467439577|FG001|Overall Study|Lost Lens|5|||
129858555|NCT03086447|467439576|FG000|Overall Study|Product quality complaint|0|||
129858556|NCT03086447|467439577|FG001|Overall Study|Product quality complaint|1|||
129858557|NCT03086447|467439576|FG000|Overall Study|Lens Damage|1|||
129858558|NCT03086447|467439577|FG001|Overall Study|Lens Damage|6|||
129858559|NCT03086447|467439576|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
129858560|NCT03086447|467439577|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
129858561|NCT03086447|467439576|FG000|Overall Study|Test Article No Longer Available|1|||
129858562|NCT03086447|467439577|FG001|Overall Study|Test Article No Longer Available|0|||
129858563|NCT03086447|467439576|FG000|Overall Study|Protocol Violation|2|||
129858564|NCT03086447|467439577|FG001|Overall Study|Protocol Violation|4|||
129858565|NCT03086447|467439576|FG000|Overall Study|Lost to Follow-up|0|||
129858566|NCT03086447|467439577|FG001|Overall Study|Lost to Follow-up|1|||
129858567|NCT03086447|467439576|FG000|Overall Study|Adverse Event|3|||
129858568|NCT03086447|467439577|FG001|Overall Study|Adverse Event|0|||
129858569|NCT03086447|467439576|FG000|Overall Study|Lens Discomfort|2|||
129858570|NCT03086447|467439577|FG001|Overall Study|Lens Discomfort|1|||
129858571|NCT02276482|467439578|FG000|Overall Study|Adverse Event|1|||
129858572|NCT02276482|467439579|FG001|Overall Study|Adverse Event|0|||
129858573|NCT02276482|467439578|FG000|Overall Study|Withdrawal by Subject|1|||
129858574|NCT02276482|467439579|FG001|Overall Study|Withdrawal by Subject|0|||
129858575|NCT02276482|467439578|FG000|Overall Study|Gram-negative infection|1|||
129858576|NCT02276482|467439579|FG001|Overall Study|Gram-negative infection|0|||
129910100|NCT04629950|467633802|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
129910101|NCT04629950|467633803|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
129910102|NCT04629950|467633804|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
129910103|NCT04629950|467633801|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
129910104|NCT04629950|467633802|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
129910105|NCT04629950|467633803|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
129910106|NCT04629950|467633804|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
129910107|NCT04629950|467633801|FG000|Extension Study|Withdrawal by Subject|0|||
129910108|NCT04629950|467633802|FG001|Extension Study|Withdrawal by Subject|0|||
129910109|NCT04629950|467633803|FG002|Extension Study|Withdrawal by Subject|1|||
129910110|NCT04629950|467633804|FG003|Extension Study|Withdrawal by Subject|0|||
129910111|NCT04629950|467633801|FG000|Extension Study|Adverse Event|0|||
129910112|NCT04629950|467633802|FG001|Extension Study|Adverse Event|0|||
129910113|NCT04629950|467633803|FG002|Extension Study|Adverse Event|0|||
129910114|NCT04629950|467633804|FG003|Extension Study|Adverse Event|1|||
129910115|NCT02088853|467633805|FG000|Overall Study|Pregnancy|1|||
129910116|NCT02088853|467633806|FG001|Overall Study|Pregnancy|0|||
129910117|NCT00396084|467633807|FG000|Overall Study|Adverse Event|0|||
129910118|NCT00396084|467633808|FG001|Overall Study|Adverse Event|0|||
129910119|NCT00396084|467633809|FG002|Overall Study|Adverse Event|0|||
129910120|NCT00396084|467633810|FG003|Overall Study|Adverse Event|0|||
129910121|NCT00396084|467633811|FG004|Overall Study|Adverse Event|1|||
129910122|NCT00396084|467633812|FG005|Overall Study|Adverse Event|2|||
129910123|NCT00396084|467633807|FG000|Overall Study|Withdrawal by Subject|0|||
129910124|NCT00396084|467633808|FG001|Overall Study|Withdrawal by Subject|0|||
129910125|NCT00396084|467633809|FG002|Overall Study|Withdrawal by Subject|0|||
129910126|NCT00396084|467633810|FG003|Overall Study|Withdrawal by Subject|1|||
129910127|NCT00396084|467633811|FG004|Overall Study|Withdrawal by Subject|0|||
129858577|NCT02276482|467439578|FG000|Overall Study|Reason not specified|0|||
129858578|NCT02276482|467439579|FG001|Overall Study|Reason not specified|1|||
129858579|NCT00838110|467441390|FG000|Overall Study|Death|0|||
129858580|NCT00838110|467441391|FG001|Overall Study|Death|0|||
129858581|NCT00838110|467441392|FG002|Overall Study|Death|1|||
129858582|NCT00838110|467441393|FG003|Overall Study|Death|2|||
129858583|NCT00838110|467441390|FG000|Overall Study|Adverse Event|11|||
129858584|NCT00838110|467441391|FG001|Overall Study|Adverse Event|10|||
129858585|NCT00838110|467441392|FG002|Overall Study|Adverse Event|8|||
129858586|NCT00838110|467441393|FG003|Overall Study|Adverse Event|7|||
129858587|NCT00838110|467441390|FG000|Overall Study|Withdrawal by Subject|5|||
129858588|NCT00838110|467441391|FG001|Overall Study|Withdrawal by Subject|6|||
129858589|NCT00838110|467441392|FG002|Overall Study|Withdrawal by Subject|3|||
129858590|NCT00838110|467441393|FG003|Overall Study|Withdrawal by Subject|4|||
129858591|NCT00838110|467441390|FG000|Overall Study|Other|3|||
129858592|NCT00838110|467441391|FG001|Overall Study|Other|3|||
129858593|NCT00838110|467441392|FG002|Overall Study|Other|3|||
129858594|NCT00838110|467441393|FG003|Overall Study|Other|2|||
129858595|NCT00838110|467441390|FG000|Overall Study|Protocol Violation|0|||
129858596|NCT00838110|467441391|FG001|Overall Study|Protocol Violation|2|||
129858597|NCT00838110|467441392|FG002|Overall Study|Protocol Violation|1|||
129858598|NCT00838110|467441393|FG003|Overall Study|Protocol Violation|1|||
129858599|NCT00838110|467441390|FG000|Overall Study|Lost to Follow-up|3|||
129858600|NCT00838110|467441391|FG001|Overall Study|Lost to Follow-up|0|||
129858601|NCT00838110|467441392|FG002|Overall Study|Lost to Follow-up|0|||
129858602|NCT00838110|467441393|FG003|Overall Study|Lost to Follow-up|0|||
129858603|NCT00838110|467441390|FG000|Overall Study|Did not meet eligibility criteria|0|||
129858604|NCT00838110|467441391|FG001|Overall Study|Did not meet eligibility criteria|0|||
129858605|NCT00838110|467441392|FG002|Overall Study|Did not meet eligibility criteria|1|||
129858606|NCT00838110|467441393|FG003|Overall Study|Did not meet eligibility criteria|2|||
129858607|NCT00838110|467441390|FG000|Overall Study|Randomized but not treated|0|||
129910128|NCT00396084|467633812|FG005|Overall Study|Withdrawal by Subject|0|||
129910129|NCT02708108|467633813|FG000|Overall Study|Death|1|||
129858608|NCT00838110|467441391|FG001|Overall Study|Randomized but not treated|1|||
129858609|NCT00838110|467441392|FG002|Overall Study|Randomized but not treated|0|||
129910130|NCT02708108|467633814|FG001|Overall Study|Death|2|||
129910131|NCT02708108|467633813|FG000|Overall Study|Regimen change|1|||
129910132|NCT02708108|467633814|FG001|Overall Study|Regimen change|0|||
129910133|NCT02708108|467633813|FG000|Overall Study|No MRD and no imaging available|0|||
129858610|NCT00838110|467441393|FG003|Overall Study|Randomized but not treated|0|||
129858611|NCT01262651|467441394|FG000|Overall Study|Adverse Event|40|||
129858612|NCT01262651|467441395|FG001|Overall Study|Adverse Event|35|||
129858613|NCT01262651|467441394|FG000|Overall Study|Withdrawal by Subject|15|||
129858614|NCT01262651|467441395|FG001|Overall Study|Withdrawal by Subject|11|||
129858615|NCT01262651|467441394|FG000|Overall Study|Withdrawal by Investigator|2|||
129858616|NCT01262651|467441395|FG001|Overall Study|Withdrawal by Investigator|2|||
129910134|NCT02708108|467633814|FG001|Overall Study|No MRD and no imaging available|1|||
129910135|NCT01697969|467633817|FG000|Overall Study|Did not meet inc/exc criteria|3|||
129910136|NCT01561989|467633818|FG000|Overall Study|accural target not met.|5|||
129910137|NCT01561989|467633819|FG001|Overall Study|accural target not met.|6|||
129910138|NCT00440011|467633820|FG000|Overall Study|Adverse Event|2|||
129910139|NCT00440011|467633821|FG001|Overall Study|Adverse Event|0|||
129910140|NCT00440011|467633820|FG000|Overall Study|Lost to Follow-up|0|||
129910141|NCT00440011|467633821|FG001|Overall Study|Lost to Follow-up|2|||
129910142|NCT00440011|467633820|FG000|Overall Study|Protocol Violation|1|||
129910143|NCT00440011|467633821|FG001|Overall Study|Protocol Violation|1|||
129910144|NCT00440011|467633820|FG000|Overall Study|Withdrawal by Subject|1|||
129910145|NCT00440011|467633821|FG001|Overall Study|Withdrawal by Subject|0|||
129910146|NCT01803555|467633823|FG000|Overall Study|Adverse Event|3|||
129910147|NCT01803555|467633824|FG001|Overall Study|Adverse Event|2|||
129910148|NCT01803555|467633823|FG000|Overall Study|Withdrawal by Subject|3|||
129910149|NCT01803555|467633824|FG001|Overall Study|Withdrawal by Subject|3|||
129858617|NCT01262651|467441394|FG000|Overall Study|Met Withdrawal Criteria|1|||
129858618|NCT01262651|467441395|FG001|Overall Study|Met Withdrawal Criteria|0|||
129858619|NCT04969783|467441401|FG000|Overall Study|Lost to Follow-up|2|||
129858620|NCT04969783|467441402|FG001|Overall Study|Lost to Follow-up|0|||
129858621|NCT04969783|467441401|FG000|Overall Study|Withdrawal by Subject|4|||
129858622|NCT04969783|467441402|FG001|Overall Study|Withdrawal by Subject|0|||
129858623|NCT04969783|467441401|FG000|Overall Study|Physician Decision|6|||
129858624|NCT04969783|467441402|FG001|Overall Study|Physician Decision|0|||
129858625|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
129858626|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
129858627|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
129858628|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858629|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858630|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858631|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858632|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858633|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858634|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858635|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858636|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858637|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858638|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
129858639|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
129858640|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
129858641|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
129858642|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858643|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858644|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858645|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858646|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858647|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858648|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858649|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858650|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858651|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858652|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
129858653|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
129858654|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
129858655|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
129858656|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858657|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858658|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129910150|NCT01803555|467633823|FG000|Overall Study|Non-compliance|1|||
129910151|NCT01803555|467633824|FG001|Overall Study|Non-compliance|1|||
129858659|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858660|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858661|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858662|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858663|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129910152|NCT01803555|467633823|FG000|Overall Study|Protocol Violation|3|||
129858664|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858665|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858666|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
129858667|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
129858668|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
129910153|NCT01803555|467633824|FG001|Overall Study|Protocol Violation|5|||
129910154|NCT01803555|467633823|FG000|Overall Study|Lost to Follow-up|0|||
129910155|NCT01803555|467633824|FG001|Overall Study|Lost to Follow-up|2|||
129910156|NCT01803555|467633823|FG000|Overall Study|Other than specified|3|||
129910157|NCT01803555|467633824|FG001|Overall Study|Other than specified|5|||
129910158|NCT01551355|467633825|FG000|Overall Study|Lost to Follow-up|51|||
129910159|NCT01551355|467633826|FG001|Overall Study|Lost to Follow-up|49|||
129910160|NCT01551355|467633827|FG002|Overall Study|Lost to Follow-up|34|||
129910161|NCT01551355|467633828|FG003|Overall Study|Lost to Follow-up|24|||
129910162|NCT01551355|467633829|FG004|Overall Study|Lost to Follow-up|9|||
129910163|NCT01551355|467633830|FG005|Overall Study|Lost to Follow-up|6|||
129910164|NCT01925339|467633831|FG000|Overall Study|Adverse Event|2|||
129910165|NCT01925339|467633832|FG001|Overall Study|Adverse Event|0|||
129910166|NCT01538719|467633833|FG000|Overall Study|Lost to Follow-up|2|||
129910167|NCT01538719|467633834|FG001|Overall Study|Lost to Follow-up|0|||
129910168|NCT03664960|467633835|FG000|Overall Study|Adverse Event|0|||
129910169|NCT03664960|467633836|FG001|Overall Study|Adverse Event|3|||
129910170|NCT03664960|467633835|FG000|Overall Study|Lost to Follow-up|3|||
129910171|NCT03664960|467633836|FG001|Overall Study|Lost to Follow-up|2|||
129910172|NCT03664960|467633835|FG000|Overall Study|Physician Decision|1|||
129910173|NCT03664960|467633836|FG001|Overall Study|Physician Decision|0|||
129910174|NCT03664960|467633835|FG000|Overall Study|Withdrawal by Subject|3|||
129910175|NCT03664960|467633836|FG001|Overall Study|Withdrawal by Subject|14|||
129910176|NCT03664960|467633835|FG000|Overall Study|Sponsor Decision|1|||
129910177|NCT03664960|467633836|FG001|Overall Study|Sponsor Decision|1|||
129910178|NCT03664960|467633835|FG000|Overall Study|Other|1|||
129910179|NCT03664960|467633836|FG001|Overall Study|Other|2|||
129910180|NCT00774852|467633838|FG000|Overall Study|Adverse Event|9|||
129910181|NCT00774852|467633839|FG001|Overall Study|Adverse Event|6|||
129910182|NCT00774852|467633838|FG000|Overall Study|Death|2|||
129910183|NCT00774852|467633839|FG001|Overall Study|Death|1|||
129910184|NCT00774852|467633838|FG000|Overall Study|Lack of Efficacy|3|||
129910185|NCT00774852|467633839|FG001|Overall Study|Lack of Efficacy|7|||
129910186|NCT00774852|467633838|FG000|Overall Study|Lost to Follow-up|9|||
129910187|NCT00774852|467633839|FG001|Overall Study|Lost to Follow-up|5|||
129910188|NCT00774852|467633838|FG000|Overall Study|Physician Decision|2|||
129910189|NCT00774852|467633839|FG001|Overall Study|Physician Decision|6|||
129910190|NCT00774852|467633838|FG000|Overall Study|Pregnancy|1|||
129910191|NCT00774852|467633839|FG001|Overall Study|Pregnancy|2|||
129910192|NCT00774852|467633838|FG000|Overall Study|Withdrawal by Subject|2|||
129910193|NCT00774852|467633839|FG001|Overall Study|Withdrawal by Subject|2|||
129910194|NCT00774852|467633838|FG000|Overall Study|Non-responder|15|||
129910195|NCT00774852|467633839|FG001|Overall Study|Non-responder|11|||
129910196|NCT00774852|467633838|FG000|Overall Study|Subject non-compliance|0|||
129910197|NCT00774852|467633839|FG001|Overall Study|Subject non-compliance|1|||
129910198|NCT00774852|467633838|FG000|Overall Study|Protocol Violation|1|||
129858669|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
129858670|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858671|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858672|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858673|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858674|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858675|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858676|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858677|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858678|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858679|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858680|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
129858681|NCT02349295|467441403|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129910199|NCT00774852|467633839|FG001|Overall Study|Protocol Violation|0|||
129910200|NCT00774852|467633838|FG000|Overall Study|Subject received prohibited medication|1|||
129910201|NCT00774852|467633839|FG001|Overall Study|Subject received prohibited medication|0|||
129910202|NCT03997916|467633840|FG000|Overall Study|Protocol Violation|35|||
129910203|NCT01780298|467635246|FG000|Overall Study|Physician Decision|1|||
129910204|NCT01780298|467635247|FG001|Overall Study|Physician Decision|5|||
129910205|NCT01780298|467635248|FG002|Overall Study|Physician Decision|1|||
129910206|NCT01780298|467635249|FG003|Overall Study|Physician Decision|1|||
129910207|NCT01780298|467635246|FG000|Overall Study|Subject not matched|1|||
129910208|NCT01780298|467635247|FG001|Overall Study|Subject not matched|0|||
129910209|NCT01780298|467635248|FG002|Overall Study|Subject not matched|1|||
129910210|NCT01780298|467635249|FG003|Overall Study|Subject not matched|0|||
129910211|NCT01780298|467635246|FG000|Overall Study|Adverse Event|0|||
129910212|NCT01780298|467635247|FG001|Overall Study|Adverse Event|0|||
129910213|NCT01780298|467635248|FG002|Overall Study|Adverse Event|2|||
129858682|NCT02349295|467441404|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
129858683|NCT02349295|467441405|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
129910214|NCT01780298|467635249|FG003|Overall Study|Adverse Event|0|||
129910215|NCT04907474|467635250|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
129979687|NCT03752970|467889437|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
129858684|NCT02349295|467441406|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858685|NCT02349295|467441407|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858686|NCT02349295|467441408|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858687|NCT02349295|467441409|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858688|NCT02349295|467441410|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858689|NCT02349295|467441411|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858690|NCT02349295|467441412|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858691|NCT02349295|467441413|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858692|NCT02349295|467441414|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858693|NCT02349295|467441415|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858694|NCT02349295|467441416|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
129858695|NCT02349295|467441403|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
129858696|NCT02349295|467441404|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
129858697|NCT02349295|467441405|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
129858698|NCT02349295|467441406|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
129858699|NCT02349295|467441407|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
129858700|NCT02349295|467441408|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
129858701|NCT02349295|467441409|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
129858702|NCT02349295|467441410|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
129858703|NCT02349295|467441411|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
129858704|NCT02349295|467441412|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
129858705|NCT02349295|467441413|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
129858706|NCT02349295|467441414|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
129858707|NCT02349295|467441415|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
129858708|NCT02349295|467441416|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
129858709|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858710|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858711|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858712|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858713|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858714|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858715|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858716|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
129858717|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
129858718|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
129858719|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
129858720|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858721|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858722|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
129858723|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858724|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858725|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858726|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858727|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858728|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858729|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858730|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
129858731|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
129858732|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
129858733|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
129858734|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858735|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858736|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
129858737|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858738|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858739|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858740|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858741|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858742|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858743|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858744|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
129858745|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858746|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
129858747|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858748|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858749|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129910216|NCT04907474|467635251|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
129858750|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
129858751|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
129858752|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
129858753|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
129858754|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
129858755|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
129858756|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
129858757|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
129858758|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
129858759|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
129858760|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
129858761|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
129858762|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
129858763|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
129858764|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
129858765|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858766|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858767|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858768|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858769|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858770|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858771|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858772|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
129858773|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
129858774|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
129858775|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
129858776|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858777|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858778|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
129858779|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858780|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858781|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858782|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858783|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858784|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858785|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858786|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
129858787|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
129910217|NCT03873779|467635252|FG000|Overall Study|Withdrawal by Subject|1|||
129910218|NCT02581215|467635253|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
129910219|NCT02581215|467635254|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
129910220|NCT02581215|467635253|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129910221|NCT02581215|467635254|FG001|Overall Study|Eligibility Criteria Not Met|1|||
129910222|NCT04279574|467635257|FG000|Overall Study|Death|1|||
129910223|NCT04279574|467635258|FG001|Overall Study|Death|0|||
129910224|NCT04279574|467635257|FG000|Overall Study|lost restoration, tooth fracture|1|||
129910225|NCT04279574|467635258|FG001|Overall Study|lost restoration, tooth fracture|0|||
129910226|NCT04279574|467635257|FG000|Overall Study|Lost to Follow-up|0|||
129910227|NCT04279574|467635258|FG001|Overall Study|Lost to Follow-up|1|||
129910228|NCT04188379|467635259|FG000|Overall Study|Withdrawal by Subject|10|||
129910229|NCT04188379|467635260|FG001|Overall Study|Withdrawal by Subject|3|||
129910230|NCT04188379|467635259|FG000|Overall Study|Physician Decision|0|||
129910231|NCT04188379|467635260|FG001|Overall Study|Physician Decision|1|||
129910232|NCT04188379|467635259|FG000|Overall Study|Adverse Event|3|||
129910233|NCT04188379|467635260|FG001|Overall Study|Adverse Event|1|||
129910234|NCT04188379|467635259|FG000|Overall Study|Pregnancy|1|||
129910235|NCT04188379|467635260|FG001|Overall Study|Pregnancy|0|||
129910236|NCT04188379|467635259|FG000|Overall Study|Lack of Efficacy|8|||
129910237|NCT04188379|467635260|FG001|Overall Study|Lack of Efficacy|5|||
129910238|NCT04188379|467635259|FG000|Overall Study|Other|0|||
129910239|NCT04188379|467635260|FG001|Overall Study|Other|3|||
129910240|NCT02566902|467635266|FG000|Overall Study|Protocol Violation|2|||
129858788|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858789|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858790|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858791|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129910241|NCT02566902|467635267|FG001|Overall Study|Protocol Violation|1|||
129910242|NCT02411084|467635268|FG000|Overall Study|Lack of Efficacy|6|||
129910243|NCT02411084|467635269|FG001|Overall Study|Lack of Efficacy|3|||
129910244|NCT02411084|467635268|FG000|Overall Study|Death|5|||
129910245|NCT02411084|467635269|FG001|Overall Study|Death|4|||
129910246|NCT02411084|467635268|FG000|Overall Study|Adverse Event|2|||
129910247|NCT02411084|467635269|FG001|Overall Study|Adverse Event|1|||
129910248|NCT02411084|467635268|FG000|Overall Study|Other reasons|0|||
129910249|NCT02411084|467635269|FG001|Overall Study|Other reasons|5|||
129910250|NCT05773313|467635274|FG000|Overall Study|Lost to Follow-up|3|||
129910251|NCT02748317|467635275|FG000|Overall Study|Withdrawal by Subject|14|||
129910252|NCT02748317|467635275|FG000|Overall Study|Lost to Follow-up|8|||
129910253|NCT02748317|467635275|FG000|Overall Study|Death|1|||
129910254|NCT00332241|467635277|FG000|Overall Study|Lack of Efficacy|6|||
129910255|NCT00332241|467635278|FG001|Overall Study|Lack of Efficacy|1|||
129910256|NCT00332241|467635277|FG000|Overall Study|Adverse Event|3|||
129910257|NCT00332241|467635278|FG001|Overall Study|Adverse Event|5|||
129910258|NCT00332241|467635277|FG000|Overall Study|Withdrawal by Subject|2|||
129910259|NCT00332241|467635278|FG001|Overall Study|Withdrawal by Subject|1|||
129910260|NCT00332241|467635277|FG000|Overall Study|Lost to Follow-up|4|||
129910261|NCT00332241|467635278|FG001|Overall Study|Lost to Follow-up|1|||
129910262|NCT00802464|467635280|FG000|Month 0 - Month 8|Adverse Event|0|||
129910263|NCT00802464|467635281|FG001|Month 0 - Month 8|Adverse Event|1|||
129910264|NCT00802464|467635282|FG002|Month 0 - Month 8|Adverse Event|1|||
129910265|NCT00802464|467635283|FG003|Month 0 - Month 8|Adverse Event|2|||
129910266|NCT00802464|467635280|FG000|Month 0 - Month 8|Protocol Violation|0|||
129910267|NCT00802464|467635281|FG001|Month 0 - Month 8|Protocol Violation|0|||
129910268|NCT00802464|467635282|FG002|Month 0 - Month 8|Protocol Violation|1|||
129910269|NCT00802464|467635283|FG003|Month 0 - Month 8|Protocol Violation|0|||
129910270|NCT00802464|467635280|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
129910271|NCT00802464|467635281|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
129910272|NCT00802464|467635282|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
129910273|NCT00802464|467635283|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
129910274|NCT00802464|467635280|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
129910275|NCT00802464|467635281|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
129910276|NCT00802464|467635282|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
129910277|NCT00802464|467635283|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
129910278|NCT00802464|467635280|FG000|Month 0 - Month 8|Other|0|||
129910279|NCT00802464|467635281|FG001|Month 0 - Month 8|Other|0|||
129910280|NCT00802464|467635282|FG002|Month 0 - Month 8|Other|1|||
129910281|NCT00802464|467635283|FG003|Month 0 - Month 8|Other|0|||
129910282|NCT00802464|467635280|FG000|Month 8 - Month 14|Adverse Event|0|||
129910283|NCT00802464|467635281|FG001|Month 8 - Month 14|Adverse Event|1|||
129910284|NCT00802464|467635282|FG002|Month 8 - Month 14|Adverse Event|0|||
129910285|NCT00802464|467635283|FG003|Month 8 - Month 14|Adverse Event|0|||
129910286|NCT00802464|467635280|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
129910287|NCT00802464|467635281|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
129910288|NCT00802464|467635282|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
129910289|NCT00802464|467635283|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
129910290|NCT00802464|467635280|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
129910291|NCT00802464|467635281|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
129910292|NCT00802464|467635282|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
129910293|NCT00802464|467635283|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
129910294|NCT01471691|467635286|FG000|Overall Study|Lack of Efficacy|0|||
129910295|NCT01471691|467635287|FG001|Overall Study|Lack of Efficacy|1|||
129910296|NCT01808339|467635288|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910297|NCT01808339|467635289|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910298|NCT01808339|467635290|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910299|NCT01808339|467635291|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
129910300|NCT01808339|467635292|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
129910301|NCT01808339|467635293|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
129910302|NCT01808339|467635288|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910303|NCT01808339|467635289|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129910304|NCT01808339|467635290|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910305|NCT01808339|467635291|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
129910306|NCT01808339|467635292|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910307|NCT01808339|467635293|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
129910308|NCT01808339|467635288|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910309|NCT01808339|467635289|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910310|NCT01808339|467635290|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
129910311|NCT01808339|467635291|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910312|NCT01808339|467635292|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910313|NCT01808339|467635293|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
129910314|NCT02622568|467635294|FG000|Overall Study|Lost to Follow-up|5|||
129910315|NCT02622568|467635295|FG001|Overall Study|Lost to Follow-up|5|||
129910316|NCT00371787|467635296|FG000|Overall Study|Withdrawal by Subject|3|||
129910317|NCT00371787|467635297|FG001|Overall Study|Withdrawal by Subject|1|||
129910318|NCT01854385|467635298|FG000|Pre-Treatment|Withdrawal by Subject|4|||
129910319|NCT01854385|467635298|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
129910320|NCT01854385|467635298|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
129910321|NCT01854385|467635298|FG000|Pre-Treatment|Unable to come for study visits|1|||
129910322|NCT01854385|467635298|FG000|Treatment|Lost to Follow-up|1|||
129910323|NCT02597920|467635303|FG000|Overall Study|Worsening of other pre-existing disease|0|||
129910324|NCT02597920|467635304|FG001|Overall Study|Worsening of other pre-existing disease|1|||
129910325|NCT02597920|467635305|FG002|Overall Study|Worsening of other pre-existing disease|0|||
129910326|NCT02597920|467635303|FG000|Overall Study|Other adverse event|20|||
129910327|NCT02597920|467635304|FG001|Overall Study|Other adverse event|30|||
129910328|NCT02597920|467635305|FG002|Overall Study|Other adverse event|0|||
129910329|NCT02597920|467635303|FG000|Overall Study|Lost to Follow-up|7|||
129910330|NCT02597920|467635304|FG001|Overall Study|Lost to Follow-up|9|||
129910331|NCT02597920|467635305|FG002|Overall Study|Lost to Follow-up|0|||
129910332|NCT02597920|467635303|FG000|Overall Study|Refuse to continue in the study|3|||
129910333|NCT02597920|467635304|FG001|Overall Study|Refuse to continue in the study|13|||
129910334|NCT02597920|467635305|FG002|Overall Study|Refuse to continue in the study|1|||
129910335|NCT02597920|467635303|FG000|Overall Study|Other than specified|10|||
129910336|NCT02597920|467635304|FG001|Overall Study|Other than specified|31|||
129910337|NCT02597920|467635305|FG002|Overall Study|Other than specified|5|||
129910338|NCT02597920|467635303|FG000|Overall Study|Other|1|||
129910339|NCT02597920|467635304|FG001|Overall Study|Other|0|||
129910340|NCT02597920|467635305|FG002|Overall Study|Other|0|||
129910341|NCT00642850|467635306|FG000|Overall Study|Death|7|||
129910342|NCT00642850|467635306|FG000|Overall Study|Adverse Event|2|||
129910343|NCT00642850|467635306|FG000|Overall Study|Lack of Efficacy|1|||
129910344|NCT00642850|467635306|FG000|Overall Study|Protocol Violation|2|||
129910345|NCT00642850|467635306|FG000|Overall Study|Kidney transplantation|8|||
129910346|NCT00642850|467635306|FG000|Overall Study|Blood transfusion|6|||
129858792|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
129858793|NCT02349295|467441403|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858794|NCT02349295|467441404|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858795|NCT02349295|467441405|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858796|NCT02349295|467441406|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858797|NCT02349295|467441407|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858798|NCT02349295|467441408|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858799|NCT02349295|467441409|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858800|NCT02349295|467441410|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
129858801|NCT02349295|467441411|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
129858802|NCT02349295|467441412|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129910347|NCT00642850|467635306|FG000|Overall Study|Other reasons|7|||
129910348|NCT02379819|467635307|FG000|Overall Study|Withdrawal by Subject|10|||
129910349|NCT02379819|467635307|FG000|Overall Study|Death|2|||
129910350|NCT02379819|467635307|FG000|Overall Study|Lack of Efficacy|1|||
129910351|NCT02379819|467635307|FG000|Overall Study|Lost to Follow-up|1|||
129910352|NCT00350792|467635308|FG000|Overall Study|Adverse Event|11|||
129910353|NCT00350792|467635308|FG000|Overall Study|Death from Study Disease|1|||
129910354|NCT00350792|467635308|FG000|Overall Study|Death from Study Drug Toxicity|1|||
129910355|NCT00350792|467635308|FG000|Overall Study|Death Not Study Drug Related|2|||
129910356|NCT00350792|467635308|FG000|Overall Study|Protocol Violation|1|||
129910357|NCT00350792|467635308|FG000|Overall Study|Withdrawal by Subject|4|||
129910358|NCT00350792|467635308|FG000|Overall Study|Physician Decision|2|||
129910359|NCT00350792|467635308|FG000|Overall Study|Lack of Efficacy|11|||
129910360|NCT03988023|467635309|FG000|Overall Study|Non-compliance|3|||
129910361|NCT03988023|467635310|FG001|Overall Study|Non-compliance|0|||
129910362|NCT03988023|467635309|FG000|Overall Study|Withdrawal by Subject|39|||
129910363|NCT03988023|467635310|FG001|Overall Study|Withdrawal by Subject|37|||
129910364|NCT03988023|467635309|FG000|Overall Study|Adverse Event|0|||
129910365|NCT03988023|467635310|FG001|Overall Study|Adverse Event|2|||
129858803|NCT02349295|467441413|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858804|NCT02349295|467441414|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858805|NCT02349295|467441415|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129858806|NCT02349295|467441416|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
129910366|NCT03988023|467635309|FG000|Overall Study|Physician Decision|0|||
129910367|NCT03988023|467635310|FG001|Overall Study|Physician Decision|1|||
129910368|NCT03988023|467635309|FG000|Overall Study|Lost to Follow-up|5|||
129910369|NCT03988023|467635310|FG001|Overall Study|Lost to Follow-up|8|||
129910370|NCT03988023|467635309|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
129910371|NCT03988023|467635310|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
129910372|NCT03988023|467635309|FG000|Overall Study|Lack of Efficacy|3|||
129910373|NCT03988023|467635310|FG001|Overall Study|Lack of Efficacy|1|||
129910374|NCT03988023|467635309|FG000|Overall Study|COVID-19 pandemic|225|||
129910375|NCT03988023|467635310|FG001|Overall Study|COVID-19 pandemic|227|||
129910376|NCT00785512|467635311|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
129910377|NCT00785512|467635312|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
129910378|NCT00785512|467635311|FG000|Overall Study|Adverse Event|0|||
129910379|NCT00785512|467635312|FG001|Overall Study|Adverse Event|0|||
129910380|NCT00785512|467635311|FG000|Overall Study|Lack of Efficacy|0|||
129910381|NCT00785512|467635312|FG001|Overall Study|Lack of Efficacy|2|||
129910382|NCT00785512|467635311|FG000|Overall Study|Withdrawal by Subject|0|||
129910383|NCT00785512|467635312|FG001|Overall Study|Withdrawal by Subject|1|||
129910384|NCT00785512|467635311|FG000|Overall Study|Lost to Follow-up|3|||
129910385|NCT00785512|467635312|FG001|Overall Study|Lost to Follow-up|0|||
129910386|NCT00785512|467635311|FG000|Overall Study|Precedure Refused|0|||
129910387|NCT00785512|467635312|FG001|Overall Study|Precedure Refused|0|||
129910388|NCT00785512|467635311|FG000|Overall Study|IVRS Programing Error|0|||
129858807|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858808|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858809|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858810|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858811|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858812|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858813|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858814|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858815|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858816|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858817|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
129858818|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
129858819|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
129858820|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
129858821|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858822|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858823|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858824|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858825|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858826|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858827|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858828|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858829|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858830|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858831|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858832|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
129858833|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
129858834|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
129858835|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858836|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858837|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858838|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858839|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858840|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858841|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858842|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858843|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858844|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858845|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858846|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
129858847|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
129858848|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
129858849|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858850|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858851|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858852|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858853|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858854|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858855|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858856|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129910389|NCT00785512|467635312|FG001|Overall Study|IVRS Programing Error|0|||
129910390|NCT00785512|467635311|FG000|Overall Study|Physician Decision|0|||
129910391|NCT00785512|467635312|FG001|Overall Study|Physician Decision|0|||
129910392|NCT00785512|467635311|FG000|Overall Study|Lack of compliance|0|||
129910393|NCT00785512|467635312|FG001|Overall Study|Lack of compliance|1|||
129910394|NCT04452318|467635316|FG000|Overall Study|Physician Decision|1|||
129910395|NCT04452318|467635317|FG001|Overall Study|Physician Decision|2|||
129910396|NCT04452318|467635318|FG002|Overall Study|Physician Decision|0|||
129910397|NCT04452318|467635319|FG003|Overall Study|Physician Decision|2|||
129910398|NCT04452318|467635320|FG004|Overall Study|Physician Decision|0|||
129910399|NCT04452318|467635321|FG005|Overall Study|Physician Decision|2|||
129910400|NCT04452318|467635322|FG006|Overall Study|Physician Decision|5|||
129910401|NCT04452318|467635316|FG000|Overall Study|Death|2|||
129910402|NCT04452318|467635317|FG001|Overall Study|Death|3|||
129910403|NCT04452318|467635318|FG002|Overall Study|Death|0|||
129910404|NCT04452318|467635319|FG003|Overall Study|Death|0|||
129910405|NCT04452318|467635320|FG004|Overall Study|Death|0|||
129910406|NCT04452318|467635321|FG005|Overall Study|Death|0|||
129910407|NCT04452318|467635322|FG006|Overall Study|Death|0|||
129910408|NCT04452318|467635316|FG000|Overall Study|Lost to Follow-up|38|||
129910409|NCT04452318|467635317|FG001|Overall Study|Lost to Follow-up|28|||
129910410|NCT04452318|467635318|FG002|Overall Study|Lost to Follow-up|0|||
129910411|NCT04452318|467635319|FG003|Overall Study|Lost to Follow-up|3|||
129910412|NCT04452318|467635320|FG004|Overall Study|Lost to Follow-up|3|||
129910413|NCT04452318|467635321|FG005|Overall Study|Lost to Follow-up|2|||
129910414|NCT04452318|467635322|FG006|Overall Study|Lost to Follow-up|1|||
129910415|NCT04452318|467635316|FG000|Overall Study|Withdrawal by Subject|46|||
129910416|NCT04452318|467635317|FG001|Overall Study|Withdrawal by Subject|40|||
129910417|NCT04452318|467635318|FG002|Overall Study|Withdrawal by Subject|0|||
129910418|NCT04452318|467635319|FG003|Overall Study|Withdrawal by Subject|18|||
129910419|NCT04452318|467635320|FG004|Overall Study|Withdrawal by Subject|6|||
129910420|NCT04452318|467635321|FG005|Overall Study|Withdrawal by Subject|8|||
129910421|NCT04452318|467635322|FG006|Overall Study|Withdrawal by Subject|6|||
129910422|NCT00595413|467635323|FG000|Overall Study|Adverse Event|0|||
129910423|NCT00595413|467635324|FG001|Overall Study|Adverse Event|2|||
129910424|NCT00595413|467635325|FG002|Overall Study|Adverse Event|1|||
129910425|NCT00595413|467635326|FG003|Overall Study|Adverse Event|1|||
129910426|NCT00595413|467635323|FG000|Overall Study|Lost to Follow-up|2|||
129910427|NCT00595413|467635324|FG001|Overall Study|Lost to Follow-up|2|||
129910428|NCT00595413|467635325|FG002|Overall Study|Lost to Follow-up|1|||
129910429|NCT00595413|467635326|FG003|Overall Study|Lost to Follow-up|3|||
129910430|NCT00595413|467635323|FG000|Overall Study|Death|0|||
129910431|NCT00595413|467635324|FG001|Overall Study|Death|0|||
129910432|NCT00595413|467635325|FG002|Overall Study|Death|1|||
129910433|NCT00595413|467635326|FG003|Overall Study|Death|0|||
129910434|NCT00595413|467635323|FG000|Overall Study|Other|5|||
129910435|NCT00595413|467635324|FG001|Overall Study|Other|1|||
129910436|NCT00595413|467635325|FG002|Overall Study|Other|5|||
129910437|NCT00595413|467635326|FG003|Overall Study|Other|0|||
129910438|NCT04149002|467635327|FG000|Overall Study|Lost to Follow-up|1|||
129910439|NCT04149002|467635328|FG001|Overall Study|Lost to Follow-up|0|||
129910440|NCT04149002|467635327|FG000|Overall Study|Withdrawal by Subject|1|||
129910441|NCT04149002|467635328|FG001|Overall Study|Withdrawal by Subject|0|||
129910442|NCT03233633|467635329|FG000|Overall Study|Adverse Event|2|||
129910443|NCT03233633|467635329|FG000|Overall Study|Less Than 3 Days of Data|6|||
129910444|NCT04583423|467635331|FG000|Overall Study|Lost to Follow-up|0|||
129910445|NCT04583423|467635332|FG001|Overall Study|Lost to Follow-up|1|||
129910446|NCT04583423|467635333|FG002|Overall Study|Lost to Follow-up|0|||
129910447|NCT04583423|467635334|FG003|Overall Study|Lost to Follow-up|2|||
129910448|NCT04583423|467635331|FG000|Overall Study|Study Terminated by Sponsor|32|||
129910449|NCT04583423|467635332|FG001|Overall Study|Study Terminated by Sponsor|35|||
129910450|NCT04583423|467635333|FG002|Overall Study|Study Terminated by Sponsor|36|||
129910451|NCT04583423|467635334|FG003|Overall Study|Study Terminated by Sponsor|33|||
129910452|NCT04583423|467635331|FG000|Overall Study|Withdrawal by Subject|3|||
129910453|NCT04583423|467635332|FG001|Overall Study|Withdrawal by Subject|1|||
129910454|NCT04583423|467635333|FG002|Overall Study|Withdrawal by Subject|2|||
129910455|NCT04583423|467635334|FG003|Overall Study|Withdrawal by Subject|1|||
129910456|NCT01198145|467635335|FG000|Overall Study|Withdrawal by Subject|1|||
129910457|NCT01198145|467635336|FG001|Overall Study|Withdrawal by Subject|1|||
129910458|NCT00603954|467635339|FG000|Overall Study|Protocol Violation|1|||
129910459|NCT00603954|467635340|FG001|Overall Study|Protocol Violation|2|||
129910460|NCT01736215|467635341|FG000|Overall Study|Early termination of erythropoietin use|1|||
129910461|NCT01736215|467635341|FG000|Overall Study|Adverse Event|4|||
129910462|NCT01736215|467635341|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
129910463|NCT01736215|467635341|FG000|Overall Study|Insufficient data to perform analysis|8|||
129910464|NCT03447249|467635345|FG000|Overall Study|Adverse Event|1|||
129910465|NCT03447249|467635346|FG001|Overall Study|Adverse Event|0|||
129910466|NCT03447249|467635345|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
129910467|NCT03447249|467635346|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129910468|NCT03447249|467635345|FG000|Overall Study|Other|3|||
129910469|NCT03447249|467635346|FG001|Overall Study|Other|0|||
129910470|NCT01248936|467635347|FG000|Overall Study|Sponsor Decision|259|||
129910471|NCT01248936|467635347|FG000|Overall Study|Progression of Disease|50|||
129910472|NCT01248936|467635347|FG000|Overall Study|Death|26|||
129858857|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858858|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858859|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858860|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
129858861|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858862|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
129858863|NCT02349295|467441403|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858864|NCT02349295|467441404|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858865|NCT02349295|467441405|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858866|NCT02349295|467441406|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858867|NCT02349295|467441407|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858868|NCT02349295|467441408|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858869|NCT02349295|467441409|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858870|NCT02349295|467441410|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858871|NCT02349295|467441411|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858872|NCT02349295|467441412|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858873|NCT02349295|467441413|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858874|NCT02349295|467441414|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
129858875|NCT02349295|467441415|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858876|NCT02349295|467441416|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
129858877|NCT02863926|467441417|FG000|Overall Study|Physician Decision|1|||
129858878|NCT02863926|467441418|FG001|Overall Study|Physician Decision|0|||
129858879|NCT02863926|467441417|FG000|Overall Study|Lost to Follow-up|1|||
129858880|NCT02863926|467441418|FG001|Overall Study|Lost to Follow-up|1|||
129858881|NCT01914926|467441434|FG000|Overall Study|Adverse Event|1|||
129858882|NCT01914926|467441435|FG001|Overall Study|Adverse Event|0|||
129858883|NCT01914926|467441434|FG000|Overall Study|uncooperative, agitated and removed|0|||
129858884|NCT01914926|467441435|FG001|Overall Study|uncooperative, agitated and removed|1|||
129858885|NCT01917526|467441436|FG000|Overall Study|Protocol Violation|1|||
129858886|NCT01917526|467441437|FG001|Overall Study|Protocol Violation|1|||
129858887|NCT00434057|467441438|FG000|Overall Study|Withdrawal by Subject|1|||
129858888|NCT02117570|467441439|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
129858889|NCT02117570|467441440|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
129858890|NCT02117570|467441441|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
129858891|NCT02117570|467441439|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
129858892|NCT02117570|467441440|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
129858893|NCT02117570|467441441|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
129858894|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
129858895|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
129858896|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
129858897|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
129858898|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
129858899|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
129858900|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
129858901|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
129858902|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
129858903|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
129858904|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
129858905|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
129858906|NCT02117570|467441439|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
129858907|NCT02117570|467441440|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
129858908|NCT02117570|467441441|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
129858909|NCT03701555|467441442|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
129858910|NCT03701555|467441443|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
129858911|NCT03701555|467441444|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
129858912|NCT03701555|467441445|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
129858913|NCT03701555|467441446|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
129858914|NCT03701555|467441447|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
129858915|NCT03701555|467441448|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
129858916|NCT03701555|467441449|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
129858917|NCT03701555|467441450|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
129858918|NCT03701555|467441451|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
129858919|NCT03701555|467441452|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
129858920|NCT03701555|467441453|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
129858921|NCT03701555|467441454|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
129858922|NCT03701555|467441455|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
129858923|NCT03701555|467441456|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
129858924|NCT03701555|467441457|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
129858925|NCT03701555|467441458|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
129858926|NCT03701555|467441459|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
129858927|NCT03701555|467441460|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
129858928|NCT03701555|467441461|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
129858929|NCT03701555|467441462|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
129858930|NCT03701555|467441463|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
129858931|NCT03701555|467441464|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
129858932|NCT03701555|467441465|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
129858933|NCT03701555|467441466|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
129858934|NCT03701555|467441467|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
129858935|NCT03701555|467441468|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
129858936|NCT03701555|467441469|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
129858937|NCT03701555|467441470|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
129858938|NCT03701555|467441471|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
129858939|NCT03701555|467441472|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
129858940|NCT03701555|467441473|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
129858941|NCT03701555|467441474|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
129858942|NCT03701555|467441475|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
129858943|NCT03701555|467441476|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
129858944|NCT03701555|467441477|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
129858945|NCT03701555|467441442|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
129858946|NCT03701555|467441443|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
129858947|NCT03701555|467441444|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
129858948|NCT03701555|467441445|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
129858949|NCT03701555|467441446|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
129858950|NCT03701555|467441447|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
129858951|NCT03701555|467441448|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
129858952|NCT03701555|467441449|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
129858953|NCT03701555|467441450|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
129858954|NCT03701555|467441451|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
129858955|NCT03701555|467441452|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
129858956|NCT03701555|467441453|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
129858957|NCT03701555|467441454|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
129858958|NCT03701555|467441455|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
129858959|NCT03701555|467441456|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
129858960|NCT03701555|467441457|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
129858961|NCT03701555|467441458|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
129858962|NCT03701555|467441459|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
129858963|NCT03701555|467441460|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
129858964|NCT03701555|467441461|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
129858965|NCT03701555|467441462|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
129858966|NCT03701555|467441463|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
129858967|NCT03701555|467441464|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
129858968|NCT03701555|467441465|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
129858969|NCT03701555|467441466|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
129858970|NCT03701555|467441467|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
129858971|NCT03701555|467441468|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
129858972|NCT03701555|467441469|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
129858973|NCT03701555|467441470|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
129858974|NCT03701555|467441471|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
129858975|NCT03701555|467441472|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
129858976|NCT03701555|467441473|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
129858977|NCT03701555|467441474|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
129858978|NCT03701555|467441475|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
129858979|NCT03701555|467441476|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
129858980|NCT03701555|467441477|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
129858981|NCT03701555|467441442|FG000|Part 2 (Day 1)|Other|0|||
129858982|NCT03701555|467441443|FG001|Part 2 (Day 1)|Other|0|||
129858983|NCT03701555|467441444|FG002|Part 2 (Day 1)|Other|0|||
129858984|NCT03701555|467441445|FG003|Part 2 (Day 1)|Other|0|||
129858985|NCT03701555|467441446|FG004|Part 2 (Day 1)|Other|0|||
129858986|NCT03701555|467441447|FG005|Part 2 (Day 1)|Other|0|||
129858987|NCT03701555|467441448|FG006|Part 2 (Day 1)|Other|0|||
129858988|NCT03701555|467441449|FG007|Part 2 (Day 1)|Other|0|||
129858989|NCT03701555|467441450|FG008|Part 2 (Day 1)|Other|0|||
129858990|NCT03701555|467441451|FG009|Part 2 (Day 1)|Other|0|||
129858991|NCT03701555|467441452|FG010|Part 2 (Day 1)|Other|3|||
129858992|NCT03701555|467441453|FG011|Part 2 (Day 1)|Other|1|||
129858993|NCT03701555|467441454|FG012|Part 2 (Day 1)|Other|0|||
129858994|NCT03701555|467441455|FG013|Part 2 (Day 1)|Other|1|||
129858995|NCT03701555|467441456|FG014|Part 2 (Day 1)|Other|0|||
129858996|NCT03701555|467441457|FG015|Part 2 (Day 1)|Other|2|||
129858997|NCT03701555|467441458|FG016|Part 2 (Day 1)|Other|2|||
129858998|NCT03701555|467441459|FG017|Part 2 (Day 1)|Other|0|||
129858999|NCT03701555|467441460|FG018|Part 2 (Day 1)|Other|0|||
129859000|NCT03701555|467441461|FG019|Part 2 (Day 1)|Other|0|||
129859001|NCT03701555|467441462|FG020|Part 2 (Day 1)|Other|0|||
129859002|NCT03701555|467441463|FG021|Part 2 (Day 1)|Other|0|||
129859003|NCT03701555|467441464|FG022|Part 2 (Day 1)|Other|0|||
129859004|NCT03701555|467441465|FG023|Part 2 (Day 1)|Other|0|||
129859005|NCT03701555|467441466|FG024|Part 2 (Day 1)|Other|0|||
129859006|NCT03701555|467441467|FG025|Part 2 (Day 1)|Other|0|||
129859007|NCT03701555|467441468|FG026|Part 2 (Day 1)|Other|0|||
129859008|NCT03701555|467441469|FG027|Part 2 (Day 1)|Other|0|||
129859009|NCT03701555|467441470|FG028|Part 2 (Day 1)|Other|0|||
129859010|NCT03701555|467441471|FG029|Part 2 (Day 1)|Other|0|||
129859011|NCT03701555|467441472|FG030|Part 2 (Day 1)|Other|0|||
129859012|NCT03701555|467441473|FG031|Part 2 (Day 1)|Other|0|||
129859013|NCT03701555|467441474|FG032|Part 2 (Day 1)|Other|0|||
129859014|NCT03701555|467441475|FG033|Part 2 (Day 1)|Other|0|||
129859015|NCT03701555|467441476|FG034|Part 2 (Day 1)|Other|0|||
129859016|NCT03701555|467441477|FG035|Part 2 (Day 1)|Other|0|||
129859017|NCT03701555|467441442|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
129859018|NCT03701555|467441443|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
129859019|NCT03701555|467441444|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
129859020|NCT03701555|467441445|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
129859021|NCT03701555|467441446|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
129859022|NCT03701555|467441447|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
129859023|NCT03701555|467441448|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
129859024|NCT03701555|467441449|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
129859025|NCT03701555|467441450|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
129859026|NCT03701555|467441451|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
129859027|NCT03701555|467441452|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
129859028|NCT03701555|467441453|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
129859029|NCT03701555|467441454|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
129859030|NCT03701555|467441455|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
129859031|NCT03701555|467441456|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
129859032|NCT03701555|467441457|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
129859033|NCT03701555|467441458|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
129859034|NCT03701555|467441459|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
129859035|NCT03701555|467441460|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
129859036|NCT03701555|467441461|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
129859037|NCT03701555|467441462|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
129859038|NCT03701555|467441463|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
129859039|NCT03701555|467441464|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
129859040|NCT03701555|467441465|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
129859041|NCT03701555|467441466|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
129859042|NCT03701555|467441467|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
129859043|NCT03701555|467441468|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
129859044|NCT03701555|467441469|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
129859045|NCT03701555|467441470|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
129859046|NCT03701555|467441471|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
129859047|NCT03701555|467441472|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
129859048|NCT03701555|467441473|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
129859049|NCT03701555|467441474|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
129859050|NCT03701555|467441475|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
129859051|NCT03701555|467441476|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
129859052|NCT03701555|467441477|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
129859053|NCT03701555|467441442|FG000|Part 3 (Day 1)|Subject Decision|0|||
129859054|NCT03701555|467441443|FG001|Part 3 (Day 1)|Subject Decision|0|||
129859055|NCT03701555|467441444|FG002|Part 3 (Day 1)|Subject Decision|0|||
129859056|NCT03701555|467441445|FG003|Part 3 (Day 1)|Subject Decision|0|||
129859057|NCT03701555|467441446|FG004|Part 3 (Day 1)|Subject Decision|0|||
129859058|NCT03701555|467441447|FG005|Part 3 (Day 1)|Subject Decision|0|||
129859059|NCT03701555|467441448|FG006|Part 3 (Day 1)|Subject Decision|0|||
129859060|NCT03701555|467441449|FG007|Part 3 (Day 1)|Subject Decision|0|||
129859061|NCT03701555|467441450|FG008|Part 3 (Day 1)|Subject Decision|0|||
129859062|NCT03701555|467441451|FG009|Part 3 (Day 1)|Subject Decision|0|||
129859063|NCT03701555|467441452|FG010|Part 3 (Day 1)|Subject Decision|0|||
129859064|NCT03701555|467441453|FG011|Part 3 (Day 1)|Subject Decision|0|||
129859065|NCT03701555|467441454|FG012|Part 3 (Day 1)|Subject Decision|0|||
129859066|NCT03701555|467441455|FG013|Part 3 (Day 1)|Subject Decision|0|||
129859067|NCT03701555|467441456|FG014|Part 3 (Day 1)|Subject Decision|0|||
129859068|NCT03701555|467441457|FG015|Part 3 (Day 1)|Subject Decision|0|||
129859069|NCT03701555|467441458|FG016|Part 3 (Day 1)|Subject Decision|0|||
129859070|NCT03701555|467441459|FG017|Part 3 (Day 1)|Subject Decision|0|||
129859071|NCT03701555|467441460|FG018|Part 3 (Day 1)|Subject Decision|0|||
129859072|NCT03701555|467441461|FG019|Part 3 (Day 1)|Subject Decision|0|||
129859073|NCT03701555|467441462|FG020|Part 3 (Day 1)|Subject Decision|0|||
129859074|NCT03701555|467441463|FG021|Part 3 (Day 1)|Subject Decision|0|||
129859075|NCT03701555|467441464|FG022|Part 3 (Day 1)|Subject Decision|0|||
129859076|NCT03701555|467441465|FG023|Part 3 (Day 1)|Subject Decision|0|||
129859077|NCT03701555|467441466|FG024|Part 3 (Day 1)|Subject Decision|0|||
129859078|NCT03701555|467441467|FG025|Part 3 (Day 1)|Subject Decision|0|||
129859079|NCT03701555|467441468|FG026|Part 3 (Day 1)|Subject Decision|1|||
129859080|NCT03701555|467441469|FG027|Part 3 (Day 1)|Subject Decision|0|||
129859081|NCT03701555|467441470|FG028|Part 3 (Day 1)|Subject Decision|0|||
129859082|NCT03701555|467441471|FG029|Part 3 (Day 1)|Subject Decision|0|||
129859083|NCT03701555|467441472|FG030|Part 3 (Day 1)|Subject Decision|0|||
129859084|NCT03701555|467441473|FG031|Part 3 (Day 1)|Subject Decision|2|||
129859085|NCT03701555|467441474|FG032|Part 3 (Day 1)|Subject Decision|1|||
129859086|NCT03701555|467441475|FG033|Part 3 (Day 1)|Subject Decision|1|||
129859087|NCT03701555|467441476|FG034|Part 3 (Day 1)|Subject Decision|0|||
129859088|NCT03701555|467441477|FG035|Part 3 (Day 1)|Subject Decision|0|||
129859089|NCT03701555|467441442|FG000|Part 3 (Day 1)|Other|0|||
129859090|NCT03701555|467441443|FG001|Part 3 (Day 1)|Other|0|||
129859091|NCT03701555|467441444|FG002|Part 3 (Day 1)|Other|0|||
129859092|NCT03701555|467441445|FG003|Part 3 (Day 1)|Other|0|||
129859093|NCT03701555|467441446|FG004|Part 3 (Day 1)|Other|0|||
129859094|NCT03701555|467441447|FG005|Part 3 (Day 1)|Other|0|||
129859095|NCT03701555|467441448|FG006|Part 3 (Day 1)|Other|0|||
129859096|NCT03701555|467441449|FG007|Part 3 (Day 1)|Other|0|||
129859097|NCT03701555|467441450|FG008|Part 3 (Day 1)|Other|0|||
129859098|NCT03701555|467441451|FG009|Part 3 (Day 1)|Other|0|||
129859099|NCT03701555|467441452|FG010|Part 3 (Day 1)|Other|0|||
129859100|NCT03701555|467441453|FG011|Part 3 (Day 1)|Other|0|||
129859101|NCT03701555|467441454|FG012|Part 3 (Day 1)|Other|0|||
129859102|NCT03701555|467441455|FG013|Part 3 (Day 1)|Other|0|||
129859103|NCT03701555|467441456|FG014|Part 3 (Day 1)|Other|0|||
129859104|NCT03701555|467441457|FG015|Part 3 (Day 1)|Other|0|||
129859105|NCT03701555|467441458|FG016|Part 3 (Day 1)|Other|0|||
129859106|NCT03701555|467441459|FG017|Part 3 (Day 1)|Other|0|||
129859107|NCT03701555|467441460|FG018|Part 3 (Day 1)|Other|0|||
129859108|NCT03701555|467441461|FG019|Part 3 (Day 1)|Other|0|||
129859109|NCT03701555|467441462|FG020|Part 3 (Day 1)|Other|0|||
129859110|NCT03701555|467441463|FG021|Part 3 (Day 1)|Other|0|||
129859111|NCT03701555|467441464|FG022|Part 3 (Day 1)|Other|0|||
129859112|NCT03701555|467441465|FG023|Part 3 (Day 1)|Other|0|||
129859113|NCT03701555|467441466|FG024|Part 3 (Day 1)|Other|1|||
129859114|NCT03701555|467441467|FG025|Part 3 (Day 1)|Other|1|||
129859115|NCT03701555|467441468|FG026|Part 3 (Day 1)|Other|0|||
129859116|NCT03701555|467441469|FG027|Part 3 (Day 1)|Other|0|||
129859117|NCT03701555|467441470|FG028|Part 3 (Day 1)|Other|0|||
129859118|NCT03701555|467441471|FG029|Part 3 (Day 1)|Other|1|||
129859119|NCT03701555|467441472|FG030|Part 3 (Day 1)|Other|1|||
129859120|NCT03701555|467441473|FG031|Part 3 (Day 1)|Other|0|||
129859121|NCT03701555|467441474|FG032|Part 3 (Day 1)|Other|1|||
129859122|NCT03701555|467441475|FG033|Part 3 (Day 1)|Other|1|||
129859123|NCT03701555|467441476|FG034|Part 3 (Day 1)|Other|0|||
129859124|NCT03701555|467441477|FG035|Part 3 (Day 1)|Other|0|||
129859125|NCT03349710|467441478|FG000|Treatment Period|Death|0|||
129859126|NCT03349710|467441479|FG001|Treatment Period|Death|0|||
129859127|NCT03349710|467441480|FG002|Treatment Period|Death|1|||
129859128|NCT03349710|467441481|FG003|Treatment Period|Death|0|||
129859129|NCT03349710|467441478|FG000|Treatment Period|Disease Progression|0|||
129859130|NCT03349710|467441479|FG001|Treatment Period|Disease Progression|2|||
129859131|NCT03349710|467441480|FG002|Treatment Period|Disease Progression|0|||
129859132|NCT03349710|467441481|FG003|Treatment Period|Disease Progression|1|||
129859133|NCT03349710|467441478|FG000|Treatment Period|Study Drug Toxicity|1|||
129859134|NCT03349710|467441479|FG001|Treatment Period|Study Drug Toxicity|0|||
129859135|NCT03349710|467441480|FG002|Treatment Period|Study Drug Toxicity|1|||
129859136|NCT03349710|467441481|FG003|Treatment Period|Study Drug Toxicity|1|||
129859137|NCT03349710|467441478|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
129859138|NCT03349710|467441479|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
129859139|NCT03349710|467441480|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
129859140|NCT03349710|467441481|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
129859141|NCT03349710|467441478|FG000|Treatment Period|admin reason by sponsor|0|||
129859142|NCT03349710|467441479|FG001|Treatment Period|admin reason by sponsor|7|||
129859143|NCT03349710|467441480|FG002|Treatment Period|admin reason by sponsor|0|||
129859144|NCT03349710|467441481|FG003|Treatment Period|admin reason by sponsor|19|||
129859145|NCT03349710|467441478|FG000|Treatment Period|Other Reason|2|||
129859146|NCT03349710|467441479|FG001|Treatment Period|Other Reason|0|||
129859147|NCT03349710|467441480|FG002|Treatment Period|Other Reason|2|||
129859148|NCT03349710|467441481|FG003|Treatment Period|Other Reason|1|||
129859149|NCT03349710|467441478|FG000|Treatment Period|completed|6|||
129859150|NCT03349710|467441479|FG001|Treatment Period|completed|0|||
129859151|NCT03349710|467441480|FG002|Treatment Period|completed|18|||
129859152|NCT03349710|467441481|FG003|Treatment Period|completed|1|||
129859153|NCT03349710|467441478|FG000|Treatment Period|participant request to discontinue|0|||
129859154|NCT03349710|467441479|FG001|Treatment Period|participant request to discontinue|0|||
129859155|NCT03349710|467441480|FG002|Treatment Period|participant request to discontinue|4|||
129859156|NCT03349710|467441481|FG003|Treatment Period|participant request to discontinue|0|||
129859157|NCT03349710|467441478|FG000|Treatment Period|participant withdrew consent|1|||
129859158|NCT03349710|467441479|FG001|Treatment Period|participant withdrew consent|0|||
129859159|NCT03349710|467441480|FG002|Treatment Period|participant withdrew consent|0|||
129859160|NCT03349710|467441481|FG003|Treatment Period|participant withdrew consent|0|||
129859161|NCT01296568|467441482|FG000|Continued Access Phase|Lost to Follow-up|1|||
129859162|NCT01296568|467441482|FG000|Continued Access Phase|Withdrawal by Subject|1|||
129859163|NCT01296568|467441482|FG000|Continued Access Phase|Disease Progression|1|||
129859164|NCT04258020|467441483|FG000|Overall Study|Withdrawal by Subject|1|||
129859165|NCT04258020|467441484|FG001|Overall Study|Withdrawal by Subject|0|||
129859166|NCT03305016|467441485|FG000|Overall Study|Withdrawal by Subject|2|||
129859167|NCT01519206|467441486|FG000|Overall Study|Lost to Follow-up|3|||
129859168|NCT01519206|467441486|FG000|Overall Study|Missed Visit|2|||
129859169|NCT04139317|467441487|FG000|Overall Study|Adverse Event|10|||
129859170|NCT04139317|467441488|FG001|Overall Study|Adverse Event|2|||
129859171|NCT04139317|467441487|FG000|Overall Study|Death|6|||
129859172|NCT04139317|467441488|FG001|Overall Study|Death|4|||
129859173|NCT04139317|467441487|FG000|Overall Study|Lost to Follow-up|1|||
129859174|NCT04139317|467441488|FG001|Overall Study|Lost to Follow-up|0|||
129859175|NCT04139317|467441487|FG000|Overall Study|Physician Decision|3|||
129859176|NCT04139317|467441488|FG001|Overall Study|Physician Decision|1|||
129859177|NCT04139317|467441487|FG000|Overall Study|Progressive Disease|19|||
129859178|NCT04139317|467441488|FG001|Overall Study|Progressive Disease|9|||
129859179|NCT04139317|467441487|FG000|Overall Study|Subject Decision|2|||
129859180|NCT04139317|467441488|FG001|Overall Study|Subject Decision|2|||
129859181|NCT06027216|467441489|FG000|Overall Study|Did not qualify|8|||
129859182|NCT02365467|467441490|FG000|Overall Study|Death|3|||
129859183|NCT02043782|467441491|FG000|Period 1|Adverse Event|0|||
129859184|NCT02043782|467441492|FG001|Period 1|Adverse Event|0|||
129859185|NCT02043782|467441493|FG002|Period 1|Adverse Event|1|||
129859186|NCT02043782|467441494|FG003|Period 1|Adverse Event|0|||
129859187|NCT02043782|467441495|FG004|Period 1|Adverse Event|0|||
129859188|NCT02043782|467441496|FG005|Period 1|Adverse Event|0|||
129859189|NCT01306162|467441499|FG000|Period 1|Adverse Event|0|||
129859190|NCT01306162|467441500|FG001|Period 1|Adverse Event|0|||
129859191|NCT01306162|467441501|FG002|Period 1|Adverse Event|0|||
129859192|NCT01306162|467441502|FG003|Period 1|Adverse Event|1|||
129859193|NCT01306162|467441499|FG000|Washout 1|Non-compliance to protocol|0|||
129859194|NCT01306162|467441500|FG001|Washout 1|Non-compliance to protocol|1|||
129859195|NCT01306162|467441501|FG002|Washout 1|Non-compliance to protocol|0|||
129859196|NCT01306162|467441502|FG003|Washout 1|Non-compliance to protocol|0|||
129859197|NCT02959437|467441503|FG000|Overall Study|Death|33|||
129859198|NCT02959437|467441504|FG001|Overall Study|Death|3|||
129859199|NCT02959437|467441505|FG002|Overall Study|Death|0|||
129859200|NCT02959437|467441506|FG003|Overall Study|Death|0|||
129859201|NCT02959437|467441503|FG000|Overall Study|Lost to Follow-up|3|||
129859202|NCT02959437|467441504|FG001|Overall Study|Lost to Follow-up|1|||
129859203|NCT02959437|467441505|FG002|Overall Study|Lost to Follow-up|0|||
129859204|NCT02959437|467441506|FG003|Overall Study|Lost to Follow-up|0|||
129859205|NCT02959437|467441503|FG000|Overall Study|Withdrawal by Subject|11|||
129859206|NCT02959437|467441504|FG001|Overall Study|Withdrawal by Subject|3|||
129859207|NCT02959437|467441505|FG002|Overall Study|Withdrawal by Subject|0|||
129859208|NCT02959437|467441506|FG003|Overall Study|Withdrawal by Subject|0|||
129859209|NCT02959437|467441503|FG000|Overall Study|Progressive Disease|9|||
129859210|NCT02959437|467441504|FG001|Overall Study|Progressive Disease|1|||
129859211|NCT02959437|467441505|FG002|Overall Study|Progressive Disease|0|||
129859212|NCT02959437|467441506|FG003|Overall Study|Progressive Disease|0|||
129859213|NCT02959437|467441503|FG000|Overall Study|Study Terminated by Sponsor|4|||
129859214|NCT02959437|467441504|FG001|Overall Study|Study Terminated by Sponsor|0|||
129859215|NCT02959437|467441505|FG002|Overall Study|Study Terminated by Sponsor|0|||
129859216|NCT02959437|467441506|FG003|Overall Study|Study Terminated by Sponsor|0|||
129859217|NCT02959437|467441503|FG000|Overall Study|Other Unspecified|2|||
129859218|NCT02959437|467441504|FG001|Overall Study|Other Unspecified|0|||
129859219|NCT02959437|467441505|FG002|Overall Study|Other Unspecified|0|||
129859220|NCT02959437|467441506|FG003|Overall Study|Other Unspecified|0|||
129859221|NCT00833989|467441511|FG000|Overall Study|Physician Decision|0|||
129859222|NCT00833989|467441512|FG001|Overall Study|Physician Decision|0|||
129859223|NCT00833989|467441513|FG002|Overall Study|Physician Decision|0|||
129859224|NCT00833989|467441514|FG003|Overall Study|Physician Decision|1|||
129859225|NCT00833989|467441511|FG000|Overall Study|Withdrawal by Subject|3|||
129859226|NCT00833989|467441512|FG001|Overall Study|Withdrawal by Subject|0|||
129859227|NCT00833989|467441513|FG002|Overall Study|Withdrawal by Subject|1|||
129859228|NCT00833989|467441514|FG003|Overall Study|Withdrawal by Subject|1|||
129859229|NCT01949480|467441515|FG000|Overall Study|Physician Decision|5|||
129859230|NCT01949480|467441516|FG001|Overall Study|Physician Decision|8|||
129859231|NCT00214136|467441517|FG000|Overall Study|Death|5|||
129859232|NCT04287920|467441518|FG000|Overall Study|Lost to Follow-up|1|||
129859233|NCT04287920|467441519|FG001|Overall Study|Lost to Follow-up|1|||
129859234|NCT04287920|467441518|FG000|Overall Study|Withdrawal by Subject|0|||
129859235|NCT04287920|467441519|FG001|Overall Study|Withdrawal by Subject|3|||
129859236|NCT04313634|467441520|FG000|Overall Study|Adverse Event|2|||
129859237|NCT04313634|467441521|FG001|Overall Study|Adverse Event|2|||
129859238|NCT04313634|467441522|FG002|Overall Study|Adverse Event|0|||
129859239|NCT04313634|467441520|FG000|Overall Study|Withdrawal by Subject|1|||
129859240|NCT04313634|467441521|FG001|Overall Study|Withdrawal by Subject|0|||
129859241|NCT04313634|467441522|FG002|Overall Study|Withdrawal by Subject|1|||
129859242|NCT04313634|467441520|FG000|Overall Study|Protocol Violation|0|||
129859243|NCT04313634|467441521|FG001|Overall Study|Protocol Violation|0|||
129859244|NCT04313634|467441522|FG002|Overall Study|Protocol Violation|1|||
129859245|NCT01220557|467441528|FG000|Overall Study|Lost to Follow-up|5|||
129859246|NCT01220557|467441529|FG001|Overall Study|Lost to Follow-up|3|||
129859247|NCT01220557|467441528|FG000|Overall Study|attended less than 6 lessons|1|||
129859248|NCT01220557|467441529|FG001|Overall Study|attended less than 6 lessons|2|||
129859249|NCT01196975|467441533|FG000|Overall Study|Adverse Event|2|||
129859250|NCT01196975|467441534|FG001|Overall Study|Adverse Event|2|||
129859251|NCT01196975|467441535|FG002|Overall Study|Adverse Event|0|||
129859252|NCT01196975|467441536|FG003|Overall Study|Adverse Event|0|||
129859253|NCT01196975|467441537|FG004|Overall Study|Adverse Event|2|||
129859254|NCT01196975|467441533|FG000|Overall Study|Withdrawal by Subject|2|||
129859255|NCT01196975|467441534|FG001|Overall Study|Withdrawal by Subject|1|||
129859256|NCT01196975|467441535|FG002|Overall Study|Withdrawal by Subject|0|||
129859257|NCT01196975|467441536|FG003|Overall Study|Withdrawal by Subject|1|||
129859258|NCT01196975|467441537|FG004|Overall Study|Withdrawal by Subject|0|||
129859259|NCT01196975|467441533|FG000|Overall Study|Lost to Follow-up|11|||
129859260|NCT01196975|467441534|FG001|Overall Study|Lost to Follow-up|6|||
129859261|NCT01196975|467441535|FG002|Overall Study|Lost to Follow-up|5|||
129859262|NCT01196975|467441536|FG003|Overall Study|Lost to Follow-up|5|||
129859263|NCT01196975|467441537|FG004|Overall Study|Lost to Follow-up|11|||
129859264|NCT01365494|467441538|FG000|Overall Study|Adverse Event|1|||
129859265|NCT01365494|467441539|FG001|Overall Study|Adverse Event|0|||
129859266|NCT01365494|467441538|FG000|Overall Study|Withdrawal by Subject|0|||
129859267|NCT01365494|467441539|FG001|Overall Study|Withdrawal by Subject|1|||
129859268|NCT01365494|467441538|FG000|Overall Study|Lost to Follow-up|1|||
129859269|NCT01365494|467441539|FG001|Overall Study|Lost to Follow-up|2|||
129859270|NCT04558346|467441540|FG000|Overall Study|Withdrawal by Subject|2|||
129859271|NCT04558346|467441541|FG001|Overall Study|Withdrawal by Subject|0|||
129859272|NCT04558346|467441540|FG000|Overall Study|Lost to Follow-up|0|||
129859273|NCT04558346|467441541|FG001|Overall Study|Lost to Follow-up|1|||
129859274|NCT04558346|467441540|FG000|Overall Study|Adverse Event|0|||
129859275|NCT04558346|467441541|FG001|Overall Study|Adverse Event|1|||
129859276|NCT01003249|467441544|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129859277|NCT01003249|467441545|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
129859278|NCT01003249|467441544|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
129859279|NCT01003249|467441545|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
129859280|NCT01003249|467441544|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
129859281|NCT01003249|467441545|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
129859282|NCT01003249|467441544|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
129859283|NCT01003249|467441545|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
129859284|NCT01962974|467441546|FG000|Overall Study|Study termination|7|||
129859285|NCT03394924|467441550|FG000|Overall Study|Adverse Event|0|||
129859286|NCT03394924|467441551|FG001|Overall Study|Adverse Event|5|||
129859287|NCT03394924|467441552|FG002|Overall Study|Adverse Event|0|||
129859288|NCT03394924|467441550|FG000|Overall Study|Withdrawal by Subject|2|||
129859289|NCT03394924|467441551|FG001|Overall Study|Withdrawal by Subject|0|||
129859290|NCT03394924|467441552|FG002|Overall Study|Withdrawal by Subject|0|||
129859291|NCT03394924|467441550|FG000|Overall Study|Lost to Follow-up|0|||
129859292|NCT03394924|467441551|FG001|Overall Study|Lost to Follow-up|1|||
129859293|NCT03394924|467441552|FG002|Overall Study|Lost to Follow-up|0|||
129859294|NCT03394924|467441550|FG000|Overall Study|Did not meet all inclusion criteria|1|||
129859295|NCT03394924|467441551|FG001|Overall Study|Did not meet all inclusion criteria|0|||
129859296|NCT03394924|467441552|FG002|Overall Study|Did not meet all inclusion criteria|0|||
129859297|NCT03588572|467441555|FG000|Visitation 1|Lack of Efficacy|1|||
129859298|NCT03588572|467441556|FG001|Visitation 1|Lack of Efficacy|1|||
129859299|NCT03588572|467441555|FG000|Visitation 2|Lost to Follow-up|1|||
129859300|NCT03588572|467441556|FG001|Visitation 2|Lost to Follow-up|1|||
129859301|NCT03588572|467441555|FG000|Visitation 2|Lack of Efficacy|0|||
129859302|NCT03588572|467441556|FG001|Visitation 2|Lack of Efficacy|1|||
129859303|NCT03588572|467441555|FG000|Visitation 2|Withdrawal by Subject|1|||
129859304|NCT03588572|467441556|FG001|Visitation 2|Withdrawal by Subject|0|||
129859305|NCT03588572|467441555|FG000|Visitation 3|Lost to Follow-up|1|||
129859306|NCT03588572|467441556|FG001|Visitation 3|Lost to Follow-up|1|||
129859307|NCT03588572|467441555|FG000|Visitation 3|Physician Decision|1|||
129859308|NCT03588572|467441556|FG001|Visitation 3|Physician Decision|1|||
129859309|NCT03588572|467441555|FG000|Visitation 3|Withdrawal by Subject|1|||
129859310|NCT03588572|467441556|FG001|Visitation 3|Withdrawal by Subject|0|||
129859311|NCT00659334|467441563|FG000|Overall Study|Screen Failure|8|||
129859312|NCT00659334|467441564|FG001|Overall Study|Screen Failure|5|||
129859313|NCT00659334|467441565|FG002|Overall Study|Screen Failure|0|||
129859314|NCT00659334|467441566|FG003|Overall Study|Screen Failure|0|||
129859315|NCT00659334|467441567|FG004|Overall Study|Screen Failure|0|||
129859316|NCT00659334|467441568|FG005|Overall Study|Screen Failure|0|||
129859317|NCT00659334|467441569|FG006|Overall Study|Screen Failure|1|||
129859318|NCT01174342|467441570|FG000|Overall Study|Conversion to cesarean section|4|||
129859319|NCT01308580|467441571|FG000|Overall Study|Lost to Follow-up|12|||
129859320|NCT01308580|467441572|FG001|Overall Study|Lost to Follow-up|7|||
129859321|NCT02535065|467441573|FG000|Overall Study|Death|13|||
129859322|NCT02535065|467441573|FG000|Overall Study|Lost to Follow-up|1|||
129859323|NCT02535065|467441573|FG000|Overall Study|Withdrawal by Subject|6|||
129859324|NCT00110617|467441575|FG000|Overall Study|Adverse Event|2|||
129859325|NCT00110617|467441576|FG001|Overall Study|Adverse Event|4|||
129859326|NCT00110617|467441575|FG000|Overall Study|Abnormal Laboratory Value|4|||
129859327|NCT00110617|467441576|FG001|Overall Study|Abnormal Laboratory Value|2|||
129859328|NCT00110617|467441575|FG000|Overall Study|Lack of Efficacy|1|||
129859329|NCT00110617|467441576|FG001|Overall Study|Lack of Efficacy|0|||
129859330|NCT00110617|467441575|FG000|Overall Study|Patient no longer requires study drug|1|||
129859331|NCT00110617|467441576|FG001|Overall Study|Patient no longer requires study drug|0|||
129859332|NCT00110617|467441575|FG000|Overall Study|Protocol Violation|5|||
129859333|NCT00110617|467441576|FG001|Overall Study|Protocol Violation|0|||
129859334|NCT00110617|467441575|FG000|Overall Study|Withdrawal by Subject|10|||
129859335|NCT00110617|467441576|FG001|Overall Study|Withdrawal by Subject|4|||
129859336|NCT00110617|467441575|FG000|Overall Study|Lost to Follow-up|9|||
129859337|NCT00110617|467441576|FG001|Overall Study|Lost to Follow-up|1|||
129859338|NCT00110617|467441575|FG000|Overall Study|Administrative problems|6|||
129859339|NCT00110617|467441576|FG001|Overall Study|Administrative problems|5|||
129859340|NCT00110617|467441575|FG000|Overall Study|Death|1|||
129859341|NCT00110617|467441576|FG001|Overall Study|Death|1|||
129859342|NCT00110617|467441575|FG000|Overall Study|Did not receive study drug|0|||
129859343|NCT00110617|467441576|FG001|Overall Study|Did not receive study drug|12|||
129859344|NCT00045110|467441578|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
129859345|NCT00045110|467441579|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
129859346|NCT00045110|467441580|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
129859347|NCT00045110|467441578|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
129859348|NCT00045110|467441579|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
129859349|NCT00045110|467441580|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
129859350|NCT00045110|467441578|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
129859351|NCT00045110|467441579|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
129859352|NCT00045110|467441580|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
129859353|NCT01218646|467441581|FG000|Overall Study|Adverse Event|0|||
129859354|NCT01218646|467441582|FG001|Overall Study|Adverse Event|0|||
129859355|NCT01218646|467441583|FG002|Overall Study|Adverse Event|1|||
129859356|NCT01218646|467441584|FG003|Overall Study|Adverse Event|0|||
129859357|NCT01218646|467441581|FG000|Overall Study|Lost to Follow-up|1|||
129859358|NCT01218646|467441582|FG001|Overall Study|Lost to Follow-up|0|||
129859359|NCT01218646|467441583|FG002|Overall Study|Lost to Follow-up|0|||
129859360|NCT01218646|467441584|FG003|Overall Study|Lost to Follow-up|0|||
129859361|NCT01218646|467441581|FG000|Overall Study|Protocol Violation|0|||
129859362|NCT01218646|467441582|FG001|Overall Study|Protocol Violation|0|||
129859363|NCT01218646|467441583|FG002|Overall Study|Protocol Violation|1|||
129859364|NCT01218646|467441584|FG003|Overall Study|Protocol Violation|1|||
129859365|NCT04537923|467444134|FG000|Overall Study|Adverse Event|2|||
129859366|NCT04537923|467444135|FG001|Overall Study|Adverse Event|1|||
129859367|NCT04537923|467444136|FG002|Overall Study|Adverse Event|2|||
129859368|NCT04537923|467444137|FG003|Overall Study|Adverse Event|4|||
129859369|NCT04537923|467444134|FG000|Overall Study|Death|3|||
129859370|NCT04537923|467444135|FG001|Overall Study|Death|3|||
129859371|NCT04537923|467444136|FG002|Overall Study|Death|1|||
129859372|NCT04537923|467444137|FG003|Overall Study|Death|11|||
129859373|NCT04537923|467444134|FG000|Overall Study|Lost to Follow-up|1|||
129859374|NCT04537923|467444135|FG001|Overall Study|Lost to Follow-up|2|||
129859375|NCT04537923|467444136|FG002|Overall Study|Lost to Follow-up|1|||
129859376|NCT04537923|467444137|FG003|Overall Study|Lost to Follow-up|6|||
129859377|NCT04537923|467444134|FG000|Overall Study|Physician Decision|1|||
129910473|NCT01248936|467635347|FG000|Overall Study|Withdrawal of Consent|20|||
129910474|NCT01248936|467635347|FG000|Overall Study|Adverse Event|8|||
129859378|NCT04537923|467444135|FG001|Overall Study|Physician Decision|0|||
129859379|NCT04537923|467444136|FG002|Overall Study|Physician Decision|2|||
129859380|NCT04537923|467444137|FG003|Overall Study|Physician Decision|5|||
129859381|NCT04537923|467444134|FG000|Overall Study|Pregnancy|1|||
129859382|NCT04537923|467444135|FG001|Overall Study|Pregnancy|0|||
129859383|NCT04537923|467444136|FG002|Overall Study|Pregnancy|0|||
129859384|NCT04537923|467444137|FG003|Overall Study|Pregnancy|0|||
129859385|NCT04537923|467444134|FG000|Overall Study|Withdrawal by Subject|4|||
129859386|NCT04537923|467444135|FG001|Overall Study|Withdrawal by Subject|4|||
129859387|NCT04537923|467444136|FG002|Overall Study|Withdrawal by Subject|4|||
129859388|NCT04537923|467444137|FG003|Overall Study|Withdrawal by Subject|58|||
129859389|NCT04537923|467444134|FG000|Overall Study|Missed study visits|2|||
129859390|NCT04537923|467444135|FG001|Overall Study|Missed study visits|0|||
129859391|NCT04537923|467444136|FG002|Overall Study|Missed study visits|0|||
129859392|NCT04537923|467444137|FG003|Overall Study|Missed study visits|3|||
129859393|NCT04537923|467444134|FG000|Overall Study|Sponsor's decision|0|||
129859394|NCT04537923|467444135|FG001|Overall Study|Sponsor's decision|0|||
129859395|NCT04537923|467444136|FG002|Overall Study|Sponsor's decision|1|||
129859396|NCT04537923|467444137|FG003|Overall Study|Sponsor's decision|1|||
129859397|NCT04537923|467444134|FG000|Overall Study|Safety reasons|1|||
129859398|NCT04537923|467444135|FG001|Overall Study|Safety reasons|0|||
129859399|NCT04537923|467444136|FG002|Overall Study|Safety reasons|0|||
129859400|NCT04537923|467444137|FG003|Overall Study|Safety reasons|0|||
129859401|NCT04745169|467444139|FG000|Overall Study|Kidney transplantation|1|||
129859402|NCT04745169|467444139|FG000|Overall Study|Participant health problems|3|||
129859403|NCT04745169|467444139|FG000|Overall Study|Physician Decision|2|||
129859404|NCT02041195|467444140|FG000|Overall Study|Adverse Event|1|||
129859405|NCT02041195|467444141|FG001|Overall Study|Adverse Event|2|||
129859406|NCT02041195|467444142|FG002|Overall Study|Adverse Event|0|||
129859407|NCT02041195|467444143|FG003|Overall Study|Adverse Event|0|||
129859408|NCT02041195|467444144|FG004|Overall Study|Adverse Event|0|||
129859409|NCT02041195|467444145|FG005|Overall Study|Adverse Event|0|||
129859410|NCT02041195|467444146|FG006|Overall Study|Adverse Event|3|||
129859411|NCT02041195|467444147|FG007|Overall Study|Adverse Event|0|||
129859412|NCT02041195|467444140|FG000|Overall Study|Withdrawal by Subject|1|||
129859413|NCT02041195|467444141|FG001|Overall Study|Withdrawal by Subject|0|||
129859414|NCT02041195|467444142|FG002|Overall Study|Withdrawal by Subject|0|||
129859415|NCT02041195|467444143|FG003|Overall Study|Withdrawal by Subject|0|||
129859416|NCT02041195|467444144|FG004|Overall Study|Withdrawal by Subject|0|||
129859417|NCT02041195|467444145|FG005|Overall Study|Withdrawal by Subject|0|||
129859418|NCT02041195|467444146|FG006|Overall Study|Withdrawal by Subject|4|||
129859419|NCT02041195|467444147|FG007|Overall Study|Withdrawal by Subject|3|||
129859420|NCT02041195|467444140|FG000|Overall Study|Unable to comply with study visits|0|||
129859421|NCT02041195|467444141|FG001|Overall Study|Unable to comply with study visits|1|||
129859422|NCT02041195|467444142|FG002|Overall Study|Unable to comply with study visits|0|||
129859423|NCT02041195|467444143|FG003|Overall Study|Unable to comply with study visits|0|||
129859424|NCT02041195|467444144|FG004|Overall Study|Unable to comply with study visits|1|||
129859425|NCT02041195|467444145|FG005|Overall Study|Unable to comply with study visits|0|||
129859426|NCT02041195|467444146|FG006|Overall Study|Unable to comply with study visits|0|||
129859427|NCT02041195|467444147|FG007|Overall Study|Unable to comply with study visits|0|||
129859428|NCT01747772|467444148|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
129859429|NCT00626522|467444149|FG000|Overall Study|Protocol Violation|0|||
129859430|NCT00626522|467444150|FG001|Overall Study|Protocol Violation|0|||
129859431|NCT00626522|467444151|FG002|Overall Study|Protocol Violation|0|||
129859432|NCT00626522|467444152|FG003|Overall Study|Protocol Violation|0|||
129859433|NCT00626522|467444153|FG004|Overall Study|Protocol Violation|1|||
129859434|NCT00626522|467444154|FG005|Overall Study|Protocol Violation|0|||
129859435|NCT00626522|467444149|FG000|Overall Study|Adverse Event|2|||
129859436|NCT00626522|467444150|FG001|Overall Study|Adverse Event|1|||
129859437|NCT00626522|467444151|FG002|Overall Study|Adverse Event|2|||
129859438|NCT00626522|467444152|FG003|Overall Study|Adverse Event|0|||
129859439|NCT00626522|467444153|FG004|Overall Study|Adverse Event|1|||
129859440|NCT00626522|467444154|FG005|Overall Study|Adverse Event|1|||
129859441|NCT00626522|467444149|FG000|Overall Study|Withdrawal by Subject|2|||
129859442|NCT00626522|467444150|FG001|Overall Study|Withdrawal by Subject|5|||
129859443|NCT00626522|467444151|FG002|Overall Study|Withdrawal by Subject|5|||
129859444|NCT00626522|467444152|FG003|Overall Study|Withdrawal by Subject|0|||
129859445|NCT00626522|467444153|FG004|Overall Study|Withdrawal by Subject|4|||
129859446|NCT00626522|467444154|FG005|Overall Study|Withdrawal by Subject|1|||
129859447|NCT00626522|467444149|FG000|Overall Study|COPD exacerbation|0|||
129859448|NCT00626522|467444150|FG001|Overall Study|COPD exacerbation|0|||
129859449|NCT00626522|467444151|FG002|Overall Study|COPD exacerbation|0|||
129859450|NCT00626522|467444152|FG003|Overall Study|COPD exacerbation|1|||
129859451|NCT00626522|467444153|FG004|Overall Study|COPD exacerbation|1|||
129859452|NCT00626522|467444154|FG005|Overall Study|COPD exacerbation|0|||
129859453|NCT00626522|467444149|FG000|Overall Study|Lost to Follow-up|0|||
129859454|NCT00626522|467444150|FG001|Overall Study|Lost to Follow-up|1|||
129859455|NCT00626522|467444151|FG002|Overall Study|Lost to Follow-up|0|||
129859456|NCT00626522|467444152|FG003|Overall Study|Lost to Follow-up|0|||
129859457|NCT00626522|467444153|FG004|Overall Study|Lost to Follow-up|0|||
129859458|NCT00626522|467444154|FG005|Overall Study|Lost to Follow-up|0|||
129859459|NCT00626522|467444149|FG000|Overall Study|Inconsistent reason reported|1|||
129859460|NCT00626522|467444150|FG001|Overall Study|Inconsistent reason reported|0|||
129859461|NCT00626522|467444151|FG002|Overall Study|Inconsistent reason reported|0|||
129859462|NCT00626522|467444152|FG003|Overall Study|Inconsistent reason reported|0|||
129859463|NCT00626522|467444153|FG004|Overall Study|Inconsistent reason reported|0|||
129859464|NCT00626522|467444154|FG005|Overall Study|Inconsistent reason reported|0|||
129859465|NCT00626522|467444149|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
129859466|NCT00626522|467444150|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
129859467|NCT00626522|467444151|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
129859468|NCT00626522|467444152|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
129859469|NCT00626522|467444153|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
129859470|NCT00626522|467444154|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
129859471|NCT00896168|467444155|FG000|Overall Study|Adverse Event|4|||
129859472|NCT00896168|467444156|FG001|Overall Study|Adverse Event|7|||
129859473|NCT00896168|467444155|FG000|Overall Study|Treatment failure|8|||
129859474|NCT00896168|467444156|FG001|Overall Study|Treatment failure|10|||
129859475|NCT00896168|467444155|FG000|Overall Study|Lost to Follow-up|1|||
129859476|NCT00896168|467444156|FG001|Overall Study|Lost to Follow-up|1|||
129859477|NCT00896168|467444155|FG000|Overall Study|Other|1|||
129859478|NCT00896168|467444156|FG001|Overall Study|Other|1|||
129859479|NCT04717596|467444164|FG000|Overall Study|Withdrawal by Subject|4|||
129859480|NCT02460991|467444166|FG000|Overall Study|Withdrawal by Subject|0|||
129859481|NCT02460991|467444167|FG001|Overall Study|Withdrawal by Subject|2|||
129859482|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
129859483|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
129859484|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Death|1|||
129859485|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Death|0|||
129859486|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
129859487|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
129859488|NCT00455195|467444169|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
129859489|NCT00455195|467444170|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
129859490|NCT02148250|467444171|FG000|Screening|Withdrawal by Subject|5|||
129859491|NCT02148250|467444172|FG001|Screening|Withdrawal by Subject|0|||
129859492|NCT02370602|467444175|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129859493|NCT02370602|467444176|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129859494|NCT02370602|467444177|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129859495|NCT02370602|467444178|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
129859496|NCT02370602|467444179|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
129859497|NCT02370602|467444180|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
129859498|NCT00237744|467444181|FG000|Overall Study|Withdrawal by Subject|3|||
129859499|NCT00237744|467444182|FG001|Overall Study|Withdrawal by Subject|1|||
129859500|NCT00237744|467444183|FG002|Overall Study|Withdrawal by Subject|0|||
129859501|NCT02097472|467444184|FG000|Received Vaccination 2|Adverse Event|0|||
129859502|NCT02097472|467444185|FG001|Received Vaccination 2|Adverse Event|0|||
129859503|NCT02097472|467444186|FG002|Received Vaccination 2|Adverse Event|0|||
129859504|NCT02097472|467444187|FG003|Received Vaccination 2|Adverse Event|0|||
129859505|NCT02097472|467444188|FG004|Received Vaccination 2|Adverse Event|0|||
129859506|NCT02097472|467444189|FG005|Received Vaccination 2|Adverse Event|0|||
129859507|NCT02097472|467444190|FG006|Received Vaccination 2|Adverse Event|1|||
129859508|NCT02097472|467444191|FG007|Received Vaccination 2|Adverse Event|0|||
129859509|NCT02119416|467444192|FG000|Overall Study|Protocol Violation|1|||
129859510|NCT02119416|467444193|FG001|Overall Study|Protocol Violation|1|||
129859511|NCT02119416|467444194|FG002|Overall Study|Protocol Violation|1|||
129859512|NCT02119416|467444192|FG000|Overall Study|wrong pubertal stage|1|||
129859513|NCT02119416|467444193|FG001|Overall Study|wrong pubertal stage|0|||
129859514|NCT02119416|467444194|FG002|Overall Study|wrong pubertal stage|1|||
129859515|NCT03043664|467444197|FG000|Overall Study|Lost to Follow-up|1|||
129859516|NCT03593655|467444198|FG000|First Product Use Period|Withdrawal by Subject|1|||
129859517|NCT03593655|467444199|FG001|First Product Use Period|Withdrawal by Subject|1|||
129859518|NCT03593655|467444198|FG000|First Product Use Period|Lost to Follow-up|1|||
129859519|NCT03593655|467444199|FG001|First Product Use Period|Lost to Follow-up|3|||
129859520|NCT03593655|467444198|FG000|Second Product Use Period|Withdrawal by Subject|1|||
129859521|NCT03593655|467444199|FG001|Second Product Use Period|Withdrawal by Subject|1|||
129859522|NCT03593655|467444198|FG000|Second Product Use Period|Lost to Follow-up|1|||
129859523|NCT03593655|467444199|FG001|Second Product Use Period|Lost to Follow-up|0|||
129859524|NCT03593655|467444198|FG000|Third Product Use Period|Lost to Follow-up|1|||
129859525|NCT03593655|467444199|FG001|Third Product Use Period|Lost to Follow-up|2|||
129859526|NCT03593655|467444198|FG000|Third Product Use Period|Physician Decision|0|||
129859527|NCT03593655|467444199|FG001|Third Product Use Period|Physician Decision|1|||
129859528|NCT03593655|467444198|FG000|Third Product Use Period|Withdrawal by Subject|0|||
129859529|NCT03593655|467444199|FG001|Third Product Use Period|Withdrawal by Subject|1|||
129859530|NCT03732209|467444202|FG000|Overall Study|Lost to Follow-up|4|||
129859531|NCT03732209|467444203|FG001|Overall Study|Lost to Follow-up|4|||
129859532|NCT03732209|467444202|FG000|Overall Study|Withdrawal by Subject|8|||
129859533|NCT03732209|467444203|FG001|Overall Study|Withdrawal by Subject|9|||
129859534|NCT05046795|467444204|FG000|Overall Study|Adverse Event|13|||
129859535|NCT05046795|467444205|FG001|Overall Study|Adverse Event|15|||
129859536|NCT05046795|467444204|FG000|Overall Study|Withdrawal by Subject|4|||
129859537|NCT05046795|467444205|FG001|Overall Study|Withdrawal by Subject|7|||
129859538|NCT05046795|467444204|FG000|Overall Study|Physician Decision|1|||
129859539|NCT05046795|467444205|FG001|Overall Study|Physician Decision|2|||
129859540|NCT05046795|467444204|FG000|Overall Study|Protocol Violation|1|||
129859541|NCT05046795|467444205|FG001|Overall Study|Protocol Violation|2|||
129859542|NCT05046795|467444204|FG000|Overall Study|Death|1|||
129859543|NCT05046795|467444205|FG001|Overall Study|Death|0|||
129859544|NCT05046795|467444204|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
129859545|NCT05046795|467444205|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
129859546|NCT02864082|467444206|FG000|Overall Study|Adverse Event|1|||
129859547|NCT02864082|467444207|FG001|Overall Study|Adverse Event|1|||
129859548|NCT02864082|467444206|FG000|Overall Study|Lost to Follow-up|0|||
129859549|NCT02864082|467444207|FG001|Overall Study|Lost to Follow-up|1|||
129859550|NCT02864082|467444206|FG000|Overall Study|Withdrawal by Subject|2|||
129859551|NCT02864082|467444207|FG001|Overall Study|Withdrawal by Subject|2|||
129859552|NCT01127178|467444208|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
129859553|NCT01127178|467444209|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
129859554|NCT01127178|467444208|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
129859555|NCT01127178|467444209|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
129859556|NCT01127178|467444208|FG000|Dose Escalation: Treatment Phase|Other|2|||
129859557|NCT01127178|467444209|FG001|Dose Escalation: Treatment Phase|Other|0|||
129859558|NCT01127178|467444208|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
129859559|NCT01127178|467444209|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
129859560|NCT01127178|467444208|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
129859561|NCT01127178|467444209|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
129859562|NCT01127178|467444208|FG000|Dose Escalation: Extension Phase|Other|1|||
129859563|NCT01127178|467444209|FG001|Dose Escalation: Extension Phase|Other|0|||
129859564|NCT03621696|467444210|FG000|Overall Study|Not eligible|0|||
129859565|NCT03621696|467444211|FG001|Overall Study|Not eligible|0|||
129859566|NCT03621696|467444212|FG002|Overall Study|Not eligible|0|||
129859567|NCT03621696|467444213|FG003|Overall Study|Not eligible|5|||
129859568|NCT03621696|467444210|FG000|Overall Study|Withdrawal by Subject|1|||
129859569|NCT03621696|467444211|FG001|Overall Study|Withdrawal by Subject|1|||
129859570|NCT03621696|467444212|FG002|Overall Study|Withdrawal by Subject|1|||
129859571|NCT03621696|467444213|FG003|Overall Study|Withdrawal by Subject|0|||
129859572|NCT03621696|467444210|FG000|Overall Study|Physician Decision|0|||
129859573|NCT03621696|467444211|FG001|Overall Study|Physician Decision|0|||
129859574|NCT03621696|467444212|FG002|Overall Study|Physician Decision|1|||
129859575|NCT03621696|467444213|FG003|Overall Study|Physician Decision|0|||
129859576|NCT04349553|467444214|FG000|Overall Study|Withdrawal by Subject|1|||
129859577|NCT04349553|467444215|FG001|Overall Study|Withdrawal by Subject|0|||
129859578|NCT04349553|467444216|FG002|Overall Study|Withdrawal by Subject|1|||
129859579|NCT04349553|467444217|FG003|Overall Study|Withdrawal by Subject|0|||
129859580|NCT02063724|467444218|FG000|Overall Study|Disease progression|1|||
129859581|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
129859582|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
129859583|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
129859584|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
129859585|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
129859586|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
129859587|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
129859588|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
129859589|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
129859590|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
129859591|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
129859592|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
129859593|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
129859594|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
129859595|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
129859596|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
129859597|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
129859598|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
129859599|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
129859600|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
129859601|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
129859602|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
129859603|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
129859604|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
129859605|NCT01715805|467444219|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
129859606|NCT01715805|467444220|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
129859607|NCT01715805|467444221|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
129859608|NCT01715805|467444222|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
129859609|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
129910475|NCT01248936|467635347|FG000|Overall Study|Lost to Follow-up|7|||
129910476|NCT01248936|467635347|FG000|Overall Study|Refused Treatment|1|||
129859610|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
129859611|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
129859612|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
129859613|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
129859614|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
129859615|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
129859616|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
129859617|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
129859618|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
129859619|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
129859620|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
129859621|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
129859622|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
129859623|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
129859624|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
129859625|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
129859626|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
129859627|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
129859628|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
129859629|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
129859630|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
129859631|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
129859632|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
129859633|NCT01715805|467444219|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
129859634|NCT01715805|467444220|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
129859635|NCT01715805|467444221|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
129859636|NCT01715805|467444222|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
129859637|NCT01618864|467444225|FG000|Overall Study|Withdrawal by Subject|2|||
129859638|NCT01618864|467444225|FG000|Overall Study|Lost to Follow-up|2|||
129859639|NCT05177770|467444226|FG000|Overall Study|Death|4|||
129859640|NCT05177770|467444226|FG000|Overall Study|Withdrawal by Subject|1|||
129859641|NCT05177770|467444226|FG000|Overall Study|Adverse Event prior to dosing|1|||
129859642|NCT00709722|467444231|FG000|Overall Study|Adverse Event|1|||
129859643|NCT04667117|467444232|FG000|Investigational Period|Lost to Follow-up|0|||
129859644|NCT04667117|467444233|FG001|Investigational Period|Lost to Follow-up|0|||
129859645|NCT04667117|467444234|FG002|Investigational Period|Lost to Follow-up|1|||
129859646|NCT04667117|467444232|FG000|Investigational Period|Protocol Deviation|0|||
129859647|NCT04667117|467444233|FG001|Investigational Period|Protocol Deviation|1|||
129859648|NCT04667117|467444234|FG002|Investigational Period|Protocol Deviation|0|||
129859649|NCT04667117|467444232|FG000|Extension Period|Lost to Follow-up|1|||
129859650|NCT04667117|467444233|FG001|Extension Period|Lost to Follow-up|0|||
129859651|NCT04667117|467444234|FG002|Extension Period|Lost to Follow-up|0|||
129859652|NCT02372396|467444248|FG000|Overall Study|Lost to Follow-up|7|||
129859653|NCT02372396|467444249|FG001|Overall Study|Lost to Follow-up|9|||
129859654|NCT01272934|467444252|FG000|Overall Study|Adverse Event|0|||
129859655|NCT01272934|467444253|FG001|Overall Study|Adverse Event|1|||
129859656|NCT01272934|467444252|FG000|Overall Study|Abnormal Laboratory Value|0|||
129859657|NCT01272934|467444253|FG001|Overall Study|Abnormal Laboratory Value|1|||
129859658|NCT02310750|467444256|FG000|HP Period 1|Lost to Follow-up|0|||
129859659|NCT02310750|467444257|FG001|HP Period 1|Lost to Follow-up|0|||
129859660|NCT02310750|467444258|FG002|HP Period 1|Lost to Follow-up|0|||
129859661|NCT02310750|467444259|FG003|HP Period 1|Lost to Follow-up|0|||
129859662|NCT02310750|467444260|FG004|HP Period 1|Lost to Follow-up|0|||
129859663|NCT02310750|467444261|FG005|HP Period 1|Lost to Follow-up|0|||
129859664|NCT02310750|467444262|FG006|HP Period 1|Lost to Follow-up|1|||
129859665|NCT02310750|467444263|FG007|HP Period 1|Lost to Follow-up|0|||
129859666|NCT02310750|467444264|FG008|HP Period 1|Lost to Follow-up|0|||
129859667|NCT02310750|467444265|FG009|HP Period 1|Lost to Follow-up|0|||
129859668|NCT02310750|467444266|FG010|HP Period 1|Lost to Follow-up|0|||
129859669|NCT02310750|467444267|FG011|HP Period 1|Lost to Follow-up|0|||
129859670|NCT02310750|467444268|FG012|HP Period 1|Lost to Follow-up|0|||
129859671|NCT02310750|467444269|FG013|HP Period 1|Lost to Follow-up|0|||
129859672|NCT02310750|467444270|FG014|HP Period 1|Lost to Follow-up|0|||
129859673|NCT02310750|467444271|FG015|HP Period 1|Lost to Follow-up|0|||
129859674|NCT02310750|467444256|FG000|HP Period 1|Withdrawal by Subject|1|||
129859675|NCT02310750|467444257|FG001|HP Period 1|Withdrawal by Subject|0|||
129859676|NCT02310750|467444258|FG002|HP Period 1|Withdrawal by Subject|0|||
129859677|NCT02310750|467444259|FG003|HP Period 1|Withdrawal by Subject|1|||
129859678|NCT02310750|467444260|FG004|HP Period 1|Withdrawal by Subject|0|||
129859679|NCT02310750|467444261|FG005|HP Period 1|Withdrawal by Subject|0|||
129859680|NCT02310750|467444262|FG006|HP Period 1|Withdrawal by Subject|0|||
129910477|NCT01248936|467635347|FG000|Overall Study|Other reason|3|||
129910478|NCT04556981|467635348|FG000|Overall Study|Death|0|||
129859681|NCT02310750|467444263|FG007|HP Period 1|Withdrawal by Subject|0|||
129859682|NCT02310750|467444264|FG008|HP Period 1|Withdrawal by Subject|0|||
129859683|NCT02310750|467444265|FG009|HP Period 1|Withdrawal by Subject|0|||
129859684|NCT02310750|467444266|FG010|HP Period 1|Withdrawal by Subject|0|||
129859685|NCT02310750|467444267|FG011|HP Period 1|Withdrawal by Subject|0|||
129859686|NCT02310750|467444268|FG012|HP Period 1|Withdrawal by Subject|0|||
129859687|NCT02310750|467444269|FG013|HP Period 1|Withdrawal by Subject|0|||
129859688|NCT02310750|467444270|FG014|HP Period 1|Withdrawal by Subject|0|||
129859689|NCT02310750|467444271|FG015|HP Period 1|Withdrawal by Subject|0|||
129859690|NCT02310750|467444256|FG000|HP Washout 1|Lost to Follow-up|0|||
129859691|NCT02310750|467444257|FG001|HP Washout 1|Lost to Follow-up|0|||
129859692|NCT02310750|467444258|FG002|HP Washout 1|Lost to Follow-up|1|||
129859693|NCT02310750|467444259|FG003|HP Washout 1|Lost to Follow-up|1|||
129859694|NCT02310750|467444260|FG004|HP Washout 1|Lost to Follow-up|2|||
129859695|NCT02310750|467444261|FG005|HP Washout 1|Lost to Follow-up|2|||
129859696|NCT02310750|467444262|FG006|HP Washout 1|Lost to Follow-up|3|||
129859697|NCT02310750|467444263|FG007|HP Washout 1|Lost to Follow-up|0|||
129859698|NCT02310750|467444264|FG008|HP Washout 1|Lost to Follow-up|0|||
129859699|NCT02310750|467444265|FG009|HP Washout 1|Lost to Follow-up|0|||
129859700|NCT02310750|467444266|FG010|HP Washout 1|Lost to Follow-up|0|||
129859701|NCT02310750|467444267|FG011|HP Washout 1|Lost to Follow-up|0|||
129859702|NCT02310750|467444268|FG012|HP Washout 1|Lost to Follow-up|0|||
129859703|NCT02310750|467444269|FG013|HP Washout 1|Lost to Follow-up|0|||
129859704|NCT02310750|467444270|FG014|HP Washout 1|Lost to Follow-up|0|||
129859705|NCT02310750|467444271|FG015|HP Washout 1|Lost to Follow-up|0|||
129859706|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859707|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859708|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859709|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
129859710|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859711|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
129859712|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859713|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859714|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
129859715|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
129859716|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859717|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859718|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859719|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859720|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859721|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
129859722|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859723|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859724|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859725|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859726|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859727|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859728|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859729|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859730|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859731|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
129859732|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859733|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859734|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859735|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859736|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859737|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
129859738|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859739|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859740|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859741|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859742|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859743|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859744|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859745|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
129859746|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
129859747|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
129859748|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859749|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859750|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859751|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859752|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859753|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
129859754|NCT02310750|467444256|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859755|NCT02310750|467444257|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859756|NCT02310750|467444258|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859757|NCT02310750|467444259|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859758|NCT02310750|467444260|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859759|NCT02310750|467444261|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859760|NCT02310750|467444262|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859761|NCT02310750|467444263|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
129859762|NCT02310750|467444264|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
129859763|NCT02310750|467444265|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859764|NCT02310750|467444266|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859765|NCT02310750|467444267|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859766|NCT02310750|467444268|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859767|NCT02310750|467444269|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859768|NCT02310750|467444270|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859769|NCT02310750|467444271|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
129859770|NCT02310750|467444256|FG000|HP Washout 2|Lost to Follow-up|0|||
129859771|NCT02310750|467444257|FG001|HP Washout 2|Lost to Follow-up|0|||
129859772|NCT02310750|467444258|FG002|HP Washout 2|Lost to Follow-up|0|||
129859773|NCT02310750|467444259|FG003|HP Washout 2|Lost to Follow-up|0|||
129859774|NCT02310750|467444260|FG004|HP Washout 2|Lost to Follow-up|1|||
129859775|NCT02310750|467444261|FG005|HP Washout 2|Lost to Follow-up|0|||
129859776|NCT02310750|467444262|FG006|HP Washout 2|Lost to Follow-up|7|||
129859777|NCT02310750|467444263|FG007|HP Washout 2|Lost to Follow-up|0|||
129859778|NCT02310750|467444264|FG008|HP Washout 2|Lost to Follow-up|0|||
129859779|NCT02310750|467444265|FG009|HP Washout 2|Lost to Follow-up|0|||
129859780|NCT02310750|467444266|FG010|HP Washout 2|Lost to Follow-up|0|||
129859781|NCT02310750|467444267|FG011|HP Washout 2|Lost to Follow-up|0|||
129859782|NCT02310750|467444268|FG012|HP Washout 2|Lost to Follow-up|0|||
129859783|NCT02310750|467444269|FG013|HP Washout 2|Lost to Follow-up|0|||
129859784|NCT02310750|467444270|FG014|HP Washout 2|Lost to Follow-up|0|||
129859785|NCT02310750|467444271|FG015|HP Washout 2|Lost to Follow-up|0|||
129859786|NCT01226745|467444272|FG000|Overall Study|Did not complete schedule of assessments|8|||
129859787|NCT01226745|467444273|FG001|Overall Study|Did not complete schedule of assessments|3|||
129859788|NCT01226745|467444274|FG002|Overall Study|Did not complete schedule of assessments|6|||
129859789|NCT01226745|467444275|FG003|Overall Study|Did not complete schedule of assessments|0|||
129859790|NCT01226745|467444276|FG004|Overall Study|Did not complete schedule of assessments|0|||
129859791|NCT01226745|467444277|FG005|Overall Study|Did not complete schedule of assessments|1|||
129859792|NCT01226745|467444272|FG000|Overall Study|Lost to Follow-up|2|||
129859793|NCT01226745|467444273|FG001|Overall Study|Lost to Follow-up|6|||
129859794|NCT01226745|467444274|FG002|Overall Study|Lost to Follow-up|6|||
129859795|NCT01226745|467444275|FG003|Overall Study|Lost to Follow-up|1|||
129859796|NCT01226745|467444276|FG004|Overall Study|Lost to Follow-up|1|||
129859797|NCT01226745|467444277|FG005|Overall Study|Lost to Follow-up|2|||
129859798|NCT01226745|467444272|FG000|Overall Study|Death|1|||
129859799|NCT01226745|467444273|FG001|Overall Study|Death|0|||
129859800|NCT01226745|467444274|FG002|Overall Study|Death|0|||
129859801|NCT01226745|467444275|FG003|Overall Study|Death|0|||
129859802|NCT01226745|467444276|FG004|Overall Study|Death|0|||
129859803|NCT01226745|467444277|FG005|Overall Study|Death|1|||
129859804|NCT01226745|467444272|FG000|Overall Study|Other|6|||
129859805|NCT01226745|467444273|FG001|Overall Study|Other|7|||
129859806|NCT01226745|467444274|FG002|Overall Study|Other|8|||
129859807|NCT01226745|467444275|FG003|Overall Study|Other|4|||
129859808|NCT01226745|467444276|FG004|Overall Study|Other|3|||
129859809|NCT01226745|467444277|FG005|Overall Study|Other|1|||
129859810|NCT01435577|467444280|FG000|Overall Study|Adverse Event|10|||
129859811|NCT01435577|467444281|FG001|Overall Study|Adverse Event|0|||
129859812|NCT01435577|467444280|FG000|Overall Study|Lack of Efficacy|7|||
129859813|NCT01435577|467444281|FG001|Overall Study|Lack of Efficacy|51|||
129859814|NCT01435577|467444280|FG000|Overall Study|Alternative treatment started|0|||
129859815|NCT01435577|467444281|FG001|Overall Study|Alternative treatment started|1|||
129859816|NCT00718718|467444282|FG000|Prior to Week 12|Adverse Event|0|||
129859817|NCT00718718|467444283|FG001|Prior to Week 12|Adverse Event|0|||
129859818|NCT00718718|467444284|FG002|Prior to Week 12|Adverse Event|0|||
129859819|NCT00718718|467444285|FG003|Prior to Week 12|Adverse Event|0|||
129859820|NCT00718718|467444286|FG004|Prior to Week 12|Adverse Event|0|||
129859821|NCT00718718|467444287|FG005|Prior to Week 12|Adverse Event|0|||
129859822|NCT00718718|467444288|FG006|Prior to Week 12|Adverse Event|0|||
129859823|NCT00718718|467444289|FG007|Prior to Week 12|Adverse Event|1|||
129859824|NCT00718718|467444290|FG008|Prior to Week 12|Adverse Event|1|||
129859825|NCT00718718|467444291|FG009|Prior to Week 12|Adverse Event|0|||
129859826|NCT00718718|467444282|FG000|Prior to Week 12|Withdrawal by Subject|0|||
129859827|NCT00718718|467444283|FG001|Prior to Week 12|Withdrawal by Subject|0|||
129859828|NCT00718718|467444284|FG002|Prior to Week 12|Withdrawal by Subject|0|||
129859829|NCT00718718|467444285|FG003|Prior to Week 12|Withdrawal by Subject|0|||
129859830|NCT00718718|467444286|FG004|Prior to Week 12|Withdrawal by Subject|3|||
129859831|NCT00718718|467444287|FG005|Prior to Week 12|Withdrawal by Subject|0|||
129859832|NCT00718718|467444288|FG006|Prior to Week 12|Withdrawal by Subject|1|||
129859833|NCT00718718|467444289|FG007|Prior to Week 12|Withdrawal by Subject|1|||
129859834|NCT00718718|467444290|FG008|Prior to Week 12|Withdrawal by Subject|1|||
129859835|NCT00718718|467444291|FG009|Prior to Week 12|Withdrawal by Subject|0|||
129859836|NCT00718718|467444282|FG000|Prior to Week 12|Other|1|||
129859837|NCT00718718|467444283|FG001|Prior to Week 12|Other|0|||
129859838|NCT00718718|467444284|FG002|Prior to Week 12|Other|1|||
129859839|NCT00718718|467444285|FG003|Prior to Week 12|Other|0|||
129859840|NCT00718718|467444286|FG004|Prior to Week 12|Other|0|||
129859841|NCT00718718|467444287|FG005|Prior to Week 12|Other|0|||
129859842|NCT00718718|467444288|FG006|Prior to Week 12|Other|0|||
129859843|NCT00718718|467444289|FG007|Prior to Week 12|Other|0|||
129859844|NCT00718718|467444290|FG008|Prior to Week 12|Other|0|||
129859845|NCT00718718|467444291|FG009|Prior to Week 12|Other|0|||
129859846|NCT00718718|467444282|FG000|Week 12 to End of Study|Adverse Event|0|||
129859847|NCT00718718|467444283|FG001|Week 12 to End of Study|Adverse Event|0|||
129859848|NCT00718718|467444284|FG002|Week 12 to End of Study|Adverse Event|0|||
129859849|NCT00718718|467444285|FG003|Week 12 to End of Study|Adverse Event|0|||
129859850|NCT00718718|467444286|FG004|Week 12 to End of Study|Adverse Event|0|||
129859851|NCT00718718|467444287|FG005|Week 12 to End of Study|Adverse Event|0|||
129859852|NCT00718718|467444288|FG006|Week 12 to End of Study|Adverse Event|0|||
129859853|NCT00718718|467444289|FG007|Week 12 to End of Study|Adverse Event|1|||
129859854|NCT00718718|467444290|FG008|Week 12 to End of Study|Adverse Event|0|||
129859855|NCT00718718|467444291|FG009|Week 12 to End of Study|Adverse Event|0|||
129859856|NCT00718718|467444282|FG000|Week 12 to End of Study|Death|0|||
129859857|NCT00718718|467444283|FG001|Week 12 to End of Study|Death|0|||
129859858|NCT00718718|467444284|FG002|Week 12 to End of Study|Death|0|||
129859859|NCT00718718|467444285|FG003|Week 12 to End of Study|Death|0|||
129859860|NCT00718718|467444286|FG004|Week 12 to End of Study|Death|0|||
129859861|NCT00718718|467444287|FG005|Week 12 to End of Study|Death|1|||
129859862|NCT00718718|467444288|FG006|Week 12 to End of Study|Death|0|||
129859863|NCT00718718|467444289|FG007|Week 12 to End of Study|Death|0|||
129859864|NCT00718718|467444290|FG008|Week 12 to End of Study|Death|0|||
129859865|NCT00718718|467444291|FG009|Week 12 to End of Study|Death|0|||
129859866|NCT00718718|467444282|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
129859867|NCT00718718|467444283|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
129859868|NCT00718718|467444284|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
129859869|NCT00718718|467444285|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
129859870|NCT00718718|467444286|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
129859871|NCT00718718|467444287|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
129859872|NCT00718718|467444288|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
129859873|NCT00718718|467444289|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
129859874|NCT00718718|467444290|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
129859875|NCT00718718|467444291|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
129859876|NCT00718718|467444282|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
129859877|NCT00718718|467444283|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
129859878|NCT00718718|467444284|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
129859879|NCT00718718|467444285|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
129859880|NCT00718718|467444286|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
129859881|NCT00718718|467444287|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
129859882|NCT00718718|467444288|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
129859883|NCT00718718|467444289|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
129859884|NCT00718718|467444290|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
129859885|NCT00718718|467444291|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
129859886|NCT00718718|467444282|FG000|Week 12 to End of Study|Other|0|||
129859887|NCT00718718|467444283|FG001|Week 12 to End of Study|Other|1|||
129859888|NCT00718718|467444284|FG002|Week 12 to End of Study|Other|0|||
129859889|NCT00718718|467444285|FG003|Week 12 to End of Study|Other|1|||
129859890|NCT00718718|467444286|FG004|Week 12 to End of Study|Other|0|||
129859891|NCT00718718|467444287|FG005|Week 12 to End of Study|Other|0|||
129859892|NCT00718718|467444288|FG006|Week 12 to End of Study|Other|1|||
129859893|NCT00718718|467444289|FG007|Week 12 to End of Study|Other|0|||
129859894|NCT00718718|467444290|FG008|Week 12 to End of Study|Other|0|||
129859895|NCT00718718|467444291|FG009|Week 12 to End of Study|Other|0|||
129859896|NCT02715765|467444302|FG000|Overall Study|Study Termination|3|||
129859897|NCT02715765|467444303|FG001|Overall Study|Study Termination|0|||
129859898|NCT02715765|467444304|FG002|Overall Study|Study Termination|0|||
129859899|NCT01462344|467444305|FG000|Overall Study|Withdrawal by Subject|245|||
129859900|NCT01462344|467444306|FG001|Overall Study|Withdrawal by Subject|226|||
129859901|NCT01462344|467444305|FG000|Overall Study|Adverse Event|24|||
129859902|NCT01462344|467444306|FG001|Overall Study|Adverse Event|23|||
129859903|NCT01462344|467444305|FG000|Overall Study|Asthma Exacerbation|34|||
129859904|NCT01462344|467444306|FG001|Overall Study|Asthma Exacerbation|35|||
129859905|NCT01462344|467444305|FG000|Overall Study|Lack of Efficacy|5|||
129859906|NCT01462344|467444306|FG001|Overall Study|Lack of Efficacy|6|||
129859907|NCT01462344|467444305|FG000|Overall Study|Protocol Violation|68|||
129859908|NCT01462344|467444306|FG001|Overall Study|Protocol Violation|53|||
129859909|NCT01462344|467444305|FG000|Overall Study|Lost to Follow-up|7|||
129859910|NCT01462344|467444306|FG001|Overall Study|Lost to Follow-up|7|||
129859911|NCT03387852|467444307|FG000|Overall Study|Adverse event (AE)|3|||
129859912|NCT03387852|467444308|FG001|Overall Study|Adverse event (AE)|0|||
129859913|NCT03387852|467444309|FG002|Overall Study|Adverse event (AE)|2|||
129859914|NCT03387852|467444310|FG003|Overall Study|Adverse event (AE)|0|||
129859915|NCT03387852|467444307|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
129859916|NCT03387852|467444308|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
129859917|NCT03387852|467444309|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
129859918|NCT03387852|467444310|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
129859919|NCT03387852|467444307|FG000|Overall Study|Withdrawal by participant|1|||
129859920|NCT03387852|467444308|FG001|Overall Study|Withdrawal by participant|1|||
129859921|NCT03387852|467444309|FG002|Overall Study|Withdrawal by participant|3|||
129859922|NCT03387852|467444310|FG003|Overall Study|Withdrawal by participant|2|||
129859923|NCT03387852|467444307|FG000|Overall Study|Other- Unspecified|1|||
129859924|NCT03387852|467444308|FG001|Overall Study|Other- Unspecified|1|||
129859925|NCT03387852|467444309|FG002|Overall Study|Other- Unspecified|2|||
129859926|NCT03387852|467444310|FG003|Overall Study|Other- Unspecified|1|||
129859927|NCT03387852|467444307|FG000|Overall Study|Poor compliance to protocol|0|||
129859928|NCT03387852|467444308|FG001|Overall Study|Poor compliance to protocol|0|||
129859929|NCT03387852|467444309|FG002|Overall Study|Poor compliance to protocol|0|||
129859930|NCT03387852|467444310|FG003|Overall Study|Poor compliance to protocol|1|||
129859931|NCT03387852|467444307|FG000|Overall Study|Randomized and not treated|0|||
129859932|NCT03387852|467444308|FG001|Overall Study|Randomized and not treated|0|||
129859933|NCT03387852|467444309|FG002|Overall Study|Randomized and not treated|0|||
129859934|NCT03387852|467444310|FG003|Overall Study|Randomized and not treated|1|||
129859935|NCT04177758|467444311|FG000|Overall Study|Lost to Follow-up|19|||
129859936|NCT04177758|467444312|FG001|Overall Study|Lost to Follow-up|11|||
129859937|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
129859938|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
129859939|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
129859940|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
129859941|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
129859942|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
129859943|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
129859944|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
129859945|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
129859946|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
129859947|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
129859948|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
129859949|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
129859950|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
129859951|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
129859952|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
129859953|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
129859954|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
129859955|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
129859956|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
129859957|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
129859958|NCT01781572|467444313|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
129859959|NCT01781572|467444314|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
129859960|NCT01781572|467444315|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
129859961|NCT01781572|467444313|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
129859962|NCT01781572|467444314|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
129859963|NCT01781572|467444315|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
129859964|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
129859965|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
129859966|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
129859967|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
129859968|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
129910479|NCT04556981|467635349|FG001|Overall Study|Death|1|||
129859969|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
129859970|NCT01781572|467444313|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
129859971|NCT01781572|467444314|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
129859972|NCT01781572|467444315|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
129859973|NCT01781572|467444313|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
129859974|NCT01781572|467444314|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
129859975|NCT01781572|467444315|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
129859976|NCT01781572|467444313|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
129859977|NCT01781572|467444314|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
129859978|NCT01781572|467444315|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
129859979|NCT01781572|467444313|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
129859980|NCT01781572|467444314|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
129859981|NCT01781572|467444315|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
129859982|NCT01781572|467444313|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
129859983|NCT01781572|467444314|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
129859984|NCT01781572|467444315|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
129859985|NCT01781572|467444313|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
129859986|NCT01781572|467444314|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
129859987|NCT01781572|467444315|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
129859988|NCT01781572|467444313|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
129859989|NCT01781572|467444314|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
129859990|NCT01781572|467444315|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
129859991|NCT03156023|467444316|FG000|Overall Study|Withdrawal by Subject|1|||
129859992|NCT03156023|467444317|FG001|Overall Study|Withdrawal by Subject|0|||
129859993|NCT03156023|467444318|FG002|Overall Study|Withdrawal by Subject|2|||
129859994|NCT03156023|467444319|FG003|Overall Study|Withdrawal by Subject|1|||
129859995|NCT03156023|467444320|FG004|Overall Study|Withdrawal by Subject|1|||
129859996|NCT03156023|467444316|FG000|Overall Study|Lost to Follow-up|0|||
129859997|NCT03156023|467444317|FG001|Overall Study|Lost to Follow-up|0|||
129859998|NCT03156023|467444318|FG002|Overall Study|Lost to Follow-up|0|||
129859999|NCT03156023|467444319|FG003|Overall Study|Lost to Follow-up|0|||
129860000|NCT03156023|467444320|FG004|Overall Study|Lost to Follow-up|1|||
129860001|NCT00726752|467444321|FG000|Overall Study|Lack of Efficacy|6|||
129860002|NCT04827576|467445554|FG000|Overall Study|Death|5|||
129860003|NCT04827576|467445555|FG001|Overall Study|Death|17|||
129860004|NCT04827576|467445556|FG002|Overall Study|Death|17|||
129860005|NCT04827576|467445557|FG003|Overall Study|Death|32|||
129860006|NCT04827576|467445554|FG000|Overall Study|Study Terminated by Sponsor|2|||
129860007|NCT04827576|467445555|FG001|Overall Study|Study Terminated by Sponsor|9|||
129860008|NCT04827576|467445556|FG002|Overall Study|Study Terminated by Sponsor|7|||
129860009|NCT04827576|467445557|FG003|Overall Study|Study Terminated by Sponsor|5|||
129860010|NCT04827576|467445554|FG000|Overall Study|Investigator's Discretion|1|||
129860011|NCT04827576|467445555|FG001|Overall Study|Investigator's Discretion|0|||
129860012|NCT04827576|467445556|FG002|Overall Study|Investigator's Discretion|2|||
129860013|NCT04827576|467445557|FG003|Overall Study|Investigator's Discretion|5|||
129860014|NCT04827576|467445554|FG000|Overall Study|Withdrew Consent|0|||
129860015|NCT04827576|467445555|FG001|Overall Study|Withdrew Consent|3|||
129860016|NCT04827576|467445556|FG002|Overall Study|Withdrew Consent|0|||
129860017|NCT04827576|467445557|FG003|Overall Study|Withdrew Consent|0|||
129860018|NCT04827576|467445554|FG000|Overall Study|Lost to Follow-up|1|||
129860019|NCT04827576|467445555|FG001|Overall Study|Lost to Follow-up|0|||
129860020|NCT04827576|467445556|FG002|Overall Study|Lost to Follow-up|0|||
129860021|NCT04827576|467445557|FG003|Overall Study|Lost to Follow-up|0|||
129860022|NCT01261611|467445558|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
129860023|NCT01261611|467445559|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
129860024|NCT01261611|467445560|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
129860025|NCT01261611|467445558|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
129860026|NCT01261611|467445559|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
129860027|NCT01261611|467445560|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
129860028|NCT01261611|467445558|FG000|Treatment Cycle 1|Adverse Event|0|||
129860029|NCT01261611|467445559|FG001|Treatment Cycle 1|Adverse Event|1|||
129860030|NCT01261611|467445560|FG002|Treatment Cycle 1|Adverse Event|0|||
129860031|NCT01261611|467445558|FG000|Treatment Cycle 1|Protocol Violation|0|||
129860032|NCT01261611|467445559|FG001|Treatment Cycle 1|Protocol Violation|0|||
129860033|NCT01261611|467445560|FG002|Treatment Cycle 1|Protocol Violation|2|||
129860034|NCT01261611|467445558|FG000|Treatment Cycle 2|Completed study|4|||
129860035|NCT01261611|467445559|FG001|Treatment Cycle 2|Completed study|0|||
129860036|NCT01261611|467445560|FG002|Treatment Cycle 2|Completed study|0|||
129860037|NCT01261611|467445558|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
129860038|NCT01261611|467445559|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
129860039|NCT01261611|467445560|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
129860040|NCT01261611|467445558|FG000|Treatment Cycle 2|Adverse Event|1|||
129860041|NCT01261611|467445559|FG001|Treatment Cycle 2|Adverse Event|0|||
129860042|NCT01261611|467445560|FG002|Treatment Cycle 2|Adverse Event|0|||
129860043|NCT01261611|467445558|FG000|Treatment Cycle 2|Protocol Violation|2|||
129860044|NCT01261611|467445559|FG001|Treatment Cycle 2|Protocol Violation|0|||
129860045|NCT01261611|467445560|FG002|Treatment Cycle 2|Protocol Violation|0|||
129860046|NCT01261611|467445558|FG000|Treatment Cycle 2|Not otherwise specified|2|||
129860047|NCT01261611|467445559|FG001|Treatment Cycle 2|Not otherwise specified|0|||
129860048|NCT01261611|467445560|FG002|Treatment Cycle 2|Not otherwise specified|0|||
129860049|NCT01261611|467445558|FG000|Treatment Cycle 3|Completed study|24|||
129860050|NCT01261611|467445559|FG001|Treatment Cycle 3|Completed study|0|||
129860051|NCT01261611|467445560|FG002|Treatment Cycle 3|Completed study|0|||
129860052|NCT01261611|467445558|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
129860053|NCT01261611|467445559|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
129860054|NCT01261611|467445560|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
129860055|NCT01261611|467445558|FG000|Treatment Cycle 3|Adverse Event|1|||
129860056|NCT01261611|467445559|FG001|Treatment Cycle 3|Adverse Event|0|||
129860057|NCT01261611|467445560|FG002|Treatment Cycle 3|Adverse Event|0|||
129860058|NCT01261611|467445558|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
129860059|NCT01261611|467445559|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
129860060|NCT01261611|467445560|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
129860061|NCT01261611|467445558|FG000|Treatment Cycle 4|Completed study|87|||
129860062|NCT01261611|467445559|FG001|Treatment Cycle 4|Completed study|0|||
129860063|NCT01261611|467445560|FG002|Treatment Cycle 4|Completed study|0|||
129860064|NCT01261611|467445558|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
129860065|NCT01261611|467445559|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
129860066|NCT01261611|467445560|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
129860067|NCT01261611|467445558|FG000|Treatment Cycle 4|Adverse Event|1|||
129860068|NCT01261611|467445559|FG001|Treatment Cycle 4|Adverse Event|0|||
129860069|NCT01261611|467445560|FG002|Treatment Cycle 4|Adverse Event|0|||
129860070|NCT01261611|467445558|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
129860071|NCT01261611|467445559|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
129860072|NCT01261611|467445560|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
129860073|NCT01261611|467445558|FG000|Treatment Cycle 4|Not otherwise specified|3|||
129860074|NCT01261611|467445559|FG001|Treatment Cycle 4|Not otherwise specified|0|||
129860075|NCT01261611|467445560|FG002|Treatment Cycle 4|Not otherwise specified|0|||
129860076|NCT01261611|467445558|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
129860077|NCT01261611|467445559|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
129860078|NCT01261611|467445560|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
129860079|NCT01261611|467445558|FG000|Treatment Cycle 5|Adverse Event|1|||
129860080|NCT01261611|467445559|FG001|Treatment Cycle 5|Adverse Event|0|||
129860081|NCT01261611|467445560|FG002|Treatment Cycle 5|Adverse Event|0|||
129860082|NCT01261611|467445558|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
129860083|NCT01261611|467445559|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
129860084|NCT01261611|467445560|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
129860085|NCT02527798|467445561|FG000|Overall Study|Physician Decision|1|||
129860086|NCT02527798|467445562|FG001|Overall Study|Physician Decision|0|||
129860087|NCT02527798|467445563|FG002|Overall Study|Physician Decision|1|||
129860088|NCT02527798|467445564|FG003|Overall Study|Physician Decision|1|||
129860089|NCT02527798|467445565|FG004|Overall Study|Physician Decision|0|||
129860090|NCT02527798|467445566|FG005|Overall Study|Physician Decision|0|||
129860091|NCT02527798|467445561|FG000|Overall Study|Death|0|||
129860092|NCT02527798|467445562|FG001|Overall Study|Death|0|||
129860093|NCT02527798|467445563|FG002|Overall Study|Death|1|||
129860094|NCT02527798|467445564|FG003|Overall Study|Death|0|||
129860095|NCT02527798|467445565|FG004|Overall Study|Death|0|||
129860096|NCT02527798|467445566|FG005|Overall Study|Death|0|||
129860097|NCT02527798|467445561|FG000|Overall Study|Withdrawal by Subject|0|||
129860098|NCT02527798|467445562|FG001|Overall Study|Withdrawal by Subject|1|||
129860099|NCT02527798|467445563|FG002|Overall Study|Withdrawal by Subject|2|||
129860100|NCT02527798|467445564|FG003|Overall Study|Withdrawal by Subject|0|||
129860101|NCT02527798|467445565|FG004|Overall Study|Withdrawal by Subject|0|||
129860102|NCT02527798|467445566|FG005|Overall Study|Withdrawal by Subject|0|||
129860103|NCT02527798|467445561|FG000|Overall Study|Reason undisclosed|1|||
129860104|NCT02527798|467445562|FG001|Overall Study|Reason undisclosed|0|||
129860105|NCT02527798|467445563|FG002|Overall Study|Reason undisclosed|1|||
129860106|NCT02527798|467445564|FG003|Overall Study|Reason undisclosed|0|||
129860107|NCT02527798|467445565|FG004|Overall Study|Reason undisclosed|0|||
129860108|NCT02527798|467445566|FG005|Overall Study|Reason undisclosed|0|||
129910480|NCT04556981|467635348|FG000|Overall Study|Lost to Follow-up|2|||
129860109|NCT02527798|467445561|FG000|Overall Study|Did not receive intervention|1|||
129860110|NCT02527798|467445562|FG001|Overall Study|Did not receive intervention|1|||
129860111|NCT02527798|467445563|FG002|Overall Study|Did not receive intervention|0|||
129860112|NCT02527798|467445564|FG003|Overall Study|Did not receive intervention|0|||
129860113|NCT02527798|467445565|FG004|Overall Study|Did not receive intervention|0|||
129860114|NCT02527798|467445566|FG005|Overall Study|Did not receive intervention|0|||
129860115|NCT02891187|467445568|FG000|Overall Study|Lost to Follow-up|1|||
129860116|NCT02891187|467445569|FG001|Overall Study|Lost to Follow-up|2|||
129860117|NCT02395120|467445572|FG000|Overall Study|Missed follow-up dental exam|57|||
129860118|NCT02395120|467445573|FG001|Overall Study|Missed follow-up dental exam|62|||
129860119|NCT02395120|467445574|FG002|Overall Study|Missed follow-up dental exam|6|||
129860120|NCT02395120|467445575|FG003|Overall Study|Missed follow-up dental exam|6|||
129910481|NCT04556981|467635349|FG001|Overall Study|Lost to Follow-up|11|||
129860121|NCT02395120|467445576|FG004|Overall Study|Missed follow-up dental exam|51|||
129860122|NCT00674986|467445577|FG000|Overall Study|Adverse Event|2|||
129860123|NCT00674986|467445578|FG001|Overall Study|Adverse Event|1|||
129860124|NCT00674986|467445577|FG000|Overall Study|Subject withdrew consent|12|||
129860125|NCT00674986|467445578|FG001|Overall Study|Subject withdrew consent|19|||
129860126|NCT00674986|467445577|FG000|Overall Study|Lost to Follow-up|25|||
129860127|NCT00674986|467445578|FG001|Overall Study|Lost to Follow-up|53|||
129860128|NCT00674986|467445577|FG000|Overall Study|Other reasons|4|||
129860129|NCT00674986|467445578|FG001|Overall Study|Other reasons|8|||
129860130|NCT04546581|467445584|FG000|Overall Study|Adverse Event|9|||
129860131|NCT04546581|467445585|FG001|Overall Study|Adverse Event|3|||
129860132|NCT04546581|467445584|FG000|Overall Study|Physician Decision|0|||
129860133|NCT04546581|467445585|FG001|Overall Study|Physician Decision|1|||
129860134|NCT04546581|467445584|FG000|Overall Study|Protocol Violation|1|||
129860135|NCT04546581|467445585|FG001|Overall Study|Protocol Violation|2|||
129860136|NCT04546581|467445584|FG000|Overall Study|Withdrawal by Subject|3|||
129860137|NCT04546581|467445585|FG001|Overall Study|Withdrawal by Subject|7|||
129860138|NCT02526693|467445586|FG000|Overall Study|Physician Decision|3|||
129860139|NCT02526693|467445587|FG001|Overall Study|Physician Decision|1|||
129860140|NCT01983293|467445588|FG000|Overall Study|Withdrawal by Subject|29|||
129860141|NCT01983293|467445589|FG001|Overall Study|Withdrawal by Subject|15|||
129860142|NCT01983293|467445588|FG000|Overall Study|Missing 12-month visit|3|||
129860143|NCT01983293|467445589|FG001|Overall Study|Missing 12-month visit|3|||
129860144|NCT01983293|467445588|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
129860145|NCT01983293|467445589|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
129860146|NCT01275625|467445590|FG000|Overall Study|Death|1|||
129860147|NCT01275625|467445590|FG000|Overall Study|Lack of Efficacy|2|||
129860148|NCT01275625|467445590|FG000|Overall Study|Lost to Follow-up|1|||
129860149|NCT01275625|467445590|FG000|Overall Study|Withdrawal by Subject|3|||
129860150|NCT01275625|467445590|FG000|Overall Study|Protocol Violation|1|||
129860151|NCT01275625|467445590|FG000|Overall Study|Adverse Event|4|||
129860152|NCT01275625|467445590|FG000|Overall Study|Other|1|||
129860153|NCT01585103|467445592|FG000|Overall Study|Unable to swallow Cytosponge|6|||
129860154|NCT01349569|467445594|FG000|Overall Study|Lack of Efficacy|4|||
129860155|NCT03581305|467445595|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
129860156|NCT03581305|467445596|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
129860157|NCT03581305|467445595|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
129860158|NCT03581305|467445596|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
129860159|NCT03581305|467445595|FG000|Serotonergic Study|Withdrawal by Subject|5|||
129860160|NCT03581305|467445596|FG001|Serotonergic Study|Withdrawal by Subject|1|||
129860161|NCT01798927|467445599|FG000|Overall Study|Withdrawal by Subject|1|||
129860162|NCT03750552|467445600|FG000|Overall Study|Adverse Event|5|||
129860163|NCT03750552|467445601|FG001|Overall Study|Adverse Event|1|||
129860164|NCT03750552|467445600|FG000|Overall Study|Withdrawal by Subject|1|||
129860165|NCT03750552|467445601|FG001|Overall Study|Withdrawal by Subject|1|||
129860166|NCT03750552|467445600|FG000|Overall Study|Other|2|||
129860167|NCT03750552|467445601|FG001|Overall Study|Other|0|||
129860168|NCT02280044|467445602|FG000|Overall Study|Planned alternate|0|||
129860169|NCT02280044|467445603|FG001|Overall Study|Planned alternate|2|||
129860170|NCT01944631|467445606|FG000|Overall Study|Adverse Event|1|||
129860171|NCT01944631|467445607|FG001|Overall Study|Adverse Event|0|||
129860172|NCT01944631|467445606|FG000|Overall Study|Lost to Follow-up|3|||
129860173|NCT01944631|467445607|FG001|Overall Study|Lost to Follow-up|1|||
129860174|NCT01944631|467445606|FG000|Overall Study|Withdrawal by Subject|0|||
129860175|NCT01944631|467445607|FG001|Overall Study|Withdrawal by Subject|1|||
129860176|NCT01003899|467445608|FG000|Overall Study|Other Adverse Event|8|||
129860177|NCT01003899|467445608|FG000|Overall Study|Not entered|4|||
129860178|NCT01003899|467445608|FG000|Overall Study|Not treated|1|||
129860179|NCT01003899|467445608|FG000|Overall Study|Progressive disease|34|||
129860180|NCT03822533|467445610|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
129860181|NCT03822533|467445611|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
129860182|NCT03822533|467445610|FG000|3 Month Follow-up|Lost to Follow-up|2|||
129860183|NCT03822533|467445611|FG001|3 Month Follow-up|Lost to Follow-up|2|||
129860184|NCT03822533|467445610|FG000|6 Month Follow-up|Lost to Follow-up|3|||
129860185|NCT03822533|467445611|FG001|6 Month Follow-up|Lost to Follow-up|0|||
129860186|NCT03822533|467445610|FG000|12 Month Follow-up|Lost to Follow-up|2|||
129860187|NCT03822533|467445611|FG001|12 Month Follow-up|Lost to Follow-up|3|||
129860188|NCT03822533|467445610|FG000|12 Month Follow-up|Pregnancy|0|||
129860189|NCT03822533|467445611|FG001|12 Month Follow-up|Pregnancy|1|||
129860190|NCT03822533|467445610|FG000|12 Month Follow-up|Surgery|2|||
129860191|NCT03822533|467445611|FG001|12 Month Follow-up|Surgery|0|||
129860192|NCT03822533|467445610|FG000|12 Month Follow-up|Wrong address|1|||
129860193|NCT03822533|467445611|FG001|12 Month Follow-up|Wrong address|0|||
129860194|NCT03822533|467445610|FG000|12 Month Follow-up|No symptoms|1|||
129860195|NCT03822533|467445611|FG001|12 Month Follow-up|No symptoms|0|||
129860196|NCT03822533|467445610|FG000|12 Month Follow-up|Changed primary care center|0|||
129860197|NCT03822533|467445611|FG001|12 Month Follow-up|Changed primary care center|1|||
129860198|NCT02489500|467445612|FG000|Overall Study|Death|1|||
129860199|NCT02489500|467445613|FG001|Overall Study|Death|1|||
129860200|NCT01412944|467445615|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860201|NCT01412944|467445616|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860202|NCT01412944|467445617|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
129860203|NCT01412944|467445618|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860204|NCT01412944|467445619|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860205|NCT01412944|467445620|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
129860206|NCT01412944|467445615|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860207|NCT01412944|467445616|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860208|NCT01412944|467445617|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860209|NCT01412944|467445618|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860210|NCT01412944|467445619|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
129860211|NCT01412944|467445620|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
129860212|NCT01412944|467445615|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860213|NCT01412944|467445616|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860214|NCT01412944|467445617|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860215|NCT01412944|467445618|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860216|NCT01412944|467445619|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
129860217|NCT01412944|467445620|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
129860218|NCT01412944|467445615|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
129860219|NCT01412944|467445616|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860220|NCT01412944|467445617|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860221|NCT01412944|467445618|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860222|NCT01412944|467445619|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860223|NCT01412944|467445620|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
129860224|NCT01412944|467445615|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
129860225|NCT01412944|467445616|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
129860226|NCT01412944|467445617|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
129860227|NCT01412944|467445618|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
129860228|NCT01412944|467445619|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
129860229|NCT01412944|467445620|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
129860230|NCT01412944|467445615|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860231|NCT01412944|467445616|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
129860232|NCT01412944|467445617|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860233|NCT01412944|467445618|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860234|NCT01412944|467445619|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860235|NCT01412944|467445620|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
129860236|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860237|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860238|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860239|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860240|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860241|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860242|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Adverse Event|0|||
129860243|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Adverse Event|0|||
129860244|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Adverse Event|0|||
129860245|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Adverse Event|0|||
129860246|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Adverse Event|1|||
129860247|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Adverse Event|0|||
129860248|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
129860249|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
129860250|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
129860251|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
129860252|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
129860253|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
129860254|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860255|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860256|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860257|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860258|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860259|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
129860260|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860261|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860262|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860263|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860264|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
129860265|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860266|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
129860267|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
129860268|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860269|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860270|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860271|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
129860272|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
129860273|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
129860274|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
129860275|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
129860276|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
129860277|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
129860278|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860279|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
129860280|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860281|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860282|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860283|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
129860284|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860285|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
129860286|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860287|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860288|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860289|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
129860290|NCT01412944|467445615|FG000|Entire: IV + Maintenance|Adverse Event|0|||
129860291|NCT01412944|467445616|FG001|Entire: IV + Maintenance|Adverse Event|1|||
129860292|NCT01412944|467445617|FG002|Entire: IV + Maintenance|Adverse Event|0|||
129860293|NCT01412944|467445618|FG003|Entire: IV + Maintenance|Adverse Event|0|||
129860294|NCT01412944|467445619|FG004|Entire: IV + Maintenance|Adverse Event|0|||
129860295|NCT01412944|467445620|FG005|Entire: IV + Maintenance|Adverse Event|0|||
129860296|NCT01990950|467445621|FG000|Overall Study|Death|3|||
129860297|NCT01990950|467445621|FG000|Overall Study|Lost to Follow-up|2|||
129860298|NCT01990950|467445621|FG000|Overall Study|Withdrawal by Subject|6|||
129860299|NCT01259713|467445623|FG000|Overall Study|Adverse Event|54|||
129860300|NCT01259713|467445624|FG001|Overall Study|Adverse Event|23|||
129860301|NCT01259713|467445623|FG000|Overall Study|Death Not Related to IFI|8|||
129860302|NCT01259713|467445624|FG001|Overall Study|Death Not Related to IFI|1|||
129860303|NCT01259713|467445623|FG000|Overall Study|Investigators Discretion|14|||
129860304|NCT01259713|467445624|FG001|Overall Study|Investigators Discretion|6|||
129860305|NCT01259713|467445623|FG000|Overall Study|Lack of Efficacy|2|||
129860306|NCT01259713|467445624|FG001|Overall Study|Lack of Efficacy|0|||
129860307|NCT01259713|467445623|FG000|Overall Study|Protocol Violation|5|||
129860308|NCT01259713|467445624|FG001|Overall Study|Protocol Violation|4|||
129860309|NCT01259713|467445623|FG000|Overall Study|Subject Withdrew Consent|12|||
129860310|NCT01259713|467445624|FG001|Overall Study|Subject Withdrew Consent|7|||
129860311|NCT06111742|467445625|FG000|Overall Study|Did not receive intervention|1|||
129860312|NCT06111742|467445626|FG001|Overall Study|Did not receive intervention|0|||
129860313|NCT06111742|467445627|FG002|Overall Study|Did not receive intervention|0|||
129860314|NCT06111742|467445625|FG000|Overall Study|Withdrawal by Subject|2|||
129860315|NCT06111742|467445626|FG001|Overall Study|Withdrawal by Subject|0|||
129860316|NCT06111742|467445627|FG002|Overall Study|Withdrawal by Subject|0|||
129860317|NCT02473952|467445628|FG000|Overall Study|Adverse Event|2|||
129860318|NCT02473952|467445629|FG001|Overall Study|Adverse Event|2|||
129860319|NCT02473952|467445628|FG000|Overall Study|Withdrawal by Subject|0|||
129860320|NCT02473952|467445629|FG001|Overall Study|Withdrawal by Subject|6|||
129860321|NCT00922428|467445634|FG000|Overall Study|retrospective/extremely implausible data|2|||
129860322|NCT00922428|467445634|FG000|Overall Study|no medication use or questionable use|13|||
129860323|NCT00448539|467445635|FG000|Overall Study|Medication non-compliance|4|||
129860324|NCT00448539|467445636|FG001|Overall Study|Medication non-compliance|1|||
129860325|NCT00448539|467445635|FG000|Overall Study|Protocol Violation|1|||
129860326|NCT00448539|467445636|FG001|Overall Study|Protocol Violation|0|||
129860327|NCT00448539|467445635|FG000|Overall Study|Request of the investigator or sponsor|67|||
129860328|NCT00448539|467445636|FG001|Overall Study|Request of the investigator or sponsor|54|||
129860329|NCT00448539|467445635|FG000|Overall Study|Withdrawal by Subject|20|||
129860330|NCT00448539|467445636|FG001|Overall Study|Withdrawal by Subject|24|||
129860331|NCT00448539|467445635|FG000|Overall Study|Diary non-compliance|1|||
129860332|NCT00448539|467445636|FG001|Overall Study|Diary non-compliance|0|||
129449702|NCT00823823|465945655|FG001|Overall Study|Protocol Violation|5|||
129860333|NCT00448539|467445635|FG000|Overall Study|Adverse Event|9|||
129860334|NCT00448539|467445636|FG001|Overall Study|Adverse Event|26|||
129860335|NCT00448539|467445635|FG000|Overall Study|Lack of Efficacy|27|||
129860336|NCT00448539|467445636|FG001|Overall Study|Lack of Efficacy|40|||
129860337|NCT00448539|467445635|FG000|Overall Study|Miscellaneous|2|||
129860338|NCT00448539|467445636|FG001|Overall Study|Miscellaneous|1|||
129449703|NCT02234284|465945656|FG000|Overall Study|Death|4|||
129860339|NCT00448539|467445635|FG000|Overall Study|Change of meds|2|||
129860340|NCT00448539|467445636|FG001|Overall Study|Change of meds|3|||
129860341|NCT00448539|467445635|FG000|Overall Study|Lost to Follow-up|1|||
129860342|NCT00448539|467445636|FG001|Overall Study|Lost to Follow-up|3|||
129860343|NCT02103439|467445637|FG000|Overall Study|Adverse Event|0|||
129860344|NCT02103439|467445638|FG001|Overall Study|Adverse Event|2|||
129860345|NCT02103439|467445637|FG000|Overall Study|Withdrawal by Subject|3|||
129860346|NCT02103439|467445638|FG001|Overall Study|Withdrawal by Subject|1|||
129860347|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
129860348|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
129860349|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
129860350|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
129860351|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
129860352|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
129860353|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
129860354|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
129860355|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
129860356|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
129860357|NCT00695903|467445639|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
129860358|NCT00695903|467445640|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
129860359|NCT00695903|467445639|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
129860360|NCT00695903|467445640|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
129860361|NCT00695903|467445639|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
129860362|NCT00695903|467445640|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
129860363|NCT00695903|467445639|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
129860364|NCT00695903|467445640|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
129860365|NCT03966157|467445641|FG000|Overall Study|Physician Decision|1|||
129860366|NCT03966157|467445642|FG001|Overall Study|Physician Decision|0|||
129860367|NCT01650259|467445647|FG000|Overall Study|Improvement|105|||
129860368|NCT01650259|467445648|FG001|Overall Study|Improvement|0|||
129860369|NCT01650259|467445647|FG000|Overall Study|Adverse Event|127|||
129860370|NCT01650259|467445648|FG001|Overall Study|Adverse Event|0|||
129860371|NCT01650259|467445647|FG000|Overall Study|Lack of Efficacy|143|||
129860372|NCT01650259|467445648|FG001|Overall Study|Lack of Efficacy|0|||
129860373|NCT01650259|467445647|FG000|Overall Study|Lost to Follow-up|435|||
129860374|NCT01650259|467445648|FG001|Overall Study|Lost to Follow-up|0|||
129860375|NCT01650259|467445647|FG000|Overall Study|Patients had no visit after entry|70|||
129860376|NCT01650259|467445648|FG001|Overall Study|Patients had no visit after entry|0|||
129860377|NCT01650259|467445647|FG000|Overall Study|CRF not collected|98|||
129860378|NCT01650259|467445648|FG001|Overall Study|CRF not collected|82|||
129860379|NCT01650259|467445647|FG000|Overall Study|Not treated|1|||
129860380|NCT01650259|467445648|FG001|Overall Study|Not treated|7|||
129860381|NCT01650259|467445647|FG000|Overall Study|Other than listed|64|||
129860382|NCT01650259|467445648|FG001|Overall Study|Other than listed|146|||
129860383|NCT02663128|467445655|FG000|Period 2|Physician Decision|0|||
129860384|NCT02663128|467445656|FG001|Period 2|Physician Decision|0|||
129860385|NCT02663128|467445657|FG002|Period 2|Physician Decision|0|||
129860386|NCT02663128|467445658|FG003|Period 2|Physician Decision|0|||
129860387|NCT02663128|467445659|FG004|Period 2|Physician Decision|1|||
129860388|NCT02663128|467445660|FG005|Period 2|Physician Decision|0|||
129860389|NCT01358526|467445667|FG000|Open-label Titration Period|Adverse Event|95|||
129860390|NCT01358526|467445668|FG001|Open-label Titration Period|Adverse Event|0|||
129860391|NCT01358526|467445669|FG002|Open-label Titration Period|Adverse Event|0|||
129860392|NCT01358526|467445667|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
129860393|NCT01358526|467445668|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
129860394|NCT01358526|467445669|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
129860395|NCT01358526|467445667|FG000|Open-label Titration Period|Lost to Follow-up|25|||
129860396|NCT01358526|467445668|FG001|Open-label Titration Period|Lost to Follow-up|0|||
129860397|NCT01358526|467445669|FG002|Open-label Titration Period|Lost to Follow-up|0|||
129860398|NCT01358526|467445667|FG000|Open-label Titration Period|Lack of Efficacy|107|||
129860399|NCT01358526|467445668|FG001|Open-label Titration Period|Lack of Efficacy|0|||
129860400|NCT01358526|467445669|FG002|Open-label Titration Period|Lack of Efficacy|0|||
129860401|NCT01358526|467445667|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
129860402|NCT01358526|467445668|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
129860403|NCT01358526|467445669|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
129860404|NCT01358526|467445667|FG000|Open-label Titration Period|Administrative|8|||
129860405|NCT01358526|467445668|FG001|Open-label Titration Period|Administrative|0|||
129860406|NCT01358526|467445669|FG002|Open-label Titration Period|Administrative|0|||
129860407|NCT01358526|467445667|FG000|Open-label Titration Period|Did not qualify|178|||
129860408|NCT01358526|467445668|FG001|Open-label Titration Period|Did not qualify|0|||
129860409|NCT01358526|467445669|FG002|Open-label Titration Period|Did not qualify|0|||
129860410|NCT01358526|467445667|FG000|Double-blind Phase|Adverse Event|0|||
129860411|NCT01358526|467445668|FG001|Double-blind Phase|Adverse Event|24|||
129860412|NCT01358526|467445669|FG002|Double-blind Phase|Adverse Event|23|||
129860413|NCT01358526|467445667|FG000|Double-blind Phase|Withdrawal by Subject|0|||
129860414|NCT01358526|467445668|FG001|Double-blind Phase|Withdrawal by Subject|10|||
129860415|NCT01358526|467445669|FG002|Double-blind Phase|Withdrawal by Subject|8|||
129860416|NCT01358526|467445667|FG000|Double-blind Phase|Lost to Follow-up|0|||
129860417|NCT01358526|467445668|FG001|Double-blind Phase|Lost to Follow-up|4|||
129860418|NCT01358526|467445669|FG002|Double-blind Phase|Lost to Follow-up|1|||
129860419|NCT01358526|467445667|FG000|Double-blind Phase|Lack of Efficacy|0|||
129860420|NCT01358526|467445668|FG001|Double-blind Phase|Lack of Efficacy|31|||
129860421|NCT01358526|467445669|FG002|Double-blind Phase|Lack of Efficacy|73|||
129860422|NCT01358526|467445667|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
129860423|NCT01358526|467445668|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
129860424|NCT01358526|467445669|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
129860425|NCT01358526|467445667|FG000|Double-blind Phase|Administrative|0|||
129860426|NCT01358526|467445668|FG001|Double-blind Phase|Administrative|6|||
129860427|NCT01358526|467445669|FG002|Double-blind Phase|Administrative|10|||
129860428|NCT03277313|467445681|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
129860429|NCT03277313|467445682|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
129860430|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
129860431|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
129860432|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
129860433|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
129860434|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
129860435|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
129860436|NCT03277313|467445681|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
129860437|NCT03277313|467445682|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
129860438|NCT02763384|467445685|FG000|Overall Study|Physician Decision|1|||
129860439|NCT02763384|467445685|FG000|Overall Study|Rapid decline - went on hospice|1|||
129860440|NCT02096900|467445686|FG000|Overall Study|Did not receive medication|3|||
129860441|NCT02096900|467445687|FG001|Overall Study|Did not receive medication|1|||
129860442|NCT02096900|467445686|FG000|Overall Study|Surgery cancelled- medication received|1|||
129860443|NCT02096900|467445687|FG001|Overall Study|Surgery cancelled- medication received|1|||
129860444|NCT03034577|467445690|FG000|Overall Study|Withdrawal by Subject|6|||
129860445|NCT03034577|467445691|FG001|Overall Study|Withdrawal by Subject|9|||
129860446|NCT03034577|467445690|FG000|Overall Study|Lost to Follow-up|25|||
129860447|NCT03034577|467445691|FG001|Overall Study|Lost to Follow-up|26|||
129860448|NCT01128413|467445694|FG000|Overall Study|Withdrawal by Subject|1|||
129860449|NCT01128413|467445695|FG001|Overall Study|Withdrawal by Subject|0|||
129860450|NCT01128413|467445694|FG000|Overall Study|NICOM Monitor Problems|2|||
129860451|NCT01128413|467445695|FG001|Overall Study|NICOM Monitor Problems|1|||
129860452|NCT01128413|467445694|FG000|Overall Study|Pt made DNR|1|||
129860453|NCT01128413|467445695|FG001|Overall Study|Pt made DNR|0|||
129860454|NCT02075593|467445699|FG000|Overall Study|Withdrawal by Subject|1|||
129860455|NCT02010060|467445700|FG000|Overall Study|Lost to Follow-up|1|||
129860456|NCT02010060|467445701|FG001|Overall Study|Lost to Follow-up|2|||
129860457|NCT02010060|467445702|FG002|Overall Study|Lost to Follow-up|2|||
129860458|NCT02010060|467445700|FG000|Overall Study|Injury|0|||
129860459|NCT02010060|467445701|FG001|Overall Study|Injury|1|||
129860460|NCT02010060|467445702|FG002|Overall Study|Injury|0|||
129860461|NCT00660010|467445703|FG000|Overall Study|Withdrawal by Subject|2|||
129860462|NCT00660010|467445703|FG000|Overall Study|Lost to Follow-up|3|||
129860463|NCT00660010|467445703|FG000|Overall Study|Adverse Event|1|||
129860464|NCT00660010|467445703|FG000|Overall Study|Noncompliance with visit schedule|3|||
129860465|NCT06167031|467445704|FG000|Overall Study|Lost to Follow-up|5|||
129860466|NCT06167031|467445705|FG001|Overall Study|Lost to Follow-up|1|||
129860467|NCT00920426|467447767|FG000|ITZ111451|Adverse Event|1|||
129860468|NCT00920426|467447768|FG001|ITZ111451|Adverse Event|0|||
129860469|NCT00920426|467447769|FG002|ITZ111451|Adverse Event|0|||
129860470|NCT00920426|467447770|FG003|ITZ111451|Adverse Event|0|||
129860471|NCT01432366|467447771|FG000|Overall Study|Non-Responder|7|||
129860472|NCT01432366|467447771|FG000|Overall Study|Adverse Event|8|||
129860473|NCT01432366|467447771|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
129860474|NCT01432366|467447771|FG000|Overall Study|Pregnancy|1|||
129860475|NCT01432366|467447771|FG000|Overall Study|Lost to Follow-up|13|||
129860476|NCT01432366|467447771|FG000|Overall Study|Lack of Efficacy|1|||
129860477|NCT01432366|467447771|FG000|Overall Study|Site Closed|20|||
129860478|NCT01432366|467447771|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
129860479|NCT01432366|467447771|FG000|Overall Study|Other|14|||
129860480|NCT01808690|467447772|FG000|Overall Study|Withdrawal by Subject|1|||
129860481|NCT01808690|467447773|FG001|Overall Study|Withdrawal by Subject|2|||
129860482|NCT00377234|467447780|FG000|Overall Study|Adverse Event|14|||
129860483|NCT00377234|467447781|FG001|Overall Study|Adverse Event|17|||
129860484|NCT00377234|467447780|FG000|Overall Study|Withdrawal by Subject|11|||
129860485|NCT00377234|467447781|FG001|Overall Study|Withdrawal by Subject|9|||
129860486|NCT00377234|467447780|FG000|Overall Study|Lost to Follow-up|4|||
129860487|NCT00377234|467447781|FG001|Overall Study|Lost to Follow-up|2|||
129860488|NCT00377234|467447780|FG000|Overall Study|Administrative|2|||
129860489|NCT00377234|467447781|FG001|Overall Study|Administrative|1|||
129860490|NCT00377234|467447780|FG000|Overall Study|Not assigned|3|||
129860491|NCT00377234|467447781|FG001|Overall Study|Not assigned|2|||
129860492|NCT01880424|467447782|FG000|Overall Study|Adverse Event|7|||
129860493|NCT01880424|467447783|FG001|Overall Study|Adverse Event|6|||
129860494|NCT01880424|467447782|FG000|Overall Study|Lack of Efficacy|1|||
129860495|NCT01880424|467447783|FG001|Overall Study|Lack of Efficacy|4|||
129860496|NCT01880424|467447782|FG000|Overall Study|Lost to Follow-up|3|||
129860497|NCT01880424|467447783|FG001|Overall Study|Lost to Follow-up|2|||
129860498|NCT01880424|467447782|FG000|Overall Study|Protocol Violation|11|||
129860499|NCT01880424|467447783|FG001|Overall Study|Protocol Violation|13|||
129860500|NCT01880424|467447782|FG000|Overall Study|Withdrawal by Subject|10|||
129860501|NCT01880424|467447783|FG001|Overall Study|Withdrawal by Subject|30|||
129860502|NCT01880424|467447782|FG000|Overall Study|Other|1|||
129860503|NCT01880424|467447783|FG001|Overall Study|Other|0|||
129860504|NCT02062632|467447784|FG000|Overall Study|No treatment data|1|||
129860505|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
129860506|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
129860507|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
129860508|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
129860509|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
129860510|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
129860511|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
129860512|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
129860513|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
129860514|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
129860515|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
129860516|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
129860517|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
129860518|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
129860519|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
129860520|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
129860521|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
129860522|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
129860523|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
129860524|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
129860525|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
129860526|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
129860527|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
129860528|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
129860529|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860530|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860531|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860532|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860533|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860534|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860535|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860536|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860537|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860538|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860539|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860540|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860541|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860542|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860543|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860544|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
129860545|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860546|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860547|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
129860548|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
129860549|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
129860550|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860551|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860552|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860553|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860554|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860555|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860556|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860557|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860558|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860559|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860560|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860561|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860562|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860563|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860564|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
129860565|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
129860566|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
129860567|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
129860568|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
129860569|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
129860570|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
129860571|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
129860572|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
129860573|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
129860574|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
129860575|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
129860576|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
129860577|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
129860578|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
129860579|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
129860580|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
129860581|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
129860582|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
129860583|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
129860584|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
129860585|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
129860586|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860587|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860588|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860589|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860590|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860591|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860592|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860593|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860594|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860595|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860596|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860597|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860598|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860599|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860600|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860601|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860602|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860603|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860604|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
129860605|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
129860606|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
129860607|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860608|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
129860609|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
129860610|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860611|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860612|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860613|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860614|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860615|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860616|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860617|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860618|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860619|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860620|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860621|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860622|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860623|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860624|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
129860625|NCT01490632|467447789|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860626|NCT01490632|467447790|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860627|NCT01490632|467447791|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860628|NCT01490632|467447792|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860629|NCT01490632|467447793|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
129860630|NCT01490632|467447794|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860631|NCT01490632|467447795|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860632|NCT01490632|467447796|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860633|NCT01490632|467447797|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860634|NCT01490632|467447798|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860635|NCT01490632|467447799|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860636|NCT01490632|467447800|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860637|NCT01490632|467447801|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860638|NCT01490632|467447802|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860639|NCT01490632|467447803|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860640|NCT01490632|467447804|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860641|NCT01490632|467447805|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860642|NCT01490632|467447806|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860643|NCT01490632|467447807|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860644|NCT01490632|467447808|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
129860645|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860646|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860647|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860648|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860649|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860650|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
129860651|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
129860652|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860653|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860654|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
129860655|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
129860656|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
129860657|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860658|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860659|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860660|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860661|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860662|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860663|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860664|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
129860665|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860666|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860667|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860668|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860669|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860670|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860671|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
129860672|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860673|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
129860674|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
129860675|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
129860676|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860677|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860678|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860679|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860680|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860681|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860682|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860683|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860684|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
129860685|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860686|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129910482|NCT04556981|467635348|FG000|Overall Study|Moved from the study area|1|||
129910483|NCT04556981|467635349|FG001|Overall Study|Moved from the study area|4|||
129910484|NCT04556981|467635348|FG000|Overall Study|Withdrawal by Subject|2|||
129910485|NCT04556981|467635349|FG001|Overall Study|Withdrawal by Subject|2|||
129860687|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860688|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860689|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860690|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860691|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
129860692|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860693|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860694|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
129860695|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860696|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860697|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860698|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860699|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860700|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860701|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860702|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860703|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860704|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
129860705|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860706|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860707|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860708|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860709|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860710|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860711|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
129860712|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860713|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860714|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860715|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860716|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860717|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860718|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860719|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860720|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860721|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860722|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860723|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860724|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
129860725|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860726|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860727|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860728|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860729|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860730|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
129860731|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860732|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860733|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860734|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860735|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860736|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860737|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860738|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860739|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860740|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860741|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860742|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860743|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860744|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
129860745|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860746|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860747|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860748|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860749|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860750|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860751|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
129910486|NCT04556981|467635348|FG000|Overall Study|Other|2|||
129860752|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860753|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
129860754|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860755|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
129860756|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
129860757|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860758|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860759|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860760|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860761|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860762|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860763|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860764|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
129860765|NCT01490632|467447789|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860766|NCT01490632|467447790|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860767|NCT01490632|467447791|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860768|NCT01490632|467447792|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860769|NCT01490632|467447793|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860770|NCT01490632|467447794|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
129860771|NCT01490632|467447795|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
129860772|NCT01490632|467447796|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
129860773|NCT01490632|467447797|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
129860774|NCT01490632|467447798|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
129860775|NCT01490632|467447799|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
129860776|NCT01490632|467447800|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
129860777|NCT01490632|467447801|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860778|NCT01490632|467447802|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860779|NCT01490632|467447803|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860780|NCT01490632|467447804|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860781|NCT01490632|467447805|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860782|NCT01490632|467447806|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860783|NCT01490632|467447807|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860784|NCT01490632|467447808|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
129860785|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860786|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860787|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860788|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860789|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860790|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860791|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860792|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860793|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860794|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860795|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860796|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860797|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860798|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860799|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
129860800|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
129860801|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860802|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860803|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860804|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
129860805|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860806|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860807|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860808|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860809|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860810|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860811|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860812|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860813|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860814|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860815|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860816|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860817|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860818|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
129860819|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860820|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860821|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860822|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860823|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860824|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
129860825|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860826|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860827|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860828|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860829|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860830|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860831|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860832|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860833|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860834|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860835|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860836|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860837|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860838|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860839|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
129860840|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
129860841|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860842|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860843|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860844|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
129860845|NCT01490632|467447789|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860846|NCT01490632|467447790|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860847|NCT01490632|467447791|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860848|NCT01490632|467447792|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860849|NCT01490632|467447793|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860850|NCT01490632|467447794|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860851|NCT01490632|467447795|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860852|NCT01490632|467447796|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860853|NCT01490632|467447797|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860854|NCT01490632|467447798|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860855|NCT01490632|467447799|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860856|NCT01490632|467447800|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860857|NCT01490632|467447801|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
129860858|NCT01490632|467447802|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
129860859|NCT01490632|467447803|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
129860860|NCT01490632|467447804|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
129860861|NCT01490632|467447805|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860862|NCT01490632|467447806|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860863|NCT01490632|467447807|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860864|NCT01490632|467447808|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
129860865|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
129860866|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
129860867|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
129860868|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
129860869|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
129860870|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
129860871|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
129860872|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
129860873|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
129860874|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
129860875|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
129860876|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
129860877|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
129860878|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
129860879|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
129860880|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
129860881|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
129860882|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
129860883|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
129860884|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
129860885|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Death|0|||
129860886|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Death|0|||
129860887|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Death|0|||
129860888|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Death|0|||
129860889|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Death|0|||
129860890|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Death|0|||
129860891|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Death|0|||
129860892|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Death|0|||
129860893|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Death|0|||
129860894|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Death|0|||
129860895|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Death|0|||
129860896|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Death|0|||
129860897|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Death|0|||
129860898|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Death|0|||
129860899|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Death|0|||
129860900|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Death|0|||
129860901|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Death|0|||
129860902|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Death|0|||
129860903|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Death|1|||
129860904|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Death|0|||
129860905|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860906|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860907|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860908|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860909|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860910|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860911|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860912|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860913|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860914|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860915|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860916|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860917|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860918|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860919|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860920|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860921|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
129860922|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
129860923|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
129860924|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
129860925|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860926|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860927|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860928|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860929|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860930|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860931|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860932|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860933|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860934|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860935|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860936|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860937|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860938|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860939|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860940|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860941|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860942|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860943|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
129860944|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
129860945|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
129860946|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
129860947|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
129860948|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
129860949|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
129860950|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
129860951|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
129860952|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
129860953|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
129860954|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
129860955|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
129860956|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
129860957|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
129860958|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
129860959|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
129860960|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
129860961|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
129860962|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
129860963|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
129860964|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
129860965|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
129860966|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
129860967|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
129860968|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
129860969|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
129860970|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
129860971|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
129860972|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
129860973|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
129860974|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
129860975|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
129860976|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
129860977|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
129860978|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
129860979|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
129860980|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
129860981|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
129860982|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
129860983|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
129860984|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
129860985|NCT01490632|467447789|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860986|NCT01490632|467447790|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860987|NCT01490632|467447791|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860988|NCT01490632|467447792|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860989|NCT01490632|467447793|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860990|NCT01490632|467447794|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860991|NCT01490632|467447795|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129910487|NCT04556981|467635349|FG001|Overall Study|Other|1|||
129860992|NCT01490632|467447796|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860993|NCT01490632|467447797|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860994|NCT01490632|467447798|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860995|NCT01490632|467447799|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860996|NCT01490632|467447800|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860997|NCT01490632|467447801|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860998|NCT01490632|467447802|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129860999|NCT01490632|467447803|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129861000|NCT01490632|467447804|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129861001|NCT01490632|467447805|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
129861002|NCT01490632|467447806|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
129861003|NCT01490632|467447807|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
129861004|NCT01490632|467447808|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
129861005|NCT00856856|467447814|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
129861006|NCT00856856|467447814|FG000|4-year Clinical Follow-up|Missed visit|1|||
129861007|NCT02696317|467447818|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
129861008|NCT02696317|467447819|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
129861009|NCT02696317|467447818|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
129861010|NCT02696317|467447819|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
129861011|NCT01343368|467447820|FG000|Overall Study|Death|1|||
129861012|NCT01343368|467447821|FG001|Overall Study|Death|0|||
129861013|NCT01343368|467447820|FG000|Overall Study|Lost to Follow-up|1|||
129861014|NCT01343368|467447821|FG001|Overall Study|Lost to Follow-up|0|||
129861015|NCT04955639|467447822|FG000|Overall Study|Withdrawal by Subject|2|||
129861016|NCT04955639|467447823|FG001|Overall Study|Withdrawal by Subject|2|||
129861017|NCT04955639|467447822|FG000|Overall Study|Week 26 survey not completed|2|||
129861018|NCT04955639|467447823|FG001|Overall Study|Week 26 survey not completed|2|||
129861019|NCT04447404|467447824|FG000|Overall Study|Death|2|||
129861020|NCT04447404|467447825|FG001|Overall Study|Death|0|||
129861021|NCT01369342|467447826|FG000|Overall Study|Withdrawal by Subject|7|||
129861022|NCT01369342|467447827|FG001|Overall Study|Withdrawal by Subject|7|||
129861023|NCT01369342|467447828|FG002|Overall Study|Withdrawal by Subject|2|||
129861024|NCT01369342|467447826|FG000|Overall Study|Lost to Follow-up|5|||
129861025|NCT01369342|467447827|FG001|Overall Study|Lost to Follow-up|2|||
129861026|NCT01369342|467447828|FG002|Overall Study|Lost to Follow-up|1|||
129861027|NCT01369342|467447826|FG000|Overall Study|Not Treated|1|||
129861028|NCT01369342|467447827|FG001|Overall Study|Not Treated|0|||
129861029|NCT01369342|467447828|FG002|Overall Study|Not Treated|0|||
129861030|NCT00321854|467447829|FG000|Overall Study|Adverse Event|41|||
129861031|NCT00321854|467447830|FG001|Overall Study|Adverse Event|43|||
129861032|NCT00321854|467447829|FG000|Overall Study|Lack of Efficacy|9|||
129861033|NCT00321854|467447830|FG001|Overall Study|Lack of Efficacy|14|||
129861034|NCT00321854|467447829|FG000|Overall Study|Protocol Violation|6|||
129861035|NCT00321854|467447830|FG001|Overall Study|Protocol Violation|5|||
129861036|NCT00321854|467447829|FG000|Overall Study|Lost to Follow-up|0|||
129861037|NCT00321854|467447830|FG001|Overall Study|Lost to Follow-up|2|||
129861038|NCT00321854|467447829|FG000|Overall Study|Withdrawal by Subject|6|||
129861039|NCT00321854|467447830|FG001|Overall Study|Withdrawal by Subject|17|||
129861040|NCT00321854|467447829|FG000|Overall Study|Other|1|||
129861041|NCT00321854|467447830|FG001|Overall Study|Other|1|||
129861042|NCT04723576|467447831|FG000|Overall Study|Withdrawal by Subject|2133|||
129861043|NCT04723576|467447832|FG001|Overall Study|Withdrawal by Subject|3234|||
129861044|NCT02384759|467447834|FG000|Overall Study|Patients not treated|3|||
129861045|NCT02384759|467447835|FG001|Overall Study|Patients not treated|2|||
129861046|NCT03759873|467447841|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
129861047|NCT03759873|467447842|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
129861048|NCT03759873|467447843|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
129861049|NCT03759873|467447844|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
129861050|NCT03759873|467447841|FG000|Overall Study|Moved outside eligible area|0|||
129861051|NCT03759873|467447842|FG001|Overall Study|Moved outside eligible area|2|||
129861052|NCT03759873|467447843|FG002|Overall Study|Moved outside eligible area|0|||
129861053|NCT03759873|467447844|FG003|Overall Study|Moved outside eligible area|0|||
129861054|NCT03759873|467447841|FG000|Overall Study|Withdrawal by Subject|0|||
129861055|NCT03759873|467447842|FG001|Overall Study|Withdrawal by Subject|0|||
129861056|NCT03759873|467447843|FG002|Overall Study|Withdrawal by Subject|1|||
129861057|NCT03759873|467447844|FG003|Overall Study|Withdrawal by Subject|0|||
129861058|NCT03579563|467447845|FG000|Overall Study|Lost to Follow-up|0|||
129861059|NCT03579563|467447846|FG001|Overall Study|Lost to Follow-up|0|||
129861060|NCT03579563|467447847|FG002|Overall Study|Lost to Follow-up|0|||
129861061|NCT03579563|467447848|FG003|Overall Study|Lost to Follow-up|0|||
129861062|NCT03579563|467447849|FG004|Overall Study|Lost to Follow-up|1|||
129861063|NCT03579563|467447850|FG005|Overall Study|Lost to Follow-up|0|||
129861064|NCT03579563|467447845|FG000|Overall Study|Lack of Efficacy|1|||
129861065|NCT03579563|467447846|FG001|Overall Study|Lack of Efficacy|1|||
129861066|NCT03579563|467447847|FG002|Overall Study|Lack of Efficacy|4|||
129861067|NCT03579563|467447848|FG003|Overall Study|Lack of Efficacy|1|||
129861068|NCT03579563|467447849|FG004|Overall Study|Lack of Efficacy|2|||
129861069|NCT03579563|467447850|FG005|Overall Study|Lack of Efficacy|3|||
129861070|NCT03579563|467447845|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
129861071|NCT03579563|467447846|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129861072|NCT03579563|467447847|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129861073|NCT03579563|467447848|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
129861074|NCT03579563|467447849|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
129910488|NCT01388361|467635350|FG000|Overall Study|Adverse Event|0|||
129861075|NCT03579563|467447850|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
129861076|NCT03579563|467447845|FG000|Overall Study|Time/distance concern|0|||
129861077|NCT03579563|467447846|FG001|Overall Study|Time/distance concern|0|||
129861078|NCT03579563|467447847|FG002|Overall Study|Time/distance concern|1|||
129861079|NCT03579563|467447848|FG003|Overall Study|Time/distance concern|0|||
129861080|NCT03579563|467447849|FG004|Overall Study|Time/distance concern|0|||
129861081|NCT03579563|467447850|FG005|Overall Study|Time/distance concern|1|||
129861082|NCT03579563|467447845|FG000|Overall Study|COVID shutdown|2|||
129861083|NCT03579563|467447846|FG001|Overall Study|COVID shutdown|3|||
129861084|NCT03579563|467447847|FG002|Overall Study|COVID shutdown|4|||
129861085|NCT03579563|467447848|FG003|Overall Study|COVID shutdown|3|||
129861086|NCT03579563|467447849|FG004|Overall Study|COVID shutdown|1|||
129861087|NCT03579563|467447850|FG005|Overall Study|COVID shutdown|2|||
129861088|NCT03579563|467447845|FG000|Overall Study|Protocol administration error|1|||
129861089|NCT03579563|467447846|FG001|Overall Study|Protocol administration error|0|||
129861090|NCT03579563|467447847|FG002|Overall Study|Protocol administration error|1|||
129861091|NCT03579563|467447848|FG003|Overall Study|Protocol administration error|0|||
129861092|NCT03579563|467447849|FG004|Overall Study|Protocol administration error|1|||
129861093|NCT03579563|467447850|FG005|Overall Study|Protocol administration error|5|||
129861094|NCT03526250|467447851|FG000|Overall Study|Adverse Event|4|||
129861095|NCT03526250|467447851|FG000|Overall Study|Progressive Disease|16|||
129861096|NCT03526250|467447851|FG000|Overall Study|No Treatment|3|||
129861097|NCT02647359|467447852|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
129861098|NCT02647359|467447853|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
129861099|NCT02647359|467447852|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
129861100|NCT02647359|467447853|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
129861101|NCT02647359|467447852|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
129861102|NCT02647359|467447853|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
129861103|NCT02647359|467447852|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
129861104|NCT02647359|467447853|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
129861105|NCT02647359|467447852|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
129861106|NCT02647359|467447853|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
129861107|NCT02647359|467447852|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
129861108|NCT02647359|467447853|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
129861109|NCT00511004|467447854|FG000|Overall Study|Lost to Follow-up|0|||
129861110|NCT00511004|467447855|FG001|Overall Study|Lost to Follow-up|0|||
129861111|NCT00511004|467447856|FG002|Overall Study|Lost to Follow-up|4|||
129861112|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
129861113|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
129861114|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
129861115|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
129861116|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
129861117|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
129861118|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
129861119|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
129861120|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
129861121|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
129861122|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
129861123|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
129861124|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
129861125|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
129861126|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
129861127|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
129861128|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
129861129|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
129861130|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
129861131|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
129861132|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
129861133|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
129861134|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
129861135|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
129861136|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
129861137|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
129861138|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
129861139|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
129861140|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
129861141|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
129861142|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
129861143|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
129861144|NCT04818346|467447861|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
129861145|NCT04818346|467447862|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
129861146|NCT04818346|467447863|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
129861147|NCT04818346|467447864|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
129861148|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
129861149|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
129861150|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
129861151|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
129861152|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
129861153|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
129861154|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
129861155|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
129861156|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
129861157|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
129861158|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
129861159|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
129861160|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
129861161|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
129861162|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
129861163|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
129861164|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
129861165|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
129861166|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
129861167|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
129861168|NCT04818346|467447861|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
129861169|NCT04818346|467447862|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
129861170|NCT04818346|467447863|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
129861171|NCT04818346|467447864|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
129861172|NCT01672801|467447865|FG000|Overall Study|Screen Failure|0|||
129861173|NCT01672801|467447866|FG001|Overall Study|Screen Failure|1|||
129861174|NCT01362140|467447867|FG000|Overall Study|Noncompliance|1|||
129861175|NCT01362140|467447868|FG001|Overall Study|Noncompliance|0|||
129861176|NCT01362140|467447867|FG000|Overall Study|Adverse Event|2|||
129861177|NCT01362140|467447868|FG001|Overall Study|Adverse Event|2|||
129861178|NCT01362140|467447867|FG000|Overall Study|Withdrawal by Subject|3|||
129861179|NCT01362140|467447868|FG001|Overall Study|Withdrawal by Subject|3|||
129861180|NCT01362140|467447867|FG000|Overall Study|Administrative Decision|0|||
129861181|NCT01362140|467447868|FG001|Overall Study|Administrative Decision|1|||
129861182|NCT01362140|467447867|FG000|Overall Study|Death|2|||
129861183|NCT01362140|467447868|FG001|Overall Study|Death|1|||
129861184|NCT01362140|467447867|FG000|Overall Study|Other|1|||
129861185|NCT01362140|467447868|FG001|Overall Study|Other|1|||
129861186|NCT01362140|467447867|FG000|Overall Study|Protocol-specified Criteria|1|||
129861187|NCT01362140|467447868|FG001|Overall Study|Protocol-specified Criteria|2|||
129861188|NCT01362140|467447867|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
129861189|NCT01362140|467447868|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
129861190|NCT00492284|467447870|FG000|Overall Study|Adverse Event|0|||
129861191|NCT00492284|467447871|FG001|Overall Study|Adverse Event|1|||
129861192|NCT00492284|467447872|FG002|Overall Study|Adverse Event|1|||
129861193|NCT00492284|467447873|FG003|Overall Study|Adverse Event|2|||
129861194|NCT00492284|467447870|FG000|Overall Study|Lost to Follow-up|0|||
129861195|NCT00492284|467447871|FG001|Overall Study|Lost to Follow-up|0|||
129861196|NCT00492284|467447872|FG002|Overall Study|Lost to Follow-up|3|||
129861197|NCT00492284|467447873|FG003|Overall Study|Lost to Follow-up|1|||
129861198|NCT00492284|467447870|FG000|Overall Study|Death|0|||
129861199|NCT00492284|467447871|FG001|Overall Study|Death|3|||
129861200|NCT00492284|467447872|FG002|Overall Study|Death|2|||
129861201|NCT00492284|467447873|FG003|Overall Study|Death|5|||
129861202|NCT00492284|467447870|FG000|Overall Study|Withdrawal by Subject|1|||
129910489|NCT01388361|467635351|FG001|Overall Study|Adverse Event|5|||
129910490|NCT01388361|467635352|FG002|Overall Study|Adverse Event|1|||
129861203|NCT00492284|467447871|FG001|Overall Study|Withdrawal by Subject|0|||
129861204|NCT00492284|467447872|FG002|Overall Study|Withdrawal by Subject|0|||
129861205|NCT00492284|467447873|FG003|Overall Study|Withdrawal by Subject|2|||
129861206|NCT06476366|467447874|FG000|Overall Study|Lost to Follow-up|1|||
129861207|NCT06476366|467447875|FG001|Overall Study|Lost to Follow-up|3|||
129861208|NCT06476366|467447874|FG000|Overall Study|Adverse Event|1|||
129861209|NCT06476366|467447875|FG001|Overall Study|Adverse Event|0|||
129861210|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
129861211|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
129861212|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
129861213|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
129861214|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
129861215|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
129861216|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
129861217|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
129861218|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
129861219|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
129861220|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
129861221|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
129861222|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
129861223|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
129861224|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
129861225|NCT00355082|467447883|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
129861226|NCT00355082|467447884|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
129861227|NCT00355082|467447885|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
129861228|NCT00355082|467447883|FG000|Continuation Phase|Adverse Event|2|||
129861229|NCT00355082|467447884|FG001|Continuation Phase|Adverse Event|0|||
129861230|NCT00355082|467447885|FG002|Continuation Phase|Adverse Event|1|||
129861231|NCT00355082|467447883|FG000|Continuation Phase|Lost to Follow-up|2|||
129861232|NCT00355082|467447884|FG001|Continuation Phase|Lost to Follow-up|0|||
129861233|NCT00355082|467447885|FG002|Continuation Phase|Lost to Follow-up|1|||
129861234|NCT00355082|467447883|FG000|Continuation Phase|Protocol Violation|1|||
129861235|NCT00355082|467447884|FG001|Continuation Phase|Protocol Violation|0|||
129861236|NCT00355082|467447885|FG002|Continuation Phase|Protocol Violation|1|||
129861237|NCT00355082|467447883|FG000|Continuation Phase|Withdrawal by Subject|4|||
129861238|NCT00355082|467447884|FG001|Continuation Phase|Withdrawal by Subject|0|||
129861239|NCT00355082|467447885|FG002|Continuation Phase|Withdrawal by Subject|0|||
129861240|NCT00355082|467447883|FG000|Continuation Phase|Lack of Efficacy|5|||
129861241|NCT00355082|467447884|FG001|Continuation Phase|Lack of Efficacy|0|||
129861242|NCT00355082|467447885|FG002|Continuation Phase|Lack of Efficacy|0|||
129861243|NCT00355082|467447883|FG000|Continuation Phase|Site Closed by Sponsor|8|||
129861244|NCT00355082|467447884|FG001|Continuation Phase|Site Closed by Sponsor|0|||
129861245|NCT00355082|467447885|FG002|Continuation Phase|Site Closed by Sponsor|0|||
129861246|NCT00355082|467447883|FG000|Continuation Phase|Scheduling Error|1|||
129861247|NCT00355082|467447884|FG001|Continuation Phase|Scheduling Error|0|||
129861248|NCT00355082|467447885|FG002|Continuation Phase|Scheduling Error|0|||
129861249|NCT00355082|467447883|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
129861250|NCT00355082|467447884|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
129861251|NCT00355082|467447885|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
129861252|NCT04598152|467447889|FG000|Overall Study|Lost to Follow-up|0|||
129910491|NCT01388361|467635350|FG000|Overall Study|Protocol Violation|0|||
129861253|NCT04598152|467447890|FG001|Overall Study|Lost to Follow-up|1|||
129861254|NCT03346759|467447891|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
129861255|NCT03346759|467447892|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
129861256|NCT03346759|467447891|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
129861257|NCT03346759|467447892|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
129861258|NCT03346759|467447891|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
129910492|NCT01388361|467635351|FG001|Overall Study|Protocol Violation|0|||
129910493|NCT01388361|467635352|FG002|Overall Study|Protocol Violation|2|||
129910494|NCT01388361|467635350|FG000|Overall Study|Withdrawal criteria|12|||
129910495|NCT01388361|467635351|FG001|Overall Study|Withdrawal criteria|7|||
129910496|NCT01388361|467635352|FG002|Overall Study|Withdrawal criteria|10|||
129861259|NCT03346759|467447892|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
129861260|NCT02132611|467447893|FG000|Overall Study|Death|2|||
129861261|NCT02194621|467447895|FG000|Overall Study|6 withdrew prior to randomization|2|||
129861262|NCT02194621|467447896|FG001|Overall Study|6 withdrew prior to randomization|2|||
129861263|NCT02194621|467447897|FG002|Overall Study|6 withdrew prior to randomization|2|||
129861264|NCT02194621|467447895|FG000|Overall Study|Withdrawal by Subject|4|||
129861265|NCT02194621|467447896|FG001|Overall Study|Withdrawal by Subject|4|||
129861266|NCT02194621|467447897|FG002|Overall Study|Withdrawal by Subject|7|||
129861267|NCT02493127|467447905|FG000|Overall Study|Lost to Follow-up|1|||
129861268|NCT02493127|467447906|FG001|Overall Study|Lost to Follow-up|1|||
129910497|NCT01388361|467635350|FG000|Overall Study|Unclassified|0|||
129910498|NCT01388361|467635351|FG001|Overall Study|Unclassified|0|||
129910499|NCT01388361|467635352|FG002|Overall Study|Unclassified|1|||
129910500|NCT00068601|467635354|FG000|Overall Study|Ineligible|11|||
129910501|NCT00068601|467635355|FG001|Overall Study|Ineligible|13|||
129910502|NCT00068601|467635354|FG000|Overall Study|Not evaluable: withdrew consent|5|||
129910503|NCT00068601|467635355|FG001|Overall Study|Not evaluable: withdrew consent|4|||
129910504|NCT00068601|467635354|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
129910505|NCT00068601|467635355|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
129910506|NCT00068601|467635354|FG000|Overall Study|Death|11|||
129910507|NCT00068601|467635355|FG001|Overall Study|Death|3|||
129910508|NCT00068601|467635354|FG000|Overall Study|Lost to Follow-up|3|||
129910509|NCT00068601|467635355|FG001|Overall Study|Lost to Follow-up|2|||
129910510|NCT00068601|467635354|FG000|Overall Study|Missing primary outcome data|30|||
129910511|NCT00068601|467635355|FG001|Overall Study|Missing primary outcome data|34|||
129910512|NCT01070069|467635356|FG000|Overall Study|Death|1|||
129910513|NCT01070069|467635357|FG001|Overall Study|Death|0|||
129910514|NCT01070069|467635358|FG002|Overall Study|Death|2|||
129910515|NCT01070069|467635359|FG003|Overall Study|Death|0|||
129910516|NCT01070069|467635360|FG004|Overall Study|Death|1|||
129910517|NCT01070069|467635356|FG000|Overall Study|Withdrawal by Subject|1|||
129910518|NCT01070069|467635357|FG001|Overall Study|Withdrawal by Subject|1|||
129910519|NCT01070069|467635358|FG002|Overall Study|Withdrawal by Subject|4|||
129910520|NCT01070069|467635359|FG003|Overall Study|Withdrawal by Subject|0|||
129910521|NCT01070069|467635360|FG004|Overall Study|Withdrawal by Subject|0|||
129910522|NCT01070069|467635356|FG000|Overall Study|Lost to Follow-up|4|||
129910523|NCT01070069|467635357|FG001|Overall Study|Lost to Follow-up|1|||
129910524|NCT01070069|467635358|FG002|Overall Study|Lost to Follow-up|0|||
129910525|NCT01070069|467635359|FG003|Overall Study|Lost to Follow-up|0|||
129910526|NCT01070069|467635360|FG004|Overall Study|Lost to Follow-up|3|||
129910527|NCT00419341|467635372|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
129910528|NCT00419341|467635372|FG000|Wash in/Wash Out Period|Adverse Event|2|||
129910529|NCT00419341|467635372|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
129910530|NCT00419341|467635372|FG000|Efficacy Period|Withdrawal by Subject|6|||
129910531|NCT00419341|467635372|FG000|Efficacy Period|Protocol Violation|1|||
129910532|NCT00419341|467635372|FG000|Efficacy Period|Lost to Follow-up|1|||
129910533|NCT00419341|467635372|FG000|Efficacy Period|Non-compliance|1|||
129910534|NCT00419341|467635372|FG000|Efficacy Period|Termination of study site|1|||
129910535|NCT01499199|467635374|FG000|Overall Study|Adverse Event|1|||
129910536|NCT01499199|467635374|FG000|Overall Study|Lack of Efficacy|1|||
129910537|NCT04732338|467635380|FG000|Overall Study|Lost to Follow-up|3|||
129910538|NCT04732338|467635381|FG001|Overall Study|Lost to Follow-up|3|||
129910539|NCT02539225|467635387|FG000|Part A|Adverse Event|13|||
129910540|NCT02539225|467635388|FG001|Part A|Adverse Event|4|||
129910541|NCT02539225|467635387|FG000|Part A|Withdrawal by Subject|2|||
129910542|NCT02539225|467635388|FG001|Part A|Withdrawal by Subject|4|||
129910543|NCT02539225|467635387|FG000|Part A|Physician Decision|4|||
129910544|NCT02539225|467635388|FG001|Part A|Physician Decision|7|||
129910545|NCT02539225|467635387|FG000|Part A|Did Not Receive study Drug|1|||
129910546|NCT02539225|467635388|FG001|Part A|Did Not Receive study Drug|1|||
129910547|NCT02539225|467635387|FG000|Pre Treatment for Part B|Progressive disease|1|||
129910548|NCT02539225|467635388|FG001|Pre Treatment for Part B|Progressive disease|1|||
129910549|NCT02539225|467635387|FG000|Pre Treatment for Part B|Adverse Event|1|||
129910550|NCT02539225|467635388|FG001|Pre Treatment for Part B|Adverse Event|1|||
129910551|NCT02539225|467635387|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
129910552|NCT02539225|467635388|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
129910553|NCT02539225|467635387|FG000|Pre Treatment for Part B|Physician Decision|2|||
129910554|NCT02539225|467635388|FG001|Pre Treatment for Part B|Physician Decision|0|||
129910555|NCT02539225|467635387|FG000|Part B|Adverse Event|4|||
129910556|NCT02539225|467635388|FG001|Part B|Adverse Event|4|||
129910557|NCT02539225|467635387|FG000|Part B|Withdrawal by Subject|0|||
129910558|NCT02539225|467635388|FG001|Part B|Withdrawal by Subject|3|||
129910559|NCT02539225|467635387|FG000|Part B|Physician Decision|0|||
129910560|NCT02539225|467635388|FG001|Part B|Physician Decision|9|||
129910561|NCT04766034|467635391|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910562|NCT04766034|467635392|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910563|NCT04766034|467635393|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910564|NCT04766034|467635394|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
129910565|NCT04766034|467635395|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
129910566|NCT04766034|467635391|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910567|NCT04766034|467635392|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910568|NCT04766034|467635393|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910569|NCT04766034|467635394|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
129910570|NCT04766034|467635395|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
129910571|NCT04766034|467635391|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
129979688|NCT03752970|467889435|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
129910572|NCT04766034|467635392|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
129910573|NCT04766034|467635393|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
129910574|NCT04766034|467635394|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
129910575|NCT04766034|467635395|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
129910576|NCT04766034|467635391|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
129910577|NCT04766034|467635392|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
129910578|NCT04766034|467635393|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
129910579|NCT04766034|467635394|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
129910580|NCT04766034|467635395|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
129910581|NCT03960463|467637558|FG000|Overall Study|Withdrawal by Subject|2|||
129910582|NCT03960463|467637559|FG001|Overall Study|Withdrawal by Subject|0|||
129910583|NCT05568615|467637560|FG000|Overall Study|Death|1|||
129910584|NCT05568615|467637560|FG000|Overall Study|Physician Decision|1|||
129910585|NCT03529110|467637561|FG000|Overall Study|Progressive Disease|66|||
129910586|NCT03529110|467637562|FG001|Overall Study|Progressive Disease|158|||
129910587|NCT03529110|467637561|FG000|Overall Study|Clinical Progression|4|||
129910588|NCT03529110|467637562|FG001|Overall Study|Clinical Progression|12|||
129910589|NCT03529110|467637561|FG000|Overall Study|Adverse Event|35|||
129910590|NCT03529110|467637562|FG001|Overall Study|Adverse Event|17|||
129910591|NCT03529110|467637561|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
129910592|NCT03529110|467637562|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
129910593|NCT03529110|467637561|FG000|Overall Study|Lack of Efficacy|3|||
129910594|NCT03529110|467637562|FG001|Overall Study|Lack of Efficacy|3|||
129910595|NCT03529110|467637561|FG000|Overall Study|Physician Decision|2|||
129910596|NCT03529110|467637562|FG001|Overall Study|Physician Decision|8|||
129910597|NCT03529110|467637561|FG000|Overall Study|Miscellaneous|2|||
129910598|NCT03529110|467637562|FG001|Overall Study|Miscellaneous|5|||
129910599|NCT04922021|467637565|FG000|Overall Study|Withdrawal by Subject|4|||
129910600|NCT04922021|467637566|FG001|Overall Study|Withdrawal by Subject|10|||
129910601|NCT04922021|467637565|FG000|Overall Study|Adverse Event|2|||
129910602|NCT04922021|467637566|FG001|Overall Study|Adverse Event|2|||
129910603|NCT04922021|467637565|FG000|Overall Study|Lack of Efficacy|0|||
129910604|NCT04922021|467637566|FG001|Overall Study|Lack of Efficacy|1|||
129910605|NCT04922021|467637565|FG000|Overall Study|Multiple reasons|1|||
129910606|NCT04922021|467637566|FG001|Overall Study|Multiple reasons|0|||
129910607|NCT02544074|467637576|FG000|Overall Study|Withdrawal by Subject|0|||
129910608|NCT02544074|467637577|FG001|Overall Study|Withdrawal by Subject|1|||
129910609|NCT02544074|467637578|FG002|Overall Study|Withdrawal by Subject|0|||
129910610|NCT02544074|467637579|FG003|Overall Study|Withdrawal by Subject|0|||
129910611|NCT02544074|467637580|FG004|Overall Study|Withdrawal by Subject|0|||
129910612|NCT02544074|467637581|FG005|Overall Study|Withdrawal by Subject|0|||
129910613|NCT02544074|467637582|FG006|Overall Study|Withdrawal by Subject|0|||
129910614|NCT02544074|467637583|FG007|Overall Study|Withdrawal by Subject|0|||
129910615|NCT02544074|467637584|FG008|Overall Study|Withdrawal by Subject|0|||
129910616|NCT02544074|467637585|FG009|Overall Study|Withdrawal by Subject|0|||
129910617|NCT02544074|467637586|FG010|Overall Study|Withdrawal by Subject|0|||
129910618|NCT02544074|467637587|FG011|Overall Study|Withdrawal by Subject|0|||
129910619|NCT02544074|467637588|FG012|Overall Study|Withdrawal by Subject|0|||
129910620|NCT02544074|467637589|FG013|Overall Study|Withdrawal by Subject|0|||
129910621|NCT02544074|467637590|FG014|Overall Study|Withdrawal by Subject|0|||
129910622|NCT02544074|467637591|FG015|Overall Study|Withdrawal by Subject|0|||
129910623|NCT02544074|467637592|FG016|Overall Study|Withdrawal by Subject|0|||
129910624|NCT02544074|467637593|FG017|Overall Study|Withdrawal by Subject|0|||
129910625|NCT02544074|467637594|FG018|Overall Study|Withdrawal by Subject|0|||
129910626|NCT02544074|467637595|FG019|Overall Study|Withdrawal by Subject|0|||
129910627|NCT02544074|467637596|FG020|Overall Study|Withdrawal by Subject|0|||
129910628|NCT02544074|467637576|FG000|Overall Study|Tablet error|0|||
129910629|NCT02544074|467637577|FG001|Overall Study|Tablet error|0|||
129910630|NCT02544074|467637578|FG002|Overall Study|Tablet error|0|||
129910631|NCT02544074|467637579|FG003|Overall Study|Tablet error|0|||
129910632|NCT02544074|467637580|FG004|Overall Study|Tablet error|0|||
129910633|NCT02544074|467637581|FG005|Overall Study|Tablet error|1|||
129910634|NCT02544074|467637582|FG006|Overall Study|Tablet error|0|||
129910635|NCT02544074|467637583|FG007|Overall Study|Tablet error|0|||
129910636|NCT02544074|467637584|FG008|Overall Study|Tablet error|0|||
129910637|NCT02544074|467637585|FG009|Overall Study|Tablet error|1|||
129910638|NCT02544074|467637586|FG010|Overall Study|Tablet error|0|||
129910639|NCT02544074|467637587|FG011|Overall Study|Tablet error|0|||
129910640|NCT02544074|467637588|FG012|Overall Study|Tablet error|0|||
129910641|NCT02544074|467637589|FG013|Overall Study|Tablet error|0|||
129449704|NCT02234284|465945657|FG001|Overall Study|Death|2|||
129910642|NCT02544074|467637590|FG014|Overall Study|Tablet error|0|||
129910643|NCT02544074|467637591|FG015|Overall Study|Tablet error|0|||
129910644|NCT02544074|467637592|FG016|Overall Study|Tablet error|0|||
129910645|NCT02544074|467637593|FG017|Overall Study|Tablet error|0|||
129910646|NCT02544074|467637594|FG018|Overall Study|Tablet error|0|||
129910647|NCT02544074|467637595|FG019|Overall Study|Tablet error|0|||
129910648|NCT02544074|467637596|FG020|Overall Study|Tablet error|0|||
129910649|NCT04139668|467637597|FG000|Overall Study|Withdrawal by Subject|1|||
129910650|NCT03025789|467637602|FG000|Overall Study|Lack of Efficacy|6|||
129910651|NCT03025789|467637603|FG001|Overall Study|Lack of Efficacy|1|||
129910652|NCT03025789|467637602|FG000|Overall Study|Death|1|||
129910653|NCT03025789|467637603|FG001|Overall Study|Death|0|||
129910654|NCT03025789|467637602|FG000|Overall Study|Withdrawal by Subject|0|||
129910655|NCT03025789|467637603|FG001|Overall Study|Withdrawal by Subject|2|||
129910656|NCT02723955|467637605|FG000|Escalation Phase|Death|1|||
129910657|NCT02723955|467637606|FG001|Escalation Phase|Death|1|||
129910658|NCT02723955|467637607|FG002|Escalation Phase|Death|2|||
129910659|NCT02723955|467637608|FG003|Escalation Phase|Death|7|||
129910660|NCT02723955|467637609|FG004|Escalation Phase|Death|18|||
129910661|NCT02723955|467637610|FG005|Escalation Phase|Death|17|||
129910662|NCT02723955|467637611|FG006|Escalation Phase|Death|11|||
129910663|NCT02723955|467637612|FG007|Escalation Phase|Death|21|||
129910664|NCT02723955|467637613|FG008|Escalation Phase|Death|3|||
129910665|NCT02723955|467637614|FG009|Escalation Phase|Death|0|||
129910666|NCT02723955|467637615|FG010|Escalation Phase|Death|0|||
129910667|NCT02723955|467637616|FG011|Escalation Phase|Death|0|||
129910668|NCT02723955|467637617|FG012|Escalation Phase|Death|2|||
129910669|NCT02723955|467637618|FG013|Escalation Phase|Death|4|||
129910670|NCT02723955|467637619|FG014|Escalation Phase|Death|5|||
129910671|NCT02723955|467637620|FG015|Escalation Phase|Death|6|||
129910672|NCT02723955|467637621|FG016|Escalation Phase|Death|6|||
129910673|NCT02723955|467637622|FG017|Escalation Phase|Death|7|||
129910674|NCT02723955|467637623|FG018|Escalation Phase|Death|1|||
129910675|NCT02723955|467637624|FG019|Escalation Phase|Death|3|||
129910676|NCT02723955|467637625|FG020|Escalation Phase|Death|13|||
129910677|NCT02723955|467637626|FG021|Escalation Phase|Death|3|||
129910678|NCT02723955|467637627|FG022|Escalation Phase|Death|2|||
129910679|NCT02723955|467637628|FG023|Escalation Phase|Death|4|||
129910680|NCT02723955|467637629|FG024|Escalation Phase|Death|31|||
129910681|NCT02723955|467637630|FG025|Escalation Phase|Death|7|||
129910682|NCT02723955|467637631|FG026|Escalation Phase|Death|13|||
129910683|NCT02723955|467637632|FG027|Escalation Phase|Death|0|||
129910684|NCT02723955|467637633|FG028|Escalation Phase|Death|1|||
129910685|NCT02723955|467637634|FG029|Escalation Phase|Death|0|||
129910686|NCT02723955|467637635|FG030|Escalation Phase|Death|0|||
129910687|NCT02723955|467637636|FG031|Escalation Phase|Death|0|||
129910688|NCT02723955|467637637|FG032|Escalation Phase|Death|0|||
129910689|NCT02723955|467637638|FG033|Escalation Phase|Death|0|||
129910690|NCT02723955|467637639|FG034|Escalation Phase|Death|0|||
129910691|NCT02723955|467637640|FG035|Escalation Phase|Death|0|||
129910692|NCT02723955|467637641|FG036|Escalation Phase|Death|0|||
129910693|NCT02723955|467637642|FG037|Escalation Phase|Death|0|||
129910694|NCT02723955|467637643|FG038|Escalation Phase|Death|0|||
129910695|NCT02723955|467637644|FG039|Escalation Phase|Death|0|||
129910696|NCT02723955|467637645|FG040|Escalation Phase|Death|0|||
129910697|NCT02723955|467637646|FG041|Escalation Phase|Death|0|||
129910698|NCT02723955|467637647|FG042|Escalation Phase|Death|0|||
129910699|NCT02723955|467637605|FG000|Escalation Phase|Lost to Follow-up|0|||
129910700|NCT02723955|467637606|FG001|Escalation Phase|Lost to Follow-up|0|||
129910701|NCT02723955|467637607|FG002|Escalation Phase|Lost to Follow-up|0|||
129910702|NCT02723955|467637608|FG003|Escalation Phase|Lost to Follow-up|0|||
129910703|NCT02723955|467637609|FG004|Escalation Phase|Lost to Follow-up|0|||
129910704|NCT02723955|467637610|FG005|Escalation Phase|Lost to Follow-up|2|||
129910705|NCT02723955|467637611|FG006|Escalation Phase|Lost to Follow-up|1|||
129910706|NCT02723955|467637612|FG007|Escalation Phase|Lost to Follow-up|1|||
129910707|NCT02723955|467637613|FG008|Escalation Phase|Lost to Follow-up|1|||
129910708|NCT02723955|467637614|FG009|Escalation Phase|Lost to Follow-up|0|||
129910709|NCT02723955|467637615|FG010|Escalation Phase|Lost to Follow-up|0|||
129910710|NCT02723955|467637616|FG011|Escalation Phase|Lost to Follow-up|0|||
129910711|NCT02723955|467637617|FG012|Escalation Phase|Lost to Follow-up|1|||
129910712|NCT02723955|467637618|FG013|Escalation Phase|Lost to Follow-up|0|||
129910713|NCT02723955|467637619|FG014|Escalation Phase|Lost to Follow-up|0|||
129910714|NCT02723955|467637620|FG015|Escalation Phase|Lost to Follow-up|0|||
129910715|NCT02723955|467637621|FG016|Escalation Phase|Lost to Follow-up|1|||
129910716|NCT02723955|467637622|FG017|Escalation Phase|Lost to Follow-up|2|||
129910717|NCT02723955|467637623|FG018|Escalation Phase|Lost to Follow-up|0|||
129910718|NCT02723955|467637624|FG019|Escalation Phase|Lost to Follow-up|1|||
129910719|NCT02723955|467637625|FG020|Escalation Phase|Lost to Follow-up|2|||
129910720|NCT02723955|467637626|FG021|Escalation Phase|Lost to Follow-up|1|||
129910721|NCT02723955|467637627|FG022|Escalation Phase|Lost to Follow-up|0|||
129910722|NCT02723955|467637628|FG023|Escalation Phase|Lost to Follow-up|0|||
129910723|NCT02723955|467637629|FG024|Escalation Phase|Lost to Follow-up|1|||
129861269|NCT03230916|467447915|FG000|Overall Study|Withdrawal by Subject|0|||
129861270|NCT03230916|467447916|FG001|Overall Study|Withdrawal by Subject|0|||
129861271|NCT03230916|467447917|FG002|Overall Study|Withdrawal by Subject|0|||
129861272|NCT03230916|467447918|FG003|Overall Study|Withdrawal by Subject|0|||
129861273|NCT03230916|467447919|FG004|Overall Study|Withdrawal by Subject|0|||
129861274|NCT03230916|467447920|FG005|Overall Study|Withdrawal by Subject|1|||
129861275|NCT03230916|467447921|FG006|Overall Study|Withdrawal by Subject|0|||
129861276|NCT03230916|467447922|FG007|Overall Study|Withdrawal by Subject|0|||
129861277|NCT03230916|467447923|FG008|Overall Study|Withdrawal by Subject|0|||
129861278|NCT03230916|467447924|FG009|Overall Study|Withdrawal by Subject|0|||
129861279|NCT03230916|467447925|FG010|Overall Study|Withdrawal by Subject|0|||
129861280|NCT00680407|467447928|FG000|Overall Study|Lost to Follow-up|3|||
129861281|NCT00680407|467447929|FG001|Overall Study|Lost to Follow-up|3|||
129861282|NCT00680407|467447930|FG002|Overall Study|Lost to Follow-up|1|||
129861283|NCT00680407|467447928|FG000|Overall Study|Withdrawal by Subject|5|||
129861284|NCT00680407|467447929|FG001|Overall Study|Withdrawal by Subject|2|||
129861285|NCT00680407|467447930|FG002|Overall Study|Withdrawal by Subject|2|||
129861286|NCT03069482|467449553|FG000|Overall Study|Lost to Follow-up|0|||
129861287|NCT03069482|467449554|FG001|Overall Study|Lost to Follow-up|1|||
129861288|NCT03069482|467449553|FG000|Overall Study|Physician Decision|1|||
129861289|NCT03069482|467449554|FG001|Overall Study|Physician Decision|0|||
129861290|NCT00791765|467449555|FG000|Weeks 1 to 12|Adverse Event|0|||
129861291|NCT00791765|467449556|FG001|Weeks 1 to 12|Adverse Event|1|||
129861292|NCT00791765|467449555|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
129861293|NCT00791765|467449556|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
129861294|NCT00791765|467449555|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
129861295|NCT00791765|467449556|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
129861296|NCT00791765|467449555|FG000|Weeks 1 to 12|Physician Decision|1|||
129861297|NCT00791765|467449556|FG001|Weeks 1 to 12|Physician Decision|0|||
129861298|NCT00791765|467449555|FG000|Weeks 1 to 12|Disease progression|3|||
129861299|NCT00791765|467449556|FG001|Weeks 1 to 12|Disease progression|0|||
129861300|NCT00791765|467449555|FG000|Weeks 1 to 12|Ineligibility determined|0|||
129861301|NCT00791765|467449556|FG001|Weeks 1 to 12|Ineligibility determined|3|||
129861302|NCT00791765|467449555|FG000|Weeks 13 to 24|Protocol deviation|2|||
129861303|NCT00791765|467449556|FG001|Weeks 13 to 24|Protocol deviation|0|||
129861304|NCT00791765|467449555|FG000|Weeks 13 to 24|Adverse Event|0|||
129861305|NCT00791765|467449556|FG001|Weeks 13 to 24|Adverse Event|3|||
129861306|NCT00791765|467449555|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
129861307|NCT00791765|467449556|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
129861308|NCT00791765|467449555|FG000|Weeks 13 to 24|Disease progression|0|||
129861309|NCT00791765|467449556|FG001|Weeks 13 to 24|Disease progression|1|||
129861310|NCT00791765|467449555|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
129861311|NCT00791765|467449556|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
129861312|NCT00791765|467449555|FG000|Weeks 13 to 24|Other|0|||
129861313|NCT00791765|467449556|FG001|Weeks 13 to 24|Other|1|||
129861314|NCT01877408|467449567|FG000|Overall Study|Lost to Follow-up|0|||
129861315|NCT01877408|467449568|FG001|Overall Study|Lost to Follow-up|2|||
129861316|NCT00156065|467449569|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
129861317|NCT00156065|467449570|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
129861318|NCT00156065|467449571|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
129861319|NCT00156065|467449569|FG000|Overall Study|Adverse Event|8|||
129861320|NCT00156065|467449570|FG001|Overall Study|Adverse Event|11|||
129861321|NCT00156065|467449571|FG002|Overall Study|Adverse Event|4|||
129861322|NCT00156065|467449569|FG000|Overall Study|Lack of Efficacy|2|||
129861323|NCT00156065|467449570|FG001|Overall Study|Lack of Efficacy|9|||
129861324|NCT00156065|467449571|FG002|Overall Study|Lack of Efficacy|3|||
129861325|NCT00156065|467449569|FG000|Overall Study|Withdrawal by Subject|13|||
129861326|NCT00156065|467449570|FG001|Overall Study|Withdrawal by Subject|26|||
129861327|NCT00156065|467449571|FG002|Overall Study|Withdrawal by Subject|16|||
129861328|NCT00156065|467449569|FG000|Overall Study|Lost to Follow-up|5|||
129861329|NCT00156065|467449570|FG001|Overall Study|Lost to Follow-up|7|||
129861330|NCT00156065|467449571|FG002|Overall Study|Lost to Follow-up|1|||
129861331|NCT00156065|467449569|FG000|Overall Study|Other|2|||
129861332|NCT00156065|467449570|FG001|Overall Study|Other|9|||
129861333|NCT00156065|467449571|FG002|Overall Study|Other|3|||
129910724|NCT02723955|467637630|FG025|Escalation Phase|Lost to Follow-up|1|||
129910725|NCT02723955|467637631|FG026|Escalation Phase|Lost to Follow-up|3|||
129861334|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861335|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129910726|NCT02723955|467637632|FG027|Escalation Phase|Lost to Follow-up|0|||
129910727|NCT02723955|467637633|FG028|Escalation Phase|Lost to Follow-up|1|||
129861336|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861337|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
129861338|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861339|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
129861340|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
129861341|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
129861342|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
129861343|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
129861344|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
129861345|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
129861346|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861347|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861348|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861349|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
129861350|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861351|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
129861352|NCT01292603|467449572|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861353|NCT01292603|467449573|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861354|NCT01292603|467449574|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861355|NCT01292603|467449575|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
129861356|NCT01292603|467449576|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861357|NCT01292603|467449577|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
129861358|NCT01292603|467449572|FG000|Part 1: Regular Follow-Up Period|Death|3|||
129861359|NCT01292603|467449573|FG001|Part 1: Regular Follow-Up Period|Death|1|||
129861360|NCT01292603|467449574|FG002|Part 1: Regular Follow-Up Period|Death|3|||
129861361|NCT01292603|467449575|FG003|Part 1: Regular Follow-Up Period|Death|1|||
129861362|NCT01292603|467449576|FG004|Part 1: Regular Follow-Up Period|Death|0|||
129861363|NCT01292603|467449577|FG005|Part 1: Regular Follow-Up Period|Death|0|||
129861364|NCT01292603|467449572|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
129861365|NCT01292603|467449573|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
129861366|NCT01292603|467449574|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
129861367|NCT01292603|467449575|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
129861368|NCT01292603|467449576|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
129861369|NCT01292603|467449577|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
129861370|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Death|0|||
129861371|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Death|0|||
129861372|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Death|0|||
129861373|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Death|0|||
129861374|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Death|1|||
129861375|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Death|0|||
129861376|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861377|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861378|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861379|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861380|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
129861381|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
129861382|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861383|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861384|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861385|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
129861386|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
129861387|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
129861388|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861389|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861390|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861391|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
129861392|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
129861393|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
129861394|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861395|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861396|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861397|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
129861398|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
129861399|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
129861400|NCT01292603|467449572|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861401|NCT01292603|467449573|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861402|NCT01292603|467449574|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861403|NCT01292603|467449575|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129910728|NCT02723955|467637634|FG029|Escalation Phase|Lost to Follow-up|0|||
129910729|NCT02723955|467637635|FG030|Escalation Phase|Lost to Follow-up|0|||
129910730|NCT02723955|467637636|FG031|Escalation Phase|Lost to Follow-up|0|||
129910731|NCT02723955|467637637|FG032|Escalation Phase|Lost to Follow-up|0|||
129910732|NCT02723955|467637638|FG033|Escalation Phase|Lost to Follow-up|0|||
129910733|NCT02723955|467637639|FG034|Escalation Phase|Lost to Follow-up|0|||
129861404|NCT01292603|467449576|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
129861405|NCT01292603|467449577|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
129861406|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Death|0|||
129861407|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Death|0|||
129861408|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Death|0|||
129861409|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Death|0|||
129861410|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Death|6|||
129861411|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Death|3|||
129861412|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
129861413|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
129861414|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
129861415|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
129861416|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
129861417|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
129861418|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
129861419|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
129861420|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
129861421|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
129861422|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
129861423|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
129861424|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861425|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861426|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861427|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861428|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
129861429|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
129861430|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861431|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861432|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861433|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861434|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
129861435|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
129861436|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
129861437|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
129861438|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
129861439|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
129861440|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
129861441|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
129861442|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861443|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861444|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861445|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
129861446|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
129861447|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
129861448|NCT01292603|467449572|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
129861449|NCT01292603|467449573|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
129861450|NCT01292603|467449574|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
129861451|NCT01292603|467449575|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
129861452|NCT01292603|467449576|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
129861453|NCT01292603|467449577|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
129861454|NCT01292603|467449572|FG000|Overall Survival Status|Death|3|||
129861455|NCT01292603|467449573|FG001|Overall Survival Status|Death|1|||
129861456|NCT01292603|467449574|FG002|Overall Survival Status|Death|3|||
129861457|NCT01292603|467449575|FG003|Overall Survival Status|Death|1|||
129861458|NCT01292603|467449576|FG004|Overall Survival Status|Death|16|||
129861459|NCT01292603|467449577|FG005|Overall Survival Status|Death|10|||
129861460|NCT03870763|467449580|FG000|Overall Study|Study terminated by sponsor|0|||
129861461|NCT03870763|467449581|FG001|Overall Study|Study terminated by sponsor|2|||
129861462|NCT03870763|467449582|FG002|Overall Study|Study terminated by sponsor|0|||
129861463|NCT03870763|467449580|FG000|Overall Study|Withdrawal by Subject|0|||
129861464|NCT03870763|467449581|FG001|Overall Study|Withdrawal by Subject|1|||
129861465|NCT03870763|467449582|FG002|Overall Study|Withdrawal by Subject|0|||
129861466|NCT03870763|467449580|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
129910734|NCT02723955|467637640|FG035|Escalation Phase|Lost to Follow-up|0|||
129910735|NCT02723955|467637641|FG036|Escalation Phase|Lost to Follow-up|0|||
129910736|NCT02723955|467637642|FG037|Escalation Phase|Lost to Follow-up|0|||
129861467|NCT03870763|467449581|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
129861468|NCT03870763|467449582|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
129861469|NCT03586648|467449585|FG000|Period 1|Withdrawal by Subject|0|||
129861470|NCT03586648|467449586|FG001|Period 1|Withdrawal by Subject|1|||
129861471|NCT03586648|467449585|FG000|Period 1|Lost to Follow-up|1|||
129861472|NCT03586648|467449586|FG001|Period 1|Lost to Follow-up|1|||
129861473|NCT03586648|467449585|FG000|Period 1|Adverse Event|1|||
129861474|NCT03586648|467449586|FG001|Period 1|Adverse Event|0|||
129861475|NCT03586648|467449585|FG000|Period 1|Study related symptoms or complaints|2|||
129861476|NCT03586648|467449586|FG001|Period 1|Study related symptoms or complaints|1|||
129861477|NCT03586648|467449585|FG000|Period 1|Physician Decision|0|||
129861478|NCT03586648|467449586|FG001|Period 1|Physician Decision|1|||
129861479|NCT03586648|467449585|FG000|Period 2|Adverse Event|1|||
129861480|NCT03586648|467449586|FG001|Period 2|Adverse Event|0|||
129861481|NCT00907153|467449587|FG000|Overall Study|Lost to Follow-up|1|||
129861482|NCT00907153|467449588|FG001|Overall Study|Lost to Follow-up|1|||
129861483|NCT00907153|467449587|FG000|Overall Study|Withdrawal by Subject|1|||
129861484|NCT00907153|467449588|FG001|Overall Study|Withdrawal by Subject|3|||
129861485|NCT03147248|467449589|FG000|Overall Study|Adverse Event|0|||
129861486|NCT03147248|467449590|FG001|Overall Study|Adverse Event|2|||
129861487|NCT03147248|467449591|FG002|Overall Study|Adverse Event|2|||
129861488|NCT03147248|467449592|FG003|Overall Study|Adverse Event|2|||
129861489|NCT03147248|467449593|FG004|Overall Study|Adverse Event|6|||
129861490|NCT03147248|467449594|FG005|Overall Study|Adverse Event|11|||
129861491|NCT03147248|467449589|FG000|Overall Study|Disease progression|1|||
129861492|NCT03147248|467449590|FG001|Overall Study|Disease progression|0|||
129861493|NCT03147248|467449591|FG002|Overall Study|Disease progression|0|||
129861494|NCT03147248|467449592|FG003|Overall Study|Disease progression|0|||
129861495|NCT03147248|467449593|FG004|Overall Study|Disease progression|0|||
129861496|NCT03147248|467449594|FG005|Overall Study|Disease progression|2|||
129861497|NCT03147248|467449589|FG000|Overall Study|Withdrawal by Subject|0|||
129861498|NCT03147248|467449590|FG001|Overall Study|Withdrawal by Subject|0|||
129861499|NCT03147248|467449591|FG002|Overall Study|Withdrawal by Subject|0|||
129861500|NCT03147248|467449592|FG003|Overall Study|Withdrawal by Subject|0|||
129861501|NCT03147248|467449593|FG004|Overall Study|Withdrawal by Subject|12|||
129861502|NCT03147248|467449594|FG005|Overall Study|Withdrawal by Subject|9|||
129861503|NCT03147248|467449589|FG000|Overall Study|Protocol Violation|0|||
129861504|NCT03147248|467449590|FG001|Overall Study|Protocol Violation|0|||
129910737|NCT02723955|467637643|FG038|Escalation Phase|Lost to Follow-up|0|||
129910738|NCT02723955|467637644|FG039|Escalation Phase|Lost to Follow-up|0|||
129910739|NCT02723955|467637645|FG040|Escalation Phase|Lost to Follow-up|0|||
129910740|NCT02723955|467637646|FG041|Escalation Phase|Lost to Follow-up|0|||
129910741|NCT02723955|467637647|FG042|Escalation Phase|Lost to Follow-up|0|||
129910742|NCT02723955|467637605|FG000|Escalation Phase|Physician Decision|0|||
129910743|NCT02723955|467637606|FG001|Escalation Phase|Physician Decision|0|||
129910744|NCT02723955|467637607|FG002|Escalation Phase|Physician Decision|0|||
129910745|NCT02723955|467637608|FG003|Escalation Phase|Physician Decision|0|||
129910746|NCT02723955|467637609|FG004|Escalation Phase|Physician Decision|0|||
129910747|NCT02723955|467637610|FG005|Escalation Phase|Physician Decision|2|||
129910748|NCT02723955|467637611|FG006|Escalation Phase|Physician Decision|0|||
129910749|NCT02723955|467637612|FG007|Escalation Phase|Physician Decision|0|||
129910750|NCT02723955|467637613|FG008|Escalation Phase|Physician Decision|0|||
129910751|NCT02723955|467637614|FG009|Escalation Phase|Physician Decision|0|||
129910752|NCT02723955|467637615|FG010|Escalation Phase|Physician Decision|0|||
129910753|NCT02723955|467637616|FG011|Escalation Phase|Physician Decision|0|||
129910754|NCT02723955|467637617|FG012|Escalation Phase|Physician Decision|0|||
129910755|NCT02723955|467637618|FG013|Escalation Phase|Physician Decision|0|||
129910756|NCT02723955|467637619|FG014|Escalation Phase|Physician Decision|0|||
129910757|NCT02723955|467637620|FG015|Escalation Phase|Physician Decision|0|||
129861505|NCT03147248|467449591|FG002|Overall Study|Protocol Violation|0|||
129861506|NCT03147248|467449592|FG003|Overall Study|Protocol Violation|0|||
129861507|NCT03147248|467449593|FG004|Overall Study|Protocol Violation|2|||
129861508|NCT03147248|467449594|FG005|Overall Study|Protocol Violation|0|||
129861509|NCT03147248|467449589|FG000|Overall Study|Lost to Follow-up|0|||
129910758|NCT02723955|467637621|FG016|Escalation Phase|Physician Decision|0|||
129910759|NCT02723955|467637622|FG017|Escalation Phase|Physician Decision|0|||
129910760|NCT02723955|467637623|FG018|Escalation Phase|Physician Decision|0|||
129861510|NCT03147248|467449590|FG001|Overall Study|Lost to Follow-up|0|||
129910761|NCT02723955|467637624|FG019|Escalation Phase|Physician Decision|0|||
129861511|NCT03147248|467449591|FG002|Overall Study|Lost to Follow-up|0|||
129861512|NCT03147248|467449592|FG003|Overall Study|Lost to Follow-up|0|||
129910762|NCT02723955|467637625|FG020|Escalation Phase|Physician Decision|0|||
129861513|NCT03147248|467449593|FG004|Overall Study|Lost to Follow-up|2|||
129861514|NCT03147248|467449594|FG005|Overall Study|Lost to Follow-up|0|||
129861515|NCT03147248|467449589|FG000|Overall Study|Pregnancy|0|||
129861516|NCT03147248|467449590|FG001|Overall Study|Pregnancy|0|||
129861517|NCT03147248|467449591|FG002|Overall Study|Pregnancy|0|||
129861518|NCT03147248|467449592|FG003|Overall Study|Pregnancy|0|||
129861519|NCT03147248|467449593|FG004|Overall Study|Pregnancy|1|||
129861520|NCT03147248|467449594|FG005|Overall Study|Pregnancy|0|||
129861521|NCT03147248|467449589|FG000|Overall Study|Death|0|||
129861522|NCT03147248|467449590|FG001|Overall Study|Death|0|||
129861523|NCT03147248|467449591|FG002|Overall Study|Death|0|||
129861524|NCT03147248|467449592|FG003|Overall Study|Death|0|||
129861525|NCT03147248|467449593|FG004|Overall Study|Death|0|||
129861526|NCT03147248|467449594|FG005|Overall Study|Death|4|||
129861527|NCT03147248|467449589|FG000|Overall Study|Physician Decision|0|||
129861528|NCT03147248|467449590|FG001|Overall Study|Physician Decision|0|||
129861529|NCT03147248|467449591|FG002|Overall Study|Physician Decision|0|||
129861530|NCT03147248|467449592|FG003|Overall Study|Physician Decision|0|||
129861531|NCT03147248|467449593|FG004|Overall Study|Physician Decision|2|||
129861532|NCT03147248|467449594|FG005|Overall Study|Physician Decision|4|||
129861533|NCT03147248|467449589|FG000|Overall Study|Prolonged Dosing Interval|0|||
129861534|NCT03147248|467449590|FG001|Overall Study|Prolonged Dosing Interval|0|||
129861535|NCT03147248|467449591|FG002|Overall Study|Prolonged Dosing Interval|0|||
129861536|NCT03147248|467449592|FG003|Overall Study|Prolonged Dosing Interval|0|||
129861537|NCT03147248|467449593|FG004|Overall Study|Prolonged Dosing Interval|1|||
129861538|NCT03147248|467449594|FG005|Overall Study|Prolonged Dosing Interval|1|||
129861539|NCT02388724|467449597|FG000|Overall Study|Reason not Specified|0|||
129861540|NCT02388724|467449598|FG001|Overall Study|Reason not Specified|1|||
129861541|NCT02388724|467449597|FG000|Overall Study|Major Protocol Deviation|3|||
129861542|NCT02388724|467449598|FG001|Overall Study|Major Protocol Deviation|3|||
129861543|NCT02388724|467449597|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
129861544|NCT02388724|467449598|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
129861545|NCT02388724|467449597|FG000|Overall Study|Voluntary Withdrawal|6|||
129861546|NCT02388724|467449598|FG001|Overall Study|Voluntary Withdrawal|5|||
129861547|NCT02388724|467449597|FG000|Overall Study|Randomized but not Treated|0|||
129861548|NCT02388724|467449598|FG001|Overall Study|Randomized but not Treated|2|||
129861549|NCT02605954|467449599|FG000|Overall Study|Adverse Event|5|||
129861550|NCT02605954|467449600|FG001|Overall Study|Adverse Event|1|||
129861551|NCT02605954|467449599|FG000|Overall Study|Investigator's Discretion|1|||
129861552|NCT02605954|467449600|FG001|Overall Study|Investigator's Discretion|0|||
129861553|NCT02605954|467449599|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129861554|NCT02605954|467449600|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129861555|NCT02605954|467449599|FG000|Overall Study|Withdrew Consent|2|||
129861556|NCT02605954|467449600|FG001|Overall Study|Withdrew Consent|2|||
129861557|NCT02605954|467449599|FG000|Overall Study|Lost to Follow-up|3|||
129861558|NCT02605954|467449600|FG001|Overall Study|Lost to Follow-up|0|||
129861559|NCT02605954|467449599|FG000|Overall Study|Randomized but not treated|0|||
129861560|NCT02605954|467449600|FG001|Overall Study|Randomized but not treated|1|||
129861561|NCT03214367|467449601|FG000|Lead-in Period|Withdrawal by Subject|50|||
129861562|NCT03214367|467449602|FG001|Lead-in Period|Withdrawal by Subject|0|||
129861563|NCT03214367|467449603|FG002|Lead-in Period|Withdrawal by Subject|0|||
129861564|NCT03214367|467449604|FG003|Lead-in Period|Withdrawal by Subject|0|||
129861565|NCT03214367|467449605|FG004|Lead-in Period|Withdrawal by Subject|2|||
129861566|NCT03214367|467449606|FG005|Lead-in Period|Withdrawal by Subject|0|||
129861567|NCT03214367|467449607|FG006|Lead-in Period|Withdrawal by Subject|0|||
129861568|NCT03214367|467449608|FG007|Lead-in Period|Withdrawal by Subject|0|||
129861569|NCT03214367|467449601|FG000|Lead-in Period|Adverse Event|3|||
129861570|NCT03214367|467449602|FG001|Lead-in Period|Adverse Event|0|||
129861571|NCT03214367|467449603|FG002|Lead-in Period|Adverse Event|0|||
129861572|NCT03214367|467449604|FG003|Lead-in Period|Adverse Event|0|||
129861573|NCT03214367|467449605|FG004|Lead-in Period|Adverse Event|0|||
129861574|NCT03214367|467449606|FG005|Lead-in Period|Adverse Event|0|||
129861575|NCT03214367|467449607|FG006|Lead-in Period|Adverse Event|0|||
129861576|NCT03214367|467449608|FG007|Lead-in Period|Adverse Event|0|||
129861577|NCT03214367|467449601|FG000|Lead-in Period|Lost to Follow-up|12|||
129861578|NCT03214367|467449602|FG001|Lead-in Period|Lost to Follow-up|0|||
129861579|NCT03214367|467449603|FG002|Lead-in Period|Lost to Follow-up|0|||
129861580|NCT03214367|467449604|FG003|Lead-in Period|Lost to Follow-up|0|||
129861581|NCT03214367|467449605|FG004|Lead-in Period|Lost to Follow-up|0|||
129861582|NCT03214367|467449606|FG005|Lead-in Period|Lost to Follow-up|0|||
129861583|NCT03214367|467449607|FG006|Lead-in Period|Lost to Follow-up|0|||
129910763|NCT02723955|467637626|FG021|Escalation Phase|Physician Decision|0|||
129910764|NCT02723955|467637627|FG022|Escalation Phase|Physician Decision|0|||
129910765|NCT02723955|467637628|FG023|Escalation Phase|Physician Decision|0|||
129449705|NCT02234284|465945656|FG000|Overall Study|Withdrawal by Subject|1|||
129861584|NCT03214367|467449608|FG007|Lead-in Period|Lost to Follow-up|0|||
129861585|NCT03214367|467449601|FG000|Lead-in Period|Sponsor Decision|11|||
129861586|NCT03214367|467449602|FG001|Lead-in Period|Sponsor Decision|0|||
129861587|NCT03214367|467449603|FG002|Lead-in Period|Sponsor Decision|0|||
129861588|NCT03214367|467449604|FG003|Lead-in Period|Sponsor Decision|0|||
129861589|NCT03214367|467449605|FG004|Lead-in Period|Sponsor Decision|0|||
129861590|NCT03214367|467449606|FG005|Lead-in Period|Sponsor Decision|0|||
129861591|NCT03214367|467449607|FG006|Lead-in Period|Sponsor Decision|0|||
129861592|NCT03214367|467449608|FG007|Lead-in Period|Sponsor Decision|0|||
129861593|NCT03214367|467449601|FG000|Lead-in Period|Physician Decision|12|||
129861594|NCT03214367|467449602|FG001|Lead-in Period|Physician Decision|0|||
129861595|NCT03214367|467449603|FG002|Lead-in Period|Physician Decision|0|||
129861596|NCT03214367|467449604|FG003|Lead-in Period|Physician Decision|0|||
129861597|NCT03214367|467449605|FG004|Lead-in Period|Physician Decision|0|||
129861598|NCT03214367|467449606|FG005|Lead-in Period|Physician Decision|0|||
129861599|NCT03214367|467449607|FG006|Lead-in Period|Physician Decision|0|||
129861600|NCT03214367|467449608|FG007|Lead-in Period|Physician Decision|0|||
129861601|NCT03214367|467449601|FG000|Lead-in Period|Protocol Violation|5|||
129861602|NCT03214367|467449602|FG001|Lead-in Period|Protocol Violation|0|||
129861603|NCT03214367|467449603|FG002|Lead-in Period|Protocol Violation|0|||
129861604|NCT03214367|467449604|FG003|Lead-in Period|Protocol Violation|0|||
129861605|NCT03214367|467449605|FG004|Lead-in Period|Protocol Violation|0|||
129861606|NCT03214367|467449606|FG005|Lead-in Period|Protocol Violation|0|||
129861607|NCT03214367|467449607|FG006|Lead-in Period|Protocol Violation|0|||
129861608|NCT03214367|467449608|FG007|Lead-in Period|Protocol Violation|0|||
129861609|NCT03214367|467449601|FG000|Lead-in Period|Treatment Interruption|1|||
129861610|NCT03214367|467449602|FG001|Lead-in Period|Treatment Interruption|0|||
129861611|NCT03214367|467449603|FG002|Lead-in Period|Treatment Interruption|0|||
129861612|NCT03214367|467449604|FG003|Lead-in Period|Treatment Interruption|0|||
129861613|NCT03214367|467449605|FG004|Lead-in Period|Treatment Interruption|0|||
129861614|NCT03214367|467449606|FG005|Lead-in Period|Treatment Interruption|0|||
129861615|NCT03214367|467449607|FG006|Lead-in Period|Treatment Interruption|0|||
129861616|NCT03214367|467449608|FG007|Lead-in Period|Treatment Interruption|0|||
129861617|NCT03214367|467449601|FG000|Treatment Period|Adverse Event|0|||
129861618|NCT03214367|467449602|FG001|Treatment Period|Adverse Event|1|||
129861619|NCT03214367|467449603|FG002|Treatment Period|Adverse Event|4|||
129861620|NCT03214367|467449604|FG003|Treatment Period|Adverse Event|2|||
129861621|NCT03214367|467449605|FG004|Treatment Period|Adverse Event|0|||
129861622|NCT03214367|467449606|FG005|Treatment Period|Adverse Event|0|||
129861623|NCT03214367|467449607|FG006|Treatment Period|Adverse Event|0|||
129861624|NCT03214367|467449608|FG007|Treatment Period|Adverse Event|0|||
129861625|NCT03214367|467449601|FG000|Treatment Period|Death|0|||
129861626|NCT03214367|467449602|FG001|Treatment Period|Death|1|||
129861627|NCT03214367|467449603|FG002|Treatment Period|Death|1|||
129861628|NCT03214367|467449604|FG003|Treatment Period|Death|1|||
129861629|NCT03214367|467449605|FG004|Treatment Period|Death|0|||
129861630|NCT03214367|467449606|FG005|Treatment Period|Death|0|||
129861631|NCT03214367|467449607|FG006|Treatment Period|Death|0|||
129861632|NCT03214367|467449608|FG007|Treatment Period|Death|0|||
129861633|NCT03214367|467449601|FG000|Treatment Period|Lost to Follow-up|0|||
129861634|NCT03214367|467449602|FG001|Treatment Period|Lost to Follow-up|5|||
129861635|NCT03214367|467449603|FG002|Treatment Period|Lost to Follow-up|3|||
129861636|NCT03214367|467449604|FG003|Treatment Period|Lost to Follow-up|2|||
129861637|NCT03214367|467449605|FG004|Treatment Period|Lost to Follow-up|0|||
129861638|NCT03214367|467449606|FG005|Treatment Period|Lost to Follow-up|2|||
129861639|NCT03214367|467449607|FG006|Treatment Period|Lost to Follow-up|1|||
129861640|NCT03214367|467449608|FG007|Treatment Period|Lost to Follow-up|0|||
129861641|NCT03214367|467449601|FG000|Treatment Period|Sponsor Decision|0|||
129910766|NCT02723955|467637629|FG024|Escalation Phase|Physician Decision|0|||
129910767|NCT02723955|467637630|FG025|Escalation Phase|Physician Decision|0|||
129449706|NCT02234284|465945657|FG001|Overall Study|Withdrawal by Subject|0|||
129861642|NCT03214367|467449602|FG001|Treatment Period|Sponsor Decision|3|||
129861643|NCT03214367|467449603|FG002|Treatment Period|Sponsor Decision|0|||
129861644|NCT03214367|467449604|FG003|Treatment Period|Sponsor Decision|0|||
129861645|NCT03214367|467449605|FG004|Treatment Period|Sponsor Decision|0|||
129861646|NCT03214367|467449606|FG005|Treatment Period|Sponsor Decision|0|||
129861647|NCT03214367|467449607|FG006|Treatment Period|Sponsor Decision|0|||
129861648|NCT03214367|467449608|FG007|Treatment Period|Sponsor Decision|0|||
129861649|NCT03214367|467449601|FG000|Treatment Period|Physician Decision|0|||
129861650|NCT03214367|467449602|FG001|Treatment Period|Physician Decision|1|||
129861651|NCT03214367|467449603|FG002|Treatment Period|Physician Decision|2|||
129861652|NCT03214367|467449604|FG003|Treatment Period|Physician Decision|0|||
129861653|NCT03214367|467449605|FG004|Treatment Period|Physician Decision|0|||
129861654|NCT03214367|467449606|FG005|Treatment Period|Physician Decision|0|||
129910768|NCT02723955|467637631|FG026|Escalation Phase|Physician Decision|2|||
129910769|NCT02723955|467637632|FG027|Escalation Phase|Physician Decision|0|||
129910770|NCT02723955|467637633|FG028|Escalation Phase|Physician Decision|0|||
129910771|NCT02723955|467637634|FG029|Escalation Phase|Physician Decision|0|||
129910772|NCT02723955|467637635|FG030|Escalation Phase|Physician Decision|0|||
129910773|NCT02723955|467637636|FG031|Escalation Phase|Physician Decision|0|||
129910774|NCT02723955|467637637|FG032|Escalation Phase|Physician Decision|0|||
129910775|NCT02723955|467637638|FG033|Escalation Phase|Physician Decision|0|||
129910776|NCT02723955|467637639|FG034|Escalation Phase|Physician Decision|0|||
129910777|NCT02723955|467637640|FG035|Escalation Phase|Physician Decision|0|||
129910778|NCT02723955|467637641|FG036|Escalation Phase|Physician Decision|0|||
129910779|NCT02723955|467637642|FG037|Escalation Phase|Physician Decision|0|||
129910780|NCT02723955|467637643|FG038|Escalation Phase|Physician Decision|0|||
129910781|NCT02723955|467637644|FG039|Escalation Phase|Physician Decision|0|||
129910782|NCT02723955|467637645|FG040|Escalation Phase|Physician Decision|0|||
129910783|NCT02723955|467637646|FG041|Escalation Phase|Physician Decision|0|||
129910784|NCT02723955|467637647|FG042|Escalation Phase|Physician Decision|0|||
129910785|NCT02723955|467637605|FG000|Escalation Phase|Withdrawal by Subject|0|||
129910786|NCT02723955|467637606|FG001|Escalation Phase|Withdrawal by Subject|0|||
129910787|NCT02723955|467637607|FG002|Escalation Phase|Withdrawal by Subject|0|||
129910788|NCT02723955|467637608|FG003|Escalation Phase|Withdrawal by Subject|0|||
129910789|NCT02723955|467637609|FG004|Escalation Phase|Withdrawal by Subject|1|||
129910790|NCT02723955|467637610|FG005|Escalation Phase|Withdrawal by Subject|1|||
129910791|NCT02723955|467637611|FG006|Escalation Phase|Withdrawal by Subject|1|||
129910792|NCT02723955|467637612|FG007|Escalation Phase|Withdrawal by Subject|1|||
129910793|NCT02723955|467637613|FG008|Escalation Phase|Withdrawal by Subject|0|||
129910794|NCT02723955|467637614|FG009|Escalation Phase|Withdrawal by Subject|0|||
129910795|NCT02723955|467637615|FG010|Escalation Phase|Withdrawal by Subject|0|||
129910796|NCT02723955|467637616|FG011|Escalation Phase|Withdrawal by Subject|0|||
129910797|NCT02723955|467637617|FG012|Escalation Phase|Withdrawal by Subject|1|||
129910798|NCT02723955|467637618|FG013|Escalation Phase|Withdrawal by Subject|0|||
129910799|NCT02723955|467637619|FG014|Escalation Phase|Withdrawal by Subject|0|||
129910800|NCT02723955|467637620|FG015|Escalation Phase|Withdrawal by Subject|0|||
129910801|NCT02723955|467637621|FG016|Escalation Phase|Withdrawal by Subject|1|||
129910802|NCT02723955|467637622|FG017|Escalation Phase|Withdrawal by Subject|0|||
129910803|NCT02723955|467637623|FG018|Escalation Phase|Withdrawal by Subject|0|||
129910804|NCT02723955|467637624|FG019|Escalation Phase|Withdrawal by Subject|0|||
129910805|NCT02723955|467637625|FG020|Escalation Phase|Withdrawal by Subject|0|||
129910806|NCT02723955|467637626|FG021|Escalation Phase|Withdrawal by Subject|0|||
129910807|NCT02723955|467637627|FG022|Escalation Phase|Withdrawal by Subject|0|||
129910808|NCT02723955|467637628|FG023|Escalation Phase|Withdrawal by Subject|2|||
129910809|NCT02723955|467637629|FG024|Escalation Phase|Withdrawal by Subject|0|||
129910810|NCT02723955|467637630|FG025|Escalation Phase|Withdrawal by Subject|1|||
129910811|NCT02723955|467637631|FG026|Escalation Phase|Withdrawal by Subject|0|||
129910812|NCT02723955|467637632|FG027|Escalation Phase|Withdrawal by Subject|0|||
129910813|NCT02723955|467637633|FG028|Escalation Phase|Withdrawal by Subject|1|||
129910814|NCT02723955|467637634|FG029|Escalation Phase|Withdrawal by Subject|0|||
129910815|NCT02723955|467637635|FG030|Escalation Phase|Withdrawal by Subject|0|||
129910816|NCT02723955|467637636|FG031|Escalation Phase|Withdrawal by Subject|0|||
129910817|NCT02723955|467637637|FG032|Escalation Phase|Withdrawal by Subject|0|||
129910818|NCT02723955|467637638|FG033|Escalation Phase|Withdrawal by Subject|0|||
129910819|NCT02723955|467637639|FG034|Escalation Phase|Withdrawal by Subject|0|||
129910820|NCT02723955|467637640|FG035|Escalation Phase|Withdrawal by Subject|0|||
129910821|NCT02723955|467637641|FG036|Escalation Phase|Withdrawal by Subject|0|||
129910822|NCT02723955|467637642|FG037|Escalation Phase|Withdrawal by Subject|0|||
129910823|NCT02723955|467637643|FG038|Escalation Phase|Withdrawal by Subject|0|||
129910824|NCT02723955|467637644|FG039|Escalation Phase|Withdrawal by Subject|0|||
129910825|NCT02723955|467637645|FG040|Escalation Phase|Withdrawal by Subject|0|||
129910826|NCT02723955|467637646|FG041|Escalation Phase|Withdrawal by Subject|0|||
129910827|NCT02723955|467637647|FG042|Escalation Phase|Withdrawal by Subject|0|||
129910828|NCT02723955|467637605|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910829|NCT02723955|467637606|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910830|NCT02723955|467637607|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910831|NCT02723955|467637608|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910832|NCT02723955|467637609|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
129910833|NCT02723955|467637610|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
129449707|NCT02234284|465945656|FG000|Overall Study|Lost to Follow-up|20|||
129910834|NCT02723955|467637611|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
129910835|NCT02723955|467637612|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
129910836|NCT02723955|467637613|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
129910837|NCT02723955|467637614|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129449708|NCT02234284|465945657|FG001|Overall Study|Lost to Follow-up|7|||
129910838|NCT02723955|467637615|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910839|NCT02723955|467637616|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910840|NCT02723955|467637617|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910841|NCT02723955|467637618|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910842|NCT02723955|467637619|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910843|NCT02723955|467637620|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910844|NCT02723955|467637621|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910845|NCT02723955|467637622|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910846|NCT02723955|467637623|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910847|NCT02723955|467637624|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910848|NCT02723955|467637625|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910849|NCT02723955|467637626|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910850|NCT02723955|467637627|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910851|NCT02723955|467637628|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910852|NCT02723955|467637629|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910853|NCT02723955|467637630|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910854|NCT02723955|467637631|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910855|NCT02723955|467637632|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910856|NCT02723955|467637633|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910857|NCT02723955|467637634|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910858|NCT02723955|467637635|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910859|NCT02723955|467637636|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910860|NCT02723955|467637637|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910861|NCT02723955|467637638|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910862|NCT02723955|467637639|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910863|NCT02723955|467637640|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910864|NCT02723955|467637641|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910865|NCT02723955|467637642|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910866|NCT02723955|467637643|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910867|NCT02723955|467637644|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910868|NCT02723955|467637645|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910869|NCT02723955|467637646|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910870|NCT02723955|467637647|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
129910871|NCT02723955|467637605|FG000|Escalation Phase|Site Closed|0|||
129910872|NCT02723955|467637606|FG001|Escalation Phase|Site Closed|0|||
129910873|NCT02723955|467637607|FG002|Escalation Phase|Site Closed|0|||
129910874|NCT02723955|467637608|FG003|Escalation Phase|Site Closed|0|||
129910875|NCT02723955|467637609|FG004|Escalation Phase|Site Closed|0|||
129910876|NCT02723955|467637610|FG005|Escalation Phase|Site Closed|0|||
129910877|NCT02723955|467637611|FG006|Escalation Phase|Site Closed|0|||
129910878|NCT02723955|467637612|FG007|Escalation Phase|Site Closed|0|||
129910879|NCT02723955|467637613|FG008|Escalation Phase|Site Closed|0|||
129910880|NCT02723955|467637614|FG009|Escalation Phase|Site Closed|0|||
129910881|NCT02723955|467637615|FG010|Escalation Phase|Site Closed|0|||
129910882|NCT02723955|467637616|FG011|Escalation Phase|Site Closed|0|||
129910883|NCT02723955|467637617|FG012|Escalation Phase|Site Closed|0|||
129910884|NCT02723955|467637618|FG013|Escalation Phase|Site Closed|0|||
129910885|NCT02723955|467637619|FG014|Escalation Phase|Site Closed|0|||
129910886|NCT02723955|467637620|FG015|Escalation Phase|Site Closed|1|||
129910887|NCT02723955|467637621|FG016|Escalation Phase|Site Closed|0|||
129910888|NCT02723955|467637622|FG017|Escalation Phase|Site Closed|2|||
129910889|NCT02723955|467637623|FG018|Escalation Phase|Site Closed|0|||
129910890|NCT02723955|467637624|FG019|Escalation Phase|Site Closed|0|||
129910891|NCT02723955|467637625|FG020|Escalation Phase|Site Closed|1|||
129910892|NCT02723955|467637626|FG021|Escalation Phase|Site Closed|0|||
129910893|NCT02723955|467637627|FG022|Escalation Phase|Site Closed|0|||
129910894|NCT02723955|467637628|FG023|Escalation Phase|Site Closed|0|||
129910895|NCT02723955|467637629|FG024|Escalation Phase|Site Closed|3|||
129910896|NCT02723955|467637630|FG025|Escalation Phase|Site Closed|1|||
129910897|NCT02723955|467637631|FG026|Escalation Phase|Site Closed|3|||
129910898|NCT02723955|467637632|FG027|Escalation Phase|Site Closed|1|||
129910899|NCT02723955|467637633|FG028|Escalation Phase|Site Closed|1|||
129910900|NCT02723955|467637634|FG029|Escalation Phase|Site Closed|0|||
129861655|NCT03214367|467449607|FG006|Treatment Period|Physician Decision|0|||
129861656|NCT03214367|467449608|FG007|Treatment Period|Physician Decision|0|||
129861657|NCT03214367|467449601|FG000|Treatment Period|Protocol Violation|0|||
129861658|NCT03214367|467449602|FG001|Treatment Period|Protocol Violation|3|||
129861659|NCT03214367|467449603|FG002|Treatment Period|Protocol Violation|0|||
129861660|NCT03214367|467449604|FG003|Treatment Period|Protocol Violation|0|||
129861661|NCT03214367|467449605|FG004|Treatment Period|Protocol Violation|0|||
129861662|NCT03214367|467449606|FG005|Treatment Period|Protocol Violation|0|||
129861663|NCT03214367|467449607|FG006|Treatment Period|Protocol Violation|0|||
129861664|NCT03214367|467449608|FG007|Treatment Period|Protocol Violation|0|||
129861665|NCT03214367|467449601|FG000|Treatment Period|Withdrawal by Subject|0|||
129861666|NCT03214367|467449602|FG001|Treatment Period|Withdrawal by Subject|20|||
129861667|NCT03214367|467449603|FG002|Treatment Period|Withdrawal by Subject|23|||
129861668|NCT03214367|467449604|FG003|Treatment Period|Withdrawal by Subject|14|||
129861669|NCT03214367|467449605|FG004|Treatment Period|Withdrawal by Subject|0|||
129861670|NCT03214367|467449606|FG005|Treatment Period|Withdrawal by Subject|1|||
129861671|NCT03214367|467449607|FG006|Treatment Period|Withdrawal by Subject|1|||
129861672|NCT03214367|467449608|FG007|Treatment Period|Withdrawal by Subject|1|||
129861673|NCT03508843|467449609|FG000|Overall Study|Withdrawal by Subject|1|||
129861674|NCT03508843|467449609|FG000|Overall Study|technical difficulties|2|||
129861675|NCT03555396|467449610|FG000|Overall Study|Death|3|||
129861676|NCT03555396|467449611|FG001|Overall Study|Death|1|||
129861677|NCT03555396|467449610|FG000|Overall Study|Lost to Follow-up|0|||
129861678|NCT03555396|467449611|FG001|Overall Study|Lost to Follow-up|2|||
129861679|NCT01816594|467449621|FG000|Overall Study|Local Progress|0|||
129861680|NCT01816594|467449622|FG001|Overall Study|Local Progress|2|||
129861681|NCT01816594|467449621|FG000|Overall Study|Adverse Event|9|||
129861682|NCT01816594|467449622|FG001|Overall Study|Adverse Event|0|||
129861683|NCT01816594|467449621|FG000|Overall Study|Withdrawal by Subject|1|||
129861684|NCT01816594|467449622|FG001|Overall Study|Withdrawal by Subject|0|||
129861685|NCT01816594|467449621|FG000|Overall Study|Physician Decision|1|||
129861686|NCT01816594|467449622|FG001|Overall Study|Physician Decision|0|||
129861687|NCT03905655|467449623|FG000|Overall Study|Adverse Event|1|||
129861688|NCT03905655|467449624|FG001|Overall Study|Adverse Event|0|||
129861689|NCT03905655|467449625|FG002|Overall Study|Adverse Event|1|||
129861690|NCT03905655|467449626|FG003|Overall Study|Adverse Event|1|||
129861691|NCT02566031|467449627|FG000|Overall Study|Patient/guardian decision|14|||
129861692|NCT02566031|467449628|FG001|Overall Study|Patient/guardian decision|7|||
129861693|NCT02566031|467449627|FG000|Overall Study|Protocol deviation|2|||
129861694|NCT02566031|467449628|FG001|Overall Study|Protocol deviation|3|||
129861695|NCT02566031|467449627|FG000|Overall Study|Adverse Event|3|||
129861696|NCT02566031|467449628|FG001|Overall Study|Adverse Event|1|||
129861697|NCT02566031|467449627|FG000|Overall Study|Lost to Follow-up|1|||
129861698|NCT02566031|467449628|FG001|Overall Study|Lost to Follow-up|1|||
129861699|NCT00413153|467449629|FG000|Overall Study|Withdrawal by Subject|1|||
129861700|NCT00413153|467449630|FG001|Overall Study|Withdrawal by Subject|1|||
129861701|NCT00413153|467449629|FG000|Overall Study|Adverse Event|1|||
129861702|NCT00413153|467449630|FG001|Overall Study|Adverse Event|0|||
129861703|NCT03204279|467449631|FG000|Overall Study|Withdrawal by Subject|0|||
129861704|NCT03204279|467449632|FG001|Overall Study|Withdrawal by Subject|1|||
129861705|NCT04969250|467449633|FG000|Overall Study|Protocol Violation|0|||
129861706|NCT04969250|467449634|FG001|Overall Study|Protocol Violation|2|||
129861707|NCT04969250|467449635|FG002|Overall Study|Protocol Violation|3|||
129861708|NCT04969250|467449636|FG003|Overall Study|Protocol Violation|8|||
129861709|NCT04969250|467449633|FG000|Overall Study|Withdrawal by Subject|0|||
129861710|NCT04969250|467449634|FG001|Overall Study|Withdrawal by Subject|1|||
129861711|NCT04969250|467449635|FG002|Overall Study|Withdrawal by Subject|0|||
129861712|NCT04969250|467449636|FG003|Overall Study|Withdrawal by Subject|0|||
129861713|NCT02278328|467449637|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
129861714|NCT02278328|467449638|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
129861715|NCT02278328|467449639|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
129861716|NCT02278328|467449637|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
129861717|NCT02278328|467449638|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
129861718|NCT02278328|467449639|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
129861719|NCT02278328|467449637|FG000|Neuropsych Screening|incomplete consent|0|||
129861720|NCT02278328|467449638|FG001|Neuropsych Screening|incomplete consent|0|||
129861721|NCT02278328|467449639|FG002|Neuropsych Screening|incomplete consent|2|||
129910901|NCT02723955|467637635|FG030|Escalation Phase|Site Closed|0|||
129910902|NCT02723955|467637636|FG031|Escalation Phase|Site Closed|0|||
129861722|NCT03834779|467449645|FG000|Overall Study|Death|1|||
129861723|NCT03834779|467449646|FG001|Overall Study|Death|2|||
129861724|NCT03834779|467449645|FG000|Overall Study|Lost to Follow-up|6|||
129861725|NCT03834779|467449646|FG001|Overall Study|Lost to Follow-up|4|||
129861726|NCT01292928|467449648|FG000|Overall Study|Death|8|||
129861727|NCT01292928|467449648|FG000|Overall Study|Withdrawal by Subject|8|||
129861728|NCT01292928|467449648|FG000|Overall Study|Lost to Follow-up|6|||
129861729|NCT01292928|467449648|FG000|Overall Study|Physician Decision|2|||
129910903|NCT02723955|467637637|FG032|Escalation Phase|Site Closed|0|||
129910904|NCT02723955|467637638|FG033|Escalation Phase|Site Closed|0|||
129910905|NCT02723955|467637639|FG034|Escalation Phase|Site Closed|0|||
129910906|NCT02723955|467637640|FG035|Escalation Phase|Site Closed|0|||
129910907|NCT02723955|467637641|FG036|Escalation Phase|Site Closed|0|||
129910908|NCT02723955|467637642|FG037|Escalation Phase|Site Closed|0|||
129910909|NCT02723955|467637643|FG038|Escalation Phase|Site Closed|0|||
129910910|NCT02723955|467637644|FG039|Escalation Phase|Site Closed|0|||
129910911|NCT02723955|467637645|FG040|Escalation Phase|Site Closed|0|||
129910912|NCT02723955|467637646|FG041|Escalation Phase|Site Closed|0|||
129910913|NCT02723955|467637647|FG042|Escalation Phase|Site Closed|0|||
129910914|NCT02723955|467637605|FG000|Expansion Phase|Death|0|||
129910915|NCT02723955|467637606|FG001|Expansion Phase|Death|0|||
129910916|NCT02723955|467637607|FG002|Expansion Phase|Death|0|||
129910917|NCT02723955|467637608|FG003|Expansion Phase|Death|0|||
129910918|NCT02723955|467637609|FG004|Expansion Phase|Death|0|||
129910919|NCT02723955|467637610|FG005|Expansion Phase|Death|0|||
129910920|NCT02723955|467637611|FG006|Expansion Phase|Death|0|||
129910921|NCT02723955|467637612|FG007|Expansion Phase|Death|0|||
129910922|NCT02723955|467637613|FG008|Expansion Phase|Death|0|||
129910923|NCT02723955|467637614|FG009|Expansion Phase|Death|25|||
129910924|NCT02723955|467637615|FG010|Expansion Phase|Death|69|||
129910925|NCT02723955|467637616|FG011|Expansion Phase|Death|48|||
129910926|NCT02723955|467637617|FG012|Expansion Phase|Death|0|||
129910927|NCT02723955|467637618|FG013|Expansion Phase|Death|0|||
129910928|NCT02723955|467637619|FG014|Expansion Phase|Death|0|||
129910929|NCT02723955|467637620|FG015|Expansion Phase|Death|0|||
129910930|NCT02723955|467637621|FG016|Expansion Phase|Death|0|||
129910931|NCT02723955|467637622|FG017|Expansion Phase|Death|0|||
129910932|NCT02723955|467637623|FG018|Expansion Phase|Death|0|||
129910933|NCT02723955|467637624|FG019|Expansion Phase|Death|0|||
129910934|NCT02723955|467637625|FG020|Expansion Phase|Death|0|||
129910935|NCT02723955|467637626|FG021|Expansion Phase|Death|0|||
129910936|NCT02723955|467637627|FG022|Expansion Phase|Death|0|||
129910937|NCT02723955|467637628|FG023|Expansion Phase|Death|0|||
129910938|NCT02723955|467637629|FG024|Expansion Phase|Death|0|||
129910939|NCT02723955|467637630|FG025|Expansion Phase|Death|0|||
129910940|NCT02723955|467637631|FG026|Expansion Phase|Death|0|||
129910941|NCT02723955|467637632|FG027|Expansion Phase|Death|0|||
129910942|NCT02723955|467637633|FG028|Expansion Phase|Death|0|||
129910943|NCT02723955|467637634|FG029|Expansion Phase|Death|12|||
129910944|NCT02723955|467637635|FG030|Expansion Phase|Death|202|||
129910945|NCT02723955|467637636|FG031|Expansion Phase|Death|31|||
129910946|NCT02723955|467637637|FG032|Expansion Phase|Death|17|||
129910947|NCT02723955|467637638|FG033|Expansion Phase|Death|2|||
129910948|NCT02723955|467637639|FG034|Expansion Phase|Death|3|||
129910949|NCT02723955|467637640|FG035|Expansion Phase|Death|3|||
129910950|NCT02723955|467637641|FG036|Expansion Phase|Death|1|||
129910951|NCT02723955|467637642|FG037|Expansion Phase|Death|0|||
129910952|NCT02723955|467637643|FG038|Expansion Phase|Death|0|||
129910953|NCT02723955|467637644|FG039|Expansion Phase|Death|0|||
129910954|NCT02723955|467637645|FG040|Expansion Phase|Death|0|||
129910955|NCT02723955|467637646|FG041|Expansion Phase|Death|0|||
129910956|NCT02723955|467637647|FG042|Expansion Phase|Death|0|||
129910957|NCT02723955|467637605|FG000|Expansion Phase|Lost to Follow-up|0|||
129910958|NCT02723955|467637606|FG001|Expansion Phase|Lost to Follow-up|0|||
129910959|NCT02723955|467637607|FG002|Expansion Phase|Lost to Follow-up|0|||
129910960|NCT02723955|467637608|FG003|Expansion Phase|Lost to Follow-up|0|||
129910961|NCT02723955|467637609|FG004|Expansion Phase|Lost to Follow-up|0|||
129910962|NCT02723955|467637610|FG005|Expansion Phase|Lost to Follow-up|0|||
129910963|NCT02723955|467637611|FG006|Expansion Phase|Lost to Follow-up|0|||
129910964|NCT02723955|467637612|FG007|Expansion Phase|Lost to Follow-up|0|||
129910965|NCT02723955|467637613|FG008|Expansion Phase|Lost to Follow-up|0|||
129910966|NCT02723955|467637614|FG009|Expansion Phase|Lost to Follow-up|0|||
129910967|NCT02723955|467637615|FG010|Expansion Phase|Lost to Follow-up|4|||
129910968|NCT02723955|467637616|FG011|Expansion Phase|Lost to Follow-up|1|||
129910969|NCT02723955|467637617|FG012|Expansion Phase|Lost to Follow-up|0|||
129910970|NCT02723955|467637618|FG013|Expansion Phase|Lost to Follow-up|0|||
129910971|NCT02723955|467637619|FG014|Expansion Phase|Lost to Follow-up|0|||
129910972|NCT02723955|467637620|FG015|Expansion Phase|Lost to Follow-up|0|||
129910973|NCT02723955|467637621|FG016|Expansion Phase|Lost to Follow-up|0|||
129910974|NCT02723955|467637622|FG017|Expansion Phase|Lost to Follow-up|0|||
129910975|NCT02723955|467637623|FG018|Expansion Phase|Lost to Follow-up|0|||
129910976|NCT02723955|467637624|FG019|Expansion Phase|Lost to Follow-up|0|||
129910977|NCT02723955|467637625|FG020|Expansion Phase|Lost to Follow-up|0|||
129910978|NCT02723955|467637626|FG021|Expansion Phase|Lost to Follow-up|0|||
129910979|NCT02723955|467637627|FG022|Expansion Phase|Lost to Follow-up|0|||
129910980|NCT02723955|467637628|FG023|Expansion Phase|Lost to Follow-up|0|||
129910981|NCT02723955|467637629|FG024|Expansion Phase|Lost to Follow-up|0|||
129910982|NCT02723955|467637630|FG025|Expansion Phase|Lost to Follow-up|0|||
129910983|NCT02723955|467637631|FG026|Expansion Phase|Lost to Follow-up|0|||
129910984|NCT02723955|467637632|FG027|Expansion Phase|Lost to Follow-up|0|||
129910985|NCT02723955|467637633|FG028|Expansion Phase|Lost to Follow-up|0|||
129910986|NCT02723955|467637634|FG029|Expansion Phase|Lost to Follow-up|1|||
129910987|NCT02723955|467637635|FG030|Expansion Phase|Lost to Follow-up|19|||
129910988|NCT02723955|467637636|FG031|Expansion Phase|Lost to Follow-up|2|||
129910989|NCT02723955|467637637|FG032|Expansion Phase|Lost to Follow-up|1|||
129910990|NCT02723955|467637638|FG033|Expansion Phase|Lost to Follow-up|0|||
129910991|NCT02723955|467637639|FG034|Expansion Phase|Lost to Follow-up|0|||
129910992|NCT02723955|467637640|FG035|Expansion Phase|Lost to Follow-up|0|||
129910993|NCT02723955|467637641|FG036|Expansion Phase|Lost to Follow-up|0|||
129910994|NCT02723955|467637642|FG037|Expansion Phase|Lost to Follow-up|0|||
129910995|NCT02723955|467637643|FG038|Expansion Phase|Lost to Follow-up|0|||
129910996|NCT02723955|467637644|FG039|Expansion Phase|Lost to Follow-up|0|||
129910997|NCT02723955|467637645|FG040|Expansion Phase|Lost to Follow-up|0|||
129910998|NCT02723955|467637646|FG041|Expansion Phase|Lost to Follow-up|0|||
129910999|NCT02723955|467637647|FG042|Expansion Phase|Lost to Follow-up|0|||
129911000|NCT02723955|467637605|FG000|Expansion Phase|Physician Decision|0|||
129911001|NCT02723955|467637606|FG001|Expansion Phase|Physician Decision|0|||
129911002|NCT02723955|467637607|FG002|Expansion Phase|Physician Decision|0|||
129911003|NCT02723955|467637608|FG003|Expansion Phase|Physician Decision|0|||
129911004|NCT02723955|467637609|FG004|Expansion Phase|Physician Decision|0|||
129911005|NCT02723955|467637610|FG005|Expansion Phase|Physician Decision|0|||
129911006|NCT02723955|467637611|FG006|Expansion Phase|Physician Decision|0|||
129911007|NCT02723955|467637612|FG007|Expansion Phase|Physician Decision|0|||
129911008|NCT02723955|467637613|FG008|Expansion Phase|Physician Decision|0|||
129911009|NCT02723955|467637614|FG009|Expansion Phase|Physician Decision|0|||
129911010|NCT02723955|467637615|FG010|Expansion Phase|Physician Decision|0|||
129911011|NCT02723955|467637616|FG011|Expansion Phase|Physician Decision|0|||
129911012|NCT02723955|467637617|FG012|Expansion Phase|Physician Decision|0|||
129911013|NCT02723955|467637618|FG013|Expansion Phase|Physician Decision|0|||
129911014|NCT02723955|467637619|FG014|Expansion Phase|Physician Decision|0|||
129911015|NCT02723955|467637620|FG015|Expansion Phase|Physician Decision|0|||
129911016|NCT02723955|467637621|FG016|Expansion Phase|Physician Decision|0|||
129911017|NCT02723955|467637622|FG017|Expansion Phase|Physician Decision|0|||
129911018|NCT02723955|467637623|FG018|Expansion Phase|Physician Decision|0|||
129911019|NCT02723955|467637624|FG019|Expansion Phase|Physician Decision|0|||
129911020|NCT02723955|467637625|FG020|Expansion Phase|Physician Decision|0|||
129911021|NCT02723955|467637626|FG021|Expansion Phase|Physician Decision|0|||
129911022|NCT02723955|467637627|FG022|Expansion Phase|Physician Decision|0|||
129911023|NCT02723955|467637628|FG023|Expansion Phase|Physician Decision|0|||
129911024|NCT02723955|467637629|FG024|Expansion Phase|Physician Decision|0|||
129911025|NCT02723955|467637630|FG025|Expansion Phase|Physician Decision|0|||
129911026|NCT02723955|467637631|FG026|Expansion Phase|Physician Decision|0|||
129911027|NCT02723955|467637632|FG027|Expansion Phase|Physician Decision|0|||
129911028|NCT02723955|467637633|FG028|Expansion Phase|Physician Decision|0|||
129911029|NCT02723955|467637634|FG029|Expansion Phase|Physician Decision|0|||
129911030|NCT02723955|467637635|FG030|Expansion Phase|Physician Decision|1|||
129911031|NCT02723955|467637636|FG031|Expansion Phase|Physician Decision|1|||
129911032|NCT02723955|467637637|FG032|Expansion Phase|Physician Decision|0|||
129911033|NCT02723955|467637638|FG033|Expansion Phase|Physician Decision|0|||
129911034|NCT02723955|467637639|FG034|Expansion Phase|Physician Decision|0|||
129911035|NCT02723955|467637640|FG035|Expansion Phase|Physician Decision|0|||
129911036|NCT02723955|467637641|FG036|Expansion Phase|Physician Decision|0|||
129911037|NCT02723955|467637642|FG037|Expansion Phase|Physician Decision|0|||
129911038|NCT02723955|467637643|FG038|Expansion Phase|Physician Decision|0|||
129911039|NCT02723955|467637644|FG039|Expansion Phase|Physician Decision|0|||
129911040|NCT02723955|467637645|FG040|Expansion Phase|Physician Decision|0|||
129911041|NCT02723955|467637646|FG041|Expansion Phase|Physician Decision|0|||
129911042|NCT02723955|467637647|FG042|Expansion Phase|Physician Decision|0|||
129911043|NCT02723955|467637605|FG000|Expansion Phase|Withdrawal by Subject|0|||
129911044|NCT02723955|467637606|FG001|Expansion Phase|Withdrawal by Subject|0|||
129911045|NCT02723955|467637607|FG002|Expansion Phase|Withdrawal by Subject|0|||
129911046|NCT02723955|467637608|FG003|Expansion Phase|Withdrawal by Subject|0|||
129911047|NCT02723955|467637609|FG004|Expansion Phase|Withdrawal by Subject|0|||
129911048|NCT02723955|467637610|FG005|Expansion Phase|Withdrawal by Subject|0|||
129911049|NCT02723955|467637611|FG006|Expansion Phase|Withdrawal by Subject|0|||
129911050|NCT02723955|467637612|FG007|Expansion Phase|Withdrawal by Subject|0|||
129911051|NCT02723955|467637613|FG008|Expansion Phase|Withdrawal by Subject|0|||
129911052|NCT02723955|467637614|FG009|Expansion Phase|Withdrawal by Subject|2|||
129911053|NCT02723955|467637615|FG010|Expansion Phase|Withdrawal by Subject|1|||
129911054|NCT02723955|467637616|FG011|Expansion Phase|Withdrawal by Subject|0|||
129911055|NCT02723955|467637617|FG012|Expansion Phase|Withdrawal by Subject|0|||
129911056|NCT02723955|467637618|FG013|Expansion Phase|Withdrawal by Subject|0|||
129911057|NCT02723955|467637619|FG014|Expansion Phase|Withdrawal by Subject|0|||
129449709|NCT00233363|465945664|FG000|Overall Study|Adverse Event|1|||
129449710|NCT00233363|465945665|FG001|Overall Study|Adverse Event|2|||
129911058|NCT02723955|467637620|FG015|Expansion Phase|Withdrawal by Subject|0|||
129911059|NCT02723955|467637621|FG016|Expansion Phase|Withdrawal by Subject|0|||
129861730|NCT00130533|467449653|FG000|Overall Study|Withdrawal by Subject|33|||
129861731|NCT00130533|467449654|FG001|Overall Study|Withdrawal by Subject|6|||
129861732|NCT00130533|467449653|FG000|Overall Study|Adverse Event|34|||
129861733|NCT00130533|467449654|FG001|Overall Study|Adverse Event|1|||
129861734|NCT00130533|467449653|FG000|Overall Study|Disease relapse|9|||
129911060|NCT02723955|467637622|FG017|Expansion Phase|Withdrawal by Subject|0|||
129911061|NCT02723955|467637623|FG018|Expansion Phase|Withdrawal by Subject|0|||
129861735|NCT00130533|467449654|FG001|Overall Study|Disease relapse|13|||
129861736|NCT00130533|467449653|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
129861737|NCT00130533|467449654|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
129861738|NCT00130533|467449653|FG000|Overall Study|Death|4|||
129861739|NCT00130533|467449654|FG001|Overall Study|Death|2|||
129861740|NCT00130533|467449653|FG000|Overall Study|Protocol Violation|5|||
129861741|NCT00130533|467449654|FG001|Overall Study|Protocol Violation|1|||
129861742|NCT00130533|467449653|FG000|Overall Study|Lost to Follow-up|1|||
129861743|NCT00130533|467449654|FG001|Overall Study|Lost to Follow-up|1|||
129861744|NCT00130533|467449653|FG000|Overall Study|Sponsor´s decision|2|||
129861745|NCT00130533|467449654|FG001|Overall Study|Sponsor´s decision|0|||
129861746|NCT00130533|467449653|FG000|Overall Study|Second Primary Malignancy|0|||
129861747|NCT00130533|467449654|FG001|Overall Study|Second Primary Malignancy|1|||
129911062|NCT02723955|467637624|FG019|Expansion Phase|Withdrawal by Subject|0|||
129911063|NCT02723955|467637625|FG020|Expansion Phase|Withdrawal by Subject|0|||
129911064|NCT02723955|467637626|FG021|Expansion Phase|Withdrawal by Subject|0|||
129911065|NCT02723955|467637627|FG022|Expansion Phase|Withdrawal by Subject|0|||
129911066|NCT02723955|467637628|FG023|Expansion Phase|Withdrawal by Subject|0|||
129911067|NCT02723955|467637629|FG024|Expansion Phase|Withdrawal by Subject|0|||
129911068|NCT02723955|467637630|FG025|Expansion Phase|Withdrawal by Subject|0|||
129911069|NCT02723955|467637631|FG026|Expansion Phase|Withdrawal by Subject|0|||
129911070|NCT02723955|467637632|FG027|Expansion Phase|Withdrawal by Subject|0|||
129911071|NCT02723955|467637633|FG028|Expansion Phase|Withdrawal by Subject|0|||
129911072|NCT02723955|467637634|FG029|Expansion Phase|Withdrawal by Subject|0|||
129911073|NCT02723955|467637635|FG030|Expansion Phase|Withdrawal by Subject|8|||
129911074|NCT02723955|467637636|FG031|Expansion Phase|Withdrawal by Subject|4|||
129911075|NCT02723955|467637637|FG032|Expansion Phase|Withdrawal by Subject|0|||
129911076|NCT02723955|467637638|FG033|Expansion Phase|Withdrawal by Subject|0|||
129911077|NCT02723955|467637639|FG034|Expansion Phase|Withdrawal by Subject|0|||
129911078|NCT02723955|467637640|FG035|Expansion Phase|Withdrawal by Subject|1|||
129911079|NCT02723955|467637641|FG036|Expansion Phase|Withdrawal by Subject|0|||
129911080|NCT02723955|467637642|FG037|Expansion Phase|Withdrawal by Subject|0|||
129911081|NCT02723955|467637643|FG038|Expansion Phase|Withdrawal by Subject|0|||
129861748|NCT00130533|467449653|FG000|Overall Study|Other|12|||
129861749|NCT00130533|467449654|FG001|Overall Study|Other|5|||
129861750|NCT01059565|467449655|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
129861751|NCT01059565|467449656|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
129861752|NCT01059565|467449655|FG000|24-Week Randomized Phase|Adverse Event|5|||
129861753|NCT01059565|467449656|FG001|24-Week Randomized Phase|Adverse Event|0|||
129861754|NCT01059565|467449655|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
129861755|NCT01059565|467449656|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
129861756|NCT01059565|467449655|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
129861757|NCT01059565|467449656|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
129861758|NCT01059565|467449655|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
129861759|NCT01059565|467449656|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
129861760|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Adverse Event|2|||
129861761|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Adverse Event|0|||
129861762|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
129861763|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
129861764|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
129861765|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
129861766|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
129861767|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
129911082|NCT02723955|467637644|FG039|Expansion Phase|Withdrawal by Subject|0|||
129911083|NCT02723955|467637645|FG040|Expansion Phase|Withdrawal by Subject|0|||
129861768|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
129861769|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
129861770|NCT01059565|467449655|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
129861771|NCT01059565|467449656|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
129861772|NCT03263429|467449661|FG000|Overall Study|Withdrawal by Subject|0|||
129861773|NCT03263429|467449662|FG001|Overall Study|Withdrawal by Subject|1|||
129861774|NCT03263429|467449663|FG002|Overall Study|Withdrawal by Subject|0|||
129861775|NCT03263429|467449661|FG000|Overall Study|Follow-Up Period Completed|0|||
129861776|NCT03263429|467449662|FG001|Overall Study|Follow-Up Period Completed|2|||
129861777|NCT03263429|467449663|FG002|Overall Study|Follow-Up Period Completed|0|||
129861778|NCT03263429|467449661|FG000|Overall Study|Death|3|||
129861779|NCT03263429|467449662|FG001|Overall Study|Death|5|||
129861780|NCT03263429|467449663|FG002|Overall Study|Death|16|||
129861781|NCT03263429|467449661|FG000|Overall Study|Participant unable to return|0|||
129861782|NCT03263429|467449662|FG001|Overall Study|Participant unable to return|0|||
129861783|NCT03263429|467449663|FG002|Overall Study|Participant unable to return|1|||
129861784|NCT03263429|467449661|FG000|Overall Study|Study Closed|0|||
129861785|NCT03263429|467449662|FG001|Overall Study|Study Closed|0|||
129861786|NCT03263429|467449663|FG002|Overall Study|Study Closed|1|||
129861787|NCT01605617|467449664|FG000|First Intervention|Adverse Event|0|||
129861788|NCT01605617|467449665|FG001|First Intervention|Adverse Event|1|||
129861789|NCT01605617|467449664|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
129861790|NCT01605617|467449665|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
129861791|NCT03638141|467449666|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
129861792|NCT02513563|467449670|FG000|Overall Study|Death|4|||
129861793|NCT02513563|467449670|FG000|Overall Study|Withdrawal by Subject|4|||
129861794|NCT02513563|467449670|FG000|Overall Study|Physician Decision|1|||
129861795|NCT01556438|467449673|FG000|Overall Study|Adverse Event|4|||
129861796|NCT01556438|467449674|FG001|Overall Study|Adverse Event|2|||
129861797|NCT01556438|467449673|FG000|Overall Study|Sponsor Decision|0|||
129861798|NCT01556438|467449674|FG001|Overall Study|Sponsor Decision|2|||
129861799|NCT01556438|467449673|FG000|Overall Study|Progressive Disease|0|||
129861800|NCT01556438|467449674|FG001|Overall Study|Progressive Disease|6|||
129861801|NCT01556438|467449673|FG000|Overall Study|Death|0|||
129861802|NCT01556438|467449674|FG001|Overall Study|Death|1|||
129861803|NCT03695172|467449675|FG000|Overall Study|Withdrawal by Subject|1|||
129861804|NCT03695172|467449676|FG001|Overall Study|Withdrawal by Subject|1|||
129861805|NCT03695172|467449677|FG002|Overall Study|Withdrawal by Subject|0|||
129861806|NCT02734212|467449681|FG000|Overall Study|Lost to Follow-up|5|||
129861807|NCT02734212|467449682|FG001|Overall Study|Lost to Follow-up|10|||
129861808|NCT00688636|467449685|FG000|Overall Study|Adverse Event|2|||
129861809|NCT00688636|467449686|FG001|Overall Study|Adverse Event|1|||
129861810|NCT04053764|467449687|FG000|Overall Study|Withdrawal by Subject|6|||
129861811|NCT04053764|467449688|FG001|Overall Study|Withdrawal by Subject|2|||
129861812|NCT04053764|467449687|FG000|Overall Study|Physician Decision|2|||
129861813|NCT04053764|467449688|FG001|Overall Study|Physician Decision|1|||
129861814|NCT04053764|467449687|FG000|Overall Study|Adverse Event|1|||
129861815|NCT04053764|467449688|FG001|Overall Study|Adverse Event|0|||
129861816|NCT04053764|467449687|FG000|Overall Study|Pregnancy|1|||
129861817|NCT04053764|467449688|FG001|Overall Study|Pregnancy|0|||
129861818|NCT02384954|467449692|FG000|Phase 1|Progressive Disease|2|||
129861819|NCT02384954|467449693|FG001|Phase 1|Progressive Disease|0|||
129861820|NCT02384954|467449694|FG002|Phase 1|Progressive Disease|1|||
129861821|NCT02384954|467449695|FG003|Phase 1|Progressive Disease|1|||
129861822|NCT02384954|467449696|FG004|Phase 1|Progressive Disease|0|||
129861823|NCT02384954|467449697|FG005|Phase 1|Progressive Disease|0|||
129861824|NCT02384954|467449698|FG006|Phase 1|Progressive Disease|0|||
129861825|NCT02384954|467449699|FG007|Phase 1|Progressive Disease|0|||
129861826|NCT02384954|467449700|FG008|Phase 1|Progressive Disease|0|||
129861827|NCT02384954|467449692|FG000|Phase 1|Adverse Event|0|||
129861828|NCT02384954|467449693|FG001|Phase 1|Adverse Event|0|||
129861829|NCT02384954|467449694|FG002|Phase 1|Adverse Event|1|||
129861830|NCT02384954|467449695|FG003|Phase 1|Adverse Event|0|||
129911084|NCT02723955|467637646|FG041|Expansion Phase|Withdrawal by Subject|0|||
129911085|NCT02723955|467637647|FG042|Expansion Phase|Withdrawal by Subject|0|||
129861831|NCT02384954|467449696|FG004|Phase 1|Adverse Event|0|||
129861832|NCT02384954|467449697|FG005|Phase 1|Adverse Event|0|||
129861833|NCT02384954|467449698|FG006|Phase 1|Adverse Event|0|||
129861834|NCT02384954|467449699|FG007|Phase 1|Adverse Event|0|||
129861835|NCT02384954|467449700|FG008|Phase 1|Adverse Event|0|||
129861836|NCT02384954|467449692|FG000|Phase 2|Progressive Disease|0|||
129861837|NCT02384954|467449693|FG001|Phase 2|Progressive Disease|0|||
129861838|NCT02384954|467449694|FG002|Phase 2|Progressive Disease|0|||
129861839|NCT02384954|467449695|FG003|Phase 2|Progressive Disease|0|||
129861840|NCT02384954|467449696|FG004|Phase 2|Progressive Disease|0|||
129979689|NCT03752970|467889436|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
129861841|NCT02384954|467449697|FG005|Phase 2|Progressive Disease|0|||
129861842|NCT02384954|467449698|FG006|Phase 2|Progressive Disease|0|||
129861843|NCT02384954|467449699|FG007|Phase 2|Progressive Disease|1|||
129861844|NCT02384954|467449700|FG008|Phase 2|Progressive Disease|2|||
129911086|NCT02723955|467637605|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911087|NCT02723955|467637606|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911088|NCT02723955|467637607|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911089|NCT02723955|467637608|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911090|NCT02723955|467637609|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911091|NCT02723955|467637610|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911092|NCT02723955|467637611|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911093|NCT02723955|467637612|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911094|NCT02723955|467637613|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911095|NCT02723955|467637614|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
129911096|NCT02723955|467637615|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
129911097|NCT02723955|467637616|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
129911098|NCT02723955|467637617|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911099|NCT02723955|467637618|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911100|NCT02723955|467637619|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911101|NCT02723955|467637620|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911102|NCT02723955|467637621|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911103|NCT02723955|467637622|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911104|NCT02723955|467637623|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911105|NCT02723955|467637624|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911106|NCT02723955|467637625|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911107|NCT02723955|467637626|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911108|NCT02723955|467637627|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911109|NCT02723955|467637628|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911110|NCT02723955|467637629|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911111|NCT02723955|467637630|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911112|NCT02723955|467637631|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911113|NCT02723955|467637632|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911114|NCT02723955|467637633|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911115|NCT02723955|467637634|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911116|NCT02723955|467637635|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
129911117|NCT02723955|467637636|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911118|NCT02723955|467637637|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911119|NCT02723955|467637638|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911120|NCT02723955|467637639|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911121|NCT02723955|467637640|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911122|NCT02723955|467637641|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911123|NCT02723955|467637642|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911124|NCT02723955|467637643|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911125|NCT02723955|467637644|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911126|NCT02723955|467637645|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911127|NCT02723955|467637646|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911128|NCT02723955|467637647|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
129911129|NCT02723955|467637605|FG000|Expansion Phase|Site Closed|0|||
129911130|NCT02723955|467637606|FG001|Expansion Phase|Site Closed|0|||
129911131|NCT02723955|467637607|FG002|Expansion Phase|Site Closed|0|||
129911132|NCT02723955|467637608|FG003|Expansion Phase|Site Closed|0|||
129911133|NCT02723955|467637609|FG004|Expansion Phase|Site Closed|0|||
129911134|NCT02723955|467637610|FG005|Expansion Phase|Site Closed|0|||
129911135|NCT02723955|467637611|FG006|Expansion Phase|Site Closed|0|||
129911136|NCT02723955|467637612|FG007|Expansion Phase|Site Closed|0|||
129911137|NCT02723955|467637613|FG008|Expansion Phase|Site Closed|0|||
129911138|NCT02723955|467637614|FG009|Expansion Phase|Site Closed|1|||
129911139|NCT02723955|467637615|FG010|Expansion Phase|Site Closed|2|||
129911140|NCT02723955|467637616|FG011|Expansion Phase|Site Closed|6|||
129911141|NCT02723955|467637617|FG012|Expansion Phase|Site Closed|0|||
129911142|NCT02723955|467637618|FG013|Expansion Phase|Site Closed|0|||
129861845|NCT02384954|467449692|FG000|Phase 2|Adverse Event|0|||
129861846|NCT02384954|467449693|FG001|Phase 2|Adverse Event|0|||
129861847|NCT02384954|467449694|FG002|Phase 2|Adverse Event|0|||
129861848|NCT02384954|467449695|FG003|Phase 2|Adverse Event|0|||
129861849|NCT02384954|467449696|FG004|Phase 2|Adverse Event|0|||
129861850|NCT02384954|467449697|FG005|Phase 2|Adverse Event|0|||
129861851|NCT02384954|467449698|FG006|Phase 2|Adverse Event|0|||
129861852|NCT02384954|467449699|FG007|Phase 2|Adverse Event|1|||
129861853|NCT02384954|467449700|FG008|Phase 2|Adverse Event|1|||
129861854|NCT02384954|467449692|FG000|Phase 2|Failure to meet continuation criteria|0|||
129861855|NCT02384954|467449693|FG001|Phase 2|Failure to meet continuation criteria|0|||
129861856|NCT02384954|467449694|FG002|Phase 2|Failure to meet continuation criteria|0|||
129861857|NCT02384954|467449695|FG003|Phase 2|Failure to meet continuation criteria|0|||
129861858|NCT02384954|467449696|FG004|Phase 2|Failure to meet continuation criteria|0|||
129861859|NCT02384954|467449697|FG005|Phase 2|Failure to meet continuation criteria|0|||
129861860|NCT02384954|467449698|FG006|Phase 2|Failure to meet continuation criteria|0|||
129861861|NCT02384954|467449699|FG007|Phase 2|Failure to meet continuation criteria|1|||
129861862|NCT02384954|467449700|FG008|Phase 2|Failure to meet continuation criteria|0|||
129861863|NCT01910129|467449705|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
129861864|NCT01910129|467449706|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
129861865|NCT01910129|467449707|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
129861866|NCT01910129|467449705|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
129861867|NCT01910129|467449706|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
129861868|NCT01910129|467449707|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
129861869|NCT03150056|467449708|FG000|Overall Study|Withdrawal by Subject|0|||
129861870|NCT03150056|467449709|FG001|Overall Study|Withdrawal by Subject|0|||
129861871|NCT03150056|467449710|FG002|Overall Study|Withdrawal by Subject|0|||
129861872|NCT03150056|467449711|FG003|Overall Study|Withdrawal by Subject|0|||
129861873|NCT03150056|467449712|FG004|Overall Study|Withdrawal by Subject|0|||
129861874|NCT03150056|467449713|FG005|Overall Study|Withdrawal by Subject|2|||
129861875|NCT03150056|467449708|FG000|Overall Study|Study terminated by Sponsor|1|||
129861876|NCT03150056|467449709|FG001|Overall Study|Study terminated by Sponsor|3|||
129861877|NCT03150056|467449710|FG002|Overall Study|Study terminated by Sponsor|1|||
129861878|NCT03150056|467449711|FG003|Overall Study|Study terminated by Sponsor|1|||
129861879|NCT03150056|467449712|FG004|Overall Study|Study terminated by Sponsor|5|||
129861880|NCT03150056|467449713|FG005|Overall Study|Study terminated by Sponsor|6|||
129861881|NCT03150056|467449708|FG000|Overall Study|Death|9|||
129861882|NCT03150056|467449709|FG001|Overall Study|Death|2|||
129861883|NCT03150056|467449710|FG002|Overall Study|Death|2|||
129861884|NCT03150056|467449711|FG003|Overall Study|Death|7|||
129861885|NCT03150056|467449712|FG004|Overall Study|Death|8|||
129861886|NCT03150056|467449713|FG005|Overall Study|Death|10|||
129861887|NCT01581281|467449714|FG000|Overall Study|Early Study Closure|15|||
129861888|NCT01581281|467449715|FG001|Overall Study|Early Study Closure|6|||
129861889|NCT01581281|467449716|FG002|Overall Study|Early Study Closure|12|||
129861890|NCT04370054|467449719|FG000|Treatment Phase|Lost to Follow-up|1|||
129861891|NCT04370054|467449719|FG000|Treatment Phase|Withdrawal by Subject|1|||
129861892|NCT04370054|467449719|FG000|Follow-Up Phase|Ongoing|75|||
129861893|NCT00722761|467449720|FG000|Overall Study|Lost to Follow-up|1|||
129861894|NCT00722761|467449721|FG001|Overall Study|Lost to Follow-up|4|||
129861895|NCT00722761|467449720|FG000|Overall Study|Withdrawal by Subject|5|||
129861896|NCT00722761|467449721|FG001|Overall Study|Withdrawal by Subject|2|||
129861897|NCT06273774|467449723|FG000|Overall Study|Participant was out of state.|0|||
129861898|NCT06273774|467449724|FG001|Overall Study|Participant was out of state.|0|||
129861899|NCT06273774|467449725|FG002|Overall Study|Participant was out of state.|0|||
129861900|NCT06273774|467449726|FG003|Overall Study|Participant was out of state.|0|||
129861901|NCT06273774|467449727|FG004|Overall Study|Participant was out of state.|0|||
129861902|NCT06273774|467449728|FG005|Overall Study|Participant was out of state.|1|||
129861903|NCT06273774|467449723|FG000|Overall Study|Lost to Follow-up|0|||
129861904|NCT06273774|467449724|FG001|Overall Study|Lost to Follow-up|0|||
129861905|NCT06273774|467449725|FG002|Overall Study|Lost to Follow-up|0|||
129861906|NCT06273774|467449726|FG003|Overall Study|Lost to Follow-up|0|||
129861907|NCT06273774|467449727|FG004|Overall Study|Lost to Follow-up|1|||
129861908|NCT06273774|467449728|FG005|Overall Study|Lost to Follow-up|0|||
129861909|NCT05819749|467449733|FG000|Overall Study|Lost to Follow-up|1|||
129861910|NCT00924287|467452156|FG000|Overall Study|Death|1|||
129861911|NCT01625897|467452157|FG000|Overall Study|Adverse Event|27|||
129861912|NCT01625897|467452158|FG001|Overall Study|Adverse Event|10|||
129861913|NCT01625897|467452157|FG000|Overall Study|Physician Decision|0|||
129861914|NCT01625897|467452158|FG001|Overall Study|Physician Decision|1|||
129861915|NCT01625897|467452157|FG000|Overall Study|Withdrawal by Subject|25|||
129861916|NCT01625897|467452158|FG001|Overall Study|Withdrawal by Subject|3|||
129861917|NCT01912612|467452161|FG000|Overall Study|Adverse Event|4|||
129861918|NCT01912612|467452162|FG001|Overall Study|Adverse Event|0|||
129861919|NCT01912612|467452163|FG002|Overall Study|Adverse Event|0|||
129861920|NCT01912612|467452161|FG000|Overall Study|Withdrew consent|1|||
129861921|NCT01912612|467452162|FG001|Overall Study|Withdrew consent|0|||
129861922|NCT01912612|467452163|FG002|Overall Study|Withdrew consent|0|||
129911143|NCT02723955|467637619|FG014|Expansion Phase|Site Closed|0|||
129911144|NCT02723955|467637620|FG015|Expansion Phase|Site Closed|0|||
129911145|NCT02723955|467637621|FG016|Expansion Phase|Site Closed|0|||
129861923|NCT01912612|467452161|FG000|Overall Study|Study design change|0|||
129861924|NCT01912612|467452162|FG001|Overall Study|Study design change|0|||
129861925|NCT01912612|467452163|FG002|Overall Study|Study design change|3|||
129861926|NCT02008890|467452165|FG000|Period 1|Withdrawal by Subject|7|||
129861927|NCT02008890|467452166|FG001|Period 1|Withdrawal by Subject|7|||
129861928|NCT02008890|467452167|FG002|Period 1|Withdrawal by Subject|5|||
129861929|NCT02008890|467452168|FG003|Period 1|Withdrawal by Subject|0|||
129861930|NCT02008890|467452169|FG004|Period 1|Withdrawal by Subject|0|||
129861931|NCT02008890|467452165|FG000|Period 1|Pregnancy|1|||
129861932|NCT02008890|467452166|FG001|Period 1|Pregnancy|0|||
129861933|NCT02008890|467452167|FG002|Period 1|Pregnancy|0|||
129861934|NCT02008890|467452168|FG003|Period 1|Pregnancy|0|||
129861935|NCT02008890|467452169|FG004|Period 1|Pregnancy|0|||
129861936|NCT02008890|467452165|FG000|Period 1|Physician Decision|1|||
129861937|NCT02008890|467452166|FG001|Period 1|Physician Decision|0|||
129861938|NCT02008890|467452167|FG002|Period 1|Physician Decision|1|||
129861939|NCT02008890|467452168|FG003|Period 1|Physician Decision|0|||
129861940|NCT02008890|467452169|FG004|Period 1|Physician Decision|0|||
129861941|NCT02008890|467452165|FG000|Period 1|Adverse Event|6|||
129861942|NCT02008890|467452166|FG001|Period 1|Adverse Event|8|||
129861943|NCT02008890|467452167|FG002|Period 1|Adverse Event|6|||
129861944|NCT02008890|467452168|FG003|Period 1|Adverse Event|0|||
129861945|NCT02008890|467452169|FG004|Period 1|Adverse Event|0|||
129861946|NCT02008890|467452165|FG000|Period 2|Adverse Event|12|||
129861947|NCT02008890|467452166|FG001|Period 2|Adverse Event|7|||
129861948|NCT02008890|467452167|FG002|Period 2|Adverse Event|0|||
129861949|NCT02008890|467452168|FG003|Period 2|Adverse Event|5|||
129861950|NCT02008890|467452169|FG004|Period 2|Adverse Event|5|||
129861951|NCT02008890|467452165|FG000|Period 2|Withdrawal by Subject|11|||
129861952|NCT02008890|467452166|FG001|Period 2|Withdrawal by Subject|8|||
129861953|NCT02008890|467452167|FG002|Period 2|Withdrawal by Subject|0|||
129861954|NCT02008890|467452168|FG003|Period 2|Withdrawal by Subject|7|||
129861955|NCT02008890|467452169|FG004|Period 2|Withdrawal by Subject|2|||
129861956|NCT02008890|467452165|FG000|Period 2|Physician Decision|4|||
129861957|NCT02008890|467452166|FG001|Period 2|Physician Decision|0|||
129861958|NCT02008890|467452167|FG002|Period 2|Physician Decision|0|||
129861959|NCT02008890|467452168|FG003|Period 2|Physician Decision|2|||
129861960|NCT02008890|467452169|FG004|Period 2|Physician Decision|1|||
129861961|NCT02008890|467452165|FG000|Period 2|Lost to Follow-up|0|||
129861962|NCT02008890|467452166|FG001|Period 2|Lost to Follow-up|0|||
129861963|NCT02008890|467452167|FG002|Period 2|Lost to Follow-up|1|||
129861964|NCT02008890|467452168|FG003|Period 2|Lost to Follow-up|0|||
129861965|NCT02008890|467452169|FG004|Period 2|Lost to Follow-up|0|||
129861966|NCT02008890|467452165|FG000|Extension Period|Withdrawal by Subject|3|||
129861967|NCT02008890|467452166|FG001|Extension Period|Withdrawal by Subject|2|||
129861968|NCT02008890|467452167|FG002|Extension Period|Withdrawal by Subject|0|||
129861969|NCT02008890|467452168|FG003|Extension Period|Withdrawal by Subject|4|||
129861970|NCT02008890|467452169|FG004|Extension Period|Withdrawal by Subject|2|||
129861971|NCT02008890|467452165|FG000|Extension Period|Lost to Follow-up|1|||
129861972|NCT02008890|467452166|FG001|Extension Period|Lost to Follow-up|0|||
129861973|NCT02008890|467452167|FG002|Extension Period|Lost to Follow-up|0|||
129861974|NCT02008890|467452168|FG003|Extension Period|Lost to Follow-up|0|||
129861975|NCT02008890|467452169|FG004|Extension Period|Lost to Follow-up|0|||
129861976|NCT02008890|467452165|FG000|Extension Period|Adverse Event|1|||
129861977|NCT02008890|467452166|FG001|Extension Period|Adverse Event|3|||
129861978|NCT02008890|467452167|FG002|Extension Period|Adverse Event|0|||
129911146|NCT02723955|467637622|FG017|Expansion Phase|Site Closed|0|||
129911147|NCT02723955|467637623|FG018|Expansion Phase|Site Closed|0|||
129911148|NCT02723955|467637624|FG019|Expansion Phase|Site Closed|0|||
129449711|NCT00233363|465945664|FG000|Overall Study|Lack of Efficacy|0|||
129449712|NCT00233363|465945665|FG001|Overall Study|Lack of Efficacy|2|||
129449713|NCT00233363|465945664|FG000|Overall Study|Withdrawal by Subject|1|||
129861979|NCT02008890|467452168|FG003|Extension Period|Adverse Event|0|||
129861980|NCT02008890|467452169|FG004|Extension Period|Adverse Event|2|||
129861981|NCT02207816|467452170|FG000|Overall Study|Serious Adverse Event|0|||
129861982|NCT02207816|467452171|FG001|Overall Study|Serious Adverse Event|5|||
129861983|NCT02207816|467452172|FG002|Overall Study|Serious Adverse Event|2|||
129861984|NCT02207816|467452170|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129861985|NCT02207816|467452171|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
129861986|NCT02207816|467452172|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129861987|NCT02207816|467452170|FG000|Overall Study|Withdrawal by Subject|4|||
129861988|NCT02207816|467452171|FG001|Overall Study|Withdrawal by Subject|9|||
129861989|NCT02207816|467452172|FG002|Overall Study|Withdrawal by Subject|7|||
129861990|NCT02207816|467452170|FG000|Overall Study|Migrated/Moved From Study Area|41|||
129861991|NCT02207816|467452171|FG001|Overall Study|Migrated/Moved From Study Area|60|||
129861992|NCT02207816|467452172|FG002|Overall Study|Migrated/Moved From Study Area|51|||
129911149|NCT02723955|467637625|FG020|Expansion Phase|Site Closed|0|||
129861993|NCT02207816|467452170|FG000|Overall Study|Lost to Follow-up|3|||
129861994|NCT02207816|467452171|FG001|Overall Study|Lost to Follow-up|9|||
129861995|NCT02207816|467452172|FG002|Overall Study|Lost to Follow-up|1|||
129861996|NCT02207816|467452170|FG000|Overall Study|Other|1|||
129861997|NCT02207816|467452171|FG001|Overall Study|Other|2|||
129861998|NCT02207816|467452172|FG002|Overall Study|Other|4|||
129861999|NCT00765843|467452175|FG000|Overall Study|Lost to Follow-up|1|||
129862000|NCT00765843|467452176|FG001|Overall Study|Lost to Follow-up|3|||
129862001|NCT00765843|467452177|FG002|Overall Study|Lost to Follow-up|2|||
129862002|NCT00765843|467452175|FG000|Overall Study|did not return to receive intervention|0|||
129862003|NCT00765843|467452176|FG001|Overall Study|did not return to receive intervention|1|||
129862004|NCT00765843|467452177|FG002|Overall Study|did not return to receive intervention|0|||
129862005|NCT00765843|467452175|FG000|Overall Study|Adverse Event|0|||
129862006|NCT00765843|467452176|FG001|Overall Study|Adverse Event|0|||
129862007|NCT00765843|467452177|FG002|Overall Study|Adverse Event|1|||
129862008|NCT02277106|467452178|FG000|Stage 2|Adverse Event|0|||
129862009|NCT02277106|467452179|FG001|Stage 2|Adverse Event|0|||
129862010|NCT02277106|467452180|FG002|Stage 2|Adverse Event|1|||
129862011|NCT01064739|467452181|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
129862012|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
129862013|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
129862014|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
129862015|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
129862016|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
129862017|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
129862018|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
129862019|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
129862020|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
129862021|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
129862022|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
129862023|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
129862024|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
129862025|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
129862026|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
129862027|NCT01571362|467452184|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
129862028|NCT01571362|467452185|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
129862029|NCT01571362|467452186|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
129862030|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129862031|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
129862032|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
129862033|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129862034|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
129862035|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
129862036|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129862037|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Adverse Event|9|||
129862038|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Adverse Event|14|||
129862039|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129862040|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
129862041|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
129862042|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
129862043|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
129862044|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
129862045|NCT01571362|467452184|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
129862046|NCT01571362|467452185|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
129862047|NCT01571362|467452186|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
129862048|NCT01669629|467452188|FG000|Period 1|protocol deviation|1|||
129862049|NCT01669629|467452189|FG001|Period 1|protocol deviation|2|||
129862050|NCT01221597|467452190|FG000|Overall Study|Adverse Event|4|||
129862051|NCT01221597|467452191|FG001|Overall Study|Adverse Event|1|||
129862052|NCT01221597|467452190|FG000|Overall Study|Withdrawal by Subject|20|||
129862053|NCT01221597|467452191|FG001|Overall Study|Withdrawal by Subject|6|||
129862054|NCT01221597|467452190|FG000|Overall Study|Lost to Follow-up|6|||
129862055|NCT01221597|467452191|FG001|Overall Study|Lost to Follow-up|5|||
129862056|NCT01221597|467452190|FG000|Overall Study|Protocol Violation|1|||
129862057|NCT01221597|467452191|FG001|Overall Study|Protocol Violation|0|||
129862058|NCT01221597|467452190|FG000|Overall Study|Other|3|||
129862059|NCT01221597|467452191|FG001|Overall Study|Other|4|||
129862060|NCT01221597|467452190|FG000|Overall Study|Death|2|||
129862061|NCT01221597|467452191|FG001|Overall Study|Death|0|||
129911150|NCT02723955|467637626|FG021|Expansion Phase|Site Closed|0|||
129911151|NCT02723955|467637627|FG022|Expansion Phase|Site Closed|0|||
129911152|NCT02723955|467637628|FG023|Expansion Phase|Site Closed|0|||
129911153|NCT02723955|467637629|FG024|Expansion Phase|Site Closed|0|||
129911154|NCT02723955|467637630|FG025|Expansion Phase|Site Closed|0|||
129911155|NCT02723955|467637631|FG026|Expansion Phase|Site Closed|0|||
129911156|NCT02723955|467637632|FG027|Expansion Phase|Site Closed|0|||
129911157|NCT02723955|467637633|FG028|Expansion Phase|Site Closed|0|||
129911158|NCT02723955|467637634|FG029|Expansion Phase|Site Closed|0|||
129911159|NCT02723955|467637635|FG030|Expansion Phase|Site Closed|8|||
129911160|NCT02723955|467637636|FG031|Expansion Phase|Site Closed|4|||
129911161|NCT02723955|467637637|FG032|Expansion Phase|Site Closed|2|||
129911162|NCT02723955|467637638|FG033|Expansion Phase|Site Closed|2|||
129911163|NCT02723955|467637639|FG034|Expansion Phase|Site Closed|0|||
129911164|NCT02723955|467637640|FG035|Expansion Phase|Site Closed|0|||
129911165|NCT02723955|467637641|FG036|Expansion Phase|Site Closed|0|||
129911166|NCT02723955|467637642|FG037|Expansion Phase|Site Closed|0|||
129911167|NCT02723955|467637643|FG038|Expansion Phase|Site Closed|0|||
129911168|NCT02723955|467637644|FG039|Expansion Phase|Site Closed|0|||
129911169|NCT02723955|467637645|FG040|Expansion Phase|Site Closed|0|||
129911170|NCT02723955|467637646|FG041|Expansion Phase|Site Closed|0|||
129911171|NCT02723955|467637647|FG042|Expansion Phase|Site Closed|0|||
129911172|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Death|0|||
129911173|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Death|0|||
129911174|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Death|0|||
129911175|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Death|0|||
129911176|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Death|0|||
129911177|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Death|0|||
129911178|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Death|0|||
129911179|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Death|0|||
129911180|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Death|0|||
129911181|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Death|0|||
129911182|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Death|0|||
129911183|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Death|0|||
129911184|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Death|0|||
129911185|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Death|0|||
129911186|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Death|0|||
129911187|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Death|0|||
129911188|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Death|0|||
129911189|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Death|0|||
129911190|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Death|0|||
129911191|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Death|0|||
129911192|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Death|0|||
129911193|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Death|0|||
129911194|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Death|0|||
129911195|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Death|0|||
129911196|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Death|0|||
129911197|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Death|0|||
129911198|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Death|0|||
129911199|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Death|0|||
129911200|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Death|0|||
129911201|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Death|0|||
129911202|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Death|0|||
129911203|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Death|0|||
129911204|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Death|0|||
129911205|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Death|0|||
129911206|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Death|0|||
129911207|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Death|0|||
129911208|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Death|0|||
129911209|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Death|1|||
129911210|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Death|14|||
129911211|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Death|32|||
129911212|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Death|2|||
129911213|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Death|1|||
129911214|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Death|0|||
129911215|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911216|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911217|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911218|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911219|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911220|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911221|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911222|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129449714|NCT00233363|465945665|FG001|Overall Study|Withdrawal by Subject|1|||
129911223|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911224|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911225|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911226|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911227|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129862062|NCT00121238|467452193|FG000|Overall Study|disease progression before intervention|1|||
129862063|NCT00121238|467452193|FG000|Overall Study|Protocol Violation|2|||
129862064|NCT01026974|467452202|FG000|Overall Study|Withdrawal by Subject|0|||
129862065|NCT01026974|467452203|FG001|Overall Study|Withdrawal by Subject|1|||
129862066|NCT01026974|467452204|FG002|Overall Study|Withdrawal by Subject|7|||
129862067|NCT01026974|467452205|FG003|Overall Study|Withdrawal by Subject|2|||
129862068|NCT01026974|467452202|FG000|Overall Study|Lost to Follow-up|1|||
129862069|NCT01026974|467452203|FG001|Overall Study|Lost to Follow-up|1|||
129862070|NCT01026974|467452204|FG002|Overall Study|Lost to Follow-up|4|||
129862071|NCT01026974|467452205|FG003|Overall Study|Lost to Follow-up|0|||
129862072|NCT01026974|467452202|FG000|Overall Study|Adverse Event|0|||
129862073|NCT01026974|467452203|FG001|Overall Study|Adverse Event|0|||
129862074|NCT01026974|467452204|FG002|Overall Study|Adverse Event|0|||
129862075|NCT01026974|467452205|FG003|Overall Study|Adverse Event|1|||
129862076|NCT01026974|467452202|FG000|Overall Study|Inappropriate enrollment|0|||
129862077|NCT01026974|467452203|FG001|Overall Study|Inappropriate enrollment|0|||
129862078|NCT01026974|467452204|FG002|Overall Study|Inappropriate enrollment|1|||
129862079|NCT01026974|467452205|FG003|Overall Study|Inappropriate enrollment|0|||
129862080|NCT00325468|467452207|FG000|Overall Study|Adverse Event|1|||
129862081|NCT00325468|467452208|FG001|Overall Study|Adverse Event|1|||
129862082|NCT00325468|467452209|FG002|Overall Study|Adverse Event|0|||
129862083|NCT00325468|467452210|FG003|Overall Study|Adverse Event|5|||
129862084|NCT00325468|467452211|FG004|Overall Study|Adverse Event|1|||
129862085|NCT00325468|467452207|FG000|Overall Study|Death|2|||
129862086|NCT00325468|467452208|FG001|Overall Study|Death|0|||
129862087|NCT00325468|467452209|FG002|Overall Study|Death|2|||
129862088|NCT00325468|467452210|FG003|Overall Study|Death|4|||
129862089|NCT00325468|467452211|FG004|Overall Study|Death|0|||
129862090|NCT00325468|467452207|FG000|Overall Study|Lost to Follow-up|0|||
129862091|NCT00325468|467452208|FG001|Overall Study|Lost to Follow-up|0|||
129862092|NCT00325468|467452209|FG002|Overall Study|Lost to Follow-up|1|||
129862093|NCT00325468|467452210|FG003|Overall Study|Lost to Follow-up|2|||
129862094|NCT00325468|467452211|FG004|Overall Study|Lost to Follow-up|2|||
129862095|NCT00325468|467452207|FG000|Overall Study|Physician Decision|1|||
129862096|NCT00325468|467452208|FG001|Overall Study|Physician Decision|1|||
129862097|NCT00325468|467452209|FG002|Overall Study|Physician Decision|0|||
129862098|NCT00325468|467452210|FG003|Overall Study|Physician Decision|1|||
129862099|NCT00325468|467452211|FG004|Overall Study|Physician Decision|0|||
129862100|NCT00325468|467452207|FG000|Overall Study|Withdrawal by Subject|3|||
129862101|NCT00325468|467452208|FG001|Overall Study|Withdrawal by Subject|1|||
129862102|NCT00325468|467452209|FG002|Overall Study|Withdrawal by Subject|0|||
129862103|NCT00325468|467452210|FG003|Overall Study|Withdrawal by Subject|14|||
129862104|NCT00325468|467452211|FG004|Overall Study|Withdrawal by Subject|4|||
129862105|NCT00325468|467452207|FG000|Overall Study|site closure etc|4|||
129862106|NCT00325468|467452208|FG001|Overall Study|site closure etc|2|||
129862107|NCT00325468|467452209|FG002|Overall Study|site closure etc|1|||
129862108|NCT00325468|467452210|FG003|Overall Study|site closure etc|8|||
129862109|NCT00325468|467452211|FG004|Overall Study|site closure etc|1|||
129862110|NCT03280121|467452212|FG000|Overall Study|Physician Decision|1|||
129862111|NCT03280121|467452212|FG000|Overall Study|Lost to Follow-up|1|||
129862112|NCT03280121|467452212|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
129862113|NCT01314118|467452213|FG000|Overall Study|Adverse Event|9|||
129862114|NCT01314118|467452213|FG000|Overall Study|Progressive disease|27|||
129862115|NCT01314118|467452213|FG000|Overall Study|Physician Decision|11|||
129862116|NCT01314118|467452213|FG000|Overall Study|Death|4|||
129862117|NCT01314118|467452213|FG000|Overall Study|Protocol Violation|5|||
129862118|NCT01314118|467452213|FG000|Overall Study|Withdrawal by Subject|11|||
129862119|NCT01314118|467452213|FG000|Overall Study|Other|2|||
129862120|NCT01314118|467452213|FG000|Overall Study|Ongoing|62|||
129862121|NCT05585307|467452221|FG000|Overall Study|Lost to Follow-up|0|||
129862122|NCT05585307|467452222|FG001|Overall Study|Lost to Follow-up|0|||
129862123|NCT05585307|467452223|FG002|Overall Study|Lost to Follow-up|0|||
129862124|NCT05585307|467452224|FG003|Overall Study|Lost to Follow-up|0|||
129862125|NCT05585307|467452225|FG004|Overall Study|Lost to Follow-up|0|||
129862126|NCT05585307|467452226|FG005|Overall Study|Lost to Follow-up|0|||
129862127|NCT05585307|467452227|FG006|Overall Study|Lost to Follow-up|1|||
129862128|NCT05585307|467452228|FG007|Overall Study|Lost to Follow-up|0|||
129862129|NCT04420221|467452229|FG000|Overall Study|Withdrawal by Subject|0|||
129862130|NCT04420221|467452230|FG001|Overall Study|Withdrawal by Subject|0|||
129862131|NCT04420221|467452231|FG002|Overall Study|Withdrawal by Subject|0|||
129862132|NCT04420221|467452232|FG003|Overall Study|Withdrawal by Subject|0|||
129862133|NCT04420221|467452233|FG004|Overall Study|Withdrawal by Subject|0|||
129862134|NCT04420221|467452234|FG005|Overall Study|Withdrawal by Subject|20|||
129862135|NCT04420221|467452235|FG006|Overall Study|Withdrawal by Subject|5|||
129862136|NCT04420221|467452229|FG000|Overall Study|Other|0|||
129862137|NCT04420221|467452230|FG001|Overall Study|Other|0|||
129862138|NCT04420221|467452231|FG002|Overall Study|Other|0|||
129862139|NCT04420221|467452232|FG003|Overall Study|Other|0|||
129862140|NCT04420221|467452233|FG004|Overall Study|Other|0|||
129862141|NCT04420221|467452234|FG005|Overall Study|Other|1|||
129911228|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911229|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911230|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911231|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911232|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911233|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911234|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911235|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911236|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911237|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911238|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911239|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911240|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911241|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911242|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911243|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911244|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911245|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911246|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911247|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911248|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911249|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911250|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911251|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911252|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911253|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911254|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
129911255|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911256|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911257|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
129911258|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911259|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911260|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911261|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911262|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911263|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911264|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911265|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911266|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911267|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911268|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911269|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911270|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911271|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911272|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911273|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911274|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911275|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911276|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911277|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911278|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911279|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911280|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911281|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911282|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911283|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911284|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911285|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911286|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911287|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911288|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911289|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911290|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911291|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911292|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911293|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911294|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911295|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
129449715|NCT00233363|465945664|FG000|Overall Study|Aggravation of complication|1|||
129911296|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
129911297|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
129911298|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911299|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
129911300|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
129911301|NCT02723955|467637605|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
129911302|NCT02723955|467637606|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
129911303|NCT02723955|467637607|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
129911304|NCT02723955|467637608|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
129911305|NCT02723955|467637609|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
129911306|NCT02723955|467637610|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
129911307|NCT02723955|467637611|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
129911308|NCT02723955|467637612|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
129911309|NCT02723955|467637613|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
129911310|NCT02723955|467637614|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
129911311|NCT02723955|467637615|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
129911312|NCT02723955|467637616|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
129911313|NCT02723955|467637617|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
129911314|NCT02723955|467637618|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
129911315|NCT02723955|467637619|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
129911316|NCT02723955|467637620|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
129911317|NCT02723955|467637621|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
129911318|NCT02723955|467637622|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
129911319|NCT02723955|467637623|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
129911320|NCT02723955|467637624|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
129911321|NCT02723955|467637625|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
129911322|NCT02723955|467637626|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
129911323|NCT02723955|467637627|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
129911324|NCT02723955|467637628|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
129911325|NCT02723955|467637629|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
129911326|NCT02723955|467637630|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
129911327|NCT02723955|467637631|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
129911328|NCT02723955|467637632|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
129911329|NCT02723955|467637633|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
129911330|NCT02723955|467637634|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
129911331|NCT02723955|467637635|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
129911332|NCT02723955|467637636|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
129911333|NCT02723955|467637637|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
129911334|NCT02723955|467637638|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
129911335|NCT02723955|467637639|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
129911336|NCT02723955|467637640|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
129911337|NCT02723955|467637641|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
129911338|NCT02723955|467637642|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
129911339|NCT02723955|467637643|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
129911340|NCT02723955|467637644|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
129911341|NCT02723955|467637645|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
129911342|NCT02723955|467637646|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
129911343|NCT02723955|467637647|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
129911344|NCT04999085|467637648|FG000|Overall Study|Death|1|||
129911345|NCT00402246|467637649|FG000|Overall Study|Death|62|||
129911346|NCT00402246|467637650|FG001|Overall Study|Death|58|||
129911347|NCT00402246|467637649|FG000|Overall Study|Lost to Follow-up|20|||
129911348|NCT00402246|467637650|FG001|Overall Study|Lost to Follow-up|28|||
129911349|NCT00402246|467637649|FG000|Overall Study|Withdrawal by Subject|72|||
129911350|NCT00402246|467637650|FG001|Overall Study|Withdrawal by Subject|87|||
129911351|NCT00402246|467637649|FG000|Overall Study|Physician Decision|24|||
129911352|NCT00402246|467637650|FG001|Overall Study|Physician Decision|26|||
129911353|NCT00402246|467637649|FG000|Overall Study|Protocol Violation|25|||
129911354|NCT00402246|467637650|FG001|Overall Study|Protocol Violation|24|||
129911355|NCT00402246|467637649|FG000|Overall Study|Missed Final Visit|1|||
129911356|NCT00402246|467637650|FG001|Overall Study|Missed Final Visit|2|||
129911357|NCT00402246|467637649|FG000|Overall Study|Insurance Issues|2|||
129911358|NCT00402246|467637650|FG001|Overall Study|Insurance Issues|1|||
129911359|NCT00402246|467637649|FG000|Overall Study|Heart Transplant|0|||
129911360|NCT00402246|467637650|FG001|Overall Study|Heart Transplant|1|||
129911361|NCT00402246|467637649|FG000|Overall Study|Patient's device explanted|6|||
129911362|NCT00402246|467637650|FG001|Overall Study|Patient's device explanted|2|||
129911363|NCT00402246|467637649|FG000|Overall Study|Center Closure|5|||
129911364|NCT00402246|467637650|FG001|Overall Study|Center Closure|3|||
129911365|NCT00402246|467637649|FG000|Overall Study|Deterioriating Condition|3|||
129911366|NCT00402246|467637650|FG001|Overall Study|Deterioriating Condition|2|||
129911367|NCT01266122|467637654|FG000|Overall Study|Lost to Follow-up|6|||
129911368|NCT01266122|467637655|FG001|Overall Study|Lost to Follow-up|6|||
129911369|NCT00421889|467637656|FG000|Overall Study|Adverse Event|1|||
129911370|NCT00421889|467637657|FG001|Overall Study|Adverse Event|0|||
129911371|NCT00421889|467637658|FG002|Overall Study|Adverse Event|1|||
129911372|NCT00421889|467637659|FG003|Overall Study|Adverse Event|1|||
129911373|NCT00421889|467637660|FG004|Overall Study|Adverse Event|1|||
129862142|NCT04420221|467452235|FG006|Overall Study|Other|1|||
129862143|NCT04420221|467452229|FG000|Overall Study|Lost to Follow-up|0|||
129862144|NCT04420221|467452230|FG001|Overall Study|Lost to Follow-up|0|||
129862145|NCT04420221|467452231|FG002|Overall Study|Lost to Follow-up|0|||
129862146|NCT04420221|467452232|FG003|Overall Study|Lost to Follow-up|0|||
129862147|NCT04420221|467452233|FG004|Overall Study|Lost to Follow-up|0|||
129862148|NCT04420221|467452234|FG005|Overall Study|Lost to Follow-up|3|||
129862149|NCT04420221|467452235|FG006|Overall Study|Lost to Follow-up|2|||
129862150|NCT04420221|467452229|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
129862151|NCT04420221|467452230|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
129862152|NCT04420221|467452231|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
129862153|NCT04420221|467452232|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
129862154|NCT04420221|467452233|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
129862155|NCT04420221|467452234|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
129862156|NCT04420221|467452235|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
129862157|NCT04642638|467452236|FG000|Overall Study|Withdrawal by Subject|23|||
129862158|NCT04642638|467452237|FG001|Overall Study|Withdrawal by Subject|29|||
129862159|NCT04642638|467452238|FG002|Overall Study|Withdrawal by Subject|9|||
129862160|NCT04642638|467452239|FG003|Overall Study|Withdrawal by Subject|7|||
129862161|NCT04642638|467452240|FG004|Overall Study|Withdrawal by Subject|61|||
129862162|NCT04642638|467452241|FG005|Overall Study|Withdrawal by Subject|27|||
129862163|NCT04642638|467452236|FG000|Overall Study|Lost to Follow-up|17|||
129862164|NCT04642638|467452237|FG001|Overall Study|Lost to Follow-up|18|||
129862165|NCT04642638|467452238|FG002|Overall Study|Lost to Follow-up|5|||
129862166|NCT04642638|467452239|FG003|Overall Study|Lost to Follow-up|5|||
129862167|NCT04642638|467452240|FG004|Overall Study|Lost to Follow-up|6|||
129862168|NCT04642638|467452241|FG005|Overall Study|Lost to Follow-up|3|||
129862169|NCT04642638|467452236|FG000|Overall Study|Adverse Event|0|||
129862170|NCT04642638|467452237|FG001|Overall Study|Adverse Event|0|||
129862171|NCT04642638|467452238|FG002|Overall Study|Adverse Event|1|||
129862172|NCT04642638|467452239|FG003|Overall Study|Adverse Event|0|||
129862173|NCT04642638|467452240|FG004|Overall Study|Adverse Event|10|||
129862174|NCT04642638|467452241|FG005|Overall Study|Adverse Event|3|||
129862175|NCT04642638|467452236|FG000|Overall Study|Reason Not Specified|1|||
129862176|NCT04642638|467452237|FG001|Overall Study|Reason Not Specified|4|||
129862177|NCT04642638|467452238|FG002|Overall Study|Reason Not Specified|0|||
129862178|NCT04642638|467452239|FG003|Overall Study|Reason Not Specified|0|||
129862179|NCT04642638|467452240|FG004|Overall Study|Reason Not Specified|38|||
129862180|NCT04642638|467452241|FG005|Overall Study|Reason Not Specified|16|||
129862181|NCT04642638|467452236|FG000|Overall Study|Physician Decision|0|||
129862182|NCT04642638|467452237|FG001|Overall Study|Physician Decision|0|||
129862183|NCT04642638|467452238|FG002|Overall Study|Physician Decision|0|||
129862184|NCT04642638|467452239|FG003|Overall Study|Physician Decision|0|||
129862185|NCT04642638|467452240|FG004|Overall Study|Physician Decision|2|||
129862186|NCT04642638|467452241|FG005|Overall Study|Physician Decision|1|||
129862187|NCT04642638|467452236|FG000|Overall Study|Protocol Deviation|0|||
129862188|NCT04642638|467452237|FG001|Overall Study|Protocol Deviation|0|||
129862189|NCT04642638|467452238|FG002|Overall Study|Protocol Deviation|0|||
129862190|NCT04642638|467452239|FG003|Overall Study|Protocol Deviation|0|||
129862191|NCT04642638|467452240|FG004|Overall Study|Protocol Deviation|1|||
129862192|NCT04642638|467452241|FG005|Overall Study|Protocol Deviation|3|||
129862193|NCT04642638|467452236|FG000|Overall Study|Study Terminated|0|||
129862194|NCT04642638|467452237|FG001|Overall Study|Study Terminated|0|||
129862195|NCT04642638|467452238|FG002|Overall Study|Study Terminated|0|||
129862196|NCT04642638|467452239|FG003|Overall Study|Study Terminated|0|||
129862197|NCT04642638|467452240|FG004|Overall Study|Study Terminated|484|||
129862198|NCT04642638|467452241|FG005|Overall Study|Study Terminated|250|||
129862199|NCT04642638|467452236|FG000|Overall Study|Pregnancy|0|||
129862200|NCT04642638|467452237|FG001|Overall Study|Pregnancy|0|||
129862201|NCT04642638|467452238|FG002|Overall Study|Pregnancy|0|||
129862202|NCT04642638|467452239|FG003|Overall Study|Pregnancy|0|||
129862203|NCT04642638|467452240|FG004|Overall Study|Pregnancy|1|||
129862204|NCT04642638|467452241|FG005|Overall Study|Pregnancy|0|||
129862205|NCT00990652|467452242|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
129862206|NCT00990652|467452242|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
129862207|NCT02085408|467452244|FG000|Step 1: Induction|Disease Progression|19|||
129862208|NCT02085408|467452245|FG001|Step 1: Induction|Disease Progression|19|||
129862209|NCT02085408|467452244|FG000|Step 1: Induction|Adverse Event|18|||
129862210|NCT02085408|467452245|FG001|Step 1: Induction|Adverse Event|17|||
129862211|NCT02085408|467452244|FG000|Step 1: Induction|Death|33|||
129862212|NCT02085408|467452245|FG001|Step 1: Induction|Death|30|||
129862213|NCT02085408|467452244|FG000|Step 1: Induction|Withdrawal by Subject|16|||
129862214|NCT02085408|467452245|FG001|Step 1: Induction|Withdrawal by Subject|8|||
129862215|NCT02085408|467452244|FG000|Step 1: Induction|Alternative Therapy|15|||
129862216|NCT02085408|467452245|FG001|Step 1: Induction|Alternative Therapy|19|||
129862217|NCT02085408|467452244|FG000|Step 1: Induction|Complicating Disease|2|||
129862218|NCT02085408|467452245|FG001|Step 1: Induction|Complicating Disease|3|||
129862219|NCT02085408|467452244|FG000|Step 1: Induction|Other|27|||
129862220|NCT02085408|467452245|FG001|Step 1: Induction|Other|39|||
129862221|NCT02085408|467452244|FG000|Step 1: Induction|Never started treatment|6|||
129862222|NCT02085408|467452245|FG001|Step 1: Induction|Never started treatment|4|||
129862223|NCT02085408|467452244|FG000|Step 2: Consolidation|Disease Progression|5|||
129862224|NCT02085408|467452245|FG001|Step 2: Consolidation|Disease Progression|20|||
129862225|NCT02085408|467452244|FG000|Step 2: Consolidation|Adverse Event|9|||
129862226|NCT02085408|467452245|FG001|Step 2: Consolidation|Adverse Event|8|||
129862227|NCT02085408|467452244|FG000|Step 2: Consolidation|Death|4|||
129862228|NCT02085408|467452245|FG001|Step 2: Consolidation|Death|3|||
129862229|NCT02085408|467452244|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
129862230|NCT02085408|467452245|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
129862231|NCT02085408|467452244|FG000|Step 2: Consolidation|Alternative Therapy|9|||
129862232|NCT02085408|467452245|FG001|Step 2: Consolidation|Alternative Therapy|3|||
129862233|NCT02085408|467452244|FG000|Step 2: Consolidation|Complicating Disease|0|||
129862234|NCT02085408|467452245|FG001|Step 2: Consolidation|Complicating Disease|2|||
129862235|NCT02085408|467452244|FG000|Step 2: Consolidation|Other|6|||
129862236|NCT02085408|467452245|FG001|Step 2: Consolidation|Other|6|||
129862237|NCT02085408|467452244|FG000|Step 2: Consolidation|Never started treatment|4|||
129862238|NCT02085408|467452245|FG001|Step 2: Consolidation|Never started treatment|3|||
129862239|NCT02085408|467452244|FG000|Step 3: Maintenance|Disease Progression|13|||
129862240|NCT02085408|467452245|FG001|Step 3: Maintenance|Disease Progression|11|||
129862241|NCT02085408|467452244|FG000|Step 3: Maintenance|Adverse Event|2|||
129862242|NCT02085408|467452245|FG001|Step 3: Maintenance|Adverse Event|4|||
129862243|NCT02085408|467452244|FG000|Step 3: Maintenance|Death|1|||
129862244|NCT02085408|467452245|FG001|Step 3: Maintenance|Death|2|||
129862245|NCT02085408|467452244|FG000|Step 3: Maintenance|Alternative Therapy|1|||
129862246|NCT02085408|467452245|FG001|Step 3: Maintenance|Alternative Therapy|1|||
129862247|NCT02085408|467452244|FG000|Step 3: Maintenance|Complicating Disease|0|||
129862248|NCT02085408|467452245|FG001|Step 3: Maintenance|Complicating Disease|1|||
129862249|NCT02085408|467452244|FG000|Step 3: Maintenance|Other|3|||
129862250|NCT02085408|467452245|FG001|Step 3: Maintenance|Other|2|||
129862251|NCT02085408|467452244|FG000|Step 3: Maintenance|Never started treatment|5|||
129862252|NCT02085408|467452245|FG001|Step 3: Maintenance|Never started treatment|1|||
129862253|NCT00319098|467452246|FG000|Overall Study|Serious adverse event|3|||
129862254|NCT00319098|467452247|FG001|Overall Study|Serious adverse event|0|||
129862255|NCT00319098|467452246|FG000|Overall Study|Adverse Event|20|||
129862256|NCT00319098|467452247|FG001|Overall Study|Adverse Event|1|||
129862257|NCT00319098|467452246|FG000|Overall Study|Withdrawal by Subject|37|||
129862258|NCT00319098|467452247|FG001|Overall Study|Withdrawal by Subject|8|||
129862259|NCT00319098|467452246|FG000|Overall Study|Migrated/moved from study area|2|||
129862260|NCT00319098|467452247|FG001|Overall Study|Migrated/moved from study area|1|||
129862261|NCT00319098|467452246|FG000|Overall Study|Lost to Follow-up|37|||
129862262|NCT00319098|467452247|FG001|Overall Study|Lost to Follow-up|13|||
129862263|NCT00319098|467452246|FG000|Overall Study|Others|33|||
129862264|NCT00319098|467452247|FG001|Overall Study|Others|8|||
129862265|NCT00319098|467452246|FG000|Overall Study|Protocol Violation|3|||
129862266|NCT00319098|467452247|FG001|Overall Study|Protocol Violation|1|||
129862267|NCT00965523|467452248|FG000|Study 221|Progressive Disease|4|||
129862268|NCT00965523|467452248|FG000|Study 221|Physician Decision|3|||
129862269|NCT00965523|467452248|FG000|Study 224|Progressive Disease|5|||
129862270|NCT00965523|467452248|FG000|Study 224|Physician Decision|1|||
129862271|NCT03595904|467452250|FG000|Overall Study|Protocol Violation|3|||
129862272|NCT03595904|467452251|FG001|Overall Study|Protocol Violation|1|||
129862273|NCT03595904|467452250|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
129862274|NCT03595904|467452251|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
129862275|NCT03595904|467452250|FG000|Overall Study|Insurance complications|1|||
129862276|NCT03595904|467452251|FG001|Overall Study|Insurance complications|0|||
129862277|NCT03595904|467452250|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
129862278|NCT03595904|467452251|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
129862279|NCT02187991|467452252|FG000|Overall Study|Adverse Event|13|||
129862280|NCT02187991|467452253|FG001|Overall Study|Adverse Event|14|||
129862281|NCT02187991|467452254|FG002|Overall Study|Adverse Event|3|||
129862282|NCT02187991|467452255|FG003|Overall Study|Adverse Event|2|||
129862283|NCT02187991|467452252|FG000|Overall Study|Withdrawal by Subject|9|||
129862284|NCT02187991|467452253|FG001|Overall Study|Withdrawal by Subject|6|||
129862285|NCT02187991|467452254|FG002|Overall Study|Withdrawal by Subject|3|||
129862286|NCT02187991|467452255|FG003|Overall Study|Withdrawal by Subject|2|||
129862287|NCT02187991|467452252|FG000|Overall Study|Physician Decision|4|||
129862288|NCT02187991|467452253|FG001|Overall Study|Physician Decision|4|||
129862289|NCT02187991|467452254|FG002|Overall Study|Physician Decision|0|||
129862290|NCT02187991|467452255|FG003|Overall Study|Physician Decision|2|||
129862291|NCT02187991|467452252|FG000|Overall Study|Other, unrelated complication|7|||
129862292|NCT02187991|467452253|FG001|Overall Study|Other, unrelated complication|1|||
129862293|NCT02187991|467452254|FG002|Overall Study|Other, unrelated complication|1|||
129862294|NCT02187991|467452255|FG003|Overall Study|Other, unrelated complication|2|||
129862295|NCT02187991|467452252|FG000|Overall Study|Death|1|||
129862296|NCT02187991|467452253|FG001|Overall Study|Death|3|||
129862297|NCT02187991|467452254|FG002|Overall Study|Death|0|||
129862298|NCT02187991|467452255|FG003|Overall Study|Death|0|||
129862299|NCT01392560|467452256|FG000|Overall Study|Adverse Event|2|||
129862300|NCT01392560|467452256|FG000|Overall Study|not entered|8|||
129862301|NCT01392560|467452256|FG000|Overall Study|discontinued during placebo run-in|2|||
129862302|NCT01939028|467452257|FG000|Overall Study|Withdrawal by Subject|5|||
129862303|NCT01939028|467452257|FG000|Overall Study|Physician Decision|7|||
129862304|NCT00700401|467452265|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
129862305|NCT00700401|467452265|FG000|Overall Study|Adverse Event|5|||
129862306|NCT00700401|467452265|FG000|Overall Study|Refused Treatment|2|||
129862307|NCT00700401|467452265|FG000|Overall Study|Lost to Follow-up|1|||
129862308|NCT00700401|467452265|FG000|Overall Study|Treatment never started|1|||
129862309|NCT00700401|467452265|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
129862310|NCT00700401|467452265|FG000|Overall Study|Withdrawal by Subject|2|||
129862311|NCT03273946|467452266|FG000|Overall Study|Withdrawal by Subject|5|||
129862312|NCT03273946|467452266|FG000|Overall Study|Unwillingness of the guardian|1|||
129862313|NCT03273946|467452266|FG000|Overall Study|Participant refused to use the drug|2|||
129862314|NCT03273946|467452266|FG000|Overall Study|Participant relative refused to use drug|1|||
129862315|NCT00295750|467452269|FG000|Overall Study|Adverse Event|19|||
129862316|NCT00295750|467452270|FG001|Overall Study|Adverse Event|15|||
129862317|NCT00295750|467452271|FG002|Overall Study|Adverse Event|12|||
129862318|NCT00295750|467452269|FG000|Overall Study|Lack of Efficacy|1|||
129862319|NCT00295750|467452270|FG001|Overall Study|Lack of Efficacy|1|||
129862320|NCT00295750|467452271|FG002|Overall Study|Lack of Efficacy|0|||
129862321|NCT00295750|467452269|FG000|Overall Study|Lost to Follow-up|1|||
129862322|NCT00295750|467452270|FG001|Overall Study|Lost to Follow-up|4|||
129862323|NCT00295750|467452271|FG002|Overall Study|Lost to Follow-up|1|||
129862324|NCT00295750|467452269|FG000|Overall Study|Taking prohibited therapy|2|||
129862325|NCT00295750|467452270|FG001|Overall Study|Taking prohibited therapy|3|||
129862326|NCT00295750|467452271|FG002|Overall Study|Taking prohibited therapy|2|||
129862327|NCT00295750|467452269|FG000|Overall Study|Administrative errors|2|||
129862328|NCT00295750|467452270|FG001|Overall Study|Administrative errors|4|||
129862329|NCT00295750|467452271|FG002|Overall Study|Administrative errors|5|||
129862330|NCT00295750|467452269|FG000|Overall Study|Trial drug errors|1|||
129862331|NCT00295750|467452270|FG001|Overall Study|Trial drug errors|1|||
129862332|NCT00295750|467452271|FG002|Overall Study|Trial drug errors|0|||
129862333|NCT00295750|467452269|FG000|Overall Study|Disease progression|2|||
129862334|NCT00295750|467452270|FG001|Overall Study|Disease progression|1|||
129862335|NCT00295750|467452271|FG002|Overall Study|Disease progression|0|||
129862336|NCT00295750|467452269|FG000|Overall Study|Personal reasons|0|||
129862337|NCT00295750|467452270|FG001|Overall Study|Personal reasons|1|||
129862338|NCT00295750|467452271|FG002|Overall Study|Personal reasons|0|||
129862339|NCT00295750|467452269|FG000|Overall Study|Randomized but never received trial drug|4|||
129862340|NCT00295750|467452270|FG001|Overall Study|Randomized but never received trial drug|3|||
129862341|NCT00295750|467452271|FG002|Overall Study|Randomized but never received trial drug|3|||
129862342|NCT00295750|467452269|FG000|Overall Study|Withdrawal by Subject|9|||
129862343|NCT00295750|467452270|FG001|Overall Study|Withdrawal by Subject|4|||
129862344|NCT00295750|467452271|FG002|Overall Study|Withdrawal by Subject|7|||
129862345|NCT00295750|467452269|FG000|Overall Study|Protocol Violation|2|||
129862346|NCT00295750|467452270|FG001|Overall Study|Protocol Violation|4|||
129862347|NCT00295750|467452271|FG002|Overall Study|Protocol Violation|2|||
129862348|NCT02199028|467452277|FG000|Week 1|Adverse Event|1|||
129862349|NCT02199028|467452278|FG001|Week 1|Adverse Event|0|||
129862350|NCT02199028|467452277|FG000|Week 3|Adverse Event|1|||
129862351|NCT02199028|467452278|FG001|Week 3|Adverse Event|0|||
129862352|NCT00522275|467452279|FG000|Overall Study|Adverse Event|35|||
129862353|NCT00522275|467452279|FG000|Overall Study|Lack of Efficacy|80|||
129862354|NCT00522275|467452279|FG000|Overall Study|Subject withdrew consent|16|||
129862355|NCT00522275|467452279|FG000|Overall Study|Protocol deviation|1|||
129862356|NCT00522275|467452279|FG000|Overall Study|Unsatisfactory compliance|11|||
129862357|NCT00522275|467452279|FG000|Overall Study|Lost to Follow-up|8|||
129862358|NCT00522275|467452279|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
129862359|NCT00522275|467452279|FG000|Overall Study|Other: Subject is pregnant|2|||
129862360|NCT00522275|467452279|FG000|Overall Study|Other: Subject relocated|2|||
129862361|NCT00522275|467452279|FG000|Overall Study|Other: Subject arrested|1|||
129862362|NCT00522275|467452279|FG000|Overall Study|Other: Site / clinic closed|4|||
129449716|NCT00233363|465945665|FG001|Overall Study|Aggravation of complication|0|||
129862363|NCT00522275|467452279|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
129862364|NCT00522275|467452279|FG000|Overall Study|Other: Sponsor request|2|||
129862365|NCT00522275|467452279|FG000|Overall Study|Other: Subject ran out of medication|1|||
129862366|NCT00522275|467452279|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
129862367|NCT00092131|467452280|FG000|Treatment Period I|Adverse Event|1|||
129862368|NCT00092131|467452281|FG001|Treatment Period I|Adverse Event|0|||
129862369|NCT00092131|467452280|FG000|Treatment Period II|Adverse Event|0|||
129862370|NCT00092131|467452281|FG001|Treatment Period II|Adverse Event|1|||
129862371|NCT02341417|467452282|FG000|Overall Study|Withdrawal by Subject|0|||
129911374|NCT00421889|467637661|FG005|Overall Study|Adverse Event|4|||
129911375|NCT00421889|467637662|FG006|Overall Study|Adverse Event|1|||
129911376|NCT00421889|467637663|FG007|Overall Study|Adverse Event|0|||
129911377|NCT00421889|467637664|FG008|Overall Study|Adverse Event|2|||
129911378|NCT00421889|467637656|FG000|Overall Study|Withdrawal by Subject|1|||
129911379|NCT00421889|467637657|FG001|Overall Study|Withdrawal by Subject|3|||
129911380|NCT00421889|467637658|FG002|Overall Study|Withdrawal by Subject|0|||
129911381|NCT00421889|467637659|FG003|Overall Study|Withdrawal by Subject|0|||
129911382|NCT00421889|467637660|FG004|Overall Study|Withdrawal by Subject|2|||
129911383|NCT00421889|467637661|FG005|Overall Study|Withdrawal by Subject|0|||
129911384|NCT00421889|467637662|FG006|Overall Study|Withdrawal by Subject|0|||
129911385|NCT00421889|467637663|FG007|Overall Study|Withdrawal by Subject|0|||
129911386|NCT00421889|467637664|FG008|Overall Study|Withdrawal by Subject|0|||
129911387|NCT00421889|467637656|FG000|Overall Study|Death|0|||
129911388|NCT00421889|467637657|FG001|Overall Study|Death|0|||
129911389|NCT00421889|467637658|FG002|Overall Study|Death|0|||
129911390|NCT00421889|467637659|FG003|Overall Study|Death|0|||
129911391|NCT00421889|467637660|FG004|Overall Study|Death|1|||
129911392|NCT00421889|467637661|FG005|Overall Study|Death|1|||
129911393|NCT00421889|467637662|FG006|Overall Study|Death|0|||
129911394|NCT00421889|467637663|FG007|Overall Study|Death|0|||
129911395|NCT00421889|467637664|FG008|Overall Study|Death|0|||
129911396|NCT00421889|467637656|FG000|Overall Study|Progressive disease|3|||
129911397|NCT00421889|467637657|FG001|Overall Study|Progressive disease|2|||
129911398|NCT00421889|467637658|FG002|Overall Study|Progressive disease|2|||
129911399|NCT00421889|467637659|FG003|Overall Study|Progressive disease|3|||
129911400|NCT00421889|467637660|FG004|Overall Study|Progressive disease|2|||
129911401|NCT00421889|467637661|FG005|Overall Study|Progressive disease|21|||
129911402|NCT00421889|467637662|FG006|Overall Study|Progressive disease|3|||
129911403|NCT00421889|467637663|FG007|Overall Study|Progressive disease|1|||
129911404|NCT00421889|467637664|FG008|Overall Study|Progressive disease|5|||
129911405|NCT00421889|467637656|FG000|Overall Study|Patient/Investigator request|0|||
129911406|NCT00421889|467637657|FG001|Overall Study|Patient/Investigator request|0|||
129911407|NCT00421889|467637658|FG002|Overall Study|Patient/Investigator request|0|||
129911408|NCT00421889|467637659|FG003|Overall Study|Patient/Investigator request|0|||
129911409|NCT00421889|467637660|FG004|Overall Study|Patient/Investigator request|0|||
129911410|NCT00421889|467637661|FG005|Overall Study|Patient/Investigator request|9|||
129911411|NCT00421889|467637662|FG006|Overall Study|Patient/Investigator request|0|||
129911412|NCT00421889|467637663|FG007|Overall Study|Patient/Investigator request|1|||
129911413|NCT00421889|467637664|FG008|Overall Study|Patient/Investigator request|3|||
129911414|NCT00421889|467637656|FG000|Overall Study|Lost to Follow-up|0|||
129911415|NCT00421889|467637657|FG001|Overall Study|Lost to Follow-up|0|||
129911416|NCT00421889|467637658|FG002|Overall Study|Lost to Follow-up|0|||
129911417|NCT00421889|467637659|FG003|Overall Study|Lost to Follow-up|0|||
129911418|NCT00421889|467637660|FG004|Overall Study|Lost to Follow-up|0|||
129911419|NCT00421889|467637661|FG005|Overall Study|Lost to Follow-up|0|||
129911420|NCT00421889|467637662|FG006|Overall Study|Lost to Follow-up|0|||
129911421|NCT00421889|467637663|FG007|Overall Study|Lost to Follow-up|0|||
129911422|NCT00421889|467637664|FG008|Overall Study|Lost to Follow-up|1|||
129911423|NCT03756571|467637665|FG000|Overall Study|Lost to Follow-up|1|||
129911424|NCT03756571|467637666|FG001|Overall Study|Lost to Follow-up|1|||
129911425|NCT00978042|467637667|FG000|Initial Treatment Period|Treated in Error|0|||
129911426|NCT00978042|467637668|FG001|Initial Treatment Period|Treated in Error|3|||
129911427|NCT00978042|467637667|FG000|Initial Treatment Period|Ineligibility|1|||
129911428|NCT00978042|467637668|FG001|Initial Treatment Period|Ineligibility|0|||
129911429|NCT00978042|467637667|FG000|Initial Treatment Period|Lost to Follow-up|21|||
129911430|NCT00978042|467637668|FG001|Initial Treatment Period|Lost to Follow-up|3|||
129911431|NCT00978042|467637667|FG000|Initial Treatment Period|Adverse Event|2|||
129911432|NCT00978042|467637668|FG001|Initial Treatment Period|Adverse Event|0|||
129911433|NCT00978042|467637667|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
129911434|NCT00978042|467637668|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
129911435|NCT00978042|467637667|FG000|Initial Treatment Period|Consent withdrawn|22|||
129911436|NCT00978042|467637668|FG001|Initial Treatment Period|Consent withdrawn|9|||
129911437|NCT00978042|467637667|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
129911438|NCT00978042|467637668|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
129449717|NCT01576172|465945666|FG000|Overall Study|Ineligible|2|||
129911439|NCT00520546|467637669|FG000|Overall Study|Withdrawal by Subject|1|||
129911440|NCT00520546|467637669|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
129911441|NCT02101281|467637673|FG000|Overall Study|Adverse Event|0|||
129911442|NCT02101281|467637674|FG001|Overall Study|Adverse Event|1|||
129911443|NCT00174382|467637675|FG000|Overall Study|Death|2|||
129911444|NCT00174382|467637675|FG000|Overall Study|Adverse Event|19|||
129911445|NCT00174382|467637675|FG000|Overall Study|Withdrawal by Subject|6|||
129911446|NCT00174382|467637675|FG000|Overall Study|Protocol Violation|3|||
129911447|NCT00174382|467637675|FG000|Overall Study|Arrived early for last visit in error|1|||
129911448|NCT00174382|467637675|FG000|Overall Study|Subject felt pill not effective enough|1|||
129911449|NCT00174382|467637675|FG000|Overall Study|Lost to Follow-up|1|||
129911450|NCT00296036|467637676|FG000|Overall Study|Withdrawal by Subject|1|||
129911451|NCT00296036|467637677|FG001|Overall Study|Withdrawal by Subject|0|||
129911452|NCT00296036|467637678|FG002|Overall Study|Withdrawal by Subject|2|||
129911453|NCT00296036|467637679|FG003|Overall Study|Withdrawal by Subject|1|||
129911454|NCT00296036|467637680|FG004|Overall Study|Withdrawal by Subject|2|||
129911455|NCT00296036|467637681|FG005|Overall Study|Withdrawal by Subject|1|||
129911456|NCT00296036|467637676|FG000|Overall Study|Protocol Violation|0|||
129911457|NCT00296036|467637677|FG001|Overall Study|Protocol Violation|0|||
129911458|NCT00296036|467637678|FG002|Overall Study|Protocol Violation|0|||
129911459|NCT00296036|467637679|FG003|Overall Study|Protocol Violation|0|||
129911460|NCT00296036|467637680|FG004|Overall Study|Protocol Violation|0|||
129911461|NCT00296036|467637681|FG005|Overall Study|Protocol Violation|3|||
129911462|NCT03403413|467637682|FG000|Overall Study|Lack of Efficacy|2|||
129911463|NCT03655262|467637683|FG000|Overall Study|Withdrawal by Subject|0|||
129911464|NCT03655262|467637684|FG001|Overall Study|Withdrawal by Subject|0|||
129911465|NCT03655262|467637685|FG002|Overall Study|Withdrawal by Subject|1|||
129911466|NCT03951805|467637687|FG000|Overall Study|Adverse Event|1|||
129911467|NCT03951805|467637688|FG001|Overall Study|Adverse Event|0|||
129911468|NCT03951805|467637689|FG002|Overall Study|Adverse Event|0|||
129911469|NCT03951805|467637690|FG003|Overall Study|Adverse Event|0|||
129911470|NCT00604669|467637691|FG000|Overall Study|lack of information in chart|7|||
129911471|NCT01695954|467637692|FG000|Overall Study|Withdrawal by Subject|4|||
129911472|NCT01695954|467637693|FG001|Overall Study|Withdrawal by Subject|0|||
129911473|NCT01695954|467637692|FG000|Overall Study|Adverse Event|0|||
129911474|NCT01695954|467637693|FG001|Overall Study|Adverse Event|2|||
129911475|NCT04328727|467637695|FG000|Overall Study|Guardian Decision|1|||
129911476|NCT04328727|467637695|FG000|Overall Study|Participant decision|4|||
129911477|NCT04328727|467637695|FG000|Overall Study|Death|3|||
129911478|NCT03684044|467637696|FG000|Overall Study|Adverse Event|3|||
129911479|NCT03684044|467637697|FG001|Overall Study|Adverse Event|0|||
129911480|NCT03684044|467637696|FG000|Overall Study|Death|4|||
129911481|NCT03684044|467637697|FG001|Overall Study|Death|7|||
129911482|NCT03684044|467637696|FG000|Overall Study|Lost to Follow-up|3|||
129862372|NCT02341417|467452283|FG001|Overall Study|Withdrawal by Subject|2|||
129862373|NCT02341417|467452284|FG002|Overall Study|Withdrawal by Subject|0|||
129862374|NCT02341417|467452282|FG000|Overall Study|Decision by sponsor|2|||
129862375|NCT02341417|467452283|FG001|Overall Study|Decision by sponsor|0|||
129862376|NCT02341417|467452284|FG002|Overall Study|Decision by sponsor|0|||
129862377|NCT02341417|467452282|FG000|Overall Study|Death|0|||
129862378|NCT02341417|467452283|FG001|Overall Study|Death|0|||
129862379|NCT02341417|467452284|FG002|Overall Study|Death|1|||
129862380|NCT02576067|467452285|FG000|Overall Study|Death|0|||
129862381|NCT02576067|467452286|FG001|Overall Study|Death|1|||
129862382|NCT02576067|467452285|FG000|Overall Study|Lack of Efficacy|1|||
129862383|NCT02576067|467452286|FG001|Overall Study|Lack of Efficacy|0|||
129862384|NCT02576067|467452285|FG000|Overall Study|Lost to Follow-up|11|||
129862385|NCT02576067|467452286|FG001|Overall Study|Lost to Follow-up|0|||
129862386|NCT02576067|467452285|FG000|Overall Study|Withdrawal by Subject|11|||
129862387|NCT02576067|467452286|FG001|Overall Study|Withdrawal by Subject|2|||
129862388|NCT02576067|467452285|FG000|Overall Study|study closure of main CIRT trial)|0|||
129862389|NCT02576067|467452286|FG001|Overall Study|study closure of main CIRT trial)|8|||
129862390|NCT02576067|467452285|FG000|Overall Study|not randomized, failed run-in|7|||
129862391|NCT02576067|467452286|FG001|Overall Study|not randomized, failed run-in|0|||
129862392|NCT02576067|467452285|FG000|Overall Study|screen failure/ re-enrolled|0|||
129862393|NCT02576067|467452286|FG001|Overall Study|screen failure/ re-enrolled|25|||
129862394|NCT02576067|467452285|FG000|Overall Study|Physician Decision|4|||
129862395|NCT02576067|467452286|FG001|Overall Study|Physician Decision|0|||
129862396|NCT04773587|467452289|FG000|Overall Study|Lost to Follow-up|11|||
129862397|NCT04773587|467452290|FG001|Overall Study|Lost to Follow-up|3|||
129862398|NCT04773587|467452289|FG000|Overall Study|Adverse Event|6|||
129862399|NCT04773587|467452290|FG001|Overall Study|Adverse Event|3|||
129911483|NCT03684044|467637697|FG001|Overall Study|Lost to Follow-up|2|||
129911484|NCT03684044|467637696|FG000|Overall Study|Patient Not Available|0|||
129911485|NCT03684044|467637697|FG001|Overall Study|Patient Not Available|2|||
129862400|NCT04773587|467452289|FG000|Overall Study|Lack of Efficacy|5|||
129862401|NCT04773587|467452290|FG001|Overall Study|Lack of Efficacy|2|||
129862402|NCT04773587|467452289|FG000|Overall Study|Withdrawal by Subject|4|||
129862403|NCT04773587|467452290|FG001|Overall Study|Withdrawal by Subject|5|||
129862404|NCT04773587|467452289|FG000|Overall Study|Noncompliance|1|||
129862405|NCT04773587|467452290|FG001|Overall Study|Noncompliance|0|||
129911486|NCT03684044|467637696|FG000|Overall Study|Physician Decision|1|||
129911487|NCT03684044|467637697|FG001|Overall Study|Physician Decision|0|||
129911488|NCT03684044|467637696|FG000|Overall Study|Withdrawal by Subject|11|||
129911489|NCT03684044|467637697|FG001|Overall Study|Withdrawal by Subject|9|||
129911490|NCT03703336|467637698|FG000|Overall Study|Parent withdrew consent|29|||
129911491|NCT03703336|467637699|FG001|Overall Study|Parent withdrew consent|8|||
129911492|NCT03703336|467637698|FG000|Overall Study|Migration|3|||
129911493|NCT03703336|467637699|FG001|Overall Study|Migration|3|||
129911494|NCT03703336|467637698|FG000|Overall Study|Protocol Violation|3|||
129911495|NCT03703336|467637699|FG001|Overall Study|Protocol Violation|1|||
129911496|NCT03703336|467637698|FG000|Overall Study|Physician Decision|2|||
129911497|NCT03703336|467637699|FG001|Overall Study|Physician Decision|0|||
129911498|NCT03703336|467637698|FG000|Overall Study|Adverse Event|0|||
129911499|NCT03703336|467637699|FG001|Overall Study|Adverse Event|2|||
129911500|NCT03703336|467637698|FG000|Overall Study|Lost to Follow-up|1|||
129911501|NCT03703336|467637699|FG001|Overall Study|Lost to Follow-up|0|||
129911502|NCT03930420|467637701|FG000|Overall Study|Withdrawal by Subject|7|||
129911503|NCT03930420|467637702|FG001|Overall Study|Withdrawal by Subject|9|||
129911504|NCT00580866|467637703|FG000|Overall Study|Lost to Follow-up|2|||
129911505|NCT00580866|467637704|FG001|Overall Study|Lost to Follow-up|2|||
129911506|NCT00609336|467637705|FG000|Overall Study|Protocol Violation|3|||
129911507|NCT00609336|467637705|FG000|Overall Study|Death|1|||
129911508|NCT00609336|467637705|FG000|Overall Study|LA or Met at Surgery|9|||
129911509|NCT02238483|467637706|FG000|Overall Study|Withdrawal by Subject|2|||
129911510|NCT02238483|467637707|FG001|Overall Study|Withdrawal by Subject|7|||
129911511|NCT02238483|467637706|FG000|Overall Study|Lost to Follow-up|1|||
129911512|NCT02238483|467637707|FG001|Overall Study|Lost to Follow-up|1|||
129911513|NCT02238483|467637706|FG000|Overall Study|Protocol Violation|1|||
129911514|NCT02238483|467637707|FG001|Overall Study|Protocol Violation|2|||
129911515|NCT02238483|467637706|FG000|Overall Study|Death|1|||
129911516|NCT02238483|467637707|FG001|Overall Study|Death|0|||
129911517|NCT02238483|467637706|FG000|Overall Study|Adverse Event|7|||
129911518|NCT02238483|467637707|FG001|Overall Study|Adverse Event|3|||
129911519|NCT02238483|467637706|FG000|Overall Study|Withdrawn due to physician decision|1|||
129911520|NCT02238483|467637707|FG001|Overall Study|Withdrawn due to physician decision|0|||
129911521|NCT02238483|467637706|FG000|Overall Study|Completion status not recorded|1|||
129911522|NCT02238483|467637707|FG001|Overall Study|Completion status not recorded|1|||
129911523|NCT02238483|467637706|FG000|Overall Study|Illness in family member|1|||
129911524|NCT02238483|467637707|FG001|Overall Study|Illness in family member|0|||
129911525|NCT02477605|467637708|FG000|Overall Study|Discontinued prior to treatment|1|||
129911526|NCT02477605|467637709|FG001|Overall Study|Discontinued prior to treatment|0|||
129911527|NCT02477605|467637708|FG000|Overall Study|Lost to Follow-up|0|||
129911528|NCT02477605|467637709|FG001|Overall Study|Lost to Follow-up|2|||
129911529|NCT02477605|467637708|FG000|Overall Study|Withdrawal by Subject|0|||
129911530|NCT02477605|467637709|FG001|Overall Study|Withdrawal by Subject|1|||
129911531|NCT02477605|467637708|FG000|Overall Study|Administered gas during surgery|0|||
129911532|NCT02477605|467637709|FG001|Overall Study|Administered gas during surgery|1|||
129911533|NCT02574455|467637710|FG000|Overall Study|Death|197|||
129911534|NCT02574455|467637711|FG001|Overall Study|Death|210|||
129911535|NCT02574455|467637710|FG000|Overall Study|Withdrawal of Consent|11|||
129911536|NCT02574455|467637711|FG001|Overall Study|Withdrawal of Consent|28|||
129911537|NCT02574455|467637710|FG000|Overall Study|Lost to Follow-up|4|||
129911538|NCT02574455|467637711|FG001|Overall Study|Lost to Follow-up|4|||
129911539|NCT02574455|467637710|FG000|Overall Study|Sponsor's Decision|55|||
129911540|NCT02574455|467637711|FG001|Overall Study|Sponsor's Decision|20|||
129911541|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Death|117|||
129911542|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Death|197|||
129911543|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
129911544|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
129911545|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
129911546|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
129911547|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
129911548|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
129911549|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
129911550|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
129911551|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
129911552|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
129911553|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
129911554|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
129911555|NCT02677896|467637712|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
129911556|NCT02677896|467637713|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
129911557|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
129911558|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
129911559|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
129911560|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
129911561|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
129911562|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
129911563|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
129911564|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
129911565|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
129911566|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
129911567|NCT02677896|467637712|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
129911568|NCT02677896|467637713|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
129911569|NCT00567489|467637714|FG000|Overall Study|Adverse Event|6|||
129911570|NCT00567489|467637715|FG001|Overall Study|Adverse Event|14|||
129911571|NCT00567489|467637714|FG000|Overall Study|Physician Decision|0|||
129911572|NCT00567489|467637715|FG001|Overall Study|Physician Decision|4|||
129911573|NCT00567489|467637714|FG000|Overall Study|Withdrawal by Subject|0|||
129911574|NCT00567489|467637715|FG001|Overall Study|Withdrawal by Subject|2|||
129911575|NCT00567489|467637714|FG000|Overall Study|Renal Transplantation|0|||
129911576|NCT00567489|467637715|FG001|Overall Study|Renal Transplantation|3|||
129911577|NCT00567489|467637714|FG000|Overall Study|Other|1|||
129911578|NCT00567489|467637715|FG001|Overall Study|Other|0|||
129911579|NCT03565315|467637719|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
129911580|NCT03565315|467637720|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
129911581|NCT03565315|467637721|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
129911582|NCT03565315|467637722|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
129911583|NCT01083316|467637723|FG000|Overall Study|Adverse Event|2|||
129911584|NCT01083316|467637723|FG000|Overall Study|Withdrawal by Subject|1|||
129911585|NCT04200365|467637724|FG000|Overall Study|Adverse Event|2|||
129911586|NCT04200365|467637724|FG000|Overall Study|Progressive Disease|4|||
129911587|NCT04200365|467637724|FG000|Overall Study|Lack of Efficacy|1|||
129911588|NCT04200365|467637724|FG000|Overall Study|Study Closure|4|||
129911589|NCT02318134|467637731|FG000|Overall Study|Withdrawal by Subject|2|||
129911590|NCT02318134|467637732|FG001|Overall Study|Withdrawal by Subject|1|||
129911591|NCT01976312|467637733|FG000|Overall Study|Pregnancy|0|||
129911592|NCT01976312|467637734|FG001|Overall Study|Pregnancy|1|||
129911593|NCT01976312|467637733|FG000|Overall Study|Lost to Follow-up|2|||
129911594|NCT01976312|467637734|FG001|Overall Study|Lost to Follow-up|0|||
129911595|NCT01976312|467637733|FG000|Overall Study|Withdrawal by Subject|7|||
129911596|NCT01976312|467637734|FG001|Overall Study|Withdrawal by Subject|2|||
129911597|NCT01976312|467637733|FG000|Overall Study|Adverse Event|6|||
129911598|NCT01976312|467637734|FG001|Overall Study|Adverse Event|6|||
129911599|NCT01976312|467637733|FG000|Overall Study|Protocol Violation|2|||
129911600|NCT01976312|467637734|FG001|Overall Study|Protocol Violation|0|||
129911601|NCT01609218|467637741|FG000|Period 1|Adverse Event|3|||
129911602|NCT01609218|467637742|FG001|Period 1|Adverse Event|5|||
129911603|NCT01609218|467637741|FG000|Period 1|Sponsor Decision|0|||
129911604|NCT01609218|467637742|FG001|Period 1|Sponsor Decision|1|||
129911605|NCT01609218|467637741|FG000|Period 2|Adverse Event|1|||
129911606|NCT01609218|467637742|FG001|Period 2|Adverse Event|0|||
129911607|NCT04428112|467637748|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
129911608|NCT04428112|467637749|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
129911609|NCT04428112|467637748|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
129911610|NCT04428112|467637749|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
129911611|NCT04428112|467637748|FG000|Overall Study|Withdrawal by Subject|9|||
129911612|NCT04428112|467637749|FG001|Overall Study|Withdrawal by Subject|4|||
129911613|NCT04428112|467637748|FG000|Overall Study|Lost to Follow-up|27|||
129911614|NCT04428112|467637749|FG001|Overall Study|Lost to Follow-up|7|||
129911615|NCT01207492|467637750|FG000|Overall Study|Still on study|1|||
129911616|NCT01207492|467637750|FG000|Overall Study|Withdrawal by Subject|9|||
129911617|NCT01207492|467637750|FG000|Overall Study|Physician Decision|1|||
129911618|NCT01207492|467637750|FG000|Overall Study|Progressive disease|3|||
129911619|NCT01207492|467637750|FG000|Overall Study|Toxicity|1|||
129911620|NCT02769858|467637751|FG000|Overall Study|Withdrawal by Subject|2|||
129911621|NCT04814186|467639402|FG000|Treatment Phase|Adverse Event|1|||
129911622|NCT04814186|467639402|FG000|Treatment Phase|Death|6|||
129911623|NCT04814186|467639402|FG000|Treatment Phase|Withdrawal by Subject|2|||
129911624|NCT04814186|467639402|FG000|Treatment Phase|Other|1|||
129911625|NCT04814186|467639402|FG000|Follow-Up Phase|Adverse Event|1|||
129911626|NCT04814186|467639402|FG000|Follow-Up Phase|Death|6|||
129911627|NCT04814186|467639402|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
129911628|NCT04814186|467639402|FG000|Follow-Up Phase|Other|1|||
129911629|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
129911630|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
129911631|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
129911632|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
129911633|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
129911634|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
129911635|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
129911636|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
129911637|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
129911638|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
129449718|NCT01576172|465945667|FG001|Overall Study|Ineligible|1|||
129911639|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
129911640|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
129911641|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911642|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
129911643|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
129911644|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911645|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911646|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
129911647|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
129911648|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
129911649|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
129911650|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
129911651|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
129911652|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
129911653|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911654|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
129911655|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911656|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911657|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911658|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
129911659|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
129911660|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911661|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911662|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911663|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911664|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
129911665|NCT04043455|467639405|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911666|NCT04043455|467639406|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
129911667|NCT04043455|467639407|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911668|NCT04043455|467639408|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911669|NCT04043455|467639409|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911670|NCT04043455|467639410|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
129911671|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911672|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911673|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911674|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911675|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
129911676|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
129911677|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911678|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911679|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911680|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
129911681|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
129911682|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
129911683|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911684|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911685|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129862406|NCT04773587|467452289|FG000|Overall Study|Protocol Violation|1|||
129862407|NCT04773587|467452290|FG001|Overall Study|Protocol Violation|0|||
129862408|NCT04773587|467452289|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
129862409|NCT04773587|467452290|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
129862410|NCT02372409|467452291|FG000|Overall Study|Lost to Follow-up|1|||
129862411|NCT02372409|467452292|FG001|Overall Study|Lost to Follow-up|0|||
129862412|NCT02372409|467452291|FG000|Overall Study|Disease progression|1|||
129862413|NCT02372409|467452292|FG001|Overall Study|Disease progression|1|||
129862414|NCT01808313|467452293|FG000|Overall Study|Adverse Event|5|||
129862415|NCT01808313|467452293|FG000|Overall Study|Protocol Violation|2|||
129862416|NCT01808313|467452293|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129862417|NCT01808313|467452293|FG000|Overall Study|Lost to Follow-up|1|||
129862418|NCT01808313|467452293|FG000|Overall Study|Physician Decision|1|||
129862419|NCT04656847|467452296|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
129862420|NCT03301051|467452297|FG000|Overall Study|Adverse Event|0|||
129862421|NCT03301051|467452298|FG001|Overall Study|Adverse Event|4|||
129862422|NCT03301051|467452297|FG000|Overall Study|Withdrawal by Subject|59|||
129911686|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911687|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
129911688|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
129911689|NCT04043455|467639405|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911690|NCT04043455|467639406|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911691|NCT04043455|467639407|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911692|NCT04043455|467639408|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
129911693|NCT04043455|467639409|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
129911694|NCT04043455|467639410|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
129911695|NCT05194917|467639411|FG000|Overall Study|Lost to Follow-up|7|||
129911696|NCT05194917|467639412|FG001|Overall Study|Lost to Follow-up|5|||
129911697|NCT05194917|467639413|FG002|Overall Study|Lost to Follow-up|6|||
129911698|NCT05194917|467639414|FG003|Overall Study|Lost to Follow-up|5|||
129911699|NCT04688450|467639417|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
129911700|NCT04688450|467639417|FG000|Overall Study|Withdrawal by Subject|1|||
129911701|NCT03189524|467639418|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
129911702|NCT03189524|467639419|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
129911703|NCT03189524|467639420|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
129911704|NCT03189524|467639418|FG000|Overall Study|Death|2|||
129911705|NCT03189524|467639419|FG001|Overall Study|Death|2|||
129911706|NCT03189524|467639420|FG002|Overall Study|Death|1|||
129911707|NCT03189524|467639418|FG000|Overall Study|Lost to Follow-up|1|||
129911708|NCT03189524|467639419|FG001|Overall Study|Lost to Follow-up|0|||
129911709|NCT03189524|467639420|FG002|Overall Study|Lost to Follow-up|8|||
129911710|NCT03189524|467639418|FG000|Overall Study|Withdrawal by Subject|1|||
129911711|NCT03189524|467639419|FG001|Overall Study|Withdrawal by Subject|1|||
129911712|NCT03189524|467639420|FG002|Overall Study|Withdrawal by Subject|3|||
129911713|NCT03189524|467639418|FG000|Overall Study|Progressive Disease|0|||
129911714|NCT03189524|467639419|FG001|Overall Study|Progressive Disease|2|||
129911715|NCT03189524|467639420|FG002|Overall Study|Progressive Disease|0|||
129911716|NCT02980276|467639421|FG000|Overall Study|Withdrawal by Subject|4|||
129911717|NCT02980276|467639422|FG001|Overall Study|Withdrawal by Subject|4|||
129911718|NCT02980276|467639421|FG000|Overall Study|Physician Decision|0|||
129911719|NCT02980276|467639422|FG001|Overall Study|Physician Decision|1|||
129862423|NCT03301051|467452298|FG001|Overall Study|Withdrawal by Subject|65|||
129862424|NCT03301051|467452297|FG000|Overall Study|Lost to Follow-up|263|||
129862425|NCT03301051|467452298|FG001|Overall Study|Lost to Follow-up|282|||
129862426|NCT03301051|467452297|FG000|Overall Study|Protocol Violation|1|||
129862427|NCT03301051|467452298|FG001|Overall Study|Protocol Violation|3|||
129862428|NCT03301051|467452297|FG000|Overall Study|Physician Decision|1|||
129862429|NCT03301051|467452298|FG001|Overall Study|Physician Decision|3|||
129862430|NCT03301051|467452297|FG000|Overall Study|Death|1|||
129862431|NCT03301051|467452298|FG001|Overall Study|Death|1|||
129862432|NCT03301051|467452297|FG000|Overall Study|Miscellaneous|8|||
129862433|NCT03301051|467452298|FG001|Overall Study|Miscellaneous|4|||
129862434|NCT03301051|467452297|FG000|Overall Study|Randomized, not vaccinated|13|||
129862435|NCT03301051|467452298|FG001|Overall Study|Randomized, not vaccinated|10|||
129862436|NCT00047879|467452299|FG000|Overall Study|Progressive disease|4|||
129862437|NCT00047879|467452300|FG001|Overall Study|Progressive disease|3|||
129862438|NCT00622167|467452301|FG000|Overall Study|Did not meet angiographic criteria|20|||
129862439|NCT01954017|467452304|FG000|Overall Study|Adverse Event|0|||
129862440|NCT01954017|467452305|FG001|Overall Study|Adverse Event|0|||
129862441|NCT01954017|467452306|FG002|Overall Study|Adverse Event|1|||
129862442|NCT01954017|467452304|FG000|Overall Study|Death|2|||
129862443|NCT01954017|467452305|FG001|Overall Study|Death|1|||
129862444|NCT01954017|467452306|FG002|Overall Study|Death|1|||
129862445|NCT01954017|467452304|FG000|Overall Study|Withdrawal by Subject|0|||
129862446|NCT01954017|467452305|FG001|Overall Study|Withdrawal by Subject|1|||
129862447|NCT01954017|467452306|FG002|Overall Study|Withdrawal by Subject|0|||
129862448|NCT01954017|467452304|FG000|Overall Study|Protocol Violation|0|||
129862449|NCT01954017|467452305|FG001|Overall Study|Protocol Violation|3|||
129862450|NCT01954017|467452306|FG002|Overall Study|Protocol Violation|2|||
129862451|NCT01954017|467452304|FG000|Overall Study|Necrotizing enterocolitis|1|||
129862452|NCT01954017|467452305|FG001|Overall Study|Necrotizing enterocolitis|0|||
129862453|NCT01954017|467452306|FG002|Overall Study|Necrotizing enterocolitis|1|||
129862454|NCT01954017|467452304|FG000|Overall Study|Enteral intake stopped >7 days|0|||
129911720|NCT02980276|467639421|FG000|Overall Study|Lost to Follow-up|18|||
129862455|NCT01954017|467452305|FG001|Overall Study|Enteral intake stopped >7 days|1|||
129862456|NCT01954017|467452306|FG002|Overall Study|Enteral intake stopped >7 days|1|||
129862457|NCT01954017|467452304|FG000|Overall Study|All other reasons|2|||
129862458|NCT01954017|467452305|FG001|Overall Study|All other reasons|2|||
129862459|NCT01954017|467452306|FG002|Overall Study|All other reasons|7|||
129862460|NCT00435370|467452311|FG000|Overall Study|Adverse Event|8|||
129862461|NCT00435370|467452312|FG001|Overall Study|Adverse Event|8|||
129862462|NCT00435370|467452311|FG000|Overall Study|Withdrawal by Subject|10|||
129862463|NCT00435370|467452312|FG001|Overall Study|Withdrawal by Subject|10|||
129862464|NCT00435370|467452311|FG000|Overall Study|Antipsychotic medication changed|4|||
129862465|NCT00435370|467452312|FG001|Overall Study|Antipsychotic medication changed|2|||
129862466|NCT03674177|467452316|FG000|Overall Study|Lost to Follow-up|2|||
129862467|NCT03674177|467452317|FG001|Overall Study|Lost to Follow-up|1|||
129862468|NCT03674177|467452318|FG002|Overall Study|Lost to Follow-up|0|||
129862469|NCT03674177|467452319|FG003|Overall Study|Lost to Follow-up|2|||
129862470|NCT00714168|467452320|FG000|Overall Study|Pregnancy|5|||
129862471|NCT00714168|467452321|FG001|Overall Study|Pregnancy|4|||
129862472|NCT00714168|467452320|FG000|Overall Study|Lost to Follow-up|32|||
129862473|NCT00714168|467452321|FG001|Overall Study|Lost to Follow-up|50|||
129862474|NCT00714168|467452320|FG000|Overall Study|Relocation|4|||
129862475|NCT00714168|467452321|FG001|Overall Study|Relocation|3|||
129862476|NCT00714168|467452320|FG000|Overall Study|Non-study medical condition|3|||
129862477|NCT00714168|467452321|FG001|Overall Study|Non-study medical condition|2|||
129862478|NCT02298192|467452325|FG000|Overall Study|Unclassified|3|||
129862479|NCT02298192|467452326|FG001|Overall Study|Unclassified|2|||
129862480|NCT02298192|467452325|FG000|Overall Study|Withdrawal criteria|2|||
129862481|NCT02298192|467452326|FG001|Overall Study|Withdrawal criteria|0|||
129862482|NCT02298192|467452325|FG000|Overall Study|Withdrawal by Subject|6|||
129862483|NCT02298192|467452326|FG001|Overall Study|Withdrawal by Subject|1|||
129862484|NCT02298192|467452325|FG000|Overall Study|Lost to Follow-up|2|||
129862485|NCT02298192|467452326|FG001|Overall Study|Lost to Follow-up|1|||
129862486|NCT02298192|467452325|FG000|Overall Study|Adverse Event|6|||
129862487|NCT02298192|467452326|FG001|Overall Study|Adverse Event|2|||
129862488|NCT04764396|467452330|FG000|Overall Study|Physician Decision|1|||
129862489|NCT04764396|467452331|FG001|Overall Study|Physician Decision|0|||
129862490|NCT02653482|467452333|FG000|Overall Study|Death|1|||
129862491|NCT02653482|467452334|FG001|Overall Study|Death|1|||
129862492|NCT01864564|467452337|FG000|Overall Study|Lost to Follow-up|17|||
129862493|NCT01864564|467452338|FG001|Overall Study|Lost to Follow-up|23|||
129862494|NCT01864564|467452337|FG000|Overall Study|Withdrawal by Subject|20|||
129862495|NCT01864564|467452338|FG001|Overall Study|Withdrawal by Subject|11|||
129862496|NCT01864564|467452337|FG000|Overall Study|Protocol Violation|0|||
129862497|NCT01864564|467452338|FG001|Overall Study|Protocol Violation|27|||
129862498|NCT01864564|467452337|FG000|Overall Study|not reported|0|||
129862499|NCT01864564|467452338|FG001|Overall Study|not reported|34|||
129862500|NCT03077724|467452339|FG000|Overall Study|Lost to Follow-up|5|||
129862501|NCT03077724|467452340|FG001|Overall Study|Lost to Follow-up|1|||
129862502|NCT03077724|467452339|FG000|Overall Study|Withdrawal by Subject|3|||
129862503|NCT03077724|467452340|FG001|Overall Study|Withdrawal by Subject|1|||
129862504|NCT04414696|467452343|FG000|3-month Follow up|Withdrawal by Subject|1|||
129862505|NCT04414696|467452344|FG001|3-month Follow up|Withdrawal by Subject|0|||
129862506|NCT04414696|467452343|FG000|3-month Follow up|Lost to Follow-up|22|||
129862507|NCT04414696|467452344|FG001|3-month Follow up|Lost to Follow-up|23|||
129862508|NCT04414696|467452343|FG000|6-month Follow up|Withdrawal by Subject|1|||
129862509|NCT04414696|467452344|FG001|6-month Follow up|Withdrawal by Subject|2|||
129862510|NCT04414696|467452343|FG000|6-month Follow up|Lost to Follow-up|5|||
129862511|NCT04414696|467452344|FG001|6-month Follow up|Lost to Follow-up|2|||
129862512|NCT05912400|467454577|FG000|Overall Study|Lost to Follow-up|1|||
129862513|NCT05912400|467454578|FG001|Overall Study|Lost to Follow-up|0|||
129862514|NCT05912400|467454577|FG000|Overall Study|Physician Decision|6|||
129862515|NCT05912400|467454578|FG001|Overall Study|Physician Decision|0|||
129862516|NCT05912400|467454577|FG000|Overall Study|Withdrawal by Subject|1|||
129862517|NCT05912400|467454578|FG001|Overall Study|Withdrawal by Subject|0|||
129862518|NCT02522494|467454579|FG000|Overall Study|Lost to Follow-up|6|||
129862519|NCT02522494|467454580|FG001|Overall Study|Lost to Follow-up|2|||
129862520|NCT02522494|467454579|FG000|Overall Study|Withdrawal by Subject|1|||
129862521|NCT02522494|467454580|FG001|Overall Study|Withdrawal by Subject|0|||
129862522|NCT02522494|467454579|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
129862523|NCT02522494|467454580|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
129862524|NCT02522494|467454579|FG000|Overall Study|Participant did not watch the video|1|||
129862525|NCT02522494|467454580|FG001|Overall Study|Participant did not watch the video|0|||
129862526|NCT02522494|467454579|FG000|Overall Study|Death|0|||
129862527|NCT02522494|467454580|FG001|Overall Study|Death|1|||
129862528|NCT03461003|467454581|FG000|Overall Study|Lost to Follow-up|2|||
129862529|NCT03461003|467454582|FG001|Overall Study|Lost to Follow-up|2|||
129862530|NCT03461003|467454581|FG000|Overall Study|Withdrawal by Subject|3|||
129862531|NCT03461003|467454582|FG001|Overall Study|Withdrawal by Subject|1|||
129862532|NCT03489304|467454583|FG000|Overall Study|Lost to Follow-up|4|||
129911721|NCT02980276|467639422|FG001|Overall Study|Lost to Follow-up|18|||
129911722|NCT02980276|467639421|FG000|Overall Study|Death|1|||
129911723|NCT02980276|467639422|FG001|Overall Study|Death|0|||
129911724|NCT02980276|467639421|FG000|Overall Study|Miscellaneous other|10|||
129911725|NCT02980276|467639422|FG001|Overall Study|Miscellaneous other|4|||
129911726|NCT04300647|467639423|FG000|Pre-Crossover|Death|19|||
129911727|NCT04300647|467639424|FG001|Pre-Crossover|Death|58|||
129911728|NCT04300647|467639425|FG002|Pre-Crossover|Death|0|||
129911729|NCT04300647|467639423|FG000|Pre-Crossover|Lost to Follow-up|0|||
129911730|NCT04300647|467639424|FG001|Pre-Crossover|Lost to Follow-up|3|||
129911731|NCT04300647|467639425|FG002|Pre-Crossover|Lost to Follow-up|0|||
129911732|NCT04300647|467639423|FG000|Pre-Crossover|Withdrawal by Subject|2|||
129911733|NCT04300647|467639424|FG001|Pre-Crossover|Withdrawal by Subject|4|||
129911734|NCT04300647|467639425|FG002|Pre-Crossover|Withdrawal by Subject|0|||
129911735|NCT04300647|467639423|FG000|Pre-Crossover|On-going in Study|24|||
129911736|NCT04300647|467639424|FG001|Pre-Crossover|On-going in Study|61|||
129911737|NCT04300647|467639425|FG002|Pre-Crossover|On-going in Study|0|||
129911738|NCT04300647|467639423|FG000|Post-Crossover|Death|0|||
129911739|NCT04300647|467639424|FG001|Post-Crossover|Death|0|||
129911740|NCT04300647|467639425|FG002|Post-Crossover|Death|3|||
129911741|NCT04300647|467639423|FG000|Post-Crossover|Lost to Follow-up|0|||
129911742|NCT04300647|467639424|FG001|Post-Crossover|Lost to Follow-up|0|||
129911743|NCT04300647|467639425|FG002|Post-Crossover|Lost to Follow-up|1|||
129911744|NCT04300647|467639423|FG000|Post-Crossover|Withdrawal by Subject|0|||
129911745|NCT04300647|467639424|FG001|Post-Crossover|Withdrawal by Subject|0|||
129911746|NCT04300647|467639425|FG002|Post-Crossover|Withdrawal by Subject|1|||
129911747|NCT04300647|467639423|FG000|Post-Crossover|On-going in Study|0|||
129911748|NCT04300647|467639424|FG001|Post-Crossover|On-going in Study|0|||
129911749|NCT04300647|467639425|FG002|Post-Crossover|On-going in Study|8|||
129911750|NCT03346538|467639429|FG000|Overall Study|Physician Decision|0|||
129911751|NCT03346538|467639430|FG001|Overall Study|Physician Decision|1|||
129911752|NCT03346538|467639431|FG002|Overall Study|Physician Decision|0|||
129911753|NCT03346538|467639429|FG000|Overall Study|Withdrawal by Subject|3|||
129911754|NCT03346538|467639430|FG001|Overall Study|Withdrawal by Subject|2|||
129911755|NCT03346538|467639431|FG002|Overall Study|Withdrawal by Subject|0|||
129911756|NCT03346538|467639429|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
129911757|NCT03346538|467639430|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
129911758|NCT03346538|467639431|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
129911759|NCT01353313|467639432|FG000|Overall Study|Lost to Follow-up|22|||
129911760|NCT01353313|467639433|FG001|Overall Study|Lost to Follow-up|23|||
129911761|NCT01353313|467639432|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
129911762|NCT01353313|467639433|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
129911763|NCT02824029|467639435|FG000|Overall Study|Didn't receive treatment|2|||
129911764|NCT02824029|467639435|FG000|Overall Study|Patient decision to discontinue treatment|3|||
129911765|NCT02824029|467639435|FG000|Overall Study|Non-compliant|5|||
129911766|NCT02824029|467639435|FG000|Overall Study|Progression of disease|15|||
129911767|NCT02824029|467639435|FG000|Overall Study|Inadequate response to therapy|2|||
129911768|NCT02824029|467639435|FG000|Overall Study|Possible progression per treating physician|1|||
129911769|NCT04524390|467639437|FG000|Double Blind|Consent Withdrawal by subject|2|||
129911770|NCT04524390|467639438|FG001|Double Blind|Consent Withdrawal by subject|1|||
129911771|NCT04524390|467639439|FG002|Double Blind|Consent Withdrawal by subject|0|||
129911772|NCT04524390|467639437|FG000|Double Blind|Adverse Event|5|||
129911773|NCT04524390|467639438|FG001|Double Blind|Adverse Event|3|||
129911774|NCT04524390|467639439|FG002|Double Blind|Adverse Event|0|||
129911775|NCT04524390|467639437|FG000|Double Blind|Liver Transplant|5|||
129911776|NCT04524390|467639438|FG001|Double Blind|Liver Transplant|6|||
129911777|NCT04524390|467639439|FG002|Double Blind|Liver Transplant|0|||
129911778|NCT04524390|467639437|FG000|Double Blind|Disease Progression|0|||
129911779|NCT04524390|467639438|FG001|Double Blind|Disease Progression|1|||
129911780|NCT04524390|467639439|FG002|Double Blind|Disease Progression|0|||
129911781|NCT04524390|467639437|FG000|Open-Label|Drug interruption criteria|0|||
129911782|NCT04524390|467639438|FG001|Open-Label|Drug interruption criteria|0|||
129911783|NCT04524390|467639439|FG002|Open-Label|Drug interruption criteria|1|||
129911784|NCT04524390|467639437|FG000|Open-Label|Liver Transplant|0|||
129911785|NCT04524390|467639438|FG001|Open-Label|Liver Transplant|0|||
129911786|NCT04524390|467639439|FG002|Open-Label|Liver Transplant|1|||
129911787|NCT04524390|467639437|FG000|Open-Label|Disease Progression|0|||
129911788|NCT04524390|467639438|FG001|Open-Label|Disease Progression|0|||
129911789|NCT04524390|467639439|FG002|Open-Label|Disease Progression|1|||
129911790|NCT04524390|467639437|FG000|Open-Label|Adverse Event|0|||
129911791|NCT04524390|467639438|FG001|Open-Label|Adverse Event|0|||
129911792|NCT04524390|467639439|FG002|Open-Label|Adverse Event|3|||
129911793|NCT04524390|467639437|FG000|Open-Label|Study Termination by sponsor|0|||
129911794|NCT04524390|467639438|FG001|Open-Label|Study Termination by sponsor|0|||
129911795|NCT04524390|467639439|FG002|Open-Label|Study Termination by sponsor|45|||
129911796|NCT04540913|467639447|FG000|Overall Study|Withdrawal by Subject|14|||
129911797|NCT04540913|467639448|FG001|Overall Study|Withdrawal by Subject|3|||
129911798|NCT03613740|467639449|FG000|Overall Study|Lost to Follow-up|1|||
129911799|NCT03613740|467639450|FG001|Overall Study|Lost to Follow-up|1|||
129911800|NCT01693120|467639452|FG000|Enrollment|Lost to Follow-up|1|||
129911801|NCT01693120|467639452|FG000|Enrollment|Withdrawal by Subject|10|||
129911802|NCT01693120|467639452|FG000|Enrollment|Protocol Violation|46|||
129911803|NCT01693120|467639452|FG000|Enrollment|Physician Decision|3|||
129911804|NCT01693120|467639452|FG000|Enrollment|Adverse Event|1|||
129911805|NCT01693120|467639452|FG000|Enrollment|Study closed|8|||
129911806|NCT01693120|467639452|FG000|Enrollment|Other|1|||
129911807|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
129911808|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
129911809|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
129911810|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
129911811|NCT01693120|467639452|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
129911812|NCT04153565|467639453|FG000|Overall Study|Death|13|||
129911813|NCT01443845|467639460|FG000|Overall Study|Protocol Violation|43|||
129911814|NCT01443845|467639461|FG001|Overall Study|Protocol Violation|45|||
129911815|NCT01443845|467639460|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
129911816|NCT01443845|467639461|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
129911817|NCT01443845|467639460|FG000|Overall Study|Deterioration in pulmonary function|1|||
129911818|NCT01443845|467639461|FG001|Overall Study|Deterioration in pulmonary function|4|||
129911819|NCT01443845|467639460|FG000|Overall Study|Lack of Efficacy|10|||
129911820|NCT01443845|467639461|FG001|Overall Study|Lack of Efficacy|5|||
129911821|NCT01443845|467639460|FG000|Overall Study|Adverse Event|64|||
129911822|NCT01443845|467639461|FG001|Overall Study|Adverse Event|138|||
129911823|NCT01443845|467639460|FG000|Overall Study|Withdrawal by Subject|63|||
129911824|NCT01443845|467639461|FG001|Overall Study|Withdrawal by Subject|67|||
129911825|NCT01443845|467639460|FG000|Overall Study|Military Conflict - Site Terminated|20|||
129911826|NCT01443845|467639461|FG001|Overall Study|Military Conflict - Site Terminated|21|||
129911827|NCT01443845|467639460|FG000|Overall Study|Lost to Follow-up|9|||
129911828|NCT01443845|467639461|FG001|Overall Study|Lost to Follow-up|13|||
129911829|NCT01610297|467639463|FG000|Overall Study|Lost to Follow-up|1|||
129911830|NCT01007396|467639464|FG000|Overall Study|Lost to Follow-up|47|||
129911831|NCT03283371|467639465|FG000|Placebo-controlled|Adverse Event|1|||
129911832|NCT03283371|467639466|FG001|Placebo-controlled|Adverse Event|1|||
129911833|NCT03283371|467639467|FG002|Placebo-controlled|Adverse Event|0|||
129911834|NCT03283371|467639468|FG003|Placebo-controlled|Adverse Event|0|||
129911835|NCT03283371|467639465|FG000|Placebo-controlled|Lack of Efficacy|1|||
129911836|NCT03283371|467639466|FG001|Placebo-controlled|Lack of Efficacy|0|||
129911837|NCT03283371|467639467|FG002|Placebo-controlled|Lack of Efficacy|0|||
129911838|NCT03283371|467639468|FG003|Placebo-controlled|Lack of Efficacy|0|||
129911839|NCT03283371|467639465|FG000|Placebo-controlled|Withdrawal by Subject|1|||
129911840|NCT03283371|467639466|FG001|Placebo-controlled|Withdrawal by Subject|1|||
129911841|NCT03283371|467639467|FG002|Placebo-controlled|Withdrawal by Subject|0|||
129911842|NCT03283371|467639468|FG003|Placebo-controlled|Withdrawal by Subject|0|||
129911843|NCT03283371|467639465|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
129911844|NCT03283371|467639466|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
129911845|NCT03283371|467639467|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
129911846|NCT03283371|467639468|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
129911847|NCT03283371|467639465|FG000|Open-label Phase|Adverse Event|0|||
129911848|NCT03283371|467639466|FG001|Open-label Phase|Adverse Event|0|||
129911849|NCT03283371|467639467|FG002|Open-label Phase|Adverse Event|2|||
129911850|NCT03283371|467639468|FG003|Open-label Phase|Adverse Event|0|||
129911851|NCT03283371|467639465|FG000|Open-label Phase|Withdrawal by Subject|0|||
129911852|NCT03283371|467639466|FG001|Open-label Phase|Withdrawal by Subject|0|||
129911853|NCT03283371|467639467|FG002|Open-label Phase|Withdrawal by Subject|1|||
129911854|NCT03283371|467639468|FG003|Open-label Phase|Withdrawal by Subject|0|||
129911855|NCT03283371|467639465|FG000|Open-label Phase|Other|0|||
129911856|NCT03283371|467639466|FG001|Open-label Phase|Other|0|||
129911857|NCT03283371|467639467|FG002|Open-label Phase|Other|1|||
129911858|NCT03283371|467639468|FG003|Open-label Phase|Other|1|||
129911859|NCT03076515|467639470|FG000|Overall Study|DMC decision based on interim analysis|25|||
129911860|NCT03076515|467639471|FG001|Overall Study|DMC decision based on interim analysis|29|||
129911861|NCT02554786|467639474|FG000|Overall Study|Subject/guardian decision|29|||
129911862|NCT02554786|467639475|FG001|Overall Study|Subject/guardian decision|17|||
129911863|NCT02554786|467639476|FG002|Overall Study|Subject/guardian decision|18|||
129911864|NCT02554786|467639477|FG003|Overall Study|Subject/guardian decision|30|||
129911865|NCT02554786|467639478|FG004|Overall Study|Subject/guardian decision|20|||
129911866|NCT02554786|467639474|FG000|Overall Study|Lost to Follow-up|4|||
129911867|NCT02554786|467639475|FG001|Overall Study|Lost to Follow-up|3|||
129911868|NCT02554786|467639476|FG002|Overall Study|Lost to Follow-up|4|||
129911869|NCT02554786|467639477|FG003|Overall Study|Lost to Follow-up|2|||
129911870|NCT02554786|467639478|FG004|Overall Study|Lost to Follow-up|2|||
129911871|NCT02554786|467639474|FG000|Overall Study|Protocol deviation|1|||
129911872|NCT02554786|467639475|FG001|Overall Study|Protocol deviation|3|||
129911873|NCT02554786|467639476|FG002|Overall Study|Protocol deviation|3|||
129862533|NCT02239679|467454587|FG000|Overall Study|Lost to Follow-up|1|||
129862534|NCT02239679|467454588|FG001|Overall Study|Lost to Follow-up|0|||
129862535|NCT02239679|467454589|FG002|Overall Study|Lost to Follow-up|0|||
129862536|NCT02239679|467454587|FG000|Overall Study|Withdrawal by Subject|2|||
129862537|NCT02239679|467454588|FG001|Overall Study|Withdrawal by Subject|3|||
129862538|NCT02239679|467454589|FG002|Overall Study|Withdrawal by Subject|1|||
129862539|NCT02047045|467454590|FG000|Baseline|Withdrawal by Subject|3|||
129862540|NCT02047045|467454591|FG001|Baseline|Withdrawal by Subject|2|||
129862541|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
129862542|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
129862543|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
129862544|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
129862545|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
129862546|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
129862547|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
129862548|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
129862549|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
129862550|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
129862551|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
129862552|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
129862553|NCT02047045|467454590|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
129862554|NCT02047045|467454591|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
129862555|NCT02047045|467454590|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
129862556|NCT02047045|467454591|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
129862557|NCT04066114|467454592|FG000|Overall Study|Adverse Event|1|||
129862558|NCT04066114|467454593|FG001|Overall Study|Adverse Event|0|||
129862559|NCT04066114|467454594|FG002|Overall Study|Adverse Event|0|||
129862560|NCT04066114|467454592|FG000|Overall Study|Withdrawal by Subject|1|||
129862561|NCT04066114|467454593|FG001|Overall Study|Withdrawal by Subject|0|||
129862562|NCT04066114|467454594|FG002|Overall Study|Withdrawal by Subject|0|||
129862563|NCT04066114|467454592|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
129862564|NCT04066114|467454593|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
129862565|NCT04066114|467454594|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
129862566|NCT02564523|467454597|FG000|Overall Study|Withdrawal by Subject|3|||
129862567|NCT02564523|467454598|FG001|Overall Study|Withdrawal by Subject|0|||
129862568|NCT02564523|467454599|FG002|Overall Study|Withdrawal by Subject|1|||
129862569|NCT02564523|467454600|FG003|Overall Study|Withdrawal by Subject|0|||
129862570|NCT02564523|467454601|FG004|Overall Study|Withdrawal by Subject|1|||
129862571|NCT02564523|467454602|FG005|Overall Study|Withdrawal by Subject|0|||
129862572|NCT02564523|467454603|FG006|Overall Study|Withdrawal by Subject|1|||
129862573|NCT02564523|467454604|FG007|Overall Study|Withdrawal by Subject|0|||
129862574|NCT02564523|467454605|FG008|Overall Study|Withdrawal by Subject|0|||
129862575|NCT02564523|467454606|FG009|Overall Study|Withdrawal by Subject|0|||
129862576|NCT02564523|467454607|FG010|Overall Study|Withdrawal by Subject|1|||
129862577|NCT02564523|467454608|FG011|Overall Study|Withdrawal by Subject|0|||
129862578|NCT02564523|467454609|FG012|Overall Study|Withdrawal by Subject|1|||
129862579|NCT02564523|467454610|FG013|Overall Study|Withdrawal by Subject|0|||
129862580|NCT02564523|467454611|FG014|Overall Study|Withdrawal by Subject|0|||
129862581|NCT02564523|467454612|FG015|Overall Study|Withdrawal by Subject|0|||
129862582|NCT02564523|467454613|FG016|Overall Study|Withdrawal by Subject|0|||
129862583|NCT02564523|467454614|FG017|Overall Study|Withdrawal by Subject|0|||
129862584|NCT02564523|467454597|FG000|Overall Study|Adverse Event|0|||
129862585|NCT02564523|467454598|FG001|Overall Study|Adverse Event|0|||
129862586|NCT02564523|467454599|FG002|Overall Study|Adverse Event|0|||
129862587|NCT02564523|467454600|FG003|Overall Study|Adverse Event|0|||
129862588|NCT02564523|467454601|FG004|Overall Study|Adverse Event|0|||
129862589|NCT02564523|467454602|FG005|Overall Study|Adverse Event|0|||
129862590|NCT02564523|467454603|FG006|Overall Study|Adverse Event|0|||
129862591|NCT02564523|467454604|FG007|Overall Study|Adverse Event|0|||
129862592|NCT02564523|467454605|FG008|Overall Study|Adverse Event|0|||
129862593|NCT02564523|467454606|FG009|Overall Study|Adverse Event|0|||
129862594|NCT02564523|467454607|FG010|Overall Study|Adverse Event|0|||
129862595|NCT02564523|467454608|FG011|Overall Study|Adverse Event|0|||
129862596|NCT02564523|467454609|FG012|Overall Study|Adverse Event|0|||
129862597|NCT02564523|467454610|FG013|Overall Study|Adverse Event|0|||
129911874|NCT02554786|467639477|FG003|Overall Study|Protocol deviation|4|||
129862598|NCT02564523|467454611|FG014|Overall Study|Adverse Event|0|||
129862599|NCT02564523|467454612|FG015|Overall Study|Adverse Event|0|||
129862600|NCT02564523|467454613|FG016|Overall Study|Adverse Event|0|||
129862601|NCT02564523|467454614|FG017|Overall Study|Adverse Event|1|||
129862602|NCT02564523|467454597|FG000|Overall Study|Death|0|||
129862603|NCT02564523|467454598|FG001|Overall Study|Death|0|||
129862604|NCT02564523|467454599|FG002|Overall Study|Death|0|||
129862605|NCT02564523|467454600|FG003|Overall Study|Death|0|||
129862606|NCT02564523|467454601|FG004|Overall Study|Death|0|||
129862607|NCT02564523|467454602|FG005|Overall Study|Death|0|||
129862608|NCT02564523|467454603|FG006|Overall Study|Death|1|||
129862609|NCT02564523|467454604|FG007|Overall Study|Death|0|||
129862610|NCT02564523|467454605|FG008|Overall Study|Death|0|||
129862611|NCT02564523|467454606|FG009|Overall Study|Death|0|||
129862612|NCT02564523|467454607|FG010|Overall Study|Death|1|||
129862613|NCT02564523|467454608|FG011|Overall Study|Death|0|||
129862614|NCT02564523|467454609|FG012|Overall Study|Death|0|||
129862615|NCT02564523|467454610|FG013|Overall Study|Death|0|||
129862616|NCT02564523|467454611|FG014|Overall Study|Death|0|||
129862617|NCT02564523|467454612|FG015|Overall Study|Death|0|||
129862618|NCT02564523|467454613|FG016|Overall Study|Death|0|||
129862619|NCT02564523|467454614|FG017|Overall Study|Death|0|||
129862620|NCT02564523|467454597|FG000|Overall Study|Lost to Follow-up|2|||
129862621|NCT02564523|467454598|FG001|Overall Study|Lost to Follow-up|1|||
129862622|NCT02564523|467454599|FG002|Overall Study|Lost to Follow-up|4|||
129862623|NCT02564523|467454600|FG003|Overall Study|Lost to Follow-up|0|||
129862624|NCT02564523|467454601|FG004|Overall Study|Lost to Follow-up|1|||
129862625|NCT02564523|467454602|FG005|Overall Study|Lost to Follow-up|0|||
129862626|NCT02564523|467454603|FG006|Overall Study|Lost to Follow-up|1|||
129862627|NCT02564523|467454604|FG007|Overall Study|Lost to Follow-up|0|||
129862628|NCT02564523|467454605|FG008|Overall Study|Lost to Follow-up|0|||
129862629|NCT02564523|467454606|FG009|Overall Study|Lost to Follow-up|0|||
129862630|NCT02564523|467454607|FG010|Overall Study|Lost to Follow-up|0|||
129862631|NCT02564523|467454608|FG011|Overall Study|Lost to Follow-up|1|||
129862632|NCT02564523|467454609|FG012|Overall Study|Lost to Follow-up|1|||
129862633|NCT02564523|467454610|FG013|Overall Study|Lost to Follow-up|0|||
129862634|NCT02564523|467454611|FG014|Overall Study|Lost to Follow-up|0|||
129862635|NCT02564523|467454612|FG015|Overall Study|Lost to Follow-up|0|||
129862636|NCT02564523|467454613|FG016|Overall Study|Lost to Follow-up|0|||
129862637|NCT02564523|467454614|FG017|Overall Study|Lost to Follow-up|0|||
129862638|NCT02564523|467454597|FG000|Overall Study|Physician Decision|0|||
129862639|NCT02564523|467454598|FG001|Overall Study|Physician Decision|0|||
129862640|NCT02564523|467454599|FG002|Overall Study|Physician Decision|0|||
129862641|NCT02564523|467454600|FG003|Overall Study|Physician Decision|0|||
129862642|NCT02564523|467454601|FG004|Overall Study|Physician Decision|1|||
129862643|NCT02564523|467454602|FG005|Overall Study|Physician Decision|0|||
129862644|NCT02564523|467454603|FG006|Overall Study|Physician Decision|0|||
129862645|NCT02564523|467454604|FG007|Overall Study|Physician Decision|0|||
129862646|NCT02564523|467454605|FG008|Overall Study|Physician Decision|0|||
129862647|NCT02564523|467454606|FG009|Overall Study|Physician Decision|0|||
129862648|NCT02564523|467454607|FG010|Overall Study|Physician Decision|1|||
129862649|NCT02564523|467454608|FG011|Overall Study|Physician Decision|0|||
129862650|NCT02564523|467454609|FG012|Overall Study|Physician Decision|0|||
129862651|NCT02564523|467454610|FG013|Overall Study|Physician Decision|0|||
129862652|NCT02564523|467454611|FG014|Overall Study|Physician Decision|0|||
129862653|NCT02564523|467454612|FG015|Overall Study|Physician Decision|0|||
129862654|NCT02564523|467454613|FG016|Overall Study|Physician Decision|0|||
129862655|NCT02564523|467454614|FG017|Overall Study|Physician Decision|0|||
129862656|NCT02564523|467454597|FG000|Overall Study|Protocol Violation|2|||
129862657|NCT02564523|467454598|FG001|Overall Study|Protocol Violation|2|||
129862658|NCT02564523|467454599|FG002|Overall Study|Protocol Violation|5|||
129862659|NCT02564523|467454600|FG003|Overall Study|Protocol Violation|0|||
129862660|NCT02564523|467454601|FG004|Overall Study|Protocol Violation|1|||
129862661|NCT02564523|467454602|FG005|Overall Study|Protocol Violation|0|||
129862662|NCT02564523|467454603|FG006|Overall Study|Protocol Violation|0|||
129862663|NCT02564523|467454604|FG007|Overall Study|Protocol Violation|0|||
129862664|NCT02564523|467454605|FG008|Overall Study|Protocol Violation|0|||
129862665|NCT02564523|467454606|FG009|Overall Study|Protocol Violation|0|||
129862666|NCT02564523|467454607|FG010|Overall Study|Protocol Violation|0|||
129862667|NCT02564523|467454608|FG011|Overall Study|Protocol Violation|0|||
129862668|NCT02564523|467454609|FG012|Overall Study|Protocol Violation|0|||
129862669|NCT02564523|467454610|FG013|Overall Study|Protocol Violation|0|||
129862670|NCT02564523|467454611|FG014|Overall Study|Protocol Violation|0|||
129862671|NCT02564523|467454612|FG015|Overall Study|Protocol Violation|0|||
129862672|NCT02564523|467454613|FG016|Overall Study|Protocol Violation|0|||
129862673|NCT02564523|467454614|FG017|Overall Study|Protocol Violation|0|||
129862674|NCT02564523|467454597|FG000|Overall Study|Other|3|||
129862675|NCT02564523|467454598|FG001|Overall Study|Other|0|||
129862676|NCT02564523|467454599|FG002|Overall Study|Other|0|||
129862677|NCT02564523|467454600|FG003|Overall Study|Other|1|||
129862678|NCT02564523|467454601|FG004|Overall Study|Other|0|||
129862679|NCT02564523|467454602|FG005|Overall Study|Other|0|||
129862680|NCT02564523|467454603|FG006|Overall Study|Other|0|||
129862681|NCT02564523|467454604|FG007|Overall Study|Other|0|||
129862682|NCT02564523|467454605|FG008|Overall Study|Other|0|||
129911875|NCT02554786|467639478|FG004|Overall Study|Protocol deviation|2|||
129911876|NCT02554786|467639474|FG000|Overall Study|Technical problems|1|||
129911877|NCT02554786|467639475|FG001|Overall Study|Technical problems|1|||
129911878|NCT02554786|467639476|FG002|Overall Study|Technical problems|0|||
129911879|NCT02554786|467639477|FG003|Overall Study|Technical problems|2|||
129911880|NCT02554786|467639478|FG004|Overall Study|Technical problems|1|||
129911881|NCT02554786|467639474|FG000|Overall Study|Adverse Event|0|||
129911882|NCT02554786|467639475|FG001|Overall Study|Adverse Event|0|||
129911883|NCT02554786|467639476|FG002|Overall Study|Adverse Event|0|||
129911884|NCT02554786|467639477|FG003|Overall Study|Adverse Event|0|||
129911885|NCT02554786|467639478|FG004|Overall Study|Adverse Event|2|||
129911886|NCT02554786|467639474|FG000|Overall Study|Death|0|||
129911887|NCT02554786|467639475|FG001|Overall Study|Death|0|||
129911888|NCT02554786|467639476|FG002|Overall Study|Death|0|||
129911889|NCT02554786|467639477|FG003|Overall Study|Death|1|||
129911890|NCT02554786|467639478|FG004|Overall Study|Death|0|||
129911891|NCT02554786|467639474|FG000|Overall Study|Non-compliance with study treatment|0|||
129911892|NCT02554786|467639475|FG001|Overall Study|Non-compliance with study treatment|1|||
129911893|NCT02554786|467639476|FG002|Overall Study|Non-compliance with study treatment|1|||
129911894|NCT02554786|467639477|FG003|Overall Study|Non-compliance with study treatment|0|||
129911895|NCT02554786|467639478|FG004|Overall Study|Non-compliance with study treatment|1|||
129911896|NCT02554786|467639474|FG000|Overall Study|Physician Decision|0|||
129911897|NCT02554786|467639475|FG001|Overall Study|Physician Decision|1|||
129911898|NCT02554786|467639476|FG002|Overall Study|Physician Decision|4|||
129911899|NCT02554786|467639477|FG003|Overall Study|Physician Decision|1|||
129911900|NCT02554786|467639478|FG004|Overall Study|Physician Decision|1|||
129911901|NCT02554786|467639474|FG000|Overall Study|Pregnancy|0|||
129911902|NCT02554786|467639475|FG001|Overall Study|Pregnancy|0|||
129911903|NCT02554786|467639476|FG002|Overall Study|Pregnancy|0|||
129911904|NCT02554786|467639477|FG003|Overall Study|Pregnancy|1|||
129911905|NCT02554786|467639478|FG004|Overall Study|Pregnancy|1|||
129911906|NCT04704284|467639479|FG000|Overall Study|Withdrawal by Subject|1|||
129911907|NCT00539734|467639481|FG000|Overall Study|Protocol Violation|1|||
129911908|NCT02692417|467639484|FG000|Overall Study|Withdrawal by Subject|5|||
129911909|NCT02692417|467639485|FG001|Overall Study|Withdrawal by Subject|1|||
129911910|NCT02692417|467639484|FG000|Overall Study|Adverse Event|1|||
129911911|NCT02692417|467639485|FG001|Overall Study|Adverse Event|0|||
129911912|NCT02372253|467639486|FG000|Overall Study|Non Compliance|2|||
129911913|NCT02372253|467639487|FG001|Overall Study|Non Compliance|0|||
129911914|NCT02178098|467639493|FG000|Overall Study|Withdrawal by Subject|0|||
129911915|NCT02178098|467639494|FG001|Overall Study|Withdrawal by Subject|6|||
129911916|NCT02178098|467639493|FG000|Overall Study|Adverse Event|1|||
129911917|NCT02178098|467639494|FG001|Overall Study|Adverse Event|2|||
129911918|NCT02178098|467639493|FG000|Overall Study|Protocol Violation|1|||
129911919|NCT02178098|467639494|FG001|Overall Study|Protocol Violation|1|||
129911920|NCT02178098|467639493|FG000|Overall Study|Lost to Follow-up|0|||
129911921|NCT02178098|467639494|FG001|Overall Study|Lost to Follow-up|1|||
129911922|NCT02178098|467639493|FG000|Overall Study|Sponsor Request|1|||
129911923|NCT02178098|467639494|FG001|Overall Study|Sponsor Request|0|||
129911924|NCT02178098|467639493|FG000|Overall Study|Other|2|||
129911925|NCT02178098|467639494|FG001|Overall Study|Other|2|||
129911926|NCT01044303|467639497|FG000|Overall Study|Lost to Follow-up|2|||
129911927|NCT01109524|467639498|FG000|Overall Study|Disease Progression|29|||
129911928|NCT01109524|467639498|FG000|Overall Study|Study Drug toxicity|6|||
129911929|NCT01109524|467639498|FG000|Overall Study|Adverse Event|4|||
129911930|NCT01109524|467639498|FG000|Overall Study|Withdrawal by Subject|2|||
129911931|NCT01109524|467639498|FG000|Overall Study|Maximum clinical benefit|3|||
129911932|NCT01109524|467639498|FG000|Overall Study|Death|2|||
129911933|NCT01109524|467639498|FG000|Overall Study|No longer meets criteria|2|||
129911934|NCT01109524|467639498|FG000|Overall Study|Participant requested to end treatment|4|||
129911935|NCT01109524|467639498|FG000|Overall Study|Other|5|||
129911936|NCT04048382|467639510|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
129911937|NCT04048382|467639511|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
129911938|NCT04048382|467639510|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
129911939|NCT04048382|467639511|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
129911940|NCT04048382|467639510|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
129911941|NCT04048382|467639511|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
129911942|NCT01205048|467639513|FG000|Overall Study|Withdrawal by Subject|14|||
129911943|NCT01205048|467639513|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
129911944|NCT01205048|467639513|FG000|Overall Study|Lost to Follow-up|4|||
129911945|NCT01205048|467639513|FG000|Overall Study|Other|2|||
129911946|NCT01255670|467639514|FG000|Overall Study|Adverse Event|10|||
129911947|NCT01255670|467639515|FG001|Overall Study|Adverse Event|10|||
129911948|NCT01255670|467639514|FG000|Overall Study|Lost to Follow-up|16|||
129911949|NCT01255670|467639515|FG001|Overall Study|Lost to Follow-up|10|||
129911950|NCT01037985|467639516|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
129911951|NCT01037985|467639517|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
129911952|NCT01037985|467639516|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
129911953|NCT01037985|467639517|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
129911954|NCT01037985|467639516|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
129911955|NCT01037985|467639517|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
129911956|NCT01037985|467639516|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
129911957|NCT01037985|467639517|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
129911958|NCT02269475|467639518|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
129911959|NCT02269475|467639519|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
129911960|NCT02269475|467639518|FG000|Overall Study|Withdrawal by Subject|0|||
129911961|NCT02269475|467639519|FG001|Overall Study|Withdrawal by Subject|1|||
129911962|NCT02730871|467639520|FG000|Overall Study|Adverse Event|6|||
129911963|NCT02730871|467639521|FG001|Overall Study|Adverse Event|0|||
129911964|NCT00823472|467639522|FG000|Overall Study|Physician Decision|24|||
129911965|NCT00823472|467639523|FG001|Overall Study|Physician Decision|28|||
129911966|NCT04992390|467639524|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
129911967|NCT04992390|467639525|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
129911968|NCT04992390|467639526|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
129911969|NCT04992390|467639524|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
129911970|NCT04992390|467639525|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
129911971|NCT04992390|467639526|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
129911972|NCT04992390|467639524|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
129911973|NCT04992390|467639525|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
129911974|NCT04992390|467639526|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
129862683|NCT02564523|467454606|FG009|Overall Study|Other|0|||
129911975|NCT04992390|467639524|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
129911976|NCT04992390|467639525|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
129911977|NCT04992390|467639526|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
129911978|NCT04992390|467639524|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
129862684|NCT02564523|467454607|FG010|Overall Study|Other|0|||
129862685|NCT02564523|467454608|FG011|Overall Study|Other|0|||
129862686|NCT02564523|467454609|FG012|Overall Study|Other|0|||
129862687|NCT02564523|467454610|FG013|Overall Study|Other|0|||
129862688|NCT02564523|467454611|FG014|Overall Study|Other|0|||
129862689|NCT02564523|467454612|FG015|Overall Study|Other|0|||
129862690|NCT02564523|467454613|FG016|Overall Study|Other|0|||
129862691|NCT02564523|467454614|FG017|Overall Study|Other|0|||
129862692|NCT04862143|467454629|FG000|Overall Study|Adverse Event|1|||
129862693|NCT04862143|467454629|FG000|Overall Study|Study terminated by sponsor|1|||
129862694|NCT03031938|467454630|FG000|Overall Study|Death|1|||
129862695|NCT03031938|467454631|FG001|Overall Study|Death|0|||
129862696|NCT02479412|467454634|FG000|Overall Study|Adverse Event|0|||
129862697|NCT02479412|467454635|FG001|Overall Study|Adverse Event|0|||
129862698|NCT02479412|467454636|FG002|Overall Study|Adverse Event|1|||
129862699|NCT02479412|467454637|FG003|Overall Study|Adverse Event|0|||
129862700|NCT02479412|467454638|FG004|Overall Study|Adverse Event|0|||
129862701|NCT02479412|467454639|FG005|Overall Study|Adverse Event|0|||
129862702|NCT02479412|467454640|FG006|Overall Study|Adverse Event|0|||
129862703|NCT02479412|467454641|FG007|Overall Study|Adverse Event|0|||
129862704|NCT02479412|467454642|FG008|Overall Study|Adverse Event|0|||
129862705|NCT02479412|467454634|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129862706|NCT02479412|467454635|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129862707|NCT02479412|467454636|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129862708|NCT02479412|467454637|FG003|Overall Study|Study-specific withdrawal criteria|1|||
129862709|NCT02479412|467454638|FG004|Overall Study|Study-specific withdrawal criteria|0|||
129862710|NCT02479412|467454639|FG005|Overall Study|Study-specific withdrawal criteria|0|||
129862711|NCT02479412|467454640|FG006|Overall Study|Study-specific withdrawal criteria|0|||
129862712|NCT02479412|467454641|FG007|Overall Study|Study-specific withdrawal criteria|1|||
129862713|NCT02479412|467454642|FG008|Overall Study|Study-specific withdrawal criteria|1|||
129862714|NCT02479412|467454634|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
129862715|NCT02479412|467454635|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
129862716|NCT02479412|467454636|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
129862717|NCT02479412|467454637|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
129862718|NCT02479412|467454638|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
129862719|NCT02479412|467454639|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
129862720|NCT02479412|467454640|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
129862721|NCT02479412|467454641|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
129862722|NCT02479412|467454642|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
129862723|NCT00454051|467454643|FG000|Overall Study|Adverse Event|1|||
129862724|NCT00454051|467454644|FG001|Overall Study|Adverse Event|2|||
129862725|NCT00454051|467454643|FG000|Overall Study|Withdrawal by Subject|1|||
129862726|NCT00454051|467454644|FG001|Overall Study|Withdrawal by Subject|0|||
129862727|NCT00454051|467454643|FG000|Overall Study|Protocol Violation|1|||
129862728|NCT00454051|467454644|FG001|Overall Study|Protocol Violation|1|||
129862729|NCT03117738|467454645|FG000|Overall Study|Withdrawal by Subject|3|||
129862730|NCT03117738|467454646|FG001|Overall Study|Withdrawal by Subject|1|||
129862731|NCT03117738|467454645|FG000|Overall Study|Lost to Follow-up|1|||
129862732|NCT03117738|467454646|FG001|Overall Study|Lost to Follow-up|4|||
129862733|NCT03667053|467454648|FG000|Overall Study|Withdrawal by Subject|1|||
129862734|NCT03667053|467454649|FG001|Overall Study|Withdrawal by Subject|0|||
129862735|NCT03667053|467454650|FG002|Overall Study|Withdrawal by Subject|0|||
129862736|NCT00487162|467454657|FG000|Overall Study|Adverse Event|0|||
129862737|NCT00487162|467454658|FG001|Overall Study|Adverse Event|1|||
129862738|NCT00487162|467454657|FG000|Overall Study|Physician Decision|0|||
129862739|NCT00487162|467454658|FG001|Overall Study|Physician Decision|1|||
129862740|NCT00487162|467454657|FG000|Overall Study|Withdrawal by Subject|2|||
129862741|NCT00487162|467454658|FG001|Overall Study|Withdrawal by Subject|3|||
129862742|NCT01491854|467454659|FG000|Overall Study|mainly due to premature termination|93|||
129862743|NCT01491854|467454659|FG000|Overall Study|Death|1|||
129862744|NCT01491854|467454659|FG000|Overall Study|Withdrawal by Subject|3|||
129862745|NCT01491854|467454659|FG000|Overall Study|Lost to Follow-up|33|||
129862746|NCT05545072|467454665|FG000|Overall Study|Lost to Follow-up|1|||
129862747|NCT05545072|467454666|FG001|Overall Study|Lost to Follow-up|0|||
129862748|NCT05545072|467454665|FG000|Overall Study|Study ended prematurely due to funding|2|||
129862749|NCT05545072|467454666|FG001|Overall Study|Study ended prematurely due to funding|2|||
129862750|NCT04732286|467454672|FG000|Overall Study|Progressive Disease|2|||
129862751|NCT04732286|467454672|FG000|Overall Study|Physician Decision|1|||
129862752|NCT04732286|467454672|FG000|Overall Study|Study Terminated by Sponsor|31|||
129862753|NCT04732286|467454672|FG000|Overall Study|Withdrawal by Subject|10|||
129862754|NCT04732286|467454672|FG000|Overall Study|Non-compliance With Study Drug|1|||
129862755|NCT04732286|467454672|FG000|Overall Study|Lost to Follow-up|4|||
129862756|NCT04732286|467454672|FG000|Overall Study|Death|51|||
129862757|NCT01474681|467454673|FG000|Overall Study|Death|0|||
129862758|NCT01474681|467454674|FG001|Overall Study|Death|3|||
129862759|NCT01474681|467454675|FG002|Overall Study|Death|2|||
129862760|NCT01474681|467454676|FG003|Overall Study|Death|6|||
129862761|NCT03998618|467454677|FG000|Overall Study|Death|7|||
129862762|NCT03998618|467454678|FG001|Overall Study|Death|11|||
129862763|NCT03998618|467454677|FG000|Overall Study|hospice enrollment|3|||
129862764|NCT03998618|467454678|FG001|Overall Study|hospice enrollment|3|||
129862765|NCT03998618|467454677|FG000|Overall Study|Not feeling well/health problems|3|||
129862766|NCT03998618|467454678|FG001|Overall Study|Not feeling well/health problems|5|||
129862767|NCT03998618|467454677|FG000|Overall Study|Lost to Follow-up|6|||
129862768|NCT03998618|467454678|FG001|Overall Study|Lost to Follow-up|6|||
129862769|NCT03998618|467454677|FG000|Overall Study|Withdrawal by Subject|0|||
129862770|NCT03998618|467454678|FG001|Overall Study|Withdrawal by Subject|4|||
129862771|NCT02834780|467454679|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
129862772|NCT02834780|467454680|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
129862773|NCT02834780|467454681|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
129862774|NCT02834780|467454682|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
129862775|NCT02834780|467454683|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
129862776|NCT02834780|467454684|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
129862777|NCT02834780|467454685|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
129862778|NCT02834780|467454686|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
129862779|NCT02834780|467454687|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
129862780|NCT02834780|467454688|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
129862781|NCT02834780|467454689|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
129862782|NCT02834780|467454690|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
129862783|NCT02834780|467454691|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
129862784|NCT02834780|467454679|FG000|Overall Study|Withdrawal by Subject|0|||
129862785|NCT02834780|467454680|FG001|Overall Study|Withdrawal by Subject|0|||
129862786|NCT02834780|467454681|FG002|Overall Study|Withdrawal by Subject|1|||
129862787|NCT02834780|467454682|FG003|Overall Study|Withdrawal by Subject|0|||
129862788|NCT02834780|467454683|FG004|Overall Study|Withdrawal by Subject|0|||
129862789|NCT02834780|467454684|FG005|Overall Study|Withdrawal by Subject|0|||
129862790|NCT02834780|467454685|FG006|Overall Study|Withdrawal by Subject|0|||
129862791|NCT02834780|467454686|FG007|Overall Study|Withdrawal by Subject|0|||
129862792|NCT02834780|467454687|FG008|Overall Study|Withdrawal by Subject|0|||
129862793|NCT02834780|467454688|FG009|Overall Study|Withdrawal by Subject|0|||
129911979|NCT04992390|467639525|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
129911980|NCT04992390|467639526|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
129862794|NCT02834780|467454689|FG010|Overall Study|Withdrawal by Subject|1|||
129862795|NCT02834780|467454690|FG011|Overall Study|Withdrawal by Subject|0|||
129862796|NCT02834780|467454691|FG012|Overall Study|Withdrawal by Subject|0|||
129862797|NCT02834780|467454679|FG000|Overall Study|Adverse Event|0|||
129862798|NCT02834780|467454680|FG001|Overall Study|Adverse Event|0|||
129911981|NCT04992390|467639524|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
129862799|NCT02834780|467454681|FG002|Overall Study|Adverse Event|0|||
129862800|NCT02834780|467454682|FG003|Overall Study|Adverse Event|0|||
129862801|NCT02834780|467454683|FG004|Overall Study|Adverse Event|1|||
129862802|NCT02834780|467454684|FG005|Overall Study|Adverse Event|0|||
129862803|NCT02834780|467454685|FG006|Overall Study|Adverse Event|1|||
129862804|NCT02834780|467454686|FG007|Overall Study|Adverse Event|1|||
129862805|NCT02834780|467454687|FG008|Overall Study|Adverse Event|0|||
129862806|NCT02834780|467454688|FG009|Overall Study|Adverse Event|2|||
129862807|NCT02834780|467454689|FG010|Overall Study|Adverse Event|0|||
129862808|NCT02834780|467454690|FG011|Overall Study|Adverse Event|3|||
129862809|NCT02834780|467454691|FG012|Overall Study|Adverse Event|2|||
129862810|NCT02834780|467454679|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862811|NCT02834780|467454680|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
129862812|NCT02834780|467454681|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
129862813|NCT02834780|467454682|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862814|NCT02834780|467454683|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862815|NCT02834780|467454684|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862816|NCT02834780|467454685|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862817|NCT02834780|467454686|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
129862818|NCT02834780|467454687|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
129862819|NCT02834780|467454688|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
129862820|NCT02834780|467454689|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
129862821|NCT02834780|467454690|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
129862822|NCT02834780|467454691|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
129862823|NCT02834780|467454679|FG000|Overall Study|Other|1|||
129862824|NCT02834780|467454680|FG001|Overall Study|Other|0|||
129862825|NCT02834780|467454681|FG002|Overall Study|Other|1|||
129862826|NCT02834780|467454682|FG003|Overall Study|Other|2|||
129862827|NCT02834780|467454683|FG004|Overall Study|Other|0|||
129862828|NCT02834780|467454684|FG005|Overall Study|Other|0|||
129862829|NCT02834780|467454685|FG006|Overall Study|Other|0|||
129862830|NCT02834780|467454686|FG007|Overall Study|Other|0|||
129862831|NCT02834780|467454687|FG008|Overall Study|Other|0|||
129862832|NCT02834780|467454688|FG009|Overall Study|Other|0|||
129862833|NCT02834780|467454689|FG010|Overall Study|Other|0|||
129862834|NCT02834780|467454690|FG011|Overall Study|Other|0|||
129862835|NCT02834780|467454691|FG012|Overall Study|Other|1|||
129862836|NCT02081846|467454692|FG000|Overall Study|Withdrawal by Subject|1|||
129862837|NCT02081846|467454693|FG001|Overall Study|Withdrawal by Subject|0|||
129862838|NCT02081846|467454692|FG000|Overall Study|invalid consent|1|||
129862839|NCT02081846|467454693|FG001|Overall Study|invalid consent|0|||
129862840|NCT03282227|467454694|FG000|Overall Study|Exposure Goals Achieved|60|||
129862841|NCT03282227|467454694|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
129862842|NCT03282227|467454694|FG000|Overall Study|Adverse Event|15|||
129862843|NCT03282227|467454694|FG000|Overall Study|Lost to Follow-up|21|||
129862844|NCT03282227|467454694|FG000|Overall Study|Withdrawal by Subject|20|||
129862845|NCT03282227|467454694|FG000|Overall Study|Lack of Efficacy|12|||
129862846|NCT03282227|467454694|FG000|Overall Study|Sponsor decision|3|||
129862847|NCT03282227|467454694|FG000|Overall Study|Physician Decision|2|||
129862848|NCT03282227|467454694|FG000|Overall Study|Pregnancy|2|||
129862849|NCT03282227|467454694|FG000|Overall Study|Other|1|||
129862850|NCT01881126|467454716|FG000|Overall Study|Non-compliance|1|||
129862851|NCT01881126|467454717|FG001|Overall Study|Non-compliance|1|||
129862852|NCT01881126|467454716|FG000|Overall Study|Adverse Event|0|||
129862853|NCT01881126|467454717|FG001|Overall Study|Adverse Event|1|||
129862854|NCT01090453|467454720|FG000|Overall Study|Withdrawal by Subject|1|||
129862855|NCT01090453|467454721|FG001|Overall Study|Withdrawal by Subject|2|||
129862856|NCT01090453|467454720|FG000|Overall Study|Lost to Follow-up|7|||
129862857|NCT01090453|467454721|FG001|Overall Study|Lost to Follow-up|7|||
129862858|NCT01090453|467454720|FG000|Overall Study|Non serious AEs|1|||
129862859|NCT01090453|467454721|FG001|Overall Study|Non serious AEs|0|||
129862860|NCT01090453|467454720|FG000|Overall Study|Protocol Violation|2|||
129862861|NCT01090453|467454721|FG001|Overall Study|Protocol Violation|0|||
129862862|NCT01090453|467454720|FG000|Overall Study|Other|2|||
129862863|NCT01090453|467454721|FG001|Overall Study|Other|4|||
129862864|NCT01090453|467454720|FG000|Overall Study|Eligibility Criteria|0|||
129862865|NCT01090453|467454721|FG001|Overall Study|Eligibility Criteria|1|||
129862866|NCT04072159|467454722|FG000|Overall Study|Lost to Follow-up|6|||
129862867|NCT04072159|467454723|FG001|Overall Study|Lost to Follow-up|6|||
129862868|NCT04072159|467454722|FG000|Overall Study|Withdrawal by Subject|2|||
129862869|NCT04072159|467454723|FG001|Overall Study|Withdrawal by Subject|0|||
129862870|NCT00695669|467454729|FG000|Overall Study|Adverse Event|0|||
129862871|NCT00695669|467454730|FG001|Overall Study|Adverse Event|0|||
129862872|NCT00695669|467454731|FG002|Overall Study|Adverse Event|2|||
129862873|NCT00695669|467454732|FG003|Overall Study|Adverse Event|0|||
129862874|NCT00695669|467454729|FG000|Overall Study|Lost to Follow-up|4|||
129862875|NCT00695669|467454730|FG001|Overall Study|Lost to Follow-up|4|||
129862876|NCT00695669|467454731|FG002|Overall Study|Lost to Follow-up|1|||
129862877|NCT00695669|467454732|FG003|Overall Study|Lost to Follow-up|4|||
129862878|NCT05045625|467454733|FG000|Overall Study|Lost to Follow-up|3|||
129911982|NCT04992390|467639525|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
129911983|NCT04992390|467639526|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
129911984|NCT04992390|467639524|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
129911985|NCT04992390|467639525|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
129911986|NCT04992390|467639526|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
129911987|NCT04992390|467639524|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
129911988|NCT04992390|467639525|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
129911989|NCT04992390|467639526|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
129911990|NCT04992390|467639524|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
129911991|NCT04992390|467639525|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
129911992|NCT04992390|467639526|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
129911993|NCT04992390|467639524|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
129911994|NCT04992390|467639525|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
129911995|NCT04992390|467639526|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
129911996|NCT04992390|467639524|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
129911997|NCT04992390|467639525|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
129911998|NCT04992390|467639526|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
129911999|NCT04992390|467639524|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
129912000|NCT04992390|467639525|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
129912001|NCT04992390|467639526|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
129912002|NCT04992390|467639524|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
129912003|NCT04992390|467639525|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
129912004|NCT04992390|467639526|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
129912005|NCT04992390|467639524|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
129912006|NCT04992390|467639525|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
129912007|NCT04992390|467639526|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
129912008|NCT04992390|467639524|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
129912009|NCT04992390|467639525|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
129912010|NCT04992390|467639526|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
129912011|NCT04992390|467639524|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
129912012|NCT04992390|467639525|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
129912013|NCT04992390|467639526|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
129912014|NCT02807779|467639527|FG000|Overall Study|Lost to Follow-up|1|||
129912015|NCT02807779|467639528|FG001|Overall Study|Lost to Follow-up|0|||
129912016|NCT02807779|467639529|FG002|Overall Study|Lost to Follow-up|0|||
129912017|NCT02807779|467639527|FG000|Overall Study|Physician Decision|2|||
129912018|NCT02807779|467639528|FG001|Overall Study|Physician Decision|0|||
129912019|NCT02807779|467639529|FG002|Overall Study|Physician Decision|1|||
129912020|NCT02807779|467639527|FG000|Overall Study|Death|1|||
129912021|NCT02807779|467639528|FG001|Overall Study|Death|1|||
129912022|NCT02807779|467639529|FG002|Overall Study|Death|0|||
129912023|NCT03783026|467640630|FG000|Treatment Phase|Adverse Event|15|||
129912024|NCT03783026|467640630|FG000|Treatment Phase|Lack of Efficacy|11|||
129912025|NCT03783026|467640630|FG000|Treatment Phase|Withdrawal by Subject|6|||
129912026|NCT03783026|467640630|FG000|Treatment Phase|Lost to Follow-up|2|||
129912027|NCT03783026|467640630|FG000|Treatment Phase|Protocol Deviation|8|||
129912028|NCT03783026|467640630|FG000|Treatment Phase|Did Not Receive Treatment|1|||
129912029|NCT03783026|467640630|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
129912030|NCT01853748|467640631|FG000|Allocation|Withdrawal by Subject|1|||
129912031|NCT01853748|467640632|FG001|Allocation|Withdrawal by Subject|13|||
129912032|NCT01853748|467640631|FG000|Allocation|not sufficient to receive intervention|0|||
129912033|NCT01853748|467640632|FG001|Allocation|not sufficient to receive intervention|1|||
129912034|NCT01853748|467640631|FG000|Follow-Up|Withdrawal by Subject|7|||
129912035|NCT01853748|467640632|FG001|Follow-Up|Withdrawal by Subject|6|||
129912036|NCT01853748|467640631|FG000|Follow-Up|Adverse Event|67|||
129912037|NCT01853748|467640632|FG001|Follow-Up|Adverse Event|7|||
129912038|NCT01853748|467640631|FG000|Follow-Up|not available for data collection|16|||
129912039|NCT01853748|467640632|FG001|Follow-Up|not available for data collection|4|||
129912040|NCT03397108|467640643|FG000|Overall Study|Lost to Follow-up|15|||
129912041|NCT03397108|467640644|FG001|Overall Study|Lost to Follow-up|0|||
129912042|NCT03397108|467640643|FG000|Overall Study|Insufficient milk production|3|||
129912043|NCT03397108|467640644|FG001|Overall Study|Insufficient milk production|2|||
129912044|NCT03397108|467640643|FG000|Overall Study|Withdrawal by Subject|2|||
129912045|NCT03397108|467640644|FG001|Overall Study|Withdrawal by Subject|0|||
129912046|NCT03554265|467640645|FG000|Overall Study|Withdrawal by Subject|2|||
129912047|NCT03554265|467640646|FG001|Overall Study|Withdrawal by Subject|2|||
129912048|NCT03554265|467640647|FG002|Overall Study|Withdrawal by Subject|3|||
129912049|NCT03554265|467640645|FG000|Overall Study|Physician Decision|0|||
129912050|NCT03554265|467640646|FG001|Overall Study|Physician Decision|0|||
129912051|NCT03554265|467640647|FG002|Overall Study|Physician Decision|1|||
129912052|NCT05386238|467640648|FG000|Overall Study|Lost to Follow-up|3|||
129912053|NCT05386238|467640649|FG001|Overall Study|Lost to Follow-up|2|||
129912054|NCT05386238|467640648|FG000|Overall Study|Withdrawal by Subject|0|||
129912055|NCT05386238|467640649|FG001|Overall Study|Withdrawal by Subject|1|||
129912056|NCT04755660|467640650|FG000|Overall Study|Lost to Follow-up|1|||
129912057|NCT04755660|467640651|FG001|Overall Study|Lost to Follow-up|1|||
129912058|NCT04755660|467640652|FG002|Overall Study|Lost to Follow-up|0|||
129912059|NCT04755660|467640650|FG000|Overall Study|Withdrawal by Subject|0|||
129912060|NCT04755660|467640651|FG001|Overall Study|Withdrawal by Subject|1|||
129912061|NCT04755660|467640652|FG002|Overall Study|Withdrawal by Subject|1|||
129912062|NCT04755660|467640650|FG000|Overall Study|Physician Decision|0|||
129912063|NCT04755660|467640651|FG001|Overall Study|Physician Decision|0|||
129912064|NCT04755660|467640652|FG002|Overall Study|Physician Decision|1|||
129912065|NCT05672667|467640653|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
129912066|NCT03088813|467640654|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
129912067|NCT03088813|467640655|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
129912068|NCT03088813|467640656|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
129912069|NCT03088813|467640657|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
129912070|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
129912071|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
129912072|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
129912073|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
129912074|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
129912075|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
129912076|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
129912077|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
129912078|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
129912079|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
129912080|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
129912081|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
129912082|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
129912083|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
129912084|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
129912085|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
129912086|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
129912087|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
129912088|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
129912089|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
129912090|NCT03088813|467640654|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
129912091|NCT03088813|467640655|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
129912092|NCT03088813|467640656|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
129912093|NCT03088813|467640657|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
129912094|NCT01903811|467640665|FG000|Overall Study|No measurable disease|1|||
129912095|NCT01903811|467640666|FG001|Overall Study|No measurable disease|1|||
129912096|NCT01903811|467640665|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
129912097|NCT01903811|467640666|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
129912098|NCT01903811|467640665|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
129912099|NCT01903811|467640666|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
129912100|NCT01903811|467640665|FG000|Overall Study|Withdrawal by Subject|0|||
129912101|NCT01903811|467640666|FG001|Overall Study|Withdrawal by Subject|1|||
129912102|NCT00670046|467640667|FG000|Overall Study|Lost to Follow-up|1|||
129912103|NCT00670046|467640668|FG001|Overall Study|Lost to Follow-up|1|||
129912104|NCT00670046|467640667|FG000|Overall Study|Withdrawal by Subject|0|||
129912105|NCT00670046|467640668|FG001|Overall Study|Withdrawal by Subject|1|||
129912106|NCT03624972|467640671|FG000|Overall Study|Lost to Follow-up|2|||
129912107|NCT03624972|467640672|FG001|Overall Study|Lost to Follow-up|0|||
129912108|NCT03624972|467640673|FG002|Overall Study|Lost to Follow-up|0|||
129912109|NCT03624972|467640671|FG000|Overall Study|Withdrawal by Subject|0|||
129912110|NCT03624972|467640672|FG001|Overall Study|Withdrawal by Subject|2|||
129912111|NCT03624972|467640673|FG002|Overall Study|Withdrawal by Subject|0|||
129912112|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
129912113|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
129912114|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
129912115|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
129912116|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
129912117|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
129912118|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
129912119|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
129912120|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
129912121|NCT03990649|467640681|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
129912122|NCT03990649|467640682|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
129912123|NCT03990649|467640683|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
129912124|NCT03990649|467640681|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
129912125|NCT03990649|467640682|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
129912126|NCT03990649|467640683|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
129912127|NCT03990649|467640681|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
129912128|NCT03990649|467640682|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
129912129|NCT03990649|467640683|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
129912130|NCT03990649|467640681|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
129912131|NCT03990649|467640682|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
129912132|NCT03990649|467640683|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
129912133|NCT02647905|467640692|FG000|Overall Study|Lost to Follow-up|1|||
129912134|NCT02647905|467640692|FG000|Overall Study|Withdrawal by Subject|2|||
129912135|NCT02015520|467640693|FG000|Overall Study|Lack of Efficacy|1|||
129912136|NCT02015520|467640694|FG001|Overall Study|Lack of Efficacy|0|||
129912137|NCT02015520|467640695|FG002|Overall Study|Lack of Efficacy|3|||
129912138|NCT02015520|467640696|FG003|Overall Study|Lack of Efficacy|2|||
129912139|NCT02015520|467640693|FG000|Overall Study|Adverse Event|0|||
129912140|NCT02015520|467640694|FG001|Overall Study|Adverse Event|0|||
129912141|NCT02015520|467640695|FG002|Overall Study|Adverse Event|0|||
129912142|NCT02015520|467640696|FG003|Overall Study|Adverse Event|1|||
129912143|NCT02015520|467640693|FG000|Overall Study|Withdrawal by Subject|2|||
129912144|NCT02015520|467640694|FG001|Overall Study|Withdrawal by Subject|2|||
129912145|NCT02015520|467640695|FG002|Overall Study|Withdrawal by Subject|1|||
129912146|NCT02015520|467640696|FG003|Overall Study|Withdrawal by Subject|0|||
129912147|NCT02015520|467640693|FG000|Overall Study|Death|1|||
129912148|NCT02015520|467640694|FG001|Overall Study|Death|0|||
129912149|NCT02015520|467640695|FG002|Overall Study|Death|0|||
129912150|NCT02015520|467640696|FG003|Overall Study|Death|0|||
129912151|NCT02015520|467640693|FG000|Overall Study|Lost to Follow-up|0|||
129912152|NCT02015520|467640694|FG001|Overall Study|Lost to Follow-up|0|||
129912153|NCT02015520|467640695|FG002|Overall Study|Lost to Follow-up|1|||
129912154|NCT02015520|467640696|FG003|Overall Study|Lost to Follow-up|0|||
129912155|NCT02015520|467640693|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
129912156|NCT02015520|467640694|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
129912157|NCT02015520|467640695|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
129912158|NCT02015520|467640696|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
129912159|NCT02015520|467640693|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
129912160|NCT02015520|467640694|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
129912161|NCT02015520|467640695|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
129912162|NCT02015520|467640696|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
129912163|NCT05119855|467640697|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
129912164|NCT05119855|467640698|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
129912165|NCT05119855|467640697|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
129912166|NCT05119855|467640698|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
129912167|NCT05119855|467640697|FG000|Overall Study|Lost to Follow-up|6|||
129912168|NCT05119855|467640698|FG001|Overall Study|Lost to Follow-up|8|||
129912169|NCT02932579|467640699|FG000|Overall Study|Withdrawal by Subject|4|||
129912170|NCT02932579|467640700|FG001|Overall Study|Withdrawal by Subject|1|||
129912171|NCT01972724|467640701|FG000|Double-Blind|Rescue Criteria Met|1|||
129912172|NCT01972724|467640702|FG001|Double-Blind|Rescue Criteria Met|0|||
129912173|NCT01972724|467640703|FG002|Double-Blind|Rescue Criteria Met|0|||
129912174|NCT01972724|467640701|FG000|Double-Blind|Adverse Event|1|||
129912175|NCT01972724|467640702|FG001|Double-Blind|Adverse Event|0|||
129912176|NCT01972724|467640703|FG002|Double-Blind|Adverse Event|0|||
129912177|NCT01972724|467640701|FG000|Double-Blind|Withdrawal of Consent|2|||
129912178|NCT01972724|467640702|FG001|Double-Blind|Withdrawal of Consent|1|||
129912179|NCT01972724|467640703|FG002|Double-Blind|Withdrawal of Consent|0|||
129912180|NCT01972724|467640701|FG000|Double-Blind|Significant Protocol Deviation|5|||
129912181|NCT01972724|467640702|FG001|Double-Blind|Significant Protocol Deviation|8|||
129912182|NCT01972724|467640703|FG002|Double-Blind|Significant Protocol Deviation|0|||
129912183|NCT01972724|467640701|FG000|Open-Label|Withdrew Consent|0|||
129912184|NCT01972724|467640702|FG001|Open-Label|Withdrew Consent|0|||
129912185|NCT01972724|467640703|FG002|Open-Label|Withdrew Consent|3|||
129912186|NCT01972724|467640701|FG000|Open-Label|Significant Protocol Deviation|0|||
129912187|NCT01972724|467640702|FG001|Open-Label|Significant Protocol Deviation|0|||
129912188|NCT01972724|467640703|FG002|Open-Label|Significant Protocol Deviation|2|||
129912189|NCT00111813|467640710|FG000|Overall Study|Adverse Event|1|||
129912190|NCT00111813|467640711|FG001|Overall Study|Adverse Event|2|||
129912191|NCT00111813|467640712|FG002|Overall Study|Adverse Event|4|||
129912192|NCT00111813|467640713|FG003|Overall Study|Adverse Event|2|||
129912193|NCT00111813|467640714|FG004|Overall Study|Adverse Event|2|||
129912194|NCT00111813|467640715|FG005|Overall Study|Adverse Event|2|||
129912195|NCT00111813|467640710|FG000|Overall Study|Progressive disease|2|||
129912196|NCT00111813|467640711|FG001|Overall Study|Progressive disease|1|||
129912197|NCT00111813|467640712|FG002|Overall Study|Progressive disease|5|||
129912198|NCT00111813|467640713|FG003|Overall Study|Progressive disease|3|||
129912199|NCT00111813|467640714|FG004|Overall Study|Progressive disease|4|||
129912200|NCT00111813|467640715|FG005|Overall Study|Progressive disease|3|||
129912201|NCT00111813|467640710|FG000|Overall Study|Lack of Efficacy|0|||
129912202|NCT00111813|467640711|FG001|Overall Study|Lack of Efficacy|0|||
129912203|NCT00111813|467640712|FG002|Overall Study|Lack of Efficacy|0|||
129912204|NCT00111813|467640713|FG003|Overall Study|Lack of Efficacy|0|||
129912205|NCT00111813|467640714|FG004|Overall Study|Lack of Efficacy|0|||
129912206|NCT00111813|467640715|FG005|Overall Study|Lack of Efficacy|1|||
129912207|NCT00111813|467640710|FG000|Overall Study|Other|0|||
129912208|NCT00111813|467640711|FG001|Overall Study|Other|0|||
129912209|NCT00111813|467640712|FG002|Overall Study|Other|1|||
129912210|NCT00111813|467640713|FG003|Overall Study|Other|0|||
129912211|NCT00111813|467640714|FG004|Overall Study|Other|0|||
129912212|NCT00111813|467640715|FG005|Overall Study|Other|0|||
129912213|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
129912214|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
129912215|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
129912216|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
129912217|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
129912218|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
129912219|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
129912220|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
129912221|NCT00393484|467640724|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
129912222|NCT00393484|467640725|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
129912223|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
129912224|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
129912225|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
129912226|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
129912227|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
129912228|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
129912229|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
129912230|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
129912231|NCT00393484|467640724|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
129912232|NCT00393484|467640725|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
129912233|NCT03201562|467640726|FG000|Overall Study|Physician Decision|0|||
129912234|NCT03201562|467640727|FG001|Overall Study|Physician Decision|0|||
129912235|NCT03201562|467640728|FG002|Overall Study|Physician Decision|1|||
129912236|NCT03201562|467640726|FG000|Overall Study|Adverse Event|0|||
129912237|NCT03201562|467640727|FG001|Overall Study|Adverse Event|0|||
129912238|NCT03201562|467640728|FG002|Overall Study|Adverse Event|1|||
129912239|NCT03201562|467640726|FG000|Overall Study|Lost to Follow-up|0|||
129912240|NCT03201562|467640727|FG001|Overall Study|Lost to Follow-up|1|||
129912241|NCT03201562|467640728|FG002|Overall Study|Lost to Follow-up|2|||
129912242|NCT00031694|467640735|FG000|Overall Study|Adverse Event|12|||
129912243|NCT00031694|467640735|FG000|Overall Study|Death|2|||
129912244|NCT00031694|467640735|FG000|Overall Study|Withdrawal by Subject|5|||
129912245|NCT02556138|467640739|FG000|Overall Study|Withdrawal by Subject|1|||
129912246|NCT04939246|467640740|FG000|After Treatment|Death|4|||
129912247|NCT04939246|467640740|FG000|After Treatment|Lost to Follow-up|1|||
129912248|NCT04939246|467640740|FG000|After Treatment|Discharged to hospice|2|||
129912249|NCT04994509|467640741|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
129912250|NCT04994509|467640742|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
129912251|NCT04994509|467640743|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
129912252|NCT04994509|467640741|FG000|Overall Study|Withdrew Consent|73|||
129912253|NCT04994509|467640742|FG001|Overall Study|Withdrew Consent|72|||
129912254|NCT04994509|467640743|FG002|Overall Study|Withdrew Consent|46|||
129912255|NCT04994509|467640741|FG000|Overall Study|Lost to Follow-up|39|||
129912256|NCT04994509|467640742|FG001|Overall Study|Lost to Follow-up|36|||
129912257|NCT04994509|467640743|FG002|Overall Study|Lost to Follow-up|26|||
129912258|NCT04994509|467640741|FG000|Overall Study|HIV-1 Infection|4|||
129912259|NCT04994509|467640742|FG001|Overall Study|HIV-1 Infection|20|||
129912260|NCT04994509|467640743|FG002|Overall Study|HIV-1 Infection|12|||
129912261|NCT04994509|467640741|FG000|Overall Study|Investigator's Discretion|9|||
129912262|NCT04994509|467640742|FG001|Overall Study|Investigator's Discretion|8|||
129912263|NCT04994509|467640743|FG002|Overall Study|Investigator's Discretion|11|||
129912264|NCT04994509|467640741|FG000|Overall Study|Randomized but Never Treated|10|||
129912265|NCT04994509|467640742|FG001|Overall Study|Randomized but Never Treated|10|||
129912266|NCT04994509|467640743|FG002|Overall Study|Randomized but Never Treated|3|||
129912267|NCT04994509|467640741|FG000|Overall Study|Pregnancy|5|||
129912268|NCT04994509|467640742|FG001|Overall Study|Pregnancy|5|||
129912269|NCT04994509|467640743|FG002|Overall Study|Pregnancy|0|||
129912270|NCT04994509|467640741|FG000|Overall Study|Death|0|||
129912271|NCT04994509|467640742|FG001|Overall Study|Death|5|||
129912272|NCT04994509|467640743|FG002|Overall Study|Death|0|||
129912273|NCT04994509|467640741|FG000|Overall Study|Adverse Event|2|||
129912274|NCT04994509|467640742|FG001|Overall Study|Adverse Event|1|||
129912275|NCT04994509|467640743|FG002|Overall Study|Adverse Event|0|||
129912276|NCT04994509|467640741|FG000|Overall Study|Non-compliance With Study Drug|1|||
129912277|NCT04994509|467640742|FG001|Overall Study|Non-compliance With Study Drug|1|||
129912278|NCT04994509|467640743|FG002|Overall Study|Non-compliance With Study Drug|1|||
129912279|NCT04994509|467640741|FG000|Overall Study|Withdrew Assent|3|||
129912280|NCT04994509|467640742|FG001|Overall Study|Withdrew Assent|0|||
129912281|NCT04994509|467640743|FG002|Overall Study|Withdrew Assent|0|||
129912282|NCT04994509|467640741|FG000|Overall Study|Protocol Violation|1|||
129912283|NCT04994509|467640742|FG001|Overall Study|Protocol Violation|0|||
129912284|NCT04994509|467640743|FG002|Overall Study|Protocol Violation|0|||
129912285|NCT02576509|467642447|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
129912286|NCT02576509|467642448|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
129912287|NCT02576509|467642447|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
129912288|NCT02576509|467642448|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
129912289|NCT02576509|467642447|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
129912290|NCT02576509|467642448|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
129912291|NCT02576509|467642447|FG000|Treatment Period|Disease progression|263|||
129912292|NCT02576509|467642448|FG001|Treatment Period|Disease progression|244|||
129912293|NCT02576509|467642447|FG000|Treatment Period|Study drug toxicity|37|||
129912294|NCT02576509|467642448|FG001|Treatment Period|Study drug toxicity|41|||
129912295|NCT02576509|467642447|FG000|Treatment Period|Death|1|||
129912296|NCT02576509|467642448|FG001|Treatment Period|Death|1|||
129912297|NCT02576509|467642447|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
129912298|NCT02576509|467642448|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
129912299|NCT02576509|467642447|FG000|Treatment Period|Participant request to stop treatment|8|||
129912300|NCT02576509|467642448|FG001|Treatment Period|Participant request to stop treatment|18|||
129912301|NCT02576509|467642447|FG000|Treatment Period|Participant withdrew consent|3|||
129912302|NCT02576509|467642448|FG001|Treatment Period|Participant withdrew consent|7|||
129912303|NCT02576509|467642447|FG000|Treatment Period|Lost to Follow-up|0|||
129912304|NCT02576509|467642448|FG001|Treatment Period|Lost to Follow-up|1|||
129912305|NCT02576509|467642447|FG000|Treatment Period|Maximum clinical benefit|1|||
129912306|NCT02576509|467642448|FG001|Treatment Period|Maximum clinical benefit|0|||
129912307|NCT02576509|467642447|FG000|Treatment Period|Poor/non-compliance|1|||
129912308|NCT02576509|467642448|FG001|Treatment Period|Poor/non-compliance|1|||
129912309|NCT02576509|467642447|FG000|Treatment Period|Participant no longer meets criteria|1|||
129912310|NCT02576509|467642448|FG001|Treatment Period|Participant no longer meets criteria|0|||
129912311|NCT02576509|467642447|FG000|Treatment Period|Other reason|12|||
129912312|NCT02576509|467642448|FG001|Treatment Period|Other reason|8|||
129912313|NCT02576509|467642447|FG000|Treatment Period|NOT REPORTED|1|||
129912314|NCT02576509|467642448|FG001|Treatment Period|NOT REPORTED|0|||
129912315|NCT02576509|467642447|FG000|Treatment Period|Administrative reason by sponsor|0|||
129912316|NCT02576509|467642448|FG001|Treatment Period|Administrative reason by sponsor|1|||
129912317|NCT03725722|467642453|FG000|Overall Study|Lack of Efficacy|2|||
129862879|NCT01857531|467454747|FG000|Overall Study|Withdrawal by Subject|4|||
129862880|NCT03943095|467454748|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
129862881|NCT03943095|467454749|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
129862882|NCT03943095|467454748|FG000|Overall Study|Withdrawal by Subject|1|||
129862883|NCT03943095|467454749|FG001|Overall Study|Withdrawal by Subject|0|||
129862884|NCT02269670|467454750|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
129862885|NCT04657211|467454753|FG000|Overall Study|Withdrawal by Subject|21|||
129862886|NCT04657211|467454753|FG000|Overall Study|Lost to Follow-up|113|||
129862887|NCT04657211|467454753|FG000|Overall Study|Death|47|||
129862888|NCT04657211|467454753|FG000|Overall Study|Transfer to another institution|21|||
129862889|NCT04657211|467454753|FG000|Overall Study|Other|29|||
129862890|NCT02693665|467454754|FG000|Overall Study|Death|3|||
129862891|NCT02693665|467454755|FG001|Overall Study|Death|2|||
129862892|NCT02693665|467454754|FG000|Overall Study|Lost to Follow-up|7|||
129862893|NCT02693665|467454755|FG001|Overall Study|Lost to Follow-up|3|||
129862894|NCT02693665|467454754|FG000|Overall Study|Protocol Violation|1|||
129862895|NCT02693665|467454755|FG001|Overall Study|Protocol Violation|0|||
129862896|NCT02693665|467454754|FG000|Overall Study|Withdrawal by Subject|2|||
129862897|NCT02693665|467454755|FG001|Overall Study|Withdrawal by Subject|0|||
129862898|NCT02693665|467454754|FG000|Overall Study|patient wanted to leave it behind|1|||
129862899|NCT02693665|467454755|FG001|Overall Study|patient wanted to leave it behind|0|||
129862900|NCT02693665|467454754|FG000|Overall Study|anxiety|1|||
129862901|NCT02693665|467454755|FG001|Overall Study|anxiety|0|||
129862902|NCT02693665|467454754|FG000|Overall Study|family issues|1|||
129862903|NCT02693665|467454755|FG001|Overall Study|family issues|0|||
129862904|NCT02693665|467454754|FG000|Overall Study|no reason given|1|||
129862905|NCT02693665|467454755|FG001|Overall Study|no reason given|0|||
129862906|NCT00710424|467454758|FG000|Overall Study|Adverse Event|30|||
129862907|NCT00710424|467454759|FG001|Overall Study|Adverse Event|12|||
129862908|NCT00710424|467454758|FG000|Overall Study|Lack of Efficacy|4|||
129862909|NCT00710424|467454759|FG001|Overall Study|Lack of Efficacy|5|||
129862910|NCT00710424|467454758|FG000|Overall Study|Withdrawal by Subject|5|||
129862911|NCT00710424|467454759|FG001|Overall Study|Withdrawal by Subject|3|||
129862912|NCT00710424|467454758|FG000|Overall Study|Lost to Follow-up|0|||
129862913|NCT00710424|467454759|FG001|Overall Study|Lost to Follow-up|1|||
129862914|NCT00710424|467454758|FG000|Overall Study|Refused medication, no side effects|1|||
129862915|NCT00710424|467454759|FG001|Overall Study|Refused medication, no side effects|0|||
129862916|NCT00710424|467454758|FG000|Overall Study|Non-compliance with stable analgesia|1|||
129862917|NCT00710424|467454759|FG001|Overall Study|Non-compliance with stable analgesia|0|||
129862918|NCT00710424|467454758|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
129862919|NCT00710424|467454759|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
129862920|NCT00710424|467454758|FG000|Overall Study|Subject thought medication changed|1|||
129862921|NCT00710424|467454759|FG001|Overall Study|Subject thought medication changed|0|||
129862922|NCT00710424|467454758|FG000|Overall Study|Ceased treatment due to travel|1|||
129862923|NCT00710424|467454759|FG001|Overall Study|Ceased treatment due to travel|0|||
129862924|NCT00710424|467454758|FG000|Overall Study|Subject preferred paracetamol|0|||
129862925|NCT00710424|467454759|FG001|Overall Study|Subject preferred paracetamol|1|||
129862926|NCT00710424|467454758|FG000|Overall Study|Felt good so stopped treatment|0|||
129862927|NCT00710424|467454759|FG001|Overall Study|Felt good so stopped treatment|1|||
129862928|NCT01962493|467454760|FG000|Overall Study|Adverse Event|1|||
129862929|NCT01962493|467454761|FG001|Overall Study|Adverse Event|2|||
129862930|NCT01962493|467454760|FG000|Overall Study|Protocol Violation|0|||
129862931|NCT01962493|467454761|FG001|Overall Study|Protocol Violation|1|||
129862932|NCT01962493|467454760|FG000|Overall Study|Withdrawal by Subject|4|||
129862933|NCT01962493|467454761|FG001|Overall Study|Withdrawal by Subject|2|||
129862934|NCT03776136|467454762|FG000|Overall Study|Death|85|||
129862935|NCT03776136|467454762|FG000|Overall Study|Withdrawal by Subject|3|||
129862936|NCT03776136|467454762|FG000|Overall Study|Sponsor Decision|15|||
129862937|NCT02621931|467456580|FG000|Overall Study|Death|0|||
129862938|NCT02621931|467456581|FG001|Overall Study|Death|1|||
129862939|NCT02621931|467456582|FG002|Overall Study|Death|0|||
129862940|NCT02621931|467456580|FG000|Overall Study|Adverse Event|8|||
129862941|NCT02621931|467456581|FG001|Overall Study|Adverse Event|5|||
129862942|NCT02621931|467456582|FG002|Overall Study|Adverse Event|7|||
129862943|NCT02621931|467456580|FG000|Overall Study|Withdrawal by Subject|12|||
129862944|NCT02621931|467456581|FG001|Overall Study|Withdrawal by Subject|10|||
129862945|NCT02621931|467456582|FG002|Overall Study|Withdrawal by Subject|11|||
129862946|NCT02621931|467456580|FG000|Overall Study|Protocol Violation|2|||
129862947|NCT02621931|467456581|FG001|Overall Study|Protocol Violation|2|||
129862948|NCT02621931|467456582|FG002|Overall Study|Protocol Violation|2|||
129862949|NCT02621931|467456580|FG000|Overall Study|Pregnancy|2|||
129862950|NCT02621931|467456581|FG001|Overall Study|Pregnancy|0|||
129862951|NCT02621931|467456582|FG002|Overall Study|Pregnancy|0|||
129862952|NCT02621931|467456580|FG000|Overall Study|Noncompliance to study procedures|0|||
129862953|NCT02621931|467456581|FG001|Overall Study|Noncompliance to study procedures|1|||
129862954|NCT02621931|467456582|FG002|Overall Study|Noncompliance to study procedures|2|||
129862955|NCT02621931|467456580|FG000|Overall Study|Lost to Follow-up|8|||
129862956|NCT02621931|467456581|FG001|Overall Study|Lost to Follow-up|7|||
129862957|NCT02621931|467456582|FG002|Overall Study|Lost to Follow-up|10|||
129862958|NCT02621931|467456580|FG000|Overall Study|Lack of Efficacy|0|||
129862959|NCT02621931|467456581|FG001|Overall Study|Lack of Efficacy|0|||
129862960|NCT02621931|467456582|FG002|Overall Study|Lack of Efficacy|1|||
129862961|NCT02621931|467456580|FG000|Overall Study|Other|1|||
129862962|NCT02621931|467456581|FG001|Overall Study|Other|1|||
129862963|NCT02621931|467456582|FG002|Overall Study|Other|3|||
129862964|NCT01588184|467456583|FG000|Overall Study|Death|1|||
129862965|NCT01588184|467456584|FG001|Overall Study|Death|0|||
129862966|NCT01588184|467456585|FG002|Overall Study|Death|0|||
129862967|NCT01588184|467456586|FG003|Overall Study|Death|1|||
129862968|NCT01588184|467456587|FG004|Overall Study|Death|1|||
129862969|NCT01588184|467456588|FG005|Overall Study|Death|1|||
129862970|NCT01588184|467456583|FG000|Overall Study|Withdrawal by Subject|2|||
129862971|NCT01588184|467456584|FG001|Overall Study|Withdrawal by Subject|4|||
129862972|NCT01588184|467456585|FG002|Overall Study|Withdrawal by Subject|0|||
129862973|NCT01588184|467456586|FG003|Overall Study|Withdrawal by Subject|1|||
129862974|NCT01588184|467456587|FG004|Overall Study|Withdrawal by Subject|0|||
129862975|NCT01588184|467456588|FG005|Overall Study|Withdrawal by Subject|0|||
129862976|NCT01588184|467456583|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
129862977|NCT01588184|467456584|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
129862978|NCT01588184|467456585|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
129862979|NCT01588184|467456586|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
129862980|NCT01588184|467456587|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
129862981|NCT01588184|467456588|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
129862982|NCT01588184|467456583|FG000|Overall Study|multiple reasons|0|||
129862983|NCT01588184|467456584|FG001|Overall Study|multiple reasons|3|||
129862984|NCT01588184|467456585|FG002|Overall Study|multiple reasons|0|||
129862985|NCT01588184|467456586|FG003|Overall Study|multiple reasons|1|||
129862986|NCT01588184|467456587|FG004|Overall Study|multiple reasons|0|||
129862987|NCT01588184|467456588|FG005|Overall Study|multiple reasons|0|||
129862988|NCT02811861|467456589|FG000|Overall Study|Radiological Disease Progression|123|||
129862989|NCT02811861|467456590|FG001|Overall Study|Radiological Disease Progression|97|||
129862990|NCT02811861|467456591|FG002|Overall Study|Radiological Disease Progression|174|||
129862991|NCT02811861|467456589|FG000|Overall Study|Clinical Disease Progression|20|||
129862992|NCT02811861|467456590|FG001|Overall Study|Clinical Disease Progression|19|||
129862993|NCT02811861|467456591|FG002|Overall Study|Clinical Disease Progression|22|||
129862994|NCT02811861|467456589|FG000|Overall Study|Adverse Event|63|||
129862995|NCT02811861|467456590|FG001|Overall Study|Adverse Event|60|||
129862996|NCT02811861|467456591|FG002|Overall Study|Adverse Event|41|||
129862997|NCT02811861|467456589|FG000|Overall Study|Lost to Follow-up|0|||
129862998|NCT02811861|467456590|FG001|Overall Study|Lost to Follow-up|0|||
129862999|NCT02811861|467456591|FG002|Overall Study|Lost to Follow-up|1|||
129863000|NCT02811861|467456589|FG000|Overall Study|Subject Choice|29|||
129863001|NCT02811861|467456590|FG001|Overall Study|Subject Choice|17|||
129863002|NCT02811861|467456591|FG002|Overall Study|Subject Choice|23|||
129863003|NCT02811861|467456589|FG000|Overall Study|Withdrawal by Subject|4|||
129863004|NCT02811861|467456590|FG001|Overall Study|Withdrawal by Subject|4|||
129863005|NCT02811861|467456591|FG002|Overall Study|Withdrawal by Subject|9|||
129863006|NCT02811861|467456589|FG000|Overall Study|Other|4|||
129863007|NCT02811861|467456590|FG001|Overall Study|Other|13|||
129863008|NCT02811861|467456591|FG002|Overall Study|Other|3|||
129863009|NCT02811861|467456589|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
129863010|NCT02811861|467456590|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
129863011|NCT02811861|467456591|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
129863012|NCT02811861|467456589|FG000|Overall Study|Randomized but not treated|2|||
129863013|NCT02811861|467456590|FG001|Overall Study|Randomized but not treated|3|||
129863014|NCT02811861|467456591|FG002|Overall Study|Randomized but not treated|17|||
129863015|NCT02925455|467456592|FG000|Overall Study|Withdrawal by Subject|2|||
129863016|NCT02925455|467456593|FG001|Overall Study|Withdrawal by Subject|0|||
129863017|NCT00360308|467456596|FG000|Overall Study|Adverse Event|15|||
129863018|NCT00360308|467456597|FG001|Overall Study|Adverse Event|14|||
129863019|NCT00360308|467456598|FG002|Overall Study|Adverse Event|25|||
129863020|NCT00360308|467456596|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
129863021|NCT00360308|467456597|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
129863022|NCT00360308|467456598|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129863023|NCT00360308|467456596|FG000|Overall Study|Protocol Violation|2|||
129863024|NCT00360308|467456597|FG001|Overall Study|Protocol Violation|1|||
129863025|NCT00360308|467456598|FG002|Overall Study|Protocol Violation|2|||
129863026|NCT00360308|467456596|FG000|Overall Study|Withdrawal by Subject|11|||
129863027|NCT00360308|467456597|FG001|Overall Study|Withdrawal by Subject|7|||
129863028|NCT00360308|467456598|FG002|Overall Study|Withdrawal by Subject|14|||
129863029|NCT00360308|467456596|FG000|Overall Study|Lack of Efficacy|3|||
129863030|NCT00360308|467456597|FG001|Overall Study|Lack of Efficacy|0|||
129863031|NCT00360308|467456598|FG002|Overall Study|Lack of Efficacy|2|||
129863032|NCT00360308|467456596|FG000|Overall Study|Other|2|||
129863033|NCT00360308|467456597|FG001|Overall Study|Other|1|||
129863034|NCT00360308|467456598|FG002|Overall Study|Other|1|||
129863035|NCT00360308|467456596|FG000|Overall Study|Study termination by sponsor|43|||
129863036|NCT00360308|467456597|FG001|Overall Study|Study termination by sponsor|55|||
129863037|NCT00360308|467456598|FG002|Overall Study|Study termination by sponsor|44|||
129863038|NCT01217073|467456599|FG000|Base Period|Adverse Event|1|||
129863039|NCT01217073|467456600|FG001|Base Period|Adverse Event|0|||
129863040|NCT01217073|467456601|FG002|Base Period|Adverse Event|1|||
129863041|NCT01217073|467456602|FG003|Base Period|Adverse Event|0|||
129863042|NCT01217073|467456603|FG004|Base Period|Adverse Event|4|||
129863043|NCT01217073|467456604|FG005|Base Period|Adverse Event|1|||
129863044|NCT01217073|467456605|FG006|Base Period|Adverse Event|0|||
129863045|NCT01217073|467456606|FG007|Base Period|Adverse Event|0|||
129863046|NCT01217073|467456599|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
129863047|NCT01217073|467456600|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863048|NCT01217073|467456601|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863049|NCT01217073|467456602|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863050|NCT01217073|467456603|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863051|NCT01217073|467456604|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863052|NCT01217073|467456605|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863053|NCT01217073|467456606|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
129863054|NCT01217073|467456599|FG000|Base Period|Excluded medication|0|||
129863055|NCT01217073|467456600|FG001|Base Period|Excluded medication|0|||
129863056|NCT01217073|467456601|FG002|Base Period|Excluded medication|0|||
129863057|NCT01217073|467456602|FG003|Base Period|Excluded medication|0|||
129863058|NCT01217073|467456603|FG004|Base Period|Excluded medication|1|||
129863059|NCT01217073|467456604|FG005|Base Period|Excluded medication|0|||
129863060|NCT01217073|467456605|FG006|Base Period|Excluded medication|0|||
129863061|NCT01217073|467456606|FG007|Base Period|Excluded medication|0|||
129863062|NCT01217073|467456599|FG000|Base Period|Lack of Efficacy|0|||
129863063|NCT01217073|467456600|FG001|Base Period|Lack of Efficacy|0|||
129863064|NCT01217073|467456601|FG002|Base Period|Lack of Efficacy|0|||
129863065|NCT01217073|467456602|FG003|Base Period|Lack of Efficacy|0|||
129863066|NCT01217073|467456603|FG004|Base Period|Lack of Efficacy|0|||
129863067|NCT01217073|467456604|FG005|Base Period|Lack of Efficacy|1|||
129863068|NCT01217073|467456605|FG006|Base Period|Lack of Efficacy|0|||
129863069|NCT01217073|467456606|FG007|Base Period|Lack of Efficacy|0|||
129863070|NCT01217073|467456599|FG000|Base Period|Lost to Follow-up|0|||
129863071|NCT01217073|467456600|FG001|Base Period|Lost to Follow-up|0|||
129863072|NCT01217073|467456601|FG002|Base Period|Lost to Follow-up|1|||
129863073|NCT01217073|467456602|FG003|Base Period|Lost to Follow-up|1|||
129863074|NCT01217073|467456603|FG004|Base Period|Lost to Follow-up|3|||
129863075|NCT01217073|467456604|FG005|Base Period|Lost to Follow-up|0|||
129863076|NCT01217073|467456605|FG006|Base Period|Lost to Follow-up|0|||
129863077|NCT01217073|467456606|FG007|Base Period|Lost to Follow-up|0|||
129863078|NCT01217073|467456599|FG000|Base Period|Physician Decision|0|||
129863079|NCT01217073|467456600|FG001|Base Period|Physician Decision|0|||
129863080|NCT01217073|467456601|FG002|Base Period|Physician Decision|0|||
129863081|NCT01217073|467456602|FG003|Base Period|Physician Decision|0|||
129863082|NCT01217073|467456603|FG004|Base Period|Physician Decision|1|||
129863083|NCT01217073|467456604|FG005|Base Period|Physician Decision|0|||
129863084|NCT01217073|467456605|FG006|Base Period|Physician Decision|0|||
129863085|NCT01217073|467456606|FG007|Base Period|Physician Decision|0|||
129863086|NCT01217073|467456599|FG000|Base Period|Protocol Violation|1|||
129863087|NCT01217073|467456600|FG001|Base Period|Protocol Violation|0|||
129863088|NCT01217073|467456601|FG002|Base Period|Protocol Violation|0|||
129863089|NCT01217073|467456602|FG003|Base Period|Protocol Violation|0|||
129863090|NCT01217073|467456603|FG004|Base Period|Protocol Violation|1|||
129863091|NCT01217073|467456604|FG005|Base Period|Protocol Violation|2|||
129863092|NCT01217073|467456605|FG006|Base Period|Protocol Violation|0|||
129863093|NCT01217073|467456606|FG007|Base Period|Protocol Violation|0|||
129863094|NCT01217073|467456599|FG000|Base Period|Withdrawal by Subject|4|||
129863095|NCT01217073|467456600|FG001|Base Period|Withdrawal by Subject|5|||
129863096|NCT01217073|467456601|FG002|Base Period|Withdrawal by Subject|5|||
129863097|NCT01217073|467456602|FG003|Base Period|Withdrawal by Subject|1|||
129863098|NCT01217073|467456603|FG004|Base Period|Withdrawal by Subject|5|||
129863099|NCT01217073|467456604|FG005|Base Period|Withdrawal by Subject|5|||
129863100|NCT01217073|467456605|FG006|Base Period|Withdrawal by Subject|0|||
129863101|NCT01217073|467456606|FG007|Base Period|Withdrawal by Subject|0|||
129863102|NCT01217073|467456599|FG000|Extension Period|Adverse Event|0|||
129863103|NCT01217073|467456600|FG001|Extension Period|Adverse Event|0|||
129912318|NCT03725722|467642454|FG001|Overall Study|Lack of Efficacy|1|||
129912319|NCT03725722|467642455|FG002|Overall Study|Lack of Efficacy|2|||
129912320|NCT03725722|467642456|FG003|Overall Study|Lack of Efficacy|0|||
129912321|NCT03725722|467642457|FG004|Overall Study|Lack of Efficacy|2|||
129912322|NCT03725722|467642453|FG000|Overall Study|Adverse Event|2|||
129912323|NCT03725722|467642454|FG001|Overall Study|Adverse Event|2|||
129912324|NCT03725722|467642455|FG002|Overall Study|Adverse Event|1|||
129912325|NCT03725722|467642456|FG003|Overall Study|Adverse Event|0|||
129912326|NCT03725722|467642457|FG004|Overall Study|Adverse Event|6|||
129912327|NCT03725722|467642453|FG000|Overall Study|Withdrawal by Subject|4|||
129912328|NCT03725722|467642454|FG001|Overall Study|Withdrawal by Subject|1|||
129912329|NCT03725722|467642455|FG002|Overall Study|Withdrawal by Subject|0|||
129912330|NCT03725722|467642456|FG003|Overall Study|Withdrawal by Subject|4|||
129912331|NCT03725722|467642457|FG004|Overall Study|Withdrawal by Subject|4|||
129912332|NCT03725722|467642453|FG000|Overall Study|Lost to Follow-up|3|||
129912333|NCT03725722|467642454|FG001|Overall Study|Lost to Follow-up|1|||
129912334|NCT03725722|467642455|FG002|Overall Study|Lost to Follow-up|2|||
129912335|NCT03725722|467642456|FG003|Overall Study|Lost to Follow-up|2|||
129863104|NCT01217073|467456601|FG002|Extension Period|Adverse Event|0|||
129863105|NCT01217073|467456602|FG003|Extension Period|Adverse Event|0|||
129863106|NCT01217073|467456603|FG004|Extension Period|Adverse Event|0|||
129863107|NCT01217073|467456604|FG005|Extension Period|Adverse Event|0|||
129863108|NCT01217073|467456605|FG006|Extension Period|Adverse Event|19|||
129863109|NCT01217073|467456606|FG007|Extension Period|Adverse Event|5|||
129863110|NCT01217073|467456599|FG000|Extension Period|ALT/AST|0|||
129863111|NCT01217073|467456600|FG001|Extension Period|ALT/AST|0|||
129863112|NCT01217073|467456601|FG002|Extension Period|ALT/AST|0|||
129863113|NCT01217073|467456602|FG003|Extension Period|ALT/AST|0|||
129863114|NCT01217073|467456603|FG004|Extension Period|ALT/AST|0|||
129863115|NCT01217073|467456604|FG005|Extension Period|ALT/AST|0|||
129863116|NCT01217073|467456605|FG006|Extension Period|ALT/AST|2|||
129863117|NCT01217073|467456606|FG007|Extension Period|ALT/AST|0|||
129863118|NCT01217073|467456599|FG000|Extension Period|Contraindication to study medication|0|||
129863119|NCT01217073|467456600|FG001|Extension Period|Contraindication to study medication|0|||
129863120|NCT01217073|467456601|FG002|Extension Period|Contraindication to study medication|0|||
129863121|NCT01217073|467456602|FG003|Extension Period|Contraindication to study medication|0|||
129863122|NCT01217073|467456603|FG004|Extension Period|Contraindication to study medication|0|||
129863123|NCT01217073|467456604|FG005|Extension Period|Contraindication to study medication|0|||
129863124|NCT01217073|467456605|FG006|Extension Period|Contraindication to study medication|1|||
129863125|NCT01217073|467456606|FG007|Extension Period|Contraindication to study medication|0|||
129863126|NCT01217073|467456599|FG000|Extension Period|Creatinine/eGFR|0|||
129863127|NCT01217073|467456600|FG001|Extension Period|Creatinine/eGFR|0|||
129863128|NCT01217073|467456601|FG002|Extension Period|Creatinine/eGFR|0|||
129863129|NCT01217073|467456602|FG003|Extension Period|Creatinine/eGFR|0|||
129863130|NCT01217073|467456603|FG004|Extension Period|Creatinine/eGFR|0|||
129863131|NCT01217073|467456604|FG005|Extension Period|Creatinine/eGFR|0|||
129863132|NCT01217073|467456605|FG006|Extension Period|Creatinine/eGFR|11|||
129863133|NCT01217073|467456606|FG007|Extension Period|Creatinine/eGFR|1|||
129863134|NCT01217073|467456599|FG000|Extension Period|Death|0|||
129863135|NCT01217073|467456600|FG001|Extension Period|Death|0|||
129863136|NCT01217073|467456601|FG002|Extension Period|Death|0|||
129912336|NCT03725722|467642457|FG004|Overall Study|Lost to Follow-up|1|||
129863137|NCT01217073|467456602|FG003|Extension Period|Death|0|||
129863138|NCT01217073|467456603|FG004|Extension Period|Death|0|||
129863139|NCT01217073|467456604|FG005|Extension Period|Death|0|||
129863140|NCT01217073|467456605|FG006|Extension Period|Death|1|||
129863141|NCT01217073|467456606|FG007|Extension Period|Death|0|||
129863142|NCT01217073|467456599|FG000|Extension Period|Excluded medication|0|||
129863143|NCT01217073|467456600|FG001|Extension Period|Excluded medication|0|||
129863144|NCT01217073|467456601|FG002|Extension Period|Excluded medication|0|||
129863145|NCT01217073|467456602|FG003|Extension Period|Excluded medication|0|||
129863146|NCT01217073|467456603|FG004|Extension Period|Excluded medication|0|||
129863147|NCT01217073|467456604|FG005|Extension Period|Excluded medication|0|||
129863148|NCT01217073|467456605|FG006|Extension Period|Excluded medication|2|||
129863149|NCT01217073|467456606|FG007|Extension Period|Excluded medication|0|||
129912337|NCT03725722|467642453|FG000|Overall Study|Personal reasons|0|||
129912338|NCT03725722|467642454|FG001|Overall Study|Personal reasons|0|||
129912339|NCT03725722|467642455|FG002|Overall Study|Personal reasons|1|||
129912340|NCT03725722|467642456|FG003|Overall Study|Personal reasons|0|||
129912341|NCT03725722|467642457|FG004|Overall Study|Personal reasons|1|||
129912342|NCT03725722|467642453|FG000|Overall Study|COVID-19 situation|0|||
129912343|NCT03725722|467642454|FG001|Overall Study|COVID-19 situation|1|||
129912344|NCT03725722|467642455|FG002|Overall Study|COVID-19 situation|0|||
129912345|NCT03725722|467642456|FG003|Overall Study|COVID-19 situation|0|||
129912346|NCT03725722|467642457|FG004|Overall Study|COVID-19 situation|0|||
129912347|NCT05505045|467642458|FG000|Overall Study|Withdrawal by Subject|2|||
129912348|NCT05505045|467642459|FG001|Overall Study|Withdrawal by Subject|1|||
129912349|NCT01643070|467642460|FG000|Overall Study|Withdrawal by Subject|3|||
129912350|NCT01643070|467642461|FG001|Overall Study|Withdrawal by Subject|1|||
129912351|NCT01643070|467642460|FG000|Overall Study|Death|1|||
129912352|NCT01643070|467642461|FG001|Overall Study|Death|0|||
129912353|NCT01643070|467642460|FG000|Overall Study|Pregressive disease|0|||
129912354|NCT01643070|467642461|FG001|Overall Study|Pregressive disease|2|||
129912355|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
129912356|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
129912357|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
129912358|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
129912359|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
129912360|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
129912361|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
129912362|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
129912363|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
129912364|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
129912365|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
129912366|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
129912367|NCT01600014|467642462|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
129912368|NCT01600014|467642463|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
129912369|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
129912370|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
129912371|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
129912372|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
129912373|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
129912374|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
129912375|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
129912376|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
129912377|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
129912378|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
129912379|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
129912380|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
129912381|NCT01600014|467642462|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
129912382|NCT01600014|467642463|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
129912383|NCT01600014|467642462|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
129912384|NCT01600014|467642463|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
129912385|NCT01600014|467642462|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
129912386|NCT01600014|467642463|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
129912387|NCT01600014|467642462|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
129863150|NCT01217073|467456599|FG000|Extension Period|Lack of Efficacy|0|||
129863151|NCT01217073|467456600|FG001|Extension Period|Lack of Efficacy|0|||
129863152|NCT01217073|467456601|FG002|Extension Period|Lack of Efficacy|0|||
129863153|NCT01217073|467456602|FG003|Extension Period|Lack of Efficacy|0|||
129863154|NCT01217073|467456603|FG004|Extension Period|Lack of Efficacy|0|||
129863155|NCT01217073|467456604|FG005|Extension Period|Lack of Efficacy|0|||
129863156|NCT01217073|467456605|FG006|Extension Period|Lack of Efficacy|3|||
129863157|NCT01217073|467456606|FG007|Extension Period|Lack of Efficacy|0|||
129863158|NCT01217073|467456599|FG000|Extension Period|Lost to Follow-up|0|||
129863159|NCT01217073|467456600|FG001|Extension Period|Lost to Follow-up|0|||
129863160|NCT01217073|467456601|FG002|Extension Period|Lost to Follow-up|0|||
129912388|NCT01600014|467642463|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
129912389|NCT04278586|467642464|FG000|Overall Study|Withdrawal by Subject|13|||
129912390|NCT04278586|467642465|FG001|Overall Study|Withdrawal by Subject|6|||
129912391|NCT04278586|467642464|FG000|Overall Study|Lost to Follow-up|37|||
129912392|NCT04278586|467642465|FG001|Overall Study|Lost to Follow-up|24|||
129863161|NCT01217073|467456602|FG003|Extension Period|Lost to Follow-up|0|||
129912393|NCT04310735|467642471|FG000|Overall Study|Withdrawal by Subject|1|||
129863162|NCT01217073|467456603|FG004|Extension Period|Lost to Follow-up|0|||
129863163|NCT01217073|467456604|FG005|Extension Period|Lost to Follow-up|0|||
129863164|NCT01217073|467456605|FG006|Extension Period|Lost to Follow-up|9|||
129912394|NCT04310735|467642472|FG001|Overall Study|Withdrawal by Subject|3|||
129912395|NCT04310735|467642473|FG002|Overall Study|Withdrawal by Subject|8|||
129912396|NCT04310735|467642471|FG000|Overall Study|Equipment malfunction|0|||
129912397|NCT04310735|467642472|FG001|Overall Study|Equipment malfunction|1|||
129912398|NCT04310735|467642473|FG002|Overall Study|Equipment malfunction|0|||
129912399|NCT04038957|467642479|FG000|Overall Study|Withdrawal by Subject|1|||
129912400|NCT04038957|467642479|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
129912401|NCT01998984|467642484|FG000|Overall Study|Adverse Event|0|||
129912402|NCT01998984|467642485|FG001|Overall Study|Adverse Event|0|||
129912403|NCT01998984|467642486|FG002|Overall Study|Adverse Event|0|||
129912404|NCT01998984|467642487|FG003|Overall Study|Adverse Event|1|||
129912405|NCT01998984|467642484|FG000|Overall Study|Lost to Follow-up|0|||
129912406|NCT01998984|467642485|FG001|Overall Study|Lost to Follow-up|1|||
129912407|NCT01998984|467642486|FG002|Overall Study|Lost to Follow-up|0|||
129912408|NCT01998984|467642487|FG003|Overall Study|Lost to Follow-up|1|||
129912409|NCT01998984|467642484|FG000|Overall Study|Withdrawal by Subject|0|||
129912410|NCT01998984|467642485|FG001|Overall Study|Withdrawal by Subject|0|||
129912411|NCT01998984|467642486|FG002|Overall Study|Withdrawal by Subject|1|||
129912412|NCT01998984|467642487|FG003|Overall Study|Withdrawal by Subject|0|||
129912413|NCT01998984|467642484|FG000|Overall Study|Other|0|||
129912414|NCT01998984|467642485|FG001|Overall Study|Other|0|||
129912415|NCT01998984|467642486|FG002|Overall Study|Other|0|||
129912416|NCT01998984|467642487|FG003|Overall Study|Other|1|||
129912417|NCT01843374|467642488|FG000|Overall Study|Death|155|||
129912418|NCT01843374|467642489|FG001|Overall Study|Death|313|||
129912419|NCT01843374|467642488|FG000|Overall Study|Withdrawal by Subject|14|||
129912420|NCT01843374|467642489|FG001|Overall Study|Withdrawal by Subject|20|||
129912421|NCT01843374|467642488|FG000|Overall Study|Withdrawing due to Other reason|20|||
129912422|NCT01843374|467642489|FG001|Overall Study|Withdrawing due to Other reason|46|||
129912423|NCT02605837|467642490|FG000|Overall Study|Adverse Event|3|||
129912424|NCT02605837|467642491|FG001|Overall Study|Adverse Event|1|||
129912425|NCT02605837|467642490|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129912426|NCT02605837|467642491|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129912427|NCT02605837|467642490|FG000|Overall Study|Withdrawal by Subject|8|||
129912428|NCT02605837|467642491|FG001|Overall Study|Withdrawal by Subject|8|||
129912429|NCT02605837|467642490|FG000|Overall Study|Physician Decision|0|||
129912430|NCT02605837|467642491|FG001|Overall Study|Physician Decision|1|||
129912431|NCT02652260|467642492|FG000|Base Study|Pregnancy|0|||
129912432|NCT02652260|467642493|FG001|Base Study|Pregnancy|1|||
129912433|NCT02652260|467642492|FG000|Base Study|Withdrawal by Subject|0|||
129912434|NCT02652260|467642493|FG001|Base Study|Withdrawal by Subject|1|||
129912435|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
129912436|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
129912437|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
129912438|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
129912439|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
129912440|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
129912441|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
129912442|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
129912443|NCT02652260|467642492|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
129912444|NCT02652260|467642493|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
129912445|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
129912446|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
129912447|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
129912448|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
129912449|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
129912450|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
129912451|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
129912452|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
129912453|NCT02652260|467642492|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
129912454|NCT02652260|467642493|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
129912455|NCT02652260|467642492|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
129912456|NCT02652260|467642493|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
129912457|NCT02652260|467642492|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
129912458|NCT02652260|467642493|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
129912459|NCT05056246|467642494|FG000|Overall Study|Adverse Event|0|||
129912460|NCT05056246|467642495|FG001|Overall Study|Adverse Event|0|||
129912461|NCT05056246|467642496|FG002|Overall Study|Adverse Event|0|||
129912462|NCT05056246|467642497|FG003|Overall Study|Adverse Event|0|||
129912463|NCT05056246|467642498|FG004|Overall Study|Adverse Event|1|||
129912464|NCT05056246|467642494|FG000|Overall Study|Lost to Follow-up|0|||
129912465|NCT05056246|467642495|FG001|Overall Study|Lost to Follow-up|0|||
129912466|NCT05056246|467642496|FG002|Overall Study|Lost to Follow-up|0|||
129912467|NCT05056246|467642497|FG003|Overall Study|Lost to Follow-up|2|||
129912468|NCT05056246|467642498|FG004|Overall Study|Lost to Follow-up|0|||
129912469|NCT05056246|467642494|FG000|Overall Study|Withdrawal by Subject|0|||
129912470|NCT05056246|467642495|FG001|Overall Study|Withdrawal by Subject|1|||
129912471|NCT05056246|467642496|FG002|Overall Study|Withdrawal by Subject|0|||
129912472|NCT05056246|467642497|FG003|Overall Study|Withdrawal by Subject|0|||
129912473|NCT05056246|467642498|FG004|Overall Study|Withdrawal by Subject|0|||
129912474|NCT04714320|467642500|FG000|Overall Study|Voluntary Withdrawal|4|||
129912475|NCT04714320|467642501|FG001|Overall Study|Voluntary Withdrawal|1|||
129912476|NCT04714320|467642502|FG002|Overall Study|Voluntary Withdrawal|2|||
129912477|NCT04714320|467642500|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
129912478|NCT04714320|467642501|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
129912479|NCT04714320|467642502|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
129912480|NCT04714320|467642500|FG000|Overall Study|Reason Not Specified|1|||
129912481|NCT04714320|467642501|FG001|Overall Study|Reason Not Specified|3|||
129912482|NCT04714320|467642502|FG002|Overall Study|Reason Not Specified|3|||
129912483|NCT05057897|467642503|FG000|Overall Study|Site closure|2|||
129912484|NCT05057897|467642504|FG001|Overall Study|Site closure|2|||
129912485|NCT05057897|467642503|FG000|Overall Study|Death|1|||
129912486|NCT05057897|467642504|FG001|Overall Study|Death|0|||
129912487|NCT03575052|467642513|FG000|Overall Study|Adverse Event|6|||
129912488|NCT03575052|467642514|FG001|Overall Study|Adverse Event|10|||
129912489|NCT03575052|467642513|FG000|Overall Study|Not further specified|5|||
129912490|NCT03575052|467642514|FG001|Overall Study|Not further specified|7|||
129912491|NCT03575052|467642513|FG000|Overall Study|Withdrawal by Subject|5|||
129912492|NCT03575052|467642514|FG001|Overall Study|Withdrawal by Subject|6|||
129912493|NCT03575052|467642513|FG000|Overall Study|Lost to Follow-up|3|||
129912494|NCT03575052|467642514|FG001|Overall Study|Lost to Follow-up|0|||
129912495|NCT03575052|467642513|FG000|Overall Study|Death|2|||
129912496|NCT03575052|467642514|FG001|Overall Study|Death|1|||
129912497|NCT03575052|467642513|FG000|Overall Study|Lack of Efficacy|2|||
129912498|NCT03575052|467642514|FG001|Overall Study|Lack of Efficacy|1|||
129912499|NCT03575052|467642513|FG000|Overall Study|Study drug noncompliance|1|||
129912500|NCT03575052|467642514|FG001|Overall Study|Study drug noncompliance|2|||
129912501|NCT03575052|467642513|FG000|Overall Study|Protocol Violation|0|||
129912502|NCT03575052|467642514|FG001|Overall Study|Protocol Violation|2|||
129912503|NCT03575052|467642513|FG000|Overall Study|Physician Decision|1|||
129912504|NCT03575052|467642514|FG001|Overall Study|Physician Decision|0|||
129912505|NCT03438188|467642515|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
129912506|NCT03438188|467642516|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
129912507|NCT03438188|467642517|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
129912508|NCT03438188|467642515|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
129912509|NCT03438188|467642516|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
129912510|NCT03438188|467642517|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
129912511|NCT03438188|467642515|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
129912512|NCT03438188|467642516|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
129912513|NCT03438188|467642517|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
129912514|NCT03438188|467642515|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
129912515|NCT03438188|467642516|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
129912516|NCT03438188|467642517|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
129912517|NCT03438188|467642515|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
129912518|NCT03438188|467642516|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
129912519|NCT03438188|467642517|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
129912520|NCT04300231|467642518|FG000|Overall Study|Protocol Violation|4|||
129912521|NCT04300231|467642519|FG001|Overall Study|Protocol Violation|3|||
129912522|NCT04300231|467642520|FG002|Overall Study|Protocol Violation|0|||
129912523|NCT04300231|467642521|FG003|Overall Study|Protocol Violation|2|||
129912524|NCT02300298|467642528|FG000|Disposition for Nintedanib|Progressive disease|10|||
129912525|NCT02300298|467642529|FG001|Disposition for Nintedanib|Progressive disease|0|||
129912526|NCT02300298|467642528|FG000|Disposition for Docetaxel|Progressive disease|0|||
129912527|NCT02300298|467642529|FG001|Disposition for Docetaxel|Progressive disease|6|||
129912528|NCT02300298|467642528|FG000|Disposition for Docetaxel|other adverse event|0|||
129912529|NCT02300298|467642529|FG001|Disposition for Docetaxel|other adverse event|4|||
129912530|NCT03285763|467642530|FG000|Overall Study|Death|470|||
129912531|NCT03285763|467642530|FG000|Overall Study|Lost to Follow-up|18|||
129912532|NCT03285763|467642530|FG000|Overall Study|Physician Decision|2|||
129912533|NCT03285763|467642530|FG000|Overall Study|Study Terminated By Sponsor|79|||
129912534|NCT03285763|467642530|FG000|Overall Study|Withdrawal by Subject|33|||
129912535|NCT03456076|467642531|FG000|Overall Study|Withdrawal by Subject|5|||
129912536|NCT03456076|467642532|FG001|Overall Study|Withdrawal by Subject|9|||
129912537|NCT03456076|467642531|FG000|Overall Study|Protocol deviation|0|||
129912538|NCT03456076|467642532|FG001|Overall Study|Protocol deviation|1|||
129912539|NCT03456076|467642531|FG000|Overall Study|Lost to Follow-up|0|||
129912540|NCT03456076|467642532|FG001|Overall Study|Lost to Follow-up|1|||
129912541|NCT03456076|467642531|FG000|Overall Study|Death|2|||
129912542|NCT03456076|467642532|FG001|Overall Study|Death|5|||
129912543|NCT03456076|467642531|FG000|Overall Study|Study ongoing|123|||
129912544|NCT03456076|467642532|FG001|Overall Study|Study ongoing|111|||
129912545|NCT00505934|467642533|FG000|Overall Study|Adverse Event|1|||
129912546|NCT00505934|467642533|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
129912547|NCT00505934|467642533|FG000|Overall Study|Other: IV dose needed to be changed|1|||
129912548|NCT03050814|467642534|FG000|Overall Study|Screen failures|0|||
129912549|NCT03050814|467642535|FG001|Overall Study|Screen failures|0|||
129912550|NCT03050814|467642536|FG002|Overall Study|Screen failures|4|||
129912551|NCT05137236|467642540|FG000|Part A|Other than Specified|1|||
129912552|NCT05137236|467642541|FG001|Part A|Other than Specified|0|||
129912553|NCT05137236|467642542|FG002|Part A|Other than Specified|0|||
129912554|NCT05137236|467642543|FG003|Part A|Other than Specified|0|||
129912555|NCT05137236|467642544|FG004|Part A|Other than Specified|0|||
129912556|NCT05137236|467642545|FG005|Part A|Other than Specified|0|||
129912557|NCT05137236|467642546|FG006|Part A|Other than Specified|0|||
129912558|NCT05137236|467642547|FG007|Part A|Other than Specified|0|||
129912559|NCT05137236|467642540|FG000|Part A|Withdrawal by Subject|0|||
129912560|NCT05137236|467642541|FG001|Part A|Withdrawal by Subject|4|||
129912561|NCT05137236|467642542|FG002|Part A|Withdrawal by Subject|1|||
129912562|NCT05137236|467642543|FG003|Part A|Withdrawal by Subject|1|||
129912563|NCT05137236|467642544|FG004|Part A|Withdrawal by Subject|3|||
129912564|NCT05137236|467642545|FG005|Part A|Withdrawal by Subject|2|||
129912565|NCT05137236|467642546|FG006|Part A|Withdrawal by Subject|0|||
129912566|NCT05137236|467642547|FG007|Part A|Withdrawal by Subject|0|||
129912567|NCT05137236|467642540|FG000|Part A|Lost to Follow-up|5|||
129912568|NCT05137236|467642541|FG001|Part A|Lost to Follow-up|7|||
129912569|NCT05137236|467642542|FG002|Part A|Lost to Follow-up|1|||
129912570|NCT05137236|467642543|FG003|Part A|Lost to Follow-up|3|||
129912571|NCT05137236|467642544|FG004|Part A|Lost to Follow-up|3|||
129912572|NCT05137236|467642545|FG005|Part A|Lost to Follow-up|8|||
129912573|NCT05137236|467642546|FG006|Part A|Lost to Follow-up|0|||
129912574|NCT05137236|467642547|FG007|Part A|Lost to Follow-up|0|||
129912575|NCT05137236|467642540|FG000|Part B|Withdrawal by Subject|0|||
129912576|NCT05137236|467642541|FG001|Part B|Withdrawal by Subject|0|||
129912577|NCT05137236|467642542|FG002|Part B|Withdrawal by Subject|0|||
129912578|NCT05137236|467642543|FG003|Part B|Withdrawal by Subject|0|||
129912579|NCT05137236|467642544|FG004|Part B|Withdrawal by Subject|0|||
129912580|NCT05137236|467642545|FG005|Part B|Withdrawal by Subject|0|||
129912581|NCT05137236|467642546|FG006|Part B|Withdrawal by Subject|0|||
129912582|NCT05137236|467642547|FG007|Part B|Withdrawal by Subject|2|||
129912583|NCT05137236|467642540|FG000|Part B|Lost to Follow-up|0|||
129912584|NCT05137236|467642541|FG001|Part B|Lost to Follow-up|0|||
129912585|NCT05137236|467642542|FG002|Part B|Lost to Follow-up|0|||
129912586|NCT05137236|467642543|FG003|Part B|Lost to Follow-up|0|||
129912587|NCT05137236|467642544|FG004|Part B|Lost to Follow-up|0|||
129912588|NCT05137236|467642545|FG005|Part B|Lost to Follow-up|0|||
129912589|NCT05137236|467642546|FG006|Part B|Lost to Follow-up|5|||
129912590|NCT05137236|467642547|FG007|Part B|Lost to Follow-up|5|||
129912591|NCT05137236|467642540|FG000|Part B|Death|0|||
129912592|NCT05137236|467642541|FG001|Part B|Death|0|||
129912593|NCT05137236|467642542|FG002|Part B|Death|0|||
129912594|NCT05137236|467642543|FG003|Part B|Death|0|||
129912595|NCT05137236|467642544|FG004|Part B|Death|0|||
129912596|NCT05137236|467642545|FG005|Part B|Death|0|||
129912597|NCT05137236|467642546|FG006|Part B|Death|0|||
129912598|NCT05137236|467642547|FG007|Part B|Death|2|||
129912599|NCT02724956|467642548|FG000|Overall Study|Physician Decision|1|||
129912600|NCT02724956|467642549|FG001|Overall Study|Physician Decision|0|||
129912601|NCT02724956|467642548|FG000|Overall Study|Lack of Efficacy|0|||
129912602|NCT02724956|467642549|FG001|Overall Study|Lack of Efficacy|1|||
129912603|NCT02724956|467642548|FG000|Overall Study|Withdrawal by Subject|0|||
129912604|NCT02724956|467642549|FG001|Overall Study|Withdrawal by Subject|1|||
129912605|NCT00431834|467642550|FG000|Overall Study|Withdrawal by Subject|7|||
129912606|NCT00431834|467642550|FG000|Overall Study|Death|3|||
129912607|NCT00431834|467642550|FG000|Overall Study|Missed Endpoint Visit|2|||
129912608|NCT00431834|467642550|FG000|Overall Study|Lost to Follow-up|1|||
129912609|NCT02461628|467642554|FG000|Overall Study|Refused to complete survey|4|||
129912610|NCT02461628|467642555|FG001|Overall Study|Refused to complete survey|7|||
129912611|NCT02121002|467642567|FG000|Overall Study|Physician Decision|2|||
129912612|NCT02121002|467642568|FG001|Overall Study|Physician Decision|0|||
129912613|NCT02121002|467642569|FG002|Overall Study|Physician Decision|0|||
129912614|NCT02121002|467642567|FG000|Overall Study|Withdrawal by Subject|3|||
129912615|NCT02121002|467642568|FG001|Overall Study|Withdrawal by Subject|1|||
129912616|NCT02121002|467642569|FG002|Overall Study|Withdrawal by Subject|4|||
129912617|NCT02121002|467642567|FG000|Overall Study|Protocol Violation|1|||
129912618|NCT02121002|467642568|FG001|Overall Study|Protocol Violation|2|||
129912619|NCT02121002|467642569|FG002|Overall Study|Protocol Violation|4|||
129912620|NCT02121002|467642567|FG000|Overall Study|Concomitant therapy|0|||
129912621|NCT02121002|467642568|FG001|Overall Study|Concomitant therapy|1|||
129912622|NCT02121002|467642569|FG002|Overall Study|Concomitant therapy|1|||
129912623|NCT02121002|467642567|FG000|Overall Study|Others|1|||
129912624|NCT02121002|467642568|FG001|Overall Study|Others|0|||
129912625|NCT02121002|467642569|FG002|Overall Study|Others|1|||
129912626|NCT02590432|467642570|FG000|Open-label Treatment Period|Adverse Event|97|||
129912627|NCT02590432|467642571|FG001|Open-label Treatment Period|Adverse Event|79|||
129912628|NCT02590432|467642572|FG002|Open-label Treatment Period|Adverse Event|0|||
129912629|NCT02590432|467642573|FG003|Open-label Treatment Period|Adverse Event|0|||
129912630|NCT02590432|467642574|FG004|Open-label Treatment Period|Adverse Event|0|||
129912631|NCT02590432|467642575|FG005|Open-label Treatment Period|Adverse Event|0|||
129912632|NCT02590432|467642576|FG006|Open-label Treatment Period|Adverse Event|0|||
129912633|NCT02590432|467642577|FG007|Open-label Treatment Period|Adverse Event|0|||
129912634|NCT02590432|467642578|FG008|Open-label Treatment Period|Adverse Event|0|||
129912635|NCT02590432|467642570|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
129912636|NCT02590432|467642571|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
129912637|NCT02590432|467642572|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
129912638|NCT02590432|467642573|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
129912639|NCT02590432|467642574|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
129912640|NCT02590432|467642575|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
129912641|NCT02590432|467642576|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
129912642|NCT02590432|467642577|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
129912643|NCT02590432|467642578|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
129912644|NCT02590432|467642570|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
129912645|NCT02590432|467642571|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
129912646|NCT02590432|467642572|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
129912647|NCT02590432|467642573|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
129912648|NCT02590432|467642574|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
129912649|NCT02590432|467642575|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
129912650|NCT02590432|467642576|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
129912651|NCT02590432|467642577|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
129912652|NCT02590432|467642578|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
129912653|NCT02590432|467642570|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
129912654|NCT02590432|467642571|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
129912655|NCT02590432|467642572|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129912656|NCT02590432|467642573|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
129912657|NCT02590432|467642574|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
129912658|NCT02590432|467642575|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
129912659|NCT02590432|467642576|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
129912660|NCT02590432|467642577|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
129912661|NCT02590432|467642578|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
129912662|NCT02590432|467642570|FG000|Open-label Treatment Period|Protocol Violation|10|||
129912663|NCT02590432|467642571|FG001|Open-label Treatment Period|Protocol Violation|4|||
129912664|NCT02590432|467642572|FG002|Open-label Treatment Period|Protocol Violation|0|||
129912665|NCT02590432|467642573|FG003|Open-label Treatment Period|Protocol Violation|0|||
129912666|NCT02590432|467642574|FG004|Open-label Treatment Period|Protocol Violation|0|||
129912667|NCT02590432|467642575|FG005|Open-label Treatment Period|Protocol Violation|0|||
129912668|NCT02590432|467642576|FG006|Open-label Treatment Period|Protocol Violation|0|||
129912669|NCT02590432|467642577|FG007|Open-label Treatment Period|Protocol Violation|0|||
129912670|NCT02590432|467642578|FG008|Open-label Treatment Period|Protocol Violation|0|||
129912671|NCT02590432|467642570|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
129912672|NCT02590432|467642571|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
129912673|NCT02590432|467642572|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912674|NCT02590432|467642573|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912675|NCT02590432|467642574|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912676|NCT02590432|467642575|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912677|NCT02590432|467642576|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912678|NCT02590432|467642577|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912679|NCT02590432|467642578|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
129912680|NCT02590432|467642570|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
129912681|NCT02590432|467642571|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
129912682|NCT02590432|467642572|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912683|NCT02590432|467642573|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912684|NCT02590432|467642574|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912685|NCT02590432|467642575|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912686|NCT02590432|467642576|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912687|NCT02590432|467642577|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912688|NCT02590432|467642578|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
129912689|NCT02590432|467642570|FG000|Double-blind Treatment Period|Adverse Event|0|||
129912690|NCT02590432|467642571|FG001|Double-blind Treatment Period|Adverse Event|0|||
129912691|NCT02590432|467642572|FG002|Double-blind Treatment Period|Adverse Event|14|||
129912692|NCT02590432|467642573|FG003|Double-blind Treatment Period|Adverse Event|12|||
129912693|NCT02590432|467642574|FG004|Double-blind Treatment Period|Adverse Event|6|||
129912694|NCT02590432|467642575|FG005|Double-blind Treatment Period|Adverse Event|22|||
129912695|NCT02590432|467642576|FG006|Double-blind Treatment Period|Adverse Event|20|||
129912696|NCT02590432|467642577|FG007|Double-blind Treatment Period|Adverse Event|0|||
129912697|NCT02590432|467642578|FG008|Double-blind Treatment Period|Adverse Event|0|||
129912698|NCT02590432|467642570|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
129912699|NCT02590432|467642571|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
129912700|NCT02590432|467642572|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
129912701|NCT02590432|467642573|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
129912702|NCT02590432|467642574|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
129912703|NCT02590432|467642575|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
129912704|NCT02590432|467642576|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
129912705|NCT02590432|467642577|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
129912706|NCT02590432|467642578|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
129912707|NCT02590432|467642570|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
129912708|NCT02590432|467642571|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
129912709|NCT02590432|467642572|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
129912710|NCT02590432|467642573|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
129912711|NCT02590432|467642574|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
129912712|NCT02590432|467642575|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
129912713|NCT02590432|467642576|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
129912714|NCT02590432|467642577|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
129449719|NCT01576172|465945666|FG000|Overall Study|Withdrawal by Subject|2|||
129449720|NCT01576172|465945667|FG001|Overall Study|Withdrawal by Subject|0|||
129912715|NCT02590432|467642578|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
129912716|NCT02590432|467642570|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129912717|NCT02590432|467642571|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129912718|NCT02590432|467642572|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129912719|NCT02590432|467642573|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129912720|NCT02590432|467642574|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
129912721|NCT02590432|467642575|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
129912722|NCT02590432|467642576|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
129912723|NCT02590432|467642577|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
129912724|NCT02590432|467642578|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
129912725|NCT02590432|467642570|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912726|NCT02590432|467642571|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912727|NCT02590432|467642572|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912728|NCT02590432|467642573|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912729|NCT02590432|467642574|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912730|NCT02590432|467642575|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
129912731|NCT02590432|467642576|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912732|NCT02590432|467642577|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912733|NCT02590432|467642578|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
129912734|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912735|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912736|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912737|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912738|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912739|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912740|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
129912741|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
129912742|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
129912743|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912744|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912745|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912746|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912747|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912748|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912749|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912750|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
129912751|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
129912752|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912753|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912754|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912755|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912756|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912757|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912758|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
129912759|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
129912760|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
129912761|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912762|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912763|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912764|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912765|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912766|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912767|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912768|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
129912769|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
129912770|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912771|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912772|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912773|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912774|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912775|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912776|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912777|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
129912778|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
129912779|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912780|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912781|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912782|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912783|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912784|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912785|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912786|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
129912787|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
129912788|NCT02590432|467642570|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912789|NCT02590432|467642571|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912790|NCT02590432|467642572|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129863165|NCT01217073|467456606|FG007|Extension Period|Lost to Follow-up|1|||
129863166|NCT01217073|467456599|FG000|Extension Period|Non-compliance with study drug|0|||
129863167|NCT01217073|467456600|FG001|Extension Period|Non-compliance with study drug|0|||
129863168|NCT01217073|467456601|FG002|Extension Period|Non-compliance with study drug|0|||
129863169|NCT01217073|467456602|FG003|Extension Period|Non-compliance with study drug|0|||
129863170|NCT01217073|467456603|FG004|Extension Period|Non-compliance with study drug|0|||
129863171|NCT01217073|467456604|FG005|Extension Period|Non-compliance with study drug|0|||
129863172|NCT01217073|467456605|FG006|Extension Period|Non-compliance with study drug|0|||
129863173|NCT01217073|467456606|FG007|Extension Period|Non-compliance with study drug|1|||
129863174|NCT01217073|467456599|FG000|Extension Period|Physician Decision|0|||
129863175|NCT01217073|467456600|FG001|Extension Period|Physician Decision|0|||
129863176|NCT01217073|467456601|FG002|Extension Period|Physician Decision|0|||
129863177|NCT01217073|467456602|FG003|Extension Period|Physician Decision|0|||
129863178|NCT01217073|467456603|FG004|Extension Period|Physician Decision|0|||
129863179|NCT01217073|467456604|FG005|Extension Period|Physician Decision|0|||
129863180|NCT01217073|467456605|FG006|Extension Period|Physician Decision|4|||
129863181|NCT01217073|467456606|FG007|Extension Period|Physician Decision|1|||
129863182|NCT01217073|467456599|FG000|Extension Period|Protocol Violation|0|||
129863183|NCT01217073|467456600|FG001|Extension Period|Protocol Violation|0|||
129863184|NCT01217073|467456601|FG002|Extension Period|Protocol Violation|0|||
129863185|NCT01217073|467456602|FG003|Extension Period|Protocol Violation|0|||
129863186|NCT01217073|467456603|FG004|Extension Period|Protocol Violation|0|||
129863187|NCT01217073|467456604|FG005|Extension Period|Protocol Violation|0|||
129863188|NCT01217073|467456605|FG006|Extension Period|Protocol Violation|2|||
129863189|NCT01217073|467456606|FG007|Extension Period|Protocol Violation|1|||
129863190|NCT01217073|467456599|FG000|Extension Period|Site discontinued study participation|0|||
129863191|NCT01217073|467456600|FG001|Extension Period|Site discontinued study participation|0|||
129863192|NCT01217073|467456601|FG002|Extension Period|Site discontinued study participation|0|||
129863193|NCT01217073|467456602|FG003|Extension Period|Site discontinued study participation|0|||
129863194|NCT01217073|467456603|FG004|Extension Period|Site discontinued study participation|0|||
129863195|NCT01217073|467456604|FG005|Extension Period|Site discontinued study participation|0|||
129863196|NCT01217073|467456605|FG006|Extension Period|Site discontinued study participation|7|||
129863197|NCT01217073|467456606|FG007|Extension Period|Site discontinued study participation|2|||
129863198|NCT01217073|467456599|FG000|Extension Period|Withdrawal by Subject|0|||
129863199|NCT01217073|467456600|FG001|Extension Period|Withdrawal by Subject|0|||
129863200|NCT01217073|467456601|FG002|Extension Period|Withdrawal by Subject|0|||
129863201|NCT01217073|467456602|FG003|Extension Period|Withdrawal by Subject|0|||
129863202|NCT01217073|467456603|FG004|Extension Period|Withdrawal by Subject|0|||
129863203|NCT01217073|467456604|FG005|Extension Period|Withdrawal by Subject|0|||
129863204|NCT01217073|467456605|FG006|Extension Period|Withdrawal by Subject|30|||
129863205|NCT01217073|467456606|FG007|Extension Period|Withdrawal by Subject|8|||
129863206|NCT04004611|467456607|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863207|NCT04004611|467456608|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863208|NCT04004611|467456609|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863209|NCT04004611|467456610|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863210|NCT04004611|467456611|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863211|NCT04004611|467456612|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863212|NCT04004611|467456613|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863213|NCT04004611|467456614|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
129863214|NCT04004611|467456615|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
129863215|NCT04004611|467456607|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863216|NCT04004611|467456608|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863217|NCT04004611|467456609|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863218|NCT04004611|467456610|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863219|NCT04004611|467456611|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863220|NCT04004611|467456612|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
129863221|NCT04004611|467456613|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
129863222|NCT04004611|467456614|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
129863223|NCT04004611|467456615|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
129863224|NCT04004611|467456607|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863225|NCT04004611|467456608|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863226|NCT04004611|467456609|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863227|NCT04004611|467456610|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129449721|NCT01576172|465945666|FG000|Overall Study|Insurance issue|1|||
129863228|NCT04004611|467456611|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
129863229|NCT04004611|467456612|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863230|NCT04004611|467456613|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863231|NCT04004611|467456614|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863232|NCT04004611|467456615|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
129863233|NCT04004611|467456607|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
129912791|NCT02590432|467642573|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912792|NCT02590432|467642574|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912793|NCT02590432|467642575|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912794|NCT02590432|467642576|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912795|NCT02590432|467642577|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
129912796|NCT02590432|467642578|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
129912797|NCT02006758|467642579|FG000|Overall Study|Protocol Violation|1|||
129912798|NCT02006758|467642579|FG000|Overall Study|Death|1|||
129912799|NCT02006758|467642579|FG000|Overall Study|Lost to Follow-up|4|||
129912800|NCT02006758|467642579|FG000|Overall Study|Withdrawal by Subject|4|||
129912801|NCT02006758|467642579|FG000|Overall Study|Procedurally excluded|1|||
129912802|NCT02006758|467642579|FG000|Overall Study|Other|2|||
129912803|NCT04788641|467642580|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
129912804|NCT04788641|467642581|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
129912805|NCT04788641|467642582|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
129912806|NCT04788641|467642583|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
129912807|NCT04788641|467642580|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
129912808|NCT04788641|467642581|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
129912809|NCT04788641|467642582|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
129912810|NCT04788641|467642583|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
129912811|NCT04788641|467642580|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
129912812|NCT04788641|467642581|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
129912813|NCT04788641|467642582|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
129912814|NCT04788641|467642583|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
129912815|NCT02740231|467642588|FG000|Overall Study|Withdrawal by Subject|1|||
129912816|NCT02740231|467642589|FG001|Overall Study|Withdrawal by Subject|1|||
129912817|NCT02740231|467642590|FG002|Overall Study|Withdrawal by Subject|1|||
129912818|NCT02740231|467642591|FG003|Overall Study|Withdrawal by Subject|0|||
129912819|NCT02740231|467642588|FG000|Overall Study|Lack of Efficacy|0|||
129912820|NCT02740231|467642589|FG001|Overall Study|Lack of Efficacy|1|||
129912821|NCT02740231|467642590|FG002|Overall Study|Lack of Efficacy|0|||
129912822|NCT02740231|467642591|FG003|Overall Study|Lack of Efficacy|4|||
129912823|NCT02740231|467642588|FG000|Overall Study|Lost to Follow-up|1|||
129912824|NCT02740231|467642589|FG001|Overall Study|Lost to Follow-up|3|||
129912825|NCT02740231|467642590|FG002|Overall Study|Lost to Follow-up|0|||
129912826|NCT02740231|467642591|FG003|Overall Study|Lost to Follow-up|3|||
129912827|NCT02740231|467642588|FG000|Overall Study|Adverse Event|0|||
129912828|NCT02740231|467642589|FG001|Overall Study|Adverse Event|1|||
129912829|NCT02740231|467642590|FG002|Overall Study|Adverse Event|0|||
129912830|NCT02740231|467642591|FG003|Overall Study|Adverse Event|1|||
129912831|NCT02462759|467642592|FG000|Part 1: Double Blind|Death|1|||
129912832|NCT02462759|467642593|FG001|Part 1: Double Blind|Death|0|||
129912833|NCT02462759|467642594|FG002|Part 1: Double Blind|Death|0|||
129912834|NCT00243503|467642597|FG000|Overall Study|Adverse Event|11|||
129912835|NCT00243503|467642597|FG000|Overall Study|Withdrawal by Subject|1|||
129912836|NCT00243503|467642597|FG000|Overall Study|Lack of Efficacy|44|||
129912837|NCT00243503|467642597|FG000|Overall Study|Death|1|||
129912838|NCT00243503|467642597|FG000|Overall Study|Other|1|||
129912839|NCT01000480|467642598|FG000|Induction Phase|Adverse Event|2|||
129912840|NCT01000480|467642598|FG000|Induction Phase|Lost to Follow-up|1|||
129912841|NCT01000480|467642598|FG000|Induction Phase|Physician Decision|1|||
129912842|NCT01000480|467642598|FG000|Induction Phase|Entry Criteria Not Met|3|||
129912843|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Adverse Event|4|||
129912844|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
129912845|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
129912846|NCT01000480|467642598|FG000|Concurrent Therapy Phase|Physician Decision|1|||
129912847|NCT04600752|467642603|FG000|Overall Study|Physician Decision|0|||
129912848|NCT04600752|467642604|FG001|Overall Study|Physician Decision|0|||
129912849|NCT04600752|467642605|FG002|Overall Study|Physician Decision|1|||
129912850|NCT04600752|467642603|FG000|Overall Study|Adverse Event|0|||
129912851|NCT04600752|467642604|FG001|Overall Study|Adverse Event|1|||
129449722|NCT01576172|465945667|FG001|Overall Study|Insurance issue|0|||
129449723|NCT02790138|465945668|FG000|Overall Study|Adverse Event|5|||
129912852|NCT04600752|467642605|FG002|Overall Study|Adverse Event|0|||
129912853|NCT04600752|467642603|FG000|Overall Study|Withdrawal by Subject|2|||
129912854|NCT04600752|467642604|FG001|Overall Study|Withdrawal by Subject|1|||
129912855|NCT04600752|467642605|FG002|Overall Study|Withdrawal by Subject|0|||
129863234|NCT04004611|467456608|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
129863235|NCT04004611|467456609|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
129863236|NCT04004611|467456610|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
129863237|NCT04004611|467456611|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
129863238|NCT04004611|467456612|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
129863239|NCT04004611|467456613|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
129863240|NCT04004611|467456614|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
129863241|NCT04004611|467456615|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
129863242|NCT04004611|467456607|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
129863243|NCT04004611|467456608|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863244|NCT04004611|467456609|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
129863245|NCT04004611|467456610|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863246|NCT04004611|467456611|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863247|NCT04004611|467456612|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863248|NCT04004611|467456613|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863249|NCT04004611|467456614|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863250|NCT04004611|467456615|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
129863251|NCT04004611|467456607|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863252|NCT04004611|467456608|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
129863253|NCT04004611|467456609|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863254|NCT04004611|467456610|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863255|NCT04004611|467456611|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863256|NCT04004611|467456612|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863257|NCT04004611|467456613|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863258|NCT04004611|467456614|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863259|NCT04004611|467456615|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
129863260|NCT04420689|467456616|FG000|Overall Study|COVID-19 related hospitalization|0|||
129863261|NCT04420689|467456617|FG001|Overall Study|COVID-19 related hospitalization|0|||
129863262|NCT04420689|467456618|FG002|Overall Study|COVID-19 related hospitalization|0|||
129863263|NCT04420689|467456619|FG003|Overall Study|COVID-19 related hospitalization|0|||
129863264|NCT04420689|467456620|FG004|Overall Study|COVID-19 related hospitalization|1|||
129863265|NCT04420689|467456621|FG005|Overall Study|COVID-19 related hospitalization|0|||
129863266|NCT04420689|467456622|FG006|Overall Study|COVID-19 related hospitalization|0|||
129863267|NCT04420689|467456616|FG000|Overall Study|Physician Decision|0|||
129863268|NCT04420689|467456617|FG001|Overall Study|Physician Decision|0|||
129863269|NCT04420689|467456618|FG002|Overall Study|Physician Decision|0|||
129863270|NCT04420689|467456619|FG003|Overall Study|Physician Decision|0|||
129863271|NCT04420689|467456620|FG004|Overall Study|Physician Decision|0|||
129863272|NCT04420689|467456621|FG005|Overall Study|Physician Decision|1|||
129863273|NCT04420689|467456622|FG006|Overall Study|Physician Decision|0|||
129863274|NCT00515502|467456623|FG000|Treatment Period 1|Adverse Event|0|||
129863275|NCT00515502|467456624|FG001|Treatment Period 1|Adverse Event|0|||
129863276|NCT00515502|467456625|FG002|Treatment Period 1|Adverse Event|0|||
129863277|NCT00515502|467456626|FG003|Treatment Period 1|Adverse Event|0|||
129863278|NCT00515502|467456627|FG004|Treatment Period 1|Adverse Event|0|||
129863279|NCT00515502|467456628|FG005|Treatment Period 1|Adverse Event|0|||
129863280|NCT00515502|467456629|FG006|Treatment Period 1|Adverse Event|1|||
129863281|NCT00515502|467456630|FG007|Treatment Period 1|Adverse Event|0|||
129863282|NCT00515502|467456631|FG008|Treatment Period 1|Adverse Event|1|||
129863283|NCT00515502|467456632|FG009|Treatment Period 1|Adverse Event|0|||
129863284|NCT00515502|467456633|FG010|Treatment Period 1|Adverse Event|0|||
129863285|NCT00515502|467456634|FG011|Treatment Period 1|Adverse Event|1|||
129863286|NCT00515502|467456623|FG000|Treatment Period 2|Adverse Event|0|||
129863287|NCT00515502|467456624|FG001|Treatment Period 2|Adverse Event|1|||
129863288|NCT00515502|467456625|FG002|Treatment Period 2|Adverse Event|0|||
129863289|NCT00515502|467456626|FG003|Treatment Period 2|Adverse Event|0|||
129863290|NCT00515502|467456627|FG004|Treatment Period 2|Adverse Event|0|||
129863291|NCT00515502|467456628|FG005|Treatment Period 2|Adverse Event|0|||
129863292|NCT00515502|467456629|FG006|Treatment Period 2|Adverse Event|0|||
129863293|NCT00515502|467456630|FG007|Treatment Period 2|Adverse Event|0|||
129863294|NCT00515502|467456631|FG008|Treatment Period 2|Adverse Event|0|||
129863295|NCT00515502|467456632|FG009|Treatment Period 2|Adverse Event|0|||
129863296|NCT00515502|467456633|FG010|Treatment Period 2|Adverse Event|0|||
129863297|NCT00515502|467456634|FG011|Treatment Period 2|Adverse Event|0|||
129863298|NCT02732938|467456638|FG000|Overall Study|Death|0|||
129863299|NCT02732938|467456639|FG001|Overall Study|Death|11|||
129863300|NCT02732938|467456640|FG002|Overall Study|Death|0|||
129863301|NCT02732938|467456638|FG000|Overall Study|Randomized but did not receive treatment|0|||
129863302|NCT02732938|467456639|FG001|Overall Study|Randomized but did not receive treatment|1|||
129863303|NCT02732938|467456640|FG002|Overall Study|Randomized but did not receive treatment|0|||
129863304|NCT02732938|467456638|FG000|Overall Study|Refused further follow-up|1|||
129863305|NCT02732938|467456639|FG001|Overall Study|Refused further follow-up|0|||
129863306|NCT02732938|467456640|FG002|Overall Study|Refused further follow-up|0|||
129863307|NCT02732938|467456638|FG000|Overall Study|Study terminated by sponsor|3|||
129863308|NCT02732938|467456639|FG001|Overall Study|Study terminated by sponsor|6|||
129863309|NCT02732938|467456640|FG002|Overall Study|Study terminated by sponsor|0|||
129863310|NCT03927950|467456641|FG000|Overall Study|Adverse Event|9|||
129863311|NCT03647501|467456642|FG000|Overall Study|Lost to Follow-up|1|||
129863312|NCT03647501|467456643|FG001|Overall Study|Lost to Follow-up|1|||
129863313|NCT03647501|467456642|FG000|Overall Study|Withdrawal by Subject|0|||
129863314|NCT03647501|467456643|FG001|Overall Study|Withdrawal by Subject|1|||
129863315|NCT04530448|467456644|FG000|Overall Study|Physician Decision|3|||
129863316|NCT04530448|467456645|FG001|Overall Study|Physician Decision|0|||
129863317|NCT01433354|467456648|FG000|Overall Study|Adverse Event|6|||
129863318|NCT01433354|467456648|FG000|Overall Study|Lost to Follow-up|1|||
129863319|NCT01433354|467456648|FG000|Overall Study|Administrative problems|90|||
129863320|NCT01433354|467456648|FG000|Overall Study|Protocol Violation|2|||
129863321|NCT01433354|467456648|FG000|Overall Study|Lack of Efficacy|17|||
129863322|NCT01433354|467456648|FG000|Overall Study|Subject Withdrew Consent|3|||
129863323|NCT01540851|467456652|FG000|Overall Study|Lost to Follow-up|14|||
129863324|NCT01540851|467456653|FG001|Overall Study|Lost to Follow-up|15|||
129863325|NCT01540851|467456652|FG000|Overall Study|Withdrawal by Subject|7|||
129863326|NCT01540851|467456653|FG001|Overall Study|Withdrawal by Subject|3|||
129863327|NCT02013622|467456654|FG000|Overall Study|Lost to Follow-up|10|||
129863328|NCT02013622|467456654|FG000|Overall Study|Adverse Event|3|||
129863329|NCT02013622|467456654|FG000|Overall Study|Met Withdrawal Criteria|3|||
129863330|NCT02013622|467456654|FG000|Overall Study|Withdrawal by Subject|6|||
129863331|NCT02013622|467456654|FG000|Overall Study|Protocol Deviation|1|||
129863332|NCT02013622|467456654|FG000|Overall Study|Lack of Efficacy|1|||
129863333|NCT04307004|467456662|FG000|Randomization 1|Withdrawal by Subject|25|||
129863334|NCT04307004|467456663|FG001|Randomization 1|Withdrawal by Subject|26|||
129863335|NCT04307004|467456664|FG002|Randomization 1|Withdrawal by Subject|0|||
129863336|NCT04307004|467456665|FG003|Randomization 1|Withdrawal by Subject|0|||
129863337|NCT04307004|467456662|FG000|Randomization 2|Withdrawal by Subject|0|||
129863338|NCT04307004|467456663|FG001|Randomization 2|Withdrawal by Subject|0|||
129863339|NCT04307004|467456664|FG002|Randomization 2|Withdrawal by Subject|28|||
129863340|NCT04307004|467456665|FG003|Randomization 2|Withdrawal by Subject|23|||
129863341|NCT01324271|467456666|FG000|Overall Study|Lost to Follow-up|3|||
129863342|NCT01324271|467456667|FG001|Overall Study|Lost to Follow-up|0|||
129863343|NCT01324271|467456666|FG000|Overall Study|Physician Decision|1|||
129863344|NCT01324271|467456667|FG001|Overall Study|Physician Decision|0|||
129863345|NCT05130970|467456668|FG000|Overall Study|Adverse Event|1|||
129863346|NCT05130970|467456669|FG001|Overall Study|Adverse Event|1|||
129912856|NCT04600752|467642603|FG000|Overall Study|Lack of Efficacy|1|||
129863347|NCT05130970|467456668|FG000|Overall Study|Death|0|||
129863348|NCT05130970|467456669|FG001|Overall Study|Death|1|||
129863349|NCT05130970|467456668|FG000|Overall Study|Lost to Follow-up|0|||
129863350|NCT05130970|467456669|FG001|Overall Study|Lost to Follow-up|1|||
129863351|NCT05130970|467456668|FG000|Overall Study|Physician Decision|0|||
129863352|NCT05130970|467456669|FG001|Overall Study|Physician Decision|1|||
129863353|NCT05130970|467456668|FG000|Overall Study|Withdrawal by Subject|1|||
129863354|NCT05130970|467456669|FG001|Overall Study|Withdrawal by Subject|1|||
129863355|NCT03996473|467456670|FG000|Treatment Assignment|Withdrawal by Subject|1|||
129863356|NCT03996473|467456670|FG000|Treatment Assignment|Progressive disease|6|||
129863357|NCT03996473|467456670|FG000|Treatment Assignment|Study drug never administered|1|||
129863358|NCT03996473|467456670|FG000|Active Follow-up|Death|1|||
129863359|NCT03996473|467456670|FG000|Long-term Follow-up|Death|5|||
129863360|NCT06116591|467456671|FG000|Overall Study|No longer met eligibility criteria|0|||
129912857|NCT04600752|467642604|FG001|Overall Study|Lack of Efficacy|0|||
129912858|NCT04600752|467642605|FG002|Overall Study|Lack of Efficacy|0|||
129912859|NCT02374307|467642606|FG000|3-months Follow-up|Lost to Follow-up|1|||
129912860|NCT02374307|467642607|FG001|3-months Follow-up|Lost to Follow-up|2|||
129912861|NCT02374307|467642606|FG000|3-months Follow-up|Withdrawal by Subject|1|||
129912862|NCT02374307|467642607|FG001|3-months Follow-up|Withdrawal by Subject|4|||
129912863|NCT02374307|467642606|FG000|3-months Follow-up|Death|1|||
129912864|NCT02374307|467642607|FG001|3-months Follow-up|Death|2|||
129912865|NCT02374307|467642606|FG000|3-months Follow-up|Missed first follow-up|5|||
129912866|NCT02374307|467642607|FG001|3-months Follow-up|Missed first follow-up|1|||
129912867|NCT02374307|467642606|FG000|6-months Follow-up|Lost to Follow-up|1|||
129912868|NCT02374307|467642607|FG001|6-months Follow-up|Lost to Follow-up|2|||
129912869|NCT02374307|467642606|FG000|6-months Follow-up|Death|2|||
129912870|NCT02374307|467642607|FG001|6-months Follow-up|Death|1|||
129912871|NCT02374307|467642606|FG000|6-months Follow-up|Withdrawal by Subject|0|||
129912872|NCT02374307|467642607|FG001|6-months Follow-up|Withdrawal by Subject|3|||
129912873|NCT00087139|467642613|FG000|Overall Study|Adverse Event|18|||
129912874|NCT00087139|467642614|FG001|Overall Study|Adverse Event|17|||
129912875|NCT00087139|467642615|FG002|Overall Study|Adverse Event|13|||
129912876|NCT00087139|467642613|FG000|Overall Study|Death|2|||
129912877|NCT00087139|467642614|FG001|Overall Study|Death|1|||
129912878|NCT00087139|467642615|FG002|Overall Study|Death|0|||
129912879|NCT00087139|467642613|FG000|Overall Study|Withdrawal by Subject|3|||
129912880|NCT00087139|467642614|FG001|Overall Study|Withdrawal by Subject|2|||
129912881|NCT00087139|467642615|FG002|Overall Study|Withdrawal by Subject|2|||
129912882|NCT00087139|467642613|FG000|Overall Study|Physician Decision|1|||
129912883|NCT00087139|467642614|FG001|Overall Study|Physician Decision|1|||
129912884|NCT00087139|467642615|FG002|Overall Study|Physician Decision|1|||
129912885|NCT00087139|467642613|FG000|Overall Study|Disease progression|9|||
129912886|NCT00087139|467642614|FG001|Overall Study|Disease progression|19|||
129912887|NCT00087139|467642615|FG002|Overall Study|Disease progression|12|||
129912888|NCT00087139|467642613|FG000|Overall Study|Ineligible|4|||
129912889|NCT00087139|467642614|FG001|Overall Study|Ineligible|7|||
129912890|NCT00087139|467642615|FG002|Overall Study|Ineligible|4|||
129912891|NCT00087139|467642613|FG000|Overall Study|Symptomatic deterioration|1|||
129912892|NCT00087139|467642614|FG001|Overall Study|Symptomatic deterioration|1|||
129912893|NCT00087139|467642615|FG002|Overall Study|Symptomatic deterioration|3|||
129912894|NCT00087139|467642613|FG000|Overall Study|Use of coumadin|1|||
129912895|NCT00087139|467642614|FG001|Overall Study|Use of coumadin|0|||
129912896|NCT00087139|467642615|FG002|Overall Study|Use of coumadin|0|||
129912897|NCT00087139|467642613|FG000|Overall Study|Response achieved|0|||
129912898|NCT00087139|467642614|FG001|Overall Study|Response achieved|1|||
129912899|NCT00087139|467642615|FG002|Overall Study|Response achieved|0|||
129912900|NCT00087139|467642613|FG000|Overall Study|Extradural disease|0|||
129912901|NCT00087139|467642614|FG001|Overall Study|Extradural disease|0|||
129912902|NCT00087139|467642615|FG002|Overall Study|Extradural disease|1|||
129912903|NCT00065260|467642618|FG000|Overall Study|Death|0|||
129912904|NCT00065260|467642619|FG001|Overall Study|Death|1|||
129912905|NCT00001277|467642620|FG000|Overall Study|Adverse Event|0|||
129912906|NCT00001277|467642621|FG001|Overall Study|Adverse Event|0|||
129912907|NCT00001277|467642622|FG002|Overall Study|Adverse Event|1|||
129912908|NCT00001277|467642620|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
129912909|NCT00001277|467642621|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
129912910|NCT00001277|467642622|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
129912911|NCT03101371|467642625|FG000|Overall Study|Physician Decision|0|||
129912912|NCT03101371|467642626|FG001|Overall Study|Physician Decision|1|||
129912913|NCT03101371|467642625|FG000|Overall Study|Lost to Follow-up|1|||
129912914|NCT03101371|467642626|FG001|Overall Study|Lost to Follow-up|4|||
129912915|NCT03101371|467642625|FG000|Overall Study|Did not meet eligibility criteria|2|||
129912916|NCT03101371|467642626|FG001|Overall Study|Did not meet eligibility criteria|1|||
129912917|NCT04019444|467642628|FG000|Overall Study|Withdrawal by Subject|0|||
129912918|NCT04019444|467642629|FG001|Overall Study|Withdrawal by Subject|1|||
129912919|NCT04019444|467642630|FG002|Overall Study|Withdrawal by Subject|0|||
129912920|NCT04019444|467642631|FG003|Overall Study|Withdrawal by Subject|1|||
129912921|NCT04019444|467642628|FG000|Overall Study|Solicited Event|0|||
129912922|NCT04019444|467642629|FG001|Overall Study|Solicited Event|0|||
129912923|NCT04019444|467642630|FG002|Overall Study|Solicited Event|2|||
129912924|NCT04019444|467642631|FG003|Overall Study|Solicited Event|0|||
129912925|NCT01303445|467642643|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
129912926|NCT01303445|467642644|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
129912927|NCT01303445|467642643|FG000|Second Intervention (7 Days)|Adverse Event|0|||
129912928|NCT01303445|467642644|FG001|Second Intervention (7 Days)|Adverse Event|2|||
129912929|NCT01303445|467642643|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
129912930|NCT01303445|467642644|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
129912931|NCT01303445|467642643|FG000|Washout (14 Days)|Protocol Violation|1|||
129912932|NCT01303445|467642644|FG001|Washout (14 Days)|Protocol Violation|0|||
129912933|NCT01303445|467642643|FG000|Washout (14 Days)|Lost to Follow-up|0|||
129912934|NCT01303445|467642644|FG001|Washout (14 Days)|Lost to Follow-up|2|||
129912935|NCT01303445|467642643|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
129912936|NCT01303445|467642644|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
129912937|NCT01303445|467642643|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
129912938|NCT01303445|467642644|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
129912939|NCT03481660|467644345|FG000|Overall Study|Adverse Event|5|||
129912940|NCT03481660|467644346|FG001|Overall Study|Adverse Event|4|||
129912941|NCT03481660|467644345|FG000|Overall Study|Death|13|||
129912942|NCT03481660|467644346|FG001|Overall Study|Death|9|||
129912943|NCT03481660|467644345|FG000|Overall Study|Lost to Follow-up|2|||
129912944|NCT03481660|467644346|FG001|Overall Study|Lost to Follow-up|2|||
129912945|NCT03481660|467644345|FG000|Overall Study|Physician Decision|2|||
129912946|NCT03481660|467644346|FG001|Overall Study|Physician Decision|3|||
129912947|NCT03481660|467644345|FG000|Overall Study|Withdrawal by Subject|14|||
129912948|NCT03481660|467644346|FG001|Overall Study|Withdrawal by Subject|7|||
129912949|NCT03398148|467644347|FG000|Substudy 1 Period 1|Adverse Event|5|||
129912950|NCT03398148|467644348|FG001|Substudy 1 Period 1|Adverse Event|2|||
129912951|NCT03398148|467644349|FG002|Substudy 1 Period 1|Adverse Event|2|||
129912952|NCT03398148|467644350|FG003|Substudy 1 Period 1|Adverse Event|0|||
129912953|NCT03398148|467644351|FG004|Substudy 1 Period 1|Adverse Event|8|||
129912954|NCT03398148|467644352|FG005|Substudy 1 Period 1|Adverse Event|0|||
129912955|NCT03398148|467644353|FG006|Substudy 1 Period 1|Adverse Event|0|||
129912956|NCT03398148|467644354|FG007|Substudy 1 Period 1|Adverse Event|0|||
129912957|NCT03398148|467644355|FG008|Substudy 1 Period 1|Adverse Event|0|||
129912958|NCT03398148|467644356|FG009|Substudy 1 Period 1|Adverse Event|0|||
129912959|NCT03398148|467644357|FG010|Substudy 1 Period 1|Adverse Event|0|||
129912960|NCT03398148|467644358|FG011|Substudy 1 Period 1|Adverse Event|0|||
129912961|NCT03398148|467644359|FG012|Substudy 1 Period 1|Adverse Event|0|||
129912962|NCT03398148|467644360|FG013|Substudy 1 Period 1|Adverse Event|0|||
129912963|NCT03398148|467644361|FG014|Substudy 1 Period 1|Adverse Event|0|||
129912964|NCT03398148|467644347|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
129912965|NCT03398148|467644348|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
129912966|NCT03398148|467644349|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912967|NCT03398148|467644350|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
129912968|NCT03398148|467644351|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
129912969|NCT03398148|467644352|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912970|NCT03398148|467644353|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912971|NCT03398148|467644354|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912972|NCT03398148|467644355|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912973|NCT03398148|467644356|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912974|NCT03398148|467644357|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912975|NCT03398148|467644358|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912976|NCT03398148|467644359|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912977|NCT03398148|467644360|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912978|NCT03398148|467644361|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
129912979|NCT03398148|467644347|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
129912980|NCT03398148|467644348|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
129912981|NCT03398148|467644349|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
129912982|NCT03398148|467644350|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
129912983|NCT03398148|467644351|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
129912984|NCT03398148|467644352|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
129912985|NCT03398148|467644353|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
129912986|NCT03398148|467644354|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
129912987|NCT03398148|467644355|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
129912988|NCT03398148|467644356|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
129912989|NCT03398148|467644357|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
129912990|NCT03398148|467644358|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
129912991|NCT03398148|467644359|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
129912992|NCT03398148|467644360|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
129912993|NCT03398148|467644361|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
129912994|NCT03398148|467644347|FG000|Substudy 1 Period 1|Other|0|||
129912995|NCT03398148|467644348|FG001|Substudy 1 Period 1|Other|1|||
129912996|NCT03398148|467644349|FG002|Substudy 1 Period 1|Other|0|||
129912997|NCT03398148|467644350|FG003|Substudy 1 Period 1|Other|0|||
129912998|NCT03398148|467644351|FG004|Substudy 1 Period 1|Other|3|||
129912999|NCT03398148|467644352|FG005|Substudy 1 Period 1|Other|0|||
129449724|NCT02790138|465945669|FG001|Overall Study|Adverse Event|2|||
129913000|NCT03398148|467644353|FG006|Substudy 1 Period 1|Other|0|||
129913001|NCT03398148|467644354|FG007|Substudy 1 Period 1|Other|0|||
129449725|NCT02790138|465945668|FG000|Overall Study|Significant Protocol Deviation|0|||
129913002|NCT03398148|467644355|FG008|Substudy 1 Period 1|Other|0|||
129913003|NCT03398148|467644356|FG009|Substudy 1 Period 1|Other|0|||
129913004|NCT03398148|467644357|FG010|Substudy 1 Period 1|Other|0|||
129913005|NCT03398148|467644358|FG011|Substudy 1 Period 1|Other|0|||
129913006|NCT03398148|467644359|FG012|Substudy 1 Period 1|Other|0|||
129913007|NCT03398148|467644360|FG013|Substudy 1 Period 1|Other|0|||
129913008|NCT03398148|467644361|FG014|Substudy 1 Period 1|Other|0|||
129913009|NCT03398148|467644347|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913010|NCT03398148|467644348|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913011|NCT03398148|467644349|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913012|NCT03398148|467644350|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913013|NCT03398148|467644351|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
129913014|NCT03398148|467644352|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913015|NCT03398148|467644353|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913016|NCT03398148|467644354|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913017|NCT03398148|467644355|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913018|NCT03398148|467644356|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913019|NCT03398148|467644357|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913020|NCT03398148|467644358|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913021|NCT03398148|467644359|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913022|NCT03398148|467644360|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913023|NCT03398148|467644361|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
129913024|NCT03398148|467644347|FG000|Substudy 1 Period 2|Adverse Event|0|||
129913025|NCT03398148|467644348|FG001|Substudy 1 Period 2|Adverse Event|0|||
129913026|NCT03398148|467644349|FG002|Substudy 1 Period 2|Adverse Event|0|||
129913027|NCT03398148|467644350|FG003|Substudy 1 Period 2|Adverse Event|0|||
129913028|NCT03398148|467644351|FG004|Substudy 1 Period 2|Adverse Event|0|||
129913029|NCT03398148|467644352|FG005|Substudy 1 Period 2|Adverse Event|2|||
129913030|NCT03398148|467644353|FG006|Substudy 1 Period 2|Adverse Event|4|||
129913031|NCT03398148|467644354|FG007|Substudy 1 Period 2|Adverse Event|0|||
129913032|NCT03398148|467644355|FG008|Substudy 1 Period 2|Adverse Event|0|||
129913033|NCT03398148|467644356|FG009|Substudy 1 Period 2|Adverse Event|0|||
129913034|NCT03398148|467644357|FG010|Substudy 1 Period 2|Adverse Event|0|||
129913035|NCT03398148|467644358|FG011|Substudy 1 Period 2|Adverse Event|0|||
129913036|NCT03398148|467644359|FG012|Substudy 1 Period 2|Adverse Event|0|||
129913037|NCT03398148|467644360|FG013|Substudy 1 Period 2|Adverse Event|0|||
129913038|NCT03398148|467644361|FG014|Substudy 1 Period 2|Adverse Event|0|||
129913039|NCT03398148|467644347|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913040|NCT03398148|467644348|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913041|NCT03398148|467644349|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913042|NCT03398148|467644350|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913043|NCT03398148|467644351|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913044|NCT03398148|467644352|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913045|NCT03398148|467644353|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
129913046|NCT03398148|467644354|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
129913047|NCT03398148|467644355|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913048|NCT03398148|467644356|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913049|NCT03398148|467644357|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913050|NCT03398148|467644358|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913051|NCT03398148|467644359|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913052|NCT03398148|467644360|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913053|NCT03398148|467644361|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
129913054|NCT03398148|467644347|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
129913055|NCT03398148|467644348|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
129913056|NCT03398148|467644349|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
129913057|NCT03398148|467644350|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
129913058|NCT03398148|467644351|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
129913059|NCT03398148|467644352|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
129913060|NCT03398148|467644353|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
129913061|NCT03398148|467644354|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
129913062|NCT03398148|467644355|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
129913063|NCT03398148|467644356|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
129913064|NCT03398148|467644357|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
129913065|NCT03398148|467644358|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
129913066|NCT03398148|467644359|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
129913067|NCT03398148|467644360|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
129913068|NCT03398148|467644361|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
129913069|NCT03398148|467644347|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913070|NCT03398148|467644348|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913071|NCT03398148|467644349|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913072|NCT03398148|467644350|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913073|NCT03398148|467644351|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913074|NCT03398148|467644352|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913075|NCT03398148|467644353|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
129913076|NCT03398148|467644354|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913077|NCT03398148|467644355|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913078|NCT03398148|467644356|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913079|NCT03398148|467644357|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913080|NCT03398148|467644358|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913081|NCT03398148|467644359|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913082|NCT03398148|467644360|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913083|NCT03398148|467644361|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913084|NCT03398148|467644347|FG000|Substudy 1 Period 2|Other|0|||
129913085|NCT03398148|467644348|FG001|Substudy 1 Period 2|Other|0|||
129913086|NCT03398148|467644349|FG002|Substudy 1 Period 2|Other|0|||
129913087|NCT03398148|467644350|FG003|Substudy 1 Period 2|Other|0|||
129913088|NCT03398148|467644351|FG004|Substudy 1 Period 2|Other|0|||
129913089|NCT03398148|467644352|FG005|Substudy 1 Period 2|Other|0|||
129913090|NCT03398148|467644353|FG006|Substudy 1 Period 2|Other|1|||
129913091|NCT03398148|467644354|FG007|Substudy 1 Period 2|Other|0|||
129913092|NCT03398148|467644355|FG008|Substudy 1 Period 2|Other|0|||
129913093|NCT03398148|467644356|FG009|Substudy 1 Period 2|Other|0|||
129913094|NCT03398148|467644357|FG010|Substudy 1 Period 2|Other|0|||
129913095|NCT03398148|467644358|FG011|Substudy 1 Period 2|Other|0|||
129913096|NCT03398148|467644359|FG012|Substudy 1 Period 2|Other|0|||
129913097|NCT03398148|467644360|FG013|Substudy 1 Period 2|Other|0|||
129913098|NCT03398148|467644361|FG014|Substudy 1 Period 2|Other|0|||
129913099|NCT03398148|467644347|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913100|NCT03398148|467644348|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913101|NCT03398148|467644349|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913102|NCT03398148|467644350|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913103|NCT03398148|467644351|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913104|NCT03398148|467644352|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913105|NCT03398148|467644353|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
129913106|NCT03398148|467644354|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913107|NCT03398148|467644355|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913108|NCT03398148|467644356|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913109|NCT03398148|467644357|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913110|NCT03398148|467644358|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913111|NCT03398148|467644359|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913112|NCT03398148|467644360|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913113|NCT03398148|467644361|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
129913114|NCT03398148|467644347|FG000|Substudy 2 Period 1|Adverse Event|0|||
129913115|NCT03398148|467644348|FG001|Substudy 2 Period 1|Adverse Event|0|||
129913116|NCT03398148|467644349|FG002|Substudy 2 Period 1|Adverse Event|0|||
129913117|NCT03398148|467644350|FG003|Substudy 2 Period 1|Adverse Event|0|||
129913118|NCT03398148|467644351|FG004|Substudy 2 Period 1|Adverse Event|0|||
129913119|NCT03398148|467644352|FG005|Substudy 2 Period 1|Adverse Event|0|||
129913120|NCT03398148|467644353|FG006|Substudy 2 Period 1|Adverse Event|0|||
129913121|NCT03398148|467644354|FG007|Substudy 2 Period 1|Adverse Event|0|||
129913122|NCT03398148|467644355|FG008|Substudy 2 Period 1|Adverse Event|0|||
129913123|NCT03398148|467644356|FG009|Substudy 2 Period 1|Adverse Event|12|||
129913124|NCT03398148|467644357|FG010|Substudy 2 Period 1|Adverse Event|2|||
129913125|NCT03398148|467644358|FG011|Substudy 2 Period 1|Adverse Event|0|||
129913126|NCT03398148|467644359|FG012|Substudy 2 Period 1|Adverse Event|0|||
129913127|NCT03398148|467644360|FG013|Substudy 2 Period 1|Adverse Event|0|||
129913128|NCT03398148|467644361|FG014|Substudy 2 Period 1|Adverse Event|0|||
129913129|NCT03398148|467644347|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913130|NCT03398148|467644348|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913131|NCT03398148|467644349|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913132|NCT03398148|467644350|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913133|NCT03398148|467644351|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913134|NCT03398148|467644352|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913135|NCT03398148|467644353|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913136|NCT03398148|467644354|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913137|NCT03398148|467644355|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913138|NCT03398148|467644356|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
129913139|NCT03398148|467644357|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
129913140|NCT03398148|467644358|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913141|NCT03398148|467644359|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913142|NCT03398148|467644360|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913143|NCT03398148|467644361|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
129913144|NCT03398148|467644347|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
129913145|NCT03398148|467644348|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
129913146|NCT03398148|467644349|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
129913147|NCT03398148|467644350|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
129913148|NCT03398148|467644351|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
129913149|NCT03398148|467644352|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
129913150|NCT03398148|467644353|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
129913151|NCT03398148|467644354|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
129913152|NCT03398148|467644355|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
129913153|NCT03398148|467644356|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
129913154|NCT03398148|467644357|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
129913155|NCT03398148|467644358|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
129913156|NCT03398148|467644359|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
129913157|NCT03398148|467644360|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
129449726|NCT02790138|465945669|FG001|Overall Study|Significant Protocol Deviation|1|||
129863361|NCT06116591|467456672|FG001|Overall Study|No longer met eligibility criteria|1|||
129863362|NCT06116591|467456671|FG000|Overall Study|Other: Change in life situation|0|||
129863363|NCT06116591|467456672|FG001|Overall Study|Other: Change in life situation|1|||
129863364|NCT01381692|467456673|FG000|Overall Study|Adverse Event|1|||
129863365|NCT01381692|467456674|FG001|Overall Study|Adverse Event|0|||
129863366|NCT01381692|467456675|FG002|Overall Study|Adverse Event|0|||
129863367|NCT01381692|467456676|FG003|Overall Study|Adverse Event|0|||
129863368|NCT01381692|467456677|FG004|Overall Study|Adverse Event|0|||
129863369|NCT01381692|467456678|FG005|Overall Study|Adverse Event|0|||
129863370|NCT01270347|467456679|FG000|Core Phase|Adverse Event|1|||
129863371|NCT01270347|467456680|FG001|Core Phase|Adverse Event|6|||
129863372|NCT01270347|467456679|FG000|Core Phase|Withdrawal by Subject|1|||
129863373|NCT01270347|467456680|FG001|Core Phase|Withdrawal by Subject|2|||
129863374|NCT01270347|467456679|FG000|Core Phase|Lost to Follow-up|0|||
129863375|NCT01270347|467456680|FG001|Core Phase|Lost to Follow-up|1|||
129863376|NCT01270347|467456679|FG000|Core Phase|Miscellaneous|8|||
129863377|NCT01270347|467456680|FG001|Core Phase|Miscellaneous|14|||
129863378|NCT01270347|467456679|FG000|Extension Phase|Adverse Event|1|||
129863379|NCT01270347|467456680|FG001|Extension Phase|Adverse Event|3|||
129863380|NCT01270347|467456679|FG000|Extension Phase|Withdrawal by Subject|3|||
129863381|NCT01270347|467456680|FG001|Extension Phase|Withdrawal by Subject|4|||
129863382|NCT01270347|467456679|FG000|Extension Phase|Miscellaneous|2|||
129863383|NCT01270347|467456680|FG001|Extension Phase|Miscellaneous|2|||
129863384|NCT02189798|467456681|FG000|Extended Use Phase|Withdrawal by Subject|0|||
129863385|NCT02189798|467456682|FG001|Extended Use Phase|Withdrawal by Subject|4|||
129863386|NCT02189798|467456681|FG000|Extended Use Phase|Physician Decision|1|||
129863387|NCT02189798|467456682|FG001|Extended Use Phase|Physician Decision|0|||
129863388|NCT02189798|467456681|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
129863389|NCT02189798|467456682|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
129863390|NCT02189798|467456681|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
129863391|NCT02189798|467456682|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
129863392|NCT02189798|467456681|FG000|Extended Use Phase|Travel Issues|2|||
129863393|NCT02189798|467456682|FG001|Extended Use Phase|Travel Issues|1|||
129863394|NCT02189798|467456681|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
129863395|NCT02189798|467456682|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
129863396|NCT02273141|467456683|FG000|Overall Study|Adverse Event|0|||
129863397|NCT02273141|467456684|FG001|Overall Study|Adverse Event|1|||
129863398|NCT02273141|467456683|FG000|Overall Study|Lost to Follow-up|1|||
129863399|NCT02273141|467456684|FG001|Overall Study|Lost to Follow-up|3|||
129863400|NCT02273141|467456683|FG000|Overall Study|Withdrawal by Subject|10|||
129863401|NCT02273141|467456684|FG001|Overall Study|Withdrawal by Subject|15|||
129863402|NCT02273141|467456683|FG000|Overall Study|Various|6|||
129863403|NCT02273141|467456684|FG001|Overall Study|Various|6|||
129863404|NCT00529399|467456685|FG000|Overall Study|Lost to Follow-up|1|||
129863405|NCT00529399|467456686|FG001|Overall Study|Lost to Follow-up|0|||
129863406|NCT00529399|467456687|FG002|Overall Study|Lost to Follow-up|1|||
129863407|NCT00529399|467456685|FG000|Overall Study|Withdrawal by Subject|1|||
129863408|NCT00529399|467456686|FG001|Overall Study|Withdrawal by Subject|0|||
129863409|NCT00529399|467456687|FG002|Overall Study|Withdrawal by Subject|1|||
129863410|NCT00529399|467456685|FG000|Overall Study|Non-compliant|0|||
129863411|NCT00529399|467456686|FG001|Overall Study|Non-compliant|1|||
129863412|NCT00529399|467456687|FG002|Overall Study|Non-compliant|0|||
129863413|NCT04313881|467456692|FG000|Overall Study|Death|138|||
129863414|NCT04313881|467456693|FG001|Overall Study|Death|126|||
129863415|NCT04313881|467456692|FG000|Overall Study|Study terminated by sponsor|108|||
129863416|NCT04313881|467456693|FG001|Overall Study|Study terminated by sponsor|129|||
129863417|NCT04313881|467456692|FG000|Overall Study|Consent withdrawn|19|||
129863418|NCT04313881|467456693|FG001|Overall Study|Consent withdrawn|15|||
129863419|NCT04313881|467456692|FG000|Overall Study|Reason not Specified|3|||
129863420|NCT04313881|467456693|FG001|Overall Study|Reason not Specified|1|||
129863421|NCT01572727|467456694|FG000|Overall Study|Adverse Event|43|||
129863422|NCT01572727|467456695|FG001|Overall Study|Adverse Event|15|||
129863423|NCT01572727|467456694|FG000|Overall Study|Lost to Follow-up|1|||
129863424|NCT01572727|467456695|FG001|Overall Study|Lost to Follow-up|1|||
129913158|NCT03398148|467644361|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
129913159|NCT03398148|467644347|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913160|NCT03398148|467644348|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913161|NCT03398148|467644349|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913162|NCT03398148|467644350|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913163|NCT03398148|467644351|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913164|NCT03398148|467644352|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913165|NCT03398148|467644353|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913166|NCT03398148|467644354|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913167|NCT03398148|467644355|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913168|NCT03398148|467644356|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913169|NCT03398148|467644357|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
129913170|NCT03398148|467644358|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913171|NCT03398148|467644359|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913172|NCT03398148|467644360|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913173|NCT03398148|467644361|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
129913174|NCT03398148|467644347|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913175|NCT03398148|467644348|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913176|NCT03398148|467644349|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913177|NCT03398148|467644350|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913178|NCT03398148|467644351|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913179|NCT03398148|467644352|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913180|NCT03398148|467644353|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913181|NCT03398148|467644354|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913182|NCT03398148|467644355|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913183|NCT03398148|467644356|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913184|NCT03398148|467644357|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
129913185|NCT03398148|467644358|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913186|NCT03398148|467644359|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913187|NCT03398148|467644360|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913188|NCT03398148|467644361|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
129913189|NCT03398148|467644347|FG000|Substudy 2 Period 1|Other|0|||
129913190|NCT03398148|467644348|FG001|Substudy 2 Period 1|Other|0|||
129913191|NCT03398148|467644349|FG002|Substudy 2 Period 1|Other|0|||
129913192|NCT03398148|467644350|FG003|Substudy 2 Period 1|Other|0|||
129913193|NCT03398148|467644351|FG004|Substudy 2 Period 1|Other|0|||
129913194|NCT03398148|467644352|FG005|Substudy 2 Period 1|Other|0|||
129913195|NCT03398148|467644353|FG006|Substudy 2 Period 1|Other|0|||
129913196|NCT03398148|467644354|FG007|Substudy 2 Period 1|Other|0|||
129913197|NCT03398148|467644355|FG008|Substudy 2 Period 1|Other|0|||
129913198|NCT03398148|467644356|FG009|Substudy 2 Period 1|Other|4|||
129913199|NCT03398148|467644357|FG010|Substudy 2 Period 1|Other|4|||
129913200|NCT03398148|467644358|FG011|Substudy 2 Period 1|Other|0|||
129913201|NCT03398148|467644359|FG012|Substudy 2 Period 1|Other|0|||
129913202|NCT03398148|467644360|FG013|Substudy 2 Period 1|Other|0|||
129913203|NCT03398148|467644361|FG014|Substudy 2 Period 1|Other|0|||
129913204|NCT03398148|467644347|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913205|NCT03398148|467644348|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913206|NCT03398148|467644349|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913207|NCT03398148|467644350|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913208|NCT03398148|467644351|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913209|NCT03398148|467644352|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913210|NCT03398148|467644353|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913211|NCT03398148|467644354|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913212|NCT03398148|467644355|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913213|NCT03398148|467644356|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913214|NCT03398148|467644357|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
129913215|NCT03398148|467644358|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913216|NCT03398148|467644359|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913217|NCT03398148|467644360|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913218|NCT03398148|467644361|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
129913219|NCT03398148|467644347|FG000|Substudy 2 Period 2|Adverse Event|0|||
129913220|NCT03398148|467644348|FG001|Substudy 2 Period 2|Adverse Event|0|||
129913221|NCT03398148|467644349|FG002|Substudy 2 Period 2|Adverse Event|0|||
129913222|NCT03398148|467644350|FG003|Substudy 2 Period 2|Adverse Event|0|||
129913223|NCT03398148|467644351|FG004|Substudy 2 Period 2|Adverse Event|0|||
129913224|NCT03398148|467644352|FG005|Substudy 2 Period 2|Adverse Event|0|||
129913225|NCT03398148|467644353|FG006|Substudy 2 Period 2|Adverse Event|0|||
129913226|NCT03398148|467644354|FG007|Substudy 2 Period 2|Adverse Event|0|||
129913227|NCT03398148|467644355|FG008|Substudy 2 Period 2|Adverse Event|0|||
129913228|NCT03398148|467644356|FG009|Substudy 2 Period 2|Adverse Event|0|||
129913229|NCT03398148|467644357|FG010|Substudy 2 Period 2|Adverse Event|0|||
129913230|NCT03398148|467644358|FG011|Substudy 2 Period 2|Adverse Event|0|||
129913231|NCT03398148|467644359|FG012|Substudy 2 Period 2|Adverse Event|0|||
129913232|NCT03398148|467644360|FG013|Substudy 2 Period 2|Adverse Event|1|||
129913233|NCT03398148|467644361|FG014|Substudy 2 Period 2|Adverse Event|3|||
129913234|NCT03398148|467644347|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
129913235|NCT03398148|467644348|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
129913236|NCT03398148|467644349|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
129913237|NCT03398148|467644350|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
129913238|NCT03398148|467644351|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
129913239|NCT03398148|467644352|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
129913240|NCT03398148|467644353|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
129913241|NCT03398148|467644354|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
129913242|NCT03398148|467644355|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
129913243|NCT03398148|467644356|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
129913244|NCT03398148|467644357|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
129913245|NCT03398148|467644358|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
129913246|NCT03398148|467644359|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
129913247|NCT03398148|467644360|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
129913248|NCT03398148|467644361|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
129913249|NCT03398148|467644347|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913250|NCT03398148|467644348|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913251|NCT03398148|467644349|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913252|NCT03398148|467644350|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913253|NCT03398148|467644351|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913254|NCT03398148|467644352|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913255|NCT03398148|467644353|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913256|NCT03398148|467644354|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913257|NCT03398148|467644355|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913258|NCT03398148|467644356|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913259|NCT03398148|467644357|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913260|NCT03398148|467644358|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
129913261|NCT03398148|467644359|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
129913262|NCT03398148|467644360|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
129913263|NCT03398148|467644361|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
129913264|NCT03398148|467644347|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
129913265|NCT03398148|467644348|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
129913266|NCT03398148|467644349|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
129913267|NCT03398148|467644350|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
129913268|NCT03398148|467644351|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
129913269|NCT03398148|467644352|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
129913270|NCT03398148|467644353|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
129913271|NCT03398148|467644354|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
129913272|NCT03398148|467644355|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
129913273|NCT03398148|467644356|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
129913274|NCT03398148|467644357|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
129913275|NCT03398148|467644358|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
129913276|NCT03398148|467644359|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
129913277|NCT03398148|467644360|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
129913278|NCT03398148|467644361|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
129913279|NCT03398148|467644347|FG000|Substudy 2 Period 2|Other|0|||
129913280|NCT03398148|467644348|FG001|Substudy 2 Period 2|Other|0|||
129913281|NCT03398148|467644349|FG002|Substudy 2 Period 2|Other|0|||
129913282|NCT03398148|467644350|FG003|Substudy 2 Period 2|Other|0|||
129913283|NCT03398148|467644351|FG004|Substudy 2 Period 2|Other|0|||
129913284|NCT03398148|467644352|FG005|Substudy 2 Period 2|Other|0|||
129913285|NCT03398148|467644353|FG006|Substudy 2 Period 2|Other|0|||
129913286|NCT03398148|467644354|FG007|Substudy 2 Period 2|Other|0|||
129913287|NCT03398148|467644355|FG008|Substudy 2 Period 2|Other|0|||
129913288|NCT03398148|467644356|FG009|Substudy 2 Period 2|Other|0|||
129913289|NCT03398148|467644357|FG010|Substudy 2 Period 2|Other|0|||
129913290|NCT03398148|467644358|FG011|Substudy 2 Period 2|Other|0|||
129913291|NCT03398148|467644359|FG012|Substudy 2 Period 2|Other|0|||
129913292|NCT03398148|467644360|FG013|Substudy 2 Period 2|Other|1|||
129913293|NCT03398148|467644361|FG014|Substudy 2 Period 2|Other|1|||
129913294|NCT03398148|467644347|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913295|NCT03398148|467644348|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913296|NCT03398148|467644349|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913297|NCT03398148|467644350|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913298|NCT03398148|467644351|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913299|NCT03398148|467644352|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913300|NCT03398148|467644353|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913301|NCT03398148|467644354|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913302|NCT03398148|467644355|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
129863425|NCT01572727|467456694|FG000|Overall Study|Physician Decision|23|||
129863426|NCT01572727|467456695|FG001|Overall Study|Physician Decision|9|||
129863427|NCT01572727|467456694|FG000|Overall Study|Progressive disease|59|||
129863428|NCT01572727|467456695|FG001|Overall Study|Progressive disease|82|||
129863429|NCT01572727|467456694|FG000|Overall Study|Protocol Violation|0|||
129863430|NCT01572727|467456695|FG001|Overall Study|Protocol Violation|1|||
129863431|NCT01572727|467456694|FG000|Overall Study|Study terminated by sponsor|61|||
129863432|NCT01572727|467456695|FG001|Overall Study|Study terminated by sponsor|83|||
129863433|NCT01572727|467456694|FG000|Overall Study|Parent/guardian decision|14|||
129863434|NCT01572727|467456695|FG001|Overall Study|Parent/guardian decision|9|||
129863435|NCT01572727|467456694|FG000|Overall Study|Death|2|||
129863436|NCT01572727|467456695|FG001|Overall Study|Death|2|||
129863437|NCT01572727|467456694|FG000|Overall Study|Untreated|4|||
129863438|NCT01572727|467456695|FG001|Overall Study|Untreated|7|||
129863439|NCT02195986|467456698|FG000|Overall Study|Adverse Event|3|||
129863440|NCT02195986|467456699|FG001|Overall Study|Adverse Event|0|||
129863441|NCT02195986|467456700|FG002|Overall Study|Adverse Event|0|||
129863442|NCT02195986|467456698|FG000|Overall Study|Withdrawal by Subject|0|||
129863443|NCT02195986|467456699|FG001|Overall Study|Withdrawal by Subject|3|||
129863444|NCT02195986|467456700|FG002|Overall Study|Withdrawal by Subject|0|||
129863445|NCT02195986|467456698|FG000|Overall Study|Family Emergency|0|||
129863446|NCT02195986|467456699|FG001|Overall Study|Family Emergency|0|||
129863447|NCT02195986|467456700|FG002|Overall Study|Family Emergency|1|||
129863448|NCT02195986|467456698|FG000|Overall Study|Protocol Violation|0|||
129863449|NCT02195986|467456699|FG001|Overall Study|Protocol Violation|1|||
129863450|NCT02195986|467456700|FG002|Overall Study|Protocol Violation|1|||
129863451|NCT02195986|467456698|FG000|Overall Study|Non-compliance|0|||
129863452|NCT02195986|467456699|FG001|Overall Study|Non-compliance|1|||
129863453|NCT02195986|467456700|FG002|Overall Study|Non-compliance|0|||
129863454|NCT03449030|467456703|FG000|Overall Study|Withdrawal by Subject|0|||
129863455|NCT03449030|467456704|FG001|Overall Study|Withdrawal by Subject|0|||
129863456|NCT03449030|467456705|FG002|Overall Study|Withdrawal by Subject|0|||
129863457|NCT03449030|467456706|FG003|Overall Study|Withdrawal by Subject|1|||
129863458|NCT03449030|467456707|FG004|Overall Study|Withdrawal by Subject|1|||
129863459|NCT03449030|467456708|FG005|Overall Study|Withdrawal by Subject|1|||
129863460|NCT03449030|467456709|FG006|Overall Study|Withdrawal by Subject|1|||
129863461|NCT03449030|467456710|FG007|Overall Study|Withdrawal by Subject|2|||
129863462|NCT03449030|467456711|FG008|Overall Study|Withdrawal by Subject|0|||
129863463|NCT03449030|467456712|FG009|Overall Study|Withdrawal by Subject|0|||
129863464|NCT03449030|467456703|FG000|Overall Study|Symptomatic Deterioration|0|||
129863465|NCT03449030|467456704|FG001|Overall Study|Symptomatic Deterioration|1|||
129863466|NCT03449030|467456705|FG002|Overall Study|Symptomatic Deterioration|0|||
129863467|NCT03449030|467456706|FG003|Overall Study|Symptomatic Deterioration|0|||
129863468|NCT03449030|467456707|FG004|Overall Study|Symptomatic Deterioration|0|||
129863469|NCT03449030|467456708|FG005|Overall Study|Symptomatic Deterioration|1|||
129863470|NCT03449030|467456709|FG006|Overall Study|Symptomatic Deterioration|1|||
129863471|NCT03449030|467456710|FG007|Overall Study|Symptomatic Deterioration|0|||
129863472|NCT03449030|467456711|FG008|Overall Study|Symptomatic Deterioration|2|||
129863473|NCT03449030|467456712|FG009|Overall Study|Symptomatic Deterioration|0|||
129863474|NCT03449030|467456703|FG000|Overall Study|Progressive Disease|1|||
129863475|NCT03449030|467456704|FG001|Overall Study|Progressive Disease|0|||
129863476|NCT03449030|467456705|FG002|Overall Study|Progressive Disease|1|||
129863477|NCT03449030|467456706|FG003|Overall Study|Progressive Disease|4|||
129863478|NCT03449030|467456707|FG004|Overall Study|Progressive Disease|5|||
129863479|NCT03449030|467456708|FG005|Overall Study|Progressive Disease|3|||
129863480|NCT03449030|467456709|FG006|Overall Study|Progressive Disease|0|||
129863481|NCT03449030|467456710|FG007|Overall Study|Progressive Disease|1|||
129863482|NCT03449030|467456711|FG008|Overall Study|Progressive Disease|1|||
129863483|NCT03449030|467456712|FG009|Overall Study|Progressive Disease|1|||
129863484|NCT03449030|467456703|FG000|Overall Study|Adverse Event|0|||
129863485|NCT03449030|467456704|FG001|Overall Study|Adverse Event|0|||
129863486|NCT03449030|467456705|FG002|Overall Study|Adverse Event|0|||
129863487|NCT03449030|467456706|FG003|Overall Study|Adverse Event|0|||
129863488|NCT03449030|467456707|FG004|Overall Study|Adverse Event|0|||
129863489|NCT03449030|467456708|FG005|Overall Study|Adverse Event|2|||
129863490|NCT03449030|467456709|FG006|Overall Study|Adverse Event|0|||
129863491|NCT03449030|467456710|FG007|Overall Study|Adverse Event|0|||
129863492|NCT03449030|467456711|FG008|Overall Study|Adverse Event|0|||
129863493|NCT03449030|467456712|FG009|Overall Study|Adverse Event|0|||
129863494|NCT03449030|467456703|FG000|Overall Study|Death|0|||
129863495|NCT03449030|467456704|FG001|Overall Study|Death|0|||
129863496|NCT03449030|467456705|FG002|Overall Study|Death|0|||
129913303|NCT03398148|467644356|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
129863497|NCT03449030|467456706|FG003|Overall Study|Death|0|||
129863498|NCT03449030|467456707|FG004|Overall Study|Death|1|||
129863499|NCT03449030|467456708|FG005|Overall Study|Death|0|||
129863500|NCT03449030|467456709|FG006|Overall Study|Death|0|||
129863501|NCT03449030|467456710|FG007|Overall Study|Death|0|||
129863502|NCT03449030|467456711|FG008|Overall Study|Death|0|||
129863503|NCT03449030|467456712|FG009|Overall Study|Death|0|||
129913304|NCT03398148|467644357|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913305|NCT03398148|467644358|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913306|NCT03398148|467644359|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
129913307|NCT03398148|467644360|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
129913308|NCT03398148|467644361|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
129913309|NCT02791230|467644362|FG000|Overall Study|Adverse Event|10|||
129913310|NCT02791230|467644363|FG001|Overall Study|Adverse Event|9|||
129913311|NCT02791230|467644364|FG002|Overall Study|Adverse Event|66|||
129913312|NCT02791230|467644362|FG000|Overall Study|Death|38|||
129913313|NCT02791230|467644363|FG001|Overall Study|Death|25|||
129913314|NCT02791230|467644364|FG002|Overall Study|Death|184|||
129913315|NCT02791230|467644362|FG000|Overall Study|Lack of Efficacy|1|||
129913316|NCT02791230|467644363|FG001|Overall Study|Lack of Efficacy|0|||
129913317|NCT02791230|467644364|FG002|Overall Study|Lack of Efficacy|3|||
129913318|NCT02791230|467644362|FG000|Overall Study|Lost to Follow-up|0|||
129913319|NCT02791230|467644363|FG001|Overall Study|Lost to Follow-up|0|||
129913320|NCT02791230|467644364|FG002|Overall Study|Lost to Follow-up|10|||
129913321|NCT02791230|467644362|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
129913322|NCT02791230|467644363|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
129913323|NCT02791230|467644364|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
129913324|NCT02791230|467644362|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
129913325|NCT02791230|467644363|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
129913326|NCT02791230|467644364|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
129913327|NCT02791230|467644362|FG000|Overall Study|Study sites terminated by sponsor|1|||
129913328|NCT02791230|467644363|FG001|Overall Study|Study sites terminated by sponsor|0|||
129863504|NCT02415400|467456713|FG000|Overall Study|Adverse Event|0|||
129863505|NCT02415400|467456714|FG001|Overall Study|Adverse Event|1|||
129863506|NCT02415400|467456715|FG002|Overall Study|Adverse Event|1|||
129863507|NCT02415400|467456716|FG003|Overall Study|Adverse Event|2|||
129863508|NCT02415400|467456713|FG000|Overall Study|Participant request to stop therapy|4|||
129863509|NCT02415400|467456714|FG001|Overall Study|Participant request to stop therapy|3|||
129863510|NCT02415400|467456715|FG002|Overall Study|Participant request to stop therapy|8|||
129863511|NCT02415400|467456716|FG003|Overall Study|Participant request to stop therapy|6|||
129863512|NCT02415400|467456713|FG000|Overall Study|Participant withdrew consent|14|||
129863513|NCT02415400|467456714|FG001|Overall Study|Participant withdrew consent|12|||
129863514|NCT02415400|467456715|FG002|Overall Study|Participant withdrew consent|30|||
129863515|NCT02415400|467456716|FG003|Overall Study|Participant withdrew consent|21|||
129863516|NCT02415400|467456713|FG000|Overall Study|Death|39|||
129863517|NCT02415400|467456714|FG001|Overall Study|Death|41|||
129863518|NCT02415400|467456715|FG002|Overall Study|Death|35|||
129863519|NCT02415400|467456716|FG003|Overall Study|Death|42|||
129863520|NCT02415400|467456713|FG000|Overall Study|Lost to Follow-up|3|||
129863521|NCT02415400|467456714|FG001|Overall Study|Lost to Follow-up|3|||
129863522|NCT02415400|467456715|FG002|Overall Study|Lost to Follow-up|2|||
129863523|NCT02415400|467456716|FG003|Overall Study|Lost to Follow-up|5|||
129863524|NCT02415400|467456713|FG000|Overall Study|Poor/Non-Compliance|0|||
129863525|NCT02415400|467456714|FG001|Overall Study|Poor/Non-Compliance|1|||
129863526|NCT02415400|467456715|FG002|Overall Study|Poor/Non-Compliance|3|||
129863527|NCT02415400|467456716|FG003|Overall Study|Poor/Non-Compliance|4|||
129863528|NCT02415400|467456713|FG000|Overall Study|Participant no longer meets criteria|2|||
129863529|NCT02415400|467456714|FG001|Overall Study|Participant no longer meets criteria|0|||
129863530|NCT02415400|467456715|FG002|Overall Study|Participant no longer meets criteria|0|||
129863531|NCT02415400|467456716|FG003|Overall Study|Participant no longer meets criteria|1|||
129863532|NCT02415400|467456713|FG000|Overall Study|Participant doesn't answer phone|1|||
129863533|NCT02415400|467456714|FG001|Overall Study|Participant doesn't answer phone|0|||
129863534|NCT02415400|467456715|FG002|Overall Study|Participant doesn't answer phone|0|||
129863535|NCT02415400|467456716|FG003|Overall Study|Participant doesn't answer phone|0|||
129863536|NCT02415400|467456713|FG000|Overall Study|Participant wanted home visits|1|||
129863537|NCT02415400|467456714|FG001|Overall Study|Participant wanted home visits|0|||
129863538|NCT02415400|467456715|FG002|Overall Study|Participant wanted home visits|0|||
129863539|NCT02415400|467456716|FG003|Overall Study|Participant wanted home visits|0|||
129863540|NCT02415400|467456713|FG000|Overall Study|Randomized in error|2|||
129863541|NCT02415400|467456714|FG001|Overall Study|Randomized in error|0|||
129863542|NCT02415400|467456715|FG002|Overall Study|Randomized in error|0|||
129913329|NCT02791230|467644364|FG002|Overall Study|Study sites terminated by sponsor|5|||
129913330|NCT02791230|467644362|FG000|Overall Study|Other|9|||
129913331|NCT02791230|467644363|FG001|Overall Study|Other|1|||
129913332|NCT02791230|467644364|FG002|Overall Study|Other|28|||
129913333|NCT02791230|467644362|FG000|Overall Study|Protocol Violation|0|||
129913334|NCT02791230|467644363|FG001|Overall Study|Protocol Violation|0|||
129913335|NCT02791230|467644364|FG002|Overall Study|Protocol Violation|4|||
129913336|NCT02791230|467644362|FG000|Overall Study|Withdrawal by Subject|24|||
129913337|NCT02791230|467644363|FG001|Overall Study|Withdrawal by Subject|13|||
129913338|NCT02791230|467644364|FG002|Overall Study|Withdrawal by Subject|172|||
129913339|NCT02791230|467644362|FG000|Overall Study|Enrolled but not treated|0|||
129913340|NCT02791230|467644363|FG001|Overall Study|Enrolled but not treated|0|||
129913341|NCT02791230|467644364|FG002|Overall Study|Enrolled but not treated|5|||
129913342|NCT01259401|467644365|FG000|4-month Follow-up|Death|0|||
129913343|NCT01259401|467644366|FG001|4-month Follow-up|Death|1|||
129913344|NCT01259401|467644365|FG000|4-month Follow-up|Lost to Follow-up|0|||
129913345|NCT01259401|467644366|FG001|4-month Follow-up|Lost to Follow-up|1|||
129913346|NCT04201834|467644374|FG000|Overall Study|Screen fail|1|||
129913347|NCT04104321|467644377|FG000|Overall Study|didn't take the study drug|3|||
129913348|NCT03481777|467644378|FG000|Overall Study|Withdrawal by Subject|36|||
129913349|NCT03481777|467644379|FG001|Overall Study|Withdrawal by Subject|31|||
129913350|NCT03481777|467644378|FG000|Overall Study|Non stroke = non target population|277|||
129913351|NCT03481777|467644379|FG001|Overall Study|Non stroke = non target population|254|||
129913352|NCT05696080|467644380|FG000|Overall Study|Lost to Follow-up|2|||
129913353|NCT05696080|467644381|FG001|Overall Study|Lost to Follow-up|1|||
129913354|NCT05696080|467644380|FG000|Overall Study|Physician Decision|1|||
129913355|NCT05696080|467644381|FG001|Overall Study|Physician Decision|0|||
129913356|NCT05696080|467644380|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
129913357|NCT05696080|467644381|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
129913358|NCT05696080|467644380|FG000|Overall Study|Withdrawal by Subject|12|||
129913359|NCT05696080|467644381|FG001|Overall Study|Withdrawal by Subject|0|||
129913360|NCT03954184|467644384|FG000|Overall Study|Lost to Follow-up|500|||
129913361|NCT03954184|467644385|FG001|Overall Study|Lost to Follow-up|0|||
129913362|NCT03398200|467644386|FG000|Overall Study|Withdrawal by Subject|0|||
129913363|NCT03398200|467644387|FG001|Overall Study|Withdrawal by Subject|1|||
129863543|NCT02415400|467456716|FG003|Overall Study|Randomized in error|0|||
129863544|NCT02415400|467456713|FG000|Overall Study|No study drug on site|0|||
129863545|NCT02415400|467456714|FG001|Overall Study|No study drug on site|1|||
129863546|NCT02415400|467456715|FG002|Overall Study|No study drug on site|0|||
129863547|NCT02415400|467456716|FG003|Overall Study|No study drug on site|0|||
129863548|NCT02415400|467456713|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
129863549|NCT02415400|467456714|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
129863550|NCT02415400|467456715|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
129863551|NCT02415400|467456716|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
129863552|NCT02415400|467456713|FG000|Overall Study|Coagulation values cannot be set|0|||
129863553|NCT02415400|467456714|FG001|Overall Study|Coagulation values cannot be set|0|||
129863554|NCT02415400|467456715|FG002|Overall Study|Coagulation values cannot be set|1|||
129863555|NCT02415400|467456716|FG003|Overall Study|Coagulation values cannot be set|0|||
129863556|NCT02415400|467456713|FG000|Overall Study|State regulations prevent participation|0|||
129863557|NCT02415400|467456714|FG001|Overall Study|State regulations prevent participation|0|||
129863558|NCT02415400|467456715|FG002|Overall Study|State regulations prevent participation|1|||
129863559|NCT02415400|467456716|FG003|Overall Study|State regulations prevent participation|0|||
129863560|NCT02415400|467456713|FG000|Overall Study|Poor treatment monitoring|0|||
129863561|NCT02415400|467456714|FG001|Overall Study|Poor treatment monitoring|0|||
129863562|NCT02415400|467456715|FG002|Overall Study|Poor treatment monitoring|1|||
129863563|NCT02415400|467456716|FG003|Overall Study|Poor treatment monitoring|0|||
129863564|NCT02415400|467456713|FG000|Overall Study|Participant in jail|0|||
129863565|NCT02415400|467456714|FG001|Overall Study|Participant in jail|0|||
129913364|NCT05478525|467644388|FG000|Overall Study|Withdrawal by Subject|0|||
129913365|NCT05478525|467644389|FG001|Overall Study|Withdrawal by Subject|1|||
129913366|NCT05478525|467644390|FG002|Overall Study|Withdrawal by Subject|2|||
129913367|NCT05478525|467644391|FG003|Overall Study|Withdrawal by Subject|0|||
129913368|NCT05478525|467644388|FG000|Overall Study|COVID-19 Infection|2|||
129913369|NCT05478525|467644389|FG001|Overall Study|COVID-19 Infection|0|||
129913370|NCT05478525|467644390|FG002|Overall Study|COVID-19 Infection|1|||
129913371|NCT05478525|467644391|FG003|Overall Study|COVID-19 Infection|1|||
129913372|NCT01649271|467644392|FG000|Overall Study|Progressive disease|4|||
129913373|NCT01649271|467644393|FG001|Overall Study|Progressive disease|5|||
129913374|NCT01649271|467644392|FG000|Overall Study|Other Adverse Event|0|||
129913375|NCT01649271|467644393|FG001|Overall Study|Other Adverse Event|2|||
129863566|NCT02415400|467456715|FG002|Overall Study|Participant in jail|1|||
129863567|NCT02415400|467456716|FG003|Overall Study|Participant in jail|0|||
129913376|NCT01649271|467644392|FG000|Overall Study|Withdrawal by Subject|1|||
129913377|NCT01649271|467644393|FG001|Overall Study|Withdrawal by Subject|0|||
129913378|NCT01649271|467644392|FG000|Overall Study|Other than stated above|1|||
129913379|NCT01649271|467644393|FG001|Overall Study|Other than stated above|0|||
129863568|NCT02415400|467456713|FG000|Overall Study|Investigator decision|0|||
129863569|NCT02415400|467456714|FG001|Overall Study|Investigator decision|0|||
129913380|NCT05644002|467644394|FG000|Overall Study|Lost to Follow-up|1|||
129913381|NCT05644002|467644395|FG001|Overall Study|Lost to Follow-up|2|||
129913382|NCT05644002|467644394|FG000|Overall Study|Withdrawal by Subject|0|||
129913383|NCT05644002|467644395|FG001|Overall Study|Withdrawal by Subject|1|||
129913384|NCT04842500|467644396|FG000|Overall Study|Withdrawal by Subject|4|||
129913385|NCT04842500|467644397|FG001|Overall Study|Withdrawal by Subject|1|||
129913386|NCT04842500|467644398|FG002|Overall Study|Withdrawal by Subject|2|||
129913387|NCT04842500|467644399|FG003|Overall Study|Withdrawal by Subject|3|||
129913388|NCT04842500|467644396|FG000|Overall Study|Protocol Violation|1|||
129913389|NCT04842500|467644397|FG001|Overall Study|Protocol Violation|0|||
129913390|NCT04842500|467644398|FG002|Overall Study|Protocol Violation|0|||
129913391|NCT04842500|467644399|FG003|Overall Study|Protocol Violation|1|||
129913392|NCT05756075|467644402|FG000|Overall Study|Withdrawal by Subject|16|||
129913393|NCT05756075|467644403|FG001|Overall Study|Withdrawal by Subject|9|||
129913394|NCT03821844|467644404|FG000|Overall Study|Death|37|||
129913395|NCT03821844|467644405|FG001|Overall Study|Death|31|||
129913396|NCT03821844|467644404|FG000|Overall Study|Discharged|10|||
129913397|NCT03821844|467644405|FG001|Overall Study|Discharged|14|||
129913398|NCT03821844|467644404|FG000|Overall Study|Not present in facility at followup|2|||
129913399|NCT03821844|467644405|FG001|Overall Study|Not present in facility at followup|3|||
129913400|NCT03899961|467644407|FG000|Overall Study|-delivery prior to|2|||
129913401|NCT03899961|467644408|FG001|Overall Study|-delivery prior to|7|||
129913402|NCT03899961|467644407|FG000|Overall Study|req general anesth|1|||
129913403|NCT03899961|467644408|FG001|Overall Study|req general anesth|2|||
129913404|NCT03899961|467644407|FG000|Overall Study|capacity|5|||
129913405|NCT03899961|467644408|FG001|Overall Study|capacity|6|||
129913406|NCT03899961|467644407|FG000|Overall Study|Withdrawal by Subject|1|||
129913407|NCT03899961|467644408|FG001|Overall Study|Withdrawal by Subject|1|||
129913408|NCT02058108|467644409|FG000|Overall Study|Abnormal Laboratory Values|0|||
129913409|NCT02058108|467644410|FG001|Overall Study|Abnormal Laboratory Values|1|||
129913410|NCT02058108|467644409|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
129913411|NCT02058108|467644410|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
129913412|NCT02058108|467644409|FG000|Overall Study|No longer requires study drug|0|||
129913413|NCT02058108|467644410|FG001|Overall Study|No longer requires study drug|1|||
129913414|NCT02058108|467644409|FG000|Overall Study|Withdrawal by Subject|1|||
129913415|NCT02058108|467644410|FG001|Overall Study|Withdrawal by Subject|0|||
129913416|NCT02058108|467644409|FG000|Overall Study|Administrative problems|3|||
129913417|NCT02058108|467644410|FG001|Overall Study|Administrative problems|3|||
129913418|NCT02058108|467644409|FG000|Overall Study|Protocol Violation|0|||
129913419|NCT02058108|467644410|FG001|Overall Study|Protocol Violation|1|||
129913420|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
129913421|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
129913422|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
129913423|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
129913424|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
129913425|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913426|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913427|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
129913428|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913429|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
129913430|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
129913431|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
129913432|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
129913433|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
129913434|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
129913435|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
129913436|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
129913437|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
129913438|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
129913439|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
129913440|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
129913441|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
129913442|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
129913443|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
129913444|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
129913445|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913446|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913447|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
129913448|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913449|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
129913450|NCT04759833|467644414|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913451|NCT04759833|467644415|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
129913452|NCT04759833|467644416|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913453|NCT04759833|467644417|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913454|NCT04759833|467644418|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
129913455|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
129913456|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
129913457|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
129913458|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
129913459|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
129913460|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913461|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913462|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913463|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
129913464|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
129913465|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
129913466|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
129913467|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
129913468|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
129913469|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
129913470|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
129913471|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
129913472|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
129913473|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
129913474|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
129913475|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
129913476|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
129913477|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
129913478|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
129913479|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
129913480|NCT04759833|467644414|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
129913481|NCT04759833|467644415|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
129913482|NCT04759833|467644416|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
129913483|NCT04759833|467644417|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
129913484|NCT04759833|467644418|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
129913485|NCT04711135|467644419|FG000|Overall Study|Physician Decision|0|||
129913486|NCT04711135|467644420|FG001|Overall Study|Physician Decision|1|||
129913487|NCT04711135|467644419|FG000|Overall Study|Ongoing treatment|0|||
129913488|NCT04711135|467644420|FG001|Overall Study|Ongoing treatment|1|||
129913489|NCT00998881|467644423|FG000|Overall Study|Adverse Event|2|||
129913490|NCT00998881|467644424|FG001|Overall Study|Adverse Event|2|||
129913491|NCT00998881|467644423|FG000|Overall Study|Lack of Efficacy|1|||
129913492|NCT00998881|467644424|FG001|Overall Study|Lack of Efficacy|0|||
129913493|NCT00998881|467644423|FG000|Overall Study|Physician Decision|3|||
129913494|NCT00998881|467644424|FG001|Overall Study|Physician Decision|0|||
129913495|NCT00998881|467644423|FG000|Overall Study|Withdrawal by Subject|1|||
129913496|NCT00998881|467644424|FG001|Overall Study|Withdrawal by Subject|0|||
129913497|NCT00998881|467644423|FG000|Overall Study|Personal matter|1|||
129913498|NCT00998881|467644424|FG001|Overall Study|Personal matter|0|||
129913499|NCT00818246|467644425|FG000|Overall Study|Impossible to match pictures|5|||
129913500|NCT01121991|467644426|FG000|Overall Study|Lack of Ovarian Response|2|||
129913501|NCT01121991|467644426|FG000|Overall Study|No Oocytes Retrieved|3|||
129913502|NCT01121991|467644426|FG000|Overall Study|No Fertilization|1|||
129913503|NCT00409838|467644427|FG000|Short-term Period|Adverse Event|0|||
129913504|NCT00409838|467644428|FG001|Short-term Period|Adverse Event|1|||
129913505|NCT00409838|467644427|FG000|Short-term Period|Lost to Follow-up|0|||
129913506|NCT00409838|467644428|FG001|Short-term Period|Lost to Follow-up|1|||
129913507|NCT00409838|467644427|FG000|Short-term Period|Withdrawal by Subject|2|||
129913508|NCT00409838|467644428|FG001|Short-term Period|Withdrawal by Subject|3|||
129913509|NCT00409838|467644427|FG000|Short-term Period|Never Treated|1|||
129913510|NCT00409838|467644428|FG001|Short-term Period|Never Treated|0|||
129913511|NCT00409838|467644427|FG000|Long-term Extension Period|Adverse Event|10|||
129913512|NCT00409838|467644428|FG001|Long-term Extension Period|Adverse Event|0|||
129449727|NCT02790138|465945668|FG000|Overall Study|Lost to Follow-up|1|||
129913513|NCT00409838|467644427|FG000|Long-term Extension Period|Death|1|||
129913514|NCT00409838|467644428|FG001|Long-term Extension Period|Death|0|||
129449728|NCT02790138|465945669|FG001|Overall Study|Lost to Follow-up|0|||
129449729|NCT02790138|465945668|FG000|Overall Study|Voluntary Withdrawal|8|||
129863570|NCT02415400|467456715|FG002|Overall Study|Investigator decision|1|||
129863571|NCT02415400|467456716|FG003|Overall Study|Investigator decision|1|||
129863572|NCT02415400|467456713|FG000|Overall Study|Site closure; participant won't transfer|0|||
129863573|NCT02415400|467456714|FG001|Overall Study|Site closure; participant won't transfer|0|||
129863574|NCT02415400|467456715|FG002|Overall Study|Site closure; participant won't transfer|0|||
129863575|NCT02415400|467456716|FG003|Overall Study|Site closure; participant won't transfer|1|||
129863576|NCT02270450|467456717|FG000|Overall Study|Refusal unrelated to adverse event|3|||
129863577|NCT02270450|467456718|FG001|Overall Study|Refusal unrelated to adverse event|1|||
129863578|NCT02270450|467456719|FG002|Overall Study|Refusal unrelated to adverse event|5|||
129863579|NCT02270450|467456720|FG003|Overall Study|Refusal unrelated to adverse event|14|||
129863580|NCT02270450|467456717|FG000|Overall Study|Progression/relapse|1|||
129863581|NCT02270450|467456718|FG001|Overall Study|Progression/relapse|2|||
129863582|NCT02270450|467456719|FG002|Overall Study|Progression/relapse|4|||
129863583|NCT02270450|467456720|FG003|Overall Study|Progression/relapse|9|||
129863584|NCT02270450|467456717|FG000|Overall Study|Death|19|||
129863585|NCT02270450|467456718|FG001|Overall Study|Death|19|||
129863586|NCT02270450|467456719|FG002|Overall Study|Death|31|||
129863587|NCT02270450|467456720|FG003|Overall Study|Death|59|||
129863588|NCT02363738|467456721|FG000|Overall Study|Adverse Event|5|||
129863589|NCT02363738|467456722|FG001|Overall Study|Adverse Event|2|||
129863590|NCT02363738|467456721|FG000|Overall Study|Lack of Efficacy|1|||
129863591|NCT02363738|467456722|FG001|Overall Study|Lack of Efficacy|2|||
129863592|NCT02363738|467456721|FG000|Overall Study|Lost to Follow-up|2|||
129863593|NCT02363738|467456722|FG001|Overall Study|Lost to Follow-up|1|||
129863594|NCT02576678|467456728|FG000|Overall Study|Adverse Event|0|||
129863595|NCT02576678|467456729|FG001|Overall Study|Adverse Event|0|||
129863596|NCT02576678|467456730|FG002|Overall Study|Adverse Event|2|||
129863597|NCT02576678|467456728|FG000|Overall Study|Withdrawal by Subject|3|||
129863598|NCT02576678|467456729|FG001|Overall Study|Withdrawal by Subject|1|||
129863599|NCT02576678|467456730|FG002|Overall Study|Withdrawal by Subject|2|||
129863600|NCT02576678|467456728|FG000|Overall Study|Lost to Follow-up|0|||
129863601|NCT02576678|467456729|FG001|Overall Study|Lost to Follow-up|0|||
129863602|NCT02576678|467456730|FG002|Overall Study|Lost to Follow-up|1|||
129863603|NCT02576678|467456728|FG000|Overall Study|Miscellaneous|2|||
129863604|NCT02576678|467456729|FG001|Overall Study|Miscellaneous|0|||
129863605|NCT02576678|467456730|FG002|Overall Study|Miscellaneous|0|||
129863606|NCT02491671|467456731|FG000|Overall Study|Adverse Event|6|||
129449730|NCT02790138|465945669|FG001|Overall Study|Voluntary Withdrawal|9|||
129449731|NCT02790138|465945668|FG000|Overall Study|Lack of Efficacy|6|||
129863607|NCT02491671|467456732|FG001|Overall Study|Adverse Event|8|||
129863608|NCT02491671|467456731|FG000|Overall Study|Death|0|||
129863609|NCT02491671|467456732|FG001|Overall Study|Death|2|||
129863610|NCT02491671|467456731|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
129863611|NCT02491671|467456732|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
129863612|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
129863613|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
129863614|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
129863615|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
129863616|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
129863617|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
129863618|NCT02251990|467456736|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
129863619|NCT02251990|467456737|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
129863620|NCT02251990|467456736|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
129863621|NCT02251990|467456737|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
129863622|NCT02251990|467456736|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
129863623|NCT02251990|467456737|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
129863624|NCT03265600|467456738|FG000|Overall Study|Lost to Follow-up|17|||
129863625|NCT03265600|467456739|FG001|Overall Study|Lost to Follow-up|5|||
129863626|NCT03265600|467456738|FG000|Overall Study|Withdrawal by Subject|4|||
129863627|NCT03265600|467456739|FG001|Overall Study|Withdrawal by Subject|2|||
129863628|NCT03265600|467456738|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
129863629|NCT03265600|467456739|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
129863630|NCT04330638|467456740|FG000|Overall Study|Adverse Event|9|||
129863631|NCT04330638|467456741|FG001|Overall Study|Adverse Event|10|||
129863632|NCT04330638|467456742|FG002|Overall Study|Adverse Event|15|||
129863633|NCT04330638|467456743|FG003|Overall Study|Adverse Event|6|||
129863634|NCT04330638|467456744|FG004|Overall Study|Adverse Event|10|||
129863635|NCT04330638|467456745|FG005|Overall Study|Adverse Event|5|||
129863636|NCT04330638|467456740|FG000|Overall Study|Other|2|||
129863637|NCT04330638|467456741|FG001|Overall Study|Other|2|||
129863638|NCT04330638|467456742|FG002|Overall Study|Other|5|||
129863639|NCT04330638|467456743|FG003|Overall Study|Other|1|||
129863640|NCT04330638|467456744|FG004|Overall Study|Other|3|||
129863641|NCT04330638|467456745|FG005|Overall Study|Other|2|||
129863642|NCT04330638|467456740|FG000|Overall Study|Withdrawal by Subject|4|||
129863643|NCT04330638|467456741|FG001|Overall Study|Withdrawal by Subject|0|||
129863644|NCT04330638|467456742|FG002|Overall Study|Withdrawal by Subject|0|||
129863645|NCT04330638|467456743|FG003|Overall Study|Withdrawal by Subject|0|||
129863646|NCT04330638|467456744|FG004|Overall Study|Withdrawal by Subject|0|||
129863647|NCT04330638|467456745|FG005|Overall Study|Withdrawal by Subject|0|||
129863648|NCT04330638|467456740|FG000|Overall Study|Lost to Follow-up|3|||
129863649|NCT04330638|467456741|FG001|Overall Study|Lost to Follow-up|2|||
129863650|NCT04330638|467456742|FG002|Overall Study|Lost to Follow-up|3|||
129863651|NCT04330638|467456743|FG003|Overall Study|Lost to Follow-up|2|||
129863652|NCT04330638|467456744|FG004|Overall Study|Lost to Follow-up|3|||
129863653|NCT04330638|467456745|FG005|Overall Study|Lost to Follow-up|0|||
129863654|NCT00322348|467456746|FG000|Overall Study|Adverse Event|0|||
129863655|NCT00322348|467456747|FG001|Overall Study|Adverse Event|1|||
129863656|NCT00322348|467456746|FG000|Overall Study|Withdrawal by Subject|1|||
129863657|NCT00322348|467456747|FG001|Overall Study|Withdrawal by Subject|4|||
129863658|NCT00322348|467456746|FG000|Overall Study|Lost to Follow-up|1|||
129863659|NCT00322348|467456747|FG001|Overall Study|Lost to Follow-up|0|||
129863660|NCT00322348|467456746|FG000|Overall Study|Death|0|||
129863661|NCT00322348|467456747|FG001|Overall Study|Death|2|||
129863662|NCT00322348|467456746|FG000|Overall Study|Disease Progression|30|||
129863663|NCT00322348|467456747|FG001|Overall Study|Disease Progression|25|||
129863664|NCT00322348|467456746|FG000|Overall Study|Reasons not specified|5|||
129863665|NCT00322348|467456747|FG001|Overall Study|Reasons not specified|1|||
129863666|NCT03336619|467456748|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
129863667|NCT03336619|467456749|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
129863668|NCT03336619|467456748|FG000|Overall Study|Withdrawal by Subject|17|||
129863669|NCT03336619|467456749|FG001|Overall Study|Withdrawal by Subject|16|||
129863670|NCT03336619|467456748|FG000|Overall Study|Adverse Event|2|||
129863671|NCT03336619|467456749|FG001|Overall Study|Adverse Event|5|||
129863672|NCT03336619|467456748|FG000|Overall Study|Physician Decision|3|||
129863673|NCT03336619|467456749|FG001|Overall Study|Physician Decision|0|||
129863674|NCT02820623|467456750|FG000|Overall Study|Withdrawal by Subject|1|||
129863675|NCT02820623|467456751|FG001|Overall Study|Withdrawal by Subject|3|||
129863676|NCT02820623|467456752|FG002|Overall Study|Withdrawal by Subject|3|||
129863677|NCT02820623|467456750|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
129863678|NCT02820623|467456751|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
129863679|NCT02820623|467456752|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
129863680|NCT02820623|467456750|FG000|Overall Study|Therapist unable to enroll clients|1|||
129863681|NCT02820623|467456751|FG001|Overall Study|Therapist unable to enroll clients|1|||
129863682|NCT02820623|467456752|FG002|Overall Study|Therapist unable to enroll clients|3|||
129863683|NCT02820623|467456750|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
129863684|NCT02820623|467456751|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
129863685|NCT02820623|467456752|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
129863686|NCT01965834|467456753|FG000|Overall Study|Lack of Efficacy|4|||
129863687|NCT00744653|467456755|FG000|Overall Study|antineoplastic treatment|11|||
129863688|NCT00744653|467456755|FG000|Overall Study|Death|1|||
129863689|NCT00744653|467456755|FG000|Overall Study|Lost to Follow-up|1|||
129863690|NCT00744653|467456755|FG000|Overall Study|Physician Decision|3|||
129863691|NCT03826667|467456756|FG000|Overall Study|Protocol deviation|21|||
129863692|NCT00617344|467456757|FG000|Overall Study|Serious adverse event|1|||
129863693|NCT00617344|467456758|FG001|Overall Study|Serious adverse event|0|||
129863694|NCT00617344|467456759|FG002|Overall Study|Serious adverse event|0|||
129863695|NCT00617344|467456757|FG000|Overall Study|Other Adverse Event|1|||
129863696|NCT00617344|467456758|FG001|Overall Study|Other Adverse Event|1|||
129863697|NCT00617344|467456759|FG002|Overall Study|Other Adverse Event|0|||
129863698|NCT00617344|467456757|FG000|Overall Study|Protocol Violation|10|||
129863699|NCT00617344|467456758|FG001|Overall Study|Protocol Violation|8|||
129863700|NCT00617344|467456759|FG002|Overall Study|Protocol Violation|5|||
129863701|NCT00617344|467456757|FG000|Overall Study|Lost to Follow-up|5|||
129863702|NCT00617344|467456758|FG001|Overall Study|Lost to Follow-up|4|||
129863703|NCT00617344|467456759|FG002|Overall Study|Lost to Follow-up|1|||
129863704|NCT00617344|467456757|FG000|Overall Study|Withdrawal by Subject|8|||
129863705|NCT00617344|467456758|FG001|Overall Study|Withdrawal by Subject|9|||
129863706|NCT00617344|467456759|FG002|Overall Study|Withdrawal by Subject|2|||
129863707|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
129863708|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
129863709|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
129863710|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
129863711|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
129863712|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
129863713|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
129863714|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
129863715|NCT00679939|467456762|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
129863716|NCT00679939|467456763|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
129863717|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
129863718|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
129863719|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
129863720|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
129863721|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
129863722|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
129863723|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
129863724|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
129863725|NCT00679939|467456762|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
129863726|NCT00679939|467456763|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
129863727|NCT00941330|467456768|FG000|Overall Study|Other|1|||
129863728|NCT00941330|467456769|FG001|Overall Study|Other|0|||
129863729|NCT00941330|467456768|FG000|Overall Study|Physician Decision|0|||
129863730|NCT00941330|467456769|FG001|Overall Study|Physician Decision|2|||
129863731|NCT02985866|467458344|FG000|Overall Study|Poor CGM data|1|||
129863732|NCT02985866|467458345|FG001|Overall Study|Poor CGM data|1|||
129863733|NCT00686166|467458350|FG000|Overall Study|Adverse Event|7|||
129863734|NCT00686166|467458350|FG000|Overall Study|Withdrawal by Subject|1|||
129863735|NCT00686166|467458350|FG000|Overall Study|Progression/Relapse|1|||
129863736|NCT00686166|467458350|FG000|Overall Study|Death|1|||
129863737|NCT00686166|467458350|FG000|Overall Study|Not Protocol Specified|1|||
129863738|NCT00686166|467458350|FG000|Overall Study|Ineligible|5|||
129863739|NCT00686166|467458350|FG000|Overall Study|Did not begin protocol therapy|4|||
129863740|NCT01549613|467458353|FG000|Overall Study|Lost to Follow-up|11|||
129913515|NCT00409838|467644427|FG000|Long-term Extension Period|Lack of Efficacy|2|||
129863741|NCT01549613|467458354|FG001|Overall Study|Lost to Follow-up|11|||
129863742|NCT02216123|467458355|FG000|Overall Study|Lost to Follow-up|4|||
129863743|NCT02216123|467458356|FG001|Overall Study|Lost to Follow-up|2|||
129863744|NCT02216123|467458355|FG000|Overall Study|Withdrawal by Subject|2|||
129863745|NCT02216123|467458356|FG001|Overall Study|Withdrawal by Subject|0|||
129863746|NCT04477187|467458359|FG000|Overall Study|Lost to Follow-up|2|||
129863747|NCT00464815|467458361|FG000|Overall Study|Withdrawal by Subject|6|||
129863748|NCT00464815|467458362|FG001|Overall Study|Withdrawal by Subject|3|||
129863749|NCT00254982|467458363|FG000|Overall Study|Other|2|||
129863750|NCT00254982|467458364|FG001|Overall Study|Other|1|||
129863751|NCT00254982|467458363|FG000|Overall Study|Lack of Efficacy|5|||
129863752|NCT00254982|467458364|FG001|Overall Study|Lack of Efficacy|3|||
129863753|NCT00254982|467458363|FG000|Overall Study|Lost to Follow-up|5|||
129863754|NCT00254982|467458364|FG001|Overall Study|Lost to Follow-up|3|||
129863755|NCT00254982|467458363|FG000|Overall Study|Adverse Event|18|||
129863756|NCT00254982|467458364|FG001|Overall Study|Adverse Event|16|||
129863757|NCT00254982|467458363|FG000|Overall Study|Withdrawal by Subject|1|||
129863758|NCT00254982|467458364|FG001|Overall Study|Withdrawal by Subject|1|||
129863759|NCT00254982|467458363|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
129863760|NCT00254982|467458364|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
129863761|NCT00254982|467458363|FG000|Overall Study|Protocol deviation|1|||
129863762|NCT00254982|467458364|FG001|Overall Study|Protocol deviation|1|||
129863763|NCT00254982|467458363|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
129863764|NCT00254982|467458364|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
129863765|NCT00254982|467458363|FG000|Overall Study|Malignancy|0|||
129863766|NCT00254982|467458364|FG001|Overall Study|Malignancy|2|||
129863767|NCT00254982|467458363|FG000|Overall Study|Opportunistic infection|1|||
129863768|NCT00254982|467458364|FG001|Overall Study|Opportunistic infection|0|||
129863769|NCT00254982|467458363|FG000|Overall Study|Abnormal liver function tests|2|||
129863770|NCT00254982|467458364|FG001|Overall Study|Abnormal liver function tests|1|||
129863771|NCT01613248|467458369|FG000|Overall Study|Adverse Event|0|||
129863772|NCT01613248|467458370|FG001|Overall Study|Adverse Event|0|||
129863773|NCT01613248|467458371|FG002|Overall Study|Adverse Event|0|||
129863774|NCT01613248|467458372|FG003|Overall Study|Adverse Event|1|||
129863775|NCT01613248|467458373|FG004|Overall Study|Adverse Event|0|||
129863776|NCT01613248|467458374|FG005|Overall Study|Adverse Event|0|||
129863777|NCT01613248|467458369|FG000|Overall Study|Withdrawal by Subject|3|||
129863778|NCT01613248|467458370|FG001|Overall Study|Withdrawal by Subject|2|||
129863779|NCT01613248|467458371|FG002|Overall Study|Withdrawal by Subject|2|||
129863780|NCT01613248|467458372|FG003|Overall Study|Withdrawal by Subject|5|||
129863781|NCT01613248|467458373|FG004|Overall Study|Withdrawal by Subject|0|||
129863782|NCT01613248|467458374|FG005|Overall Study|Withdrawal by Subject|1|||
129863783|NCT01613248|467458369|FG000|Overall Study|Lost to Follow-up|5|||
129863784|NCT01613248|467458370|FG001|Overall Study|Lost to Follow-up|7|||
129863785|NCT01613248|467458371|FG002|Overall Study|Lost to Follow-up|4|||
129863786|NCT01613248|467458372|FG003|Overall Study|Lost to Follow-up|8|||
129863787|NCT01613248|467458373|FG004|Overall Study|Lost to Follow-up|4|||
129863788|NCT01613248|467458374|FG005|Overall Study|Lost to Follow-up|2|||
129863789|NCT01613248|467458369|FG000|Overall Study|Study Terminated by Sponsor|4|||
129863790|NCT01613248|467458370|FG001|Overall Study|Study Terminated by Sponsor|6|||
129863791|NCT01613248|467458371|FG002|Overall Study|Study Terminated by Sponsor|8|||
129863792|NCT01613248|467458372|FG003|Overall Study|Study Terminated by Sponsor|8|||
129863793|NCT01613248|467458373|FG004|Overall Study|Study Terminated by Sponsor|9|||
129863794|NCT01613248|467458374|FG005|Overall Study|Study Terminated by Sponsor|11|||
129863795|NCT01613248|467458369|FG000|Overall Study|Physician Decision|8|||
129863796|NCT01613248|467458370|FG001|Overall Study|Physician Decision|8|||
129863797|NCT01613248|467458371|FG002|Overall Study|Physician Decision|9|||
129863798|NCT01613248|467458372|FG003|Overall Study|Physician Decision|4|||
129863799|NCT01613248|467458373|FG004|Overall Study|Physician Decision|7|||
129863800|NCT01613248|467458374|FG005|Overall Study|Physician Decision|6|||
129863801|NCT01613248|467458369|FG000|Overall Study|Lack of Qualifying Event|9|||
129863802|NCT01613248|467458370|FG001|Overall Study|Lack of Qualifying Event|11|||
129863803|NCT01613248|467458371|FG002|Overall Study|Lack of Qualifying Event|10|||
129863804|NCT01613248|467458372|FG003|Overall Study|Lack of Qualifying Event|11|||
129863805|NCT01613248|467458373|FG004|Overall Study|Lack of Qualifying Event|15|||
129863806|NCT01613248|467458374|FG005|Overall Study|Lack of Qualifying Event|18|||
129863807|NCT01613248|467458369|FG000|Overall Study|Pregnancy|0|||
129863808|NCT01613248|467458370|FG001|Overall Study|Pregnancy|0|||
129863809|NCT01613248|467458371|FG002|Overall Study|Pregnancy|0|||
129863810|NCT01613248|467458372|FG003|Overall Study|Pregnancy|1|||
129863811|NCT01613248|467458373|FG004|Overall Study|Pregnancy|0|||
129863812|NCT01613248|467458374|FG005|Overall Study|Pregnancy|0|||
129863813|NCT02015676|467458386|FG000|Overall Study|Adverse Event|2|||
129863814|NCT02015676|467458387|FG001|Overall Study|Adverse Event|18|||
129863815|NCT02015676|467458388|FG002|Overall Study|Adverse Event|0|||
129863816|NCT02015676|467458386|FG000|Overall Study|Lack of Efficacy|2|||
129863817|NCT02015676|467458387|FG001|Overall Study|Lack of Efficacy|4|||
129863818|NCT02015676|467458388|FG002|Overall Study|Lack of Efficacy|0|||
129863819|NCT02015676|467458386|FG000|Overall Study|Protocol Violation|1|||
129863820|NCT02015676|467458387|FG001|Overall Study|Protocol Violation|0|||
129863821|NCT02015676|467458388|FG002|Overall Study|Protocol Violation|0|||
129863822|NCT02015676|467458386|FG000|Overall Study|Withdrawal by Subject|1|||
129863823|NCT02015676|467458387|FG001|Overall Study|Withdrawal by Subject|7|||
129863824|NCT02015676|467458388|FG002|Overall Study|Withdrawal by Subject|1|||
129863825|NCT02015676|467458386|FG000|Overall Study|Administrative reasons|0|||
129863826|NCT02015676|467458387|FG001|Overall Study|Administrative reasons|3|||
129863827|NCT02015676|467458388|FG002|Overall Study|Administrative reasons|1|||
129863828|NCT02015676|467458386|FG000|Overall Study|Death|0|||
129863829|NCT02015676|467458387|FG001|Overall Study|Death|1|||
129863830|NCT02015676|467458388|FG002|Overall Study|Death|0|||
129863831|NCT02015676|467458386|FG000|Overall Study|Disease progression|3|||
129863832|NCT02015676|467458387|FG001|Overall Study|Disease progression|1|||
129863833|NCT02015676|467458388|FG002|Overall Study|Disease progression|1|||
129863834|NCT00476476|467458389|FG000|Overall Study|Adverse Event|2|||
129863835|NCT00476476|467458390|FG001|Overall Study|Adverse Event|7|||
129863836|NCT00476476|467458389|FG000|Overall Study|Progressive Disease|0|||
129863837|NCT00476476|467458390|FG001|Overall Study|Progressive Disease|17|||
129863838|NCT03321396|467458394|FG000|Overall Study|Physician Decision|1|||
129863839|NCT03644186|467458401|FG000|Overall Study|Withdrawal by Subject|1|||
129863840|NCT03644186|467458402|FG001|Overall Study|Withdrawal by Subject|1|||
129863841|NCT04391023|467458403|FG000|Overall Study|Withdrawal by Subject|2|||
129863842|NCT04391023|467458404|FG001|Overall Study|Withdrawal by Subject|2|||
129863843|NCT01869491|467458405|FG000|Overall Study|Adverse Event|3|||
129863844|NCT01869491|467458406|FG001|Overall Study|Adverse Event|5|||
129863845|NCT01869491|467458405|FG000|Overall Study|Lack of Efficacy|0|||
129863846|NCT01869491|467458406|FG001|Overall Study|Lack of Efficacy|3|||
129863847|NCT01869491|467458405|FG000|Overall Study|Withdrawal by Subject|6|||
129863848|NCT01869491|467458406|FG001|Overall Study|Withdrawal by Subject|7|||
129863849|NCT01869491|467458405|FG000|Overall Study|Lost to Follow-up|11|||
129863850|NCT01869491|467458406|FG001|Overall Study|Lost to Follow-up|9|||
129863851|NCT01869491|467458405|FG000|Overall Study|No further need of investigational product|1|||
129863852|NCT01869491|467458406|FG001|Overall Study|No further need of investigational product|0|||
129863853|NCT04009291|467458407|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863854|NCT04009291|467458408|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863855|NCT04009291|467458409|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863856|NCT04009291|467458410|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
129863857|NCT04009291|467458411|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
129863858|NCT04009291|467458407|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863859|NCT04009291|467458408|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863860|NCT04009291|467458409|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863861|NCT04009291|467458410|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
129863862|NCT04009291|467458411|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
129863863|NCT05553808|467458414|FG000|Overall Study|Death|25|||
129863864|NCT05553808|467458415|FG001|Overall Study|Death|62|||
129863865|NCT05553808|467458414|FG000|Overall Study|Site Closed|6|||
129863866|NCT05553808|467458415|FG001|Overall Study|Site Closed|6|||
129863867|NCT05553808|467458414|FG000|Overall Study|Lost to Follow-up|1|||
129863868|NCT05553808|467458415|FG001|Overall Study|Lost to Follow-up|0|||
129863869|NCT05553808|467458414|FG000|Overall Study|Withdrawal by Subject|3|||
129863870|NCT05553808|467458415|FG001|Overall Study|Withdrawal by Subject|2|||
129863871|NCT00727272|467458422|FG000|Washout Period A|Adverse Event|0|||
129863872|NCT00727272|467458423|FG001|Washout Period A|Adverse Event|0|||
129863873|NCT00727272|467458424|FG002|Washout Period A|Adverse Event|1|||
129863874|NCT00727272|467458422|FG000|Washout Period B|Withdrawal by Subject|0|||
129863875|NCT00727272|467458423|FG001|Washout Period B|Withdrawal by Subject|0|||
129863876|NCT00727272|467458424|FG002|Washout Period B|Withdrawal by Subject|1|||
129863877|NCT00651664|467458425|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
129863878|NCT00651664|467458426|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
129863879|NCT00651664|467458427|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
129863880|NCT00651664|467458428|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
129863881|NCT00651664|467458429|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
129863882|NCT00651664|467458430|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
129863883|NCT00651664|467458431|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
129863884|NCT00651664|467458432|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
129863885|NCT00651664|467458433|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
129863886|NCT00651664|467458434|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
129863887|NCT00651664|467458425|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863888|NCT00651664|467458426|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863889|NCT00651664|467458427|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863890|NCT00651664|467458428|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863891|NCT00651664|467458429|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863892|NCT00651664|467458430|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863893|NCT00651664|467458431|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863894|NCT00651664|467458432|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863895|NCT00651664|467458433|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
129863896|NCT00651664|467458434|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
129863897|NCT00651664|467458425|FG000|Overall Study|Progressive Disease|3|||
129863898|NCT00651664|467458426|FG001|Overall Study|Progressive Disease|3|||
129863899|NCT00651664|467458427|FG002|Overall Study|Progressive Disease|3|||
129863900|NCT00651664|467458428|FG003|Overall Study|Progressive Disease|12|||
129863901|NCT00651664|467458429|FG004|Overall Study|Progressive Disease|4|||
129863902|NCT00651664|467458430|FG005|Overall Study|Progressive Disease|1|||
129863903|NCT00651664|467458431|FG006|Overall Study|Progressive Disease|3|||
129863904|NCT00651664|467458432|FG007|Overall Study|Progressive Disease|6|||
129863905|NCT00651664|467458433|FG008|Overall Study|Progressive Disease|5|||
129863906|NCT00651664|467458434|FG009|Overall Study|Progressive Disease|5|||
129863907|NCT00651664|467458425|FG000|Overall Study|Patient Declined Further Treatment|0|||
129863908|NCT00651664|467458426|FG001|Overall Study|Patient Declined Further Treatment|0|||
129863909|NCT00651664|467458427|FG002|Overall Study|Patient Declined Further Treatment|0|||
129913516|NCT00409838|467644428|FG001|Long-term Extension Period|Lack of Efficacy|0|||
129863910|NCT00651664|467458428|FG003|Overall Study|Patient Declined Further Treatment|1|||
129863911|NCT00651664|467458429|FG004|Overall Study|Patient Declined Further Treatment|1|||
129913517|NCT00409838|467644427|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
129913518|NCT00409838|467644428|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
129913519|NCT00409838|467644427|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
129863912|NCT00651664|467458430|FG005|Overall Study|Patient Declined Further Treatment|1|||
129863913|NCT00651664|467458431|FG006|Overall Study|Patient Declined Further Treatment|0|||
129863914|NCT00651664|467458432|FG007|Overall Study|Patient Declined Further Treatment|0|||
129863915|NCT00651664|467458433|FG008|Overall Study|Patient Declined Further Treatment|0|||
129863916|NCT00651664|467458434|FG009|Overall Study|Patient Declined Further Treatment|1|||
129863917|NCT00651664|467458425|FG000|Overall Study|Symptomatic Deterioration|0|||
129863918|NCT00651664|467458426|FG001|Overall Study|Symptomatic Deterioration|0|||
129863919|NCT00651664|467458427|FG002|Overall Study|Symptomatic Deterioration|0|||
129863920|NCT00651664|467458428|FG003|Overall Study|Symptomatic Deterioration|1|||
129863921|NCT00651664|467458429|FG004|Overall Study|Symptomatic Deterioration|0|||
129863922|NCT00651664|467458430|FG005|Overall Study|Symptomatic Deterioration|0|||
129863923|NCT00651664|467458431|FG006|Overall Study|Symptomatic Deterioration|1|||
129863924|NCT00651664|467458432|FG007|Overall Study|Symptomatic Deterioration|0|||
129863925|NCT00651664|467458433|FG008|Overall Study|Symptomatic Deterioration|1|||
129863926|NCT00651664|467458434|FG009|Overall Study|Symptomatic Deterioration|0|||
129863927|NCT00651664|467458425|FG000|Overall Study|Reason not Specified|0|||
129863928|NCT00651664|467458426|FG001|Overall Study|Reason not Specified|0|||
129863929|NCT00651664|467458427|FG002|Overall Study|Reason not Specified|0|||
129863930|NCT00651664|467458428|FG003|Overall Study|Reason not Specified|0|||
129863931|NCT00651664|467458429|FG004|Overall Study|Reason not Specified|0|||
129863932|NCT00651664|467458430|FG005|Overall Study|Reason not Specified|0|||
129863933|NCT00651664|467458431|FG006|Overall Study|Reason not Specified|1|||
129863934|NCT00651664|467458432|FG007|Overall Study|Reason not Specified|0|||
129863935|NCT00651664|467458433|FG008|Overall Study|Reason not Specified|0|||
129863936|NCT00651664|467458434|FG009|Overall Study|Reason not Specified|0|||
129863937|NCT00535730|467458435|FG000|Overall Study|Adverse Event|1|||
129863938|NCT00535730|467458436|FG001|Overall Study|Adverse Event|1|||
129863939|NCT00535730|467458435|FG000|Overall Study|Lost to Follow-up|0|||
129863940|NCT00535730|467458436|FG001|Overall Study|Lost to Follow-up|1|||
129863941|NCT00535730|467458435|FG000|Overall Study|Physician Decision|0|||
129863942|NCT00535730|467458436|FG001|Overall Study|Physician Decision|1|||
129863943|NCT00535730|467458435|FG000|Overall Study|Protocol Violation|1|||
129863944|NCT00535730|467458436|FG001|Overall Study|Protocol Violation|0|||
129863945|NCT00535730|467458435|FG000|Overall Study|Withdrawal by Subject|0|||
129863946|NCT00535730|467458436|FG001|Overall Study|Withdrawal by Subject|4|||
129863947|NCT02293538|467458437|FG000|Overall Study|Adverse Event|0|||
129863948|NCT02293538|467458438|FG001|Overall Study|Adverse Event|1|||
129863949|NCT02293538|467458437|FG000|Overall Study|Lost to Follow-up|1|||
129863950|NCT02293538|467458438|FG001|Overall Study|Lost to Follow-up|0|||
129863951|NCT02293538|467458437|FG000|Overall Study|Withdrawal by Subject|0|||
129863952|NCT02293538|467458438|FG001|Overall Study|Withdrawal by Subject|1|||
129863953|NCT00936858|467458439|FG000|Overall Study|Death|3|||
129863954|NCT00936858|467458439|FG000|Overall Study|Progression|29|||
129863955|NCT00936858|467458439|FG000|Overall Study|Withdrawal by Subject|5|||
129863956|NCT00936858|467458439|FG000|Overall Study|Adverse Event|1|||
129863957|NCT00936858|467458439|FG000|Overall Study|Physician Decision|7|||
129863958|NCT00936858|467458439|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
129863959|NCT00936858|467458439|FG000|Overall Study|Lost to Follow-up|1|||
129863960|NCT00989287|467458442|FG000|Overall Study|Adverse Event|1|||
129863961|NCT00989287|467458443|FG001|Overall Study|Adverse Event|0|||
129863962|NCT00989287|467458442|FG000|Overall Study|Lost to Follow-up|0|||
129863963|NCT00989287|467458443|FG001|Overall Study|Lost to Follow-up|1|||
129863964|NCT00729833|467458444|FG000|Overall Study|Death|5|||
129863965|NCT00729833|467458445|FG001|Overall Study|Death|1|||
129863966|NCT00729833|467458446|FG002|Overall Study|Death|3|||
129863967|NCT00729833|467458447|FG003|Overall Study|Death|5|||
129863968|NCT00729833|467458444|FG000|Overall Study|Study Terminated by Sponsor|0|||
129863969|NCT00729833|467458445|FG001|Overall Study|Study Terminated by Sponsor|0|||
129863970|NCT00729833|467458446|FG002|Overall Study|Study Terminated by Sponsor|1|||
129863971|NCT00729833|467458447|FG003|Overall Study|Study Terminated by Sponsor|0|||
129863972|NCT00729833|467458444|FG000|Overall Study|Lost to Follow-up|1|||
129863973|NCT00729833|467458445|FG001|Overall Study|Lost to Follow-up|0|||
129863974|NCT00729833|467458446|FG002|Overall Study|Lost to Follow-up|0|||
129863975|NCT00729833|467458447|FG003|Overall Study|Lost to Follow-up|0|||
129863976|NCT00729833|467458444|FG000|Overall Study|Withdrawal by Subject|3|||
129863977|NCT00729833|467458445|FG001|Overall Study|Withdrawal by Subject|1|||
129863978|NCT00729833|467458446|FG002|Overall Study|Withdrawal by Subject|3|||
129863979|NCT00729833|467458447|FG003|Overall Study|Withdrawal by Subject|0|||
129863980|NCT00729833|467458444|FG000|Overall Study|Unspecified Reasons|11|||
129863981|NCT00729833|467458445|FG001|Overall Study|Unspecified Reasons|5|||
129863982|NCT00729833|467458446|FG002|Overall Study|Unspecified Reasons|5|||
129863983|NCT00729833|467458447|FG003|Overall Study|Unspecified Reasons|1|||
129863984|NCT01041638|467458448|FG000|Overall Study|Adverse Event|4|||
129863985|NCT01041638|467458448|FG000|Overall Study|Death|1|||
129863986|NCT01041638|467458448|FG000|Overall Study|Lack of Efficacy|7|||
129863987|NCT01041638|467458448|FG000|Overall Study|Physician Decision|4|||
129863988|NCT01041638|467458448|FG000|Overall Study|Withdrawal by Subject|11|||
129863989|NCT00417079|467458449|FG000|Overall Study|Disease progression|267|||
129863990|NCT00417079|467458450|FG001|Overall Study|Disease progression|180|||
129863991|NCT00417079|467458449|FG000|Overall Study|Adverse Event|32|||
129863992|NCT00417079|467458450|FG001|Overall Study|Adverse Event|67|||
129863993|NCT00417079|467458449|FG000|Overall Study|Non-compliance to protocol|0|||
129863994|NCT00417079|467458450|FG001|Overall Study|Non-compliance to protocol|1|||
129863995|NCT00417079|467458449|FG000|Overall Study|Lost to Follow-up|2|||
129863996|NCT00417079|467458450|FG001|Overall Study|Lost to Follow-up|0|||
129863997|NCT00417079|467458449|FG000|Overall Study|Withdrawal by Subject|17|||
129863998|NCT00417079|467458450|FG001|Overall Study|Withdrawal by Subject|8|||
129863999|NCT00417079|467458449|FG000|Overall Study|Not treated|6|||
129864000|NCT00417079|467458450|FG001|Overall Study|Not treated|7|||
129864001|NCT00417079|467458449|FG000|Overall Study|Screened failure|2|||
129864002|NCT00417079|467458450|FG001|Overall Study|Screened failure|1|||
129864003|NCT00417079|467458449|FG000|Overall Study|Investigator's decision|1|||
129864004|NCT00417079|467458450|FG001|Overall Study|Investigator's decision|4|||
129864005|NCT00417079|467458449|FG000|Overall Study|Non-confirmed Disease progression|1|||
129864006|NCT00417079|467458450|FG001|Overall Study|Non-confirmed Disease progression|1|||
129864007|NCT00417079|467458449|FG000|Overall Study|Clinical deterioration|1|||
129864008|NCT00417079|467458450|FG001|Overall Study|Clinical deterioration|0|||
129864009|NCT00417079|467458449|FG000|Overall Study|Screening error|2|||
129864010|NCT00417079|467458450|FG001|Overall Study|Screening error|1|||
129864011|NCT00417079|467458449|FG000|Overall Study|Withdrawal by subject's family|0|||
129864012|NCT00417079|467458450|FG001|Overall Study|Withdrawal by subject's family|1|||
129864013|NCT00417079|467458449|FG000|Overall Study|Patient unable to come to the clinic|0|||
129864014|NCT00417079|467458450|FG001|Overall Study|Patient unable to come to the clinic|1|||
129864015|NCT00417079|467458449|FG000|Overall Study|abnormal liver function tests|0|||
129864016|NCT00417079|467458450|FG001|Overall Study|abnormal liver function tests|1|||
129864017|NCT01687257|467458452|FG000|Overall Study|Efficacy Failure|6|||
129864018|NCT01687257|467458453|FG001|Overall Study|Efficacy Failure|0|||
129864019|NCT01687257|467458454|FG002|Overall Study|Efficacy Failure|5|||
129864020|NCT01687257|467458452|FG000|Overall Study|Subject Withdrew Consent|1|||
129864021|NCT01687257|467458453|FG001|Overall Study|Subject Withdrew Consent|1|||
129864022|NCT01687257|467458454|FG002|Overall Study|Subject Withdrew Consent|1|||
129864023|NCT01687257|467458452|FG000|Overall Study|Adverse Event|1|||
129864024|NCT01687257|467458453|FG001|Overall Study|Adverse Event|0|||
129864025|NCT01687257|467458454|FG002|Overall Study|Adverse Event|0|||
129864026|NCT01687257|467458452|FG000|Overall Study|Investigator's Discretion|0|||
129864027|NCT01687257|467458453|FG001|Overall Study|Investigator's Discretion|3|||
129864028|NCT01687257|467458454|FG002|Overall Study|Investigator's Discretion|0|||
129864029|NCT04403698|467458456|FG000|Overall Study|Adverse Event|1|||
129864030|NCT04403698|467458457|FG001|Overall Study|Adverse Event|1|||
129864031|NCT04403698|467458456|FG000|Overall Study|Lost to Follow-up|1|||
129864032|NCT04403698|467458457|FG001|Overall Study|Lost to Follow-up|0|||
129864033|NCT04403698|467458456|FG000|Overall Study|Protocol Violation|0|||
129864034|NCT04403698|467458457|FG001|Overall Study|Protocol Violation|1|||
129864035|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
129864036|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
129864037|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
129864038|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
129864039|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
129864040|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864041|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
129864042|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864043|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864044|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
129864045|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
129864046|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
129864047|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
129864048|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
129864049|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
129864050|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864051|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864052|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129864053|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864054|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129864055|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864056|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864057|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
129864058|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864059|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
129864060|NCT03152552|467458458|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864061|NCT03152552|467458459|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864062|NCT03152552|467458460|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864063|NCT03152552|467458461|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
129864064|NCT03152552|467458462|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
129864065|NCT03152552|467458458|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
129864066|NCT03152552|467458459|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
129864067|NCT03152552|467458460|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
129864068|NCT03152552|467458461|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
129864069|NCT03152552|467458462|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
129864070|NCT04899349|467458465|FG000|Overall Study|Study terminated by Sponsor|2|||
129864071|NCT04899349|467458466|FG001|Overall Study|Study terminated by Sponsor|0|||
129864072|NCT01022762|467458468|FG000|Overall Study|Adverse Event|3|||
129864073|NCT01022762|467458469|FG001|Overall Study|Adverse Event|1|||
129864074|NCT01022762|467458468|FG000|Overall Study|Lack of Efficacy|0|||
129864075|NCT01022762|467458469|FG001|Overall Study|Lack of Efficacy|1|||
129864076|NCT01022762|467458468|FG000|Overall Study|Protocol Violation|7|||
129864077|NCT01022762|467458469|FG001|Overall Study|Protocol Violation|6|||
129864078|NCT01022762|467458468|FG000|Overall Study|Unclassified|12|||
129864079|NCT01022762|467458469|FG001|Overall Study|Unclassified|20|||
129864080|NCT01302119|467458470|FG000|Overall Study|Withdrawal by Subject|30|||
129864081|NCT01302119|467458471|FG001|Overall Study|Withdrawal by Subject|20|||
129864082|NCT01302119|467458470|FG000|Overall Study|Lost to Follow-up|10|||
129864083|NCT01302119|467458471|FG001|Overall Study|Lost to Follow-up|4|||
129864084|NCT01302119|467458470|FG000|Overall Study|Adverse Event|2|||
129864085|NCT01302119|467458471|FG001|Overall Study|Adverse Event|1|||
129864086|NCT01302119|467458470|FG000|Overall Study|Non-compliance|4|||
129864087|NCT01302119|467458471|FG001|Overall Study|Non-compliance|2|||
129864088|NCT01302119|467458470|FG000|Overall Study|Non-specific|4|||
129864089|NCT01302119|467458471|FG001|Overall Study|Non-specific|1|||
129864090|NCT04084314|467458472|FG000|Overall Study|Subject/guardian decision|91|||
129864091|NCT04084314|467458472|FG000|Overall Study|Adverse Event|24|||
129864092|NCT04084314|467458472|FG000|Overall Study|Lost to Follow-up|19|||
129864093|NCT04084314|467458472|FG000|Overall Study|New therapy for study indication|9|||
129864094|NCT04084314|467458472|FG000|Overall Study|Pregnancy|9|||
129864095|NCT04084314|467458472|FG000|Overall Study|Withdrawal of informed consent|8|||
129864096|NCT04084314|467458472|FG000|Overall Study|Physician Decision|4|||
129864097|NCT04084314|467458472|FG000|Overall Study|Protocol Deviation|3|||
129864098|NCT00802074|467458476|FG000|Overall Study|Adverse Event|1|||
129864099|NCT00802074|467458477|FG001|Overall Study|Adverse Event|1|||
129864100|NCT00802074|467458478|FG002|Overall Study|Adverse Event|1|||
129864101|NCT00802074|467458479|FG003|Overall Study|Adverse Event|0|||
129864102|NCT00802074|467458480|FG004|Overall Study|Adverse Event|0|||
129864103|NCT00802074|467458481|FG005|Overall Study|Adverse Event|0|||
129864104|NCT00802074|467458476|FG000|Overall Study|Withdrawal by Subject|1|||
129864105|NCT00802074|467458477|FG001|Overall Study|Withdrawal by Subject|0|||
129864106|NCT00802074|467458478|FG002|Overall Study|Withdrawal by Subject|0|||
129864107|NCT00802074|467458479|FG003|Overall Study|Withdrawal by Subject|0|||
129864108|NCT00802074|467458480|FG004|Overall Study|Withdrawal by Subject|0|||
129864109|NCT00802074|467458481|FG005|Overall Study|Withdrawal by Subject|0|||
129864110|NCT03743038|467458482|FG000|Overall Study|Physician Decision|1|||
129864111|NCT01300546|467458483|FG000|Overall Study|Withdrawal by Subject|1|||
129864112|NCT01300546|467458484|FG001|Overall Study|Withdrawal by Subject|0|||
129864113|NCT01300546|467458483|FG000|Overall Study|Lost to Follow-up|0|||
129864114|NCT01300546|467458484|FG001|Overall Study|Lost to Follow-up|2|||
129864115|NCT01300546|467458483|FG000|Overall Study|Lack of Efficacy|0|||
129864116|NCT01300546|467458484|FG001|Overall Study|Lack of Efficacy|3|||
129864117|NCT01300546|467458483|FG000|Overall Study|Adverse Event|0|||
129913520|NCT00409838|467644428|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
129913521|NCT00409838|467644427|FG000|Long-term Extension Period|Pregnancy|1|||
129864118|NCT01300546|467458484|FG001|Overall Study|Adverse Event|1|||
129864119|NCT00613951|467458493|FG000|Overall Study|Adverse Event|1|||
129864120|NCT00613951|467458494|FG001|Overall Study|Adverse Event|0|||
129864121|NCT00613951|467458495|FG002|Overall Study|Adverse Event|1|||
129864122|NCT00613951|467458493|FG000|Overall Study|Lack of Efficacy|0|||
129913522|NCT00409838|467644428|FG001|Long-term Extension Period|Pregnancy|0|||
129913523|NCT01619410|467644429|FG000|Overall Study|Lost to Follow-up|7|||
129913524|NCT01619410|467644430|FG001|Overall Study|Lost to Follow-up|4|||
129913525|NCT01250769|467644432|FG000|Overall Study|Withdrawal by Subject|0|||
129913526|NCT01250769|467644433|FG001|Overall Study|Withdrawal by Subject|1|||
129913527|NCT01250769|467644434|FG002|Overall Study|Withdrawal by Subject|1|||
129913528|NCT01250769|467644435|FG003|Overall Study|Withdrawal by Subject|0|||
129913529|NCT01250769|467644432|FG000|Overall Study|Adverse Event|0|||
129913530|NCT01250769|467644433|FG001|Overall Study|Adverse Event|0|||
129913531|NCT01250769|467644434|FG002|Overall Study|Adverse Event|1|||
129913532|NCT01250769|467644435|FG003|Overall Study|Adverse Event|0|||
129913533|NCT00999167|467644437|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
129913534|NCT00999167|467644438|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
129913535|NCT00999167|467644439|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
129913536|NCT00999167|467644437|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
129913537|NCT00999167|467644438|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
129913538|NCT00999167|467644439|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
129913539|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
129913540|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
129913541|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
129913542|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
129913543|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
129913544|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
129913545|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
129913546|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
129913547|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
129913548|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
129913549|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
129913550|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
129913551|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
129913552|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
129913553|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
129913554|NCT00999167|467644437|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
129913555|NCT00999167|467644438|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
129913556|NCT00999167|467644439|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
129913557|NCT05052996|467644444|FG000|Overall Study|Still on study|0|||
129913558|NCT05052996|467644445|FG001|Overall Study|Still on study|0|||
129913559|NCT05052996|467644446|FG002|Overall Study|Still on study|47|||
129913560|NCT05052996|467644447|FG003|Overall Study|Still on study|44|||
129913561|NCT05052996|467644444|FG000|Overall Study|Cohort terminated by sponsor|21|||
129913562|NCT05052996|467644445|FG001|Overall Study|Cohort terminated by sponsor|12|||
129913563|NCT05052996|467644446|FG002|Overall Study|Cohort terminated by sponsor|0|||
129913564|NCT05052996|467644447|FG003|Overall Study|Cohort terminated by sponsor|0|||
129913565|NCT05052996|467644444|FG000|Overall Study|Withdrew consent|1|||
129913566|NCT05052996|467644445|FG001|Overall Study|Withdrew consent|0|||
129913567|NCT05052996|467644446|FG002|Overall Study|Withdrew consent|1|||
129913568|NCT05052996|467644447|FG003|Overall Study|Withdrew consent|2|||
129913569|NCT05052996|467644444|FG000|Overall Study|Lost to Follow-up|1|||
129913570|NCT05052996|467644445|FG001|Overall Study|Lost to Follow-up|0|||
129913571|NCT05052996|467644446|FG002|Overall Study|Lost to Follow-up|0|||
129913572|NCT05052996|467644447|FG003|Overall Study|Lost to Follow-up|2|||
129913573|NCT05052996|467644444|FG000|Overall Study|Adverse Event|0|||
129913574|NCT05052996|467644445|FG001|Overall Study|Adverse Event|0|||
129913575|NCT05052996|467644446|FG002|Overall Study|Adverse Event|2|||
129913576|NCT05052996|467644447|FG003|Overall Study|Adverse Event|0|||
129913577|NCT05052996|467644444|FG000|Overall Study|Randomized but never treated|0|||
129913578|NCT05052996|467644445|FG001|Overall Study|Randomized but never treated|0|||
129913579|NCT05052996|467644446|FG002|Overall Study|Randomized but never treated|1|||
129913580|NCT05052996|467644447|FG003|Overall Study|Randomized but never treated|1|||
129913581|NCT05052996|467644444|FG000|Overall Study|Protocol Violation|1|||
129913582|NCT05052996|467644445|FG001|Overall Study|Protocol Violation|0|||
129913583|NCT05052996|467644446|FG002|Overall Study|Protocol Violation|0|||
129913584|NCT05052996|467644447|FG003|Overall Study|Protocol Violation|0|||
129913585|NCT00522951|467644451|FG000|Period 1|body motion|0|||
129913586|NCT00522951|467644452|FG001|Period 1|body motion|1|||
129913587|NCT00522951|467644451|FG000|Washout Period|Adverse Event|0|||
129913588|NCT00522951|467644452|FG001|Washout Period|Adverse Event|1|||
129913589|NCT00522951|467644451|FG000|Washout Period|Death|0|||
129913590|NCT00522951|467644452|FG001|Washout Period|Death|1|||
129913591|NCT00522951|467644451|FG000|Period 2|Withdrawal by Subject|1|||
129913592|NCT00522951|467644452|FG001|Period 2|Withdrawal by Subject|0|||
129913593|NCT00522951|467644451|FG000|Period 2|residual contrast medium|1|||
129913594|NCT00522951|467644452|FG001|Period 2|residual contrast medium|1|||
129864123|NCT00613951|467458494|FG001|Overall Study|Lack of Efficacy|1|||
129864124|NCT00613951|467458495|FG002|Overall Study|Lack of Efficacy|1|||
129864125|NCT00613951|467458493|FG000|Overall Study|Protocol Violation|1|||
129864126|NCT00613951|467458494|FG001|Overall Study|Protocol Violation|1|||
129864127|NCT00613951|467458495|FG002|Overall Study|Protocol Violation|1|||
129913595|NCT03101930|467644457|FG000|Overall Study|Withdrawal by Subject|2|||
129913596|NCT03101930|467644458|FG001|Overall Study|Withdrawal by Subject|1|||
129913597|NCT03101930|467644459|FG002|Overall Study|Withdrawal by Subject|2|||
129913598|NCT01747486|467644460|FG000|Stage 1|Physician Decision|3|||
129913599|NCT01747486|467644461|FG001|Stage 1|Physician Decision|0|||
129913600|NCT01747486|467644460|FG000|Stage 1|Withdrawal by Subject|4|||
129913601|NCT01747486|467644461|FG001|Stage 1|Withdrawal by Subject|3|||
129913602|NCT01747486|467644460|FG000|Stage 1|Disease progression|4|||
129913603|NCT01747486|467644461|FG001|Stage 1|Disease progression|9|||
129913604|NCT01747486|467644460|FG000|Stage 1|Death|1|||
129913605|NCT01747486|467644461|FG001|Stage 1|Death|1|||
129913606|NCT01747486|467644460|FG000|Stage 2|Physician Decision|2|||
129913607|NCT01747486|467644461|FG001|Stage 2|Physician Decision|0|||
129913608|NCT01747486|467644460|FG000|Stage 2|Withdrawal by Subject|1|||
129913609|NCT01747486|467644461|FG001|Stage 2|Withdrawal by Subject|0|||
129913610|NCT01747486|467644460|FG000|Stage 2|New Cancer Therapy|3|||
129913611|NCT01747486|467644461|FG001|Stage 2|New Cancer Therapy|0|||
129913612|NCT01747486|467644460|FG000|Stage 2|Disease Progression|3|||
129913613|NCT01747486|467644461|FG001|Stage 2|Disease Progression|0|||
129913614|NCT01771731|467644462|FG000|Overall Study|Physician Decision|1|||
129913615|NCT01771731|467644463|FG001|Overall Study|Physician Decision|0|||
129913616|NCT01771731|467644462|FG000|Overall Study|Protocol Violation|0|||
129913617|NCT01771731|467644463|FG001|Overall Study|Protocol Violation|1|||
129913618|NCT01771731|467644462|FG000|Overall Study|Adverse event: Pain Crisis|1|||
129913619|NCT01771731|467644463|FG001|Overall Study|Adverse event: Pain Crisis|1|||
129913620|NCT00976495|467644464|FG000|Overall Study|Withdrawal by Subject|0|||
129913621|NCT00976495|467644465|FG001|Overall Study|Withdrawal by Subject|1|||
129913622|NCT00976495|467644466|FG002|Overall Study|Withdrawal by Subject|0|||
129913623|NCT02538341|467644467|FG000|Overall Study|Lost to Follow-up|51|||
129913624|NCT02538341|467644468|FG001|Overall Study|Lost to Follow-up|46|||
129913625|NCT02538341|467644467|FG000|Overall Study|Withdrawal by Subject|3|||
129913626|NCT02538341|467644468|FG001|Overall Study|Withdrawal by Subject|1|||
129913627|NCT02538341|467644467|FG000|Overall Study|Death|2|||
129913628|NCT02538341|467644468|FG001|Overall Study|Death|0|||
129913629|NCT00331136|467644469|FG000|Overall Study|Adverse Event|3|||
129913630|NCT00331136|467644470|FG001|Overall Study|Adverse Event|5|||
129913631|NCT00331136|467644471|FG002|Overall Study|Adverse Event|0|||
129913632|NCT00331136|467644472|FG003|Overall Study|Adverse Event|1|||
129913633|NCT00331136|467644469|FG000|Overall Study|Withdrawal by Subject|0|||
129913634|NCT00331136|467644470|FG001|Overall Study|Withdrawal by Subject|1|||
129913635|NCT00331136|467644471|FG002|Overall Study|Withdrawal by Subject|0|||
129913636|NCT00331136|467644472|FG003|Overall Study|Withdrawal by Subject|0|||
129913637|NCT00331136|467644469|FG000|Overall Study|Lost to Follow-up|0|||
129913638|NCT00331136|467644470|FG001|Overall Study|Lost to Follow-up|1|||
129913639|NCT00331136|467644471|FG002|Overall Study|Lost to Follow-up|0|||
129913640|NCT00331136|467644472|FG003|Overall Study|Lost to Follow-up|0|||
129913641|NCT00331136|467644469|FG000|Overall Study|Protocol Violation|1|||
129913642|NCT00331136|467644470|FG001|Overall Study|Protocol Violation|0|||
129913643|NCT00331136|467644471|FG002|Overall Study|Protocol Violation|0|||
129913644|NCT00331136|467644472|FG003|Overall Study|Protocol Violation|0|||
129913645|NCT00331136|467644469|FG000|Overall Study|Not treated|1|||
129913646|NCT00331136|467644470|FG001|Overall Study|Not treated|0|||
129913647|NCT00331136|467644471|FG002|Overall Study|Not treated|0|||
129913648|NCT00331136|467644472|FG003|Overall Study|Not treated|0|||
129913649|NCT02321514|467644473|FG000|Overall Study|Death|15|||
129913650|NCT02321514|467644473|FG000|Overall Study|Missed Visit|7|||
129913651|NCT02321514|467644473|FG000|Overall Study|Study Exit|3|||
129913652|NCT04484935|467644476|FG000|Overall Study|Other|0|||
129913653|NCT04484935|467644477|FG001|Overall Study|Other|1|||
129913654|NCT04484935|467644476|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129913655|NCT04484935|467644477|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129913656|NCT04484935|467644476|FG000|Overall Study|Lost to Follow-up|1|||
129913657|NCT04484935|467644477|FG001|Overall Study|Lost to Follow-up|0|||
129913658|NCT04484935|467644476|FG000|Overall Study|Death|2|||
129913659|NCT04484935|467644477|FG001|Overall Study|Death|1|||
129913660|NCT01094184|467644481|FG000|Overall Study|Death|35|||
129913661|NCT01094184|467644482|FG001|Overall Study|Death|11|||
129913662|NCT03892564|467644483|FG000|Overall Study|Withdrawal by Subject|2|||
129913663|NCT01216176|467646537|FG000|Overall Study|Adverse Event|0|||
129913664|NCT01216176|467646538|FG001|Overall Study|Adverse Event|8|||
129913665|NCT01216176|467646539|FG002|Overall Study|Adverse Event|0|||
129913666|NCT01216176|467646537|FG000|Overall Study|Physician Decision|0|||
129913667|NCT01216176|467646538|FG001|Overall Study|Physician Decision|0|||
129913668|NCT01216176|467646539|FG002|Overall Study|Physician Decision|1|||
129913669|NCT00212355|467646542|FG000|Overall Study|Adverse Event|1|||
129913670|NCT00212355|467646542|FG000|Overall Study|Withdrawal by Subject|1|||
129913671|NCT00212355|467646542|FG000|Overall Study|A change of address|1|||
129913672|NCT00186992|467646546|FG000|Overall Study|Withdrawal by Subject|5|||
129913673|NCT00186992|467646546|FG000|Overall Study|Physician's discretion|13|||
129913674|NCT00186992|467646546|FG000|Overall Study|PI Discretion|4|||
129913675|NCT00186992|467646546|FG000|Overall Study|Ineligible|2|||
129449732|NCT02790138|465945669|FG001|Overall Study|Lack of Efficacy|7|||
129864128|NCT00613951|467458493|FG000|Overall Study|Unclassified|5|||
129864129|NCT00613951|467458494|FG001|Overall Study|Unclassified|3|||
129864130|NCT00613951|467458495|FG002|Overall Study|Unclassified|2|||
129864131|NCT04439110|467458496|FG000|Overall Study|Ineligible|2|||
129864132|NCT04439110|467458496|FG000|Overall Study|Adverse Event|4|||
129864133|NCT04439110|467458496|FG000|Overall Study|Death|2|||
129864134|NCT04439110|467458496|FG000|Overall Study|Disease proression|25|||
129864135|NCT04439110|467458496|FG000|Overall Study|Withdrawal by Subject|1|||
129864136|NCT04439110|467458496|FG000|Overall Study|Alternative therapy|1|||
129864137|NCT04439110|467458496|FG000|Overall Study|Other complicating disease|1|||
129864138|NCT04439110|467458496|FG000|Overall Study|Personal reasons|1|||
129864139|NCT04439110|467458496|FG000|Overall Study|Still on treatment|1|||
129864140|NCT00127608|467458497|FG000|Overall Study|VZV DNA negative|1|||
129864141|NCT00506493|467458503|FG000|Overall Study|Death|6|||
129864142|NCT00506493|467458503|FG000|Overall Study|Withdrawal by Subject|5|||
129864143|NCT01266642|467458504|FG000|Overall Study|Protocol Violation|0|||
129864144|NCT01266642|467458505|FG001|Overall Study|Protocol Violation|1|||
129864145|NCT00955357|467459924|FG000|Titration Phase|Adverse Event|9|||
129864146|NCT00955357|467459925|FG001|Titration Phase|Adverse Event|46|||
129864147|NCT00955357|467459924|FG000|Titration Phase|Lack of Efficacy|0|||
129864148|NCT00955357|467459925|FG001|Titration Phase|Lack of Efficacy|2|||
129864149|NCT00955357|467459924|FG000|Titration Phase|Protocol Violation|3|||
129864150|NCT00955357|467459925|FG001|Titration Phase|Protocol Violation|7|||
129864151|NCT00955357|467459924|FG000|Titration Phase|Lost to Follow-up|1|||
129864152|NCT00955357|467459925|FG001|Titration Phase|Lost to Follow-up|3|||
129864153|NCT00955357|467459924|FG000|Titration Phase|Withdrawal by Subject|3|||
129864154|NCT00955357|467459925|FG001|Titration Phase|Withdrawal by Subject|5|||
129864155|NCT00955357|467459924|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
129864156|NCT00955357|467459925|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
129864157|NCT00955357|467459924|FG000|Titration Phase|Study medication not tolerated|0|||
129864158|NCT00955357|467459925|FG001|Titration Phase|Study medication not tolerated|1|||
129864159|NCT00955357|467459924|FG000|Titration Phase|Non compliance to study procedures|0|||
129864160|NCT00955357|467459925|FG001|Titration Phase|Non compliance to study procedures|1|||
129864161|NCT00955357|467459924|FG000|Maintenance Phase|Adverse Event|3|||
129864162|NCT00955357|467459925|FG001|Maintenance Phase|Adverse Event|23|||
129864163|NCT00955357|467459924|FG000|Maintenance Phase|Lack of Efficacy|0|||
129864164|NCT00955357|467459925|FG001|Maintenance Phase|Lack of Efficacy|4|||
129864165|NCT00955357|467459924|FG000|Maintenance Phase|Protocol Violation|2|||
129864166|NCT00955357|467459925|FG001|Maintenance Phase|Protocol Violation|6|||
129864167|NCT00955357|467459924|FG000|Maintenance Phase|Lost to Follow-up|2|||
129864168|NCT00955357|467459925|FG001|Maintenance Phase|Lost to Follow-up|7|||
129864169|NCT00955357|467459924|FG000|Maintenance Phase|Withdrawal by Subject|4|||
129864170|NCT00955357|467459925|FG001|Maintenance Phase|Withdrawal by Subject|4|||
129864171|NCT00955357|467459924|FG000|Maintenance Phase|Patient moving out of area|0|||
129864172|NCT00955357|467459925|FG001|Maintenance Phase|Patient moving out of area|1|||
129864173|NCT00955357|467459924|FG000|Maintenance Phase|Non compliance to study procedures|1|||
129864174|NCT00955357|467459925|FG001|Maintenance Phase|Non compliance to study procedures|0|||
129864175|NCT01925950|467459927|FG000|Part 2|Withdrawal by Subject|1|||
129864176|NCT01925950|467459928|FG001|Part 2|Withdrawal by Subject|0|||
129864177|NCT00381940|467459929|FG000|Overall Study|Lack of Efficacy|3|||
129864178|NCT00381940|467459929|FG000|Overall Study|Protocol Violation|1|||
129864179|NCT00381940|467459929|FG000|Overall Study|Ineligible|1|||
129864180|NCT03162224|467459930|FG000|Overall Study|Death|4|||
129864181|NCT03162224|467459931|FG001|Overall Study|Death|5|||
129864182|NCT03162224|467459932|FG002|Overall Study|Death|8|||
129864183|NCT03162224|467459930|FG000|Overall Study|Withdrawal by Subject|1|||
129864184|NCT03162224|467459931|FG001|Overall Study|Withdrawal by Subject|0|||
129864185|NCT03162224|467459932|FG002|Overall Study|Withdrawal by Subject|1|||
129864186|NCT03162224|467459930|FG000|Overall Study|Lost to Follow-up|0|||
129913676|NCT00186992|467646546|FG000|Overall Study|Lost to Follow-up|2|||
129864187|NCT03162224|467459931|FG001|Overall Study|Lost to Follow-up|1|||
129864188|NCT03162224|467459932|FG002|Overall Study|Lost to Follow-up|0|||
129864189|NCT03162224|467459930|FG000|Overall Study|Other|6|||
129864190|NCT03162224|467459931|FG001|Overall Study|Other|2|||
129913677|NCT00186992|467646546|FG000|Overall Study|Still on Study|9|||
129913678|NCT03683069|467646547|FG000|Overall Study|see limitations|12|||
129913679|NCT03683069|467646548|FG001|Overall Study|see limitations|13|||
129913680|NCT03769168|467646549|FG000|Overall Study|Adverse Event|0|||
129913681|NCT03769168|467646550|FG001|Overall Study|Adverse Event|1|||
129913682|NCT03769168|467646549|FG000|Overall Study|Lack of Efficacy|2|||
129913683|NCT03769168|467646550|FG001|Overall Study|Lack of Efficacy|4|||
129913684|NCT03769168|467646549|FG000|Overall Study|Post study access to treatment|3|||
129913685|NCT03769168|467646550|FG001|Overall Study|Post study access to treatment|11|||
129913686|NCT03769168|467646549|FG000|Overall Study|Physician Decision|1|||
129913687|NCT03769168|467646550|FG001|Overall Study|Physician Decision|4|||
129913688|NCT03769168|467646549|FG000|Overall Study|Subject Decision|2|||
129913689|NCT03769168|467646550|FG001|Overall Study|Subject Decision|4|||
129913690|NCT03769168|467646549|FG000|Overall Study|Guardian decision|1|||
129913691|NCT03769168|467646550|FG001|Overall Study|Guardian decision|0|||
129913692|NCT04941287|467646551|FG000|Overall Study|Rapid decline before starting treatment|3|||
129913693|NCT04941287|467646552|FG001|Overall Study|Rapid decline before starting treatment|1|||
129913694|NCT04065048|467646553|FG000|Overall Study|Withdrawal by Subject|1|||
129913695|NCT04065048|467646554|FG001|Overall Study|Withdrawal by Subject|2|||
129913696|NCT04065048|467646555|FG002|Overall Study|Withdrawal by Subject|1|||
129913697|NCT04065048|467646556|FG003|Overall Study|Withdrawal by Subject|1|||
129913698|NCT04065048|467646553|FG000|Overall Study|Adverse Event|1|||
129913699|NCT04065048|467646554|FG001|Overall Study|Adverse Event|0|||
129913700|NCT04065048|467646555|FG002|Overall Study|Adverse Event|1|||
129913701|NCT04065048|467646556|FG003|Overall Study|Adverse Event|0|||
129913702|NCT05104697|467646557|FG000|Overall Study|Withdrawal by Subject|0|||
129913703|NCT05104697|467646558|FG001|Overall Study|Withdrawal by Subject|1|||
129913704|NCT03845465|467646559|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
129913705|NCT03845465|467646560|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
129913706|NCT03845465|467646559|FG000|6-month Data Collection|Withdrawal by Subject|0|||
129913707|NCT03845465|467646560|FG001|6-month Data Collection|Withdrawal by Subject|2|||
129913708|NCT03845465|467646559|FG000|12-month Data Collection|Withdrawal by Subject|0|||
129913709|NCT03845465|467646560|FG001|12-month Data Collection|Withdrawal by Subject|2|||
129913710|NCT05307978|467646576|FG000|Overall Study|Lost to Follow-up|0|||
129913711|NCT05307978|467646577|FG001|Overall Study|Lost to Follow-up|1|||
129913712|NCT05307978|467646578|FG002|Overall Study|Lost to Follow-up|0|||
129913713|NCT05307978|467646579|FG003|Overall Study|Lost to Follow-up|4|||
129913714|NCT05307978|467646580|FG004|Overall Study|Lost to Follow-up|0|||
129913715|NCT05307978|467646581|FG005|Overall Study|Lost to Follow-up|0|||
129913716|NCT05307978|467646582|FG006|Overall Study|Lost to Follow-up|1|||
129913717|NCT03324984|467646583|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
129913718|NCT03324984|467646584|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
129913719|NCT05656911|467646585|FG000|Treatment Phase|Physician Decision|2|||
129913720|NCT05656911|467646586|FG001|Treatment Phase|Physician Decision|0|||
129913721|NCT05656911|467646585|FG000|Treatment Phase|Lack of Efficacy|6|||
129913722|NCT05656911|467646586|FG001|Treatment Phase|Lack of Efficacy|3|||
129913723|NCT05656911|467646585|FG000|Treatment Phase|Subject Decision|4|||
129913724|NCT05656911|467646586|FG001|Treatment Phase|Subject Decision|2|||
129913725|NCT05656911|467646585|FG000|Treatment Phase|Other Reasons|1|||
129913726|NCT05656911|467646586|FG001|Treatment Phase|Other Reasons|0|||
129913727|NCT05656911|467646585|FG000|Treatment Phase|Adverse Event|3|||
129913728|NCT05656911|467646586|FG001|Treatment Phase|Adverse Event|1|||
129913729|NCT05656911|467646585|FG000|Follow-up Phase|Subject Decision|0|||
129913730|NCT05656911|467646586|FG001|Follow-up Phase|Subject Decision|1|||
129913731|NCT05656911|467646585|FG000|Follow-up Phase|Missing|1|||
129913732|NCT05656911|467646586|FG001|Follow-up Phase|Missing|0|||
129913733|NCT05075408|467646587|FG000|Overall Study|Withdrawal by Subject|5|||
129913734|NCT05075408|467646588|FG001|Overall Study|Withdrawal by Subject|3|||
129913735|NCT05075408|467646589|FG002|Overall Study|Withdrawal by Subject|4|||
129913736|NCT05075408|467646587|FG000|Overall Study|Adverse Event|5|||
129913737|NCT05075408|467646588|FG001|Overall Study|Adverse Event|7|||
129913738|NCT05075408|467646589|FG002|Overall Study|Adverse Event|8|||
129913739|NCT05075408|467646587|FG000|Overall Study|Protocol Violation|0|||
129913740|NCT05075408|467646588|FG001|Overall Study|Protocol Violation|1|||
129913741|NCT05075408|467646589|FG002|Overall Study|Protocol Violation|0|||
129913742|NCT05075408|467646587|FG000|Overall Study|Lost to Follow-up|2|||
129913743|NCT05075408|467646588|FG001|Overall Study|Lost to Follow-up|1|||
129913744|NCT05075408|467646589|FG002|Overall Study|Lost to Follow-up|1|||
129913745|NCT05075408|467646587|FG000|Overall Study|Physician Decision|1|||
129913746|NCT05075408|467646588|FG001|Overall Study|Physician Decision|0|||
129913747|NCT05075408|467646589|FG002|Overall Study|Physician Decision|0|||
129913748|NCT05075408|467646587|FG000|Overall Study|Other-unspecified|3|||
129913749|NCT05075408|467646588|FG001|Overall Study|Other-unspecified|2|||
129864191|NCT03162224|467459932|FG002|Overall Study|Other|1|||
129864192|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
129864193|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
129864194|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
129913750|NCT05075408|467646589|FG002|Overall Study|Other-unspecified|0|||
129913751|NCT02837510|467646590|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
129913752|NCT02837510|467646591|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
129913753|NCT02837510|467646590|FG000|Washout (2 Weeks)|Adverse Event|0|||
129913754|NCT02837510|467646591|FG001|Washout (2 Weeks)|Adverse Event|1|||
129913755|NCT02837510|467646590|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
129913756|NCT02837510|467646591|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
129913757|NCT02837510|467646590|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
129913758|NCT02837510|467646591|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
129913759|NCT02837510|467646590|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
129913760|NCT02837510|467646591|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
129913761|NCT02837510|467646590|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
129913762|NCT02837510|467646591|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
129913763|NCT05419505|467646592|FG000|Overall Study|Adverse Event|0|||
129913764|NCT05419505|467646593|FG001|Overall Study|Adverse Event|0|||
129913765|NCT05419505|467646594|FG002|Overall Study|Adverse Event|0|||
129913766|NCT05419505|467646595|FG003|Overall Study|Adverse Event|1|||
129913767|NCT05419505|467646596|FG004|Overall Study|Adverse Event|0|||
129913768|NCT05419505|467646597|FG005|Overall Study|Adverse Event|0|||
129913769|NCT05419505|467646598|FG006|Overall Study|Adverse Event|0|||
129913770|NCT05419505|467646599|FG007|Overall Study|Adverse Event|0|||
129913771|NCT05419505|467646592|FG000|Overall Study|Withdrawal by Subject|1|||
129913772|NCT05419505|467646593|FG001|Overall Study|Withdrawal by Subject|2|||
129913773|NCT05419505|467646594|FG002|Overall Study|Withdrawal by Subject|0|||
129913774|NCT05419505|467646595|FG003|Overall Study|Withdrawal by Subject|0|||
129913775|NCT05419505|467646596|FG004|Overall Study|Withdrawal by Subject|0|||
129913776|NCT05419505|467646597|FG005|Overall Study|Withdrawal by Subject|0|||
129913777|NCT05419505|467646598|FG006|Overall Study|Withdrawal by Subject|1|||
129913778|NCT05419505|467646599|FG007|Overall Study|Withdrawal by Subject|0|||
129913779|NCT05419505|467646592|FG000|Overall Study|Lost to Follow-up|2|||
129913780|NCT05419505|467646593|FG001|Overall Study|Lost to Follow-up|1|||
129913781|NCT05419505|467646594|FG002|Overall Study|Lost to Follow-up|0|||
129913782|NCT05419505|467646595|FG003|Overall Study|Lost to Follow-up|0|||
129913783|NCT05419505|467646596|FG004|Overall Study|Lost to Follow-up|1|||
129913784|NCT05419505|467646597|FG005|Overall Study|Lost to Follow-up|2|||
129913785|NCT05419505|467646598|FG006|Overall Study|Lost to Follow-up|0|||
129913786|NCT05419505|467646599|FG007|Overall Study|Lost to Follow-up|1|||
129913787|NCT02780388|467646602|FG000|Overall Study|Lost to Follow-up|0|||
129913788|NCT02780388|467646603|FG001|Overall Study|Lost to Follow-up|1|||
129913789|NCT02780388|467646604|FG002|Overall Study|Lost to Follow-up|0|||
129913790|NCT02780388|467646605|FG003|Overall Study|Lost to Follow-up|0|||
129913791|NCT02780388|467646606|FG004|Overall Study|Lost to Follow-up|0|||
129913792|NCT02780388|467646602|FG000|Overall Study|Withdrawal by Subject|1|||
129913793|NCT02780388|467646603|FG001|Overall Study|Withdrawal by Subject|1|||
129913794|NCT02780388|467646604|FG002|Overall Study|Withdrawal by Subject|0|||
129913795|NCT02780388|467646605|FG003|Overall Study|Withdrawal by Subject|0|||
129913796|NCT02780388|467646606|FG004|Overall Study|Withdrawal by Subject|0|||
129913797|NCT04527146|467646607|FG000|Overall Study|Withdrawal by Subject|12|||
129913798|NCT04527146|467646608|FG001|Overall Study|Withdrawal by Subject|15|||
129913799|NCT04527146|467646609|FG002|Overall Study|Withdrawal by Subject|7|||
129913800|NCT04527146|467646610|FG003|Overall Study|Withdrawal by Subject|16|||
129913801|NCT04527146|467646607|FG000|Overall Study|Lost to Follow-up|13|||
129913802|NCT04527146|467646608|FG001|Overall Study|Lost to Follow-up|9|||
129913803|NCT04527146|467646609|FG002|Overall Study|Lost to Follow-up|16|||
129913804|NCT04527146|467646610|FG003|Overall Study|Lost to Follow-up|13|||
129913805|NCT04527146|467646607|FG000|Overall Study|Death|0|||
129913806|NCT04527146|467646608|FG001|Overall Study|Death|1|||
129913807|NCT04527146|467646609|FG002|Overall Study|Death|1|||
129913808|NCT04527146|467646610|FG003|Overall Study|Death|0|||
129913809|NCT04527146|467646607|FG000|Overall Study|Adverse Event|0|||
129913810|NCT04527146|467646608|FG001|Overall Study|Adverse Event|0|||
129913811|NCT04527146|467646609|FG002|Overall Study|Adverse Event|1|||
129913812|NCT04527146|467646610|FG003|Overall Study|Adverse Event|0|||
129913813|NCT04527146|467646607|FG000|Overall Study|Ineligible after randomization|2|||
129913814|NCT04527146|467646608|FG001|Overall Study|Ineligible after randomization|0|||
129913815|NCT04527146|467646609|FG002|Overall Study|Ineligible after randomization|2|||
129913816|NCT04527146|467646610|FG003|Overall Study|Ineligible after randomization|2|||
129913817|NCT04527146|467646607|FG000|Overall Study|Moved to a different group|6|||
129913818|NCT04527146|467646608|FG001|Overall Study|Moved to a different group|3|||
129913819|NCT04527146|467646609|FG002|Overall Study|Moved to a different group|0|||
129913820|NCT04527146|467646610|FG003|Overall Study|Moved to a different group|2|||
129913821|NCT05107401|467646611|FG000|Overall Study|Lost to Follow-up|13|||
129913822|NCT05107401|467646612|FG001|Overall Study|Lost to Follow-up|12|||
129913823|NCT04468776|467646619|FG000|Overall Study|Lost to Follow-up|4|||
129913824|NCT04468776|467646620|FG001|Overall Study|Lost to Follow-up|3|||
129913825|NCT04468776|467646621|FG002|Overall Study|Lost to Follow-up|4|||
129913826|NCT04468776|467646619|FG000|Overall Study|Withdrawal by Subject|1|||
129913827|NCT04468776|467646620|FG001|Overall Study|Withdrawal by Subject|10|||
129913828|NCT04468776|467646621|FG002|Overall Study|Withdrawal by Subject|4|||
129913829|NCT04468776|467646619|FG000|Overall Study|Physician Decision|0|||
129913830|NCT04468776|467646620|FG001|Overall Study|Physician Decision|1|||
129913831|NCT04468776|467646621|FG002|Overall Study|Physician Decision|1|||
129913832|NCT04440176|467646624|FG000|Overall Study|Withdrawal by Subject|5|||
129913833|NCT04440176|467646625|FG001|Overall Study|Withdrawal by Subject|3|||
129913834|NCT04440176|467646624|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129913835|NCT04440176|467646625|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129913836|NCT04440176|467646624|FG000|Overall Study|Adverse Event|2|||
129913837|NCT04440176|467646625|FG001|Overall Study|Adverse Event|6|||
129913838|NCT04440176|467646624|FG000|Overall Study|Lost to Follow-up|22|||
129913839|NCT04440176|467646625|FG001|Overall Study|Lost to Follow-up|23|||
129913840|NCT04440176|467646624|FG000|Overall Study|Medication error without associated adverse event|0|||
129913841|NCT04440176|467646625|FG001|Overall Study|Medication error without associated adverse event|1|||
129913842|NCT04440176|467646624|FG000|Overall Study|No longer met eligibility criteria|7|||
129913843|NCT04440176|467646625|FG001|Overall Study|No longer met eligibility criteria|1|||
129913844|NCT04440176|467646624|FG000|Overall Study|Other|1|||
129913845|NCT04440176|467646625|FG001|Overall Study|Other|2|||
129913846|NCT04440176|467646624|FG000|Overall Study|Protocol deviation|6|||
129913847|NCT04440176|467646625|FG001|Overall Study|Protocol deviation|8|||
129913848|NCT04440176|467646624|FG000|Overall Study|Randomized but not vaccinated|6|||
129913849|NCT04440176|467646625|FG001|Overall Study|Randomized but not vaccinated|3|||
129913850|NCT04608045|467646632|FG000|Overall Study|Physician Decision|1|||
129913851|NCT03103321|467646634|FG000|Overall Study|Protocol Violation|1|||
129913852|NCT03103321|467646635|FG001|Overall Study|Protocol Violation|1|||
129913853|NCT03103321|467646636|FG002|Overall Study|Protocol Violation|1|||
129913854|NCT03103321|467646637|FG003|Overall Study|Protocol Violation|0|||
129913855|NCT04247542|467646638|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
129913856|NCT04247542|467646639|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
129913857|NCT04247542|467646640|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
129913858|NCT04247542|467646638|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
129913859|NCT04247542|467646639|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
129913860|NCT04247542|467646640|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
129913861|NCT04118452|467646641|FG000|Overall Study|Lost to Follow-up|5|||
129913862|NCT04118452|467646642|FG001|Overall Study|Lost to Follow-up|5|||
129913863|NCT04118452|467646641|FG000|Overall Study|Withdrawal by Subject|17|||
129913864|NCT04118452|467646642|FG001|Overall Study|Withdrawal by Subject|17|||
129913865|NCT04847999|467646643|FG000|Overall Study|Lost to Follow-up|0|||
129913866|NCT04847999|467646644|FG001|Overall Study|Lost to Follow-up|1|||
129913867|NCT02879448|467646645|FG000|Overall Study|Death|251|||
129913868|NCT02879448|467646646|FG001|Overall Study|Death|263|||
129913869|NCT02879448|467646645|FG000|Overall Study|Lost to Follow-up|23|||
129913870|NCT02879448|467646646|FG001|Overall Study|Lost to Follow-up|28|||
129913871|NCT02879448|467646645|FG000|Overall Study|Withdrawal by Subject|42|||
129913872|NCT02879448|467646646|FG001|Overall Study|Withdrawal by Subject|79|||
129913873|NCT02879448|467646645|FG000|Overall Study|Other Reasons|8|||
129913874|NCT02879448|467646646|FG001|Overall Study|Other Reasons|12|||
129913875|NCT05952076|467646647|FG000|Overall Study|Death|1|||
129913876|NCT05952076|467646648|FG001|Overall Study|Death|1|||
129913877|NCT05952076|467646647|FG000|Overall Study|Lost to Follow-up|0|||
129913878|NCT05952076|467646648|FG001|Overall Study|Lost to Follow-up|1|||
129913879|NCT05288283|467646649|FG000|Overall Study|Study Terminated Early|1|||
129913880|NCT05288283|467646650|FG001|Overall Study|Study Terminated Early|1|||
129913881|NCT05086744|467646651|FG000|Part A|Adverse Event|0|||
129913882|NCT05086744|467646652|FG001|Part A|Adverse Event|1|||
129913883|NCT05086744|467646651|FG000|Part A|Lack of Efficacy|3|||
129913884|NCT05086744|467646652|FG001|Part A|Lack of Efficacy|0|||
129913885|NCT05086744|467646651|FG000|Part A|Protocol deviation|1|||
129913886|NCT05086744|467646652|FG001|Part A|Protocol deviation|0|||
129913887|NCT05086744|467646651|FG000|Part A|Subject decision|1|||
129913888|NCT05086744|467646652|FG001|Part A|Subject decision|0|||
129913889|NCT05086744|467646651|FG000|Part B|Adverse Event|0|||
129913890|NCT05086744|467646652|FG001|Part B|Adverse Event|1|||
129913891|NCT05086744|467646651|FG000|Part B|Lack of Efficacy|0|||
129913892|NCT05086744|467646652|FG001|Part B|Lack of Efficacy|1|||
129913893|NCT05086744|467646651|FG000|Part B|Study terminated by sponsor|1|||
129913894|NCT05086744|467646652|FG001|Part B|Study terminated by sponsor|6|||
129913895|NCT01704079|467646653|FG000|Overall Study|Withdrawal by Subject|5|||
129913896|NCT01704079|467646654|FG001|Overall Study|Withdrawal by Subject|7|||
129913897|NCT01704079|467646653|FG000|Overall Study|Lost to Follow-up|2|||
129913898|NCT01704079|467646654|FG001|Overall Study|Lost to Follow-up|5|||
129913899|NCT01704079|467646653|FG000|Overall Study|Adverse Event|4|||
129913900|NCT01704079|467646654|FG001|Overall Study|Adverse Event|7|||
129913901|NCT01704079|467646653|FG000|Overall Study|Protocol Violation|1|||
129913902|NCT01704079|467646654|FG001|Overall Study|Protocol Violation|0|||
129913903|NCT01704079|467646653|FG000|Overall Study|Subject noncompliance|2|||
129913904|NCT01704079|467646654|FG001|Overall Study|Subject noncompliance|3|||
129913905|NCT01704079|467646653|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
129913906|NCT01704079|467646654|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
129913907|NCT05986565|467646655|FG000|Overall Study|Lost to Follow-up|8|||
129913908|NCT05986565|467646656|FG001|Overall Study|Lost to Follow-up|3|||
129913909|NCT05986565|467646655|FG000|Overall Study|Withdrawal by Subject|0|||
129913910|NCT05986565|467646656|FG001|Overall Study|Withdrawal by Subject|1|||
129913911|NCT02991807|467646658|FG000|Overall Study|Withdrawal by Subject|2|||
129913912|NCT02991807|467646659|FG001|Overall Study|Withdrawal by Subject|1|||
129913913|NCT02991807|467646658|FG000|Overall Study|Physician Decision|0|||
129913914|NCT02991807|467646659|FG001|Overall Study|Physician Decision|1|||
129913915|NCT02991807|467646658|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
129913916|NCT02991807|467646659|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
129913917|NCT00792636|467646661|FG000|Overall Study|Protocol Violation|17|||
129913918|NCT00792636|467646662|FG001|Overall Study|Protocol Violation|23|||
129913919|NCT00792636|467646663|FG002|Overall Study|Protocol Violation|20|||
129913920|NCT00792636|467646661|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
129913921|NCT00792636|467646662|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
129913922|NCT00792636|467646663|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
129913923|NCT00792636|467646661|FG000|Overall Study|Lost to Follow-up|13|||
129913924|NCT00792636|467646662|FG001|Overall Study|Lost to Follow-up|19|||
129913925|NCT00792636|467646663|FG002|Overall Study|Lost to Follow-up|14|||
129913926|NCT00792636|467646661|FG000|Overall Study|Withdrew Consent|10|||
129913927|NCT00792636|467646662|FG001|Overall Study|Withdrew Consent|13|||
129913928|NCT00792636|467646663|FG002|Overall Study|Withdrew Consent|9|||
129913929|NCT00792636|467646661|FG000|Overall Study|Lack of Efficacy|3|||
129913930|NCT00792636|467646662|FG001|Overall Study|Lack of Efficacy|4|||
129913931|NCT00792636|467646663|FG002|Overall Study|Lack of Efficacy|13|||
129913932|NCT00792636|467646661|FG000|Overall Study|Adverse Event|4|||
129913933|NCT00792636|467646662|FG001|Overall Study|Adverse Event|2|||
129913934|NCT00792636|467646663|FG002|Overall Study|Adverse Event|3|||
129913935|NCT00792636|467646661|FG000|Overall Study|Investigator Discretion|2|||
129913936|NCT00792636|467646662|FG001|Overall Study|Investigator Discretion|0|||
129913937|NCT00792636|467646663|FG002|Overall Study|Investigator Discretion|2|||
129913938|NCT01046136|467646664|FG000|Overall Study|Withdrawal by Subject|0|||
129913939|NCT01046136|467646665|FG001|Overall Study|Withdrawal by Subject|4|||
129913940|NCT01046136|467646664|FG000|Overall Study|Physician Decision|1|||
129913941|NCT01046136|467646665|FG001|Overall Study|Physician Decision|1|||
129913942|NCT01046136|467646664|FG000|Overall Study|Lost to Follow-up|3|||
129913943|NCT01046136|467646665|FG001|Overall Study|Lost to Follow-up|3|||
129913944|NCT04579250|467646666|FG000|Overall Study|Withdrawal by Subject|1|||
129913945|NCT04579250|467646667|FG001|Overall Study|Withdrawal by Subject|1|||
129913946|NCT04579250|467646668|FG002|Overall Study|Withdrawal by Subject|0|||
129913947|NCT04579250|467646666|FG000|Overall Study|Lost to Follow-up|1|||
129913948|NCT04579250|467646667|FG001|Overall Study|Lost to Follow-up|1|||
129864195|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
129864196|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
129864197|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
129864198|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
129864199|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
129864200|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
129864201|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
129864202|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
129864203|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
129864204|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
129864205|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
129864206|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
129864207|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
129864208|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
129864209|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
129864210|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
129864211|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
129864212|NCT04162769|467459933|FG000|Double-blind Treatment (12-Week)|Other|0|||
129913949|NCT04579250|467646668|FG002|Overall Study|Lost to Follow-up|0|||
129864213|NCT04162769|467459934|FG001|Double-blind Treatment (12-Week)|Other|1|||
129864214|NCT04162769|467459935|FG002|Double-blind Treatment (12-Week)|Other|1|||
129864215|NCT04162769|467459936|FG003|Double-blind Treatment (12-Week)|Other|0|||
129864216|NCT04162769|467459933|FG000|OLE Period (52-Week)|Adverse Event|0|||
129864217|NCT04162769|467459934|FG001|OLE Period (52-Week)|Adverse Event|0|||
129913950|NCT04579250|467646666|FG000|Overall Study|Moved from area|0|||
129913951|NCT04579250|467646667|FG001|Overall Study|Moved from area|1|||
129913952|NCT04579250|467646668|FG002|Overall Study|Moved from area|2|||
129913953|NCT00727909|467646669|FG000|Overall Study|Withdrawal by Subject|5|||
129913954|NCT00727909|467646670|FG001|Overall Study|Withdrawal by Subject|11|||
129864218|NCT04162769|467459935|FG002|OLE Period (52-Week)|Adverse Event|0|||
129864219|NCT04162769|467459936|FG003|OLE Period (52-Week)|Adverse Event|5|||
129864220|NCT04162769|467459933|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
129864221|NCT04162769|467459934|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
129864222|NCT04162769|467459935|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
129864223|NCT04162769|467459936|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
129864224|NCT04162769|467459933|FG000|OLE Period (52-Week)|Physician Decision|0|||
129864225|NCT04162769|467459934|FG001|OLE Period (52-Week)|Physician Decision|0|||
129864226|NCT04162769|467459935|FG002|OLE Period (52-Week)|Physician Decision|0|||
129864227|NCT04162769|467459936|FG003|OLE Period (52-Week)|Physician Decision|1|||
129864228|NCT04162769|467459933|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
129864229|NCT04162769|467459934|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
129864230|NCT04162769|467459935|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
129864231|NCT04162769|467459936|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
129864232|NCT04162769|467459933|FG000|OLE Period (52-Week)|Protocol deviation|0|||
129864233|NCT04162769|467459934|FG001|OLE Period (52-Week)|Protocol deviation|0|||
129864234|NCT04162769|467459935|FG002|OLE Period (52-Week)|Protocol deviation|0|||
129864235|NCT04162769|467459936|FG003|OLE Period (52-Week)|Protocol deviation|2|||
129864236|NCT00725452|467459939|FG000|Overall Study|Adverse Event|3|||
129864237|NCT00725452|467459939|FG000|Overall Study|Lack of Efficacy|2|||
129864238|NCT00725452|467459939|FG000|Overall Study|Reason not specified|1|||
129864239|NCT00725452|467459939|FG000|Overall Study|Physician Decision|1|||
129864240|NCT00725452|467459939|FG000|Overall Study|Withdrawal by Subject|3|||
129864241|NCT00725452|467459939|FG000|Overall Study|Lost to Follow-up|1|||
129864242|NCT00620750|467459941|FG000|Overall Study|Lost to Follow-up|25|||
129864243|NCT00746590|467459942|FG000|Overall Study|Death|1|||
129864244|NCT04402866|467459943|FG000|Overall Study|Discontinued Prior to Treatment|0|||
129864245|NCT04402866|467459944|FG001|Overall Study|Discontinued Prior to Treatment|0|||
129864246|NCT04402866|467459945|FG002|Overall Study|Discontinued Prior to Treatment|0|||
129864247|NCT04402866|467459946|FG003|Overall Study|Discontinued Prior to Treatment|0|||
129864248|NCT04402866|467459947|FG004|Overall Study|Discontinued Prior to Treatment|2|||
129864249|NCT04402866|467459948|FG005|Overall Study|Discontinued Prior to Treatment|3|||
129864250|NCT04402866|467459943|FG000|Overall Study|Adverse Event|2|||
129864251|NCT04402866|467459944|FG001|Overall Study|Adverse Event|1|||
129864252|NCT04402866|467459945|FG002|Overall Study|Adverse Event|0|||
129864253|NCT04402866|467459946|FG003|Overall Study|Adverse Event|0|||
129864254|NCT04402866|467459947|FG004|Overall Study|Adverse Event|13|||
129864255|NCT04402866|467459948|FG005|Overall Study|Adverse Event|8|||
129864256|NCT04402866|467459943|FG000|Overall Study|Miscellaneous|0|||
129864257|NCT04402866|467459944|FG001|Overall Study|Miscellaneous|0|||
129864258|NCT04402866|467459945|FG002|Overall Study|Miscellaneous|1|||
129864259|NCT04402866|467459946|FG003|Overall Study|Miscellaneous|0|||
129864260|NCT04402866|467459947|FG004|Overall Study|Miscellaneous|0|||
129864261|NCT04402866|467459948|FG005|Overall Study|Miscellaneous|0|||
129864262|NCT04402866|467459943|FG000|Overall Study|Lost to Follow-up|0|||
129864263|NCT04402866|467459944|FG001|Overall Study|Lost to Follow-up|0|||
129864264|NCT04402866|467459945|FG002|Overall Study|Lost to Follow-up|0|||
129864265|NCT04402866|467459946|FG003|Overall Study|Lost to Follow-up|0|||
129864266|NCT04402866|467459947|FG004|Overall Study|Lost to Follow-up|0|||
129864267|NCT04402866|467459948|FG005|Overall Study|Lost to Follow-up|1|||
129864268|NCT04402866|467459943|FG000|Overall Study|Withdrawal by Subject|0|||
129864269|NCT04402866|467459944|FG001|Overall Study|Withdrawal by Subject|0|||
129864270|NCT04402866|467459945|FG002|Overall Study|Withdrawal by Subject|0|||
129864271|NCT04402866|467459946|FG003|Overall Study|Withdrawal by Subject|0|||
129864272|NCT04402866|467459947|FG004|Overall Study|Withdrawal by Subject|0|||
129864273|NCT04402866|467459948|FG005|Overall Study|Withdrawal by Subject|2|||
129864274|NCT00971048|467459951|FG000|Overall Study|Protocol Violation|1|||
129864275|NCT00971048|467459952|FG001|Overall Study|Protocol Violation|2|||
129864276|NCT00971048|467459953|FG002|Overall Study|Protocol Violation|0|||
129864277|NCT00971048|467459954|FG003|Overall Study|Protocol Violation|1|||
129864278|NCT00971048|467459951|FG000|Overall Study|Adverse Event|0|||
129864279|NCT00971048|467459952|FG001|Overall Study|Adverse Event|0|||
129864280|NCT00971048|467459953|FG002|Overall Study|Adverse Event|1|||
129864281|NCT00971048|467459954|FG003|Overall Study|Adverse Event|0|||
129864282|NCT00971048|467459951|FG000|Overall Study|Physician Decision|0|||
129864283|NCT00971048|467459952|FG001|Overall Study|Physician Decision|0|||
129864284|NCT00971048|467459953|FG002|Overall Study|Physician Decision|0|||
129864285|NCT00971048|467459954|FG003|Overall Study|Physician Decision|1|||
129864286|NCT01654549|467459955|FG000|Overall Study|H.pylori eradication not successful|0|||
129864287|NCT01654549|467459956|FG001|Overall Study|H.pylori eradication not successful|1|||
129864288|NCT02308748|467459965|FG000|Period 1|Withdrawal by Subject|0|||
129864289|NCT02308748|467459966|FG001|Period 1|Withdrawal by Subject|0|||
129864290|NCT02308748|467459967|FG002|Period 1|Withdrawal by Subject|1|||
129864291|NCT02308748|467459968|FG003|Period 1|Withdrawal by Subject|0|||
129864292|NCT02308748|467459969|FG004|Period 1|Withdrawal by Subject|0|||
129864293|NCT02308748|467459970|FG005|Period 1|Withdrawal by Subject|0|||
129864294|NCT02308748|467459971|FG006|Period 1|Withdrawal by Subject|0|||
129864295|NCT02308748|467459972|FG007|Period 1|Withdrawal by Subject|0|||
129913955|NCT00727909|467646671|FG002|Overall Study|Withdrawal by Subject|8|||
129913956|NCT00727909|467646672|FG003|Overall Study|Withdrawal by Subject|5|||
129913957|NCT00727909|467646669|FG000|Overall Study|Death|0|||
129913958|NCT00727909|467646670|FG001|Overall Study|Death|0|||
129913959|NCT00727909|467646671|FG002|Overall Study|Death|1|||
129913960|NCT00727909|467646672|FG003|Overall Study|Death|0|||
129913961|NCT03446157|467646673|FG000|Overall Study|Death|11|||
129913962|NCT03446157|467646674|FG001|Overall Study|Death|9|||
129913963|NCT03446157|467646673|FG000|Overall Study|Lost to Follow-up|0|||
129913964|NCT03446157|467646674|FG001|Overall Study|Lost to Follow-up|1|||
129913965|NCT03446157|467646673|FG000|Overall Study|Withdrawal by Subject|2|||
129913966|NCT03446157|467646674|FG001|Overall Study|Withdrawal by Subject|1|||
129913967|NCT00411151|467646675|FG000|Overall Study|Death|38|||
129913968|NCT00411151|467646675|FG000|Overall Study|Withdrawal by Subject|2|||
129913969|NCT00411151|467646675|FG000|Overall Study|Lost to Follow-up|2|||
129913970|NCT00411151|467646675|FG000|Overall Study|Protocol Violation|1|||
129913971|NCT00411151|467646675|FG000|Overall Study|Trial prematurely closed|4|||
129913972|NCT04110054|467646676|FG000|Overall Study|COVID-19 reason other than AE|0|||
129913973|NCT04110054|467646677|FG001|Overall Study|COVID-19 reason other than AE|0|||
129913974|NCT04110054|467646678|FG002|Overall Study|COVID-19 reason other than AE|2|||
129913975|NCT04110054|467646679|FG003|Overall Study|COVID-19 reason other than AE|0|||
129913976|NCT04110054|467646676|FG000|Overall Study|Withdrawal by Subject|0|||
129913977|NCT04110054|467646677|FG001|Overall Study|Withdrawal by Subject|3|||
129913978|NCT04110054|467646678|FG002|Overall Study|Withdrawal by Subject|2|||
129913979|NCT04110054|467646679|FG003|Overall Study|Withdrawal by Subject|0|||
129913980|NCT04110054|467646676|FG000|Overall Study|Adverse Event|1|||
129913981|NCT04110054|467646677|FG001|Overall Study|Adverse Event|1|||
129913982|NCT04110054|467646678|FG002|Overall Study|Adverse Event|4|||
129913983|NCT04110054|467646679|FG003|Overall Study|Adverse Event|3|||
129913984|NCT00093015|467646680|FG000|Overall Study|Withdrawal by Subject|194|||
129913985|NCT00093015|467646681|FG001|Overall Study|Withdrawal by Subject|171|||
129913986|NCT00093015|467646680|FG000|Overall Study|Lost to Follow-up|96|||
129913987|NCT00093015|467646681|FG001|Overall Study|Lost to Follow-up|108|||
129913988|NCT00093015|467646680|FG000|Overall Study|Death|375|||
129913989|NCT00093015|467646681|FG001|Overall Study|Death|385|||
129913990|NCT00632203|467646683|FG000|Overall Study|Did not start study treatment|1|||
129913991|NCT00632203|467646684|FG001|Overall Study|Did not start study treatment|0|||
129913992|NCT03432858|467646694|FG000|Overall Study|Protocol Violation|2|||
129913993|NCT03432858|467646695|FG001|Overall Study|Protocol Violation|1|||
129913994|NCT03432858|467646696|FG002|Overall Study|Protocol Violation|9|||
129913995|NCT03432858|467646694|FG000|Overall Study|Withdrawal by Subject|0|||
129913996|NCT03432858|467646695|FG001|Overall Study|Withdrawal by Subject|1|||
129913997|NCT03432858|467646696|FG002|Overall Study|Withdrawal by Subject|1|||
129913998|NCT03432858|467646694|FG000|Overall Study|Procedure canceled/rescheduled|0|||
129913999|NCT03432858|467646695|FG001|Overall Study|Procedure canceled/rescheduled|9|||
129914000|NCT03432858|467646696|FG002|Overall Study|Procedure canceled/rescheduled|6|||
129914001|NCT03432858|467646694|FG000|Overall Study|Required postop mobilization with splinting|0|||
129914002|NCT03432858|467646695|FG001|Overall Study|Required postop mobilization with splinting|0|||
129914003|NCT03432858|467646696|FG002|Overall Study|Required postop mobilization with splinting|1|||
129914004|NCT04402294|467646697|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
129914005|NCT04402294|467646698|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
129914006|NCT04402294|467646697|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
129914007|NCT04402294|467646698|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
129914008|NCT05096819|467648840|FG000|Overall Study|Withdrawal by Subject|3|||
129914009|NCT05096819|467648841|FG001|Overall Study|Withdrawal by Subject|0|||
129914010|NCT03547908|467648842|FG000|Blinded Phase|Lost to Follow-up|3|||
129914011|NCT03547908|467648843|FG001|Blinded Phase|Lost to Follow-up|3|||
129914012|NCT03547908|467648844|FG002|Blinded Phase|Lost to Follow-up|0|||
129914013|NCT03547908|467648845|FG003|Blinded Phase|Lost to Follow-up|0|||
129864296|NCT02308748|467459973|FG008|Period 1|Withdrawal by Subject|0|||
129864297|NCT02308748|467459974|FG009|Period 1|Withdrawal by Subject|0|||
129864298|NCT02308748|467459965|FG000|Period 2|Adverse Event|0|||
129864299|NCT02308748|467459966|FG001|Period 2|Adverse Event|0|||
129864300|NCT02308748|467459967|FG002|Period 2|Adverse Event|0|||
129864301|NCT02308748|467459968|FG003|Period 2|Adverse Event|0|||
129864302|NCT02308748|467459969|FG004|Period 2|Adverse Event|0|||
129864303|NCT02308748|467459970|FG005|Period 2|Adverse Event|0|||
129864304|NCT02308748|467459971|FG006|Period 2|Adverse Event|0|||
129864305|NCT02308748|467459972|FG007|Period 2|Adverse Event|1|||
129864306|NCT02308748|467459973|FG008|Period 2|Adverse Event|0|||
129864307|NCT02308748|467459974|FG009|Period 2|Adverse Event|0|||
129864308|NCT02308748|467459965|FG000|Period 3|Protocol Violation|0|||
129864309|NCT02308748|467459966|FG001|Period 3|Protocol Violation|0|||
129864310|NCT02308748|467459967|FG002|Period 3|Protocol Violation|0|||
129864311|NCT02308748|467459968|FG003|Period 3|Protocol Violation|0|||
129864312|NCT02308748|467459969|FG004|Period 3|Protocol Violation|0|||
129864313|NCT02308748|467459970|FG005|Period 3|Protocol Violation|0|||
129864314|NCT02308748|467459971|FG006|Period 3|Protocol Violation|0|||
129864315|NCT02308748|467459972|FG007|Period 3|Protocol Violation|0|||
129864316|NCT02308748|467459973|FG008|Period 3|Protocol Violation|0|||
129864317|NCT02308748|467459974|FG009|Period 3|Protocol Violation|1|||
129864318|NCT02308748|467459965|FG000|Period 5|Adverse Event|1|||
129864319|NCT02308748|467459966|FG001|Period 5|Adverse Event|0|||
129864320|NCT02308748|467459967|FG002|Period 5|Adverse Event|0|||
129864321|NCT02308748|467459968|FG003|Period 5|Adverse Event|0|||
129864322|NCT02308748|467459969|FG004|Period 5|Adverse Event|0|||
129864323|NCT02308748|467459970|FG005|Period 5|Adverse Event|0|||
129864324|NCT02308748|467459971|FG006|Period 5|Adverse Event|0|||
129864325|NCT02308748|467459972|FG007|Period 5|Adverse Event|0|||
129864326|NCT02308748|467459973|FG008|Period 5|Adverse Event|1|||
129864327|NCT02308748|467459974|FG009|Period 5|Adverse Event|0|||
129864328|NCT03570619|467459982|FG000|Overall Study|Adverse Event|2|||
129864329|NCT03570619|467459983|FG001|Overall Study|Adverse Event|0|||
129864330|NCT03570619|467459984|FG002|Overall Study|Adverse Event|1|||
129864331|NCT03570619|467459982|FG000|Overall Study|new diagnosis of new malignancy|1|||
129864332|NCT03570619|467459983|FG001|Overall Study|new diagnosis of new malignancy|0|||
129864333|NCT03570619|467459984|FG002|Overall Study|new diagnosis of new malignancy|0|||
129864334|NCT03570619|467459982|FG000|Overall Study|Physician Decision|1|||
129864335|NCT03570619|467459983|FG001|Overall Study|Physician Decision|1|||
129864336|NCT03570619|467459984|FG002|Overall Study|Physician Decision|0|||
129864337|NCT03570619|467459982|FG000|Overall Study|Withdrawal by Subject|0|||
129864338|NCT03570619|467459983|FG001|Overall Study|Withdrawal by Subject|2|||
129864339|NCT03570619|467459984|FG002|Overall Study|Withdrawal by Subject|0|||
129864340|NCT01565707|467459987|FG000|Overall Study|Adverse Event|1|||
129864341|NCT01565707|467459988|FG001|Overall Study|Adverse Event|6|||
129864342|NCT01565707|467459989|FG002|Overall Study|Adverse Event|2|||
129864343|NCT01565707|467459990|FG003|Overall Study|Adverse Event|1|||
129864344|NCT01565707|467459987|FG000|Overall Study|Lost to Follow-up|1|||
129864345|NCT01565707|467459988|FG001|Overall Study|Lost to Follow-up|0|||
129864346|NCT01565707|467459989|FG002|Overall Study|Lost to Follow-up|0|||
129864347|NCT01565707|467459990|FG003|Overall Study|Lost to Follow-up|0|||
129864348|NCT01565707|467459987|FG000|Overall Study|Protocol Violation|1|||
129864349|NCT01565707|467459988|FG001|Overall Study|Protocol Violation|0|||
129864350|NCT01565707|467459989|FG002|Overall Study|Protocol Violation|0|||
129864351|NCT01565707|467459990|FG003|Overall Study|Protocol Violation|1|||
129864352|NCT01565707|467459987|FG000|Overall Study|Withdrawal by Subject|3|||
129864353|NCT01565707|467459988|FG001|Overall Study|Withdrawal by Subject|1|||
129864354|NCT01565707|467459989|FG002|Overall Study|Withdrawal by Subject|1|||
129864355|NCT01565707|467459990|FG003|Overall Study|Withdrawal by Subject|1|||
129864356|NCT01565707|467459987|FG000|Overall Study|Randomized but not evaluable|2|||
129864357|NCT01565707|467459988|FG001|Overall Study|Randomized but not evaluable|0|||
129864358|NCT01565707|467459989|FG002|Overall Study|Randomized but not evaluable|0|||
129864359|NCT01565707|467459990|FG003|Overall Study|Randomized but not evaluable|0|||
129864360|NCT01565707|467459987|FG000|Overall Study|Miscellaneous|1|||
129864361|NCT01565707|467459988|FG001|Overall Study|Miscellaneous|1|||
129864362|NCT01565707|467459989|FG002|Overall Study|Miscellaneous|0|||
129864363|NCT01565707|467459990|FG003|Overall Study|Miscellaneous|2|||
129864364|NCT05207813|467459991|FG000|Overall Study|Lost to Follow-up|2|||
129864365|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
129864366|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
129864367|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
129864368|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129864369|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129864370|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
129864371|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864372|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129914014|NCT03547908|467648842|FG000|Blinded Phase|Withdrew Consent|2|||
129914015|NCT03547908|467648843|FG001|Blinded Phase|Withdrew Consent|3|||
129914016|NCT03547908|467648844|FG002|Blinded Phase|Withdrew Consent|0|||
129914017|NCT03547908|467648845|FG003|Blinded Phase|Withdrew Consent|0|||
129914018|NCT03547908|467648842|FG000|Blinded Phase|Investigator's Discretion|2|||
129914019|NCT03547908|467648843|FG001|Blinded Phase|Investigator's Discretion|1|||
129914020|NCT03547908|467648844|FG002|Blinded Phase|Investigator's Discretion|0|||
129914021|NCT03547908|467648845|FG003|Blinded Phase|Investigator's Discretion|0|||
129914022|NCT03547908|467648842|FG000|Blinded Phase|Death|2|||
129914023|NCT03547908|467648843|FG001|Blinded Phase|Death|0|||
129914024|NCT03547908|467648844|FG002|Blinded Phase|Death|0|||
129914025|NCT03547908|467648845|FG003|Blinded Phase|Death|0|||
129914026|NCT03547908|467648842|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
129914027|NCT03547908|467648843|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
129914028|NCT03547908|467648844|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
129914029|NCT03547908|467648845|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
129914030|NCT03547908|467648842|FG000|Blinded Phase|Adverse Event|1|||
129914031|NCT03547908|467648843|FG001|Blinded Phase|Adverse Event|0|||
129914032|NCT03547908|467648844|FG002|Blinded Phase|Adverse Event|0|||
129914033|NCT03547908|467648845|FG003|Blinded Phase|Adverse Event|0|||
129914034|NCT03547908|467648842|FG000|Blinded Phase|Randomized But Never Treated|1|||
129914035|NCT03547908|467648843|FG001|Blinded Phase|Randomized But Never Treated|0|||
129914036|NCT03547908|467648844|FG002|Blinded Phase|Randomized But Never Treated|0|||
129914037|NCT03547908|467648845|FG003|Blinded Phase|Randomized But Never Treated|0|||
129914038|NCT03547908|467648842|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
129914039|NCT03547908|467648843|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
129914040|NCT03547908|467648844|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
129914041|NCT03547908|467648845|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
129914042|NCT03547908|467648842|FG000|Open-label Extension Phase|Death|0|||
129914043|NCT03547908|467648843|FG001|Open-label Extension Phase|Death|0|||
129914044|NCT03547908|467648844|FG002|Open-label Extension Phase|Death|1|||
129914045|NCT03547908|467648845|FG003|Open-label Extension Phase|Death|0|||
129914046|NCT02152137|467648847|FG000|Overall Study|Withdrawal by Subject|1|||
129914047|NCT02152137|467648847|FG000|Overall Study|Originally assigned to Arm B|3|||
129914048|NCT03358875|467648848|FG000|Overall Study|Death|409|||
129914049|NCT03358875|467648849|FG001|Overall Study|Death|223|||
129914050|NCT03358875|467648848|FG000|Overall Study|Study Closed by Sponsor|66|||
129914051|NCT03358875|467648849|FG001|Overall Study|Study Closed by Sponsor|29|||
129914052|NCT03358875|467648848|FG000|Overall Study|Withdrawal by Subject|13|||
129914053|NCT03358875|467648849|FG001|Overall Study|Withdrawal by Subject|16|||
129914054|NCT03358875|467648848|FG000|Overall Study|Lost to Follow-up|13|||
129914055|NCT03358875|467648849|FG001|Overall Study|Lost to Follow-up|2|||
129914056|NCT03358875|467648848|FG000|Overall Study|Miscellaneous|33|||
129914057|NCT03358875|467648849|FG001|Overall Study|Miscellaneous|0|||
129914058|NCT03358875|467648848|FG000|Overall Study|Remained on Study|1|||
129914059|NCT03358875|467648849|FG001|Overall Study|Remained on Study|0|||
129914060|NCT06194214|467648853|FG000|Overall Study|Adverse Event|1|||
129914061|NCT05687903|467648854|FG000|Overall Study|Protocol Deviation|1|||
129914062|NCT05687903|467648855|FG001|Overall Study|Protocol Deviation|1|||
129914063|NCT05687903|467648856|FG002|Overall Study|Protocol Deviation|0|||
129914064|NCT05687903|467648857|FG003|Overall Study|Protocol Deviation|1|||
129914065|NCT05687903|467648858|FG004|Overall Study|Protocol Deviation|0|||
129914066|NCT05613205|467648859|FG000|Overall Study|Lost to Follow-up|0|||
129914067|NCT05613205|467648860|FG001|Overall Study|Lost to Follow-up|0|||
129914068|NCT05613205|467648861|FG002|Overall Study|Lost to Follow-up|1|||
129864373|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
129864374|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864375|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864376|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
129864377|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
129864378|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
129864379|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864380|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864381|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864382|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
129864383|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
129864384|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
129864385|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
129864386|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129864387|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129864388|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
129864389|NCT04988308|467459995|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
129864390|NCT04988308|467459996|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
129864391|NCT04988308|467459997|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
129864392|NCT04988308|467459998|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
129864393|NCT04988308|467459999|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
129864394|NCT04988308|467460000|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
129864395|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129864396|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129864397|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
129864398|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
129864399|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
129864400|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
129864401|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129864402|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129864403|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
129864404|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
129864405|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
129864406|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
129864407|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129864408|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129864409|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
129864410|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
129864411|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
129864412|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
129864413|NCT04988308|467459995|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
129864414|NCT04988308|467459996|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
129864415|NCT04988308|467459997|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
129864416|NCT04988308|467459998|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
129864417|NCT04988308|467459999|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
129864418|NCT04988308|467460000|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
129864419|NCT02625623|467460002|FG000|Overall Study|Participants randomized but not treated|9|||
129864420|NCT02625623|467460003|FG001|Overall Study|Participants randomized but not treated|1|||
129864421|NCT00808808|467460004|FG000|Overall Study|Vaccinated; survey not completed|131|||
129864422|NCT00808808|467460005|FG001|Overall Study|Vaccinated; survey not completed|169|||
129864423|NCT00808808|467460006|FG002|Overall Study|Vaccinated; survey not completed|302|||
129864424|NCT00808808|467460004|FG000|Overall Study|Employee was not vaccinated.|2686|||
129864425|NCT00808808|467460005|FG001|Overall Study|Employee was not vaccinated.|2268|||
129864426|NCT00808808|467460006|FG002|Overall Study|Employee was not vaccinated.|2255|||
129864427|NCT01371851|467460008|FG000|Overall Study|Lost to Follow-up|5|||
129864428|NCT01371851|467460009|FG001|Overall Study|Lost to Follow-up|8|||
129914069|NCT05613205|467648862|FG003|Overall Study|Lost to Follow-up|1|||
129914070|NCT05613205|467648863|FG004|Overall Study|Lost to Follow-up|0|||
129914071|NCT05613205|467648859|FG000|Overall Study|Withdrawal by Subject|0|||
129914072|NCT05613205|467648860|FG001|Overall Study|Withdrawal by Subject|0|||
129914073|NCT05613205|467648861|FG002|Overall Study|Withdrawal by Subject|1|||
129914074|NCT05613205|467648862|FG003|Overall Study|Withdrawal by Subject|1|||
129914075|NCT05613205|467648863|FG004|Overall Study|Withdrawal by Subject|0|||
129914076|NCT00448669|467648864|FG000|Overall Study|Lost to Follow-up|52|||
129914077|NCT00448669|467648865|FG001|Overall Study|Lost to Follow-up|63|||
129914078|NCT00448669|467648864|FG000|Overall Study|Withdrawal by Subject|90|||
129914079|NCT00448669|467648865|FG001|Overall Study|Withdrawal by Subject|74|||
129914080|NCT00448669|467648864|FG000|Overall Study|Relocated|49|||
129914081|NCT00448669|467648865|FG001|Overall Study|Relocated|36|||
129914082|NCT00448669|467648864|FG000|Overall Study|Were withdrawn by investigator|10|||
129914083|NCT00448669|467648865|FG001|Overall Study|Were withdrawn by investigator|6|||
129914084|NCT00448669|467648864|FG000|Overall Study|Death|2|||
129914085|NCT00448669|467648865|FG001|Overall Study|Death|4|||
129914086|NCT00448669|467648864|FG000|Overall Study|Had other reasons|5|||
129914087|NCT00448669|467648865|FG001|Overall Study|Had other reasons|6|||
129914088|NCT00448669|467648864|FG000|Overall Study|HIV-infected at enrollment|1|||
129914089|NCT00448669|467648865|FG001|Overall Study|HIV-infected at enrollment|2|||
129914090|NCT00448669|467648864|FG000|Overall Study|Never started drug|9|||
129914091|NCT00448669|467648865|FG001|Overall Study|Never started drug|7|||
129914092|NCT04287985|467648866|FG000|Overall Study|Adverse Event|1|||
129914093|NCT04287985|467648867|FG001|Overall Study|Adverse Event|0|||
129914094|NCT04287985|467648868|FG002|Overall Study|Adverse Event|0|||
129914095|NCT04287985|467648869|FG003|Overall Study|Adverse Event|0|||
129914096|NCT04287985|467648866|FG000|Overall Study|Protocol Violation|0|||
129914097|NCT04287985|467648867|FG001|Overall Study|Protocol Violation|1|||
129914098|NCT04287985|467648868|FG002|Overall Study|Protocol Violation|0|||
129914099|NCT04287985|467648869|FG003|Overall Study|Protocol Violation|0|||
129914100|NCT04287985|467648866|FG000|Overall Study|Physician Decision|0|||
129914101|NCT04287985|467648867|FG001|Overall Study|Physician Decision|0|||
129914102|NCT04287985|467648868|FG002|Overall Study|Physician Decision|0|||
129914103|NCT04287985|467648869|FG003|Overall Study|Physician Decision|1|||
129914104|NCT04287985|467648866|FG000|Overall Study|Withdrawal by Subject|2|||
129914105|NCT04287985|467648867|FG001|Overall Study|Withdrawal by Subject|1|||
129914106|NCT04287985|467648868|FG002|Overall Study|Withdrawal by Subject|1|||
129914107|NCT04287985|467648869|FG003|Overall Study|Withdrawal by Subject|2|||
129914108|NCT01340066|467648874|FG000|Placebo Run in Period|Screen Failures|27|||
129914109|NCT01340066|467648875|FG001|Placebo Run in Period|Screen Failures|0|||
129914110|NCT01340066|467648876|FG002|Placebo Run in Period|Screen Failures|0|||
129914111|NCT01340066|467648874|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
129914112|NCT01340066|467648875|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
129914113|NCT01340066|467648876|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
129914114|NCT01340066|467648874|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
129914115|NCT01340066|467648875|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
129914116|NCT01340066|467648876|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
129914117|NCT01340066|467648874|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
129914118|NCT01340066|467648875|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
129914119|NCT01340066|467648876|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
129914120|NCT02789020|467648877|FG000|Overall Study|Withdrawal by Subject|6|||
129914121|NCT02789020|467648878|FG001|Overall Study|Withdrawal by Subject|5|||
129914122|NCT03771352|467648894|FG000|Overall Study|Screen failure|2|||
129914123|NCT03771352|467648894|FG000|Overall Study|Withdrawal by Subject|2|||
129914124|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
129914125|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
129914126|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
129914127|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
129914128|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
129914129|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
129914130|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
129914131|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
129914132|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
129914133|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
129914134|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
129914135|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
129914136|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
129914137|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
129914138|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
129914139|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
129914140|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
129914141|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
129914142|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
129914143|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
129914144|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
129914145|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
129914146|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
129914147|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
129914148|NCT03338816|467648904|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
129914149|NCT03338816|467648905|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
129914150|NCT03338816|467648906|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
129914151|NCT03338816|467648907|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
129914152|NCT04238247|467648908|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
129914153|NCT04238247|467648909|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
129914154|NCT04238247|467648910|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
129914155|NCT04238247|467648911|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
129914156|NCT04238247|467648908|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
129914157|NCT04238247|467648909|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
129914158|NCT04238247|467648910|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
129914159|NCT04238247|467648911|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
129914160|NCT04238247|467648908|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
129914161|NCT04238247|467648909|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
129914162|NCT04238247|467648910|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
129914163|NCT04238247|467648911|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
129914164|NCT04238247|467648908|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
129914165|NCT04238247|467648909|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
129914166|NCT04238247|467648910|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
129914167|NCT04238247|467648911|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
129914168|NCT03092726|467648912|FG000|Overall Study|Adverse Event|3|||
129914169|NCT03092726|467648913|FG001|Overall Study|Adverse Event|10|||
129914170|NCT03092726|467648912|FG000|Overall Study|Lack of Efficacy|0|||
129914171|NCT03092726|467648913|FG001|Overall Study|Lack of Efficacy|1|||
129914172|NCT03092726|467648912|FG000|Overall Study|Lost to Follow-up|1|||
129914173|NCT03092726|467648913|FG001|Overall Study|Lost to Follow-up|0|||
129914174|NCT03092726|467648912|FG000|Overall Study|Withdrawal by Subject|5|||
129914175|NCT03092726|467648913|FG001|Overall Study|Withdrawal by Subject|3|||
129914176|NCT04950127|467648914|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
129914177|NCT04950127|467648915|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
129914178|NCT04950127|467648916|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914179|NCT04950127|467648917|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914180|NCT04950127|467648918|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914181|NCT04950127|467648919|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
129914182|NCT04950127|467648914|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
129914183|NCT04950127|467648915|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
129914184|NCT04950127|467648916|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914185|NCT04950127|467648917|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914186|NCT04950127|467648918|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914187|NCT04950127|467648919|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
129914188|NCT04950127|467648914|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
129914189|NCT04950127|467648915|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
129914190|NCT04950127|467648916|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914191|NCT04950127|467648917|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914192|NCT04950127|467648918|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914193|NCT04950127|467648919|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
129914194|NCT04950127|467648914|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914195|NCT04950127|467648915|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914196|NCT04950127|467648916|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914197|NCT04950127|467648917|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914198|NCT04950127|467648918|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
129914199|NCT04950127|467648919|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
129914200|NCT04950127|467648914|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914201|NCT04950127|467648915|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914202|NCT04950127|467648916|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914203|NCT04950127|467648917|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914204|NCT04950127|467648918|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
129914205|NCT04950127|467648919|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
129914206|NCT03833167|467648924|FG000|Overall Study|Withdrawal by Subject|4|||
129914207|NCT03833167|467648925|FG001|Overall Study|Withdrawal by Subject|6|||
129914208|NCT03833167|467648924|FG000|Overall Study|Ongoing|186|||
129914209|NCT03833167|467648925|FG001|Overall Study|Ongoing|194|||
129914210|NCT03833167|467648924|FG000|Overall Study|Lost to Follow-up|1|||
129914211|NCT03833167|467648925|FG001|Overall Study|Lost to Follow-up|1|||
129914212|NCT03833167|467648924|FG000|Overall Study|Physician Decision|0|||
129914213|NCT03833167|467648925|FG001|Overall Study|Physician Decision|2|||
129914214|NCT03833167|467648924|FG000|Overall Study|Death|34|||
129914215|NCT03833167|467648925|FG001|Overall Study|Death|22|||
129914216|NCT01948661|467648927|FG000|Overall Study|Withdrawal by Subject|2|||
129914217|NCT01948661|467648928|FG001|Overall Study|Withdrawal by Subject|4|||
129914218|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Adverse Event|4|||
129914219|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Adverse Event|1|||
129914220|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
129914221|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
129914222|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
129914223|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
129914224|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
129914225|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
129914226|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
129914227|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
129914228|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Other|6|||
129914229|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Other|1|||
129914230|NCT03271489|467648929|FG000|Double-Blind (DB) Period|Missing|1|||
129914231|NCT03271489|467648930|FG001|Double-Blind (DB) Period|Missing|0|||
129914232|NCT03271489|467648929|FG000|Open-Label (OL) Period|Adverse Event|2|||
129914233|NCT03271489|467648930|FG001|Open-Label (OL) Period|Adverse Event|0|||
129914234|NCT03271489|467648929|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
129914235|NCT03271489|467648930|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
129914236|NCT03271489|467648929|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
129914237|NCT03271489|467648930|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
129914238|NCT03271489|467648929|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
129914239|NCT03271489|467648930|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
129914240|NCT03271489|467648929|FG000|Open-Label (OL) Period|No Specified|2|||
129914241|NCT03271489|467648930|FG001|Open-Label (OL) Period|No Specified|2|||
129914242|NCT03271489|467648929|FG000|Open-Label (OL) Period|Missing|2|||
129914243|NCT03271489|467648930|FG001|Open-Label (OL) Period|Missing|0|||
129914244|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
129914245|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
129914246|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
129914247|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
129914248|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
129914249|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
129914250|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
129914251|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
129914252|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
129914253|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
129914254|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
129914255|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
129914256|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
129914257|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
129914258|NCT03271489|467648929|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
129914259|NCT03271489|467648930|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
129914260|NCT03330795|467648931|FG000|Overall Study|Death|3|||
129914261|NCT03330795|467648931|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
129914262|NCT05064735|467648932|FG000|Overall Study|Withdrawal by Subject|7|||
129914263|NCT05064735|467648933|FG001|Overall Study|Withdrawal by Subject|8|||
129914264|NCT05064735|467648932|FG000|Overall Study|Lost to Follow-up|7|||
129914265|NCT05064735|467648933|FG001|Overall Study|Lost to Follow-up|2|||
129914266|NCT05064735|467648932|FG000|Overall Study|Physician Decision|2|||
129914267|NCT05064735|467648933|FG001|Overall Study|Physician Decision|1|||
129914268|NCT05064735|467648932|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
129914269|NCT05064735|467648933|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
129914270|NCT05064735|467648932|FG000|Overall Study|Site Closure|7|||
129914271|NCT05064735|467648933|FG001|Overall Study|Site Closure|2|||
129914272|NCT02886286|467648934|FG000|Overall Study|pump motor stall|0|||
129914273|NCT02886286|467648935|FG001|Overall Study|pump motor stall|1|||
129914274|NCT02376790|467648936|FG000|Overall Study|Withdrawal by Subject|43|||
129914275|NCT02376790|467648937|FG001|Overall Study|Withdrawal by Subject|36|||
129914276|NCT02376790|467648938|FG002|Overall Study|Withdrawal by Subject|37|||
129914277|NCT02376790|467648936|FG000|Overall Study|Decision by Sponsor|2|||
129914278|NCT02376790|467648937|FG001|Overall Study|Decision by Sponsor|1|||
129914279|NCT02376790|467648938|FG002|Overall Study|Decision by Sponsor|4|||
129914280|NCT02376790|467648936|FG000|Overall Study|Lost to Follow-up|15|||
129914281|NCT02376790|467648937|FG001|Overall Study|Lost to Follow-up|10|||
129914282|NCT02376790|467648938|FG002|Overall Study|Lost to Follow-up|12|||
129914283|NCT03014453|467648939|FG000|Overall Study|Lost to Follow-up|12|||
129914284|NCT03014453|467648939|FG000|Overall Study|Discontinued GER|3|||
129914285|NCT03014453|467648939|FG000|Overall Study|Excluded|19|||
129914286|NCT03014453|467648939|FG000|Overall Study|Refused to take part in|37|||
129914287|NCT05450458|467648940|FG000|Overall Study|Lost to Follow-up|4|||
129914288|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
129914289|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
129914290|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
129914291|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
129914292|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
129914293|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
129914294|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
129914295|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
129914296|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129914297|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129914298|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129914299|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
129914300|NCT02794480|467648941|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129914301|NCT02794480|467648942|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
129914302|NCT02794480|467648943|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129914303|NCT02794480|467648944|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129914304|NCT02794480|467648941|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
129914305|NCT02794480|467648942|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129914306|NCT02794480|467648943|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129914307|NCT02794480|467648944|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
129914308|NCT00262301|467648945|FG000|Double-blind Phase|Lost to Follow-up|1|||
129914309|NCT00262301|467648946|FG001|Double-blind Phase|Lost to Follow-up|0|||
129914310|NCT00262301|467648947|FG002|Double-blind Phase|Lost to Follow-up|0|||
129914311|NCT00262301|467648945|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
129914312|NCT00262301|467648946|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
129914313|NCT00262301|467648947|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
129914314|NCT01017146|467648948|FG000|Overall Study|Adverse Event|11|||
129914315|NCT01017146|467648949|FG001|Overall Study|Adverse Event|1|||
129914316|NCT01017146|467648948|FG000|Overall Study|Lost to Follow-up|14|||
129914317|NCT01017146|467648949|FG001|Overall Study|Lost to Follow-up|14|||
129914318|NCT01017146|467648948|FG000|Overall Study|Noncompliance with Study Product|1|||
129914319|NCT01017146|467648949|FG001|Overall Study|Noncompliance with Study Product|1|||
129914320|NCT01017146|467648948|FG000|Overall Study|Withdrawal by Subject|32|||
129914321|NCT01017146|467648949|FG001|Overall Study|Withdrawal by Subject|16|||
129914322|NCT01017146|467648948|FG000|Overall Study|Relocation|0|||
129914323|NCT01017146|467648949|FG001|Overall Study|Relocation|4|||
129914324|NCT01017146|467648948|FG000|Overall Study|Pregnancy|2|||
129914325|NCT01017146|467648949|FG001|Overall Study|Pregnancy|1|||
129914326|NCT01017146|467648948|FG000|Overall Study|Protocol Violation|2|||
129914327|NCT01017146|467648949|FG001|Overall Study|Protocol Violation|0|||
129914328|NCT01017146|467648948|FG000|Overall Study|Took Excluded Medication|2|||
129914329|NCT01017146|467648949|FG001|Overall Study|Took Excluded Medication|0|||
129914330|NCT01017146|467648948|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
129914331|NCT01017146|467648949|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
129914332|NCT01017146|467648948|FG000|Overall Study|Change in Work Situation|1|||
129914333|NCT01017146|467648949|FG001|Overall Study|Change in Work Situation|0|||
129914334|NCT00901901|467648953|FG000|Treatment Period|Adverse Event|120|||
129914335|NCT00901901|467648954|FG001|Treatment Period|Adverse Event|128|||
129914336|NCT00901901|467648953|FG000|Treatment Period|Withdrawal by Subject|26|||
129864429|NCT01371851|467460008|FG000|Overall Study|was arrested and put in jail|0|||
129864430|NCT01371851|467460009|FG001|Overall Study|was arrested and put in jail|1|||
129864431|NCT01371851|467460008|FG000|Overall Study|non study related adverse event|1|||
129864432|NCT01371851|467460009|FG001|Overall Study|non study related adverse event|0|||
129864433|NCT01371851|467460008|FG000|Overall Study|Blood Pressure outside study parameters|2|||
129864434|NCT01371851|467460009|FG001|Overall Study|Blood Pressure outside study parameters|0|||
129864435|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
129864436|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
129864437|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
129864438|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
129864439|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
129864440|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
129864441|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
129864442|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
129864443|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
129864444|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
129864445|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
129864446|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
129864447|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
129864448|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
129864449|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
129864450|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
129864451|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
129864452|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
129864453|NCT00833638|467460010|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
129864454|NCT00833638|467460011|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
129864455|NCT00833638|467460012|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
129864456|NCT00833638|467460010|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
129864457|NCT00833638|467460011|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
129864458|NCT00833638|467460012|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
129864459|NCT00833638|467460010|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
129864460|NCT00833638|467460011|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
129864461|NCT00833638|467460012|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
129864462|NCT02352948|467460013|FG000|Overall Study|Death|47|||
129864463|NCT02352948|467460014|FG001|Overall Study|Death|48|||
129864464|NCT02352948|467460015|FG002|Overall Study|Death|114|||
129864465|NCT02352948|467460016|FG003|Overall Study|Death|74|||
129864466|NCT02352948|467460017|FG004|Overall Study|Death|77|||
129864467|NCT02352948|467460018|FG005|Overall Study|Death|44|||
129864468|NCT02352948|467460013|FG000|Overall Study|Lost to Follow-up|1|||
129864469|NCT02352948|467460014|FG001|Overall Study|Lost to Follow-up|0|||
129864470|NCT02352948|467460015|FG002|Overall Study|Lost to Follow-up|2|||
129864471|NCT02352948|467460016|FG003|Overall Study|Lost to Follow-up|1|||
129864472|NCT02352948|467460017|FG004|Overall Study|Lost to Follow-up|2|||
129864473|NCT02352948|467460018|FG005|Overall Study|Lost to Follow-up|1|||
129864474|NCT02352948|467460013|FG000|Overall Study|Withdrawal by Subject|1|||
129864475|NCT02352948|467460014|FG001|Overall Study|Withdrawal by Subject|10|||
129864476|NCT02352948|467460015|FG002|Overall Study|Withdrawal by Subject|11|||
129864477|NCT02352948|467460016|FG003|Overall Study|Withdrawal by Subject|23|||
129864478|NCT02352948|467460017|FG004|Overall Study|Withdrawal by Subject|9|||
129864479|NCT02352948|467460018|FG005|Overall Study|Withdrawal by Subject|4|||
129864480|NCT02352948|467460013|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129864481|NCT02352948|467460014|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129864482|NCT02352948|467460015|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
129864483|NCT02352948|467460016|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
129864484|NCT02352948|467460017|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
129864485|NCT02352948|467460018|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
129864486|NCT02352948|467460013|FG000|Overall Study|Other|0|||
129864487|NCT02352948|467460014|FG001|Overall Study|Other|0|||
129864488|NCT02352948|467460015|FG002|Overall Study|Other|2|||
129864489|NCT02352948|467460016|FG003|Overall Study|Other|0|||
129864490|NCT02352948|467460017|FG004|Overall Study|Other|0|||
129864491|NCT02352948|467460018|FG005|Overall Study|Other|0|||
129864492|NCT00490646|467460019|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
129864493|NCT00490646|467460020|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
129864494|NCT00490646|467460019|FG000|Overall Study|Never Treated (had an adverse event)|1|||
129864495|NCT00490646|467460020|FG001|Overall Study|Never Treated (had an adverse event)|0|||
129864496|NCT00490646|467460019|FG000|Overall Study|Never Treated (withdrew consent)|0|||
129914337|NCT00901901|467648954|FG001|Treatment Period|Withdrawal by Subject|24|||
129914338|NCT00901901|467648953|FG000|Treatment Period|Physician Decision|2|||
129914339|NCT00901901|467648954|FG001|Treatment Period|Physician Decision|2|||
129914340|NCT00901901|467648953|FG000|Treatment Period|Lost to Follow-up|3|||
129914341|NCT00901901|467648954|FG001|Treatment Period|Lost to Follow-up|5|||
129914342|NCT00901901|467648953|FG000|Treatment Period|Noncompliance with study medication|4|||
129914343|NCT00901901|467648954|FG001|Treatment Period|Noncompliance with study medication|1|||
129914344|NCT00901901|467648953|FG000|Treatment Period|Missing|1|||
129914345|NCT00901901|467648954|FG001|Treatment Period|Missing|0|||
129914346|NCT00901901|467648953|FG000|Treatment Period|Never treated|0|||
129914347|NCT00901901|467648954|FG001|Treatment Period|Never treated|3|||
129914348|NCT00901901|467648953|FG000|Treatment Period|Protocol driven decision point|0|||
129914349|NCT00901901|467648954|FG001|Treatment Period|Protocol driven decision point|2|||
129914350|NCT00901901|467648953|FG000|Treatment Period|Study terminated by sponsor|2|||
129914351|NCT00901901|467648954|FG001|Treatment Period|Study terminated by sponsor|0|||
129914352|NCT00901901|467648953|FG000|Treatment Period|Protocol Violation|5|||
129914353|NCT00901901|467648954|FG001|Treatment Period|Protocol Violation|9|||
129914354|NCT00901901|467648953|FG000|Treatment Period|Switch to commercial drug|1|||
129914355|NCT00901901|467648954|FG001|Treatment Period|Switch to commercial drug|1|||
129914356|NCT00901901|467648953|FG000|Treatment Period|Transfer to treatment continuation study|5|||
129914357|NCT00901901|467648954|FG001|Treatment Period|Transfer to treatment continuation study|2|||
129914358|NCT00901901|467648953|FG000|Follow-up Period|Death|181|||
129914359|NCT00901901|467648954|FG001|Follow-up Period|Death|208|||
129914360|NCT00901901|467648953|FG000|Follow-up Period|Protocol driven decision point|47|||
129914361|NCT00901901|467648954|FG001|Follow-up Period|Protocol driven decision point|36|||
129914362|NCT00901901|467648953|FG000|Follow-up Period|Withdrawal by Subject|6|||
129914363|NCT00901901|467648954|FG001|Follow-up Period|Withdrawal by Subject|9|||
129914364|NCT00901901|467648953|FG000|Follow-up Period|Lost to Follow-up|12|||
129914365|NCT00901901|467648954|FG001|Follow-up Period|Lost to Follow-up|8|||
129914366|NCT00901901|467648953|FG000|Follow-up Period|Missing|94|||
129914367|NCT00901901|467648954|FG001|Follow-up Period|Missing|80|||
129914368|NCT05171777|467648957|FG000|Treatment Crossover Period|Adverse Event|9|||
129914369|NCT05171777|467648958|FG001|Treatment Crossover Period|Adverse Event|6|||
129914370|NCT05171777|467648959|FG002|Treatment Crossover Period|Adverse Event|0|||
129914371|NCT05171777|467648960|FG003|Treatment Crossover Period|Adverse Event|0|||
129914372|NCT05171777|467648957|FG000|Treatment Crossover Period|Death|5|||
129914373|NCT05171777|467648958|FG001|Treatment Crossover Period|Death|5|||
129914374|NCT05171777|467648959|FG002|Treatment Crossover Period|Death|0|||
129914375|NCT05171777|467648960|FG003|Treatment Crossover Period|Death|0|||
129914376|NCT05171777|467648957|FG000|Treatment Crossover Period|Disease Relapse|0|||
129914377|NCT05171777|467648958|FG001|Treatment Crossover Period|Disease Relapse|1|||
129914378|NCT05171777|467648959|FG002|Treatment Crossover Period|Disease Relapse|0|||
129914379|NCT05171777|467648960|FG003|Treatment Crossover Period|Disease Relapse|0|||
129914380|NCT05171777|467648957|FG000|Treatment Crossover Period|Reason not Specified|2|||
129914381|NCT05171777|467648958|FG001|Treatment Crossover Period|Reason not Specified|1|||
129914382|NCT05171777|467648959|FG002|Treatment Crossover Period|Reason not Specified|0|||
129914383|NCT05171777|467648960|FG003|Treatment Crossover Period|Reason not Specified|0|||
129914384|NCT05171777|467648957|FG000|Treatment Crossover Period|Physician Decision|0|||
129914385|NCT05171777|467648958|FG001|Treatment Crossover Period|Physician Decision|1|||
129914386|NCT05171777|467648959|FG002|Treatment Crossover Period|Physician Decision|0|||
129914387|NCT05171777|467648960|FG003|Treatment Crossover Period|Physician Decision|0|||
129914388|NCT05171777|467648957|FG000|Treatment Crossover Period|Progressive Disease|13|||
129914389|NCT05171777|467648958|FG001|Treatment Crossover Period|Progressive Disease|9|||
129914390|NCT05171777|467648959|FG002|Treatment Crossover Period|Progressive Disease|0|||
129914391|NCT05171777|467648960|FG003|Treatment Crossover Period|Progressive Disease|0|||
129914392|NCT05171777|467648957|FG000|Treatment Crossover Period|Protocol Violation|0|||
129914393|NCT05171777|467648958|FG001|Treatment Crossover Period|Protocol Violation|2|||
129914394|NCT05171777|467648959|FG002|Treatment Crossover Period|Protocol Violation|0|||
129914395|NCT05171777|467648960|FG003|Treatment Crossover Period|Protocol Violation|0|||
129914396|NCT05171777|467648957|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
129914397|NCT05171777|467648958|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
129914398|NCT05171777|467648959|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
129914399|NCT05171777|467648960|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
129914400|NCT05171777|467648957|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
129914401|NCT05171777|467648958|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
129914402|NCT05171777|467648959|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
129914403|NCT05171777|467648960|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
129914404|NCT05171777|467648957|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
129914405|NCT05171777|467648958|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
129914406|NCT05171777|467648959|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
129914407|NCT05171777|467648960|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
129914408|NCT05171777|467648957|FG000|Treatment Continuation Period|Death|0|||
129864497|NCT00490646|467460020|FG001|Overall Study|Never Treated (withdrew consent)|1|||
129864498|NCT05608629|467460022|FG000|Overall Study|Lost to Follow-up|2|||
129864499|NCT01453595|467460023|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129864500|NCT01453595|467460024|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129864501|NCT01453595|467460025|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129864502|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
129864503|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
129864504|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
129864505|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
129864506|NCT00983073|467460026|FG000|Titration and Optimal Dose Period|Other reason|4|||
129864507|NCT00983073|467460026|FG000|Maintenance Period|Adverse Event|5|||
129864508|NCT00983073|467460026|FG000|Maintenance Period|Withdrawal by Subject|2|||
129864509|NCT00983073|467460026|FG000|Maintenance Period|Lack of Efficacy|2|||
129864510|NCT00983073|467460026|FG000|Maintenance Period|Other Reason|7|||
129864511|NCT02962908|467460029|FG000|Overall Study|Lost to Follow-up|0|||
129864512|NCT02962908|467460030|FG001|Overall Study|Lost to Follow-up|3|||
129864513|NCT02962908|467460031|FG002|Overall Study|Lost to Follow-up|0|||
129864514|NCT02962908|467460032|FG003|Overall Study|Lost to Follow-up|1|||
129864515|NCT02962908|467460029|FG000|Overall Study|Withdrawal by Subject|0|||
129864516|NCT02962908|467460030|FG001|Overall Study|Withdrawal by Subject|3|||
129864517|NCT02962908|467460031|FG002|Overall Study|Withdrawal by Subject|0|||
129864518|NCT02962908|467460032|FG003|Overall Study|Withdrawal by Subject|2|||
129864519|NCT02962908|467460029|FG000|Overall Study|Protocol Violation|0|||
129864520|NCT02962908|467460030|FG001|Overall Study|Protocol Violation|1|||
129864521|NCT02962908|467460031|FG002|Overall Study|Protocol Violation|0|||
129864522|NCT02962908|467460032|FG003|Overall Study|Protocol Violation|0|||
129864523|NCT02962908|467460029|FG000|Overall Study|Physician Decision|0|||
129864524|NCT02962908|467460030|FG001|Overall Study|Physician Decision|1|||
129864525|NCT02962908|467460031|FG002|Overall Study|Physician Decision|0|||
129864526|NCT02962908|467460032|FG003|Overall Study|Physician Decision|0|||
129864527|NCT01261338|467460033|FG000|Overall Study|Withdrawal by Subject|3|||
129864528|NCT01261338|467460034|FG001|Overall Study|Withdrawal by Subject|2|||
129864529|NCT02313428|467460035|FG000|Overall Study|Lost to Follow-up|1|||
129864530|NCT02313428|467460036|FG001|Overall Study|Lost to Follow-up|1|||
129864531|NCT05374421|467460037|FG000|Overall Study|Withdrawal by Subject|3|||
129864532|NCT05374421|467460038|FG001|Overall Study|Withdrawal by Subject|4|||
129864533|NCT02899728|467460039|FG000|Overall Study|Withdrawal by Subject|1|||
129864534|NCT02899728|467460040|FG001|Overall Study|Withdrawal by Subject|1|||
129864535|NCT05557942|467460041|FG000|Overall Study|Death|0|||
129864536|NCT05557942|467460042|FG001|Overall Study|Death|0|||
129864537|NCT05557942|467460043|FG002|Overall Study|Death|0|||
129864538|NCT05557942|467460044|FG003|Overall Study|Death|2|||
129864539|NCT05557942|467460045|FG004|Overall Study|Death|1|||
129864540|NCT05557942|467460046|FG005|Overall Study|Death|1|||
129864541|NCT05557942|467460041|FG000|Overall Study|Physician Decision|1|||
129864542|NCT05557942|467460042|FG001|Overall Study|Physician Decision|1|||
129864543|NCT05557942|467460043|FG002|Overall Study|Physician Decision|2|||
129864544|NCT05557942|467460044|FG003|Overall Study|Physician Decision|3|||
129864545|NCT05557942|467460045|FG004|Overall Study|Physician Decision|0|||
129864546|NCT05557942|467460046|FG005|Overall Study|Physician Decision|2|||
129864547|NCT05557942|467460041|FG000|Overall Study|Study terminated by sponsor|17|||
129864548|NCT05557942|467460042|FG001|Overall Study|Study terminated by sponsor|17|||
129864549|NCT05557942|467460043|FG002|Overall Study|Study terminated by sponsor|14|||
129864550|NCT05557942|467460044|FG003|Overall Study|Study terminated by sponsor|40|||
129864551|NCT05557942|467460045|FG004|Overall Study|Study terminated by sponsor|45|||
129864552|NCT05557942|467460046|FG005|Overall Study|Study terminated by sponsor|37|||
129864553|NCT05557942|467460041|FG000|Overall Study|Protocol Violation|0|||
129864554|NCT05557942|467460042|FG001|Overall Study|Protocol Violation|0|||
129864555|NCT05557942|467460043|FG002|Overall Study|Protocol Violation|0|||
129864556|NCT05557942|467460044|FG003|Overall Study|Protocol Violation|0|||
129864557|NCT05557942|467460045|FG004|Overall Study|Protocol Violation|0|||
129864558|NCT05557942|467460046|FG005|Overall Study|Protocol Violation|1|||
129864559|NCT05557942|467460041|FG000|Overall Study|Withdrawal by Subject|0|||
129864560|NCT05557942|467460042|FG001|Overall Study|Withdrawal by Subject|0|||
129864561|NCT05557942|467460043|FG002|Overall Study|Withdrawal by Subject|0|||
129864562|NCT05557942|467460044|FG003|Overall Study|Withdrawal by Subject|0|||
129864563|NCT05557942|467460045|FG004|Overall Study|Withdrawal by Subject|2|||
129864564|NCT05557942|467460046|FG005|Overall Study|Withdrawal by Subject|0|||
129864565|NCT02477618|467460047|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
129864566|NCT02477618|467460048|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
129864567|NCT02477618|467460047|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
129864568|NCT02477618|467460048|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
129864569|NCT02477618|467460047|FG000|Overall Study|Adverse Event|1|||
129864570|NCT02477618|467460048|FG001|Overall Study|Adverse Event|1|||
129864571|NCT02477618|467460047|FG000|Overall Study|Transferred Away from Study Site|1|||
129864572|NCT02477618|467460048|FG001|Overall Study|Transferred Away from Study Site|0|||
129864573|NCT02477618|467460047|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
129864574|NCT02477618|467460048|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
129864575|NCT00655980|467460052|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
129864576|NCT00655980|467460053|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
129864577|NCT00655980|467460054|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
129864578|NCT05540522|467460055|FG000|Overall Study|Adverse Event|1|||
129864579|NCT05540522|467460056|FG001|Overall Study|Adverse Event|0|||
129864580|NCT05540522|467460057|FG002|Overall Study|Adverse Event|2|||
129864581|NCT05540522|467460058|FG003|Overall Study|Adverse Event|5|||
129864582|NCT05540522|467460055|FG000|Overall Study|Lost to Follow-up|487|||
129864583|NCT05540522|467460056|FG001|Overall Study|Lost to Follow-up|427|||
129864584|NCT05540522|467460057|FG002|Overall Study|Lost to Follow-up|146|||
129864585|NCT05540522|467460058|FG003|Overall Study|Lost to Follow-up|166|||
129864586|NCT05540522|467460055|FG000|Overall Study|Physician Decision|11|||
129864587|NCT05540522|467460056|FG001|Overall Study|Physician Decision|19|||
129864588|NCT05540522|467460057|FG002|Overall Study|Physician Decision|8|||
129864589|NCT05540522|467460058|FG003|Overall Study|Physician Decision|13|||
129864590|NCT05540522|467460055|FG000|Overall Study|Pregnancy|1|||
129864591|NCT05540522|467460056|FG001|Overall Study|Pregnancy|0|||
129864592|NCT05540522|467460057|FG002|Overall Study|Pregnancy|0|||
129864593|NCT05540522|467460058|FG003|Overall Study|Pregnancy|0|||
129864594|NCT05540522|467460055|FG000|Overall Study|Protocol Violation|3|||
129864595|NCT05540522|467460056|FG001|Overall Study|Protocol Violation|1|||
129864596|NCT05540522|467460057|FG002|Overall Study|Protocol Violation|9|||
129864597|NCT05540522|467460058|FG003|Overall Study|Protocol Violation|7|||
129864598|NCT05540522|467460055|FG000|Overall Study|Withdrawal by Subject|168|||
129864599|NCT05540522|467460056|FG001|Overall Study|Withdrawal by Subject|134|||
129864600|NCT05540522|467460057|FG002|Overall Study|Withdrawal by Subject|331|||
129864601|NCT05540522|467460058|FG003|Overall Study|Withdrawal by Subject|322|||
129864602|NCT05540522|467460055|FG000|Overall Study|Death|7|||
129864603|NCT05540522|467460056|FG001|Overall Study|Death|9|||
129864604|NCT05540522|467460057|FG002|Overall Study|Death|49|||
129864605|NCT05540522|467460058|FG003|Overall Study|Death|46|||
129864606|NCT05540522|467460055|FG000|Overall Study|Not vaccinated|34|||
129864607|NCT05540522|467460056|FG001|Overall Study|Not vaccinated|53|||
129864608|NCT05540522|467460057|FG002|Overall Study|Not vaccinated|57|||
129864609|NCT05540522|467460058|FG003|Overall Study|Not vaccinated|50|||
129864610|NCT05540522|467460055|FG000|Overall Study|No longer meets eligibility criteria|0|||
129864611|NCT05540522|467460056|FG001|Overall Study|No longer meets eligibility criteria|0|||
129864612|NCT05540522|467460057|FG002|Overall Study|No longer meets eligibility criteria|3|||
129864613|NCT05540522|467460058|FG003|Overall Study|No longer meets eligibility criteria|2|||
129864614|NCT05540522|467460055|FG000|Overall Study|Other (Unspecified)|8|||
129864615|NCT05540522|467460056|FG001|Overall Study|Other (Unspecified)|10|||
129864616|NCT05540522|467460057|FG002|Overall Study|Other (Unspecified)|4|||
129864617|NCT05540522|467460058|FG003|Overall Study|Other (Unspecified)|2|||
129864618|NCT03754803|467460059|FG000|Overall Study|Withdrawal by Subject|2|||
129864619|NCT05239039|467460060|FG000|Overall Study|Withdrawal by Subject|0|||
129864620|NCT05239039|467460061|FG001|Overall Study|Withdrawal by Subject|1|||
129864621|NCT00936390|467460064|FG000|Overall Study|Protocol Violation|21|||
129864622|NCT00936390|467460065|FG001|Overall Study|Protocol Violation|25|||
129864623|NCT04348604|467460066|FG000|Week 8|Withdrawal by Subject|1|||
129864624|NCT04348604|467460067|FG001|Week 8|Withdrawal by Subject|1|||
129864625|NCT04348604|467460066|FG000|Week 8|Lost to Follow-up|1|||
129864626|NCT04348604|467460067|FG001|Week 8|Lost to Follow-up|2|||
129864627|NCT04348604|467460066|FG000|Week 8|Suspended|0|||
129864628|NCT04348604|467460067|FG001|Week 8|Suspended|1|||
129864629|NCT04348604|467460066|FG000|Week 12|Lost to Follow-up|1|||
129864630|NCT04348604|467460067|FG001|Week 12|Lost to Follow-up|2|||
129864631|NCT04348604|467460066|FG000|Week 12|Withdrawal by Subject|1|||
129864632|NCT04348604|467460067|FG001|Week 12|Withdrawal by Subject|0|||
129864633|NCT04348604|467460066|FG000|Week 24|Lost to Follow-up|2|||
129864634|NCT04348604|467460067|FG001|Week 24|Lost to Follow-up|1|||
129914409|NCT05171777|467648958|FG001|Treatment Continuation Period|Death|0|||
129914410|NCT05171777|467648959|FG002|Treatment Continuation Period|Death|1|||
129914411|NCT05171777|467648960|FG003|Treatment Continuation Period|Death|6|||
129914412|NCT05171777|467648957|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
129914413|NCT05171777|467648958|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
129914414|NCT05171777|467648959|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
129914415|NCT05171777|467648960|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
129914416|NCT00632749|467648961|FG000|Overall Study|Progressive disease|3|||
129914417|NCT00632749|467648962|FG001|Overall Study|Progressive disease|2|||
129914418|NCT00632749|467648963|FG002|Overall Study|Progressive disease|2|||
129914419|NCT00632749|467648964|FG003|Overall Study|Progressive disease|2|||
129914420|NCT00632749|467648965|FG004|Overall Study|Progressive disease|4|||
129914421|NCT00632749|467648966|FG005|Overall Study|Progressive disease|4|||
129914422|NCT00632749|467648967|FG006|Overall Study|Progressive disease|3|||
129914423|NCT00632749|467648968|FG007|Overall Study|Progressive disease|2|||
129914424|NCT00632749|467648969|FG008|Overall Study|Progressive disease|3|||
129914425|NCT00632749|467648970|FG009|Overall Study|Progressive disease|2|||
129914426|NCT00632749|467648971|FG010|Overall Study|Progressive disease|4|||
129914427|NCT00632749|467648972|FG011|Overall Study|Progressive disease|3|||
129914428|NCT00632749|467648973|FG012|Overall Study|Progressive disease|2|||
129914429|NCT00632749|467648974|FG013|Overall Study|Progressive disease|4|||
129914430|NCT00632749|467648961|FG000|Overall Study|Other Adverse event|1|||
129914431|NCT00632749|467648962|FG001|Overall Study|Other Adverse event|1|||
129914432|NCT00632749|467648963|FG002|Overall Study|Other Adverse event|1|||
129914433|NCT00632749|467648964|FG003|Overall Study|Other Adverse event|1|||
129914434|NCT00632749|467648965|FG004|Overall Study|Other Adverse event|2|||
129914435|NCT00632749|467648966|FG005|Overall Study|Other Adverse event|4|||
129914436|NCT00632749|467648967|FG006|Overall Study|Other Adverse event|1|||
129914437|NCT00632749|467648968|FG007|Overall Study|Other Adverse event|2|||
129914438|NCT00632749|467648969|FG008|Overall Study|Other Adverse event|2|||
129914439|NCT00632749|467648970|FG009|Overall Study|Other Adverse event|0|||
129914440|NCT00632749|467648971|FG010|Overall Study|Other Adverse event|1|||
129914441|NCT00632749|467648972|FG011|Overall Study|Other Adverse event|0|||
129914442|NCT00632749|467648973|FG012|Overall Study|Other Adverse event|1|||
129914443|NCT00632749|467648974|FG013|Overall Study|Other Adverse event|0|||
129914444|NCT00632749|467648961|FG000|Overall Study|Refuse to continue medication|0|||
129914445|NCT00632749|467648962|FG001|Overall Study|Refuse to continue medication|0|||
129914446|NCT00632749|467648963|FG002|Overall Study|Refuse to continue medication|0|||
129914447|NCT00632749|467648964|FG003|Overall Study|Refuse to continue medication|1|||
129914448|NCT00632749|467648965|FG004|Overall Study|Refuse to continue medication|0|||
129914449|NCT00632749|467648966|FG005|Overall Study|Refuse to continue medication|0|||
129914450|NCT00632749|467648967|FG006|Overall Study|Refuse to continue medication|0|||
129914451|NCT00632749|467648968|FG007|Overall Study|Refuse to continue medication|0|||
129914452|NCT00632749|467648969|FG008|Overall Study|Refuse to continue medication|0|||
129914453|NCT00632749|467648970|FG009|Overall Study|Refuse to continue medication|1|||
129914454|NCT00632749|467648971|FG010|Overall Study|Refuse to continue medication|0|||
129914455|NCT00632749|467648972|FG011|Overall Study|Refuse to continue medication|0|||
129914456|NCT00632749|467648973|FG012|Overall Study|Refuse to continue medication|0|||
129914457|NCT00632749|467648974|FG013|Overall Study|Refuse to continue medication|0|||
129914458|NCT00632749|467648961|FG000|Overall Study|Reason other than those specified above|0|||
129914459|NCT00632749|467648962|FG001|Overall Study|Reason other than those specified above|2|||
129914460|NCT00632749|467648963|FG002|Overall Study|Reason other than those specified above|0|||
129914461|NCT00632749|467648964|FG003|Overall Study|Reason other than those specified above|0|||
129914462|NCT00632749|467648965|FG004|Overall Study|Reason other than those specified above|1|||
129914463|NCT00632749|467648966|FG005|Overall Study|Reason other than those specified above|0|||
129914464|NCT00632749|467648967|FG006|Overall Study|Reason other than those specified above|1|||
129914465|NCT00632749|467648968|FG007|Overall Study|Reason other than those specified above|0|||
129914466|NCT00632749|467648969|FG008|Overall Study|Reason other than those specified above|0|||
129914467|NCT00632749|467648970|FG009|Overall Study|Reason other than those specified above|0|||
129914468|NCT00632749|467648971|FG010|Overall Study|Reason other than those specified above|2|||
129914469|NCT00632749|467648972|FG011|Overall Study|Reason other than those specified above|1|||
129914470|NCT00632749|467648973|FG012|Overall Study|Reason other than those specified above|0|||
129914471|NCT00632749|467648974|FG013|Overall Study|Reason other than those specified above|2|||
129914472|NCT01136876|467648975|FG000|Overall Study|Lost to Follow-up|0|||
129914473|NCT01136876|467648976|FG001|Overall Study|Lost to Follow-up|1|||
129914474|NCT01136876|467648975|FG000|Overall Study|Physician Decision|3|||
129914475|NCT01136876|467648976|FG001|Overall Study|Physician Decision|5|||
129914476|NCT01136876|467648975|FG000|Overall Study|Missing NGAL measurement|2|||
129914477|NCT01136876|467648976|FG001|Overall Study|Missing NGAL measurement|5|||
129914478|NCT04128319|467648979|FG000|Overall Study|Death|3|||
129914479|NCT00976937|467648982|FG000|Overall Study|Adverse Event|4|||
129914480|NCT00976937|467648983|FG001|Overall Study|Adverse Event|5|||
129914481|NCT00976937|467648982|FG000|Overall Study|Lost to Follow-up|2|||
129914482|NCT00976937|467648983|FG001|Overall Study|Lost to Follow-up|1|||
129864635|NCT02097108|467460068|FG000|Overall Study|Adverse Event|1|||
129864636|NCT02097108|467460068|FG000|Overall Study|patient was abroad for 6 months|1|||
129864637|NCT05245864|467460069|FG000|Overall Study|Withdrawal by Subject|1|||
129864638|NCT05245864|467460070|FG001|Overall Study|Withdrawal by Subject|1|||
129864639|NCT01329029|467460071|FG000|Overall Study|Withdrawal by Subject|117|||
129864640|NCT01329029|467460072|FG001|Overall Study|Withdrawal by Subject|87|||
129864641|NCT01329029|467460071|FG000|Overall Study|Adverse Event|82|||
129864642|NCT01329029|467460072|FG001|Overall Study|Adverse Event|29|||
129864643|NCT01329029|467460071|FG000|Overall Study|Death|16|||
129864644|NCT01329029|467460072|FG001|Overall Study|Death|19|||
129864645|NCT01329029|467460071|FG000|Overall Study|Other|14|||
129864646|NCT01329029|467460072|FG001|Overall Study|Other|20|||
129864647|NCT01329029|467460071|FG000|Overall Study|COPD Exacerbation|11|||
129864648|NCT01329029|467460072|FG001|Overall Study|COPD Exacerbation|18|||
129864649|NCT01329029|467460071|FG000|Overall Study|Physician Decision|16|||
129864650|NCT01329029|467460072|FG001|Overall Study|Physician Decision|13|||
129864651|NCT01329029|467460071|FG000|Overall Study|Lost to Follow-up|8|||
129864652|NCT01329029|467460072|FG001|Overall Study|Lost to Follow-up|5|||
129864653|NCT01329029|467460071|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
129864654|NCT01329029|467460072|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
129864655|NCT02119260|467462403|FG000|Overall Study|Adverse Event|1|||
129864656|NCT02119260|467462404|FG001|Overall Study|Adverse Event|0|||
129864657|NCT02119260|467462405|FG002|Overall Study|Adverse Event|0|||
129864658|NCT02119260|467462406|FG003|Overall Study|Adverse Event|0|||
129864659|NCT02119260|467462407|FG004|Overall Study|Adverse Event|0|||
129864660|NCT02119260|467462408|FG005|Overall Study|Adverse Event|0|||
129864661|NCT02119260|467462409|FG006|Overall Study|Adverse Event|0|||
129864662|NCT02119260|467462403|FG000|Overall Study|Withdrew consent|0|||
129864663|NCT02119260|467462404|FG001|Overall Study|Withdrew consent|1|||
129864664|NCT02119260|467462405|FG002|Overall Study|Withdrew consent|1|||
129864665|NCT02119260|467462406|FG003|Overall Study|Withdrew consent|0|||
129864666|NCT02119260|467462407|FG004|Overall Study|Withdrew consent|0|||
129864667|NCT02119260|467462408|FG005|Overall Study|Withdrew consent|0|||
129864668|NCT02119260|467462409|FG006|Overall Study|Withdrew consent|0|||
129864669|NCT00844857|467462410|FG000|Overall Study|Adverse Event|24|||
129864670|NCT00844857|467462411|FG001|Overall Study|Adverse Event|5|||
129864671|NCT00844857|467462410|FG000|Overall Study|Sponsor Decision|1|||
129864672|NCT00844857|467462411|FG001|Overall Study|Sponsor Decision|1|||
129864673|NCT00844857|467462410|FG000|Overall Study|Physician Decision|2|||
129864674|NCT00844857|467462411|FG001|Overall Study|Physician Decision|0|||
129864675|NCT00844857|467462410|FG000|Overall Study|Parent/Caregiver Decision|6|||
129864676|NCT00844857|467462411|FG001|Overall Study|Parent/Caregiver Decision|2|||
129864677|NCT00844857|467462410|FG000|Overall Study|Withdrawal by Subject|8|||
129864678|NCT00844857|467462411|FG001|Overall Study|Withdrawal by Subject|7|||
129864679|NCT00844857|467462410|FG000|Overall Study|Protocol Violation|6|||
129864680|NCT00844857|467462411|FG001|Overall Study|Protocol Violation|0|||
129864681|NCT00844857|467462410|FG000|Overall Study|Lack of Efficacy|5|||
129864682|NCT00844857|467462411|FG001|Overall Study|Lack of Efficacy|5|||
129864683|NCT00844857|467462410|FG000|Overall Study|Clinical Relapse|0|||
129864684|NCT00844857|467462411|FG001|Overall Study|Clinical Relapse|1|||
129864685|NCT00844857|467462410|FG000|Overall Study|Entry Criteria Not Met|0|||
129864686|NCT00844857|467462411|FG001|Overall Study|Entry Criteria Not Met|1|||
129864687|NCT00844857|467462410|FG000|Overall Study|Lost to Follow-up|2|||
129864688|NCT00844857|467462411|FG001|Overall Study|Lost to Follow-up|3|||
129864689|NCT00844857|467462410|FG000|Overall Study|Did Not Take Study Drug|3|||
129864690|NCT00844857|467462411|FG001|Overall Study|Did Not Take Study Drug|1|||
129864691|NCT00844857|467462410|FG000|Overall Study|Good Clinical Practice Violations|21|||
129864692|NCT00844857|467462411|FG001|Overall Study|Good Clinical Practice Violations|11|||
129864693|NCT02057874|467462412|FG000|Overall Study|participant did not return for scan|1|||
129864694|NCT01738984|467462413|FG000|Overall Study|Pregnancy|4|||
129864695|NCT01738984|467462414|FG001|Overall Study|Pregnancy|0|||
129864696|NCT01738984|467462413|FG000|Overall Study|Withdrawal by Subject|1|||
129864697|NCT01738984|467462414|FG001|Overall Study|Withdrawal by Subject|0|||
129864698|NCT01738984|467462413|FG000|Overall Study|Lost to Follow-up|59|||
129864699|NCT01738984|467462414|FG001|Overall Study|Lost to Follow-up|39|||
129864700|NCT00857207|467462418|FG000|Overall Study|Withdrawal by Subject|13|||
129864701|NCT00857207|467462419|FG001|Overall Study|Withdrawal by Subject|0|||
129864702|NCT00857207|467462418|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
129864703|NCT00857207|467462419|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
129864704|NCT00857207|467462418|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
129864705|NCT00857207|467462419|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
129864706|NCT01258608|467462420|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
129864707|NCT01258608|467462421|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
129864708|NCT01258608|467462420|FG000|Overall Study|Clinical progression|1|||
129864709|NCT01258608|467462421|FG001|Overall Study|Clinical progression|0|||
129864710|NCT01258608|467462420|FG000|Overall Study|Sponsor decision|0|||
129864711|NCT01258608|467462421|FG001|Overall Study|Sponsor decision|1|||
129914483|NCT00976937|467648982|FG000|Overall Study|Withdrawal by Subject|5|||
129914484|NCT00976937|467648983|FG001|Overall Study|Withdrawal by Subject|3|||
129914485|NCT00976937|467648982|FG000|Overall Study|Poor compliance to protocol|3|||
129914486|NCT00976937|467648983|FG001|Overall Study|Poor compliance to protocol|0|||
129914487|NCT00976937|467648982|FG000|Overall Study|Personal and Familial Reason|2|||
129914488|NCT00976937|467648983|FG001|Overall Study|Personal and Familial Reason|2|||
129914489|NCT01011946|467648984|FG000|Overall Study|Transferred to another hospital|2|||
129914490|NCT01011946|467648984|FG000|Overall Study|No pathological lab value|1|||
129914491|NCT03988842|467648985|FG000|Overall Study|Death|1|||
129914492|NCT00709098|467648988|FG000|Double-blind Period|Withdrawal of consent|3|||
129914493|NCT00709098|467648989|FG001|Double-blind Period|Withdrawal of consent|3|||
129914494|NCT00709098|467648990|FG002|Double-blind Period|Withdrawal of consent|0|||
129914495|NCT00709098|467648988|FG000|Double-blind Period|Administrative reason|1|||
129914496|NCT00709098|467648989|FG001|Double-blind Period|Administrative reason|3|||
129914497|NCT00709098|467648990|FG002|Double-blind Period|Administrative reason|0|||
129914498|NCT00709098|467648988|FG000|Double-blind Period|Death|1|||
129914499|NCT00709098|467648989|FG001|Double-blind Period|Death|1|||
129914500|NCT00709098|467648990|FG002|Double-blind Period|Death|0|||
129914501|NCT00709098|467648988|FG000|Double-blind Period|Lost to Follow-up|1|||
129914502|NCT00709098|467648989|FG001|Double-blind Period|Lost to Follow-up|1|||
129914503|NCT00709098|467648990|FG002|Double-blind Period|Lost to Follow-up|0|||
129914504|NCT00709098|467648988|FG000|Open-label Period|Withdrawal of consent|0|||
129914505|NCT00709098|467648989|FG001|Open-label Period|Withdrawal of consent|0|||
129914506|NCT00709098|467648990|FG002|Open-label Period|Withdrawal of consent|7|||
129914507|NCT00709098|467648988|FG000|Open-label Period|Administrative reason|0|||
129914508|NCT00709098|467648989|FG001|Open-label Period|Administrative reason|0|||
129914509|NCT00709098|467648990|FG002|Open-label Period|Administrative reason|5|||
129914510|NCT00709098|467648988|FG000|Open-label Period|Death|0|||
129914511|NCT00709098|467648989|FG001|Open-label Period|Death|0|||
129914512|NCT00709098|467648990|FG002|Open-label Period|Death|1|||
129914513|NCT00709098|467648988|FG000|Open-label Period|Lost to Follow-up|0|||
129914514|NCT00709098|467648989|FG001|Open-label Period|Lost to Follow-up|0|||
129914515|NCT00709098|467648990|FG002|Open-label Period|Lost to Follow-up|1|||
129914516|NCT01227265|467648992|FG000|Overall Study|Did Not Receive Treatment|1|||
129914517|NCT01227265|467648993|FG001|Overall Study|Did Not Receive Treatment|2|||
129914518|NCT01227265|467648994|FG002|Overall Study|Did Not Receive Treatment|0|||
129914519|NCT01227265|467648992|FG000|Overall Study|Administrative|1|||
129914520|NCT01227265|467648993|FG001|Overall Study|Administrative|0|||
129914521|NCT01227265|467648994|FG002|Overall Study|Administrative|2|||
129914522|NCT01227265|467648992|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
129914523|NCT01227265|467648993|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
129914524|NCT01227265|467648994|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
129914525|NCT01227265|467648992|FG000|Overall Study|Protocol Violation|2|||
129914526|NCT01227265|467648993|FG001|Overall Study|Protocol Violation|1|||
129914527|NCT01227265|467648994|FG002|Overall Study|Protocol Violation|0|||
129914528|NCT01227265|467648992|FG000|Overall Study|Withdrawal by Subject|7|||
129914529|NCT01227265|467648993|FG001|Overall Study|Withdrawal by Subject|7|||
129914530|NCT01227265|467648994|FG002|Overall Study|Withdrawal by Subject|3|||
129914531|NCT01227265|467648992|FG000|Overall Study|Lost to Follow-up|2|||
129914532|NCT01227265|467648993|FG001|Overall Study|Lost to Follow-up|0|||
129914533|NCT01227265|467648994|FG002|Overall Study|Lost to Follow-up|3|||
129914534|NCT01227265|467648992|FG000|Overall Study|Adverse Event|6|||
129914535|NCT01227265|467648993|FG001|Overall Study|Adverse Event|10|||
129914536|NCT01227265|467648994|FG002|Overall Study|Adverse Event|5|||
129914537|NCT03582722|467649000|FG000|Overall Study|Lost to Follow-up|1|||
129914538|NCT03582722|467649001|FG001|Overall Study|Lost to Follow-up|4|||
129914539|NCT03582722|467649000|FG000|Overall Study|Withdrawal by Subject|3|||
129914540|NCT03582722|467649001|FG001|Overall Study|Withdrawal by Subject|3|||
129914541|NCT03690206|467649002|FG000|Overall Study|Withdrawal by Subject|2|||
129914542|NCT03690206|467649003|FG001|Overall Study|Withdrawal by Subject|0|||
129914543|NCT03690206|467649004|FG002|Overall Study|Withdrawal by Subject|0|||
129914544|NCT03690206|467649002|FG000|Overall Study|ICF withdrawal|2|||
129914545|NCT03690206|467649003|FG001|Overall Study|ICF withdrawal|0|||
129914546|NCT03690206|467649004|FG002|Overall Study|ICF withdrawal|0|||
129914547|NCT06024174|467649005|FG000|Overall Study|Other Reasons|1|||
129914548|NCT06024174|467649005|FG000|Overall Study|Study terminated by Sponsor|4|||
129914549|NCT05028582|467649006|FG000|Overall Study|Lost to Follow-up|11|||
129914550|NCT05028582|467649007|FG001|Overall Study|Lost to Follow-up|9|||
129914551|NCT05028582|467649006|FG000|Overall Study|Withdrawal by Subject|9|||
129914552|NCT05028582|467649007|FG001|Overall Study|Withdrawal by Subject|10|||
129914553|NCT05028582|467649006|FG000|Overall Study|Adverse Event|5|||
129914554|NCT05028582|467649007|FG001|Overall Study|Adverse Event|2|||
129914555|NCT05028582|467649006|FG000|Overall Study|Miscellaneous|3|||
129914556|NCT05028582|467649007|FG001|Overall Study|Miscellaneous|2|||
129914557|NCT05028582|467649006|FG000|Overall Study|Lack of Efficacy|3|||
129914558|NCT05028582|467649007|FG001|Overall Study|Lack of Efficacy|1|||
129914559|NCT05028582|467649006|FG000|Overall Study|Physician Decision|0|||
129914560|NCT05028582|467649007|FG001|Overall Study|Physician Decision|1|||
129914561|NCT01959698|467649008|FG000|Overall Study|Adverse Event|0|||
129914562|NCT01959698|467649009|FG001|Overall Study|Adverse Event|0|||
129914563|NCT01959698|467649010|FG002|Overall Study|Adverse Event|0|||
129914564|NCT01959698|467649011|FG003|Overall Study|Adverse Event|0|||
129914565|NCT01959698|467649012|FG004|Overall Study|Adverse Event|0|||
129914566|NCT01959698|467649013|FG005|Overall Study|Adverse Event|0|||
129914567|NCT01959698|467649014|FG006|Overall Study|Adverse Event|1|||
129914568|NCT01959698|467649008|FG000|Overall Study|Physician Decision|1|||
129914569|NCT01959698|467649009|FG001|Overall Study|Physician Decision|0|||
129914570|NCT01959698|467649010|FG002|Overall Study|Physician Decision|1|||
129449733|NCT02790138|465945668|FG000|Overall Study|Reason not Specified|1|||
129449734|NCT02790138|465945669|FG001|Overall Study|Reason not Specified|0|||
129449735|NCT01786603|465945670|FG000|Overall Study|Death|5|||
129449736|NCT01786603|465945671|FG001|Overall Study|Death|1|||
129449737|NCT01786603|465945670|FG000|Overall Study|Adverse Event|6|||
129864712|NCT01258608|467462420|FG000|Overall Study|Physician Decision|6|||
129864713|NCT01258608|467462421|FG001|Overall Study|Physician Decision|1|||
129914571|NCT01959698|467649011|FG003|Overall Study|Physician Decision|2|||
129914572|NCT01959698|467649012|FG004|Overall Study|Physician Decision|0|||
129914573|NCT01959698|467649013|FG005|Overall Study|Physician Decision|3|||
129914574|NCT01959698|467649014|FG006|Overall Study|Physician Decision|3|||
129914575|NCT03744312|467651320|FG000|Overall Study|Withdrawal by Subject|0|||
129914576|NCT03744312|467651321|FG001|Overall Study|Withdrawal by Subject|1|||
129914577|NCT03744312|467651320|FG000|Overall Study|Screen fail|0|||
129914578|NCT03744312|467651321|FG001|Overall Study|Screen fail|1|||
129914579|NCT03012841|467651322|FG000|Overall Study|Protocol Violation|0|||
129914580|NCT03012841|467651323|FG001|Overall Study|Protocol Violation|10|||
129864714|NCT01258608|467462420|FG000|Overall Study|Lost to Follow-up|0|||
129864715|NCT01258608|467462421|FG001|Overall Study|Lost to Follow-up|1|||
129864716|NCT01258608|467462420|FG000|Overall Study|Lack of compliance|1|||
129864717|NCT01258608|467462421|FG001|Overall Study|Lack of compliance|0|||
129864718|NCT01258608|467462420|FG000|Overall Study|Lack of Efficacy|0|||
129864719|NCT01258608|467462421|FG001|Overall Study|Lack of Efficacy|1|||
129864720|NCT01258608|467462420|FG000|Overall Study|Adverse Event|6|||
129864721|NCT01258608|467462421|FG001|Overall Study|Adverse Event|10|||
129864722|NCT01258608|467462420|FG000|Overall Study|Withdrawal by Subject|6|||
129864723|NCT01258608|467462421|FG001|Overall Study|Withdrawal by Subject|5|||
129864724|NCT02943408|467462423|FG000|Overall Study|Lost to Follow-up|7|||
129864725|NCT02943408|467462424|FG001|Overall Study|Lost to Follow-up|1|||
129864726|NCT02943408|467462423|FG000|Overall Study|Withdrawal by Subject|0|||
129864727|NCT02943408|467462424|FG001|Overall Study|Withdrawal by Subject|1|||
129864728|NCT01621126|467462427|FG000|Overall Study|Physician Decision|6|||
129864729|NCT00886340|467462429|FG000|Overall Study|Withdrawal by Subject|0|||
129864730|NCT00886340|467462430|FG001|Overall Study|Withdrawal by Subject|7|||
129864731|NCT01949311|467462431|FG000|Overall Study|Lost to Follow-up|73|||
129864732|NCT01949311|467462431|FG000|Overall Study|Terminated by Sponsor|708|||
129864733|NCT01949311|467462431|FG000|Overall Study|Withdrawal by Subject|375|||
129864734|NCT01949311|467462431|FG000|Overall Study|Lack of Efficacy|50|||
129864735|NCT01949311|467462431|FG000|Overall Study|Protocol Deviation|34|||
129864736|NCT01949311|467462431|FG000|Overall Study|Pregnancy|20|||
129864737|NCT01949311|467462431|FG000|Overall Study|Physician Decision|9|||
129864738|NCT01949311|467462431|FG000|Overall Study|Other|4|||
129864739|NCT01949311|467462431|FG000|Overall Study|Adverse Event|107|||
129864740|NCT02338154|467462432|FG000|Overall Study|Death|46|||
129864741|NCT02338154|467462432|FG000|Overall Study|Valve Implant Failure|17|||
129864742|NCT02338154|467462432|FG000|Overall Study|Valve Explant|11|||
129864743|NCT02338154|467462432|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
129864744|NCT02338154|467462432|FG000|Overall Study|Lost to Follow-up|8|||
129864745|NCT02338154|467462432|FG000|Overall Study|Other Reason|3|||
129914581|NCT03012841|467651322|FG000|Overall Study|Lost to Follow-up|6|||
129914582|NCT03012841|467651323|FG001|Overall Study|Lost to Follow-up|1|||
129914583|NCT03012841|467651322|FG000|Overall Study|Withdrawal by Subject|6|||
129914584|NCT03012841|467651323|FG001|Overall Study|Withdrawal by Subject|0|||
129914585|NCT03012841|467651322|FG000|Overall Study|Unable to complete 12 month visit|6|||
129914586|NCT03012841|467651323|FG001|Overall Study|Unable to complete 12 month visit|0|||
129449738|NCT01786603|465945671|FG001|Overall Study|Adverse Event|2|||
129864746|NCT02338154|467462432|FG000|Overall Study|Patients Without Exit Form|47|||
129864747|NCT02338154|467462432|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
129864748|NCT02120027|467462435|FG000|Overall Study|Adverse Event|4|||
129864749|NCT02120027|467462436|FG001|Overall Study|Adverse Event|5|||
129914587|NCT03012841|467651322|FG000|Overall Study|Subject relocation|1|||
129914588|NCT03012841|467651323|FG001|Overall Study|Subject relocation|0|||
129449739|NCT01786603|465945670|FG000|Overall Study|Physician decision to withdraw|6|||
129864750|NCT02120027|467462435|FG000|Overall Study|Lack of Efficacy|3|||
129864751|NCT02120027|467462436|FG001|Overall Study|Lack of Efficacy|5|||
129864752|NCT02120027|467462435|FG000|Overall Study|Lost to Follow-up|5|||
129864753|NCT02120027|467462436|FG001|Overall Study|Lost to Follow-up|13|||
129864754|NCT02120027|467462435|FG000|Overall Study|Other|4|||
129914589|NCT03012841|467651322|FG000|Overall Study|Seasonal winter travel|1|||
129914590|NCT03012841|467651323|FG001|Overall Study|Seasonal winter travel|0|||
129914591|NCT03012841|467651322|FG000|Overall Study|Physician Decision|0|||
129914592|NCT03012841|467651323|FG001|Overall Study|Physician Decision|2|||
129914593|NCT03012841|467651322|FG000|Overall Study|No ablation performed|0|||
129864755|NCT02120027|467462436|FG001|Overall Study|Other|0|||
129914594|NCT03012841|467651323|FG001|Overall Study|No ablation performed|2|||
129914595|NCT03012841|467651322|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
129914596|NCT03012841|467651323|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
129914597|NCT03012841|467651322|FG000|Overall Study|Insurance change|0|||
129914598|NCT03012841|467651323|FG001|Overall Study|Insurance change|1|||
129914599|NCT03416023|467651334|FG000|Overall Study|Exclusion criteria failure|1|||
129914600|NCT03416023|467651334|FG000|Overall Study|Withdrawal by Subject|6|||
129914601|NCT03416023|467651334|FG000|Overall Study|Explanted|7|||
129914602|NCT03416023|467651334|FG000|Overall Study|Physician Decision|1|||
129914603|NCT03416023|467651334|FG000|Overall Study|Lost to Follow-up|1|||
129914604|NCT03416023|467651334|FG000|Overall Study|Death|1|||
129914605|NCT04878354|467651335|FG000|Overall Study|Adverse Event|4|||
129914606|NCT04878354|467651336|FG001|Overall Study|Adverse Event|13|||
129914607|NCT04878354|467651335|FG000|Overall Study|Withdrawal by Subject|14|||
129914608|NCT04878354|467651336|FG001|Overall Study|Withdrawal by Subject|12|||
129914609|NCT04878354|467651335|FG000|Overall Study|Lost to Follow-up|4|||
129914610|NCT04878354|467651336|FG001|Overall Study|Lost to Follow-up|1|||
129914611|NCT04878354|467651335|FG000|Overall Study|Lack of Efficacy|1|||
129914612|NCT04878354|467651336|FG001|Overall Study|Lack of Efficacy|0|||
129914613|NCT04878354|467651335|FG000|Overall Study|Protocol Violation|0|||
129914614|NCT04878354|467651336|FG001|Overall Study|Protocol Violation|1|||
129914615|NCT04878354|467651335|FG000|Overall Study|"Reason stated as other in CRF"|2|||
129914616|NCT04878354|467651336|FG001|Overall Study|"Reason stated as other in CRF"|3|||
129914617|NCT05510232|467651337|FG000|Overall Study|Withdrawal by Subject|2|||
129914618|NCT05510232|467651338|FG001|Overall Study|Withdrawal by Subject|7|||
129914619|NCT05510232|467651339|FG002|Overall Study|Withdrawal by Subject|6|||
129914620|NCT04855760|467651341|FG000|Overall Study|Adverse Event|21|||
129914621|NCT04855760|467651341|FG000|Overall Study|Withdrawal by Subject|116|||
129914622|NCT04855760|467651341|FG000|Overall Study|Lack of Efficacy|21|||
129914623|NCT04855760|467651341|FG000|Overall Study|Lost to Follow-up|49|||
129864756|NCT02120027|467462435|FG000|Overall Study|Physician Decision|4|||
129864757|NCT02120027|467462436|FG001|Overall Study|Physician Decision|3|||
129864758|NCT02120027|467462435|FG000|Overall Study|Protocol Violation|18|||
129864759|NCT02120027|467462436|FG001|Overall Study|Protocol Violation|21|||
129864760|NCT02120027|467462435|FG000|Overall Study|Study terminated by Sponsor|45|||
129864761|NCT02120027|467462436|FG001|Overall Study|Study terminated by Sponsor|47|||
129864762|NCT02120027|467462435|FG000|Overall Study|Withdrawal by Subject|33|||
129864763|NCT02120027|467462436|FG001|Overall Study|Withdrawal by Subject|25|||
129864764|NCT00447057|467462442|FG000|Overall Study|Adverse Event|4|||
129864765|NCT00447057|467462443|FG001|Overall Study|Adverse Event|10|||
129864766|NCT00447057|467462444|FG002|Overall Study|Adverse Event|0|||
129864767|NCT00447057|467462445|FG003|Overall Study|Adverse Event|3|||
129864768|NCT00447057|467462442|FG000|Overall Study|Death due to study disease|6|||
129864769|NCT00447057|467462443|FG001|Overall Study|Death due to study disease|4|||
129864770|NCT00447057|467462444|FG002|Overall Study|Death due to study disease|1|||
129864771|NCT00447057|467462445|FG003|Overall Study|Death due to study disease|1|||
129864772|NCT00447057|467462442|FG000|Overall Study|Lost to Follow-up|0|||
129864773|NCT00447057|467462443|FG001|Overall Study|Lost to Follow-up|1|||
129864774|NCT00447057|467462444|FG002|Overall Study|Lost to Follow-up|0|||
129864775|NCT00447057|467462445|FG003|Overall Study|Lost to Follow-up|0|||
129864776|NCT00447057|467462442|FG000|Overall Study|Entry criteria not met|1|||
129864777|NCT00447057|467462443|FG001|Overall Study|Entry criteria not met|1|||
129864778|NCT00447057|467462444|FG002|Overall Study|Entry criteria not met|0|||
129864779|NCT00447057|467462445|FG003|Overall Study|Entry criteria not met|0|||
129864780|NCT00447057|467462442|FG000|Overall Study|Protocol Violation|0|||
129864781|NCT00447057|467462443|FG001|Overall Study|Protocol Violation|1|||
129864782|NCT00447057|467462444|FG002|Overall Study|Protocol Violation|0|||
129864783|NCT00447057|467462445|FG003|Overall Study|Protocol Violation|0|||
129864784|NCT00447057|467462442|FG000|Overall Study|Withdrawal by Subject|4|||
129864785|NCT00447057|467462443|FG001|Overall Study|Withdrawal by Subject|5|||
129864786|NCT00447057|467462444|FG002|Overall Study|Withdrawal by Subject|1|||
129864787|NCT00447057|467462445|FG003|Overall Study|Withdrawal by Subject|1|||
129864788|NCT00447057|467462442|FG000|Overall Study|Physician Decision|9|||
129864789|NCT00447057|467462443|FG001|Overall Study|Physician Decision|6|||
129864790|NCT00447057|467462444|FG002|Overall Study|Physician Decision|3|||
129864791|NCT00447057|467462445|FG003|Overall Study|Physician Decision|1|||
129864792|NCT00447057|467462442|FG000|Overall Study|Sponsor decision|1|||
129864793|NCT00447057|467462443|FG001|Overall Study|Sponsor decision|1|||
129864794|NCT00447057|467462444|FG002|Overall Study|Sponsor decision|0|||
129864795|NCT00447057|467462445|FG003|Overall Study|Sponsor decision|0|||
129864796|NCT00447057|467462442|FG000|Overall Study|Progressive disease|58|||
129864797|NCT00447057|467462443|FG001|Overall Study|Progressive disease|43|||
129864798|NCT00447057|467462444|FG002|Overall Study|Progressive disease|13|||
129864799|NCT00447057|467462445|FG003|Overall Study|Progressive disease|18|||
129864800|NCT00447057|467462442|FG000|Overall Study|Death due to adverse event|0|||
129864801|NCT00447057|467462443|FG001|Overall Study|Death due to adverse event|0|||
129864802|NCT00447057|467462444|FG002|Overall Study|Death due to adverse event|1|||
129864803|NCT00447057|467462445|FG003|Overall Study|Death due to adverse event|2|||
129864804|NCT00447057|467462442|FG000|Overall Study|Death, study drug related|0|||
129864805|NCT00447057|467462443|FG001|Overall Study|Death, study drug related|1|||
129864806|NCT00447057|467462444|FG002|Overall Study|Death, study drug related|0|||
129864807|NCT00447057|467462445|FG003|Overall Study|Death, study drug related|0|||
129864808|NCT00440531|467462446|FG000|Overall Study|Adverse Event|1|||
129864809|NCT00440531|467462447|FG001|Overall Study|Adverse Event|0|||
129864810|NCT00440531|467462448|FG002|Overall Study|Adverse Event|2|||
129864811|NCT00440531|467462446|FG000|Overall Study|Withdrawal by Subject|2|||
129864812|NCT00440531|467462447|FG001|Overall Study|Withdrawal by Subject|0|||
129864813|NCT00440531|467462448|FG002|Overall Study|Withdrawal by Subject|0|||
129864814|NCT00440531|467462446|FG000|Overall Study|Protocol Violation|1|||
129864815|NCT00440531|467462447|FG001|Overall Study|Protocol Violation|2|||
129864816|NCT00440531|467462448|FG002|Overall Study|Protocol Violation|0|||
129864817|NCT00440531|467462446|FG000|Overall Study|Lost to Follow-up|4|||
129864818|NCT00440531|467462447|FG001|Overall Study|Lost to Follow-up|3|||
129864819|NCT00440531|467462448|FG002|Overall Study|Lost to Follow-up|5|||
129864820|NCT00440531|467462446|FG000|Overall Study|see pre-assignment details|2|||
129864821|NCT00440531|467462447|FG001|Overall Study|see pre-assignment details|0|||
129864822|NCT00440531|467462448|FG002|Overall Study|see pre-assignment details|0|||
129864823|NCT01471054|467462452|FG000|Overall Study|Study terminated prematurely|4|||
129864824|NCT01471054|467462453|FG001|Overall Study|Study terminated prematurely|0|||
129864825|NCT01843192|467462454|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
129864826|NCT01843192|467462455|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
129864827|NCT01843192|467462456|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
129864828|NCT04493216|467462457|FG000|Overall Study|Study terminated by sponsor|30|||
129864829|NCT04493216|467462458|FG001|Overall Study|Study terminated by sponsor|33|||
129864830|NCT04493216|467462459|FG002|Overall Study|Study terminated by sponsor|28|||
129864831|NCT04493216|467462460|FG003|Overall Study|Study terminated by sponsor|27|||
129864832|NCT04493216|467462457|FG000|Overall Study|Withdrawal by Subject|2|||
129864833|NCT04493216|467462458|FG001|Overall Study|Withdrawal by Subject|1|||
129864834|NCT04493216|467462459|FG002|Overall Study|Withdrawal by Subject|1|||
129864835|NCT04493216|467462460|FG003|Overall Study|Withdrawal by Subject|2|||
129864836|NCT04493216|467462457|FG000|Overall Study|Protocol Violation|1|||
129864837|NCT04493216|467462458|FG001|Overall Study|Protocol Violation|2|||
129864838|NCT04493216|467462459|FG002|Overall Study|Protocol Violation|0|||
129864839|NCT04493216|467462460|FG003|Overall Study|Protocol Violation|2|||
129864840|NCT04493216|467462457|FG000|Overall Study|Physician Decision|0|||
129864841|NCT04493216|467462458|FG001|Overall Study|Physician Decision|0|||
129864842|NCT04493216|467462459|FG002|Overall Study|Physician Decision|1|||
129864843|NCT04493216|467462460|FG003|Overall Study|Physician Decision|0|||
129864844|NCT04493216|467462457|FG000|Overall Study|Lost to Follow-up|2|||
129864845|NCT04493216|467462458|FG001|Overall Study|Lost to Follow-up|1|||
129864846|NCT04493216|467462459|FG002|Overall Study|Lost to Follow-up|0|||
129864847|NCT04493216|467462460|FG003|Overall Study|Lost to Follow-up|1|||
129864848|NCT04493216|467462457|FG000|Overall Study|Adverse Event|1|||
129864849|NCT04493216|467462458|FG001|Overall Study|Adverse Event|4|||
129864850|NCT04493216|467462459|FG002|Overall Study|Adverse Event|5|||
129864851|NCT04493216|467462460|FG003|Overall Study|Adverse Event|2|||
129864852|NCT04493216|467462457|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
129864853|NCT04493216|467462458|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
129864854|NCT04493216|467462459|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
129864855|NCT04493216|467462460|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
129864856|NCT02181803|467462463|FG000|Overall Study|Withdrawal by Subject|0|||
129864857|NCT02181803|467462464|FG001|Overall Study|Withdrawal by Subject|2|||
129864858|NCT02181803|467462465|FG002|Overall Study|Withdrawal by Subject|0|||
129864859|NCT02181803|467462466|FG003|Overall Study|Withdrawal by Subject|0|||
129864860|NCT02181803|467462467|FG004|Overall Study|Withdrawal by Subject|0|||
129864861|NCT02181803|467462468|FG005|Overall Study|Withdrawal by Subject|0|||
129864862|NCT02181803|467462469|FG006|Overall Study|Withdrawal by Subject|0|||
129864863|NCT02181803|467462470|FG007|Overall Study|Withdrawal by Subject|0|||
129864864|NCT02181803|467462471|FG008|Overall Study|Withdrawal by Subject|0|||
129864865|NCT02181803|467462463|FG000|Overall Study|Physician Decision|0|||
129864866|NCT02181803|467462464|FG001|Overall Study|Physician Decision|0|||
129864867|NCT02181803|467462465|FG002|Overall Study|Physician Decision|0|||
129864868|NCT02181803|467462466|FG003|Overall Study|Physician Decision|1|||
129864869|NCT02181803|467462467|FG004|Overall Study|Physician Decision|0|||
129864870|NCT02181803|467462468|FG005|Overall Study|Physician Decision|0|||
129449740|NCT01786603|465945671|FG001|Overall Study|Physician decision to withdraw|7|||
129864871|NCT02181803|467462469|FG006|Overall Study|Physician Decision|0|||
129864872|NCT02181803|467462470|FG007|Overall Study|Physician Decision|1|||
129864873|NCT02181803|467462471|FG008|Overall Study|Physician Decision|0|||
129864874|NCT02181803|467462463|FG000|Overall Study|Adverse Event|0|||
129864875|NCT02181803|467462464|FG001|Overall Study|Adverse Event|2|||
129864876|NCT02181803|467462465|FG002|Overall Study|Adverse Event|0|||
129864877|NCT02181803|467462466|FG003|Overall Study|Adverse Event|1|||
129864878|NCT02181803|467462467|FG004|Overall Study|Adverse Event|0|||
129864879|NCT02181803|467462468|FG005|Overall Study|Adverse Event|0|||
129864880|NCT02181803|467462469|FG006|Overall Study|Adverse Event|1|||
129864881|NCT02181803|467462470|FG007|Overall Study|Adverse Event|0|||
129864882|NCT02181803|467462471|FG008|Overall Study|Adverse Event|0|||
129864883|NCT00951041|467462472|FG000|Overall Study|Withdrawal by Subject|1|||
129864884|NCT00951041|467462473|FG001|Overall Study|Withdrawal by Subject|1|||
129864885|NCT00951041|467462472|FG000|Overall Study|Lost to Follow-up|1|||
129864886|NCT00951041|467462473|FG001|Overall Study|Lost to Follow-up|0|||
129864887|NCT00951041|467462472|FG000|Overall Study|Other|3|||
129864888|NCT00951041|467462473|FG001|Overall Study|Other|0|||
129864889|NCT01514448|467462474|FG000|Overall Study|Death|7|||
129864890|NCT01514448|467462475|FG001|Overall Study|Death|8|||
129864891|NCT01514448|467462474|FG000|Overall Study|Withdrawal by Subject|2|||
129864892|NCT01514448|467462475|FG001|Overall Study|Withdrawal by Subject|0|||
129864893|NCT01514448|467462474|FG000|Overall Study|Lost to Follow-up|2|||
129864894|NCT01514448|467462475|FG001|Overall Study|Lost to Follow-up|0|||
129864895|NCT01514448|467462474|FG000|Overall Study|New Cancer Therapy|1|||
129864896|NCT01514448|467462475|FG001|Overall Study|New Cancer Therapy|0|||
129864897|NCT02314624|467462476|FG000|Overall Study|No participating patient|16|||
129864898|NCT02314624|467462477|FG001|Overall Study|No participating patient|13|||
129864899|NCT02314624|467462476|FG000|Overall Study|Participant withdrew|7|||
129864900|NCT02314624|467462477|FG001|Overall Study|Participant withdrew|2|||
129864901|NCT02314624|467462476|FG000|Overall Study|Lost to Follow-up|2|||
129864902|NCT02314624|467462477|FG001|Overall Study|Lost to Follow-up|5|||
129864903|NCT02314624|467462476|FG000|Overall Study|Dropped/Excluded by PI|6|||
129864904|NCT02314624|467462477|FG001|Overall Study|Dropped/Excluded by PI|6|||
129864905|NCT03151005|467462478|FG000|Overall Study|Lost to Follow-up|5|||
129864906|NCT03151005|467462479|FG001|Overall Study|Lost to Follow-up|5|||
129864907|NCT03912259|467462482|FG000|Overall Study|Adverse Event (AE)|2|||
129864908|NCT03912259|467462483|FG001|Overall Study|Adverse Event (AE)|4|||
129864909|NCT03912259|467462482|FG000|Overall Study|Lack of Efficacy|4|||
129864910|NCT03912259|467462483|FG001|Overall Study|Lack of Efficacy|1|||
129864911|NCT03912259|467462482|FG000|Overall Study|Withdrawal by Subject|11|||
129864912|NCT03912259|467462483|FG001|Overall Study|Withdrawal by Subject|1|||
129864913|NCT04786444|467462484|FG000|Overall Study|Withdrawal by Subject|4|||
129864914|NCT04786444|467462485|FG001|Overall Study|Withdrawal by Subject|7|||
129864915|NCT04786444|467462486|FG002|Overall Study|Withdrawal by Subject|2|||
129864916|NCT04786444|467462484|FG000|Overall Study|Lost to Follow-up|11|||
129864917|NCT04786444|467462485|FG001|Overall Study|Lost to Follow-up|9|||
129864918|NCT04786444|467462486|FG002|Overall Study|Lost to Follow-up|10|||
129864919|NCT04786444|467462484|FG000|Overall Study|Subject would like to become pregnant|0|||
129864920|NCT04786444|467462485|FG001|Overall Study|Subject would like to become pregnant|1|||
129864921|NCT04786444|467462486|FG002|Overall Study|Subject would like to become pregnant|0|||
129864922|NCT02131272|467462487|FG000|Overall Study|Withdrawal by parent|0|||
129864923|NCT02131272|467462488|FG001|Overall Study|Withdrawal by parent|1|||
129864924|NCT02131272|467462487|FG000|Overall Study|Withdrawal by Subject|0|||
129864925|NCT02131272|467462488|FG001|Overall Study|Withdrawal by Subject|1|||
129864926|NCT02131272|467462487|FG000|Overall Study|Withdrawal Criteria|1|||
129864927|NCT02131272|467462488|FG001|Overall Study|Withdrawal Criteria|0|||
129864928|NCT02462876|467462489|FG000|Overall Study|Death|3|||
129864929|NCT02462876|467462489|FG000|Overall Study|Lost to Follow-up|7|||
129864930|NCT02462876|467462489|FG000|Overall Study|Surgical Bypass|9|||
129864931|NCT02462876|467462489|FG000|Overall Study|Amputation Above the Metatarsals|1|||
129864932|NCT02462876|467462489|FG000|Overall Study|36 months follow-up visit missed|1|||
129864933|NCT02462876|467462489|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
129864934|NCT02462876|467462489|FG000|Overall Study|Patient did not come back to the vascular department|1|||
129864935|NCT02462876|467462489|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
129864936|NCT02462876|467462489|FG000|Overall Study|Patient refused to come back|1|||
129914624|NCT04855760|467651341|FG000|Overall Study|Protocol Violation|2|||
129914625|NCT04855760|467651341|FG000|Overall Study|Physician Decision|5|||
129914626|NCT04855760|467651341|FG000|Overall Study|Pregnancy|1|||
129914627|NCT04855760|467651341|FG000|Overall Study|Non-Compliance with Study Drug|11|||
129914628|NCT04855760|467651341|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
129914629|NCT04855760|467651341|FG000|Overall Study|Study Completed by Sponsor|202|||
129914630|NCT04855760|467651341|FG000|Overall Study|Other|13|||
129914631|NCT01631214|467651350|FG000|Overall Study|Withdrawal by Subject|276|||
129914632|NCT01631214|467651351|FG001|Overall Study|Withdrawal by Subject|290|||
129914633|NCT01631214|467651350|FG000|Overall Study|Death|113|||
129914634|NCT01631214|467651351|FG001|Overall Study|Death|106|||
129914635|NCT01631214|467651350|FG000|Overall Study|Lost to Follow-up|54|||
129914636|NCT01631214|467651351|FG001|Overall Study|Lost to Follow-up|40|||
129914637|NCT01631214|467651350|FG000|Overall Study|Adverse Event|45|||
129914638|NCT01631214|467651351|FG001|Overall Study|Adverse Event|45|||
129914639|NCT01631214|467651350|FG000|Overall Study|Other|22|||
129914640|NCT01631214|467651351|FG001|Overall Study|Other|19|||
129914641|NCT01631214|467651350|FG000|Overall Study|Noncompliance|16|||
129914642|NCT01631214|467651351|FG001|Overall Study|Noncompliance|15|||
129914643|NCT01631214|467651350|FG000|Overall Study|Requirement for Alternative Therapy|8|||
129914644|NCT01631214|467651351|FG001|Overall Study|Requirement for Alternative Therapy|3|||
129914645|NCT01631214|467651350|FG000|Overall Study|Protocol Deviation|4|||
129914646|NCT01631214|467651351|FG001|Overall Study|Protocol Deviation|3|||
129914647|NCT01631214|467651350|FG000|Overall Study|Ineligibility determined|5|||
129914648|NCT01631214|467651351|FG001|Overall Study|Ineligibility determined|2|||
129914649|NCT01631214|467651350|FG000|Overall Study|Administrative Decision|1|||
129914650|NCT01631214|467651351|FG001|Overall Study|Administrative Decision|0|||
129914651|NCT04112316|467651357|FG000|First Period (8 Weeks)|Protocol Violation|1|||
129914652|NCT04112316|467651358|FG001|First Period (8 Weeks)|Protocol Violation|0|||
129914653|NCT04112316|467651357|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
129914654|NCT04112316|467651358|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
129914655|NCT03857620|467651359|FG000|Overall Study|Death|4|||
129914656|NCT03857620|467651360|FG001|Overall Study|Death|5|||
129914657|NCT03857620|467651361|FG002|Overall Study|Death|7|||
129914658|NCT03857620|467651359|FG000|Overall Study|Lost to Follow-up|2|||
129914659|NCT03857620|467651360|FG001|Overall Study|Lost to Follow-up|5|||
129914660|NCT03857620|467651361|FG002|Overall Study|Lost to Follow-up|3|||
129914661|NCT03857620|467651359|FG000|Overall Study|Disease progression or relapse after study registration|1|||
129914662|NCT03857620|467651360|FG001|Overall Study|Disease progression or relapse after study registration|5|||
129914663|NCT03857620|467651361|FG002|Overall Study|Disease progression or relapse after study registration|1|||
129914664|NCT03857620|467651359|FG000|Overall Study|Ineligible|5|||
129914665|NCT03857620|467651360|FG001|Overall Study|Ineligible|0|||
129914666|NCT03857620|467651361|FG002|Overall Study|Ineligible|2|||
129914667|NCT03857620|467651359|FG000|Overall Study|No malignancy|1|||
129914668|NCT03857620|467651360|FG001|Overall Study|No malignancy|0|||
129914669|NCT03857620|467651361|FG002|Overall Study|No malignancy|1|||
129914670|NCT03857620|467651359|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
129914671|NCT03857620|467651360|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
129914672|NCT03857620|467651361|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
129914673|NCT03857620|467651359|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
129914674|NCT03857620|467651360|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
129914675|NCT03857620|467651361|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
129914676|NCT03857620|467651359|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
129914677|NCT03857620|467651360|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
129914678|NCT03857620|467651361|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
129914679|NCT03857620|467651359|FG000|Overall Study|Surgery not performed, patient decision|0|||
129914680|NCT03857620|467651360|FG001|Overall Study|Surgery not performed, patient decision|3|||
129914681|NCT03857620|467651361|FG002|Overall Study|Surgery not performed, patient decision|1|||
129914682|NCT03857620|467651359|FG000|Overall Study|Surgery not performed, other reason|3|||
129914683|NCT03857620|467651360|FG001|Overall Study|Surgery not performed, other reason|1|||
129914684|NCT03857620|467651361|FG002|Overall Study|Surgery not performed, other reason|4|||
129914685|NCT03857620|467651359|FG000|Overall Study|Worsening performance status after surgery performed|0|||
129914686|NCT03857620|467651360|FG001|Overall Study|Worsening performance status after surgery performed|1|||
129914687|NCT03857620|467651361|FG002|Overall Study|Worsening performance status after surgery performed|1|||
129914688|NCT02473250|467651362|FG000|Overall Study|Lost to Follow-up|10|||
129914689|NCT02473250|467651362|FG000|Overall Study|Physician Decision|5|||
129914690|NCT02473250|467651362|FG000|Overall Study|Did not tolerate medication washout|3|||
129914691|NCT02473250|467651362|FG000|Overall Study|Antidepressant effect of divalproex|2|||
129914692|NCT03517553|467651363|FG000|Overall Study|Withdrawal by Subject|2|||
129914693|NCT03271151|467651364|FG000|Overall Study|Lost to Follow-up|1|||
129914694|NCT03271151|467651365|FG001|Overall Study|Lost to Follow-up|3|||
129914695|NCT03271151|467651364|FG000|Overall Study|Withdrawal by Subject|1|||
129914696|NCT03271151|467651365|FG001|Overall Study|Withdrawal by Subject|0|||
129449741|NCT01786603|465945670|FG000|Overall Study|Lost to Follow-up|1|||
129864937|NCT02462876|467462489|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
129864938|NCT02462876|467462489|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
129864939|NCT03166618|467462494|FG000|Overall Study|Study was Terminated|0|||
129864940|NCT03166618|467462495|FG001|Overall Study|Study was Terminated|1|||
129864941|NCT02163733|467462499|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
129864942|NCT02163733|467462500|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
129864943|NCT02163733|467462501|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
129864944|NCT02163733|467462499|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
129864945|NCT02163733|467462500|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
129864946|NCT02163733|467462501|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
129864947|NCT01260350|467462508|FG000|Overall Study|Lack of Efficacy|0|||
129864948|NCT01260350|467462509|FG001|Overall Study|Lack of Efficacy|0|||
129864949|NCT01260350|467462510|FG002|Overall Study|Lack of Efficacy|0|||
129864950|NCT01260350|467462511|FG003|Overall Study|Lack of Efficacy|0|||
129864951|NCT01260350|467462512|FG004|Overall Study|Lack of Efficacy|0|||
129914697|NCT04093362|467651366|FG000|Overall Study|Study Termination|1|||
129914698|NCT04093362|467651367|FG001|Overall Study|Study Termination|1|||
129914699|NCT04093362|467651366|FG000|Overall Study|Withdrawal of Consent|1|||
129914700|NCT04093362|467651367|FG001|Overall Study|Withdrawal of Consent|0|||
129914701|NCT04093362|467651366|FG000|Overall Study|Death|1|||
129914702|NCT04093362|467651367|FG001|Overall Study|Death|3|||
129914703|NCT04093362|467651366|FG000|Overall Study|Reason not Specified|1|||
129914704|NCT04093362|467651367|FG001|Overall Study|Reason not Specified|2|||
129914705|NCT03433339|467651370|FG000|Overall Study|Lost to Follow-up|2|||
129914706|NCT03433339|467651371|FG001|Overall Study|Lost to Follow-up|0|||
129914707|NCT03433339|467651370|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
129914708|NCT03433339|467651371|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
129914709|NCT03433339|467651370|FG000|Overall Study|Withdrawal by Subject|0|||
129914710|NCT03433339|467651371|FG001|Overall Study|Withdrawal by Subject|2|||
129914711|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914712|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914713|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914714|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
129914715|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
129914716|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914717|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914718|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914719|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
129914720|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
129914721|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914722|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914723|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914724|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
129914725|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
129914726|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914727|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914728|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914729|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
129914730|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
129914731|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914732|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914733|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914734|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
129914735|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
129914736|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
129914737|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
129914738|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
129914739|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
129914740|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
129914741|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914742|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914743|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914744|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
129914745|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
129914746|NCT01898494|467651387|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914747|NCT01898494|467651388|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914748|NCT01898494|467651389|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914749|NCT01898494|467651390|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
129914750|NCT01898494|467651391|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
129914751|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
129914752|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
129914753|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
129914754|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
129914755|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
129914756|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
129914757|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
129914758|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
129914759|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
129914760|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
129914761|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
129914762|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
129914763|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
129914764|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
129914765|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
129914766|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914767|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
129914768|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914769|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914770|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
129914771|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914772|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914773|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
129914774|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914775|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
129914776|NCT01898494|467651387|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
129914777|NCT01898494|467651388|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
129914778|NCT01898494|467651389|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
129914779|NCT01898494|467651390|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
129914780|NCT01898494|467651391|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
129914781|NCT03289039|467651394|FG000|Overall Study|Withdrawal by Subject|0|||
129914782|NCT03289039|467651395|FG001|Overall Study|Withdrawal by Subject|1|||
129914783|NCT03289039|467651394|FG000|Overall Study|Became ineligible prior to treatment start|0|||
129914784|NCT03289039|467651395|FG001|Overall Study|Became ineligible prior to treatment start|1|||
129914785|NCT03289039|467651394|FG000|Overall Study|progressed before treatment start|1|||
129914786|NCT03289039|467651395|FG001|Overall Study|progressed before treatment start|0|||
129914787|NCT04732494|467651396|FG000|Overall Study|Death|39|||
129914788|NCT04732494|467651397|FG001|Overall Study|Death|36|||
129914789|NCT04732494|467651396|FG000|Overall Study|Study Closed by Sponsor|20|||
129914790|NCT04732494|467651397|FG001|Overall Study|Study Closed by Sponsor|15|||
129914791|NCT04732494|467651396|FG000|Overall Study|Withdrawal by Subject|2|||
129914792|NCT04732494|467651397|FG001|Overall Study|Withdrawal by Subject|7|||
129914793|NCT04732494|467651396|FG000|Overall Study|Lost to Follow-up|1|||
129914794|NCT04732494|467651397|FG001|Overall Study|Lost to Follow-up|5|||
129914795|NCT01718743|467651398|FG000|Overall Study|Physician Decision|7|||
129914796|NCT01718743|467651398|FG000|Overall Study|Withdrawal by Subject|14|||
129914797|NCT01718743|467651398|FG000|Overall Study|Progressive Disease|22|||
129914798|NCT01718743|467651398|FG000|Overall Study|Toxicity|1|||
129914799|NCT01718743|467651398|FG000|Overall Study|Malignancy|1|||
129914800|NCT05136404|467651402|FG000|Period 1|Adverse Event|0|||
129914801|NCT05136404|467651403|FG001|Period 1|Adverse Event|1|||
129914802|NCT05136404|467651404|FG002|Period 1|Adverse Event|1|||
129914803|NCT05136404|467651402|FG000|Period 2|Inappropriate Behavior|0|||
129914804|NCT05136404|467651403|FG001|Period 2|Inappropriate Behavior|0|||
129914805|NCT05136404|467651404|FG002|Period 2|Inappropriate Behavior|1|||
129914806|NCT05136404|467651402|FG000|Period 3|Adverse Event|0|||
129914807|NCT05136404|467651403|FG001|Period 3|Adverse Event|0|||
129914808|NCT05136404|467651404|FG002|Period 3|Adverse Event|1|||
129914809|NCT03263026|467651406|FG000|Overall Study|Withdrawal by Subject|1|||
129914810|NCT03263026|467651407|FG001|Overall Study|Withdrawal by Subject|0|||
129914811|NCT03263026|467651406|FG000|Overall Study|Death|1|||
129914812|NCT03263026|467651407|FG001|Overall Study|Death|0|||
129914813|NCT03263026|467651406|FG000|Overall Study|Other/ Various|41|||
129914814|NCT03263026|467651407|FG001|Overall Study|Other/ Various|29|||
129914815|NCT03739996|467651410|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
129914816|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
129914817|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
129914818|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
129914819|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
129914820|NCT03739996|467651410|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
129914821|NCT03739996|467651410|FG000|Step 3 (SOC ART)|Death|1|||
129914822|NCT03739996|467651410|FG000|Step 3 (SOC ART)|Participant moved|1|||
129914823|NCT02553642|467651411|FG000|Overall Study|Withdrawal by Subject|0|||
129914824|NCT02553642|467651412|FG001|Overall Study|Withdrawal by Subject|3|||
129914825|NCT02553642|467651411|FG000|Overall Study|Physician Decision|0|||
129914826|NCT02553642|467651412|FG001|Overall Study|Physician Decision|1|||
129914827|NCT02553642|467651411|FG000|Overall Study|Additional cancer dx|0|||
129914828|NCT02553642|467651412|FG001|Overall Study|Additional cancer dx|1|||
129914829|NCT02553642|467651411|FG000|Overall Study|Never started treatment|0|||
129914830|NCT02553642|467651412|FG001|Overall Study|Never started treatment|1|||
129914831|NCT05444192|467651413|FG000|Overall Study|Lost to Follow-up|1|||
129914832|NCT05444192|467651414|FG001|Overall Study|Lost to Follow-up|0|||
129914833|NCT00894543|467651418|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
129914834|NCT00894543|467651419|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
129914835|NCT00894543|467651418|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
129914836|NCT00894543|467651419|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
129914837|NCT01532388|467651420|FG000|3-month Follow-up|Lost to Follow-up|68|||
129914838|NCT01532388|467651421|FG001|3-month Follow-up|Lost to Follow-up|68|||
129914839|NCT01532388|467651420|FG000|6-month Follow-up|Lost to Follow-up|74|||
129914840|NCT01532388|467651421|FG001|6-month Follow-up|Lost to Follow-up|66|||
129914841|NCT01532388|467651420|FG000|12-month Follow-up|Lost to Follow-up|69|||
129914842|NCT01532388|467651421|FG001|12-month Follow-up|Lost to Follow-up|67|||
129914843|NCT02538900|467651424|FG000|Overall Study|Death|2|||
129914844|NCT02538900|467651425|FG001|Overall Study|Death|2|||
129914845|NCT02538900|467651426|FG002|Overall Study|Death|2|||
129914846|NCT02538900|467651424|FG000|Overall Study|Withdrawal by Subject|18|||
129914847|NCT02538900|467651425|FG001|Overall Study|Withdrawal by Subject|16|||
129914848|NCT02538900|467651426|FG002|Overall Study|Withdrawal by Subject|15|||
129914849|NCT02874534|467651427|FG000|Overall Study|Withdrawal by Subject|5|||
129914850|NCT02874534|467651428|FG001|Overall Study|Withdrawal by Subject|8|||
129914851|NCT02874534|467651427|FG000|Overall Study|Lost to Follow-up|2|||
129914852|NCT02874534|467651428|FG001|Overall Study|Lost to Follow-up|2|||
129914853|NCT02874534|467651427|FG000|Overall Study|Ongoing in study|1|||
129914854|NCT02874534|467651428|FG001|Overall Study|Ongoing in study|1|||
129914855|NCT02923180|467651429|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
129914856|NCT02923180|467651429|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
129914857|NCT05198310|467651430|FG000|Overall Study|Lost to Follow-up|0|||
129914858|NCT05198310|467651431|FG001|Overall Study|Lost to Follow-up|1|||
129914859|NCT05198310|467651432|FG002|Overall Study|Lost to Follow-up|0|||
129914860|NCT05198310|467651433|FG003|Overall Study|Lost to Follow-up|0|||
129864952|NCT01260350|467462513|FG005|Overall Study|Lack of Efficacy|0|||
129864953|NCT01260350|467462514|FG006|Overall Study|Lack of Efficacy|0|||
129864954|NCT01260350|467462515|FG007|Overall Study|Lack of Efficacy|0|||
129864955|NCT01260350|467462516|FG008|Overall Study|Lack of Efficacy|0|||
129864956|NCT01260350|467462517|FG009|Overall Study|Lack of Efficacy|0|||
129864957|NCT01260350|467462518|FG010|Overall Study|Lack of Efficacy|0|||
129864958|NCT01260350|467462519|FG011|Overall Study|Lack of Efficacy|0|||
129864959|NCT01260350|467462520|FG012|Overall Study|Lack of Efficacy|0|||
129864960|NCT01260350|467462521|FG013|Overall Study|Lack of Efficacy|0|||
129864961|NCT01260350|467462522|FG014|Overall Study|Lack of Efficacy|0|||
129864962|NCT01260350|467462523|FG015|Overall Study|Lack of Efficacy|0|||
129864963|NCT01260350|467462524|FG016|Overall Study|Lack of Efficacy|0|||
129864964|NCT01260350|467462525|FG017|Overall Study|Lack of Efficacy|1|||
129864965|NCT01260350|467462526|FG018|Overall Study|Lack of Efficacy|0|||
129864966|NCT01260350|467462527|FG019|Overall Study|Lack of Efficacy|0|||
129864967|NCT01260350|467462528|FG020|Overall Study|Lack of Efficacy|3|||
129864968|NCT01260350|467462529|FG021|Overall Study|Lack of Efficacy|0|||
129864969|NCT01260350|467462508|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864970|NCT01260350|467462509|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864971|NCT01260350|467462510|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864972|NCT01260350|467462511|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864973|NCT01260350|467462512|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864974|NCT01260350|467462513|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864975|NCT01260350|467462514|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864976|NCT01260350|467462515|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864977|NCT01260350|467462516|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
129864978|NCT01260350|467462517|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864979|NCT01260350|467462518|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864980|NCT01260350|467462519|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864981|NCT01260350|467462520|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864982|NCT01260350|467462521|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864983|NCT01260350|467462522|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864984|NCT01260350|467462523|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864985|NCT01260350|467462524|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864986|NCT01260350|467462525|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864987|NCT01260350|467462526|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864988|NCT01260350|467462527|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864989|NCT01260350|467462528|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864990|NCT01260350|467462529|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
129864991|NCT02794285|467462532|FG000|Overall Study|Adverse Event|11|||
129864992|NCT02794285|467462533|FG001|Overall Study|Adverse Event|4|||
129864993|NCT02794285|467462534|FG002|Overall Study|Adverse Event|5|||
129864994|NCT02794285|467462535|FG003|Overall Study|Adverse Event|8|||
129864995|NCT02794285|467462532|FG000|Overall Study|Condition Under Investigation Improved|1|||
129864996|NCT02794285|467462533|FG001|Overall Study|Condition Under Investigation Improved|0|||
129864997|NCT02794285|467462534|FG002|Overall Study|Condition Under Investigation Improved|0|||
129864998|NCT02794285|467462535|FG003|Overall Study|Condition Under Investigation Improved|0|||
129864999|NCT02794285|467462532|FG000|Overall Study|Condition Under Investigation Worsened|0|||
129865000|NCT02794285|467462533|FG001|Overall Study|Condition Under Investigation Worsened|2|||
129865001|NCT02794285|467462534|FG002|Overall Study|Condition Under Investigation Worsened|1|||
129865002|NCT02794285|467462535|FG003|Overall Study|Condition Under Investigation Worsened|0|||
129865003|NCT02794285|467462532|FG000|Overall Study|Death|2|||
129865004|NCT02794285|467462533|FG001|Overall Study|Death|1|||
129865005|NCT02794285|467462534|FG002|Overall Study|Death|2|||
129865006|NCT02794285|467462535|FG003|Overall Study|Death|0|||
129865007|NCT02794285|467462532|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
129865008|NCT02794285|467462533|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
129865009|NCT02794285|467462534|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
129865010|NCT02794285|467462535|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
129865011|NCT02794285|467462532|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
129865012|NCT02794285|467462533|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
129865013|NCT02794285|467462534|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
129865014|NCT02794285|467462535|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
129865015|NCT02794285|467462532|FG000|Overall Study|Lack of Efficacy|10|||
129865016|NCT02794285|467462533|FG001|Overall Study|Lack of Efficacy|6|||
129865017|NCT02794285|467462534|FG002|Overall Study|Lack of Efficacy|3|||
129865018|NCT02794285|467462535|FG003|Overall Study|Lack of Efficacy|3|||
129865019|NCT02794285|467462532|FG000|Overall Study|Lost to Follow-up|5|||
129865020|NCT02794285|467462533|FG001|Overall Study|Lost to Follow-up|6|||
129865021|NCT02794285|467462534|FG002|Overall Study|Lost to Follow-up|3|||
129865022|NCT02794285|467462535|FG003|Overall Study|Lost to Follow-up|1|||
129865023|NCT02794285|467462532|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
129865024|NCT02794285|467462533|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
129914861|NCT05198310|467651434|FG004|Overall Study|Lost to Follow-up|0|||
129914862|NCT05198310|467651435|FG005|Overall Study|Lost to Follow-up|0|||
129914863|NCT05198310|467651436|FG006|Overall Study|Lost to Follow-up|0|||
129914864|NCT05198310|467651437|FG007|Overall Study|Lost to Follow-up|0|||
129914865|NCT05198310|467651430|FG000|Overall Study|Withdrawal by Subject|0|||
129914866|NCT05198310|467651431|FG001|Overall Study|Withdrawal by Subject|0|||
129914867|NCT05198310|467651432|FG002|Overall Study|Withdrawal by Subject|0|||
129914868|NCT05198310|467651433|FG003|Overall Study|Withdrawal by Subject|2|||
129914869|NCT05198310|467651434|FG004|Overall Study|Withdrawal by Subject|0|||
129914870|NCT05198310|467651435|FG005|Overall Study|Withdrawal by Subject|2|||
129914871|NCT05198310|467651436|FG006|Overall Study|Withdrawal by Subject|1|||
129914872|NCT05198310|467651437|FG007|Overall Study|Withdrawal by Subject|3|||
129914873|NCT04436107|467651438|FG000|Overall Study|Sponsor Ended Study|2|||
129914874|NCT04436107|467651439|FG001|Overall Study|Sponsor Ended Study|4|||
129914875|NCT04436107|467651440|FG002|Overall Study|Sponsor Ended Study|8|||
129914876|NCT04436107|467651441|FG003|Overall Study|Sponsor Ended Study|20|||
129914877|NCT04436107|467651438|FG000|Overall Study|Death|3|||
129914878|NCT04436107|467651439|FG001|Overall Study|Death|5|||
129914879|NCT04436107|467651440|FG002|Overall Study|Death|3|||
129914880|NCT04436107|467651441|FG003|Overall Study|Death|18|||
129914881|NCT04436107|467651438|FG000|Overall Study|Withdrawal by Subject|1|||
129914882|NCT04436107|467651439|FG001|Overall Study|Withdrawal by Subject|1|||
129914883|NCT04436107|467651440|FG002|Overall Study|Withdrawal by Subject|0|||
129914884|NCT04436107|467651441|FG003|Overall Study|Withdrawal by Subject|1|||
129914885|NCT01095796|467651442|FG000|Overall Study|Randomized but Not Treated|5|||
129914886|NCT01095796|467651443|FG001|Overall Study|Randomized but Not Treated|2|||
129914887|NCT01095796|467651442|FG000|Overall Study|Adverse Event|9|||
129914888|NCT01095796|467651443|FG001|Overall Study|Adverse Event|19|||
129914889|NCT01095796|467651442|FG000|Overall Study|Death|3|||
129914890|NCT01095796|467651443|FG001|Overall Study|Death|2|||
129914891|NCT01095796|467651442|FG000|Overall Study|Pregnancy|2|||
129914892|NCT01095796|467651443|FG001|Overall Study|Pregnancy|0|||
129914893|NCT01095796|467651442|FG000|Overall Study|Lack of Efficacy|5|||
129914894|NCT01095796|467651443|FG001|Overall Study|Lack of Efficacy|3|||
129914895|NCT01095796|467651442|FG000|Overall Study|Investigator's Discretion|7|||
129914896|NCT01095796|467651443|FG001|Overall Study|Investigator's Discretion|2|||
129914897|NCT01095796|467651442|FG000|Overall Study|Withdrew Consent|16|||
129914898|NCT01095796|467651443|FG001|Overall Study|Withdrew Consent|22|||
129914899|NCT01095796|467651442|FG000|Overall Study|Lost to Follow-up|27|||
129914900|NCT01095796|467651443|FG001|Overall Study|Lost to Follow-up|29|||
129914901|NCT01095796|467651442|FG000|Overall Study|Participant Noncompliance|5|||
129914902|NCT01095796|467651443|FG001|Overall Study|Participant Noncompliance|10|||
129914903|NCT01095796|467651442|FG000|Overall Study|Protocol Violation|1|||
129914904|NCT01095796|467651443|FG001|Overall Study|Protocol Violation|0|||
129914905|NCT01095796|467651442|FG000|Overall Study|Participant Transferred to Another Study|215|||
129914906|NCT01095796|467651443|FG001|Overall Study|Participant Transferred to Another Study|200|||
129914907|NCT01989455|467651448|FG000|Overall Study|Adverse Event|0|||
129914908|NCT01989455|467651449|FG001|Overall Study|Adverse Event|1|||
129914909|NCT01989455|467651450|FG002|Overall Study|Adverse Event|0|||
129914910|NCT01989455|467651451|FG003|Overall Study|Adverse Event|0|||
129914911|NCT01989455|467651452|FG004|Overall Study|Adverse Event|0|||
129914912|NCT01989455|467651448|FG000|Overall Study|Withdrawal by Subject|0|||
129914913|NCT01989455|467651449|FG001|Overall Study|Withdrawal by Subject|1|||
129914914|NCT01989455|467651450|FG002|Overall Study|Withdrawal by Subject|0|||
129914915|NCT01989455|467651451|FG003|Overall Study|Withdrawal by Subject|0|||
129914916|NCT01989455|467651452|FG004|Overall Study|Withdrawal by Subject|0|||
129914917|NCT01989455|467651448|FG000|Overall Study|Technical problems with infusion|0|||
129914918|NCT01989455|467651449|FG001|Overall Study|Technical problems with infusion|0|||
129914919|NCT01989455|467651450|FG002|Overall Study|Technical problems with infusion|1|||
129914920|NCT01989455|467651451|FG003|Overall Study|Technical problems with infusion|0|||
129914921|NCT01989455|467651452|FG004|Overall Study|Technical problems with infusion|1|||
129914922|NCT02638337|467651453|FG000|Overall Study|Adverse Event|6|||
129914923|NCT02638337|467651454|FG001|Overall Study|Adverse Event|10|||
129914924|NCT02638337|467651453|FG000|Overall Study|Protocol Violation|3|||
129914925|NCT02638337|467651454|FG001|Overall Study|Protocol Violation|0|||
129914926|NCT02638337|467651453|FG000|Overall Study|Withdrawal by Subject|13|||
129914927|NCT02638337|467651454|FG001|Overall Study|Withdrawal by Subject|16|||
129914928|NCT02638337|467651453|FG000|Overall Study|Lost to Follow-up|7|||
129914929|NCT02638337|467651454|FG001|Overall Study|Lost to Follow-up|7|||
129449742|NCT01786603|465945671|FG001|Overall Study|Lost to Follow-up|2|||
129449743|NCT01226459|465945672|FG000|Overall Study|Adverse Event|2|||
129449744|NCT01226459|465945673|FG001|Overall Study|Adverse Event|8|||
129449745|NCT01226459|465945672|FG000|Overall Study|Protocol Violation|4|||
129449746|NCT01226459|465945673|FG001|Overall Study|Protocol Violation|3|||
129449747|NCT01226459|465945672|FG000|Overall Study|Withdrawal by Subject|10|||
129449748|NCT01226459|465945673|FG001|Overall Study|Withdrawal by Subject|13|||
129449749|NCT01226459|465945672|FG000|Overall Study|Lost to Follow-up|4|||
129449750|NCT01226459|465945673|FG001|Overall Study|Lost to Follow-up|8|||
129449751|NCT01226459|465945672|FG000|Overall Study|Pregnancy|1|||
129449752|NCT01226459|465945673|FG001|Overall Study|Pregnancy|0|||
129449753|NCT00474708|465945674|FG000|Overall Study|Lack of Efficacy|11|||
129449754|NCT00474708|465945675|FG001|Overall Study|Lack of Efficacy|5|||
129449755|NCT00474708|465945674|FG000|Overall Study|Suicide ideation/behavior|0|||
129449756|NCT00474708|465945675|FG001|Overall Study|Suicide ideation/behavior|1|||
129449757|NCT00474708|465945674|FG000|Overall Study|Withdrawal by Subject|7|||
129449758|NCT00474708|465945675|FG001|Overall Study|Withdrawal by Subject|0|||
129449759|NCT00474708|465945674|FG000|Overall Study|Lack of compliance|12|||
129449760|NCT00474708|465945675|FG001|Overall Study|Lack of compliance|4|||
129449761|NCT00474708|465945674|FG000|Overall Study|Lost to Follow-up|18|||
129449762|NCT00474708|465945675|FG001|Overall Study|Lost to Follow-up|9|||
129449763|NCT00474708|465945674|FG000|Overall Study|Physician Decision|9|||
129449764|NCT00474708|465945675|FG001|Overall Study|Physician Decision|6|||
129449765|NCT03700320|465945679|FG000|Overall Study|Adverse Event|5|||
129449766|NCT03700320|465945680|FG001|Overall Study|Adverse Event|31|||
129449767|NCT03700320|465945679|FG000|Overall Study|Lack of Efficacy|2|||
129449768|NCT03700320|465945680|FG001|Overall Study|Lack of Efficacy|5|||
129449769|NCT03700320|465945679|FG000|Overall Study|Withdrawal by Subject|29|||
129449770|NCT03700320|465945680|FG001|Overall Study|Withdrawal by Subject|75|||
129449771|NCT03700320|465945679|FG000|Overall Study|Lost to Follow-up|16|||
129865025|NCT02794285|467462534|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
129865026|NCT02794285|467462535|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
129865027|NCT02794285|467462532|FG000|Overall Study|Withdrawal by Subject|38|||
129865028|NCT02794285|467462533|FG001|Overall Study|Withdrawal by Subject|29|||
129865029|NCT02794285|467462534|FG002|Overall Study|Withdrawal by Subject|20|||
129865030|NCT02794285|467462535|FG003|Overall Study|Withdrawal by Subject|12|||
129865031|NCT02794285|467462532|FG000|Overall Study|Missing|1|||
129865032|NCT02794285|467462533|FG001|Overall Study|Missing|0|||
129865033|NCT02794285|467462534|FG002|Overall Study|Missing|0|||
129865034|NCT02794285|467462535|FG003|Overall Study|Missing|0|||
129865035|NCT02794285|467462532|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
129865036|NCT02794285|467462533|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
129865037|NCT02794285|467462534|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
129865038|NCT02794285|467462535|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
129865039|NCT02794285|467462532|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
129865040|NCT02794285|467462533|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
129865041|NCT02794285|467462534|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
129865042|NCT02794285|467462535|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
129865043|NCT00868439|467462536|FG000|Overall Study|Adverse Event|4|||
129865044|NCT00868439|467462537|FG001|Overall Study|Adverse Event|3|||
129865045|NCT00868439|467462536|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
129865046|NCT00868439|467462537|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
129865047|NCT00868439|467462536|FG000|Overall Study|Death|0|||
129865048|NCT00868439|467462537|FG001|Overall Study|Death|1|||
129865049|NCT00868439|467462536|FG000|Overall Study|Protocol Violation|1|||
129449772|NCT03700320|465945680|FG001|Overall Study|Lost to Follow-up|23|||
129449773|NCT03700320|465945679|FG000|Overall Study|Pregnancy|2|||
129865050|NCT00868439|467462537|FG001|Overall Study|Protocol Violation|1|||
129914930|NCT02638337|467651453|FG000|Overall Study|Other - Miscellaneous|4|||
129449774|NCT03700320|465945680|FG001|Overall Study|Pregnancy|4|||
129449775|NCT03700320|465945679|FG000|Overall Study|Protocol Deviation|7|||
129449776|NCT03700320|465945680|FG001|Overall Study|Protocol Deviation|31|||
129865051|NCT00868439|467462536|FG000|Overall Study|Physician Decision|1|||
129865052|NCT00868439|467462537|FG001|Overall Study|Physician Decision|0|||
129865053|NCT00868439|467462536|FG000|Overall Study|Withdrawal by Subject|0|||
129914931|NCT02638337|467651454|FG001|Overall Study|Other - Miscellaneous|3|||
129865054|NCT00868439|467462537|FG001|Overall Study|Withdrawal by Subject|1|||
129449777|NCT03700320|465945679|FG000|Overall Study|Non-compliance with Study Drug|1|||
129449778|NCT03700320|465945680|FG001|Overall Study|Non-compliance with Study Drug|3|||
129865055|NCT00937924|467462548|FG000|Overall Study|Lost to Follow-up|44|||
129865056|NCT00937924|467462549|FG001|Overall Study|Lost to Follow-up|44|||
129865057|NCT00937924|467462550|FG002|Overall Study|Lost to Follow-up|41|||
129865058|NCT00224874|467462551|FG000|Overall Study|Withdrawal by Subject|0|||
129865059|NCT00224874|467462552|FG001|Overall Study|Withdrawal by Subject|0|||
129865060|NCT00224874|467462553|FG002|Overall Study|Withdrawal by Subject|1|||
129865061|NCT00224874|467462554|FG003|Overall Study|Withdrawal by Subject|0|||
129865062|NCT05072080|467462557|FG000|Overall Study|Death|0|||
129865063|NCT05072080|467462558|FG001|Overall Study|Death|0|||
129865064|NCT05072080|467462559|FG002|Overall Study|Death|1|||
129865065|NCT05072080|467462560|FG003|Overall Study|Death|0|||
129865066|NCT05072080|467462557|FG000|Overall Study|Lost to Follow-up|65|||
129865067|NCT05072080|467462558|FG001|Overall Study|Lost to Follow-up|70|||
129865068|NCT05072080|467462559|FG002|Overall Study|Lost to Follow-up|58|||
129865069|NCT05072080|467462560|FG003|Overall Study|Lost to Follow-up|23|||
129865070|NCT05072080|467462557|FG000|Overall Study|Physician Decision|2|||
129865071|NCT05072080|467462558|FG001|Overall Study|Physician Decision|1|||
129865072|NCT05072080|467462559|FG002|Overall Study|Physician Decision|1|||
129865073|NCT05072080|467462560|FG003|Overall Study|Physician Decision|0|||
129865074|NCT05072080|467462557|FG000|Overall Study|Withdrawal by Subject|45|||
129865075|NCT05072080|467462558|FG001|Overall Study|Withdrawal by Subject|30|||
129865076|NCT05072080|467462559|FG002|Overall Study|Withdrawal by Subject|27|||
129865077|NCT05072080|467462560|FG003|Overall Study|Withdrawal by Subject|7|||
129865078|NCT05072080|467462557|FG000|Overall Study|Sponsor Decision|0|||
129865079|NCT05072080|467462558|FG001|Overall Study|Sponsor Decision|1|||
129865080|NCT05072080|467462559|FG002|Overall Study|Sponsor Decision|0|||
129865081|NCT05072080|467462560|FG003|Overall Study|Sponsor Decision|0|||
129865082|NCT05072080|467462557|FG000|Overall Study|Subject moved|1|||
129865083|NCT05072080|467462558|FG001|Overall Study|Subject moved|3|||
129865084|NCT05072080|467462559|FG002|Overall Study|Subject moved|5|||
129865085|NCT05072080|467462560|FG003|Overall Study|Subject moved|2|||
129865086|NCT05072080|467462557|FG000|Overall Study|Withdrawal by parent|0|||
129865087|NCT05072080|467462558|FG001|Overall Study|Withdrawal by parent|0|||
129865088|NCT05072080|467462559|FG002|Overall Study|Withdrawal by parent|1|||
129865089|NCT05072080|467462560|FG003|Overall Study|Withdrawal by parent|0|||
129865090|NCT05072080|467462557|FG000|Overall Study|Subject was deployed|0|||
129865091|NCT05072080|467462558|FG001|Overall Study|Subject was deployed|1|||
129865092|NCT05072080|467462559|FG002|Overall Study|Subject was deployed|0|||
129865093|NCT05072080|467462560|FG003|Overall Study|Subject was deployed|0|||
129865094|NCT05072080|467462557|FG000|Overall Study|Subject left site without receiving dose|0|||
129865095|NCT05072080|467462558|FG001|Overall Study|Subject left site without receiving dose|1|||
129865096|NCT05072080|467462559|FG002|Overall Study|Subject left site without receiving dose|0|||
129865097|NCT05072080|467462560|FG003|Overall Study|Subject left site without receiving dose|0|||
129865098|NCT05072080|467462557|FG000|Overall Study|Subject incarcerated|0|||
129865099|NCT05072080|467462558|FG001|Overall Study|Subject incarcerated|1|||
129865100|NCT05072080|467462559|FG002|Overall Study|Subject incarcerated|0|||
129865101|NCT05072080|467462560|FG003|Overall Study|Subject incarcerated|1|||
129865102|NCT05072080|467462557|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
129865103|NCT05072080|467462558|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
129865104|NCT05072080|467462559|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
129865105|NCT05072080|467462560|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
129865106|NCT05072080|467462557|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
129865107|NCT05072080|467462558|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
129865108|NCT05072080|467462559|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
129865109|NCT05072080|467462560|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
129865110|NCT02633137|467462561|FG000|Overall Study|Adverse Event|1|||
129865111|NCT02633137|467462561|FG000|Overall Study|Lack of Efficacy|2|||
129865112|NCT02633137|467462561|FG000|Overall Study|Withdrawal by Subject|1|||
129865113|NCT01972841|467462562|FG000|Overall Study|Randomized but Never Received Treatment|2|||
129865114|NCT01972841|467462563|FG001|Overall Study|Randomized but Never Received Treatment|5|||
129865115|NCT01972841|467462564|FG002|Overall Study|Randomized but Never Received Treatment|4|||
129865116|NCT01972841|467462565|FG003|Overall Study|Randomized but Never Received Treatment|2|||
129865117|NCT01972841|467462566|FG004|Overall Study|Randomized but Never Received Treatment|6|||
129865118|NCT01972841|467462567|FG005|Overall Study|Randomized but Never Received Treatment|13|||
129865119|NCT01972841|467462562|FG000|Overall Study|Adverse Event|13|||
129865120|NCT01972841|467462563|FG001|Overall Study|Adverse Event|8|||
129865121|NCT01972841|467462564|FG002|Overall Study|Adverse Event|12|||
129865122|NCT01972841|467462565|FG003|Overall Study|Adverse Event|9|||
129865123|NCT01972841|467462566|FG004|Overall Study|Adverse Event|21|||
129865124|NCT01972841|467462567|FG005|Overall Study|Adverse Event|26|||
129865125|NCT01972841|467462562|FG000|Overall Study|Lack of Efficacy|1|||
129865126|NCT01972841|467462563|FG001|Overall Study|Lack of Efficacy|0|||
129865127|NCT01972841|467462564|FG002|Overall Study|Lack of Efficacy|0|||
129865128|NCT01972841|467462565|FG003|Overall Study|Lack of Efficacy|2|||
129865129|NCT01972841|467462566|FG004|Overall Study|Lack of Efficacy|4|||
129865130|NCT01972841|467462567|FG005|Overall Study|Lack of Efficacy|1|||
129865131|NCT01972841|467462562|FG000|Overall Study|Lost to Follow-up|4|||
129865132|NCT01972841|467462563|FG001|Overall Study|Lost to Follow-up|2|||
129865133|NCT01972841|467462564|FG002|Overall Study|Lost to Follow-up|4|||
129865134|NCT01972841|467462565|FG003|Overall Study|Lost to Follow-up|2|||
129865135|NCT01972841|467462566|FG004|Overall Study|Lost to Follow-up|9|||
129865136|NCT01972841|467462567|FG005|Overall Study|Lost to Follow-up|3|||
129865137|NCT01972841|467462562|FG000|Overall Study|Protocol Violation|2|||
129865138|NCT01972841|467462563|FG001|Overall Study|Protocol Violation|2|||
129865139|NCT01972841|467462564|FG002|Overall Study|Protocol Violation|3|||
129865140|NCT01972841|467462565|FG003|Overall Study|Protocol Violation|5|||
129865141|NCT01972841|467462566|FG004|Overall Study|Protocol Violation|9|||
129865142|NCT01972841|467462567|FG005|Overall Study|Protocol Violation|4|||
129865143|NCT01972841|467462562|FG000|Overall Study|Withdrawal by participants|21|||
129865144|NCT01972841|467462563|FG001|Overall Study|Withdrawal by participants|27|||
129865145|NCT01972841|467462564|FG002|Overall Study|Withdrawal by participants|23|||
129865146|NCT01972841|467462565|FG003|Overall Study|Withdrawal by participants|16|||
129865147|NCT01972841|467462566|FG004|Overall Study|Withdrawal by participants|33|||
129865148|NCT01972841|467462567|FG005|Overall Study|Withdrawal by participants|34|||
129865149|NCT01972841|467462562|FG000|Overall Study|Miscellaneous|0|||
129865150|NCT01972841|467462563|FG001|Overall Study|Miscellaneous|0|||
129865151|NCT01972841|467462564|FG002|Overall Study|Miscellaneous|4|||
129865152|NCT01972841|467462565|FG003|Overall Study|Miscellaneous|1|||
129865153|NCT01972841|467462566|FG004|Overall Study|Miscellaneous|0|||
129865154|NCT01972841|467462567|FG005|Overall Study|Miscellaneous|4|||
129865155|NCT01972841|467462562|FG000|Overall Study|Did not have end of treatment page|0|||
129865156|NCT01972841|467462563|FG001|Overall Study|Did not have end of treatment page|0|||
129865157|NCT01972841|467462564|FG002|Overall Study|Did not have end of treatment page|0|||
129865158|NCT01972841|467462565|FG003|Overall Study|Did not have end of treatment page|0|||
129865159|NCT01972841|467462566|FG004|Overall Study|Did not have end of treatment page|1|||
129865160|NCT01972841|467462567|FG005|Overall Study|Did not have end of treatment page|0|||
129865161|NCT04969198|467462568|FG000|Overall Study|Withdrawal by Subject|20|||
129865162|NCT04969198|467462568|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
129865163|NCT04969198|467462568|FG000|Overall Study|Lost to Follow-up|20|||
129865164|NCT02701985|467462569|FG000|Overall Study|Withdrawal by Subject|1|||
129865165|NCT02701985|467462570|FG001|Overall Study|Withdrawal by Subject|1|||
129865166|NCT02701985|467462569|FG000|Overall Study|Lost to Follow-up|1|||
129865167|NCT02701985|467462570|FG001|Overall Study|Lost to Follow-up|0|||
129865168|NCT02701985|467462569|FG000|Overall Study|Death|1|||
129865169|NCT02701985|467462570|FG001|Overall Study|Death|0|||
129865170|NCT02701985|467462569|FG000|Overall Study|Adverse Event|0|||
129865171|NCT02701985|467462570|FG001|Overall Study|Adverse Event|5|||
129865172|NCT01640808|467462571|FG000|Overall Study|Unable to continue dynamic CT|14|||
129865173|NCT01640808|467462572|FG001|Overall Study|Unable to continue dynamic CT|4|||
129865174|NCT01640808|467462571|FG000|Overall Study|Withdrawal by Subject|12|||
129865175|NCT01640808|467462572|FG001|Overall Study|Withdrawal by Subject|4|||
129865176|NCT01640808|467462571|FG000|Overall Study|Lost to Follow-up|4|||
129865177|NCT01640808|467462572|FG001|Overall Study|Lost to Follow-up|0|||
129865178|NCT01640808|467462571|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
129865179|NCT01640808|467462572|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
129865180|NCT01640808|467462571|FG000|Overall Study|Administration of anticancer drugs|2|||
129865181|NCT01640808|467462572|FG001|Overall Study|Administration of anticancer drugs|1|||
129865182|NCT01640808|467462571|FG000|Overall Study|Physician Decision|19|||
129865183|NCT01640808|467462572|FG001|Overall Study|Physician Decision|5|||
129865184|NCT01640808|467462571|FG000|Overall Study|Randomized but not treated|4|||
129865185|NCT01640808|467462572|FG001|Overall Study|Randomized but not treated|2|||
129865186|NCT01178086|467462573|FG000|Overall Study|Participant refusal|7|||
129865187|NCT01178086|467462573|FG000|Overall Study|Physician Decision|44|||
129865188|NCT01178086|467462573|FG000|Overall Study|Switch to other CLL therapy|113|||
129865189|NCT01178086|467462573|FG000|Overall Study|Death|59|||
129865190|NCT01178086|467462573|FG000|Overall Study|Other unspecified|89|||
129865191|NCT01178086|467462573|FG000|Overall Study|Excluded from EAS|20|||
129865192|NCT03543254|467462574|FG000|Overall Study|Lost to Follow-up|1|||
129865193|NCT00234065|467462575|FG000|Overall Study|Adverse Event|268|||
129865194|NCT00234065|467462576|FG001|Overall Study|Adverse Event|166|||
129865195|NCT00234065|467462575|FG000|Overall Study|Withdrawal by Subject|73|||
129865196|NCT00234065|467462576|FG001|Overall Study|Withdrawal by Subject|56|||
129865197|NCT00234065|467462575|FG000|Overall Study|Physician Decision|23|||
129865198|NCT00234065|467462576|FG001|Overall Study|Physician Decision|22|||
129865199|NCT00234065|467462575|FG000|Overall Study|Not Classified|111|||
129865200|NCT00234065|467462576|FG001|Overall Study|Not Classified|112|||
129865201|NCT00126438|467462577|FG000|Overall Study|Withdrawal due to adverse event|1|||
129865202|NCT00126438|467462578|FG001|Overall Study|Withdrawal due to adverse event|0|||
129865203|NCT00126438|467462577|FG000|Overall Study|Lost to Follow-up|22|||
129865204|NCT00126438|467462578|FG001|Overall Study|Lost to Follow-up|0|||
129865205|NCT00126438|467462577|FG000|Overall Study|Protocol Violation|8|||
129865206|NCT00126438|467462578|FG001|Overall Study|Protocol Violation|8|||
129865207|NCT00126438|467462577|FG000|Overall Study|Withdrawal by Subject|3|||
129865208|NCT00126438|467462578|FG001|Overall Study|Withdrawal by Subject|2|||
129865209|NCT00593567|467464623|FG000|Overall Study|Adverse Event|2|||
129865210|NCT00593567|467464624|FG001|Overall Study|Adverse Event|0|||
129865211|NCT00593567|467464623|FG000|Overall Study|Physician Decision|2|||
129865212|NCT00593567|467464624|FG001|Overall Study|Physician Decision|0|||
129865213|NCT00593567|467464623|FG000|Overall Study|Protocol Violation|13|||
129865214|NCT00593567|467464624|FG001|Overall Study|Protocol Violation|7|||
129865215|NCT00593567|467464623|FG000|Overall Study|Lack of Efficacy|2|||
129865216|NCT00593567|467464624|FG001|Overall Study|Lack of Efficacy|1|||
129865217|NCT00593567|467464623|FG000|Overall Study|Withdrawal by Subject|1|||
129865218|NCT00593567|467464624|FG001|Overall Study|Withdrawal by Subject|2|||
129865219|NCT01559844|467464625|FG000|Overall Study|Consent Withdrawn|7|||
129865220|NCT01559844|467464625|FG000|Overall Study|Death|5|||
129865221|NCT01559844|467464625|FG000|Overall Study|Efficacy Failure|10|||
129865222|NCT01559844|467464625|FG000|Overall Study|No Longer A Transplant Candidate|3|||
129865223|NCT01786512|467464626|FG000|Overall Study|Lost to Follow-up|0|||
129865224|NCT01786512|467464627|FG001|Overall Study|Lost to Follow-up|0|||
129865225|NCT01786512|467464628|FG002|Overall Study|Lost to Follow-up|0|||
129865226|NCT01786512|467464629|FG003|Overall Study|Lost to Follow-up|0|||
129865227|NCT01786512|467464630|FG004|Overall Study|Lost to Follow-up|0|||
129865228|NCT01786512|467464631|FG005|Overall Study|Lost to Follow-up|0|||
129865229|NCT01786512|467464632|FG006|Overall Study|Lost to Follow-up|0|||
129865230|NCT01786512|467464633|FG007|Overall Study|Lost to Follow-up|0|||
129865231|NCT01786512|467464634|FG008|Overall Study|Lost to Follow-up|0|||
129865232|NCT01786512|467464635|FG009|Overall Study|Lost to Follow-up|1|||
129865233|NCT01786512|467464636|FG010|Overall Study|Lost to Follow-up|0|||
129865234|NCT01786512|467464626|FG000|Overall Study|Decision by sponsor|0|||
129865235|NCT01786512|467464627|FG001|Overall Study|Decision by sponsor|0|||
129865236|NCT01786512|467464628|FG002|Overall Study|Decision by sponsor|0|||
129865237|NCT01786512|467464629|FG003|Overall Study|Decision by sponsor|0|||
129865238|NCT01786512|467464630|FG004|Overall Study|Decision by sponsor|0|||
129865239|NCT01786512|467464631|FG005|Overall Study|Decision by sponsor|0|||
129865240|NCT01786512|467464632|FG006|Overall Study|Decision by sponsor|0|||
129865241|NCT01786512|467464633|FG007|Overall Study|Decision by sponsor|0|||
129865242|NCT01786512|467464634|FG008|Overall Study|Decision by sponsor|0|||
129865243|NCT01786512|467464635|FG009|Overall Study|Decision by sponsor|0|||
129865244|NCT01786512|467464636|FG010|Overall Study|Decision by sponsor|2|||
129865245|NCT01786512|467464626|FG000|Overall Study|Withdrawal by Subject|0|||
129865246|NCT01786512|467464627|FG001|Overall Study|Withdrawal by Subject|1|||
129865247|NCT01786512|467464628|FG002|Overall Study|Withdrawal by Subject|0|||
129865248|NCT01786512|467464629|FG003|Overall Study|Withdrawal by Subject|0|||
129865249|NCT01786512|467464630|FG004|Overall Study|Withdrawal by Subject|0|||
129865250|NCT01786512|467464631|FG005|Overall Study|Withdrawal by Subject|0|||
129865251|NCT01786512|467464632|FG006|Overall Study|Withdrawal by Subject|1|||
129865252|NCT01786512|467464633|FG007|Overall Study|Withdrawal by Subject|0|||
129865253|NCT01786512|467464634|FG008|Overall Study|Withdrawal by Subject|0|||
129865254|NCT01786512|467464635|FG009|Overall Study|Withdrawal by Subject|3|||
129865255|NCT01786512|467464636|FG010|Overall Study|Withdrawal by Subject|7|||
129865256|NCT01786512|467464626|FG000|Overall Study|Death|0|||
129865257|NCT01786512|467464627|FG001|Overall Study|Death|0|||
129865258|NCT01786512|467464628|FG002|Overall Study|Death|0|||
129865259|NCT01786512|467464629|FG003|Overall Study|Death|0|||
129865260|NCT01786512|467464630|FG004|Overall Study|Death|0|||
129865261|NCT01786512|467464631|FG005|Overall Study|Death|0|||
129865262|NCT01786512|467464632|FG006|Overall Study|Death|0|||
129865263|NCT01786512|467464633|FG007|Overall Study|Death|0|||
129865264|NCT01786512|467464634|FG008|Overall Study|Death|4|||
129865265|NCT01786512|467464635|FG009|Overall Study|Death|1|||
129865266|NCT01786512|467464636|FG010|Overall Study|Death|3|||
129865267|NCT00605293|467464637|FG000|Overall Study|Death|2|||
129865268|NCT00605293|467464638|FG001|Overall Study|Death|1|||
129865269|NCT00605293|467464637|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129865270|NCT00605293|467464638|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129865271|NCT00605293|467464637|FG000|Overall Study|Adverse Event|1|||
129865272|NCT00605293|467464638|FG001|Overall Study|Adverse Event|0|||
129865273|NCT00605293|467464637|FG000|Overall Study|Holidays Dialysis Out|1|||
129865274|NCT00605293|467464638|FG001|Overall Study|Holidays Dialysis Out|0|||
129865275|NCT00605293|467464637|FG000|Overall Study|Blood Transfusion|7|||
129865276|NCT00605293|467464638|FG001|Overall Study|Blood Transfusion|1|||
129865277|NCT00605293|467464637|FG000|Overall Study|Renal Transplantation|3|||
129865278|NCT00605293|467464638|FG001|Overall Study|Renal Transplantation|1|||
129865279|NCT00605293|467464637|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
129865280|NCT00605293|467464638|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
129865281|NCT00605293|467464637|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
129865282|NCT00605293|467464638|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
129865283|NCT00605293|467464637|FG000|Overall Study|Principal Investigator Decision|0|||
129865284|NCT00605293|467464638|FG001|Overall Study|Principal Investigator Decision|1|||
129865285|NCT03137303|467464639|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
129865286|NCT03137303|467464640|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
129865287|NCT03137303|467464639|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
129914932|NCT05512962|467651455|FG000|Overall Study|Withdrawal by Subject|1|||
129914933|NCT05512962|467651456|FG001|Overall Study|Withdrawal by Subject|0|||
129914934|NCT02860130|467651457|FG000|Overall Study|Adverse Event|2|||
129865288|NCT03137303|467464640|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
129865289|NCT03137303|467464639|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
129865290|NCT03137303|467464640|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
129865291|NCT03137303|467464639|FG000|T3: 9-month Follow-up|Death|1|||
129865292|NCT03137303|467464640|FG001|T3: 9-month Follow-up|Death|0|||
129865293|NCT03137303|467464639|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
129865294|NCT03137303|467464640|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
129914935|NCT02860130|467651458|FG001|Overall Study|Adverse Event|3|||
129449779|NCT03700320|465945679|FG000|Overall Study|Reason not Specified|0|||
129865295|NCT03137303|467464639|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
129865296|NCT03137303|467464640|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
129865297|NCT03137303|467464639|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
129865298|NCT03137303|467464640|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
129865299|NCT03561090|467464641|FG000|Overall Study|Adverse Event|11|||
129865300|NCT03561090|467464642|FG001|Overall Study|Adverse Event|7|||
129865301|NCT03561090|467464641|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129865302|NCT03561090|467464642|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129865303|NCT03561090|467464641|FG000|Overall Study|Protocol Violation|2|||
129865304|NCT03561090|467464642|FG001|Overall Study|Protocol Violation|2|||
129865305|NCT03561090|467464641|FG000|Overall Study|Withdrawal by Subject|7|||
129865306|NCT03561090|467464642|FG001|Overall Study|Withdrawal by Subject|7|||
129865307|NCT03561090|467464641|FG000|Overall Study|Lost to Follow-up|7|||
129865308|NCT03561090|467464642|FG001|Overall Study|Lost to Follow-up|2|||
129865309|NCT03561090|467464641|FG000|Overall Study|Study Terminated by Sponsor|10|||
129865310|NCT03561090|467464642|FG001|Overall Study|Study Terminated by Sponsor|15|||
129865311|NCT03561090|467464641|FG000|Overall Study|Randomized by Mistake|1|||
129865312|NCT03561090|467464642|FG001|Overall Study|Randomized by Mistake|1|||
129865313|NCT03561090|467464641|FG000|Overall Study|Other Not Specified|0|||
129865314|NCT03561090|467464642|FG001|Overall Study|Other Not Specified|2|||
129865315|NCT00713648|467464649|FG000|Overall Study|Adverse Event|1|||
129865316|NCT00713648|467464649|FG000|Overall Study|Unclassified|2|||
129865317|NCT00713648|467464649|FG000|Overall Study|According to Protocol|2|||
129865318|NCT00713648|467464649|FG000|Overall Study|Development of antibodies|3|||
129865319|NCT02633800|467464650|FG000|Overall Study|Death|3|||
129865320|NCT02633800|467464651|FG001|Overall Study|Death|3|||
129865321|NCT02633800|467464650|FG000|Overall Study|Reason not provided|1|||
129865322|NCT02633800|467464651|FG001|Overall Study|Reason not provided|0|||
129865323|NCT02633800|467464650|FG000|Overall Study|Radiologic(al) progression|23|||
129865324|NCT02633800|467464651|FG001|Overall Study|Radiologic(al) progression|23|||
129865325|NCT02633800|467464650|FG000|Overall Study|Clinical progression|3|||
129865326|NCT02633800|467464651|FG001|Overall Study|Clinical progression|6|||
129865327|NCT02633800|467464650|FG000|Overall Study|Study terminated by sponsor|6|||
129865328|NCT02633800|467464651|FG001|Overall Study|Study terminated by sponsor|5|||
129865329|NCT02633800|467464650|FG000|Overall Study|Adverse event, non-fatal|7|||
129865330|NCT02633800|467464651|FG001|Overall Study|Adverse event, non-fatal|2|||
129865331|NCT02633800|467464650|FG000|Overall Study|Withdrawal by Subject|0|||
129865332|NCT02633800|467464651|FG001|Overall Study|Withdrawal by Subject|3|||
129865333|NCT02633800|467464650|FG000|Overall Study|Patient Request|1|||
129865334|NCT02633800|467464651|FG001|Overall Study|Patient Request|1|||
129865335|NCT00082173|467464652|FG000|Overall Study|Withdrawal by Subject|3|||
129865336|NCT00082173|467464653|FG001|Overall Study|Withdrawal by Subject|5|||
129865337|NCT00082173|467464652|FG000|Overall Study|Lost to Follow-up|1|||
129865338|NCT00082173|467464653|FG001|Overall Study|Lost to Follow-up|0|||
129865339|NCT00082173|467464652|FG000|Overall Study|Adverse Event|1|||
129865340|NCT00082173|467464653|FG001|Overall Study|Adverse Event|0|||
129865341|NCT00082173|467464652|FG000|Overall Study|Culture negative or resistant at baselin|5|||
129865342|NCT00082173|467464653|FG001|Overall Study|Culture negative or resistant at baselin|6|||
129865343|NCT01733732|467464654|FG000|Overall Study|Adverse Event|1|||
129865344|NCT01733732|467464655|FG001|Overall Study|Adverse Event|0|||
129865345|NCT01733732|467464654|FG000|Overall Study|Did not attend all study visits|1|||
129865346|NCT01733732|467464655|FG001|Overall Study|Did not attend all study visits|0|||
129865347|NCT01358968|467464661|FG000|Period 2|Adverse Event|0|||
129865348|NCT01358968|467464662|FG001|Period 2|Adverse Event|1|||
129865349|NCT01358968|467464663|FG002|Period 2|Adverse Event|0|||
129865350|NCT01358968|467464664|FG003|Period 2|Adverse Event|0|||
129865351|NCT01358968|467464661|FG000|Continued Access Phase|Progression of Disease|0|||
129865352|NCT01358968|467464662|FG001|Continued Access Phase|Progression of Disease|0|||
129865353|NCT01358968|467464663|FG002|Continued Access Phase|Progression of Disease|8|||
129865354|NCT01358968|467464664|FG003|Continued Access Phase|Progression of Disease|4|||
129865355|NCT01358968|467464661|FG000|Continued Access Phase|Protocol Violation|0|||
129865356|NCT01358968|467464662|FG001|Continued Access Phase|Protocol Violation|0|||
129865357|NCT01358968|467464663|FG002|Continued Access Phase|Protocol Violation|0|||
129865358|NCT01358968|467464664|FG003|Continued Access Phase|Protocol Violation|2|||
129865359|NCT01358968|467464661|FG000|Continued Access Phase|Withdrawal by Subject|0|||
129914936|NCT02860130|467651457|FG000|Overall Study|Protocol Violation|1|||
129914937|NCT02860130|467651458|FG001|Overall Study|Protocol Violation|1|||
129914938|NCT02860130|467651457|FG000|Overall Study|Withdrawal by Subject|0|||
129914939|NCT02860130|467651458|FG001|Overall Study|Withdrawal by Subject|2|||
129914940|NCT02860130|467651457|FG000|Overall Study|Physician Decision|2|||
129914941|NCT02860130|467651458|FG001|Overall Study|Physician Decision|2|||
129914942|NCT02860130|467651457|FG000|Overall Study|Other|2|||
129914943|NCT02860130|467651458|FG001|Overall Study|Other|1|||
129914944|NCT05575076|467651460|FG000|Overall Study|Adverse Event|24|||
129914945|NCT05575076|467651460|FG000|Overall Study|Death|7|||
129914946|NCT05575076|467651460|FG000|Overall Study|Lost to Follow-up|16|||
129914947|NCT05575076|467651460|FG000|Overall Study|Non-Compliance|3|||
129914948|NCT05575076|467651460|FG000|Overall Study|Physician Decision|6|||
129914949|NCT05575076|467651460|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
129914950|NCT05575076|467651460|FG000|Overall Study|Withdrawal by Subject|71|||
129914951|NCT05575076|467651460|FG000|Overall Study|Study Terminated by Sponsor|630|||
129914952|NCT05575076|467651460|FG000|Overall Study|Other|17|||
129914953|NCT03380390|467651461|FG000|Overall Study|Adverse Event|3|||
129914954|NCT01127373|467651462|FG000|Overall Study|Not Treated|3|||
129914955|NCT01127373|467651462|FG000|Overall Study|Lost to Follow-up|7|||
129914956|NCT01127373|467651462|FG000|Overall Study|Withdrawal by Subject|1|||
129914957|NCT01127373|467651462|FG000|Overall Study|Disease progression|1|||
129914958|NCT01426412|467651469|FG000|Overall Study|Withdrawal by Subject|1|||
129914959|NCT01426412|467651470|FG001|Overall Study|Withdrawal by Subject|0|||
129914960|NCT01426412|467651471|FG002|Overall Study|Withdrawal by Subject|0|||
129914961|NCT01426412|467651472|FG003|Overall Study|Withdrawal by Subject|0|||
129914962|NCT01426412|467651473|FG004|Overall Study|Withdrawal by Subject|1|||
129914963|NCT01426412|467651474|FG005|Overall Study|Withdrawal by Subject|0|||
129914964|NCT01426412|467651475|FG006|Overall Study|Withdrawal by Subject|0|||
129914965|NCT01426412|467651476|FG007|Overall Study|Withdrawal by Subject|3|||
129914966|NCT01426412|467651477|FG008|Overall Study|Withdrawal by Subject|1|||
129914967|NCT01084707|467651479|FG000|Overall Study|Withdrawal by Subject|6|||
129914968|NCT02272816|467651480|FG000|Overall Study|Adverse Event|1|||
129914969|NCT02671435|467651485|FG000|Overall Study|Death|1|||
129914970|NCT02671435|467651486|FG001|Overall Study|Death|3|||
129914971|NCT02671435|467651487|FG002|Overall Study|Death|0|||
129914972|NCT02671435|467651488|FG003|Overall Study|Death|16|||
129914973|NCT02671435|467651489|FG004|Overall Study|Death|14|||
129914974|NCT02671435|467651490|FG005|Overall Study|Death|29|||
129914975|NCT02671435|467651491|FG006|Overall Study|Death|34|||
129914976|NCT02671435|467651492|FG007|Overall Study|Death|28|||
129914977|NCT02671435|467651493|FG008|Overall Study|Death|19|||
129914978|NCT02671435|467651494|FG009|Overall Study|Death|10|||
129914979|NCT02671435|467651495|FG010|Overall Study|Death|8|||
129914980|NCT02671435|467651496|FG011|Overall Study|Death|29|||
129914981|NCT02671435|467651497|FG012|Overall Study|Death|29|||
129914982|NCT02671435|467651498|FG013|Overall Study|Death|29|||
129914983|NCT02671435|467651499|FG014|Overall Study|Death|27|||
129914984|NCT02671435|467651485|FG000|Overall Study|Lost to Follow-up|0|||
129914985|NCT02671435|467651486|FG001|Overall Study|Lost to Follow-up|0|||
129914986|NCT02671435|467651487|FG002|Overall Study|Lost to Follow-up|1|||
129914987|NCT02671435|467651488|FG003|Overall Study|Lost to Follow-up|0|||
129914988|NCT02671435|467651489|FG004|Overall Study|Lost to Follow-up|1|||
129914989|NCT02671435|467651490|FG005|Overall Study|Lost to Follow-up|1|||
129914990|NCT02671435|467651491|FG006|Overall Study|Lost to Follow-up|2|||
129914991|NCT02671435|467651492|FG007|Overall Study|Lost to Follow-up|2|||
129914992|NCT02671435|467651493|FG008|Overall Study|Lost to Follow-up|0|||
129914993|NCT02671435|467651494|FG009|Overall Study|Lost to Follow-up|2|||
129914994|NCT02671435|467651495|FG010|Overall Study|Lost to Follow-up|0|||
129914995|NCT02671435|467651496|FG011|Overall Study|Lost to Follow-up|3|||
129914996|NCT02671435|467651497|FG012|Overall Study|Lost to Follow-up|3|||
129914997|NCT02671435|467651498|FG013|Overall Study|Lost to Follow-up|2|||
129914998|NCT02671435|467651499|FG014|Overall Study|Lost to Follow-up|0|||
129914999|NCT02671435|467651485|FG000|Overall Study|Withdrawal by Subject|2|||
129915000|NCT02671435|467651486|FG001|Overall Study|Withdrawal by Subject|0|||
129915001|NCT02671435|467651487|FG002|Overall Study|Withdrawal by Subject|2|||
129915002|NCT02671435|467651488|FG003|Overall Study|Withdrawal by Subject|2|||
129915003|NCT02671435|467651489|FG004|Overall Study|Withdrawal by Subject|2|||
129915004|NCT02671435|467651490|FG005|Overall Study|Withdrawal by Subject|7|||
129915005|NCT02671435|467651491|FG006|Overall Study|Withdrawal by Subject|2|||
129915006|NCT02671435|467651492|FG007|Overall Study|Withdrawal by Subject|7|||
129915007|NCT02671435|467651493|FG008|Overall Study|Withdrawal by Subject|1|||
129915008|NCT02671435|467651494|FG009|Overall Study|Withdrawal by Subject|1|||
129915009|NCT02671435|467651495|FG010|Overall Study|Withdrawal by Subject|2|||
129915010|NCT02671435|467651496|FG011|Overall Study|Withdrawal by Subject|4|||
129915011|NCT02671435|467651497|FG012|Overall Study|Withdrawal by Subject|4|||
129915012|NCT02671435|467651498|FG013|Overall Study|Withdrawal by Subject|4|||
129915013|NCT02671435|467651499|FG014|Overall Study|Withdrawal by Subject|2|||
129915014|NCT02671435|467651485|FG000|Overall Study|Un-specified|0|||
129915015|NCT02671435|467651486|FG001|Overall Study|Un-specified|0|||
129865360|NCT01358968|467464662|FG001|Continued Access Phase|Withdrawal by Subject|0|||
129865361|NCT01358968|467464663|FG002|Continued Access Phase|Withdrawal by Subject|3|||
129865362|NCT01358968|467464664|FG003|Continued Access Phase|Withdrawal by Subject|0|||
129865363|NCT01358968|467464661|FG000|Continued Access Phase|Death|0|||
129865364|NCT01358968|467464662|FG001|Continued Access Phase|Death|0|||
129865365|NCT01358968|467464663|FG002|Continued Access Phase|Death|1|||
129865366|NCT01358968|467464664|FG003|Continued Access Phase|Death|1|||
129865367|NCT01814371|467464665|FG000|Overall Study|Lost to Follow-up|30|||
129865368|NCT01814371|467464666|FG001|Overall Study|Lost to Follow-up|27|||
129865369|NCT01692782|467464667|FG000|Overall Study|Adverse Event|12|||
129865370|NCT01692782|467464668|FG001|Overall Study|Adverse Event|32|||
129865371|NCT01692782|467464669|FG002|Overall Study|Adverse Event|2|||
129865372|NCT01692782|467464667|FG000|Overall Study|Lack of Efficacy|1|||
129865373|NCT01692782|467464668|FG001|Overall Study|Lack of Efficacy|2|||
129865374|NCT01692782|467464669|FG002|Overall Study|Lack of Efficacy|0|||
129865375|NCT01692782|467464667|FG000|Overall Study|Lost to Follow-up|2|||
129865376|NCT01692782|467464668|FG001|Overall Study|Lost to Follow-up|7|||
129865377|NCT01692782|467464669|FG002|Overall Study|Lost to Follow-up|1|||
129865378|NCT01692782|467464667|FG000|Overall Study|Pregnancy|1|||
129865379|NCT01692782|467464668|FG001|Overall Study|Pregnancy|0|||
129865380|NCT01692782|467464669|FG002|Overall Study|Pregnancy|0|||
129865381|NCT01692782|467464667|FG000|Overall Study|Protocol Violation|1|||
129865382|NCT01692782|467464668|FG001|Overall Study|Protocol Violation|0|||
129865383|NCT01692782|467464669|FG002|Overall Study|Protocol Violation|2|||
129865384|NCT01692782|467464667|FG000|Overall Study|Non-complance with study drug|0|||
129865385|NCT01692782|467464668|FG001|Overall Study|Non-complance with study drug|4|||
129865386|NCT01692782|467464669|FG002|Overall Study|Non-complance with study drug|1|||
129865387|NCT01692782|467464667|FG000|Overall Study|Non-compliant with study visits|0|||
129865388|NCT01692782|467464668|FG001|Overall Study|Non-compliant with study visits|0|||
129865389|NCT01692782|467464669|FG002|Overall Study|Non-compliant with study visits|1|||
129865390|NCT01692782|467464667|FG000|Overall Study|SAE not related to study drug|0|||
129865391|NCT01692782|467464668|FG001|Overall Study|SAE not related to study drug|1|||
129865392|NCT01692782|467464669|FG002|Overall Study|SAE not related to study drug|0|||
129865393|NCT01692782|467464667|FG000|Overall Study|Withdrawal by Subject|3|||
129865394|NCT01692782|467464668|FG001|Overall Study|Withdrawal by Subject|10|||
129865395|NCT01692782|467464669|FG002|Overall Study|Withdrawal by Subject|3|||
129865396|NCT03252587|467464670|FG000|Overall Study|Adverse Event|3|||
129865397|NCT03252587|467464671|FG001|Overall Study|Adverse Event|8|||
129865398|NCT03252587|467464672|FG002|Overall Study|Adverse Event|6|||
129865399|NCT03252587|467464673|FG003|Overall Study|Adverse Event|12|||
129865400|NCT03252587|467464670|FG000|Overall Study|Lack of Efficacy|7|||
129865401|NCT03252587|467464671|FG001|Overall Study|Lack of Efficacy|2|||
129865402|NCT03252587|467464672|FG002|Overall Study|Lack of Efficacy|2|||
129865403|NCT03252587|467464673|FG003|Overall Study|Lack of Efficacy|4|||
129865404|NCT03252587|467464670|FG000|Overall Study|Lost to Follow-up|2|||
129865405|NCT03252587|467464671|FG001|Overall Study|Lost to Follow-up|0|||
129865406|NCT03252587|467464672|FG002|Overall Study|Lost to Follow-up|0|||
129865407|NCT03252587|467464673|FG003|Overall Study|Lost to Follow-up|2|||
129865408|NCT03252587|467464670|FG000|Overall Study|Pregnancy|2|||
129865409|NCT03252587|467464671|FG001|Overall Study|Pregnancy|1|||
129865410|NCT03252587|467464672|FG002|Overall Study|Pregnancy|0|||
129865411|NCT03252587|467464673|FG003|Overall Study|Pregnancy|1|||
129865412|NCT03252587|467464670|FG000|Overall Study|Withdrawal by Subject|8|||
129865413|NCT03252587|467464671|FG001|Overall Study|Withdrawal by Subject|4|||
129865414|NCT03252587|467464672|FG002|Overall Study|Withdrawal by Subject|4|||
129865415|NCT03252587|467464673|FG003|Overall Study|Withdrawal by Subject|4|||
129865416|NCT03252587|467464670|FG000|Overall Study|Other Reasons|2|||
129865417|NCT03252587|467464671|FG001|Overall Study|Other Reasons|5|||
129865418|NCT03252587|467464672|FG002|Overall Study|Other Reasons|5|||
129865419|NCT03252587|467464673|FG003|Overall Study|Other Reasons|4|||
129865420|NCT04052204|467464674|FG000|Overall Study|Death|1|||
129865421|NCT04052204|467464675|FG001|Overall Study|Death|0|||
129865422|NCT04052204|467464676|FG002|Overall Study|Death|0|||
129865423|NCT04052204|467464674|FG000|Overall Study|Progressive disease|1|||
129865424|NCT04052204|467464675|FG001|Overall Study|Progressive disease|0|||
129865425|NCT04052204|467464676|FG002|Overall Study|Progressive disease|0|||
129865426|NCT04052204|467464674|FG000|Overall Study|Other|1|||
129865427|NCT04052204|467464675|FG001|Overall Study|Other|0|||
129865428|NCT04052204|467464676|FG002|Overall Study|Other|0|||
129865429|NCT03945188|467464677|FG000|Overall Study|Protocol Violation|1|||
129865430|NCT03945188|467464678|FG001|Overall Study|Protocol Violation|0|||
129865431|NCT03945188|467464677|FG000|Overall Study|Disease worsening|79|||
129865432|NCT03945188|467464678|FG001|Overall Study|Disease worsening|73|||
129865433|NCT03945188|467464677|FG000|Overall Study|Physician Decision|2|||
129865434|NCT03945188|467464678|FG001|Overall Study|Physician Decision|2|||
129865435|NCT03945188|467464677|FG000|Overall Study|Lack of Efficacy|7|||
129865436|NCT03945188|467464678|FG001|Overall Study|Lack of Efficacy|4|||
129865437|NCT03945188|467464677|FG000|Overall Study|Pregnancy|2|||
129865438|NCT03945188|467464678|FG001|Overall Study|Pregnancy|0|||
129865439|NCT03945188|467464677|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
129915016|NCT02671435|467651487|FG002|Overall Study|Un-specified|0|||
129915017|NCT02671435|467651488|FG003|Overall Study|Un-specified|0|||
129915018|NCT02671435|467651489|FG004|Overall Study|Un-specified|1|||
129915019|NCT02671435|467651490|FG005|Overall Study|Un-specified|3|||
129915020|NCT02671435|467651491|FG006|Overall Study|Un-specified|2|||
129915021|NCT02671435|467651492|FG007|Overall Study|Un-specified|3|||
129915022|NCT02671435|467651493|FG008|Overall Study|Un-specified|0|||
129915023|NCT02671435|467651494|FG009|Overall Study|Un-specified|5|||
129915024|NCT02671435|467651495|FG010|Overall Study|Un-specified|8|||
129915025|NCT02671435|467651496|FG011|Overall Study|Un-specified|4|||
129915026|NCT02671435|467651497|FG012|Overall Study|Un-specified|5|||
129915027|NCT02671435|467651498|FG013|Overall Study|Un-specified|9|||
129915028|NCT02671435|467651499|FG014|Overall Study|Un-specified|8|||
129915029|NCT02412748|467651502|FG000|Overall Study|Lost to Follow-up|38|||
129915030|NCT02412748|467651503|FG001|Overall Study|Lost to Follow-up|39|||
129915031|NCT03069313|467651504|FG000|Overall Study|Adverse Event|5|||
129915032|NCT04820686|467651508|FG000|Overall Study|Withdrawal by Subject|5|||
129915033|NCT04820686|467651509|FG001|Overall Study|Withdrawal by Subject|2|||
129915034|NCT04820686|467651510|FG002|Overall Study|Withdrawal by Subject|3|||
129915035|NCT04820686|467651508|FG000|Overall Study|Study Termination|25|||
129915036|NCT04820686|467651509|FG001|Overall Study|Study Termination|13|||
129915037|NCT04820686|467651510|FG002|Overall Study|Study Termination|14|||
129915038|NCT04820686|467651508|FG000|Overall Study|Adverse Event|0|||
129915039|NCT04820686|467651509|FG001|Overall Study|Adverse Event|1|||
129915040|NCT04820686|467651510|FG002|Overall Study|Adverse Event|0|||
129915041|NCT01872078|467651511|FG000|Overall Study|Adverse Event|0|||
129915042|NCT01872078|467651512|FG001|Overall Study|Adverse Event|0|||
129915043|NCT01872078|467651513|FG002|Overall Study|Adverse Event|1|||
129915044|NCT01872078|467651514|FG003|Overall Study|Adverse Event|0|||
129915045|NCT01872078|467651511|FG000|Overall Study|Dose administration non-compliance|0|||
129915046|NCT01872078|467651512|FG001|Overall Study|Dose administration non-compliance|0|||
129915047|NCT01872078|467651513|FG002|Overall Study|Dose administration non-compliance|0|||
129915048|NCT01872078|467651514|FG003|Overall Study|Dose administration non-compliance|1|||
129915049|NCT01872078|467651511|FG000|Overall Study|Protocol Violation|0|||
129915050|NCT01872078|467651512|FG001|Overall Study|Protocol Violation|0|||
129915051|NCT01872078|467651513|FG002|Overall Study|Protocol Violation|1|||
129915052|NCT01872078|467651514|FG003|Overall Study|Protocol Violation|0|||
129915053|NCT01872078|467651511|FG000|Overall Study|Withdrawal by Subject|0|||
129915054|NCT01872078|467651512|FG001|Overall Study|Withdrawal by Subject|0|||
129915055|NCT01872078|467651513|FG002|Overall Study|Withdrawal by Subject|1|||
129915056|NCT01872078|467651514|FG003|Overall Study|Withdrawal by Subject|0|||
129915057|NCT01872078|467651511|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
129915058|NCT01872078|467651512|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
129915059|NCT01872078|467651513|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
129915060|NCT01872078|467651514|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
129915061|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
129915062|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
129915063|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
129915064|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
129915065|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
129915066|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
129915067|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
129915068|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
129915069|NCT01424670|467651515|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
129915070|NCT01424670|467651516|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
129915071|NCT01424670|467651515|FG000|Continuation Period|Adverse Event|13|||
129915072|NCT01424670|467651516|FG001|Continuation Period|Adverse Event|5|||
129915073|NCT01424670|467651515|FG000|Continuation Period|Lost to Follow-up|2|||
129915074|NCT01424670|467651516|FG001|Continuation Period|Lost to Follow-up|0|||
129915075|NCT01424670|467651515|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
129915076|NCT01424670|467651516|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
129915077|NCT01424670|467651515|FG000|Continuation Period|Physician Decision|5|||
129915078|NCT01424670|467651516|FG001|Continuation Period|Physician Decision|4|||
129915079|NCT01424670|467651515|FG000|Continuation Period|Withdrawal by Subject|13|||
129915080|NCT01424670|467651516|FG001|Continuation Period|Withdrawal by Subject|4|||
129915081|NCT00761189|467651517|FG000|Overall Study|Adverse Event|42|||
129915082|NCT00761189|467651517|FG000|Overall Study|Lack of Efficacy|45|||
129915083|NCT00761189|467651517|FG000|Overall Study|Lost to Follow-up|36|||
129915084|NCT00761189|467651517|FG000|Overall Study|Withdrawal by Subject|49|||
129915085|NCT00761189|467651517|FG000|Overall Study|Other|13|||
129865440|NCT03945188|467464678|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
129865441|NCT03945188|467464677|FG000|Overall Study|Adverse Event|10|||
129865442|NCT03945188|467464678|FG001|Overall Study|Adverse Event|5|||
129865443|NCT03945188|467464677|FG000|Overall Study|Other|2|||
129865444|NCT03945188|467464678|FG001|Overall Study|Other|2|||
129865445|NCT03945188|467464677|FG000|Overall Study|Lost to Follow-up|1|||
129865446|NCT03945188|467464678|FG001|Overall Study|Lost to Follow-up|2|||
129865447|NCT01618162|467464699|FG000|Overall Study|Protocol Violation|13|||
129865448|NCT01618162|467464700|FG001|Overall Study|Protocol Violation|10|||
129865449|NCT01618162|467464699|FG000|Overall Study|Adverse Event|9|||
129865450|NCT01618162|467464700|FG001|Overall Study|Adverse Event|2|||
129865451|NCT01618162|467464699|FG000|Overall Study|Withdrawal Criteria|2|||
129865452|NCT01618162|467464700|FG001|Overall Study|Withdrawal Criteria|10|||
129865453|NCT01618162|467464699|FG000|Overall Study|Unclassified|14|||
129865454|NCT01618162|467464700|FG001|Overall Study|Unclassified|13|||
129865455|NCT03152526|467464706|FG000|Overall Study|Withdrawal by Subject|0|||
129865456|NCT03152526|467464707|FG001|Overall Study|Withdrawal by Subject|1|||
129865457|NCT02395042|467464708|FG000|Treatment 1 Period|Adverse Event|1|||
129865458|NCT02395042|467464709|FG001|Treatment 1 Period|Adverse Event|3|||
129865459|NCT02395042|467464710|FG002|Treatment 1 Period|Adverse Event|1|||
129865460|NCT02395042|467464708|FG000|Treatment 1 Period|Lack of Efficacy|1|||
129865461|NCT02395042|467464709|FG001|Treatment 1 Period|Lack of Efficacy|1|||
129865462|NCT02395042|467464710|FG002|Treatment 1 Period|Lack of Efficacy|0|||
129865463|NCT02395042|467464708|FG000|Treatment 1 Period|Lost to Follow-up|1|||
129865464|NCT02395042|467464709|FG001|Treatment 1 Period|Lost to Follow-up|0|||
129865465|NCT02395042|467464710|FG002|Treatment 1 Period|Lost to Follow-up|0|||
129865466|NCT02395042|467464708|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
129865467|NCT02395042|467464709|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
129865468|NCT02395042|467464710|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
129865469|NCT02395042|467464708|FG000|Treatment 2 Period|Lack of Efficacy|1|||
129865470|NCT02395042|467464709|FG001|Treatment 2 Period|Lack of Efficacy|1|||
129865471|NCT02395042|467464710|FG002|Treatment 2 Period|Lack of Efficacy|0|||
129865472|NCT02807558|467464711|FG000|Overall Study|Consent withdrawn by participant|4|||
129865473|NCT02807558|467464712|FG001|Overall Study|Consent withdrawn by participant|0|||
129865474|NCT02807558|467464713|FG002|Overall Study|Consent withdrawn by participant|4|||
129865475|NCT02807558|467464714|FG003|Overall Study|Consent withdrawn by participant|2|||
129865476|NCT02807558|467464715|FG004|Overall Study|Consent withdrawn by participant|1|||
129865477|NCT02807558|467464716|FG005|Overall Study|Consent withdrawn by participant|0|||
129865478|NCT02807558|467464711|FG000|Overall Study|Non-compliance with Study Drug|0|||
129865479|NCT02807558|467464712|FG001|Overall Study|Non-compliance with Study Drug|0|||
129865480|NCT02807558|467464713|FG002|Overall Study|Non-compliance with Study Drug|1|||
129865481|NCT02807558|467464714|FG003|Overall Study|Non-compliance with Study Drug|0|||
129865482|NCT02807558|467464715|FG004|Overall Study|Non-compliance with Study Drug|0|||
129865483|NCT02807558|467464716|FG005|Overall Study|Non-compliance with Study Drug|0|||
129865484|NCT02807558|467464711|FG000|Overall Study|Adverse Event|0|||
129865485|NCT02807558|467464712|FG001|Overall Study|Adverse Event|0|||
129865486|NCT02807558|467464713|FG002|Overall Study|Adverse Event|9|||
129865487|NCT02807558|467464714|FG003|Overall Study|Adverse Event|0|||
129865488|NCT02807558|467464715|FG004|Overall Study|Adverse Event|0|||
129865489|NCT02807558|467464716|FG005|Overall Study|Adverse Event|0|||
129865490|NCT02807558|467464711|FG000|Overall Study|Death|23|||
129915086|NCT03481816|467651521|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
129915087|NCT03481816|467651522|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
129865491|NCT02807558|467464712|FG001|Overall Study|Death|2|||
129865492|NCT02807558|467464713|FG002|Overall Study|Death|3|||
129865493|NCT02807558|467464714|FG003|Overall Study|Death|43|||
129865494|NCT02807558|467464715|FG004|Overall Study|Death|24|||
129865495|NCT02807558|467464716|FG005|Overall Study|Death|15|||
129865496|NCT02807558|467464711|FG000|Overall Study|Progressive Disease|0|||
129865497|NCT02807558|467464712|FG001|Overall Study|Progressive Disease|0|||
129865498|NCT02807558|467464713|FG002|Overall Study|Progressive Disease|1|||
129865499|NCT02807558|467464714|FG003|Overall Study|Progressive Disease|0|||
129915088|NCT03481816|467651521|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
129915089|NCT03481816|467651522|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
129915090|NCT03481816|467651521|FG000|Dose Expansion|Withdrawal by Subject|0|||
129915091|NCT03481816|467651522|FG001|Dose Expansion|Withdrawal by Subject|2|||
129915092|NCT03481816|467651521|FG000|Dose Expansion|Physician Decision|0|||
129915093|NCT03481816|467651522|FG001|Dose Expansion|Physician Decision|5|||
129915094|NCT04924062|467652854|FG000|Overall Study|Death|49|||
129915095|NCT04924062|467652855|FG001|Overall Study|Death|63|||
129915096|NCT04924062|467652854|FG000|Overall Study|Participant On-going|26|||
129915097|NCT04924062|467652855|FG001|Overall Study|Participant On-going|20|||
129915098|NCT04607044|467652858|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
129915099|NCT04607044|467652858|FG000|Overall Study|Adverse Event|1|||
129915100|NCT04607044|467652858|FG000|Overall Study|Did not receive study device|3|||
129915101|NCT04607044|467652858|FG000|Overall Study|Death|1|||
129915102|NCT03651895|467652859|FG000|First Drug Assignment|Adverse Event|4|||
129915103|NCT03651895|467652860|FG001|First Drug Assignment|Adverse Event|5|||
129915104|NCT03651895|467652859|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
129915105|NCT03651895|467652860|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
129915106|NCT02525692|467652861|FG000|Overall Study|Withdrawal by Subject|1|||
129915107|NCT02525692|467652862|FG001|Overall Study|Withdrawal by Subject|1|||
129915108|NCT02525692|467652863|FG002|Overall Study|Withdrawal by Subject|0|||
129915109|NCT02525692|467652864|FG003|Overall Study|Withdrawal by Subject|5|||
129915110|NCT02525692|467652865|FG004|Overall Study|Withdrawal by Subject|0|||
129915111|NCT02525692|467652866|FG005|Overall Study|Withdrawal by Subject|1|||
129915112|NCT02525692|467652861|FG000|Overall Study|Death|16|||
129915113|NCT02525692|467652862|FG001|Overall Study|Death|18|||
129915114|NCT02525692|467652863|FG002|Overall Study|Death|7|||
129915115|NCT02525692|467652864|FG003|Overall Study|Death|20|||
129915116|NCT02525692|467652865|FG004|Overall Study|Death|3|||
129915117|NCT02525692|467652866|FG005|Overall Study|Death|6|||
129915118|NCT02525692|467652861|FG000|Overall Study|Lost to Follow-up|0|||
129915119|NCT02525692|467652862|FG001|Overall Study|Lost to Follow-up|0|||
129915120|NCT02525692|467652863|FG002|Overall Study|Lost to Follow-up|1|||
129915121|NCT02525692|467652864|FG003|Overall Study|Lost to Follow-up|5|||
129915122|NCT02525692|467652865|FG004|Overall Study|Lost to Follow-up|0|||
129915123|NCT02525692|467652866|FG005|Overall Study|Lost to Follow-up|0|||
129915124|NCT02396199|467652867|FG000|Overall Study|Lost to Follow-up|1|||
129915125|NCT02396199|467652867|FG000|Overall Study|Death|4|||
129915126|NCT04337372|467652876|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
129915127|NCT04337372|467652877|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
129915128|NCT04337372|467652878|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
129915129|NCT04337372|467652879|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
129915130|NCT04337372|467652876|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
129915131|NCT04337372|467652877|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
129915132|NCT04337372|467652878|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
129915133|NCT04337372|467652879|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
129915134|NCT04337372|467652876|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
129915135|NCT04337372|467652877|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
129915136|NCT04337372|467652878|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
129915137|NCT04337372|467652879|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
129915138|NCT04337372|467652876|FG000|Day 2: EEG Measures|Protocol Violation|6|||
129915139|NCT04337372|467652877|FG001|Day 2: EEG Measures|Protocol Violation|6|||
129915140|NCT04337372|467652878|FG002|Day 2: EEG Measures|Protocol Violation|5|||
129915141|NCT04337372|467652879|FG003|Day 2: EEG Measures|Protocol Violation|17|||
129915142|NCT05307783|467652880|FG000|Overall Study|Death|7|||
129915143|NCT05307783|467652880|FG000|Overall Study|Lost to Follow-up|4|||
129915144|NCT04883645|467652881|FG000|Overall Study|Death|1|||
129915145|NCT04869982|467652882|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
129915146|NCT04869982|467652883|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
129915147|NCT04869982|467652882|FG000|Overall Study|Migrated / moved from the study area|1|||
129915148|NCT04869982|467652883|FG001|Overall Study|Migrated / moved from the study area|1|||
129915149|NCT04869982|467652882|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
129915150|NCT04869982|467652883|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
129915151|NCT04869982|467652882|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
129915152|NCT04869982|467652883|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
129915153|NCT04869982|467652882|FG000|Overall Study|Solicited adverse event|2|||
129915154|NCT04869982|467652883|FG001|Overall Study|Solicited adverse event|1|||
129915155|NCT00567398|467652884|FG000|Overall Study|Adverse Event|6|||
129449780|NCT03700320|465945680|FG001|Overall Study|Reason not Specified|1|||
129449781|NCT00175877|465945681|FG000|Overall Study|Adverse Event|136|||
129915156|NCT00567398|467652885|FG001|Overall Study|Adverse Event|14|||
129915157|NCT00567398|467652884|FG000|Overall Study|Physician Decision|0|||
129915158|NCT00567398|467652885|FG001|Overall Study|Physician Decision|4|||
129915159|NCT00567398|467652884|FG000|Overall Study|Withdrawal by Subject|0|||
129915160|NCT00567398|467652885|FG001|Overall Study|Withdrawal by Subject|2|||
129915161|NCT00567398|467652884|FG000|Overall Study|Renal Transplantation|0|||
129865500|NCT02807558|467464715|FG004|Overall Study|Progressive Disease|0|||
129865501|NCT02807558|467464716|FG005|Overall Study|Progressive Disease|0|||
129865502|NCT02807558|467464711|FG000|Overall Study|Other than specified|1|||
129865503|NCT02807558|467464712|FG001|Overall Study|Other than specified|0|||
129865504|NCT02807558|467464713|FG002|Overall Study|Other than specified|2|||
129865505|NCT02807558|467464714|FG003|Overall Study|Other than specified|0|||
129865506|NCT02807558|467464715|FG004|Overall Study|Other than specified|1|||
129865507|NCT02807558|467464716|FG005|Overall Study|Other than specified|1|||
129865508|NCT02807558|467464711|FG000|Overall Study|Lack of Efficacy|0|||
129865509|NCT02807558|467464712|FG001|Overall Study|Lack of Efficacy|0|||
129865510|NCT02807558|467464713|FG002|Overall Study|Lack of Efficacy|9|||
129865511|NCT02807558|467464714|FG003|Overall Study|Lack of Efficacy|0|||
129865512|NCT02807558|467464715|FG004|Overall Study|Lack of Efficacy|0|||
129865513|NCT02807558|467464716|FG005|Overall Study|Lack of Efficacy|0|||
129865514|NCT02477111|467464717|FG000|Overall Study|Death|28|||
129865515|NCT02477111|467464717|FG000|Overall Study|Withdrawal by Subject|19|||
129865516|NCT02477111|467464717|FG000|Overall Study|Lost to Follow-up|4|||
129865517|NCT02192502|467464719|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
129865518|NCT02192502|467464720|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
129865519|NCT02192502|467464719|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
129865520|NCT02192502|467464720|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
129865521|NCT02192502|467464719|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
129865522|NCT02192502|467464720|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
129865523|NCT01328574|467464729|FG000|Overall Study|Refused further treatment|1|||
129865524|NCT00003298|467464730|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
129865525|NCT00003298|467464730|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
129865526|NCT00003298|467464730|FG000|Surgery|Unresectable at surgery|3|||
129865527|NCT00003298|467464730|FG000|Surgery|Progression before surgery|2|||
129865528|NCT00003298|467464730|FG000|Surgery|Unevaluable and off study|2|||
129865529|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
129865530|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
129865531|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
129865532|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
129865533|NCT00003298|467464730|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
129865534|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
129865535|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
129865536|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
129865537|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
129865538|NCT00003298|467464730|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
129865539|NCT01994954|467464735|FG000|Overall Study|Death|1|||
129865540|NCT01994954|467464736|FG001|Overall Study|Death|0|||
129865541|NCT01994954|467464735|FG000|Overall Study|Withdrawal by Subject|9|||
129865542|NCT01994954|467464736|FG001|Overall Study|Withdrawal by Subject|14|||
129865543|NCT01994954|467464735|FG000|Overall Study|Physician Decision|2|||
129865544|NCT01994954|467464736|FG001|Overall Study|Physician Decision|2|||
129865545|NCT01994954|467464735|FG000|Overall Study|Lost to Follow-up|8|||
129865546|NCT01994954|467464736|FG001|Overall Study|Lost to Follow-up|10|||
129865547|NCT01994954|467464735|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
129865548|NCT01994954|467464736|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
129865549|NCT00675766|467464737|FG000|Overall Study|Lost to Follow-up|6|||
129865550|NCT00675766|467464738|FG001|Overall Study|Lost to Follow-up|5|||
129865551|NCT00675766|467464739|FG002|Overall Study|Lost to Follow-up|21|||
129865552|NCT00675766|467464740|FG003|Overall Study|Lost to Follow-up|26|||
129865553|NCT01454583|467464747|FG000|1st Year|Lost to Follow-up|1057|||
129865554|NCT01454583|467464748|FG001|1st Year|Lost to Follow-up|318|||
129865555|NCT01454583|467464749|FG002|1st Year|Lost to Follow-up|180|||
129865556|NCT01454583|467464747|FG000|2nd Year|Lost to Follow-up|3965|||
129865557|NCT01454583|467464748|FG001|2nd Year|Lost to Follow-up|1049|||
129865558|NCT01454583|467464749|FG002|2nd Year|Lost to Follow-up|737|||
129865559|NCT01454583|467464747|FG000|3rd Year|Lost to Follow-up|1959|||
129865560|NCT01454583|467464748|FG001|3rd Year|Lost to Follow-up|512|||
129865561|NCT01454583|467464749|FG002|3rd Year|Lost to Follow-up|297|||
129865562|NCT02677116|467464752|FG000|Overall Study|Adverse Event|0|||
129865563|NCT02677116|467464753|FG001|Overall Study|Adverse Event|1|||
129865564|NCT02677116|467464754|FG002|Overall Study|Adverse Event|0|||
129865565|NCT02677116|467464755|FG003|Overall Study|Adverse Event|0|||
129865566|NCT02677116|467464756|FG004|Overall Study|Adverse Event|0|||
129865567|NCT02677116|467464757|FG005|Overall Study|Adverse Event|1|||
129865568|NCT02677116|467464758|FG006|Overall Study|Adverse Event|1|||
129865569|NCT02677116|467464759|FG007|Overall Study|Adverse Event|0|||
129865570|NCT02677116|467464760|FG008|Overall Study|Adverse Event|0|||
129865571|NCT02677116|467464752|FG000|Overall Study|Physician Decision|0|||
129865572|NCT02677116|467464753|FG001|Overall Study|Physician Decision|2|||
129865573|NCT02677116|467464754|FG002|Overall Study|Physician Decision|3|||
129865574|NCT02677116|467464755|FG003|Overall Study|Physician Decision|2|||
129915162|NCT00567398|467652885|FG001|Overall Study|Renal Transplantation|3|||
129915163|NCT00567398|467652884|FG000|Overall Study|Other|1|||
129915164|NCT00567398|467652885|FG001|Overall Study|Other|0|||
129915165|NCT02201108|467652888|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
129915166|NCT02201108|467652889|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
129915167|NCT02201108|467652890|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
129915168|NCT02201108|467652888|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
129915169|NCT02201108|467652889|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
129915170|NCT02201108|467652890|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
129915171|NCT02201108|467652888|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
129915172|NCT02201108|467652889|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
129915173|NCT02201108|467652890|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
129915174|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
129915175|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
129915176|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
129915177|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
129915178|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
129915179|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
129915180|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Other reason|4|||
129915181|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Other reason|7|||
129915182|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Other reason|0|||
129915183|NCT02201108|467652888|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
129915184|NCT02201108|467652889|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
129915185|NCT02201108|467652890|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
129915186|NCT02201108|467652888|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
129915187|NCT02201108|467652889|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
129915188|NCT02201108|467652890|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
129915189|NCT02201108|467652888|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
129915190|NCT02201108|467652889|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
129915191|NCT02201108|467652890|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
129915192|NCT03055377|467652900|FG000|Treatment Phase|Lost to Follow-up|28|||
129915193|NCT03055377|467652901|FG001|Treatment Phase|Lost to Follow-up|24|||
129915194|NCT03055377|467652900|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
129915195|NCT03055377|467652901|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
129915196|NCT04143061|467652903|FG000|Overall Study|Protocol Deviation|0|||
129915197|NCT04143061|467652904|FG001|Overall Study|Protocol Deviation|0|||
129915198|NCT04143061|467652905|FG002|Overall Study|Protocol Deviation|0|||
129915199|NCT04143061|467652906|FG003|Overall Study|Protocol Deviation|0|||
129915200|NCT04143061|467652907|FG004|Overall Study|Protocol Deviation|0|||
129915201|NCT04143061|467652908|FG005|Overall Study|Protocol Deviation|0|||
129915202|NCT04143061|467652909|FG006|Overall Study|Protocol Deviation|5|||
129915203|NCT04143061|467652910|FG007|Overall Study|Protocol Deviation|5|||
129915204|NCT04143061|467652903|FG000|Overall Study|Withdrawal by Subject|2|||
129915205|NCT04143061|467652904|FG001|Overall Study|Withdrawal by Subject|0|||
129915206|NCT04143061|467652905|FG002|Overall Study|Withdrawal by Subject|0|||
129915207|NCT04143061|467652906|FG003|Overall Study|Withdrawal by Subject|0|||
129915208|NCT04143061|467652907|FG004|Overall Study|Withdrawal by Subject|0|||
129915209|NCT04143061|467652908|FG005|Overall Study|Withdrawal by Subject|1|||
129915210|NCT04143061|467652909|FG006|Overall Study|Withdrawal by Subject|0|||
129915211|NCT04143061|467652910|FG007|Overall Study|Withdrawal by Subject|0|||
129915212|NCT04143061|467652903|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129915213|NCT04143061|467652904|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129915214|NCT04143061|467652905|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129915215|NCT04143061|467652906|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129915216|NCT04143061|467652907|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
129915217|NCT04143061|467652908|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
129915218|NCT04143061|467652909|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
129915219|NCT04143061|467652910|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
129915220|NCT03602014|467652911|FG000|Overall Study|Lost to Follow-up|2|||
129915221|NCT03602014|467652912|FG001|Overall Study|Lost to Follow-up|0|||
129915222|NCT03602014|467652913|FG002|Overall Study|Lost to Follow-up|0|||
129915223|NCT04905407|467652914|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
129915224|NCT04905407|467652915|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
129915225|NCT04905407|467652916|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
129915226|NCT04905407|467652917|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
129915227|NCT04905407|467652914|FG000|Part 1 and Part 2|Death|7|||
129915228|NCT04905407|467652915|FG001|Part 1 and Part 2|Death|7|||
129915229|NCT04905407|467652916|FG002|Part 1 and Part 2|Death|7|||
129865575|NCT02677116|467464756|FG004|Overall Study|Physician Decision|1|||
129865576|NCT02677116|467464757|FG005|Overall Study|Physician Decision|3|||
129865577|NCT02677116|467464758|FG006|Overall Study|Physician Decision|1|||
129915230|NCT04905407|467652917|FG003|Part 1 and Part 2|Death|0|||
129915231|NCT04905407|467652914|FG000|Part 1 and Part 2|Other than specified|0|||
129915232|NCT04905407|467652915|FG001|Part 1 and Part 2|Other than specified|0|||
129915233|NCT04905407|467652916|FG002|Part 1 and Part 2|Other than specified|1|||
129915234|NCT04905407|467652917|FG003|Part 1 and Part 2|Other than specified|0|||
129915235|NCT04905407|467652914|FG000|Part 3|Death|0|||
129915236|NCT04905407|467652915|FG001|Part 3|Death|0|||
129915237|NCT04905407|467652916|FG002|Part 3|Death|0|||
129915238|NCT04905407|467652917|FG003|Part 3|Death|2|||
129915239|NCT04823611|467652918|FG000|Overall Study|Adverse Event|2|||
129915240|NCT04823611|467652919|FG001|Overall Study|Adverse Event|0|||
129915241|NCT04823611|467652920|FG002|Overall Study|Adverse Event|1|||
129915242|NCT04823611|467652921|FG003|Overall Study|Adverse Event|0|||
129915243|NCT04823611|467652922|FG004|Overall Study|Adverse Event|0|||
129915244|NCT04823611|467652923|FG005|Overall Study|Adverse Event|0|||
129915245|NCT04823611|467652924|FG006|Overall Study|Adverse Event|0|||
129915246|NCT01894061|467652926|FG000|Overall Study|Screen failure|1|||
129915247|NCT01894061|467652926|FG000|Overall Study|Withdrawal by Subject|1|||
129915248|NCT01673984|467652927|FG000|Overall Study|Adverse Event|1|||
129915249|NCT01673984|467652928|FG001|Overall Study|Adverse Event|0|||
129915250|NCT01673984|467652927|FG000|Overall Study|Study termination|9|||
129915251|NCT01673984|467652928|FG001|Overall Study|Study termination|6|||
129915252|NCT04437433|467652929|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
129915253|NCT04437433|467652930|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
129915254|NCT04437433|467652929|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
129915255|NCT04437433|467652930|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
129915256|NCT04437433|467652929|FG000|Overall Study|Adverse Event|9|||
129915257|NCT04437433|467652930|FG001|Overall Study|Adverse Event|0|||
129915258|NCT04437433|467652929|FG000|Overall Study|Lack of Efficacy|4|||
129915259|NCT04437433|467652930|FG001|Overall Study|Lack of Efficacy|0|||
129915260|NCT04437433|467652929|FG000|Overall Study|Withdrawal by Subject|4|||
129915261|NCT04437433|467652930|FG001|Overall Study|Withdrawal by Subject|1|||
129915262|NCT04437433|467652929|FG000|Overall Study|Protocol Deviation|0|||
129915263|NCT04437433|467652930|FG001|Overall Study|Protocol Deviation|1|||
129915264|NCT04437433|467652929|FG000|Overall Study|Other, not specified|0|||
129915265|NCT04437433|467652930|FG001|Overall Study|Other, not specified|1|||
129915266|NCT04048681|467652931|FG000|Overall Study|family emergency|0|||
129915267|NCT04048681|467652932|FG001|Overall Study|family emergency|0|||
129915268|NCT04048681|467652933|FG002|Overall Study|family emergency|0|||
129915269|NCT04048681|467652934|FG003|Overall Study|family emergency|1|||
129915270|NCT04048681|467652935|FG004|Overall Study|family emergency|0|||
129915271|NCT02919449|467652936|FG000|Overall Study|Withdrawal by Subject|1|||
129915272|NCT02919449|467652936|FG000|Overall Study|Investigator decision|1|||
129915273|NCT05623345|467652939|FG000|Overall Study|Withdrawal by Subject|14|||
129915274|NCT05623345|467652940|FG001|Overall Study|Withdrawal by Subject|0|||
129915275|NCT05623345|467652941|FG002|Overall Study|Withdrawal by Subject|9|||
129915276|NCT05623345|467652942|FG003|Overall Study|Withdrawal by Subject|20|||
129915277|NCT05623345|467652939|FG000|Overall Study|Lost to Follow-up|3|||
129915278|NCT05623345|467652940|FG001|Overall Study|Lost to Follow-up|0|||
129915279|NCT05623345|467652941|FG002|Overall Study|Lost to Follow-up|7|||
129915280|NCT05623345|467652942|FG003|Overall Study|Lost to Follow-up|2|||
129915281|NCT05623345|467652939|FG000|Overall Study|Termination of Study By Sponsor|37|||
129915282|NCT05623345|467652940|FG001|Overall Study|Termination of Study By Sponsor|4|||
129915283|NCT05623345|467652941|FG002|Overall Study|Termination of Study By Sponsor|40|||
129915284|NCT05623345|467652942|FG003|Overall Study|Termination of Study By Sponsor|38|||
129915285|NCT05384730|467652943|FG000|Overall Study|Adverse Event|1|||
129865578|NCT02677116|467464759|FG007|Overall Study|Physician Decision|1|||
129865579|NCT02677116|467464760|FG008|Overall Study|Physician Decision|2|||
129865580|NCT02677116|467464752|FG000|Overall Study|Withdrawal by parent or guardian|2|||
129865581|NCT02677116|467464753|FG001|Overall Study|Withdrawal by parent or guardian|1|||
129865582|NCT02677116|467464754|FG002|Overall Study|Withdrawal by parent or guardian|0|||
129915286|NCT05384730|467652944|FG001|Overall Study|Adverse Event|0|||
129915287|NCT05384730|467652943|FG000|Overall Study|Lack of social support|2|||
129915288|NCT05384730|467652944|FG001|Overall Study|Lack of social support|0|||
129915289|NCT05384730|467652943|FG000|Overall Study|Hospital readmission|2|||
129915290|NCT05384730|467652944|FG001|Overall Study|Hospital readmission|0|||
129915291|NCT05384730|467652943|FG000|Overall Study|Disease progression|5|||
129915292|NCT05384730|467652944|FG001|Overall Study|Disease progression|0|||
129915293|NCT05384730|467652943|FG000|Overall Study|Overwhelmed with College commitments|0|||
129915294|NCT05384730|467652944|FG001|Overall Study|Overwhelmed with College commitments|2|||
129865583|NCT02677116|467464755|FG003|Overall Study|Withdrawal by parent or guardian|1|||
129915295|NCT01772472|467652946|FG000|Overall Study|Death|126|||
129915296|NCT01772472|467652947|FG001|Overall Study|Death|94|||
129915297|NCT01772472|467652946|FG000|Overall Study|Lost to Follow-up|51|||
129915298|NCT01772472|467652947|FG001|Overall Study|Lost to Follow-up|50|||
129865584|NCT02677116|467464756|FG004|Overall Study|Withdrawal by parent or guardian|0|||
129865585|NCT02677116|467464757|FG005|Overall Study|Withdrawal by parent or guardian|0|||
129865586|NCT02677116|467464758|FG006|Overall Study|Withdrawal by parent or guardian|2|||
129865587|NCT02677116|467464759|FG007|Overall Study|Withdrawal by parent or guardian|1|||
129865588|NCT02677116|467464760|FG008|Overall Study|Withdrawal by parent or guardian|0|||
129865589|NCT02677116|467464752|FG000|Overall Study|Withdrawal by Subject|1|||
129865590|NCT02677116|467464753|FG001|Overall Study|Withdrawal by Subject|0|||
129865591|NCT02677116|467464754|FG002|Overall Study|Withdrawal by Subject|0|||
129865592|NCT02677116|467464755|FG003|Overall Study|Withdrawal by Subject|0|||
129865593|NCT02677116|467464756|FG004|Overall Study|Withdrawal by Subject|0|||
129865594|NCT02677116|467464757|FG005|Overall Study|Withdrawal by Subject|0|||
129865595|NCT02677116|467464758|FG006|Overall Study|Withdrawal by Subject|0|||
129865596|NCT02677116|467464759|FG007|Overall Study|Withdrawal by Subject|0|||
129865597|NCT02677116|467464760|FG008|Overall Study|Withdrawal by Subject|0|||
129865598|NCT03182868|467464761|FG000|Overall Study|Protocol Violation|3|||
129865599|NCT03182868|467464762|FG001|Overall Study|Protocol Violation|0|||
129865600|NCT03182868|467464763|FG002|Overall Study|Protocol Violation|4|||
129865601|NCT03182868|467464764|FG003|Overall Study|Protocol Violation|1|||
129865602|NCT03182868|467464765|FG004|Overall Study|Protocol Violation|8|||
129865603|NCT02363946|467464767|FG000|Overall Study|Lost to Follow-up|0|||
129865604|NCT02363946|467464768|FG001|Overall Study|Lost to Follow-up|0|||
129865605|NCT02363946|467464769|FG002|Overall Study|Lost to Follow-up|0|||
129865606|NCT02363946|467464770|FG003|Overall Study|Lost to Follow-up|0|||
129865607|NCT02363946|467464771|FG004|Overall Study|Lost to Follow-up|0|||
129865608|NCT02363946|467464772|FG005|Overall Study|Lost to Follow-up|0|||
129865609|NCT02363946|467464773|FG006|Overall Study|Lost to Follow-up|0|||
129865610|NCT02363946|467464774|FG007|Overall Study|Lost to Follow-up|1|||
129865611|NCT02363946|467464775|FG008|Overall Study|Lost to Follow-up|0|||
129865612|NCT02363946|467464776|FG009|Overall Study|Lost to Follow-up|0|||
129865613|NCT02363946|467464777|FG010|Overall Study|Lost to Follow-up|0|||
129865614|NCT02363946|467464778|FG011|Overall Study|Lost to Follow-up|0|||
129865615|NCT02363946|467464779|FG012|Overall Study|Lost to Follow-up|0|||
129865616|NCT01967732|467464780|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
129865617|NCT01967732|467464781|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
129865618|NCT01967732|467464782|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
129865619|NCT01967732|467464783|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
129865620|NCT01967732|467464780|FG000|First Intervention (Day 1)|Poor venous access|0|||
129865621|NCT01967732|467464781|FG001|First Intervention (Day 1)|Poor venous access|1|||
129865622|NCT01967732|467464782|FG002|First Intervention (Day 1)|Poor venous access|0|||
129865623|NCT01967732|467464783|FG003|First Intervention (Day 1)|Poor venous access|0|||
129865624|NCT03342638|467464784|FG000|Overall Study|Withdrawal by Subject|1|||
129865625|NCT03342638|467464785|FG001|Overall Study|Withdrawal by Subject|0|||
129865626|NCT03342638|467464784|FG000|Overall Study|Physician Decision|0|||
129865627|NCT03342638|467464785|FG001|Overall Study|Physician Decision|1|||
129865628|NCT01292239|467464801|FG000|Overall Study|Other|1|||
129865629|NCT01292239|467464802|FG001|Overall Study|Other|1|||
129865630|NCT01292239|467464801|FG000|Overall Study|Withdrawal by Subject|3|||
129865631|NCT01292239|467464802|FG001|Overall Study|Withdrawal by Subject|6|||
129865632|NCT00113568|467464803|FG000|Overall Study|Adverse Event|97|||
129865633|NCT00113568|467464803|FG000|Overall Study|Death|1|||
129865634|NCT00113568|467464803|FG000|Overall Study|Lack of Efficacy|30|||
129865635|NCT00113568|467464803|FG000|Overall Study|Lost to Follow-up|156|||
129865636|NCT00113568|467464803|FG000|Overall Study|Protocol Violation|32|||
129865637|NCT00113568|467464803|FG000|Overall Study|Withdrawal by Subject|117|||
129865638|NCT00113568|467464803|FG000|Overall Study|Other|112|||
129865639|NCT00262821|467464804|FG000|Overall Study|Ineligible - wrong stage|0|||
129865640|NCT00262821|467464805|FG001|Overall Study|Ineligible - wrong stage|3|||
129865641|NCT00262821|467464804|FG000|Overall Study|Ineligible - wrong cell type|2|||
129865642|NCT00262821|467464805|FG001|Overall Study|Ineligible - wrong cell type|2|||
129865643|NCT00262821|467464804|FG000|Overall Study|Ineligible - wrong primary|0|||
129865644|NCT00262821|467464805|FG001|Overall Study|Ineligible - wrong primary|1|||
129865645|NCT00262821|467464804|FG000|Overall Study|Ineligible - inadequate pathology|1|||
129865646|NCT00262821|467464805|FG001|Overall Study|Ineligible - inadequate pathology|3|||
129865647|NCT00262821|467464804|FG000|Overall Study|Ineligible - elevated creatinine|0|||
129865648|NCT00262821|467464805|FG001|Overall Study|Ineligible - elevated creatinine|2|||
129865649|NCT00262821|467464804|FG000|Overall Study|Ineligible - required test not done|1|||
129865650|NCT00262821|467464805|FG001|Overall Study|Ineligible - required test not done|4|||
129865651|NCT00262821|467464804|FG000|Overall Study|Inevaluable - inadequate data|0|||
129865652|NCT00262821|467464805|FG001|Overall Study|Inevaluable - inadequate data|4|||
129865653|NCT01988779|467464807|FG000|Overall Study|Withdrawal by Subject|2|||
129865654|NCT01988779|467464808|FG001|Overall Study|Withdrawal by Subject|2|||
129865655|NCT01988779|467464807|FG000|Overall Study|Protocol Violation|1|||
129865656|NCT01988779|467464808|FG001|Overall Study|Protocol Violation|0|||
129865657|NCT00584727|467464809|FG000|First Intervention|Discontinuation|0|||
129865658|NCT00584727|467464810|FG001|First Intervention|Discontinuation|0|||
129865659|NCT00584727|467464811|FG002|First Intervention|Discontinuation|1|||
129865660|NCT00584727|467464812|FG003|First Intervention|Discontinuation|0|||
129865661|NCT00584727|467464813|FG004|First Intervention|Discontinuation|0|||
129865662|NCT00584727|467464814|FG005|First Intervention|Discontinuation|0|||
129865663|NCT00584727|467464809|FG000|Third Intervention|Protocol Violation|0|||
129865664|NCT00584727|467464810|FG001|Third Intervention|Protocol Violation|0|||
129865665|NCT00584727|467464811|FG002|Third Intervention|Protocol Violation|1|||
129865666|NCT00584727|467464812|FG003|Third Intervention|Protocol Violation|0|||
129865667|NCT00584727|467464813|FG004|Third Intervention|Protocol Violation|4|||
129865668|NCT00584727|467464814|FG005|Third Intervention|Protocol Violation|2|||
129865669|NCT00377403|467464816|FG000|Overall Study|Unable to contact for telephone intervie|4|||
129865670|NCT00377403|467464817|FG001|Overall Study|Unable to contact for telephone intervie|7|||
129865671|NCT01922076|467464818|FG000|Overall Study|Adverse Event|0|||
129865672|NCT01922076|467464819|FG001|Overall Study|Adverse Event|0|||
129865673|NCT01922076|467464820|FG002|Overall Study|Adverse Event|0|||
129915299|NCT01772472|467652946|FG000|Overall Study|Other|9|||
129915300|NCT01772472|467652947|FG001|Overall Study|Other|7|||
129915301|NCT01772472|467652946|FG000|Overall Study|Physician Decision|1|||
129915302|NCT01772472|467652947|FG001|Overall Study|Physician Decision|7|||
129915303|NCT01772472|467652946|FG000|Overall Study|Withdrawal by Subject|115|||
129915304|NCT01772472|467652947|FG001|Overall Study|Withdrawal by Subject|90|||
129915305|NCT01772472|467652946|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
129915306|NCT01772472|467652947|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
129915307|NCT02697136|467652948|FG000|Overall Study|Adverse Event|3|||
129915308|NCT02697136|467652949|FG001|Overall Study|Adverse Event|0|||
129865674|NCT01922076|467464821|FG003|Overall Study|Adverse Event|0|||
129865675|NCT01922076|467464822|FG004|Overall Study|Adverse Event|1|||
129865676|NCT01922076|467464823|FG005|Overall Study|Adverse Event|0|||
129865677|NCT01922076|467464824|FG006|Overall Study|Adverse Event|0|||
129865678|NCT01922076|467464818|FG000|Overall Study|Physician Decision|0|||
129865679|NCT01922076|467464819|FG001|Overall Study|Physician Decision|0|||
129865680|NCT01922076|467464820|FG002|Overall Study|Physician Decision|1|||
129865681|NCT01922076|467464821|FG003|Overall Study|Physician Decision|0|||
129865682|NCT01922076|467464822|FG004|Overall Study|Physician Decision|0|||
129865683|NCT01922076|467464823|FG005|Overall Study|Physician Decision|0|||
129865684|NCT01922076|467464824|FG006|Overall Study|Physician Decision|0|||
129865685|NCT01922076|467464818|FG000|Overall Study|Withdrawal by Subject|0|||
129865686|NCT01922076|467464819|FG001|Overall Study|Withdrawal by Subject|0|||
129865687|NCT01922076|467464820|FG002|Overall Study|Withdrawal by Subject|0|||
129865688|NCT01922076|467464821|FG003|Overall Study|Withdrawal by Subject|1|||
129865689|NCT01922076|467464822|FG004|Overall Study|Withdrawal by Subject|0|||
129865690|NCT01922076|467464823|FG005|Overall Study|Withdrawal by Subject|1|||
129865691|NCT01922076|467464824|FG006|Overall Study|Withdrawal by Subject|1|||
129865692|NCT01018394|467464827|FG000|Overall Study|Withdrawal by Subject|5|||
129865693|NCT01018394|467464828|FG001|Overall Study|Withdrawal by Subject|5|||
129865694|NCT01018394|467464827|FG000|Overall Study|Lost to Follow-up|4|||
129865695|NCT01018394|467464828|FG001|Overall Study|Lost to Follow-up|3|||
129865696|NCT00683644|467464829|FG000|Overall Study|Withdrawal by Subject|4|||
129865697|NCT00683644|467464830|FG001|Overall Study|Withdrawal by Subject|2|||
129865698|NCT00683644|467464829|FG000|Overall Study|Lost to Follow-up|1|||
129865699|NCT00683644|467464830|FG001|Overall Study|Lost to Follow-up|4|||
129865700|NCT00683644|467464829|FG000|Overall Study|Adverse Event|1|||
129865701|NCT00683644|467464830|FG001|Overall Study|Adverse Event|2|||
129865702|NCT00683644|467464829|FG000|Overall Study|Low copper, other health problems,|7|||
129865703|NCT00683644|467464830|FG001|Overall Study|Low copper, other health problems,|6|||
129865704|NCT01669122|467464833|FG000|Period I|Lost to Follow-up|1|||
129865705|NCT01669122|467464833|FG000|Washout Period II|Protocol Violation|2|||
129865706|NCT03762473|467464834|FG000|Overall Study|Death|1|||
129865707|NCT03762473|467464835|FG001|Overall Study|Death|0|||
129865708|NCT05132699|467464836|FG000|Overall Study|Withdrawal by Subject|3|||
129865709|NCT05132699|467464837|FG001|Overall Study|Withdrawal by Subject|0|||
129865710|NCT02858895|467464840|FG000|Overall Study|Disease progression|31|||
129865711|NCT02858895|467464840|FG000|Overall Study|Death|2|||
129915309|NCT03578536|467652953|FG000|Overall Study|Lost to Follow-up|1|||
129915310|NCT04431726|467652954|FG000|Overall Study|Ongoing in the Study|55|||
129915311|NCT04116736|467652955|FG000|Overall Study|Withdrew consent during study|3|||
129865712|NCT02858895|467464840|FG000|Overall Study|Adverse Event|1|||
129865713|NCT02858895|467464840|FG000|Overall Study|Withdrawal by Subject|3|||
129865714|NCT02858895|467464840|FG000|Overall Study|hospice,|1|||
129865715|NCT02858895|467464840|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
129865716|NCT02277444|467464849|FG000|Overall Study|Adverse Event|10|||
129865717|NCT02277444|467464849|FG000|Overall Study|Withdrawal by Subject|3|||
129865718|NCT02277444|467464849|FG000|Overall Study|Other|1|||
129915312|NCT04116736|467652956|FG001|Overall Study|Withdrew consent during study|1|||
129915313|NCT04116736|467652955|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
129915314|NCT04116736|467652956|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
129915315|NCT04116736|467652955|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
129865719|NCT02277444|467464849|FG000|Overall Study|Enrolled and not Treated|3|||
129865720|NCT02277444|467464849|FG000|Overall Study|Ongoing|113|||
129865721|NCT00785291|467467113|FG000|Overall Study|Never began treatment|8|||
129865722|NCT00785291|467467114|FG001|Overall Study|Never began treatment|4|||
129865723|NCT00785291|467467115|FG002|Overall Study|Never began treatment|4|||
129865724|NCT00785291|467467113|FG000|Overall Study|Adverse Event|39|||
129865725|NCT00785291|467467114|FG001|Overall Study|Adverse Event|70|||
129865726|NCT00785291|467467115|FG002|Overall Study|Adverse Event|56|||
129865727|NCT00785291|467467113|FG000|Overall Study|Death|7|||
129865728|NCT00785291|467467114|FG001|Overall Study|Death|4|||
129865729|NCT00785291|467467115|FG002|Overall Study|Death|3|||
129865730|NCT00785291|467467113|FG000|Overall Study|Withdrawal by Subject|35|||
129865731|NCT00785291|467467114|FG001|Overall Study|Withdrawal by Subject|36|||
129865732|NCT00785291|467467115|FG002|Overall Study|Withdrawal by Subject|17|||
129865733|NCT00785291|467467113|FG000|Overall Study|Alternative Therapy|12|||
129865734|NCT00785291|467467114|FG001|Overall Study|Alternative Therapy|6|||
129865735|NCT00785291|467467115|FG002|Overall Study|Alternative Therapy|7|||
129865736|NCT00785291|467467113|FG000|Overall Study|Complicating illness|6|||
129865737|NCT00785291|467467114|FG001|Overall Study|Complicating illness|4|||
129865738|NCT00785291|467467115|FG002|Overall Study|Complicating illness|4|||
129865739|NCT00785291|467467113|FG000|Overall Study|Other Medical Reasons|29|||
129865740|NCT00785291|467467114|FG001|Overall Study|Other Medical Reasons|25|||
129865741|NCT00785291|467467115|FG002|Overall Study|Other Medical Reasons|15|||
129865742|NCT00570674|467467116|FG000|Overall Study|Withdrawal by Subject|0|||
129865743|NCT00570674|467467117|FG001|Overall Study|Withdrawal by Subject|0|||
129865744|NCT00570674|467467118|FG002|Overall Study|Withdrawal by Subject|1|||
129865745|NCT00570674|467467119|FG003|Overall Study|Withdrawal by Subject|0|||
129865746|NCT00570674|467467120|FG004|Overall Study|Withdrawal by Subject|0|||
129865747|NCT00570674|467467121|FG005|Overall Study|Withdrawal by Subject|0|||
129865748|NCT00570674|467467122|FG006|Overall Study|Withdrawal by Subject|0|||
129865749|NCT02979639|467467123|FG000|Overall Study|Withdrawal based on medical judgement|1|||
129865750|NCT02979639|467467123|FG000|Overall Study|Lost to Follow-up|8|||
129865751|NCT02979639|467467123|FG000|Overall Study|Withdrawal by Subject|3|||
129865752|NCT02979639|467467123|FG000|Overall Study|Adverse Event|2|||
129865753|NCT04050865|467467126|FG000|Overall Study|Adverse Event|1|||
129865754|NCT04050865|467467127|FG001|Overall Study|Adverse Event|0|||
129865755|NCT04050865|467467126|FG000|Overall Study|no insert|1|||
129865756|NCT04050865|467467127|FG001|Overall Study|no insert|0|||
129865757|NCT04050865|467467126|FG000|Overall Study|Only 1 insert|2|||
129865758|NCT04050865|467467127|FG001|Overall Study|Only 1 insert|3|||
129865759|NCT04050865|467467126|FG000|Overall Study|Physician Decision|0|||
129865760|NCT04050865|467467127|FG001|Overall Study|Physician Decision|1|||
129865761|NCT04050865|467467126|FG000|Overall Study|Withdrawal by Subject|0|||
129865762|NCT04050865|467467127|FG001|Overall Study|Withdrawal by Subject|1|||
129865763|NCT04205630|467467136|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
129865764|NCT04205630|467467136|FG000|Overall Study|Disease clinical progression|7|||
129865765|NCT04205630|467467136|FG000|Overall Study|Withdrawal by Subject|2|||
129865766|NCT04205630|467467136|FG000|Overall Study|Adverse Event|17|||
129865767|NCT04205630|467467136|FG000|Overall Study|Other|1|||
129865768|NCT00160680|467467147|FG000|Overall Study|Adverse Event|0|||
129865769|NCT00160680|467467148|FG001|Overall Study|Adverse Event|1|||
129865770|NCT00160680|467467147|FG000|Overall Study|Lack of Efficacy|2|||
129865771|NCT00160680|467467148|FG001|Overall Study|Lack of Efficacy|1|||
129865772|NCT00160680|467467147|FG000|Overall Study|Lost to Follow-up|3|||
129865773|NCT00160680|467467148|FG001|Overall Study|Lost to Follow-up|2|||
129865774|NCT00160680|467467147|FG000|Overall Study|Withdrawal by Subject|4|||
129865775|NCT00160680|467467148|FG001|Overall Study|Withdrawal by Subject|9|||
129865776|NCT03393000|467467149|FG000|Overall Study|Death|11|||
129865777|NCT03393000|467467149|FG000|Overall Study|Withdrawal by Subject|2|||
129865778|NCT03393000|467467149|FG000|Overall Study|Physician Decision|1|||
129865779|NCT01773070|467467150|FG000|Overall Study|Withdrawal by Subject|24|||
129865780|NCT01773070|467467150|FG000|Overall Study|Lost to Follow-up|39|||
129865781|NCT01773070|467467150|FG000|Overall Study|Other|15|||
129865782|NCT01773070|467467150|FG000|Overall Study|Death (unrelated to study procedures)|3|||
129865783|NCT02450331|467467151|FG000|Overall Study|Death|162|||
129865784|NCT02450331|467467152|FG001|Overall Study|Death|171|||
129865785|NCT02450331|467467151|FG000|Overall Study|Lost to Follow-up|14|||
129865786|NCT02450331|467467152|FG001|Overall Study|Lost to Follow-up|12|||
129865787|NCT02450331|467467151|FG000|Overall Study|Withdrawal by Subject|55|||
129865788|NCT02450331|467467152|FG001|Overall Study|Withdrawal by Subject|44|||
129865789|NCT02450331|467467151|FG000|Overall Study|Non-specified other|1|||
129865790|NCT02450331|467467152|FG001|Overall Study|Non-specified other|1|||
129865791|NCT02723864|467467153|FG000|Overall Study|Refused further treatment|1|||
129865792|NCT02723864|467467154|FG001|Overall Study|Refused further treatment|0|||
129865793|NCT02723864|467467155|FG002|Overall Study|Refused further treatment|0|||
129865794|NCT02723864|467467156|FG003|Overall Study|Refused further treatment|0|||
129865795|NCT02723864|467467157|FG004|Overall Study|Refused further treatment|1|||
129865796|NCT02723864|467467158|FG005|Overall Study|Refused further treatment|2|||
129915316|NCT04116736|467652956|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
129915317|NCT04116736|467652955|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
129915318|NCT04116736|467652956|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
129915319|NCT04116736|467652955|FG000|Overall Study|Subject was enrolled in error|2|||
129915320|NCT04116736|467652956|FG001|Overall Study|Subject was enrolled in error|0|||
129915321|NCT04116736|467652955|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
129915322|NCT04116736|467652956|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
129915323|NCT04116736|467652955|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
129915324|NCT04116736|467652956|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
129915325|NCT04116736|467652955|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
129915326|NCT04116736|467652956|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
129915327|NCT04157348|467652960|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
129915328|NCT04157348|467652961|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
129915329|NCT04157348|467652960|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129915330|NCT04157348|467652961|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129915331|NCT04157348|467652960|FG000|Double-blind Treatment Period|Adverse Event|0|||
129915332|NCT04157348|467652961|FG001|Double-blind Treatment Period|Adverse Event|1|||
129915333|NCT04157348|467652960|FG000|Open-label Extension Period|Adverse Event|1|||
129915334|NCT04157348|467652961|FG001|Open-label Extension Period|Adverse Event|1|||
129915335|NCT04157348|467652960|FG000|Open-label Extension Period|Death|0|||
129915336|NCT04157348|467652961|FG001|Open-label Extension Period|Death|1|||
129915337|NCT04157348|467652960|FG000|Open-label Extension Period|Lack of Efficacy|2|||
129915338|NCT04157348|467652961|FG001|Open-label Extension Period|Lack of Efficacy|2|||
129915339|NCT04157348|467652960|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
129915340|NCT04157348|467652961|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
129915341|NCT04157348|467652960|FG000|Open-label Extension Period|Ongoing|60|||
129915342|NCT04157348|467652961|FG001|Open-label Extension Period|Ongoing|57|||
129915343|NCT04157348|467652960|FG000|Open-label Extension Period|other reasons|1|||
129915344|NCT04157348|467652961|FG001|Open-label Extension Period|other reasons|1|||
129915345|NCT04854096|467652962|FG000|Overall Study|Adverse Event|1|||
129915346|NCT04854096|467652963|FG001|Overall Study|Adverse Event|0|||
129915347|NCT04854096|467652962|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
129915348|NCT04854096|467652963|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
129915349|NCT04854096|467652962|FG000|Overall Study|Withdrawal by Subject|1|||
129915350|NCT04854096|467652963|FG001|Overall Study|Withdrawal by Subject|0|||
129915351|NCT04854096|467652962|FG000|Overall Study|Other reasons|1|||
129915352|NCT04854096|467652963|FG001|Overall Study|Other reasons|0|||
129915353|NCT04757610|467652964|FG000|Overall Study|Adverse Event|13|||
129915354|NCT04757610|467652965|FG001|Overall Study|Adverse Event|10|||
129915355|NCT04757610|467652966|FG002|Overall Study|Adverse Event|5|||
129915356|NCT04757610|467652964|FG000|Overall Study|Death|5|||
129915357|NCT04757610|467652965|FG001|Overall Study|Death|13|||
129915358|NCT04757610|467652966|FG002|Overall Study|Death|8|||
129915359|NCT04757610|467652964|FG000|Overall Study|Lack of Efficacy|1|||
129915360|NCT04757610|467652965|FG001|Overall Study|Lack of Efficacy|2|||
129915361|NCT04757610|467652966|FG002|Overall Study|Lack of Efficacy|3|||
129915362|NCT04757610|467652964|FG000|Overall Study|Lost to Follow-up|7|||
129915363|NCT04757610|467652965|FG001|Overall Study|Lost to Follow-up|2|||
129915364|NCT04757610|467652966|FG002|Overall Study|Lost to Follow-up|7|||
129915365|NCT04757610|467652964|FG000|Overall Study|Physician Decision|4|||
129915366|NCT04757610|467652965|FG001|Overall Study|Physician Decision|1|||
129915367|NCT04757610|467652966|FG002|Overall Study|Physician Decision|2|||
129915368|NCT04757610|467652964|FG000|Overall Study|Withdrawal by Subject|26|||
129915369|NCT04757610|467652965|FG001|Overall Study|Withdrawal by Subject|25|||
129915370|NCT04757610|467652966|FG002|Overall Study|Withdrawal by Subject|25|||
129915371|NCT04757610|467652964|FG000|Overall Study|Study Terminated by Sponsor|105|||
129915372|NCT04757610|467652965|FG001|Overall Study|Study Terminated by Sponsor|105|||
129915373|NCT04757610|467652966|FG002|Overall Study|Study Terminated by Sponsor|110|||
129865797|NCT02723864|467467159|FG006|Overall Study|Refused further treatment|0|||
129865798|NCT02723864|467467153|FG000|Overall Study|Exceed treatment hold time|0|||
129865799|NCT02723864|467467154|FG001|Overall Study|Exceed treatment hold time|1|||
129865800|NCT02723864|467467155|FG002|Overall Study|Exceed treatment hold time|0|||
129865801|NCT02723864|467467156|FG003|Overall Study|Exceed treatment hold time|0|||
129865802|NCT02723864|467467157|FG004|Overall Study|Exceed treatment hold time|0|||
129865803|NCT02723864|467467158|FG005|Overall Study|Exceed treatment hold time|0|||
129865804|NCT02723864|467467159|FG006|Overall Study|Exceed treatment hold time|0|||
129865805|NCT02723864|467467153|FG000|Overall Study|Clinical progression|0|||
129865806|NCT02723864|467467154|FG001|Overall Study|Clinical progression|0|||
129865807|NCT02723864|467467155|FG002|Overall Study|Clinical progression|1|||
129915374|NCT04757610|467652964|FG000|Overall Study|Randomized in Error|1|||
129915375|NCT04757610|467652965|FG001|Overall Study|Randomized in Error|0|||
129915376|NCT04757610|467652966|FG002|Overall Study|Randomized in Error|0|||
129915377|NCT02965846|467652967|FG000|Overall Study|Lost to Follow-up|1|||
129915378|NCT02965846|467652968|FG001|Overall Study|Lost to Follow-up|0|||
129915379|NCT02965846|467652969|FG002|Overall Study|Lost to Follow-up|0|||
129915380|NCT02965846|467652967|FG000|Overall Study|Withdrawal by Subject|0|||
129915381|NCT02965846|467652968|FG001|Overall Study|Withdrawal by Subject|1|||
129915382|NCT02965846|467652969|FG002|Overall Study|Withdrawal by Subject|0|||
129915383|NCT02965846|467652967|FG000|Overall Study|Study Terminated By Sponsor|4|||
129915384|NCT02965846|467652968|FG001|Overall Study|Study Terminated By Sponsor|4|||
129915385|NCT02965846|467652969|FG002|Overall Study|Study Terminated By Sponsor|0|||
129915386|NCT02965846|467652967|FG000|Overall Study|Participants not randomized|0|||
129915387|NCT02965846|467652968|FG001|Overall Study|Participants not randomized|0|||
129915388|NCT02965846|467652969|FG002|Overall Study|Participants not randomized|33|||
129915389|NCT00879333|467652970|FG000|Overall Study|Adverse Event|94|||
129915390|NCT00879333|467652971|FG001|Overall Study|Adverse Event|34|||
129915391|NCT00879333|467652970|FG000|Overall Study|Abnormal Laboratory Value|1|||
129915392|NCT00879333|467652971|FG001|Overall Study|Abnormal Laboratory Value|0|||
129915393|NCT00879333|467652970|FG000|Overall Study|Withdrawal by Subject|20|||
129865808|NCT02723864|467467156|FG003|Overall Study|Clinical progression|0|||
129865809|NCT02723864|467467157|FG004|Overall Study|Clinical progression|0|||
129865810|NCT02723864|467467158|FG005|Overall Study|Clinical progression|3|||
129865811|NCT02723864|467467159|FG006|Overall Study|Clinical progression|1|||
129865812|NCT02723864|467467153|FG000|Overall Study|Physician Decision|0|||
129865813|NCT02723864|467467154|FG001|Overall Study|Physician Decision|0|||
129865814|NCT02723864|467467155|FG002|Overall Study|Physician Decision|0|||
129865815|NCT02723864|467467156|FG003|Overall Study|Physician Decision|0|||
129865816|NCT02723864|467467157|FG004|Overall Study|Physician Decision|0|||
129865817|NCT02723864|467467158|FG005|Overall Study|Physician Decision|0|||
129865818|NCT02723864|467467159|FG006|Overall Study|Physician Decision|1|||
129865819|NCT02723864|467467153|FG000|Overall Study|Changes in patient condition|0|||
129865820|NCT02723864|467467154|FG001|Overall Study|Changes in patient condition|0|||
129865821|NCT02723864|467467155|FG002|Overall Study|Changes in patient condition|0|||
129865822|NCT02723864|467467156|FG003|Overall Study|Changes in patient condition|0|||
129865823|NCT02723864|467467157|FG004|Overall Study|Changes in patient condition|0|||
129865824|NCT02723864|467467158|FG005|Overall Study|Changes in patient condition|1|||
129865825|NCT02723864|467467159|FG006|Overall Study|Changes in patient condition|0|||
129865826|NCT02723864|467467153|FG000|Overall Study|Patient choice|0|||
129865827|NCT02723864|467467154|FG001|Overall Study|Patient choice|0|||
129865828|NCT02723864|467467155|FG002|Overall Study|Patient choice|0|||
129865829|NCT02723864|467467156|FG003|Overall Study|Patient choice|0|||
129865830|NCT02723864|467467157|FG004|Overall Study|Patient choice|0|||
129865831|NCT02723864|467467158|FG005|Overall Study|Patient choice|1|||
129865832|NCT02723864|467467159|FG006|Overall Study|Patient choice|0|||
129865833|NCT02723864|467467153|FG000|Overall Study|Adverse Event|0|||
129865834|NCT02723864|467467154|FG001|Overall Study|Adverse Event|0|||
129865835|NCT02723864|467467155|FG002|Overall Study|Adverse Event|0|||
129865836|NCT02723864|467467156|FG003|Overall Study|Adverse Event|0|||
129865837|NCT02723864|467467157|FG004|Overall Study|Adverse Event|0|||
129865838|NCT02723864|467467158|FG005|Overall Study|Adverse Event|1|||
129865839|NCT02723864|467467159|FG006|Overall Study|Adverse Event|0|||
129865840|NCT02723864|467467153|FG000|Overall Study|Started new treatment|0|||
129865841|NCT02723864|467467154|FG001|Overall Study|Started new treatment|0|||
129865842|NCT02723864|467467155|FG002|Overall Study|Started new treatment|0|||
129865843|NCT02723864|467467156|FG003|Overall Study|Started new treatment|0|||
129865844|NCT02723864|467467157|FG004|Overall Study|Started new treatment|0|||
129865845|NCT02723864|467467158|FG005|Overall Study|Started new treatment|1|||
129865846|NCT02723864|467467159|FG006|Overall Study|Started new treatment|0|||
129865847|NCT02723864|467467153|FG000|Overall Study|Switched to alternative treatment|0|||
129865848|NCT02723864|467467154|FG001|Overall Study|Switched to alternative treatment|0|||
129865849|NCT02723864|467467155|FG002|Overall Study|Switched to alternative treatment|0|||
129865850|NCT02723864|467467156|FG003|Overall Study|Switched to alternative treatment|0|||
129865851|NCT02723864|467467157|FG004|Overall Study|Switched to alternative treatment|0|||
129865852|NCT02723864|467467158|FG005|Overall Study|Switched to alternative treatment|1|||
129865853|NCT02723864|467467159|FG006|Overall Study|Switched to alternative treatment|0|||
129865854|NCT02723864|467467153|FG000|Overall Study|Late determination of ineligibility|0|||
129865855|NCT02723864|467467154|FG001|Overall Study|Late determination of ineligibility|0|||
129865856|NCT02723864|467467155|FG002|Overall Study|Late determination of ineligibility|0|||
129865857|NCT02723864|467467156|FG003|Overall Study|Late determination of ineligibility|0|||
129865858|NCT02723864|467467157|FG004|Overall Study|Late determination of ineligibility|0|||
129865859|NCT02723864|467467158|FG005|Overall Study|Late determination of ineligibility|1|||
129865860|NCT02723864|467467159|FG006|Overall Study|Late determination of ineligibility|0|||
129865861|NCT03232983|467467164|FG000|Period 1|Physician Decision|0|||
129865862|NCT03232983|467467165|FG001|Period 1|Physician Decision|0|||
129865863|NCT03232983|467467166|FG002|Period 1|Physician Decision|1|||
129865864|NCT03232983|467467167|FG003|Period 1|Physician Decision|0|||
129865865|NCT03232983|467467164|FG000|Washout Period 2|Physician Decision|0|||
129865866|NCT03232983|467467165|FG001|Washout Period 2|Physician Decision|0|||
129865867|NCT03232983|467467166|FG002|Washout Period 2|Physician Decision|1|||
129865868|NCT03232983|467467167|FG003|Washout Period 2|Physician Decision|0|||
129865869|NCT03232983|467467164|FG000|Washout Period 2|Withdrawal by Subject|0|||
129865870|NCT03232983|467467165|FG001|Washout Period 2|Withdrawal by Subject|0|||
129865871|NCT03232983|467467166|FG002|Washout Period 2|Withdrawal by Subject|0|||
129865872|NCT03232983|467467167|FG003|Washout Period 2|Withdrawal by Subject|1|||
129865873|NCT03232983|467467164|FG000|Period 4|Withdrawal by Subject|1|||
129865874|NCT03232983|467467165|FG001|Period 4|Withdrawal by Subject|0|||
129865875|NCT03232983|467467166|FG002|Period 4|Withdrawal by Subject|0|||
129865876|NCT03232983|467467167|FG003|Period 4|Withdrawal by Subject|0|||
129865877|NCT03643952|467467168|FG000|Overall Study|Lack of Efficacy|1|||
129865878|NCT00530855|467467172|FG000|Overall Study|Lack of Efficacy|20|||
129865879|NCT00530855|467467172|FG000|Overall Study|Withdrawal by Subject|30|||
129865880|NCT00530855|467467172|FG000|Overall Study|Fatal Serious AE|3|||
129865881|NCT00530855|467467172|FG000|Overall Study|Non Fatal Serious AE|7|||
129865882|NCT00530855|467467172|FG000|Overall Study|Non Fatal Non Serious AE|12|||
129865883|NCT00530855|467467172|FG000|Overall Study|Protocol Violation|3|||
129865884|NCT00530855|467467172|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
129865885|NCT00530855|467467172|FG000|Overall Study|Lost to Follow-up|9|||
129865886|NCT00530855|467467172|FG000|Overall Study|Other reason for premature termination|17|||
129865887|NCT00815295|467467173|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
129865888|NCT00815295|467467174|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
129865889|NCT00815295|467467175|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
129865890|NCT01292876|467467176|FG000|Overall Study|Physician Decision|4|||
129865891|NCT01627327|467467177|FG000|Overall Study|Adverse Event|6|||
129865892|NCT01627327|467467178|FG001|Overall Study|Adverse Event|12|||
129865893|NCT01627327|467467177|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
129865894|NCT01627327|467467178|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
129865895|NCT01627327|467467177|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
129865896|NCT01627327|467467178|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
129865897|NCT01627327|467467177|FG000|Overall Study|Protocol Violation|4|||
129865898|NCT01627327|467467178|FG001|Overall Study|Protocol Violation|10|||
129865899|NCT01627327|467467177|FG000|Overall Study|Lost to Follow-up|1|||
129865900|NCT01627327|467467178|FG001|Overall Study|Lost to Follow-up|3|||
129865901|NCT01627327|467467177|FG000|Overall Study|Physician Decision|1|||
129865902|NCT01627327|467467178|FG001|Overall Study|Physician Decision|0|||
129865903|NCT01627327|467467177|FG000|Overall Study|Withdrawal by Subject|3|||
129865904|NCT01627327|467467178|FG001|Overall Study|Withdrawal by Subject|3|||
129865905|NCT04528069|467467184|FG000|Overall Study|Adverse Event|1|||
129865906|NCT04528069|467467184|FG000|Overall Study|Lost to Follow-up|1|||
129865907|NCT04528069|467467184|FG000|Overall Study|Patient Unable to Come|1|||
129865908|NCT04528069|467467184|FG000|Overall Study|Patient Unable to Attend|1|||
129865909|NCT02525874|467467187|FG000|Overall Study|Other|1|||
129865910|NCT02525874|467467187|FG000|Overall Study|Investigator Decision|1|||
129865911|NCT02525874|467467187|FG000|Overall Study|Consent withdrawn|22|||
129865912|NCT02525874|467467187|FG000|Overall Study|Non-compliance with study drug|3|||
129865913|NCT02525874|467467187|FG000|Overall Study|Adverse Event|17|||
129865914|NCT02525874|467467187|FG000|Overall Study|Lost to Follow-up|7|||
129865915|NCT02525874|467467187|FG000|Overall Study|Disease progression, defined by protocol|2|||
129865916|NCT02525874|467467187|FG000|Overall Study|Disease relapse|4|||
129865917|NCT02525874|467467187|FG000|Overall Study|Alternative Treatment for MS|2|||
129865918|NCT02525874|467467187|FG000|Overall Study|New lesions in Brain|1|||
129865919|NCT04124926|467467202|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
129865920|NCT04124926|467467203|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
129865921|NCT04124926|467467204|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
129865922|NCT04124926|467467205|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
129865923|NCT04124926|467467206|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
129865924|NCT04124926|467467202|FG000|Healing Phase|Protocol Violation|0|||
129865925|NCT04124926|467467203|FG001|Healing Phase|Protocol Violation|1|||
129865926|NCT04124926|467467204|FG002|Healing Phase|Protocol Violation|0|||
129865927|NCT04124926|467467205|FG003|Healing Phase|Protocol Violation|0|||
129865928|NCT04124926|467467206|FG004|Healing Phase|Protocol Violation|0|||
129865929|NCT04124926|467467202|FG000|Healing Phase|Lost to Follow-up|5|||
129865930|NCT04124926|467467203|FG001|Healing Phase|Lost to Follow-up|4|||
129865931|NCT04124926|467467204|FG002|Healing Phase|Lost to Follow-up|0|||
129865932|NCT04124926|467467205|FG003|Healing Phase|Lost to Follow-up|0|||
129865933|NCT04124926|467467206|FG004|Healing Phase|Lost to Follow-up|0|||
129865934|NCT04124926|467467202|FG000|Healing Phase|Voluntary Withdrawal|10|||
129865935|NCT04124926|467467203|FG001|Healing Phase|Voluntary Withdrawal|7|||
129865936|NCT04124926|467467204|FG002|Healing Phase|Voluntary Withdrawal|0|||
129865937|NCT04124926|467467205|FG003|Healing Phase|Voluntary Withdrawal|0|||
129865938|NCT04124926|467467206|FG004|Healing Phase|Voluntary Withdrawal|0|||
129865939|NCT04124926|467467202|FG000|Healing Phase|Withdrawal of Consent|5|||
129865940|NCT04124926|467467203|FG001|Healing Phase|Withdrawal of Consent|3|||
129865941|NCT04124926|467467204|FG002|Healing Phase|Withdrawal of Consent|0|||
129865942|NCT04124926|467467205|FG003|Healing Phase|Withdrawal of Consent|0|||
129865943|NCT04124926|467467206|FG004|Healing Phase|Withdrawal of Consent|0|||
129865944|NCT04124926|467467202|FG000|Healing Phase|Miscellaneous|8|||
129865945|NCT04124926|467467203|FG001|Healing Phase|Miscellaneous|7|||
129865946|NCT04124926|467467204|FG002|Healing Phase|Miscellaneous|0|||
129865947|NCT04124926|467467205|FG003|Healing Phase|Miscellaneous|0|||
129865948|NCT04124926|467467206|FG004|Healing Phase|Miscellaneous|0|||
129865949|NCT04124926|467467202|FG000|Healing Phase|Randomized but not Treated|0|||
129865950|NCT04124926|467467203|FG001|Healing Phase|Randomized but not Treated|3|||
129865951|NCT04124926|467467204|FG002|Healing Phase|Randomized but not Treated|0|||
129865952|NCT04124926|467467205|FG003|Healing Phase|Randomized but not Treated|0|||
129865953|NCT04124926|467467206|FG004|Healing Phase|Randomized but not Treated|0|||
129865954|NCT04124926|467467202|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
129865955|NCT04124926|467467203|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
129865956|NCT04124926|467467204|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
129865957|NCT04124926|467467205|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
129865958|NCT04124926|467467206|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
129865959|NCT04124926|467467202|FG000|Maintenance Phase|Protocol Violation|0|||
129865960|NCT04124926|467467203|FG001|Maintenance Phase|Protocol Violation|0|||
129865961|NCT04124926|467467204|FG002|Maintenance Phase|Protocol Violation|3|||
129865962|NCT04124926|467467205|FG003|Maintenance Phase|Protocol Violation|0|||
129865963|NCT04124926|467467206|FG004|Maintenance Phase|Protocol Violation|0|||
129865964|NCT04124926|467467202|FG000|Maintenance Phase|Lost to Follow-up|0|||
129865965|NCT04124926|467467203|FG001|Maintenance Phase|Lost to Follow-up|0|||
129865966|NCT04124926|467467204|FG002|Maintenance Phase|Lost to Follow-up|7|||
129865967|NCT04124926|467467205|FG003|Maintenance Phase|Lost to Follow-up|8|||
129865968|NCT04124926|467467206|FG004|Maintenance Phase|Lost to Follow-up|9|||
129865969|NCT04124926|467467202|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
129865970|NCT04124926|467467203|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
129865971|NCT04124926|467467204|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
129865972|NCT04124926|467467205|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
129865973|NCT04124926|467467206|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
129865974|NCT04124926|467467202|FG000|Maintenance Phase|Pregnancy|0|||
129865975|NCT04124926|467467203|FG001|Maintenance Phase|Pregnancy|0|||
129865976|NCT04124926|467467204|FG002|Maintenance Phase|Pregnancy|0|||
129865977|NCT04124926|467467205|FG003|Maintenance Phase|Pregnancy|1|||
129865978|NCT04124926|467467206|FG004|Maintenance Phase|Pregnancy|0|||
129865979|NCT04124926|467467202|FG000|Maintenance Phase|Lack of Efficacy|0|||
129865980|NCT04124926|467467203|FG001|Maintenance Phase|Lack of Efficacy|0|||
129865981|NCT04124926|467467204|FG002|Maintenance Phase|Lack of Efficacy|0|||
129865982|NCT04124926|467467205|FG003|Maintenance Phase|Lack of Efficacy|0|||
129865983|NCT04124926|467467206|FG004|Maintenance Phase|Lack of Efficacy|1|||
129865984|NCT04124926|467467202|FG000|Maintenance Phase|Withdrawal of Consent|0|||
129865985|NCT04124926|467467203|FG001|Maintenance Phase|Withdrawal of Consent|0|||
129865986|NCT04124926|467467204|FG002|Maintenance Phase|Withdrawal of Consent|5|||
129865987|NCT04124926|467467205|FG003|Maintenance Phase|Withdrawal of Consent|5|||
129865988|NCT04124926|467467206|FG004|Maintenance Phase|Withdrawal of Consent|5|||
129865989|NCT04124926|467467202|FG000|Maintenance Phase|Miscellaneous|0|||
129865990|NCT04124926|467467203|FG001|Maintenance Phase|Miscellaneous|0|||
129865991|NCT04124926|467467204|FG002|Maintenance Phase|Miscellaneous|1|||
129865992|NCT04124926|467467205|FG003|Maintenance Phase|Miscellaneous|2|||
129865993|NCT04124926|467467206|FG004|Maintenance Phase|Miscellaneous|4|||
129865994|NCT04124926|467467202|FG000|Maintenance Phase|Randomized but not Treated|0|||
129865995|NCT04124926|467467203|FG001|Maintenance Phase|Randomized but not Treated|0|||
129865996|NCT04124926|467467204|FG002|Maintenance Phase|Randomized but not Treated|2|||
129865997|NCT04124926|467467205|FG003|Maintenance Phase|Randomized but not Treated|2|||
129865998|NCT04124926|467467206|FG004|Maintenance Phase|Randomized but not Treated|0|||
129865999|NCT00423176|467467207|FG000|Overall Study|Adverse Event|4|||
129866000|NCT00423176|467467208|FG001|Overall Study|Adverse Event|6|||
129866001|NCT00423176|467467207|FG000|Overall Study|Treatment Failure|1|||
129866002|NCT00423176|467467208|FG001|Overall Study|Treatment Failure|6|||
129866003|NCT00423176|467467207|FG000|Overall Study|Lost to Follow-up|4|||
129866004|NCT00423176|467467208|FG001|Overall Study|Lost to Follow-up|7|||
129866005|NCT00423176|467467207|FG000|Overall Study|Withdrawal by Subject|4|||
129866006|NCT00423176|467467208|FG001|Overall Study|Withdrawal by Subject|3|||
129866007|NCT00423176|467467207|FG000|Overall Study|Protocol Violation|1|||
129866008|NCT00423176|467467208|FG001|Overall Study|Protocol Violation|3|||
129866009|NCT00423176|467467207|FG000|Overall Study|Did not meet protocol eligibility|2|||
129866010|NCT00423176|467467208|FG001|Overall Study|Did not meet protocol eligibility|4|||
129866011|NCT04867369|467467211|FG000|Overall Study|Withdrawal by Subject|1|||
129866012|NCT04867369|467467212|FG001|Overall Study|Withdrawal by Subject|0|||
129866013|NCT05554237|467467213|FG000|Part 2 (7 Days)|Adverse Event|0|||
129866014|NCT05554237|467467214|FG001|Part 2 (7 Days)|Adverse Event|0|||
129866015|NCT05554237|467467215|FG002|Part 2 (7 Days)|Adverse Event|0|||
129866016|NCT05554237|467467216|FG003|Part 2 (7 Days)|Adverse Event|0|||
129866017|NCT05554237|467467217|FG004|Part 2 (7 Days)|Adverse Event|2|||
129866018|NCT05554237|467467218|FG005|Part 2 (7 Days)|Adverse Event|0|||
129866019|NCT05554237|467467219|FG006|Part 2 (7 Days)|Adverse Event|0|||
129866020|NCT05554237|467467220|FG007|Part 2 (7 Days)|Adverse Event|0|||
129866021|NCT05554237|467467221|FG008|Part 2 (7 Days)|Adverse Event|0|||
129866022|NCT05554237|467467222|FG009|Part 2 (7 Days)|Adverse Event|1|||
129866023|NCT05554237|467467223|FG010|Part 2 (7 Days)|Adverse Event|0|||
129866024|NCT05554237|467467224|FG011|Part 2 (7 Days)|Adverse Event|0|||
129866025|NCT05554237|467467225|FG012|Part 2 (7 Days)|Adverse Event|1|||
129866026|NCT05554237|467467226|FG013|Part 2 (7 Days)|Adverse Event|0|||
129866027|NCT04435366|467467227|FG000|Year 1 (12 Months)|Adverse Event|3|||
129866028|NCT04435366|467467228|FG001|Year 1 (12 Months)|Adverse Event|0|||
129866029|NCT04435366|467467229|FG002|Year 1 (12 Months)|Adverse Event|2|||
129866030|NCT04435366|467467227|FG000|Year 1 (12 Months)|Death|2|||
129866031|NCT04435366|467467228|FG001|Year 1 (12 Months)|Death|0|||
129866032|NCT04435366|467467229|FG002|Year 1 (12 Months)|Death|1|||
129866033|NCT04435366|467467227|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
129866034|NCT04435366|467467228|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
129866035|NCT04435366|467467229|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
129866036|NCT04435366|467467227|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
129866037|NCT04435366|467467228|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
129866038|NCT04435366|467467229|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
129866039|NCT04435366|467467227|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
129866040|NCT04435366|467467228|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
129866041|NCT04435366|467467229|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
129866042|NCT04435366|467467227|FG000|Year 1 (12 Months)|Not treated|0|||
129866043|NCT04435366|467467228|FG001|Year 1 (12 Months)|Not treated|0|||
129866044|NCT04435366|467467229|FG002|Year 1 (12 Months)|Not treated|1|||
129866045|NCT04435366|467467227|FG000|Year 2 (12 Months)|Death|1|||
129866046|NCT04435366|467467228|FG001|Year 2 (12 Months)|Death|4|||
129866047|NCT04435366|467467229|FG002|Year 2 (12 Months)|Death|6|||
129866048|NCT04435366|467467227|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
129866049|NCT04435366|467467228|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
129866050|NCT04435366|467467229|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
129866051|NCT04435366|467467227|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
129866052|NCT04435366|467467228|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
129866053|NCT04435366|467467229|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
129866054|NCT04435366|467467227|FG000|Year 2 (12 Months)|Adverse Event|2|||
129866055|NCT04435366|467467228|FG001|Year 2 (12 Months)|Adverse Event|1|||
129866056|NCT04435366|467467229|FG002|Year 2 (12 Months)|Adverse Event|6|||
129866057|NCT03492281|467467233|FG000|Overall Study|Withdrawal by Subject|21|||
129866058|NCT03492281|467467234|FG001|Overall Study|Withdrawal by Subject|14|||
129866059|NCT03492281|467467235|FG002|Overall Study|Withdrawal by Subject|13|||
129866060|NCT03492281|467467233|FG000|Overall Study|Lost to Follow-up|14|||
129866061|NCT03492281|467467234|FG001|Overall Study|Lost to Follow-up|15|||
129866062|NCT03492281|467467235|FG002|Overall Study|Lost to Follow-up|10|||
129866063|NCT03492281|467467233|FG000|Overall Study|Adverse Event|6|||
129866064|NCT03492281|467467234|FG001|Overall Study|Adverse Event|8|||
129866065|NCT03492281|467467235|FG002|Overall Study|Adverse Event|13|||
129866066|NCT03492281|467467233|FG000|Overall Study|Lack of Efficacy|3|||
129866067|NCT03492281|467467234|FG001|Overall Study|Lack of Efficacy|0|||
129866068|NCT03492281|467467235|FG002|Overall Study|Lack of Efficacy|1|||
129866069|NCT03492281|467467233|FG000|Overall Study|Physician Decision|1|||
129866070|NCT03492281|467467234|FG001|Overall Study|Physician Decision|0|||
129866071|NCT03492281|467467235|FG002|Overall Study|Physician Decision|3|||
129866072|NCT03492281|467467233|FG000|Overall Study|Protocol Violation|0|||
129866073|NCT03492281|467467234|FG001|Overall Study|Protocol Violation|2|||
129866074|NCT03492281|467467235|FG002|Overall Study|Protocol Violation|1|||
129866075|NCT03492281|467467233|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
129866076|NCT03492281|467467234|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
129866077|NCT03492281|467467235|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
129866078|NCT03492281|467467233|FG000|Overall Study|Death|0|||
129866079|NCT03492281|467467234|FG001|Overall Study|Death|0|||
129866080|NCT03492281|467467235|FG002|Overall Study|Death|1|||
129866081|NCT03492281|467467233|FG000|Overall Study|Captured as Other in Database|8|||
129866082|NCT03492281|467467234|FG001|Overall Study|Captured as Other in Database|6|||
129866083|NCT03492281|467467235|FG002|Overall Study|Captured as Other in Database|3|||
129866084|NCT04575467|467467236|FG000|Overall Study|Adverse Event|0|||
129866085|NCT04575467|467467237|FG001|Overall Study|Adverse Event|1|||
129866086|NCT04575467|467467238|FG002|Overall Study|Adverse Event|0|||
129866087|NCT04575467|467467239|FG003|Overall Study|Adverse Event|0|||
129866088|NCT01483924|467467240|FG000|Overall Study|Withdrawal by Subject|2|||
129866089|NCT01483924|467467241|FG001|Overall Study|Withdrawal by Subject|0|||
129866090|NCT01483924|467467242|FG002|Overall Study|Withdrawal by Subject|0|||
129866091|NCT01483924|467467243|FG003|Overall Study|Withdrawal by Subject|1|||
129866092|NCT01483924|467467244|FG004|Overall Study|Withdrawal by Subject|1|||
129866093|NCT01483924|467467240|FG000|Overall Study|Adverse Event|0|||
129866094|NCT01483924|467467241|FG001|Overall Study|Adverse Event|0|||
129866095|NCT01483924|467467242|FG002|Overall Study|Adverse Event|1|||
129866096|NCT01483924|467467243|FG003|Overall Study|Adverse Event|1|||
129866097|NCT01483924|467467244|FG004|Overall Study|Adverse Event|0|||
129866098|NCT01483924|467467240|FG000|Overall Study|Non-compliance|0|||
129866099|NCT01483924|467467241|FG001|Overall Study|Non-compliance|0|||
129866100|NCT01483924|467467242|FG002|Overall Study|Non-compliance|0|||
129866101|NCT01483924|467467243|FG003|Overall Study|Non-compliance|1|||
129866102|NCT01483924|467467244|FG004|Overall Study|Non-compliance|1|||
129866103|NCT01483924|467467240|FG000|Overall Study|Sponsor concern over ECG result|0|||
129866104|NCT01483924|467467241|FG001|Overall Study|Sponsor concern over ECG result|0|||
129866105|NCT01483924|467467242|FG002|Overall Study|Sponsor concern over ECG result|0|||
129866106|NCT01483924|467467243|FG003|Overall Study|Sponsor concern over ECG result|1|||
129866107|NCT01483924|467467244|FG004|Overall Study|Sponsor concern over ECG result|0|||
129866108|NCT03565887|467467250|FG000|Overall Study|Adverse Event|1|||
129866109|NCT03565887|467467251|FG001|Overall Study|Adverse Event|0|||
129866110|NCT03565887|467467250|FG000|Overall Study|Withdrawal by Subject|0|||
129866111|NCT03565887|467467251|FG001|Overall Study|Withdrawal by Subject|2|||
129866112|NCT00449176|467467253|FG000|Overall Study|Withdrawal by Subject|39|||
129866113|NCT00449176|467467254|FG001|Overall Study|Withdrawal by Subject|43|||
129866114|NCT00449176|467467255|FG002|Overall Study|Withdrawal by Subject|59|||
129866115|NCT00449176|467467253|FG000|Overall Study|Lost to Follow-up|13|||
129866116|NCT00449176|467467254|FG001|Overall Study|Lost to Follow-up|8|||
129866117|NCT00449176|467467255|FG002|Overall Study|Lost to Follow-up|12|||
129866118|NCT00449176|467467253|FG000|Overall Study|Adverse Event|51|||
129866119|NCT00449176|467467254|FG001|Overall Study|Adverse Event|107|||
129866120|NCT00449176|467467255|FG002|Overall Study|Adverse Event|15|||
129866121|NCT00449176|467467253|FG000|Overall Study|Lack of Efficacy|13|||
129866122|NCT00449176|467467254|FG001|Overall Study|Lack of Efficacy|7|||
129866123|NCT00449176|467467255|FG002|Overall Study|Lack of Efficacy|50|||
129866124|NCT00449176|467467253|FG000|Overall Study|Study drug non-compliant|14|||
129866125|NCT00449176|467467254|FG001|Overall Study|Study drug non-compliant|11|||
129866126|NCT00449176|467467255|FG002|Overall Study|Study drug non-compliant|11|||
129866127|NCT00449176|467467253|FG000|Overall Study|all other|22|||
129866128|NCT00449176|467467254|FG001|Overall Study|all other|19|||
129866129|NCT00449176|467467255|FG002|Overall Study|all other|20|||
129866130|NCT00295022|467467259|FG000|Overall Study|Adverse Event|1|||
129866131|NCT00295022|467467260|FG001|Overall Study|Adverse Event|1|||
129866132|NCT00295022|467467261|FG002|Overall Study|Adverse Event|2|||
129866133|NCT00295022|467467259|FG000|Overall Study|Lost to Follow-up|0|||
129866134|NCT00295022|467467260|FG001|Overall Study|Lost to Follow-up|0|||
129866135|NCT00295022|467467261|FG002|Overall Study|Lost to Follow-up|1|||
129866136|NCT00295022|467467259|FG000|Overall Study|Withdrawal by Subject|0|||
129866137|NCT00295022|467467260|FG001|Overall Study|Withdrawal by Subject|0|||
129866138|NCT00295022|467467261|FG002|Overall Study|Withdrawal by Subject|2|||
129866139|NCT00734630|467467262|FG000|Overall Study|Lack of Efficacy|4|||
129866140|NCT00734630|467467263|FG001|Overall Study|Lack of Efficacy|4|||
129866141|NCT00734630|467467262|FG000|Overall Study|Withdrawal by Subject|7|||
129866142|NCT00734630|467467263|FG001|Overall Study|Withdrawal by Subject|9|||
129866143|NCT00734630|467467262|FG000|Overall Study|Lost to Follow-up|13|||
129866144|NCT00734630|467467263|FG001|Overall Study|Lost to Follow-up|7|||
129866145|NCT00734630|467467262|FG000|Overall Study|Protocol Violation|0|||
129866146|NCT00734630|467467263|FG001|Overall Study|Protocol Violation|3|||
129866147|NCT00734630|467467262|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129866148|NCT00734630|467467263|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
129866149|NCT00734630|467467262|FG000|Overall Study|Adverse Event|3|||
129866150|NCT00734630|467467263|FG001|Overall Study|Adverse Event|6|||
129866151|NCT00734630|467467262|FG000|Overall Study|Randomized in Error|0|||
129866152|NCT00734630|467467263|FG001|Overall Study|Randomized in Error|1|||
129866153|NCT00734630|467467262|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
129866154|NCT00734630|467467263|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
129866155|NCT00734630|467467262|FG000|Overall Study|Poor Compliance|1|||
129866156|NCT00734630|467467263|FG001|Overall Study|Poor Compliance|1|||
129866157|NCT02300220|467467270|FG000|Overall Study|Lost to Follow-up|1|||
129866158|NCT02300220|467467271|FG001|Overall Study|Lost to Follow-up|2|||
129866159|NCT02300220|467467270|FG000|Overall Study|Death|1|||
129866160|NCT02300220|467467271|FG001|Overall Study|Death|1|||
129866161|NCT02300220|467467270|FG000|Overall Study|Adverse Event|1|||
129915394|NCT00879333|467652971|FG001|Overall Study|Withdrawal by Subject|7|||
129915395|NCT00879333|467652970|FG000|Overall Study|Lost to Follow-up|2|||
129915396|NCT00879333|467652971|FG001|Overall Study|Lost to Follow-up|1|||
129915397|NCT00879333|467652970|FG000|Overall Study|Administrative Problems|2|||
129915398|NCT00879333|467652971|FG001|Overall Study|Administrative Problems|0|||
129915399|NCT00879333|467652970|FG000|Overall Study|Death|16|||
129915400|NCT00879333|467652971|FG001|Overall Study|Death|5|||
129915401|NCT00879333|467652970|FG000|Overall Study|Disease Progression|292|||
129915402|NCT00879333|467652971|FG001|Overall Study|Disease Progression|169|||
129915403|NCT00879333|467652970|FG000|Overall Study|Protocol Violation|1|||
129915404|NCT00879333|467652971|FG001|Overall Study|Protocol Violation|1|||
129915405|NCT04154384|467652972|FG000|Overall Study|Lost to Follow-up|24|||
129915406|NCT04154384|467652973|FG001|Overall Study|Lost to Follow-up|33|||
129915407|NCT04154384|467652974|FG002|Overall Study|Lost to Follow-up|0|||
129915408|NCT04154384|467652972|FG000|Overall Study|Withdrawal by Subject|7|||
129915409|NCT04154384|467652973|FG001|Overall Study|Withdrawal by Subject|18|||
129915410|NCT04154384|467652974|FG002|Overall Study|Withdrawal by Subject|0|||
129915411|NCT04154384|467652972|FG000|Overall Study|Missing outcome data|1|||
129915412|NCT04154384|467652973|FG001|Overall Study|Missing outcome data|0|||
129915413|NCT04154384|467652974|FG002|Overall Study|Missing outcome data|0|||
129915414|NCT05048186|467652975|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
129915415|NCT05048186|467652976|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
129915416|NCT05048186|467652975|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
129915417|NCT05048186|467652976|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
129915418|NCT00951379|467652977|FG000|Overall Study|Adverse Event|4|||
129915419|NCT00951379|467652978|FG001|Overall Study|Adverse Event|1|||
129915420|NCT00951379|467652977|FG000|Overall Study|Withdrawal by Subject|1|||
129915421|NCT00951379|467652978|FG001|Overall Study|Withdrawal by Subject|0|||
129915422|NCT00951379|467652977|FG000|Overall Study|Noncompliance|1|||
129915423|NCT00951379|467652978|FG001|Overall Study|Noncompliance|0|||
129915424|NCT00951379|467652977|FG000|Overall Study|Disease Progression|0|||
129915425|NCT00951379|467652978|FG001|Overall Study|Disease Progression|1|||
129915426|NCT04218266|467652979|FG000|Overall Study|Death|1|||
129915427|NCT04218266|467652980|FG001|Overall Study|Death|2|||
129915428|NCT04218266|467652981|FG002|Overall Study|Death|3|||
129915429|NCT04218266|467652979|FG000|Overall Study|Adverse Event|13|||
129915430|NCT04218266|467652980|FG001|Overall Study|Adverse Event|14|||
129915431|NCT04218266|467652981|FG002|Overall Study|Adverse Event|11|||
129915432|NCT04218266|467652979|FG000|Overall Study|Other|7|||
129915433|NCT04218266|467652980|FG001|Overall Study|Other|5|||
129915434|NCT04218266|467652981|FG002|Overall Study|Other|14|||
129915435|NCT04218266|467652979|FG000|Overall Study|Physician Decision|1|||
129915436|NCT04218266|467652980|FG001|Overall Study|Physician Decision|3|||
129915437|NCT04218266|467652981|FG002|Overall Study|Physician Decision|2|||
129915438|NCT04218266|467652979|FG000|Overall Study|Non-compliance with study drug|0|||
129915439|NCT04218266|467652980|FG001|Overall Study|Non-compliance with study drug|0|||
129915440|NCT04218266|467652981|FG002|Overall Study|Non-compliance with study drug|1|||
129915441|NCT04218266|467652979|FG000|Overall Study|Withdrawal by Subject|1|||
129915442|NCT04218266|467652980|FG001|Overall Study|Withdrawal by Subject|3|||
129915443|NCT04218266|467652981|FG002|Overall Study|Withdrawal by Subject|1|||
129915444|NCT04218266|467652979|FG000|Overall Study|Study drug never administered|2|||
129915445|NCT04218266|467652980|FG001|Overall Study|Study drug never administered|0|||
129915446|NCT04218266|467652981|FG002|Overall Study|Study drug never administered|0|||
129915447|NCT01494922|467652983|FG000|Overall Study|Adverse Event|1|||
129915448|NCT02891915|467652984|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
129915449|NCT02891915|467652985|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
129915450|NCT02891915|467652984|FG000|Overall Study|Withdrawal by Subject|3|||
129915451|NCT02891915|467652985|FG001|Overall Study|Withdrawal by Subject|3|||
129915452|NCT02891915|467652984|FG000|Overall Study|Became Ineligible After Enrollment|2|||
129915453|NCT02891915|467652985|FG001|Overall Study|Became Ineligible After Enrollment|1|||
129915454|NCT02891915|467652984|FG000|Overall Study|Lost to Follow-up|1|||
129915455|NCT02891915|467652985|FG001|Overall Study|Lost to Follow-up|4|||
129915456|NCT02891915|467652984|FG000|Overall Study|Physician Decision|1|||
129915457|NCT02891915|467652985|FG001|Overall Study|Physician Decision|0|||
129915458|NCT01091168|467652986|FG000|Overall Study|Progressive disease|250|||
129915459|NCT01091168|467652987|FG001|Overall Study|Progressive disease|234|||
129915460|NCT01091168|467652986|FG000|Overall Study|Adverse Event|21|||
129915461|NCT01091168|467652987|FG001|Overall Study|Adverse Event|24|||
129915462|NCT01091168|467652986|FG000|Overall Study|Lost to Follow-up|0|||
129915463|NCT01091168|467652987|FG001|Overall Study|Lost to Follow-up|1|||
129915464|NCT01091168|467652986|FG000|Overall Study|Physician, patient's decision, other|27|||
129915465|NCT01091168|467652987|FG001|Overall Study|Physician, patient's decision, other|37|||
129915466|NCT04567615|467652990|FG000|Randomization|Participant withdrew consent|1|||
129915467|NCT04567615|467652991|FG001|Randomization|Participant withdrew consent|0|||
129915468|NCT04567615|467652992|FG002|Randomization|Participant withdrew consent|0|||
129915469|NCT04567615|467652990|FG000|Randomization|Adverse event unrelated to study drug|0|||
129915470|NCT04567615|467652991|FG001|Randomization|Adverse event unrelated to study drug|1|||
129915471|NCT04567615|467652992|FG002|Randomization|Adverse event unrelated to study drug|0|||
129915472|NCT04567615|467652990|FG000|Treatment Period|Participant Withdrew Consent|2|||
129915473|NCT04567615|467652991|FG001|Treatment Period|Participant Withdrew Consent|5|||
129915474|NCT04567615|467652992|FG002|Treatment Period|Participant Withdrew Consent|1|||
129915475|NCT04567615|467652990|FG000|Treatment Period|Death|1|||
129915476|NCT04567615|467652991|FG001|Treatment Period|Death|2|||
129915477|NCT04567615|467652992|FG002|Treatment Period|Death|0|||
129915478|NCT04567615|467652990|FG000|Treatment Period|Lost to Follow-up|0|||
129915479|NCT04567615|467652991|FG001|Treatment Period|Lost to Follow-up|1|||
129915480|NCT04567615|467652992|FG002|Treatment Period|Lost to Follow-up|0|||
129915481|NCT04567615|467652990|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
129915482|NCT04567615|467652991|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
129866162|NCT02300220|467467271|FG001|Overall Study|Adverse Event|1|||
129866163|NCT02300220|467467270|FG000|Overall Study|Protocol Violation|1|||
129866164|NCT02300220|467467271|FG001|Overall Study|Protocol Violation|0|||
129866165|NCT02300220|467467270|FG000|Overall Study|Withdrawal by Subject|0|||
129866166|NCT02300220|467467271|FG001|Overall Study|Withdrawal by Subject|2|||
129866167|NCT02300220|467467270|FG000|Overall Study|Did not tolerate IMP|0|||
129866168|NCT02300220|467467271|FG001|Overall Study|Did not tolerate IMP|1|||
129866169|NCT01441102|467467273|FG000|Overall Study|Adverse Event|1|||
129866170|NCT01441102|467467273|FG000|Overall Study|Withdrawal by Subject|2|||
129866171|NCT03085485|467467274|FG000|Overall Study|Death|1|||
129866172|NCT03085485|467467275|FG001|Overall Study|Death|0|||
129866173|NCT03085485|467467274|FG000|Overall Study|Lost to Follow-up|1|||
129866174|NCT03085485|467467275|FG001|Overall Study|Lost to Follow-up|0|||
129866175|NCT02291614|467467278|FG000|Overall Study|Lost to Follow-up|0|||
129866176|NCT02291614|467467279|FG001|Overall Study|Lost to Follow-up|0|||
129866177|NCT02291614|467467280|FG002|Overall Study|Lost to Follow-up|0|||
129866178|NCT02291614|467467281|FG003|Overall Study|Lost to Follow-up|0|||
129866179|NCT02291614|467467282|FG004|Overall Study|Lost to Follow-up|0|||
129866180|NCT02291614|467467283|FG005|Overall Study|Lost to Follow-up|0|||
129866181|NCT02291614|467467284|FG006|Overall Study|Lost to Follow-up|0|||
129866182|NCT02291614|467467285|FG007|Overall Study|Lost to Follow-up|1|||
129866183|NCT02291614|467467286|FG008|Overall Study|Lost to Follow-up|0|||
129915483|NCT04567615|467652992|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
129915484|NCT04567615|467652990|FG000|Treatment Period|Disease Progression|85|||
129915485|NCT04567615|467652991|FG001|Treatment Period|Disease Progression|63|||
129915486|NCT04567615|467652992|FG002|Treatment Period|Disease Progression|16|||
129915487|NCT04567615|467652990|FG000|Treatment Period|Study Drug Toxicity|3|||
129915488|NCT04567615|467652991|FG001|Treatment Period|Study Drug Toxicity|10|||
129915489|NCT04567615|467652992|FG002|Treatment Period|Study Drug Toxicity|4|||
129915490|NCT04567615|467652990|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
129866184|NCT02291614|467467287|FG009|Overall Study|Lost to Follow-up|0|||
129866185|NCT02291614|467467288|FG010|Overall Study|Lost to Follow-up|0|||
129866186|NCT02291614|467467278|FG000|Overall Study|Withdrawal by Subject|0|||
129866187|NCT02291614|467467279|FG001|Overall Study|Withdrawal by Subject|1|||
129915491|NCT04567615|467652991|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
129915492|NCT04567615|467652992|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
129915493|NCT04567615|467652990|FG000|Treatment Period|Other Reasons|1|||
129915494|NCT04567615|467652991|FG001|Treatment Period|Other Reasons|2|||
129915495|NCT04567615|467652992|FG002|Treatment Period|Other Reasons|0|||
129915496|NCT04567615|467652990|FG000|Treatment Period|Still On-going Treatment|21|||
129915497|NCT04567615|467652991|FG001|Treatment Period|Still On-going Treatment|22|||
129915498|NCT04567615|467652992|FG002|Treatment Period|Still On-going Treatment|2|||
129915499|NCT04059354|467654368|FG000|Overall Study|COVID-19 pandemic|3|||
129915500|NCT05403801|467654369|FG000|Overall Study|Withdrawal by Subject|2|||
129866188|NCT02291614|467467280|FG002|Overall Study|Withdrawal by Subject|0|||
129866189|NCT02291614|467467281|FG003|Overall Study|Withdrawal by Subject|0|||
129866190|NCT02291614|467467282|FG004|Overall Study|Withdrawal by Subject|0|||
129866191|NCT02291614|467467283|FG005|Overall Study|Withdrawal by Subject|0|||
129866192|NCT02291614|467467284|FG006|Overall Study|Withdrawal by Subject|0|||
129866193|NCT02291614|467467285|FG007|Overall Study|Withdrawal by Subject|0|||
129866194|NCT02291614|467467286|FG008|Overall Study|Withdrawal by Subject|0|||
129866195|NCT02291614|467467287|FG009|Overall Study|Withdrawal by Subject|2|||
129866196|NCT02291614|467467288|FG010|Overall Study|Withdrawal by Subject|2|||
129866197|NCT02291614|467467278|FG000|Overall Study|Decision by sponsor|0|||
129866198|NCT02291614|467467279|FG001|Overall Study|Decision by sponsor|0|||
129866199|NCT02291614|467467280|FG002|Overall Study|Decision by sponsor|0|||
129866200|NCT02291614|467467281|FG003|Overall Study|Decision by sponsor|1|||
129866201|NCT02291614|467467282|FG004|Overall Study|Decision by sponsor|0|||
129866202|NCT02291614|467467283|FG005|Overall Study|Decision by sponsor|0|||
129866203|NCT02291614|467467284|FG006|Overall Study|Decision by sponsor|0|||
129866204|NCT02291614|467467285|FG007|Overall Study|Decision by sponsor|0|||
129866205|NCT02291614|467467286|FG008|Overall Study|Decision by sponsor|0|||
129866206|NCT02291614|467467287|FG009|Overall Study|Decision by sponsor|0|||
129866207|NCT02291614|467467288|FG010|Overall Study|Decision by sponsor|0|||
129866208|NCT02291614|467467278|FG000|Overall Study|Death|0|||
129866209|NCT02291614|467467279|FG001|Overall Study|Death|0|||
129866210|NCT02291614|467467280|FG002|Overall Study|Death|1|||
129866211|NCT02291614|467467281|FG003|Overall Study|Death|0|||
129866212|NCT02291614|467467282|FG004|Overall Study|Death|1|||
129866213|NCT02291614|467467283|FG005|Overall Study|Death|1|||
129866214|NCT02291614|467467284|FG006|Overall Study|Death|1|||
129866215|NCT02291614|467467285|FG007|Overall Study|Death|0|||
129866216|NCT02291614|467467286|FG008|Overall Study|Death|0|||
129866217|NCT02291614|467467287|FG009|Overall Study|Death|0|||
129866218|NCT02291614|467467288|FG010|Overall Study|Death|0|||
129866219|NCT00843167|467467289|FG000|Treatment Period|Adverse Event|1|||
129866220|NCT00843167|467467290|FG001|Treatment Period|Adverse Event|5|||
129866221|NCT00843167|467467289|FG000|Treatment Period|Withdrawal by Subject|2|||
129866222|NCT00843167|467467290|FG001|Treatment Period|Withdrawal by Subject|3|||
129866223|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
129866224|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
129866225|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
129866226|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
129866227|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
129866228|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
129866229|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866230|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866231|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866232|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
129866233|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
129866234|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866235|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866236|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866237|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
129866238|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
129866239|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
129866240|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
129866241|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
129866242|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
129866243|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
129866244|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866245|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866246|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866247|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
129866248|NCT01662310|467467293|FG000|Run-In or Stabilization Phase|Other|1|||
129866249|NCT01662310|467467294|FG001|Run-In or Stabilization Phase|Other|0|||
129866250|NCT01662310|467467295|FG002|Run-In or Stabilization Phase|Other|0|||
129915501|NCT02349412|467654372|FG000|Overall Study|Withdrawal by Subject|7|||
129915502|NCT02349412|467654373|FG001|Overall Study|Withdrawal by Subject|7|||
129915503|NCT03460236|467654374|FG000|Overall Study|failed radiographic screening|16|||
129915504|NCT03460236|467654374|FG000|Overall Study|Withdrawal by Subject|11|||
129915505|NCT00979576|467654377|FG000|Combination Treatment Phase|Progressive disease|3|||
129915506|NCT00979576|467654378|FG001|Combination Treatment Phase|Progressive disease|1|||
129915507|NCT00979576|467654379|FG002|Combination Treatment Phase|Progressive disease|5|||
129915508|NCT00979576|467654377|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
129915509|NCT00979576|467654378|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
129915510|NCT00979576|467654379|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
129915511|NCT00979576|467654377|FG000|Combination Treatment Phase|Adverse Event|0|||
129915512|NCT00979576|467654378|FG001|Combination Treatment Phase|Adverse Event|2|||
129915513|NCT00979576|467654379|FG002|Combination Treatment Phase|Adverse Event|2|||
129915514|NCT00979576|467654377|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
129915515|NCT00979576|467654378|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
129915516|NCT00979576|467654379|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
129915517|NCT04840199|467654380|FG000|Overall Study|Study Terminated by Sponsor|8|||
129915518|NCT04840199|467654381|FG001|Overall Study|Study Terminated by Sponsor|9|||
129915519|NCT04840199|467654380|FG000|Overall Study|Lost to Follow-up|0|||
129915520|NCT04840199|467654381|FG001|Overall Study|Lost to Follow-up|2|||
129915521|NCT04840199|467654380|FG000|Overall Study|Withdrawal by Subject|2|||
129915522|NCT04840199|467654381|FG001|Overall Study|Withdrawal by Subject|0|||
129915523|NCT04840199|467654380|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
129915524|NCT04840199|467654381|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
129915525|NCT05215847|467654382|FG000|Overall Study|Lost to Follow-up|1|||
129915526|NCT02819843|467654389|FG000|Overall Study|Disease progression before RT|0|||
129915527|NCT02819843|467654390|FG001|Overall Study|Disease progression before RT|1|||
129915528|NCT03055858|467654392|FG000|Overall Study|Death|9|||
129915529|NCT03055858|467654392|FG000|Overall Study|Withdrawal by Subject|11|||
129915530|NCT03055858|467654392|FG000|Overall Study|Lost to Follow-up|6|||
129915531|NCT03055858|467654392|FG000|Overall Study|Missed Follow-Up Visits|18|||
129915532|NCT04586920|467654393|FG000|Overall Study|Lost to Follow-up|0|||
129915533|NCT04586920|467654394|FG001|Overall Study|Lost to Follow-up|0|||
129915534|NCT04586920|467654395|FG002|Overall Study|Lost to Follow-up|0|||
129915535|NCT04586920|467654396|FG003|Overall Study|Lost to Follow-up|0|||
129915536|NCT04586920|467654397|FG004|Overall Study|Lost to Follow-up|0|||
129915537|NCT04586920|467654398|FG005|Overall Study|Lost to Follow-up|0|||
129915538|NCT04586920|467654399|FG006|Overall Study|Lost to Follow-up|1|||
129915539|NCT04586920|467654400|FG007|Overall Study|Lost to Follow-up|1|||
129915540|NCT04586920|467654401|FG008|Overall Study|Lost to Follow-up|0|||
129915541|NCT04586920|467654402|FG009|Overall Study|Lost to Follow-up|1|||
129915542|NCT04586920|467654403|FG010|Overall Study|Lost to Follow-up|0|||
129915543|NCT04586920|467654404|FG011|Overall Study|Lost to Follow-up|0|||
129915544|NCT04586920|467654405|FG012|Overall Study|Lost to Follow-up|0|||
129915545|NCT04586920|467654406|FG013|Overall Study|Lost to Follow-up|1|||
129915546|NCT04586920|467654407|FG014|Overall Study|Lost to Follow-up|0|||
129915547|NCT04586920|467654408|FG015|Overall Study|Lost to Follow-up|0|||
129449782|NCT00175877|465945681|FG000|Overall Study|Withdrawal by Subject|141|||
129449783|NCT00175877|465945681|FG000|Overall Study|Lost to Follow-up|9|||
129449784|NCT00175877|465945681|FG000|Overall Study|Lack of Efficacy|26|||
129449785|NCT00175877|465945681|FG000|Overall Study|Protocol Violation|15|||
129449786|NCT00175877|465945681|FG000|Overall Study|Other Reason|20|||
129449787|NCT00175877|465945681|FG000|Overall Study|AE & Other|1|||
129449788|NCT00175877|465945681|FG000|Overall Study|Withdrawal by subject & Other|1|||
129449789|NCT01092143|465945684|FG000|Overall Study|Adverse Event|10|||
129449790|NCT01092143|465945685|FG001|Overall Study|Adverse Event|5|||
129449791|NCT01092143|465945686|FG002|Overall Study|Adverse Event|1|||
129449792|NCT01092143|465945687|FG003|Overall Study|Adverse Event|4|||
129449793|NCT01092143|465945688|FG004|Overall Study|Adverse Event|3|||
129449794|NCT01092143|465945684|FG000|Overall Study|Lost to Follow-up|1|||
129449795|NCT01092143|465945685|FG001|Overall Study|Lost to Follow-up|0|||
129449796|NCT01092143|465945686|FG002|Overall Study|Lost to Follow-up|1|||
129449797|NCT01092143|465945687|FG003|Overall Study|Lost to Follow-up|0|||
129449798|NCT01092143|465945688|FG004|Overall Study|Lost to Follow-up|0|||
129449799|NCT01092143|465945684|FG000|Overall Study|Consent withdrawn|2|||
129449800|NCT01092143|465945685|FG001|Overall Study|Consent withdrawn|1|||
129915548|NCT04586920|467654409|FG016|Overall Study|Lost to Follow-up|0|||
129915549|NCT04586920|467654410|FG017|Overall Study|Lost to Follow-up|0|||
129915550|NCT04586920|467654393|FG000|Overall Study|Withdrawal by Subject|0|||
129449801|NCT01092143|465945686|FG002|Overall Study|Consent withdrawn|0|||
129449802|NCT01092143|465945687|FG003|Overall Study|Consent withdrawn|1|||
129449803|NCT01092143|465945688|FG004|Overall Study|Consent withdrawn|3|||
129449804|NCT01092143|465945684|FG000|Overall Study|Not treated|0|||
129915551|NCT04586920|467654394|FG001|Overall Study|Withdrawal by Subject|0|||
129449805|NCT01092143|465945685|FG001|Overall Study|Not treated|0|||
129449806|NCT01092143|465945686|FG002|Overall Study|Not treated|1|||
129915552|NCT04586920|467654395|FG002|Overall Study|Withdrawal by Subject|0|||
129915553|NCT04586920|467654396|FG003|Overall Study|Withdrawal by Subject|0|||
129915554|NCT04586920|467654397|FG004|Overall Study|Withdrawal by Subject|0|||
129915555|NCT04586920|467654398|FG005|Overall Study|Withdrawal by Subject|0|||
129915556|NCT04586920|467654399|FG006|Overall Study|Withdrawal by Subject|0|||
129915557|NCT04586920|467654400|FG007|Overall Study|Withdrawal by Subject|1|||
129915558|NCT04586920|467654401|FG008|Overall Study|Withdrawal by Subject|0|||
129915559|NCT04586920|467654402|FG009|Overall Study|Withdrawal by Subject|1|||
129915560|NCT04586920|467654403|FG010|Overall Study|Withdrawal by Subject|0|||
129915561|NCT04586920|467654404|FG011|Overall Study|Withdrawal by Subject|1|||
129915562|NCT04586920|467654405|FG012|Overall Study|Withdrawal by Subject|0|||
129915563|NCT04586920|467654406|FG013|Overall Study|Withdrawal by Subject|0|||
129915564|NCT04586920|467654407|FG014|Overall Study|Withdrawal by Subject|0|||
129915565|NCT04586920|467654408|FG015|Overall Study|Withdrawal by Subject|0|||
129915566|NCT04586920|467654409|FG016|Overall Study|Withdrawal by Subject|0|||
129915567|NCT04586920|467654410|FG017|Overall Study|Withdrawal by Subject|0|||
129915568|NCT02728557|467654415|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
129915569|NCT02728557|467654416|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
129915570|NCT02728557|467654415|FG000|Overall Study|Dissatisfaction with research tasks|0|||
129915571|NCT02728557|467654416|FG001|Overall Study|Dissatisfaction with research tasks|1|||
129915572|NCT02728557|467654415|FG000|Overall Study|Scheduling or change in availability|1|||
129915573|NCT02728557|467654416|FG001|Overall Study|Scheduling or change in availability|1|||
129915574|NCT03897686|467654417|FG000|Overall Study|Protocol Violation|1|||
129915575|NCT03897686|467654418|FG001|Overall Study|Protocol Violation|1|||
129915576|NCT03897686|467654417|FG000|Overall Study|Withdrawal by Subject|1|||
129915577|NCT03897686|467654418|FG001|Overall Study|Withdrawal by Subject|1|||
129915578|NCT03416010|467654419|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
129915579|NCT03416010|467654420|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
129915580|NCT03416010|467654419|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
129915581|NCT03416010|467654420|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
129915582|NCT03416010|467654419|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
129915583|NCT03416010|467654420|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
129915584|NCT03416010|467654419|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
129915585|NCT03416010|467654420|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
129915586|NCT03416010|467654419|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
129915587|NCT03416010|467654420|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
129915588|NCT03416010|467654419|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
129915589|NCT03416010|467654420|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
129915590|NCT03416010|467654419|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
129915591|NCT03416010|467654420|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
129915592|NCT05415436|467654424|FG000|Overall Study|Surgeon cancelled procedure|1|||
129915593|NCT05415436|467654425|FG001|Overall Study|Surgeon cancelled procedure|0|||
129866251|NCT01662310|467467296|FG003|Run-In or Stabilization Phase|Other|0|||
129866252|NCT01662310|467467297|FG004|Run-In or Stabilization Phase|Other|0|||
129866253|NCT01662310|467467293|FG000|Double-Blind Phase|Adverse Event|0|||
129866254|NCT01662310|467467294|FG001|Double-Blind Phase|Adverse Event|0|||
129866255|NCT01662310|467467295|FG002|Double-Blind Phase|Adverse Event|1|||
129866256|NCT01662310|467467296|FG003|Double-Blind Phase|Adverse Event|0|||
129866257|NCT01662310|467467297|FG004|Double-Blind Phase|Adverse Event|0|||
129866258|NCT01662310|467467293|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129866259|NCT01662310|467467294|FG001|Double-Blind Phase|Lost to Follow-up|3|||
129866260|NCT01662310|467467295|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129866261|NCT01662310|467467296|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129866262|NCT01662310|467467297|FG004|Double-Blind Phase|Lost to Follow-up|0|||
129866263|NCT01662310|467467293|FG000|Double-Blind Phase|Pregnancy|0|||
129866264|NCT01662310|467467294|FG001|Double-Blind Phase|Pregnancy|2|||
129866265|NCT01662310|467467295|FG002|Double-Blind Phase|Pregnancy|0|||
129866266|NCT01662310|467467296|FG003|Double-Blind Phase|Pregnancy|0|||
129866267|NCT01662310|467467297|FG004|Double-Blind Phase|Pregnancy|0|||
129866268|NCT01662310|467467293|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129866269|NCT01662310|467467294|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
129866270|NCT01662310|467467295|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
129866271|NCT01662310|467467296|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129866272|NCT01662310|467467297|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129866273|NCT01662310|467467293|FG000|Double-Blind Phase|Other|0|||
129866274|NCT01662310|467467294|FG001|Double-Blind Phase|Other|0|||
129866275|NCT01662310|467467295|FG002|Double-Blind Phase|Other|1|||
129866276|NCT01662310|467467296|FG003|Double-Blind Phase|Other|0|||
129866277|NCT01662310|467467297|FG004|Double-Blind Phase|Other|0|||
129866278|NCT01662310|467467293|FG000|Double-Blind Phase|Randomized but not treated|0|||
129866279|NCT01662310|467467294|FG001|Double-Blind Phase|Randomized but not treated|1|||
129866280|NCT01662310|467467295|FG002|Double-Blind Phase|Randomized but not treated|0|||
129866281|NCT01662310|467467296|FG003|Double-Blind Phase|Randomized but not treated|0|||
129915594|NCT05415436|467654424|FG000|Overall Study|Death|1|||
129915595|NCT05415436|467654425|FG001|Overall Study|Death|0|||
129915596|NCT03819686|467654432|FG000|Overall Study|Lost to Follow-up|2|||
129915597|NCT03819686|467654433|FG001|Overall Study|Lost to Follow-up|3|||
129915598|NCT03157167|467654447|FG000|Overall Study|Withdrawal by Subject|1|||
129915599|NCT03157167|467654448|FG001|Overall Study|Withdrawal by Subject|0|||
129915600|NCT03157167|467654449|FG002|Overall Study|Withdrawal by Subject|0|||
129915601|NCT06023082|467654453|FG000|Overall Study|Withdrawal by Subject|2|||
129915602|NCT06023082|467654453|FG000|Overall Study|Lost to Follow-up|15|||
129915603|NCT06023082|467654453|FG000|Overall Study|Side effects|5|||
129915604|NCT03584516|467654454|FG000|Part 1|Death|2|||
129915605|NCT03584516|467654455|FG001|Part 1|Death|3|||
129915606|NCT03584516|467654456|FG002|Part 1|Death|0|||
129915607|NCT03584516|467654457|FG003|Part 1|Death|0|||
129915608|NCT03584516|467654458|FG004|Part 1|Death|0|||
129915609|NCT03584516|467654459|FG005|Part 1|Death|0|||
129915610|NCT03584516|467654454|FG000|Part 1|Withdrawal by Subject|2|||
129915611|NCT03584516|467654455|FG001|Part 1|Withdrawal by Subject|0|||
129915612|NCT03584516|467654456|FG002|Part 1|Withdrawal by Subject|0|||
129915613|NCT03584516|467654457|FG003|Part 1|Withdrawal by Subject|0|||
129915614|NCT03584516|467654458|FG004|Part 1|Withdrawal by Subject|0|||
129915615|NCT03584516|467654459|FG005|Part 1|Withdrawal by Subject|0|||
129915616|NCT03584516|467654454|FG000|Part 1|Lost to Follow-up|1|||
129915617|NCT03584516|467654455|FG001|Part 1|Lost to Follow-up|0|||
129915618|NCT03584516|467654456|FG002|Part 1|Lost to Follow-up|0|||
129915619|NCT03584516|467654457|FG003|Part 1|Lost to Follow-up|0|||
129915620|NCT03584516|467654458|FG004|Part 1|Lost to Follow-up|0|||
129915621|NCT03584516|467654459|FG005|Part 1|Lost to Follow-up|0|||
129915622|NCT03584516|467654454|FG000|Part 1|Study Terminated by Sponsor|0|||
129915623|NCT03584516|467654455|FG001|Part 1|Study Terminated by Sponsor|2|||
129915624|NCT03584516|467654456|FG002|Part 1|Study Terminated by Sponsor|0|||
129915625|NCT03584516|467654457|FG003|Part 1|Study Terminated by Sponsor|0|||
129915626|NCT03584516|467654458|FG004|Part 1|Study Terminated by Sponsor|0|||
129915627|NCT03584516|467654459|FG005|Part 1|Study Terminated by Sponsor|0|||
129915628|NCT03584516|467654454|FG000|Part 1 Expansion|Death|0|||
129915629|NCT03584516|467654455|FG001|Part 1 Expansion|Death|0|||
129915630|NCT03584516|467654456|FG002|Part 1 Expansion|Death|9|||
129915631|NCT03584516|467654457|FG003|Part 1 Expansion|Death|8|||
129915632|NCT03584516|467654458|FG004|Part 1 Expansion|Death|4|||
129915633|NCT03584516|467654459|FG005|Part 1 Expansion|Death|5|||
129915634|NCT03584516|467654454|FG000|Part 1 Expansion|Lost to Follow-up|0|||
129915635|NCT03584516|467654455|FG001|Part 1 Expansion|Lost to Follow-up|0|||
129915636|NCT03584516|467654456|FG002|Part 1 Expansion|Lost to Follow-up|0|||
129915637|NCT03584516|467654457|FG003|Part 1 Expansion|Lost to Follow-up|1|||
129915638|NCT03584516|467654458|FG004|Part 1 Expansion|Lost to Follow-up|0|||
129915639|NCT03584516|467654459|FG005|Part 1 Expansion|Lost to Follow-up|0|||
129915640|NCT03584516|467654454|FG000|Part 1 Expansion|Physician Decision|0|||
129915641|NCT03584516|467654455|FG001|Part 1 Expansion|Physician Decision|0|||
129915642|NCT03584516|467654456|FG002|Part 1 Expansion|Physician Decision|4|||
129915643|NCT03584516|467654457|FG003|Part 1 Expansion|Physician Decision|3|||
129915644|NCT03584516|467654458|FG004|Part 1 Expansion|Physician Decision|2|||
129915645|NCT03584516|467654459|FG005|Part 1 Expansion|Physician Decision|3|||
129915646|NCT03584516|467654454|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
129915647|NCT03584516|467654455|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
129915648|NCT03584516|467654456|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
129915649|NCT03584516|467654457|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
129915650|NCT03584516|467654458|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
129915651|NCT03584516|467654459|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
129915652|NCT03584516|467654454|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
129915653|NCT03584516|467654455|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
129915654|NCT03584516|467654456|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
129915655|NCT03584516|467654457|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
129915656|NCT03584516|467654458|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
129915657|NCT03584516|467654459|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
129915658|NCT03584516|467654454|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915659|NCT03584516|467654455|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915660|NCT03584516|467654456|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915661|NCT03584516|467654457|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
129915662|NCT03584516|467654458|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915663|NCT03584516|467654459|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
129915664|NCT03584516|467654454|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915665|NCT03584516|467654455|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915666|NCT03584516|467654456|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915667|NCT03584516|467654457|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129915668|NCT03584516|467654458|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
129449807|NCT01092143|465945687|FG003|Overall Study|Not treated|0|||
129866282|NCT01662310|467467297|FG004|Double-Blind Phase|Randomized but not treated|0|||
129866283|NCT01662310|467467293|FG000|Open-Label Extension Phase|Adverse Event|0|||
129866284|NCT01662310|467467294|FG001|Open-Label Extension Phase|Adverse Event|0|||
129866285|NCT01662310|467467295|FG002|Open-Label Extension Phase|Adverse Event|0|||
129866286|NCT01662310|467467296|FG003|Open-Label Extension Phase|Adverse Event|3|||
129866287|NCT01662310|467467297|FG004|Open-Label Extension Phase|Adverse Event|0|||
129866288|NCT01662310|467467293|FG000|Open-Label Extension Phase|Death|0|||
129866289|NCT01662310|467467294|FG001|Open-Label Extension Phase|Death|0|||
129866290|NCT01662310|467467295|FG002|Open-Label Extension Phase|Death|0|||
129866291|NCT01662310|467467296|FG003|Open-Label Extension Phase|Death|1|||
129866292|NCT01662310|467467297|FG004|Open-Label Extension Phase|Death|0|||
129866293|NCT01662310|467467293|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
129866294|NCT01662310|467467294|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
129866295|NCT01662310|467467295|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
129866296|NCT01662310|467467296|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
129866297|NCT01662310|467467297|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
129866298|NCT01662310|467467293|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129866299|NCT01662310|467467294|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129866300|NCT01662310|467467295|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
129866301|NCT01662310|467467296|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
129866302|NCT01662310|467467297|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
129866303|NCT01662310|467467293|FG000|Open-Label Extension Phase|Pregnancy|0|||
129866304|NCT01662310|467467294|FG001|Open-Label Extension Phase|Pregnancy|0|||
129866305|NCT01662310|467467295|FG002|Open-Label Extension Phase|Pregnancy|0|||
129866306|NCT01662310|467467296|FG003|Open-Label Extension Phase|Pregnancy|1|||
129866307|NCT01662310|467467297|FG004|Open-Label Extension Phase|Pregnancy|0|||
129866308|NCT01662310|467467293|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
129866309|NCT01662310|467467294|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
129866310|NCT01662310|467467295|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
129866311|NCT01662310|467467296|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
129866312|NCT01662310|467467297|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
129866313|NCT04302350|467467301|FG000|Overall Study|Physician Decision|1|||
129866314|NCT04302350|467467302|FG001|Overall Study|Physician Decision|1|||
129866315|NCT04302350|467467303|FG002|Overall Study|Physician Decision|2|||
129866316|NCT04302350|467467301|FG000|Overall Study|Lack of Efficacy|1|||
129866317|NCT04302350|467467302|FG001|Overall Study|Lack of Efficacy|1|||
129866318|NCT04302350|467467303|FG002|Overall Study|Lack of Efficacy|4|||
129866319|NCT04302350|467467301|FG000|Overall Study|Adverse Event|0|||
129866320|NCT04302350|467467302|FG001|Overall Study|Adverse Event|1|||
129866321|NCT04302350|467467303|FG002|Overall Study|Adverse Event|2|||
129866322|NCT02012491|467467306|FG000|Overall Study|Lost to Follow-up|1|||
129866323|NCT02012491|467467307|FG001|Overall Study|Lost to Follow-up|0|||
129866324|NCT02012491|467467306|FG000|Overall Study|Protocol Violation|0|||
129866325|NCT02012491|467467307|FG001|Overall Study|Protocol Violation|1|||
129866326|NCT02012491|467467306|FG000|Overall Study|Withdrawal by Subject|1|||
129866327|NCT02012491|467467307|FG001|Overall Study|Withdrawal by Subject|0|||
129866328|NCT00450411|467467308|FG000|Overall Study|Protocol Violation|6|||
129866329|NCT00450411|467467308|FG000|Overall Study|No protocol treatment|2|||
129866330|NCT02137369|467467319|FG000|Overall Study|Withdrawal by Subject|3|||
129866331|NCT02137369|467467320|FG001|Overall Study|Withdrawal by Subject|2|||
129866332|NCT02137369|467467319|FG000|Overall Study|Adverse Event|2|||
129866333|NCT02137369|467467320|FG001|Overall Study|Adverse Event|0|||
129866334|NCT02137369|467467319|FG000|Overall Study|Lost to Follow-up|1|||
129866335|NCT02137369|467467320|FG001|Overall Study|Lost to Follow-up|0|||
129866336|NCT02137369|467467319|FG000|Overall Study|Moved away|2|||
129866337|NCT02137369|467467320|FG001|Overall Study|Moved away|0|||
129866338|NCT03969719|467467321|FG000|Overall Study|Other reasons not specified|1|||
129866339|NCT03969719|467467322|FG001|Overall Study|Other reasons not specified|1|||
129866340|NCT03969719|467467323|FG002|Overall Study|Other reasons not specified|3|||
129866341|NCT03969719|467467321|FG000|Overall Study|Withdrawal by Subject|2|||
129866342|NCT03969719|467467322|FG001|Overall Study|Withdrawal by Subject|3|||
129866343|NCT03969719|467467323|FG002|Overall Study|Withdrawal by Subject|2|||
129866344|NCT03969719|467467321|FG000|Overall Study|Protocol Violation|1|||
129866345|NCT03969719|467467322|FG001|Overall Study|Protocol Violation|2|||
129866346|NCT03969719|467467323|FG002|Overall Study|Protocol Violation|0|||
129866347|NCT03969719|467467321|FG000|Overall Study|Adverse Event|0|||
129866348|NCT03969719|467467322|FG001|Overall Study|Adverse Event|2|||
129866349|NCT03969719|467467323|FG002|Overall Study|Adverse Event|0|||
129866350|NCT03969719|467467321|FG000|Overall Study|Lost to Follow-up|0|||
129866351|NCT03969719|467467322|FG001|Overall Study|Lost to Follow-up|1|||
129866352|NCT03969719|467467323|FG002|Overall Study|Lost to Follow-up|0|||
129866353|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
129866354|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
129915669|NCT03584516|467654459|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
129915670|NCT04868110|467654462|FG000|Overall Study|Withdrawal by Subject|3|||
129915671|NCT04868110|467654463|FG001|Overall Study|Withdrawal by Subject|4|||
129915672|NCT00593489|467654473|FG000|Allocation|did not attend workshop; allocation not|2|||
129915673|NCT00593489|467654474|FG001|Allocation|did not attend workshop; allocation not|1|||
129915674|NCT02742519|467654475|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
129915675|NCT02742519|467654476|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
129915676|NCT02742519|467654477|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
129915677|NCT02742519|467654475|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
129915678|NCT02742519|467654476|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
129915679|NCT02742519|467654477|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
129915680|NCT02742519|467654475|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
129915681|NCT02742519|467654476|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
129915682|NCT02742519|467654477|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
129915683|NCT04377308|467654479|FG000|Overall Study|Withdrawal by Subject|0|||
129915684|NCT04377308|467654480|FG001|Overall Study|Withdrawal by Subject|1|||
129915685|NCT02759016|467654481|FG000|Overall Study|Not treated with BI 836826|1|||
129915686|NCT02759016|467654482|FG001|Overall Study|Not treated with BI 836826|0|||
129915687|NCT02759016|467654481|FG000|Overall Study|Progressive disease|1|||
129915688|NCT02759016|467654482|FG001|Overall Study|Progressive disease|0|||
129915689|NCT02759016|467654481|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
129915690|NCT02759016|467654482|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
129915691|NCT02759016|467654481|FG000|Overall Study|Other not defined above|2|||
129915692|NCT02759016|467654482|FG001|Overall Study|Other not defined above|1|||
129915693|NCT03580369|467654483|FG000|Overall Study|No treatment due to mis-randomization|1|||
129915694|NCT03580369|467654484|FG001|Overall Study|No treatment due to mis-randomization|0|||
129915695|NCT03580369|467654485|FG002|Overall Study|No treatment due to mis-randomization|0|||
129915696|NCT03580369|467654486|FG003|Overall Study|No treatment due to mis-randomization|0|||
129915697|NCT03580369|467654487|FG004|Overall Study|No treatment due to mis-randomization|3|||
129915698|NCT03580369|467654488|FG005|Overall Study|No treatment due to mis-randomization|0|||
129915699|NCT03580369|467654489|FG006|Overall Study|No treatment due to mis-randomization|0|||
129915700|NCT03580369|467654490|FG007|Overall Study|No treatment due to mis-randomization|0|||
129915701|NCT03580369|467654483|FG000|Overall Study|Reason unknown|0|||
129915702|NCT03580369|467654484|FG001|Overall Study|Reason unknown|0|||
129915703|NCT03580369|467654485|FG002|Overall Study|Reason unknown|1|||
129915704|NCT03580369|467654486|FG003|Overall Study|Reason unknown|0|||
129915705|NCT03580369|467654487|FG004|Overall Study|Reason unknown|0|||
129915706|NCT03580369|467654488|FG005|Overall Study|Reason unknown|0|||
129915707|NCT03580369|467654489|FG006|Overall Study|Reason unknown|0|||
129915708|NCT03580369|467654490|FG007|Overall Study|Reason unknown|0|||
129915709|NCT03580369|467654483|FG000|Overall Study|Technical problems|0|||
129915710|NCT03580369|467654484|FG001|Overall Study|Technical problems|0|||
129915711|NCT03580369|467654485|FG002|Overall Study|Technical problems|0|||
129915712|NCT03580369|467654486|FG003|Overall Study|Technical problems|0|||
129915713|NCT03580369|467654487|FG004|Overall Study|Technical problems|1|||
129915714|NCT03580369|467654488|FG005|Overall Study|Technical problems|0|||
129915715|NCT03580369|467654489|FG006|Overall Study|Technical problems|2|||
129915716|NCT03580369|467654490|FG007|Overall Study|Technical problems|0|||
129915717|NCT03580369|467654483|FG000|Overall Study|Pregnancy|2|||
129915718|NCT03580369|467654484|FG001|Overall Study|Pregnancy|0|||
129915719|NCT03580369|467654485|FG002|Overall Study|Pregnancy|3|||
129915720|NCT03580369|467654486|FG003|Overall Study|Pregnancy|0|||
129915721|NCT03580369|467654487|FG004|Overall Study|Pregnancy|2|||
129915722|NCT03580369|467654488|FG005|Overall Study|Pregnancy|0|||
129915723|NCT03580369|467654489|FG006|Overall Study|Pregnancy|0|||
129915724|NCT03580369|467654490|FG007|Overall Study|Pregnancy|0|||
129915725|NCT03580369|467654483|FG000|Overall Study|Lost to Follow-up|2|||
129915726|NCT03580369|467654484|FG001|Overall Study|Lost to Follow-up|0|||
129915727|NCT03580369|467654485|FG002|Overall Study|Lost to Follow-up|2|||
129915728|NCT03580369|467654486|FG003|Overall Study|Lost to Follow-up|0|||
129915729|NCT03580369|467654487|FG004|Overall Study|Lost to Follow-up|3|||
129915730|NCT03580369|467654488|FG005|Overall Study|Lost to Follow-up|0|||
129915731|NCT03580369|467654489|FG006|Overall Study|Lost to Follow-up|1|||
129915732|NCT03580369|467654490|FG007|Overall Study|Lost to Follow-up|0|||
129915733|NCT03580369|467654483|FG000|Overall Study|Physician Decision|4|||
129915734|NCT03580369|467654484|FG001|Overall Study|Physician Decision|0|||
129915735|NCT03580369|467654485|FG002|Overall Study|Physician Decision|4|||
129915736|NCT03580369|467654486|FG003|Overall Study|Physician Decision|1|||
129915737|NCT03580369|467654487|FG004|Overall Study|Physician Decision|1|||
129915738|NCT03580369|467654488|FG005|Overall Study|Physician Decision|0|||
129915739|NCT03580369|467654489|FG006|Overall Study|Physician Decision|0|||
129915740|NCT03580369|467654490|FG007|Overall Study|Physician Decision|0|||
129915741|NCT03580369|467654483|FG000|Overall Study|Lack of Efficacy|3|||
129915742|NCT03580369|467654484|FG001|Overall Study|Lack of Efficacy|0|||
129915743|NCT03580369|467654485|FG002|Overall Study|Lack of Efficacy|7|||
129915744|NCT03580369|467654486|FG003|Overall Study|Lack of Efficacy|0|||
129866355|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
129866356|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
129866357|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
129866358|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
129866359|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
129866360|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
129866361|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
129866362|NCT02130193|467467325|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
129866363|NCT02130193|467467326|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
129866364|NCT02130193|467467327|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
129866365|NCT01297959|467467328|FG000|Overall Study|Adverse Event|0|||
129866366|NCT01297959|467467329|FG001|Overall Study|Adverse Event|1|||
129866367|NCT01297959|467467328|FG000|Overall Study|Protocol Violation|2|||
129866368|NCT01297959|467467329|FG001|Overall Study|Protocol Violation|1|||
129866369|NCT01297959|467467328|FG000|Overall Study|Withdrawal by Subject|5|||
129866370|NCT01297959|467467329|FG001|Overall Study|Withdrawal by Subject|4|||
129866371|NCT01297959|467467328|FG000|Overall Study|Physician Decision|0|||
129866372|NCT01297959|467467329|FG001|Overall Study|Physician Decision|1|||
129866373|NCT01297959|467467328|FG000|Overall Study|Unrelated medical illness / complication|0|||
129866374|NCT01297959|467467329|FG001|Overall Study|Unrelated medical illness / complication|2|||
129866375|NCT01297959|467467328|FG000|Overall Study|Other|13|||
129866376|NCT01297959|467467329|FG001|Overall Study|Other|7|||
129866377|NCT01667432|467467330|FG000|Overall Study|Premature Study Termination|26|||
129866378|NCT01667432|467467330|FG000|Overall Study|Failure to Return|10|||
129866379|NCT01667432|467467330|FG000|Overall Study|Moved to Another Center|3|||
129866380|NCT01667432|467467330|FG000|Overall Study|Lost to Follow-up|3|||
129866381|NCT01667432|467467330|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
129866382|NCT01667432|467467330|FG000|Overall Study|Insufficient Therapeutic Response|4|||
129866383|NCT01667432|467467330|FG000|Overall Study|Adverse Event|1|||
129866384|NCT01667432|467467330|FG000|Overall Study|Protocol Deviation|2|||
129866385|NCT01667432|467467330|FG000|Overall Study|Principal Investigator Decision|1|||
129866386|NCT01667432|467467330|FG000|Overall Study|Reason Not Specified|2|||
129866387|NCT01667432|467467330|FG000|Overall Study|Missing Information|4|||
129866388|NCT02077166|467467331|FG000|Overall Study|Death|6|||
129866389|NCT02077166|467467332|FG001|Overall Study|Death|7|||
129866390|NCT02077166|467467333|FG002|Overall Study|Death|5|||
129866391|NCT02077166|467467334|FG003|Overall Study|Death|6|||
129866392|NCT02077166|467467335|FG004|Overall Study|Death|4|||
129866393|NCT02077166|467467336|FG005|Overall Study|Death|32|||
129866394|NCT02077166|467467337|FG006|Overall Study|Death|22|||
129866395|NCT02077166|467467331|FG000|Overall Study|Study Closure by Sponsor|3|||
129866396|NCT02077166|467467332|FG001|Overall Study|Study Closure by Sponsor|0|||
129866397|NCT02077166|467467333|FG002|Overall Study|Study Closure by Sponsor|2|||
129866398|NCT02077166|467467334|FG003|Overall Study|Study Closure by Sponsor|2|||
129866399|NCT02077166|467467335|FG004|Overall Study|Study Closure by Sponsor|2|||
129866400|NCT02077166|467467336|FG005|Overall Study|Study Closure by Sponsor|12|||
129866401|NCT02077166|467467337|FG006|Overall Study|Study Closure by Sponsor|4|||
129866402|NCT02077166|467467331|FG000|Overall Study|Lost to Follow-up|0|||
129866403|NCT02077166|467467332|FG001|Overall Study|Lost to Follow-up|0|||
129866404|NCT02077166|467467333|FG002|Overall Study|Lost to Follow-up|0|||
129866405|NCT02077166|467467334|FG003|Overall Study|Lost to Follow-up|0|||
129866406|NCT02077166|467467335|FG004|Overall Study|Lost to Follow-up|0|||
129866407|NCT02077166|467467336|FG005|Overall Study|Lost to Follow-up|1|||
129866408|NCT02077166|467467337|FG006|Overall Study|Lost to Follow-up|0|||
129866409|NCT02077166|467467331|FG000|Overall Study|Withdrawal by Subject|3|||
129866410|NCT02077166|467467332|FG001|Overall Study|Withdrawal by Subject|0|||
129866411|NCT02077166|467467333|FG002|Overall Study|Withdrawal by Subject|1|||
129866412|NCT02077166|467467334|FG003|Overall Study|Withdrawal by Subject|1|||
129866413|NCT02077166|467467335|FG004|Overall Study|Withdrawal by Subject|1|||
129866414|NCT02077166|467467336|FG005|Overall Study|Withdrawal by Subject|3|||
129866415|NCT02077166|467467337|FG006|Overall Study|Withdrawal by Subject|0|||
129866416|NCT02077166|467467331|FG000|Overall Study|Other, Not Specified|0|||
129866417|NCT02077166|467467332|FG001|Overall Study|Other, Not Specified|0|||
129866418|NCT02077166|467467333|FG002|Overall Study|Other, Not Specified|1|||
129866419|NCT02077166|467467334|FG003|Overall Study|Other, Not Specified|0|||
129866420|NCT02077166|467467335|FG004|Overall Study|Other, Not Specified|1|||
129866421|NCT02077166|467467336|FG005|Overall Study|Other, Not Specified|7|||
129866422|NCT02077166|467467337|FG006|Overall Study|Other, Not Specified|8|||
129866423|NCT01712009|467469496|FG000|Overall Study|Withdrawal by Subject|24|||
129866424|NCT01712009|467469497|FG001|Overall Study|Withdrawal by Subject|15|||
129866425|NCT01712009|467469498|FG002|Overall Study|Withdrawal by Subject|8|||
129866426|NCT01712009|467469496|FG000|Overall Study|Lost to Follow-up|2|||
129866427|NCT01712009|467469497|FG001|Overall Study|Lost to Follow-up|0|||
129866428|NCT01712009|467469498|FG002|Overall Study|Lost to Follow-up|1|||
129866429|NCT01712009|467469496|FG000|Overall Study|Decision by Sponsor|12|||
129866430|NCT01712009|467469497|FG001|Overall Study|Decision by Sponsor|14|||
129915745|NCT03580369|467654487|FG004|Overall Study|Lack of Efficacy|2|||
129866431|NCT01712009|467469498|FG002|Overall Study|Decision by Sponsor|12|||
129866432|NCT02160314|467469499|FG000|Overall Study|Adverse Event|0|||
129866433|NCT02160314|467469500|FG001|Overall Study|Adverse Event|6|||
129866434|NCT02160314|467469499|FG000|Overall Study|Protocol Violation|0|||
129866435|NCT02160314|467469500|FG001|Overall Study|Protocol Violation|4|||
129866436|NCT02160314|467469499|FG000|Overall Study|Withdrawal by Subject|1|||
129866437|NCT02160314|467469500|FG001|Overall Study|Withdrawal by Subject|2|||
129915746|NCT03580369|467654488|FG005|Overall Study|Lack of Efficacy|0|||
129915747|NCT03580369|467654489|FG006|Overall Study|Lack of Efficacy|3|||
129915748|NCT03580369|467654490|FG007|Overall Study|Lack of Efficacy|0|||
129915749|NCT03580369|467654483|FG000|Overall Study|Protocol Violation|6|||
129866438|NCT02160314|467469499|FG000|Overall Study|Lost to Follow-up|0|||
129866439|NCT02160314|467469500|FG001|Overall Study|Lost to Follow-up|1|||
129866440|NCT01377480|467469504|FG000|Overall Study|Protocol Violation|0|||
129866441|NCT01377480|467469505|FG001|Overall Study|Protocol Violation|0|||
129866442|NCT01377480|467469506|FG002|Overall Study|Protocol Violation|0|||
129866443|NCT01377480|467469507|FG003|Overall Study|Protocol Violation|4|||
129866444|NCT01377480|467469504|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
129866445|NCT01377480|467469505|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
129866446|NCT01377480|467469506|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
129866447|NCT01377480|467469507|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
129866448|NCT01377480|467469504|FG000|Overall Study|Withdrawal by Subject|0|||
129866449|NCT01377480|467469505|FG001|Overall Study|Withdrawal by Subject|0|||
129866450|NCT01377480|467469506|FG002|Overall Study|Withdrawal by Subject|1|||
129866451|NCT01377480|467469507|FG003|Overall Study|Withdrawal by Subject|0|||
129866452|NCT01377480|467469504|FG000|Overall Study|Serious adverse event|0|||
129866453|NCT01377480|467469505|FG001|Overall Study|Serious adverse event|0|||
129866454|NCT01377480|467469506|FG002|Overall Study|Serious adverse event|1|||
129866455|NCT01377480|467469507|FG003|Overall Study|Serious adverse event|1|||
129866456|NCT01377480|467469504|FG000|Overall Study|Other|0|||
129866457|NCT01377480|467469505|FG001|Overall Study|Other|0|||
129866458|NCT01377480|467469506|FG002|Overall Study|Other|7|||
129866459|NCT01377480|467469507|FG003|Overall Study|Other|6|||
129866460|NCT03576768|467469511|FG000|Overall Study|Lost to Follow-up|3|||
129866461|NCT03576768|467469512|FG001|Overall Study|Lost to Follow-up|3|||
129866462|NCT03576768|467469513|FG002|Overall Study|Lost to Follow-up|0|||
129866463|NCT03576768|467469514|FG003|Overall Study|Lost to Follow-up|0|||
129866464|NCT00590902|467469515|FG000|Overall Study|Death|1|||
129866465|NCT01986881|467469516|FG000|Overall Study|Death|228|||
129866466|NCT01986881|467469517|FG001|Overall Study|Death|233|||
129866467|NCT01986881|467469518|FG002|Overall Study|Death|247|||
129866468|NCT01986881|467469516|FG000|Overall Study|Lost to Follow-up|51|||
129866469|NCT01986881|467469517|FG001|Overall Study|Lost to Follow-up|44|||
129866470|NCT01986881|467469518|FG002|Overall Study|Lost to Follow-up|55|||
129866471|NCT01986881|467469516|FG000|Overall Study|Physician Decision|7|||
129866472|NCT01986881|467469517|FG001|Overall Study|Physician Decision|4|||
129866473|NCT01986881|467469518|FG002|Overall Study|Physician Decision|6|||
129866474|NCT01986881|467469516|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
129866475|NCT01986881|467469517|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
129866476|NCT01986881|467469518|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
129866477|NCT01986881|467469516|FG000|Overall Study|Withdrawal by Subject|41|||
129866478|NCT01986881|467469517|FG001|Overall Study|Withdrawal by Subject|60|||
129866479|NCT01986881|467469518|FG002|Overall Study|Withdrawal by Subject|45|||
129915750|NCT03580369|467654484|FG001|Overall Study|Protocol Violation|0|||
129915751|NCT03580369|467654485|FG002|Overall Study|Protocol Violation|6|||
129915752|NCT03580369|467654486|FG003|Overall Study|Protocol Violation|1|||
129915753|NCT03580369|467654487|FG004|Overall Study|Protocol Violation|8|||
129915754|NCT03580369|467654488|FG005|Overall Study|Protocol Violation|2|||
129915755|NCT03580369|467654489|FG006|Overall Study|Protocol Violation|1|||
129915756|NCT03580369|467654490|FG007|Overall Study|Protocol Violation|0|||
129915757|NCT03580369|467654483|FG000|Overall Study|Adverse Event|7|||
129915758|NCT03580369|467654484|FG001|Overall Study|Adverse Event|0|||
129915759|NCT03580369|467654485|FG002|Overall Study|Adverse Event|14|||
129866480|NCT01986881|467469516|FG000|Overall Study|Subject Moved|0|||
129866481|NCT01986881|467469517|FG001|Overall Study|Subject Moved|1|||
129866482|NCT01986881|467469518|FG002|Overall Study|Subject Moved|0|||
129866483|NCT01986881|467469516|FG000|Overall Study|Other|1|||
129866484|NCT01986881|467469517|FG001|Overall Study|Other|2|||
129866485|NCT01986881|467469518|FG002|Overall Study|Other|2|||
129866486|NCT03563716|467469527|FG000|Overall Study|Death|20|||
129866487|NCT03563716|467469528|FG001|Overall Study|Death|14|||
129866488|NCT03563716|467469527|FG000|Overall Study|Withdrawal by Subject|3|||
129866489|NCT03563716|467469528|FG001|Overall Study|Withdrawal by Subject|3|||
129866490|NCT03563716|467469527|FG000|Overall Study|Still on Study|45|||
129866491|NCT03563716|467469528|FG001|Overall Study|Still on Study|50|||
129866492|NCT02583425|467469529|FG000|Screening|Did not meet entry criteria|12|||
129866493|NCT02583425|467469529|FG000|Baseline|Did not meet continued criteria|5|||
129915760|NCT03580369|467654486|FG003|Overall Study|Adverse Event|1|||
129866494|NCT02583425|467469529|FG000|Treatment Period|Adverse Event|1|||
129449808|NCT01092143|465945688|FG004|Overall Study|Not treated|0|||
129449809|NCT01092143|465945684|FG000|Overall Study|did not reversibility criteria|0|||
129866495|NCT01597050|467469532|FG000|Overall Study|Withdrawal by Subject|1|||
129866496|NCT01597050|467469533|FG001|Overall Study|Withdrawal by Subject|0|||
129866497|NCT00483184|467469534|FG000|Overall Study|Withdrawal by Subject|2|||
129866498|NCT00483184|467469535|FG001|Overall Study|Withdrawal by Subject|2|||
129866499|NCT00483184|467469536|FG002|Overall Study|Withdrawal by Subject|0|||
129866500|NCT00483184|467469534|FG000|Overall Study|Lost to Follow-up|1|||
129866501|NCT00483184|467469535|FG001|Overall Study|Lost to Follow-up|0|||
129866502|NCT00483184|467469536|FG002|Overall Study|Lost to Follow-up|0|||
129866503|NCT00483184|467469534|FG000|Overall Study|Adverse Event|1|||
129866504|NCT00483184|467469535|FG001|Overall Study|Adverse Event|2|||
129866505|NCT00483184|467469536|FG002|Overall Study|Adverse Event|2|||
129866506|NCT00483184|467469534|FG000|Overall Study|Protocol Violation|1|||
129866507|NCT00483184|467469535|FG001|Overall Study|Protocol Violation|0|||
129866508|NCT00483184|467469536|FG002|Overall Study|Protocol Violation|1|||
129866509|NCT00558428|467469537|FG000|Overall Study|Adverse Event|6|||
129866510|NCT00558428|467469538|FG001|Overall Study|Adverse Event|22|||
129866511|NCT00558428|467469539|FG002|Overall Study|Adverse Event|3|||
129866512|NCT00558428|467469540|FG003|Overall Study|Adverse Event|4|||
129866513|NCT00558428|467469537|FG000|Overall Study|Lost to Follow-up|0|||
129866514|NCT00558428|467469538|FG001|Overall Study|Lost to Follow-up|1|||
129449810|NCT01092143|465945685|FG001|Overall Study|did not reversibility criteria|0|||
129449811|NCT01092143|465945686|FG002|Overall Study|did not reversibility criteria|1|||
129449812|NCT01092143|465945687|FG003|Overall Study|did not reversibility criteria|0|||
129866515|NCT00558428|467469539|FG002|Overall Study|Lost to Follow-up|0|||
129866516|NCT00558428|467469540|FG003|Overall Study|Lost to Follow-up|0|||
129915761|NCT03580369|467654487|FG004|Overall Study|Adverse Event|6|||
129915762|NCT03580369|467654488|FG005|Overall Study|Adverse Event|0|||
129915763|NCT03580369|467654489|FG006|Overall Study|Adverse Event|1|||
129915764|NCT03580369|467654490|FG007|Overall Study|Adverse Event|0|||
129866517|NCT00558428|467469537|FG000|Overall Study|Lack of Efficacy|0|||
129866518|NCT00558428|467469538|FG001|Overall Study|Lack of Efficacy|0|||
129915765|NCT03580369|467654483|FG000|Overall Study|Withdrawal by Subject|19|||
129915766|NCT03580369|467654484|FG001|Overall Study|Withdrawal by Subject|0|||
129915767|NCT03580369|467654485|FG002|Overall Study|Withdrawal by Subject|17|||
129915768|NCT03580369|467654486|FG003|Overall Study|Withdrawal by Subject|0|||
129915769|NCT03580369|467654487|FG004|Overall Study|Withdrawal by Subject|16|||
129915770|NCT03580369|467654488|FG005|Overall Study|Withdrawal by Subject|1|||
129915771|NCT03580369|467654489|FG006|Overall Study|Withdrawal by Subject|7|||
129915772|NCT03580369|467654490|FG007|Overall Study|Withdrawal by Subject|0|||
129915773|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
129915774|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
129915775|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
129915776|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
129915777|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
129915778|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
129915779|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
129915780|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
129915781|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
129915782|NCT03939312|467654493|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
129915783|NCT03939312|467654493|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
129915784|NCT03939312|467654493|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
129915785|NCT02119650|467654495|FG000|Overall Study|Adverse Event|3|||
129915786|NCT02119650|467654496|FG001|Overall Study|Adverse Event|4|||
129866519|NCT00558428|467469539|FG002|Overall Study|Lack of Efficacy|1|||
129866520|NCT00558428|467469540|FG003|Overall Study|Lack of Efficacy|2|||
129866521|NCT00558428|467469537|FG000|Overall Study|Non compliant with protocol|1|||
129866522|NCT00558428|467469538|FG001|Overall Study|Non compliant with protocol|0|||
129866523|NCT00558428|467469539|FG002|Overall Study|Non compliant with protocol|0|||
129866524|NCT00558428|467469540|FG003|Overall Study|Non compliant with protocol|3|||
129866525|NCT00558428|467469537|FG000|Overall Study|Consent withdrawn|2|||
129866526|NCT00558428|467469538|FG001|Overall Study|Consent withdrawn|1|||
129866527|NCT00558428|467469539|FG002|Overall Study|Consent withdrawn|0|||
129866528|NCT00558428|467469540|FG003|Overall Study|Consent withdrawn|1|||
129866529|NCT00558428|467469537|FG000|Overall Study|Other|3|||
129866530|NCT00558428|467469538|FG001|Overall Study|Other|0|||
129866531|NCT00558428|467469539|FG002|Overall Study|Other|0|||
129866532|NCT00558428|467469540|FG003|Overall Study|Other|1|||
129866533|NCT05224050|467469541|FG000|Overall Study|Withdrawal by Subject|9|||
129866534|NCT05224050|467469541|FG000|Overall Study|Lost to Follow-up|3|||
129866535|NCT01137474|467469542|FG000|Overall Study|Adverse Event|3|||
129866536|NCT01137474|467469543|FG001|Overall Study|Adverse Event|5|||
129866537|NCT01137474|467469544|FG002|Overall Study|Adverse Event|1|||
129866538|NCT01137474|467469545|FG003|Overall Study|Adverse Event|3|||
129866539|NCT01137474|467469542|FG000|Overall Study|Withdrawal by Subject|7|||
129866540|NCT01137474|467469543|FG001|Overall Study|Withdrawal by Subject|2|||
129866541|NCT01137474|467469544|FG002|Overall Study|Withdrawal by Subject|6|||
129866542|NCT01137474|467469545|FG003|Overall Study|Withdrawal by Subject|9|||
129866543|NCT01137474|467469542|FG000|Overall Study|No longer met study criteria|6|||
129866544|NCT01137474|467469543|FG001|Overall Study|No longer met study criteria|1|||
129866545|NCT01137474|467469544|FG002|Overall Study|No longer met study criteria|0|||
129866546|NCT01137474|467469545|FG003|Overall Study|No longer met study criteria|5|||
129866547|NCT01137474|467469542|FG000|Overall Study|Lost to Follow-up|5|||
129866548|NCT01137474|467469543|FG001|Overall Study|Lost to Follow-up|1|||
129866549|NCT01137474|467469544|FG002|Overall Study|Lost to Follow-up|0|||
129866550|NCT01137474|467469545|FG003|Overall Study|Lost to Follow-up|2|||
129866551|NCT01137474|467469542|FG000|Overall Study|Lack of Efficacy|0|||
129866552|NCT01137474|467469543|FG001|Overall Study|Lack of Efficacy|0|||
129866553|NCT01137474|467469544|FG002|Overall Study|Lack of Efficacy|0|||
129915787|NCT02119650|467654495|FG000|Overall Study|Subject decision|2|||
129866554|NCT01137474|467469545|FG003|Overall Study|Lack of Efficacy|2|||
129866555|NCT01137474|467469542|FG000|Overall Study|Other|3|||
129915788|NCT02119650|467654496|FG001|Overall Study|Subject decision|3|||
129915789|NCT02119650|467654495|FG000|Overall Study|Disease progression|11|||
129915790|NCT02119650|467654496|FG001|Overall Study|Disease progression|14|||
129866556|NCT01137474|467469543|FG001|Overall Study|Other|1|||
129866557|NCT01137474|467469544|FG002|Overall Study|Other|0|||
129866558|NCT01137474|467469545|FG003|Overall Study|Other|0|||
129866559|NCT01137474|467469542|FG000|Overall Study|Pregnancy|0|||
129866560|NCT01137474|467469543|FG001|Overall Study|Pregnancy|1|||
129866561|NCT01137474|467469544|FG002|Overall Study|Pregnancy|0|||
129866562|NCT01137474|467469545|FG003|Overall Study|Pregnancy|0|||
129866563|NCT01137474|467469542|FG000|Overall Study|Administrative reason by sponsor|0|||
129866564|NCT01137474|467469543|FG001|Overall Study|Administrative reason by sponsor|1|||
129866565|NCT01137474|467469544|FG002|Overall Study|Administrative reason by sponsor|0|||
129866566|NCT01137474|467469545|FG003|Overall Study|Administrative reason by sponsor|0|||
129866567|NCT02219048|467469546|FG000|Overall Study|Adverse Event|2|||
129866568|NCT02219048|467469547|FG001|Overall Study|Adverse Event|5|||
129866569|NCT02219048|467469546|FG000|Overall Study|No longer meets eligibility criteria|1|||
129866570|NCT02219048|467469547|FG001|Overall Study|No longer meets eligibility criteria|0|||
129866571|NCT02219048|467469546|FG000|Overall Study|Study terminated by sponsor|16|||
129866572|NCT02219048|467469547|FG001|Overall Study|Study terminated by sponsor|15|||
129866573|NCT02219048|467469546|FG000|Overall Study|Withdrawal by Subject|2|||
129866574|NCT02219048|467469547|FG001|Overall Study|Withdrawal by Subject|0|||
129866575|NCT02219048|467469546|FG000|Overall Study|Other|0|||
129866576|NCT02219048|467469547|FG001|Overall Study|Other|1|||
129866577|NCT04794803|467469548|FG000|Overall Study|Death|1|||
129866578|NCT04794803|467469549|FG001|Overall Study|Death|3|||
129866579|NCT04794803|467469548|FG000|Overall Study|Lost to Follow-up|2|||
129866580|NCT04794803|467469549|FG001|Overall Study|Lost to Follow-up|2|||
129866581|NCT04794803|467469548|FG000|Overall Study|Withdrawal by Subject|1|||
129866582|NCT04794803|467469549|FG001|Overall Study|Withdrawal by Subject|0|||
129866583|NCT04794803|467469548|FG000|Overall Study|Physician Decision|1|||
129866584|NCT04794803|467469549|FG001|Overall Study|Physician Decision|1|||
129866585|NCT04794803|467469548|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
129866586|NCT04794803|467469549|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
129866587|NCT04794803|467469548|FG000|Overall Study|Refused to continue the treatment|1|||
129866588|NCT04794803|467469549|FG001|Overall Study|Refused to continue the treatment|0|||
129866589|NCT04794803|467469548|FG000|Overall Study|Patient admitted to ICU|0|||
129866590|NCT04794803|467469549|FG001|Overall Study|Patient admitted to ICU|1|||
129866591|NCT00911534|467469550|FG000|Overall Study|Adverse Event|4|||
129866592|NCT00911534|467469551|FG001|Overall Study|Adverse Event|4|||
129866593|NCT00911534|467469550|FG000|Overall Study|Lost to Follow-up|2|||
129866594|NCT00911534|467469551|FG001|Overall Study|Lost to Follow-up|4|||
129866595|NCT00911534|467469550|FG000|Overall Study|Withdrawal by Subject|2|||
129866596|NCT00911534|467469551|FG001|Overall Study|Withdrawal by Subject|1|||
129866597|NCT00911534|467469550|FG000|Overall Study|Lack of Efficacy|4|||
129866598|NCT00911534|467469551|FG001|Overall Study|Lack of Efficacy|1|||
129866599|NCT00911534|467469550|FG000|Overall Study|Withdrawal of consent|1|||
129866600|NCT00911534|467469551|FG001|Overall Study|Withdrawal of consent|4|||
129866601|NCT00911534|467469550|FG000|Overall Study|Other|2|||
129866602|NCT00911534|467469551|FG001|Overall Study|Other|2|||
129866603|NCT03896035|467469552|FG000|Overall Study|Lost to Follow-up|2|||
129866604|NCT03896035|467469553|FG001|Overall Study|Lost to Follow-up|6|||
129866605|NCT03896035|467469552|FG000|Overall Study|Withdrawal by Subject|0|||
129866606|NCT03896035|467469553|FG001|Overall Study|Withdrawal by Subject|1|||
129866607|NCT03896035|467469552|FG000|Overall Study|Health/family health issues during COVID|0|||
129866608|NCT03896035|467469553|FG001|Overall Study|Health/family health issues during COVID|4|||
129866609|NCT01506193|467469554|FG000|Overall Study|Protocol Violation|1|||
129866610|NCT01506193|467469555|FG001|Overall Study|Protocol Violation|0|||
129866611|NCT01506193|467469556|FG002|Overall Study|Protocol Violation|1|||
129866612|NCT01506193|467469554|FG000|Overall Study|Migrated/moved from study area|0|||
129866613|NCT01506193|467469555|FG001|Overall Study|Migrated/moved from study area|0|||
129866614|NCT01506193|467469556|FG002|Overall Study|Migrated/moved from study area|1|||
129866615|NCT01506193|467469554|FG000|Overall Study|Adverse event, non-fatal|0|||
129866616|NCT01506193|467469555|FG001|Overall Study|Adverse event, non-fatal|0|||
129866617|NCT01506193|467469556|FG002|Overall Study|Adverse event, non-fatal|1|||
129866618|NCT01506193|467469554|FG000|Overall Study|Withdrawal by Subject|5|||
129866619|NCT01506193|467469555|FG001|Overall Study|Withdrawal by Subject|1|||
129866620|NCT01506193|467469556|FG002|Overall Study|Withdrawal by Subject|8|||
129866621|NCT01506193|467469554|FG000|Overall Study|Lost to Follow-up|8|||
129866622|NCT01506193|467469555|FG001|Overall Study|Lost to Follow-up|3|||
129866623|NCT01506193|467469556|FG002|Overall Study|Lost to Follow-up|3|||
129866624|NCT01388816|467469557|FG000|Overall Study|Adverse Event|0|||
129866625|NCT01388816|467469558|FG001|Overall Study|Adverse Event|2|||
129866626|NCT01388816|467469559|FG002|Overall Study|Adverse Event|0|||
129866627|NCT01388816|467469560|FG003|Overall Study|Adverse Event|0|||
129866628|NCT01388816|467469557|FG000|Overall Study|Lost to Follow-up|0|||
129866629|NCT01388816|467469558|FG001|Overall Study|Lost to Follow-up|1|||
129866630|NCT01388816|467469559|FG002|Overall Study|Lost to Follow-up|0|||
129866631|NCT01388816|467469560|FG003|Overall Study|Lost to Follow-up|0|||
129866632|NCT01388816|467469557|FG000|Overall Study|Withdrawal by Subject|2|||
129866633|NCT01388816|467469558|FG001|Overall Study|Withdrawal by Subject|1|||
129866634|NCT01388816|467469559|FG002|Overall Study|Withdrawal by Subject|1|||
129866635|NCT01388816|467469560|FG003|Overall Study|Withdrawal by Subject|0|||
129866636|NCT01388816|467469557|FG000|Overall Study|Protocol Violation|0|||
129866637|NCT01388816|467469558|FG001|Overall Study|Protocol Violation|0|||
129866638|NCT01388816|467469559|FG002|Overall Study|Protocol Violation|2|||
129866639|NCT01388816|467469560|FG003|Overall Study|Protocol Violation|0|||
129915791|NCT02119650|467654495|FG000|Overall Study|Death|5|||
129866640|NCT00743366|467469561|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
129866641|NCT00743366|467469562|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
129866642|NCT03206203|467469563|FG000|Treatment|Death|38|||
129866643|NCT03206203|467469564|FG001|Treatment|Death|26|||
129866644|NCT03206203|467469565|FG002|Treatment|Death|0|||
129866645|NCT03206203|467469563|FG000|Treatment|Withdrawal by Subject|1|||
129866646|NCT03206203|467469564|FG001|Treatment|Withdrawal by Subject|0|||
129866647|NCT03206203|467469565|FG002|Treatment|Withdrawal by Subject|0|||
129866648|NCT03206203|467469563|FG000|Treatment|Lost to Follow-up|4|||
129866649|NCT03206203|467469564|FG001|Treatment|Lost to Follow-up|0|||
129866650|NCT03206203|467469565|FG002|Treatment|Lost to Follow-up|0|||
129866651|NCT03206203|467469563|FG000|Treatment|N/A in Follow-Up|8|||
129866652|NCT03206203|467469564|FG001|Treatment|N/A in Follow-Up|1|||
129866653|NCT03206203|467469565|FG002|Treatment|N/A in Follow-Up|0|||
129866654|NCT03206203|467469563|FG000|Treatment|Disease progression|0|||
129866655|NCT03206203|467469564|FG001|Treatment|Disease progression|1|||
129866656|NCT03206203|467469565|FG002|Treatment|Disease progression|0|||
129866657|NCT03206203|467469563|FG000|Treatment|Refused follow-up|0|||
129866658|NCT03206203|467469564|FG001|Treatment|Refused follow-up|1|||
129866659|NCT03206203|467469565|FG002|Treatment|Refused follow-up|0|||
129866660|NCT03206203|467469563|FG000|Treatment|Cross over to Arm 1|0|||
129866661|NCT03206203|467469564|FG001|Treatment|Cross over to Arm 1|19|||
129866662|NCT03206203|467469565|FG002|Treatment|Cross over to Arm 1|0|||
129866663|NCT03206203|467469563|FG000|Optional Cross-Over|Death|0|||
129866664|NCT03206203|467469564|FG001|Optional Cross-Over|Death|0|||
129866665|NCT03206203|467469565|FG002|Optional Cross-Over|Death|14|||
129866666|NCT03206203|467469563|FG000|Optional Cross-Over|Refused follow-up|0|||
129866667|NCT03206203|467469564|FG001|Optional Cross-Over|Refused follow-up|0|||
129866668|NCT03206203|467469565|FG002|Optional Cross-Over|Refused follow-up|2|||
129866669|NCT00335322|467469566|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
129866670|NCT00335322|467469567|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
129866671|NCT00335322|467469568|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
129866672|NCT01152580|467469569|FG000|Overall Study|Withdrawal by Subject|0|||
129866673|NCT01152580|467469570|FG001|Overall Study|Withdrawal by Subject|1|||
129866674|NCT02275065|467469571|FG000|Overall Study|Randomized but not treated|1|||
129866675|NCT02275065|467469572|FG001|Overall Study|Randomized but not treated|0|||
129866676|NCT02275065|467469573|FG002|Overall Study|Randomized but not treated|1|||
129866677|NCT02275065|467469574|FG003|Overall Study|Randomized but not treated|1|||
129866678|NCT02275065|467469575|FG004|Overall Study|Randomized but not treated|0|||
129866679|NCT03015402|467469576|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129866680|NCT03015402|467469577|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
129866681|NCT03015402|467469576|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129866682|NCT03015402|467469577|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
129866683|NCT03213158|467469578|FG000|Overall Study|Withdrawal by Subject|1|||
129866684|NCT03213158|467469578|FG000|Overall Study|Physician Decision|2|||
129866685|NCT01995461|467469579|FG000|Overall Study|Death|1|||
129866686|NCT01995461|467469579|FG000|Overall Study|Lost to Follow-up|2|||
129866687|NCT01995461|467469579|FG000|Overall Study|Withdrawal by Subject|2|||
129866688|NCT00736645|467469582|FG000|Overall Study|Adverse Event|0|||
129866689|NCT00736645|467469583|FG001|Overall Study|Adverse Event|2|||
129866690|NCT00736645|467469584|FG002|Overall Study|Adverse Event|0|||
129866691|NCT00736645|467469585|FG003|Overall Study|Adverse Event|0|||
129866692|NCT03792126|467469587|FG000|Overall Study|Adverse Event|1|||
129866693|NCT03792126|467469588|FG001|Overall Study|Adverse Event|2|||
129866694|NCT03792126|467469587|FG000|Overall Study|Death|0|||
129866695|NCT03792126|467469588|FG001|Overall Study|Death|1|||
129866696|NCT03792126|467469587|FG000|Overall Study|Lost to Follow-up|1|||
129866697|NCT03792126|467469588|FG001|Overall Study|Lost to Follow-up|0|||
129866698|NCT03792126|467469587|FG000|Overall Study|Withdrawal by Subject|0|||
129866699|NCT03792126|467469588|FG001|Overall Study|Withdrawal by Subject|1|||
129866700|NCT03792126|467469587|FG000|Overall Study|COVID-19 Restrictions|1|||
129866701|NCT03792126|467469588|FG001|Overall Study|COVID-19 Restrictions|3|||
129866702|NCT03792126|467469587|FG000|Overall Study|Symptoms resolved|0|||
129866703|NCT03792126|467469588|FG001|Overall Study|Symptoms resolved|3|||
129866704|NCT03240692|467469589|FG000|Overall Study|Physician Decision|1|||
129866705|NCT03240692|467469589|FG000|Overall Study|Withdrawal by Subject|1|||
129866706|NCT04322682|467469590|FG000|Overall Study|Withdrawal by Subject|33|||
129866707|NCT04322682|467469591|FG001|Overall Study|Withdrawal by Subject|47|||
129866708|NCT04322682|467469590|FG000|Overall Study|Death|5|||
129866709|NCT04322682|467469591|FG001|Overall Study|Death|9|||
129866710|NCT04322682|467469590|FG000|Overall Study|Lost to Follow-up|4|||
129866711|NCT04322682|467469591|FG001|Overall Study|Lost to Follow-up|8|||
129866712|NCT04322682|467469590|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
129866713|NCT04322682|467469591|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
129866714|NCT02238379|467469592|FG000|Overall Study|Lost to Follow-up|1|||
129866715|NCT02238379|467469593|FG001|Overall Study|Lost to Follow-up|0|||
129866716|NCT04123067|467469594|FG000|Overall Study|Lost to Follow-up|0|||
129866717|NCT04123067|467469595|FG001|Overall Study|Lost to Follow-up|1|||
129866718|NCT00441090|467469596|FG000|Overall Study|Adverse Event|0|||
129866719|NCT00441090|467469597|FG001|Overall Study|Adverse Event|1|||
129866720|NCT00441090|467469598|FG002|Overall Study|Adverse Event|1|||
129866721|NCT00441090|467469599|FG003|Overall Study|Adverse Event|0|||
129866722|NCT00441090|467469600|FG004|Overall Study|Adverse Event|0|||
129866723|NCT00441090|467469596|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866724|NCT00441090|467469597|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866725|NCT00441090|467469598|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866726|NCT00441090|467469599|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
129866727|NCT00441090|467469600|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
129866728|NCT00441090|467469596|FG000|Overall Study|Withdrawal by Subject|1|||
129866729|NCT00441090|467469597|FG001|Overall Study|Withdrawal by Subject|0|||
129866730|NCT00441090|467469598|FG002|Overall Study|Withdrawal by Subject|1|||
129866731|NCT00441090|467469599|FG003|Overall Study|Withdrawal by Subject|0|||
129866732|NCT00441090|467469600|FG004|Overall Study|Withdrawal by Subject|0|||
129866733|NCT00441090|467469596|FG000|Overall Study|Lack of Efficacy|1|||
129866734|NCT00441090|467469597|FG001|Overall Study|Lack of Efficacy|0|||
129866735|NCT00441090|467469598|FG002|Overall Study|Lack of Efficacy|0|||
129866736|NCT00441090|467469599|FG003|Overall Study|Lack of Efficacy|0|||
129866737|NCT00441090|467469600|FG004|Overall Study|Lack of Efficacy|0|||
129866738|NCT00605280|467469601|FG000|Year 1|Protocol Violation|0|||
129866739|NCT00605280|467469602|FG001|Year 1|Protocol Violation|0|||
129866740|NCT00605280|467469603|FG002|Year 1|Protocol Violation|0|||
129866741|NCT00605280|467469604|FG003|Year 1|Protocol Violation|1|||
129866742|NCT00605280|467469601|FG000|Year 1|Adverse Event|3|||
129866743|NCT00605280|467469602|FG001|Year 1|Adverse Event|1|||
129866744|NCT00605280|467469603|FG002|Year 1|Adverse Event|1|||
129866745|NCT00605280|467469604|FG003|Year 1|Adverse Event|5|||
129866746|NCT00605280|467469601|FG000|Year 1|Physician Decision|7|||
129866747|NCT00605280|467469602|FG001|Year 1|Physician Decision|4|||
129866748|NCT00605280|467469603|FG002|Year 1|Physician Decision|0|||
129866749|NCT00605280|467469604|FG003|Year 1|Physician Decision|6|||
129866750|NCT00605280|467469601|FG000|Year 1|Withdrawal by Subject|2|||
129866751|NCT00605280|467469602|FG001|Year 1|Withdrawal by Subject|4|||
129866752|NCT00605280|467469603|FG002|Year 1|Withdrawal by Subject|0|||
129866753|NCT00605280|467469604|FG003|Year 1|Withdrawal by Subject|4|||
129866754|NCT00605280|467469601|FG000|Year 1|Other|2|||
129866755|NCT00605280|467469602|FG001|Year 1|Other|1|||
129866756|NCT00605280|467469603|FG002|Year 1|Other|0|||
129866757|NCT00605280|467469604|FG003|Year 1|Other|1|||
129866758|NCT00605280|467469601|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
129866759|NCT00605280|467469602|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
129866760|NCT00605280|467469603|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
129866761|NCT00605280|467469604|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
129866762|NCT00605280|467469601|FG000|Year 2|Adverse Event|4|||
129866763|NCT00605280|467469602|FG001|Year 2|Adverse Event|0|||
129866764|NCT00605280|467469603|FG002|Year 2|Adverse Event|2|||
129866765|NCT00605280|467469604|FG003|Year 2|Adverse Event|4|||
129866766|NCT00605280|467469601|FG000|Year 2|Physician Decision|11|||
129866767|NCT00605280|467469602|FG001|Year 2|Physician Decision|6|||
129866768|NCT00605280|467469603|FG002|Year 2|Physician Decision|4|||
129866769|NCT00605280|467469604|FG003|Year 2|Physician Decision|11|||
129866770|NCT00605280|467469601|FG000|Year 2|Withdrawal by Subject|4|||
129866771|NCT00605280|467469602|FG001|Year 2|Withdrawal by Subject|0|||
129866772|NCT00605280|467469603|FG002|Year 2|Withdrawal by Subject|0|||
129866773|NCT00605280|467469604|FG003|Year 2|Withdrawal by Subject|4|||
129866774|NCT00605280|467469601|FG000|Year 2|Other|1|||
129866775|NCT00605280|467469602|FG001|Year 2|Other|0|||
129866776|NCT00605280|467469603|FG002|Year 2|Other|0|||
129866777|NCT00605280|467469604|FG003|Year 2|Other|1|||
129866778|NCT00605280|467469601|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
129866779|NCT00605280|467469602|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
129866780|NCT00605280|467469603|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
129866781|NCT00605280|467469604|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
129866782|NCT00605280|467469601|FG000|Year 3 Extension|Adverse Event|2|||
129866783|NCT00605280|467469602|FG001|Year 3 Extension|Adverse Event|0|||
129866784|NCT00605280|467469603|FG002|Year 3 Extension|Adverse Event|0|||
129866785|NCT00605280|467469604|FG003|Year 3 Extension|Adverse Event|2|||
129866786|NCT00605280|467469601|FG000|Year 3 Extension|Physician Decision|0|||
129866787|NCT00605280|467469602|FG001|Year 3 Extension|Physician Decision|0|||
129866788|NCT00605280|467469603|FG002|Year 3 Extension|Physician Decision|0|||
129866789|NCT00605280|467469604|FG003|Year 3 Extension|Physician Decision|2|||
129866790|NCT00605280|467469601|FG000|Year 3 Extension|Withdrawal by Subject|2|||
129866791|NCT00605280|467469602|FG001|Year 3 Extension|Withdrawal by Subject|0|||
129866792|NCT00605280|467469603|FG002|Year 3 Extension|Withdrawal by Subject|0|||
129915792|NCT02119650|467654496|FG001|Overall Study|Death|1|||
129915793|NCT02119650|467654495|FG000|Overall Study|Noncompliance with study treatment|1|||
129915794|NCT02119650|467654496|FG001|Overall Study|Noncompliance with study treatment|1|||
129915795|NCT02119650|467654495|FG000|Overall Study|Study terminated by the sponsor|1|||
129915796|NCT02119650|467654496|FG001|Overall Study|Study terminated by the sponsor|0|||
129915797|NCT02119650|467654495|FG000|Overall Study|Physician Decision|0|||
129915798|NCT02119650|467654496|FG001|Overall Study|Physician Decision|2|||
129915799|NCT02119650|467654495|FG000|Overall Study|Multiple reasons for termination|2|||
129866793|NCT00605280|467469604|FG003|Year 3 Extension|Withdrawal by Subject|5|||
129866794|NCT00605280|467469601|FG000|Year 3 Extension|Other|2|||
129866795|NCT00605280|467469602|FG001|Year 3 Extension|Other|0|||
129866796|NCT00605280|467469603|FG002|Year 3 Extension|Other|0|||
129866797|NCT00605280|467469604|FG003|Year 3 Extension|Other|0|||
129866798|NCT00605280|467469601|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
129866799|NCT00605280|467469602|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
129866800|NCT00605280|467469603|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
129866801|NCT00605280|467469604|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
129866802|NCT01775904|467469608|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
129866803|NCT01775904|467469608|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
129866804|NCT00518115|467469609|FG000|Overall Study|Adverse Event|6|||
129866805|NCT00518115|467469610|FG001|Overall Study|Adverse Event|1|||
129866806|NCT00518115|467469611|FG002|Overall Study|Adverse Event|5|||
129866807|NCT00518115|467469612|FG003|Overall Study|Adverse Event|6|||
129866808|NCT00518115|467469613|FG004|Overall Study|Adverse Event|5|||
129866809|NCT00518115|467469614|FG005|Overall Study|Adverse Event|5|||
129866810|NCT00518115|467469615|FG006|Overall Study|Adverse Event|5|||
129866811|NCT00518115|467469616|FG007|Overall Study|Adverse Event|10|||
129866812|NCT00518115|467469617|FG008|Overall Study|Adverse Event|2|||
129866813|NCT00518115|467469618|FG009|Overall Study|Adverse Event|9|||
129866814|NCT00518115|467469609|FG000|Overall Study|Lost to Follow-up|0|||
129866815|NCT00518115|467469610|FG001|Overall Study|Lost to Follow-up|0|||
129866816|NCT00518115|467469611|FG002|Overall Study|Lost to Follow-up|2|||
129866817|NCT00518115|467469612|FG003|Overall Study|Lost to Follow-up|3|||
129866818|NCT00518115|467469613|FG004|Overall Study|Lost to Follow-up|1|||
129866819|NCT00518115|467469614|FG005|Overall Study|Lost to Follow-up|3|||
129866820|NCT00518115|467469615|FG006|Overall Study|Lost to Follow-up|0|||
129866821|NCT00518115|467469616|FG007|Overall Study|Lost to Follow-up|1|||
129866822|NCT00518115|467469617|FG008|Overall Study|Lost to Follow-up|1|||
129866823|NCT00518115|467469618|FG009|Overall Study|Lost to Follow-up|1|||
129866824|NCT00518115|467469609|FG000|Overall Study|Protocol Violation|1|||
129866825|NCT00518115|467469610|FG001|Overall Study|Protocol Violation|3|||
129866826|NCT00518115|467469611|FG002|Overall Study|Protocol Violation|1|||
129866827|NCT00518115|467469612|FG003|Overall Study|Protocol Violation|0|||
129866828|NCT00518115|467469613|FG004|Overall Study|Protocol Violation|0|||
129866829|NCT00518115|467469614|FG005|Overall Study|Protocol Violation|0|||
129866830|NCT00518115|467469615|FG006|Overall Study|Protocol Violation|0|||
129866831|NCT00518115|467469616|FG007|Overall Study|Protocol Violation|0|||
129866832|NCT00518115|467469617|FG008|Overall Study|Protocol Violation|0|||
129866833|NCT00518115|467469618|FG009|Overall Study|Protocol Violation|0|||
129915800|NCT02119650|467654496|FG001|Overall Study|Multiple reasons for termination|1|||
129866834|NCT00518115|467469609|FG000|Overall Study|Withdrawal by Subject|1|||
129866835|NCT00518115|467469610|FG001|Overall Study|Withdrawal by Subject|1|||
129915801|NCT01721291|467654498|FG000|Overall Study|Withdrawal by Subject|1|||
129915802|NCT01721291|467654499|FG001|Overall Study|Withdrawal by Subject|0|||
129915803|NCT01721291|467654498|FG000|Overall Study|did not like the treatment|1|||
129866836|NCT00518115|467469611|FG002|Overall Study|Withdrawal by Subject|5|||
129866837|NCT00518115|467469612|FG003|Overall Study|Withdrawal by Subject|0|||
129866838|NCT00518115|467469613|FG004|Overall Study|Withdrawal by Subject|2|||
129915804|NCT01721291|467654499|FG001|Overall Study|did not like the treatment|0|||
129915805|NCT04442126|467654510|FG000|Overall Study|Withdrawal by Subject|0|||
129866839|NCT00518115|467469614|FG005|Overall Study|Withdrawal by Subject|1|||
129866840|NCT00518115|467469615|FG006|Overall Study|Withdrawal by Subject|0|||
129866841|NCT00518115|467469616|FG007|Overall Study|Withdrawal by Subject|2|||
129866842|NCT00518115|467469617|FG008|Overall Study|Withdrawal by Subject|1|||
129866843|NCT00518115|467469618|FG009|Overall Study|Withdrawal by Subject|3|||
129866844|NCT00518115|467469609|FG000|Overall Study|Lack of Efficacy|1|||
129866845|NCT00518115|467469610|FG001|Overall Study|Lack of Efficacy|0|||
129915806|NCT04442126|467654511|FG001|Overall Study|Withdrawal by Subject|0|||
129866846|NCT00518115|467469611|FG002|Overall Study|Lack of Efficacy|1|||
129866847|NCT00518115|467469612|FG003|Overall Study|Lack of Efficacy|1|||
129866848|NCT00518115|467469613|FG004|Overall Study|Lack of Efficacy|0|||
129866849|NCT00518115|467469614|FG005|Overall Study|Lack of Efficacy|0|||
129866850|NCT00518115|467469615|FG006|Overall Study|Lack of Efficacy|0|||
129866851|NCT00518115|467469616|FG007|Overall Study|Lack of Efficacy|1|||
129866852|NCT00518115|467469617|FG008|Overall Study|Lack of Efficacy|0|||
129866853|NCT00518115|467469618|FG009|Overall Study|Lack of Efficacy|0|||
129866854|NCT00518115|467469609|FG000|Overall Study|Non-Compliance|1|||
129866855|NCT00518115|467469610|FG001|Overall Study|Non-Compliance|0|||
129866856|NCT00518115|467469611|FG002|Overall Study|Non-Compliance|1|||
129866857|NCT00518115|467469612|FG003|Overall Study|Non-Compliance|0|||
129866858|NCT00518115|467469613|FG004|Overall Study|Non-Compliance|1|||
129866859|NCT00518115|467469614|FG005|Overall Study|Non-Compliance|1|||
129866860|NCT00518115|467469615|FG006|Overall Study|Non-Compliance|1|||
129866861|NCT00518115|467469616|FG007|Overall Study|Non-Compliance|1|||
129866862|NCT00518115|467469617|FG008|Overall Study|Non-Compliance|0|||
129866863|NCT00518115|467469618|FG009|Overall Study|Non-Compliance|1|||
129866864|NCT00518115|467469609|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
129866865|NCT00518115|467469610|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
129866866|NCT00518115|467469611|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866867|NCT00518115|467469612|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866868|NCT00518115|467469613|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866869|NCT00518115|467469614|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
129866870|NCT00518115|467469615|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866871|NCT00518115|467469616|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866872|NCT00518115|467469617|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866873|NCT00518115|467469618|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
129866874|NCT00518115|467469609|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
129866875|NCT00518115|467469610|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866876|NCT00518115|467469611|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866877|NCT00518115|467469612|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866878|NCT00518115|467469613|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866879|NCT00518115|467469614|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866880|NCT00518115|467469615|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866881|NCT00518115|467469616|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866882|NCT00518115|467469617|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866883|NCT00518115|467469618|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
129866884|NCT00518115|467469609|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866885|NCT00518115|467469610|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866886|NCT00518115|467469611|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
129866887|NCT00518115|467469612|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866888|NCT00518115|467469613|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866889|NCT00518115|467469614|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866890|NCT00518115|467469615|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866891|NCT00518115|467469616|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866892|NCT00518115|467469617|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
129866893|NCT00518115|467469618|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
129866894|NCT00518115|467469609|FG000|Overall Study|Wrong Monotherapy Administered|0|||
129866895|NCT00518115|467469610|FG001|Overall Study|Wrong Monotherapy Administered|0|||
129866896|NCT00518115|467469611|FG002|Overall Study|Wrong Monotherapy Administered|1|||
129866897|NCT00518115|467469612|FG003|Overall Study|Wrong Monotherapy Administered|0|||
129866898|NCT00518115|467469613|FG004|Overall Study|Wrong Monotherapy Administered|0|||
129866899|NCT00518115|467469614|FG005|Overall Study|Wrong Monotherapy Administered|0|||
129866900|NCT00518115|467469615|FG006|Overall Study|Wrong Monotherapy Administered|1|||
129866901|NCT00518115|467469616|FG007|Overall Study|Wrong Monotherapy Administered|0|||
129866902|NCT00518115|467469617|FG008|Overall Study|Wrong Monotherapy Administered|0|||
129866903|NCT00518115|467469618|FG009|Overall Study|Wrong Monotherapy Administered|0|||
129866904|NCT00518115|467469609|FG000|Overall Study|Violation of Exclusion Criteria|0|||
129915807|NCT04442126|467654512|FG002|Overall Study|Withdrawal by Subject|0|||
129915808|NCT04442126|467654513|FG003|Overall Study|Withdrawal by Subject|2|||
129866905|NCT00518115|467469610|FG001|Overall Study|Violation of Exclusion Criteria|0|||
129866906|NCT00518115|467469611|FG002|Overall Study|Violation of Exclusion Criteria|0|||
129866907|NCT00518115|467469612|FG003|Overall Study|Violation of Exclusion Criteria|1|||
129866908|NCT00518115|467469613|FG004|Overall Study|Violation of Exclusion Criteria|0|||
129866909|NCT00518115|467469614|FG005|Overall Study|Violation of Exclusion Criteria|0|||
129866910|NCT00518115|467469615|FG006|Overall Study|Violation of Exclusion Criteria|1|||
129866911|NCT00518115|467469616|FG007|Overall Study|Violation of Exclusion Criteria|0|||
129866912|NCT00518115|467469617|FG008|Overall Study|Violation of Exclusion Criteria|0|||
129866913|NCT00518115|467469618|FG009|Overall Study|Violation of Exclusion Criteria|0|||
129866914|NCT00518115|467469609|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
129866915|NCT00518115|467469610|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
129866916|NCT00518115|467469611|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
129866917|NCT00518115|467469612|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
129866918|NCT00518115|467469613|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
129866919|NCT00518115|467469614|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
129866920|NCT00518115|467469615|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
129866921|NCT00518115|467469616|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
129866922|NCT00518115|467469617|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
129866923|NCT00518115|467469618|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
129866924|NCT00518115|467469609|FG000|Overall Study|Withdrew Consent|0|||
129866925|NCT00518115|467469610|FG001|Overall Study|Withdrew Consent|0|||
129866926|NCT00518115|467469611|FG002|Overall Study|Withdrew Consent|0|||
129866927|NCT00518115|467469612|FG003|Overall Study|Withdrew Consent|0|||
129866928|NCT00518115|467469613|FG004|Overall Study|Withdrew Consent|0|||
129866929|NCT00518115|467469614|FG005|Overall Study|Withdrew Consent|1|||
129866930|NCT00518115|467469615|FG006|Overall Study|Withdrew Consent|0|||
129866931|NCT00518115|467469616|FG007|Overall Study|Withdrew Consent|0|||
129866932|NCT00518115|467469617|FG008|Overall Study|Withdrew Consent|0|||
129866933|NCT00518115|467469618|FG009|Overall Study|Withdrew Consent|0|||
129866934|NCT00518115|467469609|FG000|Overall Study|Moved Out of State|0|||
129866935|NCT00518115|467469610|FG001|Overall Study|Moved Out of State|0|||
129866936|NCT00518115|467469611|FG002|Overall Study|Moved Out of State|0|||
129866937|NCT00518115|467469612|FG003|Overall Study|Moved Out of State|0|||
129866938|NCT00518115|467469613|FG004|Overall Study|Moved Out of State|0|||
129866939|NCT00518115|467469614|FG005|Overall Study|Moved Out of State|0|||
129866940|NCT00518115|467469615|FG006|Overall Study|Moved Out of State|0|||
129866941|NCT00518115|467469616|FG007|Overall Study|Moved Out of State|0|||
129866942|NCT00518115|467469617|FG008|Overall Study|Moved Out of State|0|||
129866943|NCT00518115|467469618|FG009|Overall Study|Moved Out of State|1|||
129866944|NCT04891419|467469619|FG000|Overall Study|Withdrawal by Subject|4|||
129866945|NCT04891419|467469620|FG001|Overall Study|Withdrawal by Subject|0|||
129866946|NCT04891419|467469619|FG000|Overall Study|Lost to Follow-up|1|||
129866947|NCT04891419|467469620|FG001|Overall Study|Lost to Follow-up|3|||
129866948|NCT00827918|467469621|FG000|Overall Study|Adverse Event|4|||
129866949|NCT00827918|467469622|FG001|Overall Study|Adverse Event|0|||
129866950|NCT00827918|467469623|FG002|Overall Study|Adverse Event|0|||
129866951|NCT00827918|467469621|FG000|Overall Study|Lack of Efficacy|16|||
129866952|NCT00827918|467469622|FG001|Overall Study|Lack of Efficacy|4|||
129915809|NCT04442126|467654514|FG004|Overall Study|Withdrawal by Subject|1|||
129915810|NCT04442126|467654515|FG005|Overall Study|Withdrawal by Subject|0|||
129915811|NCT04442126|467654516|FG006|Overall Study|Withdrawal by Subject|1|||
129915812|NCT04442126|467654517|FG007|Overall Study|Withdrawal by Subject|1|||
129915813|NCT04442126|467654518|FG008|Overall Study|Withdrawal by Subject|3|||
129915814|NCT04442126|467654510|FG000|Overall Study|Death|1|||
129915815|NCT04442126|467654511|FG001|Overall Study|Death|0|||
129915816|NCT04442126|467654512|FG002|Overall Study|Death|0|||
129915817|NCT04442126|467654513|FG003|Overall Study|Death|1|||
129915818|NCT04442126|467654514|FG004|Overall Study|Death|2|||
129915819|NCT04442126|467654515|FG005|Overall Study|Death|2|||
129915820|NCT04442126|467654516|FG006|Overall Study|Death|4|||
129915821|NCT04442126|467654517|FG007|Overall Study|Death|1|||
129915822|NCT04442126|467654518|FG008|Overall Study|Death|5|||
129915823|NCT04442126|467654510|FG000|Overall Study|Study Terminated by Sponsor|0|||
129866953|NCT00827918|467469623|FG002|Overall Study|Lack of Efficacy|15|||
129866954|NCT00827918|467469621|FG000|Overall Study|Physician Decision|1|||
129866955|NCT00827918|467469622|FG001|Overall Study|Physician Decision|0|||
129866956|NCT00827918|467469623|FG002|Overall Study|Physician Decision|0|||
129866957|NCT00827918|467469621|FG000|Overall Study|Pregnancy|0|||
129866958|NCT00827918|467469622|FG001|Overall Study|Pregnancy|1|||
129866959|NCT00827918|467469623|FG002|Overall Study|Pregnancy|0|||
129866960|NCT00827918|467469621|FG000|Overall Study|Progressive Disease|1|||
129915824|NCT04442126|467654511|FG001|Overall Study|Study Terminated by Sponsor|0|||
129915825|NCT04442126|467654512|FG002|Overall Study|Study Terminated by Sponsor|0|||
129915826|NCT04442126|467654513|FG003|Overall Study|Study Terminated by Sponsor|0|||
129866961|NCT00827918|467469622|FG001|Overall Study|Progressive Disease|1|||
129866962|NCT00827918|467469623|FG002|Overall Study|Progressive Disease|0|||
129866963|NCT00827918|467469621|FG000|Overall Study|Protocol Violation|0|||
129866964|NCT00827918|467469622|FG001|Overall Study|Protocol Violation|1|||
129866965|NCT00827918|467469623|FG002|Overall Study|Protocol Violation|0|||
129915827|NCT04442126|467654514|FG004|Overall Study|Study Terminated by Sponsor|0|||
129866966|NCT00827918|467469621|FG000|Overall Study|Withdrawal by Subject|6|||
129866967|NCT00827918|467469622|FG001|Overall Study|Withdrawal by Subject|2|||
129866968|NCT00827918|467469623|FG002|Overall Study|Withdrawal by Subject|6|||
129915828|NCT04442126|467654515|FG005|Overall Study|Study Terminated by Sponsor|1|||
129915829|NCT04442126|467654516|FG006|Overall Study|Study Terminated by Sponsor|4|||
129915830|NCT04442126|467654517|FG007|Overall Study|Study Terminated by Sponsor|2|||
129915831|NCT04442126|467654518|FG008|Overall Study|Study Terminated by Sponsor|10|||
129915832|NCT04442126|467654510|FG000|Overall Study|Lost to Follow-up|0|||
129915833|NCT04442126|467654511|FG001|Overall Study|Lost to Follow-up|0|||
129915834|NCT04442126|467654512|FG002|Overall Study|Lost to Follow-up|0|||
129915835|NCT04442126|467654513|FG003|Overall Study|Lost to Follow-up|0|||
129915836|NCT04442126|467654514|FG004|Overall Study|Lost to Follow-up|0|||
129915837|NCT04442126|467654515|FG005|Overall Study|Lost to Follow-up|0|||
129915838|NCT04442126|467654516|FG006|Overall Study|Lost to Follow-up|0|||
129915839|NCT04442126|467654517|FG007|Overall Study|Lost to Follow-up|1|||
129915840|NCT04442126|467654518|FG008|Overall Study|Lost to Follow-up|2|||
129915841|NCT04442126|467654510|FG000|Overall Study|Progressive Disease|0|||
129915842|NCT04442126|467654511|FG001|Overall Study|Progressive Disease|1|||
129915843|NCT04442126|467654512|FG002|Overall Study|Progressive Disease|3|||
129915844|NCT04442126|467654513|FG003|Overall Study|Progressive Disease|0|||
129915845|NCT04442126|467654514|FG004|Overall Study|Progressive Disease|3|||
129915846|NCT04442126|467654515|FG005|Overall Study|Progressive Disease|0|||
129915847|NCT04442126|467654516|FG006|Overall Study|Progressive Disease|0|||
129915848|NCT04442126|467654517|FG007|Overall Study|Progressive Disease|0|||
129915849|NCT04442126|467654518|FG008|Overall Study|Progressive Disease|0|||
129915850|NCT04442126|467654510|FG000|Overall Study|Other|0|||
129915851|NCT04442126|467654511|FG001|Overall Study|Other|0|||
129915852|NCT04442126|467654512|FG002|Overall Study|Other|0|||
129915853|NCT04442126|467654513|FG003|Overall Study|Other|0|||
129915854|NCT04442126|467654514|FG004|Overall Study|Other|0|||
129915855|NCT04442126|467654515|FG005|Overall Study|Other|0|||
129915856|NCT04442126|467654516|FG006|Overall Study|Other|0|||
129915857|NCT04442126|467654517|FG007|Overall Study|Other|0|||
129915858|NCT04442126|467654518|FG008|Overall Study|Other|1|||
129915859|NCT06450405|467654519|FG000|Overall Study|Study funding terminated.|0|||
129915860|NCT06450405|467654520|FG001|Overall Study|Study funding terminated.|2|||
129915861|NCT05134337|467655847|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
129915862|NCT05134337|467655848|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
129915863|NCT04923347|467655849|FG000|Overall Study|Withdrawal by Subject|14|||
129915864|NCT03424811|467655850|FG000|Overall Study|Lost to Follow-up|9|||
129915865|NCT03424811|467655851|FG001|Overall Study|Lost to Follow-up|0|||
129915866|NCT03948763|467655852|FG000|Overall Study|Sponsor's decision|0|||
129915867|NCT03948763|467655853|FG001|Overall Study|Sponsor's decision|2|||
129915868|NCT03948763|467655854|FG002|Overall Study|Sponsor's decision|6|||
129915869|NCT03948763|467655855|FG003|Overall Study|Sponsor's decision|4|||
129915870|NCT03948763|467655856|FG004|Overall Study|Sponsor's decision|0|||
129915871|NCT03948763|467655852|FG000|Overall Study|Physician Decision|0|||
129915872|NCT03948763|467655853|FG001|Overall Study|Physician Decision|0|||
129915873|NCT03948763|467655854|FG002|Overall Study|Physician Decision|1|||
129915874|NCT03948763|467655855|FG003|Overall Study|Physician Decision|0|||
129915875|NCT03948763|467655856|FG004|Overall Study|Physician Decision|0|||
129915876|NCT03948763|467655852|FG000|Overall Study|Lost to Follow-up|0|||
129915877|NCT03948763|467655853|FG001|Overall Study|Lost to Follow-up|0|||
129915878|NCT03948763|467655854|FG002|Overall Study|Lost to Follow-up|0|||
129915879|NCT03948763|467655855|FG003|Overall Study|Lost to Follow-up|0|||
129915880|NCT03948763|467655856|FG004|Overall Study|Lost to Follow-up|1|||
129915881|NCT03948763|467655852|FG000|Overall Study|Death|2|||
129915882|NCT03948763|467655853|FG001|Overall Study|Death|12|||
129915883|NCT03948763|467655854|FG002|Overall Study|Death|13|||
129915884|NCT03948763|467655855|FG003|Overall Study|Death|10|||
129915885|NCT03948763|467655856|FG004|Overall Study|Death|11|||
129915886|NCT03948763|467655852|FG000|Overall Study|Withdrawal by Subject|1|||
129915887|NCT03948763|467655853|FG001|Overall Study|Withdrawal by Subject|1|||
129915888|NCT03948763|467655854|FG002|Overall Study|Withdrawal by Subject|0|||
129915889|NCT03948763|467655855|FG003|Overall Study|Withdrawal by Subject|2|||
129915890|NCT03948763|467655856|FG004|Overall Study|Withdrawal by Subject|4|||
129915891|NCT04511702|467655857|FG000|Overall Study|Lost to Follow-up|3|||
129915892|NCT04511702|467655858|FG001|Overall Study|Lost to Follow-up|0|||
129915893|NCT04511702|467655859|FG002|Overall Study|Lost to Follow-up|4|||
129915894|NCT04511702|467655857|FG000|Overall Study|Withdrawal by Subject|17|||
129915895|NCT04511702|467655858|FG001|Overall Study|Withdrawal by Subject|1|||
129915896|NCT04511702|467655859|FG002|Overall Study|Withdrawal by Subject|8|||
129915897|NCT02840474|467655862|FG000|Overall Study|Lost to Follow-up|1|||
129915898|NCT02840474|467655863|FG001|Overall Study|Lost to Follow-up|0|||
129915899|NCT03192891|467655864|FG000|Overall Study|Lost to Follow-up|55|||
129915900|NCT05141903|467655866|FG000|Overall Study|Withdrawal by Subject|0|||
129915901|NCT05141903|467655867|FG001|Overall Study|Withdrawal by Subject|1|||
129915902|NCT05141903|467655868|FG002|Overall Study|Withdrawal by Subject|1|||
129915903|NCT05141903|467655869|FG003|Overall Study|Withdrawal by Subject|0|||
129915904|NCT05141903|467655870|FG004|Overall Study|Withdrawal by Subject|0|||
129915905|NCT05141903|467655866|FG000|Overall Study|Other|1|||
129915906|NCT05141903|467655867|FG001|Overall Study|Other|1|||
129915907|NCT05141903|467655868|FG002|Overall Study|Other|0|||
129915908|NCT05141903|467655869|FG003|Overall Study|Other|0|||
129915909|NCT05141903|467655870|FG004|Overall Study|Other|0|||
129915910|NCT04716634|467655871|FG000|Overall Study|Death|24|||
129915911|NCT04716634|467655872|FG001|Overall Study|Death|24|||
129915912|NCT04716634|467655873|FG002|Overall Study|Death|8|||
129915913|NCT04716634|467655871|FG000|Overall Study|Closed by Sponsor|4|||
129915914|NCT04716634|467655872|FG001|Overall Study|Closed by Sponsor|4|||
129915915|NCT04716634|467655873|FG002|Overall Study|Closed by Sponsor|5|||
129915916|NCT04716634|467655871|FG000|Overall Study|Lost to Follow-up|1|||
129915917|NCT04716634|467655872|FG001|Overall Study|Lost to Follow-up|0|||
129915918|NCT04716634|467655873|FG002|Overall Study|Lost to Follow-up|1|||
129915919|NCT04716634|467655871|FG000|Overall Study|Withdrawal by Subject|0|||
129915920|NCT04716634|467655872|FG001|Overall Study|Withdrawal by Subject|0|||
129915921|NCT04716634|467655873|FG002|Overall Study|Withdrawal by Subject|1|||
129915922|NCT02630823|467655882|FG000|Overall Study|Withdrawal by Subject|1|||
129915923|NCT02630823|467655882|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
129915924|NCT05387447|467655883|FG000|Overall Study|Participants changed their minds about study participation.|3|||
129915925|NCT05387447|467655884|FG001|Overall Study|Participants changed their minds about study participation.|5|||
129915926|NCT03391466|467655887|FG000|Overall Study|Death|82|||
129915927|NCT03391466|467655888|FG001|Overall Study|Death|85|||
129915928|NCT03391466|467655887|FG000|Overall Study|Still on study|93|||
129915929|NCT03391466|467655888|FG001|Overall Study|Still on study|74|||
129915930|NCT03391466|467655887|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
129915931|NCT03391466|467655888|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
129915932|NCT03391466|467655887|FG000|Overall Study|Lost to Follow-up|5|||
129915933|NCT03391466|467655888|FG001|Overall Study|Lost to Follow-up|5|||
129915934|NCT03391466|467655887|FG000|Overall Study|Investigator decision|0|||
129915935|NCT03391466|467655888|FG001|Overall Study|Investigator decision|1|||
129915936|NCT03391466|467655887|FG000|Overall Study|Other|0|||
129915937|NCT03391466|467655888|FG001|Overall Study|Other|1|||
129915938|NCT03655132|467655891|FG000|Overall Study|Lost to Follow-up|2|||
129915939|NCT03655132|467655892|FG001|Overall Study|Lost to Follow-up|1|||
129915940|NCT03655132|467655891|FG000|Overall Study|Withdrawal by Subject|0|||
129915941|NCT03655132|467655892|FG001|Overall Study|Withdrawal by Subject|1|||
129915942|NCT03655132|467655891|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
129915943|NCT03655132|467655892|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
129915944|NCT01707030|467655901|FG000|Overall Study|Death|1|||
129915945|NCT01707030|467655902|FG001|Overall Study|Death|1|||
129915946|NCT01707030|467655901|FG000|Overall Study|Withdrawal by Subject|2|||
129915947|NCT01707030|467655902|FG001|Overall Study|Withdrawal by Subject|3|||
129915948|NCT01707030|467655901|FG000|Overall Study|Lost to Follow-up|8|||
129915949|NCT01707030|467655902|FG001|Overall Study|Lost to Follow-up|13|||
129915950|NCT04820855|467655903|FG000|Overall Study|Lost to Follow-up|6|||
129915951|NCT04820855|467655904|FG001|Overall Study|Lost to Follow-up|9|||
129915952|NCT00650104|467655906|FG000|Overall Study|Adverse Event|17|||
129915953|NCT00650104|467655906|FG000|Overall Study|Death|2|||
129915954|NCT00650104|467655906|FG000|Overall Study|Withdrawal by Subject|11|||
129915955|NCT00650104|467655906|FG000|Overall Study|Physician Decision|7|||
129915956|NCT00650104|467655906|FG000|Overall Study|Lost to Follow-up|1|||
129915957|NCT00650104|467655906|FG000|Overall Study|Non-compliance|2|||
129915958|NCT00650104|467655906|FG000|Overall Study|Sponsor Terminated Dosing|1|||
129915959|NCT01376700|467655907|FG000|Overall Study|Sponsor terminated study early|8|||
129915960|NCT01376700|467655907|FG000|Overall Study|Low or high titer inhibitor|8|||
129915961|NCT00601900|467655919|FG000|Overall Study|Withdrawal by Subject|0|||
129915962|NCT00601900|467655920|FG001|Overall Study|Withdrawal by Subject|3|||
129915963|NCT02500758|467655924|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
129915964|NCT02500758|467655925|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
129915965|NCT02500758|467655924|FG000|Washout (1 Week)|Lost to Follow-up|2|||
129915966|NCT02500758|467655925|FG001|Washout (1 Week)|Lost to Follow-up|2|||
129915967|NCT02500758|467655924|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
129915968|NCT02500758|467655925|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
129915969|NCT02500758|467655924|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
129866969|NCT00127101|467469624|FG000|Base Protocol|Adverse Event|0|||
129866970|NCT00127101|467469625|FG001|Base Protocol|Adverse Event|2|||
129866971|NCT00127101|467469626|FG002|Base Protocol|Adverse Event|1|||
129866972|NCT00127101|467469627|FG003|Base Protocol|Adverse Event|0|||
129866973|NCT00127101|467469628|FG004|Base Protocol|Adverse Event|0|||
129866974|NCT00127101|467469629|FG005|Base Protocol|Adverse Event|0|||
129866975|NCT00127101|467469624|FG000|Base Protocol|Lack of Efficacy|1|||
129866976|NCT00127101|467469625|FG001|Base Protocol|Lack of Efficacy|0|||
129866977|NCT00127101|467469626|FG002|Base Protocol|Lack of Efficacy|0|||
129866978|NCT00127101|467469627|FG003|Base Protocol|Lack of Efficacy|0|||
129866979|NCT00127101|467469628|FG004|Base Protocol|Lack of Efficacy|2|||
129866980|NCT00127101|467469629|FG005|Base Protocol|Lack of Efficacy|0|||
129866981|NCT00127101|467469624|FG000|Base Protocol|Withdrawal by Subject|1|||
129866982|NCT00127101|467469625|FG001|Base Protocol|Withdrawal by Subject|2|||
129866983|NCT00127101|467469626|FG002|Base Protocol|Withdrawal by Subject|1|||
129866984|NCT00127101|467469627|FG003|Base Protocol|Withdrawal by Subject|0|||
129866985|NCT00127101|467469628|FG004|Base Protocol|Withdrawal by Subject|0|||
129866986|NCT00127101|467469629|FG005|Base Protocol|Withdrawal by Subject|1|||
129866987|NCT00127101|467469624|FG000|Continuation Phase|Adverse Event|0|||
129866988|NCT00127101|467469625|FG001|Continuation Phase|Adverse Event|0|||
129866989|NCT00127101|467469626|FG002|Continuation Phase|Adverse Event|0|||
129866990|NCT00127101|467469627|FG003|Continuation Phase|Adverse Event|0|||
129866991|NCT00127101|467469628|FG004|Continuation Phase|Adverse Event|1|||
129866992|NCT00127101|467469629|FG005|Continuation Phase|Adverse Event|1|||
129866993|NCT00127101|467469624|FG000|Continuation Phase|Lack of Efficacy|0|||
129866994|NCT00127101|467469625|FG001|Continuation Phase|Lack of Efficacy|0|||
129866995|NCT00127101|467469626|FG002|Continuation Phase|Lack of Efficacy|0|||
129866996|NCT00127101|467469627|FG003|Continuation Phase|Lack of Efficacy|0|||
129866997|NCT00127101|467469628|FG004|Continuation Phase|Lack of Efficacy|0|||
129866998|NCT00127101|467469629|FG005|Continuation Phase|Lack of Efficacy|1|||
129866999|NCT00127101|467469624|FG000|Continuation Phase|Withdrawal by Subject|0|||
129867000|NCT00127101|467469625|FG001|Continuation Phase|Withdrawal by Subject|0|||
129867001|NCT00127101|467469626|FG002|Continuation Phase|Withdrawal by Subject|1|||
129867002|NCT00127101|467469627|FG003|Continuation Phase|Withdrawal by Subject|0|||
129867003|NCT00127101|467469628|FG004|Continuation Phase|Withdrawal by Subject|2|||
129867004|NCT00127101|467469629|FG005|Continuation Phase|Withdrawal by Subject|1|||
129867005|NCT01302847|467469630|FG000|Overall Study|Death|0|||
129867006|NCT01302847|467469631|FG001|Overall Study|Death|1|||
129867007|NCT01302847|467469632|FG002|Overall Study|Death|0|||
129867008|NCT01302847|467469633|FG003|Overall Study|Death|0|||
129867009|NCT01302847|467469634|FG004|Overall Study|Death|0|||
129867010|NCT01302847|467469635|FG005|Overall Study|Death|1|||
129867011|NCT01302847|467469636|FG006|Overall Study|Death|1|||
129867012|NCT01302847|467469637|FG007|Overall Study|Death|0|||
129867013|NCT01302847|467469630|FG000|Overall Study|Pregnancy|2|||
129867014|NCT01302847|467469631|FG001|Overall Study|Pregnancy|0|||
129867015|NCT01302847|467469632|FG002|Overall Study|Pregnancy|0|||
129867016|NCT01302847|467469633|FG003|Overall Study|Pregnancy|0|||
129867017|NCT01302847|467469634|FG004|Overall Study|Pregnancy|0|||
129867018|NCT01302847|467469635|FG005|Overall Study|Pregnancy|0|||
129867019|NCT01302847|467469636|FG006|Overall Study|Pregnancy|0|||
129867020|NCT01302847|467469637|FG007|Overall Study|Pregnancy|0|||
129867021|NCT01302847|467469630|FG000|Overall Study|Virologic failure|0|||
129867022|NCT01302847|467469631|FG001|Overall Study|Virologic failure|2|||
129867023|NCT01302847|467469632|FG002|Overall Study|Virologic failure|0|||
129867024|NCT01302847|467469633|FG003|Overall Study|Virologic failure|2|||
129867025|NCT01302847|467469634|FG004|Overall Study|Virologic failure|1|||
129867026|NCT01302847|467469635|FG005|Overall Study|Virologic failure|3|||
129867027|NCT01302847|467469636|FG006|Overall Study|Virologic failure|1|||
129867028|NCT01302847|467469637|FG007|Overall Study|Virologic failure|2|||
129867029|NCT01302847|467469630|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129867030|NCT01302847|467469631|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129867031|NCT01302847|467469632|FG002|Overall Study|Severe debilitation, unable to continue|0|||
129449813|NCT01092143|465945688|FG004|Overall Study|did not reversibility criteria|0|||
129867032|NCT01302847|467469633|FG003|Overall Study|Severe debilitation, unable to continue|0|||
129867033|NCT01302847|467469634|FG004|Overall Study|Severe debilitation, unable to continue|0|||
129867034|NCT01302847|467469635|FG005|Overall Study|Severe debilitation, unable to continue|1|||
129867035|NCT01302847|467469636|FG006|Overall Study|Severe debilitation, unable to continue|1|||
129867036|NCT01302847|467469637|FG007|Overall Study|Severe debilitation, unable to continue|0|||
129867037|NCT01302847|467469630|FG000|Overall Study|Not able to get to clinic|1|||
129867038|NCT01302847|467469631|FG001|Overall Study|Not able to get to clinic|1|||
129867039|NCT01302847|467469632|FG002|Overall Study|Not able to get to clinic|0|||
129867040|NCT01302847|467469633|FG003|Overall Study|Not able to get to clinic|0|||
129867041|NCT01302847|467469634|FG004|Overall Study|Not able to get to clinic|0|||
129867042|NCT01302847|467469635|FG005|Overall Study|Not able to get to clinic|0|||
129867043|NCT01302847|467469636|FG006|Overall Study|Not able to get to clinic|0|||
129867044|NCT01302847|467469637|FG007|Overall Study|Not able to get to clinic|0|||
129867045|NCT01302847|467469630|FG000|Overall Study|Site closing|2|||
129867046|NCT01302847|467469631|FG001|Overall Study|Site closing|2|||
129867047|NCT01302847|467469632|FG002|Overall Study|Site closing|0|||
129867048|NCT01302847|467469633|FG003|Overall Study|Site closing|0|||
129867049|NCT01302847|467469634|FG004|Overall Study|Site closing|0|||
129867050|NCT01302847|467469635|FG005|Overall Study|Site closing|0|||
129867051|NCT01302847|467469636|FG006|Overall Study|Site closing|0|||
129867052|NCT01302847|467469637|FG007|Overall Study|Site closing|0|||
129867053|NCT01302847|467469630|FG000|Overall Study|Withdrawal by Subject|1|||
129867054|NCT01302847|467469631|FG001|Overall Study|Withdrawal by Subject|0|||
129867055|NCT01302847|467469632|FG002|Overall Study|Withdrawal by Subject|0|||
129867056|NCT01302847|467469633|FG003|Overall Study|Withdrawal by Subject|0|||
129867057|NCT01302847|467469634|FG004|Overall Study|Withdrawal by Subject|1|||
129867058|NCT01302847|467469635|FG005|Overall Study|Withdrawal by Subject|0|||
129867059|NCT01302847|467469636|FG006|Overall Study|Withdrawal by Subject|0|||
129867060|NCT01302847|467469637|FG007|Overall Study|Withdrawal by Subject|1|||
129867061|NCT01302847|467469630|FG000|Overall Study|Not willing to adhere to requirements|5|||
129867062|NCT01302847|467469631|FG001|Overall Study|Not willing to adhere to requirements|0|||
129867063|NCT01302847|467469632|FG002|Overall Study|Not willing to adhere to requirements|1|||
129867064|NCT01302847|467469633|FG003|Overall Study|Not willing to adhere to requirements|0|||
129867065|NCT01302847|467469634|FG004|Overall Study|Not willing to adhere to requirements|0|||
129867066|NCT01302847|467469635|FG005|Overall Study|Not willing to adhere to requirements|0|||
129867067|NCT01302847|467469636|FG006|Overall Study|Not willing to adhere to requirements|0|||
129867068|NCT01302847|467469637|FG007|Overall Study|Not willing to adhere to requirements|2|||
129867069|NCT01302847|467469630|FG000|Overall Study|Site unable to contact participant|2|||
129867070|NCT01302847|467469631|FG001|Overall Study|Site unable to contact participant|1|||
129867071|NCT01302847|467469632|FG002|Overall Study|Site unable to contact participant|0|||
129867072|NCT01302847|467469633|FG003|Overall Study|Site unable to contact participant|0|||
129867073|NCT01302847|467469634|FG004|Overall Study|Site unable to contact participant|0|||
129867074|NCT01302847|467469635|FG005|Overall Study|Site unable to contact participant|0|||
129867075|NCT01302847|467469636|FG006|Overall Study|Site unable to contact participant|2|||
129867076|NCT01302847|467469637|FG007|Overall Study|Site unable to contact participant|0|||
129867077|NCT00374322|467469638|FG000|Overall Study|Lost to Follow-up|92|||
129867078|NCT00374322|467469639|FG001|Overall Study|Lost to Follow-up|90|||
129867079|NCT00374322|467469638|FG000|Overall Study|Protocol Violation|8|||
129867080|NCT00374322|467469639|FG001|Overall Study|Protocol Violation|3|||
129867081|NCT00374322|467469638|FG000|Overall Study|Withdrawal by Subject|235|||
129867082|NCT00374322|467469639|FG001|Overall Study|Withdrawal by Subject|167|||
129867083|NCT00374322|467469638|FG000|Overall Study|Sponsor Terminated Study|866|||
129867084|NCT00374322|467469639|FG001|Overall Study|Sponsor Terminated Study|990|||
129867085|NCT00374322|467469638|FG000|Overall Study|Physician Decision|36|||
129867086|NCT00374322|467469639|FG001|Overall Study|Physician Decision|32|||
129867087|NCT00374322|467469638|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
129867088|NCT00374322|467469639|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
129867089|NCT00374322|467469638|FG000|Overall Study|Sponsor Decision|2|||
129867090|NCT00374322|467469639|FG001|Overall Study|Sponsor Decision|3|||
129867091|NCT00374322|467469638|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
129867092|NCT00374322|467469639|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
129867093|NCT00374322|467469638|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
129867094|NCT00374322|467469639|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
129867095|NCT00374322|467469638|FG000|Overall Study|Severe Toxicity|1|||
129867096|NCT00374322|467469639|FG001|Overall Study|Severe Toxicity|0|||
129867097|NCT00374322|467469638|FG000|Overall Study|Site Closed|2|||
129867098|NCT00374322|467469639|FG001|Overall Study|Site Closed|2|||
129867099|NCT00374322|467469638|FG000|Overall Study|Participant Changed Physician|1|||
129867100|NCT00374322|467469639|FG001|Overall Study|Participant Changed Physician|0|||
129867101|NCT00374322|467469638|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
129867102|NCT00374322|467469639|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
129867103|NCT00374322|467469638|FG000|Overall Study|Noncompliance with Study Requirements|0|||
129867104|NCT00374322|467469639|FG001|Overall Study|Noncompliance with Study Requirements|1|||
129867105|NCT00374322|467469638|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
129867106|NCT00374322|467469639|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
129867107|NCT00374322|467469638|FG000|Overall Study|Did Not Receive Study Medication|8|||
129867108|NCT00374322|467469639|FG001|Overall Study|Did Not Receive Study Medication|6|||
129867109|NCT00707031|467469640|FG000|Overall Study|Adverse Event|45|||
129867110|NCT00707031|467469641|FG001|Overall Study|Adverse Event|45|||
129867111|NCT00707031|467469640|FG000|Overall Study|Lack of Efficacy|19|||
129867112|NCT00707031|467469641|FG001|Overall Study|Lack of Efficacy|6|||
129867113|NCT00707031|467469640|FG000|Overall Study|Lost to Follow-up|2|||
129867114|NCT00707031|467469641|FG001|Overall Study|Lost to Follow-up|1|||
129867115|NCT00707031|467469640|FG000|Overall Study|Protocol Violation|1|||
129867116|NCT00707031|467469641|FG001|Overall Study|Protocol Violation|0|||
129867117|NCT00707031|467469640|FG000|Overall Study|Withdrawal by Subject|7|||
129867118|NCT00707031|467469641|FG001|Overall Study|Withdrawal by Subject|8|||
129915970|NCT02500758|467655925|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
129867119|NCT00707031|467469640|FG000|Overall Study|Poor Compliance to Protocol|7|||
129867120|NCT00707031|467469641|FG001|Overall Study|Poor Compliance to Protocol|13|||
129867121|NCT00707031|467469640|FG000|Overall Study|Familial or Personal Reasons|12|||
129867122|NCT00707031|467469641|FG001|Overall Study|Familial or Personal Reasons|15|||
129867123|NCT00707031|467469640|FG000|Overall Study|Serious Noncompliance|2|||
129867124|NCT00707031|467469641|FG001|Overall Study|Serious Noncompliance|3|||
129867125|NCT00707031|467469640|FG000|Overall Study|Sponsor Decision|9|||
129867126|NCT00707031|467469641|FG001|Overall Study|Sponsor Decision|8|||
129867127|NCT01389973|467469647|FG000|Overall Study|Lost to Follow-up|1|||
129867128|NCT01389973|467469647|FG000|Overall Study|Trial Stopped by Sponsor|9|||
129867129|NCT01389973|467469647|FG000|Overall Study|Other|10|||
129867130|NCT02626780|467469648|FG000|Overall Study|Withdrawal by Subject|3|||
129867131|NCT04304833|467469649|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
129867132|NCT04304833|467469650|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
129867133|NCT03456700|467469651|FG000|Overall Study|Withdrawal by Subject|1|||
129867134|NCT01951625|467469652|FG000|Treatment Period|Protocol Violation|2|||
129867135|NCT01951625|467469653|FG001|Treatment Period|Protocol Violation|0|||
129867136|NCT01951625|467469654|FG002|Treatment Period|Protocol Violation|1|||
129867137|NCT01951625|467469655|FG003|Treatment Period|Protocol Violation|3|||
129867138|NCT01951625|467469656|FG004|Treatment Period|Protocol Violation|2|||
129867139|NCT01951625|467469652|FG000|Treatment Period|Physician Decision|0|||
129867140|NCT01951625|467469653|FG001|Treatment Period|Physician Decision|0|||
129867141|NCT01951625|467469654|FG002|Treatment Period|Physician Decision|0|||
129867142|NCT01951625|467469655|FG003|Treatment Period|Physician Decision|0|||
129867143|NCT01951625|467469656|FG004|Treatment Period|Physician Decision|1|||
129867144|NCT01951625|467469652|FG000|Treatment Period|Protocol driven decision point|0|||
129867145|NCT01951625|467469653|FG001|Treatment Period|Protocol driven decision point|5|||
129867146|NCT01951625|467469654|FG002|Treatment Period|Protocol driven decision point|0|||
129867147|NCT01951625|467469655|FG003|Treatment Period|Protocol driven decision point|2|||
129867148|NCT01951625|467469656|FG004|Treatment Period|Protocol driven decision point|1|||
129867149|NCT01951625|467469652|FG000|Treatment Period|Non compliance with study drug|1|||
129867150|NCT01951625|467469653|FG001|Treatment Period|Non compliance with study drug|2|||
129867151|NCT01951625|467469654|FG002|Treatment Period|Non compliance with study drug|2|||
129867152|NCT01951625|467469655|FG003|Treatment Period|Non compliance with study drug|0|||
129867153|NCT01951625|467469656|FG004|Treatment Period|Non compliance with study drug|0|||
129867154|NCT01951625|467469652|FG000|Treatment Period|Death|3|||
129867155|NCT01951625|467469653|FG001|Treatment Period|Death|2|||
129867156|NCT01951625|467469654|FG002|Treatment Period|Death|2|||
129867157|NCT01951625|467469655|FG003|Treatment Period|Death|1|||
129867158|NCT01951625|467469656|FG004|Treatment Period|Death|2|||
129867159|NCT01951625|467469652|FG000|Treatment Period|Adverse Event|7|||
129867160|NCT01951625|467469653|FG001|Treatment Period|Adverse Event|10|||
129867161|NCT01951625|467469654|FG002|Treatment Period|Adverse Event|9|||
129867162|NCT01951625|467469655|FG003|Treatment Period|Adverse Event|8|||
129867163|NCT01951625|467469656|FG004|Treatment Period|Adverse Event|8|||
129867164|NCT01951625|467469652|FG000|Treatment Period|Withdrawal by Subject|5|||
129867165|NCT01951625|467469653|FG001|Treatment Period|Withdrawal by Subject|2|||
129867166|NCT01951625|467469654|FG002|Treatment Period|Withdrawal by Subject|1|||
129867167|NCT01951625|467469655|FG003|Treatment Period|Withdrawal by Subject|7|||
129867168|NCT01951625|467469656|FG004|Treatment Period|Withdrawal by Subject|3|||
129867169|NCT01951625|467469652|FG000|Treatment Period|Lost to Follow-up|1|||
129867170|NCT01951625|467469653|FG001|Treatment Period|Lost to Follow-up|0|||
129867171|NCT01951625|467469654|FG002|Treatment Period|Lost to Follow-up|0|||
129867172|NCT01951625|467469655|FG003|Treatment Period|Lost to Follow-up|1|||
129867173|NCT01951625|467469656|FG004|Treatment Period|Lost to Follow-up|0|||
129867174|NCT01951625|467469652|FG000|Follow Up Period|Non-compliance with study drug|1|||
129867175|NCT01951625|467469653|FG001|Follow Up Period|Non-compliance with study drug|0|||
129867176|NCT01951625|467469654|FG002|Follow Up Period|Non-compliance with study drug|0|||
129867177|NCT01951625|467469655|FG003|Follow Up Period|Non-compliance with study drug|0|||
129867178|NCT01951625|467469656|FG004|Follow Up Period|Non-compliance with study drug|0|||
129867179|NCT01951625|467469652|FG000|Follow Up Period|Death|1|||
129867180|NCT01951625|467469653|FG001|Follow Up Period|Death|3|||
129867181|NCT01951625|467469654|FG002|Follow Up Period|Death|2|||
129915971|NCT02500758|467655924|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
129867182|NCT01951625|467469655|FG003|Follow Up Period|Death|2|||
129867183|NCT01951625|467469656|FG004|Follow Up Period|Death|1|||
129867184|NCT01951625|467469652|FG000|Follow Up Period|Logistical difficulties|1|||
129867185|NCT01951625|467469653|FG001|Follow Up Period|Logistical difficulties|2|||
129867186|NCT01951625|467469654|FG002|Follow Up Period|Logistical difficulties|0|||
129867187|NCT01951625|467469655|FG003|Follow Up Period|Logistical difficulties|0|||
129867188|NCT01951625|467469656|FG004|Follow Up Period|Logistical difficulties|0|||
129867189|NCT01951625|467469652|FG000|Follow Up Period|Adverse Event|0|||
129867190|NCT01951625|467469653|FG001|Follow Up Period|Adverse Event|3|||
129867191|NCT01951625|467469654|FG002|Follow Up Period|Adverse Event|2|||
129867192|NCT01951625|467469655|FG003|Follow Up Period|Adverse Event|3|||
129915972|NCT02500758|467655925|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
129867193|NCT01951625|467469656|FG004|Follow Up Period|Adverse Event|5|||
129867194|NCT01951625|467469652|FG000|Follow Up Period|Withdrawal by Subject|4|||
129867195|NCT01951625|467469653|FG001|Follow Up Period|Withdrawal by Subject|1|||
129867196|NCT01951625|467469654|FG002|Follow Up Period|Withdrawal by Subject|0|||
129867197|NCT01951625|467469655|FG003|Follow Up Period|Withdrawal by Subject|5|||
129867198|NCT01951625|467469656|FG004|Follow Up Period|Withdrawal by Subject|3|||
129867199|NCT01951625|467469652|FG000|Follow Up Period|Lost to Follow-up|1|||
129867200|NCT01951625|467469653|FG001|Follow Up Period|Lost to Follow-up|0|||
129867201|NCT01951625|467469654|FG002|Follow Up Period|Lost to Follow-up|0|||
129867202|NCT01951625|467469655|FG003|Follow Up Period|Lost to Follow-up|1|||
129867203|NCT01951625|467469656|FG004|Follow Up Period|Lost to Follow-up|1|||
129867204|NCT03053050|467469659|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
129867205|NCT03053050|467469660|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
129867206|NCT03053050|467469661|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
129867207|NCT03053050|467469662|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
129867208|NCT03053050|467469659|FG000|Randomized Phase|Withdrew Consent|16|||
129867209|NCT03053050|467469660|FG001|Randomized Phase|Withdrew Consent|8|||
129867210|NCT03053050|467469661|FG002|Randomized Phase|Withdrew Consent|9|||
129867211|NCT03053050|467469662|FG003|Randomized Phase|Withdrew Consent|0|||
129867212|NCT03053050|467469659|FG000|Randomized Phase|Investigator's Discretion|6|||
129867213|NCT03053050|467469660|FG001|Randomized Phase|Investigator's Discretion|6|||
129867214|NCT03053050|467469661|FG002|Randomized Phase|Investigator's Discretion|3|||
129867215|NCT03053050|467469662|FG003|Randomized Phase|Investigator's Discretion|0|||
129867216|NCT03053050|467469659|FG000|Randomized Phase|Lost to Follow-up|5|||
129867217|NCT03053050|467469660|FG001|Randomized Phase|Lost to Follow-up|1|||
129867218|NCT03053050|467469661|FG002|Randomized Phase|Lost to Follow-up|1|||
129867219|NCT03053050|467469662|FG003|Randomized Phase|Lost to Follow-up|0|||
129867220|NCT03053050|467469659|FG000|Randomized Phase|Adverse Event|0|||
129867221|NCT03053050|467469660|FG001|Randomized Phase|Adverse Event|1|||
129867222|NCT03053050|467469661|FG002|Randomized Phase|Adverse Event|0|||
129867223|NCT03053050|467469662|FG003|Randomized Phase|Adverse Event|0|||
129867224|NCT03053050|467469659|FG000|Randomized Phase|Randomized but Never Treated|2|||
129867225|NCT03053050|467469660|FG001|Randomized Phase|Randomized but Never Treated|2|||
129867226|NCT03053050|467469661|FG002|Randomized Phase|Randomized but Never Treated|2|||
129867227|NCT03053050|467469662|FG003|Randomized Phase|Randomized but Never Treated|0|||
129867228|NCT03053050|467469659|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
129867229|NCT03053050|467469660|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
129867230|NCT03053050|467469661|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
129867231|NCT03053050|467469662|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
129867232|NCT03053050|467469659|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
129867233|NCT03053050|467469660|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
129867234|NCT03053050|467469661|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
129867235|NCT03053050|467469662|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
129867236|NCT03053050|467469659|FG000|Open-label Phase|Withdrew Consent|0|||
129867237|NCT03053050|467469660|FG001|Open-label Phase|Withdrew Consent|0|||
129867238|NCT03053050|467469661|FG002|Open-label Phase|Withdrew Consent|0|||
129867239|NCT03053050|467469662|FG003|Open-label Phase|Withdrew Consent|6|||
129867240|NCT03053050|467469659|FG000|Open-label Phase|Investigator's Discretion|0|||
129867241|NCT03053050|467469660|FG001|Open-label Phase|Investigator's Discretion|0|||
129867242|NCT03053050|467469661|FG002|Open-label Phase|Investigator's Discretion|0|||
129867243|NCT03053050|467469662|FG003|Open-label Phase|Investigator's Discretion|4|||
129867244|NCT05338333|467469663|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
129867245|NCT05338333|467469664|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
129867246|NCT02459574|467469668|FG000|Overall Study|Withdrawal by Subject|6|||
129867247|NCT02459574|467469669|FG001|Overall Study|Withdrawal by Subject|6|||
129867248|NCT02459574|467469670|FG002|Overall Study|Withdrawal by Subject|2|||
129867249|NCT02459574|467469668|FG000|Overall Study|Lost to Follow-up|1|||
129867250|NCT02459574|467469669|FG001|Overall Study|Lost to Follow-up|1|||
129867251|NCT02459574|467469670|FG002|Overall Study|Lost to Follow-up|0|||
129867252|NCT02459574|467469668|FG000|Overall Study|Death|0|||
129867253|NCT02459574|467469669|FG001|Overall Study|Death|1|||
129867254|NCT02459574|467469670|FG002|Overall Study|Death|0|||
129867255|NCT00251745|467469671|FG000|Overall Study|Adverse Event|7|||
129867256|NCT00251745|467469672|FG001|Overall Study|Adverse Event|9|||
129867257|NCT00251745|467469673|FG002|Overall Study|Adverse Event|11|||
129867258|NCT00251745|467469671|FG000|Overall Study|Lost to Follow-up|4|||
129867259|NCT00251745|467469672|FG001|Overall Study|Lost to Follow-up|2|||
129867260|NCT00251745|467469673|FG002|Overall Study|Lost to Follow-up|5|||
129867261|NCT00251745|467469671|FG000|Overall Study|Withdrawal by Subject|13|||
129867262|NCT00251745|467469672|FG001|Overall Study|Withdrawal by Subject|7|||
129867263|NCT00251745|467469673|FG002|Overall Study|Withdrawal by Subject|3|||
129867264|NCT00251745|467469671|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
129867265|NCT00251745|467469672|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
129867266|NCT00251745|467469673|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
129867267|NCT00251745|467469671|FG000|Overall Study|Lack of Efficacy|3|||
129867268|NCT00251745|467469672|FG001|Overall Study|Lack of Efficacy|0|||
129867269|NCT00251745|467469673|FG002|Overall Study|Lack of Efficacy|0|||
129867270|NCT00251745|467469671|FG000|Overall Study|Noncompliant|0|||
129867271|NCT00251745|467469672|FG001|Overall Study|Noncompliant|2|||
129867272|NCT00251745|467469673|FG002|Overall Study|Noncompliant|2|||
129867273|NCT00251745|467469671|FG000|Overall Study|Pregnancy|0|||
129867274|NCT00251745|467469672|FG001|Overall Study|Pregnancy|1|||
129867275|NCT00251745|467469673|FG002|Overall Study|Pregnancy|0|||
129867276|NCT00251745|467469671|FG000|Overall Study|Per Subject Request|0|||
129867277|NCT00251745|467469672|FG001|Overall Study|Per Subject Request|0|||
129867278|NCT00251745|467469673|FG002|Overall Study|Per Subject Request|1|||
129867279|NCT00251745|467469671|FG000|Overall Study|Per Investigator Request|1|||
129867280|NCT00251745|467469672|FG001|Overall Study|Per Investigator Request|0|||
129867281|NCT00251745|467469673|FG002|Overall Study|Per Investigator Request|0|||
129867282|NCT04866017|467469676|FG000|Overall Study|Study Terminated by Sponsor|13|||
129867283|NCT04866017|467469677|FG001|Overall Study|Study Terminated by Sponsor|14|||
129867284|NCT04866017|467469678|FG002|Overall Study|Study Terminated by Sponsor|13|||
129915973|NCT00274469|467655927|FG000|Overall Study|Death|63|||
129915974|NCT00274469|467655928|FG001|Overall Study|Death|74|||
129915975|NCT00274469|467655927|FG000|Overall Study|Did not consent to OS follow-up|16|||
129915976|NCT00274469|467655928|FG001|Overall Study|Did not consent to OS follow-up|19|||
129915977|NCT04093752|467655932|FG000|Overall Study|Adverse Event|7|||
129915978|NCT04093752|467655933|FG001|Overall Study|Adverse Event|19|||
129915979|NCT04093752|467655934|FG002|Overall Study|Adverse Event|18|||
129915980|NCT04093752|467655935|FG003|Overall Study|Adverse Event|4|||
129915981|NCT04093752|467655932|FG000|Overall Study|Withdrawal by Subject|6|||
129915982|NCT04093752|467655933|FG001|Overall Study|Withdrawal by Subject|6|||
129915983|NCT04093752|467655934|FG002|Overall Study|Withdrawal by Subject|8|||
129915984|NCT04093752|467655935|FG003|Overall Study|Withdrawal by Subject|20|||
129915985|NCT04093752|467655932|FG000|Overall Study|Lost to Follow-up|2|||
129915986|NCT04093752|467655933|FG001|Overall Study|Lost to Follow-up|1|||
129915987|NCT04093752|467655934|FG002|Overall Study|Lost to Follow-up|1|||
129915988|NCT04093752|467655935|FG003|Overall Study|Lost to Follow-up|1|||
129915989|NCT04093752|467655932|FG000|Overall Study|Death|0|||
129915990|NCT04093752|467655933|FG001|Overall Study|Death|0|||
129915991|NCT04093752|467655934|FG002|Overall Study|Death|1|||
129915992|NCT04093752|467655935|FG003|Overall Study|Death|2|||
129915993|NCT04093752|467655932|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
129915994|NCT04093752|467655933|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
129915995|NCT04093752|467655934|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
129915996|NCT04093752|467655935|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
129915997|NCT04093752|467655932|FG000|Overall Study|Covid 19|0|||
129915998|NCT04093752|467655933|FG001|Overall Study|Covid 19|0|||
129915999|NCT04093752|467655934|FG002|Overall Study|Covid 19|0|||
129916000|NCT04093752|467655935|FG003|Overall Study|Covid 19|1|||
129916001|NCT04093752|467655932|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
129916002|NCT04093752|467655933|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
129916003|NCT04093752|467655934|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
129916004|NCT04093752|467655935|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
129916005|NCT04093752|467655932|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
129916006|NCT04093752|467655933|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
129916007|NCT04093752|467655934|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
129916008|NCT04093752|467655935|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
129867285|NCT04866017|467469676|FG000|Overall Study|Death|8|||
129867286|NCT04866017|467469677|FG001|Overall Study|Death|4|||
129867287|NCT04866017|467469678|FG002|Overall Study|Death|8|||
129867288|NCT04866017|467469676|FG000|Overall Study|Withdrawal by Subject|1|||
129867289|NCT04866017|467469677|FG001|Overall Study|Withdrawal by Subject|0|||
129867290|NCT04866017|467469678|FG002|Overall Study|Withdrawal by Subject|1|||
129867291|NCT04866017|467469676|FG000|Overall Study|Physician Decision|0|||
129867292|NCT04866017|467469677|FG001|Overall Study|Physician Decision|1|||
129916009|NCT04093752|467655932|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
129916010|NCT04093752|467655933|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
129916011|NCT04093752|467655934|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
129916012|NCT04093752|467655935|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
129916013|NCT02140645|467655937|FG000|Overall Study|Not linked|5489|||
129916014|NCT02140645|467655938|FG001|Overall Study|Not linked|61654|||
129916015|NCT02140645|467655939|FG002|Overall Study|Not linked|4236|||
129916016|NCT02140645|467655940|FG003|Overall Study|Not linked|13833|||
129916017|NCT02140645|467655941|FG004|Overall Study|Not linked|3286|||
129916018|NCT02140645|467655942|FG005|Overall Study|Not linked|70896|||
129916019|NCT01101451|467655943|FG000|Overall Study|Eligible and never treated|0|||
129916020|NCT01101451|467655944|FG001|Overall Study|Eligible and never treated|5|||
129916021|NCT01101451|467655943|FG000|Overall Study|Ineligible and treated|12|||
129867293|NCT04866017|467469678|FG002|Overall Study|Physician Decision|0|||
129916022|NCT01101451|467655944|FG001|Overall Study|Ineligible and treated|8|||
129916023|NCT01101451|467655943|FG000|Overall Study|Ineligible and never treated|2|||
129916024|NCT01101451|467655944|FG001|Overall Study|Ineligible and never treated|2|||
129916025|NCT00073749|467655953|FG000|Overall Study|Disease Progression|2|||
129916026|NCT00073749|467655954|FG001|Overall Study|Disease Progression|0|||
129916027|NCT00073749|467655955|FG002|Overall Study|Disease Progression|3|||
129916028|NCT00073749|467655956|FG003|Overall Study|Disease Progression|2|||
129916029|NCT00073749|467655957|FG004|Overall Study|Disease Progression|3|||
129916030|NCT00073749|467655958|FG005|Overall Study|Disease Progression|1|||
129916031|NCT00073749|467655959|FG006|Overall Study|Disease Progression|3|||
129916032|NCT00073749|467655953|FG000|Overall Study|Death|0|||
129916033|NCT00073749|467655954|FG001|Overall Study|Death|1|||
129916034|NCT00073749|467655955|FG002|Overall Study|Death|1|||
129916035|NCT00073749|467655956|FG003|Overall Study|Death|0|||
129916036|NCT00073749|467655957|FG004|Overall Study|Death|0|||
129916037|NCT00073749|467655958|FG005|Overall Study|Death|0|||
129916038|NCT00073749|467655959|FG006|Overall Study|Death|29|||
129916039|NCT00073749|467655953|FG000|Overall Study|Adverse Event|0|||
129916040|NCT00073749|467655954|FG001|Overall Study|Adverse Event|3|||
129916041|NCT00073749|467655955|FG002|Overall Study|Adverse Event|6|||
129916042|NCT00073749|467655956|FG003|Overall Study|Adverse Event|4|||
129916043|NCT00073749|467655957|FG004|Overall Study|Adverse Event|2|||
129916044|NCT00073749|467655958|FG005|Overall Study|Adverse Event|1|||
129916045|NCT00073749|467655959|FG006|Overall Study|Adverse Event|0|||
129916046|NCT00073749|467655953|FG000|Overall Study|Physician Decision|0|||
129916047|NCT00073749|467655954|FG001|Overall Study|Physician Decision|0|||
129916048|NCT00073749|467655955|FG002|Overall Study|Physician Decision|1|||
129916049|NCT00073749|467655956|FG003|Overall Study|Physician Decision|0|||
129916050|NCT00073749|467655957|FG004|Overall Study|Physician Decision|0|||
129916051|NCT00073749|467655958|FG005|Overall Study|Physician Decision|2|||
129916052|NCT00073749|467655959|FG006|Overall Study|Physician Decision|0|||
129916053|NCT00073749|467655953|FG000|Overall Study|Withdrawal by Subject|0|||
129916054|NCT00073749|467655954|FG001|Overall Study|Withdrawal by Subject|1|||
129916055|NCT00073749|467655955|FG002|Overall Study|Withdrawal by Subject|0|||
129916056|NCT00073749|467655956|FG003|Overall Study|Withdrawal by Subject|0|||
129916057|NCT00073749|467655957|FG004|Overall Study|Withdrawal by Subject|1|||
129916058|NCT00073749|467655958|FG005|Overall Study|Withdrawal by Subject|0|||
129916059|NCT00073749|467655959|FG006|Overall Study|Withdrawal by Subject|2|||
129916060|NCT00073749|467655953|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
129916061|NCT00073749|467655954|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129916062|NCT00073749|467655955|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
129916063|NCT00073749|467655956|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
129916064|NCT00073749|467655957|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
129916065|NCT00073749|467655958|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
129916066|NCT00073749|467655959|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
129916067|NCT00073749|467655953|FG000|Overall Study|Lost to Follow-up|0|||
129916068|NCT00073749|467655954|FG001|Overall Study|Lost to Follow-up|0|||
129916069|NCT00073749|467655955|FG002|Overall Study|Lost to Follow-up|0|||
129916070|NCT00073749|467655956|FG003|Overall Study|Lost to Follow-up|0|||
129916071|NCT00073749|467655957|FG004|Overall Study|Lost to Follow-up|0|||
129916072|NCT00073749|467655958|FG005|Overall Study|Lost to Follow-up|0|||
129916073|NCT00073749|467655959|FG006|Overall Study|Lost to Follow-up|2|||
129916074|NCT00073749|467655953|FG000|Overall Study|Other|0|||
129916075|NCT00073749|467655954|FG001|Overall Study|Other|0|||
129916076|NCT00073749|467655955|FG002|Overall Study|Other|0|||
129916077|NCT00073749|467655956|FG003|Overall Study|Other|0|||
129916078|NCT00073749|467655957|FG004|Overall Study|Other|0|||
129916079|NCT00073749|467655958|FG005|Overall Study|Other|2|||
129916080|NCT00073749|467655959|FG006|Overall Study|Other|0|||
129916081|NCT00611559|467655960|FG000|Overall Study|Lost to Follow-up|0|||
129916082|NCT00611559|467655961|FG001|Overall Study|Lost to Follow-up|1|||
129916083|NCT00611559|467655962|FG002|Overall Study|Lost to Follow-up|0|||
129916084|NCT00611559|467655960|FG000|Overall Study|Protocol Violation|1|||
129916085|NCT00611559|467655961|FG001|Overall Study|Protocol Violation|0|||
129916086|NCT00611559|467655962|FG002|Overall Study|Protocol Violation|1|||
129916087|NCT04999592|467655963|FG000|Overall Study|Withdrawal by Subject|1|||
129916088|NCT04999592|467655964|FG001|Overall Study|Withdrawal by Subject|0|||
129916089|NCT04095104|467655965|FG000|Overall Study|Withdrawal by Subject|0|||
129916090|NCT04095104|467655966|FG001|Overall Study|Withdrawal by Subject|1|||
129916091|NCT03912831|467655967|FG000|Overall Study|Death|1|||
129916092|NCT03912831|467655968|FG001|Overall Study|Death|1|||
129916093|NCT03912831|467655969|FG002|Overall Study|Death|1|||
129916094|NCT03912831|467655970|FG003|Overall Study|Death|1|||
129916095|NCT03912831|467655971|FG004|Overall Study|Death|1|||
129916096|NCT03912831|467655972|FG005|Overall Study|Death|1|||
129916097|NCT03912831|467655967|FG000|Overall Study|Reason not Specified|0|||
129916098|NCT03912831|467655968|FG001|Overall Study|Reason not Specified|0|||
129867294|NCT01475136|467469679|FG000|Overall Study|Sponsor Decision|0|||
129867295|NCT01475136|467469680|FG001|Overall Study|Sponsor Decision|1|||
129867296|NCT01475136|467469681|FG002|Overall Study|Sponsor Decision|0|||
129867297|NCT01475136|467469682|FG003|Overall Study|Sponsor Decision|0|||
129867298|NCT01475136|467469679|FG000|Overall Study|Entry Criteria Not Met|0|||
129867299|NCT01475136|467469680|FG001|Overall Study|Entry Criteria Not Met|2|||
129867300|NCT01475136|467469681|FG002|Overall Study|Entry Criteria Not Met|3|||
129867301|NCT01475136|467469682|FG003|Overall Study|Entry Criteria Not Met|1|||
129867302|NCT01475136|467469679|FG000|Overall Study|Withdrawal by Subject|0|||
129867303|NCT01475136|467469680|FG001|Overall Study|Withdrawal by Subject|0|||
129867304|NCT01475136|467469681|FG002|Overall Study|Withdrawal by Subject|0|||
129867305|NCT01475136|467469682|FG003|Overall Study|Withdrawal by Subject|2|||
129867306|NCT01475136|467469679|FG000|Overall Study|Adverse Event|1|||
129867307|NCT01475136|467469680|FG001|Overall Study|Adverse Event|0|||
129867308|NCT01475136|467469681|FG002|Overall Study|Adverse Event|0|||
129867309|NCT01475136|467469682|FG003|Overall Study|Adverse Event|1|||
129867310|NCT01475136|467469679|FG000|Overall Study|Death|0|||
129867311|NCT01475136|467469680|FG001|Overall Study|Death|0|||
129867312|NCT01475136|467469681|FG002|Overall Study|Death|0|||
129867313|NCT01475136|467469682|FG003|Overall Study|Death|1|||
129867314|NCT00003508|467471443|FG000|Overall Study|Not evaluable|5|||
129867315|NCT04918784|467471444|FG000|Overall Study|Amputation - no longer eligible|1|||
129867316|NCT04918784|467471445|FG001|Overall Study|Amputation - no longer eligible|2|||
129867317|NCT04918784|467471444|FG000|Overall Study|Death|1|||
129867318|NCT04918784|467471445|FG001|Overall Study|Death|0|||
129867319|NCT04918784|467471444|FG000|Overall Study|patient non-compliance|3|||
129867320|NCT04918784|467471445|FG001|Overall Study|patient non-compliance|1|||
129867321|NCT04918784|467471444|FG000|Overall Study|Adverse Event|1|||
129867322|NCT04918784|467471445|FG001|Overall Study|Adverse Event|0|||
129867323|NCT04179175|467471449|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
129867324|NCT04179175|467471450|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
129867325|NCT04179175|467471451|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
129867326|NCT04179175|467471452|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
129867327|NCT04179175|467471453|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
129867328|NCT04179175|467471454|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
129867329|NCT04179175|467471449|FG000|Overall Study|Adverse Event|5|||
129867330|NCT04179175|467471450|FG001|Overall Study|Adverse Event|3|||
129867331|NCT04179175|467471451|FG002|Overall Study|Adverse Event|3|||
129867332|NCT04179175|467471452|FG003|Overall Study|Adverse Event|4|||
129867333|NCT04179175|467471453|FG004|Overall Study|Adverse Event|6|||
129867334|NCT04179175|467471454|FG005|Overall Study|Adverse Event|6|||
129867335|NCT04179175|467471449|FG000|Overall Study|Lack of Efficacy|5|||
129867336|NCT04179175|467471450|FG001|Overall Study|Lack of Efficacy|1|||
129867337|NCT04179175|467471451|FG002|Overall Study|Lack of Efficacy|3|||
129867338|NCT04179175|467471452|FG003|Overall Study|Lack of Efficacy|2|||
129867339|NCT04179175|467471453|FG004|Overall Study|Lack of Efficacy|18|||
129867340|NCT04179175|467471454|FG005|Overall Study|Lack of Efficacy|7|||
129867341|NCT04179175|467471449|FG000|Overall Study|Lost to Follow-up|5|||
129867342|NCT04179175|467471450|FG001|Overall Study|Lost to Follow-up|3|||
129867343|NCT04179175|467471451|FG002|Overall Study|Lost to Follow-up|2|||
129867344|NCT04179175|467471452|FG003|Overall Study|Lost to Follow-up|2|||
129867345|NCT04179175|467471453|FG004|Overall Study|Lost to Follow-up|4|||
129867346|NCT04179175|467471454|FG005|Overall Study|Lost to Follow-up|5|||
129867347|NCT04179175|467471449|FG000|Overall Study|Physician Decision|2|||
129867348|NCT04179175|467471450|FG001|Overall Study|Physician Decision|0|||
129867349|NCT04179175|467471451|FG002|Overall Study|Physician Decision|2|||
129867350|NCT04179175|467471452|FG003|Overall Study|Physician Decision|3|||
129867351|NCT04179175|467471453|FG004|Overall Study|Physician Decision|1|||
129867352|NCT04179175|467471454|FG005|Overall Study|Physician Decision|1|||
129867353|NCT04179175|467471449|FG000|Overall Study|Pregnancy|3|||
129867354|NCT04179175|467471450|FG001|Overall Study|Pregnancy|0|||
129867355|NCT04179175|467471451|FG002|Overall Study|Pregnancy|3|||
129867356|NCT04179175|467471452|FG003|Overall Study|Pregnancy|0|||
129867357|NCT04179175|467471453|FG004|Overall Study|Pregnancy|1|||
129867358|NCT04179175|467471454|FG005|Overall Study|Pregnancy|2|||
129867359|NCT04179175|467471449|FG000|Overall Study|Withdrawal by Subject|22|||
129867360|NCT04179175|467471450|FG001|Overall Study|Withdrawal by Subject|10|||
129867361|NCT04179175|467471451|FG002|Overall Study|Withdrawal by Subject|12|||
129867362|NCT04179175|467471452|FG003|Overall Study|Withdrawal by Subject|8|||
129867363|NCT04179175|467471453|FG004|Overall Study|Withdrawal by Subject|23|||
129867364|NCT04179175|467471454|FG005|Overall Study|Withdrawal by Subject|31|||
129867365|NCT04179175|467471449|FG000|Overall Study|Technical problems|0|||
129867366|NCT04179175|467471450|FG001|Overall Study|Technical problems|0|||
129867367|NCT04179175|467471451|FG002|Overall Study|Technical problems|1|||
129867368|NCT04179175|467471452|FG003|Overall Study|Technical problems|1|||
129867369|NCT04179175|467471453|FG004|Overall Study|Technical problems|0|||
129867370|NCT04179175|467471454|FG005|Overall Study|Technical problems|0|||
129916099|NCT03912831|467655969|FG002|Overall Study|Reason not Specified|0|||
129867371|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
129867372|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
129867373|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
129867374|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
129867375|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
129867376|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
129867377|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Death|1|||
129867378|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Death|0|||
129867379|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Adverse Event|1|||
129867380|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Adverse Event|0|||
129867381|NCT02586025|467471464|FG000|Neoadjuvant Treatment|Physician Decision|2|||
129867382|NCT02586025|467471465|FG001|Neoadjuvant Treatment|Physician Decision|1|||
129867383|NCT02586025|467471464|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
129867384|NCT02586025|467471465|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
129867385|NCT02586025|467471464|FG000|Adjuvant Treatment|Recurrent Disease|4|||
129867386|NCT02586025|467471465|FG001|Adjuvant Treatment|Recurrent Disease|5|||
129867387|NCT02586025|467471464|FG000|Adjuvant Treatment|Physician Decision|0|||
129867388|NCT02586025|467471465|FG001|Adjuvant Treatment|Physician Decision|1|||
129867389|NCT02586025|467471464|FG000|Adjuvant Treatment|Pregnancy|1|||
129867390|NCT02586025|467471465|FG001|Adjuvant Treatment|Pregnancy|0|||
129867391|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Death|11|||
129867392|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Death|11|||
129867393|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
129867394|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
129867395|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
129867396|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
129867397|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
129867398|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
129867399|NCT02586025|467471464|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
129867400|NCT02586025|467471465|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
129867401|NCT00175825|467471466|FG000|Overall Study|Adverse Event|3|||
129867402|NCT00175825|467471467|FG001|Overall Study|Adverse Event|2|||
129867403|NCT00175825|467471468|FG002|Overall Study|Adverse Event|1|||
129867404|NCT00175825|467471469|FG003|Overall Study|Adverse Event|1|||
129867405|NCT00175825|467471466|FG000|Overall Study|Lost to Follow-up|1|||
129867406|NCT00175825|467471467|FG001|Overall Study|Lost to Follow-up|2|||
129867407|NCT00175825|467471468|FG002|Overall Study|Lost to Follow-up|0|||
129867408|NCT00175825|467471469|FG003|Overall Study|Lost to Follow-up|0|||
129867409|NCT00175825|467471466|FG000|Overall Study|Withdrawal by Subject|1|||
129867410|NCT00175825|467471467|FG001|Overall Study|Withdrawal by Subject|0|||
129867411|NCT00175825|467471468|FG002|Overall Study|Withdrawal by Subject|0|||
129867412|NCT00175825|467471469|FG003|Overall Study|Withdrawal by Subject|0|||
129867413|NCT02030015|467471470|FG000|Overall Study|Withdrawal by Subject|3|||
129867414|NCT02030015|467471470|FG000|Overall Study|Death|13|||
129867415|NCT03014674|467471472|FG000|Overall Study|Withdrawal by Subject|1|||
129867416|NCT03014674|467471473|FG001|Overall Study|Withdrawal by Subject|0|||
129867417|NCT03014674|467471474|FG002|Overall Study|Withdrawal by Subject|0|||
129867418|NCT03224182|467471475|FG000|Overall Study|Study Drug Not Instilled|6|||
129867419|NCT03224182|467471476|FG001|Overall Study|Study Drug Not Instilled|1|||
129867420|NCT03224182|467471475|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
129867421|NCT03224182|467471476|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
129867422|NCT03224182|467471475|FG000|Overall Study|Withdrew of Consent|4|||
129867423|NCT03224182|467471476|FG001|Overall Study|Withdrew of Consent|2|||
129867424|NCT03224182|467471475|FG000|Overall Study|Investigator Decision|3|||
129867425|NCT03224182|467471476|FG001|Overall Study|Investigator Decision|1|||
129867426|NCT03224182|467471475|FG000|Overall Study|Sponsor Decision|26|||
129867427|NCT03224182|467471476|FG001|Overall Study|Sponsor Decision|12|||
129867428|NCT03224182|467471475|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
129867429|NCT03224182|467471476|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
129867430|NCT03224182|467471475|FG000|Overall Study|Lost to Follow-up|1|||
129867431|NCT03224182|467471476|FG001|Overall Study|Lost to Follow-up|0|||
129867432|NCT03224182|467471475|FG000|Overall Study|Participant Had Recurrence|11|||
129867433|NCT03224182|467471476|FG001|Overall Study|Participant Had Recurrence|5|||
129867434|NCT03224182|467471475|FG000|Overall Study|Death|0|||
129867435|NCT03224182|467471476|FG001|Overall Study|Death|1|||
129867436|NCT03224182|467471475|FG000|Overall Study|Reason not Specified|3|||
129867437|NCT03224182|467471476|FG001|Overall Study|Reason not Specified|3|||
129867438|NCT03224182|467471475|FG000|Overall Study|Other|1|||
129867439|NCT03224182|467471476|FG001|Overall Study|Other|0|||
129867440|NCT02822222|467471477|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
129867441|NCT02822222|467471478|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
129867442|NCT04279314|467471479|FG000|Overall Study|Adverse Event|55|||
129867443|NCT04279314|467471479|FG000|Overall Study|Withdrawal by Subject|5|||
129867444|NCT04279314|467471479|FG000|Overall Study|Lack of Efficacy|5|||
129867445|NCT04279314|467471479|FG000|Overall Study|Protocol Violation|3|||
129867446|NCT04279314|467471479|FG000|Overall Study|Other (not COVID-19 related)|2|||
129867447|NCT02481310|467471480|FG000|Follow up|Still in follow up|0|||
129867448|NCT02481310|467471481|FG001|Follow up|Still in follow up|3|||
129867449|NCT02481310|467471482|FG002|Follow up|Still in follow up|0|||
129867450|NCT00833560|467471483|FG000|Overall Study|Toxicity|13|||
129867451|NCT00833560|467471483|FG000|Overall Study|Adverse Event|11|||
129867452|NCT00833560|467471483|FG000|Overall Study|Protocol Violation|6|||
129867453|NCT00833560|467471483|FG000|Overall Study|Lack of Efficacy|4|||
129867454|NCT00833560|467471483|FG000|Overall Study|Death|2|||
129867455|NCT00833560|467471483|FG000|Overall Study|Pregression of other disease|1|||
129867456|NCT00833560|467471483|FG000|Overall Study|Other|5|||
129867457|NCT00643916|467471484|FG000|Overall Study|Protocol Violation|0|||
129867458|NCT00643916|467471485|FG001|Overall Study|Protocol Violation|1|||
129867459|NCT00643916|467471486|FG002|Overall Study|Protocol Violation|1|||
129867460|NCT00643916|467471487|FG003|Overall Study|Protocol Violation|1|||
129867461|NCT00643916|467471488|FG004|Overall Study|Protocol Violation|0|||
129867462|NCT00643916|467471489|FG005|Overall Study|Protocol Violation|0|||
129867463|NCT00643916|467471484|FG000|Overall Study|Lost to Follow-up|0|||
129867464|NCT00643916|467471485|FG001|Overall Study|Lost to Follow-up|1|||
129867465|NCT00643916|467471486|FG002|Overall Study|Lost to Follow-up|0|||
129867466|NCT00643916|467471487|FG003|Overall Study|Lost to Follow-up|0|||
129867467|NCT00643916|467471488|FG004|Overall Study|Lost to Follow-up|0|||
129867468|NCT00643916|467471489|FG005|Overall Study|Lost to Follow-up|0|||
129867469|NCT00643916|467471484|FG000|Overall Study|Withdrawal by Subject|2|||
129867470|NCT00643916|467471485|FG001|Overall Study|Withdrawal by Subject|2|||
129867471|NCT00643916|467471486|FG002|Overall Study|Withdrawal by Subject|2|||
129867472|NCT00643916|467471487|FG003|Overall Study|Withdrawal by Subject|1|||
129867473|NCT00643916|467471488|FG004|Overall Study|Withdrawal by Subject|0|||
129867474|NCT00643916|467471489|FG005|Overall Study|Withdrawal by Subject|1|||
129867475|NCT00643916|467471484|FG000|Overall Study|Not Vaccinated|2|||
129867476|NCT00643916|467471485|FG001|Overall Study|Not Vaccinated|2|||
129867477|NCT00643916|467471486|FG002|Overall Study|Not Vaccinated|3|||
129867478|NCT00643916|467471487|FG003|Overall Study|Not Vaccinated|0|||
129867479|NCT00643916|467471488|FG004|Overall Study|Not Vaccinated|2|||
129867480|NCT00643916|467471489|FG005|Overall Study|Not Vaccinated|0|||
129867481|NCT00499031|467471490|FG000|Overall Study|Improper pre-protocol treatment|1|||
129867482|NCT00499031|467471490|FG000|Overall Study|Required test not done|1|||
129867483|NCT00499031|467471490|FG000|Overall Study|Never treated|1|||
129867484|NCT02606279|467471500|FG000|Overall Study|Lost to Follow-up|0|||
129867485|NCT02606279|467471501|FG001|Overall Study|Lost to Follow-up|1|||
129867486|NCT02184611|467471502|FG000|Overall Study|Lack of Efficacy|11|||
129867487|NCT02184611|467471503|FG001|Overall Study|Lack of Efficacy|15|||
129867488|NCT02184611|467471502|FG000|Overall Study|Withdrawal by Subject|5|||
129867489|NCT02184611|467471503|FG001|Overall Study|Withdrawal by Subject|6|||
129867490|NCT02184611|467471502|FG000|Overall Study|Adverse Event|4|||
129867491|NCT02184611|467471503|FG001|Overall Study|Adverse Event|5|||
129867492|NCT02184611|467471502|FG000|Overall Study|Protocol Violation|1|||
129867493|NCT02184611|467471503|FG001|Overall Study|Protocol Violation|1|||
129867494|NCT02184611|467471502|FG000|Overall Study|Protocol defined stopping criteria|0|||
129867495|NCT02184611|467471503|FG001|Overall Study|Protocol defined stopping criteria|1|||
129867496|NCT00985725|467471506|FG000|Overall Study|Adverse Event|4|||
129867497|NCT00985725|467471507|FG001|Overall Study|Adverse Event|1|||
129867498|NCT00985725|467471506|FG000|Overall Study|Protocol Violation|1|||
129867499|NCT00985725|467471507|FG001|Overall Study|Protocol Violation|3|||
129867500|NCT00985725|467471506|FG000|Overall Study|Withdrawal by Subject|4|||
129867501|NCT00985725|467471507|FG001|Overall Study|Withdrawal by Subject|4|||
129867502|NCT00985725|467471506|FG000|Overall Study|Lost to Follow-up|1|||
129867503|NCT00985725|467471507|FG001|Overall Study|Lost to Follow-up|1|||
129867504|NCT00985725|467471506|FG000|Overall Study|Lack of Efficacy|0|||
129867505|NCT00985725|467471507|FG001|Overall Study|Lack of Efficacy|1|||
129867506|NCT00985725|467471506|FG000|Overall Study|Non-compliance|1|||
129867507|NCT00985725|467471507|FG001|Overall Study|Non-compliance|2|||
129867508|NCT00985725|467471506|FG000|Overall Study|Out-of-window visits|0|||
129867509|NCT00985725|467471507|FG001|Overall Study|Out-of-window visits|1|||
129867510|NCT02428296|467471512|FG000|Overall Study|Adverse Event|7|||
129867511|NCT02428296|467471512|FG000|Overall Study|Withdrawal by Subject|2|||
129867512|NCT02230956|467471515|FG000|Overall Study|Adverse Event|1|||
129867513|NCT02230956|467471516|FG001|Overall Study|Adverse Event|1|||
129867514|NCT02230956|467471517|FG002|Overall Study|Adverse Event|0|||
129867515|NCT02230956|467471515|FG000|Overall Study|Lack of Efficacy|1|||
129867516|NCT02230956|467471516|FG001|Overall Study|Lack of Efficacy|1|||
129867517|NCT02230956|467471517|FG002|Overall Study|Lack of Efficacy|1|||
129867518|NCT02230956|467471515|FG000|Overall Study|Lost to Follow-up|1|||
129867519|NCT02230956|467471516|FG001|Overall Study|Lost to Follow-up|1|||
129867520|NCT02230956|467471517|FG002|Overall Study|Lost to Follow-up|2|||
129867521|NCT02230956|467471515|FG000|Overall Study|Personal Reasons|2|||
129867522|NCT02230956|467471516|FG001|Overall Study|Personal Reasons|1|||
129867523|NCT02230956|467471517|FG002|Overall Study|Personal Reasons|1|||
129867524|NCT02230956|467471515|FG000|Overall Study|Protocol Violation|0|||
129867525|NCT02230956|467471516|FG001|Overall Study|Protocol Violation|1|||
129916100|NCT03912831|467655970|FG003|Overall Study|Reason not Specified|0|||
129916101|NCT03912831|467655971|FG004|Overall Study|Reason not Specified|1|||
129916102|NCT03912831|467655972|FG005|Overall Study|Reason not Specified|0|||
129916103|NCT03912831|467655967|FG000|Overall Study|Withdrawal by Participant|0|||
129916104|NCT03912831|467655968|FG001|Overall Study|Withdrawal by Participant|0|||
129916105|NCT03912831|467655969|FG002|Overall Study|Withdrawal by Participant|0|||
129916106|NCT03912831|467655970|FG003|Overall Study|Withdrawal by Participant|0|||
129916107|NCT03912831|467655971|FG004|Overall Study|Withdrawal by Participant|1|||
129916108|NCT03912831|467655972|FG005|Overall Study|Withdrawal by Participant|0|||
129916109|NCT04774237|467655974|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916110|NCT04774237|467655975|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916111|NCT04774237|467655976|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916112|NCT04774237|467655977|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916113|NCT04774237|467655978|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
129916114|NCT04774237|467655979|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
129916115|NCT03152786|467657182|FG000|Overall Study|Withdrawal by Subject|2|||
129916116|NCT03152786|467657183|FG001|Overall Study|Withdrawal by Subject|1|||
129916117|NCT00753090|467657195|FG000|Overall Study|Withdrawal by Subject|10|||
129916118|NCT00753090|467657196|FG001|Overall Study|Withdrawal by Subject|10|||
129916119|NCT00753090|467657195|FG000|Overall Study|Death|17|||
129916120|NCT00753090|467657196|FG001|Overall Study|Death|6|||
129916121|NCT00753090|467657195|FG000|Overall Study|Study Prosthesis Removed|12|||
129916122|NCT00753090|467657196|FG001|Overall Study|Study Prosthesis Removed|3|||
129916123|NCT00753090|467657195|FG000|Overall Study|Lost to Follow-up|2|||
129916124|NCT00753090|467657196|FG001|Overall Study|Lost to Follow-up|2|||
129916125|NCT00753090|467657195|FG000|Overall Study|Other|127|||
129916126|NCT00753090|467657196|FG001|Overall Study|Other|75|||
129916127|NCT06066541|467657197|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
129916128|NCT06066541|467657198|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
129916129|NCT06066541|467657199|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
129916130|NCT06066541|467657200|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
129916131|NCT06066541|467657201|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
129916132|NCT06066541|467657202|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
129916133|NCT06066541|467657203|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
129916134|NCT06066541|467657197|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
129916135|NCT06066541|467657198|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
129916136|NCT06066541|467657199|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
129916137|NCT06066541|467657200|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
129916138|NCT06066541|467657201|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
129916139|NCT06066541|467657202|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
129916140|NCT06066541|467657203|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
129916141|NCT04533022|467657204|FG000|Overall Study|Withdrawal by Subject|15|||
129916142|NCT04533022|467657204|FG000|Overall Study|Adverse Event|6|||
129916143|NCT04533022|467657204|FG000|Overall Study|Death|1|||
129916144|NCT04533022|467657204|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
129916145|NCT04533022|467657204|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
129916146|NCT02163447|467657205|FG000|Overall Study|Withdrawal by Subject|2|||
129916147|NCT02163447|467657206|FG001|Overall Study|Withdrawal by Subject|0|||
129916148|NCT02163447|467657207|FG002|Overall Study|Withdrawal by Subject|1|||
129916149|NCT02163447|467657205|FG000|Overall Study|Lost to Follow-up|1|||
129916150|NCT02163447|467657206|FG001|Overall Study|Lost to Follow-up|3|||
129916151|NCT02163447|467657207|FG002|Overall Study|Lost to Follow-up|0|||
129916152|NCT02163447|467657205|FG000|Overall Study|Moved out of study area|2|||
129916153|NCT02163447|467657206|FG001|Overall Study|Moved out of study area|3|||
129916154|NCT02163447|467657207|FG002|Overall Study|Moved out of study area|2|||
129916155|NCT02163447|467657205|FG000|Overall Study|Became HIV infected at time of delivery|1|||
129916156|NCT02163447|467657206|FG001|Overall Study|Became HIV infected at time of delivery|0|||
129916157|NCT02163447|467657207|FG002|Overall Study|Became HIV infected at time of delivery|0|||
129916158|NCT04052516|467657209|FG000|Overall Study|Withdrawal by Subject|4|||
129916159|NCT04052516|467657210|FG001|Overall Study|Withdrawal by Subject|5|||
129916160|NCT04052516|467657211|FG002|Overall Study|Withdrawal by Subject|6|||
129916161|NCT04052516|467657209|FG000|Overall Study|Adverse Event|3|||
129916162|NCT04052516|467657210|FG001|Overall Study|Adverse Event|2|||
129916163|NCT04052516|467657211|FG002|Overall Study|Adverse Event|8|||
129916164|NCT04052516|467657209|FG000|Overall Study|Lost to Follow-up|2|||
129916165|NCT04052516|467657210|FG001|Overall Study|Lost to Follow-up|5|||
129916166|NCT04052516|467657211|FG002|Overall Study|Lost to Follow-up|3|||
129916167|NCT04052516|467657209|FG000|Overall Study|Protocol Violation|1|||
129916168|NCT04052516|467657210|FG001|Overall Study|Protocol Violation|1|||
129916169|NCT04052516|467657211|FG002|Overall Study|Protocol Violation|0|||
129916170|NCT04052516|467657209|FG000|Overall Study|Death|1|||
129916171|NCT04052516|467657210|FG001|Overall Study|Death|0|||
129916172|NCT04052516|467657211|FG002|Overall Study|Death|0|||
129916173|NCT04052516|467657209|FG000|Overall Study|Physician Decision|0|||
129916174|NCT04052516|467657210|FG001|Overall Study|Physician Decision|1|||
129916175|NCT04052516|467657211|FG002|Overall Study|Physician Decision|0|||
129916176|NCT04052516|467657209|FG000|Overall Study|Pregnancy|1|||
129916177|NCT04052516|467657210|FG001|Overall Study|Pregnancy|0|||
129916178|NCT04052516|467657211|FG002|Overall Study|Pregnancy|0|||
129916179|NCT04052516|467657209|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
129916180|NCT04052516|467657210|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
129916181|NCT04052516|467657211|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
129916182|NCT04052516|467657209|FG000|Overall Study|Reason not recorded|0|||
129916183|NCT04052516|467657210|FG001|Overall Study|Reason not recorded|1|||
129916184|NCT04052516|467657211|FG002|Overall Study|Reason not recorded|0|||
129916185|NCT05113966|467657212|FG000|Overall Study|Death|21|||
129916186|NCT05113966|467657212|FG000|Overall Study|Study Terminated by Sponsor|9|||
129916187|NCT05386355|467657213|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916188|NCT05386355|467657214|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916189|NCT05386355|467657215|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916190|NCT05386355|467657216|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
129916191|NCT06143670|467657217|FG000|Overall Study|Lost to Follow-up|0|||
129916192|NCT06143670|467657218|FG001|Overall Study|Lost to Follow-up|1|||
129916193|NCT06143670|467657217|FG000|Overall Study|Withdrawal by Subject|3|||
129916194|NCT06143670|467657218|FG001|Overall Study|Withdrawal by Subject|0|||
129449814|NCT01092143|465945684|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
129867526|NCT02230956|467471517|FG002|Overall Study|Protocol Violation|1|||
129867527|NCT02230956|467471515|FG000|Overall Study|Other Miscellaneous Reason|0|||
129867528|NCT02230956|467471516|FG001|Overall Study|Other Miscellaneous Reason|1|||
129867529|NCT02230956|467471517|FG002|Overall Study|Other Miscellaneous Reason|2|||
129867530|NCT00338884|467471518|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
129867531|NCT00338884|467471518|FG000|Overall Study|Adverse Event|14|||
129867532|NCT00338884|467471518|FG000|Overall Study|Death|8|||
129867533|NCT00338884|467471518|FG000|Overall Study|Other|4|||
129867534|NCT00338884|467471518|FG000|Overall Study|Global Deterioration of Health Status|3|||
129867535|NCT00338884|467471518|FG000|Overall Study|Withdrawal by Subject|3|||
129867536|NCT00338884|467471518|FG000|Overall Study|Lost to Follow-up|1|||
129867537|NCT00338884|467471518|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
129867538|NCT01970982|467471520|FG000|Overall Study|Withdrawal by Subject|0|||
129867539|NCT01970982|467471521|FG001|Overall Study|Withdrawal by Subject|0|||
129867540|NCT01970982|467471522|FG002|Overall Study|Withdrawal by Subject|2|||
129867541|NCT01984684|467471527|FG000|Overall Study|Lost to Follow-up|25|||
129867542|NCT01984684|467471528|FG001|Overall Study|Lost to Follow-up|24|||
129867543|NCT01984684|467471527|FG000|Overall Study|Adverse Event|8|||
129867544|NCT01984684|467471528|FG001|Overall Study|Adverse Event|12|||
129867545|NCT01984684|467471527|FG000|Overall Study|Withdrawal by Subject|9|||
129867546|NCT01984684|467471528|FG001|Overall Study|Withdrawal by Subject|9|||
129867547|NCT01984684|467471527|FG000|Overall Study|Lack of Efficacy|3|||
129867548|NCT01984684|467471528|FG001|Overall Study|Lack of Efficacy|6|||
129867549|NCT01984684|467471527|FG000|Overall Study|Physician Decision|4|||
129867550|NCT01984684|467471528|FG001|Overall Study|Physician Decision|2|||
129867551|NCT01984684|467471527|FG000|Overall Study|Protocol Violation|4|||
129867552|NCT01984684|467471528|FG001|Overall Study|Protocol Violation|2|||
129867553|NCT01984684|467471527|FG000|Overall Study|Death|0|||
129867554|NCT01984684|467471528|FG001|Overall Study|Death|1|||
129867555|NCT01984684|467471527|FG000|Overall Study|Noncompliance with study drug|2|||
129867556|NCT01984684|467471528|FG001|Overall Study|Noncompliance with study drug|1|||
129867557|NCT01984684|467471527|FG000|Overall Study|Subject incarcerated|1|||
129867558|NCT01984684|467471528|FG001|Overall Study|Subject incarcerated|0|||
129867559|NCT01984684|467471527|FG000|Overall Study|Study drug not available at site|1|||
129867560|NCT01984684|467471528|FG001|Overall Study|Study drug not available at site|1|||
129867561|NCT01984684|467471527|FG000|Overall Study|Subject had inadequate IV access|0|||
129867562|NCT01984684|467471528|FG001|Overall Study|Subject had inadequate IV access|1|||
129867563|NCT05711641|467471533|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
129867564|NCT05711641|467471534|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
129867565|NCT05711641|467471533|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
129867566|NCT05711641|467471534|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
129867567|NCT04575051|467471535|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
129867568|NCT04575051|467471536|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
129867569|NCT04575051|467471537|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
129867570|NCT04575051|467471538|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
129867571|NCT04575051|467471539|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
129867572|NCT04575051|467471535|FG000|Time Period 1|Missing follow up|1|||
129867573|NCT04575051|467471536|FG001|Time Period 1|Missing follow up|3|||
129867574|NCT04575051|467471537|FG002|Time Period 1|Missing follow up|1|||
129867575|NCT04575051|467471538|FG003|Time Period 1|Missing follow up|3|||
129867576|NCT04575051|467471539|FG004|Time Period 1|Missing follow up|2|||
129867577|NCT04575051|467471535|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
129867578|NCT04575051|467471536|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
129867579|NCT04575051|467471537|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
129867580|NCT04575051|467471538|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
129867581|NCT04575051|467471539|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
129867582|NCT04575051|467471535|FG000|Time Period 2|Missing follow up|1|||
129867583|NCT04575051|467471536|FG001|Time Period 2|Missing follow up|8|||
129867584|NCT04575051|467471537|FG002|Time Period 2|Missing follow up|7|||
129867585|NCT04575051|467471538|FG003|Time Period 2|Missing follow up|0|||
129867586|NCT04575051|467471539|FG004|Time Period 2|Missing follow up|1|||
129867587|NCT04575051|467471535|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
129867588|NCT04575051|467471536|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
129867589|NCT04575051|467471537|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
129867590|NCT04575051|467471538|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
129867591|NCT04575051|467471539|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
129867592|NCT04575051|467471535|FG000|Time Period 3|Missing follow up|8|||
129867593|NCT04575051|467471536|FG001|Time Period 3|Missing follow up|6|||
129867594|NCT04575051|467471537|FG002|Time Period 3|Missing follow up|4|||
129867595|NCT04575051|467471538|FG003|Time Period 3|Missing follow up|3|||
129867596|NCT04575051|467471539|FG004|Time Period 3|Missing follow up|0|||
129916195|NCT03747484|467657219|FG000|Overall Study|Lack of Efficacy|0|||
129916196|NCT03747484|467657220|FG001|Overall Study|Lack of Efficacy|1|||
129916197|NCT03747484|467657221|FG002|Overall Study|Lack of Efficacy|1|||
129916198|NCT03747484|467657222|FG003|Overall Study|Lack of Efficacy|2|||
129916199|NCT03747484|467657223|FG004|Overall Study|Lack of Efficacy|2|||
129916200|NCT02597946|467657227|FG000|Overall Study|Withdrawal by Subject|1|||
129916201|NCT02597946|467657227|FG000|Overall Study|Progressive disease|16|||
129916202|NCT02597946|467657227|FG000|Overall Study|Other than above|1|||
129916203|NCT03625882|467657231|FG000|Overall Study|Protocol Violation|3|||
129916204|NCT05058391|467657239|FG000|Overall Study|Adverse Event|1|||
129916205|NCT03833245|467657240|FG000|Overall Study|Death|0|||
129916206|NCT03833245|467657241|FG001|Overall Study|Death|1|||
129916207|NCT05038566|467657243|FG000|Overall Study|Technical Difficulties with the Device|0|||
129916208|NCT05038566|467657244|FG001|Overall Study|Technical Difficulties with the Device|1|||
129916209|NCT05919082|467657245|FG000|Overall Study|Adverse Event|3|||
129916210|NCT05919082|467657246|FG001|Overall Study|Adverse Event|0|||
129916211|NCT05919082|467657245|FG000|Overall Study|Lost to Follow-up|0|||
129916212|NCT05919082|467657246|FG001|Overall Study|Lost to Follow-up|1|||
129916213|NCT05919082|467657245|FG000|Overall Study|Withdrawal by Subject|8|||
129916214|NCT05919082|467657246|FG001|Overall Study|Withdrawal by Subject|9|||
129916215|NCT05919082|467657245|FG000|Overall Study|Lack of Efficacy|0|||
129916216|NCT05919082|467657246|FG001|Overall Study|Lack of Efficacy|1|||
129916217|NCT05919082|467657245|FG000|Overall Study|Investigator Decision|1|||
129916218|NCT05919082|467657246|FG001|Overall Study|Investigator Decision|0|||
129916219|NCT03089398|467657255|FG000|Overall Study|Death|4|||
129916220|NCT03089398|467657256|FG001|Overall Study|Death|9|||
129916221|NCT03089398|467657255|FG000|Overall Study|Lost to Follow-up|21|||
129916222|NCT03089398|467657256|FG001|Overall Study|Lost to Follow-up|30|||
129916223|NCT03089398|467657255|FG000|Overall Study|Withdrawal by Subject|2|||
129916224|NCT03089398|467657256|FG001|Overall Study|Withdrawal by Subject|2|||
129916225|NCT05062265|467657257|FG000|Overall Study|Withdrawal by Subject|1|||
129916226|NCT05062265|467657258|FG001|Overall Study|Withdrawal by Subject|0|||
129916227|NCT05439603|467657259|FG000|Overall Study|met withdrawal criteria|2|||
129916228|NCT02682316|467657264|FG000|Overall Study|Benign Final Pathology|27|||
129916229|NCT02682316|467657265|FG001|Overall Study|Benign Final Pathology|26|||
129916230|NCT02682316|467657264|FG000|Overall Study|Reoperation before 30 days|7|||
129916231|NCT02682316|467657265|FG001|Overall Study|Reoperation before 30 days|6|||
129916232|NCT02682316|467657264|FG000|Overall Study|Ineligible|1|||
129916233|NCT02682316|467657265|FG001|Overall Study|Ineligible|0|||
129916234|NCT02682316|467657264|FG000|Overall Study|Death|1|||
129916235|NCT02682316|467657265|FG001|Overall Study|Death|0|||
129916236|NCT02682316|467657264|FG000|Overall Study|Lost to Follow-up|7|||
129916237|NCT02682316|467657265|FG001|Overall Study|Lost to Follow-up|3|||
129916238|NCT00150813|467657267|FG000|Overall Study|Adverse Event|1|||
129916239|NCT00150813|467657267|FG000|Overall Study|Lack of Efficacy|1|||
129916240|NCT00150813|467657267|FG000|Overall Study|Lost to Follow-up|5|||
129916241|NCT00150813|467657267|FG000|Overall Study|Withdrawal by Subject|5|||
129916242|NCT00150813|467657267|FG000|Overall Study|Remission|3|||
129916243|NCT00150813|467657267|FG000|Overall Study|Planned pregancy|1|||
129916244|NCT00150813|467657267|FG000|Overall Study|Switch to commercially available LEV|2|||
129916245|NCT03052608|467657269|FG000|Treatment Phase|Adverse Event|10|||
129916246|NCT03052608|467657270|FG001|Treatment Phase|Adverse Event|12|||
129916247|NCT03052608|467657269|FG000|Treatment Phase|Death|6|||
129916248|NCT03052608|467657270|FG001|Treatment Phase|Death|4|||
129916249|NCT03052608|467657269|FG000|Treatment Phase|Withdrawal by Subject|4|||
129916250|NCT03052608|467657270|FG001|Treatment Phase|Withdrawal by Subject|12|||
129916251|NCT03052608|467657269|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
129916252|NCT03052608|467657270|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
129916253|NCT03052608|467657269|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
129916254|NCT03052608|467657270|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
129916255|NCT03052608|467657269|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
129916256|NCT03052608|467657270|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
129916257|NCT03052608|467657269|FG000|Treatment Phase|Ongoing|103|||
129916258|NCT03052608|467657270|FG001|Treatment Phase|Ongoing|31|||
129916259|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Death|23|||
129916260|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Death|28|||
129916261|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
129916262|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
129916263|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
129916264|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
129916265|NCT03052608|467657269|FG000|Long-Term Follow-up Phase|Ongoing|122|||
129916266|NCT03052608|467657270|FG001|Long-Term Follow-up Phase|Ongoing|99|||
129916267|NCT03113500|467657271|FG000|Overall Study|Withdrawal by Subject|1|||
129916268|NCT05249439|467657273|FG000|Overall Study|Withdrawal by Subject|2|||
129916269|NCT05249439|467657274|FG001|Overall Study|Withdrawal by Subject|5|||
129916270|NCT05249439|467657273|FG000|Overall Study|Physician Decision|3|||
129916271|NCT05249439|467657274|FG001|Overall Study|Physician Decision|1|||
129867597|NCT04575051|467471535|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
129867598|NCT04575051|467471536|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
129867599|NCT04575051|467471537|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
129867600|NCT04575051|467471538|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
129867601|NCT04575051|467471539|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
129867602|NCT04575051|467471535|FG000|Time Period 4|Missing follow up|17|||
129867603|NCT04575051|467471536|FG001|Time Period 4|Missing follow up|3|||
129867604|NCT04575051|467471537|FG002|Time Period 4|Missing follow up|4|||
129867605|NCT04575051|467471538|FG003|Time Period 4|Missing follow up|2|||
129867606|NCT04575051|467471539|FG004|Time Period 4|Missing follow up|1|||
129867607|NCT04575051|467471535|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
129867608|NCT04575051|467471536|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
129867609|NCT04575051|467471537|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
129867610|NCT04575051|467471538|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
129867611|NCT04575051|467471539|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
129867612|NCT04575051|467471535|FG000|Time Period 5|Missing follow up|11|||
129867613|NCT04575051|467471536|FG001|Time Period 5|Missing follow up|8|||
129867614|NCT04575051|467471537|FG002|Time Period 5|Missing follow up|12|||
129867615|NCT04575051|467471538|FG003|Time Period 5|Missing follow up|3|||
129867616|NCT04575051|467471539|FG004|Time Period 5|Missing follow up|11|||
129867617|NCT03624504|467471540|FG000|Overall Study|Unsuccessful Implant|1|||
129867618|NCT02862457|467471541|FG000|Overall Study|Death|1|||
129867619|NCT02862457|467471542|FG001|Overall Study|Death|3|||
129867620|NCT02862457|467471543|FG002|Overall Study|Death|2|||
129867621|NCT02862457|467471544|FG003|Overall Study|Death|3|||
129867622|NCT02862457|467471545|FG004|Overall Study|Death|0|||
129867623|NCT02862457|467471546|FG005|Overall Study|Death|2|||
129867624|NCT02862457|467471547|FG006|Overall Study|Death|1|||
129867625|NCT02862457|467471541|FG000|Overall Study|Lost to Follow-up|1|||
129867626|NCT02862457|467471542|FG001|Overall Study|Lost to Follow-up|0|||
129867627|NCT02862457|467471543|FG002|Overall Study|Lost to Follow-up|0|||
129867628|NCT02862457|467471544|FG003|Overall Study|Lost to Follow-up|1|||
129867629|NCT02862457|467471545|FG004|Overall Study|Lost to Follow-up|0|||
129867630|NCT02862457|467471546|FG005|Overall Study|Lost to Follow-up|0|||
129867631|NCT02862457|467471547|FG006|Overall Study|Lost to Follow-up|0|||
129867632|NCT02862457|467471541|FG000|Overall Study|Withdrawal by Subject|0|||
129867633|NCT02862457|467471542|FG001|Overall Study|Withdrawal by Subject|0|||
129867634|NCT02862457|467471543|FG002|Overall Study|Withdrawal by Subject|1|||
129867635|NCT02862457|467471544|FG003|Overall Study|Withdrawal by Subject|0|||
129867636|NCT02862457|467471545|FG004|Overall Study|Withdrawal by Subject|0|||
129867637|NCT02862457|467471546|FG005|Overall Study|Withdrawal by Subject|1|||
129867638|NCT02862457|467471547|FG006|Overall Study|Withdrawal by Subject|0|||
129867639|NCT00951483|467471550|FG000|Overall Study|Physician Decision|4|||
129867640|NCT00951483|467471551|FG001|Overall Study|Physician Decision|0|||
129867641|NCT00951483|467471550|FG000|Overall Study|Withdrawal by Subject|15|||
129867642|NCT00951483|467471551|FG001|Overall Study|Withdrawal by Subject|0|||
129867643|NCT03364751|467471554|FG000|Overall Study|Withdrawal by Subject|1|||
129867644|NCT03364751|467471555|FG001|Overall Study|Withdrawal by Subject|0|||
129867645|NCT03364751|467471556|FG002|Overall Study|Withdrawal by Subject|0|||
129867646|NCT03364751|467471557|FG003|Overall Study|Withdrawal by Subject|0|||
129867647|NCT03364751|467471554|FG000|Overall Study|Lost to Follow-up|0|||
129867648|NCT03364751|467471555|FG001|Overall Study|Lost to Follow-up|1|||
129867649|NCT03364751|467471556|FG002|Overall Study|Lost to Follow-up|0|||
129867650|NCT03364751|467471557|FG003|Overall Study|Lost to Follow-up|0|||
129867651|NCT03583554|467471558|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
129867652|NCT03583554|467471559|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
129867653|NCT03583554|467471560|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
129867654|NCT03178266|467471561|FG000|Overall Study|Death|0|||
129867655|NCT03178266|467471562|FG001|Overall Study|Death|1|||
129867656|NCT03178266|467471561|FG000|Overall Study|Disont. Early|0|||
129867657|NCT03178266|467471562|FG001|Overall Study|Disont. Early|1|||
129867658|NCT03178266|467471561|FG000|Overall Study|Withdrawal by Subject|0|||
129867659|NCT03178266|467471562|FG001|Overall Study|Withdrawal by Subject|2|||
129867660|NCT02342886|467471563|FG000|Overall Study|Treatment non-compliance|1|||
129867661|NCT02342886|467471564|FG001|Overall Study|Treatment non-compliance|0|||
129867662|NCT02342886|467471565|FG002|Overall Study|Treatment non-compliance|0|||
129867663|NCT02342886|467471566|FG003|Overall Study|Treatment non-compliance|1|||
129867664|NCT02342886|467471567|FG004|Overall Study|Treatment non-compliance|0|||
129867665|NCT02342886|467471563|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
129867666|NCT02342886|467471564|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
129867667|NCT02342886|467471565|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
129867668|NCT02342886|467471566|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
129867669|NCT02342886|467471567|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
129867670|NCT02342886|467471563|FG000|Overall Study|Adverse event/specific toxicity|4|||
129916272|NCT03526861|467657279|FG000|Initial Treatment Period|Not dosed|1|||
129916273|NCT03526861|467657280|FG001|Initial Treatment Period|Not dosed|1|||
129916274|NCT03526861|467657281|FG002|Initial Treatment Period|Not dosed|1|||
129916275|NCT03526861|467657282|FG003|Initial Treatment Period|Not dosed|0|||
129916276|NCT03526861|467657283|FG004|Initial Treatment Period|Not dosed|0|||
129916277|NCT03526861|467657284|FG005|Initial Treatment Period|Not dosed|0|||
129916278|NCT03526861|467657285|FG006|Initial Treatment Period|Not dosed|0|||
129916279|NCT03526861|467657286|FG007|Initial Treatment Period|Not dosed|0|||
129916280|NCT03526861|467657287|FG008|Initial Treatment Period|Not dosed|0|||
129916281|NCT03526861|467657279|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
129916282|NCT03526861|467657280|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
129916283|NCT03526861|467657281|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
129916284|NCT03526861|467657282|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916285|NCT03526861|467657283|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916286|NCT03526861|467657284|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916287|NCT03526861|467657285|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916288|NCT03526861|467657286|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916289|NCT03526861|467657287|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916290|NCT03526861|467657279|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
129916291|NCT03526861|467657280|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
129449815|NCT01092143|465945685|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
129867671|NCT02342886|467471564|FG001|Overall Study|Adverse event/specific toxicity|3|||
129867672|NCT02342886|467471565|FG002|Overall Study|Adverse event/specific toxicity|11|||
129867673|NCT02342886|467471566|FG003|Overall Study|Adverse event/specific toxicity|2|||
129867674|NCT02342886|467471567|FG004|Overall Study|Adverse event/specific toxicity|1|||
129867675|NCT02342886|467471563|FG000|Overall Study|Lost to Follow-up|1|||
129867676|NCT02342886|467471564|FG001|Overall Study|Lost to Follow-up|0|||
129867677|NCT02342886|467471565|FG002|Overall Study|Lost to Follow-up|0|||
129867678|NCT02342886|467471566|FG003|Overall Study|Lost to Follow-up|0|||
129867679|NCT02342886|467471567|FG004|Overall Study|Lost to Follow-up|0|||
129867680|NCT02342886|467471563|FG000|Overall Study|Death|1|||
129867681|NCT02342886|467471564|FG001|Overall Study|Death|2|||
129867682|NCT02342886|467471565|FG002|Overall Study|Death|1|||
129867683|NCT02342886|467471566|FG003|Overall Study|Death|0|||
129867684|NCT02342886|467471567|FG004|Overall Study|Death|1|||
129867685|NCT02342886|467471563|FG000|Overall Study|Withdrawal by Subject|0|||
129867686|NCT02342886|467471564|FG001|Overall Study|Withdrawal by Subject|1|||
129867687|NCT02342886|467471565|FG002|Overall Study|Withdrawal by Subject|0|||
129867688|NCT02342886|467471566|FG003|Overall Study|Withdrawal by Subject|1|||
129867689|NCT02342886|467471567|FG004|Overall Study|Withdrawal by Subject|0|||
129867690|NCT02342886|467471563|FG000|Overall Study|Investigator/sponsor decision|0|||
129867691|NCT02342886|467471564|FG001|Overall Study|Investigator/sponsor decision|2|||
129867692|NCT02342886|467471565|FG002|Overall Study|Investigator/sponsor decision|0|||
129867693|NCT02342886|467471566|FG003|Overall Study|Investigator/sponsor decision|3|||
129867694|NCT02342886|467471567|FG004|Overall Study|Investigator/sponsor decision|1|||
129867695|NCT02342886|467471563|FG000|Overall Study|Pregnancy|0|||
129867696|NCT02342886|467471564|FG001|Overall Study|Pregnancy|0|||
129867697|NCT02342886|467471565|FG002|Overall Study|Pregnancy|2|||
129867698|NCT02342886|467471566|FG003|Overall Study|Pregnancy|0|||
129867699|NCT02342886|467471567|FG004|Overall Study|Pregnancy|0|||
129867700|NCT02342886|467471563|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867701|NCT02342886|467471564|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867702|NCT02342886|467471565|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
129867703|NCT02342886|467471566|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867704|NCT02342886|467471567|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
129867705|NCT02342886|467471563|FG000|Overall Study|Protocol Violation|0|||
129867706|NCT02342886|467471564|FG001|Overall Study|Protocol Violation|0|||
129867707|NCT02342886|467471565|FG002|Overall Study|Protocol Violation|0|||
129867708|NCT02342886|467471566|FG003|Overall Study|Protocol Violation|2|||
129867709|NCT02342886|467471567|FG004|Overall Study|Protocol Violation|0|||
129867710|NCT01328080|467471568|FG000|Overall Study|Lost to Follow-up|5|||
129867711|NCT00862134|467471569|FG000|Overall Study|Death|1|||
129867712|NCT00862134|467471570|FG001|Overall Study|Death|0|||
129867713|NCT00862134|467471569|FG000|Overall Study|Physician Decision|0|||
129867714|NCT00862134|467471570|FG001|Overall Study|Physician Decision|1|||
129916292|NCT03526861|467657281|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
129916293|NCT03526861|467657282|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916294|NCT03526861|467657283|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916295|NCT03526861|467657284|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129867715|NCT00862134|467471569|FG000|Overall Study|Withdrawal by Subject|1|||
129867716|NCT00862134|467471570|FG001|Overall Study|Withdrawal by Subject|2|||
129867717|NCT00862134|467471569|FG000|Overall Study|Sponsor terminated study|5|||
129867718|NCT00862134|467471570|FG001|Overall Study|Sponsor terminated study|7|||
129867719|NCT00862134|467471569|FG000|Overall Study|Adverse Event|2|||
129867720|NCT00862134|467471570|FG001|Overall Study|Adverse Event|2|||
129867721|NCT00862134|467471569|FG000|Overall Study|Withdrew prior to dosing|2|||
129867722|NCT00862134|467471570|FG001|Overall Study|Withdrew prior to dosing|0|||
129867723|NCT02191267|467471571|FG000|Overall Study|Withdrawal by Subject|1|||
129867724|NCT02191267|467471572|FG001|Overall Study|Withdrawal by Subject|0|||
129867725|NCT02191267|467471573|FG002|Overall Study|Withdrawal by Subject|0|||
129867726|NCT00765674|467471574|FG000|Overall Study|Adverse Event|7|||
129867727|NCT00765674|467471575|FG001|Overall Study|Adverse Event|2|||
129867728|NCT00765674|467471576|FG002|Overall Study|Adverse Event|8|||
129867729|NCT00765674|467471577|FG003|Overall Study|Adverse Event|11|||
129867730|NCT00765674|467471574|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
129867731|NCT00765674|467471575|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
129867732|NCT00765674|467471576|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
129867733|NCT00765674|467471577|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
129867734|NCT00765674|467471574|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
129867735|NCT00765674|467471575|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
129867736|NCT00765674|467471576|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
129867737|NCT00765674|467471577|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
129867738|NCT00765674|467471574|FG000|Overall Study|Lack of Efficacy|2|||
129867739|NCT00765674|467471575|FG001|Overall Study|Lack of Efficacy|3|||
129867740|NCT00765674|467471576|FG002|Overall Study|Lack of Efficacy|1|||
129867741|NCT00765674|467471577|FG003|Overall Study|Lack of Efficacy|2|||
129867742|NCT00765674|467471574|FG000|Overall Study|Protocol Violation|2|||
129867743|NCT00765674|467471575|FG001|Overall Study|Protocol Violation|0|||
129867744|NCT00765674|467471576|FG002|Overall Study|Protocol Violation|1|||
129867745|NCT00765674|467471577|FG003|Overall Study|Protocol Violation|0|||
129867746|NCT00765674|467471574|FG000|Overall Study|Withdrawal by Subject|5|||
129867747|NCT00765674|467471575|FG001|Overall Study|Withdrawal by Subject|7|||
129867748|NCT00765674|467471576|FG002|Overall Study|Withdrawal by Subject|3|||
129867749|NCT00765674|467471577|FG003|Overall Study|Withdrawal by Subject|8|||
129867750|NCT00765674|467471574|FG000|Overall Study|Lost to Follow-up|4|||
129867751|NCT00765674|467471575|FG001|Overall Study|Lost to Follow-up|6|||
129867752|NCT00765674|467471576|FG002|Overall Study|Lost to Follow-up|2|||
129867753|NCT00765674|467471577|FG003|Overall Study|Lost to Follow-up|1|||
129867754|NCT00765674|467471574|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
129867755|NCT00765674|467471575|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
129867756|NCT00765674|467471576|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
129867757|NCT00765674|467471577|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
129867758|NCT01813474|467471578|FG000|Overall Study|Withdrawal by Subject|0|||
129867759|NCT01813474|467471579|FG001|Overall Study|Withdrawal by Subject|0|||
129867760|NCT01813474|467471580|FG002|Overall Study|Withdrawal by Subject|1|||
129867761|NCT01813474|467471578|FG000|Overall Study|Adverse Event|1|||
129867762|NCT01813474|467471579|FG001|Overall Study|Adverse Event|1|||
129867763|NCT01813474|467471580|FG002|Overall Study|Adverse Event|0|||
129867764|NCT01813474|467471578|FG000|Overall Study|Lack of Efficacy|2|||
129867765|NCT01813474|467471579|FG001|Overall Study|Lack of Efficacy|6|||
129867766|NCT01813474|467471580|FG002|Overall Study|Lack of Efficacy|9|||
129867767|NCT01813474|467471578|FG000|Overall Study|Death|0|||
129867768|NCT01813474|467471579|FG001|Overall Study|Death|0|||
129867769|NCT01813474|467471580|FG002|Overall Study|Death|1|||
129867770|NCT00316082|467471581|FG000|Overall Study|Lack of Efficacy|2|||
129867771|NCT00316082|467471582|FG001|Overall Study|Lack of Efficacy|3|||
129867772|NCT00316082|467471583|FG002|Overall Study|Lack of Efficacy|3|||
129867773|NCT00316082|467471584|FG003|Overall Study|Lack of Efficacy|4|||
129867774|NCT00316082|467471585|FG004|Overall Study|Lack of Efficacy|6|||
129867775|NCT00316082|467471581|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
129867776|NCT00316082|467471582|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
129867777|NCT00316082|467471583|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
129867778|NCT00316082|467471584|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
129867779|NCT00316082|467471585|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
129867780|NCT00316082|467471581|FG000|Overall Study|Lost to Follow-up|7|||
129867781|NCT00316082|467471582|FG001|Overall Study|Lost to Follow-up|6|||
129867782|NCT00316082|467471583|FG002|Overall Study|Lost to Follow-up|7|||
129867783|NCT00316082|467471584|FG003|Overall Study|Lost to Follow-up|8|||
129867784|NCT00316082|467471585|FG004|Overall Study|Lost to Follow-up|6|||
129867785|NCT00316082|467471581|FG000|Overall Study|Poor/noncompliance|6|||
129867786|NCT00316082|467471582|FG001|Overall Study|Poor/noncompliance|1|||
129867787|NCT00316082|467471583|FG002|Overall Study|Poor/noncompliance|4|||
129867788|NCT00316082|467471584|FG003|Overall Study|Poor/noncompliance|1|||
129867789|NCT00316082|467471585|FG004|Overall Study|Poor/noncompliance|4|||
129867790|NCT00316082|467471581|FG000|Overall Study|Adverse Event|4|||
129867791|NCT00316082|467471582|FG001|Overall Study|Adverse Event|2|||
129916296|NCT03526861|467657285|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916297|NCT03526861|467657286|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916298|NCT03526861|467657287|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
129916299|NCT03526861|467657279|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916300|NCT03526861|467657280|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916301|NCT03526861|467657281|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916302|NCT03526861|467657282|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
129916303|NCT03526861|467657283|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
129916304|NCT03526861|467657284|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916305|NCT03526861|467657285|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
129916306|NCT03526861|467657286|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916307|NCT03526861|467657287|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916308|NCT03526861|467657279|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916309|NCT03526861|467657280|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916310|NCT03526861|467657281|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916311|NCT03526861|467657282|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
129916312|NCT03526861|467657283|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
129916313|NCT03526861|467657284|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
129916314|NCT03526861|467657285|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
129916315|NCT03526861|467657286|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
129916316|NCT03526861|467657287|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
129916317|NCT03526861|467657279|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916318|NCT03526861|467657280|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916319|NCT03526861|467657281|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916320|NCT03526861|467657282|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
129916321|NCT03526861|467657283|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916322|NCT03526861|467657284|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916323|NCT03526861|467657285|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916324|NCT03526861|467657286|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916325|NCT03526861|467657287|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916326|NCT03526861|467657279|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916327|NCT03526861|467657280|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916328|NCT03526861|467657281|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916329|NCT03526861|467657282|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916330|NCT03526861|467657283|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916331|NCT03526861|467657284|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916332|NCT03526861|467657285|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916333|NCT03526861|467657286|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
129916334|NCT03526861|467657287|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
129916335|NCT03526861|467657279|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916336|NCT03526861|467657280|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916337|NCT03526861|467657281|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916338|NCT03526861|467657282|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916339|NCT03526861|467657283|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916340|NCT03526861|467657284|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916341|NCT03526861|467657285|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916342|NCT03526861|467657286|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
129916343|NCT03526861|467657287|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
129916344|NCT03526861|467657279|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916345|NCT03526861|467657280|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129867792|NCT00316082|467471583|FG002|Overall Study|Adverse Event|5|||
129867793|NCT00316082|467471584|FG003|Overall Study|Adverse Event|1|||
129867794|NCT00316082|467471585|FG004|Overall Study|Adverse Event|3|||
129867795|NCT00316082|467471581|FG000|Overall Study|Subject no longer meets study criteria|3|||
129867796|NCT00316082|467471582|FG001|Overall Study|Subject no longer meets study criteria|1|||
129867797|NCT00316082|467471583|FG002|Overall Study|Subject no longer meets study criteria|2|||
129867798|NCT00316082|467471584|FG003|Overall Study|Subject no longer meets study criteria|2|||
129867799|NCT00316082|467471585|FG004|Overall Study|Subject no longer meets study criteria|1|||
129867800|NCT00316082|467471581|FG000|Overall Study|Physician Decision|1|||
129867801|NCT00316082|467471582|FG001|Overall Study|Physician Decision|1|||
129867802|NCT00316082|467471583|FG002|Overall Study|Physician Decision|2|||
129867803|NCT00316082|467471584|FG003|Overall Study|Physician Decision|1|||
129867804|NCT00316082|467471585|FG004|Overall Study|Physician Decision|1|||
129867805|NCT00316082|467471581|FG000|Overall Study|Death|0|||
129867806|NCT00316082|467471582|FG001|Overall Study|Death|0|||
129867807|NCT00316082|467471583|FG002|Overall Study|Death|1|||
129916346|NCT03526861|467657281|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916347|NCT03526861|467657282|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916348|NCT03526861|467657283|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916349|NCT03526861|467657284|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916350|NCT03526861|467657285|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916351|NCT03526861|467657286|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
129916352|NCT03526861|467657287|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
129916353|NCT03527160|467657289|FG000|Overall Study|No urine collected|13|||
129916354|NCT03527160|467657289|FG000|Overall Study|No clinical serum creatinine collected|6|||
129916355|NCT03527160|467657289|FG000|Overall Study|Did not meet inclusion|2|||
129916356|NCT03767517|467657290|FG000|Overall Study|Lost to Follow-up|16|||
129916357|NCT03767517|467657291|FG001|Overall Study|Lost to Follow-up|10|||
129916358|NCT03767517|467657290|FG000|Overall Study|Death|2|||
129916359|NCT03767517|467657291|FG001|Overall Study|Death|3|||
129916360|NCT03775109|467658485|FG000|Overall Study|Adverse Event|1|||
129916361|NCT03775109|467658486|FG001|Overall Study|Adverse Event|0|||
129916362|NCT03775109|467658485|FG000|Overall Study|COVID-19 outbreak|2|||
129916363|NCT03775109|467658486|FG001|Overall Study|COVID-19 outbreak|0|||
129916364|NCT03775109|467658485|FG000|Overall Study|Lost to Follow-up|0|||
129916365|NCT03775109|467658486|FG001|Overall Study|Lost to Follow-up|2|||
129916366|NCT03775109|467658485|FG000|Overall Study|Withdrawal by Subject|1|||
129867808|NCT00316082|467471584|FG003|Overall Study|Death|0|||
129867809|NCT00316082|467471585|FG004|Overall Study|Death|0|||
129916367|NCT03775109|467658486|FG001|Overall Study|Withdrawal by Subject|1|||
129916368|NCT03775109|467658485|FG000|Overall Study|Death|0|||
129916369|NCT03775109|467658486|FG001|Overall Study|Death|1|||
129916370|NCT03775109|467658485|FG000|Overall Study|Lack of Efficacy|1|||
129916371|NCT03775109|467658486|FG001|Overall Study|Lack of Efficacy|0|||
129449816|NCT01092143|465945686|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
129867810|NCT00316082|467471581|FG000|Overall Study|Administrative reason by sponsor|0|||
129867811|NCT00316082|467471582|FG001|Overall Study|Administrative reason by sponsor|0|||
129867812|NCT00316082|467471583|FG002|Overall Study|Administrative reason by sponsor|1|||
129867813|NCT00316082|467471584|FG003|Overall Study|Administrative reason by sponsor|0|||
129916372|NCT03347383|467658487|FG000|Overall Study|Death|39|||
129916373|NCT03347383|467658487|FG000|Overall Study|Withdrawal by Subject|3|||
129916374|NCT03347383|467658487|FG000|Overall Study|Lost to Follow-up|9|||
129867814|NCT00316082|467471585|FG004|Overall Study|Administrative reason by sponsor|0|||
129867815|NCT00528775|467471590|FG000|Overall Study|Other not specified|1|||
129867816|NCT00829387|467471593|FG000|Overall Study|Withdrawal by Subject|2|||
129867817|NCT00829387|467471594|FG001|Overall Study|Withdrawal by Subject|3|||
129867818|NCT00829387|467471593|FG000|Overall Study|Disqualified by PI|1|||
129867819|NCT00829387|467471594|FG001|Overall Study|Disqualified by PI|0|||
129867820|NCT03519854|467471597|FG000|Overall Study|Technical Error|0|||
129867821|NCT03519854|467471598|FG001|Overall Study|Technical Error|0|||
129867822|NCT03519854|467471599|FG002|Overall Study|Technical Error|1|||
129867823|NCT03519854|467471600|FG003|Overall Study|Technical Error|0|||
129867824|NCT03519854|467471601|FG004|Overall Study|Technical Error|0|||
129867825|NCT03519854|467471602|FG005|Overall Study|Technical Error|0|||
129867826|NCT03519854|467471603|FG006|Overall Study|Technical Error|0|||
129867827|NCT03519854|467471604|FG007|Overall Study|Technical Error|0|||
129867828|NCT03519854|467471605|FG008|Overall Study|Technical Error|0|||
129867829|NCT03519854|467471606|FG009|Overall Study|Technical Error|0|||
129867830|NCT03519854|467471607|FG010|Overall Study|Technical Error|0|||
129867831|NCT03519854|467471608|FG011|Overall Study|Technical Error|0|||
129867832|NCT03519854|467471609|FG012|Overall Study|Technical Error|0|||
129867833|NCT03519854|467471610|FG013|Overall Study|Technical Error|0|||
129867834|NCT03519854|467471611|FG014|Overall Study|Technical Error|0|||
129867835|NCT03519854|467471612|FG015|Overall Study|Technical Error|0|||
129867836|NCT03519854|467471613|FG016|Overall Study|Technical Error|0|||
129867837|NCT03519854|467471614|FG017|Overall Study|Technical Error|0|||
129867838|NCT02747238|467471615|FG000|Overall Study|Lack of Efficacy|0|||
129867839|NCT02747238|467471616|FG001|Overall Study|Lack of Efficacy|1|||
129867840|NCT02747238|467471615|FG000|Overall Study|Data lost|3|||
129867841|NCT02747238|467471616|FG001|Overall Study|Data lost|5|||
129867842|NCT00951275|467471617|FG000|Overall Study|Administrative Reason|1|||
129867843|NCT00951275|467471617|FG000|Overall Study|Adverse Event|7|||
129867844|NCT00951275|467471617|FG000|Overall Study|Withdrawal by Subject|4|||
129867845|NCT00951275|467471617|FG000|Overall Study|Protocol Violation|1|||
129867846|NCT01112579|467471621|FG000|Overall Study|Missed Visit|1|||
129867847|NCT01112579|467471622|FG001|Overall Study|Missed Visit|1|||
129867848|NCT01112579|467471621|FG000|Overall Study|Death|0|||
129867849|NCT01112579|467471622|FG001|Overall Study|Death|2|||
129867850|NCT00818753|467471623|FG000|Overall Study|Protocol Violation|1|||
129867851|NCT00818753|467471624|FG001|Overall Study|Protocol Violation|0|||
129867852|NCT00818753|467471625|FG002|Overall Study|Protocol Violation|0|||
129867853|NCT00818753|467471623|FG000|Overall Study|Other reason (not specified)|0|||
129867854|NCT00818753|467471624|FG001|Overall Study|Other reason (not specified)|0|||
129449817|NCT01092143|465945687|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
129867855|NCT00818753|467471625|FG002|Overall Study|Other reason (not specified)|1|||
129867856|NCT00818753|467471623|FG000|Overall Study|Randomised and not treated|2|||
129867857|NCT00818753|467471624|FG001|Overall Study|Randomised and not treated|0|||
129867858|NCT00818753|467471625|FG002|Overall Study|Randomised and not treated|0|||
129867859|NCT04154787|467471626|FG000|Overall Study|Adverse Event|0|||
129867860|NCT04154787|467471627|FG001|Overall Study|Adverse Event|1|||
129867861|NCT04154787|467471628|FG002|Overall Study|Adverse Event|0|||
129867862|NCT04154787|467471626|FG000|Overall Study|Patient Requires Other Treatment|0|||
129867863|NCT04154787|467471627|FG001|Overall Study|Patient Requires Other Treatment|1|||
129867864|NCT04154787|467471628|FG002|Overall Study|Patient Requires Other Treatment|0|||
129867865|NCT04154787|467471626|FG000|Overall Study|Study Terminated By Sponsor|0|||
129867866|NCT04154787|467471627|FG001|Overall Study|Study Terminated By Sponsor|6|||
129867867|NCT04154787|467471628|FG002|Overall Study|Study Terminated By Sponsor|1|||
129867868|NCT04154787|467471626|FG000|Overall Study|Subject Decision|0|||
129867869|NCT04154787|467471627|FG001|Overall Study|Subject Decision|1|||
129867870|NCT04154787|467471628|FG002|Overall Study|Subject Decision|0|||
129867871|NCT04154787|467471626|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
129867872|NCT04154787|467471627|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
129867873|NCT04154787|467471628|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
129867874|NCT03703466|467471629|FG000|Overall Study|Death|2|||
129867875|NCT03703466|467471630|FG001|Overall Study|Death|1|||
129867876|NCT03703466|467471631|FG002|Overall Study|Death|0|||
129867877|NCT03703466|467471629|FG000|Overall Study|Withdrawal by Subject|0|||
129867878|NCT03703466|467471630|FG001|Overall Study|Withdrawal by Subject|3|||
129867879|NCT03703466|467471631|FG002|Overall Study|Withdrawal by Subject|0|||
129867880|NCT03703466|467471629|FG000|Overall Study|Completed < 3 Cycles|2|||
129867881|NCT03703466|467471630|FG001|Overall Study|Completed < 3 Cycles|2|||
129867882|NCT03703466|467471631|FG002|Overall Study|Completed < 3 Cycles|2|||
129867883|NCT04508699|467471633|FG000|Overall Study|Lack of Efficacy|2|||
129867884|NCT04508699|467471634|FG001|Overall Study|Lack of Efficacy|15|||
129867885|NCT04508699|467471633|FG000|Overall Study|Withdrawal by Subject|0|||
129867886|NCT04508699|467471634|FG001|Overall Study|Withdrawal by Subject|2|||
129867887|NCT03355326|467471635|FG000|Overall Study|Protocol Violation|3|||
129867888|NCT03355326|467471636|FG001|Overall Study|Protocol Violation|3|||
129867889|NCT00608582|467471639|FG000|Overall Study|Lost to Follow-up|2|||
129867890|NCT00608582|467471640|FG001|Overall Study|Lost to Follow-up|0|||
129867891|NCT00608582|467471639|FG000|Overall Study|No Best Response in Phase 1 located|1|||
129867892|NCT00608582|467471640|FG001|Overall Study|No Best Response in Phase 1 located|1|||
129867893|NCT00608582|467471639|FG000|Overall Study|Illicit Drug Use|1|||
129867894|NCT00608582|467471640|FG001|Overall Study|Illicit Drug Use|0|||
129867895|NCT00608582|467471639|FG000|Overall Study|Early stage Design Change|0|||
129867896|NCT00608582|467471640|FG001|Overall Study|Early stage Design Change|3|||
129867897|NCT04605978|467473309|FG000|Overall Study|Adverse Event|2|||
129867898|NCT04605978|467473310|FG001|Overall Study|Adverse Event|1|||
129867899|NCT04605978|467473309|FG000|Overall Study|Withdrawal nonmedical reason|1|||
129867900|NCT04605978|467473310|FG001|Overall Study|Withdrawal nonmedical reason|1|||
129867901|NCT05159622|467473311|FG000|Overall Study|Lost to Follow-up|4|||
129867902|NCT05159622|467473312|FG001|Overall Study|Lost to Follow-up|5|||
129867903|NCT03318523|467473313|FG000|PC Period: Up to Year 1|Adverse Event|1|||
129867904|NCT03318523|467473314|FG001|PC Period: Up to Year 1|Adverse Event|0|||
129867905|NCT03318523|467473315|FG002|PC Period: Up to Year 1|Adverse Event|2|||
129867906|NCT03318523|467473316|FG003|PC Period: Up to Year 1|Adverse Event|0|||
129867907|NCT03318523|467473317|FG004|PC Period: Up to Year 1|Adverse Event|0|||
129867908|NCT03318523|467473318|FG005|PC Period: Up to Year 1|Adverse Event|0|||
129867909|NCT03318523|467473319|FG006|PC Period: Up to Year 1|Adverse Event|0|||
129867910|NCT03318523|467473320|FG007|PC Period: Up to Year 1|Adverse Event|0|||
129867911|NCT03318523|467473321|FG008|PC Period: Up to Year 1|Adverse Event|0|||
129867912|NCT03318523|467473322|FG009|PC Period: Up to Year 1|Adverse Event|0|||
129867913|NCT03318523|467473313|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
129867914|NCT03318523|467473314|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
129867915|NCT03318523|467473315|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867916|NCT03318523|467473316|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
129867917|NCT03318523|467473317|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867918|NCT03318523|467473318|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867919|NCT03318523|467473319|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867920|NCT03318523|467473320|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867921|NCT03318523|467473321|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867922|NCT03318523|467473322|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
129867923|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867924|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867925|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867926|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867927|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
129867928|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867929|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867930|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
129867931|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
129867932|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
129867933|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129916375|NCT05691452|467658495|FG000|Overall Study|Withdrawal by Subject|1|||
129916376|NCT05691452|467658496|FG001|Overall Study|Withdrawal by Subject|1|||
129916377|NCT05691452|467658497|FG002|Overall Study|Withdrawal by Subject|0|||
129916378|NCT05691452|467658495|FG000|Overall Study|Physician Decision|1|||
129916379|NCT05691452|467658496|FG001|Overall Study|Physician Decision|0|||
129916380|NCT05691452|467658497|FG002|Overall Study|Physician Decision|0|||
129916381|NCT05691452|467658495|FG000|Overall Study|Lost to Follow-up|0|||
129916382|NCT05691452|467658496|FG001|Overall Study|Lost to Follow-up|0|||
129916383|NCT05691452|467658497|FG002|Overall Study|Lost to Follow-up|1|||
129916384|NCT05691452|467658495|FG000|Overall Study|Adverse Event|0|||
129916385|NCT05691452|467658496|FG001|Overall Study|Adverse Event|0|||
129916386|NCT05691452|467658497|FG002|Overall Study|Adverse Event|1|||
129916387|NCT01938547|467658500|FG000|Overall Study|Physician Decision|1|||
129916388|NCT05320432|467658503|FG000|Overall Study|Withdrawal by Subject|0|||
129916389|NCT05320432|467658504|FG001|Overall Study|Withdrawal by Subject|2|||
129916390|NCT04842643|467658505|FG000|Overall Study|Physician Decision|1|||
129916391|NCT04842643|467658505|FG000|Overall Study|Other|1|||
129867934|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867935|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867936|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867937|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
129867938|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867939|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
129867940|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
129867941|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
129867942|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
129867943|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867944|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867945|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867946|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867947|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867948|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
129867949|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867950|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867951|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867952|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
129867953|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867954|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867955|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867956|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867957|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867958|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867959|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867960|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867961|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
129867962|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
129867963|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867964|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867965|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867966|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
129867967|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
129867968|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
129867969|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
129867970|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
129867971|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
129867972|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
129867973|NCT03318523|467473313|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129916392|NCT03484702|467658506|FG000|Treatment Period|Death|3|||
129916393|NCT03484702|467658507|FG001|Treatment Period|Death|1|||
129916394|NCT03484702|467658508|FG002|Treatment Period|Death|0|||
129916395|NCT03484702|467658509|FG003|Treatment Period|Death|0|||
129916396|NCT03484702|467658510|FG004|Treatment Period|Death|0|||
129916397|NCT03484702|467658511|FG005|Treatment Period|Death|0|||
129916398|NCT03484702|467658506|FG000|Treatment Period|Adverse Event|1|||
129916399|NCT03484702|467658507|FG001|Treatment Period|Adverse Event|0|||
129916400|NCT03484702|467658508|FG002|Treatment Period|Adverse Event|0|||
129916401|NCT03484702|467658509|FG003|Treatment Period|Adverse Event|0|||
129916402|NCT03484702|467658510|FG004|Treatment Period|Adverse Event|0|||
129916403|NCT03484702|467658511|FG005|Treatment Period|Adverse Event|0|||
129916404|NCT03484702|467658506|FG000|Treatment Period|Participant Withdrew from Study|0|||
129916405|NCT03484702|467658507|FG001|Treatment Period|Participant Withdrew from Study|1|||
129916406|NCT03484702|467658508|FG002|Treatment Period|Participant Withdrew from Study|0|||
129916407|NCT03484702|467658509|FG003|Treatment Period|Participant Withdrew from Study|0|||
129916408|NCT03484702|467658510|FG004|Treatment Period|Participant Withdrew from Study|0|||
129916409|NCT03484702|467658511|FG005|Treatment Period|Participant Withdrew from Study|0|||
129916410|NCT03484702|467658506|FG000|Treatment Period|Physician Decision|0|||
129916411|NCT03484702|467658507|FG001|Treatment Period|Physician Decision|1|||
129916412|NCT03484702|467658508|FG002|Treatment Period|Physician Decision|0|||
129916413|NCT03484702|467658509|FG003|Treatment Period|Physician Decision|0|||
129916414|NCT03484702|467658510|FG004|Treatment Period|Physician Decision|0|||
129916415|NCT03484702|467658511|FG005|Treatment Period|Physician Decision|1|||
129916416|NCT00739648|467658520|FG000|Overall Study|Adverse Event|3|||
129916417|NCT00739648|467658521|FG001|Overall Study|Adverse Event|15|||
129916418|NCT00739648|467658520|FG000|Overall Study|Withdrawal by Subject|13|||
129916419|NCT00739648|467658521|FG001|Overall Study|Withdrawal by Subject|25|||
129916420|NCT00739648|467658520|FG000|Overall Study|Lost to Follow-up|4|||
129916421|NCT00739648|467658521|FG001|Overall Study|Lost to Follow-up|7|||
129916422|NCT00739648|467658520|FG000|Overall Study|Death|2|||
129916423|NCT00739648|467658521|FG001|Overall Study|Death|0|||
129916424|NCT00739648|467658520|FG000|Overall Study|Do not know|4|||
129916425|NCT00739648|467658521|FG001|Overall Study|Do not know|6|||
129916426|NCT05110495|467658522|FG000|Overall Study|Lost to Follow-up|1|||
129916427|NCT05110495|467658522|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
129916428|NCT04173663|467658523|FG000|Overall Study|Withdrawal by Subject|1|||
129916429|NCT04173663|467658524|FG001|Overall Study|Withdrawal by Subject|6|||
129916430|NCT04173663|467658523|FG000|Overall Study|Lost to Follow-up|17|||
129916431|NCT04173663|467658524|FG001|Overall Study|Lost to Follow-up|24|||
129916432|NCT01757665|467658526|FG000|Overall Study|Still on Study - Visit Completed|240|||
129916433|NCT01757665|467658527|FG001|Overall Study|Still on Study - Visit Completed|30|||
129916434|NCT01757665|467658526|FG000|Overall Study|Still on Study - Visit Pending|398|||
129916435|NCT01757665|467658527|FG001|Overall Study|Still on Study - Visit Pending|40|||
129916436|NCT01757665|467658526|FG000|Overall Study|Still on Study - Missed Visit|14|||
129916437|NCT01757665|467658527|FG001|Overall Study|Still on Study - Missed Visit|1|||
129916438|NCT01757665|467658526|FG000|Overall Study|Death|25|||
129916439|NCT01757665|467658527|FG001|Overall Study|Death|8|||
129916440|NCT01757665|467658526|FG000|Overall Study|Explant|1|||
129916441|NCT01757665|467658527|FG001|Overall Study|Explant|2|||
129916442|NCT01757665|467658526|FG000|Overall Study|Withdrawal by Subject|10|||
129916443|NCT01757665|467658527|FG001|Overall Study|Withdrawal by Subject|0|||
129916444|NCT01757665|467658526|FG000|Overall Study|Lost to Follow-up|1|||
129916445|NCT01757665|467658527|FG001|Overall Study|Lost to Follow-up|1|||
129916446|NCT01757665|467658526|FG000|Overall Study|Not Implanted with Device|5|||
129916447|NCT01757665|467658527|FG001|Overall Study|Not Implanted with Device|1|||
129916448|NCT05816551|467658530|FG000|Overall Study|Withdrawal by Subject|0|||
129916449|NCT05816551|467658531|FG001|Overall Study|Withdrawal by Subject|1|||
129916450|NCT05816551|467658530|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
129916451|NCT05816551|467658531|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
129916452|NCT02651324|467658540|FG000|Overall Study|drug not administered, due dispensing issue|1|||
129916453|NCT02651324|467658541|FG001|Overall Study|drug not administered, due dispensing issue|0|||
129916454|NCT05461131|467658542|FG000|Overall Study|Lost to Follow-up|0|||
129916455|NCT05461131|467658543|FG001|Overall Study|Lost to Follow-up|2|||
129916456|NCT03101904|467658545|FG000|Wash Out (10 Days)|Adverse Event|1|||
129916457|NCT03101904|467658546|FG001|Wash Out (10 Days)|Adverse Event|0|||
129916458|NCT03101904|467658545|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
129916459|NCT03101904|467658546|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
129916460|NCT04538417|467658547|FG000|Overall Study|Withdrawal by Subject|2|||
129916461|NCT03385629|467658549|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
129916462|NCT03385629|467658550|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
129916463|NCT03385629|467658549|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
129916464|NCT03385629|467658550|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
129916465|NCT03385629|467658549|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
129916466|NCT03385629|467658550|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
129916467|NCT05633407|467658554|FG000|Overall Study|Physician Decision|2|||
129916468|NCT05633407|467658555|FG001|Overall Study|Physician Decision|0|||
129916469|NCT05633407|467658554|FG000|Overall Study|Adverse Event|1|||
129916470|NCT05633407|467658555|FG001|Overall Study|Adverse Event|0|||
129916471|NCT05633407|467658554|FG000|Overall Study|Withdrawal by Subject|1|||
129916472|NCT05633407|467658555|FG001|Overall Study|Withdrawal by Subject|0|||
129867974|NCT03318523|467473314|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867975|NCT03318523|467473315|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867976|NCT03318523|467473316|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867977|NCT03318523|467473317|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
129867978|NCT03318523|467473318|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867979|NCT03318523|467473319|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867980|NCT03318523|467473320|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
129867981|NCT03318523|467473321|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
129867982|NCT03318523|467473322|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
129867983|NCT03581981|467473326|FG000|Overall Study|Withdrawal by Subject|12|||
129867984|NCT03581981|467473327|FG001|Overall Study|Withdrawal by Subject|13|||
129867985|NCT03581981|467473326|FG000|Overall Study|Physician Decision|1|||
129867986|NCT03581981|467473327|FG001|Overall Study|Physician Decision|2|||
129867987|NCT03581981|467473326|FG000|Overall Study|Lost to Follow-up|0|||
129867988|NCT03581981|467473327|FG001|Overall Study|Lost to Follow-up|4|||
129867989|NCT02080871|467473328|FG000|Overall Study|Death|1|||
129867990|NCT02080871|467473328|FG000|Overall Study|Lost to Follow-up|1|||
129867991|NCT00234052|467473329|FG000|Treatment|Withdrawal by Subject|3|||
129867992|NCT00234052|467473329|FG000|Treatment|Adverse Event|5|||
129867993|NCT00234052|467473329|FG000|Treatment|Death|2|||
129867994|NCT00234052|467473329|FG000|Treatment|Progressive Disease|11|||
129867995|NCT00234052|467473329|FG000|Follow-up for 5 Years|Death|41|||
129867996|NCT00234052|467473329|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
129867997|NCT00234052|467473329|FG000|Follow-up for 5 Years|Other|7|||
129867998|NCT01410474|467473330|FG000|Overall Study|Withdrawal by Subject|0|||
129867999|NCT01410474|467473331|FG001|Overall Study|Withdrawal by Subject|1|||
129868000|NCT00828984|467473333|FG000|Overall Study|Adverse Event|2|||
129868001|NCT00828984|467473334|FG001|Overall Study|Adverse Event|3|||
129868002|NCT00828984|467473335|FG002|Overall Study|Adverse Event|0|||
129868003|NCT00828984|467473333|FG000|Overall Study|Lost to Follow-up|5|||
129868004|NCT00828984|467473334|FG001|Overall Study|Lost to Follow-up|3|||
129868005|NCT00828984|467473335|FG002|Overall Study|Lost to Follow-up|1|||
129868006|NCT00828984|467473333|FG000|Overall Study|Withdrawal by Subject|4|||
129868007|NCT00828984|467473334|FG001|Overall Study|Withdrawal by Subject|4|||
129868008|NCT00828984|467473335|FG002|Overall Study|Withdrawal by Subject|4|||
129868009|NCT00828984|467473333|FG000|Overall Study|Ineligable|1|||
129868010|NCT00828984|467473334|FG001|Overall Study|Ineligable|2|||
129868011|NCT00828984|467473335|FG002|Overall Study|Ineligable|0|||
129868012|NCT00828984|467473333|FG000|Overall Study|Medical Contraindication|0|||
129868013|NCT00828984|467473334|FG001|Overall Study|Medical Contraindication|1|||
129868014|NCT00828984|467473335|FG002|Overall Study|Medical Contraindication|0|||
129868015|NCT00828984|467473333|FG000|Overall Study|Noncompliant|1|||
129868016|NCT00828984|467473334|FG001|Overall Study|Noncompliant|2|||
129868017|NCT00828984|467473335|FG002|Overall Study|Noncompliant|3|||
129868018|NCT00828984|467473333|FG000|Overall Study|ConMed|1|||
129868019|NCT00828984|467473334|FG001|Overall Study|ConMed|1|||
129868020|NCT00828984|467473335|FG002|Overall Study|ConMed|1|||
129868021|NCT01615328|467473339|FG000|Overall Study|Lost to Follow-up|3|||
129868022|NCT01615328|467473340|FG001|Overall Study|Lost to Follow-up|5|||
129868023|NCT00863655|467473341|FG000|Overall Study|Protocol Violation|4|||
129868024|NCT00863655|467473342|FG001|Overall Study|Protocol Violation|0|||
129868025|NCT00863655|467473341|FG000|Overall Study|Adverse Event|52|||
129868026|NCT00863655|467473342|FG001|Overall Study|Adverse Event|8|||
129868027|NCT00863655|467473341|FG000|Overall Study|Withdrawal by Subject|47|||
129868028|NCT00863655|467473342|FG001|Overall Study|Withdrawal by Subject|7|||
129868029|NCT00863655|467473341|FG000|Overall Study|Administrative problems|1|||
129868030|NCT00863655|467473342|FG001|Overall Study|Administrative problems|0|||
129868031|NCT00863655|467473341|FG000|Overall Study|Death|7|||
129868032|NCT00863655|467473342|FG001|Overall Study|Death|1|||
129868033|NCT00863655|467473341|FG000|Overall Study|New cancer therapy|5|||
129868034|NCT00863655|467473342|FG001|Overall Study|New cancer therapy|1|||
129868035|NCT00863655|467473341|FG000|Overall Study|Disease progression|364|||
129868036|NCT00863655|467473342|FG001|Overall Study|Disease progression|221|||
129868037|NCT00863655|467473341|FG000|Overall Study|Treatment completed as per protocol|5|||
129868038|NCT00863655|467473342|FG001|Overall Study|Treatment completed as per protocol|1|||
129868039|NCT02157779|467473345|FG000|Overall Study|Logistical|9|||
129868040|NCT02157779|467473346|FG001|Overall Study|Logistical|3|||
129868041|NCT02157779|467473345|FG000|Overall Study|Stopped attending, reason unknown|11|||
129868042|NCT02157779|467473346|FG001|Overall Study|Stopped attending, reason unknown|7|||
129868043|NCT02157779|467473345|FG000|Overall Study|No response to outreach after Baseline|1|||
129868044|NCT02157779|467473346|FG001|Overall Study|No response to outreach after Baseline|1|||
129868045|NCT02157779|467473345|FG000|Overall Study|Moved|1|||
129868046|NCT02157779|467473346|FG001|Overall Study|Moved|0|||
129916473|NCT05633407|467658554|FG000|Overall Study|Other|1|||
129916474|NCT05633407|467658555|FG001|Overall Study|Other|1|||
129868047|NCT02157779|467473345|FG000|Overall Study|Medical|1|||
129868048|NCT02157779|467473346|FG001|Overall Study|Medical|0|||
129868049|NCT02157779|467473345|FG000|Overall Study|Legal issue|1|||
129868050|NCT02157779|467473346|FG001|Overall Study|Legal issue|0|||
129868051|NCT02548455|467473347|FG000|Overall Study|Withdrawal by Subject|27|||
129868052|NCT02548455|467473347|FG000|Overall Study|Death|26|||
129868053|NCT02548455|467473347|FG000|Overall Study|Lost to Follow-up|14|||
129868054|NCT02548455|467473347|FG000|Overall Study|Visit not completed|173|||
129868055|NCT00002558|467473352|FG000|Overall Study|Withdrawal by Subject|0|||
129868056|NCT00002558|467473353|FG001|Overall Study|Withdrawal by Subject|1|||
129868057|NCT02261493|467473356|FG000|Overall Study|Noncompliance|0|||
129868058|NCT02261493|467473357|FG001|Overall Study|Noncompliance|0|||
129868059|NCT02261493|467473358|FG002|Overall Study|Noncompliance|2|||
129868060|NCT02261493|467473356|FG000|Overall Study|Physician Decision|0|||
129868061|NCT02261493|467473357|FG001|Overall Study|Physician Decision|1|||
129868062|NCT02261493|467473358|FG002|Overall Study|Physician Decision|0|||
129868063|NCT02261493|467473356|FG000|Overall Study|Undisclosed alcohol abuse|0|||
129868064|NCT02261493|467473357|FG001|Overall Study|Undisclosed alcohol abuse|1|||
129868065|NCT02261493|467473358|FG002|Overall Study|Undisclosed alcohol abuse|0|||
129868066|NCT02261493|467473356|FG000|Overall Study|Protocol Violation|1|||
129868067|NCT02261493|467473357|FG001|Overall Study|Protocol Violation|0|||
129868068|NCT02261493|467473358|FG002|Overall Study|Protocol Violation|0|||
129868069|NCT02261493|467473356|FG000|Overall Study|Personal Reasons|14|||
129868070|NCT02261493|467473357|FG001|Overall Study|Personal Reasons|14|||
129868071|NCT02261493|467473358|FG002|Overall Study|Personal Reasons|16|||
129868072|NCT02261493|467473356|FG000|Overall Study|Lost to Follow-up|14|||
129868073|NCT02261493|467473357|FG001|Overall Study|Lost to Follow-up|27|||
129868074|NCT02261493|467473358|FG002|Overall Study|Lost to Follow-up|8|||
129868075|NCT02261493|467473356|FG000|Overall Study|Pregnancy|1|||
129868076|NCT02261493|467473357|FG001|Overall Study|Pregnancy|2|||
129868077|NCT02261493|467473358|FG002|Overall Study|Pregnancy|0|||
129868078|NCT02261493|467473356|FG000|Overall Study|Lack of Efficacy|0|||
129868079|NCT02261493|467473357|FG001|Overall Study|Lack of Efficacy|1|||
129868080|NCT02261493|467473358|FG002|Overall Study|Lack of Efficacy|0|||
129868081|NCT02261493|467473356|FG000|Overall Study|Adverse Event|0|||
129868082|NCT02261493|467473357|FG001|Overall Study|Adverse Event|1|||
129868083|NCT02261493|467473358|FG002|Overall Study|Adverse Event|0|||
129868084|NCT02065336|467473359|FG000|Extension Phase|Study Terminated by Sponsor|0|||
129868085|NCT02065336|467473360|FG001|Extension Phase|Study Terminated by Sponsor|0|||
129868086|NCT02065336|467473361|FG002|Extension Phase|Study Terminated by Sponsor|0|||
129868087|NCT02065336|467473362|FG003|Extension Phase|Study Terminated by Sponsor|0|||
129868088|NCT02065336|467473363|FG004|Extension Phase|Study Terminated by Sponsor|0|||
129868089|NCT02065336|467473364|FG005|Extension Phase|Study Terminated by Sponsor|0|||
129868090|NCT02065336|467473365|FG006|Extension Phase|Study Terminated by Sponsor|0|||
129868091|NCT02065336|467473366|FG007|Extension Phase|Study Terminated by Sponsor|0|||
129868092|NCT02065336|467473367|FG008|Extension Phase|Study Terminated by Sponsor|2|||
129868093|NCT02065336|467473368|FG009|Extension Phase|Study Terminated by Sponsor|8|||
129868094|NCT00626028|467473369|FG000|Overall Study|Adverse Event|1|||
129868095|NCT00626028|467473370|FG001|Overall Study|Adverse Event|1|||
129868096|NCT00626028|467473369|FG000|Overall Study|Device Failure|0|||
129868097|NCT00626028|467473370|FG001|Overall Study|Device Failure|1|||
129868098|NCT00626028|467473369|FG000|Overall Study|Physician Decision|2|||
129868099|NCT00626028|467473370|FG001|Overall Study|Physician Decision|1|||
129868100|NCT00626028|467473369|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
129868101|NCT00626028|467473370|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
129868102|NCT00831779|467473372|FG000|Overall Study|Lost to Follow-up|1|||
129868103|NCT00831779|467473373|FG001|Overall Study|Lost to Follow-up|0|||
129868104|NCT00831779|467473372|FG000|Overall Study|No longer met criteria|0|||
129868105|NCT00831779|467473373|FG001|Overall Study|No longer met criteria|1|||
129868106|NCT02436330|467473374|FG000|Cohort 1|Lost to Follow-up|5|||
129868107|NCT02436330|467473375|FG001|Cohort 1|Lost to Follow-up|2|||
129868108|NCT02436330|467473374|FG000|Cohort 1|Withdrawal by Subject|0|||
129868109|NCT02436330|467473375|FG001|Cohort 1|Withdrawal by Subject|1|||
129868110|NCT02436330|467473374|FG000|Cohort 2|Lost to Follow-up|2|||
129868111|NCT02436330|467473375|FG001|Cohort 2|Lost to Follow-up|0|||
129868112|NCT02436330|467473374|FG000|Cohort 2|Withdrawal by Subject|2|||
129916475|NCT02814838|467658560|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
129868113|NCT02436330|467473375|FG001|Cohort 2|Withdrawal by Subject|3|||
129868114|NCT02436330|467473374|FG000|Cohort 3|Lost to Follow-up|1|||
129868115|NCT02436330|467473375|FG001|Cohort 3|Lost to Follow-up|0|||
129868116|NCT02436330|467473374|FG000|Cohort 3|Withdrawal by Subject|4|||
129868117|NCT02436330|467473375|FG001|Cohort 3|Withdrawal by Subject|0|||
129868118|NCT02436330|467473374|FG000|Cohort 4|Lost to Follow-up|1|||
129868119|NCT02436330|467473375|FG001|Cohort 4|Lost to Follow-up|0|||
129868120|NCT02436330|467473374|FG000|Cohort 4|Withdrawal by Subject|1|||
129868121|NCT02436330|467473375|FG001|Cohort 4|Withdrawal by Subject|0|||
129868122|NCT02436330|467473374|FG000|Cohort 5|Lost to Follow-up|3|||
129868123|NCT02436330|467473375|FG001|Cohort 5|Lost to Follow-up|2|||
129868124|NCT02436330|467473374|FG000|Cohort 5|Withdrawal by Subject|3|||
129868125|NCT02436330|467473375|FG001|Cohort 5|Withdrawal by Subject|2|||
129868126|NCT02436330|467473374|FG000|Cohort 6|Lost to Follow-up|2|||
129868127|NCT02436330|467473375|FG001|Cohort 6|Lost to Follow-up|0|||
129868128|NCT02436330|467473374|FG000|Cohort 6|Withdrawal by Subject|1|||
129868129|NCT02436330|467473375|FG001|Cohort 6|Withdrawal by Subject|1|||
129868130|NCT00162370|467473377|FG000|Efficacy Population|Lost to Follow-up|51|||
129868131|NCT04040751|467473378|FG000|Overall Study|Withdrawal by Subject|2|||
129868132|NCT04040751|467473379|FG001|Overall Study|Withdrawal by Subject|0|||
129868133|NCT04040751|467473380|FG002|Overall Study|Withdrawal by Subject|2|||
129868134|NCT04040751|467473381|FG003|Overall Study|Withdrawal by Subject|0|||
129868135|NCT00540124|467473383|FG000|Overall Study|Adverse Event|0|||
129868136|NCT00540124|467473384|FG001|Overall Study|Adverse Event|2|||
129868137|NCT00540124|467473385|FG002|Overall Study|Adverse Event|1|||
129868138|NCT00540124|467473383|FG000|Overall Study|Entry Criteria Not Met|2|||
129868139|NCT00540124|467473384|FG001|Overall Study|Entry Criteria Not Met|0|||
129868140|NCT00540124|467473385|FG002|Overall Study|Entry Criteria Not Met|0|||
129868141|NCT00540124|467473383|FG000|Overall Study|Lack of Efficacy|1|||
129868142|NCT00540124|467473384|FG001|Overall Study|Lack of Efficacy|0|||
129868143|NCT00540124|467473385|FG002|Overall Study|Lack of Efficacy|0|||
129868144|NCT00540124|467473383|FG000|Overall Study|Withdrawal by Subject|1|||
129868145|NCT00540124|467473384|FG001|Overall Study|Withdrawal by Subject|1|||
129868146|NCT00540124|467473385|FG002|Overall Study|Withdrawal by Subject|0|||
129868147|NCT00587964|467473387|FG000|Overall Study|Withdrawal by Subject|1|||
129868148|NCT00587964|467473387|FG000|Overall Study|Lost to Follow-up|1|||
129868149|NCT00587964|467473387|FG000|Overall Study|Patient found to be ineligible|1|||
129868150|NCT00587964|467473387|FG000|Overall Study|Patient did not receive intervention|5|||
129868151|NCT00587964|467473387|FG000|Overall Study|Progression of Disease|4|||
129868152|NCT01569438|467473392|FG000|Overall Study|Lack of Efficacy|1|||
129868153|NCT01569438|467473393|FG001|Overall Study|Lack of Efficacy|2|||
129868154|NCT01569438|467473392|FG000|Overall Study|Withdrawal by Subject|0|||
129868155|NCT01569438|467473393|FG001|Overall Study|Withdrawal by Subject|3|||
129868156|NCT01569438|467473392|FG000|Overall Study|Adverse Event|2|||
129868157|NCT01569438|467473393|FG001|Overall Study|Adverse Event|15|||
129868158|NCT01569438|467473392|FG000|Overall Study|Protocol Violation|2|||
129868159|NCT01569438|467473393|FG001|Overall Study|Protocol Violation|0|||
129868160|NCT01569438|467473392|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
129868161|NCT01569438|467473393|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
129868162|NCT01569438|467473392|FG000|Overall Study|Sponsor/Physician decision|1|||
129868163|NCT01569438|467473393|FG001|Overall Study|Sponsor/Physician decision|1|||
129868164|NCT01569438|467473392|FG000|Overall Study|Unable to adhere to study schedule|0|||
129868165|NCT01569438|467473393|FG001|Overall Study|Unable to adhere to study schedule|1|||
129868166|NCT01207102|467473394|FG000|Overall Study|Withdrawal by Subject|5|||
129868167|NCT01207102|467473394|FG000|Overall Study|Adverse Event|2|||
129916476|NCT02814838|467658561|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
129916477|NCT02814838|467658560|FG000|Overall Study|Consent withdrawal|1|||
129916478|NCT02814838|467658561|FG001|Overall Study|Consent withdrawal|1|||
129916479|NCT02910713|467658563|FG000|Overall Study|Protocol Violation|2|||
129916480|NCT02910713|467658563|FG000|Overall Study|Subject Choice|4|||
129916481|NCT02910713|467658563|FG000|Overall Study|Received One Application|10|||
129916482|NCT02910713|467658563|FG000|Overall Study|Received Neither Application|18|||
129916483|NCT02910713|467658563|FG000|Overall Study|Enrollment cap|7|||
129916484|NCT02910713|467658563|FG000|Overall Study|Investigator Discretion|1|||
129916485|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
129916486|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916487|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916488|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916489|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
129916490|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
129916491|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
129916492|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
129916493|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
129916494|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
129916495|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
129916496|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
129916497|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
129916498|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
129916499|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
129916500|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
129916501|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916502|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916503|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916504|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
129916505|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
129916506|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
129916507|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
129916508|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
129916509|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
129916510|NCT05338086|467659763|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
129916511|NCT05338086|467659764|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
129916512|NCT05338086|467659765|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
129916513|NCT05338086|467659766|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
129916514|NCT05338086|467659767|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
129916515|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Death|0|||
129916516|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Death|0|||
129916517|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Death|1|||
129916518|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Death|0|||
129916519|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Death|0|||
129916520|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
129916521|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
129916522|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
129916523|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
129916524|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
129916525|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916526|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916527|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
129916528|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916529|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
129916530|NCT05338086|467659763|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
129916531|NCT05338086|467659764|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
129916532|NCT05338086|467659765|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
129916533|NCT05338086|467659766|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
129916534|NCT05338086|467659767|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
129916535|NCT03940703|467659768|FG000|Overall Study|Still under treatment|31|||
129916536|NCT03940703|467659769|FG001|Overall Study|Still under treatment|0|||
129916537|NCT04521478|467659770|FG000|Overall Study|Protocol Violation|2|||
129916538|NCT04521478|467659771|FG001|Overall Study|Protocol Violation|0|||
129916539|NCT04521478|467659772|FG002|Overall Study|Protocol Violation|1|||
129916540|NCT04521478|467659773|FG003|Overall Study|Protocol Violation|0|||
129916541|NCT04521478|467659774|FG004|Overall Study|Protocol Violation|0|||
129868168|NCT01207102|467473394|FG000|Overall Study|progression|2|||
129868169|NCT01207102|467473394|FG000|Overall Study|Withdrawal by Treating Physician|1|||
129868170|NCT01777854|467473397|FG000|Overall Study|Physician Decision|3|||
129868171|NCT01777854|467473398|FG001|Overall Study|Physician Decision|3|||
129868172|NCT03649230|467473399|FG000|Overall Study|Adverse Event|12|||
129868173|NCT03649230|467473399|FG000|Overall Study|Death|8|||
129868174|NCT03649230|467473399|FG000|Overall Study|Withdrawal by Subject|6|||
129868175|NCT03649230|467473399|FG000|Overall Study|Physician Decision|5|||
129868176|NCT03649230|467473399|FG000|Overall Study|Disease progression|5|||
129868177|NCT03649230|467473399|FG000|Overall Study|Switched to non-HEC|5|||
129868178|NCT03649230|467473399|FG000|Overall Study|Chemotherapy discontinued|4|||
129868179|NCT03649230|467473399|FG000|Overall Study|Received only 3 HEC cycles|4|||
129868180|NCT03649230|467473399|FG000|Overall Study|Screen Failure|3|||
129868181|NCT03649230|467473399|FG000|Overall Study|Patient stopped treatment|2|||
129868182|NCT03649230|467473399|FG000|Overall Study|Protocol Violation|1|||
129868183|NCT03649230|467473399|FG000|Overall Study|Non-compliance|1|||
129868184|NCT03649230|467473399|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
129868185|NCT01693068|467473401|FG000|Randomization Period|On-study|2|||
129868186|NCT01693068|467473402|FG001|Randomization Period|On-study|5|||
129868187|NCT01693068|467473403|FG002|Randomization Period|On-study|0|||
129868188|NCT01693068|467473401|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
129868189|NCT01693068|467473402|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
129868190|NCT01693068|467473403|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
129868191|NCT01239030|467473413|FG000|Double Blind|Adverse Event|0|||
129868192|NCT01239030|467473414|FG001|Double Blind|Adverse Event|1|||
129868193|NCT01239030|467473415|FG002|Double Blind|Adverse Event|0|||
129868194|NCT01239030|467473416|FG003|Double Blind|Adverse Event|2|||
129868195|NCT01239030|467473417|FG004|Double Blind|Adverse Event|0|||
129868196|NCT01239030|467473413|FG000|Double Blind|Withdrawal by Subject|0|||
129868197|NCT01239030|467473414|FG001|Double Blind|Withdrawal by Subject|1|||
129868198|NCT01239030|467473415|FG002|Double Blind|Withdrawal by Subject|1|||
129868199|NCT01239030|467473416|FG003|Double Blind|Withdrawal by Subject|0|||
129868200|NCT01239030|467473417|FG004|Double Blind|Withdrawal by Subject|1|||
129868201|NCT01239030|467473413|FG000|Double Blind|Lost to Follow-up|1|||
129868202|NCT01239030|467473414|FG001|Double Blind|Lost to Follow-up|1|||
129868203|NCT01239030|467473415|FG002|Double Blind|Lost to Follow-up|0|||
129868204|NCT01239030|467473416|FG003|Double Blind|Lost to Follow-up|0|||
129868205|NCT01239030|467473417|FG004|Double Blind|Lost to Follow-up|0|||
129868206|NCT01239030|467473413|FG000|Double Blind|Physician Decision|0|||
129868207|NCT01239030|467473414|FG001|Double Blind|Physician Decision|1|||
129868208|NCT01239030|467473415|FG002|Double Blind|Physician Decision|0|||
129868209|NCT01239030|467473416|FG003|Double Blind|Physician Decision|0|||
129868210|NCT01239030|467473417|FG004|Double Blind|Physician Decision|0|||
129868211|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
129868212|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
129868213|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
129868214|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
129868215|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
129868216|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
129868217|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
129868218|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
129868219|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
129868220|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
129868221|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
129868222|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
129868223|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
129868224|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
129868225|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
129868226|NCT01239030|467473413|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
129868227|NCT01239030|467473414|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
129868228|NCT01239030|467473415|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
129868229|NCT01239030|467473416|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
129868230|NCT01239030|467473417|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
129868231|NCT02432105|467473422|FG000|Overall Study|Lost to Follow-up|1|||
129868232|NCT02432105|467473423|FG001|Overall Study|Lost to Follow-up|1|||
129868233|NCT02432105|467473424|FG002|Overall Study|Lost to Follow-up|0|||
129868234|NCT02432105|467473422|FG000|Overall Study|Withdrawal by Subject|1|||
129868235|NCT02432105|467473423|FG001|Overall Study|Withdrawal by Subject|0|||
129868236|NCT02432105|467473424|FG002|Overall Study|Withdrawal by Subject|1|||
129868237|NCT02432105|467473422|FG000|Overall Study|Culture positive for yeast|0|||
129868238|NCT02432105|467473423|FG001|Overall Study|Culture positive for yeast|1|||
129868239|NCT02432105|467473424|FG002|Overall Study|Culture positive for yeast|0|||
129868240|NCT02432105|467473422|FG000|Overall Study|Randomized in error|0|||
129868241|NCT02432105|467473423|FG001|Overall Study|Randomized in error|0|||
129868242|NCT02432105|467473424|FG002|Overall Study|Randomized in error|2|||
129868243|NCT01400503|467473425|FG000|Overall Study|Withdrawal by Subject|1|||
129868244|NCT01400503|467473425|FG000|Overall Study|Study Terminated by Sponsor|58|||
129868245|NCT01400503|467473425|FG000|Overall Study|Other|1|||
129868246|NCT00058123|467473426|FG000|Overall Study|Wrong histology|9|||
129868247|NCT00058123|467473426|FG000|Overall Study|Received >3 prior treatments|1|||
129868248|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
129868249|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
129868250|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
129868251|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868252|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868253|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868254|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868255|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868256|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129868257|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
129868258|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
129868259|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
129868260|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868261|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868262|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868263|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868264|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868265|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129868266|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
129868267|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
129868268|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
129868269|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868270|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868271|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868272|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868273|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868274|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129868275|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129868276|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868277|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
129868278|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868279|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868280|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868281|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868282|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868283|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129868284|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868285|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868286|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129868287|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129916542|NCT04521478|467659775|FG005|Overall Study|Protocol Violation|0|||
129916543|NCT04521478|467659770|FG000|Overall Study|Technical Problems|0|||
129916544|NCT04521478|467659771|FG001|Overall Study|Technical Problems|0|||
129916545|NCT04521478|467659772|FG002|Overall Study|Technical Problems|0|||
129916546|NCT04521478|467659773|FG003|Overall Study|Technical Problems|1|||
129916547|NCT04521478|467659774|FG004|Overall Study|Technical Problems|0|||
129916548|NCT04521478|467659775|FG005|Overall Study|Technical Problems|0|||
129916549|NCT04521478|467659770|FG000|Overall Study|Burden of Study Procedures|1|||
129916550|NCT04521478|467659771|FG001|Overall Study|Burden of Study Procedures|0|||
129868288|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868289|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868290|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129916551|NCT04521478|467659772|FG002|Overall Study|Burden of Study Procedures|0|||
129916552|NCT04521478|467659773|FG003|Overall Study|Burden of Study Procedures|1|||
129916553|NCT04521478|467659774|FG004|Overall Study|Burden of Study Procedures|0|||
129916554|NCT04521478|467659775|FG005|Overall Study|Burden of Study Procedures|1|||
129868291|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868292|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129868293|NCT01212770|467473427|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
129868294|NCT01212770|467473428|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
129868295|NCT01212770|467473429|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
129868296|NCT01212770|467473430|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868297|NCT01212770|467473431|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868298|NCT01212770|467473432|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868299|NCT01212770|467473433|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868300|NCT01212770|467473434|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868301|NCT01212770|467473435|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
129868302|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868303|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
129868304|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
129868305|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
129868306|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868307|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129916555|NCT04521478|467659770|FG000|Overall Study|Lack of Efficacy|0|||
129916556|NCT04521478|467659771|FG001|Overall Study|Lack of Efficacy|0|||
129916557|NCT04521478|467659772|FG002|Overall Study|Lack of Efficacy|0|||
129916558|NCT04521478|467659773|FG003|Overall Study|Lack of Efficacy|0|||
129916559|NCT04521478|467659774|FG004|Overall Study|Lack of Efficacy|1|||
129916560|NCT04521478|467659775|FG005|Overall Study|Lack of Efficacy|1|||
129916561|NCT04521478|467659770|FG000|Overall Study|Adverse Event|7|||
129916562|NCT04521478|467659771|FG001|Overall Study|Adverse Event|0|||
129916563|NCT04521478|467659772|FG002|Overall Study|Adverse Event|2|||
129916564|NCT04521478|467659773|FG003|Overall Study|Adverse Event|1|||
129916565|NCT04521478|467659774|FG004|Overall Study|Adverse Event|2|||
129916566|NCT04521478|467659775|FG005|Overall Study|Adverse Event|7|||
129916567|NCT04521478|467659770|FG000|Overall Study|No Reason Available|0|||
129916568|NCT04521478|467659771|FG001|Overall Study|No Reason Available|2|||
129916569|NCT04521478|467659772|FG002|Overall Study|No Reason Available|0|||
129916570|NCT04521478|467659773|FG003|Overall Study|No Reason Available|0|||
129916571|NCT04521478|467659774|FG004|Overall Study|No Reason Available|1|||
129916572|NCT04521478|467659775|FG005|Overall Study|No Reason Available|0|||
129916573|NCT04521478|467659770|FG000|Overall Study|Other than listed|3|||
129916574|NCT04521478|467659771|FG001|Overall Study|Other than listed|3|||
129916575|NCT04521478|467659772|FG002|Overall Study|Other than listed|3|||
129916576|NCT04521478|467659773|FG003|Overall Study|Other than listed|2|||
129916577|NCT04521478|467659774|FG004|Overall Study|Other than listed|3|||
129916578|NCT04521478|467659775|FG005|Overall Study|Other than listed|3|||
129916579|NCT04521478|467659770|FG000|Overall Study|Not treated|0|||
129916580|NCT04521478|467659771|FG001|Overall Study|Not treated|0|||
129916581|NCT04521478|467659772|FG002|Overall Study|Not treated|0|||
129916582|NCT04521478|467659773|FG003|Overall Study|Not treated|0|||
129916583|NCT04521478|467659774|FG004|Overall Study|Not treated|0|||
129916584|NCT04521478|467659775|FG005|Overall Study|Not treated|1|||
129916585|NCT04850807|467659780|FG000|Overall Study|Death|50|||
129916586|NCT04850807|467659781|FG001|Overall Study|Death|55|||
129916587|NCT04850807|467659780|FG000|Overall Study|Discharged|17|||
129916588|NCT04850807|467659781|FG001|Overall Study|Discharged|13|||
129916589|NCT04850807|467659780|FG000|Overall Study|Incomplete baseline data|3|||
129916590|NCT04850807|467659781|FG001|Overall Study|Incomplete baseline data|2|||
129916591|NCT02187003|467659782|FG000|Overall Study|Adverse Event|2|||
129916592|NCT02187003|467659783|FG001|Overall Study|Adverse Event|0|||
129916593|NCT02187003|467659782|FG000|Overall Study|Lost to Follow-up|14|||
129916594|NCT02187003|467659783|FG001|Overall Study|Lost to Follow-up|10|||
129916595|NCT02187003|467659782|FG000|Overall Study|Withdrawal by Subject|3|||
129868308|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
129868309|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868310|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
129868311|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868312|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
129868313|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
129868314|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
129868315|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
129868316|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
129868317|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868318|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868319|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
129868320|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
129868321|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
129868322|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
129868323|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
129868324|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
129868325|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
129868326|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
129868327|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
129916596|NCT02187003|467659783|FG001|Overall Study|Withdrawal by Subject|7|||
129916597|NCT02187003|467659782|FG000|Overall Study|Protocol Violation|2|||
129916598|NCT02187003|467659783|FG001|Overall Study|Protocol Violation|4|||
129916599|NCT02187003|467659782|FG000|Overall Study|Other|5|||
129916600|NCT02187003|467659783|FG001|Overall Study|Other|5|||
129916601|NCT02187003|467659782|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129916602|NCT02187003|467659783|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
129916603|NCT04593472|467659784|FG000|Overall Study|Death|31|||
129916604|NCT04593472|467659785|FG001|Overall Study|Death|27|||
129916605|NCT04593472|467659784|FG000|Overall Study|Withdrawal by Subject|12|||
129868328|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
129868329|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868330|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868331|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
129868332|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868333|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868334|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868335|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868336|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868337|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
129868338|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868339|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868340|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868341|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
129868342|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868343|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868344|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868345|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868346|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
129868347|NCT01212770|467473427|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868348|NCT01212770|467473428|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868349|NCT01212770|467473429|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
129868350|NCT01212770|467473430|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
129868351|NCT01212770|467473431|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868352|NCT01212770|467473432|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868353|NCT01212770|467473433|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868354|NCT01212770|467473434|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868355|NCT01212770|467473435|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
129868356|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868357|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
129868358|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
129868359|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868360|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868361|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868362|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868363|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129868364|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
129868365|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868366|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
129868367|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
129868368|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868369|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868370|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868371|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129868372|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
129868373|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
129868374|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868375|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
129868376|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868377|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868378|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868379|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868380|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868381|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868382|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
129868383|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868384|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
129868385|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
129868386|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868387|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868388|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868389|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129868390|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
129868391|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
129868392|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868393|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
129868394|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
129868395|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868396|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868397|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868398|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
129868399|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
129868400|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
129868401|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868402|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
129868403|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129868404|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868405|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868406|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868407|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868408|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129868409|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129868410|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868411|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129868412|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129868413|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868414|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868415|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868416|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129868417|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129868418|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
129868419|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868420|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
129868421|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
129868422|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868423|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868424|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868425|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129868426|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
129868427|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
129868428|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868429|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
129868430|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
129868431|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868432|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868433|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868434|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129868435|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129868436|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
129868437|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868438|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
129868439|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868440|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868441|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868442|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868443|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868444|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868445|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129868446|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868447|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868448|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868449|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868450|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868451|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868452|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868453|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
129868454|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
129868455|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868456|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
129868457|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129868458|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868459|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129916606|NCT04593472|467659785|FG001|Overall Study|Withdrawal by Subject|12|||
129916607|NCT04593472|467659784|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
129916608|NCT04593472|467659785|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
129916609|NCT04593472|467659784|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
129916610|NCT04593472|467659785|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
129916611|NCT04593472|467659784|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
129916612|NCT04593472|467659785|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
129916613|NCT04593472|467659784|FG000|Overall Study|Lost to Follow-up|0|||
129916614|NCT04593472|467659785|FG001|Overall Study|Lost to Follow-up|2|||
129916615|NCT04593472|467659784|FG000|Overall Study|Still collecting 24-month assessment|17|||
129916616|NCT04593472|467659785|FG001|Overall Study|Still collecting 24-month assessment|10|||
129916617|NCT03896516|467659786|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
129916618|NCT03896516|467659787|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
129916619|NCT03896516|467659786|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
129916620|NCT03896516|467659787|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
129916621|NCT03896516|467659786|FG000|Washout Period|Physician Decision|3|||
129916622|NCT03896516|467659787|FG001|Washout Period|Physician Decision|1|||
129916623|NCT03896516|467659786|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
129916624|NCT03896516|467659787|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
129916625|NCT04549168|467659790|FG000|Randomization Phase|Adverse Event|0|||
129916626|NCT04549168|467659791|FG001|Randomization Phase|Adverse Event|0|||
129916627|NCT04549168|467659792|FG002|Randomization Phase|Adverse Event|1|||
129916628|NCT04549168|467659790|FG000|Randomization Phase|Other|0|||
129916629|NCT04549168|467659791|FG001|Randomization Phase|Other|2|||
129916630|NCT04549168|467659792|FG002|Randomization Phase|Other|0|||
129916631|NCT04549168|467659790|FG000|Randomization Phase|Withdrawal by Subject|0|||
129916632|NCT04549168|467659791|FG001|Randomization Phase|Withdrawal by Subject|2|||
129916633|NCT04549168|467659792|FG002|Randomization Phase|Withdrawal by Subject|1|||
129916634|NCT02662062|467659796|FG000|Overall Study|Withdrawal by Subject|1|||
129916635|NCT06311084|467659797|FG000|Overall Study|Lost to Follow-up|14|||
129916636|NCT03988634|467659798|FG000|Double-Blind|Adverse Event|4|||
129916637|NCT03988634|467659799|FG001|Double-Blind|Adverse Event|0|||
129916638|NCT03988634|467659800|FG002|Double-Blind|Adverse Event|0|||
129916639|NCT03988634|467659798|FG000|Double-Blind|Death|18|||
129916640|NCT03988634|467659799|FG001|Double-Blind|Death|26|||
129916641|NCT03988634|467659800|FG002|Double-Blind|Death|0|||
129916642|NCT03988634|467659798|FG000|Double-Blind|Lost to Follow-up|6|||
129916643|NCT03988634|467659799|FG001|Double-Blind|Lost to Follow-up|7|||
129916644|NCT03988634|467659800|FG002|Double-Blind|Lost to Follow-up|0|||
129916645|NCT03988634|467659798|FG000|Double-Blind|Physician Decision|9|||
129916646|NCT03988634|467659799|FG001|Double-Blind|Physician Decision|5|||
129916647|NCT03988634|467659800|FG002|Double-Blind|Physician Decision|0|||
129916648|NCT03988634|467659798|FG000|Double-Blind|Subject decision|24|||
129916649|NCT03988634|467659799|FG001|Double-Blind|Subject decision|13|||
129916650|NCT03988634|467659800|FG002|Double-Blind|Subject decision|0|||
129868460|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868461|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129868462|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129868463|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129868464|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868465|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
129868466|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
129868467|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868468|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868469|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868470|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868471|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129868472|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
129868473|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868474|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
129868475|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
129916651|NCT03988634|467659798|FG000|Open-Label|Adverse Event|0|||
129916652|NCT03988634|467659799|FG001|Open-Label|Adverse Event|0|||
129916653|NCT03988634|467659800|FG002|Open-Label|Adverse Event|7|||
129916654|NCT03988634|467659798|FG000|Open-Label|Physician Decision|0|||
129868476|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129916655|NCT03988634|467659799|FG001|Open-Label|Physician Decision|0|||
129916656|NCT03988634|467659800|FG002|Open-Label|Physician Decision|1|||
129916657|NCT03988634|467659798|FG000|Open-Label|Technical problems|0|||
129916658|NCT03988634|467659799|FG001|Open-Label|Technical problems|0|||
129868477|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868478|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868479|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868480|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
129868481|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129868482|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868483|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
129868484|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
129868485|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868486|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868487|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868488|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868489|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
129868490|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
129868491|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868492|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
129868493|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
129868494|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868495|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868496|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868497|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868498|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868499|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129868500|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868501|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868502|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
129868503|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868504|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868505|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868506|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868507|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868508|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129868509|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868510|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
129868511|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868512|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868513|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868514|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868515|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868516|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129868517|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
129868518|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
129868519|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
129868520|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
129868521|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
129868522|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
129868523|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
129868524|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
129868525|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
129868526|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
129868527|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868528|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868529|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
129868530|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868531|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868532|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868533|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868534|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868535|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129868536|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868537|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868538|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
129868539|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868540|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868541|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868542|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868543|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129868544|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
129868545|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129916659|NCT03988634|467659800|FG002|Open-Label|Technical problems|1|||
129916660|NCT04725240|467659801|FG000|Overall Study|Adverse Event|2|||
129916661|NCT00676715|467659808|FG000|Treatment Period (TP)|Adverse Event|0|||
129916662|NCT00676715|467659809|FG001|Treatment Period (TP)|Adverse Event|3|||
129916663|NCT00676715|467659810|FG002|Treatment Period (TP)|Adverse Event|2|||
129916664|NCT00676715|467659811|FG003|Treatment Period (TP)|Adverse Event|2|||
129916665|NCT00676715|467659808|FG000|Treatment Period (TP)|Death|0|||
129916666|NCT00676715|467659809|FG001|Treatment Period (TP)|Death|0|||
129916667|NCT00676715|467659810|FG002|Treatment Period (TP)|Death|1|||
129916668|NCT00676715|467659811|FG003|Treatment Period (TP)|Death|0|||
129916669|NCT00676715|467659808|FG000|Treatment Period (TP)|Failure to return|1|||
129916670|NCT00676715|467659809|FG001|Treatment Period (TP)|Failure to return|0|||
129916671|NCT00676715|467659810|FG002|Treatment Period (TP)|Failure to return|0|||
129916672|NCT00676715|467659811|FG003|Treatment Period (TP)|Failure to return|0|||
129916673|NCT00676715|467659808|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
129916674|NCT00676715|467659809|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
129916675|NCT00676715|467659810|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
129916676|NCT00676715|467659811|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
129916677|NCT00676715|467659808|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
129916678|NCT00676715|467659809|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
129916679|NCT00676715|467659810|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
129916680|NCT00676715|467659811|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
129916681|NCT00676715|467659808|FG000|Treatment Period (TP)|Withdrew consent|3|||
129916682|NCT00676715|467659809|FG001|Treatment Period (TP)|Withdrew consent|3|||
129916683|NCT00676715|467659810|FG002|Treatment Period (TP)|Withdrew consent|3|||
129916684|NCT00676715|467659811|FG003|Treatment Period (TP)|Withdrew consent|3|||
129916685|NCT00676715|467659808|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
129916686|NCT00676715|467659809|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
129916687|NCT00676715|467659810|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
129916688|NCT00676715|467659811|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
129916689|NCT00676715|467659808|FG000|Treatment Period (TP)|Administrative|0|||
129916690|NCT00676715|467659809|FG001|Treatment Period (TP)|Administrative|0|||
129916691|NCT00676715|467659810|FG002|Treatment Period (TP)|Administrative|0|||
129916692|NCT00676715|467659811|FG003|Treatment Period (TP)|Administrative|1|||
129916693|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
129916694|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
129916695|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
129916696|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
129916697|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
129916698|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
129916699|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
129916700|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
129916701|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
129916702|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
129916703|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
129916704|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
129916705|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
129916706|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
129916707|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
129916708|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
129916709|NCT00676715|467659808|FG000|Treatment-free Period (TFP)|Death|1|||
129916710|NCT00676715|467659809|FG001|Treatment-free Period (TFP)|Death|1|||
129916711|NCT00676715|467659810|FG002|Treatment-free Period (TFP)|Death|1|||
129449818|NCT01092143|465945688|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
129916712|NCT00676715|467659811|FG003|Treatment-free Period (TFP)|Death|0|||
129916713|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Reason not provided|3|||
129916714|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Reason not provided|4|||
129916715|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Reason not provided|1|||
129916716|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Reason not provided|4|||
129916717|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
129916718|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
129916719|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
129449819|NCT01092143|465945684|FG000|Overall Study|Ineligible patient|1|||
129868546|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868547|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
129868548|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868549|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868550|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868551|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868552|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868553|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129868554|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868555|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
129868556|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129868557|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868558|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868559|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868560|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868561|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129868562|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129868563|NCT01212770|467473427|FG000|Long-term Safety Phase (Year 5)|Death|0|||
129868564|NCT01212770|467473428|FG001|Long-term Safety Phase (Year 5)|Death|0|||
129868565|NCT01212770|467473429|FG002|Long-term Safety Phase (Year 5)|Death|0|||
129868566|NCT01212770|467473430|FG003|Long-term Safety Phase (Year 5)|Death|0|||
129868567|NCT01212770|467473431|FG004|Long-term Safety Phase (Year 5)|Death|0|||
129868568|NCT01212770|467473432|FG005|Long-term Safety Phase (Year 5)|Death|0|||
129868569|NCT01212770|467473433|FG006|Long-term Safety Phase (Year 5)|Death|0|||
129868570|NCT01212770|467473434|FG007|Long-term Safety Phase (Year 5)|Death|1|||
129868571|NCT01212770|467473435|FG008|Long-term Safety Phase (Year 5)|Death|0|||
129868572|NCT02085252|467473451|FG000|Overall Study|Withdrawal of Consent|1|||
129868573|NCT02085252|467473452|FG001|Overall Study|Withdrawal of Consent|0|||
129868574|NCT02085252|467473451|FG000|Overall Study|Adverse Event|0|||
129868575|NCT02085252|467473452|FG001|Overall Study|Adverse Event|1|||
129868576|NCT02085252|467473451|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
129868577|NCT02085252|467473452|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
129868578|NCT02085252|467473451|FG000|Overall Study|Reason Not Specified|0|||
129868579|NCT02085252|467473452|FG001|Overall Study|Reason Not Specified|1|||
129868580|NCT02085252|467473451|FG000|Overall Study|Reason Unknown|0|||
129868581|NCT02085252|467473452|FG001|Overall Study|Reason Unknown|1|||
129868582|NCT03260868|467473454|FG000|Overall Study|Poor Compliance to Protocol|0|||
129868583|NCT03260868|467473455|FG001|Overall Study|Poor Compliance to Protocol|2|||
129868584|NCT03260868|467473454|FG000|Overall Study|Study Terminated By Sponsor|2|||
129868585|NCT03260868|467473455|FG001|Overall Study|Study Terminated By Sponsor|1|||
129868586|NCT03260868|467473454|FG000|Overall Study|Other than specified above|1|||
129868587|NCT03260868|467473455|FG001|Overall Study|Other than specified above|0|||
129868588|NCT02925676|467473456|FG000|Overall Study|Withdrawal by Subject|1|||
129868589|NCT00541450|467473457|FG000|Phase A|Adverse Event|3|||
129868590|NCT00541450|467473458|FG001|Phase A|Adverse Event|0|||
129868591|NCT00541450|467473457|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
129868592|NCT00541450|467473458|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
129868593|NCT00541450|467473457|FG000|Phase A|Hyperglycemia|0|||
129868594|NCT00541450|467473458|FG001|Phase A|Hyperglycemia|1|||
129868595|NCT00541450|467473457|FG000|Phase A|Lost to Follow-up|6|||
129868596|NCT00541450|467473458|FG001|Phase A|Lost to Follow-up|4|||
129868597|NCT00541450|467473457|FG000|Phase A|Physician Decision|2|||
129868598|NCT00541450|467473458|FG001|Phase A|Physician Decision|0|||
129868599|NCT00541450|467473457|FG000|Phase A|Protocol Violation|2|||
129868600|NCT00541450|467473458|FG001|Phase A|Protocol Violation|3|||
129868601|NCT00541450|467473457|FG000|Phase A|Withdrawal by Subject|7|||
129868602|NCT00541450|467473458|FG001|Phase A|Withdrawal by Subject|7|||
129868603|NCT00541450|467473457|FG000|Phase B|Adverse Event|6|||
129868604|NCT00541450|467473458|FG001|Phase B|Adverse Event|6|||
129868605|NCT00541450|467473457|FG000|Phase B|Hyperglycemia|10|||
129868606|NCT00541450|467473458|FG001|Phase B|Hyperglycemia|9|||
129868607|NCT00541450|467473457|FG000|Phase B|Lost to Follow-up|6|||
129868608|NCT00541450|467473458|FG001|Phase B|Lost to Follow-up|4|||
129868609|NCT00541450|467473457|FG000|Phase B|Physician Decision|4|||
129868610|NCT00541450|467473458|FG001|Phase B|Physician Decision|2|||
129868611|NCT00541450|467473457|FG000|Phase B|Pregnancy|0|||
129868612|NCT00541450|467473458|FG001|Phase B|Pregnancy|1|||
129868613|NCT00541450|467473457|FG000|Phase B|Protocol Violation|3|||
129868614|NCT00541450|467473458|FG001|Phase B|Protocol Violation|3|||
129868615|NCT00541450|467473457|FG000|Phase B|Withdrawal by Subject|8|||
129868616|NCT00541450|467473458|FG001|Phase B|Withdrawal by Subject|6|||
129868617|NCT01298999|467473459|FG000|Overall Study|Physician Decision|0|||
129868618|NCT01298999|467473460|FG001|Overall Study|Physician Decision|1|||
129868619|NCT01298999|467473459|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
129868620|NCT01298999|467473460|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
129868621|NCT00803452|467473461|FG000|Overall Study|Adverse Event|0|||
129916720|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
129916721|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
129916722|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
129916723|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
129916724|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
129916725|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Adverse Event|0|||
129916726|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Adverse Event|3|||
129916727|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Adverse Event|1|||
129916728|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Adverse Event|0|||
129916729|NCT00676715|467659808|FG000|Open Label Extension (OLE)|Death|2|||
129916730|NCT00676715|467659809|FG001|Open Label Extension (OLE)|Death|0|||
129916731|NCT00676715|467659810|FG002|Open Label Extension (OLE)|Death|2|||
129916732|NCT00676715|467659811|FG003|Open Label Extension (OLE)|Death|2|||
129916733|NCT01820260|467659812|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916734|NCT01820260|467659813|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916735|NCT01820260|467659814|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916736|NCT01820260|467659815|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916737|NCT01820260|467659816|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916738|NCT01820260|467659817|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916739|NCT01820260|467659818|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
129916740|NCT01820260|467659819|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916741|NCT01820260|467659820|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916742|NCT01820260|467659821|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916743|NCT01820260|467659822|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916744|NCT01820260|467659823|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916745|NCT01820260|467659824|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916746|NCT01820260|467659825|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
129916747|NCT01820260|467659812|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916748|NCT01820260|467659813|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916749|NCT01820260|467659814|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916750|NCT01820260|467659815|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916751|NCT01820260|467659816|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916752|NCT01820260|467659817|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916753|NCT01820260|467659818|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916754|NCT01820260|467659819|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916755|NCT01820260|467659820|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916756|NCT01820260|467659821|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
129916757|NCT01820260|467659822|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129868622|NCT00803452|467473462|FG001|Overall Study|Adverse Event|2|||
129868623|NCT00803452|467473461|FG000|Overall Study|Lost to Follow-up|0|||
129868624|NCT00803452|467473462|FG001|Overall Study|Lost to Follow-up|3|||
129868625|NCT03360942|467473463|FG000|Overall Study|Device explanted|2|||
129868626|NCT03360942|467473463|FG000|Overall Study|Study closure|1|||
129868627|NCT03360942|467473463|FG000|Overall Study|Withdrawal by Subject|2|||
129868628|NCT05073133|467473464|FG000|Overall Study|Death|2|||
129868629|NCT00289887|467475091|FG000|Overall Study|Adverse Event|3|||
129868630|NCT00289887|467475092|FG001|Overall Study|Adverse Event|3|||
129868631|NCT00289887|467475091|FG000|Overall Study|Lack of Efficacy|3|||
129868632|NCT00289887|467475092|FG001|Overall Study|Lack of Efficacy|11|||
129868633|NCT00289887|467475091|FG000|Overall Study|Lost to Follow-up|3|||
129868634|NCT00289887|467475092|FG001|Overall Study|Lost to Follow-up|3|||
129868635|NCT00289887|467475091|FG000|Overall Study|Protocol Violation|3|||
129868636|NCT00289887|467475092|FG001|Overall Study|Protocol Violation|1|||
129868637|NCT00289887|467475091|FG000|Overall Study|Withdrawal by Subject|3|||
129868638|NCT00289887|467475092|FG001|Overall Study|Withdrawal by Subject|8|||
129868639|NCT00289887|467475091|FG000|Overall Study|Other|7|||
129868640|NCT00289887|467475092|FG001|Overall Study|Other|3|||
129868641|NCT01266850|467475093|FG000|Overall Study|Lost to Follow-up|19|||
129868642|NCT01266850|467475094|FG001|Overall Study|Lost to Follow-up|19|||
129868643|NCT01266850|467475095|FG002|Overall Study|Lost to Follow-up|13|||
129868644|NCT01266850|467475096|FG003|Overall Study|Lost to Follow-up|13|||
129868645|NCT01266850|467475097|FG004|Overall Study|Lost to Follow-up|12|||
129868646|NCT01266850|467475093|FG000|Overall Study|Withdrawal by Subject|8|||
129868647|NCT01266850|467475094|FG001|Overall Study|Withdrawal by Subject|9|||
129868648|NCT01266850|467475095|FG002|Overall Study|Withdrawal by Subject|6|||
129449820|NCT01092143|465945685|FG001|Overall Study|Ineligible patient|0|||
129868649|NCT01266850|467475096|FG003|Overall Study|Withdrawal by Subject|9|||
129868650|NCT01266850|467475097|FG004|Overall Study|Withdrawal by Subject|12|||
129868651|NCT01266850|467475093|FG000|Overall Study|Physician Decision|3|||
129868652|NCT01266850|467475094|FG001|Overall Study|Physician Decision|6|||
129868653|NCT01266850|467475095|FG002|Overall Study|Physician Decision|4|||
129868654|NCT01266850|467475096|FG003|Overall Study|Physician Decision|4|||
129868655|NCT01266850|467475097|FG004|Overall Study|Physician Decision|3|||
129868656|NCT01266850|467475093|FG000|Overall Study|Protocol Violation|0|||
129868657|NCT01266850|467475094|FG001|Overall Study|Protocol Violation|1|||
129868658|NCT01266850|467475095|FG002|Overall Study|Protocol Violation|0|||
129868659|NCT01266850|467475096|FG003|Overall Study|Protocol Violation|1|||
129868660|NCT01266850|467475097|FG004|Overall Study|Protocol Violation|2|||
129868661|NCT01266850|467475093|FG000|Overall Study|Adverse Event|0|||
129868662|NCT01266850|467475094|FG001|Overall Study|Adverse Event|0|||
129868663|NCT01266850|467475095|FG002|Overall Study|Adverse Event|0|||
129868664|NCT01266850|467475096|FG003|Overall Study|Adverse Event|0|||
129868665|NCT01266850|467475097|FG004|Overall Study|Adverse Event|1|||
129868666|NCT01266850|467475093|FG000|Overall Study|Site Closure|0|||
129868667|NCT01266850|467475094|FG001|Overall Study|Site Closure|1|||
129868668|NCT01266850|467475095|FG002|Overall Study|Site Closure|1|||
129868669|NCT01266850|467475096|FG003|Overall Study|Site Closure|1|||
129868670|NCT01266850|467475097|FG004|Overall Study|Site Closure|0|||
129868671|NCT00437645|467475101|FG000|Overall Study|Adverse Event|15|||
129868672|NCT00437645|467475102|FG001|Overall Study|Adverse Event|84|||
129868673|NCT00437645|467475101|FG000|Overall Study|Withdrawal by Subject|10|||
129868674|NCT00437645|467475102|FG001|Overall Study|Withdrawal by Subject|22|||
129868675|NCT00437645|467475101|FG000|Overall Study|Protocol Violation|3|||
129868676|NCT00437645|467475102|FG001|Overall Study|Protocol Violation|3|||
129868677|NCT00437645|467475101|FG000|Overall Study|Lost to Follow-up|2|||
129868678|NCT00437645|467475102|FG001|Overall Study|Lost to Follow-up|3|||
129868679|NCT00437645|467475101|FG000|Overall Study|Administrative problems|2|||
129868680|NCT00437645|467475102|FG001|Overall Study|Administrative problems|1|||
129868681|NCT00437645|467475101|FG000|Overall Study|Lack of Efficacy|2|||
129868682|NCT00437645|467475102|FG001|Overall Study|Lack of Efficacy|1|||
129868683|NCT00437645|467475101|FG000|Overall Study|Condition no longer requires study drug|1|||
129868684|NCT00437645|467475102|FG001|Overall Study|Condition no longer requires study drug|1|||
129868685|NCT03751631|467475106|FG000|Overall Study|Withdrawal by Subject|0|||
129868686|NCT03751631|467475107|FG001|Overall Study|Withdrawal by Subject|0|||
129868687|NCT03751631|467475108|FG002|Overall Study|Withdrawal by Subject|1|||
129868688|NCT03751631|467475109|FG003|Overall Study|Withdrawal by Subject|1|||
129868689|NCT03751631|467475110|FG004|Overall Study|Withdrawal by Subject|0|||
129868690|NCT03751631|467475111|FG005|Overall Study|Withdrawal by Subject|0|||
129868691|NCT03382782|467475116|FG000|Cohort 1|Withdrawal by Subject|11|||
129868692|NCT03382782|467475117|FG001|Cohort 1|Withdrawal by Subject|5|||
129868693|NCT03382782|467475118|FG002|Cohort 1|Withdrawal by Subject|0|||
129868694|NCT03382782|467475116|FG000|Cohort 2|Withdrawal by Subject|1|||
129868695|NCT03382782|467475117|FG001|Cohort 2|Withdrawal by Subject|1|||
129868696|NCT03382782|467475118|FG002|Cohort 2|Withdrawal by Subject|0|||
129868697|NCT03382782|467475116|FG000|Cohort 3|Withdrawal by Subject|1|||
129868698|NCT03382782|467475117|FG001|Cohort 3|Withdrawal by Subject|2|||
129868699|NCT03382782|467475118|FG002|Cohort 3|Withdrawal by Subject|0|||
129868700|NCT00428090|467475121|FG000|Overall Study|Adverse Event|10|||
129868701|NCT00428090|467475122|FG001|Overall Study|Adverse Event|8|||
129868702|NCT00428090|467475123|FG002|Overall Study|Adverse Event|10|||
129868703|NCT00428090|467475124|FG003|Overall Study|Adverse Event|11|||
129868704|NCT00428090|467475121|FG000|Overall Study|Lost to Follow-up|3|||
129868705|NCT00428090|467475122|FG001|Overall Study|Lost to Follow-up|6|||
129868706|NCT00428090|467475123|FG002|Overall Study|Lost to Follow-up|1|||
129868707|NCT00428090|467475124|FG003|Overall Study|Lost to Follow-up|4|||
129868708|NCT00428090|467475121|FG000|Overall Study|Protocol Violation|3|||
129916758|NCT01820260|467659823|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129868709|NCT00428090|467475122|FG001|Overall Study|Protocol Violation|1|||
129868710|NCT00428090|467475123|FG002|Overall Study|Protocol Violation|3|||
129868711|NCT00428090|467475124|FG003|Overall Study|Protocol Violation|3|||
129868712|NCT00428090|467475121|FG000|Overall Study|Withdrawal by Subject|10|||
129868713|NCT00428090|467475122|FG001|Overall Study|Withdrawal by Subject|12|||
129868714|NCT00428090|467475123|FG002|Overall Study|Withdrawal by Subject|15|||
129868715|NCT00428090|467475124|FG003|Overall Study|Withdrawal by Subject|5|||
129868716|NCT00428090|467475121|FG000|Overall Study|Sponsor terminated study|0|||
129868717|NCT00428090|467475122|FG001|Overall Study|Sponsor terminated study|1|||
129868718|NCT00428090|467475123|FG002|Overall Study|Sponsor terminated study|0|||
129868719|NCT00428090|467475124|FG003|Overall Study|Sponsor terminated study|0|||
129868720|NCT00428090|467475121|FG000|Overall Study|Non-compliance|4|||
129868721|NCT00428090|467475122|FG001|Overall Study|Non-compliance|0|||
129916759|NCT01820260|467659824|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916760|NCT01820260|467659825|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
129916761|NCT04831281|467659827|FG000|Overall Study|Adverse Event|1|||
129916762|NCT04831281|467659828|FG001|Overall Study|Adverse Event|0|||
129916763|NCT04831281|467659829|FG002|Overall Study|Adverse Event|3|||
129916764|NCT04831281|467659827|FG000|Overall Study|Withdrawal by Subject|0|||
129916765|NCT04831281|467659828|FG001|Overall Study|Withdrawal by Subject|1|||
129916766|NCT04831281|467659829|FG002|Overall Study|Withdrawal by Subject|2|||
129916767|NCT04831281|467659827|FG000|Overall Study|Undetermined|1|||
129916768|NCT04831281|467659828|FG001|Overall Study|Undetermined|1|||
129916769|NCT04831281|467659829|FG002|Overall Study|Undetermined|0|||
129916770|NCT02249949|467659830|FG000|Overall Study|Cancelled prior to treatment|2|||
129916771|NCT02097420|467659831|FG000|Overall Study|Death|6|||
129916772|NCT02097420|467659831|FG000|Overall Study|Valve explanted|13|||
129916773|NCT02097420|467659831|FG000|Overall Study|Other Reason|1|||
129916774|NCT03161379|467659839|FG000|Overall Study|Withdrawal by Subject|4|||
129916775|NCT03161379|467659839|FG000|Overall Study|disease progression during chemotherapy|5|||
129916776|NCT03161379|467659839|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
129916777|NCT03161379|467659839|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
129916778|NCT02312960|467659844|FG000|Overall Study|Death|24|||
129916779|NCT02312960|467659845|FG001|Overall Study|Death|32|||
129916780|NCT02312960|467659846|FG002|Overall Study|Death|25|||
129916781|NCT02312960|467659847|FG003|Overall Study|Death|11|||
129916782|NCT02312960|467659848|FG004|Overall Study|Death|5|||
129916783|NCT02312960|467659849|FG005|Overall Study|Death|5|||
129916784|NCT02312960|467659850|FG006|Overall Study|Death|8|||
129916785|NCT02312960|467659851|FG007|Overall Study|Death|5|||
129916786|NCT02312960|467659852|FG008|Overall Study|Death|7|||
129916787|NCT02312960|467659853|FG009|Overall Study|Death|3|||
129916788|NCT02312960|467659854|FG010|Overall Study|Death|3|||
129916789|NCT02312960|467659855|FG011|Overall Study|Death|1|||
129916790|NCT02312960|467659856|FG012|Overall Study|Death|25|||
129916791|NCT02312960|467659857|FG013|Overall Study|Death|19|||
129916792|NCT02312960|467659844|FG000|Overall Study|Missing|0|||
129916793|NCT02312960|467659845|FG001|Overall Study|Missing|0|||
129916794|NCT02312960|467659846|FG002|Overall Study|Missing|2|||
129916795|NCT02312960|467659847|FG003|Overall Study|Missing|0|||
129916796|NCT02312960|467659848|FG004|Overall Study|Missing|0|||
129916797|NCT02312960|467659849|FG005|Overall Study|Missing|0|||
129916798|NCT02312960|467659850|FG006|Overall Study|Missing|0|||
129916799|NCT02312960|467659851|FG007|Overall Study|Missing|0|||
129916800|NCT02312960|467659852|FG008|Overall Study|Missing|0|||
129916801|NCT02312960|467659853|FG009|Overall Study|Missing|0|||
129916802|NCT02312960|467659854|FG010|Overall Study|Missing|0|||
129916803|NCT02312960|467659855|FG011|Overall Study|Missing|0|||
129916804|NCT02312960|467659856|FG012|Overall Study|Missing|0|||
129916805|NCT02312960|467659857|FG013|Overall Study|Missing|0|||
129916806|NCT02312960|467659844|FG000|Overall Study|Lost to Follow-up|0|||
129916807|NCT02312960|467659845|FG001|Overall Study|Lost to Follow-up|0|||
129916808|NCT02312960|467659846|FG002|Overall Study|Lost to Follow-up|1|||
129916809|NCT02312960|467659847|FG003|Overall Study|Lost to Follow-up|0|||
129916810|NCT02312960|467659848|FG004|Overall Study|Lost to Follow-up|0|||
129916811|NCT02312960|467659849|FG005|Overall Study|Lost to Follow-up|0|||
129916812|NCT02312960|467659850|FG006|Overall Study|Lost to Follow-up|1|||
129916813|NCT02312960|467659851|FG007|Overall Study|Lost to Follow-up|1|||
129916814|NCT02312960|467659852|FG008|Overall Study|Lost to Follow-up|0|||
129449821|NCT01092143|465945686|FG002|Overall Study|Ineligible patient|0|||
129916815|NCT02312960|467659853|FG009|Overall Study|Lost to Follow-up|1|||
129916816|NCT02312960|467659854|FG010|Overall Study|Lost to Follow-up|0|||
129916817|NCT02312960|467659855|FG011|Overall Study|Lost to Follow-up|0|||
129916818|NCT02312960|467659856|FG012|Overall Study|Lost to Follow-up|1|||
129916819|NCT02312960|467659857|FG013|Overall Study|Lost to Follow-up|0|||
129916820|NCT02312960|467659844|FG000|Overall Study|Withdrawal by Subject|1|||
129916821|NCT02312960|467659845|FG001|Overall Study|Withdrawal by Subject|2|||
129916822|NCT02312960|467659846|FG002|Overall Study|Withdrawal by Subject|0|||
129868722|NCT00428090|467475123|FG002|Overall Study|Non-compliance|1|||
129868723|NCT00428090|467475124|FG003|Overall Study|Non-compliance|3|||
129868724|NCT00428090|467475121|FG000|Overall Study|Par. did not returned to visit|1|||
129868725|NCT00428090|467475122|FG001|Overall Study|Par. did not returned to visit|0|||
129868726|NCT00428090|467475123|FG002|Overall Study|Par. did not returned to visit|0|||
129868727|NCT00428090|467475124|FG003|Overall Study|Par. did not returned to visit|1|||
129868728|NCT00428090|467475121|FG000|Overall Study|Follow-Up visit not possible|1|||
129868729|NCT00428090|467475122|FG001|Overall Study|Follow-Up visit not possible|0|||
129868730|NCT00428090|467475123|FG002|Overall Study|Follow-Up visit not possible|0|||
129868731|NCT00428090|467475124|FG003|Overall Study|Follow-Up visit not possible|0|||
129868732|NCT00428090|467475121|FG000|Overall Study|Prohibited medication used for SAE|1|||
129868733|NCT00428090|467475122|FG001|Overall Study|Prohibited medication used for SAE|0|||
129868734|NCT00428090|467475123|FG002|Overall Study|Prohibited medication used for SAE|0|||
129868735|NCT00428090|467475124|FG003|Overall Study|Prohibited medication used for SAE|0|||
129868736|NCT00428090|467475121|FG000|Overall Study|Death of par.|1|||
129868737|NCT00428090|467475122|FG001|Overall Study|Death of par.|0|||
129868738|NCT00428090|467475123|FG002|Overall Study|Death of par.|1|||
129868739|NCT00428090|467475124|FG003|Overall Study|Death of par.|0|||
129868740|NCT00428090|467475121|FG000|Overall Study|Visit 7 exceed the visit window|0|||
129868741|NCT00428090|467475122|FG001|Overall Study|Visit 7 exceed the visit window|1|||
129868742|NCT00428090|467475123|FG002|Overall Study|Visit 7 exceed the visit window|0|||
129868743|NCT00428090|467475124|FG003|Overall Study|Visit 7 exceed the visit window|0|||
129868744|NCT00428090|467475121|FG000|Overall Study|Medical monitor terminated par.|0|||
129868745|NCT00428090|467475122|FG001|Overall Study|Medical monitor terminated par.|1|||
129868746|NCT00428090|467475123|FG002|Overall Study|Medical monitor terminated par.|0|||
129868747|NCT00428090|467475124|FG003|Overall Study|Medical monitor terminated par.|0|||
129868748|NCT00428090|467475121|FG000|Overall Study|Mental status of par. was|0|||
129868749|NCT00428090|467475122|FG001|Overall Study|Mental status of par. was|1|||
129868750|NCT00428090|467475123|FG002|Overall Study|Mental status of par. was|0|||
129868751|NCT00428090|467475124|FG003|Overall Study|Mental status of par. was|0|||
129868752|NCT00428090|467475121|FG000|Overall Study|Worsening of AD|0|||
129868753|NCT00428090|467475122|FG001|Overall Study|Worsening of AD|0|||
129868754|NCT00428090|467475123|FG002|Overall Study|Worsening of AD|1|||
129868755|NCT00428090|467475124|FG003|Overall Study|Worsening of AD|0|||
129868756|NCT00428090|467475121|FG000|Overall Study|Excluded for concerning QTc value|0|||
129868757|NCT00428090|467475122|FG001|Overall Study|Excluded for concerning QTc value|0|||
129868758|NCT00428090|467475123|FG002|Overall Study|Excluded for concerning QTc value|1|||
129868759|NCT00428090|467475124|FG003|Overall Study|Excluded for concerning QTc value|0|||
129868760|NCT00428090|467475121|FG000|Overall Study|Insufficient AD documentation|0|||
129868761|NCT00428090|467475122|FG001|Overall Study|Insufficient AD documentation|0|||
129868762|NCT00428090|467475123|FG002|Overall Study|Insufficient AD documentation|1|||
129868763|NCT00428090|467475124|FG003|Overall Study|Insufficient AD documentation|0|||
129868764|NCT00428090|467475121|FG000|Overall Study|High MMSE scores|0|||
129868765|NCT00428090|467475122|FG001|Overall Study|High MMSE scores|0|||
129868766|NCT00428090|467475123|FG002|Overall Study|High MMSE scores|1|||
129868767|NCT00428090|467475124|FG003|Overall Study|High MMSE scores|0|||
129868768|NCT00428090|467475121|FG000|Overall Study|Deterioration of cognitive status|0|||
129868769|NCT00428090|467475122|FG001|Overall Study|Deterioration of cognitive status|0|||
129868770|NCT00428090|467475123|FG002|Overall Study|Deterioration of cognitive status|1|||
129868771|NCT00428090|467475124|FG003|Overall Study|Deterioration of cognitive status|0|||
129868772|NCT00428090|467475121|FG000|Overall Study|Serious adverse event|0|||
129868773|NCT00428090|467475122|FG001|Overall Study|Serious adverse event|0|||
129868774|NCT00428090|467475123|FG002|Overall Study|Serious adverse event|1|||
129868775|NCT00428090|467475124|FG003|Overall Study|Serious adverse event|0|||
129868776|NCT00428090|467475121|FG000|Overall Study|Excluded for heart insufficiency|0|||
129868777|NCT00428090|467475122|FG001|Overall Study|Excluded for heart insufficiency|0|||
129868778|NCT00428090|467475123|FG002|Overall Study|Excluded for heart insufficiency|1|||
129868779|NCT00428090|467475124|FG003|Overall Study|Excluded for heart insufficiency|0|||
129868780|NCT00428090|467475121|FG000|Overall Study|Raised Creatinine Value|0|||
129868781|NCT00428090|467475122|FG001|Overall Study|Raised Creatinine Value|0|||
129868782|NCT00428090|467475123|FG002|Overall Study|Raised Creatinine Value|0|||
129868783|NCT00428090|467475124|FG003|Overall Study|Raised Creatinine Value|1|||
129868784|NCT03409666|467475125|FG000|Overall Study|Physician Decision|0|||
129868785|NCT03409666|467475126|FG001|Overall Study|Physician Decision|1|||
129868786|NCT03409666|467475125|FG000|Overall Study|Protocol Violation|0|||
129868787|NCT03409666|467475126|FG001|Overall Study|Protocol Violation|3|||
129868788|NCT01791725|467475130|FG000|Overall Study|Withdrawal by Subject|0|||
129868789|NCT01791725|467475131|FG001|Overall Study|Withdrawal by Subject|1|||
129868790|NCT01791725|467475132|FG002|Overall Study|Withdrawal by Subject|0|||
129868791|NCT00512148|467475133|FG000|Primay Study Period|Withdrawal by Subject|1|||
129868792|NCT00677833|467475134|FG000|Overall Study|Withdrawal by Subject|4|||
129868793|NCT00677833|467475135|FG001|Overall Study|Withdrawal by Subject|0|||
129868794|NCT00677833|467475136|FG002|Overall Study|Withdrawal by Subject|1|||
129868795|NCT00677833|467475137|FG003|Overall Study|Withdrawal by Subject|3|||
129868796|NCT00677833|467475134|FG000|Overall Study|Lost to Follow-up|0|||
129868797|NCT00677833|467475135|FG001|Overall Study|Lost to Follow-up|0|||
129868798|NCT00677833|467475136|FG002|Overall Study|Lost to Follow-up|1|||
129868799|NCT00677833|467475137|FG003|Overall Study|Lost to Follow-up|0|||
129868800|NCT03255824|467475138|FG000|Overall Study|Under-sedation|2|||
129868801|NCT03255824|467475139|FG001|Overall Study|Under-sedation|1|||
129868802|NCT02001194|467475141|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
129868803|NCT02001194|467475142|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
129868804|NCT02001194|467475143|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
129868805|NCT02001194|467475144|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
129868806|NCT02001194|467475141|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
129868807|NCT02001194|467475142|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
129868808|NCT02001194|467475143|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
129868809|NCT02001194|467475144|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
129868810|NCT02690974|467475148|FG000|Overall Study|Adverse Event|16|||
129868811|NCT02690974|467475148|FG000|Overall Study|Death|9|||
129868812|NCT02690974|467475148|FG000|Overall Study|Subject/guardian decision|4|||
129868813|NCT02690974|467475148|FG000|Overall Study|Lost to Follow-up|3|||
129868814|NCT02690974|467475148|FG000|Overall Study|Withdrawal of Informed Consent|3|||
129868815|NCT02690974|467475148|FG000|Overall Study|Physician Decision|2|||
129868816|NCT02690974|467475148|FG000|Overall Study|Non-compliance with study treatment|1|||
129868817|NCT02690974|467475148|FG000|Overall Study|Protocol-defined stopping criteria|1|||
129868818|NCT02690974|467475148|FG000|Overall Study|Protocol Deviation|1|||
129868819|NCT01666951|467475153|FG000|Overall Study|Not dosed|1|||
129868820|NCT01666951|467475154|FG001|Overall Study|Not dosed|1|||
129868821|NCT00522301|467475155|FG000|Overall Study|Withdrawal by Subject|1|||
129868822|NCT00522301|467475155|FG000|Overall Study|Adverse Event|5|||
129916823|NCT02312960|467659847|FG003|Overall Study|Withdrawal by Subject|0|||
129916824|NCT02312960|467659848|FG004|Overall Study|Withdrawal by Subject|1|||
129916825|NCT02312960|467659849|FG005|Overall Study|Withdrawal by Subject|0|||
129916826|NCT02312960|467659850|FG006|Overall Study|Withdrawal by Subject|1|||
129916827|NCT02312960|467659851|FG007|Overall Study|Withdrawal by Subject|2|||
129916828|NCT02312960|467659852|FG008|Overall Study|Withdrawal by Subject|2|||
129916829|NCT02312960|467659853|FG009|Overall Study|Withdrawal by Subject|3|||
129916830|NCT02312960|467659854|FG010|Overall Study|Withdrawal by Subject|0|||
129916831|NCT02312960|467659855|FG011|Overall Study|Withdrawal by Subject|0|||
129916832|NCT02312960|467659856|FG012|Overall Study|Withdrawal by Subject|2|||
129916833|NCT02312960|467659857|FG013|Overall Study|Withdrawal by Subject|0|||
129916834|NCT02728076|467659858|FG000|Overall Study|Physician Decision|4|||
129916835|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Adverse Event|2|||
129916836|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Adverse Event|1|||
129916837|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Adverse Event|1|||
129916838|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
129916839|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
129916840|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
129916841|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
129916842|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
129916843|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
129916844|NCT05458011|467659859|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
129916845|NCT05458011|467659860|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
129916846|NCT05458011|467659861|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
129916847|NCT05458011|467659859|FG000|OL Period (12 Weeks)|Adverse Event|1|||
129916848|NCT05458011|467659860|FG001|OL Period (12 Weeks)|Adverse Event|2|||
129916849|NCT05458011|467659861|FG002|OL Period (12 Weeks)|Adverse Event|1|||
129916850|NCT05458011|467659859|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
129916851|NCT05458011|467659860|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
129916852|NCT05458011|467659861|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
129916853|NCT00931710|467659863|FG000|Overall Study|Adverse Event|16|||
129916854|NCT00931710|467659864|FG001|Overall Study|Adverse Event|10|||
129916855|NCT00931710|467659863|FG000|Overall Study|Abnormal test procedure results|2|||
129916856|NCT00931710|467659864|FG001|Overall Study|Abnormal test procedure results|0|||
129916857|NCT00931710|467659863|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
129916858|NCT00931710|467659864|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
129916859|NCT00931710|467659863|FG000|Overall Study|Patient withdrew consent|4|||
129916860|NCT00931710|467659864|FG001|Overall Study|Patient withdrew consent|9|||
129916861|NCT00931710|467659863|FG000|Overall Study|Lost to Follow-up|6|||
129916862|NCT00931710|467659864|FG001|Overall Study|Lost to Follow-up|5|||
129916863|NCT00931710|467659863|FG000|Overall Study|Protocol deviation|1|||
129916864|NCT00931710|467659864|FG001|Overall Study|Protocol deviation|2|||
129916865|NCT02913872|467659865|FG000|Overall Study|Withdrawal by Subject|1|||
129916866|NCT03361748|467659873|FG000|Overall Study|Death|77|||
129916867|NCT03361748|467659873|FG000|Overall Study|Lost to Follow-up|4|||
129916868|NCT03361748|467659873|FG000|Overall Study|Withdrawal by Subject|20|||
129916869|NCT01361711|467659874|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
129916870|NCT01361711|467659874|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
129916871|NCT01361711|467659874|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
129916872|NCT01361711|467659874|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
129916873|NCT01361711|467659874|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
129916874|NCT01361711|467659874|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
129916875|NCT01361711|467659874|FG000|Completed Week 18 of Treatment|Other|9|||
129916876|NCT01361711|467659874|FG000|10 Year Follow-up|Still in follow-up|22|||
129916877|NCT01361711|467659874|FG000|10 Year Follow-up|Death|7|||
129916878|NCT01361711|467659874|FG000|10 Year Follow-up|Developed new cancer|1|||
129916879|NCT01361711|467659874|FG000|10 Year Follow-up|Lost to Follow-up|2|||
129916880|NCT01361711|467659874|FG000|10 Year Follow-up|New treatment started|6|||
129916881|NCT01361711|467659874|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
129916882|NCT01361711|467659874|FG000|10 Year Follow-up|Progressive Disease|1|||
129916883|NCT02596126|467659875|FG000|Overall Study|Lost to Follow-up|12|||
129916884|NCT02596126|467659876|FG001|Overall Study|Lost to Follow-up|21|||
129916885|NCT02596126|467659875|FG000|Overall Study|Protocol Violation|7|||
129916886|NCT02596126|467659876|FG001|Overall Study|Protocol Violation|9|||
129916887|NCT05179395|467659877|FG000|Overall Study|Lack of Efficacy|1|||
129916888|NCT05792423|467659882|FG000|Overall Study|Withdrawal by Subject|2|||
129916889|NCT02471638|467659883|FG000|Overall Study|Early Term Withdrawal|10|||
129916890|NCT04178733|467661286|FG000|Overall Study|Investigator Decision|0|||
129916891|NCT04178733|467661287|FG001|Overall Study|Investigator Decision|0|||
129916892|NCT04178733|467661288|FG002|Overall Study|Investigator Decision|0|||
129916893|NCT04178733|467661289|FG003|Overall Study|Investigator Decision|1|||
129916894|NCT04178733|467661290|FG004|Overall Study|Investigator Decision|2|||
129916895|NCT02287311|467661294|FG000|Cohort 1: Dose Level 1|Death|2|||
129916896|NCT02287311|467661295|FG001|Cohort 1: Dose Level 1|Death|0|||
129916897|NCT02287311|467661296|FG002|Cohort 1: Dose Level 1|Death|0|||
129916898|NCT02287311|467661297|FG003|Cohort 1: Dose Level 1|Death|3|||
129916899|NCT02287311|467661298|FG004|Cohort 1: Dose Level 1|Death|0|||
129916900|NCT02287311|467661299|FG005|Cohort 1: Dose Level 1|Death|0|||
129916901|NCT02287311|467661300|FG006|Cohort 1: Dose Level 1|Death|1|||
129916902|NCT02287311|467661301|FG007|Cohort 1: Dose Level 1|Death|0|||
129916903|NCT02287311|467661302|FG008|Cohort 1: Dose Level 1|Death|0|||
129916904|NCT02287311|467661294|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916905|NCT02287311|467661295|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916906|NCT02287311|467661296|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916907|NCT02287311|467661297|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
129916908|NCT02287311|467661298|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916909|NCT02287311|467661299|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916910|NCT02287311|467661300|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
129916911|NCT02287311|467661301|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916912|NCT02287311|467661302|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
129916913|NCT02287311|467661294|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
129916914|NCT02287311|467661295|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
129916915|NCT02287311|467661296|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
129868823|NCT00337272|467475156|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
129868824|NCT00337272|467475157|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
129868825|NCT00337272|467475156|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
129868826|NCT00337272|467475157|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
129868827|NCT00337272|467475156|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
129868828|NCT00337272|467475157|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
129868829|NCT00337272|467475156|FG000|Treatment Period|Non-compliance|1|||
129868830|NCT00337272|467475157|FG001|Treatment Period|Non-compliance|1|||
129868831|NCT00337272|467475156|FG000|Treatment Period|Withdrawal by Subject|0|||
129868832|NCT00337272|467475157|FG001|Treatment Period|Withdrawal by Subject|1|||
129868833|NCT00337272|467475156|FG000|Withdrawal Period|Non-compliance|0|||
129868834|NCT00337272|467475157|FG001|Withdrawal Period|Non-compliance|1|||
129868835|NCT02366910|467475161|FG000|Overall Study|Withdrawal by Subject|2|||
129868836|NCT02366910|467475161|FG000|Overall Study|Screen Failure|3|||
129868837|NCT02623322|467475165|FG000|Overall Study|Lost to Follow-up|2|||
129868838|NCT02623322|467475166|FG001|Overall Study|Lost to Follow-up|1|||
129868839|NCT02623322|467475167|FG002|Overall Study|Lost to Follow-up|0|||
129868840|NCT03284788|467475168|FG000|Overall Study|Withdrawal by Subject|2|||
129868841|NCT03813238|467475175|FG000|Overall Study|Adverse Event|0|||
129868842|NCT03813238|467475176|FG001|Overall Study|Adverse Event|6|||
129868843|NCT03813238|467475175|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129868844|NCT03813238|467475176|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129868845|NCT03813238|467475175|FG000|Overall Study|Lost to Follow-up|0|||
129868846|NCT03813238|467475176|FG001|Overall Study|Lost to Follow-up|1|||
129868847|NCT03813238|467475175|FG000|Overall Study|Other than specified|1|||
129868848|NCT03813238|467475176|FG001|Overall Study|Other than specified|2|||
129868849|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
129868850|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
129868851|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
129868852|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
129868853|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
129868854|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
129868855|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
129868856|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
129868857|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
129868858|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
129868859|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
129868860|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
129868861|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Death|6|||
129868862|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Death|3|||
129868863|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Death|0|||
129868864|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Death|1|||
129868865|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Death|1|||
129868866|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Death|0|||
129868867|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
129916916|NCT02287311|467661297|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
129916917|NCT02287311|467661298|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
129916918|NCT02287311|467661299|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
129916919|NCT02287311|467661300|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
129916920|NCT02287311|467661301|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
129916921|NCT02287311|467661302|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
129916922|NCT02287311|467661294|FG000|Cohort 2: Dose Level 2|Death|0|||
129916923|NCT02287311|467661295|FG001|Cohort 2: Dose Level 2|Death|2|||
129916924|NCT02287311|467661296|FG002|Cohort 2: Dose Level 2|Death|0|||
129916925|NCT02287311|467661297|FG003|Cohort 2: Dose Level 2|Death|0|||
129916926|NCT02287311|467661298|FG004|Cohort 2: Dose Level 2|Death|2|||
129916927|NCT02287311|467661299|FG005|Cohort 2: Dose Level 2|Death|0|||
129916928|NCT02287311|467661300|FG006|Cohort 2: Dose Level 2|Death|0|||
129916929|NCT02287311|467661301|FG007|Cohort 2: Dose Level 2|Death|2|||
129916930|NCT02287311|467661302|FG008|Cohort 2: Dose Level 2|Death|0|||
129916931|NCT02287311|467661294|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916932|NCT02287311|467661295|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916933|NCT02287311|467661296|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916934|NCT02287311|467661297|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916935|NCT02287311|467661298|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
129916936|NCT02287311|467661299|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916937|NCT02287311|467661300|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916938|NCT02287311|467661301|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916939|NCT02287311|467661302|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
129916940|NCT02287311|467661294|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916941|NCT02287311|467661295|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
129916942|NCT02287311|467661296|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916943|NCT02287311|467661297|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916944|NCT02287311|467661298|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916945|NCT02287311|467661299|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916946|NCT02287311|467661300|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916947|NCT02287311|467661301|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916948|NCT02287311|467661302|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
129916949|NCT02287311|467661294|FG000|Cohort 3: Dose Level 3|Death|0|||
129916950|NCT02287311|467661295|FG001|Cohort 3: Dose Level 3|Death|0|||
129916951|NCT02287311|467661296|FG002|Cohort 3: Dose Level 3|Death|4|||
129916952|NCT02287311|467661297|FG003|Cohort 3: Dose Level 3|Death|0|||
129916953|NCT02287311|467661298|FG004|Cohort 3: Dose Level 3|Death|0|||
129916954|NCT02287311|467661299|FG005|Cohort 3: Dose Level 3|Death|4|||
129916955|NCT02287311|467661300|FG006|Cohort 3: Dose Level 3|Death|0|||
129916956|NCT02287311|467661301|FG007|Cohort 3: Dose Level 3|Death|0|||
129916957|NCT02287311|467661302|FG008|Cohort 3: Dose Level 3|Death|2|||
129916958|NCT02287311|467661294|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916959|NCT02287311|467661295|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916960|NCT02287311|467661296|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
129916961|NCT02287311|467661297|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916962|NCT02287311|467661298|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916963|NCT02287311|467661299|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
129916964|NCT02287311|467661300|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916965|NCT02287311|467661301|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916966|NCT02287311|467661302|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
129916967|NCT02287311|467661294|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916968|NCT02287311|467661295|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916969|NCT02287311|467661296|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916970|NCT02287311|467661297|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916971|NCT02287311|467661298|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916972|NCT02287311|467661299|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
129916973|NCT02287311|467661300|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129868868|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
129868869|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
129868870|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
129868871|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
129868872|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
129868873|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868874|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
129868875|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
129916974|NCT02287311|467661301|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
129916975|NCT02287311|467661302|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
129916976|NCT05418296|467661307|FG000|Overall Study|Withdrawal by Subject|4|||
129916977|NCT05418296|467661308|FG001|Overall Study|Withdrawal by Subject|1|||
129916978|NCT03713086|467661315|FG000|Overall Study|Withdrawal by Subject|0|||
129916979|NCT03713086|467661316|FG001|Overall Study|Withdrawal by Subject|2|||
129916980|NCT03713086|467661317|FG002|Overall Study|Withdrawal by Subject|1|||
129916981|NCT03713086|467661318|FG003|Overall Study|Withdrawal by Subject|0|||
129916982|NCT03713086|467661315|FG000|Overall Study|Lost to Follow-up|0|||
129916983|NCT03713086|467661316|FG001|Overall Study|Lost to Follow-up|1|||
129916984|NCT03713086|467661317|FG002|Overall Study|Lost to Follow-up|0|||
129916985|NCT03713086|467661318|FG003|Overall Study|Lost to Follow-up|1|||
129916986|NCT05374837|467661323|FG000|Overall Study|Lost to Follow-up|17|||
129916987|NCT05374837|467661324|FG001|Overall Study|Lost to Follow-up|18|||
129916988|NCT05054374|467661341|FG000|Overall Study|Withdrawal by Subject|1|||
129916989|NCT05054374|467661342|FG001|Overall Study|Withdrawal by Subject|0|||
129916990|NCT05054374|467661343|FG002|Overall Study|Withdrawal by Subject|0|||
129916991|NCT05054374|467661344|FG003|Overall Study|Withdrawal by Subject|0|||
129916992|NCT05054374|467661341|FG000|Overall Study|Progressive Disease|5|||
129916993|NCT05054374|467661342|FG001|Overall Study|Progressive Disease|0|||
129916994|NCT05054374|467661343|FG002|Overall Study|Progressive Disease|0|||
129916995|NCT05054374|467661344|FG003|Overall Study|Progressive Disease|0|||
129916996|NCT03453619|467661348|FG000|Core Study (Part A)|Physician Decision|0|||
129916997|NCT03453619|467661349|FG001|Core Study (Part A)|Physician Decision|0|||
129916998|NCT03453619|467661350|FG002|Core Study (Part A)|Physician Decision|2|||
129916999|NCT03453619|467661351|FG003|Core Study (Part A)|Physician Decision|0|||
129917000|NCT03453619|467661348|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
129917001|NCT03453619|467661349|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
129917002|NCT03453619|467661350|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
129917003|NCT03453619|467661351|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
129917004|NCT03453619|467661348|FG000|Core Study (Part A)|Other|0|||
129917005|NCT03453619|467661349|FG001|Core Study (Part A)|Other|1|||
129917006|NCT03453619|467661350|FG002|Core Study (Part A)|Other|0|||
129917007|NCT03453619|467661351|FG003|Core Study (Part A)|Other|0|||
129917008|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
129917009|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
129917010|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
129917011|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
129917012|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
129917013|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
129917014|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
129917015|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
129917016|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
129917017|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
129917018|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
129917019|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
129917020|NCT03453619|467661348|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
129917021|NCT03453619|467661349|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
129917022|NCT03453619|467661350|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
129917023|NCT03453619|467661351|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
129917024|NCT04089371|467661352|FG000|Overall Study|Withdrawal by Subject|0|||
129917025|NCT04089371|467661353|FG001|Overall Study|Withdrawal by Subject|1|||
129917026|NCT04089371|467661352|FG000|Overall Study|Study terminated early|0|||
129917027|NCT04089371|467661353|FG001|Overall Study|Study terminated early|9|||
129917028|NCT05229120|467661354|FG000|Overall Study|Withdrawal by Subject|8|||
129917029|NCT05862870|467661357|FG000|Overall Study|Lost to Follow-up|3|||
129917030|NCT02900924|467661358|FG000|Overall Study|Death|52|||
129917031|NCT02900924|467661358|FG000|Overall Study|Lost to Follow-up|4|||
129917032|NCT02900924|467661358|FG000|Overall Study|Withdrawal by Subject|20|||
129917033|NCT02900924|467661358|FG000|Overall Study|Missed Visit|33|||
129917034|NCT02365766|467661378|FG000|Overall Study|Withdrawal by Subject|0|||
129917035|NCT02365766|467661379|FG001|Overall Study|Withdrawal by Subject|0|||
129917036|NCT02365766|467661380|FG002|Overall Study|Withdrawal by Subject|1|||
129917037|NCT02365766|467661378|FG000|Overall Study|Eligibility Criteria Not Met|0|||
129917038|NCT02365766|467661379|FG001|Overall Study|Eligibility Criteria Not Met|0|||
129917039|NCT02365766|467661380|FG002|Overall Study|Eligibility Criteria Not Met|1|||
129917040|NCT03763708|467661384|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
129917041|NCT03763708|467661385|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917042|NCT03763708|467661386|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917043|NCT03763708|467661387|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917044|NCT03763708|467661388|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917045|NCT03763708|467661389|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917046|NCT03763708|467661390|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917047|NCT03763708|467661391|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917048|NCT03763708|467661392|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
129917049|NCT03763708|467661384|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917050|NCT03763708|467661385|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917051|NCT03763708|467661386|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
129917052|NCT03763708|467661387|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917053|NCT03763708|467661388|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917054|NCT03763708|467661389|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917055|NCT03763708|467661390|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129917056|NCT03763708|467661391|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129868876|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868877|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868878|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
129868879|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
129868880|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
129868881|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
129868882|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
129868883|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
129868884|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
129868885|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
129868886|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
129868887|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
129868888|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
129868889|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
129868890|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
129868891|NCT03104699|467475177|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
129868892|NCT03104699|467475178|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
129868893|NCT03104699|467475179|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
129868894|NCT03104699|467475180|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
129868895|NCT03104699|467475181|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
129868896|NCT03104699|467475182|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
129868897|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868898|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868899|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868900|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868901|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
129868902|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
129868903|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Death|0|||
129868904|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Death|0|||
129868905|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Death|0|||
129868906|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Death|0|||
129868907|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Death|0|||
129868908|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Death|107|||
129868909|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868910|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868911|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868912|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868913|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
129868914|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
129868915|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868916|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868917|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868918|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868919|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
129868920|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
129868921|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868922|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868923|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868924|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868925|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
129868926|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
129868927|NCT03104699|467475177|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
129868928|NCT03104699|467475178|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
129868929|NCT03104699|467475179|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
129868930|NCT03104699|467475180|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
129868931|NCT03104699|467475181|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
129449822|NCT01092143|465945687|FG003|Overall Study|Ineligible patient|0|||
129868932|NCT03104699|467475182|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
129868933|NCT01690130|467475183|FG000|Overall Study|Subject have cancelled visit.|1|||
129868934|NCT01690130|467475184|FG001|Overall Study|Subject have cancelled visit.|0|||
129868935|NCT01644734|467475185|FG000|Overall Study|Adverse Event|4|||
129868936|NCT01644734|467475185|FG000|Overall Study|Lost to Follow-up|17|||
129868937|NCT01644734|467475185|FG000|Overall Study|Reasons other than stated above|7|||
129868938|NCT01644734|467475185|FG000|Overall Study|Missing documentation|238|||
129868939|NCT03338894|467475186|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
129868940|NCT04465357|467475187|FG000|Overall Study|Adverse Event|2|||
129868941|NCT04465357|467475187|FG000|Overall Study|Lack of Efficacy|1|||
129868942|NCT04465357|467475187|FG000|Overall Study|Lost to Follow-up|2|||
129868943|NCT04465357|467475187|FG000|Overall Study|Withdrawal by Subject|6|||
129868944|NCT04465357|467475187|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
129868945|NCT01375114|467475189|FG000|Overall Study|Lost to Follow-up|1|||
129868946|NCT01375114|467475190|FG001|Overall Study|Lost to Follow-up|0|||
129868947|NCT01375114|467475191|FG002|Overall Study|Lost to Follow-up|1|||
129868948|NCT01375114|467475189|FG000|Overall Study|Disease Progression|3|||
129868949|NCT01375114|467475190|FG001|Overall Study|Disease Progression|2|||
129868950|NCT01375114|467475191|FG002|Overall Study|Disease Progression|2|||
129868951|NCT01375114|467475189|FG000|Overall Study|Patient Changed Mind|0|||
129868952|NCT01375114|467475190|FG001|Overall Study|Patient Changed Mind|0|||
129868953|NCT01375114|467475191|FG002|Overall Study|Patient Changed Mind|2|||
129868954|NCT01375114|467475189|FG000|Overall Study|Pruritus|0|||
129868955|NCT01375114|467475190|FG001|Overall Study|Pruritus|0|||
129868956|NCT01375114|467475191|FG002|Overall Study|Pruritus|1|||
129868957|NCT01375114|467475189|FG000|Overall Study|Restlessness|0|||
129868958|NCT01375114|467475190|FG001|Overall Study|Restlessness|0|||
129868959|NCT01375114|467475191|FG002|Overall Study|Restlessness|1|||
129868960|NCT01375114|467475189|FG000|Overall Study|Diarrhea|0|||
129868961|NCT01375114|467475190|FG001|Overall Study|Diarrhea|0|||
129868962|NCT01375114|467475191|FG002|Overall Study|Diarrhea|1|||
129868963|NCT01375114|467475189|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
129868964|NCT01375114|467475190|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
129868965|NCT01375114|467475191|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
129868966|NCT01375114|467475189|FG000|Overall Study|Nausea|0|||
129868967|NCT01375114|467475190|FG001|Overall Study|Nausea|1|||
129868968|NCT01375114|467475191|FG002|Overall Study|Nausea|0|||
129868969|NCT01375114|467475189|FG000|Overall Study|Increased AST/ALT|0|||
129868970|NCT01375114|467475190|FG001|Overall Study|Increased AST/ALT|1|||
129868971|NCT01375114|467475191|FG002|Overall Study|Increased AST/ALT|0|||
129868972|NCT01375114|467475189|FG000|Overall Study|Vaginal Hemorrhage|0|||
129868973|NCT01375114|467475190|FG001|Overall Study|Vaginal Hemorrhage|1|||
129868974|NCT01375114|467475191|FG002|Overall Study|Vaginal Hemorrhage|0|||
129868975|NCT01375114|467475189|FG000|Overall Study|Family problem|0|||
129868976|NCT01375114|467475190|FG001|Overall Study|Family problem|1|||
129868977|NCT01375114|467475191|FG002|Overall Study|Family problem|0|||
129868978|NCT01375114|467475189|FG000|Overall Study|Protocol Violation|2|||
129868979|NCT01375114|467475190|FG001|Overall Study|Protocol Violation|0|||
129868980|NCT01375114|467475191|FG002|Overall Study|Protocol Violation|0|||
129868981|NCT03575325|467475192|FG000|Overall Study|Death|1|||
129868982|NCT02618967|467475193|FG000|Overall Study|Lost to Follow-up|0|||
129868983|NCT02618967|467475194|FG001|Overall Study|Lost to Follow-up|0|||
129868984|NCT02618967|467475195|FG002|Overall Study|Lost to Follow-up|1|||
129868985|NCT02618967|467475196|FG003|Overall Study|Lost to Follow-up|0|||
129868986|NCT02618967|467475197|FG004|Overall Study|Lost to Follow-up|2|||
129868987|NCT02618967|467475198|FG005|Overall Study|Lost to Follow-up|0|||
129868988|NCT02618967|467475199|FG006|Overall Study|Lost to Follow-up|0|||
129868989|NCT02618967|467475200|FG007|Overall Study|Lost to Follow-up|0|||
129868990|NCT02618967|467475193|FG000|Overall Study|Withdrawal by Subject|1|||
129868991|NCT02618967|467475194|FG001|Overall Study|Withdrawal by Subject|0|||
129868992|NCT02618967|467475195|FG002|Overall Study|Withdrawal by Subject|0|||
129868993|NCT02618967|467475196|FG003|Overall Study|Withdrawal by Subject|0|||
129868994|NCT02618967|467475197|FG004|Overall Study|Withdrawal by Subject|0|||
129868995|NCT02618967|467475198|FG005|Overall Study|Withdrawal by Subject|0|||
129868996|NCT02618967|467475199|FG006|Overall Study|Withdrawal by Subject|0|||
129868997|NCT02618967|467475200|FG007|Overall Study|Withdrawal by Subject|0|||
129868998|NCT02612311|467475201|FG000|Overall Study|Adverse Event|16|||
129868999|NCT02612311|467475202|FG001|Overall Study|Adverse Event|12|||
129869000|NCT02612311|467475203|FG002|Overall Study|Adverse Event|7|||
129869001|NCT02612311|467475204|FG003|Overall Study|Adverse Event|13|||
129869002|NCT02612311|467475201|FG000|Overall Study|Death|29|||
129869003|NCT02612311|467475202|FG001|Overall Study|Death|10|||
129869004|NCT02612311|467475203|FG002|Overall Study|Death|11|||
129917057|NCT03763708|467661392|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
129869005|NCT02612311|467475204|FG003|Overall Study|Death|11|||
129869006|NCT02612311|467475201|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
129869007|NCT02612311|467475202|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
129869008|NCT02612311|467475203|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
129869009|NCT02612311|467475204|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
129869010|NCT02612311|467475201|FG000|Overall Study|Investigator's Decision|11|||
129869011|NCT02612311|467475202|FG001|Overall Study|Investigator's Decision|15|||
129869012|NCT02612311|467475203|FG002|Overall Study|Investigator's Decision|6|||
129869013|NCT02612311|467475204|FG003|Overall Study|Investigator's Decision|6|||
129869014|NCT02612311|467475201|FG000|Overall Study|Lack of Efficacy|0|||
129869015|NCT02612311|467475202|FG001|Overall Study|Lack of Efficacy|0|||
129869016|NCT02612311|467475203|FG002|Overall Study|Lack of Efficacy|1|||
129869017|NCT02612311|467475204|FG003|Overall Study|Lack of Efficacy|1|||
129869018|NCT02612311|467475201|FG000|Overall Study|Lost to Follow-up|2|||
129869019|NCT02612311|467475202|FG001|Overall Study|Lost to Follow-up|2|||
129869020|NCT02612311|467475203|FG002|Overall Study|Lost to Follow-up|1|||
129869021|NCT02612311|467475204|FG003|Overall Study|Lost to Follow-up|2|||
129869022|NCT02612311|467475201|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
129869023|NCT02612311|467475202|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
129869024|NCT02612311|467475203|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
129869025|NCT02612311|467475204|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
129869026|NCT02612311|467475201|FG000|Overall Study|Site Terminated by Sponsor|29|||
129869027|NCT02612311|467475202|FG001|Overall Study|Site Terminated by Sponsor|12|||
129869028|NCT02612311|467475203|FG002|Overall Study|Site Terminated by Sponsor|13|||
129869029|NCT02612311|467475204|FG003|Overall Study|Site Terminated by Sponsor|5|||
129869030|NCT02612311|467475201|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
129869031|NCT02612311|467475202|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
129869032|NCT02612311|467475203|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
129869033|NCT02612311|467475204|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
129869034|NCT02612311|467475201|FG000|Overall Study|Reason Not Specified|3|||
129869035|NCT02612311|467475202|FG001|Overall Study|Reason Not Specified|7|||
129869036|NCT02612311|467475203|FG002|Overall Study|Reason Not Specified|4|||
129869037|NCT02612311|467475204|FG003|Overall Study|Reason Not Specified|5|||
129869038|NCT02612311|467475201|FG000|Overall Study|Unknown/Missing|10|||
129869039|NCT02612311|467475202|FG001|Overall Study|Unknown/Missing|13|||
129869040|NCT02612311|467475203|FG002|Overall Study|Unknown/Missing|4|||
129869041|NCT02612311|467475204|FG003|Overall Study|Unknown/Missing|0|||
129869042|NCT02612311|467475201|FG000|Overall Study|Non-Compliance with Study|1|||
129869043|NCT02612311|467475202|FG001|Overall Study|Non-Compliance with Study|0|||
129869044|NCT02612311|467475203|FG002|Overall Study|Non-Compliance with Study|0|||
129869045|NCT02612311|467475204|FG003|Overall Study|Non-Compliance with Study|0|||
129869046|NCT04393441|467475205|FG000|Overall Study|Adverse Event|0|||
129869047|NCT04393441|467475206|FG001|Overall Study|Adverse Event|3|||
129869048|NCT04393441|467475205|FG000|Overall Study|Withdrawal by Subject|5|||
129869049|NCT04393441|467475206|FG001|Overall Study|Withdrawal by Subject|7|||
129869050|NCT04393441|467475205|FG000|Overall Study|Lost to Follow-up|0|||
129869051|NCT04393441|467475206|FG001|Overall Study|Lost to Follow-up|2|||
129869052|NCT04393441|467475205|FG000|Overall Study|Protocol Deviation|2|||
129869053|NCT04393441|467475206|FG001|Overall Study|Protocol Deviation|1|||
129869054|NCT04393441|467475205|FG000|Overall Study|Reason not Specified|1|||
129869055|NCT04393441|467475206|FG001|Overall Study|Reason not Specified|1|||
129869056|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
129869057|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
129869058|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|disease progression|58|||
129869059|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|disease progression|47|||
129869060|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Death|3|||
129869061|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Death|6|||
129869062|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
129869063|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
129869064|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
129869065|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
129869066|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
129869067|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
129869068|NCT02472964|467475209|FG000|Part 1 (up to Week 24)|Other|2|||
129869069|NCT02472964|467475210|FG001|Part 1 (up to Week 24)|Other|1|||
129869070|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
129869071|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
129869072|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
129869073|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
129869074|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Death|0|||
129869075|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Death|1|||
129449823|NCT01092143|465945688|FG004|Overall Study|Ineligible patient|0|||
129869076|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
129869077|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
129869078|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
129869079|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
129869080|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
129869081|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
129869082|NCT02472964|467475209|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
129869083|NCT02472964|467475210|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
129869084|NCT01749982|467475216|FG000|Overall Study|Physician Decision|0|||
129869085|NCT01749982|467475217|FG001|Overall Study|Physician Decision|0|||
129869086|NCT01749982|467475218|FG002|Overall Study|Physician Decision|0|||
129869087|NCT01749982|467475219|FG003|Overall Study|Physician Decision|1|||
129869088|NCT01749982|467475216|FG000|Overall Study|Lost to Follow-up|0|||
129869089|NCT01749982|467475217|FG001|Overall Study|Lost to Follow-up|0|||
129869090|NCT01749982|467475218|FG002|Overall Study|Lost to Follow-up|0|||
129869091|NCT01749982|467475219|FG003|Overall Study|Lost to Follow-up|1|||
129869092|NCT01749982|467475216|FG000|Overall Study|Withdrawal by Subject|0|||
129869093|NCT01749982|467475217|FG001|Overall Study|Withdrawal by Subject|0|||
129869094|NCT01749982|467475218|FG002|Overall Study|Withdrawal by Subject|0|||
129869095|NCT01749982|467475219|FG003|Overall Study|Withdrawal by Subject|1|||
129869096|NCT01596582|467475220|FG000|Overall Study|Deemed ineligible after study visit|3|||
129869097|NCT01596582|467475221|FG001|Overall Study|Deemed ineligible after study visit|6|||
129869098|NCT01596582|467475220|FG000|Overall Study|Missing all outcome data|1|||
129869099|NCT01596582|467475221|FG001|Overall Study|Missing all outcome data|1|||
129869100|NCT03923933|467475226|FG000|Overall Study|Lost to Follow-up|1|||
129869101|NCT03923933|467475227|FG001|Overall Study|Lost to Follow-up|0|||
129869102|NCT03923933|467475226|FG000|Overall Study|Withdrawal by Subject|0|||
129869103|NCT03923933|467475227|FG001|Overall Study|Withdrawal by Subject|1|||
129869104|NCT00419263|467475228|FG000|Overall Study|Lost to Follow-up|2|||
129869105|NCT00419263|467475229|FG001|Overall Study|Lost to Follow-up|1|||
129869106|NCT00419263|467475230|FG002|Overall Study|Lost to Follow-up|1|||
129869107|NCT00419263|467475228|FG000|Overall Study|Randomized in Error, Not Treated|1|||
129869108|NCT00419263|467475229|FG001|Overall Study|Randomized in Error, Not Treated|1|||
129869109|NCT00419263|467475230|FG002|Overall Study|Randomized in Error, Not Treated|0|||
129869110|NCT00419263|467475228|FG000|Overall Study|Adverse Event|0|||
129869111|NCT00419263|467475229|FG001|Overall Study|Adverse Event|0|||
129869112|NCT00419263|467475230|FG002|Overall Study|Adverse Event|1|||
129869113|NCT00419263|467475228|FG000|Overall Study|Withdrawal by Subject|0|||
129869114|NCT00419263|467475229|FG001|Overall Study|Withdrawal by Subject|0|||
129869115|NCT00419263|467475230|FG002|Overall Study|Withdrawal by Subject|1|||
129869116|NCT03311373|467475233|FG000|Overall Study|Adverse Event|1|||
129869117|NCT03311373|467475233|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
129869118|NCT03311373|467475233|FG000|Overall Study|Lost to Follow-up|1|||
129869119|NCT03311373|467475233|FG000|Overall Study|Physician Decision|1|||
129869120|NCT03311373|467475233|FG000|Overall Study|Withdrawal by Subject|3|||
129869121|NCT00977665|467475234|FG000|Overall Study|Withdrawal by Subject|1|||
129869122|NCT00977665|467475235|FG001|Overall Study|Withdrawal by Subject|3|||
129869123|NCT00977665|467475234|FG000|Overall Study|Physician Decision|2|||
129869124|NCT00977665|467475235|FG001|Overall Study|Physician Decision|1|||
129869125|NCT00977665|467475234|FG000|Overall Study|Sponsor requested withdrawal|0|||
129869126|NCT00977665|467475235|FG001|Overall Study|Sponsor requested withdrawal|1|||
129869127|NCT00977665|467475234|FG000|Overall Study|Lost to Follow-up|1|||
129869128|NCT00977665|467475235|FG001|Overall Study|Lost to Follow-up|0|||
129869129|NCT00977665|467475234|FG000|Overall Study|Death|3|||
129869130|NCT00977665|467475235|FG001|Overall Study|Death|2|||
129869131|NCT00977665|467475234|FG000|Overall Study|Adverse Event|14|||
129869132|NCT00977665|467475235|FG001|Overall Study|Adverse Event|7|||
129869133|NCT00977665|467475234|FG000|Overall Study|Treatment failure|0|||
129869134|NCT00977665|467475235|FG001|Overall Study|Treatment failure|1|||
129869135|NCT02151266|467475244|FG000|Overall Study|Lost to Follow-up|1|||
129869136|NCT02151266|467475245|FG001|Overall Study|Lost to Follow-up|4|||
129869137|NCT02151266|467475246|FG002|Overall Study|Lost to Follow-up|1|||
129869138|NCT02151266|467475244|FG000|Overall Study|Did NOT receive intervention|3|||
129869139|NCT02151266|467475245|FG001|Overall Study|Did NOT receive intervention|6|||
129869140|NCT02151266|467475246|FG002|Overall Study|Did NOT receive intervention|2|||
129869141|NCT02151266|467475244|FG000|Overall Study|Not able to exercise|4|||
129869142|NCT02151266|467475245|FG001|Overall Study|Not able to exercise|5|||
129869143|NCT02151266|467475246|FG002|Overall Study|Not able to exercise|4|||
129869144|NCT02816138|467475250|FG000|Overall Study|Adverse Event|1|||
129869145|NCT00981084|467475251|FG000|Post Intervention (Data Analysis)|poor effort|1|||
129869146|NCT00981084|467475252|FG001|Post Intervention (Data Analysis)|poor effort|1|||
129869147|NCT00981084|467475251|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
129869148|NCT00981084|467475252|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
129869149|NCT02291679|467475253|FG000|Overall Study|Adverse Event|2|||
129869150|NCT02291679|467475254|FG001|Overall Study|Adverse Event|12|||
129869151|NCT02291679|467475255|FG002|Overall Study|Adverse Event|19|||
129869152|NCT02291679|467475253|FG000|Overall Study|Protocol Violation|5|||
129869153|NCT02291679|467475254|FG001|Overall Study|Protocol Violation|1|||
129869154|NCT02291679|467475255|FG002|Overall Study|Protocol Violation|7|||
129869155|NCT02291679|467475253|FG000|Overall Study|Withdrew Consent|18|||
129917058|NCT03763708|467661384|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917059|NCT03763708|467661385|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917060|NCT03763708|467661386|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917061|NCT03763708|467661387|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
129917062|NCT03763708|467661388|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917063|NCT03763708|467661389|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917064|NCT03763708|467661390|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917065|NCT03763708|467661391|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917066|NCT03763708|467661392|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
129917067|NCT03763708|467661384|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917068|NCT03763708|467661385|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917069|NCT03763708|467661386|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917070|NCT03763708|467661387|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917071|NCT03763708|467661388|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
129917072|NCT03763708|467661389|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917073|NCT03763708|467661390|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917074|NCT03763708|467661391|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917075|NCT03763708|467661392|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
129917076|NCT03763708|467661384|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917077|NCT03763708|467661385|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917078|NCT03763708|467661386|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917079|NCT03763708|467661387|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917080|NCT03763708|467661388|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917081|NCT03763708|467661389|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
129917082|NCT03763708|467661390|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917083|NCT03763708|467661391|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917084|NCT03763708|467661392|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
129917085|NCT03763708|467661384|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917086|NCT03763708|467661385|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917087|NCT03763708|467661386|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917088|NCT03763708|467661387|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917089|NCT03763708|467661388|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917090|NCT03763708|467661389|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917091|NCT03763708|467661390|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
129917092|NCT03763708|467661391|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917093|NCT03763708|467661392|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
129917094|NCT03763708|467661384|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
129917095|NCT03763708|467661385|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
129917096|NCT03763708|467661386|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
129917097|NCT03763708|467661387|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
129917098|NCT03763708|467661388|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
129917099|NCT03763708|467661389|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
129917100|NCT03763708|467661390|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
129917101|NCT03763708|467661391|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
129917102|NCT03763708|467661392|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
129917103|NCT03763708|467661384|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
129917104|NCT03763708|467661385|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
129917105|NCT03763708|467661386|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
129917106|NCT03763708|467661387|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
129917107|NCT03763708|467661388|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
129917108|NCT03763708|467661389|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
129917109|NCT03763708|467661390|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
129917110|NCT03763708|467661391|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
129917111|NCT03763708|467661392|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
129917112|NCT03763708|467661384|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
129917113|NCT03763708|467661385|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
129917114|NCT03763708|467661386|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
129917115|NCT03763708|467661387|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
129917116|NCT03763708|467661388|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
129917117|NCT03763708|467661389|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
129917118|NCT03763708|467661390|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
129917119|NCT03763708|467661391|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
129917120|NCT03763708|467661392|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
129917121|NCT02307565|467661395|FG000|Overall Study|Adverse Event|3|||
129917122|NCT02307565|467661396|FG001|Overall Study|Adverse Event|2|||
129917123|NCT02307565|467661395|FG000|Overall Study|Withdrawal by Subject|2|||
129917124|NCT02307565|467661396|FG001|Overall Study|Withdrawal by Subject|2|||
129917125|NCT04936035|467661403|FG000|Overall Study|Adverse Event|0|||
129917126|NCT04936035|467661404|FG001|Overall Study|Adverse Event|1|||
129917127|NCT04936035|467661405|FG002|Overall Study|Adverse Event|0|||
129869156|NCT02291679|467475254|FG001|Overall Study|Withdrew Consent|10|||
129869157|NCT02291679|467475255|FG002|Overall Study|Withdrew Consent|15|||
129869158|NCT02291679|467475253|FG000|Overall Study|Lost to Follow-up|12|||
129869159|NCT02291679|467475254|FG001|Overall Study|Lost to Follow-up|10|||
129869160|NCT02291679|467475255|FG002|Overall Study|Lost to Follow-up|9|||
129869161|NCT02291679|467475253|FG000|Overall Study|Insufficient Therapeutic Response|5|||
129869162|NCT02291679|467475254|FG001|Overall Study|Insufficient Therapeutic Response|5|||
129869163|NCT02291679|467475255|FG002|Overall Study|Insufficient Therapeutic Response|7|||
129869164|NCT02291679|467475253|FG000|Overall Study|Other|2|||
129869165|NCT02291679|467475254|FG001|Overall Study|Other|4|||
129869166|NCT02291679|467475255|FG002|Overall Study|Other|2|||
129869167|NCT00725296|467475256|FG000|Overall Study|Adverse Event|11|||
129869168|NCT00725296|467475256|FG000|Overall Study|Lack of Efficacy|7|||
129869169|NCT00725296|467475256|FG000|Overall Study|Withdrawal by Subject|3|||
129869170|NCT00725296|467475256|FG000|Overall Study|Non-Compliance|2|||
129869171|NCT00725296|467475256|FG000|Overall Study|Lost to Follow-up|1|||
129869172|NCT00725296|467475256|FG000|Overall Study|Other|38|||
129869173|NCT02127372|467476799|FG000|Overall Study|Withdrawal by Subject|1|||
129869174|NCT02127372|467476800|FG001|Overall Study|Withdrawal by Subject|0|||
129869175|NCT03320018|467476803|FG000|Treatment Period|Withdrawal by Subject|1|||
129869176|NCT03320018|467476804|FG001|Treatment Period|Withdrawal by Subject|0|||
129869177|NCT03320018|467476803|FG000|Day 90 Follow up|Death|0|||
129869178|NCT03320018|467476804|FG001|Day 90 Follow up|Death|1|||
129869179|NCT00420199|467476805|FG000|Overall Study|Participant no longer met study criteria|1|||
129869180|NCT00420199|467476806|FG001|Overall Study|Participant no longer met study criteria|0|||
129869181|NCT04020341|467476809|FG000|Overall Study|Adverse Event|8|||
129869182|NCT04020341|467476810|FG001|Overall Study|Adverse Event|6|||
129869183|NCT04020341|467476809|FG000|Overall Study|Lost to Follow-up|8|||
129869184|NCT04020341|467476810|FG001|Overall Study|Lost to Follow-up|2|||
129869185|NCT04020341|467476809|FG000|Overall Study|Withdrawal by Subject|16|||
129869186|NCT04020341|467476810|FG001|Overall Study|Withdrawal by Subject|16|||
129869187|NCT04020341|467476809|FG000|Overall Study|Participant not able to swallow the tablet|1|||
129869188|NCT04020341|467476810|FG001|Overall Study|Participant not able to swallow the tablet|0|||
129869189|NCT04020341|467476809|FG000|Overall Study|Physician Decision|0|||
129869190|NCT04020341|467476810|FG001|Overall Study|Physician Decision|2|||
129869191|NCT04020341|467476809|FG000|Overall Study|Protocol Deviation|0|||
129869192|NCT04020341|467476810|FG001|Overall Study|Protocol Deviation|2|||
129869193|NCT05763628|467476811|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
129869194|NCT05763628|467476812|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
129869195|NCT05763628|467476811|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
129869196|NCT05763628|467476812|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
129869197|NCT05763628|467476811|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
129869198|NCT05763628|467476812|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
129869199|NCT04683926|467476813|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
129869200|NCT04683926|467476814|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
129869201|NCT04683926|467476815|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
129869202|NCT04683926|467476816|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
129869203|NCT02123108|467476819|FG000|Overall Study|Death|2|||
129869204|NCT02123108|467476820|FG001|Overall Study|Death|3|||
129869205|NCT00716092|467476821|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
129869206|NCT00716092|467476822|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
129869207|NCT00716092|467476823|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
129869208|NCT01132326|467476824|FG000|Overall Study|Lack of Efficacy|25|||
129869209|NCT01132326|467476824|FG000|Overall Study|Adverse Event|37|||
129869210|NCT01132326|467476824|FG000|Overall Study|Protocol Violation|1|||
129869211|NCT01132326|467476824|FG000|Overall Study|Lost to Follow-up|16|||
129869212|NCT01132326|467476824|FG000|Overall Study|Withdrawal by Subject|40|||
129869213|NCT01132326|467476824|FG000|Overall Study|Physician Decision|10|||
129869214|NCT01132326|467476824|FG000|Overall Study|Study Termination|80|||
129869215|NCT01132326|467476824|FG000|Overall Study|Declining Health|1|||
129869216|NCT01132326|467476824|FG000|Overall Study|Pregnancy|1|||
129869217|NCT01132326|467476824|FG000|Overall Study|Caregiver Withdrew Consent|1|||
129869218|NCT01132326|467476824|FG000|Overall Study|Death|5|||
129869219|NCT01132326|467476824|FG000|Overall Study|Subject Unable to Come To Visits|1|||
129869220|NCT00677235|467476825|FG000|Overall Study|Withdrawal by Subject|1|||
129869221|NCT00677235|467476826|FG001|Overall Study|Withdrawal by Subject|1|||
129869222|NCT00677235|467476825|FG000|Overall Study|Lost to Follow-up|2|||
129869223|NCT00677235|467476826|FG001|Overall Study|Lost to Follow-up|1|||
129869224|NCT00677235|467476825|FG000|Overall Study|Death|37|||
129869225|NCT00677235|467476826|FG001|Overall Study|Death|36|||
129869226|NCT00677235|467476825|FG000|Overall Study|Adverse Experience|1|||
129869227|NCT00677235|467476826|FG001|Overall Study|Adverse Experience|0|||
129869228|NCT00952367|467476827|FG000|Overall Study|Withdrawal by Subject|2|||
129869229|NCT00952367|467476827|FG000|Overall Study|Noncoordination|1|||
129869230|NCT00952367|467476827|FG000|Overall Study|Protocol Violation|3|||
129869231|NCT01040260|467476828|FG000|Overall Study|Withdrawal by Subject|12|||
129869232|NCT01040260|467476829|FG001|Overall Study|Withdrawal by Subject|6|||
129917128|NCT04936035|467661406|FG003|Overall Study|Adverse Event|0|||
129917129|NCT04936035|467661407|FG004|Overall Study|Adverse Event|0|||
129917130|NCT04936035|467661403|FG000|Overall Study|Death|0|||
129917131|NCT04936035|467661404|FG001|Overall Study|Death|0|||
129917132|NCT04936035|467661405|FG002|Overall Study|Death|0|||
129917133|NCT04936035|467661406|FG003|Overall Study|Death|1|||
129917134|NCT04936035|467661407|FG004|Overall Study|Death|0|||
129917135|NCT04936035|467661403|FG000|Overall Study|Lost to Follow-up|0|||
129917136|NCT04936035|467661404|FG001|Overall Study|Lost to Follow-up|1|||
129917137|NCT04936035|467661405|FG002|Overall Study|Lost to Follow-up|1|||
129917138|NCT04936035|467661406|FG003|Overall Study|Lost to Follow-up|2|||
129917139|NCT04936035|467661407|FG004|Overall Study|Lost to Follow-up|1|||
129917140|NCT04936035|467661403|FG000|Overall Study|Physician Decision|0|||
129917141|NCT04936035|467661404|FG001|Overall Study|Physician Decision|1|||
129917142|NCT04936035|467661405|FG002|Overall Study|Physician Decision|0|||
129917143|NCT04936035|467661406|FG003|Overall Study|Physician Decision|0|||
129917144|NCT04936035|467661407|FG004|Overall Study|Physician Decision|0|||
129869233|NCT01040260|467476828|FG000|Overall Study|Lost to Follow-up|3|||
129869234|NCT01040260|467476829|FG001|Overall Study|Lost to Follow-up|5|||
129869235|NCT04570436|467476833|FG000|Overall Study|Adverse Event|0|||
129869236|NCT04570436|467476834|FG001|Overall Study|Adverse Event|0|||
129869237|NCT04570436|467476835|FG002|Overall Study|Adverse Event|1|||
129869238|NCT04570436|467476836|FG003|Overall Study|Adverse Event|0|||
129869239|NCT04570436|467476837|FG004|Overall Study|Adverse Event|0|||
129869240|NCT04570436|467476838|FG005|Overall Study|Adverse Event|0|||
129869241|NCT04570436|467476839|FG006|Overall Study|Adverse Event|0|||
129869242|NCT04570436|467476840|FG007|Overall Study|Adverse Event|0|||
129869243|NCT04570436|467476841|FG008|Overall Study|Adverse Event|0|||
129869244|NCT04570436|467476842|FG009|Overall Study|Adverse Event|0|||
129869245|NCT04570436|467476833|FG000|Overall Study|Physician Decision|1|||
129869246|NCT04570436|467476834|FG001|Overall Study|Physician Decision|0|||
129869247|NCT04570436|467476835|FG002|Overall Study|Physician Decision|0|||
129869248|NCT04570436|467476836|FG003|Overall Study|Physician Decision|0|||
129869249|NCT04570436|467476837|FG004|Overall Study|Physician Decision|0|||
129869250|NCT04570436|467476838|FG005|Overall Study|Physician Decision|0|||
129869251|NCT04570436|467476839|FG006|Overall Study|Physician Decision|0|||
129869252|NCT04570436|467476840|FG007|Overall Study|Physician Decision|0|||
129869253|NCT04570436|467476841|FG008|Overall Study|Physician Decision|0|||
129869254|NCT04570436|467476842|FG009|Overall Study|Physician Decision|0|||
129869255|NCT00781391|467476843|FG000|Overall Study|never received study drug|24|||
129869256|NCT00781391|467476844|FG001|Overall Study|never received study drug|23|||
129869257|NCT00781391|467476845|FG002|Overall Study|never received study drug|32|||
129869258|NCT00781391|467476843|FG000|Overall Study|Protocol Violation|19|||
129869259|NCT00781391|467476844|FG001|Overall Study|Protocol Violation|17|||
129869260|NCT00781391|467476845|FG002|Overall Study|Protocol Violation|20|||
129869261|NCT00781391|467476843|FG000|Overall Study|Death|789|||
129869262|NCT00781391|467476844|FG001|Overall Study|Death|730|||
129869263|NCT00781391|467476845|FG002|Overall Study|Death|706|||
129869264|NCT00781391|467476843|FG000|Overall Study|Withdrawal by Subject|47|||
129869265|NCT00781391|467476844|FG001|Overall Study|Withdrawal by Subject|37|||
129869266|NCT00781391|467476845|FG002|Overall Study|Withdrawal by Subject|25|||
129869267|NCT00781391|467476843|FG000|Overall Study|Lost to Follow-up|0|||
129869268|NCT00781391|467476844|FG001|Overall Study|Lost to Follow-up|0|||
129869269|NCT00781391|467476845|FG002|Overall Study|Lost to Follow-up|1|||
129869270|NCT00689221|467476848|FG000|Overall Study|Ongoing at cut-off date|39|||
129869271|NCT00689221|467476849|FG001|Overall Study|Ongoing at cut-off date|36|||
129917145|NCT04936035|467661403|FG000|Overall Study|Protocol Deviation|0|||
129917146|NCT04936035|467661404|FG001|Overall Study|Protocol Deviation|0|||
129449824|NCT01092143|465945684|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
129869272|NCT01812655|467476850|FG000|Overall Study|Protocol Violation|1|||
129869273|NCT01812655|467476851|FG001|Overall Study|Protocol Violation|1|||
129869274|NCT01812655|467476852|FG002|Overall Study|Protocol Violation|0|||
129869275|NCT04435665|467476854|FG000|Overall Study|Lost to Follow-up|0|||
129869276|NCT04435665|467476855|FG001|Overall Study|Lost to Follow-up|0|||
129869277|NCT04435665|467476856|FG002|Overall Study|Lost to Follow-up|0|||
129869278|NCT04435665|467476857|FG003|Overall Study|Lost to Follow-up|1|||
129869279|NCT04672941|467476858|FG000|Overall Study|Investigator decision|1|||
129869280|NCT04672941|467476858|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
129869281|NCT04672941|467476858|FG000|Overall Study|COVID-19 related but no adverse event|1|||
129869282|NCT04672941|467476858|FG000|Overall Study|Adverse Event|2|||
129869283|NCT04672941|467476858|FG000|Overall Study|Lost to Follow-up|2|||
129869284|NCT00765388|467476859|FG000|Period 1|Lack of Efficacy|1|||
129869285|NCT00765388|467476860|FG001|Period 1|Lack of Efficacy|2|||
129869286|NCT00765388|467476859|FG000|Period 1|Lost to Follow-up|0|||
129869287|NCT00765388|467476860|FG001|Period 1|Lost to Follow-up|1|||
129917147|NCT04936035|467661405|FG002|Overall Study|Protocol Deviation|1|||
129917148|NCT04936035|467661406|FG003|Overall Study|Protocol Deviation|0|||
129917149|NCT04936035|467661407|FG004|Overall Study|Protocol Deviation|0|||
129917150|NCT04936035|467661403|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
129917151|NCT04936035|467661404|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
129869288|NCT00765388|467476859|FG000|Period 1|Herpes Zoster|0|||
129869289|NCT00765388|467476860|FG001|Period 1|Herpes Zoster|1|||
129869290|NCT00765388|467476859|FG000|Period 1|Hip operation|0|||
129869291|NCT00765388|467476860|FG001|Period 1|Hip operation|1|||
129869292|NCT01563536|467476869|FG000|Overall Study|Withdrawal by Subject|0|||
129869293|NCT01563536|467476870|FG001|Overall Study|Withdrawal by Subject|2|||
129917152|NCT04936035|467661405|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
129917153|NCT04936035|467661406|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
129917154|NCT04936035|467661407|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
129917155|NCT04936035|467661403|FG000|Overall Study|Reason Unknown|0|||
129917156|NCT04936035|467661404|FG001|Overall Study|Reason Unknown|0|||
129917157|NCT04936035|467661405|FG002|Overall Study|Reason Unknown|0|||
129917158|NCT04936035|467661406|FG003|Overall Study|Reason Unknown|0|||
129917159|NCT04936035|467661407|FG004|Overall Study|Reason Unknown|1|||
129917160|NCT04936035|467661403|FG000|Overall Study|Withdrawal by Subject|1|||
129917161|NCT04936035|467661404|FG001|Overall Study|Withdrawal by Subject|0|||
129917162|NCT04936035|467661405|FG002|Overall Study|Withdrawal by Subject|0|||
129917163|NCT04936035|467661406|FG003|Overall Study|Withdrawal by Subject|0|||
129917164|NCT04936035|467661407|FG004|Overall Study|Withdrawal by Subject|0|||
129917165|NCT04936035|467661403|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917166|NCT04936035|467661404|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917167|NCT04936035|467661405|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917168|NCT04936035|467661406|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
129917169|NCT04936035|467661407|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
129917170|NCT04936035|467661403|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917171|NCT04936035|467661404|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917172|NCT04936035|467661405|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917173|NCT04936035|467661406|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
129917174|NCT04936035|467661407|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
129917175|NCT04936035|467661403|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129917176|NCT04936035|467661404|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129917177|NCT04936035|467661405|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129917178|NCT04936035|467661406|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
129869294|NCT01563536|467476869|FG000|Overall Study|Lost to Follow-up|1|||
129917179|NCT04936035|467661407|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
129917180|NCT03978871|467661418|FG000|Overall Study|Lost to Follow-up|11|||
129917181|NCT03978871|467661419|FG001|Overall Study|Lost to Follow-up|12|||
129917182|NCT04072822|467661420|FG000|Treatment|Adverse Event|9|||
129917183|NCT04072822|467661421|FG001|Treatment|Adverse Event|5|||
129917184|NCT04072822|467661420|FG000|Treatment|Met Stopping Criteria|13|||
129917185|NCT04072822|467661421|FG001|Treatment|Met Stopping Criteria|24|||
129917186|NCT04072822|467661420|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
129917187|NCT04072822|467661421|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
129917188|NCT04072822|467661420|FG000|Treatment|Withdrawal by Subject|0|||
129917189|NCT04072822|467661421|FG001|Treatment|Withdrawal by Subject|2|||
129917190|NCT04072822|467661420|FG000|Treatment|Death|0|||
129917191|NCT04072822|467661421|FG001|Treatment|Death|2|||
129917192|NCT04072822|467661420|FG000|Treatment|Lost to Follow-up|11|||
129917193|NCT04072822|467661421|FG001|Treatment|Lost to Follow-up|3|||
129917194|NCT04072822|467661420|FG000|Treatment|Physician Decision|1|||
129917195|NCT04072822|467661421|FG001|Treatment|Physician Decision|0|||
129917196|NCT04072822|467661420|FG000|Treatment|Other|7|||
129917197|NCT04072822|467661421|FG001|Treatment|Other|9|||
129917198|NCT04072822|467661420|FG000|Follow-up|Withdrawal by Subject|1|||
129917199|NCT04072822|467661421|FG001|Follow-up|Withdrawal by Subject|0|||
129869295|NCT01563536|467476870|FG001|Overall Study|Lost to Follow-up|0|||
129869296|NCT00538590|467476873|FG000|Overall Study|Death|1|||
129917200|NCT04072822|467661420|FG000|Follow-up|Lost to Follow-up|5|||
129917201|NCT04072822|467661421|FG001|Follow-up|Lost to Follow-up|4|||
129917202|NCT04391894|467661423|FG000|Overall Study|Adverse Event|1|||
129917203|NCT04391894|467661424|FG001|Overall Study|Adverse Event|1|||
129917204|NCT04391894|467661425|FG002|Overall Study|Adverse Event|1|||
129917205|NCT04391894|467661426|FG003|Overall Study|Adverse Event|1|||
129917206|NCT04391894|467661427|FG004|Overall Study|Adverse Event|1|||
129917207|NCT04391894|467661423|FG000|Overall Study|Lost to Follow-up|1|||
129917208|NCT04391894|467661424|FG001|Overall Study|Lost to Follow-up|0|||
129917209|NCT04391894|467661425|FG002|Overall Study|Lost to Follow-up|0|||
129917210|NCT04391894|467661426|FG003|Overall Study|Lost to Follow-up|0|||
129917211|NCT04391894|467661427|FG004|Overall Study|Lost to Follow-up|0|||
129917212|NCT04391894|467661423|FG000|Overall Study|Protocol Violation|0|||
129917213|NCT04391894|467661424|FG001|Overall Study|Protocol Violation|0|||
129917214|NCT04391894|467661425|FG002|Overall Study|Protocol Violation|0|||
129917215|NCT04391894|467661426|FG003|Overall Study|Protocol Violation|1|||
129869297|NCT00538590|467476874|FG001|Overall Study|Death|0|||
129869298|NCT01256567|467476875|FG000|Overall Study|Withdrawal by Subject|1|||
129869299|NCT00671931|467476881|FG000|Overall Study|Physician Decision|1|||
129869300|NCT00671931|467476882|FG001|Overall Study|Physician Decision|0|||
129869301|NCT00671931|467476883|FG002|Overall Study|Physician Decision|0|||
129869302|NCT00671931|467476884|FG003|Overall Study|Physician Decision|2|||
129869303|NCT00671931|467476885|FG004|Overall Study|Physician Decision|1|||
129869304|NCT01169675|467476888|FG000|Overall Study|Progressive disease|13|||
129869305|NCT01169675|467476889|FG001|Overall Study|Progressive disease|2|||
129869306|NCT01169675|467476890|FG002|Overall Study|Progressive disease|5|||
129869307|NCT01169675|467476891|FG003|Overall Study|Progressive disease|15|||
129869308|NCT01169675|467476892|FG004|Overall Study|Progressive disease|1|||
129869309|NCT01169675|467476888|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129869310|NCT01169675|467476889|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129869311|NCT01169675|467476890|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129869312|NCT01169675|467476891|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129869313|NCT01169675|467476892|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129869314|NCT01169675|467476888|FG000|Overall Study|Adverse Event|5|||
129869315|NCT01169675|467476889|FG001|Overall Study|Adverse Event|1|||
129869316|NCT01169675|467476890|FG002|Overall Study|Adverse Event|2|||
129869317|NCT01169675|467476891|FG003|Overall Study|Adverse Event|0|||
129869318|NCT01169675|467476892|FG004|Overall Study|Adverse Event|0|||
129869319|NCT01169675|467476888|FG000|Overall Study|Withdrawal by Subject|1|||
129869320|NCT01169675|467476889|FG001|Overall Study|Withdrawal by Subject|0|||
129869321|NCT01169675|467476890|FG002|Overall Study|Withdrawal by Subject|0|||
129869322|NCT01169675|467476891|FG003|Overall Study|Withdrawal by Subject|1|||
129869323|NCT01169675|467476892|FG004|Overall Study|Withdrawal by Subject|2|||
129869324|NCT01169675|467476888|FG000|Overall Study|Other Reason Not Defined Above|0|||
129869325|NCT01169675|467476889|FG001|Overall Study|Other Reason Not Defined Above|0|||
129869326|NCT01169675|467476890|FG002|Overall Study|Other Reason Not Defined Above|0|||
129869327|NCT01169675|467476891|FG003|Overall Study|Other Reason Not Defined Above|1|||
129869328|NCT01169675|467476892|FG004|Overall Study|Other Reason Not Defined Above|1|||
129869329|NCT04839965|467476893|FG000|Overall Study|Death|6|||
129869330|NCT04839965|467476894|FG001|Overall Study|Death|6|||
129869331|NCT04839965|467476893|FG000|Overall Study|Lost to Follow-up|1|||
129869332|NCT04839965|467476894|FG001|Overall Study|Lost to Follow-up|0|||
129869333|NCT02365519|467476895|FG000|Randomized and Treated|Adverse Event|0|||
129869334|NCT02365519|467476896|FG001|Randomized and Treated|Adverse Event|1|||
129869335|NCT02365519|467476897|FG002|Randomized and Treated|Adverse Event|0|||
129869336|NCT02365519|467476895|FG000|Randomized and Treated|Withdrawal by Subject|0|||
129869337|NCT02365519|467476896|FG001|Randomized and Treated|Withdrawal by Subject|1|||
129869338|NCT02365519|467476897|FG002|Randomized and Treated|Withdrawal by Subject|1|||
129869339|NCT02048072|467476898|FG000|Overall Study|Adverse Event|3|||
129869340|NCT02048072|467476898|FG000|Overall Study|Lost to Follow-up|1|||
129869341|NCT02355028|467476899|FG000|Overall Study|Adverse Event|2|||
129869342|NCT02355028|467476900|FG001|Overall Study|Adverse Event|0|||
129869343|NCT02355028|467476899|FG000|Overall Study|Withdrawal by Subject|1|||
129869344|NCT02355028|467476900|FG001|Overall Study|Withdrawal by Subject|1|||
129869345|NCT02355028|467476899|FG000|Overall Study|Deemed ineligible after randomization|8|||
129869346|NCT02355028|467476900|FG001|Overall Study|Deemed ineligible after randomization|4|||
129869347|NCT02276222|467476901|FG000|Overall Study|Adverse Event|62|||
129869348|NCT02276222|467476902|FG001|Overall Study|Adverse Event|11|||
129917216|NCT04391894|467661427|FG004|Overall Study|Protocol Violation|0|||
129869349|NCT02276222|467476901|FG000|Overall Study|Death|3|||
129869350|NCT02276222|467476902|FG001|Overall Study|Death|4|||
129917217|NCT04391894|467661423|FG000|Overall Study|Withdrawal by Subject|2|||
129917218|NCT04391894|467661424|FG001|Overall Study|Withdrawal by Subject|0|||
129917219|NCT04391894|467661425|FG002|Overall Study|Withdrawal by Subject|3|||
129917220|NCT04391894|467661426|FG003|Overall Study|Withdrawal by Subject|0|||
129917221|NCT04391894|467661427|FG004|Overall Study|Withdrawal by Subject|1|||
129917222|NCT04391894|467661423|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917223|NCT04391894|467661424|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917224|NCT04391894|467661425|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917225|NCT04391894|467661426|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
129917226|NCT04391894|467661427|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
129917227|NCT02323321|467661431|FG000|Overall Study|Re-Transplant|1|||
129917228|NCT02323321|467661431|FG000|Overall Study|Death|12|||
129917229|NCT00446225|467661432|FG000|Overall Study|Protocol Violation|1|||
129917230|NCT00446225|467661433|FG001|Overall Study|Protocol Violation|0|||
129917231|NCT04450342|467661434|FG000|Overall Study|Adverse Event|1|||
129917232|NCT04450342|467661435|FG001|Overall Study|Adverse Event|1|||
129917233|NCT04450342|467661436|FG002|Overall Study|Adverse Event|0|||
129917234|NCT04450342|467661434|FG000|Overall Study|Device not used|1|||
129917235|NCT04450342|467661435|FG001|Overall Study|Device not used|0|||
129869351|NCT02276222|467476901|FG000|Overall Study|Lack of Efficacy|13|||
129869352|NCT02276222|467476902|FG001|Overall Study|Lack of Efficacy|3|||
129869353|NCT02276222|467476901|FG000|Overall Study|Protocol Violation|3|||
129869354|NCT02276222|467476902|FG001|Overall Study|Protocol Violation|2|||
129869355|NCT02276222|467476901|FG000|Overall Study|Withdrawal by Subject|79|||
129869356|NCT02276222|467476902|FG001|Overall Study|Withdrawal by Subject|33|||
129869357|NCT02276222|467476901|FG000|Overall Study|non compliance with study medication|6|||
129869358|NCT02276222|467476902|FG001|Overall Study|non compliance with study medication|2|||
129869359|NCT02276222|467476901|FG000|Overall Study|sponsor decision|0|||
129869360|NCT02276222|467476902|FG001|Overall Study|sponsor decision|3|||
129869361|NCT02276222|467476901|FG000|Overall Study|Lost to Follow-up|15|||
129869362|NCT02276222|467476902|FG001|Overall Study|Lost to Follow-up|5|||
129869363|NCT02276222|467476901|FG000|Overall Study|Physician Decision|2|||
129869364|NCT02276222|467476902|FG001|Overall Study|Physician Decision|1|||
129869365|NCT02276222|467476901|FG000|Overall Study|sheduling conflict|1|||
129869366|NCT02276222|467476902|FG001|Overall Study|sheduling conflict|0|||
129869367|NCT02276222|467476901|FG000|Overall Study|subject withdrew after randomization|1|||
129869368|NCT02276222|467476902|FG001|Overall Study|subject withdrew after randomization|0|||
129869369|NCT01971723|467476903|FG000|Overall Study|Withdrawal by Subject|1|||
129869370|NCT01971723|467476904|FG001|Overall Study|Withdrawal by Subject|1|||
129869371|NCT01971723|467476903|FG000|Overall Study|Protocol Violation|1|||
129869372|NCT01971723|467476904|FG001|Overall Study|Protocol Violation|2|||
129869373|NCT03645759|467476905|FG000|Overall Study|Lost to Follow-up|3|||
129869374|NCT03645759|467476906|FG001|Overall Study|Lost to Follow-up|2|||
129869375|NCT01648270|467476907|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
129869376|NCT00902694|467476908|FG000|Overall Study|Death|1|||
129869377|NCT00902694|467476909|FG001|Overall Study|Death|3|||
129869378|NCT00902694|467476908|FG000|Overall Study|Lost to Follow-up|1|||
129869379|NCT00902694|467476909|FG001|Overall Study|Lost to Follow-up|0|||
129869380|NCT00902694|467476908|FG000|Overall Study|Censored per protocol|3|||
129869381|NCT00902694|467476909|FG001|Overall Study|Censored per protocol|1|||
129869382|NCT00902694|467476908|FG000|Overall Study|Pregnancy|1|||
129869383|NCT00902694|467476909|FG001|Overall Study|Pregnancy|1|||
129869384|NCT00902694|467476908|FG000|Overall Study|Incarceration|1|||
129869385|NCT00902694|467476909|FG001|Overall Study|Incarceration|0|||
129869386|NCT04969263|467476910|FG000|Overall Study|Death|1|||
129869387|NCT04969263|467476910|FG000|Overall Study|Lost to Follow-up|2|||
129869388|NCT04969263|467476910|FG000|Overall Study|Withdrawal by Subject|5|||
129869389|NCT04969263|467476910|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
129869390|NCT02693743|467476912|FG000|Overall Study|Physician Decision|1|||
129869391|NCT02693743|467476913|FG001|Overall Study|Physician Decision|0|||
129869392|NCT01024608|467476915|FG000|Overall Study|Adverse Event|1|||
129869393|NCT01024608|467476916|FG001|Overall Study|Adverse Event|0|||
129869394|NCT01024608|467476915|FG000|Overall Study|Withdrawal by Subject|1|||
129869395|NCT01024608|467476916|FG001|Overall Study|Withdrawal by Subject|0|||
129869396|NCT01024608|467476915|FG000|Overall Study|Lost to Follow-up|0|||
129917236|NCT04450342|467661436|FG002|Overall Study|Device not used|0|||
129917237|NCT04450342|467661434|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
129869397|NCT01024608|467476916|FG001|Overall Study|Lost to Follow-up|1|||
129869398|NCT01024608|467476915|FG000|Overall Study|Protocol Violation|0|||
129869399|NCT01024608|467476916|FG001|Overall Study|Protocol Violation|3|||
129869400|NCT01024608|467476915|FG000|Overall Study|Never received study treatment|2|||
129869401|NCT01024608|467476916|FG001|Overall Study|Never received study treatment|0|||
129869402|NCT01592370|467476932|FG000|Overall Study|Disease Progression|62|||
129869403|NCT01592370|467476933|FG001|Overall Study|Disease Progression|16|||
129869404|NCT01592370|467476934|FG002|Overall Study|Disease Progression|52|||
129869405|NCT01592370|467476935|FG003|Overall Study|Disease Progression|3|||
129869406|NCT01592370|467476936|FG004|Overall Study|Disease Progression|3|||
129869407|NCT01592370|467476937|FG005|Overall Study|Disease Progression|31|||
129869408|NCT01592370|467476938|FG006|Overall Study|Disease Progression|14|||
129869409|NCT01592370|467476932|FG000|Overall Study|Study Drug Toxicity|14|||
129869410|NCT01592370|467476933|FG001|Overall Study|Study Drug Toxicity|3|||
129869411|NCT01592370|467476934|FG002|Overall Study|Study Drug Toxicity|0|||
129869412|NCT01592370|467476935|FG003|Overall Study|Study Drug Toxicity|0|||
129869413|NCT01592370|467476936|FG004|Overall Study|Study Drug Toxicity|0|||
129869414|NCT01592370|467476937|FG005|Overall Study|Study Drug Toxicity|0|||
129869415|NCT01592370|467476938|FG006|Overall Study|Study Drug Toxicity|1|||
129869416|NCT01592370|467476932|FG000|Overall Study|AE unrelated to study drug|4|||
129869417|NCT01592370|467476933|FG001|Overall Study|AE unrelated to study drug|3|||
129869418|NCT01592370|467476934|FG002|Overall Study|AE unrelated to study drug|0|||
129869419|NCT01592370|467476935|FG003|Overall Study|AE unrelated to study drug|0|||
129869420|NCT01592370|467476936|FG004|Overall Study|AE unrelated to study drug|0|||
129869421|NCT01592370|467476937|FG005|Overall Study|AE unrelated to study drug|0|||
129869422|NCT01592370|467476938|FG006|Overall Study|AE unrelated to study drug|1|||
129869423|NCT01592370|467476932|FG000|Overall Study|Request to discontinue study treatment|5|||
129869424|NCT01592370|467476933|FG001|Overall Study|Request to discontinue study treatment|0|||
129869425|NCT01592370|467476934|FG002|Overall Study|Request to discontinue study treatment|2|||
129869426|NCT01592370|467476935|FG003|Overall Study|Request to discontinue study treatment|0|||
129869427|NCT01592370|467476936|FG004|Overall Study|Request to discontinue study treatment|1|||
129869428|NCT01592370|467476937|FG005|Overall Study|Request to discontinue study treatment|2|||
129869429|NCT01592370|467476938|FG006|Overall Study|Request to discontinue study treatment|0|||
129869430|NCT01592370|467476932|FG000|Overall Study|Withdrew consent|1|||
129869431|NCT01592370|467476933|FG001|Overall Study|Withdrew consent|2|||
129869432|NCT01592370|467476934|FG002|Overall Study|Withdrew consent|1|||
129869433|NCT01592370|467476935|FG003|Overall Study|Withdrew consent|1|||
129869434|NCT01592370|467476936|FG004|Overall Study|Withdrew consent|0|||
129869435|NCT01592370|467476937|FG005|Overall Study|Withdrew consent|0|||
129869436|NCT01592370|467476938|FG006|Overall Study|Withdrew consent|0|||
129869437|NCT01592370|467476932|FG000|Overall Study|Maximum clinical benefit|11|||
129869438|NCT01592370|467476933|FG001|Overall Study|Maximum clinical benefit|1|||
129869439|NCT01592370|467476934|FG002|Overall Study|Maximum clinical benefit|7|||
129869440|NCT01592370|467476935|FG003|Overall Study|Maximum clinical benefit|1|||
129869441|NCT01592370|467476936|FG004|Overall Study|Maximum clinical benefit|0|||
129869442|NCT01592370|467476937|FG005|Overall Study|Maximum clinical benefit|0|||
129869443|NCT01592370|467476938|FG006|Overall Study|Maximum clinical benefit|0|||
129869444|NCT01592370|467476932|FG000|Overall Study|No longer meets study criteria|1|||
129869445|NCT01592370|467476933|FG001|Overall Study|No longer meets study criteria|0|||
129869446|NCT01592370|467476934|FG002|Overall Study|No longer meets study criteria|0|||
129869447|NCT01592370|467476935|FG003|Overall Study|No longer meets study criteria|0|||
129869448|NCT01592370|467476936|FG004|Overall Study|No longer meets study criteria|0|||
129869449|NCT01592370|467476937|FG005|Overall Study|No longer meets study criteria|0|||
129869450|NCT01592370|467476938|FG006|Overall Study|No longer meets study criteria|0|||
129869451|NCT01592370|467476932|FG000|Overall Study|Other Reasons|6|||
129869452|NCT01592370|467476933|FG001|Overall Study|Other Reasons|0|||
129869453|NCT01592370|467476934|FG002|Overall Study|Other Reasons|10|||
129869454|NCT01592370|467476935|FG003|Overall Study|Other Reasons|0|||
129869455|NCT01592370|467476936|FG004|Overall Study|Other Reasons|0|||
129869456|NCT01592370|467476937|FG005|Overall Study|Other Reasons|1|||
129869457|NCT01592370|467476938|FG006|Overall Study|Other Reasons|0|||
129869458|NCT02412137|467476943|FG000|Overall Study|Withdrawal by Subject|2|||
129869459|NCT02412137|467476944|FG001|Overall Study|Withdrawal by Subject|0|||
129869460|NCT02412137|467476943|FG000|Overall Study|Lost to Follow-up|21|||
129869461|NCT02412137|467476944|FG001|Overall Study|Lost to Follow-up|14|||
129869462|NCT02412137|467476943|FG000|Overall Study|Physician Decision|28|||
129917238|NCT04450342|467661435|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
129917239|NCT04450342|467661436|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
129869463|NCT02412137|467476944|FG001|Overall Study|Physician Decision|9|||
129869464|NCT01323530|467478885|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
129869465|NCT01323530|467478886|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869466|NCT01323530|467478887|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869467|NCT01323530|467478888|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869468|NCT01323530|467478889|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869469|NCT01323530|467478890|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
129869470|NCT01323530|467478891|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
129869471|NCT01323530|467478885|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129917240|NCT04450342|467661434|FG000|Overall Study|Physician Decision|1|||
129869472|NCT01323530|467478886|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129917241|NCT04450342|467661435|FG001|Overall Study|Physician Decision|0|||
129917242|NCT04450342|467661436|FG002|Overall Study|Physician Decision|1|||
129917243|NCT04450342|467661434|FG000|Overall Study|Protocol Deviation|0|||
129917244|NCT04450342|467661435|FG001|Overall Study|Protocol Deviation|1|||
129917245|NCT04450342|467661436|FG002|Overall Study|Protocol Deviation|0|||
129917246|NCT04450342|467661434|FG000|Overall Study|Reoperation|1|||
129917247|NCT04450342|467661435|FG001|Overall Study|Reoperation|1|||
129917248|NCT04450342|467661436|FG002|Overall Study|Reoperation|0|||
129917249|NCT04450342|467661434|FG000|Overall Study|Screen Failures|0|||
129917250|NCT04450342|467661435|FG001|Overall Study|Screen Failures|0|||
129917251|NCT04450342|467661436|FG002|Overall Study|Screen Failures|2|||
129917252|NCT04450342|467661434|FG000|Overall Study|Site Terminated by Sponsor|1|||
129917253|NCT04450342|467661435|FG001|Overall Study|Site Terminated by Sponsor|1|||
129917254|NCT04450342|467661436|FG002|Overall Study|Site Terminated by Sponsor|1|||
129917255|NCT04450342|467661434|FG000|Overall Study|Study Terminated by Sponsor|31|||
129917256|NCT04450342|467661435|FG001|Overall Study|Study Terminated by Sponsor|29|||
129917257|NCT04450342|467661436|FG002|Overall Study|Study Terminated by Sponsor|6|||
129917258|NCT04450342|467661434|FG000|Overall Study|Withdrawal by Subject|0|||
129917259|NCT04450342|467661435|FG001|Overall Study|Withdrawal by Subject|1|||
129917260|NCT04450342|467661436|FG002|Overall Study|Withdrawal by Subject|2|||
129917261|NCT03396588|467661437|FG000|Overall Study|Physician Decision|2|||
129917262|NCT03396588|467661438|FG001|Overall Study|Physician Decision|3|||
129917263|NCT00812461|467661439|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
129917264|NCT00812461|467661440|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
129917265|NCT00812461|467661439|FG000|All Treated Patients|Adverse Event|8|||
129917266|NCT00812461|467661440|FG001|All Treated Patients|Adverse Event|15|||
129917267|NCT00812461|467661439|FG000|All Treated Patients|Lack of Efficacy|13|||
129917268|NCT00812461|467661440|FG001|All Treated Patients|Lack of Efficacy|7|||
129917269|NCT00812461|467661439|FG000|All Treated Patients|Non-compliance|6|||
129917270|NCT00812461|467661440|FG001|All Treated Patients|Non-compliance|9|||
129917271|NCT00812461|467661439|FG000|All Treated Patients|Protocol Violation|36|||
129917272|NCT00812461|467661440|FG001|All Treated Patients|Protocol Violation|27|||
129917273|NCT00812461|467661439|FG000|All Treated Patients|Withdrawal by Subject|45|||
129917274|NCT00812461|467661440|FG001|All Treated Patients|Withdrawal by Subject|54|||
129917275|NCT00812461|467661439|FG000|All Treated Patients|Lost to Follow-up|11|||
129917276|NCT00812461|467661440|FG001|All Treated Patients|Lost to Follow-up|14|||
129917277|NCT00812461|467661439|FG000|All Treated Patients|Other Reason|13|||
129917278|NCT00812461|467661440|FG001|All Treated Patients|Other Reason|21|||
129917279|NCT04402489|467663028|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917280|NCT04402489|467663029|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
129917281|NCT04402489|467663030|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917282|NCT04402489|467663031|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917283|NCT04402489|467663032|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
129917284|NCT04402489|467663028|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
129917285|NCT04402489|467663029|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917286|NCT04402489|467663030|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917287|NCT04402489|467663031|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917288|NCT04402489|467663032|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
129917289|NCT04402489|467663028|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
129917290|NCT04402489|467663029|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
129917291|NCT04402489|467663030|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
129917292|NCT04402489|467663031|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
129917293|NCT04402489|467663032|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
129917294|NCT04402489|467663028|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917295|NCT04402489|467663029|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917296|NCT04402489|467663030|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
129917297|NCT04402489|467663031|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917298|NCT04402489|467663032|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
129917299|NCT04402489|467663028|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917300|NCT04402489|467663029|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917301|NCT04402489|467663030|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917302|NCT04402489|467663031|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
129917303|NCT04402489|467663032|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
129917304|NCT04402489|467663028|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
129917305|NCT04402489|467663029|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
129917306|NCT04402489|467663030|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
129917307|NCT04402489|467663031|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
129917308|NCT04402489|467663032|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
129917309|NCT04833777|467663038|FG000|Overall Study|Lost to Follow-up|1|||
129917310|NCT04833777|467663039|FG001|Overall Study|Lost to Follow-up|0|||
129917311|NCT03648840|467663046|FG000|First IV Infusion Session|Adverse Event|0|||
129917312|NCT03648840|467663047|FG001|First IV Infusion Session|Adverse Event|2|||
129917313|NCT03648840|467663046|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
129917314|NCT03648840|467663047|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
129917315|NCT03648840|467663046|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
129917316|NCT03648840|467663047|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
129917317|NCT03648840|467663046|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
129917318|NCT03648840|467663047|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
129917319|NCT05382936|467663050|FG000|Overall Study|Progressive Disease|3|||
129917320|NCT05382936|467663051|FG001|Overall Study|Progressive Disease|5|||
129917321|NCT05382936|467663052|FG002|Overall Study|Progressive Disease|2|||
129917322|NCT05382936|467663053|FG003|Overall Study|Progressive Disease|5|||
129917323|NCT05382936|467663050|FG000|Overall Study|Adverse Event|0|||
129917324|NCT05382936|467663051|FG001|Overall Study|Adverse Event|1|||
129917325|NCT05382936|467663052|FG002|Overall Study|Adverse Event|1|||
129917326|NCT05382936|467663053|FG003|Overall Study|Adverse Event|0|||
129917327|NCT05382936|467663050|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
129917328|NCT05382936|467663051|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
129917329|NCT05382936|467663052|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
129917330|NCT05382936|467663053|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
129917331|NCT05382936|467663050|FG000|Overall Study|Withdrawal by Subject|0|||
129917332|NCT05382936|467663051|FG001|Overall Study|Withdrawal by Subject|0|||
129917333|NCT05382936|467663052|FG002|Overall Study|Withdrawal by Subject|1|||
129917334|NCT05382936|467663053|FG003|Overall Study|Withdrawal by Subject|1|||
129917335|NCT05063994|467663054|FG000|Cortef Run-In|Withdrawal of Consent|1|||
129917336|NCT05063994|467663055|FG001|Cortef Run-In|Withdrawal of Consent|0|||
129917337|NCT05063994|467663056|FG002|Cortef Run-In|Withdrawal of Consent|0|||
129917338|NCT05063994|467663054|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
129917339|NCT05063994|467663055|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
129917340|NCT05063994|467663056|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
129917341|NCT05063994|467663054|FG000|Treatment|Physician Decision|0|||
129917342|NCT05063994|467663055|FG001|Treatment|Physician Decision|0|||
129917343|NCT05063994|467663056|FG002|Treatment|Physician Decision|1|||
129917344|NCT05063994|467663054|FG000|Treatment|Withdrawal by Subject|0|||
129917345|NCT05063994|467663055|FG001|Treatment|Withdrawal by Subject|0|||
129917346|NCT05063994|467663056|FG002|Treatment|Withdrawal by Subject|1|||
129917347|NCT05063994|467663054|FG000|Treatment|Withdrawal of Consent|0|||
129917348|NCT05063994|467663055|FG001|Treatment|Withdrawal of Consent|0|||
129917349|NCT05063994|467663056|FG002|Treatment|Withdrawal of Consent|1|||
129917350|NCT04630262|467663060|FG000|Overall Study|Intraoperative Screen Failure|5|||
129917351|NCT04630262|467663060|FG000|Overall Study|Study terminated prematurely|71|||
129917352|NCT04630262|467663060|FG000|Overall Study|Withdrawal by Subject|2|||
129917353|NCT04630262|467663060|FG000|Overall Study|Physician Decision|2|||
129917354|NCT01195831|467663062|FG000|Overall Study|Lost to Follow-up|2|||
129917355|NCT01195831|467663063|FG001|Overall Study|Lost to Follow-up|4|||
129917356|NCT01195831|467663062|FG000|Overall Study|Withdrawal by Subject|2|||
129917357|NCT01195831|467663063|FG001|Overall Study|Withdrawal by Subject|2|||
129917358|NCT01195831|467663062|FG000|Overall Study|Adverse Event|4|||
129917359|NCT01195831|467663063|FG001|Overall Study|Adverse Event|2|||
129917360|NCT01195831|467663062|FG000|Overall Study|Protocol Violation|0|||
129917361|NCT01195831|467663063|FG001|Overall Study|Protocol Violation|2|||
129917362|NCT01857934|467663064|FG000|Overall Study|Relapse or progression|2|||
129917363|NCT01857934|467663064|FG000|Overall Study|Unacceptable toxicity|3|||
129917364|NCT01857934|467663064|FG000|Overall Study|Unwillingness or inability to comply|2|||
129917365|NCT01857934|467663064|FG000|Overall Study|Physician Decision|3|||
129917366|NCT04703322|467663066|FG000|Overall Study|Ongoing|8|||
129917367|NCT04703322|467663066|FG000|Overall Study|Withdrawal by Subject|1|||
129917368|NCT04638998|467663070|FG000|Overall Study|Withdrawal by Subject|1|||
129917369|NCT04638998|467663071|FG001|Overall Study|Withdrawal by Subject|3|||
129917370|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior use|4424|||
129917371|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior use|24726|||
129917372|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior use|0|||
129917373|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior use|0|||
129917374|NCT03692676|467663072|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
129917375|NCT03692676|467663073|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
129917376|NCT03692676|467663074|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
129917377|NCT03692676|467663075|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
129917378|NCT03692676|467663072|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
129917379|NCT03692676|467663073|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
129917380|NCT03692676|467663074|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
129917381|NCT03692676|467663075|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
129917382|NCT03692676|467663072|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
129917383|NCT03692676|467663073|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
129917384|NCT03692676|467663074|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
129917385|NCT03692676|467663075|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
129917386|NCT03692676|467663072|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
129917387|NCT03692676|467663073|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
129917388|NCT03692676|467663074|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
129917389|NCT03692676|467663075|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
129917390|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
129917391|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
129917392|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
129917393|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
129917394|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
129917395|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
129917396|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
129917397|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
129917398|NCT03692676|467663072|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
129917399|NCT03692676|467663073|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
129917400|NCT03692676|467663074|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
129917401|NCT03692676|467663075|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
129917402|NCT03692676|467663072|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
129917403|NCT03692676|467663073|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
129917404|NCT03692676|467663074|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
129917405|NCT03692676|467663075|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
129917406|NCT03692676|467663072|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
129917407|NCT03692676|467663073|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
129917408|NCT03692676|467663074|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
129917409|NCT03692676|467663075|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
129917410|NCT03692676|467663072|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
129917411|NCT03692676|467663073|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
129917412|NCT03692676|467663074|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
129917413|NCT03692676|467663075|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
129917414|NCT03692676|467663072|FG000|Overall Study|Other|0|||
129917415|NCT03692676|467663073|FG001|Overall Study|Other|805|||
129917416|NCT03692676|467663074|FG002|Overall Study|Other|758|||
129917417|NCT03692676|467663075|FG003|Overall Study|Other|277|||
129917418|NCT03692676|467663072|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
129917419|NCT03692676|467663073|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
129917420|NCT03692676|467663074|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
129917421|NCT03692676|467663075|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
129917422|NCT03692611|467663077|FG000|Overall Study|Found to be ineligible postrandomization|3|||
129917423|NCT03692611|467663078|FG001|Overall Study|Found to be ineligible postrandomization|0|||
129917424|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
129917425|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
129917426|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
129917427|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
129917428|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
129917429|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
129917430|NCT02549339|467663088|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
129917431|NCT02549339|467663089|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
129917432|NCT02549339|467663088|FG000|12-month Follow-up|Lack of Efficacy|0|||
129917433|NCT02549339|467663089|FG001|12-month Follow-up|Lack of Efficacy|2|||
129917434|NCT02549339|467663088|FG000|12-month Follow-up|Withdrawal by Subject|8|||
129917435|NCT02549339|467663089|FG001|12-month Follow-up|Withdrawal by Subject|3|||
129917436|NCT02549339|467663088|FG000|12-month Follow-up|Lost to Follow-up|1|||
129917437|NCT02549339|467663089|FG001|12-month Follow-up|Lost to Follow-up|3|||
129917438|NCT02549339|467663088|FG000|12-month Follow-up|Other|0|||
129917439|NCT02549339|467663089|FG001|12-month Follow-up|Other|3|||
129917440|NCT03016169|467663090|FG000|Overall Study|Lost to Follow-up|4|||
129917441|NCT03016169|467663090|FG000|Overall Study|Death|54|||
129917442|NCT03016169|467663090|FG000|Overall Study|Device Explant|11|||
129917443|NCT03016169|467663090|FG000|Overall Study|Withdrawal by Subject|19|||
129917444|NCT03016169|467663090|FG000|Overall Study|Other Reasons|1|||
129917445|NCT02724878|467663091|FG000|Overall Study|Still on Active Therapy|15|||
129917446|NCT02724878|467663091|FG000|Overall Study|Disease Progression|31|||
129917447|NCT02724878|467663091|FG000|Overall Study|Toxicity|5|||
129917448|NCT02724878|467663091|FG000|Overall Study|Death|1|||
129917449|NCT02724878|467663091|FG000|Overall Study|Withdrawal by Subject|4|||
129917450|NCT02724878|467663091|FG000|Overall Study|Lost to Follow-up|2|||
129917451|NCT02724878|467663091|FG000|Overall Study|Protocol Violation|1|||
129917452|NCT02724878|467663091|FG000|Overall Study|Ineligible for Study Drug|5|||
129917453|NCT02724878|467663091|FG000|Overall Study|not started|1|||
129917454|NCT03958955|467663093|FG000|Overall Study|Adverse Event|1|||
129917455|NCT04838262|467663094|FG000|Overall Study|Withdrawal by Subject|9|||
129917456|NCT04838262|467663095|FG001|Overall Study|Withdrawal by Subject|4|||
129917457|NCT03175029|467663098|FG000|Overall Study|Withdrawal by Subject|2|||
129917458|NCT03175029|467663099|FG001|Overall Study|Withdrawal by Subject|1|||
129917459|NCT03175029|467663098|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
129917460|NCT03175029|467663099|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
129917461|NCT00512070|467663102|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
129917462|NCT00512070|467663103|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
129917463|NCT00512070|467663104|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
129917464|NCT00512070|467663102|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
129917465|NCT00512070|467663103|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
129917466|NCT00512070|467663104|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
129917467|NCT00961571|467663105|FG000|Overall Study|Physician Decision|39|||
129917468|NCT02506959|467663109|FG000|Overall Study|Physician Decision|2|||
129917469|NCT02506959|467663110|FG001|Overall Study|Physician Decision|1|||
129917470|NCT04382898|467663112|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
129917471|NCT04382898|467663113|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917472|NCT04382898|467663114|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917473|NCT04382898|467663115|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917474|NCT04382898|467663116|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
129917475|NCT04382898|467663112|FG000|Part 1: Dose Titration|Death|6|||
129917476|NCT04382898|467663113|FG001|Part 1: Dose Titration|Death|0|||
129917477|NCT04382898|467663114|FG002|Part 1: Dose Titration|Death|0|||
129917478|NCT04382898|467663115|FG003|Part 1: Dose Titration|Death|0|||
129917479|NCT04382898|467663116|FG004|Part 1: Dose Titration|Death|0|||
129917480|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129869473|NCT01323530|467478887|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
129869474|NCT01323530|467478888|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129869475|NCT01323530|467478889|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
129869476|NCT01323530|467478890|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129869477|NCT01323530|467478891|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
129869478|NCT01323530|467478885|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869479|NCT01323530|467478886|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
129869480|NCT01323530|467478887|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869481|NCT01323530|467478888|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869482|NCT01323530|467478889|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
129869483|NCT01323530|467478890|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
129869484|NCT01323530|467478891|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
129869485|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869486|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869487|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869488|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129869489|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129917481|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129917482|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
129917483|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129917484|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
129917485|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
129869490|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
129917486|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
129917487|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
129917488|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
129917489|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
129869491|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
129869492|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129917490|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Death|0|||
129917491|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Death|17|||
129869493|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869494|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869495|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869496|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869497|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
129869498|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
129869499|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869500|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869501|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869502|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869503|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869504|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
129869505|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
129869506|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869507|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869508|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869509|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869510|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869511|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
129869512|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
129869513|NCT01323530|467478885|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869514|NCT01323530|467478886|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869515|NCT01323530|467478887|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869516|NCT01323530|467478888|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869517|NCT01323530|467478889|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869518|NCT01323530|467478890|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
129869519|NCT01323530|467478891|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
129869520|NCT02532179|467478892|FG000|Overall Study|Lost to Follow-up|1|||
129869521|NCT02532179|467478892|FG000|Overall Study|Pregnancy|1|||
129869522|NCT02532179|467478892|FG000|Overall Study|Subject received depot steroid injection|1|||
129869523|NCT01735201|467478897|FG000|Overall Study|Adverse Event|1|||
129869524|NCT01735201|467478898|FG001|Overall Study|Adverse Event|1|||
129869525|NCT01735201|467478899|FG002|Overall Study|Adverse Event|0|||
129869526|NCT01735201|467478900|FG003|Overall Study|Adverse Event|1|||
129869527|NCT01735201|467478901|FG004|Overall Study|Adverse Event|1|||
129869528|NCT01735201|467478902|FG005|Overall Study|Adverse Event|3|||
129869529|NCT01735201|467478903|FG006|Overall Study|Adverse Event|2|||
129869530|NCT01735201|467478904|FG007|Overall Study|Adverse Event|1|||
129869531|NCT01735201|467478897|FG000|Overall Study|Personal Reasons|1|||
129869532|NCT01735201|467478898|FG001|Overall Study|Personal Reasons|0|||
129869533|NCT01735201|467478899|FG002|Overall Study|Personal Reasons|0|||
129869534|NCT01735201|467478900|FG003|Overall Study|Personal Reasons|0|||
129869535|NCT01735201|467478901|FG004|Overall Study|Personal Reasons|0|||
129869536|NCT01735201|467478902|FG005|Overall Study|Personal Reasons|0|||
129869537|NCT01735201|467478903|FG006|Overall Study|Personal Reasons|0|||
129869538|NCT01735201|467478904|FG007|Overall Study|Personal Reasons|0|||
129869539|NCT01735201|467478897|FG000|Overall Study|Protocol Violation|1|||
129869540|NCT01735201|467478898|FG001|Overall Study|Protocol Violation|0|||
129869541|NCT01735201|467478899|FG002|Overall Study|Protocol Violation|0|||
129869542|NCT01735201|467478900|FG003|Overall Study|Protocol Violation|0|||
129869543|NCT01735201|467478901|FG004|Overall Study|Protocol Violation|0|||
129869544|NCT01735201|467478902|FG005|Overall Study|Protocol Violation|0|||
129869545|NCT01735201|467478903|FG006|Overall Study|Protocol Violation|0|||
129869546|NCT01735201|467478904|FG007|Overall Study|Protocol Violation|0|||
129869547|NCT01735201|467478897|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129869548|NCT01735201|467478898|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129869549|NCT01735201|467478899|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129869550|NCT01735201|467478900|FG003|Overall Study|Other Miscellaneous Reasons|1|||
129869551|NCT01735201|467478901|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129869552|NCT01735201|467478902|FG005|Overall Study|Other Miscellaneous Reasons|2|||
129869553|NCT01735201|467478903|FG006|Overall Study|Other Miscellaneous Reasons|1|||
129869554|NCT01735201|467478904|FG007|Overall Study|Other Miscellaneous Reasons|1|||
129869555|NCT01553318|467478905|FG000|Overall Study|Protocol Violation|3|||
129869556|NCT01553318|467478906|FG001|Overall Study|Protocol Violation|2|||
129869557|NCT04128293|467478907|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129869558|NCT04128293|467478908|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129869559|NCT04128293|467478909|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129917492|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Death|13|||
129869560|NCT04128293|467478910|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
129869561|NCT01357616|467478911|FG000|Overall Study|Adverse Event|1|||
129869562|NCT01357616|467478912|FG001|Overall Study|Adverse Event|1|||
129869563|NCT01357616|467478911|FG000|Overall Study|Lost to Follow-up|4|||
129869564|NCT01357616|467478912|FG001|Overall Study|Lost to Follow-up|3|||
129869565|NCT01357616|467478911|FG000|Overall Study|Protocol Violation|0|||
129869566|NCT01357616|467478912|FG001|Overall Study|Protocol Violation|2|||
129869567|NCT01357616|467478911|FG000|Overall Study|Inadequate Control of IOP|1|||
129869568|NCT01357616|467478912|FG001|Overall Study|Inadequate Control of IOP|2|||
129869569|NCT01357616|467478911|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
129869570|NCT01357616|467478912|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
129869571|NCT01357616|467478911|FG000|Overall Study|Withdrawal by Subject|1|||
129869572|NCT01357616|467478912|FG001|Overall Study|Withdrawal by Subject|0|||
129869573|NCT03432364|467478914|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
129869574|NCT01699022|467478919|FG000|Overall Study|Early discontinuation from the study|3|||
129869575|NCT02066402|467478922|FG000|Overall Study|Adverse Event|1|||
129869576|NCT02066402|467478923|FG001|Overall Study|Adverse Event|2|||
129869577|NCT02066402|467478922|FG000|Overall Study|Lost to Follow-up|11|||
129869578|NCT02066402|467478923|FG001|Overall Study|Lost to Follow-up|8|||
129869579|NCT02066402|467478922|FG000|Overall Study|Withdrawal by Subject|14|||
129869580|NCT02066402|467478923|FG001|Overall Study|Withdrawal by Subject|11|||
129869581|NCT02066402|467478922|FG000|Overall Study|Progressive disease-clinical progression|0|||
129869582|NCT02066402|467478923|FG001|Overall Study|Progressive disease-clinical progression|1|||
129869583|NCT02066402|467478922|FG000|Overall Study|Protocol driven decision point|0|||
129869584|NCT02066402|467478923|FG001|Overall Study|Protocol driven decision point|1|||
129869585|NCT00152464|467478924|FG000|Overall Study|Adverse Event|3|||
129869586|NCT00152464|467478925|FG001|Overall Study|Adverse Event|6|||
129869587|NCT00152464|467478924|FG000|Overall Study|Lost to Follow-up|8|||
129869588|NCT00152464|467478925|FG001|Overall Study|Lost to Follow-up|4|||
129869589|NCT00152464|467478924|FG000|Overall Study|Protocol Violation|3|||
129869590|NCT00152464|467478925|FG001|Overall Study|Protocol Violation|1|||
129869591|NCT00152464|467478924|FG000|Overall Study|Withdrawal by Subject|21|||
129869592|NCT00152464|467478925|FG001|Overall Study|Withdrawal by Subject|22|||
129869593|NCT00152464|467478924|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
129869594|NCT00152464|467478925|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
129869595|NCT00152464|467478924|FG000|Overall Study|Eczema deterioration|0|||
129869596|NCT00152464|467478925|FG001|Overall Study|Eczema deterioration|1|||
129869597|NCT00152464|467478924|FG000|Overall Study|Parent decision|1|||
129869598|NCT00152464|467478925|FG001|Overall Study|Parent decision|1|||
129869599|NCT00152464|467478924|FG000|Overall Study|Investigator decision|1|||
129869600|NCT00152464|467478925|FG001|Overall Study|Investigator decision|0|||
129869601|NCT00152464|467478924|FG000|Overall Study|Lack of Efficacy|1|||
129869602|NCT00152464|467478925|FG001|Overall Study|Lack of Efficacy|0|||
129869603|NCT00152464|467478924|FG000|Overall Study|Eczema poorly controlled|1|||
129869604|NCT00152464|467478925|FG001|Overall Study|Eczema poorly controlled|0|||
129869605|NCT00152464|467478924|FG000|Overall Study|Patient relocated|1|||
129869606|NCT00152464|467478925|FG001|Overall Study|Patient relocated|0|||
129869607|NCT04493931|467478927|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
129869608|NCT04493931|467478928|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869609|NCT04493931|467478929|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869610|NCT04493931|467478930|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869611|NCT04493931|467478931|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869612|NCT04493931|467478932|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869613|NCT04493931|467478933|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
129869614|NCT04493931|467478927|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869615|NCT04493931|467478928|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
129869616|NCT04493931|467478929|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869617|NCT04493931|467478930|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869618|NCT04493931|467478931|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869619|NCT04493931|467478932|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869620|NCT04493931|467478933|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
129869621|NCT04493931|467478927|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869622|NCT04493931|467478928|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
129869623|NCT04493931|467478929|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869624|NCT04493931|467478930|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869625|NCT04493931|467478931|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869626|NCT04493931|467478932|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869627|NCT04493931|467478933|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
129869628|NCT04493931|467478927|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869629|NCT04493931|467478928|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869630|NCT04493931|467478929|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
129869631|NCT04493931|467478930|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869632|NCT04493931|467478931|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869633|NCT04493931|467478932|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869634|NCT04493931|467478933|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
129869635|NCT00430248|467478935|FG000|Overall Study|Adverse Event|49|||
129869636|NCT00430248|467478936|FG001|Overall Study|Adverse Event|61|||
129869637|NCT00430248|467478937|FG002|Overall Study|Adverse Event|64|||
129869638|NCT00430248|467478935|FG000|Overall Study|Protocol Violation|10|||
129869639|NCT00430248|467478936|FG001|Overall Study|Protocol Violation|2|||
129869640|NCT00430248|467478937|FG002|Overall Study|Protocol Violation|4|||
129869641|NCT00430248|467478935|FG000|Overall Study|Personal Reasons|12|||
129869642|NCT00430248|467478936|FG001|Overall Study|Personal Reasons|24|||
129869643|NCT00430248|467478937|FG002|Overall Study|Personal Reasons|9|||
129869644|NCT00430248|467478935|FG000|Overall Study|Lost to Follow-up|28|||
129869645|NCT00430248|467478936|FG001|Overall Study|Lost to Follow-up|33|||
129869646|NCT00430248|467478937|FG002|Overall Study|Lost to Follow-up|28|||
129869647|NCT00430248|467478935|FG000|Overall Study|Therapeutic Failure|1|||
129869648|NCT00430248|467478936|FG001|Overall Study|Therapeutic Failure|1|||
129869649|NCT00430248|467478937|FG002|Overall Study|Therapeutic Failure|1|||
129869650|NCT00430248|467478935|FG000|Overall Study|Withdrawal by Subject|14|||
129869651|NCT00430248|467478936|FG001|Overall Study|Withdrawal by Subject|20|||
129869652|NCT00430248|467478937|FG002|Overall Study|Withdrawal by Subject|16|||
129869653|NCT00430248|467478935|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129869654|NCT00430248|467478936|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
129869655|NCT00430248|467478937|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129869656|NCT00430248|467478935|FG000|Overall Study|Gout Flare|3|||
129869657|NCT00430248|467478936|FG001|Overall Study|Gout Flare|7|||
129869658|NCT00430248|467478937|FG002|Overall Study|Gout Flare|2|||
129869659|NCT00430248|467478935|FG000|Overall Study|Reason Not Specified|8|||
129869660|NCT00430248|467478936|FG001|Overall Study|Reason Not Specified|8|||
129869661|NCT00430248|467478937|FG002|Overall Study|Reason Not Specified|11|||
129869662|NCT01754467|467478943|FG000|Overall Study|Lost to Follow-up|1|||
129869663|NCT01970462|467478944|FG000|Overall Study|Lost to Follow-up|0|||
129869664|NCT01970462|467478945|FG001|Overall Study|Lost to Follow-up|2|||
129869665|NCT00929162|467478946|FG000|Overall Study|Adverse Event|8|||
129869666|NCT00929162|467478947|FG001|Overall Study|Adverse Event|5|||
129869667|NCT00929162|467478946|FG000|Overall Study|Withdrawal by Subject|3|||
129869668|NCT00929162|467478947|FG001|Overall Study|Withdrawal by Subject|1|||
129869669|NCT00929162|467478946|FG000|Overall Study|Protocol Violation|32|||
129869670|NCT00929162|467478947|FG001|Overall Study|Protocol Violation|30|||
129869671|NCT00929162|467478946|FG000|Overall Study|Other termination reason|5|||
129869672|NCT00929162|467478947|FG001|Overall Study|Other termination reason|6|||
129869673|NCT01274182|467478948|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129869674|NCT01274182|467478949|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129869675|NCT01274182|467478950|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
129869676|NCT01274182|467478948|FG000|Overall Study|Adverse Event|4|||
129869677|NCT01274182|467478949|FG001|Overall Study|Adverse Event|5|||
129869678|NCT01274182|467478950|FG002|Overall Study|Adverse Event|3|||
129869679|NCT01274182|467478948|FG000|Overall Study|Withdrawal by Subject|5|||
129869680|NCT01274182|467478949|FG001|Overall Study|Withdrawal by Subject|5|||
129869681|NCT01274182|467478950|FG002|Overall Study|Withdrawal by Subject|3|||
129869682|NCT01274182|467478948|FG000|Overall Study|Lost to Follow-up|2|||
129869683|NCT01274182|467478949|FG001|Overall Study|Lost to Follow-up|3|||
129869684|NCT01274182|467478950|FG002|Overall Study|Lost to Follow-up|1|||
129869685|NCT01274182|467478948|FG000|Overall Study|Protocol Violation|3|||
129869686|NCT01274182|467478949|FG001|Overall Study|Protocol Violation|2|||
129869687|NCT01274182|467478950|FG002|Overall Study|Protocol Violation|0|||
129869688|NCT01274182|467478948|FG000|Overall Study|Death|1|||
129869689|NCT01274182|467478949|FG001|Overall Study|Death|0|||
129869690|NCT01274182|467478950|FG002|Overall Study|Death|1|||
129869691|NCT01822587|467478951|FG000|Overall Study|Lost to Follow-up|7|||
129869692|NCT01822587|467478952|FG001|Overall Study|Lost to Follow-up|9|||
129869693|NCT01822587|467478953|FG002|Overall Study|Lost to Follow-up|12|||
129869694|NCT01822587|467478951|FG000|Overall Study|Physician Decision|9|||
129869695|NCT01822587|467478952|FG001|Overall Study|Physician Decision|6|||
129869696|NCT01822587|467478953|FG002|Overall Study|Physician Decision|6|||
129869697|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
129869698|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
129869699|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
129869700|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
129869701|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
129869702|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
129917493|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Death|1|||
129869703|NCT02355002|467478954|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
129869704|NCT02355002|467478955|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
129869705|NCT02355002|467478954|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
129869706|NCT02355002|467478955|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
129869707|NCT02355002|467478954|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
129869708|NCT02355002|467478955|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
129869709|NCT02355002|467478954|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
129869710|NCT02355002|467478955|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
129869711|NCT00708916|467478956|FG000|Overall Study|Subject Noncompliance|2|||
129869712|NCT00708916|467478956|FG000|Overall Study|Adverse Event|2|||
129869713|NCT03205371|467478966|FG000|Overall Study|Withdrawal by Subject|4|||
129869714|NCT03205371|467478967|FG001|Overall Study|Withdrawal by Subject|1|||
129869715|NCT03205371|467478968|FG002|Overall Study|Withdrawal by Subject|0|||
129869716|NCT03205371|467478969|FG003|Overall Study|Withdrawal by Subject|0|||
129869717|NCT03205371|467478970|FG004|Overall Study|Withdrawal by Subject|0|||
129869718|NCT03205371|467478971|FG005|Overall Study|Withdrawal by Subject|0|||
129869719|NCT03205371|467478972|FG006|Overall Study|Withdrawal by Subject|4|||
129869720|NCT03205371|467478973|FG007|Overall Study|Withdrawal by Subject|0|||
129869721|NCT03205371|467478974|FG008|Overall Study|Withdrawal by Subject|2|||
129869722|NCT03205371|467478975|FG009|Overall Study|Withdrawal by Subject|0|||
129869723|NCT03205371|467478976|FG010|Overall Study|Withdrawal by Subject|0|||
129869724|NCT03205371|467478977|FG011|Overall Study|Withdrawal by Subject|1|||
129869725|NCT03205371|467478966|FG000|Overall Study|Lost to Follow-up|0|||
129869726|NCT03205371|467478967|FG001|Overall Study|Lost to Follow-up|0|||
129869727|NCT03205371|467478968|FG002|Overall Study|Lost to Follow-up|0|||
129869728|NCT03205371|467478969|FG003|Overall Study|Lost to Follow-up|0|||
129869729|NCT03205371|467478970|FG004|Overall Study|Lost to Follow-up|0|||
129869730|NCT03205371|467478971|FG005|Overall Study|Lost to Follow-up|0|||
129869731|NCT03205371|467478972|FG006|Overall Study|Lost to Follow-up|5|||
129869732|NCT03205371|467478973|FG007|Overall Study|Lost to Follow-up|2|||
129869733|NCT03205371|467478974|FG008|Overall Study|Lost to Follow-up|3|||
129869734|NCT03205371|467478975|FG009|Overall Study|Lost to Follow-up|0|||
129869735|NCT03205371|467478976|FG010|Overall Study|Lost to Follow-up|0|||
129869736|NCT03205371|467478977|FG011|Overall Study|Lost to Follow-up|0|||
129869737|NCT03205371|467478966|FG000|Overall Study|Protocol Violation|0|||
129869738|NCT03205371|467478967|FG001|Overall Study|Protocol Violation|0|||
129869739|NCT03205371|467478968|FG002|Overall Study|Protocol Violation|0|||
129869740|NCT03205371|467478969|FG003|Overall Study|Protocol Violation|0|||
129869741|NCT03205371|467478970|FG004|Overall Study|Protocol Violation|0|||
129869742|NCT03205371|467478971|FG005|Overall Study|Protocol Violation|0|||
129869743|NCT03205371|467478972|FG006|Overall Study|Protocol Violation|1|||
129869744|NCT03205371|467478973|FG007|Overall Study|Protocol Violation|0|||
129869745|NCT03205371|467478974|FG008|Overall Study|Protocol Violation|0|||
129869746|NCT03205371|467478975|FG009|Overall Study|Protocol Violation|0|||
129869747|NCT03205371|467478976|FG010|Overall Study|Protocol Violation|0|||
129869748|NCT03205371|467478977|FG011|Overall Study|Protocol Violation|0|||
129869749|NCT03205371|467478966|FG000|Overall Study|Adverse Event|0|||
129869750|NCT03205371|467478967|FG001|Overall Study|Adverse Event|0|||
129869751|NCT03205371|467478968|FG002|Overall Study|Adverse Event|0|||
129869752|NCT03205371|467478969|FG003|Overall Study|Adverse Event|0|||
129869753|NCT03205371|467478970|FG004|Overall Study|Adverse Event|0|||
129869754|NCT03205371|467478971|FG005|Overall Study|Adverse Event|0|||
129869755|NCT03205371|467478972|FG006|Overall Study|Adverse Event|0|||
129869756|NCT03205371|467478973|FG007|Overall Study|Adverse Event|1|||
129869757|NCT03205371|467478974|FG008|Overall Study|Adverse Event|0|||
129869758|NCT03205371|467478975|FG009|Overall Study|Adverse Event|0|||
129869759|NCT03205371|467478976|FG010|Overall Study|Adverse Event|0|||
129869760|NCT03205371|467478977|FG011|Overall Study|Adverse Event|0|||
129869761|NCT01077544|467478981|FG000|Overall Study|New Cancer Therapy|3|||
129869762|NCT01077544|467478982|FG001|Overall Study|New Cancer Therapy|3|||
129869763|NCT01077544|467478981|FG000|Overall Study|Adverse Event|0|||
129869764|NCT01077544|467478982|FG001|Overall Study|Adverse Event|1|||
129869765|NCT01077544|467478981|FG000|Overall Study|Disease Progression|0|||
129869766|NCT01077544|467478982|FG001|Overall Study|Disease Progression|1|||
129869767|NCT03804710|467478985|FG000|Overall Study|Adverse Event|0|||
129869768|NCT03804710|467478986|FG001|Overall Study|Adverse Event|3|||
129869769|NCT03804710|467478985|FG000|Overall Study|Withdrawal by Subject|2|||
129869770|NCT03804710|467478986|FG001|Overall Study|Withdrawal by Subject|1|||
129869771|NCT03804710|467478985|FG000|Overall Study|Other|0|||
129869772|NCT03804710|467478986|FG001|Overall Study|Other|1|||
129869773|NCT04542018|467478987|FG000|Overall Study|Withdrawal by Subject|0|||
129869774|NCT04542018|467478988|FG001|Overall Study|Withdrawal by Subject|0|||
129869775|NCT04542018|467478989|FG002|Overall Study|Withdrawal by Subject|4|||
129869776|NCT04542018|467478987|FG000|Overall Study|Protocol Violation|0|||
129869777|NCT04542018|467478988|FG001|Overall Study|Protocol Violation|0|||
129869778|NCT04542018|467478989|FG002|Overall Study|Protocol Violation|2|||
129869779|NCT02454101|467478990|FG000|Overall Study|Adverse Event|2|||
129869780|NCT02454101|467478991|FG001|Overall Study|Adverse Event|3|||
129869781|NCT02454101|467478990|FG000|Overall Study|Lost to Follow-up|3|||
129869782|NCT02454101|467478991|FG001|Overall Study|Lost to Follow-up|4|||
129869783|NCT04510675|467478992|FG000|Overall Study|Withdrawal by Subject|5|||
129869784|NCT04198805|467478993|FG000|Overall Study|Death|0|||
129869785|NCT04198805|467478994|FG001|Overall Study|Death|0|||
129869786|NCT04198805|467478995|FG002|Overall Study|Death|0|||
129869787|NCT04198805|467478996|FG003|Overall Study|Death|1|||
129869788|NCT04198805|467478993|FG000|Overall Study|Early Termination|8|||
129869789|NCT04198805|467478994|FG001|Overall Study|Early Termination|4|||
129869790|NCT04198805|467478995|FG002|Overall Study|Early Termination|6|||
129869791|NCT04198805|467478996|FG003|Overall Study|Early Termination|9|||
129869792|NCT01330433|467478997|FG000|Overall Study|Death|1|||
129869793|NCT01330433|467478998|FG001|Overall Study|Death|3|||
129869794|NCT01330433|467478997|FG000|Overall Study|Lost to Follow-up|1|||
129869795|NCT01330433|467478998|FG001|Overall Study|Lost to Follow-up|0|||
129869796|NCT01494584|467478999|FG000|Overall Study|Study Closed/Terminated|1|||
129869797|NCT01499082|467479000|FG000|Overall Study|Randomized but not Treated|0|||
129869798|NCT01499082|467479001|FG001|Overall Study|Randomized but not Treated|1|||
129869799|NCT01499082|467479000|FG000|Overall Study|Adverse Event|12|||
129869800|NCT01499082|467479001|FG001|Overall Study|Adverse Event|16|||
129869801|NCT01499082|467479000|FG000|Overall Study|Lack of Efficacy|1|||
129869802|NCT01499082|467479001|FG001|Overall Study|Lack of Efficacy|1|||
129869803|NCT01499082|467479000|FG000|Overall Study|Protocol Violation|6|||
129869804|NCT01499082|467479001|FG001|Overall Study|Protocol Violation|8|||
129869805|NCT01499082|467479000|FG000|Overall Study|Diverse Reasons|18|||
129869806|NCT01499082|467479001|FG001|Overall Study|Diverse Reasons|14|||
129869807|NCT01499082|467479000|FG000|Overall Study|Site Closure for Noncompliance|5|||
129869808|NCT01499082|467479001|FG001|Overall Study|Site Closure for Noncompliance|2|||
129869809|NCT01499082|467479000|FG000|Overall Study|Hypoglycemia|2|||
129869810|NCT01499082|467479001|FG001|Overall Study|Hypoglycemia|3|||
129869811|NCT01499082|467479000|FG000|Overall Study|Lost to Follow-up|1|||
129869812|NCT01499082|467479001|FG001|Overall Study|Lost to Follow-up|3|||
129869813|NCT03599349|467479002|FG000|Overall Study|Lost to Follow-up|1|||
129869814|NCT01830127|467479008|FG000|Overall Study|Adverse Event|1|||
129869815|NCT01830127|467479009|FG001|Overall Study|Adverse Event|6|||
129869816|NCT01830127|467479008|FG000|Overall Study|Lack of Efficacy|3|||
129869817|NCT01830127|467479009|FG001|Overall Study|Lack of Efficacy|0|||
129869818|NCT01830127|467479008|FG000|Overall Study|Withdrawal by Subject|1|||
129869819|NCT01830127|467479009|FG001|Overall Study|Withdrawal by Subject|1|||
129869820|NCT01830127|467479008|FG000|Overall Study|Other reason not defined above|0|||
129869821|NCT01830127|467479009|FG001|Overall Study|Other reason not defined above|2|||
129869822|NCT00567190|467479015|FG000|Overall Study|Death|235|||
129869823|NCT00567190|467479016|FG001|Overall Study|Death|280|||
129869824|NCT00567190|467479015|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
129869825|NCT00567190|467479016|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
129869826|NCT00344461|467479022|FG000|Overall Study|Adverse Event|6|||
129869827|NCT00344461|467479022|FG000|Overall Study|Death|1|||
129869828|NCT00344461|467479022|FG000|Overall Study|Lack of Efficacy|2|||
129869829|NCT00344461|467479022|FG000|Overall Study|Lost to Follow-up|2|||
129869830|NCT00344461|467479022|FG000|Overall Study|Physician Decision|2|||
129869831|NCT00344461|467479022|FG000|Overall Study|Protocol Violation|6|||
129869832|NCT00344461|467479022|FG000|Overall Study|Withdrawal by Subject|2|||
129869833|NCT00636610|467479023|FG000|Overall Study|Adverse Event|4|||
129869834|NCT00636610|467479024|FG001|Overall Study|Adverse Event|4|||
129869835|NCT00636610|467479023|FG000|Overall Study|Death|6|||
129869836|NCT00636610|467479024|FG001|Overall Study|Death|3|||
129869837|NCT00636610|467479023|FG000|Overall Study|Physician decision to withdraw patient|15|||
129869838|NCT00636610|467479024|FG001|Overall Study|Physician decision to withdraw patient|9|||
129869839|NCT00636610|467479023|FG000|Overall Study|Subject decision to withdraw|15|||
129869840|NCT00636610|467479024|FG001|Overall Study|Subject decision to withdraw|11|||
129869841|NCT00636610|467479023|FG000|Overall Study|Disease progression - radiographic|41|||
129917494|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Death|0|||
129917495|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
129917496|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
129917497|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
129917498|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
129917499|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
129917500|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
129917501|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
129917502|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
129917503|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
129917504|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
129917505|NCT04382898|467663112|FG000|Part 2: Dose Expansion|Other|0|||
129917506|NCT04382898|467663113|FG001|Part 2: Dose Expansion|Other|0|||
129917507|NCT04382898|467663114|FG002|Part 2: Dose Expansion|Other|1|||
129917508|NCT04382898|467663115|FG003|Part 2: Dose Expansion|Other|0|||
129917509|NCT04382898|467663116|FG004|Part 2: Dose Expansion|Other|0|||
129917510|NCT03932682|467663117|FG000|Overall Study|Death|1|||
129917511|NCT03932682|467663118|FG001|Overall Study|Death|2|||
129917512|NCT03932682|467663117|FG000|Overall Study|Withdrawal by Subject|37|||
129917513|NCT03932682|467663118|FG001|Overall Study|Withdrawal by Subject|45|||
129917514|NCT03932682|467663117|FG000|Overall Study|Lost to Follow-up|19|||
129917515|NCT03932682|467663118|FG001|Overall Study|Lost to Follow-up|25|||
129917516|NCT03932682|467663117|FG000|Overall Study|Protocol Violation|0|||
129917517|NCT03932682|467663118|FG001|Overall Study|Protocol Violation|2|||
129917518|NCT03932682|467663117|FG000|Overall Study|Other|9|||
129869842|NCT00636610|467479024|FG001|Overall Study|Disease progression - radiographic|51|||
129869843|NCT00636610|467479023|FG000|Overall Study|Disease progression - clinical|8|||
129869844|NCT00636610|467479024|FG001|Overall Study|Disease progression - clinical|3|||
129869845|NCT00636610|467479023|FG000|Overall Study|Reason for discontinuation not available|3|||
129869846|NCT00636610|467479024|FG001|Overall Study|Reason for discontinuation not available|2|||
129869847|NCT00553696|467479032|FG000|Overall Study|Adverse Event|2|||
129869848|NCT00553696|467479033|FG001|Overall Study|Adverse Event|4|||
129869849|NCT00553696|467479034|FG002|Overall Study|Adverse Event|0|||
129869850|NCT00553696|467479035|FG003|Overall Study|Adverse Event|1|||
129869851|NCT00553696|467479032|FG000|Overall Study|Global deterioration of health status|0|||
129869852|NCT00553696|467479033|FG001|Overall Study|Global deterioration of health status|2|||
129869853|NCT00553696|467479034|FG002|Overall Study|Global deterioration of health status|0|||
129869854|NCT00553696|467479035|FG003|Overall Study|Global deterioration of health status|0|||
129869855|NCT00553696|467479032|FG000|Overall Study|Objective progression or relapse|2|||
129869856|NCT00553696|467479033|FG001|Overall Study|Objective progression or relapse|9|||
129869857|NCT00553696|467479034|FG002|Overall Study|Objective progression or relapse|6|||
129869858|NCT00553696|467479035|FG003|Overall Study|Objective progression or relapse|0|||
129869859|NCT00553696|467479032|FG000|Overall Study|Withdrawal by Subject|0|||
129869860|NCT00553696|467479033|FG001|Overall Study|Withdrawal by Subject|1|||
129869861|NCT00553696|467479034|FG002|Overall Study|Withdrawal by Subject|0|||
129869862|NCT00553696|467479035|FG003|Overall Study|Withdrawal by Subject|0|||
129869863|NCT00686881|467479036|FG000|Overall Study|Withdrawal by Subject|11|||
129869864|NCT00686881|467479037|FG001|Overall Study|Withdrawal by Subject|18|||
129869865|NCT00686881|467479036|FG000|Overall Study|Lost to Follow-up|0|||
129869866|NCT00686881|467479037|FG001|Overall Study|Lost to Follow-up|1|||
129869867|NCT00686881|467479036|FG000|Overall Study|Treatment-related adverse event|10|||
129869868|NCT00686881|467479037|FG001|Overall Study|Treatment-related adverse event|9|||
129869869|NCT00686881|467479036|FG000|Overall Study|Met discontinuation criteria|5|||
129869870|NCT00686881|467479037|FG001|Overall Study|Met discontinuation criteria|0|||
129869871|NCT00686881|467479036|FG000|Overall Study|Onset of malignant tumor|11|||
129869872|NCT00686881|467479037|FG001|Overall Study|Onset of malignant tumor|11|||
129869873|NCT00686881|467479036|FG000|Overall Study|Lack of Efficacy|4|||
129869874|NCT00686881|467479037|FG001|Overall Study|Lack of Efficacy|3|||
129869875|NCT00686881|467479036|FG000|Overall Study|Physician Decision|1|||
129869876|NCT00686881|467479037|FG001|Overall Study|Physician Decision|0|||
129917519|NCT03932682|467663118|FG001|Overall Study|Other|23|||
129869877|NCT00686881|467479036|FG000|Overall Study|Circumstances of site|1|||
129869878|NCT00686881|467479037|FG001|Overall Study|Circumstances of site|1|||
129869879|NCT00686881|467479036|FG000|Overall Study|Did not meet protocol eligibility|1|||
129869880|NCT00686881|467479037|FG001|Overall Study|Did not meet protocol eligibility|0|||
129869881|NCT00686881|467479036|FG000|Overall Study|Irregular visits|1|||
129869882|NCT00686881|467479037|FG001|Overall Study|Irregular visits|0|||
129917520|NCT03126019|467663124|FG000|Overall Study|Death|5|||
129917521|NCT03126019|467663125|FG001|Overall Study|Death|27|||
129917522|NCT03126019|467663124|FG000|Overall Study|Lost to Follow-up|2|||
129917523|NCT03126019|467663125|FG001|Overall Study|Lost to Follow-up|4|||
129869883|NCT00686881|467479036|FG000|Overall Study|Study discontinuation|35|||
129917524|NCT03126019|467663124|FG000|Overall Study|Withdrawal by Subject|1|||
129917525|NCT03126019|467663125|FG001|Overall Study|Withdrawal by Subject|9|||
129917526|NCT03126019|467663124|FG000|Overall Study|Physician Decision|1|||
129449825|NCT01092143|465945685|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
129449826|NCT01092143|465945686|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
129869884|NCT00686881|467479037|FG001|Overall Study|Study discontinuation|32|||
129869885|NCT00686881|467479036|FG000|Overall Study|Never received study drug|2|||
129869886|NCT00686881|467479037|FG001|Overall Study|Never received study drug|6|||
129869887|NCT05899686|467479038|FG000|Overall Study|Protocol Violation|1|||
129869888|NCT02170025|467479039|FG000|Overall Study|Adverse Event|2|||
129869889|NCT02170025|467479040|FG001|Overall Study|Adverse Event|0|||
129869890|NCT00572195|467479041|FG000|Overall Study|Withdrawal by Subject|50|||
129869891|NCT00572195|467479041|FG000|Overall Study|Death|9|||
129869892|NCT00572195|467479041|FG000|Overall Study|Adverse Event|4|||
129869893|NCT00572195|467479041|FG000|Overall Study|Lost to Follow-up|5|||
129869894|NCT03657277|467479042|FG000|Overall Study|Physician Decision|2|||
129869895|NCT03657277|467479042|FG000|Overall Study|Lost to Follow-up|1|||
129869896|NCT03657277|467479042|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
129869897|NCT04349280|467479043|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
129869898|NCT04349280|467479044|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
129869899|NCT04349280|467479043|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
129869900|NCT04349280|467479044|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
129869901|NCT04349280|467479043|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
129869902|NCT04349280|467479044|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
129869903|NCT00657618|467479045|FG000|Overall Study|Adverse Event|32|||
129869904|NCT00657618|467479045|FG000|Overall Study|Withdrawal by Subject|8|||
129869905|NCT00657618|467479045|FG000|Overall Study|negative for leishmaniasis|2|||
129869906|NCT00657618|467479045|FG000|Overall Study|didn't start due to schedule conflicts|1|||
129869907|NCT04981678|467479046|FG000|Overall Study|Lost to Follow-up|0|||
129869908|NCT04981678|467479047|FG001|Overall Study|Lost to Follow-up|1|||
129869909|NCT04922554|467479048|FG000|Overall Study|Adverse Event|4|||
129869910|NCT04922554|467479049|FG001|Overall Study|Adverse Event|0|||
129869911|NCT04922554|467479048|FG000|Overall Study|Withdrawal by Subject|1|||
129869912|NCT04922554|467479049|FG001|Overall Study|Withdrawal by Subject|0|||
129869913|NCT03597568|467480615|FG000|Overall Study|Withdrawal by Subject|1|||
129869914|NCT03597568|467480616|FG001|Overall Study|Withdrawal by Subject|1|||
129869915|NCT03597568|467480615|FG000|Overall Study|Unable to analyze vascular data|1|||
129869916|NCT03597568|467480616|FG001|Overall Study|Unable to analyze vascular data|1|||
129869917|NCT02052310|467480617|FG000|Overall Study|Death|64|||
129869918|NCT02052310|467480618|FG001|Overall Study|Death|54|||
129869919|NCT02052310|467480617|FG000|Overall Study|Withdrawal by Subject|37|||
129869920|NCT02052310|467480618|FG001|Overall Study|Withdrawal by Subject|49|||
129869921|NCT02052310|467480617|FG000|Overall Study|Other than specified|32|||
129869922|NCT02052310|467480618|FG001|Overall Study|Other than specified|29|||
129869923|NCT02052310|467480617|FG000|Overall Study|Adverse Event|29|||
129869924|NCT02052310|467480618|FG001|Overall Study|Adverse Event|22|||
129869925|NCT02052310|467480617|FG000|Overall Study|Kidney Transplant|23|||
129869926|NCT02052310|467480618|FG001|Overall Study|Kidney Transplant|29|||
129869927|NCT02052310|467480617|FG000|Overall Study|Physician Decision|14|||
129869928|NCT02052310|467480618|FG001|Overall Study|Physician Decision|7|||
129869929|NCT02052310|467480617|FG000|Overall Study|Lack of Efficacy|6|||
129869930|NCT02052310|467480618|FG001|Overall Study|Lack of Efficacy|1|||
129869931|NCT02052310|467480617|FG000|Overall Study|Site Terminated by Sponsor|5|||
129869932|NCT02052310|467480618|FG001|Overall Study|Site Terminated by Sponsor|13|||
129869933|NCT02052310|467480617|FG000|Overall Study|Lost to Follow-up|4|||
129869934|NCT02052310|467480618|FG001|Overall Study|Lost to Follow-up|2|||
129869935|NCT02052310|467480617|FG000|Overall Study|Protocol Violation|1|||
129869936|NCT02052310|467480618|FG001|Overall Study|Protocol Violation|6|||
129869937|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
129869938|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
129869939|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
129869940|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
129869941|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
129869942|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
129869943|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
129869944|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
129869945|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Other|18|||
129869946|NCT02565914|467480619|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
129869947|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
129869948|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Other|1|||
129869949|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
129869950|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
129869951|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
129869952|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
129869953|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
129869954|NCT02565914|467480619|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
129869955|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
129869956|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
129869957|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
129449827|NCT01092143|465945687|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
129869958|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
129869959|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
129869960|NCT02565914|467480619|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
129869961|NCT01505387|467480620|FG000|Overall Study|Protocol Violation|1|||
129869962|NCT01505387|467480621|FG001|Overall Study|Protocol Violation|0|||
129869963|NCT01505387|467480620|FG000|Overall Study|Withdrawal by Subject|1|||
129869964|NCT01505387|467480621|FG001|Overall Study|Withdrawal by Subject|1|||
129869965|NCT01197508|467480628|FG000|Overall Study|Withdrawal by Subject|8|||
129869966|NCT01197508|467480629|FG001|Overall Study|Withdrawal by Subject|7|||
129869967|NCT01197508|467480630|FG002|Overall Study|Withdrawal by Subject|15|||
129869968|NCT01197508|467480631|FG003|Overall Study|Withdrawal by Subject|4|||
129869969|NCT01197508|467480628|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
129869970|NCT01197508|467480629|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
129869971|NCT01197508|467480630|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
129869972|NCT01197508|467480631|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
129869973|NCT01197508|467480628|FG000|Overall Study|Adverse Event|10|||
129869974|NCT01197508|467480629|FG001|Overall Study|Adverse Event|13|||
129869975|NCT01197508|467480630|FG002|Overall Study|Adverse Event|23|||
129869976|NCT01197508|467480631|FG003|Overall Study|Adverse Event|3|||
129869977|NCT01197508|467480628|FG000|Overall Study|Severe non-compliance to protocol|0|||
129869978|NCT01197508|467480629|FG001|Overall Study|Severe non-compliance to protocol|3|||
129869979|NCT01197508|467480630|FG002|Overall Study|Severe non-compliance to protocol|1|||
129869980|NCT01197508|467480631|FG003|Overall Study|Severe non-compliance to protocol|3|||
129869981|NCT01197508|467480628|FG000|Overall Study|Condition under investigation worsened|1|||
129869982|NCT01197508|467480629|FG001|Overall Study|Condition under investigation worsened|1|||
129869983|NCT01197508|467480630|FG002|Overall Study|Condition under investigation worsened|1|||
129449828|NCT01092143|465945688|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
129449829|NCT01092143|465945684|FG000|Overall Study|Patient travel|0|||
129449830|NCT01092143|465945685|FG001|Overall Study|Patient travel|0|||
129449831|NCT01092143|465945686|FG002|Overall Study|Patient travel|0|||
129449832|NCT01092143|465945687|FG003|Overall Study|Patient travel|0|||
129869984|NCT01197508|467480631|FG003|Overall Study|Condition under investigation worsened|1|||
129869985|NCT01197508|467480628|FG000|Overall Study|Lack of Efficacy|1|||
129869986|NCT01197508|467480629|FG001|Overall Study|Lack of Efficacy|2|||
129869987|NCT01197508|467480630|FG002|Overall Study|Lack of Efficacy|2|||
129869988|NCT01197508|467480631|FG003|Overall Study|Lack of Efficacy|1|||
129869989|NCT01197508|467480628|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129917527|NCT03126019|467663125|FG001|Overall Study|Physician Decision|0|||
129917528|NCT03126019|467663124|FG000|Overall Study|Transitioned to Rollover Study|0|||
129917529|NCT03126019|467663125|FG001|Overall Study|Transitioned to Rollover Study|11|||
129917530|NCT03126019|467663124|FG000|Overall Study|Did Not Return to Site for Care|0|||
129917531|NCT03126019|467663125|FG001|Overall Study|Did Not Return to Site for Care|1|||
129917532|NCT03126019|467663124|FG000|Overall Study|Site Closed|0|||
129917533|NCT03126019|467663125|FG001|Overall Study|Site Closed|1|||
129917534|NCT01566695|467663126|FG000|Overall Study|Lack of Efficacy|1|||
129917535|NCT01566695|467663127|FG001|Overall Study|Lack of Efficacy|0|||
129917536|NCT01566695|467663126|FG000|Overall Study|Adverse Event|3|||
129917537|NCT01566695|467663127|FG001|Overall Study|Adverse Event|0|||
129869990|NCT01197508|467480629|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129869991|NCT01197508|467480630|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129869992|NCT01197508|467480631|FG003|Overall Study|Study-specific withdrawal criteria|2|||
129869993|NCT01197508|467480628|FG000|Overall Study|Lost to Follow-up|1|||
129869994|NCT01197508|467480629|FG001|Overall Study|Lost to Follow-up|1|||
129869995|NCT01197508|467480630|FG002|Overall Study|Lost to Follow-up|2|||
129869996|NCT01197508|467480631|FG003|Overall Study|Lost to Follow-up|0|||
129869997|NCT01197508|467480628|FG000|Overall Study|Other|2|||
129869998|NCT01197508|467480629|FG001|Overall Study|Other|3|||
129869999|NCT01197508|467480630|FG002|Overall Study|Other|2|||
129870000|NCT01197508|467480631|FG003|Overall Study|Other|2|||
129870001|NCT00266825|467480632|FG000|Completed Follow-Up|Lost to Follow-up|14|||
129870002|NCT00266825|467480633|FG001|Completed Follow-Up|Lost to Follow-up|19|||
129870003|NCT00266825|467480632|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
129870004|NCT00266825|467480633|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
129917538|NCT01566695|467663126|FG000|Overall Study|Death|79|||
129917539|NCT01566695|467663127|FG001|Overall Study|Death|86|||
129917540|NCT01566695|467663126|FG000|Overall Study|Withdrawal by Subject|13|||
129870005|NCT01301391|467480636|FG000|Overall Study|Death|13|||
129917541|NCT01566695|467663127|FG001|Overall Study|Withdrawal by Subject|12|||
129870006|NCT01301391|467480636|FG000|Overall Study|Lost to Follow-up|3|||
129917542|NCT01566695|467663126|FG000|Overall Study|Lost to Follow-up|0|||
129917543|NCT01566695|467663127|FG001|Overall Study|Lost to Follow-up|3|||
129917544|NCT01566695|467663126|FG000|Overall Study|Other reasons|11|||
129917545|NCT01566695|467663127|FG001|Overall Study|Other reasons|8|||
129917546|NCT05956002|467663128|FG000|Treatment Period 3|Adverse Event|0|||
129870007|NCT01301391|467480636|FG000|Overall Study|Physician Decision|2|||
129870008|NCT01301391|467480636|FG000|Overall Study|Sponsor's decision|8|||
129870009|NCT02799784|467480640|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
129870010|NCT02799784|467480641|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
129870011|NCT02799784|467480640|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
129870012|NCT02799784|467480641|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
129870013|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
129870014|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
129870015|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
129870016|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
129870017|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
129870018|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
129870019|NCT02799784|467480640|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
129870020|NCT02799784|467480641|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
129917547|NCT05956002|467663129|FG001|Treatment Period 3|Adverse Event|0|||
129917548|NCT05956002|467663130|FG002|Treatment Period 3|Adverse Event|1|||
129917549|NCT05956002|467663131|FG003|Treatment Period 3|Adverse Event|0|||
129917550|NCT02281955|467663134|FG000|Overall Study|Death|1|||
129870021|NCT02570126|467480646|FG000|Overall Study|Lost to Follow-up|2|||
129870022|NCT02570126|467480647|FG001|Overall Study|Lost to Follow-up|0|||
129870023|NCT02570126|467480646|FG000|Overall Study|Unable To Arrange Visit 3|1|||
129870024|NCT02570126|467480647|FG001|Overall Study|Unable To Arrange Visit 3|0|||
129870025|NCT02570126|467480646|FG000|Overall Study|Violation Of Procedures GSK|0|||
129870026|NCT02570126|467480647|FG001|Overall Study|Violation Of Procedures GSK|1|||
129870027|NCT02570126|467480646|FG000|Overall Study|Protocol Violation|0|||
129870028|NCT02570126|467480647|FG001|Overall Study|Protocol Violation|1|||
129870029|NCT02570126|467480646|FG000|Overall Study|Withdrawal by Subject|3|||
129870030|NCT02570126|467480647|FG001|Overall Study|Withdrawal by Subject|7|||
129870031|NCT00917579|467480648|FG000|Washout >= 2 Weeks|Adverse Event|1|||
129870032|NCT00917579|467480649|FG001|Washout >= 2 Weeks|Adverse Event|0|||
129870033|NCT00917579|467480648|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
129870034|NCT00917579|467480649|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
129870035|NCT00754338|467480650|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870036|NCT00754338|467480651|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
129870037|NCT00754338|467480652|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
129870038|NCT00754338|467480653|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870039|NCT00754338|467480650|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870040|NCT00754338|467480651|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
129870041|NCT00754338|467480652|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
129870042|NCT00754338|467480653|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
129917551|NCT00378105|467663140|FG000|Overall Study|Adverse Event|3|||
129917552|NCT00378105|467663141|FG001|Overall Study|Adverse Event|1|||
129917553|NCT00378105|467663140|FG000|Overall Study|Withdrawal by Subject|3|||
129917554|NCT00378105|467663141|FG001|Overall Study|Withdrawal by Subject|3|||
129917555|NCT00378105|467663140|FG000|Overall Study|Death|1|||
129917556|NCT00378105|467663141|FG001|Overall Study|Death|0|||
129917557|NCT00378105|467663140|FG000|Overall Study|Going to transplant|7|||
129917558|NCT00378105|467663141|FG001|Overall Study|Going to transplant|8|||
129917559|NCT00378105|467663140|FG000|Overall Study|Progressive disease|3|||
129917560|NCT00378105|467663141|FG001|Overall Study|Progressive disease|3|||
129917561|NCT00378105|467663140|FG000|Overall Study|remain on study|3|||
129917562|NCT00378105|467663141|FG001|Overall Study|remain on study|11|||
129917563|NCT00378105|467663140|FG000|Overall Study|Physician Decision|0|||
129917564|NCT00378105|467663141|FG001|Overall Study|Physician Decision|2|||
129917565|NCT00378105|467663140|FG000|Overall Study|Going non-protocol therapy|0|||
129917566|NCT00378105|467663141|FG001|Overall Study|Going non-protocol therapy|1|||
129917567|NCT00378105|467663140|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
129917568|NCT00378105|467663141|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
129917569|NCT05192200|467663142|FG000|Treatment Period|Other|1|||
129917570|NCT05192200|467663142|FG000|Treatment Period|Lack of Efficacy|1|||
129917571|NCT05192200|467663142|FG000|Treatment Period|Withdrawal by Subject|1|||
129917572|NCT05192200|467663142|FG000|Follow-up|Withdrawal by Subject|1|||
129917573|NCT04533347|467663145|FG000|Overall Study|Adverse Event|1|||
129917574|NCT04533347|467663146|FG001|Overall Study|Adverse Event|2|||
129917575|NCT04533347|467663145|FG000|Overall Study|Lost to Follow-up|2|||
129917576|NCT04533347|467663146|FG001|Overall Study|Lost to Follow-up|0|||
129917577|NCT04533347|467663145|FG000|Overall Study|Withdrawal by Subject|1|||
129917578|NCT04533347|467663146|FG001|Overall Study|Withdrawal by Subject|0|||
129917579|NCT03907397|467663147|FG000|Overall Study|Lost to Follow-up|0|||
129917580|NCT03907397|467663148|FG001|Overall Study|Lost to Follow-up|1|||
129917581|NCT03907397|467663147|FG000|Overall Study|Physician Decision|2|||
129917582|NCT03907397|467663148|FG001|Overall Study|Physician Decision|1|||
129917583|NCT03907397|467663147|FG000|Overall Study|Withdrawal by Subject|5|||
129917584|NCT03907397|467663148|FG001|Overall Study|Withdrawal by Subject|4|||
129917585|NCT03907397|467663147|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
129917586|NCT03907397|467663148|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
129870043|NCT04385368|467480662|FG000|Overall Study|Death|5|||
129870044|NCT04385368|467480663|FG001|Overall Study|Death|5|||
129870045|NCT04385368|467480662|FG000|Overall Study|Physician Decision|3|||
129870046|NCT04385368|467480663|FG001|Overall Study|Physician Decision|0|||
129917587|NCT00220740|467663154|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
129917588|NCT00220740|467663155|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
129449833|NCT01092143|465945688|FG004|Overall Study|Patient travel|1|||
129449834|NCT01092143|465945684|FG000|Overall Study|Non compliance with study medication|0|||
129917589|NCT00220740|467663154|FG000|Efficacy Period|Adverse Event|1|||
129917590|NCT00220740|467663155|FG001|Efficacy Period|Adverse Event|1|||
129917591|NCT00220740|467663154|FG000|Efficacy Period|Withdrawal by Subject|1|||
129917592|NCT00220740|467663155|FG001|Efficacy Period|Withdrawal by Subject|0|||
129917593|NCT00220740|467663154|FG000|Efficacy Period|Protocol Violation|1|||
129870047|NCT04385368|467480662|FG000|Overall Study|Withdrawal by Subject|4|||
129870048|NCT04385368|467480663|FG001|Overall Study|Withdrawal by Subject|3|||
129870049|NCT02740049|467480665|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
129870050|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
129870051|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
129870052|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
129870053|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
129870054|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
129870055|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
129870056|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
129870057|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
129870058|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870059|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870060|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870061|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
129870062|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
129870063|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
129870064|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
129870065|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
129870066|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
129870067|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
129870068|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
129870069|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870070|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
129870071|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870072|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870073|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
129870074|NCT01256411|467480666|FG000|Extension by Maximum Treatment|Adverse Event|4|||
129870075|NCT01256411|467480667|FG001|Extension by Maximum Treatment|Adverse Event|2|||
129870076|NCT01256411|467480668|FG002|Extension by Maximum Treatment|Adverse Event|1|||
129870077|NCT01256411|467480669|FG003|Extension by Maximum Treatment|Adverse Event|0|||
129870078|NCT01256411|467480670|FG004|Extension by Maximum Treatment|Adverse Event|0|||
129870079|NCT01256411|467480671|FG005|Extension by Maximum Treatment|Adverse Event|0|||
129870080|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870081|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870082|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870083|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
129870084|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
129870085|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
129870086|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870087|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870088|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870089|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870090|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
129870091|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
129870092|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870093|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870094|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870095|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870096|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
129870097|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
129870098|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870099|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870100|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870101|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
129870102|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
129917594|NCT00220740|467663155|FG001|Efficacy Period|Protocol Violation|0|||
129917595|NCT00220740|467663154|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
129449835|NCT01092143|465945685|FG001|Overall Study|Non compliance with study medication|0|||
129870103|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
129870104|NCT01256411|467480666|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870105|NCT01256411|467480667|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870106|NCT01256411|467480668|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870107|NCT01256411|467480669|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
129870108|NCT01256411|467480670|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
129870109|NCT01256411|467480671|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
129870110|NCT02316769|467480672|FG000|Overall Study|Physician Decision|1|||
129870111|NCT02316769|467480673|FG001|Overall Study|Physician Decision|0|||
129870112|NCT02316769|467480672|FG000|Overall Study|Withdrawal by Subject|1|||
129870113|NCT02316769|467480673|FG001|Overall Study|Withdrawal by Subject|0|||
129870114|NCT02054806|467480674|FG000|Overall Study|Sponsor Decision|31|||
129870115|NCT02054806|467480674|FG000|Overall Study|Withdrawal by Subject|43|||
129870116|NCT02054806|467480674|FG000|Overall Study|Protocol Violation|2|||
129870117|NCT02054806|467480674|FG000|Overall Study|Lost to Follow-up|10|||
129870118|NCT02054806|467480674|FG000|Overall Study|Death|391|||
129870119|NCT04721925|467480675|FG000|2-Month Assessment|Lost to Follow-up|5|||
129870120|NCT04721925|467480676|FG001|2-Month Assessment|Lost to Follow-up|3|||
129870121|NCT04721925|467480675|FG000|4-Month Assessment|Lost to Follow-up|3|||
129870122|NCT04721925|467480676|FG001|4-Month Assessment|Lost to Follow-up|6|||
129870123|NCT01113502|467480680|FG000|Overall Study|Withdrawal by Subject|1|||
129870124|NCT01113502|467480681|FG001|Overall Study|Withdrawal by Subject|0|||
129870125|NCT01113502|467480682|FG002|Overall Study|Withdrawal by Subject|1|||
129870126|NCT01113502|467480683|FG003|Overall Study|Withdrawal by Subject|1|||
129870127|NCT01113502|467480684|FG004|Overall Study|Withdrawal by Subject|0|||
129870128|NCT01113502|467480680|FG000|Overall Study|Adverse Event|0|||
129870129|NCT01113502|467480681|FG001|Overall Study|Adverse Event|0|||
129870130|NCT01113502|467480682|FG002|Overall Study|Adverse Event|3|||
129870131|NCT01113502|467480683|FG003|Overall Study|Adverse Event|2|||
129870132|NCT01113502|467480684|FG004|Overall Study|Adverse Event|0|||
129870133|NCT04535947|467480695|FG000|Overall Study|Adverse Event|1|||
129870134|NCT04535947|467480696|FG001|Overall Study|Adverse Event|4|||
129870135|NCT04535947|467480695|FG000|Overall Study|Other reasons not specified|2|||
129870136|NCT04535947|467480696|FG001|Overall Study|Other reasons not specified|0|||
129870137|NCT04535947|467480695|FG000|Overall Study|Withdrawal by Subject|1|||
129870138|NCT04535947|467480696|FG001|Overall Study|Withdrawal by Subject|1|||
129870139|NCT03002610|467480697|FG000|Overall Study|Withdrawal by Subject|6|||
129870140|NCT03002610|467480698|FG001|Overall Study|Withdrawal by Subject|25|||
129870141|NCT03002610|467480699|FG002|Overall Study|Withdrawal by Subject|13|||
129870142|NCT03802123|467480700|FG000|Overall Study|Withdrawal by Subject|3|||
129870143|NCT03802123|467480700|FG000|Overall Study|Physician Decision|1|||
129870144|NCT03802123|467480700|FG000|Overall Study|Subject moved to hospice care|1|||
129870145|NCT03802123|467480700|FG000|Overall Study|technician error|1|||
129870146|NCT03802123|467480700|FG000|Overall Study|Death|3|||
129870147|NCT01362439|467480704|FG000|Overall Study|Adverse Event|1|||
129870148|NCT01362439|467480704|FG000|Overall Study|Lack of Efficacy|3|||
129870149|NCT01362439|467480704|FG000|Overall Study|Lost to Follow-up|2|||
129870150|NCT01362439|467480704|FG000|Overall Study|Study medication non-compliant|1|||
129870151|NCT01362439|467480704|FG000|Overall Study|Participant who withdrew consent|8|||
129870152|NCT00658567|467480706|FG000|Overall Study|Adverse Event|5|||
129870153|NCT00658567|467480707|FG001|Overall Study|Adverse Event|2|||
129870154|NCT00658567|467480708|FG002|Overall Study|Adverse Event|3|||
129870155|NCT00658567|467480706|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
129870156|NCT00658567|467480707|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
129870157|NCT00658567|467480708|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
129870158|NCT00658567|467480706|FG000|Overall Study|Physician Decision|0|||
129870159|NCT00658567|467480707|FG001|Overall Study|Physician Decision|1|||
129870160|NCT00658567|467480708|FG002|Overall Study|Physician Decision|0|||
129870161|NCT00658567|467480706|FG000|Overall Study|At Discretion of Sponsor|1|||
129870162|NCT00658567|467480707|FG001|Overall Study|At Discretion of Sponsor|1|||
129870163|NCT00658567|467480708|FG002|Overall Study|At Discretion of Sponsor|1|||
129870164|NCT02835339|467480709|FG000|Overall Study|Did not receive allocated intervention|13|||
129870165|NCT02835339|467480710|FG001|Overall Study|Did not receive allocated intervention|16|||
129870166|NCT03923959|467480711|FG000|Overall Study|Death|16|||
129870167|NCT03923959|467480712|FG001|Overall Study|Death|12|||
129870168|NCT03923959|467480711|FG000|Overall Study|Lost to Follow-up|56|||
129870169|NCT03923959|467480712|FG001|Overall Study|Lost to Follow-up|56|||
129870170|NCT03923959|467480711|FG000|Overall Study|Withdrawal by Subject|1|||
129870171|NCT03923959|467480712|FG001|Overall Study|Withdrawal by Subject|1|||
129870172|NCT03923959|467480711|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
129870173|NCT03923959|467480712|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
129870174|NCT04918147|467480713|FG000|Overall Study|Disease flare as defined in protocol|0|||
129870175|NCT04918147|467480714|FG001|Overall Study|Disease flare as defined in protocol|2|||
129870176|NCT02954354|467480715|FG000|Overall Study|Adverse Event|2|||
129870177|NCT02954354|467480716|FG001|Overall Study|Adverse Event|2|||
129870178|NCT02954354|467480717|FG002|Overall Study|Adverse Event|4|||
129870179|NCT02954354|467480715|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
129870180|NCT02954354|467480716|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
129870181|NCT02954354|467480717|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
129870182|NCT02954354|467480715|FG000|Overall Study|Lack of Efficacy|0|||
129870183|NCT02954354|467480716|FG001|Overall Study|Lack of Efficacy|2|||
129870184|NCT02954354|467480717|FG002|Overall Study|Lack of Efficacy|0|||
129870185|NCT02954354|467480715|FG000|Overall Study|Withdrawal by Subject|17|||
129870186|NCT02954354|467480716|FG001|Overall Study|Withdrawal by Subject|9|||
129870187|NCT02954354|467480717|FG002|Overall Study|Withdrawal by Subject|11|||
129870188|NCT02954354|467480715|FG000|Overall Study|Lost to Follow-up|12|||
129870189|NCT02954354|467480716|FG001|Overall Study|Lost to Follow-up|5|||
129870190|NCT02954354|467480717|FG002|Overall Study|Lost to Follow-up|0|||
129870191|NCT02954354|467480715|FG000|Overall Study|Miscellaneous|2|||
129870192|NCT02954354|467480716|FG001|Overall Study|Miscellaneous|2|||
129870193|NCT02954354|467480717|FG002|Overall Study|Miscellaneous|1|||
129870194|NCT03338829|467480718|FG000|Overall Study|Lost to Follow-up|4|||
129870195|NCT03338829|467480719|FG001|Overall Study|Lost to Follow-up|2|||
129870196|NCT03338829|467480720|FG002|Overall Study|Lost to Follow-up|4|||
129870197|NCT03338829|467480718|FG000|Overall Study|Pregnancy loss|1|||
129870198|NCT03338829|467480719|FG001|Overall Study|Pregnancy loss|1|||
129870199|NCT03338829|467480720|FG002|Overall Study|Pregnancy loss|0|||
129870200|NCT03338829|467480718|FG000|Overall Study|Protocol Violation|0|||
129870201|NCT03338829|467480719|FG001|Overall Study|Protocol Violation|1|||
129870202|NCT03338829|467480720|FG002|Overall Study|Protocol Violation|0|||
129870203|NCT02684006|467480721|FG000|Overall Study|Other|18|||
129870204|NCT02684006|467480722|FG001|Overall Study|Other|6|||
129870205|NCT02684006|467480721|FG000|Overall Study|Protocol Violation|2|||
129870206|NCT02684006|467480722|FG001|Overall Study|Protocol Violation|1|||
129870207|NCT02684006|467480721|FG000|Overall Study|Non-compliance with study drug|1|||
129870208|NCT02684006|467480722|FG001|Overall Study|Non-compliance with study drug|1|||
129870209|NCT02684006|467480721|FG000|Overall Study|No longer met eligibility criteria|6|||
129870210|NCT02684006|467480722|FG001|Overall Study|No longer met eligibility criteria|2|||
129870211|NCT02684006|467480721|FG000|Overall Study|Lost to Follow-up|0|||
129870212|NCT02684006|467480722|FG001|Overall Study|Lost to Follow-up|1|||
129870213|NCT02684006|467480721|FG000|Overall Study|Death|25|||
129870214|NCT02684006|467480722|FG001|Overall Study|Death|22|||
129870215|NCT02684006|467480721|FG000|Overall Study|Global deterioration of health status|18|||
129870216|NCT02684006|467480722|FG001|Overall Study|Global deterioration of health status|20|||
129870217|NCT02684006|467480721|FG000|Overall Study|Physician Decision|15|||
129870218|NCT02684006|467480722|FG001|Overall Study|Physician Decision|8|||
129870219|NCT02684006|467480721|FG000|Overall Study|Adverse Event|86|||
129870220|NCT02684006|467480722|FG001|Overall Study|Adverse Event|65|||
129870221|NCT02684006|467480721|FG000|Overall Study|Withdrawal by Subject|29|||
129870222|NCT02684006|467480722|FG001|Overall Study|Withdrawal by Subject|43|||
129870223|NCT02684006|467480721|FG000|Overall Study|Progressive disease|236|||
129870224|NCT02684006|467480722|FG001|Overall Study|Progressive disease|266|||
129870225|NCT02684006|467480721|FG000|Overall Study|Participation terminated by sponsor|6|||
129870226|NCT02684006|467480722|FG001|Overall Study|Participation terminated by sponsor|9|||
129870227|NCT04495179|467480723|FG000|Overall Study|Lost to Follow-up|0|||
129870228|NCT04495179|467480724|FG001|Overall Study|Lost to Follow-up|1|||
129870229|NCT04495179|467480723|FG000|Overall Study|Withdrawal by Subject|2|||
129870230|NCT04495179|467480724|FG001|Overall Study|Withdrawal by Subject|4|||
129870231|NCT04495179|467480723|FG000|Overall Study|Study terminated by sponsor|0|||
129870232|NCT04495179|467480724|FG001|Overall Study|Study terminated by sponsor|18|||
129870233|NCT04495179|467480723|FG000|Overall Study|Death|0|||
129870234|NCT04495179|467480724|FG001|Overall Study|Death|4|||
129870235|NCT04495179|467480723|FG000|Overall Study|Adverse Event|0|||
129870236|NCT04495179|467480724|FG001|Overall Study|Adverse Event|1|||
129870237|NCT01368965|467480728|FG000|Overall Study|Lost to Follow-up|12|||
129870238|NCT02355743|467480739|FG000|Overall Study|Withdrawal by Subject|1|||
129870239|NCT02355743|467480739|FG000|Overall Study|Lost to Follow-up|1|||
129870240|NCT04212091|467480740|FG000|Overall Study|Lost to Follow-up|0|||
129870241|NCT04212091|467480741|FG001|Overall Study|Lost to Follow-up|0|||
129870242|NCT04212091|467480742|FG002|Overall Study|Lost to Follow-up|0|||
129870243|NCT04212091|467480743|FG003|Overall Study|Lost to Follow-up|0|||
129870244|NCT04212091|467480744|FG004|Overall Study|Lost to Follow-up|1|||
129870245|NCT04212091|467480745|FG005|Overall Study|Lost to Follow-up|1|||
129870246|NCT04212091|467480740|FG000|Overall Study|Participant unable to adhere to visit|0|||
129870247|NCT04212091|467480741|FG001|Overall Study|Participant unable to adhere to visit|0|||
129870248|NCT04212091|467480742|FG002|Overall Study|Participant unable to adhere to visit|0|||
129870249|NCT04212091|467480743|FG003|Overall Study|Participant unable to adhere to visit|0|||
129870250|NCT04212091|467480744|FG004|Overall Study|Participant unable to adhere to visit|1|||
129870251|NCT04212091|467480745|FG005|Overall Study|Participant unable to adhere to visit|0|||
129870252|NCT00715429|467480746|FG000|Overall Study|Did not complete the study diary|0|||
129870253|NCT00715429|467480747|FG001|Overall Study|Did not complete the study diary|1|||
129870254|NCT04085328|467480748|FG000|Overall Study|Witihdrew Consent|16|||
129870255|NCT04085328|467480749|FG001|Overall Study|Witihdrew Consent|16|||
129870256|NCT04085328|467480748|FG000|Overall Study|Adverse Event|8|||
129870257|NCT04085328|467480749|FG001|Overall Study|Adverse Event|7|||
129870258|NCT04085328|467480748|FG000|Overall Study|Lost to Follow-up|7|||
129870259|NCT04085328|467480749|FG001|Overall Study|Lost to Follow-up|2|||
129870260|NCT04085328|467480748|FG000|Overall Study|Physician Decision|0|||
129870261|NCT04085328|467480749|FG001|Overall Study|Physician Decision|1|||
129870262|NCT04085328|467480748|FG000|Overall Study|Pregnancy|0|||
129870263|NCT04085328|467480749|FG001|Overall Study|Pregnancy|1|||
129870264|NCT04085328|467480748|FG000|Overall Study|Reasons Related to COVID-19|5|||
129870265|NCT04085328|467480749|FG001|Overall Study|Reasons Related to COVID-19|8|||
129870266|NCT04085328|467480748|FG000|Overall Study|Did not meet inclusion criteria|1|||
129870267|NCT04085328|467480749|FG001|Overall Study|Did not meet inclusion criteria|1|||
129870268|NCT04085328|467480748|FG000|Overall Study|Early termination|1|||
129870269|NCT04085328|467480749|FG001|Overall Study|Early termination|0|||
129870270|NCT00514735|467480750|FG000|Overall Study|Withdrawal by Subject|13|||
129870271|NCT00514735|467480751|FG001|Overall Study|Withdrawal by Subject|5|||
129870272|NCT00514735|467480750|FG000|Overall Study|Death|1|||
129870273|NCT00514735|467480751|FG001|Overall Study|Death|0|||
129870274|NCT00514735|467480750|FG000|Overall Study|Lost to Follow-up|0|||
129870275|NCT00514735|467480751|FG001|Overall Study|Lost to Follow-up|1|||
129870276|NCT01428076|467480762|FG000|Overall Study|Adverse Event|0|||
129870277|NCT01428076|467480763|FG001|Overall Study|Adverse Event|1|||
129870278|NCT02216773|467480764|FG000|Overall Study|Disease progression|4|||
129870279|NCT02216773|467480765|FG001|Overall Study|Disease progression|2|||
129870280|NCT02216773|467480764|FG000|Overall Study|Insufficient FLRV|4|||
129870281|NCT02216773|467480765|FG001|Overall Study|Insufficient FLRV|0|||
129870282|NCT02216773|467480764|FG000|Overall Study|Abandoned|4|||
129870283|NCT02216773|467480765|FG001|Overall Study|Abandoned|3|||
129870284|NCT04274894|467480766|FG000|Overall Study|Adverse Event|7|||
129870285|NCT04274894|467480766|FG000|Overall Study|Withdrew consent|5|||
129870286|NCT04274894|467480766|FG000|Overall Study|Lost to Follow-up|9|||
129870287|NCT04274894|467480766|FG000|Overall Study|COVID-19 infection|1|||
129870288|NCT04274894|467480766|FG000|Overall Study|Other, not specified|20|||
129870289|NCT01936857|467480767|FG000|Overall Study|Sent to prison or 06 center|11|||
129870290|NCT01936857|467480768|FG001|Overall Study|Sent to prison or 06 center|12|||
129870291|NCT01936857|467480767|FG000|Overall Study|Lost to Follow-up|10|||
129870292|NCT01936857|467480768|FG001|Overall Study|Lost to Follow-up|7|||
129870293|NCT01936857|467480767|FG000|Overall Study|Death|7|||
129870294|NCT01936857|467480768|FG001|Overall Study|Death|3|||
129870295|NCT01936857|467480767|FG000|Overall Study|Moved|2|||
129870296|NCT01936857|467480768|FG001|Overall Study|Moved|1|||
129870297|NCT01936857|467480767|FG000|Overall Study|Withdrawal by Subject|1|||
129870298|NCT01936857|467480768|FG001|Overall Study|Withdrawal by Subject|0|||
129870299|NCT01936857|467480767|FG000|Overall Study|Side effect of medication|1|||
129870300|NCT01936857|467480768|FG001|Overall Study|Side effect of medication|0|||
129870301|NCT01936857|467480767|FG000|Overall Study|Other|2|||
129870302|NCT01936857|467480768|FG001|Overall Study|Other|2|||
129870303|NCT02279043|467480769|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
129870304|NCT02279043|467480770|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
129870305|NCT02279043|467480771|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
129870306|NCT02279043|467480769|FG000|Overall Study|Lost to Follow-up|46|||
129870307|NCT02279043|467480770|FG001|Overall Study|Lost to Follow-up|88|||
129870308|NCT02279043|467480771|FG002|Overall Study|Lost to Follow-up|0|||
129870309|NCT02124265|467480772|FG000|Overall Study|Adverse Event|1|||
129870310|NCT00490282|467480773|FG000|Overall Study|Withdrawal by Subject|3|||
129870311|NCT01666808|467480774|FG000|Overall Study|Lost to Follow-up|9|||
129870312|NCT01666808|467480775|FG001|Overall Study|Lost to Follow-up|15|||
129870313|NCT01666808|467480774|FG000|Overall Study|Withdrawal by Subject|3|||
129870314|NCT01666808|467480775|FG001|Overall Study|Withdrawal by Subject|1|||
129870315|NCT01666808|467480774|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
129870316|NCT01666808|467480775|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
129870317|NCT01525602|467480776|FG000|Overall Study|Adverse Event|1|||
129870318|NCT01525602|467480777|FG001|Overall Study|Adverse Event|0|||
129870319|NCT01525602|467480778|FG002|Overall Study|Adverse Event|1|||
129870320|NCT01525602|467480779|FG003|Overall Study|Adverse Event|1|||
129870321|NCT01525602|467480780|FG004|Overall Study|Adverse Event|3|||
129870322|NCT01525602|467480781|FG005|Overall Study|Adverse Event|3|||
129870323|NCT01525602|467480782|FG006|Overall Study|Adverse Event|0|||
129870324|NCT01525602|467480783|FG007|Overall Study|Adverse Event|1|||
129870325|NCT01525602|467480776|FG000|Overall Study|Disease progression|6|||
129870326|NCT01525602|467480777|FG001|Overall Study|Disease progression|3|||
129870327|NCT01525602|467480778|FG002|Overall Study|Disease progression|2|||
129870328|NCT01525602|467480779|FG003|Overall Study|Disease progression|5|||
129870329|NCT01525602|467480780|FG004|Overall Study|Disease progression|22|||
129870330|NCT01525602|467480781|FG005|Overall Study|Disease progression|2|||
129870331|NCT01525602|467480782|FG006|Overall Study|Disease progression|3|||
129870332|NCT01525602|467480783|FG007|Overall Study|Disease progression|3|||
129870333|NCT01525602|467480776|FG000|Overall Study|Clinical progression|2|||
129870334|NCT01525602|467480777|FG001|Overall Study|Clinical progression|0|||
129870335|NCT01525602|467480778|FG002|Overall Study|Clinical progression|0|||
129870336|NCT01525602|467480779|FG003|Overall Study|Clinical progression|0|||
129870337|NCT01525602|467480780|FG004|Overall Study|Clinical progression|0|||
129870338|NCT01525602|467480781|FG005|Overall Study|Clinical progression|0|||
129870339|NCT01525602|467480782|FG006|Overall Study|Clinical progression|1|||
129870340|NCT01525602|467480783|FG007|Overall Study|Clinical progression|1|||
129870341|NCT01525602|467480776|FG000|Overall Study|Non-compliance|0|||
129870342|NCT01525602|467480777|FG001|Overall Study|Non-compliance|0|||
129870343|NCT01525602|467480778|FG002|Overall Study|Non-compliance|0|||
129870344|NCT01525602|467480779|FG003|Overall Study|Non-compliance|0|||
129870345|NCT01525602|467480780|FG004|Overall Study|Non-compliance|1|||
129870346|NCT01525602|467480781|FG005|Overall Study|Non-compliance|0|||
129870347|NCT01525602|467480782|FG006|Overall Study|Non-compliance|0|||
129870348|NCT01525602|467480783|FG007|Overall Study|Non-compliance|0|||
129870349|NCT01525602|467480776|FG000|Overall Study|Withdrawal by Subject|0|||
129870350|NCT01525602|467480777|FG001|Overall Study|Withdrawal by Subject|0|||
129870351|NCT01525602|467480778|FG002|Overall Study|Withdrawal by Subject|0|||
129870352|NCT01525602|467480779|FG003|Overall Study|Withdrawal by Subject|0|||
129870353|NCT01525602|467480780|FG004|Overall Study|Withdrawal by Subject|3|||
129870354|NCT01525602|467480781|FG005|Overall Study|Withdrawal by Subject|1|||
129870355|NCT01525602|467480782|FG006|Overall Study|Withdrawal by Subject|0|||
129870356|NCT01525602|467480783|FG007|Overall Study|Withdrawal by Subject|1|||
129870357|NCT01525602|467480776|FG000|Overall Study|Physician Decision|0|||
129870358|NCT01525602|467480777|FG001|Overall Study|Physician Decision|0|||
129870359|NCT01525602|467480778|FG002|Overall Study|Physician Decision|0|||
129870360|NCT01525602|467480779|FG003|Overall Study|Physician Decision|0|||
129870361|NCT01525602|467480780|FG004|Overall Study|Physician Decision|3|||
129870362|NCT01525602|467480781|FG005|Overall Study|Physician Decision|0|||
129870363|NCT01525602|467480782|FG006|Overall Study|Physician Decision|1|||
129870364|NCT01525602|467480783|FG007|Overall Study|Physician Decision|0|||
129870365|NCT01525602|467480776|FG000|Overall Study|Death|0|||
129870366|NCT01525602|467480777|FG001|Overall Study|Death|0|||
129870367|NCT01525602|467480778|FG002|Overall Study|Death|0|||
129870368|NCT01525602|467480779|FG003|Overall Study|Death|0|||
129870369|NCT01525602|467480780|FG004|Overall Study|Death|1|||
129870370|NCT01525602|467480781|FG005|Overall Study|Death|1|||
129870371|NCT01525602|467480782|FG006|Overall Study|Death|0|||
129870372|NCT01525602|467480783|FG007|Overall Study|Death|0|||
129870373|NCT01525602|467480776|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870374|NCT01525602|467480777|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870375|NCT01525602|467480778|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870376|NCT01525602|467480779|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870377|NCT01525602|467480780|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870378|NCT01525602|467480781|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
129870379|NCT01525602|467480782|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
129870380|NCT01525602|467480783|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
129870381|NCT01194570|467482394|FG000|Overall Study|Adverse Event|22|||
129870382|NCT01194570|467482395|FG001|Overall Study|Adverse Event|40|||
129870383|NCT01194570|467482394|FG000|Overall Study|Death|6|||
129870384|NCT01194570|467482395|FG001|Overall Study|Death|20|||
129870385|NCT01194570|467482394|FG000|Overall Study|Lack of Efficacy|32|||
129870386|NCT01194570|467482395|FG001|Overall Study|Lack of Efficacy|33|||
129870387|NCT01194570|467482394|FG000|Overall Study|Lost to Follow-up|4|||
129870388|NCT01194570|467482395|FG001|Overall Study|Lost to Follow-up|15|||
129870389|NCT01194570|467482394|FG000|Overall Study|Non-Compliance|2|||
129870390|NCT01194570|467482395|FG001|Overall Study|Non-Compliance|2|||
129870391|NCT01194570|467482394|FG000|Overall Study|Non-Compliance With Study Drug|2|||
129870392|NCT01194570|467482395|FG001|Overall Study|Non-Compliance With Study Drug|2|||
129870393|NCT01194570|467482394|FG000|Overall Study|Other|18|||
129870394|NCT01194570|467482395|FG001|Overall Study|Other|47|||
129870395|NCT01194570|467482394|FG000|Overall Study|Physician Decision|10|||
129870396|NCT01194570|467482395|FG001|Overall Study|Physician Decision|25|||
129870397|NCT01194570|467482394|FG000|Overall Study|Protocol Violation|1|||
129870398|NCT01194570|467482395|FG001|Overall Study|Protocol Violation|2|||
129870399|NCT01194570|467482394|FG000|Overall Study|Study Terminated By Sponsor|0|||
129870400|NCT01194570|467482395|FG001|Overall Study|Study Terminated By Sponsor|1|||
129870401|NCT01194570|467482394|FG000|Overall Study|Withdrawal by Subject|57|||
129870402|NCT01194570|467482395|FG001|Overall Study|Withdrawal by Subject|82|||
129870403|NCT01194570|467482394|FG000|Overall Study|Pregnancy|1|||
129870404|NCT01194570|467482395|FG001|Overall Study|Pregnancy|1|||
129870405|NCT03076970|467482399|FG000|Washout Period 2|Adverse Event|0|||
129870406|NCT03076970|467482400|FG001|Washout Period 2|Adverse Event|0|||
129870407|NCT03076970|467482401|FG002|Washout Period 2|Adverse Event|0|||
129870408|NCT03076970|467482402|FG003|Washout Period 2|Adverse Event|0|||
129870409|NCT03076970|467482403|FG004|Washout Period 2|Adverse Event|1|||
129870410|NCT03076970|467482404|FG005|Washout Period 2|Adverse Event|0|||
129870411|NCT03076970|467482399|FG000|Period 3|Withdrawal by Subject|0|||
129870412|NCT03076970|467482400|FG001|Period 3|Withdrawal by Subject|0|||
129870413|NCT03076970|467482401|FG002|Period 3|Withdrawal by Subject|0|||
129870414|NCT03076970|467482402|FG003|Period 3|Withdrawal by Subject|0|||
129870415|NCT03076970|467482403|FG004|Period 3|Withdrawal by Subject|0|||
129870416|NCT03076970|467482404|FG005|Period 3|Withdrawal by Subject|1|||
129870417|NCT03076970|467482399|FG000|Period 3|Failure to meet I/E criteria|0|||
129870418|NCT03076970|467482400|FG001|Period 3|Failure to meet I/E criteria|0|||
129870419|NCT03076970|467482401|FG002|Period 3|Failure to meet I/E criteria|0|||
129870420|NCT03076970|467482402|FG003|Period 3|Failure to meet I/E criteria|0|||
129870421|NCT03076970|467482403|FG004|Period 3|Failure to meet I/E criteria|1|||
129870422|NCT03076970|467482404|FG005|Period 3|Failure to meet I/E criteria|0|||
129870423|NCT02543658|467482405|FG000|Overall Study|Lack of Efficacy|0|||
129870424|NCT02543658|467482406|FG001|Overall Study|Lack of Efficacy|4|||
129870425|NCT00789815|467482407|FG000|Overall Study|Protocol Violation|6|||
129870426|NCT00789815|467482408|FG001|Overall Study|Protocol Violation|1|||
129870427|NCT00789815|467482407|FG000|Overall Study|Intubation due to massive bleeding|1|||
129870428|NCT00789815|467482408|FG001|Overall Study|Intubation due to massive bleeding|0|||
129870429|NCT01111123|467482414|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
129870430|NCT01111123|467482415|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
129870431|NCT01111123|467482414|FG000|Maintenance Phase|Lost to Follow-up|0|||
129870432|NCT01111123|467482415|FG001|Maintenance Phase|Lost to Follow-up|2|||
129870433|NCT00119405|467482416|FG000|Overall Study|Withdrawal by Subject|1|||
129870434|NCT02563002|467482430|FG000|Overall Study|Death|72|||
129870435|NCT02563002|467482431|FG001|Overall Study|Death|87|||
129870436|NCT02563002|467482430|FG000|Overall Study|Lost to Follow-up|5|||
129870437|NCT02563002|467482431|FG001|Overall Study|Lost to Follow-up|0|||
129870438|NCT02563002|467482430|FG000|Overall Study|Physician Decision|0|||
129870439|NCT02563002|467482431|FG001|Overall Study|Physician Decision|2|||
129870440|NCT02563002|467482430|FG000|Overall Study|Withdrawal by Subject|2|||
129870441|NCT02563002|467482431|FG001|Overall Study|Withdrawal by Subject|10|||
129870442|NCT02563002|467482430|FG000|Overall Study|Sponsor decision|74|||
129870443|NCT02563002|467482431|FG001|Overall Study|Sponsor decision|55|||
129870444|NCT03466086|467482432|FG000|Period 1|Sponsor decision due to study timeline|1|||
129870445|NCT03466086|467482433|FG001|Period 1|Sponsor decision due to study timeline|0|||
129870446|NCT03466086|467482432|FG000|Period 1|Withdrawal by Subject|1|||
129870447|NCT03466086|467482433|FG001|Period 1|Withdrawal by Subject|0|||
129870448|NCT00595504|467482434|FG000|Overall Study|Withdrawal by Subject|1|||
129870449|NCT00595504|467482435|FG001|Overall Study|Withdrawal by Subject|3|||
129870450|NCT00595504|467482434|FG000|Overall Study|Physician Decision|1|||
129870451|NCT00595504|467482435|FG001|Overall Study|Physician Decision|0|||
129870452|NCT01949870|467482436|FG000|Overall Study|Lack of Efficacy|2|||
129870453|NCT01949870|467482436|FG000|Overall Study|Adverse Event|1|||
129870454|NCT01949870|467482436|FG000|Overall Study|Study termination|1|||
129870455|NCT01949870|467482436|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
129870456|NCT00677352|467482437|FG000|Treatment Phase|Adverse Event|14|||
129870457|NCT00677352|467482438|FG001|Treatment Phase|Adverse Event|22|||
129870458|NCT00677352|467482437|FG000|Treatment Phase|Lack of Efficacy|2|||
129870459|NCT00677352|467482438|FG001|Treatment Phase|Lack of Efficacy|3|||
129870460|NCT00677352|467482437|FG000|Treatment Phase|Lost to Follow-up|0|||
129870461|NCT00677352|467482438|FG001|Treatment Phase|Lost to Follow-up|1|||
129870462|NCT00677352|467482437|FG000|Treatment Phase|Withdrawal by Subject|7|||
129870463|NCT00677352|467482438|FG001|Treatment Phase|Withdrawal by Subject|7|||
129870464|NCT00677352|467482437|FG000|Treatment Phase|Physician Decision|1|||
129870465|NCT00677352|467482438|FG001|Treatment Phase|Physician Decision|0|||
129870466|NCT00677352|467482437|FG000|Treatment Phase|Pregnancy|0|||
129870467|NCT00677352|467482438|FG001|Treatment Phase|Pregnancy|1|||
129870468|NCT00677352|467482437|FG000|Treatment Phase|Protocol Violation|1|||
129870469|NCT00677352|467482438|FG001|Treatment Phase|Protocol Violation|1|||
129870470|NCT00677352|467482437|FG000|Treatment Phase|Transference or work related matter|0|||
129870471|NCT00677352|467482438|FG001|Treatment Phase|Transference or work related matter|5|||
129870472|NCT00677352|467482437|FG000|Treatment Phase|Not treated|0|||
129870473|NCT00677352|467482438|FG001|Treatment Phase|Not treated|2|||
129870474|NCT00677352|467482437|FG000|Tapering Phase|Adverse Event|1|||
129870475|NCT00677352|467482438|FG001|Tapering Phase|Adverse Event|5|||
129870476|NCT00677352|467482437|FG000|Tapering Phase|Withdrawal by Subject|5|||
129870477|NCT00677352|467482438|FG001|Tapering Phase|Withdrawal by Subject|3|||
129870478|NCT00677352|467482437|FG000|Tapering Phase|Pregnancy|0|||
129870479|NCT00677352|467482438|FG001|Tapering Phase|Pregnancy|1|||
129870480|NCT00677352|467482437|FG000|Tapering Phase|Job transfer|0|||
129870481|NCT00677352|467482438|FG001|Tapering Phase|Job transfer|1|||
129870482|NCT02182973|467482439|FG000|Overall Study|Withdrawal by Subject|3|||
129870483|NCT02182973|467482440|FG001|Overall Study|Withdrawal by Subject|0|||
129870484|NCT01235546|467482441|FG000|Overall Study|Staff error, medication not administered|1|||
129870485|NCT01235546|467482442|FG001|Overall Study|Staff error, medication not administered|0|||
129870486|NCT01235546|467482441|FG000|Overall Study|Protocol Violation|1|||
129870487|NCT01235546|467482442|FG001|Overall Study|Protocol Violation|1|||
129870488|NCT01123382|467482443|FG000|Overall Study|Withdrawal by Subject|1|||
129870489|NCT01123382|467482444|FG001|Overall Study|Withdrawal by Subject|4|||
129870490|NCT01123382|467482443|FG000|Overall Study|Lost to Follow-up|1|||
129870491|NCT01123382|467482444|FG001|Overall Study|Lost to Follow-up|2|||
129870492|NCT01281644|467482445|FG000|Overall Study|Lost to Follow-up|3|||
129870493|NCT01281644|467482445|FG000|Overall Study|Withdrawal by Subject|2|||
129870494|NCT01755702|467482446|FG000|Wash Out Period I|Other Reason|3|||
129870495|NCT01755702|467482446|FG000|Washout Period II|Other Reason|5|||
129870496|NCT00594854|467482447|FG000|Overall Study|Study terminated|7|||
129870497|NCT00594854|467482448|FG001|Overall Study|Study terminated|10|||
129870498|NCT03172702|467482449|FG000|Overall Study|Adverse Event|9|||
129870499|NCT03172702|467482449|FG000|Overall Study|Death|2|||
129870500|NCT03172702|467482449|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
129917596|NCT00220740|467663155|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
129917597|NCT01057433|467663156|FG000|Overall Study|Adverse Event|1|||
129917598|NCT05268302|467663157|FG000|Overall Study|Death|0|||
129917599|NCT05268302|467663158|FG001|Overall Study|Death|1|||
129917600|NCT02811679|467663159|FG000|Overall Study|Adverse Event|1|||
129917601|NCT02811679|467663159|FG000|Overall Study|Lack of Efficacy|6|||
129917602|NCT02811679|467663159|FG000|Overall Study|Early study closure due to slow accrual|3|||
129917603|NCT05319860|467663161|FG000|Overall Study|Death|1|||
129917604|NCT05319860|467663162|FG001|Overall Study|Death|1|||
129917605|NCT05319860|467663161|FG000|Overall Study|Lost to Follow-up|3|||
129917606|NCT05319860|467663162|FG001|Overall Study|Lost to Follow-up|1|||
129917607|NCT05319860|467663161|FG000|Overall Study|Withdrawal by Subject|1|||
129917608|NCT05319860|467663162|FG001|Overall Study|Withdrawal by Subject|7|||
129917609|NCT04314895|467663163|FG000|Overall Study|Lost to Follow-up|1|||
129917610|NCT04314895|467663163|FG000|Overall Study|Death|10|||
129917611|NCT04314895|467663163|FG000|Overall Study|Physician Decision|2|||
129917612|NCT03941860|467663164|FG000|Overall Study|Withdrawal by Subject|0|||
129917613|NCT03941860|467663165|FG001|Overall Study|Withdrawal by Subject|1|||
129917614|NCT01180634|467665290|FG000|Overall Study|Adverse Event|4|||
129917615|NCT01180634|467665291|FG001|Overall Study|Adverse Event|1|||
129917616|NCT01180634|467665290|FG000|Overall Study|Miscellaneous|2|||
129917617|NCT01180634|467665291|FG001|Overall Study|Miscellaneous|0|||
129917618|NCT01180634|467665290|FG000|Overall Study|Withdrawal by Subject|4|||
129917619|NCT01180634|467665291|FG001|Overall Study|Withdrawal by Subject|0|||
129917620|NCT04419168|467665292|FG000|Overall Study|Protocol Violation|1|||
129917621|NCT04419168|467665293|FG001|Overall Study|Protocol Violation|1|||
129917622|NCT04419168|467665292|FG000|Overall Study|Lost to Follow-up|7|||
129917623|NCT04419168|467665293|FG001|Overall Study|Lost to Follow-up|7|||
129917624|NCT04419168|467665292|FG000|Overall Study|Missed 6-month Visit|48|||
129917625|NCT04419168|467665293|FG001|Overall Study|Missed 6-month Visit|45|||
129917626|NCT04490915|467665294|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
129917627|NCT04490915|467665295|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
129917628|NCT04490915|467665294|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129917629|NCT04490915|467665295|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129917630|NCT04490915|467665294|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129917631|NCT04490915|467665295|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
129917632|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
129917633|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
129917634|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
129917635|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
129917636|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
129917637|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
129917638|NCT04490915|467665294|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
129917639|NCT04490915|467665295|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
129917640|NCT05009251|467665296|FG000|Overall Study|Protocol Violation|100|||
129917641|NCT05009251|467665297|FG001|Overall Study|Protocol Violation|105|||
129917642|NCT05009251|467665298|FG002|Overall Study|Protocol Violation|119|||
129917643|NCT05009251|467665299|FG003|Overall Study|Protocol Violation|120|||
129917644|NCT05009251|467665300|FG004|Overall Study|Protocol Violation|119|||
129917645|NCT05009251|467665296|FG000|Overall Study|Death|25|||
129917646|NCT05009251|467665297|FG001|Overall Study|Death|22|||
129917647|NCT05009251|467665298|FG002|Overall Study|Death|24|||
129917648|NCT05009251|467665299|FG003|Overall Study|Death|19|||
129917649|NCT05009251|467665300|FG004|Overall Study|Death|15|||
129917650|NCT05406921|467665304|FG000|Overall Study|Withdrawal by Subject|25|||
129917651|NCT05406921|467665305|FG001|Overall Study|Withdrawal by Subject|0|||
129917652|NCT05406921|467665306|FG002|Overall Study|Withdrawal by Subject|25|||
129917653|NCT05406921|467665304|FG000|Overall Study|Protocol Violation|0|||
129917654|NCT05406921|467665305|FG001|Overall Study|Protocol Violation|12|||
129917655|NCT05406921|467665306|FG002|Overall Study|Protocol Violation|0|||
129917656|NCT00616967|467665311|FG000|Overall Study|Withdrawal by Subject|0|||
129917657|NCT00616967|467665312|FG001|Overall Study|Withdrawal by Subject|0|||
129917658|NCT00616967|467665313|FG002|Overall Study|Withdrawal by Subject|1|||
129917659|NCT02910583|467665314|FG000|Overall Study|Death|7|||
129917660|NCT02910583|467665315|FG001|Overall Study|Death|3|||
129917661|NCT02910583|467665314|FG000|Overall Study|Lost to Follow-up|1|||
129917662|NCT02910583|467665315|FG001|Overall Study|Lost to Follow-up|0|||
129917663|NCT02910583|467665314|FG000|Overall Study|Withdrawal by Subject|12|||
129917664|NCT02910583|467665315|FG001|Overall Study|Withdrawal by Subject|8|||
129917665|NCT02910583|467665314|FG000|Overall Study|Other, Not Specified|6|||
129917666|NCT02910583|467665315|FG001|Overall Study|Other, Not Specified|3|||
129917667|NCT01331005|467665317|FG000|Overall Study|Lost to Follow-up|2|||
129917668|NCT01331005|467665318|FG001|Overall Study|Lost to Follow-up|1|||
129917669|NCT01331005|467665317|FG000|Overall Study|Withdrawal by Subject|2|||
129917670|NCT01331005|467665318|FG001|Overall Study|Withdrawal by Subject|3|||
129917671|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
129979690|NCT03752970|467889437|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
129870501|NCT03172702|467482449|FG000|Overall Study|Withdrawal by Subject|5|||
129870502|NCT03172702|467482449|FG000|Overall Study|Other|2|||
129870503|NCT06134180|467482460|FG000|Overall Study|Lost to Follow-up|4|||
129870504|NCT02152982|467482461|FG000|Overall Study|Ineligible|4|||
129870505|NCT02152982|467482462|FG001|Overall Study|Ineligible|4|||
129870506|NCT02152982|467482461|FG000|Overall Study|Did not start treatment|12|||
129870507|NCT02152982|467482462|FG001|Overall Study|Did not start treatment|6|||
129870508|NCT00569582|467482463|FG000|Overall Study|Withdrawal by Subject|5|||
129870509|NCT00569582|467482463|FG000|Overall Study|Death|2|||
129870510|NCT00569582|467482463|FG000|Overall Study|Adverse Event|7|||
129870511|NCT00569582|467482463|FG000|Overall Study|Subject was too ill to travel.|1|||
129870512|NCT00569582|467482463|FG000|Overall Study|Subject was non-compliant.|1|||
129917672|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
129917673|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
129917674|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
129917675|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
129917676|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
129917677|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
129917678|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
129917679|NCT05059262|467665319|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
129917680|NCT05059262|467665320|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
129917681|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
129917682|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
129917683|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
129870513|NCT02782169|467482472|FG000|Overall Study|Lost to Follow-up|1|||
129870514|NCT02782169|467482473|FG001|Overall Study|Lost to Follow-up|2|||
129870515|NCT02975973|467482474|FG000|Overall Study|Adverse Event|1|||
129870516|NCT02975973|467482475|FG001|Overall Study|Adverse Event|1|||
129870517|NCT02975973|467482476|FG002|Overall Study|Adverse Event|1|||
129870518|NCT02975973|467482477|FG003|Overall Study|Adverse Event|0|||
129870519|NCT00771810|467482478|FG000|Overall Study|Adverse Event|3|||
129870520|NCT00771810|467482479|FG001|Overall Study|Adverse Event|0|||
129870521|NCT00771810|467482480|FG002|Overall Study|Adverse Event|2|||
129870522|NCT00771810|467482478|FG000|Overall Study|Lost to Follow-up|0|||
129870523|NCT00771810|467482479|FG001|Overall Study|Lost to Follow-up|0|||
129870524|NCT00771810|467482480|FG002|Overall Study|Lost to Follow-up|1|||
129870525|NCT00771810|467482478|FG000|Overall Study|Physician Decision|1|||
129870526|NCT00771810|467482479|FG001|Overall Study|Physician Decision|2|||
129917684|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
129917685|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
129917686|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
129917687|NCT05059262|467665319|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
129917688|NCT05059262|467665320|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
129917689|NCT02029443|467665334|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
129917690|NCT02029443|467665335|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
129917691|NCT02029443|467665336|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
129917692|NCT02029443|467665337|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
129917693|NCT02029443|467665338|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
129917694|NCT02029443|467665334|FG000|Overall Study|Death|13|||
129917695|NCT02029443|467665335|FG001|Overall Study|Death|2|||
129917696|NCT02029443|467665336|FG002|Overall Study|Death|2|||
129917697|NCT02029443|467665337|FG003|Overall Study|Death|11|||
129917698|NCT02029443|467665338|FG004|Overall Study|Death|2|||
129917699|NCT02029443|467665334|FG000|Overall Study|Lost to Follow-up|1|||
129917700|NCT02029443|467665335|FG001|Overall Study|Lost to Follow-up|0|||
129917701|NCT02029443|467665336|FG002|Overall Study|Lost to Follow-up|1|||
129917702|NCT02029443|467665337|FG003|Overall Study|Lost to Follow-up|1|||
129917703|NCT02029443|467665338|FG004|Overall Study|Lost to Follow-up|0|||
129917704|NCT02029443|467665334|FG000|Overall Study|Started other anti-cancer therapy|17|||
129917705|NCT02029443|467665335|FG001|Overall Study|Started other anti-cancer therapy|4|||
129917706|NCT02029443|467665336|FG002|Overall Study|Started other anti-cancer therapy|7|||
129917707|NCT02029443|467665337|FG003|Overall Study|Started other anti-cancer therapy|9|||
129917708|NCT02029443|467665338|FG004|Overall Study|Started other anti-cancer therapy|3|||
129917709|NCT02029443|467665334|FG000|Overall Study|Withdrawal by Subject|3|||
129870527|NCT00771810|467482480|FG002|Overall Study|Physician Decision|2|||
129870528|NCT00771810|467482478|FG000|Overall Study|Protocol Violation|0|||
129870529|NCT00771810|467482479|FG001|Overall Study|Protocol Violation|1|||
129870530|NCT00771810|467482480|FG002|Overall Study|Protocol Violation|1|||
129870531|NCT00771810|467482478|FG000|Overall Study|Withdrawal by Subject|1|||
129870532|NCT00771810|467482479|FG001|Overall Study|Withdrawal by Subject|2|||
129917710|NCT02029443|467665335|FG001|Overall Study|Withdrawal by Subject|1|||
129917711|NCT02029443|467665336|FG002|Overall Study|Withdrawal by Subject|1|||
129917712|NCT02029443|467665337|FG003|Overall Study|Withdrawal by Subject|1|||
129917713|NCT02029443|467665338|FG004|Overall Study|Withdrawal by Subject|0|||
129917714|NCT02029443|467665334|FG000|Overall Study|Other|6|||
129917715|NCT02029443|467665335|FG001|Overall Study|Other|6|||
129917716|NCT02029443|467665336|FG002|Overall Study|Other|4|||
129917717|NCT02029443|467665337|FG003|Overall Study|Other|2|||
129917718|NCT02029443|467665338|FG004|Overall Study|Other|0|||
129917719|NCT03393975|467665340|FG000|Urgent Treatment Period|Physician Decision|0|||
129917720|NCT03393975|467665341|FG001|Urgent Treatment Period|Physician Decision|0|||
129917721|NCT03393975|467665342|FG002|Urgent Treatment Period|Physician Decision|0|||
129917722|NCT03393975|467665343|FG003|Urgent Treatment Period|Physician Decision|1|||
129917723|NCT03393975|467665340|FG000|Prophylaxis Period 1|Reason not Specified|0|||
129917724|NCT03393975|467665341|FG001|Prophylaxis Period 1|Reason not Specified|1|||
129917725|NCT03393975|467665342|FG002|Prophylaxis Period 1|Reason not Specified|0|||
129917726|NCT03393975|467665343|FG003|Prophylaxis Period 1|Reason not Specified|0|||
129917727|NCT03393975|467665340|FG000|Prophylaxis Period 2|Reason not Specified|0|||
129917728|NCT03393975|467665341|FG001|Prophylaxis Period 2|Reason not Specified|1|||
129917729|NCT03393975|467665342|FG002|Prophylaxis Period 2|Reason not Specified|0|||
129917730|NCT03393975|467665343|FG003|Prophylaxis Period 2|Reason not Specified|0|||
129917731|NCT05021640|467665347|FG000|Overall Study|Lost to Follow-up|0|||
129917732|NCT05021640|467665348|FG001|Overall Study|Lost to Follow-up|0|||
129917733|NCT05021640|467665349|FG002|Overall Study|Lost to Follow-up|0|||
129917734|NCT05021640|467665350|FG003|Overall Study|Lost to Follow-up|0|||
129917735|NCT05021640|467665351|FG004|Overall Study|Lost to Follow-up|1|||
129917736|NCT04737772|467665352|FG000|Phase 2 Study|Lost to Follow-up|15|||
129917737|NCT04737772|467665353|FG001|Phase 2 Study|Lost to Follow-up|15|||
129917738|NCT04737772|467665352|FG000|Phase 2 Study|Withdrawal by Subject|0|||
129917739|NCT04737772|467665353|FG001|Phase 2 Study|Withdrawal by Subject|1|||
129917740|NCT04737772|467665352|FG000|Phase 2 Study|Did not take any coaching calls|4|||
129917741|NCT04737772|467665353|FG001|Phase 2 Study|Did not take any coaching calls|0|||
129917742|NCT04737772|467665352|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
129917743|NCT04737772|467665353|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
129917744|NCT04737772|467665352|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
129917745|NCT04737772|467665353|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
129917746|NCT04083235|467665354|FG000|Overall Study|Death|252|||
129917747|NCT04083235|467665355|FG001|Overall Study|Death|277|||
129917748|NCT04083235|467665354|FG000|Overall Study|Withdrawal by Subject|13|||
129917749|NCT04083235|467665355|FG001|Overall Study|Withdrawal by Subject|17|||
129917750|NCT04083235|467665354|FG000|Overall Study|Lost to Follow-up|1|||
129917751|NCT04083235|467665355|FG001|Overall Study|Lost to Follow-up|1|||
129917752|NCT04083235|467665354|FG000|Overall Study|Does not meet entry criteria|1|||
129917753|NCT04083235|467665355|FG001|Overall Study|Does not meet entry criteria|0|||
129917754|NCT04083235|467665354|FG000|Overall Study|Did not receive treatment|13|||
129917755|NCT04083235|467665355|FG001|Overall Study|Did not receive treatment|8|||
129917756|NCT04083235|467665354|FG000|Overall Study|Ongoing at the time of DCO|44|||
129917757|NCT04083235|467665355|FG001|Overall Study|Ongoing at the time of DCO|7|||
129917758|NCT04263311|467665359|FG000|Overall Study|Lost to Follow-up|1|||
129917759|NCT04263311|467665360|FG001|Overall Study|Lost to Follow-up|2|||
129917760|NCT04263311|467665361|FG002|Overall Study|Lost to Follow-up|0|||
129917761|NCT04263311|467665359|FG000|Overall Study|Health Issues|1|||
129917762|NCT04263311|467665360|FG001|Overall Study|Health Issues|0|||
129917763|NCT04263311|467665361|FG002|Overall Study|Health Issues|0|||
129917764|NCT04263311|467665359|FG000|Overall Study|Left the country|1|||
129917765|NCT04263311|467665360|FG001|Overall Study|Left the country|0|||
129917766|NCT04263311|467665361|FG002|Overall Study|Left the country|0|||
129917767|NCT04263311|467665359|FG000|Overall Study|Unable to maintain time commitment|1|||
129917768|NCT04263311|467665360|FG001|Overall Study|Unable to maintain time commitment|0|||
129917769|NCT04263311|467665361|FG002|Overall Study|Unable to maintain time commitment|0|||
129917770|NCT04263311|467665359|FG000|Overall Study|No longer interested|1|||
129917771|NCT04263311|467665360|FG001|Overall Study|No longer interested|0|||
129917772|NCT04263311|467665361|FG002|Overall Study|No longer interested|0|||
129917773|NCT04263311|467665359|FG000|Overall Study|Ineligible post consent|0|||
129917774|NCT04263311|467665360|FG001|Overall Study|Ineligible post consent|0|||
129917775|NCT04263311|467665361|FG002|Overall Study|Ineligible post consent|5|||
129917776|NCT02592330|467665362|FG000|Overall Study|Withdrawal by Subject|1|||
129917777|NCT02592330|467665363|FG001|Overall Study|Withdrawal by Subject|0|||
129917778|NCT02592330|467665362|FG000|Overall Study|Failed Biopsy|1|||
129917779|NCT02592330|467665363|FG001|Overall Study|Failed Biopsy|0|||
129917780|NCT04673929|467665364|FG000|Overall Study|Death|73|||
129917781|NCT04673929|467665364|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
129917782|NCT02927769|467665366|FG000|Induction Phase|Study drug toxicity|1|||
129917783|NCT02927769|467665367|FG001|Induction Phase|Study drug toxicity|1|||
129917784|NCT02927769|467665366|FG000|Induction Phase|Disease progression|0|||
129917785|NCT02927769|467665367|FG001|Induction Phase|Disease progression|1|||
129917786|NCT02927769|467665366|FG000|Intensification Phase|Study drug toxicity|1|||
129917787|NCT02927769|467665367|FG001|Intensification Phase|Study drug toxicity|0|||
129917788|NCT02807636|467665370|FG000|Overall Study|Lost to Follow-up|10|||
129917789|NCT02807636|467665371|FG001|Overall Study|Lost to Follow-up|13|||
129917790|NCT02807636|467665372|FG002|Overall Study|Lost to Follow-up|6|||
129917791|NCT02807636|467665370|FG000|Overall Study|Protocol Deviation|1|||
129917792|NCT02807636|467665371|FG001|Overall Study|Protocol Deviation|0|||
129917793|NCT02807636|467665372|FG002|Overall Study|Protocol Deviation|0|||
129917794|NCT02807636|467665370|FG000|Overall Study|Symptomatic Deterioration|0|||
129917795|NCT02807636|467665371|FG001|Overall Study|Symptomatic Deterioration|1|||
129917796|NCT02807636|467665372|FG002|Overall Study|Symptomatic Deterioration|0|||
129917797|NCT02807636|467665370|FG000|Overall Study|Withdrawal by Subject|39|||
129917798|NCT02807636|467665371|FG001|Overall Study|Withdrawal by Subject|28|||
129917799|NCT02807636|467665372|FG002|Overall Study|Withdrawal by Subject|24|||
129917800|NCT02807636|467665370|FG000|Overall Study|Death|303|||
129917801|NCT02807636|467665371|FG001|Overall Study|Death|332|||
129917802|NCT02807636|467665372|FG002|Overall Study|Death|272|||
129917803|NCT02807636|467665370|FG000|Overall Study|Study Terminated By Sponsor|47|||
129917804|NCT02807636|467665371|FG001|Overall Study|Study Terminated By Sponsor|76|||
129917805|NCT02807636|467665372|FG002|Overall Study|Study Terminated By Sponsor|60|||
129917806|NCT02807636|467665370|FG000|Overall Study|Physician Decision|0|||
129917807|NCT02807636|467665371|FG001|Overall Study|Physician Decision|1|||
129917808|NCT02807636|467665372|FG002|Overall Study|Physician Decision|0|||
129917809|NCT05082909|467665373|FG000|Overall Study|Protocol Violation|0|||
129917810|NCT05082909|467665374|FG001|Overall Study|Protocol Violation|0|||
129917811|NCT05082909|467665375|FG002|Overall Study|Protocol Violation|1|||
129917812|NCT05082909|467665376|FG003|Overall Study|Protocol Violation|0|||
129917813|NCT05082909|467665377|FG004|Overall Study|Protocol Violation|0|||
129917814|NCT05082909|467665378|FG005|Overall Study|Protocol Violation|0|||
129917815|NCT04088630|467665379|FG000|Overall Study|Lost to Follow-up|3|||
129917816|NCT04088630|467665380|FG001|Overall Study|Lost to Follow-up|2|||
129917817|NCT04088630|467665381|FG002|Overall Study|Lost to Follow-up|6|||
129917818|NCT04088630|467665379|FG000|Overall Study|Death|3|||
129917819|NCT04088630|467665380|FG001|Overall Study|Death|1|||
129917820|NCT04088630|467665381|FG002|Overall Study|Death|1|||
129917821|NCT04088630|467665379|FG000|Overall Study|Physician Decision|0|||
129917822|NCT04088630|467665380|FG001|Overall Study|Physician Decision|1|||
129917823|NCT04088630|467665381|FG002|Overall Study|Physician Decision|1|||
129917824|NCT03315754|467665384|FG000|Overall Study|COVID-19 complications leading to death|1|||
129917825|NCT03315754|467665384|FG000|Overall Study|insurance coverage issue|1|||
129917826|NCT02954341|467665385|FG000|Overall Study|Attempted Implant unsuccessful|5|||
129917827|NCT02954341|467665385|FG000|Overall Study|Death|90|||
129917828|NCT02954341|467665385|FG000|Overall Study|Withdrawal by Subject|4|||
129870533|NCT00771810|467482480|FG002|Overall Study|Withdrawal by Subject|0|||
129870534|NCT00771810|467482478|FG000|Overall Study|Other|0|||
129870535|NCT00771810|467482479|FG001|Overall Study|Other|0|||
129870536|NCT00771810|467482480|FG002|Overall Study|Other|1|||
129870537|NCT00045305|467482484|FG000|Overall Study|Lack of Efficacy|6|||
129870538|NCT00045305|467482484|FG000|Overall Study|Adverse Event|3|||
129870539|NCT00045305|467482484|FG000|Overall Study|Death|3|||
129870540|NCT00045305|467482484|FG000|Overall Study|site error|2|||
129870541|NCT03848403|467482490|FG000|Period 2 (Day 8)|Adverse Event|1|||
129870542|NCT03848403|467482491|FG001|Period 2 (Day 8)|Adverse Event|2|||
129870543|NCT03848403|467482492|FG002|Period 2 (Day 8)|Adverse Event|2|||
129870544|NCT03848403|467482490|FG000|Period 2 (Day 8)|Physician Decision|0|||
129870545|NCT03848403|467482491|FG001|Period 2 (Day 8)|Physician Decision|1|||
129870546|NCT03848403|467482492|FG002|Period 2 (Day 8)|Physician Decision|0|||
129870547|NCT03848403|467482490|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
129870548|NCT03848403|467482491|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
129870549|NCT03848403|467482492|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
129870550|NCT01939548|467482493|FG000|Overall Study|Non compliance|0|||
129917829|NCT02954341|467665385|FG000|Overall Study|Physician Decision|13|||
129917830|NCT02954341|467665385|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
129917831|NCT02954341|467665385|FG000|Overall Study|Not implanted due to physician's decision|1|||
129917832|NCT02954341|467665385|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
129917833|NCT05227209|467665389|FG000|Overall Study|Adverse Event|11|||
129917834|NCT05227209|467665389|FG000|Overall Study|Lost to Follow-up|1|||
129870551|NCT01939548|467482494|FG001|Overall Study|Non compliance|2|||
129870552|NCT01939548|467482495|FG002|Overall Study|Non compliance|0|||
129870553|NCT01939548|467482493|FG000|Overall Study|Study Terminated by Sponsor|17|||
129917835|NCT05227209|467665389|FG000|Overall Study|Withdrawal by Subject|7|||
129917836|NCT05227209|467665389|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
129870554|NCT01939548|467482494|FG001|Overall Study|Study Terminated by Sponsor|19|||
129917837|NCT04245501|467665392|FG000|Overall Study|Adverse Event|2|||
129917838|NCT04245501|467665393|FG001|Overall Study|Adverse Event|0|||
129917839|NCT04245501|467665392|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
129870555|NCT01939548|467482495|FG002|Overall Study|Study Terminated by Sponsor|12|||
129917840|NCT04245501|467665393|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
129917841|NCT01426425|467665394|FG000|Overall Study|Exited prior to EP study|22|||
129917842|NCT01426425|467665394|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
129449836|NCT01092143|465945686|FG002|Overall Study|Non compliance with study medication|0|||
129870556|NCT01939548|467482493|FG000|Overall Study|Insufficient Clinical Response|1|||
129870557|NCT01939548|467482494|FG001|Overall Study|Insufficient Clinical Response|0|||
129870558|NCT01939548|467482495|FG002|Overall Study|Insufficient Clinical Response|0|||
129870559|NCT01939548|467482493|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
129870560|NCT01939548|467482494|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
129870561|NCT01939548|467482495|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
129870562|NCT01939548|467482493|FG000|Overall Study|Withdrawal by Subject|4|||
129870563|NCT01939548|467482494|FG001|Overall Study|Withdrawal by Subject|4|||
129870564|NCT01939548|467482495|FG002|Overall Study|Withdrawal by Subject|1|||
129870565|NCT01939548|467482493|FG000|Overall Study|Protocol Violation|7|||
129870566|NCT01939548|467482494|FG001|Overall Study|Protocol Violation|6|||
129870567|NCT01939548|467482495|FG002|Overall Study|Protocol Violation|5|||
129870568|NCT01939548|467482493|FG000|Overall Study|Lost to Follow-up|5|||
129870569|NCT01939548|467482494|FG001|Overall Study|Lost to Follow-up|5|||
129870570|NCT01939548|467482495|FG002|Overall Study|Lost to Follow-up|3|||
129870571|NCT01939548|467482493|FG000|Overall Study|Adverse Event|2|||
129870572|NCT01939548|467482494|FG001|Overall Study|Adverse Event|9|||
129870573|NCT01939548|467482495|FG002|Overall Study|Adverse Event|7|||
129870574|NCT01939548|467482493|FG000|Overall Study|Death|0|||
129870575|NCT01939548|467482494|FG001|Overall Study|Death|0|||
129870576|NCT01939548|467482495|FG002|Overall Study|Death|1|||
129870577|NCT01939548|467482493|FG000|Overall Study|Participant dropped|0|||
129870578|NCT01939548|467482494|FG001|Overall Study|Participant dropped|0|||
129870579|NCT01939548|467482495|FG002|Overall Study|Participant dropped|1|||
129870580|NCT01939548|467482493|FG000|Overall Study|Participant unwilling to continue|0|||
129870581|NCT01939548|467482494|FG001|Overall Study|Participant unwilling to continue|1|||
129870582|NCT01939548|467482495|FG002|Overall Study|Participant unwilling to continue|0|||
129870583|NCT01939548|467482493|FG000|Overall Study|Participant withdrew consent|0|||
129870584|NCT01939548|467482494|FG001|Overall Study|Participant withdrew consent|2|||
129870585|NCT01939548|467482495|FG002|Overall Study|Participant withdrew consent|0|||
129870586|NCT01939548|467482493|FG000|Overall Study|Did not complete follow-up|0|||
129870587|NCT01939548|467482494|FG001|Overall Study|Did not complete follow-up|1|||
129870588|NCT01939548|467482495|FG002|Overall Study|Did not complete follow-up|0|||
129870589|NCT02114151|467482503|FG000|Overall Study|Death|1|||
129870590|NCT02114151|467482503|FG000|Overall Study|Lost to Follow-up|1|||
129870591|NCT02114151|467482503|FG000|Overall Study|Withdrawal by Subject|5|||
129870592|NCT02638948|467482506|FG000|Overall Study|Withdrawal by Subject|4|||
129870593|NCT02638948|467482507|FG001|Overall Study|Withdrawal by Subject|5|||
129870594|NCT02638948|467482508|FG002|Overall Study|Withdrawal by Subject|3|||
129870595|NCT02638948|467482509|FG003|Overall Study|Withdrawal by Subject|1|||
129870596|NCT02638948|467482506|FG000|Overall Study|Administrative Reason by Sponsor|0|||
129870597|NCT02638948|467482507|FG001|Overall Study|Administrative Reason by Sponsor|1|||
129870598|NCT02638948|467482508|FG002|Overall Study|Administrative Reason by Sponsor|0|||
129870599|NCT02638948|467482509|FG003|Overall Study|Administrative Reason by Sponsor|4|||
129870600|NCT02638948|467482506|FG000|Overall Study|Adverse Event|0|||
129870601|NCT02638948|467482507|FG001|Overall Study|Adverse Event|0|||
129870602|NCT02638948|467482508|FG002|Overall Study|Adverse Event|1|||
129870603|NCT02638948|467482509|FG003|Overall Study|Adverse Event|1|||
129870604|NCT02638948|467482506|FG000|Overall Study|Lack of Efficacy|1|||
129870605|NCT02638948|467482507|FG001|Overall Study|Lack of Efficacy|1|||
129870606|NCT02638948|467482508|FG002|Overall Study|Lack of Efficacy|0|||
129870607|NCT02638948|467482509|FG003|Overall Study|Lack of Efficacy|0|||
129870608|NCT02638948|467482506|FG000|Overall Study|Lost to Follow-up|0|||
129870609|NCT02638948|467482507|FG001|Overall Study|Lost to Follow-up|0|||
129870610|NCT02638948|467482508|FG002|Overall Study|Lost to Follow-up|1|||
129870611|NCT02638948|467482509|FG003|Overall Study|Lost to Follow-up|1|||
129870612|NCT02638948|467482506|FG000|Overall Study|Poor/Non-Compliance|0|||
129870613|NCT02638948|467482507|FG001|Overall Study|Poor/Non-Compliance|2|||
129870614|NCT02638948|467482508|FG002|Overall Study|Poor/Non-Compliance|1|||
129870615|NCT02638948|467482509|FG003|Overall Study|Poor/Non-Compliance|0|||
129870616|NCT02638948|467482506|FG000|Overall Study|Participant no longer met study criteria|0|||
129870617|NCT02638948|467482507|FG001|Overall Study|Participant no longer met study criteria|1|||
129870618|NCT02638948|467482508|FG002|Overall Study|Participant no longer met study criteria|0|||
129870619|NCT02638948|467482509|FG003|Overall Study|Participant no longer met study criteria|0|||
129870620|NCT02638948|467482506|FG000|Overall Study|Other than specified above|4|||
129870621|NCT02638948|467482507|FG001|Overall Study|Other than specified above|1|||
129870622|NCT02638948|467482508|FG002|Overall Study|Other than specified above|1|||
129870623|NCT02638948|467482509|FG003|Overall Study|Other than specified above|1|||
129870624|NCT00810264|467482513|FG000|Overall Study|Lost to Follow-up|191|||
129870625|NCT00810264|467482513|FG000|Overall Study|Withdrawal by subject or physician|721|||
129870626|NCT00810264|467482513|FG000|Overall Study|Death|641|||
129870627|NCT06213701|467482514|FG000|Overall Study|Withdrawal by Subject|2|||
129870628|NCT06213701|467482515|FG001|Overall Study|Withdrawal by Subject|1|||
129870629|NCT06213701|467482516|FG002|Overall Study|Withdrawal by Subject|0|||
129870630|NCT02495025|467482523|FG000|Overall Study|Lost to Follow-up|21|||
129870631|NCT02495025|467482524|FG001|Overall Study|Lost to Follow-up|14|||
129870632|NCT02495025|467482523|FG000|Overall Study|Withdrawal by Subject|5|||
129870633|NCT02495025|467482524|FG001|Overall Study|Withdrawal by Subject|0|||
129870634|NCT02134587|467482528|FG000|Overall Study|Did not completed all meetings|30|||
129870635|NCT00265889|467482529|FG000|Overall Study|Physician Decision|1|||
129870636|NCT00265889|467482529|FG000|Overall Study|Protocol Violation|1|||
129870637|NCT00265889|467482529|FG000|Overall Study|Insurance denied the request|3|||
129870638|NCT01515748|467482533|FG000|Overall Study|Withdrawal by Subject|32|||
129870639|NCT01515748|467482534|FG001|Overall Study|Withdrawal by Subject|41|||
129870640|NCT01515748|467482533|FG000|Overall Study|Lost to Follow-up|2|||
129870641|NCT01515748|467482534|FG001|Overall Study|Lost to Follow-up|4|||
129870642|NCT01515748|467482533|FG000|Overall Study|Other than specified above|5|||
129870643|NCT01515748|467482534|FG001|Overall Study|Other than specified above|10|||
129870644|NCT03221387|467482537|FG000|Overall Study|Lost to Follow-up|1|||
129870645|NCT03221387|467482537|FG000|Overall Study|Lung transplant|1|||
129870646|NCT04102579|467482541|FG000|Overall Study|Withdrawal by Subject|3|||
129870647|NCT04102579|467482542|FG001|Overall Study|Withdrawal by Subject|4|||
129870648|NCT04102579|467482541|FG000|Overall Study|Lost to Follow-up|0|||
129870649|NCT04102579|467482542|FG001|Overall Study|Lost to Follow-up|1|||
129870650|NCT04102579|467482541|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
129870651|NCT04102579|467482542|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
129870652|NCT04102579|467482541|FG000|Overall Study|Other than Specified|1|||
129870653|NCT04102579|467482542|FG001|Overall Study|Other than Specified|0|||
129870654|NCT04102579|467482541|FG000|Overall Study|Not Dosed with Study Drug|0|||
129870655|NCT04102579|467482542|FG001|Overall Study|Not Dosed with Study Drug|1|||
129870656|NCT01337674|467484128|FG000|Treatment Period 1|Adverse Event|0|||
129870657|NCT01337674|467484129|FG001|Treatment Period 1|Adverse Event|1|||
129870658|NCT01337674|467484130|FG002|Treatment Period 1|Adverse Event|0|||
129870659|NCT01337674|467484131|FG003|Treatment Period 1|Adverse Event|0|||
129870660|NCT01337674|467484128|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
129870661|NCT01337674|467484129|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
129870662|NCT01337674|467484130|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
129870663|NCT01337674|467484131|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
129870664|NCT01337674|467484128|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129870665|NCT01337674|467484129|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129870666|NCT01337674|467484130|FG002|Treatment Period 2|Withdrawal by Subject|1|||
129870667|NCT01337674|467484131|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129870668|NCT01203930|467484132|FG000|Overall Study|Disease Progression|0|||
129870669|NCT01203930|467484133|FG001|Overall Study|Disease Progression|4|||
129870670|NCT01203930|467484132|FG000|Overall Study|Death|3|||
129870671|NCT01203930|467484133|FG001|Overall Study|Death|1|||
129870672|NCT01203930|467484132|FG000|Overall Study|Withdrew Consent|1|||
129870673|NCT01203930|467484133|FG001|Overall Study|Withdrew Consent|10|||
129870674|NCT01203930|467484132|FG000|Overall Study|Investigator Request|0|||
129870675|NCT01203930|467484133|FG001|Overall Study|Investigator Request|8|||
129870676|NCT01203930|467484132|FG000|Overall Study|Study Terminated by Sponsor|0|||
129870677|NCT01203930|467484133|FG001|Overall Study|Study Terminated by Sponsor|12|||
129870678|NCT01203930|467484132|FG000|Overall Study|Poor tolerance of study drug|0|||
129870679|NCT01203930|467484133|FG001|Overall Study|Poor tolerance of study drug|1|||
129870680|NCT01203930|467484132|FG000|Overall Study|Adverse Event|17|||
129870681|NCT01203930|467484133|FG001|Overall Study|Adverse Event|5|||
129870682|NCT02178059|467484134|FG000|Washout|Physician Decision|1|||
129870683|NCT02178059|467484135|FG001|Washout|Physician Decision|0|||
129870684|NCT05178121|467484136|FG000|Overall Study|Other|4|||
129870685|NCT05178121|467484136|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
129870686|NCT02035332|467484140|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
129870687|NCT00662857|467484141|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
129870688|NCT00662857|467484142|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
129870689|NCT00662857|467484141|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
129870690|NCT00662857|467484142|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
129870691|NCT00662857|467484141|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
129870692|NCT00662857|467484142|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
129870693|NCT00838682|467484143|FG000|Overall Study|Lost to Follow-up|21|||
129870694|NCT00838682|467484144|FG001|Overall Study|Lost to Follow-up|14|||
129870695|NCT00838682|467484143|FG000|Overall Study|detection of exclusion criteria|4|||
129870696|NCT00838682|467484144|FG001|Overall Study|detection of exclusion criteria|3|||
129870697|NCT00838682|467484143|FG000|Overall Study|Protocol Violation|0|||
129870698|NCT00838682|467484144|FG001|Overall Study|Protocol Violation|1|||
129870699|NCT00838682|467484143|FG000|Overall Study|Withdrawal by Subject|0|||
129870700|NCT00838682|467484144|FG001|Overall Study|Withdrawal by Subject|1|||
129870701|NCT03966053|467484145|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
129870702|NCT00989092|467484148|FG000|Overall Study|Physician Decision|9|||
129870703|NCT00989092|467484149|FG001|Overall Study|Physician Decision|6|||
129870704|NCT00989092|467484148|FG000|Overall Study|Adverse Event|20|||
129870705|NCT00989092|467484149|FG001|Overall Study|Adverse Event|1|||
129870706|NCT00989092|467484148|FG000|Overall Study|Chemotherapy initiated|12|||
129870707|NCT00989092|467484149|FG001|Overall Study|Chemotherapy initiated|4|||
129870708|NCT00989092|467484148|FG000|Overall Study|Withdrawal by Subject|17|||
129870709|NCT00989092|467484149|FG001|Overall Study|Withdrawal by Subject|9|||
129870710|NCT00989092|467484148|FG000|Overall Study|Death|14|||
129870711|NCT00989092|467484149|FG001|Overall Study|Death|2|||
129870712|NCT00989092|467484148|FG000|Overall Study|Ineligibility determined|3|||
129870713|NCT00989092|467484149|FG001|Overall Study|Ineligibility determined|3|||
129870714|NCT00989092|467484148|FG000|Overall Study|Lost to Follow-up|6|||
129870715|NCT00989092|467484149|FG001|Overall Study|Lost to Follow-up|2|||
129870716|NCT00989092|467484148|FG000|Overall Study|Other|3|||
129870717|NCT00989092|467484149|FG001|Overall Study|Other|1|||
129870718|NCT00989092|467484148|FG000|Overall Study|Protocol deviation|2|||
129870719|NCT00989092|467484149|FG001|Overall Study|Protocol deviation|0|||
129870720|NCT00989092|467484148|FG000|Overall Study|Erythropoietin therapy initiated|2|||
129870721|NCT00989092|467484149|FG001|Overall Study|Erythropoietin therapy initiated|0|||
129870722|NCT00989092|467484148|FG000|Overall Study|Did not receive study drug|2|||
129870723|NCT00989092|467484149|FG001|Overall Study|Did not receive study drug|0|||
129870724|NCT04098406|467484153|FG000|Overall Study|Adverse Event|2|||
129870725|NCT04098406|467484154|FG001|Overall Study|Adverse Event|1|||
129870726|NCT04098406|467484153|FG000|Overall Study|Withdrawal by Subject|1|||
129870727|NCT04098406|467484154|FG001|Overall Study|Withdrawal by Subject|0|||
129870728|NCT01332227|467484155|FG000|Overall Study|Adverse Event|4|||
129870729|NCT01332227|467484156|FG001|Overall Study|Adverse Event|1|||
129870730|NCT01332227|467484155|FG000|Overall Study|Withdrawal by Subject|5|||
129870731|NCT01332227|467484156|FG001|Overall Study|Withdrawal by Subject|1|||
129870732|NCT01332227|467484155|FG000|Overall Study|Lost to Follow-up|2|||
129870733|NCT01332227|467484156|FG001|Overall Study|Lost to Follow-up|0|||
129870734|NCT01332227|467484155|FG000|Overall Study|Lack of Efficacy|3|||
129870735|NCT01332227|467484156|FG001|Overall Study|Lack of Efficacy|1|||
129870736|NCT01332227|467484155|FG000|Overall Study|Poor compliance/noncompliance|1|||
129870737|NCT01332227|467484156|FG001|Overall Study|Poor compliance/noncompliance|1|||
129870738|NCT01332227|467484155|FG000|Overall Study|Patient moved from area|1|||
129870739|NCT01332227|467484156|FG001|Overall Study|Patient moved from area|0|||
129870740|NCT01332227|467484155|FG000|Overall Study|Patient began prohibited medication|0|||
129870741|NCT01332227|467484156|FG001|Overall Study|Patient began prohibited medication|1|||
129870742|NCT00514943|467484157|FG000|Stage 1|Progressive disease|4|||
129870743|NCT00514943|467484158|FG001|Stage 1|Progressive disease|8|||
129870744|NCT00514943|467484157|FG000|Stage 1|Other Adverse Event|16|||
129870745|NCT00514943|467484158|FG001|Stage 1|Other Adverse Event|6|||
129870746|NCT00514943|467484157|FG000|Stage 1|Not treated|1|||
129870747|NCT00514943|467484158|FG001|Stage 1|Not treated|2|||
129870748|NCT00514943|467484157|FG000|Stage 1|Patient refused to continue study meds|8|||
129870749|NCT00514943|467484158|FG001|Stage 1|Patient refused to continue study meds|3|||
129870750|NCT00514943|467484157|FG000|Stage 1|Other than stated above|1|||
129870751|NCT00514943|467484158|FG001|Stage 1|Other than stated above|7|||
129870752|NCT00514943|467484157|FG000|Stage 2|Progressive disease|27|||
129870753|NCT00514943|467484158|FG001|Stage 2|Progressive disease|24|||
129870754|NCT00514943|467484157|FG000|Stage 2|Other Adverse Event|3|||
129870755|NCT00514943|467484158|FG001|Stage 2|Other Adverse Event|10|||
129870756|NCT00514943|467484157|FG000|Stage 2|Patient refused to continue study meds|2|||
129870757|NCT00514943|467484158|FG001|Stage 2|Patient refused to continue study meds|0|||
129870758|NCT00514943|467484157|FG000|Stage 2|Other than stated above|0|||
129870759|NCT00514943|467484158|FG001|Stage 2|Other than stated above|2|||
129870760|NCT02173548|467484163|FG000|Overall Study|Lost to Follow-up|0|||
129870761|NCT02173548|467484164|FG001|Overall Study|Lost to Follow-up|2|||
129870762|NCT02173548|467484163|FG000|Overall Study|Withdrawal by Subject|1|||
129870763|NCT02173548|467484164|FG001|Overall Study|Withdrawal by Subject|0|||
129870764|NCT01783418|467484168|FG000|Overall Study|Withdrawal by Subject|1|||
129870765|NCT01783418|467484169|FG001|Overall Study|Withdrawal by Subject|0|||
129870766|NCT03548207|467484170|FG000|Overall Study|Death|10|||
129870767|NCT03548207|467484171|FG001|Overall Study|Death|23|||
129870768|NCT03548207|467484172|FG002|Overall Study|Death|3|||
129870769|NCT03548207|467484170|FG000|Overall Study|Lost to Follow-up|0|||
129870770|NCT03548207|467484171|FG001|Overall Study|Lost to Follow-up|2|||
129870771|NCT03548207|467484172|FG002|Overall Study|Lost to Follow-up|0|||
129870772|NCT03548207|467484170|FG000|Overall Study|Withdrawal by Subject|0|||
129870773|NCT03548207|467484171|FG001|Overall Study|Withdrawal by Subject|3|||
129870774|NCT03548207|467484172|FG002|Overall Study|Withdrawal by Subject|0|||
129870775|NCT03548207|467484170|FG000|Overall Study|Sponsor decision|19|||
129870776|NCT03548207|467484171|FG001|Overall Study|Sponsor decision|40|||
129870777|NCT03548207|467484172|FG002|Overall Study|Sponsor decision|6|||
129870778|NCT03548207|467484170|FG000|Overall Study|Randomized but not treated|6|||
129870779|NCT03548207|467484171|FG001|Overall Study|Randomized but not treated|10|||
129870780|NCT03548207|467484172|FG002|Overall Study|Randomized but not treated|4|||
129870781|NCT00415610|467484173|FG000|Overall Study|Death|3|||
129870782|NCT00415610|467484174|FG001|Overall Study|Death|2|||
129870783|NCT00415610|467484175|FG002|Overall Study|Death|5|||
129870784|NCT00999466|467484178|FG000|Main Part|Withdrawal by Subject|0|||
129870785|NCT00999466|467484179|FG001|Main Part|Withdrawal by Subject|0|||
129870786|NCT00999466|467484180|FG002|Main Part|Withdrawal by Subject|2|||
129870787|NCT00999466|467484178|FG000|Main Part|Adverse Event|0|||
129870788|NCT00999466|467484179|FG001|Main Part|Adverse Event|4|||
129870789|NCT00999466|467484180|FG002|Main Part|Adverse Event|2|||
129870790|NCT03040713|467484181|FG000|Overall Study|Positive amyloid scan|3|||
129870791|NCT04539821|467484182|FG000|Overall Study|Withdrawal by Subject|2|||
129870792|NCT04539821|467484182|FG000|Overall Study|continued care with their physician|20|||
129870793|NCT04539821|467484182|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
129870794|NCT02641392|467484183|FG000|Overall Study|Lost to Follow-up|0|||
129870795|NCT02641392|467484184|FG001|Overall Study|Lost to Follow-up|0|||
129870796|NCT02641392|467484185|FG002|Overall Study|Lost to Follow-up|2|||
129870797|NCT02641392|467484183|FG000|Overall Study|Withdrawal by Subject|0|||
129870798|NCT02641392|467484184|FG001|Overall Study|Withdrawal by Subject|0|||
129870799|NCT02641392|467484185|FG002|Overall Study|Withdrawal by Subject|17|||
129870800|NCT02641392|467484183|FG000|Overall Study|Adverse Event|0|||
129870801|NCT02641392|467484184|FG001|Overall Study|Adverse Event|1|||
129870802|NCT02641392|467484185|FG002|Overall Study|Adverse Event|25|||
129870803|NCT02641392|467484183|FG000|Overall Study|Study Terminated by Sponsor|4|||
129870804|NCT02641392|467484184|FG001|Overall Study|Study Terminated by Sponsor|12|||
129870805|NCT02641392|467484185|FG002|Overall Study|Study Terminated by Sponsor|144|||
129870806|NCT02641392|467484183|FG000|Overall Study|Lack of Efficacy|0|||
129870807|NCT02641392|467484184|FG001|Overall Study|Lack of Efficacy|0|||
129870808|NCT02641392|467484185|FG002|Overall Study|Lack of Efficacy|101|||
129870809|NCT02641392|467484183|FG000|Overall Study|Miscellaneous|0|||
129870810|NCT02641392|467484184|FG001|Overall Study|Miscellaneous|0|||
129870811|NCT02641392|467484185|FG002|Overall Study|Miscellaneous|3|||
129870812|NCT02641392|467484183|FG000|Overall Study|Death|0|||
129870813|NCT02641392|467484184|FG001|Overall Study|Death|0|||
129870814|NCT02641392|467484185|FG002|Overall Study|Death|1|||
129870815|NCT02691182|467484186|FG000|Overall Study|Withdrawal by Subject|4|||
129870816|NCT02691182|467484187|FG001|Overall Study|Withdrawal by Subject|7|||
129870817|NCT02691182|467484188|FG002|Overall Study|Withdrawal by Subject|6|||
129870818|NCT02691182|467484189|FG003|Overall Study|Withdrawal by Subject|8|||
129870819|NCT02691182|467484186|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
129870820|NCT02691182|467484187|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
129870821|NCT02691182|467484188|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
129870822|NCT02691182|467484189|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
129870823|NCT02691182|467484186|FG000|Overall Study|Lost to Follow-up|8|||
129870824|NCT02691182|467484187|FG001|Overall Study|Lost to Follow-up|33|||
129870825|NCT02691182|467484188|FG002|Overall Study|Lost to Follow-up|19|||
129870826|NCT02691182|467484189|FG003|Overall Study|Lost to Follow-up|22|||
129870827|NCT02691182|467484186|FG000|Overall Study|Adverse Event|3|||
129870828|NCT02691182|467484187|FG001|Overall Study|Adverse Event|10|||
129870829|NCT02691182|467484188|FG002|Overall Study|Adverse Event|10|||
129917843|NCT01426425|467665394|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
129917844|NCT03281291|467665400|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
129917845|NCT03281291|467665401|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
129917846|NCT03281291|467665402|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
129917847|NCT03281291|467665403|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
129917848|NCT03281291|467665404|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
129917849|NCT03281291|467665400|FG000|Overall Study|Protocol Deviation|2|||
129917850|NCT03281291|467665401|FG001|Overall Study|Protocol Deviation|0|||
129917851|NCT03281291|467665402|FG002|Overall Study|Protocol Deviation|1|||
129917852|NCT03281291|467665403|FG003|Overall Study|Protocol Deviation|2|||
129917853|NCT03281291|467665404|FG004|Overall Study|Protocol Deviation|1|||
129917854|NCT03281291|467665400|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
129917855|NCT03281291|467665401|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
129917856|NCT03281291|467665402|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
129917857|NCT03281291|467665403|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
129917858|NCT03281291|467665404|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
129917859|NCT03281291|467665400|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
129917860|NCT03281291|467665401|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
129917861|NCT03281291|467665402|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
129917862|NCT03281291|467665403|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
129917863|NCT03281291|467665404|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
129917864|NCT03281291|467665400|FG000|Overall Study|Lost to Follow-up|10|||
129917865|NCT03281291|467665401|FG001|Overall Study|Lost to Follow-up|10|||
129917866|NCT03281291|467665402|FG002|Overall Study|Lost to Follow-up|4|||
129870830|NCT02691182|467484189|FG003|Overall Study|Adverse Event|11|||
129870831|NCT02691182|467484186|FG000|Overall Study|Physician Decision|3|||
129870832|NCT02691182|467484187|FG001|Overall Study|Physician Decision|7|||
129870833|NCT02691182|467484188|FG002|Overall Study|Physician Decision|14|||
129870834|NCT02691182|467484189|FG003|Overall Study|Physician Decision|8|||
129870835|NCT02691182|467484186|FG000|Overall Study|Lack of Efficacy|0|||
129870836|NCT02691182|467484187|FG001|Overall Study|Lack of Efficacy|0|||
129870837|NCT02691182|467484188|FG002|Overall Study|Lack of Efficacy|0|||
129870838|NCT02691182|467484189|FG003|Overall Study|Lack of Efficacy|4|||
129870839|NCT02691182|467484186|FG000|Overall Study|Protocol Violation|2|||
129870840|NCT02691182|467484187|FG001|Overall Study|Protocol Violation|6|||
129870841|NCT02691182|467484188|FG002|Overall Study|Protocol Violation|6|||
129870842|NCT02691182|467484189|FG003|Overall Study|Protocol Violation|8|||
129870843|NCT02691182|467484186|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
129870844|NCT02691182|467484187|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
129870845|NCT02691182|467484188|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
129870846|NCT02691182|467484189|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
129870847|NCT02691182|467484186|FG000|Overall Study|Missing|0|||
129870848|NCT02691182|467484187|FG001|Overall Study|Missing|5|||
129870849|NCT02691182|467484188|FG002|Overall Study|Missing|1|||
129870850|NCT02691182|467484189|FG003|Overall Study|Missing|5|||
129870851|NCT00645164|467484190|FG000|Overall Study|Lost to Follow-up|2|||
129870852|NCT00645164|467484190|FG000|Overall Study|Withdrawal by Subject|4|||
129870853|NCT00645164|467484190|FG000|Overall Study|Protocol Violation|1|||
129870854|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
129870855|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
129870856|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
129870857|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
129870858|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
129870859|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
129870860|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
129870861|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
129870862|NCT00117676|467484191|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
129870863|NCT00117676|467484192|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
129870864|NCT00117676|467484191|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
129870865|NCT00117676|467484192|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
129917867|NCT03281291|467665403|FG003|Overall Study|Lost to Follow-up|6|||
129917868|NCT03281291|467665404|FG004|Overall Study|Lost to Follow-up|10|||
129917869|NCT03281291|467665400|FG000|Overall Study|Other|0|||
129917870|NCT03281291|467665401|FG001|Overall Study|Other|2|||
129917871|NCT03281291|467665402|FG002|Overall Study|Other|0|||
129917872|NCT03281291|467665403|FG003|Overall Study|Other|2|||
129917873|NCT03281291|467665404|FG004|Overall Study|Other|1|||
129917874|NCT05524233|467665405|FG000|Overall Study|Lost to Follow-up|2|||
129917875|NCT05524233|467665405|FG000|Overall Study|Adverse Event|2|||
129917876|NCT05524233|467665405|FG000|Overall Study|Withdrawal by Subject|1|||
129917877|NCT04390048|467665406|FG000|Overall Study|Withdrawal by Subject|1|||
129917878|NCT04390048|467665407|FG001|Overall Study|Withdrawal by Subject|3|||
129917879|NCT04556656|467665409|FG000|Overall Study|Withdrawal by Subject|14|||
129917880|NCT04556656|467665410|FG001|Overall Study|Withdrawal by Subject|12|||
129917881|NCT04556656|467665409|FG000|Overall Study|Physician Decision|1|||
129917882|NCT04556656|467665410|FG001|Overall Study|Physician Decision|0|||
129917883|NCT04556656|467665409|FG000|Overall Study|Adverse Event|4|||
129917884|NCT04556656|467665410|FG001|Overall Study|Adverse Event|7|||
129917885|NCT04556656|467665409|FG000|Overall Study|Death|4|||
129917886|NCT04556656|467665410|FG001|Overall Study|Death|0|||
129917887|NCT04556656|467665409|FG000|Overall Study|Lost to Follow-up|3|||
129917888|NCT04556656|467665410|FG001|Overall Study|Lost to Follow-up|2|||
129917889|NCT04556656|467665409|FG000|Overall Study|Not further specified|2|||
129917890|NCT04556656|467665410|FG001|Overall Study|Not further specified|1|||
129917891|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917892|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917893|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917894|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917895|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917896|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917897|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
129917898|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917899|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917900|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917901|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917902|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917903|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917904|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917905|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917906|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917907|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917908|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917909|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917910|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917911|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917912|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917913|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917914|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917915|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917916|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917917|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
129917918|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917919|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917920|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917921|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
129917922|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917923|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917924|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917925|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917926|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917927|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917928|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917929|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917930|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917931|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917932|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917933|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917934|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917935|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129870866|NCT00117676|467484191|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
129917936|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917937|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917938|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129870867|NCT00117676|467484192|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
129870868|NCT00117676|467484191|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
129870869|NCT00117676|467484192|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
129870870|NCT00117676|467484191|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
129870871|NCT00117676|467484192|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
129870872|NCT00117676|467484191|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
129870873|NCT00117676|467484192|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
129870874|NCT00117676|467484191|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
129870875|NCT00117676|467484192|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
129917939|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917940|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917941|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917942|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917943|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917944|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
129917945|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
129917946|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
129917947|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
129917948|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
129917949|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
129917950|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
129917951|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
129917952|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
129917953|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
129917954|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
129917955|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
129917956|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
129917957|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
129917958|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
129917959|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
129917960|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
129917961|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
129917962|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
129917963|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
129917964|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
129917965|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
129917966|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
129917967|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
129917968|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
129917969|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
129917970|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
129917971|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
129917972|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917973|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917974|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917975|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917976|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917977|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917978|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
129917979|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917980|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129870876|NCT00117676|467484191|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
129870877|NCT00117676|467484192|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
129870878|NCT00117676|467484191|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
129870879|NCT00117676|467484192|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
129917981|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917982|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917983|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917984|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
129917985|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917986|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917987|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917988|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917989|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917990|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917991|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917992|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917993|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917994|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917995|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917996|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917997|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917998|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
129917999|NCT02783300|467665418|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918000|NCT02783300|467665419|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918001|NCT02783300|467665420|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918002|NCT02783300|467665421|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918003|NCT02783300|467665422|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
129918004|NCT02783300|467665423|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918005|NCT02783300|467665424|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
129918006|NCT02783300|467665425|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918007|NCT02783300|467665426|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918008|NCT02783300|467665427|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
129918009|NCT02783300|467665428|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918010|NCT02783300|467665429|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918011|NCT02783300|467665430|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
129918012|NCT02783300|467665431|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918013|NCT02783300|467665432|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918014|NCT02783300|467665433|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918015|NCT02783300|467665434|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918016|NCT02783300|467665435|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918017|NCT02783300|467665436|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918018|NCT02783300|467665437|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918019|NCT02783300|467665438|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918020|NCT02783300|467665439|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918021|NCT02783300|467665440|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918022|NCT02783300|467665441|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918023|NCT02783300|467665442|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918024|NCT02783300|467665443|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918025|NCT02783300|467665444|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
129918026|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918027|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918028|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918029|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918030|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918031|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918032|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918033|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918034|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918035|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918036|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918037|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918038|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918039|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918040|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918041|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
129918042|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918043|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
129918044|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
129918045|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
129918046|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918047|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918048|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918049|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918050|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
129870880|NCT00117676|467484191|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
129870881|NCT00117676|467484192|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
129870882|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
129870883|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
129870884|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
129870885|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
129870886|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
129870887|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
129870888|NCT00117676|467484191|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
129870889|NCT00117676|467484192|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
129870890|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
129870891|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
129870892|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
129870893|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
129870894|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
129870895|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
129870896|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
129870897|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
129870898|NCT00117676|467484191|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
129870899|NCT00117676|467484192|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
129870900|NCT00117676|467484191|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
129870901|NCT00117676|467484192|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
129870902|NCT00117676|467484191|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
129870903|NCT00117676|467484192|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
129870904|NCT00117676|467484191|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
129870905|NCT00117676|467484192|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
129870906|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
129870907|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
129870908|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
129870909|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
129870910|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
129870911|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
129870912|NCT00117676|467484191|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
129870913|NCT00117676|467484192|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
129870914|NCT00117676|467484191|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
129870915|NCT00117676|467484192|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
129870916|NCT00117676|467484191|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
129870917|NCT00117676|467484192|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
129870918|NCT00117676|467484191|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
129870919|NCT00117676|467484192|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
129870920|NCT00117676|467484191|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
129870921|NCT00117676|467484192|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
129870922|NCT00117676|467484191|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
129870923|NCT00117676|467484192|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
129870924|NCT00952822|467484193|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
129870925|NCT00952822|467484194|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
129870926|NCT00952822|467484195|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
129870927|NCT00952822|467484196|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
129870928|NCT00952822|467484193|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
129870929|NCT00952822|467484194|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
129870930|NCT00952822|467484195|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
129870931|NCT00952822|467484196|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
129870932|NCT00691938|467484199|FG000|Overall Study|QTc prolongation|1|||
129870933|NCT00691938|467484200|FG001|Overall Study|QTc prolongation|0|||
129870934|NCT00691938|467484201|FG002|Overall Study|QTc prolongation|0|||
129870935|NCT00691938|467484202|FG003|Overall Study|QTc prolongation|0|||
129870936|NCT00691938|467484203|FG004|Overall Study|QTc prolongation|0|||
129870937|NCT00691938|467484204|FG005|Overall Study|QTc prolongation|0|||
129870938|NCT00691938|467484205|FG006|Overall Study|QTc prolongation|0|||
129870939|NCT04860518|467484209|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
129870940|NCT04860518|467484210|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
129870941|NCT04555096|467484215|FG000|Overall Study|Death|4|||
129870942|NCT04555096|467484216|FG001|Overall Study|Death|4|||
129870943|NCT04555096|467484215|FG000|Overall Study|Withdrawal by Subject|1|||
129870944|NCT04555096|467484216|FG001|Overall Study|Withdrawal by Subject|0|||
129870945|NCT04555096|467484215|FG000|Overall Study|Other|0|||
129870946|NCT04555096|467484216|FG001|Overall Study|Other|1|||
129870947|NCT03641313|467484219|FG000|Overall Study|Death|1|||
129870948|NCT03641313|467484219|FG000|Overall Study|Withdrawal by Subject|2|||
129870949|NCT03641313|467484219|FG000|Overall Study|Declining health|1|||
129870950|NCT03641313|467484219|FG000|Overall Study|Adverse Event|1|||
129870951|NCT04642898|467484220|FG000|Overall Study|Withdrawal by Subject|2|||
129870952|NCT04642898|467484221|FG001|Overall Study|Withdrawal by Subject|4|||
129870953|NCT04642898|467484222|FG002|Overall Study|Withdrawal by Subject|4|||
129870954|NCT04642898|467484223|FG003|Overall Study|Withdrawal by Subject|6|||
129870955|NCT04642898|467484224|FG004|Overall Study|Withdrawal by Subject|2|||
129870956|NCT04642898|467484225|FG005|Overall Study|Withdrawal by Subject|6|||
129870957|NCT04642898|467484220|FG000|Overall Study|Lost to Follow-up|0|||
129870958|NCT04642898|467484221|FG001|Overall Study|Lost to Follow-up|0|||
129870959|NCT04642898|467484222|FG002|Overall Study|Lost to Follow-up|0|||
129870960|NCT04642898|467484223|FG003|Overall Study|Lost to Follow-up|2|||
129870961|NCT04642898|467484224|FG004|Overall Study|Lost to Follow-up|0|||
129870962|NCT04642898|467484225|FG005|Overall Study|Lost to Follow-up|1|||
129870963|NCT04642898|467484220|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
129870964|NCT04642898|467484221|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
129870965|NCT04642898|467484222|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
129870966|NCT04642898|467484223|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
129870967|NCT04642898|467484224|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
129870968|NCT04642898|467484225|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
129870969|NCT04642898|467484220|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870970|NCT04642898|467484221|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870971|NCT04642898|467484222|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870972|NCT04642898|467484223|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870973|NCT04642898|467484224|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
129870974|NCT04642898|467484225|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
129870975|NCT03574597|467484226|FG000|Overall Study|Withdrawal by Subject|67|||
129870976|NCT03574597|467484227|FG001|Overall Study|Withdrawal by Subject|96|||
129870977|NCT03574597|467484226|FG000|Overall Study|Lost to Follow-up|192|||
129870978|NCT03574597|467484227|FG001|Overall Study|Lost to Follow-up|188|||
129870979|NCT03434678|467484228|FG000|Overall Study|Withdrawal by Subject|13|||
129870980|NCT03434678|467484229|FG001|Overall Study|Withdrawal by Subject|13|||
129870981|NCT03434678|467484228|FG000|Overall Study|Found to be ineligible post randomization|2|||
129870982|NCT03434678|467484229|FG001|Overall Study|Found to be ineligible post randomization|1|||
129870983|NCT06060457|467484232|FG000|Overall Study|Adverse Event|1|||
129870984|NCT06060457|467484233|FG001|Overall Study|Adverse Event|1|||
129870985|NCT06060457|467484232|FG000|Overall Study|Death|2|||
129870986|NCT06060457|467484233|FG001|Overall Study|Death|2|||
129870987|NCT06060457|467484232|FG000|Overall Study|Lost to Follow-up|17|||
129870988|NCT06060457|467484233|FG001|Overall Study|Lost to Follow-up|19|||
129870989|NCT06060457|467484232|FG000|Overall Study|Physician Decision|0|||
129870990|NCT06060457|467484233|FG001|Overall Study|Physician Decision|1|||
129870991|NCT06060457|467484232|FG000|Overall Study|Protocol Violation|1|||
129870992|NCT06060457|467484233|FG001|Overall Study|Protocol Violation|1|||
129870993|NCT06060457|467484232|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
129918051|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918052|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
129918053|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918054|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918055|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918056|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918057|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918058|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918059|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918060|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918061|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918062|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918063|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918064|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918065|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918066|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918067|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918068|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918069|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
129918070|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918071|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
129918072|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
129918073|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918074|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918075|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918076|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129870994|NCT06060457|467484233|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
129870995|NCT06060457|467484232|FG000|Overall Study|Withdrawal by Subject|12|||
129870996|NCT06060457|467484233|FG001|Overall Study|Withdrawal by Subject|15|||
129870997|NCT06060457|467484232|FG000|Overall Study|Other Than Specified|2|||
129870998|NCT06060457|467484233|FG001|Overall Study|Other Than Specified|1|||
129870999|NCT02061202|467484234|FG000|Overall Study|Lost to Follow-up|1|||
129871000|NCT02061202|467484235|FG001|Overall Study|Lost to Follow-up|1|||
129871001|NCT01533493|467484236|FG000|Overall Study|Adverse Event|2|||
129871002|NCT01533493|467484237|FG001|Overall Study|Adverse Event|1|||
129871003|NCT01533493|467484236|FG000|Overall Study|Withdrawal by Subject|1|||
129871004|NCT01533493|467484237|FG001|Overall Study|Withdrawal by Subject|2|||
129871005|NCT01533493|467484236|FG000|Overall Study|Lost to Follow-up|2|||
129871006|NCT01533493|467484237|FG001|Overall Study|Lost to Follow-up|0|||
129871007|NCT05163522|467484240|FG000|Overall Study|Withdrawal by Subject|0|||
129871008|NCT05163522|467484241|FG001|Overall Study|Withdrawal by Subject|0|||
129871009|NCT05163522|467484242|FG002|Overall Study|Withdrawal by Subject|1|||
129871010|NCT05163522|467484243|FG003|Overall Study|Withdrawal by Subject|0|||
129871011|NCT05163522|467484244|FG004|Overall Study|Withdrawal by Subject|0|||
129871012|NCT05163522|467484245|FG005|Overall Study|Withdrawal by Subject|0|||
129871013|NCT05163522|467484246|FG006|Overall Study|Withdrawal by Subject|0|||
129871014|NCT05163522|467484247|FG007|Overall Study|Withdrawal by Subject|0|||
129871015|NCT05163522|467484248|FG008|Overall Study|Withdrawal by Subject|0|||
129871016|NCT05163522|467484249|FG009|Overall Study|Withdrawal by Subject|0|||
129871017|NCT05163522|467484250|FG010|Overall Study|Withdrawal by Subject|0|||
129871018|NCT02660827|467484251|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
129871019|NCT02660827|467484251|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
129871020|NCT02660827|467484251|FG000|From Study to End of Continued Access|Adverse Event|3|||
129871021|NCT02660827|467484251|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
129871022|NCT02660827|467484251|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
129871023|NCT02660827|467484251|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
129871024|NCT02660827|467484251|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
129871025|NCT02660827|467484251|FG000|Period 2: Continued Access Period|Adverse Event|3|||
129449837|NCT01092143|465945687|FG003|Overall Study|Non compliance with study medication|0|||
129871026|NCT02953938|467484252|FG000|Overall Study|Adverse Event|0|||
129871027|NCT02953938|467484253|FG001|Overall Study|Adverse Event|1|||
129871028|NCT02953938|467484252|FG000|Overall Study|Withdrawal by Subject|1|||
129871029|NCT02953938|467484253|FG001|Overall Study|Withdrawal by Subject|1|||
129871030|NCT00313820|467484257|FG000|Assigned to Treatment|Other|1|||
129871031|NCT00313820|467484258|FG001|Assigned to Treatment|Other|0|||
129871032|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
129871033|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
129871034|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
129871035|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
129871036|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
129871037|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
129871038|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
129871039|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
129871040|NCT00313820|467484257|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
129871041|NCT00313820|467484258|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
129871042|NCT00939484|467485799|FG000|Overall Study|Progression/Relapse|8|||
129871043|NCT00939484|467485800|FG001|Overall Study|Progression/Relapse|20|||
129871044|NCT00939484|467485801|FG002|Overall Study|Progression/Relapse|3|||
129871045|NCT01224925|467485802|FG000|Overall Study|Lost to Follow-up|3|||
129871046|NCT01224925|467485803|FG001|Overall Study|Lost to Follow-up|2|||
129871047|NCT00245102|467485805|FG000|Overall Study|Not Treated|1|||
129871048|NCT00245102|467485806|FG001|Overall Study|Not Treated|0|||
129871049|NCT00245102|467485807|FG002|Overall Study|Not Treated|1|||
129871050|NCT00245102|467485808|FG003|Overall Study|Not Treated|0|||
129871051|NCT00245102|467485809|FG004|Overall Study|Not Treated|0|||
129871052|NCT00245102|467485810|FG005|Overall Study|Not Treated|0|||
129871053|NCT00245102|467485805|FG000|Overall Study|Protocol Violation|1|||
129871054|NCT00245102|467485806|FG001|Overall Study|Protocol Violation|0|||
129871055|NCT00245102|467485807|FG002|Overall Study|Protocol Violation|0|||
129871056|NCT00245102|467485808|FG003|Overall Study|Protocol Violation|0|||
129871057|NCT00245102|467485809|FG004|Overall Study|Protocol Violation|0|||
129871058|NCT00245102|467485810|FG005|Overall Study|Protocol Violation|0|||
129871059|NCT00245102|467485805|FG000|Overall Study|Death|0|||
129871060|NCT00245102|467485806|FG001|Overall Study|Death|0|||
129871061|NCT00245102|467485807|FG002|Overall Study|Death|0|||
129871062|NCT00245102|467485808|FG003|Overall Study|Death|1|||
129871063|NCT00245102|467485809|FG004|Overall Study|Death|0|||
129871064|NCT00245102|467485810|FG005|Overall Study|Death|0|||
129871065|NCT00245102|467485805|FG000|Overall Study|Adverse Event|4|||
129871066|NCT00245102|467485806|FG001|Overall Study|Adverse Event|2|||
129871067|NCT00245102|467485807|FG002|Overall Study|Adverse Event|5|||
129871068|NCT00245102|467485808|FG003|Overall Study|Adverse Event|1|||
129871069|NCT00245102|467485809|FG004|Overall Study|Adverse Event|0|||
129871070|NCT00245102|467485810|FG005|Overall Study|Adverse Event|2|||
129871071|NCT00245102|467485805|FG000|Overall Study|Decline in performance|0|||
129871072|NCT00245102|467485806|FG001|Overall Study|Decline in performance|2|||
129871073|NCT00245102|467485807|FG002|Overall Study|Decline in performance|0|||
129871074|NCT00245102|467485808|FG003|Overall Study|Decline in performance|1|||
129871075|NCT00245102|467485809|FG004|Overall Study|Decline in performance|0|||
129871076|NCT00245102|467485810|FG005|Overall Study|Decline in performance|2|||
129871077|NCT00245102|467485805|FG000|Overall Study|Participant needed surgery|0|||
129871078|NCT00245102|467485806|FG001|Overall Study|Participant needed surgery|0|||
129871079|NCT00245102|467485807|FG002|Overall Study|Participant needed surgery|1|||
129871080|NCT00245102|467485808|FG003|Overall Study|Participant needed surgery|0|||
129871081|NCT00245102|467485809|FG004|Overall Study|Participant needed surgery|0|||
129871082|NCT00245102|467485810|FG005|Overall Study|Participant needed surgery|0|||
129871083|NCT00245102|467485805|FG000|Overall Study|Clinical progression|1|||
129871084|NCT00245102|467485806|FG001|Overall Study|Clinical progression|0|||
129871085|NCT00245102|467485807|FG002|Overall Study|Clinical progression|0|||
129871086|NCT00245102|467485808|FG003|Overall Study|Clinical progression|0|||
129871087|NCT00245102|467485809|FG004|Overall Study|Clinical progression|0|||
129871088|NCT00245102|467485810|FG005|Overall Study|Clinical progression|0|||
129871089|NCT01756352|467485813|FG000|Overall Study|moved away and lost to followup|1|||
129871090|NCT03315143|467485814|FG000|Overall Study|Death|240|||
129871091|NCT03315143|467485815|FG001|Overall Study|Death|246|||
129871092|NCT03315143|467485814|FG000|Overall Study|Withdrawal by Subject|57|||
129871093|NCT03315143|467485815|FG001|Overall Study|Withdrawal by Subject|68|||
129871094|NCT03315143|467485814|FG000|Overall Study|Site Terminated by Sponsor|256|||
129871095|NCT03315143|467485815|FG001|Overall Study|Site Terminated by Sponsor|282|||
129871096|NCT03315143|467485814|FG000|Overall Study|Study Terminated by Sponsor|4723|||
129871097|NCT03315143|467485815|FG001|Overall Study|Study Terminated by Sponsor|4664|||
129871098|NCT03315143|467485814|FG000|Overall Study|Reason not Specified|16|||
129871099|NCT03315143|467485815|FG001|Overall Study|Reason not Specified|32|||
129871100|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
129871101|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
129871102|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
129871103|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
129871104|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
129871105|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
129918077|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918078|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918079|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
129918080|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918081|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918082|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918083|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918084|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918085|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918086|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918087|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129871106|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
129871107|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
129871108|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
129871109|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
129871110|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
129871111|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
129871112|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
129871113|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
129871114|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
129871115|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
129871116|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
129871117|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
129871118|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
129871119|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
129871120|NCT00549757|467485816|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
129871121|NCT00549757|467485817|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
129871122|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Death|143|||
129871123|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Death|136|||
129871124|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
129871125|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
129871126|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
129871127|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
129871128|NCT00549757|467485816|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
129871129|NCT00549757|467485817|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
129871130|NCT01127646|467485818|FG000|Overall Study|Entry Criteria Not Met|1|||
129871131|NCT01127646|467485819|FG001|Overall Study|Entry Criteria Not Met|0|||
129871132|NCT01127646|467485818|FG000|Overall Study|Protocol Violation|0|||
129871133|NCT01127646|467485819|FG001|Overall Study|Protocol Violation|1|||
129871134|NCT04067401|467485820|FG000|Overall Study|Withdrawal by Subject|7|||
129871135|NCT04067401|467485821|FG001|Overall Study|Withdrawal by Subject|0|||
129871136|NCT04067401|467485820|FG000|Overall Study|no data provided|1|||
129871137|NCT04067401|467485821|FG001|Overall Study|no data provided|0|||
129871138|NCT01662063|467485824|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
129871139|NCT01662063|467485825|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
129871140|NCT01662063|467485826|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
129871141|NCT01662063|467485824|FG000|Overall Study|Lack of Efficacy|1|||
129871142|NCT01662063|467485825|FG001|Overall Study|Lack of Efficacy|6|||
129871143|NCT01662063|467485826|FG002|Overall Study|Lack of Efficacy|0|||
129871144|NCT01662063|467485824|FG000|Overall Study|Lost to Follow-up|0|||
129871145|NCT01662063|467485825|FG001|Overall Study|Lost to Follow-up|4|||
129871146|NCT01662063|467485826|FG002|Overall Study|Lost to Follow-up|0|||
129871147|NCT01662063|467485824|FG000|Overall Study|Protocol Violation|1|||
129871148|NCT01662063|467485825|FG001|Overall Study|Protocol Violation|0|||
129871149|NCT01662063|467485826|FG002|Overall Study|Protocol Violation|0|||
129871150|NCT01662063|467485824|FG000|Overall Study|Withdrawal by Subject|2|||
129871151|NCT01662063|467485825|FG001|Overall Study|Withdrawal by Subject|4|||
129871152|NCT01662063|467485826|FG002|Overall Study|Withdrawal by Subject|1|||
129871153|NCT01662063|467485824|FG000|Overall Study|Physician Decision|0|||
129871154|NCT01662063|467485825|FG001|Overall Study|Physician Decision|2|||
129871155|NCT01662063|467485826|FG002|Overall Study|Physician Decision|0|||
129871156|NCT01662063|467485824|FG000|Overall Study|Other|0|||
129871157|NCT01662063|467485825|FG001|Overall Study|Other|1|||
129871158|NCT01662063|467485826|FG002|Overall Study|Other|0|||
129871159|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
129871160|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
129871161|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
129449838|NCT01092143|465945688|FG004|Overall Study|Non compliance with study medication|1|||
129449839|NCT01092143|465945684|FG000|Overall Study|Randomized by mistake|0|||
129871162|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
129871163|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
129871164|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
129871165|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
129871166|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
129871167|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
129871168|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
129871169|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
129871170|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
129871171|NCT00293267|467485827|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
129871172|NCT00293267|467485828|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
129871173|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
129871174|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
129871175|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
129871176|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
129871177|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
129871178|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
129871179|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
129871180|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
129871181|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Death|3|||
129871182|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Death|0|||
129871183|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
129871184|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
129871185|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
129871186|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
129871187|NCT00293267|467485827|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
129871188|NCT00293267|467485828|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
129871189|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
129871190|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
129871191|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
129871192|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
129871193|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
129871194|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
129871195|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
129871196|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
129871197|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
129871198|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
129871199|NCT00293267|467485827|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
129871200|NCT00293267|467485828|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
129871201|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
129871202|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
129871203|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
129871204|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
129871205|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
129871206|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
129871207|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
129871208|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
129871209|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
129871210|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
129871211|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
129871212|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
129871213|NCT00293267|467485827|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
129871214|NCT00293267|467485828|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
129918088|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129871215|NCT01477853|467485829|FG000|Phase A|Adverse Event|1|||
129871216|NCT01477853|467485830|FG001|Phase A|Adverse Event|2|||
129871217|NCT01477853|467485831|FG002|Phase A|Adverse Event|2|||
129871218|NCT01477853|467485829|FG000|Phase A|Lost to Follow-up|4|||
129871219|NCT01477853|467485830|FG001|Phase A|Lost to Follow-up|3|||
129871220|NCT01477853|467485831|FG002|Phase A|Lost to Follow-up|2|||
129871221|NCT01477853|467485829|FG000|Phase A|Physician Decision|1|||
129871222|NCT01477853|467485830|FG001|Phase A|Physician Decision|0|||
129871223|NCT01477853|467485831|FG002|Phase A|Physician Decision|1|||
129871224|NCT01477853|467485829|FG000|Phase A|Study terminated by sponsor|37|||
129871225|NCT01477853|467485830|FG001|Phase A|Study terminated by sponsor|40|||
129871226|NCT01477853|467485831|FG002|Phase A|Study terminated by sponsor|39|||
129871227|NCT01477853|467485829|FG000|Phase B|Lost to Follow-up|0|||
129871228|NCT01477853|467485830|FG001|Phase B|Lost to Follow-up|1|||
129871229|NCT01477853|467485831|FG002|Phase B|Lost to Follow-up|0|||
129871230|NCT01477853|467485829|FG000|Phase B|Study terminated by sponsor|12|||
129871231|NCT01477853|467485830|FG001|Phase B|Study terminated by sponsor|10|||
129871232|NCT01477853|467485831|FG002|Phase B|Study terminated by sponsor|11|||
129871233|NCT01050816|467485832|FG000|Overall Study|Lost to Follow-up|2|||
129871234|NCT01050816|467485832|FG000|Overall Study|patient's refusal|2|||
129871235|NCT03086330|467485833|FG000|Overall Study|Withdrawal by Subject|3|||
129871236|NCT03086330|467485834|FG001|Overall Study|Withdrawal by Subject|2|||
129871237|NCT03086330|467485833|FG000|Overall Study|Lost to Follow-up|1|||
129871238|NCT03086330|467485834|FG001|Overall Study|Lost to Follow-up|2|||
129871239|NCT01814748|467485842|FG000|Overall Study|Lost to Follow-up|1|||
129871240|NCT01814748|467485843|FG001|Overall Study|Lost to Follow-up|2|||
129871241|NCT01814748|467485842|FG000|Overall Study|Study site terminated by sponsor|1|||
129871242|NCT01814748|467485843|FG001|Overall Study|Study site terminated by sponsor|1|||
129871243|NCT01814748|467485842|FG000|Overall Study|Withdrawal by Subject|6|||
129871244|NCT01814748|467485843|FG001|Overall Study|Withdrawal by Subject|4|||
129871245|NCT04044456|467485844|FG000|Overall Study|Lost to Follow-up|4|||
129871246|NCT04044456|467485845|FG001|Overall Study|Lost to Follow-up|1|||
129871247|NCT04044456|467485844|FG000|Overall Study|Withdrawal by Subject|1|||
129871248|NCT04044456|467485845|FG001|Overall Study|Withdrawal by Subject|0|||
129871249|NCT01972529|467485846|FG000|Overall Study|Adverse Event|0|||
129871250|NCT01972529|467485847|FG001|Overall Study|Adverse Event|1|||
129871251|NCT01972529|467485848|FG002|Overall Study|Adverse Event|0|||
129871252|NCT01972529|467485849|FG003|Overall Study|Adverse Event|0|||
129871253|NCT01972529|467485846|FG000|Overall Study|Lost to Follow-up|1|||
129871254|NCT01972529|467485847|FG001|Overall Study|Lost to Follow-up|0|||
129871255|NCT01972529|467485848|FG002|Overall Study|Lost to Follow-up|0|||
129871256|NCT01972529|467485849|FG003|Overall Study|Lost to Follow-up|0|||
129871257|NCT01972529|467485846|FG000|Overall Study|Participant Choice|0|||
129871258|NCT01972529|467485847|FG001|Overall Study|Participant Choice|1|||
129871259|NCT01972529|467485848|FG002|Overall Study|Participant Choice|0|||
129871260|NCT01972529|467485849|FG003|Overall Study|Participant Choice|0|||
129871261|NCT01972529|467485846|FG000|Overall Study|Withdrawl of Consent|1|||
129871262|NCT01972529|467485847|FG001|Overall Study|Withdrawl of Consent|2|||
129871263|NCT01972529|467485848|FG002|Overall Study|Withdrawl of Consent|0|||
129871264|NCT01972529|467485849|FG003|Overall Study|Withdrawl of Consent|1|||
129871265|NCT01972529|467485846|FG000|Overall Study|Other|0|||
129871266|NCT01972529|467485847|FG001|Overall Study|Other|0|||
129871267|NCT01972529|467485848|FG002|Overall Study|Other|0|||
129871268|NCT01972529|467485849|FG003|Overall Study|Other|2|||
129871269|NCT01972529|467485846|FG000|Overall Study|Not treated|0|||
129871270|NCT01972529|467485847|FG001|Overall Study|Not treated|1|||
129871271|NCT01972529|467485848|FG002|Overall Study|Not treated|2|||
129871272|NCT01972529|467485849|FG003|Overall Study|Not treated|1|||
129871273|NCT02274857|467485850|FG000|Overall Study|Adverse Event|1|||
129871274|NCT02274857|467485851|FG001|Overall Study|Adverse Event|0|||
129871275|NCT02274857|467485850|FG000|Overall Study|Death|1|||
129871276|NCT02274857|467485851|FG001|Overall Study|Death|2|||
129871277|NCT02274857|467485850|FG000|Overall Study|Lost to Follow-up|3|||
129871278|NCT02274857|467485851|FG001|Overall Study|Lost to Follow-up|0|||
129871279|NCT02274857|467485850|FG000|Overall Study|Physician Decision|2|||
129871280|NCT02274857|467485851|FG001|Overall Study|Physician Decision|0|||
129871281|NCT02274857|467485850|FG000|Overall Study|Trial screen failure|0|||
129871282|NCT02274857|467485851|FG001|Overall Study|Trial screen failure|2|||
129871283|NCT02274857|467485850|FG000|Overall Study|Withdrawal by Subject|11|||
129871284|NCT02274857|467485851|FG001|Overall Study|Withdrawal by Subject|2|||
129871285|NCT02274857|467485850|FG000|Overall Study|Other|2|||
129871286|NCT02274857|467485851|FG001|Overall Study|Other|0|||
129871287|NCT00330174|467485854|FG000|Overall Study|Withdrawal by Subject|7|||
129871288|NCT00330174|467485855|FG001|Overall Study|Withdrawal by Subject|7|||
129871289|NCT00330174|467485854|FG000|Overall Study|Lost to Follow-up|4|||
129871290|NCT00330174|467485855|FG001|Overall Study|Lost to Follow-up|1|||
129871291|NCT00330174|467485854|FG000|Overall Study|Clinical deterioration|1|||
129871292|NCT00330174|467485855|FG001|Overall Study|Clinical deterioration|2|||
129871293|NCT00330174|467485854|FG000|Overall Study|Excessive missed visits|3|||
129871294|NCT00330174|467485855|FG001|Overall Study|Excessive missed visits|8|||
129918089|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918090|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918091|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918092|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918093|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918094|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918095|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918096|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
129918097|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918098|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
129918099|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
129918100|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
129918101|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918102|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918103|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918104|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918105|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918106|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
129918107|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918108|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918109|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918110|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918111|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918112|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918113|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918114|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918115|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918116|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918117|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918118|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918119|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918120|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918121|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918122|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
129918123|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918124|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918125|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918126|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918127|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918128|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918129|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
129918130|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918131|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918132|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918133|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
129918134|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918135|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918136|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918137|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918138|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918139|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918140|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918141|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918142|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918143|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129871295|NCT00330174|467485854|FG000|Overall Study|Miscellaneous reasons|7|||
129871296|NCT00330174|467485855|FG001|Overall Study|Miscellaneous reasons|1|||
129871297|NCT00611858|467485856|FG000|Overall Study|Adverse Event|2|||
129871298|NCT00611858|467485856|FG000|Overall Study|Withdrawal by Subject|2|||
129871299|NCT01844284|467485857|FG000|Overall Study|Lost to Follow-up|12|||
129871300|NCT01844284|467485858|FG001|Overall Study|Lost to Follow-up|7|||
129871301|NCT01058304|467485859|FG000|Overall Study|Withdrawal by Subject|8|||
129871302|NCT01058304|467485860|FG001|Overall Study|Withdrawal by Subject|5|||
129871303|NCT01058304|467485859|FG000|Overall Study|Lost to Follow-up|13|||
129871304|NCT01058304|467485860|FG001|Overall Study|Lost to Follow-up|16|||
129871305|NCT01058304|467485859|FG000|Overall Study|Developed exclusion criterion|6|||
129871306|NCT01058304|467485860|FG001|Overall Study|Developed exclusion criterion|12|||
129871307|NCT01820559|467485861|FG000|Overall Study|Adverse Event|4|||
129871308|NCT01820559|467485862|FG001|Overall Study|Adverse Event|6|||
129871309|NCT01820559|467485863|FG002|Overall Study|Adverse Event|13|||
129871310|NCT01820559|467485861|FG000|Overall Study|Withdrawal by Subject|1|||
129871311|NCT01820559|467485862|FG001|Overall Study|Withdrawal by Subject|2|||
129871312|NCT01820559|467485863|FG002|Overall Study|Withdrawal by Subject|5|||
129871313|NCT01820559|467485861|FG000|Overall Study|Protocol Violation|2|||
129871314|NCT01820559|467485862|FG001|Overall Study|Protocol Violation|1|||
129871315|NCT01820559|467485863|FG002|Overall Study|Protocol Violation|3|||
129871316|NCT01820559|467485861|FG000|Overall Study|Subject's non-compliance|1|||
129871317|NCT01820559|467485862|FG001|Overall Study|Subject's non-compliance|0|||
129871318|NCT01820559|467485863|FG002|Overall Study|Subject's non-compliance|2|||
129871319|NCT01820559|467485861|FG000|Overall Study|Lost to Follow-up|3|||
129871320|NCT01820559|467485862|FG001|Overall Study|Lost to Follow-up|2|||
129871321|NCT01820559|467485863|FG002|Overall Study|Lost to Follow-up|2|||
129871322|NCT01820559|467485861|FG000|Overall Study|At sponsor request|0|||
129871323|NCT01820559|467485862|FG001|Overall Study|At sponsor request|0|||
129871324|NCT01820559|467485863|FG002|Overall Study|At sponsor request|1|||
129871325|NCT01820559|467485861|FG000|Overall Study|Lack of Efficacy|3|||
129871326|NCT01820559|467485862|FG001|Overall Study|Lack of Efficacy|2|||
129871327|NCT01820559|467485863|FG002|Overall Study|Lack of Efficacy|3|||
129871328|NCT02755597|467485864|FG000|Overall Study|Withdrew consent|27|||
129871329|NCT02755597|467485865|FG001|Overall Study|Withdrew consent|11|||
129871330|NCT02755597|467485864|FG000|Overall Study|Lost to Follow-up|1|||
129871331|NCT02755597|467485865|FG001|Overall Study|Lost to Follow-up|0|||
129871332|NCT02755597|467485864|FG000|Overall Study|Death|78|||
129871333|NCT02755597|467485865|FG001|Overall Study|Death|36|||
129871334|NCT02755597|467485864|FG000|Overall Study|Study terminated by Sponsor|67|||
129871335|NCT02755597|467485865|FG001|Overall Study|Study terminated by Sponsor|47|||
129871336|NCT02755597|467485864|FG000|Overall Study|Other, not specified|20|||
129871337|NCT02755597|467485865|FG001|Overall Study|Other, not specified|3|||
129871338|NCT02755597|467485864|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
129871339|NCT02755597|467485865|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
129871340|NCT02657031|467485871|FG000|Overall Study|Adverse Event|1|||
129871341|NCT02657031|467485872|FG001|Overall Study|Adverse Event|2|||
129871342|NCT05007392|467485873|FG000|Overall Study|Randomized but not treated|1|||
129871343|NCT05007392|467485874|FG001|Overall Study|Randomized but not treated|2|||
129871344|NCT05007392|467485873|FG000|Overall Study|Other|5|||
129871345|NCT05007392|467485874|FG001|Overall Study|Other|4|||
129871346|NCT05007392|467485873|FG000|Overall Study|Lost to Follow-up|1|||
129871347|NCT05007392|467485874|FG001|Overall Study|Lost to Follow-up|2|||
129871348|NCT05007392|467485873|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
129871349|NCT05007392|467485874|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
129871350|NCT05007392|467485873|FG000|Overall Study|Use of prohibited concomitant drug|1|||
129871351|NCT05007392|467485874|FG001|Overall Study|Use of prohibited concomitant drug|1|||
129871352|NCT05007392|467485873|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
129871353|NCT05007392|467485874|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
129871354|NCT05007392|467485873|FG000|Overall Study|Adverse Event|10|||
129871355|NCT05007392|467485874|FG001|Overall Study|Adverse Event|6|||
129871356|NCT05007392|467485873|FG000|Overall Study|Participant choice|5|||
129871357|NCT05007392|467485874|FG001|Overall Study|Participant choice|10|||
129871358|NCT05007392|467485873|FG000|Overall Study|Withdrawal of consent|5|||
129871359|NCT05007392|467485874|FG001|Overall Study|Withdrawal of consent|4|||
129871360|NCT01218126|467485875|FG000|Overall Study|Adverse Event|8|||
129871361|NCT01218126|467485876|FG001|Overall Study|Adverse Event|10|||
129871362|NCT01218126|467485877|FG002|Overall Study|Adverse Event|12|||
129871363|NCT01218126|467485878|FG003|Overall Study|Adverse Event|16|||
129871364|NCT01218126|467485875|FG000|Overall Study|Lack of Efficacy|7|||
129449840|NCT01092143|465945685|FG001|Overall Study|Randomized by mistake|0|||
129449841|NCT01092143|465945686|FG002|Overall Study|Randomized by mistake|0|||
129449842|NCT01092143|465945687|FG003|Overall Study|Randomized by mistake|1|||
129449843|NCT01092143|465945688|FG004|Overall Study|Randomized by mistake|0|||
129449844|NCT01092143|465945684|FG000|Overall Study|Pregnancy|0|||
129449845|NCT01092143|465945685|FG001|Overall Study|Pregnancy|0|||
129449846|NCT01092143|465945686|FG002|Overall Study|Pregnancy|0|||
129449847|NCT01092143|465945687|FG003|Overall Study|Pregnancy|1|||
129449848|NCT01092143|465945688|FG004|Overall Study|Pregnancy|0|||
129449849|NCT03986866|465945689|FG000|Overall Study|Withdrawal by Subject|0|||
129449850|NCT03986866|465945690|FG001|Overall Study|Withdrawal by Subject|3|||
129449851|NCT03986866|465945689|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
129449852|NCT03986866|465945690|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
129449853|NCT05093322|465945693|FG000|Overall Study|Death|6|||
129449854|NCT05093322|465945694|FG001|Overall Study|Death|2|||
129449855|NCT05093322|465945693|FG000|Overall Study|Other|4|||
129449856|NCT05093322|465945694|FG001|Overall Study|Other|1|||
129449857|NCT03318978|465945697|FG000|Overall Study|Withdrawal by Subject|1|||
129449858|NCT03734016|465945701|FG000|Overall Study|Sponsor Ended Study|225|||
129449859|NCT03734016|465945702|FG001|Overall Study|Sponsor Ended Study|200|||
129449860|NCT03734016|465945701|FG000|Overall Study|Death|69|||
129449861|NCT03734016|465945702|FG001|Overall Study|Death|83|||
129449862|NCT03734016|465945701|FG000|Overall Study|Withdrawal by Subject|21|||
129449863|NCT03734016|465945702|FG001|Overall Study|Withdrawal by Subject|27|||
129449864|NCT03734016|465945701|FG000|Overall Study|Physician Decision|1|||
129449865|NCT03734016|465945702|FG001|Overall Study|Physician Decision|12|||
129449866|NCT03734016|465945701|FG000|Overall Study|Lost to Follow-up|6|||
129449867|NCT03734016|465945702|FG001|Overall Study|Lost to Follow-up|2|||
129449868|NCT03734016|465945701|FG000|Overall Study|Miscellaneous|5|||
129449869|NCT03734016|465945702|FG001|Overall Study|Miscellaneous|1|||
129449870|NCT01994382|465947268|FG000|Overall Study|Informed consent withdrawn|0|||
129449871|NCT01994382|465947269|FG001|Overall Study|Informed consent withdrawn|0|||
129449872|NCT01994382|465947270|FG002|Overall Study|Informed consent withdrawn|0|||
129449873|NCT01994382|465947271|FG003|Overall Study|Informed consent withdrawn|0|||
129449874|NCT01994382|465947272|FG004|Overall Study|Informed consent withdrawn|0|||
129449875|NCT01994382|465947273|FG005|Overall Study|Informed consent withdrawn|0|||
129449876|NCT01994382|465947274|FG006|Overall Study|Informed consent withdrawn|1|||
129449877|NCT01994382|465947275|FG007|Overall Study|Informed consent withdrawn|0|||
129449878|NCT01994382|465947276|FG008|Overall Study|Informed consent withdrawn|0|||
129449879|NCT01994382|465947277|FG009|Overall Study|Informed consent withdrawn|0|||
129449880|NCT01994382|465947278|FG010|Overall Study|Informed consent withdrawn|0|||
129449881|NCT01994382|465947279|FG011|Overall Study|Informed consent withdrawn|0|||
129449882|NCT01994382|465947280|FG012|Overall Study|Informed consent withdrawn|0|||
129449883|NCT01994382|465947281|FG013|Overall Study|Informed consent withdrawn|0|||
129449884|NCT01994382|465947282|FG014|Overall Study|Informed consent withdrawn|0|||
129449885|NCT01994382|465947283|FG015|Overall Study|Informed consent withdrawn|0|||
129449886|NCT01994382|465947284|FG016|Overall Study|Informed consent withdrawn|0|||
129449887|NCT01994382|465947268|FG000|Overall Study|Progressive disease|3|||
129449888|NCT01994382|465947269|FG001|Overall Study|Progressive disease|4|||
129449889|NCT01994382|465947270|FG002|Overall Study|Progressive disease|4|||
129449890|NCT01994382|465947271|FG003|Overall Study|Progressive disease|3|||
129449891|NCT01994382|465947272|FG004|Overall Study|Progressive disease|2|||
129449892|NCT01994382|465947273|FG005|Overall Study|Progressive disease|3|||
129449893|NCT01994382|465947274|FG006|Overall Study|Progressive disease|3|||
129449894|NCT01994382|465947275|FG007|Overall Study|Progressive disease|6|||
129449895|NCT01994382|465947276|FG008|Overall Study|Progressive disease|2|||
129449896|NCT01994382|465947277|FG009|Overall Study|Progressive disease|2|||
129449897|NCT01994382|465947278|FG010|Overall Study|Progressive disease|13|||
129449898|NCT01994382|465947279|FG011|Overall Study|Progressive disease|8|||
129449899|NCT01994382|465947280|FG012|Overall Study|Progressive disease|7|||
129449900|NCT01994382|465947281|FG013|Overall Study|Progressive disease|3|||
129449901|NCT01994382|465947282|FG014|Overall Study|Progressive disease|6|||
129449902|NCT01994382|465947283|FG015|Overall Study|Progressive disease|44|||
129918144|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918145|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918146|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918147|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
129918148|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
129918149|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
129918150|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
129918151|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918152|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
129918153|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
129918154|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918155|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918156|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918157|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918158|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918159|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918160|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
129918161|NCT02783300|467665418|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918162|NCT02783300|467665419|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918163|NCT02783300|467665420|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918164|NCT02783300|467665421|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918165|NCT02783300|467665422|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918166|NCT02783300|467665423|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918167|NCT02783300|467665424|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918168|NCT02783300|467665425|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918169|NCT02783300|467665426|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918170|NCT02783300|467665427|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918171|NCT02783300|467665428|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918172|NCT02783300|467665429|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918173|NCT02783300|467665430|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918174|NCT02783300|467665431|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
129918175|NCT02783300|467665432|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918176|NCT02783300|467665433|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918177|NCT02783300|467665434|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918178|NCT02783300|467665435|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918179|NCT02783300|467665436|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918180|NCT02783300|467665437|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
129918181|NCT02783300|467665438|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918182|NCT02783300|467665439|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918183|NCT02783300|467665440|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
129918184|NCT02783300|467665441|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
129918185|NCT02783300|467665442|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
129918186|NCT02783300|467665443|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
129918187|NCT02783300|467665444|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
129918188|NCT02783300|467665418|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918189|NCT02783300|467665419|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918190|NCT02783300|467665420|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129871365|NCT01218126|467485876|FG001|Overall Study|Lack of Efficacy|2|||
129871366|NCT01218126|467485877|FG002|Overall Study|Lack of Efficacy|2|||
129871367|NCT01218126|467485878|FG003|Overall Study|Lack of Efficacy|6|||
129871368|NCT01218126|467485875|FG000|Overall Study|Protocol Violation|5|||
129871369|NCT01218126|467485876|FG001|Overall Study|Protocol Violation|2|||
129871370|NCT01218126|467485877|FG002|Overall Study|Protocol Violation|2|||
129871371|NCT01218126|467485878|FG003|Overall Study|Protocol Violation|3|||
129871372|NCT01218126|467485875|FG000|Overall Study|Protocol-defined stopping criteria|1|||
129871373|NCT01218126|467485876|FG001|Overall Study|Protocol-defined stopping criteria|1|||
129871374|NCT01218126|467485877|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129871375|NCT01218126|467485878|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129871376|NCT01218126|467485875|FG000|Overall Study|Lost to Follow-up|0|||
129871377|NCT01218126|467485876|FG001|Overall Study|Lost to Follow-up|0|||
129871378|NCT01218126|467485877|FG002|Overall Study|Lost to Follow-up|0|||
129871379|NCT01218126|467485878|FG003|Overall Study|Lost to Follow-up|2|||
129871380|NCT01218126|467485875|FG000|Overall Study|Physician Decision|1|||
129871381|NCT01218126|467485876|FG001|Overall Study|Physician Decision|2|||
129871382|NCT01218126|467485877|FG002|Overall Study|Physician Decision|4|||
129449903|NCT01994382|465947284|FG016|Overall Study|Progressive disease|28|||
129918191|NCT02783300|467665421|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918192|NCT02783300|467665422|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918193|NCT02783300|467665423|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918194|NCT02783300|467665424|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918195|NCT02783300|467665425|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918196|NCT02783300|467665426|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918197|NCT02783300|467665427|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918198|NCT02783300|467665428|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918199|NCT02783300|467665429|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918200|NCT02783300|467665430|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918201|NCT02783300|467665431|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918202|NCT02783300|467665432|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918203|NCT02783300|467665433|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918204|NCT02783300|467665434|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918205|NCT02783300|467665435|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918206|NCT02783300|467665436|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918207|NCT02783300|467665437|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918208|NCT02783300|467665438|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918209|NCT02783300|467665439|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918210|NCT02783300|467665440|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918211|NCT02783300|467665441|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918212|NCT02783300|467665442|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918213|NCT02783300|467665443|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
129918214|NCT02783300|467665444|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
129918215|NCT02783300|467665418|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918216|NCT02783300|467665419|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918217|NCT02783300|467665420|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918218|NCT02783300|467665421|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918219|NCT02783300|467665422|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918220|NCT02783300|467665423|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918221|NCT02783300|467665424|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918222|NCT02783300|467665425|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918223|NCT02783300|467665426|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918224|NCT02783300|467665427|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918225|NCT02783300|467665428|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918226|NCT02783300|467665429|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918227|NCT02783300|467665430|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918228|NCT02783300|467665431|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918229|NCT02783300|467665432|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918230|NCT02783300|467665433|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918231|NCT02783300|467665434|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918232|NCT02783300|467665435|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918233|NCT02783300|467665436|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918234|NCT02783300|467665437|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918235|NCT02783300|467665438|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918236|NCT02783300|467665439|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918237|NCT02783300|467665440|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918238|NCT02783300|467665441|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
129871383|NCT01218126|467485878|FG003|Overall Study|Physician Decision|2|||
129871384|NCT01218126|467485875|FG000|Overall Study|Withdrawal by Subject|2|||
129871385|NCT01218126|467485876|FG001|Overall Study|Withdrawal by Subject|5|||
129871386|NCT01218126|467485877|FG002|Overall Study|Withdrawal by Subject|4|||
129871387|NCT01218126|467485878|FG003|Overall Study|Withdrawal by Subject|6|||
129871388|NCT01860703|467485879|FG000|Overall Study|Adverse Event|1|||
129871389|NCT01860703|467485880|FG001|Overall Study|Adverse Event|4|||
129871390|NCT01860703|467485881|FG002|Overall Study|Adverse Event|0|||
129871391|NCT01860703|467485882|FG003|Overall Study|Adverse Event|2|||
129871392|NCT01860703|467485879|FG000|Overall Study|Withdrawal by Subject|0|||
129871393|NCT01860703|467485880|FG001|Overall Study|Withdrawal by Subject|1|||
129871394|NCT01860703|467485881|FG002|Overall Study|Withdrawal by Subject|0|||
129871395|NCT01860703|467485882|FG003|Overall Study|Withdrawal by Subject|0|||
129871396|NCT01860703|467485879|FG000|Overall Study|Personal reason|1|||
129871397|NCT01860703|467485880|FG001|Overall Study|Personal reason|0|||
129871398|NCT01860703|467485881|FG002|Overall Study|Personal reason|1|||
129871399|NCT01860703|467485882|FG003|Overall Study|Personal reason|0|||
129871400|NCT02453685|467485887|FG000|Overall Study|Adverse Event|0|||
129871401|NCT02453685|467485888|FG001|Overall Study|Adverse Event|1|||
129871402|NCT02453685|467485887|FG000|Overall Study|Protocol Violation|7|||
129871403|NCT02453685|467485888|FG001|Overall Study|Protocol Violation|4|||
129871404|NCT02453685|467485887|FG000|Overall Study|Lost to Follow-up|0|||
129871405|NCT02453685|467485888|FG001|Overall Study|Lost to Follow-up|1|||
129871406|NCT02453685|467485887|FG000|Overall Study|Withdrawal by Subject|8|||
129871407|NCT02453685|467485888|FG001|Overall Study|Withdrawal by Subject|4|||
129871408|NCT02453685|467485887|FG000|Overall Study|Unclassified|4|||
129871409|NCT02453685|467485888|FG001|Overall Study|Unclassified|2|||
129871410|NCT00453986|467485889|FG000|Overall Study|Lost to Follow-up|6|||
129871411|NCT00453986|467485890|FG001|Overall Study|Lost to Follow-up|5|||
129871412|NCT00453986|467485891|FG002|Overall Study|Lost to Follow-up|6|||
129871413|NCT00453986|467485892|FG003|Overall Study|Lost to Follow-up|2|||
129871414|NCT00453986|467485893|FG004|Overall Study|Lost to Follow-up|0|||
129871415|NCT02778100|467485896|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
129871416|NCT02778100|467485897|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
129871417|NCT00522626|467485902|FG000|Overall Study|Lost to Follow-up|7|||
129871418|NCT03419364|467485905|FG000|Overall Study|Delivery due to maternal condition|2|||
129871419|NCT03419364|467485906|FG001|Overall Study|Delivery due to maternal condition|0|||
129871420|NCT03419364|467485907|FG002|Overall Study|Delivery due to maternal condition|0|||
129871421|NCT01338025|467485911|FG000|Overall Study|Unexpected closure of study|10|||
129871422|NCT01338025|467485912|FG001|Overall Study|Unexpected closure of study|9|||
129871423|NCT01338025|467485911|FG000|Overall Study|Withdrawal by Subject|0|||
129871424|NCT01338025|467485912|FG001|Overall Study|Withdrawal by Subject|2|||
129871425|NCT01338025|467485911|FG000|Overall Study|Found ineligible after starting|1|||
129871426|NCT01338025|467485912|FG001|Overall Study|Found ineligible after starting|0|||
129871427|NCT04120233|467485915|FG000|Overall Study|Adverse Event|0|||
129871428|NCT04120233|467485916|FG001|Overall Study|Adverse Event|0|||
129871429|NCT04120233|467485917|FG002|Overall Study|Adverse Event|0|||
129871430|NCT04120233|467485918|FG003|Overall Study|Adverse Event|0|||
129871431|NCT04120233|467485919|FG004|Overall Study|Adverse Event|1|||
129871432|NCT04120233|467485920|FG005|Overall Study|Adverse Event|0|||
129871433|NCT03779906|467485921|FG000|Overall Study|Lost to Follow-up|7|||
129871434|NCT03779906|467485921|FG000|Overall Study|COVID pandemic|1|||
129871435|NCT02553460|467485924|FG000|Overall Study|Death|3|||
129871436|NCT02553460|467485924|FG000|Overall Study|Withdrawal by Subject|1|||
129871437|NCT02553460|467485924|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
129871438|NCT02553460|467485924|FG000|Overall Study|Relapse or Transplant|14|||
129871439|NCT02553460|467485924|FG000|Overall Study|No response to treatment|2|||
129871440|NCT02553460|467485924|FG000|Overall Study|CAR T cells|2|||
129871441|NCT04814368|467485925|FG000|Overall Study|Study Terminated by Sponsor|0|||
129871442|NCT04814368|467485926|FG001|Overall Study|Study Terminated by Sponsor|3|||
129871443|NCT04814368|467485927|FG002|Overall Study|Study Terminated by Sponsor|0|||
129871444|NCT04814368|467485928|FG003|Overall Study|Study Terminated by Sponsor|2|||
129871445|NCT04814368|467485925|FG000|Overall Study|Subject Decision|1|||
129871446|NCT04814368|467485926|FG001|Overall Study|Subject Decision|2|||
129871447|NCT04814368|467485927|FG002|Overall Study|Subject Decision|0|||
129871448|NCT04814368|467485928|FG003|Overall Study|Subject Decision|0|||
129871449|NCT01953003|467487485|FG000|Overall Study|Not treated|0|||
129871450|NCT01953003|467487486|FG001|Overall Study|Not treated|1|||
129871451|NCT01953003|467487485|FG000|Overall Study|Progressive disease|35|||
129871452|NCT01953003|467487486|FG001|Overall Study|Progressive disease|45|||
129871453|NCT01953003|467487485|FG000|Overall Study|Related Adverse events|7|||
129871454|NCT01953003|467487486|FG001|Overall Study|Related Adverse events|2|||
129871455|NCT01953003|467487485|FG000|Overall Study|Non-related adverse events|0|||
129871456|NCT01953003|467487486|FG001|Overall Study|Non-related adverse events|2|||
129871457|NCT01953003|467487485|FG000|Overall Study|Protocol Violation|0|||
129871458|NCT01953003|467487486|FG001|Overall Study|Protocol Violation|1|||
129871459|NCT01953003|467487485|FG000|Overall Study|Withdrawal by Subject|14|||
129871460|NCT01953003|467487486|FG001|Overall Study|Withdrawal by Subject|4|||
129871461|NCT00224770|467487495|FG000|Overall Study|Lost to Follow-up|4|||
129871462|NCT00224770|467487496|FG001|Overall Study|Lost to Follow-up|2|||
129871463|NCT00224770|467487497|FG002|Overall Study|Lost to Follow-up|0|||
129871464|NCT01106430|467487498|FG000|Overall Study|Adverse Event|8|||
129871465|NCT01106430|467487499|FG001|Overall Study|Adverse Event|10|||
129871466|NCT01106430|467487498|FG000|Overall Study|Lack of Efficacy|2|||
129871467|NCT01106430|467487499|FG001|Overall Study|Lack of Efficacy|13|||
129871468|NCT01106430|467487498|FG000|Overall Study|Lost to Follow-up|5|||
129871469|NCT01106430|467487499|FG001|Overall Study|Lost to Follow-up|1|||
129871470|NCT01106430|467487498|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
129871471|NCT01106430|467487499|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
129871472|NCT01106430|467487498|FG000|Overall Study|Moved Out Of State|0|||
129871473|NCT01106430|467487499|FG001|Overall Study|Moved Out Of State|1|||
129871474|NCT01106430|467487498|FG000|Overall Study|Refused To Take Medication|0|||
129871475|NCT01106430|467487499|FG001|Overall Study|Refused To Take Medication|1|||
129871476|NCT01106430|467487498|FG000|Overall Study|Noncompliance|0|||
129871477|NCT01106430|467487499|FG001|Overall Study|Noncompliance|1|||
129871478|NCT01106430|467487498|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
129871479|NCT01106430|467487499|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
129918239|NCT02783300|467665442|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918240|NCT02783300|467665443|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
129918241|NCT02783300|467665444|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
129918242|NCT03930342|467665450|FG000|Overall Study|Lost to Follow-up|70|||
129918243|NCT03930342|467665451|FG001|Overall Study|Lost to Follow-up|77|||
129918244|NCT05691309|467666932|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
129918245|NCT05691309|467666932|FG000|Overall Study|vancomycin levels not evaluable|2|||
129918246|NCT01804816|467666933|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
129918247|NCT01804816|467666933|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
129918248|NCT04421378|467666939|FG000|Overall Study|Adverse Event|2|||
129918249|NCT04421378|467666940|FG001|Overall Study|Adverse Event|7|||
129918250|NCT04421378|467666941|FG002|Overall Study|Adverse Event|0|||
129918251|NCT04421378|467666942|FG003|Overall Study|Adverse Event|1|||
129918252|NCT04421378|467666943|FG004|Overall Study|Adverse Event|0|||
129918253|NCT04421378|467666939|FG000|Overall Study|Physician Decision|1|||
129918254|NCT04421378|467666940|FG001|Overall Study|Physician Decision|2|||
129918255|NCT04421378|467666941|FG002|Overall Study|Physician Decision|0|||
129918256|NCT04421378|467666942|FG003|Overall Study|Physician Decision|0|||
129918257|NCT04421378|467666943|FG004|Overall Study|Physician Decision|0|||
129918258|NCT04421378|467666939|FG000|Overall Study|Progressive Disease|16|||
129918259|NCT04421378|467666940|FG001|Overall Study|Progressive Disease|4|||
129918260|NCT04421378|467666941|FG002|Overall Study|Progressive Disease|18|||
129918261|NCT04421378|467666942|FG003|Overall Study|Progressive Disease|11|||
129918262|NCT04421378|467666943|FG004|Overall Study|Progressive Disease|3|||
129918263|NCT04421378|467666939|FG000|Overall Study|Study Terminated by Sponsor|0|||
129918264|NCT04421378|467666940|FG001|Overall Study|Study Terminated by Sponsor|1|||
129918265|NCT04421378|467666941|FG002|Overall Study|Study Terminated by Sponsor|1|||
129918266|NCT04421378|467666942|FG003|Overall Study|Study Terminated by Sponsor|0|||
129918267|NCT04421378|467666943|FG004|Overall Study|Study Terminated by Sponsor|0|||
129871480|NCT01106430|467487498|FG000|Overall Study|Previous Use Of Marijuana|1|||
129918268|NCT04421378|467666939|FG000|Overall Study|Withdrawal by Subject|3|||
129918269|NCT04421378|467666940|FG001|Overall Study|Withdrawal by Subject|1|||
129918270|NCT04421378|467666941|FG002|Overall Study|Withdrawal by Subject|0|||
129918271|NCT04421378|467666942|FG003|Overall Study|Withdrawal by Subject|2|||
129871481|NCT01106430|467487499|FG001|Overall Study|Previous Use Of Marijuana|0|||
129871482|NCT01106430|467487498|FG000|Overall Study|Protocol Violation|7|||
129871483|NCT01106430|467487499|FG001|Overall Study|Protocol Violation|2|||
129871484|NCT01106430|467487498|FG000|Overall Study|Withdrawal by Subject|8|||
129918272|NCT04421378|467666943|FG004|Overall Study|Withdrawal by Subject|0|||
129918273|NCT04421378|467666939|FG000|Overall Study|Other|1|||
129918274|NCT04421378|467666940|FG001|Overall Study|Other|0|||
129918275|NCT04421378|467666941|FG002|Overall Study|Other|0|||
129449904|NCT01994382|465947268|FG000|Overall Study|Physician Decision|0|||
129871485|NCT01106430|467487499|FG001|Overall Study|Withdrawal by Subject|4|||
129871486|NCT03704584|467487500|FG000|Overall Study|Withdrawal by Subject|1|||
129871487|NCT03704584|467487501|FG001|Overall Study|Withdrawal by Subject|0|||
129871488|NCT03439189|467487502|FG000|Overall Study|Protocol Violation|19|||
129871489|NCT03439189|467487502|FG000|Overall Study|Lack of Efficacy|63|||
129871490|NCT04791761|467487506|FG000|Overall Study|Lost to Follow-up|8|||
129871491|NCT04791761|467487507|FG001|Overall Study|Lost to Follow-up|6|||
129871492|NCT04791761|467487508|FG002|Overall Study|Lost to Follow-up|10|||
129871493|NCT04791761|467487506|FG000|Overall Study|Withdrawal by Subject|0|||
129871494|NCT04791761|467487507|FG001|Overall Study|Withdrawal by Subject|1|||
129871495|NCT04791761|467487508|FG002|Overall Study|Withdrawal by Subject|1|||
129871496|NCT04791761|467487506|FG000|Overall Study|Protocol Violation|0|||
129871497|NCT04791761|467487507|FG001|Overall Study|Protocol Violation|1|||
129871498|NCT04791761|467487508|FG002|Overall Study|Protocol Violation|1|||
129871499|NCT00508261|467487511|FG000|Overall Study|Other|0|||
129871500|NCT00508261|467487512|FG001|Overall Study|Other|1|||
129871501|NCT00508261|467487513|FG002|Overall Study|Other|1|||
129871502|NCT00508261|467487514|FG003|Overall Study|Other|0|||
129871503|NCT00508261|467487511|FG000|Overall Study|Serious Adverse Event|0|||
129871504|NCT00508261|467487512|FG001|Overall Study|Serious Adverse Event|1|||
129871505|NCT00508261|467487513|FG002|Overall Study|Serious Adverse Event|0|||
129871506|NCT00508261|467487514|FG003|Overall Study|Serious Adverse Event|0|||
129871507|NCT00508261|467487511|FG000|Overall Study|Withdrawal by Subject|3|||
129871508|NCT00508261|467487512|FG001|Overall Study|Withdrawal by Subject|4|||
129871509|NCT00508261|467487513|FG002|Overall Study|Withdrawal by Subject|4|||
129871510|NCT00508261|467487514|FG003|Overall Study|Withdrawal by Subject|0|||
129871511|NCT00508261|467487511|FG000|Overall Study|Migrated/ moved from study area|0|||
129871512|NCT00508261|467487512|FG001|Overall Study|Migrated/ moved from study area|1|||
129871513|NCT00508261|467487513|FG002|Overall Study|Migrated/ moved from study area|0|||
129871514|NCT00508261|467487514|FG003|Overall Study|Migrated/ moved from study area|0|||
129871515|NCT00508261|467487511|FG000|Overall Study|Lost to Follow-up|0|||
129871516|NCT00508261|467487512|FG001|Overall Study|Lost to Follow-up|1|||
129871517|NCT00508261|467487513|FG002|Overall Study|Lost to Follow-up|1|||
129871518|NCT00508261|467487514|FG003|Overall Study|Lost to Follow-up|1|||
129871519|NCT00180479|467487515|FG000|Overall Study|Death|4|||
129871520|NCT00180479|467487516|FG001|Overall Study|Death|2|||
129871521|NCT00180479|467487515|FG000|Overall Study|Lost to Follow-up|9|||
129871522|NCT00180479|467487516|FG001|Overall Study|Lost to Follow-up|7|||
129871523|NCT00180479|467487515|FG000|Overall Study|Withdrawal by Subject|3|||
129871524|NCT00180479|467487516|FG001|Overall Study|Withdrawal by Subject|3|||
129871525|NCT00180479|467487515|FG000|Overall Study|Informed consent not signed|0|||
129871526|NCT00180479|467487516|FG001|Overall Study|Informed consent not signed|1|||
129871527|NCT02459262|467487523|FG000|Overall Study|Withdrawal by Subject|0|||
129871528|NCT02459262|467487524|FG001|Overall Study|Withdrawal by Subject|0|||
129871529|NCT02459262|467487525|FG002|Overall Study|Withdrawal by Subject|0|||
129871530|NCT02459262|467487526|FG003|Overall Study|Withdrawal by Subject|0|||
129871531|NCT02459262|467487527|FG004|Overall Study|Withdrawal by Subject|0|||
129871532|NCT02459262|467487528|FG005|Overall Study|Withdrawal by Subject|0|||
129871533|NCT02459262|467487529|FG006|Overall Study|Withdrawal by Subject|0|||
129871534|NCT02459262|467487530|FG007|Overall Study|Withdrawal by Subject|0|||
129871535|NCT02459262|467487531|FG008|Overall Study|Withdrawal by Subject|0|||
129871536|NCT02459262|467487532|FG009|Overall Study|Withdrawal by Subject|1|||
129871537|NCT02459262|467487533|FG010|Overall Study|Withdrawal by Subject|0|||
129871538|NCT03518125|467487535|FG000|Overall Study|Lost to Follow-up|0|||
129871539|NCT03518125|467487536|FG001|Overall Study|Lost to Follow-up|2|||
129871540|NCT03518125|467487537|FG002|Overall Study|Lost to Follow-up|0|||
129918276|NCT04421378|467666942|FG003|Overall Study|Other|0|||
129918277|NCT04421378|467666943|FG004|Overall Study|Other|0|||
129918278|NCT03090152|467666944|FG000|Overall Study|Withdrawal by Subject|0|||
129918279|NCT03090152|467666945|FG001|Overall Study|Withdrawal by Subject|2|||
129918280|NCT03090152|467666946|FG002|Overall Study|Withdrawal by Subject|1|||
129918281|NCT03090152|467666944|FG000|Overall Study|Surgery Canceled|1|||
129918282|NCT03090152|467666945|FG001|Overall Study|Surgery Canceled|0|||
129918283|NCT03090152|467666946|FG002|Overall Study|Surgery Canceled|0|||
129918284|NCT03090152|467666944|FG000|Overall Study|Epidural catheter could not be placed|0|||
129918285|NCT03090152|467666945|FG001|Overall Study|Epidural catheter could not be placed|2|||
129918286|NCT03090152|467666946|FG002|Overall Study|Epidural catheter could not be placed|0|||
129918287|NCT00170573|467666950|FG000|Overall Study|Violation of inclusion criteria|13|||
129918288|NCT05470400|467666953|FG000|Overall Study|Lost to Follow-up|0|||
129918289|NCT05470400|467666954|FG001|Overall Study|Lost to Follow-up|0|||
129918290|NCT05470400|467666955|FG002|Overall Study|Lost to Follow-up|0|||
129918291|NCT05470400|467666956|FG003|Overall Study|Lost to Follow-up|0|||
129918292|NCT05470400|467666957|FG004|Overall Study|Lost to Follow-up|0|||
129918293|NCT05470400|467666958|FG005|Overall Study|Lost to Follow-up|0|||
129918294|NCT05470400|467666959|FG006|Overall Study|Lost to Follow-up|0|||
129918295|NCT05470400|467666960|FG007|Overall Study|Lost to Follow-up|1|||
129918296|NCT05470400|467666953|FG000|Overall Study|Withdrawal by Subject|1|||
129918297|NCT05470400|467666954|FG001|Overall Study|Withdrawal by Subject|0|||
129918298|NCT05470400|467666955|FG002|Overall Study|Withdrawal by Subject|0|||
129918299|NCT05470400|467666956|FG003|Overall Study|Withdrawal by Subject|0|||
129918300|NCT05470400|467666957|FG004|Overall Study|Withdrawal by Subject|0|||
129918301|NCT05470400|467666958|FG005|Overall Study|Withdrawal by Subject|1|||
129918302|NCT05470400|467666959|FG006|Overall Study|Withdrawal by Subject|0|||
129918303|NCT05470400|467666960|FG007|Overall Study|Withdrawal by Subject|2|||
129918304|NCT03138512|467666961|FG000|Randomization|Participants withdrew consent|0|||
129918305|NCT03138512|467666962|FG001|Randomization|Participants withdrew consent|1|||
129918306|NCT03138512|467666963|FG002|Randomization|Participants withdrew consent|1|||
129918307|NCT03138512|467666964|FG003|Randomization|Participants withdrew consent|0|||
129918308|NCT03138512|467666965|FG004|Randomization|Participants withdrew consent|0|||
129918309|NCT03138512|467666961|FG000|Randomization|Participant no longer meets study criteria|0|||
129918310|NCT03138512|467666962|FG001|Randomization|Participant no longer meets study criteria|3|||
129918311|NCT03138512|467666963|FG002|Randomization|Participant no longer meets study criteria|1|||
129918312|NCT03138512|467666964|FG003|Randomization|Participant no longer meets study criteria|1|||
129918313|NCT03138512|467666965|FG004|Randomization|Participant no longer meets study criteria|3|||
129918314|NCT03138512|467666961|FG000|Randomization|Other reasons|1|||
129918315|NCT03138512|467666962|FG001|Randomization|Other reasons|0|||
129871541|NCT03518125|467487538|FG003|Overall Study|Lost to Follow-up|0|||
129871542|NCT03518125|467487539|FG004|Overall Study|Lost to Follow-up|3|||
129871543|NCT03518125|467487540|FG005|Overall Study|Lost to Follow-up|5|||
129871544|NCT03518125|467487535|FG000|Overall Study|Physician Decision|0|||
129871545|NCT03518125|467487536|FG001|Overall Study|Physician Decision|1|||
129871546|NCT03518125|467487537|FG002|Overall Study|Physician Decision|0|||
129871547|NCT03518125|467487538|FG003|Overall Study|Physician Decision|0|||
129871548|NCT03518125|467487539|FG004|Overall Study|Physician Decision|0|||
129871549|NCT03518125|467487540|FG005|Overall Study|Physician Decision|0|||
129871550|NCT03518125|467487535|FG000|Overall Study|Withdrawal by Subject|1|||
129871551|NCT03518125|467487536|FG001|Overall Study|Withdrawal by Subject|1|||
129871552|NCT03518125|467487537|FG002|Overall Study|Withdrawal by Subject|0|||
129871553|NCT03518125|467487538|FG003|Overall Study|Withdrawal by Subject|1|||
129871554|NCT03518125|467487539|FG004|Overall Study|Withdrawal by Subject|1|||
129871555|NCT03518125|467487540|FG005|Overall Study|Withdrawal by Subject|3|||
129871556|NCT03518125|467487535|FG000|Overall Study|Missed Day 394 Visit|1|||
129871557|NCT03518125|467487536|FG001|Overall Study|Missed Day 394 Visit|0|||
129871558|NCT03518125|467487537|FG002|Overall Study|Missed Day 394 Visit|0|||
129871559|NCT03518125|467487538|FG003|Overall Study|Missed Day 394 Visit|0|||
129871560|NCT03518125|467487539|FG004|Overall Study|Missed Day 394 Visit|0|||
129871561|NCT03518125|467487540|FG005|Overall Study|Missed Day 394 Visit|0|||
129871562|NCT01078155|467487545|FG000|Overall Study|Adverse Event|7|||
129871563|NCT01078155|467487545|FG000|Overall Study|Lack of Efficacy|16|||
129871564|NCT01078155|467487545|FG000|Overall Study|Participant's Decision|6|||
129871565|NCT01078155|467487545|FG000|Overall Study|Lost to Follow-up|15|||
129871566|NCT03286751|467487546|FG000|Washout Period 1|Withdrawal by Subject|0|||
129871567|NCT03286751|467487547|FG001|Washout Period 1|Withdrawal by Subject|0|||
129871568|NCT03286751|467487548|FG002|Washout Period 1|Withdrawal by Subject|0|||
129871569|NCT03286751|467487549|FG003|Washout Period 1|Withdrawal by Subject|0|||
129871570|NCT03286751|467487550|FG004|Washout Period 1|Withdrawal by Subject|1|||
129871571|NCT03286751|467487551|FG005|Washout Period 1|Withdrawal by Subject|0|||
129871572|NCT03286751|467487546|FG000|Washout Period 2|Personal Reasons|0|||
129871573|NCT03286751|467487547|FG001|Washout Period 2|Personal Reasons|1|||
129871574|NCT03286751|467487548|FG002|Washout Period 2|Personal Reasons|0|||
129871575|NCT03286751|467487549|FG003|Washout Period 2|Personal Reasons|0|||
129871576|NCT03286751|467487550|FG004|Washout Period 2|Personal Reasons|0|||
129871577|NCT03286751|467487551|FG005|Washout Period 2|Personal Reasons|0|||
129871578|NCT03286751|467487546|FG000|Washout Period 5|Adverse Event|0|||
129871579|NCT03286751|467487547|FG001|Washout Period 5|Adverse Event|0|||
129871580|NCT03286751|467487548|FG002|Washout Period 5|Adverse Event|0|||
129871581|NCT03286751|467487549|FG003|Washout Period 5|Adverse Event|0|||
129871582|NCT03286751|467487550|FG004|Washout Period 5|Adverse Event|1|||
129871583|NCT03286751|467487551|FG005|Washout Period 5|Adverse Event|0|||
129871584|NCT00238433|467487552|FG000|Overall Study|Screen failure|1|||
129871585|NCT00238433|467487552|FG000|Overall Study|Lost to Follow-up|1|||
129871586|NCT00238433|467487552|FG000|Overall Study|Death|1|||
129871587|NCT02403180|467487558|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
129871588|NCT02403180|467487559|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
129871589|NCT02403180|467487558|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
129871590|NCT02403180|467487559|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
129871591|NCT01445652|467487563|FG000|Overall Study|Not comfortable in lenses|5|||
129871592|NCT01445652|467487564|FG001|Overall Study|Not comfortable in lenses|0|||
129871593|NCT01445652|467487563|FG000|Overall Study|Failed to attend scheduled visit|2|||
129871594|NCT01445652|467487564|FG001|Overall Study|Failed to attend scheduled visit|3|||
129871595|NCT01445652|467487563|FG000|Overall Study|Failed teach session|2|||
129871596|NCT01445652|467487564|FG001|Overall Study|Failed teach session|0|||
129871597|NCT01445652|467487563|FG000|Overall Study|Adverse Event|1|||
129871598|NCT01445652|467487564|FG001|Overall Study|Adverse Event|0|||
129871599|NCT03595332|467487567|FG000|Overall Study|Lost to Follow-up|16|||
129918316|NCT03138512|467666963|FG002|Randomization|Other reasons|0|||
129918317|NCT03138512|467666964|FG003|Randomization|Other reasons|0|||
129918318|NCT03138512|467666965|FG004|Randomization|Other reasons|0|||
129918319|NCT03138512|467666961|FG000|Treatment Part A|Disease recurrence|10|||
129918320|NCT03138512|467666962|FG001|Treatment Part A|Disease recurrence|20|||
129918321|NCT03138512|467666963|FG002|Treatment Part A|Disease recurrence|0|||
129918322|NCT03138512|467666964|FG003|Treatment Part A|Disease recurrence|0|||
129918323|NCT03138512|467666965|FG004|Treatment Part A|Disease recurrence|0|||
129918324|NCT03138512|467666961|FG000|Treatment Part A|Study Drug Toxicity|132|||
129918325|NCT03138512|467666962|FG001|Treatment Part A|Study Drug Toxicity|5|||
129918326|NCT03138512|467666963|FG002|Treatment Part A|Study Drug Toxicity|0|||
129918327|NCT03138512|467666964|FG003|Treatment Part A|Study Drug Toxicity|0|||
129918328|NCT03138512|467666965|FG004|Treatment Part A|Study Drug Toxicity|0|||
129918329|NCT03138512|467666961|FG000|Treatment Part A|Death|1|||
129918330|NCT03138512|467666962|FG001|Treatment Part A|Death|0|||
129918331|NCT03138512|467666963|FG002|Treatment Part A|Death|0|||
129918332|NCT03138512|467666964|FG003|Treatment Part A|Death|0|||
129918333|NCT03138512|467666965|FG004|Treatment Part A|Death|0|||
129918334|NCT03138512|467666961|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
129918335|NCT03138512|467666962|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
129918336|NCT03138512|467666963|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
129918337|NCT03138512|467666964|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
129918338|NCT03138512|467666965|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
129918339|NCT03138512|467666961|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
129918340|NCT03138512|467666962|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
129918341|NCT03138512|467666963|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
129918342|NCT03138512|467666964|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
129918343|NCT03138512|467666965|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
129918344|NCT03138512|467666961|FG000|Treatment Part A|Participant withdrew consent|2|||
129918345|NCT03138512|467666962|FG001|Treatment Part A|Participant withdrew consent|4|||
129918346|NCT03138512|467666963|FG002|Treatment Part A|Participant withdrew consent|0|||
129918347|NCT03138512|467666964|FG003|Treatment Part A|Participant withdrew consent|0|||
129918348|NCT03138512|467666965|FG004|Treatment Part A|Participant withdrew consent|0|||
129918349|NCT03138512|467666961|FG000|Treatment Part A|Lost to Follow-up|0|||
129918350|NCT03138512|467666962|FG001|Treatment Part A|Lost to Follow-up|1|||
129918351|NCT03138512|467666963|FG002|Treatment Part A|Lost to Follow-up|0|||
129918352|NCT03138512|467666964|FG003|Treatment Part A|Lost to Follow-up|0|||
129918353|NCT03138512|467666965|FG004|Treatment Part A|Lost to Follow-up|0|||
129918354|NCT03138512|467666961|FG000|Treatment Part A|Poor/non-compliance|1|||
129918355|NCT03138512|467666962|FG001|Treatment Part A|Poor/non-compliance|0|||
129918356|NCT03138512|467666963|FG002|Treatment Part A|Poor/non-compliance|0|||
129918357|NCT03138512|467666964|FG003|Treatment Part A|Poor/non-compliance|0|||
129918358|NCT03138512|467666965|FG004|Treatment Part A|Poor/non-compliance|0|||
129918359|NCT03138512|467666961|FG000|Treatment Part A|Pregnancy|0|||
129918360|NCT03138512|467666962|FG001|Treatment Part A|Pregnancy|1|||
129918361|NCT03138512|467666963|FG002|Treatment Part A|Pregnancy|0|||
129918362|NCT03138512|467666964|FG003|Treatment Part A|Pregnancy|0|||
129918363|NCT03138512|467666965|FG004|Treatment Part A|Pregnancy|0|||
129918364|NCT03138512|467666961|FG000|Treatment Part A|Other reasons|11|||
129918365|NCT03138512|467666962|FG001|Treatment Part A|Other reasons|8|||
129918366|NCT03138512|467666963|FG002|Treatment Part A|Other reasons|0|||
129918367|NCT03138512|467666964|FG003|Treatment Part A|Other reasons|0|||
129918368|NCT03138512|467666965|FG004|Treatment Part A|Other reasons|0|||
129918369|NCT03138512|467666961|FG000|Treatment Part B|Disease recurrence|0|||
129918370|NCT03138512|467666962|FG001|Treatment Part B|Disease recurrence|0|||
129918371|NCT03138512|467666963|FG002|Treatment Part B|Disease recurrence|6|||
129918372|NCT03138512|467666964|FG003|Treatment Part B|Disease recurrence|12|||
129918373|NCT03138512|467666965|FG004|Treatment Part B|Disease recurrence|10|||
129918374|NCT03138512|467666961|FG000|Treatment Part B|Study drug toxicity|0|||
129918375|NCT03138512|467666962|FG001|Treatment Part B|Study drug toxicity|0|||
129918376|NCT03138512|467666963|FG002|Treatment Part B|Study drug toxicity|63|||
129918377|NCT03138512|467666964|FG003|Treatment Part B|Study drug toxicity|3|||
129918378|NCT03138512|467666965|FG004|Treatment Part B|Study drug toxicity|45|||
129918379|NCT03138512|467666961|FG000|Treatment Part B|Death|0|||
129918380|NCT03138512|467666962|FG001|Treatment Part B|Death|0|||
129918381|NCT03138512|467666963|FG002|Treatment Part B|Death|1|||
129918382|NCT03138512|467666964|FG003|Treatment Part B|Death|0|||
129918383|NCT03138512|467666965|FG004|Treatment Part B|Death|0|||
129918384|NCT03138512|467666961|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
129918385|NCT03138512|467666962|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
129918386|NCT03138512|467666963|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
129918387|NCT03138512|467666964|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
129918388|NCT03138512|467666965|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
129871600|NCT03595332|467487568|FG001|Overall Study|Lost to Follow-up|22|||
129871601|NCT03595332|467487567|FG000|Overall Study|Unable to retrieve ID from school|0|||
129449905|NCT01994382|465947269|FG001|Overall Study|Physician Decision|1|||
129449906|NCT01994382|465947270|FG002|Overall Study|Physician Decision|0|||
129449907|NCT01994382|465947271|FG003|Overall Study|Physician Decision|0|||
129449908|NCT01994382|465947272|FG004|Overall Study|Physician Decision|0|||
129449909|NCT01994382|465947273|FG005|Overall Study|Physician Decision|0|||
129449910|NCT01994382|465947274|FG006|Overall Study|Physician Decision|0|||
129449911|NCT01994382|465947275|FG007|Overall Study|Physician Decision|0|||
129449912|NCT01994382|465947276|FG008|Overall Study|Physician Decision|0|||
129449913|NCT01994382|465947277|FG009|Overall Study|Physician Decision|0|||
129449914|NCT01994382|465947278|FG010|Overall Study|Physician Decision|3|||
129449915|NCT01994382|465947279|FG011|Overall Study|Physician Decision|1|||
129449916|NCT01994382|465947280|FG012|Overall Study|Physician Decision|1|||
129449917|NCT01994382|465947281|FG013|Overall Study|Physician Decision|0|||
129449918|NCT01994382|465947282|FG014|Overall Study|Physician Decision|1|||
129449919|NCT01994382|465947283|FG015|Overall Study|Physician Decision|4|||
129449920|NCT01994382|465947284|FG016|Overall Study|Physician Decision|2|||
129449921|NCT01994382|465947268|FG000|Overall Study|Death|0|||
129449922|NCT01994382|465947269|FG001|Overall Study|Death|0|||
129449923|NCT01994382|465947270|FG002|Overall Study|Death|0|||
129449924|NCT01994382|465947271|FG003|Overall Study|Death|0|||
129449925|NCT01994382|465947272|FG004|Overall Study|Death|1|||
129449926|NCT01994382|465947273|FG005|Overall Study|Death|0|||
129871602|NCT03595332|467487568|FG001|Overall Study|Unable to retrieve ID from school|2|||
129871603|NCT02227875|467487569|FG000|Overall Study|Protocol Violation|10|||
129871604|NCT02227875|467487570|FG001|Overall Study|Protocol Violation|7|||
129871605|NCT02227875|467487569|FG000|Overall Study|Other|1|||
129871606|NCT02227875|467487570|FG001|Overall Study|Other|3|||
129871607|NCT02227875|467487569|FG000|Overall Study|Physician Decision|1|||
129871608|NCT02227875|467487570|FG001|Overall Study|Physician Decision|0|||
129871609|NCT02227875|467487569|FG000|Overall Study|Adverse Event|3|||
129871610|NCT02227875|467487570|FG001|Overall Study|Adverse Event|0|||
129871611|NCT02227875|467487569|FG000|Overall Study|Withdrawal by Subject|12|||
129871612|NCT02227875|467487570|FG001|Overall Study|Withdrawal by Subject|13|||
129871613|NCT02227875|467487569|FG000|Overall Study|Lost to Follow-up|10|||
129871614|NCT02227875|467487570|FG001|Overall Study|Lost to Follow-up|10|||
129871615|NCT04209725|467487573|FG000|Overall Study|Adverse Event|1|||
129871616|NCT00166296|467487574|FG000|Overall Study|Withdrawal by Subject|1|||
129871617|NCT00166296|467487575|FG001|Overall Study|Withdrawal by Subject|3|||
129871618|NCT00166296|467487574|FG000|Overall Study|Adverse Event|2|||
129871619|NCT00166296|467487575|FG001|Overall Study|Adverse Event|4|||
129871620|NCT00166296|467487574|FG000|Overall Study|Lost to Follow-up|4|||
129871621|NCT00166296|467487575|FG001|Overall Study|Lost to Follow-up|2|||
129871622|NCT03412396|467487592|FG000|Overall Study|Withdrawal by Subject|2|||
129871623|NCT03412396|467487592|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
129871624|NCT03412396|467487592|FG000|Overall Study|Did not undergo RP|2|||
129871625|NCT04899245|467487601|FG000|Overall Study|Withdrawal by Subject|3|||
129871626|NCT04899245|467487602|FG001|Overall Study|Withdrawal by Subject|5|||
129871627|NCT04899245|467487603|FG002|Overall Study|Withdrawal by Subject|2|||
129449927|NCT01994382|465947274|FG006|Overall Study|Death|0|||
129449928|NCT01994382|465947275|FG007|Overall Study|Death|0|||
129449929|NCT01994382|465947276|FG008|Overall Study|Death|1|||
129449930|NCT01994382|465947277|FG009|Overall Study|Death|1|||
129449931|NCT01994382|465947278|FG010|Overall Study|Death|0|||
129871628|NCT04899245|467487601|FG000|Overall Study|No longer eligible - Left staff position|0|||
129871629|NCT04899245|467487602|FG001|Overall Study|No longer eligible - Left staff position|0|||
129871630|NCT04899245|467487603|FG002|Overall Study|No longer eligible - Left staff position|1|||
129871631|NCT04899245|467487601|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
129449932|NCT01994382|465947279|FG011|Overall Study|Death|0|||
129449933|NCT01994382|465947280|FG012|Overall Study|Death|0|||
129871632|NCT04899245|467487602|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
129871633|NCT04899245|467487603|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
129871634|NCT04899245|467487601|FG000|Overall Study|No longer eligible - Moved away from area|2|||
129871635|NCT04899245|467487602|FG001|Overall Study|No longer eligible - Moved away from area|2|||
129871636|NCT04899245|467487603|FG002|Overall Study|No longer eligible - Moved away from area|0|||
129871637|NCT02753595|467487608|FG000|Overall Study|Sponsor termination|2|||
129871638|NCT02753595|467487609|FG001|Overall Study|Sponsor termination|2|||
129871639|NCT01570868|467487610|FG000|Overall Study|Adverse Event|8|||
129871640|NCT01570868|467487611|FG001|Overall Study|Adverse Event|1|||
129871641|NCT01570868|467487610|FG000|Overall Study|FDA Recommendation|23|||
129871642|NCT01570868|467487611|FG001|Overall Study|FDA Recommendation|3|||
129871643|NCT01570868|467487610|FG000|Overall Study|Physician Decision|10|||
129871644|NCT01570868|467487611|FG001|Overall Study|Physician Decision|4|||
129871645|NCT01570868|467487610|FG000|Overall Study|Lost to Follow-up|1|||
129871646|NCT01570868|467487611|FG001|Overall Study|Lost to Follow-up|0|||
129871647|NCT01570868|467487610|FG000|Overall Study|Withdrawal by Subject|1|||
129871648|NCT01570868|467487611|FG001|Overall Study|Withdrawal by Subject|0|||
129871649|NCT02515279|467487615|FG000|Overall Study|Adverse Event|7|||
129871650|NCT02515279|467487615|FG000|Overall Study|Lack of Efficacy|31|||
129871651|NCT02515279|467487615|FG000|Overall Study|Lost to Follow-up|9|||
129918389|NCT03138512|467666961|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
129918390|NCT03138512|467666962|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
129918391|NCT03138512|467666963|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
129918392|NCT03138512|467666964|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
129918393|NCT03138512|467666965|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
129918394|NCT03138512|467666961|FG000|Treatment Part B|Participant withdrew consent|0|||
129918395|NCT03138512|467666962|FG001|Treatment Part B|Participant withdrew consent|0|||
129918396|NCT03138512|467666963|FG002|Treatment Part B|Participant withdrew consent|1|||
129918397|NCT03138512|467666964|FG003|Treatment Part B|Participant withdrew consent|1|||
129918398|NCT03138512|467666965|FG004|Treatment Part B|Participant withdrew consent|2|||
129918399|NCT03138512|467666961|FG000|Treatment Part B|Lost to Follow-up|0|||
129918400|NCT03138512|467666962|FG001|Treatment Part B|Lost to Follow-up|0|||
129918401|NCT03138512|467666963|FG002|Treatment Part B|Lost to Follow-up|0|||
129918402|NCT03138512|467666964|FG003|Treatment Part B|Lost to Follow-up|1|||
129918403|NCT03138512|467666965|FG004|Treatment Part B|Lost to Follow-up|0|||
129918404|NCT03138512|467666961|FG000|Treatment Part B|Poor/non-compliance|0|||
129918405|NCT03138512|467666962|FG001|Treatment Part B|Poor/non-compliance|0|||
129918406|NCT03138512|467666963|FG002|Treatment Part B|Poor/non-compliance|1|||
129918407|NCT03138512|467666964|FG003|Treatment Part B|Poor/non-compliance|1|||
129918408|NCT03138512|467666965|FG004|Treatment Part B|Poor/non-compliance|1|||
129918409|NCT03138512|467666961|FG000|Treatment Part B|Other reasons|0|||
129918410|NCT03138512|467666962|FG001|Treatment Part B|Other reasons|0|||
129918411|NCT03138512|467666963|FG002|Treatment Part B|Other reasons|3|||
129918412|NCT03138512|467666964|FG003|Treatment Part B|Other reasons|1|||
129918413|NCT03138512|467666965|FG004|Treatment Part B|Other reasons|5|||
129918414|NCT05323084|467666967|FG000|Period 2 - Washout|Lost to Follow-up|0|||
129918415|NCT05323084|467666968|FG001|Period 2 - Washout|Lost to Follow-up|1|||
129918416|NCT04382404|467666969|FG000|Overall Study|Adverse Event|1|||
129918417|NCT04382404|467666969|FG000|Overall Study|Lost to Follow-up|2|||
129918418|NCT05687916|467666971|FG000|Overall Study|Adverse Event|1|||
129918419|NCT05687916|467666972|FG001|Overall Study|Adverse Event|2|||
129871652|NCT02515279|467487615|FG000|Overall Study|Withdrawal by Subject|18|||
129871653|NCT02515279|467487615|FG000|Overall Study|End-of-treatment visit not attended|17|||
129871654|NCT02515279|467487615|FG000|Overall Study|Other|22|||
129871655|NCT01800968|467487617|FG000|Overall Study|Death|23|||
129918420|NCT05687916|467666973|FG002|Overall Study|Adverse Event|0|||
129918421|NCT05687916|467666971|FG000|Overall Study|Withdrawal by Subject|1|||
129918422|NCT05687916|467666972|FG001|Overall Study|Withdrawal by Subject|0|||
129918423|NCT05687916|467666973|FG002|Overall Study|Withdrawal by Subject|1|||
129918424|NCT05687916|467666971|FG000|Overall Study|Protocol Violation|0|||
129918425|NCT05687916|467666972|FG001|Overall Study|Protocol Violation|2|||
129871656|NCT01800968|467487618|FG001|Overall Study|Death|16|||
129871657|NCT01800968|467487617|FG000|Overall Study|Lost to Follow-up|5|||
129871658|NCT01800968|467487618|FG001|Overall Study|Lost to Follow-up|7|||
129871659|NCT01800968|467487617|FG000|Overall Study|Withdrawal by Subject|7|||
129918426|NCT05687916|467666973|FG002|Overall Study|Protocol Violation|1|||
129918427|NCT05687916|467666971|FG000|Overall Study|Reason not Specified|1|||
129918428|NCT05687916|467666972|FG001|Overall Study|Reason not Specified|0|||
129918429|NCT05687916|467666973|FG002|Overall Study|Reason not Specified|0|||
129918430|NCT03332017|467666974|FG000|Overall Study|Lost to Follow-up|1|||
129871660|NCT01800968|467487618|FG001|Overall Study|Withdrawal by Subject|9|||
129918431|NCT03332017|467666975|FG001|Overall Study|Lost to Follow-up|2|||
129918432|NCT03332017|467666974|FG000|Overall Study|Death|17|||
129918433|NCT03332017|467666975|FG001|Overall Study|Death|16|||
129918434|NCT03332017|467666974|FG000|Overall Study|Withdrawal by Subject|6|||
129449934|NCT01994382|465947281|FG013|Overall Study|Death|0|||
129871661|NCT01800968|467487617|FG000|Overall Study|Physician Decision|1|||
129871662|NCT01800968|467487618|FG001|Overall Study|Physician Decision|0|||
129871663|NCT03185481|467487622|FG000|Overall Study|Adverse Event|1|||
129871664|NCT03185481|467487622|FG000|Overall Study|Study Terminated by Sponsor|4|||
129871665|NCT01422408|467487623|FG000|Overall Study|Adverse Event|1|||
129871666|NCT01422408|467487623|FG000|Overall Study|Withdrawal by Subject|3|||
129871667|NCT03371940|467487629|FG000|Overall Study|Withdrawal by Subject|8|||
129871668|NCT03371940|467487630|FG001|Overall Study|Withdrawal by Subject|1|||
129871669|NCT03371940|467487631|FG002|Overall Study|Withdrawal by Subject|3|||
129871670|NCT03371940|467487632|FG003|Overall Study|Withdrawal by Subject|4|||
129871671|NCT05099926|467487638|FG000|Overall Study|Lost to Follow-up|1|||
129871672|NCT00386022|467487642|FG000|Plus Estrogen|Lost to Follow-up|2|||
129871673|NCT00386022|467487643|FG001|Plus Estrogen|Lost to Follow-up|0|||
129871674|NCT00386022|467487642|FG000|Plus Estrogen|Adverse Event|0|||
129871675|NCT00386022|467487643|FG001|Plus Estrogen|Adverse Event|1|||
129871676|NCT00724152|467487645|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
129871677|NCT00724152|467487646|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
129871678|NCT00724152|467487647|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
129871679|NCT00724152|467487645|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
129871680|NCT00724152|467487646|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
129871681|NCT00724152|467487647|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
129871682|NCT03266770|467487651|FG000|Overall Study|Physician Decision|3|||
129871683|NCT03266770|467487651|FG000|Overall Study|Insufficient study supplies|1|||
129871684|NCT03266770|467487651|FG000|Overall Study|Adverse Event|1|||
129871685|NCT00031486|467487655|FG000|Overall Study|Adverse Event|1|||
129871686|NCT00031486|467487656|FG001|Overall Study|Adverse Event|0|||
129871687|NCT00031486|467487655|FG000|Overall Study|Lost to Follow-up|0|||
129871688|NCT00031486|467487656|FG001|Overall Study|Lost to Follow-up|1|||
129871689|NCT00031486|467487655|FG000|Overall Study|Withdrawal by Subject|3|||
129871690|NCT00031486|467487656|FG001|Overall Study|Withdrawal by Subject|2|||
129871691|NCT00031486|467487655|FG000|Overall Study|Death|0|||
129871692|NCT00031486|467487656|FG001|Overall Study|Death|3|||
129871693|NCT00031486|467487655|FG000|Overall Study|Non-compliant|0|||
129871694|NCT00031486|467487656|FG001|Overall Study|Non-compliant|4|||
129871695|NCT00031486|467487655|FG000|Overall Study|Did not meet eligibility requirement|2|||
129871696|NCT00031486|467487656|FG001|Overall Study|Did not meet eligibility requirement|1|||
129871697|NCT00031486|467487655|FG000|Overall Study|Other|1|||
129449935|NCT01994382|465947282|FG014|Overall Study|Death|0|||
129871698|NCT00031486|467487656|FG001|Overall Study|Other|1|||
129871699|NCT03078816|467487657|FG000|Overall Study|Withdrawal by Subject|1|||
129871700|NCT00949884|467489411|FG000|Overall Study|Adverse Event|14|||
129871701|NCT00949884|467489412|FG001|Overall Study|Adverse Event|3|||
129871702|NCT00949884|467489413|FG002|Overall Study|Adverse Event|12|||
129871703|NCT00949884|467489411|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
129871704|NCT00949884|467489412|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
129871705|NCT00949884|467489413|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
129871706|NCT00949884|467489411|FG000|Overall Study|Lost to Follow-up|7|||
129871707|NCT00949884|467489412|FG001|Overall Study|Lost to Follow-up|5|||
129918435|NCT03332017|467666975|FG001|Overall Study|Withdrawal by Subject|14|||
129918436|NCT03332017|467666974|FG000|Overall Study|Other|1|||
129918437|NCT03332017|467666975|FG001|Overall Study|Other|3|||
129918438|NCT03332017|467666974|FG000|Overall Study|Remained in Study (Ongoing)|47|||
129918439|NCT03332017|467666975|FG001|Overall Study|Remained in Study (Ongoing)|110|||
129918440|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
129918441|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
129918442|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
129918443|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918444|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918445|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918446|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918447|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918448|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918449|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918450|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918451|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918452|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
129918453|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
129871708|NCT00949884|467489413|FG002|Overall Study|Lost to Follow-up|5|||
129871709|NCT00949884|467489411|FG000|Overall Study|Physician Decision|5|||
129871710|NCT00949884|467489412|FG001|Overall Study|Physician Decision|0|||
129871711|NCT00949884|467489413|FG002|Overall Study|Physician Decision|6|||
129871712|NCT00949884|467489411|FG000|Overall Study|Treatment non-compliance|5|||
129871713|NCT00949884|467489412|FG001|Overall Study|Treatment non-compliance|0|||
129871714|NCT00949884|467489413|FG002|Overall Study|Treatment non-compliance|8|||
129871715|NCT00949884|467489411|FG000|Overall Study|Withdrawal by Subject|13|||
129871716|NCT00949884|467489412|FG001|Overall Study|Withdrawal by Subject|4|||
129871717|NCT00949884|467489413|FG002|Overall Study|Withdrawal by Subject|16|||
129918454|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
129871718|NCT00949884|467489411|FG000|Overall Study|Lack of Efficacy|4|||
129871719|NCT00949884|467489412|FG001|Overall Study|Lack of Efficacy|2|||
129871720|NCT00949884|467489413|FG002|Overall Study|Lack of Efficacy|7|||
129871721|NCT00949884|467489411|FG000|Overall Study|Study terminated by sponsor|0|||
129871722|NCT00949884|467489412|FG001|Overall Study|Study terminated by sponsor|0|||
129871723|NCT00949884|467489413|FG002|Overall Study|Study terminated by sponsor|1|||
129871724|NCT03092375|467489414|FG000|Overall Study|Lack of Efficacy|0|||
129871725|NCT03092375|467489415|FG001|Overall Study|Lack of Efficacy|1|||
129871726|NCT03092375|467489416|FG002|Overall Study|Lack of Efficacy|1|||
129871727|NCT03092375|467489417|FG003|Overall Study|Lack of Efficacy|0|||
129871728|NCT01255592|467489420|FG000|Overall Study|Adverse Event|5|||
129871729|NCT01255592|467489421|FG001|Overall Study|Adverse Event|0|||
129871730|NCT01255592|467489420|FG000|Overall Study|Withdrawal by Subject|1|||
129871731|NCT01255592|467489421|FG001|Overall Study|Withdrawal by Subject|0|||
129871732|NCT01255592|467489420|FG000|Overall Study|Other|0|||
129871733|NCT01255592|467489421|FG001|Overall Study|Other|1|||
129871734|NCT01777321|467489423|FG000|Overall Study|Withdrawal by Subject|0|||
129871735|NCT01777321|467489424|FG001|Overall Study|Withdrawal by Subject|1|||
129871736|NCT00089141|467489425|FG000|Overall Study|Termination of trial|18|||
129871737|NCT00089141|467489426|FG001|Overall Study|Termination of trial|24|||
129871738|NCT05131165|467489427|FG000|Overall Study|Death|1|||
129871739|NCT05131165|467489428|FG001|Overall Study|Death|1|||
129871740|NCT05131165|467489429|FG002|Overall Study|Death|0|||
129871741|NCT05131165|467489427|FG000|Overall Study|Lost to Follow-up|2|||
129871742|NCT05131165|467489428|FG001|Overall Study|Lost to Follow-up|2|||
129871743|NCT05131165|467489429|FG002|Overall Study|Lost to Follow-up|5|||
129871744|NCT05131165|467489427|FG000|Overall Study|Transferred out of clinic|1|||
129871745|NCT05131165|467489428|FG001|Overall Study|Transferred out of clinic|0|||
129871746|NCT05131165|467489429|FG002|Overall Study|Transferred out of clinic|3|||
129871747|NCT05131165|467489427|FG000|Overall Study|Dropped out|1|||
129871748|NCT05131165|467489428|FG001|Overall Study|Dropped out|2|||
129871749|NCT05131165|467489429|FG002|Overall Study|Dropped out|0|||
129918455|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918456|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918457|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918458|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129871750|NCT00526630|467489437|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
129871751|NCT00526630|467489438|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
129918459|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918460|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129871752|NCT00526630|467489437|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
129871753|NCT00526630|467489438|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
129871754|NCT05168579|467489439|FG000|Overall Study|Lack of Consent|1|||
129871755|NCT05168579|467489440|FG001|Overall Study|Lack of Consent|0|||
129871756|NCT05168579|467489439|FG000|Overall Study|Conflicts with time|2|||
129871757|NCT05168579|467489440|FG001|Overall Study|Conflicts with time|0|||
129871758|NCT05168579|467489439|FG000|Overall Study|Time slots were full|3|||
129918461|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918462|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918463|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918464|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918465|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
129918466|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
129918467|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
129918468|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918469|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918470|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918471|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918472|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918473|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918474|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918475|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918476|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918477|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918478|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
129918479|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
129918480|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
129871759|NCT05168579|467489440|FG001|Overall Study|Time slots were full|0|||
129871760|NCT05168579|467489439|FG000|Overall Study|Lost to Follow-up|0|||
129871761|NCT05168579|467489440|FG001|Overall Study|Lost to Follow-up|15|||
129918481|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918482|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918483|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918484|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918485|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918486|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129871762|NCT00840801|467489441|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
129871763|NCT00840801|467489442|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
129871764|NCT00840801|467489443|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
129871765|NCT00840801|467489441|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
129871766|NCT00840801|467489442|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
129871767|NCT00840801|467489443|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
129871768|NCT00840801|467489441|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
129871769|NCT00840801|467489442|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
129871770|NCT00840801|467489443|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
129871771|NCT00840801|467489441|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
129871772|NCT00840801|467489442|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
129871773|NCT00840801|467489443|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
129871774|NCT01242748|467489444|FG000|Overall Study|Adverse Event|10|||
129871775|NCT01242748|467489445|FG001|Overall Study|Adverse Event|5|||
129871776|NCT01242748|467489444|FG000|Overall Study|Lost to Follow-up|6|||
129871777|NCT01242748|467489445|FG001|Overall Study|Lost to Follow-up|2|||
129871778|NCT01242748|467489444|FG000|Overall Study|Physician Decision|3|||
129871779|NCT01242748|467489445|FG001|Overall Study|Physician Decision|2|||
129871780|NCT01242748|467489444|FG000|Overall Study|Protocol Violation|1|||
129871781|NCT01242748|467489445|FG001|Overall Study|Protocol Violation|0|||
129871782|NCT01242748|467489444|FG000|Overall Study|Withdrawal by Subject|10|||
129871783|NCT01242748|467489445|FG001|Overall Study|Withdrawal by Subject|2|||
129871784|NCT01242748|467489444|FG000|Overall Study|Miscellaneous reasons|8|||
129918487|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918488|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918489|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129871785|NCT01242748|467489445|FG001|Overall Study|Miscellaneous reasons|3|||
129871786|NCT01750879|467489451|FG000|Overall Study|Adverse Event|8|||
129871787|NCT01750879|467489452|FG001|Overall Study|Adverse Event|0|||
129871788|NCT01750879|467489451|FG000|Overall Study|Lack of Efficacy|1|||
129871789|NCT01750879|467489452|FG001|Overall Study|Lack of Efficacy|0|||
129871790|NCT01750879|467489451|FG000|Overall Study|Withdrawal by Subject|1|||
129871791|NCT01750879|467489452|FG001|Overall Study|Withdrawal by Subject|0|||
129871792|NCT01750879|467489451|FG000|Overall Study|Did not complete per protocol|0|||
129871793|NCT01750879|467489452|FG001|Overall Study|Did not complete per protocol|3|||
129871794|NCT02093663|467489459|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
129871795|NCT02093663|467489460|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871796|NCT02093663|467489461|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871797|NCT02093663|467489462|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871798|NCT02093663|467489463|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
129871799|NCT02093663|467489459|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
129871800|NCT02093663|467489460|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871801|NCT02093663|467489461|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871802|NCT02093663|467489462|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871803|NCT02093663|467489463|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871804|NCT02093663|467489459|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
129871805|NCT02093663|467489460|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
129871806|NCT02093663|467489461|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
129871807|NCT02093663|467489462|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
129871808|NCT02093663|467489463|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
129918490|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918491|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
129918492|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
129918493|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
129918494|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
129918495|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918496|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918497|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918498|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918499|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918500|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918501|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129449936|NCT01994382|465947283|FG015|Overall Study|Death|1|||
129918502|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129449937|NCT01994382|465947284|FG016|Overall Study|Death|0|||
129871809|NCT02093663|467489459|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871810|NCT02093663|467489460|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871811|NCT02093663|467489461|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
129871812|NCT02093663|467489462|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871813|NCT02093663|467489463|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
129871814|NCT02093663|467489459|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871815|NCT02093663|467489460|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871816|NCT02093663|467489461|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
129918503|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129871817|NCT02093663|467489462|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871818|NCT02093663|467489463|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
129871819|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
129871820|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
129871821|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
129871822|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
129871823|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
129918504|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
129918505|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
129918506|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
129918507|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
129918508|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918509|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918510|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918511|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918512|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918513|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918514|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918515|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918516|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129449938|NCT01994382|465947268|FG000|Overall Study|Adverse Event|0|||
129871824|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
129871825|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
129871826|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
129871827|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
129871828|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
129871829|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129871830|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129871831|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
129871832|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
129871833|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
129871834|NCT02093663|467489459|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871835|NCT02093663|467489460|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871836|NCT02093663|467489461|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871837|NCT02093663|467489462|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
129871838|NCT02093663|467489463|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
129871839|NCT00508404|467489466|FG000|Overall Study|Ongoing at Data Cut-off|12|||
129871840|NCT00508404|467489466|FG000|Overall Study|Adverse Event|2|||
129871841|NCT00508404|467489466|FG000|Overall Study|Death|16|||
129871842|NCT00508404|467489466|FG000|Overall Study|Physician Decision|2|||
129871843|NCT00508404|467489466|FG000|Overall Study|Withdrawal by Subject|3|||
129871844|NCT00508404|467489466|FG000|Overall Study|Protocol-specified Criteria|2|||
129871845|NCT00508404|467489466|FG000|Overall Study|Lost to Follow-up|2|||
129871846|NCT00508404|467489466|FG000|Overall Study|Other - Not Specified|3|||
129871847|NCT01424930|467489468|FG000|Overall Study|Adverse Event|0|||
129871848|NCT01424930|467489469|FG001|Overall Study|Adverse Event|1|||
129871849|NCT01424930|467489468|FG000|Overall Study|Death|1|||
129871850|NCT01424930|467489469|FG001|Overall Study|Death|0|||
129871851|NCT01424930|467489468|FG000|Overall Study|Progressive Disease|3|||
129871852|NCT01424930|467489469|FG001|Overall Study|Progressive Disease|6|||
129871853|NCT01424930|467489468|FG000|Overall Study|Screen Failure|0|||
129871854|NCT01424930|467489469|FG001|Overall Study|Screen Failure|1|||
129871855|NCT01424930|467489468|FG000|Overall Study|Reason not specified|0|||
129871856|NCT01424930|467489469|FG001|Overall Study|Reason not specified|6|||
129871857|NCT01621880|467489470|FG000|Overall Study|Adverse Event|5|||
129871858|NCT01621880|467489471|FG001|Overall Study|Adverse Event|1|||
129871859|NCT01621880|467489470|FG000|Overall Study|Withdrawal by Subject|5|||
129871860|NCT01621880|467489471|FG001|Overall Study|Withdrawal by Subject|4|||
129871861|NCT00106184|467489473|FG000|Overall Study|Withdrawal by Subject|3|||
129871862|NCT00106184|467489474|FG001|Overall Study|Withdrawal by Subject|2|||
129871863|NCT02313909|467489475|FG000|Overall Study|Consent withdrawn by participant|33|||
129871864|NCT02313909|467489476|FG001|Overall Study|Consent withdrawn by participant|33|||
129871865|NCT02313909|467489475|FG000|Overall Study|Lost to Follow-up|24|||
129871866|NCT02313909|467489476|FG001|Overall Study|Lost to Follow-up|17|||
129871867|NCT00948974|467489482|FG000|Overall Study|Lost to Follow-up|23|||
129871868|NCT00948974|467489483|FG001|Overall Study|Lost to Follow-up|20|||
129871869|NCT00409682|467489491|FG000|Open-label Induction Period|Adverse Event|1|||
129871870|NCT00409682|467489492|FG001|Open-label Induction Period|Adverse Event|0|||
129871871|NCT00409682|467489493|FG002|Open-label Induction Period|Adverse Event|0|||
129871872|NCT00409682|467489491|FG000|Open-label Induction Period|Lack of Efficacy|1|||
129871873|NCT00409682|467489492|FG001|Open-label Induction Period|Lack of Efficacy|0|||
129871874|NCT00409682|467489493|FG002|Open-label Induction Period|Lack of Efficacy|0|||
129871875|NCT00409682|467489491|FG000|Open-label Induction Period|Protocol Violation|1|||
129871876|NCT00409682|467489492|FG001|Open-label Induction Period|Protocol Violation|0|||
129871877|NCT00409682|467489493|FG002|Open-label Induction Period|Protocol Violation|0|||
129871878|NCT00409682|467489491|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
129871879|NCT00409682|467489492|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
129871880|NCT00409682|467489493|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
129871881|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
129871882|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
129918517|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
129918518|NCT01261312|467666976|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
129918519|NCT01261312|467666977|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918520|NCT01261312|467666978|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
129918521|NCT01261312|467666979|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129871883|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
129871884|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
129871885|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
129871886|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
129871887|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
129871888|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
129871889|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
129449939|NCT01994382|465947269|FG001|Overall Study|Adverse Event|1|||
129918522|NCT01261312|467666980|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918523|NCT01261312|467666981|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918524|NCT01261312|467666982|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918525|NCT01261312|467666983|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918526|NCT01261312|467666984|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918527|NCT01261312|467666985|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918528|NCT01261312|467666986|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918529|NCT01261312|467666987|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918530|NCT01261312|467666988|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
129918531|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918532|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918533|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918534|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
129918535|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
129918536|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
129918537|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918538|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918539|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918540|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918541|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918542|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918543|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
129918544|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918545|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918546|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918547|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918548|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
129918549|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
129918550|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918551|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918552|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918553|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918554|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918555|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918556|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
129918557|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918558|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918559|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918560|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918561|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
129449940|NCT01994382|465947270|FG002|Overall Study|Adverse Event|2|||
129918562|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
129918563|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918564|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918565|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918566|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918567|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918568|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918569|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
129918570|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918571|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918572|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918573|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
129918574|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
129918575|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
129918576|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918577|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918578|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918579|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918580|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918581|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918582|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
129918583|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918584|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918585|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918586|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918587|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918588|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
129918589|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918590|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918591|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918592|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918593|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918594|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918595|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
129918596|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918597|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918598|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918599|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
129918600|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
129918601|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
129918602|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918603|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918604|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918605|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918606|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918607|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918608|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
129918609|NCT01261312|467666976|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918610|NCT01261312|467666977|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918611|NCT01261312|467666978|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918612|NCT01261312|467666979|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
129918613|NCT01261312|467666980|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
129918614|NCT01261312|467666981|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
129918615|NCT01261312|467666982|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918616|NCT01261312|467666983|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918617|NCT01261312|467666984|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918618|NCT01261312|467666985|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918619|NCT01261312|467666986|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918620|NCT01261312|467666987|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129918621|NCT01261312|467666988|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
129449941|NCT01994382|465947271|FG003|Overall Study|Adverse Event|0|||
129918622|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918623|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918624|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918625|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918626|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918627|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918628|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
129918629|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
129918630|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
129918631|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918632|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918633|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918634|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
129918635|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918636|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918637|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918638|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918639|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918640|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918641|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918642|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
129918643|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
129918644|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918645|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918646|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918647|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
129918648|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918649|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918650|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918651|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918652|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918653|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918654|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
129918655|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
129918656|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
129918657|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918658|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918659|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918660|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
129918661|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
129918662|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
129918663|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
129918664|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
129918665|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
129918666|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
129918667|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
129918668|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
129918669|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
129918670|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
129918671|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
129918672|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
129918673|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
129918674|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918675|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918676|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918677|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918678|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918679|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918680|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
129918681|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
129918682|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
129918683|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918684|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918685|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918686|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
129918687|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918688|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918689|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918690|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918691|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918692|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918693|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
129918694|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
129918695|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
129918696|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918697|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918698|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918699|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
129918700|NCT01261312|467666976|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918701|NCT01261312|467666977|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918702|NCT01261312|467666978|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918703|NCT01261312|467666979|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918704|NCT01261312|467666980|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918705|NCT01261312|467666981|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918706|NCT01261312|467666982|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
129918707|NCT01261312|467666983|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
129918708|NCT01261312|467666984|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
129918709|NCT01261312|467666985|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918710|NCT01261312|467666986|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918711|NCT01261312|467666987|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918712|NCT01261312|467666988|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
129918713|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918714|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918715|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918716|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918717|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918718|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918719|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918720|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918721|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
129918722|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
129918723|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
129918724|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
129918725|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
129918726|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918727|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918728|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918729|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129871890|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
129871891|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
129871892|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
129871893|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
129871894|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
129871895|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
129871896|NCT00409682|467489491|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
129871897|NCT00409682|467489492|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
129871898|NCT00409682|467489493|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
129871899|NCT01896869|467489496|FG000|Overall Study|Withdrawal by Subject|0|||
129449942|NCT01994382|465947272|FG004|Overall Study|Adverse Event|0|||
129449943|NCT01994382|465947273|FG005|Overall Study|Adverse Event|0|||
129871900|NCT01896869|467489497|FG001|Overall Study|Withdrawal by Subject|6|||
129871901|NCT01896869|467489496|FG000|Overall Study|Lost to Follow-up|1|||
129871902|NCT01896869|467489497|FG001|Overall Study|Lost to Follow-up|0|||
129871903|NCT00118716|467489503|FG000|Overall Study|Adverse Event|2|||
129871904|NCT00118716|467489504|FG001|Overall Study|Adverse Event|7|||
129871905|NCT00118716|467489503|FG000|Overall Study|Protocol Violation|5|||
129871906|NCT00118716|467489504|FG001|Overall Study|Protocol Violation|4|||
129871907|NCT00118716|467489503|FG000|Overall Study|Withdrawal by Subject|0|||
129871908|NCT00118716|467489504|FG001|Overall Study|Withdrawal by Subject|1|||
129871909|NCT00118716|467489503|FG000|Overall Study|Exacerbation|2|||
129871910|NCT00118716|467489504|FG001|Overall Study|Exacerbation|2|||
129871911|NCT00118716|467489503|FG000|Overall Study|Discontinued by sponsor|1|||
129871912|NCT00118716|467489504|FG001|Overall Study|Discontinued by sponsor|1|||
129871913|NCT00118716|467489503|FG000|Overall Study|Non-compliance|1|||
129871914|NCT00118716|467489504|FG001|Overall Study|Non-compliance|3|||
129871915|NCT00118716|467489503|FG000|Overall Study|misrandomized|1|||
129871916|NCT00118716|467489504|FG001|Overall Study|misrandomized|1|||
129871917|NCT00118716|467489503|FG000|Overall Study|Expired drug use|1|||
129871918|NCT00118716|467489504|FG001|Overall Study|Expired drug use|2|||
129871919|NCT00118716|467489503|FG000|Overall Study|Investigator discretion|0|||
129871920|NCT00118716|467489504|FG001|Overall Study|Investigator discretion|1|||
129871921|NCT00454571|467489506|FG000|Overall Study|Adverse Event|2|||
129871922|NCT00454571|467489507|FG001|Overall Study|Adverse Event|0|||
129871923|NCT00454571|467489506|FG000|Overall Study|Physician Decision|0|||
129871924|NCT00454571|467489507|FG001|Overall Study|Physician Decision|1|||
129871925|NCT00454571|467489506|FG000|Overall Study|Protocol Violation|1|||
129871926|NCT00454571|467489507|FG001|Overall Study|Protocol Violation|0|||
129871927|NCT00454571|467489506|FG000|Overall Study|Withdrawal by Subject|10|||
129871928|NCT00454571|467489507|FG001|Overall Study|Withdrawal by Subject|5|||
129871929|NCT02436811|467489508|FG000|Overall Study|Lost to Follow-up|2|||
129871930|NCT02436811|467489509|FG001|Overall Study|Lost to Follow-up|9|||
129871931|NCT02436811|467489510|FG002|Overall Study|Lost to Follow-up|7|||
129871932|NCT02657317|467489511|FG000|Overall Study|Withdrawal by Subject|2|||
129871933|NCT02657317|467489512|FG001|Overall Study|Withdrawal by Subject|0|||
129871934|NCT02657317|467489511|FG000|Overall Study|Lost to Follow-up|3|||
129871935|NCT02657317|467489512|FG001|Overall Study|Lost to Follow-up|3|||
129871936|NCT01201811|467489513|FG000|Overall Study|Adverse Event|6|||
129871937|NCT01201811|467489513|FG000|Overall Study|Disease progression|3|||
129871938|NCT01201811|467489513|FG000|Overall Study|Withdrawal by Subject|3|||
129871939|NCT01201811|467489513|FG000|Overall Study|Death|4|||
129871940|NCT01201811|467489513|FG000|Overall Study|Treatment Failure|2|||
129871941|NCT01201811|467489513|FG000|Overall Study|Physician Decision|1|||
129871942|NCT01089374|467489514|FG000|Overall Study|Lost to Follow-up|3|||
129871943|NCT01089374|467489515|FG001|Overall Study|Lost to Follow-up|0|||
129871944|NCT01089374|467489514|FG000|Overall Study|Withdrawal by Subject|1|||
129871945|NCT01089374|467489515|FG001|Overall Study|Withdrawal by Subject|0|||
129871946|NCT01089374|467489514|FG000|Overall Study|Study closed early - low accrual|6|||
129871947|NCT01089374|467489515|FG001|Overall Study|Study closed early - low accrual|0|||
129871948|NCT02856113|467489516|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129918730|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918731|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918732|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129871949|NCT02856113|467489517|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129871950|NCT02856113|467489516|FG000|Overall Study|Significant Protocol Deviation|1|||
129871951|NCT02856113|467489517|FG001|Overall Study|Significant Protocol Deviation|0|||
129871952|NCT02856113|467489516|FG000|Overall Study|Lost to Follow-up|3|||
129871953|NCT02856113|467489517|FG001|Overall Study|Lost to Follow-up|5|||
129871954|NCT02856113|467489516|FG000|Overall Study|Voluntary Withdrawal|3|||
129871955|NCT02856113|467489517|FG001|Overall Study|Voluntary Withdrawal|5|||
129871956|NCT02856113|467489516|FG000|Overall Study|Pregnancy|0|||
129871957|NCT02856113|467489517|FG001|Overall Study|Pregnancy|1|||
129871958|NCT02856113|467489516|FG000|Overall Study|Principal Investigator Discretion|2|||
129871959|NCT02856113|467489517|FG001|Overall Study|Principal Investigator Discretion|1|||
129871960|NCT02856113|467489516|FG000|Overall Study|Randomized but not Treated|1|||
129871961|NCT02856113|467489517|FG001|Overall Study|Randomized but not Treated|0|||
129871962|NCT02856113|467489516|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
129871963|NCT02856113|467489517|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
129871964|NCT03494166|467489518|FG000|Overall Study|Death|0|||
129871965|NCT03494166|467489519|FG001|Overall Study|Death|0|||
129871966|NCT03494166|467489520|FG002|Overall Study|Death|0|||
129871967|NCT03494166|467489521|FG003|Overall Study|Death|1|||
129871968|NCT03494166|467489522|FG004|Overall Study|Death|3|||
129871969|NCT03494166|467489523|FG005|Overall Study|Death|0|||
129871970|NCT03494166|467489518|FG000|Overall Study|Lost to Follow-up|2|||
129871971|NCT03494166|467489519|FG001|Overall Study|Lost to Follow-up|2|||
129871972|NCT03494166|467489520|FG002|Overall Study|Lost to Follow-up|2|||
129871973|NCT03494166|467489521|FG003|Overall Study|Lost to Follow-up|2|||
129871974|NCT03494166|467489522|FG004|Overall Study|Lost to Follow-up|14|||
129871975|NCT03494166|467489523|FG005|Overall Study|Lost to Follow-up|0|||
129871976|NCT03494166|467489518|FG000|Overall Study|Withdrawal by Subject|10|||
129871977|NCT03494166|467489519|FG001|Overall Study|Withdrawal by Subject|7|||
129871978|NCT03494166|467489520|FG002|Overall Study|Withdrawal by Subject|0|||
129871979|NCT03494166|467489521|FG003|Overall Study|Withdrawal by Subject|5|||
129871980|NCT03494166|467489522|FG004|Overall Study|Withdrawal by Subject|3|||
129871981|NCT03494166|467489523|FG005|Overall Study|Withdrawal by Subject|17|||
129871982|NCT03494166|467489518|FG000|Overall Study|Screen failure|1|||
129871983|NCT03494166|467489519|FG001|Overall Study|Screen failure|0|||
129871984|NCT03494166|467489520|FG002|Overall Study|Screen failure|0|||
129871985|NCT03494166|467489521|FG003|Overall Study|Screen failure|0|||
129871986|NCT03494166|467489522|FG004|Overall Study|Screen failure|1|||
129871987|NCT03494166|467489523|FG005|Overall Study|Screen failure|0|||
129871988|NCT02857426|467489524|FG000|Overall Study|Disease progression|34|||
129871989|NCT02857426|467489525|FG001|Overall Study|Disease progression|13|||
129871990|NCT02857426|467489524|FG000|Overall Study|Study drug toxicity|4|||
129871991|NCT02857426|467489525|FG001|Overall Study|Study drug toxicity|1|||
129871992|NCT02857426|467489524|FG000|Overall Study|Death|1|||
129871993|NCT02857426|467489525|FG001|Overall Study|Death|0|||
129871994|NCT02857426|467489524|FG000|Overall Study|Adverse event unrelated to study drug|6|||
129871995|NCT02857426|467489525|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129871996|NCT02857426|467489524|FG000|Overall Study|Participant withdrew consent|1|||
129871997|NCT02857426|467489525|FG001|Overall Study|Participant withdrew consent|1|||
129871998|NCT02857426|467489524|FG000|Overall Study|Maximum clinical benefit|1|||
129871999|NCT02857426|467489525|FG001|Overall Study|Maximum clinical benefit|0|||
129872000|NCT02857426|467489524|FG000|Overall Study|Completed treatment|0|||
129872001|NCT02857426|467489525|FG001|Overall Study|Completed treatment|2|||
129872002|NCT02831257|467489529|FG000|Overall Study|Lack of Efficacy|3|||
129872003|NCT02831257|467489529|FG000|Overall Study|Adverse Event|2|||
129872004|NCT02831257|467489529|FG000|Overall Study|Physician Decision|1|||
129872005|NCT02831257|467489529|FG000|Overall Study|Withdrawal by Subject|6|||
129872006|NCT00855595|467489530|FG000|Overall Study|Withdrawal by Subject|1|||
129872007|NCT00855595|467489531|FG001|Overall Study|Withdrawal by Subject|2|||
129872008|NCT00855595|467489530|FG000|Overall Study|Lost to Follow-up|3|||
129872009|NCT00855595|467489531|FG001|Overall Study|Lost to Follow-up|3|||
129872010|NCT00855595|467489530|FG000|Overall Study|Adverse Event|1|||
129872011|NCT00855595|467489531|FG001|Overall Study|Adverse Event|1|||
129872012|NCT00855595|467489530|FG000|Overall Study|patient moved out of state|1|||
129872013|NCT00855595|467489531|FG001|Overall Study|patient moved out of state|0|||
129872014|NCT00855595|467489530|FG000|Overall Study|patient left country|0|||
129872015|NCT00855595|467489531|FG001|Overall Study|patient left country|1|||
129872016|NCT01780935|467489532|FG000|Overall Study|Admin problems due to early termination|321|||
129872017|NCT01780935|467489533|FG001|Overall Study|Admin problems due to early termination|309|||
129872018|NCT01780935|467489532|FG000|Overall Study|Adverse Event|2|||
129872019|NCT01780935|467489533|FG001|Overall Study|Adverse Event|4|||
129872020|NCT01780935|467489532|FG000|Overall Study|Death|1|||
129872021|NCT01780935|467489533|FG001|Overall Study|Death|6|||
129872022|NCT01780935|467489532|FG000|Overall Study|Lost to Follow-up|2|||
129918733|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129872023|NCT01780935|467489533|FG001|Overall Study|Lost to Follow-up|6|||
129872024|NCT01780935|467489532|FG000|Overall Study|Physician Decision|1|||
129872025|NCT01780935|467489533|FG001|Overall Study|Physician Decision|1|||
129872026|NCT01780935|467489532|FG000|Overall Study|Protocol deviation|0|||
129872027|NCT01780935|467489533|FG001|Overall Study|Protocol deviation|1|||
129872028|NCT01780935|467489532|FG000|Overall Study|Patient withdrew consent|8|||
129872029|NCT01780935|467489533|FG001|Overall Study|Patient withdrew consent|9|||
129872030|NCT04035200|467489534|FG000|Overall Study|Lost to Follow-up|0|||
129872031|NCT04035200|467489535|FG001|Overall Study|Lost to Follow-up|1|||
129872032|NCT04035200|467489536|FG002|Overall Study|Lost to Follow-up|0|||
129918734|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918735|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
129918736|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
129918737|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
129918738|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
129918739|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918740|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918741|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918742|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918743|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918744|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918745|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918746|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918747|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
129918748|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
129918749|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
129918750|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
129918751|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
129918752|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918753|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918754|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918755|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918756|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918757|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918758|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918759|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918760|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
129918761|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
129918762|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
129918763|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
129918764|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
129918765|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918766|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918767|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918768|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918769|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918770|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918771|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918772|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918773|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
129918774|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
129918775|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
129918776|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
129918777|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
129918778|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918779|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918780|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918781|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918782|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918783|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918784|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918785|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918786|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
129918787|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
129918788|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
129918789|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
129918790|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
129918791|NCT01261312|467666976|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918792|NCT01261312|467666977|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918793|NCT01261312|467666978|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129449944|NCT01994382|465947274|FG006|Overall Study|Adverse Event|0|||
129449945|NCT01994382|465947275|FG007|Overall Study|Adverse Event|0|||
129449946|NCT01994382|465947276|FG008|Overall Study|Adverse Event|0|||
129918794|NCT01261312|467666979|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129449947|NCT01994382|465947277|FG009|Overall Study|Adverse Event|0|||
129872033|NCT04035200|467489534|FG000|Overall Study|Withdrawal by Subject|1|||
129872034|NCT04035200|467489535|FG001|Overall Study|Withdrawal by Subject|4|||
129872035|NCT04035200|467489536|FG002|Overall Study|Withdrawal by Subject|4|||
129872036|NCT04035200|467489534|FG000|Overall Study|COVID-19|1|||
129872037|NCT04035200|467489535|FG001|Overall Study|COVID-19|0|||
129872038|NCT04035200|467489536|FG002|Overall Study|COVID-19|0|||
129872039|NCT04035200|467489534|FG000|Overall Study|Early Termination|0|||
129872040|NCT04035200|467489535|FG001|Overall Study|Early Termination|1|||
129872041|NCT04035200|467489536|FG002|Overall Study|Early Termination|0|||
129872042|NCT04035200|467489534|FG000|Overall Study|Non-compliance|0|||
129872043|NCT04035200|467489535|FG001|Overall Study|Non-compliance|1|||
129872044|NCT04035200|467489536|FG002|Overall Study|Non-compliance|0|||
129872045|NCT03033225|467489537|FG000|Overall Study|Withdrawal by Subject|5|||
129872046|NCT03685591|467489545|FG000|Overall Study|Global Deterioration of Health Status|0|||
129872047|NCT03685591|467489546|FG001|Overall Study|Global Deterioration of Health Status|0|||
129872048|NCT03685591|467489547|FG002|Overall Study|Global Deterioration of Health Status|0|||
129872049|NCT03685591|467489548|FG003|Overall Study|Global Deterioration of Health Status|1|||
129872050|NCT03685591|467489549|FG004|Overall Study|Global Deterioration of Health Status|2|||
129872051|NCT03685591|467489550|FG005|Overall Study|Global Deterioration of Health Status|4|||
129872052|NCT03685591|467489551|FG006|Overall Study|Global Deterioration of Health Status|1|||
129872053|NCT03685591|467489552|FG007|Overall Study|Global Deterioration of Health Status|1|||
129872054|NCT03685591|467489553|FG008|Overall Study|Global Deterioration of Health Status|0|||
129918795|NCT01261312|467666980|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918796|NCT01261312|467666981|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918797|NCT01261312|467666982|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918798|NCT01261312|467666983|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918799|NCT01261312|467666984|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
129918800|NCT01261312|467666985|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
129918801|NCT01261312|467666986|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
129918802|NCT01261312|467666987|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
129918803|NCT01261312|467666988|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
129918804|NCT01809691|467666992|FG000|Overall Study|Currently on Treatment|192|||
129918805|NCT01809691|467666993|FG001|Overall Study|Currently on Treatment|100|||
129918806|NCT01809691|467666992|FG000|Overall Study|No Protocol Treatment|10|||
129918807|NCT01809691|467666993|FG001|Overall Study|No Protocol Treatment|11|||
129918808|NCT01809691|467666992|FG000|Overall Study|Adverse Event|80|||
129918809|NCT01809691|467666993|FG001|Overall Study|Adverse Event|21|||
129918810|NCT01809691|467666992|FG000|Overall Study|Disease Progression|226|||
129918811|NCT01809691|467666993|FG001|Overall Study|Disease Progression|372|||
129918812|NCT01809691|467666992|FG000|Overall Study|Death|26|||
129918813|NCT01809691|467666993|FG001|Overall Study|Death|13|||
129918814|NCT01809691|467666992|FG000|Overall Study|Participant Refusal|70|||
129918815|NCT01809691|467666993|FG001|Overall Study|Participant Refusal|72|||
129918816|NCT01809691|467666992|FG000|Overall Study|Other, Not Specified|34|||
129918817|NCT01809691|467666993|FG001|Overall Study|Other, Not Specified|52|||
129918818|NCT01580488|467666994|FG000|Overall Study|Withdrawal by Subject|1|||
129918819|NCT04401800|467666997|FG000|Overall Study|Death|17|||
129918820|NCT04401800|467666997|FG000|Overall Study|Lost to Follow-up|5|||
129918821|NCT04401800|467666997|FG000|Overall Study|Withdrawal by Subject|4|||
129918822|NCT03338790|467667004|FG000|Overall Study|Disease Progression|65|||
129918823|NCT03338790|467667005|FG001|Overall Study|Disease Progression|43|||
129918824|NCT03338790|467667006|FG002|Overall Study|Disease Progression|50|||
129872055|NCT03685591|467489545|FG000|Overall Study|Progressive Disease|1|||
129872056|NCT03685591|467489546|FG001|Overall Study|Progressive Disease|1|||
129872057|NCT03685591|467489547|FG002|Overall Study|Progressive Disease|0|||
129872058|NCT03685591|467489548|FG003|Overall Study|Progressive Disease|3|||
129872059|NCT03685591|467489549|FG004|Overall Study|Progressive Disease|5|||
129872060|NCT03685591|467489550|FG005|Overall Study|Progressive Disease|4|||
129872061|NCT03685591|467489551|FG006|Overall Study|Progressive Disease|3|||
129918825|NCT03338790|467667007|FG003|Overall Study|Disease Progression|37|||
129918826|NCT03338790|467667004|FG000|Overall Study|Study Drug Toxicity|9|||
129918827|NCT03338790|467667005|FG001|Overall Study|Study Drug Toxicity|8|||
129918828|NCT03338790|467667006|FG002|Overall Study|Study Drug Toxicity|15|||
129918829|NCT03338790|467667007|FG003|Overall Study|Study Drug Toxicity|0|||
129918830|NCT03338790|467667004|FG000|Overall Study|Death|1|||
129918831|NCT03338790|467667005|FG001|Overall Study|Death|1|||
129918832|NCT03338790|467667006|FG002|Overall Study|Death|1|||
129918833|NCT03338790|467667007|FG003|Overall Study|Death|0|||
129918834|NCT03338790|467667004|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
129918835|NCT03338790|467667005|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
129918836|NCT03338790|467667006|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
129918837|NCT03338790|467667007|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
129918838|NCT03338790|467667004|FG000|Overall Study|Participant request to discontinue study treatment|3|||
129918839|NCT03338790|467667005|FG001|Overall Study|Participant request to discontinue study treatment|3|||
129918840|NCT03338790|467667006|FG002|Overall Study|Participant request to discontinue study treatment|2|||
129918841|NCT03338790|467667007|FG003|Overall Study|Participant request to discontinue study treatment|1|||
129918842|NCT03338790|467667004|FG000|Overall Study|Poor/non-compliance|0|||
129918843|NCT03338790|467667005|FG001|Overall Study|Poor/non-compliance|1|||
129918844|NCT03338790|467667006|FG002|Overall Study|Poor/non-compliance|0|||
129918845|NCT03338790|467667007|FG003|Overall Study|Poor/non-compliance|0|||
129918846|NCT03338790|467667004|FG000|Overall Study|Participant withdrew consent|1|||
129918847|NCT03338790|467667005|FG001|Overall Study|Participant withdrew consent|0|||
129918848|NCT03338790|467667006|FG002|Overall Study|Participant withdrew consent|1|||
129918849|NCT03338790|467667007|FG003|Overall Study|Participant withdrew consent|1|||
129918850|NCT03338790|467667004|FG000|Overall Study|Other reasons|0|||
129918851|NCT03338790|467667005|FG001|Overall Study|Other reasons|5|||
129918852|NCT03338790|467667006|FG002|Overall Study|Other reasons|0|||
129918853|NCT03338790|467667007|FG003|Overall Study|Other reasons|2|||
129918854|NCT03338790|467667004|FG000|Overall Study|Not reported|0|||
129918855|NCT03338790|467667005|FG001|Overall Study|Not reported|0|||
129918856|NCT03338790|467667006|FG002|Overall Study|Not reported|1|||
129918857|NCT03338790|467667007|FG003|Overall Study|Not reported|0|||
129918858|NCT03338790|467667004|FG000|Overall Study|Completed treatment period|1|||
129918859|NCT03338790|467667005|FG001|Overall Study|Completed treatment period|2|||
129918860|NCT03338790|467667006|FG002|Overall Study|Completed treatment period|0|||
129918861|NCT03338790|467667007|FG003|Overall Study|Completed treatment period|0|||
129918862|NCT04588298|467667014|FG000|Overall Study|Adverse Event|0|||
129918863|NCT04588298|467667015|FG001|Overall Study|Adverse Event|0|||
129918864|NCT04588298|467667016|FG002|Overall Study|Adverse Event|1|||
129918865|NCT04588298|467667017|FG003|Overall Study|Adverse Event|0|||
129918866|NCT04588298|467667018|FG004|Overall Study|Adverse Event|2|||
129918867|NCT04588298|467667014|FG000|Overall Study|Withdrawal by Subject|1|||
129918868|NCT04588298|467667015|FG001|Overall Study|Withdrawal by Subject|0|||
129918869|NCT04588298|467667016|FG002|Overall Study|Withdrawal by Subject|0|||
129918870|NCT04588298|467667017|FG003|Overall Study|Withdrawal by Subject|1|||
129918871|NCT04588298|467667018|FG004|Overall Study|Withdrawal by Subject|0|||
129918872|NCT03846505|467667020|FG000|Treatment Phase|Withdrawal by Subject|9|||
129918873|NCT03846505|467667021|FG001|Treatment Phase|Withdrawal by Subject|11|||
129918874|NCT03846505|467667020|FG000|Treatment Phase|Lost to Follow-up|6|||
129918875|NCT03846505|467667021|FG001|Treatment Phase|Lost to Follow-up|2|||
129918876|NCT03846505|467667020|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
129918877|NCT03846505|467667021|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
129918878|NCT03846505|467667020|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
129918879|NCT03846505|467667021|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
129918880|NCT03535272|467667024|FG000|Overall Study|Lost to Follow-up|71|||
129918881|NCT03535272|467667025|FG001|Overall Study|Lost to Follow-up|73|||
129918882|NCT03892616|467667026|FG000|Washout Period 2|Met discontinuation criterion|0|||
129918883|NCT03892616|467667027|FG001|Washout Period 2|Met discontinuation criterion|0|||
129918884|NCT03892616|467667028|FG002|Washout Period 2|Met discontinuation criterion|0|||
129918885|NCT03892616|467667029|FG003|Washout Period 2|Met discontinuation criterion|0|||
129918886|NCT03892616|467667030|FG004|Washout Period 2|Met discontinuation criterion|0|||
129918887|NCT03892616|467667031|FG005|Washout Period 2|Met discontinuation criterion|0|||
129918888|NCT03892616|467667032|FG006|Washout Period 2|Met discontinuation criterion|0|||
129918889|NCT03892616|467667033|FG007|Washout Period 2|Met discontinuation criterion|0|||
129918890|NCT03892616|467667034|FG008|Washout Period 2|Met discontinuation criterion|1|||
129918891|NCT03892616|467667035|FG009|Washout Period 2|Met discontinuation criterion|0|||
129918892|NCT03892616|467667036|FG010|Washout Period 2|Met discontinuation criterion|0|||
129918893|NCT03892616|467667037|FG011|Washout Period 2|Met discontinuation criterion|0|||
129918894|NCT05592418|467667041|FG000|Overall Study|Adverse Event|1|||
129918895|NCT05592418|467667042|FG001|Overall Study|Adverse Event|0|||
129918896|NCT05592418|467667041|FG000|Overall Study|Lost to Follow-up|1|||
129872062|NCT03685591|467489552|FG007|Overall Study|Progressive Disease|2|||
129872063|NCT03685591|467489553|FG008|Overall Study|Progressive Disease|1|||
129872064|NCT03685591|467489545|FG000|Overall Study|Other|0|||
129872065|NCT03685591|467489546|FG001|Overall Study|Other|0|||
129872066|NCT03685591|467489547|FG002|Overall Study|Other|1|||
129872067|NCT03685591|467489548|FG003|Overall Study|Other|0|||
129872068|NCT03685591|467489549|FG004|Overall Study|Other|2|||
129872069|NCT03685591|467489550|FG005|Overall Study|Other|3|||
129872070|NCT03685591|467489551|FG006|Overall Study|Other|0|||
129872071|NCT03685591|467489552|FG007|Overall Study|Other|0|||
129872072|NCT03685591|467489553|FG008|Overall Study|Other|0|||
129872073|NCT03685591|467489545|FG000|Overall Study|Withdrawal by Subject|0|||
129872074|NCT03685591|467489546|FG001|Overall Study|Withdrawal by Subject|0|||
129872075|NCT03685591|467489547|FG002|Overall Study|Withdrawal by Subject|0|||
129872076|NCT03685591|467489548|FG003|Overall Study|Withdrawal by Subject|0|||
129872077|NCT03685591|467489549|FG004|Overall Study|Withdrawal by Subject|3|||
129872078|NCT03685591|467489550|FG005|Overall Study|Withdrawal by Subject|2|||
129872079|NCT03685591|467489551|FG006|Overall Study|Withdrawal by Subject|0|||
129872080|NCT03685591|467489552|FG007|Overall Study|Withdrawal by Subject|0|||
129872081|NCT03685591|467489553|FG008|Overall Study|Withdrawal by Subject|1|||
129872082|NCT03685591|467489545|FG000|Overall Study|Adverse Event|0|||
129872083|NCT03685591|467489546|FG001|Overall Study|Adverse Event|0|||
129872084|NCT03685591|467489547|FG002|Overall Study|Adverse Event|0|||
129872085|NCT03685591|467489548|FG003|Overall Study|Adverse Event|1|||
129872086|NCT03685591|467489549|FG004|Overall Study|Adverse Event|1|||
129872087|NCT03685591|467489550|FG005|Overall Study|Adverse Event|4|||
129872088|NCT03685591|467489551|FG006|Overall Study|Adverse Event|0|||
129872089|NCT03685591|467489552|FG007|Overall Study|Adverse Event|1|||
129872090|NCT03685591|467489553|FG008|Overall Study|Adverse Event|1|||
129872091|NCT00168038|467489554|FG000|Overall Study|Adverse Event|1|||
129872092|NCT00168038|467489554|FG000|Overall Study|Therapy failure|1|||
129872093|NCT01685138|467489555|FG000|Overall Study|Lost to Follow-up|1|||
129872094|NCT01685138|467489555|FG000|Overall Study|Protocol Violation|1|||
129872095|NCT01685138|467489555|FG000|Overall Study|No longer requires treatment|1|||
129872096|NCT01685138|467489555|FG000|Overall Study|Subject/guardian decision|2|||
129872097|NCT01685138|467489555|FG000|Overall Study|Physician Decision|6|||
129872098|NCT01685138|467489555|FG000|Overall Study|Death|10|||
129872099|NCT01685138|467489555|FG000|Overall Study|Adverse Event|18|||
129872100|NCT01685138|467489555|FG000|Overall Study|Progressive disease|53|||
129872101|NCT02220894|467489560|FG000|Overall Study|Adverse Event|127|||
129872102|NCT02220894|467489561|FG001|Overall Study|Adverse Event|74|||
129872103|NCT02220894|467489560|FG000|Overall Study|Death|418|||
129872104|NCT02220894|467489561|FG001|Overall Study|Death|508|||
129872105|NCT02220894|467489560|FG000|Overall Study|Lost to Follow-up|0|||
129872106|NCT02220894|467489561|FG001|Overall Study|Lost to Follow-up|4|||
129872107|NCT02220894|467489560|FG000|Overall Study|Site Terminated by Sponsor|2|||
129872108|NCT02220894|467489561|FG001|Overall Study|Site Terminated by Sponsor|0|||
129872109|NCT02220894|467489560|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
129872110|NCT02220894|467489561|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
129872111|NCT02220894|467489560|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129872112|NCT02220894|467489561|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129872113|NCT02220894|467489560|FG000|Overall Study|Withdrawal by Subject|10|||
129872114|NCT02220894|467489561|FG001|Overall Study|Withdrawal by Subject|9|||
129872115|NCT00500903|467489566|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
129872116|NCT00500903|467489567|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
129872117|NCT00500903|467489568|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
129872118|NCT00500903|467489566|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
129872119|NCT00500903|467489567|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129872120|NCT00500903|467489568|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129872121|NCT00500903|467489566|FG000|Overall Study|Progressive Disease|41|||
129872122|NCT00500903|467489567|FG001|Overall Study|Progressive Disease|2|||
129872123|NCT00500903|467489568|FG002|Overall Study|Progressive Disease|15|||
129872124|NCT00500903|467489566|FG000|Overall Study|Patient Declined Further Treatment|0|||
129872125|NCT00500903|467489567|FG001|Overall Study|Patient Declined Further Treatment|0|||
129872126|NCT00500903|467489568|FG002|Overall Study|Patient Declined Further Treatment|3|||
129872127|NCT00500903|467489566|FG000|Overall Study|Symptomatic Deterioration|2|||
129872128|NCT00500903|467489567|FG001|Overall Study|Symptomatic Deterioration|0|||
129872129|NCT00500903|467489568|FG002|Overall Study|Symptomatic Deterioration|0|||
129872130|NCT00500903|467489566|FG000|Overall Study|Reason Not Specified|10|||
129872131|NCT00500903|467489567|FG001|Overall Study|Reason Not Specified|0|||
129872132|NCT00500903|467489568|FG002|Overall Study|Reason Not Specified|2|||
129872133|NCT01648348|467489573|FG000|Overall Study|Cancel|1|||
129872134|NCT01648348|467489574|FG001|Overall Study|Cancel|0|||
129872135|NCT01648348|467489575|FG002|Overall Study|Cancel|0|||
129872136|NCT01648348|467489576|FG003|Overall Study|Cancel|0|||
129872137|NCT01648348|467489577|FG004|Overall Study|Cancel|3|||
129872138|NCT01648348|467489578|FG005|Overall Study|Cancel|6|||
129872139|NCT01648348|467489573|FG000|Overall Study|Replaced for MTD analysis|1|||
129872140|NCT01648348|467489574|FG001|Overall Study|Replaced for MTD analysis|0|||
129872141|NCT01648348|467489575|FG002|Overall Study|Replaced for MTD analysis|1|||
129872142|NCT01648348|467489576|FG003|Overall Study|Replaced for MTD analysis|0|||
129872143|NCT01648348|467489577|FG004|Overall Study|Replaced for MTD analysis|0|||
129872144|NCT01648348|467489578|FG005|Overall Study|Replaced for MTD analysis|0|||
129872145|NCT00696410|467489579|FG000|Overall Study|Lost to Follow-up|2|||
129872146|NCT00696410|467489580|FG001|Overall Study|Lost to Follow-up|0|||
129872147|NCT00696410|467489579|FG000|Overall Study|Withdrawal by Subject|8|||
129872148|NCT00696410|467489580|FG001|Overall Study|Withdrawal by Subject|0|||
129872149|NCT00696410|467489579|FG000|Overall Study|Physician Decision|3|||
129872150|NCT00696410|467489580|FG001|Overall Study|Physician Decision|0|||
129872151|NCT01951638|467489581|FG000|Treatment Period|Protocol Violation|0|||
129872152|NCT01951638|467489582|FG001|Treatment Period|Protocol Violation|0|||
129872153|NCT01951638|467489583|FG002|Treatment Period|Protocol Violation|0|||
129872154|NCT01951638|467489584|FG003|Treatment Period|Protocol Violation|2|||
129872155|NCT01951638|467489585|FG004|Treatment Period|Protocol Violation|0|||
129872156|NCT01951638|467489581|FG000|Treatment Period|Protocol-driven decision point|1|||
129872157|NCT01951638|467489582|FG001|Treatment Period|Protocol-driven decision point|3|||
129872158|NCT01951638|467489583|FG002|Treatment Period|Protocol-driven decision point|0|||
129872159|NCT01951638|467489584|FG003|Treatment Period|Protocol-driven decision point|0|||
129872160|NCT01951638|467489585|FG004|Treatment Period|Protocol-driven decision point|0|||
129872161|NCT01951638|467489581|FG000|Treatment Period|Logistical difficulties|0|||
129872162|NCT01951638|467489582|FG001|Treatment Period|Logistical difficulties|1|||
129872163|NCT01951638|467489583|FG002|Treatment Period|Logistical difficulties|1|||
129872164|NCT01951638|467489584|FG003|Treatment Period|Logistical difficulties|0|||
129872165|NCT01951638|467489585|FG004|Treatment Period|Logistical difficulties|0|||
129872166|NCT01951638|467489581|FG000|Treatment Period|Withdrawal by Subject|9|||
129872167|NCT01951638|467489582|FG001|Treatment Period|Withdrawal by Subject|6|||
129872168|NCT01951638|467489583|FG002|Treatment Period|Withdrawal by Subject|4|||
129872169|NCT01951638|467489584|FG003|Treatment Period|Withdrawal by Subject|5|||
129872170|NCT01951638|467489585|FG004|Treatment Period|Withdrawal by Subject|4|||
129872171|NCT01951638|467489581|FG000|Treatment Period|Death|0|||
129872172|NCT01951638|467489582|FG001|Treatment Period|Death|0|||
129872173|NCT01951638|467489583|FG002|Treatment Period|Death|0|||
129872174|NCT01951638|467489584|FG003|Treatment Period|Death|3|||
129872175|NCT01951638|467489585|FG004|Treatment Period|Death|1|||
129872176|NCT01951638|467489581|FG000|Treatment Period|Adverse Event|3|||
129872177|NCT01951638|467489582|FG001|Treatment Period|Adverse Event|4|||
129872178|NCT01951638|467489583|FG002|Treatment Period|Adverse Event|8|||
129872179|NCT01951638|467489584|FG003|Treatment Period|Adverse Event|6|||
129872180|NCT01951638|467489585|FG004|Treatment Period|Adverse Event|5|||
129872181|NCT01951638|467489581|FG000|Follow-up Period|Protocol Violation|0|||
129872182|NCT01951638|467489582|FG001|Follow-up Period|Protocol Violation|0|||
129872183|NCT01951638|467489583|FG002|Follow-up Period|Protocol Violation|0|||
129872184|NCT01951638|467489584|FG003|Follow-up Period|Protocol Violation|1|||
129872185|NCT01951638|467489585|FG004|Follow-up Period|Protocol Violation|0|||
129872186|NCT01951638|467489581|FG000|Follow-up Period|Logistical difficulties|0|||
129872187|NCT01951638|467489582|FG001|Follow-up Period|Logistical difficulties|2|||
129872188|NCT01951638|467489583|FG002|Follow-up Period|Logistical difficulties|0|||
129872189|NCT01951638|467489584|FG003|Follow-up Period|Logistical difficulties|0|||
129872190|NCT01951638|467489585|FG004|Follow-up Period|Logistical difficulties|1|||
129872191|NCT01951638|467489581|FG000|Follow-up Period|Withdrawal by Subject|1|||
129872192|NCT01951638|467489582|FG001|Follow-up Period|Withdrawal by Subject|5|||
129872193|NCT01951638|467489583|FG002|Follow-up Period|Withdrawal by Subject|2|||
129872194|NCT01951638|467489584|FG003|Follow-up Period|Withdrawal by Subject|1|||
129872195|NCT01951638|467489585|FG004|Follow-up Period|Withdrawal by Subject|2|||
129872196|NCT01951638|467489581|FG000|Follow-up Period|Lost to Follow-up|0|||
129872197|NCT01951638|467489582|FG001|Follow-up Period|Lost to Follow-up|1|||
129872198|NCT01951638|467489583|FG002|Follow-up Period|Lost to Follow-up|0|||
129872199|NCT01951638|467489584|FG003|Follow-up Period|Lost to Follow-up|1|||
129872200|NCT01951638|467489585|FG004|Follow-up Period|Lost to Follow-up|0|||
129872201|NCT01951638|467489581|FG000|Follow-up Period|Death|1|||
129872202|NCT01951638|467489582|FG001|Follow-up Period|Death|0|||
129872203|NCT01951638|467489583|FG002|Follow-up Period|Death|1|||
129872204|NCT01951638|467489584|FG003|Follow-up Period|Death|4|||
129872205|NCT01951638|467489585|FG004|Follow-up Period|Death|1|||
129872206|NCT01951638|467489581|FG000|Follow-up Period|Adverse Event|0|||
129872207|NCT01951638|467489582|FG001|Follow-up Period|Adverse Event|1|||
129872208|NCT01951638|467489583|FG002|Follow-up Period|Adverse Event|2|||
129872209|NCT01951638|467489584|FG003|Follow-up Period|Adverse Event|1|||
129872210|NCT01951638|467489585|FG004|Follow-up Period|Adverse Event|1|||
129872211|NCT00552084|467489586|FG000|Overall Study|Adverse Event|2|||
129872212|NCT00552084|467489587|FG001|Overall Study|Adverse Event|3|||
129872213|NCT00552084|467489586|FG000|Overall Study|Withdrawal by Subject|4|||
129872214|NCT00552084|467489587|FG001|Overall Study|Withdrawal by Subject|5|||
129872215|NCT00552084|467489586|FG000|Overall Study|Protocol Violation|1|||
129918897|NCT05592418|467667042|FG001|Overall Study|Lost to Follow-up|3|||
129918898|NCT05592418|467667041|FG000|Overall Study|Withdrawal by Subject|2|||
129918899|NCT05592418|467667042|FG001|Overall Study|Withdrawal by Subject|7|||
129918900|NCT05569252|467667046|FG000|Overall Study|Adverse event (central vision loss)|1|||
129918901|NCT05569252|467667047|FG001|Overall Study|Adverse event (central vision loss)|0|||
129918902|NCT05569252|467667048|FG002|Overall Study|Adverse event (central vision loss)|0|||
129918903|NCT05569252|467667049|FG003|Overall Study|Adverse event (central vision loss)|0|||
129918904|NCT03665597|467667050|FG000|Period 1|Adverse Event|1|||
129918905|NCT03665597|467667051|FG001|Period 1|Adverse Event|0|||
129918906|NCT03665597|467667052|FG002|Period 1|Adverse Event|0|||
129918907|NCT03665597|467667053|FG003|Period 1|Adverse Event|1|||
129918908|NCT03665597|467667054|FG004|Period 1|Adverse Event|0|||
129918909|NCT03665597|467667055|FG005|Period 1|Adverse Event|0|||
129918910|NCT03665597|467667056|FG006|Period 1|Adverse Event|0|||
129918911|NCT03665597|467667050|FG000|Period 1|Screen Failure|0|||
129918912|NCT03665597|467667051|FG001|Period 1|Screen Failure|0|||
129918913|NCT03665597|467667052|FG002|Period 1|Screen Failure|0|||
129918914|NCT03665597|467667053|FG003|Period 1|Screen Failure|1|||
129918915|NCT03665597|467667054|FG004|Period 1|Screen Failure|0|||
129918916|NCT03665597|467667055|FG005|Period 1|Screen Failure|0|||
129918917|NCT03665597|467667056|FG006|Period 1|Screen Failure|0|||
129918918|NCT03665597|467667050|FG000|Period 1|Death|0|||
129918919|NCT03665597|467667051|FG001|Period 1|Death|0|||
129918920|NCT03665597|467667052|FG002|Period 1|Death|0|||
129918921|NCT03665597|467667053|FG003|Period 1|Death|0|||
129918922|NCT03665597|467667054|FG004|Period 1|Death|0|||
129918923|NCT03665597|467667055|FG005|Period 1|Death|0|||
129918924|NCT03665597|467667056|FG006|Period 1|Death|45|||
129918925|NCT03665597|467667050|FG000|Period 1|Withdrawal by Subject|0|||
129918926|NCT03665597|467667051|FG001|Period 1|Withdrawal by Subject|0|||
129918927|NCT03665597|467667052|FG002|Period 1|Withdrawal by Subject|0|||
129918928|NCT03665597|467667053|FG003|Period 1|Withdrawal by Subject|0|||
129918929|NCT03665597|467667054|FG004|Period 1|Withdrawal by Subject|0|||
129918930|NCT03665597|467667055|FG005|Period 1|Withdrawal by Subject|0|||
129918931|NCT03665597|467667056|FG006|Period 1|Withdrawal by Subject|5|||
129918932|NCT03665597|467667050|FG000|Period 2|Adverse Event|0|||
129918933|NCT03665597|467667051|FG001|Period 2|Adverse Event|0|||
129918934|NCT03665597|467667052|FG002|Period 2|Adverse Event|0|||
129918935|NCT03665597|467667053|FG003|Period 2|Adverse Event|0|||
129918936|NCT03665597|467667054|FG004|Period 2|Adverse Event|0|||
129918937|NCT03665597|467667055|FG005|Period 2|Adverse Event|1|||
129918938|NCT03665597|467667056|FG006|Period 2|Adverse Event|0|||
129918939|NCT03665597|467667050|FG000|Period 3|Adverse Event|0|||
129918940|NCT03665597|467667051|FG001|Period 3|Adverse Event|1|||
129918941|NCT03665597|467667052|FG002|Period 3|Adverse Event|0|||
129918942|NCT03665597|467667053|FG003|Period 3|Adverse Event|0|||
129918943|NCT03665597|467667054|FG004|Period 3|Adverse Event|0|||
129918944|NCT03665597|467667055|FG005|Period 3|Adverse Event|0|||
129918945|NCT03665597|467667056|FG006|Period 3|Adverse Event|0|||
129918946|NCT03665597|467667050|FG000|Period 3|Death|0|||
129918947|NCT03665597|467667051|FG001|Period 3|Death|0|||
129918948|NCT03665597|467667052|FG002|Period 3|Death|0|||
129918949|NCT03665597|467667053|FG003|Period 3|Death|0|||
129918950|NCT03665597|467667054|FG004|Period 3|Death|1|||
129918951|NCT03665597|467667055|FG005|Period 3|Death|0|||
129918952|NCT03665597|467667056|FG006|Period 3|Death|0|||
129918953|NCT03665597|467667050|FG000|Period 4|Adverse Event|2|||
129918954|NCT03665597|467667051|FG001|Period 4|Adverse Event|2|||
129918955|NCT03665597|467667052|FG002|Period 4|Adverse Event|2|||
129918956|NCT03665597|467667053|FG003|Period 4|Adverse Event|2|||
129918957|NCT03665597|467667054|FG004|Period 4|Adverse Event|1|||
129918958|NCT03665597|467667055|FG005|Period 4|Adverse Event|0|||
129918959|NCT03665597|467667056|FG006|Period 4|Adverse Event|0|||
129918960|NCT03665597|467667050|FG000|Period 4|Death|0|||
129918961|NCT03665597|467667051|FG001|Period 4|Death|0|||
129918962|NCT03665597|467667052|FG002|Period 4|Death|2|||
129918963|NCT03665597|467667053|FG003|Period 4|Death|0|||
129918964|NCT03665597|467667054|FG004|Period 4|Death|0|||
129918965|NCT03665597|467667055|FG005|Period 4|Death|0|||
129918966|NCT03665597|467667056|FG006|Period 4|Death|0|||
129918967|NCT03665597|467667050|FG000|Period 4|Physician Decision|1|||
129918968|NCT03665597|467667051|FG001|Period 4|Physician Decision|2|||
129918969|NCT03665597|467667052|FG002|Period 4|Physician Decision|0|||
129918970|NCT03665597|467667053|FG003|Period 4|Physician Decision|0|||
129918971|NCT03665597|467667054|FG004|Period 4|Physician Decision|0|||
129918972|NCT03665597|467667055|FG005|Period 4|Physician Decision|0|||
129918973|NCT03665597|467667056|FG006|Period 4|Physician Decision|0|||
129918974|NCT04831216|467667057|FG000|Overall Study|Lost to Follow-up|32|||
129918975|NCT03110315|467667064|FG000|Overall Study|Withdrawal by Subject|1|||
129918976|NCT03110315|467667065|FG001|Overall Study|Withdrawal by Subject|0|||
129918977|NCT04727554|467667070|FG000|Overall Study|Lost to Follow-up|0|||
129918978|NCT04727554|467667071|FG001|Overall Study|Lost to Follow-up|1|||
129449948|NCT01994382|465947278|FG010|Overall Study|Adverse Event|15|||
129449949|NCT01994382|465947279|FG011|Overall Study|Adverse Event|2|||
129449950|NCT01994382|465947280|FG012|Overall Study|Adverse Event|7|||
129449951|NCT01994382|465947281|FG013|Overall Study|Adverse Event|3|||
129449952|NCT01994382|465947282|FG014|Overall Study|Adverse Event|17|||
129449953|NCT01994382|465947283|FG015|Overall Study|Adverse Event|6|||
129449954|NCT01994382|465947284|FG016|Overall Study|Adverse Event|3|||
129449955|NCT01994382|465947268|FG000|Overall Study|Other than specified|0|||
129449956|NCT01994382|465947269|FG001|Overall Study|Other than specified|0|||
129449957|NCT01994382|465947270|FG002|Overall Study|Other than specified|0|||
129449958|NCT01994382|465947271|FG003|Overall Study|Other than specified|0|||
129449959|NCT01994382|465947272|FG004|Overall Study|Other than specified|0|||
129449960|NCT01994382|465947273|FG005|Overall Study|Other than specified|0|||
129449961|NCT01994382|465947274|FG006|Overall Study|Other than specified|0|||
129449962|NCT01994382|465947275|FG007|Overall Study|Other than specified|0|||
129449963|NCT01994382|465947276|FG008|Overall Study|Other than specified|0|||
129449964|NCT01994382|465947277|FG009|Overall Study|Other than specified|0|||
129918979|NCT04727554|467667070|FG000|Overall Study|Death|2|||
129918980|NCT04727554|467667071|FG001|Overall Study|Death|6|||
129918981|NCT04727554|467667070|FG000|Overall Study|Withdrawal by Subject|1|||
129918982|NCT04727554|467667071|FG001|Overall Study|Withdrawal by Subject|0|||
129918983|NCT05371652|467667072|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
129918984|NCT05371652|467667072|FG000|Overall Study|Withdrawal by Subject|12|||
129918985|NCT05371652|467667072|FG000|Overall Study|Adverse Event|1|||
129918986|NCT05371652|467667072|FG000|Overall Study|Other|11|||
129918987|NCT04024813|467668755|FG000|Overall Study|Study terminated by Sponsor|1|||
129918988|NCT02729311|467668756|FG000|Overall Study|Withdrawal by Subject|8|||
129918989|NCT02729311|467668757|FG001|Overall Study|Withdrawal by Subject|2|||
129918990|NCT05034952|467668758|FG000|Overall Study|Adverse Event|1|||
129918991|NCT05034952|467668759|FG001|Overall Study|Adverse Event|0|||
129449965|NCT01994382|465947278|FG010|Overall Study|Other than specified|2|||
129449966|NCT01994382|465947279|FG011|Overall Study|Other than specified|0|||
129449967|NCT01994382|465947280|FG012|Overall Study|Other than specified|2|||
129449968|NCT01994382|465947281|FG013|Overall Study|Other than specified|0|||
129449969|NCT01994382|465947282|FG014|Overall Study|Other than specified|0|||
129918992|NCT05034952|467668760|FG002|Overall Study|Adverse Event|0|||
129918993|NCT05034952|467668761|FG003|Overall Study|Adverse Event|0|||
129918994|NCT05034952|467668758|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
129918995|NCT05034952|467668759|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
129918996|NCT05034952|467668760|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
129918997|NCT05034952|467668761|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
129918998|NCT05034952|467668758|FG000|Overall Study|Lost to Follow-up|1|||
129449970|NCT01994382|465947283|FG015|Overall Study|Other than specified|4|||
129872216|NCT00552084|467489587|FG001|Overall Study|Protocol Violation|0|||
129872217|NCT00552084|467489586|FG000|Overall Study|change in anti-arrythmic drug|1|||
129872218|NCT00552084|467489587|FG001|Overall Study|change in anti-arrythmic drug|1|||
129872219|NCT02240108|467490690|FG000|Overall Study|Other than specified|8|||
129872220|NCT02240108|467490691|FG001|Overall Study|Other than specified|6|||
129872221|NCT02240108|467490690|FG000|Overall Study|Adverse Event|1|||
129872222|NCT02240108|467490691|FG001|Overall Study|Adverse Event|9|||
129872223|NCT02240108|467490690|FG000|Overall Study|Pregnancy|1|||
129872224|NCT02240108|467490691|FG001|Overall Study|Pregnancy|0|||
129872225|NCT02240108|467490690|FG000|Overall Study|Withdrawal by Subject|4|||
129872226|NCT02240108|467490691|FG001|Overall Study|Withdrawal by Subject|9|||
129872227|NCT02240108|467490690|FG000|Overall Study|StudyTerminated by Sponsor|0|||
129872228|NCT02240108|467490691|FG001|Overall Study|StudyTerminated by Sponsor|1|||
129872229|NCT01345630|467490692|FG000|Overall Study|Adverse Event|22|||
129872230|NCT01345630|467490693|FG001|Overall Study|Adverse Event|23|||
129872231|NCT01345630|467490692|FG000|Overall Study|Lost to Follow-up|17|||
129872232|NCT01345630|467490693|FG001|Overall Study|Lost to Follow-up|16|||
129872233|NCT01345630|467490692|FG000|Overall Study|Protocol Violation|4|||
129872234|NCT01345630|467490693|FG001|Overall Study|Protocol Violation|1|||
129872235|NCT01345630|467490692|FG000|Overall Study|Medication error without associated AE|0|||
129872236|NCT01345630|467490693|FG001|Overall Study|Medication error without associated AE|1|||
129872237|NCT01345630|467490692|FG000|Overall Study|Study terminated by sponsor|254|||
129872238|NCT01345630|467490693|FG001|Overall Study|Study terminated by sponsor|285|||
129872239|NCT01345630|467490692|FG000|Overall Study|Other reasons|6|||
129872240|NCT01345630|467490693|FG001|Overall Study|Other reasons|8|||
129872241|NCT01345630|467490692|FG000|Overall Study|Withdrawn due to pregnancy|1|||
129872242|NCT01345630|467490693|FG001|Overall Study|Withdrawn due to pregnancy|2|||
129872243|NCT01345630|467490692|FG000|Overall Study|No longer willing to participate|9|||
129872244|NCT01345630|467490693|FG001|Overall Study|No longer willing to participate|12|||
129872245|NCT01345630|467490692|FG000|Overall Study|Insufficient clinical response|48|||
129872246|NCT01345630|467490693|FG001|Overall Study|Insufficient clinical response|11|||
129872247|NCT04233372|467490694|FG000|Overall Study|Lost to Follow-up|104|||
129872248|NCT04233372|467490694|FG000|Overall Study|Adverse Event|8|||
129872249|NCT04233372|467490694|FG000|Overall Study|Withdrawal by Subject|2|||
129872250|NCT03938454|467490695|FG000|Overall Study|Protocol Violation|1|||
129872251|NCT03938454|467490695|FG000|Overall Study|Withdrawal by Subject|2|||
129872252|NCT03938454|467490695|FG000|Overall Study|Lost to Follow-up|3|||
129872253|NCT01090310|467490696|FG000|Core Study|Adverse Event|2|||
129872254|NCT01090310|467490697|FG001|Core Study|Adverse Event|2|||
129872255|NCT01090310|467490698|FG002|Core Study|Adverse Event|1|||
129872256|NCT01090310|467490699|FG003|Core Study|Adverse Event|1|||
129872257|NCT01090310|467490696|FG000|Core Study|Subject withdrew consent|0|||
129872258|NCT01090310|467490697|FG001|Core Study|Subject withdrew consent|3|||
129872259|NCT01090310|467490698|FG002|Core Study|Subject withdrew consent|1|||
129872260|NCT01090310|467490699|FG003|Core Study|Subject withdrew consent|1|||
129872261|NCT01090310|467490696|FG000|Core Study|Abnormal test procedure result|0|||
129872262|NCT01090310|467490697|FG001|Core Study|Abnormal test procedure result|0|||
129872263|NCT01090310|467490698|FG002|Core Study|Abnormal test procedure result|1|||
129872264|NCT01090310|467490699|FG003|Core Study|Abnormal test procedure result|0|||
129872265|NCT01090310|467490696|FG000|Core Study|Administrative reasons|5|||
129872266|NCT01090310|467490697|FG001|Core Study|Administrative reasons|6|||
129872267|NCT01090310|467490698|FG002|Core Study|Administrative reasons|4|||
129872268|NCT01090310|467490699|FG003|Core Study|Administrative reasons|4|||
129872269|NCT01090310|467490696|FG000|Core Study|Protocol deviation|1|||
129872270|NCT01090310|467490697|FG001|Core Study|Protocol deviation|0|||
129872271|NCT01090310|467490698|FG002|Core Study|Protocol deviation|0|||
129872272|NCT01090310|467490699|FG003|Core Study|Protocol deviation|1|||
129872273|NCT01090310|467490696|FG000|Extension Study|Aministrative problems|13|||
129918999|NCT05034952|467668759|FG001|Overall Study|Lost to Follow-up|4|||
129872274|NCT01090310|467490697|FG001|Extension Study|Aministrative problems|15|||
129872275|NCT01090310|467490698|FG002|Extension Study|Aministrative problems|14|||
129872276|NCT01090310|467490699|FG003|Extension Study|Aministrative problems|18|||
129872277|NCT01090310|467490696|FG000|Extension Study|Adverse Event|0|||
129872278|NCT01090310|467490697|FG001|Extension Study|Adverse Event|0|||
129872279|NCT01090310|467490698|FG002|Extension Study|Adverse Event|0|||
129872280|NCT01090310|467490699|FG003|Extension Study|Adverse Event|1|||
129872281|NCT01090310|467490696|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
129872282|NCT01090310|467490697|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
129919000|NCT05034952|467668760|FG002|Overall Study|Lost to Follow-up|3|||
129919001|NCT05034952|467668761|FG003|Overall Study|Lost to Follow-up|3|||
129919002|NCT05034952|467668758|FG000|Overall Study|Other|0|||
129919003|NCT05034952|467668759|FG001|Overall Study|Other|0|||
129919004|NCT05034952|467668760|FG002|Overall Study|Other|0|||
129919005|NCT05034952|467668761|FG003|Overall Study|Other|1|||
129919006|NCT04950660|467668766|FG000|Overall Study|Protocol Violation|4|||
129919007|NCT04950660|467668767|FG001|Overall Study|Protocol Violation|2|||
129919008|NCT04950660|467668766|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
129919009|NCT04950660|467668767|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
129919010|NCT04950660|467668766|FG000|Overall Study|Withdrawal by Subject|0|||
129919011|NCT04950660|467668767|FG001|Overall Study|Withdrawal by Subject|1|||
129919012|NCT04950660|467668766|FG000|Overall Study|Hypotension|1|||
129919013|NCT04950660|467668767|FG001|Overall Study|Hypotension|0|||
129919014|NCT02437318|467668768|FG000|Overall Study|Progressive disease|207|||
129919015|NCT02437318|467668769|FG001|Overall Study|Progressive disease|240|||
129919016|NCT02437318|467668768|FG000|Overall Study|Subject/guardian decision|24|||
129919017|NCT02437318|467668769|FG001|Overall Study|Subject/guardian decision|11|||
129919018|NCT02437318|467668768|FG000|Overall Study|Physician Decision|29|||
129919019|NCT02437318|467668769|FG001|Overall Study|Physician Decision|22|||
129919020|NCT02437318|467668768|FG000|Overall Study|Adverse Event|14|||
129919021|NCT02437318|467668769|FG001|Overall Study|Adverse Event|4|||
129919022|NCT02437318|467668768|FG000|Overall Study|Death|4|||
129919023|NCT02437318|467668769|FG001|Overall Study|Death|4|||
129919024|NCT02437318|467668768|FG000|Overall Study|Protocol deviation|5|||
129919025|NCT02437318|467668769|FG001|Overall Study|Protocol deviation|7|||
129919026|NCT02437318|467668768|FG000|Overall Study|Sponsor decision|1|||
129919027|NCT02437318|467668769|FG001|Overall Study|Sponsor decision|0|||
129919028|NCT00920621|467668771|FG000|Overall Study|Lost to Follow-up|16|||
129919029|NCT00920621|467668772|FG001|Overall Study|Lost to Follow-up|17|||
129919030|NCT00920621|467668773|FG002|Overall Study|Lost to Follow-up|19|||
129919031|NCT00920621|467668774|FG003|Overall Study|Lost to Follow-up|21|||
129919032|NCT00920621|467668771|FG000|Overall Study|Fetal/neonatal deaths|16|||
129919033|NCT00920621|467668772|FG001|Overall Study|Fetal/neonatal deaths|14|||
129919034|NCT00920621|467668773|FG002|Overall Study|Fetal/neonatal deaths|16|||
129919035|NCT00920621|467668774|FG003|Overall Study|Fetal/neonatal deaths|14|||
129919036|NCT00920621|467668771|FG000|Overall Study|Blood sample not collected|22|||
129919037|NCT00920621|467668772|FG001|Overall Study|Blood sample not collected|14|||
129919038|NCT00920621|467668773|FG002|Overall Study|Blood sample not collected|0|||
129919039|NCT00920621|467668774|FG003|Overall Study|Blood sample not collected|0|||
129919040|NCT04321031|467668777|FG000|Overall Study|Adverse Event|0|||
129919041|NCT04321031|467668778|FG001|Overall Study|Adverse Event|2|||
129919042|NCT04321031|467668779|FG002|Overall Study|Adverse Event|2|||
129919043|NCT04321031|467668780|FG003|Overall Study|Adverse Event|2|||
129919044|NCT04321031|467668781|FG004|Overall Study|Adverse Event|2|||
129919045|NCT04321031|467668782|FG005|Overall Study|Adverse Event|2|||
129919046|NCT04321031|467668783|FG006|Overall Study|Adverse Event|0|||
129919047|NCT04321031|467668777|FG000|Overall Study|Lost to Follow-up|0|||
129919048|NCT04321031|467668778|FG001|Overall Study|Lost to Follow-up|0|||
129919049|NCT04321031|467668779|FG002|Overall Study|Lost to Follow-up|0|||
129872283|NCT01090310|467490698|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
129872284|NCT01090310|467490699|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
129872285|NCT01090310|467490696|FG000|Extension Study|Subject withdrew consent|0|||
129872286|NCT01090310|467490697|FG001|Extension Study|Subject withdrew consent|1|||
129872287|NCT01090310|467490698|FG002|Extension Study|Subject withdrew consent|0|||
129872288|NCT01090310|467490699|FG003|Extension Study|Subject withdrew consent|0|||
129872289|NCT01142388|467490700|FG000|Overall Study|Lack of Efficacy|21|||
129872290|NCT01142388|467490701|FG001|Overall Study|Lack of Efficacy|31|||
129872291|NCT01142388|467490700|FG000|Overall Study|Adverse Event|9|||
129872292|NCT01142388|467490701|FG001|Overall Study|Adverse Event|5|||
129872293|NCT01142388|467490700|FG000|Overall Study|Death|3|||
129872294|NCT01142388|467490701|FG001|Overall Study|Death|2|||
129872295|NCT01142388|467490700|FG000|Overall Study|Withdrawal by Subject|5|||
129872296|NCT01142388|467490701|FG001|Overall Study|Withdrawal by Subject|3|||
129872297|NCT01142388|467490700|FG000|Overall Study|Alternative therapy|1|||
129872298|NCT01142388|467490701|FG001|Overall Study|Alternative therapy|0|||
129872299|NCT01142388|467490700|FG000|Overall Study|Other complications|0|||
129872300|NCT01142388|467490701|FG001|Overall Study|Other complications|2|||
129872301|NCT01142388|467490700|FG000|Overall Study|Other|1|||
129872302|NCT01142388|467490701|FG001|Overall Study|Other|1|||
129872303|NCT01142388|467490700|FG000|Overall Study|Never started therapy|7|||
129872304|NCT01142388|467490701|FG001|Overall Study|Never started therapy|3|||
129872305|NCT00695786|467490702|FG000|Overall Study|Adverse Event|0|||
129872306|NCT00695786|467490703|FG001|Overall Study|Adverse Event|3|||
129872307|NCT00695786|467490704|FG002|Overall Study|Adverse Event|4|||
129872308|NCT00695786|467490705|FG003|Overall Study|Adverse Event|2|||
129872309|NCT00695786|467490702|FG000|Overall Study|Lost to Follow-up|0|||
129872310|NCT00695786|467490703|FG001|Overall Study|Lost to Follow-up|5|||
129872311|NCT00695786|467490704|FG002|Overall Study|Lost to Follow-up|1|||
129872312|NCT00695786|467490705|FG003|Overall Study|Lost to Follow-up|1|||
129872313|NCT00695786|467490702|FG000|Overall Study|Withdrawal by Subject|0|||
129872314|NCT00695786|467490703|FG001|Overall Study|Withdrawal by Subject|4|||
129872315|NCT00695786|467490704|FG002|Overall Study|Withdrawal by Subject|3|||
129872316|NCT00695786|467490705|FG003|Overall Study|Withdrawal by Subject|1|||
129872317|NCT00695786|467490702|FG000|Overall Study|Deemed Ineligible|1|||
129872318|NCT00695786|467490703|FG001|Overall Study|Deemed Ineligible|0|||
129872319|NCT00695786|467490704|FG002|Overall Study|Deemed Ineligible|0|||
129872320|NCT00695786|467490705|FG003|Overall Study|Deemed Ineligible|0|||
129872321|NCT00695786|467490702|FG000|Overall Study|Lack of Efficacy|0|||
129872322|NCT00695786|467490703|FG001|Overall Study|Lack of Efficacy|0|||
129872323|NCT00695786|467490704|FG002|Overall Study|Lack of Efficacy|0|||
129872324|NCT00695786|467490705|FG003|Overall Study|Lack of Efficacy|4|||
129872325|NCT01364922|467490709|FG000|Open-label (OL) Period|Adverse Event|7|||
129872326|NCT01364922|467490710|FG001|Open-label (OL) Period|Adverse Event|0|||
129872327|NCT01364922|467490711|FG002|Open-label (OL) Period|Adverse Event|0|||
129872328|NCT01364922|467490709|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
129872329|NCT01364922|467490710|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
129872330|NCT01364922|467490711|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
129872331|NCT01364922|467490709|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
129872332|NCT01364922|467490710|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
129872333|NCT01364922|467490711|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
129919050|NCT04321031|467668780|FG003|Overall Study|Lost to Follow-up|1|||
129919051|NCT04321031|467668781|FG004|Overall Study|Lost to Follow-up|0|||
129919052|NCT04321031|467668782|FG005|Overall Study|Lost to Follow-up|2|||
129919053|NCT04321031|467668783|FG006|Overall Study|Lost to Follow-up|1|||
129919054|NCT04321031|467668777|FG000|Overall Study|Withdrawal by Subject|2|||
129919055|NCT04321031|467668778|FG001|Overall Study|Withdrawal by Subject|2|||
129919056|NCT04321031|467668779|FG002|Overall Study|Withdrawal by Subject|1|||
129919057|NCT04321031|467668780|FG003|Overall Study|Withdrawal by Subject|3|||
129919058|NCT04321031|467668781|FG004|Overall Study|Withdrawal by Subject|1|||
129919059|NCT04321031|467668782|FG005|Overall Study|Withdrawal by Subject|0|||
129919060|NCT04321031|467668783|FG006|Overall Study|Withdrawal by Subject|1|||
129919061|NCT04321031|467668777|FG000|Overall Study|Non-compliance with study drug|0|||
129872334|NCT01364922|467490709|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
129872335|NCT01364922|467490710|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
129872336|NCT01364922|467490711|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
129872337|NCT01364922|467490709|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
129872338|NCT01364922|467490710|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
129872339|NCT01364922|467490711|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
129872340|NCT01364922|467490709|FG000|Open-label (OL) Period|Other, Unspecified|1|||
129872341|NCT01364922|467490710|FG001|Open-label (OL) Period|Other, Unspecified|0|||
129872342|NCT01364922|467490711|FG002|Open-label (OL) Period|Other, Unspecified|0|||
129872343|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
129872344|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
129872345|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
129919062|NCT04321031|467668778|FG001|Overall Study|Non-compliance with study drug|0|||
129919063|NCT04321031|467668779|FG002|Overall Study|Non-compliance with study drug|0|||
129919064|NCT04321031|467668780|FG003|Overall Study|Non-compliance with study drug|0|||
129919065|NCT04321031|467668781|FG004|Overall Study|Non-compliance with study drug|0|||
129919066|NCT04321031|467668782|FG005|Overall Study|Non-compliance with study drug|1|||
129919067|NCT04321031|467668783|FG006|Overall Study|Non-compliance with study drug|0|||
129919068|NCT04321031|467668777|FG000|Overall Study|Other|0|||
129919069|NCT04321031|467668778|FG001|Overall Study|Other|0|||
129919070|NCT04321031|467668779|FG002|Overall Study|Other|0|||
129919071|NCT04321031|467668780|FG003|Overall Study|Other|1|||
129919072|NCT04321031|467668781|FG004|Overall Study|Other|0|||
129919073|NCT04321031|467668782|FG005|Overall Study|Other|0|||
129919074|NCT04321031|467668783|FG006|Overall Study|Other|0|||
129919075|NCT03143153|467668786|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
129919076|NCT03143153|467668787|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
129919077|NCT03143153|467668788|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
129919078|NCT03143153|467668786|FG000|Pre-Treatment|Participant withdrew consent|0|||
129919079|NCT03143153|467668787|FG001|Pre-Treatment|Participant withdrew consent|1|||
129919080|NCT03143153|467668788|FG002|Pre-Treatment|Participant withdrew consent|12|||
129919081|NCT03143153|467668786|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
129919082|NCT03143153|467668787|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
129919083|NCT03143153|467668788|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
129919084|NCT03143153|467668786|FG000|Pre-Treatment|Other Reasons|1|||
129872346|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
129872347|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
129872348|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
129872349|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Adverse Event|0|||
129872350|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Adverse Event|0|||
129872351|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Adverse Event|1|||
129872352|NCT01364922|467490709|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
129872353|NCT01364922|467490710|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
129872354|NCT01364922|467490711|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
129872355|NCT04244396|467490712|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
129872356|NCT04244396|467490712|FG000|Overall Study|Withdrawal by Subject|2|||
129872357|NCT04244396|467490712|FG000|Overall Study|Study termination|37|||
129872358|NCT01787097|467490713|FG000|Overall Study|Withdrawal by Subject|1|||
129872359|NCT01787097|467490714|FG001|Overall Study|Withdrawal by Subject|0|||
129872360|NCT01787097|467490715|FG002|Overall Study|Withdrawal by Subject|0|||
129872361|NCT01787097|467490716|FG003|Overall Study|Withdrawal by Subject|0|||
129872362|NCT00553501|467490723|FG000|Overall Study|Adverse Event|2|||
129872363|NCT00553501|467490723|FG000|Overall Study|Death|1|||
129872364|NCT00553501|467490723|FG000|Overall Study|Progression|1|||
129872365|NCT02293395|467490724|FG000|Overall Study|Lost to Follow-up|1|||
129872366|NCT02293395|467490725|FG001|Overall Study|Lost to Follow-up|0|||
129872367|NCT02293395|467490724|FG000|Overall Study|Withdrawal by Subject|8|||
129872368|NCT02293395|467490725|FG001|Overall Study|Withdrawal by Subject|7|||
129872369|NCT01464021|467490728|FG000|Overall Study|Withdrawal by Subject|13|||
129872370|NCT01464021|467490728|FG000|Overall Study|Lost to Follow-up|1|||
129872371|NCT01464021|467490728|FG000|Overall Study|Lack of Efficacy|1|||
129872372|NCT01464021|467490728|FG000|Overall Study|various|11|||
129872373|NCT00861614|467490729|FG000|Overall Study|Disease Progression|182|||
129872374|NCT00861614|467490730|FG001|Overall Study|Disease Progression|263|||
129872375|NCT00861614|467490729|FG000|Overall Study|Study Drug Toxicity|79|||
129872376|NCT00861614|467490730|FG001|Overall Study|Study Drug Toxicity|6|||
129872377|NCT00861614|467490729|FG000|Overall Study|Death|32|||
129872378|NCT00861614|467490730|FG001|Overall Study|Death|19|||
129872379|NCT00861614|467490729|FG000|Overall Study|Adverse Event|27|||
129872380|NCT00861614|467490730|FG001|Overall Study|Adverse Event|23|||
129872381|NCT00861614|467490729|FG000|Overall Study|Withdrawal by Subject|34|||
129872382|NCT00861614|467490730|FG001|Overall Study|Withdrawal by Subject|35|||
129872383|NCT00861614|467490729|FG000|Overall Study|Other|17|||
129872384|NCT00861614|467490730|FG001|Overall Study|Other|22|||
129872385|NCT03391765|467490731|FG000|Overall Study|Adverse Event|2|||
129872386|NCT03391765|467490732|FG001|Overall Study|Adverse Event|0|||
129872387|NCT03391765|467490733|FG002|Overall Study|Adverse Event|0|||
129872388|NCT03391765|467490734|FG003|Overall Study|Adverse Event|2|||
129872389|NCT03391765|467490731|FG000|Overall Study|Withdrew consent|5|||
129872390|NCT03391765|467490732|FG001|Overall Study|Withdrew consent|7|||
129872391|NCT03391765|467490733|FG002|Overall Study|Withdrew consent|2|||
129872392|NCT03391765|467490734|FG003|Overall Study|Withdrew consent|5|||
129872393|NCT03391765|467490731|FG000|Overall Study|Other, not specified|44|||
129872394|NCT03391765|467490732|FG001|Overall Study|Other, not specified|38|||
129919085|NCT03143153|467668787|FG001|Pre-Treatment|Other Reasons|2|||
129919086|NCT03143153|467668788|FG002|Pre-Treatment|Other Reasons|1|||
129872395|NCT03391765|467490733|FG002|Overall Study|Other, not specified|21|||
129872396|NCT03391765|467490734|FG003|Overall Study|Other, not specified|16|||
129872397|NCT00944658|467490735|FG000|Treatment 12 Weeks|Adverse Event|0|||
129919087|NCT03143153|467668786|FG000|Pre-Treatment|Disease Progression|1|||
129872398|NCT00944658|467490736|FG001|Treatment 12 Weeks|Adverse Event|2|||
129872399|NCT01289418|467490740|FG000|Day 8 Survey|email address invalid|283|||
129872400|NCT01289418|467490740|FG000|Day 8 Survey|participants did not complete the survey|1935|||
129872401|NCT01289418|467490740|FG000|Day 29 Survey|email address invalid|283|||
129872402|NCT01289418|467490740|FG000|Day 29 Survey|participants did not complete the survey|2185|||
129872403|NCT02832622|467490746|FG000|Overall Study|MPP not programmed|1259|||
129872404|NCT02832622|467490746|FG000|Overall Study|Withdrawal by Subject|123|||
129872405|NCT02832622|467490746|FG000|Overall Study|Death|119|||
129872406|NCT02832622|467490746|FG000|Overall Study|Unsuccessful CRT implant|93|||
129872407|NCT02832622|467490746|FG000|Overall Study|Lost to Follow-up|45|||
129872408|NCT02832622|467490746|FG000|Overall Study|Patient non-compliance|42|||
129872409|NCT02832622|467490746|FG000|Overall Study|Withdrawal by other reasons|25|||
129872410|NCT02832622|467490746|FG000|Overall Study|System explant|24|||
129872411|NCT02832622|467490746|FG000|Overall Study|Physician Decision|6|||
129872412|NCT02472652|467490747|FG000|Overall Study|Lost to Follow-up|1|||
129872413|NCT00998400|467490752|FG000|Overall Study|Lack of interest/motivation|1|||
129872414|NCT00998400|467490753|FG001|Overall Study|Lack of interest/motivation|2|||
129872415|NCT00998400|467490752|FG000|Overall Study|Logistical problems|1|||
129872416|NCT00998400|467490753|FG001|Overall Study|Logistical problems|0|||
129872417|NCT03185832|467490754|FG000|Overall Study|Death|9|||
129872418|NCT03185832|467490755|FG001|Overall Study|Death|14|||
129872419|NCT03185832|467490756|FG002|Overall Study|Death|9|||
129872420|NCT03185832|467490757|FG003|Overall Study|Death|7|||
129872421|NCT03185832|467490754|FG000|Overall Study|Withdrawn - vital status available|0|||
129872422|NCT03185832|467490755|FG001|Overall Study|Withdrawn - vital status available|1|||
129872423|NCT03185832|467490756|FG002|Overall Study|Withdrawn - vital status available|1|||
129872424|NCT03185832|467490757|FG003|Overall Study|Withdrawn - vital status available|4|||
129872425|NCT01083641|467490758|FG000|Overall Study|Withdrawal by Subject|2|||
129872426|NCT03386032|467490759|FG000|Overall Study|Lack of Efficacy|6|||
129872427|NCT03386032|467490760|FG001|Overall Study|Lack of Efficacy|2|||
129872428|NCT03386032|467490761|FG002|Overall Study|Lack of Efficacy|0|||
129872429|NCT03386032|467490759|FG000|Overall Study|Adverse Event|2|||
129872430|NCT03386032|467490760|FG001|Overall Study|Adverse Event|2|||
129872431|NCT03386032|467490761|FG002|Overall Study|Adverse Event|0|||
129872432|NCT03386032|467490759|FG000|Overall Study|Withdrawal by Subject|1|||
129872433|NCT03386032|467490760|FG001|Overall Study|Withdrawal by Subject|0|||
129872434|NCT03386032|467490761|FG002|Overall Study|Withdrawal by Subject|0|||
129872435|NCT03386032|467490759|FG000|Overall Study|Lost to Follow-up|9|||
129872436|NCT03386032|467490760|FG001|Overall Study|Lost to Follow-up|3|||
129872437|NCT03386032|467490761|FG002|Overall Study|Lost to Follow-up|0|||
129872438|NCT01807156|467490766|FG000|Overall Study|Physician Decision|1|||
129872439|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
129872440|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
129872441|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
129872442|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
129872443|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
129872444|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
129872445|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
129872446|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
129872447|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
129872448|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
129872449|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
129872450|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
129872451|NCT01493687|467490769|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
129872452|NCT01493687|467490770|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
129872453|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
129872454|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
129872455|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
129872456|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
129872457|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
129872458|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
129872459|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
129872460|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
129872461|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
129872462|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
129872463|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
129872464|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
129872465|NCT01493687|467490769|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
129872466|NCT01493687|467490770|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
129872467|NCT01493687|467490769|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
129872468|NCT01493687|467490770|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
129872469|NCT02364180|467490774|FG000|Overall Study|Screen Fail|1|||
129872470|NCT02323646|467490775|FG000|Treatment Course 1|Adverse Event|1|||
129872471|NCT02323646|467490776|FG001|Treatment Course 1|Adverse Event|0|||
129872472|NCT02323646|467490777|FG002|Treatment Course 1|Adverse Event|1|||
129872473|NCT02323646|467490775|FG000|Treatment Course 1|Heavy Bleeding|1|||
129872474|NCT02323646|467490776|FG001|Treatment Course 1|Heavy Bleeding|1|||
129872475|NCT02323646|467490777|FG002|Treatment Course 1|Heavy Bleeding|0|||
129872476|NCT02323646|467490775|FG000|Treatment Course 1|Lost to Follow-up|1|||
129872477|NCT02323646|467490776|FG001|Treatment Course 1|Lost to Follow-up|0|||
129872478|NCT02323646|467490777|FG002|Treatment Course 1|Lost to Follow-up|2|||
129872479|NCT02323646|467490775|FG000|Treatment Course 1|Withdrawal by Subject|0|||
129872480|NCT02323646|467490776|FG001|Treatment Course 1|Withdrawal by Subject|2|||
129872481|NCT02323646|467490777|FG002|Treatment Course 1|Withdrawal by Subject|0|||
129872482|NCT02323646|467490775|FG000|Treatment Course 2|Adverse Event|1|||
129872483|NCT02323646|467490776|FG001|Treatment Course 2|Adverse Event|0|||
129872484|NCT02323646|467490777|FG002|Treatment Course 2|Adverse Event|1|||
129872485|NCT02323646|467490775|FG000|Treatment Course 2|Lost to Follow-up|0|||
129872486|NCT02323646|467490776|FG001|Treatment Course 2|Lost to Follow-up|0|||
129872487|NCT02323646|467490777|FG002|Treatment Course 2|Lost to Follow-up|1|||
129872488|NCT02323646|467490775|FG000|Treatment Course 2|Non-compliance|0|||
129872489|NCT02323646|467490776|FG001|Treatment Course 2|Non-compliance|1|||
129872490|NCT02323646|467490777|FG002|Treatment Course 2|Non-compliance|1|||
129872491|NCT00521144|467490778|FG000|Overall Study|Not Treated|0|||
129872492|NCT00521144|467490779|FG001|Overall Study|Not Treated|0|||
129872493|NCT00521144|467490780|FG002|Overall Study|Not Treated|0|||
129872494|NCT00521144|467490781|FG003|Overall Study|Not Treated|1|||
129872495|NCT00521144|467490782|FG004|Overall Study|Not Treated|0|||
129872496|NCT00521144|467490778|FG000|Overall Study|Adverse Event|0|||
129872497|NCT00521144|467490779|FG001|Overall Study|Adverse Event|1|||
129872498|NCT00521144|467490780|FG002|Overall Study|Adverse Event|0|||
129872499|NCT00521144|467490781|FG003|Overall Study|Adverse Event|0|||
129872500|NCT00521144|467490782|FG004|Overall Study|Adverse Event|1|||
129872501|NCT00521144|467490778|FG000|Overall Study|Progressive Disease|4|||
129872502|NCT00521144|467490779|FG001|Overall Study|Progressive Disease|2|||
129872503|NCT00521144|467490780|FG002|Overall Study|Progressive Disease|2|||
129872504|NCT00521144|467490781|FG003|Overall Study|Progressive Disease|0|||
129872505|NCT00521144|467490782|FG004|Overall Study|Progressive Disease|6|||
129872506|NCT01370525|467490783|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
129872507|NCT01370525|467490784|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
129872508|NCT01370525|467490783|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129872509|NCT01370525|467490784|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129872510|NCT01370525|467490783|FG000|Overall Study|Adverse Event|0|||
129872511|NCT01370525|467490784|FG001|Overall Study|Adverse Event|1|||
129872512|NCT01370525|467490783|FG000|Overall Study|Protocol Violation|2|||
129872513|NCT01370525|467490784|FG001|Overall Study|Protocol Violation|1|||
129872514|NCT01370525|467490783|FG000|Overall Study|Lost to follow up|2|||
129872515|NCT01370525|467490784|FG001|Overall Study|Lost to follow up|6|||
129872516|NCT02940574|467490791|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
129872517|NCT02940574|467490792|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
129872518|NCT02940574|467490791|FG000|1-year Follow-up|Lost to Follow-up|3|||
129872519|NCT02940574|467490792|FG001|1-year Follow-up|Lost to Follow-up|4|||
129872520|NCT00387894|467490793|FG000|Overall Study|Withdrawal by Subject|1|||
129872521|NCT02421666|467490796|FG000|6-month Follow-up|Lost to Follow-up|8|||
129872522|NCT02421666|467490797|FG001|6-month Follow-up|Lost to Follow-up|7|||
129872523|NCT02421666|467490796|FG000|6-month Follow-up|Withdrawal by Subject|5|||
129872524|NCT02421666|467490797|FG001|6-month Follow-up|Withdrawal by Subject|6|||
129872525|NCT02421666|467490796|FG000|12-month Follow-up|Lost to Follow-up|5|||
129872526|NCT02421666|467490797|FG001|12-month Follow-up|Lost to Follow-up|5|||
129872527|NCT02421666|467490796|FG000|12-month Follow-up|Withdrawal by Subject|6|||
129872528|NCT02421666|467490797|FG001|12-month Follow-up|Withdrawal by Subject|11|||
129872529|NCT01119768|467490802|FG000|Treatment Period|Lack of Efficacy|18|||
129872530|NCT01119768|467490803|FG001|Treatment Period|Lack of Efficacy|25|||
129872531|NCT01059643|467490804|FG000|Overall Study|Adverse Event|3|||
129872532|NCT01059643|467490804|FG000|Overall Study|Withdrawal by Subject|2|||
129872533|NCT01059643|467490804|FG000|Overall Study|Physician Decision|1|||
129872534|NCT00689026|467490822|FG000|Overall Study|Withdrawal by Subject|13|||
129872535|NCT00689026|467490823|FG001|Overall Study|Withdrawal by Subject|6|||
129872536|NCT00459342|467490824|FG000|Overall Study|Not eligible|1|||
129872537|NCT02686034|467490825|FG000|Run-In Period 1|Eligibility|12|||
129872538|NCT02686034|467490826|FG001|Run-In Period 1|Eligibility|10|||
129872539|NCT02686034|467490825|FG000|Run-In Period 1|Withdrawal by Subject|4|||
129872540|NCT02686034|467490826|FG001|Run-In Period 1|Withdrawal by Subject|3|||
129872541|NCT02686034|467490825|FG000|Run-In Period 1|Lost to Follow-up|4|||
129872542|NCT02686034|467490826|FG001|Run-In Period 1|Lost to Follow-up|4|||
129872543|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
129872544|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
129872545|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
129872546|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
129872547|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Adverse Event|0|||
129872548|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Adverse Event|2|||
129872549|NCT02686034|467490825|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
129872550|NCT02686034|467490826|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
129872551|NCT02686034|467490825|FG000|Open Label Period 3|Lost to Follow-up|0|||
129872552|NCT02686034|467490826|FG001|Open Label Period 3|Lost to Follow-up|1|||
129872553|NCT03017079|467490827|FG000|Overall Study|Physician Decision|1|||
129872554|NCT03017079|467490828|FG001|Overall Study|Physician Decision|1|||
129872555|NCT03017079|467490827|FG000|Overall Study|Death|3|||
129872556|NCT03017079|467490828|FG001|Overall Study|Death|2|||
129872557|NCT03017079|467490827|FG000|Overall Study|Lack of Efficacy|2|||
129872558|NCT03017079|467490828|FG001|Overall Study|Lack of Efficacy|2|||
129872559|NCT03017079|467490827|FG000|Overall Study|Protocol Violation|0|||
129449971|NCT01994382|465947284|FG016|Overall Study|Other than specified|4|||
129449972|NCT01994382|465947268|FG000|Overall Study|Withdrawal by Subject|0|||
129872560|NCT03017079|467490828|FG001|Overall Study|Protocol Violation|1|||
129872561|NCT00643123|467491873|FG000|Overall Study|Lost to Follow-up|4|||
129872562|NCT00643123|467491874|FG001|Overall Study|Lost to Follow-up|0|||
129872563|NCT00643123|467491873|FG000|Overall Study|Withdrawal by Subject|1|||
129872564|NCT00643123|467491874|FG001|Overall Study|Withdrawal by Subject|1|||
129872565|NCT02923739|467491875|FG000|Overall Study|Withdrawal by Subject|2|||
129872566|NCT02923739|467491876|FG001|Overall Study|Withdrawal by Subject|0|||
129872567|NCT02923739|467491877|FG002|Overall Study|Withdrawal by Subject|0|||
129872568|NCT02923739|467491878|FG003|Overall Study|Withdrawal by Subject|0|||
129872569|NCT02923739|467491875|FG000|Overall Study|Failed Screening|3|||
129872570|NCT02923739|467491876|FG001|Overall Study|Failed Screening|0|||
129872571|NCT02923739|467491877|FG002|Overall Study|Failed Screening|0|||
129872572|NCT02923739|467491878|FG003|Overall Study|Failed Screening|0|||
129872573|NCT01591382|467491883|FG000|Overall Study|Discharged Prior to Study Completion|2|||
129872574|NCT01591382|467491884|FG001|Overall Study|Discharged Prior to Study Completion|1|||
129872575|NCT01591382|467491883|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
129872576|NCT01591382|467491884|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
129872577|NCT00855062|467491892|FG000|Step1|Early Study Closure|5|||
129872578|NCT00855062|467491893|FG001|Step1|Early Study Closure|7|||
129872579|NCT00855062|467491892|FG000|Step1|Adverse Event|1|||
129872580|NCT00855062|467491893|FG001|Step1|Adverse Event|1|||
129872581|NCT00855062|467491892|FG000|Step1|Protocol Violation|1|||
129872582|NCT00855062|467491893|FG001|Step1|Protocol Violation|0|||
129872583|NCT00855062|467491892|FG000|Step1|Pregnancy|1|||
129872584|NCT00855062|467491893|FG001|Step1|Pregnancy|0|||
129872585|NCT00855062|467491892|FG000|Step1|Withdrawal by Subject|2|||
129872586|NCT00855062|467491893|FG001|Step1|Withdrawal by Subject|3|||
129872587|NCT00855062|467491892|FG000|Step2|Early Study Closure|6|||
129872588|NCT00855062|467491893|FG001|Step2|Early Study Closure|2|||
129872589|NCT00855062|467491892|FG000|Step2|Adverse Event|0|||
129872590|NCT00855062|467491893|FG001|Step2|Adverse Event|3|||
129872591|NCT00855062|467491892|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
129872592|NCT00855062|467491893|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
129872593|NCT01960725|467491896|FG000|Overall Study|Lost to Follow-up|4|||
129872594|NCT01960725|467491897|FG001|Overall Study|Lost to Follow-up|3|||
129872595|NCT01960725|467491896|FG000|Overall Study|Withdrawal by Subject|1|||
129872596|NCT01960725|467491897|FG001|Overall Study|Withdrawal by Subject|0|||
129872597|NCT01960725|467491896|FG000|Overall Study|unable to obtain blood sample|1|||
129872598|NCT01960725|467491897|FG001|Overall Study|unable to obtain blood sample|2|||
129872599|NCT02110901|467491898|FG000|Overall Study|Death|6|||
129872600|NCT02110901|467491899|FG001|Overall Study|Death|3|||
129872601|NCT02110901|467491898|FG000|Overall Study|Lost to Follow-up|12|||
129872602|NCT02110901|467491899|FG001|Overall Study|Lost to Follow-up|8|||
129872603|NCT02110901|467491898|FG000|Overall Study|Withdrawal by Subject|7|||
129872604|NCT02110901|467491899|FG001|Overall Study|Withdrawal by Subject|3|||
129872605|NCT02110901|467491898|FG000|Overall Study|received a kidney transplant|5|||
129872606|NCT02110901|467491899|FG001|Overall Study|received a kidney transplant|0|||
129872607|NCT02634788|467491900|FG000|Overall Study|Adverse Event|0|||
129872608|NCT02634788|467491901|FG001|Overall Study|Adverse Event|8|||
129872609|NCT02634788|467491902|FG002|Overall Study|Adverse Event|3|||
129872610|NCT02634788|467491903|FG003|Overall Study|Adverse Event|1|||
129872611|NCT02634788|467491900|FG000|Overall Study|Lack of Efficacy|4|||
129872612|NCT02634788|467491901|FG001|Overall Study|Lack of Efficacy|0|||
129872613|NCT02634788|467491902|FG002|Overall Study|Lack of Efficacy|1|||
129872614|NCT02634788|467491903|FG003|Overall Study|Lack of Efficacy|4|||
129872615|NCT02634788|467491900|FG000|Overall Study|Lost to Follow-up|0|||
129872616|NCT02634788|467491901|FG001|Overall Study|Lost to Follow-up|1|||
129872617|NCT02634788|467491902|FG002|Overall Study|Lost to Follow-up|0|||
129872618|NCT02634788|467491903|FG003|Overall Study|Lost to Follow-up|0|||
129872619|NCT02634788|467491900|FG000|Overall Study|Withdrawal by Subject|0|||
129872620|NCT02634788|467491901|FG001|Overall Study|Withdrawal by Subject|1|||
129872621|NCT02634788|467491902|FG002|Overall Study|Withdrawal by Subject|1|||
129872622|NCT02634788|467491903|FG003|Overall Study|Withdrawal by Subject|0|||
129872623|NCT00758459|467491904|FG000|Overall Study|Adverse Event|3|||
129872624|NCT00758459|467491905|FG001|Overall Study|Adverse Event|2|||
129872625|NCT00758459|467491904|FG000|Overall Study|Protocol Violation|0|||
129872626|NCT00758459|467491905|FG001|Overall Study|Protocol Violation|1|||
129872627|NCT00758459|467491904|FG000|Overall Study|Withdrawal by Subject|0|||
129872628|NCT00758459|467491905|FG001|Overall Study|Withdrawal by Subject|1|||
129872629|NCT02496767|467491920|FG000|Open-label Lead-in Phase|Adverse Event|176|||
129872630|NCT02496767|467491921|FG001|Open-label Lead-in Phase|Adverse Event|0|||
129872631|NCT02496767|467491922|FG002|Open-label Lead-in Phase|Adverse Event|0|||
129872632|NCT02496767|467491923|FG003|Open-label Lead-in Phase|Adverse Event|0|||
129872633|NCT02496767|467491924|FG004|Open-label Lead-in Phase|Adverse Event|0|||
129872634|NCT02496767|467491925|FG005|Open-label Lead-in Phase|Adverse Event|0|||
129872635|NCT02496767|467491926|FG006|Open-label Lead-in Phase|Adverse Event|0|||
129872636|NCT02496767|467491927|FG007|Open-label Lead-in Phase|Adverse Event|0|||
129872637|NCT02496767|467491920|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
129872638|NCT02496767|467491921|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
129872639|NCT02496767|467491922|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
129872640|NCT02496767|467491923|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
129872641|NCT02496767|467491924|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
129872642|NCT02496767|467491925|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
129872643|NCT02496767|467491926|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
129872644|NCT02496767|467491927|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
129872645|NCT02496767|467491920|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
129872646|NCT02496767|467491921|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872647|NCT02496767|467491922|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872648|NCT02496767|467491923|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872649|NCT02496767|467491924|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872650|NCT02496767|467491925|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872651|NCT02496767|467491926|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872652|NCT02496767|467491927|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
129872653|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872654|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
129872655|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
129872656|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
129872657|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
129872658|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872659|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872660|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129872661|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872662|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
129872663|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
129872664|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
129872665|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
129872666|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872667|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872668|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
129872669|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
129872670|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
129872671|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
129872672|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
129872673|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
129872674|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
129872675|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
129872676|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
129872677|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
129872678|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
129872679|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
129872680|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
129872681|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
129872682|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
129872683|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
129872684|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
129872685|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872686|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
129872687|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
129872688|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
129872689|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
129872690|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872691|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872692|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129872693|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872694|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
129872695|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
129872696|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872697|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872698|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872699|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872700|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129872701|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872702|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
129872703|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872704|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
129872705|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
129872706|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872707|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872708|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129872709|NCT02496767|467491920|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872710|NCT02496767|467491921|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
129872711|NCT02496767|467491922|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872712|NCT02496767|467491923|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872713|NCT02496767|467491924|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872714|NCT02496767|467491925|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872715|NCT02496767|467491926|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872716|NCT02496767|467491927|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
129872717|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872718|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872719|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872720|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872721|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872722|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
129872723|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
129872724|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
129872725|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872726|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872727|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872728|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872729|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
129872730|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
129872731|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
129872732|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
129872733|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Death|0|||
129872734|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Death|0|||
129872735|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Death|0|||
129872736|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Death|0|||
129872737|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Death|0|||
129872738|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Death|0|||
129872739|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Death|1|||
129872740|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Death|2|||
129872741|NCT02496767|467491920|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872742|NCT02496767|467491921|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872743|NCT02496767|467491922|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872744|NCT02496767|467491923|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872745|NCT02496767|467491924|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
129872746|NCT02496767|467491925|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
129872747|NCT02496767|467491926|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
129872748|NCT02496767|467491927|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
129872749|NCT01281202|467491928|FG000|Overall Study|Adverse Event|2|||
129872750|NCT01281202|467491929|FG001|Overall Study|Adverse Event|0|||
129872751|NCT01281202|467491928|FG000|Overall Study|Withdrawal by Subject|2|||
129872752|NCT01281202|467491929|FG001|Overall Study|Withdrawal by Subject|2|||
129872753|NCT01281202|467491928|FG000|Overall Study|Protocol Violation|11|||
129872754|NCT01281202|467491929|FG001|Overall Study|Protocol Violation|10|||
129872755|NCT01281202|467491928|FG000|Overall Study|Administrative|2|||
129872756|NCT01281202|467491929|FG001|Overall Study|Administrative|8|||
129872757|NCT01281202|467491928|FG000|Overall Study|Lost to Follow-up|11|||
129872758|NCT01281202|467491929|FG001|Overall Study|Lost to Follow-up|13|||
129872759|NCT01281202|467491928|FG000|Overall Study|Incarceration|0|||
129872760|NCT01281202|467491929|FG001|Overall Study|Incarceration|3|||
129872761|NCT02889133|467491933|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
129872762|NCT02889133|467491934|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
129872763|NCT02889133|467491933|FG000|Completed Primary Outcome|Manufacturing error|3|||
129872764|NCT02889133|467491934|FG001|Completed Primary Outcome|Manufacturing error|8|||
129872765|NCT02889133|467491933|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
129872766|NCT02889133|467491934|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
129872767|NCT02889133|467491933|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
129449973|NCT01994382|465947269|FG001|Overall Study|Withdrawal by Subject|0|||
129449974|NCT01994382|465947270|FG002|Overall Study|Withdrawal by Subject|0|||
129449975|NCT01994382|465947271|FG003|Overall Study|Withdrawal by Subject|0|||
129449976|NCT01994382|465947272|FG004|Overall Study|Withdrawal by Subject|0|||
129449977|NCT01994382|465947273|FG005|Overall Study|Withdrawal by Subject|0|||
129449978|NCT01994382|465947274|FG006|Overall Study|Withdrawal by Subject|0|||
129449979|NCT01994382|465947275|FG007|Overall Study|Withdrawal by Subject|0|||
129449980|NCT01994382|465947276|FG008|Overall Study|Withdrawal by Subject|0|||
129449981|NCT01994382|465947277|FG009|Overall Study|Withdrawal by Subject|0|||
129449982|NCT01994382|465947278|FG010|Overall Study|Withdrawal by Subject|6|||
129449983|NCT01994382|465947279|FG011|Overall Study|Withdrawal by Subject|0|||
129449984|NCT01994382|465947280|FG012|Overall Study|Withdrawal by Subject|2|||
129449985|NCT01994382|465947281|FG013|Overall Study|Withdrawal by Subject|0|||
129449986|NCT01994382|465947282|FG014|Overall Study|Withdrawal by Subject|4|||
129449987|NCT01994382|465947283|FG015|Overall Study|Withdrawal by Subject|3|||
129449988|NCT01994382|465947284|FG016|Overall Study|Withdrawal by Subject|0|||
129449989|NCT01994382|465947268|FG000|Overall Study|Lost to Follow-up|0|||
129449990|NCT01994382|465947269|FG001|Overall Study|Lost to Follow-up|0|||
129449991|NCT01994382|465947270|FG002|Overall Study|Lost to Follow-up|0|||
129449992|NCT01994382|465947271|FG003|Overall Study|Lost to Follow-up|0|||
129449993|NCT01994382|465947272|FG004|Overall Study|Lost to Follow-up|0|||
129449994|NCT01994382|465947273|FG005|Overall Study|Lost to Follow-up|0|||
129449995|NCT01994382|465947274|FG006|Overall Study|Lost to Follow-up|0|||
129449996|NCT01994382|465947275|FG007|Overall Study|Lost to Follow-up|0|||
129449997|NCT01994382|465947276|FG008|Overall Study|Lost to Follow-up|0|||
129449998|NCT01994382|465947277|FG009|Overall Study|Lost to Follow-up|0|||
129449999|NCT01994382|465947278|FG010|Overall Study|Lost to Follow-up|1|||
129450000|NCT01994382|465947279|FG011|Overall Study|Lost to Follow-up|0|||
129450001|NCT01994382|465947280|FG012|Overall Study|Lost to Follow-up|0|||
129450002|NCT01994382|465947281|FG013|Overall Study|Lost to Follow-up|0|||
129450003|NCT01994382|465947282|FG014|Overall Study|Lost to Follow-up|0|||
129450004|NCT01994382|465947283|FG015|Overall Study|Lost to Follow-up|0|||
129450005|NCT01994382|465947284|FG016|Overall Study|Lost to Follow-up|0|||
129450006|NCT01994382|465947268|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450007|NCT01994382|465947269|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450008|NCT01994382|465947270|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450009|NCT01994382|465947271|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450010|NCT01994382|465947272|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450011|NCT01994382|465947273|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450012|NCT01994382|465947274|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450013|NCT01994382|465947275|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450014|NCT01994382|465947276|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450015|NCT01994382|465947277|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450016|NCT01994382|465947278|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
129450017|NCT01994382|465947279|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450018|NCT01994382|465947280|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
129450019|NCT01994382|465947281|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450020|NCT01994382|465947282|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
129450021|NCT01994382|465947283|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
129450022|NCT01994382|465947284|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
129450023|NCT01994382|465947268|FG000|Overall Study|Protocol violation/noncompliance|0|||
129450024|NCT01994382|465947269|FG001|Overall Study|Protocol violation/noncompliance|0|||
129450025|NCT01994382|465947270|FG002|Overall Study|Protocol violation/noncompliance|0|||
129450026|NCT01994382|465947271|FG003|Overall Study|Protocol violation/noncompliance|0|||
129872768|NCT02889133|467491934|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
129872769|NCT02889133|467491933|FG000|Completed Primary Outcome|Protocol Violation|1|||
129872770|NCT02889133|467491934|FG001|Completed Primary Outcome|Protocol Violation|0|||
129450027|NCT01994382|465947272|FG004|Overall Study|Protocol violation/noncompliance|0|||
129450028|NCT01994382|465947273|FG005|Overall Study|Protocol violation/noncompliance|0|||
129872771|NCT02889133|467491933|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
129872772|NCT02889133|467491934|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
129872773|NCT02889133|467491933|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
129872774|NCT02889133|467491934|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
129872775|NCT02889133|467491933|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
129872776|NCT02889133|467491934|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
129872777|NCT02889133|467491933|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
129872778|NCT02889133|467491934|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
129872779|NCT02889133|467491933|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
129872780|NCT02889133|467491934|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
129872781|NCT02277990|467491935|FG000|Overall Study|Death|170|||
129872782|NCT02277990|467491936|FG001|Overall Study|Death|188|||
129872783|NCT02277990|467491935|FG000|Overall Study|Withdrawal by Subject|64|||
129872784|NCT02277990|467491936|FG001|Overall Study|Withdrawal by Subject|53|||
129872785|NCT02277990|467491935|FG000|Overall Study|Physician Decision|40|||
129872786|NCT02277990|467491936|FG001|Overall Study|Physician Decision|34|||
129872787|NCT02277990|467491935|FG000|Overall Study|Lost to Follow-up|66|||
129872788|NCT02277990|467491936|FG001|Overall Study|Lost to Follow-up|69|||
129872789|NCT02277990|467491935|FG000|Overall Study|Had other reason|26|||
129872790|NCT02277990|467491936|FG001|Overall Study|Had other reason|32|||
129872791|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
129872792|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
129872793|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
129872794|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
129872795|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
129872796|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
129872797|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
129872798|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
129872799|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
129872800|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
129872801|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
129872802|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
129872803|NCT04711603|467491937|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
129872804|NCT04711603|467491938|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
129872805|NCT04711603|467491939|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
129872806|NCT04711603|467491940|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
129872807|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
129872808|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
129872809|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
129872810|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
129872811|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
129872812|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
129872813|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
129872814|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
129872815|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
129872816|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
129872817|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
129872818|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
129872819|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
129872820|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
129872821|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
129872822|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
129872823|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
129872824|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
129872825|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
129872826|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
129872827|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
129872828|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
129872829|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
129872830|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
129872831|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
129872832|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
129872833|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
129872834|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
129872835|NCT04711603|467491937|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
129872836|NCT04711603|467491938|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
129872837|NCT04711603|467491939|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
129872838|NCT04711603|467491940|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
129872839|NCT05479604|467491945|FG000|Overall Study|Lost to Follow-up|1|||
129872840|NCT05479604|467491946|FG001|Overall Study|Lost to Follow-up|5|||
129872841|NCT03138733|467491947|FG000|Overall Study|Death|17|||
129872842|NCT03138733|467491948|FG001|Overall Study|Death|18|||
129872843|NCT03138733|467491947|FG000|Overall Study|Withdrawal by Subject|11|||
129872844|NCT03138733|467491948|FG001|Overall Study|Withdrawal by Subject|6|||
129872845|NCT03138733|467491947|FG000|Overall Study|Lost to Follow-up|3|||
129872846|NCT03138733|467491948|FG001|Overall Study|Lost to Follow-up|2|||
129872847|NCT03138733|467491947|FG000|Overall Study|Adverse Event|1|||
129872848|NCT03138733|467491948|FG001|Overall Study|Adverse Event|0|||
129872849|NCT03138733|467491947|FG000|Overall Study|Protocol Violation|1|||
129872850|NCT03138733|467491948|FG001|Overall Study|Protocol Violation|3|||
129872851|NCT03138733|467491947|FG000|Overall Study|Administrative or logistical reason|1|||
129872852|NCT03138733|467491948|FG001|Overall Study|Administrative or logistical reason|0|||
129872853|NCT03138733|467491947|FG000|Overall Study|The patient was transferred to another hospital|1|||
129872854|NCT03138733|467491948|FG001|Overall Study|The patient was transferred to another hospital|0|||
129872855|NCT04252742|467491956|FG000|Overall Study|Decision by sponsor|0|||
129872856|NCT04252742|467491957|FG001|Overall Study|Decision by sponsor|2|||
129872857|NCT04252742|467491956|FG000|Overall Study|Withdrawal by Subject|15|||
129872858|NCT04252742|467491957|FG001|Overall Study|Withdrawal by Subject|9|||
129872859|NCT04252742|467491956|FG000|Overall Study|Lost to Follow-up|0|||
129872860|NCT04252742|467491957|FG001|Overall Study|Lost to Follow-up|1|||
129872861|NCT04270747|467491960|FG000|Through Week 16|Adverse Event|1|||
129872862|NCT04270747|467491961|FG001|Through Week 16|Adverse Event|2|||
129872863|NCT04270747|467491962|FG002|Through Week 16|Adverse Event|0|||
129872864|NCT04270747|467491960|FG000|Through Week 16|Death|0|||
129872865|NCT04270747|467491961|FG001|Through Week 16|Death|2|||
129872866|NCT04270747|467491962|FG002|Through Week 16|Death|0|||
129872867|NCT04270747|467491960|FG000|Through Week 16|Consent Withdrawn|3|||
129872868|NCT04270747|467491961|FG001|Through Week 16|Consent Withdrawn|3|||
129872869|NCT04270747|467491962|FG002|Through Week 16|Consent Withdrawn|0|||
129872870|NCT04270747|467491960|FG000|Through Week 16|Physician Decision|1|||
129872871|NCT04270747|467491961|FG001|Through Week 16|Physician Decision|1|||
129872872|NCT04270747|467491962|FG002|Through Week 16|Physician Decision|0|||
129872873|NCT04270747|467491960|FG000|Through Week 16|Lost to Follow-up|2|||
129872874|NCT04270747|467491961|FG001|Through Week 16|Lost to Follow-up|0|||
129872875|NCT04270747|467491962|FG002|Through Week 16|Lost to Follow-up|0|||
129872876|NCT04270747|467491960|FG000|Through Week 16|Protocol Violation|1|||
129872877|NCT04270747|467491961|FG001|Through Week 16|Protocol Violation|2|||
129872878|NCT04270747|467491962|FG002|Through Week 16|Protocol Violation|0|||
129872879|NCT04270747|467491960|FG000|Through Week 16|Protocol Specified Criteria|6|||
129872880|NCT04270747|467491961|FG001|Through Week 16|Protocol Specified Criteria|7|||
129872881|NCT04270747|467491962|FG002|Through Week 16|Protocol Specified Criteria|0|||
129872882|NCT04270747|467491960|FG000|Through Week 16|Miscellaneous|1|||
129872883|NCT04270747|467491961|FG001|Through Week 16|Miscellaneous|1|||
129872884|NCT04270747|467491962|FG002|Through Week 16|Miscellaneous|0|||
129872885|NCT04270747|467491960|FG000|Post Week 16|Adverse Event|7|||
129872886|NCT04270747|467491961|FG001|Post Week 16|Adverse Event|5|||
129872887|NCT04270747|467491962|FG002|Post Week 16|Adverse Event|1|||
129872888|NCT04270747|467491960|FG000|Post Week 16|Death|2|||
129872889|NCT04270747|467491961|FG001|Post Week 16|Death|0|||
129872890|NCT04270747|467491962|FG002|Post Week 16|Death|2|||
129872891|NCT04270747|467491960|FG000|Post Week 16|Consent Withdrawn|4|||
129872892|NCT04270747|467491961|FG001|Post Week 16|Consent Withdrawn|3|||
129872893|NCT04270747|467491962|FG002|Post Week 16|Consent Withdrawn|6|||
129872894|NCT04270747|467491960|FG000|Post Week 16|Physician Decision|3|||
129872895|NCT04270747|467491961|FG001|Post Week 16|Physician Decision|1|||
129872896|NCT04270747|467491962|FG002|Post Week 16|Physician Decision|1|||
129919088|NCT03143153|467668787|FG001|Pre-Treatment|Disease Progression|1|||
129919089|NCT03143153|467668788|FG002|Pre-Treatment|Disease Progression|2|||
129919090|NCT03143153|467668786|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
129919091|NCT03143153|467668787|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
129919092|NCT03143153|467668788|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
129919093|NCT03143153|467668786|FG000|Treatment|Disease progression|174|||
129919094|NCT03143153|467668787|FG001|Treatment|Disease progression|184|||
129919095|NCT03143153|467668788|FG002|Treatment|Disease progression|193|||
129919096|NCT03143153|467668786|FG000|Treatment|Study drug toxicity|59|||
129919097|NCT03143153|467668787|FG001|Treatment|Study drug toxicity|33|||
129919098|NCT03143153|467668788|FG002|Treatment|Study drug toxicity|40|||
129919099|NCT03143153|467668786|FG000|Treatment|Death|5|||
129919100|NCT03143153|467668787|FG001|Treatment|Death|3|||
129919101|NCT03143153|467668788|FG002|Treatment|Death|4|||
129919102|NCT03143153|467668786|FG000|Treatment|Adverse event unrelated to study drug|19|||
129919103|NCT03143153|467668787|FG001|Treatment|Adverse event unrelated to study drug|28|||
129919104|NCT03143153|467668788|FG002|Treatment|Adverse event unrelated to study drug|12|||
129919105|NCT03143153|467668786|FG000|Treatment|Participant request to discontinue study treatment|13|||
129919106|NCT03143153|467668787|FG001|Treatment|Participant request to discontinue study treatment|15|||
129919107|NCT03143153|467668788|FG002|Treatment|Participant request to discontinue study treatment|20|||
129919108|NCT03143153|467668786|FG000|Treatment|Participant withdrew consent|3|||
129919109|NCT03143153|467668787|FG001|Treatment|Participant withdrew consent|4|||
129919110|NCT03143153|467668788|FG002|Treatment|Participant withdrew consent|12|||
129919111|NCT03143153|467668786|FG000|Treatment|Pregnancy|1|||
129919112|NCT03143153|467668787|FG001|Treatment|Pregnancy|0|||
129919113|NCT03143153|467668788|FG002|Treatment|Pregnancy|0|||
129919114|NCT03143153|467668786|FG000|Treatment|Maximum clinical benefit|1|||
129919115|NCT03143153|467668787|FG001|Treatment|Maximum clinical benefit|3|||
129919116|NCT03143153|467668788|FG002|Treatment|Maximum clinical benefit|4|||
129919117|NCT03143153|467668786|FG000|Treatment|Completed treatment as per Protocol|13|||
129919118|NCT03143153|467668787|FG001|Treatment|Completed treatment as per Protocol|8|||
129919119|NCT03143153|467668788|FG002|Treatment|Completed treatment as per Protocol|0|||
129919120|NCT03143153|467668786|FG000|Treatment|Other reasons|12|||
129919121|NCT03143153|467668787|FG001|Treatment|Other reasons|7|||
129919122|NCT03143153|467668788|FG002|Treatment|Other reasons|15|||
129919123|NCT03143153|467668786|FG000|Treatment|Not reported|1|||
129919124|NCT03143153|467668787|FG001|Treatment|Not reported|0|||
129919125|NCT03143153|467668788|FG002|Treatment|Not reported|0|||
129919126|NCT02312557|467668789|FG000|Overall Study|Survival follow-up|4|||
129919127|NCT04237298|467668790|FG000|Overall Study|Lost to Follow-up|4|||
129919128|NCT04237298|467668791|FG001|Overall Study|Lost to Follow-up|5|||
129919129|NCT02530671|467668792|FG000|Overall Study|Lost to Follow-up|2|||
129919130|NCT02530671|467668793|FG001|Overall Study|Lost to Follow-up|0|||
129919131|NCT02530671|467668792|FG000|Overall Study|Withdrawal by Subject|1|||
129919132|NCT02530671|467668793|FG001|Overall Study|Withdrawal by Subject|0|||
129919133|NCT02736409|467668794|FG000|Overall Study|Withdrawal by Subject|4|||
129919134|NCT02736409|467668795|FG001|Overall Study|Withdrawal by Subject|2|||
129919135|NCT02736409|467668796|FG002|Overall Study|Withdrawal by Subject|17|||
129919136|NCT02736409|467668797|FG003|Overall Study|Withdrawal by Subject|3|||
129919137|NCT02736409|467668794|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129919138|NCT02736409|467668795|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129919139|NCT02736409|467668796|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129919140|NCT02736409|467668797|FG003|Overall Study|Non-Compliance with Study Drug|1|||
129919141|NCT02736409|467668794|FG000|Overall Study|Adverse Event|0|||
129919142|NCT02736409|467668795|FG001|Overall Study|Adverse Event|1|||
129919143|NCT02736409|467668796|FG002|Overall Study|Adverse Event|5|||
129919144|NCT02736409|467668797|FG003|Overall Study|Adverse Event|4|||
129919145|NCT02736409|467668794|FG000|Overall Study|Other|0|||
129919146|NCT02736409|467668795|FG001|Overall Study|Other|0|||
129919147|NCT02736409|467668796|FG002|Overall Study|Other|1|||
129919148|NCT02736409|467668797|FG003|Overall Study|Other|1|||
129919149|NCT02736409|467668794|FG000|Overall Study|Pregnancy|0|||
129919150|NCT02736409|467668795|FG001|Overall Study|Pregnancy|0|||
129919151|NCT02736409|467668796|FG002|Overall Study|Pregnancy|1|||
129919152|NCT02736409|467668797|FG003|Overall Study|Pregnancy|0|||
129919153|NCT02736409|467668794|FG000|Overall Study|Lost to Follow-up|0|||
129919154|NCT02736409|467668795|FG001|Overall Study|Lost to Follow-up|0|||
129919155|NCT02736409|467668796|FG002|Overall Study|Lost to Follow-up|2|||
129919156|NCT02736409|467668797|FG003|Overall Study|Lost to Follow-up|1|||
129919157|NCT02736409|467668794|FG000|Overall Study|Physician Decision|0|||
129919158|NCT02736409|467668795|FG001|Overall Study|Physician Decision|0|||
129919159|NCT02736409|467668796|FG002|Overall Study|Physician Decision|0|||
129919160|NCT02736409|467668797|FG003|Overall Study|Physician Decision|2|||
129919161|NCT01415154|467668798|FG000|Overall Study|Lack of Efficacy|4|||
129919162|NCT01415154|467668799|FG001|Overall Study|Lack of Efficacy|5|||
129919163|NCT01415154|467668798|FG000|Overall Study|Withdrawal by Subject|7|||
129919164|NCT01415154|467668799|FG001|Overall Study|Withdrawal by Subject|8|||
129919165|NCT01415154|467668798|FG000|Overall Study|Lost to Follow-up|1|||
129919166|NCT01415154|467668799|FG001|Overall Study|Lost to Follow-up|4|||
129872897|NCT04270747|467491960|FG000|Post Week 16|Lost to Follow-up|2|||
129872898|NCT04270747|467491961|FG001|Post Week 16|Lost to Follow-up|1|||
129872899|NCT04270747|467491962|FG002|Post Week 16|Lost to Follow-up|0|||
129872900|NCT04270747|467491960|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
129872901|NCT04270747|467491961|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
129872902|NCT04270747|467491962|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
129872903|NCT04270747|467491960|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
129872904|NCT04270747|467491961|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
129872905|NCT04270747|467491962|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
129872906|NCT04270747|467491960|FG000|Post Week 16|Miscellaneous|1|||
129872907|NCT04270747|467491961|FG001|Post Week 16|Miscellaneous|0|||
129872908|NCT04270747|467491962|FG002|Post Week 16|Miscellaneous|1|||
129872909|NCT01784068|467491966|FG000|NTCS Phase|Adverse Event|5|||
129872910|NCT01784068|467491967|FG001|NTCS Phase|Adverse Event|0|||
129872911|NCT01784068|467491966|FG000|NTCS Phase|Physician Decision|2|||
129872912|NCT01784068|467491967|FG001|NTCS Phase|Physician Decision|0|||
129872913|NCT01784068|467491966|FG000|NTCS Phase|Patient/guardian decision|3|||
129872914|NCT01784068|467491967|FG001|NTCS Phase|Patient/guardian decision|0|||
129872915|NCT01784068|467491966|FG000|NTCS Phase|Death|2|||
129872916|NCT01784068|467491967|FG001|NTCS Phase|Death|0|||
129872917|NCT01784068|467491966|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
129872918|NCT01784068|467491967|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
129872919|NCT01784068|467491966|FG000|TFR Phase|Physician Decision|0|||
129872920|NCT01784068|467491967|FG001|TFR Phase|Physician Decision|1|||
129872921|NCT01784068|467491966|FG000|TFR Phase|Patient/guardian decision|0|||
129872922|NCT01784068|467491967|FG001|TFR Phase|Patient/guardian decision|3|||
129872923|NCT01784068|467491966|FG000|TFR Phase|Death|0|||
129872924|NCT01784068|467491967|FG001|TFR Phase|Death|1|||
129872925|NCT01784068|467491966|FG000|TFR Phase|Lack of Efficacy|0|||
129872926|NCT01784068|467491967|FG001|TFR Phase|Lack of Efficacy|88|||
129872927|NCT00946296|467491968|FG000|Overall Study|Physician Decision|3|||
129872928|NCT00946296|467491969|FG001|Overall Study|Physician Decision|0|||
129872929|NCT02068495|467491975|FG000|Overall Study|Case Report Forms Uncollected|60|||
129872930|NCT02068495|467491975|FG000|Overall Study|Protocol Deviation|49|||
129872931|NCT04992546|467491977|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
129872932|NCT04992546|467491977|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
129872933|NCT04992546|467491977|FG000|Open-Label Treatment Period|Adverse Event|3|||
129872934|NCT04992546|467491977|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
129872935|NCT02703922|467491978|FG000|Overall Study|Death|5|||
129872936|NCT02703922|467491979|FG001|Overall Study|Death|8|||
129872937|NCT02703922|467491978|FG000|Overall Study|Lost to Follow-up|10|||
129872938|NCT02703922|467491979|FG001|Overall Study|Lost to Follow-up|10|||
129872939|NCT00394355|467491981|FG000|Overall Study|Adverse Event|10|||
129872940|NCT00394355|467491982|FG001|Overall Study|Adverse Event|6|||
129872941|NCT00394355|467491983|FG002|Overall Study|Adverse Event|7|||
129872942|NCT00394355|467491984|FG003|Overall Study|Adverse Event|8|||
129872943|NCT00394355|467491981|FG000|Overall Study|Did not meet protocol eligibility|1|||
129872944|NCT00394355|467491982|FG001|Overall Study|Did not meet protocol eligibility|5|||
129872945|NCT00394355|467491983|FG002|Overall Study|Did not meet protocol eligibility|4|||
129872946|NCT00394355|467491984|FG003|Overall Study|Did not meet protocol eligibility|2|||
129872947|NCT00394355|467491981|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
129872948|NCT00394355|467491982|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
129872949|NCT00394355|467491983|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
129872950|NCT00394355|467491984|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
129872951|NCT00394355|467491981|FG000|Overall Study|Subject withdrawal - related to drug|1|||
129872952|NCT00394355|467491982|FG001|Overall Study|Subject withdrawal - related to drug|0|||
129872953|NCT00394355|467491983|FG002|Overall Study|Subject withdrawal - related to drug|0|||
129872954|NCT00394355|467491984|FG003|Overall Study|Subject withdrawal - related to drug|0|||
129872955|NCT00394355|467491981|FG000|Overall Study|Lost to Follow-up|7|||
129872956|NCT00394355|467491982|FG001|Overall Study|Lost to Follow-up|5|||
129872957|NCT00394355|467491983|FG002|Overall Study|Lost to Follow-up|4|||
129872958|NCT00394355|467491984|FG003|Overall Study|Lost to Follow-up|3|||
129872959|NCT00394355|467491981|FG000|Overall Study|Noncompliance with protocol|4|||
129872960|NCT00394355|467491982|FG001|Overall Study|Noncompliance with protocol|3|||
129872961|NCT00394355|467491983|FG002|Overall Study|Noncompliance with protocol|10|||
129872962|NCT00394355|467491984|FG003|Overall Study|Noncompliance with protocol|8|||
129872963|NCT00394355|467491981|FG000|Overall Study|Administrative|0|||
129872964|NCT00394355|467491982|FG001|Overall Study|Administrative|1|||
129872965|NCT00394355|467491983|FG002|Overall Study|Administrative|1|||
129872966|NCT00394355|467491984|FG003|Overall Study|Administrative|1|||
129872967|NCT00394355|467491981|FG000|Overall Study|Lack of Efficacy|0|||
129872968|NCT00394355|467491982|FG001|Overall Study|Lack of Efficacy|0|||
129872969|NCT00394355|467491983|FG002|Overall Study|Lack of Efficacy|2|||
129872970|NCT00394355|467491984|FG003|Overall Study|Lack of Efficacy|3|||
129872971|NCT02618616|467491985|FG000|Overall Study|Lack of Efficacy|4|||
129872972|NCT02618616|467491986|FG001|Overall Study|Lack of Efficacy|0|||
129872973|NCT02618616|467491985|FG000|Overall Study|Pregnancy|0|||
129872974|NCT02618616|467491986|FG001|Overall Study|Pregnancy|1|||
129872975|NCT02618616|467491985|FG000|Overall Study|Adverse Event|8|||
129872976|NCT02618616|467491986|FG001|Overall Study|Adverse Event|0|||
129872977|NCT02618616|467491985|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
129872978|NCT02618616|467491986|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
129872979|NCT02618616|467491985|FG000|Overall Study|Consent withdrawn by subject|8|||
129872980|NCT02618616|467491986|FG001|Overall Study|Consent withdrawn by subject|5|||
129872981|NCT02618616|467491985|FG000|Overall Study|Lost to Follow-up|0|||
129872982|NCT02618616|467491986|FG001|Overall Study|Lost to Follow-up|1|||
129872983|NCT04225988|467491989|FG000|Overall Study|Withdrawal by Subject|2|||
129872984|NCT04225988|467491990|FG001|Overall Study|Withdrawal by Subject|0|||
129872985|NCT03538951|467491995|FG000|Overall Study|Withdrawal by Subject|1|||
129872986|NCT03538951|467491996|FG001|Overall Study|Withdrawal by Subject|2|||
129919167|NCT01415154|467668798|FG000|Overall Study|Protocol Violation|0|||
129919168|NCT01415154|467668799|FG001|Overall Study|Protocol Violation|1|||
129919169|NCT01415154|467668798|FG000|Overall Study|Satisfactory Response|0|||
129919170|NCT01415154|467668799|FG001|Overall Study|Satisfactory Response|1|||
129919171|NCT01415154|467668798|FG000|Overall Study|Adverse Event|1|||
129919172|NCT01415154|467668799|FG001|Overall Study|Adverse Event|1|||
129919173|NCT05536440|467668818|FG000|Overall Study|Adverse Event|0|||
129919174|NCT05536440|467668819|FG001|Overall Study|Adverse Event|0|||
129919175|NCT05536440|467668820|FG002|Overall Study|Adverse Event|0|||
129919176|NCT05536440|467668821|FG003|Overall Study|Adverse Event|0|||
129919177|NCT05536440|467668822|FG004|Overall Study|Adverse Event|0|||
129919178|NCT05536440|467668823|FG005|Overall Study|Adverse Event|0|||
129919179|NCT05536440|467668824|FG006|Overall Study|Adverse Event|0|||
129919180|NCT05536440|467668825|FG007|Overall Study|Adverse Event|0|||
129919181|NCT05536440|467668826|FG008|Overall Study|Adverse Event|1|||
129919182|NCT06283173|467668827|FG000|Overall Study|Did not show for first visit|10|||
129919183|NCT06283173|467668827|FG000|Overall Study|Lost to Follow-up|12|||
129919184|NCT06283173|467668827|FG000|Overall Study|Physician Decision|7|||
129919185|NCT03436745|467668836|FG000|Overall Study|Ineligible|0|||
129919186|NCT03436745|467668837|FG001|Overall Study|Ineligible|0|||
129919187|NCT03436745|467668838|FG002|Overall Study|Ineligible|1|||
129919188|NCT03673111|467668842|FG000|Overall Study|Protocol Violation|0|||
129919189|NCT03673111|467668843|FG001|Overall Study|Protocol Violation|0|||
129919190|NCT03673111|467668844|FG002|Overall Study|Protocol Violation|0|||
129919191|NCT03673111|467668845|FG003|Overall Study|Protocol Violation|0|||
129919192|NCT03673111|467668846|FG004|Overall Study|Protocol Violation|0|||
129919193|NCT03673111|467668847|FG005|Overall Study|Protocol Violation|0|||
129919194|NCT03673111|467668848|FG006|Overall Study|Protocol Violation|0|||
129919195|NCT03673111|467668849|FG007|Overall Study|Protocol Violation|0|||
129919196|NCT03673111|467668850|FG008|Overall Study|Protocol Violation|0|||
129919197|NCT03673111|467668851|FG009|Overall Study|Protocol Violation|0|||
129919198|NCT03673111|467668852|FG010|Overall Study|Protocol Violation|1|||
129919199|NCT03673111|467668853|FG011|Overall Study|Protocol Violation|0|||
129919200|NCT03673111|467668854|FG012|Overall Study|Protocol Violation|0|||
129919201|NCT03673111|467668855|FG013|Overall Study|Protocol Violation|0|||
129919202|NCT03673111|467668842|FG000|Overall Study|Adverse Event|1|||
129919203|NCT03673111|467668843|FG001|Overall Study|Adverse Event|0|||
129919204|NCT03673111|467668844|FG002|Overall Study|Adverse Event|0|||
129919205|NCT03673111|467668845|FG003|Overall Study|Adverse Event|0|||
129919206|NCT03673111|467668846|FG004|Overall Study|Adverse Event|0|||
129919207|NCT03673111|467668847|FG005|Overall Study|Adverse Event|0|||
129919208|NCT03673111|467668848|FG006|Overall Study|Adverse Event|0|||
129919209|NCT03673111|467668849|FG007|Overall Study|Adverse Event|0|||
129919210|NCT03673111|467668850|FG008|Overall Study|Adverse Event|0|||
129919211|NCT03673111|467668851|FG009|Overall Study|Adverse Event|0|||
129919212|NCT03673111|467668852|FG010|Overall Study|Adverse Event|0|||
129919213|NCT03673111|467668853|FG011|Overall Study|Adverse Event|0|||
129919214|NCT03673111|467668854|FG012|Overall Study|Adverse Event|0|||
129919215|NCT03673111|467668855|FG013|Overall Study|Adverse Event|0|||
129919216|NCT04485039|467668858|FG000|TPOXX Only|Adverse Event|2|||
129919217|NCT04485039|467668858|FG000|TPOXX Only|Physician Decision|1|||
129919218|NCT04485039|467668858|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
129919219|NCT04485039|467668858|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
129919220|NCT04005716|467668862|FG000|Overall Study|Death|175|||
129919221|NCT04005716|467668863|FG001|Overall Study|Death|196|||
129919222|NCT04005716|467668862|FG000|Overall Study|Withdrawal by Subject|1|||
129919223|NCT04005716|467668863|FG001|Overall Study|Withdrawal by Subject|6|||
129919224|NCT04005716|467668862|FG000|Overall Study|Lost to Follow-up|2|||
129919225|NCT04005716|467668863|FG001|Overall Study|Lost to Follow-up|2|||
129919226|NCT04021602|467668864|FG000|Overall Study|Lost to Follow-up|3|||
129919227|NCT04021602|467668865|FG001|Overall Study|Lost to Follow-up|3|||
129919228|NCT04021602|467668866|FG002|Overall Study|Lost to Follow-up|1|||
129919229|NCT04021602|467668864|FG000|Overall Study|Adverse Event|1|||
129919230|NCT04021602|467668865|FG001|Overall Study|Adverse Event|0|||
129919231|NCT04021602|467668866|FG002|Overall Study|Adverse Event|1|||
129919232|NCT02120456|467668867|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919233|NCT02120456|467668868|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919234|NCT02120456|467668869|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919235|NCT02120456|467668870|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919236|NCT02120456|467668871|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919237|NCT02120456|467668872|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919238|NCT02120456|467668873|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
129919239|NCT02120456|467668874|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919240|NCT02120456|467668875|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
129919241|NCT02120456|467668867|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919242|NCT02120456|467668868|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919243|NCT02120456|467668869|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919244|NCT02120456|467668870|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919245|NCT02120456|467668871|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919246|NCT02120456|467668872|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919247|NCT02120456|467668873|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
129919248|NCT02120456|467668874|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919249|NCT02120456|467668875|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
129919250|NCT02120456|467668867|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919251|NCT02120456|467668868|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919252|NCT02120456|467668869|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919253|NCT02120456|467668870|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919254|NCT02120456|467668871|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919255|NCT02120456|467668872|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919256|NCT02120456|467668873|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919257|NCT02120456|467668874|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
129919258|NCT02120456|467668875|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
129919259|NCT04347161|467668878|FG000|Overall Study|Death|0|||
129919260|NCT04347161|467668879|FG001|Overall Study|Death|2|||
129919261|NCT04347161|467668878|FG000|Overall Study|Withdrawal by Subject|1|||
129919262|NCT04347161|467668879|FG001|Overall Study|Withdrawal by Subject|0|||
129919263|NCT04347161|467668878|FG000|Overall Study|Lost to Follow-up|0|||
129919264|NCT04347161|467668879|FG001|Overall Study|Lost to Follow-up|1|||
129919265|NCT04347161|467668878|FG000|Overall Study|No longer on study medication|1|||
129919266|NCT04347161|467668879|FG001|Overall Study|No longer on study medication|1|||
129919267|NCT04169373|467668880|FG000|Week 1 to Week 14|Adverse Event|1|||
129919268|NCT04169373|467668881|FG001|Week 1 to Week 14|Adverse Event|0|||
129919269|NCT04169373|467668882|FG002|Week 1 to Week 14|Adverse Event|1|||
129919270|NCT04169373|467668883|FG003|Week 1 to Week 14|Adverse Event|2|||
129919271|NCT04169373|467668880|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
129919272|NCT04169373|467668881|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
129919273|NCT04169373|467668882|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
129919274|NCT04169373|467668883|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
129919275|NCT04169373|467668880|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
129919276|NCT04169373|467668881|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
129919277|NCT04169373|467668882|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
129919278|NCT04169373|467668883|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
129919279|NCT04169373|467668880|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
129919280|NCT04169373|467668881|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
129919281|NCT04169373|467668882|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
129919282|NCT04169373|467668883|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
129919283|NCT04169373|467668880|FG000|Week 1 to Week 14|Other|1|||
129919284|NCT04169373|467668881|FG001|Week 1 to Week 14|Other|3|||
129919285|NCT04169373|467668882|FG002|Week 1 to Week 14|Other|3|||
129919286|NCT04169373|467668883|FG003|Week 1 to Week 14|Other|5|||
129919287|NCT04169373|467668880|FG000|Week 14 to Week 52|Adverse Event|1|||
129919288|NCT04169373|467668881|FG001|Week 14 to Week 52|Adverse Event|0|||
129919289|NCT04169373|467668882|FG002|Week 14 to Week 52|Adverse Event|0|||
129919290|NCT04169373|467668883|FG003|Week 14 to Week 52|Adverse Event|1|||
129919291|NCT04169373|467668880|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
129919292|NCT04169373|467668881|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
129919293|NCT04169373|467668882|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
129919294|NCT04169373|467668883|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
129919295|NCT04169373|467668880|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
129919296|NCT04169373|467668881|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
129919297|NCT04169373|467668882|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
129919298|NCT04169373|467668883|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
129919299|NCT04169373|467668880|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
129919300|NCT04169373|467668881|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
129919301|NCT04169373|467668882|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
129919302|NCT04169373|467668883|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
129919303|NCT04169373|467668880|FG000|Week 14 to Week 52|Other|4|||
129919304|NCT04169373|467668881|FG001|Week 14 to Week 52|Other|5|||
129919305|NCT04169373|467668882|FG002|Week 14 to Week 52|Other|4|||
129919306|NCT04169373|467668883|FG003|Week 14 to Week 52|Other|5|||
129919307|NCT04169373|467668880|FG000|Week 14 to Week 52|Ongoing|0|||
129919308|NCT04169373|467668881|FG001|Week 14 to Week 52|Ongoing|1|||
129919309|NCT04169373|467668882|FG002|Week 14 to Week 52|Ongoing|0|||
129919310|NCT04169373|467668883|FG003|Week 14 to Week 52|Ongoing|0|||
129919311|NCT03135548|467668885|FG000|Overall Study|Lost to Follow-up|3|||
129919312|NCT03135548|467668886|FG001|Overall Study|Lost to Follow-up|0|||
129919313|NCT03135548|467668887|FG002|Overall Study|Lost to Follow-up|0|||
129919314|NCT03135548|467668885|FG000|Overall Study|Withdrawal by Subject|2|||
129919315|NCT03135548|467668886|FG001|Overall Study|Withdrawal by Subject|2|||
129919316|NCT03135548|467668887|FG002|Overall Study|Withdrawal by Subject|1|||
129919317|NCT03135548|467668885|FG000|Overall Study|Other than listed|0|||
129919318|NCT03135548|467668886|FG001|Overall Study|Other than listed|2|||
129919319|NCT03135548|467668887|FG002|Overall Study|Other than listed|2|||
129919320|NCT03445988|467668893|FG000|Overall Study|Lost to Follow-up|14|||
129919321|NCT03445988|467668894|FG001|Overall Study|Lost to Follow-up|26|||
129919322|NCT03445988|467668895|FG002|Overall Study|Lost to Follow-up|27|||
129919323|NCT03445988|467668896|FG003|Overall Study|Lost to Follow-up|66|||
129919324|NCT03445988|467668893|FG000|Overall Study|Withdrawal by Subject|7|||
129919325|NCT03445988|467668894|FG001|Overall Study|Withdrawal by Subject|4|||
129919326|NCT03445988|467668895|FG002|Overall Study|Withdrawal by Subject|3|||
129919327|NCT03445988|467668896|FG003|Overall Study|Withdrawal by Subject|5|||
129919328|NCT03445988|467668893|FG000|Overall Study|Death (unrelated to study)|5|||
129919329|NCT03445988|467668894|FG001|Overall Study|Death (unrelated to study)|1|||
129919330|NCT03445988|467668895|FG002|Overall Study|Death (unrelated to study)|2|||
129919331|NCT03445988|467668896|FG003|Overall Study|Death (unrelated to study)|4|||
129919332|NCT03988608|467668897|FG000|Overall Study|Adverse Event|1|||
129919333|NCT03988608|467668897|FG000|Overall Study|Lost to Follow-up|1|||
129919334|NCT03988608|467668897|FG000|Overall Study|Withdrawal by Subject|3|||
129919335|NCT03988608|467668897|FG000|Overall Study|Death|1|||
129919336|NCT02689284|467668904|FG000|Overall Study|Adverse Event|1|||
129919337|NCT02689284|467668905|FG001|Overall Study|Adverse Event|8|||
129919338|NCT02689284|467668904|FG000|Overall Study|Death|0|||
129919339|NCT02689284|467668905|FG001|Overall Study|Death|1|||
129919340|NCT02689284|467668904|FG000|Overall Study|Physician Decision|1|||
129919341|NCT02689284|467668905|FG001|Overall Study|Physician Decision|2|||
129919342|NCT02689284|467668904|FG000|Overall Study|Withdrawal by Subject|0|||
129919343|NCT02689284|467668905|FG001|Overall Study|Withdrawal by Subject|1|||
129919344|NCT02689284|467668904|FG000|Overall Study|progression of cancer|1|||
129919345|NCT02689284|467668905|FG001|Overall Study|progression of cancer|72|||
129919346|NCT02689284|467668904|FG000|Overall Study|decreased heart function|0|||
129919347|NCT02689284|467668905|FG001|Overall Study|decreased heart function|1|||
129919348|NCT02689284|467668904|FG000|Overall Study|concern for anemia|0|||
129919349|NCT02689284|467668905|FG001|Overall Study|concern for anemia|1|||
129919350|NCT02689284|467668904|FG000|Overall Study|no measurable cancer for evaluation|0|||
129919351|NCT02689284|467668905|FG001|Overall Study|no measurable cancer for evaluation|1|||
129919352|NCT03519581|467668908|FG000|Overall Study|Lost to Follow-up|3|||
129919353|NCT03519581|467668909|FG001|Overall Study|Lost to Follow-up|2|||
129919354|NCT03519581|467668908|FG000|Overall Study|Adverse Event|5|||
129919355|NCT03519581|467668909|FG001|Overall Study|Adverse Event|2|||
129919356|NCT03519581|467668908|FG000|Overall Study|Withdrawal by Subject|2|||
129919357|NCT03519581|467668909|FG001|Overall Study|Withdrawal by Subject|0|||
129919358|NCT03519581|467668908|FG000|Overall Study|Change to insurance|2|||
129919359|NCT03519581|467668909|FG001|Overall Study|Change to insurance|1|||
129919360|NCT03519581|467668908|FG000|Overall Study|Other|2|||
129919361|NCT03519581|467668909|FG001|Overall Study|Other|4|||
129919362|NCT01494662|467668911|FG000|Overall Study|Withdrawal by Subject|0|||
129919363|NCT01494662|467668912|FG001|Overall Study|Withdrawal by Subject|0|||
129919364|NCT01494662|467668913|FG002|Overall Study|Withdrawal by Subject|1|||
129919365|NCT01494662|467668914|FG003|Overall Study|Withdrawal by Subject|0|||
129919366|NCT01494662|467668915|FG004|Overall Study|Withdrawal by Subject|0|||
129919367|NCT01494662|467668916|FG005|Overall Study|Withdrawal by Subject|0|||
129919368|NCT01494662|467668917|FG006|Overall Study|Withdrawal by Subject|0|||
129919369|NCT01494662|467668911|FG000|Overall Study|Physician Decision|0|||
129919370|NCT01494662|467668912|FG001|Overall Study|Physician Decision|0|||
129919371|NCT01494662|467668913|FG002|Overall Study|Physician Decision|1|||
129919372|NCT01494662|467668914|FG003|Overall Study|Physician Decision|0|||
129919373|NCT01494662|467668915|FG004|Overall Study|Physician Decision|0|||
129919374|NCT01494662|467668916|FG005|Overall Study|Physician Decision|0|||
129919375|NCT01494662|467668917|FG006|Overall Study|Physician Decision|0|||
129919376|NCT05311384|467668918|FG000|Overall Study|Uncontrolled health conditions|2|||
129919377|NCT05311384|467668918|FG000|Overall Study|Withdrawal by Subject|1|||
129919378|NCT02724631|467668921|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
129919379|NCT04060355|467670278|FG000|Overall Study|Lost to Follow-up|41|||
129919380|NCT01140880|467670279|FG000|Overall Study|Death|0|||
129919381|NCT01140880|467670280|FG001|Overall Study|Death|1|||
129919382|NCT01140880|467670279|FG000|Overall Study|Withdrawal by Subject|6|||
129919383|NCT01140880|467670280|FG001|Overall Study|Withdrawal by Subject|3|||
129919384|NCT01140880|467670279|FG000|Overall Study|Lost to Follow-up|8|||
129919385|NCT01140880|467670280|FG001|Overall Study|Lost to Follow-up|10|||
129919386|NCT01140880|467670279|FG000|Overall Study|Protocol Violation|0|||
129919387|NCT01140880|467670280|FG001|Overall Study|Protocol Violation|30|||
129919388|NCT02992925|467670286|FG000|Cohort 2|Physician Decision|0|||
129919389|NCT02992925|467670287|FG001|Cohort 2|Physician Decision|0|||
129919390|NCT02992925|467670288|FG002|Cohort 2|Physician Decision|1|||
129919391|NCT02992925|467670289|FG003|Cohort 2|Physician Decision|0|||
129919392|NCT02992925|467670286|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
129919393|NCT02992925|467670287|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
129919394|NCT02992925|467670288|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
129919395|NCT02992925|467670289|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
129919396|NCT03779204|467670290|FG000|Overall Study|Lost to Follow-up|2|||
129919397|NCT03779204|467670291|FG001|Overall Study|Lost to Follow-up|0|||
129919398|NCT04150718|467670292|FG000|Overall Study|Withdrawal by Subject|2|||
129919399|NCT04150718|467670293|FG001|Overall Study|Withdrawal by Subject|7|||
129919400|NCT04150718|467670294|FG002|Overall Study|Withdrawal by Subject|1|||
129919401|NCT04150718|467670292|FG000|Overall Study|Lost to Follow-up|1|||
129919402|NCT04150718|467670293|FG001|Overall Study|Lost to Follow-up|2|||
129919403|NCT04150718|467670294|FG002|Overall Study|Lost to Follow-up|0|||
129919404|NCT04150718|467670292|FG000|Overall Study|Ineligible|1|||
129919405|NCT04150718|467670293|FG001|Overall Study|Ineligible|0|||
129919406|NCT04150718|467670294|FG002|Overall Study|Ineligible|10|||
129919407|NCT05633953|467670295|FG000|Overall Study|Adverse Event|7|||
129919408|NCT05633953|467670295|FG000|Overall Study|Death|30|||
129919409|NCT05633953|467670295|FG000|Overall Study|Lost to Follow-up|1|||
129919410|NCT05633953|467670295|FG000|Overall Study|Osilodrostat discontinued|4|||
129919411|NCT05633953|467670295|FG000|Overall Study|Physician Decision|1|||
129919412|NCT05633953|467670295|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
129919413|NCT05633953|467670295|FG000|Overall Study|Progressive disease|2|||
129919414|NCT04034251|467670296|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
129919415|NCT04034251|467670297|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
129919416|NCT04034251|467670298|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
129919417|NCT04783935|467670311|FG000|Overall Study|Withdrawal by Subject|6|||
129919418|NCT04783935|467670311|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
129919419|NCT04783935|467670311|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
129919420|NCT04783935|467670311|FG000|Overall Study|Lost to Follow-up|3|||
129919421|NCT04783935|467670311|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
129919422|NCT05273749|467670315|FG000|Overall Study|Adverse Event|14|||
129919423|NCT05273749|467670316|FG001|Overall Study|Adverse Event|8|||
129919424|NCT05273749|467670315|FG000|Overall Study|Lack of Efficacy|2|||
129919425|NCT05273749|467670316|FG001|Overall Study|Lack of Efficacy|8|||
129919426|NCT05273749|467670315|FG000|Overall Study|Physician Decision|0|||
129919427|NCT05273749|467670316|FG001|Overall Study|Physician Decision|2|||
129919428|NCT05273749|467670315|FG000|Overall Study|Withdrawal by Subject|14|||
129919429|NCT05273749|467670316|FG001|Overall Study|Withdrawal by Subject|16|||
129919430|NCT05273749|467670315|FG000|Overall Study|Lost to Follow-up|10|||
129919431|NCT05273749|467670316|FG001|Overall Study|Lost to Follow-up|10|||
129919432|NCT05273749|467670315|FG000|Overall Study|Pregnancy|1|||
129919433|NCT05273749|467670316|FG001|Overall Study|Pregnancy|0|||
129919434|NCT05273749|467670315|FG000|Overall Study|Non-Compliance|3|||
129919435|NCT05273749|467670316|FG001|Overall Study|Non-Compliance|2|||
129919436|NCT05273749|467670315|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
129919437|NCT05273749|467670316|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
129919438|NCT04956861|467670321|FG000|Overall Study|Withdrawal by Subject|4|||
129919439|NCT04956861|467670322|FG001|Overall Study|Withdrawal by Subject|4|||
129919440|NCT04956861|467670323|FG002|Overall Study|Withdrawal by Subject|2|||
129919441|NCT04956861|467670321|FG000|Overall Study|Physician Decision|4|||
129919442|NCT04956861|467670322|FG001|Overall Study|Physician Decision|5|||
129919443|NCT04956861|467670323|FG002|Overall Study|Physician Decision|1|||
129919444|NCT05337748|467670327|FG000|Overall Study|Withdrawal by Subject|1|||
129919445|NCT05337748|467670328|FG001|Overall Study|Withdrawal by Subject|0|||
129919446|NCT05337748|467670327|FG000|Overall Study|Death|1|||
129919447|NCT05337748|467670328|FG001|Overall Study|Death|0|||
129919448|NCT04806594|467670329|FG000|Overall Study|Withdrawal by Subject|2|||
129919449|NCT04806594|467670329|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
129919450|NCT02543281|467670332|FG000|Overall Study|Lost to Follow-up|0|||
129919451|NCT02543281|467670333|FG001|Overall Study|Lost to Follow-up|0|||
129919452|NCT02543281|467670334|FG002|Overall Study|Lost to Follow-up|1|||
129919453|NCT05563246|467670335|FG000|Overall Study|Withdrawal by Subject|1|||
129919454|NCT05563246|467670336|FG001|Overall Study|Withdrawal by Subject|2|||
129919455|NCT05563246|467670337|FG002|Overall Study|Withdrawal by Subject|0|||
129919456|NCT05563246|467670338|FG003|Overall Study|Withdrawal by Subject|0|||
129919457|NCT05563246|467670335|FG000|Overall Study|Protocol Deviation|0|||
129919458|NCT05563246|467670336|FG001|Overall Study|Protocol Deviation|1|||
129919459|NCT05563246|467670337|FG002|Overall Study|Protocol Deviation|0|||
129919460|NCT05563246|467670338|FG003|Overall Study|Protocol Deviation|0|||
129919461|NCT05563246|467670335|FG000|Overall Study|Physician Decision|0|||
129919462|NCT05563246|467670336|FG001|Overall Study|Physician Decision|1|||
129919463|NCT05563246|467670337|FG002|Overall Study|Physician Decision|0|||
129919464|NCT05563246|467670338|FG003|Overall Study|Physician Decision|0|||
129919465|NCT05563246|467670335|FG000|Overall Study|Adverse Event|0|||
129919466|NCT05563246|467670336|FG001|Overall Study|Adverse Event|0|||
129919467|NCT05563246|467670337|FG002|Overall Study|Adverse Event|2|||
129919468|NCT05563246|467670338|FG003|Overall Study|Adverse Event|0|||
129919469|NCT05563246|467670335|FG000|Overall Study|Lost to Follow-up|0|||
129919470|NCT05563246|467670336|FG001|Overall Study|Lost to Follow-up|0|||
129919471|NCT05563246|467670337|FG002|Overall Study|Lost to Follow-up|1|||
129919472|NCT05563246|467670338|FG003|Overall Study|Lost to Follow-up|0|||
129919473|NCT01416831|467670340|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
129919474|NCT01416831|467670341|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
129919475|NCT05215314|467670342|FG000|Overall Study|Lost to Follow-up|2|||
129919476|NCT05215314|467670343|FG001|Overall Study|Lost to Follow-up|2|||
129919477|NCT05215314|467670342|FG000|Overall Study|Withdrawal by Subject|2|||
129919478|NCT05215314|467670343|FG001|Overall Study|Withdrawal by Subject|0|||
129919479|NCT05215314|467670342|FG000|Overall Study|Physician Decision|1|||
129919480|NCT05215314|467670343|FG001|Overall Study|Physician Decision|0|||
129919481|NCT04784559|467670344|FG000|Overall Study|Withdrawal by Subject|3|||
129919482|NCT04784559|467670345|FG001|Overall Study|Withdrawal by Subject|2|||
129919483|NCT04784559|467670346|FG002|Overall Study|Withdrawal by Subject|1|||
129919484|NCT04784559|467670344|FG000|Overall Study|Death|2|||
129919485|NCT04784559|467670345|FG001|Overall Study|Death|1|||
129919486|NCT04784559|467670346|FG002|Overall Study|Death|2|||
129919487|NCT04784559|467670344|FG000|Overall Study|Lost to Follow-up|0|||
129919488|NCT04784559|467670345|FG001|Overall Study|Lost to Follow-up|0|||
129919489|NCT04784559|467670346|FG002|Overall Study|Lost to Follow-up|2|||
129919490|NCT04784559|467670344|FG000|Overall Study|Participant worsened, PI decision|1|||
129919491|NCT04784559|467670345|FG001|Overall Study|Participant worsened, PI decision|0|||
129919492|NCT04784559|467670346|FG002|Overall Study|Participant worsened, PI decision|0|||
129919493|NCT04784559|467670344|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
129919494|NCT04784559|467670345|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
129919495|NCT04784559|467670346|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
129919496|NCT04784559|467670344|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
129919497|NCT04784559|467670345|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
129919498|NCT04784559|467670346|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
129919499|NCT04784559|467670344|FG000|Overall Study|Did not meet all inclusion criteria|0|||
129919500|NCT04784559|467670345|FG001|Overall Study|Did not meet all inclusion criteria|1|||
129919501|NCT04784559|467670346|FG002|Overall Study|Did not meet all inclusion criteria|0|||
129919502|NCT04784559|467670344|FG000|Overall Study|The participant was transferred to IRCU|0|||
129919503|NCT04784559|467670345|FG001|Overall Study|The participant was transferred to IRCU|1|||
129919504|NCT04784559|467670346|FG002|Overall Study|The participant was transferred to IRCU|0|||
129919505|NCT04784559|467670344|FG000|Overall Study|SAE|0|||
129919506|NCT04784559|467670345|FG001|Overall Study|SAE|1|||
129919507|NCT04784559|467670346|FG002|Overall Study|SAE|0|||
129919508|NCT04784559|467670344|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
129919509|NCT04784559|467670345|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
129919510|NCT04784559|467670346|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
129919511|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
129919512|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
129919513|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
129919514|NCT04294225|467670349|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
129919515|NCT04294225|467670349|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
129919516|NCT04812535|467670351|FG000|Overall Study|Withdrawal by Subject|0|||
129919517|NCT04812535|467670352|FG001|Overall Study|Withdrawal by Subject|0|||
129919518|NCT04812535|467670353|FG002|Overall Study|Withdrawal by Subject|0|||
129919519|NCT04812535|467670354|FG003|Overall Study|Withdrawal by Subject|1|||
129919520|NCT04812535|467670351|FG000|Overall Study|Death|7|||
129919521|NCT04812535|467670352|FG001|Overall Study|Death|2|||
129919522|NCT04812535|467670353|FG002|Overall Study|Death|4|||
129919523|NCT04812535|467670354|FG003|Overall Study|Death|1|||
129919524|NCT04812535|467670351|FG000|Overall Study|Due to premature study termination by sponsor|2|||
129919525|NCT04812535|467670352|FG001|Overall Study|Due to premature study termination by sponsor|0|||
129919526|NCT04812535|467670353|FG002|Overall Study|Due to premature study termination by sponsor|1|||
129919527|NCT04812535|467670354|FG003|Overall Study|Due to premature study termination by sponsor|3|||
129919528|NCT03336333|467670355|FG000|Overall Study|Remained on study at time of data cut-off|202|||
129919529|NCT03336333|467670356|FG001|Overall Study|Remained on study at time of data cut-off|219|||
129919530|NCT03336333|467670357|FG002|Overall Study|Remained on study at time of data cut-off|102|||
129919531|NCT03336333|467670355|FG000|Overall Study|Death|14|||
129919532|NCT03336333|467670356|FG001|Overall Study|Death|16|||
129919533|NCT03336333|467670357|FG002|Overall Study|Death|8|||
129919534|NCT03336333|467670355|FG000|Overall Study|Withdrawal by Subject|16|||
129919535|NCT03336333|467670356|FG001|Overall Study|Withdrawal by Subject|5|||
129919536|NCT03336333|467670357|FG002|Overall Study|Withdrawal by Subject|1|||
129919537|NCT03336333|467670355|FG000|Overall Study|Physician Decision|5|||
129919538|NCT03336333|467670356|FG001|Overall Study|Physician Decision|1|||
129919539|NCT03336333|467670357|FG002|Overall Study|Physician Decision|0|||
129919540|NCT03336333|467670355|FG000|Overall Study|Lost to Follow-up|1|||
129919541|NCT03336333|467670356|FG001|Overall Study|Lost to Follow-up|0|||
129919542|NCT03336333|467670357|FG002|Overall Study|Lost to Follow-up|0|||
129919543|NCT03792555|467670364|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
129919544|NCT03792555|467670365|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
129919545|NCT03792555|467670366|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
129919546|NCT03792555|467670364|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
129919547|NCT03792555|467670365|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
129919548|NCT03792555|467670366|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
129919549|NCT03792555|467670364|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
129919550|NCT03792555|467670365|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
129919551|NCT03792555|467670366|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
129919552|NCT03623321|467670367|FG000|Overall Study|Adverse Event|32|||
129919553|NCT03623321|467670367|FG000|Overall Study|Death|9|||
129919554|NCT03623321|467670367|FG000|Overall Study|Lack of Efficacy|9|||
129919555|NCT03623321|467670367|FG000|Overall Study|Lost to Follow-up|6|||
129919556|NCT03623321|467670367|FG000|Overall Study|Noncompliance with study drug|6|||
129919557|NCT03623321|467670367|FG000|Overall Study|Use of prohibited medication|3|||
129919558|NCT03623321|467670367|FG000|Overall Study|Physician Decision|5|||
129919559|NCT03623321|467670367|FG000|Overall Study|Protocol Violation|1|||
129919560|NCT03623321|467670367|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
129919561|NCT03623321|467670367|FG000|Overall Study|Not further specified|43|||
129919562|NCT02243709|467670369|FG000|Phase 1|Lost to Follow-up|0|||
129919563|NCT02243709|467670370|FG001|Phase 1|Lost to Follow-up|1|||
129919564|NCT02243709|467670369|FG000|Phase 1|Withdrawal by Subject|1|||
129919565|NCT02243709|467670370|FG001|Phase 1|Withdrawal by Subject|0|||
129919566|NCT02243709|467670369|FG000|Phase 1|Protocol Violation|0|||
129919567|NCT02243709|467670370|FG001|Phase 1|Protocol Violation|1|||
129919568|NCT02243709|467670369|FG000|Phase 1|Adverse Event|0|||
129919569|NCT02243709|467670370|FG001|Phase 1|Adverse Event|1|||
129919570|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Physician Decision|1|||
129919571|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Physician Decision|0|||
129919572|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
129919573|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
129919574|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
129919575|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
129919576|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Pregnancy|0|||
129919577|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Pregnancy|2|||
129919578|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
129919579|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
129919580|NCT01785719|467670373|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
129919581|NCT01785719|467670374|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
129919582|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
129919583|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
129919584|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
129919585|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
129919586|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
129919587|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
129919588|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
129919589|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
129919590|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
129919591|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
129919592|NCT01785719|467670373|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
129919593|NCT01785719|467670374|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
129919594|NCT01785719|467670373|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
129919595|NCT01785719|467670374|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
129919596|NCT01785719|467670373|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
129919597|NCT01785719|467670374|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
129919598|NCT01785719|467670373|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
129919599|NCT01785719|467670374|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
129919600|NCT03443323|467670375|FG000|Overall Study|Lost to Follow-up|2|||
129919601|NCT03443323|467670376|FG001|Overall Study|Lost to Follow-up|2|||
129919602|NCT03443323|467670375|FG000|Overall Study|PI withdrawal|1|||
129919603|NCT03443323|467670376|FG001|Overall Study|PI withdrawal|0|||
129919604|NCT04610892|467670378|FG000|Overall Study|Adverse Event|1|||
129919605|NCT04610892|467670379|FG001|Overall Study|Adverse Event|0|||
129919606|NCT04610892|467670380|FG002|Overall Study|Adverse Event|0|||
129919607|NCT04610892|467670381|FG003|Overall Study|Adverse Event|1|||
129919608|NCT04610892|467670382|FG004|Overall Study|Adverse Event|3|||
129919609|NCT04610892|467670378|FG000|Overall Study|Death|0|||
129919610|NCT04610892|467670379|FG001|Overall Study|Death|1|||
129919611|NCT04610892|467670380|FG002|Overall Study|Death|0|||
129919612|NCT04610892|467670381|FG003|Overall Study|Death|1|||
129919613|NCT04610892|467670382|FG004|Overall Study|Death|0|||
129919614|NCT04610892|467670378|FG000|Overall Study|Withdrawal by Subject|3|||
129919615|NCT04610892|467670379|FG001|Overall Study|Withdrawal by Subject|2|||
129919616|NCT04610892|467670380|FG002|Overall Study|Withdrawal by Subject|0|||
129919617|NCT04610892|467670381|FG003|Overall Study|Withdrawal by Subject|6|||
129919618|NCT04610892|467670382|FG004|Overall Study|Withdrawal by Subject|6|||
129919619|NCT04610892|467670378|FG000|Overall Study|Subjects who did not receive treatment|1|||
129919620|NCT04610892|467670379|FG001|Overall Study|Subjects who did not receive treatment|0|||
129919621|NCT04610892|467670380|FG002|Overall Study|Subjects who did not receive treatment|0|||
129919622|NCT04610892|467670381|FG003|Overall Study|Subjects who did not receive treatment|0|||
129919623|NCT04610892|467670382|FG004|Overall Study|Subjects who did not receive treatment|2|||
129919624|NCT05520190|467670383|FG000|Overall Study|Lost to Follow-up|7|||
129919625|NCT05520190|467670383|FG000|Overall Study|Withdrawal by Subject|2|||
129919626|NCT01999075|467670384|FG000|Overall Study|Lost to Follow-up|0|||
129919627|NCT01999075|467670385|FG001|Overall Study|Lost to Follow-up|2|||
129919628|NCT01999075|467670384|FG000|Overall Study|Withdrawal by Subject|2|||
129919629|NCT01999075|467670385|FG001|Overall Study|Withdrawal by Subject|7|||
129919630|NCT01999075|467670384|FG000|Overall Study|Enrolled in drug trial|3|||
129919631|NCT01999075|467670385|FG001|Overall Study|Enrolled in drug trial|1|||
129919632|NCT01999075|467670384|FG000|Overall Study|Became ineligible|0|||
129919633|NCT01999075|467670385|FG001|Overall Study|Became ineligible|2|||
129919634|NCT03056040|467670391|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
129919635|NCT03056040|467670392|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
129919636|NCT03056040|467670391|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
129919637|NCT03056040|467670392|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
129919638|NCT03056040|467670391|FG000|Primary Evaluation Period|Pregnancy|0|||
129919639|NCT03056040|467670392|FG001|Primary Evaluation Period|Pregnancy|1|||
129919640|NCT03056040|467670391|FG000|Primary Evaluation Period|Randomized, not treated|1|||
129919641|NCT03056040|467670392|FG001|Primary Evaluation Period|Randomized, not treated|1|||
129919642|NCT03056040|467670391|FG000|Extension Period|Physician Decision|3|||
129919643|NCT03056040|467670392|FG001|Extension Period|Physician Decision|3|||
129919644|NCT03056040|467670391|FG000|Extension Period|Lost to Follow-up|0|||
129919645|NCT03056040|467670392|FG001|Extension Period|Lost to Follow-up|1|||
129919646|NCT03056040|467670391|FG000|Extension Period|Death|0|||
129919647|NCT03056040|467670392|FG001|Extension Period|Death|3|||
129919648|NCT03056040|467670391|FG000|Extension Period|Withdrawal by Subject|1|||
129919649|NCT03056040|467670392|FG001|Extension Period|Withdrawal by Subject|0|||
129919650|NCT05268393|467670396|FG000|Overall Study|Withdrawal by Subject|2|||
129919651|NCT05268393|467670397|FG001|Overall Study|Withdrawal by Subject|1|||
129919652|NCT04410042|467670401|FG000|Overall Study|Not Eligible|1|||
129919653|NCT04410042|467670402|FG001|Overall Study|Not Eligible|1|||
129919654|NCT03720795|467670405|FG000|Phase 1|Lost to Follow-up|4|||
129919655|NCT03720795|467670405|FG000|Phase 1|Withdrawal by Subject|6|||
129919656|NCT03720795|467670405|FG000|Phase 1|Protocol Violation|1|||
129919657|NCT03720795|467670405|FG000|Phase 1|Other|1|||
129919658|NCT03720795|467670405|FG000|Phase 2|Lost to Follow-up|5|||
129919659|NCT03720795|467670405|FG000|Phase 2|Withdrawal by Subject|10|||
129919660|NCT03720795|467670405|FG000|Phase 2|Protocol Violation|2|||
129919661|NCT03720795|467670405|FG000|3 Month Follow Up|Lost to Follow-up|2|||
129919662|NCT03302494|467670406|FG000|Overall Study|Other|7|||
129919663|NCT03302494|467670407|FG001|Overall Study|Other|4|||
129919664|NCT03302494|467670408|FG002|Overall Study|Other|6|||
129919665|NCT03302494|467670406|FG000|Overall Study|Withdrawal by Subject|10|||
129919666|NCT03302494|467670407|FG001|Overall Study|Withdrawal by Subject|2|||
129919667|NCT03302494|467670408|FG002|Overall Study|Withdrawal by Subject|9|||
129919668|NCT03302494|467670406|FG000|Overall Study|Study Terminated by Sponsor|32|||
129919669|NCT03302494|467670407|FG001|Overall Study|Study Terminated by Sponsor|29|||
129919670|NCT03302494|467670408|FG002|Overall Study|Study Terminated by Sponsor|30|||
129919671|NCT03302494|467670406|FG000|Overall Study|Physician Decision|1|||
129919672|NCT03302494|467670407|FG001|Overall Study|Physician Decision|0|||
129919673|NCT03302494|467670408|FG002|Overall Study|Physician Decision|1|||
129919674|NCT03302494|467670406|FG000|Overall Study|Lost to Follow-up|1|||
129919675|NCT03302494|467670407|FG001|Overall Study|Lost to Follow-up|3|||
129919676|NCT03302494|467670408|FG002|Overall Study|Lost to Follow-up|3|||
129919677|NCT03302494|467670406|FG000|Overall Study|Death|13|||
129919678|NCT03302494|467670407|FG001|Overall Study|Death|11|||
129919679|NCT03302494|467670408|FG002|Overall Study|Death|4|||
129919680|NCT03302494|467670406|FG000|Overall Study|Adverse Event|1|||
129919681|NCT03302494|467670407|FG001|Overall Study|Adverse Event|2|||
129919682|NCT03302494|467670408|FG002|Overall Study|Adverse Event|0|||
129919683|NCT03302494|467670406|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
129919684|NCT03302494|467670407|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
129919685|NCT03302494|467670408|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
129919686|NCT05134233|467670409|FG000|Overall Study|Pregnancy|1|||
129919687|NCT05134233|467670409|FG000|Overall Study|MEP value too low|2|||
129919688|NCT05134233|467670409|FG000|Overall Study|Lost to Follow-up|1|||
129919689|NCT04763265|467670410|FG000|Overall Study|Adverse Event|1|||
129919690|NCT04763265|467670411|FG001|Overall Study|Adverse Event|0|||
129919691|NCT04763265|467670410|FG000|Overall Study|Lost to Follow-up|2|||
129919692|NCT04763265|467670411|FG001|Overall Study|Lost to Follow-up|4|||
129919693|NCT04763265|467670410|FG000|Overall Study|Withdrawal by Subject|0|||
129919694|NCT04763265|467670411|FG001|Overall Study|Withdrawal by Subject|1|||
129919695|NCT05071807|467670414|FG000|Overall Study|Withdrawal by Subject|4|||
129919696|NCT05071807|467670415|FG001|Overall Study|Withdrawal by Subject|0|||
129919697|NCT05071807|467670414|FG000|Overall Study|Unrelated medical issues|3|||
129919698|NCT05071807|467670415|FG001|Overall Study|Unrelated medical issues|0|||
129919699|NCT05071807|467670414|FG000|Overall Study|Relocated|0|||
129919700|NCT05071807|467670415|FG001|Overall Study|Relocated|1|||
129919701|NCT05609760|467670426|FG000|Overall Study|Lost to Follow-up|0|||
129919702|NCT05609760|467670427|FG001|Overall Study|Lost to Follow-up|1|||
129919703|NCT05609760|467670426|FG000|Overall Study|Withdrawal by Subject|1|||
129919704|NCT05609760|467670427|FG001|Overall Study|Withdrawal by Subject|0|||
129919705|NCT04049643|467670428|FG000|Overall Study|Lack of Efficacy|1|||
129919706|NCT04049643|467670429|FG001|Overall Study|Lack of Efficacy|1|||
129919707|NCT04049643|467670430|FG002|Overall Study|Lack of Efficacy|0|||
129919708|NCT04049643|467670428|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129919709|NCT04049643|467670429|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
129919710|NCT04049643|467670430|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
129919711|NCT05089734|467670431|FG000|Overall Study|Still on study|122|||
129919712|NCT05089734|467670432|FG001|Overall Study|Still on study|101|||
129919713|NCT05089734|467670431|FG000|Overall Study|Death|161|||
129919714|NCT05089734|467670432|FG001|Overall Study|Death|179|||
129919715|NCT05089734|467670431|FG000|Overall Study|Withdrew consent|11|||
129919716|NCT05089734|467670432|FG001|Overall Study|Withdrew consent|24|||
129919717|NCT05089734|467670431|FG000|Overall Study|Lost to Follow-up|5|||
129919718|NCT05089734|467670432|FG001|Overall Study|Lost to Follow-up|0|||
129919719|NCT05302596|467670433|FG000|Overall Study|Withdrawal by Subject|1|||
129919720|NCT05302596|467670434|FG001|Overall Study|Withdrawal by Subject|1|||
129919721|NCT03376321|467672103|FG000|Overall Study|Other|5|||
129919722|NCT03376321|467672104|FG001|Overall Study|Other|1|||
129919723|NCT03376321|467672103|FG000|Overall Study|Withdrawal by Subject|8|||
129919724|NCT03376321|467672104|FG001|Overall Study|Withdrawal by Subject|14|||
129919725|NCT03376321|467672103|FG000|Overall Study|Lost to Follow-up|1|||
129919726|NCT03376321|467672104|FG001|Overall Study|Lost to Follow-up|7|||
129919727|NCT03376321|467672103|FG000|Overall Study|Death|4|||
129919728|NCT03376321|467672104|FG001|Overall Study|Death|0|||
129919729|NCT03376321|467672103|FG000|Overall Study|Randomized, not treated|5|||
129919730|NCT03376321|467672104|FG001|Overall Study|Randomized, not treated|3|||
129919731|NCT02671903|467672105|FG000|Period 0 (Run-In)|Death|0|||
129919732|NCT02671903|467672106|FG001|Period 0 (Run-In)|Death|0|||
129919733|NCT02671903|467672107|FG002|Period 0 (Run-In)|Death|3|||
129919734|NCT02671903|467672105|FG000|Period 0 (Run-In)|Physician Decision|0|||
129919735|NCT02671903|467672106|FG001|Period 0 (Run-In)|Physician Decision|0|||
129919736|NCT02671903|467672107|FG002|Period 0 (Run-In)|Physician Decision|4|||
129919737|NCT02671903|467672105|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
129919738|NCT02671903|467672106|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
129919739|NCT02671903|467672107|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
129919740|NCT02671903|467672105|FG000|Period 0 (Run-In)|Protocol Violation|0|||
129919741|NCT02671903|467672106|FG001|Period 0 (Run-In)|Protocol Violation|0|||
129919742|NCT02671903|467672107|FG002|Period 0 (Run-In)|Protocol Violation|1|||
129919743|NCT02671903|467672105|FG000|Period 0 (Run-In)|Adverse Event|0|||
129919744|NCT02671903|467672106|FG001|Period 0 (Run-In)|Adverse Event|0|||
129919745|NCT02671903|467672107|FG002|Period 0 (Run-In)|Adverse Event|1|||
129919746|NCT02671903|467672105|FG000|Period 0 (Run-In)|Implantation Failure|0|||
129919747|NCT02671903|467672106|FG001|Period 0 (Run-In)|Implantation Failure|0|||
129919748|NCT02671903|467672107|FG002|Period 0 (Run-In)|Implantation Failure|2|||
129919749|NCT02671903|467672105|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
129919750|NCT02671903|467672106|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
129919751|NCT02671903|467672107|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
129919752|NCT04258709|467672108|FG000|Overall Study|Lost to Follow-up|10|||
129919753|NCT04258709|467672109|FG001|Overall Study|Lost to Follow-up|4|||
129919754|NCT04258709|467672108|FG000|Overall Study|Withdrawal by Subject|1|||
129919755|NCT04258709|467672109|FG001|Overall Study|Withdrawal by Subject|0|||
129919756|NCT04258709|467672108|FG000|Overall Study|Fetal demise|0|||
129919757|NCT04258709|467672109|FG001|Overall Study|Fetal demise|1|||
129919758|NCT04258709|467672108|FG000|Overall Study|Protocol Violation|1|||
129919759|NCT04258709|467672109|FG001|Overall Study|Protocol Violation|1|||
129919760|NCT02287610|467672110|FG000|Overall Study|Lost to Follow-up|3|||
129919761|NCT02287610|467672110|FG000|Overall Study|Withdrawal by Subject|8|||
129919762|NCT02287610|467672110|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
129919763|NCT06074523|467672111|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
129919764|NCT06074523|467672111|FG000|Overall Study|Withdrawal by Subject|1|||
129919765|NCT04318548|467672117|FG000|Overall Study|Adverse Event|0|||
129919766|NCT04318548|467672118|FG001|Overall Study|Adverse Event|0|||
129919767|NCT04318548|467672119|FG002|Overall Study|Adverse Event|1|||
129919768|NCT04318548|467672117|FG000|Overall Study|Lost to Follow-up|6|||
129919769|NCT04318548|467672118|FG001|Overall Study|Lost to Follow-up|13|||
129919770|NCT04318548|467672119|FG002|Overall Study|Lost to Follow-up|9|||
129919771|NCT04318548|467672117|FG000|Overall Study|Protocol Violation|1|||
129919772|NCT04318548|467672118|FG001|Overall Study|Protocol Violation|0|||
129919773|NCT04318548|467672119|FG002|Overall Study|Protocol Violation|2|||
129919774|NCT04318548|467672117|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
129919775|NCT04318548|467672118|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
129919776|NCT04318548|467672119|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
129919777|NCT04318548|467672117|FG000|Overall Study|Migrated / moved from the study area|0|||
129919778|NCT04318548|467672118|FG001|Overall Study|Migrated / moved from the study area|0|||
129919779|NCT04318548|467672119|FG002|Overall Study|Migrated / moved from the study area|1|||
129919780|NCT04318548|467672117|FG000|Overall Study|Other|1|||
129919781|NCT04318548|467672118|FG001|Overall Study|Other|2|||
129919782|NCT04318548|467672119|FG002|Overall Study|Other|3|||
129919783|NCT05247489|467672120|FG000|Overall Study|Lost to Follow-up|5|||
129919784|NCT05247489|467672121|FG001|Overall Study|Lost to Follow-up|1|||
129919785|NCT05247489|467672120|FG000|Overall Study|Withdrawal by Subject|6|||
129919786|NCT05247489|467672121|FG001|Overall Study|Withdrawal by Subject|7|||
129919787|NCT05247489|467672120|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
129919788|NCT05247489|467672121|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
129919789|NCT05247489|467672120|FG000|Overall Study|Left Country|1|||
129919790|NCT05247489|467672121|FG001|Overall Study|Left Country|0|||
129919791|NCT05247489|467672120|FG000|Overall Study|Noncompliance with Investigational Product|1|||
129919792|NCT05247489|467672121|FG001|Overall Study|Noncompliance with Investigational Product|0|||
129919793|NCT05247489|467672120|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
129919794|NCT05247489|467672121|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
129919795|NCT03771898|467672122|FG000|Overall Study|Adverse Event|1|||
129919796|NCT03771898|467672123|FG001|Overall Study|Adverse Event|0|||
129919797|NCT03771898|467672124|FG002|Overall Study|Adverse Event|0|||
129919798|NCT03771898|467672125|FG003|Overall Study|Adverse Event|0|||
129919799|NCT03771898|467672126|FG004|Overall Study|Adverse Event|0|||
129919800|NCT03771898|467672122|FG000|Overall Study|Lost to Follow-up|1|||
129919801|NCT03771898|467672123|FG001|Overall Study|Lost to Follow-up|1|||
129919802|NCT03771898|467672124|FG002|Overall Study|Lost to Follow-up|1|||
129919803|NCT03771898|467672125|FG003|Overall Study|Lost to Follow-up|0|||
129919804|NCT03771898|467672126|FG004|Overall Study|Lost to Follow-up|0|||
129919805|NCT03771898|467672122|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129919806|NCT03771898|467672123|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129919807|NCT03771898|467672124|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129919808|NCT03771898|467672125|FG003|Overall Study|Withdrawal by parent/guardian|0|||
129919809|NCT03771898|467672126|FG004|Overall Study|Withdrawal by parent/guardian|0|||
129919810|NCT03771898|467672122|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919811|NCT03771898|467672123|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919812|NCT03771898|467672124|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919813|NCT03771898|467672125|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
129919814|NCT03771898|467672126|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
129919815|NCT04541706|467672127|FG000|Overall Study|Withdrawal by Subject|3|||
129919816|NCT04541706|467672127|FG000|Overall Study|Progressive disease|33|||
129919817|NCT04541706|467672127|FG000|Overall Study|Physician Decision|1|||
129919818|NCT04541706|467672127|FG000|Overall Study|Lost to Follow-up|2|||
129919819|NCT04541706|467672127|FG000|Overall Study|Death|5|||
129919820|NCT04541706|467672127|FG000|Overall Study|Adverse Event|1|||
129919821|NCT04927065|467672132|FG000|First Booster|Adverse Event|1|||
129919822|NCT04927065|467672133|FG001|First Booster|Adverse Event|0|||
129919823|NCT04927065|467672134|FG002|First Booster|Adverse Event|0|||
129919824|NCT04927065|467672135|FG003|First Booster|Adverse Event|0|||
129919825|NCT04927065|467672136|FG004|First Booster|Adverse Event|0|||
129919826|NCT04927065|467672137|FG005|First Booster|Adverse Event|0|||
129919827|NCT04927065|467672138|FG006|First Booster|Adverse Event|0|||
129919828|NCT04927065|467672139|FG007|First Booster|Adverse Event|1|||
129919829|NCT04927065|467672140|FG008|First Booster|Adverse Event|0|||
129919830|NCT04927065|467672141|FG009|First Booster|Adverse Event|0|||
129919831|NCT04927065|467672142|FG010|First Booster|Adverse Event|0|||
129919832|NCT04927065|467672143|FG011|First Booster|Adverse Event|0|||
129919833|NCT04927065|467672144|FG012|First Booster|Adverse Event|0|||
129919834|NCT04927065|467672145|FG013|First Booster|Adverse Event|0|||
129919835|NCT04927065|467672146|FG014|First Booster|Adverse Event|0|||
129919836|NCT04927065|467672147|FG015|First Booster|Adverse Event|0|||
129919837|NCT04927065|467672132|FG000|First Booster|Death|1|||
129919838|NCT04927065|467672133|FG001|First Booster|Death|0|||
129919839|NCT04927065|467672134|FG002|First Booster|Death|0|||
129919840|NCT04927065|467672135|FG003|First Booster|Death|1|||
129919841|NCT04927065|467672136|FG004|First Booster|Death|0|||
129919842|NCT04927065|467672137|FG005|First Booster|Death|1|||
129919843|NCT04927065|467672138|FG006|First Booster|Death|0|||
129919844|NCT04927065|467672139|FG007|First Booster|Death|0|||
129919845|NCT04927065|467672140|FG008|First Booster|Death|0|||
129919846|NCT04927065|467672141|FG009|First Booster|Death|0|||
129919847|NCT04927065|467672142|FG010|First Booster|Death|0|||
129919848|NCT04927065|467672143|FG011|First Booster|Death|0|||
129919849|NCT04927065|467672144|FG012|First Booster|Death|0|||
129919850|NCT04927065|467672145|FG013|First Booster|Death|0|||
129919851|NCT04927065|467672146|FG014|First Booster|Death|0|||
129919852|NCT04927065|467672147|FG015|First Booster|Death|0|||
129919853|NCT04927065|467672132|FG000|First Booster|Lost to Follow-up|8|||
129919854|NCT04927065|467672133|FG001|First Booster|Lost to Follow-up|20|||
129919855|NCT04927065|467672134|FG002|First Booster|Lost to Follow-up|0|||
129919856|NCT04927065|467672135|FG003|First Booster|Lost to Follow-up|11|||
129919857|NCT04927065|467672136|FG004|First Booster|Lost to Follow-up|43|||
129919858|NCT04927065|467672137|FG005|First Booster|Lost to Follow-up|30|||
129919859|NCT04927065|467672138|FG006|First Booster|Lost to Follow-up|28|||
129919860|NCT04927065|467672139|FG007|First Booster|Lost to Follow-up|23|||
129919861|NCT04927065|467672140|FG008|First Booster|Lost to Follow-up|4|||
129919862|NCT04927065|467672141|FG009|First Booster|Lost to Follow-up|15|||
129919863|NCT04927065|467672142|FG010|First Booster|Lost to Follow-up|0|||
129919864|NCT04927065|467672143|FG011|First Booster|Lost to Follow-up|0|||
129919865|NCT04927065|467672144|FG012|First Booster|Lost to Follow-up|0|||
129919866|NCT04927065|467672145|FG013|First Booster|Lost to Follow-up|0|||
129919867|NCT04927065|467672146|FG014|First Booster|Lost to Follow-up|0|||
129919868|NCT04927065|467672147|FG015|First Booster|Lost to Follow-up|0|||
129919869|NCT04927065|467672132|FG000|First Booster|Physician Decision|1|||
129919870|NCT04927065|467672133|FG001|First Booster|Physician Decision|0|||
129919871|NCT04927065|467672134|FG002|First Booster|Physician Decision|0|||
129919872|NCT04927065|467672135|FG003|First Booster|Physician Decision|3|||
129919873|NCT04927065|467672136|FG004|First Booster|Physician Decision|1|||
129919874|NCT04927065|467672137|FG005|First Booster|Physician Decision|1|||
129919875|NCT04927065|467672138|FG006|First Booster|Physician Decision|0|||
129919876|NCT04927065|467672139|FG007|First Booster|Physician Decision|3|||
129919877|NCT04927065|467672140|FG008|First Booster|Physician Decision|0|||
129919878|NCT04927065|467672141|FG009|First Booster|Physician Decision|0|||
129919879|NCT04927065|467672142|FG010|First Booster|Physician Decision|0|||
129919880|NCT04927065|467672143|FG011|First Booster|Physician Decision|0|||
129919881|NCT04927065|467672144|FG012|First Booster|Physician Decision|0|||
129919882|NCT04927065|467672145|FG013|First Booster|Physician Decision|0|||
129919883|NCT04927065|467672146|FG014|First Booster|Physician Decision|0|||
129919884|NCT04927065|467672147|FG015|First Booster|Physician Decision|0|||
129919885|NCT04927065|467672132|FG000|First Booster|Protocol Violation|4|||
129919886|NCT04927065|467672133|FG001|First Booster|Protocol Violation|4|||
129919887|NCT04927065|467672134|FG002|First Booster|Protocol Violation|0|||
129919888|NCT04927065|467672135|FG003|First Booster|Protocol Violation|3|||
129919889|NCT04927065|467672136|FG004|First Booster|Protocol Violation|0|||
129919890|NCT04927065|467672137|FG005|First Booster|Protocol Violation|0|||
129919891|NCT04927065|467672138|FG006|First Booster|Protocol Violation|0|||
129919892|NCT04927065|467672139|FG007|First Booster|Protocol Violation|2|||
129919893|NCT04927065|467672140|FG008|First Booster|Protocol Violation|0|||
129919894|NCT04927065|467672141|FG009|First Booster|Protocol Violation|0|||
129919895|NCT04927065|467672142|FG010|First Booster|Protocol Violation|0|||
129919896|NCT04927065|467672143|FG011|First Booster|Protocol Violation|0|||
129919897|NCT04927065|467672144|FG012|First Booster|Protocol Violation|0|||
129919898|NCT04927065|467672145|FG013|First Booster|Protocol Violation|0|||
129919899|NCT04927065|467672146|FG014|First Booster|Protocol Violation|0|||
129919900|NCT04927065|467672147|FG015|First Booster|Protocol Violation|0|||
129919901|NCT04927065|467672132|FG000|First Booster|Withdrawal by Subject|8|||
129919902|NCT04927065|467672133|FG001|First Booster|Withdrawal by Subject|23|||
129919903|NCT04927065|467672134|FG002|First Booster|Withdrawal by Subject|0|||
129919904|NCT04927065|467672135|FG003|First Booster|Withdrawal by Subject|19|||
129919905|NCT04927065|467672136|FG004|First Booster|Withdrawal by Subject|20|||
129919906|NCT04927065|467672137|FG005|First Booster|Withdrawal by Subject|15|||
129919907|NCT04927065|467672138|FG006|First Booster|Withdrawal by Subject|6|||
129919908|NCT04927065|467672139|FG007|First Booster|Withdrawal by Subject|24|||
129919909|NCT04927065|467672140|FG008|First Booster|Withdrawal by Subject|0|||
129919910|NCT04927065|467672141|FG009|First Booster|Withdrawal by Subject|4|||
129919911|NCT04927065|467672142|FG010|First Booster|Withdrawal by Subject|0|||
129919912|NCT04927065|467672143|FG011|First Booster|Withdrawal by Subject|0|||
129919913|NCT04927065|467672144|FG012|First Booster|Withdrawal by Subject|0|||
129919914|NCT04927065|467672145|FG013|First Booster|Withdrawal by Subject|0|||
129919915|NCT04927065|467672146|FG014|First Booster|Withdrawal by Subject|0|||
129919916|NCT04927065|467672147|FG015|First Booster|Withdrawal by Subject|0|||
129919917|NCT04927065|467672132|FG000|First Booster|Other Than Specified|1|||
129919918|NCT04927065|467672133|FG001|First Booster|Other Than Specified|1|||
129919919|NCT04927065|467672134|FG002|First Booster|Other Than Specified|0|||
129919920|NCT04927065|467672135|FG003|First Booster|Other Than Specified|1|||
129919921|NCT04927065|467672136|FG004|First Booster|Other Than Specified|2|||
129919922|NCT04927065|467672137|FG005|First Booster|Other Than Specified|3|||
129919923|NCT04927065|467672138|FG006|First Booster|Other Than Specified|2|||
129919924|NCT04927065|467672139|FG007|First Booster|Other Than Specified|6|||
129919925|NCT04927065|467672140|FG008|First Booster|Other Than Specified|0|||
129919926|NCT04927065|467672141|FG009|First Booster|Other Than Specified|4|||
129919927|NCT04927065|467672142|FG010|First Booster|Other Than Specified|0|||
129919928|NCT04927065|467672143|FG011|First Booster|Other Than Specified|0|||
129919929|NCT04927065|467672144|FG012|First Booster|Other Than Specified|0|||
129919930|NCT04927065|467672145|FG013|First Booster|Other Than Specified|0|||
129919931|NCT04927065|467672146|FG014|First Booster|Other Than Specified|0|||
129919932|NCT04927065|467672147|FG015|First Booster|Other Than Specified|0|||
129919933|NCT04927065|467672132|FG000|Second Booster|Death|0|||
129919934|NCT04927065|467672133|FG001|Second Booster|Death|0|||
129919935|NCT04927065|467672134|FG002|Second Booster|Death|0|||
129919936|NCT04927065|467672135|FG003|Second Booster|Death|0|||
129919937|NCT04927065|467672136|FG004|Second Booster|Death|0|||
129919938|NCT04927065|467672137|FG005|Second Booster|Death|0|||
129919939|NCT04927065|467672138|FG006|Second Booster|Death|0|||
129919940|NCT04927065|467672139|FG007|Second Booster|Death|0|||
129919941|NCT04927065|467672140|FG008|Second Booster|Death|0|||
129919942|NCT04927065|467672141|FG009|Second Booster|Death|0|||
129919943|NCT04927065|467672142|FG010|Second Booster|Death|2|||
129919944|NCT04927065|467672143|FG011|Second Booster|Death|0|||
129919945|NCT04927065|467672144|FG012|Second Booster|Death|2|||
129919946|NCT04927065|467672145|FG013|Second Booster|Death|2|||
129919947|NCT04927065|467672146|FG014|Second Booster|Death|0|||
129919948|NCT04927065|467672147|FG015|Second Booster|Death|0|||
129919949|NCT04927065|467672132|FG000|Second Booster|Lost to Follow-up|0|||
129919950|NCT04927065|467672133|FG001|Second Booster|Lost to Follow-up|0|||
129919951|NCT04927065|467672134|FG002|Second Booster|Lost to Follow-up|3|||
129919952|NCT04927065|467672135|FG003|Second Booster|Lost to Follow-up|0|||
129919953|NCT04927065|467672136|FG004|Second Booster|Lost to Follow-up|0|||
129919954|NCT04927065|467672137|FG005|Second Booster|Lost to Follow-up|0|||
129919955|NCT04927065|467672138|FG006|Second Booster|Lost to Follow-up|0|||
129919956|NCT04927065|467672139|FG007|Second Booster|Lost to Follow-up|0|||
129919957|NCT04927065|467672140|FG008|Second Booster|Lost to Follow-up|0|||
129919958|NCT04927065|467672141|FG009|Second Booster|Lost to Follow-up|0|||
129919959|NCT04927065|467672142|FG010|Second Booster|Lost to Follow-up|14|||
129919960|NCT04927065|467672143|FG011|Second Booster|Lost to Follow-up|10|||
129919961|NCT04927065|467672144|FG012|Second Booster|Lost to Follow-up|13|||
129919962|NCT04927065|467672145|FG013|Second Booster|Lost to Follow-up|16|||
129919963|NCT04927065|467672146|FG014|Second Booster|Lost to Follow-up|0|||
129919964|NCT04927065|467672147|FG015|Second Booster|Lost to Follow-up|0|||
129919965|NCT04927065|467672132|FG000|Second Booster|Physician Decision|0|||
129919966|NCT04927065|467672133|FG001|Second Booster|Physician Decision|0|||
129919967|NCT04927065|467672134|FG002|Second Booster|Physician Decision|0|||
129919968|NCT04927065|467672135|FG003|Second Booster|Physician Decision|0|||
129919969|NCT04927065|467672136|FG004|Second Booster|Physician Decision|0|||
129919970|NCT04927065|467672137|FG005|Second Booster|Physician Decision|0|||
129919971|NCT04927065|467672138|FG006|Second Booster|Physician Decision|0|||
129919972|NCT04927065|467672139|FG007|Second Booster|Physician Decision|0|||
129919973|NCT04927065|467672140|FG008|Second Booster|Physician Decision|0|||
129919974|NCT04927065|467672141|FG009|Second Booster|Physician Decision|0|||
129919975|NCT04927065|467672142|FG010|Second Booster|Physician Decision|0|||
129919976|NCT04927065|467672143|FG011|Second Booster|Physician Decision|3|||
129919977|NCT04927065|467672144|FG012|Second Booster|Physician Decision|0|||
129919978|NCT04927065|467672145|FG013|Second Booster|Physician Decision|1|||
129919979|NCT04927065|467672146|FG014|Second Booster|Physician Decision|0|||
129919980|NCT04927065|467672147|FG015|Second Booster|Physician Decision|0|||
129919981|NCT04927065|467672132|FG000|Second Booster|Withdrawal by Subject|0|||
129919982|NCT04927065|467672133|FG001|Second Booster|Withdrawal by Subject|0|||
129919983|NCT04927065|467672134|FG002|Second Booster|Withdrawal by Subject|4|||
129919984|NCT04927065|467672135|FG003|Second Booster|Withdrawal by Subject|0|||
129919985|NCT04927065|467672136|FG004|Second Booster|Withdrawal by Subject|0|||
129919986|NCT04927065|467672137|FG005|Second Booster|Withdrawal by Subject|0|||
129919987|NCT04927065|467672138|FG006|Second Booster|Withdrawal by Subject|0|||
129919988|NCT04927065|467672139|FG007|Second Booster|Withdrawal by Subject|0|||
129919989|NCT04927065|467672140|FG008|Second Booster|Withdrawal by Subject|0|||
129919990|NCT04927065|467672141|FG009|Second Booster|Withdrawal by Subject|0|||
129919991|NCT04927065|467672142|FG010|Second Booster|Withdrawal by Subject|3|||
129919992|NCT04927065|467672143|FG011|Second Booster|Withdrawal by Subject|16|||
129919993|NCT04927065|467672144|FG012|Second Booster|Withdrawal by Subject|13|||
129919994|NCT04927065|467672145|FG013|Second Booster|Withdrawal by Subject|9|||
129919995|NCT04927065|467672146|FG014|Second Booster|Withdrawal by Subject|0|||
129919996|NCT04927065|467672147|FG015|Second Booster|Withdrawal by Subject|0|||
129919997|NCT04927065|467672132|FG000|Second Booster|Other Than Specified|0|||
129919998|NCT04927065|467672133|FG001|Second Booster|Other Than Specified|0|||
129919999|NCT04927065|467672134|FG002|Second Booster|Other Than Specified|0|||
129920000|NCT04927065|467672135|FG003|Second Booster|Other Than Specified|0|||
129920001|NCT04927065|467672136|FG004|Second Booster|Other Than Specified|0|||
129920002|NCT04927065|467672137|FG005|Second Booster|Other Than Specified|0|||
129920003|NCT04927065|467672138|FG006|Second Booster|Other Than Specified|0|||
129920004|NCT04927065|467672139|FG007|Second Booster|Other Than Specified|0|||
129920005|NCT04927065|467672140|FG008|Second Booster|Other Than Specified|0|||
129920006|NCT04927065|467672141|FG009|Second Booster|Other Than Specified|0|||
129920007|NCT04927065|467672142|FG010|Second Booster|Other Than Specified|1|||
129920008|NCT04927065|467672143|FG011|Second Booster|Other Than Specified|1|||
129920009|NCT04927065|467672144|FG012|Second Booster|Other Than Specified|4|||
129920010|NCT04927065|467672145|FG013|Second Booster|Other Than Specified|0|||
129920011|NCT04927065|467672146|FG014|Second Booster|Other Than Specified|0|||
129920012|NCT04927065|467672147|FG015|Second Booster|Other Than Specified|0|||
129920013|NCT04927065|467672132|FG000|Third Booster|Lost to Follow-up|0|||
129920014|NCT04927065|467672133|FG001|Third Booster|Lost to Follow-up|0|||
129920015|NCT04927065|467672134|FG002|Third Booster|Lost to Follow-up|0|||
129920016|NCT04927065|467672135|FG003|Third Booster|Lost to Follow-up|0|||
129920017|NCT04927065|467672136|FG004|Third Booster|Lost to Follow-up|0|||
129920018|NCT04927065|467672137|FG005|Third Booster|Lost to Follow-up|0|||
129920019|NCT04927065|467672138|FG006|Third Booster|Lost to Follow-up|0|||
129920020|NCT04927065|467672139|FG007|Third Booster|Lost to Follow-up|0|||
129920021|NCT04927065|467672140|FG008|Third Booster|Lost to Follow-up|0|||
129920022|NCT04927065|467672141|FG009|Third Booster|Lost to Follow-up|0|||
129920023|NCT04927065|467672142|FG010|Third Booster|Lost to Follow-up|0|||
129920024|NCT04927065|467672143|FG011|Third Booster|Lost to Follow-up|0|||
129920025|NCT04927065|467672144|FG012|Third Booster|Lost to Follow-up|0|||
129920026|NCT04927065|467672145|FG013|Third Booster|Lost to Follow-up|0|||
129920027|NCT04927065|467672146|FG014|Third Booster|Lost to Follow-up|0|||
129920028|NCT04927065|467672147|FG015|Third Booster|Lost to Follow-up|1|||
129920029|NCT04927065|467672132|FG000|Third Booster|Withdrawal by Subject|0|||
129920030|NCT04927065|467672133|FG001|Third Booster|Withdrawal by Subject|0|||
129920031|NCT04927065|467672134|FG002|Third Booster|Withdrawal by Subject|0|||
129920032|NCT04927065|467672135|FG003|Third Booster|Withdrawal by Subject|0|||
129920033|NCT04927065|467672136|FG004|Third Booster|Withdrawal by Subject|0|||
129920034|NCT04927065|467672137|FG005|Third Booster|Withdrawal by Subject|0|||
129920035|NCT04927065|467672138|FG006|Third Booster|Withdrawal by Subject|0|||
129920036|NCT04927065|467672139|FG007|Third Booster|Withdrawal by Subject|0|||
129920037|NCT04927065|467672140|FG008|Third Booster|Withdrawal by Subject|0|||
129920038|NCT04927065|467672141|FG009|Third Booster|Withdrawal by Subject|0|||
129920039|NCT04927065|467672142|FG010|Third Booster|Withdrawal by Subject|0|||
129920040|NCT04927065|467672143|FG011|Third Booster|Withdrawal by Subject|0|||
129920041|NCT04927065|467672144|FG012|Third Booster|Withdrawal by Subject|0|||
129920042|NCT04927065|467672145|FG013|Third Booster|Withdrawal by Subject|0|||
129920043|NCT04927065|467672146|FG014|Third Booster|Withdrawal by Subject|0|||
129920044|NCT04927065|467672147|FG015|Third Booster|Withdrawal by Subject|1|||
129920045|NCT03406871|467672148|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
129920046|NCT03406871|467672149|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
129920047|NCT03406871|467672150|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
129920048|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
129920049|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
129920050|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
129920051|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
129920052|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
129920053|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
129920054|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
129920055|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
129920056|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
129920057|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Death|0|||
129920058|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Death|1|||
129920059|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Death|0|||
129920060|NCT03406871|467672148|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
129920061|NCT03406871|467672149|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
129920062|NCT03406871|467672150|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
129920063|NCT03366649|467672151|FG000|Overall Study|Failed preoperative screening|4|||
129920064|NCT03366649|467672152|FG001|Overall Study|Failed preoperative screening|0|||
129920065|NCT03366649|467672153|FG002|Overall Study|Failed preoperative screening|0|||
129920066|NCT03366649|467672151|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
129920067|NCT03366649|467672152|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
129920068|NCT03366649|467672153|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
129920069|NCT01744782|467672159|FG000|Overall Study|Death|1|||
129920070|NCT03683719|467672167|FG000|Overall Study|Lack of Efficacy|1|||
129920071|NCT03683719|467672168|FG001|Overall Study|Lack of Efficacy|3|||
129920072|NCT03683719|467672169|FG002|Overall Study|Lack of Efficacy|4|||
129920073|NCT03683719|467672170|FG003|Overall Study|Lack of Efficacy|0|||
129920074|NCT03683719|467672171|FG004|Overall Study|Lack of Efficacy|4|||
129920075|NCT03683719|467672167|FG000|Overall Study|Adverse Event|6|||
129920076|NCT03683719|467672168|FG001|Overall Study|Adverse Event|6|||
129920077|NCT03683719|467672169|FG002|Overall Study|Adverse Event|0|||
129920078|NCT03683719|467672170|FG003|Overall Study|Adverse Event|1|||
129920079|NCT03683719|467672171|FG004|Overall Study|Adverse Event|3|||
129920080|NCT03683719|467672167|FG000|Overall Study|Withdrawal by Subject|4|||
129920081|NCT03683719|467672168|FG001|Overall Study|Withdrawal by Subject|4|||
129920082|NCT03683719|467672169|FG002|Overall Study|Withdrawal by Subject|3|||
129920083|NCT03683719|467672170|FG003|Overall Study|Withdrawal by Subject|5|||
129920084|NCT03683719|467672171|FG004|Overall Study|Withdrawal by Subject|5|||
129920085|NCT03683719|467672167|FG000|Overall Study|Lost to Follow-up|1|||
129920086|NCT03683719|467672168|FG001|Overall Study|Lost to Follow-up|0|||
129920087|NCT03683719|467672169|FG002|Overall Study|Lost to Follow-up|0|||
129920088|NCT03683719|467672170|FG003|Overall Study|Lost to Follow-up|1|||
129920089|NCT03683719|467672171|FG004|Overall Study|Lost to Follow-up|1|||
129920090|NCT03683719|467672167|FG000|Overall Study|Other personal reasons|0|||
129920091|NCT03683719|467672168|FG001|Overall Study|Other personal reasons|0|||
129920092|NCT03683719|467672169|FG002|Overall Study|Other personal reasons|1|||
129920093|NCT03683719|467672170|FG003|Overall Study|Other personal reasons|0|||
129920094|NCT03683719|467672171|FG004|Overall Study|Other personal reasons|1|||
129920095|NCT01413100|467672172|FG000|Overall Study|Withdrawal by Subject|1|||
129920096|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
129920097|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
129920098|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
129920099|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
129920100|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
129920101|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
129920102|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
129920103|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
129920104|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
129920105|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
129920106|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
129920107|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
129920108|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
129920109|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
129920110|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
129920111|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
129920112|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
129920113|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
129920114|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
129920115|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
129920116|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
129920117|NCT05369403|467672173|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
129920118|NCT05369403|467672174|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
129920119|NCT05369403|467672175|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
129920120|NCT05369403|467672173|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
129450029|NCT01994382|465947274|FG006|Overall Study|Protocol violation/noncompliance|0|||
129920121|NCT05369403|467672174|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
129920122|NCT05369403|467672175|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
129920123|NCT05369403|467672173|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
129920124|NCT05369403|467672174|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
129920125|NCT05369403|467672175|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
129920126|NCT05369403|467672173|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
129920127|NCT05369403|467672174|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
129920128|NCT05369403|467672175|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
129920129|NCT04896476|467672187|FG000|Overall Study|Withdrawal by Subject|1|||
129920130|NCT04896476|467672187|FG000|Overall Study|Lost to Follow-up|2|||
129920131|NCT03476187|467672188|FG000|Overall Study|Protocol Violation|7|||
129920132|NCT03476187|467672188|FG000|Overall Study|Physician Decision|5|||
129920133|NCT03924986|467672189|FG000|Overall Study|Death|57|||
129920134|NCT03924986|467672190|FG001|Overall Study|Death|66|||
129920135|NCT03924986|467672189|FG000|Overall Study|Study Concluded by Sponsor|51|||
129920136|NCT03924986|467672190|FG001|Overall Study|Study Concluded by Sponsor|41|||
129920137|NCT03924986|467672189|FG000|Overall Study|Withdrawal by Subject|15|||
129920138|NCT03924986|467672190|FG001|Overall Study|Withdrawal by Subject|20|||
129920139|NCT03924986|467672189|FG000|Overall Study|Lost to Follow-up|7|||
129920140|NCT03924986|467672190|FG001|Overall Study|Lost to Follow-up|5|||
129920141|NCT03924986|467672189|FG000|Overall Study|Miscellaneous|1|||
129920142|NCT03924986|467672190|FG001|Overall Study|Miscellaneous|0|||
129920143|NCT05948670|467672192|FG000|Overall Study|Protocol Violation|6|||
129920144|NCT05948670|467672193|FG001|Overall Study|Protocol Violation|8|||
129920145|NCT05948670|467672192|FG000|Overall Study|Withdrawal by Subject|0|||
129920146|NCT05948670|467672193|FG001|Overall Study|Withdrawal by Subject|1|||
129920147|NCT03699709|467672194|FG000|Overall Study|Death|1|||
129920148|NCT03699709|467672195|FG001|Overall Study|Death|2|||
129920149|NCT03699709|467672194|FG000|Overall Study|Lost to Follow-up|10|||
129920150|NCT03699709|467672195|FG001|Overall Study|Lost to Follow-up|3|||
129920151|NCT03699709|467672194|FG000|Overall Study|Withdrawal by Subject|5|||
129920152|NCT03699709|467672195|FG001|Overall Study|Withdrawal by Subject|0|||
129920153|NCT03699709|467672194|FG000|Overall Study|incarcerated|1|||
129920154|NCT03699709|467672195|FG001|Overall Study|incarcerated|0|||
129920155|NCT03699709|467672194|FG000|Overall Study|scheduled, but no show|0|||
129920156|NCT03699709|467672195|FG001|Overall Study|scheduled, but no show|1|||
129920157|NCT04562649|467672197|FG000|Overall Study|Withdrawal by Subject|11|||
129920158|NCT04562649|467672198|FG001|Overall Study|Withdrawal by Subject|8|||
129920159|NCT04562649|467672197|FG000|Overall Study|Lost to Follow-up|26|||
129920160|NCT04562649|467672198|FG001|Overall Study|Lost to Follow-up|20|||
129920161|NCT04029688|467672202|FG000|Overall Study|Death|8|||
129920162|NCT04029688|467672203|FG001|Overall Study|Death|3|||
129920163|NCT04029688|467672204|FG002|Overall Study|Death|6|||
129920164|NCT04029688|467672205|FG003|Overall Study|Death|2|||
129920165|NCT04029688|467672206|FG004|Overall Study|Death|5|||
129920166|NCT04029688|467672207|FG005|Overall Study|Death|0|||
129920167|NCT04029688|467672208|FG006|Overall Study|Death|2|||
129920168|NCT04029688|467672209|FG007|Overall Study|Death|3|||
129920169|NCT04029688|467672202|FG000|Overall Study|Study Terminated by Sponsor|0|||
129920170|NCT04029688|467672203|FG001|Overall Study|Study Terminated by Sponsor|0|||
129920171|NCT04029688|467672204|FG002|Overall Study|Study Terminated by Sponsor|0|||
129920172|NCT04029688|467672205|FG003|Overall Study|Study Terminated by Sponsor|0|||
129920173|NCT04029688|467672206|FG004|Overall Study|Study Terminated by Sponsor|1|||
129920174|NCT04029688|467672207|FG005|Overall Study|Study Terminated by Sponsor|3|||
129920175|NCT04029688|467672208|FG006|Overall Study|Study Terminated by Sponsor|1|||
129920176|NCT04029688|467672209|FG007|Overall Study|Study Terminated by Sponsor|3|||
129920177|NCT04029688|467672202|FG000|Overall Study|Withdrawal by Subject|0|||
129920178|NCT04029688|467672203|FG001|Overall Study|Withdrawal by Subject|0|||
129920179|NCT04029688|467672204|FG002|Overall Study|Withdrawal by Subject|0|||
129920180|NCT04029688|467672205|FG003|Overall Study|Withdrawal by Subject|1|||
129920181|NCT04029688|467672206|FG004|Overall Study|Withdrawal by Subject|0|||
129920182|NCT04029688|467672207|FG005|Overall Study|Withdrawal by Subject|0|||
129920183|NCT04029688|467672208|FG006|Overall Study|Withdrawal by Subject|0|||
129920184|NCT04029688|467672209|FG007|Overall Study|Withdrawal by Subject|0|||
129920185|NCT04739956|467672217|FG000|Overall Study|Withdrawal by Subject|1|||
129920186|NCT04739956|467672218|FG001|Overall Study|Withdrawal by Subject|1|||
129920187|NCT03920111|467672219|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
129920188|NCT03920111|467672220|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
129920189|NCT03920111|467672221|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
129920190|NCT03396926|467672224|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
129920191|NCT03396926|467672225|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
129920192|NCT00450658|467672226|FG000|Overall Study|Adverse Event|24|||
129920193|NCT00450658|467672227|FG001|Overall Study|Adverse Event|15|||
129920194|NCT00450658|467672226|FG000|Overall Study|Withdrawal by Subject|43|||
129920195|NCT00450658|467672227|FG001|Overall Study|Withdrawal by Subject|26|||
129920196|NCT00450658|467672226|FG000|Overall Study|Lost to Follow-up|22|||
129920197|NCT00450658|467672227|FG001|Overall Study|Lost to Follow-up|5|||
129920198|NCT00450658|467672226|FG000|Overall Study|UGI ulcer|33|||
129920199|NCT00450658|467672227|FG001|Overall Study|UGI ulcer|34|||
129920200|NCT00450658|467672226|FG000|Overall Study|misc|21|||
129920201|NCT00450658|467672227|FG001|Overall Study|misc|10|||
129920202|NCT05763823|467672228|FG000|Overall Study|Death|6|||
129920203|NCT05763823|467672228|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129920204|NCT05763823|467672228|FG000|Overall Study|Withdrawal by Subject|6|||
129920205|NCT01573442|467672231|FG000|Overall Study|Cancels|9|||
129920206|NCT01573442|467672232|FG001|Overall Study|Cancels|10|||
129920207|NCT05710107|467672234|FG000|Overall Study|Withdrawal by Subject|1|||
129920208|NCT05710107|467672235|FG001|Overall Study|Withdrawal by Subject|1|||
129920209|NCT05710107|467672234|FG000|Overall Study|Lost to Follow-up|8|||
129920210|NCT05710107|467672235|FG001|Overall Study|Lost to Follow-up|9|||
129920211|NCT05710107|467672234|FG000|Overall Study|Unable to place assigned block|2|||
129920212|NCT05710107|467672235|FG001|Overall Study|Unable to place assigned block|0|||
129920213|NCT05710107|467672234|FG000|Overall Study|Withdrawn by study team|0|||
129920214|NCT05710107|467672235|FG001|Overall Study|Withdrawn by study team|1|||
129920215|NCT04166773|467672236|FG000|Overall Study|Adverse Event|2|||
129920216|NCT04166773|467672237|FG001|Overall Study|Adverse Event|0|||
129920217|NCT04166773|467672238|FG002|Overall Study|Adverse Event|2|||
129920218|NCT04166773|467672239|FG003|Overall Study|Adverse Event|1|||
129920219|NCT04166773|467672236|FG000|Overall Study|Lost to Follow-up|4|||
129920220|NCT04166773|467672237|FG001|Overall Study|Lost to Follow-up|2|||
129920221|NCT04166773|467672238|FG002|Overall Study|Lost to Follow-up|1|||
129920222|NCT04166773|467672239|FG003|Overall Study|Lost to Follow-up|3|||
129920223|NCT04166773|467672236|FG000|Overall Study|Physician Decision|0|||
129920224|NCT04166773|467672237|FG001|Overall Study|Physician Decision|0|||
129920225|NCT04166773|467672238|FG002|Overall Study|Physician Decision|0|||
129920226|NCT04166773|467672239|FG003|Overall Study|Physician Decision|1|||
129920227|NCT04166773|467672236|FG000|Overall Study|Withdrawal by Subject|1|||
129920228|NCT04166773|467672237|FG001|Overall Study|Withdrawal by Subject|1|||
129920229|NCT04166773|467672238|FG002|Overall Study|Withdrawal by Subject|2|||
129920230|NCT04166773|467672239|FG003|Overall Study|Withdrawal by Subject|5|||
129920231|NCT04456517|467672241|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
129920232|NCT04456517|467672242|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
129920233|NCT02919683|467672243|FG000|Post-Surgery Follow-Up|Death|2|||
129920234|NCT02919683|467672244|FG001|Post-Surgery Follow-Up|Death|2|||
129920235|NCT02919683|467672243|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
129920236|NCT02919683|467672244|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
129920237|NCT05551637|467672245|FG000|Overall Study|Lack of Efficacy|0|||
129920238|NCT05551637|467672246|FG001|Overall Study|Lack of Efficacy|6|||
129920239|NCT05551637|467672245|FG000|Overall Study|Lost to Follow-up|1|||
129920240|NCT05551637|467672246|FG001|Overall Study|Lost to Follow-up|1|||
129920241|NCT06491433|467672247|FG000|Overall Study|Protocol Violation|51|||
129920242|NCT06491433|467672247|FG000|Overall Study|consent withdrawal|2|||
129920243|NCT06491433|467672247|FG000|Overall Study|screen failure|1|||
129920244|NCT01606215|467672252|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
129920245|NCT01606215|467672253|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
129920246|NCT04592549|467672254|FG000|Overall Study|Withdrawal by Subject|0|||
129920247|NCT04592549|467672255|FG001|Overall Study|Withdrawal by Subject|1|||
129920248|NCT04592549|467672256|FG002|Overall Study|Withdrawal by Subject|0|||
129920249|NCT04592549|467672257|FG003|Overall Study|Withdrawal by Subject|1|||
129920250|NCT04592549|467672258|FG004|Overall Study|Withdrawal by Subject|1|||
129920251|NCT04592549|467672259|FG005|Overall Study|Withdrawal by Subject|0|||
129920252|NCT04592549|467672254|FG000|Overall Study|Lost to Follow-up|2|||
129920253|NCT04592549|467672255|FG001|Overall Study|Lost to Follow-up|0|||
129920254|NCT04592549|467672256|FG002|Overall Study|Lost to Follow-up|0|||
129920255|NCT04592549|467672257|FG003|Overall Study|Lost to Follow-up|1|||
129920256|NCT04592549|467672258|FG004|Overall Study|Lost to Follow-up|1|||
129920257|NCT04592549|467672259|FG005|Overall Study|Lost to Follow-up|1|||
129920258|NCT05184192|467672260|FG000|Overall Study|Lost to Follow-up|4|||
129920259|NCT05184192|467672261|FG001|Overall Study|Lost to Follow-up|7|||
129920260|NCT05184192|467672260|FG000|Overall Study|Adverse Event|1|||
129920261|NCT05184192|467672261|FG001|Overall Study|Adverse Event|4|||
129920262|NCT05184192|467672260|FG000|Overall Study|PI withdrawal|1|||
129920263|NCT05184192|467672261|FG001|Overall Study|PI withdrawal|2|||
129920264|NCT05184192|467672260|FG000|Overall Study|Withdrew due to adverse effect|1|||
129920265|NCT05184192|467672261|FG001|Overall Study|Withdrew due to adverse effect|0|||
129920266|NCT05184192|467672260|FG000|Overall Study|Medication schedule|1|||
129920267|NCT05184192|467672261|FG001|Overall Study|Medication schedule|0|||
129920268|NCT05184192|467672260|FG000|Overall Study|Concern for adverse effects|0|||
129920269|NCT05184192|467672261|FG001|Overall Study|Concern for adverse effects|4|||
129920270|NCT02727699|467673862|FG000|Overall Study|Adverse Event|2|||
129920271|NCT02727699|467673863|FG001|Overall Study|Adverse Event|0|||
129920272|NCT02727699|467673862|FG000|Overall Study|Withdrawal by Subject|5|||
129920273|NCT02727699|467673863|FG001|Overall Study|Withdrawal by Subject|3|||
129920274|NCT02727699|467673862|FG000|Overall Study|Protocol Violation|0|||
129920275|NCT02727699|467673863|FG001|Overall Study|Protocol Violation|1|||
129920276|NCT02727699|467673862|FG000|Overall Study|Physician Decision|0|||
129920277|NCT02727699|467673863|FG001|Overall Study|Physician Decision|1|||
129920278|NCT02727699|467673862|FG000|Overall Study|Lost to Follow-up|1|||
129920279|NCT02727699|467673863|FG001|Overall Study|Lost to Follow-up|0|||
129920280|NCT02727699|467673862|FG000|Overall Study|Sponsor Decision|1|||
129920281|NCT02727699|467673863|FG001|Overall Study|Sponsor Decision|0|||
129920282|NCT03131648|467673868|FG000|Initial Treatment Period|Not dosed|2|||
129920283|NCT03131648|467673869|FG001|Initial Treatment Period|Not dosed|2|||
129920284|NCT03131648|467673870|FG002|Initial Treatment Period|Not dosed|0|||
129920285|NCT03131648|467673871|FG003|Initial Treatment Period|Not dosed|0|||
129920286|NCT03131648|467673872|FG004|Initial Treatment Period|Not dosed|0|||
129920287|NCT03131648|467673873|FG005|Initial Treatment Period|Not dosed|0|||
129920288|NCT03131648|467673874|FG006|Initial Treatment Period|Not dosed|0|||
129920289|NCT03131648|467673875|FG007|Initial Treatment Period|Not dosed|0|||
129920290|NCT03131648|467673868|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
129920291|NCT03131648|467673869|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
129920292|NCT03131648|467673870|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920293|NCT03131648|467673871|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920294|NCT03131648|467673872|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920295|NCT03131648|467673873|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920296|NCT03131648|467673874|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920297|NCT03131648|467673875|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129920298|NCT03131648|467673868|FG000|Open-label Treatment|Discontinued IMP|0|||
129920299|NCT03131648|467673869|FG001|Open-label Treatment|Discontinued IMP|0|||
129920300|NCT03131648|467673870|FG002|Open-label Treatment|Discontinued IMP|0|||
129920301|NCT03131648|467673871|FG003|Open-label Treatment|Discontinued IMP|0|||
129920302|NCT03131648|467673872|FG004|Open-label Treatment|Discontinued IMP|0|||
129920303|NCT03131648|467673873|FG005|Open-label Treatment|Discontinued IMP|0|||
129920304|NCT03131648|467673874|FG006|Open-label Treatment|Discontinued IMP|112|||
129920305|NCT03131648|467673875|FG007|Open-label Treatment|Discontinued IMP|0|||
129920306|NCT03131648|467673868|FG000|Open-label Treatment|Completed Week 50|0|||
129920307|NCT03131648|467673869|FG001|Open-label Treatment|Completed Week 50|0|||
129920308|NCT03131648|467673870|FG002|Open-label Treatment|Completed Week 50|0|||
129920309|NCT03131648|467673871|FG003|Open-label Treatment|Completed Week 50|0|||
129920310|NCT03131648|467673872|FG004|Open-label Treatment|Completed Week 50|0|||
129920311|NCT03131648|467673873|FG005|Open-label Treatment|Completed Week 50|0|||
129920312|NCT03131648|467673874|FG006|Open-label Treatment|Completed Week 50|6|||
129920313|NCT03131648|467673875|FG007|Open-label Treatment|Completed Week 50|0|||
129920314|NCT03131648|467673868|FG000|Maintenance Treatment Period|Not dosed|0|||
129920315|NCT03131648|467673869|FG001|Maintenance Treatment Period|Not dosed|0|||
129920316|NCT03131648|467673870|FG002|Maintenance Treatment Period|Not dosed|3|||
129920317|NCT03131648|467673871|FG003|Maintenance Treatment Period|Not dosed|2|||
129920318|NCT03131648|467673872|FG004|Maintenance Treatment Period|Not dosed|1|||
129920319|NCT03131648|467673873|FG005|Maintenance Treatment Period|Not dosed|0|||
129920320|NCT03131648|467673874|FG006|Maintenance Treatment Period|Not dosed|0|||
129920321|NCT03131648|467673875|FG007|Maintenance Treatment Period|Not dosed|0|||
129920322|NCT03131648|467673868|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
129920323|NCT03131648|467673869|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
129920324|NCT03131648|467673870|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
129920325|NCT03131648|467673871|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
129920326|NCT03131648|467673872|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
129920327|NCT03131648|467673873|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
129920328|NCT03131648|467673874|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
129920329|NCT03131648|467673875|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
129920330|NCT03131648|467673868|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920331|NCT03131648|467673869|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920332|NCT03131648|467673870|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
129920333|NCT03131648|467673871|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
129920334|NCT03131648|467673872|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
129920335|NCT03131648|467673873|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
129920336|NCT03131648|467673874|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920337|NCT03131648|467673875|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129920338|NCT03131648|467673868|FG000|Maintenance Treatment Period|Completed Week 50|0|||
129920339|NCT03131648|467673869|FG001|Maintenance Treatment Period|Completed Week 50|0|||
129920340|NCT03131648|467673870|FG002|Maintenance Treatment Period|Completed Week 50|0|||
129920341|NCT03131648|467673871|FG003|Maintenance Treatment Period|Completed Week 50|0|||
129920342|NCT03131648|467673872|FG004|Maintenance Treatment Period|Completed Week 50|1|||
129920343|NCT03131648|467673873|FG005|Maintenance Treatment Period|Completed Week 50|0|||
129920344|NCT03131648|467673874|FG006|Maintenance Treatment Period|Completed Week 50|0|||
129920345|NCT03131648|467673875|FG007|Maintenance Treatment Period|Completed Week 50|0|||
129920346|NCT03131648|467673868|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920347|NCT03131648|467673869|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920348|NCT03131648|467673870|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920349|NCT03131648|467673871|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920350|NCT03131648|467673872|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920351|NCT03131648|467673873|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920352|NCT03131648|467673874|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
129920353|NCT03131648|467673875|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
129920354|NCT05324124|467673876|FG000|Period 1|Withdrawal by Subject|1|||
129920355|NCT05324124|467673877|FG001|Period 1|Withdrawal by Subject|0|||
129920356|NCT05324124|467673876|FG000|Period 1|Physician Decision|0|||
129920357|NCT05324124|467673877|FG001|Period 1|Physician Decision|1|||
129920358|NCT04241068|467673878|FG000|Core Treatment Period|Adverse Event|91|||
129920359|NCT04241068|467673878|FG000|Core Treatment Period|Change of Treatment|4|||
129920360|NCT04241068|467673878|FG000|Core Treatment Period|Consent Withdrawn|143|||
129920361|NCT04241068|467673878|FG000|Core Treatment Period|Death|26|||
129920362|NCT04241068|467673878|FG000|Core Treatment Period|Disease Progression|67|||
129920363|NCT04241068|467673878|FG000|Core Treatment Period|Investigator Decision|40|||
129920364|NCT04241068|467673878|FG000|Core Treatment Period|Loss of Capacity|9|||
129920365|NCT04241068|467673878|FG000|Core Treatment Period|Lost to Follow-up|11|||
129920366|NCT04241068|467673878|FG000|Core Treatment Period|Relocation|4|||
129920367|NCT04241068|467673878|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
129920368|NCT04241068|467673878|FG000|Core Treatment Period|Study Visit Burden|40|||
129920369|NCT04241068|467673878|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
129920370|NCT04241068|467673878|FG000|Core Treatment Period|Missing|2|||
129920371|NCT04241068|467673878|FG000|Core Treatment Period|Reason Not Specified|41|||
129920372|NCT04241068|467673878|FG000|LTE Period|Adverse Event|19|||
129920373|NCT04241068|467673878|FG000|LTE Period|Change of Treatment|1|||
129920374|NCT04241068|467673878|FG000|LTE Period|Consent Withdrawn|71|||
129920375|NCT04241068|467673878|FG000|LTE Period|Death|8|||
129920376|NCT04241068|467673878|FG000|LTE Period|Disease Progression|11|||
129920377|NCT04241068|467673878|FG000|LTE Period|Investigator Decision|12|||
129920378|NCT04241068|467673878|FG000|LTE Period|Loss of Capacity|2|||
129920379|NCT04241068|467673878|FG000|LTE Period|Lost to Follow-up|7|||
129920380|NCT04241068|467673878|FG000|LTE Period|Relocation|6|||
129920381|NCT04241068|467673878|FG000|LTE Period|Site Terminated by Sponsor|26|||
129920382|NCT04241068|467673878|FG000|LTE Period|Study Terminated by Sponsor|276|||
129920383|NCT04241068|467673878|FG000|LTE Period|Study Visit Burden|10|||
129920384|NCT04241068|467673878|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
129920385|NCT04241068|467673878|FG000|LTE Period|Reason Not Specified|65|||
129920386|NCT03792256|467673879|FG000|Overall Study|Death|0|||
129920387|NCT03792256|467673880|FG001|Overall Study|Death|1|||
129920388|NCT03792256|467673879|FG000|Overall Study|Lack of Efficacy|0|||
129920389|NCT03792256|467673880|FG001|Overall Study|Lack of Efficacy|1|||
129920390|NCT03792256|467673879|FG000|Overall Study|Withdrawal by Subject|0|||
129920391|NCT03792256|467673880|FG001|Overall Study|Withdrawal by Subject|1|||
129920392|NCT04760678|467673883|FG000|Overall Study|Death|13|||
129920393|NCT04760678|467673883|FG000|Overall Study|Lost to Follow-up|48|||
129920394|NCT04760678|467673883|FG000|Overall Study|Withdrawal by Subject|1|||
129920395|NCT05368103|467673886|FG000|Overall Study|Withdrawal by Subject|4|||
129920396|NCT05368103|467673886|FG000|Overall Study|Lost to Follow-up|1|||
129920397|NCT05368103|467673886|FG000|Overall Study|Lack of Efficacy|3|||
129920398|NCT03675282|467673887|FG000|Overall Study|Lost to Follow-up|4|||
129920399|NCT03675282|467673888|FG001|Overall Study|Lost to Follow-up|8|||
129920400|NCT03675282|467673889|FG002|Overall Study|Lost to Follow-up|1|||
129920401|NCT03675282|467673890|FG003|Overall Study|Lost to Follow-up|0|||
129920402|NCT03675282|467673891|FG004|Overall Study|Lost to Follow-up|2|||
129920403|NCT03675282|467673892|FG005|Overall Study|Lost to Follow-up|7|||
129920404|NCT03675282|467673887|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
129920405|NCT03675282|467673888|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
129920406|NCT03675282|467673889|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
129920407|NCT03675282|467673890|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
129920408|NCT03675282|467673891|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
129920409|NCT03675282|467673892|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
129920410|NCT03675282|467673887|FG000|Overall Study|Physician Decision|1|||
129920411|NCT03675282|467673888|FG001|Overall Study|Physician Decision|0|||
129920412|NCT03675282|467673889|FG002|Overall Study|Physician Decision|0|||
129920413|NCT03675282|467673890|FG003|Overall Study|Physician Decision|0|||
129920414|NCT03675282|467673891|FG004|Overall Study|Physician Decision|0|||
129920415|NCT03675282|467673892|FG005|Overall Study|Physician Decision|0|||
129920416|NCT05875142|467673893|FG000|Overall Study|Lost to Follow-up|0|||
129920417|NCT05875142|467673894|FG001|Overall Study|Lost to Follow-up|1|||
129920418|NCT05875142|467673895|FG002|Overall Study|Lost to Follow-up|1|||
129920419|NCT05784662|467673896|FG000|Overall Study|Lost to Follow-up|21|||
129920420|NCT05784662|467673897|FG001|Overall Study|Lost to Follow-up|17|||
129920421|NCT03853746|467673899|FG000|Overall Study|Withdrawal by Subject|1|||
129920422|NCT00999804|467673900|FG000|Overall Study|Lack of Efficacy|9|||
129920423|NCT00999804|467673901|FG001|Overall Study|Lack of Efficacy|2|||
129920424|NCT00999804|467673900|FG000|Overall Study|Adverse Event|4|||
129920425|NCT00999804|467673901|FG001|Overall Study|Adverse Event|3|||
129920426|NCT00999804|467673900|FG000|Overall Study|Withdrawal by Subject|4|||
129920427|NCT00999804|467673901|FG001|Overall Study|Withdrawal by Subject|0|||
129920428|NCT00999804|467673900|FG000|Overall Study|Death|1|||
129920429|NCT00999804|467673901|FG001|Overall Study|Death|0|||
129920430|NCT00999804|467673900|FG000|Overall Study|Ineligible|3|||
129920431|NCT00999804|467673901|FG001|Overall Study|Ineligible|0|||
129920432|NCT05256706|467673903|FG000|Overall Study|Lost to Follow-up|9|||
129920433|NCT05256706|467673904|FG001|Overall Study|Lost to Follow-up|3|||
129920434|NCT05256706|467673903|FG000|Overall Study|Withdrawal by Subject|7|||
129920435|NCT05256706|467673904|FG001|Overall Study|Withdrawal by Subject|11|||
129920436|NCT05256706|467673903|FG000|Overall Study|Screen Failures|3|||
129920437|NCT05256706|467673904|FG001|Overall Study|Screen Failures|0|||
129920438|NCT01997840|467673905|FG000|Overall Study|Lost to Follow-up|0|||
129920439|NCT01997840|467673906|FG001|Overall Study|Lost to Follow-up|0|||
129920440|NCT01997840|467673907|FG002|Overall Study|Lost to Follow-up|1|||
129920441|NCT01997840|467673908|FG003|Overall Study|Lost to Follow-up|0|||
129920442|NCT01997840|467673905|FG000|Overall Study|Withdrawal by participant|0|||
129920443|NCT01997840|467673906|FG001|Overall Study|Withdrawal by participant|0|||
129920444|NCT01997840|467673907|FG002|Overall Study|Withdrawal by participant|8|||
129920445|NCT01997840|467673908|FG003|Overall Study|Withdrawal by participant|1|||
129920446|NCT01997840|467673905|FG000|Overall Study|Physician Decision|0|||
129920447|NCT01997840|467673906|FG001|Overall Study|Physician Decision|0|||
129920448|NCT01997840|467673907|FG002|Overall Study|Physician Decision|3|||
129920449|NCT01997840|467673908|FG003|Overall Study|Physician Decision|0|||
129920450|NCT01997840|467673905|FG000|Overall Study|Progressive disease|3|||
129920451|NCT01997840|467673906|FG001|Overall Study|Progressive disease|4|||
129920452|NCT01997840|467673907|FG002|Overall Study|Progressive disease|57|||
129920453|NCT01997840|467673908|FG003|Overall Study|Progressive disease|8|||
129920454|NCT01997840|467673905|FG000|Overall Study|Other reasons|0|||
129920455|NCT01997840|467673906|FG001|Overall Study|Other reasons|0|||
129920456|NCT01997840|467673907|FG002|Overall Study|Other reasons|1|||
129920457|NCT01997840|467673908|FG003|Overall Study|Other reasons|0|||
129920458|NCT01997840|467673905|FG000|Overall Study|Adverse Event|0|||
129920459|NCT01997840|467673906|FG001|Overall Study|Adverse Event|0|||
129920460|NCT01997840|467673907|FG002|Overall Study|Adverse Event|15|||
129920461|NCT01997840|467673908|FG003|Overall Study|Adverse Event|2|||
129920462|NCT03850678|467673909|FG000|Overall Study|Withdrawal by Subject|3|||
129920463|NCT03850678|467673910|FG001|Overall Study|Withdrawal by Subject|0|||
129920464|NCT03850678|467673909|FG000|Overall Study|Experimenter Error|1|||
129920465|NCT03850678|467673910|FG001|Overall Study|Experimenter Error|1|||
129920466|NCT03850678|467673909|FG000|Overall Study|Did Not Condition To Experiment|7|||
129920467|NCT03850678|467673910|FG001|Overall Study|Did Not Condition To Experiment|2|||
129920468|NCT04322643|467673920|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
129920469|NCT03891667|467673921|FG000|Overall Study|Physician Decision|1|||
129920470|NCT03891667|467673922|FG001|Overall Study|Physician Decision|1|||
129920471|NCT03891667|467673921|FG000|Overall Study|COVID related pause|1|||
129920472|NCT03891667|467673922|FG001|Overall Study|COVID related pause|0|||
129920473|NCT03891667|467673921|FG000|Overall Study|Withdrawal by Subject|0|||
129920474|NCT03891667|467673922|FG001|Overall Study|Withdrawal by Subject|1|||
129920475|NCT03891667|467673921|FG000|Overall Study|Adverse Event|0|||
129920476|NCT03891667|467673922|FG001|Overall Study|Adverse Event|1|||
129920477|NCT05076708|467673932|FG000|Overall Study|Withdrawal by Subject|4|||
129920478|NCT05076708|467673932|FG000|Overall Study|Lost to study during switch phase|8|||
129920479|NCT04717492|467673935|FG000|Overall Study|Withdrawal by Subject|2|||
129920480|NCT04717492|467673936|FG001|Overall Study|Withdrawal by Subject|13|||
129920481|NCT04717492|467673935|FG000|Overall Study|Lost to Follow-up|2|||
129920482|NCT04717492|467673936|FG001|Overall Study|Lost to Follow-up|9|||
129920483|NCT03150810|467673937|FG000|Overall Study|Death|4|||
129920484|NCT03150810|467673938|FG001|Overall Study|Death|8|||
129920485|NCT03150810|467673939|FG002|Overall Study|Death|7|||
129920486|NCT03150810|467673940|FG003|Overall Study|Death|2|||
129920487|NCT03150810|467673941|FG004|Overall Study|Death|2|||
129920488|NCT03150810|467673942|FG005|Overall Study|Death|10|||
129920489|NCT03150810|467673943|FG006|Overall Study|Death|8|||
129920490|NCT03150810|467673944|FG007|Overall Study|Death|6|||
129920491|NCT03150810|467673945|FG008|Overall Study|Death|18|||
129920492|NCT03150810|467673946|FG009|Overall Study|Death|3|||
129920493|NCT03150810|467673947|FG010|Overall Study|Death|19|||
129920494|NCT03150810|467673948|FG011|Overall Study|Death|1|||
129920495|NCT03150810|467673949|FG012|Overall Study|Death|19|||
129920496|NCT03150810|467673937|FG000|Overall Study|Withdrawal by Subject|0|||
129920497|NCT03150810|467673938|FG001|Overall Study|Withdrawal by Subject|1|||
129920498|NCT03150810|467673939|FG002|Overall Study|Withdrawal by Subject|1|||
129920499|NCT03150810|467673940|FG003|Overall Study|Withdrawal by Subject|1|||
129920500|NCT03150810|467673941|FG004|Overall Study|Withdrawal by Subject|0|||
129920501|NCT03150810|467673942|FG005|Overall Study|Withdrawal by Subject|0|||
129920502|NCT03150810|467673943|FG006|Overall Study|Withdrawal by Subject|2|||
129920503|NCT03150810|467673944|FG007|Overall Study|Withdrawal by Subject|0|||
129920504|NCT03150810|467673945|FG008|Overall Study|Withdrawal by Subject|2|||
129920505|NCT03150810|467673946|FG009|Overall Study|Withdrawal by Subject|0|||
129920506|NCT03150810|467673947|FG010|Overall Study|Withdrawal by Subject|1|||
129920507|NCT03150810|467673948|FG011|Overall Study|Withdrawal by Subject|0|||
129920508|NCT03150810|467673949|FG012|Overall Study|Withdrawal by Subject|1|||
129920509|NCT03150810|467673937|FG000|Overall Study|Sponsor Decision|0|||
129920510|NCT03150810|467673938|FG001|Overall Study|Sponsor Decision|2|||
129920511|NCT03150810|467673939|FG002|Overall Study|Sponsor Decision|0|||
129920512|NCT03150810|467673940|FG003|Overall Study|Sponsor Decision|0|||
129920513|NCT03150810|467673941|FG004|Overall Study|Sponsor Decision|1|||
129920514|NCT03150810|467673942|FG005|Overall Study|Sponsor Decision|1|||
129920515|NCT03150810|467673943|FG006|Overall Study|Sponsor Decision|0|||
129920516|NCT03150810|467673944|FG007|Overall Study|Sponsor Decision|0|||
129920517|NCT03150810|467673945|FG008|Overall Study|Sponsor Decision|1|||
129920518|NCT03150810|467673946|FG009|Overall Study|Sponsor Decision|0|||
129920519|NCT03150810|467673947|FG010|Overall Study|Sponsor Decision|0|||
129920520|NCT03150810|467673948|FG011|Overall Study|Sponsor Decision|0|||
129920521|NCT03150810|467673949|FG012|Overall Study|Sponsor Decision|5|||
129920522|NCT03150810|467673937|FG000|Overall Study|Lost to Follow-up|0|||
129920523|NCT03150810|467673938|FG001|Overall Study|Lost to Follow-up|1|||
129920524|NCT03150810|467673939|FG002|Overall Study|Lost to Follow-up|1|||
129920525|NCT03150810|467673940|FG003|Overall Study|Lost to Follow-up|0|||
129920526|NCT03150810|467673941|FG004|Overall Study|Lost to Follow-up|0|||
129920527|NCT03150810|467673942|FG005|Overall Study|Lost to Follow-up|0|||
129920528|NCT03150810|467673943|FG006|Overall Study|Lost to Follow-up|1|||
129920529|NCT03150810|467673944|FG007|Overall Study|Lost to Follow-up|0|||
129920530|NCT03150810|467673945|FG008|Overall Study|Lost to Follow-up|0|||
129920531|NCT03150810|467673946|FG009|Overall Study|Lost to Follow-up|0|||
129920532|NCT03150810|467673947|FG010|Overall Study|Lost to Follow-up|1|||
129920533|NCT03150810|467673948|FG011|Overall Study|Lost to Follow-up|0|||
129920534|NCT03150810|467673949|FG012|Overall Study|Lost to Follow-up|0|||
129920535|NCT03150810|467673937|FG000|Overall Study|Physician Decision|0|||
129920536|NCT03150810|467673938|FG001|Overall Study|Physician Decision|0|||
129920537|NCT03150810|467673939|FG002|Overall Study|Physician Decision|0|||
129920538|NCT03150810|467673940|FG003|Overall Study|Physician Decision|0|||
129920539|NCT03150810|467673941|FG004|Overall Study|Physician Decision|0|||
129920540|NCT03150810|467673942|FG005|Overall Study|Physician Decision|1|||
129920541|NCT03150810|467673943|FG006|Overall Study|Physician Decision|1|||
129920542|NCT03150810|467673944|FG007|Overall Study|Physician Decision|0|||
129920543|NCT03150810|467673945|FG008|Overall Study|Physician Decision|0|||
129920544|NCT03150810|467673946|FG009|Overall Study|Physician Decision|0|||
129920545|NCT03150810|467673947|FG010|Overall Study|Physician Decision|0|||
129920546|NCT03150810|467673948|FG011|Overall Study|Physician Decision|0|||
129920547|NCT03150810|467673949|FG012|Overall Study|Physician Decision|0|||
129920548|NCT03150810|467673937|FG000|Overall Study|Site withdrawal from study|0|||
129920549|NCT03150810|467673938|FG001|Overall Study|Site withdrawal from study|1|||
129920550|NCT03150810|467673939|FG002|Overall Study|Site withdrawal from study|0|||
129920551|NCT03150810|467673940|FG003|Overall Study|Site withdrawal from study|0|||
129920552|NCT03150810|467673941|FG004|Overall Study|Site withdrawal from study|0|||
129920553|NCT03150810|467673942|FG005|Overall Study|Site withdrawal from study|0|||
129920554|NCT03150810|467673943|FG006|Overall Study|Site withdrawal from study|0|||
129920555|NCT03150810|467673944|FG007|Overall Study|Site withdrawal from study|0|||
129920556|NCT03150810|467673945|FG008|Overall Study|Site withdrawal from study|0|||
129920557|NCT03150810|467673946|FG009|Overall Study|Site withdrawal from study|1|||
129920558|NCT03150810|467673947|FG010|Overall Study|Site withdrawal from study|1|||
129920559|NCT03150810|467673948|FG011|Overall Study|Site withdrawal from study|0|||
129920560|NCT03150810|467673949|FG012|Overall Study|Site withdrawal from study|0|||
129920561|NCT03150810|467673937|FG000|Overall Study|Hospice|0|||
129920562|NCT03150810|467673938|FG001|Overall Study|Hospice|0|||
129920563|NCT03150810|467673939|FG002|Overall Study|Hospice|0|||
129920564|NCT03150810|467673940|FG003|Overall Study|Hospice|0|||
129920565|NCT03150810|467673941|FG004|Overall Study|Hospice|0|||
129920566|NCT03150810|467673942|FG005|Overall Study|Hospice|1|||
129920567|NCT03150810|467673943|FG006|Overall Study|Hospice|0|||
129920568|NCT03150810|467673944|FG007|Overall Study|Hospice|0|||
129920569|NCT03150810|467673945|FG008|Overall Study|Hospice|0|||
129920570|NCT03150810|467673946|FG009|Overall Study|Hospice|0|||
129920571|NCT03150810|467673947|FG010|Overall Study|Hospice|0|||
129920572|NCT03150810|467673948|FG011|Overall Study|Hospice|0|||
129920573|NCT03150810|467673949|FG012|Overall Study|Hospice|0|||
129920574|NCT03150810|467673937|FG000|Overall Study|Participant relocated abroad.|0|||
129920575|NCT03150810|467673938|FG001|Overall Study|Participant relocated abroad.|0|||
129920576|NCT03150810|467673939|FG002|Overall Study|Participant relocated abroad.|0|||
129920577|NCT03150810|467673940|FG003|Overall Study|Participant relocated abroad.|0|||
129920578|NCT03150810|467673941|FG004|Overall Study|Participant relocated abroad.|0|||
129920579|NCT03150810|467673942|FG005|Overall Study|Participant relocated abroad.|1|||
129920580|NCT03150810|467673943|FG006|Overall Study|Participant relocated abroad.|0|||
129920581|NCT03150810|467673944|FG007|Overall Study|Participant relocated abroad.|0|||
129920582|NCT03150810|467673945|FG008|Overall Study|Participant relocated abroad.|0|||
129920583|NCT03150810|467673946|FG009|Overall Study|Participant relocated abroad.|0|||
129920584|NCT03150810|467673947|FG010|Overall Study|Participant relocated abroad.|0|||
129920585|NCT03150810|467673948|FG011|Overall Study|Participant relocated abroad.|0|||
129920586|NCT03150810|467673949|FG012|Overall Study|Participant relocated abroad.|0|||
129920587|NCT03150810|467673937|FG000|Overall Study|Transferred care to oncologist|0|||
129920588|NCT03150810|467673938|FG001|Overall Study|Transferred care to oncologist|0|||
129920589|NCT03150810|467673939|FG002|Overall Study|Transferred care to oncologist|0|||
129920590|NCT03150810|467673940|FG003|Overall Study|Transferred care to oncologist|0|||
129920591|NCT03150810|467673941|FG004|Overall Study|Transferred care to oncologist|0|||
129920592|NCT03150810|467673942|FG005|Overall Study|Transferred care to oncologist|0|||
129920593|NCT03150810|467673943|FG006|Overall Study|Transferred care to oncologist|2|||
129920594|NCT03150810|467673944|FG007|Overall Study|Transferred care to oncologist|0|||
129920595|NCT03150810|467673945|FG008|Overall Study|Transferred care to oncologist|0|||
129920596|NCT03150810|467673946|FG009|Overall Study|Transferred care to oncologist|0|||
129920597|NCT03150810|467673947|FG010|Overall Study|Transferred care to oncologist|0|||
129920598|NCT03150810|467673948|FG011|Overall Study|Transferred care to oncologist|0|||
129920599|NCT03150810|467673949|FG012|Overall Study|Transferred care to oncologist|0|||
129920600|NCT03903146|467673951|FG000|Overall Study|Lost to Follow-up|6|||
129920601|NCT03903146|467673952|FG001|Overall Study|Lost to Follow-up|4|||
129920602|NCT03903146|467673951|FG000|Overall Study|Withdrawal by Subject|0|||
129920603|NCT03903146|467673952|FG001|Overall Study|Withdrawal by Subject|1|||
129920604|NCT04176965|467673953|FG000|Overall Study|Death|1|||
129920605|NCT04176965|467673954|FG001|Overall Study|Death|2|||
129920606|NCT04176965|467673953|FG000|Overall Study|Lost to Follow-up|10|||
129920607|NCT04176965|467673954|FG001|Overall Study|Lost to Follow-up|2|||
129920608|NCT04176965|467673953|FG000|Overall Study|Withdrawal by Subject|6|||
129920609|NCT04176965|467673954|FG001|Overall Study|Withdrawal by Subject|1|||
129920610|NCT04072380|467673956|FG000|Overall Study|Adverse Event|4|||
129920611|NCT04072380|467673957|FG001|Overall Study|Adverse Event|6|||
129920612|NCT04072380|467673958|FG002|Overall Study|Adverse Event|0|||
129920613|NCT04072380|467673956|FG000|Overall Study|Withdrawal by Subject|3|||
129920614|NCT04072380|467673957|FG001|Overall Study|Withdrawal by Subject|1|||
129920615|NCT04072380|467673958|FG002|Overall Study|Withdrawal by Subject|1|||
129920616|NCT04072380|467673956|FG000|Overall Study|Physician Decision|2|||
129920617|NCT04072380|467673957|FG001|Overall Study|Physician Decision|0|||
129920618|NCT04072380|467673958|FG002|Overall Study|Physician Decision|0|||
129920619|NCT04072380|467673956|FG000|Overall Study|Protocol Violation|0|||
129920620|NCT04072380|467673957|FG001|Overall Study|Protocol Violation|2|||
129920621|NCT04072380|467673958|FG002|Overall Study|Protocol Violation|3|||
129920622|NCT04072380|467673956|FG000|Overall Study|Intercurrent Illness and Others|3|||
129920623|NCT04072380|467673957|FG001|Overall Study|Intercurrent Illness and Others|5|||
129920624|NCT04072380|467673958|FG002|Overall Study|Intercurrent Illness and Others|6|||
129920625|NCT03033576|467673961|FG000|Overall Study|Ineligible|1|||
129920626|NCT03033576|467673962|FG001|Overall Study|Ineligible|1|||
129920627|NCT03033576|467673961|FG000|Overall Study|Adverse Event|4|||
129920628|NCT03033576|467673962|FG001|Overall Study|Adverse Event|20|||
129920629|NCT03033576|467673961|FG000|Overall Study|Progression/relapse|9|||
129920630|NCT03033576|467673962|FG001|Overall Study|Progression/relapse|36|||
129920631|NCT03033576|467673961|FG000|Overall Study|Death|1|||
129920632|NCT03033576|467673962|FG001|Overall Study|Death|1|||
129920633|NCT03033576|467673961|FG000|Overall Study|Patient refusal|1|||
129920634|NCT03033576|467673962|FG001|Overall Study|Patient refusal|6|||
129920635|NCT03033576|467673961|FG000|Overall Study|Other, unspecified reasons|0|||
129920636|NCT03033576|467673962|FG001|Overall Study|Other, unspecified reasons|4|||
129920637|NCT03033576|467673961|FG000|Overall Study|Currently on protocol therapy|0|||
129920638|NCT03033576|467673962|FG001|Overall Study|Currently on protocol therapy|2|||
129920639|NCT05179837|467673963|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
129920640|NCT05179837|467673963|FG000|Overall Study|Device malfunctioned|1|||
129920641|NCT05179837|467673963|FG000|Overall Study|Image quality too low|2|||
129920642|NCT05051124|467673964|FG000|Overall Study|Lost to Follow-up|2|||
129920643|NCT05051124|467673964|FG000|Overall Study|Withdrawal by Subject|1|||
129920644|NCT05051124|467673964|FG000|Overall Study|Residential relocation|2|||
129920645|NCT05051124|467673964|FG000|Overall Study|Death|1|||
129920646|NCT04782973|467673965|FG000|Overall Study|Withdrawal by Subject|5|||
129920647|NCT04782973|467673965|FG000|Overall Study|Protocol Violation|6|||
129920648|NCT04782973|467673965|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
129920649|NCT03557697|467673966|FG000|Overall Study|Withdrawal by Subject|2|||
129920650|NCT03557697|467673967|FG001|Overall Study|Withdrawal by Subject|4|||
129920651|NCT04749615|467673968|FG000|Overall Study|Lost to Follow-up|6|||
129920652|NCT04749615|467673969|FG001|Overall Study|Lost to Follow-up|10|||
129920653|NCT05478499|467673986|FG000|Overall Study|Adverse Event|4|||
129920654|NCT05478499|467673987|FG001|Overall Study|Adverse Event|2|||
129920655|NCT05478499|467673986|FG000|Overall Study|Withdrawal by Subject|3|||
129920656|NCT05478499|467673987|FG001|Overall Study|Withdrawal by Subject|2|||
129920657|NCT05478499|467673986|FG000|Overall Study|Lack of Efficacy|1|||
129920658|NCT05478499|467673987|FG001|Overall Study|Lack of Efficacy|0|||
129920659|NCT05478499|467673986|FG000|Overall Study|Lost to Follow-up|1|||
129920660|NCT05478499|467673987|FG001|Overall Study|Lost to Follow-up|0|||
129920661|NCT05478499|467673986|FG000|Overall Study|Other reasons|0|||
129920662|NCT05478499|467673987|FG001|Overall Study|Other reasons|1|||
129920663|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
129920664|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
129920665|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
129920666|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920667|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920668|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920669|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
129920670|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920671|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
129920672|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920673|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920674|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920675|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920676|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
129920677|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920678|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
129920679|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
129920680|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920681|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920682|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920683|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
129920684|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
129920685|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920686|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920687|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920688|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920689|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920690|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
129920691|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920692|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
129920693|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920694|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920695|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920696|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920697|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
129920698|NCT02962895|467673988|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920699|NCT02962895|467673989|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920700|NCT02962895|467673990|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920701|NCT02962895|467673991|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
129920702|NCT02962895|467673992|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920703|NCT02962895|467673993|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920704|NCT02962895|467673994|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
129920705|NCT02962895|467673988|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920706|NCT02962895|467673989|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920707|NCT02962895|467673990|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920708|NCT02962895|467673991|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920709|NCT02962895|467673992|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920710|NCT02962895|467673993|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
129920711|NCT02962895|467673994|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
129920712|NCT02962895|467673988|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920713|NCT02962895|467673989|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920714|NCT02962895|467673990|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920715|NCT02962895|467673991|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920716|NCT02962895|467673992|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
129920717|NCT02962895|467673993|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
129920718|NCT02962895|467673994|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
129920719|NCT02962895|467673988|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920720|NCT02962895|467673989|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920721|NCT02962895|467673990|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920722|NCT02962895|467673991|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920723|NCT02962895|467673992|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920724|NCT02962895|467673993|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
129920725|NCT02962895|467673994|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
129920726|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920727|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
129920728|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920729|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920730|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920731|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920732|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
129920733|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920734|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920735|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920736|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920737|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
129920738|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920739|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
129920740|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920741|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920742|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920743|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920744|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
129920745|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920746|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
129920747|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920748|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
129920749|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
129920750|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
129920751|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920752|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920753|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
129920754|NCT02962895|467673988|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
129920755|NCT02962895|467673989|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
129920756|NCT02962895|467673990|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
129920757|NCT02962895|467673991|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
129920758|NCT02962895|467673992|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
129920759|NCT02962895|467673993|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
129920760|NCT02962895|467673994|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
129920761|NCT05481320|467673995|FG000|Overall Study|Withdrawal by Subject|1|||
129920762|NCT05481320|467673996|FG001|Overall Study|Withdrawal by Subject|1|||
129920763|NCT05481320|467673995|FG000|Overall Study|Care recipent passed away|0|||
129920764|NCT05481320|467673996|FG001|Overall Study|Care recipent passed away|1|||
129920765|NCT05481320|467673995|FG000|Overall Study|Out-of-window assessment|0|||
129920766|NCT05481320|467673996|FG001|Overall Study|Out-of-window assessment|1|||
129920767|NCT05481320|467673995|FG000|Overall Study|No longer a primary caregiver|3|||
129920768|NCT05481320|467673996|FG001|Overall Study|No longer a primary caregiver|0|||
129920769|NCT05481320|467673995|FG000|Overall Study|Unable to contact|1|||
129920770|NCT05481320|467673996|FG001|Overall Study|Unable to contact|0|||
129920771|NCT05282173|467673998|FG000|Overall Study|Missed|3|||
129920772|NCT05282173|467673999|FG001|Overall Study|Missed|2|||
129920773|NCT05282173|467674000|FG002|Overall Study|Missed|4|||
129920774|NCT03364647|467674002|FG000|Overall Study|Withdrawal by Subject|3|||
129920775|NCT03364647|467674003|FG001|Overall Study|Withdrawal by Subject|1|||
129920776|NCT03476460|467674004|FG000|Overall Study|Withdrawal by Subject|3|||
129920777|NCT03476460|467674005|FG001|Overall Study|Withdrawal by Subject|2|||
129920778|NCT03476460|467674004|FG000|Overall Study|Non-compliance with treatment|3|||
129920779|NCT03476460|467674005|FG001|Overall Study|Non-compliance with treatment|0|||
129920780|NCT03476460|467674004|FG000|Overall Study|Missing laboratory tests|5|||
129920781|NCT03476460|467674005|FG001|Overall Study|Missing laboratory tests|5|||
129920782|NCT03476460|467674004|FG000|Overall Study|Adverse Event|0|||
129920783|NCT03476460|467674005|FG001|Overall Study|Adverse Event|1|||
129920784|NCT06037369|467674016|FG000|Overall Study|Lost to Follow-up|0|||
129920785|NCT06037369|467674017|FG001|Overall Study|Lost to Follow-up|1|||
129920786|NCT05351554|467674024|FG000|Overall Study|Study terminated by sponsor|1|||
129920787|NCT03774082|467674025|FG000|Overall Study|Death|6|||
129920788|NCT03774082|467674026|FG001|Overall Study|Death|3|||
129920789|NCT03774082|467674027|FG002|Overall Study|Death|2|||
129920790|NCT03774082|467674025|FG000|Overall Study|Subject decision|0|||
129920791|NCT03774082|467674026|FG001|Overall Study|Subject decision|3|||
129920792|NCT03774082|467674027|FG002|Overall Study|Subject decision|0|||
129920793|NCT03774082|467674025|FG000|Overall Study|Lost to Follow-up|2|||
129920794|NCT03774082|467674026|FG001|Overall Study|Lost to Follow-up|0|||
129920795|NCT03774082|467674027|FG002|Overall Study|Lost to Follow-up|0|||
129920796|NCT03774082|467674025|FG000|Overall Study|Guardian decision|0|||
129920797|NCT03774082|467674026|FG001|Overall Study|Guardian decision|0|||
129920798|NCT03774082|467674027|FG002|Overall Study|Guardian decision|1|||
129920799|NCT03774082|467674025|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
129920800|NCT03774082|467674026|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
129920801|NCT03774082|467674027|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
129920802|NCT05093829|467674028|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920803|NCT05093829|467674029|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920804|NCT05093829|467674030|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
129920805|NCT05093829|467674031|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920806|NCT05093829|467674032|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
129920807|NCT04353661|467676040|FG000|Overall Study|Protocol Violation|0|||
129920808|NCT04353661|467676041|FG001|Overall Study|Protocol Violation|0|||
129920809|NCT04353661|467676042|FG002|Overall Study|Protocol Violation|1|||
129920810|NCT04353661|467676040|FG000|Overall Study|Study termination by the Sponsor|1|||
129920811|NCT04353661|467676041|FG001|Overall Study|Study termination by the Sponsor|1|||
129920812|NCT04353661|467676042|FG002|Overall Study|Study termination by the Sponsor|1|||
129920813|NCT00667251|467676043|FG000|Overall Study|Disease progression|232|||
129920814|NCT00667251|467676044|FG001|Overall Study|Disease progression|203|||
129920815|NCT00667251|467676043|FG000|Overall Study|Toxicity|44|||
129920816|NCT00667251|467676044|FG001|Overall Study|Toxicity|23|||
129920817|NCT00667251|467676043|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
129920818|NCT00667251|467676044|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
129920819|NCT00667251|467676043|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
129920820|NCT00667251|467676044|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
129920821|NCT00667251|467676043|FG000|Overall Study|Symptomatic progression|8|||
129920822|NCT00667251|467676044|FG001|Overall Study|Symptomatic progression|4|||
129920823|NCT00667251|467676043|FG000|Overall Study|Death|6|||
129920824|NCT00667251|467676044|FG001|Overall Study|Death|11|||
129920825|NCT00667251|467676043|FG000|Overall Study|Intercurrent illness|5|||
129920826|NCT00667251|467676044|FG001|Overall Study|Intercurrent illness|6|||
129920827|NCT00667251|467676043|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
129920828|NCT00667251|467676044|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
129920829|NCT00667251|467676043|FG000|Overall Study|Randomized not Treated|4|||
129920830|NCT00667251|467676044|FG001|Overall Study|Randomized not Treated|1|||
129920831|NCT02995434|467676049|FG000|Overall Study|Adverse Event|1|||
129920832|NCT02995434|467676050|FG001|Overall Study|Adverse Event|0|||
129920833|NCT02995434|467676049|FG000|Overall Study|Withdrawal by Subject|6|||
129920834|NCT02995434|467676050|FG001|Overall Study|Withdrawal by Subject|3|||
129920835|NCT03047928|467676051|FG000|Overall Study|Adverse Event|0|||
129920836|NCT03047928|467676052|FG001|Overall Study|Adverse Event|2|||
129920837|NCT03047928|467676053|FG002|Overall Study|Adverse Event|0|||
129920838|NCT03047928|467676051|FG000|Overall Study|Protocol Violation|0|||
129920839|NCT03047928|467676052|FG001|Overall Study|Protocol Violation|1|||
129920840|NCT03047928|467676053|FG002|Overall Study|Protocol Violation|0|||
129920841|NCT03047928|467676051|FG000|Overall Study|included in another protocol|0|||
129920842|NCT03047928|467676052|FG001|Overall Study|included in another protocol|1|||
129920843|NCT03047928|467676053|FG002|Overall Study|included in another protocol|0|||
129920844|NCT04179500|467676054|FG000|Treatment|Withdrawal by Subject|1|||
129920845|NCT04179500|467676054|FG000|Treatment|Adverse Event|2|||
129920846|NCT04179500|467676054|FG000|Treatment|pyrazinamide resistance|1|||
129920847|NCT04492007|467676055|FG000|Overall Study|Lost to Follow-up|1|||
129920848|NCT04492007|467676056|FG001|Overall Study|Lost to Follow-up|1|||
129920849|NCT04492007|467676057|FG002|Overall Study|Lost to Follow-up|2|||
129920850|NCT04492007|467676058|FG003|Overall Study|Lost to Follow-up|2|||
129920851|NCT04492007|467676055|FG000|Overall Study|Protocol Violation|1|||
129920852|NCT04492007|467676056|FG001|Overall Study|Protocol Violation|1|||
129920853|NCT04492007|467676057|FG002|Overall Study|Protocol Violation|1|||
129920854|NCT04492007|467676058|FG003|Overall Study|Protocol Violation|1|||
129920855|NCT04492007|467676055|FG000|Overall Study|Withdrawal by Subject|0|||
129920856|NCT04492007|467676056|FG001|Overall Study|Withdrawal by Subject|0|||
129920857|NCT04492007|467676057|FG002|Overall Study|Withdrawal by Subject|1|||
129920858|NCT04492007|467676058|FG003|Overall Study|Withdrawal by Subject|1|||
129920859|NCT04177823|467676061|FG000|Overall Study|Physician Decision|1|||
129920860|NCT04177823|467676061|FG000|Overall Study|Withdrawal by Subject|1|||
129920861|NCT05178316|467676064|FG000|Overall Study|Adverse Event|5|||
129920862|NCT05178316|467676065|FG001|Overall Study|Adverse Event|4|||
129920863|NCT05178316|467676066|FG002|Overall Study|Adverse Event|9|||
129920864|NCT05178316|467676064|FG000|Overall Study|Enrolled in Error|1|||
129920865|NCT05178316|467676065|FG001|Overall Study|Enrolled in Error|2|||
129920866|NCT05178316|467676066|FG002|Overall Study|Enrolled in Error|1|||
129920867|NCT05178316|467676064|FG000|Overall Study|Lost to Follow-up|3|||
129920868|NCT05178316|467676065|FG001|Overall Study|Lost to Follow-up|15|||
129920869|NCT05178316|467676066|FG002|Overall Study|Lost to Follow-up|11|||
129920870|NCT05178316|467676064|FG000|Overall Study|Noncompliance|1|||
129920871|NCT05178316|467676065|FG001|Overall Study|Noncompliance|3|||
129920872|NCT05178316|467676066|FG002|Overall Study|Noncompliance|1|||
129920873|NCT05178316|467676064|FG000|Overall Study|Other|0|||
129920874|NCT05178316|467676065|FG001|Overall Study|Other|1|||
129920875|NCT05178316|467676066|FG002|Overall Study|Other|0|||
129920876|NCT05178316|467676064|FG000|Overall Study|Physician Decision|0|||
129920877|NCT05178316|467676065|FG001|Overall Study|Physician Decision|3|||
129920878|NCT05178316|467676066|FG002|Overall Study|Physician Decision|2|||
129920879|NCT05178316|467676064|FG000|Overall Study|Protocol deviation|1|||
129920880|NCT05178316|467676065|FG001|Overall Study|Protocol deviation|0|||
129920881|NCT05178316|467676066|FG002|Overall Study|Protocol deviation|1|||
129920882|NCT05178316|467676064|FG000|Overall Study|Sponsor decision|1|||
129920883|NCT05178316|467676065|FG001|Overall Study|Sponsor decision|0|||
129920884|NCT05178316|467676066|FG002|Overall Study|Sponsor decision|1|||
129920885|NCT05178316|467676064|FG000|Overall Study|Withdrawal by Subject|5|||
129920886|NCT05178316|467676065|FG001|Overall Study|Withdrawal by Subject|11|||
129920887|NCT05178316|467676066|FG002|Overall Study|Withdrawal by Subject|5|||
129920888|NCT03457142|467676067|FG000|Overall Study|Death|1|||
129920889|NCT01748448|467676070|FG000|Treatment Period|Consent withdrawn by subject|1|||
129920890|NCT01748448|467676071|FG001|Treatment Period|Consent withdrawn by subject|0|||
129920891|NCT01748448|467676070|FG000|Treatment Period|Adverse Event|1|||
129920892|NCT01748448|467676071|FG001|Treatment Period|Adverse Event|0|||
129920893|NCT01748448|467676070|FG000|Treatment Period|Personal|0|||
129920894|NCT01748448|467676071|FG001|Treatment Period|Personal|1|||
129920895|NCT02907099|467676072|FG000|Overall Study|Adverse Event|1|||
129920896|NCT02907099|467676072|FG000|Overall Study|Withdrawal by Subject|2|||
129920897|NCT02907099|467676072|FG000|Overall Study|Screen Fail|2|||
129920898|NCT04977947|467676073|FG000|Overall Study|Lost to Follow-up|1|||
129920899|NCT04977947|467676074|FG001|Overall Study|Lost to Follow-up|1|||
129920900|NCT03436290|467676075|FG000|Overall Study|Post-randomization Exclusion|1|||
129920901|NCT03436290|467676076|FG001|Overall Study|Post-randomization Exclusion|0|||
129920902|NCT03436290|467676075|FG000|Overall Study|Death|6|||
129920903|NCT03436290|467676076|FG001|Overall Study|Death|0|||
129920904|NCT03436290|467676075|FG000|Overall Study|Withdrawal by Subject|4|||
129920905|NCT03436290|467676076|FG001|Overall Study|Withdrawal by Subject|0|||
129920906|NCT03436290|467676075|FG000|Overall Study|Protocol Violation|30|||
129920907|NCT03436290|467676076|FG001|Overall Study|Protocol Violation|0|||
129920908|NCT04274764|467676077|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
129920909|NCT04274764|467676078|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
129920910|NCT02677298|467676081|FG000|Double Blind Phase|Adverse Event|2|||
129920911|NCT02677298|467676082|FG001|Double Blind Phase|Adverse Event|1|||
129920912|NCT02677298|467676083|FG002|Double Blind Phase|Adverse Event|0|||
129920913|NCT02677298|467676081|FG000|Double Blind Phase|Physician Decision|5|||
129920914|NCT02677298|467676082|FG001|Double Blind Phase|Physician Decision|0|||
129920915|NCT02677298|467676083|FG002|Double Blind Phase|Physician Decision|0|||
129920916|NCT02677298|467676081|FG000|Double Blind Phase|Lost to Follow-up|11|||
129920917|NCT02677298|467676082|FG001|Double Blind Phase|Lost to Follow-up|7|||
129920918|NCT02677298|467676083|FG002|Double Blind Phase|Lost to Follow-up|0|||
129920919|NCT02677298|467676081|FG000|Double Blind Phase|Withdrawal by Subject|11|||
129920920|NCT02677298|467676082|FG001|Double Blind Phase|Withdrawal by Subject|8|||
129920921|NCT02677298|467676083|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129920922|NCT02677298|467676081|FG000|Double Blind Phase|No study drug available at site|0|||
129920923|NCT02677298|467676082|FG001|Double Blind Phase|No study drug available at site|1|||
129920924|NCT02677298|467676083|FG002|Double Blind Phase|No study drug available at site|0|||
129920925|NCT02677298|467676081|FG000|Open Label Phase|Adverse Event|0|||
129920926|NCT02677298|467676082|FG001|Open Label Phase|Adverse Event|0|||
129920927|NCT02677298|467676083|FG002|Open Label Phase|Adverse Event|4|||
129920928|NCT02677298|467676081|FG000|Open Label Phase|Physician Decision|0|||
129920929|NCT02677298|467676082|FG001|Open Label Phase|Physician Decision|0|||
129920930|NCT02677298|467676083|FG002|Open Label Phase|Physician Decision|1|||
129920931|NCT02677298|467676081|FG000|Open Label Phase|Lost to Follow-up|0|||
129920932|NCT02677298|467676082|FG001|Open Label Phase|Lost to Follow-up|0|||
129920933|NCT02677298|467676083|FG002|Open Label Phase|Lost to Follow-up|17|||
129920934|NCT02677298|467676081|FG000|Open Label Phase|Withdrawal by Subject|0|||
129920935|NCT02677298|467676082|FG001|Open Label Phase|Withdrawal by Subject|0|||
129920936|NCT02677298|467676083|FG002|Open Label Phase|Withdrawal by Subject|38|||
129920937|NCT03611621|467676084|FG000|Overall Study|Graft loss|3|||
129920938|NCT03611621|467676084|FG000|Overall Study|Death|3|||
129920939|NCT03611621|467676084|FG000|Overall Study|Lost to Follow-up|1|||
129920940|NCT03039023|467676098|FG000|Overall Study|Withdrawal by Subject|1|||
129920941|NCT03039023|467676099|FG001|Overall Study|Withdrawal by Subject|0|||
129920942|NCT03039023|467676100|FG002|Overall Study|Withdrawal by Subject|1|||
129920943|NCT03039023|467676101|FG003|Overall Study|Withdrawal by Subject|1|||
129920944|NCT03039023|467676102|FG004|Overall Study|Withdrawal by Subject|0|||
129920945|NCT03039023|467676098|FG000|Overall Study|Physician Decision|0|||
129920946|NCT03039023|467676099|FG001|Overall Study|Physician Decision|0|||
129920947|NCT03039023|467676100|FG002|Overall Study|Physician Decision|0|||
129920948|NCT03039023|467676101|FG003|Overall Study|Physician Decision|1|||
129920949|NCT03039023|467676102|FG004|Overall Study|Physician Decision|0|||
129920950|NCT04130438|467676103|FG000|Overall Study|Lost to Follow-up|0|||
129920951|NCT04130438|467676104|FG001|Overall Study|Lost to Follow-up|0|||
129920952|NCT04130438|467676105|FG002|Overall Study|Lost to Follow-up|1|||
129920953|NCT03232138|467676108|FG000|Overall Study|Physician Decision|1|||
129920954|NCT03232138|467676109|FG001|Overall Study|Physician Decision|0|||
129920955|NCT03232138|467676108|FG000|Overall Study|Adverse Event|2|||
129920956|NCT03232138|467676109|FG001|Overall Study|Adverse Event|0|||
129920957|NCT03232138|467676108|FG000|Overall Study|Withdrawal by Subject|1|||
129920958|NCT03232138|467676109|FG001|Overall Study|Withdrawal by Subject|2|||
129920959|NCT04142788|467676110|FG000|Overall Study|Trial terminated prematurely|2|||
129920960|NCT04142788|467676111|FG001|Overall Study|Trial terminated prematurely|2|||
129920961|NCT05516147|467676115|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
129920962|NCT04764448|467676117|FG000|Overall Study|Study terminated by sponsor|2|||
129920963|NCT04764448|467676118|FG001|Overall Study|Study terminated by sponsor|2|||
129920964|NCT04764448|467676119|FG002|Overall Study|Study terminated by sponsor|5|||
129920965|NCT04764448|467676117|FG000|Overall Study|Withdrawal by Subject|3|||
129920966|NCT04764448|467676118|FG001|Overall Study|Withdrawal by Subject|3|||
129920967|NCT04764448|467676119|FG002|Overall Study|Withdrawal by Subject|1|||
129920968|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Other|0|||
129920969|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Other|0|||
129920970|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Other|0|||
129920971|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Other|0|||
129920972|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Other|0|||
129920973|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Other|0|||
129920974|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Other|0|||
129920975|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Other|0|||
129920976|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Other|0|||
129920977|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Other|0|||
129920978|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Other|1|||
129920979|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Other|1|||
129920980|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Other|1|||
129920981|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Other|0|||
129920982|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Other|3|||
129920983|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Other|1|||
129920984|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Other|1|||
129920985|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Other|0|||
129920986|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920987|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920988|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920989|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920990|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920991|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920992|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
129920993|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920994|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
129920995|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920996|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920997|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
129920998|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
129920999|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921000|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921001|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921002|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921003|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
129921004|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921005|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921006|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921007|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921008|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921009|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921010|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921011|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
129921012|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921013|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921014|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921015|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921016|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921017|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921018|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921019|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921020|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921021|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
129921022|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921023|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921024|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921025|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921026|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921027|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921028|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921029|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921030|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921031|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
129921032|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921033|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921034|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921035|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921036|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921037|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921038|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921039|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
129921040|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Death|0|||
129921041|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Death|0|||
129921042|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Death|0|||
129921043|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Death|0|||
129921044|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Death|0|||
129921045|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Death|0|||
129921046|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Death|0|||
129921047|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Death|0|||
129921048|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Death|0|||
129921049|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Death|1|||
129921050|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Death|0|||
129921051|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Death|1|||
129921052|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Death|0|||
129921053|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Death|1|||
129921054|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Death|0|||
129921055|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Death|0|||
129921056|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Death|2|||
129921057|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Death|0|||
129921058|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
129921059|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
129921060|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
129921061|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
129921062|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
129921063|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
129921064|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
129921065|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
129921066|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
129921067|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
129921068|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
129921069|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
129921070|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
129921071|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
129921072|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
129921073|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
129921074|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
129921075|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
129921076|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Adverse Event|0|||
129921077|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Adverse Event|0|||
129921078|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Adverse Event|0|||
129921079|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Adverse Event|0|||
129921080|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Adverse Event|0|||
129921081|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Adverse Event|0|||
129921082|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Adverse Event|2|||
129921083|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Adverse Event|0|||
129921084|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Adverse Event|0|||
129921085|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Adverse Event|0|||
129921086|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Adverse Event|1|||
129921087|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Adverse Event|2|||
129921088|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Adverse Event|0|||
129921089|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Adverse Event|1|||
129921090|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Adverse Event|0|||
129921091|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Adverse Event|0|||
129921092|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Adverse Event|1|||
129921093|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Adverse Event|0|||
129921094|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
129921095|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
129921096|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
129921097|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
129921098|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
129921099|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
129921100|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
129921101|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
129921102|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
129921103|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
129921104|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
129921105|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
129921106|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
129921107|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
129921108|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
129921109|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
129921110|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
129921111|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
129921112|NCT03269136|467676130|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921113|NCT03269136|467676131|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921114|NCT03269136|467676132|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921115|NCT03269136|467676133|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921116|NCT03269136|467676134|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921117|NCT03269136|467676135|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921118|NCT03269136|467676136|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921119|NCT03269136|467676137|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921120|NCT03269136|467676138|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921121|NCT03269136|467676139|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921122|NCT03269136|467676140|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921123|NCT03269136|467676141|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921124|NCT03269136|467676142|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129921125|NCT03269136|467676143|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
129921126|NCT03269136|467676144|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
129921127|NCT03269136|467676145|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921128|NCT03269136|467676146|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129921129|NCT03269136|467676147|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129921130|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Other|0|||
129921131|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Other|0|||
129921132|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Other|0|||
129921133|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Other|0|||
129921134|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Other|0|||
129921135|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Other|0|||
129921136|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Other|0|||
129921137|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Other|0|||
129921138|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Other|0|||
129921139|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Other|0|||
129921140|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Other|0|||
129921141|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Other|0|||
129921142|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Other|0|||
129921143|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Other|0|||
129921144|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Other|0|||
129921145|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Other|0|||
129921146|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Other|0|||
129921147|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Other|1|||
129921148|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921149|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921150|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921151|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921152|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921153|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921154|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921155|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921156|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921157|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921158|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921159|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921160|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921161|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921162|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921163|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921164|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
129921165|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
129921166|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
129921167|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
129921168|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
129921169|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
129921170|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
129921171|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
129921172|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
129921173|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
129921174|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
129921175|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
129921176|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
129921177|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
129921178|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
129921179|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
129921180|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
129921181|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
129921182|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
129921183|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
129921184|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
129921185|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
129921186|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
129921187|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
129921188|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
129921189|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
129921190|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
129921191|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
129921192|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
129921193|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
129921194|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
129921195|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
129921196|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
129921197|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
129921198|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
129921199|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
129921200|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
129921201|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
129921202|NCT03269136|467676130|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
129921203|NCT03269136|467676131|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
129921204|NCT03269136|467676132|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
129921205|NCT03269136|467676133|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
129921206|NCT03269136|467676134|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
129921207|NCT03269136|467676135|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
129921208|NCT03269136|467676136|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
129921209|NCT03269136|467676137|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
129921210|NCT03269136|467676138|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
129921211|NCT03269136|467676139|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
129921212|NCT03269136|467676140|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
129921213|NCT03269136|467676141|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
129921214|NCT03269136|467676142|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
129921215|NCT03269136|467676143|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
129921216|NCT03269136|467676144|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
129921217|NCT03269136|467676145|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
129921218|NCT03269136|467676146|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
129921219|NCT03269136|467676147|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
129921220|NCT04952909|467676150|FG000|Overall Study|Death|3|||
129921221|NCT05308004|467676151|FG000|Overall Study|Not seen by Palliative Care NP|0|||
129921222|NCT05308004|467676152|FG001|Overall Study|Not seen by Palliative Care NP|1|||
129921223|NCT03575897|467676153|FG000|Overall Study|Lost to Follow-up|12|||
129921224|NCT03575897|467676154|FG001|Overall Study|Lost to Follow-up|13|||
129921225|NCT05116787|467676161|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
129921226|NCT05116787|467676162|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
129921227|NCT05116787|467676161|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
129921228|NCT05116787|467676162|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
129921229|NCT05116787|467676161|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
129921230|NCT05116787|467676162|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
129921231|NCT05116787|467676161|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
129921232|NCT05116787|467676162|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
129921233|NCT04359108|467676163|FG000|Overall Study|Withdrawal by Subject|1|||
129921234|NCT04359108|467676164|FG001|Overall Study|Withdrawal by Subject|0|||
129921235|NCT04359108|467676163|FG000|Overall Study|Unable or too feeble to walk independently|0|||
129921236|NCT04359108|467676164|FG001|Overall Study|Unable or too feeble to walk independently|2|||
129921237|NCT04359108|467676163|FG000|Overall Study|Argus II system stopped functioning|0|||
129921238|NCT04359108|467676164|FG001|Overall Study|Argus II system stopped functioning|1|||
129921239|NCT04359108|467676163|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
129921240|NCT04359108|467676164|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
129921241|NCT06393088|467676165|FG000|Overall Study|Withdrawal by Subject|0|||
129921242|NCT06393088|467676166|FG001|Overall Study|Withdrawal by Subject|2|||
129921243|NCT02515773|467676167|FG000|Overall Study|Withdrawal by Subject|12|||
129921244|NCT02515773|467676168|FG001|Overall Study|Withdrawal by Subject|2|||
129921245|NCT02515773|467676167|FG000|Overall Study|Lost to Follow-up|119|||
129921246|NCT02515773|467676168|FG001|Overall Study|Lost to Follow-up|126|||
129921247|NCT02515773|467676167|FG000|Overall Study|Discharged from Clinic Services|53|||
129921248|NCT02515773|467676168|FG001|Overall Study|Discharged from Clinic Services|84|||
129921249|NCT02515773|467676167|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
129921250|NCT02515773|467676168|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
129921251|NCT02515773|467676167|FG000|Overall Study|Follow-up at non-study site|8|||
129921252|NCT02515773|467676168|FG001|Overall Study|Follow-up at non-study site|16|||
129921253|NCT02515773|467676167|FG000|Overall Study|Moved from area|9|||
129921254|NCT02515773|467676168|FG001|Overall Study|Moved from area|14|||
129921255|NCT03652688|467676169|FG000|Baseline|Withdrawal by Subject|0|||
129921256|NCT03652688|467676170|FG001|Baseline|Withdrawal by Subject|3|||
129921257|NCT03652688|467676169|FG000|Follow-up|Lost to Follow-up|56|||
129921258|NCT03652688|467676170|FG001|Follow-up|Lost to Follow-up|54|||
129921259|NCT04924660|467676171|FG000|United States|Death|29|||
129921260|NCT04924660|467676172|FG001|United States|Death|32|||
129921261|NCT04924660|467676173|FG002|United States|Death|34|||
129921262|NCT04924660|467676174|FG003|United States|Death|25|||
129921263|NCT04924660|467676175|FG004|United States|Death|26|||
129921264|NCT04924660|467676176|FG005|United States|Death|23|||
129921265|NCT04924660|467676171|FG000|United States|Lost to Follow-up|15|||
129921266|NCT04924660|467676172|FG001|United States|Lost to Follow-up|10|||
129921267|NCT04924660|467676173|FG002|United States|Lost to Follow-up|13|||
129921268|NCT04924660|467676174|FG003|United States|Lost to Follow-up|5|||
129921269|NCT04924660|467676175|FG004|United States|Lost to Follow-up|19|||
129921270|NCT04924660|467676176|FG005|United States|Lost to Follow-up|20|||
129921271|NCT04924660|467676171|FG000|United States|Withdrawal by Subject|8|||
129921272|NCT04924660|467676172|FG001|United States|Withdrawal by Subject|3|||
129921273|NCT04924660|467676173|FG002|United States|Withdrawal by Subject|3|||
129921274|NCT04924660|467676174|FG003|United States|Withdrawal by Subject|3|||
129921275|NCT04924660|467676175|FG004|United States|Withdrawal by Subject|8|||
129921276|NCT04924660|467676176|FG005|United States|Withdrawal by Subject|4|||
129921277|NCT04924660|467676171|FG000|Spain|Death|0|||
129921278|NCT04924660|467676172|FG001|Spain|Death|0|||
129921279|NCT04924660|467676173|FG002|Spain|Death|0|||
129921280|NCT04924660|467676174|FG003|Spain|Death|0|||
129921281|NCT04924660|467676175|FG004|Spain|Death|0|||
129921282|NCT04924660|467676176|FG005|Spain|Death|2|||
129921283|NCT04924660|467676171|FG000|Spain|Lost to Follow-up|0|||
129921284|NCT04924660|467676172|FG001|Spain|Lost to Follow-up|0|||
129921285|NCT04924660|467676173|FG002|Spain|Lost to Follow-up|0|||
129921286|NCT04924660|467676174|FG003|Spain|Lost to Follow-up|0|||
129921287|NCT04924660|467676175|FG004|Spain|Lost to Follow-up|1|||
129921288|NCT04924660|467676176|FG005|Spain|Lost to Follow-up|0|||
129921289|NCT04924660|467676171|FG000|Brazil|Death|0|||
129921290|NCT04924660|467676172|FG001|Brazil|Death|0|||
129921291|NCT04924660|467676173|FG002|Brazil|Death|0|||
129921292|NCT04924660|467676174|FG003|Brazil|Death|0|||
129921293|NCT04924660|467676175|FG004|Brazil|Death|1|||
129921294|NCT04924660|467676176|FG005|Brazil|Death|0|||
129921295|NCT04924660|467676171|FG000|Italy|Lost to Follow-up|0|||
129921296|NCT04924660|467676172|FG001|Italy|Lost to Follow-up|0|||
129921297|NCT04924660|467676173|FG002|Italy|Lost to Follow-up|0|||
129921298|NCT04924660|467676174|FG003|Italy|Lost to Follow-up|0|||
129921299|NCT04924660|467676175|FG004|Italy|Lost to Follow-up|0|||
129921300|NCT04924660|467676176|FG005|Italy|Lost to Follow-up|1|||
129921301|NCT04924660|467676171|FG000|South Africa|Death|0|||
129921302|NCT04924660|467676172|FG001|South Africa|Death|0|||
129921303|NCT04924660|467676173|FG002|South Africa|Death|0|||
129921304|NCT04924660|467676174|FG003|South Africa|Death|0|||
129921305|NCT04924660|467676175|FG004|South Africa|Death|0|||
129921306|NCT04924660|467676176|FG005|South Africa|Death|1|||
129921307|NCT04924660|467676171|FG000|South Africa|Lost to Follow-up|0|||
129921308|NCT04924660|467676172|FG001|South Africa|Lost to Follow-up|0|||
129921309|NCT04924660|467676173|FG002|South Africa|Lost to Follow-up|0|||
129921310|NCT04924660|467676174|FG003|South Africa|Lost to Follow-up|0|||
129921311|NCT04924660|467676175|FG004|South Africa|Lost to Follow-up|0|||
129921312|NCT04924660|467676176|FG005|South Africa|Lost to Follow-up|1|||
129921313|NCT03611491|467676177|FG000|Overall Study|Lost to Follow-up|1|||
129921314|NCT05894577|467676178|FG000|Overall Study|No receipt of study drug|14|||
129921315|NCT05894577|467676179|FG001|Overall Study|No receipt of study drug|13|||
129921316|NCT05894577|467676178|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
129921317|NCT05894577|467676179|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
129921318|NCT05894577|467676178|FG000|Overall Study|Screen Fail|2|||
129921319|NCT05894577|467676179|FG001|Overall Study|Screen Fail|0|||
129921320|NCT05894577|467676178|FG000|Overall Study|Study drug recall|86|||
129921321|NCT05894577|467676179|FG001|Overall Study|Study drug recall|63|||
129921322|NCT04015167|467676192|FG000|Overall Study|Lost to Follow-up|40|||
129921323|NCT04015167|467676192|FG000|Overall Study|Adverse Event|5|||
129921324|NCT04015167|467676192|FG000|Overall Study|Withdrawal by Subject|2|||
129921325|NCT04015167|467676192|FG000|Overall Study|Subject went to jail|1|||
129921326|NCT03640312|467676193|FG000|Overall Study|Lost to Follow-up|3|||
129921327|NCT03640312|467676194|FG001|Overall Study|Lost to Follow-up|6|||
129921328|NCT02761057|467676200|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
129921329|NCT02761057|467676201|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
129921330|NCT02761057|467676202|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
129921331|NCT02761057|467676203|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
129921332|NCT02761057|467676200|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
129921333|NCT02761057|467676201|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
129921334|NCT02761057|467676202|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
129921335|NCT02761057|467676203|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
129921336|NCT02761057|467676200|FG000|Overall Study|Currently On Study Treatment|0|||
129921337|NCT02761057|467676201|FG001|Overall Study|Currently On Study Treatment|3|||
129921338|NCT02761057|467676202|FG002|Overall Study|Currently On Study Treatment|0|||
129921339|NCT02761057|467676203|FG003|Overall Study|Currently On Study Treatment|0|||
129921340|NCT02761057|467676200|FG000|Overall Study|Adverse Event|11|||
129921341|NCT02761057|467676201|FG001|Overall Study|Adverse Event|9|||
129921342|NCT02761057|467676202|FG002|Overall Study|Adverse Event|5|||
129921343|NCT02761057|467676203|FG003|Overall Study|Adverse Event|3|||
129921344|NCT02761057|467676200|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
129921345|NCT02761057|467676201|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
129921346|NCT02761057|467676202|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
129921347|NCT02761057|467676203|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
129921348|NCT02761057|467676200|FG000|Overall Study|Progression/Relapse|29|||
129921349|NCT02761057|467676201|FG001|Overall Study|Progression/Relapse|27|||
129921350|NCT02761057|467676202|FG002|Overall Study|Progression/Relapse|20|||
129921351|NCT02761057|467676203|FG003|Overall Study|Progression/Relapse|23|||
129921352|NCT02761057|467676200|FG000|Overall Study|Death|2|||
129921353|NCT02761057|467676201|FG001|Overall Study|Death|2|||
129921354|NCT02761057|467676202|FG002|Overall Study|Death|1|||
129921355|NCT02761057|467676203|FG003|Overall Study|Death|1|||
129921356|NCT02761057|467676200|FG000|Overall Study|Other - Not Protocol Specified|2|||
129921357|NCT02761057|467676201|FG001|Overall Study|Other - Not Protocol Specified|1|||
129921358|NCT02761057|467676202|FG002|Overall Study|Other - Not Protocol Specified|2|||
129921359|NCT02761057|467676203|FG003|Overall Study|Other - Not Protocol Specified|0|||
129921360|NCT04876118|467676204|FG000|Overall Study|Pregnancy|1|||
129921361|NCT04876118|467676204|FG000|Overall Study|Withdrawal by Subject|14|||
129921362|NCT04229992|467677893|FG000|Overall Study|Withdrawal by Subject|0|||
129921363|NCT04229992|467677894|FG001|Overall Study|Withdrawal by Subject|2|||
129921364|NCT04229992|467677895|FG002|Overall Study|Withdrawal by Subject|1|||
129921365|NCT04229992|467677896|FG003|Overall Study|Withdrawal by Subject|1|||
129921366|NCT04229992|467677893|FG000|Overall Study|Adverse Event|1|||
129921367|NCT04229992|467677894|FG001|Overall Study|Adverse Event|1|||
129921368|NCT04229992|467677895|FG002|Overall Study|Adverse Event|3|||
129921369|NCT04229992|467677896|FG003|Overall Study|Adverse Event|1|||
129921370|NCT04229992|467677893|FG000|Overall Study|Lost to Follow-up|0|||
129921371|NCT04229992|467677894|FG001|Overall Study|Lost to Follow-up|0|||
129921372|NCT04229992|467677895|FG002|Overall Study|Lost to Follow-up|0|||
129921373|NCT04229992|467677896|FG003|Overall Study|Lost to Follow-up|1|||
129921374|NCT03770273|467677897|FG000|Overall Study|Adverse Event|2|||
129921375|NCT03770273|467677898|FG001|Overall Study|Adverse Event|0|||
129921376|NCT03770273|467677897|FG000|Overall Study|Lost to Follow-up|1|||
129921377|NCT03770273|467677898|FG001|Overall Study|Lost to Follow-up|1|||
129921378|NCT00418886|467677899|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
129921379|NCT00418886|467677900|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
129921380|NCT00418886|467677899|FG000|Randomized Period|Death|122|||
129921381|NCT00418886|467677900|FG001|Randomized Period|Death|147|||
129921382|NCT00418886|467677899|FG000|Randomized Period|Withdrawal by Subject|9|||
129921383|NCT00418886|467677900|FG001|Randomized Period|Withdrawal by Subject|10|||
129921384|NCT00418886|467677899|FG000|Randomized Period|Lost to Follow-up|4|||
129921385|NCT00418886|467677900|FG001|Randomized Period|Lost to Follow-up|6|||
129921386|NCT00418886|467677899|FG000|Randomized Period|withdrawn due to other reason|1|||
129921387|NCT00418886|467677900|FG001|Randomized Period|withdrawn due to other reason|0|||
129921388|NCT00418886|467677899|FG000|Randomized Period|randomised but no treatment received|0|||
129921389|NCT00418886|467677900|FG001|Randomized Period|randomised but no treatment received|1|||
129921390|NCT04060654|467677901|FG000|Overall Study|Withdrawal by Subject|1|||
129921391|NCT04060654|467677901|FG000|Overall Study|Lost to Follow-up|5|||
129921392|NCT03707951|467677902|FG000|Overall Study|Lost to Follow-up|8|||
129921393|NCT03707951|467677903|FG001|Overall Study|Lost to Follow-up|17|||
129921394|NCT03707951|467677902|FG000|Overall Study|Withdrawal by Subject|6|||
129921395|NCT03707951|467677903|FG001|Overall Study|Withdrawal by Subject|6|||
129921396|NCT04887129|467677904|FG000|Overall Study|Lost to Follow-up|0|||
129921397|NCT04887129|467677905|FG001|Overall Study|Lost to Follow-up|24|||
129921398|NCT04887129|467677904|FG000|Overall Study|Withdrawal by Subject|9|||
129921399|NCT04887129|467677905|FG001|Overall Study|Withdrawal by Subject|57|||
129921400|NCT04887129|467677904|FG000|Overall Study|Other|2|||
129921401|NCT04887129|467677905|FG001|Overall Study|Other|9|||
129921402|NCT05177848|467677910|FG000|Overall Study|Lost to Follow-up|1|||
129921403|NCT05177848|467677911|FG001|Overall Study|Lost to Follow-up|4|||
129921404|NCT05177848|467677910|FG000|Overall Study|Discontinued|2|||
129921405|NCT05177848|467677911|FG001|Overall Study|Discontinued|1|||
129921406|NCT02035787|467677912|FG000|Overall Study- 12 Months|Adverse Event|3|||
129921407|NCT02035787|467677913|FG001|Overall Study- 12 Months|Adverse Event|0|||
129921408|NCT02035787|467677912|FG000|Overall Study- 12 Months|Complete response|4|||
129921409|NCT02035787|467677913|FG001|Overall Study- 12 Months|Complete response|1|||
129921410|NCT02035787|467677912|FG000|Overall Study- 12 Months|Protocol Violation|1|||
129921411|NCT02035787|467677913|FG001|Overall Study- 12 Months|Protocol Violation|1|||
129921412|NCT06414213|467677914|FG000|Overall Study|Lost to Follow-up|1|||
129921413|NCT06414213|467677915|FG001|Overall Study|Lost to Follow-up|1|||
129921414|NCT06414213|467677916|FG002|Overall Study|Lost to Follow-up|3|||
129921415|NCT03338933|467677917|FG000|Screening Visit|Lost to Follow-up|1|||
129921416|NCT03338933|467677918|FG001|Screening Visit|Lost to Follow-up|3|||
129921417|NCT03338933|467677919|FG002|Screening Visit|Lost to Follow-up|1|||
129921418|NCT03338933|467677920|FG003|Screening Visit|Lost to Follow-up|4|||
129921419|NCT03338933|467677917|FG000|Screening Visit|Screen fail after consent|2|||
129921420|NCT03338933|467677918|FG001|Screening Visit|Screen fail after consent|7|||
129921421|NCT03338933|467677919|FG002|Screening Visit|Screen fail after consent|1|||
129921422|NCT03338933|467677920|FG003|Screening Visit|Screen fail after consent|4|||
129921423|NCT03338933|467677917|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
129921424|NCT03338933|467677918|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
129921425|NCT03338933|467677919|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
129921426|NCT03338933|467677920|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
129921427|NCT03338933|467677917|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
129921428|NCT03338933|467677918|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
129921429|NCT03338933|467677919|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
129921430|NCT03338933|467677920|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
129921431|NCT03338933|467677917|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
129921432|NCT03338933|467677918|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
129921433|NCT03338933|467677919|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
129921434|NCT03338933|467677920|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
129921435|NCT01084876|467677922|FG000|Main Study Treatment Period|Adverse Event|12|||
129921436|NCT01084876|467677923|FG001|Main Study Treatment Period|Adverse Event|7|||
129921437|NCT01084876|467677922|FG000|Main Study Treatment Period|Disease Progression|41|||
129921438|NCT01084876|467677923|FG001|Main Study Treatment Period|Disease Progression|24|||
129921439|NCT01084876|467677922|FG000|Main Study Treatment Period|Physician Decision|2|||
129921440|NCT01084876|467677923|FG001|Main Study Treatment Period|Physician Decision|0|||
129921441|NCT01084876|467677922|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
129921442|NCT01084876|467677923|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
129921443|NCT01084876|467677922|FG000|Main Study Treatment Period|Other Reason|0|||
129921444|NCT01084876|467677923|FG001|Main Study Treatment Period|Other Reason|1|||
129921445|NCT01084876|467677922|FG000|Main Study Treatment Period|Other|0|||
129921446|NCT01084876|467677923|FG001|Main Study Treatment Period|Other|1|||
129921447|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
129921448|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
129921449|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
129921450|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
129921451|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
129921452|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
129921453|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
129921454|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
129921455|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
129921456|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
129921457|NCT01084876|467677922|FG000|Treatment Period Beyond Cycle 8|Other|6|||
129921458|NCT01084876|467677923|FG001|Treatment Period Beyond Cycle 8|Other|9|||
129921459|NCT02924272|467677933|FG000|Overall Study|Site Terminated by Sponsor|4|||
129921460|NCT02924272|467677934|FG001|Overall Study|Site Terminated by Sponsor|1|||
129921461|NCT02924272|467677933|FG000|Overall Study|Withdrawal by Subject|2|||
129921462|NCT02924272|467677934|FG001|Overall Study|Withdrawal by Subject|0|||
129921463|NCT02924272|467677933|FG000|Overall Study|Adverse Event|3|||
129921464|NCT02924272|467677934|FG001|Overall Study|Adverse Event|0|||
129921465|NCT02924272|467677933|FG000|Overall Study|Progressive Disease|11|||
129921466|NCT02924272|467677934|FG001|Overall Study|Progressive Disease|8|||
129921467|NCT02924272|467677933|FG000|Overall Study|Clinical Deterioration|1|||
129921468|NCT02924272|467677934|FG001|Overall Study|Clinical Deterioration|0|||
129921469|NCT02924272|467677933|FG000|Overall Study|Death|1|||
129921470|NCT02924272|467677934|FG001|Overall Study|Death|0|||
129921471|NCT02924272|467677933|FG000|Overall Study|Reason Not Specified|1|||
129921472|NCT02924272|467677934|FG001|Overall Study|Reason Not Specified|0|||
129921473|NCT03468218|467677942|FG000|Overall Study|Adverse Event|5|||
129921474|NCT03468218|467677942|FG000|Overall Study|Progressive Disease|16|||
129921475|NCT03468218|467677942|FG000|Overall Study|Death|1|||
129921476|NCT03468218|467677942|FG000|Overall Study|Alternate therapy|1|||
129921477|NCT03468218|467677942|FG000|Overall Study|Withdrawal by Subject|2|||
129921478|NCT03829410|467677944|FG000|Overall Study|Adverse Event|1|||
129921479|NCT03829410|467677945|FG001|Overall Study|Adverse Event|0|||
129921480|NCT03829410|467677946|FG002|Overall Study|Adverse Event|1|||
129921481|NCT03829410|467677947|FG003|Overall Study|Adverse Event|4|||
129921482|NCT03829410|467677944|FG000|Overall Study|Physician Decision|0|||
129921483|NCT03829410|467677945|FG001|Overall Study|Physician Decision|0|||
129921484|NCT03829410|467677946|FG002|Overall Study|Physician Decision|0|||
129921485|NCT03829410|467677947|FG003|Overall Study|Physician Decision|2|||
129921486|NCT03829410|467677944|FG000|Overall Study|Disease Progressing|3|||
129921487|NCT03829410|467677945|FG001|Overall Study|Disease Progressing|4|||
129921488|NCT03829410|467677946|FG002|Overall Study|Disease Progressing|2|||
129921489|NCT03829410|467677947|FG003|Overall Study|Disease Progressing|31|||
129921490|NCT03829410|467677944|FG000|Overall Study|Miscellaneous|2|||
129921491|NCT03829410|467677945|FG001|Overall Study|Miscellaneous|4|||
129921492|NCT03829410|467677946|FG002|Overall Study|Miscellaneous|3|||
129921493|NCT03829410|467677947|FG003|Overall Study|Miscellaneous|10|||
129921494|NCT03719443|467677948|FG000|Overall Study|Lost to Follow-up|0|||
129921495|NCT03719443|467677949|FG001|Overall Study|Lost to Follow-up|0|||
129921496|NCT03719443|467677950|FG002|Overall Study|Lost to Follow-up|1|||
129921497|NCT03719443|467677951|FG003|Overall Study|Lost to Follow-up|0|||
129921498|NCT03719443|467677952|FG004|Overall Study|Lost to Follow-up|1|||
129921499|NCT03719443|467677953|FG005|Overall Study|Lost to Follow-up|0|||
129921500|NCT03719443|467677954|FG006|Overall Study|Lost to Follow-up|1|||
129921501|NCT03719443|467677948|FG000|Overall Study|Withdrawal by Subject|0|||
129921502|NCT03719443|467677949|FG001|Overall Study|Withdrawal by Subject|0|||
129921503|NCT03719443|467677950|FG002|Overall Study|Withdrawal by Subject|1|||
129921504|NCT03719443|467677951|FG003|Overall Study|Withdrawal by Subject|0|||
129921505|NCT03719443|467677952|FG004|Overall Study|Withdrawal by Subject|0|||
129921506|NCT03719443|467677953|FG005|Overall Study|Withdrawal by Subject|0|||
129921507|NCT03719443|467677954|FG006|Overall Study|Withdrawal by Subject|0|||
129921508|NCT06205407|467677955|FG000|Period 2|Withdrawal by Subject|0|||
129921509|NCT06205407|467677956|FG001|Period 2|Withdrawal by Subject|1|||
129921510|NCT06205407|467677955|FG000|Period 2|Adverse Event|2|||
129921511|NCT06205407|467677956|FG001|Period 2|Adverse Event|1|||
129921512|NCT04676022|467677958|FG000|Overall Study|Screen Failure/|1|||
129921513|NCT04676022|467677959|FG001|Overall Study|Screen Failure/|1|||
129921514|NCT04676022|467677960|FG002|Overall Study|Screen Failure/|85|||
129921515|NCT04676022|467677958|FG000|Overall Study|Lost to Follow-up|1|||
129921516|NCT04676022|467677959|FG001|Overall Study|Lost to Follow-up|1|||
129921517|NCT04676022|467677960|FG002|Overall Study|Lost to Follow-up|0|||
129921518|NCT04676022|467677958|FG000|Overall Study|Adverse Event|2|||
129921519|NCT04676022|467677959|FG001|Overall Study|Adverse Event|0|||
129921520|NCT04676022|467677960|FG002|Overall Study|Adverse Event|1|||
129921521|NCT04676022|467677958|FG000|Overall Study|Physician Decision|2|||
129921522|NCT04676022|467677959|FG001|Overall Study|Physician Decision|0|||
129921523|NCT04676022|467677960|FG002|Overall Study|Physician Decision|1|||
129921524|NCT04676022|467677958|FG000|Overall Study|Withdrawal by Subject|3|||
129921525|NCT04676022|467677959|FG001|Overall Study|Withdrawal by Subject|1|||
129921526|NCT04676022|467677960|FG002|Overall Study|Withdrawal by Subject|6|||
129921527|NCT04676022|467677958|FG000|Overall Study|Will not move forward with permanent implant|6|||
129921528|NCT04676022|467677959|FG001|Overall Study|Will not move forward with permanent implant|0|||
129921529|NCT04676022|467677960|FG002|Overall Study|Will not move forward with permanent implant|0|||
129921530|NCT04676022|467677958|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
129921531|NCT04676022|467677959|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
129921532|NCT04676022|467677960|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
129921533|NCT05409183|467677964|FG000|Complete Study|Adverse Event|1|||
129921534|NCT05409183|467677965|FG001|Complete Study|Adverse Event|2|||
129921535|NCT05409183|467677964|FG000|Complete Study|Withdrawal by Subject|3|||
129921536|NCT05409183|467677965|FG001|Complete Study|Withdrawal by Subject|0|||
129921537|NCT02274662|467677966|FG000|Overall Study|Death|1|||
129921538|NCT02274662|467677966|FG000|Overall Study|Lost to Follow-up|3|||
129921539|NCT03194217|467677967|FG000|Overall Study|Adverse Event|0|||
129921540|NCT03194217|467677968|FG001|Overall Study|Adverse Event|2|||
129921541|NCT03194217|467677969|FG002|Overall Study|Adverse Event|3|||
129921542|NCT03194217|467677970|FG003|Overall Study|Adverse Event|3|||
129921543|NCT03194217|467677967|FG000|Overall Study|Failure to meet randomisation criteria|0|||
129921544|NCT03194217|467677968|FG001|Overall Study|Failure to meet randomisation criteria|0|||
129921545|NCT03194217|467677969|FG002|Overall Study|Failure to meet randomisation criteria|0|||
129921546|NCT03194217|467677970|FG003|Overall Study|Failure to meet randomisation criteria|1|||
129921547|NCT03194217|467677967|FG000|Overall Study|Other|0|||
129921548|NCT03194217|467677968|FG001|Overall Study|Other|1|||
129921549|NCT03194217|467677969|FG002|Overall Study|Other|1|||
129921550|NCT03194217|467677970|FG003|Overall Study|Other|0|||
129450030|NCT01994382|465947275|FG007|Overall Study|Protocol violation/noncompliance|0|||
129450031|NCT01994382|465947276|FG008|Overall Study|Protocol violation/noncompliance|0|||
129450032|NCT01994382|465947277|FG009|Overall Study|Protocol violation/noncompliance|0|||
129450033|NCT01994382|465947278|FG010|Overall Study|Protocol violation/noncompliance|0|||
129450034|NCT01994382|465947279|FG011|Overall Study|Protocol violation/noncompliance|1|||
129450035|NCT01994382|465947280|FG012|Overall Study|Protocol violation/noncompliance|0|||
129450036|NCT01994382|465947281|FG013|Overall Study|Protocol violation/noncompliance|0|||
129450037|NCT01994382|465947282|FG014|Overall Study|Protocol violation/noncompliance|0|||
129450038|NCT01994382|465947283|FG015|Overall Study|Protocol violation/noncompliance|0|||
129450039|NCT01994382|465947284|FG016|Overall Study|Protocol violation/noncompliance|2|||
129450040|NCT01994382|465947268|FG000|Overall Study|Rolled over to Phase 2a|0|||
129450041|NCT01994382|465947269|FG001|Overall Study|Rolled over to Phase 2a|0|||
129450042|NCT01994382|465947270|FG002|Overall Study|Rolled over to Phase 2a|1|||
129450043|NCT01994382|465947271|FG003|Overall Study|Rolled over to Phase 2a|0|||
129450044|NCT01994382|465947272|FG004|Overall Study|Rolled over to Phase 2a|0|||
129450045|NCT01994382|465947273|FG005|Overall Study|Rolled over to Phase 2a|0|||
129450046|NCT01994382|465947274|FG006|Overall Study|Rolled over to Phase 2a|0|||
129450047|NCT01994382|465947275|FG007|Overall Study|Rolled over to Phase 2a|0|||
129450048|NCT01994382|465947276|FG008|Overall Study|Rolled over to Phase 2a|0|||
129450049|NCT01994382|465947277|FG009|Overall Study|Rolled over to Phase 2a|2|||
129450050|NCT01994382|465947278|FG010|Overall Study|Rolled over to Phase 2a|0|||
129450051|NCT01994382|465947279|FG011|Overall Study|Rolled over to Phase 2a|0|||
129450052|NCT01994382|465947280|FG012|Overall Study|Rolled over to Phase 2a|0|||
129450053|NCT01994382|465947281|FG013|Overall Study|Rolled over to Phase 2a|0|||
129450054|NCT01994382|465947282|FG014|Overall Study|Rolled over to Phase 2a|0|||
129450055|NCT01994382|465947283|FG015|Overall Study|Rolled over to Phase 2a|0|||
129450056|NCT01994382|465947284|FG016|Overall Study|Rolled over to Phase 2a|0|||
129450057|NCT01835015|465947285|FG000|Overall Study|Adverse Event|0|||
129450058|NCT01835015|465947286|FG001|Overall Study|Adverse Event|0|||
129450059|NCT01835015|465947287|FG002|Overall Study|Adverse Event|1|||
129450060|NCT01835015|465947288|FG003|Overall Study|Adverse Event|0|||
129450061|NCT01835015|465947289|FG004|Overall Study|Adverse Event|0|||
129450062|NCT04109222|465947294|FG000|Overall Study|Adverse Event|1|||
129450063|NCT04109222|465947295|FG001|Overall Study|Adverse Event|0|||
129450064|NCT04109222|465947296|FG002|Overall Study|Adverse Event|0|||
129450065|NCT04569032|465947299|FG000|Overall Study|Death|10|||
129450066|NCT04569032|465947300|FG001|Overall Study|Death|13|||
129450067|NCT04569032|465947299|FG000|Overall Study|Withdrawal by Subject|2|||
129921551|NCT02936752|467677971|FG000|Overall Study|Death|2|||
129921552|NCT02936752|467677972|FG001|Overall Study|Death|1|||
129921553|NCT02936752|467677971|FG000|Overall Study|Physician Decision|4|||
129921554|NCT02936752|467677972|FG001|Overall Study|Physician Decision|0|||
129921555|NCT02936752|467677971|FG000|Overall Study|Withdrawal by Subject|0|||
129921556|NCT02936752|467677972|FG001|Overall Study|Withdrawal by Subject|2|||
129921557|NCT04489771|467677975|FG000|Overall Study|Death|27|||
129921558|NCT04489771|467677976|FG001|Overall Study|Death|25|||
129921559|NCT04489771|467677975|FG000|Overall Study|Withdrawal by Subject|1|||
129921560|NCT04489771|467677976|FG001|Overall Study|Withdrawal by Subject|0|||
129921561|NCT04489771|467677975|FG000|Overall Study|Participants Ongoing in Study|50|||
129921562|NCT04489771|467677976|FG001|Overall Study|Participants Ongoing in Study|51|||
129921563|NCT04509674|467677981|FG000|Overall Study|Not treated|33|||
129921564|NCT04509674|467677982|FG001|Overall Study|Not treated|26|||
129921565|NCT04509674|467677981|FG000|Overall Study|Protocol Violation|9|||
129921566|NCT04509674|467677982|FG001|Overall Study|Protocol Violation|10|||
129921567|NCT04509674|467677981|FG000|Overall Study|Lost to Follow-up|31|||
129921568|NCT04509674|467677982|FG001|Overall Study|Lost to Follow-up|39|||
129921569|NCT04509674|467677981|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
129921570|NCT04509674|467677982|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
129921571|NCT04509674|467677981|FG000|Overall Study|Adverse event, serious fatal event|11|||
129921572|NCT04509674|467677982|FG001|Overall Study|Adverse event, serious fatal event|4|||
129921573|NCT04509674|467677981|FG000|Overall Study|Adverse event, non-fatal event|107|||
129921574|NCT04509674|467677982|FG001|Overall Study|Adverse event, non-fatal event|118|||
129921575|NCT04509674|467677981|FG000|Overall Study|Other reason than listed|106|||
129921576|NCT04509674|467677982|FG001|Overall Study|Other reason than listed|95|||
129921577|NCT03197662|467677983|FG000|Overall Study|Withdrawn by family|0|||
129921578|NCT03197662|467677984|FG001|Overall Study|Withdrawn by family|2|||
129921579|NCT01214616|467677985|FG000|Overall Study|Progressive disease|2|||
129450068|NCT04569032|465947300|FG001|Overall Study|Withdrawal by Subject|0|||
129450069|NCT04569032|465947299|FG000|Overall Study|Lost to Follow-up|0|||
129450070|NCT04569032|465947300|FG001|Overall Study|Lost to Follow-up|1|||
129450071|NCT04569032|465947299|FG000|Overall Study|In long term follow up|22|||
129450072|NCT04569032|465947300|FG001|Overall Study|In long term follow up|34|||
129450073|NCT00701090|465947302|FG000|Overall Study|Adverse Event|11|||
129450074|NCT00701090|465947303|FG001|Overall Study|Adverse Event|2|||
129450075|NCT00701090|465947302|FG000|Overall Study|Death|0|||
129450076|NCT00701090|465947303|FG001|Overall Study|Death|1|||
129921580|NCT01214616|467677986|FG001|Overall Study|Progressive disease|2|||
129921581|NCT01214616|467677987|FG002|Overall Study|Progressive disease|2|||
129921582|NCT01214616|467677988|FG003|Overall Study|Progressive disease|4|||
129921583|NCT01214616|467677985|FG000|Overall Study|Dose limiting toxicity|0|||
129921584|NCT01214616|467677986|FG001|Overall Study|Dose limiting toxicity|2|||
129921585|NCT01214616|467677987|FG002|Overall Study|Dose limiting toxicity|0|||
129921586|NCT01214616|467677988|FG003|Overall Study|Dose limiting toxicity|0|||
129921587|NCT01214616|467677985|FG000|Overall Study|Other adverse events|0|||
129921588|NCT01214616|467677986|FG001|Overall Study|Other adverse events|1|||
129921589|NCT01214616|467677987|FG002|Overall Study|Other adverse events|1|||
129921590|NCT01214616|467677988|FG003|Overall Study|Other adverse events|1|||
129921591|NCT01214616|467677985|FG000|Overall Study|Withdrawal by Subject|1|||
129921592|NCT01214616|467677986|FG001|Overall Study|Withdrawal by Subject|0|||
129921593|NCT01214616|467677987|FG002|Overall Study|Withdrawal by Subject|0|||
129921594|NCT01214616|467677988|FG003|Overall Study|Withdrawal by Subject|1|||
129921595|NCT03721952|467677989|FG000|Overall Study|Lost to Follow-up|0|||
129921596|NCT03721952|467677990|FG001|Overall Study|Lost to Follow-up|0|||
129921597|NCT03721952|467677991|FG002|Overall Study|Lost to Follow-up|2|||
129921598|NCT03721952|467677992|FG003|Overall Study|Lost to Follow-up|0|||
129921599|NCT03721952|467677993|FG004|Overall Study|Lost to Follow-up|0|||
129921600|NCT03721952|467677989|FG000|Overall Study|Protocol Violation|0|||
129921601|NCT03721952|467677990|FG001|Overall Study|Protocol Violation|1|||
129921602|NCT03721952|467677991|FG002|Overall Study|Protocol Violation|0|||
129921603|NCT03721952|467677992|FG003|Overall Study|Protocol Violation|0|||
129921604|NCT03721952|467677993|FG004|Overall Study|Protocol Violation|0|||
129921605|NCT03721952|467677989|FG000|Overall Study|Withdrawal by Subject|1|||
129921606|NCT03721952|467677990|FG001|Overall Study|Withdrawal by Subject|0|||
129921607|NCT03721952|467677991|FG002|Overall Study|Withdrawal by Subject|40|||
129921608|NCT03721952|467677992|FG003|Overall Study|Withdrawal by Subject|28|||
129921609|NCT03721952|467677993|FG004|Overall Study|Withdrawal by Subject|0|||
129921610|NCT05292365|467677996|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
129921611|NCT05292365|467677997|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
129921612|NCT05292365|467677998|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
129921613|NCT05292365|467677999|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
129921614|NCT04495894|467678008|FG000|Overall Study|Withdrawal by Subject|2|||
129921615|NCT04495894|467678009|FG001|Overall Study|Withdrawal by Subject|0|||
129921616|NCT04495894|467678010|FG002|Overall Study|Withdrawal by Subject|2|||
129921617|NCT04495894|467678011|FG003|Overall Study|Withdrawal by Subject|3|||
129921618|NCT04495894|467678008|FG000|Overall Study|Early termination|0|||
129921619|NCT04495894|467678009|FG001|Overall Study|Early termination|0|||
129921620|NCT04495894|467678010|FG002|Overall Study|Early termination|3|||
129921621|NCT04495894|467678011|FG003|Overall Study|Early termination|0|||
129921622|NCT05579899|467678013|FG000|Overall Study|Lost to Follow-up|3|||
129921623|NCT05579899|467678014|FG001|Overall Study|Lost to Follow-up|1|||
129921624|NCT05579899|467678013|FG000|Overall Study|Adverse Event|0|||
129921625|NCT05579899|467678014|FG001|Overall Study|Adverse Event|3|||
129921626|NCT05579899|467678013|FG000|Overall Study|Pregnancy|0|||
129921627|NCT05579899|467678014|FG001|Overall Study|Pregnancy|1|||
129921628|NCT05579899|467678013|FG000|Overall Study|Withdrawal by Subject|0|||
129921629|NCT05579899|467678014|FG001|Overall Study|Withdrawal by Subject|3|||
129921630|NCT01000961|467678018|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
129921631|NCT01000961|467678019|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129921632|NCT01000961|467678018|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
129921633|NCT01000961|467678019|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
129921634|NCT04185298|467678023|FG000|Overall Study|Lost to Follow-up|1|||
129921635|NCT04185298|467678024|FG001|Overall Study|Lost to Follow-up|3|||
129921636|NCT04185298|467678023|FG000|Overall Study|Withdrawal by Subject|0|||
129921637|NCT04185298|467678024|FG001|Overall Study|Withdrawal by Subject|3|||
129921638|NCT01798498|467678025|FG000|Overall Study|Lost to Follow-up|1|||
129921639|NCT03896789|467678026|FG000|Baseline|Lost to Follow-up|1|||
129921640|NCT03896789|467678027|FG001|Baseline|Lost to Follow-up|2|||
129921641|NCT03896789|467678026|FG000|Baseline|Death|3|||
129921642|NCT03896789|467678027|FG001|Baseline|Death|6|||
129921643|NCT03896789|467678026|FG000|Post-Randomization|Lost to Follow-up|12|||
129921644|NCT03896789|467678027|FG001|Post-Randomization|Lost to Follow-up|11|||
129921645|NCT03896789|467678026|FG000|Post-Randomization|Death|12|||
129921646|NCT03896789|467678027|FG001|Post-Randomization|Death|13|||
129921647|NCT03447470|467678028|FG000|Overall Study|Death|0|||
129921648|NCT03447470|467678029|FG001|Overall Study|Death|1|||
129921649|NCT03447470|467678030|FG002|Overall Study|Death|3|||
129921650|NCT03447470|467678031|FG003|Overall Study|Death|0|||
129921651|NCT03447470|467678032|FG004|Overall Study|Death|1|||
129921652|NCT03447470|467678033|FG005|Overall Study|Death|0|||
129921653|NCT03447470|467678034|FG006|Overall Study|Death|3|||
129921654|NCT03447470|467678035|FG007|Overall Study|Death|3|||
129921655|NCT03447470|467678036|FG008|Overall Study|Death|1|||
129921656|NCT03447470|467678028|FG000|Overall Study|Withdrawal by Subject|1|||
129921657|NCT03447470|467678029|FG001|Overall Study|Withdrawal by Subject|0|||
129921658|NCT03447470|467678030|FG002|Overall Study|Withdrawal by Subject|0|||
129921659|NCT03447470|467678031|FG003|Overall Study|Withdrawal by Subject|0|||
129921660|NCT03447470|467678032|FG004|Overall Study|Withdrawal by Subject|1|||
129921661|NCT03447470|467678033|FG005|Overall Study|Withdrawal by Subject|0|||
129921662|NCT03447470|467678034|FG006|Overall Study|Withdrawal by Subject|1|||
129921663|NCT03447470|467678035|FG007|Overall Study|Withdrawal by Subject|1|||
129921664|NCT03447470|467678036|FG008|Overall Study|Withdrawal by Subject|3|||
129921665|NCT03447470|467678028|FG000|Overall Study|Treatment discontinued|3|||
129921666|NCT03447470|467678029|FG001|Overall Study|Treatment discontinued|2|||
129921667|NCT03447470|467678030|FG002|Overall Study|Treatment discontinued|4|||
129921668|NCT03447470|467678031|FG003|Overall Study|Treatment discontinued|6|||
129921669|NCT03447470|467678032|FG004|Overall Study|Treatment discontinued|2|||
129921670|NCT03447470|467678033|FG005|Overall Study|Treatment discontinued|1|||
129921671|NCT03447470|467678034|FG006|Overall Study|Treatment discontinued|2|||
129921672|NCT03447470|467678035|FG007|Overall Study|Treatment discontinued|4|||
129921673|NCT03447470|467678036|FG008|Overall Study|Treatment discontinued|3|||
129921674|NCT03382652|467678037|FG000|Overall Study|Lost to Follow-up|6|||
129921675|NCT03382652|467678037|FG000|Overall Study|Death|4|||
129921676|NCT03382652|467678037|FG000|Overall Study|Revision|5|||
129921677|NCT03382652|467678037|FG000|Overall Study|Patient withdrew|3|||
129921678|NCT03382652|467678037|FG000|Overall Study|Other reasons|21|||
129921679|NCT04810650|467678038|FG000|Overall Study|Disenrolled in error|0|||
129921680|NCT04810650|467678039|FG001|Overall Study|Disenrolled in error|0|||
129921681|NCT04810650|467678040|FG002|Overall Study|Disenrolled in error|0|||
129921682|NCT04810650|467678041|FG003|Overall Study|Disenrolled in error|0|||
129921683|NCT04810650|467678042|FG004|Overall Study|Disenrolled in error|0|||
129921684|NCT04810650|467678043|FG005|Overall Study|Disenrolled in error|0|||
129921685|NCT04810650|467678044|FG006|Overall Study|Disenrolled in error|0|||
129921686|NCT04810650|467678045|FG007|Overall Study|Disenrolled in error|0|||
129921687|NCT04810650|467678046|FG008|Overall Study|Disenrolled in error|1|||
129921688|NCT04810650|467678047|FG009|Overall Study|Disenrolled in error|0|||
129921689|NCT04810650|467678048|FG010|Overall Study|Disenrolled in error|0|||
129921690|NCT04810650|467678049|FG011|Overall Study|Disenrolled in error|0|||
129921691|NCT04810650|467678050|FG012|Overall Study|Disenrolled in error|0|||
129921692|NCT04810650|467678051|FG013|Overall Study|Disenrolled in error|0|||
129921693|NCT04810650|467678038|FG000|Overall Study|Death|0|||
129921694|NCT04810650|467678039|FG001|Overall Study|Death|0|||
129921695|NCT04810650|467678040|FG002|Overall Study|Death|0|||
129921696|NCT04810650|467678041|FG003|Overall Study|Death|0|||
129921697|NCT04810650|467678042|FG004|Overall Study|Death|0|||
129921698|NCT04810650|467678043|FG005|Overall Study|Death|0|||
129921699|NCT04810650|467678044|FG006|Overall Study|Death|2|||
129921700|NCT04810650|467678045|FG007|Overall Study|Death|2|||
129921701|NCT04810650|467678046|FG008|Overall Study|Death|0|||
129921702|NCT04810650|467678047|FG009|Overall Study|Death|1|||
129921703|NCT04810650|467678048|FG010|Overall Study|Death|0|||
129921704|NCT04810650|467678049|FG011|Overall Study|Death|0|||
129921705|NCT04810650|467678050|FG012|Overall Study|Death|2|||
129921706|NCT04810650|467678051|FG013|Overall Study|Death|1|||
129921707|NCT04810650|467678038|FG000|Overall Study|Moved/transferred care|0|||
129921708|NCT04810650|467678039|FG001|Overall Study|Moved/transferred care|0|||
129921709|NCT04810650|467678040|FG002|Overall Study|Moved/transferred care|0|||
129921710|NCT04810650|467678041|FG003|Overall Study|Moved/transferred care|0|||
129921711|NCT04810650|467678042|FG004|Overall Study|Moved/transferred care|0|||
129921712|NCT04810650|467678043|FG005|Overall Study|Moved/transferred care|0|||
129921713|NCT04810650|467678044|FG006|Overall Study|Moved/transferred care|0|||
129921714|NCT04810650|467678045|FG007|Overall Study|Moved/transferred care|1|||
129921715|NCT04810650|467678046|FG008|Overall Study|Moved/transferred care|12|||
129921716|NCT04810650|467678047|FG009|Overall Study|Moved/transferred care|10|||
129921717|NCT04810650|467678048|FG010|Overall Study|Moved/transferred care|0|||
129921718|NCT04810650|467678049|FG011|Overall Study|Moved/transferred care|0|||
129921719|NCT04810650|467678050|FG012|Overall Study|Moved/transferred care|0|||
129921720|NCT04810650|467678051|FG013|Overall Study|Moved/transferred care|0|||
129921721|NCT04810650|467678038|FG000|Overall Study|Lost to Follow-up|15|||
129921722|NCT04810650|467678039|FG001|Overall Study|Lost to Follow-up|12|||
129921723|NCT04810650|467678040|FG002|Overall Study|Lost to Follow-up|7|||
129921724|NCT04810650|467678041|FG003|Overall Study|Lost to Follow-up|9|||
129921725|NCT04810650|467678042|FG004|Overall Study|Lost to Follow-up|10|||
129921726|NCT04810650|467678043|FG005|Overall Study|Lost to Follow-up|6|||
129921727|NCT04810650|467678044|FG006|Overall Study|Lost to Follow-up|0|||
129921728|NCT04810650|467678045|FG007|Overall Study|Lost to Follow-up|0|||
129921729|NCT04810650|467678046|FG008|Overall Study|Lost to Follow-up|0|||
129921730|NCT04810650|467678047|FG009|Overall Study|Lost to Follow-up|0|||
129921731|NCT04810650|467678048|FG010|Overall Study|Lost to Follow-up|1|||
129921732|NCT04810650|467678049|FG011|Overall Study|Lost to Follow-up|0|||
129921733|NCT04810650|467678050|FG012|Overall Study|Lost to Follow-up|3|||
129921734|NCT04810650|467678051|FG013|Overall Study|Lost to Follow-up|9|||
129921735|NCT04810650|467678038|FG000|Overall Study|Participant declined|0|||
129921736|NCT04810650|467678039|FG001|Overall Study|Participant declined|0|||
129921737|NCT04810650|467678040|FG002|Overall Study|Participant declined|0|||
129921738|NCT04810650|467678041|FG003|Overall Study|Participant declined|0|||
129921739|NCT04810650|467678042|FG004|Overall Study|Participant declined|0|||
129921740|NCT04810650|467678043|FG005|Overall Study|Participant declined|0|||
129921741|NCT04810650|467678044|FG006|Overall Study|Participant declined|0|||
129921742|NCT04810650|467678045|FG007|Overall Study|Participant declined|0|||
129921743|NCT04810650|467678046|FG008|Overall Study|Participant declined|0|||
129921744|NCT04810650|467678047|FG009|Overall Study|Participant declined|0|||
129921745|NCT04810650|467678048|FG010|Overall Study|Participant declined|2|||
129921746|NCT04810650|467678049|FG011|Overall Study|Participant declined|0|||
129921747|NCT04810650|467678050|FG012|Overall Study|Participant declined|0|||
129921748|NCT04810650|467678051|FG013|Overall Study|Participant declined|0|||
129921749|NCT05794243|467678052|FG000|Overall Study|Withdrawal by Subject|1|||
129921750|NCT05794243|467678053|FG001|Overall Study|Withdrawal by Subject|0|||
129921751|NCT05794243|467678054|FG002|Overall Study|Withdrawal by Subject|1|||
129921752|NCT05794243|467678052|FG000|Overall Study|Physician Decision|0|||
129921753|NCT05794243|467678053|FG001|Overall Study|Physician Decision|3|||
129921754|NCT05794243|467678054|FG002|Overall Study|Physician Decision|1|||
129921755|NCT04788511|467678055|FG000|Overall Study|Withdrawal by Subject|2|||
129450077|NCT00701090|465947302|FG000|Overall Study|Lack of Efficacy|5|||
129921756|NCT04788511|467678056|FG001|Overall Study|Withdrawal by Subject|1|||
129921757|NCT04788511|467678055|FG000|Overall Study|Lost to Follow-up|2|||
129921758|NCT04788511|467678056|FG001|Overall Study|Lost to Follow-up|7|||
129921759|NCT04788511|467678055|FG000|Overall Study|Death|3|||
129921760|NCT04788511|467678056|FG001|Overall Study|Death|4|||
129921761|NCT04187833|467678057|FG000|Overall Study|Withdrawal by Subject|1|||
129921762|NCT05008835|467678059|FG000|Overall Study|Adverse Event|5|||
129921763|NCT05008835|467678060|FG001|Overall Study|Adverse Event|2|||
129921764|NCT05008835|467678061|FG002|Overall Study|Adverse Event|1|||
129921765|NCT05008835|467678059|FG000|Overall Study|Lack of Efficacy|0|||
129921766|NCT05008835|467678060|FG001|Overall Study|Lack of Efficacy|0|||
129921767|NCT05008835|467678061|FG002|Overall Study|Lack of Efficacy|1|||
129921768|NCT05008835|467678059|FG000|Overall Study|Study terminated by sponsor|0|||
129921769|NCT05008835|467678060|FG001|Overall Study|Study terminated by sponsor|0|||
129921770|NCT05008835|467678061|FG002|Overall Study|Study terminated by sponsor|1|||
129921771|NCT05008835|467678059|FG000|Overall Study|Not further specified|3|||
129921772|NCT05008835|467678060|FG001|Overall Study|Not further specified|2|||
129921773|NCT05008835|467678061|FG002|Overall Study|Not further specified|1|||
129921774|NCT04171999|467678062|FG000|Overall Study|deemed ineligible after randomization|2|||
129921775|NCT04171999|467678063|FG001|Overall Study|deemed ineligible after randomization|1|||
129921776|NCT04948697|467678064|FG000|Overall Study|Progressive disease|27|||
129921777|NCT04948697|467678065|FG001|Overall Study|Progressive disease|18|||
129921778|NCT04948697|467678064|FG000|Overall Study|Adverse Event|14|||
129921779|NCT04948697|467678065|FG001|Overall Study|Adverse Event|4|||
129921780|NCT04948697|467678064|FG000|Overall Study|Participant moved to long term extension study|7|||
129921781|NCT04948697|467678065|FG001|Overall Study|Participant moved to long term extension study|4|||
129921782|NCT04948697|467678064|FG000|Overall Study|Withdrawal by Subject|10|||
129921783|NCT04948697|467678065|FG001|Overall Study|Withdrawal by Subject|0|||
129921784|NCT04948697|467678064|FG000|Overall Study|Closed by Sponsor|3|||
129921785|NCT04948697|467678065|FG001|Overall Study|Closed by Sponsor|2|||
129921786|NCT04948697|467678064|FG000|Overall Study|Physician Decision|0|||
129921787|NCT04948697|467678065|FG001|Overall Study|Physician Decision|2|||
129921788|NCT04948697|467678064|FG000|Overall Study|Lost to Follow-up|0|||
129921789|NCT04948697|467678065|FG001|Overall Study|Lost to Follow-up|1|||
129921790|NCT04948697|467678064|FG000|Overall Study|Other-Miscellaneous|1|||
129921791|NCT04948697|467678065|FG001|Overall Study|Other-Miscellaneous|0|||
129921792|NCT04948697|467678064|FG000|Overall Study|Randomized but not treated|0|||
129921793|NCT04948697|467678065|FG001|Overall Study|Randomized but not treated|1|||
129921794|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
129921795|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
129921796|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
129921797|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
129921798|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
129921799|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
129921800|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
129921801|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
129921802|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
129921803|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
129921804|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
129921805|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
129921806|NCT04338061|467678066|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
129921807|NCT04338061|467678067|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
129921808|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
129450078|NCT00701090|465947303|FG001|Overall Study|Lack of Efficacy|4|||
129921809|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
129921810|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
129921811|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
129921812|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
129921813|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
129921814|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
129921815|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
129921816|NCT04338061|467678066|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
129921817|NCT04338061|467678067|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
129921818|NCT03365882|467678068|FG000|Randomization|Still Receiving Protocol Treatment|2|||
129921819|NCT03365882|467678069|FG001|Randomization|Still Receiving Protocol Treatment|0|||
129921820|NCT03365882|467678068|FG000|Randomization|Adverse Event|1|||
129921821|NCT03365882|467678069|FG001|Randomization|Adverse Event|2|||
129921822|NCT03365882|467678068|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
129921823|NCT03365882|467678069|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
129921824|NCT03365882|467678068|FG000|Randomization|Progression/Relapse|21|||
129921825|NCT03365882|467678069|FG001|Randomization|Progression/Relapse|3|||
129921826|NCT03365882|467678068|FG000|Randomization|Death|1|||
129921827|NCT03365882|467678069|FG001|Randomization|Death|0|||
129921828|NCT03365882|467678068|FG000|Randomization|Other - Not Protocol Specified|1|||
129921829|NCT03365882|467678069|FG001|Randomization|Other - Not Protocol Specified|1|||
129921830|NCT03365882|467678068|FG000|Randomization|Major Protocol Deviation|0|||
129921831|NCT03365882|467678069|FG001|Randomization|Major Protocol Deviation|1|||
129921832|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
129921833|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
129921834|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
129921835|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
129921836|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
129921837|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
129921838|NCT03365882|467678068|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
129921839|NCT03365882|467678069|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
129921840|NCT04515576|467680603|FG000|Overall Study|Withdrawal by Subject|0|||
129921841|NCT04515576|467680604|FG001|Overall Study|Withdrawal by Subject|0|||
129921842|NCT04515576|467680605|FG002|Overall Study|Withdrawal by Subject|0|||
129921843|NCT04515576|467680606|FG003|Overall Study|Withdrawal by Subject|0|||
129921844|NCT04515576|467680607|FG004|Overall Study|Withdrawal by Subject|0|||
129921845|NCT04515576|467680608|FG005|Overall Study|Withdrawal by Subject|1|||
129921846|NCT04971395|467680609|FG000|Overall Study|Withdrawal by Subject|0|||
129921847|NCT04971395|467680610|FG001|Overall Study|Withdrawal by Subject|1|||
129921848|NCT04971395|467680611|FG002|Overall Study|Withdrawal by Subject|0|||
129921849|NCT03953508|467680612|FG000|Baseline|Lost to Follow-up|3|||
129921850|NCT03953508|467680613|FG001|Baseline|Lost to Follow-up|2|||
129921851|NCT03953508|467680612|FG000|6-month Follow-up|Lost to Follow-up|62|||
129921852|NCT03953508|467680613|FG001|6-month Follow-up|Lost to Follow-up|70|||
129921853|NCT03771417|467680614|FG000|Overall Study|Withdrawal by Subject|1|||
129921854|NCT03771417|467680615|FG001|Overall Study|Withdrawal by Subject|0|||
129921855|NCT03771417|467680616|FG002|Overall Study|Withdrawal by Subject|0|||
129921856|NCT03771417|467680614|FG000|Overall Study|Covid-19 Shutdown|0|||
129921857|NCT03771417|467680615|FG001|Overall Study|Covid-19 Shutdown|1|||
129921858|NCT03771417|467680616|FG002|Overall Study|Covid-19 Shutdown|0|||
129921859|NCT02100813|467680617|FG000|Overall Study|Adverse Event|0|||
129921860|NCT02100813|467680618|FG001|Overall Study|Adverse Event|0|||
129921861|NCT02100813|467680619|FG002|Overall Study|Adverse Event|0|||
129921862|NCT02100813|467680620|FG003|Overall Study|Adverse Event|0|||
129921863|NCT02100813|467680621|FG004|Overall Study|Adverse Event|0|||
129921864|NCT02100813|467680622|FG005|Overall Study|Adverse Event|0|||
129921865|NCT02100813|467680623|FG006|Overall Study|Adverse Event|0|||
129921866|NCT02100813|467680624|FG007|Overall Study|Adverse Event|1|||
129921867|NCT04856163|467680625|FG000|Overall Study|Lost to Follow-up|97|||
129921868|NCT04856163|467680626|FG001|Overall Study|Lost to Follow-up|100|||
129921869|NCT00881621|467680632|FG000|Overall Study|Physician Decision|34|||
129921870|NCT03936322|467680637|FG000|Overall Study|Lost to Follow-up|1|||
129921871|NCT03936322|467680637|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
129921872|NCT05434078|467680639|FG000|Overall Study|Lost to Follow-up|2|||
129921873|NCT05434078|467680640|FG001|Overall Study|Lost to Follow-up|1|||
129921874|NCT05434078|467680639|FG000|Overall Study|Withdrawal by Subject|1|||
129921875|NCT05434078|467680640|FG001|Overall Study|Withdrawal by Subject|0|||
129921876|NCT01160211|467680641|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
129921877|NCT01160211|467680642|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
129921878|NCT01160211|467680643|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
129921879|NCT01160211|467680641|FG000|Overall Study|Lost to Follow-up|4|||
129921880|NCT01160211|467680642|FG001|Overall Study|Lost to Follow-up|8|||
129921881|NCT01160211|467680643|FG002|Overall Study|Lost to Follow-up|4|||
129921882|NCT01160211|467680641|FG000|Overall Study|Physician Decision|1|||
129921883|NCT01160211|467680642|FG001|Overall Study|Physician Decision|0|||
129921884|NCT01160211|467680643|FG002|Overall Study|Physician Decision|0|||
129921885|NCT01160211|467680641|FG000|Overall Study|Withdrawal by Subject|4|||
129921886|NCT01160211|467680642|FG001|Overall Study|Withdrawal by Subject|2|||
129921887|NCT01160211|467680643|FG002|Overall Study|Withdrawal by Subject|2|||
129921888|NCT01160211|467680641|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
129921889|NCT01160211|467680642|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
129921890|NCT01160211|467680643|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
129921891|NCT02734290|467680647|FG000|Overall Study|Adverse Event|1|||
129921892|NCT02734290|467680648|FG001|Overall Study|Adverse Event|0|||
129921893|NCT02734290|467680647|FG000|Overall Study|Death|1|||
129921894|NCT02734290|467680648|FG001|Overall Study|Death|0|||
129921895|NCT03158129|467680649|FG000|Overall Study|Adverse Event|0|||
129921896|NCT03158129|467680650|FG001|Overall Study|Adverse Event|1|||
129921897|NCT03158129|467680651|FG002|Overall Study|Adverse Event|0|||
129921898|NCT03158129|467680652|FG003|Overall Study|Adverse Event|0|||
129921899|NCT03158129|467680649|FG000|Overall Study|Death|0|||
129921900|NCT03158129|467680650|FG001|Overall Study|Death|0|||
129921901|NCT03158129|467680651|FG002|Overall Study|Death|0|||
129921902|NCT03158129|467680652|FG003|Overall Study|Death|1|||
129921903|NCT03158129|467680649|FG000|Overall Study|High surgical risk|1|||
129921904|NCT03158129|467680650|FG001|Overall Study|High surgical risk|1|||
129921905|NCT03158129|467680651|FG002|Overall Study|High surgical risk|0|||
129921906|NCT03158129|467680652|FG003|Overall Study|High surgical risk|0|||
129921907|NCT03158129|467680649|FG000|Overall Study|Progression|1|||
129921908|NCT03158129|467680650|FG001|Overall Study|Progression|1|||
129921909|NCT03158129|467680651|FG002|Overall Study|Progression|0|||
129921910|NCT03158129|467680652|FG003|Overall Study|Progression|0|||
129921911|NCT03158129|467680649|FG000|Overall Study|Lack of resectability|0|||
129921912|NCT03158129|467680650|FG001|Overall Study|Lack of resectability|1|||
129921913|NCT03158129|467680651|FG002|Overall Study|Lack of resectability|0|||
129921914|NCT03158129|467680652|FG003|Overall Study|Lack of resectability|0|||
129921915|NCT03158129|467680649|FG000|Overall Study|Declined surgery|0|||
129921916|NCT03158129|467680650|FG001|Overall Study|Declined surgery|1|||
129921917|NCT03158129|467680651|FG002|Overall Study|Declined surgery|0|||
129921918|NCT03158129|467680652|FG003|Overall Study|Declined surgery|0|||
129921919|NCT03158129|467680649|FG000|Overall Study|No longer surgical candidate|0|||
129921920|NCT03158129|467680650|FG001|Overall Study|No longer surgical candidate|0|||
129921921|NCT03158129|467680651|FG002|Overall Study|No longer surgical candidate|0|||
129921922|NCT03158129|467680652|FG003|Overall Study|No longer surgical candidate|1|||
129921923|NCT02577835|467680653|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
129921924|NCT02979522|467680654|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
129921925|NCT02979522|467680655|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
129921926|NCT02979522|467680654|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
129921927|NCT02979522|467680655|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
129921928|NCT04064164|467680656|FG000|Overall Study|Withdrawal by Subject|8|||
129921929|NCT04064164|467680657|FG001|Overall Study|Withdrawal by Subject|8|||
129921930|NCT04059484|467680658|FG000|Overall Study|Adverse Event|2|||
129921931|NCT04059484|467680659|FG001|Overall Study|Adverse Event|5|||
129921932|NCT04059484|467680658|FG000|Overall Study|Withdrawal by Subject|5|||
129921933|NCT04059484|467680659|FG001|Overall Study|Withdrawal by Subject|3|||
129921934|NCT04059484|467680658|FG000|Overall Study|Progressive disease|112|||
129921935|NCT04059484|467680659|FG001|Overall Study|Progressive disease|112|||
129921936|NCT04059484|467680658|FG000|Overall Study|Other|8|||
129921937|NCT04059484|467680659|FG001|Overall Study|Other|3|||
129921938|NCT04059484|467680658|FG000|Overall Study|Ongoing|20|||
129921939|NCT04059484|467680659|FG001|Overall Study|Ongoing|20|||
129921940|NCT02949362|467680660|FG000|Retrospective Period|Inform consent not signed by participant|4|||
129921941|NCT02949362|467680661|FG001|Retrospective Period|Inform consent not signed by participant|1|||
129921942|NCT02949362|467680662|FG002|Retrospective Period|Inform consent not signed by participant|0|||
129921943|NCT02949362|467680663|FG003|Retrospective Period|Inform consent not signed by participant|0|||
129921944|NCT02949362|467680660|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
129921945|NCT02949362|467680661|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
129921946|NCT02949362|467680662|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
129921947|NCT02949362|467680663|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
129921948|NCT02949362|467680660|FG000|Prospective Period|Other|0|||
129921949|NCT02949362|467680661|FG001|Prospective Period|Other|0|||
129921950|NCT02949362|467680662|FG002|Prospective Period|Other|0|||
129921951|NCT02949362|467680663|FG003|Prospective Period|Other|4|||
129921952|NCT04633122|467680667|FG000|Overall Study|Remained on treatment|19|||
129921953|NCT04633122|467680668|FG001|Overall Study|Remained on treatment|14|||
129921954|NCT04633122|467680667|FG000|Overall Study|Survival follow-up stopped|22|||
129921955|NCT04633122|467680668|FG001|Overall Study|Survival follow-up stopped|25|||
129921956|NCT03307343|467680669|FG000|Overall Study|Withdrawal by Subject|1|||
129921957|NCT03307343|467680670|FG001|Overall Study|Withdrawal by Subject|2|||
129921958|NCT03307343|467680669|FG000|Overall Study|Pregnancy|0|||
129921959|NCT03307343|467680670|FG001|Overall Study|Pregnancy|2|||
129921960|NCT03307343|467680669|FG000|Overall Study|Physician Decision|1|||
129921961|NCT03307343|467680670|FG001|Overall Study|Physician Decision|0|||
129921962|NCT03307343|467680669|FG000|Overall Study|Lost to Follow-up|0|||
129921963|NCT03307343|467680670|FG001|Overall Study|Lost to Follow-up|2|||
129921964|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
129921965|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
129921966|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
129921967|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
129921968|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129921969|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
129921970|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129921971|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
129921972|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
129921973|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129921974|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129921975|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
129921976|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
129921977|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
129921978|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
129921979|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
129921980|NCT04963270|467680672|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
129921981|NCT04963270|467680673|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
129921982|NCT04963270|467680674|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
129921983|NCT04963270|467680675|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
129921984|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129921985|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129921986|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
129921987|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
129921988|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
129921989|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
129921990|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
129921991|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
129921992|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
129921993|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
129921994|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
129921995|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
129921996|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
129921997|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
129921998|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
129921999|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
129922000|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
129922001|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
129922002|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
129922003|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
129922004|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
129922005|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
129922006|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
129922007|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
129922008|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
129922009|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
129922010|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
129922011|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
129922012|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
129922013|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
129922014|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
129922015|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
129922016|NCT04963270|467680672|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
129922017|NCT04963270|467680673|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
129922018|NCT04963270|467680674|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
129922019|NCT04963270|467680675|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
129922020|NCT04624633|467680677|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
129922021|NCT04624633|467680678|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
129922022|NCT04624633|467680677|FG000|Overall Study|Death|1|||
129922023|NCT04624633|467680678|FG001|Overall Study|Death|0|||
129922024|NCT04316871|467680679|FG000|Overall Study|Protocol Violation|2|||
129922025|NCT04316871|467680680|FG001|Overall Study|Protocol Violation|2|||
129922026|NCT04316871|467680681|FG002|Overall Study|Protocol Violation|2|||
129922027|NCT04316871|467680682|FG003|Overall Study|Protocol Violation|2|||
129922028|NCT05087992|467680683|FG000|Overall Study|Adverse Event|0|||
129922029|NCT05087992|467680684|FG001|Overall Study|Adverse Event|1|||
129922030|NCT05087992|467680685|FG002|Overall Study|Adverse Event|0|||
129922031|NCT05087992|467680683|FG000|Overall Study|Withdrawal by Subject|2|||
129922032|NCT05087992|467680684|FG001|Overall Study|Withdrawal by Subject|0|||
129922033|NCT05087992|467680685|FG002|Overall Study|Withdrawal by Subject|0|||
129922034|NCT05087992|467680683|FG000|Overall Study|clinical disease progression|3|||
129922035|NCT05087992|467680684|FG001|Overall Study|clinical disease progression|1|||
129922036|NCT05087992|467680685|FG002|Overall Study|clinical disease progression|0|||
129922037|NCT05087992|467680683|FG000|Overall Study|objective disease progression|4|||
129922038|NCT05087992|467680684|FG001|Overall Study|objective disease progression|1|||
129922039|NCT05087992|467680685|FG002|Overall Study|objective disease progression|0|||
129922040|NCT01842542|467680686|FG000|Overall Study|Withdrawal by Subject|2|||
129922041|NCT01842542|467680686|FG000|Overall Study|Lack of Efficacy|1|||
129922042|NCT01842542|467680686|FG000|Overall Study|Protocol Non-compliance|2|||
129922043|NCT01842542|467680686|FG000|Overall Study|Lost to Follow-up|1|||
129922044|NCT01824394|467680692|FG000|Overall Study|Early Termination|1|||
129922045|NCT01824394|467680693|FG001|Overall Study|Early Termination|1|||
129922046|NCT01824394|467680694|FG002|Overall Study|Early Termination|3|||
129922047|NCT01824394|467680692|FG000|Overall Study|Withdrawn due to Study Termination|91|||
129922048|NCT01824394|467680693|FG001|Overall Study|Withdrawn due to Study Termination|83|||
129922049|NCT01824394|467680694|FG002|Overall Study|Withdrawn due to Study Termination|41|||
129922050|NCT01824394|467680692|FG000|Overall Study|Lost to Follow-up|0|||
129922051|NCT01824394|467680693|FG001|Overall Study|Lost to Follow-up|9|||
129922052|NCT01824394|467680694|FG002|Overall Study|Lost to Follow-up|3|||
129922053|NCT01824394|467680692|FG000|Overall Study|Death|3|||
129922054|NCT01824394|467680693|FG001|Overall Study|Death|2|||
129922055|NCT01824394|467680694|FG002|Overall Study|Death|4|||
129922056|NCT01824394|467680692|FG000|Overall Study|Discontinued Subjects|1|||
129922057|NCT01824394|467680693|FG001|Overall Study|Discontinued Subjects|1|||
129922058|NCT01824394|467680694|FG002|Overall Study|Discontinued Subjects|2|||
129922059|NCT01824394|467680692|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
129922060|NCT01824394|467680693|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
129922061|NCT01824394|467680694|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
129922062|NCT05780437|467680695|FG000|Overall Study|Withdrawal by Subject|22|||
129922063|NCT05780437|467680696|FG001|Overall Study|Withdrawal by Subject|16|||
129922064|NCT03452579|467680697|FG000|Overall Study|Death|0|||
129922065|NCT03452579|467680698|FG001|Overall Study|Death|1|||
129922066|NCT03452579|467680697|FG000|Overall Study|Withdrawal by Subject|2|||
129922067|NCT03452579|467680698|FG001|Overall Study|Withdrawal by Subject|0|||
129922068|NCT03452579|467680697|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
129922069|NCT03452579|467680698|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
129922070|NCT03452579|467680697|FG000|Overall Study|Physician Decision|1|||
129922071|NCT03452579|467680698|FG001|Overall Study|Physician Decision|1|||
129922072|NCT03452579|467680697|FG000|Overall Study|Adverse Event|1|||
129922073|NCT03452579|467680698|FG001|Overall Study|Adverse Event|4|||
129922074|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
129922075|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
129922076|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
129922077|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
129922078|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
129922079|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
129922080|NCT04652700|467680703|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
129922081|NCT04652700|467680704|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
129922082|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
129922083|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
129922084|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
129922085|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
129922086|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
129922087|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
129922088|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
129922089|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
129922090|NCT04652700|467680703|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
129922091|NCT04652700|467680704|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
129922092|NCT04209465|467680705|FG000|Overall Study|Adverse Event|0|||
129922093|NCT04209465|467680706|FG001|Overall Study|Adverse Event|0|||
129922094|NCT04209465|467680707|FG002|Overall Study|Adverse Event|0|||
129922095|NCT04209465|467680708|FG003|Overall Study|Adverse Event|0|||
129922096|NCT04209465|467680709|FG004|Overall Study|Adverse Event|0|||
129922097|NCT04209465|467680710|FG005|Overall Study|Adverse Event|1|||
129922098|NCT04209465|467680711|FG006|Overall Study|Adverse Event|0|||
129922099|NCT04209465|467680712|FG007|Overall Study|Adverse Event|0|||
129922100|NCT04209465|467680713|FG008|Overall Study|Adverse Event|1|||
129922101|NCT04209465|467680714|FG009|Overall Study|Adverse Event|0|||
129922102|NCT04209465|467680715|FG010|Overall Study|Adverse Event|2|||
129922103|NCT04209465|467680716|FG011|Overall Study|Adverse Event|1|||
129922104|NCT04209465|467680717|FG012|Overall Study|Adverse Event|1|||
129922105|NCT04209465|467680705|FG000|Overall Study|Death|1|||
129922106|NCT04209465|467680706|FG001|Overall Study|Death|0|||
129922107|NCT04209465|467680707|FG002|Overall Study|Death|0|||
129922108|NCT04209465|467680708|FG003|Overall Study|Death|0|||
129922109|NCT04209465|467680709|FG004|Overall Study|Death|2|||
129922110|NCT04209465|467680710|FG005|Overall Study|Death|7|||
129922111|NCT04209465|467680711|FG006|Overall Study|Death|2|||
129922112|NCT04209465|467680712|FG007|Overall Study|Death|2|||
129922113|NCT04209465|467680713|FG008|Overall Study|Death|1|||
129922114|NCT04209465|467680714|FG009|Overall Study|Death|1|||
129922115|NCT04209465|467680715|FG010|Overall Study|Death|1|||
129922116|NCT04209465|467680716|FG011|Overall Study|Death|0|||
129922117|NCT04209465|467680717|FG012|Overall Study|Death|10|||
129922118|NCT04209465|467680705|FG000|Overall Study|Physician Decision|0|||
129922119|NCT04209465|467680706|FG001|Overall Study|Physician Decision|1|||
129922120|NCT04209465|467680707|FG002|Overall Study|Physician Decision|0|||
129922121|NCT04209465|467680708|FG003|Overall Study|Physician Decision|0|||
129922122|NCT04209465|467680709|FG004|Overall Study|Physician Decision|0|||
129922123|NCT04209465|467680710|FG005|Overall Study|Physician Decision|0|||
129922124|NCT04209465|467680711|FG006|Overall Study|Physician Decision|0|||
129922125|NCT04209465|467680712|FG007|Overall Study|Physician Decision|0|||
129922126|NCT04209465|467680713|FG008|Overall Study|Physician Decision|0|||
129922127|NCT04209465|467680714|FG009|Overall Study|Physician Decision|0|||
129922128|NCT04209465|467680715|FG010|Overall Study|Physician Decision|0|||
129922129|NCT04209465|467680716|FG011|Overall Study|Physician Decision|0|||
129922130|NCT04209465|467680717|FG012|Overall Study|Physician Decision|0|||
129922131|NCT04209465|467680705|FG000|Overall Study|Progressive Disease|0|||
129922132|NCT04209465|467680706|FG001|Overall Study|Progressive Disease|0|||
129922133|NCT04209465|467680707|FG002|Overall Study|Progressive Disease|1|||
129922134|NCT04209465|467680708|FG003|Overall Study|Progressive Disease|2|||
129922135|NCT04209465|467680709|FG004|Overall Study|Progressive Disease|8|||
129922136|NCT04209465|467680710|FG005|Overall Study|Progressive Disease|5|||
129922137|NCT04209465|467680711|FG006|Overall Study|Progressive Disease|3|||
129922138|NCT04209465|467680712|FG007|Overall Study|Progressive Disease|4|||
129922139|NCT04209465|467680713|FG008|Overall Study|Progressive Disease|1|||
129922140|NCT04209465|467680714|FG009|Overall Study|Progressive Disease|3|||
129922141|NCT04209465|467680715|FG010|Overall Study|Progressive Disease|2|||
129922142|NCT04209465|467680716|FG011|Overall Study|Progressive Disease|1|||
129922143|NCT04209465|467680717|FG012|Overall Study|Progressive Disease|0|||
129922144|NCT04209465|467680705|FG000|Overall Study|Withdrawal by Subject|0|||
129922145|NCT04209465|467680706|FG001|Overall Study|Withdrawal by Subject|0|||
129922146|NCT04209465|467680707|FG002|Overall Study|Withdrawal by Subject|0|||
129922147|NCT04209465|467680708|FG003|Overall Study|Withdrawal by Subject|0|||
129922148|NCT04209465|467680709|FG004|Overall Study|Withdrawal by Subject|0|||
129922149|NCT04209465|467680710|FG005|Overall Study|Withdrawal by Subject|1|||
129922150|NCT04209465|467680711|FG006|Overall Study|Withdrawal by Subject|2|||
129922151|NCT04209465|467680712|FG007|Overall Study|Withdrawal by Subject|0|||
129922152|NCT04209465|467680713|FG008|Overall Study|Withdrawal by Subject|1|||
129922153|NCT04209465|467680714|FG009|Overall Study|Withdrawal by Subject|0|||
129922154|NCT04209465|467680715|FG010|Overall Study|Withdrawal by Subject|0|||
129922155|NCT04209465|467680716|FG011|Overall Study|Withdrawal by Subject|2|||
129922156|NCT04209465|467680717|FG012|Overall Study|Withdrawal by Subject|2|||
129922157|NCT04209465|467680705|FG000|Overall Study|Lost to Follow-up|0|||
129922158|NCT04209465|467680706|FG001|Overall Study|Lost to Follow-up|0|||
129922159|NCT04209465|467680707|FG002|Overall Study|Lost to Follow-up|0|||
129922160|NCT04209465|467680708|FG003|Overall Study|Lost to Follow-up|0|||
129922161|NCT04209465|467680709|FG004|Overall Study|Lost to Follow-up|0|||
129922162|NCT04209465|467680710|FG005|Overall Study|Lost to Follow-up|1|||
129922163|NCT04209465|467680711|FG006|Overall Study|Lost to Follow-up|0|||
129922164|NCT04209465|467680712|FG007|Overall Study|Lost to Follow-up|0|||
129922165|NCT04209465|467680713|FG008|Overall Study|Lost to Follow-up|1|||
129922166|NCT04209465|467680714|FG009|Overall Study|Lost to Follow-up|0|||
129922167|NCT04209465|467680715|FG010|Overall Study|Lost to Follow-up|0|||
129922168|NCT04209465|467680716|FG011|Overall Study|Lost to Follow-up|1|||
129922169|NCT04209465|467680717|FG012|Overall Study|Lost to Follow-up|0|||
129922170|NCT04209465|467680705|FG000|Overall Study|Started new therapy|0|||
129922171|NCT04209465|467680706|FG001|Overall Study|Started new therapy|0|||
129922172|NCT04209465|467680707|FG002|Overall Study|Started new therapy|0|||
129922173|NCT04209465|467680708|FG003|Overall Study|Started new therapy|0|||
129922174|NCT04209465|467680709|FG004|Overall Study|Started new therapy|0|||
129922175|NCT04209465|467680710|FG005|Overall Study|Started new therapy|1|||
129922176|NCT04209465|467680711|FG006|Overall Study|Started new therapy|0|||
129922177|NCT04209465|467680712|FG007|Overall Study|Started new therapy|0|||
129922178|NCT04209465|467680713|FG008|Overall Study|Started new therapy|0|||
129922179|NCT04209465|467680714|FG009|Overall Study|Started new therapy|0|||
129922180|NCT04209465|467680715|FG010|Overall Study|Started new therapy|0|||
129922181|NCT04209465|467680716|FG011|Overall Study|Started new therapy|0|||
129922182|NCT04209465|467680717|FG012|Overall Study|Started new therapy|0|||
129922183|NCT04209465|467680705|FG000|Overall Study|Study terminated early by sponsor|0|||
129922184|NCT04209465|467680706|FG001|Overall Study|Study terminated early by sponsor|0|||
129922185|NCT04209465|467680707|FG002|Overall Study|Study terminated early by sponsor|0|||
129922186|NCT04209465|467680708|FG003|Overall Study|Study terminated early by sponsor|0|||
129922187|NCT04209465|467680709|FG004|Overall Study|Study terminated early by sponsor|0|||
129922188|NCT04209465|467680710|FG005|Overall Study|Study terminated early by sponsor|0|||
129922189|NCT04209465|467680711|FG006|Overall Study|Study terminated early by sponsor|3|||
129922190|NCT04209465|467680712|FG007|Overall Study|Study terminated early by sponsor|0|||
129922191|NCT04209465|467680713|FG008|Overall Study|Study terminated early by sponsor|0|||
129922192|NCT04209465|467680714|FG009|Overall Study|Study terminated early by sponsor|0|||
129922193|NCT04209465|467680715|FG010|Overall Study|Study terminated early by sponsor|0|||
129922194|NCT04209465|467680716|FG011|Overall Study|Study terminated early by sponsor|0|||
129922195|NCT04209465|467680717|FG012|Overall Study|Study terminated early by sponsor|3|||
129922196|NCT04209465|467680705|FG000|Overall Study|Other|0|||
129922197|NCT04209465|467680706|FG001|Overall Study|Other|0|||
129922198|NCT04209465|467680707|FG002|Overall Study|Other|0|||
129922199|NCT04209465|467680708|FG003|Overall Study|Other|0|||
129922200|NCT04209465|467680709|FG004|Overall Study|Other|0|||
129922201|NCT04209465|467680710|FG005|Overall Study|Other|0|||
129922202|NCT04209465|467680711|FG006|Overall Study|Other|0|||
129922203|NCT04209465|467680712|FG007|Overall Study|Other|0|||
129922204|NCT04209465|467680713|FG008|Overall Study|Other|1|||
129922205|NCT04209465|467680714|FG009|Overall Study|Other|0|||
129922206|NCT04209465|467680715|FG010|Overall Study|Other|0|||
129922207|NCT04209465|467680716|FG011|Overall Study|Other|0|||
129922208|NCT04209465|467680717|FG012|Overall Study|Other|0|||
129922209|NCT05603143|467680718|FG000|Overall Study|Withdrew consent|6|||
129922210|NCT05603143|467680719|FG001|Overall Study|Withdrew consent|2|||
129922211|NCT05603143|467680718|FG000|Overall Study|Randomized but never treated|0|||
129922212|NCT05603143|467680719|FG001|Overall Study|Randomized but never treated|3|||
129922213|NCT05603143|467680718|FG000|Overall Study|Adverse Event|2|||
129922214|NCT05603143|467680719|FG001|Overall Study|Adverse Event|0|||
129922215|NCT05603143|467680718|FG000|Overall Study|Death|0|||
129922216|NCT05603143|467680719|FG001|Overall Study|Death|1|||
129922217|NCT05603143|467680718|FG000|Overall Study|Investigator's discretion|1|||
129922218|NCT05603143|467680719|FG001|Overall Study|Investigator's discretion|0|||
129922219|NCT05603143|467680718|FG000|Overall Study|Lost to Follow-up|0|||
129922220|NCT05603143|467680719|FG001|Overall Study|Lost to Follow-up|1|||
129922221|NCT05603143|467680718|FG000|Overall Study|Protocol Violation|0|||
129922222|NCT05603143|467680719|FG001|Overall Study|Protocol Violation|1|||
129922223|NCT03097549|467680720|FG000|Overall Study|Withdrawal by Subject|1|||
129922224|NCT03097549|467680721|FG001|Overall Study|Withdrawal by Subject|0|||
129922225|NCT03097549|467680720|FG000|Overall Study|Lost to Follow-up|1|||
129922226|NCT03097549|467680721|FG001|Overall Study|Lost to Follow-up|0|||
129922227|NCT05783102|467680722|FG000|Overall Study|Lost to Follow-up|1|||
129922228|NCT05783102|467680722|FG000|Overall Study|Withdrawal by Subject|2|||
129922229|NCT04505904|467680723|FG000|Overall Study|Withdrawal by Subject|1|||
129922230|NCT04505904|467680724|FG001|Overall Study|Withdrawal by Subject|2|||
129922231|NCT04505904|467680725|FG002|Overall Study|Withdrawal by Subject|0|||
129922232|NCT04505904|467680726|FG003|Overall Study|Withdrawal by Subject|0|||
129922233|NCT04505904|467680723|FG000|Overall Study|Physician Decision|1|||
129922234|NCT04505904|467680724|FG001|Overall Study|Physician Decision|0|||
129922235|NCT04505904|467680725|FG002|Overall Study|Physician Decision|0|||
129922236|NCT04505904|467680726|FG003|Overall Study|Physician Decision|0|||
129922237|NCT04505904|467680723|FG000|Overall Study|Adverse Event|0|||
129922238|NCT04505904|467680724|FG001|Overall Study|Adverse Event|1|||
129922239|NCT04505904|467680725|FG002|Overall Study|Adverse Event|0|||
129922240|NCT04505904|467680726|FG003|Overall Study|Adverse Event|0|||
129922241|NCT04277442|467680729|FG000|Overall Study|Death|1|||
129922242|NCT03544281|467680730|FG000|Main Study Phase|Death|3|||
129922243|NCT03544281|467680731|FG001|Main Study Phase|Death|2|||
129922244|NCT03544281|467680732|FG002|Main Study Phase|Death|6|||
129922245|NCT03544281|467680733|FG003|Main Study Phase|Death|8|||
129922246|NCT03544281|467680734|FG004|Main Study Phase|Death|4|||
129922247|NCT03544281|467680735|FG005|Main Study Phase|Death|2|||
129922248|NCT03544281|467680736|FG006|Main Study Phase|Death|4|||
129922249|NCT03544281|467680737|FG007|Main Study Phase|Death|5|||
129922250|NCT03544281|467680738|FG008|Main Study Phase|Death|5|||
129922251|NCT03544281|467680739|FG009|Main Study Phase|Death|8|||
129922252|NCT03544281|467680740|FG010|Main Study Phase|Death|6|||
129922253|NCT03544281|467680741|FG011|Main Study Phase|Death|4|||
129922254|NCT03544281|467680742|FG012|Main Study Phase|Death|0|||
129922255|NCT03544281|467680743|FG013|Main Study Phase|Death|0|||
129922256|NCT03544281|467680744|FG014|Main Study Phase|Death|0|||
129922257|NCT03544281|467680745|FG015|Main Study Phase|Death|0|||
129922258|NCT03544281|467680746|FG016|Main Study Phase|Death|0|||
129922259|NCT03544281|467680747|FG017|Main Study Phase|Death|0|||
129922260|NCT03544281|467680748|FG018|Main Study Phase|Death|0|||
129922261|NCT03544281|467680749|FG019|Main Study Phase|Death|0|||
129922262|NCT03544281|467680750|FG020|Main Study Phase|Death|0|||
129922263|NCT03544281|467680751|FG021|Main Study Phase|Death|0|||
129922264|NCT03544281|467680730|FG000|Main Study Phase|Lost to Follow-up|0|||
129922265|NCT03544281|467680731|FG001|Main Study Phase|Lost to Follow-up|0|||
129922266|NCT03544281|467680732|FG002|Main Study Phase|Lost to Follow-up|0|||
129922267|NCT03544281|467680733|FG003|Main Study Phase|Lost to Follow-up|0|||
129922268|NCT03544281|467680734|FG004|Main Study Phase|Lost to Follow-up|0|||
129922269|NCT03544281|467680735|FG005|Main Study Phase|Lost to Follow-up|0|||
129922270|NCT03544281|467680736|FG006|Main Study Phase|Lost to Follow-up|0|||
129922271|NCT03544281|467680737|FG007|Main Study Phase|Lost to Follow-up|0|||
129922272|NCT03544281|467680738|FG008|Main Study Phase|Lost to Follow-up|0|||
129922273|NCT03544281|467680739|FG009|Main Study Phase|Lost to Follow-up|0|||
129922274|NCT03544281|467680740|FG010|Main Study Phase|Lost to Follow-up|1|||
129922275|NCT03544281|467680741|FG011|Main Study Phase|Lost to Follow-up|0|||
129922276|NCT03544281|467680742|FG012|Main Study Phase|Lost to Follow-up|0|||
129922277|NCT03544281|467680743|FG013|Main Study Phase|Lost to Follow-up|0|||
129922278|NCT03544281|467680744|FG014|Main Study Phase|Lost to Follow-up|0|||
129922279|NCT03544281|467680745|FG015|Main Study Phase|Lost to Follow-up|0|||
129922280|NCT03544281|467680746|FG016|Main Study Phase|Lost to Follow-up|0|||
129922281|NCT03544281|467680747|FG017|Main Study Phase|Lost to Follow-up|0|||
129922282|NCT03544281|467680748|FG018|Main Study Phase|Lost to Follow-up|0|||
129922283|NCT03544281|467680749|FG019|Main Study Phase|Lost to Follow-up|0|||
129922284|NCT03544281|467680750|FG020|Main Study Phase|Lost to Follow-up|0|||
129922285|NCT03544281|467680751|FG021|Main Study Phase|Lost to Follow-up|0|||
129922286|NCT03544281|467680730|FG000|Main Study Phase|Physician Decision|0|||
129922287|NCT03544281|467680731|FG001|Main Study Phase|Physician Decision|0|||
129922288|NCT03544281|467680732|FG002|Main Study Phase|Physician Decision|0|||
129922289|NCT03544281|467680733|FG003|Main Study Phase|Physician Decision|0|||
129922290|NCT03544281|467680734|FG004|Main Study Phase|Physician Decision|0|||
129922291|NCT03544281|467680735|FG005|Main Study Phase|Physician Decision|0|||
129922292|NCT03544281|467680736|FG006|Main Study Phase|Physician Decision|0|||
129922293|NCT03544281|467680737|FG007|Main Study Phase|Physician Decision|1|||
129922294|NCT03544281|467680738|FG008|Main Study Phase|Physician Decision|0|||
129922295|NCT03544281|467680739|FG009|Main Study Phase|Physician Decision|0|||
129922296|NCT03544281|467680740|FG010|Main Study Phase|Physician Decision|0|||
129922297|NCT03544281|467680741|FG011|Main Study Phase|Physician Decision|0|||
129922298|NCT03544281|467680742|FG012|Main Study Phase|Physician Decision|0|||
129922299|NCT03544281|467680743|FG013|Main Study Phase|Physician Decision|0|||
129922300|NCT03544281|467680744|FG014|Main Study Phase|Physician Decision|0|||
129922301|NCT03544281|467680745|FG015|Main Study Phase|Physician Decision|0|||
129922302|NCT03544281|467680746|FG016|Main Study Phase|Physician Decision|0|||
129922303|NCT03544281|467680747|FG017|Main Study Phase|Physician Decision|0|||
129922304|NCT03544281|467680748|FG018|Main Study Phase|Physician Decision|0|||
129922305|NCT03544281|467680749|FG019|Main Study Phase|Physician Decision|0|||
129922306|NCT03544281|467680750|FG020|Main Study Phase|Physician Decision|0|||
129922307|NCT03544281|467680751|FG021|Main Study Phase|Physician Decision|0|||
129922308|NCT03544281|467680730|FG000|Main Study Phase|Withdrawal by Subject|2|||
129922309|NCT03544281|467680731|FG001|Main Study Phase|Withdrawal by Subject|0|||
129922310|NCT03544281|467680732|FG002|Main Study Phase|Withdrawal by Subject|1|||
129922311|NCT03544281|467680733|FG003|Main Study Phase|Withdrawal by Subject|2|||
129922312|NCT03544281|467680734|FG004|Main Study Phase|Withdrawal by Subject|0|||
129922313|NCT03544281|467680735|FG005|Main Study Phase|Withdrawal by Subject|0|||
129922314|NCT03544281|467680736|FG006|Main Study Phase|Withdrawal by Subject|0|||
129922315|NCT03544281|467680737|FG007|Main Study Phase|Withdrawal by Subject|0|||
129922316|NCT03544281|467680738|FG008|Main Study Phase|Withdrawal by Subject|2|||
129922317|NCT03544281|467680739|FG009|Main Study Phase|Withdrawal by Subject|3|||
129922318|NCT03544281|467680740|FG010|Main Study Phase|Withdrawal by Subject|0|||
129922319|NCT03544281|467680741|FG011|Main Study Phase|Withdrawal by Subject|4|||
129922320|NCT03544281|467680742|FG012|Main Study Phase|Withdrawal by Subject|0|||
129922321|NCT03544281|467680743|FG013|Main Study Phase|Withdrawal by Subject|0|||
129922322|NCT03544281|467680744|FG014|Main Study Phase|Withdrawal by Subject|0|||
129922323|NCT03544281|467680745|FG015|Main Study Phase|Withdrawal by Subject|0|||
129922324|NCT03544281|467680746|FG016|Main Study Phase|Withdrawal by Subject|0|||
129922325|NCT03544281|467680747|FG017|Main Study Phase|Withdrawal by Subject|0|||
129922326|NCT03544281|467680748|FG018|Main Study Phase|Withdrawal by Subject|0|||
129922327|NCT03544281|467680749|FG019|Main Study Phase|Withdrawal by Subject|0|||
129922328|NCT03544281|467680750|FG020|Main Study Phase|Withdrawal by Subject|0|||
129922329|NCT03544281|467680751|FG021|Main Study Phase|Withdrawal by Subject|0|||
129922330|NCT03544281|467680730|FG000|Main Study Phase|Ongoing|3|||
129922331|NCT03544281|467680731|FG001|Main Study Phase|Ongoing|1|||
129922332|NCT03544281|467680732|FG002|Main Study Phase|Ongoing|2|||
129922333|NCT03544281|467680733|FG003|Main Study Phase|Ongoing|4|||
129922334|NCT03544281|467680734|FG004|Main Study Phase|Ongoing|2|||
129922335|NCT03544281|467680735|FG005|Main Study Phase|Ongoing|4|||
129922336|NCT03544281|467680736|FG006|Main Study Phase|Ongoing|4|||
129922337|NCT03544281|467680737|FG007|Main Study Phase|Ongoing|0|||
129922338|NCT03544281|467680738|FG008|Main Study Phase|Ongoing|2|||
129922339|NCT03544281|467680739|FG009|Main Study Phase|Ongoing|2|||
129922340|NCT03544281|467680740|FG010|Main Study Phase|Ongoing|1|||
129922341|NCT03544281|467680741|FG011|Main Study Phase|Ongoing|0|||
129922342|NCT03544281|467680742|FG012|Main Study Phase|Ongoing|0|||
129922343|NCT03544281|467680743|FG013|Main Study Phase|Ongoing|0|||
129922344|NCT03544281|467680744|FG014|Main Study Phase|Ongoing|0|||
129922345|NCT03544281|467680745|FG015|Main Study Phase|Ongoing|0|||
129922346|NCT03544281|467680746|FG016|Main Study Phase|Ongoing|0|||
129922347|NCT03544281|467680747|FG017|Main Study Phase|Ongoing|0|||
129922348|NCT03544281|467680748|FG018|Main Study Phase|Ongoing|0|||
129922349|NCT03544281|467680749|FG019|Main Study Phase|Ongoing|0|||
129922350|NCT03544281|467680750|FG020|Main Study Phase|Ongoing|0|||
129922351|NCT03544281|467680751|FG021|Main Study Phase|Ongoing|0|||
129922352|NCT03544281|467680730|FG000|Main Study Phase|Investigator Site Closed|0|||
129922353|NCT03544281|467680731|FG001|Main Study Phase|Investigator Site Closed|0|||
129922354|NCT03544281|467680732|FG002|Main Study Phase|Investigator Site Closed|0|||
129922355|NCT03544281|467680733|FG003|Main Study Phase|Investigator Site Closed|0|||
129922356|NCT03544281|467680734|FG004|Main Study Phase|Investigator Site Closed|0|||
129922357|NCT03544281|467680735|FG005|Main Study Phase|Investigator Site Closed|0|||
129922358|NCT03544281|467680736|FG006|Main Study Phase|Investigator Site Closed|0|||
129922359|NCT03544281|467680737|FG007|Main Study Phase|Investigator Site Closed|0|||
129922360|NCT03544281|467680738|FG008|Main Study Phase|Investigator Site Closed|0|||
129922361|NCT03544281|467680739|FG009|Main Study Phase|Investigator Site Closed|1|||
129922362|NCT03544281|467680740|FG010|Main Study Phase|Investigator Site Closed|0|||
129922363|NCT03544281|467680741|FG011|Main Study Phase|Investigator Site Closed|0|||
129922364|NCT03544281|467680742|FG012|Main Study Phase|Investigator Site Closed|0|||
129922365|NCT03544281|467680743|FG013|Main Study Phase|Investigator Site Closed|0|||
129922366|NCT03544281|467680744|FG014|Main Study Phase|Investigator Site Closed|0|||
129922367|NCT03544281|467680745|FG015|Main Study Phase|Investigator Site Closed|0|||
129922368|NCT03544281|467680746|FG016|Main Study Phase|Investigator Site Closed|0|||
129922369|NCT03544281|467680747|FG017|Main Study Phase|Investigator Site Closed|0|||
129922370|NCT03544281|467680748|FG018|Main Study Phase|Investigator Site Closed|0|||
129922371|NCT03544281|467680749|FG019|Main Study Phase|Investigator Site Closed|0|||
129922372|NCT03544281|467680750|FG020|Main Study Phase|Investigator Site Closed|0|||
129922373|NCT03544281|467680751|FG021|Main Study Phase|Investigator Site Closed|0|||
129922374|NCT03544281|467680730|FG000|Main Study Phase|Did not receive study treatment|0|||
129922375|NCT03544281|467680731|FG001|Main Study Phase|Did not receive study treatment|0|||
129922376|NCT03544281|467680732|FG002|Main Study Phase|Did not receive study treatment|0|||
129922377|NCT03544281|467680733|FG003|Main Study Phase|Did not receive study treatment|0|||
129922378|NCT03544281|467680734|FG004|Main Study Phase|Did not receive study treatment|0|||
129922379|NCT03544281|467680735|FG005|Main Study Phase|Did not receive study treatment|0|||
129922380|NCT03544281|467680736|FG006|Main Study Phase|Did not receive study treatment|1|||
129922381|NCT03544281|467680737|FG007|Main Study Phase|Did not receive study treatment|0|||
129922382|NCT03544281|467680738|FG008|Main Study Phase|Did not receive study treatment|0|||
129922383|NCT03544281|467680739|FG009|Main Study Phase|Did not receive study treatment|0|||
129922384|NCT03544281|467680740|FG010|Main Study Phase|Did not receive study treatment|0|||
129922385|NCT03544281|467680741|FG011|Main Study Phase|Did not receive study treatment|0|||
129922386|NCT03544281|467680742|FG012|Main Study Phase|Did not receive study treatment|0|||
129922387|NCT03544281|467680743|FG013|Main Study Phase|Did not receive study treatment|0|||
129922388|NCT03544281|467680744|FG014|Main Study Phase|Did not receive study treatment|0|||
129922389|NCT03544281|467680745|FG015|Main Study Phase|Did not receive study treatment|0|||
129922390|NCT03544281|467680746|FG016|Main Study Phase|Did not receive study treatment|0|||
129922391|NCT03544281|467680747|FG017|Main Study Phase|Did not receive study treatment|0|||
129922392|NCT03544281|467680748|FG018|Main Study Phase|Did not receive study treatment|0|||
129922393|NCT03544281|467680749|FG019|Main Study Phase|Did not receive study treatment|0|||
129922394|NCT03544281|467680750|FG020|Main Study Phase|Did not receive study treatment|0|||
129922395|NCT03544281|467680751|FG021|Main Study Phase|Did not receive study treatment|0|||
129922396|NCT03544281|467680730|FG000|PACT Phase|Adverse Event|0|||
129922397|NCT03544281|467680731|FG001|PACT Phase|Adverse Event|0|||
129922398|NCT03544281|467680732|FG002|PACT Phase|Adverse Event|0|||
129922399|NCT03544281|467680733|FG003|PACT Phase|Adverse Event|0|||
129922400|NCT03544281|467680734|FG004|PACT Phase|Adverse Event|0|||
129922401|NCT03544281|467680735|FG005|PACT Phase|Adverse Event|0|||
129922402|NCT03544281|467680736|FG006|PACT Phase|Adverse Event|0|||
129922403|NCT03544281|467680737|FG007|PACT Phase|Adverse Event|0|||
129922404|NCT03544281|467680738|FG008|PACT Phase|Adverse Event|0|||
129922405|NCT03544281|467680739|FG009|PACT Phase|Adverse Event|0|||
129922406|NCT03544281|467680740|FG010|PACT Phase|Adverse Event|0|||
129922407|NCT03544281|467680741|FG011|PACT Phase|Adverse Event|0|||
129922408|NCT03544281|467680742|FG012|PACT Phase|Adverse Event|1|||
129922409|NCT03544281|467680743|FG013|PACT Phase|Adverse Event|0|||
129922410|NCT03544281|467680744|FG014|PACT Phase|Adverse Event|0|||
129922411|NCT03544281|467680745|FG015|PACT Phase|Adverse Event|0|||
129922412|NCT03544281|467680746|FG016|PACT Phase|Adverse Event|0|||
129922413|NCT03544281|467680747|FG017|PACT Phase|Adverse Event|1|||
129922414|NCT03544281|467680748|FG018|PACT Phase|Adverse Event|1|||
129922415|NCT03544281|467680749|FG019|PACT Phase|Adverse Event|0|||
129922416|NCT03544281|467680750|FG020|PACT Phase|Adverse Event|0|||
129922417|NCT03544281|467680751|FG021|PACT Phase|Adverse Event|0|||
129922418|NCT03092518|467680753|FG000|Overall Study|Ineligible|2|||
129922419|NCT02547987|467680756|FG000|Overall Study|Withdrawal by Subject|1|||
129922420|NCT02547987|467680756|FG000|Overall Study|Adverse Event|2|||
129922421|NCT04282148|467680757|FG000|Overall Study|Death|7|||
129922422|NCT04282148|467680757|FG000|Overall Study|Withdrawal by Subject|1|||
129922423|NCT04282148|467680757|FG000|Overall Study|Physician Decision|1|||
129922424|NCT02146378|467680758|FG000|Overall Study|No information of administration|2|||
129922425|NCT04925986|467680759|FG000|Overall Study|Death|0|||
129922426|NCT04925986|467680760|FG001|Overall Study|Death|0|||
129922427|NCT04925986|467680761|FG002|Overall Study|Death|2|||
129922428|NCT04925986|467680762|FG003|Overall Study|Death|0|||
129922429|NCT04925986|467680759|FG000|Overall Study|Lack of Efficacy|1|||
129922430|NCT04925986|467680760|FG001|Overall Study|Lack of Efficacy|2|||
129922431|NCT04925986|467680761|FG002|Overall Study|Lack of Efficacy|0|||
129922432|NCT04925986|467680762|FG003|Overall Study|Lack of Efficacy|1|||
129922433|NCT04925986|467680759|FG000|Overall Study|Withdrawal by Subject|0|||
129922434|NCT04925986|467680760|FG001|Overall Study|Withdrawal by Subject|0|||
129922435|NCT04925986|467680761|FG002|Overall Study|Withdrawal by Subject|1|||
129922436|NCT04925986|467680762|FG003|Overall Study|Withdrawal by Subject|2|||
129922437|NCT06181760|467680763|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
129922438|NCT06181760|467680764|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
129922439|NCT06181760|467680765|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
129922440|NCT06181760|467680766|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
129922441|NCT03524612|467680767|FG000|Overall Study|Lack of Efficacy|10|||
129922442|NCT03524612|467680767|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
129922443|NCT03524612|467680767|FG000|Overall Study|Adverse Event|10|||
129922444|NCT03524612|467680767|FG000|Overall Study|Withdrawal by Subject|7|||
129922445|NCT03524612|467680767|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
129922446|NCT03524612|467680767|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
129922447|NCT03524612|467680767|FG000|Overall Study|New therapy for study indication|6|||
129922448|NCT03524612|467680767|FG000|Overall Study|Death|3|||
129922449|NCT03524612|467680767|FG000|Overall Study|Lost to Follow-up|2|||
129922450|NCT03524612|467680767|FG000|Overall Study|Protocol Violation|1|||
129922451|NCT04770532|467680768|FG000|Overall Study|Withdrawal by Subject|0|||
129922452|NCT04770532|467680769|FG001|Overall Study|Withdrawal by Subject|3|||
129922453|NCT04770532|467680768|FG000|Overall Study|Physician Decision|1|||
129922454|NCT04770532|467680769|FG001|Overall Study|Physician Decision|0|||
129922455|NCT04770532|467680768|FG000|Overall Study|Death|2|||
129922456|NCT04770532|467680769|FG001|Overall Study|Death|2|||
129922457|NCT05457647|467680771|FG000|Overall Study|Lost to Follow-up|3|||
129922458|NCT04938492|467680772|FG000|Overall Study|Lost to Follow-up|17|||
129922459|NCT04938492|467680773|FG001|Overall Study|Lost to Follow-up|18|||
129922460|NCT02683447|467680774|FG000|Overall Study|Lost to Follow-up|2|||
129922461|NCT03448107|467680775|FG000|Overall Study|Lost to Follow-up|229|||
129922462|NCT03448107|467680776|FG001|Overall Study|Lost to Follow-up|258|||
129922463|NCT04025554|467680777|FG000|Overall Study|Adverse Event|3|||
129922464|NCT03115476|467680778|FG000|LP0084-1369|Death|1|||
129922465|NCT03115476|467680779|FG001|LP0084-1369|Death|0|||
129922466|NCT03115476|467680780|FG002|LP0084-1369|Death|2|||
129922467|NCT03115476|467680778|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
129922468|NCT03115476|467680779|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
129922469|NCT03115476|467680780|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
129922470|NCT05257486|467680784|FG000|Overall Study|Protocol Violation|3|||
129922471|NCT03976362|467680785|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
129922472|NCT03976362|467680786|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129922473|NCT03976362|467680787|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
129922474|NCT03976362|467680785|FG000|Induction Phase|Death|62|||
129922475|NCT03976362|467680786|FG001|Induction Phase|Death|0|||
129922476|NCT03976362|467680787|FG002|Induction Phase|Death|0|||
129922477|NCT03976362|467680785|FG000|Maintenance Phase|Participants Ongoing|0|||
129922478|NCT03976362|467680786|FG001|Maintenance Phase|Participants Ongoing|106|||
129922479|NCT03976362|467680787|FG002|Maintenance Phase|Participants Ongoing|103|||
129922480|NCT03976362|467680785|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129922481|NCT03976362|467680786|FG001|Maintenance Phase|Withdrawal by Subject|4|||
129922482|NCT03976362|467680787|FG002|Maintenance Phase|Withdrawal by Subject|4|||
129922483|NCT03976362|467680785|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
129922484|NCT03976362|467680786|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
129922485|NCT03976362|467680787|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
129922486|NCT03976362|467680785|FG000|Maintenance Phase|Death|0|||
129450079|NCT00701090|465947302|FG000|Overall Study|Lost to Follow-up|9|||
129450080|NCT00701090|465947303|FG001|Overall Study|Lost to Follow-up|9|||
129450081|NCT00701090|465947302|FG000|Overall Study|Physician Decision|3|||
129450082|NCT00701090|465947303|FG001|Overall Study|Physician Decision|4|||
129450083|NCT00701090|465947302|FG000|Overall Study|Protocol Violation|2|||
129450084|NCT00701090|465947303|FG001|Overall Study|Protocol Violation|3|||
129450085|NCT00701090|465947302|FG000|Overall Study|Withdrawal by Subject|11|||
129450086|NCT00701090|465947303|FG001|Overall Study|Withdrawal by Subject|16|||
129450087|NCT00701090|465947302|FG000|Overall Study|Other|7|||
129450088|NCT00701090|465947303|FG001|Overall Study|Other|12|||
129450089|NCT00873366|465947304|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
129450090|NCT00873366|465947304|FG000|Overall Study|Off tamoxifen due to side effects|2|||
129450091|NCT00873366|465947304|FG000|Overall Study|Refused to continue DM-BT testing|3|||
129450092|NCT01537198|465947316|FG000|Overall Study|RSV infection|2|||
129450093|NCT01537198|465947316|FG000|Overall Study|Adverse Event|4|||
129450094|NCT01537198|465947316|FG000|Overall Study|No Further Visits to the Clinic|37|||
129450095|NCT01537198|465947316|FG000|Overall Study|Other|111|||
129450096|NCT01231659|465947317|FG000|Overall Study|Adverse Event|9|||
129450097|NCT01231659|465947317|FG000|Overall Study|Disease Progression|48|||
129450098|NCT01231659|465947317|FG000|Overall Study|Death|2|||
129450099|NCT01231659|465947317|FG000|Overall Study|Patient refused to complete study visit|1|||
129450100|NCT01231659|465947317|FG000|Overall Study|Other protocol defined criteria|12|||
129450101|NCT02247960|465947318|FG000|Patient Consent and Randomization|Physician Decision|2|||
129450102|NCT02247960|465947319|FG001|Patient Consent and Randomization|Physician Decision|2|||
129450103|NCT02247960|465947318|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
129450104|NCT02247960|465947319|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
129450105|NCT02247960|465947318|FG000|Catheter Removed|Lost to Follow-up|7|||
129450106|NCT02247960|465947319|FG001|Catheter Removed|Lost to Follow-up|10|||
129450107|NCT00356889|465947320|FG000|Overall Study|Protocol Violation|2|||
129450108|NCT00356889|465947320|FG000|Overall Study|Adverse Event|1|||
129450109|NCT00702325|465947321|FG000|Overall Study|Adverse Event|1|||
129450110|NCT00702325|465947322|FG001|Overall Study|Adverse Event|0|||
129450111|NCT00702325|465947321|FG000|Overall Study|Withdrawal by Subject|7|||
129450112|NCT00702325|465947322|FG001|Overall Study|Withdrawal by Subject|7|||
129450113|NCT00702325|465947321|FG000|Overall Study|Lost to Follow-up|3|||
129450114|NCT00702325|465947322|FG001|Overall Study|Lost to Follow-up|4|||
129450115|NCT00702325|465947321|FG000|Overall Study|Incorrect enrollment|5|||
129450116|NCT00702325|465947322|FG001|Overall Study|Incorrect enrollment|7|||
129450117|NCT00702325|465947321|FG000|Overall Study|Developed study discontinuation criteria|18|||
129450118|NCT00702325|465947322|FG001|Overall Study|Developed study discontinuation criteria|28|||
129450119|NCT00702325|465947321|FG000|Overall Study|Severe noncompliance to protocol|3|||
129450120|NCT00702325|465947322|FG001|Overall Study|Severe noncompliance to protocol|3|||
129450121|NCT00702325|465947321|FG000|Overall Study|Termination due to lab results|1|||
129450122|NCT00702325|465947322|FG001|Overall Study|Termination due to lab results|0|||
129922487|NCT03976362|467680786|FG001|Maintenance Phase|Death|186|||
129922488|NCT03976362|467680787|FG002|Maintenance Phase|Death|187|||
129922489|NCT00613106|467680788|FG000|Overall Study|Adverse Event|3|||
129922490|NCT00613106|467680789|FG001|Overall Study|Adverse Event|1|||
129922491|NCT00613106|467680788|FG000|Overall Study|Withdrawal by Subject|6|||
129922492|NCT00613106|467680789|FG001|Overall Study|Withdrawal by Subject|3|||
129922493|NCT00613106|467680788|FG000|Overall Study|Lost to Follow-up|7|||
129922494|NCT00613106|467680789|FG001|Overall Study|Lost to Follow-up|2|||
129922495|NCT00613106|467680788|FG000|Overall Study|misc|4|||
129922496|NCT00613106|467680789|FG001|Overall Study|misc|3|||
129922497|NCT05084508|467680798|FG000|Overall Study|Lost to Follow-up|6|||
129922498|NCT05084508|467680799|FG001|Overall Study|Lost to Follow-up|3|||
129922499|NCT05084508|467680800|FG002|Overall Study|Lost to Follow-up|7|||
129922500|NCT05084508|467680801|FG003|Overall Study|Lost to Follow-up|3|||
129922501|NCT05084508|467680798|FG000|Overall Study|Withdrawal by Subject|0|||
129922502|NCT05084508|467680799|FG001|Overall Study|Withdrawal by Subject|2|||
129922503|NCT05084508|467680800|FG002|Overall Study|Withdrawal by Subject|3|||
129922504|NCT05084508|467680801|FG003|Overall Study|Withdrawal by Subject|1|||
129922505|NCT05084508|467680798|FG000|Overall Study|Other|0|||
129922506|NCT05084508|467680799|FG001|Overall Study|Other|0|||
129922507|NCT05084508|467680800|FG002|Overall Study|Other|0|||
129450123|NCT00702325|465947321|FG000|Overall Study|Didn't follow study medication dosage|0|||
129450124|NCT00702325|465947322|FG001|Overall Study|Didn't follow study medication dosage|2|||
129450125|NCT00702325|465947321|FG000|Overall Study|Withdrew consent|0|||
129450126|NCT00702325|465947322|FG001|Overall Study|Withdrew consent|1|||
129922508|NCT05084508|467680801|FG003|Overall Study|Other|1|||
129922509|NCT05296525|467680802|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
129922510|NCT05296525|467680803|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
129922511|NCT05296525|467680804|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
129922512|NCT05296525|467680805|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
129450127|NCT00702325|465947321|FG000|Overall Study|Incorrectly Discontinued|0|||
129922513|NCT04065841|467680810|FG000|Overall Study|Adverse Event|4|||
129922514|NCT04065841|467680811|FG001|Overall Study|Adverse Event|2|||
129922515|NCT04065841|467680812|FG002|Overall Study|Adverse Event|10|||
129922516|NCT04065841|467680813|FG003|Overall Study|Adverse Event|1|||
129922517|NCT04065841|467680810|FG000|Overall Study|Lost to Follow-up|1|||
129922518|NCT04065841|467680811|FG001|Overall Study|Lost to Follow-up|2|||
129922519|NCT04065841|467680812|FG002|Overall Study|Lost to Follow-up|2|||
129922520|NCT04065841|467680813|FG003|Overall Study|Lost to Follow-up|2|||
129922521|NCT04065841|467680810|FG000|Overall Study|Physician Decision|1|||
129922522|NCT04065841|467680811|FG001|Overall Study|Physician Decision|0|||
129922523|NCT04065841|467680812|FG002|Overall Study|Physician Decision|0|||
129922524|NCT04065841|467680813|FG003|Overall Study|Physician Decision|0|||
129922525|NCT04065841|467680810|FG000|Overall Study|Protocol Violation|0|||
129922526|NCT04065841|467680811|FG001|Overall Study|Protocol Violation|1|||
129922527|NCT04065841|467680812|FG002|Overall Study|Protocol Violation|0|||
129922528|NCT04065841|467680813|FG003|Overall Study|Protocol Violation|0|||
129922529|NCT04065841|467680810|FG000|Overall Study|Study terminated by Sponsor|22|||
129922530|NCT04065841|467680811|FG001|Overall Study|Study terminated by Sponsor|16|||
129922531|NCT04065841|467680812|FG002|Overall Study|Study terminated by Sponsor|28|||
129922532|NCT04065841|467680813|FG003|Overall Study|Study terminated by Sponsor|17|||
129922533|NCT04065841|467680810|FG000|Overall Study|Withdrawal by Subject|1|||
129922534|NCT04065841|467680811|FG001|Overall Study|Withdrawal by Subject|1|||
129922535|NCT04065841|467680812|FG002|Overall Study|Withdrawal by Subject|2|||
129922536|NCT04065841|467680813|FG003|Overall Study|Withdrawal by Subject|0|||
129922537|NCT01420237|467680814|FG000|Overall Study|Death|13|||
129922538|NCT01420237|467680814|FG000|Overall Study|Withdrawal by Subject|41|||
129922539|NCT01420237|467680814|FG000|Overall Study|Lost to Follow-up|32|||
129922540|NCT01420237|467680814|FG000|Overall Study|Adverse Event|10|||
129922541|NCT01420237|467680814|FG000|Overall Study|Investigative Site Termination|43|||
129922542|NCT01420237|467680814|FG000|Overall Study|Censored because study device not implanted|21|||
129922543|NCT01420237|467680814|FG000|Overall Study|Censored because surgery not performed|2|||
129922544|NCT01420237|467680814|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
129922545|NCT01420237|467680814|FG000|Overall Study|Sponsor terminated study early|127|||
129922546|NCT04492722|467680815|FG000|Overall Study|Adverse Event|7|||
129922547|NCT04492722|467680816|FG001|Overall Study|Adverse Event|2|||
129922548|NCT04492722|467680817|FG002|Overall Study|Adverse Event|3|||
129922549|NCT04492722|467680818|FG003|Overall Study|Adverse Event|0|||
129922550|NCT04492722|467680815|FG000|Overall Study|Death|0|||
129922551|NCT04492722|467680816|FG001|Overall Study|Death|0|||
129922552|NCT04492722|467680817|FG002|Overall Study|Death|0|||
129922553|NCT04492722|467680818|FG003|Overall Study|Death|1|||
129922554|NCT04492722|467680815|FG000|Overall Study|Lost to Follow-up|0|||
129922555|NCT04492722|467680816|FG001|Overall Study|Lost to Follow-up|1|||
129922556|NCT04492722|467680817|FG002|Overall Study|Lost to Follow-up|0|||
129922557|NCT04492722|467680818|FG003|Overall Study|Lost to Follow-up|1|||
129922558|NCT04492722|467680815|FG000|Overall Study|Physician Decision|0|||
129922559|NCT04492722|467680816|FG001|Overall Study|Physician Decision|3|||
129922560|NCT04492722|467680817|FG002|Overall Study|Physician Decision|1|||
129922561|NCT04492722|467680818|FG003|Overall Study|Physician Decision|1|||
129922562|NCT04492722|467680815|FG000|Overall Study|Withdrawal by Subject|6|||
129922563|NCT04492722|467680816|FG001|Overall Study|Withdrawal by Subject|6|||
129922564|NCT04492722|467680817|FG002|Overall Study|Withdrawal by Subject|0|||
129922565|NCT04492722|467680818|FG003|Overall Study|Withdrawal by Subject|3|||
129922566|NCT04492722|467680815|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
129922567|NCT04492722|467680816|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
129922568|NCT04492722|467680817|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
129922569|NCT04492722|467680818|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
129922570|NCT04492722|467680815|FG000|Overall Study|Due to Covid-19 pandemic|7|||
129922571|NCT04492722|467680816|FG001|Overall Study|Due to Covid-19 pandemic|3|||
129922572|NCT04492722|467680817|FG002|Overall Study|Due to Covid-19 pandemic|7|||
129922573|NCT04492722|467680818|FG003|Overall Study|Due to Covid-19 pandemic|6|||
129922574|NCT04492722|467680815|FG000|Overall Study|Failure to meet randomisation criteria|2|||
129922575|NCT04492722|467680816|FG001|Overall Study|Failure to meet randomisation criteria|3|||
129922576|NCT04492722|467680817|FG002|Overall Study|Failure to meet randomisation criteria|4|||
129922577|NCT04492722|467680818|FG003|Overall Study|Failure to meet randomisation criteria|2|||
129922578|NCT04492722|467680815|FG000|Overall Study|Early termination from the study|54|||
129922579|NCT04492722|467680816|FG001|Overall Study|Early termination from the study|51|||
129922580|NCT04492722|467680817|FG002|Overall Study|Early termination from the study|50|||
129922581|NCT04492722|467680818|FG003|Overall Study|Early termination from the study|50|||
129922582|NCT04492722|467680815|FG000|Overall Study|Missing|3|||
129922583|NCT04492722|467680816|FG001|Overall Study|Missing|0|||
129922584|NCT04492722|467680817|FG002|Overall Study|Missing|0|||
129922585|NCT04492722|467680818|FG003|Overall Study|Missing|5|||
129922586|NCT04492722|467680815|FG000|Overall Study|Participants who did not receive treatment|0|||
129922587|NCT04492722|467680816|FG001|Overall Study|Participants who did not receive treatment|1|||
129922588|NCT04492722|467680817|FG002|Overall Study|Participants who did not receive treatment|4|||
129922589|NCT04492722|467680818|FG003|Overall Study|Participants who did not receive treatment|0|||
129922590|NCT03631784|467680820|FG000|Overall Study|Participants Ongoing|1|||
129922591|NCT03631784|467680821|FG001|Overall Study|Participants Ongoing|0|||
129922592|NCT03631784|467680820|FG000|Overall Study|Withdrawal by Subject|3|||
129922593|NCT03631784|467680821|FG001|Overall Study|Withdrawal by Subject|3|||
129922594|NCT03631784|467680820|FG000|Overall Study|Sponsor's Decision|36|||
129922595|NCT03631784|467680821|FG001|Overall Study|Sponsor's Decision|52|||
129922596|NCT03631784|467680820|FG000|Overall Study|Lost to Follow-up|1|||
129922597|NCT03631784|467680821|FG001|Overall Study|Lost to Follow-up|0|||
129922598|NCT03631784|467680820|FG000|Overall Study|Death|71|||
129922599|NCT03631784|467680821|FG001|Overall Study|Death|49|||
129922600|NCT05030233|467680827|FG000|Overall Study|withdrawn for transfer|1|||
129922601|NCT05030233|467680828|FG001|Overall Study|withdrawn for transfer|0|||
129922602|NCT04437615|467680829|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
129922603|NCT02921230|467682962|FG000|Overall Study|Withdrawal by Subject|20|||
129922604|NCT02921230|467682963|FG001|Overall Study|Withdrawal by Subject|8|||
129922605|NCT02921230|467682962|FG000|Overall Study|Death|12|||
129922606|NCT02921230|467682963|FG001|Overall Study|Death|3|||
129922607|NCT02921230|467682962|FG000|Overall Study|Protocol Violation|17|||
129922608|NCT02921230|467682963|FG001|Overall Study|Protocol Violation|6|||
129922609|NCT02921230|467682962|FG000|Overall Study|Early completion|5|||
129922610|NCT02921230|467682963|FG001|Overall Study|Early completion|1|||
129922611|NCT02921230|467682962|FG000|Overall Study|Pending data entry|1|||
129450128|NCT00702325|465947322|FG001|Overall Study|Incorrectly Discontinued|1|||
129450129|NCT01022502|465947326|FG000|Overall Study|Adverse Event|1|||
129450130|NCT01022502|465947326|FG000|Overall Study|employment related reasons|1|||
129450131|NCT01022502|465947326|FG000|Overall Study|Withdrawal by Subject|1|||
129450132|NCT03716050|465947327|FG000|Overall Study|Lost to Follow-up|0|||
129450133|NCT03716050|465947328|FG001|Overall Study|Lost to Follow-up|0|||
129450134|NCT03716050|465947329|FG002|Overall Study|Lost to Follow-up|1|||
129450135|NCT03716050|465947330|FG003|Overall Study|Lost to Follow-up|0|||
129450136|NCT03716050|465947331|FG004|Overall Study|Lost to Follow-up|0|||
129450137|NCT03716050|465947332|FG005|Overall Study|Lost to Follow-up|0|||
129450138|NCT03716050|465947333|FG006|Overall Study|Lost to Follow-up|0|||
129450139|NCT03716050|465947334|FG007|Overall Study|Lost to Follow-up|0|||
129450140|NCT03716050|465947327|FG000|Overall Study|Physician Decision|0|||
129450141|NCT03716050|465947328|FG001|Overall Study|Physician Decision|0|||
129450142|NCT03716050|465947329|FG002|Overall Study|Physician Decision|0|||
129450143|NCT03716050|465947330|FG003|Overall Study|Physician Decision|1|||
129450144|NCT03716050|465947331|FG004|Overall Study|Physician Decision|0|||
129450145|NCT03716050|465947332|FG005|Overall Study|Physician Decision|0|||
129450146|NCT03716050|465947333|FG006|Overall Study|Physician Decision|0|||
129450147|NCT03716050|465947334|FG007|Overall Study|Physician Decision|0|||
129450148|NCT03716050|465947327|FG000|Overall Study|Protocol Violation|0|||
129450149|NCT03716050|465947328|FG001|Overall Study|Protocol Violation|0|||
129450150|NCT03716050|465947329|FG002|Overall Study|Protocol Violation|0|||
129450151|NCT03716050|465947330|FG003|Overall Study|Protocol Violation|1|||
129450152|NCT03716050|465947331|FG004|Overall Study|Protocol Violation|0|||
129450153|NCT03716050|465947332|FG005|Overall Study|Protocol Violation|0|||
129450154|NCT03716050|465947333|FG006|Overall Study|Protocol Violation|0|||
129450155|NCT03716050|465947334|FG007|Overall Study|Protocol Violation|2|||
129450156|NCT03123250|465947335|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
129450157|NCT01390272|465947336|FG000|Overall Study|Death|3|||
129450158|NCT01390272|465947337|FG001|Overall Study|Death|2|||
129450159|NCT01390272|465947336|FG000|Overall Study|Withdrawal by Subject|9|||
129450160|NCT01390272|465947337|FG001|Overall Study|Withdrawal by Subject|5|||
129450161|NCT01390272|465947336|FG000|Overall Study|Patient moved, no longer eligible|5|||
129450162|NCT01390272|465947337|FG001|Overall Study|Patient moved, no longer eligible|8|||
129450163|NCT03199040|465947338|FG000|Overall Study|Lack of Efficacy|2|||
129450164|NCT03199040|465947339|FG001|Overall Study|Lack of Efficacy|0|||
129450165|NCT03199040|465947338|FG000|Overall Study|Withdrawal by Subject|2|||
129450166|NCT03199040|465947339|FG001|Overall Study|Withdrawal by Subject|0|||
129450167|NCT03199040|465947338|FG000|Overall Study|Adverse Event|0|||
129450168|NCT03199040|465947339|FG001|Overall Study|Adverse Event|1|||
129450169|NCT03199040|465947338|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
129450170|NCT03199040|465947339|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
129450171|NCT00199836|465947340|FG000|Overall Study|Progressive Disease|5|||
129450172|NCT00199836|465947340|FG000|Overall Study|Death|1|||
129450173|NCT01854645|465947346|FG000|Overall Study|Protocol-Specified Criteria|13|||
129450174|NCT01854645|465947347|FG001|Overall Study|Protocol-Specified Criteria|10|||
129450175|NCT01854645|465947348|FG002|Overall Study|Protocol-Specified Criteria|8|||
129450176|NCT01854645|465947349|FG003|Overall Study|Protocol-Specified Criteria|5|||
129450177|NCT01854645|465947350|FG004|Overall Study|Protocol-Specified Criteria|7|||
129450178|NCT01854645|465947346|FG000|Overall Study|Administrative Reasons / Missing|0|||
129450179|NCT01854645|465947347|FG001|Overall Study|Administrative Reasons / Missing|0|||
129450180|NCT01854645|465947348|FG002|Overall Study|Administrative Reasons / Missing|0|||
129450181|NCT01854645|465947349|FG003|Overall Study|Administrative Reasons / Missing|1|||
129450182|NCT01854645|465947350|FG004|Overall Study|Administrative Reasons / Missing|1|||
129450183|NCT01854645|465947346|FG000|Overall Study|Protocol Violation|3|||
129450184|NCT01854645|465947347|FG001|Overall Study|Protocol Violation|0|||
129450185|NCT01854645|465947348|FG002|Overall Study|Protocol Violation|5|||
129450186|NCT01854645|465947349|FG003|Overall Study|Protocol Violation|4|||
129450187|NCT01854645|465947350|FG004|Overall Study|Protocol Violation|1|||
129450188|NCT01854645|465947346|FG000|Overall Study|Lost to Follow-up|10|||
129450189|NCT01854645|465947347|FG001|Overall Study|Lost to Follow-up|7|||
129922612|NCT02921230|467682963|FG001|Overall Study|Pending data entry|0|||
129922613|NCT01396278|467682966|FG000|Overall Study|Adverse Event|0|||
129922614|NCT01396278|467682967|FG001|Overall Study|Adverse Event|0|||
129922615|NCT01396278|467682968|FG002|Overall Study|Adverse Event|0|||
129922616|NCT01396278|467682969|FG003|Overall Study|Adverse Event|2|||
129450190|NCT01854645|465947348|FG002|Overall Study|Lost to Follow-up|8|||
129450191|NCT01854645|465947349|FG003|Overall Study|Lost to Follow-up|5|||
129450192|NCT01854645|465947350|FG004|Overall Study|Lost to Follow-up|0|||
129922617|NCT01396278|467682970|FG004|Overall Study|Adverse Event|0|||
129450193|NCT01854645|465947346|FG000|Overall Study|Physician Decision|1|||
129450194|NCT01854645|465947347|FG001|Overall Study|Physician Decision|5|||
129450195|NCT01854645|465947348|FG002|Overall Study|Physician Decision|3|||
129450196|NCT01854645|465947349|FG003|Overall Study|Physician Decision|3|||
129450197|NCT01854645|465947350|FG004|Overall Study|Physician Decision|7|||
129450198|NCT01854645|465947346|FG000|Overall Study|Withdrawal by Subject|31|||
129450199|NCT01854645|465947347|FG001|Overall Study|Withdrawal by Subject|41|||
129922618|NCT01396278|467682966|FG000|Overall Study|Withdraw due to trial termination|2|||
129922619|NCT01396278|467682967|FG001|Overall Study|Withdraw due to trial termination|1|||
129922620|NCT01396278|467682968|FG002|Overall Study|Withdraw due to trial termination|1|||
129922621|NCT01396278|467682969|FG003|Overall Study|Withdraw due to trial termination|0|||
129922622|NCT01396278|467682970|FG004|Overall Study|Withdraw due to trial termination|2|||
129922623|NCT04552223|467682974|FG000|Overall Study|Withdrawal by Subject|1|||
129922624|NCT03701399|467682979|FG000|Overall Study|Adverse Event|3|||
129922625|NCT03701399|467682980|FG001|Overall Study|Adverse Event|5|||
129922626|NCT03701399|467682979|FG000|Overall Study|Withdrawal by Subject|6|||
129922627|NCT03701399|467682980|FG001|Overall Study|Withdrawal by Subject|3|||
129922628|NCT03701399|467682979|FG000|Overall Study|Investigators decision|1|||
129922629|NCT03701399|467682980|FG001|Overall Study|Investigators decision|2|||
129922630|NCT03701399|467682979|FG000|Overall Study|Lost to Follow-up|1|||
129922631|NCT03701399|467682980|FG001|Overall Study|Lost to Follow-up|2|||
129922632|NCT03701399|467682979|FG000|Overall Study|Death|1|||
129922633|NCT03701399|467682980|FG001|Overall Study|Death|1|||
129922634|NCT03701399|467682979|FG000|Overall Study|Randomized but not treated|1|||
129922635|NCT03701399|467682980|FG001|Overall Study|Randomized but not treated|0|||
129922636|NCT04342494|467682981|FG000|Overall Study|Questionnaire partially completed|1|||
129922637|NCT04342494|467682982|FG001|Overall Study|Questionnaire partially completed|0|||
129922638|NCT04342494|467682983|FG002|Overall Study|Questionnaire partially completed|2|||
129922639|NCT04342494|467682984|FG003|Overall Study|Questionnaire partially completed|0|||
129922640|NCT04342494|467682985|FG004|Overall Study|Questionnaire partially completed|1|||
129922641|NCT04342494|467682981|FG000|Overall Study|Lost to Follow-up|49|||
129922642|NCT04342494|467682982|FG001|Overall Study|Lost to Follow-up|38|||
129922643|NCT04342494|467682983|FG002|Overall Study|Lost to Follow-up|34|||
129922644|NCT04342494|467682984|FG003|Overall Study|Lost to Follow-up|34|||
129922645|NCT04342494|467682985|FG004|Overall Study|Lost to Follow-up|35|||
129922646|NCT05119023|467682986|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
129922647|NCT05119023|467682986|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
129922648|NCT05119023|467682986|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
129922649|NCT04806451|467682990|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
129922650|NCT04806451|467682991|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
129922651|NCT04806451|467682990|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
129922652|NCT04806451|467682991|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
129922653|NCT04806451|467682990|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
129922654|NCT04806451|467682991|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
129922655|NCT05835336|467682992|FG000|Overall Study|Withdrawal by Subject|5|||
129922656|NCT05835336|467682992|FG000|Overall Study|Did not complete the personalization process|3|||
129922657|NCT03134196|467682999|FG000|Overall Study|Death|2|||
129922658|NCT03134196|467683000|FG001|Overall Study|Death|1|||
129922659|NCT03134196|467682999|FG000|Overall Study|Lost to Follow-up|13|||
129922660|NCT03134196|467683000|FG001|Overall Study|Lost to Follow-up|15|||
129922661|NCT03134196|467682999|FG000|Overall Study|Physician Decision|0|||
129922662|NCT03134196|467683000|FG001|Overall Study|Physician Decision|1|||
129922663|NCT03134196|467682999|FG000|Overall Study|Withdrawal by Subject|19|||
129922664|NCT03134196|467683000|FG001|Overall Study|Withdrawal by Subject|12|||
129922665|NCT03134196|467682999|FG000|Overall Study|Site Unable to Contact Participant|2|||
129922666|NCT03134196|467683000|FG001|Overall Study|Site Unable to Contact Participant|0|||
129922667|NCT03134196|467682999|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
129922668|NCT03134196|467683000|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
129922669|NCT03134196|467682999|FG000|Overall Study|Scheduling Conflict|1|||
129922670|NCT03134196|467683000|FG001|Overall Study|Scheduling Conflict|0|||
129922671|NCT06516705|467683009|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
129922672|NCT06516705|467683010|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
129922673|NCT06516705|467683009|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
129922674|NCT06516705|467683010|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
129922675|NCT06516705|467683009|FG000|T3 ( 3 Month After Education)|covid-19|1|||
129922676|NCT06516705|467683010|FG001|T3 ( 3 Month After Education)|covid-19|2|||
129922677|NCT06516705|467683009|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
129922678|NCT06516705|467683010|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
129922679|NCT06516705|467683009|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
129922680|NCT06516705|467683010|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
129922681|NCT06516705|467683009|FG000|T4 ( 6 Month After Education)|covid-19|3|||
129922682|NCT06516705|467683010|FG001|T4 ( 6 Month After Education)|covid-19|2|||
129922683|NCT06516705|467683009|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
129922684|NCT06516705|467683010|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
129922685|NCT03199469|467683011|FG000|Overall Study|Randomized, not treated|0|||
129922686|NCT03199469|467683012|FG001|Overall Study|Randomized, not treated|3|||
129922687|NCT03199469|467683011|FG000|Overall Study|Withdrawal by Subject|1|||
129922688|NCT03199469|467683012|FG001|Overall Study|Withdrawal by Subject|0|||
129922689|NCT03199469|467683011|FG000|Overall Study|Death|1|||
129922690|NCT03199469|467683012|FG001|Overall Study|Death|3|||
129922691|NCT03199469|467683011|FG000|Overall Study|Ongoing|5|||
129922692|NCT03199469|467683012|FG001|Overall Study|Ongoing|14|||
129922693|NCT04292223|467683016|FG000|Overall Study|Adverse Event|1|||
129922694|NCT04292223|467683016|FG000|Overall Study|Lost to Follow-up|1|||
129922695|NCT04292223|467683016|FG000|Overall Study|Noncompliance with study drug|2|||
129922696|NCT04292223|467683016|FG000|Overall Study|Patient moved out of the state|1|||
129922697|NCT00753545|467683017|FG000|Overall Study|Death|98|||
129922698|NCT00753545|467683018|FG001|Overall Study|Death|112|||
129922699|NCT00753545|467683017|FG000|Overall Study|Lost to Follow-up|2|||
129922700|NCT00753545|467683018|FG001|Overall Study|Lost to Follow-up|3|||
129922701|NCT00753545|467683017|FG000|Overall Study|Protocol Violation|1|||
129922702|NCT00753545|467683018|FG001|Overall Study|Protocol Violation|0|||
129922703|NCT00753545|467683017|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
129922704|NCT00753545|467683018|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
129922705|NCT05453773|467683019|FG000|Overall Study|Withdrawal by Subject|3|||
129922706|NCT05453773|467683019|FG000|Overall Study|Lost to Follow-up|3|||
129922707|NCT05453773|467683019|FG000|Overall Study|Difficult Blood Draw|3|||
129922708|NCT02023866|467683023|FG000|Overall Study|Non-compliance|2|||
129922709|NCT02023866|467683023|FG000|Overall Study|Adverse Event|3|||
129922710|NCT02023866|467683023|FG000|Overall Study|Withdrawal by Subject|1|||
129922711|NCT04091750|467683037|FG000|Overall Study|Adverse Event|4|||
129922712|NCT04091750|467683037|FG000|Overall Study|Withdrawal by Subject|1|||
129922713|NCT04293055|467683038|FG000|Overall Study|Lost to Follow-up|1|||
129922714|NCT04293055|467683039|FG001|Overall Study|Lost to Follow-up|1|||
129922715|NCT04293055|467683038|FG000|Overall Study|Did not trigger randomization|6|||
129922716|NCT04293055|467683039|FG001|Overall Study|Did not trigger randomization|5|||
129922717|NCT03560609|467683040|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
129922718|NCT03560609|467683041|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
129922719|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
129922720|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
129922721|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
129922722|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
129922723|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
129922724|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
129922725|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
129922726|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
129922727|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
129922728|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
129922729|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
129922730|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
129922731|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
129922732|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
129922733|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
129922734|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
129922735|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
129922736|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
129922737|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922738|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
129922739|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
129922740|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922741|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922742|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
129922743|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922744|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922745|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
129922746|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
129922747|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922748|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
129922749|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
129922750|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
129922751|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
129922752|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922753|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922754|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
129922755|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
129922756|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
129922757|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
129922758|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
129922759|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
129922760|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
129922761|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
129922762|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
129922763|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
129922764|NCT01369355|467683051|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
129922765|NCT01369355|467683052|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
129922766|NCT01369355|467683053|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
129922767|NCT01369355|467683054|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
129922768|NCT01369355|467683055|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
129922769|NCT01369355|467683056|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
129922770|NCT01369355|467683057|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
129922771|NCT01369355|467683058|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
129922772|NCT01369355|467683059|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
129922773|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922774|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922775|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922776|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922777|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922778|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
129922779|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
129922780|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
129922781|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
129922782|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Death|0|||
129922783|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Death|0|||
129922784|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Death|0|||
129922785|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Death|0|||
129922786|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Death|0|||
129922787|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Death|0|||
129922788|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Death|0|||
129922789|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Death|1|||
129922790|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Death|3|||
129922791|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922792|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922793|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922794|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922795|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922796|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
129922797|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
129922798|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
129922799|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
129922800|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922801|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922802|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922803|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922804|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922805|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922806|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
129922807|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
129922808|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
129922809|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922810|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922811|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922812|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922813|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922814|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
129922815|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
129922816|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
129922817|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
129922818|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922819|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922820|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922821|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922822|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922823|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
129922824|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
129922825|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
129922826|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
129922827|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922828|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922829|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922830|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129450200|NCT01854645|465947348|FG002|Overall Study|Withdrawal by Subject|30|||
129450201|NCT01854645|465947349|FG003|Overall Study|Withdrawal by Subject|21|||
129450202|NCT01854645|465947350|FG004|Overall Study|Withdrawal by Subject|24|||
129450203|NCT01854645|465947346|FG000|Overall Study|Lack of Efficacy|7|||
129450204|NCT01854645|465947347|FG001|Overall Study|Lack of Efficacy|12|||
129450205|NCT01854645|465947348|FG002|Overall Study|Lack of Efficacy|9|||
129450206|NCT01854645|465947349|FG003|Overall Study|Lack of Efficacy|3|||
129450207|NCT01854645|465947350|FG004|Overall Study|Lack of Efficacy|9|||
129450208|NCT01854645|465947346|FG000|Overall Study|Adverse Event|33|||
129450209|NCT01854645|465947347|FG001|Overall Study|Adverse Event|31|||
129450210|NCT01854645|465947348|FG002|Overall Study|Adverse Event|19|||
129450211|NCT01854645|465947349|FG003|Overall Study|Adverse Event|20|||
129922831|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922832|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
129922833|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
129922834|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
129450212|NCT01854645|465947350|FG004|Overall Study|Adverse Event|11|||
129450213|NCT00430482|465947351|FG000|Completed Treatment|Insufficient Treatment|7|||
129450214|NCT00430482|465947352|FG001|Completed Treatment|Insufficient Treatment|11|||
129450215|NCT00545402|465947353|FG000|Overall Study|Discontinuation of treatment|17|||
129450216|NCT00545402|465947354|FG001|Overall Study|Discontinuation of treatment|9|||
129450217|NCT00545402|465947353|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
129450218|NCT00545402|465947354|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
129450219|NCT00545402|465947353|FG000|Overall Study|Death|5|||
129450220|NCT00545402|465947354|FG001|Overall Study|Death|7|||
129450221|NCT00545402|465947353|FG000|Overall Study|Graft loss|2|||
129450222|NCT00545402|465947354|FG001|Overall Study|Graft loss|4|||
129450223|NCT00545402|465947353|FG000|Overall Study|Withdrawal by Subject|0|||
129450224|NCT00545402|465947354|FG001|Overall Study|Withdrawal by Subject|1|||
129450225|NCT00545402|465947353|FG000|Overall Study|Protocol Violation|1|||
129450226|NCT00545402|465947354|FG001|Overall Study|Protocol Violation|0|||
129450227|NCT00545402|465947353|FG000|Overall Study|Reason not specified|1|||
129450228|NCT00545402|465947354|FG001|Overall Study|Reason not specified|1|||
129450229|NCT00555477|465947355|FG000|Overall Study|Adverse Event|0|||
129450230|NCT00555477|465947356|FG001|Overall Study|Adverse Event|9|||
129450231|NCT00555477|465947355|FG000|Overall Study|Withdrawal by Subject|1|||
129450232|NCT00555477|465947356|FG001|Overall Study|Withdrawal by Subject|2|||
129450233|NCT00555477|465947355|FG000|Overall Study|Physician Decision|1|||
129450234|NCT00555477|465947356|FG001|Overall Study|Physician Decision|2|||
129450235|NCT01721876|465947357|FG000|Overall Study|Not treated|1|||
129450236|NCT01721876|465947358|FG001|Overall Study|Not treated|4|||
129450237|NCT01721876|465947357|FG000|Overall Study|Disease progression / relapse|123|||
129450238|NCT01721876|465947358|FG001|Overall Study|Disease progression / relapse|156|||
129450239|NCT01721876|465947357|FG000|Overall Study|Death|6|||
129450240|NCT01721876|465947358|FG001|Overall Study|Death|13|||
129450241|NCT01721876|465947357|FG000|Overall Study|Adverse Event|41|||
129450242|NCT01721876|465947358|FG001|Overall Study|Adverse Event|165|||
129450243|NCT01721876|465947357|FG000|Overall Study|Protocol Violation|2|||
129450244|NCT01721876|465947358|FG001|Overall Study|Protocol Violation|1|||
129450245|NCT01721876|465947357|FG000|Overall Study|Withdrawal by Subject|15|||
129450246|NCT01721876|465947358|FG001|Overall Study|Withdrawal by Subject|38|||
129450247|NCT01721876|465947357|FG000|Overall Study|Reason not listed|34|||
129450248|NCT01721876|465947358|FG001|Overall Study|Reason not listed|63|||
129450249|NCT01721876|465947357|FG000|Overall Study|Sponsor terminated trial|0|||
129450250|NCT01721876|465947358|FG001|Overall Study|Sponsor terminated trial|4|||
129450251|NCT01721057|465947361|FG000|Treatment Period|Withdrawal by Subject|11|||
129450252|NCT01721057|465947362|FG001|Treatment Period|Withdrawal by Subject|5|||
129450253|NCT01721057|465947363|FG002|Treatment Period|Withdrawal by Subject|8|||
129450254|NCT01721057|465947364|FG003|Treatment Period|Withdrawal by Subject|0|||
129450255|NCT01721057|465947365|FG004|Treatment Period|Withdrawal by Subject|0|||
129450256|NCT01721057|465947366|FG005|Treatment Period|Withdrawal by Subject|0|||
129450257|NCT01721057|465947367|FG006|Treatment Period|Withdrawal by Subject|0|||
129450258|NCT01721057|465947361|FG000|Treatment Period|Adverse Event|7|||
129450259|NCT01721057|465947362|FG001|Treatment Period|Adverse Event|10|||
129922835|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
129450260|NCT01721057|465947363|FG002|Treatment Period|Adverse Event|12|||
129450261|NCT01721057|465947364|FG003|Treatment Period|Adverse Event|0|||
129450262|NCT01721057|465947365|FG004|Treatment Period|Adverse Event|0|||
129450263|NCT01721057|465947366|FG005|Treatment Period|Adverse Event|0|||
129450264|NCT01721057|465947367|FG006|Treatment Period|Adverse Event|0|||
129450265|NCT01721057|465947361|FG000|Treatment Period|Lack of Efficacy|7|||
129450266|NCT01721057|465947362|FG001|Treatment Period|Lack of Efficacy|3|||
129450267|NCT01721057|465947363|FG002|Treatment Period|Lack of Efficacy|0|||
129450268|NCT01721057|465947364|FG003|Treatment Period|Lack of Efficacy|0|||
129450269|NCT01721057|465947365|FG004|Treatment Period|Lack of Efficacy|0|||
129450270|NCT01721057|465947366|FG005|Treatment Period|Lack of Efficacy|0|||
129450271|NCT01721057|465947367|FG006|Treatment Period|Lack of Efficacy|0|||
129922836|NCT01369355|467683051|FG000|Long-term Extension (Week 44-272)|Other|0|||
129922837|NCT01369355|467683052|FG001|Long-term Extension (Week 44-272)|Other|0|||
129922838|NCT01369355|467683053|FG002|Long-term Extension (Week 44-272)|Other|0|||
129922839|NCT01369355|467683054|FG003|Long-term Extension (Week 44-272)|Other|0|||
129922840|NCT01369355|467683055|FG004|Long-term Extension (Week 44-272)|Other|0|||
129450272|NCT01721057|465947361|FG000|Treatment Period|Lost to Follow-up|1|||
129922841|NCT01369355|467683056|FG005|Long-term Extension (Week 44-272)|Other|0|||
129922842|NCT01369355|467683057|FG006|Long-term Extension (Week 44-272)|Other|110|||
129922843|NCT01369355|467683058|FG007|Long-term Extension (Week 44-272)|Other|9|||
129922844|NCT01369355|467683059|FG008|Long-term Extension (Week 44-272)|Other|17|||
129922845|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
129922846|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922847|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922848|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922849|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129922850|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
129450273|NCT01721057|465947362|FG001|Treatment Period|Lost to Follow-up|0|||
129922851|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
129922852|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922853|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922854|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922855|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922856|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
129922857|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922858|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
129922859|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922860|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922861|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922862|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
129922863|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922864|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
129922865|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922866|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922867|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922868|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
129922869|NCT01902173|467683060|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922870|NCT01902173|467683061|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
129922871|NCT01902173|467683062|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922872|NCT01902173|467683063|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922873|NCT01902173|467683064|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922874|NCT01902173|467683065|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
129922875|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922876|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922877|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
129922878|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922879|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922880|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
129922881|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922882|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922883|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
129922884|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922885|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922886|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
129922887|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922888|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922889|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922890|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
129922891|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922892|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
129922893|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922894|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922895|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922896|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
129922897|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922898|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
129922899|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922900|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922901|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922902|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922903|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
129922904|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
129922905|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922906|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922907|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922908|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922909|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
129922910|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
129922911|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922912|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922913|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922914|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922915|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
129922916|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
129922917|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129922918|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129922919|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129450274|NCT01721057|465947363|FG002|Treatment Period|Lost to Follow-up|0|||
129450275|NCT01721057|465947364|FG003|Treatment Period|Lost to Follow-up|0|||
129450276|NCT01721057|465947365|FG004|Treatment Period|Lost to Follow-up|0|||
129922920|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129922921|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
129450277|NCT01721057|465947366|FG005|Treatment Period|Lost to Follow-up|0|||
129922922|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
129922923|NCT01902173|467683060|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922924|NCT01902173|467683061|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922925|NCT01902173|467683062|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922926|NCT01902173|467683063|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922927|NCT01902173|467683064|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
129922928|NCT01902173|467683065|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
129922929|NCT02262728|467683066|FG000|Follow-up Phase (3 Years)|Death|0|||
129922930|NCT02262728|467683067|FG001|Follow-up Phase (3 Years)|Death|1|||
129922931|NCT02262728|467683066|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
129922932|NCT02262728|467683067|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
129922933|NCT02262728|467683066|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
129922934|NCT02262728|467683067|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
129922935|NCT00227344|467683070|FG000|Overall Study|study terminated early|12|||
129922936|NCT00227344|467683071|FG001|Overall Study|study terminated early|5|||
129922937|NCT01987895|467683072|FG000|Overall Study|Withdrawal by Subject|12|||
129922938|NCT01987895|467683073|FG001|Overall Study|Withdrawal by Subject|7|||
129922939|NCT01987895|467683072|FG000|Overall Study|Physician Decision|8|||
129922940|NCT01987895|467683073|FG001|Overall Study|Physician Decision|10|||
129922941|NCT01987895|467683072|FG000|Overall Study|Death|7|||
129922942|NCT01987895|467683073|FG001|Overall Study|Death|7|||
129922943|NCT01987895|467683072|FG000|Overall Study|Lost to Follow-up|3|||
129922944|NCT01987895|467683073|FG001|Overall Study|Lost to Follow-up|5|||
129922945|NCT01987895|467683072|FG000|Overall Study|randomized before giving IC|0|||
129922946|NCT01987895|467683073|FG001|Overall Study|randomized before giving IC|1|||
129922947|NCT05364671|467683074|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
129922948|NCT05364671|467683075|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
129922949|NCT05364671|467683074|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
129922950|NCT05364671|467683075|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
129922951|NCT05364671|467683074|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
129922952|NCT05364671|467683075|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
129922953|NCT05364671|467683074|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
129922954|NCT05364671|467683075|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
129922955|NCT05364671|467683074|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
129922956|NCT05364671|467683075|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
129922957|NCT05256017|467683076|FG000|Treatment Period|Withdrawal by Subject|1|||
129922958|NCT05256017|467683077|FG001|Treatment Period|Withdrawal by Subject|1|||
129922959|NCT05256017|467683076|FG000|Follow-up|Lost to Follow-up|7|||
129922960|NCT05256017|467683077|FG001|Follow-up|Lost to Follow-up|1|||
129922961|NCT05256017|467683076|FG000|Follow-up|Withdrawal by Subject|1|||
129922962|NCT05256017|467683077|FG001|Follow-up|Withdrawal by Subject|0|||
129922963|NCT05256017|467683076|FG000|Follow-up|Death|0|||
129922964|NCT05256017|467683077|FG001|Follow-up|Death|1|||
129922965|NCT03536754|467683082|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
129922966|NCT03536754|467683083|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
129922967|NCT03536754|467683084|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
129922968|NCT03536754|467683085|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
129922969|NCT03536754|467683086|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
129922970|NCT03536754|467683082|FG000|Open Label Extension|Other|0|||
129922971|NCT03536754|467683083|FG001|Open Label Extension|Other|0|||
129922972|NCT03536754|467683084|FG002|Open Label Extension|Other|0|||
129922973|NCT03536754|467683085|FG003|Open Label Extension|Other|0|||
129922974|NCT03536754|467683086|FG004|Open Label Extension|Other|1|||
129922975|NCT04858321|467683088|FG000|Overall Study|Withdrawal by Subject|3|||
129922976|NCT05057247|467683089|FG000|Overall Study|Death|4|||
129922977|NCT05057247|467683089|FG000|Overall Study|Physician Decision|3|||
129922978|NCT05057247|467683089|FG000|Overall Study|Progressive Disease|7|||
129922979|NCT05057247|467683089|FG000|Overall Study|Withdrawal by Subject|3|||
129922980|NCT05057247|467683089|FG000|Overall Study|Adverse Event|6|||
129922981|NCT05057247|467683089|FG000|Overall Study|Subject Non-Compliance|1|||
129922982|NCT05057247|467683089|FG000|Overall Study|On treatment|2|||
129922983|NCT04632992|467683100|FG000|Overall Study|Adverse Event|0|||
129922984|NCT04632992|467683101|FG001|Overall Study|Adverse Event|0|||
129922985|NCT04632992|467683102|FG002|Overall Study|Adverse Event|0|||
129922986|NCT04632992|467683103|FG003|Overall Study|Adverse Event|0|||
129922987|NCT04632992|467683104|FG004|Overall Study|Adverse Event|0|||
129922988|NCT04632992|467683105|FG005|Overall Study|Adverse Event|0|||
129922989|NCT04632992|467683106|FG006|Overall Study|Adverse Event|0|||
129922990|NCT04632992|467683107|FG007|Overall Study|Adverse Event|0|||
129922991|NCT04632992|467683108|FG008|Overall Study|Adverse Event|0|||
129922992|NCT04632992|467683109|FG009|Overall Study|Adverse Event|0|||
129922993|NCT04632992|467683110|FG010|Overall Study|Adverse Event|0|||
129922994|NCT04632992|467683111|FG011|Overall Study|Adverse Event|0|||
129922995|NCT04632992|467683112|FG012|Overall Study|Adverse Event|1|||
129922996|NCT04632992|467683113|FG013|Overall Study|Adverse Event|0|||
129922997|NCT04632992|467683100|FG000|Overall Study|Death|17|||
129922998|NCT04632992|467683101|FG001|Overall Study|Death|1|||
129922999|NCT04632992|467683102|FG002|Overall Study|Death|14|||
129923000|NCT04632992|467683103|FG003|Overall Study|Death|14|||
129923001|NCT04632992|467683104|FG004|Overall Study|Death|13|||
129923002|NCT04632992|467683105|FG005|Overall Study|Death|6|||
129923003|NCT04632992|467683106|FG006|Overall Study|Death|7|||
129923004|NCT04632992|467683107|FG007|Overall Study|Death|12|||
129923005|NCT04632992|467683108|FG008|Overall Study|Death|15|||
129923006|NCT04632992|467683109|FG009|Overall Study|Death|20|||
129923007|NCT04632992|467683110|FG010|Overall Study|Death|8|||
129923008|NCT04632992|467683111|FG011|Overall Study|Death|2|||
129923009|NCT04632992|467683112|FG012|Overall Study|Death|10|||
129923010|NCT04632992|467683113|FG013|Overall Study|Death|1|||
129923011|NCT04632992|467683100|FG000|Overall Study|Lost to Follow-up|1|||
129923012|NCT04632992|467683101|FG001|Overall Study|Lost to Follow-up|0|||
129923013|NCT04632992|467683102|FG002|Overall Study|Lost to Follow-up|1|||
129923014|NCT04632992|467683103|FG003|Overall Study|Lost to Follow-up|0|||
129923015|NCT04632992|467683104|FG004|Overall Study|Lost to Follow-up|2|||
129923016|NCT04632992|467683105|FG005|Overall Study|Lost to Follow-up|0|||
129923017|NCT04632992|467683106|FG006|Overall Study|Lost to Follow-up|1|||
129923018|NCT04632992|467683107|FG007|Overall Study|Lost to Follow-up|1|||
129923019|NCT04632992|467683108|FG008|Overall Study|Lost to Follow-up|1|||
129923020|NCT04632992|467683109|FG009|Overall Study|Lost to Follow-up|1|||
129923021|NCT04632992|467683110|FG010|Overall Study|Lost to Follow-up|2|||
129923022|NCT04632992|467683111|FG011|Overall Study|Lost to Follow-up|0|||
129923023|NCT04632992|467683112|FG012|Overall Study|Lost to Follow-up|0|||
129923024|NCT04632992|467683113|FG013|Overall Study|Lost to Follow-up|0|||
129923025|NCT04632992|467683100|FG000|Overall Study|Reason not Specified|2|||
129923026|NCT04632992|467683101|FG001|Overall Study|Reason not Specified|0|||
129923027|NCT04632992|467683102|FG002|Overall Study|Reason not Specified|1|||
129923028|NCT04632992|467683103|FG003|Overall Study|Reason not Specified|1|||
129923029|NCT04632992|467683104|FG004|Overall Study|Reason not Specified|0|||
129923030|NCT04632992|467683105|FG005|Overall Study|Reason not Specified|0|||
129923031|NCT04632992|467683106|FG006|Overall Study|Reason not Specified|0|||
129923032|NCT04632992|467683107|FG007|Overall Study|Reason not Specified|0|||
129923033|NCT04632992|467683108|FG008|Overall Study|Reason not Specified|0|||
129923034|NCT04632992|467683109|FG009|Overall Study|Reason not Specified|0|||
129923035|NCT04632992|467683110|FG010|Overall Study|Reason not Specified|1|||
129923036|NCT04632992|467683111|FG011|Overall Study|Reason not Specified|0|||
129923037|NCT04632992|467683112|FG012|Overall Study|Reason not Specified|0|||
129923038|NCT04632992|467683113|FG013|Overall Study|Reason not Specified|0|||
129923039|NCT04632992|467683100|FG000|Overall Study|Physician Decision|0|||
129923040|NCT04632992|467683101|FG001|Overall Study|Physician Decision|0|||
129923041|NCT04632992|467683102|FG002|Overall Study|Physician Decision|0|||
129923042|NCT04632992|467683103|FG003|Overall Study|Physician Decision|2|||
129923043|NCT04632992|467683104|FG004|Overall Study|Physician Decision|1|||
129923044|NCT04632992|467683105|FG005|Overall Study|Physician Decision|0|||
129923045|NCT04632992|467683106|FG006|Overall Study|Physician Decision|0|||
129923046|NCT04632992|467683107|FG007|Overall Study|Physician Decision|0|||
129923047|NCT04632992|467683108|FG008|Overall Study|Physician Decision|0|||
129923048|NCT04632992|467683109|FG009|Overall Study|Physician Decision|0|||
129923049|NCT04632992|467683110|FG010|Overall Study|Physician Decision|0|||
129923050|NCT04632992|467683111|FG011|Overall Study|Physician Decision|0|||
129923051|NCT04632992|467683112|FG012|Overall Study|Physician Decision|3|||
129923052|NCT04632992|467683113|FG013|Overall Study|Physician Decision|0|||
129923053|NCT04632992|467683100|FG000|Overall Study|Progressive Disease|0|||
129923054|NCT04632992|467683101|FG001|Overall Study|Progressive Disease|0|||
129923055|NCT04632992|467683102|FG002|Overall Study|Progressive Disease|0|||
129923056|NCT04632992|467683103|FG003|Overall Study|Progressive Disease|0|||
129923057|NCT04632992|467683104|FG004|Overall Study|Progressive Disease|1|||
129923058|NCT04632992|467683105|FG005|Overall Study|Progressive Disease|0|||
129923059|NCT04632992|467683106|FG006|Overall Study|Progressive Disease|0|||
129923060|NCT04632992|467683107|FG007|Overall Study|Progressive Disease|0|||
129923061|NCT04632992|467683108|FG008|Overall Study|Progressive Disease|0|||
129923062|NCT04632992|467683109|FG009|Overall Study|Progressive Disease|1|||
129923063|NCT04632992|467683110|FG010|Overall Study|Progressive Disease|1|||
129923064|NCT04632992|467683111|FG011|Overall Study|Progressive Disease|0|||
129923065|NCT04632992|467683112|FG012|Overall Study|Progressive Disease|2|||
129923066|NCT04632992|467683113|FG013|Overall Study|Progressive Disease|0|||
129923067|NCT04632992|467683100|FG000|Overall Study|Withdrawal by Subject|4|||
129923068|NCT04632992|467683101|FG001|Overall Study|Withdrawal by Subject|1|||
129923069|NCT04632992|467683102|FG002|Overall Study|Withdrawal by Subject|5|||
129923070|NCT04632992|467683103|FG003|Overall Study|Withdrawal by Subject|4|||
129923071|NCT04632992|467683104|FG004|Overall Study|Withdrawal by Subject|3|||
129923072|NCT04632992|467683105|FG005|Overall Study|Withdrawal by Subject|3|||
129923073|NCT04632992|467683106|FG006|Overall Study|Withdrawal by Subject|0|||
129923074|NCT04632992|467683107|FG007|Overall Study|Withdrawal by Subject|5|||
129450278|NCT01721057|465947367|FG006|Treatment Period|Lost to Follow-up|0|||
129450279|NCT01721057|465947361|FG000|Treatment Period|Physician Decision|0|||
129450280|NCT01721057|465947362|FG001|Treatment Period|Physician Decision|1|||
129923075|NCT04632992|467683108|FG008|Overall Study|Withdrawal by Subject|0|||
129923076|NCT04632992|467683109|FG009|Overall Study|Withdrawal by Subject|2|||
129923077|NCT04632992|467683110|FG010|Overall Study|Withdrawal by Subject|8|||
129923078|NCT04632992|467683111|FG011|Overall Study|Withdrawal by Subject|0|||
129923079|NCT04632992|467683112|FG012|Overall Study|Withdrawal by Subject|1|||
129923080|NCT04632992|467683113|FG013|Overall Study|Withdrawal by Subject|1|||
129923081|NCT05647304|467683114|FG000|Overall Study|Withdrawal by Subject|1|||
129923082|NCT05647304|467683115|FG001|Overall Study|Withdrawal by Subject|0|||
129923083|NCT03603600|467683116|FG000|Overall Study|Withdrawal by Subject|5|||
129923084|NCT03603600|467683117|FG001|Overall Study|Withdrawal by Subject|7|||
129923085|NCT03603600|467683116|FG000|Overall Study|Lost to Follow-up|2|||
129923086|NCT03603600|467683117|FG001|Overall Study|Lost to Follow-up|3|||
129923087|NCT03603600|467683116|FG000|Overall Study|Death|3|||
129923088|NCT03603600|467683117|FG001|Overall Study|Death|1|||
129923089|NCT03603600|467683116|FG000|Overall Study|Physician Decision|2|||
129923090|NCT03603600|467683117|FG001|Overall Study|Physician Decision|1|||
129923091|NCT03603600|467683116|FG000|Overall Study|Other reason|1|||
129923092|NCT03603600|467683117|FG001|Overall Study|Other reason|0|||
129923093|NCT03812679|467685252|FG000|Overall Study|Adverse Event|2|||
129923094|NCT03812679|467685252|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
129923095|NCT03812679|467685252|FG000|Overall Study|Renal transplant|1|||
129923096|NCT03812679|467685252|FG000|Overall Study|Withdrawal by Subject|1|||
129923097|NCT03812679|467685252|FG000|Overall Study|Termination of study|2|||
129923098|NCT03812679|467685252|FG000|Overall Study|Water device replacement|1|||
129923099|NCT05028634|467685253|FG000|Overall Study|Withdrawal by Subject|0|||
129923100|NCT05028634|467685254|FG001|Overall Study|Withdrawal by Subject|1|||
129923101|NCT05653427|467685255|FG000|Overall Study|Study Terminated by Sponsor|13|||
129923102|NCT05486078|467685263|FG000|Overall Study|4 drop out and one withdrawn|5|||
129923103|NCT04256941|467685264|FG000|Overall Study|Withdrawal by Subject|0|||
129923104|NCT04256941|467685265|FG001|Overall Study|Withdrawal by Subject|1|||
129923105|NCT04256941|467685264|FG000|Overall Study|Death|1|||
129923106|NCT04256941|467685265|FG001|Overall Study|Death|0|||
129923107|NCT04256941|467685264|FG000|Overall Study|Disease Progession|0|||
129923108|NCT04256941|467685265|FG001|Overall Study|Disease Progession|2|||
129923109|NCT02908477|467685272|FG000|Overall Study|Withdrawal by Subject|8|||
129923110|NCT02908477|467685273|FG001|Overall Study|Withdrawal by Subject|28|||
129923111|NCT02140554|467685274|FG000|Overall Study|Withdrawal of consent|1|||
129923112|NCT02140554|467685275|FG001|Overall Study|Withdrawal of consent|0|||
129923113|NCT02140554|467685276|FG002|Overall Study|Withdrawal of consent|4|||
129923114|NCT02140554|467685274|FG000|Overall Study|Physician Decision|1|||
129923115|NCT02140554|467685275|FG001|Overall Study|Physician Decision|0|||
129923116|NCT02140554|467685276|FG002|Overall Study|Physician Decision|2|||
129923117|NCT02140554|467685274|FG000|Overall Study|Death|0|||
129923118|NCT02140554|467685275|FG001|Overall Study|Death|0|||
129923119|NCT02140554|467685276|FG002|Overall Study|Death|1|||
129923120|NCT02140554|467685274|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
129923121|NCT02140554|467685275|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
129923122|NCT02140554|467685276|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
129923123|NCT05590403|467685277|FG000|Overall Study|Lost to Follow-up|13|||
129923124|NCT05590403|467685278|FG001|Overall Study|Lost to Follow-up|1|||
129923125|NCT05590403|467685279|FG002|Overall Study|Lost to Follow-up|7|||
129923126|NCT05590403|467685280|FG003|Overall Study|Lost to Follow-up|3|||
129923127|NCT05590403|467685281|FG004|Overall Study|Lost to Follow-up|4|||
129923128|NCT05590403|467685277|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
129923129|NCT05590403|467685278|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
129923130|NCT05590403|467685279|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
129923131|NCT05590403|467685280|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
129450281|NCT01721057|465947363|FG002|Treatment Period|Physician Decision|3|||
129450282|NCT01721057|465947364|FG003|Treatment Period|Physician Decision|0|||
129923132|NCT05590403|467685281|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
129923133|NCT05590403|467685277|FG000|Overall Study|Other|2|||
129923134|NCT05590403|467685278|FG001|Overall Study|Other|0|||
129923135|NCT05590403|467685279|FG002|Overall Study|Other|2|||
129923136|NCT05590403|467685280|FG003|Overall Study|Other|2|||
129923137|NCT05590403|467685281|FG004|Overall Study|Other|0|||
129923138|NCT05590403|467685277|FG000|Overall Study|Migrated / moved from the study area|1|||
129923139|NCT05590403|467685278|FG001|Overall Study|Migrated / moved from the study area|1|||
129923140|NCT05590403|467685279|FG002|Overall Study|Migrated / moved from the study area|0|||
129923141|NCT05590403|467685280|FG003|Overall Study|Migrated / moved from the study area|3|||
129923142|NCT05590403|467685281|FG004|Overall Study|Migrated / moved from the study area|1|||
129450283|NCT01721057|465947365|FG004|Treatment Period|Physician Decision|0|||
129923143|NCT05590403|467685277|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
129923144|NCT05590403|467685278|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
129923145|NCT05590403|467685279|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
129923146|NCT05590403|467685280|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
129923147|NCT05590403|467685281|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
129923148|NCT05659537|467685282|FG000|Overall Study|Adverse Event|5|||
129923149|NCT05659537|467685282|FG000|Overall Study|Lost to Follow-up|4|||
129923150|NCT05659537|467685282|FG000|Overall Study|Withdrawal by Subject|13|||
129923151|NCT05659537|467685282|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
129923152|NCT05659537|467685282|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
129923153|NCT05659537|467685282|FG000|Overall Study|Participant was suffering from anaemia|1|||
129923154|NCT04728347|467685283|FG000|Overall Study|Sponsor decision|0|||
129923155|NCT04728347|467685284|FG001|Overall Study|Sponsor decision|0|||
129923156|NCT04728347|467685285|FG002|Overall Study|Sponsor decision|1|||
129923157|NCT04728347|467685286|FG003|Overall Study|Sponsor decision|0|||
129923158|NCT03766009|467685288|FG000|Usual Care|Death|0|||
129923159|NCT03766009|467685289|FG001|Usual Care|Death|0|||
129923160|NCT03766009|467685290|FG002|Usual Care|Death|0|||
129923161|NCT03766009|467685291|FG003|Usual Care|Death|1|||
129923162|NCT03766009|467685292|FG004|Usual Care|Death|0|||
129923163|NCT03766009|467685293|FG005|Usual Care|Death|0|||
129923164|NCT03766009|467685288|FG000|Usual Care|Lost to Follow-up|0|||
129923165|NCT03766009|467685289|FG001|Usual Care|Lost to Follow-up|0|||
129923166|NCT03766009|467685290|FG002|Usual Care|Lost to Follow-up|0|||
129923167|NCT03766009|467685291|FG003|Usual Care|Lost to Follow-up|1|||
129923168|NCT03766009|467685292|FG004|Usual Care|Lost to Follow-up|0|||
129923169|NCT03766009|467685293|FG005|Usual Care|Lost to Follow-up|0|||
129923170|NCT03766009|467685288|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923171|NCT03766009|467685289|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923172|NCT03766009|467685290|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
129923173|NCT03766009|467685291|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923174|NCT03766009|467685292|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
129923175|NCT03766009|467685293|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
129923176|NCT03766009|467685288|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923177|NCT03766009|467685289|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
129923178|NCT03766009|467685290|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923179|NCT03766009|467685291|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
129923180|NCT03766009|467685292|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923181|NCT03766009|467685293|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
129923182|NCT03766009|467685288|FG000|Usual Care|No treatment or declined surgery|0|||
129923183|NCT03766009|467685289|FG001|Usual Care|No treatment or declined surgery|0|||
129923184|NCT03766009|467685290|FG002|Usual Care|No treatment or declined surgery|0|||
129923185|NCT03766009|467685291|FG003|Usual Care|No treatment or declined surgery|2|||
129923186|NCT03766009|467685292|FG004|Usual Care|No treatment or declined surgery|0|||
129923187|NCT03766009|467685293|FG005|Usual Care|No treatment or declined surgery|0|||
129923188|NCT03766009|467685288|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
129923189|NCT03766009|467685289|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
129923190|NCT03766009|467685290|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
129923191|NCT03766009|467685291|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
129923192|NCT03766009|467685292|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
129923193|NCT03766009|467685293|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
129923194|NCT03766009|467685288|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923195|NCT03766009|467685289|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
129923196|NCT03766009|467685290|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923197|NCT03766009|467685291|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923198|NCT03766009|467685292|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923199|NCT03766009|467685293|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
129923200|NCT03766009|467685288|FG000|Usual Care|Ineligible|0|||
129923201|NCT03766009|467685289|FG001|Usual Care|Ineligible|1|||
129923202|NCT03766009|467685290|FG002|Usual Care|Ineligible|0|||
129923203|NCT03766009|467685291|FG003|Usual Care|Ineligible|0|||
129923204|NCT03766009|467685292|FG004|Usual Care|Ineligible|0|||
129923205|NCT03766009|467685293|FG005|Usual Care|Ineligible|0|||
129923206|NCT03766009|467685288|FG000|Usual Care|Other: Staff turnover|0|||
129923207|NCT03766009|467685289|FG001|Usual Care|Other: Staff turnover|0|||
129923208|NCT03766009|467685290|FG002|Usual Care|Other: Staff turnover|0|||
129923209|NCT03766009|467685291|FG003|Usual Care|Other: Staff turnover|0|||
129923210|NCT03766009|467685292|FG004|Usual Care|Other: Staff turnover|0|||
129923211|NCT03766009|467685293|FG005|Usual Care|Other: Staff turnover|2|||
129923212|NCT04526704|467685298|FG000|Overall Study|Adverse Event|1|||
129923213|NCT04526704|467685299|FG001|Overall Study|Adverse Event|0|||
129923214|NCT04526704|467685298|FG000|Overall Study|Physician Decision|1|||
129923215|NCT04526704|467685299|FG001|Overall Study|Physician Decision|0|||
129923216|NCT04526704|467685298|FG000|Overall Study|Withdrawal by Subject|2|||
129923217|NCT04526704|467685299|FG001|Overall Study|Withdrawal by Subject|0|||
129923218|NCT02737436|467685300|FG000|Washout Period|Lost to Follow-up|5|||
129923219|NCT02737436|467685301|FG001|Washout Period|Lost to Follow-up|11|||
129923220|NCT02737436|467685300|FG000|Data Analysis|Scanning data problems|5|||
129923221|NCT02737436|467685301|FG001|Data Analysis|Scanning data problems|8|||
129923222|NCT02105766|467685302|FG000|Overall Study|Physician Decision|1|||
129923223|NCT02105766|467685303|FG001|Overall Study|Physician Decision|1|||
129923224|NCT02105766|467685304|FG002|Overall Study|Physician Decision|0|||
129923225|NCT02105766|467685302|FG000|Overall Study|Lost to Follow-up|2|||
129923226|NCT02105766|467685303|FG001|Overall Study|Lost to Follow-up|0|||
129923227|NCT02105766|467685304|FG002|Overall Study|Lost to Follow-up|0|||
129923228|NCT02105766|467685302|FG000|Overall Study|Death|1|||
129923229|NCT02105766|467685303|FG001|Overall Study|Death|1|||
129923230|NCT02105766|467685304|FG002|Overall Study|Death|0|||
129923231|NCT00554788|467685305|FG000|Overall Study|Adverse Event|0|||
129923232|NCT00554788|467685306|FG001|Overall Study|Adverse Event|1|||
129923233|NCT00554788|467685307|FG002|Overall Study|Adverse Event|2|||
129923234|NCT00554788|467685305|FG000|Overall Study|Lost to Follow-up|4|||
129923235|NCT00554788|467685306|FG001|Overall Study|Lost to Follow-up|3|||
129923236|NCT00554788|467685307|FG002|Overall Study|Lost to Follow-up|3|||
129923237|NCT00554788|467685305|FG000|Overall Study|Physician Decision|1|||
129923238|NCT00554788|467685306|FG001|Overall Study|Physician Decision|1|||
129923239|NCT00554788|467685307|FG002|Overall Study|Physician Decision|3|||
129923240|NCT00554788|467685305|FG000|Overall Study|Withdrawal by Subject|0|||
129923241|NCT00554788|467685306|FG001|Overall Study|Withdrawal by Subject|0|||
129923242|NCT00554788|467685307|FG002|Overall Study|Withdrawal by Subject|1|||
129923243|NCT00554788|467685305|FG000|Overall Study|Refusal of further protocol therapy|0|||
129923244|NCT00554788|467685306|FG001|Overall Study|Refusal of further protocol therapy|1|||
129923245|NCT00554788|467685307|FG002|Overall Study|Refusal of further protocol therapy|1|||
129923246|NCT00554788|467685305|FG000|Overall Study|Progressive disease|0|||
129923247|NCT00554788|467685306|FG001|Overall Study|Progressive disease|0|||
129923248|NCT00554788|467685307|FG002|Overall Study|Progressive disease|3|||
129923249|NCT00554788|467685305|FG000|Overall Study|Ineligible|2|||
129923250|NCT00554788|467685306|FG001|Overall Study|Ineligible|0|||
129923251|NCT00554788|467685307|FG002|Overall Study|Ineligible|1|||
129923252|NCT03897465|467685308|FG000|Overall Study|Lost to Follow-up|2|||
129923253|NCT03897465|467685309|FG001|Overall Study|Lost to Follow-up|1|||
129923254|NCT03897465|467685308|FG000|Overall Study|Adverse Event|2|||
129923255|NCT03897465|467685309|FG001|Overall Study|Adverse Event|0|||
129923256|NCT03897465|467685308|FG000|Overall Study|complete healing by V2|1|||
129923257|NCT03897465|467685309|FG001|Overall Study|complete healing by V2|0|||
129923258|NCT03897465|467685308|FG000|Overall Study|occurence of exclusion criterion|1|||
129923259|NCT03897465|467685309|FG001|Overall Study|occurence of exclusion criterion|1|||
129923260|NCT03897465|467685308|FG000|Overall Study|Other|1|||
129923261|NCT03897465|467685309|FG001|Overall Study|Other|0|||
129923262|NCT02985957|467685311|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923263|NCT02985957|467685312|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923264|NCT02985957|467685313|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923265|NCT02985957|467685314|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923266|NCT02985957|467685315|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129923267|NCT02985957|467685316|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923268|NCT02985957|467685317|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129923269|NCT02985957|467685311|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
129923270|NCT02985957|467685312|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
129923271|NCT02985957|467685313|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
129923272|NCT02985957|467685314|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
129923273|NCT02985957|467685315|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
129923274|NCT02985957|467685316|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
129923275|NCT02985957|467685317|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
129923276|NCT02985957|467685311|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923277|NCT02985957|467685312|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923278|NCT02985957|467685313|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923279|NCT02985957|467685314|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923280|NCT02985957|467685315|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923281|NCT02985957|467685316|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129923282|NCT02985957|467685317|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
129923283|NCT02985957|467685311|FG000|Treatment Period|Death|0|||
129923284|NCT02985957|467685312|FG001|Treatment Period|Death|0|||
129923285|NCT02985957|467685313|FG002|Treatment Period|Death|0|||
129923286|NCT02985957|467685314|FG003|Treatment Period|Death|0|||
129923287|NCT02985957|467685315|FG004|Treatment Period|Death|1|||
129923288|NCT02985957|467685316|FG005|Treatment Period|Death|0|||
129923289|NCT02985957|467685317|FG006|Treatment Period|Death|0|||
129923290|NCT02985957|467685311|FG000|Treatment Period|Participant withdrew consent|0|||
129923291|NCT02985957|467685312|FG001|Treatment Period|Participant withdrew consent|0|||
129923292|NCT02985957|467685313|FG002|Treatment Period|Participant withdrew consent|0|||
129923293|NCT02985957|467685314|FG003|Treatment Period|Participant withdrew consent|1|||
129923294|NCT02985957|467685315|FG004|Treatment Period|Participant withdrew consent|3|||
129923295|NCT02985957|467685316|FG005|Treatment Period|Participant withdrew consent|0|||
129923296|NCT02985957|467685317|FG006|Treatment Period|Participant withdrew consent|1|||
129923297|NCT02985957|467685311|FG000|Treatment Period|Lost to Follow-up|0|||
129923298|NCT02985957|467685312|FG001|Treatment Period|Lost to Follow-up|0|||
129923299|NCT02985957|467685313|FG002|Treatment Period|Lost to Follow-up|0|||
129923300|NCT02985957|467685314|FG003|Treatment Period|Lost to Follow-up|0|||
129923301|NCT02985957|467685315|FG004|Treatment Period|Lost to Follow-up|1|||
129923302|NCT02985957|467685316|FG005|Treatment Period|Lost to Follow-up|0|||
129923303|NCT02985957|467685317|FG006|Treatment Period|Lost to Follow-up|0|||
129923304|NCT02985957|467685311|FG000|Treatment Period|Other reasons|0|||
129923305|NCT02985957|467685312|FG001|Treatment Period|Other reasons|0|||
129450284|NCT01721057|465947366|FG005|Treatment Period|Physician Decision|0|||
129450285|NCT01721057|465947367|FG006|Treatment Period|Physician Decision|0|||
129450286|NCT01721057|465947361|FG000|Treatment Period|Death|2|||
129923306|NCT02985957|467685313|FG002|Treatment Period|Other reasons|1|||
129923307|NCT02985957|467685314|FG003|Treatment Period|Other reasons|3|||
129923308|NCT02985957|467685315|FG004|Treatment Period|Other reasons|6|||
129923309|NCT02985957|467685316|FG005|Treatment Period|Other reasons|0|||
129923310|NCT02985957|467685317|FG006|Treatment Period|Other reasons|1|||
129923311|NCT02985957|467685311|FG000|Treatment Period|Not reported|0|||
129923312|NCT02985957|467685312|FG001|Treatment Period|Not reported|1|||
129923313|NCT02985957|467685313|FG002|Treatment Period|Not reported|2|||
129923314|NCT02985957|467685314|FG003|Treatment Period|Not reported|5|||
129923315|NCT02985957|467685315|FG004|Treatment Period|Not reported|0|||
129923316|NCT02985957|467685316|FG005|Treatment Period|Not reported|0|||
129923317|NCT02985957|467685317|FG006|Treatment Period|Not reported|0|||
129923318|NCT02985957|467685311|FG000|Treatment Period|Maximum clinical benefit|0|||
129923319|NCT02985957|467685312|FG001|Treatment Period|Maximum clinical benefit|0|||
129923320|NCT02985957|467685313|FG002|Treatment Period|Maximum clinical benefit|1|||
129923321|NCT02985957|467685314|FG003|Treatment Period|Maximum clinical benefit|1|||
129923322|NCT02985957|467685315|FG004|Treatment Period|Maximum clinical benefit|0|||
129923323|NCT02985957|467685316|FG005|Treatment Period|Maximum clinical benefit|0|||
129923324|NCT02985957|467685317|FG006|Treatment Period|Maximum clinical benefit|2|||
129923325|NCT02985957|467685311|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
129923326|NCT02985957|467685312|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
129923327|NCT02985957|467685313|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
129923328|NCT02985957|467685314|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
129923329|NCT02985957|467685315|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
129923330|NCT02985957|467685316|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
129923331|NCT02985957|467685317|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
129923332|NCT02985957|467685311|FG000|Treatment Period|Study drug toxicity|1|||
129923333|NCT02985957|467685312|FG001|Treatment Period|Study drug toxicity|23|||
129923334|NCT02985957|467685313|FG002|Treatment Period|Study drug toxicity|20|||
129923335|NCT02985957|467685314|FG003|Treatment Period|Study drug toxicity|11|||
129923336|NCT02985957|467685315|FG004|Treatment Period|Study drug toxicity|19|||
129923337|NCT02985957|467685316|FG005|Treatment Period|Study drug toxicity|3|||
129923338|NCT02985957|467685317|FG006|Treatment Period|Study drug toxicity|5|||
129923339|NCT02985957|467685311|FG000|Treatment Period|Disease progression|0|||
129923340|NCT02985957|467685312|FG001|Treatment Period|Disease progression|16|||
129923341|NCT02985957|467685313|FG002|Treatment Period|Disease progression|20|||
129923342|NCT02985957|467685314|FG003|Treatment Period|Disease progression|39|||
129923343|NCT02985957|467685315|FG004|Treatment Period|Disease progression|29|||
129923344|NCT02985957|467685316|FG005|Treatment Period|Disease progression|11|||
129923345|NCT02985957|467685317|FG006|Treatment Period|Disease progression|28|||
129923346|NCT02985957|467685311|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
129923347|NCT02985957|467685312|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
129923348|NCT02985957|467685313|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
129923349|NCT02985957|467685314|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
129923350|NCT02985957|467685315|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
129923351|NCT02985957|467685316|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
129923352|NCT02985957|467685317|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
129923353|NCT02985957|467685311|FG000|Treatment Period|Poor/Non-Compliance|0|||
129923354|NCT02985957|467685312|FG001|Treatment Period|Poor/Non-Compliance|0|||
129923355|NCT02985957|467685313|FG002|Treatment Period|Poor/Non-Compliance|0|||
129923356|NCT02985957|467685314|FG003|Treatment Period|Poor/Non-Compliance|0|||
129923357|NCT02985957|467685315|FG004|Treatment Period|Poor/Non-Compliance|1|||
129923358|NCT02985957|467685316|FG005|Treatment Period|Poor/Non-Compliance|1|||
129923359|NCT02985957|467685317|FG006|Treatment Period|Poor/Non-Compliance|0|||
129923360|NCT02985957|467685311|FG000|Treatment Period|Continuing in Treatment Period|0|||
129923361|NCT02985957|467685312|FG001|Treatment Period|Continuing in Treatment Period|1|||
129923362|NCT02985957|467685313|FG002|Treatment Period|Continuing in Treatment Period|0|||
129923363|NCT02985957|467685314|FG003|Treatment Period|Continuing in Treatment Period|4|||
129923364|NCT02985957|467685315|FG004|Treatment Period|Continuing in Treatment Period|4|||
129923365|NCT02985957|467685316|FG005|Treatment Period|Continuing in Treatment Period|0|||
129923366|NCT02985957|467685317|FG006|Treatment Period|Continuing in Treatment Period|0|||
129923367|NCT04719390|467685330|FG000|Overall Study|Withdrawal by Subject|1|||
129923368|NCT06190691|467685331|FG000|Overall Study|Adverse Event|2|||
129923369|NCT06190691|467685332|FG001|Overall Study|Adverse Event|0|||
129923370|NCT06190691|467685333|FG002|Overall Study|Adverse Event|0|||
129923371|NCT06190691|467685334|FG003|Overall Study|Adverse Event|0|||
129923372|NCT05746455|467685335|FG000|Overall Study|Discharged from Clinical Service|1|||
129923373|NCT05746455|467685335|FG000|Overall Study|Lost to Follow-up|1|||
129923374|NCT02485938|467685336|FG000|Overall Study|Withdrawal of consent|2|||
129923375|NCT02485938|467685337|FG001|Overall Study|Withdrawal of consent|0|||
129450287|NCT01721057|465947362|FG001|Treatment Period|Death|0|||
129450288|NCT01721057|465947363|FG002|Treatment Period|Death|0|||
129450289|NCT01721057|465947364|FG003|Treatment Period|Death|0|||
129450290|NCT01721057|465947365|FG004|Treatment Period|Death|0|||
129450291|NCT01721057|465947366|FG005|Treatment Period|Death|0|||
129450292|NCT01721057|465947367|FG006|Treatment Period|Death|0|||
129450293|NCT01721057|465947361|FG000|Rescue Period|Adverse Event|0|||
129450294|NCT01721057|465947362|FG001|Rescue Period|Adverse Event|0|||
129450295|NCT01721057|465947363|FG002|Rescue Period|Adverse Event|0|||
129450296|NCT01721057|465947364|FG003|Rescue Period|Adverse Event|1|||
129450297|NCT01721057|465947365|FG004|Rescue Period|Adverse Event|0|||
129450298|NCT01721057|465947366|FG005|Rescue Period|Adverse Event|0|||
129923376|NCT03016754|467685340|FG000|Overall Study|Death|5|||
129923377|NCT03016754|467685341|FG001|Overall Study|Death|4|||
129923378|NCT03016754|467685342|FG002|Overall Study|Death|5|||
129923379|NCT03016754|467685343|FG003|Overall Study|Death|1|||
129923380|NCT03016754|467685340|FG000|Overall Study|Lost to Follow-up|23|||
129923381|NCT03016754|467685341|FG001|Overall Study|Lost to Follow-up|17|||
129923382|NCT03016754|467685342|FG002|Overall Study|Lost to Follow-up|4|||
129923383|NCT03016754|467685343|FG003|Overall Study|Lost to Follow-up|2|||
129923384|NCT03016754|467685340|FG000|Overall Study|Withdrawal by Subject|6|||
129923385|NCT03016754|467685341|FG001|Overall Study|Withdrawal by Subject|6|||
129923386|NCT03016754|467685342|FG002|Overall Study|Withdrawal by Subject|2|||
129923387|NCT03016754|467685343|FG003|Overall Study|Withdrawal by Subject|2|||
129923388|NCT03016754|467685340|FG000|Overall Study|Other/Unknown|2|||
129923389|NCT03016754|467685341|FG001|Overall Study|Other/Unknown|4|||
129923390|NCT03016754|467685342|FG002|Overall Study|Other/Unknown|2|||
129923391|NCT03016754|467685343|FG003|Overall Study|Other/Unknown|1|||
129923392|NCT03016754|467685340|FG000|Overall Study|Protocol Violation|0|||
129923393|NCT03016754|467685341|FG001|Overall Study|Protocol Violation|0|||
129923394|NCT03016754|467685342|FG002|Overall Study|Protocol Violation|0|||
129923395|NCT03016754|467685343|FG003|Overall Study|Protocol Violation|4|||
129923396|NCT03839940|467685344|FG000|Overall Study|Withdrawal by Subject|3|||
129923397|NCT03839940|467685345|FG001|Overall Study|Withdrawal by Subject|0|||
129923398|NCT03839940|467685344|FG000|Overall Study|Protocol Violation|0|||
129923399|NCT03839940|467685345|FG001|Overall Study|Protocol Violation|1|||
129923400|NCT03839940|467685344|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
129923401|NCT03839940|467685345|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
129923402|NCT03241745|467685346|FG000|Overall Study|Adverse Event|7|||
129923403|NCT03241745|467685346|FG000|Overall Study|Death|1|||
129923404|NCT03241745|467685346|FG000|Overall Study|Withdrawal by Subject|5|||
129923405|NCT03241745|467685346|FG000|Overall Study|Treatment delay >28 days|2|||
129923406|NCT03241745|467685346|FG000|Overall Study|Lack of Efficacy|14|||
129923407|NCT03023410|467685347|FG000|Overall Study|study termination|0|||
129923408|NCT03023410|467685348|FG001|Overall Study|study termination|1|||
129923409|NCT04799899|467685350|FG000|Overall Study|Lost to Follow-up|2|||
129923410|NCT04799899|467685351|FG001|Overall Study|Lost to Follow-up|4|||
129923411|NCT00470704|467685352|FG000|Overall Study|Withdrawal by Subject|4|||
129923412|NCT00470704|467685353|FG001|Overall Study|Withdrawal by Subject|3|||
129923413|NCT00470704|467685352|FG000|Overall Study|Relapse/Progression|37|||
129923414|NCT00470704|467685353|FG001|Overall Study|Relapse/Progression|42|||
129923415|NCT00470704|467685352|FG000|Overall Study|toxicity|0|||
129923416|NCT00470704|467685353|FG001|Overall Study|toxicity|1|||
129923417|NCT04019873|467685354|FG000|Overall Study|Discontinued from the treatment|1|||
129923418|NCT04019873|467685355|FG001|Overall Study|Discontinued from the treatment|39|||
129923419|NCT04019873|467685356|FG002|Overall Study|Discontinued from the treatment|2|||
129923420|NCT04683744|467685357|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
129923421|NCT04683744|467685358|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
129923422|NCT04683744|467685359|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
129923423|NCT04295798|467685367|FG000|Overall Study|Lost to Follow-up|1|||
129923424|NCT04927364|467685368|FG000|Overall Study|Withdrawal by Subject|3|||
129923425|NCT04927364|467685368|FG000|Overall Study|Unable to complete preassessment MRI|1|||
129923426|NCT04650269|467685374|FG000|Overall Study|Death|3|||
129923427|NCT04650269|467685374|FG000|Overall Study|Lost to Follow-up|6|||
129923428|NCT01437709|467685375|FG000|Overall Study|Adverse Event|0|||
129923429|NCT01437709|467685376|FG001|Overall Study|Adverse Event|1|||
129923430|NCT01437709|467685377|FG002|Overall Study|Adverse Event|0|||
129450299|NCT01721057|465947367|FG006|Rescue Period|Adverse Event|0|||
129450300|NCT01721057|465947361|FG000|Rescue Period|Lack of Efficacy|0|||
129450301|NCT01721057|465947362|FG001|Rescue Period|Lack of Efficacy|0|||
129450302|NCT01721057|465947363|FG002|Rescue Period|Lack of Efficacy|0|||
129923431|NCT01437709|467685375|FG000|Overall Study|Pt trasnferred care|0|||
129923432|NCT01437709|467685376|FG001|Overall Study|Pt trasnferred care|1|||
129923433|NCT01437709|467685377|FG002|Overall Study|Pt trasnferred care|0|||
129923434|NCT00085735|467685378|FG000|Overall Study|Adverse Event|1|||
129923435|NCT00085735|467685379|FG001|Overall Study|Adverse Event|0|||
129450303|NCT01721057|465947364|FG003|Rescue Period|Lack of Efficacy|2|||
129450304|NCT01721057|465947365|FG004|Rescue Period|Lack of Efficacy|0|||
129923436|NCT00085735|467685380|FG002|Overall Study|Adverse Event|0|||
129450305|NCT01721057|465947366|FG005|Rescue Period|Lack of Efficacy|0|||
129450306|NCT01721057|465947367|FG006|Rescue Period|Lack of Efficacy|0|||
129450307|NCT01202279|465947368|FG000|Overall Study|Adverse Event|8|||
129450308|NCT01202279|465947369|FG001|Overall Study|Adverse Event|6|||
129450309|NCT01202279|465947368|FG000|Overall Study|Withdrawal by Subject|13|||
129450310|NCT01202279|465947369|FG001|Overall Study|Withdrawal by Subject|10|||
129450311|NCT01202279|465947368|FG000|Overall Study|Physician Decision|0|||
129450312|NCT01202279|465947369|FG001|Overall Study|Physician Decision|1|||
129450313|NCT01202279|465947368|FG000|Overall Study|Lost to Follow-up|10|||
129450314|NCT01202279|465947369|FG001|Overall Study|Lost to Follow-up|7|||
129450315|NCT01202279|465947368|FG000|Overall Study|Protocol Violation|1|||
129450316|NCT01202279|465947369|FG001|Overall Study|Protocol Violation|1|||
129450317|NCT01202279|465947368|FG000|Overall Study|study compliance|5|||
129450318|NCT01202279|465947369|FG001|Overall Study|study compliance|2|||
129450319|NCT01177683|465947370|FG000|Study Treatment|Disease Progressions during treatment|2|||
129450320|NCT01177683|465947371|FG001|Study Treatment|Disease Progressions during treatment|0|||
129450321|NCT01177683|465947372|FG002|Study Treatment|Disease Progressions during treatment|3|||
129450322|NCT01177683|465947370|FG000|Study Treatment|Adverse Event|0|||
129923437|NCT00085735|467685381|FG003|Overall Study|Adverse Event|0|||
129923438|NCT00085735|467685382|FG004|Overall Study|Adverse Event|0|||
129923439|NCT00085735|467685383|FG005|Overall Study|Adverse Event|0|||
129923440|NCT00085735|467685378|FG000|Overall Study|Lack of Efficacy|2|||
129923441|NCT00085735|467685379|FG001|Overall Study|Lack of Efficacy|4|||
129923442|NCT00085735|467685380|FG002|Overall Study|Lack of Efficacy|6|||
129923443|NCT00085735|467685381|FG003|Overall Study|Lack of Efficacy|3|||
129923444|NCT00085735|467685382|FG004|Overall Study|Lack of Efficacy|4|||
129923445|NCT00085735|467685383|FG005|Overall Study|Lack of Efficacy|3|||
129923446|NCT00085735|467685378|FG000|Overall Study|Lost to Follow-up|0|||
129923447|NCT00085735|467685379|FG001|Overall Study|Lost to Follow-up|1|||
129923448|NCT00085735|467685380|FG002|Overall Study|Lost to Follow-up|0|||
129923449|NCT00085735|467685381|FG003|Overall Study|Lost to Follow-up|0|||
129923450|NCT00085735|467685382|FG004|Overall Study|Lost to Follow-up|1|||
129923451|NCT00085735|467685383|FG005|Overall Study|Lost to Follow-up|0|||
129923452|NCT00085735|467685378|FG000|Overall Study|Physician Decision|2|||
129923453|NCT00085735|467685379|FG001|Overall Study|Physician Decision|3|||
129923454|NCT00085735|467685380|FG002|Overall Study|Physician Decision|2|||
129923455|NCT00085735|467685381|FG003|Overall Study|Physician Decision|3|||
129923456|NCT00085735|467685382|FG004|Overall Study|Physician Decision|11|||
129923457|NCT00085735|467685383|FG005|Overall Study|Physician Decision|8|||
129923458|NCT00085735|467685378|FG000|Overall Study|Protocol Violation|1|||
129923459|NCT00085735|467685379|FG001|Overall Study|Protocol Violation|0|||
129923460|NCT00085735|467685380|FG002|Overall Study|Protocol Violation|0|||
129923461|NCT00085735|467685381|FG003|Overall Study|Protocol Violation|0|||
129923462|NCT00085735|467685382|FG004|Overall Study|Protocol Violation|0|||
129923463|NCT00085735|467685383|FG005|Overall Study|Protocol Violation|0|||
129923464|NCT00085735|467685378|FG000|Overall Study|Withdrawal by Subject|1|||
129923465|NCT00085735|467685379|FG001|Overall Study|Withdrawal by Subject|0|||
129923466|NCT00085735|467685380|FG002|Overall Study|Withdrawal by Subject|4|||
129923467|NCT00085735|467685381|FG003|Overall Study|Withdrawal by Subject|5|||
129923468|NCT00085735|467685382|FG004|Overall Study|Withdrawal by Subject|7|||
129923469|NCT00085735|467685383|FG005|Overall Study|Withdrawal by Subject|8|||
129923470|NCT00085735|467685378|FG000|Overall Study|Patient ineligible|1|||
129923471|NCT00085735|467685379|FG001|Overall Study|Patient ineligible|0|||
129923472|NCT00085735|467685380|FG002|Overall Study|Patient ineligible|3|||
129923473|NCT00085735|467685381|FG003|Overall Study|Patient ineligible|7|||
129923474|NCT00085735|467685382|FG004|Overall Study|Patient ineligible|17|||
129923475|NCT00085735|467685383|FG005|Overall Study|Patient ineligible|8|||
129923476|NCT00085735|467685378|FG000|Overall Study|Excess residual disease|2|||
129923477|NCT00085735|467685379|FG001|Overall Study|Excess residual disease|2|||
129923478|NCT00085735|467685380|FG002|Overall Study|Excess residual disease|1|||
129923479|NCT00085735|467685381|FG003|Overall Study|Excess residual disease|1|||
129923480|NCT00085735|467685382|FG004|Overall Study|Excess residual disease|1|||
129923481|NCT00085735|467685383|FG005|Overall Study|Excess residual disease|4|||
129923482|NCT00085735|467685378|FG000|Overall Study|Reason not documented|1|||
129923483|NCT00085735|467685379|FG001|Overall Study|Reason not documented|0|||
129923484|NCT00085735|467685380|FG002|Overall Study|Reason not documented|1|||
129923485|NCT00085735|467685381|FG003|Overall Study|Reason not documented|0|||
129923486|NCT00085735|467685382|FG004|Overall Study|Reason not documented|1|||
129923487|NCT00085735|467685383|FG005|Overall Study|Reason not documented|0|||
129923488|NCT00085735|467685378|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
129450323|NCT01177683|465947371|FG001|Study Treatment|Adverse Event|1|||
129450324|NCT01177683|465947372|FG002|Study Treatment|Adverse Event|12|||
129923489|NCT00085735|467685379|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
129923490|NCT00085735|467685380|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
129923491|NCT00085735|467685381|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
129923492|NCT00085735|467685382|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
129923493|NCT00085735|467685383|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
129923494|NCT02919306|467685384|FG000|Overall Study|Withdrawal by Subject|1|||
129923495|NCT02919306|467685385|FG001|Overall Study|Withdrawal by Subject|0|||
129923496|NCT02919306|467685384|FG000|Overall Study|Protocol Violation|1|||
129923497|NCT02919306|467685385|FG001|Overall Study|Protocol Violation|0|||
129923498|NCT04473222|467685386|FG000|Overall Study|Lost to Follow-up|13|||
129923499|NCT04473222|467685387|FG001|Overall Study|Lost to Follow-up|13|||
129923500|NCT04473222|467685386|FG000|Overall Study|Withdrawal by Subject|0|||
129923501|NCT04473222|467685387|FG001|Overall Study|Withdrawal by Subject|1|||
129923502|NCT04473222|467685386|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
129923503|NCT04473222|467685387|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
129923504|NCT04195698|467685390|FG000|Overall Study|Adverse Event|4|||
129923505|NCT04195698|467685391|FG001|Overall Study|Adverse Event|11|||
129923506|NCT04195698|467685390|FG000|Overall Study|Withdrawal by Subject|9|||
129923507|NCT04195698|467685391|FG001|Overall Study|Withdrawal by Subject|10|||
129923508|NCT04195698|467685390|FG000|Overall Study|Lost to Follow-up|5|||
129923509|NCT04195698|467685391|FG001|Overall Study|Lost to Follow-up|4|||
129923510|NCT04195698|467685390|FG000|Overall Study|Lack of Efficacy|2|||
129923511|NCT04195698|467685391|FG001|Overall Study|Lack of Efficacy|10|||
129923512|NCT04195698|467685390|FG000|Overall Study|Other|5|||
129923513|NCT04195698|467685391|FG001|Overall Study|Other|4|||
129923514|NCT05459688|467685392|FG000|Overall Study|Lost to Follow-up|6|||
129923515|NCT05459688|467685392|FG000|Overall Study|Physician Decision|1|||
129923516|NCT05459688|467685392|FG000|Overall Study|Withdrawal by Subject|19|||
129923517|NCT05459688|467685392|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
129923518|NCT04908722|467685393|FG000|Overall Study|Protocol deviation|1|||
129923519|NCT04908722|467685394|FG001|Overall Study|Protocol deviation|0|||
129923520|NCT04908722|467685395|FG002|Overall Study|Protocol deviation|0|||
129923521|NCT04908722|467685396|FG003|Overall Study|Protocol deviation|0|||
129923522|NCT04908722|467685397|FG004|Overall Study|Protocol deviation|0|||
129923523|NCT04908722|467685398|FG005|Overall Study|Protocol deviation|1|||
129923524|NCT04908722|467685393|FG000|Overall Study|Lost to Follow-up|33|||
129923525|NCT04908722|467685394|FG001|Overall Study|Lost to Follow-up|33|||
129923526|NCT04908722|467685395|FG002|Overall Study|Lost to Follow-up|36|||
129923527|NCT04908722|467685396|FG003|Overall Study|Lost to Follow-up|30|||
129923528|NCT04908722|467685397|FG004|Overall Study|Lost to Follow-up|32|||
129923529|NCT04908722|467685398|FG005|Overall Study|Lost to Follow-up|34|||
129923530|NCT04908722|467685393|FG000|Overall Study|Physician Decision|1|||
129923531|NCT04908722|467685394|FG001|Overall Study|Physician Decision|1|||
129923532|NCT04908722|467685395|FG002|Overall Study|Physician Decision|1|||
129923533|NCT04908722|467685396|FG003|Overall Study|Physician Decision|2|||
129923534|NCT04908722|467685397|FG004|Overall Study|Physician Decision|0|||
129923535|NCT04908722|467685398|FG005|Overall Study|Physician Decision|0|||
129923536|NCT04908722|467685393|FG000|Overall Study|Death|1|||
129923537|NCT04908722|467685394|FG001|Overall Study|Death|0|||
129923538|NCT04908722|467685395|FG002|Overall Study|Death|0|||
129923539|NCT04908722|467685396|FG003|Overall Study|Death|0|||
129923540|NCT04908722|467685397|FG004|Overall Study|Death|0|||
129923541|NCT04908722|467685398|FG005|Overall Study|Death|1|||
129923542|NCT04908722|467685393|FG000|Overall Study|Withdrawal by Subject|12|||
129923543|NCT04908722|467685394|FG001|Overall Study|Withdrawal by Subject|8|||
129923544|NCT04908722|467685395|FG002|Overall Study|Withdrawal by Subject|7|||
129923545|NCT04908722|467685396|FG003|Overall Study|Withdrawal by Subject|6|||
129923546|NCT04908722|467685397|FG004|Overall Study|Withdrawal by Subject|12|||
129923547|NCT04908722|467685398|FG005|Overall Study|Withdrawal by Subject|14|||
129923548|NCT04908722|467685393|FG000|Overall Study|Other|3|||
129923549|NCT04908722|467685394|FG001|Overall Study|Other|1|||
129923550|NCT04908722|467685395|FG002|Overall Study|Other|3|||
129923551|NCT04908722|467685396|FG003|Overall Study|Other|2|||
129923552|NCT04908722|467685397|FG004|Overall Study|Other|4|||
129923553|NCT04908722|467685398|FG005|Overall Study|Other|1|||
129923554|NCT04908722|467685393|FG000|Overall Study|Initiated prohibited medication|0|||
129923555|NCT04908722|467685394|FG001|Overall Study|Initiated prohibited medication|0|||
129923556|NCT04908722|467685395|FG002|Overall Study|Initiated prohibited medication|0|||
129923557|NCT04908722|467685396|FG003|Overall Study|Initiated prohibited medication|1|||
129923558|NCT04908722|467685397|FG004|Overall Study|Initiated prohibited medication|0|||
129923559|NCT04908722|467685398|FG005|Overall Study|Initiated prohibited medication|1|||
129923560|NCT04908722|467685393|FG000|Overall Study|Randomized but not vaccinated|3|||
129923561|NCT04908722|467685394|FG001|Overall Study|Randomized but not vaccinated|1|||
129923562|NCT04908722|467685395|FG002|Overall Study|Randomized but not vaccinated|2|||
129923563|NCT04908722|467685396|FG003|Overall Study|Randomized but not vaccinated|2|||
129923564|NCT04908722|467685397|FG004|Overall Study|Randomized but not vaccinated|3|||
129923565|NCT04908722|467685398|FG005|Overall Study|Randomized but not vaccinated|4|||
129923566|NCT02319759|467685399|FG000|Week 0 - 16|Lack of Efficacy|1|||
129923567|NCT02319759|467685400|FG001|Week 0 - 16|Lack of Efficacy|0|||
129923568|NCT02319759|467685401|FG002|Week 0 - 16|Lack of Efficacy|0|||
129923569|NCT02319759|467685402|FG003|Week 0 - 16|Lack of Efficacy|0|||
129923570|NCT02319759|467685403|FG004|Week 0 - 16|Lack of Efficacy|0|||
129450325|NCT01177683|465947370|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129450326|NCT01177683|465947371|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
129450327|NCT01177683|465947372|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
129450328|NCT01177683|465947370|FG000|Study Treatment|Alternative therapy|0|||
129450329|NCT01177683|465947371|FG001|Study Treatment|Alternative therapy|0|||
129450330|NCT01177683|465947372|FG002|Study Treatment|Alternative therapy|4|||
129450331|NCT01177683|465947370|FG000|Study Treatment|Physician Decision|1|||
129450332|NCT01177683|465947371|FG001|Study Treatment|Physician Decision|0|||
129450333|NCT01177683|465947372|FG002|Study Treatment|Physician Decision|1|||
129450334|NCT01177683|465947370|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
129450335|NCT01177683|465947371|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
129450336|NCT01177683|465947372|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
129450337|NCT01177683|465947370|FG000|Study Treatment|Symptomatic Deterioration|0|||
129450338|NCT01177683|465947371|FG001|Study Treatment|Symptomatic Deterioration|0|||
129450339|NCT01177683|465947372|FG002|Study Treatment|Symptomatic Deterioration|1|||
129450340|NCT01177683|465947370|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
129450341|NCT01177683|465947371|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
129450342|NCT01177683|465947372|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
129450343|NCT01177683|465947370|FG000|Follow up|Patient lost to follow up|0|||
129450344|NCT01177683|465947371|FG001|Follow up|Patient lost to follow up|0|||
129450345|NCT01177683|465947372|FG002|Follow up|Patient lost to follow up|2|||
129450346|NCT01177683|465947370|FG000|Follow up|Death|2|||
129450347|NCT01177683|465947371|FG001|Follow up|Death|1|||
129450348|NCT01177683|465947372|FG002|Follow up|Death|7|||
129450349|NCT01177683|465947370|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
129450350|NCT01177683|465947371|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
129450351|NCT01177683|465947372|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
129450352|NCT02546765|465947376|FG000|Overall Study|Withdrawal by Subject|0|||
129450353|NCT02546765|465947377|FG001|Overall Study|Withdrawal by Subject|1|||
129450354|NCT02546765|465947378|FG002|Overall Study|Withdrawal by Subject|0|||
129450355|NCT02546765|465947379|FG003|Overall Study|Withdrawal by Subject|0|||
129450356|NCT00475722|465947380|FG000|Overall Study|Withdrawal by Subject|12|||
129450357|NCT00475722|465947381|FG001|Overall Study|Withdrawal by Subject|12|||
129450358|NCT00475722|465947380|FG000|Overall Study|Protocol Violation|3|||
129450359|NCT00475722|465947381|FG001|Overall Study|Protocol Violation|0|||
129450360|NCT00916279|465947382|FG000|Overall Study|Death|2|||
129450361|NCT00916279|465947382|FG000|Overall Study|Lost to Follow-up|2|||
129450362|NCT02064920|465947383|FG000|Overall Study|Adverse Event|0|||
129450363|NCT02064920|465947384|FG001|Overall Study|Adverse Event|4|||
129450364|NCT02064920|465947383|FG000|Overall Study|Physician Decision|0|||
129450365|NCT02064920|465947384|FG001|Overall Study|Physician Decision|1|||
129450366|NCT02064920|465947383|FG000|Overall Study|Technical Problems|0|||
129450367|NCT02064920|465947384|FG001|Overall Study|Technical Problems|1|||
129450368|NCT02064920|465947383|FG000|Overall Study|Withdrawal by Subject|1|||
129450369|NCT02064920|465947384|FG001|Overall Study|Withdrawal by Subject|3|||
129450370|NCT02109562|465947385|FG000|Overall Study|Insufficient clinical response|2|||
129450371|NCT02109562|465947386|FG001|Overall Study|Insufficient clinical response|0|||
129450372|NCT02109562|465947387|FG002|Overall Study|Insufficient clinical response|4|||
129450373|NCT02109562|465947385|FG000|Overall Study|Adverse Event|0|||
129450374|NCT02109562|465947386|FG001|Overall Study|Adverse Event|2|||
129450375|NCT02109562|465947387|FG002|Overall Study|Adverse Event|3|||
129450376|NCT02109562|465947385|FG000|Overall Study|Lost to Follow-up|1|||
129450377|NCT02109562|465947386|FG001|Overall Study|Lost to Follow-up|0|||
129450378|NCT02109562|465947387|FG002|Overall Study|Lost to Follow-up|1|||
129450379|NCT02109562|465947385|FG000|Overall Study|Protocol Violation|0|||
129450380|NCT02109562|465947386|FG001|Overall Study|Protocol Violation|3|||
129450381|NCT02109562|465947387|FG002|Overall Study|Protocol Violation|1|||
129450382|NCT02109562|465947385|FG000|Overall Study|Withdrawal by Subject|20|||
129450383|NCT02109562|465947386|FG001|Overall Study|Withdrawal by Subject|25|||
129450384|NCT02109562|465947387|FG002|Overall Study|Withdrawal by Subject|21|||
129450385|NCT02109562|465947385|FG000|Overall Study|Physician Decision|3|||
129450386|NCT02109562|465947386|FG001|Overall Study|Physician Decision|4|||
129450387|NCT02109562|465947387|FG002|Overall Study|Physician Decision|5|||
129450388|NCT00310804|465947388|FG000|Overall Study|Lost to Follow-up|2|||
129923571|NCT02319759|467685399|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
129450389|NCT00310804|465947389|FG001|Overall Study|Lost to Follow-up|0|||
129450390|NCT00310804|465947388|FG000|Overall Study|Withdrawal by Subject|3|||
129450391|NCT00310804|465947389|FG001|Overall Study|Withdrawal by Subject|0|||
129450392|NCT00688155|465947394|FG000|Overall Study|Withdrawal by Subject|2|||
129450393|NCT00688155|465947395|FG001|Overall Study|Withdrawal by Subject|2|||
129450394|NCT00688155|465947396|FG002|Overall Study|Withdrawal by Subject|1|||
129450395|NCT00688155|465947397|FG003|Overall Study|Withdrawal by Subject|1|||
129450396|NCT01889238|465947401|FG000|Overall Study|Death|1|||
129450397|NCT01889238|465947401|FG000|Overall Study|Withdrawal by Subject|1|||
129450398|NCT01889238|465947401|FG000|Overall Study|Adverse Event|6|||
129923572|NCT02319759|467685400|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
129923573|NCT02319759|467685401|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
129923574|NCT02319759|467685402|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
129923575|NCT02319759|467685403|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
129923576|NCT02319759|467685399|FG000|Week 16 - 24|Lack of Efficacy|1|||
129923577|NCT02319759|467685400|FG001|Week 16 - 24|Lack of Efficacy|0|||
129923578|NCT02319759|467685401|FG002|Week 16 - 24|Lack of Efficacy|1|||
129923579|NCT02319759|467685402|FG003|Week 16 - 24|Lack of Efficacy|0|||
129923580|NCT02319759|467685403|FG004|Week 16 - 24|Lack of Efficacy|0|||
129923581|NCT02319759|467685399|FG000|Week 16 - 24|Lost to Follow-up|1|||
129923582|NCT02319759|467685400|FG001|Week 16 - 24|Lost to Follow-up|0|||
129923583|NCT02319759|467685401|FG002|Week 16 - 24|Lost to Follow-up|0|||
129923584|NCT02319759|467685402|FG003|Week 16 - 24|Lost to Follow-up|0|||
129923585|NCT02319759|467685403|FG004|Week 16 - 24|Lost to Follow-up|0|||
129923586|NCT02319759|467685399|FG000|Week 16 - 24|Withdrawal by Subject|0|||
129923587|NCT02319759|467685400|FG001|Week 16 - 24|Withdrawal by Subject|0|||
129923588|NCT02319759|467685401|FG002|Week 16 - 24|Withdrawal by Subject|2|||
129923589|NCT02319759|467685402|FG003|Week 16 - 24|Withdrawal by Subject|0|||
129923590|NCT02319759|467685403|FG004|Week 16 - 24|Withdrawal by Subject|0|||
129923591|NCT02319759|467685399|FG000|Week 24 - 56|Adverse Event|0|||
129923592|NCT02319759|467685400|FG001|Week 24 - 56|Adverse Event|0|||
129923593|NCT02319759|467685401|FG002|Week 24 - 56|Adverse Event|2|||
129923594|NCT02319759|467685402|FG003|Week 24 - 56|Adverse Event|0|||
129923595|NCT02319759|467685403|FG004|Week 24 - 56|Adverse Event|0|||
129923596|NCT02319759|467685399|FG000|Week 24 - 56|Lack of Efficacy|0|||
129923597|NCT02319759|467685400|FG001|Week 24 - 56|Lack of Efficacy|0|||
129923598|NCT02319759|467685401|FG002|Week 24 - 56|Lack of Efficacy|0|||
129923599|NCT02319759|467685402|FG003|Week 24 - 56|Lack of Efficacy|2|||
129923600|NCT02319759|467685403|FG004|Week 24 - 56|Lack of Efficacy|1|||
129923601|NCT02319759|467685399|FG000|Week 24 - 56|Withdrawal by Subject|0|||
129923602|NCT02319759|467685400|FG001|Week 24 - 56|Withdrawal by Subject|1|||
129923603|NCT02319759|467685401|FG002|Week 24 - 56|Withdrawal by Subject|0|||
129923604|NCT02319759|467685402|FG003|Week 24 - 56|Withdrawal by Subject|0|||
129923605|NCT02319759|467685403|FG004|Week 24 - 56|Withdrawal by Subject|0|||
129923606|NCT02319759|467685399|FG000|Week 24 - 56|Lost to Follow-up|0|||
129923607|NCT02319759|467685400|FG001|Week 24 - 56|Lost to Follow-up|0|||
129923608|NCT02319759|467685401|FG002|Week 24 - 56|Lost to Follow-up|0|||
129923609|NCT02319759|467685402|FG003|Week 24 - 56|Lost to Follow-up|0|||
129923610|NCT02319759|467685403|FG004|Week 24 - 56|Lost to Follow-up|1|||
129923611|NCT06424236|467685406|FG000|Overall Study|Adverse Event|0|||
129923612|NCT06424236|467685407|FG001|Overall Study|Adverse Event|1|||
129923613|NCT06424236|467685408|FG002|Overall Study|Adverse Event|0|||
129923614|NCT06424236|467685406|FG000|Overall Study|Withdrawal by Subject|3|||
129923615|NCT06424236|467685407|FG001|Overall Study|Withdrawal by Subject|1|||
129923616|NCT06424236|467685408|FG002|Overall Study|Withdrawal by Subject|2|||
129923617|NCT06424236|467685406|FG000|Overall Study|Physician Decision|0|||
129923618|NCT06424236|467685407|FG001|Overall Study|Physician Decision|1|||
129923619|NCT06424236|467685408|FG002|Overall Study|Physician Decision|0|||
129923620|NCT06424236|467685406|FG000|Overall Study|Study Terminated by Sponsor|11|||
129923621|NCT06424236|467685407|FG001|Overall Study|Study Terminated by Sponsor|20|||
129923622|NCT06424236|467685408|FG002|Overall Study|Study Terminated by Sponsor|16|||
129923623|NCT06424236|467685406|FG000|Overall Study|Lost to Follow-up|0|||
129923624|NCT06424236|467685407|FG001|Overall Study|Lost to Follow-up|1|||
129923625|NCT06424236|467685408|FG002|Overall Study|Lost to Follow-up|0|||
129923626|NCT06424236|467685406|FG000|Overall Study|Disease Progression|0|||
129923627|NCT06424236|467685407|FG001|Overall Study|Disease Progression|1|||
129923628|NCT06424236|467685408|FG002|Overall Study|Disease Progression|2|||
129923629|NCT06424236|467685406|FG000|Overall Study|Other|0|||
129923630|NCT06424236|467685407|FG001|Overall Study|Other|0|||
129923631|NCT06424236|467685408|FG002|Overall Study|Other|1|||
129923632|NCT03339713|467685410|FG000|Overall Study|Lost to Follow-up|2|||
129923633|NCT03339713|467685411|FG001|Overall Study|Lost to Follow-up|1|||
129923634|NCT03339713|467685410|FG000|Overall Study|Protocol Violation|1|||
129923635|NCT03339713|467685411|FG001|Overall Study|Protocol Violation|0|||
129923636|NCT03339713|467685410|FG000|Overall Study|Withdrawal by Subject|1|||
129923637|NCT03339713|467685411|FG001|Overall Study|Withdrawal by Subject|1|||
129923638|NCT01959425|467685412|FG000|Overall Study|Withdrawal by Subject|5|||
129923639|NCT01959425|467685413|FG001|Overall Study|Withdrawal by Subject|4|||
129923640|NCT01959425|467685412|FG000|Overall Study|Lost to Follow-up|1|||
129923641|NCT01959425|467685413|FG001|Overall Study|Lost to Follow-up|0|||
129923642|NCT01959425|467685412|FG000|Overall Study|Discontinued Subjects|6|||
129923643|NCT01959425|467685413|FG001|Overall Study|Discontinued Subjects|4|||
129923644|NCT05540665|467685415|FG000|Overall Study|Study terminated by sponsor|6|||
129923645|NCT05540665|467685416|FG001|Overall Study|Study terminated by sponsor|6|||
129923646|NCT05540665|467685417|FG002|Overall Study|Study terminated by sponsor|7|||
129923647|NCT02619838|467685418|FG000|Overall Study|Lost to Follow-up|9|||
129923648|NCT02619838|467685418|FG000|Overall Study|Withdrawal by Subject|15|||
129923649|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
129923650|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
129923651|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
129923652|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
129923653|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
129923654|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
129923655|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
129923656|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
129923657|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
129923658|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
129923659|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
129923660|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
129923661|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
129923662|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
129923663|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
129923664|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
129923665|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
129923666|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
129923667|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
129923668|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
129923669|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
129923670|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
129923671|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
129923672|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
129923673|NCT01715285|467685419|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
129923674|NCT01715285|467685420|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
129923675|NCT01715285|467685421|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
129923676|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
129923677|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
129923678|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
129923679|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
129923680|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
129923681|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
129923682|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
129923683|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
129923684|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
129923685|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
129923686|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
129923687|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
129923688|NCT01715285|467685419|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
129923689|NCT01715285|467685420|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
129923690|NCT01715285|467685421|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
129923691|NCT02359890|467685424|FG000|Overall Study|Not meeting eligibility|4|||
129923692|NCT02359890|467685424|FG000|Overall Study|Never treated with study catheter|6|||
129923693|NCT02489903|467685428|FG000|Screening|Screen Failure|24|||
129923694|NCT02489903|467685429|FG001|Screening|Screen Failure|0|||
129923695|NCT02489903|467685430|FG002|Screening|Screen Failure|0|||
129923696|NCT02489903|467685431|FG003|Screening|Screen Failure|8|||
129923697|NCT02489903|467685428|FG000|Randomized and Received Treatment|Protocol Violation|0|||
129923698|NCT02489903|467685429|FG001|Randomized and Received Treatment|Protocol Violation|1|||
129923699|NCT02489903|467685430|FG002|Randomized and Received Treatment|Protocol Violation|0|||
129923700|NCT02489903|467685431|FG003|Randomized and Received Treatment|Protocol Violation|0|||
129923701|NCT02489903|467685428|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
129923702|NCT02489903|467685429|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
129923703|NCT02489903|467685430|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
129923704|NCT02489903|467685431|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
129923705|NCT02489903|467685428|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
129923706|NCT02489903|467685429|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
129923707|NCT02489903|467685430|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
129923708|NCT02489903|467685431|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
129923709|NCT02489903|467685428|FG000|Randomized and Received Treatment|Death|10|||
129923710|NCT02489903|467685429|FG001|Randomized and Received Treatment|Death|1|||
129923711|NCT02489903|467685430|FG002|Randomized and Received Treatment|Death|0|||
129923712|NCT02489903|467685431|FG003|Randomized and Received Treatment|Death|0|||
129923713|NCT05126433|467685432|FG000|Overall Study|Withdrawal by Subject|3|||
129923714|NCT05126433|467685433|FG001|Overall Study|Withdrawal by Subject|0|||
129923715|NCT05126433|467685434|FG002|Overall Study|Withdrawal by Subject|4|||
129923716|NCT05126433|467685432|FG000|Overall Study|Death|9|||
129923717|NCT05126433|467685433|FG001|Overall Study|Death|3|||
129923718|NCT05126433|467685434|FG002|Overall Study|Death|5|||
129450399|NCT01889238|465947401|FG000|Overall Study|Disease Progression|104|||
129450400|NCT01889238|465947401|FG000|Overall Study|Other|6|||
129450401|NCT04136184|465947402|FG000|Overall Study|Lost to Follow-up|0|||
129923719|NCT05126433|467685432|FG000|Overall Study|Study Terminated by sponsor|0|||
129923720|NCT05126433|467685433|FG001|Overall Study|Study Terminated by sponsor|1|||
129923721|NCT05126433|467685434|FG002|Overall Study|Study Terminated by sponsor|2|||
129923722|NCT05126433|467685432|FG000|Overall Study|Progressive Disease|1|||
129923723|NCT05126433|467685433|FG001|Overall Study|Progressive Disease|4|||
129923724|NCT05126433|467685434|FG002|Overall Study|Progressive Disease|3|||
129923725|NCT05126433|467685432|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
129923726|NCT05126433|467685433|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
129923727|NCT05126433|467685434|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
129923728|NCT04137289|467685435|FG000|Overall Study|Death|0|||
129923729|NCT04137289|467685436|FG001|Overall Study|Death|0|||
129923730|NCT04137289|467685437|FG002|Overall Study|Death|0|||
129923731|NCT04137289|467685438|FG003|Overall Study|Death|0|||
129923732|NCT04137289|467685439|FG004|Overall Study|Death|0|||
129923733|NCT04137289|467685440|FG005|Overall Study|Death|0|||
129923734|NCT04137289|467685441|FG006|Overall Study|Death|1|||
129923735|NCT04137289|467685442|FG007|Overall Study|Death|0|||
129923736|NCT04137289|467685443|FG008|Overall Study|Death|0|||
129923737|NCT04137289|467685435|FG000|Overall Study|Clinical disease progression|0|||
129923738|NCT04137289|467685436|FG001|Overall Study|Clinical disease progression|0|||
129923739|NCT04137289|467685437|FG002|Overall Study|Clinical disease progression|0|||
129923740|NCT04137289|467685438|FG003|Overall Study|Clinical disease progression|4|||
129923741|NCT04137289|467685439|FG004|Overall Study|Clinical disease progression|4|||
129923742|NCT04137289|467685440|FG005|Overall Study|Clinical disease progression|2|||
129923743|NCT04137289|467685441|FG006|Overall Study|Clinical disease progression|5|||
129923744|NCT04137289|467685442|FG007|Overall Study|Clinical disease progression|1|||
129923745|NCT04137289|467685443|FG008|Overall Study|Clinical disease progression|0|||
129923746|NCT04137289|467685435|FG000|Overall Study|Lost to Follow-up|0|||
129923747|NCT04137289|467685436|FG001|Overall Study|Lost to Follow-up|0|||
129923748|NCT04137289|467685437|FG002|Overall Study|Lost to Follow-up|0|||
129923749|NCT04137289|467685438|FG003|Overall Study|Lost to Follow-up|1|||
129923750|NCT04137289|467685439|FG004|Overall Study|Lost to Follow-up|0|||
129923751|NCT04137289|467685440|FG005|Overall Study|Lost to Follow-up|0|||
129923752|NCT04137289|467685441|FG006|Overall Study|Lost to Follow-up|0|||
129923753|NCT04137289|467685442|FG007|Overall Study|Lost to Follow-up|0|||
129923754|NCT04137289|467685443|FG008|Overall Study|Lost to Follow-up|0|||
129923755|NCT04137289|467685435|FG000|Overall Study|Adverse Event|0|||
129923756|NCT04137289|467685436|FG001|Overall Study|Adverse Event|0|||
129923757|NCT04137289|467685437|FG002|Overall Study|Adverse Event|1|||
129923758|NCT04137289|467685438|FG003|Overall Study|Adverse Event|0|||
129923759|NCT04137289|467685439|FG004|Overall Study|Adverse Event|0|||
129923760|NCT04137289|467685440|FG005|Overall Study|Adverse Event|1|||
129923761|NCT04137289|467685441|FG006|Overall Study|Adverse Event|0|||
129923762|NCT04137289|467685442|FG007|Overall Study|Adverse Event|0|||
129923763|NCT04137289|467685443|FG008|Overall Study|Adverse Event|0|||
129923764|NCT04137289|467685435|FG000|Overall Study|Lack of clinical benefit|0|||
129923765|NCT04137289|467685436|FG001|Overall Study|Lack of clinical benefit|0|||
129923766|NCT04137289|467685437|FG002|Overall Study|Lack of clinical benefit|0|||
129923767|NCT04137289|467685438|FG003|Overall Study|Lack of clinical benefit|0|||
129923768|NCT04137289|467685439|FG004|Overall Study|Lack of clinical benefit|0|||
129923769|NCT04137289|467685440|FG005|Overall Study|Lack of clinical benefit|0|||
129923770|NCT04137289|467685441|FG006|Overall Study|Lack of clinical benefit|0|||
129923771|NCT04137289|467685442|FG007|Overall Study|Lack of clinical benefit|0|||
129923772|NCT04137289|467685443|FG008|Overall Study|Lack of clinical benefit|1|||
129923773|NCT04137289|467685435|FG000|Overall Study|Objective disease progression|1|||
129923774|NCT04137289|467685436|FG001|Overall Study|Objective disease progression|1|||
129923775|NCT04137289|467685437|FG002|Overall Study|Objective disease progression|6|||
129923776|NCT04137289|467685438|FG003|Overall Study|Objective disease progression|18|||
129923777|NCT04137289|467685439|FG004|Overall Study|Objective disease progression|12|||
129923778|NCT04137289|467685440|FG005|Overall Study|Objective disease progression|20|||
129923779|NCT04137289|467685441|FG006|Overall Study|Objective disease progression|18|||
129923780|NCT04137289|467685442|FG007|Overall Study|Objective disease progression|7|||
129923781|NCT04137289|467685443|FG008|Overall Study|Objective disease progression|6|||
129923782|NCT03869866|467687193|FG000|Overall Study|Protocol Violation|1|||
129923783|NCT03869866|467687193|FG000|Overall Study|Withdrawal by Subject|3|||
129450402|NCT04136184|465947403|FG001|Overall Study|Lost to Follow-up|3|||
129923784|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
129923785|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
129923786|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
129450403|NCT04136184|465947402|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
129923787|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
129923788|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
129923789|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
129923790|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Death|0|||
129923791|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Death|0|||
129923792|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Death|0|||
129923793|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Death|0|||
129923794|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Death|0|||
129923795|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Death|2|||
129923796|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923797|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923798|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923799|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923800|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
129923801|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
129923802|NCT04066244|467687194|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923803|NCT04066244|467687195|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923804|NCT04066244|467687196|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923805|NCT04066244|467687197|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923806|NCT04066244|467687198|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
129923807|NCT04066244|467687199|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
129923808|NCT01073566|467687200|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
129923809|NCT01073566|467687201|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
129923810|NCT05006872|467687221|FG000|Overall Study|Lost to Follow-up|37|||
129923811|NCT05006872|467687222|FG001|Overall Study|Lost to Follow-up|31|||
129923812|NCT05499377|467687228|FG000|Overall Study|Withdrawal by Subject|2|||
129923813|NCT05499377|467687229|FG001|Overall Study|Withdrawal by Subject|0|||
129923814|NCT05499377|467687228|FG000|Overall Study|Physician Decision|1|||
129923815|NCT05499377|467687229|FG001|Overall Study|Physician Decision|0|||
129923816|NCT02677805|467687231|FG000|Double Blind Phase|Lost to Follow-up|8|||
129923817|NCT02677805|467687232|FG001|Double Blind Phase|Lost to Follow-up|3|||
129923818|NCT02677805|467687233|FG002|Double Blind Phase|Lost to Follow-up|0|||
129923819|NCT02677805|467687231|FG000|Double Blind Phase|Withdrawal by Subject|5|||
129923820|NCT02677805|467687232|FG001|Double Blind Phase|Withdrawal by Subject|2|||
129923821|NCT02677805|467687233|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129923822|NCT02677805|467687231|FG000|Open Label Phase|Lost to Follow-up|0|||
129923823|NCT02677805|467687232|FG001|Open Label Phase|Lost to Follow-up|0|||
129923824|NCT02677805|467687233|FG002|Open Label Phase|Lost to Follow-up|10|||
129923825|NCT02677805|467687231|FG000|Open Label Phase|Withdrawal by Subject|0|||
129923826|NCT02677805|467687232|FG001|Open Label Phase|Withdrawal by Subject|0|||
129923827|NCT02677805|467687233|FG002|Open Label Phase|Withdrawal by Subject|6|||
129923828|NCT04350463|467687238|FG000|Overall Study|Other reason|0|||
129923829|NCT04350463|467687239|FG001|Overall Study|Other reason|0|||
129923830|NCT04350463|467687240|FG002|Overall Study|Other reason|0|||
129923831|NCT04350463|467687241|FG003|Overall Study|Other reason|1|||
129923832|NCT04350463|467687238|FG000|Overall Study|Lost to Follow-up|0|||
129923833|NCT04350463|467687239|FG001|Overall Study|Lost to Follow-up|0|||
129923834|NCT04350463|467687240|FG002|Overall Study|Lost to Follow-up|0|||
129923835|NCT04350463|467687241|FG003|Overall Study|Lost to Follow-up|2|||
129923836|NCT04350463|467687238|FG000|Overall Study|Withdrawal by Subject|4|||
129923837|NCT04350463|467687239|FG001|Overall Study|Withdrawal by Subject|0|||
129923838|NCT04350463|467687240|FG002|Overall Study|Withdrawal by Subject|1|||
129923839|NCT04350463|467687241|FG003|Overall Study|Withdrawal by Subject|4|||
129923840|NCT04350463|467687238|FG000|Overall Study|Adverse Event|0|||
129923841|NCT04350463|467687239|FG001|Overall Study|Adverse Event|0|||
129923842|NCT04350463|467687240|FG002|Overall Study|Adverse Event|0|||
129923843|NCT04350463|467687241|FG003|Overall Study|Adverse Event|2|||
129923844|NCT04350463|467687238|FG000|Overall Study|Death|27|||
129923845|NCT04350463|467687239|FG001|Overall Study|Death|2|||
129923846|NCT04350463|467687240|FG002|Overall Study|Death|13|||
129923847|NCT04350463|467687241|FG003|Overall Study|Death|26|||
129923848|NCT04111536|467687242|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129923849|NCT04111536|467687243|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129923850|NCT04111536|467687242|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
129923851|NCT04111536|467687243|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
129923852|NCT04111536|467687242|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
129923853|NCT04111536|467687243|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129923854|NCT04111536|467687242|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
129923855|NCT04111536|467687243|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
129923856|NCT05714761|467687244|FG000|Overall Study|Lost to Follow-up|3|||
129923857|NCT05714761|467687244|FG000|Overall Study|Withdrawal by Subject|3|||
129923858|NCT05714761|467687244|FG000|Overall Study|unblinding of sensor data|1|||
129923859|NCT05714761|467687244|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
129923860|NCT05714761|467687244|FG000|Overall Study|did not return second CGM sensor|4|||
129923861|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
129923862|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
129923863|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
129923864|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
129923865|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
129923866|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
129923867|NCT02547233|467687246|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
129923868|NCT02547233|467687247|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
129923869|NCT02547233|467687246|FG000|12-month Follow-up|Withdrawal by Subject|10|||
129923870|NCT02547233|467687247|FG001|12-month Follow-up|Withdrawal by Subject|10|||
129923871|NCT02547233|467687246|FG000|12-month Follow-up|Lost to Follow-up|3|||
129923872|NCT02547233|467687247|FG001|12-month Follow-up|Lost to Follow-up|3|||
129923873|NCT02547233|467687246|FG000|12-month Follow-up|Lack of Efficacy|1|||
129923874|NCT02547233|467687247|FG001|12-month Follow-up|Lack of Efficacy|2|||
129923875|NCT02547233|467687246|FG000|12-month Follow-up|Protocol Violation|0|||
129923876|NCT02547233|467687247|FG001|12-month Follow-up|Protocol Violation|1|||
129923877|NCT02547233|467687246|FG000|12-month Follow-up|Other|0|||
129923878|NCT02547233|467687247|FG001|12-month Follow-up|Other|1|||
129923879|NCT05362487|467687248|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
129923880|NCT04096040|467687249|FG000|Overall Study|Protocol Violation|12|||
129923881|NCT04096040|467687249|FG000|Overall Study|Non-compliant site|4|||
129923882|NCT04973254|467687250|FG000|Overall Study|Not adherent|0|||
129923883|NCT04973254|467687251|FG001|Overall Study|Not adherent|1|||
129923884|NCT04973254|467687252|FG002|Overall Study|Not adherent|0|||
129923885|NCT05170009|467687253|FG000|Overall Study|Physician Decision|0|||
129923886|NCT05170009|467687254|FG001|Overall Study|Physician Decision|1|||
129923887|NCT05415722|467687255|FG000|Overall Study|Lost to Follow-up|0|||
129923888|NCT05415722|467687256|FG001|Overall Study|Lost to Follow-up|2|||
129923889|NCT05415722|467687257|FG002|Overall Study|Lost to Follow-up|0|||
129923890|NCT05415722|467687258|FG003|Overall Study|Lost to Follow-up|1|||
129923891|NCT05415722|467687259|FG004|Overall Study|Lost to Follow-up|0|||
129923892|NCT05415722|467687260|FG005|Overall Study|Lost to Follow-up|0|||
129923893|NCT05415722|467687261|FG006|Overall Study|Lost to Follow-up|1|||
129923894|NCT05415722|467687255|FG000|Overall Study|Physician Decision|0|||
129923895|NCT05415722|467687256|FG001|Overall Study|Physician Decision|0|||
129923896|NCT05415722|467687257|FG002|Overall Study|Physician Decision|0|||
129923897|NCT05415722|467687258|FG003|Overall Study|Physician Decision|1|||
129923898|NCT05415722|467687259|FG004|Overall Study|Physician Decision|0|||
129923899|NCT05415722|467687260|FG005|Overall Study|Physician Decision|0|||
129923900|NCT05415722|467687261|FG006|Overall Study|Physician Decision|1|||
129923901|NCT05415722|467687255|FG000|Overall Study|Protocol Violation|0|||
129923902|NCT05415722|467687256|FG001|Overall Study|Protocol Violation|0|||
129923903|NCT05415722|467687257|FG002|Overall Study|Protocol Violation|0|||
129923904|NCT05415722|467687258|FG003|Overall Study|Protocol Violation|1|||
129923905|NCT05415722|467687259|FG004|Overall Study|Protocol Violation|0|||
129923906|NCT05415722|467687260|FG005|Overall Study|Protocol Violation|0|||
129923907|NCT05415722|467687261|FG006|Overall Study|Protocol Violation|0|||
129923908|NCT05415722|467687255|FG000|Overall Study|Sponsor Discretion|0|||
129923909|NCT05415722|467687256|FG001|Overall Study|Sponsor Discretion|0|||
129923910|NCT05415722|467687257|FG002|Overall Study|Sponsor Discretion|0|||
129923911|NCT05415722|467687258|FG003|Overall Study|Sponsor Discretion|0|||
129923912|NCT05415722|467687259|FG004|Overall Study|Sponsor Discretion|1|||
129923913|NCT05415722|467687260|FG005|Overall Study|Sponsor Discretion|1|||
129923914|NCT05415722|467687261|FG006|Overall Study|Sponsor Discretion|0|||
129923915|NCT05415722|467687255|FG000|Overall Study|Withdrawal by Subject|0|||
129923916|NCT05415722|467687256|FG001|Overall Study|Withdrawal by Subject|1|||
129923917|NCT05415722|467687257|FG002|Overall Study|Withdrawal by Subject|0|||
129923918|NCT05415722|467687258|FG003|Overall Study|Withdrawal by Subject|1|||
129923919|NCT05415722|467687259|FG004|Overall Study|Withdrawal by Subject|1|||
129923920|NCT05415722|467687260|FG005|Overall Study|Withdrawal by Subject|0|||
129923921|NCT05415722|467687261|FG006|Overall Study|Withdrawal by Subject|1|||
129923922|NCT04629716|467687264|FG000|Overall Study|Lost to Follow-up|7|||
129923923|NCT04629716|467687265|FG001|Overall Study|Lost to Follow-up|3|||
129923924|NCT04537715|467687267|FG000|Overall Study|Death|3|||
129923925|NCT04537715|467687268|FG001|Overall Study|Death|1|||
129923926|NCT04537715|467687267|FG000|Overall Study|Withdrawal by Subject|3|||
129923927|NCT04537715|467687268|FG001|Overall Study|Withdrawal by Subject|1|||
129923928|NCT04537715|467687267|FG000|Overall Study|Other|4|||
129923929|NCT04537715|467687268|FG001|Overall Study|Other|3|||
129923930|NCT04537715|467687267|FG000|Overall Study|Progressive disease|1|||
129923931|NCT04537715|467687268|FG001|Overall Study|Progressive disease|0|||
129923932|NCT04623671|467687270|FG000|Overall Study|Adverse Event|0|||
129923933|NCT04623671|467687271|FG001|Overall Study|Adverse Event|1|||
129923934|NCT04623671|467687270|FG000|Overall Study|Lost to Follow-up|2|||
129923935|NCT04623671|467687271|FG001|Overall Study|Lost to Follow-up|1|||
129923936|NCT04623671|467687270|FG000|Overall Study|Death|5|||
129923937|NCT04623671|467687271|FG001|Overall Study|Death|5|||
129923938|NCT04542317|467687272|FG000|Overall Study|Care recipients passed away|18|||
129923939|NCT04542317|467687273|FG001|Overall Study|Care recipients passed away|13|||
129923940|NCT04542317|467687272|FG000|Overall Study|No longer a primary caregiver|5|||
129923941|NCT04542317|467687273|FG001|Overall Study|No longer a primary caregiver|1|||
129923942|NCT04542317|467687272|FG000|Overall Study|Withdrawal by Subject|4|||
129923943|NCT04542317|467687273|FG001|Overall Study|Withdrawal by Subject|2|||
129923944|NCT04542317|467687272|FG000|Overall Study|Caregivers passed away|0|||
129923945|NCT04542317|467687273|FG001|Overall Study|Caregivers passed away|2|||
129923946|NCT03848065|467687276|FG000|Overall Study|Death|0|||
129923947|NCT03848065|467687277|FG001|Overall Study|Death|1|||
129923948|NCT03848065|467687278|FG002|Overall Study|Death|0|||
129923949|NCT03848065|467687276|FG000|Overall Study|Lost to Follow-up|0|||
129923950|NCT03848065|467687277|FG001|Overall Study|Lost to Follow-up|0|||
129923951|NCT03848065|467687278|FG002|Overall Study|Lost to Follow-up|1|||
129923952|NCT03848065|467687276|FG000|Overall Study|Physician Decision|0|||
129923953|NCT03848065|467687277|FG001|Overall Study|Physician Decision|0|||
129923954|NCT03848065|467687278|FG002|Overall Study|Physician Decision|1|||
129923955|NCT03496168|467687279|FG000|Overall Study|Other Reasons|1|||
129923956|NCT03496168|467687279|FG000|Overall Study|Adverse Event|1|||
129923957|NCT03270501|467687286|FG000|Overall Study|Screen failure|6|||
129923958|NCT03270501|467687286|FG000|Overall Study|Lost to Follow-up|2|||
129923959|NCT03270501|467687286|FG000|Overall Study|Adverse Event|1|||
129923960|NCT04599062|467687289|FG000|Overall Study|Physician Decision|1|||
129923961|NCT04599062|467687290|FG001|Overall Study|Physician Decision|0|||
129923962|NCT04074759|467687292|FG000|Overall Study|Withdrawal by Subject|0|||
129923963|NCT04074759|467687293|FG001|Overall Study|Withdrawal by Subject|0|||
129923964|NCT04074759|467687294|FG002|Overall Study|Withdrawal by Subject|0|||
129923965|NCT04074759|467687295|FG003|Overall Study|Withdrawal by Subject|0|||
129923966|NCT04074759|467687296|FG004|Overall Study|Withdrawal by Subject|0|||
129923967|NCT04074759|467687297|FG005|Overall Study|Withdrawal by Subject|2|||
129923968|NCT04074759|467687298|FG006|Overall Study|Withdrawal by Subject|0|||
129923969|NCT04074759|467687299|FG007|Overall Study|Withdrawal by Subject|2|||
129923970|NCT04074759|467687300|FG008|Overall Study|Withdrawal by Subject|1|||
129923971|NCT04074759|467687301|FG009|Overall Study|Withdrawal by Subject|2|||
129923972|NCT04074759|467687302|FG010|Overall Study|Withdrawal by Subject|9|||
129923973|NCT04074759|467687303|FG011|Overall Study|Withdrawal by Subject|2|||
129923974|NCT04074759|467687304|FG012|Overall Study|Withdrawal by Subject|1|||
129923975|NCT04074759|467687305|FG013|Overall Study|Withdrawal by Subject|3|||
129923976|NCT04074759|467687306|FG014|Overall Study|Withdrawal by Subject|2|||
129923977|NCT04074759|467687307|FG015|Overall Study|Withdrawal by Subject|0|||
129923978|NCT04074759|467687308|FG016|Overall Study|Withdrawal by Subject|0|||
129923979|NCT04074759|467687309|FG017|Overall Study|Withdrawal by Subject|3|||
129923980|NCT04074759|467687310|FG018|Overall Study|Withdrawal by Subject|1|||
129923981|NCT04074759|467687292|FG000|Overall Study|Death|1|||
129923982|NCT04074759|467687293|FG001|Overall Study|Death|0|||
129923983|NCT04074759|467687294|FG002|Overall Study|Death|1|||
129923984|NCT04074759|467687295|FG003|Overall Study|Death|1|||
129923985|NCT04074759|467687296|FG004|Overall Study|Death|2|||
129923986|NCT04074759|467687297|FG005|Overall Study|Death|0|||
129923987|NCT04074759|467687298|FG006|Overall Study|Death|1|||
129923988|NCT04074759|467687299|FG007|Overall Study|Death|0|||
129923989|NCT04074759|467687300|FG008|Overall Study|Death|3|||
129923990|NCT04074759|467687301|FG009|Overall Study|Death|2|||
129923991|NCT04074759|467687302|FG010|Overall Study|Death|4|||
129923992|NCT04074759|467687303|FG011|Overall Study|Death|1|||
129923993|NCT04074759|467687304|FG012|Overall Study|Death|0|||
129923994|NCT04074759|467687305|FG013|Overall Study|Death|2|||
129923995|NCT04074759|467687306|FG014|Overall Study|Death|1|||
129923996|NCT04074759|467687307|FG015|Overall Study|Death|0|||
129923997|NCT04074759|467687308|FG016|Overall Study|Death|1|||
129923998|NCT04074759|467687309|FG017|Overall Study|Death|0|||
129923999|NCT04074759|467687310|FG018|Overall Study|Death|1|||
129924000|NCT04074759|467687292|FG000|Overall Study|Lost to Follow-up|0|||
129924001|NCT04074759|467687293|FG001|Overall Study|Lost to Follow-up|0|||
129924002|NCT04074759|467687294|FG002|Overall Study|Lost to Follow-up|0|||
129924003|NCT04074759|467687295|FG003|Overall Study|Lost to Follow-up|0|||
129924004|NCT04074759|467687296|FG004|Overall Study|Lost to Follow-up|0|||
129924005|NCT04074759|467687297|FG005|Overall Study|Lost to Follow-up|0|||
129924006|NCT04074759|467687298|FG006|Overall Study|Lost to Follow-up|0|||
129924007|NCT04074759|467687299|FG007|Overall Study|Lost to Follow-up|0|||
129924008|NCT04074759|467687300|FG008|Overall Study|Lost to Follow-up|0|||
129924009|NCT04074759|467687301|FG009|Overall Study|Lost to Follow-up|0|||
129924010|NCT04074759|467687302|FG010|Overall Study|Lost to Follow-up|1|||
129924011|NCT04074759|467687303|FG011|Overall Study|Lost to Follow-up|0|||
129924012|NCT04074759|467687304|FG012|Overall Study|Lost to Follow-up|0|||
129924013|NCT04074759|467687305|FG013|Overall Study|Lost to Follow-up|0|||
129924014|NCT04074759|467687306|FG014|Overall Study|Lost to Follow-up|0|||
129924015|NCT04074759|467687307|FG015|Overall Study|Lost to Follow-up|0|||
129924016|NCT04074759|467687308|FG016|Overall Study|Lost to Follow-up|1|||
129924017|NCT04074759|467687309|FG017|Overall Study|Lost to Follow-up|0|||
129924018|NCT04074759|467687310|FG018|Overall Study|Lost to Follow-up|1|||
129924019|NCT04074759|467687292|FG000|Overall Study|Other|0|||
129924020|NCT04074759|467687293|FG001|Overall Study|Other|1|||
129924021|NCT04074759|467687294|FG002|Overall Study|Other|1|||
129924022|NCT04074759|467687295|FG003|Overall Study|Other|0|||
129924023|NCT04074759|467687296|FG004|Overall Study|Other|2|||
129924024|NCT04074759|467687297|FG005|Overall Study|Other|1|||
129924025|NCT04074759|467687298|FG006|Overall Study|Other|2|||
129924026|NCT04074759|467687299|FG007|Overall Study|Other|1|||
129924027|NCT04074759|467687300|FG008|Overall Study|Other|1|||
129924028|NCT04074759|467687301|FG009|Overall Study|Other|4|||
129924029|NCT04074759|467687302|FG010|Overall Study|Other|4|||
129924030|NCT04074759|467687303|FG011|Overall Study|Other|2|||
129924031|NCT04074759|467687304|FG012|Overall Study|Other|0|||
129924032|NCT04074759|467687305|FG013|Overall Study|Other|0|||
129924033|NCT04074759|467687306|FG014|Overall Study|Other|0|||
129924034|NCT04074759|467687307|FG015|Overall Study|Other|1|||
129924035|NCT04074759|467687308|FG016|Overall Study|Other|0|||
129924036|NCT04074759|467687309|FG017|Overall Study|Other|0|||
129924037|NCT04074759|467687310|FG018|Overall Study|Other|0|||
129924038|NCT04074759|467687292|FG000|Overall Study|Missing end of study status|0|||
129924039|NCT04074759|467687293|FG001|Overall Study|Missing end of study status|0|||
129924040|NCT04074759|467687294|FG002|Overall Study|Missing end of study status|0|||
129924041|NCT04074759|467687295|FG003|Overall Study|Missing end of study status|0|||
129924042|NCT04074759|467687296|FG004|Overall Study|Missing end of study status|0|||
129924043|NCT04074759|467687297|FG005|Overall Study|Missing end of study status|0|||
129924044|NCT04074759|467687298|FG006|Overall Study|Missing end of study status|0|||
129924045|NCT04074759|467687299|FG007|Overall Study|Missing end of study status|0|||
129924046|NCT04074759|467687300|FG008|Overall Study|Missing end of study status|0|||
129924047|NCT04074759|467687301|FG009|Overall Study|Missing end of study status|0|||
129924048|NCT04074759|467687302|FG010|Overall Study|Missing end of study status|2|||
129924049|NCT04074759|467687303|FG011|Overall Study|Missing end of study status|0|||
129924050|NCT04074759|467687304|FG012|Overall Study|Missing end of study status|0|||
129924051|NCT04074759|467687305|FG013|Overall Study|Missing end of study status|0|||
129924052|NCT04074759|467687306|FG014|Overall Study|Missing end of study status|0|||
129924053|NCT04074759|467687307|FG015|Overall Study|Missing end of study status|0|||
129924054|NCT04074759|467687308|FG016|Overall Study|Missing end of study status|1|||
129924055|NCT04074759|467687309|FG017|Overall Study|Missing end of study status|0|||
129924056|NCT04074759|467687310|FG018|Overall Study|Missing end of study status|0|||
129924057|NCT05329220|467687313|FG000|Active Trial Period|Adverse Event|0|||
129924058|NCT05329220|467687314|FG001|Active Trial Period|Adverse Event|0|||
129924059|NCT05329220|467687315|FG002|Active Trial Period|Adverse Event|0|||
129924060|NCT05329220|467687316|FG003|Active Trial Period|Adverse Event|0|||
129924061|NCT05329220|467687317|FG004|Active Trial Period|Adverse Event|1|||
129924062|NCT05329220|467687318|FG005|Active Trial Period|Adverse Event|0|||
129924063|NCT05329220|467687313|FG000|Active Trial Period|Lost to Follow-up|0|||
129924064|NCT05329220|467687314|FG001|Active Trial Period|Lost to Follow-up|0|||
129924065|NCT05329220|467687315|FG002|Active Trial Period|Lost to Follow-up|0|||
129924066|NCT05329220|467687316|FG003|Active Trial Period|Lost to Follow-up|0|||
129924067|NCT05329220|467687317|FG004|Active Trial Period|Lost to Follow-up|32|||
129924068|NCT05329220|467687318|FG005|Active Trial Period|Lost to Follow-up|28|||
129924069|NCT05329220|467687313|FG000|Active Trial Period|Physician Decision|0|||
129924070|NCT05329220|467687314|FG001|Active Trial Period|Physician Decision|0|||
129924071|NCT05329220|467687315|FG002|Active Trial Period|Physician Decision|0|||
129924072|NCT05329220|467687316|FG003|Active Trial Period|Physician Decision|0|||
129924073|NCT05329220|467687317|FG004|Active Trial Period|Physician Decision|2|||
129924074|NCT05329220|467687318|FG005|Active Trial Period|Physician Decision|0|||
129924075|NCT05329220|467687313|FG000|Active Trial Period|Protocol Violation|0|||
129924076|NCT05329220|467687314|FG001|Active Trial Period|Protocol Violation|0|||
129924077|NCT05329220|467687315|FG002|Active Trial Period|Protocol Violation|0|||
129924078|NCT05329220|467687316|FG003|Active Trial Period|Protocol Violation|0|||
129924079|NCT05329220|467687317|FG004|Active Trial Period|Protocol Violation|1|||
129924080|NCT05329220|467687318|FG005|Active Trial Period|Protocol Violation|3|||
129924081|NCT05329220|467687313|FG000|Active Trial Period|Withdrawal by Subject|0|||
129924082|NCT05329220|467687314|FG001|Active Trial Period|Withdrawal by Subject|0|||
129924083|NCT05329220|467687315|FG002|Active Trial Period|Withdrawal by Subject|0|||
129924084|NCT05329220|467687316|FG003|Active Trial Period|Withdrawal by Subject|1|||
129924085|NCT05329220|467687317|FG004|Active Trial Period|Withdrawal by Subject|12|||
129924086|NCT05329220|467687318|FG005|Active Trial Period|Withdrawal by Subject|13|||
129924087|NCT05329220|467687313|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924088|NCT05329220|467687314|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924089|NCT05329220|467687315|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924090|NCT05329220|467687316|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924091|NCT05329220|467687317|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
129924092|NCT05329220|467687318|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
129924093|NCT05329220|467687313|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924094|NCT05329220|467687314|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924095|NCT05329220|467687315|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924096|NCT05329220|467687316|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924097|NCT05329220|467687317|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
129924098|NCT05329220|467687318|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
129924099|NCT05329220|467687313|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
129924100|NCT05329220|467687314|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
129924101|NCT05329220|467687315|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
129924102|NCT05329220|467687316|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
129924103|NCT05329220|467687317|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
129924104|NCT05329220|467687318|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
129924105|NCT05329220|467687313|FG000|Follow-up Period|Adverse Event|0|||
129924106|NCT05329220|467687314|FG001|Follow-up Period|Adverse Event|0|||
129924107|NCT05329220|467687315|FG002|Follow-up Period|Adverse Event|0|||
129924108|NCT05329220|467687316|FG003|Follow-up Period|Adverse Event|0|||
129924109|NCT05329220|467687317|FG004|Follow-up Period|Adverse Event|2|||
129924110|NCT05329220|467687318|FG005|Follow-up Period|Adverse Event|1|||
129924111|NCT05329220|467687313|FG000|Follow-up Period|Death|0|||
129924112|NCT05329220|467687314|FG001|Follow-up Period|Death|0|||
129924113|NCT05329220|467687315|FG002|Follow-up Period|Death|1|||
129924114|NCT05329220|467687316|FG003|Follow-up Period|Death|1|||
129924115|NCT05329220|467687317|FG004|Follow-up Period|Death|0|||
129924116|NCT05329220|467687318|FG005|Follow-up Period|Death|1|||
129924117|NCT05329220|467687313|FG000|Follow-up Period|Lost to Follow-up|0|||
129924118|NCT05329220|467687314|FG001|Follow-up Period|Lost to Follow-up|1|||
129924119|NCT05329220|467687315|FG002|Follow-up Period|Lost to Follow-up|2|||
129924120|NCT05329220|467687316|FG003|Follow-up Period|Lost to Follow-up|2|||
129924121|NCT05329220|467687317|FG004|Follow-up Period|Lost to Follow-up|113|||
129924122|NCT05329220|467687318|FG005|Follow-up Period|Lost to Follow-up|89|||
129924123|NCT05329220|467687313|FG000|Follow-up Period|Physician Decision|0|||
129924124|NCT05329220|467687314|FG001|Follow-up Period|Physician Decision|0|||
129924125|NCT05329220|467687315|FG002|Follow-up Period|Physician Decision|0|||
129924126|NCT05329220|467687316|FG003|Follow-up Period|Physician Decision|0|||
129924127|NCT05329220|467687317|FG004|Follow-up Period|Physician Decision|2|||
129924128|NCT05329220|467687318|FG005|Follow-up Period|Physician Decision|2|||
129924129|NCT05329220|467687313|FG000|Follow-up Period|Protocol Violation|0|||
129924130|NCT05329220|467687314|FG001|Follow-up Period|Protocol Violation|0|||
129924131|NCT05329220|467687315|FG002|Follow-up Period|Protocol Violation|0|||
129924132|NCT05329220|467687316|FG003|Follow-up Period|Protocol Violation|0|||
129924133|NCT05329220|467687317|FG004|Follow-up Period|Protocol Violation|0|||
129924134|NCT05329220|467687318|FG005|Follow-up Period|Protocol Violation|1|||
129924135|NCT05329220|467687313|FG000|Follow-up Period|Withdrawal by Subject|0|||
129924136|NCT05329220|467687314|FG001|Follow-up Period|Withdrawal by Subject|0|||
129924137|NCT05329220|467687315|FG002|Follow-up Period|Withdrawal by Subject|1|||
129924138|NCT05329220|467687316|FG003|Follow-up Period|Withdrawal by Subject|1|||
129924139|NCT05329220|467687317|FG004|Follow-up Period|Withdrawal by Subject|34|||
129924140|NCT05329220|467687318|FG005|Follow-up Period|Withdrawal by Subject|35|||
129924141|NCT05329220|467687313|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924142|NCT05329220|467687314|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924143|NCT05329220|467687315|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
129924144|NCT05329220|467687316|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924145|NCT05329220|467687317|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924146|NCT05329220|467687318|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
129924147|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924148|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924149|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924150|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924151|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
129450404|NCT04136184|465947403|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
129924152|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
129924153|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924154|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129450405|NCT02844816|465947407|FG000|Overall Study|No protocol treatment received|5|||
129450406|NCT02844816|465947408|FG001|Overall Study|No protocol treatment received|1|||
129924155|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924156|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924157|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
129924158|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
129924159|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924160|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924161|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924162|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924163|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
129924164|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
129924165|NCT05329220|467687313|FG000|Follow-up Period|EARLY TERMINATION|0|||
129924166|NCT05329220|467687314|FG001|Follow-up Period|EARLY TERMINATION|0|||
129924167|NCT05329220|467687315|FG002|Follow-up Period|EARLY TERMINATION|0|||
129924168|NCT05329220|467687316|FG003|Follow-up Period|EARLY TERMINATION|0|||
129924169|NCT05329220|467687317|FG004|Follow-up Period|EARLY TERMINATION|0|||
129924170|NCT05329220|467687318|FG005|Follow-up Period|EARLY TERMINATION|1|||
129924171|NCT05329220|467687313|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924172|NCT05329220|467687314|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924173|NCT05329220|467687315|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924174|NCT05329220|467687316|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924175|NCT05329220|467687317|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
129924176|NCT05329220|467687318|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
129924177|NCT05329220|467687313|FG000|Follow-up Period|DROPPED|0|||
129924178|NCT05329220|467687314|FG001|Follow-up Period|DROPPED|0|||
129924179|NCT05329220|467687315|FG002|Follow-up Period|DROPPED|0|||
129924180|NCT05329220|467687316|FG003|Follow-up Period|DROPPED|0|||
129924181|NCT05329220|467687317|FG004|Follow-up Period|DROPPED|0|||
129924182|NCT05329220|467687318|FG005|Follow-up Period|DROPPED|1|||
129924183|NCT05329220|467687313|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924184|NCT05329220|467687314|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924185|NCT05329220|467687315|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924186|NCT05329220|467687316|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924187|NCT05329220|467687317|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
129924188|NCT05329220|467687318|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
129924189|NCT03931174|467687321|FG000|Providers|Staff left organization|26|||
129924190|NCT03931174|467687322|FG001|Providers|Staff left organization|25|||
129924191|NCT03931174|467687321|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
129924192|NCT03931174|467687322|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
129924193|NCT03931174|467687321|FG000|Providers|Lost to Follow-up|4|||
129924194|NCT03931174|467687322|FG001|Providers|Lost to Follow-up|4|||
129924195|NCT03931174|467687321|FG000|Patients|Post-consent screening failure|1|||
129924196|NCT03931174|467687322|FG001|Patients|Post-consent screening failure|1|||
129924197|NCT03931174|467687321|FG000|Patients|Death|1|||
129924198|NCT03931174|467687322|FG001|Patients|Death|1|||
129924199|NCT03931174|467687321|FG000|Patients|Lost to Follow-up|60|||
129924200|NCT03931174|467687322|FG001|Patients|Lost to Follow-up|89|||
129924201|NCT03322267|467687323|FG000|Overall Study|Lack of Efficacy|11|||
129924202|NCT03322267|467687323|FG000|Overall Study|Adverse Event|1|||
129924203|NCT03322267|467687323|FG000|Overall Study|Withdrawal by Subject|2|||
129924204|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
129924205|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
129924206|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
129924207|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
129924208|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
129924209|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
129924210|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
129924211|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
129924212|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
129924213|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
129924214|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
129924215|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
129924216|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
129924217|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
129924218|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
129924219|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
129924220|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
129924221|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
129924222|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
129924223|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
129924224|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924225|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
129924226|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924227|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924228|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
129924229|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
129924230|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
129924231|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
129924232|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
129924233|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
129924234|NCT03852472|467687333|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
129924235|NCT03852472|467687334|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
129924236|NCT03852472|467687335|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
129924237|NCT03852472|467687336|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
129924238|NCT03852472|467687337|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
129924239|NCT03852472|467687333|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
129924240|NCT03852472|467687334|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
129924241|NCT03852472|467687335|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
129924242|NCT03852472|467687336|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
129924243|NCT03852472|467687337|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
129924244|NCT03852472|467687333|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
129924245|NCT03852472|467687334|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
129924246|NCT03852472|467687335|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
129924247|NCT03852472|467687336|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
129924248|NCT03852472|467687337|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
129924249|NCT03852472|467687333|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
129924250|NCT03852472|467687334|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
129924251|NCT03852472|467687335|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
129924252|NCT03852472|467687336|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
129924253|NCT03852472|467687337|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
129924254|NCT03852472|467687333|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
129924255|NCT03852472|467687334|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
129924256|NCT03852472|467687335|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
129924257|NCT03852472|467687336|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
129924258|NCT03852472|467687337|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
129924259|NCT03852472|467687333|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
129924260|NCT03852472|467687334|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
129924261|NCT03852472|467687335|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
129924262|NCT03852472|467687336|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
129924263|NCT03852472|467687337|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
129924264|NCT03852472|467687333|FG000|Period 2 - Week 44|Adverse Event|0|||
129924265|NCT03852472|467687334|FG001|Period 2 - Week 44|Adverse Event|3|||
129924266|NCT03852472|467687335|FG002|Period 2 - Week 44|Adverse Event|1|||
129924267|NCT03852472|467687336|FG003|Period 2 - Week 44|Adverse Event|2|||
129924268|NCT03852472|467687337|FG004|Period 2 - Week 44|Adverse Event|2|||
129924269|NCT03852472|467687333|FG000|Period 2 - Week 44|COVID-19 Related|0|||
129924270|NCT03852472|467687334|FG001|Period 2 - Week 44|COVID-19 Related|0|||
129924271|NCT03852472|467687335|FG002|Period 2 - Week 44|COVID-19 Related|0|||
129924272|NCT03852472|467687336|FG003|Period 2 - Week 44|COVID-19 Related|1|||
129924273|NCT03852472|467687337|FG004|Period 2 - Week 44|COVID-19 Related|0|||
129924274|NCT03852472|467687333|FG000|Period 2 - Week 44|Reason not stated|0|||
129924275|NCT03852472|467687334|FG001|Period 2 - Week 44|Reason not stated|0|||
129924276|NCT03852472|467687335|FG002|Period 2 - Week 44|Reason not stated|0|||
129924277|NCT03852472|467687336|FG003|Period 2 - Week 44|Reason not stated|0|||
129924278|NCT03852472|467687337|FG004|Period 2 - Week 44|Reason not stated|1|||
129924279|NCT06457802|467687338|FG000|Overall Study|Early termination of study prior to participant completion|2|||
129924280|NCT06457802|467687339|FG001|Overall Study|Early termination of study prior to participant completion|2|||
129924281|NCT01467427|467687340|FG000|Overall Study|Withdrawal by Subject|1|||
129924282|NCT01467427|467687341|FG001|Overall Study|Withdrawal by Subject|0|||
129924283|NCT01467427|467687340|FG000|Overall Study|Not continuing in extension phase|0|||
129924284|NCT01467427|467687341|FG001|Overall Study|Not continuing in extension phase|2|||
129924285|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
129924286|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
129924287|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
129924288|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
129924289|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
129924290|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
129924291|NCT01467427|467687340|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
129924292|NCT01467427|467687341|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
129924293|NCT03161028|467687342|FG000|Overall Study|Withdrawal by Subject|6|||
129924294|NCT03161028|467687343|FG001|Overall Study|Withdrawal by Subject|4|||
129924295|NCT03161028|467687342|FG000|Overall Study|Adverse Event|5|||
129924296|NCT03161028|467687343|FG001|Overall Study|Adverse Event|1|||
129924297|NCT03161028|467687342|FG000|Overall Study|Study drug side effects|2|||
129924298|NCT03161028|467687343|FG001|Overall Study|Study drug side effects|2|||
129924299|NCT03161028|467687342|FG000|Overall Study|Administrative PD/UP|4|||
129924300|NCT03161028|467687343|FG001|Overall Study|Administrative PD/UP|2|||
129924301|NCT03161028|467687342|FG000|Overall Study|Lost to Follow-up|2|||
129924302|NCT03161028|467687343|FG001|Overall Study|Lost to Follow-up|0|||
129924303|NCT03161028|467687342|FG000|Overall Study|Unable to comply with procedures|1|||
129924304|NCT03161028|467687343|FG001|Overall Study|Unable to comply with procedures|1|||
129924305|NCT03492216|467687344|FG000|Overall Study|Death|1|||
129924306|NCT03492216|467687345|FG001|Overall Study|Death|0|||
129924307|NCT03492216|467687346|FG002|Overall Study|Death|4|||
129924308|NCT03492216|467687347|FG003|Overall Study|Death|0|||
129924309|NCT03492216|467687344|FG000|Overall Study|Withdrawal by Subject|5|||
129924310|NCT03492216|467687345|FG001|Overall Study|Withdrawal by Subject|3|||
129924311|NCT03492216|467687346|FG002|Overall Study|Withdrawal by Subject|1|||
129924312|NCT03492216|467687347|FG003|Overall Study|Withdrawal by Subject|1|||
129924313|NCT03492216|467687344|FG000|Overall Study|Lost to Follow-up|9|||
129924314|NCT03492216|467687345|FG001|Overall Study|Lost to Follow-up|2|||
129924315|NCT03492216|467687346|FG002|Overall Study|Lost to Follow-up|7|||
129924316|NCT03492216|467687347|FG003|Overall Study|Lost to Follow-up|8|||
129924317|NCT03492216|467687344|FG000|Overall Study|Moved|5|||
129924318|NCT03492216|467687345|FG001|Overall Study|Moved|3|||
129924319|NCT03492216|467687346|FG002|Overall Study|Moved|3|||
129924320|NCT03492216|467687347|FG003|Overall Study|Moved|5|||
129924321|NCT03492216|467687344|FG000|Overall Study|Too ill|0|||
129924322|NCT03492216|467687345|FG001|Overall Study|Too ill|1|||
129924323|NCT03492216|467687346|FG002|Overall Study|Too ill|0|||
129924324|NCT03492216|467687347|FG003|Overall Study|Too ill|0|||
129924325|NCT03492216|467687344|FG000|Overall Study|Incarcerated|0|||
129924326|NCT03492216|467687345|FG001|Overall Study|Incarcerated|0|||
129924327|NCT03492216|467687346|FG002|Overall Study|Incarcerated|2|||
129924328|NCT03492216|467687347|FG003|Overall Study|Incarcerated|0|||
129924329|NCT00736723|467687348|FG000|Overall Study|Withdrawal by Subject|4|||
129924330|NCT00736723|467687349|FG001|Overall Study|Withdrawal by Subject|3|||
129924331|NCT04797897|467687350|FG000|Overall Study|Study Termination by Sponsor|1|||
129924332|NCT04797897|467687351|FG001|Overall Study|Study Termination by Sponsor|1|||
129924333|NCT03024437|467687357|FG000|Overall Study|Adverse Event|0|||
129924334|NCT03024437|467687358|FG001|Overall Study|Adverse Event|1|||
129924335|NCT03024437|467687359|FG002|Overall Study|Adverse Event|3|||
129924336|NCT03024437|467687360|FG003|Overall Study|Adverse Event|5|||
129924337|NCT03024437|467687361|FG004|Overall Study|Adverse Event|0|||
129924338|NCT03024437|467687357|FG000|Overall Study|Physician Decision|1|||
129924339|NCT03024437|467687358|FG001|Overall Study|Physician Decision|0|||
129924340|NCT03024437|467687359|FG002|Overall Study|Physician Decision|0|||
129924341|NCT03024437|467687360|FG003|Overall Study|Physician Decision|1|||
129924342|NCT03024437|467687361|FG004|Overall Study|Physician Decision|0|||
129924343|NCT03024437|467687357|FG000|Overall Study|Disease progression, relapse|1|||
129924344|NCT03024437|467687358|FG001|Overall Study|Disease progression, relapse|0|||
129924345|NCT03024437|467687359|FG002|Overall Study|Disease progression, relapse|0|||
129924346|NCT03024437|467687360|FG003|Overall Study|Disease progression, relapse|3|||
129924347|NCT03024437|467687361|FG004|Overall Study|Disease progression, relapse|0|||
129924348|NCT03024437|467687357|FG000|Overall Study|Disease progression, refractory disease|4|||
129924349|NCT03024437|467687358|FG001|Overall Study|Disease progression, refractory disease|4|||
129924350|NCT03024437|467687359|FG002|Overall Study|Disease progression, refractory disease|2|||
129924351|NCT03024437|467687360|FG003|Overall Study|Disease progression, refractory disease|2|||
129924352|NCT03024437|467687361|FG004|Overall Study|Disease progression, refractory disease|1|||
129924353|NCT03024437|467687357|FG000|Overall Study|Newly diagnosed cancer|0|||
129924354|NCT03024437|467687358|FG001|Overall Study|Newly diagnosed cancer|0|||
129924355|NCT03024437|467687359|FG002|Overall Study|Newly diagnosed cancer|0|||
129924356|NCT03024437|467687360|FG003|Overall Study|Newly diagnosed cancer|1|||
129924357|NCT03024437|467687361|FG004|Overall Study|Newly diagnosed cancer|0|||
129924358|NCT03024437|467687357|FG000|Overall Study|Moved out of state|0|||
129924359|NCT03024437|467687358|FG001|Overall Study|Moved out of state|1|||
129924360|NCT03024437|467687359|FG002|Overall Study|Moved out of state|0|||
129924361|NCT03024437|467687360|FG003|Overall Study|Moved out of state|0|||
129924362|NCT03024437|467687361|FG004|Overall Study|Moved out of state|0|||
129924363|NCT03024437|467687357|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924364|NCT03024437|467687358|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924365|NCT03024437|467687359|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
129924366|NCT03024437|467687360|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924367|NCT03024437|467687361|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
129924368|NCT02601313|467687362|FG000|Overall Study|Death|2|||
129924369|NCT02601313|467687363|FG001|Overall Study|Death|41|||
129924370|NCT02601313|467687364|FG002|Overall Study|Death|6|||
129924371|NCT02601313|467687362|FG000|Overall Study|Enrolled but never treated|0|||
129924372|NCT02601313|467687363|FG001|Overall Study|Enrolled but never treated|6|||
129924373|NCT02601313|467687364|FG002|Overall Study|Enrolled but never treated|3|||
129924374|NCT02601313|467687362|FG000|Overall Study|Enrolled, did not initiate AC|4|||
129924375|NCT02601313|467687363|FG001|Overall Study|Enrolled, did not initiate AC|0|||
129924376|NCT02601313|467687364|FG002|Overall Study|Enrolled, did not initiate AC|0|||
129924377|NCT02601313|467687362|FG000|Overall Study|Full consent withdrawal|0|||
129924378|NCT02601313|467687363|FG001|Overall Study|Full consent withdrawal|3|||
129924379|NCT02601313|467687364|FG002|Overall Study|Full consent withdrawal|2|||
129924380|NCT02601313|467687362|FG000|Overall Study|Lost to Follow-up|0|||
129924381|NCT02601313|467687363|FG001|Overall Study|Lost to Follow-up|1|||
129924382|NCT02601313|467687364|FG002|Overall Study|Lost to Follow-up|1|||
129924383|NCT02364557|467687365|FG000|Overall Study|Protocol Violation|3|||
129924384|NCT02364557|467687366|FG001|Overall Study|Protocol Violation|1|||
129924385|NCT04828005|467687367|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
129924386|NCT04828005|467687368|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
129924387|NCT04828005|467687369|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
129924388|NCT04828005|467687370|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
129924389|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
129924390|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
129924391|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
129924392|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
129924393|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
129924394|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
129924395|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
129924396|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
129924397|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
129924398|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
129924399|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
129924400|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
129924401|NCT04828005|467687367|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
129924402|NCT04828005|467687368|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
129924403|NCT04828005|467687369|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
129924404|NCT04828005|467687370|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
129924405|NCT04828005|467687367|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
129924406|NCT04828005|467687368|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
129924407|NCT04828005|467687369|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
129924408|NCT04828005|467687370|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
129924409|NCT04828005|467687367|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
129924410|NCT04828005|467687368|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
129924411|NCT04828005|467687369|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
129924412|NCT04828005|467687370|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
129924413|NCT04828005|467687367|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
129924414|NCT04828005|467687368|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
129924415|NCT04828005|467687369|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
129924416|NCT04828005|467687370|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
129924417|NCT04828005|467687367|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
129450407|NCT02844816|465947407|FG000|Overall Study|Ineligible|22|||
129924418|NCT04828005|467687368|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
129924419|NCT04828005|467687369|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
129924420|NCT04828005|467687370|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
129924421|NCT02975882|467689275|FG000|Overall Study|Adverse Event|1|||
129924422|NCT02975882|467689276|FG001|Overall Study|Adverse Event|2|||
129924423|NCT02975882|467689277|FG002|Overall Study|Adverse Event|1|||
129924424|NCT02975882|467689278|FG003|Overall Study|Adverse Event|1|||
129924425|NCT02975882|467689275|FG000|Overall Study|Death|0|||
129924426|NCT02975882|467689276|FG001|Overall Study|Death|1|||
129924427|NCT02975882|467689277|FG002|Overall Study|Death|0|||
129924428|NCT02975882|467689278|FG003|Overall Study|Death|0|||
129924429|NCT02975882|467689275|FG000|Overall Study|Lack of Efficacy|3|||
129450408|NCT02844816|465947408|FG001|Overall Study|Ineligible|15|||
129924430|NCT02975882|467689276|FG001|Overall Study|Lack of Efficacy|7|||
129924431|NCT02975882|467689277|FG002|Overall Study|Lack of Efficacy|4|||
129924432|NCT02975882|467689278|FG003|Overall Study|Lack of Efficacy|3|||
129924433|NCT02975882|467689275|FG000|Overall Study|Physician Decision|0|||
129924434|NCT02975882|467689276|FG001|Overall Study|Physician Decision|2|||
129924435|NCT02975882|467689277|FG002|Overall Study|Physician Decision|4|||
129924436|NCT02975882|467689278|FG003|Overall Study|Physician Decision|2|||
129924437|NCT02975882|467689275|FG000|Overall Study|Ineligible|0|||
129924438|NCT02975882|467689276|FG001|Overall Study|Ineligible|1|||
129924439|NCT02975882|467689277|FG002|Overall Study|Ineligible|0|||
129924440|NCT02975882|467689278|FG003|Overall Study|Ineligible|0|||
129924441|NCT03867500|467689279|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
129924442|NCT04802967|467689286|FG000|Part B|Withdrawal by Subject|0|||
129924443|NCT04802967|467689287|FG001|Part B|Withdrawal by Subject|0|||
129924444|NCT04802967|467689288|FG002|Part B|Withdrawal by Subject|0|||
129924445|NCT04802967|467689289|FG003|Part B|Withdrawal by Subject|0|||
129924446|NCT04802967|467689290|FG004|Part B|Withdrawal by Subject|0|||
129924447|NCT04802967|467689291|FG005|Part B|Withdrawal by Subject|1|||
129924448|NCT04802967|467689292|FG006|Part B|Withdrawal by Subject|0|||
129924449|NCT04802967|467689293|FG007|Part B|Withdrawal by Subject|0|||
129924450|NCT04802967|467689294|FG008|Part B|Withdrawal by Subject|0|||
129924451|NCT04802967|467689295|FG009|Part B|Withdrawal by Subject|0|||
129924452|NCT03524118|467689300|FG000|Overall Study|Lost to Follow-up|0|||
129924453|NCT03524118|467689301|FG001|Overall Study|Lost to Follow-up|0|||
129924454|NCT03524118|467689302|FG002|Overall Study|Lost to Follow-up|0|||
129924455|NCT03524118|467689303|FG003|Overall Study|Lost to Follow-up|0|||
129924456|NCT03524118|467689304|FG004|Overall Study|Lost to Follow-up|1|||
129924457|NCT03524118|467689305|FG005|Overall Study|Lost to Follow-up|0|||
129924458|NCT03524118|467689300|FG000|Overall Study|Other|0|||
129924459|NCT03524118|467689301|FG001|Overall Study|Other|1|||
129924460|NCT03524118|467689302|FG002|Overall Study|Other|0|||
129924461|NCT03524118|467689303|FG003|Overall Study|Other|0|||
129924462|NCT03524118|467689304|FG004|Overall Study|Other|1|||
129924463|NCT03524118|467689305|FG005|Overall Study|Other|1|||
129924464|NCT03524118|467689300|FG000|Overall Study|Physician Decision|0|||
129924465|NCT03524118|467689301|FG001|Overall Study|Physician Decision|0|||
129924466|NCT03524118|467689302|FG002|Overall Study|Physician Decision|0|||
129924467|NCT03524118|467689303|FG003|Overall Study|Physician Decision|0|||
129924468|NCT03524118|467689304|FG004|Overall Study|Physician Decision|1|||
129924469|NCT03524118|467689305|FG005|Overall Study|Physician Decision|0|||
129924470|NCT03524118|467689300|FG000|Overall Study|Protocol Violation|0|||
129924471|NCT03524118|467689301|FG001|Overall Study|Protocol Violation|0|||
129924472|NCT03524118|467689302|FG002|Overall Study|Protocol Violation|1|||
129924473|NCT03524118|467689303|FG003|Overall Study|Protocol Violation|0|||
129924474|NCT03524118|467689304|FG004|Overall Study|Protocol Violation|1|||
129924475|NCT03524118|467689305|FG005|Overall Study|Protocol Violation|0|||
129924476|NCT03524118|467689300|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129924477|NCT03524118|467689301|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129924478|NCT03524118|467689302|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129924479|NCT03524118|467689303|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
129924480|NCT03524118|467689304|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
129924481|NCT03524118|467689305|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129924482|NCT01824875|467689306|FG000|Overall Study|Disease progression|22|||
129924483|NCT01824875|467689307|FG001|Overall Study|Disease progression|15|||
129924484|NCT01824875|467689306|FG000|Overall Study|Withdrawal by Subject|5|||
129924485|NCT01824875|467689307|FG001|Overall Study|Withdrawal by Subject|4|||
129924486|NCT01824875|467689306|FG000|Overall Study|Adverse Event|4|||
129924487|NCT01824875|467689307|FG001|Overall Study|Adverse Event|10|||
129924488|NCT01824875|467689306|FG000|Overall Study|Alternative therapy|3|||
129924489|NCT01824875|467689307|FG001|Overall Study|Alternative therapy|0|||
129924490|NCT01824875|467689306|FG000|Overall Study|Complicating disease|1|||
129924491|NCT01824875|467689307|FG001|Overall Study|Complicating disease|0|||
129924492|NCT01824875|467689306|FG000|Overall Study|Physician Decision|0|||
129924493|NCT01824875|467689307|FG001|Overall Study|Physician Decision|1|||
129924494|NCT01824875|467689306|FG000|Overall Study|Non-compliance|1|||
129924495|NCT01824875|467689307|FG001|Overall Study|Non-compliance|1|||
129924496|NCT01824875|467689306|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
129924497|NCT01824875|467689307|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
129924498|NCT01824875|467689306|FG000|Overall Study|Administrative issues|0|||
129924499|NCT01824875|467689307|FG001|Overall Study|Administrative issues|2|||
129924500|NCT01824875|467689306|FG000|Overall Study|Ineligible or never started treatment|9|||
129924501|NCT01824875|467689307|FG001|Overall Study|Ineligible or never started treatment|5|||
129924502|NCT01824875|467689306|FG000|Overall Study|Other|0|||
129924503|NCT01824875|467689307|FG001|Overall Study|Other|2|||
129924504|NCT01098812|467689310|FG000|Overall Study|Death|2|||
129924505|NCT01098812|467689311|FG001|Overall Study|Death|0|||
129924506|NCT01098812|467689312|FG002|Overall Study|Death|1|||
129924507|NCT01098812|467689310|FG000|Overall Study|Lost to Follow-up|0|||
129924508|NCT01098812|467689311|FG001|Overall Study|Lost to Follow-up|1|||
129924509|NCT01098812|467689312|FG002|Overall Study|Lost to Follow-up|0|||
129924510|NCT04625283|467689315|FG000|Overall Study|post randomization exclusion|28|||
129924511|NCT04625283|467689316|FG001|Overall Study|post randomization exclusion|20|||
129924512|NCT02817776|467689317|FG000|Overall Study|Excluded|33|||
129924513|NCT02817776|467689317|FG000|Overall Study|Lost to Follow-up|20|||
129924514|NCT02817776|467689317|FG000|Overall Study|Withdrawal by Subject|33|||
129924515|NCT02817776|467689317|FG000|Overall Study|Death|2|||
129924516|NCT03462030|467689320|FG000|Overall Study|Withdrawal by Subject|1|||
129924517|NCT03462030|467689321|FG001|Overall Study|Withdrawal by Subject|1|||
129924518|NCT02598388|467689322|FG000|Overall Study|Lost to Follow-up|1|||
129924519|NCT02598388|467689323|FG001|Overall Study|Lost to Follow-up|0|||
129924520|NCT02598388|467689324|FG002|Overall Study|Lost to Follow-up|1|||
129924521|NCT02598388|467689325|FG003|Overall Study|Lost to Follow-up|0|||
129924522|NCT02598388|467689326|FG004|Overall Study|Lost to Follow-up|5|||
129924523|NCT02598388|467689327|FG005|Overall Study|Lost to Follow-up|1|||
129924524|NCT02598388|467689328|FG006|Overall Study|Lost to Follow-up|2|||
129924525|NCT02598388|467689329|FG007|Overall Study|Lost to Follow-up|1|||
129924526|NCT02598388|467689330|FG008|Overall Study|Lost to Follow-up|0|||
129924527|NCT02598388|467689331|FG009|Overall Study|Lost to Follow-up|0|||
129924528|NCT02598388|467689332|FG010|Overall Study|Lost to Follow-up|1|||
129924529|NCT02598388|467689333|FG011|Overall Study|Lost to Follow-up|0|||
129924530|NCT02598388|467689322|FG000|Overall Study|Withdrawal by Subject|0|||
129924531|NCT02598388|467689323|FG001|Overall Study|Withdrawal by Subject|0|||
129924532|NCT02598388|467689324|FG002|Overall Study|Withdrawal by Subject|0|||
129924533|NCT02598388|467689325|FG003|Overall Study|Withdrawal by Subject|0|||
129924534|NCT02598388|467689326|FG004|Overall Study|Withdrawal by Subject|2|||
129924535|NCT02598388|467689327|FG005|Overall Study|Withdrawal by Subject|0|||
129924536|NCT02598388|467689328|FG006|Overall Study|Withdrawal by Subject|2|||
129924537|NCT02598388|467689329|FG007|Overall Study|Withdrawal by Subject|0|||
129924538|NCT02598388|467689330|FG008|Overall Study|Withdrawal by Subject|0|||
129924539|NCT02598388|467689331|FG009|Overall Study|Withdrawal by Subject|1|||
129924540|NCT02598388|467689332|FG010|Overall Study|Withdrawal by Subject|0|||
129924541|NCT02598388|467689333|FG011|Overall Study|Withdrawal by Subject|0|||
129924542|NCT02598388|467689322|FG000|Overall Study|Other|0|||
129924543|NCT02598388|467689323|FG001|Overall Study|Other|0|||
129924544|NCT02598388|467689324|FG002|Overall Study|Other|1|||
129924545|NCT02598388|467689325|FG003|Overall Study|Other|0|||
129924546|NCT02598388|467689326|FG004|Overall Study|Other|3|||
129924547|NCT02598388|467689327|FG005|Overall Study|Other|0|||
129924548|NCT02598388|467689328|FG006|Overall Study|Other|1|||
129924549|NCT02598388|467689329|FG007|Overall Study|Other|0|||
129924550|NCT02598388|467689330|FG008|Overall Study|Other|0|||
129924551|NCT02598388|467689331|FG009|Overall Study|Other|0|||
129924552|NCT02598388|467689332|FG010|Overall Study|Other|0|||
129924553|NCT02598388|467689333|FG011|Overall Study|Other|0|||
129924554|NCT05020249|467689334|FG000|Overall Study|Protocol Violation|1|||
129924555|NCT05020249|467689335|FG001|Overall Study|Protocol Violation|0|||
129924556|NCT04971681|467689346|FG000|Followup|Lost to Follow-up|1|||
129924557|NCT04971681|467689347|FG001|Followup|Lost to Follow-up|0|||
129924558|NCT00686335|467689348|FG000|Run-in Period|Adverse Event|1|||
129924559|NCT00686335|467689348|FG000|Run-in Period|asthma exacerbation|1|||
129924560|NCT00686335|467689348|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
129924561|NCT04149704|467689349|FG000|Three Month Follow-up|Death|2|||
129924562|NCT04149704|467689350|FG001|Three Month Follow-up|Death|0|||
129924563|NCT04149704|467689351|FG002|Three Month Follow-up|Death|0|||
129924564|NCT04149704|467689352|FG003|Three Month Follow-up|Death|0|||
129924565|NCT04149704|467689349|FG000|Three Month Follow-up|Lost to Follow-up|1|||
129924566|NCT04149704|467689350|FG001|Three Month Follow-up|Lost to Follow-up|4|||
129924567|NCT04149704|467689351|FG002|Three Month Follow-up|Lost to Follow-up|5|||
129924568|NCT04149704|467689352|FG003|Three Month Follow-up|Lost to Follow-up|5|||
129924569|NCT04149704|467689349|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
129924570|NCT04149704|467689350|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
129924571|NCT04149704|467689351|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
129924572|NCT04149704|467689352|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
129924573|NCT04149704|467689349|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
129924574|NCT04149704|467689350|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
129924575|NCT04149704|467689351|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
129924576|NCT04149704|467689352|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
129924577|NCT02268253|467689353|FG000|Stage 1|Withdrawal by Subject|1|||
129924578|NCT02268253|467689354|FG001|Stage 1|Withdrawal by Subject|0|||
129924579|NCT02268253|467689355|FG002|Stage 1|Withdrawal by Subject|0|||
129924580|NCT02268253|467689356|FG003|Stage 1|Withdrawal by Subject|0|||
129924581|NCT02268253|467689357|FG004|Stage 1|Withdrawal by Subject|0|||
129924582|NCT02268253|467689358|FG005|Stage 1|Withdrawal by Subject|0|||
129924583|NCT02268253|467689359|FG006|Stage 1|Withdrawal by Subject|0|||
129924584|NCT02268253|467689353|FG000|Stage 1|Death|0|||
129924585|NCT02268253|467689354|FG001|Stage 1|Death|2|||
129924586|NCT02268253|467689355|FG002|Stage 1|Death|2|||
129924587|NCT02268253|467689356|FG003|Stage 1|Death|2|||
129924588|NCT02268253|467689357|FG004|Stage 1|Death|1|||
129924589|NCT02268253|467689358|FG005|Stage 1|Death|1|||
129924590|NCT02268253|467689359|FG006|Stage 1|Death|0|||
129924591|NCT02268253|467689353|FG000|Stage 2|Disease Recurrence/ Progression|0|||
129924592|NCT02268253|467689354|FG001|Stage 2|Disease Recurrence/ Progression|0|||
129924593|NCT02268253|467689355|FG002|Stage 2|Disease Recurrence/ Progression|1|||
129924594|NCT02268253|467689356|FG003|Stage 2|Disease Recurrence/ Progression|0|||
129924595|NCT02268253|467689357|FG004|Stage 2|Disease Recurrence/ Progression|0|||
129924596|NCT02268253|467689358|FG005|Stage 2|Disease Recurrence/ Progression|0|||
129924597|NCT02268253|467689359|FG006|Stage 2|Disease Recurrence/ Progression|0|||
129924598|NCT02268253|467689353|FG000|Stage 2|Withdrawal by Subject|0|||
129924599|NCT02268253|467689354|FG001|Stage 2|Withdrawal by Subject|0|||
129924600|NCT02268253|467689355|FG002|Stage 2|Withdrawal by Subject|2|||
129924601|NCT02268253|467689356|FG003|Stage 2|Withdrawal by Subject|0|||
129924602|NCT02268253|467689357|FG004|Stage 2|Withdrawal by Subject|0|||
129924603|NCT02268253|467689358|FG005|Stage 2|Withdrawal by Subject|2|||
129924604|NCT02268253|467689359|FG006|Stage 2|Withdrawal by Subject|0|||
129924605|NCT02268253|467689353|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924606|NCT02268253|467689354|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924607|NCT02268253|467689355|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
129924608|NCT02268253|467689356|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924609|NCT02268253|467689357|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924610|NCT02268253|467689358|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
129924611|NCT02268253|467689359|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
129924612|NCT02268253|467689353|FG000|Stage 2|Death|0|||
129924613|NCT02268253|467689354|FG001|Stage 2|Death|0|||
129924614|NCT02268253|467689355|FG002|Stage 2|Death|19|||
129924615|NCT02268253|467689356|FG003|Stage 2|Death|0|||
129924616|NCT02268253|467689357|FG004|Stage 2|Death|0|||
129924617|NCT02268253|467689358|FG005|Stage 2|Death|20|||
129924618|NCT02268253|467689359|FG006|Stage 2|Death|1|||
129924619|NCT02268253|467689353|FG000|Stage 2|Lost to Follow-up|0|||
129924620|NCT02268253|467689354|FG001|Stage 2|Lost to Follow-up|0|||
129924621|NCT02268253|467689355|FG002|Stage 2|Lost to Follow-up|0|||
129924622|NCT02268253|467689356|FG003|Stage 2|Lost to Follow-up|0|||
129924623|NCT02268253|467689357|FG004|Stage 2|Lost to Follow-up|0|||
129924624|NCT02268253|467689358|FG005|Stage 2|Lost to Follow-up|4|||
129924625|NCT02268253|467689359|FG006|Stage 2|Lost to Follow-up|0|||
129924626|NCT02268253|467689353|FG000|Stage 2|Transferred to Hospice|0|||
129924627|NCT02268253|467689354|FG001|Stage 2|Transferred to Hospice|0|||
129924628|NCT02268253|467689355|FG002|Stage 2|Transferred to Hospice|0|||
129924629|NCT02268253|467689356|FG003|Stage 2|Transferred to Hospice|0|||
129924630|NCT02268253|467689357|FG004|Stage 2|Transferred to Hospice|0|||
129924631|NCT02268253|467689358|FG005|Stage 2|Transferred to Hospice|2|||
129924632|NCT02268253|467689359|FG006|Stage 2|Transferred to Hospice|0|||
129924633|NCT02268253|467689353|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
129924634|NCT02268253|467689354|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
129924635|NCT02268253|467689355|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
129924636|NCT02268253|467689356|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
129924637|NCT02268253|467689357|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
129924638|NCT02268253|467689358|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
129924639|NCT02268253|467689359|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
129924640|NCT02268253|467689353|FG000|Stage 3A|Withdrawal by Subject|0|||
129924641|NCT02268253|467689354|FG001|Stage 3A|Withdrawal by Subject|0|||
129924642|NCT02268253|467689355|FG002|Stage 3A|Withdrawal by Subject|2|||
129924643|NCT02268253|467689356|FG003|Stage 3A|Withdrawal by Subject|0|||
129924644|NCT02268253|467689357|FG004|Stage 3A|Withdrawal by Subject|0|||
129924645|NCT02268253|467689358|FG005|Stage 3A|Withdrawal by Subject|0|||
129924646|NCT02268253|467689359|FG006|Stage 3A|Withdrawal by Subject|0|||
129924647|NCT02268253|467689353|FG000|Stage 3A|Physician Decision|0|||
129924648|NCT02268253|467689354|FG001|Stage 3A|Physician Decision|0|||
129924649|NCT02268253|467689355|FG002|Stage 3A|Physician Decision|2|||
129924650|NCT02268253|467689356|FG003|Stage 3A|Physician Decision|0|||
129924651|NCT02268253|467689357|FG004|Stage 3A|Physician Decision|0|||
129924652|NCT02268253|467689358|FG005|Stage 3A|Physician Decision|0|||
129924653|NCT02268253|467689359|FG006|Stage 3A|Physician Decision|0|||
129924654|NCT02268253|467689353|FG000|Stage 3A|Study Terminated by Sponsor|0|||
129924655|NCT02268253|467689354|FG001|Stage 3A|Study Terminated by Sponsor|0|||
129924656|NCT02268253|467689355|FG002|Stage 3A|Study Terminated by Sponsor|2|||
129924657|NCT02268253|467689356|FG003|Stage 3A|Study Terminated by Sponsor|0|||
129924658|NCT02268253|467689357|FG004|Stage 3A|Study Terminated by Sponsor|0|||
129924659|NCT02268253|467689358|FG005|Stage 3A|Study Terminated by Sponsor|0|||
129924660|NCT02268253|467689359|FG006|Stage 3A|Study Terminated by Sponsor|0|||
129924661|NCT02268253|467689353|FG000|Stage 3A|Lost to Follow-up|0|||
129924662|NCT02268253|467689354|FG001|Stage 3A|Lost to Follow-up|0|||
129924663|NCT02268253|467689355|FG002|Stage 3A|Lost to Follow-up|1|||
129924664|NCT02268253|467689356|FG003|Stage 3A|Lost to Follow-up|0|||
129924665|NCT02268253|467689357|FG004|Stage 3A|Lost to Follow-up|0|||
129924666|NCT02268253|467689358|FG005|Stage 3A|Lost to Follow-up|0|||
129924667|NCT02268253|467689359|FG006|Stage 3A|Lost to Follow-up|0|||
129924668|NCT02268253|467689353|FG000|Stage 3A|Death|0|||
129924669|NCT02268253|467689354|FG001|Stage 3A|Death|0|||
129924670|NCT02268253|467689355|FG002|Stage 3A|Death|5|||
129924671|NCT02268253|467689356|FG003|Stage 3A|Death|0|||
129924672|NCT02268253|467689357|FG004|Stage 3A|Death|0|||
129924673|NCT02268253|467689358|FG005|Stage 3A|Death|0|||
129924674|NCT02268253|467689359|FG006|Stage 3A|Death|0|||
129924675|NCT05672069|467689360|FG000|Overall Study|Implant removal|1|||
129924676|NCT05672069|467689360|FG000|Overall Study|Lost to Follow-up|2|||
129924677|NCT05949788|467689361|FG000|Overall Study|severe birth deformity|2|||
129924678|NCT05949788|467689362|FG001|Overall Study|severe birth deformity|7|||
129924679|NCT05949788|467689361|FG000|Overall Study|twin-twin transfusion syndrome|2|||
129924680|NCT05949788|467689362|FG001|Overall Study|twin-twin transfusion syndrome|7|||
129924681|NCT05949788|467689361|FG000|Overall Study|neonatal hemolytic disease|3|||
129924682|NCT05949788|467689362|FG001|Overall Study|neonatal hemolytic disease|8|||
129924683|NCT05949788|467689361|FG000|Overall Study|death within 14 days after birth|2|||
129924684|NCT05949788|467689362|FG001|Overall Study|death within 14 days after birth|6|||
129924685|NCT05949788|467689361|FG000|Overall Study|transfer to another hospital|2|||
129924686|NCT05949788|467689362|FG001|Overall Study|transfer to another hospital|6|||
129924687|NCT05213390|467689363|FG000|Overall Study|Withdrawal by Subject|2|||
129924688|NCT05213390|467689363|FG000|Overall Study|Lost to Follow-up|12|||
129924689|NCT05213390|467689363|FG000|Overall Study|Protocol Violation|9|||
129924690|NCT01824537|467689364|FG000|Overall Study|Lost to Follow-up|78|||
129924691|NCT01824537|467689365|FG001|Overall Study|Lost to Follow-up|87|||
129924692|NCT03808818|467689380|FG000|Overall Study|Death|6|||
129924693|NCT03808818|467689381|FG001|Overall Study|Death|6|||
129924694|NCT03808818|467689380|FG000|Overall Study|Withdrawal by Subject|7|||
129924695|NCT03808818|467689381|FG001|Overall Study|Withdrawal by Subject|18|||
129924696|NCT03808818|467689380|FG000|Overall Study|Lost to Follow-up|31|||
129924697|NCT03808818|467689381|FG001|Overall Study|Lost to Follow-up|33|||
129924698|NCT02191618|467689388|FG000|Overall Study|Withdrawal by Subject|3|||
129924699|NCT02191618|467689388|FG000|Overall Study|Missed Visit|4|||
129924700|NCT03031470|467689390|FG000|Overall Study|Adverse Event|3|||
129924701|NCT03031470|467689391|FG001|Overall Study|Adverse Event|0|||
129450409|NCT02844816|465947407|FG000|Overall Study|Participant refusal|5|||
129450410|NCT02844816|465947408|FG001|Overall Study|Participant refusal|5|||
129450411|NCT02844816|465947407|FG000|Overall Study|Adverse Event|5|||
129450412|NCT02844816|465947408|FG001|Overall Study|Adverse Event|4|||
129450413|NCT02844816|465947407|FG000|Overall Study|Death|0|||
129450414|NCT02844816|465947408|FG001|Overall Study|Death|1|||
129450415|NCT02844816|465947407|FG000|Overall Study|Disease progression/recurrence|50|||
129450416|NCT02844816|465947408|FG001|Overall Study|Disease progression/recurrence|24|||
129450417|NCT02844816|465947407|FG000|Overall Study|Physician Decision|1|||
129924702|NCT03031470|467689390|FG000|Overall Study|Death|3|||
129924703|NCT03031470|467689391|FG001|Overall Study|Death|1|||
129924704|NCT03031470|467689390|FG000|Overall Study|Lost to Follow-up|1|||
129924705|NCT03031470|467689391|FG001|Overall Study|Lost to Follow-up|1|||
129924706|NCT03031470|467689390|FG000|Overall Study|Withdrawal by Subject|1|||
129924707|NCT03031470|467689391|FG001|Overall Study|Withdrawal by Subject|0|||
129924708|NCT03031470|467689390|FG000|Overall Study|Protocol entry criteria not met|0|||
129924709|NCT03031470|467689391|FG001|Overall Study|Protocol entry criteria not met|1|||
129924710|NCT03031470|467689390|FG000|Overall Study|Cancel the operation|0|||
129924711|NCT03031470|467689391|FG001|Overall Study|Cancel the operation|1|||
129924712|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
129924713|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
129924714|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
129924715|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
129924716|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
129924717|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
129924718|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
129924719|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
129924720|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
129924721|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
129924722|NCT03461276|467689392|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
129924723|NCT03461276|467689393|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
129924724|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
129924725|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
129924726|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
129924727|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
129450418|NCT02844816|465947408|FG001|Overall Study|Physician Decision|1|||
129924728|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
129924729|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
129924730|NCT03461276|467689392|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
129924731|NCT03461276|467689393|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
129924732|NCT04663737|467689397|FG000|Overall Study|Withdrawal by Subject|2|||
129924733|NCT04663737|467689398|FG001|Overall Study|Withdrawal by Subject|0|||
129924734|NCT01943409|467689402|FG000|Overall Study|resumed oral/entral|24|||
129924735|NCT01943409|467689403|FG001|Overall Study|resumed oral/entral|20|||
129924736|NCT01943409|467689402|FG000|Overall Study|Protocol Violation|14|||
129924737|NCT01943409|467689403|FG001|Overall Study|Protocol Violation|24|||
129924738|NCT01943409|467689402|FG000|Overall Study|Death|3|||
129924739|NCT01943409|467689403|FG001|Overall Study|Death|1|||
129924740|NCT01943409|467689402|FG000|Overall Study|Withdrawal by Subject|4|||
129924741|NCT01943409|467689403|FG001|Overall Study|Withdrawal by Subject|3|||
129924742|NCT02310646|467689404|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
129924743|NCT02310646|467689405|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
129924744|NCT02310646|467689404|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
129924745|NCT02310646|467689405|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
129924746|NCT04700163|467689406|FG000|Overall Study|Lost to Follow-up|0|||
129924747|NCT04700163|467689407|FG001|Overall Study|Lost to Follow-up|0|||
129924748|NCT04700163|467689408|FG002|Overall Study|Lost to Follow-up|0|||
129924749|NCT04700163|467689409|FG003|Overall Study|Lost to Follow-up|0|||
129924750|NCT04700163|467689410|FG004|Overall Study|Lost to Follow-up|0|||
129924751|NCT04700163|467689411|FG005|Overall Study|Lost to Follow-up|1|||
129924752|NCT03865498|467689418|FG000|Overall Study|Lack of Efficacy|12|||
129924753|NCT03865498|467689419|FG001|Overall Study|Lack of Efficacy|11|||
129924754|NCT03865498|467689418|FG000|Overall Study|Lost to Follow-up|125|||
129924755|NCT03865498|467689419|FG001|Overall Study|Lost to Follow-up|133|||
129924756|NCT03865498|467689418|FG000|Overall Study|Withdrawal by Subject|2|||
129924757|NCT03865498|467689419|FG001|Overall Study|Withdrawal by Subject|4|||
129924758|NCT05869383|467689420|FG000|Overall Study|Withdrawal by Subject|2|||
129924759|NCT05869383|467689421|FG001|Overall Study|Withdrawal by Subject|0|||
129924760|NCT04137367|467689422|FG000|Overall Study|Lost to Follow-up|8|||
129924761|NCT04137367|467689423|FG001|Overall Study|Lost to Follow-up|6|||
129924762|NCT04137367|467689424|FG002|Overall Study|Lost to Follow-up|4|||
129924763|NCT03907878|467689425|FG000|Treatment Period|Withdrawal by Subject|5|||
129924764|NCT03907878|467689425|FG000|Treatment Period|Adverse Event|4|||
129924765|NCT03907878|467689425|FG000|Treatment Period|Lack of Efficacy|1|||
129924766|NCT03907878|467689425|FG000|Treatment Period|Protocol Violation|1|||
129924767|NCT03907878|467689425|FG000|Follow-up Period|Adverse Event|3|||
129924768|NCT03907878|467689425|FG000|Follow-up Period|Withdrawal by Subject|3|||
129924769|NCT05144009|467689426|FG000|Overall Study|Lost to Follow-up|0|||
129924770|NCT05144009|467689427|FG001|Overall Study|Lost to Follow-up|1|||
129924771|NCT05144009|467689426|FG000|Overall Study|Study Termination by the Sponsor|11|||
129924772|NCT05144009|467689427|FG001|Overall Study|Study Termination by the Sponsor|11|||
129924773|NCT05144009|467689426|FG000|Overall Study|Disease Progression|1|||
129924774|NCT05144009|467689427|FG001|Overall Study|Disease Progression|0|||
129924775|NCT05144009|467689426|FG000|Overall Study|Participant Decision|0|||
129924776|NCT05144009|467689427|FG001|Overall Study|Participant Decision|2|||
129924777|NCT05144009|467689426|FG000|Overall Study|Death|5|||
129924778|NCT05144009|467689427|FG001|Overall Study|Death|10|||
129924779|NCT04499924|467689428|FG000|Overall Study|Study termination by sponsor|4|||
129924780|NCT04499924|467689429|FG001|Overall Study|Study termination by sponsor|6|||
129924781|NCT04499924|467689428|FG000|Overall Study|Withdrawal by Subject|1|||
129924782|NCT04499924|467689429|FG001|Overall Study|Withdrawal by Subject|3|||
129924783|NCT01648023|467689434|FG000|Overall Study|Screen Fail Post Randomization|1|||
129924784|NCT01648023|467689435|FG001|Overall Study|Screen Fail Post Randomization|2|||
129924785|NCT02231164|467689442|FG000|Overall Study|Adverse Event|1|||
129924786|NCT02231164|467689443|FG001|Overall Study|Adverse Event|1|||
129924787|NCT02231164|467689442|FG000|Overall Study|Lack of Efficacy|4|||
129924788|NCT02231164|467689443|FG001|Overall Study|Lack of Efficacy|3|||
129924789|NCT02231164|467689442|FG000|Overall Study|Withdrawal by Subject|1|||
129924790|NCT02231164|467689443|FG001|Overall Study|Withdrawal by Subject|2|||
129924791|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
129924792|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
129924793|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
129924794|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
129924795|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
129924796|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
129450419|NCT02717754|465947410|FG000|Overall Study|Incorrect Infusion Duration|0|||
129450420|NCT02717754|465947411|FG001|Overall Study|Incorrect Infusion Duration|0|||
129450421|NCT02717754|465947412|FG002|Overall Study|Incorrect Infusion Duration|0|||
129924797|NCT02547363|467689444|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
129924798|NCT02547363|467689445|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
129924799|NCT02547363|467689444|FG000|12-month Follow-up|Withdrawal by Subject|4|||
129924800|NCT02547363|467689445|FG001|12-month Follow-up|Withdrawal by Subject|3|||
129924801|NCT02547363|467689444|FG000|12-month Follow-up|Lost to Follow-up|4|||
129924802|NCT02547363|467689445|FG001|12-month Follow-up|Lost to Follow-up|1|||
129924803|NCT02547363|467689444|FG000|12-month Follow-up|Lack of Efficacy|1|||
129924804|NCT02547363|467689445|FG001|12-month Follow-up|Lack of Efficacy|1|||
129924805|NCT02547363|467689444|FG000|12-month Follow-up|Other|1|||
129924806|NCT02547363|467689445|FG001|12-month Follow-up|Other|0|||
129924807|NCT05281562|467689448|FG000|Overall Study|Ineligible patient|1|||
129924808|NCT05281562|467689449|FG001|Overall Study|Ineligible patient|0|||
129924809|NCT04436276|467689450|FG000|Overall Study|Adverse Event|0|||
129924810|NCT04436276|467689451|FG001|Overall Study|Adverse Event|0|||
129924811|NCT04436276|467689452|FG002|Overall Study|Adverse Event|0|||
129924812|NCT04436276|467689453|FG003|Overall Study|Adverse Event|0|||
129924813|NCT04436276|467689454|FG004|Overall Study|Adverse Event|0|||
129924814|NCT04436276|467689455|FG005|Overall Study|Adverse Event|0|||
129924815|NCT04436276|467689456|FG006|Overall Study|Adverse Event|0|||
129924816|NCT04436276|467689457|FG007|Overall Study|Adverse Event|0|||
129924817|NCT04436276|467689458|FG008|Overall Study|Adverse Event|0|||
129924818|NCT04436276|467689459|FG009|Overall Study|Adverse Event|0|||
129924819|NCT04436276|467689460|FG010|Overall Study|Adverse Event|0|||
129924820|NCT04436276|467689461|FG011|Overall Study|Adverse Event|0|||
129924821|NCT04436276|467689462|FG012|Overall Study|Adverse Event|0|||
129924822|NCT04436276|467689463|FG013|Overall Study|Adverse Event|0|||
129924823|NCT04436276|467689464|FG014|Overall Study|Adverse Event|0|||
129924824|NCT04436276|467689465|FG015|Overall Study|Adverse Event|0|||
129924825|NCT04436276|467689466|FG016|Overall Study|Adverse Event|1|||
129924826|NCT04436276|467689467|FG017|Overall Study|Adverse Event|0|||
129924827|NCT04436276|467689468|FG018|Overall Study|Adverse Event|0|||
129924828|NCT04436276|467689469|FG019|Overall Study|Adverse Event|0|||
129924829|NCT04436276|467689470|FG020|Overall Study|Adverse Event|0|||
129924830|NCT04436276|467689471|FG021|Overall Study|Adverse Event|0|||
129924831|NCT04436276|467689472|FG022|Overall Study|Adverse Event|0|||
129924832|NCT04436276|467689450|FG000|Overall Study|Death|0|||
129924833|NCT04436276|467689451|FG001|Overall Study|Death|0|||
129924834|NCT04436276|467689452|FG002|Overall Study|Death|0|||
129924835|NCT04436276|467689453|FG003|Overall Study|Death|0|||
129924836|NCT04436276|467689454|FG004|Overall Study|Death|0|||
129924837|NCT04436276|467689455|FG005|Overall Study|Death|0|||
129924838|NCT04436276|467689456|FG006|Overall Study|Death|0|||
129924839|NCT04436276|467689457|FG007|Overall Study|Death|0|||
129924840|NCT04436276|467689458|FG008|Overall Study|Death|0|||
129924841|NCT04436276|467689459|FG009|Overall Study|Death|0|||
129924842|NCT04436276|467689460|FG010|Overall Study|Death|0|||
129924843|NCT04436276|467689461|FG011|Overall Study|Death|0|||
129924844|NCT04436276|467689462|FG012|Overall Study|Death|1|||
129924845|NCT04436276|467689463|FG013|Overall Study|Death|0|||
129924846|NCT04436276|467689464|FG014|Overall Study|Death|1|||
129924847|NCT04436276|467689465|FG015|Overall Study|Death|0|||
129924848|NCT04436276|467689466|FG016|Overall Study|Death|0|||
129924849|NCT04436276|467689467|FG017|Overall Study|Death|0|||
129924850|NCT04436276|467689468|FG018|Overall Study|Death|0|||
129924851|NCT04436276|467689469|FG019|Overall Study|Death|2|||
129924852|NCT04436276|467689470|FG020|Overall Study|Death|0|||
129924853|NCT04436276|467689471|FG021|Overall Study|Death|1|||
129924854|NCT04436276|467689472|FG022|Overall Study|Death|0|||
129924855|NCT04436276|467689450|FG000|Overall Study|Lost to Follow-up|0|||
129924856|NCT04436276|467689451|FG001|Overall Study|Lost to Follow-up|2|||
129924857|NCT04436276|467689452|FG002|Overall Study|Lost to Follow-up|2|||
129924858|NCT04436276|467689453|FG003|Overall Study|Lost to Follow-up|1|||
129924859|NCT04436276|467689454|FG004|Overall Study|Lost to Follow-up|4|||
129924860|NCT04436276|467689455|FG005|Overall Study|Lost to Follow-up|1|||
129924861|NCT04436276|467689456|FG006|Overall Study|Lost to Follow-up|0|||
129924862|NCT04436276|467689457|FG007|Overall Study|Lost to Follow-up|0|||
129924863|NCT04436276|467689458|FG008|Overall Study|Lost to Follow-up|1|||
129924864|NCT04436276|467689459|FG009|Overall Study|Lost to Follow-up|0|||
129924865|NCT04436276|467689460|FG010|Overall Study|Lost to Follow-up|5|||
129924866|NCT04436276|467689461|FG011|Overall Study|Lost to Follow-up|5|||
129924867|NCT04436276|467689462|FG012|Overall Study|Lost to Follow-up|4|||
129924868|NCT04436276|467689463|FG013|Overall Study|Lost to Follow-up|1|||
129924869|NCT04436276|467689464|FG014|Overall Study|Lost to Follow-up|7|||
129924870|NCT04436276|467689465|FG015|Overall Study|Lost to Follow-up|7|||
129924871|NCT04436276|467689466|FG016|Overall Study|Lost to Follow-up|1|||
129924872|NCT04436276|467689467|FG017|Overall Study|Lost to Follow-up|0|||
129924873|NCT04436276|467689468|FG018|Overall Study|Lost to Follow-up|1|||
129924874|NCT04436276|467689469|FG019|Overall Study|Lost to Follow-up|1|||
129924875|NCT04436276|467689470|FG020|Overall Study|Lost to Follow-up|2|||
129924876|NCT04436276|467689471|FG021|Overall Study|Lost to Follow-up|1|||
129924877|NCT04436276|467689472|FG022|Overall Study|Lost to Follow-up|1|||
129924878|NCT04436276|467689450|FG000|Overall Study|Physician Decision|1|||
129924879|NCT04436276|467689451|FG001|Overall Study|Physician Decision|0|||
129924880|NCT04436276|467689452|FG002|Overall Study|Physician Decision|2|||
129924881|NCT04436276|467689453|FG003|Overall Study|Physician Decision|1|||
129924882|NCT04436276|467689454|FG004|Overall Study|Physician Decision|0|||
129924883|NCT04436276|467689455|FG005|Overall Study|Physician Decision|0|||
129924884|NCT04436276|467689456|FG006|Overall Study|Physician Decision|0|||
129924885|NCT04436276|467689457|FG007|Overall Study|Physician Decision|0|||
129924886|NCT04436276|467689458|FG008|Overall Study|Physician Decision|0|||
129924887|NCT04436276|467689459|FG009|Overall Study|Physician Decision|0|||
129924888|NCT04436276|467689460|FG010|Overall Study|Physician Decision|0|||
129924889|NCT04436276|467689461|FG011|Overall Study|Physician Decision|1|||
129924890|NCT04436276|467689462|FG012|Overall Study|Physician Decision|2|||
129924891|NCT04436276|467689463|FG013|Overall Study|Physician Decision|0|||
129924892|NCT04436276|467689464|FG014|Overall Study|Physician Decision|0|||
129924893|NCT04436276|467689465|FG015|Overall Study|Physician Decision|0|||
129924894|NCT04436276|467689466|FG016|Overall Study|Physician Decision|0|||
129924895|NCT04436276|467689467|FG017|Overall Study|Physician Decision|0|||
129924896|NCT04436276|467689468|FG018|Overall Study|Physician Decision|0|||
129924897|NCT04436276|467689469|FG019|Overall Study|Physician Decision|0|||
129924898|NCT04436276|467689470|FG020|Overall Study|Physician Decision|1|||
129924899|NCT04436276|467689471|FG021|Overall Study|Physician Decision|2|||
129924900|NCT04436276|467689472|FG022|Overall Study|Physician Decision|0|||
129924901|NCT04436276|467689450|FG000|Overall Study|Protocol Violation|0|||
129924902|NCT04436276|467689451|FG001|Overall Study|Protocol Violation|0|||
129924903|NCT04436276|467689452|FG002|Overall Study|Protocol Violation|0|||
129924904|NCT04436276|467689453|FG003|Overall Study|Protocol Violation|0|||
129924905|NCT04436276|467689454|FG004|Overall Study|Protocol Violation|0|||
129924906|NCT04436276|467689455|FG005|Overall Study|Protocol Violation|0|||
129924907|NCT04436276|467689456|FG006|Overall Study|Protocol Violation|0|||
129924908|NCT04436276|467689457|FG007|Overall Study|Protocol Violation|0|||
129924909|NCT04436276|467689458|FG008|Overall Study|Protocol Violation|0|||
129924910|NCT04436276|467689459|FG009|Overall Study|Protocol Violation|0|||
129924911|NCT04436276|467689460|FG010|Overall Study|Protocol Violation|0|||
129924912|NCT04436276|467689461|FG011|Overall Study|Protocol Violation|0|||
129924913|NCT04436276|467689462|FG012|Overall Study|Protocol Violation|0|||
129924914|NCT04436276|467689463|FG013|Overall Study|Protocol Violation|1|||
129924915|NCT04436276|467689464|FG014|Overall Study|Protocol Violation|0|||
129924916|NCT04436276|467689465|FG015|Overall Study|Protocol Violation|1|||
129924917|NCT04436276|467689466|FG016|Overall Study|Protocol Violation|0|||
129924918|NCT04436276|467689467|FG017|Overall Study|Protocol Violation|0|||
129924919|NCT04436276|467689468|FG018|Overall Study|Protocol Violation|0|||
129924920|NCT04436276|467689469|FG019|Overall Study|Protocol Violation|0|||
129924921|NCT04436276|467689470|FG020|Overall Study|Protocol Violation|0|||
129924922|NCT04436276|467689471|FG021|Overall Study|Protocol Violation|0|||
129924923|NCT04436276|467689472|FG022|Overall Study|Protocol Violation|0|||
129924924|NCT04436276|467689450|FG000|Overall Study|Withdrawal by Subject|25|||
129924925|NCT04436276|467689451|FG001|Overall Study|Withdrawal by Subject|22|||
129924926|NCT04436276|467689452|FG002|Overall Study|Withdrawal by Subject|24|||
129924927|NCT04436276|467689453|FG003|Overall Study|Withdrawal by Subject|23|||
129924928|NCT04436276|467689454|FG004|Overall Study|Withdrawal by Subject|14|||
129924929|NCT04436276|467689455|FG005|Overall Study|Withdrawal by Subject|0|||
129924930|NCT04436276|467689456|FG006|Overall Study|Withdrawal by Subject|0|||
129924931|NCT04436276|467689457|FG007|Overall Study|Withdrawal by Subject|1|||
129924932|NCT04436276|467689458|FG008|Overall Study|Withdrawal by Subject|0|||
129924933|NCT04436276|467689459|FG009|Overall Study|Withdrawal by Subject|1|||
129924934|NCT04436276|467689460|FG010|Overall Study|Withdrawal by Subject|17|||
129924935|NCT04436276|467689461|FG011|Overall Study|Withdrawal by Subject|7|||
129924936|NCT04436276|467689462|FG012|Overall Study|Withdrawal by Subject|10|||
129924937|NCT04436276|467689463|FG013|Overall Study|Withdrawal by Subject|6|||
129924938|NCT04436276|467689464|FG014|Overall Study|Withdrawal by Subject|20|||
129924939|NCT04436276|467689465|FG015|Overall Study|Withdrawal by Subject|6|||
129924940|NCT04436276|467689466|FG016|Overall Study|Withdrawal by Subject|11|||
129924941|NCT04436276|467689467|FG017|Overall Study|Withdrawal by Subject|4|||
129924942|NCT04436276|467689468|FG018|Overall Study|Withdrawal by Subject|14|||
129924943|NCT04436276|467689469|FG019|Overall Study|Withdrawal by Subject|24|||
129924944|NCT04436276|467689470|FG020|Overall Study|Withdrawal by Subject|24|||
129924945|NCT04436276|467689471|FG021|Overall Study|Withdrawal by Subject|16|||
129924946|NCT04436276|467689472|FG022|Overall Study|Withdrawal by Subject|14|||
129924947|NCT04436276|467689450|FG000|Overall Study|Other|3|||
129924948|NCT04436276|467689451|FG001|Overall Study|Other|2|||
129924949|NCT04436276|467689452|FG002|Overall Study|Other|5|||
129924950|NCT04436276|467689453|FG003|Overall Study|Other|9|||
129924951|NCT04436276|467689454|FG004|Overall Study|Other|23|||
129924952|NCT04436276|467689455|FG005|Overall Study|Other|1|||
129924953|NCT04436276|467689456|FG006|Overall Study|Other|0|||
129924954|NCT04436276|467689457|FG007|Overall Study|Other|0|||
129924955|NCT04436276|467689458|FG008|Overall Study|Other|0|||
129924956|NCT04436276|467689459|FG009|Overall Study|Other|0|||
129924957|NCT04436276|467689460|FG010|Overall Study|Other|3|||
129924958|NCT04436276|467689461|FG011|Overall Study|Other|1|||
129924959|NCT04436276|467689462|FG012|Overall Study|Other|1|||
129924960|NCT04436276|467689463|FG013|Overall Study|Other|2|||
129924961|NCT04436276|467689464|FG014|Overall Study|Other|3|||
129924962|NCT04436276|467689465|FG015|Overall Study|Other|0|||
129924963|NCT04436276|467689466|FG016|Overall Study|Other|0|||
129924964|NCT04436276|467689467|FG017|Overall Study|Other|6|||
129924965|NCT04436276|467689468|FG018|Overall Study|Other|1|||
129924966|NCT04436276|467689469|FG019|Overall Study|Other|0|||
129924967|NCT04436276|467689470|FG020|Overall Study|Other|2|||
129924968|NCT04436276|467689471|FG021|Overall Study|Other|2|||
129924969|NCT04436276|467689472|FG022|Overall Study|Other|60|||
129924970|NCT05977530|467689474|FG000|Overall Study|Withdrawal by Subject|1|||
129924971|NCT05977530|467689474|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
129924972|NCT00506519|467691031|FG000|Overall Study|Death|4|||
129924973|NCT00506519|467691032|FG001|Overall Study|Death|6|||
129924974|NCT00506519|467691033|FG002|Overall Study|Death|0|||
129924975|NCT00506519|467691031|FG000|Overall Study|Adverse Event|1|||
129924976|NCT00506519|467691032|FG001|Overall Study|Adverse Event|0|||
129924977|NCT00506519|467691033|FG002|Overall Study|Adverse Event|0|||
129924978|NCT01129102|467691034|FG000|Overall Study|No study drug treatment|2|||
129924979|NCT01129102|467691035|FG001|Overall Study|No study drug treatment|3|||
129924980|NCT01129102|467691036|FG002|Overall Study|No study drug treatment|1|||
129924981|NCT01129102|467691034|FG000|Overall Study|Withdrawal by Subject|2|||
129924982|NCT01129102|467691035|FG001|Overall Study|Withdrawal by Subject|0|||
129924983|NCT01129102|467691036|FG002|Overall Study|Withdrawal by Subject|3|||
129924984|NCT01129102|467691034|FG000|Overall Study|Protocol Violation|0|||
129924985|NCT01129102|467691035|FG001|Overall Study|Protocol Violation|1|||
129924986|NCT01129102|467691036|FG002|Overall Study|Protocol Violation|1|||
129924987|NCT01129102|467691034|FG000|Overall Study|Pregnancy|0|||
129924988|NCT01129102|467691035|FG001|Overall Study|Pregnancy|0|||
129924989|NCT01129102|467691036|FG002|Overall Study|Pregnancy|1|||
129924990|NCT01129102|467691034|FG000|Overall Study|Adverse Event|2|||
129924991|NCT01129102|467691035|FG001|Overall Study|Adverse Event|2|||
129924992|NCT01129102|467691036|FG002|Overall Study|Adverse Event|1|||
129924993|NCT01129102|467691034|FG000|Overall Study|Lost to Follow-up|2|||
129924994|NCT01129102|467691035|FG001|Overall Study|Lost to Follow-up|0|||
129924995|NCT01129102|467691036|FG002|Overall Study|Lost to Follow-up|0|||
129924996|NCT03379675|467691037|FG000|Overall Study|Lost to Follow-up|0|||
129924997|NCT03379675|467691038|FG001|Overall Study|Lost to Follow-up|1|||
129924998|NCT03379675|467691039|FG002|Overall Study|Lost to Follow-up|0|||
129924999|NCT03379675|467691037|FG000|Overall Study|Adverse Event|2|||
129925000|NCT03379675|467691038|FG001|Overall Study|Adverse Event|0|||
129925001|NCT03379675|467691039|FG002|Overall Study|Adverse Event|0|||
129925002|NCT03379675|467691037|FG000|Overall Study|Withdrawal by Subject|2|||
129925003|NCT03379675|467691038|FG001|Overall Study|Withdrawal by Subject|1|||
129925004|NCT03379675|467691039|FG002|Overall Study|Withdrawal by Subject|2|||
129925005|NCT02979327|467691041|FG000|First Intervention|Protocol Violation|1|||
129925006|NCT02979327|467691042|FG001|First Intervention|Protocol Violation|0|||
129925007|NCT03474679|467691051|FG000|Overall Study|Death|7|||
129925008|NCT03474679|467691051|FG000|Overall Study|Withdrawal by Subject|1|||
129925009|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
129925010|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
129925011|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
129925012|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
129925013|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
129925014|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
129925015|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Death|6|||
129925016|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Death|0|||
129925017|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Death|0|||
129925018|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
129925019|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
129925020|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
129925021|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
129925022|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
129925023|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
129925024|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
129925025|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
129925026|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
129925027|NCT01539083|467691054|FG000|Before Randomization (VCD Induction)|Other|5|||
129925028|NCT01539083|467691055|FG001|Before Randomization (VCD Induction)|Other|0|||
129925029|NCT01539083|467691056|FG002|Before Randomization (VCD Induction)|Other|0|||
129925030|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
129925031|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
129925032|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
129925033|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Other|0|||
129925034|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Other|1|||
129925035|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Other|1|||
129925036|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
129925037|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
129925038|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
129925039|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
129925040|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
129925041|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
129925042|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
129925043|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
129925044|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
129925045|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
129925046|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
129925047|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
129925048|NCT01539083|467691054|FG000|After Randomization (TP and VTP)|Death|0|||
129925049|NCT01539083|467691055|FG001|After Randomization (TP and VTP)|Death|6|||
129925050|NCT01539083|467691056|FG002|After Randomization (TP and VTP)|Death|11|||
129925051|NCT02573493|467691057|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
129925052|NCT02573493|467691058|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
129925053|NCT02573493|467691059|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
129925054|NCT02573493|467691060|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
129925055|NCT04332926|467691061|FG000|Overall Study|Withdrawal by Subject|6|||
129925056|NCT04332926|467691061|FG000|Overall Study|Physician Decision|6|||
129925057|NCT04016662|467691071|FG000|Run-In Phase|Death|1|||
129925058|NCT04016662|467691071|FG000|Run-In Phase|Withdrawal by Subject|11|||
129925059|NCT04016662|467691071|FG000|Run-In Phase|Not meeting screening eligibility|9|||
129925060|NCT04016662|467691071|FG000|Run-In Phase|Physician Decision|3|||
129925061|NCT04016662|467691071|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
129925062|NCT04016662|467691071|FG000|PLGS (12 Weeks)|Death|1|||
129925063|NCT04016662|467691071|FG000|SAP (12 Weeks)|Death|1|||
129925064|NCT01802788|467691072|FG000|Overall Study|Withdrawal by Subject|102|||
129925065|NCT01802788|467691073|FG001|Overall Study|Withdrawal by Subject|5|||
129925066|NCT01802788|467691072|FG000|Overall Study|Death|382|||
129925067|NCT01802788|467691073|FG001|Overall Study|Death|18|||
129925068|NCT01802788|467691072|FG000|Overall Study|Lost to Follow-up|31|||
129925069|NCT01802788|467691073|FG001|Overall Study|Lost to Follow-up|2|||
129925070|NCT01802788|467691072|FG000|Overall Study|Physician Decision|3|||
129925071|NCT01802788|467691073|FG001|Overall Study|Physician Decision|0|||
129925072|NCT01802788|467691072|FG000|Overall Study|Patient Non-Compliance|1|||
129925073|NCT01802788|467691073|FG001|Overall Study|Patient Non-Compliance|0|||
129925074|NCT01802788|467691072|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
129925075|NCT01802788|467691073|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
129925076|NCT01802788|467691072|FG000|Overall Study|Other Reasons|19|||
129925077|NCT01802788|467691073|FG001|Overall Study|Other Reasons|0|||
129925078|NCT03021096|467691074|FG000|Overall Study|Lost to Follow-up|4|||
129925079|NCT03021096|467691074|FG000|Overall Study|Protocol Violation|2|||
129925080|NCT03904147|467691079|FG000|Overall Study|Death|15|||
129925081|NCT03904147|467691080|FG001|Overall Study|Death|13|||
129925082|NCT03904147|467691081|FG002|Overall Study|Death|15|||
129925083|NCT03904147|467691079|FG000|Overall Study|Withdrawal by Subject|7|||
129925084|NCT03904147|467691080|FG001|Overall Study|Withdrawal by Subject|12|||
129925085|NCT03904147|467691081|FG002|Overall Study|Withdrawal by Subject|1|||
129925086|NCT03904147|467691079|FG000|Overall Study|1Y visit completed after 365 days|1|||
129925087|NCT03904147|467691080|FG001|Overall Study|1Y visit completed after 365 days|1|||
129925088|NCT03904147|467691081|FG002|Overall Study|1Y visit completed after 365 days|0|||
129925089|NCT00764751|467691089|FG000|Overall Study|Adverse Event|1|||
129925090|NCT00764751|467691090|FG001|Overall Study|Adverse Event|1|||
129925091|NCT00764751|467691089|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
129925092|NCT00764751|467691090|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
129925093|NCT03011333|467691096|FG000|Overall Study|Lost to Follow-up|0|||
129925094|NCT03011333|467691097|FG001|Overall Study|Lost to Follow-up|1|||
129925095|NCT03011333|467691098|FG002|Overall Study|Lost to Follow-up|0|||
129925096|NCT03011333|467691099|FG003|Overall Study|Lost to Follow-up|1|||
129925097|NCT03011333|467691100|FG004|Overall Study|Lost to Follow-up|4|||
129925098|NCT03011333|467691101|FG005|Overall Study|Lost to Follow-up|4|||
129925099|NCT03011333|467691102|FG006|Overall Study|Lost to Follow-up|5|||
129925100|NCT02998268|467691106|FG000|Overall Study|Adverse Event|0|||
129925101|NCT02998268|467691107|FG001|Overall Study|Adverse Event|2|||
129450422|NCT02717754|465947413|FG003|Overall Study|Incorrect Infusion Duration|10|||
129925102|NCT02998268|467691106|FG000|Overall Study|Withdrawal by Subject|0|||
129925103|NCT02998268|467691107|FG001|Overall Study|Withdrawal by Subject|1|||
129925104|NCT05269667|467691108|FG000|Overall Study|Study Terminated by Sponsor|4|||
129450423|NCT02717754|465947414|FG004|Overall Study|Incorrect Infusion Duration|20|||
129925105|NCT04413708|467691109|FG000|Overall Study|Lost to Follow-up|1|||
129925106|NCT04413708|467691110|FG001|Overall Study|Lost to Follow-up|2|||
129925107|NCT05399459|467691121|FG000|Overall Study|Randomized but not treated|29|||
129925108|NCT05399459|467691122|FG001|Overall Study|Randomized but not treated|30|||
129925109|NCT05399459|467691123|FG002|Overall Study|Randomized but not treated|38|||
129925110|NCT05399459|467691121|FG000|Overall Study|Lost to Follow-up|1|||
129925111|NCT05399459|467691122|FG001|Overall Study|Lost to Follow-up|0|||
129925112|NCT05399459|467691123|FG002|Overall Study|Lost to Follow-up|0|||
129925113|NCT03020199|467691126|FG000|Treatment Period|Adverse Event|0|||
129925114|NCT03020199|467691127|FG001|Treatment Period|Adverse Event|2|||
129925115|NCT03020199|467691126|FG000|Treatment Period|Lack of Efficacy|1|||
129925116|NCT03020199|467691127|FG001|Treatment Period|Lack of Efficacy|6|||
129925117|NCT03020199|467691126|FG000|Treatment Period|Lost to Follow-up|1|||
129925118|NCT03020199|467691127|FG001|Treatment Period|Lost to Follow-up|6|||
129925119|NCT03020199|467691126|FG000|Treatment Period|Physician Decision|0|||
129925120|NCT03020199|467691127|FG001|Treatment Period|Physician Decision|1|||
129925121|NCT03020199|467691126|FG000|Treatment Period|Subject/guardian decision|8|||
129925122|NCT03020199|467691127|FG001|Treatment Period|Subject/guardian decision|15|||
129925123|NCT03020199|467691126|FG000|Treatment Period|Subjects not treated|3|||
129925124|NCT03020199|467691127|FG001|Treatment Period|Subjects not treated|4|||
129925125|NCT03020199|467691126|FG000|Follow-up Period|Disease relapse|32|||
129925126|NCT03020199|467691127|FG001|Follow-up Period|Disease relapse|7|||
129925127|NCT03020199|467691126|FG000|Follow-up Period|Lack of Efficacy|1|||
129925128|NCT03020199|467691127|FG001|Follow-up Period|Lack of Efficacy|2|||
129925129|NCT03020199|467691126|FG000|Follow-up Period|Lost to Follow-up|4|||
129925130|NCT03020199|467691127|FG001|Follow-up Period|Lost to Follow-up|6|||
129925131|NCT03020199|467691126|FG000|Follow-up Period|Physician Decision|2|||
129925132|NCT03020199|467691127|FG001|Follow-up Period|Physician Decision|2|||
129925133|NCT03020199|467691126|FG000|Follow-up Period|Protocol Violation|1|||
129925134|NCT03020199|467691127|FG001|Follow-up Period|Protocol Violation|2|||
129925135|NCT03020199|467691126|FG000|Follow-up Period|Study terminated by Sponsor|6|||
129925136|NCT03020199|467691127|FG001|Follow-up Period|Study terminated by Sponsor|3|||
129925137|NCT03020199|467691126|FG000|Follow-up Period|Subject/guardian decision|14|||
129925138|NCT03020199|467691127|FG001|Follow-up Period|Subject/guardian decision|9|||
129925139|NCT05583578|467691128|FG000|Overall Study|Withdrawal by Subject|2|||
129925140|NCT05583578|467691129|FG001|Overall Study|Withdrawal by Subject|0|||
129925141|NCT05201079|467691130|FG000|Overall Study|Adverse Event|7|||
129925142|NCT05201079|467691131|FG001|Overall Study|Adverse Event|11|||
129925143|NCT05201079|467691130|FG000|Overall Study|Death|1|||
129925144|NCT05201079|467691131|FG001|Overall Study|Death|1|||
129925145|NCT05201079|467691130|FG000|Overall Study|Lack of Efficacy|0|||
129925146|NCT05201079|467691131|FG001|Overall Study|Lack of Efficacy|2|||
129925147|NCT05201079|467691130|FG000|Overall Study|Lost to Follow-up|0|||
129925148|NCT05201079|467691131|FG001|Overall Study|Lost to Follow-up|1|||
129925149|NCT05201079|467691130|FG000|Overall Study|Physician Decision|1|||
129925150|NCT05201079|467691131|FG001|Overall Study|Physician Decision|1|||
129925151|NCT05201079|467691130|FG000|Overall Study|Protocol Violation|1|||
129925152|NCT05201079|467691131|FG001|Overall Study|Protocol Violation|0|||
129925153|NCT05201079|467691130|FG000|Overall Study|Withdrawal by Subject|1|||
129925154|NCT05201079|467691131|FG001|Overall Study|Withdrawal by Subject|0|||
129925155|NCT05201079|467691130|FG000|Overall Study|Forbidden medication|9|||
129925156|NCT05201079|467691131|FG001|Overall Study|Forbidden medication|5|||
129925157|NCT05201079|467691130|FG000|Overall Study|Transfer to another hospital|0|||
129925158|NCT05201079|467691131|FG001|Overall Study|Transfer to another hospital|1|||
129925159|NCT05201079|467691130|FG000|Overall Study|Clinical condition|1|||
129925160|NCT05201079|467691131|FG001|Overall Study|Clinical condition|0|||
129925161|NCT05201079|467691130|FG000|Overall Study|SAE and sepsis|1|||
129925162|NCT05201079|467691131|FG001|Overall Study|SAE and sepsis|0|||
129925163|NCT05386030|467691135|FG000|Overall Study|Death|1|||
129925164|NCT05386030|467691136|FG001|Overall Study|Death|0|||
129925165|NCT05386030|467691135|FG000|Overall Study|Physician Decision|2|||
129925166|NCT05386030|467691136|FG001|Overall Study|Physician Decision|1|||
129925167|NCT05386030|467691135|FG000|Overall Study|Lost to Follow-up|19|||
129925168|NCT05386030|467691136|FG001|Overall Study|Lost to Follow-up|7|||
129925169|NCT05386030|467691135|FG000|Overall Study|Withdrawal by Subject|20|||
129925170|NCT05386030|467691136|FG001|Overall Study|Withdrawal by Subject|10|||
129925171|NCT05386030|467691135|FG000|Overall Study|Eligibility criteria violation|1|||
129925172|NCT05386030|467691136|FG001|Overall Study|Eligibility criteria violation|1|||
129925173|NCT05386030|467691135|FG000|Overall Study|Personal Reasons|1|||
129925174|NCT05386030|467691136|FG001|Overall Study|Personal Reasons|0|||
129925175|NCT04719832|467691137|FG000|Overall Study|Adverse Event|2|||
129925176|NCT04719832|467691138|FG001|Overall Study|Adverse Event|0|||
129925177|NCT04719832|467691137|FG000|Overall Study|Lack of Efficacy|2|||
129925178|NCT04719832|467691138|FG001|Overall Study|Lack of Efficacy|4|||
129925179|NCT04719832|467691137|FG000|Overall Study|Lost to Follow-up|0|||
129925180|NCT04719832|467691138|FG001|Overall Study|Lost to Follow-up|2|||
129925181|NCT04719832|467691137|FG000|Overall Study|Physician Decision|0|||
129925182|NCT04719832|467691138|FG001|Overall Study|Physician Decision|1|||
129925183|NCT04719832|467691137|FG000|Overall Study|Pregnancy|1|||
129925184|NCT04719832|467691138|FG001|Overall Study|Pregnancy|1|||
129925185|NCT04719832|467691137|FG000|Overall Study|Withdrawal by Subject|5|||
129925186|NCT04719832|467691138|FG001|Overall Study|Withdrawal by Subject|5|||
129925187|NCT04719832|467691137|FG000|Overall Study|Randomized, not treated|0|||
129925188|NCT04719832|467691138|FG001|Overall Study|Randomized, not treated|2|||
129925189|NCT04719832|467691137|FG000|Overall Study|GCP violations|4|||
129925190|NCT04719832|467691138|FG001|Overall Study|GCP violations|7|||
129925191|NCT05228457|467691139|FG000|Overall Study|Withdrawal by Subject|1|||
129925192|NCT05228457|467691140|FG001|Overall Study|Withdrawal by Subject|1|||
129925193|NCT04880863|467691141|FG000|Overall Study|Adverse Event|1|||
129925194|NCT04880863|467691141|FG000|Overall Study|Patient decision|2|||
129925195|NCT04880863|467691141|FG000|Overall Study|Confirmed Disease Progression|15|||
129925196|NCT04880863|467691141|FG000|Overall Study|Death|3|||
129925197|NCT04880863|467691141|FG000|Overall Study|Physician Decision|4|||
129925198|NCT04880863|467691141|FG000|Overall Study|Unconfirmed Disease Progression|4|||
129925199|NCT04880863|467691141|FG000|Overall Study|Withdrawal by Subject|2|||
129925200|NCT04880863|467691141|FG000|Overall Study|Study discontinuation by the sponsor|4|||
129925201|NCT04880863|467691141|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
129925202|NCT04880863|467691141|FG000|Overall Study|Not received study drug NAP|2|||
129925203|NCT04898673|467691142|FG000|Overall Study|Screenfail|1|||
129925204|NCT04898673|467691143|FG001|Overall Study|Screenfail|0|||
129925205|NCT01544114|467691146|FG000|Overall Study|Withdrawal by Subject|0|||
129925206|NCT01544114|467691147|FG001|Overall Study|Withdrawal by Subject|0|||
129925207|NCT01544114|467691148|FG002|Overall Study|Withdrawal by Subject|3|||
129925208|NCT01544114|467691146|FG000|Overall Study|Lost to Follow-up|0|||
129925209|NCT01544114|467691147|FG001|Overall Study|Lost to Follow-up|2|||
129925210|NCT01544114|467691148|FG002|Overall Study|Lost to Follow-up|0|||
129925211|NCT01544114|467691146|FG000|Overall Study|Adverse Event|1|||
129925212|NCT01544114|467691147|FG001|Overall Study|Adverse Event|1|||
129925213|NCT01544114|467691148|FG002|Overall Study|Adverse Event|2|||
129925214|NCT01544114|467691146|FG000|Overall Study|Protocol Violation|0|||
129925215|NCT01544114|467691147|FG001|Overall Study|Protocol Violation|1|||
129925216|NCT01544114|467691148|FG002|Overall Study|Protocol Violation|0|||
129925217|NCT01733316|467691153|FG000|RP103 Phase|Non-compliance|1|||
129925218|NCT01733316|467691153|FG000|Long Term Extension Phase|Adverse Event|1|||
129925219|NCT01733316|467691153|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
129925220|NCT01733316|467691153|FG000|Long Term Extension Phase|Sponsor Decision|2|||
129925221|NCT05239455|467691163|FG000|Overall Study|Adverse Event|1|||
129925222|NCT05239455|467691163|FG000|Overall Study|Sponsor Decision|5|||
129925223|NCT05239455|467691163|FG000|Overall Study|Incomplete Blood Collection|1|||
129925224|NCT01799265|467691164|FG000|Overall Study|Lost to Follow-up|1|||
129925225|NCT01799265|467691165|FG001|Overall Study|Lost to Follow-up|0|||
129925226|NCT01799265|467691164|FG000|Overall Study|Protocol Violation|2|||
129925227|NCT01799265|467691165|FG001|Overall Study|Protocol Violation|1|||
129925228|NCT01799265|467691164|FG000|Overall Study|inadequate sleep study|0|||
129925229|NCT01799265|467691165|FG001|Overall Study|inadequate sleep study|2|||
129925230|NCT03459729|467691166|FG000|Overall Study|Physician Decision|2|||
129925231|NCT04200456|467691171|FG000|Overall Study|Physician Decision|0|||
129925232|NCT04200456|467691172|FG001|Overall Study|Physician Decision|1|||
129925233|NCT04200456|467691171|FG000|Overall Study|Withdrawal by Subject|2|||
129925234|NCT04200456|467691172|FG001|Overall Study|Withdrawal by Subject|2|||
129925235|NCT04200456|467691171|FG000|Overall Study|Lack of Efficacy|1|||
129925236|NCT04200456|467691172|FG001|Overall Study|Lack of Efficacy|1|||
129925237|NCT04200456|467691171|FG000|Overall Study|Adverse event, non-fatal|0|||
129925238|NCT04200456|467691172|FG001|Overall Study|Adverse event, non-fatal|1|||
129925239|NCT04200456|467691171|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
129925240|NCT04200456|467691172|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
129925241|NCT01186367|467693331|FG000|Overall Study|Lost to Follow-up|7|||
129925242|NCT01186367|467693332|FG001|Overall Study|Lost to Follow-up|4|||
129925243|NCT01186367|467693333|FG002|Overall Study|Lost to Follow-up|7|||
129925244|NCT01186367|467693331|FG000|Overall Study|Did not receive study treatment|0|||
129925245|NCT01186367|467693332|FG001|Overall Study|Did not receive study treatment|1|||
129925246|NCT01186367|467693333|FG002|Overall Study|Did not receive study treatment|0|||
129925247|NCT03945292|467693334|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
129925248|NCT03945292|467693335|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925249|NCT03945292|467693336|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
129925250|NCT03945292|467693337|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925251|NCT03945292|467693338|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925252|NCT03945292|467693339|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925253|NCT03945292|467693340|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925254|NCT03945292|467693341|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
129925255|NCT03945292|467693334|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925256|NCT03945292|467693335|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925257|NCT03945292|467693336|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
129925258|NCT03945292|467693337|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925259|NCT03945292|467693338|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925260|NCT03945292|467693339|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925261|NCT03945292|467693340|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925262|NCT03945292|467693341|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
129925263|NCT03945292|467693334|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925264|NCT03945292|467693335|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925265|NCT03945292|467693336|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925266|NCT03945292|467693337|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925267|NCT03945292|467693338|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925268|NCT03945292|467693339|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925269|NCT03945292|467693340|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
129925270|NCT03945292|467693341|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
129925271|NCT04987320|467693342|FG000|Overall Study|Withdrawal by Subject|0|||
129925272|NCT04987320|467693343|FG001|Overall Study|Withdrawal by Subject|1|||
129925273|NCT02675751|467693346|FG000|Overall Study|Lost to Follow-up|16|||
129925274|NCT03371381|467693347|FG000|Overall Study|Death|5|||
129925275|NCT03371381|467693347|FG000|Overall Study|Study terminated by sponsor|3|||
129925276|NCT03371381|467693347|FG000|Overall Study|Other|4|||
129925277|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
129925278|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925279|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925280|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925281|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925282|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925283|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
129925284|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925285|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925286|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
129925287|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925288|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925289|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925290|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129925291|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
129925292|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
129925293|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
129925294|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925295|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925296|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925297|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
129925298|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925299|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
129925300|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925301|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925302|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925303|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925304|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129925305|NCT03628924|467693348|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
129925306|NCT03628924|467693349|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925307|NCT03628924|467693350|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
129925308|NCT03628924|467693351|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925309|NCT03628924|467693352|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925310|NCT03628924|467693353|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925311|NCT03628924|467693354|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
129925312|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
129925313|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
129925314|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
129925315|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
129925316|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
129925317|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
129925318|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
129925319|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925320|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925321|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925322|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
129925323|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
129925324|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
129925325|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
129925326|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925327|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925328|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925329|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
129925330|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
129925331|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
129925332|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
129925333|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
129925334|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
129925335|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
129925336|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
129925337|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
129925338|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
129925339|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
129925340|NCT03628924|467693348|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925341|NCT03628924|467693349|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925342|NCT03628924|467693350|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925343|NCT03628924|467693351|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
129925344|NCT03628924|467693352|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
129925345|NCT03628924|467693353|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
129925346|NCT03628924|467693354|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
129925347|NCT06019559|467693355|FG000|Overall Study|Withdrawal by Subject|7|||
129925348|NCT06019559|467693356|FG001|Overall Study|Withdrawal by Subject|6|||
129925349|NCT06019559|467693357|FG002|Overall Study|Withdrawal by Subject|5|||
129925350|NCT06019559|467693355|FG000|Overall Study|Lost to Follow-up|2|||
129925351|NCT06019559|467693356|FG001|Overall Study|Lost to Follow-up|0|||
129925352|NCT06019559|467693357|FG002|Overall Study|Lost to Follow-up|3|||
129925353|NCT06215521|467693359|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925354|NCT06215521|467693360|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
129925355|NCT06215521|467693361|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925356|NCT06215521|467693362|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925357|NCT06215521|467693363|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925358|NCT06215521|467693364|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
129925359|NCT04044768|467693365|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
129925360|NCT04044768|467693366|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
129925361|NCT01574274|467693367|FG000|Overall Study|Ineligible|0|||
129925362|NCT01574274|467693368|FG001|Overall Study|Ineligible|1|||
129925363|NCT01574274|467693367|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
129925364|NCT01574274|467693368|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
129925365|NCT01574274|467693367|FG000|Overall Study|Ph+ B-ALL|3|||
129925366|NCT01574274|467693368|FG001|Overall Study|Ph+ B-ALL|4|||
129925367|NCT01574274|467693367|FG000|Overall Study|Induction Death|2|||
129925368|NCT01574274|467693368|FG001|Overall Study|Induction Death|0|||
129925369|NCT01574274|467693367|FG000|Overall Study|Induction Failure|4|||
129925370|NCT01574274|467693368|FG001|Overall Study|Induction Failure|1|||
129925371|NCT01574274|467693367|FG000|Overall Study|Adverse Event|16|||
129925372|NCT01574274|467693368|FG001|Overall Study|Adverse Event|13|||
129925373|NCT01574274|467693367|FG000|Overall Study|Remission Death|1|||
129925374|NCT01574274|467693368|FG001|Overall Study|Remission Death|0|||
129925375|NCT01574274|467693367|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
129925376|NCT01574274|467693368|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
129925377|NCT01574274|467693367|FG000|Overall Study|Other, unknown|3|||
129925378|NCT01574274|467693368|FG001|Overall Study|Other, unknown|2|||
129925379|NCT05089019|467693372|FG000|Period 1|Withdrawal by Subject|0|||
129925380|NCT05089019|467693373|FG001|Period 1|Withdrawal by Subject|1|||
129925381|NCT05089019|467693372|FG000|Washout Period|Adverse Event|3|||
129925382|NCT05089019|467693373|FG001|Washout Period|Adverse Event|4|||
129925383|NCT05089019|467693372|FG000|Washout Period|Lost to Follow-up|1|||
129925384|NCT05089019|467693373|FG001|Washout Period|Lost to Follow-up|0|||
129925385|NCT05089019|467693372|FG000|Washout Period|Physician Decision|2|||
129925386|NCT05089019|467693373|FG001|Washout Period|Physician Decision|0|||
129925387|NCT05089019|467693372|FG000|Washout Period|Withdrawal by Subject|6|||
129925388|NCT05089019|467693373|FG001|Washout Period|Withdrawal by Subject|3|||
129925389|NCT05089019|467693372|FG000|Period 2|Adverse Event|4|||
129925390|NCT05089019|467693373|FG001|Period 2|Adverse Event|2|||
129925391|NCT05089019|467693372|FG000|Period 2|Lost to Follow-up|1|||
129925392|NCT05089019|467693373|FG001|Period 2|Lost to Follow-up|0|||
129925393|NCT05089019|467693372|FG000|Period 2|Withdrawal by Subject|0|||
129925394|NCT05089019|467693373|FG001|Period 2|Withdrawal by Subject|1|||
129925395|NCT03858634|467693374|FG000|Overall Study|Withdrawal by Subject|1|||
129925396|NCT03858634|467693375|FG001|Overall Study|Withdrawal by Subject|0|||
129925397|NCT03858634|467693374|FG000|Overall Study|Adverse Event|1|||
129925398|NCT03858634|467693375|FG001|Overall Study|Adverse Event|0|||
129925399|NCT03858634|467693374|FG000|Overall Study|Lost to Follow-up|0|||
129925400|NCT03858634|467693375|FG001|Overall Study|Lost to Follow-up|1|||
129925401|NCT03858634|467693374|FG000|Overall Study|Other, Not Specified|1|||
129925402|NCT03858634|467693375|FG001|Overall Study|Other, Not Specified|1|||
129925403|NCT04676763|467693376|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
129925404|NCT04676763|467693377|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
129925405|NCT04676763|467693378|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
129925406|NCT04676763|467693376|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
129925407|NCT04676763|467693377|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
129925408|NCT04676763|467693378|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
129925409|NCT04676763|467693376|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
129925410|NCT04676763|467693377|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
129925411|NCT04676763|467693378|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
129925412|NCT03150173|467693379|FG000|Overall Study|Lost to Follow-up|13|||
129925413|NCT03150173|467693380|FG001|Overall Study|Lost to Follow-up|5|||
129925414|NCT01593917|467693381|FG000|Overall Study|Death|67|||
129925415|NCT01593917|467693381|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
129925416|NCT01593917|467693381|FG000|Overall Study|Withdrawal by Subject|23|||
129925417|NCT01593917|467693381|FG000|Overall Study|Lost to Follow-up|12|||
129925418|NCT01593917|467693381|FG000|Overall Study|Protocol Violation|5|||
129925419|NCT01593917|467693381|FG000|Overall Study|Physician Decision|3|||
129925420|NCT02043678|467693386|FG000|Overall Study|Never treated|11|||
129925421|NCT02043678|467693387|FG001|Overall Study|Never treated|9|||
129925422|NCT02043678|467693386|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
129925423|NCT02043678|467693387|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
129925424|NCT02043678|467693386|FG000|Overall Study|AE without clinical PD|54|||
129925425|NCT02043678|467693387|FG001|Overall Study|AE without clinical PD|36|||
129925426|NCT02043678|467693386|FG000|Overall Study|Lost to Follow-up|1|||
129925427|NCT02043678|467693387|FG001|Overall Study|Lost to Follow-up|1|||
129925428|NCT02043678|467693386|FG000|Overall Study|Other|10|||
129925429|NCT02043678|467693387|FG001|Overall Study|Other|14|||
129925430|NCT02043678|467693386|FG000|Overall Study|Clinical PD|114|||
129925431|NCT02043678|467693387|FG001|Overall Study|Clinical PD|148|||
129925432|NCT02043678|467693386|FG000|Overall Study|Radiological PD|100|||
129925433|NCT02043678|467693387|FG001|Overall Study|Radiological PD|90|||
129925434|NCT02043678|467693386|FG000|Overall Study|Protocol-driven decision point|59|||
129925435|NCT02043678|467693387|FG001|Overall Study|Protocol-driven decision point|58|||
129925436|NCT02043678|467693386|FG000|Overall Study|Withdrawal by Subject|16|||
129925437|NCT02043678|467693387|FG001|Overall Study|Withdrawal by Subject|20|||
129925438|NCT02043678|467693386|FG000|Overall Study|Protocol Violation|1|||
129925439|NCT02043678|467693387|FG001|Overall Study|Protocol Violation|0|||
129925440|NCT02043678|467693386|FG000|Overall Study|Deterioration of general conditions|1|||
129925441|NCT02043678|467693387|FG001|Overall Study|Deterioration of general conditions|1|||
129925442|NCT02043678|467693386|FG000|Overall Study|Logistical difficulties|2|||
129925443|NCT02043678|467693387|FG001|Overall Study|Logistical difficulties|0|||
129925444|NCT02043678|467693386|FG000|Overall Study|Non-compliance with study drug|3|||
129925445|NCT02043678|467693387|FG001|Overall Study|Non-compliance with study drug|1|||
129925446|NCT02043678|467693386|FG000|Overall Study|Physician Decision|4|||
129925447|NCT02043678|467693387|FG001|Overall Study|Physician Decision|3|||
129925448|NCT02043678|467693386|FG000|Overall Study|Subject decision|0|||
129925449|NCT02043678|467693387|FG001|Overall Study|Subject decision|1|||
129925450|NCT02043678|467693386|FG000|Overall Study|Switching to other therapy|3|||
129925451|NCT02043678|467693387|FG001|Overall Study|Switching to other therapy|2|||
129925452|NCT02043678|467693386|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
129925453|NCT02043678|467693387|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
129925454|NCT02043678|467693386|FG000|Overall Study|Missing|1|||
129925455|NCT02043678|467693387|FG001|Overall Study|Missing|0|||
129925456|NCT02043678|467693386|FG000|Overall Study|Adverse Event|0|||
129925457|NCT02043678|467693387|FG001|Overall Study|Adverse Event|1|||
129925458|NCT05543629|467693388|FG000|Overall Study|Death|1|||
129925459|NCT05543629|467693389|FG001|Overall Study|Death|0|||
129925460|NCT05543629|467693390|FG002|Overall Study|Death|1|||
129925461|NCT05543629|467693391|FG003|Overall Study|Death|0|||
129925462|NCT05543629|467693392|FG004|Overall Study|Death|0|||
129925463|NCT05543629|467693393|FG005|Overall Study|Death|1|||
129925464|NCT05543629|467693394|FG006|Overall Study|Death|2|||
129925465|NCT05543629|467693395|FG007|Overall Study|Death|2|||
129925466|NCT05543629|467693388|FG000|Overall Study|Other Reasons|0|||
129925467|NCT05543629|467693389|FG001|Overall Study|Other Reasons|0|||
129925468|NCT05543629|467693390|FG002|Overall Study|Other Reasons|0|||
129925469|NCT05543629|467693391|FG003|Overall Study|Other Reasons|0|||
129925470|NCT05543629|467693392|FG004|Overall Study|Other Reasons|1|||
129925471|NCT05543629|467693393|FG005|Overall Study|Other Reasons|0|||
129925472|NCT05543629|467693394|FG006|Overall Study|Other Reasons|0|||
129925473|NCT05543629|467693395|FG007|Overall Study|Other Reasons|0|||
129925474|NCT05543629|467693388|FG000|Overall Study|Physician Decision|0|||
129925475|NCT05543629|467693389|FG001|Overall Study|Physician Decision|0|||
129925476|NCT05543629|467693390|FG002|Overall Study|Physician Decision|3|||
129925477|NCT05543629|467693391|FG003|Overall Study|Physician Decision|0|||
129925478|NCT05543629|467693392|FG004|Overall Study|Physician Decision|0|||
129925479|NCT05543629|467693393|FG005|Overall Study|Physician Decision|0|||
129925480|NCT05543629|467693394|FG006|Overall Study|Physician Decision|1|||
129925481|NCT05543629|467693395|FG007|Overall Study|Physician Decision|0|||
129925482|NCT05543629|467693388|FG000|Overall Study|Study terminated by Sponsor|1|||
129925483|NCT05543629|467693389|FG001|Overall Study|Study terminated by Sponsor|0|||
129925484|NCT05543629|467693390|FG002|Overall Study|Study terminated by Sponsor|0|||
129925485|NCT05543629|467693391|FG003|Overall Study|Study terminated by Sponsor|1|||
129925486|NCT05543629|467693392|FG004|Overall Study|Study terminated by Sponsor|0|||
129925487|NCT05543629|467693393|FG005|Overall Study|Study terminated by Sponsor|4|||
129925488|NCT05543629|467693394|FG006|Overall Study|Study terminated by Sponsor|1|||
129925489|NCT05543629|467693395|FG007|Overall Study|Study terminated by Sponsor|0|||
129925490|NCT05543629|467693388|FG000|Overall Study|Withdrawal by Subject|1|||
129925491|NCT05543629|467693389|FG001|Overall Study|Withdrawal by Subject|1|||
129925492|NCT05543629|467693390|FG002|Overall Study|Withdrawal by Subject|0|||
129925493|NCT05543629|467693391|FG003|Overall Study|Withdrawal by Subject|2|||
129925494|NCT05543629|467693392|FG004|Overall Study|Withdrawal by Subject|1|||
129925495|NCT05543629|467693393|FG005|Overall Study|Withdrawal by Subject|1|||
129925496|NCT05543629|467693394|FG006|Overall Study|Withdrawal by Subject|1|||
129925497|NCT05543629|467693395|FG007|Overall Study|Withdrawal by Subject|1|||
129925498|NCT05543629|467693388|FG000|Overall Study|Not Reported|2|||
129925499|NCT05543629|467693389|FG001|Overall Study|Not Reported|2|||
129925500|NCT05543629|467693390|FG002|Overall Study|Not Reported|0|||
129925501|NCT05543629|467693391|FG003|Overall Study|Not Reported|0|||
129925502|NCT05543629|467693392|FG004|Overall Study|Not Reported|1|||
129925503|NCT05543629|467693393|FG005|Overall Study|Not Reported|1|||
129925504|NCT05543629|467693394|FG006|Overall Study|Not Reported|3|||
129925505|NCT05543629|467693395|FG007|Overall Study|Not Reported|0|||
129925506|NCT03216057|467693396|FG000|Overall Study|Lost to Follow-up|2|||
129925507|NCT03216057|467693397|FG001|Overall Study|Lost to Follow-up|2|||
129925508|NCT04568603|467693398|FG000|Overall Study|Physician Decision|1|||
129925509|NCT04564742|467693399|FG000|Overall Study|Lost to Follow-up|1|||
129925510|NCT04564742|467693400|FG001|Overall Study|Lost to Follow-up|0|||
129925511|NCT04564742|467693399|FG000|Overall Study|Consent Withdrawal|4|||
129925512|NCT04564742|467693400|FG001|Overall Study|Consent Withdrawal|4|||
129925513|NCT03313076|467693404|FG000|Overall Study|Withdrawal by Subject|2|||
129925514|NCT03313076|467693405|FG001|Overall Study|Withdrawal by Subject|0|||
129925515|NCT03313076|467693406|FG002|Overall Study|Withdrawal by Subject|0|||
129925516|NCT03313076|467693407|FG003|Overall Study|Withdrawal by Subject|0|||
129925517|NCT03313076|467693404|FG000|Overall Study|Lost to Follow-up|0|||
129925518|NCT03313076|467693405|FG001|Overall Study|Lost to Follow-up|2|||
129925519|NCT03313076|467693406|FG002|Overall Study|Lost to Follow-up|2|||
129925520|NCT03313076|467693407|FG003|Overall Study|Lost to Follow-up|2|||
129925521|NCT04307355|467693408|FG000|Overall Study|Non-Compliance|3|||
129925522|NCT04307355|467693409|FG001|Overall Study|Non-Compliance|3|||
129925523|NCT04307355|467693410|FG002|Overall Study|Non-Compliance|0|||
129925524|NCT04032704|467693414|FG000|Part A|Withdrawal by Subject|0|||
129925525|NCT04032704|467693415|FG001|Part A|Withdrawal by Subject|0|||
129925526|NCT04032704|467693416|FG002|Part A|Withdrawal by Subject|3|||
129925527|NCT04032704|467693417|FG003|Part A|Withdrawal by Subject|0|||
129925528|NCT04032704|467693418|FG004|Part A|Withdrawal by Subject|1|||
129925529|NCT04032704|467693419|FG005|Part A|Withdrawal by Subject|7|||
129925530|NCT04032704|467693420|FG006|Part A|Withdrawal by Subject|0|||
129925531|NCT04032704|467693421|FG007|Part A|Withdrawal by Subject|0|||
129925532|NCT04032704|467693422|FG008|Part A|Withdrawal by Subject|0|||
129925533|NCT04032704|467693423|FG009|Part A|Withdrawal by Subject|0|||
129925534|NCT04032704|467693424|FG010|Part A|Withdrawal by Subject|0|||
129925535|NCT04032704|467693425|FG011|Part A|Withdrawal by Subject|0|||
129925536|NCT04032704|467693426|FG012|Part A|Withdrawal by Subject|0|||
129925537|NCT04032704|467693427|FG013|Part A|Withdrawal by Subject|0|||
129925538|NCT04032704|467693428|FG014|Part A|Withdrawal by Subject|0|||
129925539|NCT04032704|467693429|FG015|Part A|Withdrawal by Subject|0|||
129925540|NCT04032704|467693430|FG016|Part A|Withdrawal by Subject|0|||
129925541|NCT04032704|467693431|FG017|Part A|Withdrawal by Subject|0|||
129925542|NCT04032704|467693414|FG000|Part A|Lost to Follow-up|1|||
129925543|NCT04032704|467693415|FG001|Part A|Lost to Follow-up|0|||
129925544|NCT04032704|467693416|FG002|Part A|Lost to Follow-up|0|||
129925545|NCT04032704|467693417|FG003|Part A|Lost to Follow-up|0|||
129925546|NCT04032704|467693418|FG004|Part A|Lost to Follow-up|0|||
129925547|NCT04032704|467693419|FG005|Part A|Lost to Follow-up|0|||
129925548|NCT04032704|467693420|FG006|Part A|Lost to Follow-up|0|||
129925549|NCT04032704|467693421|FG007|Part A|Lost to Follow-up|0|||
129925550|NCT04032704|467693422|FG008|Part A|Lost to Follow-up|0|||
129925551|NCT04032704|467693423|FG009|Part A|Lost to Follow-up|0|||
129925552|NCT04032704|467693424|FG010|Part A|Lost to Follow-up|0|||
129925553|NCT04032704|467693425|FG011|Part A|Lost to Follow-up|0|||
129925554|NCT04032704|467693426|FG012|Part A|Lost to Follow-up|0|||
129925555|NCT04032704|467693427|FG013|Part A|Lost to Follow-up|0|||
129925556|NCT04032704|467693428|FG014|Part A|Lost to Follow-up|0|||
129925557|NCT04032704|467693429|FG015|Part A|Lost to Follow-up|0|||
129925558|NCT04032704|467693430|FG016|Part A|Lost to Follow-up|0|||
129925559|NCT04032704|467693431|FG017|Part A|Lost to Follow-up|0|||
129925560|NCT04032704|467693414|FG000|Part A|Death|9|||
129925561|NCT04032704|467693415|FG001|Part A|Death|2|||
129925562|NCT04032704|467693416|FG002|Part A|Death|10|||
129925563|NCT04032704|467693417|FG003|Part A|Death|7|||
129925564|NCT04032704|467693418|FG004|Part A|Death|4|||
129925565|NCT04032704|467693419|FG005|Part A|Death|5|||
129925566|NCT04032704|467693420|FG006|Part A|Death|0|||
129925567|NCT04032704|467693421|FG007|Part A|Death|0|||
129925568|NCT04032704|467693422|FG008|Part A|Death|0|||
129925569|NCT04032704|467693423|FG009|Part A|Death|0|||
129925570|NCT04032704|467693424|FG010|Part A|Death|0|||
129925571|NCT04032704|467693425|FG011|Part A|Death|0|||
129925572|NCT04032704|467693426|FG012|Part A|Death|0|||
129925573|NCT04032704|467693427|FG013|Part A|Death|0|||
129925574|NCT04032704|467693428|FG014|Part A|Death|0|||
129925575|NCT04032704|467693429|FG015|Part A|Death|0|||
129925576|NCT04032704|467693430|FG016|Part A|Death|0|||
129925577|NCT04032704|467693431|FG017|Part A|Death|0|||
129925578|NCT04032704|467693414|FG000|Part B|Other|0|||
129925579|NCT04032704|467693415|FG001|Part B|Other|0|||
129925580|NCT04032704|467693416|FG002|Part B|Other|0|||
129925581|NCT04032704|467693417|FG003|Part B|Other|0|||
129925582|NCT04032704|467693418|FG004|Part B|Other|0|||
129925583|NCT04032704|467693419|FG005|Part B|Other|0|||
129925584|NCT04032704|467693420|FG006|Part B|Other|0|||
129925585|NCT04032704|467693421|FG007|Part B|Other|1|||
129925586|NCT04032704|467693422|FG008|Part B|Other|2|||
129925587|NCT04032704|467693423|FG009|Part B|Other|1|||
129925588|NCT04032704|467693424|FG010|Part B|Other|1|||
129925589|NCT04032704|467693425|FG011|Part B|Other|1|||
129925590|NCT04032704|467693426|FG012|Part B|Other|5|||
129450424|NCT02717754|465947415|FG005|Overall Study|Incorrect Infusion Duration|20|||
129925591|NCT04032704|467693427|FG013|Part B|Other|13|||
129925592|NCT04032704|467693428|FG014|Part B|Other|0|||
129925593|NCT04032704|467693429|FG015|Part B|Other|0|||
129925594|NCT04032704|467693430|FG016|Part B|Other|0|||
129925595|NCT04032704|467693431|FG017|Part B|Other|0|||
129925596|NCT04032704|467693414|FG000|Part B|Study termination by Sponsor|0|||
129925597|NCT04032704|467693415|FG001|Part B|Study termination by Sponsor|0|||
129925598|NCT04032704|467693416|FG002|Part B|Study termination by Sponsor|0|||
129925599|NCT04032704|467693417|FG003|Part B|Study termination by Sponsor|0|||
129925600|NCT04032704|467693418|FG004|Part B|Study termination by Sponsor|0|||
129925601|NCT04032704|467693419|FG005|Part B|Study termination by Sponsor|0|||
129925602|NCT04032704|467693420|FG006|Part B|Study termination by Sponsor|0|||
129925603|NCT04032704|467693421|FG007|Part B|Study termination by Sponsor|0|||
129925604|NCT04032704|467693422|FG008|Part B|Study termination by Sponsor|1|||
129925605|NCT04032704|467693423|FG009|Part B|Study termination by Sponsor|0|||
129925606|NCT04032704|467693424|FG010|Part B|Study termination by Sponsor|0|||
129925607|NCT04032704|467693425|FG011|Part B|Study termination by Sponsor|0|||
129925608|NCT04032704|467693426|FG012|Part B|Study termination by Sponsor|0|||
129925609|NCT04032704|467693427|FG013|Part B|Study termination by Sponsor|0|||
129925610|NCT04032704|467693428|FG014|Part B|Study termination by Sponsor|0|||
129925611|NCT04032704|467693429|FG015|Part B|Study termination by Sponsor|0|||
129925612|NCT04032704|467693430|FG016|Part B|Study termination by Sponsor|0|||
129925613|NCT04032704|467693431|FG017|Part B|Study termination by Sponsor|0|||
129925614|NCT04032704|467693414|FG000|Part B|Withdrawal by Subject|0|||
129925615|NCT04032704|467693415|FG001|Part B|Withdrawal by Subject|0|||
129925616|NCT04032704|467693416|FG002|Part B|Withdrawal by Subject|0|||
129925617|NCT04032704|467693417|FG003|Part B|Withdrawal by Subject|0|||
129450425|NCT01200238|465947416|FG000|Overall Study|Adverse Event|2|||
129450426|NCT01200238|465947417|FG001|Overall Study|Adverse Event|1|||
129925618|NCT04032704|467693418|FG004|Part B|Withdrawal by Subject|0|||
129925619|NCT04032704|467693419|FG005|Part B|Withdrawal by Subject|0|||
129925620|NCT04032704|467693420|FG006|Part B|Withdrawal by Subject|3|||
129925621|NCT04032704|467693421|FG007|Part B|Withdrawal by Subject|2|||
129925622|NCT04032704|467693422|FG008|Part B|Withdrawal by Subject|2|||
129925623|NCT04032704|467693423|FG009|Part B|Withdrawal by Subject|1|||
129925624|NCT04032704|467693424|FG010|Part B|Withdrawal by Subject|4|||
129925625|NCT04032704|467693425|FG011|Part B|Withdrawal by Subject|6|||
129925626|NCT04032704|467693426|FG012|Part B|Withdrawal by Subject|2|||
129925627|NCT04032704|467693427|FG013|Part B|Withdrawal by Subject|1|||
129925628|NCT04032704|467693428|FG014|Part B|Withdrawal by Subject|0|||
129925629|NCT04032704|467693429|FG015|Part B|Withdrawal by Subject|1|||
129925630|NCT04032704|467693430|FG016|Part B|Withdrawal by Subject|0|||
129925631|NCT04032704|467693431|FG017|Part B|Withdrawal by Subject|0|||
129925632|NCT04032704|467693414|FG000|Part B|Lost to Follow-up|0|||
129925633|NCT04032704|467693415|FG001|Part B|Lost to Follow-up|0|||
129925634|NCT04032704|467693416|FG002|Part B|Lost to Follow-up|0|||
129925635|NCT04032704|467693417|FG003|Part B|Lost to Follow-up|0|||
129925636|NCT04032704|467693418|FG004|Part B|Lost to Follow-up|0|||
129925637|NCT04032704|467693419|FG005|Part B|Lost to Follow-up|0|||
129925638|NCT04032704|467693420|FG006|Part B|Lost to Follow-up|0|||
129925639|NCT04032704|467693421|FG007|Part B|Lost to Follow-up|0|||
129925640|NCT04032704|467693422|FG008|Part B|Lost to Follow-up|0|||
129925641|NCT04032704|467693423|FG009|Part B|Lost to Follow-up|0|||
129925642|NCT04032704|467693424|FG010|Part B|Lost to Follow-up|0|||
129925643|NCT04032704|467693425|FG011|Part B|Lost to Follow-up|1|||
129925644|NCT04032704|467693426|FG012|Part B|Lost to Follow-up|0|||
129925645|NCT04032704|467693427|FG013|Part B|Lost to Follow-up|0|||
129925646|NCT04032704|467693428|FG014|Part B|Lost to Follow-up|0|||
129925647|NCT04032704|467693429|FG015|Part B|Lost to Follow-up|0|||
129925648|NCT04032704|467693430|FG016|Part B|Lost to Follow-up|0|||
129925649|NCT04032704|467693431|FG017|Part B|Lost to Follow-up|0|||
129925650|NCT04032704|467693414|FG000|Part B|Death|0|||
129925651|NCT04032704|467693415|FG001|Part B|Death|0|||
129925652|NCT04032704|467693416|FG002|Part B|Death|0|||
129925653|NCT04032704|467693417|FG003|Part B|Death|0|||
129925654|NCT04032704|467693418|FG004|Part B|Death|0|||
129925655|NCT04032704|467693419|FG005|Part B|Death|0|||
129925656|NCT04032704|467693420|FG006|Part B|Death|13|||
129925657|NCT04032704|467693421|FG007|Part B|Death|13|||
129925658|NCT04032704|467693422|FG008|Part B|Death|14|||
129925659|NCT04032704|467693423|FG009|Part B|Death|12|||
129925660|NCT04032704|467693424|FG010|Part B|Death|12|||
129925661|NCT04032704|467693425|FG011|Part B|Death|13|||
129925662|NCT04032704|467693426|FG012|Part B|Death|7|||
129925663|NCT04032704|467693427|FG013|Part B|Death|17|||
129925664|NCT04032704|467693428|FG014|Part B|Death|2|||
129925665|NCT04032704|467693429|FG015|Part B|Death|1|||
129925666|NCT04032704|467693430|FG016|Part B|Death|2|||
129925667|NCT04032704|467693431|FG017|Part B|Death|2|||
129925668|NCT02861300|467693432|FG000|Overall Study|Death|0|||
129925669|NCT02861300|467693433|FG001|Overall Study|Death|0|||
129925670|NCT02861300|467693434|FG002|Overall Study|Death|0|||
129925671|NCT02861300|467693435|FG003|Overall Study|Death|0|||
129925672|NCT02861300|467693436|FG004|Overall Study|Death|0|||
129925673|NCT02861300|467693437|FG005|Overall Study|Death|0|||
129925674|NCT02861300|467693438|FG006|Overall Study|Death|24|||
129925675|NCT02861300|467693432|FG000|Overall Study|Delay in treatment|0|||
129925676|NCT02861300|467693433|FG001|Overall Study|Delay in treatment|0|||
129925677|NCT02861300|467693434|FG002|Overall Study|Delay in treatment|0|||
129925678|NCT02861300|467693435|FG003|Overall Study|Delay in treatment|0|||
129925679|NCT02861300|467693436|FG004|Overall Study|Delay in treatment|0|||
129925680|NCT02861300|467693437|FG005|Overall Study|Delay in treatment|1|||
129925681|NCT02861300|467693438|FG006|Overall Study|Delay in treatment|0|||
129925682|NCT02861300|467693432|FG000|Overall Study|Disease Progression|0|||
129925683|NCT02861300|467693433|FG001|Overall Study|Disease Progression|1|||
129925684|NCT02861300|467693434|FG002|Overall Study|Disease Progression|0|||
129925685|NCT02861300|467693435|FG003|Overall Study|Disease Progression|0|||
129925686|NCT02861300|467693436|FG004|Overall Study|Disease Progression|0|||
129925687|NCT02861300|467693437|FG005|Overall Study|Disease Progression|0|||
129925688|NCT02861300|467693438|FG006|Overall Study|Disease Progression|2|||
129925689|NCT02861300|467693432|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
129925690|NCT02861300|467693433|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
129925691|NCT02861300|467693434|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
129925692|NCT02861300|467693435|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
129925693|NCT02861300|467693436|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
129925694|NCT02861300|467693437|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
129925695|NCT02861300|467693438|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
129925696|NCT02861300|467693432|FG000|Overall Study|Clinical Complications|0|||
129925697|NCT02861300|467693433|FG001|Overall Study|Clinical Complications|0|||
129925698|NCT02861300|467693434|FG002|Overall Study|Clinical Complications|0|||
129925699|NCT02861300|467693435|FG003|Overall Study|Clinical Complications|0|||
129925700|NCT02861300|467693436|FG004|Overall Study|Clinical Complications|0|||
129925701|NCT02861300|467693437|FG005|Overall Study|Clinical Complications|0|||
129925702|NCT02861300|467693438|FG006|Overall Study|Clinical Complications|1|||
129925703|NCT02465268|467693439|FG000|Overall Study|Withdrawal by Subject|4|||
129925704|NCT02465268|467693440|FG001|Overall Study|Withdrawal by Subject|3|||
129925705|NCT02465268|467693441|FG002|Overall Study|Withdrawal by Subject|1|||
129925706|NCT02465268|467693439|FG000|Overall Study|Not evaluable per protocol criteria|3|||
129925707|NCT02465268|467693440|FG001|Overall Study|Not evaluable per protocol criteria|2|||
129925708|NCT02465268|467693441|FG002|Overall Study|Not evaluable per protocol criteria|1|||
129925709|NCT02465268|467693439|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
129925710|NCT02465268|467693440|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
129925711|NCT02465268|467693441|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
129925712|NCT02465268|467693439|FG000|Overall Study|Study drug did not pass QA/QC|1|||
129925713|NCT02465268|467693440|FG001|Overall Study|Study drug did not pass QA/QC|0|||
129925714|NCT02465268|467693441|FG002|Overall Study|Study drug did not pass QA/QC|0|||
129925715|NCT02465268|467693439|FG000|Overall Study|Adverse Event|0|||
129925716|NCT02465268|467693440|FG001|Overall Study|Adverse Event|1|||
129925717|NCT02465268|467693441|FG002|Overall Study|Adverse Event|0|||
129925718|NCT02465268|467693439|FG000|Overall Study|Physician Decision|0|||
129925719|NCT02465268|467693440|FG001|Overall Study|Physician Decision|1|||
129925720|NCT02465268|467693441|FG002|Overall Study|Physician Decision|0|||
129925721|NCT03133546|467693442|FG000|Overall Study|Death|46|||
129925722|NCT03133546|467693443|FG001|Overall Study|Death|43|||
129925723|NCT03133546|467693442|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
129925724|NCT03133546|467693443|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
129925725|NCT04907851|467693444|FG000|Overall Study|Consent withdrawn|1|||
129925726|NCT04907851|467693445|FG001|Overall Study|Consent withdrawn|2|||
129925727|NCT04907851|467693446|FG002|Overall Study|Consent withdrawn|0|||
129925728|NCT04907851|467693444|FG000|Overall Study|Death|5|||
129925729|NCT04907851|467693445|FG001|Overall Study|Death|15|||
129925730|NCT04907851|467693446|FG002|Overall Study|Death|10|||
129925731|NCT01210807|467693451|FG000|Overall Study|Lost to Follow-up|1|||
129925732|NCT01210807|467693452|FG001|Overall Study|Lost to Follow-up|2|||
129925733|NCT01210807|467693451|FG000|Overall Study|Not implanted bilaterally|2|||
129925734|NCT01210807|467693452|FG001|Overall Study|Not implanted bilaterally|1|||
129925735|NCT05477186|467693457|FG000|Overall Study|Vaccine not administered|0|||
129925736|NCT05477186|467693458|FG001|Overall Study|Vaccine not administered|2|||
129925737|NCT05477186|467693459|FG002|Overall Study|Vaccine not administered|1|||
129925738|NCT05477186|467693460|FG003|Overall Study|Vaccine not administered|0|||
129925739|NCT05477186|467693461|FG004|Overall Study|Vaccine not administered|1|||
129925740|NCT05477186|467693462|FG005|Overall Study|Vaccine not administered|0|||
129925741|NCT05477186|467693463|FG006|Overall Study|Vaccine not administered|0|||
129925742|NCT05477186|467693457|FG000|Overall Study|Withdrawal by Subject|1|||
129925743|NCT05477186|467693458|FG001|Overall Study|Withdrawal by Subject|0|||
129925744|NCT05477186|467693459|FG002|Overall Study|Withdrawal by Subject|0|||
129925745|NCT05477186|467693460|FG003|Overall Study|Withdrawal by Subject|0|||
129925746|NCT05477186|467693461|FG004|Overall Study|Withdrawal by Subject|0|||
129925747|NCT05477186|467693462|FG005|Overall Study|Withdrawal by Subject|1|||
129925748|NCT05477186|467693463|FG006|Overall Study|Withdrawal by Subject|0|||
129925749|NCT05477186|467693457|FG000|Overall Study|Lost to Follow-up|1|||
129925750|NCT05477186|467693458|FG001|Overall Study|Lost to Follow-up|0|||
129925751|NCT05477186|467693459|FG002|Overall Study|Lost to Follow-up|2|||
129925752|NCT05477186|467693460|FG003|Overall Study|Lost to Follow-up|1|||
129925753|NCT05477186|467693461|FG004|Overall Study|Lost to Follow-up|1|||
129925754|NCT05477186|467693462|FG005|Overall Study|Lost to Follow-up|0|||
129925755|NCT05477186|467693463|FG006|Overall Study|Lost to Follow-up|2|||
129925756|NCT00324805|467693464|FG000|Overall Study|Adverse Event|62|||
129925757|NCT00324805|467693465|FG001|Overall Study|Adverse Event|203|||
129925758|NCT00324805|467693464|FG000|Overall Study|Progression|7|||
129925759|NCT00324805|467693465|FG001|Overall Study|Progression|35|||
129925760|NCT00324805|467693464|FG000|Overall Study|Withdrawal by Subject|51|||
129925761|NCT00324805|467693465|FG001|Overall Study|Withdrawal by Subject|174|||
129925762|NCT00324805|467693464|FG000|Overall Study|Death|6|||
129925763|NCT00324805|467693465|FG001|Overall Study|Death|9|||
129925764|NCT00324805|467693464|FG000|Overall Study|Alternative therapy|4|||
129925765|NCT00324805|467693465|FG001|Overall Study|Alternative therapy|8|||
129925766|NCT00324805|467693464|FG000|Overall Study|Other complicating disease|1|||
129925767|NCT00324805|467693465|FG001|Overall Study|Other complicating disease|9|||
129925768|NCT00324805|467693464|FG000|Overall Study|Other reasons|7|||
129925769|NCT00324805|467693465|FG001|Overall Study|Other reasons|26|||
129925770|NCT00324805|467693464|FG000|Overall Study|Other|0|||
129925771|NCT00324805|467693465|FG001|Overall Study|Other|2|||
129925772|NCT00324805|467693464|FG000|Overall Study|Did not start therapy|12|||
129925773|NCT00324805|467693465|FG001|Overall Study|Did not start therapy|17|||
129925774|NCT05792085|467693467|FG000|Overall Study|Death|0|||
129925775|NCT05792085|467693468|FG001|Overall Study|Death|0|||
129925776|NCT05792085|467693469|FG002|Overall Study|Death|0|||
129925777|NCT05792085|467693470|FG003|Overall Study|Death|0|||
129925778|NCT05792085|467693471|FG004|Overall Study|Death|1|||
129925779|NCT01919554|467693472|FG000|Overall Study|Withdrawal by Subject|0|||
129925780|NCT01919554|467693473|FG001|Overall Study|Withdrawal by Subject|0|||
129925781|NCT01919554|467693474|FG002|Overall Study|Withdrawal by Subject|1|||
129925782|NCT01919554|467693475|FG003|Overall Study|Withdrawal by Subject|1|||
129925783|NCT04524442|467693478|FG000|Overall Study|Subject Decision|1|||
129925784|NCT03213691|467693481|FG000|Overall Study|Adverse Event|2|||
129925785|NCT03213691|467693481|FG000|Overall Study|Death|3|||
129925786|NCT03213691|467693481|FG000|Overall Study|Physician Decision|1|||
129925787|NCT03213691|467693481|FG000|Overall Study|Progressive Disease|14|||
129925788|NCT03213691|467693481|FG000|Overall Study|Ineligible|1|||
129925789|NCT01152450|467693484|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
129925790|NCT01152450|467693485|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
129925791|NCT01152450|467693486|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
129925792|NCT01152450|467693487|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
129925793|NCT01152450|467693488|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
129925794|NCT01152450|467693489|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
129925795|NCT01152450|467693484|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
129925796|NCT01152450|467693485|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
129925797|NCT01152450|467693486|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
129925798|NCT01152450|467693487|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
129925799|NCT01152450|467693488|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
129925800|NCT01152450|467693489|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
129925801|NCT01152450|467693484|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925802|NCT01152450|467693485|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
129925803|NCT01152450|467693486|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
129925804|NCT01152450|467693487|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925805|NCT01152450|467693488|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925806|NCT01152450|467693489|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
129925807|NCT03058289|467693493|FG000|Overall Study|Radiographic Deterioration|0|||
129925808|NCT03058289|467693494|FG001|Overall Study|Radiographic Deterioration|3|||
129925809|NCT03058289|467693495|FG002|Overall Study|Radiographic Deterioration|1|||
129925810|NCT03058289|467693496|FG003|Overall Study|Radiographic Deterioration|2|||
129925811|NCT03058289|467693497|FG004|Overall Study|Radiographic Deterioration|6|||
129925812|NCT03058289|467693498|FG005|Overall Study|Radiographic Deterioration|3|||
129925813|NCT03058289|467693499|FG006|Overall Study|Radiographic Deterioration|0|||
129925814|NCT03058289|467693500|FG007|Overall Study|Radiographic Deterioration|4|||
129925815|NCT03058289|467693501|FG008|Overall Study|Radiographic Deterioration|2|||
129925816|NCT03058289|467693493|FG000|Overall Study|Adverse Event|2|||
129925817|NCT03058289|467693494|FG001|Overall Study|Adverse Event|0|||
129925818|NCT03058289|467693495|FG002|Overall Study|Adverse Event|1|||
129925819|NCT03058289|467693496|FG003|Overall Study|Adverse Event|3|||
129925820|NCT03058289|467693497|FG004|Overall Study|Adverse Event|1|||
129925821|NCT03058289|467693498|FG005|Overall Study|Adverse Event|0|||
129925822|NCT03058289|467693499|FG006|Overall Study|Adverse Event|1|||
129925823|NCT03058289|467693500|FG007|Overall Study|Adverse Event|3|||
129925824|NCT03058289|467693501|FG008|Overall Study|Adverse Event|0|||
129925825|NCT03058289|467693493|FG000|Overall Study|Withdrawal by Subject|0|||
129925826|NCT03058289|467693494|FG001|Overall Study|Withdrawal by Subject|0|||
129925827|NCT03058289|467693495|FG002|Overall Study|Withdrawal by Subject|0|||
129925828|NCT03058289|467693496|FG003|Overall Study|Withdrawal by Subject|2|||
129925829|NCT03058289|467693497|FG004|Overall Study|Withdrawal by Subject|0|||
129925830|NCT03058289|467693498|FG005|Overall Study|Withdrawal by Subject|2|||
129925831|NCT03058289|467693499|FG006|Overall Study|Withdrawal by Subject|0|||
129925832|NCT03058289|467693500|FG007|Overall Study|Withdrawal by Subject|4|||
129925833|NCT03058289|467693501|FG008|Overall Study|Withdrawal by Subject|1|||
129925834|NCT03058289|467693493|FG000|Overall Study|Physician Decision|1|||
129925835|NCT03058289|467693494|FG001|Overall Study|Physician Decision|0|||
129925836|NCT03058289|467693495|FG002|Overall Study|Physician Decision|0|||
129925837|NCT03058289|467693496|FG003|Overall Study|Physician Decision|2|||
129925838|NCT03058289|467693497|FG004|Overall Study|Physician Decision|1|||
129925839|NCT03058289|467693498|FG005|Overall Study|Physician Decision|0|||
129925840|NCT03058289|467693499|FG006|Overall Study|Physician Decision|2|||
129925841|NCT03058289|467693500|FG007|Overall Study|Physician Decision|3|||
129925842|NCT03058289|467693501|FG008|Overall Study|Physician Decision|0|||
129925843|NCT03058289|467693493|FG000|Overall Study|Clinical Deterioration|2|||
129925844|NCT03058289|467693494|FG001|Overall Study|Clinical Deterioration|0|||
129925845|NCT03058289|467693495|FG002|Overall Study|Clinical Deterioration|0|||
129925846|NCT03058289|467693496|FG003|Overall Study|Clinical Deterioration|2|||
129925847|NCT03058289|467693497|FG004|Overall Study|Clinical Deterioration|1|||
129925848|NCT03058289|467693498|FG005|Overall Study|Clinical Deterioration|1|||
129925849|NCT03058289|467693499|FG006|Overall Study|Clinical Deterioration|0|||
129925850|NCT03058289|467693500|FG007|Overall Study|Clinical Deterioration|3|||
129925851|NCT03058289|467693501|FG008|Overall Study|Clinical Deterioration|2|||
129925852|NCT03058289|467693493|FG000|Overall Study|Lost to Follow-up|0|||
129925853|NCT03058289|467693494|FG001|Overall Study|Lost to Follow-up|0|||
129925854|NCT03058289|467693495|FG002|Overall Study|Lost to Follow-up|0|||
129925855|NCT03058289|467693496|FG003|Overall Study|Lost to Follow-up|0|||
129925856|NCT03058289|467693497|FG004|Overall Study|Lost to Follow-up|1|||
129925857|NCT03058289|467693498|FG005|Overall Study|Lost to Follow-up|0|||
129925858|NCT03058289|467693499|FG006|Overall Study|Lost to Follow-up|0|||
129925859|NCT03058289|467693500|FG007|Overall Study|Lost to Follow-up|0|||
129925860|NCT03058289|467693501|FG008|Overall Study|Lost to Follow-up|0|||
129925861|NCT03058289|467693493|FG000|Overall Study|Refused Further Treatment|0|||
129925862|NCT03058289|467693494|FG001|Overall Study|Refused Further Treatment|0|||
129925863|NCT03058289|467693495|FG002|Overall Study|Refused Further Treatment|1|||
129925864|NCT03058289|467693496|FG003|Overall Study|Refused Further Treatment|0|||
129925865|NCT03058289|467693497|FG004|Overall Study|Refused Further Treatment|1|||
129925866|NCT03058289|467693498|FG005|Overall Study|Refused Further Treatment|0|||
129925867|NCT03058289|467693499|FG006|Overall Study|Refused Further Treatment|0|||
129925868|NCT03058289|467693500|FG007|Overall Study|Refused Further Treatment|0|||
129925869|NCT03058289|467693501|FG008|Overall Study|Refused Further Treatment|0|||
129925870|NCT03058289|467693493|FG000|Overall Study|Rapid Progression of Disease|0|||
129925871|NCT03058289|467693494|FG001|Overall Study|Rapid Progression of Disease|0|||
129925872|NCT03058289|467693495|FG002|Overall Study|Rapid Progression of Disease|0|||
129925873|NCT03058289|467693496|FG003|Overall Study|Rapid Progression of Disease|1|||
129925874|NCT03058289|467693497|FG004|Overall Study|Rapid Progression of Disease|0|||
129925875|NCT03058289|467693498|FG005|Overall Study|Rapid Progression of Disease|0|||
129925876|NCT03058289|467693499|FG006|Overall Study|Rapid Progression of Disease|0|||
129925877|NCT03058289|467693500|FG007|Overall Study|Rapid Progression of Disease|0|||
129925878|NCT03058289|467693501|FG008|Overall Study|Rapid Progression of Disease|0|||
129925879|NCT05546411|467693502|FG000|Overall Study|Progressive Disease|1|||
129925880|NCT05546411|467693503|FG001|Overall Study|Progressive Disease|0|||
129925881|NCT05546411|467693502|FG000|Overall Study|Adverse Event|0|||
129925882|NCT05546411|467693503|FG001|Overall Study|Adverse Event|1|||
129925883|NCT05546411|467693502|FG000|Overall Study|Metastatic disease|1|||
129925884|NCT05546411|467693503|FG001|Overall Study|Metastatic disease|0|||
129925885|NCT02606422|467693504|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
129925886|NCT02606422|467693505|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
129925887|NCT02606422|467693504|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
129925888|NCT02606422|467693505|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
129925889|NCT02606422|467693504|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
129925890|NCT02606422|467693505|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
129925891|NCT02606422|467693504|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
129925892|NCT02606422|467693505|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
129925893|NCT04625465|467693506|FG000|Overall Study|Lost to Follow-up|2|||
129925894|NCT04625465|467693507|FG001|Overall Study|Lost to Follow-up|2|||
129925895|NCT04625465|467693508|FG002|Overall Study|Lost to Follow-up|1|||
129925896|NCT04625465|467693509|FG003|Overall Study|Lost to Follow-up|0|||
129925897|NCT04625465|467693510|FG004|Overall Study|Lost to Follow-up|0|||
129925898|NCT04625465|467693511|FG005|Overall Study|Lost to Follow-up|2|||
129925899|NCT04625465|467693512|FG006|Overall Study|Lost to Follow-up|0|||
129925900|NCT04625465|467693513|FG007|Overall Study|Lost to Follow-up|0|||
129925901|NCT04625465|467693506|FG000|Overall Study|Death|1|||
129925902|NCT04625465|467693507|FG001|Overall Study|Death|0|||
129925903|NCT04625465|467693508|FG002|Overall Study|Death|0|||
129925904|NCT04625465|467693509|FG003|Overall Study|Death|0|||
129925905|NCT04625465|467693510|FG004|Overall Study|Death|0|||
129925906|NCT04625465|467693511|FG005|Overall Study|Death|0|||
129925907|NCT04625465|467693512|FG006|Overall Study|Death|0|||
129925908|NCT04625465|467693513|FG007|Overall Study|Death|0|||
129925909|NCT04625465|467693506|FG000|Overall Study|Withdrawal by Subject|1|||
129925910|NCT04625465|467693507|FG001|Overall Study|Withdrawal by Subject|0|||
129925911|NCT04625465|467693508|FG002|Overall Study|Withdrawal by Subject|4|||
129925912|NCT04625465|467693509|FG003|Overall Study|Withdrawal by Subject|4|||
129925913|NCT04625465|467693510|FG004|Overall Study|Withdrawal by Subject|4|||
129925914|NCT04625465|467693511|FG005|Overall Study|Withdrawal by Subject|0|||
129925915|NCT04625465|467693512|FG006|Overall Study|Withdrawal by Subject|0|||
129925916|NCT04625465|467693513|FG007|Overall Study|Withdrawal by Subject|0|||
129925917|NCT05704543|467693514|FG000|Overall Study|Withdrawal by Subject|1|||
129925918|NCT05704543|467693515|FG001|Overall Study|Withdrawal by Subject|1|||
129925919|NCT05704543|467693516|FG002|Overall Study|Withdrawal by Subject|0|||
129925920|NCT05704543|467693517|FG003|Overall Study|Withdrawal by Subject|2|||
129925921|NCT05704543|467693514|FG000|Overall Study|Lost to Follow-up|1|||
129925922|NCT05704543|467693515|FG001|Overall Study|Lost to Follow-up|2|||
129925923|NCT05704543|467693516|FG002|Overall Study|Lost to Follow-up|0|||
129925924|NCT05704543|467693517|FG003|Overall Study|Lost to Follow-up|0|||
129925925|NCT03691935|467693519|FG000|Overall Study|Physician Decision|2|||
129925926|NCT03691935|467693520|FG001|Overall Study|Physician Decision|1|||
129925927|NCT03691935|467693519|FG000|Overall Study|Adverse Event|3|||
129925928|NCT03691935|467693520|FG001|Overall Study|Adverse Event|0|||
129925929|NCT05576155|467693521|FG000|Overall Study|Withdrawal by Subject|1|||
129925930|NCT05576155|467693522|FG001|Overall Study|Withdrawal by Subject|1|||
129925931|NCT05309291|467693523|FG000|Overall Study|Adverse Event|0|||
129925932|NCT05309291|467693524|FG001|Overall Study|Adverse Event|1|||
129925933|NCT05209152|467693527|FG000|Overall Study|Sponsor decision|1|||
129925934|NCT05209152|467693528|FG001|Overall Study|Sponsor decision|2|||
129925935|NCT05209152|467693527|FG000|Overall Study|Death|3|||
129925936|NCT05209152|467693528|FG001|Overall Study|Death|1|||
129925937|NCT02696707|467695065|FG000|Per Protocol Population|Physician Decision|2|||
129925938|NCT02696707|467695066|FG001|Per Protocol Population|Physician Decision|1|||
129925939|NCT02696707|467695065|FG000|Per Protocol Population|Participant Decision|0|||
129925940|NCT02696707|467695066|FG001|Per Protocol Population|Participant Decision|2|||
129925941|NCT02696707|467695065|FG000|Completed Study as Planned|Reason = LVEF|2|||
129925942|NCT02696707|467695066|FG001|Completed Study as Planned|Reason = LVEF|2|||
129925943|NCT02696707|467695065|FG000|Completed Study as Planned|Protocol Violation|2|||
129925944|NCT02696707|467695066|FG001|Completed Study as Planned|Protocol Violation|6|||
129925945|NCT02696707|467695065|FG000|Completed Study as Planned|Metastatic disease|3|||
129925946|NCT02696707|467695066|FG001|Completed Study as Planned|Metastatic disease|0|||
129925947|NCT02696707|467695065|FG000|Completed Study as Planned|Location|1|||
129925948|NCT02696707|467695066|FG001|Completed Study as Planned|Location|1|||
129925949|NCT05251909|467695071|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
129925950|NCT05251909|467695072|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
129450427|NCT01200238|465947416|FG000|Overall Study|Progressive Disease|5|||
129450428|NCT01200238|465947417|FG001|Overall Study|Progressive Disease|8|||
129450429|NCT01200238|465947416|FG000|Overall Study|Withdrawal by Subject|0|||
129450430|NCT01200238|465947417|FG001|Overall Study|Withdrawal by Subject|1|||
129450431|NCT01979835|465947418|FG000|Primary Outcome SA Measurment|failed insertion|18|||
129450432|NCT01979835|465947418|FG000|Follow-up|Lost to Follow-up|32|||
129450433|NCT02592018|465947419|FG000|Overall Study|Adverse Event|1|||
129450434|NCT02592018|465947419|FG000|Overall Study|Lost to Follow-up|1|||
129450435|NCT02710136|465947422|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
129450436|NCT02710136|465947423|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
129450437|NCT00418665|465947424|FG000|Treatment Period|Ineligibility determined|1|||
129450438|NCT00418665|465947425|FG001|Treatment Period|Ineligibility determined|1|||
129450439|NCT00418665|465947426|FG002|Treatment Period|Ineligibility determined|0|||
129450440|NCT00418665|465947424|FG000|Treatment Period|Adverse Event|2|||
129450441|NCT00418665|465947425|FG001|Treatment Period|Adverse Event|2|||
129450442|NCT00418665|465947426|FG002|Treatment Period|Adverse Event|0|||
129450443|NCT00418665|465947424|FG000|Treatment Period|Withdrawal by Subject|0|||
129450444|NCT00418665|465947425|FG001|Treatment Period|Withdrawal by Subject|3|||
129450445|NCT00418665|465947426|FG002|Treatment Period|Withdrawal by Subject|1|||
129450446|NCT00418665|465947424|FG000|Treatment Period|Requirement for alternative therapy|1|||
129450447|NCT00418665|465947425|FG001|Treatment Period|Requirement for alternative therapy|0|||
129450448|NCT00418665|465947426|FG002|Treatment Period|Requirement for alternative therapy|0|||
129450449|NCT00418665|465947424|FG000|Treatment Period|Physician Decision|1|||
129450450|NCT00418665|465947425|FG001|Treatment Period|Physician Decision|0|||
129925951|NCT06181227|467695073|FG000|Overall Study|Study terminated by sponsor|7|||
129925952|NCT06181227|467695074|FG001|Overall Study|Study terminated by sponsor|9|||
129925953|NCT05543915|467695075|FG000|Overall Study|Lost to Follow-up|0|||
129925954|NCT05543915|467695076|FG001|Overall Study|Lost to Follow-up|1|||
129925955|NCT00433329|467695079|FG000|Overall Study|Adverse Event|9|||
129925956|NCT00433329|467695079|FG000|Overall Study|Death|4|||
129925957|NCT00433329|467695079|FG000|Overall Study|Withdrew consent|3|||
129925958|NCT00433329|467695079|FG000|Overall Study|Discontinued sildenafil|2|||
129925959|NCT00433329|467695079|FG000|Overall Study|Moved out of state|1|||
129925960|NCT00433329|467695079|FG000|Overall Study|Lost to Follow-up|1|||
129925961|NCT00433329|467695079|FG000|Overall Study|Physician Decision|1|||
129925962|NCT03381196|467695080|FG000|Overall Study|Withdrawal by Subject|7|||
129925963|NCT03381196|467695081|FG001|Overall Study|Withdrawal by Subject|7|||
129925964|NCT03381196|467695080|FG000|Overall Study|Other|0|||
129925965|NCT03381196|467695081|FG001|Overall Study|Other|1|||
129925966|NCT03381196|467695080|FG000|Overall Study|Lost to Follow-up|5|||
129925967|NCT03381196|467695081|FG001|Overall Study|Lost to Follow-up|4|||
129925968|NCT03381196|467695080|FG000|Overall Study|Death|0|||
129925969|NCT03381196|467695081|FG001|Overall Study|Death|1|||
129925970|NCT03381196|467695080|FG000|Overall Study|Adverse Event|1|||
129925971|NCT03381196|467695081|FG001|Overall Study|Adverse Event|0|||
129925972|NCT03381196|467695080|FG000|Overall Study|Randomized, not treated|3|||
129925973|NCT03381196|467695081|FG001|Overall Study|Randomized, not treated|6|||
129925974|NCT04225273|467695091|FG000|Overall Study|Lost to Follow-up|3|||
129925975|NCT05270408|467695093|FG000|Started Treatment|Withdrawal by Subject|0|||
129925976|NCT05270408|467695094|FG001|Started Treatment|Withdrawal by Subject|0|||
129925977|NCT05270408|467695095|FG002|Started Treatment|Withdrawal by Subject|3|||
129925978|NCT05270408|467695093|FG000|Started Treatment|Adverse Event|0|||
129925979|NCT05270408|467695094|FG001|Started Treatment|Adverse Event|0|||
129925980|NCT05270408|467695095|FG002|Started Treatment|Adverse Event|1|||
129925981|NCT05270408|467695093|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
129925982|NCT05270408|467695094|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
129925983|NCT05270408|467695095|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
129925984|NCT03768505|467695096|FG000|Overall Study|sponsor decision|76|||
129925985|NCT03768505|467695096|FG000|Overall Study|Death|35|||
129925986|NCT03768505|467695096|FG000|Overall Study|Other -Various|30|||
129925987|NCT03768505|467695096|FG000|Overall Study|Withdrawal by Subject|22|||
129925988|NCT03768505|467695096|FG000|Overall Study|Lost to Follow-up|6|||
129925989|NCT02815566|467695097|FG000|Overall Study|Adverse Event|1|||
129925990|NCT02815566|467695098|FG001|Overall Study|Adverse Event|1|||
129925991|NCT02815566|467695097|FG000|Overall Study|Withdrawal by Subject|1|||
129925992|NCT02815566|467695098|FG001|Overall Study|Withdrawal by Subject|0|||
129925993|NCT02815566|467695097|FG000|Overall Study|Lost to Follow-up|0|||
129925994|NCT02815566|467695098|FG001|Overall Study|Lost to Follow-up|1|||
129925995|NCT03252847|467695099|FG000|Overall Study|Withdrawal by Subject|0|||
129925996|NCT03252847|467695100|FG001|Overall Study|Withdrawal by Subject|0|||
129925997|NCT03252847|467695101|FG002|Overall Study|Withdrawal by Subject|1|||
129450451|NCT00418665|465947426|FG002|Treatment Period|Physician Decision|3|||
129925998|NCT03252847|467695102|FG003|Overall Study|Withdrawal by Subject|0|||
129925999|NCT03252847|467695103|FG004|Overall Study|Withdrawal by Subject|0|||
129926000|NCT03252847|467695104|FG005|Overall Study|Withdrawal by Subject|0|||
129450452|NCT00418665|465947424|FG000|Treatment Extension|Adverse Event|1|||
129450453|NCT00418665|465947425|FG001|Treatment Extension|Adverse Event|0|||
129450454|NCT00418665|465947426|FG002|Treatment Extension|Adverse Event|0|||
129926001|NCT03252847|467695105|FG006|Overall Study|Withdrawal by Subject|0|||
129926002|NCT03252847|467695099|FG000|Overall Study|Other: Patient decision|0|||
129926003|NCT03252847|467695100|FG001|Overall Study|Other: Patient decision|0|||
129926004|NCT03252847|467695101|FG002|Overall Study|Other: Patient decision|0|||
129926005|NCT03252847|467695102|FG003|Overall Study|Other: Patient decision|0|||
129926006|NCT03252847|467695103|FG004|Overall Study|Other: Patient decision|1|||
129926007|NCT03252847|467695104|FG005|Overall Study|Other: Patient decision|0|||
129926008|NCT03252847|467695105|FG006|Overall Study|Other: Patient decision|0|||
129926009|NCT02993159|467695106|FG000|Overall Study|Withdrawal by Subject|1|||
129926010|NCT02993159|467695107|FG001|Overall Study|Withdrawal by Subject|3|||
129926011|NCT02993159|467695106|FG000|Overall Study|Protocol Violation|1|||
129926012|NCT02993159|467695107|FG001|Overall Study|Protocol Violation|0|||
129926013|NCT02993159|467695106|FG000|Overall Study|Opted out of surgery|2|||
129926014|NCT02993159|467695107|FG001|Overall Study|Opted out of surgery|0|||
129926015|NCT02993159|467695106|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
129926016|NCT02993159|467695107|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
129926017|NCT02993159|467695106|FG000|Overall Study|Physician Decision|0|||
129926018|NCT02993159|467695107|FG001|Overall Study|Physician Decision|1|||
129926019|NCT04992520|467695109|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
129926020|NCT04992520|467695110|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
129450455|NCT00418665|465947424|FG000|Treatment Extension|Withdrawal by Subject|1|||
129450456|NCT00418665|465947425|FG001|Treatment Extension|Withdrawal by Subject|0|||
129450457|NCT00418665|465947426|FG002|Treatment Extension|Withdrawal by Subject|0|||
129450458|NCT00418665|465947424|FG000|Treatment Extension|Requirement for alternative therapy|2|||
129450459|NCT00418665|465947425|FG001|Treatment Extension|Requirement for alternative therapy|2|||
129450460|NCT00418665|465947426|FG002|Treatment Extension|Requirement for alternative therapy|0|||
129450461|NCT00418665|465947424|FG000|Treatment Extension|Physician Decision|2|||
129450462|NCT00418665|465947425|FG001|Treatment Extension|Physician Decision|2|||
129450463|NCT00418665|465947426|FG002|Treatment Extension|Physician Decision|1|||
129450464|NCT00418665|465947424|FG000|Treatment Extension|Death|0|||
129450465|NCT00418665|465947425|FG001|Treatment Extension|Death|0|||
129926021|NCT04992520|467695111|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
129926022|NCT04992520|467695112|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
129926023|NCT04992520|467695113|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
129926024|NCT04992520|467695114|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
129926025|NCT04992520|467695109|FG000|Part A: First Challenge|Non-compliance|0|||
129926026|NCT04992520|467695110|FG001|Part A: First Challenge|Non-compliance|0|||
129926027|NCT04992520|467695111|FG002|Part A: First Challenge|Non-compliance|0|||
129926028|NCT04992520|467695112|FG003|Part A: First Challenge|Non-compliance|1|||
129926029|NCT04992520|467695113|FG004|Part A: First Challenge|Non-compliance|0|||
129926030|NCT04992520|467695114|FG005|Part A: First Challenge|Non-compliance|0|||
129926031|NCT04992520|467695109|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926032|NCT04992520|467695110|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926033|NCT04992520|467695111|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
129926034|NCT04992520|467695112|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926035|NCT04992520|467695113|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
129926036|NCT04992520|467695114|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
129926037|NCT04992520|467695109|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926038|NCT04992520|467695110|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926039|NCT04992520|467695111|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
129926040|NCT04992520|467695112|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926041|NCT04992520|467695113|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926042|NCT04992520|467695114|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
129926043|NCT06103188|467695117|FG000|Overall Study|Lost to Follow-up|1|||
129926044|NCT06103188|467695118|FG001|Overall Study|Lost to Follow-up|6|||
129926045|NCT06103188|467695119|FG002|Overall Study|Lost to Follow-up|4|||
129926046|NCT01175356|467695122|FG000|Overall Study|Death|1|||
129926047|NCT01175356|467695122|FG000|Overall Study|Lack of Efficacy|12|||
129926048|NCT01175356|467695122|FG000|Overall Study|Lost to Follow-up|1|||
129926049|NCT01175356|467695122|FG000|Overall Study|Physician Decision|23|||
129926050|NCT01175356|467695122|FG000|Overall Study|Ineligible|1|||
129926051|NCT01175356|467695122|FG000|Overall Study|Treatment Slot Not Available|18|||
129926052|NCT01175356|467695122|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
129450466|NCT00418665|465947426|FG002|Treatment Extension|Death|1|||
129450467|NCT01133379|465947429|FG000|Overall Study|Withdrawal by Subject|0|||
129450468|NCT01133379|465947430|FG001|Overall Study|Withdrawal by Subject|1|||
129450469|NCT01133379|465947431|FG002|Overall Study|Withdrawal by Subject|1|||
129450470|NCT01133379|465947429|FG000|Overall Study|Lost to Follow-up|1|||
129450471|NCT01133379|465947430|FG001|Overall Study|Lost to Follow-up|1|||
129450472|NCT01133379|465947431|FG002|Overall Study|Lost to Follow-up|1|||
129926053|NCT01175356|467695122|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
129926054|NCT01175356|467695122|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
129926055|NCT01175356|467695122|FG000|Overall Study|Inadequate stem cell for transplant|1|||
129450473|NCT00591214|465947432|FG000|Overall Study|Physician Decision|7|||
129450474|NCT00591214|465947432|FG000|Overall Study|Withdrawal by Subject|1|||
129450475|NCT01129921|465947435|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
129450476|NCT01129921|465947436|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
129450477|NCT01129921|465947435|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
129450478|NCT01129921|465947436|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
129450479|NCT01129921|465947435|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
129450480|NCT01129921|465947436|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
129450481|NCT01129921|465947435|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
129450482|NCT01129921|465947436|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
129450483|NCT05050318|465948745|FG000|Overall Study|Protocol Deviation|1|||
129450484|NCT05050318|465948746|FG001|Overall Study|Protocol Deviation|0|||
129450485|NCT05050318|465948747|FG002|Overall Study|Protocol Deviation|0|||
129450486|NCT00574145|465948752|FG000|Overall Study|Withdrawal by Subject|2|||
129450487|NCT00574145|465948753|FG001|Overall Study|Withdrawal by Subject|1|||
129450488|NCT03227471|465948757|FG000|Overall Study|Withdrawal by Subject|0|||
129450489|NCT03227471|465948758|FG001|Overall Study|Withdrawal by Subject|0|||
129450490|NCT03227471|465948759|FG002|Overall Study|Withdrawal by Subject|0|||
129450491|NCT03227471|465948760|FG003|Overall Study|Withdrawal by Subject|0|||
129450492|NCT03227471|465948761|FG004|Overall Study|Withdrawal by Subject|1|||
129450493|NCT03227471|465948762|FG005|Overall Study|Withdrawal by Subject|0|||
129450494|NCT03227471|465948763|FG006|Overall Study|Withdrawal by Subject|0|||
129450495|NCT03227471|465948764|FG007|Overall Study|Withdrawal by Subject|0|||
129450496|NCT03227471|465948765|FG008|Overall Study|Withdrawal by Subject|0|||
129450497|NCT03227471|465948766|FG009|Overall Study|Withdrawal by Subject|0|||
129450498|NCT03227471|465948767|FG010|Overall Study|Withdrawal by Subject|0|||
129450499|NCT03227471|465948768|FG011|Overall Study|Withdrawal by Subject|0|||
129450500|NCT03227471|465948769|FG012|Overall Study|Withdrawal by Subject|1|||
129450501|NCT03227471|465948770|FG013|Overall Study|Withdrawal by Subject|0|||
129450502|NCT03227471|465948771|FG014|Overall Study|Withdrawal by Subject|0|||
129450503|NCT03227471|465948757|FG000|Overall Study|Randomized, Never Dosed|0|||
129450504|NCT03227471|465948758|FG001|Overall Study|Randomized, Never Dosed|0|||
129450505|NCT03227471|465948759|FG002|Overall Study|Randomized, Never Dosed|0|||
129450506|NCT03227471|465948760|FG003|Overall Study|Randomized, Never Dosed|0|||
129450507|NCT03227471|465948761|FG004|Overall Study|Randomized, Never Dosed|0|||
129926056|NCT01175356|467695122|FG000|Overall Study|Initiation other tx prior to completion|9|||
129926057|NCT04005794|467695127|FG000|Overall Study|Lost to Follow-up|0|||
129926058|NCT04005794|467695128|FG001|Overall Study|Lost to Follow-up|4|||
129926059|NCT04005794|467695129|FG002|Overall Study|Lost to Follow-up|0|||
129926060|NCT04313972|467695132|FG000|Overall Study|Withdrawal by Subject|0|||
129926061|NCT04313972|467695133|FG001|Overall Study|Withdrawal by Subject|1|||
129926062|NCT00104676|467695149|FG000|Overall Study|Death|3|||
129926063|NCT00104676|467695150|FG001|Overall Study|Death|2|||
129926064|NCT00104676|467695149|FG000|Overall Study|Withdrawal by Subject|0|||
129926065|NCT00104676|467695150|FG001|Overall Study|Withdrawal by Subject|2|||
129926066|NCT00104676|467695149|FG000|Overall Study|treatment interruption|4|||
129926067|NCT00104676|467695150|FG001|Overall Study|treatment interruption|10|||
129926068|NCT05808257|467695153|FG000|Overall Study|Lost to Follow-up|8|||
129926069|NCT05808257|467695154|FG001|Overall Study|Lost to Follow-up|8|||
129926070|NCT04568486|467695155|FG000|Overall Study|Withdrawal by Subject|26|||
129926071|NCT04568486|467695155|FG000|Overall Study|Lost to Follow-up|7|||
129450508|NCT03227471|465948762|FG005|Overall Study|Randomized, Never Dosed|0|||
129450509|NCT03227471|465948763|FG006|Overall Study|Randomized, Never Dosed|0|||
129926072|NCT04042233|467695156|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
129926073|NCT04042233|467695157|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
129926074|NCT04042233|467695156|FG000|Overall Study|Protocol Violation|0|||
129926075|NCT04042233|467695157|FG001|Overall Study|Protocol Violation|2|||
129926076|NCT03899259|467695176|FG000|Overall Study|Adverse Event|5|||
129926077|NCT03899259|467695177|FG001|Overall Study|Adverse Event|4|||
129926078|NCT03899259|467695178|FG002|Overall Study|Adverse Event|6|||
129926079|NCT03899259|467695176|FG000|Overall Study|Lack of Efficacy|5|||
129926080|NCT03899259|467695177|FG001|Overall Study|Lack of Efficacy|0|||
129926081|NCT03899259|467695178|FG002|Overall Study|Lack of Efficacy|2|||
129926082|NCT03899259|467695176|FG000|Overall Study|Pregnancy|3|||
129926083|NCT03899259|467695177|FG001|Overall Study|Pregnancy|0|||
129450510|NCT03227471|465948764|FG007|Overall Study|Randomized, Never Dosed|0|||
129450511|NCT03227471|465948765|FG008|Overall Study|Randomized, Never Dosed|0|||
129450512|NCT03227471|465948766|FG009|Overall Study|Randomized, Never Dosed|0|||
129450513|NCT03227471|465948767|FG010|Overall Study|Randomized, Never Dosed|0|||
129450514|NCT03227471|465948768|FG011|Overall Study|Randomized, Never Dosed|0|||
129450515|NCT03227471|465948769|FG012|Overall Study|Randomized, Never Dosed|0|||
129450516|NCT03227471|465948770|FG013|Overall Study|Randomized, Never Dosed|0|||
129926084|NCT03899259|467695178|FG002|Overall Study|Pregnancy|1|||
129926085|NCT03899259|467695176|FG000|Overall Study|Physician Decision|0|||
129926086|NCT03899259|467695177|FG001|Overall Study|Physician Decision|1|||
129926087|NCT03899259|467695178|FG002|Overall Study|Physician Decision|0|||
129926088|NCT03899259|467695176|FG000|Overall Study|Protocol Deviation|1|||
129926089|NCT03899259|467695177|FG001|Overall Study|Protocol Deviation|1|||
129926090|NCT03899259|467695178|FG002|Overall Study|Protocol Deviation|1|||
129926091|NCT03899259|467695176|FG000|Overall Study|Withdrawal by Subject|8|||
129926092|NCT03899259|467695177|FG001|Overall Study|Withdrawal by Subject|10|||
129926093|NCT03899259|467695178|FG002|Overall Study|Withdrawal by Subject|12|||
129926094|NCT03899259|467695176|FG000|Overall Study|Lost to Follow-up|5|||
129926095|NCT03899259|467695177|FG001|Overall Study|Lost to Follow-up|6|||
129926096|NCT03899259|467695178|FG002|Overall Study|Lost to Follow-up|2|||
129926097|NCT03899259|467695176|FG000|Overall Study|Lack of Adherence|1|||
129926098|NCT03899259|467695177|FG001|Overall Study|Lack of Adherence|0|||
129926099|NCT03899259|467695178|FG002|Overall Study|Lack of Adherence|0|||
129926100|NCT03899259|467695176|FG000|Overall Study|Screen Failure|1|||
129926101|NCT03899259|467695177|FG001|Overall Study|Screen Failure|0|||
129926102|NCT03899259|467695178|FG002|Overall Study|Screen Failure|0|||
129926103|NCT03899259|467695176|FG000|Overall Study|Ongoing Study Participation|127|||
129926104|NCT03899259|467695177|FG001|Overall Study|Ongoing Study Participation|134|||
129926105|NCT03899259|467695178|FG002|Overall Study|Ongoing Study Participation|210|||
129926106|NCT01197378|467695179|FG000|Overall Study|Adverse Event|3|||
129926107|NCT01197378|467695179|FG000|Overall Study|Withdrawal by Subject|1|||
129926108|NCT01197378|467695179|FG000|Overall Study|Physician Decision|1|||
129926109|NCT01197378|467695179|FG000|Overall Study|Other|2|||
129926110|NCT05139810|467695181|FG000|Overall Study|Voluntary Withdrawal|2|||
129926111|NCT05139810|467695182|FG001|Overall Study|Voluntary Withdrawal|1|||
129926112|NCT05139810|467695183|FG002|Overall Study|Voluntary Withdrawal|0|||
129926113|NCT05139810|467695181|FG000|Overall Study|Pregnancy|1|||
129926114|NCT05139810|467695182|FG001|Overall Study|Pregnancy|0|||
129926115|NCT05139810|467695183|FG002|Overall Study|Pregnancy|0|||
129926116|NCT05139810|467695181|FG000|Overall Study|Roll Over to CS7|19|||
129926117|NCT05139810|467695182|FG001|Overall Study|Roll Over to CS7|44|||
129926118|NCT05139810|467695183|FG002|Overall Study|Roll Over to CS7|20|||
129926119|NCT05566639|467695186|FG000|Overall Study|Adverse Event|1|||
129926120|NCT05566639|467695187|FG001|Overall Study|Adverse Event|1|||
129450517|NCT03227471|465948771|FG014|Overall Study|Randomized, Never Dosed|1|||
129450518|NCT00382720|465948772|FG000|Overall Study|Adverse Event|21|||
129450519|NCT00382720|465948773|FG001|Overall Study|Adverse Event|23|||
129450520|NCT00382720|465948774|FG002|Overall Study|Adverse Event|15|||
129450521|NCT00382720|465948772|FG000|Overall Study|Protocol Violation|2|||
129450522|NCT00382720|465948773|FG001|Overall Study|Protocol Violation|5|||
129450523|NCT00382720|465948774|FG002|Overall Study|Protocol Violation|1|||
129450524|NCT00382720|465948772|FG000|Overall Study|Death|0|||
129450525|NCT00382720|465948773|FG001|Overall Study|Death|1|||
129450526|NCT00382720|465948774|FG002|Overall Study|Death|2|||
129450527|NCT00382720|465948772|FG000|Overall Study|Progressive disease|37|||
129450528|NCT00382720|465948773|FG001|Overall Study|Progressive disease|28|||
129450529|NCT00382720|465948774|FG002|Overall Study|Progressive disease|38|||
129450530|NCT00382720|465948772|FG000|Overall Study|Withdrew consent|1|||
129450531|NCT00382720|465948773|FG001|Overall Study|Withdrew consent|1|||
129450532|NCT00382720|465948774|FG002|Overall Study|Withdrew consent|2|||
129450533|NCT00382720|465948772|FG000|Overall Study|Withdrawal by Subject|11|||
129450534|NCT00382720|465948773|FG001|Overall Study|Withdrawal by Subject|20|||
129450535|NCT00382720|465948774|FG002|Overall Study|Withdrawal by Subject|12|||
129450536|NCT00382720|465948772|FG000|Overall Study|Surgery|1|||
129450537|NCT00382720|465948773|FG001|Overall Study|Surgery|1|||
129450538|NCT00382720|465948774|FG002|Overall Study|Surgery|4|||
129450539|NCT00382720|465948772|FG000|Overall Study|Patient did not receive study medication|1|||
129450540|NCT00382720|465948773|FG001|Overall Study|Patient did not receive study medication|1|||
129450541|NCT00382720|465948774|FG002|Overall Study|Patient did not receive study medication|4|||
129450542|NCT00382720|465948772|FG000|Overall Study|Clinically progressive disease|0|||
129450543|NCT00382720|465948773|FG001|Overall Study|Clinically progressive disease|1|||
129450544|NCT00382720|465948774|FG002|Overall Study|Clinically progressive disease|0|||
129450545|NCT00382720|465948772|FG000|Overall Study|Good prognosis|0|||
129450546|NCT00382720|465948773|FG001|Overall Study|Good prognosis|1|||
129450547|NCT00382720|465948774|FG002|Overall Study|Good prognosis|0|||
129450548|NCT00382720|465948772|FG000|Overall Study|Investigator/Clinical decision|5|||
129450549|NCT00382720|465948773|FG001|Overall Study|Investigator/Clinical decision|6|||
129450550|NCT00382720|465948774|FG002|Overall Study|Investigator/Clinical decision|6|||
129450551|NCT00382720|465948772|FG000|Overall Study|Discontinued at end of study|0|||
129450552|NCT00382720|465948773|FG001|Overall Study|Discontinued at end of study|1|||
129926121|NCT05566639|467695186|FG000|Overall Study|Serious Adverse Event|1|||
129926122|NCT05566639|467695187|FG001|Overall Study|Serious Adverse Event|3|||
129926123|NCT05566639|467695186|FG000|Overall Study|Death|44|||
129926124|NCT05566639|467695187|FG001|Overall Study|Death|45|||
129926125|NCT05566639|467695186|FG000|Overall Study|Lost to Follow-up|467|||
129926126|NCT05566639|467695187|FG001|Overall Study|Lost to Follow-up|461|||
129926127|NCT05566639|467695186|FG000|Overall Study|Physician Decision|45|||
129926128|NCT05566639|467695187|FG001|Overall Study|Physician Decision|44|||
129926129|NCT05566639|467695186|FG000|Overall Study|Protocol Deviation|4|||
129450553|NCT00382720|465948774|FG002|Overall Study|Discontinued at end of study|2|||
129450554|NCT02142738|465948775|FG000|Overall Study|Adverse Event|13|||
129450555|NCT02142738|465948776|FG001|Overall Study|Adverse Event|9|||
129450556|NCT02142738|465948775|FG000|Overall Study|Death|92|||
129450557|NCT02142738|465948776|FG001|Overall Study|Death|112|||
129450558|NCT02142738|465948775|FG000|Overall Study|Lost to Follow-up|0|||
129450559|NCT02142738|465948776|FG001|Overall Study|Lost to Follow-up|3|||
129450560|NCT02142738|465948775|FG000|Overall Study|Withdrawal by Subject|6|||
129450561|NCT02142738|465948776|FG001|Overall Study|Withdrawal by Subject|7|||
129450562|NCT02142738|465948775|FG000|Overall Study|Follow up ended by sponsor|43|||
129450563|NCT02142738|465948776|FG001|Overall Study|Follow up ended by sponsor|20|||
129450564|NCT03688880|465948777|FG000|Overall Study|Withdrawal by Subject|0|||
129450565|NCT03688880|465948778|FG001|Overall Study|Withdrawal by Subject|2|||
129450566|NCT03688880|465948777|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
129450567|NCT03688880|465948778|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
129450568|NCT03688880|465948777|FG000|Overall Study|Lost to Follow-up|4|||
129450569|NCT03688880|465948778|FG001|Overall Study|Lost to Follow-up|7|||
129926130|NCT05566639|467695187|FG001|Overall Study|Protocol Deviation|4|||
129926131|NCT05566639|467695186|FG000|Overall Study|Withdrawal by Subject|277|||
129926132|NCT05566639|467695187|FG001|Overall Study|Withdrawal by Subject|271|||
129926133|NCT05566639|467695186|FG000|Overall Study|Other Than Specified|52|||
129926134|NCT05566639|467695187|FG001|Overall Study|Other Than Specified|64|||
129926135|NCT04159415|467695189|FG000|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926136|NCT04159415|467695190|FG001|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926137|NCT04159415|467695191|FG002|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926138|NCT04159415|467695192|FG003|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926139|NCT04159415|467695193|FG004|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926140|NCT04159415|467695194|FG005|Open-Label Treatment Period (OLTP) 4|Ongoing|0|||
129926141|NCT04159415|467695195|FG006|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
129926142|NCT04159415|467695196|FG007|Open-Label Treatment Period (OLTP) 4|Ongoing|2|||
129926143|NCT03800654|467695197|FG000|Overall Study|Time constraints|3|||
129926144|NCT03800654|467695198|FG001|Overall Study|Time constraints|3|||
129926145|NCT03800654|467695199|FG002|Overall Study|Time constraints|3|||
129926146|NCT03800654|467695197|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
129926147|NCT03800654|467695198|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
129926148|NCT03800654|467695199|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
129926149|NCT03800654|467695197|FG000|Overall Study|Lost to Follow-up|2|||
129926150|NCT03800654|467695198|FG001|Overall Study|Lost to Follow-up|1|||
129926151|NCT03800654|467695199|FG002|Overall Study|Lost to Follow-up|6|||
129926152|NCT03800654|467695197|FG000|Overall Study|Medical Health Issue|0|||
129926153|NCT03800654|467695198|FG001|Overall Study|Medical Health Issue|0|||
129926154|NCT03800654|467695199|FG002|Overall Study|Medical Health Issue|1|||
129926155|NCT03800654|467695197|FG000|Overall Study|Personal Issues|0|||
129926156|NCT03800654|467695198|FG001|Overall Study|Personal Issues|2|||
129926157|NCT03800654|467695199|FG002|Overall Study|Personal Issues|0|||
129926158|NCT03800654|467695197|FG000|Overall Study|Protocol Violation|0|||
129926159|NCT03800654|467695198|FG001|Overall Study|Protocol Violation|1|||
129926160|NCT03800654|467695199|FG002|Overall Study|Protocol Violation|0|||
129926161|NCT06182033|467695200|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
129926162|NCT06182033|467695201|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
129926163|NCT06182033|467695200|FG000|Overall Study|Target child relocation|1|||
129926164|NCT06182033|467695201|FG001|Overall Study|Target child relocation|1|||
129926165|NCT06182033|467695200|FG000|Overall Study|Withdrawal by Subject|1|||
129926166|NCT06182033|467695201|FG001|Overall Study|Withdrawal by Subject|0|||
129926167|NCT02723591|467695202|FG000|Overall Study|Adverse Event|48|||
129926168|NCT02723591|467695203|FG001|Overall Study|Adverse Event|40|||
129926169|NCT02723591|467695202|FG000|Overall Study|Death|2|||
129450570|NCT03688880|465948777|FG000|Overall Study|Adverse Event|0|||
129450571|NCT03688880|465948778|FG001|Overall Study|Adverse Event|2|||
129450572|NCT03688880|465948777|FG000|Overall Study|Device deficiencies|0|||
129450573|NCT03688880|465948778|FG001|Overall Study|Device deficiencies|2|||
129926170|NCT02723591|467695203|FG001|Overall Study|Death|2|||
129926171|NCT02723591|467695202|FG000|Overall Study|Lack of Efficacy|4|||
129926172|NCT02723591|467695203|FG001|Overall Study|Lack of Efficacy|3|||
129926173|NCT02723591|467695202|FG000|Overall Study|Lost to Follow-up|1|||
129926174|NCT02723591|467695203|FG001|Overall Study|Lost to Follow-up|7|||
129926175|NCT02723591|467695202|FG000|Overall Study|Protocol Violation|20|||
129926176|NCT02723591|467695203|FG001|Overall Study|Protocol Violation|23|||
129926177|NCT02723591|467695202|FG000|Overall Study|Withdrawal by Subject|4|||
129926178|NCT02723591|467695203|FG001|Overall Study|Withdrawal by Subject|8|||
129926179|NCT02723591|467695202|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
129926180|NCT02723591|467695203|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
129450574|NCT03688880|465948777|FG000|Overall Study|Other|10|||
129450575|NCT03688880|465948778|FG001|Overall Study|Other|16|||
129450576|NCT02713542|465948780|FG000|Overall Study|Use of prohibited medication|14|||
129926181|NCT02723591|467695202|FG000|Overall Study|Miscellaneous|5|||
129926182|NCT02723591|467695203|FG001|Overall Study|Miscellaneous|6|||
129926183|NCT04201262|467695206|FG000|Overall Study|Adverse Event|1|||
129926184|NCT04201262|467695207|FG001|Overall Study|Adverse Event|2|||
129926185|NCT04201262|467695206|FG000|Overall Study|Continuing in the study|57|||
129926186|NCT04201262|467695207|FG001|Overall Study|Continuing in the study|0|||
129926187|NCT04201262|467695206|FG000|Overall Study|Withdrawal by Subject|0|||
129926188|NCT04201262|467695207|FG001|Overall Study|Withdrawal by Subject|1|||
129926189|NCT02151981|467695208|FG000|Overall Study|Death|184|||
129926190|NCT02151981|467695209|FG001|Overall Study|Death|88|||
129926191|NCT02151981|467695208|FG000|Overall Study|Lost to Follow-up|7|||
129926192|NCT02151981|467695209|FG001|Overall Study|Lost to Follow-up|1|||
129926193|NCT02151981|467695208|FG000|Overall Study|Withdrawal by Subject|27|||
129926194|NCT02151981|467695209|FG001|Overall Study|Withdrawal by Subject|21|||
129926195|NCT02151981|467695208|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129926196|NCT02151981|467695209|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129926197|NCT02151981|467695208|FG000|Overall Study|Other reasons|1|||
129926198|NCT02151981|467695209|FG001|Overall Study|Other reasons|2|||
129926199|NCT05446168|467695210|FG000|Overall Study|Physician Decision|0|||
129926200|NCT05446168|467695211|FG001|Overall Study|Physician Decision|1|||
129926201|NCT01946789|467695217|FG000|Overall Study|Death|0|||
129926202|NCT01946789|467695218|FG001|Overall Study|Death|2|||
129926203|NCT01946789|467695219|FG002|Overall Study|Death|1|||
129926204|NCT01946789|467695220|FG003|Overall Study|Death|1|||
129926205|NCT01946789|467695221|FG004|Overall Study|Death|1|||
129926206|NCT01946789|467695222|FG005|Overall Study|Death|1|||
129926207|NCT01946789|467695223|FG006|Overall Study|Death|3|||
129926208|NCT01946789|467695224|FG007|Overall Study|Death|1|||
129926209|NCT01946789|467695225|FG008|Overall Study|Death|2|||
129926210|NCT01946789|467695217|FG000|Overall Study|Progressive Disease|0|||
129926211|NCT01946789|467695218|FG001|Overall Study|Progressive Disease|0|||
129926212|NCT01946789|467695219|FG002|Overall Study|Progressive Disease|1|||
129926213|NCT01946789|467695220|FG003|Overall Study|Progressive Disease|0|||
129926214|NCT01946789|467695221|FG004|Overall Study|Progressive Disease|0|||
129926215|NCT01946789|467695222|FG005|Overall Study|Progressive Disease|2|||
129926216|NCT01946789|467695223|FG006|Overall Study|Progressive Disease|0|||
129926217|NCT01946789|467695224|FG007|Overall Study|Progressive Disease|0|||
129926218|NCT01946789|467695225|FG008|Overall Study|Progressive Disease|0|||
129926219|NCT01946789|467695217|FG000|Overall Study|Withdrawal by Subject|0|||
129926220|NCT01946789|467695218|FG001|Overall Study|Withdrawal by Subject|0|||
129926221|NCT01946789|467695219|FG002|Overall Study|Withdrawal by Subject|0|||
129926222|NCT01946789|467695220|FG003|Overall Study|Withdrawal by Subject|2|||
129926223|NCT01946789|467695221|FG004|Overall Study|Withdrawal by Subject|1|||
129926224|NCT01946789|467695222|FG005|Overall Study|Withdrawal by Subject|0|||
129926225|NCT01946789|467695223|FG006|Overall Study|Withdrawal by Subject|1|||
129926226|NCT01946789|467695224|FG007|Overall Study|Withdrawal by Subject|0|||
129926227|NCT01946789|467695225|FG008|Overall Study|Withdrawal by Subject|0|||
129926228|NCT05374798|467695226|FG000|Overall Study|Lost to Follow-up|2|||
129926229|NCT05374798|467695226|FG000|Overall Study|Withdrawal by Subject|2|||
129926230|NCT05374798|467695226|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
129926231|NCT01275677|467695227|FG000|Overall Study|Not at risk for recurrence.|1|||
129926232|NCT01275677|467695228|FG001|Overall Study|Not at risk for recurrence.|1|||
129926233|NCT01275677|467695227|FG000|Overall Study|No follow-up|26|||
129926234|NCT01275677|467695228|FG001|Overall Study|No follow-up|37|||
129926235|NCT01275677|467695227|FG000|Overall Study|No clinical follow up.|1|||
129926236|NCT01275677|467695228|FG001|Overall Study|No clinical follow up.|4|||
129926237|NCT04409353|467695236|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
129926238|NCT04409353|467695237|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
129926239|NCT04409353|467695238|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
129926240|NCT04409353|467695236|FG000|Overall Study|Lost to Follow-up|6|||
129926241|NCT04409353|467695237|FG001|Overall Study|Lost to Follow-up|8|||
129926242|NCT04409353|467695238|FG002|Overall Study|Lost to Follow-up|7|||
129926243|NCT04409353|467695236|FG000|Overall Study|Major surgery during participation window|4|||
129926244|NCT04409353|467695237|FG001|Overall Study|Major surgery during participation window|3|||
129926245|NCT04409353|467695238|FG002|Overall Study|Major surgery during participation window|3|||
129926246|NCT04409353|467695236|FG000|Overall Study|Life event occurred during participation window|3|||
129926247|NCT04409353|467695237|FG001|Overall Study|Life event occurred during participation window|2|||
129926248|NCT04409353|467695238|FG002|Overall Study|Life event occurred during participation window|4|||
129926249|NCT04409353|467695236|FG000|Overall Study|Lack of Efficacy|4|||
129926250|NCT04409353|467695237|FG001|Overall Study|Lack of Efficacy|1|||
129926251|NCT04409353|467695238|FG002|Overall Study|Lack of Efficacy|3|||
129926252|NCT04409353|467695236|FG000|Overall Study|Adverse Event|2|||
129926253|NCT04409353|467695237|FG001|Overall Study|Adverse Event|1|||
129926254|NCT04409353|467695238|FG002|Overall Study|Adverse Event|1|||
129926255|NCT04409353|467695236|FG000|Overall Study|Disease burden - unable to participate|0|||
129926256|NCT04409353|467695237|FG001|Overall Study|Disease burden - unable to participate|1|||
129926257|NCT04409353|467695238|FG002|Overall Study|Disease burden - unable to participate|1|||
129926258|NCT04409353|467695236|FG000|Overall Study|Intervention too complicated|1|||
129926259|NCT04409353|467695237|FG001|Overall Study|Intervention too complicated|0|||
129926260|NCT04409353|467695238|FG002|Overall Study|Intervention too complicated|1|||
129926261|NCT04081103|467695239|FG000|Overall Study|Adverse Event|1|||
129926262|NCT04081103|467695240|FG001|Overall Study|Adverse Event|1|||
129926263|NCT04081103|467695241|FG002|Overall Study|Adverse Event|1|||
129926264|NCT04081103|467695239|FG000|Overall Study|Physician Decision|0|||
129926265|NCT04081103|467695240|FG001|Overall Study|Physician Decision|0|||
129926266|NCT04081103|467695241|FG002|Overall Study|Physician Decision|1|||
129926267|NCT03034356|467695242|FG000|Baseline|Lost to Follow-up|2|||
129926268|NCT03034356|467695243|FG001|Baseline|Lost to Follow-up|4|||
129926269|NCT03034356|467695242|FG000|Baseline|Withdrawal by Subject|2|||
129926270|NCT03034356|467695243|FG001|Baseline|Withdrawal by Subject|0|||
129926271|NCT03034356|467695242|FG000|Baseline|Physician Decision|0|||
129926272|NCT03034356|467695243|FG001|Baseline|Physician Decision|1|||
129926273|NCT03034356|467695242|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
129926274|NCT03034356|467695243|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
129926275|NCT03034356|467695242|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
129926276|NCT03034356|467695243|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
129926277|NCT03034356|467695242|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
129926278|NCT03034356|467695243|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
129926279|NCT03034356|467695242|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
129926280|NCT03034356|467695243|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
129926281|NCT03854227|467696805|FG000|Overall Study|Adverse Event|0|||
129926282|NCT03854227|467696806|FG001|Overall Study|Adverse Event|0|||
129926283|NCT03854227|467696807|FG002|Overall Study|Adverse Event|0|||
129926284|NCT03854227|467696808|FG003|Overall Study|Adverse Event|1|||
129926285|NCT03854227|467696809|FG004|Overall Study|Adverse Event|0|||
129926286|NCT03854227|467696810|FG005|Overall Study|Adverse Event|0|||
129926287|NCT03854227|467696811|FG006|Overall Study|Adverse Event|1|||
129926288|NCT03854227|467696812|FG007|Overall Study|Adverse Event|0|||
129926289|NCT03854227|467696813|FG008|Overall Study|Adverse Event|0|||
129926290|NCT03854227|467696814|FG009|Overall Study|Adverse Event|3|||
129926291|NCT03854227|467696815|FG010|Overall Study|Adverse Event|0|||
129926292|NCT03854227|467696816|FG011|Overall Study|Adverse Event|1|||
129926293|NCT03854227|467696805|FG000|Overall Study|Death|0|||
129926294|NCT03854227|467696806|FG001|Overall Study|Death|0|||
129926295|NCT03854227|467696807|FG002|Overall Study|Death|0|||
129926296|NCT03854227|467696808|FG003|Overall Study|Death|0|||
129926297|NCT03854227|467696809|FG004|Overall Study|Death|0|||
129926298|NCT03854227|467696810|FG005|Overall Study|Death|1|||
129926299|NCT03854227|467696811|FG006|Overall Study|Death|0|||
129926300|NCT03854227|467696812|FG007|Overall Study|Death|0|||
129926301|NCT03854227|467696813|FG008|Overall Study|Death|0|||
129926302|NCT03854227|467696814|FG009|Overall Study|Death|1|||
129926303|NCT03854227|467696815|FG010|Overall Study|Death|0|||
129926304|NCT03854227|467696816|FG011|Overall Study|Death|1|||
129926305|NCT03854227|467696805|FG000|Overall Study|Physician Decision|0|||
129926306|NCT03854227|467696806|FG001|Overall Study|Physician Decision|0|||
129926307|NCT03854227|467696807|FG002|Overall Study|Physician Decision|0|||
129926308|NCT03854227|467696808|FG003|Overall Study|Physician Decision|0|||
129926309|NCT03854227|467696809|FG004|Overall Study|Physician Decision|0|||
129926310|NCT03854227|467696810|FG005|Overall Study|Physician Decision|1|||
129926311|NCT03854227|467696811|FG006|Overall Study|Physician Decision|0|||
129926312|NCT03854227|467696812|FG007|Overall Study|Physician Decision|0|||
129926313|NCT03854227|467696813|FG008|Overall Study|Physician Decision|1|||
129926314|NCT03854227|467696814|FG009|Overall Study|Physician Decision|1|||
129926315|NCT03854227|467696815|FG010|Overall Study|Physician Decision|0|||
129926316|NCT03854227|467696816|FG011|Overall Study|Physician Decision|1|||
129926317|NCT03854227|467696805|FG000|Overall Study|Progressive disease|1|||
129926318|NCT03854227|467696806|FG001|Overall Study|Progressive disease|1|||
129926319|NCT03854227|467696807|FG002|Overall Study|Progressive disease|1|||
129926320|NCT03854227|467696808|FG003|Overall Study|Progressive disease|2|||
129926321|NCT03854227|467696809|FG004|Overall Study|Progressive disease|3|||
129926322|NCT03854227|467696810|FG005|Overall Study|Progressive disease|1|||
129926323|NCT03854227|467696811|FG006|Overall Study|Progressive disease|2|||
129926324|NCT03854227|467696812|FG007|Overall Study|Progressive disease|5|||
129926325|NCT03854227|467696813|FG008|Overall Study|Progressive disease|2|||
129926326|NCT03854227|467696814|FG009|Overall Study|Progressive disease|5|||
129926327|NCT03854227|467696815|FG010|Overall Study|Progressive disease|1|||
129926328|NCT03854227|467696816|FG011|Overall Study|Progressive disease|6|||
129926329|NCT03854227|467696805|FG000|Overall Study|Study terminated by sponsor|0|||
129926330|NCT03854227|467696806|FG001|Overall Study|Study terminated by sponsor|0|||
129926331|NCT03854227|467696807|FG002|Overall Study|Study terminated by sponsor|0|||
129926332|NCT03854227|467696808|FG003|Overall Study|Study terminated by sponsor|0|||
129926333|NCT03854227|467696809|FG004|Overall Study|Study terminated by sponsor|0|||
129926334|NCT03854227|467696810|FG005|Overall Study|Study terminated by sponsor|0|||
129926335|NCT03854227|467696811|FG006|Overall Study|Study terminated by sponsor|0|||
129926336|NCT03854227|467696812|FG007|Overall Study|Study terminated by sponsor|0|||
129926337|NCT03854227|467696813|FG008|Overall Study|Study terminated by sponsor|0|||
129926338|NCT03854227|467696814|FG009|Overall Study|Study terminated by sponsor|1|||
129926339|NCT03854227|467696815|FG010|Overall Study|Study terminated by sponsor|0|||
129926340|NCT03854227|467696816|FG011|Overall Study|Study terminated by sponsor|0|||
129926341|NCT03854227|467696805|FG000|Overall Study|Withdrawal by Subject|0|||
129926342|NCT03854227|467696806|FG001|Overall Study|Withdrawal by Subject|0|||
129926343|NCT03854227|467696807|FG002|Overall Study|Withdrawal by Subject|1|||
129926344|NCT03854227|467696808|FG003|Overall Study|Withdrawal by Subject|0|||
129926345|NCT03854227|467696809|FG004|Overall Study|Withdrawal by Subject|0|||
129926346|NCT03854227|467696810|FG005|Overall Study|Withdrawal by Subject|0|||
129926347|NCT03854227|467696811|FG006|Overall Study|Withdrawal by Subject|0|||
129926348|NCT03854227|467696812|FG007|Overall Study|Withdrawal by Subject|0|||
129926349|NCT03854227|467696813|FG008|Overall Study|Withdrawal by Subject|0|||
129926350|NCT03854227|467696814|FG009|Overall Study|Withdrawal by Subject|1|||
129926351|NCT03854227|467696815|FG010|Overall Study|Withdrawal by Subject|1|||
129926352|NCT03854227|467696816|FG011|Overall Study|Withdrawal by Subject|0|||
129926353|NCT03854227|467696805|FG000|Overall Study|Disease relapse|0|||
129926354|NCT03854227|467696806|FG001|Overall Study|Disease relapse|0|||
129926355|NCT03854227|467696807|FG002|Overall Study|Disease relapse|0|||
129926356|NCT03854227|467696808|FG003|Overall Study|Disease relapse|0|||
129926357|NCT03854227|467696809|FG004|Overall Study|Disease relapse|0|||
129926358|NCT03854227|467696810|FG005|Overall Study|Disease relapse|0|||
129926359|NCT03854227|467696811|FG006|Overall Study|Disease relapse|0|||
129926360|NCT03854227|467696812|FG007|Overall Study|Disease relapse|0|||
129926361|NCT03854227|467696813|FG008|Overall Study|Disease relapse|1|||
129926362|NCT03854227|467696814|FG009|Overall Study|Disease relapse|0|||
129926363|NCT03854227|467696815|FG010|Overall Study|Disease relapse|0|||
129926364|NCT03854227|467696816|FG011|Overall Study|Disease relapse|0|||
129926365|NCT03854227|467696805|FG000|Overall Study|Global deterioration of health status|0|||
129926366|NCT03854227|467696806|FG001|Overall Study|Global deterioration of health status|0|||
129926367|NCT03854227|467696807|FG002|Overall Study|Global deterioration of health status|0|||
129926368|NCT03854227|467696808|FG003|Overall Study|Global deterioration of health status|0|||
129926369|NCT03854227|467696809|FG004|Overall Study|Global deterioration of health status|0|||
129926370|NCT03854227|467696810|FG005|Overall Study|Global deterioration of health status|1|||
129926371|NCT03854227|467696811|FG006|Overall Study|Global deterioration of health status|0|||
129926372|NCT03854227|467696812|FG007|Overall Study|Global deterioration of health status|1|||
129926373|NCT03854227|467696813|FG008|Overall Study|Global deterioration of health status|0|||
129926374|NCT03854227|467696814|FG009|Overall Study|Global deterioration of health status|0|||
129926375|NCT03854227|467696815|FG010|Overall Study|Global deterioration of health status|0|||
129926376|NCT03854227|467696816|FG011|Overall Study|Global deterioration of health status|0|||
129926377|NCT03854227|467696805|FG000|Overall Study|Refused further treatment|0|||
129926378|NCT03854227|467696806|FG001|Overall Study|Refused further treatment|0|||
129926379|NCT03854227|467696807|FG002|Overall Study|Refused further treatment|0|||
129926380|NCT03854227|467696808|FG003|Overall Study|Refused further treatment|0|||
129926381|NCT03854227|467696809|FG004|Overall Study|Refused further treatment|0|||
129926382|NCT03854227|467696810|FG005|Overall Study|Refused further treatment|0|||
129926383|NCT03854227|467696811|FG006|Overall Study|Refused further treatment|0|||
129926384|NCT03854227|467696812|FG007|Overall Study|Refused further treatment|0|||
129926385|NCT03854227|467696813|FG008|Overall Study|Refused further treatment|0|||
129926386|NCT03854227|467696814|FG009|Overall Study|Refused further treatment|1|||
129926387|NCT03854227|467696815|FG010|Overall Study|Refused further treatment|0|||
129926388|NCT03854227|467696816|FG011|Overall Study|Refused further treatment|1|||
129926389|NCT03854227|467696805|FG000|Overall Study|Other|0|||
129926390|NCT03854227|467696806|FG001|Overall Study|Other|0|||
129926391|NCT03854227|467696807|FG002|Overall Study|Other|0|||
129926392|NCT03854227|467696808|FG003|Overall Study|Other|0|||
129926393|NCT03854227|467696809|FG004|Overall Study|Other|0|||
129926394|NCT03854227|467696810|FG005|Overall Study|Other|0|||
129926395|NCT03854227|467696811|FG006|Overall Study|Other|0|||
129926396|NCT03854227|467696812|FG007|Overall Study|Other|0|||
129926397|NCT03854227|467696813|FG008|Overall Study|Other|1|||
129926398|NCT03854227|467696814|FG009|Overall Study|Other|1|||
129926399|NCT03854227|467696815|FG010|Overall Study|Other|0|||
129926400|NCT03854227|467696816|FG011|Overall Study|Other|0|||
129926401|NCT03668236|467696817|FG000|90-day Follow-up|Withdrawal by Subject|3|||
129926402|NCT03668236|467696818|FG001|90-day Follow-up|Withdrawal by Subject|2|||
129926403|NCT03668236|467696817|FG000|90-day Follow-up|Lost to Follow-up|3|||
129926404|NCT03668236|467696818|FG001|90-day Follow-up|Lost to Follow-up|1|||
129926405|NCT03668236|467696817|FG000|Baseline Characteristics|Lost to Follow-up|9|||
129926406|NCT03668236|467696818|FG001|Baseline Characteristics|Lost to Follow-up|5|||
129926407|NCT03668236|467696817|FG000|1-year Follow-up|Withdrawal by Subject|17|||
129926408|NCT03668236|467696818|FG001|1-year Follow-up|Withdrawal by Subject|15|||
129926409|NCT06132282|467696824|FG000|Overall Study|Lost to Follow-up|31|||
129926410|NCT04376502|467696830|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
129926411|NCT03748953|467696831|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
129926412|NCT03748953|467696832|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
129926413|NCT03748953|467696831|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
129926414|NCT03748953|467696832|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
129926415|NCT03748953|467696831|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
129926416|NCT03748953|467696832|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
129926417|NCT03748953|467696831|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
129926418|NCT03748953|467696832|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
129926419|NCT03748953|467696831|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
129926420|NCT03748953|467696832|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
129926421|NCT04119843|467696837|FG000|Overall Study|Adverse Event|3|||
129926422|NCT04119843|467696837|FG000|Overall Study|Death|1|||
129926423|NCT02841579|467696838|FG000|Overall Study|Death|1|||
129926424|NCT02841579|467696838|FG000|Overall Study|Adverse Event|1|||
129926425|NCT02841579|467696838|FG000|Overall Study|Lack of Efficacy|9|||
129926426|NCT01501955|467696842|FG000|Overall Study|Withdrawal by Subject|1|||
129926427|NCT01501955|467696843|FG001|Overall Study|Withdrawal by Subject|0|||
129926428|NCT01501955|467696842|FG000|Overall Study|Adverse Event|1|||
129926429|NCT01501955|467696843|FG001|Overall Study|Adverse Event|3|||
129926430|NCT05034328|467696844|FG000|Overall Study|Protocol Violation|1|||
129926431|NCT05034328|467696845|FG001|Overall Study|Protocol Violation|0|||
129926432|NCT05034328|467696844|FG000|Overall Study|Lost to Follow-up|0|||
129926433|NCT05034328|467696845|FG001|Overall Study|Lost to Follow-up|10|||
129926434|NCT03625167|467696850|FG000|Overall Study|Protocol Violation|5|||
129926435|NCT02969707|467696853|FG000|Overall Study|Withdrawal by Subject|6|||
129926436|NCT02969707|467696854|FG001|Overall Study|Withdrawal by Subject|5|||
129926437|NCT02969707|467696853|FG000|Overall Study|Severe anxiety|0|||
129926438|NCT02969707|467696854|FG001|Overall Study|Severe anxiety|1|||
129926439|NCT02969707|467696853|FG000|Overall Study|Positive toxicology screen|0|||
129926440|NCT02969707|467696854|FG001|Overall Study|Positive toxicology screen|2|||
129926441|NCT02969707|467696853|FG000|Overall Study|Claustrophobia|2|||
129926442|NCT02969707|467696854|FG001|Overall Study|Claustrophobia|2|||
129926443|NCT02969707|467696853|FG000|Overall Study|Non-compliance|1|||
129926444|NCT02969707|467696854|FG001|Overall Study|Non-compliance|2|||
129926445|NCT04979442|467696855|FG000|Overall Study|Death|43|||
129926446|NCT04979442|467696856|FG001|Overall Study|Death|30|||
129926447|NCT04979442|467696855|FG000|Overall Study|Withdrawal by Subject|8|||
129926448|NCT04979442|467696856|FG001|Overall Study|Withdrawal by Subject|13|||
129926449|NCT04979442|467696855|FG000|Overall Study|Physician Decision|1|||
129926450|NCT04979442|467696856|FG001|Overall Study|Physician Decision|1|||
129926451|NCT04979442|467696855|FG000|Overall Study|Lost to Follow-up|0|||
129926452|NCT04979442|467696856|FG001|Overall Study|Lost to Follow-up|2|||
129926453|NCT04979442|467696855|FG000|Overall Study|do not want to continue|0|||
129926454|NCT04979442|467696856|FG001|Overall Study|do not want to continue|1|||
129926455|NCT04314713|467696859|FG000|Overall Study|Lost to Follow-up|0|||
129926456|NCT04314713|467696860|FG001|Overall Study|Lost to Follow-up|0|||
129926457|NCT04314713|467696861|FG002|Overall Study|Lost to Follow-up|0|||
129926458|NCT04314713|467696862|FG003|Overall Study|Lost to Follow-up|1|||
129926459|NCT04314713|467696863|FG004|Overall Study|Lost to Follow-up|0|||
129926460|NCT04314713|467696864|FG005|Overall Study|Lost to Follow-up|0|||
129926461|NCT00248287|467696869|FG000|Overall Study|Adverse Event|11|||
129926462|NCT00248287|467696870|FG001|Overall Study|Adverse Event|10|||
129926463|NCT00248287|467696869|FG000|Overall Study|Death|1|||
129926464|NCT00248287|467696870|FG001|Overall Study|Death|0|||
129926465|NCT00248287|467696869|FG000|Overall Study|Lost to Follow-up|0|||
129926466|NCT00248287|467696870|FG001|Overall Study|Lost to Follow-up|1|||
129926467|NCT00248287|467696869|FG000|Overall Study|Investigator Request|4|||
129926468|NCT00248287|467696870|FG001|Overall Study|Investigator Request|3|||
129926469|NCT00248287|467696869|FG000|Overall Study|Patient Request|5|||
129926470|NCT00248287|467696870|FG001|Overall Study|Patient Request|3|||
129926471|NCT00248287|467696869|FG000|Overall Study|Other|3|||
129926472|NCT00248287|467696870|FG001|Overall Study|Other|2|||
129926473|NCT02714257|467696871|FG000|Overall Study|Withdrawal by Subject|6|||
129926474|NCT02714257|467696872|FG001|Overall Study|Withdrawal by Subject|11|||
129926475|NCT02714257|467696871|FG000|Overall Study|Death|3|||
129926476|NCT02714257|467696872|FG001|Overall Study|Death|4|||
129926477|NCT02714257|467696871|FG000|Overall Study|Lost to Follow-up|1|||
129926478|NCT02714257|467696872|FG001|Overall Study|Lost to Follow-up|6|||
129926479|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
129926480|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
129926481|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
129926482|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
129926483|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
129926484|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
129926485|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
129926486|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
129926487|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
129926488|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
129926489|NCT04103580|467696873|FG000|Phase 1 Active Caregiving|Other|3|||
129926490|NCT04103580|467696874|FG001|Phase 1 Active Caregiving|Other|3|||
129926491|NCT04103580|467696873|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
129926492|NCT04103580|467696874|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
129926493|NCT04103580|467696873|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
129926494|NCT04103580|467696874|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
129926495|NCT04103580|467696873|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
129926496|NCT04103580|467696874|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
129926497|NCT04103580|467696873|FG000|Phase 2 Bereavement|Other|8|||
129926498|NCT04103580|467696874|FG001|Phase 2 Bereavement|Other|6|||
129926499|NCT04145440|467696875|FG000|Overall Study|Physician Decision|3|||
129926500|NCT04145440|467696876|FG001|Overall Study|Physician Decision|0|||
129926501|NCT04145440|467696875|FG000|Overall Study|Use of prohibited therapy|2|||
129926502|NCT04145440|467696876|FG001|Overall Study|Use of prohibited therapy|3|||
129926503|NCT05297565|467696881|FG000|Overall Study|Other Reasons|0|||
129926504|NCT05297565|467696882|FG001|Overall Study|Other Reasons|1|||
129926505|NCT05297565|467696881|FG000|Overall Study|Physician Decision|0|||
129926506|NCT05297565|467696882|FG001|Overall Study|Physician Decision|1|||
129926507|NCT05297565|467696881|FG000|Overall Study|Disease recurrence|1|||
129926508|NCT05297565|467696882|FG001|Overall Study|Disease recurrence|0|||
129926509|NCT05670587|467696883|FG000|Overall Study|Withdrawal by Subject|3|||
129926510|NCT05940194|467696884|FG000|Overall Study|Adverse Event|0|||
129926511|NCT05940194|467696885|FG001|Overall Study|Adverse Event|1|||
129926512|NCT05940194|467696886|FG002|Overall Study|Adverse Event|0|||
129926513|NCT05940194|467696884|FG000|Overall Study|Migrated/Moved from the study area|2|||
129926514|NCT05940194|467696885|FG001|Overall Study|Migrated/Moved from the study area|2|||
129926515|NCT05940194|467696886|FG002|Overall Study|Migrated/Moved from the study area|4|||
129926516|NCT03235544|467696887|FG000|Overall Study|Death|11|||
129926517|NCT03235544|467696888|FG001|Overall Study|Death|31|||
129926518|NCT03235544|467696889|FG002|Overall Study|Death|19|||
129926519|NCT03235544|467696890|FG003|Overall Study|Death|34|||
129926520|NCT03235544|467696887|FG000|Overall Study|Lost to Follow-up|0|||
129926521|NCT03235544|467696888|FG001|Overall Study|Lost to Follow-up|1|||
129926522|NCT03235544|467696889|FG002|Overall Study|Lost to Follow-up|1|||
129926523|NCT03235544|467696890|FG003|Overall Study|Lost to Follow-up|1|||
129926524|NCT03235544|467696887|FG000|Overall Study|Withdrawal by Subject|0|||
129926525|NCT03235544|467696888|FG001|Overall Study|Withdrawal by Subject|3|||
129926526|NCT03235544|467696889|FG002|Overall Study|Withdrawal by Subject|1|||
129926527|NCT03235544|467696890|FG003|Overall Study|Withdrawal by Subject|5|||
129926528|NCT03235544|467696887|FG000|Overall Study|Disease Progression|0|||
129926529|NCT03235544|467696888|FG001|Overall Study|Disease Progression|1|||
129926530|NCT03235544|467696889|FG002|Overall Study|Disease Progression|0|||
129926531|NCT03235544|467696890|FG003|Overall Study|Disease Progression|2|||
129926532|NCT03235544|467696887|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
129926533|NCT03235544|467696888|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
129926534|NCT03235544|467696889|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
129926535|NCT03235544|467696890|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
129926536|NCT03235544|467696887|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
129926537|NCT03235544|467696888|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
129926538|NCT03235544|467696889|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
129926539|NCT03235544|467696890|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
129926540|NCT04830800|467696892|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
129926541|NCT04830800|467696893|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
129926542|NCT04830800|467696894|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
129926543|NCT04830800|467696895|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
129926544|NCT04830800|467696896|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
129926545|NCT03710603|467696899|FG000|Overall Study|Adverse Event|1|||
129926546|NCT03710603|467696900|FG001|Overall Study|Adverse Event|0|||
129926547|NCT03710603|467696899|FG000|Overall Study|Death|44|||
129926548|NCT03710603|467696900|FG001|Overall Study|Death|34|||
129926549|NCT03710603|467696899|FG000|Overall Study|Lost to Follow-up|3|||
129926550|NCT03710603|467696900|FG001|Overall Study|Lost to Follow-up|5|||
129926551|NCT03710603|467696899|FG000|Overall Study|Withdrawal by Subject|11|||
129926552|NCT03710603|467696900|FG001|Overall Study|Withdrawal by Subject|10|||
129926553|NCT01456949|467696901|FG000|Enrollment|PI death- incomplete data|6|||
129926554|NCT01456949|467696901|FG000|Enrollment|Death|1|||
129926555|NCT01456949|467696901|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
129926556|NCT01456949|467696901|FG000|Enrollment|Physician Decision|10|||
129926557|NCT01456949|467696901|FG000|Enrollment|Withdrawal by Subject|7|||
129926558|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
129926559|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
129926560|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
129926561|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
129926562|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
129926563|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
129926564|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
129926565|NCT01456949|467696901|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
129926566|NCT02626533|467696902|FG000|Overall Study|Protocol Violation|14|||
129926567|NCT02626533|467696902|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
129926568|NCT02626533|467696902|FG000|Overall Study|Withdrawal by Subject|1|||
129926569|NCT04753697|467696903|FG000|Induction Phase|Withdrawal by Subject|12|||
129926570|NCT04753697|467696904|FG001|Induction Phase|Withdrawal by Subject|5|||
129926571|NCT04753697|467696905|FG002|Induction Phase|Withdrawal by Subject|6|||
129926572|NCT04753697|467696903|FG000|Induction Phase|Physician Decision|1|||
129926573|NCT04753697|467696904|FG001|Induction Phase|Physician Decision|0|||
129926574|NCT04753697|467696905|FG002|Induction Phase|Physician Decision|0|||
129926575|NCT04753697|467696903|FG000|Induction Phase|Lost to Follow-up|2|||
129926576|NCT04753697|467696904|FG001|Induction Phase|Lost to Follow-up|2|||
129926577|NCT04753697|467696905|FG002|Induction Phase|Lost to Follow-up|1|||
129926578|NCT04753697|467696903|FG000|Induction Phase|Lack of Efficacy|1|||
129926579|NCT04753697|467696904|FG001|Induction Phase|Lack of Efficacy|0|||
129926580|NCT04753697|467696905|FG002|Induction Phase|Lack of Efficacy|0|||
129926581|NCT04753697|467696903|FG000|Maintenance Phase|Physician Decision|0|||
129926582|NCT04753697|467696904|FG001|Maintenance Phase|Physician Decision|0|||
129926583|NCT04753697|467696905|FG002|Maintenance Phase|Physician Decision|1|||
129926584|NCT04753697|467696903|FG000|Maintenance Phase|Withdrawal by Subject|3|||
129926585|NCT04753697|467696904|FG001|Maintenance Phase|Withdrawal by Subject|4|||
129926586|NCT04753697|467696905|FG002|Maintenance Phase|Withdrawal by Subject|6|||
129926587|NCT04753697|467696903|FG000|Maintenance Phase|Lost to Follow-up|2|||
129926588|NCT04753697|467696904|FG001|Maintenance Phase|Lost to Follow-up|2|||
129926589|NCT04753697|467696905|FG002|Maintenance Phase|Lost to Follow-up|0|||
129926590|NCT04753697|467696903|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
129926591|NCT04753697|467696904|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
129926592|NCT04753697|467696905|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
129926593|NCT04753697|467696903|FG000|Maintenance Phase|Adverse Event|0|||
129926594|NCT04753697|467696904|FG001|Maintenance Phase|Adverse Event|1|||
129926595|NCT04753697|467696905|FG002|Maintenance Phase|Adverse Event|1|||
129926596|NCT04753697|467696903|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
129926597|NCT04753697|467696904|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
129926598|NCT04753697|467696905|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
129926599|NCT03701763|467696906|FG000|Placebo-controlled Phase|Adverse Event|1|||
129926600|NCT03701763|467696907|FG001|Placebo-controlled Phase|Adverse Event|5|||
129926601|NCT03701763|467696908|FG002|Placebo-controlled Phase|Adverse Event|0|||
129926602|NCT03701763|467696909|FG003|Placebo-controlled Phase|Adverse Event|0|||
129926603|NCT03701763|467696906|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
129926604|NCT03701763|467696907|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
129926605|NCT03701763|467696908|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
129926606|NCT03701763|467696909|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
129926607|NCT03701763|467696906|FG000|Placebo-controlled Phase|Miscellaneous|2|||
129926608|NCT03701763|467696907|FG001|Placebo-controlled Phase|Miscellaneous|0|||
129926609|NCT03701763|467696908|FG002|Placebo-controlled Phase|Miscellaneous|0|||
129926610|NCT03701763|467696909|FG003|Placebo-controlled Phase|Miscellaneous|0|||
129926611|NCT03701763|467696906|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
129926612|NCT03701763|467696907|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
129926613|NCT03701763|467696908|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
129926614|NCT03701763|467696909|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
129926615|NCT03701763|467696906|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
129926616|NCT03701763|467696907|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
129926617|NCT03701763|467696908|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
129926618|NCT03701763|467696909|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
129926619|NCT03701763|467696906|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
129926620|NCT03701763|467696907|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
129926621|NCT03701763|467696908|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
129926622|NCT03701763|467696909|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
129926623|NCT03701763|467696906|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
129926624|NCT03701763|467696907|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
129926625|NCT03701763|467696908|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
129926626|NCT03701763|467696909|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
129926627|NCT03701763|467696906|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
129926628|NCT03701763|467696907|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
129926629|NCT03701763|467696908|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
129926630|NCT03701763|467696909|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
129926631|NCT03701763|467696906|FG000|Apremilast Extension Phase|Adverse Event|0|||
129926632|NCT03701763|467696907|FG001|Apremilast Extension Phase|Adverse Event|0|||
129926633|NCT03701763|467696908|FG002|Apremilast Extension Phase|Adverse Event|3|||
129926634|NCT03701763|467696909|FG003|Apremilast Extension Phase|Adverse Event|1|||
129926635|NCT03701763|467696906|FG000|Apremilast Extension Phase|Miscellaneous|0|||
129926636|NCT03701763|467696907|FG001|Apremilast Extension Phase|Miscellaneous|0|||
129926637|NCT03701763|467696908|FG002|Apremilast Extension Phase|Miscellaneous|2|||
129926638|NCT03701763|467696909|FG003|Apremilast Extension Phase|Miscellaneous|1|||
129926639|NCT03701763|467696906|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
129926640|NCT03701763|467696907|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
129926641|NCT03701763|467696908|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
129926642|NCT03701763|467696909|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
129926643|NCT03701763|467696906|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
129926644|NCT03701763|467696907|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
129926645|NCT03701763|467696908|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
129926646|NCT03701763|467696909|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
129926647|NCT03701763|467696906|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
129926648|NCT03701763|467696907|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
129926649|NCT03701763|467696908|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
129926650|NCT03701763|467696909|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
129926651|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
129926652|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
129926653|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
129926654|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
129926655|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
129926656|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
129926657|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
129926658|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
129926659|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Other|0|||
129926660|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Other|0|||
129926661|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Other|1|||
129926662|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Other|0|||
129926663|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
129926664|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
129926665|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
129926666|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
129926667|NCT03701763|467696906|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
129926668|NCT03701763|467696907|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
129926669|NCT03701763|467696908|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
129926670|NCT03701763|467696909|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
129926671|NCT03511664|467696915|FG000|Overall Study|Death|457|||
129926672|NCT03511664|467696916|FG001|Overall Study|Death|201|||
129926673|NCT03511664|467696917|FG002|Overall Study|Death|21|||
129926674|NCT03511664|467696915|FG000|Overall Study|Withdrew consent|40|||
129926675|NCT03511664|467696916|FG001|Overall Study|Withdrew consent|63|||
129926676|NCT03511664|467696917|FG002|Overall Study|Withdrew consent|3|||
129926677|NCT03511664|467696915|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
129926678|NCT03511664|467696916|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
129926679|NCT03511664|467696917|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
129926680|NCT03511664|467696915|FG000|Overall Study|Lost to Follow-up|8|||
129926681|NCT03511664|467696916|FG001|Overall Study|Lost to Follow-up|5|||
129926682|NCT03511664|467696917|FG002|Overall Study|Lost to Follow-up|0|||
129926683|NCT03511664|467696915|FG000|Overall Study|Physician Decision|2|||
129926684|NCT03511664|467696916|FG001|Overall Study|Physician Decision|1|||
129926685|NCT03511664|467696917|FG002|Overall Study|Physician Decision|0|||
129926686|NCT03511664|467696915|FG000|Overall Study|Patient non-compliance|1|||
129926687|NCT03511664|467696916|FG001|Overall Study|Patient non-compliance|0|||
129926688|NCT03511664|467696917|FG002|Overall Study|Patient non-compliance|0|||
129926689|NCT02823145|467696922|FG000|Enrollment|Other|1|||
129926690|NCT02823145|467696923|FG001|Enrollment|Other|0|||
129926691|NCT02823145|467696922|FG000|Treatment|Adverse Event|0|||
129926692|NCT02823145|467696923|FG001|Treatment|Adverse Event|11|||
129926693|NCT02823145|467696922|FG000|Treatment|Death|0|||
129926694|NCT02823145|467696923|FG001|Treatment|Death|3|||
129926695|NCT02823145|467696922|FG000|Treatment|Family Decision|0|||
129926696|NCT02823145|467696923|FG001|Treatment|Family Decision|1|||
129926697|NCT02823145|467696922|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
129926698|NCT02823145|467696923|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
129926699|NCT02823145|467696922|FG000|Treatment|Lack of Efficacy|0|||
129926700|NCT02823145|467696923|FG001|Treatment|Lack of Efficacy|48|||
129926701|NCT02823145|467696922|FG000|Treatment|Non-Compliance With E-Diary|0|||
129926702|NCT02823145|467696923|FG001|Treatment|Non-Compliance With E-Diary|1|||
129926703|NCT02823145|467696922|FG000|Treatment|Physician Decision|0|||
129926704|NCT02823145|467696923|FG001|Treatment|Physician Decision|2|||
129926705|NCT02823145|467696922|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
129926706|NCT02823145|467696923|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
129926707|NCT02823145|467696922|FG000|Treatment|Subject needed to take prohibited medication|0|||
129926708|NCT02823145|467696923|FG001|Treatment|Subject needed to take prohibited medication|1|||
129926709|NCT02823145|467696922|FG000|Treatment|Subject transferred to direct access programme|0|||
129926710|NCT02823145|467696923|FG001|Treatment|Subject transferred to direct access programme|1|||
129926711|NCT02823145|467696922|FG000|Treatment|Switching to commercially available drug|0|||
129926712|NCT02823145|467696923|FG001|Treatment|Switching to commercially available drug|11|||
129926713|NCT02823145|467696922|FG000|Treatment|Transitioned to commercial supply of medication|0|||
129926714|NCT02823145|467696923|FG001|Treatment|Transitioned to commercial supply of medication|1|||
129926715|NCT02823145|467696922|FG000|Treatment|Withdrawal By Caregiver|0|||
129926716|NCT02823145|467696923|FG001|Treatment|Withdrawal By Caregiver|1|||
129926717|NCT02823145|467696922|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
129926718|NCT02823145|467696923|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
129926719|NCT02823145|467696922|FG000|Treatment|Withdrawal by Subject|0|||
129926720|NCT02823145|467696923|FG001|Treatment|Withdrawal by Subject|16|||
129926721|NCT02823145|467696922|FG000|Treatment|Reason unknown|0|||
129926722|NCT02823145|467696923|FG001|Treatment|Reason unknown|1|||
129926723|NCT05292391|467696924|FG000|Overall Study|Lost to Follow-up|0|||
129926724|NCT05292391|467696925|FG001|Overall Study|Lost to Follow-up|0|||
129926725|NCT05292391|467696926|FG002|Overall Study|Lost to Follow-up|0|||
129926726|NCT05292391|467696927|FG003|Overall Study|Lost to Follow-up|1|||
129926727|NCT05292391|467696928|FG004|Overall Study|Lost to Follow-up|0|||
129926728|NCT05809453|467698962|FG000|Overall Study|Withdrawal by Subject|1|||
129926729|NCT05809453|467698963|FG001|Overall Study|Withdrawal by Subject|0|||
129926730|NCT05809453|467698964|FG002|Overall Study|Withdrawal by Subject|0|||
129926731|NCT05809453|467698965|FG003|Overall Study|Withdrawal by Subject|0|||
129926732|NCT03287817|467698966|FG000|Overall Study|Progressive disease|4|||
129926733|NCT03287817|467698967|FG001|Overall Study|Progressive disease|2|||
129926734|NCT03287817|467698968|FG002|Overall Study|Progressive disease|3|||
129926735|NCT03287817|467698969|FG003|Overall Study|Progressive disease|10|||
129926736|NCT03287817|467698970|FG004|Overall Study|Progressive disease|8|||
129926737|NCT03287817|467698966|FG000|Overall Study|Death|0|||
129926738|NCT03287817|467698967|FG001|Overall Study|Death|0|||
129926739|NCT03287817|467698968|FG002|Overall Study|Death|2|||
129926740|NCT03287817|467698969|FG003|Overall Study|Death|3|||
129926741|NCT03287817|467698970|FG004|Overall Study|Death|4|||
129926742|NCT03287817|467698966|FG000|Overall Study|Physician Decision|0|||
129926743|NCT03287817|467698967|FG001|Overall Study|Physician Decision|0|||
129926744|NCT03287817|467698968|FG002|Overall Study|Physician Decision|0|||
129926745|NCT03287817|467698969|FG003|Overall Study|Physician Decision|1|||
129926746|NCT03287817|467698970|FG004|Overall Study|Physician Decision|0|||
129926747|NCT03287817|467698966|FG000|Overall Study|Withdrawal by Subject|0|||
129926748|NCT03287817|467698967|FG001|Overall Study|Withdrawal by Subject|0|||
129926749|NCT03287817|467698968|FG002|Overall Study|Withdrawal by Subject|0|||
129926750|NCT03287817|467698969|FG003|Overall Study|Withdrawal by Subject|0|||
129926751|NCT03287817|467698970|FG004|Overall Study|Withdrawal by Subject|4|||
129926752|NCT03257410|467698971|FG000|Overall Study|Adverse Event|2|||
129926753|NCT03257410|467698972|FG001|Overall Study|Adverse Event|3|||
129926754|NCT03257410|467698971|FG000|Overall Study|Protocol Violation|1|||
129926755|NCT03257410|467698972|FG001|Overall Study|Protocol Violation|2|||
129926756|NCT03257410|467698971|FG000|Overall Study|Lost to Follow-up|1|||
129926757|NCT03257410|467698972|FG001|Overall Study|Lost to Follow-up|0|||
129926758|NCT03257410|467698971|FG000|Overall Study|Withdrawal by Subject|1|||
129926759|NCT03257410|467698972|FG001|Overall Study|Withdrawal by Subject|2|||
129926760|NCT03257410|467698971|FG000|Overall Study|Physician Decision|1|||
129926761|NCT03257410|467698972|FG001|Overall Study|Physician Decision|1|||
129926762|NCT03257410|467698971|FG000|Overall Study|Renal transplantation|2|||
129926763|NCT03257410|467698972|FG001|Overall Study|Renal transplantation|0|||
129926764|NCT03257410|467698971|FG000|Overall Study|Switch to peritoneal dialysis|1|||
129926765|NCT03257410|467698972|FG001|Overall Study|Switch to peritoneal dialysis|0|||
129926766|NCT03257410|467698971|FG000|Overall Study|Death|3|||
129926767|NCT03257410|467698972|FG001|Overall Study|Death|2|||
129926768|NCT03257410|467698971|FG000|Overall Study|Change to another dialysis center|2|||
129926769|NCT03257410|467698972|FG001|Overall Study|Change to another dialysis center|2|||
129926770|NCT03257410|467698971|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
129926771|NCT03257410|467698972|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
129926772|NCT03257410|467698971|FG000|Overall Study|Miscellaneous|2|||
129926773|NCT03257410|467698972|FG001|Overall Study|Miscellaneous|2|||
129926774|NCT03257410|467698971|FG000|Overall Study|Other|0|||
129926775|NCT03257410|467698972|FG001|Overall Study|Other|1|||
129926776|NCT02276885|467698973|FG000|Overall Study|Withdrawal by Subject|2|||
129926777|NCT02276885|467698974|FG001|Overall Study|Withdrawal by Subject|0|||
129926778|NCT02276885|467698973|FG000|Overall Study|Lost to Follow-up|5|||
129926779|NCT02276885|467698974|FG001|Overall Study|Lost to Follow-up|2|||
129926780|NCT04171141|467698975|FG000|Overall Study|Adverse Event|0|||
129926781|NCT04171141|467698976|FG001|Overall Study|Adverse Event|0|||
129926782|NCT04171141|467698977|FG002|Overall Study|Adverse Event|2|||
129926783|NCT04171141|467698978|FG003|Overall Study|Adverse Event|0|||
129926784|NCT04171141|467698979|FG004|Overall Study|Adverse Event|0|||
129926785|NCT04171141|467698980|FG005|Overall Study|Adverse Event|0|||
129926786|NCT04171141|467698981|FG006|Overall Study|Adverse Event|0|||
129926787|NCT04171141|467698982|FG007|Overall Study|Adverse Event|0|||
129926788|NCT04171141|467698983|FG008|Overall Study|Adverse Event|0|||
129926789|NCT04171141|467698984|FG009|Overall Study|Adverse Event|0|||
129926790|NCT04171141|467698985|FG010|Overall Study|Adverse Event|0|||
129926791|NCT04171141|467698986|FG011|Overall Study|Adverse Event|0|||
129926792|NCT04171141|467698987|FG012|Overall Study|Adverse Event|0|||
129926793|NCT04171141|467698988|FG013|Overall Study|Adverse Event|2|||
129926794|NCT04171141|467698989|FG014|Overall Study|Adverse Event|0|||
129926795|NCT04171141|467698990|FG015|Overall Study|Adverse Event|0|||
129926796|NCT04171141|467698975|FG000|Overall Study|Physician Decision|0|||
129926797|NCT04171141|467698976|FG001|Overall Study|Physician Decision|0|||
129926798|NCT04171141|467698977|FG002|Overall Study|Physician Decision|0|||
129926799|NCT04171141|467698978|FG003|Overall Study|Physician Decision|0|||
129926800|NCT04171141|467698979|FG004|Overall Study|Physician Decision|1|||
129926801|NCT04171141|467698980|FG005|Overall Study|Physician Decision|0|||
129926802|NCT04171141|467698981|FG006|Overall Study|Physician Decision|0|||
129926803|NCT04171141|467698982|FG007|Overall Study|Physician Decision|0|||
129926804|NCT04171141|467698983|FG008|Overall Study|Physician Decision|0|||
129926805|NCT04171141|467698984|FG009|Overall Study|Physician Decision|0|||
129926806|NCT04171141|467698985|FG010|Overall Study|Physician Decision|0|||
129926807|NCT04171141|467698986|FG011|Overall Study|Physician Decision|0|||
129926808|NCT04171141|467698987|FG012|Overall Study|Physician Decision|0|||
129926809|NCT04171141|467698988|FG013|Overall Study|Physician Decision|0|||
129926810|NCT04171141|467698989|FG014|Overall Study|Physician Decision|0|||
129926811|NCT04171141|467698990|FG015|Overall Study|Physician Decision|1|||
129926812|NCT04171141|467698975|FG000|Overall Study|Progressive disease|2|||
129926813|NCT04171141|467698976|FG001|Overall Study|Progressive disease|3|||
129926814|NCT04171141|467698977|FG002|Overall Study|Progressive disease|4|||
129926815|NCT04171141|467698978|FG003|Overall Study|Progressive disease|7|||
129926816|NCT04171141|467698979|FG004|Overall Study|Progressive disease|1|||
129926817|NCT04171141|467698980|FG005|Overall Study|Progressive disease|8|||
129926818|NCT04171141|467698981|FG006|Overall Study|Progressive disease|4|||
129926819|NCT04171141|467698982|FG007|Overall Study|Progressive disease|6|||
129926820|NCT04171141|467698983|FG008|Overall Study|Progressive disease|7|||
129926821|NCT04171141|467698984|FG009|Overall Study|Progressive disease|3|||
129926822|NCT04171141|467698985|FG010|Overall Study|Progressive disease|4|||
129926823|NCT04171141|467698986|FG011|Overall Study|Progressive disease|3|||
129926824|NCT04171141|467698987|FG012|Overall Study|Progressive disease|4|||
129926825|NCT04171141|467698988|FG013|Overall Study|Progressive disease|2|||
129926826|NCT04171141|467698989|FG014|Overall Study|Progressive disease|4|||
129926827|NCT04171141|467698990|FG015|Overall Study|Progressive disease|1|||
129926828|NCT04171141|467698975|FG000|Overall Study|Withdrawal by Subject|0|||
129926829|NCT04171141|467698976|FG001|Overall Study|Withdrawal by Subject|0|||
129926830|NCT04171141|467698977|FG002|Overall Study|Withdrawal by Subject|0|||
129926831|NCT04171141|467698978|FG003|Overall Study|Withdrawal by Subject|1|||
129926832|NCT04171141|467698979|FG004|Overall Study|Withdrawal by Subject|0|||
129926833|NCT04171141|467698980|FG005|Overall Study|Withdrawal by Subject|0|||
129926834|NCT04171141|467698981|FG006|Overall Study|Withdrawal by Subject|1|||
129926835|NCT04171141|467698982|FG007|Overall Study|Withdrawal by Subject|0|||
129926836|NCT04171141|467698983|FG008|Overall Study|Withdrawal by Subject|0|||
129926837|NCT04171141|467698984|FG009|Overall Study|Withdrawal by Subject|1|||
129926838|NCT04171141|467698985|FG010|Overall Study|Withdrawal by Subject|0|||
129926839|NCT04171141|467698986|FG011|Overall Study|Withdrawal by Subject|0|||
129926840|NCT04171141|467698987|FG012|Overall Study|Withdrawal by Subject|0|||
129926841|NCT04171141|467698988|FG013|Overall Study|Withdrawal by Subject|0|||
129926842|NCT04171141|467698989|FG014|Overall Study|Withdrawal by Subject|0|||
129926843|NCT04171141|467698990|FG015|Overall Study|Withdrawal by Subject|0|||
129926844|NCT04171141|467698975|FG000|Overall Study|Global deterioration of health status|0|||
129926845|NCT04171141|467698976|FG001|Overall Study|Global deterioration of health status|0|||
129926846|NCT04171141|467698977|FG002|Overall Study|Global deterioration of health status|0|||
129926847|NCT04171141|467698978|FG003|Overall Study|Global deterioration of health status|1|||
129926848|NCT04171141|467698979|FG004|Overall Study|Global deterioration of health status|0|||
129926849|NCT04171141|467698980|FG005|Overall Study|Global deterioration of health status|2|||
129926850|NCT04171141|467698981|FG006|Overall Study|Global deterioration of health status|1|||
129926851|NCT04171141|467698982|FG007|Overall Study|Global deterioration of health status|0|||
129926852|NCT04171141|467698983|FG008|Overall Study|Global deterioration of health status|1|||
129926853|NCT04171141|467698984|FG009|Overall Study|Global deterioration of health status|0|||
129926854|NCT04171141|467698985|FG010|Overall Study|Global deterioration of health status|0|||
129926855|NCT04171141|467698986|FG011|Overall Study|Global deterioration of health status|0|||
129926856|NCT04171141|467698987|FG012|Overall Study|Global deterioration of health status|0|||
129926857|NCT04171141|467698988|FG013|Overall Study|Global deterioration of health status|0|||
129926858|NCT04171141|467698989|FG014|Overall Study|Global deterioration of health status|1|||
129926859|NCT04171141|467698990|FG015|Overall Study|Global deterioration of health status|1|||
129926860|NCT03314454|467698993|FG000|Overall Study|Protocol Violation|1|||
129926861|NCT03652389|467698994|FG000|Overall Study|Lost to Follow-up|1|||
129926862|NCT03652389|467698995|FG001|Overall Study|Lost to Follow-up|5|||
129926863|NCT03652389|467698994|FG000|Overall Study|Withdrawal by Subject|5|||
129926864|NCT03652389|467698995|FG001|Overall Study|Withdrawal by Subject|1|||
129926865|NCT03652389|467698994|FG000|Overall Study|New diagnosis|2|||
129926866|NCT03652389|467698995|FG001|Overall Study|New diagnosis|0|||
129926867|NCT05496231|467699002|FG000|Overall Study|Adverse Event|1|||
129926868|NCT05496231|467699003|FG001|Overall Study|Adverse Event|1|||
129926869|NCT05496231|467699004|FG002|Overall Study|Adverse Event|0|||
129926870|NCT05496231|467699005|FG003|Overall Study|Adverse Event|4|||
129926871|NCT05496231|467699002|FG000|Overall Study|Withdrawal by Subject|5|||
129926872|NCT05496231|467699003|FG001|Overall Study|Withdrawal by Subject|5|||
129926873|NCT05496231|467699004|FG002|Overall Study|Withdrawal by Subject|4|||
129926874|NCT05496231|467699005|FG003|Overall Study|Withdrawal by Subject|11|||
129926875|NCT05496231|467699002|FG000|Overall Study|Migrated/moved from the study area|3|||
129926876|NCT05496231|467699003|FG001|Overall Study|Migrated/moved from the study area|5|||
129926877|NCT05496231|467699004|FG002|Overall Study|Migrated/moved from the study area|3|||
129926878|NCT05496231|467699005|FG003|Overall Study|Migrated/moved from the study area|3|||
129926879|NCT05496231|467699002|FG000|Overall Study|Lost to Follow-up|13|||
129926880|NCT05496231|467699003|FG001|Overall Study|Lost to Follow-up|6|||
129926881|NCT05496231|467699004|FG002|Overall Study|Lost to Follow-up|11|||
129926882|NCT05496231|467699005|FG003|Overall Study|Lost to Follow-up|6|||
129926883|NCT05496231|467699002|FG000|Overall Study|Other|9|||
129926884|NCT05496231|467699003|FG001|Overall Study|Other|7|||
129926885|NCT05496231|467699004|FG002|Overall Study|Other|7|||
129926886|NCT05496231|467699005|FG003|Overall Study|Other|8|||
129926887|NCT05029622|467699008|FG000|Overall Study|Lost to Follow-up|1|||
129926888|NCT05526430|467699013|FG000|Overall Study|Withdrawal by Subject|0|||
129926889|NCT05526430|467699014|FG001|Overall Study|Withdrawal by Subject|2|||
129926890|NCT05526430|467699015|FG002|Overall Study|Withdrawal by Subject|0|||
129926891|NCT05526430|467699016|FG003|Overall Study|Withdrawal by Subject|0|||
129926892|NCT03085810|467699017|FG000|Main Study|Withdrawal by Subject|77|||
129926893|NCT03085810|467699018|FG001|Main Study|Withdrawal by Subject|0|||
129926894|NCT03085810|467699019|FG002|Main Study|Withdrawal by Subject|0|||
129926895|NCT03085810|467699017|FG000|Main Study|Terminated By Sponsor|14|||
129926896|NCT03085810|467699018|FG001|Main Study|Terminated By Sponsor|0|||
129926897|NCT03085810|467699019|FG002|Main Study|Terminated By Sponsor|0|||
129926898|NCT03085810|467699017|FG000|Main Study|Protocol Violation|15|||
129926899|NCT03085810|467699018|FG001|Main Study|Protocol Violation|0|||
129926900|NCT03085810|467699019|FG002|Main Study|Protocol Violation|0|||
129926901|NCT03085810|467699017|FG000|Main Study|Physician Decision|13|||
129926902|NCT03085810|467699018|FG001|Main Study|Physician Decision|0|||
129926903|NCT03085810|467699019|FG002|Main Study|Physician Decision|0|||
129926904|NCT03085810|467699017|FG000|Main Study|Lost to Follow-up|17|||
129926905|NCT03085810|467699018|FG001|Main Study|Lost to Follow-up|0|||
129926906|NCT03085810|467699019|FG002|Main Study|Lost to Follow-up|0|||
129926907|NCT03085810|467699017|FG000|Main Study|Adverse Event|25|||
129926908|NCT03085810|467699018|FG001|Main Study|Adverse Event|0|||
129926909|NCT03085810|467699019|FG002|Main Study|Adverse Event|0|||
129926910|NCT03085810|467699017|FG000|Main Study|Pregnancy|7|||
129926911|NCT03085810|467699018|FG001|Main Study|Pregnancy|0|||
129926912|NCT03085810|467699019|FG002|Main Study|Pregnancy|0|||
129926913|NCT03085810|467699017|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
129926914|NCT03085810|467699018|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
129926915|NCT03085810|467699019|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
129926916|NCT03085810|467699017|FG000|Main Study|Lack of Efficacy|10|||
129926917|NCT03085810|467699018|FG001|Main Study|Lack of Efficacy|0|||
129926918|NCT03085810|467699019|FG002|Main Study|Lack of Efficacy|0|||
129926919|NCT03085810|467699017|FG000|Main Study|Death|12|||
129926920|NCT03085810|467699018|FG001|Main Study|Death|0|||
129926921|NCT03085810|467699019|FG002|Main Study|Death|0|||
129926922|NCT03085810|467699017|FG000|Main Study|Disease progression|1|||
129926923|NCT03085810|467699018|FG001|Main Study|Disease progression|0|||
129926924|NCT03085810|467699019|FG002|Main Study|Disease progression|0|||
129926925|NCT03085810|467699017|FG000|Main Study|Site Closure|3|||
129926926|NCT03085810|467699018|FG001|Main Study|Site Closure|0|||
129926927|NCT03085810|467699019|FG002|Main Study|Site Closure|0|||
129926928|NCT03085810|467699017|FG000|Main Study|Planned pregnancy|17|||
129926929|NCT03085810|467699018|FG001|Main Study|Planned pregnancy|0|||
129926930|NCT03085810|467699019|FG002|Main Study|Planned pregnancy|0|||
129926931|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
129926932|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
129926933|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
129926934|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
129926935|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
129926936|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
129926937|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
129926938|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
129926939|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
129926940|NCT03085810|467699017|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
129926941|NCT03085810|467699018|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
129926942|NCT03085810|467699019|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
129926943|NCT05200403|467699022|FG000|Overall Study|Withdrawal by Subject|4|||
129926944|NCT05200403|467699023|FG001|Overall Study|Withdrawal by Subject|2|||
129926945|NCT05200403|467699024|FG002|Overall Study|Withdrawal by Subject|6|||
129926946|NCT01959607|467699025|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
129926947|NCT01959607|467699026|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
129926948|NCT01959607|467699027|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129926949|NCT01959607|467699028|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
129926950|NCT04054193|467699041|FG000|Cycle 1|Physician Decision|1|||
129926951|NCT04054193|467699041|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
129926952|NCT04054193|467699041|FG000|Cycle 1|Allocated but not treated|3|||
129926953|NCT04054193|467699041|FG000|Cycles 2-3|Physician Decision|2|||
129926954|NCT04054193|467699041|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
129926955|NCT04054193|467699041|FG000|Cycles 2-3|Various reasons|17|||
129926956|NCT02966873|467699042|FG000|Overall Study|Lost to Follow-up|16|||
129926957|NCT02966873|467699043|FG001|Overall Study|Lost to Follow-up|15|||
129926958|NCT03084536|467699044|FG000|Overall Study|Determined to be ineligible|0|||
129926959|NCT03084536|467699045|FG001|Overall Study|Determined to be ineligible|0|||
129926960|NCT03084536|467699046|FG002|Overall Study|Determined to be ineligible|16|||
129926961|NCT03084536|467699044|FG000|Overall Study|Withdrawal by Subject|0|||
129926962|NCT03084536|467699045|FG001|Overall Study|Withdrawal by Subject|0|||
129926963|NCT03084536|467699046|FG002|Overall Study|Withdrawal by Subject|4|||
129926964|NCT03084536|467699044|FG000|Overall Study|Physician Decision|0|||
129926965|NCT03084536|467699045|FG001|Overall Study|Physician Decision|0|||
129926966|NCT03084536|467699046|FG002|Overall Study|Physician Decision|3|||
129926967|NCT03084536|467699044|FG000|Overall Study|Death|0|||
129926968|NCT03084536|467699045|FG001|Overall Study|Death|0|||
129926969|NCT03084536|467699046|FG002|Overall Study|Death|1|||
129926970|NCT03084536|467699044|FG000|Overall Study|Lost to Follow-up|0|||
129926971|NCT03084536|467699045|FG001|Overall Study|Lost to Follow-up|0|||
129926972|NCT03084536|467699046|FG002|Overall Study|Lost to Follow-up|1|||
129926973|NCT03084536|467699044|FG000|Overall Study|Protocol Violation|0|||
129926974|NCT03084536|467699045|FG001|Overall Study|Protocol Violation|0|||
129926975|NCT03084536|467699046|FG002|Overall Study|Protocol Violation|1|||
129926976|NCT03084536|467699044|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
129926977|NCT03084536|467699045|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
129926978|NCT03084536|467699046|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
129926979|NCT05073458|467699049|FG000|24-week Double-blind Period|Adverse Event|1|||
129926980|NCT05073458|467699050|FG001|24-week Double-blind Period|Adverse Event|0|||
129926981|NCT05073458|467699049|FG000|24-week Double-blind Period|Physician Decision|1|||
129926982|NCT05073458|467699050|FG001|24-week Double-blind Period|Physician Decision|0|||
129926983|NCT05073458|467699049|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
129926984|NCT05073458|467699050|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
129926985|NCT05073458|467699049|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
129926986|NCT05073458|467699050|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
129926987|NCT05073458|467699049|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
129926988|NCT05073458|467699050|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
129926989|NCT05073458|467699049|FG000|24-week Open-label Period|Adverse Event|1|||
129926990|NCT05073458|467699050|FG001|24-week Open-label Period|Adverse Event|2|||
129926991|NCT04850898|467699061|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
129926992|NCT04850898|467699062|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
129926993|NCT03785964|467699064|FG000|Overall Study|Adverse Event|14|||
129926994|NCT03785964|467699065|FG001|Overall Study|Adverse Event|1|||
129926995|NCT03785964|467699064|FG000|Overall Study|Unqualified Clinical Progression|1|||
129926996|NCT03785964|467699065|FG001|Overall Study|Unqualified Clinical Progression|1|||
129926997|NCT03785964|467699064|FG000|Overall Study|Participant non-compliance|1|||
129926998|NCT03785964|467699065|FG001|Overall Study|Participant non-compliance|1|||
129926999|NCT03785964|467699064|FG000|Overall Study|Not treated|1|||
129927000|NCT03785964|467699065|FG001|Overall Study|Not treated|0|||
129927001|NCT03785964|467699064|FG000|Overall Study|Other reason|5|||
129927002|NCT03785964|467699065|FG001|Overall Study|Other reason|11|||
129927003|NCT03785964|467699064|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
129927004|NCT03785964|467699065|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
129927005|NCT04117347|467699072|FG000|Overall Study|Adverse Event|0|||
129927006|NCT04117347|467699073|FG001|Overall Study|Adverse Event|0|||
129927007|NCT04117347|467699074|FG002|Overall Study|Adverse Event|1|||
129927008|NCT04117347|467699072|FG000|Overall Study|No time for study|0|||
129927009|NCT04117347|467699073|FG001|Overall Study|No time for study|2|||
129927010|NCT04117347|467699074|FG002|Overall Study|No time for study|0|||
129927011|NCT04117347|467699072|FG000|Overall Study|Family emergency|1|||
129927012|NCT04117347|467699073|FG001|Overall Study|Family emergency|0|||
129927013|NCT04117347|467699074|FG002|Overall Study|Family emergency|0|||
129927014|NCT02505984|467699075|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
129927015|NCT02505984|467699076|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
129927016|NCT02505984|467699075|FG000|Overall Study|Unreliable self-report data|1|||
129927017|NCT02505984|467699076|FG001|Overall Study|Unreliable self-report data|0|||
129927018|NCT02505984|467699075|FG000|Overall Study|Study blind opened during assessment|0|||
129927019|NCT02505984|467699076|FG001|Overall Study|Study blind opened during assessment|1|||
129927020|NCT02505984|467699075|FG000|Overall Study|Noncompliance with study protocol|0|||
129927021|NCT02505984|467699076|FG001|Overall Study|Noncompliance with study protocol|1|||
129927022|NCT03687086|467699077|FG000|Overall Study|Withdrawal by Subject|3|||
129927023|NCT03687086|467699078|FG001|Overall Study|Withdrawal by Subject|4|||
129927024|NCT03687086|467699077|FG000|Overall Study|Lost to Follow-up|1|||
129927025|NCT03687086|467699078|FG001|Overall Study|Lost to Follow-up|1|||
129927026|NCT03687086|467699077|FG000|Overall Study|Death|1|||
129927027|NCT03687086|467699078|FG001|Overall Study|Death|0|||
129927028|NCT03687086|467699077|FG000|Overall Study|Incomplete assessment|0|||
129927029|NCT03687086|467699078|FG001|Overall Study|Incomplete assessment|2|||
129927030|NCT06473662|467699083|FG000|Overall Study|Withdrawal by Subject|1|||
129927031|NCT06473662|467699084|FG001|Overall Study|Withdrawal by Subject|6|||
129927032|NCT06473662|467699085|FG002|Overall Study|Withdrawal by Subject|5|||
129927033|NCT06473662|467699083|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
129927034|NCT06473662|467699084|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
129927035|NCT06473662|467699085|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
129927036|NCT06473662|467699083|FG000|Overall Study|Starting HbA1c below 7%|0|||
129927037|NCT06473662|467699084|FG001|Overall Study|Starting HbA1c below 7%|1|||
129927038|NCT06473662|467699085|FG002|Overall Study|Starting HbA1c below 7%|1|||
129927039|NCT06473662|467699083|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
129927040|NCT06473662|467699084|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
129927041|NCT06473662|467699085|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
129927042|NCT06473662|467699083|FG000|Overall Study|Did not take medication|2|||
129927043|NCT06473662|467699084|FG001|Overall Study|Did not take medication|3|||
129927044|NCT06473662|467699085|FG002|Overall Study|Did not take medication|2|||
129927045|NCT04515849|467699086|FG000|Overall Study|Adverse Event|0|||
129927046|NCT04515849|467699087|FG001|Overall Study|Adverse Event|0|||
129927047|NCT04515849|467699088|FG002|Overall Study|Adverse Event|0|||
129927048|NCT04515849|467699089|FG003|Overall Study|Adverse Event|1|||
129927049|NCT04515849|467699090|FG004|Overall Study|Adverse Event|2|||
129927050|NCT04515849|467699086|FG000|Overall Study|Death|2|||
129927051|NCT04515849|467699087|FG001|Overall Study|Death|0|||
129927052|NCT04515849|467699088|FG002|Overall Study|Death|0|||
129927053|NCT04515849|467699089|FG003|Overall Study|Death|0|||
129927054|NCT04515849|467699090|FG004|Overall Study|Death|0|||
129927055|NCT04515849|467699086|FG000|Overall Study|Other:family emergency|0|||
129927056|NCT04515849|467699087|FG001|Overall Study|Other:family emergency|0|||
129927057|NCT04515849|467699088|FG002|Overall Study|Other:family emergency|0|||
129927058|NCT04515849|467699089|FG003|Overall Study|Other:family emergency|1|||
129927059|NCT04515849|467699090|FG004|Overall Study|Other:family emergency|0|||
129927060|NCT04515849|467699086|FG000|Overall Study|Other:randomised by error|0|||
129927061|NCT04515849|467699087|FG001|Overall Study|Other:randomised by error|1|||
129927062|NCT04515849|467699088|FG002|Overall Study|Other:randomised by error|0|||
129927063|NCT04515849|467699089|FG003|Overall Study|Other:randomised by error|0|||
129927064|NCT04515849|467699090|FG004|Overall Study|Other:randomised by error|0|||
129927065|NCT04515849|467699086|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927066|NCT04515849|467699087|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927067|NCT04515849|467699088|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927068|NCT04515849|467699089|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
129927069|NCT04515849|467699090|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
129927070|NCT04515849|467699086|FG000|Overall Study|Physician Decision|0|||
129927071|NCT04515849|467699087|FG001|Overall Study|Physician Decision|1|||
129927072|NCT04515849|467699088|FG002|Overall Study|Physician Decision|0|||
129927073|NCT04515849|467699089|FG003|Overall Study|Physician Decision|0|||
129927074|NCT04515849|467699090|FG004|Overall Study|Physician Decision|0|||
129927075|NCT04515849|467699086|FG000|Overall Study|Withdrawal by Subject|1|||
129927076|NCT04515849|467699087|FG001|Overall Study|Withdrawal by Subject|2|||
129927077|NCT04515849|467699088|FG002|Overall Study|Withdrawal by Subject|1|||
129927078|NCT04515849|467699089|FG003|Overall Study|Withdrawal by Subject|0|||
129927079|NCT04515849|467699090|FG004|Overall Study|Withdrawal by Subject|0|||
129927080|NCT04577963|467699100|FG000|Part 2|Death|0|||
129927081|NCT04577963|467699101|FG001|Part 2|Death|1|||
129927082|NCT04577963|467699102|FG002|Part 2|Death|8|||
129927083|NCT04577963|467699103|FG003|Part 2|Death|0|||
129927084|NCT04577963|467699104|FG004|Part 2|Death|20|||
129927085|NCT04577963|467699100|FG000|Part 2|Lost to Follow-up|0|||
129927086|NCT04577963|467699101|FG001|Part 2|Lost to Follow-up|0|||
129927087|NCT04577963|467699102|FG002|Part 2|Lost to Follow-up|0|||
129927088|NCT04577963|467699103|FG003|Part 2|Lost to Follow-up|0|||
129927089|NCT04577963|467699104|FG004|Part 2|Lost to Follow-up|2|||
129927090|NCT04577963|467699100|FG000|Part 2|Withdrawal by Subject|0|||
129927091|NCT04577963|467699101|FG001|Part 2|Withdrawal by Subject|0|||
129927092|NCT04577963|467699102|FG002|Part 2|Withdrawal by Subject|0|||
129927093|NCT04577963|467699103|FG003|Part 2|Withdrawal by Subject|0|||
129927094|NCT04577963|467699104|FG004|Part 2|Withdrawal by Subject|10|||
129927095|NCT04577963|467699100|FG000|Part 2|Progressive disease|0|||
129927096|NCT04577963|467699101|FG001|Part 2|Progressive disease|0|||
129927097|NCT04577963|467699102|FG002|Part 2|Progressive disease|0|||
129927098|NCT04577963|467699103|FG003|Part 2|Progressive disease|0|||
129927099|NCT04577963|467699104|FG004|Part 2|Progressive disease|2|||
129927100|NCT04577963|467699100|FG000|Part 2|Investigator decision|0|||
129927101|NCT04577963|467699101|FG001|Part 2|Investigator decision|0|||
129927102|NCT04577963|467699102|FG002|Part 2|Investigator decision|0|||
129927103|NCT04577963|467699103|FG003|Part 2|Investigator decision|0|||
129927104|NCT04577963|467699104|FG004|Part 2|Investigator decision|1|||
129927105|NCT04577963|467699100|FG000|Part 2|Sponsor terminated study|0|||
129927106|NCT04577963|467699101|FG001|Part 2|Sponsor terminated study|0|||
129927107|NCT04577963|467699102|FG002|Part 2|Sponsor terminated study|3|||
129927108|NCT04577963|467699103|FG003|Part 2|Sponsor terminated study|1|||
129927109|NCT04577963|467699104|FG004|Part 2|Sponsor terminated study|4|||
129927110|NCT04857723|467699105|FG000|Overall Study|Withdrawal by Subject|2|||
129927111|NCT03221426|467699106|FG000|Overall Study|Ongoing in study|212|||
129927112|NCT03221426|467699107|FG001|Overall Study|Ongoing in study|193|||
129927113|NCT03221426|467699108|FG002|Overall Study|Ongoing in study|61|||
129927114|NCT03221426|467699109|FG003|Overall Study|Ongoing in study|55|||
129927115|NCT03221426|467699106|FG000|Overall Study|Withdrawal by Subject|12|||
129927116|NCT03221426|467699107|FG001|Overall Study|Withdrawal by Subject|4|||
129927117|NCT03221426|467699108|FG002|Overall Study|Withdrawal by Subject|2|||
129927118|NCT03221426|467699109|FG003|Overall Study|Withdrawal by Subject|3|||
129927119|NCT03221426|467699106|FG000|Overall Study|Lost to Follow-up|4|||
129927120|NCT03221426|467699107|FG001|Overall Study|Lost to Follow-up|1|||
129927121|NCT03221426|467699108|FG002|Overall Study|Lost to Follow-up|1|||
129927122|NCT03221426|467699109|FG003|Overall Study|Lost to Follow-up|0|||
129927123|NCT03221426|467699106|FG000|Overall Study|Death|174|||
129927124|NCT03221426|467699107|FG001|Overall Study|Death|204|||
129927125|NCT03221426|467699108|FG002|Overall Study|Death|36|||
129927126|NCT03221426|467699109|FG003|Overall Study|Death|45|||
129927127|NCT04858451|467700613|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
129927128|NCT04858451|467700614|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927129|NCT04858451|467700615|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927130|NCT04858451|467700616|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927131|NCT04858451|467700617|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927132|NCT04858451|467700618|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927133|NCT04858451|467700619|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927134|NCT04858451|467700620|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927135|NCT04858451|467700621|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
129927136|NCT04858451|467700613|FG000|Part 2|Discontinued|0|||
129927137|NCT04858451|467700614|FG001|Part 2|Discontinued|0|||
129927138|NCT04858451|467700615|FG002|Part 2|Discontinued|0|||
129927139|NCT04858451|467700616|FG003|Part 2|Discontinued|0|||
129927140|NCT04858451|467700617|FG004|Part 2|Discontinued|0|||
129927141|NCT04858451|467700618|FG005|Part 2|Discontinued|0|||
129927142|NCT04858451|467700619|FG006|Part 2|Discontinued|0|||
129927143|NCT04858451|467700620|FG007|Part 2|Discontinued|0|||
129927144|NCT04858451|467700621|FG008|Part 2|Discontinued|63|||
129927145|NCT04233216|467700623|FG000|Overall Study|Lost to Follow-up|1|||
129927146|NCT04233216|467700624|FG001|Overall Study|Lost to Follow-up|0|||
129927147|NCT04233216|467700625|FG002|Overall Study|Lost to Follow-up|2|||
129927148|NCT04233216|467700626|FG003|Overall Study|Lost to Follow-up|0|||
129927149|NCT04233216|467700623|FG000|Overall Study|Physician Decision|0|||
129927150|NCT04233216|467700624|FG001|Overall Study|Physician Decision|3|||
129927151|NCT04233216|467700625|FG002|Overall Study|Physician Decision|0|||
129927152|NCT04233216|467700626|FG003|Overall Study|Physician Decision|2|||
129927153|NCT04233216|467700623|FG000|Overall Study|Withdrawal by Subject|0|||
129927154|NCT04233216|467700624|FG001|Overall Study|Withdrawal by Subject|2|||
129927155|NCT04233216|467700625|FG002|Overall Study|Withdrawal by Subject|1|||
129927156|NCT04233216|467700626|FG003|Overall Study|Withdrawal by Subject|0|||
129927157|NCT02116530|467700640|FG000|Overall Study|Withdrawal by Subject|1|||
129927158|NCT02116530|467700641|FG001|Overall Study|Withdrawal by Subject|2|||
129927159|NCT02116530|467700640|FG000|Overall Study|Adverse Event|4|||
129927160|NCT02116530|467700641|FG001|Overall Study|Adverse Event|0|||
129927161|NCT02116530|467700640|FG000|Overall Study|Physician Decision|1|||
129927162|NCT02116530|467700641|FG001|Overall Study|Physician Decision|0|||
129927163|NCT02116530|467700640|FG000|Overall Study|Lost to Follow-up|1|||
129927164|NCT02116530|467700641|FG001|Overall Study|Lost to Follow-up|0|||
129927165|NCT02116530|467700640|FG000|Overall Study|Other Medical Problems|2|||
129927166|NCT02116530|467700641|FG001|Overall Study|Other Medical Problems|2|||
129927167|NCT03766685|467700642|FG000|Overall Study|Lost to Follow-up|1|||
129927168|NCT03766685|467700643|FG001|Overall Study|Lost to Follow-up|1|||
129927169|NCT03766685|467700644|FG002|Overall Study|Lost to Follow-up|0|||
129927170|NCT03766685|467700645|FG003|Overall Study|Lost to Follow-up|0|||
129927171|NCT03766685|467700642|FG000|Overall Study|Adverse Event, not fatal|0|||
129927172|NCT03766685|467700643|FG001|Overall Study|Adverse Event, not fatal|1|||
129927173|NCT03766685|467700644|FG002|Overall Study|Adverse Event, not fatal|0|||
129927174|NCT03766685|467700645|FG003|Overall Study|Adverse Event, not fatal|1|||
129927175|NCT03766685|467700642|FG000|Overall Study|Withdrawal by Subject|0|||
129927176|NCT03766685|467700643|FG001|Overall Study|Withdrawal by Subject|2|||
129927177|NCT03766685|467700644|FG002|Overall Study|Withdrawal by Subject|0|||
129927178|NCT03766685|467700645|FG003|Overall Study|Withdrawal by Subject|0|||
129927179|NCT03766685|467700642|FG000|Overall Study|Protocol Violation|0|||
129927180|NCT03766685|467700643|FG001|Overall Study|Protocol Violation|1|||
129927181|NCT03766685|467700644|FG002|Overall Study|Protocol Violation|0|||
129927182|NCT03766685|467700645|FG003|Overall Study|Protocol Violation|0|||
129927183|NCT03766685|467700642|FG000|Overall Study|Non-compliance|0|||
129927184|NCT03766685|467700643|FG001|Overall Study|Non-compliance|2|||
129927185|NCT03766685|467700644|FG002|Overall Study|Non-compliance|0|||
129927186|NCT03766685|467700645|FG003|Overall Study|Non-compliance|0|||
129927187|NCT02927236|467700650|FG000|Characterization Phase|Physician Decision|0|||
129927188|NCT02927236|467700651|FG001|Characterization Phase|Physician Decision|3|||
129927189|NCT02927236|467700652|FG002|Characterization Phase|Physician Decision|0|||
129927190|NCT02927236|467700653|FG003|Characterization Phase|Physician Decision|2|||
129927191|NCT02927236|467700650|FG000|Characterization Phase|Lost to Follow-up|0|||
129927192|NCT02927236|467700651|FG001|Characterization Phase|Lost to Follow-up|0|||
129927193|NCT02927236|467700652|FG002|Characterization Phase|Lost to Follow-up|0|||
129927194|NCT02927236|467700653|FG003|Characterization Phase|Lost to Follow-up|3|||
129927195|NCT02927236|467700650|FG000|Characterization Phase|Withdrawal by Subject|1|||
129927196|NCT02927236|467700651|FG001|Characterization Phase|Withdrawal by Subject|0|||
129927197|NCT02927236|467700652|FG002|Characterization Phase|Withdrawal by Subject|0|||
129927198|NCT02927236|467700653|FG003|Characterization Phase|Withdrawal by Subject|1|||
129927199|NCT02927236|467700650|FG000|Treatment Phase|Adverse Event|1|||
129927200|NCT02927236|467700651|FG001|Treatment Phase|Adverse Event|0|||
129927201|NCT02927236|467700652|FG002|Treatment Phase|Adverse Event|1|||
129927202|NCT02927236|467700653|FG003|Treatment Phase|Adverse Event|1|||
129927203|NCT02927236|467700650|FG000|Treatment Phase|Protocol Violation|3|||
129927204|NCT02927236|467700651|FG001|Treatment Phase|Protocol Violation|0|||
129927205|NCT02927236|467700652|FG002|Treatment Phase|Protocol Violation|0|||
129927206|NCT02927236|467700653|FG003|Treatment Phase|Protocol Violation|1|||
129927207|NCT02927236|467700650|FG000|Treatment Phase|Lost to Follow-up|1|||
129927208|NCT02927236|467700651|FG001|Treatment Phase|Lost to Follow-up|0|||
129927209|NCT02927236|467700652|FG002|Treatment Phase|Lost to Follow-up|0|||
129927210|NCT02927236|467700653|FG003|Treatment Phase|Lost to Follow-up|0|||
129927211|NCT02927236|467700650|FG000|Follow-up Phase|Lost to Follow-up|1|||
129927212|NCT02927236|467700651|FG001|Follow-up Phase|Lost to Follow-up|0|||
129927213|NCT02927236|467700652|FG002|Follow-up Phase|Lost to Follow-up|1|||
129927214|NCT02927236|467700653|FG003|Follow-up Phase|Lost to Follow-up|0|||
129927215|NCT03974178|467700656|FG000|Overall Study|Death|0|||
129927216|NCT03974178|467700657|FG001|Overall Study|Death|1|||
129927217|NCT04508309|467700658|FG000|Overall Study|Death|0|||
129927218|NCT04508309|467700659|FG001|Overall Study|Death|0|||
129927219|NCT04508309|467700660|FG002|Overall Study|Death|0|||
129927220|NCT04508309|467700661|FG003|Overall Study|Death|0|||
129927221|NCT04508309|467700662|FG004|Overall Study|Death|1|||
129927222|NCT04508309|467700658|FG000|Overall Study|Lost to Follow-up|0|||
129927223|NCT04508309|467700659|FG001|Overall Study|Lost to Follow-up|0|||
129927224|NCT04508309|467700660|FG002|Overall Study|Lost to Follow-up|1|||
129927225|NCT04508309|467700661|FG003|Overall Study|Lost to Follow-up|1|||
129927226|NCT04508309|467700662|FG004|Overall Study|Lost to Follow-up|0|||
129927227|NCT04508309|467700658|FG000|Overall Study|Withdrawal by Subject|0|||
129927228|NCT04508309|467700659|FG001|Overall Study|Withdrawal by Subject|0|||
129927229|NCT04508309|467700660|FG002|Overall Study|Withdrawal by Subject|0|||
129927230|NCT04508309|467700661|FG003|Overall Study|Withdrawal by Subject|0|||
129927231|NCT04508309|467700662|FG004|Overall Study|Withdrawal by Subject|1|||
129927232|NCT04914676|467700666|FG000|Overall Study|Study termination|3|||
129927233|NCT04914676|467700667|FG001|Overall Study|Study termination|0|||
129927234|NCT03240016|467700668|FG000|Overall Study|Adverse Event|9|||
129927235|NCT03240016|467700668|FG000|Overall Study|Withdrawal by Subject|7|||
129927236|NCT03240016|467700668|FG000|Overall Study|Death|1|||
129927237|NCT03240016|467700668|FG000|Overall Study|Physician Decision|2|||
129927238|NCT03913442|467700669|FG000|Overall Study|Adverse Event|0|||
129927239|NCT03913442|467700670|FG001|Overall Study|Adverse Event|3|||
129927240|NCT03913442|467700669|FG000|Overall Study|Withdrawal by Subject|5|||
129927241|NCT03913442|467700670|FG001|Overall Study|Withdrawal by Subject|5|||
129927242|NCT03913442|467700669|FG000|Overall Study|Terminations|2|||
129927243|NCT03913442|467700670|FG001|Overall Study|Terminations|1|||
129927244|NCT03913442|467700669|FG000|Overall Study|Lost to Follow-up|2|||
129927245|NCT03913442|467700670|FG001|Overall Study|Lost to Follow-up|2|||
129927246|NCT00950742|467700671|FG000|Overall Study|Other Adverse Event|1|||
129927247|NCT00950742|467700672|FG001|Overall Study|Other Adverse Event|0|||
129927248|NCT00950742|467700671|FG000|Overall Study|Withdrawal by Subject|3|||
129927249|NCT00950742|467700672|FG001|Overall Study|Withdrawal by Subject|0|||
129927250|NCT00950742|467700671|FG000|Overall Study|Progressive Disease|6|||
129927251|NCT00950742|467700672|FG001|Overall Study|Progressive Disease|2|||
129927252|NCT00950742|467700671|FG000|Overall Study|Dose limiting toxicity|6|||
129927253|NCT00950742|467700672|FG001|Overall Study|Dose limiting toxicity|0|||
129927254|NCT05436262|467700674|FG000|Pre-Randomization|Withdrawal by Subject|1|||
129927255|NCT05436262|467700675|FG001|Pre-Randomization|Withdrawal by Subject|0|||
129927256|NCT05436262|467700676|FG002|Pre-Randomization|Withdrawal by Subject|0|||
129927257|NCT05436262|467700674|FG000|Randomization|Withdrawal by Subject|0|||
129927258|NCT05436262|467700675|FG001|Randomization|Withdrawal by Subject|1|||
129927259|NCT05436262|467700676|FG002|Randomization|Withdrawal by Subject|0|||
129927260|NCT05299073|467700677|FG000|Overall Study|Withdrawal by Subject|0|||
129927261|NCT05299073|467700678|FG001|Overall Study|Withdrawal by Subject|0|||
129927262|NCT05299073|467700679|FG002|Overall Study|Withdrawal by Subject|1|||
129927263|NCT05299073|467700677|FG000|Overall Study|Adverse Event|0|||
129927264|NCT05299073|467700678|FG001|Overall Study|Adverse Event|1|||
129927265|NCT05299073|467700679|FG002|Overall Study|Adverse Event|0|||
129927266|NCT05299073|467700677|FG000|Overall Study|Lost to Follow-up|0|||
129927267|NCT05299073|467700678|FG001|Overall Study|Lost to Follow-up|1|||
129927268|NCT05299073|467700679|FG002|Overall Study|Lost to Follow-up|0|||
129927269|NCT00592852|467700680|FG000|Overall Study|Non-compliance|1|||
129927270|NCT00592852|467700680|FG000|Overall Study|Adverse Event|3|||
129927271|NCT00592852|467700680|FG000|Overall Study|Found ineligible|1|||
129927272|NCT00592852|467700680|FG000|Overall Study|Withdrawal by Subject|1|||
129927273|NCT05002088|467700682|FG000|Overall Study|Withdrawal by Subject|9|||
129927274|NCT05002088|467700683|FG001|Overall Study|Withdrawal by Subject|0|||
129927275|NCT05002088|467700682|FG000|Overall Study|Lost to Follow-up|0|||
129927276|NCT05002088|467700683|FG001|Overall Study|Lost to Follow-up|1|||
129927277|NCT05002088|467700682|FG000|Overall Study|Death|16|||
129927278|NCT05002088|467700683|FG001|Overall Study|Death|2|||
129927279|NCT05002088|467700682|FG000|Overall Study|Protocol Violation|25|||
129927280|NCT05002088|467700683|FG001|Overall Study|Protocol Violation|7|||
129927281|NCT04068181|467700684|FG000|Overall Study|Death|17|||
129927282|NCT04068181|467700685|FG001|Overall Study|Death|12|||
129927283|NCT04068181|467700686|FG002|Overall Study|Death|4|||
129927284|NCT04068181|467700687|FG003|Overall Study|Death|7|||
129927285|NCT04068181|467700684|FG000|Overall Study|Lost to Follow-up|1|||
129927286|NCT04068181|467700685|FG001|Overall Study|Lost to Follow-up|0|||
129927287|NCT04068181|467700686|FG002|Overall Study|Lost to Follow-up|0|||
129927288|NCT04068181|467700687|FG003|Overall Study|Lost to Follow-up|0|||
129927289|NCT04068181|467700684|FG000|Overall Study|Withdrawal of consent from study|3|||
129927290|NCT04068181|467700685|FG001|Overall Study|Withdrawal of consent from study|0|||
129927291|NCT04068181|467700686|FG002|Overall Study|Withdrawal of consent from study|0|||
129927292|NCT04068181|467700687|FG003|Overall Study|Withdrawal of consent from study|0|||
129927293|NCT04770402|467700688|FG000|Overall Study|Lost to Follow-up|1|||
129927294|NCT04770402|467700689|FG001|Overall Study|Lost to Follow-up|2|||
129927295|NCT04770402|467700688|FG000|Overall Study|Non-compliance|1|||
129927296|NCT04770402|467700689|FG001|Overall Study|Non-compliance|0|||
129927297|NCT04770402|467700688|FG000|Overall Study|Withdrawal by Subject|0|||
129927298|NCT04770402|467700689|FG001|Overall Study|Withdrawal by Subject|1|||
129927299|NCT05194956|467700691|FG000|Washout Period|Withdrawal by Subject|0|||
129927300|NCT05194956|467700692|FG001|Washout Period|Withdrawal by Subject|2|||
129927301|NCT03905798|467700713|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
129927302|NCT03463044|467700718|FG000|Overall Study|Lost to Follow-up|0|||
129927303|NCT03463044|467700719|FG001|Overall Study|Lost to Follow-up|0|||
129927304|NCT03463044|467700720|FG002|Overall Study|Lost to Follow-up|0|||
129927305|NCT03463044|467700721|FG003|Overall Study|Lost to Follow-up|0|||
129927306|NCT03463044|467700722|FG004|Overall Study|Lost to Follow-up|0|||
129927307|NCT03463044|467700723|FG005|Overall Study|Lost to Follow-up|0|||
129927308|NCT03463044|467700724|FG006|Overall Study|Lost to Follow-up|0|||
129927309|NCT03463044|467700725|FG007|Overall Study|Lost to Follow-up|1|||
129927310|NCT03463044|467700726|FG008|Overall Study|Lost to Follow-up|0|||
129927311|NCT05192109|467700727|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129927312|NCT05192109|467700728|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129927313|NCT05192109|467700729|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927314|NCT05192109|467700730|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927315|NCT05192109|467700727|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
129927316|NCT05192109|467700728|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
129927317|NCT05192109|467700729|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927318|NCT05192109|467700730|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
129927319|NCT04498390|467700731|FG000|Overall Study|Adverse Event|0|||
129927320|NCT04498390|467700732|FG001|Overall Study|Adverse Event|0|||
129927321|NCT04498390|467700733|FG002|Overall Study|Adverse Event|1|||
129927322|NCT04498390|467700734|FG003|Overall Study|Adverse Event|0|||
129927323|NCT04498390|467700735|FG004|Overall Study|Adverse Event|0|||
129927324|NCT04498390|467700731|FG000|Overall Study|Withdrawal by Subject|0|||
129927325|NCT04498390|467700732|FG001|Overall Study|Withdrawal by Subject|0|||
129927326|NCT04498390|467700733|FG002|Overall Study|Withdrawal by Subject|0|||
129927327|NCT04498390|467700734|FG003|Overall Study|Withdrawal by Subject|1|||
129927328|NCT04498390|467700735|FG004|Overall Study|Withdrawal by Subject|0|||
129927329|NCT03478956|467700736|FG000|Randomized Treatment Period|Adverse Event|1|||
129927330|NCT03478956|467700737|FG001|Randomized Treatment Period|Adverse Event|0|||
129927331|NCT03478956|467700738|FG002|Randomized Treatment Period|Adverse Event|0|||
129927332|NCT03478956|467700739|FG003|Randomized Treatment Period|Adverse Event|0|||
129927333|NCT03478956|467700736|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
129927334|NCT03478956|467700737|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
129927335|NCT03478956|467700738|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
129927336|NCT03478956|467700739|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
129927337|NCT03478956|467700736|FG000|Open Label Extension Period|Adverse Event|0|||
129927338|NCT03478956|467700737|FG001|Open Label Extension Period|Adverse Event|0|||
129927339|NCT03478956|467700738|FG002|Open Label Extension Period|Adverse Event|4|||
129927340|NCT03478956|467700739|FG003|Open Label Extension Period|Adverse Event|0|||
129927341|NCT03478956|467700736|FG000|Open Label Extension Period|Lack of Efficacy|0|||
129927342|NCT03478956|467700737|FG001|Open Label Extension Period|Lack of Efficacy|0|||
129927343|NCT03478956|467700738|FG002|Open Label Extension Period|Lack of Efficacy|8|||
129927344|NCT03478956|467700739|FG003|Open Label Extension Period|Lack of Efficacy|0|||
129927345|NCT03478956|467700736|FG000|Open Label Extension Period|Reason Not Provided|0|||
129927346|NCT03478956|467700737|FG001|Open Label Extension Period|Reason Not Provided|0|||
129927347|NCT03478956|467700738|FG002|Open Label Extension Period|Reason Not Provided|1|||
129927348|NCT03478956|467700739|FG003|Open Label Extension Period|Reason Not Provided|0|||
129927349|NCT03478956|467700736|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
129927350|NCT03478956|467700737|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
129927351|NCT03478956|467700738|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
129927352|NCT03478956|467700739|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
129927353|NCT03478956|467700736|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
129927354|NCT03478956|467700737|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
129927355|NCT03478956|467700738|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
129927356|NCT03478956|467700739|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
129927357|NCT03478956|467700736|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129927358|NCT03478956|467700737|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129927359|NCT03478956|467700738|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
129927360|NCT03478956|467700739|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
129927361|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
129927362|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
129927363|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
129927364|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
129927365|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
129927366|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
129927367|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
129927368|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
129927369|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
129927370|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
129927371|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
129927372|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
129927373|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
129927374|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
129927375|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
129927376|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
129927377|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
129927378|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
129927379|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
129927380|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
129927381|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
129927382|NCT04800211|467700740|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
129927383|NCT04800211|467700741|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
129927384|NCT04800211|467700742|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
129927385|NCT04800211|467700740|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
129927386|NCT04800211|467700741|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
129927387|NCT04800211|467700742|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
129927388|NCT04800211|467700740|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
129927389|NCT04800211|467700741|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
129927390|NCT04800211|467700742|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
129927391|NCT04800211|467700740|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
129927392|NCT04800211|467700741|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
129927393|NCT04800211|467700742|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
129927394|NCT05170841|467700743|FG000|Single Dose Phase|Adverse Event|1|||
129927395|NCT05170841|467700744|FG001|Single Dose Phase|Adverse Event|2|||
129927396|NCT05170841|467700745|FG002|Single Dose Phase|Adverse Event|0|||
129927397|NCT05170841|467700746|FG003|Single Dose Phase|Adverse Event|2|||
129927398|NCT05170841|467700743|FG000|Multiple Dose Phase|Adverse Event|1|||
129927399|NCT05170841|467700744|FG001|Multiple Dose Phase|Adverse Event|2|||
129927400|NCT05170841|467700745|FG002|Multiple Dose Phase|Adverse Event|1|||
129927401|NCT05170841|467700746|FG003|Multiple Dose Phase|Adverse Event|4|||
129927402|NCT05170841|467700743|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
129927403|NCT05170841|467700744|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
129927404|NCT05170841|467700745|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
129927405|NCT05170841|467700746|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
129927406|NCT04865289|467700747|FG000|Overall Study|Participant ongoing in study|47|||
129927407|NCT04865289|467700748|FG001|Overall Study|Participant ongoing in study|35|||
129927408|NCT04865289|467700747|FG000|Overall Study|Death|27|||
129927409|NCT04865289|467700748|FG001|Overall Study|Death|21|||
129927410|NCT02733159|467700751|FG000|Overall Study|Adverse Event|1|||
129927411|NCT02733159|467700751|FG000|Overall Study|Lack of disease progression|1|||
129927412|NCT06122194|467700752|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
129927413|NCT06122194|467700753|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
129927414|NCT06122194|467700754|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
129927415|NCT06122194|467700755|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
129927416|NCT02887521|467700762|FG000|Overall Study|Withdrawal by Subject|0|||
129927417|NCT02887521|467700763|FG001|Overall Study|Withdrawal by Subject|3|||
129927418|NCT02709161|467700766|FG000|Overall Study|Withdrawal by Subject|1|||
129927419|NCT02709161|467700767|FG001|Overall Study|Withdrawal by Subject|0|||
129927420|NCT02561247|467702783|FG000|Overall Study|Protocol Violation|1|||
129927421|NCT02561247|467702783|FG000|Overall Study|Withdrawal by Subject|1|||
129927422|NCT02561247|467702783|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
129927423|NCT03663569|467702784|FG000|Overall Study|Discontinuation of study|11|||
129927424|NCT03663569|467702784|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
129927425|NCT03663569|467702784|FG000|Overall Study|Deceased patient|6|||
129927426|NCT03663569|467702784|FG000|Overall Study|Lost to Follow-up|18|||
129927427|NCT03663569|467702784|FG000|Overall Study|Withdrawal of consent|5|||
129927428|NCT03663569|467702784|FG000|Overall Study|Patient's request|11|||
129927429|NCT03663569|467702784|FG000|Overall Study|Adverse Event|4|||
129927430|NCT03663569|467702784|FG000|Overall Study|Not come to second visit|3|||
129927431|NCT03663569|467702784|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
129927432|NCT03663569|467702784|FG000|Overall Study|Serious adverse event|1|||
129927433|NCT04298983|467702786|FG000|Overall Study|Adverse Event|4|||
129927434|NCT04298983|467702786|FG000|Overall Study|Lack of Efficacy|3|||
129927435|NCT04248725|467702787|FG000|Post-Treatment|Lost to Follow-up|6|||
129927436|NCT04248725|467702788|FG001|Post-Treatment|Lost to Follow-up|5|||
129927437|NCT04248725|467702787|FG000|6-Month Follow Up|Lost to Follow-up|9|||
129927438|NCT04248725|467702788|FG001|6-Month Follow Up|Lost to Follow-up|8|||
129927439|NCT03656510|467702790|FG000|Overall Study|Lost to Follow-up|1|||
129927440|NCT03656510|467702791|FG001|Overall Study|Lost to Follow-up|0|||
129927441|NCT03656510|467702792|FG002|Overall Study|Lost to Follow-up|0|||
129927442|NCT03656510|467702793|FG003|Overall Study|Lost to Follow-up|0|||
129927443|NCT03656510|467702794|FG004|Overall Study|Lost to Follow-up|0|||
129927444|NCT03656510|467702795|FG005|Overall Study|Lost to Follow-up|0|||
129927445|NCT03656510|467702790|FG000|Overall Study|Withdrawal by Subject|1|||
129927446|NCT03656510|467702791|FG001|Overall Study|Withdrawal by Subject|1|||
129927447|NCT03656510|467702792|FG002|Overall Study|Withdrawal by Subject|0|||
129927448|NCT03656510|467702793|FG003|Overall Study|Withdrawal by Subject|1|||
129927449|NCT03656510|467702794|FG004|Overall Study|Withdrawal by Subject|0|||
129927450|NCT03656510|467702795|FG005|Overall Study|Withdrawal by Subject|0|||
129927451|NCT03819153|467702800|FG000|Overall Study|Withdrawal by Subject|20|||
129927452|NCT03819153|467702801|FG001|Overall Study|Withdrawal by Subject|28|||
129927453|NCT03819153|467702800|FG000|Overall Study|Lost to Follow-up|23|||
129927454|NCT03819153|467702801|FG001|Overall Study|Lost to Follow-up|30|||
129927455|NCT05671653|467702802|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
129927456|NCT05671653|467702803|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
129927457|NCT05671653|467702804|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
129927458|NCT05671653|467702805|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
129927459|NCT05671653|467702806|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
129927460|NCT05671653|467702807|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
129927461|NCT05671653|467702808|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
129927462|NCT05671653|467702809|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
129927463|NCT05671653|467702810|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
129927464|NCT05671653|467702811|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
129927465|NCT05671653|467702812|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
129927466|NCT05671653|467702813|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
129927467|NCT05671653|467702814|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
129927468|NCT05671653|467702802|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927469|NCT05671653|467702803|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927470|NCT05671653|467702804|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927471|NCT05671653|467702805|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927472|NCT05671653|467702806|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927473|NCT05671653|467702807|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
129927474|NCT05671653|467702808|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927475|NCT05671653|467702809|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927476|NCT05671653|467702810|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927477|NCT05671653|467702811|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927478|NCT05671653|467702812|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927479|NCT05671653|467702813|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927480|NCT05671653|467702814|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
129927481|NCT05671653|467702802|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927482|NCT05671653|467702803|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927483|NCT05671653|467702804|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927484|NCT05671653|467702805|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927485|NCT05671653|467702806|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927486|NCT05671653|467702807|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
129927487|NCT05671653|467702808|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927488|NCT05671653|467702809|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927489|NCT05671653|467702810|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927490|NCT05671653|467702811|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927491|NCT05671653|467702812|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927492|NCT05671653|467702813|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927493|NCT05671653|467702814|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
129927494|NCT05671653|467702802|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927495|NCT05671653|467702803|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927496|NCT05671653|467702804|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927497|NCT05671653|467702805|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927498|NCT05671653|467702806|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927499|NCT05671653|467702807|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927500|NCT05671653|467702808|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927501|NCT05671653|467702809|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927502|NCT05671653|467702810|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
129927503|NCT05671653|467702811|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927504|NCT05671653|467702812|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927505|NCT05671653|467702813|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927506|NCT05671653|467702814|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
129927507|NCT05671653|467702802|FG000|Cohort 2 Period 2|Adverse Event|0|||
129927508|NCT05671653|467702803|FG001|Cohort 2 Period 2|Adverse Event|0|||
129927509|NCT05671653|467702804|FG002|Cohort 2 Period 2|Adverse Event|0|||
129927510|NCT05671653|467702805|FG003|Cohort 2 Period 2|Adverse Event|0|||
129927511|NCT05671653|467702806|FG004|Cohort 2 Period 2|Adverse Event|0|||
129927512|NCT05671653|467702807|FG005|Cohort 2 Period 2|Adverse Event|0|||
129927513|NCT05671653|467702808|FG006|Cohort 2 Period 2|Adverse Event|0|||
129927514|NCT05671653|467702809|FG007|Cohort 2 Period 2|Adverse Event|0|||
129927515|NCT05671653|467702810|FG008|Cohort 2 Period 2|Adverse Event|0|||
129927516|NCT05671653|467702811|FG009|Cohort 2 Period 2|Adverse Event|0|||
129927517|NCT05671653|467702812|FG010|Cohort 2 Period 2|Adverse Event|1|||
129927518|NCT05671653|467702813|FG011|Cohort 2 Period 2|Adverse Event|0|||
129927519|NCT05671653|467702814|FG012|Cohort 2 Period 2|Adverse Event|0|||
129927520|NCT05671653|467702802|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
129927521|NCT05671653|467702803|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
129927522|NCT05671653|467702804|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
129927523|NCT05671653|467702805|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
129927524|NCT05671653|467702806|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
129927525|NCT05671653|467702807|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
129927526|NCT05671653|467702808|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
129927527|NCT05671653|467702809|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
129927528|NCT05671653|467702810|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
129927529|NCT05671653|467702811|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
129927530|NCT05671653|467702812|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
129927531|NCT05671653|467702813|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
129927532|NCT05671653|467702814|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
129927533|NCT05671653|467702802|FG000|Cohort 2 Period 2|Pregnancy|0|||
129927534|NCT05671653|467702803|FG001|Cohort 2 Period 2|Pregnancy|0|||
129927535|NCT05671653|467702804|FG002|Cohort 2 Period 2|Pregnancy|0|||
129927536|NCT05671653|467702805|FG003|Cohort 2 Period 2|Pregnancy|0|||
129450577|NCT02713542|465948781|FG001|Overall Study|Use of prohibited medication|5|||
129927537|NCT05671653|467702806|FG004|Cohort 2 Period 2|Pregnancy|0|||
129927538|NCT05671653|467702807|FG005|Cohort 2 Period 2|Pregnancy|0|||
129927539|NCT05671653|467702808|FG006|Cohort 2 Period 2|Pregnancy|0|||
129927540|NCT05671653|467702809|FG007|Cohort 2 Period 2|Pregnancy|0|||
129927541|NCT05671653|467702810|FG008|Cohort 2 Period 2|Pregnancy|0|||
129927542|NCT05671653|467702811|FG009|Cohort 2 Period 2|Pregnancy|0|||
129927543|NCT05671653|467702812|FG010|Cohort 2 Period 2|Pregnancy|1|||
129927544|NCT05671653|467702813|FG011|Cohort 2 Period 2|Pregnancy|0|||
129927545|NCT05671653|467702814|FG012|Cohort 2 Period 2|Pregnancy|0|||
129927546|NCT05671653|467702802|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927547|NCT05671653|467702803|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927548|NCT05671653|467702804|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927549|NCT05671653|467702805|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927550|NCT05671653|467702806|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927551|NCT05671653|467702807|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927552|NCT05671653|467702808|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927553|NCT05671653|467702809|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927554|NCT05671653|467702810|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927555|NCT05671653|467702811|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927556|NCT05671653|467702812|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
129927557|NCT05671653|467702813|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927558|NCT05671653|467702814|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
129927559|NCT05671653|467702802|FG000|Cohort 2 Period 2|Other|0|||
129927560|NCT05671653|467702803|FG001|Cohort 2 Period 2|Other|0|||
129927561|NCT05671653|467702804|FG002|Cohort 2 Period 2|Other|0|||
129927562|NCT05671653|467702805|FG003|Cohort 2 Period 2|Other|0|||
129927563|NCT05671653|467702806|FG004|Cohort 2 Period 2|Other|0|||
129927564|NCT05671653|467702807|FG005|Cohort 2 Period 2|Other|0|||
129927565|NCT05671653|467702808|FG006|Cohort 2 Period 2|Other|0|||
129927566|NCT05671653|467702809|FG007|Cohort 2 Period 2|Other|0|||
129927567|NCT05671653|467702810|FG008|Cohort 2 Period 2|Other|0|||
129927568|NCT05671653|467702811|FG009|Cohort 2 Period 2|Other|0|||
129927569|NCT05671653|467702812|FG010|Cohort 2 Period 2|Other|1|||
129927570|NCT05671653|467702813|FG011|Cohort 2 Period 2|Other|0|||
129927571|NCT05671653|467702814|FG012|Cohort 2 Period 2|Other|0|||
129927572|NCT05671653|467702802|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927573|NCT05671653|467702803|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927574|NCT05671653|467702804|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927575|NCT05671653|467702805|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927576|NCT05671653|467702806|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927577|NCT05671653|467702807|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927578|NCT05671653|467702808|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927579|NCT05671653|467702809|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927580|NCT05671653|467702810|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927581|NCT05671653|467702811|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927582|NCT05671653|467702812|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927583|NCT05671653|467702813|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
129927584|NCT05671653|467702814|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
129927585|NCT02305888|467702821|FG000|Overall Study|Lost to Follow-up|0|||
129927586|NCT02305888|467702822|FG001|Overall Study|Lost to Follow-up|0|||
129927587|NCT02305888|467702823|FG002|Overall Study|Lost to Follow-up|1|||
129927588|NCT02305888|467702821|FG000|Overall Study|Adverse Event|0|||
129927589|NCT02305888|467702822|FG001|Overall Study|Adverse Event|1|||
129450578|NCT02713542|465948780|FG000|Overall Study|Withdrawal by Subject|4|||
129927590|NCT02305888|467702823|FG002|Overall Study|Adverse Event|0|||
129450579|NCT02713542|465948781|FG001|Overall Study|Withdrawal by Subject|1|||
129450580|NCT00066742|465948782|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
129927591|NCT06232590|467702824|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
129927592|NCT06232590|467702825|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
129927593|NCT05070728|467702829|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
129927594|NCT05070728|467702830|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
129927595|NCT02589795|467702838|FG000|Overall Study|Lost to Follow-up|1|||
129927596|NCT02589795|467702839|FG001|Overall Study|Lost to Follow-up|0|||
129927597|NCT02589795|467702840|FG002|Overall Study|Lost to Follow-up|0|||
129927598|NCT02589795|467702838|FG000|Overall Study|Withdrawal by Subject|0|||
129927599|NCT02589795|467702839|FG001|Overall Study|Withdrawal by Subject|0|||
129927600|NCT02589795|467702840|FG002|Overall Study|Withdrawal by Subject|2|||
129927601|NCT02589795|467702838|FG000|Overall Study|Protocol Violation|0|||
129927602|NCT02589795|467702839|FG001|Overall Study|Protocol Violation|0|||
129927603|NCT02589795|467702840|FG002|Overall Study|Protocol Violation|1|||
129927604|NCT03599661|467702841|FG000|Overall Study|Lost to Follow-up|9|||
129927605|NCT04909801|467702844|FG000|Overall Study|Lack of Efficacy|2|||
129927606|NCT04909801|467702845|FG001|Overall Study|Lack of Efficacy|1|||
129927607|NCT04909801|467702844|FG000|Overall Study|Adverse Event|1|||
129927608|NCT04909801|467702845|FG001|Overall Study|Adverse Event|2|||
129927609|NCT04909801|467702844|FG000|Overall Study|Participant request to discontinue study treatment|1|||
129927610|NCT04909801|467702845|FG001|Overall Study|Participant request to discontinue study treatment|2|||
129927611|NCT04909801|467702844|FG000|Overall Study|Withdrawal by Subject|2|||
129927612|NCT04909801|467702845|FG001|Overall Study|Withdrawal by Subject|1|||
129927613|NCT04909801|467702844|FG000|Overall Study|other reasons|1|||
129927614|NCT04909801|467702845|FG001|Overall Study|other reasons|1|||
129927615|NCT04550221|467702848|FG000|Overall Study|Lost to Follow-up|0|||
129927616|NCT04550221|467702849|FG001|Overall Study|Lost to Follow-up|4|||
129927617|NCT04550221|467702848|FG000|Overall Study|Withdrawn|3|||
129927618|NCT04550221|467702849|FG001|Overall Study|Withdrawn|0|||
129927619|NCT04550221|467702848|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
129927620|NCT04550221|467702849|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
129927621|NCT04811040|467702850|FG000|Overall Study|Lost to Follow-up|2|||
129927622|NCT04811040|467702851|FG001|Overall Study|Lost to Follow-up|0|||
129927623|NCT04811040|467702852|FG002|Overall Study|Lost to Follow-up|0|||
129927624|NCT04811040|467702853|FG003|Overall Study|Lost to Follow-up|0|||
129927625|NCT04811040|467702850|FG000|Overall Study|Withdrew consent|1|||
129927626|NCT04811040|467702851|FG001|Overall Study|Withdrew consent|1|||
129927627|NCT04811040|467702852|FG002|Overall Study|Withdrew consent|0|||
129927628|NCT04811040|467702853|FG003|Overall Study|Withdrew consent|0|||
129927629|NCT05274074|467702854|FG000|Overall Study|Lost to Follow-up|2|||
129927630|NCT05274074|467702855|FG001|Overall Study|Lost to Follow-up|3|||
129927631|NCT05274074|467702854|FG000|Overall Study|Withdrawal by Subject|1|||
129927632|NCT05274074|467702855|FG001|Overall Study|Withdrawal by Subject|2|||
129927633|NCT01828099|467702865|FG000|Treatment Period|Adverse Event|24|||
129927634|NCT01828099|467702866|FG001|Treatment Period|Adverse Event|23|||
129927635|NCT01828099|467702865|FG000|Treatment Period|Death|10|||
129927636|NCT01828099|467702866|FG001|Treatment Period|Death|12|||
129927637|NCT01828099|467702865|FG000|Treatment Period|Lost to Follow-up|2|||
129927638|NCT01828099|467702866|FG001|Treatment Period|Lost to Follow-up|1|||
129927639|NCT01828099|467702865|FG000|Treatment Period|Non-compliance with study treatment|1|||
129927640|NCT01828099|467702866|FG001|Treatment Period|Non-compliance with study treatment|0|||
129927641|NCT01828099|467702865|FG000|Treatment Period|Physician Decision|17|||
129927642|NCT01828099|467702866|FG001|Treatment Period|Physician Decision|16|||
129927643|NCT01828099|467702865|FG000|Treatment Period|Progressive disease|99|||
129927644|NCT01828099|467702866|FG001|Treatment Period|Progressive disease|107|||
129927645|NCT01828099|467702865|FG000|Treatment Period|Subject/guardian decision|22|||
129927646|NCT01828099|467702866|FG001|Treatment Period|Subject/guardian decision|26|||
129927647|NCT01828099|467702865|FG000|Treatment Period|Study terminated by Sponsor|13|||
129927648|NCT01828099|467702866|FG001|Treatment Period|Study terminated by Sponsor|1|||
129927649|NCT01828099|467702865|FG000|Treatment Period|Protocol deviation|1|||
129927650|NCT01828099|467702866|FG001|Treatment Period|Protocol deviation|0|||
129927651|NCT01828099|467702865|FG000|Treatment Period|No longer requires treatment|0|||
129927652|NCT01828099|467702866|FG001|Treatment Period|No longer requires treatment|1|||
129927653|NCT01828099|467702865|FG000|Extension-treatment Phase|Adverse Event|0|||
129450581|NCT00066742|465948782|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
129927654|NCT01828099|467702866|FG001|Extension-treatment Phase|Adverse Event|17|||
129927655|NCT01828099|467702865|FG000|Extension-treatment Phase|Death|0|||
129927656|NCT01828099|467702866|FG001|Extension-treatment Phase|Death|11|||
129927657|NCT01828099|467702865|FG000|Extension-treatment Phase|Physician Decision|0|||
129927658|NCT01828099|467702866|FG001|Extension-treatment Phase|Physician Decision|5|||
129927659|NCT01828099|467702865|FG000|Extension-treatment Phase|Progressive disease|0|||
129927660|NCT01828099|467702866|FG001|Extension-treatment Phase|Progressive disease|54|||
129927661|NCT01828099|467702865|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
129927662|NCT01828099|467702866|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
129927663|NCT01828099|467702865|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
129927664|NCT01828099|467702866|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
129927665|NCT05934942|467702870|FG000|Run-in Period|Not treated|1|||
129927666|NCT05934942|467702870|FG000|Run-in Period|Withdrawal by Subject|1|||
129927667|NCT04362254|467702871|FG000|Overall Study|Adverse Event|1|||
129927668|NCT04362254|467702871|FG000|Overall Study|Protocol Violation|1|||
129927669|NCT04362254|467702871|FG000|Overall Study|Due to early termination of the trial|10|||
129927670|NCT04568434|467702872|FG000|Overall Study|Voluntary Withdrawal|0|||
129927671|NCT04568434|467702873|FG001|Overall Study|Voluntary Withdrawal|1|||
129450582|NCT00066742|465948782|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
129927672|NCT04568434|467702874|FG002|Overall Study|Voluntary Withdrawal|1|||
129450583|NCT00066742|465948782|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
129927673|NCT04568434|467702872|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
129927674|NCT04568434|467702873|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
129927675|NCT04568434|467702874|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
129927676|NCT04568434|467702872|FG000|Overall Study|Investigator Judgement|1|||
129927677|NCT04568434|467702873|FG001|Overall Study|Investigator Judgement|0|||
129927678|NCT04568434|467702874|FG002|Overall Study|Investigator Judgement|0|||
129927679|NCT05469464|467702875|FG000|Overall Study|Withdrawal by Subject|8|||
129927680|NCT05469464|467702876|FG001|Overall Study|Withdrawal by Subject|7|||
129927681|NCT05469464|467702877|FG002|Overall Study|Withdrawal by Subject|4|||
129927682|NCT05469464|467702878|FG003|Overall Study|Withdrawal by Subject|5|||
129927683|NCT05469464|467702875|FG000|Overall Study|Adverse Event|8|||
129927684|NCT05469464|467702876|FG001|Overall Study|Adverse Event|14|||
129927685|NCT05469464|467702877|FG002|Overall Study|Adverse Event|13|||
129927686|NCT05469464|467702878|FG003|Overall Study|Adverse Event|2|||
129927687|NCT05469464|467702875|FG000|Overall Study|Lost to Follow-up|2|||
129927688|NCT05469464|467702876|FG001|Overall Study|Lost to Follow-up|5|||
129927689|NCT05469464|467702877|FG002|Overall Study|Lost to Follow-up|3|||
129927690|NCT05469464|467702878|FG003|Overall Study|Lost to Follow-up|3|||
129927691|NCT05469464|467702875|FG000|Overall Study|Lack of Efficacy|4|||
129927692|NCT05469464|467702876|FG001|Overall Study|Lack of Efficacy|1|||
129927693|NCT05469464|467702877|FG002|Overall Study|Lack of Efficacy|2|||
129927694|NCT05469464|467702878|FG003|Overall Study|Lack of Efficacy|2|||
129927695|NCT05469464|467702875|FG000|Overall Study|Physician Decision|0|||
129927696|NCT05469464|467702876|FG001|Overall Study|Physician Decision|0|||
129927697|NCT05469464|467702877|FG002|Overall Study|Physician Decision|0|||
129927698|NCT05469464|467702878|FG003|Overall Study|Physician Decision|1|||
129927699|NCT00321048|467702879|FG000|Overall Study|Withdrawal by Subject|6|||
129927700|NCT00321048|467702880|FG001|Overall Study|Withdrawal by Subject|8|||
129927701|NCT04433208|467702881|FG000|Overall Study|Withdrawal by Subject|0|||
129927702|NCT04433208|467702882|FG001|Overall Study|Withdrawal by Subject|1|||
129927703|NCT04433208|467702883|FG002|Overall Study|Withdrawal by Subject|1|||
129927704|NCT04433208|467702884|FG003|Overall Study|Withdrawal by Subject|0|||
129927705|NCT04433208|467702885|FG004|Overall Study|Withdrawal by Subject|2|||
129927706|NCT04433208|467702886|FG005|Overall Study|Withdrawal by Subject|1|||
129927707|NCT04433208|467702881|FG000|Overall Study|Lost to Follow-up|0|||
129927708|NCT04433208|467702882|FG001|Overall Study|Lost to Follow-up|0|||
129927709|NCT04433208|467702883|FG002|Overall Study|Lost to Follow-up|0|||
129927710|NCT04433208|467702884|FG003|Overall Study|Lost to Follow-up|0|||
129927711|NCT04433208|467702885|FG004|Overall Study|Lost to Follow-up|0|||
129927712|NCT04433208|467702886|FG005|Overall Study|Lost to Follow-up|1|||
129927713|NCT05485779|467702887|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927714|NCT05485779|467702888|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927715|NCT05485779|467702889|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927716|NCT05485779|467702890|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927717|NCT05485779|467702891|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927718|NCT05485779|467702892|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927719|NCT05485779|467702893|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927720|NCT05485779|467702894|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
129927721|NCT05485779|467702895|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
129927722|NCT05485779|467702896|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927723|NCT05485779|467702897|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
129927724|NCT05485779|467702887|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927725|NCT05485779|467702888|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927726|NCT05485779|467702889|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927727|NCT05485779|467702890|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927728|NCT05485779|467702891|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927729|NCT05485779|467702892|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927730|NCT05485779|467702893|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927731|NCT05485779|467702894|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927732|NCT05485779|467702895|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927733|NCT05485779|467702896|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
129927734|NCT05485779|467702897|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
129927735|NCT05485779|467702887|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927736|NCT05485779|467702888|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927737|NCT05485779|467702889|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927738|NCT05485779|467702890|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
129927739|NCT05485779|467702891|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927740|NCT05485779|467702892|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927741|NCT05485779|467702893|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927742|NCT05485779|467702894|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927743|NCT05485779|467702895|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927744|NCT05485779|467702896|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927745|NCT05485779|467702897|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
129927746|NCT05764525|467702900|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
129927747|NCT05764525|467702901|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
129927748|NCT05764525|467702900|FG000|Overall Study|Withdrawal by Subject|4|||
129927749|NCT05764525|467702901|FG001|Overall Study|Withdrawal by Subject|8|||
129927750|NCT05764525|467702900|FG000|Overall Study|Physician Decision|1|||
129927751|NCT05764525|467702901|FG001|Overall Study|Physician Decision|0|||
129927752|NCT03030261|467702903|FG000|Overall Study|Still receiving continuation therapy|5|||
129927753|NCT05370040|467702913|FG000|Overall Study|Lost to Follow-up|0|||
129927754|NCT05370040|467702914|FG001|Overall Study|Lost to Follow-up|0|||
129927755|NCT05370040|467702915|FG002|Overall Study|Lost to Follow-up|1|||
129927756|NCT05370040|467702916|FG003|Overall Study|Lost to Follow-up|0|||
129927757|NCT05370040|467702917|FG004|Overall Study|Lost to Follow-up|1|||
129927758|NCT05370040|467702918|FG005|Overall Study|Lost to Follow-up|0|||
129927759|NCT04971109|467702919|FG000|Overall Study|Adverse Event|4|||
129927760|NCT04971109|467702920|FG001|Overall Study|Adverse Event|3|||
129927761|NCT04971109|467702919|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
129927762|NCT04971109|467702920|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
129927763|NCT04971109|467702919|FG000|Overall Study|Lost to Follow-up|8|||
129927764|NCT04971109|467702920|FG001|Overall Study|Lost to Follow-up|2|||
129927765|NCT04971109|467702919|FG000|Overall Study|Physician Decision|5|||
129927766|NCT04971109|467702920|FG001|Overall Study|Physician Decision|0|||
129927767|NCT04971109|467702919|FG000|Overall Study|Protocol Violation|0|||
129927768|NCT04971109|467702920|FG001|Overall Study|Protocol Violation|1|||
129927769|NCT04971109|467702919|FG000|Overall Study|Withdrawal by Subject|18|||
129927770|NCT04971109|467702920|FG001|Overall Study|Withdrawal by Subject|3|||
129927771|NCT04971109|467702919|FG000|Overall Study|Subject was randomized in error|1|||
129927772|NCT04971109|467702920|FG001|Overall Study|Subject was randomized in error|0|||
129927773|NCT03910478|467702921|FG000|Overall Study|Death|13|||
129927774|NCT03910478|467702922|FG001|Overall Study|Death|6|||
129927775|NCT03910478|467702921|FG000|Overall Study|Withdrawal by Subject|23|||
129927776|NCT03910478|467702922|FG001|Overall Study|Withdrawal by Subject|2|||
129927777|NCT03910478|467702921|FG000|Overall Study|Physician Decision|5|||
129927778|NCT03910478|467702922|FG001|Overall Study|Physician Decision|0|||
129927779|NCT03910478|467702921|FG000|Overall Study|Protocol Violation|1|||
129927780|NCT03910478|467702922|FG001|Overall Study|Protocol Violation|0|||
129927781|NCT03910478|467702921|FG000|Overall Study|Failure to meet continuation criteria|2|||
129927782|NCT03910478|467702922|FG001|Overall Study|Failure to meet continuation criteria|0|||
129927783|NCT03910478|467702921|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
129927784|NCT03910478|467702922|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
129927785|NCT05293171|467702924|FG000|Washout 5 to 7 Days|Adverse Event|1|||
129927786|NCT05293171|467702925|FG001|Washout 5 to 7 Days|Adverse Event|1|||
129927787|NCT05293171|467702926|FG002|Washout 5 to 7 Days|Adverse Event|0|||
129927788|NCT05293171|467702927|FG003|Washout 5 to 7 Days|Adverse Event|0|||
129927789|NCT05293171|467702928|FG004|Washout 5 to 7 Days|Adverse Event|0|||
129927790|NCT05293171|467702929|FG005|Washout 5 to 7 Days|Adverse Event|0|||
129927791|NCT05293171|467702930|FG006|Washout 5 to 7 Days|Adverse Event|0|||
129927792|NCT05293171|467702931|FG007|Washout 5 to 7 Days|Adverse Event|0|||
129927793|NCT05293171|467702932|FG008|Washout 5 to 7 Days|Adverse Event|0|||
129927794|NCT05293171|467702933|FG009|Washout 5 to 7 Days|Adverse Event|0|||
129927795|NCT05293171|467702934|FG010|Washout 5 to 7 Days|Adverse Event|0|||
129927796|NCT05293171|467702935|FG011|Washout 5 to 7 Days|Adverse Event|0|||
129927797|NCT05293171|467702924|FG000|Washout 5 to 7 Days|Adverse Event|0|||
129927798|NCT05293171|467702925|FG001|Washout 5 to 7 Days|Adverse Event|0|||
129927799|NCT05293171|467702926|FG002|Washout 5 to 7 Days|Adverse Event|0|||
129927800|NCT05293171|467702927|FG003|Washout 5 to 7 Days|Adverse Event|0|||
129927801|NCT05293171|467702928|FG004|Washout 5 to 7 Days|Adverse Event|0|||
129927802|NCT05293171|467702929|FG005|Washout 5 to 7 Days|Adverse Event|1|||
129927803|NCT05293171|467702930|FG006|Washout 5 to 7 Days|Adverse Event|0|||
129927804|NCT05293171|467702931|FG007|Washout 5 to 7 Days|Adverse Event|0|||
129927805|NCT05293171|467702932|FG008|Washout 5 to 7 Days|Adverse Event|0|||
129927806|NCT05293171|467702933|FG009|Washout 5 to 7 Days|Adverse Event|0|||
129927807|NCT05293171|467702934|FG010|Washout 5 to 7 Days|Adverse Event|0|||
129927808|NCT05293171|467702935|FG011|Washout 5 to 7 Days|Adverse Event|0|||
129927809|NCT01712490|467702941|FG000|Overall Study|Ongoing|601|||
129927810|NCT01712490|467702942|FG001|Overall Study|Ongoing|586|||
129927811|NCT01712490|467702941|FG000|Overall Study|Other|11|||
129927812|NCT01712490|467702942|FG001|Overall Study|Other|11|||
129927813|NCT01712490|467702941|FG000|Overall Study|Withdrawal by Subject|36|||
129927814|NCT01712490|467702942|FG001|Overall Study|Withdrawal by Subject|44|||
129927815|NCT01712490|467702941|FG000|Overall Study|Lost to Follow-up|16|||
129927816|NCT01712490|467702942|FG001|Overall Study|Lost to Follow-up|29|||
129927817|NCT03987022|467702945|FG000|Overall Study|Lost to Follow-up|2|||
129927818|NCT03987022|467702946|FG001|Overall Study|Lost to Follow-up|2|||
129927819|NCT03987022|467702945|FG000|Overall Study|Withdrawal by Subject|1|||
129927820|NCT03987022|467702946|FG001|Overall Study|Withdrawal by Subject|0|||
129927821|NCT05123586|467702949|FG000|Overall Study|Physician Decision|1|||
129927822|NCT05123586|467702950|FG001|Overall Study|Physician Decision|1|||
129927823|NCT05123586|467702949|FG000|Overall Study|Withdrawal by Subject|0|||
129927824|NCT05123586|467702950|FG001|Overall Study|Withdrawal by Subject|3|||
129927825|NCT03734679|467702956|FG000|Overall Study|Missed Visit|1|||
129927826|NCT03626220|467702960|FG000|Overall Study|Withdrawal by Subject|2|||
129927827|NCT03626220|467702961|FG001|Overall Study|Withdrawal by Subject|0|||
129927828|NCT04231149|467704080|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927829|NCT04231149|467704081|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
129927830|NCT04231149|467704082|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927831|NCT04231149|467704083|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927832|NCT04231149|467704084|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
129927833|NCT05877976|467704085|FG000|Overall Study|Lost to Follow-up|31|||
129927834|NCT05622812|467704086|FG000|Overall Study|Withdrawal by Subject|1|||
129927835|NCT05622812|467704087|FG001|Overall Study|Withdrawal by Subject|4|||
129927836|NCT05622812|467704086|FG000|Overall Study|Lost to Follow-up|2|||
129927837|NCT05622812|467704087|FG001|Overall Study|Lost to Follow-up|1|||
129927838|NCT03916185|467704088|FG000|Overall Study|Lost to Follow-up|0|||
129927839|NCT03916185|467704089|FG001|Overall Study|Lost to Follow-up|1|||
129927840|NCT03916185|467704090|FG002|Overall Study|Lost to Follow-up|0|||
129927841|NCT03916185|467704091|FG003|Overall Study|Lost to Follow-up|0|||
129927842|NCT03916185|467704088|FG000|Overall Study|Moved|1|||
129927843|NCT03916185|467704089|FG001|Overall Study|Moved|0|||
129927844|NCT03916185|467704090|FG002|Overall Study|Moved|0|||
129927845|NCT03916185|467704091|FG003|Overall Study|Moved|1|||
129927846|NCT03916185|467704088|FG000|Overall Study|Not Able to Get to Clinic|1|||
129927847|NCT03916185|467704089|FG001|Overall Study|Not Able to Get to Clinic|0|||
129927848|NCT03916185|467704090|FG002|Overall Study|Not Able to Get to Clinic|0|||
129927849|NCT03916185|467704091|FG003|Overall Study|Not Able to Get to Clinic|0|||
129927850|NCT02844465|467704093|FG000|Overall Study|Screen Failure|36|||
129927851|NCT02844465|467704093|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
129927852|NCT02844465|467704093|FG000|Overall Study|Withdrawal by Subject|5|||
129927853|NCT02844465|467704093|FG000|Overall Study|Lost to Follow-up|1|||
129927854|NCT02844465|467704093|FG000|Overall Study|Retreatment|1|||
129927855|NCT02460458|467704094|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
129927856|NCT02460458|467704094|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
129927857|NCT02460458|467704094|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
129927858|NCT02460458|467704094|FG000|First Prospective Phase|Lost to Follow-up|84|||
129927859|NCT02460458|467704094|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
129927860|NCT03220035|467704095|FG000|Overall Study|Adverse Event|1|||
129927861|NCT03220035|467704095|FG000|Overall Study|Protocol Violation|1|||
129927862|NCT03220035|467704095|FG000|Overall Study|Progressive Disease|2|||
129927863|NCT02433379|467704096|FG000|Overall Study|Screen Failures|55|||
129927864|NCT02433379|467704096|FG000|Overall Study|Death|57|||
129927865|NCT02433379|467704096|FG000|Overall Study|Total Withdrawals|209|||
129927866|NCT01928394|467704101|FG000|Treatment Period|Disease progression|17|||
129927867|NCT01928394|467704102|FG001|Treatment Period|Disease progression|2|||
129927868|NCT01928394|467704103|FG002|Treatment Period|Disease progression|12|||
129927869|NCT01928394|467704104|FG003|Treatment Period|Disease progression|48|||
129927870|NCT01928394|467704105|FG004|Treatment Period|Disease progression|3|||
129927871|NCT01928394|467704106|FG005|Treatment Period|Disease progression|25|||
129927872|NCT01928394|467704107|FG006|Treatment Period|Disease progression|38|||
129927873|NCT01928394|467704108|FG007|Treatment Period|Disease progression|16|||
129927874|NCT01928394|467704109|FG008|Treatment Period|Disease progression|3|||
129927875|NCT01928394|467704110|FG009|Treatment Period|Disease progression|11|||
129927876|NCT01928394|467704111|FG010|Treatment Period|Disease progression|22|||
129927877|NCT01928394|467704112|FG011|Treatment Period|Disease progression|73|||
129927878|NCT01928394|467704113|FG012|Treatment Period|Disease progression|38|||
129927879|NCT01928394|467704114|FG013|Treatment Period|Disease progression|118|||
129927880|NCT01928394|467704115|FG014|Treatment Period|Disease progression|59|||
129927881|NCT01928394|467704116|FG015|Treatment Period|Disease progression|1|||
129927882|NCT01928394|467704117|FG016|Treatment Period|Disease progression|43|||
129927883|NCT01928394|467704118|FG017|Treatment Period|Disease progression|56|||
129927884|NCT01928394|467704119|FG018|Treatment Period|Disease progression|50|||
129927885|NCT01928394|467704120|FG019|Treatment Period|Disease progression|71|||
129927886|NCT01928394|467704121|FG020|Treatment Period|Disease progression|30|||
129927887|NCT01928394|467704122|FG021|Treatment Period|Disease progression|31|||
129927888|NCT01928394|467704123|FG022|Treatment Period|Disease progression|31|||
129927889|NCT01928394|467704101|FG000|Treatment Period|Study drug toxicity|1|||
129927890|NCT01928394|467704102|FG001|Treatment Period|Study drug toxicity|1|||
129927891|NCT01928394|467704103|FG002|Treatment Period|Study drug toxicity|3|||
129927892|NCT01928394|467704104|FG003|Treatment Period|Study drug toxicity|3|||
129927893|NCT01928394|467704105|FG004|Treatment Period|Study drug toxicity|0|||
129927894|NCT01928394|467704106|FG005|Treatment Period|Study drug toxicity|9|||
129927895|NCT01928394|467704107|FG006|Treatment Period|Study drug toxicity|7|||
129927896|NCT01928394|467704108|FG007|Treatment Period|Study drug toxicity|1|||
129927897|NCT01928394|467704109|FG008|Treatment Period|Study drug toxicity|0|||
129927898|NCT01928394|467704110|FG009|Treatment Period|Study drug toxicity|5|||
129927899|NCT01928394|467704111|FG010|Treatment Period|Study drug toxicity|2|||
129927900|NCT01928394|467704112|FG011|Treatment Period|Study drug toxicity|3|||
129927901|NCT01928394|467704113|FG012|Treatment Period|Study drug toxicity|7|||
129927902|NCT01928394|467704114|FG013|Treatment Period|Study drug toxicity|5|||
129927903|NCT01928394|467704115|FG014|Treatment Period|Study drug toxicity|12|||
129927904|NCT01928394|467704116|FG015|Treatment Period|Study drug toxicity|0|||
129927905|NCT01928394|467704117|FG016|Treatment Period|Study drug toxicity|3|||
129927906|NCT01928394|467704118|FG017|Treatment Period|Study drug toxicity|3|||
129927907|NCT01928394|467704119|FG018|Treatment Period|Study drug toxicity|12|||
129927908|NCT01928394|467704120|FG019|Treatment Period|Study drug toxicity|15|||
129927909|NCT01928394|467704121|FG020|Treatment Period|Study drug toxicity|4|||
129927910|NCT01928394|467704122|FG021|Treatment Period|Study drug toxicity|7|||
129927911|NCT01928394|467704123|FG022|Treatment Period|Study drug toxicity|4|||
129927912|NCT01928394|467704101|FG000|Treatment Period|AE unrelated to study drug|0|||
129927913|NCT01928394|467704102|FG001|Treatment Period|AE unrelated to study drug|0|||
129927914|NCT01928394|467704103|FG002|Treatment Period|AE unrelated to study drug|2|||
129927915|NCT01928394|467704104|FG003|Treatment Period|AE unrelated to study drug|3|||
129927916|NCT01928394|467704105|FG004|Treatment Period|AE unrelated to study drug|0|||
129927917|NCT01928394|467704106|FG005|Treatment Period|AE unrelated to study drug|5|||
129927918|NCT01928394|467704107|FG006|Treatment Period|AE unrelated to study drug|1|||
129927919|NCT01928394|467704108|FG007|Treatment Period|AE unrelated to study drug|0|||
129927920|NCT01928394|467704109|FG008|Treatment Period|AE unrelated to study drug|0|||
129927921|NCT01928394|467704110|FG009|Treatment Period|AE unrelated to study drug|2|||
129927922|NCT01928394|467704111|FG010|Treatment Period|AE unrelated to study drug|0|||
129927923|NCT01928394|467704112|FG011|Treatment Period|AE unrelated to study drug|12|||
129927924|NCT01928394|467704113|FG012|Treatment Period|AE unrelated to study drug|6|||
129927925|NCT01928394|467704114|FG013|Treatment Period|AE unrelated to study drug|13|||
129927926|NCT01928394|467704115|FG014|Treatment Period|AE unrelated to study drug|6|||
129927927|NCT01928394|467704116|FG015|Treatment Period|AE unrelated to study drug|1|||
129927928|NCT01928394|467704117|FG016|Treatment Period|AE unrelated to study drug|1|||
129927929|NCT01928394|467704118|FG017|Treatment Period|AE unrelated to study drug|6|||
129927930|NCT01928394|467704119|FG018|Treatment Period|AE unrelated to study drug|3|||
129927931|NCT01928394|467704120|FG019|Treatment Period|AE unrelated to study drug|5|||
129927932|NCT01928394|467704121|FG020|Treatment Period|AE unrelated to study drug|1|||
129927933|NCT01928394|467704122|FG021|Treatment Period|AE unrelated to study drug|1|||
129927934|NCT01928394|467704123|FG022|Treatment Period|AE unrelated to study drug|0|||
129927935|NCT01928394|467704101|FG000|Treatment Period|Participant request to stop therapy|0|||
129927936|NCT01928394|467704102|FG001|Treatment Period|Participant request to stop therapy|0|||
129927937|NCT01928394|467704103|FG002|Treatment Period|Participant request to stop therapy|0|||
129927938|NCT01928394|467704104|FG003|Treatment Period|Participant request to stop therapy|0|||
129927939|NCT01928394|467704105|FG004|Treatment Period|Participant request to stop therapy|0|||
129927940|NCT01928394|467704106|FG005|Treatment Period|Participant request to stop therapy|3|||
129927941|NCT01928394|467704107|FG006|Treatment Period|Participant request to stop therapy|3|||
129927942|NCT01928394|467704108|FG007|Treatment Period|Participant request to stop therapy|0|||
129927943|NCT01928394|467704109|FG008|Treatment Period|Participant request to stop therapy|0|||
129927944|NCT01928394|467704110|FG009|Treatment Period|Participant request to stop therapy|0|||
129927945|NCT01928394|467704111|FG010|Treatment Period|Participant request to stop therapy|3|||
129927946|NCT01928394|467704112|FG011|Treatment Period|Participant request to stop therapy|2|||
129927947|NCT01928394|467704113|FG012|Treatment Period|Participant request to stop therapy|1|||
129927948|NCT01928394|467704114|FG013|Treatment Period|Participant request to stop therapy|2|||
129927949|NCT01928394|467704115|FG014|Treatment Period|Participant request to stop therapy|4|||
129927950|NCT01928394|467704116|FG015|Treatment Period|Participant request to stop therapy|0|||
129927951|NCT01928394|467704117|FG016|Treatment Period|Participant request to stop therapy|1|||
129927952|NCT01928394|467704118|FG017|Treatment Period|Participant request to stop therapy|3|||
129927953|NCT01928394|467704119|FG018|Treatment Period|Participant request to stop therapy|1|||
129927954|NCT01928394|467704120|FG019|Treatment Period|Participant request to stop therapy|1|||
129927955|NCT01928394|467704121|FG020|Treatment Period|Participant request to stop therapy|3|||
129927956|NCT01928394|467704122|FG021|Treatment Period|Participant request to stop therapy|1|||
129927957|NCT01928394|467704123|FG022|Treatment Period|Participant request to stop therapy|3|||
129927958|NCT01928394|467704101|FG000|Treatment Period|Participant withdrew consent|0|||
129927959|NCT01928394|467704102|FG001|Treatment Period|Participant withdrew consent|0|||
129927960|NCT01928394|467704103|FG002|Treatment Period|Participant withdrew consent|1|||
129927961|NCT01928394|467704104|FG003|Treatment Period|Participant withdrew consent|1|||
129927962|NCT01928394|467704105|FG004|Treatment Period|Participant withdrew consent|0|||
129927963|NCT01928394|467704106|FG005|Treatment Period|Participant withdrew consent|1|||
129927964|NCT01928394|467704107|FG006|Treatment Period|Participant withdrew consent|0|||
129927965|NCT01928394|467704108|FG007|Treatment Period|Participant withdrew consent|1|||
129927966|NCT01928394|467704109|FG008|Treatment Period|Participant withdrew consent|0|||
129927967|NCT01928394|467704110|FG009|Treatment Period|Participant withdrew consent|0|||
129927968|NCT01928394|467704111|FG010|Treatment Period|Participant withdrew consent|1|||
129927969|NCT01928394|467704112|FG011|Treatment Period|Participant withdrew consent|1|||
129927970|NCT01928394|467704113|FG012|Treatment Period|Participant withdrew consent|1|||
129927971|NCT01928394|467704114|FG013|Treatment Period|Participant withdrew consent|0|||
129927972|NCT01928394|467704115|FG014|Treatment Period|Participant withdrew consent|2|||
129927973|NCT01928394|467704116|FG015|Treatment Period|Participant withdrew consent|0|||
129927974|NCT01928394|467704117|FG016|Treatment Period|Participant withdrew consent|2|||
129927975|NCT01928394|467704118|FG017|Treatment Period|Participant withdrew consent|1|||
129927976|NCT01928394|467704119|FG018|Treatment Period|Participant withdrew consent|1|||
129927977|NCT01928394|467704120|FG019|Treatment Period|Participant withdrew consent|1|||
129927978|NCT01928394|467704121|FG020|Treatment Period|Participant withdrew consent|0|||
129927979|NCT01928394|467704122|FG021|Treatment Period|Participant withdrew consent|2|||
129927980|NCT01928394|467704123|FG022|Treatment Period|Participant withdrew consent|0|||
129927981|NCT01928394|467704101|FG000|Treatment Period|Poor/non-compliance|0|||
129927982|NCT01928394|467704102|FG001|Treatment Period|Poor/non-compliance|0|||
129927983|NCT01928394|467704103|FG002|Treatment Period|Poor/non-compliance|0|||
129927984|NCT01928394|467704104|FG003|Treatment Period|Poor/non-compliance|1|||
129927985|NCT01928394|467704105|FG004|Treatment Period|Poor/non-compliance|0|||
129927986|NCT01928394|467704106|FG005|Treatment Period|Poor/non-compliance|0|||
129927987|NCT01928394|467704107|FG006|Treatment Period|Poor/non-compliance|0|||
129927988|NCT01928394|467704108|FG007|Treatment Period|Poor/non-compliance|0|||
129927989|NCT01928394|467704109|FG008|Treatment Period|Poor/non-compliance|0|||
129927990|NCT01928394|467704110|FG009|Treatment Period|Poor/non-compliance|0|||
129927991|NCT01928394|467704111|FG010|Treatment Period|Poor/non-compliance|0|||
129927992|NCT01928394|467704112|FG011|Treatment Period|Poor/non-compliance|0|||
129927993|NCT01928394|467704113|FG012|Treatment Period|Poor/non-compliance|1|||
129927994|NCT01928394|467704114|FG013|Treatment Period|Poor/non-compliance|0|||
129927995|NCT01928394|467704115|FG014|Treatment Period|Poor/non-compliance|1|||
129927996|NCT01928394|467704116|FG015|Treatment Period|Poor/non-compliance|0|||
129927997|NCT01928394|467704117|FG016|Treatment Period|Poor/non-compliance|0|||
129927998|NCT01928394|467704118|FG017|Treatment Period|Poor/non-compliance|1|||
129927999|NCT01928394|467704119|FG018|Treatment Period|Poor/non-compliance|0|||
129928000|NCT01928394|467704120|FG019|Treatment Period|Poor/non-compliance|1|||
129928001|NCT01928394|467704121|FG020|Treatment Period|Poor/non-compliance|0|||
129928002|NCT01928394|467704122|FG021|Treatment Period|Poor/non-compliance|0|||
129928003|NCT01928394|467704123|FG022|Treatment Period|Poor/non-compliance|0|||
129928004|NCT01928394|467704101|FG000|Treatment Period|other reason|0|||
129928005|NCT01928394|467704102|FG001|Treatment Period|other reason|0|||
129928006|NCT01928394|467704103|FG002|Treatment Period|other reason|0|||
129928007|NCT01928394|467704104|FG003|Treatment Period|other reason|0|||
129928008|NCT01928394|467704105|FG004|Treatment Period|other reason|0|||
129928009|NCT01928394|467704106|FG005|Treatment Period|other reason|0|||
129928010|NCT01928394|467704107|FG006|Treatment Period|other reason|0|||
129928011|NCT01928394|467704108|FG007|Treatment Period|other reason|0|||
129928012|NCT01928394|467704109|FG008|Treatment Period|other reason|0|||
129928013|NCT01928394|467704110|FG009|Treatment Period|other reason|0|||
129928014|NCT01928394|467704111|FG010|Treatment Period|other reason|1|||
129928015|NCT01928394|467704112|FG011|Treatment Period|other reason|1|||
129928016|NCT01928394|467704113|FG012|Treatment Period|other reason|1|||
129928017|NCT01928394|467704114|FG013|Treatment Period|other reason|0|||
129928018|NCT01928394|467704115|FG014|Treatment Period|other reason|1|||
129928019|NCT01928394|467704116|FG015|Treatment Period|other reason|0|||
129928020|NCT01928394|467704117|FG016|Treatment Period|other reason|0|||
129928021|NCT01928394|467704118|FG017|Treatment Period|other reason|0|||
129928022|NCT01928394|467704119|FG018|Treatment Period|other reason|2|||
129928023|NCT01928394|467704120|FG019|Treatment Period|other reason|2|||
129928024|NCT01928394|467704121|FG020|Treatment Period|other reason|0|||
129928025|NCT01928394|467704122|FG021|Treatment Period|other reason|0|||
129928026|NCT01928394|467704123|FG022|Treatment Period|other reason|0|||
129928027|NCT01928394|467704101|FG000|Treatment Period|Maximum clinical benefit|0|||
129928028|NCT01928394|467704102|FG001|Treatment Period|Maximum clinical benefit|0|||
129928029|NCT01928394|467704103|FG002|Treatment Period|Maximum clinical benefit|0|||
129928030|NCT01928394|467704104|FG003|Treatment Period|Maximum clinical benefit|0|||
129928031|NCT01928394|467704105|FG004|Treatment Period|Maximum clinical benefit|0|||
129928032|NCT01928394|467704106|FG005|Treatment Period|Maximum clinical benefit|0|||
129928033|NCT01928394|467704107|FG006|Treatment Period|Maximum clinical benefit|0|||
129928034|NCT01928394|467704108|FG007|Treatment Period|Maximum clinical benefit|0|||
129928035|NCT01928394|467704109|FG008|Treatment Period|Maximum clinical benefit|0|||
129928036|NCT01928394|467704110|FG009|Treatment Period|Maximum clinical benefit|0|||
129928037|NCT01928394|467704111|FG010|Treatment Period|Maximum clinical benefit|1|||
129928038|NCT01928394|467704112|FG011|Treatment Period|Maximum clinical benefit|1|||
129928039|NCT01928394|467704113|FG012|Treatment Period|Maximum clinical benefit|0|||
129928040|NCT01928394|467704114|FG013|Treatment Period|Maximum clinical benefit|0|||
129928041|NCT01928394|467704115|FG014|Treatment Period|Maximum clinical benefit|1|||
129928042|NCT01928394|467704116|FG015|Treatment Period|Maximum clinical benefit|0|||
129928043|NCT01928394|467704117|FG016|Treatment Period|Maximum clinical benefit|0|||
129928044|NCT01928394|467704118|FG017|Treatment Period|Maximum clinical benefit|1|||
129928045|NCT01928394|467704119|FG018|Treatment Period|Maximum clinical benefit|1|||
129928046|NCT01928394|467704120|FG019|Treatment Period|Maximum clinical benefit|0|||
129928047|NCT01928394|467704121|FG020|Treatment Period|Maximum clinical benefit|2|||
129928048|NCT01928394|467704122|FG021|Treatment Period|Maximum clinical benefit|0|||
129928049|NCT01928394|467704123|FG022|Treatment Period|Maximum clinical benefit|0|||
129928050|NCT01928394|467704101|FG000|Treatment Period|Lost to Follow-up|0|||
129928051|NCT01928394|467704102|FG001|Treatment Period|Lost to Follow-up|0|||
129928052|NCT01928394|467704103|FG002|Treatment Period|Lost to Follow-up|0|||
129928053|NCT01928394|467704104|FG003|Treatment Period|Lost to Follow-up|0|||
129928054|NCT01928394|467704105|FG004|Treatment Period|Lost to Follow-up|0|||
129928055|NCT01928394|467704106|FG005|Treatment Period|Lost to Follow-up|0|||
129928056|NCT01928394|467704107|FG006|Treatment Period|Lost to Follow-up|0|||
129928057|NCT01928394|467704108|FG007|Treatment Period|Lost to Follow-up|0|||
129928058|NCT01928394|467704109|FG008|Treatment Period|Lost to Follow-up|0|||
129928059|NCT01928394|467704110|FG009|Treatment Period|Lost to Follow-up|0|||
129928060|NCT01928394|467704111|FG010|Treatment Period|Lost to Follow-up|0|||
129928061|NCT01928394|467704112|FG011|Treatment Period|Lost to Follow-up|0|||
129928062|NCT01928394|467704113|FG012|Treatment Period|Lost to Follow-up|0|||
129928063|NCT01928394|467704114|FG013|Treatment Period|Lost to Follow-up|0|||
129928064|NCT01928394|467704115|FG014|Treatment Period|Lost to Follow-up|0|||
129928065|NCT01928394|467704116|FG015|Treatment Period|Lost to Follow-up|0|||
129928066|NCT01928394|467704117|FG016|Treatment Period|Lost to Follow-up|0|||
129928067|NCT01928394|467704118|FG017|Treatment Period|Lost to Follow-up|0|||
129928068|NCT01928394|467704119|FG018|Treatment Period|Lost to Follow-up|0|||
129928069|NCT01928394|467704120|FG019|Treatment Period|Lost to Follow-up|0|||
129928070|NCT01928394|467704121|FG020|Treatment Period|Lost to Follow-up|0|||
129928071|NCT01928394|467704122|FG021|Treatment Period|Lost to Follow-up|0|||
129928072|NCT01928394|467704123|FG022|Treatment Period|Lost to Follow-up|1|||
129928073|NCT01928394|467704101|FG000|Treatment Period|Death|0|||
129928074|NCT01928394|467704102|FG001|Treatment Period|Death|0|||
129928075|NCT01928394|467704103|FG002|Treatment Period|Death|0|||
129928076|NCT01928394|467704104|FG003|Treatment Period|Death|0|||
129928077|NCT01928394|467704105|FG004|Treatment Period|Death|0|||
129928078|NCT01928394|467704106|FG005|Treatment Period|Death|0|||
129928079|NCT01928394|467704107|FG006|Treatment Period|Death|0|||
129928080|NCT01928394|467704108|FG007|Treatment Period|Death|0|||
129928081|NCT01928394|467704109|FG008|Treatment Period|Death|0|||
129928082|NCT01928394|467704110|FG009|Treatment Period|Death|0|||
129928083|NCT01928394|467704111|FG010|Treatment Period|Death|0|||
129928084|NCT01928394|467704112|FG011|Treatment Period|Death|0|||
129928085|NCT01928394|467704113|FG012|Treatment Period|Death|0|||
129928086|NCT01928394|467704114|FG013|Treatment Period|Death|1|||
129928087|NCT01928394|467704115|FG014|Treatment Period|Death|2|||
129928088|NCT01928394|467704116|FG015|Treatment Period|Death|0|||
129928089|NCT01928394|467704117|FG016|Treatment Period|Death|0|||
129928090|NCT01928394|467704118|FG017|Treatment Period|Death|0|||
129928091|NCT01928394|467704119|FG018|Treatment Period|Death|0|||
129928092|NCT01928394|467704120|FG019|Treatment Period|Death|0|||
129928093|NCT01928394|467704121|FG020|Treatment Period|Death|0|||
129928094|NCT01928394|467704122|FG021|Treatment Period|Death|0|||
129928095|NCT01928394|467704123|FG022|Treatment Period|Death|0|||
129928096|NCT01928394|467704101|FG000|Follow-up Period|Participant withdrew consent|3|||
129928097|NCT01928394|467704102|FG001|Follow-up Period|Participant withdrew consent|0|||
129928098|NCT01928394|467704103|FG002|Follow-up Period|Participant withdrew consent|1|||
129928099|NCT01928394|467704104|FG003|Follow-up Period|Participant withdrew consent|4|||
129928100|NCT01928394|467704105|FG004|Follow-up Period|Participant withdrew consent|0|||
129928101|NCT01928394|467704106|FG005|Follow-up Period|Participant withdrew consent|2|||
129928102|NCT01928394|467704107|FG006|Follow-up Period|Participant withdrew consent|5|||
129928103|NCT01928394|467704108|FG007|Follow-up Period|Participant withdrew consent|1|||
129928104|NCT01928394|467704109|FG008|Follow-up Period|Participant withdrew consent|0|||
129928105|NCT01928394|467704110|FG009|Follow-up Period|Participant withdrew consent|0|||
129928106|NCT01928394|467704111|FG010|Follow-up Period|Participant withdrew consent|5|||
129928107|NCT01928394|467704112|FG011|Follow-up Period|Participant withdrew consent|8|||
129928108|NCT01928394|467704113|FG012|Follow-up Period|Participant withdrew consent|2|||
129928109|NCT01928394|467704114|FG013|Follow-up Period|Participant withdrew consent|12|||
129928110|NCT01928394|467704115|FG014|Follow-up Period|Participant withdrew consent|7|||
129928111|NCT01928394|467704116|FG015|Follow-up Period|Participant withdrew consent|0|||
129928112|NCT01928394|467704117|FG016|Follow-up Period|Participant withdrew consent|5|||
129928113|NCT01928394|467704118|FG017|Follow-up Period|Participant withdrew consent|3|||
129928114|NCT01928394|467704119|FG018|Follow-up Period|Participant withdrew consent|2|||
129928115|NCT01928394|467704120|FG019|Follow-up Period|Participant withdrew consent|7|||
129928116|NCT01928394|467704121|FG020|Follow-up Period|Participant withdrew consent|4|||
129928117|NCT01928394|467704122|FG021|Follow-up Period|Participant withdrew consent|6|||
129928118|NCT01928394|467704123|FG022|Follow-up Period|Participant withdrew consent|2|||
129928119|NCT01928394|467704101|FG000|Follow-up Period|Death|0|||
129928120|NCT01928394|467704102|FG001|Follow-up Period|Death|0|||
129928121|NCT01928394|467704103|FG002|Follow-up Period|Death|2|||
129928122|NCT01928394|467704104|FG003|Follow-up Period|Death|6|||
129928123|NCT01928394|467704105|FG004|Follow-up Period|Death|0|||
129928124|NCT01928394|467704106|FG005|Follow-up Period|Death|6|||
129928125|NCT01928394|467704107|FG006|Follow-up Period|Death|6|||
129928126|NCT01928394|467704108|FG007|Follow-up Period|Death|2|||
129928127|NCT01928394|467704109|FG008|Follow-up Period|Death|1|||
129928128|NCT01928394|467704110|FG009|Follow-up Period|Death|2|||
129928129|NCT01928394|467704111|FG010|Follow-up Period|Death|4|||
129928130|NCT01928394|467704112|FG011|Follow-up Period|Death|12|||
129928131|NCT01928394|467704113|FG012|Follow-up Period|Death|11|||
129928132|NCT01928394|467704114|FG013|Follow-up Period|Death|25|||
129928133|NCT01928394|467704115|FG014|Follow-up Period|Death|18|||
129928134|NCT01928394|467704116|FG015|Follow-up Period|Death|0|||
129928135|NCT01928394|467704117|FG016|Follow-up Period|Death|6|||
129928136|NCT01928394|467704118|FG017|Follow-up Period|Death|5|||
129928137|NCT01928394|467704119|FG018|Follow-up Period|Death|13|||
129928138|NCT01928394|467704120|FG019|Follow-up Period|Death|13|||
129928139|NCT01928394|467704121|FG020|Follow-up Period|Death|5|||
129928140|NCT01928394|467704122|FG021|Follow-up Period|Death|3|||
129928141|NCT01928394|467704123|FG022|Follow-up Period|Death|2|||
129928142|NCT01928394|467704101|FG000|Follow-up Period|other reason|0|||
129928143|NCT01928394|467704102|FG001|Follow-up Period|other reason|0|||
129928144|NCT01928394|467704103|FG002|Follow-up Period|other reason|0|||
129928145|NCT01928394|467704104|FG003|Follow-up Period|other reason|0|||
129928146|NCT01928394|467704105|FG004|Follow-up Period|other reason|0|||
129928147|NCT01928394|467704106|FG005|Follow-up Period|other reason|0|||
129928148|NCT01928394|467704107|FG006|Follow-up Period|other reason|1|||
129928149|NCT01928394|467704108|FG007|Follow-up Period|other reason|3|||
129928150|NCT01928394|467704109|FG008|Follow-up Period|other reason|0|||
129928151|NCT01928394|467704110|FG009|Follow-up Period|other reason|0|||
129928152|NCT01928394|467704111|FG010|Follow-up Period|other reason|2|||
129928153|NCT01928394|467704112|FG011|Follow-up Period|other reason|1|||
129928154|NCT01928394|467704113|FG012|Follow-up Period|other reason|0|||
129928155|NCT01928394|467704114|FG013|Follow-up Period|other reason|1|||
129928156|NCT01928394|467704115|FG014|Follow-up Period|other reason|4|||
129928157|NCT01928394|467704116|FG015|Follow-up Period|other reason|0|||
129928158|NCT01928394|467704117|FG016|Follow-up Period|other reason|2|||
129928159|NCT01928394|467704118|FG017|Follow-up Period|other reason|0|||
129928160|NCT01928394|467704119|FG018|Follow-up Period|other reason|1|||
129928161|NCT01928394|467704120|FG019|Follow-up Period|other reason|1|||
129928162|NCT01928394|467704121|FG020|Follow-up Period|other reason|0|||
129928163|NCT01928394|467704122|FG021|Follow-up Period|other reason|0|||
129928164|NCT01928394|467704123|FG022|Follow-up Period|other reason|1|||
129928165|NCT01928394|467704101|FG000|Follow-up Period|Lost to Follow-up|0|||
129928166|NCT01928394|467704102|FG001|Follow-up Period|Lost to Follow-up|0|||
129928167|NCT01928394|467704103|FG002|Follow-up Period|Lost to Follow-up|0|||
129928168|NCT01928394|467704104|FG003|Follow-up Period|Lost to Follow-up|0|||
129928169|NCT01928394|467704105|FG004|Follow-up Period|Lost to Follow-up|0|||
129928170|NCT01928394|467704106|FG005|Follow-up Period|Lost to Follow-up|0|||
129928171|NCT01928394|467704107|FG006|Follow-up Period|Lost to Follow-up|0|||
129928172|NCT01928394|467704108|FG007|Follow-up Period|Lost to Follow-up|0|||
129928173|NCT01928394|467704109|FG008|Follow-up Period|Lost to Follow-up|0|||
129928174|NCT01928394|467704110|FG009|Follow-up Period|Lost to Follow-up|0|||
129928175|NCT01928394|467704111|FG010|Follow-up Period|Lost to Follow-up|0|||
129928176|NCT01928394|467704112|FG011|Follow-up Period|Lost to Follow-up|1|||
129928177|NCT01928394|467704113|FG012|Follow-up Period|Lost to Follow-up|1|||
129928178|NCT01928394|467704114|FG013|Follow-up Period|Lost to Follow-up|0|||
129928179|NCT01928394|467704115|FG014|Follow-up Period|Lost to Follow-up|1|||
129928180|NCT01928394|467704116|FG015|Follow-up Period|Lost to Follow-up|0|||
129928181|NCT01928394|467704117|FG016|Follow-up Period|Lost to Follow-up|1|||
129928182|NCT01928394|467704118|FG017|Follow-up Period|Lost to Follow-up|0|||
129928183|NCT01928394|467704119|FG018|Follow-up Period|Lost to Follow-up|0|||
129928184|NCT01928394|467704120|FG019|Follow-up Period|Lost to Follow-up|0|||
129928185|NCT01928394|467704121|FG020|Follow-up Period|Lost to Follow-up|0|||
129928186|NCT01928394|467704122|FG021|Follow-up Period|Lost to Follow-up|0|||
129928187|NCT01928394|467704123|FG022|Follow-up Period|Lost to Follow-up|1|||
129928188|NCT04707625|467704124|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
129928189|NCT04471246|467704125|FG000|Overall Study|Lost to Follow-up|2|||
129928190|NCT04471246|467704126|FG001|Overall Study|Lost to Follow-up|2|||
129928191|NCT03334630|467704127|FG000|Overall Study|Withdrawal by Subject|7|||
129928192|NCT03334630|467704128|FG001|Overall Study|Withdrawal by Subject|7|||
129928193|NCT03334630|467704127|FG000|Overall Study|Lost to Follow-up|3|||
129928194|NCT03334630|467704128|FG001|Overall Study|Lost to Follow-up|1|||
129928195|NCT03334630|467704127|FG000|Overall Study|Adverse Event|0|||
129928196|NCT03334630|467704128|FG001|Overall Study|Adverse Event|1|||
129928197|NCT03334630|467704127|FG000|Overall Study|Physician Decision|1|||
129928198|NCT03334630|467704128|FG001|Overall Study|Physician Decision|1|||
129928199|NCT03334630|467704127|FG000|Overall Study|Enrollment closed|2|||
129928200|NCT03334630|467704128|FG001|Overall Study|Enrollment closed|1|||
129928201|NCT03334630|467704127|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
129928202|NCT03334630|467704128|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
129928203|NCT03334630|467704127|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
129928204|NCT03334630|467704128|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
129928205|NCT02724969|467704148|FG000|Overall Study|Lost to Follow-up|12|||
129928206|NCT02724969|467704149|FG001|Overall Study|Lost to Follow-up|6|||
129928207|NCT02724969|467704148|FG000|Overall Study|Withdrawal by Subject|3|||
129928208|NCT02724969|467704149|FG001|Overall Study|Withdrawal by Subject|3|||
129928209|NCT02724969|467704148|FG000|Overall Study|Infant demise|0|||
129928210|NCT02724969|467704149|FG001|Overall Study|Infant demise|2|||
129928211|NCT01346540|467704150|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
129928212|NCT01346540|467704151|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
129928213|NCT01346540|467704150|FG000|Overall Study|Adverse Event|0|||
129928214|NCT01346540|467704151|FG001|Overall Study|Adverse Event|4|||
129928215|NCT03362476|467704156|FG000|Overall Study|Withdrawal by Subject|0|||
129928216|NCT03362476|467704157|FG001|Overall Study|Withdrawal by Subject|1|||
129928217|NCT05147116|467704164|FG000|Overall Study|Withdrawal by Subject|0|||
129928218|NCT05147116|467704165|FG001|Overall Study|Withdrawal by Subject|1|||
129928219|NCT03672916|467704166|FG000|Overall Study|Death|6|||
129928220|NCT03672916|467704166|FG000|Overall Study|Lost to Follow-up|29|||
129928221|NCT03672916|467704166|FG000|Overall Study|Adverse Event|6|||
129928222|NCT03672916|467704166|FG000|Overall Study|Withdrawal by Subject|11|||
129928223|NCT04197336|467704167|FG000|Overall Study|Withdrawal by Subject|1|||
129928224|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
129928225|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
129928226|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
129928227|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
129928228|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
129928229|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
129928230|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
129928231|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Death|0|||
129928232|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Death|1|||
129928233|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Death|0|||
129928234|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Death|0|||
129928235|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Death|0|||
129928236|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Death|0|||
129928237|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Death|0|||
129928238|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
129928239|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928240|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928241|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928242|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928243|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928244|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
129928245|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928246|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
129928247|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928248|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928249|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928250|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928251|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
129928252|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Other|1|||
129928253|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Other|0|||
129928254|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Other|0|||
129928255|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Other|0|||
129928256|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Other|0|||
129928257|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Other|0|||
129928258|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Other|0|||
129928259|NCT04585815|467704168|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
129928260|NCT04585815|467704169|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
129928261|NCT04585815|467704170|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928262|NCT04585815|467704171|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928263|NCT04585815|467704172|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928264|NCT04585815|467704173|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928265|NCT04585815|467704174|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
129928266|NCT04585815|467704168|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928267|NCT04585815|467704169|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
129928268|NCT04585815|467704170|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928269|NCT04585815|467704171|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928270|NCT04585815|467704172|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928271|NCT04585815|467704173|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928272|NCT04585815|467704174|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
129928273|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
129928274|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
129928275|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
129928276|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
129928277|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
129928278|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
129928279|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
129928280|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Death|0|||
129928281|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Death|0|||
129928282|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Death|0|||
129928283|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Death|1|||
129928284|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Death|0|||
129928285|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Death|0|||
129928286|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Death|0|||
129928287|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928288|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928289|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928290|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
129928291|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928292|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
129928293|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
129928294|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928295|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928296|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928297|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
129928298|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928299|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928300|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
129928301|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928302|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928303|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928304|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928305|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928306|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
129928307|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
129928308|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
129928309|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
129928310|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
129928311|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
129928312|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
129928313|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
129928314|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
129928315|NCT04585815|467704168|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
129928316|NCT04585815|467704169|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
129928317|NCT04585815|467704170|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
129928318|NCT04585815|467704171|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
129928319|NCT04585815|467704172|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
129928320|NCT04585815|467704173|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
129928321|NCT04585815|467704174|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
129928322|NCT04585815|467704168|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928323|NCT04585815|467704169|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928324|NCT04585815|467704170|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928325|NCT04585815|467704171|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
129928326|NCT04585815|467704172|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
129928327|NCT04585815|467704173|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
129928328|NCT04585815|467704174|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
129928329|NCT04585815|467704168|FG000|Sub-study B- Follow-up Phase|Death|0|||
129928330|NCT04585815|467704169|FG001|Sub-study B- Follow-up Phase|Death|0|||
129928331|NCT04585815|467704170|FG002|Sub-study B- Follow-up Phase|Death|1|||
129928332|NCT04585815|467704171|FG003|Sub-study B- Follow-up Phase|Death|3|||
129928333|NCT04585815|467704172|FG004|Sub-study B- Follow-up Phase|Death|0|||
129928334|NCT04585815|467704173|FG005|Sub-study B- Follow-up Phase|Death|0|||
129928335|NCT04585815|467704174|FG006|Sub-study B- Follow-up Phase|Death|1|||
129928336|NCT03571581|467704177|FG000|Overall Study|Death|2|||
129928337|NCT03571581|467704177|FG000|Overall Study|Withdrawal by Subject|2|||
129928338|NCT01309672|467704179|FG000|Overall Study|Lack of Efficacy|20|||
129928339|NCT01309672|467704179|FG000|Overall Study|Other|9|||
129928340|NCT01309672|467704179|FG000|Overall Study|Adverse Event|5|||
129928341|NCT01309672|467704179|FG000|Overall Study|Withdrawal by Subject|3|||
129928342|NCT05623228|467704180|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
129928343|NCT05623228|467704181|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928344|NCT05623228|467704182|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928345|NCT05623228|467704183|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928346|NCT05623228|467704184|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928347|NCT05623228|467704185|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928348|NCT05623228|467704186|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928349|NCT05623228|467704187|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
129928350|NCT05623228|467704180|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
129928351|NCT05623228|467704181|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928352|NCT05623228|467704182|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
129928353|NCT05623228|467704183|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
129928354|NCT05623228|467704184|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928355|NCT05623228|467704185|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928356|NCT05623228|467704186|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928357|NCT05623228|467704187|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
129928358|NCT04141891|467704189|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
129928359|NCT04141891|467704190|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
129928360|NCT04141891|467704189|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
129928361|NCT04141891|467704190|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
129928362|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
129928363|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
129928364|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
129928365|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
129928366|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
129928367|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
129928368|NCT04141891|467704189|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
129928369|NCT04141891|467704190|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
129928370|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
129928371|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
129928372|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
129928373|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
129928374|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
129928375|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
129928376|NCT04141891|467704189|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
129928377|NCT04141891|467704190|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
129928378|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
129928379|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
129928380|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
129928381|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
129928382|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
129928383|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
129928384|NCT04141891|467704189|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
129928385|NCT04141891|467704190|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
129928386|NCT04737330|467704191|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
129928387|NCT04737330|467704192|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
129928388|NCT04737330|467704191|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
129928389|NCT04737330|467704192|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
129928390|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
129928391|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
129928392|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
129928393|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
129928394|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
129450584|NCT00066742|465948782|FG000|Induction Chemoradiotherapy|Ineligible|3|||
129450585|NCT00066742|465948782|FG000|Consolidation Chemotherapy|not protocol specified|1|||
129450586|NCT00066742|465948782|FG000|Consolidation Chemotherapy|Ineligible|2|||
129450587|NCT01134614|465948788|FG000|Overall Study|Still on treatment as of March 2013|21|||
129450588|NCT01134614|465948789|FG001|Overall Study|Still on treatment as of March 2013|13|||
129450589|NCT01134614|465948788|FG000|Overall Study|Progressive disease|60|||
129450590|NCT01134614|465948789|FG001|Overall Study|Progressive disease|54|||
129450591|NCT01134614|465948788|FG000|Overall Study|Adverse Event|26|||
129450592|NCT01134614|465948789|FG001|Overall Study|Adverse Event|39|||
129450593|NCT01134614|465948788|FG000|Overall Study|Death|5|||
129450594|NCT01134614|465948789|FG001|Overall Study|Death|8|||
129450595|NCT01134614|465948788|FG000|Overall Study|Withdrawal by Subject|3|||
129450596|NCT01134614|465948789|FG001|Overall Study|Withdrawal by Subject|2|||
129450597|NCT01134614|465948788|FG000|Overall Study|Alternative therapy|2|||
129450598|NCT01134614|465948789|FG001|Overall Study|Alternative therapy|0|||
129450599|NCT01134614|465948788|FG000|Overall Study|Complicating disease|2|||
129450600|NCT01134614|465948789|FG001|Overall Study|Complicating disease|1|||
129450601|NCT01134614|465948788|FG000|Overall Study|Physician's decision|0|||
129450602|NCT01134614|465948789|FG001|Overall Study|Physician's decision|1|||
129450603|NCT01134614|465948788|FG000|Overall Study|Never started treatment|4|||
129450604|NCT01134614|465948789|FG001|Overall Study|Never started treatment|1|||
129450605|NCT01134614|465948788|FG000|Overall Study|Pt received tx not allowed on study|0|||
129450606|NCT01134614|465948789|FG001|Overall Study|Pt received tx not allowed on study|1|||
129450607|NCT01134614|465948788|FG000|Overall Study|Symptomatic deterioration|0|||
129450608|NCT01134614|465948789|FG001|Overall Study|Symptomatic deterioration|1|||
129450609|NCT01134614|465948788|FG000|Overall Study|Patient in hospice care|0|||
129450610|NCT01134614|465948789|FG001|Overall Study|Patient in hospice care|1|||
129450611|NCT02752035|465948790|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
129450612|NCT02752035|465948791|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
129450613|NCT02752035|465948792|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
129450614|NCT02752035|465948793|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
129450615|NCT02752035|465948790|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
129450616|NCT02752035|465948791|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
129450617|NCT02752035|465948792|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
129450618|NCT02752035|465948793|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
129450619|NCT02752035|465948790|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
129450620|NCT02752035|465948791|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
129450621|NCT02752035|465948792|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
129450622|NCT02752035|465948793|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
129450623|NCT02752035|465948790|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
129450624|NCT02752035|465948791|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
129450625|NCT02752035|465948792|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
129450626|NCT02752035|465948793|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
129450627|NCT02752035|465948790|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
129450628|NCT02752035|465948791|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
129450629|NCT02752035|465948792|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
129450630|NCT02752035|465948793|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
129450631|NCT02752035|465948790|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
129450632|NCT02752035|465948791|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
129450633|NCT02752035|465948792|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
129450634|NCT02752035|465948793|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
129450635|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
129450636|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
129450637|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
129450638|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
129450639|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
129450640|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
129450641|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
129450642|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
129450643|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
129450644|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
129450645|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
129928395|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
129928396|NCT04737330|467704191|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
129928397|NCT04737330|467704192|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
129928398|NCT01651403|467704197|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
129450646|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
129450647|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
129450648|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
129928399|NCT01651403|467704198|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
129928400|NCT01651403|467704197|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
129928401|NCT01651403|467704198|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
129928402|NCT01651403|467704197|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
129928403|NCT01651403|467704198|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
129928404|NCT01651403|467704197|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
129928405|NCT01651403|467704198|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
129928406|NCT01651403|467704197|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
129928407|NCT01651403|467704198|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
129928408|NCT01651403|467704197|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
129928409|NCT01651403|467704198|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
129928410|NCT05090683|467704201|FG000|Overall Study|Lost to Follow-up|10|||
129928411|NCT05090683|467704202|FG001|Overall Study|Lost to Follow-up|2|||
129928412|NCT05090683|467704201|FG000|Overall Study|Withdrawal by Subject|15|||
129928413|NCT05090683|467704202|FG001|Overall Study|Withdrawal by Subject|0|||
129928414|NCT05299723|467705357|FG000|Overall Study|Withdrawal by Subject|0|||
129928415|NCT05299723|467705358|FG001|Overall Study|Withdrawal by Subject|2|||
129928416|NCT05299723|467705359|FG002|Overall Study|Withdrawal by Subject|0|||
129928417|NCT00696111|467705360|FG000|Overall Study|Withdrawal by Subject|17|||
129928418|NCT03952338|467705361|FG000|Overall Study|Lost to Follow-up|11|||
129928419|NCT03952338|467705362|FG001|Overall Study|Lost to Follow-up|17|||
129928420|NCT03952338|467705361|FG000|Overall Study|Withdrawal by Subject|1|||
129928421|NCT03952338|467705362|FG001|Overall Study|Withdrawal by Subject|1|||
129928422|NCT03952338|467705361|FG000|Overall Study|Protocol Violation|1|||
129928423|NCT03952338|467705362|FG001|Overall Study|Protocol Violation|0|||
129928424|NCT02593773|467705363|FG000|Overall Study|Voluntary Withdrawal|3|||
129928425|NCT02593773|467705363|FG000|Overall Study|Study Terminated by Sponsor|31|||
129928426|NCT02593773|467705363|FG000|Overall Study|Death|1|||
129928427|NCT05452460|467705365|FG000|Overall Study|Lost to Follow-up|3|||
129928428|NCT05452460|467705366|FG001|Overall Study|Lost to Follow-up|3|||
129928429|NCT05452460|467705365|FG000|Overall Study|Did not receive intervention|1|||
129928430|NCT05452460|467705366|FG001|Overall Study|Did not receive intervention|0|||
129928431|NCT04447040|467705369|FG000|Overall Study|Lost to Follow-up|2|||
129928432|NCT04447040|467705370|FG001|Overall Study|Lost to Follow-up|1|||
129928433|NCT04447040|467705371|FG002|Overall Study|Lost to Follow-up|3|||
129928434|NCT04447040|467705372|FG003|Overall Study|Lost to Follow-up|3|||
129928435|NCT04447040|467705373|FG004|Overall Study|Lost to Follow-up|1|||
129928436|NCT04447040|467705374|FG005|Overall Study|Lost to Follow-up|3|||
129928437|NCT04447040|467705369|FG000|Overall Study|Withdrawal by Subject|0|||
129928438|NCT04447040|467705370|FG001|Overall Study|Withdrawal by Subject|1|||
129928439|NCT04447040|467705371|FG002|Overall Study|Withdrawal by Subject|1|||
129928440|NCT04447040|467705372|FG003|Overall Study|Withdrawal by Subject|1|||
129928441|NCT04447040|467705373|FG004|Overall Study|Withdrawal by Subject|0|||
129928442|NCT04447040|467705374|FG005|Overall Study|Withdrawal by Subject|0|||
129928443|NCT01208662|467705375|FG000|Induction and Consolidation|Disease Progression|23|||
129928444|NCT01208662|467705376|FG001|Induction and Consolidation|Disease Progression|13|||
129928445|NCT01208662|467705377|FG002|Induction and Consolidation|Disease Progression|0|||
129928446|NCT01208662|467705375|FG000|Induction and Consolidation|Adverse Event|16|||
129928447|NCT01208662|467705376|FG001|Induction and Consolidation|Adverse Event|18|||
129928448|NCT01208662|467705377|FG002|Induction and Consolidation|Adverse Event|2|||
129928449|NCT01208662|467705375|FG000|Induction and Consolidation|MD or Participant Decision|16|||
129928450|NCT01208662|467705376|FG001|Induction and Consolidation|MD or Participant Decision|34|||
129928451|NCT01208662|467705377|FG002|Induction and Consolidation|MD or Participant Decision|4|||
129928452|NCT01208662|467705375|FG000|Induction and Consolidation|Death|1|||
129928453|NCT01208662|467705376|FG001|Induction and Consolidation|Death|3|||
129928454|NCT01208662|467705377|FG002|Induction and Consolidation|Death|1|||
129928455|NCT01208662|467705375|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
129928456|NCT01208662|467705376|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
129928457|NCT01208662|467705377|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
129928458|NCT01208662|467705375|FG000|Maintenance|Disease Progression|156|||
129928459|NCT01208662|467705376|FG001|Maintenance|Disease Progression|102|||
129928460|NCT01208662|467705377|FG002|Maintenance|Disease Progression|0|||
129928461|NCT01208662|467705375|FG000|Maintenance|Adverse Event|12|||
129928462|NCT01208662|467705376|FG001|Maintenance|Adverse Event|28|||
129928463|NCT01208662|467705377|FG002|Maintenance|Adverse Event|0|||
129928464|NCT01208662|467705375|FG000|Maintenance|MD or Participant Decision|24|||
129928465|NCT01208662|467705376|FG001|Maintenance|MD or Participant Decision|36|||
129928466|NCT01208662|467705377|FG002|Maintenance|MD or Participant Decision|0|||
129928467|NCT01208662|467705375|FG000|Maintenance|Death|0|||
129928468|NCT01208662|467705376|FG001|Maintenance|Death|3|||
129928469|NCT01208662|467705377|FG002|Maintenance|Death|0|||
129928470|NCT01208662|467705375|FG000|Maintenance|Discontinued for other reasons|21|||
129928471|NCT01208662|467705376|FG001|Maintenance|Discontinued for other reasons|31|||
129928472|NCT01208662|467705377|FG002|Maintenance|Discontinued for other reasons|0|||
129928473|NCT01208662|467705375|FG000|Maintenance|Still on Treatment|78|||
129928474|NCT01208662|467705376|FG001|Maintenance|Still on Treatment|89|||
129928475|NCT01208662|467705377|FG002|Maintenance|Still on Treatment|0|||
129928476|NCT04076618|467705378|FG000|Overall Study|Lost to Follow-up|2|||
129928477|NCT04076618|467705379|FG001|Overall Study|Lost to Follow-up|1|||
129928478|NCT04076618|467705380|FG002|Overall Study|Lost to Follow-up|3|||
129928479|NCT04076618|467705378|FG000|Overall Study|Withdrawal by Subject|3|||
129928480|NCT04076618|467705379|FG001|Overall Study|Withdrawal by Subject|1|||
129928481|NCT04076618|467705380|FG002|Overall Study|Withdrawal by Subject|2|||
129928482|NCT04076618|467705378|FG000|Overall Study|Relocated out of state|0|||
129928483|NCT04076618|467705379|FG001|Overall Study|Relocated out of state|2|||
129928484|NCT04076618|467705380|FG002|Overall Study|Relocated out of state|0|||
129928485|NCT04076618|467705378|FG000|Overall Study|COVID concerns|0|||
129928486|NCT04076618|467705379|FG001|Overall Study|COVID concerns|1|||
129928487|NCT04076618|467705380|FG002|Overall Study|COVID concerns|0|||
129928488|NCT04076618|467705378|FG000|Overall Study|Adverse Event|0|||
129928489|NCT04076618|467705379|FG001|Overall Study|Adverse Event|0|||
129928490|NCT04076618|467705380|FG002|Overall Study|Adverse Event|2|||
129928491|NCT03386578|467705387|FG000|PK Component|Lost to Follow-up|0|||
129928492|NCT03386578|467705388|FG001|PK Component|Lost to Follow-up|1|||
129928493|NCT03386578|467705389|FG002|PK Component|Lost to Follow-up|0|||
129928494|NCT03386578|467705390|FG003|PK Component|Lost to Follow-up|0|||
129928495|NCT03386578|467705391|FG004|PK Component|Lost to Follow-up|0|||
129928496|NCT03386578|467705392|FG005|PK Component|Lost to Follow-up|0|||
129928497|NCT03386578|467705393|FG006|PK Component|Lost to Follow-up|1|||
129928498|NCT03386578|467705394|FG007|PK Component|Lost to Follow-up|0|||
129928499|NCT03386578|467705395|FG008|PK Component|Lost to Follow-up|0|||
129928500|NCT03386578|467705396|FG009|PK Component|Lost to Follow-up|0|||
129928501|NCT03386578|467705387|FG000|PK Component|Stillbirth/Abortion|0|||
129928502|NCT03386578|467705388|FG001|PK Component|Stillbirth/Abortion|0|||
129928503|NCT03386578|467705389|FG002|PK Component|Stillbirth/Abortion|0|||
129928504|NCT03386578|467705390|FG003|PK Component|Stillbirth/Abortion|0|||
129928505|NCT03386578|467705391|FG004|PK Component|Stillbirth/Abortion|0|||
129928506|NCT03386578|467705392|FG005|PK Component|Stillbirth/Abortion|2|||
129928507|NCT03386578|467705393|FG006|PK Component|Stillbirth/Abortion|0|||
129928508|NCT03386578|467705394|FG007|PK Component|Stillbirth/Abortion|0|||
129928509|NCT03386578|467705395|FG008|PK Component|Stillbirth/Abortion|0|||
129928510|NCT03386578|467705396|FG009|PK Component|Stillbirth/Abortion|0|||
129928511|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928512|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928513|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
129928514|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
129928515|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928516|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928517|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928518|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
129928519|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
129928520|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
129928521|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928522|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928523|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
129928524|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
129928525|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928526|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928527|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928528|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
129928529|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
129928530|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
129928531|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Death|0|||
129928532|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Death|0|||
129928533|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Death|1|||
129928534|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Death|0|||
129928535|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Death|0|||
129928536|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Death|0|||
129928537|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Death|0|||
129928538|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Death|9|||
129928539|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Death|5|||
129928540|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Death|0|||
129928541|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928542|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928543|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928544|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
129928545|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928546|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928547|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928548|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928549|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
129928550|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
129928551|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928552|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928553|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928554|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928555|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928556|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928557|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928558|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
129928559|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
129928560|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
129928561|NCT03386578|467705387|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928562|NCT03386578|467705388|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928563|NCT03386578|467705389|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928564|NCT03386578|467705390|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928565|NCT03386578|467705391|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928566|NCT03386578|467705392|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928567|NCT03386578|467705393|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928568|NCT03386578|467705394|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
129928569|NCT03386578|467705395|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
129928570|NCT03386578|467705396|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
129928571|NCT05907174|467705397|FG000|3-Month Assessment|Withdrawal by Subject|0|||
129928572|NCT05907174|467705398|FG001|3-Month Assessment|Withdrawal by Subject|0|||
129928573|NCT05907174|467705399|FG002|3-Month Assessment|Withdrawal by Subject|0|||
129928574|NCT05907174|467705400|FG003|3-Month Assessment|Withdrawal by Subject|1|||
129928575|NCT05907174|467705397|FG000|3-Month Assessment|Lost to Follow-up|1|||
129928576|NCT05907174|467705398|FG001|3-Month Assessment|Lost to Follow-up|1|||
129928577|NCT05907174|467705399|FG002|3-Month Assessment|Lost to Follow-up|1|||
129928578|NCT05907174|467705400|FG003|3-Month Assessment|Lost to Follow-up|1|||
129928579|NCT05907174|467705397|FG000|6-Month Assessment|Death|0|||
129928580|NCT05907174|467705398|FG001|6-Month Assessment|Death|0|||
129928581|NCT05907174|467705399|FG002|6-Month Assessment|Death|3|||
129928582|NCT05907174|467705400|FG003|6-Month Assessment|Death|0|||
129928583|NCT05907174|467705397|FG000|6-Month Assessment|Withdrawal by Subject|0|||
129928584|NCT05907174|467705398|FG001|6-Month Assessment|Withdrawal by Subject|0|||
129928585|NCT05907174|467705399|FG002|6-Month Assessment|Withdrawal by Subject|1|||
129928586|NCT05907174|467705400|FG003|6-Month Assessment|Withdrawal by Subject|1|||
129928587|NCT05907174|467705397|FG000|6-Month Assessment|Lost to Follow-up|0|||
129928588|NCT05907174|467705398|FG001|6-Month Assessment|Lost to Follow-up|1|||
129928589|NCT05907174|467705399|FG002|6-Month Assessment|Lost to Follow-up|1|||
129928590|NCT05907174|467705400|FG003|6-Month Assessment|Lost to Follow-up|1|||
129928591|NCT05093842|467705401|FG000|Overall Study|Pregnancy loss|1|||
129928592|NCT05093842|467705402|FG001|Overall Study|Pregnancy loss|1|||
129928593|NCT05093842|467705401|FG000|Overall Study|Lost to Follow-up|6|||
129928594|NCT05093842|467705402|FG001|Overall Study|Lost to Follow-up|0|||
129928595|NCT05093842|467705401|FG000|Overall Study|Physician Decision|0|||
129928596|NCT05093842|467705402|FG001|Overall Study|Physician Decision|1|||
129928597|NCT04066205|467705403|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
129928598|NCT04066205|467705404|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
129928599|NCT04066205|467705403|FG000|T2 Immediate Post-Intervention|did not respond|5|||
129928600|NCT04066205|467705404|FG001|T2 Immediate Post-Intervention|did not respond|3|||
129928601|NCT04685135|467705411|FG000|Overall Study|Death|126|||
129928602|NCT04685135|467705412|FG001|Overall Study|Death|53|||
129928603|NCT04685135|467705411|FG000|Overall Study|Withdrawal by Subject|12|||
129928604|NCT04685135|467705412|FG001|Overall Study|Withdrawal by Subject|16|||
129928605|NCT05868382|467705418|FG000|Overall Study|Lost to Follow-up|5|||
129928606|NCT05868382|467705419|FG001|Overall Study|Lost to Follow-up|0|||
129928607|NCT05868382|467705420|FG002|Overall Study|Lost to Follow-up|6|||
129928608|NCT05868382|467705421|FG003|Overall Study|Lost to Follow-up|4|||
129928609|NCT05868382|467705422|FG004|Overall Study|Lost to Follow-up|2|||
129928610|NCT05868382|467705423|FG005|Overall Study|Lost to Follow-up|6|||
129928611|NCT05868382|467705418|FG000|Overall Study|Withdrawal by Subject|1|||
129928612|NCT05868382|467705419|FG001|Overall Study|Withdrawal by Subject|0|||
129928613|NCT05868382|467705420|FG002|Overall Study|Withdrawal by Subject|0|||
129928614|NCT05868382|467705421|FG003|Overall Study|Withdrawal by Subject|0|||
129928615|NCT05868382|467705422|FG004|Overall Study|Withdrawal by Subject|1|||
129928616|NCT05868382|467705423|FG005|Overall Study|Withdrawal by Subject|0|||
129928617|NCT01221948|467705433|FG000|Overall Study|Physician Decision|5|||
129928618|NCT01221948|467705433|FG000|Overall Study|Withdrawal by Subject|2|||
129928619|NCT01221948|467705433|FG000|Overall Study|not disclosed|2|||
129928620|NCT01221948|467705433|FG000|Overall Study|Death|1|||
129928621|NCT01221948|467705433|FG000|Overall Study|Protocol Violation|4|||
129928622|NCT00746096|467705434|FG000|Overall Study|Adverse Event|1|||
129928623|NCT00746096|467705435|FG001|Overall Study|Adverse Event|0|||
129928624|NCT00746096|467705434|FG000|Overall Study|Withdrawal by Subject|5|||
129928625|NCT00746096|467705435|FG001|Overall Study|Withdrawal by Subject|1|||
129928626|NCT00746096|467705434|FG000|Overall Study|Lost to Follow-up|2|||
129928627|NCT00746096|467705435|FG001|Overall Study|Lost to Follow-up|1|||
129928628|NCT00746096|467705434|FG000|Overall Study|Protocol Violation|1|||
129928629|NCT00746096|467705435|FG001|Overall Study|Protocol Violation|0|||
129928630|NCT00746096|467705434|FG000|Overall Study|No study drug treatment|1|||
129928631|NCT00746096|467705435|FG001|Overall Study|No study drug treatment|1|||
129928632|NCT04295512|467705436|FG000|Overall Study|Lack of family response to schedule assessment|0|||
129928633|NCT04295512|467705437|FG001|Overall Study|Lack of family response to schedule assessment|0|||
129928634|NCT04295512|467705438|FG002|Overall Study|Lack of family response to schedule assessment|0|||
129928635|NCT04295512|467705439|FG003|Overall Study|Lack of family response to schedule assessment|2|||
129928636|NCT04295512|467705436|FG000|Overall Study|Therapist did not refer eligible family|7|||
129928637|NCT04295512|467705437|FG001|Overall Study|Therapist did not refer eligible family|7|||
129928638|NCT04295512|467705438|FG002|Overall Study|Therapist did not refer eligible family|0|||
129928639|NCT04295512|467705439|FG003|Overall Study|Therapist did not refer eligible family|0|||
129928640|NCT04587453|467705444|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
129928641|NCT04587453|467705445|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
129928642|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
129928643|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928644|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928645|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928646|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928647|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
129928648|NCT04625725|467705446|FG000|Provent Main Study|Withdrawal by Subject|242|||
129928649|NCT04625725|467705447|FG001|Provent Main Study|Withdrawal by Subject|144|||
129928650|NCT04625725|467705448|FG002|Provent Main Study|Withdrawal by Subject|0|||
129928651|NCT04625725|467705449|FG003|Provent Main Study|Withdrawal by Subject|0|||
129928652|NCT04625725|467705450|FG004|Provent Main Study|Withdrawal by Subject|0|||
129928653|NCT04625725|467705451|FG005|Provent Main Study|Withdrawal by Subject|0|||
129928654|NCT04625725|467705446|FG000|Provent Main Study|Physician Decision|5|||
129928655|NCT04625725|467705447|FG001|Provent Main Study|Physician Decision|0|||
129928656|NCT04625725|467705448|FG002|Provent Main Study|Physician Decision|0|||
129928657|NCT04625725|467705449|FG003|Provent Main Study|Physician Decision|0|||
129928658|NCT04625725|467705450|FG004|Provent Main Study|Physician Decision|0|||
129928659|NCT04625725|467705451|FG005|Provent Main Study|Physician Decision|0|||
129928660|NCT04625725|467705446|FG000|Provent Main Study|Protocol Violation|1|||
129928661|NCT04625725|467705447|FG001|Provent Main Study|Protocol Violation|0|||
129928662|NCT04625725|467705448|FG002|Provent Main Study|Protocol Violation|0|||
129928663|NCT04625725|467705449|FG003|Provent Main Study|Protocol Violation|0|||
129928664|NCT04625725|467705450|FG004|Provent Main Study|Protocol Violation|0|||
129928665|NCT04625725|467705451|FG005|Provent Main Study|Protocol Violation|0|||
129928666|NCT04625725|467705446|FG000|Provent Main Study|Lost to Follow-up|357|||
129928667|NCT04625725|467705447|FG001|Provent Main Study|Lost to Follow-up|200|||
129928668|NCT04625725|467705448|FG002|Provent Main Study|Lost to Follow-up|0|||
129928669|NCT04625725|467705449|FG003|Provent Main Study|Lost to Follow-up|0|||
129928670|NCT04625725|467705450|FG004|Provent Main Study|Lost to Follow-up|0|||
129928671|NCT04625725|467705451|FG005|Provent Main Study|Lost to Follow-up|0|||
129928672|NCT04625725|467705446|FG000|Provent Main Study|Death|22|||
129928673|NCT04625725|467705447|FG001|Provent Main Study|Death|10|||
129928674|NCT04625725|467705448|FG002|Provent Main Study|Death|0|||
129928675|NCT04625725|467705449|FG003|Provent Main Study|Death|0|||
129928676|NCT04625725|467705450|FG004|Provent Main Study|Death|0|||
129928677|NCT04625725|467705451|FG005|Provent Main Study|Death|0|||
129928678|NCT04625725|467705446|FG000|Provent Main Study|Adverse Event|2|||
129928679|NCT04625725|467705447|FG001|Provent Main Study|Adverse Event|1|||
129928680|NCT04625725|467705448|FG002|Provent Main Study|Adverse Event|0|||
129928681|NCT04625725|467705449|FG003|Provent Main Study|Adverse Event|0|||
129928682|NCT04625725|467705450|FG004|Provent Main Study|Adverse Event|0|||
129928683|NCT04625725|467705451|FG005|Provent Main Study|Adverse Event|0|||
129928684|NCT04625725|467705446|FG000|Provent Main Study|Participants dosed in sub-study|310|||
129928685|NCT04625725|467705447|FG001|Provent Main Study|Participants dosed in sub-study|193|||
129928686|NCT04625725|467705448|FG002|Provent Main Study|Participants dosed in sub-study|0|||
129928687|NCT04625725|467705449|FG003|Provent Main Study|Participants dosed in sub-study|0|||
129928688|NCT04625725|467705450|FG004|Provent Main Study|Participants dosed in sub-study|0|||
129928689|NCT04625725|467705451|FG005|Provent Main Study|Participants dosed in sub-study|0|||
129928690|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
129928691|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
129928692|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928693|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928694|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928695|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
129928696|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
129928697|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
129928698|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928699|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928700|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928701|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
129928702|NCT04625725|467705446|FG000|Provent Main Study|INCARCERATION|3|||
129928703|NCT04625725|467705447|FG001|Provent Main Study|INCARCERATION|0|||
129928704|NCT04625725|467705448|FG002|Provent Main Study|INCARCERATION|0|||
129928705|NCT04625725|467705449|FG003|Provent Main Study|INCARCERATION|0|||
129928706|NCT04625725|467705450|FG004|Provent Main Study|INCARCERATION|0|||
129928707|NCT04625725|467705451|FG005|Provent Main Study|INCARCERATION|0|||
129928708|NCT04625725|467705446|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
129928709|NCT04625725|467705447|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
129928710|NCT04625725|467705448|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928711|NCT04625725|467705449|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928712|NCT04625725|467705450|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928713|NCT04625725|467705451|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
129928714|NCT04625725|467705446|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
129928715|NCT04625725|467705447|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
129928716|NCT04625725|467705448|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928717|NCT04625725|467705449|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928718|NCT04625725|467705450|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928719|NCT04625725|467705451|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
129928720|NCT04625725|467705446|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
129928721|NCT04625725|467705447|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
129928722|NCT04625725|467705448|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928723|NCT04625725|467705449|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928724|NCT04625725|467705450|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928725|NCT04625725|467705451|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
129928726|NCT04625725|467705446|FG000|Provent Main Study|MISSING REASON|0|||
129928727|NCT04625725|467705447|FG001|Provent Main Study|MISSING REASON|1|||
129928728|NCT04625725|467705448|FG002|Provent Main Study|MISSING REASON|0|||
129928729|NCT04625725|467705449|FG003|Provent Main Study|MISSING REASON|0|||
129928730|NCT04625725|467705450|FG004|Provent Main Study|MISSING REASON|0|||
129928731|NCT04625725|467705451|FG005|Provent Main Study|MISSING REASON|0|||
129928732|NCT04625725|467705446|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928733|NCT04625725|467705447|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928734|NCT04625725|467705448|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928735|NCT04625725|467705449|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
129928736|NCT04625725|467705450|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928737|NCT04625725|467705451|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
129928738|NCT04625725|467705446|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928739|NCT04625725|467705447|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928740|NCT04625725|467705448|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
129928741|NCT04625725|467705449|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928742|NCT04625725|467705450|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928743|NCT04625725|467705451|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
129928744|NCT04625725|467705446|FG000|Provent Sub Study|Lost to Follow-up|0|||
129928745|NCT04625725|467705447|FG001|Provent Sub Study|Lost to Follow-up|0|||
129928746|NCT04625725|467705448|FG002|Provent Sub Study|Lost to Follow-up|20|||
129928747|NCT04625725|467705449|FG003|Provent Sub Study|Lost to Follow-up|10|||
129928748|NCT04625725|467705450|FG004|Provent Sub Study|Lost to Follow-up|6|||
129928749|NCT04625725|467705451|FG005|Provent Sub Study|Lost to Follow-up|4|||
129928750|NCT04625725|467705446|FG000|Provent Sub Study|Death|0|||
129928751|NCT04625725|467705447|FG001|Provent Sub Study|Death|0|||
129928752|NCT04625725|467705448|FG002|Provent Sub Study|Death|8|||
129928753|NCT04625725|467705449|FG003|Provent Sub Study|Death|5|||
129928754|NCT04625725|467705450|FG004|Provent Sub Study|Death|0|||
129928755|NCT04625725|467705451|FG005|Provent Sub Study|Death|1|||
129928756|NCT04625725|467705446|FG000|Provent Sub Study|Adverse Event|0|||
129928757|NCT04625725|467705447|FG001|Provent Sub Study|Adverse Event|0|||
129928758|NCT04625725|467705448|FG002|Provent Sub Study|Adverse Event|0|||
129928759|NCT04625725|467705449|FG003|Provent Sub Study|Adverse Event|0|||
129928760|NCT04625725|467705450|FG004|Provent Sub Study|Adverse Event|0|||
129928761|NCT04625725|467705451|FG005|Provent Sub Study|Adverse Event|1|||
129928762|NCT04625725|467705446|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928763|NCT04625725|467705447|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928764|NCT04625725|467705448|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928765|NCT04625725|467705449|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928766|NCT04625725|467705450|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
129928767|NCT04625725|467705451|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
129928768|NCT04625725|467705446|FG000|Provent Sub Study|Withdrawal by Subject|0|||
129928769|NCT04625725|467705447|FG001|Provent Sub Study|Withdrawal by Subject|0|||
129928770|NCT04625725|467705448|FG002|Provent Sub Study|Withdrawal by Subject|11|||
129928771|NCT04625725|467705449|FG003|Provent Sub Study|Withdrawal by Subject|13|||
129928772|NCT04625725|467705450|FG004|Provent Sub Study|Withdrawal by Subject|5|||
129928773|NCT04625725|467705451|FG005|Provent Sub Study|Withdrawal by Subject|6|||
129928774|NCT04625725|467705446|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928775|NCT04625725|467705447|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928776|NCT04625725|467705448|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928777|NCT04625725|467705449|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928778|NCT04625725|467705450|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
129928779|NCT04625725|467705451|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
129928780|NCT04032847|467705455|FG000|Overall Study|Study termination by sponsor|8|||
129928781|NCT04032847|467705456|FG001|Overall Study|Study termination by sponsor|0|||
129928782|NCT04032847|467705457|FG002|Overall Study|Study termination by sponsor|4|||
129928783|NCT04032847|467705455|FG000|Overall Study|Death|12|||
129928784|NCT04032847|467705456|FG001|Overall Study|Death|0|||
129928785|NCT04032847|467705457|FG002|Overall Study|Death|0|||
129928786|NCT04032847|467705455|FG000|Overall Study|Progressive disease|2|||
129928787|NCT04032847|467705456|FG001|Overall Study|Progressive disease|0|||
129928788|NCT04032847|467705457|FG002|Overall Study|Progressive disease|1|||
129928789|NCT03213665|467705458|FG000|Overall Study|Adverse Event|1|||
129928790|NCT03213665|467705458|FG000|Overall Study|Physician Decision|2|||
129450649|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
129928791|NCT03213665|467705458|FG000|Overall Study|Withdrawal by Subject|3|||
129928792|NCT03213665|467705458|FG000|Overall Study|Progressive Disease|13|||
129928793|NCT05873556|467705459|FG000|Overall Study|Lost to Follow-up|4|||
129928794|NCT05873556|467705460|FG001|Overall Study|Lost to Follow-up|1|||
129928795|NCT04689256|467705461|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
129928796|NCT04689256|467705462|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
129928797|NCT05104463|467705463|FG000|Overall Study|Adverse Event|1|||
129928798|NCT05104463|467705464|FG001|Overall Study|Adverse Event|1|||
129928799|NCT05104463|467705463|FG000|Overall Study|Lost to Follow-up|1|||
129928800|NCT05104463|467705464|FG001|Overall Study|Lost to Follow-up|1|||
129928801|NCT05104463|467705463|FG000|Overall Study|Physician Decision|1|||
129928802|NCT05104463|467705464|FG001|Overall Study|Physician Decision|0|||
129928803|NCT05104463|467705463|FG000|Overall Study|Protocol Violation|0|||
129928804|NCT05104463|467705464|FG001|Overall Study|Protocol Violation|2|||
129928805|NCT05104463|467705463|FG000|Overall Study|Withdrawal by Subject|1|||
129928806|NCT05104463|467705464|FG001|Overall Study|Withdrawal by Subject|1|||
129928807|NCT05267470|467705468|FG000|Overall Study|Decision by sponsor|0|||
129928808|NCT05267470|467705469|FG001|Overall Study|Decision by sponsor|3|||
129928809|NCT05267470|467705470|FG002|Overall Study|Decision by sponsor|19|||
129928810|NCT05267470|467705471|FG003|Overall Study|Decision by sponsor|7|||
129928811|NCT05267470|467705472|FG004|Overall Study|Decision by sponsor|3|||
129928812|NCT05267470|467705468|FG000|Overall Study|Withdrawal by Subject|1|||
129928813|NCT05267470|467705469|FG001|Overall Study|Withdrawal by Subject|1|||
129928814|NCT05267470|467705470|FG002|Overall Study|Withdrawal by Subject|2|||
129928815|NCT05267470|467705471|FG003|Overall Study|Withdrawal by Subject|2|||
129928816|NCT05267470|467705472|FG004|Overall Study|Withdrawal by Subject|0|||
129928817|NCT05267470|467705468|FG000|Overall Study|Death|3|||
129928818|NCT05267470|467705469|FG001|Overall Study|Death|5|||
129928819|NCT05267470|467705470|FG002|Overall Study|Death|8|||
129928820|NCT05267470|467705471|FG003|Overall Study|Death|18|||
129928821|NCT05267470|467705472|FG004|Overall Study|Death|1|||
129928822|NCT05267470|467705468|FG000|Overall Study|Lost to Follow-up|0|||
129928823|NCT05267470|467705469|FG001|Overall Study|Lost to Follow-up|0|||
129928824|NCT05267470|467705470|FG002|Overall Study|Lost to Follow-up|0|||
129928825|NCT05267470|467705471|FG003|Overall Study|Lost to Follow-up|1|||
129928826|NCT05267470|467705472|FG004|Overall Study|Lost to Follow-up|0|||
129450650|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
129928827|NCT03381586|467705473|FG000|Overall Study|Adverse Event|1|||
129928828|NCT03381586|467705474|FG001|Overall Study|Adverse Event|1|||
129928829|NCT03381586|467705473|FG000|Overall Study|Protocol Violation|1|||
129928830|NCT03381586|467705474|FG001|Overall Study|Protocol Violation|0|||
129928831|NCT03381586|467705473|FG000|Overall Study|Withdrawal by Subject|1|||
129928832|NCT03381586|467705474|FG001|Overall Study|Withdrawal by Subject|2|||
129928833|NCT04230681|467705475|FG000|Overall Study|Physician Decision|2|||
129928834|NCT04230681|467705476|FG001|Overall Study|Physician Decision|3|||
129928835|NCT04230681|467705475|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
129928836|NCT04230681|467705476|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
129928837|NCT04230681|467705475|FG000|Overall Study|IV inadvertently removed|0|||
129928838|NCT04230681|467705476|FG001|Overall Study|IV inadvertently removed|1|||
129979691|NCT03752970|467889435|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
129979692|NCT03752970|467889436|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
129979693|NCT03752970|467889437|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
129979694|NCT03752970|467889435|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
129979695|NCT03752970|467889436|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
129979696|NCT03752970|467889437|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
129979697|NCT01696045|467889440|FG000|Overall Study|Study drug toxicity|1|||
129979698|NCT01696045|467889441|FG001|Overall Study|Study drug toxicity|5|||
129979699|NCT01696045|467889440|FG000|Overall Study|Disease progression|2|||
129979700|NCT01696045|467889441|FG001|Overall Study|Disease progression|2|||
129979701|NCT00573859|467889442|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
129979702|NCT00573859|467889442|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
129979703|NCT03541200|467889451|FG000|Overall Study|Adverse Event|19|||
129979704|NCT03541200|467889451|FG000|Overall Study|Death|1|||
129979705|NCT03541200|467889451|FG000|Overall Study|Lost to Follow-up|10|||
129979706|NCT03541200|467889451|FG000|Overall Study|Physician Decision|1|||
129979707|NCT03541200|467889451|FG000|Overall Study|Protocol Violation|51|||
129979708|NCT03541200|467889451|FG000|Overall Study|Withdrawal by Subject|23|||
129979709|NCT03541200|467889451|FG000|Overall Study|other|8|||
129979710|NCT01283516|467889456|FG000|Overall Study|Adverse Event|0|||
129979711|NCT01283516|467889457|FG001|Overall Study|Adverse Event|0|||
129979712|NCT01283516|467889458|FG002|Overall Study|Adverse Event|0|||
129979713|NCT01283516|467889459|FG003|Overall Study|Adverse Event|0|||
129979714|NCT01283516|467889460|FG004|Overall Study|Adverse Event|0|||
129979715|NCT01283516|467889461|FG005|Overall Study|Adverse Event|0|||
129979716|NCT01283516|467889462|FG006|Overall Study|Adverse Event|2|||
129979717|NCT01283516|467889463|FG007|Overall Study|Adverse Event|0|||
129979718|NCT01283516|467889464|FG008|Overall Study|Adverse Event|28|||
129979719|NCT01283516|467889456|FG000|Overall Study|Death|0|||
129979720|NCT01283516|467889457|FG001|Overall Study|Death|0|||
129979721|NCT01283516|467889458|FG002|Overall Study|Death|0|||
129979722|NCT01283516|467889459|FG003|Overall Study|Death|0|||
129979723|NCT01283516|467889460|FG004|Overall Study|Death|0|||
129979724|NCT01283516|467889461|FG005|Overall Study|Death|1|||
129979725|NCT01283516|467889462|FG006|Overall Study|Death|0|||
129979726|NCT01283516|467889463|FG007|Overall Study|Death|1|||
129979727|NCT01283516|467889464|FG008|Overall Study|Death|12|||
129979728|NCT01283516|467889456|FG000|Overall Study|Disease Progression|2|||
129979729|NCT01283516|467889457|FG001|Overall Study|Disease Progression|2|||
129979730|NCT01283516|467889458|FG002|Overall Study|Disease Progression|3|||
129979731|NCT01283516|467889459|FG003|Overall Study|Disease Progression|3|||
129979732|NCT01283516|467889460|FG004|Overall Study|Disease Progression|13|||
129979733|NCT01283516|467889461|FG005|Overall Study|Disease Progression|8|||
129979734|NCT01283516|467889462|FG006|Overall Study|Disease Progression|6|||
129979735|NCT01283516|467889463|FG007|Overall Study|Disease Progression|3|||
129979736|NCT01283516|467889464|FG008|Overall Study|Disease Progression|139|||
129979737|NCT01283516|467889456|FG000|Overall Study|Withdrawal by Subject|0|||
129979738|NCT01283516|467889457|FG001|Overall Study|Withdrawal by Subject|0|||
129979739|NCT01283516|467889458|FG002|Overall Study|Withdrawal by Subject|0|||
129979740|NCT01283516|467889459|FG003|Overall Study|Withdrawal by Subject|0|||
129979741|NCT01283516|467889460|FG004|Overall Study|Withdrawal by Subject|1|||
129979742|NCT01283516|467889461|FG005|Overall Study|Withdrawal by Subject|0|||
129979743|NCT01283516|467889462|FG006|Overall Study|Withdrawal by Subject|1|||
129979744|NCT01283516|467889463|FG007|Overall Study|Withdrawal by Subject|0|||
129979745|NCT01283516|467889464|FG008|Overall Study|Withdrawal by Subject|36|||
129979746|NCT01283516|467889456|FG000|Overall Study|Administrative problems|0|||
129979747|NCT01283516|467889457|FG001|Overall Study|Administrative problems|0|||
129979748|NCT01283516|467889458|FG002|Overall Study|Administrative problems|0|||
129979749|NCT01283516|467889459|FG003|Overall Study|Administrative problems|0|||
129979750|NCT01283516|467889460|FG004|Overall Study|Administrative problems|0|||
129979751|NCT01283516|467889461|FG005|Overall Study|Administrative problems|1|||
129979752|NCT01283516|467889462|FG006|Overall Study|Administrative problems|1|||
129979753|NCT01283516|467889463|FG007|Overall Study|Administrative problems|1|||
129979754|NCT01283516|467889464|FG008|Overall Study|Administrative problems|39|||
129979755|NCT01283516|467889456|FG000|Overall Study|Lost to Follow-up|0|||
129979756|NCT01283516|467889457|FG001|Overall Study|Lost to Follow-up|0|||
129979757|NCT01283516|467889458|FG002|Overall Study|Lost to Follow-up|0|||
129979758|NCT01283516|467889459|FG003|Overall Study|Lost to Follow-up|0|||
129979759|NCT01283516|467889460|FG004|Overall Study|Lost to Follow-up|0|||
129928839|NCT05645757|467707809|FG000|Overall Study|Enrolled but treatment not administered|0|||
129928840|NCT05645757|467707810|FG001|Overall Study|Enrolled but treatment not administered|0|||
129928841|NCT05645757|467707811|FG002|Overall Study|Enrolled but treatment not administered|0|||
129928842|NCT05645757|467707812|FG003|Overall Study|Enrolled but treatment not administered|0|||
129928843|NCT05645757|467707813|FG004|Overall Study|Enrolled but treatment not administered|1|||
129928844|NCT05645757|467707814|FG005|Overall Study|Enrolled but treatment not administered|1|||
129928845|NCT05645757|467707815|FG006|Overall Study|Enrolled but treatment not administered|0|||
129928846|NCT05645757|467707816|FG007|Overall Study|Enrolled but treatment not administered|0|||
129928847|NCT00539591|467707817|FG000|Overall Study|Toxicity|3|||
129928848|NCT00539591|467707818|FG001|Overall Study|Toxicity|0|||
129928849|NCT00539591|467707819|FG002|Overall Study|Toxicity|0|||
129928850|NCT00539591|467707817|FG000|Overall Study|Disease progression|2|||
129928851|NCT00539591|467707818|FG001|Overall Study|Disease progression|2|||
129928852|NCT00539591|467707819|FG002|Overall Study|Disease progression|3|||
129928853|NCT02038777|467707822|FG000|Overall Study|Death|0|||
129928854|NCT02038777|467707823|FG001|Overall Study|Death|2|||
129928855|NCT02038777|467707824|FG002|Overall Study|Death|0|||
129928856|NCT02038777|467707825|FG003|Overall Study|Death|1|||
129928857|NCT02038777|467707826|FG004|Overall Study|Death|2|||
129928858|NCT02038777|467707827|FG005|Overall Study|Death|4|||
129928859|NCT02038777|467707828|FG006|Overall Study|Death|0|||
129928860|NCT02038777|467707829|FG007|Overall Study|Death|11|||
129928861|NCT02038777|467707822|FG000|Overall Study|Lost to Follow-up|0|||
129928862|NCT02038777|467707823|FG001|Overall Study|Lost to Follow-up|0|||
129928863|NCT02038777|467707824|FG002|Overall Study|Lost to Follow-up|0|||
129928864|NCT02038777|467707825|FG003|Overall Study|Lost to Follow-up|1|||
129928865|NCT02038777|467707826|FG004|Overall Study|Lost to Follow-up|0|||
129928866|NCT02038777|467707827|FG005|Overall Study|Lost to Follow-up|0|||
129928867|NCT02038777|467707828|FG006|Overall Study|Lost to Follow-up|0|||
129928868|NCT02038777|467707829|FG007|Overall Study|Lost to Follow-up|0|||
129928869|NCT02038777|467707822|FG000|Overall Study|Other|0|||
129928870|NCT02038777|467707823|FG001|Overall Study|Other|1|||
129928871|NCT02038777|467707824|FG002|Overall Study|Other|0|||
129928872|NCT02038777|467707825|FG003|Overall Study|Other|2|||
129928873|NCT02038777|467707826|FG004|Overall Study|Other|1|||
129928874|NCT02038777|467707827|FG005|Overall Study|Other|0|||
129928875|NCT02038777|467707828|FG006|Overall Study|Other|0|||
129928876|NCT02038777|467707829|FG007|Overall Study|Other|0|||
129928877|NCT02038777|467707822|FG000|Overall Study|Randomized but not treated|0|||
129928878|NCT02038777|467707823|FG001|Overall Study|Randomized but not treated|1|||
129928879|NCT02038777|467707824|FG002|Overall Study|Randomized but not treated|0|||
129928880|NCT02038777|467707825|FG003|Overall Study|Randomized but not treated|0|||
129928881|NCT02038777|467707826|FG004|Overall Study|Randomized but not treated|0|||
129928882|NCT02038777|467707827|FG005|Overall Study|Randomized but not treated|0|||
129928883|NCT02038777|467707828|FG006|Overall Study|Randomized but not treated|0|||
129928884|NCT02038777|467707829|FG007|Overall Study|Randomized but not treated|0|||
129928885|NCT02038777|467707822|FG000|Overall Study|Started Chemotherapy|1|||
129928886|NCT02038777|467707823|FG001|Overall Study|Started Chemotherapy|0|||
129928887|NCT02038777|467707824|FG002|Overall Study|Started Chemotherapy|3|||
129928888|NCT02038777|467707825|FG003|Overall Study|Started Chemotherapy|0|||
129928889|NCT02038777|467707826|FG004|Overall Study|Started Chemotherapy|0|||
129928890|NCT02038777|467707827|FG005|Overall Study|Started Chemotherapy|0|||
129928891|NCT02038777|467707828|FG006|Overall Study|Started Chemotherapy|0|||
129928892|NCT02038777|467707829|FG007|Overall Study|Started Chemotherapy|0|||
129928893|NCT02038777|467707822|FG000|Overall Study|participation terminated by sponsor|0|||
129928894|NCT02038777|467707823|FG001|Overall Study|participation terminated by sponsor|0|||
129928895|NCT02038777|467707824|FG002|Overall Study|participation terminated by sponsor|0|||
129928896|NCT02038777|467707825|FG003|Overall Study|participation terminated by sponsor|0|||
129928897|NCT02038777|467707826|FG004|Overall Study|participation terminated by sponsor|0|||
129928898|NCT02038777|467707827|FG005|Overall Study|participation terminated by sponsor|0|||
129928899|NCT02038777|467707828|FG006|Overall Study|participation terminated by sponsor|1|||
129450651|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
129450652|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
129450653|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
129928900|NCT02038777|467707829|FG007|Overall Study|participation terminated by sponsor|1|||
129928901|NCT04299464|467707830|FG000|Overall Study|Adverse Event|1|||
129928902|NCT04299464|467707831|FG001|Overall Study|Adverse Event|0|||
129928903|NCT04299464|467707832|FG002|Overall Study|Adverse Event|2|||
129928904|NCT04299464|467707830|FG000|Overall Study|Non-compliance with Study Drug|1|||
129928905|NCT04299464|467707831|FG001|Overall Study|Non-compliance with Study Drug|0|||
129928906|NCT04299464|467707832|FG002|Overall Study|Non-compliance with Study Drug|0|||
129928907|NCT04299464|467707830|FG000|Overall Study|Reason not Specified|0|||
129928908|NCT04299464|467707831|FG001|Overall Study|Reason not Specified|1|||
129928909|NCT04299464|467707832|FG002|Overall Study|Reason not Specified|3|||
129928910|NCT04299464|467707830|FG000|Overall Study|Physician Decision|0|||
129928911|NCT04299464|467707831|FG001|Overall Study|Physician Decision|1|||
129928912|NCT04299464|467707832|FG002|Overall Study|Physician Decision|1|||
129928913|NCT04299464|467707830|FG000|Overall Study|Withdrawal by Subject|0|||
129928914|NCT04299464|467707831|FG001|Overall Study|Withdrawal by Subject|2|||
129928915|NCT04299464|467707832|FG002|Overall Study|Withdrawal by Subject|1|||
129928916|NCT04079218|467707833|FG000|Overall Study|Death|1|||
129928917|NCT04079218|467707834|FG001|Overall Study|Death|0|||
129928918|NCT04079218|467707833|FG000|Overall Study|Withdrawal by Subject|3|||
129928919|NCT04079218|467707834|FG001|Overall Study|Withdrawal by Subject|0|||
129928920|NCT04079218|467707833|FG000|Overall Study|Physician Decision|4|||
129928921|NCT04079218|467707834|FG001|Overall Study|Physician Decision|0|||
129928922|NCT04079218|467707833|FG000|Overall Study|Lost to Follow-up|0|||
129928923|NCT04079218|467707834|FG001|Overall Study|Lost to Follow-up|1|||
129928924|NCT02424617|467707837|FG000|Overall Study|Adverse Event|0|||
129928925|NCT02424617|467707838|FG001|Overall Study|Adverse Event|1|||
129928926|NCT02424617|467707839|FG002|Overall Study|Adverse Event|0|||
129928927|NCT02424617|467707840|FG003|Overall Study|Adverse Event|0|||
129928928|NCT02424617|467707837|FG000|Overall Study|Investigator Decision|0|||
129928929|NCT02424617|467707838|FG001|Overall Study|Investigator Decision|0|||
129928930|NCT02424617|467707839|FG002|Overall Study|Investigator Decision|0|||
129928931|NCT02424617|467707840|FG003|Overall Study|Investigator Decision|1|||
129928932|NCT02424617|467707837|FG000|Overall Study|Withdrawal by Subject|1|||
129928933|NCT02424617|467707838|FG001|Overall Study|Withdrawal by Subject|1|||
129928934|NCT02424617|467707839|FG002|Overall Study|Withdrawal by Subject|0|||
129928935|NCT02424617|467707840|FG003|Overall Study|Withdrawal by Subject|1|||
129928936|NCT02424617|467707837|FG000|Overall Study|Progressive Disease|7|||
129928937|NCT02424617|467707838|FG001|Overall Study|Progressive Disease|6|||
129928938|NCT02424617|467707839|FG002|Overall Study|Progressive Disease|11|||
129928939|NCT02424617|467707840|FG003|Overall Study|Progressive Disease|10|||
129928940|NCT02424617|467707837|FG000|Overall Study|Other|0|||
129928941|NCT02424617|467707838|FG001|Overall Study|Other|0|||
129928942|NCT02424617|467707839|FG002|Overall Study|Other|0|||
129928943|NCT02424617|467707840|FG003|Overall Study|Other|1|||
129928944|NCT02694822|467707841|FG000|Phase 1|Death|2|||
129928945|NCT02694822|467707842|FG001|Phase 1|Death|1|||
129928946|NCT02694822|467707843|FG002|Phase 1|Death|6|||
129928947|NCT02694822|467707844|FG003|Phase 1|Death|6|||
129928948|NCT02694822|467707845|FG004|Phase 1|Death|3|||
129928949|NCT02694822|467707846|FG005|Phase 1|Death|0|||
129928950|NCT02694822|467707841|FG000|Phase 1|Withdrawal by Subject|2|||
129928951|NCT02694822|467707842|FG001|Phase 1|Withdrawal by Subject|2|||
129928952|NCT02694822|467707843|FG002|Phase 1|Withdrawal by Subject|4|||
129928953|NCT02694822|467707844|FG003|Phase 1|Withdrawal by Subject|8|||
129928954|NCT02694822|467707845|FG004|Phase 1|Withdrawal by Subject|1|||
129928955|NCT02694822|467707846|FG005|Phase 1|Withdrawal by Subject|0|||
129928956|NCT02694822|467707841|FG000|Phase 2|Death|0|||
129928957|NCT02694822|467707842|FG001|Phase 2|Death|0|||
129928958|NCT02694822|467707843|FG002|Phase 2|Death|0|||
129928959|NCT02694822|467707844|FG003|Phase 2|Death|0|||
129928960|NCT02694822|467707845|FG004|Phase 2|Death|0|||
129928961|NCT02694822|467707846|FG005|Phase 2|Death|26|||
129928962|NCT02694822|467707841|FG000|Phase 2|Withdrawal by Subject|0|||
129928963|NCT02694822|467707842|FG001|Phase 2|Withdrawal by Subject|0|||
129928964|NCT02694822|467707843|FG002|Phase 2|Withdrawal by Subject|0|||
129928965|NCT02694822|467707844|FG003|Phase 2|Withdrawal by Subject|0|||
129928966|NCT02694822|467707845|FG004|Phase 2|Withdrawal by Subject|0|||
129928967|NCT02694822|467707846|FG005|Phase 2|Withdrawal by Subject|13|||
129928968|NCT02694822|467707841|FG000|Phase 2|Administrative Study Closure|0|||
129928969|NCT02694822|467707842|FG001|Phase 2|Administrative Study Closure|0|||
129928970|NCT02694822|467707843|FG002|Phase 2|Administrative Study Closure|0|||
129928971|NCT02694822|467707844|FG003|Phase 2|Administrative Study Closure|0|||
129928972|NCT02694822|467707845|FG004|Phase 2|Administrative Study Closure|0|||
129928973|NCT02694822|467707846|FG005|Phase 2|Administrative Study Closure|2|||
129928974|NCT02694822|467707841|FG000|Phase 2|Lost to Follow-up|0|||
129928975|NCT02694822|467707842|FG001|Phase 2|Lost to Follow-up|0|||
129928976|NCT02694822|467707843|FG002|Phase 2|Lost to Follow-up|0|||
129928977|NCT02694822|467707844|FG003|Phase 2|Lost to Follow-up|0|||
129928978|NCT02694822|467707845|FG004|Phase 2|Lost to Follow-up|0|||
129928979|NCT02694822|467707846|FG005|Phase 2|Lost to Follow-up|1|||
129928980|NCT02694822|467707841|FG000|Phase 2|Participant Transferred to Another Site|0|||
129928981|NCT02694822|467707842|FG001|Phase 2|Participant Transferred to Another Site|0|||
129928982|NCT02694822|467707843|FG002|Phase 2|Participant Transferred to Another Site|0|||
129928983|NCT02694822|467707844|FG003|Phase 2|Participant Transferred to Another Site|0|||
129928984|NCT02694822|467707845|FG004|Phase 2|Participant Transferred to Another Site|0|||
129928985|NCT02694822|467707846|FG005|Phase 2|Participant Transferred to Another Site|1|||
129928986|NCT01868997|467707849|FG000|Overall Study|Adverse Event|2|||
129928987|NCT01868997|467707850|FG001|Overall Study|Adverse Event|5|||
129928988|NCT01868997|467707849|FG000|Overall Study|Lack of Efficacy|2|||
129928989|NCT01868997|467707850|FG001|Overall Study|Lack of Efficacy|0|||
129928990|NCT01868997|467707849|FG000|Overall Study|Other|3|||
129928991|NCT01868997|467707850|FG001|Overall Study|Other|1|||
129928992|NCT01960452|467707851|FG000|Overall Study|Withdrawal by Subject|2|||
129928993|NCT01960452|467707852|FG001|Overall Study|Withdrawal by Subject|1|||
129928994|NCT01960452|467707851|FG000|Overall Study|Sleep apnea in Night 1|1|||
129928995|NCT01960452|467707852|FG001|Overall Study|Sleep apnea in Night 1|0|||
129928996|NCT01960452|467707851|FG000|Overall Study|Poor Sleep in Night 1|0|||
129928997|NCT01960452|467707852|FG001|Overall Study|Poor Sleep in Night 1|2|||
129928998|NCT01960452|467707851|FG000|Overall Study|No Sex/Age Match Night 1|1|||
129928999|NCT01960452|467707852|FG001|Overall Study|No Sex/Age Match Night 1|0|||
129929000|NCT01960452|467707851|FG000|Overall Study|No Sex/Age Match Night 2|0|||
129929001|NCT01960452|467707852|FG001|Overall Study|No Sex/Age Match Night 2|2|||
129929002|NCT01960452|467707851|FG000|Overall Study|Technical Difficulties Night 2|2|||
129929003|NCT01960452|467707852|FG001|Overall Study|Technical Difficulties Night 2|0|||
129929004|NCT02052882|467707863|FG000|Overall Study|Not treated|11|||
129929005|NCT02052882|467707863|FG000|Overall Study|Protocol Violation|1|||
129929006|NCT02052882|467707863|FG000|Overall Study|Inadequate testing|1|||
129929007|NCT04778397|467707864|FG000|Overall Study|Death|59|||
129929008|NCT04778397|467707865|FG001|Overall Study|Death|54|||
129929009|NCT04778397|467707866|FG002|Overall Study|Death|11|||
129929010|NCT04778397|467707867|FG003|Overall Study|Death|9|||
129929011|NCT04778397|467707864|FG000|Overall Study|Study Terminated by Sponsor|34|||
129929012|NCT04778397|467707865|FG001|Overall Study|Study Terminated by Sponsor|42|||
129929013|NCT04778397|467707866|FG002|Overall Study|Study Terminated by Sponsor|15|||
129929014|NCT04778397|467707867|FG003|Overall Study|Study Terminated by Sponsor|12|||
129929015|NCT04778397|467707864|FG000|Overall Study|Withdrew Consent|5|||
129929016|NCT04778397|467707865|FG001|Overall Study|Withdrew Consent|4|||
129929017|NCT04778397|467707866|FG002|Overall Study|Withdrew Consent|1|||
129929018|NCT04778397|467707867|FG003|Overall Study|Withdrew Consent|1|||
129929019|NCT04778397|467707864|FG000|Overall Study|Reason Not Specified|1|||
129929020|NCT04778397|467707865|FG001|Overall Study|Reason Not Specified|3|||
129929021|NCT04778397|467707866|FG002|Overall Study|Reason Not Specified|0|||
129929022|NCT04778397|467707867|FG003|Overall Study|Reason Not Specified|2|||
129929023|NCT04778397|467707864|FG000|Overall Study|Lost to Follow-up|2|||
129929024|NCT04778397|467707865|FG001|Overall Study|Lost to Follow-up|1|||
129929025|NCT04778397|467707866|FG002|Overall Study|Lost to Follow-up|0|||
129929026|NCT04778397|467707867|FG003|Overall Study|Lost to Follow-up|1|||
129929027|NCT03249090|467707868|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
129929028|NCT03249090|467707869|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
129929029|NCT03249090|467707868|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
129929030|NCT03249090|467707869|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
129929031|NCT03249090|467707868|FG000|3 Month Time Point|Voluntary withdrawal|6|||
129929032|NCT03249090|467707869|FG001|3 Month Time Point|Voluntary withdrawal|3|||
129929033|NCT03249090|467707868|FG000|3 Month Time Point|Changed oncology practice|4|||
129929034|NCT03249090|467707869|FG001|3 Month Time Point|Changed oncology practice|2|||
129929035|NCT03249090|467707868|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
129929036|NCT03249090|467707869|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
129929037|NCT03249090|467707868|FG000|12 Month Time Point|Voluntary withdrawal|35|||
129929038|NCT03249090|467707869|FG001|12 Month Time Point|Voluntary withdrawal|4|||
129929039|NCT03249090|467707868|FG000|12 Month Time Point|Changed oncology practice|20|||
129929040|NCT03249090|467707869|FG001|12 Month Time Point|Changed oncology practice|9|||
129929041|NCT04359654|467707873|FG000|Overall Study|Withdrawal by Subject|1|||
129929042|NCT04359654|467707874|FG001|Overall Study|Withdrawal by Subject|0|||
129929043|NCT04359654|467707873|FG000|Overall Study|Adverse Event|0|||
129929044|NCT04359654|467707874|FG001|Overall Study|Adverse Event|1|||
129929045|NCT04314778|467707875|FG000|Overall Study|Lost to Follow-up|5|||
129929046|NCT04314778|467707876|FG001|Overall Study|Lost to Follow-up|3|||
129929047|NCT04024020|467707879|FG000|Overall Study|Withdrawal by Subject|2|||
129929048|NCT04024020|467707880|FG001|Overall Study|Withdrawal by Subject|2|||
129929049|NCT05646355|467707881|FG000|Overall Study|Lost to Follow-up|1|||
129929050|NCT05646355|467707882|FG001|Overall Study|Lost to Follow-up|0|||
129929051|NCT05646355|467707881|FG000|Overall Study|translated materials not available for pilot|2|||
129929052|NCT05646355|467707882|FG001|Overall Study|translated materials not available for pilot|0|||
129929053|NCT05646355|467707881|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
129929054|NCT05646355|467707882|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
129929055|NCT03523572|467707883|FG000|Dose Escalation|Progressive disease|1|||
129929056|NCT03523572|467707884|FG001|Dose Escalation|Progressive disease|0|||
129929057|NCT03523572|467707885|FG002|Dose Escalation|Progressive disease|0|||
129929058|NCT03523572|467707886|FG003|Dose Escalation|Progressive disease|0|||
129929059|NCT03523572|467707887|FG004|Dose Escalation|Progressive disease|0|||
129929060|NCT03523572|467707888|FG005|Dose Escalation|Progressive disease|0|||
129929061|NCT03523572|467707883|FG000|Dose Escalation|Clinical Progression|0|||
129929062|NCT03523572|467707884|FG001|Dose Escalation|Clinical Progression|1|||
129929063|NCT03523572|467707885|FG002|Dose Escalation|Clinical Progression|0|||
129929064|NCT03523572|467707886|FG003|Dose Escalation|Clinical Progression|0|||
129929065|NCT03523572|467707887|FG004|Dose Escalation|Clinical Progression|0|||
129929066|NCT03523572|467707888|FG005|Dose Escalation|Clinical Progression|0|||
129929067|NCT03523572|467707883|FG000|Dose Escalation|Adverse Event|2|||
129929068|NCT03523572|467707884|FG001|Dose Escalation|Adverse Event|0|||
129929069|NCT03523572|467707885|FG002|Dose Escalation|Adverse Event|0|||
129929070|NCT03523572|467707886|FG003|Dose Escalation|Adverse Event|0|||
129929071|NCT03523572|467707887|FG004|Dose Escalation|Adverse Event|0|||
129929072|NCT03523572|467707888|FG005|Dose Escalation|Adverse Event|0|||
129929073|NCT03523572|467707883|FG000|Dose Escalation|Physician Decision|1|||
129929074|NCT03523572|467707884|FG001|Dose Escalation|Physician Decision|1|||
129929075|NCT03523572|467707885|FG002|Dose Escalation|Physician Decision|0|||
129929076|NCT03523572|467707886|FG003|Dose Escalation|Physician Decision|0|||
129929077|NCT03523572|467707887|FG004|Dose Escalation|Physician Decision|0|||
129929078|NCT03523572|467707888|FG005|Dose Escalation|Physician Decision|0|||
129929079|NCT03523572|467707883|FG000|Dose Expansion|Progressive Disease|0|||
129929080|NCT03523572|467707884|FG001|Dose Expansion|Progressive Disease|0|||
129929081|NCT03523572|467707885|FG002|Dose Expansion|Progressive Disease|9|||
129929082|NCT03523572|467707886|FG003|Dose Expansion|Progressive Disease|11|||
129929083|NCT03523572|467707887|FG004|Dose Expansion|Progressive Disease|15|||
129929084|NCT03523572|467707888|FG005|Dose Expansion|Progressive Disease|2|||
129929085|NCT03523572|467707883|FG000|Dose Expansion|Clinical Progression|0|||
129929086|NCT03523572|467707884|FG001|Dose Expansion|Clinical Progression|0|||
129929087|NCT03523572|467707885|FG002|Dose Expansion|Clinical Progression|2|||
129929088|NCT03523572|467707886|FG003|Dose Expansion|Clinical Progression|2|||
129929089|NCT03523572|467707887|FG004|Dose Expansion|Clinical Progression|2|||
129929090|NCT03523572|467707888|FG005|Dose Expansion|Clinical Progression|0|||
129929091|NCT03523572|467707883|FG000|Dose Expansion|Adverse Event|0|||
129929092|NCT03523572|467707884|FG001|Dose Expansion|Adverse Event|0|||
129929093|NCT03523572|467707885|FG002|Dose Expansion|Adverse Event|10|||
129929094|NCT03523572|467707886|FG003|Dose Expansion|Adverse Event|1|||
129929095|NCT03523572|467707887|FG004|Dose Expansion|Adverse Event|5|||
129929096|NCT03523572|467707888|FG005|Dose Expansion|Adverse Event|2|||
129929097|NCT03523572|467707883|FG000|Dose Expansion|Withdrawal by Subject|0|||
129929098|NCT03523572|467707884|FG001|Dose Expansion|Withdrawal by Subject|0|||
129929099|NCT03523572|467707885|FG002|Dose Expansion|Withdrawal by Subject|1|||
129929100|NCT03523572|467707886|FG003|Dose Expansion|Withdrawal by Subject|1|||
129929101|NCT03523572|467707887|FG004|Dose Expansion|Withdrawal by Subject|0|||
129929102|NCT03523572|467707888|FG005|Dose Expansion|Withdrawal by Subject|0|||
129929103|NCT03523572|467707883|FG000|Dose Expansion|Physician Decision|0|||
129929104|NCT03523572|467707884|FG001|Dose Expansion|Physician Decision|0|||
129929105|NCT03523572|467707885|FG002|Dose Expansion|Physician Decision|1|||
129929106|NCT03523572|467707886|FG003|Dose Expansion|Physician Decision|0|||
129929107|NCT03523572|467707887|FG004|Dose Expansion|Physician Decision|1|||
129929108|NCT03523572|467707888|FG005|Dose Expansion|Physician Decision|0|||
129929109|NCT03523572|467707883|FG000|Dose Expansion|Miscellaneous|0|||
129929110|NCT03523572|467707884|FG001|Dose Expansion|Miscellaneous|0|||
129929111|NCT03523572|467707885|FG002|Dose Expansion|Miscellaneous|0|||
129929112|NCT03523572|467707886|FG003|Dose Expansion|Miscellaneous|0|||
129929113|NCT03523572|467707887|FG004|Dose Expansion|Miscellaneous|3|||
129929114|NCT03523572|467707888|FG005|Dose Expansion|Miscellaneous|0|||
129929115|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929116|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929117|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929118|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
129929119|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
129929120|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929121|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
129929122|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
129929123|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
129929124|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
129929125|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
129929126|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
129929127|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
129929128|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
129929129|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
129929130|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
129929131|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929132|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929133|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929134|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929135|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929136|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
129929137|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
129929138|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
129929139|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929140|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929141|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929142|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929143|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929144|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929145|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
129929146|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
129929147|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
129929148|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
129929149|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
129929150|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
129929151|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
129929152|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
129929153|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
129929154|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
129929155|NCT02315703|467707891|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
129929156|NCT02315703|467707892|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
129929157|NCT02315703|467707893|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
129929158|NCT02315703|467707894|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
129929159|NCT02315703|467707895|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
129929160|NCT02315703|467707896|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
129929161|NCT02315703|467707897|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
129929162|NCT02315703|467707898|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
129929163|NCT02315703|467707891|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
129929164|NCT02315703|467707892|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
129929165|NCT02315703|467707893|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929166|NCT02315703|467707894|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929167|NCT02315703|467707895|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929168|NCT02315703|467707896|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929169|NCT02315703|467707897|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929170|NCT02315703|467707898|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
129929171|NCT02315703|467707891|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929172|NCT02315703|467707892|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
129929173|NCT02315703|467707893|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929174|NCT02315703|467707894|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929175|NCT02315703|467707895|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929176|NCT02315703|467707896|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929177|NCT02315703|467707897|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929178|NCT02315703|467707898|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
129929179|NCT02315703|467707891|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
129929180|NCT02315703|467707892|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
129929181|NCT02315703|467707893|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
129929182|NCT02315703|467707894|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
129929183|NCT02315703|467707895|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
129929184|NCT02315703|467707896|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
129929185|NCT02315703|467707897|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
129929186|NCT02315703|467707898|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
129929187|NCT03476343|467707900|FG000|Overall Study|Clinical exam moved to another scanner|7|||
129929188|NCT03476343|467707900|FG000|Overall Study|Clinical order cancelled|4|||
129929189|NCT03476343|467707900|FG000|Overall Study|Neonate did not settle down for the scan|1|||
129929190|NCT03088878|467707901|FG000|Overall Study|Adverse Event|0|||
129929191|NCT03088878|467707902|FG001|Overall Study|Adverse Event|0|||
129929192|NCT03088878|467707903|FG002|Overall Study|Adverse Event|0|||
129929193|NCT03088878|467707904|FG003|Overall Study|Adverse Event|0|||
129929194|NCT03088878|467707905|FG004|Overall Study|Adverse Event|4|||
129929195|NCT03088878|467707906|FG005|Overall Study|Adverse Event|2|||
129929196|NCT03088878|467707907|FG006|Overall Study|Adverse Event|1|||
129929197|NCT03088878|467707908|FG007|Overall Study|Adverse Event|0|||
129929198|NCT03088878|467707909|FG008|Overall Study|Adverse Event|0|||
129929199|NCT03088878|467707910|FG009|Overall Study|Adverse Event|0|||
129929200|NCT03088878|467707911|FG010|Overall Study|Adverse Event|0|||
129929201|NCT03088878|467707912|FG011|Overall Study|Adverse Event|0|||
129929202|NCT03088878|467707913|FG012|Overall Study|Adverse Event|5|||
129929203|NCT03088878|467707914|FG013|Overall Study|Adverse Event|3|||
129929204|NCT03088878|467707901|FG000|Overall Study|Clinical Progression|0|||
129929205|NCT03088878|467707902|FG001|Overall Study|Clinical Progression|0|||
129929206|NCT03088878|467707903|FG002|Overall Study|Clinical Progression|0|||
129929207|NCT03088878|467707904|FG003|Overall Study|Clinical Progression|0|||
129929208|NCT03088878|467707905|FG004|Overall Study|Clinical Progression|2|||
129929209|NCT03088878|467707906|FG005|Overall Study|Clinical Progression|0|||
129929210|NCT03088878|467707907|FG006|Overall Study|Clinical Progression|0|||
129929211|NCT03088878|467707908|FG007|Overall Study|Clinical Progression|0|||
129929212|NCT03088878|467707909|FG008|Overall Study|Clinical Progression|0|||
129929213|NCT03088878|467707910|FG009|Overall Study|Clinical Progression|0|||
129929214|NCT03088878|467707911|FG010|Overall Study|Clinical Progression|0|||
129929215|NCT03088878|467707912|FG011|Overall Study|Clinical Progression|0|||
129929216|NCT03088878|467707913|FG012|Overall Study|Clinical Progression|0|||
129929217|NCT03088878|467707914|FG013|Overall Study|Clinical Progression|0|||
129929218|NCT03088878|467707901|FG000|Overall Study|Death|0|||
129929219|NCT03088878|467707902|FG001|Overall Study|Death|0|||
129929220|NCT03088878|467707903|FG002|Overall Study|Death|0|||
129929221|NCT03088878|467707904|FG003|Overall Study|Death|0|||
129929222|NCT03088878|467707905|FG004|Overall Study|Death|2|||
129929223|NCT03088878|467707906|FG005|Overall Study|Death|0|||
129929224|NCT03088878|467707907|FG006|Overall Study|Death|0|||
129929225|NCT03088878|467707908|FG007|Overall Study|Death|0|||
129929226|NCT03088878|467707909|FG008|Overall Study|Death|0|||
129929227|NCT03088878|467707910|FG009|Overall Study|Death|0|||
129929228|NCT03088878|467707911|FG010|Overall Study|Death|0|||
129929229|NCT03088878|467707912|FG011|Overall Study|Death|1|||
129929230|NCT03088878|467707913|FG012|Overall Study|Death|0|||
129929231|NCT03088878|467707914|FG013|Overall Study|Death|0|||
129929232|NCT03088878|467707901|FG000|Overall Study|Disease Progression|1|||
129929233|NCT03088878|467707902|FG001|Overall Study|Disease Progression|2|||
129929234|NCT03088878|467707903|FG002|Overall Study|Disease Progression|3|||
129929235|NCT03088878|467707904|FG003|Overall Study|Disease Progression|0|||
129929236|NCT03088878|467707905|FG004|Overall Study|Disease Progression|3|||
129929237|NCT03088878|467707906|FG005|Overall Study|Disease Progression|0|||
129929238|NCT03088878|467707907|FG006|Overall Study|Disease Progression|0|||
129929239|NCT03088878|467707908|FG007|Overall Study|Disease Progression|0|||
129929240|NCT03088878|467707909|FG008|Overall Study|Disease Progression|0|||
129929241|NCT03088878|467707910|FG009|Overall Study|Disease Progression|0|||
129929242|NCT03088878|467707911|FG010|Overall Study|Disease Progression|0|||
129929243|NCT03088878|467707912|FG011|Overall Study|Disease Progression|0|||
129929244|NCT03088878|467707913|FG012|Overall Study|Disease Progression|1|||
129929245|NCT03088878|467707914|FG013|Overall Study|Disease Progression|1|||
129929246|NCT03088878|467707901|FG000|Overall Study|Initiation of Alternative Treatment|0|||
129929247|NCT03088878|467707902|FG001|Overall Study|Initiation of Alternative Treatment|0|||
129929248|NCT03088878|467707903|FG002|Overall Study|Initiation of Alternative Treatment|0|||
129929249|NCT03088878|467707904|FG003|Overall Study|Initiation of Alternative Treatment|1|||
129929250|NCT03088878|467707905|FG004|Overall Study|Initiation of Alternative Treatment|0|||
129929251|NCT03088878|467707906|FG005|Overall Study|Initiation of Alternative Treatment|0|||
129929252|NCT03088878|467707907|FG006|Overall Study|Initiation of Alternative Treatment|0|||
129929253|NCT03088878|467707908|FG007|Overall Study|Initiation of Alternative Treatment|1|||
129929254|NCT03088878|467707909|FG008|Overall Study|Initiation of Alternative Treatment|1|||
129929255|NCT03088878|467707910|FG009|Overall Study|Initiation of Alternative Treatment|0|||
129929256|NCT03088878|467707911|FG010|Overall Study|Initiation of Alternative Treatment|0|||
129929257|NCT03088878|467707912|FG011|Overall Study|Initiation of Alternative Treatment|0|||
129929258|NCT03088878|467707913|FG012|Overall Study|Initiation of Alternative Treatment|0|||
129929259|NCT03088878|467707914|FG013|Overall Study|Initiation of Alternative Treatment|0|||
129929260|NCT03088878|467707901|FG000|Overall Study|Withdrawal by Subject|0|||
129929261|NCT03088878|467707902|FG001|Overall Study|Withdrawal by Subject|0|||
129929262|NCT03088878|467707903|FG002|Overall Study|Withdrawal by Subject|0|||
129929263|NCT03088878|467707904|FG003|Overall Study|Withdrawal by Subject|1|||
129929264|NCT03088878|467707905|FG004|Overall Study|Withdrawal by Subject|4|||
129929265|NCT03088878|467707906|FG005|Overall Study|Withdrawal by Subject|1|||
129929266|NCT03088878|467707907|FG006|Overall Study|Withdrawal by Subject|1|||
129929267|NCT03088878|467707908|FG007|Overall Study|Withdrawal by Subject|0|||
129929268|NCT03088878|467707909|FG008|Overall Study|Withdrawal by Subject|1|||
129929269|NCT03088878|467707910|FG009|Overall Study|Withdrawal by Subject|2|||
129929270|NCT03088878|467707911|FG010|Overall Study|Withdrawal by Subject|0|||
129929271|NCT03088878|467707912|FG011|Overall Study|Withdrawal by Subject|2|||
129929272|NCT03088878|467707913|FG012|Overall Study|Withdrawal by Subject|1|||
129929273|NCT03088878|467707914|FG013|Overall Study|Withdrawal by Subject|0|||
129929274|NCT03088878|467707901|FG000|Overall Study|Terminated by Sponsor|2|||
129929275|NCT03088878|467707902|FG001|Overall Study|Terminated by Sponsor|1|||
129929276|NCT03088878|467707903|FG002|Overall Study|Terminated by Sponsor|0|||
129929277|NCT03088878|467707904|FG003|Overall Study|Terminated by Sponsor|1|||
129929278|NCT03088878|467707905|FG004|Overall Study|Terminated by Sponsor|6|||
129929279|NCT03088878|467707906|FG005|Overall Study|Terminated by Sponsor|0|||
129929280|NCT03088878|467707907|FG006|Overall Study|Terminated by Sponsor|0|||
129929281|NCT03088878|467707908|FG007|Overall Study|Terminated by Sponsor|0|||
129929282|NCT03088878|467707909|FG008|Overall Study|Terminated by Sponsor|0|||
129929283|NCT03088878|467707910|FG009|Overall Study|Terminated by Sponsor|0|||
129929284|NCT03088878|467707911|FG010|Overall Study|Terminated by Sponsor|3|||
129929285|NCT03088878|467707912|FG011|Overall Study|Terminated by Sponsor|13|||
129929286|NCT03088878|467707913|FG012|Overall Study|Terminated by Sponsor|2|||
129929287|NCT03088878|467707914|FG013|Overall Study|Terminated by Sponsor|1|||
129929288|NCT03088878|467707901|FG000|Overall Study|Completed 2 years of Treatment|0|||
129929289|NCT03088878|467707902|FG001|Overall Study|Completed 2 years of Treatment|0|||
129929290|NCT03088878|467707903|FG002|Overall Study|Completed 2 years of Treatment|0|||
129929291|NCT03088878|467707904|FG003|Overall Study|Completed 2 years of Treatment|0|||
129929292|NCT03088878|467707905|FG004|Overall Study|Completed 2 years of Treatment|0|||
129929293|NCT03088878|467707906|FG005|Overall Study|Completed 2 years of Treatment|0|||
129929294|NCT03088878|467707907|FG006|Overall Study|Completed 2 years of Treatment|1|||
129929295|NCT03088878|467707908|FG007|Overall Study|Completed 2 years of Treatment|0|||
129929296|NCT03088878|467707909|FG008|Overall Study|Completed 2 years of Treatment|0|||
129929297|NCT03088878|467707910|FG009|Overall Study|Completed 2 years of Treatment|1|||
129929298|NCT03088878|467707911|FG010|Overall Study|Completed 2 years of Treatment|0|||
129929299|NCT03088878|467707912|FG011|Overall Study|Completed 2 years of Treatment|0|||
129929300|NCT03088878|467707913|FG012|Overall Study|Completed 2 years of Treatment|8|||
129929301|NCT03088878|467707914|FG013|Overall Study|Completed 2 years of Treatment|3|||
129929302|NCT03088878|467707901|FG000|Overall Study|Physician Decision|0|||
129929303|NCT03088878|467707902|FG001|Overall Study|Physician Decision|0|||
129929304|NCT03088878|467707903|FG002|Overall Study|Physician Decision|0|||
129929305|NCT03088878|467707904|FG003|Overall Study|Physician Decision|0|||
129929306|NCT03088878|467707905|FG004|Overall Study|Physician Decision|0|||
129929307|NCT03088878|467707906|FG005|Overall Study|Physician Decision|0|||
129929308|NCT03088878|467707907|FG006|Overall Study|Physician Decision|0|||
129929309|NCT03088878|467707908|FG007|Overall Study|Physician Decision|2|||
129929310|NCT03088878|467707909|FG008|Overall Study|Physician Decision|1|||
129929311|NCT03088878|467707910|FG009|Overall Study|Physician Decision|0|||
129929312|NCT03088878|467707911|FG010|Overall Study|Physician Decision|0|||
129929313|NCT03088878|467707912|FG011|Overall Study|Physician Decision|0|||
129929314|NCT03088878|467707913|FG012|Overall Study|Physician Decision|0|||
129929315|NCT03088878|467707914|FG013|Overall Study|Physician Decision|1|||
129929316|NCT03088878|467707901|FG000|Overall Study|COVID Related noncompliance|0|||
129929317|NCT03088878|467707902|FG001|Overall Study|COVID Related noncompliance|0|||
129929318|NCT03088878|467707903|FG002|Overall Study|COVID Related noncompliance|0|||
129929319|NCT03088878|467707904|FG003|Overall Study|COVID Related noncompliance|0|||
129929320|NCT03088878|467707905|FG004|Overall Study|COVID Related noncompliance|0|||
129929321|NCT03088878|467707906|FG005|Overall Study|COVID Related noncompliance|0|||
129929322|NCT03088878|467707907|FG006|Overall Study|COVID Related noncompliance|0|||
129929323|NCT03088878|467707908|FG007|Overall Study|COVID Related noncompliance|0|||
129929324|NCT03088878|467707909|FG008|Overall Study|COVID Related noncompliance|0|||
129929325|NCT03088878|467707910|FG009|Overall Study|COVID Related noncompliance|0|||
129929326|NCT03088878|467707911|FG010|Overall Study|COVID Related noncompliance|0|||
129929327|NCT03088878|467707912|FG011|Overall Study|COVID Related noncompliance|0|||
129929328|NCT03088878|467707913|FG012|Overall Study|COVID Related noncompliance|0|||
129929329|NCT03088878|467707914|FG013|Overall Study|COVID Related noncompliance|1|||
129929330|NCT03088878|467707901|FG000|Overall Study|Drug or Study Noncompliance|0|||
129929331|NCT03088878|467707902|FG001|Overall Study|Drug or Study Noncompliance|0|||
129929332|NCT03088878|467707903|FG002|Overall Study|Drug or Study Noncompliance|0|||
129929333|NCT03088878|467707904|FG003|Overall Study|Drug or Study Noncompliance|0|||
129929334|NCT03088878|467707905|FG004|Overall Study|Drug or Study Noncompliance|0|||
129929335|NCT03088878|467707906|FG005|Overall Study|Drug or Study Noncompliance|0|||
129929336|NCT03088878|467707907|FG006|Overall Study|Drug or Study Noncompliance|0|||
129929337|NCT03088878|467707908|FG007|Overall Study|Drug or Study Noncompliance|0|||
129929338|NCT03088878|467707909|FG008|Overall Study|Drug or Study Noncompliance|0|||
129929339|NCT03088878|467707910|FG009|Overall Study|Drug or Study Noncompliance|0|||
129929340|NCT03088878|467707911|FG010|Overall Study|Drug or Study Noncompliance|0|||
129929341|NCT03088878|467707912|FG011|Overall Study|Drug or Study Noncompliance|0|||
129929342|NCT03088878|467707913|FG012|Overall Study|Drug or Study Noncompliance|1|||
129929343|NCT03088878|467707914|FG013|Overall Study|Drug or Study Noncompliance|0|||
129929344|NCT05216406|467707917|FG000|Overall Study|Lost to Follow-up|8|||
129929345|NCT05216406|467707918|FG001|Overall Study|Lost to Follow-up|9|||
129929346|NCT04690582|467707921|FG000|Overall Study|Withdrawal by Subject|6|||
129929347|NCT04690582|467707922|FG001|Overall Study|Withdrawal by Subject|4|||
129929348|NCT03711474|467707923|FG000|Overall Study|Physician Decision|2|||
129929349|NCT03711474|467707924|FG001|Overall Study|Physician Decision|0|||
129929350|NCT05974501|467707925|FG000|Overall Study|Physician Decision|0|||
129929351|NCT05974501|467707926|FG001|Overall Study|Physician Decision|1|||
129929352|NCT04270942|467707929|FG000|Overall Study|Death|1|||
129929353|NCT03625115|467707931|FG000|Overall Study|Withdrawal by Subject|4|||
129929354|NCT03625115|467707932|FG001|Overall Study|Withdrawal by Subject|7|||
129929355|NCT03625115|467707931|FG000|Overall Study|Lost to Follow-up|17|||
129929356|NCT03625115|467707932|FG001|Overall Study|Lost to Follow-up|24|||
129929357|NCT01236781|467707933|FG000|Overall Study|Ineligible|2|||
129929358|NCT01236781|467707934|FG001|Overall Study|Ineligible|1|||
129929359|NCT01236781|467707933|FG000|Overall Study|Did not complete study imaging|5|||
129929360|NCT01236781|467707934|FG001|Overall Study|Did not complete study imaging|0|||
129929361|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
129929362|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
129929363|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
129929364|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
129929365|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
129929366|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
129929367|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
129929368|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
129929369|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
129929370|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
129929371|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
129929372|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
129929373|NCT04059185|467707935|FG000|Longitudinal Assessment-Adults Only|Death|4|||
129929374|NCT04059185|467707936|FG001|Longitudinal Assessment-Adults Only|Death|4|||
129929375|NCT04059185|467707937|FG002|Longitudinal Assessment-Adults Only|Death|3|||
129929376|NCT03756662|467707938|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
129929377|NCT03298451|467707945|FG000|Overall Study|Death|275|||
129929378|NCT03298451|467707946|FG001|Overall Study|Death|260|||
129929379|NCT03298451|467707947|FG002|Overall Study|Death|122|||
129929380|NCT03298451|467707948|FG003|Overall Study|Death|280|||
129929381|NCT03298451|467707945|FG000|Overall Study|Lost to Follow-up|1|||
129929382|NCT03298451|467707946|FG001|Overall Study|Lost to Follow-up|1|||
129929383|NCT03298451|467707947|FG002|Overall Study|Lost to Follow-up|0|||
129929384|NCT03298451|467707948|FG003|Overall Study|Lost to Follow-up|7|||
129929385|NCT03298451|467707945|FG000|Overall Study|Withdrawal by Subject|9|||
129929386|NCT03298451|467707946|FG001|Overall Study|Withdrawal by Subject|7|||
129929387|NCT03298451|467707947|FG002|Overall Study|Withdrawal by Subject|1|||
129929388|NCT03298451|467707948|FG003|Overall Study|Withdrawal by Subject|20|||
129929389|NCT04308681|467707953|FG000|Pre-Treatment|Not reported|1|||
129929390|NCT04308681|467707954|FG001|Pre-Treatment|Not reported|1|||
129929391|NCT04308681|467707955|FG002|Pre-Treatment|Not reported|0|||
129929392|NCT04308681|467707956|FG003|Pre-Treatment|Not reported|0|||
129929393|NCT04308681|467707957|FG004|Pre-Treatment|Not reported|0|||
129929394|NCT04308681|467707958|FG005|Pre-Treatment|Not reported|2|||
129929395|NCT04308681|467707959|FG006|Pre-Treatment|Not reported|0|||
129929396|NCT04308681|467707960|FG007|Pre-Treatment|Not reported|0|||
129929397|NCT04308681|467707953|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
129929398|NCT04308681|467707954|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
129929399|NCT04308681|467707955|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
129929400|NCT04308681|467707956|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
129929401|NCT04308681|467707957|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
129929402|NCT04308681|467707958|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
129929403|NCT04308681|467707959|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
129929404|NCT04308681|467707960|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
129929405|NCT04308681|467707953|FG000|Treatment up to Week 26|Other reasons|2|||
129929406|NCT04308681|467707954|FG001|Treatment up to Week 26|Other reasons|0|||
129929407|NCT04308681|467707955|FG002|Treatment up to Week 26|Other reasons|0|||
129929408|NCT04308681|467707956|FG003|Treatment up to Week 26|Other reasons|0|||
129929409|NCT04308681|467707957|FG004|Treatment up to Week 26|Other reasons|1|||
129929410|NCT04308681|467707958|FG005|Treatment up to Week 26|Other reasons|1|||
129929411|NCT04308681|467707959|FG006|Treatment up to Week 26|Other reasons|0|||
129929412|NCT04308681|467707960|FG007|Treatment up to Week 26|Other reasons|0|||
129929413|NCT04308681|467707953|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929414|NCT04308681|467707954|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
129929415|NCT04308681|467707955|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
129929416|NCT04308681|467707956|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929417|NCT04308681|467707957|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
129929418|NCT04308681|467707958|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929419|NCT04308681|467707959|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
129929420|NCT04308681|467707960|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
129929421|NCT04308681|467707953|FG000|Treatment up to Week 26|Adverse Event|6|||
129929422|NCT04308681|467707954|FG001|Treatment up to Week 26|Adverse Event|5|||
129929423|NCT04308681|467707955|FG002|Treatment up to Week 26|Adverse Event|5|||
129929424|NCT04308681|467707956|FG003|Treatment up to Week 26|Adverse Event|0|||
129929425|NCT04308681|467707957|FG004|Treatment up to Week 26|Adverse Event|6|||
129929426|NCT04308681|467707958|FG005|Treatment up to Week 26|Adverse Event|1|||
129929427|NCT04308681|467707959|FG006|Treatment up to Week 26|Adverse Event|0|||
129929428|NCT04308681|467707960|FG007|Treatment up to Week 26|Adverse Event|0|||
129929429|NCT04308681|467707953|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929430|NCT04308681|467707954|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
129929431|NCT04308681|467707955|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
129929432|NCT04308681|467707956|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929433|NCT04308681|467707957|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129979760|NCT01283516|467889461|FG005|Overall Study|Lost to Follow-up|0|||
129929434|NCT04308681|467707958|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929435|NCT04308681|467707959|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929436|NCT04308681|467707960|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
129929437|NCT04308681|467707953|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
129929438|NCT04308681|467707954|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
129929439|NCT04308681|467707955|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
129929440|NCT04308681|467707956|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
129929441|NCT04308681|467707957|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
129929442|NCT04308681|467707958|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
129929443|NCT04308681|467707959|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
129929444|NCT04308681|467707960|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
129929445|NCT04308681|467707953|FG000|OTE - 26 Weeks|Death|0|||
129929446|NCT04308681|467707954|FG001|OTE - 26 Weeks|Death|1|||
129929447|NCT04308681|467707955|FG002|OTE - 26 Weeks|Death|0|||
129929448|NCT04308681|467707956|FG003|OTE - 26 Weeks|Death|0|||
129929449|NCT04308681|467707957|FG004|OTE - 26 Weeks|Death|0|||
129929450|NCT04308681|467707958|FG005|OTE - 26 Weeks|Death|0|||
129929451|NCT04308681|467707959|FG006|OTE - 26 Weeks|Death|1|||
129929452|NCT04308681|467707960|FG007|OTE - 26 Weeks|Death|0|||
129929453|NCT04308681|467707953|FG000|OTE - 26 Weeks|Adverse Event|0|||
129929454|NCT04308681|467707954|FG001|OTE - 26 Weeks|Adverse Event|2|||
129929455|NCT04308681|467707955|FG002|OTE - 26 Weeks|Adverse Event|8|||
129929456|NCT04308681|467707956|FG003|OTE - 26 Weeks|Adverse Event|3|||
129929457|NCT04308681|467707957|FG004|OTE - 26 Weeks|Adverse Event|0|||
129929458|NCT04308681|467707958|FG005|OTE - 26 Weeks|Adverse Event|1|||
129929459|NCT04308681|467707959|FG006|OTE - 26 Weeks|Adverse Event|2|||
129929460|NCT04308681|467707960|FG007|OTE - 26 Weeks|Adverse Event|0|||
129929461|NCT04308681|467707953|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929462|NCT04308681|467707954|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
129929463|NCT04308681|467707955|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
129929464|NCT04308681|467707956|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929465|NCT04308681|467707957|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929466|NCT04308681|467707958|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
129929467|NCT04308681|467707959|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929468|NCT04308681|467707960|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
129929469|NCT05565820|467707961|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
129929470|NCT05565820|467707962|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
129929471|NCT05565820|467707961|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
129929472|NCT05565820|467707962|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
129929473|NCT03295721|467707965|FG000|Overall Study|Adverse Event|1|||
129929474|NCT03295721|467707966|FG001|Overall Study|Adverse Event|0|||
129929475|NCT03295721|467707967|FG002|Overall Study|Adverse Event|0|||
129929476|NCT03295721|467707965|FG000|Overall Study|Lost to Follow-up|1|||
129929477|NCT03295721|467707966|FG001|Overall Study|Lost to Follow-up|1|||
129929478|NCT03295721|467707967|FG002|Overall Study|Lost to Follow-up|1|||
129929479|NCT03295721|467707965|FG000|Overall Study|Withdrawal by Subject|1|||
129929480|NCT03295721|467707966|FG001|Overall Study|Withdrawal by Subject|0|||
129929481|NCT03295721|467707967|FG002|Overall Study|Withdrawal by Subject|1|||
129929482|NCT03295721|467707965|FG000|Overall Study|Death|0|||
129929483|NCT03295721|467707966|FG001|Overall Study|Death|0|||
129929484|NCT03295721|467707967|FG002|Overall Study|Death|1|||
129929485|NCT04786119|467707971|FG000|Overall Study|Withdrawal by Subject|2|||
129929486|NCT03325985|467707972|FG000|Overall Study|Lost to Follow-up|122|||
129929487|NCT03325985|467707973|FG001|Overall Study|Lost to Follow-up|26|||
129929488|NCT03325985|467707974|FG002|Overall Study|Lost to Follow-up|141|||
129929489|NCT03325985|467707975|FG003|Overall Study|Lost to Follow-up|28|||
129929490|NCT03325985|467707972|FG000|Overall Study|Death|99|||
129929491|NCT03325985|467707973|FG001|Overall Study|Death|36|||
129929492|NCT03325985|467707974|FG002|Overall Study|Death|94|||
129450654|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
129450655|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Death|0|||
129450656|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Death|25|||
129450657|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Death|13|||
129929493|NCT03325985|467707975|FG003|Overall Study|Death|32|||
129929494|NCT03056573|467707976|FG000|Overall Study|Death|2|||
129929495|NCT03056573|467707977|FG001|Overall Study|Death|4|||
129929496|NCT03056573|467707976|FG000|Overall Study|Withdrawal by Subject|2|||
129929497|NCT03056573|467707977|FG001|Overall Study|Withdrawal by Subject|0|||
129929498|NCT03056573|467707976|FG000|Overall Study|Lost to Follow-up|1|||
129929499|NCT03056573|467707977|FG001|Overall Study|Lost to Follow-up|1|||
129929500|NCT02684227|467707979|FG000|Overall Study|Adverse Event|1|||
129929501|NCT02684227|467707980|FG001|Overall Study|Adverse Event|7|||
129929502|NCT02684227|467707979|FG000|Overall Study|Death|0|||
129929503|NCT02684227|467707980|FG001|Overall Study|Death|2|||
129929504|NCT02684227|467707979|FG000|Overall Study|Withdrawal by Subject|0|||
129929505|NCT02684227|467707980|FG001|Overall Study|Withdrawal by Subject|1|||
129929506|NCT02684227|467707979|FG000|Overall Study|Progressive Disease|0|||
129450658|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Death|4|||
129450659|NCT02752035|465948790|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
129450660|NCT02752035|465948791|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
129450661|NCT02752035|465948792|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
129450662|NCT02752035|465948793|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
129450663|NCT02752035|465948790|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
129450664|NCT02752035|465948791|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
129450665|NCT02752035|465948792|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
129450666|NCT02752035|465948793|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
129450667|NCT02752035|465948790|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
129450668|NCT02752035|465948791|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
129450669|NCT02752035|465948792|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
129450670|NCT02752035|465948793|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
129450671|NCT02752035|465948790|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
129450672|NCT02752035|465948791|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
129450673|NCT02752035|465948792|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
129450674|NCT02752035|465948793|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
129450675|NCT02752035|465948790|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
129450676|NCT02752035|465948791|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
129450677|NCT02752035|465948792|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
129450678|NCT02752035|465948793|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
129450679|NCT01519934|465948794|FG000|Overall Study|Lost to Follow-up|3|||
129450680|NCT03861936|465948795|FG000|Overall Study|Withdrawal by Subject|4|||
129450681|NCT03861936|465948796|FG001|Overall Study|Withdrawal by Subject|1|||
129450682|NCT03861936|465948797|FG002|Overall Study|Withdrawal by Subject|3|||
129450683|NCT03861936|465948795|FG000|Overall Study|Lost to Follow-up|5|||
129450684|NCT03861936|465948796|FG001|Overall Study|Lost to Follow-up|3|||
129450685|NCT03861936|465948797|FG002|Overall Study|Lost to Follow-up|3|||
129450686|NCT03861936|465948795|FG000|Overall Study|Physician Decision|0|||
129450687|NCT03861936|465948796|FG001|Overall Study|Physician Decision|1|||
129450688|NCT03861936|465948797|FG002|Overall Study|Physician Decision|0|||
129450689|NCT03861936|465948795|FG000|Overall Study|Protocol Deviation|0|||
129450690|NCT03861936|465948796|FG001|Overall Study|Protocol Deviation|0|||
129450691|NCT03861936|465948797|FG002|Overall Study|Protocol Deviation|1|||
129450692|NCT03861936|465948795|FG000|Overall Study|Reason not Specified|5|||
129450693|NCT03861936|465948796|FG001|Overall Study|Reason not Specified|5|||
129450694|NCT03861936|465948797|FG002|Overall Study|Reason not Specified|3|||
129450695|NCT00359021|465948798|FG000|Overall Study|Adverse Event|26|||
129450696|NCT00359021|465948799|FG001|Overall Study|Adverse Event|8|||
129450697|NCT00359021|465948798|FG000|Overall Study|Subject Non-Compliant|1|||
129450698|NCT00359021|465948799|FG001|Overall Study|Subject Non-Compliant|2|||
129450699|NCT00359021|465948798|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
129450700|NCT00359021|465948799|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
129450701|NCT00359021|465948798|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
129450702|NCT00359021|465948799|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
129450703|NCT00359021|465948798|FG000|Overall Study|Withdrawal by Subject|2|||
129450704|NCT00359021|465948799|FG001|Overall Study|Withdrawal by Subject|9|||
129450705|NCT00359021|465948798|FG000|Overall Study|Lost to Follow-up|1|||
129929507|NCT02684227|467707980|FG001|Overall Study|Progressive Disease|2|||
129450706|NCT00359021|465948799|FG001|Overall Study|Lost to Follow-up|0|||
129450707|NCT00359021|465948798|FG000|Overall Study|Other|4|||
129450708|NCT00359021|465948799|FG001|Overall Study|Other|1|||
129450709|NCT00359021|465948798|FG000|Overall Study|Pregnancy|1|||
129450710|NCT00359021|465948799|FG001|Overall Study|Pregnancy|0|||
129450711|NCT01236573|465948800|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450712|NCT01236573|465948801|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450713|NCT01236573|465948802|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450714|NCT01236573|465948803|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129929508|NCT03606408|467707981|FG000|Overall Study|Adverse Event|13|||
129450715|NCT01236573|465948804|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450716|NCT01236573|465948805|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450717|NCT01236573|465948806|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
129450718|NCT01236573|465948807|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450719|NCT01236573|465948808|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
129450720|NCT01236573|465948809|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
129450721|NCT01236573|465948810|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
129450722|NCT01236573|465948800|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450723|NCT01236573|465948801|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450724|NCT01236573|465948802|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450725|NCT01236573|465948803|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129929509|NCT03606408|467707981|FG000|Overall Study|Withdrawal by Subject|7|||
129929510|NCT03606408|467707981|FG000|Overall Study|Physician Decision|4|||
129929511|NCT03606408|467707981|FG000|Overall Study|Lack of Efficacy|2|||
129929512|NCT03606408|467707981|FG000|Overall Study|Death|1|||
129929513|NCT03606408|467707981|FG000|Overall Study|new therapy for study indication|1|||
129929514|NCT03556293|467707982|FG000|Overall Study|Ineligible for analysis|1904|||
129929515|NCT03556293|467707983|FG001|Overall Study|Ineligible for analysis|1471|||
129929516|NCT03556293|467707984|FG002|Overall Study|Ineligible for analysis|1091|||
129929517|NCT03556293|467707985|FG003|Overall Study|Ineligible for analysis|1269|||
129929518|NCT05828017|467707988|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
129929519|NCT05012163|467707989|FG000|Overall Study|Protocol Violation|0|||
129929520|NCT05012163|467707990|FG001|Overall Study|Protocol Violation|0|||
129929521|NCT05012163|467707991|FG002|Overall Study|Protocol Violation|1|||
129929522|NCT05012163|467707992|FG003|Overall Study|Protocol Violation|1|||
129929523|NCT03213873|467707995|FG000|Overall Study|Withdrawal by Subject|8|||
129929524|NCT03213873|467707996|FG001|Overall Study|Withdrawal by Subject|9|||
129929525|NCT03213873|467707995|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
129929526|NCT03213873|467707996|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
129929527|NCT03213873|467707995|FG000|Overall Study|Lost to Follow-up|0|||
129929528|NCT03213873|467707996|FG001|Overall Study|Lost to Follow-up|2|||
129929529|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
129929530|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
129929531|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
129929532|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
129929533|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
129929534|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
129929535|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
129929536|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
129929537|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
129929538|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
129929539|NCT02361216|467708002|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
129929540|NCT02361216|467708003|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
129929541|NCT02852655|467708004|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
129929542|NCT02852655|467708005|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
129929543|NCT02852655|467708006|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
129929544|NCT02852655|467708004|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
129929545|NCT02852655|467708005|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
129929546|NCT02852655|467708006|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
129929547|NCT02852655|467708004|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
129929548|NCT02852655|467708005|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
129929549|NCT02852655|467708006|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
129929550|NCT02852655|467708004|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
129929551|NCT02852655|467708005|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
129929552|NCT02852655|467708006|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
129929553|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
129929554|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
129929555|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
129929556|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
129929557|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
129929558|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
129929559|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
129929560|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
129929561|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
129929562|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
129929563|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
129929564|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
129929565|NCT02852655|467708004|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
129929566|NCT02852655|467708005|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
129929567|NCT02852655|467708006|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
129929568|NCT03924635|467709683|FG000|Overall Study|Withdrawal by Subject|2|||
129929569|NCT03924635|467709684|FG001|Overall Study|Withdrawal by Subject|4|||
129929570|NCT03676192|467709685|FG000|Induction Study Period|Adverse Event|21|||
129929571|NCT03676192|467709686|FG001|Induction Study Period|Adverse Event|20|||
129929572|NCT03676192|467709685|FG000|Induction Study Period|Death|23|||
129929573|NCT03676192|467709686|FG001|Induction Study Period|Death|20|||
129929574|NCT03676192|467709685|FG000|Induction Study Period|Lost to Follow-up|3|||
129929575|NCT03676192|467709686|FG001|Induction Study Period|Lost to Follow-up|3|||
129929576|NCT03676192|467709685|FG000|Induction Study Period|Physician Decision|6|||
129450726|NCT01236573|465948804|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450727|NCT01236573|465948805|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450728|NCT01236573|465948806|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450729|NCT01236573|465948807|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450730|NCT01236573|465948808|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
129450731|NCT01236573|465948809|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450732|NCT01236573|465948810|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
129450733|NCT01236573|465948800|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450734|NCT01236573|465948801|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450735|NCT01236573|465948802|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450736|NCT01236573|465948803|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450737|NCT01236573|465948804|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450738|NCT01236573|465948805|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450739|NCT01236573|465948806|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450740|NCT01236573|465948807|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450741|NCT01236573|465948808|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450742|NCT01236573|465948809|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
129450743|NCT01236573|465948810|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
129450744|NCT02161575|465948817|FG000|Overall Study|Protocol Violation|8|||
129450745|NCT02161575|465948817|FG000|Overall Study|Lack of Efficacy|1|||
129450746|NCT02161575|465948817|FG000|Overall Study|Adverse Event|2|||
129450747|NCT04534491|465948819|FG000|Overall Study|Not completed end-of-study interview|24|||
129450748|NCT04534491|465948819|FG000|Overall Study|Non-users|70|||
129450749|NCT04534491|465948819|FG000|Overall Study|Non-verifiable users|58|||
129450750|NCT00131469|465948821|FG000|Overall Study|Withdrawal by Subject|3|||
129450751|NCT00131469|465948822|FG001|Overall Study|Withdrawal by Subject|4|||
129450752|NCT00131469|465948821|FG000|Overall Study|Protocol Violation|3|||
129450753|NCT00131469|465948822|FG001|Overall Study|Protocol Violation|1|||
129450754|NCT00131469|465948821|FG000|Overall Study|Death|0|||
129450755|NCT00131469|465948822|FG001|Overall Study|Death|1|||
129450756|NCT00131469|465948821|FG000|Overall Study|Lost to Follow-up|0|||
129450757|NCT00131469|465948822|FG001|Overall Study|Lost to Follow-up|1|||
129450758|NCT00131469|465948821|FG000|Overall Study|scan not analyzable|3|||
129450759|NCT00131469|465948822|FG001|Overall Study|scan not analyzable|6|||
129450760|NCT00736034|465948824|FG000|Overall Study|Adverse Event|2|||
129450761|NCT02566577|465948825|FG000|Overall Study|Withdrawal by Subject|1|||
129450762|NCT02566577|465948826|FG001|Overall Study|Withdrawal by Subject|1|||
129450763|NCT02566577|465948825|FG000|Overall Study|Equipment failure|1|||
129450764|NCT02566577|465948826|FG001|Overall Study|Equipment failure|1|||
129450765|NCT02566577|465948825|FG000|Overall Study|Physical limitation|1|||
129450766|NCT02566577|465948826|FG001|Overall Study|Physical limitation|0|||
129450767|NCT00073528|465948835|FG000|Overall Study|Death|488|||
129450768|NCT00073528|465948836|FG001|Overall Study|Death|473|||
129450769|NCT00073528|465948835|FG000|Overall Study|Lost to Follow-up|52|||
129450770|NCT00073528|465948836|FG001|Overall Study|Lost to Follow-up|45|||
129450771|NCT00073528|465948835|FG000|Overall Study|Withdrawal by Subject|50|||
129450772|NCT00073528|465948836|FG001|Overall Study|Withdrawal by Subject|45|||
129450773|NCT00073528|465948835|FG000|Overall Study|Study terminated by Sponsor|10|||
129450774|NCT00073528|465948836|FG001|Overall Study|Study terminated by Sponsor|29|||
129450775|NCT00073528|465948835|FG000|Overall Study|Other|18|||
129450776|NCT00073528|465948836|FG001|Overall Study|Other|19|||
129450777|NCT00073528|465948835|FG000|Overall Study|Other|9|||
129450778|NCT00073528|465948836|FG001|Overall Study|Other|12|||
129450779|NCT00073528|465948835|FG000|Overall Study|Protocol Violation|3|||
129450780|NCT00073528|465948836|FG001|Overall Study|Protocol Violation|5|||
129450781|NCT03086057|465948837|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
129450782|NCT03086057|465948838|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
129450783|NCT03086057|465948839|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
129450784|NCT03086057|465948840|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
129450785|NCT03086057|465948837|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
129450786|NCT03086057|465948838|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
129450787|NCT03086057|465948839|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
129450788|NCT03086057|465948840|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
129450789|NCT03086057|465948837|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
129450790|NCT03086057|465948838|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
129450791|NCT03086057|465948839|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
129450792|NCT03086057|465948840|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
129450793|NCT03086057|465948837|FG000|Stage 1: PrEP Uptake|Death|1|||
129450794|NCT03086057|465948838|FG001|Stage 1: PrEP Uptake|Death|0|||
129450795|NCT03086057|465948839|FG002|Stage 1: PrEP Uptake|Death|0|||
129450796|NCT03086057|465948840|FG003|Stage 1: PrEP Uptake|Death|0|||
129450797|NCT03086057|465948837|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
129450798|NCT03086057|465948838|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
129450799|NCT03086057|465948839|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
129450800|NCT03086057|465948840|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
129929577|NCT03676192|467709686|FG001|Induction Study Period|Physician Decision|3|||
129929578|NCT03676192|467709685|FG000|Induction Study Period|Progressive Disease|32|||
129929579|NCT03676192|467709686|FG001|Induction Study Period|Progressive Disease|21|||
129929580|NCT03676192|467709685|FG000|Induction Study Period|Protocol Violation|1|||
129929581|NCT03676192|467709686|FG001|Induction Study Period|Protocol Violation|2|||
129929582|NCT03676192|467709685|FG000|Induction Study Period|Withdrawal by Subject|20|||
129929583|NCT03676192|467709686|FG001|Induction Study Period|Withdrawal by Subject|15|||
129929584|NCT03209973|467709687|FG000|Overall Study|Withdrawal by Subject|7|||
129929585|NCT03209973|467709687|FG000|Overall Study|Lost to Follow-up|2|||
129929586|NCT03209973|467709687|FG000|Overall Study|Death|8|||
129929587|NCT03209973|467709687|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
129929588|NCT03209973|467709687|FG000|Overall Study|Sponsor Decision|18|||
129929589|NCT03209973|467709687|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
129929590|NCT03209973|467709687|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
129929591|NCT04766892|467709688|FG000|Overall Study|Withdrawal by Subject|1|||
129929592|NCT04766892|467709688|FG000|Overall Study|Lost to Follow-up|1|||
129929593|NCT04766892|467709688|FG000|Overall Study|Adverse Event|3|||
129929594|NCT04766892|467709688|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
129929595|NCT05906784|467709689|FG000|Overall Study|Lost to Follow-up|2|||
129929596|NCT05906784|467709690|FG001|Overall Study|Lost to Follow-up|1|||
129929597|NCT05906784|467709691|FG002|Overall Study|Lost to Follow-up|1|||
129929598|NCT05906784|467709692|FG003|Overall Study|Lost to Follow-up|1|||
129929599|NCT02668692|467709693|FG000|Overall Study|Adverse Event|1|||
129929600|NCT02668692|467709694|FG001|Overall Study|Adverse Event|0|||
129929601|NCT01627574|467709698|FG000|Overall Study|Withdrawal by Subject|8|||
129929602|NCT01627574|467709699|FG001|Overall Study|Withdrawal by Subject|5|||
129929603|NCT01627574|467709698|FG000|Overall Study|Lost to Follow-up|13|||
129929604|NCT01627574|467709699|FG001|Overall Study|Lost to Follow-up|13|||
129929605|NCT03308877|467709701|FG000|Overall Study|Lost to Follow-up|32|||
129929606|NCT03308877|467709702|FG001|Overall Study|Lost to Follow-up|28|||
129929607|NCT04677738|467709712|FG000|Overall Study|Withdrawal by Subject|4|||
129929608|NCT04677738|467709713|FG001|Overall Study|Withdrawal by Subject|2|||
129929609|NCT03519178|467709718|FG000|PF-06873600 Treatment|Adverse Event|0|||
129929610|NCT03519178|467709719|FG001|PF-06873600 Treatment|Adverse Event|0|||
129929611|NCT03519178|467709720|FG002|PF-06873600 Treatment|Adverse Event|0|||
129929612|NCT03519178|467709721|FG003|PF-06873600 Treatment|Adverse Event|0|||
129929613|NCT03519178|467709722|FG004|PF-06873600 Treatment|Adverse Event|0|||
129929614|NCT03519178|467709723|FG005|PF-06873600 Treatment|Adverse Event|0|||
129929615|NCT03519178|467709724|FG006|PF-06873600 Treatment|Adverse Event|0|||
129929616|NCT03519178|467709725|FG007|PF-06873600 Treatment|Adverse Event|2|||
129929617|NCT03519178|467709726|FG008|PF-06873600 Treatment|Adverse Event|1|||
129929618|NCT03519178|467709727|FG009|PF-06873600 Treatment|Adverse Event|0|||
129929619|NCT03519178|467709728|FG010|PF-06873600 Treatment|Adverse Event|0|||
129929620|NCT03519178|467709729|FG011|PF-06873600 Treatment|Adverse Event|0|||
129929621|NCT03519178|467709730|FG012|PF-06873600 Treatment|Adverse Event|1|||
129929622|NCT03519178|467709731|FG013|PF-06873600 Treatment|Adverse Event|3|||
129929623|NCT03519178|467709732|FG014|PF-06873600 Treatment|Adverse Event|2|||
129929624|NCT03519178|467709718|FG000|PF-06873600 Treatment|Death|0|||
129929625|NCT03519178|467709719|FG001|PF-06873600 Treatment|Death|0|||
129929626|NCT03519178|467709720|FG002|PF-06873600 Treatment|Death|0|||
129929627|NCT03519178|467709721|FG003|PF-06873600 Treatment|Death|0|||
129450801|NCT03086057|465948837|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
129929628|NCT03519178|467709722|FG004|PF-06873600 Treatment|Death|0|||
129929629|NCT03519178|467709723|FG005|PF-06873600 Treatment|Death|0|||
129929630|NCT03519178|467709724|FG006|PF-06873600 Treatment|Death|0|||
129929631|NCT03519178|467709725|FG007|PF-06873600 Treatment|Death|0|||
129929632|NCT03519178|467709726|FG008|PF-06873600 Treatment|Death|1|||
129929633|NCT03519178|467709727|FG009|PF-06873600 Treatment|Death|1|||
129929634|NCT03519178|467709728|FG010|PF-06873600 Treatment|Death|0|||
129929635|NCT03519178|467709729|FG011|PF-06873600 Treatment|Death|0|||
129450802|NCT03086057|465948838|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
129450803|NCT03086057|465948839|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
129929636|NCT03519178|467709730|FG012|PF-06873600 Treatment|Death|0|||
129929637|NCT03519178|467709731|FG013|PF-06873600 Treatment|Death|0|||
129450804|NCT03086057|465948840|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
129929638|NCT03519178|467709732|FG014|PF-06873600 Treatment|Death|1|||
129929639|NCT03519178|467709718|FG000|PF-06873600 Treatment|Physician Decision|0|||
129929640|NCT03519178|467709719|FG001|PF-06873600 Treatment|Physician Decision|0|||
129929641|NCT03519178|467709720|FG002|PF-06873600 Treatment|Physician Decision|0|||
129929642|NCT03519178|467709721|FG003|PF-06873600 Treatment|Physician Decision|0|||
129929643|NCT03519178|467709722|FG004|PF-06873600 Treatment|Physician Decision|0|||
129929644|NCT03519178|467709723|FG005|PF-06873600 Treatment|Physician Decision|0|||
129929645|NCT03519178|467709724|FG006|PF-06873600 Treatment|Physician Decision|0|||
129929646|NCT03519178|467709725|FG007|PF-06873600 Treatment|Physician Decision|1|||
129929647|NCT03519178|467709726|FG008|PF-06873600 Treatment|Physician Decision|0|||
129929648|NCT03519178|467709727|FG009|PF-06873600 Treatment|Physician Decision|0|||
129450805|NCT03086057|465948837|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
129450806|NCT03086057|465948838|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
129450807|NCT03086057|465948839|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
129450808|NCT03086057|465948840|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
129450809|NCT04305275|465948843|FG000|Overall Study|Adverse Event|4|||
129450810|NCT04305275|465948844|FG001|Overall Study|Adverse Event|0|||
129450811|NCT04305275|465948843|FG000|Overall Study|Lost to Follow-up|1|||
129450812|NCT04305275|465948844|FG001|Overall Study|Lost to Follow-up|1|||
129450813|NCT04305275|465948843|FG000|Overall Study|Withdrawal by Participant|8|||
129450814|NCT04305275|465948844|FG001|Overall Study|Withdrawal by Participant|1|||
129450815|NCT01708291|465948855|FG000|Overall Study|fighting|2|||
129450816|NCT01708291|465948856|FG001|Overall Study|fighting|1|||
129450817|NCT01536951|465948857|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450818|NCT01536951|465948858|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450819|NCT01536951|465948859|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
129450820|NCT01536951|465948860|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450821|NCT01536951|465948861|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450822|NCT01536951|465948862|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450823|NCT01536951|465948863|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450824|NCT01536951|465948864|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450825|NCT01536951|465948865|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
129450826|NCT01536951|465948857|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
129450827|NCT01536951|465948858|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
129450828|NCT01536951|465948859|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
129450829|NCT01536951|465948860|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
129450830|NCT01536951|465948861|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
129450831|NCT01536951|465948862|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
129450832|NCT01536951|465948863|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
129450833|NCT01536951|465948864|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
129450834|NCT01536951|465948865|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
129450835|NCT01843972|465948866|FG000|Overall Study|Withdrawal by Subject|0|||
129450836|NCT01843972|465948867|FG001|Overall Study|Withdrawal by Subject|0|||
129450837|NCT01843972|465948868|FG002|Overall Study|Withdrawal by Subject|0|||
129450838|NCT01843972|465948869|FG003|Overall Study|Withdrawal by Subject|0|||
129450839|NCT01843972|465948870|FG004|Overall Study|Withdrawal by Subject|1|||
129450840|NCT01843972|465948871|FG005|Overall Study|Withdrawal by Subject|0|||
129450841|NCT01843972|465948872|FG006|Overall Study|Withdrawal by Subject|0|||
129450842|NCT01843972|465948873|FG007|Overall Study|Withdrawal by Subject|0|||
129450843|NCT01843972|465948874|FG008|Overall Study|Withdrawal by Subject|0|||
129450844|NCT01843972|465948875|FG009|Overall Study|Withdrawal by Subject|0|||
129450845|NCT00932425|465948876|FG000|Overall Study|Lost to Follow-up|0|||
129450846|NCT00932425|465948877|FG001|Overall Study|Lost to Follow-up|1|||
129450847|NCT00932425|465948876|FG000|Overall Study|Withdrawal by Subject|0|||
129450848|NCT00932425|465948877|FG001|Overall Study|Withdrawal by Subject|1|||
129450849|NCT00382018|465948878|FG000|Overall Study|Progression|0|||
129450850|NCT00382018|465948879|FG001|Overall Study|Progression|136|||
129450851|NCT00382018|465948880|FG002|Overall Study|Progression|51|||
129450852|NCT00382018|465948881|FG003|Overall Study|Progression|43|||
129450853|NCT00382018|465948878|FG000|Overall Study|Death|0|||
129450854|NCT00382018|465948879|FG001|Overall Study|Death|9|||
129450855|NCT00382018|465948880|FG002|Overall Study|Death|7|||
129450856|NCT00382018|465948881|FG003|Overall Study|Death|11|||
129450857|NCT00382018|465948878|FG000|Overall Study|Withdrawal by Subject|0|||
129450858|NCT00382018|465948879|FG001|Overall Study|Withdrawal by Subject|4|||
129450859|NCT00382018|465948880|FG002|Overall Study|Withdrawal by Subject|3|||
129450860|NCT00382018|465948881|FG003|Overall Study|Withdrawal by Subject|4|||
129450861|NCT00382018|465948878|FG000|Overall Study|Other, not protocol specified|0|||
129450862|NCT00382018|465948879|FG001|Overall Study|Other, not protocol specified|16|||
129450863|NCT00382018|465948880|FG002|Overall Study|Other, not protocol specified|3|||
129450864|NCT00382018|465948881|FG003|Overall Study|Other, not protocol specified|1|||
129929649|NCT03519178|467709728|FG010|PF-06873600 Treatment|Physician Decision|1|||
129929650|NCT03519178|467709729|FG011|PF-06873600 Treatment|Physician Decision|0|||
129929651|NCT03519178|467709730|FG012|PF-06873600 Treatment|Physician Decision|0|||
129450865|NCT03805750|465948882|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
129450866|NCT03805750|465948883|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
129450867|NCT00789880|465948884|FG000|Overall Study|Adverse Event|0|||
129450868|NCT00789880|465948885|FG001|Overall Study|Adverse Event|0|||
129450869|NCT00789880|465948886|FG002|Overall Study|Adverse Event|0|||
129450870|NCT00789880|465948887|FG003|Overall Study|Adverse Event|0|||
129929652|NCT03519178|467709731|FG013|PF-06873600 Treatment|Physician Decision|4|||
129450871|NCT00789880|465948888|FG004|Overall Study|Adverse Event|1|||
129450872|NCT00789880|465948889|FG005|Overall Study|Adverse Event|0|||
129450873|NCT00789880|465948884|FG000|Overall Study|Protocol Violation|0|||
129450874|NCT00789880|465948885|FG001|Overall Study|Protocol Violation|1|||
129929653|NCT03519178|467709732|FG014|PF-06873600 Treatment|Physician Decision|1|||
129929654|NCT03519178|467709718|FG000|PF-06873600 Treatment|Progressive disease|1|||
129929655|NCT03519178|467709719|FG001|PF-06873600 Treatment|Progressive disease|1|||
129929656|NCT03519178|467709720|FG002|PF-06873600 Treatment|Progressive disease|1|||
129929657|NCT03519178|467709721|FG003|PF-06873600 Treatment|Progressive disease|1|||
129929658|NCT03519178|467709722|FG004|PF-06873600 Treatment|Progressive disease|6|||
129929659|NCT03519178|467709723|FG005|PF-06873600 Treatment|Progressive disease|7|||
129929660|NCT03519178|467709724|FG006|PF-06873600 Treatment|Progressive disease|3|||
129929661|NCT03519178|467709725|FG007|PF-06873600 Treatment|Progressive disease|7|||
129929662|NCT03519178|467709726|FG008|PF-06873600 Treatment|Progressive disease|3|||
129929663|NCT03519178|467709727|FG009|PF-06873600 Treatment|Progressive disease|5|||
129929664|NCT03519178|467709728|FG010|PF-06873600 Treatment|Progressive disease|4|||
129929665|NCT03519178|467709729|FG011|PF-06873600 Treatment|Progressive disease|3|||
129929666|NCT03519178|467709730|FG012|PF-06873600 Treatment|Progressive disease|4|||
129929667|NCT03519178|467709731|FG013|PF-06873600 Treatment|Progressive disease|28|||
129929668|NCT03519178|467709732|FG014|PF-06873600 Treatment|Progressive disease|7|||
129929669|NCT03519178|467709718|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929670|NCT03519178|467709719|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929671|NCT03519178|467709720|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929672|NCT03519178|467709721|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929673|NCT03519178|467709722|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929674|NCT03519178|467709723|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929675|NCT03519178|467709724|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929676|NCT03519178|467709725|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929677|NCT03519178|467709726|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
129929678|NCT03519178|467709727|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929679|NCT03519178|467709728|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
129929680|NCT03519178|467709729|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929681|NCT03519178|467709730|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929682|NCT03519178|467709731|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
129929683|NCT03519178|467709732|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
129929684|NCT03519178|467709718|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
129929685|NCT03519178|467709719|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
129929686|NCT03519178|467709720|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
129929687|NCT03519178|467709721|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
129929688|NCT03519178|467709722|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
129929689|NCT03519178|467709723|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
129929690|NCT03519178|467709724|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
129929691|NCT03519178|467709725|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
129929692|NCT03519178|467709726|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
129929693|NCT03519178|467709727|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
129929694|NCT03519178|467709728|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
129929695|NCT03519178|467709729|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
129929696|NCT03519178|467709730|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
129929697|NCT03519178|467709731|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
129929698|NCT03519178|467709732|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
129929699|NCT03519178|467709718|FG000|PF-06873600 Treatment|Refused further treatment|0|||
129929700|NCT03519178|467709719|FG001|PF-06873600 Treatment|Refused further treatment|1|||
129929701|NCT03519178|467709720|FG002|PF-06873600 Treatment|Refused further treatment|0|||
129929702|NCT03519178|467709721|FG003|PF-06873600 Treatment|Refused further treatment|0|||
129929703|NCT03519178|467709722|FG004|PF-06873600 Treatment|Refused further treatment|1|||
129929704|NCT03519178|467709723|FG005|PF-06873600 Treatment|Refused further treatment|0|||
129929705|NCT03519178|467709724|FG006|PF-06873600 Treatment|Refused further treatment|0|||
129929706|NCT03519178|467709725|FG007|PF-06873600 Treatment|Refused further treatment|0|||
129929707|NCT03519178|467709726|FG008|PF-06873600 Treatment|Refused further treatment|0|||
129929708|NCT03519178|467709727|FG009|PF-06873600 Treatment|Refused further treatment|0|||
129929709|NCT03519178|467709728|FG010|PF-06873600 Treatment|Refused further treatment|0|||
129929710|NCT03519178|467709729|FG011|PF-06873600 Treatment|Refused further treatment|0|||
129929711|NCT03519178|467709730|FG012|PF-06873600 Treatment|Refused further treatment|0|||
129929712|NCT03519178|467709731|FG013|PF-06873600 Treatment|Refused further treatment|0|||
129929713|NCT03519178|467709732|FG014|PF-06873600 Treatment|Refused further treatment|1|||
129929714|NCT03519178|467709718|FG000|PF-06873600 Treatment|Other|0|||
129450875|NCT00789880|465948886|FG002|Overall Study|Protocol Violation|0|||
129450876|NCT00789880|465948887|FG003|Overall Study|Protocol Violation|1|||
129929715|NCT03519178|467709719|FG001|PF-06873600 Treatment|Other|0|||
129929716|NCT03519178|467709720|FG002|PF-06873600 Treatment|Other|0|||
129929717|NCT03519178|467709721|FG003|PF-06873600 Treatment|Other|0|||
129929718|NCT03519178|467709722|FG004|PF-06873600 Treatment|Other|0|||
129929719|NCT03519178|467709723|FG005|PF-06873600 Treatment|Other|0|||
129450877|NCT00789880|465948888|FG004|Overall Study|Protocol Violation|0|||
129929720|NCT03519178|467709724|FG006|PF-06873600 Treatment|Other|0|||
129929721|NCT03519178|467709725|FG007|PF-06873600 Treatment|Other|0|||
129929722|NCT03519178|467709726|FG008|PF-06873600 Treatment|Other|1|||
129929723|NCT03519178|467709727|FG009|PF-06873600 Treatment|Other|0|||
129929724|NCT03519178|467709728|FG010|PF-06873600 Treatment|Other|0|||
129929725|NCT03519178|467709729|FG011|PF-06873600 Treatment|Other|0|||
129929726|NCT03519178|467709730|FG012|PF-06873600 Treatment|Other|0|||
129929727|NCT03519178|467709731|FG013|PF-06873600 Treatment|Other|1|||
129929728|NCT03519178|467709732|FG014|PF-06873600 Treatment|Other|3|||
129929729|NCT03519178|467709718|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
129929730|NCT03519178|467709719|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
129929731|NCT03519178|467709720|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
129929732|NCT03519178|467709721|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
129929733|NCT03519178|467709722|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
129929734|NCT03519178|467709723|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
129929735|NCT03519178|467709724|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
129929736|NCT03519178|467709725|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
129929737|NCT03519178|467709726|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
129929738|NCT03519178|467709727|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
129929739|NCT03519178|467709728|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
129929740|NCT03519178|467709729|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
129929741|NCT03519178|467709730|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
129929742|NCT03519178|467709731|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
129929743|NCT03519178|467709732|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
129929744|NCT03519178|467709718|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929745|NCT03519178|467709719|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929746|NCT03519178|467709720|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929747|NCT03519178|467709721|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929748|NCT03519178|467709722|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929749|NCT03519178|467709723|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929750|NCT03519178|467709724|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929751|NCT03519178|467709725|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929752|NCT03519178|467709726|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929753|NCT03519178|467709727|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929754|NCT03519178|467709728|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929755|NCT03519178|467709729|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929756|NCT03519178|467709730|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
129929757|NCT03519178|467709731|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
129929758|NCT03519178|467709732|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
129929759|NCT03519178|467709718|FG000|PF-06873600 Treatment|Ongoing|0|||
129929760|NCT03519178|467709719|FG001|PF-06873600 Treatment|Ongoing|0|||
129929761|NCT03519178|467709720|FG002|PF-06873600 Treatment|Ongoing|0|||
129929762|NCT03519178|467709721|FG003|PF-06873600 Treatment|Ongoing|0|||
129929763|NCT03519178|467709722|FG004|PF-06873600 Treatment|Ongoing|0|||
129929764|NCT03519178|467709723|FG005|PF-06873600 Treatment|Ongoing|0|||
129929765|NCT03519178|467709724|FG006|PF-06873600 Treatment|Ongoing|0|||
129929766|NCT03519178|467709725|FG007|PF-06873600 Treatment|Ongoing|0|||
129929767|NCT03519178|467709726|FG008|PF-06873600 Treatment|Ongoing|0|||
129929768|NCT03519178|467709727|FG009|PF-06873600 Treatment|Ongoing|0|||
129929769|NCT03519178|467709728|FG010|PF-06873600 Treatment|Ongoing|0|||
129929770|NCT03519178|467709729|FG011|PF-06873600 Treatment|Ongoing|0|||
129929771|NCT03519178|467709730|FG012|PF-06873600 Treatment|Ongoing|0|||
129929772|NCT03519178|467709731|FG013|PF-06873600 Treatment|Ongoing|1|||
129929773|NCT03519178|467709732|FG014|PF-06873600 Treatment|Ongoing|6|||
129929774|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929775|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929776|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929777|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929778|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929779|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929780|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929781|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929782|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929783|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929784|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929785|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929786|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929787|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
129929788|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
129929789|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Death|0|||
129929790|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Death|0|||
129929791|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Death|0|||
129929792|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Death|0|||
129450878|NCT00789880|465948889|FG005|Overall Study|Protocol Violation|0|||
129450879|NCT00789880|465948884|FG000|Overall Study|Withdrawal by Subject|1|||
129450880|NCT00789880|465948885|FG001|Overall Study|Withdrawal by Subject|0|||
129450881|NCT00789880|465948886|FG002|Overall Study|Withdrawal by Subject|0|||
129450882|NCT00789880|465948887|FG003|Overall Study|Withdrawal by Subject|0|||
129450883|NCT00789880|465948888|FG004|Overall Study|Withdrawal by Subject|2|||
129450884|NCT00789880|465948889|FG005|Overall Study|Withdrawal by Subject|0|||
129450885|NCT01977820|465948893|FG000|Overall Study|Sponsor terminated the study|1|||
129450886|NCT01977820|465948894|FG001|Overall Study|Sponsor terminated the study|1|||
129450887|NCT00493220|465948895|FG000|Third Intervention|Withdrawal by Subject|1|||
129450888|NCT00493220|465948896|FG001|Third Intervention|Withdrawal by Subject|0|||
129450889|NCT00493220|465948897|FG002|Third Intervention|Withdrawal by Subject|0|||
129450890|NCT00493220|465948898|FG003|Third Intervention|Withdrawal by Subject|0|||
129450891|NCT00493220|465948899|FG004|Third Intervention|Withdrawal by Subject|0|||
129450892|NCT00493220|465948900|FG005|Third Intervention|Withdrawal by Subject|0|||
129450893|NCT02568475|465948901|FG000|Overall Study|Lost to Follow-up|40|||
129450894|NCT02568475|465948902|FG001|Overall Study|Lost to Follow-up|39|||
129450895|NCT02568475|465948901|FG000|Overall Study|Withdrawal by Subject|2|||
129450896|NCT02568475|465948902|FG001|Overall Study|Withdrawal by Subject|0|||
129450897|NCT02568475|465948901|FG000|Overall Study|Discharged home|4|||
129450898|NCT02568475|465948902|FG001|Overall Study|Discharged home|4|||
129450899|NCT02568475|465948901|FG000|Overall Study|Short-term: Discharge location unknown|4|||
129450900|NCT02568475|465948902|FG001|Overall Study|Short-term: Discharge location unknown|0|||
129450901|NCT02568475|465948901|FG000|Overall Study|Transferred to another facility|1|||
129450902|NCT02568475|465948902|FG001|Overall Study|Transferred to another facility|0|||
129929793|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Death|0|||
129929794|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Death|0|||
129929795|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Death|0|||
129929796|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Death|0|||
129929797|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Death|0|||
129929798|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Death|1|||
129929799|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Death|0|||
129929800|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Death|0|||
129929801|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Death|0|||
129929802|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Death|0|||
129929803|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Death|1|||
129929804|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929805|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929806|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929807|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929808|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929809|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929810|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929811|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929812|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929813|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929814|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929815|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929816|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929817|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
129929818|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
129929819|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929820|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929821|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929822|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929823|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929824|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929825|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929826|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929827|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129450903|NCT02625233|465948903|FG000|Overall Study|Adverse Event|2|||
129450904|NCT02625233|465948904|FG001|Overall Study|Adverse Event|0|||
129450905|NCT01704287|465950332|FG000|Initial Treatment Period|Death|139|||
129450906|NCT01704287|465950333|FG001|Initial Treatment Period|Death|129|||
129450907|NCT01704287|465950334|FG002|Initial Treatment Period|Death|71|||
129450908|NCT01704287|465950335|FG003|Initial Treatment Period|Death|0|||
129450909|NCT01704287|465950336|FG004|Initial Treatment Period|Death|0|||
129450910|NCT01704287|465950332|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
129450911|NCT01704287|465950333|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
129450912|NCT01704287|465950334|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
129929828|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929829|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929830|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929831|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
129929832|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
129929833|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
129929834|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929835|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929836|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929837|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929838|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929839|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929840|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929841|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929842|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929843|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
129929844|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929845|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929846|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
129929847|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
129929848|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
129929849|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929850|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929851|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929852|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929853|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929854|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929855|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929856|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929857|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929858|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929859|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929860|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929861|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
129929862|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
129929863|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
129929864|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929865|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929866|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929867|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929868|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929869|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929870|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929871|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929872|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929873|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
129929874|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929875|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929876|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
129929877|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
129929878|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
129929879|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929880|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929881|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929882|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929883|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929884|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929885|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929886|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929887|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929888|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
129929889|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129979761|NCT01283516|467889462|FG006|Overall Study|Lost to Follow-up|0|||
129450913|NCT01704287|465950335|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
129450914|NCT01704287|465950336|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
129450915|NCT01704287|465950332|FG000|Initial Treatment Period|Lost to Follow-up|5|||
129450916|NCT01704287|465950333|FG001|Initial Treatment Period|Lost to Follow-up|3|||
129450917|NCT01704287|465950334|FG002|Initial Treatment Period|Lost to Follow-up|0|||
129450918|NCT01704287|465950335|FG003|Initial Treatment Period|Lost to Follow-up|0|||
129450919|NCT01704287|465950336|FG004|Initial Treatment Period|Lost to Follow-up|0|||
129450920|NCT01704287|465950332|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
129450921|NCT01704287|465950333|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
129450922|NCT01704287|465950334|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
129450923|NCT01704287|465950335|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
129450924|NCT01704287|465950336|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
129450925|NCT01704287|465950332|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
129450926|NCT01704287|465950333|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
129450927|NCT01704287|465950334|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
129450928|NCT01704287|465950335|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
129450929|NCT01704287|465950336|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
129450930|NCT01704287|465950332|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
129450931|NCT01704287|465950333|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
129450932|NCT01704287|465950334|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
129450933|NCT01704287|465950335|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
129450934|NCT01704287|465950336|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
129450935|NCT01704287|465950332|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
129450936|NCT01704287|465950333|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
129450937|NCT01704287|465950334|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
129450938|NCT01704287|465950335|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
129450939|NCT01704287|465950336|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
129450940|NCT04024228|465950337|FG000|Overall Study|Adverse Event|1|||
129450941|NCT04024228|465950338|FG001|Overall Study|Adverse Event|0|||
129450942|NCT04024228|465950337|FG000|Overall Study|Protocol Deviation|0|||
129450943|NCT04024228|465950338|FG001|Overall Study|Protocol Deviation|2|||
129450944|NCT04024228|465950337|FG000|Overall Study|Withdrawal by Subject|3|||
129450945|NCT04024228|465950338|FG001|Overall Study|Withdrawal by Subject|4|||
129450946|NCT04490395|465950339|FG000|Overall Study|Lost to Follow-up|0|||
129450947|NCT04490395|465950340|FG001|Overall Study|Lost to Follow-up|1|||
129450948|NCT00938717|465950341|FG000|Overall Study|Adverse Event|10|||
129450949|NCT00938717|465950342|FG001|Overall Study|Adverse Event|41|||
129450950|NCT00938717|465950341|FG000|Overall Study|Protocol Violation|11|||
129450951|NCT00938717|465950342|FG001|Overall Study|Protocol Violation|8|||
129450952|NCT00938717|465950341|FG000|Overall Study|Withdrawal by Subject|26|||
129450953|NCT00938717|465950342|FG001|Overall Study|Withdrawal by Subject|24|||
129450954|NCT00938717|465950341|FG000|Overall Study|Lost to Follow-up|13|||
129450955|NCT00938717|465950342|FG001|Overall Study|Lost to Follow-up|18|||
129450956|NCT00938717|465950341|FG000|Overall Study|Lack of Efficacy|33|||
129450957|NCT00938717|465950342|FG001|Overall Study|Lack of Efficacy|15|||
129450958|NCT00938717|465950341|FG000|Overall Study|Other reason|5|||
129450959|NCT00938717|465950342|FG001|Overall Study|Other reason|2|||
129450960|NCT01462435|465950345|FG000|Overall Study|Lack of Efficacy|1|||
129450961|NCT01462435|465950346|FG001|Overall Study|Lack of Efficacy|0|||
129450962|NCT01462435|465950347|FG002|Overall Study|Lack of Efficacy|0|||
129450963|NCT01462435|465950348|FG003|Overall Study|Lack of Efficacy|3|||
129450964|NCT01462435|465950345|FG000|Overall Study|Physician Decision|0|||
129450965|NCT01462435|465950346|FG001|Overall Study|Physician Decision|0|||
129450966|NCT01462435|465950347|FG002|Overall Study|Physician Decision|1|||
129450967|NCT01462435|465950348|FG003|Overall Study|Physician Decision|0|||
129450968|NCT01462435|465950345|FG000|Overall Study|Withdrawal by Subject|0|||
129450969|NCT01462435|465950346|FG001|Overall Study|Withdrawal by Subject|0|||
129450970|NCT01462435|465950347|FG002|Overall Study|Withdrawal by Subject|0|||
129450971|NCT01462435|465950348|FG003|Overall Study|Withdrawal by Subject|1|||
129929890|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929891|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929892|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
129929893|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
129929894|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129450972|NCT01462435|465950345|FG000|Overall Study|Lost to Follow-up|0|||
129450973|NCT01462435|465950346|FG001|Overall Study|Lost to Follow-up|0|||
129450974|NCT01462435|465950347|FG002|Overall Study|Lost to Follow-up|0|||
129450975|NCT01462435|465950348|FG003|Overall Study|Lost to Follow-up|1|||
129450976|NCT05092919|465950349|FG000|Overall Study|Lost to Follow-up|7|||
129450977|NCT05092919|465950349|FG000|Overall Study|Withdrawal by Subject|2|||
129450978|NCT01942148|465950351|FG000|Overall Study|Adverse Event|4|||
129450979|NCT01942148|465950351|FG000|Overall Study|Lack of Efficacy|2|||
129929895|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929896|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929897|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929898|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929899|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929900|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929901|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929902|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929903|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929904|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929905|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929906|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929907|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
129929908|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
129929909|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Other|0|||
129929910|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Other|0|||
129929911|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Other|0|||
129929912|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Other|0|||
129929913|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Other|0|||
129929914|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Other|0|||
129929915|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Other|0|||
129929916|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Other|0|||
129929917|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Other|0|||
129929918|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Other|0|||
129929919|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Other|0|||
129929920|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Other|0|||
129929921|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Other|0|||
129929922|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Other|1|||
129929923|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Other|3|||
129929924|NCT03519178|467709718|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929925|NCT03519178|467709719|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929926|NCT03519178|467709720|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929927|NCT03519178|467709721|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929928|NCT03519178|467709722|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929929|NCT03519178|467709723|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929930|NCT03519178|467709724|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929931|NCT03519178|467709725|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929932|NCT03519178|467709726|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929933|NCT03519178|467709727|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929934|NCT03519178|467709728|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929935|NCT03519178|467709729|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929936|NCT03519178|467709730|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
129929937|NCT03519178|467709731|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
129929938|NCT03519178|467709732|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
129929939|NCT03519178|467709718|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
129929940|NCT03519178|467709719|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
129929941|NCT03519178|467709720|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
129929942|NCT03519178|467709721|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
129929943|NCT03519178|467709722|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
129929944|NCT03519178|467709723|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
129929945|NCT03519178|467709724|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
129929946|NCT03519178|467709725|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
129929947|NCT03519178|467709726|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
129929948|NCT03519178|467709727|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
129929949|NCT03519178|467709728|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
129929950|NCT03519178|467709729|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
129929951|NCT03519178|467709730|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
129929952|NCT03519178|467709731|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
129929953|NCT03519178|467709732|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
129929954|NCT03519178|467709718|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
129929955|NCT03519178|467709719|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
129929956|NCT03519178|467709720|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
129929957|NCT03519178|467709721|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
129929958|NCT03519178|467709722|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
129929959|NCT03519178|467709723|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
129450980|NCT01942148|465950351|FG000|Overall Study|Physician Decision|11|||
129450981|NCT01942148|465950351|FG000|Overall Study|Protocol Violation|1|||
129929960|NCT03519178|467709724|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
129929961|NCT03519178|467709725|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
129929962|NCT03519178|467709726|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
129929963|NCT03519178|467709727|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
129929964|NCT03519178|467709728|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
129929965|NCT03519178|467709729|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
129929966|NCT03519178|467709730|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
129929967|NCT03519178|467709731|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
129929968|NCT03519178|467709732|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
129929969|NCT03519178|467709718|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929970|NCT03519178|467709719|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929971|NCT03519178|467709720|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929972|NCT03519178|467709721|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929973|NCT03519178|467709722|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929974|NCT03519178|467709723|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929975|NCT03519178|467709724|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929976|NCT03519178|467709725|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929977|NCT03519178|467709726|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929978|NCT03519178|467709727|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929979|NCT03519178|467709728|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
129929980|NCT03519178|467709729|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929981|NCT03519178|467709730|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929982|NCT03519178|467709731|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929983|NCT03519178|467709732|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
129929984|NCT03519178|467709718|FG000|Follow-Up|Death|0|||
129929985|NCT03519178|467709719|FG001|Follow-Up|Death|0|||
129929986|NCT03519178|467709720|FG002|Follow-Up|Death|1|||
129929987|NCT03519178|467709721|FG003|Follow-Up|Death|0|||
129929988|NCT03519178|467709722|FG004|Follow-Up|Death|0|||
129929989|NCT03519178|467709723|FG005|Follow-Up|Death|0|||
129929990|NCT03519178|467709724|FG006|Follow-Up|Death|0|||
129929991|NCT03519178|467709725|FG007|Follow-Up|Death|0|||
129929992|NCT03519178|467709726|FG008|Follow-Up|Death|3|||
129929993|NCT03519178|467709727|FG009|Follow-Up|Death|1|||
129929994|NCT03519178|467709728|FG010|Follow-Up|Death|0|||
129929995|NCT03519178|467709729|FG011|Follow-Up|Death|0|||
129929996|NCT03519178|467709730|FG012|Follow-Up|Death|2|||
129929997|NCT03519178|467709731|FG013|Follow-Up|Death|0|||
129929998|NCT03519178|467709732|FG014|Follow-Up|Death|0|||
129929999|NCT03519178|467709718|FG000|Follow-Up|Lost to Follow-up|0|||
129930000|NCT03519178|467709719|FG001|Follow-Up|Lost to Follow-up|0|||
129930001|NCT03519178|467709720|FG002|Follow-Up|Lost to Follow-up|0|||
129930002|NCT03519178|467709721|FG003|Follow-Up|Lost to Follow-up|0|||
129930003|NCT03519178|467709722|FG004|Follow-Up|Lost to Follow-up|0|||
129930004|NCT03519178|467709723|FG005|Follow-Up|Lost to Follow-up|3|||
129930005|NCT03519178|467709724|FG006|Follow-Up|Lost to Follow-up|1|||
129930006|NCT03519178|467709725|FG007|Follow-Up|Lost to Follow-up|4|||
129930007|NCT03519178|467709726|FG008|Follow-Up|Lost to Follow-up|1|||
129930008|NCT03519178|467709727|FG009|Follow-Up|Lost to Follow-up|0|||
129930009|NCT03519178|467709728|FG010|Follow-Up|Lost to Follow-up|0|||
129930010|NCT03519178|467709729|FG011|Follow-Up|Lost to Follow-up|0|||
129930011|NCT03519178|467709730|FG012|Follow-Up|Lost to Follow-up|0|||
129930012|NCT03519178|467709731|FG013|Follow-Up|Lost to Follow-up|0|||
129930013|NCT03519178|467709732|FG014|Follow-Up|Lost to Follow-up|0|||
129930014|NCT03519178|467709718|FG000|Follow-Up|Withdrawal by Subject|1|||
129930015|NCT03519178|467709719|FG001|Follow-Up|Withdrawal by Subject|2|||
129930016|NCT03519178|467709720|FG002|Follow-Up|Withdrawal by Subject|2|||
129930017|NCT03519178|467709721|FG003|Follow-Up|Withdrawal by Subject|3|||
129930018|NCT03519178|467709722|FG004|Follow-Up|Withdrawal by Subject|5|||
129930019|NCT03519178|467709723|FG005|Follow-Up|Withdrawal by Subject|1|||
129930020|NCT03519178|467709724|FG006|Follow-Up|Withdrawal by Subject|2|||
129930021|NCT03519178|467709725|FG007|Follow-Up|Withdrawal by Subject|6|||
129930022|NCT03519178|467709726|FG008|Follow-Up|Withdrawal by Subject|5|||
129930023|NCT03519178|467709727|FG009|Follow-Up|Withdrawal by Subject|2|||
129930024|NCT03519178|467709728|FG010|Follow-Up|Withdrawal by Subject|3|||
129930025|NCT03519178|467709729|FG011|Follow-Up|Withdrawal by Subject|5|||
129930026|NCT03519178|467709730|FG012|Follow-Up|Withdrawal by Subject|2|||
129930027|NCT03519178|467709731|FG013|Follow-Up|Withdrawal by Subject|0|||
129930028|NCT03519178|467709732|FG014|Follow-Up|Withdrawal by Subject|0|||
129930029|NCT03519178|467709718|FG000|Follow-Up|Other|0|||
129930030|NCT03519178|467709719|FG001|Follow-Up|Other|0|||
129930031|NCT03519178|467709720|FG002|Follow-Up|Other|0|||
129930032|NCT03519178|467709721|FG003|Follow-Up|Other|0|||
129930033|NCT03519178|467709722|FG004|Follow-Up|Other|0|||
129930034|NCT03519178|467709723|FG005|Follow-Up|Other|0|||
129930035|NCT03519178|467709724|FG006|Follow-Up|Other|0|||
129930036|NCT03519178|467709725|FG007|Follow-Up|Other|1|||
129930037|NCT03519178|467709726|FG008|Follow-Up|Other|0|||
129930038|NCT03519178|467709727|FG009|Follow-Up|Other|0|||
129930039|NCT03519178|467709728|FG010|Follow-Up|Other|0|||
129930040|NCT03519178|467709729|FG011|Follow-Up|Other|0|||
129930041|NCT03519178|467709730|FG012|Follow-Up|Other|0|||
129930042|NCT03519178|467709731|FG013|Follow-Up|Other|0|||
129930043|NCT03519178|467709732|FG014|Follow-Up|Other|0|||
129930044|NCT03519178|467709718|FG000|Long-term Follow-up|Death|0|||
129930045|NCT03519178|467709719|FG001|Long-term Follow-up|Death|0|||
129930046|NCT03519178|467709720|FG002|Long-term Follow-up|Death|0|||
129930047|NCT03519178|467709721|FG003|Long-term Follow-up|Death|0|||
129930048|NCT03519178|467709722|FG004|Long-term Follow-up|Death|0|||
129930049|NCT03519178|467709723|FG005|Long-term Follow-up|Death|0|||
129930050|NCT03519178|467709724|FG006|Long-term Follow-up|Death|0|||
129930051|NCT03519178|467709725|FG007|Long-term Follow-up|Death|0|||
129930052|NCT03519178|467709726|FG008|Long-term Follow-up|Death|0|||
129930053|NCT03519178|467709727|FG009|Long-term Follow-up|Death|0|||
129930054|NCT03519178|467709728|FG010|Long-term Follow-up|Death|0|||
129930055|NCT03519178|467709729|FG011|Long-term Follow-up|Death|0|||
129930056|NCT03519178|467709730|FG012|Long-term Follow-up|Death|0|||
129930057|NCT03519178|467709731|FG013|Long-term Follow-up|Death|4|||
129930058|NCT03519178|467709732|FG014|Long-term Follow-up|Death|4|||
129930059|NCT03519178|467709718|FG000|Long-term Follow-up|Lost to Follow-up|0|||
129930060|NCT03519178|467709719|FG001|Long-term Follow-up|Lost to Follow-up|0|||
129930061|NCT03519178|467709720|FG002|Long-term Follow-up|Lost to Follow-up|0|||
129930062|NCT03519178|467709721|FG003|Long-term Follow-up|Lost to Follow-up|0|||
129930063|NCT03519178|467709722|FG004|Long-term Follow-up|Lost to Follow-up|0|||
129930064|NCT03519178|467709723|FG005|Long-term Follow-up|Lost to Follow-up|0|||
129930065|NCT03519178|467709724|FG006|Long-term Follow-up|Lost to Follow-up|0|||
129930066|NCT03519178|467709725|FG007|Long-term Follow-up|Lost to Follow-up|0|||
129930067|NCT03519178|467709726|FG008|Long-term Follow-up|Lost to Follow-up|0|||
129930068|NCT03519178|467709727|FG009|Long-term Follow-up|Lost to Follow-up|0|||
129930069|NCT03519178|467709728|FG010|Long-term Follow-up|Lost to Follow-up|0|||
129930070|NCT03519178|467709729|FG011|Long-term Follow-up|Lost to Follow-up|0|||
129930071|NCT03519178|467709730|FG012|Long-term Follow-up|Lost to Follow-up|0|||
129930072|NCT03519178|467709731|FG013|Long-term Follow-up|Lost to Follow-up|1|||
129930073|NCT03519178|467709732|FG014|Long-term Follow-up|Lost to Follow-up|1|||
129930074|NCT03519178|467709718|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
129930075|NCT03519178|467709719|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
129930076|NCT03519178|467709720|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
129930077|NCT03519178|467709721|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
129930078|NCT03519178|467709722|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
129930079|NCT03519178|467709723|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
129930080|NCT03519178|467709724|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
129930081|NCT03519178|467709725|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
129930082|NCT03519178|467709726|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
129930083|NCT03519178|467709727|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
129930084|NCT03519178|467709728|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
129930085|NCT03519178|467709729|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
129930086|NCT03519178|467709730|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
129930087|NCT03519178|467709731|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
129930088|NCT03519178|467709732|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
129930089|NCT03519178|467709718|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
129930090|NCT03519178|467709719|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
129930091|NCT03519178|467709720|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
129930092|NCT03519178|467709721|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
129930093|NCT03519178|467709722|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
129930094|NCT03519178|467709723|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
129930095|NCT03519178|467709724|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
129930096|NCT03519178|467709725|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
129930097|NCT03519178|467709726|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
129930098|NCT03519178|467709727|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
129930099|NCT03519178|467709728|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
129930100|NCT03519178|467709729|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
129930101|NCT03519178|467709730|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
129930102|NCT03519178|467709731|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
129930103|NCT03519178|467709732|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
129930104|NCT03519178|467709718|FG000|Long-term Follow-up|Other|0|||
129450982|NCT01942148|465950351|FG000|Overall Study|Withdrawal by Subject|8|||
129450983|NCT01942148|465950351|FG000|Overall Study|Use of the prohibition medicine|1|||
129930105|NCT03519178|467709719|FG001|Long-term Follow-up|Other|0|||
129930106|NCT03519178|467709720|FG002|Long-term Follow-up|Other|0|||
129930107|NCT03519178|467709721|FG003|Long-term Follow-up|Other|0|||
129930108|NCT03519178|467709722|FG004|Long-term Follow-up|Other|0|||
129930109|NCT03519178|467709723|FG005|Long-term Follow-up|Other|0|||
129930110|NCT03519178|467709724|FG006|Long-term Follow-up|Other|0|||
129930111|NCT03519178|467709725|FG007|Long-term Follow-up|Other|0|||
129930112|NCT03519178|467709726|FG008|Long-term Follow-up|Other|0|||
129930113|NCT03519178|467709727|FG009|Long-term Follow-up|Other|0|||
129450984|NCT02163187|465950352|FG000|Overall Study|Device removed|1|||
129450985|NCT02163187|465950353|FG001|Overall Study|Device removed|0|||
129450986|NCT02163187|465950352|FG000|Overall Study|Progressive disease|1|||
129450987|NCT02163187|465950353|FG001|Overall Study|Progressive disease|0|||
129450988|NCT00257725|465950355|FG000|Overall Study|Adverse Event|3|||
129450989|NCT01858532|465950356|FG000|Overall Study|Adverse Event|58|||
129450990|NCT01858532|465950357|FG001|Overall Study|Adverse Event|50|||
129450991|NCT01858532|465950358|FG002|Overall Study|Adverse Event|23|||
129450992|NCT01858532|465950359|FG003|Overall Study|Adverse Event|28|||
129450993|NCT01858532|465950356|FG000|Overall Study|Withdrew consent|71|||
129450994|NCT01858532|465950357|FG001|Overall Study|Withdrew consent|93|||
129450995|NCT01858532|465950358|FG002|Overall Study|Withdrew consent|46|||
129450996|NCT01858532|465950359|FG003|Overall Study|Withdrew consent|27|||
129450997|NCT01858532|465950356|FG000|Overall Study|Lost to Follow-up|17|||
129450998|NCT01858532|465950357|FG001|Overall Study|Lost to Follow-up|26|||
129450999|NCT01858532|465950358|FG002|Overall Study|Lost to Follow-up|11|||
129451000|NCT01858532|465950359|FG003|Overall Study|Lost to Follow-up|14|||
129451001|NCT01858532|465950356|FG000|Overall Study|Deterioration of medical status|3|||
129451002|NCT01858532|465950357|FG001|Overall Study|Deterioration of medical status|4|||
129451003|NCT01858532|465950358|FG002|Overall Study|Deterioration of medical status|3|||
129451004|NCT01858532|465950359|FG003|Overall Study|Deterioration of medical status|7|||
129451005|NCT01858532|465950356|FG000|Overall Study|Investigator request|3|||
129451006|NCT01858532|465950357|FG001|Overall Study|Investigator request|4|||
129451007|NCT01858532|465950358|FG002|Overall Study|Investigator request|2|||
129451008|NCT01858532|465950359|FG003|Overall Study|Investigator request|6|||
129451009|NCT01858532|465950356|FG000|Overall Study|Other, not specified|29|||
129451010|NCT01858532|465950357|FG001|Overall Study|Other, not specified|15|||
129451011|NCT01858532|465950358|FG002|Overall Study|Other, not specified|13|||
129451012|NCT01858532|465950359|FG003|Overall Study|Other, not specified|11|||
129451013|NCT00514514|465950360|FG000|Pre-phase|Death|10|||
129451014|NCT00514514|465950361|FG001|Pre-phase|Death|0|||
129451015|NCT00514514|465950362|FG002|Pre-phase|Death|0|||
129451016|NCT00514514|465950360|FG000|Pre-phase|administrative problems|2|||
129451017|NCT00514514|465950361|FG001|Pre-phase|administrative problems|0|||
129451018|NCT00514514|465950362|FG002|Pre-phase|administrative problems|0|||
129451019|NCT00514514|465950360|FG000|Pre-phase|Protocol Violation|6|||
129451020|NCT00514514|465950361|FG001|Pre-phase|Protocol Violation|0|||
129930114|NCT03519178|467709728|FG010|Long-term Follow-up|Other|0|||
129930115|NCT03519178|467709729|FG011|Long-term Follow-up|Other|0|||
129930116|NCT03519178|467709730|FG012|Long-term Follow-up|Other|0|||
129930117|NCT03519178|467709731|FG013|Long-term Follow-up|Other|0|||
129930118|NCT03519178|467709732|FG014|Long-term Follow-up|Other|1|||
129930119|NCT03519178|467709718|FG000|Long-term Follow-up|Ongoing|0|||
129930120|NCT03519178|467709719|FG001|Long-term Follow-up|Ongoing|0|||
129930121|NCT03519178|467709720|FG002|Long-term Follow-up|Ongoing|0|||
129930122|NCT03519178|467709721|FG003|Long-term Follow-up|Ongoing|0|||
129930123|NCT03519178|467709722|FG004|Long-term Follow-up|Ongoing|0|||
129930124|NCT03519178|467709723|FG005|Long-term Follow-up|Ongoing|0|||
129930125|NCT03519178|467709724|FG006|Long-term Follow-up|Ongoing|0|||
129930126|NCT03519178|467709725|FG007|Long-term Follow-up|Ongoing|0|||
129930127|NCT03519178|467709726|FG008|Long-term Follow-up|Ongoing|0|||
129930128|NCT03519178|467709727|FG009|Long-term Follow-up|Ongoing|0|||
129930129|NCT03519178|467709728|FG010|Long-term Follow-up|Ongoing|0|||
129930130|NCT03519178|467709729|FG011|Long-term Follow-up|Ongoing|0|||
129930131|NCT03519178|467709730|FG012|Long-term Follow-up|Ongoing|0|||
129930132|NCT03519178|467709731|FG013|Long-term Follow-up|Ongoing|1|||
129930133|NCT03519178|467709732|FG014|Long-term Follow-up|Ongoing|0|||
129930134|NCT02240238|467709733|FG000|Phase 1|Adverse Event|0|||
129451021|NCT00514514|465950362|FG002|Pre-phase|Protocol Violation|0|||
129451022|NCT00514514|465950360|FG000|Pre-phase|condition no longer requires study drug|7|||
129451023|NCT00514514|465950361|FG001|Pre-phase|condition no longer requires study drug|0|||
129930135|NCT02240238|467709734|FG001|Phase 1|Adverse Event|0|||
129930136|NCT02240238|467709735|FG002|Phase 1|Adverse Event|0|||
129930137|NCT02240238|467709736|FG003|Phase 1|Adverse Event|0|||
129930138|NCT02240238|467709737|FG004|Phase 1|Adverse Event|0|||
129451024|NCT00514514|465950362|FG002|Pre-phase|condition no longer requires study drug|0|||
129451025|NCT00514514|465950360|FG000|Pre-phase|abnormal test procedure results|15|||
129451026|NCT00514514|465950361|FG001|Pre-phase|abnormal test procedure results|0|||
129451027|NCT00514514|465950362|FG002|Pre-phase|abnormal test procedure results|0|||
129451028|NCT00514514|465950360|FG000|Pre-phase|Lost to Follow-up|2|||
129451029|NCT00514514|465950361|FG001|Pre-phase|Lost to Follow-up|0|||
129930139|NCT02240238|467709738|FG005|Phase 1|Adverse Event|0|||
129930140|NCT02240238|467709739|FG006|Phase 1|Adverse Event|3|||
129930141|NCT02240238|467709740|FG007|Phase 1|Adverse Event|1|||
129451030|NCT00514514|465950362|FG002|Pre-phase|Lost to Follow-up|0|||
129451031|NCT00514514|465950360|FG000|Pre-phase|abnormal lab values|23|||
129451032|NCT00514514|465950361|FG001|Pre-phase|abnormal lab values|0|||
129451033|NCT00514514|465950362|FG002|Pre-phase|abnormal lab values|0|||
129930142|NCT02240238|467709741|FG008|Phase 1|Adverse Event|0|||
129930143|NCT02240238|467709742|FG009|Phase 1|Adverse Event|0|||
129930144|NCT02240238|467709743|FG010|Phase 1|Adverse Event|0|||
129930145|NCT02240238|467709744|FG011|Phase 1|Adverse Event|0|||
129930146|NCT02240238|467709733|FG000|Phase 1|Death|0|||
129930147|NCT02240238|467709734|FG001|Phase 1|Death|0|||
129930148|NCT02240238|467709735|FG002|Phase 1|Death|0|||
129930149|NCT02240238|467709736|FG003|Phase 1|Death|0|||
129930150|NCT02240238|467709737|FG004|Phase 1|Death|0|||
129930151|NCT02240238|467709738|FG005|Phase 1|Death|1|||
129930152|NCT02240238|467709739|FG006|Phase 1|Death|0|||
129930153|NCT02240238|467709740|FG007|Phase 1|Death|0|||
129930154|NCT02240238|467709741|FG008|Phase 1|Death|0|||
129930155|NCT02240238|467709742|FG009|Phase 1|Death|0|||
129930156|NCT02240238|467709743|FG010|Phase 1|Death|0|||
129930157|NCT02240238|467709744|FG011|Phase 1|Death|0|||
129930158|NCT02240238|467709733|FG000|Phase 1|Sponsor termination|0|||
129930159|NCT02240238|467709734|FG001|Phase 1|Sponsor termination|0|||
129930160|NCT02240238|467709735|FG002|Phase 1|Sponsor termination|0|||
129930161|NCT02240238|467709736|FG003|Phase 1|Sponsor termination|0|||
129930162|NCT02240238|467709737|FG004|Phase 1|Sponsor termination|0|||
129930163|NCT02240238|467709738|FG005|Phase 1|Sponsor termination|1|||
129930164|NCT02240238|467709739|FG006|Phase 1|Sponsor termination|0|||
129930165|NCT02240238|467709740|FG007|Phase 1|Sponsor termination|0|||
129930166|NCT02240238|467709741|FG008|Phase 1|Sponsor termination|0|||
129930167|NCT02240238|467709742|FG009|Phase 1|Sponsor termination|0|||
129930168|NCT02240238|467709743|FG010|Phase 1|Sponsor termination|0|||
129930169|NCT02240238|467709744|FG011|Phase 1|Sponsor termination|0|||
129930170|NCT02240238|467709733|FG000|Phase 1|Withdrawal by Subject|0|||
129930171|NCT02240238|467709734|FG001|Phase 1|Withdrawal by Subject|0|||
129930172|NCT02240238|467709735|FG002|Phase 1|Withdrawal by Subject|0|||
129930173|NCT02240238|467709736|FG003|Phase 1|Withdrawal by Subject|0|||
129930174|NCT02240238|467709737|FG004|Phase 1|Withdrawal by Subject|0|||
129930175|NCT02240238|467709738|FG005|Phase 1|Withdrawal by Subject|2|||
129930176|NCT02240238|467709739|FG006|Phase 1|Withdrawal by Subject|0|||
129930177|NCT02240238|467709740|FG007|Phase 1|Withdrawal by Subject|0|||
129930178|NCT02240238|467709741|FG008|Phase 1|Withdrawal by Subject|0|||
129930179|NCT02240238|467709742|FG009|Phase 1|Withdrawal by Subject|0|||
129930180|NCT02240238|467709743|FG010|Phase 1|Withdrawal by Subject|0|||
129930181|NCT02240238|467709744|FG011|Phase 1|Withdrawal by Subject|0|||
129451034|NCT00514514|465950360|FG000|Pre-phase|Lack of Efficacy|35|||
129451035|NCT00514514|465950361|FG001|Pre-phase|Lack of Efficacy|0|||
129451036|NCT00514514|465950362|FG002|Pre-phase|Lack of Efficacy|0|||
129930182|NCT02240238|467709733|FG000|Phase 1|Physician Decision|0|||
129930183|NCT02240238|467709734|FG001|Phase 1|Physician Decision|0|||
129930184|NCT02240238|467709735|FG002|Phase 1|Physician Decision|0|||
129930185|NCT02240238|467709736|FG003|Phase 1|Physician Decision|0|||
129930186|NCT02240238|467709737|FG004|Phase 1|Physician Decision|0|||
129930187|NCT02240238|467709738|FG005|Phase 1|Physician Decision|2|||
129930188|NCT02240238|467709739|FG006|Phase 1|Physician Decision|0|||
129930189|NCT02240238|467709740|FG007|Phase 1|Physician Decision|0|||
129930190|NCT02240238|467709741|FG008|Phase 1|Physician Decision|0|||
129930191|NCT02240238|467709742|FG009|Phase 1|Physician Decision|0|||
129930192|NCT02240238|467709743|FG010|Phase 1|Physician Decision|0|||
129930193|NCT02240238|467709744|FG011|Phase 1|Physician Decision|0|||
129930194|NCT02240238|467709733|FG000|Phase 2|Adverse Event|0|||
129930195|NCT02240238|467709734|FG001|Phase 2|Adverse Event|0|||
129930196|NCT02240238|467709735|FG002|Phase 2|Adverse Event|0|||
129930197|NCT02240238|467709736|FG003|Phase 2|Adverse Event|0|||
129930198|NCT02240238|467709737|FG004|Phase 2|Adverse Event|0|||
129930199|NCT02240238|467709738|FG005|Phase 2|Adverse Event|0|||
129930200|NCT02240238|467709739|FG006|Phase 2|Adverse Event|0|||
129930201|NCT02240238|467709740|FG007|Phase 2|Adverse Event|0|||
129930202|NCT02240238|467709741|FG008|Phase 2|Adverse Event|0|||
129930203|NCT02240238|467709742|FG009|Phase 2|Adverse Event|7|||
129930204|NCT02240238|467709743|FG010|Phase 2|Adverse Event|14|||
129930205|NCT02240238|467709744|FG011|Phase 2|Adverse Event|2|||
129930206|NCT02240238|467709733|FG000|Phase 2|Death|0|||
129451037|NCT00514514|465950360|FG000|Pre-phase|Adverse Event|137|||
129930207|NCT02240238|467709734|FG001|Phase 2|Death|0|||
129930208|NCT02240238|467709735|FG002|Phase 2|Death|0|||
129930209|NCT02240238|467709736|FG003|Phase 2|Death|0|||
129930210|NCT02240238|467709737|FG004|Phase 2|Death|0|||
129930211|NCT02240238|467709738|FG005|Phase 2|Death|0|||
129930212|NCT02240238|467709739|FG006|Phase 2|Death|0|||
129930213|NCT02240238|467709740|FG007|Phase 2|Death|0|||
129930214|NCT02240238|467709741|FG008|Phase 2|Death|0|||
129930215|NCT02240238|467709742|FG009|Phase 2|Death|3|||
129930216|NCT02240238|467709743|FG010|Phase 2|Death|2|||
129930217|NCT02240238|467709744|FG011|Phase 2|Death|1|||
129930218|NCT02240238|467709733|FG000|Phase 2|Disease progression|0|||
129930219|NCT02240238|467709734|FG001|Phase 2|Disease progression|0|||
129930220|NCT02240238|467709735|FG002|Phase 2|Disease progression|0|||
129930221|NCT02240238|467709736|FG003|Phase 2|Disease progression|0|||
129930222|NCT02240238|467709737|FG004|Phase 2|Disease progression|0|||
129930223|NCT02240238|467709738|FG005|Phase 2|Disease progression|0|||
129930224|NCT02240238|467709739|FG006|Phase 2|Disease progression|0|||
129930225|NCT02240238|467709740|FG007|Phase 2|Disease progression|0|||
129930226|NCT02240238|467709741|FG008|Phase 2|Disease progression|0|||
129930227|NCT02240238|467709742|FG009|Phase 2|Disease progression|5|||
129930228|NCT02240238|467709743|FG010|Phase 2|Disease progression|11|||
129930229|NCT02240238|467709744|FG011|Phase 2|Disease progression|1|||
129930230|NCT02240238|467709733|FG000|Phase 2|Withdrawal by Subject|0|||
129930231|NCT02240238|467709734|FG001|Phase 2|Withdrawal by Subject|0|||
129930232|NCT02240238|467709735|FG002|Phase 2|Withdrawal by Subject|0|||
129930233|NCT02240238|467709736|FG003|Phase 2|Withdrawal by Subject|0|||
129930234|NCT02240238|467709737|FG004|Phase 2|Withdrawal by Subject|0|||
129930235|NCT02240238|467709738|FG005|Phase 2|Withdrawal by Subject|0|||
129930236|NCT02240238|467709739|FG006|Phase 2|Withdrawal by Subject|0|||
129930237|NCT02240238|467709740|FG007|Phase 2|Withdrawal by Subject|0|||
129930238|NCT02240238|467709741|FG008|Phase 2|Withdrawal by Subject|0|||
129930239|NCT02240238|467709742|FG009|Phase 2|Withdrawal by Subject|1|||
129930240|NCT02240238|467709743|FG010|Phase 2|Withdrawal by Subject|1|||
129930241|NCT02240238|467709744|FG011|Phase 2|Withdrawal by Subject|0|||
129930242|NCT02240238|467709733|FG000|Phase 2|Physician Decision|0|||
129930243|NCT02240238|467709734|FG001|Phase 2|Physician Decision|0|||
129930244|NCT02240238|467709735|FG002|Phase 2|Physician Decision|0|||
129930245|NCT02240238|467709736|FG003|Phase 2|Physician Decision|0|||
129930246|NCT02240238|467709737|FG004|Phase 2|Physician Decision|0|||
129930247|NCT02240238|467709738|FG005|Phase 2|Physician Decision|0|||
129930248|NCT02240238|467709739|FG006|Phase 2|Physician Decision|0|||
129930249|NCT02240238|467709740|FG007|Phase 2|Physician Decision|0|||
129930250|NCT02240238|467709741|FG008|Phase 2|Physician Decision|0|||
129930251|NCT02240238|467709742|FG009|Phase 2|Physician Decision|1|||
129930252|NCT02240238|467709743|FG010|Phase 2|Physician Decision|3|||
129930253|NCT02240238|467709744|FG011|Phase 2|Physician Decision|0|||
129930254|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930255|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930256|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930257|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930258|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930259|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930260|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930261|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930262|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930263|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
129930264|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930265|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
129930266|NCT02240238|467709733|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930267|NCT02240238|467709734|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930268|NCT02240238|467709735|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930269|NCT02240238|467709736|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930270|NCT02240238|467709737|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930271|NCT02240238|467709738|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930272|NCT02240238|467709739|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930273|NCT02240238|467709740|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930274|NCT02240238|467709741|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930275|NCT02240238|467709742|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
129930276|NCT02240238|467709743|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930277|NCT02240238|467709744|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
129930278|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930279|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930280|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930281|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930282|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930283|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930284|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930285|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930286|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930287|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930288|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
129930289|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
129930290|NCT02240238|467709733|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930291|NCT02240238|467709734|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930292|NCT02240238|467709735|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930293|NCT02240238|467709736|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930294|NCT02240238|467709737|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930295|NCT02240238|467709738|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930296|NCT02240238|467709739|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930297|NCT02240238|467709740|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930298|NCT02240238|467709741|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930299|NCT02240238|467709742|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129451038|NCT00514514|465950361|FG001|Pre-phase|Adverse Event|0|||
129451039|NCT00514514|465950362|FG002|Pre-phase|Adverse Event|0|||
129451040|NCT00514514|465950360|FG000|Pre-phase|Withdrawal by Subject|66|||
129451041|NCT00514514|465950361|FG001|Pre-phase|Withdrawal by Subject|0|||
129451042|NCT00514514|465950362|FG002|Pre-phase|Withdrawal by Subject|0|||
129451043|NCT00514514|465950360|FG000|Randomized - 9 Month|Death|3|||
129451044|NCT00514514|465950361|FG001|Randomized - 9 Month|Death|2|||
129451045|NCT00514514|465950362|FG002|Randomized - 9 Month|Death|2|||
129451046|NCT00514514|465950360|FG000|Randomized - 9 Month|Administrative problems|1|||
129451047|NCT00514514|465950361|FG001|Randomized - 9 Month|Administrative problems|1|||
129451048|NCT00514514|465950362|FG002|Randomized - 9 Month|Administrative problems|2|||
129451049|NCT00514514|465950360|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
129451050|NCT00514514|465950361|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
129451051|NCT00514514|465950362|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
129451052|NCT00514514|465950360|FG000|Randomized - 9 Month|Protocol Violation|1|||
129451053|NCT00514514|465950361|FG001|Randomized - 9 Month|Protocol Violation|1|||
129451054|NCT00514514|465950362|FG002|Randomized - 9 Month|Protocol Violation|0|||
129451055|NCT00514514|465950360|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
129451056|NCT00514514|465950361|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
129451057|NCT00514514|465950362|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
129451058|NCT00514514|465950360|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
129451059|NCT00514514|465950361|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
129451060|NCT00514514|465950362|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
129451061|NCT00514514|465950360|FG000|Randomized - 9 Month|Adverse Event|25|||
129451062|NCT00514514|465950361|FG001|Randomized - 9 Month|Adverse Event|44|||
129451063|NCT00514514|465950362|FG002|Randomized - 9 Month|Adverse Event|27|||
129451064|NCT00514514|465950360|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
129451065|NCT00514514|465950361|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
129451066|NCT00514514|465950362|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
129451067|NCT00514514|465950360|FG000|Extension - 4 Years|Lost to Follow-up|12|||
129451068|NCT00514514|465950361|FG001|Extension - 4 Years|Lost to Follow-up|10|||
129451069|NCT00514514|465950362|FG002|Extension - 4 Years|Lost to Follow-up|9|||
129451070|NCT00514514|465950360|FG000|Extension - 4 Years|Administrative problems|3|||
129451071|NCT00514514|465950361|FG001|Extension - 4 Years|Administrative problems|1|||
129451072|NCT00514514|465950362|FG002|Extension - 4 Years|Administrative problems|1|||
129451073|NCT00514514|465950360|FG000|Extension - 4 Years|Death|8|||
129451074|NCT00514514|465950361|FG001|Extension - 4 Years|Death|3|||
129451075|NCT00514514|465950362|FG002|Extension - 4 Years|Death|6|||
129451076|NCT00514514|465950360|FG000|Extension - 4 Years|Adverse Event|9|||
129451077|NCT00514514|465950361|FG001|Extension - 4 Years|Adverse Event|6|||
129451078|NCT00514514|465950362|FG002|Extension - 4 Years|Adverse Event|3|||
129451079|NCT03785925|465950364|FG000|Overall Study|Withdrawal by Subject|15|||
129451080|NCT03785925|465950364|FG000|Overall Study|Lost to Follow-up|1|||
129451081|NCT01848288|465950367|FG000|Overall Study|Death|1|||
129930300|NCT02240238|467709743|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
129930301|NCT02240238|467709744|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
129930302|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930303|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930304|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930305|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930306|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930307|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930308|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930309|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930310|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930311|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930312|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
129930313|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
129930314|NCT02240238|467709733|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930315|NCT02240238|467709734|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930316|NCT02240238|467709735|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930317|NCT02240238|467709736|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129451082|NCT01848288|465950367|FG000|Overall Study|Protocol Violation|1|||
129451083|NCT01848288|465950367|FG000|Overall Study|Withdrawal by Subject|1|||
129451084|NCT03794583|465950372|FG000|Overall Study|Death|8|||
129451085|NCT03794583|465950372|FG000|Overall Study|Study Terminated by Sponsor|24|||
129451086|NCT03794583|465950372|FG000|Overall Study|Withdrawal by Subject|9|||
129451087|NCT00003895|465950373|FG000|Overall Study|Adverse Event|4|||
129451088|NCT00003895|465950374|FG001|Overall Study|Adverse Event|0|||
129451089|NCT00003895|465950373|FG000|Overall Study|Lack of Efficacy|1|||
129451090|NCT00003895|465950374|FG001|Overall Study|Lack of Efficacy|1|||
129451091|NCT00003895|465950373|FG000|Overall Study|Patient Vacation|2|||
129451092|NCT00003895|465950374|FG001|Overall Study|Patient Vacation|0|||
129451093|NCT00003895|465950373|FG000|Overall Study|Withdrawal by Subject|0|||
129451094|NCT00003895|465950374|FG001|Overall Study|Withdrawal by Subject|3|||
129451095|NCT00806195|465950377|FG000|Overall Study|Death|6|||
129451096|NCT00806195|465950378|FG001|Overall Study|Death|0|||
129451097|NCT00806195|465950379|FG002|Overall Study|Death|1|||
129451098|NCT00806195|465950380|FG003|Overall Study|Death|0|||
129451099|NCT00806195|465950377|FG000|Overall Study|Adverse Event|25|||
129930318|NCT02240238|467709737|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930319|NCT02240238|467709738|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930320|NCT02240238|467709739|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930321|NCT02240238|467709740|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930322|NCT02240238|467709741|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930323|NCT02240238|467709742|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930324|NCT02240238|467709743|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
129930325|NCT02240238|467709744|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
129930326|NCT02240238|467709733|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930327|NCT02240238|467709734|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930328|NCT02240238|467709735|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930329|NCT02240238|467709736|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930330|NCT02240238|467709737|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930331|NCT02240238|467709738|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930332|NCT02240238|467709739|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930333|NCT02240238|467709740|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930334|NCT02240238|467709741|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930335|NCT02240238|467709742|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930336|NCT02240238|467709743|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
129930337|NCT02240238|467709744|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
129930338|NCT02240238|467709733|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930339|NCT02240238|467709734|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930340|NCT02240238|467709735|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930341|NCT02240238|467709736|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930342|NCT02240238|467709737|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930343|NCT02240238|467709738|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930344|NCT02240238|467709739|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930345|NCT02240238|467709740|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930346|NCT02240238|467709741|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930347|NCT02240238|467709742|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930348|NCT02240238|467709743|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
129930349|NCT02240238|467709744|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
129930350|NCT04797195|467709766|FG000|Overall Study|Death|8|||
129930351|NCT04797195|467709767|FG001|Overall Study|Death|15|||
129930352|NCT04797195|467709766|FG000|Overall Study|Change from PD|15|||
129930353|NCT04797195|467709767|FG001|Overall Study|Change from PD|15|||
129930354|NCT04797195|467709766|FG000|Overall Study|Withdrawal by Subject|3|||
129930355|NCT04797195|467709767|FG001|Overall Study|Withdrawal by Subject|2|||
129930356|NCT04101357|467709768|FG000|Overall Study|Death|1|||
129930357|NCT04101357|467709769|FG001|Overall Study|Death|1|||
129930358|NCT04101357|467709770|FG002|Overall Study|Death|1|||
129930359|NCT04101357|467709771|FG003|Overall Study|Death|2|||
129930360|NCT04101357|467709772|FG004|Overall Study|Death|4|||
129930361|NCT04101357|467709773|FG005|Overall Study|Death|11|||
129930362|NCT04101357|467709774|FG006|Overall Study|Death|4|||
129930363|NCT04101357|467709775|FG007|Overall Study|Death|4|||
129930364|NCT04101357|467709776|FG008|Overall Study|Death|5|||
129930365|NCT04101357|467709777|FG009|Overall Study|Death|2|||
129930366|NCT04101357|467709778|FG010|Overall Study|Death|3|||
129930367|NCT04101357|467709768|FG000|Overall Study|Trial closure|0|||
129930368|NCT04101357|467709769|FG001|Overall Study|Trial closure|0|||
129930369|NCT04101357|467709770|FG002|Overall Study|Trial closure|0|||
129930370|NCT04101357|467709771|FG003|Overall Study|Trial closure|0|||
129451100|NCT00806195|465950378|FG001|Overall Study|Adverse Event|5|||
129451101|NCT00806195|465950379|FG002|Overall Study|Adverse Event|11|||
129930371|NCT04101357|467709772|FG004|Overall Study|Trial closure|0|||
129930372|NCT04101357|467709773|FG005|Overall Study|Trial closure|2|||
129930373|NCT04101357|467709774|FG006|Overall Study|Trial closure|2|||
129930374|NCT04101357|467709775|FG007|Overall Study|Trial closure|0|||
129930375|NCT04101357|467709776|FG008|Overall Study|Trial closure|0|||
129930376|NCT04101357|467709777|FG009|Overall Study|Trial closure|0|||
129930377|NCT04101357|467709778|FG010|Overall Study|Trial closure|1|||
129930378|NCT04101357|467709768|FG000|Overall Study|Lost to Follow-up|0|||
129930379|NCT04101357|467709769|FG001|Overall Study|Lost to Follow-up|0|||
129930380|NCT04101357|467709770|FG002|Overall Study|Lost to Follow-up|0|||
129930381|NCT04101357|467709771|FG003|Overall Study|Lost to Follow-up|1|||
129930382|NCT04101357|467709772|FG004|Overall Study|Lost to Follow-up|0|||
129930383|NCT04101357|467709773|FG005|Overall Study|Lost to Follow-up|0|||
129930384|NCT04101357|467709774|FG006|Overall Study|Lost to Follow-up|0|||
129930385|NCT04101357|467709775|FG007|Overall Study|Lost to Follow-up|1|||
129930386|NCT04101357|467709776|FG008|Overall Study|Lost to Follow-up|0|||
129930387|NCT04101357|467709777|FG009|Overall Study|Lost to Follow-up|0|||
129930388|NCT04101357|467709778|FG010|Overall Study|Lost to Follow-up|0|||
129930389|NCT04101357|467709768|FG000|Overall Study|Withdrawal by Subject|1|||
129930390|NCT04101357|467709769|FG001|Overall Study|Withdrawal by Subject|0|||
129930391|NCT04101357|467709770|FG002|Overall Study|Withdrawal by Subject|0|||
129930392|NCT04101357|467709771|FG003|Overall Study|Withdrawal by Subject|0|||
129930393|NCT04101357|467709772|FG004|Overall Study|Withdrawal by Subject|0|||
129930394|NCT04101357|467709773|FG005|Overall Study|Withdrawal by Subject|0|||
129930395|NCT04101357|467709774|FG006|Overall Study|Withdrawal by Subject|0|||
129930396|NCT04101357|467709775|FG007|Overall Study|Withdrawal by Subject|0|||
129930397|NCT04101357|467709776|FG008|Overall Study|Withdrawal by Subject|1|||
129930398|NCT04101357|467709777|FG009|Overall Study|Withdrawal by Subject|1|||
129930399|NCT04101357|467709778|FG010|Overall Study|Withdrawal by Subject|0|||
129930400|NCT04101357|467709768|FG000|Overall Study|Other|0|||
129930401|NCT04101357|467709769|FG001|Overall Study|Other|0|||
129930402|NCT04101357|467709770|FG002|Overall Study|Other|0|||
129930403|NCT04101357|467709771|FG003|Overall Study|Other|0|||
129930404|NCT04101357|467709772|FG004|Overall Study|Other|0|||
129930405|NCT04101357|467709773|FG005|Overall Study|Other|1|||
129930406|NCT04101357|467709774|FG006|Overall Study|Other|2|||
129930407|NCT04101357|467709775|FG007|Overall Study|Other|1|||
129930408|NCT04101357|467709776|FG008|Overall Study|Other|0|||
129930409|NCT04101357|467709777|FG009|Overall Study|Other|0|||
129930410|NCT04101357|467709778|FG010|Overall Study|Other|0|||
129930411|NCT04101357|467709768|FG000|Overall Study|Enrolled but not treated|0|||
129930412|NCT04101357|467709769|FG001|Overall Study|Enrolled but not treated|0|||
129930413|NCT04101357|467709770|FG002|Overall Study|Enrolled but not treated|0|||
129930414|NCT04101357|467709771|FG003|Overall Study|Enrolled but not treated|0|||
129930415|NCT04101357|467709772|FG004|Overall Study|Enrolled but not treated|0|||
129930416|NCT04101357|467709773|FG005|Overall Study|Enrolled but not treated|1|||
129930417|NCT04101357|467709774|FG006|Overall Study|Enrolled but not treated|1|||
129930418|NCT04101357|467709775|FG007|Overall Study|Enrolled but not treated|0|||
129930419|NCT04101357|467709776|FG008|Overall Study|Enrolled but not treated|0|||
129930420|NCT04101357|467709777|FG009|Overall Study|Enrolled but not treated|0|||
129930421|NCT04101357|467709778|FG010|Overall Study|Enrolled but not treated|0|||
129930422|NCT02497950|467709779|FG000|Overall Study|Death|209|||
129930423|NCT02497950|467709779|FG000|Overall Study|Transplanted|85|||
129930424|NCT02497950|467709779|FG000|Overall Study|Explanted|8|||
129930425|NCT02497950|467709779|FG000|Overall Study|Device Permanently Deactivated|4|||
129930426|NCT02497950|467709779|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
129930427|NCT02497950|467709779|FG000|Overall Study|Lost to Follow-up|6|||
129930428|NCT02497950|467709779|FG000|Overall Study|Withdrawal by Subject|2|||
129930429|NCT02497950|467709779|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
129930430|NCT02497950|467709779|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
129930431|NCT01009788|467709792|FG000|Overall Study|Withdrawal by Subject|1|||
129930432|NCT01009788|467709793|FG001|Overall Study|Withdrawal by Subject|0|||
129930433|NCT05586490|467709794|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930434|NCT05586490|467709795|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930435|NCT05586490|467709796|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
129930436|NCT05586490|467709797|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930437|NCT05586490|467709798|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
129930438|NCT05586490|467709794|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
129930439|NCT05586490|467709795|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930440|NCT05586490|467709796|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930441|NCT05586490|467709797|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930442|NCT05586490|467709798|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
129930443|NCT05586490|467709794|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
129930444|NCT05586490|467709795|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930445|NCT05586490|467709796|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930446|NCT05586490|467709797|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930447|NCT05586490|467709798|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
129930448|NCT05076266|467709799|FG000|Overall Study|Survey not complete - Participant refusal|2|||
129930449|NCT05076266|467709800|FG001|Overall Study|Survey not complete - Participant refusal|0|||
129930450|NCT04003246|467709803|FG000|Overall Study|Death|9|||
129930451|NCT04132518|467709813|FG000|Overall Study|Prematurely withdrawn from the study|0|||
129930452|NCT04132518|467709814|FG001|Overall Study|Prematurely withdrawn from the study|9|||
129930453|NCT04132518|467709815|FG002|Overall Study|Prematurely withdrawn from the study|1|||
129930454|NCT05524402|467709817|FG000|Overall Study|Withdrawal by Subject|3|||
129930455|NCT05524402|467709818|FG001|Overall Study|Withdrawal by Subject|1|||
129930456|NCT05524402|467709817|FG000|Overall Study|Lost to Follow-up|2|||
129930457|NCT05524402|467709818|FG001|Overall Study|Lost to Follow-up|1|||
129930458|NCT04544007|467709825|FG000|Overall Study|Withdrawal by Subject|1|||
129930459|NCT04544007|467709825|FG000|Overall Study|Confirmed Progressive Disease|1|||
129930460|NCT02988661|467709826|FG000|Overall Study|Death|2|||
129930461|NCT02988661|467709827|FG001|Overall Study|Death|18|||
129930462|NCT02988661|467709826|FG000|Overall Study|Lost to Follow-up|0|||
129930463|NCT02988661|467709827|FG001|Overall Study|Lost to Follow-up|33|||
129930464|NCT02988661|467709826|FG000|Overall Study|Withdrawal by Subject|0|||
129930465|NCT02988661|467709827|FG001|Overall Study|Withdrawal by Subject|6|||
129930466|NCT02988661|467709826|FG000|Overall Study|Unable to complete the 18-month survey|1|||
129930467|NCT02988661|467709827|FG001|Overall Study|Unable to complete the 18-month survey|27|||
129930468|NCT02413489|467709843|FG000|Overall Study|Death|11|||
129930469|NCT02413489|467709844|FG001|Overall Study|Death|3|||
129930470|NCT02413489|467709845|FG002|Overall Study|Death|4|||
129930471|NCT02413489|467709843|FG000|Overall Study|Withdrawal by Subject|2|||
129930472|NCT02413489|467709844|FG001|Overall Study|Withdrawal by Subject|0|||
129930473|NCT02413489|467709845|FG002|Overall Study|Withdrawal by Subject|0|||
129930474|NCT02413489|467709843|FG000|Overall Study|Study Terminated By Sponsor|2|||
129930475|NCT02413489|467709844|FG001|Overall Study|Study Terminated By Sponsor|13|||
129930476|NCT02413489|467709845|FG002|Overall Study|Study Terminated By Sponsor|1|||
129930477|NCT04294641|467711518|FG000|Overall Study|Screen failure|4|||
129930478|NCT04730739|467711520|FG000|Overall Study|Death|1|||
129930479|NCT04707469|467711523|FG000|Overall Study|Site closure|0|||
129930480|NCT04707469|467711524|FG001|Overall Study|Site closure|2|||
129930481|NCT04707469|467711525|FG002|Overall Study|Site closure|0|||
129930482|NCT04707469|467711523|FG000|Overall Study|Physician Decision|2|||
129930483|NCT04707469|467711524|FG001|Overall Study|Physician Decision|2|||
129930484|NCT04707469|467711525|FG002|Overall Study|Physician Decision|2|||
129930485|NCT04707469|467711523|FG000|Overall Study|Death|1|||
129930486|NCT04707469|467711524|FG001|Overall Study|Death|6|||
129930487|NCT04707469|467711525|FG002|Overall Study|Death|2|||
129930488|NCT04707469|467711523|FG000|Overall Study|Lost to Follow-up|9|||
129930489|NCT04707469|467711524|FG001|Overall Study|Lost to Follow-up|19|||
129930490|NCT04707469|467711525|FG002|Overall Study|Lost to Follow-up|14|||
129930491|NCT04707469|467711523|FG000|Overall Study|Withdrawal by Subject|17|||
129930492|NCT04707469|467711524|FG001|Overall Study|Withdrawal by Subject|16|||
129930493|NCT04707469|467711525|FG002|Overall Study|Withdrawal by Subject|12|||
129930494|NCT05218096|467711533|FG000|Primary Evaluation|Withdrawal by Subject|0|||
129930495|NCT05218096|467711534|FG001|Primary Evaluation|Withdrawal by Subject|0|||
129930496|NCT05218096|467711535|FG002|Primary Evaluation|Withdrawal by Subject|2|||
129930497|NCT05218096|467711536|FG003|Primary Evaluation|Withdrawal by Subject|0|||
129930498|NCT05218096|467711537|FG004|Primary Evaluation|Withdrawal by Subject|0|||
129930499|NCT05218096|467711533|FG000|Primary Evaluation|Physician Decision|1|||
129930500|NCT05218096|467711534|FG001|Primary Evaluation|Physician Decision|0|||
129930501|NCT05218096|467711535|FG002|Primary Evaluation|Physician Decision|0|||
129930502|NCT05218096|467711536|FG003|Primary Evaluation|Physician Decision|0|||
129930503|NCT05218096|467711537|FG004|Primary Evaluation|Physician Decision|0|||
129930504|NCT05218096|467711533|FG000|Extended Treatment|Clinical Deterioration|1|||
129930505|NCT05218096|467711534|FG001|Extended Treatment|Clinical Deterioration|1|||
129930506|NCT05218096|467711535|FG002|Extended Treatment|Clinical Deterioration|0|||
129930507|NCT05218096|467711536|FG003|Extended Treatment|Clinical Deterioration|0|||
129930508|NCT05218096|467711537|FG004|Extended Treatment|Clinical Deterioration|0|||
129930509|NCT05218096|467711533|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
129930510|NCT05218096|467711534|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
129930511|NCT05218096|467711535|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
129930512|NCT05218096|467711536|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
129930513|NCT05218096|467711537|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
129930514|NCT05218096|467711533|FG000|Extended Treatment|Withdrawal by Subject|1|||
129930515|NCT05218096|467711534|FG001|Extended Treatment|Withdrawal by Subject|3|||
129930516|NCT05218096|467711535|FG002|Extended Treatment|Withdrawal by Subject|0|||
129930517|NCT05218096|467711536|FG003|Extended Treatment|Withdrawal by Subject|2|||
129930518|NCT05218096|467711537|FG004|Extended Treatment|Withdrawal by Subject|2|||
129930519|NCT05218096|467711533|FG000|Extended Treatment|Lack of Efficacy|3|||
129930520|NCT05218096|467711534|FG001|Extended Treatment|Lack of Efficacy|0|||
129930521|NCT05218096|467711535|FG002|Extended Treatment|Lack of Efficacy|0|||
129930522|NCT05218096|467711536|FG003|Extended Treatment|Lack of Efficacy|0|||
129930523|NCT05218096|467711537|FG004|Extended Treatment|Lack of Efficacy|0|||
129930524|NCT05218096|467711533|FG000|Extended Treatment|Physician Decision|0|||
129930525|NCT05218096|467711534|FG001|Extended Treatment|Physician Decision|1|||
129930526|NCT05218096|467711535|FG002|Extended Treatment|Physician Decision|0|||
129930527|NCT05218096|467711536|FG003|Extended Treatment|Physician Decision|0|||
129930528|NCT05218096|467711537|FG004|Extended Treatment|Physician Decision|0|||
129930529|NCT05218096|467711533|FG000|Open-label Extension|Adverse Event|1|||
129930530|NCT05218096|467711534|FG001|Open-label Extension|Adverse Event|0|||
129930531|NCT05218096|467711535|FG002|Open-label Extension|Adverse Event|0|||
129930532|NCT05218096|467711536|FG003|Open-label Extension|Adverse Event|0|||
129930533|NCT05218096|467711537|FG004|Open-label Extension|Adverse Event|1|||
129930534|NCT05218096|467711533|FG000|Open-label Extension|Pregnancy|0|||
129930535|NCT05218096|467711534|FG001|Open-label Extension|Pregnancy|0|||
129930536|NCT05218096|467711535|FG002|Open-label Extension|Pregnancy|0|||
129930537|NCT05218096|467711536|FG003|Open-label Extension|Pregnancy|0|||
129930538|NCT05218096|467711537|FG004|Open-label Extension|Pregnancy|1|||
129930539|NCT05218096|467711533|FG000|Open-label Extension|Lack of Efficacy|1|||
129930540|NCT05218096|467711534|FG001|Open-label Extension|Lack of Efficacy|2|||
129930541|NCT05218096|467711535|FG002|Open-label Extension|Lack of Efficacy|0|||
129930542|NCT05218096|467711536|FG003|Open-label Extension|Lack of Efficacy|0|||
129930543|NCT05218096|467711537|FG004|Open-label Extension|Lack of Efficacy|0|||
129930544|NCT05218096|467711533|FG000|Open-label Extension|Lost to Follow-up|1|||
129930545|NCT05218096|467711534|FG001|Open-label Extension|Lost to Follow-up|0|||
129930546|NCT05218096|467711535|FG002|Open-label Extension|Lost to Follow-up|0|||
129930547|NCT05218096|467711536|FG003|Open-label Extension|Lost to Follow-up|0|||
129930548|NCT05218096|467711537|FG004|Open-label Extension|Lost to Follow-up|0|||
129930549|NCT05218096|467711533|FG000|Open-label Extension|Death|0|||
129930550|NCT05218096|467711534|FG001|Open-label Extension|Death|0|||
129930551|NCT05218096|467711535|FG002|Open-label Extension|Death|0|||
129930552|NCT05218096|467711536|FG003|Open-label Extension|Death|1|||
129930553|NCT05218096|467711537|FG004|Open-label Extension|Death|0|||
129930554|NCT05218096|467711533|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
129930555|NCT05218096|467711534|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
129930556|NCT05218096|467711535|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
129930557|NCT05218096|467711536|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
129930558|NCT05218096|467711537|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
129930559|NCT05269966|467711540|FG000|Overall Study|Adverse Event|4|||
129930560|NCT05269966|467711540|FG000|Overall Study|Withdrawal by Subject|1|||
129930561|NCT05269966|467711540|FG000|Overall Study|Lost to Follow-up|4|||
129930562|NCT05269966|467711540|FG000|Overall Study|Physician Decision|1|||
129930563|NCT05863156|467711549|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
129930564|NCT05863156|467711550|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
129930565|NCT05863156|467711551|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
129930566|NCT04660539|467711554|FG000|Overall Study|Adverse Event|10|||
129930567|NCT04660539|467711554|FG000|Overall Study|Lack of Efficacy|4|||
129930568|NCT04660539|467711554|FG000|Overall Study|Lost to Follow-up|5|||
129930569|NCT04660539|467711554|FG000|Overall Study|Non-Compliance With Study Drug|3|||
129930570|NCT04660539|467711554|FG000|Overall Study|Reason not Specified|12|||
129930571|NCT04660539|467711554|FG000|Overall Study|Pregnancy|2|||
129930572|NCT04660539|467711554|FG000|Overall Study|Protocol Violation|2|||
129930573|NCT04660539|467711554|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
129930574|NCT04660539|467711554|FG000|Overall Study|Withdrawal by Subject|21|||
129930575|NCT03655028|467711557|FG000|12-weeks Follow up|Death|1|||
129930576|NCT03655028|467711558|FG001|12-weeks Follow up|Death|0|||
129930577|NCT03655028|467711557|FG000|12-weeks Follow up|Physician Decision|3|||
129930578|NCT03655028|467711558|FG001|12-weeks Follow up|Physician Decision|3|||
129930579|NCT03655028|467711557|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
129930580|NCT03655028|467711558|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
129930581|NCT03655028|467711557|FG000|12-weeks Follow up|Lost to Follow-up|4|||
129930582|NCT03655028|467711558|FG001|12-weeks Follow up|Lost to Follow-up|4|||
129930583|NCT03655028|467711557|FG000|24-weeks|Lost to Follow-up|1|||
129930584|NCT03655028|467711558|FG001|24-weeks|Lost to Follow-up|1|||
129930585|NCT03655028|467711557|FG000|24-weeks|Death|0|||
129930586|NCT03655028|467711558|FG001|24-weeks|Death|1|||
129930587|NCT03513302|467711559|FG000|First Intervention (14 Days)|Screen failure|15|||
129930588|NCT03513302|467711560|FG001|First Intervention (14 Days)|Screen failure|16|||
129930589|NCT05618587|467711561|FG000|Overall Study|Lost to Follow-up|2|||
129930590|NCT05618587|467711562|FG001|Overall Study|Lost to Follow-up|0|||
129930591|NCT05167864|467711563|FG000|Overall Study|Lost to Follow-up|7|||
129930592|NCT05167864|467711564|FG001|Overall Study|Lost to Follow-up|6|||
129930593|NCT05167864|467711565|FG002|Overall Study|Lost to Follow-up|7|||
129930594|NCT05167864|467711566|FG003|Overall Study|Lost to Follow-up|9|||
129930595|NCT03852550|467711567|FG000|Overall Study|Lost to Follow-up|4|||
129930596|NCT03852550|467711568|FG001|Overall Study|Lost to Follow-up|3|||
129930597|NCT03852550|467711567|FG000|Overall Study|Only parent outcomes completed|0|||
129930598|NCT03852550|467711568|FG001|Overall Study|Only parent outcomes completed|1|||
129930599|NCT03852550|467711567|FG000|Overall Study|Withdrawal by Subject|1|||
129930600|NCT03852550|467711568|FG001|Overall Study|Withdrawal by Subject|0|||
129930601|NCT05204654|467711569|FG000|Overall Study|Study terminated due to time restraint|2|||
129451102|NCT00806195|465950380|FG003|Overall Study|Adverse Event|2|||
129930602|NCT05204654|467711570|FG001|Overall Study|Study terminated due to time restraint|2|||
129930603|NCT02296684|467711585|FG000|Overall Study|Withdrawal by Subject|0|||
129930604|NCT02296684|467711586|FG001|Overall Study|Withdrawal by Subject|1|||
129930605|NCT02296684|467711587|FG002|Overall Study|Withdrawal by Subject|1|||
129930606|NCT02296684|467711585|FG000|Overall Study|Death|2|||
129930607|NCT02296684|467711586|FG001|Overall Study|Death|0|||
129930608|NCT02296684|467711587|FG002|Overall Study|Death|0|||
129930609|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
129930610|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
129930611|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
129930612|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
129930613|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
129930614|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
129930615|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
129930616|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
129930617|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
129930618|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
129930619|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
129930620|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
129930621|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
129930622|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
129930623|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
129930624|NCT01254864|467711590|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
129930625|NCT01254864|467711591|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
129930626|NCT01254864|467711592|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
129930627|NCT01254864|467711590|FG000|Randomization Phase|Adverse Event|0|||
129930628|NCT01254864|467711591|FG001|Randomization Phase|Adverse Event|5|||
129930629|NCT01254864|467711592|FG002|Randomization Phase|Adverse Event|17|||
129930630|NCT01254864|467711590|FG000|Randomization Phase|Death|0|||
129930631|NCT01254864|467711591|FG001|Randomization Phase|Death|1|||
129930632|NCT01254864|467711592|FG002|Randomization Phase|Death|0|||
129930633|NCT01254864|467711590|FG000|Randomization Phase|Lost to Follow-up|0|||
129930634|NCT01254864|467711591|FG001|Randomization Phase|Lost to Follow-up|0|||
129930635|NCT01254864|467711592|FG002|Randomization Phase|Lost to Follow-up|1|||
129451103|NCT00806195|465950377|FG000|Overall Study|Withdrawal by Subject|119|||
129451104|NCT00806195|465950378|FG001|Overall Study|Withdrawal by Subject|31|||
129451105|NCT00806195|465950379|FG002|Overall Study|Withdrawal by Subject|76|||
129930636|NCT01254864|467711590|FG000|Randomization Phase|Physician Decision|0|||
129930637|NCT01254864|467711591|FG001|Randomization Phase|Physician Decision|20|||
129930638|NCT01254864|467711592|FG002|Randomization Phase|Physician Decision|25|||
129930639|NCT01254864|467711590|FG000|Randomization Phase|Withdrawal by Subject|0|||
129930640|NCT01254864|467711591|FG001|Randomization Phase|Withdrawal by Subject|4|||
129930641|NCT01254864|467711592|FG002|Randomization Phase|Withdrawal by Subject|2|||
129930642|NCT01254864|467711590|FG000|Randomization Phase|Non-Compliance|0|||
129930643|NCT01254864|467711591|FG001|Randomization Phase|Non-Compliance|1|||
129930644|NCT01254864|467711592|FG002|Randomization Phase|Non-Compliance|0|||
129930645|NCT01254864|467711590|FG000|Randomization Phase|Comorbidities|0|||
129930646|NCT01254864|467711591|FG001|Randomization Phase|Comorbidities|2|||
129930647|NCT01254864|467711592|FG002|Randomization Phase|Comorbidities|1|||
129930648|NCT01828112|467711595|FG000|Treatment Phase|Adverse Event|7|||
129930649|NCT01828112|467711596|FG001|Treatment Phase|Adverse Event|8|||
129930650|NCT01828112|467711597|FG002|Treatment Phase|Adverse Event|0|||
129930651|NCT01828112|467711595|FG000|Treatment Phase|Death|9|||
129930652|NCT01828112|467711596|FG001|Treatment Phase|Death|5|||
129930653|NCT01828112|467711597|FG002|Treatment Phase|Death|0|||
129930654|NCT01828112|467711595|FG000|Treatment Phase|No longer required treatment|0|||
129930655|NCT01828112|467711596|FG001|Treatment Phase|No longer required treatment|1|||
129930656|NCT01828112|467711597|FG002|Treatment Phase|No longer required treatment|0|||
129930657|NCT01828112|467711595|FG000|Treatment Phase|Physician Decision|6|||
129930658|NCT01828112|467711596|FG001|Treatment Phase|Physician Decision|7|||
129930659|NCT01828112|467711597|FG002|Treatment Phase|Physician Decision|0|||
129930660|NCT01828112|467711595|FG000|Treatment Phase|Pregnancy|1|||
129930661|NCT01828112|467711596|FG001|Treatment Phase|Pregnancy|0|||
129930662|NCT01828112|467711597|FG002|Treatment Phase|Pregnancy|0|||
129930663|NCT01828112|467711595|FG000|Treatment Phase|Progressive disease|79|||
129930664|NCT01828112|467711596|FG001|Treatment Phase|Progressive disease|87|||
129930665|NCT01828112|467711597|FG002|Treatment Phase|Progressive disease|0|||
129930666|NCT01828112|467711595|FG000|Treatment Phase|Study terminated by sponsor|1|||
129930667|NCT01828112|467711596|FG001|Treatment Phase|Study terminated by sponsor|0|||
129930668|NCT01828112|467711597|FG002|Treatment Phase|Study terminated by sponsor|0|||
129930669|NCT01828112|467711595|FG000|Treatment Phase|Subject/guardian decision|12|||
129930670|NCT01828112|467711596|FG001|Treatment Phase|Subject/guardian decision|8|||
129930671|NCT01828112|467711597|FG002|Treatment Phase|Subject/guardian decision|0|||
129930672|NCT01828112|467711595|FG000|Extension Treatment Phase|Adverse Event|0|||
129930673|NCT01828112|467711596|FG001|Extension Treatment Phase|Adverse Event|0|||
129930674|NCT01828112|467711597|FG002|Extension Treatment Phase|Adverse Event|6|||
129930675|NCT01828112|467711595|FG000|Extension Treatment Phase|Death|0|||
129930676|NCT01828112|467711596|FG001|Extension Treatment Phase|Death|0|||
129930677|NCT01828112|467711597|FG002|Extension Treatment Phase|Death|17|||
129930678|NCT01828112|467711595|FG000|Extension Treatment Phase|Physician Decision|0|||
129930679|NCT01828112|467711596|FG001|Extension Treatment Phase|Physician Decision|0|||
129930680|NCT01828112|467711597|FG002|Extension Treatment Phase|Physician Decision|5|||
129930681|NCT01828112|467711595|FG000|Extension Treatment Phase|Progressive disease|0|||
129930682|NCT01828112|467711596|FG001|Extension Treatment Phase|Progressive disease|0|||
129930683|NCT01828112|467711597|FG002|Extension Treatment Phase|Progressive disease|46|||
129930684|NCT01828112|467711595|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
129930685|NCT01828112|467711596|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
129930686|NCT01828112|467711597|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
129930687|NCT01828112|467711595|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
129930688|NCT01828112|467711596|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
129930689|NCT01828112|467711597|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
129930690|NCT02446236|467711607|FG000|Overall Study|Screen Failure|1|||
129930691|NCT02446236|467711608|FG001|Overall Study|Screen Failure|0|||
129930692|NCT02446236|467711609|FG002|Overall Study|Screen Failure|1|||
129930693|NCT02446236|467711607|FG000|Overall Study|Actively Receiving Therapy|0|||
129930694|NCT02446236|467711608|FG001|Overall Study|Actively Receiving Therapy|0|||
129930695|NCT02446236|467711609|FG002|Overall Study|Actively Receiving Therapy|1|||
129930696|NCT00429364|467711610|FG000|Overall Study|Withdrawal by Subject|11|||
129930697|NCT00429364|467711611|FG001|Overall Study|Withdrawal by Subject|5|||
129930698|NCT00429364|467711610|FG000|Overall Study|Physician Decision|4|||
129930699|NCT00429364|467711611|FG001|Overall Study|Physician Decision|2|||
129930700|NCT00429364|467711610|FG000|Overall Study|Lost to Follow-up|7|||
129930701|NCT00429364|467711611|FG001|Overall Study|Lost to Follow-up|6|||
129930702|NCT00429364|467711610|FG000|Overall Study|Death|0|||
129930703|NCT00429364|467711611|FG001|Overall Study|Death|1|||
129930704|NCT00429364|467711610|FG000|Overall Study|Underwent aortic root surgery|10|||
129930705|NCT00429364|467711611|FG001|Overall Study|Underwent aortic root surgery|18|||
129930706|NCT00429364|467711610|FG000|Overall Study|Pregnancy|0|||
129930707|NCT00429364|467711611|FG001|Overall Study|Pregnancy|1|||
129930708|NCT04871529|467711612|FG000|Overall Study|Withdrawal by Subject|0|||
129930709|NCT04871529|467711613|FG001|Overall Study|Withdrawal by Subject|1|||
129930710|NCT04871529|467711612|FG000|Overall Study|Death|0|||
129930711|NCT04871529|467711613|FG001|Overall Study|Death|1|||
129930712|NCT04871529|467711612|FG000|Overall Study|Not protocol specified|0|||
129930713|NCT04871529|467711613|FG001|Overall Study|Not protocol specified|1|||
129930714|NCT05184452|467711614|FG000|Overall Study|Lost to Follow-up|0|||
129930715|NCT05184452|467711615|FG001|Overall Study|Lost to Follow-up|0|||
129930716|NCT05184452|467711616|FG002|Overall Study|Lost to Follow-up|0|||
129930717|NCT05184452|467711617|FG003|Overall Study|Lost to Follow-up|0|||
129930718|NCT05184452|467711618|FG004|Overall Study|Lost to Follow-up|0|||
129930719|NCT05184452|467711619|FG005|Overall Study|Lost to Follow-up|2|||
129930720|NCT05184452|467711620|FG006|Overall Study|Lost to Follow-up|0|||
129930721|NCT05184452|467711621|FG007|Overall Study|Lost to Follow-up|0|||
129930722|NCT05184452|467711622|FG008|Overall Study|Lost to Follow-up|0|||
129930723|NCT05184452|467711623|FG009|Overall Study|Lost to Follow-up|1|||
129930724|NCT05184452|467711614|FG000|Overall Study|Withdrawal by Subject|0|||
129930725|NCT05184452|467711615|FG001|Overall Study|Withdrawal by Subject|0|||
129930726|NCT05184452|467711616|FG002|Overall Study|Withdrawal by Subject|0|||
129930727|NCT05184452|467711617|FG003|Overall Study|Withdrawal by Subject|0|||
129930728|NCT05184452|467711618|FG004|Overall Study|Withdrawal by Subject|0|||
129930729|NCT05184452|467711619|FG005|Overall Study|Withdrawal by Subject|1|||
129930730|NCT05184452|467711620|FG006|Overall Study|Withdrawal by Subject|0|||
129930731|NCT05184452|467711621|FG007|Overall Study|Withdrawal by Subject|0|||
129930732|NCT05184452|467711622|FG008|Overall Study|Withdrawal by Subject|0|||
129930733|NCT05184452|467711623|FG009|Overall Study|Withdrawal by Subject|1|||
129930734|NCT04428203|467711624|FG000|Overall Study|Adverse Event|1|||
129930735|NCT04428203|467711625|FG001|Overall Study|Adverse Event|0|||
129930736|NCT04428203|467711626|FG002|Overall Study|Adverse Event|0|||
129930737|NCT04428203|467711624|FG000|Overall Study|Withdrawal by Subject|1|||
129930738|NCT04428203|467711625|FG001|Overall Study|Withdrawal by Subject|0|||
129930739|NCT04428203|467711626|FG002|Overall Study|Withdrawal by Subject|1|||
129930740|NCT05280574|467711627|FG000|Overall Study|Withdrawal by Subject|0|||
129930741|NCT05280574|467711628|FG001|Overall Study|Withdrawal by Subject|2|||
129930742|NCT05280574|467711629|FG002|Overall Study|Withdrawal by Subject|0|||
129930743|NCT04056611|467711632|FG000|Overall Study|Physician Decision|1|||
129930744|NCT03733925|467711633|FG000|Overall Study|Lost to Follow-up|1|||
129930745|NCT03733925|467711633|FG000|Overall Study|Withdrawal by Subject|2|||
129930746|NCT03733925|467711633|FG000|Overall Study|Adverse Event|2|||
129930747|NCT03733925|467711633|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129930748|NCT02631746|467711634|FG000|Overall Study|Lack of Efficacy|3|||
129930749|NCT02224144|467711635|FG000|Overall Study|Lost to Follow-up|3|||
129930750|NCT02224144|467711636|FG001|Overall Study|Lost to Follow-up|1|||
129930751|NCT02224144|467711635|FG000|Overall Study|Death|2|||
129930752|NCT02224144|467711636|FG001|Overall Study|Death|0|||
129930753|NCT02224144|467711635|FG000|Overall Study|Withdrawal by Subject|0|||
129930754|NCT02224144|467711636|FG001|Overall Study|Withdrawal by Subject|1|||
129930755|NCT02780700|467711646|FG000|Overall Study|Progressive disease|1|||
129930756|NCT04086121|467711657|FG000|Overall Study|Other than listed|8|||
129930757|NCT04086121|467711657|FG000|Overall Study|Withdrawal by Subject|3|||
129930758|NCT04086121|467711657|FG000|Overall Study|Lost to Follow-up|2|||
129930759|NCT04086121|467711657|FG000|Overall Study|Adverse Event|1|||
129930760|NCT02834390|467711658|FG000|Induction Phase|Progressive disease|0|||
129930761|NCT02834390|467711659|FG001|Induction Phase|Progressive disease|1|||
129930762|NCT02834390|467711658|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
129930763|NCT02834390|467711659|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
129930764|NCT02834390|467711658|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
129930765|NCT02834390|467711659|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
129930766|NCT02834390|467711658|FG000|Consolidation Phase|Physician Decision|1|||
129930767|NCT02834390|467711659|FG001|Consolidation Phase|Physician Decision|1|||
129930768|NCT03118518|467711660|FG000|Overall Study|Early Exit after treatment|2|||
129930769|NCT03118518|467711661|FG001|Overall Study|Early Exit after treatment|8|||
129451106|NCT00806195|465950380|FG003|Overall Study|Withdrawal by Subject|35|||
129451107|NCT00806195|465950377|FG000|Overall Study|Lost to Follow-up|217|||
129451108|NCT00806195|465950378|FG001|Overall Study|Lost to Follow-up|66|||
129451109|NCT00806195|465950379|FG002|Overall Study|Lost to Follow-up|90|||
129451110|NCT00806195|465950380|FG003|Overall Study|Lost to Follow-up|34|||
129451111|NCT00806195|465950377|FG000|Overall Study|Inappropriate Enrollment|0|||
129451112|NCT00806195|465950378|FG001|Overall Study|Inappropriate Enrollment|1|||
129451113|NCT00806195|465950379|FG002|Overall Study|Inappropriate Enrollment|0|||
129451114|NCT00806195|465950380|FG003|Overall Study|Inappropriate Enrollment|0|||
129451115|NCT00806195|465950377|FG000|Overall Study|Administrative Reason|113|||
129451116|NCT00806195|465950378|FG001|Overall Study|Administrative Reason|35|||
129451117|NCT00806195|465950379|FG002|Overall Study|Administrative Reason|66|||
129451118|NCT00806195|465950380|FG003|Overall Study|Administrative Reason|26|||
129451119|NCT00806195|465950377|FG000|Overall Study|Protocol Violation|34|||
129451120|NCT00806195|465950378|FG001|Overall Study|Protocol Violation|24|||
129451121|NCT00806195|465950379|FG002|Overall Study|Protocol Violation|26|||
129451122|NCT00806195|465950380|FG003|Overall Study|Protocol Violation|9|||
129451123|NCT02490475|465950381|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
129451124|NCT02490475|465950382|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
129451125|NCT02490475|465950383|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
129451126|NCT02490475|465950384|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
129451127|NCT02490475|465950381|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
129451128|NCT02490475|465950382|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
129451129|NCT02490475|465950383|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
129451130|NCT02490475|465950384|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
129451131|NCT02490475|465950381|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
129451132|NCT02490475|465950382|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
129451133|NCT02490475|465950383|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
129451134|NCT02490475|465950384|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
129451135|NCT02490475|465950381|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
129451136|NCT02490475|465950382|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
129451137|NCT02490475|465950383|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
129451138|NCT02490475|465950384|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
129451139|NCT02490475|465950381|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
129451140|NCT02490475|465950382|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
129451141|NCT02490475|465950383|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
129451142|NCT02490475|465950384|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
129451143|NCT02490475|465950381|FG000|Period 2: Extension Phase|Refused Treatment|0|||
129451144|NCT02490475|465950382|FG001|Period 2: Extension Phase|Refused Treatment|0|||
129451145|NCT02490475|465950383|FG002|Period 2: Extension Phase|Refused Treatment|0|||
129451146|NCT02490475|465950384|FG003|Period 2: Extension Phase|Refused Treatment|1|||
129451147|NCT02490475|465950381|FG000|Period 2: Extension Phase|Adverse Event|0|||
129451148|NCT02490475|465950382|FG001|Period 2: Extension Phase|Adverse Event|0|||
129451149|NCT02490475|465950383|FG002|Period 2: Extension Phase|Adverse Event|1|||
129451150|NCT02490475|465950384|FG003|Period 2: Extension Phase|Adverse Event|0|||
129451151|NCT00139776|465950385|FG000|Period I|Did not enter Period II|575|||
129451152|NCT00139776|465950386|FG001|Period I|Did not enter Period II|0|||
129451153|NCT00139776|465950387|FG002|Period I|Did not enter Period II|0|||
129451154|NCT00139776|465950388|FG003|Period I|Did not enter Period II|0|||
129451155|NCT00139776|465950385|FG000|Period II|Not Randomized into Period III|0|||
129451156|NCT00139776|465950386|FG001|Period II|Not Randomized into Period III|322|||
129451157|NCT00139776|465950387|FG002|Period II|Not Randomized into Period III|0|||
129451158|NCT00139776|465950388|FG003|Period II|Not Randomized into Period III|0|||
129930770|NCT03118518|467711660|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
129930771|NCT03118518|467711661|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
129930772|NCT02998528|467711667|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
129930773|NCT02998528|467711668|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
129930774|NCT02998528|467711669|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
129930775|NCT02998528|467711667|FG000|Randomization Period|Participant withdrew consent|0|||
129930776|NCT02998528|467711668|FG001|Randomization Period|Participant withdrew consent|3|||
129930777|NCT02998528|467711669|FG002|Randomization Period|Participant withdrew consent|0|||
129930778|NCT02998528|467711667|FG000|Randomization Period|Participant no longer meets study criteria|1|||
129930779|NCT02998528|467711668|FG001|Randomization Period|Participant no longer meets study criteria|3|||
129930780|NCT02998528|467711669|FG002|Randomization Period|Participant no longer meets study criteria|2|||
129930781|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
129930782|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
129930783|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
129930784|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
129930785|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
129930786|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
129930787|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
129930788|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
129930789|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
129930790|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
129930791|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
129930792|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
129930793|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
129930794|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
129930795|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
129930796|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Death|1|||
129930797|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Death|0|||
129930798|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Death|0|||
129930799|NCT02998528|467711667|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
129930800|NCT02998528|467711668|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
129930801|NCT02998528|467711669|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
129930802|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
129930803|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
129930804|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
129930805|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
129930806|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
129930807|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
129930808|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
129930809|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
129930810|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
129451159|NCT00139776|465950385|FG000|Period III|Adverse Event|0|||
129930811|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
129930812|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
129930813|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
129930814|NCT02998528|467711667|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
129930815|NCT02998528|467711668|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
129930816|NCT02998528|467711669|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
129930817|NCT05660434|467711672|FG000|Overall Study|Never obtained study materials|2|||
129930818|NCT05660434|467711673|FG001|Overall Study|Never obtained study materials|1|||
129930819|NCT02575950|467711674|FG000|Overall Study|Withdrawal by Subject|0|||
129930820|NCT02575950|467711675|FG001|Overall Study|Withdrawal by Subject|0|||
129930821|NCT02575950|467711676|FG002|Overall Study|Withdrawal by Subject|0|||
129930822|NCT02575950|467711677|FG003|Overall Study|Withdrawal by Subject|2|||
129930823|NCT02575950|467711674|FG000|Overall Study|Lost to Follow-up|0|||
129930824|NCT02575950|467711675|FG001|Overall Study|Lost to Follow-up|1|||
129930825|NCT02575950|467711676|FG002|Overall Study|Lost to Follow-up|0|||
129930826|NCT02575950|467711677|FG003|Overall Study|Lost to Follow-up|3|||
129930827|NCT04271046|467711678|FG000|Overall Study|Death|0|||
129930828|NCT04271046|467711679|FG001|Overall Study|Death|2|||
129930829|NCT04271046|467711680|FG002|Overall Study|Death|0|||
129930830|NCT04271046|467711681|FG003|Overall Study|Death|2|||
129930831|NCT04271046|467711678|FG000|Overall Study|Lost to Follow-up|12|||
129930832|NCT04271046|467711679|FG001|Overall Study|Lost to Follow-up|12|||
129930833|NCT04271046|467711680|FG002|Overall Study|Lost to Follow-up|11|||
129930834|NCT04271046|467711681|FG003|Overall Study|Lost to Follow-up|11|||
129930835|NCT04271046|467711678|FG000|Overall Study|Patient with Dementia Died|2|||
129930836|NCT04271046|467711679|FG001|Overall Study|Patient with Dementia Died|0|||
129930837|NCT04271046|467711680|FG002|Overall Study|Patient with Dementia Died|2|||
129930838|NCT04271046|467711681|FG003|Overall Study|Patient with Dementia Died|0|||
129930839|NCT04271046|467711678|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
129930840|NCT04271046|467711679|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
129930841|NCT04271046|467711680|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
129930842|NCT04271046|467711681|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
129930843|NCT04797858|467713819|FG000|Overall Study|Withdrawal by Subject|0|||
129930844|NCT04797858|467713820|FG001|Overall Study|Withdrawal by Subject|1|||
129930845|NCT04797858|467713819|FG000|Overall Study|Excluded due to administrative error|7|||
129930846|NCT04797858|467713820|FG001|Overall Study|Excluded due to administrative error|8|||
129930847|NCT04826471|467713821|FG000|Overall Study|Lost to Follow-up|2|||
129930848|NCT04826471|467713821|FG000|Overall Study|Protocol Violation|3|||
129930849|NCT04826471|467713821|FG000|Overall Study|Withdrawal by Subject|1|||
129930850|NCT04414722|467713822|FG000|Overall Study|Lost to Follow-up|3|||
129930851|NCT04414722|467713823|FG001|Overall Study|Lost to Follow-up|4|||
129930852|NCT04414722|467713824|FG002|Overall Study|Lost to Follow-up|3|||
129930853|NCT04414722|467713825|FG003|Overall Study|Lost to Follow-up|2|||
129930854|NCT04414722|467713826|FG004|Overall Study|Lost to Follow-up|3|||
129930855|NCT04414722|467713822|FG000|Overall Study|Withdrawal by Subject|6|||
129930856|NCT04414722|467713823|FG001|Overall Study|Withdrawal by Subject|3|||
129930857|NCT04414722|467713824|FG002|Overall Study|Withdrawal by Subject|1|||
129930858|NCT04414722|467713825|FG003|Overall Study|Withdrawal by Subject|5|||
129930859|NCT04414722|467713826|FG004|Overall Study|Withdrawal by Subject|1|||
129930860|NCT04414722|467713822|FG000|Overall Study|Physician Decision|0|||
129930861|NCT04414722|467713823|FG001|Overall Study|Physician Decision|1|||
129930862|NCT04414722|467713824|FG002|Overall Study|Physician Decision|2|||
129930863|NCT04414722|467713825|FG003|Overall Study|Physician Decision|0|||
129930864|NCT04414722|467713826|FG004|Overall Study|Physician Decision|0|||
129930865|NCT04414722|467713822|FG000|Overall Study|Non-participatory|0|||
129930866|NCT04414722|467713823|FG001|Overall Study|Non-participatory|1|||
129930867|NCT04414722|467713824|FG002|Overall Study|Non-participatory|1|||
129930868|NCT04414722|467713825|FG003|Overall Study|Non-participatory|0|||
129930869|NCT04414722|467713826|FG004|Overall Study|Non-participatory|0|||
129930870|NCT04304144|467713827|FG000|DLT Observation Period|Physician Decision|0|||
129930871|NCT04304144|467713828|FG001|DLT Observation Period|Physician Decision|1|||
129930872|NCT04304144|467713829|FG002|DLT Observation Period|Physician Decision|0|||
129930873|NCT04304144|467713830|FG003|DLT Observation Period|Physician Decision|0|||
129930874|NCT04304144|467713827|FG000|Continued Treatment Period|Adverse Event|0|||
129930875|NCT04304144|467713828|FG001|Continued Treatment Period|Adverse Event|1|||
129930876|NCT04304144|467713829|FG002|Continued Treatment Period|Adverse Event|0|||
129930877|NCT04304144|467713830|FG003|Continued Treatment Period|Adverse Event|0|||
129930878|NCT04304144|467713827|FG000|Continued Treatment Period|Death|0|||
129930879|NCT04304144|467713828|FG001|Continued Treatment Period|Death|0|||
129930880|NCT04304144|467713829|FG002|Continued Treatment Period|Death|1|||
129930881|NCT04304144|467713830|FG003|Continued Treatment Period|Death|2|||
129930882|NCT04304144|467713827|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
129930883|NCT04304144|467713828|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
129930884|NCT04304144|467713829|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
129930885|NCT04304144|467713830|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
129930886|NCT04304144|467713827|FG000|Continued Treatment Period|Other than specified|2|||
129930887|NCT04304144|467713828|FG001|Continued Treatment Period|Other than specified|0|||
129930888|NCT04304144|467713829|FG002|Continued Treatment Period|Other than specified|1|||
129930889|NCT04304144|467713830|FG003|Continued Treatment Period|Other than specified|1|||
129930890|NCT05256654|467713831|FG000|Overall Study|Adverse Event|0|||
129451160|NCT00139776|465950386|FG001|Period III|Adverse Event|0|||
129451161|NCT00139776|465950387|FG002|Period III|Adverse Event|22|||
129451162|NCT00139776|465950388|FG003|Period III|Adverse Event|23|||
129451163|NCT00139776|465950385|FG000|Period III|Other|0|||
129451164|NCT00139776|465950386|FG001|Period III|Other|0|||
129451165|NCT00139776|465950387|FG002|Period III|Other|23|||
129451166|NCT00139776|465950388|FG003|Period III|Other|34|||
129451167|NCT00139776|465950385|FG000|Period III|Lack of Efficacy|0|||
129451168|NCT00139776|465950386|FG001|Period III|Lack of Efficacy|0|||
129451169|NCT00139776|465950387|FG002|Period III|Lack of Efficacy|10|||
129451170|NCT00139776|465950388|FG003|Period III|Lack of Efficacy|24|||
129451171|NCT00139776|465950385|FG000|Period III|Lost to Follow-up|0|||
129451172|NCT00139776|465950386|FG001|Period III|Lost to Follow-up|0|||
129451173|NCT00139776|465950387|FG002|Period III|Lost to Follow-up|5|||
129451174|NCT00139776|465950388|FG003|Period III|Lost to Follow-up|4|||
129451175|NCT00139776|465950385|FG000|Period III|Withdrawal by Subject|0|||
129451176|NCT00139776|465950386|FG001|Period III|Withdrawal by Subject|0|||
129451177|NCT00139776|465950387|FG002|Period III|Withdrawal by Subject|16|||
129451178|NCT00139776|465950388|FG003|Period III|Withdrawal by Subject|21|||
129451179|NCT04912245|465950389|FG000|Overall Study|Withdrawal by Subject|21|||
129451180|NCT04912245|465950390|FG001|Overall Study|Withdrawal by Subject|4|||
129451181|NCT04912245|465950389|FG000|Overall Study|Lost to Follow-up|5|||
129451182|NCT04912245|465950390|FG001|Overall Study|Lost to Follow-up|11|||
129451183|NCT01368536|465950397|FG000|Overall Study|Adverse Event|5|||
129451184|NCT01368536|465950398|FG001|Overall Study|Adverse Event|6|||
129451185|NCT01368536|465950399|FG002|Overall Study|Adverse Event|8|||
129451186|NCT01368536|465950397|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129451187|NCT01368536|465950398|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129451188|NCT01368536|465950399|FG002|Overall Study|Abnormal laboratory value(s)|2|||
129451189|NCT01368536|465950397|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129451190|NCT01368536|465950398|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129451191|NCT01368536|465950399|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129451192|NCT01368536|465950397|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
129451193|NCT01368536|465950398|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129451194|NCT01368536|465950399|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129451195|NCT01368536|465950397|FG000|Overall Study|No longer required study medication|0|||
129451196|NCT01368536|465950398|FG001|Overall Study|No longer required study medication|0|||
129451197|NCT01368536|465950399|FG002|Overall Study|No longer required study medication|1|||
129451198|NCT01368536|465950397|FG000|Overall Study|Withdrawal by Subject|2|||
129451199|NCT01368536|465950398|FG001|Overall Study|Withdrawal by Subject|5|||
129451200|NCT01368536|465950399|FG002|Overall Study|Withdrawal by Subject|4|||
129451201|NCT01368536|465950397|FG000|Overall Study|Lost to Follow-up|3|||
129451202|NCT01368536|465950398|FG001|Overall Study|Lost to Follow-up|3|||
129451203|NCT01368536|465950399|FG002|Overall Study|Lost to Follow-up|5|||
129451204|NCT01368536|465950397|FG000|Overall Study|Administrative problems|34|||
129451205|NCT01368536|465950398|FG001|Overall Study|Administrative problems|39|||
129451206|NCT01368536|465950399|FG002|Overall Study|Administrative problems|35|||
129451207|NCT01368536|465950397|FG000|Overall Study|Protocol deviation|0|||
129451208|NCT01368536|465950398|FG001|Overall Study|Protocol deviation|3|||
129451209|NCT01368536|465950399|FG002|Overall Study|Protocol deviation|1|||
129451210|NCT01161043|465950400|FG000|Overall Study|Withdrawal by Subject|3|||
129451211|NCT02164929|465950401|FG000|Overall Study|Converted to open procedure|1|||
129451212|NCT02164929|465950402|FG001|Overall Study|Converted to open procedure|0|||
129451213|NCT02164929|465950403|FG002|Overall Study|Converted to open procedure|0|||
129451214|NCT02164929|465950404|FG003|Overall Study|Converted to open procedure|2|||
129451215|NCT02164929|465950401|FG000|Overall Study|Failed regional block|0|||
129451216|NCT02164929|465950402|FG001|Overall Study|Failed regional block|0|||
129451217|NCT02164929|465950403|FG002|Overall Study|Failed regional block|1|||
129451218|NCT02164929|465950404|FG003|Overall Study|Failed regional block|0|||
129451219|NCT00971178|465950405|FG000|Overall Study|Lost to Follow-up|2|||
129451220|NCT00971178|465950406|FG001|Overall Study|Lost to Follow-up|2|||
129451221|NCT00971178|465950407|FG002|Overall Study|Lost to Follow-up|2|||
129451222|NCT03023059|465950409|FG000|Overall Study|Withdrawal by Subject|5|||
129451223|NCT00596947|465950414|FG000|Overall Study|study halted due to low enrollment|5|||
129451224|NCT00596947|465950415|FG001|Overall Study|study halted due to low enrollment|3|||
129451225|NCT00596947|465950414|FG000|Overall Study|Lost to Follow-up|1|||
129451226|NCT00596947|465950415|FG001|Overall Study|Lost to Follow-up|0|||
129451227|NCT00496730|465950416|FG000|Overall Study|Lost to Follow-up|4|||
129451228|NCT00496730|465950417|FG001|Overall Study|Lost to Follow-up|3|||
129451229|NCT00496730|465950416|FG000|Overall Study|Withdrawal by Subject|2|||
129451230|NCT00496730|465950417|FG001|Overall Study|Withdrawal by Subject|2|||
129451231|NCT00113074|465950418|FG000|Overall Study|Lost to Follow-up|10|||
129451232|NCT00113074|465950419|FG001|Overall Study|Lost to Follow-up|10|||
129451233|NCT00113074|465950420|FG002|Overall Study|Lost to Follow-up|14|||
129451234|NCT02114268|465950421|FG000|Overall Study|Lost to Follow-up|4|||
129451235|NCT02114268|465950422|FG001|Overall Study|Lost to Follow-up|1|||
129451236|NCT02114268|465950423|FG002|Overall Study|Lost to Follow-up|1|||
129451237|NCT02114268|465950424|FG003|Overall Study|Lost to Follow-up|0|||
129930891|NCT05256654|467713832|FG001|Overall Study|Adverse Event|0|||
129930892|NCT05256654|467713833|FG002|Overall Study|Adverse Event|1|||
129930893|NCT05256654|467713834|FG003|Overall Study|Adverse Event|0|||
129930894|NCT05256654|467713831|FG000|Overall Study|Lost to Follow-up|0|||
129930895|NCT05256654|467713832|FG001|Overall Study|Lost to Follow-up|0|||
129930896|NCT05256654|467713833|FG002|Overall Study|Lost to Follow-up|0|||
129930897|NCT05256654|467713834|FG003|Overall Study|Lost to Follow-up|1|||
129930898|NCT05256654|467713831|FG000|Overall Study|Withdrawal by Subject|1|||
129930899|NCT05256654|467713832|FG001|Overall Study|Withdrawal by Subject|2|||
129930900|NCT05256654|467713833|FG002|Overall Study|Withdrawal by Subject|1|||
129930901|NCT05256654|467713834|FG003|Overall Study|Withdrawal by Subject|3|||
129930902|NCT05256654|467713831|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
129930903|NCT05256654|467713832|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
129930904|NCT05256654|467713833|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
129930905|NCT05256654|467713834|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
129930906|NCT05256654|467713831|FG000|Overall Study|Other|0|||
129930907|NCT05256654|467713832|FG001|Overall Study|Other|0|||
129930908|NCT05256654|467713833|FG002|Overall Study|Other|0|||
129930909|NCT05256654|467713834|FG003|Overall Study|Other|1|||
129930910|NCT03442309|467713841|FG000|Overall Study|Lost to Follow-up|1676|||
129930911|NCT03442309|467713842|FG001|Overall Study|Lost to Follow-up|1642|||
129930912|NCT04862416|467713843|FG000|Overall Study|Withdrawal by Subject|0|||
129930913|NCT04862416|467713844|FG001|Overall Study|Withdrawal by Subject|1|||
129930914|NCT04862416|467713845|FG002|Overall Study|Withdrawal by Subject|0|||
129930915|NCT04862416|467713846|FG003|Overall Study|Withdrawal by Subject|1|||
129930916|NCT04862416|467713847|FG004|Overall Study|Withdrawal by Subject|0|||
129930917|NCT04862416|467713848|FG005|Overall Study|Withdrawal by Subject|0|||
129930918|NCT04862416|467713849|FG006|Overall Study|Withdrawal by Subject|0|||
129930919|NCT04862416|467713850|FG007|Overall Study|Withdrawal by Subject|0|||
129930920|NCT05207956|467713851|FG000|Overall Study|Lost to follow up|1|||
129930921|NCT05207956|467713852|FG001|Overall Study|Lost to follow up|2|||
129930922|NCT05425420|467713868|FG000|Overall Study|Physician Decision|1|||
129930923|NCT05425420|467713868|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
129930924|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
129930925|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
129930926|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
129930927|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
129930928|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
129930929|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
129930930|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
129930931|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
129930932|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
129930933|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
129930934|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
129930935|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
129930936|NCT05237284|467713871|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
129930937|NCT05237284|467713872|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
129930938|NCT05237284|467713873|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
129930939|NCT05237284|467713874|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
129930940|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
129930941|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
129930942|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
129930943|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
129930944|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
129930945|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
129930946|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
129930947|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
129930948|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
129930949|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
129930950|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
129930951|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
129930952|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
129930953|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
129930954|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
129930955|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
129451238|NCT02114268|465950425|FG004|Overall Study|Lost to Follow-up|0|||
129451239|NCT02114268|465950426|FG005|Overall Study|Lost to Follow-up|2|||
129451240|NCT02114268|465950421|FG000|Overall Study|Withdrawal by Subject|1|||
129451241|NCT02114268|465950422|FG001|Overall Study|Withdrawal by Subject|0|||
129451242|NCT02114268|465950423|FG002|Overall Study|Withdrawal by Subject|0|||
129451243|NCT02114268|465950424|FG003|Overall Study|Withdrawal by Subject|0|||
129930956|NCT05237284|467713871|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
129930957|NCT05237284|467713872|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
129930958|NCT05237284|467713873|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
129930959|NCT05237284|467713874|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
129930960|NCT04571619|467713878|FG000|Phase 1|Death|22|||
129930961|NCT04571619|467713879|FG001|Phase 1|Death|18|||
129930962|NCT04571619|467713878|FG000|Phase 1|Withdrawal by Subject|7|||
129930963|NCT04571619|467713879|FG001|Phase 1|Withdrawal by Subject|2|||
129930964|NCT04571619|467713878|FG000|Phase 2|Death|13|||
129930965|NCT04571619|467713879|FG001|Phase 2|Death|16|||
129930966|NCT04571619|467713878|FG000|Phase 2|Withdrawal by Subject|6|||
129930967|NCT04571619|467713879|FG001|Phase 2|Withdrawal by Subject|4|||
129930968|NCT03505008|467713880|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
129930969|NCT03505008|467713881|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
129930970|NCT03505008|467713882|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
129930971|NCT03505008|467713883|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
129930972|NCT03505008|467713880|FG000|Before Week 24 Randomization|Adverse Event|10|||
129930973|NCT03505008|467713881|FG001|Before Week 24 Randomization|Adverse Event|0|||
129930974|NCT03505008|467713882|FG002|Before Week 24 Randomization|Adverse Event|0|||
129930975|NCT03505008|467713883|FG003|Before Week 24 Randomization|Adverse Event|0|||
129930976|NCT03505008|467713880|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
129930977|NCT03505008|467713881|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
129930978|NCT03505008|467713882|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
129930979|NCT03505008|467713883|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
129930980|NCT03505008|467713880|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
129930981|NCT03505008|467713881|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
129930982|NCT03505008|467713882|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
129930983|NCT03505008|467713883|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
129930984|NCT03505008|467713880|FG000|Before Week 24 Randomization|Physician Decision|2|||
129930985|NCT03505008|467713881|FG001|Before Week 24 Randomization|Physician Decision|0|||
129930986|NCT03505008|467713882|FG002|Before Week 24 Randomization|Physician Decision|0|||
129930987|NCT03505008|467713883|FG003|Before Week 24 Randomization|Physician Decision|0|||
129930988|NCT03505008|467713880|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
129930989|NCT03505008|467713881|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
129930990|NCT03505008|467713882|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
129930991|NCT03505008|467713883|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
129930992|NCT03505008|467713880|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
129930993|NCT03505008|467713881|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
129930994|NCT03505008|467713882|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
129930995|NCT03505008|467713883|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
129930996|NCT03505008|467713880|FG000|Before Week 24 Randomization|Complication|1|||
129930997|NCT03505008|467713881|FG001|Before Week 24 Randomization|Complication|0|||
129930998|NCT03505008|467713882|FG002|Before Week 24 Randomization|Complication|0|||
129930999|NCT03505008|467713883|FG003|Before Week 24 Randomization|Complication|0|||
129931000|NCT03505008|467713880|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
129931001|NCT03505008|467713881|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
129931002|NCT03505008|467713882|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
129931003|NCT03505008|467713883|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
129931004|NCT03505008|467713880|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
129931005|NCT03505008|467713881|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
129931006|NCT03505008|467713882|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
129931007|NCT03505008|467713883|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
129931008|NCT03505008|467713880|FG000|After Week 24 Randomization|Adverse Event|0|||
129931009|NCT03505008|467713881|FG001|After Week 24 Randomization|Adverse Event|1|||
129931010|NCT03505008|467713882|FG002|After Week 24 Randomization|Adverse Event|2|||
129931011|NCT03505008|467713883|FG003|After Week 24 Randomization|Adverse Event|2|||
129931012|NCT03505008|467713880|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
129931013|NCT03505008|467713881|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
129931014|NCT03505008|467713882|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
129931015|NCT03505008|467713883|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
129931016|NCT03505008|467713880|FG000|After Week 24 Randomization|Protocol Violation|0|||
129931017|NCT03505008|467713881|FG001|After Week 24 Randomization|Protocol Violation|0|||
129931018|NCT03505008|467713882|FG002|After Week 24 Randomization|Protocol Violation|1|||
129931019|NCT03505008|467713883|FG003|After Week 24 Randomization|Protocol Violation|0|||
129931020|NCT04741776|467713884|FG000|Overall Study|Withdrawal by Subject|7|||
129931021|NCT04741776|467713885|FG001|Overall Study|Withdrawal by Subject|10|||
129931022|NCT04741776|467713886|FG002|Overall Study|Withdrawal by Subject|10|||
129931023|NCT04741776|467713887|FG003|Overall Study|Withdrawal by Subject|17|||
129931024|NCT04741776|467713884|FG000|Overall Study|Death|0|||
129931025|NCT04741776|467713885|FG001|Overall Study|Death|0|||
129931026|NCT04741776|467713886|FG002|Overall Study|Death|1|||
129931027|NCT04741776|467713887|FG003|Overall Study|Death|0|||
129931028|NCT05069896|467713888|FG000|Overall Study|Adverse Event|0|||
129931029|NCT05069896|467713889|FG001|Overall Study|Adverse Event|1|||
129931030|NCT05069896|467713890|FG002|Overall Study|Adverse Event|1|||
129931031|NCT05069896|467713891|FG003|Overall Study|Adverse Event|0|||
129931032|NCT05069896|467713892|FG004|Overall Study|Adverse Event|0|||
129931033|NCT05069896|467713893|FG005|Overall Study|Adverse Event|0|||
129931034|NCT05069896|467713888|FG000|Overall Study|Lost to Follow-up|0|||
129931035|NCT05069896|467713889|FG001|Overall Study|Lost to Follow-up|0|||
129931036|NCT05069896|467713890|FG002|Overall Study|Lost to Follow-up|1|||
129931037|NCT05069896|467713891|FG003|Overall Study|Lost to Follow-up|0|||
129931038|NCT05069896|467713892|FG004|Overall Study|Lost to Follow-up|1|||
129931039|NCT05069896|467713893|FG005|Overall Study|Lost to Follow-up|2|||
129931040|NCT04068831|467713894|FG000|Overall Study|Disease Progression|10|||
129931041|NCT04068831|467713895|FG001|Overall Study|Disease Progression|8|||
129931042|NCT04820322|467713896|FG000|Overall Study|Adverse Event|1|||
129931043|NCT04820322|467713897|FG001|Overall Study|Adverse Event|0|||
129931044|NCT00323856|467713901|FG000|Overall Study|Withdrawal by Subject|1|||
129931045|NCT00323856|467713901|FG000|Overall Study|Was uncooperative and noncompliant|1|||
129931046|NCT00323856|467713901|FG000|Overall Study|Reason not specified|1|||
129931047|NCT00323856|467713901|FG000|Overall Study|Missing|2|||
129931048|NCT03156465|467713902|FG000|Overall Study|Withdrawal by Subject|2|||
129931049|NCT04580914|467713914|FG000|Overall Study|Withdrawal by Subject|6|||
129931050|NCT04580914|467713914|FG000|Overall Study|Lost to Follow-up|2|||
129931051|NCT03580356|467713916|FG000|Treatment Period|Withdrawal by Subject|13|||
129931052|NCT03580356|467713917|FG001|Treatment Period|Withdrawal by Subject|0|||
129931053|NCT03580356|467713918|FG002|Treatment Period|Withdrawal by Subject|13|||
129931054|NCT03580356|467713919|FG003|Treatment Period|Withdrawal by Subject|1|||
129931055|NCT03580356|467713920|FG004|Treatment Period|Withdrawal by Subject|17|||
129931056|NCT03580356|467713921|FG005|Treatment Period|Withdrawal by Subject|0|||
129931057|NCT03580356|467713922|FG006|Treatment Period|Withdrawal by Subject|5|||
129931058|NCT03580356|467713923|FG007|Treatment Period|Withdrawal by Subject|0|||
129931059|NCT03580356|467713916|FG000|Treatment Period|Adverse Event|10|||
129931060|NCT03580356|467713917|FG001|Treatment Period|Adverse Event|0|||
129931061|NCT03580356|467713918|FG002|Treatment Period|Adverse Event|13|||
129931062|NCT03580356|467713919|FG003|Treatment Period|Adverse Event|0|||
129931063|NCT03580356|467713920|FG004|Treatment Period|Adverse Event|5|||
129931064|NCT03580356|467713921|FG005|Treatment Period|Adverse Event|0|||
129931065|NCT03580356|467713922|FG006|Treatment Period|Adverse Event|8|||
129931066|NCT03580356|467713923|FG007|Treatment Period|Adverse Event|0|||
129931067|NCT03580356|467713916|FG000|Treatment Period|Protocol Violation|5|||
129931068|NCT03580356|467713917|FG001|Treatment Period|Protocol Violation|0|||
129931069|NCT03580356|467713918|FG002|Treatment Period|Protocol Violation|6|||
129931070|NCT03580356|467713919|FG003|Treatment Period|Protocol Violation|1|||
129931071|NCT03580356|467713920|FG004|Treatment Period|Protocol Violation|9|||
129931072|NCT03580356|467713921|FG005|Treatment Period|Protocol Violation|1|||
129931073|NCT03580356|467713922|FG006|Treatment Period|Protocol Violation|1|||
129931074|NCT03580356|467713923|FG007|Treatment Period|Protocol Violation|0|||
129931075|NCT03580356|467713916|FG000|Treatment Period|Lack of Efficacy|6|||
129931076|NCT03580356|467713917|FG001|Treatment Period|Lack of Efficacy|0|||
129931077|NCT03580356|467713918|FG002|Treatment Period|Lack of Efficacy|2|||
129931078|NCT03580356|467713919|FG003|Treatment Period|Lack of Efficacy|0|||
129931079|NCT03580356|467713920|FG004|Treatment Period|Lack of Efficacy|3|||
129931080|NCT03580356|467713921|FG005|Treatment Period|Lack of Efficacy|0|||
129931081|NCT03580356|467713922|FG006|Treatment Period|Lack of Efficacy|3|||
129931082|NCT03580356|467713923|FG007|Treatment Period|Lack of Efficacy|0|||
129931083|NCT03580356|467713916|FG000|Treatment Period|Pregnancy|1|||
129931084|NCT03580356|467713917|FG001|Treatment Period|Pregnancy|0|||
129931085|NCT03580356|467713918|FG002|Treatment Period|Pregnancy|7|||
129931086|NCT03580356|467713919|FG003|Treatment Period|Pregnancy|0|||
129931087|NCT03580356|467713920|FG004|Treatment Period|Pregnancy|2|||
129931088|NCT03580356|467713921|FG005|Treatment Period|Pregnancy|0|||
129931089|NCT03580356|467713922|FG006|Treatment Period|Pregnancy|1|||
129931090|NCT03580356|467713923|FG007|Treatment Period|Pregnancy|0|||
129931091|NCT03580356|467713916|FG000|Treatment Period|Physician Decision|2|||
129931092|NCT03580356|467713917|FG001|Treatment Period|Physician Decision|0|||
129931093|NCT03580356|467713918|FG002|Treatment Period|Physician Decision|1|||
129931094|NCT03580356|467713919|FG003|Treatment Period|Physician Decision|0|||
129931095|NCT03580356|467713920|FG004|Treatment Period|Physician Decision|4|||
129931096|NCT03580356|467713921|FG005|Treatment Period|Physician Decision|0|||
129931097|NCT03580356|467713922|FG006|Treatment Period|Physician Decision|2|||
129931098|NCT03580356|467713923|FG007|Treatment Period|Physician Decision|0|||
129931099|NCT03580356|467713916|FG000|Treatment Period|Lost to Follow-up|1|||
129931100|NCT03580356|467713917|FG001|Treatment Period|Lost to Follow-up|1|||
129931101|NCT03580356|467713918|FG002|Treatment Period|Lost to Follow-up|1|||
129931102|NCT03580356|467713919|FG003|Treatment Period|Lost to Follow-up|0|||
129931103|NCT03580356|467713920|FG004|Treatment Period|Lost to Follow-up|3|||
129931104|NCT03580356|467713921|FG005|Treatment Period|Lost to Follow-up|0|||
129931105|NCT03580356|467713922|FG006|Treatment Period|Lost to Follow-up|1|||
129931106|NCT03580356|467713923|FG007|Treatment Period|Lost to Follow-up|0|||
129931107|NCT03580356|467713916|FG000|Treatment Period|Death|0|||
129931108|NCT03580356|467713917|FG001|Treatment Period|Death|0|||
129931109|NCT03580356|467713918|FG002|Treatment Period|Death|1|||
129931110|NCT03580356|467713919|FG003|Treatment Period|Death|0|||
129931111|NCT03580356|467713920|FG004|Treatment Period|Death|0|||
129931112|NCT03580356|467713921|FG005|Treatment Period|Death|0|||
129931113|NCT03580356|467713922|FG006|Treatment Period|Death|0|||
129931114|NCT03580356|467713923|FG007|Treatment Period|Death|0|||
129931115|NCT03580356|467713916|FG000|Treatment Period|Technical problems|0|||
129931116|NCT03580356|467713917|FG001|Treatment Period|Technical problems|0|||
129931117|NCT03580356|467713918|FG002|Treatment Period|Technical problems|0|||
129931118|NCT03580356|467713919|FG003|Treatment Period|Technical problems|0|||
129931119|NCT03580356|467713920|FG004|Treatment Period|Technical problems|1|||
129931120|NCT03580356|467713921|FG005|Treatment Period|Technical problems|0|||
129931121|NCT03580356|467713922|FG006|Treatment Period|Technical problems|0|||
129931122|NCT03580356|467713923|FG007|Treatment Period|Technical problems|0|||
129931123|NCT03580356|467713916|FG000|Treatment Period|Misrandomized, no treatment|0|||
129931124|NCT03580356|467713917|FG001|Treatment Period|Misrandomized, no treatment|0|||
129931125|NCT03580356|467713918|FG002|Treatment Period|Misrandomized, no treatment|1|||
129931126|NCT03580356|467713919|FG003|Treatment Period|Misrandomized, no treatment|0|||
129931127|NCT03580356|467713920|FG004|Treatment Period|Misrandomized, no treatment|2|||
129931128|NCT03580356|467713921|FG005|Treatment Period|Misrandomized, no treatment|0|||
129931129|NCT03580356|467713922|FG006|Treatment Period|Misrandomized, no treatment|0|||
129931130|NCT03580356|467713923|FG007|Treatment Period|Misrandomized, no treatment|0|||
129931131|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
129931132|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
129931133|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
129931134|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
129931135|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
129931136|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
129931137|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
129931138|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
129931139|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
129931140|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931141|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
129931142|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931143|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
129931144|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931145|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931146|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
129931147|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
129931148|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
129931149|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
129931150|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
129931151|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
129931152|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
129931153|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
129931154|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
129931155|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931156|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931157|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
129931158|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931159|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
129931160|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931161|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931162|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
129931163|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
129931164|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
129931165|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
129931166|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
129931167|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
129931168|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
129931169|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
129931170|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
129931171|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
129931172|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
129931173|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
129931174|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
129931175|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
129931176|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
129931177|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
129931178|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
129931179|NCT03580356|467713916|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
129931180|NCT03580356|467713917|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
129931181|NCT03580356|467713918|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
129931182|NCT03580356|467713919|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
129931183|NCT03580356|467713920|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
129931184|NCT03580356|467713921|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
129931185|NCT03580356|467713922|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
129931186|NCT03580356|467713923|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
129931187|NCT05715528|467713924|FG000|Overall Study|Randomized but never treated|11|||
129931188|NCT05715528|467713925|FG001|Overall Study|Randomized but never treated|13|||
129931189|NCT05715528|467713924|FG000|Overall Study|Withdrew consent|7|||
129931190|NCT05715528|467713925|FG001|Overall Study|Withdrew consent|15|||
129931191|NCT05715528|467713924|FG000|Overall Study|Lost to Follow-up|5|||
129931192|NCT05715528|467713925|FG001|Overall Study|Lost to Follow-up|13|||
129931193|NCT05715528|467713924|FG000|Overall Study|Investigator's discretion|3|||
129931194|NCT05715528|467713925|FG001|Overall Study|Investigator's discretion|1|||
129931195|NCT05715528|467713924|FG000|Overall Study|Protocol Violation|2|||
129931196|NCT05715528|467713925|FG001|Overall Study|Protocol Violation|0|||
129931197|NCT05715528|467713924|FG000|Overall Study|Non-compliance with study drug|0|||
129931198|NCT05715528|467713925|FG001|Overall Study|Non-compliance with study drug|1|||
129931199|NCT05035654|467713926|FG000|Overall Study|Physician Decision|0|||
129931200|NCT05035654|467713927|FG001|Overall Study|Physician Decision|1|||
129931201|NCT05035654|467713928|FG002|Overall Study|Physician Decision|0|||
129931202|NCT05035654|467713926|FG000|Overall Study|Adverse Event|0|||
129931203|NCT05035654|467713927|FG001|Overall Study|Adverse Event|1|||
129931204|NCT05035654|467713928|FG002|Overall Study|Adverse Event|0|||
129931205|NCT05035654|467713926|FG000|Overall Study|Withdrawal by Subject|0|||
129931206|NCT05035654|467713927|FG001|Overall Study|Withdrawal by Subject|0|||
129931207|NCT05035654|467713928|FG002|Overall Study|Withdrawal by Subject|4|||
129931208|NCT05035654|467713926|FG000|Overall Study|Bilateral Dislodgement|1|||
129931209|NCT05035654|467713927|FG001|Overall Study|Bilateral Dislodgement|0|||
129931210|NCT05035654|467713928|FG002|Overall Study|Bilateral Dislodgement|0|||
129931211|NCT02367040|467713930|FG000|Overall Study|Lost to Follow-up|1|||
129931212|NCT02367040|467713931|FG001|Overall Study|Lost to Follow-up|1|||
129931213|NCT02367040|467713930|FG000|Overall Study|Lack of Efficacy|1|||
129931214|NCT02367040|467713931|FG001|Overall Study|Lack of Efficacy|0|||
129931215|NCT02367040|467713930|FG000|Overall Study|Additional primary malignancy|0|||
129931216|NCT02367040|467713931|FG001|Overall Study|Additional primary malignancy|1|||
129931217|NCT02367040|467713930|FG000|Overall Study|AE not associated with clinical disease progression|114|||
129931218|NCT02367040|467713931|FG001|Overall Study|AE not associated with clinical disease progression|11|||
129931219|NCT02367040|467713930|FG000|Overall Study|AE associated with clinical disease progression|1|||
129931220|NCT02367040|467713931|FG001|Overall Study|AE associated with clinical disease progression|3|||
129931221|NCT02367040|467713930|FG000|Overall Study|Physician Decision|2|||
129931222|NCT02367040|467713931|FG001|Overall Study|Physician Decision|8|||
129931223|NCT02367040|467713930|FG000|Overall Study|Non-compliance with study drug|1|||
129931224|NCT02367040|467713931|FG001|Overall Study|Non-compliance with study drug|0|||
129931225|NCT02367040|467713930|FG000|Overall Study|Failure to meet continuation criteria|1|||
129931226|NCT02367040|467713931|FG001|Overall Study|Failure to meet continuation criteria|0|||
129931227|NCT02367040|467713930|FG000|Overall Study|Switching to other therapy|2|||
129931228|NCT02367040|467713931|FG001|Overall Study|Switching to other therapy|0|||
129931229|NCT02367040|467713930|FG000|Overall Study|Withdrawal by Subject|46|||
129931230|NCT02367040|467713931|FG001|Overall Study|Withdrawal by Subject|16|||
129931231|NCT02367040|467713930|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
129931232|NCT02367040|467713931|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129931233|NCT02367040|467713930|FG000|Overall Study|Patient decision|39|||
129931234|NCT02367040|467713931|FG001|Overall Study|Patient decision|14|||
129931235|NCT02367040|467713930|FG000|Overall Study|Required procedure failed|1|||
129931236|NCT02367040|467713931|FG001|Overall Study|Required procedure failed|0|||
129931237|NCT02367040|467713930|FG000|Overall Study|Randomized by mistake with study treatment|1|||
129931238|NCT02367040|467713931|FG001|Overall Study|Randomized by mistake with study treatment|0|||
129931239|NCT02367040|467713930|FG000|Overall Study|Protocol Violation|1|||
129931240|NCT02367040|467713931|FG001|Overall Study|Protocol Violation|0|||
129931241|NCT02367040|467713930|FG000|Overall Study|Progressive disease - radiological progression|51|||
129931242|NCT02367040|467713931|FG001|Overall Study|Progressive disease - radiological progression|78|||
129931243|NCT02367040|467713930|FG000|Overall Study|Progressive disease - clinical progression|6|||
129931244|NCT02367040|467713931|FG001|Overall Study|Progressive disease - clinical progression|6|||
129931245|NCT02367040|467713930|FG000|Overall Study|Drug not administered|3|||
129931246|NCT02367040|467713931|FG001|Overall Study|Drug not administered|2|||
129931247|NCT02367040|467713930|FG000|Overall Study|Progressive disease|0|||
129931248|NCT02367040|467713931|FG001|Overall Study|Progressive disease|1|||
129931249|NCT02367040|467713930|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
129931250|NCT02367040|467713931|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
129931251|NCT02367040|467713930|FG000|Overall Study|Death|2|||
129931252|NCT02367040|467713931|FG001|Overall Study|Death|0|||
129931253|NCT05856435|467713943|FG000|Overall Study|Lost to Follow-up|6|||
129931254|NCT02323880|467713944|FG000|Overall Study|Adverse Event|2|||
129931255|NCT02323880|467713945|FG001|Overall Study|Adverse Event|0|||
129931256|NCT02323880|467713946|FG002|Overall Study|Adverse Event|1|||
129931257|NCT02323880|467713947|FG003|Overall Study|Adverse Event|1|||
129931258|NCT02323880|467713948|FG004|Overall Study|Adverse Event|1|||
129931259|NCT02323880|467713949|FG005|Overall Study|Adverse Event|0|||
129931260|NCT02323880|467713950|FG006|Overall Study|Adverse Event|1|||
129931261|NCT02323880|467713951|FG007|Overall Study|Adverse Event|0|||
129931262|NCT02323880|467713944|FG000|Overall Study|Death|0|||
129931263|NCT02323880|467713945|FG001|Overall Study|Death|0|||
129931264|NCT02323880|467713946|FG002|Overall Study|Death|0|||
129931265|NCT02323880|467713947|FG003|Overall Study|Death|0|||
129931266|NCT02323880|467713948|FG004|Overall Study|Death|0|||
129931267|NCT02323880|467713949|FG005|Overall Study|Death|1|||
129931268|NCT02323880|467713950|FG006|Overall Study|Death|0|||
129931269|NCT02323880|467713951|FG007|Overall Study|Death|0|||
129931270|NCT02323880|467713944|FG000|Overall Study|Lack of Efficacy|4|||
129931271|NCT02323880|467713945|FG001|Overall Study|Lack of Efficacy|11|||
129931272|NCT02323880|467713946|FG002|Overall Study|Lack of Efficacy|5|||
129931273|NCT02323880|467713947|FG003|Overall Study|Lack of Efficacy|5|||
129931274|NCT02323880|467713948|FG004|Overall Study|Lack of Efficacy|4|||
129931275|NCT02323880|467713949|FG005|Overall Study|Lack of Efficacy|8|||
129931276|NCT02323880|467713950|FG006|Overall Study|Lack of Efficacy|4|||
129931277|NCT02323880|467713951|FG007|Overall Study|Lack of Efficacy|6|||
129931278|NCT02323880|467713944|FG000|Overall Study|Physician Decision|0|||
129931279|NCT02323880|467713945|FG001|Overall Study|Physician Decision|0|||
129931280|NCT02323880|467713946|FG002|Overall Study|Physician Decision|0|||
129931281|NCT02323880|467713947|FG003|Overall Study|Physician Decision|0|||
129931282|NCT02323880|467713948|FG004|Overall Study|Physician Decision|1|||
129931283|NCT02323880|467713949|FG005|Overall Study|Physician Decision|1|||
129931284|NCT02323880|467713950|FG006|Overall Study|Physician Decision|1|||
129931285|NCT02323880|467713951|FG007|Overall Study|Physician Decision|0|||
129931286|NCT02323880|467713944|FG000|Overall Study|Withdrawal by Subject|0|||
129931287|NCT02323880|467713945|FG001|Overall Study|Withdrawal by Subject|2|||
129931288|NCT02323880|467713946|FG002|Overall Study|Withdrawal by Subject|0|||
129931289|NCT02323880|467713947|FG003|Overall Study|Withdrawal by Subject|0|||
129931290|NCT02323880|467713948|FG004|Overall Study|Withdrawal by Subject|0|||
129931291|NCT02323880|467713949|FG005|Overall Study|Withdrawal by Subject|0|||
129931292|NCT02323880|467713950|FG006|Overall Study|Withdrawal by Subject|0|||
129931293|NCT02323880|467713951|FG007|Overall Study|Withdrawal by Subject|0|||
129931294|NCT04934072|467713953|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
129931295|NCT04934072|467713954|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
129931296|NCT04934072|467713955|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
129931297|NCT04934072|467713956|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
129931298|NCT04934072|467713957|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
129931299|NCT04934072|467713953|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
129931300|NCT04934072|467713954|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
129931301|NCT04934072|467713955|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
129931302|NCT04934072|467713956|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
129931303|NCT04934072|467713957|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
129931304|NCT04934072|467713953|FG000|Day 0 to Week 52|Other|3|||
129931305|NCT04934072|467713954|FG001|Day 0 to Week 52|Other|1|||
129931306|NCT04934072|467713955|FG002|Day 0 to Week 52|Other|0|||
129931307|NCT04934072|467713956|FG003|Day 0 to Week 52|Other|0|||
129931308|NCT04934072|467713957|FG004|Day 0 to Week 52|Other|0|||
129931309|NCT04934072|467713953|FG000|Day 0 to Week 52|Adverse Event|1|||
129931310|NCT04934072|467713954|FG001|Day 0 to Week 52|Adverse Event|3|||
129931311|NCT04934072|467713955|FG002|Day 0 to Week 52|Adverse Event|0|||
129931312|NCT04934072|467713956|FG003|Day 0 to Week 52|Adverse Event|0|||
129931313|NCT04934072|467713957|FG004|Day 0 to Week 52|Adverse Event|0|||
129931314|NCT04934072|467713953|FG000|Week 52 to Week 78|Adverse Event|0|||
129931315|NCT04934072|467713954|FG001|Week 52 to Week 78|Adverse Event|0|||
129931316|NCT04934072|467713955|FG002|Week 52 to Week 78|Adverse Event|0|||
129931317|NCT04934072|467713956|FG003|Week 52 to Week 78|Adverse Event|1|||
129931318|NCT04934072|467713957|FG004|Week 52 to Week 78|Adverse Event|1|||
129931319|NCT04934072|467713953|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
129931320|NCT04934072|467713954|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
129931321|NCT04934072|467713955|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
129931322|NCT04934072|467713956|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
129931323|NCT04934072|467713957|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
129931324|NCT04934072|467713953|FG000|Week 52 to Week 78|Other|0|||
129931325|NCT04934072|467713954|FG001|Week 52 to Week 78|Other|0|||
129931326|NCT04934072|467713955|FG002|Week 52 to Week 78|Other|1|||
129931327|NCT04934072|467713956|FG003|Week 52 to Week 78|Other|0|||
129931328|NCT04934072|467713957|FG004|Week 52 to Week 78|Other|0|||
129931329|NCT03213678|467713962|FG000|Overall Study|Death|1|||
129931330|NCT03213678|467713962|FG000|Overall Study|Physician Decision|1|||
129931331|NCT03213678|467713962|FG000|Overall Study|Progressive disease|16|||
129931332|NCT04218851|467713963|FG000|Overall Study|Death|1|||
129931333|NCT04218851|467713964|FG001|Overall Study|Death|3|||
129931334|NCT03174275|467713967|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
129931335|NCT03174275|467713967|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
129931336|NCT03174275|467713967|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
129931337|NCT03174275|467713967|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
129931338|NCT03174275|467713967|FG000|Adjuvant Chemotherapy|Progression|1|||
129931339|NCT03174275|467713967|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
129931340|NCT03174275|467713967|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
129931341|NCT03174275|467713967|FG000|Adjuvant Durvalumab|Progression|1|||
129931342|NCT03174275|467713967|FG000|Adjuvant Durvalumab|Adverse Event|3|||
129931343|NCT03174275|467713967|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
129931344|NCT03174275|467713967|FG000|Adjuvant Radiotherapy|Progression|1|||
129931345|NCT03174275|467713967|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
129931346|NCT05285137|467713968|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
129931347|NCT05285137|467713969|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
129931348|NCT05285137|467713970|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
129931349|NCT05285137|467713971|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
129931350|NCT05285137|467713972|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
129931351|NCT05285137|467713973|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
129931352|NCT05285137|467713974|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
129931353|NCT05285137|467713975|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
129931354|NCT05285137|467713976|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
129931355|NCT05285137|467713968|FG000|Overall Study|Lost to Follow-up|0|||
129931356|NCT05285137|467713969|FG001|Overall Study|Lost to Follow-up|0|||
129931357|NCT05285137|467713970|FG002|Overall Study|Lost to Follow-up|1|||
129931358|NCT05285137|467713971|FG003|Overall Study|Lost to Follow-up|3|||
129931359|NCT05285137|467713972|FG004|Overall Study|Lost to Follow-up|0|||
129931360|NCT05285137|467713973|FG005|Overall Study|Lost to Follow-up|0|||
129931361|NCT05285137|467713974|FG006|Overall Study|Lost to Follow-up|1|||
129931362|NCT05285137|467713975|FG007|Overall Study|Lost to Follow-up|0|||
129931363|NCT05285137|467713976|FG008|Overall Study|Lost to Follow-up|0|||
129931364|NCT05285137|467713968|FG000|Overall Study|Physician Decision|0|||
129931365|NCT05285137|467713969|FG001|Overall Study|Physician Decision|1|||
129931366|NCT05285137|467713970|FG002|Overall Study|Physician Decision|0|||
129931367|NCT05285137|467713971|FG003|Overall Study|Physician Decision|0|||
129931368|NCT05285137|467713972|FG004|Overall Study|Physician Decision|0|||
129931369|NCT05285137|467713973|FG005|Overall Study|Physician Decision|0|||
129931370|NCT05285137|467713974|FG006|Overall Study|Physician Decision|0|||
129931371|NCT05285137|467713975|FG007|Overall Study|Physician Decision|0|||
129931372|NCT05285137|467713976|FG008|Overall Study|Physician Decision|0|||
129931373|NCT05285137|467713968|FG000|Overall Study|Pregnancy|0|||
129931374|NCT05285137|467713969|FG001|Overall Study|Pregnancy|0|||
129931375|NCT05285137|467713970|FG002|Overall Study|Pregnancy|0|||
129931376|NCT05285137|467713971|FG003|Overall Study|Pregnancy|0|||
129931377|NCT05285137|467713972|FG004|Overall Study|Pregnancy|0|||
129931378|NCT05285137|467713973|FG005|Overall Study|Pregnancy|0|||
129931379|NCT05285137|467713974|FG006|Overall Study|Pregnancy|1|||
129931380|NCT05285137|467713975|FG007|Overall Study|Pregnancy|0|||
129931381|NCT05285137|467713976|FG008|Overall Study|Pregnancy|0|||
129931382|NCT05285137|467713968|FG000|Overall Study|Withdrawal by Subject|0|||
129931383|NCT05285137|467713969|FG001|Overall Study|Withdrawal by Subject|1|||
129931384|NCT05285137|467713970|FG002|Overall Study|Withdrawal by Subject|2|||
129931385|NCT05285137|467713971|FG003|Overall Study|Withdrawal by Subject|1|||
129931386|NCT05285137|467713972|FG004|Overall Study|Withdrawal by Subject|0|||
129931387|NCT05285137|467713973|FG005|Overall Study|Withdrawal by Subject|0|||
129931388|NCT05285137|467713974|FG006|Overall Study|Withdrawal by Subject|0|||
129931389|NCT05285137|467713975|FG007|Overall Study|Withdrawal by Subject|0|||
129931390|NCT05285137|467713976|FG008|Overall Study|Withdrawal by Subject|1|||
129931391|NCT01820611|467713977|FG000|Overall Study|Death|8|||
129931392|NCT01820611|467713977|FG000|Overall Study|Adverse Event|1|||
129931393|NCT01820611|467713977|FG000|Overall Study|Withdrawal by Subject|9|||
129931394|NCT03484819|467713978|FG000|Overall Study|Death|2|||
129931395|NCT03484819|467713978|FG000|Overall Study|Adverse Event|2|||
129931396|NCT03484819|467713978|FG000|Overall Study|Physician Decision|1|||
129931397|NCT03484819|467713978|FG000|Overall Study|Withdrawal by Subject|2|||
129931398|NCT03484819|467713978|FG000|Overall Study|Disease Progression|4|||
129931399|NCT03484819|467713978|FG000|Overall Study|Complicating Condition|1|||
129931400|NCT04456296|467713979|FG000|Overall Study|Withdrawal by Subject|14|||
129931401|NCT04456296|467713980|FG001|Overall Study|Withdrawal by Subject|21|||
129931402|NCT04456296|467713981|FG002|Overall Study|Withdrawal by Subject|21|||
129931403|NCT04456296|467713979|FG000|Overall Study|Adverse Event|2|||
129931404|NCT04456296|467713980|FG001|Overall Study|Adverse Event|2|||
129931405|NCT04456296|467713981|FG002|Overall Study|Adverse Event|2|||
129931406|NCT04456296|467713979|FG000|Overall Study|Death|1|||
129931407|NCT04456296|467713980|FG001|Overall Study|Death|0|||
129931408|NCT04456296|467713981|FG002|Overall Study|Death|0|||
129931409|NCT04456296|467713979|FG000|Overall Study|Lost to Follow-up|3|||
129931410|NCT04456296|467713980|FG001|Overall Study|Lost to Follow-up|5|||
129931411|NCT04456296|467713981|FG002|Overall Study|Lost to Follow-up|6|||
129931412|NCT04456296|467713979|FG000|Overall Study|Other than specified|0|||
129931413|NCT04456296|467713980|FG001|Overall Study|Other than specified|1|||
129931414|NCT04456296|467713981|FG002|Overall Study|Other than specified|4|||
129931415|NCT04456296|467713979|FG000|Overall Study|Randomized, not treated|2|||
129931416|NCT04456296|467713980|FG001|Overall Study|Randomized, not treated|1|||
129931417|NCT04456296|467713981|FG002|Overall Study|Randomized, not treated|0|||
129931418|NCT05736458|467713982|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
129931419|NCT05736458|467713983|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
129931420|NCT05736458|467713984|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
129931421|NCT05736458|467713982|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
129931422|NCT05736458|467713983|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
129931423|NCT05736458|467713984|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
129931424|NCT05736458|467713982|FG000|TMS/fMRI #1|Physician Decision|0|||
129931425|NCT05736458|467713983|FG001|TMS/fMRI #1|Physician Decision|0|||
129931426|NCT05736458|467713984|FG002|TMS/fMRI #1|Physician Decision|2|||
129931427|NCT05736458|467713982|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
129931428|NCT05736458|467713983|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
129931429|NCT05736458|467713984|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
129931430|NCT04247802|467713985|FG000|Overall Study|Withdrawal by Subject|1|||
129931431|NCT04247802|467713986|FG001|Overall Study|Withdrawal by Subject|3|||
129931432|NCT04247802|467713985|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
129931433|NCT04247802|467713986|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
129931434|NCT05962814|467713987|FG000|Overall Study|failed eligibility|1|||
129931435|NCT02865538|467713989|FG000|Overall Study|Withdrawal by Subject|0|||
129931436|NCT02865538|467713990|FG001|Overall Study|Withdrawal by Subject|0|||
129931437|NCT02865538|467713991|FG002|Overall Study|Withdrawal by Subject|1|||
129931438|NCT02865538|467713992|FG003|Overall Study|Withdrawal by Subject|0|||
129931439|NCT02865538|467713993|FG004|Overall Study|Withdrawal by Subject|0|||
129931440|NCT02865538|467713989|FG000|Overall Study|Lost to Follow-up|1|||
129931441|NCT02865538|467713990|FG001|Overall Study|Lost to Follow-up|0|||
129931442|NCT02865538|467713991|FG002|Overall Study|Lost to Follow-up|0|||
129931443|NCT02865538|467713992|FG003|Overall Study|Lost to Follow-up|0|||
129931444|NCT02865538|467713993|FG004|Overall Study|Lost to Follow-up|0|||
129931445|NCT03106740|467715136|FG000|Overall Study|Lost to Follow-up|2|||
129931446|NCT03106740|467715137|FG001|Overall Study|Lost to Follow-up|2|||
129931447|NCT03106740|467715136|FG000|Overall Study|Withdrawal by Subject|2|||
129931448|NCT03106740|467715137|FG001|Overall Study|Withdrawal by Subject|4|||
129931449|NCT03106740|467715136|FG000|Overall Study|Physician Decision|0|||
129931450|NCT03106740|467715137|FG001|Overall Study|Physician Decision|1|||
129931451|NCT03106740|467715136|FG000|Overall Study|Partial data|1|||
129931452|NCT03106740|467715137|FG001|Overall Study|Partial data|0|||
129931453|NCT04565990|467715138|FG000|Overall Study|Death|5|||
129931454|NCT04565990|467715138|FG000|Overall Study|Lost to Follow-up|1|||
129931455|NCT04565990|467715138|FG000|Overall Study|Withdrawal by Subject|1|||
129931456|NCT04862234|467715139|FG000|Overall Study|Surgery cancellation|1|||
129931457|NCT04862234|467715140|FG001|Overall Study|Surgery cancellation|2|||
129931458|NCT04862234|467715139|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
129931459|NCT04862234|467715140|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
129931460|NCT04862234|467715139|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
129931461|NCT04862234|467715140|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
129931462|NCT03292484|467715141|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
129931463|NCT03292484|467715141|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
129931464|NCT03292484|467715141|FG000|Overall Study|Protocol Violation|2|||
129451244|NCT02114268|465950425|FG004|Overall Study|Withdrawal by Subject|0|||
129451245|NCT02114268|465950426|FG005|Overall Study|Withdrawal by Subject|1|||
129451246|NCT02114268|465950421|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
129451247|NCT02114268|465950422|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
129451248|NCT02114268|465950423|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
129451249|NCT02114268|465950424|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
129451250|NCT02114268|465950425|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
129451251|NCT02114268|465950426|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
129451252|NCT03962738|465950427|FG000|Overall Study|Protocol Deviation|3|||
129451253|NCT03962738|465950428|FG001|Overall Study|Protocol Deviation|0|||
129451254|NCT03962738|465950429|FG002|Overall Study|Protocol Deviation|1|||
129451255|NCT03962738|465950430|FG003|Overall Study|Protocol Deviation|1|||
129451256|NCT03962738|465950427|FG000|Overall Study|Withdrawal by Subject|4|||
129451257|NCT03962738|465950428|FG001|Overall Study|Withdrawal by Subject|0|||
129451258|NCT03962738|465950429|FG002|Overall Study|Withdrawal by Subject|0|||
129451259|NCT03962738|465950430|FG003|Overall Study|Withdrawal by Subject|0|||
129451260|NCT03962738|465950427|FG000|Overall Study|Lost to Follow-up|0|||
129451261|NCT03962738|465950428|FG001|Overall Study|Lost to Follow-up|0|||
129451262|NCT03962738|465950429|FG002|Overall Study|Lost to Follow-up|1|||
129451263|NCT03962738|465950430|FG003|Overall Study|Lost to Follow-up|0|||
129451264|NCT00509067|465950431|FG000|Overall Study|Lost to Follow-up|1|||
129451265|NCT00509067|465950432|FG001|Overall Study|Lost to Follow-up|1|||
129451266|NCT00509067|465950431|FG000|Overall Study|Adverse Event|3|||
129451267|NCT00509067|465950432|FG001|Overall Study|Adverse Event|1|||
129451268|NCT00509067|465950431|FG000|Overall Study|Protocol Violation|0|||
129451269|NCT00509067|465950432|FG001|Overall Study|Protocol Violation|3|||
129451270|NCT00574288|465950433|FG000|Overall Study|Adverse Event|2|||
129451271|NCT00574288|465950434|FG001|Overall Study|Adverse Event|0|||
129451272|NCT00574288|465950435|FG002|Overall Study|Adverse Event|0|||
129451273|NCT00574288|465950436|FG003|Overall Study|Adverse Event|0|||
129451274|NCT00574288|465950437|FG004|Overall Study|Adverse Event|1|||
129451275|NCT00574288|465950438|FG005|Overall Study|Adverse Event|0|||
129451276|NCT00574288|465950439|FG006|Overall Study|Adverse Event|0|||
129451277|NCT00574288|465950433|FG000|Overall Study|Death|0|||
129451278|NCT00574288|465950434|FG001|Overall Study|Death|0|||
129451279|NCT00574288|465950435|FG002|Overall Study|Death|0|||
129451280|NCT00574288|465950436|FG003|Overall Study|Death|0|||
129451281|NCT00574288|465950437|FG004|Overall Study|Death|0|||
129451282|NCT00574288|465950438|FG005|Overall Study|Death|25|||
129451283|NCT00574288|465950439|FG006|Overall Study|Death|21|||
129451284|NCT00574288|465950433|FG000|Overall Study|Lost to Follow-up|0|||
129451285|NCT00574288|465950434|FG001|Overall Study|Lost to Follow-up|0|||
129451286|NCT00574288|465950435|FG002|Overall Study|Lost to Follow-up|0|||
129451287|NCT00574288|465950436|FG003|Overall Study|Lost to Follow-up|0|||
129451288|NCT00574288|465950437|FG004|Overall Study|Lost to Follow-up|0|||
129451289|NCT00574288|465950438|FG005|Overall Study|Lost to Follow-up|1|||
129451290|NCT00574288|465950439|FG006|Overall Study|Lost to Follow-up|2|||
129451291|NCT00574288|465950433|FG000|Overall Study|Study Terminated By Sponsor|0|||
129451292|NCT00574288|465950434|FG001|Overall Study|Study Terminated By Sponsor|0|||
129451293|NCT00574288|465950435|FG002|Overall Study|Study Terminated By Sponsor|0|||
129451294|NCT00574288|465950436|FG003|Overall Study|Study Terminated By Sponsor|0|||
129451295|NCT00574288|465950437|FG004|Overall Study|Study Terminated By Sponsor|0|||
129451296|NCT00574288|465950438|FG005|Overall Study|Study Terminated By Sponsor|0|||
129451297|NCT00574288|465950439|FG006|Overall Study|Study Terminated By Sponsor|5|||
129451298|NCT00574288|465950433|FG000|Overall Study|Progressive Disease|17|||
129451299|NCT00574288|465950434|FG001|Overall Study|Progressive Disease|2|||
129451300|NCT00574288|465950435|FG002|Overall Study|Progressive Disease|3|||
129451301|NCT00574288|465950436|FG003|Overall Study|Progressive Disease|2|||
129451302|NCT00574288|465950437|FG004|Overall Study|Progressive Disease|1|||
129451303|NCT00574288|465950438|FG005|Overall Study|Progressive Disease|0|||
129451304|NCT00574288|465950439|FG006|Overall Study|Progressive Disease|0|||
129451305|NCT00574288|465950433|FG000|Overall Study|Other|1|||
129451306|NCT00574288|465950434|FG001|Overall Study|Other|1|||
129451307|NCT00574288|465950435|FG002|Overall Study|Other|0|||
129451308|NCT00574288|465950436|FG003|Overall Study|Other|0|||
129451309|NCT00574288|465950437|FG004|Overall Study|Other|0|||
129931465|NCT03292484|467715141|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
129451310|NCT00574288|465950438|FG005|Overall Study|Other|0|||
129451311|NCT00574288|465950439|FG006|Overall Study|Other|0|||
129451312|NCT02361944|465950442|FG000|Overall Study|surgery cancellation|0|||
129451313|NCT02361944|465950443|FG001|Overall Study|surgery cancellation|1|||
129451314|NCT03654976|465950444|FG000|Overall Study|Withdrawal by Subject|12|||
129451315|NCT03654976|465950445|FG001|Overall Study|Withdrawal by Subject|11|||
129451316|NCT03654976|465950444|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
129451317|NCT03654976|465950445|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
129451318|NCT03654976|465950444|FG000|Overall Study|Adverse Event|5|||
129451319|NCT03654976|465950445|FG001|Overall Study|Adverse Event|0|||
129451320|NCT03654976|465950444|FG000|Overall Study|Lost to Follow-up|2|||
129451321|NCT03654976|465950445|FG001|Overall Study|Lost to Follow-up|0|||
129931466|NCT03292484|467715141|FG000|Overall Study|Sponsor decision|349|||
129931467|NCT03292484|467715141|FG000|Overall Study|Lost to Follow-up|7|||
129931468|NCT03292484|467715141|FG000|Overall Study|Coronavirus Disease 2019|1|||
129931469|NCT03292484|467715141|FG000|Overall Study|Other|20|||
129931470|NCT05290493|467715142|FG000|Overall Study|Withdrawal by Subject|2|||
129931471|NCT05290493|467715143|FG001|Overall Study|Withdrawal by Subject|2|||
129931472|NCT05290493|467715142|FG000|Overall Study|Adverse Event|1|||
129931473|NCT05290493|467715143|FG001|Overall Study|Adverse Event|0|||
129931474|NCT04615273|467715147|FG000|Overall Study|Withdrawal by Subject|3|||
129931475|NCT04615273|467715148|FG001|Overall Study|Withdrawal by Subject|1|||
129931476|NCT04615273|467715149|FG002|Overall Study|Withdrawal by Subject|2|||
129931477|NCT04615273|467715147|FG000|Overall Study|Adverse Event|1|||
129931478|NCT04615273|467715148|FG001|Overall Study|Adverse Event|0|||
129931479|NCT04615273|467715149|FG002|Overall Study|Adverse Event|1|||
129931480|NCT04615273|467715147|FG000|Overall Study|Lost to Follow-up|0|||
129931481|NCT04615273|467715148|FG001|Overall Study|Lost to Follow-up|1|||
129931482|NCT04615273|467715149|FG002|Overall Study|Lost to Follow-up|0|||
129931483|NCT04615273|467715147|FG000|Overall Study|Physician Decision|0|||
129931484|NCT04615273|467715148|FG001|Overall Study|Physician Decision|0|||
129931485|NCT04615273|467715149|FG002|Overall Study|Physician Decision|1|||
129931486|NCT04615273|467715147|FG000|Overall Study|Other|0|||
129931487|NCT04615273|467715148|FG001|Overall Study|Other|1|||
129931488|NCT04615273|467715149|FG002|Overall Study|Other|0|||
129931489|NCT04615273|467715147|FG000|Overall Study|Randomized but not treated|1|||
129931490|NCT04615273|467715148|FG001|Overall Study|Randomized but not treated|3|||
129931491|NCT04615273|467715149|FG002|Overall Study|Randomized but not treated|1|||
129931492|NCT03677141|467715153|FG000|Overall Study|Death|2|||
129931493|NCT03677141|467715154|FG001|Overall Study|Death|1|||
129931494|NCT03677141|467715155|FG002|Overall Study|Death|6|||
129931495|NCT03677141|467715156|FG003|Overall Study|Death|9|||
129931496|NCT03677141|467715157|FG004|Overall Study|Death|5|||
129931497|NCT03677141|467715158|FG005|Overall Study|Death|3|||
129931498|NCT03677141|467715153|FG000|Overall Study|Lost to Follow-up|0|||
129931499|NCT03677141|467715154|FG001|Overall Study|Lost to Follow-up|0|||
129931500|NCT03677141|467715155|FG002|Overall Study|Lost to Follow-up|0|||
129931501|NCT03677141|467715156|FG003|Overall Study|Lost to Follow-up|2|||
129931502|NCT03677141|467715157|FG004|Overall Study|Lost to Follow-up|0|||
129931503|NCT03677141|467715158|FG005|Overall Study|Lost to Follow-up|0|||
129931504|NCT03677141|467715153|FG000|Overall Study|Screen failure or enrolled in error|0|||
129931505|NCT03677141|467715154|FG001|Overall Study|Screen failure or enrolled in error|0|||
129931506|NCT03677141|467715155|FG002|Overall Study|Screen failure or enrolled in error|0|||
129931507|NCT03677141|467715156|FG003|Overall Study|Screen failure or enrolled in error|0|||
129931508|NCT03677141|467715157|FG004|Overall Study|Screen failure or enrolled in error|2|||
129931509|NCT03677141|467715158|FG005|Overall Study|Screen failure or enrolled in error|0|||
129931510|NCT03677141|467715153|FG000|Overall Study|Physician Decision|0|||
129931511|NCT03677141|467715154|FG001|Overall Study|Physician Decision|0|||
129931512|NCT03677141|467715155|FG002|Overall Study|Physician Decision|0|||
129931513|NCT03677141|467715156|FG003|Overall Study|Physician Decision|0|||
129931514|NCT03677141|467715157|FG004|Overall Study|Physician Decision|1|||
129931515|NCT03677141|467715158|FG005|Overall Study|Physician Decision|0|||
129451322|NCT03654976|465950444|FG000|Overall Study|Lack of Efficacy|0|||
129451323|NCT03654976|465950445|FG001|Overall Study|Lack of Efficacy|1|||
129451324|NCT00117598|465950446|FG000|Prior to Treatment Cross Over|Death|40|||
129451325|NCT00117598|465950447|FG001|Prior to Treatment Cross Over|Death|41|||
129451326|NCT00117598|465950448|FG002|Prior to Treatment Cross Over|Death|37|||
129451327|NCT00117598|465950449|FG003|Prior to Treatment Cross Over|Death|0|||
129451328|NCT00117598|465950450|FG004|Prior to Treatment Cross Over|Death|0|||
129451329|NCT00117598|465950446|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
129451330|NCT00117598|465950447|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
129451331|NCT00117598|465950448|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
129451332|NCT00117598|465950449|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
129451333|NCT00117598|465950450|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
129451334|NCT00117598|465950446|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
129931516|NCT03677141|467715153|FG000|Overall Study|Withdrawal by Subject|0|||
129931517|NCT03677141|467715154|FG001|Overall Study|Withdrawal by Subject|0|||
129931518|NCT03677141|467715155|FG002|Overall Study|Withdrawal by Subject|1|||
129931519|NCT03677141|467715156|FG003|Overall Study|Withdrawal by Subject|1|||
129451335|NCT00117598|465950447|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
129451336|NCT00117598|465950448|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
129931520|NCT03677141|467715157|FG004|Overall Study|Withdrawal by Subject|1|||
129931521|NCT03677141|467715158|FG005|Overall Study|Withdrawal by Subject|0|||
129931522|NCT05838027|467715166|FG000|Overall Study|Lost to Follow-up|5|||
129931523|NCT05838027|467715167|FG001|Overall Study|Lost to Follow-up|1|||
129931524|NCT05838027|467715166|FG000|Overall Study|Withdrawal by Subject|1|||
129931525|NCT05838027|467715167|FG001|Overall Study|Withdrawal by Subject|0|||
129931526|NCT04599634|467715168|FG000|Overall Study|Dose limiting toxicity|0|||
129931527|NCT04599634|467715169|FG001|Overall Study|Dose limiting toxicity|0|||
129931528|NCT04599634|467715170|FG002|Overall Study|Dose limiting toxicity|2|||
129931529|NCT04599634|467715171|FG003|Overall Study|Dose limiting toxicity|0|||
129931530|NCT03714815|467715172|FG000|Overall Study|Physician Decision|2|||
129931531|NCT03714815|467715172|FG000|Overall Study|Withdrawal by Subject|2|||
129931532|NCT03714815|467715172|FG000|Overall Study|Death|11|||
129931533|NCT03276676|467715177|FG000|Overall Study|Withdrawal by Subject|2|||
129931534|NCT03276676|467715178|FG001|Overall Study|Withdrawal by Subject|1|||
129931535|NCT02962076|467715181|FG000|Overall Study|MHED tracer not available|5|||
129931536|NCT02962076|467715181|FG000|Overall Study|Protocol Violation|1|||
129931537|NCT02962076|467715181|FG000|Overall Study|Physician Decision|1|||
129931538|NCT04089865|467715182|FG000|Overall Study|Withdrawal by Subject|2|||
129931539|NCT04089865|467715183|FG001|Overall Study|Withdrawal by Subject|2|||
129931540|NCT04089865|467715184|FG002|Overall Study|Withdrawal by Subject|7|||
129931541|NCT04089865|467715185|FG003|Overall Study|Withdrawal by Subject|2|||
129931542|NCT03926130|467715186|FG000|Overall Study|Adverse Event|9|||
129931543|NCT03926130|467715187|FG001|Overall Study|Adverse Event|11|||
129931544|NCT03926130|467715188|FG002|Overall Study|Adverse Event|2|||
129931545|NCT03926130|467715189|FG003|Overall Study|Adverse Event|0|||
129931546|NCT03926130|467715186|FG000|Overall Study|Death|2|||
129931547|NCT03926130|467715187|FG001|Overall Study|Death|0|||
129931548|NCT03926130|467715188|FG002|Overall Study|Death|1|||
129931549|NCT03926130|467715189|FG003|Overall Study|Death|0|||
129931550|NCT03926130|467715186|FG000|Overall Study|Lack of Efficacy|14|||
129931551|NCT03926130|467715187|FG001|Overall Study|Lack of Efficacy|11|||
129931552|NCT03926130|467715188|FG002|Overall Study|Lack of Efficacy|7|||
129931553|NCT03926130|467715189|FG003|Overall Study|Lack of Efficacy|1|||
129931554|NCT03926130|467715186|FG000|Overall Study|Lost to Follow-up|0|||
129931555|NCT03926130|467715187|FG001|Overall Study|Lost to Follow-up|7|||
129931556|NCT03926130|467715188|FG002|Overall Study|Lost to Follow-up|1|||
129931557|NCT03926130|467715189|FG003|Overall Study|Lost to Follow-up|0|||
129931558|NCT03926130|467715186|FG000|Overall Study|As Reported by Investigator|2|||
129931559|NCT03926130|467715187|FG001|Overall Study|As Reported by Investigator|6|||
129931560|NCT03926130|467715188|FG002|Overall Study|As Reported by Investigator|6|||
129931561|NCT03926130|467715189|FG003|Overall Study|As Reported by Investigator|0|||
129931562|NCT03926130|467715186|FG000|Overall Study|Physician Decision|3|||
129931563|NCT03926130|467715187|FG001|Overall Study|Physician Decision|2|||
129931564|NCT03926130|467715188|FG002|Overall Study|Physician Decision|1|||
129931565|NCT03926130|467715189|FG003|Overall Study|Physician Decision|0|||
129931566|NCT03926130|467715186|FG000|Overall Study|Pregnancy|2|||
129931567|NCT03926130|467715187|FG001|Overall Study|Pregnancy|2|||
129931568|NCT03926130|467715188|FG002|Overall Study|Pregnancy|1|||
129931569|NCT03926130|467715189|FG003|Overall Study|Pregnancy|0|||
129931570|NCT03926130|467715186|FG000|Overall Study|Withdrawal by Subject|20|||
129931571|NCT03926130|467715187|FG001|Overall Study|Withdrawal by Subject|28|||
129931572|NCT03926130|467715188|FG002|Overall Study|Withdrawal by Subject|18|||
129931573|NCT03926130|467715189|FG003|Overall Study|Withdrawal by Subject|1|||
129931574|NCT03926130|467715186|FG000|Overall Study|Non-Compliance|1|||
129931575|NCT03926130|467715187|FG001|Overall Study|Non-Compliance|1|||
129931576|NCT03926130|467715188|FG002|Overall Study|Non-Compliance|0|||
129931577|NCT03926130|467715189|FG003|Overall Study|Non-Compliance|0|||
129931578|NCT03926130|467715186|FG000|Overall Study|Disposition Not Captured|0|||
129931579|NCT03926130|467715187|FG001|Overall Study|Disposition Not Captured|2|||
129931580|NCT03926130|467715188|FG002|Overall Study|Disposition Not Captured|1|||
129931581|NCT03926130|467715189|FG003|Overall Study|Disposition Not Captured|0|||
129931582|NCT03583333|467715190|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
129931583|NCT03583333|467715191|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
129931584|NCT03583333|467715190|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
129931585|NCT03583333|467715191|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
129931586|NCT03583333|467715190|FG000|Overall Study|Withdrawal by Subject|9|||
129931587|NCT03583333|467715191|FG001|Overall Study|Withdrawal by Subject|5|||
129931588|NCT03583333|467715190|FG000|Overall Study|Physician Decision|3|||
129931589|NCT03583333|467715191|FG001|Overall Study|Physician Decision|2|||
129931590|NCT03583333|467715190|FG000|Overall Study|Death|12|||
129931591|NCT03583333|467715191|FG001|Overall Study|Death|7|||
129931592|NCT03824366|467715199|FG000|Overall Study|Death|1|||
129931593|NCT03824366|467715199|FG000|Overall Study|Previously unidentified metal artifact|1|||
129931594|NCT03824366|467715199|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
129931595|NCT03824366|467715199|FG000|Overall Study|Withdrawal by Subject|1|||
129931596|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
129979762|NCT01283516|467889463|FG007|Overall Study|Lost to Follow-up|0|||
129931597|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
129931598|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931599|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931600|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931601|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931602|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931603|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931604|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931605|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931606|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931607|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
129931608|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931609|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
129931610|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931611|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931612|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931613|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931614|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931615|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931616|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931617|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931618|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931619|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
129931620|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
129931621|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
129931622|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931623|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931624|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931625|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931626|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931627|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931628|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931629|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931630|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931631|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
129931632|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931633|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
129931634|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931635|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931636|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931637|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931638|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931639|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931640|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931641|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931642|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931643|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
129931644|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931645|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
129931646|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931647|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931648|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931649|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931650|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931651|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931652|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931653|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931654|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931655|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
129931656|NCT03536884|467715200|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931657|NCT03536884|467715201|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
129931658|NCT03536884|467715202|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931659|NCT03536884|467715203|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931660|NCT03536884|467715204|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931661|NCT03536884|467715205|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931662|NCT03536884|467715206|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931663|NCT03536884|467715207|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931664|NCT03536884|467715208|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931665|NCT03536884|467715209|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931666|NCT03536884|467715210|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931667|NCT03536884|467715211|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
129931668|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931669|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931670|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
129931671|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931672|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
129931673|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931674|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931675|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931676|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931677|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931678|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931679|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
129931680|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931681|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931682|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
129931683|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
129931684|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
129931685|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931686|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931687|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931688|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931689|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931690|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931691|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
129931692|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931693|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931694|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931695|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
129931696|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
129931697|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931698|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931699|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931700|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931701|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931702|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931703|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
129931704|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931705|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931706|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
129931707|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
129931708|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
129931709|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931710|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931711|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931712|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931713|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931714|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931715|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
129931716|NCT03536884|467715200|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931717|NCT03536884|467715201|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931718|NCT03536884|467715202|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
129931719|NCT03536884|467715203|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
129931720|NCT03536884|467715204|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
129931721|NCT03536884|467715205|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931722|NCT03536884|467715206|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931723|NCT03536884|467715207|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129451337|NCT00117598|465950449|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
129451338|NCT00117598|465950450|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
129451339|NCT00117598|465950446|FG000|Prior to Treatment Cross Over|Other|15|||
129451340|NCT00117598|465950447|FG001|Prior to Treatment Cross Over|Other|9|||
129451341|NCT00117598|465950448|FG002|Prior to Treatment Cross Over|Other|9|||
129451342|NCT00117598|465950449|FG003|Prior to Treatment Cross Over|Other|0|||
129451343|NCT00117598|465950450|FG004|Prior to Treatment Cross Over|Other|0|||
129451344|NCT00117598|465950446|FG000|After Treament Cross Over|Death|0|||
129451345|NCT00117598|465950447|FG001|After Treament Cross Over|Death|0|||
129451346|NCT00117598|465950448|FG002|After Treament Cross Over|Death|0|||
129451347|NCT00117598|465950449|FG003|After Treament Cross Over|Death|1|||
129451348|NCT00117598|465950450|FG004|After Treament Cross Over|Death|2|||
129451349|NCT00117598|465950446|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
129451350|NCT00117598|465950447|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
129451351|NCT00117598|465950448|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
129451352|NCT00117598|465950449|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
129451353|NCT00117598|465950450|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
129451354|NCT00117598|465950446|FG000|After Treament Cross Over|Other|0|||
129451355|NCT00117598|465950447|FG001|After Treament Cross Over|Other|0|||
129451356|NCT00117598|465950448|FG002|After Treament Cross Over|Other|0|||
129451357|NCT00117598|465950449|FG003|After Treament Cross Over|Other|1|||
129451358|NCT00117598|465950450|FG004|After Treament Cross Over|Other|2|||
129451359|NCT03098836|465950451|FG000|Overall Study|Adverse Event|1|||
129451360|NCT03098836|465950452|FG001|Overall Study|Adverse Event|3|||
129451361|NCT03098836|465950451|FG000|Overall Study|Lack of Efficacy|30|||
129451362|NCT03098836|465950452|FG001|Overall Study|Lack of Efficacy|15|||
129451363|NCT03098836|465950451|FG000|Overall Study|Physician Decision|2|||
129451364|NCT03098836|465950452|FG001|Overall Study|Physician Decision|1|||
129451365|NCT03098836|465950451|FG000|Overall Study|Withdrawal by Subject|3|||
129451366|NCT03098836|465950452|FG001|Overall Study|Withdrawal by Subject|2|||
129451367|NCT04688775|465950455|FG000|Placebo-controlled Period|Randomized, not treated|1|||
129451368|NCT04688775|465950456|FG001|Placebo-controlled Period|Randomized, not treated|1|||
129451369|NCT04688775|465950457|FG002|Placebo-controlled Period|Randomized, not treated|0|||
129451370|NCT04688775|465950458|FG003|Placebo-controlled Period|Randomized, not treated|0|||
129451371|NCT04688775|465950455|FG000|Placebo-controlled Period|Adverse Event|2|||
129451372|NCT04688775|465950456|FG001|Placebo-controlled Period|Adverse Event|0|||
129931724|NCT03536884|467715208|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931725|NCT03536884|467715209|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129451373|NCT04688775|465950457|FG002|Placebo-controlled Period|Adverse Event|0|||
129451374|NCT04688775|465950458|FG003|Placebo-controlled Period|Adverse Event|0|||
129451375|NCT04688775|465950455|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
129451376|NCT04688775|465950456|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
129451377|NCT04688775|465950457|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
129451378|NCT04688775|465950458|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
129451379|NCT04688775|465950455|FG000|Placebo-controlled Period|Protocol Violation|0|||
129451380|NCT04688775|465950456|FG001|Placebo-controlled Period|Protocol Violation|1|||
129451381|NCT04688775|465950457|FG002|Placebo-controlled Period|Protocol Violation|0|||
129451382|NCT04688775|465950458|FG003|Placebo-controlled Period|Protocol Violation|0|||
129451383|NCT04688775|465950455|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
129451384|NCT04688775|465950456|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
129451385|NCT04688775|465950457|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
129451386|NCT04688775|465950458|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
129451387|NCT04688775|465950455|FG000|Placebo-controlled Period|Other reasons|0|||
129931726|NCT03536884|467715210|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931727|NCT03536884|467715211|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
129931728|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931729|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931730|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931731|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931732|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
129451388|NCT04688775|465950456|FG001|Placebo-controlled Period|Other reasons|1|||
129451389|NCT04688775|465950457|FG002|Placebo-controlled Period|Other reasons|0|||
129451390|NCT04688775|465950458|FG003|Placebo-controlled Period|Other reasons|0|||
129451391|NCT04688775|465950455|FG000|Delayed Start Period|Adverse Event|0|||
129451392|NCT04688775|465950456|FG001|Delayed Start Period|Adverse Event|0|||
129451393|NCT04688775|465950457|FG002|Delayed Start Period|Adverse Event|1|||
129451394|NCT04688775|465950458|FG003|Delayed Start Period|Adverse Event|0|||
129451395|NCT04688775|465950455|FG000|Delayed Start Period|Lack of Efficacy|0|||
129451396|NCT04688775|465950456|FG001|Delayed Start Period|Lack of Efficacy|0|||
129451397|NCT04688775|465950457|FG002|Delayed Start Period|Lack of Efficacy|0|||
129451398|NCT04688775|465950458|FG003|Delayed Start Period|Lack of Efficacy|3|||
129451399|NCT04688775|465950455|FG000|Delayed Start Period|Withdrawal by Subject|0|||
129451400|NCT04688775|465950456|FG001|Delayed Start Period|Withdrawal by Subject|0|||
129451401|NCT04688775|465950457|FG002|Delayed Start Period|Withdrawal by Subject|2|||
129931733|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
129931734|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
129931735|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
129931736|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
129931737|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931738|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931739|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
129931740|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931741|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931742|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931743|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931744|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931745|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
129931746|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
129931747|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
129931748|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
129931749|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931750|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931751|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
129931752|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931753|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931754|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931755|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931756|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931757|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
129931758|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931759|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
129931760|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931761|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931762|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931763|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
129931764|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931765|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931766|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931767|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931768|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931769|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
129931770|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931771|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
129931772|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
129931773|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931774|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931775|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
129931776|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931777|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931778|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931779|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931780|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931781|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
129931782|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
129931783|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
129931784|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
129931785|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931786|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931787|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
129931788|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931789|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931790|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931791|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931792|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931793|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
129931794|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931795|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931796|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931797|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931798|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931799|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
129931800|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931801|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931802|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931803|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931804|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931805|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931806|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
129931807|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931808|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931809|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931810|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931811|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
129931812|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931813|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931814|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931815|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931816|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931817|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931818|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
129931819|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931820|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931821|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931822|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931823|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
129931824|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931825|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931826|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931827|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931828|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931829|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
129931830|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931831|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931832|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931833|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931834|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931835|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
129931836|NCT03536884|467715200|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931837|NCT03536884|467715201|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931838|NCT03536884|467715202|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931839|NCT03536884|467715203|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931840|NCT03536884|467715204|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931841|NCT03536884|467715205|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931842|NCT03536884|467715206|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931843|NCT03536884|467715207|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931844|NCT03536884|467715208|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
129931845|NCT03536884|467715209|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931846|NCT03536884|467715210|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931847|NCT03536884|467715211|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
129931848|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931849|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931850|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931851|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931852|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931853|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931854|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931855|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931856|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
129931857|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
129931858|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
129931859|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
129931860|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931861|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931862|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931863|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931864|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931865|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931866|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931867|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931868|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
129931869|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
129931870|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
129931871|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
129931872|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931873|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931874|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931875|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931876|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931877|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931878|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931879|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931880|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931881|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931882|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
129931883|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
129931884|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931885|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931886|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931887|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931888|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931889|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931890|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931891|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931892|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931893|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931894|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
129931895|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
129931896|NCT03536884|467715200|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931897|NCT03536884|467715201|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931898|NCT03536884|467715202|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931899|NCT03536884|467715203|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931900|NCT03536884|467715204|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931901|NCT03536884|467715205|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931902|NCT03536884|467715206|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931903|NCT03536884|467715207|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931904|NCT03536884|467715208|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931905|NCT03536884|467715209|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129931906|NCT03536884|467715210|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
129979763|NCT01283516|467889464|FG008|Overall Study|Lost to Follow-up|1|||
129931907|NCT03536884|467715211|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
129931908|NCT03485729|467715222|FG000|Overall Study|Withdrawal by Subject|0|||
129931909|NCT03485729|467715223|FG001|Overall Study|Withdrawal by Subject|0|||
129931910|NCT03485729|467715224|FG002|Overall Study|Withdrawal by Subject|1|||
129931911|NCT03485729|467715222|FG000|Overall Study|Disease progression|8|||
129931912|NCT03485729|467715223|FG001|Overall Study|Disease progression|13|||
129931913|NCT03485729|467715224|FG002|Overall Study|Disease progression|1|||
129931914|NCT03485729|467715222|FG000|Overall Study|Hospice care|1|||
129931915|NCT03485729|467715223|FG001|Overall Study|Hospice care|0|||
129931916|NCT03485729|467715224|FG002|Overall Study|Hospice care|0|||
129931917|NCT03485729|467715222|FG000|Overall Study|Poor performance status|1|||
129931918|NCT03485729|467715223|FG001|Overall Study|Poor performance status|0|||
129931919|NCT03485729|467715224|FG002|Overall Study|Poor performance status|0|||
129931920|NCT03485729|467715222|FG000|Overall Study|Illness|0|||
129931921|NCT03485729|467715223|FG001|Overall Study|Illness|1|||
129931922|NCT03485729|467715224|FG002|Overall Study|Illness|0|||
129931923|NCT02997202|467715234|FG000|Overall Study|Miscellaneous|2|||
129931924|NCT02997202|467715235|FG001|Overall Study|Miscellaneous|2|||
129931925|NCT02997202|467715234|FG000|Overall Study|Withdrawal by Subject|8|||
129931926|NCT02997202|467715235|FG001|Overall Study|Withdrawal by Subject|12|||
129931927|NCT02997202|467715234|FG000|Overall Study|Lost to Follow-up|5|||
129931928|NCT02997202|467715235|FG001|Overall Study|Lost to Follow-up|3|||
129931929|NCT02997202|467715234|FG000|Overall Study|Death|41|||
129931930|NCT02997202|467715235|FG001|Overall Study|Death|45|||
129931931|NCT01199133|467715236|FG000|Year 1|Adverse Event|16|||
129931932|NCT01199133|467715237|FG001|Year 1|Adverse Event|4|||
129931933|NCT01199133|467715236|FG000|Year 1|Withdrawal by Subject|8|||
129931934|NCT01199133|467715237|FG001|Year 1|Withdrawal by Subject|4|||
129931935|NCT01199133|467715236|FG000|Year 1|Any other reason not above-mentioned|6|||
129931936|NCT01199133|467715237|FG001|Year 1|Any other reason not above-mentioned|7|||
129931937|NCT01199133|467715236|FG000|Year 2|Adverse Event|1|||
129931938|NCT01199133|467715237|FG001|Year 2|Adverse Event|0|||
129931939|NCT01199133|467715236|FG000|Year 2|Withdrawal by Subject|1|||
129931940|NCT01199133|467715237|FG001|Year 2|Withdrawal by Subject|1|||
129931941|NCT01199133|467715236|FG000|Year 2|Any other reason not above-mentioned|1|||
129931942|NCT01199133|467715237|FG001|Year 2|Any other reason not above-mentioned|2|||
129931943|NCT05013385|467715239|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
129931944|NCT01447719|467715244|FG000|Overall Study|Image acquisition failure|2|||
129931945|NCT01447719|467715244|FG000|Overall Study|Invalid image or not imaged|3|||
129931946|NCT01447719|467715244|FG000|Overall Study|Subject still living at end of study|79|||
129931947|NCT01447719|467715244|FG000|Overall Study|Withdrawal by Subject|2|||
129931948|NCT01447719|467715244|FG000|Overall Study|Family withdrew autopsy consent|7|||
129931949|NCT05100628|467715245|FG000|Overall Study|Progressive Disease|1|||
129931950|NCT05100628|467715246|FG001|Overall Study|Progressive Disease|0|||
129931951|NCT05100628|467715247|FG002|Overall Study|Progressive Disease|0|||
129931952|NCT05100628|467715248|FG003|Overall Study|Progressive Disease|0|||
129931953|NCT05100628|467715245|FG000|Overall Study|Study Terminated by Sponsor|0|||
129931954|NCT05100628|467715246|FG001|Overall Study|Study Terminated by Sponsor|0|||
129931955|NCT05100628|467715247|FG002|Overall Study|Study Terminated by Sponsor|3|||
129931956|NCT05100628|467715248|FG003|Overall Study|Study Terminated by Sponsor|0|||
129931957|NCT05100628|467715245|FG000|Overall Study|unkown|0|||
129931958|NCT05100628|467715246|FG001|Overall Study|unkown|1|||
129931959|NCT05100628|467715247|FG002|Overall Study|unkown|0|||
129931960|NCT05100628|467715248|FG003|Overall Study|unkown|0|||
129931961|NCT05900154|467715251|FG000|Follow-Up Period|Lost to Follow-up|1|||
129931962|NCT05900154|467715252|FG001|Follow-Up Period|Lost to Follow-up|2|||
129931963|NCT05900154|467715253|FG002|Follow-Up Period|Lost to Follow-up|1|||
129931964|NCT05900154|467715254|FG003|Follow-Up Period|Lost to Follow-up|0|||
129931965|NCT05900154|467715255|FG004|Follow-Up Period|Lost to Follow-up|1|||
129931966|NCT05900154|467715256|FG005|Follow-Up Period|Lost to Follow-up|1|||
129931967|NCT02518048|467715263|FG000|Overall Study|Withdrawal by Subject|1|||
129931968|NCT05363163|467716608|FG000|Overall Study|Withdrawal by Subject|13|||
129931969|NCT03673501|467716611|FG000|Overall Study|Participants ongoing.|36|||
129931970|NCT03673501|467716612|FG001|Overall Study|Participants ongoing.|24|||
129931971|NCT04709419|467716613|FG000|Overall Study|Physician Decision|1|||
129931972|NCT04709419|467716614|FG001|Overall Study|Physician Decision|0|||
129931973|NCT05683340|467716615|FG000|Overall Study|Adverse Event|1|||
129931974|NCT05683340|467716616|FG001|Overall Study|Adverse Event|1|||
129931975|NCT05683340|467716615|FG000|Overall Study|Protocol Violation|1|||
129931976|NCT05683340|467716616|FG001|Overall Study|Protocol Violation|0|||
129931977|NCT05683340|467716615|FG000|Overall Study|Withdrawal by Subject|0|||
129931978|NCT05683340|467716616|FG001|Overall Study|Withdrawal by Subject|2|||
129931979|NCT02056834|467716617|FG000|Overall Study|Lost to Follow-up|7|||
129931980|NCT06106022|467716618|FG000|Overall Study|Lost to Follow-up|1|||
129931981|NCT06106022|467716619|FG001|Overall Study|Lost to Follow-up|0|||
129931982|NCT06106022|467716618|FG000|Overall Study|Voluntary Withdrawal|0|||
129931983|NCT06106022|467716619|FG001|Overall Study|Voluntary Withdrawal|2|||
129931984|NCT02839265|467716649|FG000|Overall Study|Screen Failure|2|||
129931985|NCT02839265|467716649|FG000|Overall Study|Death|1|||
129931986|NCT02839265|467716649|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
129931987|NCT03635424|467716650|FG000|Overall Study|Adverse Event|1|||
129931988|NCT03635424|467716650|FG000|Overall Study|Death|1|||
129931989|NCT03635424|467716650|FG000|Overall Study|Device not implanted|1|||
129931990|NCT05533190|467716653|FG000|Overall Study|Lost to Follow-up|19|||
129931991|NCT05533190|467716654|FG001|Overall Study|Lost to Follow-up|7|||
129931992|NCT05533190|467716653|FG000|Overall Study|Failed to download app|1|||
129931993|NCT05533190|467716654|FG001|Overall Study|Failed to download app|0|||
129931994|NCT05533190|467716653|FG000|Overall Study|Thought app was a scam|1|||
129931995|NCT05533190|467716654|FG001|Overall Study|Thought app was a scam|0|||
129931996|NCT05533190|467716653|FG000|Overall Study|Withdrawal by Subject|2|||
129931997|NCT05533190|467716654|FG001|Overall Study|Withdrawal by Subject|0|||
129931998|NCT04167553|467716658|FG000|Overall Study|Withdrawal by Subject|1|||
129931999|NCT04167553|467716659|FG001|Overall Study|Withdrawal by Subject|0|||
129932000|NCT04167553|467716660|FG002|Overall Study|Withdrawal by Subject|1|||
129932001|NCT04167553|467716661|FG003|Overall Study|Withdrawal by Subject|2|||
129932002|NCT04167553|467716662|FG004|Overall Study|Withdrawal by Subject|1|||
129932003|NCT04167553|467716663|FG005|Overall Study|Withdrawal by Subject|0|||
129932004|NCT04167553|467716664|FG006|Overall Study|Withdrawal by Subject|0|||
129932005|NCT04167553|467716658|FG000|Overall Study|Physician Decision|0|||
129932006|NCT04167553|467716659|FG001|Overall Study|Physician Decision|0|||
129932007|NCT04167553|467716660|FG002|Overall Study|Physician Decision|0|||
129932008|NCT04167553|467716661|FG003|Overall Study|Physician Decision|0|||
129932009|NCT04167553|467716662|FG004|Overall Study|Physician Decision|2|||
129932010|NCT04167553|467716663|FG005|Overall Study|Physician Decision|2|||
129932011|NCT04167553|467716664|FG006|Overall Study|Physician Decision|0|||
129932012|NCT04167553|467716658|FG000|Overall Study|Lost to Follow-up|0|||
129932013|NCT04167553|467716659|FG001|Overall Study|Lost to Follow-up|0|||
129932014|NCT04167553|467716660|FG002|Overall Study|Lost to Follow-up|2|||
129932015|NCT04167553|467716661|FG003|Overall Study|Lost to Follow-up|0|||
129932016|NCT04167553|467716662|FG004|Overall Study|Lost to Follow-up|0|||
129932017|NCT04167553|467716663|FG005|Overall Study|Lost to Follow-up|0|||
129932018|NCT04167553|467716664|FG006|Overall Study|Lost to Follow-up|0|||
129932019|NCT03858517|467716668|FG000|Overall Study|Adverse Event|1|||
129932020|NCT03858517|467716668|FG000|Overall Study|Lost to Follow-up|1|||
129932021|NCT03858517|467716668|FG000|Overall Study|removed for being incarcerated|1|||
129932022|NCT03858517|467716668|FG000|Overall Study|Sponsor Closure|48|||
129932023|NCT02828358|467716669|FG000|Overall Study|Physician Decision|7|||
129932024|NCT02828358|467716670|FG001|Overall Study|Physician Decision|1|||
129932025|NCT02828358|467716669|FG000|Overall Study|Treatment Failure|6|||
129932026|NCT02828358|467716670|FG001|Overall Study|Treatment Failure|0|||
129932027|NCT02828358|467716669|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
129932028|NCT02828358|467716670|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
129932029|NCT02828358|467716669|FG000|Overall Study|Refusal of further protocol therapy|2|||
129932030|NCT02828358|467716670|FG001|Overall Study|Refusal of further protocol therapy|0|||
129932031|NCT02828358|467716669|FG000|Overall Study|Relapse|25|||
129932032|NCT02828358|467716670|FG001|Overall Study|Relapse|0|||
129932033|NCT02828358|467716669|FG000|Overall Study|Still on therapy|5|||
129932034|NCT02828358|467716670|FG001|Overall Study|Still on therapy|0|||
129932035|NCT05172232|467716671|FG000|Overall Study|Lost to Follow-up|3|||
129932036|NCT01828021|467716672|FG000|Overall Study|Adverse Event|5|||
129932037|NCT01828021|467716672|FG000|Overall Study|Lack of Efficacy|17|||
129932038|NCT01828021|467716672|FG000|Overall Study|Withdrawal by Subject|2|||
129932039|NCT01828021|467716672|FG000|Overall Study|Ileal obstruction, unrelated|1|||
129932040|NCT03717935|467716678|FG000|Overall Study|Withdrawal by Subject|0|||
129932041|NCT03717935|467716679|FG001|Overall Study|Withdrawal by Subject|2|||
129932042|NCT02990338|467716680|FG000|Overall Study|Randomized and not treated|4|||
129932043|NCT02990338|467716681|FG001|Overall Study|Randomized and not treated|2|||
129932044|NCT02990338|467716680|FG000|Overall Study|Adverse Event|23|||
129932045|NCT02990338|467716681|FG001|Overall Study|Adverse Event|22|||
129932046|NCT02990338|467716680|FG000|Overall Study|Progressive disease|118|||
129932047|NCT02990338|467716681|FG001|Overall Study|Progressive disease|107|||
129932048|NCT02990338|467716680|FG000|Overall Study|Poor compliance to protocol|0|||
129932049|NCT02990338|467716681|FG001|Overall Study|Poor compliance to protocol|1|||
129932050|NCT02990338|467716680|FG000|Overall Study|Withdrawal by Subject|6|||
129932051|NCT02990338|467716681|FG001|Overall Study|Withdrawal by Subject|8|||
129932052|NCT02990338|467716680|FG000|Overall Study|Physician's decision|2|||
129932053|NCT02990338|467716681|FG001|Overall Study|Physician's decision|6|||
129932054|NCT02990338|467716680|FG000|Overall Study|Treatment extension study|0|||
129932055|NCT02990338|467716681|FG001|Overall Study|Treatment extension study|6|||
129932056|NCT02990338|467716680|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
129932057|NCT02990338|467716681|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
129932058|NCT02990338|467716680|FG000|Overall Study|Continue with therapy available commercially|0|||
129932059|NCT02990338|467716681|FG001|Overall Study|Continue with therapy available commercially|1|||
129932060|NCT04479761|467716683|FG000|Overall Study|could not perform the balance tasks|1|||
129932061|NCT04479761|467716684|FG001|Overall Study|could not perform the balance tasks|0|||
129932062|NCT04479761|467716685|FG002|Overall Study|could not perform the balance tasks|0|||
129932063|NCT04479761|467716683|FG000|Overall Study|Adverse Event|1|||
129932064|NCT04479761|467716684|FG001|Overall Study|Adverse Event|0|||
129932065|NCT04479761|467716685|FG002|Overall Study|Adverse Event|0|||
129932066|NCT04479761|467716683|FG000|Overall Study|one control did not meet screening criteria|0|||
129932067|NCT04479761|467716684|FG001|Overall Study|one control did not meet screening criteria|0|||
129932068|NCT04479761|467716685|FG002|Overall Study|one control did not meet screening criteria|1|||
129932069|NCT04479761|467716683|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
129932070|NCT04479761|467716684|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
129932071|NCT04479761|467716685|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
129932072|NCT04186819|467716686|FG000|Overall Study|Adverse Event|1|||
129932073|NCT04186819|467716686|FG000|Overall Study|Lost to Follow-up|1|||
129932074|NCT04186819|467716686|FG000|Overall Study|Opted for EBRT|1|||
129932075|NCT04186819|467716686|FG000|Overall Study|Opted SBRT|1|||
129932076|NCT04186819|467716686|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
129932077|NCT04186819|467716686|FG000|Overall Study|Physician Decision|1|||
129932078|NCT04186819|467716686|FG000|Overall Study|RP Delayed|1|||
129932079|NCT04186819|467716686|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
129932080|NCT04186819|467716686|FG000|Overall Study|Subject declined for financial reasons|1|||
129932081|NCT04186819|467716686|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
129932082|NCT04186819|467716686|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
129932083|NCT04186819|467716686|FG000|Overall Study|The subject opted for other treatment option|2|||
129932084|NCT04186819|467716686|FG000|Overall Study|The subject opted for other treatment options|1|||
129932085|NCT04186819|467716686|FG000|Overall Study|Withdrawal by Subject|3|||
129932086|NCT04186819|467716686|FG000|Overall Study|Reason not specified|1|||
129932087|NCT00631475|467716704|FG000|Overall Study|Death|18|||
129932088|NCT00631475|467716704|FG000|Overall Study|Adverse Event|14|||
129932089|NCT00631475|467716704|FG000|Overall Study|Withdrew consent|5|||
129932090|NCT00631475|467716704|FG000|Overall Study|Preparation for lung transplant|8|||
129932091|NCT00303459|467716705|FG000|Overall Study|Death|33|||
129932092|NCT00303459|467716706|FG001|Overall Study|Death|44|||
129932093|NCT00303459|467716705|FG000|Overall Study|Withdrawal of consent|32|||
129932094|NCT00303459|467716706|FG001|Overall Study|Withdrawal of consent|26|||
129932095|NCT00303459|467716705|FG000|Overall Study|Lost to Follow-up|5|||
129932096|NCT00303459|467716706|FG001|Overall Study|Lost to Follow-up|4|||
129932097|NCT00303459|467716705|FG000|Overall Study|Administrative reason|7|||
129932098|NCT00303459|467716706|FG001|Overall Study|Administrative reason|7|||
129932099|NCT00303459|467716705|FG000|Overall Study|Decision by the investigator|5|||
129932100|NCT00303459|467716706|FG001|Overall Study|Decision by the investigator|7|||
129932101|NCT00303459|467716705|FG000|Overall Study|Lung transplantation|1|||
129932102|NCT00303459|467716706|FG001|Overall Study|Lung transplantation|1|||
129932103|NCT04129554|467716707|FG000|Overall Study|Withdrawal by Subject|4|||
129932104|NCT04129554|467716708|FG001|Overall Study|Withdrawal by Subject|3|||
129932105|NCT04129554|467716707|FG000|Overall Study|Other|0|||
129932106|NCT04129554|467716708|FG001|Overall Study|Other|2|||
129932107|NCT01570361|467716709|FG000|Overall Study|Subject discontinued|1|||
129932108|NCT01570361|467716710|FG001|Overall Study|Subject discontinued|2|||
129932109|NCT01570361|467716709|FG000|Overall Study|Sponsor closing the study|51|||
129932110|NCT01570361|467716710|FG001|Overall Study|Sponsor closing the study|50|||
129932111|NCT01570361|467716709|FG000|Overall Study|Subject excluded|5|||
129932112|NCT01570361|467716710|FG001|Overall Study|Subject excluded|3|||
129932113|NCT01570361|467716709|FG000|Overall Study|Subject withdrew consent|14|||
129932114|NCT01570361|467716710|FG001|Overall Study|Subject withdrew consent|9|||
129932115|NCT01570361|467716709|FG000|Overall Study|Adverse Event|2|||
129932116|NCT01570361|467716710|FG001|Overall Study|Adverse Event|1|||
129932117|NCT01570361|467716709|FG000|Overall Study|Lost to Follow-up|4|||
129932118|NCT01570361|467716710|FG001|Overall Study|Lost to Follow-up|4|||
129932119|NCT01570361|467716709|FG000|Overall Study|Death|5|||
129932120|NCT01570361|467716710|FG001|Overall Study|Death|4|||
129932121|NCT01570361|467716709|FG000|Overall Study|Other|0|||
129932122|NCT01570361|467716710|FG001|Overall Study|Other|2|||
129932123|NCT02846545|467716713|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
129932124|NCT02846545|467716714|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
129932125|NCT02846545|467716713|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
129932126|NCT02846545|467716714|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
129932127|NCT02846545|467716713|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
129932128|NCT02846545|467716714|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
129932129|NCT02846545|467716713|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
129932130|NCT02846545|467716714|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
129932131|NCT02846545|467716713|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
129932132|NCT02846545|467716714|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
129932133|NCT03691298|467716717|FG000|Overall Study|Lost to Follow-up|8|||
129932134|NCT03691298|467716717|FG000|Overall Study|Sponsor terminated study|2|||
129932135|NCT02492711|467716721|FG000|Overall Study|Adverse Event|9|||
129932136|NCT02492711|467716722|FG001|Overall Study|Adverse Event|9|||
129932137|NCT02492711|467716723|FG002|Overall Study|Adverse Event|2|||
129932138|NCT02492711|467716721|FG000|Overall Study|Death|3|||
129932139|NCT02492711|467716722|FG001|Overall Study|Death|3|||
129932140|NCT02492711|467716723|FG002|Overall Study|Death|0|||
129932141|NCT02492711|467716721|FG000|Overall Study|Withdrawal by Subject|10|||
129932142|NCT02492711|467716722|FG001|Overall Study|Withdrawal by Subject|16|||
129932143|NCT02492711|467716723|FG002|Overall Study|Withdrawal by Subject|5|||
129932144|NCT02492711|467716721|FG000|Overall Study|Physician Decision|10|||
129932145|NCT02492711|467716722|FG001|Overall Study|Physician Decision|6|||
129932146|NCT02492711|467716723|FG002|Overall Study|Physician Decision|4|||
129932147|NCT02492711|467716721|FG000|Overall Study|Lost to Follow-up|0|||
129932148|NCT02492711|467716722|FG001|Overall Study|Lost to Follow-up|0|||
129932149|NCT02492711|467716723|FG002|Overall Study|Lost to Follow-up|1|||
129932150|NCT02492711|467716721|FG000|Overall Study|study treatment delay|2|||
129932151|NCT02492711|467716722|FG001|Overall Study|study treatment delay|1|||
129932152|NCT02492711|467716723|FG002|Overall Study|study treatment delay|0|||
129932153|NCT02492711|467716721|FG000|Overall Study|change in chemotherapy|0|||
129932154|NCT02492711|467716722|FG001|Overall Study|change in chemotherapy|1|||
129932155|NCT02492711|467716723|FG002|Overall Study|change in chemotherapy|0|||
129932156|NCT02492711|467716721|FG000|Overall Study|never treated|2|||
129932157|NCT02492711|467716722|FG001|Overall Study|never treated|4|||
129932158|NCT02492711|467716723|FG002|Overall Study|never treated|0|||
129932159|NCT02492711|467716721|FG000|Overall Study|Other|0|||
129932160|NCT02492711|467716722|FG001|Overall Study|Other|0|||
129932161|NCT02492711|467716723|FG002|Overall Study|Other|1|||
129932162|NCT03993392|467716730|FG000|Overall Study|Withdrawal by Subject|3|||
129932163|NCT03993392|467716730|FG000|Overall Study|Lost to Follow-up|2|||
129932164|NCT03993392|467716730|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
129932165|NCT05890105|467716734|FG000|Overall Study|Adverse Event|1|||
129932166|NCT05890105|467716735|FG001|Overall Study|Adverse Event|0|||
129932167|NCT05890105|467716736|FG002|Overall Study|Adverse Event|0|||
129932168|NCT05890105|467716734|FG000|Overall Study|Other|1|||
129932169|NCT05890105|467716735|FG001|Overall Study|Other|2|||
129932170|NCT05890105|467716736|FG002|Overall Study|Other|0|||
129932171|NCT04505410|467716737|FG000|Overall Study|Adverse Event|2|||
129932172|NCT04505410|467716738|FG001|Overall Study|Adverse Event|0|||
129932173|NCT04505410|467716737|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
129932174|NCT04505410|467716738|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
129932175|NCT04505410|467716737|FG000|Overall Study|did not want to follow diet|1|||
129932176|NCT04505410|467716738|FG001|Overall Study|did not want to follow diet|0|||
129932177|NCT04505410|467716737|FG000|Overall Study|flare up of ulcerative colitis|0|||
129932178|NCT04505410|467716738|FG001|Overall Study|flare up of ulcerative colitis|1|||
129932179|NCT04505410|467716737|FG000|Overall Study|Lost to Follow-up|0|||
129932180|NCT04505410|467716738|FG001|Overall Study|Lost to Follow-up|2|||
129932181|NCT04505410|467716737|FG000|Overall Study|Lost to Follow-up|1|||
129932182|NCT04505410|467716738|FG001|Overall Study|Lost to Follow-up|0|||
129932183|NCT04505410|467716737|FG000|Overall Study|initiated another diet on their own|0|||
129932184|NCT04505410|467716738|FG001|Overall Study|initiated another diet on their own|2|||
129932185|NCT06262477|467718120|FG000|Overall Study|Withdrawal by Subject|1|||
129932186|NCT06262477|467718121|FG001|Overall Study|Withdrawal by Subject|0|||
129932187|NCT06262477|467718120|FG000|Overall Study|Adverse Event|0|||
129932188|NCT06262477|467718121|FG001|Overall Study|Adverse Event|1|||
129932189|NCT06262477|467718120|FG000|Overall Study|Lost to Follow-up|0|||
129932190|NCT06262477|467718121|FG001|Overall Study|Lost to Follow-up|1|||
129932191|NCT04183283|467718126|FG000|Period 1|Withdrawal by Subject|0|||
129932192|NCT04183283|467718127|FG001|Period 1|Withdrawal by Subject|1|||
129932193|NCT04183283|467718128|FG002|Period 1|Withdrawal by Subject|0|||
129932194|NCT04183283|467718129|FG003|Period 1|Withdrawal by Subject|0|||
129932195|NCT04183283|467718126|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
129932196|NCT04183283|467718127|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
129932197|NCT04183283|467718128|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
129932198|NCT04183283|467718129|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
129932199|NCT04999111|467718136|FG000|Overall Study|Lost to Follow-up|21|||
129932200|NCT04999111|467718137|FG001|Overall Study|Lost to Follow-up|16|||
129932201|NCT04999111|467718138|FG002|Overall Study|Lost to Follow-up|2|||
129932202|NCT04999111|467718139|FG003|Overall Study|Lost to Follow-up|26|||
129932203|NCT04999111|467718140|FG004|Overall Study|Lost to Follow-up|30|||
129932204|NCT04999111|467718141|FG005|Overall Study|Lost to Follow-up|6|||
129932205|NCT04999111|467718136|FG000|Overall Study|Physician Decision|1|||
129932206|NCT04999111|467718137|FG001|Overall Study|Physician Decision|3|||
129932207|NCT04999111|467718138|FG002|Overall Study|Physician Decision|0|||
129932208|NCT04999111|467718139|FG003|Overall Study|Physician Decision|1|||
129932209|NCT04999111|467718140|FG004|Overall Study|Physician Decision|2|||
129932210|NCT04999111|467718141|FG005|Overall Study|Physician Decision|0|||
129932211|NCT04999111|467718136|FG000|Overall Study|Withdrawal by Subject|23|||
129932212|NCT04999111|467718137|FG001|Overall Study|Withdrawal by Subject|29|||
129932213|NCT04999111|467718138|FG002|Overall Study|Withdrawal by Subject|15|||
129932214|NCT04999111|467718139|FG003|Overall Study|Withdrawal by Subject|30|||
129932215|NCT04999111|467718140|FG004|Overall Study|Withdrawal by Subject|35|||
129932216|NCT04999111|467718141|FG005|Overall Study|Withdrawal by Subject|10|||
129932217|NCT04999111|467718136|FG000|Overall Study|Other|6|||
129932218|NCT04999111|467718137|FG001|Overall Study|Other|6|||
129932219|NCT04999111|467718138|FG002|Overall Study|Other|3|||
129932220|NCT04999111|467718139|FG003|Overall Study|Other|8|||
129932221|NCT04999111|467718140|FG004|Overall Study|Other|8|||
129932222|NCT04999111|467718141|FG005|Overall Study|Other|5|||
129932223|NCT04999111|467718136|FG000|Overall Study|Non-compliance with study schedule|1|||
129932224|NCT04999111|467718137|FG001|Overall Study|Non-compliance with study schedule|0|||
129932225|NCT04999111|467718138|FG002|Overall Study|Non-compliance with study schedule|0|||
129932226|NCT04999111|467718139|FG003|Overall Study|Non-compliance with study schedule|1|||
129932227|NCT04999111|467718140|FG004|Overall Study|Non-compliance with study schedule|1|||
129932228|NCT04999111|467718141|FG005|Overall Study|Non-compliance with study schedule|1|||
129932229|NCT04999111|467718136|FG000|Overall Study|Randomized but not vaccinated|1|||
129932230|NCT04999111|467718137|FG001|Overall Study|Randomized but not vaccinated|2|||
129932231|NCT04999111|467718138|FG002|Overall Study|Randomized but not vaccinated|0|||
129932232|NCT04999111|467718139|FG003|Overall Study|Randomized but not vaccinated|3|||
129932233|NCT04999111|467718140|FG004|Overall Study|Randomized but not vaccinated|3|||
129932234|NCT04999111|467718141|FG005|Overall Study|Randomized but not vaccinated|0|||
129932235|NCT04999111|467718136|FG000|Overall Study|Adverse Event|1|||
129932236|NCT04999111|467718137|FG001|Overall Study|Adverse Event|1|||
129932237|NCT04999111|467718138|FG002|Overall Study|Adverse Event|0|||
129932238|NCT04999111|467718139|FG003|Overall Study|Adverse Event|0|||
129932239|NCT04999111|467718140|FG004|Overall Study|Adverse Event|0|||
129932240|NCT04999111|467718141|FG005|Overall Study|Adverse Event|0|||
129932241|NCT04999111|467718136|FG000|Overall Study|Initiated prohibited medication|0|||
129932242|NCT04999111|467718137|FG001|Overall Study|Initiated prohibited medication|0|||
129932243|NCT04999111|467718138|FG002|Overall Study|Initiated prohibited medication|0|||
129932244|NCT04999111|467718139|FG003|Overall Study|Initiated prohibited medication|0|||
129932245|NCT04999111|467718140|FG004|Overall Study|Initiated prohibited medication|1|||
129932246|NCT04999111|467718141|FG005|Overall Study|Initiated prohibited medication|0|||
129932247|NCT01314105|467718148|FG000|Overall Study|Progressive Disease|6|||
129932248|NCT01314105|467718149|FG001|Overall Study|Progressive Disease|10|||
129932249|NCT01314105|467718148|FG000|Overall Study|Refused to continue taking medication|0|||
129932250|NCT01314105|467718149|FG001|Overall Study|Refused to continue taking medication|1|||
129932251|NCT01314105|467718148|FG000|Overall Study|Other Adverse Event|1|||
129932252|NCT01314105|467718149|FG001|Overall Study|Other Adverse Event|1|||
129932253|NCT03640286|467718155|FG000|Overall Study|Adverse Event|6|||
129932254|NCT03640286|467718156|FG001|Overall Study|Adverse Event|6|||
129932255|NCT03640286|467718155|FG000|Overall Study|Lost to Follow-up|3|||
129932256|NCT03640286|467718156|FG001|Overall Study|Lost to Follow-up|6|||
129932257|NCT03640286|467718155|FG000|Overall Study|Pregnancy|1|||
129932258|NCT03640286|467718156|FG001|Overall Study|Pregnancy|0|||
129932259|NCT03640286|467718155|FG000|Overall Study|Withdrawal by Subject|10|||
129932260|NCT03640286|467718156|FG001|Overall Study|Withdrawal by Subject|10|||
129932261|NCT03640286|467718155|FG000|Overall Study|Non-compliance|4|||
129932262|NCT03640286|467718156|FG001|Overall Study|Non-compliance|10|||
129932263|NCT03640286|467718155|FG000|Overall Study|Medication change|1|||
129932264|NCT03640286|467718156|FG001|Overall Study|Medication change|0|||
129932265|NCT03640286|467718155|FG000|Overall Study|Other|1|||
129932266|NCT03640286|467718156|FG001|Overall Study|Other|2|||
129932267|NCT03640286|467718155|FG000|Overall Study|Joined another lifestyle program|0|||
129932268|NCT03640286|467718156|FG001|Overall Study|Joined another lifestyle program|1|||
129932269|NCT05524116|467718157|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
129932270|NCT05524116|467718158|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
129932271|NCT05524116|467718157|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
129932272|NCT05524116|467718158|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
129932273|NCT05524116|467718157|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
129932274|NCT05524116|467718158|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
129932275|NCT05524116|467718157|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
129932276|NCT05524116|467718158|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
129932277|NCT05524116|467718157|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
129932278|NCT05524116|467718158|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
129932279|NCT03181516|467718159|FG000|Overall Study|Withdrawal by Subject|14|||
129932280|NCT03181516|467718160|FG001|Overall Study|Withdrawal by Subject|7|||
129932281|NCT03181516|467718159|FG000|Overall Study|Lost to Follow-up|2|||
129932282|NCT03181516|467718160|FG001|Overall Study|Lost to Follow-up|2|||
129932283|NCT05405985|467718161|FG000|Overall Study|Withdrawal by Subject|1|||
129932284|NCT05405985|467718162|FG001|Overall Study|Withdrawal by Subject|0|||
129932285|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
129932286|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
129932287|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
129932288|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
129932289|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
129932290|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
129932291|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
129932292|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
129932293|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
129932294|NCT04880733|467718163|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
129932295|NCT04880733|467718164|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
129932296|NCT04880733|467718165|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
129932297|NCT04880733|467718163|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
129932298|NCT04880733|467718164|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
129932299|NCT04880733|467718165|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
129932300|NCT05552508|467718166|FG000|Overall Study|Adverse Event|3|||
129932301|NCT01917084|467718167|FG000|Overall Study|Withdrawal by Subject|1|||
129932302|NCT04451772|467718174|FG000|Overall Study|Adverse Event|1|||
129932303|NCT04451772|467718175|FG001|Overall Study|Adverse Event|0|||
129932304|NCT04451772|467718176|FG002|Overall Study|Adverse Event|1|||
129932305|NCT04451772|467718177|FG003|Overall Study|Adverse Event|1|||
129932306|NCT04451772|467718178|FG004|Overall Study|Adverse Event|0|||
129932307|NCT04451772|467718179|FG005|Overall Study|Adverse Event|3|||
129932308|NCT04451772|467718174|FG000|Overall Study|Withdrawal by Subject|2|||
129932309|NCT04451772|467718175|FG001|Overall Study|Withdrawal by Subject|7|||
129932310|NCT04451772|467718176|FG002|Overall Study|Withdrawal by Subject|2|||
129932311|NCT04451772|467718177|FG003|Overall Study|Withdrawal by Subject|1|||
129932312|NCT04451772|467718178|FG004|Overall Study|Withdrawal by Subject|1|||
129932313|NCT04451772|467718179|FG005|Overall Study|Withdrawal by Subject|0|||
129932314|NCT04451772|467718174|FG000|Overall Study|Other, not specified|1|||
129932315|NCT04451772|467718175|FG001|Overall Study|Other, not specified|2|||
129932316|NCT04451772|467718176|FG002|Overall Study|Other, not specified|1|||
129932317|NCT04451772|467718177|FG003|Overall Study|Other, not specified|0|||
129932318|NCT04451772|467718178|FG004|Overall Study|Other, not specified|0|||
129932319|NCT04451772|467718179|FG005|Overall Study|Other, not specified|1|||
129932320|NCT04451772|467718174|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
129932321|NCT04451772|467718175|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
129932322|NCT04451772|467718176|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
129932323|NCT04451772|467718177|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
129932324|NCT04451772|467718178|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
129932325|NCT04451772|467718179|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
129451402|NCT04688775|465950458|FG003|Delayed Start Period|Withdrawal by Subject|4|||
129451403|NCT04688775|465950455|FG000|Delayed Start Period|Lost to Follow-up|0|||
129451404|NCT04688775|465950456|FG001|Delayed Start Period|Lost to Follow-up|0|||
129451405|NCT04688775|465950457|FG002|Delayed Start Period|Lost to Follow-up|2|||
129451406|NCT04688775|465950458|FG003|Delayed Start Period|Lost to Follow-up|1|||
129451407|NCT04688775|465950455|FG000|Delayed Start Period|other reasons|0|||
129451408|NCT04688775|465950456|FG001|Delayed Start Period|other reasons|0|||
129451409|NCT04688775|465950457|FG002|Delayed Start Period|other reasons|1|||
129451410|NCT04688775|465950458|FG003|Delayed Start Period|other reasons|0|||
129451411|NCT01770912|465950459|FG000|Overall Study|Lost to Follow-up|2|||
129451412|NCT01770912|465950460|FG001|Overall Study|Lost to Follow-up|0|||
129451413|NCT01817751|465950465|FG000|Overall Study|Physician Decision|1|||
129451414|NCT02811549|465950466|FG000|Overall Study|Lost to Follow-up|1|||
129451415|NCT02811549|465950466|FG000|Overall Study|Withdrawal by Subject|3|||
129451416|NCT02811549|465950466|FG000|Overall Study|Subject screen failed|4|||
129451417|NCT02811549|465950466|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
129451418|NCT03472924|465950468|FG000|Overall Study|Adverse Event|1|||
129451419|NCT03472924|465950469|FG001|Overall Study|Adverse Event|0|||
129451420|NCT00427349|465950470|FG000|Overall Study|Lack of Efficacy|23|||
129451421|NCT00427349|465950470|FG000|Overall Study|Adverse Event|14|||
129451422|NCT00427349|465950470|FG000|Overall Study|Death|1|||
129451423|NCT00427349|465950470|FG000|Overall Study|Withdrawal by Subject|3|||
129451424|NCT00427349|465950470|FG000|Overall Study|Alternative therapy|1|||
129451425|NCT00427349|465950470|FG000|Overall Study|Other|2|||
129451426|NCT00427349|465950470|FG000|Overall Study|Ineligible|1|||
129451427|NCT00427349|465950470|FG000|Overall Study|Never started therapy|1|||
129451428|NCT04425720|465950480|FG000|Overall Study|Withdrawal by Subject|0|||
129451429|NCT04425720|465950481|FG001|Overall Study|Withdrawal by Subject|20|||
129451430|NCT00290186|465950482|FG000|Overall Study|Adverse Event|1|||
129451431|NCT00290186|465950483|FG001|Overall Study|Adverse Event|1|||
129451432|NCT00290186|465950482|FG000|Overall Study|Lost to Follow-up|3|||
129451433|NCT00290186|465950483|FG001|Overall Study|Lost to Follow-up|2|||
129451434|NCT00290186|465950482|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
129451435|NCT00290186|465950483|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
129451436|NCT00290186|465950482|FG000|Overall Study|Withdrawal by Subject|0|||
129451437|NCT00290186|465950483|FG001|Overall Study|Withdrawal by Subject|1|||
129451438|NCT00445224|465950484|FG000|Specific Exercises|Withdrawal by Subject|3|||
129451439|NCT00445224|465950485|FG001|Specific Exercises|Withdrawal by Subject|3|||
129451440|NCT00445224|465950484|FG000|Specific Exercises|Withdrawal by Subject|1|||
129451441|NCT00445224|465950485|FG001|Specific Exercises|Withdrawal by Subject|0|||
129451442|NCT03697720|465951962|FG000|Overall Study|Lost to Follow-up|7|||
129451443|NCT03496012|465951967|FG000|Overall Study|Withdrawal by Subject|2|||
129451444|NCT03496012|465951968|FG001|Overall Study|Withdrawal by Subject|0|||
129451445|NCT03496012|465951969|FG002|Overall Study|Withdrawal by Subject|2|||
129451446|NCT03496012|465951967|FG000|Overall Study|Adverse Event|0|||
129451447|NCT03496012|465951968|FG001|Overall Study|Adverse Event|0|||
129451448|NCT03496012|465951969|FG002|Overall Study|Adverse Event|1|||
129451449|NCT03496012|465951967|FG000|Overall Study|Reason Not Specified|2|||
129451450|NCT03496012|465951968|FG001|Overall Study|Reason Not Specified|0|||
129451451|NCT03496012|465951969|FG002|Overall Study|Reason Not Specified|1|||
129451452|NCT00937937|465951970|FG000|Overall Study|Adverse Event|6|||
129451453|NCT00937937|465951970|FG000|Overall Study|Withdrawal by Subject|2|||
129451454|NCT00937937|465951970|FG000|Overall Study|Progression/relapse|61|||
129451455|NCT00937937|465951970|FG000|Overall Study|Death|1|||
129451456|NCT00937937|465951970|FG000|Overall Study|Other|2|||
129451457|NCT02248259|465951971|FG000|Treatment Period 1|Adverse Event|0|||
129451458|NCT02248259|465951972|FG001|Treatment Period 1|Adverse Event|0|||
129451459|NCT02248259|465951973|FG002|Treatment Period 1|Adverse Event|1|||
129451460|NCT02248259|465951974|FG003|Treatment Period 1|Adverse Event|0|||
129451461|NCT02807480|465951975|FG000|Overall Study|Withdrawal by Subject|14|||
129451462|NCT02807480|465951976|FG001|Overall Study|Withdrawal by Subject|10|||
129932326|NCT02278211|467718180|FG000|Overall Study|Unable to analyse PET scan|2|||
129932327|NCT05424380|467718181|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
129451463|NCT02369848|465951977|FG000|Overall Study|Death|1|||
129451464|NCT02369848|465951977|FG000|Overall Study|Withdrawal by Subject|2|||
129451465|NCT02369848|465951977|FG000|Overall Study|Lost to Follow-up|1|||
129451466|NCT03281668|465951979|FG000|Overall Study|Physician Decision|1|||
129451467|NCT03281668|465951979|FG000|Overall Study|scheduling conflict, family circumstance|2|||
129451468|NCT03281668|465951979|FG000|Overall Study|Withdrawal by Subject|4|||
129451469|NCT03281668|465951979|FG000|Overall Study|Lost to Follow-up|1|||
129451470|NCT01543152|465951980|FG000|Overall Study|Withdrawal by Subject|0|||
129451471|NCT01543152|465951981|FG001|Overall Study|Withdrawal by Subject|2|||
129451472|NCT01543152|465951982|FG002|Overall Study|Withdrawal by Subject|0|||
129451473|NCT01543152|465951983|FG003|Overall Study|Withdrawal by Subject|0|||
129451474|NCT01543152|465951984|FG004|Overall Study|Withdrawal by Subject|0|||
129451475|NCT02932410|465951985|FG000|Overall Study|Death|7|||
129451476|NCT02932410|465951986|FG001|Overall Study|Death|6|||
129932328|NCT05424380|467718182|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932329|NCT05424380|467718183|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932330|NCT05424380|467718184|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932331|NCT05424380|467718185|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932332|NCT05424380|467718186|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
129932333|NCT05424380|467718181|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
129932334|NCT05424380|467718182|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932335|NCT05424380|467718183|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932336|NCT05424380|467718184|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932337|NCT05424380|467718185|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932338|NCT05424380|467718186|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
129932339|NCT05424380|467718181|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
129932340|NCT05424380|467718182|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932341|NCT05424380|467718183|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932342|NCT05424380|467718184|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932343|NCT05424380|467718185|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932344|NCT05424380|467718186|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
129932345|NCT05424380|467718181|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932346|NCT05424380|467718182|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
129932347|NCT05424380|467718183|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932348|NCT05424380|467718184|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932349|NCT05424380|467718185|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932350|NCT05424380|467718186|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
129932351|NCT05424380|467718181|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932352|NCT05424380|467718182|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
129932353|NCT05424380|467718183|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932354|NCT05424380|467718184|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932355|NCT05424380|467718185|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932356|NCT05424380|467718186|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
129932357|NCT05424380|467718181|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932358|NCT05424380|467718182|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932359|NCT05424380|467718183|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
129932360|NCT05424380|467718184|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932361|NCT05424380|467718185|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932362|NCT05424380|467718186|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
129932363|NCT05424380|467718181|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932364|NCT05424380|467718182|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932365|NCT05424380|467718183|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
129932366|NCT05424380|467718184|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932367|NCT05424380|467718185|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932368|NCT05424380|467718186|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
129932369|NCT05424380|467718181|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932370|NCT05424380|467718182|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932371|NCT05424380|467718183|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
129932372|NCT05424380|467718184|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932373|NCT05424380|467718185|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932374|NCT05424380|467718186|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
129932375|NCT05424380|467718181|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932376|NCT05424380|467718182|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932377|NCT05424380|467718183|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932378|NCT05424380|467718184|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
129932379|NCT05424380|467718185|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932380|NCT05424380|467718186|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932381|NCT05424380|467718181|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932382|NCT05424380|467718182|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932383|NCT05424380|467718183|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932384|NCT05424380|467718184|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
129932385|NCT05424380|467718185|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932386|NCT05424380|467718186|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
129932387|NCT05424380|467718181|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932388|NCT05424380|467718182|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932389|NCT05424380|467718183|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932390|NCT05424380|467718184|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
129932391|NCT05424380|467718185|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932392|NCT05424380|467718186|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
129932393|NCT05424380|467718181|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932394|NCT05424380|467718182|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129451477|NCT02932410|465951987|FG002|Overall Study|Death|0|||
129451478|NCT02932410|465951988|FG003|Overall Study|Death|0|||
129451479|NCT02932410|465951985|FG000|Overall Study|Lost to Follow-up|1|||
129451480|NCT02932410|465951986|FG001|Overall Study|Lost to Follow-up|2|||
129451481|NCT02932410|465951987|FG002|Overall Study|Lost to Follow-up|0|||
129451482|NCT02932410|465951988|FG003|Overall Study|Lost to Follow-up|0|||
129451483|NCT02932410|465951985|FG000|Overall Study|Parent/Subjects decision|6|||
129451484|NCT02932410|465951986|FG001|Overall Study|Parent/Subjects decision|6|||
129451485|NCT02932410|465951987|FG002|Overall Study|Parent/Subjects decision|1|||
129451486|NCT02932410|465951988|FG003|Overall Study|Parent/Subjects decision|0|||
129451487|NCT02932410|465951985|FG000|Overall Study|Physician Decision|0|||
129451488|NCT02932410|465951986|FG001|Overall Study|Physician Decision|1|||
129451489|NCT02932410|465951987|FG002|Overall Study|Physician Decision|0|||
129451490|NCT02932410|465951988|FG003|Overall Study|Physician Decision|0|||
129451491|NCT02573870|465951989|FG000|Overall Study|Adverse Event|0|||
129451492|NCT02573870|465951990|FG001|Overall Study|Adverse Event|2|||
129451493|NCT02573870|465951989|FG000|Overall Study|Lack of Efficacy|0|||
129451494|NCT02573870|465951990|FG001|Overall Study|Lack of Efficacy|1|||
129451495|NCT02573870|465951989|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
129451496|NCT02573870|465951990|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
129451497|NCT02573870|465951989|FG000|Overall Study|Lost to Follow-up|0|||
129451498|NCT02573870|465951990|FG001|Overall Study|Lost to Follow-up|1|||
129451499|NCT02573870|465951989|FG000|Overall Study|Other: Fail to Meet Visit|0|||
129451500|NCT02573870|465951990|FG001|Overall Study|Other: Fail to Meet Visit|2|||
129451501|NCT01007032|465952000|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
129451502|NCT01007032|465952001|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
129451503|NCT01007032|465952002|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
129451504|NCT01007032|465952003|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
129451505|NCT01007032|465952000|FG000|Overall Study|Withdrawal by Subject|0|||
129451506|NCT01007032|465952001|FG001|Overall Study|Withdrawal by Subject|0|||
129451507|NCT01007032|465952002|FG002|Overall Study|Withdrawal by Subject|0|||
129451508|NCT01007032|465952003|FG003|Overall Study|Withdrawal by Subject|1|||
129451509|NCT00677820|465952004|FG000|Overall Study|Lost to Follow-up|1|||
129451510|NCT00677820|465952005|FG001|Overall Study|Lost to Follow-up|0|||
129451511|NCT01101438|465952009|FG000|Overall Study|Withdrawal by Subject|8|||
129451512|NCT01101438|465952010|FG001|Overall Study|Withdrawal by Subject|9|||
129451513|NCT00290290|465952033|FG000|Overall Study|Death|3|||
129451514|NCT00290290|465952034|FG001|Overall Study|Death|4|||
129451515|NCT00290290|465952033|FG000|Overall Study|Withdrawal by Subject|2|||
129451516|NCT00290290|465952034|FG001|Overall Study|Withdrawal by Subject|2|||
129451517|NCT00290290|465952033|FG000|Overall Study|Underwent clean surgical procedure|13|||
129451518|NCT00290290|465952034|FG001|Overall Study|Underwent clean surgical procedure|12|||
129451519|NCT00549939|465952037|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
129451520|NCT00549939|465952038|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
129451521|NCT00549939|465952039|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
129451522|NCT00549939|465952037|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
129451523|NCT00549939|465952038|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
129451524|NCT00549939|465952039|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
129451525|NCT00549939|465952037|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
129451526|NCT00549939|465952038|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
129451527|NCT00549939|465952039|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
129451528|NCT00549939|465952037|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
129451529|NCT00549939|465952038|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
129451530|NCT00549939|465952039|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
129451531|NCT00549939|465952037|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
129451532|NCT00549939|465952038|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
129451533|NCT00549939|465952039|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
129451534|NCT00549939|465952037|FG000|40-week Open Label Treatment Period|Other|0|||
129451535|NCT00549939|465952038|FG001|40-week Open Label Treatment Period|Other|1|||
129451536|NCT00549939|465952039|FG002|40-week Open Label Treatment Period|Other|4|||
129451537|NCT03677596|465952040|FG000|Overall Study|Adverse Event|0|||
129451538|NCT03677596|465952041|FG001|Overall Study|Adverse Event|1|||
129451539|NCT03677596|465952040|FG000|Overall Study|Death|10|||
129451540|NCT03677596|465952041|FG001|Overall Study|Death|6|||
129451541|NCT03677596|465952040|FG000|Overall Study|Lost to Follow-up|0|||
129451542|NCT03677596|465952041|FG001|Overall Study|Lost to Follow-up|1|||
129451543|NCT03677596|465952040|FG000|Overall Study|Progressive Disease|8|||
129451544|NCT03677596|465952041|FG001|Overall Study|Progressive Disease|8|||
129451545|NCT03677596|465952040|FG000|Overall Study|Withdrawal by Subject|3|||
129451546|NCT03677596|465952041|FG001|Overall Study|Withdrawal by Subject|0|||
129451547|NCT03677596|465952040|FG000|Overall Study|Disease Relapse|2|||
129451548|NCT03677596|465952041|FG001|Overall Study|Disease Relapse|2|||
129451549|NCT03677596|465952040|FG000|Overall Study|Other|0|||
129451550|NCT03677596|465952041|FG001|Overall Study|Other|1|||
129451551|NCT05197049|465952044|FG000|Overall Study|Death|0|||
129451552|NCT05197049|465952045|FG001|Overall Study|Death|1|||
129451553|NCT05197049|465952046|FG002|Overall Study|Death|0|||
129451554|NCT05197049|465952044|FG000|Overall Study|Lost to Follow-up|3|||
129451555|NCT05197049|465952045|FG001|Overall Study|Lost to Follow-up|1|||
129451556|NCT05197049|465952046|FG002|Overall Study|Lost to Follow-up|0|||
129451557|NCT05197049|465952044|FG000|Overall Study|Withdrawal by Subject|15|||
129451558|NCT05197049|465952045|FG001|Overall Study|Withdrawal by Subject|3|||
129451559|NCT05197049|465952046|FG002|Overall Study|Withdrawal by Subject|1|||
129451560|NCT05197049|465952044|FG000|Overall Study|GCP non-compliance|1|||
129451561|NCT05197049|465952045|FG001|Overall Study|GCP non-compliance|2|||
129451562|NCT05197049|465952046|FG002|Overall Study|GCP non-compliance|0|||
129451563|NCT00424749|465952055|FG000|Overall Study|Withdrawal by Subject|1|||
129451564|NCT02577406|465952056|FG000|Randomized Period|Death|1|||
129451565|NCT02577406|465952057|FG001|Randomized Period|Death|0|||
129451566|NCT02577406|465952056|FG000|Randomized Period|Other reasons|0|||
129451567|NCT02577406|465952057|FG001|Randomized Period|Other reasons|20|||
129451568|NCT02577406|465952056|FG000|Treatment Period|Death|38|||
129451569|NCT02577406|465952057|FG001|Treatment Period|Death|23|||
129451570|NCT02577406|465952056|FG000|Treatment Period|Adverse Event|17|||
129451571|NCT02577406|465952057|FG001|Treatment Period|Adverse Event|12|||
129451572|NCT02577406|465952056|FG000|Treatment Period|Progressive Disease|53|||
129451573|NCT02577406|465952057|FG001|Treatment Period|Progressive Disease|37|||
129451574|NCT02577406|465952056|FG000|Treatment Period|Withdrawal by Subject|10|||
129451575|NCT02577406|465952057|FG001|Treatment Period|Withdrawal by Subject|24|||
129451576|NCT02577406|465952056|FG000|Treatment Period|Lost to Follow-up|0|||
129451577|NCT02577406|465952057|FG001|Treatment Period|Lost to Follow-up|1|||
129451578|NCT02577406|465952056|FG000|Treatment Period|Transition to commercially available treatment|1|||
129451579|NCT02577406|465952057|FG001|Treatment Period|Transition to commercially available treatment|1|||
129451580|NCT02577406|465952056|FG000|Treatment Period|Physician Decision|1|||
129451581|NCT02577406|465952057|FG001|Treatment Period|Physician Decision|0|||
129451582|NCT02577406|465952056|FG000|Treatment Period|Disease Relapse|28|||
129451583|NCT02577406|465952057|FG001|Treatment Period|Disease Relapse|1|||
129451584|NCT02577406|465952056|FG000|Treatment Period|Protocol Violation|0|||
129451585|NCT02577406|465952057|FG001|Treatment Period|Protocol Violation|1|||
129451586|NCT02577406|465952056|FG000|Treatment Period|Other Reasons|3|||
129451587|NCT02577406|465952057|FG001|Treatment Period|Other Reasons|39|||
129451588|NCT02577406|465952056|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
129451589|NCT02577406|465952057|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
129451590|NCT02138617|465952058|FG000|Overall Study|Death|1|||
129451591|NCT02138617|465952059|FG001|Overall Study|Death|2|||
129451592|NCT02138617|465952060|FG002|Overall Study|Death|2|||
129451593|NCT02138617|465952058|FG000|Overall Study|Adverse Event|8|||
129451594|NCT02138617|465952059|FG001|Overall Study|Adverse Event|5|||
129451595|NCT02138617|465952060|FG002|Overall Study|Adverse Event|2|||
129451596|NCT02138617|465952058|FG000|Overall Study|Disease Progression|20|||
129451597|NCT02138617|465952059|FG001|Overall Study|Disease Progression|13|||
129451598|NCT02138617|465952060|FG002|Overall Study|Disease Progression|4|||
129451599|NCT02138617|465952058|FG000|Overall Study|Withdrawal by Subject|7|||
129451600|NCT02138617|465952059|FG001|Overall Study|Withdrawal by Subject|10|||
129451601|NCT02138617|465952060|FG002|Overall Study|Withdrawal by Subject|2|||
129451602|NCT02138617|465952058|FG000|Overall Study|other complicating disease|0|||
129451603|NCT02138617|465952059|FG001|Overall Study|other complicating disease|2|||
129451604|NCT02138617|465952060|FG002|Overall Study|other complicating disease|0|||
129451605|NCT02138617|465952058|FG000|Overall Study|Protocol Violation|1|||
129451606|NCT02138617|465952059|FG001|Overall Study|Protocol Violation|0|||
129451607|NCT02138617|465952060|FG002|Overall Study|Protocol Violation|0|||
129451608|NCT02138617|465952058|FG000|Overall Study|Physician Decision|7|||
129451609|NCT02138617|465952059|FG001|Overall Study|Physician Decision|6|||
129451610|NCT02138617|465952060|FG002|Overall Study|Physician Decision|0|||
129451611|NCT02138617|465952058|FG000|Overall Study|financial reason|0|||
129451612|NCT02138617|465952059|FG001|Overall Study|financial reason|1|||
129451613|NCT02138617|465952060|FG002|Overall Study|financial reason|0|||
129451614|NCT02138617|465952058|FG000|Overall Study|other therapy|3|||
129451615|NCT02138617|465952059|FG001|Overall Study|other therapy|4|||
129451616|NCT02138617|465952060|FG002|Overall Study|other therapy|0|||
129451617|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
129451618|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
129451619|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451620|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451621|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451622|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
129451623|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
129451624|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451625|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451626|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129932395|NCT05424380|467718183|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932396|NCT05424380|467718184|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932397|NCT05424380|467718185|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
129451627|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451628|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451629|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451630|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
129451631|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451632|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451633|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451634|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451635|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451636|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
129451637|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
129451638|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451639|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451640|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451641|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451642|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451643|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451644|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
129451645|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
129451646|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451647|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451648|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129932398|NCT05424380|467718186|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
129932399|NCT05424380|467718181|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932400|NCT05424380|467718182|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932401|NCT05424380|467718183|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129451649|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451650|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451651|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
129451652|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451653|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451654|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451655|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451656|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451657|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129932402|NCT05424380|467718184|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932403|NCT05424380|467718185|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
129932404|NCT05424380|467718186|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
129932405|NCT05424380|467718181|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932406|NCT05424380|467718182|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932407|NCT05424380|467718183|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932408|NCT05424380|467718184|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932409|NCT05424380|467718185|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
129932410|NCT05424380|467718186|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
129932411|NCT02909686|467718187|FG000|Overall Study|Physician Decision|3|||
129932412|NCT02909686|467718187|FG000|Overall Study|Withdrawal by Subject|2|||
129932413|NCT06037668|467718190|FG000|Overall Study|Lost to Follow-up|1|||
129932414|NCT06037668|467718191|FG001|Overall Study|Lost to Follow-up|1|||
129932415|NCT06037668|467718190|FG000|Overall Study|Protocol Violation|1|||
129932416|NCT06037668|467718191|FG001|Overall Study|Protocol Violation|0|||
129932417|NCT06037668|467718190|FG000|Overall Study|Withdrawal by Subject|1|||
129932418|NCT06037668|467718191|FG001|Overall Study|Withdrawal by Subject|0|||
129932419|NCT06037668|467718190|FG000|Overall Study|Other Study Discontinuation Reason|1|||
129932420|NCT06037668|467718191|FG001|Overall Study|Other Study Discontinuation Reason|0|||
129932421|NCT04804540|467718192|FG000|Overall Study|Adverse Event|26|||
129932422|NCT04804540|467718193|FG001|Overall Study|Adverse Event|13|||
129932423|NCT02473445|467718194|FG000|Overall Study|Withdrawal by Subject|2|||
129932424|NCT02473445|467718194|FG000|Overall Study|Sponsor Decision|20|||
129932425|NCT03015532|467718195|FG000|Overall Study|Adverse Event|0|||
129932426|NCT03015532|467718196|FG001|Overall Study|Adverse Event|0|||
129932427|NCT03015532|467718197|FG002|Overall Study|Adverse Event|0|||
129932428|NCT03015532|467718198|FG003|Overall Study|Adverse Event|0|||
129932429|NCT03015532|467718199|FG004|Overall Study|Adverse Event|0|||
129932430|NCT03015532|467718200|FG005|Overall Study|Adverse Event|2|||
129932431|NCT03015532|467718201|FG006|Overall Study|Adverse Event|1|||
129932432|NCT03015532|467718202|FG007|Overall Study|Adverse Event|0|||
129932433|NCT03015532|467718195|FG000|Overall Study|Withdrawal by Subject|0|||
129932434|NCT03015532|467718196|FG001|Overall Study|Withdrawal by Subject|0|||
129932435|NCT03015532|467718197|FG002|Overall Study|Withdrawal by Subject|0|||
129932436|NCT03015532|467718198|FG003|Overall Study|Withdrawal by Subject|0|||
129932437|NCT03015532|467718199|FG004|Overall Study|Withdrawal by Subject|0|||
129932438|NCT03015532|467718200|FG005|Overall Study|Withdrawal by Subject|0|||
129932439|NCT03015532|467718201|FG006|Overall Study|Withdrawal by Subject|1|||
129932440|NCT03015532|467718202|FG007|Overall Study|Withdrawal by Subject|0|||
129451658|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
129451659|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129932441|NCT05970861|467718203|FG000|Overall Study|Physician Decision|4|||
129932442|NCT05970861|467718204|FG001|Overall Study|Physician Decision|4|||
129932443|NCT05970861|467718203|FG000|Overall Study|Lost to Follow-up|4|||
129932444|NCT05970861|467718204|FG001|Overall Study|Lost to Follow-up|3|||
129932445|NCT04629339|467718205|FG000|Overall Study|Death|1|||
129932446|NCT04629339|467718206|FG001|Overall Study|Death|0|||
129932447|NCT04629339|467718207|FG002|Overall Study|Death|2|||
129932448|NCT04629339|467718208|FG003|Overall Study|Death|2|||
129932449|NCT04629339|467718209|FG004|Overall Study|Death|0|||
129932450|NCT04629339|467718205|FG000|Overall Study|Disease Progression|0|||
129932451|NCT04629339|467718206|FG001|Overall Study|Disease Progression|0|||
129451660|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451661|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451662|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129932452|NCT04629339|467718207|FG002|Overall Study|Disease Progression|1|||
129932453|NCT04629339|467718208|FG003|Overall Study|Disease Progression|1|||
129932454|NCT04629339|467718209|FG004|Overall Study|Disease Progression|0|||
129932455|NCT04629339|467718205|FG000|Overall Study|Lost to Follow-up|0|||
129932456|NCT04629339|467718206|FG001|Overall Study|Lost to Follow-up|0|||
129932457|NCT04629339|467718207|FG002|Overall Study|Lost to Follow-up|0|||
129932458|NCT04629339|467718208|FG003|Overall Study|Lost to Follow-up|1|||
129932459|NCT04629339|467718209|FG004|Overall Study|Lost to Follow-up|0|||
129932460|NCT04629339|467718205|FG000|Overall Study|Physician Decision|0|||
129932461|NCT04629339|467718206|FG001|Overall Study|Physician Decision|1|||
129932462|NCT04629339|467718207|FG002|Overall Study|Physician Decision|0|||
129932463|NCT04629339|467718208|FG003|Overall Study|Physician Decision|0|||
129932464|NCT04629339|467718209|FG004|Overall Study|Physician Decision|0|||
129932465|NCT04629339|467718205|FG000|Overall Study|Study Terminated by Sponsor|0|||
129932466|NCT04629339|467718206|FG001|Overall Study|Study Terminated by Sponsor|0|||
129932467|NCT04629339|467718207|FG002|Overall Study|Study Terminated by Sponsor|0|||
129932468|NCT04629339|467718208|FG003|Overall Study|Study Terminated by Sponsor|1|||
129932469|NCT04629339|467718209|FG004|Overall Study|Study Terminated by Sponsor|0|||
129932470|NCT04629339|467718205|FG000|Overall Study|Withdrawal by Subject|0|||
129932471|NCT04629339|467718206|FG001|Overall Study|Withdrawal by Subject|0|||
129932472|NCT04629339|467718207|FG002|Overall Study|Withdrawal by Subject|2|||
129932473|NCT04629339|467718208|FG003|Overall Study|Withdrawal by Subject|2|||
129932474|NCT04629339|467718209|FG004|Overall Study|Withdrawal by Subject|0|||
129932475|NCT03914469|467718210|FG000|Overall Study|Lost to Follow-up|1|||
129932476|NCT03914469|467718211|FG001|Overall Study|Lost to Follow-up|4|||
129932477|NCT04778410|467718212|FG000|Safety Run-in Period|Death|5|||
129932478|NCT04778410|467718213|FG001|Safety Run-in Period|Death|6|||
129932479|NCT04778410|467718214|FG002|Safety Run-in Period|Death|0|||
129932480|NCT04778410|467718215|FG003|Safety Run-in Period|Death|0|||
129932481|NCT04778410|467718216|FG004|Safety Run-in Period|Death|0|||
129932482|NCT04778410|467718217|FG005|Safety Run-in Period|Death|0|||
129932483|NCT04778410|467718212|FG000|Phase 2 Period|Death|0|||
129932484|NCT04778410|467718213|FG001|Phase 2 Period|Death|0|||
129932485|NCT04778410|467718214|FG002|Phase 2 Period|Death|0|||
129932486|NCT04778410|467718215|FG003|Phase 2 Period|Death|5|||
129932487|NCT04778410|467718216|FG004|Phase 2 Period|Death|18|||
129932488|NCT04778410|467718217|FG005|Phase 2 Period|Death|0|||
129932489|NCT04778410|467718212|FG000|Phase 2 Period|Lost to Follow-up|0|||
129932490|NCT04778410|467718213|FG001|Phase 2 Period|Lost to Follow-up|0|||
129932491|NCT04778410|467718214|FG002|Phase 2 Period|Lost to Follow-up|0|||
129932492|NCT04778410|467718215|FG003|Phase 2 Period|Lost to Follow-up|1|||
129932493|NCT04778410|467718216|FG004|Phase 2 Period|Lost to Follow-up|1|||
129932494|NCT04778410|467718217|FG005|Phase 2 Period|Lost to Follow-up|0|||
129932495|NCT04778410|467718212|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
129932496|NCT04778410|467718213|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
129932497|NCT04778410|467718214|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
129932498|NCT04778410|467718215|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
129932499|NCT04778410|467718216|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
129932500|NCT04778410|467718217|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
129932501|NCT04778410|467718212|FG000|Phase 2 Period|Withdrew Consent|0|||
129932502|NCT04778410|467718213|FG001|Phase 2 Period|Withdrew Consent|0|||
129932503|NCT04778410|467718214|FG002|Phase 2 Period|Withdrew Consent|0|||
129932504|NCT04778410|467718215|FG003|Phase 2 Period|Withdrew Consent|0|||
129932505|NCT04778410|467718216|FG004|Phase 2 Period|Withdrew Consent|2|||
129932506|NCT04778410|467718217|FG005|Phase 2 Period|Withdrew Consent|0|||
129932507|NCT03252288|467718222|FG000|Overall Study|Death|1|||
129932508|NCT03252288|467718223|FG001|Overall Study|Death|0|||
129932509|NCT03252288|467718224|FG002|Overall Study|Death|0|||
129932510|NCT03252288|467718222|FG000|Overall Study|Death|11|||
129932511|NCT03252288|467718223|FG001|Overall Study|Death|0|||
129932512|NCT03252288|467718224|FG002|Overall Study|Death|0|||
129932513|NCT03252288|467718222|FG000|Overall Study|Withdrawal by Subject|2|||
129932514|NCT03252288|467718223|FG001|Overall Study|Withdrawal by Subject|0|||
129932515|NCT03252288|467718224|FG002|Overall Study|Withdrawal by Subject|0|||
129932516|NCT03252288|467718222|FG000|Overall Study|Lost to Follow-up|79|||
129932517|NCT03252288|467718223|FG001|Overall Study|Lost to Follow-up|0|||
129932518|NCT03252288|467718224|FG002|Overall Study|Lost to Follow-up|0|||
129932519|NCT03252288|467718222|FG000|Overall Study|Loss of baseline data on tablets|6|||
129932520|NCT03252288|467718223|FG001|Overall Study|Loss of baseline data on tablets|0|||
129932521|NCT03252288|467718224|FG002|Overall Study|Loss of baseline data on tablets|0|||
129932522|NCT02542631|467718226|FG000|Overall Study|Adverse Event|1|||
129932523|NCT02542631|467718227|FG001|Overall Study|Adverse Event|1|||
129932524|NCT02542631|467718226|FG000|Overall Study|Sponsor Termination|1|||
129932525|NCT02542631|467718227|FG001|Overall Study|Sponsor Termination|0|||
129932526|NCT02542631|467718226|FG000|Overall Study|Withdrawal by Subject|11|||
129932527|NCT02542631|467718227|FG001|Overall Study|Withdrawal by Subject|16|||
129932528|NCT02542631|467718226|FG000|Overall Study|Protocol Violation|1|||
129932529|NCT02542631|467718227|FG001|Overall Study|Protocol Violation|1|||
129932530|NCT02542631|467718226|FG000|Overall Study|Physician Decision|6|||
129932531|NCT02542631|467718227|FG001|Overall Study|Physician Decision|4|||
129932532|NCT02542631|467718226|FG000|Overall Study|Lost to Follow-up|6|||
129932533|NCT02542631|467718227|FG001|Overall Study|Lost to Follow-up|5|||
129932534|NCT02542631|467718226|FG000|Overall Study|Death|1|||
129932535|NCT02542631|467718227|FG001|Overall Study|Death|2|||
129932536|NCT02542631|467718226|FG000|Overall Study|Other|2|||
129932537|NCT02542631|467718227|FG001|Overall Study|Other|1|||
129932538|NCT02542631|467718226|FG000|Overall Study|Used Prohibited Medication|2|||
129932539|NCT02542631|467718227|FG001|Overall Study|Used Prohibited Medication|1|||
129932540|NCT02938923|467718228|FG000|Overall Study|Death|1|||
129932541|NCT02938923|467718229|FG001|Overall Study|Death|0|||
129932542|NCT02938923|467718230|FG002|Overall Study|Death|0|||
129932543|NCT02938923|467718228|FG000|Overall Study|Physician Decision|0|||
129932544|NCT02938923|467718229|FG001|Overall Study|Physician Decision|2|||
129932545|NCT02938923|467718230|FG002|Overall Study|Physician Decision|0|||
129932546|NCT02938923|467718228|FG000|Overall Study|Withdrawal by Subject|0|||
129932547|NCT02938923|467718229|FG001|Overall Study|Withdrawal by Subject|1|||
129932548|NCT02938923|467718230|FG002|Overall Study|Withdrawal by Subject|1|||
129932549|NCT00721149|467718231|FG000|Overall Study|Physician Decision|1|||
129932550|NCT04583280|467718233|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
129932551|NCT04583280|467718234|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
129932552|NCT05158504|467718235|FG000|Overall Study|Lost to Follow-up|2|||
129932553|NCT05158504|467718236|FG001|Overall Study|Lost to Follow-up|3|||
129932554|NCT03606512|467718237|FG000|Overall Study|Lost to Follow-up|0|||
129932555|NCT03606512|467718238|FG001|Overall Study|Lost to Follow-up|1|||
129932556|NCT03606512|467718237|FG000|Overall Study|'moved from study area|0|||
129932557|NCT03606512|467718238|FG001|Overall Study|'moved from study area|1|||
129932558|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
129932559|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
129932560|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
129932561|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
129932562|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
129932563|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
129932564|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
129932565|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
129932566|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
129932567|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
129932568|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
129932569|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
129932570|NCT05513937|467718239|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
129932571|NCT05513937|467718240|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
129932572|NCT05513937|467718241|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
129932573|NCT05513937|467718242|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
129932574|NCT05513937|467718239|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
129932575|NCT05513937|467718240|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
129932576|NCT05513937|467718241|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
129932577|NCT05513937|467718242|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
129932578|NCT05513937|467718239|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
129932579|NCT05513937|467718240|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
129932580|NCT05513937|467718241|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
129932581|NCT05513937|467718242|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
129932582|NCT03245840|467718243|FG000|Overall Study|Adverse Event|6|||
129932583|NCT03245840|467718244|FG001|Overall Study|Adverse Event|0|||
129932584|NCT03245840|467718243|FG000|Overall Study|Death|2|||
129932585|NCT03245840|467718244|FG001|Overall Study|Death|0|||
129932586|NCT03245840|467718243|FG000|Overall Study|Withdrawal by Subject|31|||
129932587|NCT03245840|467718244|FG001|Overall Study|Withdrawal by Subject|1|||
129932588|NCT03245840|467718243|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129932589|NCT03245840|467718244|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129932590|NCT03245840|467718243|FG000|Overall Study|Physician Decision|4|||
129932591|NCT03245840|467718244|FG001|Overall Study|Physician Decision|1|||
129932592|NCT03245840|467718243|FG000|Overall Study|Study Terminated by Sponsor|56|||
129932593|NCT03245840|467718244|FG001|Overall Study|Study Terminated by Sponsor|6|||
129932594|NCT03245840|467718243|FG000|Overall Study|Site Terminated by Sponsor|4|||
129932595|NCT03245840|467718244|FG001|Overall Study|Site Terminated by Sponsor|0|||
129932596|NCT03245840|467718243|FG000|Overall Study|Lost to Follow-up|12|||
129932597|NCT03245840|467718244|FG001|Overall Study|Lost to Follow-up|2|||
129932598|NCT03245840|467718243|FG000|Overall Study|Pregnancy|2|||
129932599|NCT03245840|467718244|FG001|Overall Study|Pregnancy|0|||
129932600|NCT03245840|467718243|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129932601|NCT03245840|467718244|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129932602|NCT03245840|467718243|FG000|Overall Study|Not treated|1|||
129932603|NCT03245840|467718244|FG001|Overall Study|Not treated|1|||
129932604|NCT04109066|467718249|FG000|Pre-treatment|Participant withdrew consent|2|||
129932605|NCT04109066|467718250|FG001|Pre-treatment|Participant withdrew consent|0|||
129932606|NCT04109066|467718249|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
129932607|NCT04109066|467718250|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
129932608|NCT04109066|467718249|FG000|Treatment|Lack of Efficacy|2|||
129932609|NCT04109066|467718250|FG001|Treatment|Lack of Efficacy|4|||
129932610|NCT04109066|467718249|FG000|Treatment|Adverse Event|23|||
129932611|NCT04109066|467718250|FG001|Treatment|Adverse Event|7|||
129932612|NCT04109066|467718249|FG000|Treatment|Participant request to discontinue Study treatment|15|||
129932613|NCT04109066|467718250|FG001|Treatment|Participant request to discontinue Study treatment|14|||
129932614|NCT04109066|467718249|FG000|Treatment|Withdrawal by Subject|8|||
129451663|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451664|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
129451665|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
129451666|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451667|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451668|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451669|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451670|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451671|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451672|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
129451673|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451674|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451675|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451676|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451677|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451678|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451679|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
129451680|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451681|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451682|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451683|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451684|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451685|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451686|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
129451687|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
129451688|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
129451689|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
129451690|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451691|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451692|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
129451693|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
129451694|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451695|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451696|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451697|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451698|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451699|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451700|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
129451701|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451702|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
129451703|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451704|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451705|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451706|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
129451707|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451708|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451709|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451710|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451711|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451712|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451713|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451714|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
129451715|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
129451716|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451717|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451718|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451719|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451720|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
129451721|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451722|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451723|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451724|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451725|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451726|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129451727|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129932615|NCT04109066|467718250|FG001|Treatment|Withdrawal by Subject|8|||
129451728|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
129932616|NCT04109066|467718249|FG000|Treatment|Death|3|||
129932617|NCT04109066|467718250|FG001|Treatment|Death|0|||
129932618|NCT04109066|467718249|FG000|Treatment|Participant no longer meets study criteria|2|||
129932619|NCT04109066|467718250|FG001|Treatment|Participant no longer meets study criteria|2|||
129932620|NCT04109066|467718249|FG000|Treatment|Administrative reasons by sponsor|2|||
129932621|NCT04109066|467718250|FG001|Treatment|Administrative reasons by sponsor|3|||
129932622|NCT04109066|467718249|FG000|Treatment|Other reasons|17|||
129932623|NCT04109066|467718250|FG001|Treatment|Other reasons|23|||
129932624|NCT04109066|467718249|FG000|Treatment|Disease Progression|4|||
129932625|NCT04109066|467718250|FG001|Treatment|Disease Progression|7|||
129932626|NCT04109066|467718249|FG000|Treatment|Study drug toxicity|12|||
129932627|NCT04109066|467718250|FG001|Treatment|Study drug toxicity|5|||
129932628|NCT04109066|467718249|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
129932629|NCT04109066|467718250|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
129932630|NCT04109066|467718249|FG000|Treatment|Disease Recurrence|0|||
129932631|NCT04109066|467718250|FG001|Treatment|Disease Recurrence|2|||
129932632|NCT04109066|467718249|FG000|Treatment|Not reported|4|||
129932633|NCT04109066|467718250|FG001|Treatment|Not reported|8|||
129932634|NCT01586910|467719277|FG000|Overall Study|Death|4|||
129932635|NCT01586910|467719278|FG001|Overall Study|Death|4|||
129932636|NCT01586910|467719277|FG000|Overall Study|Withdrawal by Subject|6|||
129932637|NCT01586910|467719278|FG001|Overall Study|Withdrawal by Subject|43|||
129932638|NCT01586910|467719277|FG000|Overall Study|Physician withdrew Subject|5|||
129932639|NCT01586910|467719278|FG001|Overall Study|Physician withdrew Subject|24|||
129932640|NCT01064440|467719279|FG000|Overall Study|Lost to Follow-up|1|||
129932641|NCT01064440|467719280|FG001|Overall Study|Lost to Follow-up|1|||
129932642|NCT01064440|467719281|FG002|Overall Study|Lost to Follow-up|1|||
129932643|NCT01064440|467719279|FG000|Overall Study|Non-compliance|0|||
129932644|NCT01064440|467719280|FG001|Overall Study|Non-compliance|1|||
129932645|NCT01064440|467719281|FG002|Overall Study|Non-compliance|0|||
129932646|NCT01064440|467719279|FG000|Overall Study|Death|1|||
129932647|NCT01064440|467719280|FG001|Overall Study|Death|0|||
129932648|NCT01064440|467719281|FG002|Overall Study|Death|1|||
129932649|NCT01064440|467719279|FG000|Overall Study|Withdrawal by Subject|0|||
129932650|NCT01064440|467719280|FG001|Overall Study|Withdrawal by Subject|1|||
129932651|NCT01064440|467719281|FG002|Overall Study|Withdrawal by Subject|1|||
129932652|NCT01064440|467719279|FG000|Overall Study|Other: amputation|1|||
129932653|NCT01064440|467719280|FG001|Overall Study|Other: amputation|0|||
129932654|NCT01064440|467719281|FG002|Overall Study|Other: amputation|0|||
129932655|NCT04108130|467719282|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
129932656|NCT04108130|467719283|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
129932657|NCT04108130|467719282|FG000|Overall Study|Consent Withdrawn|9|||
129932658|NCT04108130|467719283|FG001|Overall Study|Consent Withdrawn|6|||
129932659|NCT04108130|467719282|FG000|Overall Study|Surgery Cancelled|4|||
129932660|NCT04108130|467719283|FG001|Overall Study|Surgery Cancelled|4|||
129932661|NCT04108130|467719282|FG000|Overall Study|Found Ineligible for Study|4|||
129932662|NCT04108130|467719283|FG001|Overall Study|Found Ineligible for Study|3|||
129932663|NCT04108130|467719282|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
129932664|NCT04108130|467719283|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
129932665|NCT04108130|467719282|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
129932666|NCT04108130|467719283|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
129932667|NCT05507333|467719284|FG000|Overall Study|Protocol Violation|1|||
129451729|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129932668|NCT02585323|467719285|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
129932669|NCT02585323|467719286|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
129932670|NCT02585323|467719285|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
129932671|NCT02585323|467719286|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
129932672|NCT02585323|467719285|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
129932673|NCT02585323|467719286|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
129932674|NCT02585323|467719285|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
129932675|NCT02585323|467719286|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
129932676|NCT01130883|467719287|FG000|Overall Study|Patient Noncompliance|6|||
129932677|NCT01130883|467719287|FG000|Overall Study|Reason Unknown|1|||
129932678|NCT01130883|467719287|FG000|Overall Study|Adverse Event|3|||
129932679|NCT03981926|467719296|FG000|Overall Study|Lost to Follow-up|5|||
129932680|NCT03981926|467719297|FG001|Overall Study|Lost to Follow-up|9|||
129932681|NCT05464069|467719298|FG000|Overall Study|Protocol Violation|3|||
129932682|NCT05464069|467719299|FG001|Overall Study|Protocol Violation|2|||
129932683|NCT05976334|467719300|FG000|Part B|Death|0|||
129932684|NCT05976334|467719301|FG001|Part B|Death|1|||
129932685|NCT05976334|467719300|FG000|Part B|Study Terminated by Sponsor|0|||
129932686|NCT05976334|467719301|FG001|Part B|Study Terminated by Sponsor|1|||
129932687|NCT05976334|467719300|FG000|Part B|Reason Not Specified|0|||
129932688|NCT05976334|467719301|FG001|Part B|Reason Not Specified|1|||
129932689|NCT02437136|467719304|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
129932690|NCT02437136|467719305|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932691|NCT02437136|467719306|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932692|NCT02437136|467719307|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932693|NCT02437136|467719308|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932694|NCT02437136|467719309|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129451730|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451731|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451732|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
129451733|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
129451734|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451735|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451736|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
129451737|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
129451738|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451739|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451740|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451741|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451742|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
129451743|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451744|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451745|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451746|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451747|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451748|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451749|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451750|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
129451751|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
129451752|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451753|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451754|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451755|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451756|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
129451757|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451758|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451759|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451760|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451761|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451762|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451763|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451764|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451765|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
129451766|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451767|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451768|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451769|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451770|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
129451771|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451772|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451773|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451774|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
129451775|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451776|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451777|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451778|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451779|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451780|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451781|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451782|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451783|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451784|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
129451785|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451786|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451787|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451788|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451789|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451790|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451791|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451792|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
129451793|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
129451794|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129932695|NCT02437136|467719310|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
129932696|NCT02437136|467719304|FG000|Expansion (Phase 2)|Death|0|||
129932697|NCT02437136|467719305|FG001|Expansion (Phase 2)|Death|0|||
129932698|NCT02437136|467719306|FG002|Expansion (Phase 2)|Death|0|||
129932699|NCT02437136|467719307|FG003|Expansion (Phase 2)|Death|6|||
129932700|NCT02437136|467719308|FG004|Expansion (Phase 2)|Death|37|||
129932701|NCT02437136|467719309|FG005|Expansion (Phase 2)|Death|29|||
129932702|NCT02437136|467719310|FG006|Expansion (Phase 2)|Death|24|||
129932703|NCT02437136|467719304|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
129932704|NCT02437136|467719305|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
129932705|NCT02437136|467719306|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
129932706|NCT02437136|467719307|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
129932707|NCT02437136|467719308|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
129932708|NCT02437136|467719309|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
129932709|NCT02437136|467719310|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
129932710|NCT02437136|467719304|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
129932711|NCT02437136|467719305|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
129932712|NCT02437136|467719306|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
129932713|NCT02437136|467719307|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
129932714|NCT02437136|467719308|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
129932715|NCT02437136|467719309|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
129932716|NCT02437136|467719310|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
129932717|NCT04632225|467719317|FG000|Overall Study|Withdrawal by Subject|2|||
129932718|NCT04632225|467719318|FG001|Overall Study|Withdrawal by Subject|2|||
129932719|NCT05224544|467719326|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
129932720|NCT05224544|467719327|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
129932721|NCT00844415|467719328|FG000|Overall Study|Withdrawal by Subject|1|||
129932722|NCT03988621|467719332|FG000|Overall Study|Lost to Follow-up|16|||
129932723|NCT03988621|467719333|FG001|Overall Study|Lost to Follow-up|17|||
129932724|NCT03988621|467719332|FG000|Overall Study|Withdrawal by Subject|14|||
129932725|NCT03988621|467719333|FG001|Overall Study|Withdrawal by Subject|7|||
129932726|NCT03988621|467719332|FG000|Overall Study|Patient Lost to Follow Up|15|||
129932727|NCT03988621|467719333|FG001|Overall Study|Patient Lost to Follow Up|15|||
129932728|NCT03988621|467719332|FG000|Overall Study|Patient death|1|||
129932729|NCT03988621|467719333|FG001|Overall Study|Patient death|5|||
129932730|NCT04158739|467719336|FG000|Overall Study|Adverse Event|1|||
129932731|NCT04158739|467719337|FG001|Overall Study|Adverse Event|0|||
129932732|NCT04158739|467719336|FG000|Overall Study|Death|0|||
129932733|NCT04158739|467719337|FG001|Overall Study|Death|1|||
129932734|NCT04158739|467719336|FG000|Overall Study|Lack of Efficacy|3|||
129932735|NCT04158739|467719337|FG001|Overall Study|Lack of Efficacy|7|||
129932736|NCT04158739|467719336|FG000|Overall Study|Physician Decision|0|||
129932737|NCT04158739|467719337|FG001|Overall Study|Physician Decision|1|||
129932738|NCT04158739|467719336|FG000|Overall Study|Withdrawal by Subject|3|||
129932739|NCT04158739|467719337|FG001|Overall Study|Withdrawal by Subject|0|||
129932740|NCT00677365|467719338|FG000|Overall Study|Adverse Event|2|||
129932741|NCT00677365|467719339|FG001|Overall Study|Adverse Event|1|||
129932742|NCT00677365|467719340|FG002|Overall Study|Adverse Event|1|||
129932743|NCT00677365|467719341|FG003|Overall Study|Adverse Event|2|||
129932744|NCT00677365|467719338|FG000|Overall Study|Withdrawal by Subject|0|||
129932745|NCT00677365|467719339|FG001|Overall Study|Withdrawal by Subject|0|||
129932746|NCT00677365|467719340|FG002|Overall Study|Withdrawal by Subject|1|||
129932747|NCT00677365|467719341|FG003|Overall Study|Withdrawal by Subject|0|||
129932748|NCT00677365|467719338|FG000|Overall Study|Other reason|0|||
129932749|NCT00677365|467719339|FG001|Overall Study|Other reason|0|||
129932750|NCT00677365|467719340|FG002|Overall Study|Other reason|0|||
129932751|NCT00677365|467719341|FG003|Overall Study|Other reason|1|||
129932752|NCT01121588|467719342|FG000|Overall Study|Death|5|||
129932753|NCT01121588|467719343|FG001|Overall Study|Death|3|||
129932754|NCT01121588|467719344|FG002|Overall Study|Death|13|||
129932755|NCT01121588|467719342|FG000|Overall Study|Study Terminated by Sponsor|1|||
129932756|NCT01121588|467719343|FG001|Overall Study|Study Terminated by Sponsor|1|||
129932757|NCT01121588|467719344|FG002|Overall Study|Study Terminated by Sponsor|0|||
129932758|NCT01121588|467719342|FG000|Overall Study|Participant Refused Further Followup|2|||
129932759|NCT01121588|467719343|FG001|Overall Study|Participant Refused Further Followup|0|||
129932760|NCT01121588|467719344|FG002|Overall Study|Participant Refused Further Followup|2|||
129932761|NCT01121588|467719342|FG000|Overall Study|Lost to Follow-up|0|||
129932762|NCT01121588|467719343|FG001|Overall Study|Lost to Follow-up|1|||
129932763|NCT01121588|467719344|FG002|Overall Study|Lost to Follow-up|1|||
129932764|NCT01121588|467719342|FG000|Overall Study|Non-Specified Reasons|9|||
129932765|NCT01121588|467719343|FG001|Overall Study|Non-Specified Reasons|4|||
129932766|NCT01121588|467719344|FG002|Overall Study|Non-Specified Reasons|2|||
129932767|NCT03663205|467719347|FG000|Overall Study|Death|144|||
129932768|NCT03663205|467719348|FG001|Overall Study|Death|69|||
129932769|NCT03663205|467719347|FG000|Overall Study|Sponsor decision|53|||
129932770|NCT03663205|467719348|FG001|Overall Study|Sponsor decision|19|||
129932771|NCT03663205|467719347|FG000|Overall Study|Withdrawal by Subject|8|||
129932772|NCT03663205|467719348|FG001|Overall Study|Withdrawal by Subject|11|||
129932773|NCT03663205|467719347|FG000|Overall Study|Lost to Follow-up|7|||
129932774|NCT03663205|467719348|FG001|Overall Study|Lost to Follow-up|9|||
129932775|NCT03663205|467719347|FG000|Overall Study|Transferred to long term extension study|11|||
129932776|NCT03663205|467719348|FG001|Overall Study|Transferred to long term extension study|3|||
129932777|NCT02577354|467719349|FG000|Overall Study|Lack of Efficacy|4|||
129932778|NCT02577354|467719350|FG001|Overall Study|Lack of Efficacy|4|||
129932779|NCT02577354|467719349|FG000|Overall Study|Lost to Follow-up|3|||
129932780|NCT02577354|467719350|FG001|Overall Study|Lost to Follow-up|1|||
129932781|NCT02577354|467719349|FG000|Overall Study|Missed Visit|4|||
129932782|NCT02577354|467719350|FG001|Overall Study|Missed Visit|3|||
129932783|NCT02577354|467719349|FG000|Overall Study|Adverse Event|4|||
129932784|NCT02577354|467719350|FG001|Overall Study|Adverse Event|5|||
129932785|NCT04206787|467719351|FG000|Overall Study|Other than listed|2|||
129932786|NCT04206787|467719351|FG000|Overall Study|Investigator decision|1|||
129932787|NCT04206787|467719351|FG000|Overall Study|Death|25|||
129932788|NCT04206787|467719351|FG000|Overall Study|Lost to Follow-up|9|||
129932789|NCT04206787|467719351|FG000|Overall Study|Withdrawal of consent|9|||
129932790|NCT03367156|467719850|FG000|Overall Study|Lack of interest|3|||
129932791|NCT03367156|467719851|FG001|Overall Study|Lack of interest|1|||
129932792|NCT03367156|467719850|FG000|Overall Study|Death|2|||
129932793|NCT03367156|467719851|FG001|Overall Study|Death|0|||
129932794|NCT03367156|467719850|FG000|Overall Study|Lost to Follow-up|2|||
129932795|NCT03367156|467719851|FG001|Overall Study|Lost to Follow-up|1|||
129932796|NCT03367156|467719850|FG000|Overall Study|Became ineligible|1|||
129932797|NCT03367156|467719851|FG001|Overall Study|Became ineligible|2|||
129932798|NCT03367156|467719850|FG000|Overall Study|Hospitalization|1|||
129932799|NCT03367156|467719851|FG001|Overall Study|Hospitalization|0|||
129932800|NCT03367156|467719850|FG000|Overall Study|Concerned about Treatment|11|||
129932801|NCT03367156|467719851|FG001|Overall Study|Concerned about Treatment|3|||
129932802|NCT03367156|467719850|FG000|Overall Study|Started new treatment|4|||
129932803|NCT03367156|467719851|FG001|Overall Study|Started new treatment|1|||
129932804|NCT05507437|467719852|FG000|Overall Study|Withdrawal by Subject|1|||
129932805|NCT05507437|467719853|FG001|Overall Study|Withdrawal by Subject|1|||
129932806|NCT05507437|467719852|FG000|Overall Study|Death|3|||
129932807|NCT05507437|467719853|FG001|Overall Study|Death|0|||
129932808|NCT03972150|467719854|FG000|Overall Study|Adverse Event|0|||
129932809|NCT03972150|467719855|FG001|Overall Study|Adverse Event|1|||
129932810|NCT03972150|467719856|FG002|Overall Study|Adverse Event|1|||
129932811|NCT03972150|467719857|FG003|Overall Study|Adverse Event|0|||
129932812|NCT03972150|467719858|FG004|Overall Study|Adverse Event|0|||
129932813|NCT03972150|467719854|FG000|Overall Study|Progressive disease|3|||
129932814|NCT03972150|467719855|FG001|Overall Study|Progressive disease|5|||
129932815|NCT03972150|467719856|FG002|Overall Study|Progressive disease|2|||
129932816|NCT03972150|467719857|FG003|Overall Study|Progressive disease|2|||
129932817|NCT03972150|467719858|FG004|Overall Study|Progressive disease|3|||
129932818|NCT04136912|467719866|FG000|Overall Study|Operational reasons|0|||
129932819|NCT04136912|467719867|FG001|Overall Study|Operational reasons|0|||
129932820|NCT04136912|467719868|FG002|Overall Study|Operational reasons|2|||
129932821|NCT04526886|467719869|FG000|Overall Study|Physician Decision|4|||
129932822|NCT04282980|467719870|FG000|Overall Study|Remained on treatment|6|||
129932823|NCT04282980|467719870|FG000|Overall Study|Survival follow-up|11|||
129932824|NCT04282980|467719870|FG000|Overall Study|Withdrawal of informed consent|1|||
129932825|NCT04282980|467719870|FG000|Overall Study|Lost to Follow-up|1|||
129932826|NCT03571386|467719871|FG000|Overall Study|scheduling conflict|4|||
129932827|NCT03571386|467719872|FG001|Overall Study|scheduling conflict|0|||
129932828|NCT03571386|467719871|FG000|Overall Study|Withdrawal by Subject|15|||
129932829|NCT03571386|467719872|FG001|Overall Study|Withdrawal by Subject|5|||
129932830|NCT04311632|467719873|FG000|Overall Study|Withdrawal by Subject|0|||
129932831|NCT04311632|467719874|FG001|Overall Study|Withdrawal by Subject|0|||
129932832|NCT04311632|467719875|FG002|Overall Study|Withdrawal by Subject|1|||
129932833|NCT04605159|467719876|FG000|Overall Study|Adverse Event|6|||
129932834|NCT04605159|467719877|FG001|Overall Study|Adverse Event|3|||
129932835|NCT04605159|467719878|FG002|Overall Study|Adverse Event|21|||
129932836|NCT04605159|467719879|FG003|Overall Study|Adverse Event|4|||
129932837|NCT04605159|467719876|FG000|Overall Study|Lost to Follow-up|74|||
129932838|NCT04605159|467719877|FG001|Overall Study|Lost to Follow-up|45|||
129932839|NCT04605159|467719878|FG002|Overall Study|Lost to Follow-up|119|||
129932840|NCT04605159|467719879|FG003|Overall Study|Lost to Follow-up|80|||
129932841|NCT04605159|467719876|FG000|Overall Study|Protocol Violation|4|||
129932842|NCT04605159|467719877|FG001|Overall Study|Protocol Violation|5|||
129932843|NCT04605159|467719878|FG002|Overall Study|Protocol Violation|2|||
129932844|NCT04605159|467719879|FG003|Overall Study|Protocol Violation|0|||
129932845|NCT04605159|467719876|FG000|Overall Study|Withdrawal by Subject|66|||
129932846|NCT04605159|467719877|FG001|Overall Study|Withdrawal by Subject|37|||
129932847|NCT04605159|467719878|FG002|Overall Study|Withdrawal by Subject|68|||
129932848|NCT04605159|467719879|FG003|Overall Study|Withdrawal by Subject|50|||
129932849|NCT04605159|467719876|FG000|Overall Study|Migrated / moved from the study area|32|||
129932850|NCT04605159|467719877|FG001|Overall Study|Migrated / moved from the study area|22|||
129932851|NCT04605159|467719878|FG002|Overall Study|Migrated / moved from the study area|41|||
129932852|NCT04605159|467719879|FG003|Overall Study|Migrated / moved from the study area|21|||
129932853|NCT04605159|467719876|FG000|Overall Study|Other|1|||
129932854|NCT04605159|467719877|FG001|Overall Study|Other|2|||
129932855|NCT04605159|467719878|FG002|Overall Study|Other|7|||
129932856|NCT04605159|467719879|FG003|Overall Study|Other|3|||
129932857|NCT04881461|467719880|FG000|Overall Study|Adverse Event|2|||
129932858|NCT04881461|467719881|FG001|Overall Study|Adverse Event|4|||
129932859|NCT04881461|467719880|FG000|Overall Study|Withdrawal by Subject|19|||
129932860|NCT04881461|467719881|FG001|Overall Study|Withdrawal by Subject|19|||
129932861|NCT04881461|467719880|FG000|Overall Study|Lost to Follow-up|4|||
129932862|NCT04881461|467719881|FG001|Overall Study|Lost to Follow-up|4|||
129932863|NCT04881461|467719880|FG000|Overall Study|Lack of Efficacy|1|||
129932864|NCT04881461|467719881|FG001|Overall Study|Lack of Efficacy|0|||
129932865|NCT04881461|467719880|FG000|Overall Study|"Reason stated as other in CRF"|1|||
129932866|NCT04881461|467719881|FG001|Overall Study|"Reason stated as other in CRF"|2|||
129932867|NCT00450216|467719882|FG000|Overall Study|Adverse Event|38|||
129932868|NCT00450216|467719883|FG001|Overall Study|Adverse Event|23|||
129932869|NCT00450216|467719882|FG000|Overall Study|Withdrawal by Subject|48|||
129932870|NCT00450216|467719883|FG001|Overall Study|Withdrawal by Subject|26|||
129932871|NCT00450216|467719882|FG000|Overall Study|Lost to Follow-up|16|||
129932872|NCT00450216|467719883|FG001|Overall Study|Lost to Follow-up|9|||
129932873|NCT00450216|467719882|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
129932874|NCT00450216|467719883|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
129932875|NCT00450216|467719882|FG000|Overall Study|misc|21|||
129932876|NCT00450216|467719883|FG001|Overall Study|misc|20|||
129932877|NCT01475786|467719884|FG000|Overall Study|Adverse Event|0|||
129932878|NCT01475786|467719885|FG001|Overall Study|Adverse Event|1|||
129932879|NCT01475786|467719886|FG002|Overall Study|Adverse Event|0|||
129932880|NCT01475786|467719884|FG000|Overall Study|Lost to Follow-up|1|||
129932881|NCT01475786|467719885|FG001|Overall Study|Lost to Follow-up|2|||
129932882|NCT01475786|467719886|FG002|Overall Study|Lost to Follow-up|1|||
129932883|NCT01475786|467719884|FG000|Overall Study|Withdrawal by Subject|0|||
129932884|NCT01475786|467719885|FG001|Overall Study|Withdrawal by Subject|1|||
129932885|NCT01475786|467719886|FG002|Overall Study|Withdrawal by Subject|1|||
129932886|NCT01475786|467719884|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
129932887|NCT01475786|467719885|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
129932888|NCT01475786|467719886|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
129932889|NCT02039401|467719887|FG000|Overall Study|Adverse Event|0|||
129932890|NCT02039401|467719888|FG001|Overall Study|Adverse Event|1|||
129932891|NCT03057054|467719889|FG000|Overall Study|Death|4|||
129932892|NCT03057054|467719890|FG001|Overall Study|Death|4|||
129932893|NCT03057054|467719889|FG000|Overall Study|Withdrawal by Subject|6|||
129932894|NCT03057054|467719890|FG001|Overall Study|Withdrawal by Subject|3|||
129932895|NCT03057054|467719889|FG000|Overall Study|Ineligible|1|||
129932896|NCT03057054|467719890|FG001|Overall Study|Ineligible|1|||
129932897|NCT03734029|467719895|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
129932898|NCT03734029|467719896|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
129932899|NCT03734029|467719895|FG000|Overall Study|Adverse Event|60|||
129451795|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129932900|NCT03734029|467719896|FG001|Overall Study|Adverse Event|14|||
129932901|NCT03734029|467719895|FG000|Overall Study|Withdrawal by Subject|12|||
129932902|NCT03734029|467719896|FG001|Overall Study|Withdrawal by Subject|11|||
129932903|NCT03734029|467719895|FG000|Overall Study|Clinical progression by investigator|10|||
129932904|NCT03734029|467719896|FG001|Overall Study|Clinical progression by investigator|8|||
129932905|NCT03734029|467719895|FG000|Overall Study|Death|5|||
129932906|NCT03734029|467719896|FG001|Overall Study|Death|2|||
129932907|NCT03734029|467719895|FG000|Overall Study|Physician Decision|4|||
129932908|NCT03734029|467719896|FG001|Overall Study|Physician Decision|3|||
129932909|NCT03734029|467719895|FG000|Overall Study|Other|2|||
129932910|NCT03734029|467719896|FG001|Overall Study|Other|0|||
129932911|NCT03734029|467719895|FG000|Overall Study|Lost to Follow-up|0|||
129932912|NCT03734029|467719896|FG001|Overall Study|Lost to Follow-up|1|||
129932913|NCT03734029|467719895|FG000|Overall Study|Randomized, but not treated|2|||
129932914|NCT03734029|467719896|FG001|Overall Study|Randomized, but not treated|12|||
129932915|NCT05422885|467720954|FG000|Overall Study|Lost to Follow-up|1|||
129932916|NCT05422885|467720954|FG000|Overall Study|Withdrawal by Subject|2|||
129932917|NCT04084574|467720955|FG000|Overall Study|Lost to Follow-up|1|||
129932918|NCT04084574|467720956|FG001|Overall Study|Lost to Follow-up|0|||
129932919|NCT04084574|467720955|FG000|Overall Study|Physician Decision|1|||
129932920|NCT04084574|467720956|FG001|Overall Study|Physician Decision|0|||
129932921|NCT04084574|467720955|FG000|Overall Study|Relocated out of state|1|||
129932922|NCT04084574|467720956|FG001|Overall Study|Relocated out of state|0|||
129451796|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451797|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451798|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
129451799|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451800|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451801|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451802|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451803|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451804|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451805|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451806|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
129451807|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451808|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451809|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451810|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451811|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451812|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
129451813|NCT04033445|465952061|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451814|NCT04033445|465952062|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451815|NCT04033445|465952063|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451816|NCT04033445|465952064|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451817|NCT04033445|465952065|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451818|NCT04033445|465952066|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451819|NCT04033445|465952067|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451820|NCT04033445|465952068|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
129451821|NCT04033445|465952069|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451822|NCT04033445|465952070|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451823|NCT04033445|465952071|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451824|NCT04033445|465952072|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451825|NCT04033445|465952073|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451826|NCT04033445|465952074|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
129451827|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451828|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451829|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451830|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451831|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451832|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451833|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451834|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451835|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
129451836|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
129451837|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
129451838|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
129451839|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
129451840|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
129451841|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451842|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451843|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451844|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451845|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451846|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129932923|NCT02944968|467720959|FG000|Overall Study|Subject excluded before study procedure|1|||
129932924|NCT02944968|467720959|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
129932925|NCT01385202|467720960|FG000|Overall Study|Lost to Follow-up|6|||
129932926|NCT01385202|467720960|FG000|Overall Study|Not Eligible|11|||
129932927|NCT01385202|467720960|FG000|Overall Study|Withdrawn|1|||
129932928|NCT02905331|467720961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
129932929|NCT02905331|467720962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
129932930|NCT02905331|467720963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
129932931|NCT02905331|467720961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
129932932|NCT02905331|467720962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
129932933|NCT02905331|467720963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
129932934|NCT02905331|467720961|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
129932935|NCT02905331|467720962|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
129932936|NCT02905331|467720963|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
129932937|NCT02905331|467720961|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
129932938|NCT02905331|467720962|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
129932939|NCT02905331|467720963|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
129932940|NCT02905331|467720961|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
129932941|NCT02905331|467720962|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
129932942|NCT02905331|467720963|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
129932943|NCT03681262|467720964|FG000|Overall Study|Continuing on study|3|||
129932944|NCT03681262|467720965|FG001|Overall Study|Continuing on study|3|||
129932945|NCT03681262|467720964|FG000|Overall Study|Lost to Follow-up|1|||
129932946|NCT03681262|467720965|FG001|Overall Study|Lost to Follow-up|0|||
129932947|NCT04102111|467720966|FG000|Overall Study|Withdrawal by Subject|2|||
129932948|NCT04102111|467720967|FG001|Overall Study|Withdrawal by Subject|3|||
129932949|NCT04102111|467720966|FG000|Overall Study|Adverse Event|1|||
129932950|NCT04102111|467720967|FG001|Overall Study|Adverse Event|1|||
129932951|NCT04102111|467720966|FG000|Overall Study|Study terminated by sponsor|1|||
129932952|NCT04102111|467720967|FG001|Overall Study|Study terminated by sponsor|3|||
129932953|NCT02782676|467720968|FG000|Overall Study|Lost to Follow-up|0|||
129932954|NCT02782676|467720969|FG001|Overall Study|Lost to Follow-up|1|||
129932955|NCT03334695|467720970|FG000|Overall Study|Lost to Follow-up|3|||
129932956|NCT03334695|467720971|FG001|Overall Study|Lost to Follow-up|3|||
129932957|NCT03334695|467720970|FG000|Overall Study|Physician Decision|1|||
129932958|NCT03334695|467720971|FG001|Overall Study|Physician Decision|2|||
129932959|NCT03334695|467720970|FG000|Overall Study|Protocol Violation|0|||
129932960|NCT03334695|467720971|FG001|Overall Study|Protocol Violation|1|||
129932961|NCT02641730|467720972|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
129932962|NCT02641730|467720973|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129932963|NCT02641730|467720974|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
129932964|NCT02641730|467720975|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
129932965|NCT02641730|467720976|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
129932966|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
129932967|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
129932968|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
129932969|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
129932970|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
129932971|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
129932972|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
129932973|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
129932974|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
129932975|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
129932976|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129932977|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129932978|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129932979|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
129932980|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
129932981|NCT02641730|467720972|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
129932982|NCT02641730|467720973|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
129932983|NCT02641730|467720974|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
129932984|NCT02641730|467720975|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
129932985|NCT02641730|467720976|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
129932986|NCT02641730|467720972|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
129932987|NCT02641730|467720973|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
129932988|NCT02641730|467720974|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
129932989|NCT02641730|467720975|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
129932990|NCT02641730|467720976|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
129932991|NCT02326974|467720981|FG000|Overall Study|Withdrawal by Subject|2|||
129932992|NCT02326974|467720981|FG000|Overall Study|failed heterogenity evaluation|5|||
129932993|NCT04173247|467720982|FG000|Overall Study|Withdrawal by Subject|0|||
129932994|NCT04173247|467720983|FG001|Overall Study|Withdrawal by Subject|2|||
129932995|NCT04173247|467720982|FG000|Overall Study|Death|1|||
129932996|NCT04173247|467720983|FG001|Overall Study|Death|0|||
129932997|NCT04173247|467720982|FG000|Overall Study|Physician Decision|1|||
129932998|NCT04173247|467720983|FG001|Overall Study|Physician Decision|0|||
129932999|NCT04924400|467720991|FG000|Overall Study|Lost to Follow-up|3|||
129933000|NCT04924400|467720992|FG001|Overall Study|Lost to Follow-up|0|||
129933001|NCT04424316|467720993|FG000|Overall Study|Adverse Event|0|||
129933002|NCT04424316|467720994|FG001|Overall Study|Adverse Event|1|||
129933003|NCT04424316|467720995|FG002|Overall Study|Adverse Event|0|||
129933004|NCT04424316|467720996|FG003|Overall Study|Adverse Event|0|||
129933005|NCT04424316|467720993|FG000|Overall Study|Death|1|||
129933006|NCT04424316|467720994|FG001|Overall Study|Death|0|||
129933007|NCT04424316|467720995|FG002|Overall Study|Death|8|||
129933008|NCT04424316|467720996|FG003|Overall Study|Death|14|||
129933009|NCT04424316|467720993|FG000|Overall Study|Lost to Follow-up|93|||
129933010|NCT04424316|467720994|FG001|Overall Study|Lost to Follow-up|88|||
129933011|NCT04424316|467720995|FG002|Overall Study|Lost to Follow-up|224|||
129933012|NCT04424316|467720996|FG003|Overall Study|Lost to Follow-up|211|||
129933013|NCT04424316|467720993|FG000|Overall Study|No longer met eligibility criteria|1|||
129933014|NCT04424316|467720994|FG001|Overall Study|No longer met eligibility criteria|0|||
129933015|NCT04424316|467720995|FG002|Overall Study|No longer met eligibility criteria|0|||
129933016|NCT04424316|467720996|FG003|Overall Study|No longer met eligibility criteria|0|||
129933017|NCT04424316|467720993|FG000|Overall Study|Other|15|||
129933018|NCT04424316|467720994|FG001|Overall Study|Other|11|||
129933019|NCT04424316|467720995|FG002|Overall Study|Other|34|||
129933020|NCT04424316|467720996|FG003|Overall Study|Other|45|||
129933021|NCT04424316|467720993|FG000|Overall Study|Physician Decision|1|||
129933022|NCT04424316|467720994|FG001|Overall Study|Physician Decision|0|||
129933023|NCT04424316|467720995|FG002|Overall Study|Physician Decision|1|||
129933024|NCT04424316|467720996|FG003|Overall Study|Physician Decision|1|||
129933025|NCT04424316|467720993|FG000|Overall Study|Protocol Violation|0|||
129933026|NCT04424316|467720994|FG001|Overall Study|Protocol Violation|1|||
129933027|NCT04424316|467720995|FG002|Overall Study|Protocol Violation|0|||
129933028|NCT04424316|467720996|FG003|Overall Study|Protocol Violation|0|||
129933029|NCT04424316|467720993|FG000|Overall Study|Withdrawal by Subject|71|||
129933030|NCT04424316|467720994|FG001|Overall Study|Withdrawal by Subject|77|||
129933031|NCT04424316|467720995|FG002|Overall Study|Withdrawal by Subject|0|||
129933032|NCT04424316|467720996|FG003|Overall Study|Withdrawal by Subject|0|||
129933033|NCT04424316|467720993|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129933034|NCT04424316|467720994|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129933035|NCT04424316|467720995|FG002|Overall Study|Withdrawal by parent/guardian|74|||
129933036|NCT04424316|467720996|FG003|Overall Study|Withdrawal by parent/guardian|81|||
129933037|NCT04424316|467720993|FG000|Overall Study|Randomized but not vaccinated|13|||
129933038|NCT04424316|467720994|FG001|Overall Study|Randomized but not vaccinated|21|||
129933039|NCT04424316|467720995|FG002|Overall Study|Randomized but not vaccinated|0|||
129933040|NCT04424316|467720996|FG003|Overall Study|Randomized but not vaccinated|0|||
129933041|NCT04424316|467720993|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
129933042|NCT04424316|467720994|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
129933043|NCT04424316|467720995|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
129933044|NCT04424316|467720996|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
129933045|NCT00412607|467720999|FG000|Overall Study|Withdrawal by Subject|9|||
129933046|NCT00412607|467720999|FG000|Overall Study|Lost to Follow-up|19|||
129451847|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451848|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451849|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
129451850|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
129933047|NCT00412607|467720999|FG000|Overall Study|Death|61|||
129933048|NCT00412607|467720999|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
129933049|NCT04707768|467721007|FG000|Overall Study|Adverse Event|9|||
129933050|NCT04707768|467721008|FG001|Overall Study|Adverse Event|18|||
129933051|NCT04707768|467721009|FG002|Overall Study|Adverse Event|3|||
129933052|NCT04707768|467721007|FG000|Overall Study|Investigator's Discretion|8|||
129933053|NCT04707768|467721008|FG001|Overall Study|Investigator's Discretion|4|||
129933054|NCT04707768|467721009|FG002|Overall Study|Investigator's Discretion|3|||
129933055|NCT04707768|467721007|FG000|Overall Study|Withdrawal by Subject|6|||
129933056|NCT04707768|467721008|FG001|Overall Study|Withdrawal by Subject|8|||
129933057|NCT04707768|467721009|FG002|Overall Study|Withdrawal by Subject|2|||
129933058|NCT04707768|467721007|FG000|Overall Study|Lack of Efficacy|1|||
129933059|NCT04707768|467721008|FG001|Overall Study|Lack of Efficacy|3|||
129933060|NCT04707768|467721009|FG002|Overall Study|Lack of Efficacy|0|||
129451851|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
129451852|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
129451853|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
129451854|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
129451855|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451856|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451857|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451858|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451859|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451860|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451861|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451862|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451863|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451864|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451865|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
129451866|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
129451867|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
129451868|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
129451869|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451870|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451871|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451872|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451873|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451874|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451875|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451876|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451877|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451878|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
129451879|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
129451880|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
129451881|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
129451882|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
129451883|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451884|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451885|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451886|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451887|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451888|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451889|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451890|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451891|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
129451892|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
129451893|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
129451894|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
129451895|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
129933061|NCT04707768|467721007|FG000|Overall Study|Lost to Follow-up|0|||
129933062|NCT04707768|467721008|FG001|Overall Study|Lost to Follow-up|0|||
129933063|NCT04707768|467721009|FG002|Overall Study|Lost to Follow-up|3|||
129933064|NCT04707768|467721007|FG000|Overall Study|Death|13|||
129933065|NCT04707768|467721008|FG001|Overall Study|Death|11|||
129933066|NCT04707768|467721009|FG002|Overall Study|Death|13|||
129933067|NCT04707768|467721007|FG000|Overall Study|Protocol Violation|2|||
129933068|NCT04707768|467721008|FG001|Overall Study|Protocol Violation|1|||
129933069|NCT04707768|467721009|FG002|Overall Study|Protocol Violation|0|||
129933070|NCT04707768|467721007|FG000|Overall Study|Non Compliance with Study Drug|1|||
129933071|NCT04707768|467721008|FG001|Overall Study|Non Compliance with Study Drug|0|||
129933072|NCT04707768|467721009|FG002|Overall Study|Non Compliance with Study Drug|0|||
129451896|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
129451897|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451898|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129933073|NCT04707768|467721007|FG000|Overall Study|Transplant|4|||
129933074|NCT04707768|467721008|FG001|Overall Study|Transplant|4|||
129933075|NCT04707768|467721009|FG002|Overall Study|Transplant|8|||
129933076|NCT04707768|467721007|FG000|Overall Study|Other|9|||
129451899|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129933077|NCT04707768|467721008|FG001|Overall Study|Other|5|||
129933078|NCT04707768|467721009|FG002|Overall Study|Other|2|||
129933079|NCT04078152|467721010|FG000|Overall Study|Other|83|||
129933080|NCT04078152|467721011|FG001|Overall Study|Other|22|||
129933081|NCT04078152|467721012|FG002|Overall Study|Other|25|||
129933082|NCT04078152|467721010|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
129933083|NCT04078152|467721011|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
129933084|NCT04078152|467721012|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
129933085|NCT04078152|467721010|FG000|Overall Study|Withdrawal by Subject|5|||
129933086|NCT04078152|467721011|FG001|Overall Study|Withdrawal by Subject|0|||
129933087|NCT04078152|467721012|FG002|Overall Study|Withdrawal by Subject|1|||
129933088|NCT04078152|467721010|FG000|Overall Study|Death|10|||
129933089|NCT04078152|467721011|FG001|Overall Study|Death|2|||
129933090|NCT04078152|467721012|FG002|Overall Study|Death|12|||
129933091|NCT04078152|467721010|FG000|Overall Study|Adverse Event|1|||
129933092|NCT04078152|467721011|FG001|Overall Study|Adverse Event|0|||
129933093|NCT04078152|467721012|FG002|Overall Study|Adverse Event|0|||
129933094|NCT02510235|467721013|FG000|Overall Study|Withdrawal by Subject|1|||
129933095|NCT02510235|467721014|FG001|Overall Study|Withdrawal by Subject|0|||
129933096|NCT03248479|467721015|FG000|Overall Study|Death|12|||
129933097|NCT03248479|467721016|FG001|Overall Study|Death|44|||
129933098|NCT03248479|467721017|FG002|Overall Study|Death|1|||
129933099|NCT03248479|467721018|FG003|Overall Study|Death|72|||
129933100|NCT03248479|467721019|FG004|Overall Study|Death|17|||
129933101|NCT03248479|467721020|FG005|Overall Study|Death|6|||
129933102|NCT03248479|467721021|FG006|Overall Study|Death|1|||
129933103|NCT03248479|467721022|FG007|Overall Study|Death|14|||
129933104|NCT03248479|467721023|FG008|Overall Study|Death|3|||
129933105|NCT03248479|467721024|FG009|Overall Study|Death|7|||
129933106|NCT03248479|467721025|FG010|Overall Study|Death|3|||
129933107|NCT03248479|467721026|FG011|Overall Study|Death|1|||
129933108|NCT03248479|467721027|FG012|Overall Study|Death|1|||
129933109|NCT03248479|467721015|FG000|Overall Study|Study terminated by sponsor|12|||
129933110|NCT03248479|467721016|FG001|Overall Study|Study terminated by sponsor|15|||
129933111|NCT03248479|467721017|FG002|Overall Study|Study terminated by sponsor|0|||
129933112|NCT03248479|467721018|FG003|Overall Study|Study terminated by sponsor|5|||
129933113|NCT03248479|467721019|FG004|Overall Study|Study terminated by sponsor|0|||
129933114|NCT03248479|467721020|FG005|Overall Study|Study terminated by sponsor|0|||
129933115|NCT03248479|467721021|FG006|Overall Study|Study terminated by sponsor|0|||
129933116|NCT03248479|467721022|FG007|Overall Study|Study terminated by sponsor|1|||
129933117|NCT03248479|467721023|FG008|Overall Study|Study terminated by sponsor|1|||
129933118|NCT03248479|467721024|FG009|Overall Study|Study terminated by sponsor|0|||
129933119|NCT03248479|467721025|FG010|Overall Study|Study terminated by sponsor|5|||
129933120|NCT03248479|467721026|FG011|Overall Study|Study terminated by sponsor|4|||
129933121|NCT03248479|467721027|FG012|Overall Study|Study terminated by sponsor|0|||
129933122|NCT03248479|467721015|FG000|Overall Study|Consent withdrawn|6|||
129933123|NCT03248479|467721016|FG001|Overall Study|Consent withdrawn|3|||
129933124|NCT03248479|467721017|FG002|Overall Study|Consent withdrawn|0|||
129933125|NCT03248479|467721018|FG003|Overall Study|Consent withdrawn|9|||
129933126|NCT03248479|467721019|FG004|Overall Study|Consent withdrawn|1|||
129933127|NCT03248479|467721020|FG005|Overall Study|Consent withdrawn|0|||
129933128|NCT03248479|467721021|FG006|Overall Study|Consent withdrawn|0|||
129933129|NCT03248479|467721022|FG007|Overall Study|Consent withdrawn|1|||
129933130|NCT03248479|467721023|FG008|Overall Study|Consent withdrawn|0|||
129933131|NCT03248479|467721024|FG009|Overall Study|Consent withdrawn|3|||
129933132|NCT03248479|467721025|FG010|Overall Study|Consent withdrawn|1|||
129933133|NCT03248479|467721026|FG011|Overall Study|Consent withdrawn|0|||
129933134|NCT03248479|467721027|FG012|Overall Study|Consent withdrawn|1|||
129933135|NCT03248479|467721015|FG000|Overall Study|Lost to Follow-up|2|||
129933136|NCT03248479|467721016|FG001|Overall Study|Lost to Follow-up|1|||
129933137|NCT03248479|467721017|FG002|Overall Study|Lost to Follow-up|0|||
129933138|NCT03248479|467721018|FG003|Overall Study|Lost to Follow-up|0|||
129933139|NCT03248479|467721019|FG004|Overall Study|Lost to Follow-up|0|||
129933140|NCT03248479|467721020|FG005|Overall Study|Lost to Follow-up|0|||
129933141|NCT03248479|467721021|FG006|Overall Study|Lost to Follow-up|0|||
129933142|NCT03248479|467721022|FG007|Overall Study|Lost to Follow-up|0|||
129933143|NCT03248479|467721023|FG008|Overall Study|Lost to Follow-up|0|||
129933144|NCT03248479|467721024|FG009|Overall Study|Lost to Follow-up|0|||
129933145|NCT03248479|467721025|FG010|Overall Study|Lost to Follow-up|0|||
129933146|NCT03248479|467721026|FG011|Overall Study|Lost to Follow-up|0|||
129933147|NCT03248479|467721027|FG012|Overall Study|Lost to Follow-up|1|||
129933148|NCT03248479|467721015|FG000|Overall Study|Not reported|0|||
129933149|NCT03248479|467721016|FG001|Overall Study|Not reported|0|||
129933150|NCT03248479|467721017|FG002|Overall Study|Not reported|0|||
129933151|NCT03248479|467721018|FG003|Overall Study|Not reported|1|||
129933152|NCT03248479|467721019|FG004|Overall Study|Not reported|1|||
129933153|NCT03248479|467721020|FG005|Overall Study|Not reported|0|||
129933154|NCT03248479|467721021|FG006|Overall Study|Not reported|0|||
129933155|NCT03248479|467721022|FG007|Overall Study|Not reported|1|||
129933156|NCT03248479|467721023|FG008|Overall Study|Not reported|1|||
129933157|NCT03248479|467721024|FG009|Overall Study|Not reported|0|||
129933158|NCT03248479|467721025|FG010|Overall Study|Not reported|0|||
129933159|NCT03248479|467721026|FG011|Overall Study|Not reported|0|||
129933160|NCT03248479|467721027|FG012|Overall Study|Not reported|0|||
129933161|NCT03735979|467721032|FG000|Overall Study|Lost to Follow-up|1|||
129933162|NCT03735979|467721033|FG001|Overall Study|Lost to Follow-up|12|||
129933163|NCT03735979|467721034|FG002|Overall Study|Lost to Follow-up|14|||
129933164|NCT03735979|467721032|FG000|Overall Study|Withdrawal by Subject|1|||
129933165|NCT03735979|467721033|FG001|Overall Study|Withdrawal by Subject|5|||
129933166|NCT03735979|467721034|FG002|Overall Study|Withdrawal by Subject|2|||
129933167|NCT03735979|467721032|FG000|Overall Study|Not due to the above reasons|1|||
129933168|NCT03735979|467721033|FG001|Overall Study|Not due to the above reasons|0|||
129933169|NCT03735979|467721034|FG002|Overall Study|Not due to the above reasons|0|||
129933170|NCT00319111|467721037|FG000|Overall Study|Adverse Event|20|||
129933171|NCT00319111|467721037|FG000|Overall Study|Withdrawal of consent|11|||
129933172|NCT00319111|467721037|FG000|Overall Study|Death|9|||
129933173|NCT00319111|467721037|FG000|Overall Study|Lack of clinical improvement|4|||
129933174|NCT00319111|467721037|FG000|Overall Study|Administrative|2|||
129933175|NCT00319111|467721037|FG000|Overall Study|Treatment failure|1|||
129933176|NCT04743973|467721038|FG000|Overall Study|Withdrawal by Subject|5|||
129933177|NCT05654662|467721039|FG000|Overall Study|Withdrawal by Subject|1|||
129933178|NCT05654662|467721040|FG001|Overall Study|Withdrawal by Subject|0|||
129933179|NCT05654662|467721039|FG000|Overall Study|A death in the family|1|||
129933180|NCT05654662|467721040|FG001|Overall Study|A death in the family|0|||
129933181|NCT03165955|467721041|FG000|Treatment|Withdrawal by Subject|3|||
129933182|NCT03165955|467721041|FG000|Treatment|Death|1|||
129933183|NCT03165955|467721041|FG000|Treatment|Adverse Event|1|||
129933184|NCT03165955|467721041|FG000|Treatment|Progressive disease|3|||
129933185|NCT04678856|467721042|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
129933186|NCT04678856|467721043|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
129933187|NCT04678856|467721042|FG000|Overall Study|Withdrawal by Subject|5|||
129933188|NCT04678856|467721043|FG001|Overall Study|Withdrawal by Subject|1|||
129933189|NCT05247034|467722460|FG000|Overall Study|Lost to Follow-up|3|||
129933190|NCT05247034|467722461|FG001|Overall Study|Lost to Follow-up|2|||
129933191|NCT05247034|467722460|FG000|Overall Study|Organizational problems when attending appointments|1|||
129933192|NCT05247034|467722461|FG001|Overall Study|Organizational problems when attending appointments|0|||
129933193|NCT04464564|467722462|FG000|Period A (Placebo lead-in)|Other|5|||
129933194|NCT04464564|467722463|FG001|Period A (Placebo lead-in)|Other|0|||
129933195|NCT04464564|467722464|FG002|Period A (Placebo lead-in)|Other|0|||
129933196|NCT04464564|467722465|FG003|Period A (Placebo lead-in)|Other|0|||
129933197|NCT04464564|467722462|FG000|Period B (Randomization Period)|Adverse Event|0|||
129933198|NCT04464564|467722463|FG001|Period B (Randomization Period)|Adverse Event|1|||
129933199|NCT04464564|467722464|FG002|Period B (Randomization Period)|Adverse Event|2|||
129933200|NCT04464564|467722465|FG003|Period B (Randomization Period)|Adverse Event|8|||
129933201|NCT04464564|467722462|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
129933202|NCT04464564|467722463|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
129933203|NCT04464564|467722464|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
129933204|NCT04464564|467722465|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
129933205|NCT04464564|467722462|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
129933206|NCT04464564|467722463|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
129933207|NCT04464564|467722464|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
129933208|NCT04464564|467722465|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
129933209|NCT04464564|467722462|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
129933210|NCT04464564|467722463|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
129933211|NCT04464564|467722464|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
129933212|NCT04464564|467722465|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
129933213|NCT04464564|467722462|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
129933214|NCT04464564|467722463|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
129933215|NCT04464564|467722464|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
129933216|NCT04464564|467722465|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
129933217|NCT04464564|467722462|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
129933218|NCT04464564|467722463|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
129933219|NCT04464564|467722464|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
129933220|NCT04464564|467722465|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
129933221|NCT04464564|467722462|FG000|Period B (Randomization Period)|Reason not Specified|0|||
129933222|NCT04464564|467722463|FG001|Period B (Randomization Period)|Reason not Specified|3|||
129933223|NCT04464564|467722464|FG002|Period B (Randomization Period)|Reason not Specified|3|||
129933224|NCT04464564|467722465|FG003|Period B (Randomization Period)|Reason not Specified|3|||
129933225|NCT03505710|467722466|FG000|Overall Study|Progressive Disease|24|||
129933226|NCT03505710|467722467|FG001|Overall Study|Progressive Disease|17|||
129933227|NCT03505710|467722468|FG002|Overall Study|Progressive Disease|43|||
129451900|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451901|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451902|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451903|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451904|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451905|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451906|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451907|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451908|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451909|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
129451910|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
129451911|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451912|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451913|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451914|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451915|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451916|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451917|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451918|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451919|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
129451920|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
129451921|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
129451922|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
129451923|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
129451924|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
129451925|NCT04033445|465952061|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451926|NCT04033445|465952062|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451927|NCT04033445|465952063|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451928|NCT04033445|465952064|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451929|NCT04033445|465952065|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451930|NCT04033445|465952066|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451931|NCT04033445|465952067|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451932|NCT04033445|465952068|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451933|NCT04033445|465952069|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451934|NCT04033445|465952070|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
129451935|NCT04033445|465952071|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451936|NCT04033445|465952072|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
129451937|NCT04033445|465952073|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
129451938|NCT04033445|465952074|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
129451939|NCT04754802|465952080|FG000|Overall Study|Lost to Follow-up|0|||
129451940|NCT04754802|465952081|FG001|Overall Study|Lost to Follow-up|2|||
129451941|NCT04754802|465952080|FG000|Overall Study|Withdrawal by Subject|2|||
129451942|NCT04754802|465952081|FG001|Overall Study|Withdrawal by Subject|0|||
129451943|NCT04451161|465952082|FG000|Overall Study|Lost to Follow-up|28|||
129451944|NCT04451161|465952083|FG001|Overall Study|Lost to Follow-up|37|||
129451945|NCT04451161|465952084|FG002|Overall Study|Lost to Follow-up|22|||
129451946|NCT04451161|465952085|FG003|Overall Study|Lost to Follow-up|13|||
129451947|NCT04451161|465952086|FG004|Overall Study|Lost to Follow-up|11|||
129451948|NCT04451161|465952087|FG005|Overall Study|Lost to Follow-up|14|||
129451949|NCT04451161|465952082|FG000|Overall Study|Withdrawal by Subject|3|||
129451950|NCT04451161|465952083|FG001|Overall Study|Withdrawal by Subject|0|||
129451951|NCT04451161|465952084|FG002|Overall Study|Withdrawal by Subject|0|||
129451952|NCT04451161|465952085|FG003|Overall Study|Withdrawal by Subject|0|||
129451953|NCT04451161|465952086|FG004|Overall Study|Withdrawal by Subject|2|||
129451954|NCT04451161|465952087|FG005|Overall Study|Withdrawal by Subject|4|||
129451955|NCT05525689|465952088|FG000|Overall Study|Lost to Follow-up|1|||
129451956|NCT05525689|465952089|FG001|Overall Study|Lost to Follow-up|0|||
129451957|NCT01671111|465952090|FG000|Overall Study|Adverse Event|2|||
129451958|NCT01671111|465952090|FG000|Overall Study|Lack of Efficacy|1|||
129451959|NCT01671111|465952090|FG000|Overall Study|Withdrawal by Subject|2|||
129451960|NCT01671111|465952090|FG000|Overall Study|Physician Decision|1|||
129451961|NCT01671111|465952090|FG000|Overall Study|Other|24|||
129451962|NCT03680911|465952091|FG000|At Home Treatment|Study Termination|3|||
129451963|NCT03680911|465952092|FG001|At Home Treatment|Study Termination|0|||
129451964|NCT03680911|465952091|FG000|At Home Treatment|Lost to Follow-up|0|||
129451965|NCT03680911|465952092|FG001|At Home Treatment|Lost to Follow-up|1|||
129451966|NCT03680911|465952091|FG000|At Home Treatment|Withdrawal by Subject|0|||
129451967|NCT03680911|465952092|FG001|At Home Treatment|Withdrawal by Subject|2|||
129451968|NCT03680911|465952091|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
129933228|NCT03505710|467722466|FG000|Overall Study|Clinical Progression|6|||
129933229|NCT03505710|467722467|FG001|Overall Study|Clinical Progression|8|||
129933230|NCT03505710|467722468|FG002|Overall Study|Clinical Progression|3|||
129933231|NCT03505710|467722466|FG000|Overall Study|Adverse Event|12|||
129933232|NCT03505710|467722467|FG001|Overall Study|Adverse Event|6|||
129933233|NCT03505710|467722468|FG002|Overall Study|Adverse Event|28|||
129933234|NCT03505710|467722466|FG000|Overall Study|Withdrawal by Subject|1|||
129933235|NCT03505710|467722467|FG001|Overall Study|Withdrawal by Subject|3|||
129933236|NCT03505710|467722468|FG002|Overall Study|Withdrawal by Subject|7|||
129933237|NCT03505710|467722466|FG000|Overall Study|Physician Decision|1|||
129933238|NCT03505710|467722467|FG001|Overall Study|Physician Decision|1|||
129933239|NCT03505710|467722468|FG002|Overall Study|Physician Decision|2|||
129933240|NCT03505710|467722466|FG000|Overall Study|Death|4|||
129933241|NCT03505710|467722467|FG001|Overall Study|Death|5|||
129933242|NCT03505710|467722468|FG002|Overall Study|Death|6|||
129933243|NCT03505710|467722466|FG000|Overall Study|Other Reasons|1|||
129933244|NCT03505710|467722467|FG001|Overall Study|Other Reasons|1|||
129933245|NCT03505710|467722468|FG002|Overall Study|Other Reasons|1|||
129933246|NCT03505710|467722466|FG000|Overall Study|Study Terminated by Sponsor|0|||
129933247|NCT03505710|467722467|FG001|Overall Study|Study Terminated by Sponsor|0|||
129933248|NCT03505710|467722468|FG002|Overall Study|Study Terminated by Sponsor|1|||
129933249|NCT00942877|467722473|FG000|Overall Study|Refused further treatment|1|||
129933250|NCT00942877|467722474|FG001|Overall Study|Refused further treatment|1|||
129933251|NCT00942877|467722473|FG000|Overall Study|Patient was not treated|1|||
129933252|NCT00942877|467722474|FG001|Overall Study|Patient was not treated|0|||
129933253|NCT00942877|467722473|FG000|Overall Study|Adverse Event|1|||
129933254|NCT00942877|467722474|FG001|Overall Study|Adverse Event|0|||
129933255|NCT00942877|467722473|FG000|Overall Study|Progressive disease|42|||
129933256|NCT00942877|467722474|FG001|Overall Study|Progressive disease|3|||
129933257|NCT02874742|467722476|FG000|Overall Study|Death|0|||
129933258|NCT02874742|467722477|FG001|Overall Study|Death|1|||
129933259|NCT02874742|467722478|FG002|Overall Study|Death|0|||
129933260|NCT02874742|467722476|FG000|Overall Study|Lost to Follow-up|5|||
129933261|NCT02874742|467722477|FG001|Overall Study|Lost to Follow-up|4|||
129933262|NCT02874742|467722478|FG002|Overall Study|Lost to Follow-up|1|||
129933263|NCT02874742|467722476|FG000|Overall Study|Withdrawal by Subject|17|||
129933264|NCT02874742|467722477|FG001|Overall Study|Withdrawal by Subject|8|||
129933265|NCT02874742|467722478|FG002|Overall Study|Withdrawal by Subject|0|||
129933266|NCT02874742|467722476|FG000|Overall Study|Other|4|||
129933267|NCT02874742|467722477|FG001|Overall Study|Other|1|||
129933268|NCT02874742|467722478|FG002|Overall Study|Other|0|||
129933269|NCT02874742|467722476|FG000|Overall Study|Progressive Disease|1|||
129933270|NCT02874742|467722477|FG001|Overall Study|Progressive Disease|0|||
129933271|NCT02874742|467722478|FG002|Overall Study|Progressive Disease|0|||
129933272|NCT02874742|467722476|FG000|Overall Study|Screen Failure|0|||
129933273|NCT02874742|467722477|FG001|Overall Study|Screen Failure|2|||
129933274|NCT02874742|467722478|FG002|Overall Study|Screen Failure|0|||
129933275|NCT00964392|467722479|FG000|Overall Study|Withdrawal by Subject|4|||
129933276|NCT00964392|467722480|FG001|Overall Study|Withdrawal by Subject|6|||
129933277|NCT00964392|467722479|FG000|Overall Study|Lost to Follow-up|4|||
129933278|NCT00964392|467722480|FG001|Overall Study|Lost to Follow-up|10|||
129933279|NCT00964392|467722479|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
129933280|NCT00964392|467722480|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
129933281|NCT00964392|467722479|FG000|Overall Study|Not completed|44|||
129933282|NCT00964392|467722480|FG001|Overall Study|Not completed|168|||
129933283|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
129933284|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
129933285|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
129933286|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
129933287|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
129933288|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
129933289|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
129933290|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
129933291|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
129933292|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
129933293|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
129933294|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
129933295|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
129933296|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
129933297|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
129933298|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
129933299|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
129933300|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
129933301|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
129933302|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
129933303|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
129933304|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
129933305|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
129933306|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
129933307|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
129933308|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
129933309|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
129933310|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
129933311|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
129933312|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
129933313|NCT04614948|467722481|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
129933314|NCT04614948|467722482|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
129933315|NCT04614948|467722483|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
129933316|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
129933317|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
129933318|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
129933319|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
129933320|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
129933321|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
129933322|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
129933323|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
129933324|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
129933325|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
129933326|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
129933327|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
129933328|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
129933329|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
129933330|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
129933331|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
129933332|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
129933333|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
129933334|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
129933335|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
129933336|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
129933337|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
129933338|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
129933339|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
129933340|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
129933341|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
129933342|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
129933343|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
129933344|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
129933345|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
129933346|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
129933347|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
129933348|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
129933349|NCT04614948|467722481|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
129933350|NCT04614948|467722482|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
129933351|NCT04614948|467722483|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
129933352|NCT04055012|467722484|FG000|Overall Study|Withdrawal by Subject|1|||
129933353|NCT04055012|467722485|FG001|Overall Study|Withdrawal by Subject|3|||
129933354|NCT04055012|467722486|FG002|Overall Study|Withdrawal by Subject|1|||
129933355|NCT04055012|467722487|FG003|Overall Study|Withdrawal by Subject|0|||
129933356|NCT04055012|467722484|FG000|Overall Study|Metformin Recall|1|||
129933357|NCT04055012|467722485|FG001|Overall Study|Metformin Recall|1|||
129933358|NCT04055012|467722486|FG002|Overall Study|Metformin Recall|1|||
129933359|NCT04055012|467722487|FG003|Overall Study|Metformin Recall|0|||
129933360|NCT03884101|467722492|FG000|Overall Study|Participant Ongoing in Study|202|||
129933361|NCT03884101|467722493|FG001|Overall Study|Participant Ongoing in Study|186|||
129933362|NCT03884101|467722492|FG000|Overall Study|Death|212|||
129933363|NCT03884101|467722493|FG001|Overall Study|Death|224|||
129933364|NCT03884101|467722492|FG000|Overall Study|Lost to Follow-up|0|||
129933365|NCT03884101|467722493|FG001|Overall Study|Lost to Follow-up|1|||
129933366|NCT03884101|467722492|FG000|Overall Study|Withdrawal by Subject|6|||
129933367|NCT03884101|467722493|FG001|Overall Study|Withdrawal by Subject|11|||
129933368|NCT05070741|467722494|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
129933369|NCT03582033|467722497|FG000|Part A|Other|0|||
129933370|NCT03582033|467722498|FG001|Part A|Other|0|||
129933371|NCT03582033|467722499|FG002|Part A|Other|0|||
129933372|NCT03582033|467722500|FG003|Part A|Other|0|||
129933373|NCT03582033|467722501|FG004|Part A|Other|2|||
129933374|NCT03582033|467722502|FG005|Part A|Other|0|||
129933375|NCT03582033|467722503|FG006|Part A|Other|0|||
129933376|NCT03582033|467722504|FG007|Part A|Other|0|||
129933377|NCT03582033|467722505|FG008|Part A|Other|0|||
129933378|NCT03582033|467722506|FG009|Part A|Other|0|||
129933379|NCT03582033|467722497|FG000|Part A|Death|1|||
129933380|NCT03582033|467722498|FG001|Part A|Death|1|||
129933381|NCT03582033|467722499|FG002|Part A|Death|2|||
129933382|NCT03582033|467722500|FG003|Part A|Death|4|||
129933383|NCT03582033|467722501|FG004|Part A|Death|11|||
129933384|NCT03582033|467722502|FG005|Part A|Death|0|||
129933385|NCT03582033|467722503|FG006|Part A|Death|0|||
129933386|NCT03582033|467722504|FG007|Part A|Death|0|||
129933387|NCT03582033|467722505|FG008|Part A|Death|0|||
129933388|NCT03582033|467722506|FG009|Part A|Death|0|||
129933389|NCT03582033|467722497|FG000|Part A|Lost to Follow-up|0|||
129933390|NCT03582033|467722498|FG001|Part A|Lost to Follow-up|0|||
129933391|NCT03582033|467722499|FG002|Part A|Lost to Follow-up|0|||
129933392|NCT03582033|467722500|FG003|Part A|Lost to Follow-up|0|||
129933393|NCT03582033|467722501|FG004|Part A|Lost to Follow-up|1|||
129933394|NCT03582033|467722502|FG005|Part A|Lost to Follow-up|0|||
129933395|NCT03582033|467722503|FG006|Part A|Lost to Follow-up|0|||
129933396|NCT03582033|467722504|FG007|Part A|Lost to Follow-up|0|||
129933397|NCT03582033|467722505|FG008|Part A|Lost to Follow-up|0|||
129933398|NCT03582033|467722506|FG009|Part A|Lost to Follow-up|0|||
129933399|NCT03582033|467722497|FG000|Part A|Study terminated by sponsor|0|||
129933400|NCT03582033|467722498|FG001|Part A|Study terminated by sponsor|0|||
129933401|NCT03582033|467722499|FG002|Part A|Study terminated by sponsor|0|||
129933402|NCT03582033|467722500|FG003|Part A|Study terminated by sponsor|2|||
129933403|NCT03582033|467722501|FG004|Part A|Study terminated by sponsor|1|||
129933404|NCT03582033|467722502|FG005|Part A|Study terminated by sponsor|0|||
129933405|NCT03582033|467722503|FG006|Part A|Study terminated by sponsor|0|||
129933406|NCT03582033|467722504|FG007|Part A|Study terminated by sponsor|0|||
129933407|NCT03582033|467722505|FG008|Part A|Study terminated by sponsor|0|||
129933408|NCT03582033|467722506|FG009|Part A|Study terminated by sponsor|0|||
129933409|NCT03582033|467722497|FG000|Part A|Withdrawal by Subject|1|||
129933410|NCT03582033|467722498|FG001|Part A|Withdrawal by Subject|1|||
129933411|NCT03582033|467722499|FG002|Part A|Withdrawal by Subject|0|||
129933412|NCT03582033|467722500|FG003|Part A|Withdrawal by Subject|1|||
129933413|NCT03582033|467722501|FG004|Part A|Withdrawal by Subject|7|||
129933414|NCT03582033|467722502|FG005|Part A|Withdrawal by Subject|0|||
129933415|NCT03582033|467722503|FG006|Part A|Withdrawal by Subject|0|||
129933416|NCT03582033|467722504|FG007|Part A|Withdrawal by Subject|0|||
129933417|NCT03582033|467722505|FG008|Part A|Withdrawal by Subject|0|||
129933418|NCT03582033|467722506|FG009|Part A|Withdrawal by Subject|0|||
129933419|NCT03582033|467722497|FG000|Part B|Death|0|||
129933420|NCT03582033|467722498|FG001|Part B|Death|0|||
129933421|NCT03582033|467722499|FG002|Part B|Death|0|||
129933422|NCT03582033|467722500|FG003|Part B|Death|0|||
129933423|NCT03582033|467722501|FG004|Part B|Death|0|||
129933424|NCT03582033|467722502|FG005|Part B|Death|2|||
129933425|NCT03582033|467722503|FG006|Part B|Death|0|||
129933426|NCT03582033|467722504|FG007|Part B|Death|0|||
129933427|NCT03582033|467722505|FG008|Part B|Death|0|||
129933428|NCT03582033|467722506|FG009|Part B|Death|0|||
129933429|NCT03582033|467722497|FG000|Part B|Study terminated by sponsor|0|||
129933430|NCT03582033|467722498|FG001|Part B|Study terminated by sponsor|0|||
129933431|NCT03582033|467722499|FG002|Part B|Study terminated by sponsor|0|||
129933432|NCT03582033|467722500|FG003|Part B|Study terminated by sponsor|0|||
129933433|NCT03582033|467722501|FG004|Part B|Study terminated by sponsor|0|||
129933434|NCT03582033|467722502|FG005|Part B|Study terminated by sponsor|12|||
129933435|NCT03582033|467722503|FG006|Part B|Study terminated by sponsor|0|||
129933436|NCT03582033|467722504|FG007|Part B|Study terminated by sponsor|0|||
129933437|NCT03582033|467722505|FG008|Part B|Study terminated by sponsor|0|||
129933438|NCT03582033|467722506|FG009|Part B|Study terminated by sponsor|0|||
129933439|NCT03582033|467722497|FG000|Part B|Withdrawal by Subject|0|||
129933440|NCT03582033|467722498|FG001|Part B|Withdrawal by Subject|0|||
129933441|NCT03582033|467722499|FG002|Part B|Withdrawal by Subject|0|||
129933442|NCT03582033|467722500|FG003|Part B|Withdrawal by Subject|0|||
129933443|NCT03582033|467722501|FG004|Part B|Withdrawal by Subject|0|||
129933444|NCT03582033|467722502|FG005|Part B|Withdrawal by Subject|6|||
129933445|NCT03582033|467722503|FG006|Part B|Withdrawal by Subject|0|||
129933446|NCT03582033|467722504|FG007|Part B|Withdrawal by Subject|0|||
129933447|NCT03582033|467722505|FG008|Part B|Withdrawal by Subject|0|||
129933448|NCT03582033|467722506|FG009|Part B|Withdrawal by Subject|0|||
129933449|NCT03582033|467722497|FG000|Part C|Other|0|||
129933450|NCT03582033|467722498|FG001|Part C|Other|0|||
129933451|NCT03582033|467722499|FG002|Part C|Other|0|||
129933452|NCT03582033|467722500|FG003|Part C|Other|0|||
129933453|NCT03582033|467722501|FG004|Part C|Other|0|||
129933454|NCT03582033|467722502|FG005|Part C|Other|0|||
129933455|NCT03582033|467722503|FG006|Part C|Other|2|||
129933456|NCT03582033|467722504|FG007|Part C|Other|0|||
129933457|NCT03582033|467722505|FG008|Part C|Other|0|||
129933458|NCT03582033|467722506|FG009|Part C|Other|0|||
129933459|NCT03582033|467722497|FG000|Part C|Death|0|||
129933460|NCT03582033|467722498|FG001|Part C|Death|0|||
129933461|NCT03582033|467722499|FG002|Part C|Death|0|||
129933462|NCT03582033|467722500|FG003|Part C|Death|0|||
129933463|NCT03582033|467722501|FG004|Part C|Death|0|||
129933464|NCT03582033|467722502|FG005|Part C|Death|0|||
129933465|NCT03582033|467722503|FG006|Part C|Death|6|||
129933466|NCT03582033|467722504|FG007|Part C|Death|1|||
129933467|NCT03582033|467722505|FG008|Part C|Death|2|||
129933468|NCT03582033|467722506|FG009|Part C|Death|0|||
129933469|NCT03582033|467722497|FG000|Part C|Study terminated by sponsor|0|||
129933470|NCT03582033|467722498|FG001|Part C|Study terminated by sponsor|0|||
129933471|NCT03582033|467722499|FG002|Part C|Study terminated by sponsor|0|||
129933472|NCT03582033|467722500|FG003|Part C|Study terminated by sponsor|0|||
129933473|NCT03582033|467722501|FG004|Part C|Study terminated by sponsor|0|||
129933474|NCT03582033|467722502|FG005|Part C|Study terminated by sponsor|0|||
129933475|NCT03582033|467722503|FG006|Part C|Study terminated by sponsor|3|||
129933476|NCT03582033|467722504|FG007|Part C|Study terminated by sponsor|3|||
129933477|NCT03582033|467722505|FG008|Part C|Study terminated by sponsor|2|||
129933478|NCT03582033|467722506|FG009|Part C|Study terminated by sponsor|0|||
129933479|NCT03582033|467722497|FG000|Part C|Withdrawal by Subject|0|||
129933480|NCT03582033|467722498|FG001|Part C|Withdrawal by Subject|0|||
129933481|NCT03582033|467722499|FG002|Part C|Withdrawal by Subject|0|||
129933482|NCT03582033|467722500|FG003|Part C|Withdrawal by Subject|0|||
129933483|NCT03582033|467722501|FG004|Part C|Withdrawal by Subject|0|||
129933484|NCT03582033|467722502|FG005|Part C|Withdrawal by Subject|0|||
129933485|NCT03582033|467722503|FG006|Part C|Withdrawal by Subject|1|||
129933486|NCT03582033|467722504|FG007|Part C|Withdrawal by Subject|2|||
129933487|NCT03582033|467722505|FG008|Part C|Withdrawal by Subject|1|||
129933488|NCT03582033|467722506|FG009|Part C|Withdrawal by Subject|0|||
129933489|NCT03582033|467722497|FG000|Part D|Death|0|||
129933490|NCT03582033|467722498|FG001|Part D|Death|0|||
129933491|NCT03582033|467722499|FG002|Part D|Death|0|||
129933492|NCT03582033|467722500|FG003|Part D|Death|0|||
129933493|NCT03582033|467722501|FG004|Part D|Death|0|||
129933494|NCT03582033|467722502|FG005|Part D|Death|0|||
129933495|NCT03582033|467722503|FG006|Part D|Death|0|||
129933496|NCT03582033|467722504|FG007|Part D|Death|0|||
129933497|NCT03582033|467722505|FG008|Part D|Death|0|||
129933498|NCT03582033|467722506|FG009|Part D|Death|1|||
129933499|NCT03582033|467722497|FG000|Part D|Study terminated by sponsor|0|||
129933500|NCT03582033|467722498|FG001|Part D|Study terminated by sponsor|0|||
129933501|NCT03582033|467722499|FG002|Part D|Study terminated by sponsor|0|||
129933502|NCT03582033|467722500|FG003|Part D|Study terminated by sponsor|0|||
129933503|NCT03582033|467722501|FG004|Part D|Study terminated by sponsor|0|||
129933504|NCT03582033|467722502|FG005|Part D|Study terminated by sponsor|0|||
129933505|NCT03582033|467722503|FG006|Part D|Study terminated by sponsor|0|||
129933506|NCT03582033|467722504|FG007|Part D|Study terminated by sponsor|0|||
129933507|NCT03582033|467722505|FG008|Part D|Study terminated by sponsor|0|||
129933508|NCT03582033|467722506|FG009|Part D|Study terminated by sponsor|4|||
129933509|NCT04631016|467722509|FG000|Overall Study|Adverse Event|3|||
129933510|NCT04631016|467722510|FG001|Overall Study|Adverse Event|0|||
129933511|NCT04631016|467722509|FG000|Overall Study|Withdrawal by Subject|5|||
129933512|NCT04631016|467722510|FG001|Overall Study|Withdrawal by Subject|4|||
129933513|NCT04631016|467722509|FG000|Overall Study|Reason unspecified|1|||
129933514|NCT04631016|467722510|FG001|Overall Study|Reason unspecified|0|||
129933515|NCT04631016|467722509|FG000|Overall Study|Failure to meet randomization criteria|2|||
129933516|NCT04631016|467722510|FG001|Overall Study|Failure to meet randomization criteria|1|||
129933517|NCT03812614|467722511|FG000|Intervention|Withdrawal by Subject|7|||
129933518|NCT03812614|467722512|FG001|Intervention|Withdrawal by Subject|2|||
129933519|NCT03812614|467722513|FG002|Intervention|Withdrawal by Subject|7|||
129933520|NCT03812614|467722514|FG003|Intervention|Withdrawal by Subject|2|||
129933521|NCT03812614|467722511|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
129933522|NCT03812614|467722512|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
129933523|NCT03812614|467722513|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
129933524|NCT03812614|467722514|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
129933525|NCT03812614|467722511|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
129933526|NCT03812614|467722512|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
129933527|NCT03812614|467722513|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
129933528|NCT03812614|467722514|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
129933529|NCT03812614|467722511|FG000|6-month Follow-up|Lost to Follow-up|0|||
129933530|NCT03812614|467722512|FG001|6-month Follow-up|Lost to Follow-up|0|||
129933531|NCT03812614|467722513|FG002|6-month Follow-up|Lost to Follow-up|12|||
129933532|NCT03812614|467722514|FG003|6-month Follow-up|Lost to Follow-up|8|||
129933533|NCT03812614|467722511|FG000|12-month Follow-up|Lost to Follow-up|18|||
129933534|NCT03812614|467722512|FG001|12-month Follow-up|Lost to Follow-up|17|||
129933535|NCT03812614|467722513|FG002|12-month Follow-up|Lost to Follow-up|5|||
129933536|NCT03812614|467722514|FG003|12-month Follow-up|Lost to Follow-up|2|||
129933537|NCT05205161|467722515|FG000|Overall Study|Study terminated by sponsor|3|||
129933538|NCT05205161|467722516|FG001|Overall Study|Study terminated by sponsor|3|||
129933539|NCT05205161|467722517|FG002|Overall Study|Study terminated by sponsor|1|||
129933540|NCT05652010|467722518|FG000|First Intervention|Withdrawal by Subject|0|||
129933541|NCT05652010|467722519|FG001|First Intervention|Withdrawal by Subject|1|||
129933542|NCT05652010|467722518|FG000|Second Intervention|Withdrawal by Subject|1|||
129933543|NCT05652010|467722519|FG001|Second Intervention|Withdrawal by Subject|0|||
129933544|NCT05741294|467722520|FG000|Overall Study|Lost to Follow-up|3|||
129933545|NCT05741294|467722520|FG000|Overall Study|Protocol deviation|3|||
129933546|NCT05741294|467722520|FG000|Overall Study|Withdrawal by Subject|1|||
129933547|NCT04163991|467722521|FG000|Overall Study|Adverse Event|0|||
129933548|NCT04163991|467722522|FG001|Overall Study|Adverse Event|0|||
129933549|NCT04163991|467722523|FG002|Overall Study|Adverse Event|0|||
129933550|NCT04163991|467722524|FG003|Overall Study|Adverse Event|1|||
129933551|NCT04163991|467722525|FG004|Overall Study|Adverse Event|0|||
129933552|NCT04163991|467722521|FG000|Overall Study|Death|0|||
129933553|NCT04163991|467722522|FG001|Overall Study|Death|0|||
129933554|NCT04163991|467722523|FG002|Overall Study|Death|1|||
129933555|NCT04163991|467722524|FG003|Overall Study|Death|0|||
129933556|NCT04163991|467722525|FG004|Overall Study|Death|0|||
129933557|NCT04163991|467722521|FG000|Overall Study|Lost to Follow-up|0|||
129933558|NCT04163991|467722522|FG001|Overall Study|Lost to Follow-up|1|||
129933559|NCT04163991|467722523|FG002|Overall Study|Lost to Follow-up|0|||
129933560|NCT04163991|467722524|FG003|Overall Study|Lost to Follow-up|0|||
129933561|NCT04163991|467722525|FG004|Overall Study|Lost to Follow-up|0|||
129933562|NCT04163991|467722521|FG000|Overall Study|Withdrawal by Subject|1|||
129933563|NCT04163991|467722522|FG001|Overall Study|Withdrawal by Subject|1|||
129933564|NCT04163991|467722523|FG002|Overall Study|Withdrawal by Subject|3|||
129933565|NCT04163991|467722524|FG003|Overall Study|Withdrawal by Subject|1|||
129933566|NCT04163991|467722525|FG004|Overall Study|Withdrawal by Subject|1|||
129933567|NCT04163991|467722521|FG000|Overall Study|Other, Not Specified|0|||
129933568|NCT04163991|467722522|FG001|Overall Study|Other, Not Specified|1|||
129933569|NCT04163991|467722523|FG002|Overall Study|Other, Not Specified|1|||
129933570|NCT04163991|467722524|FG003|Overall Study|Other, Not Specified|1|||
129933571|NCT04163991|467722525|FG004|Overall Study|Other, Not Specified|0|||
129933572|NCT03372057|467722526|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
129933573|NCT03372057|467722527|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
129933574|NCT03372057|467722528|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
129933575|NCT03372057|467722526|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
129933576|NCT03372057|467722527|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
129933577|NCT03372057|467722528|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
129933578|NCT03372057|467722526|FG000|Dose Optimization Phase|Death|16|||
129933579|NCT03372057|467722527|FG001|Dose Optimization Phase|Death|11|||
129933580|NCT03372057|467722528|FG002|Dose Optimization Phase|Death|0|||
129933581|NCT03372057|467722526|FG000|Expansion Phase|Withdrawal by Subject|0|||
129933582|NCT03372057|467722527|FG001|Expansion Phase|Withdrawal by Subject|0|||
129933583|NCT03372057|467722528|FG002|Expansion Phase|Withdrawal by Subject|4|||
129933584|NCT03372057|467722526|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
129933585|NCT03372057|467722527|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
129933586|NCT03372057|467722528|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
129933587|NCT03372057|467722526|FG000|Expansion Phase|Death|0|||
129933588|NCT03372057|467722527|FG001|Expansion Phase|Death|0|||
129933589|NCT03372057|467722528|FG002|Expansion Phase|Death|78|||
129933590|NCT03372057|467722526|FG000|Expansion Phase|Progressive Disease|0|||
129933591|NCT03372057|467722527|FG001|Expansion Phase|Progressive Disease|0|||
129933592|NCT03372057|467722528|FG002|Expansion Phase|Progressive Disease|1|||
129933593|NCT03372057|467722526|FG000|Expansion Phase|Adverse Event|0|||
129933594|NCT03372057|467722527|FG001|Expansion Phase|Adverse Event|0|||
129933595|NCT03372057|467722528|FG002|Expansion Phase|Adverse Event|1|||
129933596|NCT05953740|467722529|FG000|Period 1|Physician Decision|0|||
129933597|NCT05953740|467722530|FG001|Period 1|Physician Decision|1|||
129933598|NCT05953740|467722531|FG002|Period 1|Physician Decision|0|||
129933599|NCT05953740|467722532|FG003|Period 1|Physician Decision|0|||
129933600|NCT05953740|467722533|FG004|Period 1|Physician Decision|0|||
129933601|NCT05953740|467722534|FG005|Period 1|Physician Decision|0|||
129933602|NCT05953740|467722535|FG006|Period 1|Physician Decision|0|||
129933603|NCT05953740|467722536|FG007|Period 1|Physician Decision|0|||
129933604|NCT05953740|467722529|FG000|Period 2|Withdrawal by Subject|0|||
129933605|NCT05953740|467722530|FG001|Period 2|Withdrawal by Subject|1|||
129933606|NCT05953740|467722531|FG002|Period 2|Withdrawal by Subject|1|||
129933607|NCT05953740|467722532|FG003|Period 2|Withdrawal by Subject|0|||
129933608|NCT05953740|467722533|FG004|Period 2|Withdrawal by Subject|0|||
129933609|NCT05953740|467722534|FG005|Period 2|Withdrawal by Subject|0|||
129933610|NCT05953740|467722535|FG006|Period 2|Withdrawal by Subject|0|||
129933611|NCT05953740|467722536|FG007|Period 2|Withdrawal by Subject|0|||
129933612|NCT03880955|467722537|FG000|Overall Study|Adverse Event|1|||
129933613|NCT03880955|467722537|FG000|Overall Study|Death|1|||
129933614|NCT03880955|467722537|FG000|Overall Study|Lost to Follow-up|12|||
129933615|NCT03880955|467722537|FG000|Overall Study|Withdrawal by Subject|4|||
129933616|NCT03880955|467722537|FG000|Overall Study|Missing- Study Site Closed|27|||
129933617|NCT04214418|467722540|FG000|Overall Study|Withdrawal by Subject|1|||
129933618|NCT04214418|467722541|FG001|Overall Study|Withdrawal by Subject|0|||
129933619|NCT04214418|467722542|FG002|Overall Study|Withdrawal by Subject|0|||
129933620|NCT04214418|467722543|FG003|Overall Study|Withdrawal by Subject|0|||
129933621|NCT04214418|467722544|FG004|Overall Study|Withdrawal by Subject|0|||
129933622|NCT04214418|467722545|FG005|Overall Study|Withdrawal by Subject|0|||
129933623|NCT04214418|467722540|FG000|Overall Study|Adverse Event|0|||
129933624|NCT04214418|467722541|FG001|Overall Study|Adverse Event|2|||
129933625|NCT04214418|467722542|FG002|Overall Study|Adverse Event|0|||
129933626|NCT04214418|467722543|FG003|Overall Study|Adverse Event|0|||
129933627|NCT04214418|467722544|FG004|Overall Study|Adverse Event|0|||
129933628|NCT04214418|467722545|FG005|Overall Study|Adverse Event|0|||
129933629|NCT04214418|467722540|FG000|Overall Study|Death|1|||
129933630|NCT04214418|467722541|FG001|Overall Study|Death|0|||
129933631|NCT04214418|467722542|FG002|Overall Study|Death|0|||
129933632|NCT04214418|467722543|FG003|Overall Study|Death|0|||
129933633|NCT04214418|467722544|FG004|Overall Study|Death|0|||
129933634|NCT04214418|467722545|FG005|Overall Study|Death|0|||
129933635|NCT04635059|467722546|FG000|Overall Study|Study terminated early.|4|||
129933636|NCT03011034|467722550|FG000|Overall Study|Adverse Event|1|||
129933637|NCT03011034|467722551|FG001|Overall Study|Adverse Event|0|||
129933638|NCT05123027|467722553|FG000|Overall Study|Lost to Follow-up|17|||
129933639|NCT05123027|467722554|FG001|Overall Study|Lost to Follow-up|22|||
129933640|NCT05123027|467722553|FG000|Overall Study|Incarceration|3|||
129933641|NCT05123027|467722554|FG001|Overall Study|Incarceration|4|||
129933642|NCT05123027|467722553|FG000|Overall Study|Death|2|||
129933643|NCT05123027|467722554|FG001|Overall Study|Death|2|||
129933644|NCT05123027|467722553|FG000|Overall Study|Other|2|||
129933645|NCT05123027|467722554|FG001|Overall Study|Other|0|||
129933646|NCT05112900|467722555|FG000|Overall Study|Withdrawal by Subject|960|||
129933647|NCT05112900|467722556|FG001|Overall Study|Withdrawal by Subject|921|||
129933648|NCT05112900|467722557|FG002|Overall Study|Withdrawal by Subject|968|||
129933649|NCT00626795|467722560|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
129933650|NCT00626795|467722561|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
129933651|NCT00626795|467722562|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
129933652|NCT00626795|467722560|FG000|Blinded Treatment|Lack of Efficacy|2|||
129933653|NCT00626795|467722561|FG001|Blinded Treatment|Lack of Efficacy|0|||
129933654|NCT00626795|467722562|FG002|Blinded Treatment|Lack of Efficacy|0|||
129933655|NCT00626795|467722560|FG000|Blinded Treatment|Unacceptable adverse event|0|||
129933656|NCT00626795|467722561|FG001|Blinded Treatment|Unacceptable adverse event|0|||
129933657|NCT00626795|467722562|FG002|Blinded Treatment|Unacceptable adverse event|1|||
129933658|NCT00626795|467722560|FG000|Blinded Treatment|Protocol Violation|0|||
129933659|NCT00626795|467722561|FG001|Blinded Treatment|Protocol Violation|1|||
129933660|NCT00626795|467722562|FG002|Blinded Treatment|Protocol Violation|1|||
129933661|NCT00626795|467722560|FG000|Blinded Treatment|Withdrawal by Subject|1|||
129933662|NCT00626795|467722561|FG001|Blinded Treatment|Withdrawal by Subject|1|||
129933663|NCT00626795|467722562|FG002|Blinded Treatment|Withdrawal by Subject|0|||
129933664|NCT00626795|467722560|FG000|Blinded Treatment|Other reasons|2|||
129933665|NCT00626795|467722561|FG001|Blinded Treatment|Other reasons|0|||
129933666|NCT00626795|467722562|FG002|Blinded Treatment|Other reasons|2|||
129933667|NCT00626795|467722560|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
129933668|NCT00626795|467722561|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
129933669|NCT00626795|467722562|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
129933670|NCT04499521|467722570|FG000|Overall Study|Disease Progression|1|||
129933671|NCT04499521|467722571|FG001|Overall Study|Disease Progression|0|||
129933672|NCT05525104|467722572|FG000|Overall Study|Failed caudal analgesia|1|||
129933673|NCT05525104|467722573|FG001|Overall Study|Failed caudal analgesia|3|||
129933674|NCT05525104|467722572|FG000|Overall Study|Premedication needed|0|||
129933675|NCT05525104|467722573|FG001|Overall Study|Premedication needed|1|||
129933676|NCT05525104|467722572|FG000|Overall Study|Protocol Violation|10|||
129933677|NCT05525104|467722573|FG001|Overall Study|Protocol Violation|0|||
129933678|NCT05525104|467722572|FG000|Overall Study|Cancelled operation|1|||
129933679|NCT05525104|467722573|FG001|Overall Study|Cancelled operation|0|||
129933680|NCT03990883|467722574|FG000|Blinded Treatment Phase|Adverse Event|1|||
129933681|NCT03990883|467722575|FG001|Blinded Treatment Phase|Adverse Event|1|||
129933682|NCT03990883|467722576|FG002|Blinded Treatment Phase|Adverse Event|0|||
129933683|NCT03990883|467722574|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
129933684|NCT03990883|467722575|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
129933685|NCT03990883|467722576|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
129933686|NCT03990883|467722574|FG000|Blinded Treatment Phase|Physician Decision|1|||
129933687|NCT03990883|467722575|FG001|Blinded Treatment Phase|Physician Decision|0|||
129933688|NCT03990883|467722576|FG002|Blinded Treatment Phase|Physician Decision|0|||
129933689|NCT03990883|467722574|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
129933690|NCT03990883|467722575|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
129933691|NCT03990883|467722576|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
129933692|NCT03990883|467722574|FG000|Blinded Treatment Phase|COVID-19|3|||
129933693|NCT03990883|467722575|FG001|Blinded Treatment Phase|COVID-19|2|||
129933694|NCT03990883|467722576|FG002|Blinded Treatment Phase|COVID-19|0|||
129933695|NCT03990883|467722574|FG000|Blinded Treatment Phase|Personal Reasons|6|||
129933696|NCT03990883|467722575|FG001|Blinded Treatment Phase|Personal Reasons|3|||
129933697|NCT03990883|467722576|FG002|Blinded Treatment Phase|Personal Reasons|0|||
129933698|NCT03990883|467722574|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
129933699|NCT03990883|467722575|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
129933700|NCT03990883|467722576|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
129933701|NCT03990883|467722574|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
129933702|NCT03990883|467722575|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
129933703|NCT03990883|467722576|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
129933704|NCT03990883|467722574|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
129933705|NCT03990883|467722575|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
129933706|NCT03990883|467722576|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
129933707|NCT04389957|467723821|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
129933708|NCT04389957|467723822|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
129933709|NCT04389957|467723823|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
129933710|NCT04389957|467723824|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
129933711|NCT04389957|467723825|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
129933712|NCT02095691|467723826|FG000|Overall Study|Physician Decision|1|||
129933713|NCT00887198|467723827|FG000|Randomized Period|Ongoing|42|||
129933714|NCT00887198|467723828|FG001|Randomized Period|Ongoing|0|||
129933715|NCT00887198|467723829|FG002|Randomized Period|Ongoing|0|||
129933716|NCT00887198|467723827|FG000|Randomized Period|Adverse Event|50|||
129933717|NCT00887198|467723828|FG001|Randomized Period|Adverse Event|33|||
129933718|NCT00887198|467723829|FG002|Randomized Period|Adverse Event|0|||
129933719|NCT00887198|467723827|FG000|Randomized Period|Lost to Follow-up|1|||
129933720|NCT00887198|467723828|FG001|Randomized Period|Lost to Follow-up|0|||
129933721|NCT00887198|467723829|FG002|Randomized Period|Lost to Follow-up|0|||
129933722|NCT00887198|467723827|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
129933723|NCT00887198|467723828|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
129933724|NCT00887198|467723829|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
129933725|NCT00887198|467723827|FG000|Randomized Period|Withdrawal by Subject|41|||
129933726|NCT00887198|467723828|FG001|Randomized Period|Withdrawal by Subject|56|||
129933727|NCT00887198|467723829|FG002|Randomized Period|Withdrawal by Subject|0|||
129933728|NCT00887198|467723827|FG000|Randomized Period|Progressive disease|366|||
129933729|NCT00887198|467723828|FG001|Randomized Period|Progressive disease|370|||
129933730|NCT00887198|467723829|FG002|Randomized Period|Progressive disease|0|||
129933731|NCT00887198|467723827|FG000|Randomized Period|Other|42|||
129933732|NCT00887198|467723828|FG001|Randomized Period|Other|30|||
129933733|NCT00887198|467723829|FG002|Randomized Period|Other|0|||
129933734|NCT00887198|467723827|FG000|Randomized Period|Randomized, Not treated|4|||
129933735|NCT00887198|467723828|FG001|Randomized Period|Randomized, Not treated|2|||
129933736|NCT00887198|467723829|FG002|Randomized Period|Randomized, Not treated|0|||
129933737|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
129933738|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
129933739|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
129933740|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
129933741|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
129933742|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
129933743|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
129933744|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
129933745|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
129933746|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
129933747|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
129933748|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
129933749|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
129933750|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
129933751|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
129933752|NCT00887198|467723827|FG000|Cross Over (Placebo to AA)|Other|0|||
129933753|NCT00887198|467723828|FG001|Cross Over (Placebo to AA)|Other|0|||
129933754|NCT00887198|467723829|FG002|Cross Over (Placebo to AA)|Other|19|||
129933755|NCT05007080|467723830|FG000|Overall Study|Lost to Follow-up|0|||
129933756|NCT05007080|467723831|FG001|Overall Study|Lost to Follow-up|1|||
129933757|NCT05007080|467723832|FG002|Overall Study|Lost to Follow-up|0|||
129933758|NCT05007080|467723833|FG003|Overall Study|Lost to Follow-up|1|||
129933759|NCT05007080|467723834|FG004|Overall Study|Lost to Follow-up|1|||
129933760|NCT05007080|467723835|FG005|Overall Study|Lost to Follow-up|1|||
129933761|NCT05007080|467723830|FG000|Overall Study|Death|0|||
129933762|NCT05007080|467723831|FG001|Overall Study|Death|1|||
129933763|NCT05007080|467723832|FG002|Overall Study|Death|0|||
129933764|NCT05007080|467723833|FG003|Overall Study|Death|0|||
129933765|NCT05007080|467723834|FG004|Overall Study|Death|0|||
129933766|NCT05007080|467723835|FG005|Overall Study|Death|0|||
129933767|NCT05007080|467723830|FG000|Overall Study|Withdrawal by Subject|1|||
129933768|NCT05007080|467723831|FG001|Overall Study|Withdrawal by Subject|2|||
129933769|NCT05007080|467723832|FG002|Overall Study|Withdrawal by Subject|0|||
129933770|NCT05007080|467723833|FG003|Overall Study|Withdrawal by Subject|2|||
129933771|NCT05007080|467723834|FG004|Overall Study|Withdrawal by Subject|1|||
129933772|NCT05007080|467723835|FG005|Overall Study|Withdrawal by Subject|1|||
129933773|NCT05007080|467723830|FG000|Overall Study|Other|1|||
129933774|NCT05007080|467723831|FG001|Overall Study|Other|0|||
129933775|NCT05007080|467723832|FG002|Overall Study|Other|1|||
129933776|NCT05007080|467723833|FG003|Overall Study|Other|1|||
129933777|NCT05007080|467723834|FG004|Overall Study|Other|0|||
129933778|NCT05007080|467723835|FG005|Overall Study|Other|2|||
129933779|NCT05007080|467723830|FG000|Overall Study|Randomized not vaccinated|0|||
129933780|NCT05007080|467723831|FG001|Overall Study|Randomized not vaccinated|0|||
129933781|NCT05007080|467723832|FG002|Overall Study|Randomized not vaccinated|0|||
129933782|NCT05007080|467723833|FG003|Overall Study|Randomized not vaccinated|0|||
129933783|NCT05007080|467723834|FG004|Overall Study|Randomized not vaccinated|0|||
129933784|NCT05007080|467723835|FG005|Overall Study|Randomized not vaccinated|1|||
129933785|NCT00319046|467723836|FG000|Overall Study|withdrawal of subject's consent|7|||
129933786|NCT00319046|467723836|FG000|Overall Study|administrative reason|1|||
129933787|NCT05147584|467723837|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
129933788|NCT05460871|467723838|FG000|Overall Study|Withdrawal by Subject|1|||
129933789|NCT05460871|467723839|FG001|Overall Study|Withdrawal by Subject|2|||
129933790|NCT03498521|467723843|FG000|Overall Study|Death|191|||
129933791|NCT03498521|467723844|FG001|Overall Study|Death|64|||
129933792|NCT03498521|467723845|FG002|Overall Study|Death|72|||
129933793|NCT03498521|467723843|FG000|Overall Study|Exclusion criteria|1|||
129933794|NCT03498521|467723844|FG001|Overall Study|Exclusion criteria|0|||
129933795|NCT03498521|467723845|FG002|Overall Study|Exclusion criteria|0|||
129933796|NCT03498521|467723843|FG000|Overall Study|Lost to Follow-up|3|||
129933797|NCT03498521|467723844|FG001|Overall Study|Lost to Follow-up|3|||
129933798|NCT03498521|467723845|FG002|Overall Study|Lost to Follow-up|3|||
129933799|NCT03498521|467723843|FG000|Overall Study|No profile due to technical failure|1|||
129933800|NCT03498521|467723844|FG001|Overall Study|No profile due to technical failure|0|||
129933801|NCT03498521|467723845|FG002|Overall Study|No profile due to technical failure|0|||
129933802|NCT03498521|467723843|FG000|Overall Study|Physician Decision|0|||
129933803|NCT03498521|467723844|FG001|Overall Study|Physician Decision|1|||
129933804|NCT03498521|467723845|FG002|Overall Study|Physician Decision|0|||
129933805|NCT03498521|467723843|FG000|Overall Study|Withdrawal by Subject|9|||
129933806|NCT03498521|467723844|FG001|Overall Study|Withdrawal by Subject|6|||
129933807|NCT03498521|467723845|FG002|Overall Study|Withdrawal by Subject|2|||
129933808|NCT03498521|467723843|FG000|Overall Study|Study ongoing|121|||
129933809|NCT03498521|467723844|FG001|Overall Study|Study ongoing|36|||
129933810|NCT03498521|467723845|FG002|Overall Study|Study ongoing|15|||
129933811|NCT05830799|467723847|FG000|Overall Study|Withdrawal by Subject|1|||
129933812|NCT03652272|467723848|FG000|3 Month|Withdrawal by Subject|1|||
129933813|NCT03652272|467723849|FG001|3 Month|Withdrawal by Subject|1|||
129933814|NCT03652272|467723848|FG000|3 Month|Lost to Follow-up|16|||
129933815|NCT03652272|467723849|FG001|3 Month|Lost to Follow-up|14|||
129933816|NCT04214834|467723852|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
129933817|NCT04214834|467723853|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
129933818|NCT03370913|467723856|FG000|Overall Study|Death|1|||
129933819|NCT03370913|467723856|FG000|Overall Study|Lost to Follow-up|1|||
129933820|NCT04633538|467723857|FG000|Overall Study|Death|1|||
129933821|NCT04633538|467723857|FG000|Overall Study|Lost to Follow-up|3|||
129933822|NCT04633538|467723857|FG000|Overall Study|Withdrawal by Subject|1|||
129933823|NCT02938520|467723860|FG000|Overall Study|On-going at the time of analysis|258|||
129933824|NCT02938520|467723861|FG001|Overall Study|On-going at the time of analysis|261|||
129933825|NCT02938520|467723860|FG000|Overall Study|Physician Decision|2|||
129933826|NCT02938520|467723861|FG001|Overall Study|Physician Decision|5|||
129933827|NCT02938520|467723860|FG000|Overall Study|Lost to Follow-up|2|||
129933828|NCT02938520|467723861|FG001|Overall Study|Lost to Follow-up|2|||
129933829|NCT02938520|467723860|FG000|Overall Study|Withdrawal by Subject|7|||
129933830|NCT02938520|467723861|FG001|Overall Study|Withdrawal by Subject|7|||
129933831|NCT02938520|467723860|FG000|Overall Study|Protocol Violation|0|||
129933832|NCT02938520|467723861|FG001|Overall Study|Protocol Violation|1|||
129933833|NCT02938520|467723860|FG000|Overall Study|Lack of Efficacy|5|||
129933834|NCT02938520|467723861|FG001|Overall Study|Lack of Efficacy|3|||
129933835|NCT02938520|467723860|FG000|Overall Study|Adverse Event|9|||
129933836|NCT02938520|467723861|FG001|Overall Study|Adverse Event|4|||
129933837|NCT04675034|467723866|FG000|Overall Study|Lost to Follow-up|1|||
129933838|NCT04675034|467723867|FG001|Overall Study|Lost to Follow-up|1|||
129933839|NCT04675034|467723868|FG002|Overall Study|Lost to Follow-up|0|||
129933840|NCT04675034|467723869|FG003|Overall Study|Lost to Follow-up|2|||
129933841|NCT04675034|467723870|FG004|Overall Study|Lost to Follow-up|0|||
129933842|NCT04675034|467723866|FG000|Overall Study|Protocol Violation|1|||
129933843|NCT04675034|467723867|FG001|Overall Study|Protocol Violation|0|||
129933844|NCT04675034|467723868|FG002|Overall Study|Protocol Violation|0|||
129933845|NCT04675034|467723869|FG003|Overall Study|Protocol Violation|1|||
129933846|NCT04675034|467723870|FG004|Overall Study|Protocol Violation|3|||
129933847|NCT04675034|467723866|FG000|Overall Study|Withdrawal by Subject|9|||
129933848|NCT04675034|467723867|FG001|Overall Study|Withdrawal by Subject|3|||
129933849|NCT04675034|467723868|FG002|Overall Study|Withdrawal by Subject|4|||
129933850|NCT04675034|467723869|FG003|Overall Study|Withdrawal by Subject|8|||
129933851|NCT04675034|467723870|FG004|Overall Study|Withdrawal by Subject|6|||
129933852|NCT05008055|467723876|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
129933853|NCT05008055|467723877|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
129933854|NCT05008055|467723878|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
129933855|NCT04679389|467723881|FG000|Overall Study|Adverse Event|1|||
129933856|NCT04679389|467723882|FG001|Overall Study|Adverse Event|0|||
129933857|NCT04679389|467723881|FG000|Overall Study|Protocol Violation|2|||
129933858|NCT04679389|467723882|FG001|Overall Study|Protocol Violation|0|||
129933859|NCT04679389|467723881|FG000|Overall Study|Physician Decision|3|||
129933860|NCT04679389|467723882|FG001|Overall Study|Physician Decision|5|||
129933861|NCT04679389|467723881|FG000|Overall Study|Withdrawal by Subject|5|||
129933862|NCT04679389|467723882|FG001|Overall Study|Withdrawal by Subject|7|||
129933863|NCT01438853|467723893|FG000|Overall Study|Death|0|||
129933864|NCT01438853|467723894|FG001|Overall Study|Death|0|||
129933865|NCT01438853|467723895|FG002|Overall Study|Death|0|||
129933866|NCT01438853|467723896|FG003|Overall Study|Death|1|||
129933867|NCT01438853|467723893|FG000|Overall Study|Withdrawal by Subject|0|||
129933868|NCT01438853|467723894|FG001|Overall Study|Withdrawal by Subject|0|||
129933869|NCT01438853|467723895|FG002|Overall Study|Withdrawal by Subject|1|||
129933870|NCT01438853|467723896|FG003|Overall Study|Withdrawal by Subject|0|||
129933871|NCT02624050|467723897|FG000|Overall Study|Physician Decision|4|||
129933872|NCT02624050|467723898|FG001|Overall Study|Physician Decision|0|||
129933873|NCT02624050|467723897|FG000|Overall Study|Protocol Violation|2|||
129933874|NCT02624050|467723898|FG001|Overall Study|Protocol Violation|0|||
129933875|NCT03904576|467723899|FG000|Washout Period|Protocol Violation|1|||
129933876|NCT03904576|467723900|FG001|Washout Period|Protocol Violation|1|||
129933877|NCT03279978|467723902|FG000|Overall Study|Withdrawal by Subject|0|||
129933878|NCT03279978|467723903|FG001|Overall Study|Withdrawal by Subject|1|||
129933879|NCT03279978|467723904|FG002|Overall Study|Withdrawal by Subject|0|||
129933880|NCT03279978|467723905|FG003|Overall Study|Withdrawal by Subject|0|||
129933881|NCT03279978|467723906|FG004|Overall Study|Withdrawal by Subject|0|||
129933882|NCT03279978|467723907|FG005|Overall Study|Withdrawal by Subject|0|||
129933883|NCT03279978|467723908|FG006|Overall Study|Withdrawal by Subject|0|||
129933884|NCT03279978|467723909|FG007|Overall Study|Withdrawal by Subject|0|||
129933885|NCT03279978|467723910|FG008|Overall Study|Withdrawal by Subject|0|||
129933886|NCT03279978|467723911|FG009|Overall Study|Withdrawal by Subject|1|||
129933887|NCT03279978|467723902|FG000|Overall Study|Lost to Follow-up|1|||
129451969|NCT03680911|465952092|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
129933888|NCT03279978|467723903|FG001|Overall Study|Lost to Follow-up|0|||
129933889|NCT03279978|467723904|FG002|Overall Study|Lost to Follow-up|1|||
129933890|NCT03279978|467723905|FG003|Overall Study|Lost to Follow-up|0|||
129933891|NCT03279978|467723906|FG004|Overall Study|Lost to Follow-up|0|||
129933892|NCT03279978|467723907|FG005|Overall Study|Lost to Follow-up|0|||
129933893|NCT03279978|467723908|FG006|Overall Study|Lost to Follow-up|0|||
129933894|NCT03279978|467723909|FG007|Overall Study|Lost to Follow-up|0|||
129451970|NCT00898443|465952097|FG000|Overall Study|Withdrawal by Subject|1|||
129933895|NCT03279978|467723910|FG008|Overall Study|Lost to Follow-up|0|||
129933896|NCT03279978|467723911|FG009|Overall Study|Lost to Follow-up|0|||
129933897|NCT03279978|467723902|FG000|Overall Study|Other than stated above|0|||
129933898|NCT03279978|467723903|FG001|Overall Study|Other than stated above|0|||
129933899|NCT03279978|467723904|FG002|Overall Study|Other than stated above|0|||
129933900|NCT03279978|467723905|FG003|Overall Study|Other than stated above|0|||
129933901|NCT03279978|467723906|FG004|Overall Study|Other than stated above|0|||
129933902|NCT03279978|467723907|FG005|Overall Study|Other than stated above|0|||
129933903|NCT03279978|467723908|FG006|Overall Study|Other than stated above|1|||
129933904|NCT03279978|467723909|FG007|Overall Study|Other than stated above|0|||
129933905|NCT03279978|467723910|FG008|Overall Study|Other than stated above|0|||
129933906|NCT03279978|467723911|FG009|Overall Study|Other than stated above|0|||
129933907|NCT04330040|467723912|FG000|Overall Study|Other: Adverse event|5|||
129933908|NCT04330040|467723913|FG001|Overall Study|Other: Adverse event|0|||
129933909|NCT04330040|467723914|FG002|Overall Study|Other: Adverse event|0|||
129933910|NCT04330040|467723912|FG000|Overall Study|Disease progression|38|||
129933911|NCT04330040|467723913|FG001|Overall Study|Disease progression|10|||
129933912|NCT04330040|467723914|FG002|Overall Study|Disease progression|0|||
129933913|NCT04330040|467723912|FG000|Overall Study|Physician Decision|5|||
129933914|NCT04330040|467723913|FG001|Overall Study|Physician Decision|3|||
129933915|NCT04330040|467723914|FG002|Overall Study|Physician Decision|0|||
129933916|NCT04330040|467723912|FG000|Overall Study|Lost to Follow-up|1|||
129933917|NCT04330040|467723913|FG001|Overall Study|Lost to Follow-up|1|||
129933918|NCT04330040|467723914|FG002|Overall Study|Lost to Follow-up|0|||
129933919|NCT04330040|467723912|FG000|Overall Study|Death|2|||
129933920|NCT04330040|467723913|FG001|Overall Study|Death|1|||
129933921|NCT04330040|467723914|FG002|Overall Study|Death|0|||
129933922|NCT04330040|467723912|FG000|Overall Study|Withdrawal by Subject|3|||
129933923|NCT04330040|467723913|FG001|Overall Study|Withdrawal by Subject|3|||
129933924|NCT04330040|467723914|FG002|Overall Study|Withdrawal by Subject|0|||
129933925|NCT04330040|467723912|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
129933926|NCT04330040|467723913|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
129933927|NCT04330040|467723914|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
129933928|NCT04330040|467723912|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
129933929|NCT04330040|467723913|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
129933930|NCT04330040|467723914|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
129933931|NCT04330040|467723912|FG000|Overall Study|Other: Disease progression|1|||
129933932|NCT04330040|467723913|FG001|Overall Study|Other: Disease progression|0|||
129933933|NCT04330040|467723914|FG002|Overall Study|Other: Disease progression|0|||
129933934|NCT04330040|467723912|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
129933935|NCT04330040|467723913|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
129933936|NCT04330040|467723914|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
129933937|NCT04330040|467723912|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
129933938|NCT04330040|467723913|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
129933939|NCT04330040|467723914|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
129933940|NCT04330040|467723912|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
129933941|NCT04330040|467723913|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
129933942|NCT04330040|467723914|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
129933943|NCT01756300|467723917|FG000|Overall Study|Death|1|||
129933944|NCT01756300|467723917|FG000|Overall Study|Withdrawal by Subject|1|||
129933945|NCT04427007|467724750|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
129933946|NCT04427007|467724751|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
129933947|NCT04633278|467724752|FG000|Overall Study|Adverse Event|1|||
129933948|NCT04633278|467724753|FG001|Overall Study|Adverse Event|0|||
129933949|NCT04633278|467724752|FG000|Overall Study|Withdrawal by Subject|1|||
129933950|NCT04633278|467724753|FG001|Overall Study|Withdrawal by Subject|0|||
129933951|NCT04633278|467724752|FG000|Overall Study|Death|11|||
129933952|NCT04633278|467724753|FG001|Overall Study|Death|7|||
129933953|NCT04633278|467724752|FG000|Overall Study|Sponsor Decision|3|||
129933954|NCT04633278|467724753|FG001|Overall Study|Sponsor Decision|0|||
129933955|NCT04633278|467724752|FG000|Overall Study|Not Listed|1|||
129933956|NCT04633278|467724753|FG001|Overall Study|Not Listed|0|||
129933957|NCT03636490|467724754|FG000|Overall Study|Dropped out or incomplete data|141|||
129933958|NCT02246127|467724755|FG000|First Course Treatment|Adverse Event|9|||
129933959|NCT02246127|467724756|FG001|First Course Treatment|Adverse Event|7|||
129933960|NCT02246127|467724755|FG000|First Course Treatment|Withdrawal by Subject|6|||
129933961|NCT02246127|467724756|FG001|First Course Treatment|Withdrawal by Subject|7|||
129933962|NCT02246127|467724755|FG000|First Course Treatment|Physician Decision|9|||
129933963|NCT02246127|467724756|FG001|First Course Treatment|Physician Decision|9|||
129933964|NCT02246127|467724755|FG000|First Course Treatment|Death|3|||
129933965|NCT02246127|467724756|FG001|First Course Treatment|Death|3|||
129933966|NCT02246127|467724755|FG000|First Course Treatment|Not reported reasons|6|||
129451971|NCT00898443|465952098|FG001|Overall Study|Withdrawal by Subject|0|||
129933967|NCT02246127|467724756|FG001|First Course Treatment|Not reported reasons|7|||
129933968|NCT02246127|467724755|FG000|First Course Treatment|Not treated|3|||
129933969|NCT02246127|467724756|FG001|First Course Treatment|Not treated|3|||
129933970|NCT06262347|467724762|FG000|Overall Study|Lost to Follow-up|4|||
129933971|NCT06262347|467724763|FG001|Overall Study|Lost to Follow-up|3|||
129933972|NCT06262347|467724762|FG000|Overall Study|Withdrawal by Subject|0|||
129933973|NCT06262347|467724763|FG001|Overall Study|Withdrawal by Subject|1|||
129451972|NCT04695392|465952099|FG000|Overall Study|Withdrawn by parent/guardian|0|||
129933974|NCT06655818|467724776|FG000|Overall Study|Withdrawal by Subject|1|||
129933975|NCT04623775|467724787|FG000|Randomization|No Longer Meets Study Criteria|2|||
129933976|NCT04623775|467724788|FG001|Randomization|No Longer Meets Study Criteria|1|||
129933977|NCT04623775|467724789|FG002|Randomization|No Longer Meets Study Criteria|0|||
129933978|NCT04623775|467724790|FG003|Randomization|No Longer Meets Study Criteria|0|||
129933979|NCT04623775|467724787|FG000|Randomization|Withdrew Consent|0|||
129933980|NCT04623775|467724788|FG001|Randomization|Withdrew Consent|0|||
129933981|NCT04623775|467724789|FG002|Randomization|Withdrew Consent|0|||
129933982|NCT04623775|467724790|FG003|Randomization|Withdrew Consent|1|||
129933983|NCT04623775|467724787|FG000|Randomization|Other Reasons|0|||
129933984|NCT04623775|467724788|FG001|Randomization|Other Reasons|0|||
129933985|NCT04623775|467724789|FG002|Randomization|Other Reasons|0|||
129933986|NCT04623775|467724790|FG003|Randomization|Other Reasons|1|||
129933987|NCT04623775|467724787|FG000|Treatment Period|participant withdrew consent|4|||
129933988|NCT04623775|467724788|FG001|Treatment Period|participant withdrew consent|0|||
129933989|NCT04623775|467724789|FG002|Treatment Period|participant withdrew consent|1|||
129933990|NCT04623775|467724790|FG003|Treatment Period|participant withdrew consent|2|||
129933991|NCT04623775|467724787|FG000|Treatment Period|Death|3|||
129933992|NCT04623775|467724788|FG001|Treatment Period|Death|1|||
129933993|NCT04623775|467724789|FG002|Treatment Period|Death|4|||
129933994|NCT04623775|467724790|FG003|Treatment Period|Death|2|||
129933995|NCT04623775|467724787|FG000|Treatment Period|Lost to Follow-up|0|||
129933996|NCT04623775|467724788|FG001|Treatment Period|Lost to Follow-up|2|||
129933997|NCT04623775|467724789|FG002|Treatment Period|Lost to Follow-up|0|||
129933998|NCT04623775|467724790|FG003|Treatment Period|Lost to Follow-up|0|||
129933999|NCT04623775|467724787|FG000|Treatment Period|poor/non compliance|0|||
129934000|NCT04623775|467724788|FG001|Treatment Period|poor/non compliance|0|||
129934001|NCT04623775|467724789|FG002|Treatment Period|poor/non compliance|1|||
129934002|NCT04623775|467724790|FG003|Treatment Period|poor/non compliance|0|||
129934003|NCT04623775|467724787|FG000|Treatment Period|participant no longer meets study criteria|0|||
129934004|NCT04623775|467724788|FG001|Treatment Period|participant no longer meets study criteria|1|||
129934005|NCT04623775|467724789|FG002|Treatment Period|participant no longer meets study criteria|0|||
129934006|NCT04623775|467724790|FG003|Treatment Period|participant no longer meets study criteria|0|||
129934007|NCT04623775|467724787|FG000|Treatment Period|administrative reasons by sponsor|3|||
129934008|NCT04623775|467724788|FG001|Treatment Period|administrative reasons by sponsor|2|||
129934009|NCT04623775|467724789|FG002|Treatment Period|administrative reasons by sponsor|0|||
129934010|NCT04623775|467724790|FG003|Treatment Period|administrative reasons by sponsor|0|||
129934011|NCT04623775|467724787|FG000|Treatment Period|other reasons|2|||
129934012|NCT04623775|467724788|FG001|Treatment Period|other reasons|0|||
129934013|NCT04623775|467724789|FG002|Treatment Period|other reasons|1|||
129934014|NCT04623775|467724790|FG003|Treatment Period|other reasons|1|||
129934015|NCT04623775|467724787|FG000|Treatment Period|disease progression|40|||
129934016|NCT04623775|467724788|FG001|Treatment Period|disease progression|35|||
129934017|NCT04623775|467724789|FG002|Treatment Period|disease progression|63|||
129934018|NCT04623775|467724790|FG003|Treatment Period|disease progression|63|||
129934019|NCT04623775|467724787|FG000|Treatment Period|study drug toxicity|12|||
129934020|NCT04623775|467724788|FG001|Treatment Period|study drug toxicity|15|||
129934021|NCT04623775|467724789|FG002|Treatment Period|study drug toxicity|13|||
129934022|NCT04623775|467724790|FG003|Treatment Period|study drug toxicity|12|||
129934023|NCT04623775|467724787|FG000|Treatment Period|AE unrelated to study drug|4|||
129934024|NCT04623775|467724788|FG001|Treatment Period|AE unrelated to study drug|9|||
129934025|NCT04623775|467724789|FG002|Treatment Period|AE unrelated to study drug|12|||
129934026|NCT04623775|467724790|FG003|Treatment Period|AE unrelated to study drug|9|||
129934027|NCT04623775|467724787|FG000|Treatment Period|participant request to discontinue treatment|0|||
129934028|NCT04623775|467724788|FG001|Treatment Period|participant request to discontinue treatment|2|||
129934029|NCT04623775|467724789|FG002|Treatment Period|participant request to discontinue treatment|2|||
129934030|NCT04623775|467724790|FG003|Treatment Period|participant request to discontinue treatment|0|||
129934031|NCT04560179|467724799|FG000|Overall Study|Physician Decision|1|||
129934032|NCT04560179|467724800|FG001|Overall Study|Physician Decision|0|||
129934033|NCT04560179|467724801|FG002|Overall Study|Physician Decision|0|||
129934034|NCT04560179|467724802|FG003|Overall Study|Physician Decision|0|||
129934035|NCT04560179|467724803|FG004|Overall Study|Physician Decision|0|||
129934036|NCT04560179|467724799|FG000|Overall Study|Adverse Event|0|||
129934037|NCT04560179|467724800|FG001|Overall Study|Adverse Event|0|||
129934038|NCT04560179|467724801|FG002|Overall Study|Adverse Event|0|||
129934039|NCT04560179|467724802|FG003|Overall Study|Adverse Event|1|||
129934040|NCT04560179|467724803|FG004|Overall Study|Adverse Event|0|||
129934041|NCT04496752|467724806|FG000|Second Assessment|Lost to Follow-up|3|||
129934042|NCT04496752|467724807|FG001|Second Assessment|Lost to Follow-up|3|||
129934043|NCT04496752|467724806|FG000|Second Assessment|Adverse Event|2|||
129934044|NCT04496752|467724807|FG001|Second Assessment|Adverse Event|0|||
129934045|NCT04967599|467724810|FG000|Overall Study|Lost to Follow-up|35|||
129934046|NCT04967599|467724811|FG001|Overall Study|Lost to Follow-up|19|||
129934047|NCT04967599|467724812|FG002|Overall Study|Lost to Follow-up|23|||
129934048|NCT04369911|467724813|FG000|Overall Study|Lost to Follow-up|3|||
129934049|NCT04369911|467724814|FG001|Overall Study|Lost to Follow-up|3|||
129934050|NCT04369911|467724813|FG000|Overall Study|Withdrawal by Subject|1|||
129934051|NCT04369911|467724814|FG001|Overall Study|Withdrawal by Subject|2|||
129934052|NCT05451693|467724815|FG000|Overall Study|Withdrawal by Subject|1|||
129934053|NCT05451693|467724816|FG001|Overall Study|Withdrawal by Subject|1|||
129934054|NCT05541484|467724826|FG000|Overall Study|Withdrawal by Subject|1|||
129934055|NCT05541484|467724827|FG001|Overall Study|Withdrawal by Subject|0|||
129934056|NCT02919917|467724830|FG000|Overall Study|Withdrawal by Subject|4|||
129934057|NCT02919917|467724831|FG001|Overall Study|Withdrawal by Subject|8|||
129934058|NCT05215054|467724832|FG000|Overall Study|Lost to Follow-up|1|||
129934059|NCT05215054|467724833|FG001|Overall Study|Lost to Follow-up|1|||
129934060|NCT05215054|467724832|FG000|Overall Study|Protocol Violation|1|||
129934061|NCT05215054|467724833|FG001|Overall Study|Protocol Violation|1|||
129934062|NCT05215054|467724832|FG000|Overall Study|Withdrawal by Subject|4|||
129934063|NCT05215054|467724833|FG001|Overall Study|Withdrawal by Subject|4|||
129934064|NCT04159519|467724837|FG000|Overall Study|Adverse Event|1|||
129934065|NCT04159519|467724838|FG001|Overall Study|Adverse Event|1|||
129934066|NCT04159519|467724837|FG000|Overall Study|Lack of Efficacy|1|||
129934067|NCT04159519|467724838|FG001|Overall Study|Lack of Efficacy|0|||
129934068|NCT04159519|467724837|FG000|Overall Study|Discontinued from study|1|||
129934069|NCT04159519|467724838|FG001|Overall Study|Discontinued from study|0|||
129934070|NCT04159519|467724837|FG000|Overall Study|Protocol Violation|1|||
129934071|NCT04159519|467724838|FG001|Overall Study|Protocol Violation|1|||
129934072|NCT04159519|467724837|FG000|Overall Study|Withdrawal by Subject|4|||
129934073|NCT04159519|467724838|FG001|Overall Study|Withdrawal by Subject|4|||
129934074|NCT01651000|467724839|FG000|Overall Study|Adverse Event|2|||
129934075|NCT01651000|467724840|FG001|Overall Study|Adverse Event|8|||
129934076|NCT01651000|467724839|FG000|Overall Study|Lost to Follow-up|3|||
129934077|NCT01651000|467724840|FG001|Overall Study|Lost to Follow-up|2|||
129934078|NCT01651000|467724839|FG000|Overall Study|Protocol Violation|0|||
129934079|NCT01651000|467724840|FG001|Overall Study|Protocol Violation|3|||
129934080|NCT01651000|467724839|FG000|Overall Study|Withdrawal by Subject|2|||
129934081|NCT01651000|467724840|FG001|Overall Study|Withdrawal by Subject|10|||
129934082|NCT01651000|467724839|FG000|Overall Study|Subject noncompliance|0|||
129934083|NCT01651000|467724840|FG001|Overall Study|Subject noncompliance|3|||
129934084|NCT01651000|467724839|FG000|Overall Study|Lack of Efficacy|1|||
129934085|NCT01651000|467724840|FG001|Overall Study|Lack of Efficacy|1|||
129934086|NCT01651000|467724839|FG000|Overall Study|Physician Decision|1|||
129934087|NCT01651000|467724840|FG001|Overall Study|Physician Decision|0|||
129934088|NCT01651000|467724839|FG000|Overall Study|Administrative reason|1|||
129934089|NCT01651000|467724840|FG001|Overall Study|Administrative reason|0|||
129934090|NCT01651000|467724839|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
129934091|NCT01651000|467724840|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
129934092|NCT02765412|467724841|FG000|Overall Study|Death|482|||
129934093|NCT02765412|467724842|FG001|Overall Study|Death|855|||
129934094|NCT02163694|467725545|FG000|Overall Study|Adverse event- related to progression|4|||
129934095|NCT02163694|467725546|FG001|Overall Study|Adverse event- related to progression|10|||
129934096|NCT02163694|467725545|FG000|Overall Study|Adverse event- not related to progression|7|||
129934097|NCT02163694|467725546|FG001|Overall Study|Adverse event- not related to progression|22|||
129934098|NCT02163694|467725545|FG000|Overall Study|Withdrew consent|13|||
129934099|NCT02163694|467725546|FG001|Overall Study|Withdrew consent|28|||
129934100|NCT02163694|467725545|FG000|Overall Study|Lost to Follow-up|2|||
129934101|NCT02163694|467725546|FG001|Overall Study|Lost to Follow-up|2|||
129934102|NCT02163694|467725545|FG000|Overall Study|Sponsor discontinued study|3|||
129934103|NCT02163694|467725546|FG001|Overall Study|Sponsor discontinued study|29|||
129934104|NCT02163694|467725545|FG000|Overall Study|Progressive disease per protocol|125|||
129934105|NCT02163694|467725546|FG001|Overall Study|Progressive disease per protocol|224|||
129934106|NCT02163694|467725545|FG000|Overall Study|Other, not specified|17|||
129934107|NCT02163694|467725546|FG001|Overall Study|Other, not specified|22|||
129934108|NCT02163694|467725545|FG000|Overall Study|Randomized but Not Treated|1|||
129934109|NCT02163694|467725546|FG001|Overall Study|Randomized but Not Treated|0|||
129934110|NCT02163694|467725545|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
129934111|NCT02163694|467725546|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
129934112|NCT06010836|467725549|FG000|Overall Study|Lost to Follow-up|2|||
129934113|NCT06010836|467725550|FG001|Overall Study|Lost to Follow-up|2|||
129934114|NCT06010836|467725549|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
129934115|NCT06010836|467725550|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
129934116|NCT06010836|467725549|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
129934117|NCT06010836|467725550|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
129934118|NCT06010836|467725549|FG000|Overall Study|Did not receive intervention discussion|0|||
129934119|NCT06010836|467725550|FG001|Overall Study|Did not receive intervention discussion|4|||
129934120|NCT04524689|467725551|FG000|Overall Study|Withdrawal by Subject|1|||
129934121|NCT04524689|467725552|FG001|Overall Study|Withdrawal by Subject|1|||
129934122|NCT04524689|467725553|FG002|Overall Study|Withdrawal by Subject|0|||
129934123|NCT04524689|467725554|FG003|Overall Study|Withdrawal by Subject|0|||
129934124|NCT04524689|467725555|FG004|Overall Study|Withdrawal by Subject|1|||
129934125|NCT04524689|467725556|FG005|Overall Study|Withdrawal by Subject|0|||
129934126|NCT04524689|467725551|FG000|Overall Study|Not related to Coronavirus disease 2019|2|||
129934127|NCT04524689|467725552|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
129934128|NCT04524689|467725553|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
129934129|NCT04524689|467725554|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
129934130|NCT04524689|467725555|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
129934131|NCT04524689|467725556|FG005|Overall Study|Not related to Coronavirus disease 2019|0|||
129934132|NCT04524689|467725551|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|12|||
129934133|NCT04524689|467725552|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
129934134|NCT04524689|467725553|FG002|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
129934135|NCT04524689|467725554|FG003|Overall Study|Ongoing study treatment at the time of primary analysis|0|||
129934136|NCT04524689|467725555|FG004|Overall Study|Ongoing study treatment at the time of primary analysis|5|||
129934137|NCT04524689|467725556|FG005|Overall Study|Ongoing study treatment at the time of primary analysis|1|||
129934138|NCT03662022|467725559|FG000|Year 1 2019|prevalent case|83|||
129934139|NCT03662022|467725560|FG001|Year 1 2019|prevalent case|116|||
129934140|NCT03662022|467725561|FG002|Year 1 2019|prevalent case|158|||
129934141|NCT03662022|467725562|FG003|Year 1 2019|prevalent case|99|||
129934142|NCT03662022|467725559|FG000|Year 2 2020|incident case|18|||
129934143|NCT03662022|467725560|FG001|Year 2 2020|incident case|18|||
129934144|NCT03662022|467725561|FG002|Year 2 2020|incident case|16|||
129934145|NCT03662022|467725562|FG003|Year 2 2020|incident case|26|||
129934146|NCT03662022|467725559|FG000|Year 2 2020|other case|18|||
129934147|NCT03662022|467725560|FG001|Year 2 2020|other case|16|||
129934148|NCT03662022|467725561|FG002|Year 2 2020|other case|16|||
129934149|NCT03662022|467725562|FG003|Year 2 2020|other case|24|||
129934150|NCT03662022|467725559|FG000|Year 2 2020|Lost to Follow-up|1633|||
129934151|NCT03662022|467725560|FG001|Year 2 2020|Lost to Follow-up|1183|||
129934152|NCT03662022|467725561|FG002|Year 2 2020|Lost to Follow-up|1381|||
129934153|NCT03662022|467725562|FG003|Year 2 2020|Lost to Follow-up|2858|||
129934154|NCT03662022|467725559|FG000|Year 3 2021|incident case|24|||
129934155|NCT03662022|467725560|FG001|Year 3 2021|incident case|27|||
129934156|NCT03662022|467725561|FG002|Year 3 2021|incident case|24|||
129934157|NCT03662022|467725562|FG003|Year 3 2021|incident case|11|||
129934158|NCT03662022|467725559|FG000|Year 3 2021|other case|4|||
129934159|NCT03662022|467725560|FG001|Year 3 2021|other case|15|||
129934160|NCT03662022|467725561|FG002|Year 3 2021|other case|10|||
129934161|NCT03662022|467725562|FG003|Year 3 2021|other case|14|||
129934162|NCT03662022|467725559|FG000|Year 3 2021|Lost to Follow-up|179|||
129934163|NCT03662022|467725560|FG001|Year 3 2021|Lost to Follow-up|244|||
129934164|NCT03662022|467725561|FG002|Year 3 2021|Lost to Follow-up|480|||
129934165|NCT03662022|467725562|FG003|Year 3 2021|Lost to Follow-up|477|||
129934166|NCT03662022|467725559|FG000|Year 4 2022|incident case|25|||
129934167|NCT03662022|467725560|FG001|Year 4 2022|incident case|41|||
129934168|NCT03662022|467725561|FG002|Year 4 2022|incident case|28|||
129934169|NCT03662022|467725562|FG003|Year 4 2022|incident case|7|||
129934170|NCT03662022|467725559|FG000|Year 4 2022|other case|8|||
129934171|NCT03662022|467725560|FG001|Year 4 2022|other case|19|||
129934172|NCT03662022|467725561|FG002|Year 4 2022|other case|13|||
129934173|NCT03662022|467725562|FG003|Year 4 2022|other case|7|||
129934174|NCT03662022|467725559|FG000|Year 4 2022|Lost to Follow-up|986|||
129934175|NCT03662022|467725560|FG001|Year 4 2022|Lost to Follow-up|1079|||
129934176|NCT03662022|467725561|FG002|Year 4 2022|Lost to Follow-up|1236|||
129934177|NCT03662022|467725562|FG003|Year 4 2022|Lost to Follow-up|1826|||
129934178|NCT04490109|467725573|FG000|Overall Study|Lost to Follow-up|3|||
129934179|NCT04490109|467725574|FG001|Overall Study|Lost to Follow-up|10|||
129934180|NCT04490109|467725575|FG002|Overall Study|Lost to Follow-up|4|||
129934181|NCT04490109|467725573|FG000|Overall Study|Withdrawal by Subject|8|||
129934182|NCT04490109|467725574|FG001|Overall Study|Withdrawal by Subject|6|||
129934183|NCT04490109|467725575|FG002|Overall Study|Withdrawal by Subject|9|||
129934184|NCT04490109|467725573|FG000|Overall Study|Physician Decision|0|||
129934185|NCT04490109|467725574|FG001|Overall Study|Physician Decision|2|||
129934186|NCT04490109|467725575|FG002|Overall Study|Physician Decision|3|||
129451973|NCT04695392|465952100|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129451974|NCT04695392|465952099|FG000|Overall Study|Withdrawn by physician|0|||
129451975|NCT04695392|465952100|FG001|Overall Study|Withdrawn by physician|1|||
129451976|NCT05082376|465952103|FG000|Overall Study|Lost to Follow-up|2|||
129451977|NCT04085523|465952105|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
129451978|NCT04085523|465952106|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
129451979|NCT04085523|465952107|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
129451980|NCT04085523|465952108|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
129451981|NCT04085523|465952109|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
129451982|NCT04085523|465952110|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
129451983|NCT01877915|465952113|FG000|Overall Study|Lost to Follow-up|10|||
129451984|NCT01877915|465952114|FG001|Overall Study|Lost to Follow-up|9|||
129451985|NCT01877915|465952113|FG000|Overall Study|Withdrawal by Subject|42|||
129451986|NCT01877915|465952114|FG001|Overall Study|Withdrawal by Subject|55|||
129451987|NCT01877915|465952113|FG000|Overall Study|Other|2|||
129451988|NCT01877915|465952114|FG001|Overall Study|Other|4|||
129451989|NCT03520959|465952115|FG000|Overall Study|Study terminated by Sponsor|0|||
129451990|NCT03520959|465952116|FG001|Overall Study|Study terminated by Sponsor|1|||
129451991|NCT01449461|465952117|FG000|Overall Study|Adverse Event|0|||
129451992|NCT01449461|465952118|FG001|Overall Study|Adverse Event|3|||
129451993|NCT01449461|465952119|FG002|Overall Study|Adverse Event|2|||
129934187|NCT04490109|467725573|FG000|Overall Study|Adverse Event|2|||
129934188|NCT04490109|467725574|FG001|Overall Study|Adverse Event|1|||
129934189|NCT04490109|467725575|FG002|Overall Study|Adverse Event|0|||
129934190|NCT04490109|467725573|FG000|Overall Study|Significant Non-Compliance|2|||
129934191|NCT04490109|467725574|FG001|Overall Study|Significant Non-Compliance|4|||
129934192|NCT04490109|467725575|FG002|Overall Study|Significant Non-Compliance|4|||
129934193|NCT04490109|467725573|FG000|Overall Study|Significant Clinical Event|0|||
129934194|NCT04490109|467725574|FG001|Overall Study|Significant Clinical Event|1|||
129934195|NCT04490109|467725575|FG002|Overall Study|Significant Clinical Event|0|||
129934196|NCT04490109|467725573|FG000|Overall Study|Other Reason|4|||
129934197|NCT04490109|467725574|FG001|Overall Study|Other Reason|1|||
129934198|NCT04490109|467725575|FG002|Overall Study|Other Reason|1|||
129934199|NCT03817983|467725578|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
129934200|NCT03817983|467725579|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
129934201|NCT03817983|467725580|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
129934202|NCT03744676|467725581|FG000|Pre-Treatment Phase|Disease related complications|2|||
129934203|NCT03744676|467725581|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
129934204|NCT03744676|467725581|FG000|Pre-Treatment Phase|Death|7|||
129934205|NCT03744676|467725581|FG000|Pre-Treatment Phase|Other Reasons|7|||
129934206|NCT03744676|467725581|FG000|Treatment Phase|Participant withdrew consent|8|||
129934207|NCT03744676|467725581|FG000|Treatment Phase|Death|33|||
129934208|NCT03744676|467725581|FG000|Treatment Phase|other reasons|6|||
129934209|NCT03884439|467725588|FG000|Overall Study|No informed consent for publication of study results|38|||
129934210|NCT03884439|467725588|FG000|Overall Study|Contract violation/deficiency|7|||
129934211|NCT03547271|467725589|FG000|Overall Study|Adverse Event|1|||
129934212|NCT03547271|467725590|FG001|Overall Study|Adverse Event|1|||
129934213|NCT03547271|467725591|FG002|Overall Study|Adverse Event|0|||
129934214|NCT03547271|467725592|FG003|Overall Study|Adverse Event|0|||
129934215|NCT03547271|467725589|FG000|Overall Study|Protocol deviation|5|||
129934216|NCT03547271|467725590|FG001|Overall Study|Protocol deviation|7|||
129934217|NCT03547271|467725591|FG002|Overall Study|Protocol deviation|3|||
129934218|NCT03547271|467725592|FG003|Overall Study|Protocol deviation|0|||
129934219|NCT03547271|467725589|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
129934220|NCT03547271|467725590|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
129934221|NCT03547271|467725591|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
129934222|NCT03547271|467725592|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
129934223|NCT03547271|467725589|FG000|Overall Study|Lost to Follow-up|3|||
129934224|NCT03547271|467725590|FG001|Overall Study|Lost to Follow-up|3|||
129934225|NCT03547271|467725591|FG002|Overall Study|Lost to Follow-up|1|||
129934226|NCT03547271|467725592|FG003|Overall Study|Lost to Follow-up|0|||
129934227|NCT03533257|467725598|FG000|Overall Study|Adverse Event|4|||
129934228|NCT03533257|467725599|FG001|Overall Study|Adverse Event|2|||
129934229|NCT03533257|467725598|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
129934230|NCT03533257|467725599|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
129934231|NCT03250676|467725600|FG000|Overall Study|Adverse Event|0|||
129451994|NCT01449461|465952120|FG003|Overall Study|Adverse Event|3|||
129451995|NCT01449461|465952121|FG004|Overall Study|Adverse Event|4|||
129451996|NCT01449461|465952122|FG005|Overall Study|Adverse Event|4|||
129934232|NCT03250676|467725601|FG001|Overall Study|Adverse Event|0|||
129934233|NCT03250676|467725602|FG002|Overall Study|Adverse Event|0|||
129934234|NCT03250676|467725603|FG003|Overall Study|Adverse Event|1|||
129934235|NCT03250676|467725604|FG004|Overall Study|Adverse Event|2|||
129934236|NCT03250676|467725605|FG005|Overall Study|Adverse Event|9|||
129934237|NCT03250676|467725600|FG000|Overall Study|Withdrawal by Subject|1|||
129451997|NCT01449461|465952117|FG000|Overall Study|Death|0|||
129934238|NCT03250676|467725601|FG001|Overall Study|Withdrawal by Subject|0|||
129934239|NCT03250676|467725602|FG002|Overall Study|Withdrawal by Subject|0|||
129934240|NCT03250676|467725603|FG003|Overall Study|Withdrawal by Subject|1|||
129934241|NCT03250676|467725604|FG004|Overall Study|Withdrawal by Subject|1|||
129934242|NCT03250676|467725605|FG005|Overall Study|Withdrawal by Subject|2|||
129934243|NCT03250676|467725600|FG000|Overall Study|Physician Decision|0|||
129934244|NCT03250676|467725601|FG001|Overall Study|Physician Decision|0|||
129934245|NCT03250676|467725602|FG002|Overall Study|Physician Decision|0|||
129934246|NCT03250676|467725603|FG003|Overall Study|Physician Decision|2|||
129934247|NCT03250676|467725604|FG004|Overall Study|Physician Decision|0|||
129934248|NCT03250676|467725605|FG005|Overall Study|Physician Decision|3|||
129934249|NCT03250676|467725600|FG000|Overall Study|Withdrawal of consent|0|||
129934250|NCT03250676|467725601|FG001|Overall Study|Withdrawal of consent|0|||
129934251|NCT03250676|467725602|FG002|Overall Study|Withdrawal of consent|2|||
129934252|NCT03250676|467725603|FG003|Overall Study|Withdrawal of consent|0|||
129934253|NCT03250676|467725604|FG004|Overall Study|Withdrawal of consent|0|||
129934254|NCT03250676|467725605|FG005|Overall Study|Withdrawal of consent|2|||
129934255|NCT03250676|467725600|FG000|Overall Study|Other|1|||
129934256|NCT03250676|467725601|FG001|Overall Study|Other|0|||
129934257|NCT03250676|467725602|FG002|Overall Study|Other|0|||
129934258|NCT03250676|467725603|FG003|Overall Study|Other|0|||
129934259|NCT03250676|467725604|FG004|Overall Study|Other|0|||
129934260|NCT03250676|467725605|FG005|Overall Study|Other|0|||
129934261|NCT03250676|467725600|FG000|Overall Study|Disease progression|4|||
129934262|NCT03250676|467725601|FG001|Overall Study|Disease progression|12|||
129934263|NCT03250676|467725602|FG002|Overall Study|Disease progression|9|||
129934264|NCT03250676|467725603|FG003|Overall Study|Disease progression|7|||
129934265|NCT03250676|467725604|FG004|Overall Study|Disease progression|4|||
129934266|NCT03250676|467725605|FG005|Overall Study|Disease progression|88|||
129934267|NCT04780581|467725606|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
129934268|NCT04780581|467725607|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
129934269|NCT04780581|467725606|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
129934270|NCT04780581|467725607|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
129934271|NCT05267639|467726663|FG000|Overall Study|Withdrawal by Subject|1|||
129934272|NCT05267639|467726664|FG001|Overall Study|Withdrawal by Subject|0|||
129934273|NCT04244175|467726668|FG000|Overall Study|Adverse Event|3|||
129934274|NCT04244175|467726669|FG001|Overall Study|Adverse Event|2|||
129934275|NCT04244175|467726670|FG002|Overall Study|Adverse Event|5|||
129934276|NCT04244175|467726668|FG000|Overall Study|Lack of Efficacy|1|||
129934277|NCT04244175|467726669|FG001|Overall Study|Lack of Efficacy|0|||
129934278|NCT04244175|467726670|FG002|Overall Study|Lack of Efficacy|1|||
129934279|NCT04244175|467726668|FG000|Overall Study|Lost to Follow-up|1|||
129934280|NCT04244175|467726669|FG001|Overall Study|Lost to Follow-up|0|||
129934281|NCT04244175|467726670|FG002|Overall Study|Lost to Follow-up|0|||
129934282|NCT04244175|467726668|FG000|Overall Study|Non-compliance with study drug|1|||
129934283|NCT04244175|467726669|FG001|Overall Study|Non-compliance with study drug|0|||
129934284|NCT04244175|467726670|FG002|Overall Study|Non-compliance with study drug|1|||
129934285|NCT04244175|467726668|FG000|Overall Study|Protocol deviation|0|||
129934286|NCT04244175|467726669|FG001|Overall Study|Protocol deviation|1|||
129934287|NCT04244175|467726670|FG002|Overall Study|Protocol deviation|0|||
129934288|NCT04244175|467726668|FG000|Overall Study|Withdrawal by Subject|1|||
129934289|NCT04244175|467726669|FG001|Overall Study|Withdrawal by Subject|3|||
129934290|NCT04244175|467726670|FG002|Overall Study|Withdrawal by Subject|1|||
129934291|NCT04244175|467726668|FG000|Overall Study|Other, not specified|0|||
129934292|NCT04244175|467726669|FG001|Overall Study|Other, not specified|1|||
129934293|NCT04244175|467726670|FG002|Overall Study|Other, not specified|2|||
129934294|NCT04595331|467726671|FG000|Overall Study|Withdrawal by Subject|0|||
129934295|NCT04595331|467726672|FG001|Overall Study|Withdrawal by Subject|1|||
129934296|NCT04595331|467726671|FG000|Overall Study|Lost to Follow-up|0|||
129934297|NCT04595331|467726672|FG001|Overall Study|Lost to Follow-up|5|||
129934298|NCT04595331|467726671|FG000|Overall Study|Medical reason|0|||
129934299|NCT04595331|467726672|FG001|Overall Study|Medical reason|1|||
129934300|NCT03781089|467726673|FG000|Overall Study|Constipation|1|||
129934301|NCT03781089|467726674|FG001|Overall Study|Constipation|0|||
129934302|NCT03781089|467726673|FG000|Overall Study|Positive pregnancy test|0|||
129934303|NCT03781089|467726674|FG001|Overall Study|Positive pregnancy test|1|||
129934304|NCT05311176|467726675|FG000|Overall Study|Death|6|||
129934305|NCT05311176|467726675|FG000|Overall Study|Sponsor discontinued the study|1|||
129934306|NCT05836012|467726686|FG000|Overall Study|Lost to Follow-up|1|||
129934307|NCT05836012|467726687|FG001|Overall Study|Lost to Follow-up|0|||
129934308|NCT05836012|467726686|FG000|Overall Study|Withdrawal by Subject|1|||
129934309|NCT05836012|467726687|FG001|Overall Study|Withdrawal by Subject|3|||
129934310|NCT05836012|467726686|FG000|Overall Study|Reason not included in pre-specified categories|2|||
129934311|NCT05836012|467726687|FG001|Overall Study|Reason not included in pre-specified categories|1|||
129934312|NCT05454514|467726688|FG000|Overall Study|Withdrawal by Subject|4|||
129934313|NCT06065735|467726689|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
129934314|NCT06065735|467726690|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
129934315|NCT06065735|467726691|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
129934316|NCT06065735|467726689|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
129934317|NCT06065735|467726690|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
129934318|NCT06065735|467726691|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
129934319|NCT06065735|467726689|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
129934320|NCT06065735|467726690|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
129934321|NCT06065735|467726691|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
129934322|NCT06065735|467726689|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
129934323|NCT06065735|467726690|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
129934324|NCT06065735|467726691|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
129934325|NCT06065735|467726689|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
129934326|NCT06065735|467726690|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
129934327|NCT06065735|467726691|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
129934328|NCT03418740|467726692|FG000|Overall Study|Lost to Follow-up|13|||
129934329|NCT03418740|467726692|FG000|Overall Study|Scheduling Issues|7|||
129934330|NCT03418740|467726692|FG000|Overall Study|Withdrawal by Subject|2|||
129934331|NCT03418740|467726692|FG000|Overall Study|Unable to Continue Consent|1|||
129934332|NCT04157517|467726697|FG000|Overall Study|Death|1|||
129934333|NCT04157517|467726698|FG001|Overall Study|Death|2|||
129934334|NCT04157517|467726699|FG002|Overall Study|Death|2|||
129934335|NCT04157517|467726700|FG003|Overall Study|Death|3|||
129934336|NCT04157517|467726701|FG004|Overall Study|Death|3|||
129934337|NCT04157517|467726702|FG005|Overall Study|Death|4|||
129934338|NCT04157517|467726703|FG006|Overall Study|Death|1|||
129934339|NCT04157517|467726704|FG007|Overall Study|Death|2|||
129934340|NCT04157517|467726705|FG008|Overall Study|Death|4|||
129934341|NCT04157517|467726706|FG009|Overall Study|Death|0|||
129934342|NCT04157517|467726697|FG000|Overall Study|Withdrawal by Subject|1|||
129934343|NCT04157517|467726698|FG001|Overall Study|Withdrawal by Subject|1|||
129934344|NCT04157517|467726699|FG002|Overall Study|Withdrawal by Subject|1|||
129934345|NCT04157517|467726700|FG003|Overall Study|Withdrawal by Subject|0|||
129934346|NCT04157517|467726701|FG004|Overall Study|Withdrawal by Subject|0|||
129934347|NCT04157517|467726702|FG005|Overall Study|Withdrawal by Subject|1|||
129934348|NCT04157517|467726703|FG006|Overall Study|Withdrawal by Subject|0|||
129934349|NCT04157517|467726704|FG007|Overall Study|Withdrawal by Subject|0|||
129934350|NCT04157517|467726705|FG008|Overall Study|Withdrawal by Subject|1|||
129934351|NCT04157517|467726706|FG009|Overall Study|Withdrawal by Subject|0|||
129934352|NCT04157517|467726697|FG000|Overall Study|Other|1|||
129934353|NCT04157517|467726698|FG001|Overall Study|Other|0|||
129934354|NCT04157517|467726699|FG002|Overall Study|Other|0|||
129934355|NCT04157517|467726700|FG003|Overall Study|Other|0|||
129934356|NCT04157517|467726701|FG004|Overall Study|Other|0|||
129934357|NCT04157517|467726702|FG005|Overall Study|Other|1|||
129934358|NCT04157517|467726703|FG006|Overall Study|Other|2|||
129934359|NCT04157517|467726704|FG007|Overall Study|Other|7|||
129934360|NCT04157517|467726705|FG008|Overall Study|Other|7|||
129934361|NCT04157517|467726706|FG009|Overall Study|Other|0|||
129934362|NCT02933489|467726707|FG000|Overall Study|Ineligible|3|||
129934363|NCT02933489|467726708|FG001|Overall Study|Ineligible|3|||
129934364|NCT02933489|467726707|FG000|Overall Study|Withdrawal by Subject|27|||
129934365|NCT02933489|467726708|FG001|Overall Study|Withdrawal by Subject|18|||
129934366|NCT02933489|467726707|FG000|Overall Study|Unable to complete exams (other)|14|||
129934367|NCT02933489|467726708|FG001|Overall Study|Unable to complete exams (other)|7|||
129934368|NCT02461134|467726711|FG000|Overall Study|Adverse Event|1|||
129934369|NCT04761198|467726712|FG000|Overall Study|Progressive Disease|1|||
129934370|NCT04761198|467726713|FG001|Overall Study|Progressive Disease|0|||
129934371|NCT04761198|467726714|FG002|Overall Study|Progressive Disease|0|||
129934372|NCT04761198|467726715|FG003|Overall Study|Progressive Disease|1|||
129934373|NCT04761198|467726716|FG004|Overall Study|Progressive Disease|4|||
129934374|NCT04761198|467726717|FG005|Overall Study|Progressive Disease|1|||
129934375|NCT04761198|467726718|FG006|Overall Study|Progressive Disease|2|||
129934376|NCT04761198|467726712|FG000|Overall Study|Protocol Violation|0|||
129934377|NCT04761198|467726713|FG001|Overall Study|Protocol Violation|0|||
129934378|NCT04761198|467726714|FG002|Overall Study|Protocol Violation|0|||
129934379|NCT04761198|467726715|FG003|Overall Study|Protocol Violation|0|||
129934380|NCT04761198|467726716|FG004|Overall Study|Protocol Violation|1|||
129934381|NCT04761198|467726717|FG005|Overall Study|Protocol Violation|0|||
129934382|NCT04761198|467726718|FG006|Overall Study|Protocol Violation|0|||
129934383|NCT04761198|467726712|FG000|Overall Study|Death|2|||
129934384|NCT04761198|467726713|FG001|Overall Study|Death|1|||
129934385|NCT04761198|467726714|FG002|Overall Study|Death|2|||
129934386|NCT04761198|467726715|FG003|Overall Study|Death|5|||
129934387|NCT04761198|467726716|FG004|Overall Study|Death|14|||
129934388|NCT04761198|467726717|FG005|Overall Study|Death|2|||
129934389|NCT04761198|467726718|FG006|Overall Study|Death|5|||
129934390|NCT04761198|467726712|FG000|Overall Study|Lost to Follow-up|0|||
129934391|NCT04761198|467726713|FG001|Overall Study|Lost to Follow-up|0|||
129934392|NCT04761198|467726714|FG002|Overall Study|Lost to Follow-up|0|||
129934393|NCT04761198|467726715|FG003|Overall Study|Lost to Follow-up|0|||
129934394|NCT04761198|467726716|FG004|Overall Study|Lost to Follow-up|1|||
129934395|NCT04761198|467726717|FG005|Overall Study|Lost to Follow-up|0|||
129934396|NCT04761198|467726718|FG006|Overall Study|Lost to Follow-up|0|||
129934397|NCT04761198|467726712|FG000|Overall Study|Withdrawal by Subject|2|||
129934398|NCT04761198|467726713|FG001|Overall Study|Withdrawal by Subject|0|||
129934399|NCT04761198|467726714|FG002|Overall Study|Withdrawal by Subject|1|||
129934400|NCT04761198|467726715|FG003|Overall Study|Withdrawal by Subject|0|||
129934401|NCT04761198|467726716|FG004|Overall Study|Withdrawal by Subject|2|||
129934402|NCT04761198|467726717|FG005|Overall Study|Withdrawal by Subject|0|||
129451998|NCT01449461|465952118|FG001|Overall Study|Death|2|||
129451999|NCT01449461|465952119|FG002|Overall Study|Death|0|||
129934403|NCT04761198|467726718|FG006|Overall Study|Withdrawal by Subject|1|||
129934404|NCT04761198|467726712|FG000|Overall Study|Study Terminated by Sponsor|6|||
129934405|NCT04761198|467726713|FG001|Overall Study|Study Terminated by Sponsor|0|||
129934406|NCT04761198|467726714|FG002|Overall Study|Study Terminated by Sponsor|5|||
129934407|NCT04761198|467726715|FG003|Overall Study|Study Terminated by Sponsor|3|||
129934408|NCT04761198|467726716|FG004|Overall Study|Study Terminated by Sponsor|10|||
129934409|NCT04761198|467726717|FG005|Overall Study|Study Terminated by Sponsor|1|||
129934410|NCT04761198|467726718|FG006|Overall Study|Study Terminated by Sponsor|2|||
129934411|NCT02994927|467726719|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129934412|NCT02994927|467726720|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129934413|NCT02994927|467726719|FG000|Overall Study|Did not meet eligibility criteria|0|||
129934414|NCT02994927|467726720|FG001|Overall Study|Did not meet eligibility criteria|1|||
129934415|NCT02994927|467726719|FG000|Overall Study|Physician Decision|4|||
129934416|NCT02994927|467726720|FG001|Overall Study|Physician Decision|3|||
129934417|NCT02994927|467726719|FG000|Overall Study|Death|4|||
129934418|NCT02994927|467726720|FG001|Overall Study|Death|2|||
129934419|NCT02994927|467726719|FG000|Overall Study|Adverse Event|2|||
129934420|NCT02994927|467726720|FG001|Overall Study|Adverse Event|1|||
129934421|NCT02994927|467726719|FG000|Overall Study|Withdrawal by Subject|3|||
129934422|NCT02994927|467726720|FG001|Overall Study|Withdrawal by Subject|6|||
129934423|NCT02994927|467726719|FG000|Overall Study|Lost to Follow-up|2|||
129934424|NCT02994927|467726720|FG001|Overall Study|Lost to Follow-up|1|||
129934425|NCT03493542|467726728|FG000|Base Study|Withdrawal by Subject|0|||
129934426|NCT03493542|467726729|FG001|Base Study|Withdrawal by Subject|4|||
129934427|NCT03493542|467726730|FG002|Base Study|Withdrawal by Subject|0|||
129934428|NCT03493542|467726728|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
129934429|NCT03493542|467726729|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
129934430|NCT03493542|467726730|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
129934431|NCT03493542|467726728|FG000|Extension Study|Withdrawal by Subject|0|||
129934432|NCT03493542|467726729|FG001|Extension Study|Withdrawal by Subject|0|||
129934433|NCT03493542|467726730|FG002|Extension Study|Withdrawal by Subject|25|||
129934434|NCT04093869|467726731|FG000|Overall Study|Death|0|||
129934435|NCT04093869|467726732|FG001|Overall Study|Death|1|||
129934436|NCT04093869|467726731|FG000|Overall Study|Withdrawal by Subject|1|||
129934437|NCT04093869|467726732|FG001|Overall Study|Withdrawal by Subject|0|||
129934438|NCT03587805|467726733|FG000|Overall Study|Adverse Event|72|||
129934439|NCT03587805|467726733|FG000|Overall Study|Death|1|||
129934440|NCT03587805|467726733|FG000|Overall Study|Lost to Follow-up|78|||
129934441|NCT03587805|467726733|FG000|Overall Study|Withdrawal by Subject|105|||
129934442|NCT03587805|467726733|FG000|Overall Study|Lack of Efficacy|119|||
129934443|NCT03587805|467726733|FG000|Overall Study|Reason unknown|26|||
129934444|NCT03587805|467726733|FG000|Overall Study|COVID_19 pandemic|4|||
129934445|NCT03587805|467726733|FG000|Overall Study|Various reasons|121|||
129934446|NCT03587805|467726733|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129934447|NCT03982186|467726734|FG000|Overall Study|Lost to Follow-up|0|||
129934448|NCT03982186|467726735|FG001|Overall Study|Lost to Follow-up|1|||
129934449|NCT03982186|467726736|FG002|Overall Study|Lost to Follow-up|2|||
129934450|NCT03982186|467726737|FG003|Overall Study|Lost to Follow-up|1|||
129934451|NCT03982186|467726738|FG004|Overall Study|Lost to Follow-up|1|||
129934452|NCT03982186|467726739|FG005|Overall Study|Lost to Follow-up|0|||
129934453|NCT03982186|467726734|FG000|Overall Study|Physician Decision|0|||
129934454|NCT03982186|467726735|FG001|Overall Study|Physician Decision|1|||
129934455|NCT03982186|467726736|FG002|Overall Study|Physician Decision|0|||
129934456|NCT03982186|467726737|FG003|Overall Study|Physician Decision|0|||
129934457|NCT03982186|467726738|FG004|Overall Study|Physician Decision|0|||
129934458|NCT03982186|467726739|FG005|Overall Study|Physician Decision|0|||
129452000|NCT01449461|465952120|FG003|Overall Study|Death|0|||
129452001|NCT01449461|465952121|FG004|Overall Study|Death|7|||
129452002|NCT01449461|465952122|FG005|Overall Study|Death|1|||
129452003|NCT01449461|465952117|FG000|Overall Study|Physician Decision|0|||
129934459|NCT03982186|467726734|FG000|Overall Study|Withdrawal by Subject|3|||
129934460|NCT03982186|467726735|FG001|Overall Study|Withdrawal by Subject|4|||
129934461|NCT03982186|467726736|FG002|Overall Study|Withdrawal by Subject|1|||
129934462|NCT03982186|467726737|FG003|Overall Study|Withdrawal by Subject|7|||
129934463|NCT03982186|467726738|FG004|Overall Study|Withdrawal by Subject|2|||
129934464|NCT03982186|467726739|FG005|Overall Study|Withdrawal by Subject|0|||
129934465|NCT03982186|467726734|FG000|Overall Study|Randomized and not treated|0|||
129934466|NCT03982186|467726735|FG001|Overall Study|Randomized and not treated|0|||
129934467|NCT03982186|467726736|FG002|Overall Study|Randomized and not treated|0|||
129934468|NCT03982186|467726737|FG003|Overall Study|Randomized and not treated|1|||
129934469|NCT03982186|467726738|FG004|Overall Study|Randomized and not treated|0|||
129452004|NCT01449461|465952118|FG001|Overall Study|Physician Decision|1|||
129934470|NCT03982186|467726739|FG005|Overall Study|Randomized and not treated|0|||
129934471|NCT05020353|467727234|FG000|Overall Study|Protocol Violation|7|||
129934472|NCT05020353|467727234|FG000|Overall Study|Withdrawal by Subject|33|||
129934473|NCT03417284|467727235|FG000|Overall Study|Inadequate supply on study drug|1|||
129934474|NCT03417284|467727236|FG001|Overall Study|Inadequate supply on study drug|0|||
129934475|NCT03417284|467727237|FG002|Overall Study|Inadequate supply on study drug|0|||
129934476|NCT03417284|467727238|FG003|Overall Study|Inadequate supply on study drug|0|||
129934477|NCT03417284|467727235|FG000|Overall Study|Disease Progression|0|||
129934478|NCT03417284|467727236|FG001|Overall Study|Disease Progression|0|||
129934479|NCT03417284|467727237|FG002|Overall Study|Disease Progression|1|||
129934480|NCT03417284|467727238|FG003|Overall Study|Disease Progression|0|||
129934481|NCT05132400|467727239|FG000|Overall Study|Withdrawal by Subject|14|||
129934482|NCT05132400|467727240|FG001|Overall Study|Withdrawal by Subject|8|||
129934483|NCT05132400|467727239|FG000|Overall Study|Lost to Follow-up|132|||
129934484|NCT05132400|467727240|FG001|Overall Study|Lost to Follow-up|121|||
129934485|NCT01880515|467727242|FG000|Overall Study|Lost to Follow-up|3|||
129934486|NCT01880515|467727243|FG001|Overall Study|Lost to Follow-up|2|||
129934487|NCT01880515|467727242|FG000|Overall Study|Disease Progression|5|||
129934488|NCT01880515|467727243|FG001|Overall Study|Disease Progression|7|||
129934489|NCT03333915|467727257|FG000|Overall Study|Lost to Follow-up|0|||
129934490|NCT03333915|467727258|FG001|Overall Study|Lost to Follow-up|0|||
129934491|NCT03333915|467727259|FG002|Overall Study|Lost to Follow-up|1|||
129934492|NCT03333915|467727260|FG003|Overall Study|Lost to Follow-up|0|||
129934493|NCT03333915|467727261|FG004|Overall Study|Lost to Follow-up|0|||
129934494|NCT03333915|467727257|FG000|Overall Study|Disease Progression|0|||
129934495|NCT03333915|467727258|FG001|Overall Study|Disease Progression|1|||
129934496|NCT03333915|467727259|FG002|Overall Study|Disease Progression|0|||
129934497|NCT03333915|467727260|FG003|Overall Study|Disease Progression|0|||
129934498|NCT03333915|467727261|FG004|Overall Study|Disease Progression|0|||
129934499|NCT03333915|467727257|FG000|Overall Study|Death|0|||
129934500|NCT03333915|467727258|FG001|Overall Study|Death|0|||
129934501|NCT03333915|467727259|FG002|Overall Study|Death|0|||
129934502|NCT03333915|467727260|FG003|Overall Study|Death|37|||
129934503|NCT03333915|467727261|FG004|Overall Study|Death|18|||
129934504|NCT03333915|467727257|FG000|Overall Study|Sponsor's Decision|0|||
129934505|NCT03333915|467727258|FG001|Overall Study|Sponsor's Decision|0|||
129934506|NCT03333915|467727259|FG002|Overall Study|Sponsor's Decision|0|||
129934507|NCT03333915|467727260|FG003|Overall Study|Sponsor's Decision|48|||
129934508|NCT03333915|467727261|FG004|Overall Study|Sponsor's Decision|4|||
129934509|NCT03333915|467727257|FG000|Overall Study|Withdrawal by Subject|0|||
129934510|NCT03333915|467727258|FG001|Overall Study|Withdrawal by Subject|0|||
129934511|NCT03333915|467727259|FG002|Overall Study|Withdrawal by Subject|0|||
129934512|NCT03333915|467727260|FG003|Overall Study|Withdrawal by Subject|5|||
129934513|NCT03333915|467727261|FG004|Overall Study|Withdrawal by Subject|1|||
129934514|NCT05785130|467727263|FG000|Overall Study|Withdrawal by Subject|1|||
129934515|NCT05785130|467727264|FG001|Overall Study|Withdrawal by Subject|0|||
129934516|NCT05785130|467727263|FG000|Overall Study|Lack of Efficacy|0|||
129934517|NCT05785130|467727264|FG001|Overall Study|Lack of Efficacy|1|||
129934518|NCT02532621|467727270|FG000|Overall Study|Death|3|||
129934519|NCT02532621|467727270|FG000|Overall Study|Lost to Follow-up|3|||
129934520|NCT02532621|467727270|FG000|Overall Study|Withdrawal by Subject|6|||
129934521|NCT02532621|467727270|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
129934522|NCT02532621|467727270|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
129934523|NCT03522298|467727271|FG000|Overall Study|Adverse Event|1|||
129934524|NCT03522298|467727272|FG001|Overall Study|Adverse Event|0|||
129934525|NCT03522298|467727273|FG002|Overall Study|Adverse Event|0|||
129934526|NCT03522298|467727274|FG003|Overall Study|Adverse Event|1|||
129934527|NCT03522298|467727271|FG000|Overall Study|Death|2|||
129934528|NCT03522298|467727272|FG001|Overall Study|Death|4|||
129934529|NCT03522298|467727273|FG002|Overall Study|Death|8|||
129934530|NCT03522298|467727274|FG003|Overall Study|Death|8|||
129934531|NCT03522298|467727271|FG000|Overall Study|Patient decision|0|||
129934532|NCT03522298|467727272|FG001|Overall Study|Patient decision|2|||
129934533|NCT03522298|467727273|FG002|Overall Study|Patient decision|2|||
129934534|NCT03522298|467727274|FG003|Overall Study|Patient decision|2|||
129934535|NCT04795245|467727277|FG000|Overall Study|Unkown reason|7|||
129934536|NCT04795245|467727277|FG000|Overall Study|Death|17|||
129934537|NCT04795245|467727277|FG000|Overall Study|Other than listed|19|||
129934538|NCT04795245|467727277|FG000|Overall Study|Adverse Event|143|||
129934539|NCT04795245|467727277|FG000|Overall Study|Progressive disease|512|||
129934540|NCT04795245|467727277|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
129934541|NCT01897441|467727278|FG000|Overall Study|Lost to Follow-up|0|||
129934542|NCT01897441|467727279|FG001|Overall Study|Lost to Follow-up|0|||
129934543|NCT01897441|467727280|FG002|Overall Study|Lost to Follow-up|1|||
129934544|NCT01897441|467727281|FG003|Overall Study|Lost to Follow-up|0|||
129934545|NCT01897441|467727282|FG004|Overall Study|Lost to Follow-up|0|||
129934546|NCT01897441|467727283|FG005|Overall Study|Lost to Follow-up|0|||
129934547|NCT01897441|467727278|FG000|Overall Study|Withdrawal by Subject|0|||
129934548|NCT01897441|467727279|FG001|Overall Study|Withdrawal by Subject|0|||
129934549|NCT01897441|467727280|FG002|Overall Study|Withdrawal by Subject|0|||
129934550|NCT01897441|467727281|FG003|Overall Study|Withdrawal by Subject|0|||
129934551|NCT01897441|467727282|FG004|Overall Study|Withdrawal by Subject|1|||
129934552|NCT01897441|467727283|FG005|Overall Study|Withdrawal by Subject|0|||
129934553|NCT01897441|467727278|FG000|Overall Study|Withdrawn by Provider|0|||
129934554|NCT01897441|467727279|FG001|Overall Study|Withdrawn by Provider|2|||
129934555|NCT01897441|467727280|FG002|Overall Study|Withdrawn by Provider|0|||
129934556|NCT01897441|467727281|FG003|Overall Study|Withdrawn by Provider|0|||
129934557|NCT01897441|467727282|FG004|Overall Study|Withdrawn by Provider|0|||
129934558|NCT01897441|467727283|FG005|Overall Study|Withdrawn by Provider|0|||
129934559|NCT02806726|467727289|FG000|Overall Study|Lost to Follow-up|1|||
129934560|NCT04281498|467727290|FG000|Overall Study|Progression of disease|1|||
129934561|NCT04281498|467727290|FG000|Overall Study|Planned SCT|1|||
129934562|NCT04281498|467727290|FG000|Overall Study|Alternative Treatment|1|||
129934563|NCT01527188|467727293|FG000|Overall Study|Adverse Event|5|||
129934564|NCT01527188|467727294|FG001|Overall Study|Adverse Event|5|||
129934565|NCT01527188|467727295|FG002|Overall Study|Adverse Event|11|||
129934566|NCT01527188|467727296|FG003|Overall Study|Adverse Event|0|||
129934567|NCT01527188|467727293|FG000|Overall Study|Withdrawal by Subject|3|||
129934568|NCT01527188|467727294|FG001|Overall Study|Withdrawal by Subject|6|||
129934569|NCT01527188|467727295|FG002|Overall Study|Withdrawal by Subject|4|||
129934570|NCT01527188|467727296|FG003|Overall Study|Withdrawal by Subject|4|||
129934571|NCT01527188|467727293|FG000|Overall Study|Any other reason not above-mentioned|6|||
129934572|NCT01527188|467727294|FG001|Overall Study|Any other reason not above-mentioned|7|||
129934573|NCT01527188|467727295|FG002|Overall Study|Any other reason not above-mentioned|8|||
129934574|NCT01527188|467727296|FG003|Overall Study|Any other reason not above-mentioned|8|||
129934575|NCT04626427|467727297|FG000|Overall Study|Death|1|||
129934576|NCT04626427|467727297|FG000|Overall Study|Withdrawal by Subject|1|||
129934577|NCT04626427|467727297|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
129934578|NCT04626427|467727297|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
129934579|NCT01265537|467727298|FG000|Overall Study|Adverse Event|2|||
129934580|NCT01265537|467727299|FG001|Overall Study|Adverse Event|1|||
129934581|NCT01265537|467727298|FG000|Overall Study|Physician Decision|0|||
129934582|NCT01265537|467727299|FG001|Overall Study|Physician Decision|1|||
129934583|NCT05866926|467727300|FG000|Overall Study|Death|16|||
129934584|NCT05866926|467727301|FG001|Overall Study|Death|9|||
129934585|NCT05866926|467727300|FG000|Overall Study|Lost to Follow-up|0|||
129934586|NCT05866926|467727301|FG001|Overall Study|Lost to Follow-up|1|||
129934587|NCT05866926|467727300|FG000|Overall Study|Adverse Event|1|||
129934588|NCT05866926|467727301|FG001|Overall Study|Adverse Event|0|||
129934589|NCT05866926|467727300|FG000|Overall Study|Withdrawal by Subject|5|||
129934590|NCT05866926|467727301|FG001|Overall Study|Withdrawal by Subject|1|||
129934591|NCT05866926|467727300|FG000|Overall Study|Disease progression|1|||
129934592|NCT05866926|467727301|FG001|Overall Study|Disease progression|0|||
129934593|NCT05866926|467727300|FG000|Overall Study|other causes|2|||
129934594|NCT05866926|467727301|FG001|Overall Study|other causes|1|||
129934595|NCT03635567|467727670|FG000|Overall Study|Lost to Follow-up|4|||
129934596|NCT03635567|467727671|FG001|Overall Study|Lost to Follow-up|1|||
129934597|NCT03635567|467727670|FG000|Overall Study|Withdrawal by Subject|11|||
129934598|NCT03635567|467727671|FG001|Overall Study|Withdrawal by Subject|16|||
129934599|NCT03635567|467727670|FG000|Overall Study|Sponsor Decision|99|||
129934600|NCT03635567|467727671|FG001|Overall Study|Sponsor Decision|57|||
129934601|NCT03635567|467727670|FG000|Overall Study|Death|194|||
129934602|NCT03635567|467727671|FG001|Overall Study|Death|235|||
129934603|NCT00942734|467727681|FG000|Overall Study|Adverse Event|2|||
129934604|NCT00942734|467727681|FG000|Overall Study|Protocol Violation|3|||
129934605|NCT00942734|467727681|FG000|Overall Study|Disease Progression|2|||
129934606|NCT00942734|467727681|FG000|Overall Study|Physician Decision|1|||
129934607|NCT03816397|467727682|FG000|Overall Study|Censored at interim analysis date.|13|||
129934608|NCT03816397|467727683|FG001|Overall Study|Censored at interim analysis date.|6|||
129934609|NCT03816397|467727682|FG000|Overall Study|Withdrawal by Subject|1|||
129934610|NCT03816397|467727683|FG001|Overall Study|Withdrawal by Subject|1|||
129934611|NCT05985395|467727684|FG000|Overall Study|Physician Decision|2|||
129934612|NCT05985395|467727685|FG001|Overall Study|Physician Decision|1|||
129934613|NCT05985395|467727684|FG000|Overall Study|Withdrawal by Subject|1|||
129934614|NCT05985395|467727685|FG001|Overall Study|Withdrawal by Subject|0|||
129934615|NCT02777593|467727697|FG000|Overall Study|Still in study|1|||
129934616|NCT02777593|467727698|FG001|Overall Study|Still in study|32|||
129934617|NCT02777593|467727699|FG002|Overall Study|Still in study|3|||
129934618|NCT02777593|467727700|FG003|Overall Study|Still in study|6|||
129934619|NCT02777593|467727701|FG004|Overall Study|Still in study|5|||
129934620|NCT02777593|467727697|FG000|Overall Study|Death|21|||
129452005|NCT01449461|465952119|FG002|Overall Study|Physician Decision|0|||
129452006|NCT01449461|465952120|FG003|Overall Study|Physician Decision|4|||
129452007|NCT01449461|465952121|FG004|Overall Study|Physician Decision|1|||
129452008|NCT01449461|465952122|FG005|Overall Study|Physician Decision|0|||
129452009|NCT01449461|465952117|FG000|Overall Study|Documented Progressive Disease|4|||
129452010|NCT01449461|465952118|FG001|Overall Study|Documented Progressive Disease|7|||
129452011|NCT01449461|465952119|FG002|Overall Study|Documented Progressive Disease|14|||
129452012|NCT01449461|465952120|FG003|Overall Study|Documented Progressive Disease|15|||
129452013|NCT01449461|465952121|FG004|Overall Study|Documented Progressive Disease|24|||
129452014|NCT01449461|465952122|FG005|Overall Study|Documented Progressive Disease|5|||
129452015|NCT01449461|465952117|FG000|Overall Study|Clinical Progressive Disease|2|||
129452016|NCT01449461|465952118|FG001|Overall Study|Clinical Progressive Disease|2|||
129452017|NCT01449461|465952119|FG002|Overall Study|Clinical Progressive Disease|0|||
129452018|NCT01449461|465952120|FG003|Overall Study|Clinical Progressive Disease|3|||
129452019|NCT01449461|465952121|FG004|Overall Study|Clinical Progressive Disease|4|||
129452020|NCT01449461|465952122|FG005|Overall Study|Clinical Progressive Disease|2|||
129452021|NCT01449461|465952117|FG000|Overall Study|Protocol Violation|0|||
129452022|NCT01449461|465952118|FG001|Overall Study|Protocol Violation|0|||
129452023|NCT01449461|465952119|FG002|Overall Study|Protocol Violation|0|||
129452024|NCT01449461|465952120|FG003|Overall Study|Protocol Violation|1|||
129452025|NCT01449461|465952121|FG004|Overall Study|Protocol Violation|0|||
129452026|NCT01449461|465952122|FG005|Overall Study|Protocol Violation|0|||
129452027|NCT01449461|465952117|FG000|Overall Study|Site Terminated by Sponsor|0|||
129452028|NCT01449461|465952118|FG001|Overall Study|Site Terminated by Sponsor|1|||
129452029|NCT01449461|465952119|FG002|Overall Study|Site Terminated by Sponsor|2|||
129452030|NCT01449461|465952120|FG003|Overall Study|Site Terminated by Sponsor|3|||
129452031|NCT01449461|465952121|FG004|Overall Study|Site Terminated by Sponsor|4|||
129452032|NCT01449461|465952122|FG005|Overall Study|Site Terminated by Sponsor|1|||
129452033|NCT01449461|465952117|FG000|Overall Study|Withdrawal by Subject|0|||
129452034|NCT01449461|465952118|FG001|Overall Study|Withdrawal by Subject|1|||
129452035|NCT01449461|465952119|FG002|Overall Study|Withdrawal by Subject|0|||
129452036|NCT01449461|465952120|FG003|Overall Study|Withdrawal by Subject|0|||
129452037|NCT01449461|465952121|FG004|Overall Study|Withdrawal by Subject|2|||
129452038|NCT01449461|465952122|FG005|Overall Study|Withdrawal by Subject|1|||
129452039|NCT01449461|465952117|FG000|Overall Study|Reason not Specified|0|||
129452040|NCT01449461|465952118|FG001|Overall Study|Reason not Specified|1|||
129452041|NCT01449461|465952119|FG002|Overall Study|Reason not Specified|0|||
129452042|NCT01449461|465952120|FG003|Overall Study|Reason not Specified|3|||
129452043|NCT01449461|465952121|FG004|Overall Study|Reason not Specified|2|||
129452044|NCT01449461|465952122|FG005|Overall Study|Reason not Specified|1|||
129452045|NCT01357577|465952123|FG000|Overall Study|Lost to Follow-up|20|||
129452046|NCT01357577|465952124|FG001|Overall Study|Lost to Follow-up|16|||
129452047|NCT01357577|465952123|FG000|Overall Study|Withdrawal by Subject|16|||
129452048|NCT01357577|465952124|FG001|Overall Study|Withdrawal by Subject|8|||
129452049|NCT01357577|465952123|FG000|Overall Study|look at data in database?|1|||
129452050|NCT01357577|465952124|FG001|Overall Study|look at data in database?|2|||
129452051|NCT03977974|465952125|FG000|Period 2|Adverse Event|0|||
129452052|NCT03977974|465952126|FG001|Period 2|Adverse Event|0|||
129452053|NCT03977974|465952127|FG002|Period 2|Adverse Event|0|||
129452054|NCT03977974|465952128|FG003|Period 2|Adverse Event|0|||
129452055|NCT03977974|465952129|FG004|Period 2|Adverse Event|1|||
129452056|NCT03977974|465952130|FG005|Period 2|Adverse Event|0|||
129452057|NCT03977974|465952131|FG006|Period 2|Adverse Event|0|||
129452058|NCT03977974|465952132|FG007|Period 2|Adverse Event|0|||
129452059|NCT03977974|465952133|FG008|Period 2|Adverse Event|0|||
129452060|NCT03977974|465952134|FG009|Period 2|Adverse Event|0|||
129452061|NCT03977974|465952135|FG010|Period 2|Adverse Event|0|||
129452062|NCT03977974|465952136|FG011|Period 2|Adverse Event|0|||
129452063|NCT03977974|465952137|FG012|Period 2|Adverse Event|0|||
129452064|NCT02322125|465953279|FG000|Overall Study|Withdrawal by Subject|2|||
129452065|NCT00449670|465953281|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
129452066|NCT00449670|465953282|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
129452067|NCT00449670|465953281|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
129452068|NCT00449670|465953282|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
129452069|NCT00449670|465953281|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
129452070|NCT00449670|465953282|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
129452071|NCT00449670|465953281|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
129452072|NCT00449670|465953282|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
129452073|NCT00449670|465953281|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
129452074|NCT00449670|465953282|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
129452075|NCT00449670|465953281|FG000|Booster Phase (Study no.109873)|Other|0|||
129452076|NCT00449670|465953282|FG001|Booster Phase (Study no.109873)|Other|2|||
129452077|NCT04183790|465953283|FG000|Overall Study|Participants did not rollover to Part B|12|||
129452078|NCT04183790|465953284|FG001|Overall Study|Participants did not rollover to Part B|0|||
129452079|NCT04183790|465953283|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
129934621|NCT02777593|467727698|FG001|Overall Study|Death|28|||
129934622|NCT02777593|467727699|FG002|Overall Study|Death|0|||
129934623|NCT02777593|467727700|FG003|Overall Study|Death|5|||
129934624|NCT02777593|467727701|FG004|Overall Study|Death|0|||
129934625|NCT02777593|467727697|FG000|Overall Study|Withdrawal by Subject|8|||
129934626|NCT02777593|467727698|FG001|Overall Study|Withdrawal by Subject|4|||
129934627|NCT02777593|467727699|FG002|Overall Study|Withdrawal by Subject|1|||
129934628|NCT02777593|467727700|FG003|Overall Study|Withdrawal by Subject|1|||
129934629|NCT02777593|467727701|FG004|Overall Study|Withdrawal by Subject|0|||
129934630|NCT02777593|467727697|FG000|Overall Study|Lost to Follow-up|8|||
129934631|NCT02777593|467727698|FG001|Overall Study|Lost to Follow-up|16|||
129934632|NCT02777593|467727699|FG002|Overall Study|Lost to Follow-up|5|||
129934633|NCT02777593|467727700|FG003|Overall Study|Lost to Follow-up|0|||
129934634|NCT02777593|467727701|FG004|Overall Study|Lost to Follow-up|1|||
129934635|NCT02777593|467727697|FG000|Overall Study|Physician Decision|2|||
129934636|NCT02777593|467727698|FG001|Overall Study|Physician Decision|2|||
129934637|NCT02777593|467727699|FG002|Overall Study|Physician Decision|0|||
129934638|NCT02777593|467727700|FG003|Overall Study|Physician Decision|0|||
129934639|NCT02777593|467727701|FG004|Overall Study|Physician Decision|0|||
129934640|NCT02777593|467727697|FG000|Overall Study|Discontinued due to Other|1|||
129934641|NCT02777593|467727698|FG001|Overall Study|Discontinued due to Other|0|||
129934642|NCT02777593|467727699|FG002|Overall Study|Discontinued due to Other|0|||
129934643|NCT02777593|467727700|FG003|Overall Study|Discontinued due to Other|0|||
129934644|NCT02777593|467727701|FG004|Overall Study|Discontinued due to Other|0|||
129934645|NCT05485935|467727702|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
129934646|NCT05485935|467727703|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
129934647|NCT05485935|467727702|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
129934648|NCT05485935|467727703|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
129934649|NCT05485935|467727702|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
129934650|NCT05485935|467727703|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
129934651|NCT05485935|467727702|FG000|Period 2 (T2 and V3)|loss of contact|0|||
129934652|NCT05485935|467727703|FG001|Period 2 (T2 and V3)|loss of contact|1|||
129934653|NCT05129501|467727707|FG000|Overall Study|Lost to Follow-up|54|||
129934654|NCT05129501|467727708|FG001|Overall Study|Lost to Follow-up|41|||
129934655|NCT02325154|467727709|FG000|Overall Study|Physician Decision|1|||
129934656|NCT03782116|467727710|FG000|Completed Intervetion|Lost to Follow-up|11|||
129934657|NCT03782116|467727711|FG001|Completed Intervetion|Lost to Follow-up|7|||
129934658|NCT03782116|467727710|FG000|Completed Intervetion|Withdrawal by Subject|6|||
129934659|NCT03782116|467727711|FG001|Completed Intervetion|Withdrawal by Subject|5|||
129934660|NCT03782116|467727710|FG000|Included in Analysis|Protocol Violation|5|||
129934661|NCT03782116|467727711|FG001|Included in Analysis|Protocol Violation|5|||
129934662|NCT02611687|467728241|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
129934663|NCT02611687|467728242|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
129934664|NCT00447980|467728246|FG000|Overall Study|Withdrawal by Subject|1|||
129934665|NCT00447980|467728247|FG001|Overall Study|Withdrawal by Subject|1|||
129934666|NCT00447980|467728248|FG002|Overall Study|Withdrawal by Subject|4|||
129934667|NCT00447980|467728249|FG003|Overall Study|Withdrawal by Subject|4|||
129934668|NCT00447980|467728246|FG000|Overall Study|Lost to Follow-up|1|||
129934669|NCT00447980|467728247|FG001|Overall Study|Lost to Follow-up|1|||
129934670|NCT00447980|467728248|FG002|Overall Study|Lost to Follow-up|0|||
129934671|NCT00447980|467728249|FG003|Overall Study|Lost to Follow-up|0|||
129934672|NCT00447980|467728246|FG000|Overall Study|Did not proceed with surgery|3|||
129934673|NCT00447980|467728247|FG001|Overall Study|Did not proceed with surgery|3|||
129934674|NCT00447980|467728248|FG002|Overall Study|Did not proceed with surgery|2|||
129934675|NCT00447980|467728249|FG003|Overall Study|Did not proceed with surgery|2|||
129934676|NCT05157841|467728250|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
129934677|NCT05157841|467728251|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
129934678|NCT05157841|467728252|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
129934679|NCT05157841|467728250|FG000|Part A (14 Days)|Adverse Event|1|||
129934680|NCT05157841|467728251|FG001|Part A (14 Days)|Adverse Event|0|||
129934681|NCT05157841|467728252|FG002|Part A (14 Days)|Adverse Event|0|||
129934682|NCT05157841|467728250|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
129934683|NCT05157841|467728251|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
129934684|NCT05157841|467728252|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
129934685|NCT02076009|467728253|FG000|Overall Study|Death|172|||
129934686|NCT02076009|467728254|FG001|Overall Study|Death|153|||
129934687|NCT02076009|467728253|FG000|Overall Study|Withdrawal by Subject|16|||
129934688|NCT02076009|467728254|FG001|Overall Study|Withdrawal by Subject|12|||
129934689|NCT02076009|467728253|FG000|Overall Study|Lost to Follow-up|4|||
129934690|NCT02076009|467728254|FG001|Overall Study|Lost to Follow-up|2|||
129934691|NCT02076009|467728253|FG000|Overall Study|Progressive Disease|1|||
129934692|NCT02076009|467728254|FG001|Overall Study|Progressive Disease|0|||
129934693|NCT02076009|467728253|FG000|Overall Study|Physician Decision|0|||
129934694|NCT02076009|467728254|FG001|Overall Study|Physician Decision|1|||
129934695|NCT02076009|467728253|FG000|Overall Study|End of data collection|90|||
129934696|NCT02076009|467728254|FG001|Overall Study|End of data collection|118|||
129934697|NCT04165213|467728255|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
129934698|NCT04165213|467728256|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
129934699|NCT04165213|467728255|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
129934700|NCT04165213|467728256|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
129934701|NCT04165213|467728255|FG000|Clinician Enrollment|Termination from site|0|||
129934702|NCT04165213|467728256|FG001|Clinician Enrollment|Termination from site|1|||
129934703|NCT04165213|467728255|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
129934704|NCT04165213|467728256|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
129934705|NCT04165213|467728255|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
129934706|NCT04165213|467728256|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
129934707|NCT04165213|467728255|FG000|Caregiver Enrollment|Physician Decision|1|||
129934708|NCT04165213|467728256|FG001|Caregiver Enrollment|Physician Decision|0|||
129934709|NCT04165213|467728255|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
129934710|NCT04165213|467728256|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
129934711|NCT04165213|467728255|FG000|Caregiver Enrollment|PLWD death|2|||
129934712|NCT04165213|467728256|FG001|Caregiver Enrollment|PLWD death|0|||
129934713|NCT04165213|467728255|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
129934714|NCT04165213|467728256|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
129934715|NCT04165213|467728255|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
129934716|NCT04165213|467728256|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
129934717|NCT04165213|467728255|FG000|PLWD Enrollment|Lost to Follow-up|1|||
129934718|NCT04165213|467728256|FG001|PLWD Enrollment|Lost to Follow-up|1|||
129934719|NCT04165213|467728255|FG000|PLWD Enrollment|Physician Decision|1|||
129934720|NCT04165213|467728256|FG001|PLWD Enrollment|Physician Decision|0|||
129934721|NCT04165213|467728255|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
129934722|NCT04165213|467728256|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
129934723|NCT04165213|467728255|FG000|PLWD Enrollment|Death|2|||
129934724|NCT04165213|467728256|FG001|PLWD Enrollment|Death|0|||
129934725|NCT04165213|467728255|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
129934726|NCT04165213|467728256|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
129934727|NCT04933474|467728257|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
129934728|NCT04933474|467728258|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
129934729|NCT04933474|467728257|FG000|Overall Study|Lost to Follow-up|19|||
129934730|NCT04933474|467728258|FG001|Overall Study|Lost to Follow-up|9|||
129934731|NCT04933474|467728257|FG000|Overall Study|Life Burden - unable to participate|6|||
129934732|NCT04933474|467728258|FG001|Overall Study|Life Burden - unable to participate|2|||
129934733|NCT04933474|467728257|FG000|Overall Study|Disease Burden - unable to participate|4|||
129934734|NCT04933474|467728258|FG001|Overall Study|Disease Burden - unable to participate|1|||
129934735|NCT04933474|467728257|FG000|Overall Study|Surgery/Hospitalization|1|||
129934736|NCT04933474|467728258|FG001|Overall Study|Surgery/Hospitalization|2|||
129934737|NCT04933474|467728257|FG000|Overall Study|Dissatisfied with Intervention|1|||
129934738|NCT04933474|467728258|FG001|Overall Study|Dissatisfied with Intervention|1|||
129934739|NCT04933474|467728257|FG000|Overall Study|Withdrew interest in participation|1|||
129934740|NCT04933474|467728258|FG001|Overall Study|Withdrew interest in participation|0|||
129934741|NCT04933474|467728257|FG000|Overall Study|Had previously enrolled in the study|0|||
129934742|NCT04933474|467728258|FG001|Overall Study|Had previously enrolled in the study|1|||
129934743|NCT05988398|467728265|FG000|Overall Study|Lack of time|21|||
129934744|NCT05988398|467728266|FG001|Overall Study|Lack of time|0|||
129934745|NCT05988398|467728265|FG000|Overall Study|Absent from school|0|||
129934746|NCT05988398|467728266|FG001|Overall Study|Absent from school|38|||
129934747|NCT05988398|467728265|FG000|Overall Study|Chose not to participate|0|||
129934748|NCT05988398|467728266|FG001|Overall Study|Chose not to participate|42|||
129934749|NCT05988398|467728265|FG000|Overall Study|Other commitments (e.g., sports)|0|||
129934750|NCT05988398|467728266|FG001|Overall Study|Other commitments (e.g., sports)|25|||
129934751|NCT05718687|467728278|FG000|Overall Study|Withdrawal by Subject|3|||
129934752|NCT01220531|467728281|FG000|Overall Study|Death|7|||
129934753|NCT01220531|467728281|FG000|Overall Study|Lost to Follow-up|1|||
129934754|NCT00709956|467728282|FG000|Overall Study|Withdrawal by Subject|1|||
129934755|NCT00709956|467728283|FG001|Overall Study|Withdrawal by Subject|1|||
129934756|NCT00709956|467728282|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
129934757|NCT00709956|467728283|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
129934758|NCT03512301|467728904|FG000|Overall Study|Protocol Violation|2|||
129934759|NCT03512301|467728904|FG000|Overall Study|Did Not Qualify|3|||
129934760|NCT03512301|467728904|FG000|Overall Study|Age-ineligible|1|||
129934761|NCT03512301|467728904|FG000|Overall Study|Inadequate fluency with the English language|3|||
129934762|NCT03983382|467728905|FG000|Overall Study|Death|1|||
129934763|NCT03983382|467728905|FG000|Overall Study|Lost to Follow-up|3|||
129934764|NCT03983382|467728905|FG000|Overall Study|Physician Decision|2|||
129934765|NCT03983382|467728905|FG000|Overall Study|Withdrawal by Subject|10|||
129934766|NCT03983382|467728905|FG000|Overall Study|Change in cancer treatment|2|||
129934767|NCT04174170|467728906|FG000|Placebo Run-in Period|Not Randomized|38|||
129934768|NCT04174170|467728907|FG001|Placebo Run-in Period|Not Randomized|0|||
129934769|NCT04174170|467728908|FG002|Placebo Run-in Period|Not Randomized|0|||
129934770|NCT04174170|467728909|FG003|Placebo Run-in Period|Not Randomized|0|||
129934771|NCT04174170|467728906|FG000|Double Blind Treatment Period|Adverse Event|0|||
129934772|NCT04174170|467728907|FG001|Double Blind Treatment Period|Adverse Event|9|||
129934773|NCT04174170|467728908|FG002|Double Blind Treatment Period|Adverse Event|9|||
129934774|NCT04174170|467728909|FG003|Double Blind Treatment Period|Adverse Event|8|||
129934775|NCT04174170|467728906|FG000|Double Blind Treatment Period|Death|0|||
129934776|NCT04174170|467728907|FG001|Double Blind Treatment Period|Death|1|||
129934777|NCT04174170|467728908|FG002|Double Blind Treatment Period|Death|0|||
129934778|NCT04174170|467728909|FG003|Double Blind Treatment Period|Death|0|||
129934779|NCT04174170|467728906|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
129934780|NCT04174170|467728907|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
129934781|NCT04174170|467728908|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
129934782|NCT04174170|467728909|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
129934783|NCT04174170|467728906|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
129934784|NCT04174170|467728907|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
129934785|NCT04174170|467728908|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
129934786|NCT04174170|467728909|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
129934787|NCT04174170|467728906|FG000|Double Blind Treatment Period|Physician Decision|0|||
129934788|NCT04174170|467728907|FG001|Double Blind Treatment Period|Physician Decision|1|||
129934789|NCT04174170|467728908|FG002|Double Blind Treatment Period|Physician Decision|0|||
129934790|NCT04174170|467728909|FG003|Double Blind Treatment Period|Physician Decision|1|||
129934791|NCT04174170|467728906|FG000|Double Blind Treatment Period|Pregnancy|0|||
129934792|NCT04174170|467728907|FG001|Double Blind Treatment Period|Pregnancy|1|||
129934793|NCT04174170|467728908|FG002|Double Blind Treatment Period|Pregnancy|0|||
129934794|NCT04174170|467728909|FG003|Double Blind Treatment Period|Pregnancy|1|||
129934795|NCT04174170|467728906|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
129934796|NCT04174170|467728907|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
129934797|NCT04174170|467728908|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
129934798|NCT04174170|467728909|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
129934799|NCT04174170|467728906|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
129934800|NCT04174170|467728907|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
129934801|NCT04174170|467728908|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
129934802|NCT04174170|467728909|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
129934803|NCT04174170|467728906|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
129934804|NCT04174170|467728907|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
129934805|NCT04174170|467728908|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
129934806|NCT04174170|467728909|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
129934807|NCT04772534|467728917|FG000|Overall Study|Physician Decision|1|||
129934808|NCT04772534|467728918|FG001|Overall Study|Physician Decision|0|||
129934809|NCT04772534|467728919|FG002|Overall Study|Physician Decision|0|||
129934810|NCT04772534|467728917|FG000|Overall Study|Withdrawal by Subject|3|||
129934811|NCT04772534|467728918|FG001|Overall Study|Withdrawal by Subject|0|||
129934812|NCT04772534|467728919|FG002|Overall Study|Withdrawal by Subject|1|||
129934813|NCT03242915|467728926|FG000|Overall Study|Adverse Event|5|||
129934814|NCT03242915|467728927|FG001|Overall Study|Adverse Event|1|||
129934815|NCT03242915|467728926|FG000|Overall Study|Withdrawal by Subject|0|||
129934816|NCT03242915|467728927|FG001|Overall Study|Withdrawal by Subject|2|||
129934817|NCT03242915|467728926|FG000|Overall Study|Physician Decision|4|||
129934818|NCT03242915|467728927|FG001|Overall Study|Physician Decision|1|||
129934819|NCT04908930|467728936|FG000|Overall Study|Lost to Follow-up|1|||
129934820|NCT04908930|467728937|FG001|Overall Study|Lost to Follow-up|1|||
129934821|NCT04908930|467728938|FG002|Overall Study|Lost to Follow-up|0|||
129934822|NCT04908930|467728939|FG003|Overall Study|Lost to Follow-up|0|||
129934823|NCT04908930|467728940|FG004|Overall Study|Lost to Follow-up|0|||
129934824|NCT04908930|467728936|FG000|Overall Study|hardware in mouth|1|||
129934825|NCT04908930|467728937|FG001|Overall Study|hardware in mouth|1|||
129934826|NCT04908930|467728938|FG002|Overall Study|hardware in mouth|0|||
129934827|NCT04908930|467728939|FG003|Overall Study|hardware in mouth|0|||
129934828|NCT04908930|467728940|FG004|Overall Study|hardware in mouth|0|||
129934829|NCT04908930|467728936|FG000|Overall Study|wrong team|1|||
129934830|NCT04908930|467728937|FG001|Overall Study|wrong team|0|||
129934831|NCT04908930|467728938|FG002|Overall Study|wrong team|0|||
129934832|NCT04908930|467728939|FG003|Overall Study|wrong team|0|||
129934833|NCT04908930|467728940|FG004|Overall Study|wrong team|0|||
129934834|NCT04908930|467728936|FG000|Overall Study|quit team|2|||
129934835|NCT04908930|467728937|FG001|Overall Study|quit team|4|||
129934836|NCT04908930|467728938|FG002|Overall Study|quit team|0|||
129934837|NCT04908930|467728939|FG003|Overall Study|quit team|0|||
129934838|NCT04908930|467728940|FG004|Overall Study|quit team|0|||
129934839|NCT04908930|467728936|FG000|Overall Study|Withdrawal by Subject|1|||
129934840|NCT04908930|467728937|FG001|Overall Study|Withdrawal by Subject|2|||
129934841|NCT04908930|467728938|FG002|Overall Study|Withdrawal by Subject|0|||
129934842|NCT04908930|467728939|FG003|Overall Study|Withdrawal by Subject|0|||
129934843|NCT04908930|467728940|FG004|Overall Study|Withdrawal by Subject|0|||
129934844|NCT04908930|467728936|FG000|Overall Study|parent not liking program|0|||
129934845|NCT04908930|467728937|FG001|Overall Study|parent not liking program|1|||
129934846|NCT04908930|467728938|FG002|Overall Study|parent not liking program|0|||
129934847|NCT04908930|467728939|FG003|Overall Study|parent not liking program|0|||
129934848|NCT04908930|467728940|FG004|Overall Study|parent not liking program|0|||
129934849|NCT01499368|467728941|FG000|Overall Study|Did not meet I/E criteria|8|||
129934850|NCT01499368|467728942|FG001|Overall Study|Did not meet I/E criteria|4|||
129934851|NCT01499368|467728943|FG002|Overall Study|Did not meet I/E criteria|4|||
129934852|NCT01499368|467728941|FG000|Overall Study|Prohibited Concomitant medication|1|||
129934853|NCT01499368|467728942|FG001|Overall Study|Prohibited Concomitant medication|1|||
129934854|NCT01499368|467728943|FG002|Overall Study|Prohibited Concomitant medication|0|||
129934855|NCT01499368|467728941|FG000|Overall Study|Withdrawal by Subject|11|||
129934856|NCT01499368|467728942|FG001|Overall Study|Withdrawal by Subject|10|||
129934857|NCT01499368|467728943|FG002|Overall Study|Withdrawal by Subject|8|||
129934858|NCT01499368|467728941|FG000|Overall Study|Lost to Follow-up|3|||
129934859|NCT01499368|467728942|FG001|Overall Study|Lost to Follow-up|2|||
129934860|NCT01499368|467728943|FG002|Overall Study|Lost to Follow-up|5|||
129934861|NCT01499368|467728941|FG000|Overall Study|Adverse Event|4|||
129934862|NCT01499368|467728942|FG001|Overall Study|Adverse Event|0|||
129934863|NCT01499368|467728943|FG002|Overall Study|Adverse Event|2|||
129934864|NCT01499368|467728941|FG000|Overall Study|Physician Decision|0|||
129934865|NCT01499368|467728942|FG001|Overall Study|Physician Decision|1|||
129934866|NCT01499368|467728943|FG002|Overall Study|Physician Decision|0|||
129934867|NCT01499368|467728941|FG000|Overall Study|Deviation from visit window|0|||
129934868|NCT01499368|467728942|FG001|Overall Study|Deviation from visit window|0|||
129934869|NCT01499368|467728943|FG002|Overall Study|Deviation from visit window|1|||
129934870|NCT01499368|467728941|FG000|Overall Study|Error of Prescriptions|0|||
129934871|NCT01499368|467728942|FG001|Overall Study|Error of Prescriptions|0|||
129934872|NCT01499368|467728943|FG002|Overall Study|Error of Prescriptions|1|||
129934873|NCT03092674|467728944|FG000|Overall Study|Adverse Event or Side Effects|1|||
129934874|NCT03092674|467728945|FG001|Overall Study|Adverse Event or Side Effects|4|||
129934875|NCT03092674|467728946|FG002|Overall Study|Adverse Event or Side Effects|4|||
129934876|NCT03092674|467728944|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
129934877|NCT03092674|467728945|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
129934878|NCT03092674|467728946|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
129934879|NCT03092674|467728944|FG000|Overall Study|Progression/Relapse|5|||
129934880|NCT03092674|467728945|FG001|Overall Study|Progression/Relapse|4|||
129934881|NCT03092674|467728946|FG002|Overall Study|Progression/Relapse|8|||
129934882|NCT03092674|467728944|FG000|Overall Study|Death|4|||
129934883|NCT03092674|467728945|FG001|Overall Study|Death|8|||
129934884|NCT03092674|467728946|FG002|Overall Study|Death|2|||
129934885|NCT03092674|467728944|FG000|Overall Study|Other - Not Protocol Specified|11|||
129934886|NCT03092674|467728945|FG001|Overall Study|Other - Not Protocol Specified|8|||
129934887|NCT03092674|467728946|FG002|Overall Study|Other - Not Protocol Specified|8|||
129934888|NCT05771467|467728948|FG000|Overall Study|Lost to Follow-up|6|||
129934889|NCT05771467|467728949|FG001|Overall Study|Lost to Follow-up|3|||
129934890|NCT01553149|467728952|FG000|Overall Study|Adverse Event|0|||
129934891|NCT01553149|467728953|FG001|Overall Study|Adverse Event|9|||
129934892|NCT01553149|467728952|FG000|Overall Study|Physician Decision|5|||
129934893|NCT01553149|467728953|FG001|Overall Study|Physician Decision|10|||
129934894|NCT01553149|467728952|FG000|Overall Study|Ineligible|0|||
129934895|NCT01553149|467728953|FG001|Overall Study|Ineligible|1|||
129934896|NCT01105091|467728955|FG000|Overall Study|Death|2|||
129934897|NCT01105091|467728956|FG001|Overall Study|Death|0|||
129934898|NCT03008382|467728957|FG000|Overall Study|Withdrawal by Subject|2|||
129934899|NCT03008382|467728958|FG001|Overall Study|Withdrawal by Subject|5|||
129934900|NCT03008382|467728959|FG002|Overall Study|Withdrawal by Subject|2|||
129934901|NCT03008382|467728960|FG003|Overall Study|Withdrawal by Subject|0|||
129934902|NCT03008382|467728957|FG000|Overall Study|Protocol Violation|1|||
129934903|NCT03008382|467728958|FG001|Overall Study|Protocol Violation|0|||
129934904|NCT03008382|467728959|FG002|Overall Study|Protocol Violation|0|||
129934905|NCT03008382|467728960|FG003|Overall Study|Protocol Violation|0|||
129934906|NCT03008382|467728957|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
129934907|NCT03008382|467728958|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
129934908|NCT03008382|467728959|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
129934909|NCT03008382|467728960|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
129934910|NCT03008382|467728957|FG000|Overall Study|Lost to Follow-up|0|||
129934911|NCT03008382|467728958|FG001|Overall Study|Lost to Follow-up|0|||
129934912|NCT03008382|467728959|FG002|Overall Study|Lost to Follow-up|1|||
129934913|NCT03008382|467728960|FG003|Overall Study|Lost to Follow-up|0|||
129934914|NCT03008382|467728957|FG000|Overall Study|Screenfail|0|||
129934915|NCT03008382|467728958|FG001|Overall Study|Screenfail|0|||
129934916|NCT03008382|467728959|FG002|Overall Study|Screenfail|2|||
129934917|NCT03008382|467728960|FG003|Overall Study|Screenfail|0|||
129934918|NCT03215706|467728961|FG000|Randomization|Adverse Event unrelated to study drug|1|||
129934919|NCT03215706|467728962|FG001|Randomization|Adverse Event unrelated to study drug|0|||
129934920|NCT03215706|467728961|FG000|Randomization|participant withdrew consent|1|||
129934921|NCT03215706|467728962|FG001|Randomization|participant withdrew consent|3|||
129934922|NCT03215706|467728961|FG000|Randomization|no longer meets study criteria|1|||
129934923|NCT03215706|467728962|FG001|Randomization|no longer meets study criteria|4|||
129934924|NCT03215706|467728961|FG000|Randomization|other reasons|0|||
129934925|NCT03215706|467728962|FG001|Randomization|other reasons|2|||
129934926|NCT03215706|467728961|FG000|Treatment Period|Disease Progression|150|||
129934927|NCT03215706|467728962|FG001|Treatment Period|Disease Progression|142|||
129934928|NCT03215706|467728961|FG000|Treatment Period|Study Drug Toxicity|53|||
129934929|NCT03215706|467728962|FG001|Treatment Period|Study Drug Toxicity|21|||
129934930|NCT03215706|467728961|FG000|Treatment Period|Death|2|||
129934931|NCT03215706|467728962|FG001|Treatment Period|Death|1|||
129934932|NCT03215706|467728961|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
129934933|NCT03215706|467728962|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
129934934|NCT03215706|467728961|FG000|Treatment Period|Request to D/C treatment|1|||
129452080|NCT04183790|465953284|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
129452081|NCT04183790|465953283|FG000|Overall Study|Commercial drug is available for participant|6|||
129452082|NCT04183790|465953284|FG001|Overall Study|Commercial drug is available for participant|0|||
129452083|NCT04183790|465953283|FG000|Overall Study|Adverse Event|1|||
129452084|NCT04183790|465953284|FG001|Overall Study|Adverse Event|0|||
129452085|NCT04183790|465953283|FG000|Overall Study|Not enrolled in 107 study|0|||
129452086|NCT04183790|465953284|FG001|Overall Study|Not enrolled in 107 study|2|||
129452087|NCT01439282|465953285|FG000|Overall Study|Adverse Event|5|||
129452088|NCT01439282|465953286|FG001|Overall Study|Adverse Event|0|||
129452089|NCT01439282|465953285|FG000|Overall Study|Withdrawal by Subject|2|||
129452090|NCT01439282|465953286|FG001|Overall Study|Withdrawal by Subject|0|||
129452091|NCT01439282|465953285|FG000|Overall Study|Other|1|||
129452092|NCT01439282|465953286|FG001|Overall Study|Other|1|||
129452093|NCT02232802|465953287|FG000|Period 1|Sponsor request|1|||
129452094|NCT02232802|465953288|FG001|Period 1|Sponsor request|0|||
129452095|NCT02232802|465953287|FG000|Period 1|Adverse Event|1|||
129452096|NCT02232802|465953288|FG001|Period 1|Adverse Event|1|||
129452097|NCT01502709|465953291|FG000|Overall Study|Lost to Follow-up|4|||
129452098|NCT01502709|465953292|FG001|Overall Study|Lost to Follow-up|0|||
129452099|NCT04096274|465953293|FG000|Phase I|Lost to Follow-up|5|||
129452100|NCT04096274|465953294|FG001|Phase I|Lost to Follow-up|5|||
129452101|NCT04096274|465953293|FG000|Phase II|Lost to Follow-up|11|||
129452102|NCT04096274|465953294|FG001|Phase II|Lost to Follow-up|11|||
129452103|NCT03197493|465953296|FG000|Overall Study|Withdrawal by Subject|5|||
129452104|NCT00762892|465953298|FG000|Overall Study|Lost to Follow-up|2|||
129452105|NCT00762892|465953299|FG001|Overall Study|Lost to Follow-up|5|||
129452106|NCT00762892|465953298|FG000|Overall Study|Withdrawal by Subject|0|||
129452107|NCT00762892|465953299|FG001|Overall Study|Withdrawal by Subject|1|||
129452108|NCT00762892|465953298|FG000|Overall Study|Death|1|||
129452109|NCT00762892|465953299|FG001|Overall Study|Death|0|||
129452110|NCT00762892|465953298|FG000|Overall Study|Pregnancy|1|||
129452111|NCT00762892|465953299|FG001|Overall Study|Pregnancy|0|||
129452112|NCT00762892|465953298|FG000|Overall Study|Incarceration|1|||
129452113|NCT00762892|465953299|FG001|Overall Study|Incarceration|0|||
129452114|NCT01841749|465953300|FG000|Overall Study|Protocol Violation|1|||
129452115|NCT05807464|465953306|FG000|Overall Study|Adverse Event|1|||
129452116|NCT01846624|465953309|FG000|Overall Study|Died during induction, no midostaurin|1|||
129452117|NCT04702737|465953314|FG000|Overall Study|Decision by Sponsor|1|||
129452118|NCT04702737|465953314|FG000|Overall Study|Withdrawal of Consent from Study|3|||
129452119|NCT04702737|465953314|FG000|Overall Study|Lost to Follow-up|1|||
129934935|NCT03215706|467728962|FG001|Treatment Period|Request to D/C treatment|6|||
129934936|NCT03215706|467728961|FG000|Treatment Period|Participant withdrew consent|3|||
129934937|NCT03215706|467728962|FG001|Treatment Period|Participant withdrew consent|4|||
129452120|NCT04702737|465953314|FG000|Overall Study|Death|35|||
129452121|NCT00698997|465953317|FG000|Overall Study|Lost to Follow-up|3|||
129452122|NCT00698997|465953318|FG001|Overall Study|Lost to Follow-up|0|||
129452123|NCT00698997|465953317|FG000|Overall Study|Withdrawal by Subject|7|||
129452124|NCT00698997|465953318|FG001|Overall Study|Withdrawal by Subject|27|||
129452125|NCT01436084|465953319|FG000|Overall Study|Disease Progression|2|||
129452126|NCT01436084|465953319|FG000|Overall Study|Withdrawal by Subject|1|||
129452127|NCT01436084|465953319|FG000|Overall Study|Early Closure of Study|1|||
129452128|NCT03184077|465953321|FG000|Overall Study|Lost to Follow-up|21|||
129452129|NCT03184077|465953322|FG001|Overall Study|Lost to Follow-up|21|||
129452130|NCT03159091|465953325|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
129452131|NCT03159091|465953326|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
129452132|NCT03159091|465953325|FG000|Overall Study|Patient has taken no dose of study drug|0|||
129452133|NCT03159091|465953326|FG001|Overall Study|Patient has taken no dose of study drug|1|||
129452134|NCT00262522|465953327|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
129452135|NCT00262522|465953328|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
129934938|NCT03215706|467728961|FG000|Treatment Period|Lost to Follow-up|0|||
129934939|NCT03215706|467728962|FG001|Treatment Period|Lost to Follow-up|1|||
129934940|NCT03215706|467728961|FG000|Treatment Period|Other Reasons|4|||
129934941|NCT03215706|467728962|FG001|Treatment Period|Other Reasons|5|||
129452136|NCT00262522|465953329|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
129934942|NCT03215706|467728961|FG000|Treatment Period|Ongoing in the treatment period|105|||
129934943|NCT03215706|467728962|FG001|Treatment Period|Ongoing in the treatment period|43|||
129452137|NCT00262522|465953330|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
129452138|NCT00262522|465953327|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
129452139|NCT00262522|465953328|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
129452140|NCT00262522|465953329|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
129452141|NCT00262522|465953330|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
129934944|NCT00945724|467728963|FG000|Overall Study|Withdrawal by Subject|2|||
129934945|NCT00945724|467728963|FG000|Overall Study|Physician Decision|1|||
129452142|NCT00262522|465953327|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
129452143|NCT00262522|465953328|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
129452144|NCT00262522|465953329|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
129452145|NCT00262522|465953330|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
129934946|NCT00945724|467728963|FG000|Overall Study|Adverse Event|5|||
129934947|NCT00945724|467728963|FG000|Overall Study|Second malignancy|1|||
129934948|NCT04194450|467729573|FG000|Overall Study|not eligible|1|||
129934949|NCT04194450|467729574|FG001|Overall Study|not eligible|0|||
129934950|NCT03786926|467729584|FG000|Overall Study|Adverse Event|0|||
129934951|NCT03786926|467729585|FG001|Overall Study|Adverse Event|0|||
129934952|NCT03786926|467729586|FG002|Overall Study|Adverse Event|0|||
129934953|NCT03786926|467729587|FG003|Overall Study|Adverse Event|0|||
129934954|NCT03786926|467729588|FG004|Overall Study|Adverse Event|0|||
129934955|NCT03786926|467729589|FG005|Overall Study|Adverse Event|0|||
129934956|NCT03786926|467729590|FG006|Overall Study|Adverse Event|0|||
129934957|NCT03786926|467729591|FG007|Overall Study|Adverse Event|1|||
129934958|NCT03786926|467729592|FG008|Overall Study|Adverse Event|1|||
129934959|NCT03786926|467729593|FG009|Overall Study|Adverse Event|0|||
129934960|NCT03786926|467729594|FG010|Overall Study|Adverse Event|1|||
129934961|NCT03786926|467729584|FG000|Overall Study|Progressive disease|3|||
129934962|NCT03786926|467729585|FG001|Overall Study|Progressive disease|0|||
129934963|NCT03786926|467729586|FG002|Overall Study|Progressive disease|3|||
129934964|NCT03786926|467729587|FG003|Overall Study|Progressive disease|1|||
129934965|NCT03786926|467729588|FG004|Overall Study|Progressive disease|2|||
129934966|NCT03786926|467729589|FG005|Overall Study|Progressive disease|2|||
129934967|NCT03786926|467729590|FG006|Overall Study|Progressive disease|1|||
129934968|NCT03786926|467729591|FG007|Overall Study|Progressive disease|6|||
129934969|NCT03786926|467729592|FG008|Overall Study|Progressive disease|1|||
129934970|NCT03786926|467729593|FG009|Overall Study|Progressive disease|1|||
129934971|NCT03786926|467729594|FG010|Overall Study|Progressive disease|1|||
129934972|NCT03786926|467729584|FG000|Overall Study|Death|0|||
129934973|NCT03786926|467729585|FG001|Overall Study|Death|1|||
129934974|NCT03786926|467729586|FG002|Overall Study|Death|1|||
129934975|NCT03786926|467729587|FG003|Overall Study|Death|0|||
129934976|NCT03786926|467729588|FG004|Overall Study|Death|0|||
129934977|NCT03786926|467729589|FG005|Overall Study|Death|0|||
129934978|NCT03786926|467729590|FG006|Overall Study|Death|0|||
129934979|NCT03786926|467729591|FG007|Overall Study|Death|0|||
129934980|NCT03786926|467729592|FG008|Overall Study|Death|0|||
129934981|NCT03786926|467729593|FG009|Overall Study|Death|1|||
129934982|NCT03786926|467729594|FG010|Overall Study|Death|2|||
129934983|NCT03786926|467729584|FG000|Overall Study|Physician Decision|0|||
129934984|NCT03786926|467729585|FG001|Overall Study|Physician Decision|1|||
129934985|NCT03786926|467729586|FG002|Overall Study|Physician Decision|0|||
129934986|NCT03786926|467729587|FG003|Overall Study|Physician Decision|1|||
129934987|NCT03786926|467729588|FG004|Overall Study|Physician Decision|2|||
129934988|NCT03786926|467729589|FG005|Overall Study|Physician Decision|0|||
129934989|NCT03786926|467729590|FG006|Overall Study|Physician Decision|0|||
129934990|NCT03786926|467729591|FG007|Overall Study|Physician Decision|2|||
129934991|NCT03786926|467729592|FG008|Overall Study|Physician Decision|1|||
129934992|NCT03786926|467729593|FG009|Overall Study|Physician Decision|1|||
129934993|NCT03786926|467729594|FG010|Overall Study|Physician Decision|0|||
129934994|NCT03786926|467729584|FG000|Overall Study|Withdrawal by Subject|0|||
129934995|NCT03786926|467729585|FG001|Overall Study|Withdrawal by Subject|1|||
129934996|NCT03786926|467729586|FG002|Overall Study|Withdrawal by Subject|1|||
129934997|NCT03786926|467729587|FG003|Overall Study|Withdrawal by Subject|0|||
129934998|NCT03786926|467729588|FG004|Overall Study|Withdrawal by Subject|0|||
129934999|NCT03786926|467729589|FG005|Overall Study|Withdrawal by Subject|0|||
129935000|NCT03786926|467729590|FG006|Overall Study|Withdrawal by Subject|1|||
129935001|NCT03786926|467729591|FG007|Overall Study|Withdrawal by Subject|0|||
129935002|NCT03786926|467729592|FG008|Overall Study|Withdrawal by Subject|1|||
129452146|NCT00262522|465953327|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
129935003|NCT03786926|467729593|FG009|Overall Study|Withdrawal by Subject|0|||
129935004|NCT03786926|467729594|FG010|Overall Study|Withdrawal by Subject|1|||
129935005|NCT03786926|467729584|FG000|Overall Study|Study terminated by Sponsor|0|||
129935006|NCT03786926|467729585|FG001|Overall Study|Study terminated by Sponsor|0|||
129935007|NCT03786926|467729586|FG002|Overall Study|Study terminated by Sponsor|0|||
129935008|NCT03786926|467729587|FG003|Overall Study|Study terminated by Sponsor|0|||
129935009|NCT03786926|467729588|FG004|Overall Study|Study terminated by Sponsor|1|||
129935010|NCT03786926|467729589|FG005|Overall Study|Study terminated by Sponsor|0|||
129935011|NCT03786926|467729590|FG006|Overall Study|Study terminated by Sponsor|0|||
129935012|NCT03786926|467729591|FG007|Overall Study|Study terminated by Sponsor|4|||
129935013|NCT03786926|467729592|FG008|Overall Study|Study terminated by Sponsor|0|||
129935014|NCT03786926|467729593|FG009|Overall Study|Study terminated by Sponsor|0|||
129935015|NCT03786926|467729594|FG010|Overall Study|Study terminated by Sponsor|0|||
129935016|NCT03786926|467729584|FG000|Overall Study|Anti-neoplasm treatment|0|||
129935017|NCT03786926|467729585|FG001|Overall Study|Anti-neoplasm treatment|0|||
129935018|NCT03786926|467729586|FG002|Overall Study|Anti-neoplasm treatment|0|||
129935019|NCT03786926|467729587|FG003|Overall Study|Anti-neoplasm treatment|0|||
129935020|NCT03786926|467729588|FG004|Overall Study|Anti-neoplasm treatment|1|||
129935021|NCT03786926|467729589|FG005|Overall Study|Anti-neoplasm treatment|0|||
129935022|NCT03786926|467729590|FG006|Overall Study|Anti-neoplasm treatment|1|||
129935023|NCT03786926|467729591|FG007|Overall Study|Anti-neoplasm treatment|0|||
129935024|NCT03786926|467729592|FG008|Overall Study|Anti-neoplasm treatment|0|||
129935025|NCT03786926|467729593|FG009|Overall Study|Anti-neoplasm treatment|0|||
129935026|NCT03786926|467729594|FG010|Overall Study|Anti-neoplasm treatment|0|||
129935027|NCT03786926|467729584|FG000|Overall Study|Other|0|||
129935028|NCT03786926|467729585|FG001|Overall Study|Other|0|||
129935029|NCT03786926|467729586|FG002|Overall Study|Other|0|||
129935030|NCT03786926|467729587|FG003|Overall Study|Other|1|||
129935031|NCT03786926|467729588|FG004|Overall Study|Other|0|||
129935032|NCT03786926|467729589|FG005|Overall Study|Other|1|||
129935033|NCT03786926|467729590|FG006|Overall Study|Other|0|||
129935034|NCT03786926|467729591|FG007|Overall Study|Other|0|||
129935035|NCT03786926|467729592|FG008|Overall Study|Other|2|||
129935036|NCT03786926|467729593|FG009|Overall Study|Other|0|||
129935037|NCT03786926|467729594|FG010|Overall Study|Other|0|||
129935038|NCT05875701|467729600|FG000|Overall Study|Lost to Follow-up|2|||
129935039|NCT05875701|467729601|FG001|Overall Study|Lost to Follow-up|0|||
129935040|NCT05875701|467729600|FG000|Overall Study|Withdrawal by Subject|1|||
129935041|NCT05875701|467729601|FG001|Overall Study|Withdrawal by Subject|1|||
129935042|NCT04408755|467729602|FG000|Period A (Placebo lead-in)|Other|11|||
129935043|NCT04408755|467729603|FG001|Period A (Placebo lead-in)|Other|0|||
129935044|NCT04408755|467729604|FG002|Period A (Placebo lead-in)|Other|0|||
129935045|NCT04408755|467729605|FG003|Period A (Placebo lead-in)|Other|0|||
129935046|NCT04408755|467729602|FG000|Period B (Randomization Period)|Adverse Event|0|||
129935047|NCT04408755|467729603|FG001|Period B (Randomization Period)|Adverse Event|3|||
129935048|NCT04408755|467729604|FG002|Period B (Randomization Period)|Adverse Event|0|||
129935049|NCT04408755|467729605|FG003|Period B (Randomization Period)|Adverse Event|1|||
129935050|NCT04408755|467729602|FG000|Period B (Randomization Period)|Death|0|||
129935051|NCT04408755|467729603|FG001|Period B (Randomization Period)|Death|0|||
129935052|NCT04408755|467729604|FG002|Period B (Randomization Period)|Death|1|||
129935053|NCT04408755|467729605|FG003|Period B (Randomization Period)|Death|0|||
129935054|NCT04408755|467729602|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
129935055|NCT04408755|467729603|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
129935056|NCT04408755|467729604|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
129935057|NCT04408755|467729605|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
129935058|NCT04408755|467729602|FG000|Period B (Randomization Period)|Physician Decision|0|||
129935059|NCT04408755|467729603|FG001|Period B (Randomization Period)|Physician Decision|0|||
129935060|NCT04408755|467729604|FG002|Period B (Randomization Period)|Physician Decision|1|||
129935061|NCT04408755|467729605|FG003|Period B (Randomization Period)|Physician Decision|0|||
129935062|NCT04408755|467729602|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
129935063|NCT04408755|467729603|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
129935064|NCT04408755|467729604|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
129935065|NCT04408755|467729605|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
129935066|NCT04408755|467729602|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
129935067|NCT04408755|467729603|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
129935068|NCT04408755|467729604|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
129935069|NCT04408755|467729605|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
129935070|NCT04408755|467729602|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
129935071|NCT04408755|467729603|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
129935072|NCT04408755|467729604|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
129935073|NCT04408755|467729605|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
129935074|NCT04408755|467729602|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
129935075|NCT04408755|467729603|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
129935076|NCT04408755|467729604|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
129935077|NCT04408755|467729605|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
129935078|NCT04408755|467729602|FG000|Period B (Randomization Period)|Reason not Specified|0|||
129935079|NCT04408755|467729603|FG001|Period B (Randomization Period)|Reason not Specified|1|||
129935080|NCT04408755|467729604|FG002|Period B (Randomization Period)|Reason not Specified|0|||
129935081|NCT04408755|467729605|FG003|Period B (Randomization Period)|Reason not Specified|2|||
129935082|NCT00308997|467729606|FG000|Overall Study|Subject feigned clinical data|0|||
129935083|NCT00308997|467729607|FG001|Overall Study|Subject feigned clinical data|1|||
129935084|NCT00308997|467729606|FG000|Overall Study|Unable to tolerate intervention|1|||
129935085|NCT00308997|467729607|FG001|Overall Study|Unable to tolerate intervention|0|||
129935086|NCT04490356|467729608|FG000|Overall Study|Lost to Follow-up|1|||
129935087|NCT03733626|467729609|FG000|Overall Study|Physician Decision|4|||
129935088|NCT03733626|467729610|FG001|Overall Study|Physician Decision|4|||
129935089|NCT04586244|467729613|FG000|Overall Study|Lost to Follow-up|1|||
129935090|NCT04586244|467729614|FG001|Overall Study|Lost to Follow-up|0|||
129935091|NCT04586244|467729615|FG002|Overall Study|Lost to Follow-up|0|||
129935092|NCT04586244|467729616|FG003|Overall Study|Lost to Follow-up|1|||
129935093|NCT04586244|467729617|FG004|Overall Study|Lost to Follow-up|0|||
129935094|NCT04586244|467729613|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935095|NCT04586244|467729614|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
129935096|NCT04586244|467729615|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935097|NCT04586244|467729616|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935098|NCT04586244|467729617|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
129935099|NCT04174560|467729622|FG000|Overall Study|Lost to Follow-up|1|||
129935100|NCT04174560|467729623|FG001|Overall Study|Lost to Follow-up|0|||
129935101|NCT04174560|467729624|FG002|Overall Study|Lost to Follow-up|0|||
129935102|NCT04174560|467729625|FG003|Overall Study|Lost to Follow-up|0|||
129935103|NCT04174560|467729622|FG000|Overall Study|Withdrawal by Subject|0|||
129935104|NCT04174560|467729623|FG001|Overall Study|Withdrawal by Subject|0|||
129935105|NCT04174560|467729624|FG002|Overall Study|Withdrawal by Subject|2|||
129935106|NCT04174560|467729625|FG003|Overall Study|Withdrawal by Subject|0|||
129935107|NCT05424718|467729626|FG000|Overall Study|Lost to Follow-up|5|||
129935108|NCT05424718|467729627|FG001|Overall Study|Lost to Follow-up|4|||
129935109|NCT04046549|467729628|FG000|Overall Study|Adverse Event|1|||
129935110|NCT04046549|467729628|FG000|Overall Study|Physician Decision|1|||
129935111|NCT04046549|467729628|FG000|Overall Study|Withdrawal by Subject|3|||
129935112|NCT04046549|467729628|FG000|Overall Study|Other, Not Specified|5|||
129935113|NCT03142009|467729629|FG000|Overall Study|Lost to Follow-up|45|||
129935114|NCT03142009|467729630|FG001|Overall Study|Lost to Follow-up|30|||
129935115|NCT03872466|467729631|FG000|Overall Study|Withdrawal by Subject|1|||
129935116|NCT03872466|467729632|FG001|Overall Study|Withdrawal by Subject|0|||
129935117|NCT03872466|467729631|FG000|Overall Study|Physician Decision|2|||
129935118|NCT03872466|467729632|FG001|Overall Study|Physician Decision|0|||
129935119|NCT01778686|467729633|FG000|Overall Study|Adverse Event|0|||
129935120|NCT01778686|467729634|FG001|Overall Study|Adverse Event|0|||
129935121|NCT01778686|467729635|FG002|Overall Study|Adverse Event|1|||
129935122|NCT06059443|467729636|FG000|Overall Study|Withdrawal by Subject|2|||
129935123|NCT06059443|467729637|FG001|Overall Study|Withdrawal by Subject|0|||
129935124|NCT06059443|467729636|FG000|Overall Study|Lost to Follow-up|2|||
129935125|NCT06059443|467729637|FG001|Overall Study|Lost to Follow-up|2|||
129935126|NCT00994643|467730232|FG000|Overall Study|Withdrawal by Subject|1|||
129935127|NCT05412004|467730233|FG000|Overall Study|Adverse Event|0|||
129935128|NCT05412004|467730234|FG001|Overall Study|Adverse Event|2|||
129935129|NCT05412004|467730235|FG002|Overall Study|Adverse Event|1|||
129935130|NCT05412004|467730236|FG003|Overall Study|Adverse Event|5|||
129935131|NCT05412004|467730233|FG000|Overall Study|Assigned Treatment by Mistake|5|||
129935132|NCT05412004|467730234|FG001|Overall Study|Assigned Treatment by Mistake|10|||
129935133|NCT05412004|467730235|FG002|Overall Study|Assigned Treatment by Mistake|2|||
129935134|NCT05412004|467730236|FG003|Overall Study|Assigned Treatment by Mistake|5|||
129935135|NCT05412004|467730233|FG000|Overall Study|Lost to Follow-up|3|||
129935136|NCT05412004|467730234|FG001|Overall Study|Lost to Follow-up|0|||
129935137|NCT05412004|467730235|FG002|Overall Study|Lost to Follow-up|0|||
129935138|NCT05412004|467730236|FG003|Overall Study|Lost to Follow-up|0|||
129935139|NCT05412004|467730233|FG000|Overall Study|Patient could not travel to site|0|||
129935140|NCT05412004|467730234|FG001|Overall Study|Patient could not travel to site|1|||
129935141|NCT05412004|467730235|FG002|Overall Study|Patient could not travel to site|0|||
129935142|NCT05412004|467730236|FG003|Overall Study|Patient could not travel to site|0|||
129935143|NCT05412004|467730233|FG000|Overall Study|Physician Decision|0|||
129935144|NCT05412004|467730234|FG001|Overall Study|Physician Decision|1|||
129935145|NCT05412004|467730235|FG002|Overall Study|Physician Decision|0|||
129935146|NCT05412004|467730236|FG003|Overall Study|Physician Decision|0|||
129935147|NCT05412004|467730233|FG000|Overall Study|Pregnancy|0|||
129935148|NCT05412004|467730234|FG001|Overall Study|Pregnancy|1|||
129935149|NCT05412004|467730235|FG002|Overall Study|Pregnancy|0|||
129935150|NCT05412004|467730236|FG003|Overall Study|Pregnancy|0|||
129935151|NCT05412004|467730233|FG000|Overall Study|Protocol Violation|1|||
129935152|NCT05412004|467730234|FG001|Overall Study|Protocol Violation|0|||
129935153|NCT05412004|467730235|FG002|Overall Study|Protocol Violation|0|||
129935154|NCT05412004|467730236|FG003|Overall Study|Protocol Violation|0|||
129452147|NCT00262522|465953328|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
129452148|NCT00262522|465953329|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
129452149|NCT00262522|465953330|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
129452150|NCT00262522|465953327|FG000|Study Start Through 8 Weeks|Death|1|||
129452151|NCT00262522|465953328|FG001|Study Start Through 8 Weeks|Death|0|||
129452152|NCT00262522|465953329|FG002|Study Start Through 8 Weeks|Death|0|||
129452153|NCT00262522|465953330|FG003|Study Start Through 8 Weeks|Death|0|||
129452154|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
129452155|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
129452156|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
129935155|NCT05412004|467730233|FG000|Overall Study|Withdrawal by Subject|4|||
129935156|NCT05412004|467730234|FG001|Overall Study|Withdrawal by Subject|19|||
129935157|NCT05412004|467730235|FG002|Overall Study|Withdrawal by Subject|4|||
129935158|NCT05412004|467730236|FG003|Overall Study|Withdrawal by Subject|14|||
129935159|NCT05412004|467730233|FG000|Overall Study|Screen Failure|0|||
129935160|NCT05412004|467730234|FG001|Overall Study|Screen Failure|0|||
129935161|NCT05412004|467730235|FG002|Overall Study|Screen Failure|0|||
129935162|NCT05412004|467730236|FG003|Overall Study|Screen Failure|1|||
129935163|NCT05412004|467730233|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
129935164|NCT05412004|467730234|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
129935165|NCT05412004|467730235|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
129452157|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
129452158|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
129935166|NCT05412004|467730236|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
129935167|NCT00968149|467730237|FG000|Overall Study|Adverse Event|5|||
129935168|NCT00968149|467730238|FG001|Overall Study|Adverse Event|1|||
129935169|NCT00968149|467730237|FG000|Overall Study|Lack of Efficacy|0|||
129935170|NCT00968149|467730238|FG001|Overall Study|Lack of Efficacy|4|||
129935171|NCT00968149|467730237|FG000|Overall Study|Lost to Follow-up|0|||
129935172|NCT00968149|467730238|FG001|Overall Study|Lost to Follow-up|1|||
129935173|NCT00968149|467730237|FG000|Overall Study|Protocol Violation|4|||
129935174|NCT00968149|467730238|FG001|Overall Study|Protocol Violation|0|||
129935175|NCT00968149|467730237|FG000|Overall Study|Withdrawal by Subject|2|||
129935176|NCT00968149|467730238|FG001|Overall Study|Withdrawal by Subject|0|||
129935177|NCT03934931|467730239|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
129935178|NCT03934931|467730240|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
129935179|NCT03934931|467730241|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
129935180|NCT00495677|467730242|FG000|Stage 1 (25 Days)|Adverse Event|0|||
129935181|NCT00495677|467730243|FG001|Stage 1 (25 Days)|Adverse Event|0|||
129935182|NCT00495677|467730244|FG002|Stage 1 (25 Days)|Adverse Event|1|||
129935183|NCT00495677|467730245|FG003|Stage 1 (25 Days)|Adverse Event|0|||
129935184|NCT00495677|467730246|FG004|Stage 1 (25 Days)|Adverse Event|0|||
129935185|NCT00495677|467730247|FG005|Stage 1 (25 Days)|Adverse Event|0|||
129935186|NCT00495677|467730248|FG006|Stage 1 (25 Days)|Adverse Event|0|||
129452159|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
129935187|NCT02231749|467730252|FG000|Overall Study|Disease progression|229|||
129935188|NCT02231749|467730253|FG001|Overall Study|Disease progression|297|||
129935189|NCT02231749|467730252|FG000|Overall Study|Study Drug Toxicity|134|||
129935190|NCT02231749|467730253|FG001|Overall Study|Study Drug Toxicity|63|||
129935191|NCT02231749|467730252|FG000|Overall Study|Death|1|||
129935192|NCT02231749|467730253|FG001|Overall Study|Death|1|||
129935193|NCT02231749|467730252|FG000|Overall Study|AE unrelated to Study drug|32|||
129452160|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
129935194|NCT02231749|467730253|FG001|Overall Study|AE unrelated to Study drug|31|||
129935195|NCT02231749|467730252|FG000|Overall Study|Participant's request to discontinue|10|||
129935196|NCT02231749|467730253|FG001|Overall Study|Participant's request to discontinue|21|||
129935197|NCT02231749|467730252|FG000|Overall Study|Participant withdrew Consent|8|||
129935198|NCT02231749|467730253|FG001|Overall Study|Participant withdrew Consent|15|||
129935199|NCT02231749|467730252|FG000|Overall Study|Lost to Follow-up|1|||
129935200|NCT02231749|467730253|FG001|Overall Study|Lost to Follow-up|2|||
129935201|NCT02231749|467730252|FG000|Overall Study|Maximum Clinical Benefit|5|||
129935202|NCT02231749|467730253|FG001|Overall Study|Maximum Clinical Benefit|8|||
129935203|NCT02231749|467730252|FG000|Overall Study|Poor/Non-Compliance|0|||
129935204|NCT02231749|467730253|FG001|Overall Study|Poor/Non-Compliance|3|||
129935205|NCT02231749|467730252|FG000|Overall Study|Pregnancy|1|||
129935206|NCT02231749|467730253|FG001|Overall Study|Pregnancy|0|||
129935207|NCT02231749|467730252|FG000|Overall Study|other|0|||
129935208|NCT02231749|467730253|FG001|Overall Study|other|8|||
129935209|NCT02231749|467730252|FG000|Overall Study|No longer meets Study Criteria|1|||
129935210|NCT02231749|467730253|FG001|Overall Study|No longer meets Study Criteria|0|||
129935211|NCT02989662|467730259|FG000|Overall Study|Lost to Follow-up|0|||
129935212|NCT02989662|467730260|FG001|Overall Study|Lost to Follow-up|0|||
129935213|NCT02989662|467730261|FG002|Overall Study|Lost to Follow-up|0|||
129935214|NCT02989662|467730262|FG003|Overall Study|Lost to Follow-up|2|||
129935215|NCT02989662|467730259|FG000|Overall Study|Physician Decision|3|||
129935216|NCT02989662|467730260|FG001|Overall Study|Physician Decision|0|||
129935217|NCT02989662|467730261|FG002|Overall Study|Physician Decision|0|||
129935218|NCT02989662|467730262|FG003|Overall Study|Physician Decision|0|||
129935219|NCT02989662|467730259|FG000|Overall Study|Withdrawal by Subject|1|||
129935220|NCT02989662|467730260|FG001|Overall Study|Withdrawal by Subject|0|||
129935221|NCT02989662|467730261|FG002|Overall Study|Withdrawal by Subject|0|||
129935222|NCT02989662|467730262|FG003|Overall Study|Withdrawal by Subject|0|||
129935223|NCT02726386|467730266|FG000|Overall Study|Adverse Event|17|||
129935224|NCT02726386|467730267|FG001|Overall Study|Adverse Event|20|||
129935225|NCT02726386|467730266|FG000|Overall Study|Withdrawal by Subject|14|||
129935226|NCT02726386|467730267|FG001|Overall Study|Withdrawal by Subject|28|||
129935227|NCT02726386|467730266|FG000|Overall Study|Other reasons|7|||
129935228|NCT02726386|467730267|FG001|Overall Study|Other reasons|8|||
129935229|NCT02951052|467730273|FG000|Overall Study|Adverse Event|13|||
129935230|NCT02951052|467730274|FG001|Overall Study|Adverse Event|5|||
129935231|NCT02951052|467730273|FG000|Overall Study|Withdrawal by Subject|1|||
129935232|NCT02951052|467730274|FG001|Overall Study|Withdrawal by Subject|5|||
129935233|NCT02951052|467730273|FG000|Overall Study|Physician Decision|2|||
129935234|NCT02951052|467730274|FG001|Overall Study|Physician Decision|0|||
129935235|NCT02951052|467730273|FG000|Overall Study|Lost to Follow-up|1|||
129935236|NCT02951052|467730274|FG001|Overall Study|Lost to Follow-up|1|||
129935237|NCT02951052|467730273|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
129935238|NCT02951052|467730274|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
129935239|NCT02951052|467730273|FG000|Overall Study|Protocol Violation|5|||
129935240|NCT02951052|467730274|FG001|Overall Study|Protocol Violation|3|||
129935241|NCT02951052|467730273|FG000|Overall Study|Lack of Efficacy|3|||
129935242|NCT02951052|467730274|FG001|Overall Study|Lack of Efficacy|4|||
129935243|NCT02951052|467730273|FG000|Overall Study|Ongoing|1|||
129935244|NCT02951052|467730274|FG001|Overall Study|Ongoing|0|||
129935245|NCT04644029|467731117|FG000|Overall Study|Death|1|||
129935246|NCT04644029|467731118|FG001|Overall Study|Death|0|||
129935247|NCT04644029|467731117|FG000|Overall Study|Physician Decision|1|||
129935248|NCT04644029|467731118|FG001|Overall Study|Physician Decision|2|||
129935249|NCT04644029|467731117|FG000|Overall Study|Withdrawal by Subject|21|||
129935250|NCT04644029|467731118|FG001|Overall Study|Withdrawal by Subject|19|||
129935251|NCT04644029|467731117|FG000|Overall Study|Lost to Follow-up|31|||
129935252|NCT04644029|467731118|FG001|Overall Study|Lost to Follow-up|34|||
129935253|NCT04644029|467731117|FG000|Overall Study|Study Terminated by Sponsor|308|||
129935254|NCT04644029|467731118|FG001|Overall Study|Study Terminated by Sponsor|309|||
129935255|NCT04644029|467731117|FG000|Overall Study|Randomized in Error|2|||
129935256|NCT04644029|467731118|FG001|Overall Study|Randomized in Error|1|||
129935257|NCT04644029|467731117|FG000|Overall Study|Other|0|||
129935258|NCT04644029|467731118|FG001|Overall Study|Other|1|||
129935259|NCT02720068|467731119|FG000|Overall Study|Adverse Event|0|||
129935260|NCT02720068|467731120|FG001|Overall Study|Adverse Event|0|||
129935261|NCT02720068|467731121|FG002|Overall Study|Adverse Event|0|||
129935262|NCT02720068|467731122|FG003|Overall Study|Adverse Event|0|||
129935263|NCT02720068|467731123|FG004|Overall Study|Adverse Event|0|||
129935264|NCT02720068|467731124|FG005|Overall Study|Adverse Event|0|||
129935265|NCT02720068|467731125|FG006|Overall Study|Adverse Event|0|||
129935266|NCT02720068|467731126|FG007|Overall Study|Adverse Event|0|||
129935267|NCT02720068|467731127|FG008|Overall Study|Adverse Event|0|||
129935268|NCT02720068|467731128|FG009|Overall Study|Adverse Event|0|||
129935269|NCT02720068|467731129|FG010|Overall Study|Adverse Event|0|||
129935270|NCT02720068|467731130|FG011|Overall Study|Adverse Event|1|||
129935271|NCT02720068|467731131|FG012|Overall Study|Adverse Event|0|||
129935272|NCT02720068|467731132|FG013|Overall Study|Adverse Event|0|||
129935273|NCT02720068|467731133|FG014|Overall Study|Adverse Event|0|||
129935274|NCT02720068|467731134|FG015|Overall Study|Adverse Event|0|||
129935275|NCT02720068|467731135|FG016|Overall Study|Adverse Event|0|||
129935276|NCT02720068|467731136|FG017|Overall Study|Adverse Event|0|||
129935277|NCT02720068|467731119|FG000|Overall Study|Death|1|||
129935278|NCT02720068|467731120|FG001|Overall Study|Death|3|||
129935279|NCT02720068|467731121|FG002|Overall Study|Death|2|||
129935280|NCT02720068|467731122|FG003|Overall Study|Death|1|||
129935281|NCT02720068|467731123|FG004|Overall Study|Death|2|||
129935282|NCT02720068|467731124|FG005|Overall Study|Death|1|||
129935283|NCT02720068|467731125|FG006|Overall Study|Death|2|||
129935284|NCT02720068|467731126|FG007|Overall Study|Death|2|||
129935285|NCT02720068|467731127|FG008|Overall Study|Death|3|||
129935286|NCT02720068|467731128|FG009|Overall Study|Death|1|||
129935287|NCT02720068|467731129|FG010|Overall Study|Death|20|||
129935288|NCT02720068|467731130|FG011|Overall Study|Death|166|||
129935289|NCT02720068|467731131|FG012|Overall Study|Death|34|||
129935290|NCT02720068|467731132|FG013|Overall Study|Death|30|||
129935291|NCT02720068|467731133|FG014|Overall Study|Death|45|||
129935292|NCT02720068|467731134|FG015|Overall Study|Death|16|||
129935293|NCT02720068|467731135|FG016|Overall Study|Death|20|||
129935294|NCT02720068|467731136|FG017|Overall Study|Death|28|||
129935295|NCT02720068|467731119|FG000|Overall Study|Lost to Follow-up|0|||
129935296|NCT02720068|467731120|FG001|Overall Study|Lost to Follow-up|0|||
129935297|NCT02720068|467731121|FG002|Overall Study|Lost to Follow-up|0|||
129935298|NCT02720068|467731122|FG003|Overall Study|Lost to Follow-up|0|||
129935299|NCT02720068|467731123|FG004|Overall Study|Lost to Follow-up|0|||
129935300|NCT02720068|467731124|FG005|Overall Study|Lost to Follow-up|0|||
129935301|NCT02720068|467731125|FG006|Overall Study|Lost to Follow-up|0|||
129935302|NCT02720068|467731126|FG007|Overall Study|Lost to Follow-up|0|||
129935303|NCT02720068|467731127|FG008|Overall Study|Lost to Follow-up|0|||
129935304|NCT02720068|467731128|FG009|Overall Study|Lost to Follow-up|0|||
129935305|NCT02720068|467731129|FG010|Overall Study|Lost to Follow-up|0|||
129935306|NCT02720068|467731130|FG011|Overall Study|Lost to Follow-up|1|||
129935307|NCT02720068|467731131|FG012|Overall Study|Lost to Follow-up|0|||
129935308|NCT02720068|467731132|FG013|Overall Study|Lost to Follow-up|1|||
129935309|NCT02720068|467731133|FG014|Overall Study|Lost to Follow-up|2|||
129935310|NCT02720068|467731134|FG015|Overall Study|Lost to Follow-up|0|||
129935311|NCT02720068|467731135|FG016|Overall Study|Lost to Follow-up|0|||
129935312|NCT02720068|467731136|FG017|Overall Study|Lost to Follow-up|1|||
129935313|NCT02720068|467731119|FG000|Overall Study|Physician Decision|0|||
129935314|NCT02720068|467731120|FG001|Overall Study|Physician Decision|0|||
129935315|NCT02720068|467731121|FG002|Overall Study|Physician Decision|0|||
129935316|NCT02720068|467731122|FG003|Overall Study|Physician Decision|1|||
129935317|NCT02720068|467731123|FG004|Overall Study|Physician Decision|0|||
129935318|NCT02720068|467731124|FG005|Overall Study|Physician Decision|0|||
129935319|NCT02720068|467731125|FG006|Overall Study|Physician Decision|0|||
129935320|NCT02720068|467731126|FG007|Overall Study|Physician Decision|0|||
129935321|NCT02720068|467731127|FG008|Overall Study|Physician Decision|0|||
129935322|NCT02720068|467731128|FG009|Overall Study|Physician Decision|0|||
129935323|NCT02720068|467731129|FG010|Overall Study|Physician Decision|0|||
129935324|NCT02720068|467731130|FG011|Overall Study|Physician Decision|1|||
129935325|NCT02720068|467731131|FG012|Overall Study|Physician Decision|0|||
129935326|NCT02720068|467731132|FG013|Overall Study|Physician Decision|0|||
129935327|NCT02720068|467731133|FG014|Overall Study|Physician Decision|0|||
129935328|NCT02720068|467731134|FG015|Overall Study|Physician Decision|0|||
129935329|NCT02720068|467731135|FG016|Overall Study|Physician Decision|0|||
129935330|NCT02720068|467731136|FG017|Overall Study|Physician Decision|1|||
129935331|NCT02720068|467731119|FG000|Overall Study|Progressive Disease|2|||
129935332|NCT02720068|467731120|FG001|Overall Study|Progressive Disease|3|||
129935333|NCT02720068|467731121|FG002|Overall Study|Progressive Disease|1|||
129935334|NCT02720068|467731122|FG003|Overall Study|Progressive Disease|1|||
129935335|NCT02720068|467731123|FG004|Overall Study|Progressive Disease|1|||
129452161|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
129452162|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
129935336|NCT02720068|467731124|FG005|Overall Study|Progressive Disease|2|||
129935337|NCT02720068|467731125|FG006|Overall Study|Progressive Disease|1|||
129935338|NCT02720068|467731126|FG007|Overall Study|Progressive Disease|1|||
129935339|NCT02720068|467731127|FG008|Overall Study|Progressive Disease|0|||
129935340|NCT02720068|467731128|FG009|Overall Study|Progressive Disease|1|||
129935341|NCT02720068|467731129|FG010|Overall Study|Progressive Disease|0|||
129935342|NCT02720068|467731130|FG011|Overall Study|Progressive Disease|4|||
129935343|NCT02720068|467731131|FG012|Overall Study|Progressive Disease|1|||
129452163|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
129935344|NCT02720068|467731132|FG013|Overall Study|Progressive Disease|0|||
129935345|NCT02720068|467731133|FG014|Overall Study|Progressive Disease|0|||
129935346|NCT02720068|467731134|FG015|Overall Study|Progressive Disease|0|||
129935347|NCT02720068|467731135|FG016|Overall Study|Progressive Disease|0|||
129935348|NCT02720068|467731136|FG017|Overall Study|Progressive Disease|0|||
129935349|NCT02720068|467731119|FG000|Overall Study|Sponsor Decision|0|||
129935350|NCT02720068|467731120|FG001|Overall Study|Sponsor Decision|0|||
129935351|NCT02720068|467731121|FG002|Overall Study|Sponsor Decision|0|||
129935352|NCT02720068|467731122|FG003|Overall Study|Sponsor Decision|0|||
129935353|NCT02720068|467731123|FG004|Overall Study|Sponsor Decision|0|||
129935354|NCT02720068|467731124|FG005|Overall Study|Sponsor Decision|0|||
129935355|NCT02720068|467731125|FG006|Overall Study|Sponsor Decision|0|||
129935356|NCT02720068|467731126|FG007|Overall Study|Sponsor Decision|0|||
129935357|NCT02720068|467731127|FG008|Overall Study|Sponsor Decision|0|||
129935358|NCT02720068|467731128|FG009|Overall Study|Sponsor Decision|0|||
129935359|NCT02720068|467731129|FG010|Overall Study|Sponsor Decision|0|||
129935360|NCT02720068|467731130|FG011|Overall Study|Sponsor Decision|6|||
129935361|NCT02720068|467731131|FG012|Overall Study|Sponsor Decision|3|||
129935362|NCT02720068|467731132|FG013|Overall Study|Sponsor Decision|2|||
129935363|NCT02720068|467731133|FG014|Overall Study|Sponsor Decision|4|||
129935364|NCT02720068|467731134|FG015|Overall Study|Sponsor Decision|4|||
129935365|NCT02720068|467731135|FG016|Overall Study|Sponsor Decision|0|||
129935366|NCT02720068|467731136|FG017|Overall Study|Sponsor Decision|8|||
129935367|NCT02720068|467731119|FG000|Overall Study|Withdrawal by Subject|0|||
129935368|NCT02720068|467731120|FG001|Overall Study|Withdrawal by Subject|0|||
129935369|NCT02720068|467731121|FG002|Overall Study|Withdrawal by Subject|0|||
129935370|NCT02720068|467731122|FG003|Overall Study|Withdrawal by Subject|0|||
129935371|NCT02720068|467731123|FG004|Overall Study|Withdrawal by Subject|0|||
129935372|NCT02720068|467731124|FG005|Overall Study|Withdrawal by Subject|0|||
129935373|NCT02720068|467731125|FG006|Overall Study|Withdrawal by Subject|0|||
129935374|NCT02720068|467731126|FG007|Overall Study|Withdrawal by Subject|0|||
129935375|NCT02720068|467731127|FG008|Overall Study|Withdrawal by Subject|0|||
129935376|NCT02720068|467731128|FG009|Overall Study|Withdrawal by Subject|1|||
129935377|NCT02720068|467731129|FG010|Overall Study|Withdrawal by Subject|0|||
129935378|NCT02720068|467731130|FG011|Overall Study|Withdrawal by Subject|27|||
129935379|NCT02720068|467731131|FG012|Overall Study|Withdrawal by Subject|2|||
129935380|NCT02720068|467731132|FG013|Overall Study|Withdrawal by Subject|8|||
129935381|NCT02720068|467731133|FG014|Overall Study|Withdrawal by Subject|7|||
129935382|NCT02720068|467731134|FG015|Overall Study|Withdrawal by Subject|0|||
129935383|NCT02720068|467731135|FG016|Overall Study|Withdrawal by Subject|0|||
129935384|NCT02720068|467731136|FG017|Overall Study|Withdrawal by Subject|2|||
129935385|NCT02720068|467731119|FG000|Overall Study|Protocol Violation|0|||
129935386|NCT02720068|467731120|FG001|Overall Study|Protocol Violation|0|||
129935387|NCT02720068|467731121|FG002|Overall Study|Protocol Violation|0|||
129935388|NCT02720068|467731122|FG003|Overall Study|Protocol Violation|0|||
129935389|NCT02720068|467731123|FG004|Overall Study|Protocol Violation|0|||
129935390|NCT02720068|467731124|FG005|Overall Study|Protocol Violation|0|||
129935391|NCT02720068|467731125|FG006|Overall Study|Protocol Violation|0|||
129935392|NCT02720068|467731126|FG007|Overall Study|Protocol Violation|0|||
129935393|NCT02720068|467731127|FG008|Overall Study|Protocol Violation|0|||
129935394|NCT02720068|467731128|FG009|Overall Study|Protocol Violation|0|||
129935395|NCT02720068|467731129|FG010|Overall Study|Protocol Violation|1|||
129935396|NCT02720068|467731130|FG011|Overall Study|Protocol Violation|0|||
129935397|NCT02720068|467731131|FG012|Overall Study|Protocol Violation|0|||
129935398|NCT02720068|467731132|FG013|Overall Study|Protocol Violation|0|||
129935399|NCT02720068|467731133|FG014|Overall Study|Protocol Violation|1|||
129935400|NCT02720068|467731134|FG015|Overall Study|Protocol Violation|0|||
129935401|NCT02720068|467731135|FG016|Overall Study|Protocol Violation|1|||
129935402|NCT02720068|467731136|FG017|Overall Study|Protocol Violation|0|||
129935403|NCT00113360|467731137|FG000|Overall Study|Adverse Event|3|||
129935404|NCT00113360|467731137|FG000|Overall Study|Subject required surgery|1|||
129935405|NCT00113360|467731137|FG000|Overall Study|Did not meet eligibility criteria|3|||
129935406|NCT02467270|467731152|FG000|Overall Study|Participants Never Treated|0|||
129935407|NCT02467270|467731153|FG001|Overall Study|Participants Never Treated|1|||
129935408|NCT02467270|467731154|FG002|Overall Study|Participants Never Treated|0|||
129935409|NCT02467270|467731152|FG000|Overall Study|Ongoing|50|||
129935410|NCT02467270|467731153|FG001|Overall Study|Ongoing|41|||
129935411|NCT02467270|467731154|FG002|Overall Study|Ongoing|43|||
129935412|NCT02467270|467731152|FG000|Overall Study|Adverse Event|16|||
129935413|NCT02467270|467731153|FG001|Overall Study|Adverse Event|15|||
129935414|NCT02467270|467731154|FG002|Overall Study|Adverse Event|14|||
129935415|NCT02467270|467731152|FG000|Overall Study|Progressive Disease|7|||
129935416|NCT02467270|467731153|FG001|Overall Study|Progressive Disease|7|||
129935417|NCT02467270|467731154|FG002|Overall Study|Progressive Disease|4|||
129935418|NCT02467270|467731152|FG000|Overall Study|Death|2|||
129935419|NCT02467270|467731153|FG001|Overall Study|Death|0|||
129935420|NCT02467270|467731154|FG002|Overall Study|Death|2|||
129935421|NCT02467270|467731152|FG000|Overall Study|Lack of Efficacy|12|||
129935422|NCT02467270|467731153|FG001|Overall Study|Lack of Efficacy|18|||
129935423|NCT02467270|467731154|FG002|Overall Study|Lack of Efficacy|23|||
129935424|NCT02467270|467731152|FG000|Overall Study|Non-compliance With Study Drug|0|||
129935425|NCT02467270|467731153|FG001|Overall Study|Non-compliance With Study Drug|2|||
129935426|NCT02467270|467731154|FG002|Overall Study|Non-compliance With Study Drug|1|||
129935427|NCT02467270|467731152|FG000|Overall Study|Lost to Follow-up|2|||
129935428|NCT02467270|467731153|FG001|Overall Study|Lost to Follow-up|1|||
129935429|NCT02467270|467731154|FG002|Overall Study|Lost to Follow-up|0|||
129935430|NCT02467270|467731152|FG000|Overall Study|Pregnancy|0|||
129935431|NCT02467270|467731153|FG001|Overall Study|Pregnancy|1|||
129935432|NCT02467270|467731154|FG002|Overall Study|Pregnancy|0|||
129935433|NCT02467270|467731152|FG000|Overall Study|Physician Decision|0|||
129935434|NCT02467270|467731153|FG001|Overall Study|Physician Decision|4|||
129935435|NCT02467270|467731154|FG002|Overall Study|Physician Decision|1|||
129935436|NCT02467270|467731152|FG000|Overall Study|Withdrawal by Subject|4|||
129935437|NCT02467270|467731153|FG001|Overall Study|Withdrawal by Subject|3|||
129935438|NCT02467270|467731154|FG002|Overall Study|Withdrawal by Subject|5|||
129935439|NCT02467270|467731152|FG000|Overall Study|Reason not Specified|1|||
129935440|NCT02467270|467731153|FG001|Overall Study|Reason not Specified|2|||
129935441|NCT02467270|467731154|FG002|Overall Study|Reason not Specified|1|||
129935442|NCT00739908|467731155|FG000|Overall Study|Adverse Event|5|||
129935443|NCT00739908|467731156|FG001|Overall Study|Adverse Event|6|||
129935444|NCT00739908|467731155|FG000|Overall Study|Withdrawal by Subject|4|||
129935445|NCT00739908|467731156|FG001|Overall Study|Withdrawal by Subject|2|||
129935446|NCT00739908|467731155|FG000|Overall Study|Lost to Follow-up|14|||
129935447|NCT00739908|467731156|FG001|Overall Study|Lost to Follow-up|9|||
129935448|NCT00739908|467731155|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
129935449|NCT00739908|467731156|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
129935450|NCT00739908|467731155|FG000|Overall Study|Non-Compliance With Study Medication|0|||
129935451|NCT00739908|467731156|FG001|Overall Study|Non-Compliance With Study Medication|3|||
129935452|NCT00739908|467731155|FG000|Overall Study|Lack of Efficacy|0|||
129935453|NCT00739908|467731156|FG001|Overall Study|Lack of Efficacy|1|||
129935454|NCT00739908|467731155|FG000|Overall Study|Relocation|0|||
129935455|NCT00739908|467731156|FG001|Overall Study|Relocation|1|||
129935456|NCT04129164|467731159|FG000|Overall Study|Non-compliance with procedures|0|||
129935457|NCT04129164|467731160|FG001|Overall Study|Non-compliance with procedures|0|||
129935458|NCT04129164|467731161|FG002|Overall Study|Non-compliance with procedures|2|||
129935459|NCT04129164|467731162|FG003|Overall Study|Non-compliance with procedures|0|||
129935460|NCT04129164|467731159|FG000|Overall Study|Adverse Event|0|||
129935461|NCT04129164|467731160|FG001|Overall Study|Adverse Event|0|||
129935462|NCT04129164|467731161|FG002|Overall Study|Adverse Event|2|||
129935463|NCT04129164|467731162|FG003|Overall Study|Adverse Event|0|||
129935464|NCT04129164|467731159|FG000|Overall Study|Pregnancy|0|||
129935465|NCT04129164|467731160|FG001|Overall Study|Pregnancy|0|||
129935466|NCT04129164|467731161|FG002|Overall Study|Pregnancy|0|||
129935467|NCT04129164|467731162|FG003|Overall Study|Pregnancy|1|||
129935468|NCT04129164|467731159|FG000|Overall Study|Withdrawal by Subject|3|||
129935469|NCT04129164|467731160|FG001|Overall Study|Withdrawal by Subject|2|||
129935470|NCT04129164|467731161|FG002|Overall Study|Withdrawal by Subject|4|||
129935471|NCT04129164|467731162|FG003|Overall Study|Withdrawal by Subject|6|||
129935472|NCT04129164|467731159|FG000|Overall Study|Death|0|||
129935473|NCT04129164|467731160|FG001|Overall Study|Death|1|||
129935474|NCT04129164|467731161|FG002|Overall Study|Death|0|||
129935475|NCT04129164|467731162|FG003|Overall Study|Death|0|||
129935476|NCT04129164|467731159|FG000|Overall Study|Lost to Follow-up|0|||
129935477|NCT04129164|467731160|FG001|Overall Study|Lost to Follow-up|1|||
129935478|NCT04129164|467731161|FG002|Overall Study|Lost to Follow-up|0|||
129935479|NCT04129164|467731162|FG003|Overall Study|Lost to Follow-up|0|||
129935480|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
129935481|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
129935482|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
129935483|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
129935484|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
129935485|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
129935486|NCT03868930|467731163|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
129935487|NCT03868930|467731164|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
129935488|NCT03868930|467731163|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
129935489|NCT03868930|467731164|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
129935490|NCT04227899|467731167|FG000|Overall Study|Withdrawal by Subject|6|||
129935491|NCT04227899|467731168|FG001|Overall Study|Withdrawal by Subject|3|||
129935492|NCT04227899|467731167|FG000|Overall Study|Death|12|||
129935493|NCT04227899|467731168|FG001|Overall Study|Death|6|||
129935494|NCT04227899|467731167|FG000|Overall Study|Lost to Follow-up|2|||
129935495|NCT04227899|467731168|FG001|Overall Study|Lost to Follow-up|1|||
129935496|NCT01773993|467731170|FG000|Overall Study|No Visit After Treatment|35|||
129935497|NCT04664881|467731171|FG000|Overall Study|Withdrawal by Subject|1|||
129935498|NCT04664881|467731172|FG001|Overall Study|Withdrawal by Subject|8|||
129935499|NCT04664881|467731171|FG000|Overall Study|Physician Decision|0|||
129935500|NCT04664881|467731172|FG001|Overall Study|Physician Decision|5|||
129935501|NCT04664881|467731171|FG000|Overall Study|Lost to Follow-up|1|||
129935502|NCT04664881|467731172|FG001|Overall Study|Lost to Follow-up|0|||
129935503|NCT00328783|467731175|FG000|Overall Study|Could not tolerate ABC|21|||
129935504|NCT00328783|467731175|FG000|Overall Study|No heart in RT field|4|||
129935505|NCT00328783|467731175|FG000|Overall Study|Withdrawal by Subject|1|||
129935506|NCT00357682|467731176|FG000|Overall Study|Did not receive allocated Treatment|10|||
129935507|NCT00357682|467731177|FG001|Overall Study|Did not receive allocated Treatment|9|||
129935508|NCT00357682|467731178|FG002|Overall Study|Did not receive allocated Treatment|9|||
129935509|NCT00357682|467731179|FG003|Overall Study|Did not receive allocated Treatment|10|||
129935510|NCT00357682|467731176|FG000|Overall Study|Withdrew consent|6|||
129935511|NCT00357682|467731177|FG001|Overall Study|Withdrew consent|6|||
129935512|NCT00357682|467731178|FG002|Overall Study|Withdrew consent|5|||
129935513|NCT00357682|467731179|FG003|Overall Study|Withdrew consent|5|||
129935514|NCT00357682|467731176|FG000|Overall Study|Lost to Follow-up|39|||
129935515|NCT00357682|467731177|FG001|Overall Study|Lost to Follow-up|33|||
129935516|NCT00357682|467731178|FG002|Overall Study|Lost to Follow-up|26|||
129935517|NCT00357682|467731179|FG003|Overall Study|Lost to Follow-up|35|||
129935518|NCT00357682|467731176|FG000|Overall Study|Adverse Event|24|||
129935519|NCT00357682|467731177|FG001|Overall Study|Adverse Event|32|||
129935520|NCT00357682|467731178|FG002|Overall Study|Adverse Event|22|||
129935521|NCT00357682|467731179|FG003|Overall Study|Adverse Event|27|||
129935522|NCT00357682|467731176|FG000|Overall Study|Physician Decision|32|||
129935523|NCT00357682|467731177|FG001|Overall Study|Physician Decision|20|||
129935524|NCT00357682|467731178|FG002|Overall Study|Physician Decision|24|||
129935525|NCT00357682|467731179|FG003|Overall Study|Physician Decision|30|||
129935526|NCT00357682|467731176|FG000|Overall Study|Patient decision|73|||
129935527|NCT00357682|467731177|FG001|Overall Study|Patient decision|80|||
129935528|NCT00357682|467731178|FG002|Overall Study|Patient decision|51|||
129935529|NCT00357682|467731179|FG003|Overall Study|Patient decision|59|||
129935530|NCT00357682|467731176|FG000|Overall Study|Other reason|157|||
129935531|NCT00357682|467731177|FG001|Overall Study|Other reason|130|||
129935532|NCT00357682|467731178|FG002|Overall Study|Other reason|114|||
129935533|NCT00357682|467731179|FG003|Overall Study|Other reason|99|||
129935534|NCT03201939|467731184|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
129935535|NCT03201939|467731185|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
129935536|NCT05707351|467731188|FG000|Overall Study|Withdrawal by Subject|2|||
129935537|NCT05707351|467731188|FG000|Overall Study|Reason Not Specified|1|||
129935538|NCT04012567|467731197|FG000|Overall Study|Lost to Follow-up|0|||
129935539|NCT04012567|467731198|FG001|Overall Study|Lost to Follow-up|1|||
129935540|NCT04012567|467731197|FG000|Overall Study|Withdrawal by Subject|1|||
129935541|NCT04012567|467731198|FG001|Overall Study|Withdrawal by Subject|0|||
129935542|NCT02206828|467731201|FG000|Overall Study|Lost to Follow-up|7|||
129935543|NCT05795153|467732204|FG000|Overall Study|Adverse Event|2|||
129935544|NCT05795153|467732204|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129935545|NCT05795153|467732204|FG000|Overall Study|Lost to Follow-up|1|||
129935546|NCT05795153|467732204|FG000|Overall Study|Subject decision|2|||
129935547|NCT05180539|467732205|FG000|Overall Study|Lost to Follow-up|27|||
129935548|NCT05180539|467732206|FG001|Overall Study|Lost to Follow-up|30|||
129935549|NCT02566889|467732209|FG000|Overall Study|Withdrawal by Subject|3|||
129935550|NCT02566889|467732210|FG001|Overall Study|Withdrawal by Subject|1|||
129935551|NCT02566889|467732209|FG000|Overall Study|Adverse Event|4|||
129935552|NCT02566889|467732210|FG001|Overall Study|Adverse Event|2|||
129935553|NCT02566889|467732209|FG000|Overall Study|Other|6|||
129935554|NCT02566889|467732210|FG001|Overall Study|Other|2|||
129935555|NCT04518943|467732211|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
129935556|NCT04518943|467732212|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
129935557|NCT04518943|467732213|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
129935558|NCT04518943|467732214|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
129935559|NCT04518943|467732215|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
129935560|NCT04518943|467732216|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
129935561|NCT04518943|467732217|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
129935562|NCT04518943|467732218|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
129935563|NCT04518943|467732219|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
129935564|NCT04518943|467732220|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
129935565|NCT04518943|467732221|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
129935566|NCT04518943|467732222|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
129935567|NCT04518943|467732223|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
129935568|NCT04518943|467732224|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
129935569|NCT04518943|467732225|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
129935570|NCT04518943|467732226|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
129935571|NCT03699163|467732228|FG000|Overall Study|Physician Decision|12|||
129935572|NCT03699163|467732229|FG001|Overall Study|Physician Decision|0|||
129935573|NCT03699163|467732228|FG000|Overall Study|failed QC measures|205|||
129935574|NCT03699163|467732229|FG001|Overall Study|failed QC measures|206|||
129935575|NCT03705793|467732230|FG000|Overall Study|Lost to Follow-up|3|||
129935576|NCT03705793|467732231|FG001|Overall Study|Lost to Follow-up|4|||
129935577|NCT03705793|467732230|FG000|Overall Study|Withdrawal by Subject|2|||
129935578|NCT03705793|467732231|FG001|Overall Study|Withdrawal by Subject|1|||
129935579|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Other|0|||
129935580|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Other|2|||
129935581|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Other|1|||
129935582|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Other|2|||
129935583|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Other|2|||
129935584|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Other|0|||
129935585|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Other|0|||
129935586|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Other|0|||
129935587|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Other|0|||
129935588|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Other|0|||
129935589|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Other|0|||
129935590|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Other|0|||
129935591|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Other|0|||
129935592|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Other|0|||
129935593|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Other|0|||
129935594|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Other|0|||
129935595|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Other|0|||
129935596|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
129935597|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
129935598|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
129935599|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
129935600|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
129935601|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
129935602|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935603|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935604|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935605|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935606|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935607|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935608|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935609|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935610|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935611|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935612|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
129935613|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935614|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
129935615|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
129935616|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935617|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
129935618|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
129935619|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935620|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935621|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935622|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935623|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935624|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935625|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935626|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935627|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935628|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935629|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
129935630|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Death|2|||
129935631|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Death|1|||
129935632|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Death|1|||
129935633|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Death|0|||
129935634|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Death|0|||
129935635|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Death|0|||
129935636|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Death|0|||
129935637|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Death|0|||
129935638|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Death|0|||
129935639|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Death|0|||
129935640|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Death|0|||
129452164|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
129452165|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
129452166|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
129935641|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Death|0|||
129935642|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Death|0|||
129935643|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Death|0|||
129935644|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Death|0|||
129935645|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Death|0|||
129452167|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
129452168|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
129935646|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Death|0|||
129935647|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935648|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
129452169|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
129935649|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935650|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935651|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
129935652|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
129935653|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935654|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935655|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935656|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935657|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935658|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935659|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935660|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935661|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935662|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935663|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
129935664|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935665|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935666|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935667|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935668|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
129935669|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
129935670|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935671|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935672|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935673|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935674|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935675|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935676|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935677|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935678|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935679|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935680|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
129935681|NCT02719574|467732232|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935682|NCT02719574|467732233|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935683|NCT02719574|467732234|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
129935684|NCT02719574|467732235|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935685|NCT02719574|467732236|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935686|NCT02719574|467732237|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935687|NCT02719574|467732238|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935688|NCT02719574|467732239|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935689|NCT02719574|467732240|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935690|NCT02719574|467732241|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935691|NCT02719574|467732242|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935692|NCT02719574|467732243|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935693|NCT02719574|467732244|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935694|NCT02719574|467732245|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935695|NCT02719574|467732246|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935696|NCT02719574|467732247|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935697|NCT02719574|467732248|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
129935698|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935699|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935700|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935701|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935702|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935703|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935704|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
129935705|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
129935706|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
129935707|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935708|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935709|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935710|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935711|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935712|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935713|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935714|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
129935715|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935716|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935717|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935718|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935719|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935720|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935721|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
129935722|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
129935723|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935724|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935725|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935726|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935727|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935728|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935729|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935730|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935731|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
129935732|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Death|0|||
129935733|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Death|0|||
129935734|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Death|0|||
129935735|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Death|0|||
129935736|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Death|0|||
129935737|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Death|0|||
129935738|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Death|1|||
129935739|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Death|6|||
129935740|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Death|0|||
129935741|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Death|0|||
129935742|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Death|0|||
129935743|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Death|0|||
129935744|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Death|0|||
129935745|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Death|0|||
129935746|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Death|0|||
129935747|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Death|0|||
129935748|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Death|0|||
129935749|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935750|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935751|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935752|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935753|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935754|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935755|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
129935756|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
129935757|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935758|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935759|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935760|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935761|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935762|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935763|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935764|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935765|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
129935766|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935767|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935768|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935769|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935770|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935771|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935772|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
129935773|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
129935774|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935775|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935776|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935777|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935778|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935779|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935780|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935781|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935782|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
129935783|NCT02719574|467732232|FG000|Phase 1 (Dose Expansion)|Other|0|||
129935784|NCT02719574|467732233|FG001|Phase 1 (Dose Expansion)|Other|0|||
129935785|NCT02719574|467732234|FG002|Phase 1 (Dose Expansion)|Other|0|||
129935786|NCT02719574|467732235|FG003|Phase 1 (Dose Expansion)|Other|0|||
129935787|NCT02719574|467732236|FG004|Phase 1 (Dose Expansion)|Other|0|||
129935788|NCT02719574|467732237|FG005|Phase 1 (Dose Expansion)|Other|0|||
129935789|NCT02719574|467732238|FG006|Phase 1 (Dose Expansion)|Other|1|||
129935790|NCT02719574|467732239|FG007|Phase 1 (Dose Expansion)|Other|7|||
129935791|NCT02719574|467732240|FG008|Phase 1 (Dose Expansion)|Other|0|||
129935792|NCT02719574|467732241|FG009|Phase 1 (Dose Expansion)|Other|0|||
129935793|NCT02719574|467732242|FG010|Phase 1 (Dose Expansion)|Other|0|||
129935794|NCT02719574|467732243|FG011|Phase 1 (Dose Expansion)|Other|0|||
129935795|NCT02719574|467732244|FG012|Phase 1 (Dose Expansion)|Other|0|||
129935796|NCT02719574|467732245|FG013|Phase 1 (Dose Expansion)|Other|0|||
129935797|NCT02719574|467732246|FG014|Phase 1 (Dose Expansion)|Other|0|||
129935798|NCT02719574|467732247|FG015|Phase 1 (Dose Expansion)|Other|0|||
129935799|NCT02719574|467732248|FG016|Phase 1 (Dose Expansion)|Other|0|||
129935800|NCT02719574|467732232|FG000|Phase 2|Protocol Defined Disease Progression|0|||
129935801|NCT02719574|467732233|FG001|Phase 2|Protocol Defined Disease Progression|0|||
129935802|NCT02719574|467732234|FG002|Phase 2|Protocol Defined Disease Progression|0|||
129935803|NCT02719574|467732235|FG003|Phase 2|Protocol Defined Disease Progression|0|||
129935804|NCT02719574|467732236|FG004|Phase 2|Protocol Defined Disease Progression|0|||
129935805|NCT02719574|467732237|FG005|Phase 2|Protocol Defined Disease Progression|0|||
129935806|NCT02719574|467732238|FG006|Phase 2|Protocol Defined Disease Progression|0|||
129935807|NCT02719574|467732239|FG007|Phase 2|Protocol Defined Disease Progression|0|||
129935808|NCT02719574|467732240|FG008|Phase 2|Protocol Defined Disease Progression|0|||
129935809|NCT02719574|467732241|FG009|Phase 2|Protocol Defined Disease Progression|65|||
129935810|NCT02719574|467732242|FG010|Phase 2|Protocol Defined Disease Progression|8|||
129935811|NCT02719574|467732243|FG011|Phase 2|Protocol Defined Disease Progression|2|||
129935812|NCT02719574|467732244|FG012|Phase 2|Protocol Defined Disease Progression|4|||
129935813|NCT02719574|467732245|FG013|Phase 2|Protocol Defined Disease Progression|9|||
129935814|NCT02719574|467732246|FG014|Phase 2|Protocol Defined Disease Progression|11|||
129935815|NCT02719574|467732247|FG015|Phase 2|Protocol Defined Disease Progression|3|||
129935816|NCT02719574|467732248|FG016|Phase 2|Protocol Defined Disease Progression|4|||
129935817|NCT02719574|467732232|FG000|Phase 2|Adverse Event|0|||
129935818|NCT02719574|467732233|FG001|Phase 2|Adverse Event|0|||
129935819|NCT02719574|467732234|FG002|Phase 2|Adverse Event|0|||
129935820|NCT02719574|467732235|FG003|Phase 2|Adverse Event|0|||
129935821|NCT02719574|467732236|FG004|Phase 2|Adverse Event|0|||
129935822|NCT02719574|467732237|FG005|Phase 2|Adverse Event|0|||
129935823|NCT02719574|467732238|FG006|Phase 2|Adverse Event|0|||
129935824|NCT02719574|467732239|FG007|Phase 2|Adverse Event|0|||
129935825|NCT02719574|467732240|FG008|Phase 2|Adverse Event|0|||
129935826|NCT02719574|467732241|FG009|Phase 2|Adverse Event|27|||
129935827|NCT02719574|467732242|FG010|Phase 2|Adverse Event|0|||
129935828|NCT02719574|467732243|FG011|Phase 2|Adverse Event|1|||
129935829|NCT02719574|467732244|FG012|Phase 2|Adverse Event|1|||
129935830|NCT02719574|467732245|FG013|Phase 2|Adverse Event|1|||
129935831|NCT02719574|467732246|FG014|Phase 2|Adverse Event|2|||
129935832|NCT02719574|467732247|FG015|Phase 2|Adverse Event|2|||
129935833|NCT02719574|467732248|FG016|Phase 2|Adverse Event|3|||
129935834|NCT02719574|467732232|FG000|Phase 2|Other|0|||
129935835|NCT02719574|467732233|FG001|Phase 2|Other|0|||
129935836|NCT02719574|467732234|FG002|Phase 2|Other|0|||
129935837|NCT02719574|467732235|FG003|Phase 2|Other|0|||
129935838|NCT02719574|467732236|FG004|Phase 2|Other|0|||
129935839|NCT02719574|467732237|FG005|Phase 2|Other|0|||
129935840|NCT02719574|467732238|FG006|Phase 2|Other|0|||
129935841|NCT02719574|467732239|FG007|Phase 2|Other|0|||
129935842|NCT02719574|467732240|FG008|Phase 2|Other|0|||
129935843|NCT02719574|467732241|FG009|Phase 2|Other|20|||
129935844|NCT02719574|467732242|FG010|Phase 2|Other|7|||
129935845|NCT02719574|467732243|FG011|Phase 2|Other|0|||
129935846|NCT02719574|467732244|FG012|Phase 2|Other|5|||
129935847|NCT02719574|467732245|FG013|Phase 2|Other|7|||
129935848|NCT02719574|467732246|FG014|Phase 2|Other|0|||
129935849|NCT02719574|467732247|FG015|Phase 2|Other|1|||
129935850|NCT02719574|467732248|FG016|Phase 2|Other|4|||
129935851|NCT02719574|467732232|FG000|Phase 2|Transplant|0|||
129935852|NCT02719574|467732233|FG001|Phase 2|Transplant|0|||
129935853|NCT02719574|467732234|FG002|Phase 2|Transplant|0|||
129935854|NCT02719574|467732235|FG003|Phase 2|Transplant|0|||
129935855|NCT02719574|467732236|FG004|Phase 2|Transplant|0|||
129935856|NCT02719574|467732237|FG005|Phase 2|Transplant|0|||
129935857|NCT02719574|467732238|FG006|Phase 2|Transplant|0|||
129935858|NCT02719574|467732239|FG007|Phase 2|Transplant|0|||
129935859|NCT02719574|467732240|FG008|Phase 2|Transplant|0|||
129935860|NCT02719574|467732241|FG009|Phase 2|Transplant|15|||
129935861|NCT02719574|467732242|FG010|Phase 2|Transplant|2|||
129935862|NCT02719574|467732243|FG011|Phase 2|Transplant|0|||
129935863|NCT02719574|467732244|FG012|Phase 2|Transplant|6|||
129935864|NCT02719574|467732245|FG013|Phase 2|Transplant|1|||
129935865|NCT02719574|467732246|FG014|Phase 2|Transplant|1|||
129935866|NCT02719574|467732247|FG015|Phase 2|Transplant|0|||
129935867|NCT02719574|467732248|FG016|Phase 2|Transplant|0|||
129935868|NCT02719574|467732232|FG000|Phase 2|Death|0|||
129935869|NCT02719574|467732233|FG001|Phase 2|Death|0|||
129935870|NCT02719574|467732234|FG002|Phase 2|Death|0|||
129935871|NCT02719574|467732235|FG003|Phase 2|Death|0|||
129935872|NCT02719574|467732236|FG004|Phase 2|Death|0|||
129935873|NCT02719574|467732237|FG005|Phase 2|Death|0|||
129935874|NCT02719574|467732238|FG006|Phase 2|Death|0|||
129935875|NCT02719574|467732239|FG007|Phase 2|Death|0|||
129935876|NCT02719574|467732240|FG008|Phase 2|Death|0|||
129935877|NCT02719574|467732241|FG009|Phase 2|Death|14|||
129935878|NCT02719574|467732242|FG010|Phase 2|Death|0|||
129935879|NCT02719574|467732243|FG011|Phase 2|Death|0|||
129935880|NCT02719574|467732244|FG012|Phase 2|Death|1|||
129935881|NCT02719574|467732245|FG013|Phase 2|Death|1|||
129935882|NCT02719574|467732246|FG014|Phase 2|Death|2|||
129935883|NCT02719574|467732247|FG015|Phase 2|Death|0|||
129935884|NCT02719574|467732248|FG016|Phase 2|Death|0|||
129935885|NCT02719574|467732232|FG000|Phase 2|Investigator Decision|0|||
129935886|NCT02719574|467732233|FG001|Phase 2|Investigator Decision|0|||
129935887|NCT02719574|467732234|FG002|Phase 2|Investigator Decision|0|||
129935888|NCT02719574|467732235|FG003|Phase 2|Investigator Decision|0|||
129935889|NCT02719574|467732236|FG004|Phase 2|Investigator Decision|0|||
129935890|NCT02719574|467732237|FG005|Phase 2|Investigator Decision|0|||
129935891|NCT02719574|467732238|FG006|Phase 2|Investigator Decision|0|||
129935892|NCT02719574|467732239|FG007|Phase 2|Investigator Decision|0|||
129935893|NCT02719574|467732240|FG008|Phase 2|Investigator Decision|0|||
129935894|NCT02719574|467732241|FG009|Phase 2|Investigator Decision|6|||
129935895|NCT02719574|467732242|FG010|Phase 2|Investigator Decision|1|||
129935896|NCT02719574|467732243|FG011|Phase 2|Investigator Decision|2|||
129935897|NCT02719574|467732244|FG012|Phase 2|Investigator Decision|3|||
129935898|NCT02719574|467732245|FG013|Phase 2|Investigator Decision|1|||
129935899|NCT02719574|467732246|FG014|Phase 2|Investigator Decision|3|||
129935900|NCT02719574|467732247|FG015|Phase 2|Investigator Decision|2|||
129935901|NCT02719574|467732248|FG016|Phase 2|Investigator Decision|0|||
129935902|NCT02719574|467732232|FG000|Phase 2|Withdrawal by Subject|0|||
129935903|NCT02719574|467732233|FG001|Phase 2|Withdrawal by Subject|0|||
129935904|NCT02719574|467732234|FG002|Phase 2|Withdrawal by Subject|0|||
129935905|NCT02719574|467732235|FG003|Phase 2|Withdrawal by Subject|0|||
129935906|NCT02719574|467732236|FG004|Phase 2|Withdrawal by Subject|0|||
129935907|NCT02719574|467732237|FG005|Phase 2|Withdrawal by Subject|0|||
129935908|NCT02719574|467732238|FG006|Phase 2|Withdrawal by Subject|0|||
129935909|NCT02719574|467732239|FG007|Phase 2|Withdrawal by Subject|0|||
129935910|NCT02719574|467732240|FG008|Phase 2|Withdrawal by Subject|0|||
129935911|NCT02719574|467732241|FG009|Phase 2|Withdrawal by Subject|5|||
129935912|NCT02719574|467732242|FG010|Phase 2|Withdrawal by Subject|0|||
129935913|NCT02719574|467732243|FG011|Phase 2|Withdrawal by Subject|0|||
129935914|NCT02719574|467732244|FG012|Phase 2|Withdrawal by Subject|0|||
129935915|NCT02719574|467732245|FG013|Phase 2|Withdrawal by Subject|1|||
129935916|NCT02719574|467732246|FG014|Phase 2|Withdrawal by Subject|1|||
129935917|NCT02719574|467732247|FG015|Phase 2|Withdrawal by Subject|2|||
129935918|NCT02719574|467732248|FG016|Phase 2|Withdrawal by Subject|0|||
129935919|NCT02719574|467732232|FG000|Phase 2|Protocol Violation|0|||
129935920|NCT02719574|467732233|FG001|Phase 2|Protocol Violation|0|||
129935921|NCT02719574|467732234|FG002|Phase 2|Protocol Violation|0|||
129935922|NCT02719574|467732235|FG003|Phase 2|Protocol Violation|0|||
129935923|NCT02719574|467732236|FG004|Phase 2|Protocol Violation|0|||
129935924|NCT02719574|467732237|FG005|Phase 2|Protocol Violation|0|||
129935925|NCT02719574|467732238|FG006|Phase 2|Protocol Violation|0|||
129935926|NCT02719574|467732239|FG007|Phase 2|Protocol Violation|0|||
129935927|NCT02719574|467732240|FG008|Phase 2|Protocol Violation|0|||
129935928|NCT02719574|467732241|FG009|Phase 2|Protocol Violation|1|||
129935929|NCT02719574|467732242|FG010|Phase 2|Protocol Violation|0|||
129935930|NCT02719574|467732243|FG011|Phase 2|Protocol Violation|0|||
129935931|NCT02719574|467732244|FG012|Phase 2|Protocol Violation|0|||
129935932|NCT02719574|467732245|FG013|Phase 2|Protocol Violation|0|||
129935933|NCT02719574|467732246|FG014|Phase 2|Protocol Violation|0|||
129935934|NCT02719574|467732247|FG015|Phase 2|Protocol Violation|0|||
129935935|NCT02719574|467732248|FG016|Phase 2|Protocol Violation|0|||
129452170|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Death|2|||
129452171|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Death|0|||
129452172|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Death|1|||
129452173|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Death|0|||
129452174|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
129452175|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
129935936|NCT03875313|467732257|FG000|Overall Study|Withdrawal by Subject|1|||
129935937|NCT03875313|467732258|FG001|Overall Study|Withdrawal by Subject|3|||
129935938|NCT03875313|467732259|FG002|Overall Study|Withdrawal by Subject|0|||
129935939|NCT03875313|467732260|FG003|Overall Study|Withdrawal by Subject|0|||
129935940|NCT03875313|467732261|FG004|Overall Study|Withdrawal by Subject|0|||
129935941|NCT03875313|467732257|FG000|Overall Study|Death|0|||
129935942|NCT03875313|467732258|FG001|Overall Study|Death|0|||
129935943|NCT03875313|467732259|FG002|Overall Study|Death|0|||
129935944|NCT03875313|467732260|FG003|Overall Study|Death|0|||
129452176|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
129935945|NCT03875313|467732261|FG004|Overall Study|Death|1|||
129935946|NCT03875313|467732257|FG000|Overall Study|Lost to Follow-up|0|||
129935947|NCT03875313|467732258|FG001|Overall Study|Lost to Follow-up|0|||
129935948|NCT03875313|467732259|FG002|Overall Study|Lost to Follow-up|0|||
129935949|NCT03875313|467732260|FG003|Overall Study|Lost to Follow-up|0|||
129935950|NCT03875313|467732261|FG004|Overall Study|Lost to Follow-up|1|||
129935951|NCT03875313|467732257|FG000|Overall Study|Study Termination by Sponsor|0|||
129935952|NCT03875313|467732258|FG001|Overall Study|Study Termination by Sponsor|1|||
129935953|NCT03875313|467732259|FG002|Overall Study|Study Termination by Sponsor|1|||
129935954|NCT03875313|467732260|FG003|Overall Study|Study Termination by Sponsor|0|||
129935955|NCT03875313|467732261|FG004|Overall Study|Study Termination by Sponsor|1|||
129935956|NCT03875313|467732257|FG000|Overall Study|New Anticancer Treatment|0|||
129452177|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
129452178|NCT00262522|465953327|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
129452179|NCT00262522|465953328|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
129452180|NCT00262522|465953329|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
129452181|NCT00262522|465953330|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
129452182|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
129452183|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
129452184|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
129452185|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
129452186|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
129452187|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
129452188|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
129452189|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
129452190|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
129452191|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
129452192|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
129452193|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
129452194|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
129452195|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
129452196|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
129452197|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
129452198|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Death|2|||
129452199|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Death|0|||
129452200|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Death|2|||
129452201|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Death|0|||
129452202|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
129452203|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
129452204|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
129452205|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
129452206|NCT00262522|465953327|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
129452207|NCT00262522|465953328|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
129452208|NCT00262522|465953329|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
129452209|NCT00262522|465953330|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
129452210|NCT04814823|465953331|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
129452211|NCT03462719|465953332|FG000|Overall Study|Withdrawal by Subject|4|||
129452212|NCT03462719|465953333|FG001|Overall Study|Withdrawal by Subject|3|||
129452213|NCT03462719|465953332|FG000|Overall Study|Ongoing|87|||
129452214|NCT03462719|465953333|FG001|Overall Study|Ongoing|72|||
129452215|NCT03740165|465953334|FG000|Overall Study|Death|232|||
129452216|NCT03740165|465953335|FG001|Overall Study|Death|242|||
129452217|NCT03740165|465953336|FG002|Overall Study|Death|229|||
129452218|NCT03740165|465953334|FG000|Overall Study|Lost to Follow-up|0|||
129452219|NCT03740165|465953335|FG001|Overall Study|Lost to Follow-up|0|||
129452220|NCT03740165|465953336|FG002|Overall Study|Lost to Follow-up|1|||
129452221|NCT03740165|465953334|FG000|Overall Study|Withdrawal by Subject|7|||
129452222|NCT03740165|465953335|FG001|Overall Study|Withdrawal by Subject|4|||
129452223|NCT03740165|465953336|FG002|Overall Study|Withdrawal by Subject|3|||
129452224|NCT03740165|465953334|FG000|Overall Study|Ongoing in Study|216|||
129452225|NCT03740165|465953335|FG001|Overall Study|Ongoing in Study|212|||
129452226|NCT03740165|465953336|FG002|Overall Study|Ongoing in Study|221|||
129452227|NCT05318937|465953339|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129452228|NCT05318937|465953340|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129452229|NCT05318937|465953339|FG000|Overall Study|Lost to Follow-up|0|||
129452230|NCT05318937|465953340|FG001|Overall Study|Lost to Follow-up|1|||
129452231|NCT05318937|465953339|FG000|Overall Study|Withdrawal by Subject|0|||
129452232|NCT05318937|465953340|FG001|Overall Study|Withdrawal by Subject|2|||
129452233|NCT05318937|465953339|FG000|Overall Study|Protocol Violation|0|||
129452234|NCT05318937|465953340|FG001|Overall Study|Protocol Violation|1|||
129452235|NCT05678257|465953348|FG000|Overall Study|Withdrawal by Subject|2|||
129452236|NCT05678257|465953349|FG001|Overall Study|Withdrawal by Subject|0|||
129452237|NCT05678257|465953350|FG002|Overall Study|Withdrawal by Subject|5|||
129452238|NCT05678257|465953348|FG000|Overall Study|Physician Decision|1|||
129452239|NCT05678257|465953349|FG001|Overall Study|Physician Decision|0|||
129452240|NCT05678257|465953350|FG002|Overall Study|Physician Decision|1|||
129452241|NCT05678257|465953348|FG000|Overall Study|Adverse Event|1|||
129452242|NCT05678257|465953349|FG001|Overall Study|Adverse Event|3|||
129452243|NCT05678257|465953350|FG002|Overall Study|Adverse Event|1|||
129452244|NCT05678257|465953348|FG000|Overall Study|Progressive disease|11|||
129452245|NCT05678257|465953349|FG001|Overall Study|Progressive disease|18|||
129452246|NCT05678257|465953350|FG002|Overall Study|Progressive disease|7|||
129452247|NCT05678257|465953348|FG000|Overall Study|No longer clinically benefitting|2|||
129452248|NCT05678257|465953349|FG001|Overall Study|No longer clinically benefitting|1|||
129452249|NCT05678257|465953350|FG002|Overall Study|No longer clinically benefitting|0|||
129452250|NCT05678257|465953348|FG000|Overall Study|Sponsor decision|5|||
129452251|NCT05678257|465953349|FG001|Overall Study|Sponsor decision|9|||
129452252|NCT05678257|465953350|FG002|Overall Study|Sponsor decision|8|||
129935957|NCT03875313|467732258|FG001|Overall Study|New Anticancer Treatment|1|||
129935958|NCT03875313|467732259|FG002|Overall Study|New Anticancer Treatment|2|||
129935959|NCT03875313|467732260|FG003|Overall Study|New Anticancer Treatment|1|||
129935960|NCT03875313|467732261|FG004|Overall Study|New Anticancer Treatment|0|||
129935961|NCT03875313|467732257|FG000|Overall Study|Other, Not Specified|2|||
129935962|NCT03875313|467732258|FG001|Overall Study|Other, Not Specified|11|||
129935963|NCT03875313|467732259|FG002|Overall Study|Other, Not Specified|3|||
129452253|NCT05678257|465953348|FG000|Overall Study|Protocol Violation|0|||
129935964|NCT03875313|467732260|FG003|Overall Study|Other, Not Specified|3|||
129452254|NCT05678257|465953349|FG001|Overall Study|Protocol Violation|0|||
129935965|NCT03875313|467732261|FG004|Overall Study|Other, Not Specified|1|||
129935966|NCT03286114|467732266|FG000|Overall Study|Adverse Event|6|||
129935967|NCT03286114|467732266|FG000|Overall Study|Death|3|||
129935968|NCT01046825|467732267|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935969|NCT01046825|467732268|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
129935970|NCT01046825|467732269|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935971|NCT01046825|467732270|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935972|NCT01046825|467732271|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
129935973|NCT01046825|467732267|FG000|Overall Study|Physician Decision|0|||
129935974|NCT01046825|467732268|FG001|Overall Study|Physician Decision|1|||
129935975|NCT01046825|467732269|FG002|Overall Study|Physician Decision|2|||
129935976|NCT01046825|467732270|FG003|Overall Study|Physician Decision|0|||
129935977|NCT01046825|467732271|FG004|Overall Study|Physician Decision|0|||
129935978|NCT01046825|467732267|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935979|NCT01046825|467732268|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935980|NCT01046825|467732269|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
129935981|NCT01046825|467732270|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935982|NCT01046825|467732271|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
129935983|NCT01046825|467732267|FG000|Overall Study|Found to be ineligible|0|||
129935984|NCT01046825|467732268|FG001|Overall Study|Found to be ineligible|1|||
129935985|NCT01046825|467732269|FG002|Overall Study|Found to be ineligible|0|||
129935986|NCT01046825|467732270|FG003|Overall Study|Found to be ineligible|0|||
129935987|NCT01046825|467732271|FG004|Overall Study|Found to be ineligible|0|||
129935988|NCT01046825|467732267|FG000|Overall Study|Death|0|||
129935989|NCT01046825|467732268|FG001|Overall Study|Death|0|||
129935990|NCT01046825|467732269|FG002|Overall Study|Death|0|||
129935991|NCT01046825|467732270|FG003|Overall Study|Death|1|||
129935992|NCT01046825|467732271|FG004|Overall Study|Death|0|||
129935993|NCT01046825|467732267|FG000|Overall Study|Did not submit biology samples|0|||
129935994|NCT01046825|467732268|FG001|Overall Study|Did not submit biology samples|0|||
129935995|NCT01046825|467732269|FG002|Overall Study|Did not submit biology samples|0|||
129935996|NCT01046825|467732270|FG003|Overall Study|Did not submit biology samples|0|||
129935997|NCT01046825|467732271|FG004|Overall Study|Did not submit biology samples|13|||
129935998|NCT02075554|467732273|FG000|Overall Study|Lost to Follow-up|7|||
129935999|NCT02075554|467732273|FG000|Overall Study|Withdrawal by Subject|5|||
129936000|NCT02075554|467732273|FG000|Overall Study|Physician Decision|3|||
129936001|NCT04993677|467732280|FG000|Overall Study|Lost to Follow-up|1|||
129936002|NCT04993677|467732281|FG001|Overall Study|Lost to Follow-up|0|||
129936003|NCT04993677|467732282|FG002|Overall Study|Lost to Follow-up|0|||
129936004|NCT04993677|467732283|FG003|Overall Study|Lost to Follow-up|0|||
129936005|NCT04993677|467732280|FG000|Overall Study|Death|11|||
129936006|NCT04993677|467732281|FG001|Overall Study|Death|8|||
129936007|NCT04993677|467732282|FG002|Overall Study|Death|3|||
129936008|NCT04993677|467732283|FG003|Overall Study|Death|1|||
129936009|NCT04993677|467732280|FG000|Overall Study|Subject withdrawal of consent|4|||
129936010|NCT04993677|467732281|FG001|Overall Study|Subject withdrawal of consent|3|||
129936011|NCT04993677|467732282|FG002|Overall Study|Subject withdrawal of consent|0|||
129936012|NCT04993677|467732283|FG003|Overall Study|Subject withdrawal of consent|2|||
129936013|NCT04993677|467732280|FG000|Overall Study|Study termination by sponsor|3|||
129936014|NCT04993677|467732281|FG001|Overall Study|Study termination by sponsor|25|||
129936015|NCT04993677|467732282|FG002|Overall Study|Study termination by sponsor|3|||
129936016|NCT04993677|467732283|FG003|Overall Study|Study termination by sponsor|3|||
129936017|NCT04993677|467732280|FG000|Overall Study|Other|2|||
129452255|NCT05678257|465953350|FG002|Overall Study|Protocol Violation|1|||
129936018|NCT04993677|467732281|FG001|Overall Study|Other|3|||
129936019|NCT04993677|467732282|FG002|Overall Study|Other|3|||
129936020|NCT04993677|467732283|FG003|Overall Study|Other|2|||
129936021|NCT00003222|467732286|FG000|Overall Study|Physician Decision|0|||
129936022|NCT00003222|467732287|FG001|Overall Study|Physician Decision|1|||
129936023|NCT04757753|467732288|FG000|Overall Study|Lost to Follow-up|7|||
129936024|NCT04757753|467732289|FG001|Overall Study|Lost to Follow-up|7|||
129936025|NCT04757753|467732288|FG000|Overall Study|Withdrawal by Subject|0|||
129936026|NCT04757753|467732289|FG001|Overall Study|Withdrawal by Subject|3|||
129936027|NCT04757753|467732288|FG000|Overall Study|Endodontic treatment failure|1|||
129936028|NCT04757753|467732289|FG001|Overall Study|Endodontic treatment failure|2|||
129936029|NCT04757753|467732288|FG000|Overall Study|Tooth fracture/extraction|3|||
129936030|NCT04757753|467732289|FG001|Overall Study|Tooth fracture/extraction|0|||
129936031|NCT01313559|467732290|FG000|Overall Study|Withdrawal by Subject|1|||
129936032|NCT01313559|467732291|FG001|Overall Study|Withdrawal by Subject|2|||
129936033|NCT01313559|467732290|FG000|Overall Study|Disease progression|1|||
129936034|NCT01313559|467732291|FG001|Overall Study|Disease progression|0|||
129936035|NCT01313559|467732290|FG000|Overall Study|Rising PSA|2|||
129936036|NCT01313559|467732291|FG001|Overall Study|Rising PSA|0|||
129936037|NCT02656706|467732293|FG000|Overall Study|Insurance Denial|1|||
129936038|NCT03725332|467732294|FG000|Overall Study|Adverse Event|5|||
129936039|NCT03725332|467732295|FG001|Overall Study|Adverse Event|10|||
129936040|NCT03725332|467732294|FG000|Overall Study|Death|1|||
129936041|NCT03725332|467732295|FG001|Overall Study|Death|3|||
129936042|NCT03725332|467732294|FG000|Overall Study|Lost to Follow-up|43|||
129936043|NCT03725332|467732295|FG001|Overall Study|Lost to Follow-up|122|||
129936044|NCT03725332|467732294|FG000|Overall Study|Withdrawal by Subject|0|||
129936045|NCT03725332|467732295|FG001|Overall Study|Withdrawal by Subject|1|||
129936046|NCT03725332|467732294|FG000|Overall Study|Duplicate enrollment|0|||
129936047|NCT03725332|467732295|FG001|Overall Study|Duplicate enrollment|1|||
129936048|NCT03725332|467732294|FG000|Overall Study|Did not consent|0|||
129936049|NCT03725332|467732295|FG001|Overall Study|Did not consent|1|||
129936050|NCT02701283|467732306|FG000|Overall Study|Death|25|||
129936051|NCT02701283|467732307|FG001|Overall Study|Death|29|||
129936052|NCT02701283|467732308|FG002|Overall Study|Death|19|||
129936053|NCT02701283|467732306|FG000|Overall Study|Lost to Follow-up|3|||
129936054|NCT02701283|467732307|FG001|Overall Study|Lost to Follow-up|8|||
129936055|NCT02701283|467732308|FG002|Overall Study|Lost to Follow-up|1|||
129936056|NCT02701283|467732306|FG000|Overall Study|Withdrawal by Subject|12|||
129936057|NCT02701283|467732307|FG001|Overall Study|Withdrawal by Subject|41|||
129936058|NCT02701283|467732308|FG002|Overall Study|Withdrawal by Subject|1|||
129936059|NCT02701283|467732306|FG000|Overall Study|Missed 2-year visit|22|||
129936060|NCT02701283|467732307|FG001|Overall Study|Missed 2-year visit|27|||
129936061|NCT02701283|467732308|FG002|Overall Study|Missed 2-year visit|0|||
129936062|NCT02701283|467732306|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
129936063|NCT02701283|467732307|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
129936064|NCT02701283|467732308|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
129936065|NCT04908514|467732314|FG000|Overall Study|Lost to Follow-up|2|||
129936066|NCT04908514|467732314|FG000|Overall Study|Withdrawal by Subject|1|||
129936067|NCT03248492|467732851|FG000|Overall Study|Progressive Disease|24|||
129936068|NCT03248492|467732852|FG001|Overall Study|Progressive Disease|23|||
129936069|NCT03248492|467732853|FG002|Overall Study|Progressive Disease|11|||
129936070|NCT03248492|467732854|FG003|Overall Study|Progressive Disease|66|||
129936071|NCT03248492|467732855|FG004|Overall Study|Progressive Disease|1|||
129936072|NCT03248492|467732851|FG000|Overall Study|Adverse Event|14|||
129936073|NCT03248492|467732852|FG001|Overall Study|Adverse Event|13|||
129936074|NCT03248492|467732853|FG002|Overall Study|Adverse Event|9|||
129936075|NCT03248492|467732854|FG003|Overall Study|Adverse Event|22|||
129936076|NCT03248492|467732855|FG004|Overall Study|Adverse Event|2|||
129936077|NCT03248492|467732851|FG000|Overall Study|Withdrawal by Subject|5|||
129936078|NCT03248492|467732852|FG001|Overall Study|Withdrawal by Subject|4|||
129936079|NCT03248492|467732853|FG002|Overall Study|Withdrawal by Subject|0|||
129936080|NCT03248492|467732854|FG003|Overall Study|Withdrawal by Subject|8|||
129936081|NCT03248492|467732855|FG004|Overall Study|Withdrawal by Subject|1|||
129936082|NCT03248492|467732851|FG000|Overall Study|Physician Decision|1|||
129936083|NCT03248492|467732852|FG001|Overall Study|Physician Decision|1|||
129936084|NCT03248492|467732853|FG002|Overall Study|Physician Decision|1|||
129936085|NCT03248492|467732854|FG003|Overall Study|Physician Decision|7|||
129936086|NCT03248492|467732855|FG004|Overall Study|Physician Decision|0|||
129936087|NCT03248492|467732851|FG000|Overall Study|Death|1|||
129936088|NCT03248492|467732852|FG001|Overall Study|Death|1|||
129936089|NCT03248492|467732853|FG002|Overall Study|Death|0|||
129936090|NCT03248492|467732854|FG003|Overall Study|Death|6|||
129936091|NCT03248492|467732855|FG004|Overall Study|Death|0|||
129936092|NCT03248492|467732851|FG000|Overall Study|Study Terminated by Sponsor|3|||
129936093|NCT03248492|467732852|FG001|Overall Study|Study Terminated by Sponsor|1|||
129936094|NCT03248492|467732853|FG002|Overall Study|Study Terminated by Sponsor|0|||
129936095|NCT03248492|467732854|FG003|Overall Study|Study Terminated by Sponsor|7|||
129936096|NCT03248492|467732855|FG004|Overall Study|Study Terminated by Sponsor|0|||
129936097|NCT03248492|467732851|FG000|Overall Study|Other|2|||
129936098|NCT03248492|467732852|FG001|Overall Study|Other|5|||
129936099|NCT03248492|467732853|FG002|Overall Study|Other|0|||
129936100|NCT03248492|467732854|FG003|Overall Study|Other|14|||
129936101|NCT03248492|467732855|FG004|Overall Study|Other|0|||
129936102|NCT03767335|467732856|FG000|Overall Study|Physician Decision|1|||
129936103|NCT03767335|467732857|FG001|Overall Study|Physician Decision|1|||
129936104|NCT03767335|467732858|FG002|Overall Study|Physician Decision|0|||
129936105|NCT03767335|467732856|FG000|Overall Study|Withdrawal by Subject|0|||
129936106|NCT03767335|467732857|FG001|Overall Study|Withdrawal by Subject|0|||
129936107|NCT03767335|467732858|FG002|Overall Study|Withdrawal by Subject|6|||
129936108|NCT03767335|467732856|FG000|Overall Study|Participant excluded from efficacy population|0|||
129936109|NCT03767335|467732857|FG001|Overall Study|Participant excluded from efficacy population|0|||
129936110|NCT03767335|467732858|FG002|Overall Study|Participant excluded from efficacy population|1|||
129936111|NCT03767335|467732856|FG000|Overall Study|Death|0|||
129936112|NCT03767335|467732857|FG001|Overall Study|Death|0|||
129936113|NCT03767335|467732858|FG002|Overall Study|Death|2|||
129936114|NCT03767335|467732856|FG000|Overall Study|Progressive Disease|2|||
129936115|NCT03767335|467732857|FG001|Overall Study|Progressive Disease|2|||
129936116|NCT03767335|467732858|FG002|Overall Study|Progressive Disease|2|||
129936117|NCT03767335|467732856|FG000|Overall Study|Disease progression needing additional medication|0|||
129936118|NCT03767335|467732857|FG001|Overall Study|Disease progression needing additional medication|0|||
129936119|NCT03767335|467732858|FG002|Overall Study|Disease progression needing additional medication|17|||
129936120|NCT03767335|467732856|FG000|Overall Study|Sponsor decision|0|||
129936121|NCT03767335|467732857|FG001|Overall Study|Sponsor decision|0|||
129936122|NCT03767335|467732858|FG002|Overall Study|Sponsor decision|2|||
129936123|NCT03767335|467732856|FG000|Overall Study|Other Medical Reasons|0|||
129936124|NCT03767335|467732857|FG001|Overall Study|Other Medical Reasons|0|||
129936125|NCT03767335|467732858|FG002|Overall Study|Other Medical Reasons|3|||
129936126|NCT03705390|467732859|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
129936127|NCT03705390|467732859|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
129936128|NCT04495621|467732861|FG000|Overall Study|Withdrawal by Subject|0|||
129936129|NCT04495621|467732862|FG001|Overall Study|Withdrawal by Subject|3|||
129936130|NCT04495621|467732861|FG000|Overall Study|Death|7|||
129936131|NCT04495621|467732862|FG001|Overall Study|Death|11|||
129936132|NCT04495621|467732861|FG000|Overall Study|Investigator Decision|0|||
129936133|NCT04495621|467732862|FG001|Overall Study|Investigator Decision|7|||
129936134|NCT04495621|467732861|FG000|Overall Study|Lost to Follow-up|0|||
129936135|NCT04495621|467732862|FG001|Overall Study|Lost to Follow-up|1|||
129936136|NCT01830595|467732871|FG000|First Period|Withdrawal by Subject|1|||
129936137|NCT01830595|467732872|FG001|First Period|Withdrawal by Subject|3|||
129936138|NCT01830595|467732871|FG000|Washout|Withdrawal by Subject|2|||
129936139|NCT01830595|467732872|FG001|Washout|Withdrawal by Subject|2|||
129936140|NCT05116774|467732877|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
129936141|NCT05116774|467732878|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
129936142|NCT05116774|467732877|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
129936143|NCT05116774|467732878|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
129936144|NCT05116774|467732877|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
129936145|NCT05116774|467732878|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
129936146|NCT05116774|467732877|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
129936147|NCT05116774|467732878|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
129936148|NCT03150862|467732879|FG000|Overall Study|Death|2|||
129936149|NCT03150862|467732880|FG001|Overall Study|Death|7|||
129936150|NCT03150862|467732881|FG002|Overall Study|Death|8|||
129936151|NCT03150862|467732882|FG003|Overall Study|Death|27|||
129936152|NCT03150862|467732883|FG004|Overall Study|Death|4|||
129936153|NCT03150862|467732884|FG005|Overall Study|Death|8|||
129936154|NCT03150862|467732885|FG006|Overall Study|Death|6|||
129936155|NCT03150862|467732886|FG007|Overall Study|Death|21|||
129936156|NCT03150862|467732879|FG000|Overall Study|Withdrawal by Subject|1|||
129936157|NCT03150862|467732880|FG001|Overall Study|Withdrawal by Subject|1|||
129936158|NCT03150862|467732881|FG002|Overall Study|Withdrawal by Subject|0|||
129936159|NCT03150862|467732882|FG003|Overall Study|Withdrawal by Subject|3|||
129936160|NCT03150862|467732883|FG004|Overall Study|Withdrawal by Subject|1|||
129936161|NCT03150862|467732884|FG005|Overall Study|Withdrawal by Subject|1|||
129936162|NCT03150862|467732885|FG006|Overall Study|Withdrawal by Subject|1|||
129936163|NCT03150862|467732886|FG007|Overall Study|Withdrawal by Subject|3|||
129936164|NCT03150862|467732879|FG000|Overall Study|Lost to Follow-up|0|||
129936165|NCT03150862|467732880|FG001|Overall Study|Lost to Follow-up|0|||
129936166|NCT03150862|467732881|FG002|Overall Study|Lost to Follow-up|1|||
129936167|NCT03150862|467732882|FG003|Overall Study|Lost to Follow-up|0|||
129936168|NCT03150862|467732883|FG004|Overall Study|Lost to Follow-up|0|||
129936169|NCT03150862|467732884|FG005|Overall Study|Lost to Follow-up|0|||
129936170|NCT03150862|467732885|FG006|Overall Study|Lost to Follow-up|0|||
129936171|NCT03150862|467732886|FG007|Overall Study|Lost to Follow-up|2|||
129936172|NCT03150862|467732879|FG000|Overall Study|Sponsor's decision|0|||
129936173|NCT03150862|467732880|FG001|Overall Study|Sponsor's decision|0|||
129936174|NCT03150862|467732881|FG002|Overall Study|Sponsor's decision|0|||
129936175|NCT03150862|467732882|FG003|Overall Study|Sponsor's decision|10|||
129936176|NCT03150862|467732883|FG004|Overall Study|Sponsor's decision|3|||
129936177|NCT03150862|467732884|FG005|Overall Study|Sponsor's decision|0|||
129936178|NCT03150862|467732885|FG006|Overall Study|Sponsor's decision|1|||
129936179|NCT03150862|467732886|FG007|Overall Study|Sponsor's decision|1|||
129936180|NCT03150862|467732879|FG000|Overall Study|Change in Methylation status|0|||
129936181|NCT03150862|467732880|FG001|Overall Study|Change in Methylation status|0|||
129936182|NCT03150862|467732881|FG002|Overall Study|Change in Methylation status|0|||
129936183|NCT03150862|467732882|FG003|Overall Study|Change in Methylation status|0|||
129936184|NCT03150862|467732883|FG004|Overall Study|Change in Methylation status|1|||
129936185|NCT03150862|467732884|FG005|Overall Study|Change in Methylation status|0|||
129936186|NCT03150862|467732885|FG006|Overall Study|Change in Methylation status|0|||
129936187|NCT03150862|467732886|FG007|Overall Study|Change in Methylation status|0|||
129936188|NCT03150862|467732879|FG000|Overall Study|Roll over in to Long Term Extension|0|||
129936189|NCT03150862|467732880|FG001|Overall Study|Roll over in to Long Term Extension|0|||
129936190|NCT03150862|467732881|FG002|Overall Study|Roll over in to Long Term Extension|0|||
129936191|NCT03150862|467732882|FG003|Overall Study|Roll over in to Long Term Extension|0|||
129936192|NCT03150862|467732883|FG004|Overall Study|Roll over in to Long Term Extension|0|||
129936193|NCT03150862|467732884|FG005|Overall Study|Roll over in to Long Term Extension|0|||
129936194|NCT03150862|467732885|FG006|Overall Study|Roll over in to Long Term Extension|0|||
129936195|NCT03150862|467732886|FG007|Overall Study|Roll over in to Long Term Extension|1|||
129936196|NCT03150862|467732879|FG000|Overall Study|Progressive Disease|0|||
129936197|NCT03150862|467732880|FG001|Overall Study|Progressive Disease|0|||
129936198|NCT03150862|467732881|FG002|Overall Study|Progressive Disease|0|||
129936199|NCT03150862|467732882|FG003|Overall Study|Progressive Disease|0|||
129936200|NCT03150862|467732883|FG004|Overall Study|Progressive Disease|0|||
129936201|NCT03150862|467732884|FG005|Overall Study|Progressive Disease|0|||
129936202|NCT03150862|467732885|FG006|Overall Study|Progressive Disease|0|||
129936203|NCT03150862|467732886|FG007|Overall Study|Progressive Disease|2|||
129936204|NCT04977583|467733387|FG000|Overall Study|Lost to Follow-up|8|||
129936205|NCT04977583|467733388|FG001|Overall Study|Lost to Follow-up|4|||
129936206|NCT04977583|467733389|FG002|Overall Study|Lost to Follow-up|13|||
129936207|NCT04977583|467733387|FG000|Overall Study|Withdrawal by Subject|3|||
129936208|NCT04977583|467733388|FG001|Overall Study|Withdrawal by Subject|2|||
129936209|NCT04977583|467733389|FG002|Overall Study|Withdrawal by Subject|1|||
129936210|NCT02422615|467733392|FG000|Treatment Period|Progressive disease|314|||
129936211|NCT02422615|467733393|FG001|Treatment Period|Progressive disease|200|||
129936212|NCT02422615|467733392|FG000|Treatment Period|Adverse Event|51|||
129936213|NCT02422615|467733393|FG001|Treatment Period|Adverse Event|9|||
129936214|NCT02422615|467733392|FG000|Treatment Period|Physician Decision|32|||
129936215|NCT02422615|467733393|FG001|Treatment Period|Physician Decision|8|||
129936216|NCT02422615|467733392|FG000|Treatment Period|Subject/guardian decision|38|||
129936217|NCT02422615|467733393|FG001|Treatment Period|Subject/guardian decision|8|||
129936218|NCT02422615|467733392|FG000|Treatment Period|Death|2|||
129936219|NCT02422615|467733393|FG001|Treatment Period|Death|1|||
129936220|NCT02422615|467733392|FG000|Treatment Period|Technical problems|0|||
129936221|NCT02422615|467733393|FG001|Treatment Period|Technical problems|1|||
129936222|NCT02422615|467733392|FG000|Treatment Period|Protocol deviation|1|||
129936223|NCT02422615|467733393|FG001|Treatment Period|Protocol deviation|1|||
129936224|NCT02422615|467733392|FG000|Treatment Period|Study terminated as per protocol|46|||
129936225|NCT02422615|467733393|FG001|Treatment Period|Study terminated as per protocol|14|||
129936226|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129936227|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129936228|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Death|2|||
129936229|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Death|1|||
129936230|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
129936231|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129936232|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
129936233|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
129936234|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
129936235|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
129936236|NCT02422615|467733392|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
129936237|NCT02422615|467733393|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
129936238|NCT04121546|467733395|FG000|Overall Study|Lost to Follow-up|1|||
129936239|NCT04121546|467733396|FG001|Overall Study|Lost to Follow-up|3|||
129936240|NCT03653364|467733397|FG000|Overall Study|Withdrawal by Subject|1|||
129936241|NCT03653364|467733397|FG000|Overall Study|Enrolled in Error|1|||
129936242|NCT03653364|467733397|FG000|Overall Study|Death|1|||
129936243|NCT04940624|467733398|FG000|Overall Study|Adverse Event|4|||
129936244|NCT04940624|467733399|FG001|Overall Study|Adverse Event|11|||
129936245|NCT04940624|467733398|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129936246|NCT04940624|467733399|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129936247|NCT04940624|467733398|FG000|Overall Study|Physician Decision|1|||
129936248|NCT04940624|467733399|FG001|Overall Study|Physician Decision|0|||
129936249|NCT04940624|467733398|FG000|Overall Study|Lost to Follow-up|1|||
129936250|NCT04940624|467733399|FG001|Overall Study|Lost to Follow-up|0|||
129936251|NCT04940624|467733398|FG000|Overall Study|Reason Not Specified|1|||
129936252|NCT04940624|467733399|FG001|Overall Study|Reason Not Specified|0|||
129936253|NCT05714059|467733406|FG000|Overall Study|Withdrawal by Subject|2|||
129936254|NCT05714059|467733407|FG001|Overall Study|Withdrawal by Subject|2|||
129936255|NCT05714059|467733406|FG000|Overall Study|Adverse Event|0|||
129936256|NCT05714059|467733407|FG001|Overall Study|Adverse Event|1|||
129936257|NCT05714059|467733406|FG000|Overall Study|Lost to Follow-up|0|||
129936258|NCT05714059|467733407|FG001|Overall Study|Lost to Follow-up|1|||
129936259|NCT05714059|467733406|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
129936260|NCT05714059|467733407|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
129936261|NCT05714059|467733406|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
129936262|NCT05714059|467733407|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
129936263|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
129936264|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
129936265|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
129936266|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
129936267|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
129936268|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
129936269|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
129936270|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
129936271|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
129936272|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
129936273|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
129936274|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
129936275|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
129936276|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
129936277|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
129936278|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
129936279|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
129936280|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
129936281|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
129936282|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
129936283|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
129936284|NCT04505722|467733410|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
129936285|NCT04505722|467733411|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
129936286|NCT04505722|467733412|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
129936287|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
129936288|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
129936289|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
129936290|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
129936291|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
129936292|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
129936293|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
129936294|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
129936295|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
129936296|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
129936297|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
129936298|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
129936299|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
129936300|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
129936301|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
129936302|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
129936303|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
129936304|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
129936305|NCT04505722|467733410|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
129936306|NCT04505722|467733411|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
129936307|NCT04505722|467733412|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
129936308|NCT04755595|467733413|FG000|Overall Study|Lost to Follow-up|1|||
129936309|NCT00319696|467733414|FG000|Overall Study|Adverse Event|36|||
129452256|NCT05678257|465953348|FG000|Overall Study|Patient non-compliance|0|||
129452257|NCT05678257|465953349|FG001|Overall Study|Patient non-compliance|0|||
129452258|NCT05678257|465953350|FG002|Overall Study|Patient non-compliance|3|||
129452259|NCT02046096|465953351|FG000|Overall Study|Death|28|||
129452260|NCT02046096|465953352|FG001|Overall Study|Death|45|||
129452261|NCT02046096|465953351|FG000|Overall Study|Lost to Follow-up|9|||
129452262|NCT02046096|465953352|FG001|Overall Study|Lost to Follow-up|20|||
129452263|NCT02046096|465953351|FG000|Overall Study|Withdrawal by Subject|5|||
129452264|NCT02046096|465953352|FG001|Overall Study|Withdrawal by Subject|17|||
129452265|NCT02046096|465953351|FG000|Overall Study|Other endpoint|2|||
129452266|NCT02046096|465953352|FG001|Overall Study|Other endpoint|19|||
129452267|NCT05314517|465953353|FG000|Double-blind Period|Adverse Event|4|||
129452268|NCT05314517|465953354|FG001|Double-blind Period|Adverse Event|0|||
129452269|NCT05314517|465953355|FG002|Double-blind Period|Adverse Event|0|||
129452270|NCT05314517|465953356|FG003|Double-blind Period|Adverse Event|0|||
129452271|NCT05314517|465953353|FG000|Double-blind Period|Noncompliance|0|||
129452272|NCT05314517|465953354|FG001|Double-blind Period|Noncompliance|1|||
129936310|NCT00319696|467733414|FG000|Overall Study|withdrawal of consent|14|||
129936311|NCT00319696|467733414|FG000|Overall Study|administrative|7|||
129936312|NCT00319696|467733414|FG000|Overall Study|Lost to Follow-up|3|||
129936313|NCT03891758|467733416|FG000|Overall Study|Adverse Event|2|||
129936314|NCT03891758|467733417|FG001|Overall Study|Adverse Event|0|||
129936315|NCT03891758|467733416|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129936316|NCT03891758|467733417|FG001|Overall Study|Withdrawal by parent/guardian|2|||
129936317|NCT05039021|467734107|FG000|Overall Study|Death|1|||
129936318|NCT05039021|467734107|FG000|Overall Study|Lost to Follow-up|3|||
129936319|NCT01639131|467734108|FG000|Overall Study|Disease Progression|6|||
129936320|NCT00686595|467734112|FG000|Overall Study|Adverse Event|3|||
129936321|NCT00686595|467734112|FG000|Overall Study|Protocol Violation|1|||
129936322|NCT00686595|467734112|FG000|Overall Study|Lost to Follow-up|1|||
129936323|NCT00686595|467734112|FG000|Overall Study|Lack of Efficacy|1|||
129936324|NCT00686595|467734112|FG000|Overall Study|Poor Compliance|1|||
129936325|NCT00087685|467734124|FG000|Overall Study|Adverse Event|5|||
129936326|NCT00087685|467734124|FG000|Overall Study|Non-Compliance|1|||
129936327|NCT00087685|467734124|FG000|Overall Study|Progressive Disease|5|||
129936328|NCT00087685|467734124|FG000|Overall Study|Withdrawal by Subject|3|||
129936329|NCT03213457|467734125|FG000|Screening Period|Withdrawal by Subject|0|||
129936330|NCT03213457|467734126|FG001|Screening Period|Withdrawal by Subject|1|||
129936331|NCT03213457|467734127|FG002|Screening Period|Withdrawal by Subject|0|||
129936332|NCT03213457|467734125|FG000|Screening Period|Other|1|||
129936333|NCT03213457|467734126|FG001|Screening Period|Other|0|||
129936334|NCT03213457|467734127|FG002|Screening Period|Other|0|||
129936335|NCT03213457|467734125|FG000|Double-Blind Period|Adverse Event|3|||
129936336|NCT03213457|467734126|FG001|Double-Blind Period|Adverse Event|2|||
129936337|NCT03213457|467734127|FG002|Double-Blind Period|Adverse Event|7|||
129936338|NCT03213457|467734125|FG000|Double-Blind Period|Withdrawal by Subject|14|||
129936339|NCT03213457|467734126|FG001|Double-Blind Period|Withdrawal by Subject|2|||
129936340|NCT03213457|467734127|FG002|Double-Blind Period|Withdrawal by Subject|14|||
129936341|NCT03213457|467734125|FG000|Double-Blind Period|Lost to Follow-up|2|||
129936342|NCT03213457|467734126|FG001|Double-Blind Period|Lost to Follow-up|3|||
129936343|NCT03213457|467734127|FG002|Double-Blind Period|Lost to Follow-up|9|||
129936344|NCT03213457|467734125|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
129936345|NCT03213457|467734126|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
129936346|NCT03213457|467734127|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
129936347|NCT03213457|467734125|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
129936348|NCT03213457|467734126|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
129936349|NCT03213457|467734127|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
129936350|NCT03213457|467734125|FG000|Double-Blind Period|Pregnancy|5|||
129936351|NCT03213457|467734126|FG001|Double-Blind Period|Pregnancy|0|||
129936352|NCT03213457|467734127|FG002|Double-Blind Period|Pregnancy|0|||
129936353|NCT03213457|467734125|FG000|Double-Blind Period|Other|10|||
129936354|NCT03213457|467734126|FG001|Double-Blind Period|Other|3|||
129936355|NCT03213457|467734127|FG002|Double-Blind Period|Other|17|||
129936356|NCT03213457|467734125|FG000|Open-Label Period|Adverse Event|1|||
129936357|NCT03213457|467734126|FG001|Open-Label Period|Adverse Event|2|||
129936358|NCT03213457|467734127|FG002|Open-Label Period|Adverse Event|2|||
129936359|NCT03213457|467734125|FG000|Open-Label Period|Withdrawal by Subject|12|||
129936360|NCT03213457|467734126|FG001|Open-Label Period|Withdrawal by Subject|5|||
129452273|NCT05314517|465953355|FG002|Double-blind Period|Noncompliance|0|||
129452274|NCT05314517|465953356|FG003|Double-blind Period|Noncompliance|0|||
129936361|NCT03213457|467734127|FG002|Open-Label Period|Withdrawal by Subject|24|||
129936362|NCT03213457|467734125|FG000|Open-Label Period|Lost to Follow-up|1|||
129936363|NCT03213457|467734126|FG001|Open-Label Period|Lost to Follow-up|2|||
129936364|NCT03213457|467734127|FG002|Open-Label Period|Lost to Follow-up|8|||
129936365|NCT03213457|467734125|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
129936366|NCT03213457|467734126|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
129936367|NCT03213457|467734127|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
129936368|NCT03213457|467734125|FG000|Open-Label Period|Non-compliance with study procedures|1|||
129936369|NCT03213457|467734126|FG001|Open-Label Period|Non-compliance with study procedures|1|||
129936370|NCT03213457|467734127|FG002|Open-Label Period|Non-compliance with study procedures|2|||
129936371|NCT03213457|467734125|FG000|Open-Label Period|Exclusionary medications|0|||
129936372|NCT03213457|467734126|FG001|Open-Label Period|Exclusionary medications|0|||
129936373|NCT03213457|467734127|FG002|Open-Label Period|Exclusionary medications|1|||
129936374|NCT03213457|467734125|FG000|Open-Label Period|Other|1|||
129936375|NCT03213457|467734126|FG001|Open-Label Period|Other|1|||
129936376|NCT03213457|467734127|FG002|Open-Label Period|Other|6|||
129936377|NCT03213457|467734125|FG000|Follow-Up Period|Adverse Event|16|||
129936378|NCT03213457|467734126|FG001|Follow-Up Period|Adverse Event|8|||
129936379|NCT03213457|467734127|FG002|Follow-Up Period|Adverse Event|37|||
129936380|NCT03213457|467734125|FG000|Follow-Up Period|Withdrawal by Subject|18|||
129936381|NCT03213457|467734126|FG001|Follow-Up Period|Withdrawal by Subject|11|||
129936382|NCT03213457|467734127|FG002|Follow-Up Period|Withdrawal by Subject|55|||
129936383|NCT03213457|467734125|FG000|Follow-Up Period|Lost to Follow-up|28|||
129936384|NCT03213457|467734126|FG001|Follow-Up Period|Lost to Follow-up|15|||
129936385|NCT03213457|467734127|FG002|Follow-Up Period|Lost to Follow-up|50|||
129936386|NCT03213457|467734125|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
129936387|NCT03213457|467734126|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
129936388|NCT03213457|467734127|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
129936389|NCT03213457|467734125|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
129936390|NCT03213457|467734126|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
129936391|NCT03213457|467734127|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
129936392|NCT03213457|467734125|FG000|Follow-Up Period|Pregnancy|7|||
129936393|NCT03213457|467734126|FG001|Follow-Up Period|Pregnancy|0|||
129936394|NCT03213457|467734127|FG002|Follow-Up Period|Pregnancy|18|||
129936395|NCT03213457|467734125|FG000|Follow-Up Period|Exclusionary medications|1|||
129936396|NCT03213457|467734126|FG001|Follow-Up Period|Exclusionary medications|1|||
129936397|NCT03213457|467734127|FG002|Follow-Up Period|Exclusionary medications|5|||
129936398|NCT03213457|467734125|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
129936399|NCT03213457|467734126|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
129936400|NCT03213457|467734127|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
129936401|NCT03213457|467734125|FG000|Follow-Up Period|Other|14|||
129936402|NCT03213457|467734126|FG001|Follow-Up Period|Other|10|||
129936403|NCT03213457|467734127|FG002|Follow-Up Period|Other|31|||
129936404|NCT05934292|467734128|FG000|Overall Study|Lost to Follow-up|0|||
129936405|NCT05934292|467734129|FG001|Overall Study|Lost to Follow-up|0|||
129936406|NCT05934292|467734130|FG002|Overall Study|Lost to Follow-up|1|||
129936407|NCT05934292|467734131|FG003|Overall Study|Lost to Follow-up|0|||
129936408|NCT04479787|467734132|FG000|Through 6 Months|Withdrawal by Subject|16|||
129936409|NCT04479787|467734133|FG001|Through 6 Months|Withdrawal by Subject|14|||
129936410|NCT04479787|467734132|FG000|Through 6 Months|Unsuccessful Trial|17|||
129936411|NCT04479787|467734133|FG001|Through 6 Months|Unsuccessful Trial|0|||
129936412|NCT04479787|467734132|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
129936413|NCT04479787|467734133|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
129936414|NCT04479787|467734132|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
129936415|NCT04479787|467734133|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
129936416|NCT04479787|467734132|FG000|Through 6 Months|Lost to Follow-up|3|||
129936417|NCT04479787|467734133|FG001|Through 6 Months|Lost to Follow-up|2|||
129936418|NCT04479787|467734132|FG000|Through 6 Months|Death|3|||
129936419|NCT04479787|467734133|FG001|Through 6 Months|Death|0|||
129936420|NCT04479787|467734132|FG000|Through 6 Months|Inclusion/Exclusion|2|||
129936421|NCT04479787|467734133|FG001|Through 6 Months|Inclusion/Exclusion|1|||
129936422|NCT04479787|467734132|FG000|Through 6 Months|Subject Became Pregnant|1|||
129936423|NCT04479787|467734133|FG001|Through 6 Months|Subject Became Pregnant|1|||
129936424|NCT04479787|467734132|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
129936425|NCT04479787|467734133|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
129936426|NCT04479787|467734132|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
129936427|NCT04479787|467734133|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
129936428|NCT04479787|467734132|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
129936429|NCT04479787|467734133|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
129936430|NCT04479787|467734132|FG000|After 6 Months|Withdrawal by Subject|3|||
129936431|NCT04479787|467734133|FG001|After 6 Months|Withdrawal by Subject|13|||
129936432|NCT04479787|467734132|FG000|After 6 Months|Unsuccessful Trial|0|||
129936433|NCT04479787|467734133|FG001|After 6 Months|Unsuccessful Trial|7|||
129936434|NCT04479787|467734132|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
129936435|NCT04479787|467734133|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
129936436|NCT04479787|467734132|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
129936437|NCT04479787|467734133|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
129936438|NCT04479787|467734132|FG000|After 6 Months|Death|2|||
129936439|NCT04479787|467734133|FG001|After 6 Months|Death|0|||
129936440|NCT04479787|467734132|FG000|After 6 Months|Lost to Follow-up|1|||
129936441|NCT04479787|467734133|FG001|After 6 Months|Lost to Follow-up|1|||
129936442|NCT04479787|467734132|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
129936443|NCT04479787|467734133|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
129936444|NCT04479787|467734132|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
129936445|NCT04479787|467734133|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
129936446|NCT04479787|467734132|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
129936447|NCT04479787|467734133|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
129936448|NCT04479787|467734132|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
129936449|NCT04479787|467734133|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
129936450|NCT04899674|467734134|FG000|Test|Adverse Event|1|||
129936451|NCT03774472|467734135|FG000|Overall Study|Physician Decision|1|||
129936452|NCT03774472|467734136|FG001|Overall Study|Physician Decision|0|||
129936453|NCT03774472|467734137|FG002|Overall Study|Physician Decision|0|||
129936454|NCT03774472|467734135|FG000|Overall Study|Progression prior to 4 weeks|0|||
129936455|NCT03774472|467734136|FG001|Overall Study|Progression prior to 4 weeks|1|||
129936456|NCT03774472|467734137|FG002|Overall Study|Progression prior to 4 weeks|0|||
129936457|NCT03774472|467734135|FG000|Overall Study|Withdrawal by Subject|0|||
129936458|NCT03774472|467734136|FG001|Overall Study|Withdrawal by Subject|1|||
129936459|NCT03774472|467734137|FG002|Overall Study|Withdrawal by Subject|0|||
129936460|NCT04059406|467734138|FG000|Overall Study|Early Treatment Termination|5|||
129936461|NCT04059406|467734139|FG001|Overall Study|Early Treatment Termination|5|||
129936462|NCT04059406|467734140|FG002|Overall Study|Early Treatment Termination|15|||
129936463|NCT05155306|467734141|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
129936464|NCT05155306|467734142|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
129936465|NCT05155306|467734143|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
129936466|NCT05155306|467734144|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
129936467|NCT05155306|467734141|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
129936468|NCT05155306|467734142|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
129936469|NCT05155306|467734143|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
129936470|NCT05155306|467734144|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
129936471|NCT05601882|467734147|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
129936472|NCT05601882|467734148|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
129936473|NCT05601882|467734149|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
129936474|NCT05601882|467734150|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
129936475|NCT05601882|467734147|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
129936476|NCT05601882|467734148|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
129936477|NCT05601882|467734149|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
129936478|NCT05601882|467734150|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
129936479|NCT05601882|467734147|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
129936480|NCT05601882|467734148|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
129936481|NCT05601882|467734149|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
129936482|NCT05601882|467734150|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
129936483|NCT05601882|467734147|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
129936484|NCT05601882|467734148|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
129936485|NCT05601882|467734149|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
129936486|NCT05601882|467734150|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
129936487|NCT05601882|467734147|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
129936488|NCT05601882|467734148|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
129936489|NCT05601882|467734149|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
129936490|NCT05601882|467734150|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
129936491|NCT05601882|467734147|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
129936492|NCT05601882|467734148|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
129936493|NCT05601882|467734149|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
129936494|NCT05601882|467734150|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
129936495|NCT04158141|467734151|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
129936496|NCT04158141|467734152|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
129936497|NCT04158141|467734153|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
129936498|NCT04158141|467734151|FG000|Step 1: Registration|Adverse Event|1|||
129936499|NCT04158141|467734152|FG001|Step 1: Registration|Adverse Event|0|||
129936500|NCT04158141|467734153|FG002|Step 1: Registration|Adverse Event|0|||
129936501|NCT04158141|467734151|FG000|Step 1: Registration|Withdrawal by Subject|1|||
129936502|NCT04158141|467734152|FG001|Step 1: Registration|Withdrawal by Subject|0|||
129936503|NCT04158141|467734153|FG002|Step 1: Registration|Withdrawal by Subject|0|||
129936504|NCT04158141|467734151|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
129936505|NCT04158141|467734152|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
129936506|NCT04158141|467734153|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
129936507|NCT04121741|467734157|FG000|Overall Study|Protocol Violation|1|||
129936508|NCT04121741|467734158|FG001|Overall Study|Protocol Violation|0|||
129936509|NCT04121741|467734159|FG002|Overall Study|Protocol Violation|0|||
129936510|NCT04121741|467734160|FG003|Overall Study|Protocol Violation|0|||
129936511|NCT04121741|467734161|FG004|Overall Study|Protocol Violation|0|||
129936512|NCT04121741|467734162|FG005|Overall Study|Protocol Violation|0|||
129936513|NCT03473223|467734163|FG000|Overall Study|Lost to Follow-up|1|||
129936514|NCT03473223|467734164|FG001|Overall Study|Lost to Follow-up|1|||
129936515|NCT03473223|467734163|FG000|Overall Study|Withdrawal by Subject|47|||
129936516|NCT03473223|467734164|FG001|Overall Study|Withdrawal by Subject|42|||
129936517|NCT03473223|467734163|FG000|Overall Study|Indirect contact|32|||
129936518|NCT03473223|467734164|FG001|Overall Study|Indirect contact|29|||
129936519|NCT03473223|467734163|FG000|Overall Study|Other (Not specified)|32|||
129936520|NCT03473223|467734164|FG001|Overall Study|Other (Not specified)|20|||
129936521|NCT00115934|467734165|FG000|Overall Study|Lost to Follow-up|1|||
129936522|NCT00115934|467734166|FG001|Overall Study|Lost to Follow-up|0|||
129936523|NCT00115934|467734165|FG000|Overall Study|Did not receive intervention|3|||
129936524|NCT00115934|467734166|FG001|Overall Study|Did not receive intervention|2|||
129936525|NCT05827068|467734170|FG000|Overall Study|Lost to Follow-up|1|||
129936526|NCT05827068|467734171|FG001|Overall Study|Lost to Follow-up|4|||
129936527|NCT05827068|467734172|FG002|Overall Study|Lost to Follow-up|1|||
129936528|NCT05827068|467734173|FG003|Overall Study|Lost to Follow-up|1|||
129936529|NCT05827068|467734174|FG004|Overall Study|Lost to Follow-up|2|||
129936530|NCT05827068|467734175|FG005|Overall Study|Lost to Follow-up|4|||
129936531|NCT05827068|467734176|FG006|Overall Study|Lost to Follow-up|1|||
129936532|NCT05827068|467734170|FG000|Overall Study|Withdrawal by Subject|4|||
129936533|NCT05827068|467734171|FG001|Overall Study|Withdrawal by Subject|0|||
129936534|NCT05827068|467734172|FG002|Overall Study|Withdrawal by Subject|1|||
129936535|NCT05827068|467734173|FG003|Overall Study|Withdrawal by Subject|2|||
129936536|NCT05827068|467734174|FG004|Overall Study|Withdrawal by Subject|3|||
129936537|NCT05827068|467734175|FG005|Overall Study|Withdrawal by Subject|0|||
129936538|NCT05827068|467734176|FG006|Overall Study|Withdrawal by Subject|1|||
129936539|NCT05827068|467734170|FG000|Overall Study|Physician Decision|0|||
129936540|NCT05827068|467734171|FG001|Overall Study|Physician Decision|0|||
129936541|NCT05827068|467734172|FG002|Overall Study|Physician Decision|0|||
129936542|NCT05827068|467734173|FG003|Overall Study|Physician Decision|0|||
129936543|NCT05827068|467734174|FG004|Overall Study|Physician Decision|1|||
129936544|NCT05827068|467734175|FG005|Overall Study|Physician Decision|0|||
129936545|NCT05827068|467734176|FG006|Overall Study|Physician Decision|1|||
129936546|NCT05827068|467734170|FG000|Overall Study|Other Than Specified|0|||
129936547|NCT05827068|467734171|FG001|Overall Study|Other Than Specified|1|||
129936548|NCT05827068|467734172|FG002|Overall Study|Other Than Specified|0|||
129936549|NCT05827068|467734173|FG003|Overall Study|Other Than Specified|0|||
129936550|NCT05827068|467734174|FG004|Overall Study|Other Than Specified|0|||
129936551|NCT05827068|467734175|FG005|Overall Study|Other Than Specified|0|||
129936552|NCT05827068|467734176|FG006|Overall Study|Other Than Specified|0|||
129936553|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
129936554|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
129452275|NCT05314517|465953353|FG000|Double-blind Period|Randomized, not treated|1|||
129452276|NCT05314517|465953354|FG001|Double-blind Period|Randomized, not treated|0|||
129452277|NCT05314517|465953355|FG002|Double-blind Period|Randomized, not treated|0|||
129452278|NCT05314517|465953356|FG003|Double-blind Period|Randomized, not treated|0|||
129452279|NCT05314517|465953353|FG000|Open-label Extension|Adverse Event|0|||
129452280|NCT05314517|465953354|FG001|Open-label Extension|Adverse Event|0|||
129936555|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
129936556|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
129452281|NCT05314517|465953355|FG002|Open-label Extension|Adverse Event|1|||
129452282|NCT05314517|465953356|FG003|Open-label Extension|Adverse Event|2|||
129452283|NCT05314517|465953353|FG000|Open-label Extension|Investigator decision|0|||
129452284|NCT05314517|465953354|FG001|Open-label Extension|Investigator decision|0|||
129452285|NCT05314517|465953355|FG002|Open-label Extension|Investigator decision|1|||
129936557|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
129936558|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
129936559|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
129936560|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
129936561|NCT03867201|467734177|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
129936562|NCT03867201|467734178|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
129936563|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Adverse Event|5|||
129936564|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Adverse Event|11|||
129936565|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
129936566|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
129936567|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Physician Decision|6|||
129936568|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Physician Decision|3|||
129936569|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Pregnancy|2|||
129936570|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Pregnancy|2|||
129936571|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
129936572|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
129936573|NCT03867201|467734177|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
129936574|NCT03867201|467734178|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
129936575|NCT03867201|467734177|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
129936576|NCT03867201|467734178|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
129936577|NCT03867201|467734177|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
129936578|NCT03867201|467734178|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
129936579|NCT04039113|467734181|FG000|Overall Study|Withdrawal by Subject|8|||
129936580|NCT04039113|467734182|FG001|Overall Study|Withdrawal by Subject|11|||
129936581|NCT04039113|467734181|FG000|Overall Study|Lost to Follow-up|1|||
129936582|NCT04039113|467734182|FG001|Overall Study|Lost to Follow-up|1|||
129936583|NCT04039113|467734181|FG000|Overall Study|Adverse Event|2|||
129452286|NCT05314517|465953356|FG003|Open-label Extension|Investigator decision|0|||
129452287|NCT05314517|465953353|FG000|Open-label Extension|Lost to Follow-up|0|||
129452288|NCT05314517|465953354|FG001|Open-label Extension|Lost to Follow-up|0|||
129936584|NCT04039113|467734182|FG001|Overall Study|Adverse Event|2|||
129936585|NCT04039113|467734181|FG000|Overall Study|Death|2|||
129936586|NCT04039113|467734182|FG001|Overall Study|Death|4|||
129936587|NCT04039113|467734181|FG000|Overall Study|Site Closure|6|||
129936588|NCT04039113|467734182|FG001|Overall Study|Site Closure|0|||
129936589|NCT04039113|467734181|FG000|Overall Study|Failure to meet randomisation criteria|4|||
129936590|NCT04039113|467734182|FG001|Overall Study|Failure to meet randomisation criteria|0|||
129936591|NCT01470144|467734183|FG000|Overall Study|Adverse Event|2|||
129936592|NCT01470144|467734183|FG000|Overall Study|Death|1|||
129936593|NCT01470144|467734183|FG000|Overall Study|Lung transplant|6|||
129936594|NCT01470144|467734183|FG000|Overall Study|Patient's and investigator's decision|1|||
129936595|NCT01596972|467734626|FG000|Overall Study|Physician Decision|1|||
129936596|NCT01596972|467734627|FG001|Overall Study|Physician Decision|9|||
129936597|NCT01596972|467734626|FG000|Overall Study|Lost to Follow-up|0|||
129936598|NCT01596972|467734627|FG001|Overall Study|Lost to Follow-up|4|||
129936599|NCT01596972|467734626|FG000|Overall Study|Withdrawal by Subject|0|||
129936600|NCT01596972|467734627|FG001|Overall Study|Withdrawal by Subject|1|||
129936601|NCT01260896|467734629|FG000|First Intervention|Withdrawn Due to Emesis|2|||
129936602|NCT01260896|467734630|FG001|First Intervention|Withdrawn Due to Emesis|0|||
129936603|NCT06688357|467734631|FG000|Overall Study|Adverse Event|0|||
129936604|NCT06688357|467734632|FG001|Overall Study|Adverse Event|1|||
129936605|NCT04018495|467734633|FG000|Overall Study|Physician Decision|1|||
129936606|NCT01084863|467734636|FG000|Main Study Treatment Period|Disease progression|11|||
129936607|NCT01084863|467734637|FG001|Main Study Treatment Period|Disease progression|7|||
129936608|NCT01084863|467734636|FG000|Main Study Treatment Period|Adverse Event|5|||
129936609|NCT01084863|467734637|FG001|Main Study Treatment Period|Adverse Event|3|||
129936610|NCT01084863|467734636|FG000|Main Study Treatment Period|Other Reason|0|||
129452289|NCT05314517|465953355|FG002|Open-label Extension|Lost to Follow-up|0|||
129452290|NCT05314517|465953356|FG003|Open-label Extension|Lost to Follow-up|1|||
129936611|NCT01084863|467734637|FG001|Main Study Treatment Period|Other Reason|1|||
129936612|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
129936613|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
129936614|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
129936615|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
129936616|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
129936617|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
129936618|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
129936619|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
129936620|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Other|0|||
129936621|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Other|1|||
129936622|NCT01084863|467734636|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
129936623|NCT01084863|467734637|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
129936624|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
129936625|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
129936626|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
129936627|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
129936628|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
129936629|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
129936630|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
129936631|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
129936632|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
129936633|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
129936634|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
129936635|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
129936636|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
129936637|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
129936638|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
129936639|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
129936640|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
129936641|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
129936642|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
129936643|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
129936644|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
129936645|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
129936646|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
129936647|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
129936648|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
129936649|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
129936650|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
129936651|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
129936652|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
129936653|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
129936654|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
129936655|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
129936656|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
129936657|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
129936658|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
129936659|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
129936660|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
129936661|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
129936662|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
129936663|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
129936664|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
129936665|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
129936666|NCT03524092|467734638|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
129936667|NCT03524092|467734639|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
129936668|NCT03524092|467734640|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
129936669|NCT03524092|467734641|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
129936670|NCT03524092|467734642|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
129936671|NCT03524092|467734643|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
129936672|NCT03524092|467734638|FG000|Loss of Response Rescue Period|Adverse Event|0|||
129936673|NCT03524092|467734639|FG001|Loss of Response Rescue Period|Adverse Event|0|||
129936674|NCT03524092|467734640|FG002|Loss of Response Rescue Period|Adverse Event|0|||
129936675|NCT03524092|467734641|FG003|Loss of Response Rescue Period|Adverse Event|2|||
129936676|NCT03524092|467734642|FG004|Loss of Response Rescue Period|Adverse Event|0|||
129936677|NCT03524092|467734643|FG005|Loss of Response Rescue Period|Adverse Event|0|||
129936678|NCT03524092|467734638|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
129936679|NCT03524092|467734639|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
129936680|NCT03524092|467734640|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
129936681|NCT03524092|467734641|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
129936682|NCT03524092|467734642|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
129936683|NCT03524092|467734643|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
129936684|NCT03524092|467734638|FG000|Loss of Response Rescue Period|Pregnancy|0|||
129936685|NCT03524092|467734639|FG001|Loss of Response Rescue Period|Pregnancy|0|||
129936686|NCT03524092|467734640|FG002|Loss of Response Rescue Period|Pregnancy|0|||
129936687|NCT03524092|467734641|FG003|Loss of Response Rescue Period|Pregnancy|1|||
129936688|NCT03524092|467734642|FG004|Loss of Response Rescue Period|Pregnancy|0|||
129936689|NCT03524092|467734643|FG005|Loss of Response Rescue Period|Pregnancy|0|||
129936690|NCT03524092|467734638|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
129936691|NCT03524092|467734639|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
129936692|NCT03524092|467734640|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
129936693|NCT03524092|467734641|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
129936694|NCT03524092|467734642|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
129936695|NCT03524092|467734643|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
129936696|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
129936697|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
129936698|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
129936699|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
129936700|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
129936701|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
129936702|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
129936703|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
129936704|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
129936705|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
129936706|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
129936707|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
129936708|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
129936709|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
129936710|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
129936711|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
129936712|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
129936713|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
129936714|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
129936715|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
129936716|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
129936717|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
129936718|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
129936719|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
129936720|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
129936721|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
129936722|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
129936723|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
129936724|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
129936725|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
129936726|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
129936727|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
129936728|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
129936729|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
129936730|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
129936731|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
129936732|NCT03524092|467734638|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
129936733|NCT03524092|467734639|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
129936734|NCT03524092|467734640|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
129936735|NCT03524092|467734641|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
129936736|NCT03524092|467734642|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
129936737|NCT03524092|467734643|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
129936738|NCT03524092|467734638|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
129936739|NCT03524092|467734639|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
129936740|NCT03524092|467734640|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
129936741|NCT03524092|467734641|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
129936742|NCT03524092|467734642|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
129936743|NCT03524092|467734643|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
129936744|NCT03524092|467734638|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
129936745|NCT03524092|467734639|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
129936746|NCT03524092|467734640|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
129936747|NCT03524092|467734641|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
129936748|NCT03524092|467734642|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
129936749|NCT03524092|467734643|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
129936750|NCT03524092|467734638|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
129936751|NCT03524092|467734639|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
129936752|NCT03524092|467734640|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
129936753|NCT03524092|467734641|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
129936754|NCT03524092|467734642|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
129936755|NCT03524092|467734643|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
129936756|NCT03524092|467734638|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
129936757|NCT03524092|467734639|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
129936758|NCT03524092|467734640|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
129936759|NCT03524092|467734641|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
129936760|NCT03524092|467734642|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
129936761|NCT03524092|467734643|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
129936762|NCT03834740|467734644|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
129936763|NCT03834740|467734645|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
129936764|NCT03834740|467734646|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
129936765|NCT03275285|467734649|FG000|Overall Study|Ongoing|45|||
129936766|NCT03275285|467734650|FG001|Overall Study|Ongoing|69|||
129936767|NCT06191679|467734651|FG000|Baseline|Lost to Follow-up|1|||
129936768|NCT06191679|467734652|FG001|Baseline|Lost to Follow-up|0|||
129936769|NCT06191679|467734653|FG002|Baseline|Lost to Follow-up|1|||
129936770|NCT06191679|467734654|FG003|Baseline|Lost to Follow-up|0|||
129936771|NCT06191679|467734651|FG000|Allocation to Group|Withdrawal by Subject|0|||
129936772|NCT06191679|467734652|FG001|Allocation to Group|Withdrawal by Subject|1|||
129936773|NCT06191679|467734653|FG002|Allocation to Group|Withdrawal by Subject|2|||
129936774|NCT06191679|467734654|FG003|Allocation to Group|Withdrawal by Subject|0|||
129936775|NCT06191679|467734651|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
129936776|NCT06191679|467734652|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
129936777|NCT06191679|467734653|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
129936778|NCT06191679|467734654|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
129936779|NCT06191679|467734651|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
129936780|NCT06191679|467734652|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
129936781|NCT06191679|467734653|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
129936782|NCT06191679|467734654|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
129936783|NCT06191679|467734651|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
129936784|NCT06191679|467734652|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
129936785|NCT06191679|467734653|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
129936786|NCT06191679|467734654|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
129936787|NCT02500576|467734655|FG000|Overall Study|Adverse Event|0|||
129936788|NCT02500576|467734656|FG001|Overall Study|Adverse Event|1|||
129936789|NCT02500576|467734655|FG000|Overall Study|Death|2|||
129936790|NCT02500576|467734656|FG001|Overall Study|Death|1|||
129936791|NCT02500576|467734655|FG000|Overall Study|Lack of Efficacy|5|||
129936792|NCT02500576|467734656|FG001|Overall Study|Lack of Efficacy|5|||
129936793|NCT02500576|467734655|FG000|Overall Study|Withdrawal by Subject|1|||
129936794|NCT02500576|467734656|FG001|Overall Study|Withdrawal by Subject|1|||
129936795|NCT00353496|467734659|FG000|Overall Study|Adverse Event|1|||
129936796|NCT00353496|467734660|FG001|Overall Study|Adverse Event|0|||
129936797|NCT00353496|467734659|FG000|Overall Study|Protocol Violation|2|||
129936798|NCT00353496|467734660|FG001|Overall Study|Protocol Violation|2|||
129936799|NCT00353496|467734659|FG000|Overall Study|Withdrawal by Subject|3|||
129936800|NCT00353496|467734660|FG001|Overall Study|Withdrawal by Subject|4|||
129936801|NCT00353496|467734659|FG000|Overall Study|Physician Decision|6|||
129936802|NCT00353496|467734660|FG001|Overall Study|Physician Decision|9|||
129936803|NCT00353496|467734659|FG000|Overall Study|Not otherwise specified|4|||
129936804|NCT00353496|467734660|FG001|Overall Study|Not otherwise specified|2|||
129936805|NCT03997474|467734661|FG000|Overall Study|Death|6|||
129936806|NCT03997474|467734662|FG001|Overall Study|Death|2|||
129936807|NCT03997474|467734663|FG002|Overall Study|Death|1|||
129936808|NCT03997474|467734661|FG000|Overall Study|Physician Decision|2|||
129936809|NCT03997474|467734662|FG001|Overall Study|Physician Decision|0|||
129936810|NCT03997474|467734663|FG002|Overall Study|Physician Decision|0|||
129936811|NCT03997474|467734661|FG000|Overall Study|study terminated by sponsor|1|||
129936812|NCT03997474|467734662|FG001|Overall Study|study terminated by sponsor|0|||
129936813|NCT03997474|467734663|FG002|Overall Study|study terminated by sponsor|1|||
129936814|NCT04980300|467734665|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
129936815|NCT04980300|467734666|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
129936816|NCT04980300|467734665|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
129936817|NCT04980300|467734666|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
129936818|NCT04980300|467734665|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
129936819|NCT04980300|467734666|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
129936820|NCT04980300|467734665|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
129936821|NCT04980300|467734666|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
129936822|NCT03140670|467735523|FG000|Overall Study|Withdrawal by Subject|2|||
129936823|NCT03140670|467735523|FG000|Overall Study|Lost to Follow-up|1|||
129936824|NCT03140670|467735523|FG000|Overall Study|Physician Decision|1|||
129936825|NCT00220805|467735524|FG000|Overall Study|Adverse Event|1|||
129936826|NCT00220805|467735525|FG001|Overall Study|Adverse Event|3|||
129936827|NCT00220805|467735524|FG000|Overall Study|Withdrawal by Subject|3|||
129936828|NCT00220805|467735525|FG001|Overall Study|Withdrawal by Subject|0|||
129936829|NCT00220805|467735524|FG000|Overall Study|Lack of Efficacy|1|||
129936830|NCT00220805|467735525|FG001|Overall Study|Lack of Efficacy|0|||
129936831|NCT00220805|467735524|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
129936832|NCT00220805|467735525|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
129936833|NCT02325466|467735526|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
129936834|NCT02325466|467735527|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
129936835|NCT02325466|467735528|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
129936836|NCT02325466|467735526|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
129936837|NCT02325466|467735527|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
129936838|NCT02325466|467735528|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
129936839|NCT02325466|467735526|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
129936840|NCT02325466|467735527|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
129936841|NCT02325466|467735528|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
129936842|NCT02325466|467735526|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
129936843|NCT02325466|467735527|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
129936844|NCT02325466|467735528|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
129936845|NCT02325466|467735526|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
129936846|NCT02325466|467735527|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
129936847|NCT02325466|467735528|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
129936848|NCT02325466|467735526|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
129936849|NCT02325466|467735527|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
129936850|NCT02325466|467735528|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
129936851|NCT02325466|467735526|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
129936852|NCT02325466|467735527|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
129936853|NCT02325466|467735528|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
129936854|NCT02325466|467735526|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
129452291|NCT05314517|465953353|FG000|Open-label Extension|Withdrawal by Subject|0|||
129452292|NCT05314517|465953354|FG001|Open-label Extension|Withdrawal by Subject|0|||
129452293|NCT05314517|465953355|FG002|Open-label Extension|Withdrawal by Subject|1|||
129452294|NCT05314517|465953356|FG003|Open-label Extension|Withdrawal by Subject|2|||
129452295|NCT05314517|465953353|FG000|Open-label Extension|Use of prohibited medication|0|||
129452296|NCT05314517|465953354|FG001|Open-label Extension|Use of prohibited medication|0|||
129452297|NCT05314517|465953355|FG002|Open-label Extension|Use of prohibited medication|1|||
129452298|NCT05314517|465953356|FG003|Open-label Extension|Use of prohibited medication|0|||
129452299|NCT05314517|465953353|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
129452300|NCT05314517|465953354|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
129452301|NCT05314517|465953355|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
129452302|NCT05314517|465953356|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
129452303|NCT04969276|465953357|FG000|Overall Study|Protocol Deviation|0|||
129452304|NCT04969276|465953358|FG001|Overall Study|Protocol Deviation|1|||
129452305|NCT04969276|465953359|FG002|Overall Study|Protocol Deviation|0|||
129452306|NCT04969276|465953357|FG000|Overall Study|Withdrawal by Subject|1|||
129452307|NCT04969276|465953358|FG001|Overall Study|Withdrawal by Subject|10|||
129452308|NCT04969276|465953359|FG002|Overall Study|Withdrawal by Subject|0|||
129452309|NCT04969276|465953357|FG000|Overall Study|Lost to Follow-up|0|||
129452310|NCT04969276|465953358|FG001|Overall Study|Lost to Follow-up|1|||
129452311|NCT04969276|465953359|FG002|Overall Study|Lost to Follow-up|0|||
129452312|NCT04655144|465953363|FG000|Overall Study|Consumed THC|1|||
129452313|NCT04655144|465953364|FG001|Overall Study|Consumed THC|0|||
129452314|NCT04655144|465953363|FG000|Overall Study|Unilateral embolization|0|||
129452315|NCT04655144|465953364|FG001|Overall Study|Unilateral embolization|1|||
129452316|NCT04490018|465953368|FG000|Overall Study|Protocol Violation|0|||
129452317|NCT04490018|465953369|FG001|Overall Study|Protocol Violation|2|||
129452318|NCT04490018|465953370|FG002|Overall Study|Protocol Violation|1|||
129452319|NCT04490018|465953368|FG000|Overall Study|Lost to Follow-up|2|||
129452320|NCT04490018|465953369|FG001|Overall Study|Lost to Follow-up|2|||
129452321|NCT04490018|465953370|FG002|Overall Study|Lost to Follow-up|0|||
129452322|NCT04490018|465953368|FG000|Overall Study|Withdrawal by Subject|2|||
129452323|NCT04490018|465953369|FG001|Overall Study|Withdrawal by Subject|1|||
129452324|NCT04490018|465953370|FG002|Overall Study|Withdrawal by Subject|0|||
129452325|NCT04490018|465953368|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129452326|NCT04490018|465953369|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129452327|NCT04490018|465953370|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129452328|NCT00943579|465953372|FG000|Overall Study|Adverse Event|4|||
129452329|NCT00943579|465953373|FG001|Overall Study|Adverse Event|3|||
129452330|NCT00943579|465953372|FG000|Overall Study|Lack of Efficacy|2|||
129452331|NCT00943579|465953373|FG001|Overall Study|Lack of Efficacy|2|||
129452332|NCT03337542|465953374|FG000|Overall Study|Withdrew Consent|17|||
129452333|NCT03337542|465953374|FG000|Overall Study|Allergic Adverse Event|1|||
129452334|NCT03337542|465953374|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
129452335|NCT03337542|465953374|FG000|Overall Study|Lost to Follow-up|1|||
129452336|NCT03337542|465953374|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
129452337|NCT00282295|465953375|FG000|Overall Study|Adverse Event|0|||
129452338|NCT00282295|465953376|FG001|Overall Study|Adverse Event|1|||
129452339|NCT00282295|465953377|FG002|Overall Study|Adverse Event|0|||
129452340|NCT00282295|465953375|FG000|Overall Study|Serious Adverse Events|0|||
129452341|NCT00282295|465953376|FG001|Overall Study|Serious Adverse Events|0|||
129452342|NCT00282295|465953377|FG002|Overall Study|Serious Adverse Events|1|||
129452343|NCT00282295|465953375|FG000|Overall Study|Protocol Violation|0|||
129452344|NCT00282295|465953376|FG001|Overall Study|Protocol Violation|2|||
129452345|NCT00282295|465953377|FG002|Overall Study|Protocol Violation|1|||
129452346|NCT00282295|465953375|FG000|Overall Study|Withdrawal by Subject|2|||
129936855|NCT02325466|467735527|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
129936856|NCT02325466|467735528|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
129936857|NCT02325466|467735526|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
129936858|NCT02325466|467735527|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
129936859|NCT02325466|467735528|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
129452347|NCT00282295|465953376|FG001|Overall Study|Withdrawal by Subject|6|||
129452348|NCT00282295|465953377|FG002|Overall Study|Withdrawal by Subject|4|||
129452349|NCT00282295|465953375|FG000|Overall Study|Lost to Follow-up|1|||
129452350|NCT00282295|465953376|FG001|Overall Study|Lost to Follow-up|7|||
129452351|NCT00282295|465953377|FG002|Overall Study|Lost to Follow-up|2|||
129452352|NCT00282295|465953375|FG000|Overall Study|Other|0|||
129452353|NCT00282295|465953376|FG001|Overall Study|Other|1|||
129452354|NCT00282295|465953377|FG002|Overall Study|Other|0|||
129452355|NCT01401842|465953378|FG000|Overall Study|Withdrawal by Subject|3|||
129452356|NCT01401842|465953379|FG001|Overall Study|Withdrawal by Subject|2|||
129452357|NCT01401842|465953378|FG000|Overall Study|academic reason|4|||
129452358|NCT01401842|465953379|FG001|Overall Study|academic reason|1|||
129452359|NCT01401842|465953378|FG000|Overall Study|changed companies|20|||
129936860|NCT01105975|467735532|FG000|Overall Study|Adverse Event|2|||
129936861|NCT01105975|467735533|FG001|Overall Study|Adverse Event|1|||
129936862|NCT01105975|467735534|FG002|Overall Study|Adverse Event|5|||
129936863|NCT01105975|467735535|FG003|Overall Study|Adverse Event|1|||
129936864|NCT01105975|467735536|FG004|Overall Study|Adverse Event|0|||
129936865|NCT01105975|467735537|FG005|Overall Study|Adverse Event|1|||
129936866|NCT01105975|467735538|FG006|Overall Study|Adverse Event|2|||
129936867|NCT01105975|467735539|FG007|Overall Study|Adverse Event|4|||
129936868|NCT01105975|467735540|FG008|Overall Study|Adverse Event|1|||
129936869|NCT01105975|467735541|FG009|Overall Study|Adverse Event|4|||
129936870|NCT01105975|467735532|FG000|Overall Study|Withdrawal by Subject|2|||
129936871|NCT01105975|467735533|FG001|Overall Study|Withdrawal by Subject|2|||
129936872|NCT01105975|467735534|FG002|Overall Study|Withdrawal by Subject|2|||
129936873|NCT01105975|467735535|FG003|Overall Study|Withdrawal by Subject|0|||
129936874|NCT01105975|467735536|FG004|Overall Study|Withdrawal by Subject|4|||
129936875|NCT01105975|467735537|FG005|Overall Study|Withdrawal by Subject|1|||
129936876|NCT01105975|467735538|FG006|Overall Study|Withdrawal by Subject|2|||
129936877|NCT01105975|467735539|FG007|Overall Study|Withdrawal by Subject|1|||
129936878|NCT01105975|467735540|FG008|Overall Study|Withdrawal by Subject|0|||
129936879|NCT01105975|467735541|FG009|Overall Study|Withdrawal by Subject|3|||
129936880|NCT01105975|467735532|FG000|Overall Study|Lost to Follow-up|1|||
129936881|NCT01105975|467735533|FG001|Overall Study|Lost to Follow-up|0|||
129936882|NCT01105975|467735534|FG002|Overall Study|Lost to Follow-up|0|||
129936883|NCT01105975|467735535|FG003|Overall Study|Lost to Follow-up|1|||
129936884|NCT01105975|467735536|FG004|Overall Study|Lost to Follow-up|1|||
129936885|NCT01105975|467735537|FG005|Overall Study|Lost to Follow-up|0|||
129936886|NCT01105975|467735538|FG006|Overall Study|Lost to Follow-up|0|||
129936887|NCT01105975|467735539|FG007|Overall Study|Lost to Follow-up|0|||
129936888|NCT01105975|467735540|FG008|Overall Study|Lost to Follow-up|1|||
129936889|NCT01105975|467735541|FG009|Overall Study|Lost to Follow-up|0|||
129936890|NCT01105975|467735532|FG000|Overall Study|Physician Decision|0|||
129936891|NCT01105975|467735533|FG001|Overall Study|Physician Decision|0|||
129936892|NCT01105975|467735534|FG002|Overall Study|Physician Decision|0|||
129936893|NCT01105975|467735535|FG003|Overall Study|Physician Decision|0|||
129936894|NCT01105975|467735536|FG004|Overall Study|Physician Decision|0|||
129936895|NCT01105975|467735537|FG005|Overall Study|Physician Decision|0|||
129936896|NCT01105975|467735538|FG006|Overall Study|Physician Decision|2|||
129936897|NCT01105975|467735539|FG007|Overall Study|Physician Decision|0|||
129936898|NCT01105975|467735540|FG008|Overall Study|Physician Decision|0|||
129936899|NCT01105975|467735541|FG009|Overall Study|Physician Decision|0|||
129936900|NCT01105975|467735532|FG000|Overall Study|Protocol Violation|0|||
129936901|NCT01105975|467735533|FG001|Overall Study|Protocol Violation|2|||
129936902|NCT01105975|467735534|FG002|Overall Study|Protocol Violation|2|||
129936903|NCT01105975|467735535|FG003|Overall Study|Protocol Violation|0|||
129936904|NCT01105975|467735536|FG004|Overall Study|Protocol Violation|1|||
129936905|NCT01105975|467735537|FG005|Overall Study|Protocol Violation|1|||
129936906|NCT01105975|467735538|FG006|Overall Study|Protocol Violation|1|||
129936907|NCT01105975|467735539|FG007|Overall Study|Protocol Violation|1|||
129936908|NCT01105975|467735540|FG008|Overall Study|Protocol Violation|2|||
129936909|NCT01105975|467735541|FG009|Overall Study|Protocol Violation|2|||
129936910|NCT01105975|467735532|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936911|NCT01105975|467735533|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936912|NCT01105975|467735534|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129936913|NCT01105975|467735535|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936914|NCT01105975|467735536|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936915|NCT01105975|467735537|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
129936916|NCT01105975|467735538|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129936917|NCT01105975|467735539|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
129936918|NCT01105975|467735540|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
129936919|NCT01105975|467735541|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
129936920|NCT00312208|467735545|FG000|Overall Study|Adverse Event|97|||
129936921|NCT00312208|467735546|FG001|Overall Study|Adverse Event|61|||
129936922|NCT00312208|467735545|FG000|Overall Study|Protocol Violation|5|||
129936923|NCT00312208|467735546|FG001|Overall Study|Protocol Violation|3|||
129936924|NCT00312208|467735545|FG000|Overall Study|Death|2|||
129936925|NCT00312208|467735546|FG001|Overall Study|Death|1|||
129936926|NCT00312208|467735545|FG000|Overall Study|Lack of Efficacy|7|||
129936927|NCT00312208|467735546|FG001|Overall Study|Lack of Efficacy|4|||
129936928|NCT00312208|467735545|FG000|Overall Study|Lost to Follow-up|3|||
129936929|NCT00312208|467735546|FG001|Overall Study|Lost to Follow-up|5|||
129936930|NCT00312208|467735545|FG000|Overall Study|Withdrawal by Subject|53|||
129936931|NCT00312208|467735546|FG001|Overall Study|Withdrawal by Subject|42|||
129936932|NCT00312208|467735545|FG000|Overall Study|Other|5|||
129936933|NCT00312208|467735546|FG001|Overall Study|Other|7|||
129936934|NCT02284113|467735547|FG000|Overall Study|Adverse Event|1|||
129936935|NCT02284113|467735548|FG001|Overall Study|Adverse Event|0|||
129936936|NCT02284113|467735547|FG000|Overall Study|non-compliance|0|||
129936937|NCT02284113|467735548|FG001|Overall Study|non-compliance|1|||
129936938|NCT02284113|467735547|FG000|Overall Study|Withdrawal by Subject|0|||
129936939|NCT02284113|467735548|FG001|Overall Study|Withdrawal by Subject|1|||
129936940|NCT02284113|467735547|FG000|Overall Study|not provided|0|||
129936941|NCT02284113|467735548|FG001|Overall Study|not provided|1|||
129936942|NCT02284113|467735547|FG000|Overall Study|surgery cancelled|2|||
129936943|NCT02284113|467735548|FG001|Overall Study|surgery cancelled|0|||
129936944|NCT03885232|467735551|FG000|Overall Study|Lost to Follow-up|74|||
129936945|NCT03885232|467735552|FG001|Overall Study|Lost to Follow-up|32|||
129936946|NCT03885232|467735551|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
129936947|NCT03885232|467735552|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
129936948|NCT01315132|467735555|FG000|Overall Study|not treated due to disease progression|1|||
129936949|NCT03840902|467735558|FG000|Overall Study|Randomized but not treated|1|||
129936950|NCT03840902|467735559|FG001|Overall Study|Randomized but not treated|1|||
129936951|NCT03660930|467735560|FG000|Overall Study|Adverse Event|0|||
129936952|NCT03660930|467735561|FG001|Overall Study|Adverse Event|0|||
129936953|NCT03660930|467735562|FG002|Overall Study|Adverse Event|0|||
129936954|NCT03660930|467735563|FG003|Overall Study|Adverse Event|2|||
129936955|NCT03660930|467735564|FG004|Overall Study|Adverse Event|0|||
129936956|NCT03660930|467735565|FG005|Overall Study|Adverse Event|1|||
129936957|NCT03660930|467735566|FG006|Overall Study|Adverse Event|0|||
129936958|NCT03660930|467735567|FG007|Overall Study|Adverse Event|0|||
129936959|NCT03660930|467735560|FG000|Overall Study|Withdrawal by Subject|0|||
129936960|NCT03660930|467735561|FG001|Overall Study|Withdrawal by Subject|0|||
129936961|NCT03660930|467735562|FG002|Overall Study|Withdrawal by Subject|0|||
129936962|NCT03660930|467735563|FG003|Overall Study|Withdrawal by Subject|0|||
129936963|NCT03660930|467735564|FG004|Overall Study|Withdrawal by Subject|0|||
129936964|NCT03660930|467735565|FG005|Overall Study|Withdrawal by Subject|1|||
129936965|NCT03660930|467735566|FG006|Overall Study|Withdrawal by Subject|0|||
129936966|NCT03660930|467735567|FG007|Overall Study|Withdrawal by Subject|0|||
129936967|NCT05018143|467735570|FG000|Overall Study|Lost to Follow-up|5|||
129936968|NCT05018143|467735571|FG001|Overall Study|Lost to Follow-up|4|||
129936969|NCT05018143|467735570|FG000|Overall Study|Withdrawal by Subject|0|||
129936970|NCT05018143|467735571|FG001|Overall Study|Withdrawal by Subject|1|||
129936971|NCT01208974|467735574|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
129936972|NCT01208974|467735575|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
129936973|NCT01208974|467735576|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
129936974|NCT01208974|467735577|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
129936975|NCT01208974|467735574|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
129936976|NCT01208974|467735575|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
129936977|NCT01208974|467735576|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
129936978|NCT01208974|467735577|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
129936979|NCT01208974|467735574|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
129936980|NCT01208974|467735575|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
129936981|NCT01208974|467735576|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
129936982|NCT01208974|467735577|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
129936983|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
129936984|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
129936985|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
129936986|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
129936987|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
129936988|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
129936989|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Disease progression|14|||
129936990|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
129936991|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
129936992|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
129936993|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
129936994|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
129936995|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
129936996|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
129936997|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
129936998|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
129936999|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
129937000|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
129937001|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
129937002|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
129937003|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
129937004|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937005|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937006|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129452360|NCT01401842|465953379|FG001|Overall Study|changed companies|34|||
129452361|NCT01401842|465953378|FG000|Overall Study|discharged from US Army|3|||
129452362|NCT01401842|465953379|FG001|Overall Study|discharged from US Army|4|||
129452363|NCT01401842|465953378|FG000|Overall Study|invalid follow-up strength data|1|||
129452364|NCT01401842|465953379|FG001|Overall Study|invalid follow-up strength data|4|||
129452365|NCT01401842|465953378|FG000|Overall Study|on profile|9|||
129452366|NCT01401842|465953379|FG001|Overall Study|on profile|5|||
129452367|NCT01401842|465953378|FG000|Overall Study|other/unknown|28|||
129452368|NCT01401842|465953379|FG001|Overall Study|other/unknown|17|||
129452369|NCT00121108|465953380|FG000|Overall Study|Lost to Follow-up|10|||
129452370|NCT00121108|465953381|FG001|Overall Study|Lost to Follow-up|22|||
129452371|NCT00121108|465953380|FG000|Overall Study|Withdrawal by Subject|106|||
129452372|NCT00121108|465953381|FG001|Overall Study|Withdrawal by Subject|195|||
129452373|NCT00121108|465953380|FG000|Overall Study|Death|5|||
129452374|NCT00121108|465953381|FG001|Overall Study|Death|8|||
129452375|NCT01380379|465953382|FG000|Overall Study|Pregnancy|1|||
129452376|NCT01251653|465954565|FG000|Overall Study|Progressive Disease|1|||
129452377|NCT01251653|465954566|FG001|Overall Study|Progressive Disease|7|||
129452378|NCT01251653|465954567|FG002|Overall Study|Progressive Disease|16|||
129452379|NCT01251653|465954568|FG003|Overall Study|Progressive Disease|4|||
129452380|NCT01251653|465954569|FG004|Overall Study|Progressive Disease|0|||
129452381|NCT01251653|465954570|FG005|Overall Study|Progressive Disease|17|||
129452382|NCT01251653|465954571|FG006|Overall Study|Progressive Disease|14|||
129452383|NCT01251653|465954572|FG007|Overall Study|Progressive Disease|7|||
129452384|NCT01251653|465954573|FG008|Overall Study|Progressive Disease|5|||
129452385|NCT01251653|465954565|FG000|Overall Study|Dose-limiting toxicity|0|||
129452386|NCT01251653|465954566|FG001|Overall Study|Dose-limiting toxicity|1|||
129452387|NCT01251653|465954567|FG002|Overall Study|Dose-limiting toxicity|1|||
129452388|NCT01251653|465954568|FG003|Overall Study|Dose-limiting toxicity|1|||
129452389|NCT01251653|465954569|FG004|Overall Study|Dose-limiting toxicity|0|||
129452390|NCT01251653|465954570|FG005|Overall Study|Dose-limiting toxicity|0|||
129452391|NCT01251653|465954571|FG006|Overall Study|Dose-limiting toxicity|2|||
129452392|NCT01251653|465954572|FG007|Overall Study|Dose-limiting toxicity|0|||
129452393|NCT01251653|465954573|FG008|Overall Study|Dose-limiting toxicity|0|||
129452394|NCT01251653|465954565|FG000|Overall Study|Adverse Event|1|||
129452395|NCT01251653|465954566|FG001|Overall Study|Adverse Event|0|||
129452396|NCT01251653|465954567|FG002|Overall Study|Adverse Event|2|||
129452397|NCT01251653|465954568|FG003|Overall Study|Adverse Event|1|||
129452398|NCT01251653|465954569|FG004|Overall Study|Adverse Event|1|||
129452399|NCT01251653|465954570|FG005|Overall Study|Adverse Event|0|||
129452400|NCT01251653|465954571|FG006|Overall Study|Adverse Event|2|||
129452401|NCT01251653|465954572|FG007|Overall Study|Adverse Event|2|||
129452402|NCT01251653|465954573|FG008|Overall Study|Adverse Event|1|||
129452403|NCT01251653|465954565|FG000|Overall Study|Withdrawal by Subject|1|||
129452404|NCT01251653|465954566|FG001|Overall Study|Withdrawal by Subject|0|||
129452405|NCT01251653|465954567|FG002|Overall Study|Withdrawal by Subject|1|||
129452406|NCT01251653|465954568|FG003|Overall Study|Withdrawal by Subject|0|||
129937007|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937008|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937009|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
129937010|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
129937011|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
129937012|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937013|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937014|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937015|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937016|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
129937017|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
129937018|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937019|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129452407|NCT01251653|465954569|FG004|Overall Study|Withdrawal by Subject|1|||
129452408|NCT01251653|465954570|FG005|Overall Study|Withdrawal by Subject|1|||
129452409|NCT01251653|465954571|FG006|Overall Study|Withdrawal by Subject|0|||
129452410|NCT01251653|465954572|FG007|Overall Study|Withdrawal by Subject|1|||
129452411|NCT01251653|465954573|FG008|Overall Study|Withdrawal by Subject|0|||
129452412|NCT01251653|465954565|FG000|Overall Study|Other reason not mentioned above|0|||
129452413|NCT01251653|465954566|FG001|Overall Study|Other reason not mentioned above|0|||
129452414|NCT01251653|465954567|FG002|Overall Study|Other reason not mentioned above|0|||
129452415|NCT01251653|465954568|FG003|Overall Study|Other reason not mentioned above|0|||
129452416|NCT01251653|465954569|FG004|Overall Study|Other reason not mentioned above|0|||
129452417|NCT01251653|465954570|FG005|Overall Study|Other reason not mentioned above|0|||
129937020|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937021|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937022|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
129937023|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
129937024|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
129937025|NCT03656718|467735578|FG000|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937026|NCT03656718|467735579|FG001|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937027|NCT03656718|467735580|FG002|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937028|NCT03656718|467735581|FG003|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937029|NCT03656718|467735582|FG004|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937030|NCT03656718|467735583|FG005|Treatment Period Parts A, B, D, and E|Continuing study treatment|0|||
129937031|NCT03656718|467735584|FG006|Treatment Period Parts A, B, D, and E|Continuing study treatment|14|||
129937032|NCT03656718|467735578|FG000|Treatment Period Part C|Disease progression|0|||
129937033|NCT03656718|467735579|FG001|Treatment Period Part C|Disease progression|0|||
129937034|NCT03656718|467735580|FG002|Treatment Period Part C|Disease progression|0|||
129937035|NCT03656718|467735581|FG003|Treatment Period Part C|Disease progression|0|||
129937036|NCT03656718|467735582|FG004|Treatment Period Part C|Disease progression|12|||
129937037|NCT03656718|467735583|FG005|Treatment Period Part C|Disease progression|0|||
129937038|NCT03656718|467735584|FG006|Treatment Period Part C|Disease progression|0|||
129937039|NCT03656718|467735578|FG000|Treatment Period Part C|Death|0|||
129937040|NCT03656718|467735579|FG001|Treatment Period Part C|Death|0|||
129937041|NCT03656718|467735580|FG002|Treatment Period Part C|Death|0|||
129937042|NCT03656718|467735581|FG003|Treatment Period Part C|Death|0|||
129937043|NCT03656718|467735582|FG004|Treatment Period Part C|Death|1|||
129937044|NCT03656718|467735583|FG005|Treatment Period Part C|Death|0|||
129937045|NCT03656718|467735584|FG006|Treatment Period Part C|Death|0|||
129937046|NCT03656718|467735578|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937047|NCT03656718|467735579|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937048|NCT03656718|467735580|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937049|NCT03656718|467735581|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937050|NCT03656718|467735582|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
129937051|NCT03656718|467735583|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937052|NCT03656718|467735584|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
129937053|NCT03656718|467735578|FG000|Treatment Period Part C|Other reasons|0|||
129937054|NCT03656718|467735579|FG001|Treatment Period Part C|Other reasons|0|||
129937055|NCT03656718|467735580|FG002|Treatment Period Part C|Other reasons|0|||
129937056|NCT03656718|467735581|FG003|Treatment Period Part C|Other reasons|0|||
129937057|NCT03656718|467735582|FG004|Treatment Period Part C|Other reasons|1|||
129937058|NCT03656718|467735583|FG005|Treatment Period Part C|Other reasons|0|||
129937059|NCT03656718|467735584|FG006|Treatment Period Part C|Other reasons|0|||
129937060|NCT03656718|467735578|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
129937061|NCT03656718|467735579|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
129937062|NCT03656718|467735580|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
129937063|NCT03656718|467735581|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
129937064|NCT03656718|467735582|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
129937065|NCT03656718|467735583|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
129937066|NCT03656718|467735584|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
129937067|NCT03211247|467735585|FG000|Overall Study|Adverse Event|8|||
129937068|NCT03211247|467735586|FG001|Overall Study|Adverse Event|0|||
129937069|NCT03211247|467735587|FG002|Overall Study|Adverse Event|1|||
129937070|NCT03211247|467735588|FG003|Overall Study|Adverse Event|0|||
129937071|NCT03211247|467735589|FG004|Overall Study|Adverse Event|0|||
129937072|NCT03211247|467735585|FG000|Overall Study|Lost to Follow-up|2|||
129937073|NCT03211247|467735586|FG001|Overall Study|Lost to Follow-up|1|||
129937074|NCT03211247|467735587|FG002|Overall Study|Lost to Follow-up|0|||
129937075|NCT03211247|467735588|FG003|Overall Study|Lost to Follow-up|0|||
129937076|NCT03211247|467735589|FG004|Overall Study|Lost to Follow-up|0|||
129937077|NCT03211247|467735585|FG000|Overall Study|Physician Decision|1|||
129937078|NCT03211247|467735586|FG001|Overall Study|Physician Decision|2|||
129937079|NCT03211247|467735587|FG002|Overall Study|Physician Decision|0|||
129937080|NCT03211247|467735588|FG003|Overall Study|Physician Decision|0|||
129937081|NCT03211247|467735589|FG004|Overall Study|Physician Decision|0|||
129937082|NCT03211247|467735585|FG000|Overall Study|Non-compliance with study drug|2|||
129937083|NCT03211247|467735586|FG001|Overall Study|Non-compliance with study drug|0|||
129937084|NCT03211247|467735587|FG002|Overall Study|Non-compliance with study drug|0|||
129937085|NCT03211247|467735588|FG003|Overall Study|Non-compliance with study drug|0|||
129937086|NCT03211247|467735589|FG004|Overall Study|Non-compliance with study drug|0|||
129452418|NCT01251653|465954571|FG006|Overall Study|Other reason not mentioned above|0|||
129452419|NCT01251653|465954572|FG007|Overall Study|Other reason not mentioned above|2|||
129452420|NCT01251653|465954573|FG008|Overall Study|Other reason not mentioned above|0|||
129937087|NCT03211247|467735585|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
129937088|NCT03211247|467735586|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
129937089|NCT03211247|467735587|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
129937090|NCT03211247|467735588|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
129937091|NCT03211247|467735589|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
129937092|NCT03211247|467735585|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
129937093|NCT03211247|467735586|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
129937094|NCT03211247|467735587|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
129937095|NCT03211247|467735588|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
129452421|NCT02833974|465954575|FG000|Overall Study|Lost to Follow-up|1|||
129452422|NCT02833974|465954576|FG001|Overall Study|Lost to Follow-up|0|||
129452423|NCT02833974|465954575|FG000|Overall Study|Adverse Event|0|||
129937096|NCT03211247|467735589|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
129937097|NCT03211247|467735585|FG000|Overall Study|Protocol Violation|0|||
129937098|NCT03211247|467735586|FG001|Overall Study|Protocol Violation|1|||
129937099|NCT03211247|467735587|FG002|Overall Study|Protocol Violation|0|||
129937100|NCT03211247|467735588|FG003|Overall Study|Protocol Violation|0|||
129937101|NCT03211247|467735589|FG004|Overall Study|Protocol Violation|0|||
129937102|NCT03691493|467735592|FG000|Overall Study|Withdrawal by Subject|1|||
129937103|NCT01983683|467735593|FG000|Overall Study|Withdrawal by Subject|14|||
129937104|NCT01983683|467735594|FG001|Overall Study|Withdrawal by Subject|18|||
129937105|NCT01983683|467735593|FG000|Overall Study|Death|11|||
129452424|NCT02833974|465954576|FG001|Overall Study|Adverse Event|3|||
129452425|NCT04419610|465954577|FG000|Overall Study|Withdrawal by Subject|3|||
129452426|NCT04419610|465954578|FG001|Overall Study|Withdrawal by Subject|1|||
129452427|NCT04419610|465954577|FG000|Overall Study|Adverse Event|1|||
129452428|NCT04419610|465954578|FG001|Overall Study|Adverse Event|0|||
129452429|NCT04419610|465954577|FG000|Overall Study|discharged early|1|||
129452430|NCT04419610|465954578|FG001|Overall Study|discharged early|1|||
129452431|NCT01524198|465954579|FG000|Overall Study|Protocol Violation|8|||
129452432|NCT01524198|465954580|FG001|Overall Study|Protocol Violation|6|||
129452433|NCT01524198|465954579|FG000|Overall Study|Withdrawal by Subject|15|||
129452434|NCT01524198|465954580|FG001|Overall Study|Withdrawal by Subject|10|||
129452435|NCT00885703|465954586|FG000|Overall Study|Death|9|||
129452436|NCT00885703|465954587|FG001|Overall Study|Death|7|||
129452437|NCT00885703|465954588|FG002|Overall Study|Death|8|||
129452438|NCT00885703|465954589|FG003|Overall Study|Death|7|||
129452439|NCT00885703|465954590|FG004|Overall Study|Death|7|||
129452440|NCT00885703|465954591|FG005|Overall Study|Death|8|||
129452441|NCT00885703|465954592|FG006|Overall Study|Death|4|||
129452442|NCT00885703|465954586|FG000|Overall Study|Lost to Follow-up|0|||
129452443|NCT00885703|465954587|FG001|Overall Study|Lost to Follow-up|0|||
129452444|NCT00885703|465954588|FG002|Overall Study|Lost to Follow-up|1|||
129452445|NCT00885703|465954589|FG003|Overall Study|Lost to Follow-up|0|||
129452446|NCT00885703|465954590|FG004|Overall Study|Lost to Follow-up|0|||
129452447|NCT00885703|465954591|FG005|Overall Study|Lost to Follow-up|1|||
129452448|NCT00885703|465954592|FG006|Overall Study|Lost to Follow-up|0|||
129452449|NCT00885703|465954586|FG000|Overall Study|Withdrawal by Subject|0|||
129452450|NCT00885703|465954587|FG001|Overall Study|Withdrawal by Subject|0|||
129452451|NCT00885703|465954588|FG002|Overall Study|Withdrawal by Subject|0|||
129452452|NCT00885703|465954589|FG003|Overall Study|Withdrawal by Subject|1|||
129452453|NCT00885703|465954590|FG004|Overall Study|Withdrawal by Subject|3|||
129452454|NCT00885703|465954591|FG005|Overall Study|Withdrawal by Subject|1|||
129937106|NCT01983683|467735594|FG001|Overall Study|Death|15|||
129937107|NCT01983683|467735593|FG000|Overall Study|Physician Decision|8|||
129937108|NCT01983683|467735594|FG001|Overall Study|Physician Decision|9|||
129937109|NCT01983683|467735593|FG000|Overall Study|Lost to Follow-up|4|||
129937110|NCT01983683|467735594|FG001|Overall Study|Lost to Follow-up|8|||
129937111|NCT01983683|467735593|FG000|Overall Study|Sponsor Decision|1|||
129937112|NCT01983683|467735594|FG001|Overall Study|Sponsor Decision|1|||
129452455|NCT00885703|465954592|FG006|Overall Study|Withdrawal by Subject|1|||
129452456|NCT00885703|465954586|FG000|Overall Study|Ineligible (no CM)|1|||
129452457|NCT00885703|465954587|FG001|Overall Study|Ineligible (no CM)|3|||
129452458|NCT00885703|465954588|FG002|Overall Study|Ineligible (no CM)|2|||
129452459|NCT00885703|465954589|FG003|Overall Study|Ineligible (no CM)|1|||
129937113|NCT04882917|467735597|FG000|Overall Study|Adverse Event|0|||
129937114|NCT04882917|467735598|FG001|Overall Study|Adverse Event|1|||
129937115|NCT04882917|467735599|FG002|Overall Study|Adverse Event|2|||
129937116|NCT04882917|467735600|FG003|Overall Study|Adverse Event|2|||
129452460|NCT00885703|465954590|FG004|Overall Study|Ineligible (no CM)|2|||
129452461|NCT00885703|465954591|FG005|Overall Study|Ineligible (no CM)|3|||
129452462|NCT00885703|465954592|FG006|Overall Study|Ineligible (no CM)|1|||
129452463|NCT01183143|465954593|FG000|Overall Study|Protocol Violation|115|||
129452464|NCT01183143|465954593|FG000|Overall Study|Withdrawal by Subject|19|||
129937117|NCT04882917|467735597|FG000|Overall Study|Withdrawal by Subject|1|||
129937118|NCT04882917|467735598|FG001|Overall Study|Withdrawal by Subject|0|||
129937119|NCT04882917|467735599|FG002|Overall Study|Withdrawal by Subject|2|||
129937120|NCT04882917|467735600|FG003|Overall Study|Withdrawal by Subject|1|||
129937121|NCT04882917|467735597|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
129937122|NCT04882917|467735598|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
129937123|NCT04882917|467735599|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
129937124|NCT04882917|467735600|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
129937125|NCT00319020|467735602|FG000|Overall Study|Death|2|||
129937126|NCT00319020|467735603|FG001|Overall Study|Death|2|||
129937127|NCT00319020|467735602|FG000|Overall Study|Withdrawal by Subject|4|||
129937128|NCT00319020|467735603|FG001|Overall Study|Withdrawal by Subject|1|||
129937129|NCT00319020|467735602|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
129937130|NCT00319020|467735603|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
129937131|NCT00319020|467735602|FG000|Overall Study|Administrative reason|0|||
129937132|NCT00319020|467735603|FG001|Overall Study|Administrative reason|5|||
129937133|NCT00319020|467735602|FG000|Overall Study|Disease progression|0|||
129937134|NCT00319020|467735603|FG001|Overall Study|Disease progression|2|||
129937135|NCT00319020|467735602|FG000|Overall Study|Transplant|0|||
129937136|NCT00319020|467735603|FG001|Overall Study|Transplant|1|||
129937137|NCT00319020|467735602|FG000|Overall Study|Treatment failure|0|||
129937138|NCT00319020|467735603|FG001|Overall Study|Treatment failure|1|||
129937139|NCT00319020|467735602|FG000|Overall Study|Adverse Event|0|||
129937140|NCT00319020|467735603|FG001|Overall Study|Adverse Event|1|||
129937141|NCT04153890|467735607|FG000|Overall Study|Lost to Follow-up|9|||
129937142|NCT04153890|467735608|FG001|Overall Study|Lost to Follow-up|0|||
129937143|NCT04153890|467735609|FG002|Overall Study|Lost to Follow-up|9|||
129937144|NCT04153890|467735610|FG003|Overall Study|Lost to Follow-up|0|||
129937145|NCT04153890|467735607|FG000|Overall Study|Death|0|||
129937146|NCT04153890|467735608|FG001|Overall Study|Death|2|||
129937147|NCT04153890|467735609|FG002|Overall Study|Death|0|||
129937148|NCT04153890|467735610|FG003|Overall Study|Death|0|||
129937149|NCT04153890|467735607|FG000|Overall Study|Withdrawal by Subject|0|||
129937150|NCT04153890|467735608|FG001|Overall Study|Withdrawal by Subject|0|||
129937151|NCT04153890|467735609|FG002|Overall Study|Withdrawal by Subject|0|||
129937152|NCT04153890|467735610|FG003|Overall Study|Withdrawal by Subject|2|||
129937153|NCT05786612|467735611|FG000|Overall Study|Adverse Event|1|||
129937154|NCT05786612|467735612|FG001|Overall Study|Adverse Event|2|||
129937155|NCT05786612|467735611|FG000|Overall Study|one screening failure|0|||
129937156|NCT05786612|467735612|FG001|Overall Study|one screening failure|2|||
129937157|NCT03459196|467736848|FG000|Overall Study|Subject didn't receive study catheter|2|||
129937158|NCT01288443|467736850|FG000|Overall Study|Adverse Event|0|||
129937159|NCT01288443|467736851|FG001|Overall Study|Adverse Event|0|||
129937160|NCT01288443|467736852|FG002|Overall Study|Adverse Event|1|||
129937161|NCT01288443|467736853|FG003|Overall Study|Adverse Event|1|||
129937162|NCT01288443|467736854|FG004|Overall Study|Adverse Event|3|||
129937163|NCT01288443|467736855|FG005|Overall Study|Adverse Event|1|||
129937164|NCT01288443|467736850|FG000|Overall Study|Poor compliance to protocol|0|||
129937165|NCT01288443|467736851|FG001|Overall Study|Poor compliance to protocol|0|||
129937166|NCT01288443|467736852|FG002|Overall Study|Poor compliance to protocol|0|||
129937167|NCT01288443|467736853|FG003|Overall Study|Poor compliance to protocol|0|||
129937168|NCT01288443|467736854|FG004|Overall Study|Poor compliance to protocol|0|||
129937169|NCT01288443|467736855|FG005|Overall Study|Poor compliance to protocol|1|||
129937170|NCT01288443|467736850|FG000|Overall Study|Participant Moved|0|||
129937171|NCT01288443|467736851|FG001|Overall Study|Participant Moved|0|||
129937172|NCT01288443|467736852|FG002|Overall Study|Participant Moved|0|||
129937173|NCT01288443|467736853|FG003|Overall Study|Participant Moved|1|||
129937174|NCT01288443|467736854|FG004|Overall Study|Participant Moved|2|||
129937175|NCT01288443|467736855|FG005|Overall Study|Participant Moved|1|||
129937176|NCT01288443|467736850|FG000|Overall Study|Consent withdrawn by Participant|0|||
129937177|NCT01288443|467736851|FG001|Overall Study|Consent withdrawn by Participant|0|||
129937178|NCT01288443|467736852|FG002|Overall Study|Consent withdrawn by Participant|0|||
129937179|NCT01288443|467736853|FG003|Overall Study|Consent withdrawn by Participant|0|||
129937180|NCT01288443|467736854|FG004|Overall Study|Consent withdrawn by Participant|0|||
129937181|NCT01288443|467736855|FG005|Overall Study|Consent withdrawn by Participant|1|||
129937182|NCT01288443|467736850|FG000|Overall Study|Lost to Follow-up|0|||
129937183|NCT01288443|467736851|FG001|Overall Study|Lost to Follow-up|1|||
129937184|NCT01288443|467736852|FG002|Overall Study|Lost to Follow-up|0|||
129937185|NCT01288443|467736853|FG003|Overall Study|Lost to Follow-up|0|||
129937186|NCT01288443|467736854|FG004|Overall Study|Lost to Follow-up|0|||
129937187|NCT01288443|467736855|FG005|Overall Study|Lost to Follow-up|0|||
129452465|NCT01183143|465954593|FG000|Overall Study|Subject Questionnaires not returned|5|||
129452466|NCT01183143|465954593|FG000|Overall Study|Subjects enrolled, but not treated|11|||
129452467|NCT01490450|465954596|FG000|Period 1|Lack of Efficacy|2|||
129452468|NCT01490450|465954597|FG001|Period 1|Lack of Efficacy|0|||
129452469|NCT01490450|465954598|FG002|Period 1|Lack of Efficacy|3|||
129937188|NCT01288443|467736850|FG000|Overall Study|Study drug auto-injector administration|0|||
129937189|NCT01288443|467736851|FG001|Overall Study|Study drug auto-injector administration|0|||
129937190|NCT01288443|467736852|FG002|Overall Study|Study drug auto-injector administration|0|||
129937191|NCT01288443|467736853|FG003|Overall Study|Study drug auto-injector administration|0|||
129937192|NCT01288443|467736854|FG004|Overall Study|Study drug auto-injector administration|1|||
129937193|NCT01288443|467736855|FG005|Overall Study|Study drug auto-injector administration|1|||
129937194|NCT01288443|467736850|FG000|Overall Study|Other than above|0|||
129937195|NCT01288443|467736851|FG001|Overall Study|Other than above|0|||
129937196|NCT01288443|467736852|FG002|Overall Study|Other than above|0|||
129937197|NCT01288443|467736853|FG003|Overall Study|Other than above|2|||
129937198|NCT01288443|467736854|FG004|Overall Study|Other than above|1|||
129937199|NCT01288443|467736855|FG005|Overall Study|Other than above|0|||
129937200|NCT01964300|467736857|FG000|Overall Study|Ineligible after enrollment|0|||
129937201|NCT01964300|467736858|FG001|Overall Study|Ineligible after enrollment|1|||
129937202|NCT01964300|467736857|FG000|Overall Study|Adverse Event|1|||
129937203|NCT01964300|467736858|FG001|Overall Study|Adverse Event|1|||
129937204|NCT01964300|467736857|FG000|Overall Study|Lack of Efficacy|3|||
129937205|NCT01964300|467736858|FG001|Overall Study|Lack of Efficacy|5|||
129937206|NCT01964300|467736857|FG000|Overall Study|Withdrawal by Subject|0|||
129937207|NCT01964300|467736858|FG001|Overall Study|Withdrawal by Subject|1|||
129937208|NCT01964300|467736857|FG000|Overall Study|To receive alternative therapy|1|||
129937209|NCT01964300|467736858|FG001|Overall Study|To receive alternative therapy|2|||
129937210|NCT01964300|467736857|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
129937211|NCT01964300|467736858|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
129937212|NCT01964300|467736857|FG000|Overall Study|Weight criteria not met|0|||
129937213|NCT01964300|467736858|FG001|Overall Study|Weight criteria not met|1|||
129937214|NCT02111096|467736859|FG000|Overall Study|Adverse Event|4|||
129937215|NCT02111096|467736860|FG001|Overall Study|Adverse Event|1|||
129937216|NCT02111096|467736861|FG002|Overall Study|Adverse Event|2|||
129937217|NCT02111096|467736859|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129937218|NCT02111096|467736860|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129937219|NCT02111096|467736861|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129937220|NCT02111096|467736859|FG000|Overall Study|Lost to Follow Up|1|||
129937221|NCT02111096|467736860|FG001|Overall Study|Lost to Follow Up|1|||
129937222|NCT02111096|467736861|FG002|Overall Study|Lost to Follow Up|1|||
129937223|NCT02111096|467736859|FG000|Overall Study|Physician Decision|0|||
129937224|NCT02111096|467736860|FG001|Overall Study|Physician Decision|1|||
129937225|NCT02111096|467736861|FG002|Overall Study|Physician Decision|0|||
129937226|NCT02111096|467736859|FG000|Overall Study|Protocol Violation|1|||
129937227|NCT02111096|467736860|FG001|Overall Study|Protocol Violation|0|||
129937228|NCT02111096|467736861|FG002|Overall Study|Protocol Violation|1|||
129937229|NCT02111096|467736859|FG000|Overall Study|Terminated by Sponsor|53|||
129937230|NCT02111096|467736860|FG001|Overall Study|Terminated by Sponsor|35|||
129937231|NCT02111096|467736861|FG002|Overall Study|Terminated by Sponsor|54|||
129937232|NCT02111096|467736859|FG000|Overall Study|Withdrawal by Subject|4|||
129937233|NCT02111096|467736860|FG001|Overall Study|Withdrawal by Subject|2|||
129452470|NCT01490450|465954599|FG003|Period 1|Lack of Efficacy|0|||
129452471|NCT01490450|465954596|FG000|Period 1|Adverse Event|0|||
129452472|NCT01490450|465954597|FG001|Period 1|Adverse Event|0|||
129452473|NCT01490450|465954598|FG002|Period 1|Adverse Event|0|||
129452474|NCT01490450|465954599|FG003|Period 1|Adverse Event|5|||
129937234|NCT02111096|467736861|FG002|Overall Study|Withdrawal by Subject|8|||
129937235|NCT03709706|467736862|FG000|Overall Study|Adverse Event|0|||
129937236|NCT03709706|467736863|FG001|Overall Study|Adverse Event|1|||
129937237|NCT03709706|467736862|FG000|Overall Study|Physician Decision|14|||
129937238|NCT03709706|467736863|FG001|Overall Study|Physician Decision|8|||
129937239|NCT03709706|467736862|FG000|Overall Study|Withdrawal by Subject|2|||
129937240|NCT03709706|467736863|FG001|Overall Study|Withdrawal by Subject|1|||
129937241|NCT03709706|467736862|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
129937242|NCT03709706|467736863|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
129452475|NCT01490450|465954596|FG000|Period 1|Request to discontinue treatment|1|||
129452476|NCT01490450|465954597|FG001|Period 1|Request to discontinue treatment|0|||
129937243|NCT04868617|467736864|FG000|Overall Study|Death|1|||
129937244|NCT04868617|467736865|FG001|Overall Study|Death|0|||
129937245|NCT04868617|467736864|FG000|Overall Study|Adverse Event|1|||
129937246|NCT04868617|467736865|FG001|Overall Study|Adverse Event|0|||
129937247|NCT04868617|467736864|FG000|Overall Study|Withdrawal by Subject|1|||
129452477|NCT01490450|465954598|FG002|Period 1|Request to discontinue treatment|0|||
129452478|NCT01490450|465954599|FG003|Period 1|Request to discontinue treatment|0|||
129937248|NCT04868617|467736865|FG001|Overall Study|Withdrawal by Subject|0|||
129937249|NCT04868617|467736864|FG000|Overall Study|Device deficiency|1|||
129937250|NCT04868617|467736865|FG001|Overall Study|Device deficiency|0|||
129937251|NCT03183050|467736866|FG000|Overall Study|Lost to Follow-up|23|||
129937252|NCT02797132|467736867|FG000|Part A (15 Days)|Adverse Event|1|||
129937253|NCT02797132|467736867|FG000|Part B (24 Weeks)|Adverse Event|3|||
129937254|NCT01970007|467736868|FG000|Overall Study|Death|5|||
129937255|NCT01970007|467736868|FG000|Overall Study|Withdrawal by Subject|23|||
129937256|NCT01970007|467736868|FG000|Overall Study|Lost to Follow-up|24|||
129937257|NCT01970007|467736868|FG000|Overall Study|"Other endpoint"|3|||
129937258|NCT00754065|467736872|FG000|Overall Study|Never received treatment|12|||
129937259|NCT00754065|467736873|FG001|Overall Study|Never received treatment|2|||
129937260|NCT00754065|467736872|FG000|Overall Study|Adverse Event|19|||
129937261|NCT00754065|467736873|FG001|Overall Study|Adverse Event|25|||
129937262|NCT00754065|467736872|FG000|Overall Study|Lost to Follow-up|7|||
129937263|NCT00754065|467736873|FG001|Overall Study|Lost to Follow-up|11|||
129937264|NCT00754065|467736872|FG000|Overall Study|Protocol Violation|12|||
129937265|NCT00754065|467736873|FG001|Overall Study|Protocol Violation|10|||
129937266|NCT00754065|467736872|FG000|Overall Study|Withdrawal by Subject|4|||
129937267|NCT00754065|467736873|FG001|Overall Study|Withdrawal by Subject|5|||
129937268|NCT00754065|467736872|FG000|Overall Study|Pregnancy|6|||
129937269|NCT00754065|467736873|FG001|Overall Study|Pregnancy|0|||
129937270|NCT00754065|467736872|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
129937271|NCT00754065|467736873|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
129937272|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
129937273|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
129937274|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
129937275|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
129937276|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
129937277|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
129937278|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
129937279|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
129937280|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
129937281|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
129937282|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
129937283|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
129937284|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
129937285|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
129937286|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
129937287|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
129937288|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
129937289|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
129937290|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
129937291|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
129937292|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
129937293|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
129937294|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
129937295|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
129937296|NCT01074294|467736874|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
129937297|NCT01074294|467736875|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
129937298|NCT01074294|467736876|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
129937299|NCT01074294|467736877|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
129937300|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
129937301|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
129937302|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
129937303|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
129937304|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
129937305|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
129937306|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
129937307|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
129937308|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
129937309|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
129937310|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
129937311|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
129937312|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
129937313|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
129937314|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
129937315|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
129937316|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
129937317|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
129937318|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
129937319|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
129937320|NCT01074294|467736874|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
129937321|NCT01074294|467736875|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
129937322|NCT01074294|467736876|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
129937323|NCT01074294|467736877|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
129937324|NCT00623194|467736878|FG000|Overall Study|Lack of Efficacy|1|||
129937325|NCT00623194|467736878|FG000|Overall Study|Protocol Violation|3|||
129937326|NCT00623194|467736878|FG000|Overall Study|Unclassified|1|||
129937327|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
129937328|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
129937329|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
129937330|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
129937331|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
129937332|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
129937333|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
129937334|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
129937335|NCT00982644|467736879|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
129937336|NCT00982644|467736880|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
129937337|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
129937338|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
129937339|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
129937340|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
129937341|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
129937342|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
129937343|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
129937344|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
129937345|NCT00982644|467736879|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
129937346|NCT00982644|467736880|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
129937347|NCT00943917|467736883|FG000|Stage I|Adverse Event|1|||
129937348|NCT00943917|467736884|FG001|Stage I|Adverse Event|2|||
129937349|NCT00943917|467736885|FG002|Stage I|Adverse Event|2|||
129937350|NCT00943917|467736886|FG003|Stage I|Adverse Event|0|||
129937351|NCT00943917|467736887|FG004|Stage I|Adverse Event|0|||
129937352|NCT00943917|467736888|FG005|Stage I|Adverse Event|0|||
129937353|NCT00943917|467736889|FG006|Stage I|Adverse Event|0|||
129937354|NCT00943917|467736890|FG007|Stage I|Adverse Event|0|||
129937355|NCT00943917|467736891|FG008|Stage I|Adverse Event|0|||
129937356|NCT00943917|467736892|FG009|Stage I|Adverse Event|0|||
129937357|NCT00943917|467736893|FG010|Stage I|Adverse Event|0|||
129937358|NCT00943917|467736894|FG011|Stage I|Adverse Event|0|||
129937359|NCT00943917|467736895|FG012|Stage I|Adverse Event|0|||
129937360|NCT00943917|467736896|FG013|Stage I|Adverse Event|0|||
129937361|NCT00943917|467736897|FG014|Stage I|Adverse Event|0|||
129937362|NCT00943917|467736883|FG000|Stage I|Lost to Follow-up|0|||
129937363|NCT00943917|467736884|FG001|Stage I|Lost to Follow-up|0|||
129937364|NCT00943917|467736885|FG002|Stage I|Lost to Follow-up|1|||
129937365|NCT00943917|467736886|FG003|Stage I|Lost to Follow-up|0|||
129937366|NCT00943917|467736887|FG004|Stage I|Lost to Follow-up|0|||
129937367|NCT00943917|467736888|FG005|Stage I|Lost to Follow-up|0|||
129937368|NCT00943917|467736889|FG006|Stage I|Lost to Follow-up|0|||
129937369|NCT00943917|467736890|FG007|Stage I|Lost to Follow-up|0|||
129937370|NCT00943917|467736891|FG008|Stage I|Lost to Follow-up|0|||
129937371|NCT00943917|467736892|FG009|Stage I|Lost to Follow-up|0|||
129937372|NCT00943917|467736893|FG010|Stage I|Lost to Follow-up|0|||
129937373|NCT00943917|467736894|FG011|Stage I|Lost to Follow-up|0|||
129937374|NCT00943917|467736895|FG012|Stage I|Lost to Follow-up|0|||
129937375|NCT00943917|467736896|FG013|Stage I|Lost to Follow-up|0|||
129937376|NCT00943917|467736897|FG014|Stage I|Lost to Follow-up|0|||
129937377|NCT00943917|467736883|FG000|Stage I|hyperglycemia|0|||
129937378|NCT00943917|467736884|FG001|Stage I|hyperglycemia|0|||
129937379|NCT00943917|467736885|FG002|Stage I|hyperglycemia|1|||
129937380|NCT00943917|467736886|FG003|Stage I|hyperglycemia|0|||
129937381|NCT00943917|467736887|FG004|Stage I|hyperglycemia|0|||
129937382|NCT00943917|467736888|FG005|Stage I|hyperglycemia|0|||
129937383|NCT00943917|467736889|FG006|Stage I|hyperglycemia|0|||
129937384|NCT00943917|467736890|FG007|Stage I|hyperglycemia|0|||
129937385|NCT00943917|467736891|FG008|Stage I|hyperglycemia|0|||
129937386|NCT00943917|467736892|FG009|Stage I|hyperglycemia|0|||
129937387|NCT00943917|467736893|FG010|Stage I|hyperglycemia|0|||
129937388|NCT00943917|467736894|FG011|Stage I|hyperglycemia|0|||
129937389|NCT00943917|467736895|FG012|Stage I|hyperglycemia|0|||
129937390|NCT00943917|467736896|FG013|Stage I|hyperglycemia|0|||
129937391|NCT00943917|467736897|FG014|Stage I|hyperglycemia|0|||
129937392|NCT00943917|467736883|FG000|Stage I|A1C elevation|1|||
129937393|NCT00943917|467736884|FG001|Stage I|A1C elevation|0|||
129937394|NCT00943917|467736885|FG002|Stage I|A1C elevation|0|||
129937395|NCT00943917|467736886|FG003|Stage I|A1C elevation|0|||
129937396|NCT00943917|467736887|FG004|Stage I|A1C elevation|0|||
129937397|NCT00943917|467736888|FG005|Stage I|A1C elevation|0|||
129937398|NCT00943917|467736889|FG006|Stage I|A1C elevation|0|||
129937399|NCT00943917|467736890|FG007|Stage I|A1C elevation|0|||
129937400|NCT00943917|467736891|FG008|Stage I|A1C elevation|0|||
129937401|NCT00943917|467736892|FG009|Stage I|A1C elevation|0|||
129937402|NCT00943917|467736893|FG010|Stage I|A1C elevation|0|||
129937403|NCT00943917|467736894|FG011|Stage I|A1C elevation|0|||
129937404|NCT00943917|467736895|FG012|Stage I|A1C elevation|0|||
129937405|NCT00943917|467736896|FG013|Stage I|A1C elevation|0|||
129937406|NCT00943917|467736897|FG014|Stage I|A1C elevation|0|||
129452479|NCT01490450|465954596|FG000|Period 1|Withdrawal by Subject|0|||
129452480|NCT01490450|465954597|FG001|Period 1|Withdrawal by Subject|0|||
129452481|NCT01490450|465954598|FG002|Period 1|Withdrawal by Subject|0|||
129452482|NCT01490450|465954599|FG003|Period 1|Withdrawal by Subject|3|||
129452483|NCT01490450|465954596|FG000|Period 1|No longer met study criteria|0|||
129452484|NCT01490450|465954597|FG001|Period 1|No longer met study criteria|1|||
129452485|NCT01490450|465954598|FG002|Period 1|No longer met study criteria|1|||
129452486|NCT01490450|465954599|FG003|Period 1|No longer met study criteria|0|||
129452487|NCT01490450|465954596|FG000|Period 2|Lack of Efficacy|0|||
129452488|NCT01490450|465954597|FG001|Period 2|Lack of Efficacy|0|||
129452489|NCT01490450|465954598|FG002|Period 2|Lack of Efficacy|0|||
129452490|NCT01490450|465954599|FG003|Period 2|Lack of Efficacy|1|||
129452491|NCT01490450|465954596|FG000|Period 2|Adverse Event|1|||
129452492|NCT01490450|465954597|FG001|Period 2|Adverse Event|1|||
129452493|NCT01490450|465954598|FG002|Period 2|Adverse Event|0|||
129452494|NCT01490450|465954599|FG003|Period 2|Adverse Event|1|||
129452495|NCT01490450|465954596|FG000|Period 2|Withdrawal by Subject|1|||
129452496|NCT01490450|465954597|FG001|Period 2|Withdrawal by Subject|0|||
129452497|NCT01490450|465954598|FG002|Period 2|Withdrawal by Subject|0|||
129452498|NCT01490450|465954599|FG003|Period 2|Withdrawal by Subject|0|||
129452499|NCT01490450|465954596|FG000|Period 2|Lost to Follow-up|0|||
129452500|NCT01490450|465954597|FG001|Period 2|Lost to Follow-up|0|||
129452501|NCT01490450|465954598|FG002|Period 2|Lost to Follow-up|0|||
129452502|NCT01490450|465954599|FG003|Period 2|Lost to Follow-up|2|||
129452503|NCT02053168|465954600|FG000|Overall Study|Withdrawal by Subject|1|||
129452504|NCT02053168|465954600|FG000|Overall Study|Physician Decision|1|||
129452505|NCT02053168|465954600|FG000|Overall Study|Lost to Follow-up|1|||
129452506|NCT00636675|465954601|FG000|Overall Study|Lost to Follow-up|121|||
129452507|NCT00636675|465954602|FG001|Overall Study|Lost to Follow-up|31|||
129452508|NCT00636675|465954601|FG000|Overall Study|Withdrawal by Subject|19|||
129452509|NCT00636675|465954602|FG001|Overall Study|Withdrawal by Subject|10|||
129452510|NCT02234479|465954607|FG000|Overall Study|Withdrawal by Subject|1|||
129452511|NCT02234479|465954608|FG001|Overall Study|Withdrawal by Subject|3|||
129452512|NCT02318667|465954609|FG000|Overall Study|Adverse Event|1|||
129452513|NCT02318667|465954609|FG000|Overall Study|Lack of Efficacy|6|||
129452514|NCT02318667|465954609|FG000|Overall Study|Protocol Violation|2|||
129452515|NCT00003535|465954610|FG000|Overall Study|Not evaluable|5|||
129452516|NCT02865018|465954612|FG000|Overall Study|Withdrawal by Subject|1|||
129452517|NCT02636582|465954616|FG000|Overall Study|Surgical Pathology|1|||
129452518|NCT02636582|465954617|FG001|Overall Study|Surgical Pathology|0|||
129452519|NCT05500274|465954618|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
129452520|NCT05500274|465954619|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
129452521|NCT05500274|465954618|FG000|Overall Study|Lost to Follow-up|76|||
129452522|NCT05500274|465954619|FG001|Overall Study|Lost to Follow-up|51|||
129452523|NCT01555151|465954620|FG000|Overall Study|Withdrawal by Subject|6|||
129452524|NCT01555151|465954621|FG001|Overall Study|Withdrawal by Subject|2|||
129452525|NCT01555151|465954622|FG002|Overall Study|Withdrawal by Subject|0|||
129452526|NCT01555151|465954623|FG003|Overall Study|Withdrawal by Subject|2|||
129452527|NCT01555151|465954620|FG000|Overall Study|Administrative|3|||
129452528|NCT01555151|465954621|FG001|Overall Study|Administrative|1|||
129452529|NCT01555151|465954622|FG002|Overall Study|Administrative|2|||
129452530|NCT01555151|465954623|FG003|Overall Study|Administrative|0|||
129452531|NCT01555151|465954620|FG000|Overall Study|Protocol Violation|3|||
129452532|NCT01555151|465954621|FG001|Overall Study|Protocol Violation|3|||
129452533|NCT01555151|465954622|FG002|Overall Study|Protocol Violation|3|||
129452534|NCT01555151|465954623|FG003|Overall Study|Protocol Violation|5|||
129452535|NCT01555151|465954620|FG000|Overall Study|Adverse Event|1|||
129452536|NCT01555151|465954621|FG001|Overall Study|Adverse Event|2|||
129452537|NCT01555151|465954622|FG002|Overall Study|Adverse Event|1|||
129937407|NCT00943917|467736883|FG000|Stage I|Withdrawal by Subject|2|||
129937408|NCT00943917|467736884|FG001|Stage I|Withdrawal by Subject|1|||
129937409|NCT00943917|467736885|FG002|Stage I|Withdrawal by Subject|2|||
129937410|NCT00943917|467736886|FG003|Stage I|Withdrawal by Subject|0|||
129452538|NCT01555151|465954623|FG003|Overall Study|Adverse Event|2|||
129452539|NCT01555151|465954620|FG000|Overall Study|Lost to Follow-up|0|||
129452540|NCT01555151|465954621|FG001|Overall Study|Lost to Follow-up|0|||
129452541|NCT01555151|465954622|FG002|Overall Study|Lost to Follow-up|0|||
129452542|NCT01555151|465954623|FG003|Overall Study|Lost to Follow-up|1|||
129452543|NCT03596866|465954624|FG000|Overall Study|Site terminated by Sponsor|64|||
129937411|NCT00943917|467736887|FG004|Stage I|Withdrawal by Subject|0|||
129937412|NCT00943917|467736888|FG005|Stage I|Withdrawal by Subject|0|||
129452544|NCT03596866|465954625|FG001|Overall Study|Site terminated by Sponsor|65|||
129452545|NCT03596866|465954624|FG000|Overall Study|Death|37|||
129452546|NCT03596866|465954625|FG001|Overall Study|Death|24|||
129452547|NCT03596866|465954624|FG000|Overall Study|Withdrawal by Subject|4|||
129452548|NCT03596866|465954625|FG001|Overall Study|Withdrawal by Subject|6|||
129452549|NCT03596866|465954624|FG000|Overall Study|Missing|0|||
129452550|NCT03596866|465954625|FG001|Overall Study|Missing|6|||
129452551|NCT03596866|465954624|FG000|Overall Study|Lost to Follow-up|2|||
129452552|NCT03596866|465954625|FG001|Overall Study|Lost to Follow-up|3|||
129937413|NCT00943917|467736889|FG006|Stage I|Withdrawal by Subject|0|||
129937414|NCT00943917|467736890|FG007|Stage I|Withdrawal by Subject|0|||
129937415|NCT00943917|467736891|FG008|Stage I|Withdrawal by Subject|0|||
129937416|NCT00943917|467736892|FG009|Stage I|Withdrawal by Subject|0|||
129937417|NCT00943917|467736893|FG010|Stage I|Withdrawal by Subject|0|||
129937418|NCT00943917|467736894|FG011|Stage I|Withdrawal by Subject|0|||
129937419|NCT00943917|467736895|FG012|Stage I|Withdrawal by Subject|0|||
129937420|NCT00943917|467736896|FG013|Stage I|Withdrawal by Subject|0|||
129937421|NCT00943917|467736897|FG014|Stage I|Withdrawal by Subject|0|||
129937422|NCT00943917|467736883|FG000|Stage II|Adverse Event|0|||
129937423|NCT00943917|467736884|FG001|Stage II|Adverse Event|0|||
129937424|NCT00943917|467736885|FG002|Stage II|Adverse Event|0|||
129937425|NCT00943917|467736886|FG003|Stage II|Adverse Event|0|||
129937426|NCT00943917|467736887|FG004|Stage II|Adverse Event|0|||
129937427|NCT00943917|467736888|FG005|Stage II|Adverse Event|1|||
129937428|NCT00943917|467736889|FG006|Stage II|Adverse Event|3|||
129937429|NCT00943917|467736890|FG007|Stage II|Adverse Event|0|||
129937430|NCT00943917|467736891|FG008|Stage II|Adverse Event|1|||
129937431|NCT00943917|467736892|FG009|Stage II|Adverse Event|0|||
129937432|NCT00943917|467736893|FG010|Stage II|Adverse Event|0|||
129937433|NCT00943917|467736894|FG011|Stage II|Adverse Event|0|||
129937434|NCT00943917|467736895|FG012|Stage II|Adverse Event|0|||
129937435|NCT00943917|467736896|FG013|Stage II|Adverse Event|0|||
129937436|NCT00943917|467736897|FG014|Stage II|Adverse Event|0|||
129937437|NCT00943917|467736883|FG000|Stage II|Withdrawal by Subject|0|||
129937438|NCT00943917|467736884|FG001|Stage II|Withdrawal by Subject|0|||
129937439|NCT00943917|467736885|FG002|Stage II|Withdrawal by Subject|0|||
129937440|NCT00943917|467736886|FG003|Stage II|Withdrawal by Subject|0|||
129937441|NCT00943917|467736887|FG004|Stage II|Withdrawal by Subject|0|||
129937442|NCT00943917|467736888|FG005|Stage II|Withdrawal by Subject|1|||
129937443|NCT00943917|467736889|FG006|Stage II|Withdrawal by Subject|0|||
129937444|NCT00943917|467736890|FG007|Stage II|Withdrawal by Subject|0|||
129937445|NCT00943917|467736891|FG008|Stage II|Withdrawal by Subject|0|||
129937446|NCT00943917|467736892|FG009|Stage II|Withdrawal by Subject|0|||
129937447|NCT00943917|467736893|FG010|Stage II|Withdrawal by Subject|0|||
129937448|NCT00943917|467736894|FG011|Stage II|Withdrawal by Subject|0|||
129937449|NCT00943917|467736895|FG012|Stage II|Withdrawal by Subject|0|||
129937450|NCT00943917|467736896|FG013|Stage II|Withdrawal by Subject|0|||
129937451|NCT00943917|467736897|FG014|Stage II|Withdrawal by Subject|0|||
129937452|NCT00943917|467736883|FG000|Stage II|Pregnancy|0|||
129937453|NCT00943917|467736884|FG001|Stage II|Pregnancy|0|||
129937454|NCT00943917|467736885|FG002|Stage II|Pregnancy|0|||
129937455|NCT00943917|467736886|FG003|Stage II|Pregnancy|0|||
129937456|NCT00943917|467736887|FG004|Stage II|Pregnancy|0|||
129937457|NCT00943917|467736888|FG005|Stage II|Pregnancy|1|||
129937458|NCT00943917|467736889|FG006|Stage II|Pregnancy|0|||
129937459|NCT00943917|467736890|FG007|Stage II|Pregnancy|0|||
129937460|NCT00943917|467736891|FG008|Stage II|Pregnancy|0|||
129937461|NCT00943917|467736892|FG009|Stage II|Pregnancy|0|||
129937462|NCT00943917|467736893|FG010|Stage II|Pregnancy|0|||
129937463|NCT00943917|467736894|FG011|Stage II|Pregnancy|0|||
129937464|NCT00943917|467736895|FG012|Stage II|Pregnancy|0|||
129937465|NCT00943917|467736896|FG013|Stage II|Pregnancy|0|||
129937466|NCT00943917|467736897|FG014|Stage II|Pregnancy|0|||
129937467|NCT00943917|467736883|FG000|Stage II Continuation|Adverse Event|0|||
129937468|NCT00943917|467736884|FG001|Stage II Continuation|Adverse Event|0|||
129937469|NCT00943917|467736885|FG002|Stage II Continuation|Adverse Event|0|||
129937470|NCT00943917|467736886|FG003|Stage II Continuation|Adverse Event|0|||
129937471|NCT00943917|467736887|FG004|Stage II Continuation|Adverse Event|0|||
129937472|NCT00943917|467736888|FG005|Stage II Continuation|Adverse Event|0|||
129937473|NCT00943917|467736889|FG006|Stage II Continuation|Adverse Event|0|||
129937474|NCT00943917|467736890|FG007|Stage II Continuation|Adverse Event|0|||
129937475|NCT00943917|467736891|FG008|Stage II Continuation|Adverse Event|0|||
129937476|NCT00943917|467736892|FG009|Stage II Continuation|Adverse Event|0|||
129937477|NCT00943917|467736893|FG010|Stage II Continuation|Adverse Event|0|||
129937478|NCT00943917|467736894|FG011|Stage II Continuation|Adverse Event|1|||
129937479|NCT00943917|467736895|FG012|Stage II Continuation|Adverse Event|2|||
129937480|NCT00943917|467736896|FG013|Stage II Continuation|Adverse Event|1|||
129937481|NCT00943917|467736897|FG014|Stage II Continuation|Adverse Event|1|||
129937482|NCT00943917|467736883|FG000|Stage II Continuation|Withdrawal by Subject|0|||
129937483|NCT00943917|467736884|FG001|Stage II Continuation|Withdrawal by Subject|0|||
129937484|NCT00943917|467736885|FG002|Stage II Continuation|Withdrawal by Subject|0|||
129937485|NCT00943917|467736886|FG003|Stage II Continuation|Withdrawal by Subject|0|||
129937486|NCT00943917|467736887|FG004|Stage II Continuation|Withdrawal by Subject|0|||
129937487|NCT00943917|467736888|FG005|Stage II Continuation|Withdrawal by Subject|0|||
129452553|NCT03596866|465954624|FG000|Overall Study|Protocol Violation|1|||
129452554|NCT03596866|465954625|FG001|Overall Study|Protocol Violation|0|||
129452555|NCT03596866|465954624|FG000|Overall Study|Reason Not Specified|14|||
129452556|NCT03596866|465954625|FG001|Overall Study|Reason Not Specified|13|||
129452557|NCT02576444|465954626|FG000|Overall Study|Death|1|||
129452558|NCT02576444|465954627|FG001|Overall Study|Death|1|||
129452559|NCT02576444|465954628|FG002|Overall Study|Death|0|||
129452560|NCT02576444|465954629|FG003|Overall Study|Death|0|||
129452561|NCT02576444|465954626|FG000|Overall Study|Withdrawal by Subject|0|||
129452562|NCT02576444|465954627|FG001|Overall Study|Withdrawal by Subject|0|||
129452563|NCT02576444|465954628|FG002|Overall Study|Withdrawal by Subject|2|||
129452564|NCT02576444|465954629|FG003|Overall Study|Withdrawal by Subject|0|||
129452565|NCT02576444|465954626|FG000|Overall Study|Adverse Event|0|||
129452566|NCT02576444|465954627|FG001|Overall Study|Adverse Event|0|||
129452567|NCT02576444|465954628|FG002|Overall Study|Adverse Event|1|||
129452568|NCT02576444|465954629|FG003|Overall Study|Adverse Event|0|||
129452569|NCT02576444|465954626|FG000|Overall Study|Physician Decision|0|||
129452570|NCT02576444|465954627|FG001|Overall Study|Physician Decision|0|||
129452571|NCT02576444|465954628|FG002|Overall Study|Physician Decision|1|||
129452572|NCT02576444|465954629|FG003|Overall Study|Physician Decision|0|||
129452573|NCT00829179|465954633|FG000|Overall Study|Withdrawal by Subject|1|||
129452574|NCT03000179|465954634|FG000|Overall Study|Lost to Follow-up|2|||
129452575|NCT02343159|465954637|FG000|Overall Study|Early Study Termination|16|||
129452576|NCT02343159|465954638|FG001|Overall Study|Early Study Termination|19|||
129452577|NCT02343159|465954639|FG002|Overall Study|Early Study Termination|23|||
129452578|NCT02343159|465954637|FG000|Overall Study|Physician Decision|2|||
129452579|NCT02343159|465954638|FG001|Overall Study|Physician Decision|0|||
129452580|NCT02343159|465954639|FG002|Overall Study|Physician Decision|1|||
129452581|NCT02343159|465954637|FG000|Overall Study|Withdrawal by Subject|3|||
129452582|NCT02343159|465954638|FG001|Overall Study|Withdrawal by Subject|0|||
129452583|NCT02343159|465954639|FG002|Overall Study|Withdrawal by Subject|2|||
129452584|NCT02343159|465954637|FG000|Overall Study|Lost to Follow-up|0|||
129452585|NCT02343159|465954638|FG001|Overall Study|Lost to Follow-up|2|||
129452586|NCT02343159|465954639|FG002|Overall Study|Lost to Follow-up|2|||
129452587|NCT02343159|465954637|FG000|Overall Study|Adverse Event|4|||
129452588|NCT02343159|465954638|FG001|Overall Study|Adverse Event|4|||
129452589|NCT02343159|465954639|FG002|Overall Study|Adverse Event|2|||
129452590|NCT02343159|465954637|FG000|Overall Study|Sponsor Decision|0|||
129452591|NCT02343159|465954638|FG001|Overall Study|Sponsor Decision|1|||
129452592|NCT02343159|465954639|FG002|Overall Study|Sponsor Decision|0|||
129452593|NCT02343159|465954637|FG000|Overall Study|Enrollment Error|1|||
129452594|NCT02343159|465954638|FG001|Overall Study|Enrollment Error|0|||
129452595|NCT02343159|465954639|FG002|Overall Study|Enrollment Error|0|||
129452596|NCT01075412|465954643|FG000|Overall Study|Withdrawal by Subject|0|||
129452597|NCT01075412|465954644|FG001|Overall Study|Withdrawal by Subject|1|||
129452598|NCT00865904|465954647|FG000|Overall Study|Randomized but not Treated|2|||
129452599|NCT00865904|465954648|FG001|Overall Study|Randomized but not Treated|0|||
129452600|NCT00865904|465954649|FG002|Overall Study|Randomized but not Treated|0|||
129452601|NCT00865904|465954650|FG003|Overall Study|Randomized but not Treated|1|||
129452602|NCT00865904|465954651|FG004|Overall Study|Randomized but not Treated|1|||
129452603|NCT03625687|465954652|FG000|Overall Study|Death|1|||
129452604|NCT04315181|465954657|FG000|Overall Study|Non-responsive to drug conditions.|1|||
129452605|NCT00711425|465954658|FG000|Overall Study|Protocol Violation|1|||
129452606|NCT00711425|465954658|FG000|Overall Study|Death|2|||
129452607|NCT00711425|465954658|FG000|Overall Study|Lost to Follow-up|1|||
129452608|NCT05879107|465954661|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
129452609|NCT05879107|465954662|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
129452610|NCT05879107|465954661|FG000|Overall Study|Migrated / moved from the study area|1|||
129452611|NCT05879107|465954662|FG001|Overall Study|Migrated / moved from the study area|1|||
129452612|NCT05879107|465954661|FG000|Overall Study|Lost to Follow-up|8|||
129452613|NCT05879107|465954662|FG001|Overall Study|Lost to Follow-up|13|||
129452614|NCT05879107|465954661|FG000|Overall Study|Death|0|||
129452615|NCT05879107|465954662|FG001|Overall Study|Death|2|||
129452616|NCT05879107|465954661|FG000|Overall Study|Other|0|||
129452617|NCT05879107|465954662|FG001|Overall Study|Other|3|||
129452618|NCT04607148|465954663|FG000|Overall Study|Withdrawal by Subject|0|||
129452619|NCT04607148|465954664|FG001|Overall Study|Withdrawal by Subject|4|||
129452620|NCT04607148|465954665|FG002|Overall Study|Withdrawal by Subject|2|||
129452621|NCT04607148|465954666|FG003|Overall Study|Withdrawal by Subject|8|||
129452622|NCT04607148|465954663|FG000|Overall Study|Study Terminated by Sponsor|14|||
129452623|NCT04607148|465954664|FG001|Overall Study|Study Terminated by Sponsor|59|||
129452624|NCT04607148|465954665|FG002|Overall Study|Study Terminated by Sponsor|9|||
129452625|NCT04607148|465954666|FG003|Overall Study|Study Terminated by Sponsor|39|||
129452626|NCT04607148|465954663|FG000|Overall Study|Sponsor Decision|0|||
129452627|NCT04607148|465954664|FG001|Overall Study|Sponsor Decision|0|||
129452628|NCT04607148|465954665|FG002|Overall Study|Sponsor Decision|1|||
129452629|NCT04607148|465954666|FG003|Overall Study|Sponsor Decision|0|||
129452630|NCT04607148|465954663|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129937488|NCT00943917|467736889|FG006|Stage II Continuation|Withdrawal by Subject|0|||
129937489|NCT00943917|467736890|FG007|Stage II Continuation|Withdrawal by Subject|0|||
129937490|NCT00943917|467736891|FG008|Stage II Continuation|Withdrawal by Subject|0|||
129937491|NCT00943917|467736892|FG009|Stage II Continuation|Withdrawal by Subject|0|||
129937492|NCT00943917|467736893|FG010|Stage II Continuation|Withdrawal by Subject|0|||
129937493|NCT00943917|467736894|FG011|Stage II Continuation|Withdrawal by Subject|0|||
129937494|NCT00943917|467736895|FG012|Stage II Continuation|Withdrawal by Subject|0|||
129937495|NCT00943917|467736896|FG013|Stage II Continuation|Withdrawal by Subject|1|||
129937496|NCT00943917|467736897|FG014|Stage II Continuation|Withdrawal by Subject|3|||
129937497|NCT00943917|467736883|FG000|Stage II Continuation|Protocol Violation|0|||
129937498|NCT00943917|467736884|FG001|Stage II Continuation|Protocol Violation|0|||
129937499|NCT00943917|467736885|FG002|Stage II Continuation|Protocol Violation|0|||
129937500|NCT00943917|467736886|FG003|Stage II Continuation|Protocol Violation|0|||
129937501|NCT00943917|467736887|FG004|Stage II Continuation|Protocol Violation|0|||
129937502|NCT00943917|467736888|FG005|Stage II Continuation|Protocol Violation|0|||
129937503|NCT00943917|467736889|FG006|Stage II Continuation|Protocol Violation|0|||
129937504|NCT00943917|467736890|FG007|Stage II Continuation|Protocol Violation|0|||
129937505|NCT00943917|467736891|FG008|Stage II Continuation|Protocol Violation|0|||
129937506|NCT00943917|467736892|FG009|Stage II Continuation|Protocol Violation|1|||
129937507|NCT00943917|467736893|FG010|Stage II Continuation|Protocol Violation|0|||
129937508|NCT00943917|467736894|FG011|Stage II Continuation|Protocol Violation|1|||
129937509|NCT00943917|467736895|FG012|Stage II Continuation|Protocol Violation|0|||
129937510|NCT00943917|467736896|FG013|Stage II Continuation|Protocol Violation|0|||
129937511|NCT00943917|467736897|FG014|Stage II Continuation|Protocol Violation|0|||
129937512|NCT00943917|467736883|FG000|Stage II Continuation|hypoglycemia|0|||
129937513|NCT00943917|467736884|FG001|Stage II Continuation|hypoglycemia|0|||
129937514|NCT00943917|467736885|FG002|Stage II Continuation|hypoglycemia|0|||
129937515|NCT00943917|467736886|FG003|Stage II Continuation|hypoglycemia|0|||
129937516|NCT00943917|467736887|FG004|Stage II Continuation|hypoglycemia|0|||
129937517|NCT00943917|467736888|FG005|Stage II Continuation|hypoglycemia|0|||
129937518|NCT00943917|467736889|FG006|Stage II Continuation|hypoglycemia|0|||
129937519|NCT00943917|467736890|FG007|Stage II Continuation|hypoglycemia|0|||
129937520|NCT00943917|467736891|FG008|Stage II Continuation|hypoglycemia|0|||
129937521|NCT00943917|467736892|FG009|Stage II Continuation|hypoglycemia|0|||
129937522|NCT00943917|467736893|FG010|Stage II Continuation|hypoglycemia|0|||
129937523|NCT00943917|467736894|FG011|Stage II Continuation|hypoglycemia|0|||
129937524|NCT00943917|467736895|FG012|Stage II Continuation|hypoglycemia|1|||
129937525|NCT00943917|467736896|FG013|Stage II Continuation|hypoglycemia|0|||
129937526|NCT00943917|467736897|FG014|Stage II Continuation|hypoglycemia|0|||
129937527|NCT00943917|467736883|FG000|Stage II Continuation|A1C elevation|0|||
129937528|NCT00943917|467736884|FG001|Stage II Continuation|A1C elevation|0|||
129937529|NCT00943917|467736885|FG002|Stage II Continuation|A1C elevation|0|||
129937530|NCT00943917|467736886|FG003|Stage II Continuation|A1C elevation|0|||
129937531|NCT00943917|467736887|FG004|Stage II Continuation|A1C elevation|0|||
129937532|NCT00943917|467736888|FG005|Stage II Continuation|A1C elevation|0|||
129937533|NCT00943917|467736889|FG006|Stage II Continuation|A1C elevation|0|||
129937534|NCT00943917|467736890|FG007|Stage II Continuation|A1C elevation|0|||
129937535|NCT00943917|467736891|FG008|Stage II Continuation|A1C elevation|0|||
129937536|NCT00943917|467736892|FG009|Stage II Continuation|A1C elevation|0|||
129937537|NCT00943917|467736893|FG010|Stage II Continuation|A1C elevation|0|||
129937538|NCT00943917|467736894|FG011|Stage II Continuation|A1C elevation|0|||
129937539|NCT00943917|467736895|FG012|Stage II Continuation|A1C elevation|0|||
129937540|NCT00943917|467736896|FG013|Stage II Continuation|A1C elevation|1|||
129937541|NCT00943917|467736897|FG014|Stage II Continuation|A1C elevation|0|||
129937542|NCT01171976|467736898|FG000|Overall Study|Protocol Violation|0|||
129937543|NCT01171976|467736899|FG001|Overall Study|Protocol Violation|0|||
129937544|NCT01171976|467736900|FG002|Overall Study|Protocol Violation|1|||
129937545|NCT01171976|467736898|FG000|Overall Study|Death|2|||
129937546|NCT01171976|467736899|FG001|Overall Study|Death|4|||
129937547|NCT01171976|467736900|FG002|Overall Study|Death|1|||
129937548|NCT01171976|467736898|FG000|Overall Study|Lost to Follow-up|4|||
129937549|NCT01171976|467736899|FG001|Overall Study|Lost to Follow-up|0|||
129937550|NCT01171976|467736900|FG002|Overall Study|Lost to Follow-up|2|||
129937551|NCT01171976|467736898|FG000|Overall Study|Withdrawal by Subject|1|||
129937552|NCT01171976|467736899|FG001|Overall Study|Withdrawal by Subject|5|||
129937553|NCT01171976|467736900|FG002|Overall Study|Withdrawal by Subject|6|||
129937554|NCT01171976|467736898|FG000|Overall Study|Abnormal test result|1|||
129937555|NCT01171976|467736899|FG001|Overall Study|Abnormal test result|0|||
129937556|NCT01171976|467736900|FG002|Overall Study|Abnormal test result|0|||
129937557|NCT01171976|467736898|FG000|Overall Study|Adverse Event|6|||
129937558|NCT01171976|467736899|FG001|Overall Study|Adverse Event|2|||
129937559|NCT01171976|467736900|FG002|Overall Study|Adverse Event|5|||
129452631|NCT04607148|465954664|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129452632|NCT04607148|465954665|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129452633|NCT04607148|465954666|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129452634|NCT04607148|465954663|FG000|Overall Study|Lost to Follow-up|0|||
129452635|NCT04607148|465954664|FG001|Overall Study|Lost to Follow-up|2|||
129452636|NCT04607148|465954665|FG002|Overall Study|Lost to Follow-up|0|||
129452637|NCT04607148|465954666|FG003|Overall Study|Lost to Follow-up|0|||
129452638|NCT04607148|465954663|FG000|Overall Study|Death|0|||
129452639|NCT04607148|465954664|FG001|Overall Study|Death|3|||
129452640|NCT04607148|465954665|FG002|Overall Study|Death|0|||
129452641|NCT04607148|465954666|FG003|Overall Study|Death|1|||
129452642|NCT04607148|465954663|FG000|Overall Study|Adverse Event|0|||
129452643|NCT04607148|465954664|FG001|Overall Study|Adverse Event|1|||
129452644|NCT04607148|465954665|FG002|Overall Study|Adverse Event|0|||
129452645|NCT04607148|465954666|FG003|Overall Study|Adverse Event|0|||
129452646|NCT00916149|465954667|FG000|Overall Study|Lost to Follow-up|3|||
129452647|NCT00916149|465954668|FG001|Overall Study|Lost to Follow-up|2|||
129452648|NCT00916149|465954669|FG002|Overall Study|Lost to Follow-up|0|||
129452649|NCT00916149|465954667|FG000|Overall Study|Unable to place scalp EEG leads|1|||
129452650|NCT00916149|465954668|FG001|Overall Study|Unable to place scalp EEG leads|0|||
129452651|NCT00916149|465954669|FG002|Overall Study|Unable to place scalp EEG leads|0|||
129452652|NCT00589420|465954670|FG000|Overall Study|screen failure|1|||
129452653|NCT00912028|465954671|FG000|Overall Study|Lost to Follow-up|2|||
129452654|NCT00912028|465954672|FG001|Overall Study|Lost to Follow-up|3|||
129452655|NCT00912028|465954673|FG002|Overall Study|Lost to Follow-up|0|||
129452656|NCT00912028|465954674|FG003|Overall Study|Lost to Follow-up|1|||
129452657|NCT00912028|465954675|FG004|Overall Study|Lost to Follow-up|3|||
129452658|NCT00912028|465954671|FG000|Overall Study|Withdrawal by Subject|3|||
129452659|NCT00912028|465954672|FG001|Overall Study|Withdrawal by Subject|0|||
129452660|NCT00912028|465954673|FG002|Overall Study|Withdrawal by Subject|0|||
129452661|NCT00912028|465954674|FG003|Overall Study|Withdrawal by Subject|0|||
129452662|NCT00912028|465954675|FG004|Overall Study|Withdrawal by Subject|0|||
129452663|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
129452664|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
129452665|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
129452666|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
129452667|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
129452668|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
129452669|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129452670|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
129452671|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
129452672|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
129452673|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
129452674|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
129452675|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
129937560|NCT02754596|467736904|FG000|Overall Study|Withdrawal by Subject|3|||
129937561|NCT02754596|467736905|FG001|Overall Study|Withdrawal by Subject|4|||
129937562|NCT02754596|467736906|FG002|Overall Study|Withdrawal by Subject|0|||
129937563|NCT02754596|467736904|FG000|Overall Study|Physician Decision|1|||
129937564|NCT02754596|467736905|FG001|Overall Study|Physician Decision|1|||
129937565|NCT02754596|467736906|FG002|Overall Study|Physician Decision|1|||
129937566|NCT02754596|467736904|FG000|Overall Study|Lost to Follow-up|1|||
129937567|NCT02754596|467736905|FG001|Overall Study|Lost to Follow-up|1|||
129937568|NCT02754596|467736906|FG002|Overall Study|Lost to Follow-up|2|||
129937569|NCT02754596|467736904|FG000|Overall Study|Death|0|||
129937570|NCT02754596|467736905|FG001|Overall Study|Death|2|||
129937571|NCT02754596|467736906|FG002|Overall Study|Death|0|||
129937572|NCT02754596|467736904|FG000|Overall Study|Adverse Event|1|||
129937573|NCT02754596|467736905|FG001|Overall Study|Adverse Event|0|||
129937574|NCT02754596|467736906|FG002|Overall Study|Adverse Event|1|||
129937575|NCT02754596|467736904|FG000|Overall Study|Other|1|||
129937576|NCT02754596|467736905|FG001|Overall Study|Other|0|||
129937577|NCT02754596|467736906|FG002|Overall Study|Other|0|||
129937578|NCT03357952|467736907|FG000|Overall Study|Withdrawal by Subject|0|||
129937579|NCT03357952|467736908|FG001|Overall Study|Withdrawal by Subject|1|||
129937580|NCT03357952|467736907|FG000|Overall Study|Sponsor Decision|9|||
129937581|NCT03357952|467736908|FG001|Overall Study|Sponsor Decision|0|||
129937582|NCT01371994|467736909|FG000|Overall Study|Adverse Event|3|||
129452676|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
129452677|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
129452678|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
129452679|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
129937583|NCT01371994|467736910|FG001|Overall Study|Adverse Event|6|||
129937584|NCT01371994|467736909|FG000|Overall Study|Lack of Efficacy|3|||
129937585|NCT01371994|467736910|FG001|Overall Study|Lack of Efficacy|0|||
129452680|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
129937586|NCT01371994|467736909|FG000|Overall Study|Withdrawal by Subject|13|||
129937587|NCT01371994|467736910|FG001|Overall Study|Withdrawal by Subject|7|||
129937588|NCT01371994|467736909|FG000|Overall Study|Lost to Follow-up|1|||
129937589|NCT01371994|467736910|FG001|Overall Study|Lost to Follow-up|1|||
129937590|NCT01371994|467736909|FG000|Overall Study|Protocol Violation|24|||
129937591|NCT01371994|467736910|FG001|Overall Study|Protocol Violation|17|||
129937592|NCT01371994|467736909|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
129937593|NCT01371994|467736910|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
129937594|NCT01371994|467736909|FG000|Overall Study|Physician Decision|1|||
129937595|NCT01371994|467736910|FG001|Overall Study|Physician Decision|1|||
129937596|NCT01371994|467736909|FG000|Overall Study|Miscellaneous Reasons|6|||
129937597|NCT01371994|467736910|FG001|Overall Study|Miscellaneous Reasons|4|||
129937598|NCT03280030|467736911|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
129937599|NCT03280030|467736912|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
129937600|NCT03280030|467736913|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
129937601|NCT03280030|467736911|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
129937602|NCT03280030|467736912|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
129937603|NCT03280030|467736913|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
129937604|NCT03280030|467736911|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
129937605|NCT03280030|467736912|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
129937606|NCT03280030|467736913|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
129937607|NCT03280030|467736911|FG000|Part 2 - Efficacy|Adverse Event|0|||
129937608|NCT03280030|467736912|FG001|Part 2 - Efficacy|Adverse Event|4|||
129937609|NCT03280030|467736913|FG002|Part 2 - Efficacy|Adverse Event|6|||
129937610|NCT03280030|467736911|FG000|Part 2 - Efficacy|Death|0|||
129937611|NCT03280030|467736912|FG001|Part 2 - Efficacy|Death|3|||
129937612|NCT03280030|467736913|FG002|Part 2 - Efficacy|Death|0|||
129937613|NCT03280030|467736911|FG000|Part 2 - Efficacy|Physician Decision|0|||
129937614|NCT03280030|467736912|FG001|Part 2 - Efficacy|Physician Decision|10|||
129937615|NCT03280030|467736913|FG002|Part 2 - Efficacy|Physician Decision|16|||
129937616|NCT03280030|467736911|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
129937617|NCT03280030|467736912|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
129937618|NCT03280030|467736913|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
129937619|NCT03280030|467736911|FG000|Part 2 - Efficacy|Progressive disease|0|||
129937620|NCT03280030|467736912|FG001|Part 2 - Efficacy|Progressive disease|7|||
129937621|NCT03280030|467736913|FG002|Part 2 - Efficacy|Progressive disease|5|||
129937622|NCT03222609|467736914|FG000|Overall Study|Withdrew consent|2|||
129937623|NCT03222609|467736915|FG001|Overall Study|Withdrew consent|3|||
129937624|NCT03222609|467736916|FG002|Overall Study|Withdrew consent|4|||
129937625|NCT03222609|467736917|FG003|Overall Study|Withdrew consent|2|||
129937626|NCT03222609|467736914|FG000|Overall Study|Lost to Follow-up|1|||
129937627|NCT03222609|467736915|FG001|Overall Study|Lost to Follow-up|0|||
129937628|NCT03222609|467736916|FG002|Overall Study|Lost to Follow-up|0|||
129937629|NCT03222609|467736917|FG003|Overall Study|Lost to Follow-up|0|||
129937630|NCT03222609|467736914|FG000|Overall Study|Death|16|||
129937631|NCT03222609|467736915|FG001|Overall Study|Death|13|||
129937632|NCT03222609|467736916|FG002|Overall Study|Death|9|||
129937633|NCT03222609|467736917|FG003|Overall Study|Death|6|||
129937634|NCT03222609|467736914|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
129937635|NCT03222609|467736915|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
129937636|NCT03222609|467736916|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
129937637|NCT03222609|467736917|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
129937638|NCT05521516|467736918|FG000|Overall Study|Withdrawal by Subject|1|||
129937639|NCT05521516|467736919|FG001|Overall Study|Withdrawal by Subject|1|||
129937640|NCT00545545|467736920|FG000|Overall Study|Progressive Neoplastic Disease|1|||
129937641|NCT00545545|467736921|FG001|Overall Study|Progressive Neoplastic Disease|5|||
129937642|NCT00545545|467736922|FG002|Overall Study|Progressive Neoplastic Disease|0|||
129937643|NCT00545545|467736923|FG003|Overall Study|Progressive Neoplastic Disease|4|||
129937644|NCT00545545|467736924|FG004|Overall Study|Progressive Neoplastic Disease|8|||
129937645|NCT00545545|467736925|FG005|Overall Study|Progressive Neoplastic Disease|7|||
129937646|NCT00545545|467736920|FG000|Overall Study|Withdrawal by Subject|0|||
129937647|NCT00545545|467736921|FG001|Overall Study|Withdrawal by Subject|1|||
129937648|NCT00545545|467736922|FG002|Overall Study|Withdrawal by Subject|0|||
129937649|NCT00545545|467736923|FG003|Overall Study|Withdrawal by Subject|0|||
129937650|NCT00545545|467736924|FG004|Overall Study|Withdrawal by Subject|0|||
129937651|NCT00545545|467736925|FG005|Overall Study|Withdrawal by Subject|0|||
129937652|NCT00545545|467736920|FG000|Overall Study|Physician Decision|1|||
129937653|NCT00545545|467736921|FG001|Overall Study|Physician Decision|0|||
129937654|NCT00545545|467736922|FG002|Overall Study|Physician Decision|0|||
129937655|NCT00545545|467736923|FG003|Overall Study|Physician Decision|0|||
129937656|NCT00545545|467736924|FG004|Overall Study|Physician Decision|0|||
129937657|NCT00545545|467736925|FG005|Overall Study|Physician Decision|1|||
129937658|NCT00545545|467736920|FG000|Overall Study|Irinotecan intolerance|1|||
129937659|NCT00545545|467736921|FG001|Overall Study|Irinotecan intolerance|1|||
129937660|NCT00545545|467736922|FG002|Overall Study|Irinotecan intolerance|0|||
129937661|NCT00545545|467736923|FG003|Overall Study|Irinotecan intolerance|0|||
129937662|NCT00545545|467736924|FG004|Overall Study|Irinotecan intolerance|0|||
129937663|NCT00545545|467736925|FG005|Overall Study|Irinotecan intolerance|0|||
129937664|NCT00545545|467736920|FG000|Overall Study|No target lesions to track post surgery|0|||
129937665|NCT00545545|467736921|FG001|Overall Study|No target lesions to track post surgery|0|||
129937666|NCT00545545|467736922|FG002|Overall Study|No target lesions to track post surgery|0|||
129937667|NCT00545545|467736923|FG003|Overall Study|No target lesions to track post surgery|0|||
129937668|NCT00545545|467736924|FG004|Overall Study|No target lesions to track post surgery|1|||
129937669|NCT00545545|467736925|FG005|Overall Study|No target lesions to track post surgery|1|||
129937670|NCT00227266|467736938|FG000|Overall Study|Withdrawal by Subject|0|||
129937671|NCT00227266|467736939|FG001|Overall Study|Withdrawal by Subject|0|||
129937672|NCT00227266|467736940|FG002|Overall Study|Withdrawal by Subject|1|||
129937673|NCT00227266|467736938|FG000|Overall Study|Protocol Violation|1|||
129937674|NCT00227266|467736939|FG001|Overall Study|Protocol Violation|0|||
129937675|NCT00227266|467736940|FG002|Overall Study|Protocol Violation|1|||
129937676|NCT00227266|467736938|FG000|Overall Study|Excessive weight gain|0|||
129937677|NCT00227266|467736939|FG001|Overall Study|Excessive weight gain|0|||
129937678|NCT00227266|467736940|FG002|Overall Study|Excessive weight gain|2|||
129937679|NCT02678689|467736941|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
129937680|NCT02678689|467736942|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
129937681|NCT03959423|467736946|FG000|Overall Study|Withdrawal by Subject|2|||
129937682|NCT03959423|467736947|FG001|Overall Study|Withdrawal by Subject|3|||
129937683|NCT03959423|467736946|FG000|Overall Study|Physician Decision|0|||
129937684|NCT03959423|467736947|FG001|Overall Study|Physician Decision|1|||
129937685|NCT03959423|467736946|FG000|Overall Study|Lost to Follow-up|1|||
129937686|NCT03959423|467736947|FG001|Overall Study|Lost to Follow-up|0|||
129937687|NCT03959423|467736946|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
129937688|NCT03959423|467736947|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129937689|NCT04926740|467736948|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
129937690|NCT04926740|467736949|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
129937691|NCT04926740|467736948|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
129937692|NCT04926740|467736949|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
129937693|NCT02549352|467736950|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
129937694|NCT02549352|467736951|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
129937695|NCT02549352|467736950|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
129937696|NCT02549352|467736951|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
129937697|NCT02549352|467736950|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
129937698|NCT02549352|467736951|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
129937699|NCT02549352|467736950|FG000|12-month Follow-up|Withdrawal by Subject|4|||
129937700|NCT02549352|467736951|FG001|12-month Follow-up|Withdrawal by Subject|5|||
129937701|NCT02549352|467736950|FG000|12-month Follow-up|Lost to Follow-up|3|||
129937702|NCT02549352|467736951|FG001|12-month Follow-up|Lost to Follow-up|2|||
129937703|NCT02549352|467736950|FG000|12-month Follow-up|Death|0|||
129937704|NCT02549352|467736951|FG001|12-month Follow-up|Death|1|||
129937705|NCT02549352|467736950|FG000|12-month Follow-up|Protocol Violation|0|||
129937706|NCT02549352|467736951|FG001|12-month Follow-up|Protocol Violation|1|||
129937707|NCT02549352|467736950|FG000|12-month Follow-up|Other|1|||
129937708|NCT02549352|467736951|FG001|12-month Follow-up|Other|3|||
129937709|NCT04530487|467738009|FG000|Overall Study|Death|1|||
129937710|NCT00146172|467738010|FG000|Overall Study|Adverse Event|0|||
129937711|NCT00146172|467738011|FG001|Overall Study|Adverse Event|0|||
129937712|NCT00146172|467738012|FG002|Overall Study|Adverse Event|1|||
129937713|NCT00146172|467738013|FG003|Overall Study|Adverse Event|1|||
129937714|NCT00146172|467738014|FG004|Overall Study|Adverse Event|0|||
129937715|NCT00146172|467738015|FG005|Overall Study|Adverse Event|2|||
129937716|NCT00146172|467738016|FG006|Overall Study|Adverse Event|3|||
129937717|NCT00146172|467738017|FG007|Overall Study|Adverse Event|10|||
129937718|NCT00146172|467738010|FG000|Overall Study|Lost to Follow-up|0|||
129937719|NCT00146172|467738011|FG001|Overall Study|Lost to Follow-up|0|||
129937720|NCT00146172|467738012|FG002|Overall Study|Lost to Follow-up|0|||
129937721|NCT00146172|467738013|FG003|Overall Study|Lost to Follow-up|0|||
129937722|NCT00146172|467738014|FG004|Overall Study|Lost to Follow-up|0|||
129937723|NCT00146172|467738015|FG005|Overall Study|Lost to Follow-up|0|||
129937724|NCT00146172|467738016|FG006|Overall Study|Lost to Follow-up|0|||
129937725|NCT00146172|467738017|FG007|Overall Study|Lost to Follow-up|1|||
129937726|NCT00146172|467738010|FG000|Overall Study|Disease Progression|2|||
129937727|NCT00146172|467738011|FG001|Overall Study|Disease Progression|4|||
129937728|NCT00146172|467738012|FG002|Overall Study|Disease Progression|2|||
129937729|NCT00146172|467738013|FG003|Overall Study|Disease Progression|5|||
129937730|NCT00146172|467738014|FG004|Overall Study|Disease Progression|2|||
129937731|NCT00146172|467738015|FG005|Overall Study|Disease Progression|2|||
129937732|NCT00146172|467738016|FG006|Overall Study|Disease Progression|1|||
129937733|NCT00146172|467738017|FG007|Overall Study|Disease Progression|22|||
129937734|NCT00146172|467738010|FG000|Overall Study|Death|0|||
129937735|NCT00146172|467738011|FG001|Overall Study|Death|0|||
129937736|NCT00146172|467738012|FG002|Overall Study|Death|0|||
129937737|NCT00146172|467738013|FG003|Overall Study|Death|0|||
129937738|NCT00146172|467738014|FG004|Overall Study|Death|0|||
129937739|NCT00146172|467738015|FG005|Overall Study|Death|0|||
129937740|NCT00146172|467738016|FG006|Overall Study|Death|1|||
129937741|NCT00146172|467738017|FG007|Overall Study|Death|0|||
129937742|NCT00146172|467738010|FG000|Overall Study|Physician Decision|0|||
129937743|NCT00146172|467738011|FG001|Overall Study|Physician Decision|0|||
129937744|NCT00146172|467738012|FG002|Overall Study|Physician Decision|0|||
129937745|NCT00146172|467738013|FG003|Overall Study|Physician Decision|0|||
129937746|NCT00146172|467738014|FG004|Overall Study|Physician Decision|0|||
129937747|NCT00146172|467738015|FG005|Overall Study|Physician Decision|0|||
129937748|NCT00146172|467738016|FG006|Overall Study|Physician Decision|0|||
129937749|NCT00146172|467738017|FG007|Overall Study|Physician Decision|1|||
129937750|NCT00146172|467738010|FG000|Overall Study|Withdrawal by Subject|0|||
129937751|NCT00146172|467738011|FG001|Overall Study|Withdrawal by Subject|0|||
129937752|NCT00146172|467738012|FG002|Overall Study|Withdrawal by Subject|0|||
129937753|NCT00146172|467738013|FG003|Overall Study|Withdrawal by Subject|0|||
129937754|NCT00146172|467738014|FG004|Overall Study|Withdrawal by Subject|0|||
129937755|NCT00146172|467738015|FG005|Overall Study|Withdrawal by Subject|1|||
129937756|NCT00146172|467738016|FG006|Overall Study|Withdrawal by Subject|1|||
129937757|NCT00146172|467738017|FG007|Overall Study|Withdrawal by Subject|4|||
129937758|NCT00146172|467738010|FG000|Overall Study|Symptomatic Deterioration|1|||
129937759|NCT00146172|467738011|FG001|Overall Study|Symptomatic Deterioration|0|||
129937760|NCT00146172|467738012|FG002|Overall Study|Symptomatic Deterioration|1|||
129937761|NCT00146172|467738013|FG003|Overall Study|Symptomatic Deterioration|0|||
129937762|NCT00146172|467738014|FG004|Overall Study|Symptomatic Deterioration|1|||
129937763|NCT00146172|467738015|FG005|Overall Study|Symptomatic Deterioration|2|||
129937764|NCT00146172|467738016|FG006|Overall Study|Symptomatic Deterioration|0|||
129937765|NCT00146172|467738017|FG007|Overall Study|Symptomatic Deterioration|2|||
129937766|NCT03876457|467738020|FG000|Overall Study|Lost to Follow-up|1|||
129937767|NCT03876457|467738021|FG001|Overall Study|Lost to Follow-up|3|||
129937768|NCT01184326|467738022|FG000|Overall Study|Adverse Event|1|||
129937769|NCT01184326|467738023|FG001|Overall Study|Adverse Event|2|||
129937770|NCT01184326|467738024|FG002|Overall Study|Adverse Event|0|||
129937771|NCT01184326|467738022|FG000|Overall Study|Death|0|||
129937772|NCT01184326|467738023|FG001|Overall Study|Death|0|||
129937773|NCT01184326|467738024|FG002|Overall Study|Death|1|||
129937774|NCT01184326|467738022|FG000|Overall Study|Withdrawal by Subject|0|||
129937775|NCT01184326|467738023|FG001|Overall Study|Withdrawal by Subject|0|||
129937776|NCT01184326|467738024|FG002|Overall Study|Withdrawal by Subject|1|||
129937777|NCT01184326|467738022|FG000|Overall Study|Physician Decision|1|||
129937778|NCT01184326|467738023|FG001|Overall Study|Physician Decision|1|||
129937779|NCT01184326|467738024|FG002|Overall Study|Physician Decision|0|||
129937780|NCT01184326|467738022|FG000|Overall Study|Disease Progression|1|||
129937781|NCT01184326|467738023|FG001|Overall Study|Disease Progression|3|||
129937782|NCT01184326|467738024|FG002|Overall Study|Disease Progression|12|||
129937783|NCT01036724|467738025|FG000|Overall Study|Adverse Event|1|||
129937784|NCT01036724|467738026|FG001|Overall Study|Adverse Event|2|||
129937785|NCT01036724|467738025|FG000|Overall Study|Lack of Efficacy|1|||
129937786|NCT01036724|467738026|FG001|Overall Study|Lack of Efficacy|1|||
129937787|NCT01036724|467738025|FG000|Overall Study|Protocol Violation|4|||
129937788|NCT01036724|467738026|FG001|Overall Study|Protocol Violation|5|||
129937789|NCT00557492|467738028|FG000|Overall Study|Change in health insurance|1|||
129937790|NCT01574716|467738029|FG000|Part 1|Death|3|||
129937791|NCT01574716|467738030|FG001|Part 1|Death|1|||
129937792|NCT01574716|467738031|FG002|Part 1|Death|8|||
129937793|NCT01574716|467738032|FG003|Part 1|Death|0|||
129937794|NCT01574716|467738033|FG004|Part 1|Death|0|||
129937795|NCT01574716|467738029|FG000|Part 1|Discontinuation of study by sponsor|0|||
129452681|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
129452682|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
129452683|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
129452684|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
129452685|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
129452686|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
129452687|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Death|2|||
129452688|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Death|1|||
129937796|NCT01574716|467738030|FG001|Part 1|Discontinuation of study by sponsor|0|||
129452689|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Death|0|||
129452690|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Death|0|||
129452691|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
129937797|NCT01574716|467738031|FG002|Part 1|Discontinuation of study by sponsor|1|||
129937798|NCT01574716|467738032|FG003|Part 1|Discontinuation of study by sponsor|0|||
129937799|NCT01574716|467738033|FG004|Part 1|Discontinuation of study by sponsor|0|||
129937800|NCT01574716|467738029|FG000|Part 1|Withdrawal by Subject|0|||
129937801|NCT01574716|467738030|FG001|Part 1|Withdrawal by Subject|2|||
129937802|NCT01574716|467738031|FG002|Part 1|Withdrawal by Subject|0|||
129937803|NCT01574716|467738032|FG003|Part 1|Withdrawal by Subject|0|||
129937804|NCT01574716|467738033|FG004|Part 1|Withdrawal by Subject|0|||
129937805|NCT01574716|467738029|FG000|Part 1|Lost to Follow-up|0|||
129452692|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
129452693|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
129452694|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
129452695|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
129452696|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
129452697|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
129452698|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
129452699|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
129452700|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
129452701|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129452702|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
129452703|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
129452704|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
129452705|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
129452706|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
129452707|NCT01940471|465954676|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
129452708|NCT01940471|465954677|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
129452709|NCT01940471|465954678|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
129452710|NCT01940471|465954679|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
129452711|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
129452712|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
129452713|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
129452714|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
129452715|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129452716|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
129452717|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
129452718|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
129452719|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
129452720|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
129452721|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
129452722|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
129452723|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
129452724|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
129452725|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
129452726|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
129452727|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129452728|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
129452729|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
129452730|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
129452731|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129452732|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
129452733|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
129452734|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
129452735|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129452736|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129452737|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
129452738|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
129452739|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
129452740|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
129452741|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
129452742|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
129452743|NCT01940471|465954676|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129452744|NCT01940471|465954677|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129452745|NCT01940471|465954678|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
129452746|NCT01940471|465954679|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
129937806|NCT01574716|467738030|FG001|Part 1|Lost to Follow-up|1|||
129937807|NCT01574716|467738031|FG002|Part 1|Lost to Follow-up|0|||
129937808|NCT01574716|467738032|FG003|Part 1|Lost to Follow-up|0|||
129937809|NCT01574716|467738033|FG004|Part 1|Lost to Follow-up|0|||
129937810|NCT01574716|467738029|FG000|Part 2|Progressive disease|0|||
129937811|NCT01574716|467738030|FG001|Part 2|Progressive disease|0|||
129937812|NCT01574716|467738031|FG002|Part 2|Progressive disease|0|||
129937813|NCT01574716|467738032|FG003|Part 2|Progressive disease|1|||
129937814|NCT01574716|467738033|FG004|Part 2|Progressive disease|0|||
129937815|NCT01574716|467738029|FG000|Part 2|Death|0|||
129937816|NCT01574716|467738030|FG001|Part 2|Death|0|||
129937817|NCT01574716|467738031|FG002|Part 2|Death|0|||
129937818|NCT01574716|467738032|FG003|Part 2|Death|76|||
129937819|NCT01574716|467738033|FG004|Part 2|Death|35|||
129937820|NCT01574716|467738029|FG000|Part 2|Discontinuation of study by sponsor|0|||
129937821|NCT01574716|467738030|FG001|Part 2|Discontinuation of study by sponsor|0|||
129937822|NCT01574716|467738031|FG002|Part 2|Discontinuation of study by sponsor|0|||
129937823|NCT01574716|467738032|FG003|Part 2|Discontinuation of study by sponsor|51|||
129937824|NCT01574716|467738033|FG004|Part 2|Discontinuation of study by sponsor|31|||
129937825|NCT01574716|467738029|FG000|Part 2|Withdrawal by Subject|0|||
129937826|NCT01574716|467738030|FG001|Part 2|Withdrawal by Subject|0|||
129937827|NCT01574716|467738031|FG002|Part 2|Withdrawal by Subject|0|||
129937828|NCT01574716|467738032|FG003|Part 2|Withdrawal by Subject|5|||
129937829|NCT01574716|467738033|FG004|Part 2|Withdrawal by Subject|4|||
129937830|NCT01574716|467738029|FG000|Part 2|Brain metastases|0|||
129937831|NCT01574716|467738030|FG001|Part 2|Brain metastases|0|||
129937832|NCT01574716|467738031|FG002|Part 2|Brain metastases|0|||
129937833|NCT01574716|467738032|FG003|Part 2|Brain metastases|1|||
129937834|NCT01574716|467738033|FG004|Part 2|Brain metastases|0|||
129937835|NCT01574716|467738029|FG000|Part 2|Lost to Follow-up|0|||
129937836|NCT01574716|467738030|FG001|Part 2|Lost to Follow-up|0|||
129937837|NCT01574716|467738031|FG002|Part 2|Lost to Follow-up|0|||
129937838|NCT01574716|467738032|FG003|Part 2|Lost to Follow-up|3|||
129937839|NCT01574716|467738033|FG004|Part 2|Lost to Follow-up|0|||
129937840|NCT02438137|467738034|FG000|Overall Study|Lost to Follow-up|3|||
129937841|NCT02438137|467738035|FG001|Overall Study|Lost to Follow-up|2|||
129937842|NCT02438137|467738034|FG000|Overall Study|Adverse Event|1|||
129937843|NCT02438137|467738035|FG001|Overall Study|Adverse Event|0|||
129937844|NCT02438137|467738034|FG000|Overall Study|Withdrawal by Subject|4|||
129937845|NCT02438137|467738035|FG001|Overall Study|Withdrawal by Subject|3|||
129937846|NCT02438137|467738034|FG000|Overall Study|Physician Decision|0|||
129937847|NCT02438137|467738035|FG001|Overall Study|Physician Decision|1|||
129937848|NCT01637402|467738037|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
129937849|NCT01637402|467738038|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
129937850|NCT01637402|467738037|FG000|Standard Dose Regimen|Adverse Event|1|||
129937851|NCT01637402|467738038|FG001|Standard Dose Regimen|Adverse Event|0|||
129937852|NCT01637402|467738037|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
129937853|NCT01637402|467738038|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
129937854|NCT01637402|467738037|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
129937855|NCT01637402|467738038|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
129937856|NCT01637402|467738037|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
129937857|NCT01637402|467738038|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
129937858|NCT01637402|467738037|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
129937859|NCT01637402|467738038|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
129937860|NCT02285270|467738039|FG000|Overall Study|Lost to Follow-up|1|||
129937861|NCT02285270|467738039|FG000|Overall Study|Physician Decision|3|||
129937862|NCT02285270|467738039|FG000|Overall Study|Determined to be ineligible|1|||
129937863|NCT03621735|467738040|FG000|Overall Study|Withdrawal by Subject|13|||
129937864|NCT03621735|467738041|FG001|Overall Study|Withdrawal by Subject|13|||
129937865|NCT01627561|467738047|FG000|Overall Study|Lost to Follow-up|1|||
129937866|NCT01627561|467738048|FG001|Overall Study|Lost to Follow-up|0|||
129937867|NCT01627561|467738047|FG000|Overall Study|Withdrawal by Subject|0|||
129937868|NCT01627561|467738048|FG001|Overall Study|Withdrawal by Subject|1|||
129937869|NCT01627561|467738047|FG000|Overall Study|Migrated/moved from study area|0|||
129937870|NCT01627561|467738048|FG001|Overall Study|Migrated/moved from study area|2|||
129937871|NCT00890591|467738050|FG000|Overall Study|Lack of Efficacy|20|||
129937872|NCT01579318|467738055|FG000|Overall Study|Disease Progression|1|||
129937873|NCT02347332|467738056|FG000|Overall Study|Not treated|5|||
129937874|NCT02347332|467738057|FG001|Overall Study|Not treated|2|||
129937875|NCT02347332|467738056|FG000|Overall Study|Progressive disease|141|||
129937876|NCT02347332|467738057|FG001|Overall Study|Progressive disease|159|||
129937877|NCT02347332|467738056|FG000|Overall Study|Adverse Event|50|||
129937878|NCT02347332|467738057|FG001|Overall Study|Adverse Event|41|||
129937879|NCT02347332|467738056|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
129937880|NCT02347332|467738057|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
129937881|NCT02347332|467738056|FG000|Overall Study|Protocol Violation|1|||
129937882|NCT02347332|467738057|FG001|Overall Study|Protocol Violation|1|||
129937883|NCT02347332|467738056|FG000|Overall Study|Lost to Follow-up|2|||
129937884|NCT02347332|467738057|FG001|Overall Study|Lost to Follow-up|1|||
129937885|NCT02347332|467738056|FG000|Overall Study|Physician Decision|4|||
129937886|NCT02347332|467738057|FG001|Overall Study|Physician Decision|3|||
129937887|NCT02347332|467738056|FG000|Overall Study|Withdrawal by Subject|20|||
129937888|NCT02347332|467738057|FG001|Overall Study|Withdrawal by Subject|14|||
129937889|NCT02347332|467738056|FG000|Overall Study|Protocol requirement|1|||
129937890|NCT02347332|467738057|FG001|Overall Study|Protocol requirement|1|||
129937891|NCT02347332|467738056|FG000|Overall Study|Switch Post-Trial program|0|||
129937892|NCT02347332|467738057|FG001|Overall Study|Switch Post-Trial program|1|||
129937893|NCT00112359|467738058|FG000|Overall Study|Unrelated adverse event|16|||
129937894|NCT00112359|467738059|FG001|Overall Study|Unrelated adverse event|8|||
129937895|NCT00112359|467738058|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
129937896|NCT00112359|467738059|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
129937897|NCT00112359|467738058|FG000|Overall Study|Related adverse event|5|||
129937898|NCT00112359|467738059|FG001|Overall Study|Related adverse event|3|||
129937899|NCT00112359|467738058|FG000|Overall Study|Lost to Follow-up|0|||
129937900|NCT00112359|467738059|FG001|Overall Study|Lost to Follow-up|1|||
129937901|NCT00112359|467738058|FG000|Overall Study|Personal/administrative|1|||
129937902|NCT00112359|467738059|FG001|Overall Study|Personal/administrative|1|||
129937903|NCT00112359|467738058|FG000|Overall Study|Other|3|||
129937904|NCT00112359|467738059|FG001|Overall Study|Other|0|||
129937905|NCT01988402|467738060|FG000|Overall Study|Adverse Event|1|||
129937906|NCT01988402|467738061|FG001|Overall Study|Adverse Event|2|||
129937907|NCT01988402|467738060|FG000|Overall Study|Withdrawal by Subject|1|||
129937908|NCT01988402|467738061|FG001|Overall Study|Withdrawal by Subject|0|||
129937909|NCT01961609|467738062|FG000|Initiation|Missing|3|||
129937910|NCT01961609|467738063|FG001|Initiation|Missing|2|||
129937911|NCT01961609|467738064|FG002|Initiation|Missing|0|||
129937912|NCT01961609|467738065|FG003|Initiation|Missing|0|||
129937913|NCT01961609|467738062|FG000|Initiation|Protocol deviation|1|||
129937914|NCT01961609|467738063|FG001|Initiation|Protocol deviation|0|||
129937915|NCT01961609|467738064|FG002|Initiation|Protocol deviation|0|||
129937916|NCT01961609|467738065|FG003|Initiation|Protocol deviation|0|||
129937917|NCT01961609|467738062|FG000|Initiation|Death|0|||
129937918|NCT01961609|467738063|FG001|Initiation|Death|1|||
129937919|NCT01961609|467738064|FG002|Initiation|Death|0|||
129937920|NCT01961609|467738065|FG003|Initiation|Death|0|||
129937921|NCT01961609|467738062|FG000|Initiation|Administrative problems|1|||
129937922|NCT01961609|467738063|FG001|Initiation|Administrative problems|0|||
129937923|NCT01961609|467738064|FG002|Initiation|Administrative problems|0|||
129937924|NCT01961609|467738065|FG003|Initiation|Administrative problems|0|||
129937925|NCT01961609|467738062|FG000|Initiation|Withdrawal by Subject|1|||
129937926|NCT01961609|467738063|FG001|Initiation|Withdrawal by Subject|2|||
129937927|NCT01961609|467738064|FG002|Initiation|Withdrawal by Subject|0|||
129937928|NCT01961609|467738065|FG003|Initiation|Withdrawal by Subject|0|||
129937929|NCT01961609|467738062|FG000|Initiation|Lack of Efficacy|2|||
129937930|NCT01961609|467738063|FG001|Initiation|Lack of Efficacy|1|||
129937931|NCT01961609|467738064|FG002|Initiation|Lack of Efficacy|0|||
129937932|NCT01961609|467738065|FG003|Initiation|Lack of Efficacy|0|||
129937933|NCT01961609|467738062|FG000|Initiation|Abnormal lab values|0|||
129937934|NCT01961609|467738063|FG001|Initiation|Abnormal lab values|1|||
129937935|NCT01961609|467738064|FG002|Initiation|Abnormal lab values|0|||
129937936|NCT01961609|467738065|FG003|Initiation|Abnormal lab values|0|||
129937937|NCT01961609|467738062|FG000|Initiation|Adverse Event|3|||
129937938|NCT01961609|467738063|FG001|Initiation|Adverse Event|5|||
129937939|NCT01961609|467738064|FG002|Initiation|Adverse Event|0|||
129937940|NCT01961609|467738065|FG003|Initiation|Adverse Event|0|||
129937941|NCT01961609|467738062|FG000|Initiation|Randomized but not treated|1|||
129937942|NCT01961609|467738063|FG001|Initiation|Randomized but not treated|1|||
129937943|NCT01961609|467738064|FG002|Initiation|Randomized but not treated|0|||
129937944|NCT01961609|467738065|FG003|Initiation|Randomized but not treated|0|||
129937945|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
129937946|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
129937947|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
129937948|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
129937949|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
129937950|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
129937951|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
129937952|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
129937953|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
129937954|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
129937955|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
129937956|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
129937957|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
129937958|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
129937959|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
129937960|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
129937961|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
129937962|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
129937963|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
129937964|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
129937965|NCT01961609|467738062|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
129937966|NCT01961609|467738063|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
129452747|NCT03574753|465954684|FG000|Overall Study|Adverse Event|3|||
129452748|NCT03574753|465954684|FG000|Overall Study|Progression/relapse|19|||
129452749|NCT03574753|465954684|FG000|Overall Study|Death|1|||
129452750|NCT01744665|465954685|FG000|Monitoring Phase|Adverse Event|4|||
129452751|NCT01744665|465954685|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
129452752|NCT01744665|465954685|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
129452753|NCT01744665|465954685|FG000|Monitoring Phase|Withdrawal by Subject|5|||
129937967|NCT01961609|467738064|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
129937968|NCT01961609|467738065|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
129937969|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
129937970|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
129937971|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
129937972|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
129937973|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
129937974|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
129937975|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
129937976|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
129937977|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
129937978|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
129937979|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
129937980|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
129937981|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
129937982|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
129937983|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
129937984|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
129937985|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
129937986|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
129937987|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
129937988|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
129937989|NCT01961609|467738062|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
129937990|NCT01961609|467738063|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
129937991|NCT01961609|467738064|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
129937992|NCT01961609|467738065|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
129937993|NCT01211184|467738068|FG000|Overall Study|Withdrawal by Subject|0|||
129937994|NCT01211184|467738069|FG001|Overall Study|Withdrawal by Subject|2|||
129937995|NCT01211184|467738070|FG002|Overall Study|Withdrawal by Subject|1|||
129937996|NCT04060212|467738071|FG000|Overall Study|Withdrawal by Subject|7|||
129937997|NCT02844439|467738073|FG000|Overall Study|Withdrawal by Subject|1|||
129937998|NCT02844439|467738073|FG000|Overall Study|Lost to Follow-up|2|||
129937999|NCT02844439|467738073|FG000|Overall Study|Termination by Sponsor|4|||
129938000|NCT02844439|467738073|FG000|Overall Study|Death|28|||
129938001|NCT02844439|467738073|FG000|Overall Study|Other|5|||
129938002|NCT03170648|467738078|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
129938003|NCT03170648|467738078|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
129938004|NCT03509909|467738079|FG000|Overall Study|Withdrawal by Subject|16|||
129938005|NCT03509909|467738080|FG001|Overall Study|Withdrawal by Subject|9|||
129938006|NCT03509909|467738079|FG000|Overall Study|Lost to Follow-up|3|||
129938007|NCT03509909|467738080|FG001|Overall Study|Lost to Follow-up|4|||
129938008|NCT03509909|467738079|FG000|Overall Study|Adverse Event|2|||
129938009|NCT03509909|467738080|FG001|Overall Study|Adverse Event|0|||
129938010|NCT03500549|467738081|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
129938011|NCT03500549|467738082|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
129938012|NCT03500549|467738081|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
129938013|NCT03500549|467738082|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
129938014|NCT02107261|467738083|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
129938015|NCT02107261|467738084|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
129938016|NCT02107261|467738083|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
129938017|NCT02107261|467738084|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
129938018|NCT04337931|467738086|FG000|Overall Study|Death|4|||
129938019|NCT04337931|467738087|FG001|Overall Study|Death|1|||
129938020|NCT04337931|467738088|FG002|Overall Study|Death|7|||
129938021|NCT04337931|467738086|FG000|Overall Study|Withdrawal by Subject|0|||
129938022|NCT04337931|467738087|FG001|Overall Study|Withdrawal by Subject|1|||
129938023|NCT04337931|467738088|FG002|Overall Study|Withdrawal by Subject|0|||
129938024|NCT04337931|467738086|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
129938025|NCT04337931|467738087|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
129938026|NCT04337931|467738088|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
129938027|NCT04337931|467738086|FG000|Overall Study|Study terminated by sponsor|3|||
129938028|NCT04337931|467738087|FG001|Overall Study|Study terminated by sponsor|6|||
129938029|NCT04337931|467738088|FG002|Overall Study|Study terminated by sponsor|2|||
129938030|NCT04337931|467738086|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
129938031|NCT04337931|467738087|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
129938032|NCT04337931|467738088|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
129938033|NCT04337931|467738086|FG000|Overall Study|Colorectal cancer treatment|1|||
129938034|NCT04337931|467738087|FG001|Overall Study|Colorectal cancer treatment|0|||
129938035|NCT04337931|467738088|FG002|Overall Study|Colorectal cancer treatment|0|||
129938036|NCT04337931|467738086|FG000|Overall Study|Participant decision|0|||
129938037|NCT04337931|467738087|FG001|Overall Study|Participant decision|1|||
129938038|NCT04337931|467738088|FG002|Overall Study|Participant decision|0|||
129938039|NCT04436289|467738089|FG000|Overall Study|Death prior to hospital discharge|8|||
129938040|NCT04436289|467738090|FG001|Overall Study|Death prior to hospital discharge|5|||
129938041|NCT04436289|467738091|FG002|Overall Study|Death prior to hospital discharge|0|||
129938042|NCT04436289|467738092|FG003|Overall Study|Death prior to hospital discharge|1|||
129938043|NCT04436289|467738089|FG000|Overall Study|Withdrawal by Subject|0|||
129938044|NCT04436289|467738090|FG001|Overall Study|Withdrawal by Subject|1|||
129938045|NCT04436289|467738091|FG002|Overall Study|Withdrawal by Subject|4|||
129938046|NCT04436289|467738092|FG003|Overall Study|Withdrawal by Subject|0|||
129938047|NCT04436289|467738089|FG000|Overall Study|Extended hospital stay|0|||
129938048|NCT04436289|467738090|FG001|Overall Study|Extended hospital stay|1|||
129938049|NCT04436289|467738091|FG002|Overall Study|Extended hospital stay|0|||
129938050|NCT04436289|467738092|FG003|Overall Study|Extended hospital stay|0|||
129938051|NCT04436289|467738089|FG000|Overall Study|Lost to Follow-up|0|||
129938052|NCT04436289|467738090|FG001|Overall Study|Lost to Follow-up|4|||
129938053|NCT04436289|467738091|FG002|Overall Study|Lost to Follow-up|1|||
129938054|NCT04436289|467738092|FG003|Overall Study|Lost to Follow-up|3|||
129938055|NCT02928172|467738093|FG000|Overall Study|Device did not record data|1|||
129938056|NCT04066075|467738094|FG000|Overall Study|Lost to Follow-up|3|||
129938057|NCT04066075|467738095|FG001|Overall Study|Lost to Follow-up|3|||
129938058|NCT04066075|467738094|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
129938059|NCT04066075|467738095|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
129938060|NCT04066075|467738094|FG000|Overall Study|Withdrawal by Subject|2|||
129938061|NCT04066075|467738095|FG001|Overall Study|Withdrawal by Subject|2|||
129938062|NCT00309166|467738096|FG000|Overall Study|Adverse event, non-fatal|1|||
129938063|NCT00309166|467738097|FG001|Overall Study|Adverse event, non-fatal|0|||
129938064|NCT00309166|467738096|FG000|Overall Study|Withdrawal by Subject|4|||
129938065|NCT00309166|467738097|FG001|Overall Study|Withdrawal by Subject|3|||
129938066|NCT05139992|467738100|FG000|Overall Study|Withdrawal by Subject|12|||
129938067|NCT05139992|467738100|FG000|Overall Study|Lost to Follow-up|6|||
129938068|NCT04305327|467738101|FG000|Overall Study|Study early termination|2|||
129938069|NCT04305327|467738102|FG001|Overall Study|Study early termination|5|||
129938070|NCT04305327|467738103|FG002|Overall Study|Study early termination|2|||
129938071|NCT04305327|467738104|FG003|Overall Study|Study early termination|2|||
129938072|NCT04305327|467738101|FG000|Overall Study|Withdrawal by Subject|0|||
129938073|NCT04305327|467738102|FG001|Overall Study|Withdrawal by Subject|1|||
129938074|NCT04305327|467738103|FG002|Overall Study|Withdrawal by Subject|0|||
129938075|NCT04305327|467738104|FG003|Overall Study|Withdrawal by Subject|0|||
129938076|NCT00747565|467738105|FG000|Overall Study|Withdrawal by Subject|10|||
129938077|NCT00747565|467738106|FG001|Overall Study|Withdrawal by Subject|6|||
129938078|NCT00747565|467738105|FG000|Overall Study|Lost to Follow-up|4|||
129938079|NCT00747565|467738106|FG001|Overall Study|Lost to Follow-up|1|||
129938080|NCT03777657|467738107|FG000|Overall Study|Death|397|||
129938081|NCT03777657|467738108|FG001|Overall Study|Death|431|||
129938082|NCT03777657|467738107|FG000|Overall Study|Study Closed by Sponsor|77|||
129938083|NCT03777657|467738108|FG001|Overall Study|Study Closed by Sponsor|38|||
129938084|NCT03777657|467738107|FG000|Overall Study|Withdrawal by Subject|20|||
129938085|NCT03777657|467738108|FG001|Overall Study|Withdrawal by Subject|17|||
129938086|NCT03777657|467738107|FG000|Overall Study|Lost to Follow-up|6|||
129938087|NCT03777657|467738108|FG001|Overall Study|Lost to Follow-up|10|||
129938088|NCT05464732|467738111|FG000|Overall Study|Lost to Follow-up|0|||
129938089|NCT05464732|467738112|FG001|Overall Study|Lost to Follow-up|1|||
129938090|NCT05464732|467738111|FG000|Overall Study|Adverse Event|1|||
129938091|NCT05464732|467738112|FG001|Overall Study|Adverse Event|0|||
129938092|NCT00593840|467738115|FG000|Overall Study|Withdrawal by Subject|1|||
129938093|NCT00655499|467739183|FG000|Overall Study|not eligible|4|||
129938094|NCT04213807|467739190|FG000|Overall Study|Physician Decision|0|||
129938095|NCT04213807|467739191|FG001|Overall Study|Physician Decision|0|||
129938096|NCT04213807|467739192|FG002|Overall Study|Physician Decision|1|||
129938097|NCT02185794|467739194|FG000|Overall Study|Enrolled but Never Dosed|1|||
129938098|NCT02185794|467739195|FG001|Overall Study|Enrolled but Never Dosed|6|||
129938099|NCT02185794|467739196|FG002|Overall Study|Enrolled but Never Dosed|3|||
129938100|NCT02185794|467739197|FG003|Overall Study|Enrolled but Never Dosed|1|||
129938101|NCT02185794|467739198|FG004|Overall Study|Enrolled but Never Dosed|1|||
129938102|NCT02185794|467739199|FG005|Overall Study|Enrolled but Never Dosed|0|||
129938103|NCT02185794|467739194|FG000|Overall Study|Investigator's Discretion|1|||
129938104|NCT02185794|467739195|FG001|Overall Study|Investigator's Discretion|0|||
129938105|NCT02185794|467739196|FG002|Overall Study|Investigator's Discretion|1|||
129938106|NCT02185794|467739197|FG003|Overall Study|Investigator's Discretion|2|||
129938107|NCT02185794|467739198|FG004|Overall Study|Investigator's Discretion|2|||
129938108|NCT02185794|467739199|FG005|Overall Study|Investigator's Discretion|15|||
129938109|NCT02185794|467739194|FG000|Overall Study|Withdrew Consent|2|||
129938110|NCT02185794|467739195|FG001|Overall Study|Withdrew Consent|5|||
129938111|NCT02185794|467739196|FG002|Overall Study|Withdrew Consent|10|||
129938112|NCT02185794|467739197|FG003|Overall Study|Withdrew Consent|2|||
129938113|NCT02185794|467739198|FG004|Overall Study|Withdrew Consent|0|||
129938114|NCT02185794|467739199|FG005|Overall Study|Withdrew Consent|0|||
129938115|NCT02185794|467739194|FG000|Overall Study|Lost to Follow-up|1|||
129938116|NCT02185794|467739195|FG001|Overall Study|Lost to Follow-up|2|||
129938117|NCT02185794|467739196|FG002|Overall Study|Lost to Follow-up|2|||
129938118|NCT02185794|467739197|FG003|Overall Study|Lost to Follow-up|3|||
129938119|NCT02185794|467739198|FG004|Overall Study|Lost to Follow-up|0|||
129938120|NCT02185794|467739199|FG005|Overall Study|Lost to Follow-up|1|||
129938121|NCT00777049|467739200|FG000|Overall Study|Withdrawal by Subject|1|||
129938122|NCT00777049|467739201|FG001|Overall Study|Withdrawal by Subject|0|||
129452754|NCT01744665|465954685|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
129452755|NCT01744665|465954685|FG000|Consolidation Phase|Adverse Event|2|||
129452756|NCT01744665|465954685|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
129452757|NCT01744665|465954685|FG000|Consolidation Phase|Withdrawal by Subject|4|||
129452758|NCT01744665|465954685|FG000|Consolidation Phase|Administrative problems|9|||
129452759|NCT01744665|465954685|FG000|Re-initiation Phase|Administrative problems|10|||
129452760|NCT01744665|465954685|FG000|Re-initiation Phase|Adverse Event|1|||
129452761|NCT01744665|465954685|FG000|Re-initiation Phase|No longer required treatment|1|||
129452762|NCT01744665|465954685|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
129452763|NCT02044133|465954688|FG000|Overall Study|Lost to Follow-up|1|||
129452764|NCT02044133|465954689|FG001|Overall Study|Lost to Follow-up|1|||
129452765|NCT02044133|465954688|FG000|Overall Study|Death|1|||
129452766|NCT02044133|465954689|FG001|Overall Study|Death|0|||
129452767|NCT02044133|465954688|FG000|Overall Study|Release|3|||
129452768|NCT02044133|465954689|FG001|Overall Study|Release|4|||
129452769|NCT02044133|465954688|FG000|Overall Study|Transfer|1|||
129452770|NCT02044133|465954689|FG001|Overall Study|Transfer|0|||
129452771|NCT02044133|465954688|FG000|Overall Study|refusal of blood sampling|0|||
129452772|NCT02044133|465954689|FG001|Overall Study|refusal of blood sampling|1|||
129452773|NCT06156215|465954696|FG000|Overall Study|Withdrawal by Subject|2|||
129452774|NCT06156215|465954697|FG001|Overall Study|Withdrawal by Subject|4|||
129452775|NCT06156215|465954698|FG002|Overall Study|Withdrawal by Subject|4|||
129452776|NCT06156215|465954699|FG003|Overall Study|Withdrawal by Subject|0|||
129452777|NCT06156215|465954700|FG004|Overall Study|Withdrawal by Subject|2|||
129452778|NCT06156215|465954701|FG005|Overall Study|Withdrawal by Subject|2|||
129452779|NCT06156215|465954696|FG000|Overall Study|Left ED without completing study|9|||
129452780|NCT06156215|465954697|FG001|Overall Study|Left ED without completing study|3|||
129452781|NCT06156215|465954698|FG002|Overall Study|Left ED without completing study|9|||
129452782|NCT06156215|465954699|FG003|Overall Study|Left ED without completing study|0|||
129452783|NCT06156215|465954700|FG004|Overall Study|Left ED without completing study|8|||
129452784|NCT06156215|465954701|FG005|Overall Study|Left ED without completing study|16|||
129452785|NCT06156215|465954696|FG000|Overall Study|Physician Decision|1|||
129452786|NCT06156215|465954697|FG001|Overall Study|Physician Decision|0|||
129452787|NCT06156215|465954698|FG002|Overall Study|Physician Decision|0|||
129452788|NCT06156215|465954699|FG003|Overall Study|Physician Decision|0|||
129452789|NCT06156215|465954700|FG004|Overall Study|Physician Decision|0|||
129452790|NCT06156215|465954701|FG005|Overall Study|Physician Decision|0|||
129452791|NCT06156215|465954696|FG000|Overall Study|Became or found ineligible|2|||
129452792|NCT06156215|465954697|FG001|Overall Study|Became or found ineligible|0|||
129452793|NCT06156215|465954698|FG002|Overall Study|Became or found ineligible|2|||
129452794|NCT06156215|465954699|FG003|Overall Study|Became or found ineligible|0|||
129452795|NCT06156215|465954700|FG004|Overall Study|Became or found ineligible|1|||
129452796|NCT06156215|465954701|FG005|Overall Study|Became or found ineligible|2|||
129452797|NCT00766038|465956290|FG000|Overall Study|Lost to Follow-up|15|||
129452798|NCT00766038|465956291|FG001|Overall Study|Lost to Follow-up|14|||
129452799|NCT00847145|465956296|FG000|Overall Study|AE or Death|0|||
129452800|NCT00847145|465956297|FG001|Overall Study|AE or Death|1|||
129452801|NCT00847145|465956298|FG002|Overall Study|AE or Death|1|||
129452802|NCT00847145|465956299|FG003|Overall Study|AE or Death|0|||
129452803|NCT00847145|465956300|FG004|Overall Study|AE or Death|0|||
129452804|NCT00847145|465956301|FG005|Overall Study|AE or Death|0|||
129452805|NCT00847145|465956302|FG006|Overall Study|AE or Death|0|||
129452806|NCT00847145|465956303|FG007|Overall Study|AE or Death|0|||
129452807|NCT00847145|465956296|FG000|Overall Study|Withdrawal by Subject|3|||
129452808|NCT00847145|465956297|FG001|Overall Study|Withdrawal by Subject|4|||
129452809|NCT00847145|465956298|FG002|Overall Study|Withdrawal by Subject|6|||
129452810|NCT00847145|465956299|FG003|Overall Study|Withdrawal by Subject|1|||
129452811|NCT00847145|465956300|FG004|Overall Study|Withdrawal by Subject|0|||
129452812|NCT00847145|465956301|FG005|Overall Study|Withdrawal by Subject|0|||
129452813|NCT00847145|465956302|FG006|Overall Study|Withdrawal by Subject|1|||
129452814|NCT00847145|465956303|FG007|Overall Study|Withdrawal by Subject|1|||
129452815|NCT00847145|465956296|FG000|Overall Study|Lost to Follow-up|3|||
129452816|NCT00847145|465956297|FG001|Overall Study|Lost to Follow-up|1|||
129452817|NCT00847145|465956298|FG002|Overall Study|Lost to Follow-up|1|||
129452818|NCT00847145|465956299|FG003|Overall Study|Lost to Follow-up|0|||
129452819|NCT00847145|465956300|FG004|Overall Study|Lost to Follow-up|4|||
129452820|NCT00847145|465956301|FG005|Overall Study|Lost to Follow-up|4|||
129452821|NCT00847145|465956302|FG006|Overall Study|Lost to Follow-up|8|||
129452822|NCT00847145|465956303|FG007|Overall Study|Lost to Follow-up|2|||
129452823|NCT00847145|465956296|FG000|Overall Study|Inappropriate enrollment|0|||
129452824|NCT00847145|465956297|FG001|Overall Study|Inappropriate enrollment|0|||
129452825|NCT00847145|465956298|FG002|Overall Study|Inappropriate enrollment|0|||
129938123|NCT00777049|467739200|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
129938124|NCT00777049|467739201|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
129452826|NCT00847145|465956299|FG003|Overall Study|Inappropriate enrollment|0|||
129452827|NCT00847145|465956300|FG004|Overall Study|Inappropriate enrollment|1|||
129452828|NCT00847145|465956301|FG005|Overall Study|Inappropriate enrollment|0|||
129452829|NCT00847145|465956302|FG006|Overall Study|Inappropriate enrollment|0|||
129938125|NCT00246805|467739202|FG000|Phase 1|Lost to Follow-up|1|||
129938126|NCT00246805|467739203|FG001|Phase 1|Lost to Follow-up|0|||
129938127|NCT00609869|467739204|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
129938128|NCT00609869|467739204|FG000|Overall Study|Severe hematologic toxicity|1|||
129938129|NCT00609869|467739204|FG000|Overall Study|Withdrawal by Subject|1|||
129938130|NCT00609869|467739204|FG000|Overall Study|Seizures|1|||
129938131|NCT00609869|467739204|FG000|Overall Study|Severe tumor flare reaction|1|||
129938132|NCT00609869|467739204|FG000|Overall Study|Hepatitis B infection|1|||
129938133|NCT00609869|467739204|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
129938134|NCT00609869|467739204|FG000|Overall Study|Mantle cell: not evaluable|4|||
129938135|NCT00724126|467739205|FG000|Overall Study|Adverse Event|2|||
129938136|NCT00724126|467739206|FG001|Overall Study|Adverse Event|0|||
129938137|NCT00724126|467739205|FG000|Overall Study|Withdrawal by Subject|8|||
129938138|NCT00724126|467739206|FG001|Overall Study|Withdrawal by Subject|6|||
129938139|NCT00724126|467739205|FG000|Overall Study|Lost to Follow-up|6|||
129938140|NCT00724126|467739206|FG001|Overall Study|Lost to Follow-up|6|||
129938141|NCT00724126|467739205|FG000|Overall Study|Noncompliance|2|||
129938142|NCT00724126|467739206|FG001|Overall Study|Noncompliance|1|||
129938143|NCT00724126|467739205|FG000|Overall Study|Subject randomized although ineligible|1|||
129938144|NCT00724126|467739206|FG001|Overall Study|Subject randomized although ineligible|1|||
129938145|NCT00724126|467739205|FG000|Overall Study|Subject had to leave vicinity of site|0|||
129938146|NCT00724126|467739206|FG001|Overall Study|Subject had to leave vicinity of site|1|||
129938147|NCT00739934|467739207|FG000|Voriconazole IV|Adverse Event|6|||
129938148|NCT00739934|467739207|FG000|Voriconazole Oral|Other|3|||
129938149|NCT02502526|467739210|FG000|Overall Study|Lost to Follow-up|2|||
129938150|NCT02502526|467739211|FG001|Overall Study|Lost to Follow-up|2|||
129938151|NCT02502526|467739212|FG002|Overall Study|Lost to Follow-up|3|||
129938152|NCT02502526|467739210|FG000|Overall Study|Withdrawal by Subject|0|||
129938153|NCT02502526|467739211|FG001|Overall Study|Withdrawal by Subject|1|||
129938154|NCT02502526|467739212|FG002|Overall Study|Withdrawal by Subject|1|||
129938155|NCT02502526|467739210|FG000|Overall Study|Disqualified due to cataract grading|0|||
129938156|NCT02502526|467739211|FG001|Overall Study|Disqualified due to cataract grading|0|||
129938157|NCT02502526|467739212|FG002|Overall Study|Disqualified due to cataract grading|1|||
129938158|NCT02502526|467739210|FG000|Overall Study|Enrollment suspension|4|||
129938159|NCT02502526|467739211|FG001|Overall Study|Enrollment suspension|1|||
129938160|NCT02502526|467739212|FG002|Overall Study|Enrollment suspension|1|||
129938161|NCT01342367|467739213|FG000|Overall Study|Death|1|||
129938162|NCT01342367|467739214|FG001|Overall Study|Death|0|||
129938163|NCT01342367|467739213|FG000|Overall Study|Withdrawal by Subject|1|||
129938164|NCT01342367|467739214|FG001|Overall Study|Withdrawal by Subject|2|||
129938165|NCT00571649|467739216|FG000|Treatment Period|Adverse Event|438|||
129938166|NCT00571649|467739217|FG001|Treatment Period|Adverse Event|385|||
129938167|NCT00571649|467739216|FG000|Treatment Period|Clinical endpoint reached|50|||
129938168|NCT00571649|467739217|FG001|Treatment Period|Clinical endpoint reached|56|||
129938169|NCT00571649|467739216|FG000|Treatment Period|Withdrawal by Subject|285|||
129938170|NCT00571649|467739217|FG001|Treatment Period|Withdrawal by Subject|255|||
129938171|NCT00571649|467739216|FG000|Treatment Period|Death|76|||
129938172|NCT00571649|467739217|FG001|Treatment Period|Death|59|||
129938173|NCT00571649|467739216|FG000|Treatment Period|Physician Decision|8|||
129938174|NCT00571649|467739217|FG001|Treatment Period|Physician Decision|9|||
129938175|NCT00571649|467739216|FG000|Treatment Period|Lost to Follow-up|43|||
129938176|NCT00571649|467739217|FG001|Treatment Period|Lost to Follow-up|41|||
129938177|NCT00571649|467739216|FG000|Treatment Period|Non-compliant with study medication|88|||
129938178|NCT00571649|467739217|FG001|Treatment Period|Non-compliant with study medication|89|||
129938179|NCT00571649|467739216|FG000|Treatment Period|Patient convenience|11|||
129938180|NCT00571649|467739217|FG001|Treatment Period|Patient convenience|13|||
129938181|NCT00571649|467739216|FG000|Treatment Period|Protocol Violation|90|||
129938182|NCT00571649|467739217|FG001|Treatment Period|Protocol Violation|92|||
129938183|NCT00571649|467739216|FG000|Treatment Period|Technical problems|3|||
129938184|NCT00571649|467739217|FG001|Treatment Period|Technical problems|5|||
129938185|NCT00571649|467739216|FG000|Follow-up Period|Adverse Event|46|||
129938186|NCT00571649|467739217|FG001|Follow-up Period|Adverse Event|40|||
129938187|NCT00571649|467739216|FG000|Follow-up Period|Clinical endpoint reached|5|||
129938188|NCT00571649|467739217|FG001|Follow-up Period|Clinical endpoint reached|2|||
129938189|NCT00571649|467739216|FG000|Follow-up Period|Withdrawal by Subject|119|||
129938190|NCT00571649|467739217|FG001|Follow-up Period|Withdrawal by Subject|115|||
129938191|NCT00571649|467739216|FG000|Follow-up Period|Death|132|||
129938192|NCT00571649|467739217|FG001|Follow-up Period|Death|133|||
129938193|NCT00571649|467739216|FG000|Follow-up Period|Physician Decision|7|||
129938194|NCT00571649|467739217|FG001|Follow-up Period|Physician Decision|13|||
129938195|NCT00571649|467739216|FG000|Follow-up Period|Lost to Follow-up|95|||
129938196|NCT00571649|467739217|FG001|Follow-up Period|Lost to Follow-up|92|||
129938197|NCT00571649|467739216|FG000|Follow-up Period|Patient convenience|136|||
129938198|NCT00571649|467739217|FG001|Follow-up Period|Patient convenience|121|||
129938199|NCT00571649|467739216|FG000|Follow-up Period|Protocol Violation|5|||
129938200|NCT00571649|467739217|FG001|Follow-up Period|Protocol Violation|12|||
129938201|NCT00582972|467739218|FG000|Overall Study|Protocol Violation|2|||
129938202|NCT01566890|467739221|FG000|Overall Study|Adverse Event|1|||
129938203|NCT01566890|467739222|FG001|Overall Study|Adverse Event|0|||
129938204|NCT01566890|467739223|FG002|Overall Study|Adverse Event|0|||
129938205|NCT01566890|467739224|FG003|Overall Study|Adverse Event|0|||
129938206|NCT01566890|467739225|FG004|Overall Study|Adverse Event|0|||
129938207|NCT01566890|467739221|FG000|Overall Study|Withdrawal by Subject|3|||
129938208|NCT01566890|467739222|FG001|Overall Study|Withdrawal by Subject|1|||
129938209|NCT01566890|467739223|FG002|Overall Study|Withdrawal by Subject|1|||
129938210|NCT01566890|467739224|FG003|Overall Study|Withdrawal by Subject|1|||
129938211|NCT01566890|467739225|FG004|Overall Study|Withdrawal by Subject|0|||
129938212|NCT01566890|467739221|FG000|Overall Study|Screen failure|6|||
129938213|NCT01566890|467739222|FG001|Overall Study|Screen failure|0|||
129938214|NCT01566890|467739223|FG002|Overall Study|Screen failure|1|||
129938215|NCT01566890|467739224|FG003|Overall Study|Screen failure|1|||
129938216|NCT01566890|467739225|FG004|Overall Study|Screen failure|0|||
129938217|NCT01566890|467739221|FG000|Overall Study|Incomplete CEU data|1|||
129938218|NCT01566890|467739222|FG001|Overall Study|Incomplete CEU data|3|||
129938219|NCT01566890|467739223|FG002|Overall Study|Incomplete CEU data|5|||
129938220|NCT01566890|467739224|FG003|Overall Study|Incomplete CEU data|8|||
129938221|NCT01566890|467739225|FG004|Overall Study|Incomplete CEU data|0|||
129938222|NCT01566890|467739221|FG000|Overall Study|Lost to Follow-up|0|||
129938223|NCT01566890|467739222|FG001|Overall Study|Lost to Follow-up|0|||
129938224|NCT01566890|467739223|FG002|Overall Study|Lost to Follow-up|4|||
129938225|NCT01566890|467739224|FG003|Overall Study|Lost to Follow-up|4|||
129938226|NCT01566890|467739225|FG004|Overall Study|Lost to Follow-up|0|||
129938227|NCT01566890|467739221|FG000|Overall Study|Other|0|||
129938228|NCT01566890|467739222|FG001|Overall Study|Other|0|||
129938229|NCT01566890|467739223|FG002|Overall Study|Other|0|||
129938230|NCT01566890|467739224|FG003|Overall Study|Other|0|||
129938231|NCT01566890|467739225|FG004|Overall Study|Other|7|||
129938232|NCT01421667|467739231|FG000|Overall Study|Withdrawal by Subject|0|||
129938233|NCT01421667|467739232|FG001|Overall Study|Withdrawal by Subject|1|||
129938234|NCT01421667|467739233|FG002|Overall Study|Withdrawal by Subject|2|||
129938235|NCT01421667|467739234|FG003|Overall Study|Withdrawal by Subject|1|||
129938236|NCT01421667|467739231|FG000|Overall Study|Lost to Follow-up|0|||
129938237|NCT01421667|467739232|FG001|Overall Study|Lost to Follow-up|1|||
129938238|NCT01421667|467739233|FG002|Overall Study|Lost to Follow-up|0|||
129938239|NCT01421667|467739234|FG003|Overall Study|Lost to Follow-up|0|||
129938240|NCT01387516|467739236|FG000|Overall Study|Lost to Follow-up|4|||
129938241|NCT01387516|467739237|FG001|Overall Study|Lost to Follow-up|4|||
129938242|NCT01387516|467739238|FG002|Overall Study|Lost to Follow-up|2|||
129938243|NCT01387516|467739239|FG003|Overall Study|Lost to Follow-up|3|||
129938244|NCT01387516|467739236|FG000|Overall Study|Withdrawal by Subject|1|||
129938245|NCT01387516|467739237|FG001|Overall Study|Withdrawal by Subject|1|||
129938246|NCT01387516|467739238|FG002|Overall Study|Withdrawal by Subject|2|||
129938247|NCT01387516|467739239|FG003|Overall Study|Withdrawal by Subject|0|||
129938248|NCT01387516|467739236|FG000|Overall Study|Death|0|||
129938249|NCT01387516|467739237|FG001|Overall Study|Death|0|||
129938250|NCT01387516|467739238|FG002|Overall Study|Death|0|||
129938251|NCT01387516|467739239|FG003|Overall Study|Death|1|||
129938252|NCT01738438|467739244|FG000|Overall Study|Disease Progression|32|||
129938253|NCT01738438|467739244|FG000|Overall Study|Adverse Event|3|||
129938254|NCT02016872|467739249|FG000|Overall Study|Withdrawal by Subject|10|||
129938255|NCT02016872|467739249|FG000|Overall Study|Death Progression|2|||
129938256|NCT02016872|467739249|FG000|Overall Study|No FMISO scan|1|||
129938257|NCT02016872|467739249|FG000|Overall Study|Ineligible|2|||
129938258|NCT02415127|467739250|FG000|Overall Study|Adverse Event|1|||
129938259|NCT02415127|467739251|FG001|Overall Study|Adverse Event|0|||
129938260|NCT03789110|467739252|FG000|Overall Study|Adverse Event|2|||
129938261|NCT03789110|467739252|FG000|Overall Study|Physician Decision|1|||
129938262|NCT03789110|467739252|FG000|Overall Study|Withdrawal by Subject|2|||
129938263|NCT03789110|467739252|FG000|Overall Study|Lack of Efficacy|22|||
129938264|NCT03789110|467739252|FG000|Overall Study|still on treatment|3|||
129938265|NCT02761187|467739253|FG000|Overall Study|Too ill to Participate|13|||
129938266|NCT02761187|467739254|FG001|Overall Study|Too ill to Participate|8|||
129938267|NCT02761187|467739253|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
129938268|NCT02761187|467739254|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
129938269|NCT02761187|467739253|FG000|Overall Study|Patient withdrew consent|64|||
129938270|NCT02761187|467739254|FG001|Overall Study|Patient withdrew consent|58|||
129938271|NCT02761187|467739253|FG000|Overall Study|Physician discretion|4|||
129938272|NCT02761187|467739254|FG001|Overall Study|Physician discretion|8|||
129938273|NCT02761187|467739253|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
129938274|NCT02761187|467739254|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
129938275|NCT02761187|467739253|FG000|Overall Study|On Hospice|20|||
129938276|NCT02761187|467739254|FG001|Overall Study|On Hospice|26|||
129938277|NCT02761187|467739253|FG000|Overall Study|Deceased|474|||
129938278|NCT02761187|467739254|FG001|Overall Study|Deceased|642|||
129938279|NCT02761187|467739253|FG000|Overall Study|Lost to Follow-up|73|||
129938280|NCT02761187|467739254|FG001|Overall Study|Lost to Follow-up|63|||
129938281|NCT02761187|467739253|FG000|Overall Study|Due to study discontinued at site|100|||
129938282|NCT02761187|467739254|FG001|Overall Study|Due to study discontinued at site|85|||
129938283|NCT02761187|467739253|FG000|Overall Study|Reason not Specified|1484|||
129938284|NCT02761187|467739254|FG001|Overall Study|Reason not Specified|937|||
129938285|NCT03978637|467739255|FG000|Overall Study|Death|0|||
129938286|NCT03978637|467739256|FG001|Overall Study|Death|2|||
129938287|NCT03978637|467739257|FG002|Overall Study|Death|2|||
129938288|NCT03978637|467739258|FG003|Overall Study|Death|0|||
129938289|NCT03978637|467739255|FG000|Overall Study|Withdrawal by Subject|0|||
129938290|NCT03978637|467739256|FG001|Overall Study|Withdrawal by Subject|0|||
129938291|NCT03978637|467739257|FG002|Overall Study|Withdrawal by Subject|1|||
129938292|NCT03978637|467739258|FG003|Overall Study|Withdrawal by Subject|0|||
129938293|NCT03978637|467739255|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
129938294|NCT03978637|467739256|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
129938295|NCT03978637|467739257|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
129938296|NCT03978637|467739258|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
129938297|NCT02307682|467739259|FG000|Overall Study|Adverse Event|9|||
129938298|NCT02307682|467739260|FG001|Overall Study|Adverse Event|8|||
129938299|NCT02307682|467739261|FG002|Overall Study|Adverse Event|12|||
129938300|NCT02307682|467739259|FG000|Overall Study|Lack of Efficacy|1|||
129938301|NCT02307682|467739260|FG001|Overall Study|Lack of Efficacy|0|||
129938302|NCT02307682|467739261|FG002|Overall Study|Lack of Efficacy|1|||
129938303|NCT02307682|467739259|FG000|Overall Study|Physician Decision|2|||
129938304|NCT02307682|467739260|FG001|Overall Study|Physician Decision|2|||
129938305|NCT02307682|467739261|FG002|Overall Study|Physician Decision|8|||
129938306|NCT02307682|467739259|FG000|Overall Study|Progressive Disease|1|||
129938307|NCT02307682|467739260|FG001|Overall Study|Progressive Disease|0|||
129938308|NCT02307682|467739261|FG002|Overall Study|Progressive Disease|0|||
129938309|NCT02307682|467739259|FG000|Overall Study|Withdrawal by Subject|26|||
129938310|NCT02307682|467739260|FG001|Overall Study|Withdrawal by Subject|34|||
129938311|NCT02307682|467739261|FG002|Overall Study|Withdrawal by Subject|23|||
129938312|NCT02307682|467739259|FG000|Overall Study|Death|9|||
129938313|NCT02307682|467739260|FG001|Overall Study|Death|7|||
129938314|NCT02307682|467739261|FG002|Overall Study|Death|12|||
129938315|NCT02307682|467739259|FG000|Overall Study|Lost to Follow-up|1|||
129938316|NCT02307682|467739260|FG001|Overall Study|Lost to Follow-up|5|||
129938317|NCT02307682|467739261|FG002|Overall Study|Lost to Follow-up|6|||
129938318|NCT02307682|467739259|FG000|Overall Study|Protocol Deviation|0|||
129938319|NCT02307682|467739260|FG001|Overall Study|Protocol Deviation|0|||
129938320|NCT02307682|467739261|FG002|Overall Study|Protocol Deviation|2|||
129938321|NCT02307682|467739259|FG000|Overall Study|Other|1|||
129938322|NCT02307682|467739260|FG001|Overall Study|Other|1|||
129938323|NCT02307682|467739261|FG002|Overall Study|Other|0|||
129938324|NCT05630833|467739263|FG000|Overall Study|Adverse Event|3|||
129938325|NCT05630833|467739264|FG001|Overall Study|Adverse Event|0|||
129938326|NCT05630833|467739263|FG000|Overall Study|Lack of Efficacy|0|||
129938327|NCT05630833|467739264|FG001|Overall Study|Lack of Efficacy|1|||
129938328|NCT05630833|467739263|FG000|Overall Study|Lost to Follow-up|1|||
129938329|NCT05630833|467739264|FG001|Overall Study|Lost to Follow-up|0|||
129938330|NCT05630833|467739263|FG000|Overall Study|Withdrawal by Subject|3|||
129938331|NCT05630833|467739264|FG001|Overall Study|Withdrawal by Subject|1|||
129938332|NCT03170349|467739266|FG000|From Implant to the 30-Day Visit|Death|1|||
129938333|NCT03170349|467739266|FG000|From 30-Day to 6-Month Visit|Death|3|||
129938334|NCT03170349|467739266|FG000|From 30-Day to 6-Month Visit|Withdrawal by Subject|1|||
129938335|NCT03170349|467739266|FG000|From 30-Day to 6-Month Visit|Exited for Other Reasons|5|||
129938336|NCT03170349|467739266|FG000|From 6-Month to 1-Year Visit|Death|6|||
129938337|NCT03170349|467739266|FG000|From 6-Month to 1-Year Visit|Exited for Other Reasons|2|||
129938338|NCT03170349|467739266|FG000|From 1-Year to 2-Year Visit|Death|13|||
129938339|NCT03170349|467739266|FG000|From 1-Year to 2-Year Visit|Withdrawal by Subject|1|||
129938340|NCT03170349|467739266|FG000|From 1-Year to 2-Year Visit|Missed Visit|4|||
129938341|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Death|10|||
129938342|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Lost to Follow-up|2|||
129938343|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Withdrawal by Subject|2|||
129938344|NCT03170349|467739266|FG000|From 2-Year to 3-Year Visit|Missed Visit|1|||
129938345|NCT04503681|467740765|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
129938346|NCT04503681|467740766|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
129938347|NCT01084694|467740773|FG000|Overall Study|Withdrawal by Subject|2|||
129938348|NCT01084694|467740774|FG001|Overall Study|Withdrawal by Subject|1|||
129938349|NCT01084694|467740773|FG000|Overall Study|Death|2|||
129938350|NCT01084694|467740774|FG001|Overall Study|Death|12|||
129938351|NCT01084694|467740773|FG000|Overall Study|eligibility not maintained|2|||
129938352|NCT01084694|467740774|FG001|Overall Study|eligibility not maintained|7|||
129938353|NCT00945321|467740777|FG000|Period 1|Adverse Event|0|||
129938354|NCT00945321|467740778|FG001|Period 1|Adverse Event|0|||
129938355|NCT00945321|467740779|FG002|Period 1|Adverse Event|0|||
129938356|NCT00945321|467740780|FG003|Period 1|Adverse Event|0|||
129938357|NCT00945321|467740781|FG004|Period 1|Adverse Event|1|||
129452830|NCT00847145|465956303|FG007|Overall Study|Inappropriate enrollment|0|||
129452831|NCT00847145|465956296|FG000|Overall Study|Protocol Violation|0|||
129452832|NCT00847145|465956297|FG001|Overall Study|Protocol Violation|0|||
129452833|NCT00847145|465956298|FG002|Overall Study|Protocol Violation|3|||
129452834|NCT00847145|465956299|FG003|Overall Study|Protocol Violation|0|||
129452835|NCT00847145|465956300|FG004|Overall Study|Protocol Violation|1|||
129452836|NCT00847145|465956301|FG005|Overall Study|Protocol Violation|0|||
129452837|NCT00847145|465956302|FG006|Overall Study|Protocol Violation|0|||
129452838|NCT00847145|465956303|FG007|Overall Study|Protocol Violation|1|||
129452839|NCT00307151|465956305|FG000|Overall Study|Death|4|||
129452840|NCT00307151|465956306|FG001|Overall Study|Death|3|||
129452841|NCT00307151|465956307|FG002|Overall Study|Death|10|||
129452842|NCT00307151|465956308|FG003|Overall Study|Death|3|||
129452843|NCT00307151|465956305|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129452844|NCT00307151|465956306|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129452845|NCT00307151|465956307|FG002|Overall Study|Severe debilitation, unable to continue|0|||
129452846|NCT00307151|465956308|FG003|Overall Study|Severe debilitation, unable to continue|0|||
129452847|NCT00307151|465956305|FG000|Overall Study|Subject unable to get to clinic|1|||
129452848|NCT00307151|465956306|FG001|Overall Study|Subject unable to get to clinic|0|||
129452849|NCT00307151|465956307|FG002|Overall Study|Subject unable to get to clinic|6|||
129452850|NCT00307151|465956308|FG003|Overall Study|Subject unable to get to clinic|2|||
129452851|NCT00307151|465956305|FG000|Overall Study|Withdrew consent|0|||
129452852|NCT00307151|465956306|FG001|Overall Study|Withdrew consent|1|||
129452853|NCT00307151|465956307|FG002|Overall Study|Withdrew consent|1|||
129452854|NCT00307151|465956308|FG003|Overall Study|Withdrew consent|3|||
129452855|NCT00307151|465956305|FG000|Overall Study|Not willing to adhere to study reqs|2|||
129452856|NCT00307151|465956306|FG001|Overall Study|Not willing to adhere to study reqs|0|||
129452857|NCT00307151|465956307|FG002|Overall Study|Not willing to adhere to study reqs|2|||
129452858|NCT00307151|465956308|FG003|Overall Study|Not willing to adhere to study reqs|2|||
129452859|NCT00307151|465956305|FG000|Overall Study|Clinic unable to contact subject|3|||
129452860|NCT00307151|465956306|FG001|Overall Study|Clinic unable to contact subject|3|||
129452861|NCT00307151|465956307|FG002|Overall Study|Clinic unable to contact subject|1|||
129452862|NCT00307151|465956308|FG003|Overall Study|Clinic unable to contact subject|1|||
129452863|NCT02966509|465956311|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
129452864|NCT02966509|465956312|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
129452865|NCT02966509|465956311|FG000|Baseline Satisfaction Survey|Death|0|||
129452866|NCT02966509|465956312|FG001|Baseline Satisfaction Survey|Death|1|||
129452867|NCT02966509|465956311|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
129452868|NCT02966509|465956312|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
129452869|NCT02966509|465956311|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
129452870|NCT02966509|465956312|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
129452871|NCT02966509|465956311|FG000|6 Month Satisfaction Decision Survey|Death|22|||
129452872|NCT02966509|465956312|FG001|6 Month Satisfaction Decision Survey|Death|25|||
129452873|NCT02966509|465956311|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
129452874|NCT02966509|465956312|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
129452875|NCT02966509|465956311|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
129452876|NCT02966509|465956312|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
129452877|NCT02966509|465956311|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
129452878|NCT02966509|465956312|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
129452879|NCT02966509|465956311|FG000|6 Month Satisfaction Survey|Death|36|||
129938358|NCT00945321|467740782|FG005|Period 1|Adverse Event|0|||
129938359|NCT00945321|467740777|FG000|Period 4|Lost to Follow-up|0|||
129938360|NCT00945321|467740778|FG001|Period 4|Lost to Follow-up|0|||
129938361|NCT00945321|467740779|FG002|Period 4|Lost to Follow-up|0|||
129938362|NCT00945321|467740780|FG003|Period 4|Lost to Follow-up|0|||
129938363|NCT00945321|467740781|FG004|Period 4|Lost to Follow-up|0|||
129938364|NCT00945321|467740782|FG005|Period 4|Lost to Follow-up|1|||
129938365|NCT02633215|467740783|FG000|Overall Study|Lost to Follow-up|2|||
129938366|NCT02633215|467740784|FG001|Overall Study|Lost to Follow-up|3|||
129938367|NCT00692913|467740785|FG000|Overall Study|Adverse Event|8|||
129938368|NCT00692913|467740786|FG001|Overall Study|Adverse Event|4|||
129938369|NCT00692913|467740785|FG000|Overall Study|Lost to Follow-up|3|||
129938370|NCT00692913|467740786|FG001|Overall Study|Lost to Follow-up|5|||
129938371|NCT00692913|467740785|FG000|Overall Study|Physician Decision|2|||
129938372|NCT00692913|467740786|FG001|Overall Study|Physician Decision|0|||
129938373|NCT00692913|467740785|FG000|Overall Study|Protocol Violation|1|||
129452880|NCT02966509|465956312|FG001|6 Month Satisfaction Survey|Death|33|||
129452881|NCT02966509|465956311|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
129938374|NCT00692913|467740786|FG001|Overall Study|Protocol Violation|1|||
129938375|NCT00692913|467740785|FG000|Overall Study|Withdrawal by Subject|15|||
129938376|NCT00692913|467740786|FG001|Overall Study|Withdrawal by Subject|20|||
129938377|NCT04017611|467740787|FG000|Overall Study|Withdrawn prior to completion|1|||
129452882|NCT02966509|465956312|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
129452883|NCT02966509|465956311|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
129938378|NCT02291913|467740796|FG000|Overall Study|Progressive Disease|32|||
129938379|NCT02291913|467740796|FG000|Overall Study|Adverse Event|11|||
129938380|NCT02291913|467740796|FG000|Overall Study|Death|2|||
129938381|NCT02291913|467740796|FG000|Overall Study|Physician Decision|1|||
129938382|NCT02291913|467740796|FG000|Overall Study|Withdrawal by Subject|1|||
129938383|NCT02291913|467740796|FG000|Overall Study|Protocol Violation|1|||
129938384|NCT02866942|467740797|FG000|Overall Study|Invalid consent|1|||
129938385|NCT01268306|467740800|FG000|Overall Study|Lost to Follow-up|1|||
129938386|NCT04334317|467740801|FG000|Overall Study|Adverse Event|1|||
129938387|NCT04334317|467740802|FG001|Overall Study|Adverse Event|2|||
129938388|NCT04334317|467740803|FG002|Overall Study|Adverse Event|0|||
129938389|NCT04334317|467740804|FG003|Overall Study|Adverse Event|0|||
129938390|NCT04334317|467740801|FG000|Overall Study|Protocol Deviation|0|||
129938391|NCT04334317|467740802|FG001|Overall Study|Protocol Deviation|1|||
129938392|NCT04334317|467740803|FG002|Overall Study|Protocol Deviation|0|||
129938393|NCT04334317|467740804|FG003|Overall Study|Protocol Deviation|0|||
129938394|NCT04334317|467740801|FG000|Overall Study|Withdrawal by Subject|2|||
129938395|NCT04334317|467740802|FG001|Overall Study|Withdrawal by Subject|2|||
129938396|NCT04334317|467740803|FG002|Overall Study|Withdrawal by Subject|0|||
129938397|NCT04334317|467740804|FG003|Overall Study|Withdrawal by Subject|0|||
129938398|NCT01128595|467740809|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129938399|NCT01128595|467740810|FG001|Treatment Period 3|Withdrawal by Subject|1|||
129938400|NCT01128595|467740811|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129938401|NCT01128595|467740812|FG003|Treatment Period 3|Withdrawal by Subject|0|||
129938402|NCT00605306|467740813|FG000|Overall Study|Adverse Event|0|||
129938403|NCT00605306|467740814|FG001|Overall Study|Adverse Event|1|||
129938404|NCT00372775|467740815|FG000|Overall Study|Adverse Event|8|||
129938405|NCT00372775|467740815|FG000|Overall Study|Death|15|||
129938406|NCT00372775|467740815|FG000|Overall Study|Objective progression or relapse|30|||
129938407|NCT00372775|467740815|FG000|Overall Study|Global deterioration of health status|6|||
129938408|NCT00372775|467740815|FG000|Overall Study|Withdrawal by Subject|1|||
129938409|NCT00372775|467740815|FG000|Overall Study|Other|1|||
129938410|NCT00372775|467740815|FG000|Overall Study|Not Treated|2|||
129938411|NCT02568215|467740817|FG000|Overall Study|Death|1|||
129938412|NCT02568215|467740818|FG001|Overall Study|Death|2|||
129938413|NCT02568215|467740819|FG002|Overall Study|Death|0|||
129938414|NCT02568215|467740817|FG000|Overall Study|Physician Decision|2|||
129938415|NCT02568215|467740818|FG001|Overall Study|Physician Decision|2|||
129938416|NCT02568215|467740819|FG002|Overall Study|Physician Decision|2|||
129938417|NCT02568215|467740817|FG000|Overall Study|Lost to Follow-up|29|||
129938418|NCT02568215|467740818|FG001|Overall Study|Lost to Follow-up|32|||
129938419|NCT02568215|467740819|FG002|Overall Study|Lost to Follow-up|41|||
129938420|NCT02568215|467740817|FG000|Overall Study|Withdrawal by Subject|21|||
129938421|NCT02568215|467740818|FG001|Overall Study|Withdrawal by Subject|19|||
129938422|NCT02568215|467740819|FG002|Overall Study|Withdrawal by Subject|22|||
129938423|NCT02568215|467740817|FG000|Overall Study|Protocol Violation|1|||
129938424|NCT02568215|467740818|FG001|Overall Study|Protocol Violation|1|||
129938425|NCT02568215|467740819|FG002|Overall Study|Protocol Violation|0|||
129938426|NCT02568215|467740817|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
129938427|NCT02568215|467740818|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
129938428|NCT02568215|467740819|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
129938429|NCT02568215|467740817|FG000|Overall Study|Other|0|||
129938430|NCT02568215|467740818|FG001|Overall Study|Other|1|||
129938431|NCT02568215|467740819|FG002|Overall Study|Other|4|||
129938432|NCT00336505|467740820|FG000|Overall Study|Adverse Event|10|||
129938433|NCT00336505|467740821|FG001|Overall Study|Adverse Event|9|||
129938434|NCT00336505|467740820|FG000|Overall Study|Lack of Efficacy|8|||
129938435|NCT00336505|467740821|FG001|Overall Study|Lack of Efficacy|4|||
129938436|NCT00336505|467740820|FG000|Overall Study|Lost to Follow-up|7|||
129938437|NCT00336505|467740821|FG001|Overall Study|Lost to Follow-up|4|||
129938438|NCT00336505|467740820|FG000|Overall Study|Withdrawal by Subject|5|||
129938439|NCT00336505|467740821|FG001|Overall Study|Withdrawal by Subject|3|||
129938440|NCT00336505|467740820|FG000|Overall Study|Other|7|||
129938441|NCT00336505|467740821|FG001|Overall Study|Other|7|||
129938442|NCT01092416|467740822|FG000|Enrollment|Atherectomy device not inserted|3|||
129938443|NCT01092416|467740822|FG000|30-Day Follow-up|Death|2|||
129938444|NCT01092416|467740822|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
129938445|NCT01092416|467740822|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
129938446|NCT01092416|467740822|FG000|12-Month Follow-up|Death|16|||
129938447|NCT01092416|467740822|FG000|12-Month Follow-up|Lost to Follow-up|4|||
129938448|NCT01092416|467740822|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
129938449|NCT01092416|467740822|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
129938450|NCT01092416|467740822|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
129938451|NCT00366249|467740823|FG000|Overall Study|Adverse Event|53|||
129938452|NCT00366249|467740824|FG001|Overall Study|Adverse Event|28|||
129938453|NCT00366249|467740823|FG000|Overall Study|Death|0|||
129938454|NCT00366249|467740824|FG001|Overall Study|Death|1|||
129938455|NCT00366249|467740823|FG000|Overall Study|Physician Decision|5|||
129938456|NCT00366249|467740824|FG001|Overall Study|Physician Decision|2|||
129938457|NCT00366249|467740823|FG000|Overall Study|Lost to Follow-up|2|||
129938458|NCT00366249|467740824|FG001|Overall Study|Lost to Follow-up|0|||
129938459|NCT00366249|467740823|FG000|Overall Study|Protocol Violation|1|||
129938460|NCT00366249|467740824|FG001|Overall Study|Protocol Violation|2|||
129938461|NCT00366249|467740823|FG000|Overall Study|Withdrawal by Subject|18|||
129938462|NCT00366249|467740824|FG001|Overall Study|Withdrawal by Subject|4|||
129938463|NCT00366249|467740823|FG000|Overall Study|Lack of Efficacy|21|||
129938464|NCT00366249|467740824|FG001|Overall Study|Lack of Efficacy|21|||
129938465|NCT00366249|467740823|FG000|Overall Study|Most due to osteomylitis status|31|||
129938466|NCT00366249|467740824|FG001|Overall Study|Most due to osteomylitis status|20|||
129938467|NCT01561300|467740825|FG000|Run in on Placebo|Adverse Event|1|||
129938468|NCT01561300|467740826|FG001|Run in on Placebo|Adverse Event|0|||
129938469|NCT01952366|467740828|FG000|Overall Study|Death|22|||
129938470|NCT01952366|467740828|FG000|Overall Study|Withdrawal by Subject|9|||
129938471|NCT04860505|467740829|FG000|Overall Study|Lost to Follow-up|2|||
129938472|NCT03066609|467740832|FG000|INDUCTION|Pregnancy|0|||
129938473|NCT03066609|467740833|FG001|INDUCTION|Pregnancy|0|||
129938474|NCT03066609|467740834|FG002|INDUCTION|Pregnancy|1|||
129938475|NCT03066609|467740835|FG003|INDUCTION|Pregnancy|0|||
129938476|NCT03066609|467740832|FG000|INDUCTION|Lack of Efficacy|0|||
129938477|NCT03066609|467740833|FG001|INDUCTION|Lack of Efficacy|0|||
129938478|NCT03066609|467740834|FG002|INDUCTION|Lack of Efficacy|1|||
129938479|NCT03066609|467740835|FG003|INDUCTION|Lack of Efficacy|0|||
129938480|NCT03066609|467740832|FG000|INDUCTION|Adverse Event|2|||
129938481|NCT03066609|467740833|FG001|INDUCTION|Adverse Event|2|||
129938482|NCT03066609|467740834|FG002|INDUCTION|Adverse Event|0|||
129938483|NCT03066609|467740835|FG003|INDUCTION|Adverse Event|0|||
129938484|NCT03066609|467740832|FG000|MAINTENANCE|Adverse Event|0|||
129938485|NCT03066609|467740833|FG001|MAINTENANCE|Adverse Event|0|||
129938486|NCT03066609|467740834|FG002|MAINTENANCE|Adverse Event|0|||
129938487|NCT03066609|467740835|FG003|MAINTENANCE|Adverse Event|1|||
129938488|NCT03066609|467740832|FG000|MAINTENANCE|Withdrawal by Subject|4|||
129938489|NCT03066609|467740833|FG001|MAINTENANCE|Withdrawal by Subject|2|||
129938490|NCT03066609|467740834|FG002|MAINTENANCE|Withdrawal by Subject|1|||
129938491|NCT03066609|467740835|FG003|MAINTENANCE|Withdrawal by Subject|1|||
129938492|NCT03066609|467740832|FG000|MAINTENANCE|Lost to Follow-up|0|||
129938493|NCT03066609|467740833|FG001|MAINTENANCE|Lost to Follow-up|1|||
129938494|NCT03066609|467740834|FG002|MAINTENANCE|Lost to Follow-up|1|||
129938495|NCT03066609|467740835|FG003|MAINTENANCE|Lost to Follow-up|0|||
129938496|NCT03066609|467740832|FG000|MAINTENANCE|Pregnancy|1|||
129938497|NCT03066609|467740833|FG001|MAINTENANCE|Pregnancy|0|||
129938498|NCT03066609|467740834|FG002|MAINTENANCE|Pregnancy|0|||
129938499|NCT03066609|467740835|FG003|MAINTENANCE|Pregnancy|0|||
129938500|NCT03066609|467740832|FG000|MAINTENANCE|Lack of Efficacy|2|||
129938501|NCT03066609|467740833|FG001|MAINTENANCE|Lack of Efficacy|1|||
129938502|NCT03066609|467740834|FG002|MAINTENANCE|Lack of Efficacy|0|||
129938503|NCT03066609|467740835|FG003|MAINTENANCE|Lack of Efficacy|1|||
129938504|NCT03066609|467740832|FG000|OVERALL STUDY|Adverse Event|2|||
129938505|NCT03066609|467740833|FG001|OVERALL STUDY|Adverse Event|2|||
129938506|NCT03066609|467740834|FG002|OVERALL STUDY|Adverse Event|0|||
129938507|NCT03066609|467740835|FG003|OVERALL STUDY|Adverse Event|1|||
129938508|NCT03066609|467740832|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
129938509|NCT03066609|467740833|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
129938510|NCT03066609|467740834|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
129938511|NCT03066609|467740835|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
129938512|NCT03066609|467740832|FG000|OVERALL STUDY|Lost to Follow-up|1|||
129938513|NCT03066609|467740833|FG001|OVERALL STUDY|Lost to Follow-up|1|||
129938514|NCT03066609|467740834|FG002|OVERALL STUDY|Lost to Follow-up|1|||
129938515|NCT03066609|467740835|FG003|OVERALL STUDY|Lost to Follow-up|1|||
129938516|NCT03066609|467740832|FG000|OVERALL STUDY|Pregnancy|1|||
129938517|NCT03066609|467740833|FG001|OVERALL STUDY|Pregnancy|0|||
129938518|NCT03066609|467740834|FG002|OVERALL STUDY|Pregnancy|1|||
129938519|NCT03066609|467740835|FG003|OVERALL STUDY|Pregnancy|0|||
129938520|NCT03066609|467740832|FG000|OVERALL STUDY|Lack of Efficacy|2|||
129938521|NCT03066609|467740833|FG001|OVERALL STUDY|Lack of Efficacy|1|||
129938522|NCT03066609|467740834|FG002|OVERALL STUDY|Lack of Efficacy|1|||
129938523|NCT03066609|467740835|FG003|OVERALL STUDY|Lack of Efficacy|1|||
129938524|NCT03066609|467740832|FG000|OVERALL STUDY|discontinued follow up|0|||
129938525|NCT03066609|467740833|FG001|OVERALL STUDY|discontinued follow up|2|||
129938526|NCT03066609|467740834|FG002|OVERALL STUDY|discontinued follow up|0|||
129938527|NCT03066609|467740835|FG003|OVERALL STUDY|discontinued follow up|0|||
129938528|NCT00293397|467740839|FG000|Overall Study|Death|2|||
129938529|NCT00822120|467740840|FG000|Initial Registration|Adverse Event|1|||
129938530|NCT00822120|467740841|FG001|Initial Registration|Adverse Event|0|||
129938531|NCT00822120|467740842|FG002|Initial Registration|Adverse Event|0|||
129938532|NCT00822120|467740843|FG003|Initial Registration|Adverse Event|0|||
129938533|NCT00822120|467740844|FG004|Initial Registration|Adverse Event|0|||
129938534|NCT00822120|467740845|FG005|Initial Registration|Adverse Event|0|||
129938535|NCT00822120|467740840|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
129938536|NCT00822120|467740841|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938537|NCT00822120|467740842|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938538|NCT00822120|467740843|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938539|NCT00822120|467740844|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938540|NCT00822120|467740845|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129938541|NCT00822120|467740840|FG000|Initial Registration|Reasons not Protocol Specified|2|||
129938542|NCT00822120|467740841|FG001|Initial Registration|Reasons not Protocol Specified|0|||
129938543|NCT00822120|467740842|FG002|Initial Registration|Reasons not Protocol Specified|0|||
129938544|NCT00822120|467740843|FG003|Initial Registration|Reasons not Protocol Specified|0|||
129938545|NCT00822120|467740844|FG004|Initial Registration|Reasons not Protocol Specified|0|||
129938546|NCT00822120|467740845|FG005|Initial Registration|Reasons not Protocol Specified|0|||
129938547|NCT00822120|467740840|FG000|Initial Registration|Ineligible|22|||
129938548|NCT00822120|467740841|FG001|Initial Registration|Ineligible|1|||
129938549|NCT00822120|467740842|FG002|Initial Registration|Ineligible|0|||
129938550|NCT00822120|467740843|FG003|Initial Registration|Ineligible|0|||
129938551|NCT00822120|467740844|FG004|Initial Registration|Ineligible|0|||
129938552|NCT00822120|467740845|FG005|Initial Registration|Ineligible|0|||
129938553|NCT00822120|467740840|FG000|PET-directed Therapy|Adverse Event|0|||
129938554|NCT00822120|467740841|FG001|PET-directed Therapy|Adverse Event|0|||
129938555|NCT00822120|467740842|FG002|PET-directed Therapy|Adverse Event|0|||
129938556|NCT00822120|467740843|FG003|PET-directed Therapy|Adverse Event|1|||
129938557|NCT00822120|467740844|FG004|PET-directed Therapy|Adverse Event|0|||
129938558|NCT00822120|467740845|FG005|PET-directed Therapy|Adverse Event|0|||
129938559|NCT00822120|467740840|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938560|NCT00822120|467740841|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938561|NCT00822120|467740842|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938562|NCT00822120|467740843|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
129938563|NCT00822120|467740844|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938564|NCT00822120|467740845|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
129938565|NCT00822120|467740840|FG000|PET-directed Therapy|Death|0|||
129938566|NCT00822120|467740841|FG001|PET-directed Therapy|Death|0|||
129938567|NCT00822120|467740842|FG002|PET-directed Therapy|Death|0|||
129938568|NCT00822120|467740843|FG003|PET-directed Therapy|Death|2|||
129938569|NCT00822120|467740844|FG004|PET-directed Therapy|Death|0|||
129938570|NCT00822120|467740845|FG005|PET-directed Therapy|Death|0|||
129938571|NCT00822120|467740840|FG000|PET-directed Therapy|Protocol Violation|0|||
129938572|NCT00822120|467740841|FG001|PET-directed Therapy|Protocol Violation|0|||
129938573|NCT00822120|467740842|FG002|PET-directed Therapy|Protocol Violation|0|||
129938574|NCT00822120|467740843|FG003|PET-directed Therapy|Protocol Violation|6|||
129938575|NCT00822120|467740844|FG004|PET-directed Therapy|Protocol Violation|0|||
129938576|NCT00822120|467740845|FG005|PET-directed Therapy|Protocol Violation|0|||
129938577|NCT00503906|467740846|FG000|Overall Study|Withdrawal by Subject|1|||
129938578|NCT01324310|467740847|FG000|Overall Study|Adverse Event|1|||
129938579|NCT01324310|467740847|FG000|Overall Study|Disease Progression|1|||
129938580|NCT03170882|467740848|FG000|Overall Study|Death|17|||
129938581|NCT03170882|467740849|FG001|Overall Study|Death|29|||
129938582|NCT03170882|467740848|FG000|Overall Study|Lost to Follow-up|0|||
129938583|NCT03170882|467740849|FG001|Overall Study|Lost to Follow-up|1|||
129938584|NCT03170882|467740848|FG000|Overall Study|Withdrawal by Subject|4|||
129938585|NCT03170882|467740849|FG001|Overall Study|Withdrawal by Subject|7|||
129938586|NCT03170882|467740848|FG000|Overall Study|Reason not Specified|28|||
129938587|NCT03170882|467740849|FG001|Overall Study|Reason not Specified|36|||
129938588|NCT00622700|467740850|FG000|Core Treatment Period|Randomized but Not Treated|0|||
129938589|NCT00622700|467740851|FG001|Core Treatment Period|Randomized but Not Treated|2|||
129938590|NCT00622700|467740852|FG002|Core Treatment Period|Randomized but Not Treated|2|||
129938591|NCT00622700|467740853|FG003|Core Treatment Period|Randomized but Not Treated|0|||
129938592|NCT00622700|467740854|FG004|Core Treatment Period|Randomized but Not Treated|0|||
129938593|NCT00622700|467740855|FG005|Core Treatment Period|Randomized but Not Treated|0|||
129938594|NCT00622700|467740856|FG006|Core Treatment Period|Randomized but Not Treated|0|||
129938595|NCT00622700|467740850|FG000|Core Treatment Period|Adverse Event|18|||
129938596|NCT00622700|467740851|FG001|Core Treatment Period|Adverse Event|25|||
129938597|NCT00622700|467740852|FG002|Core Treatment Period|Adverse Event|18|||
129938598|NCT00622700|467740853|FG003|Core Treatment Period|Adverse Event|0|||
129938599|NCT00622700|467740854|FG004|Core Treatment Period|Adverse Event|0|||
129938600|NCT00622700|467740855|FG005|Core Treatment Period|Adverse Event|0|||
129938601|NCT00622700|467740856|FG006|Core Treatment Period|Adverse Event|0|||
129938602|NCT00622700|467740850|FG000|Core Treatment Period|Lack of Efficacy|19|||
129938603|NCT00622700|467740851|FG001|Core Treatment Period|Lack of Efficacy|6|||
129938604|NCT00622700|467740852|FG002|Core Treatment Period|Lack of Efficacy|12|||
129938605|NCT00622700|467740853|FG003|Core Treatment Period|Lack of Efficacy|0|||
129938606|NCT00622700|467740854|FG004|Core Treatment Period|Lack of Efficacy|0|||
129938607|NCT00622700|467740855|FG005|Core Treatment Period|Lack of Efficacy|0|||
129938608|NCT00622700|467740856|FG006|Core Treatment Period|Lack of Efficacy|0|||
129938609|NCT00622700|467740850|FG000|Core Treatment Period|Lost to Follow-up|1|||
129938610|NCT00622700|467740851|FG001|Core Treatment Period|Lost to Follow-up|1|||
129938611|NCT00622700|467740852|FG002|Core Treatment Period|Lost to Follow-up|1|||
129938612|NCT00622700|467740853|FG003|Core Treatment Period|Lost to Follow-up|0|||
129938613|NCT00622700|467740854|FG004|Core Treatment Period|Lost to Follow-up|0|||
129938614|NCT00622700|467740855|FG005|Core Treatment Period|Lost to Follow-up|0|||
129938615|NCT00622700|467740856|FG006|Core Treatment Period|Lost to Follow-up|0|||
129938616|NCT00622700|467740850|FG000|Core Treatment Period|Death|1|||
129938617|NCT00622700|467740851|FG001|Core Treatment Period|Death|0|||
129938618|NCT00622700|467740852|FG002|Core Treatment Period|Death|0|||
129938619|NCT00622700|467740853|FG003|Core Treatment Period|Death|0|||
129938620|NCT00622700|467740854|FG004|Core Treatment Period|Death|0|||
129938621|NCT00622700|467740855|FG005|Core Treatment Period|Death|0|||
129938622|NCT00622700|467740856|FG006|Core Treatment Period|Death|0|||
129938623|NCT00622700|467740850|FG000|Core Treatment Period|Progressive Disease|3|||
129938624|NCT00622700|467740851|FG001|Core Treatment Period|Progressive Disease|1|||
129938625|NCT00622700|467740852|FG002|Core Treatment Period|Progressive Disease|0|||
129938626|NCT00622700|467740853|FG003|Core Treatment Period|Progressive Disease|0|||
129938627|NCT00622700|467740854|FG004|Core Treatment Period|Progressive Disease|0|||
129938628|NCT00622700|467740855|FG005|Core Treatment Period|Progressive Disease|0|||
129938629|NCT00622700|467740856|FG006|Core Treatment Period|Progressive Disease|0|||
129938630|NCT00622700|467740850|FG000|Core Treatment Period|Withdrawal by Subject|12|||
129938631|NCT00622700|467740851|FG001|Core Treatment Period|Withdrawal by Subject|18|||
129938632|NCT00622700|467740852|FG002|Core Treatment Period|Withdrawal by Subject|15|||
129938633|NCT00622700|467740853|FG003|Core Treatment Period|Withdrawal by Subject|0|||
129938634|NCT00622700|467740854|FG004|Core Treatment Period|Withdrawal by Subject|0|||
129938635|NCT00622700|467740855|FG005|Core Treatment Period|Withdrawal by Subject|0|||
129938636|NCT00622700|467740856|FG006|Core Treatment Period|Withdrawal by Subject|0|||
129938637|NCT00622700|467740850|FG000|Core Treatment Period|Other than specified above|2|||
129938638|NCT00622700|467740851|FG001|Core Treatment Period|Other than specified above|2|||
129938639|NCT00622700|467740852|FG002|Core Treatment Period|Other than specified above|5|||
129938640|NCT00622700|467740853|FG003|Core Treatment Period|Other than specified above|0|||
129938641|NCT00622700|467740854|FG004|Core Treatment Period|Other than specified above|0|||
129938642|NCT00622700|467740855|FG005|Core Treatment Period|Other than specified above|0|||
129938643|NCT00622700|467740856|FG006|Core Treatment Period|Other than specified above|0|||
129938644|NCT00622700|467740850|FG000|Extension Treatment Period|Adverse Event|0|||
129938645|NCT00622700|467740851|FG001|Extension Treatment Period|Adverse Event|0|||
129938646|NCT00622700|467740852|FG002|Extension Treatment Period|Adverse Event|0|||
129938647|NCT00622700|467740853|FG003|Extension Treatment Period|Adverse Event|5|||
129938648|NCT00622700|467740854|FG004|Extension Treatment Period|Adverse Event|9|||
129938649|NCT00622700|467740855|FG005|Extension Treatment Period|Adverse Event|6|||
129938650|NCT00622700|467740856|FG006|Extension Treatment Period|Adverse Event|8|||
129938651|NCT00622700|467740850|FG000|Extension Treatment Period|Lack of Efficacy|0|||
129938652|NCT00622700|467740851|FG001|Extension Treatment Period|Lack of Efficacy|0|||
129938653|NCT00622700|467740852|FG002|Extension Treatment Period|Lack of Efficacy|0|||
129938654|NCT00622700|467740853|FG003|Extension Treatment Period|Lack of Efficacy|2|||
129938655|NCT00622700|467740854|FG004|Extension Treatment Period|Lack of Efficacy|8|||
129938656|NCT00622700|467740855|FG005|Extension Treatment Period|Lack of Efficacy|1|||
129938657|NCT00622700|467740856|FG006|Extension Treatment Period|Lack of Efficacy|9|||
129938658|NCT00622700|467740850|FG000|Extension Treatment Period|Protocol Violation|0|||
129938659|NCT00622700|467740851|FG001|Extension Treatment Period|Protocol Violation|0|||
129938660|NCT00622700|467740852|FG002|Extension Treatment Period|Protocol Violation|0|||
129938661|NCT00622700|467740853|FG003|Extension Treatment Period|Protocol Violation|0|||
129938662|NCT00622700|467740854|FG004|Extension Treatment Period|Protocol Violation|0|||
129938663|NCT00622700|467740855|FG005|Extension Treatment Period|Protocol Violation|2|||
129938664|NCT00622700|467740856|FG006|Extension Treatment Period|Protocol Violation|0|||
129938665|NCT00622700|467740850|FG000|Extension Treatment Period|Lost to Follow-up|0|||
129938666|NCT00622700|467740851|FG001|Extension Treatment Period|Lost to Follow-up|0|||
129938667|NCT00622700|467740852|FG002|Extension Treatment Period|Lost to Follow-up|0|||
129938668|NCT00622700|467740853|FG003|Extension Treatment Period|Lost to Follow-up|0|||
129938669|NCT00622700|467740854|FG004|Extension Treatment Period|Lost to Follow-up|1|||
129938670|NCT00622700|467740855|FG005|Extension Treatment Period|Lost to Follow-up|0|||
129938671|NCT00622700|467740856|FG006|Extension Treatment Period|Lost to Follow-up|0|||
129938672|NCT00622700|467740850|FG000|Extension Treatment Period|Progressive Disease|0|||
129938673|NCT00622700|467740851|FG001|Extension Treatment Period|Progressive Disease|0|||
129938674|NCT00622700|467740852|FG002|Extension Treatment Period|Progressive Disease|0|||
129938675|NCT00622700|467740853|FG003|Extension Treatment Period|Progressive Disease|1|||
129938676|NCT00622700|467740854|FG004|Extension Treatment Period|Progressive Disease|2|||
129938677|NCT00622700|467740855|FG005|Extension Treatment Period|Progressive Disease|0|||
129938678|NCT00622700|467740856|FG006|Extension Treatment Period|Progressive Disease|2|||
129938679|NCT00622700|467740850|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
129938680|NCT00622700|467740851|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
129938681|NCT00622700|467740852|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
129938682|NCT00622700|467740853|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
129938683|NCT00622700|467740854|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
129938684|NCT00622700|467740855|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
129938685|NCT00622700|467740856|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
129938686|NCT00622700|467740850|FG000|Extension Treatment Period|Missing|0|||
129938687|NCT00622700|467740851|FG001|Extension Treatment Period|Missing|0|||
129938688|NCT00622700|467740852|FG002|Extension Treatment Period|Missing|0|||
129938689|NCT00622700|467740853|FG003|Extension Treatment Period|Missing|2|||
129938690|NCT00622700|467740854|FG004|Extension Treatment Period|Missing|3|||
129938691|NCT00622700|467740855|FG005|Extension Treatment Period|Missing|1|||
129938692|NCT00622700|467740856|FG006|Extension Treatment Period|Missing|0|||
129938693|NCT00622700|467740850|FG000|Extension Treatment Period|Other than specified above|0|||
129938694|NCT00622700|467740851|FG001|Extension Treatment Period|Other than specified above|0|||
129938695|NCT00622700|467740852|FG002|Extension Treatment Period|Other than specified above|0|||
129938696|NCT00622700|467740853|FG003|Extension Treatment Period|Other than specified above|0|||
129938697|NCT00622700|467740854|FG004|Extension Treatment Period|Other than specified above|0|||
129938698|NCT00622700|467740855|FG005|Extension Treatment Period|Other than specified above|1|||
129938699|NCT00622700|467740856|FG006|Extension Treatment Period|Other than specified above|1|||
129938700|NCT02787005|467740876|FG000|Overall Study|Adverse Event|24|||
129938701|NCT02787005|467740877|FG001|Overall Study|Adverse Event|9|||
129938702|NCT02787005|467740878|FG002|Overall Study|Adverse Event|9|||
129938703|NCT02787005|467740879|FG003|Overall Study|Adverse Event|7|||
129938704|NCT02787005|467740880|FG004|Overall Study|Adverse Event|2|||
129938705|NCT02787005|467740876|FG000|Overall Study|Death|100|||
129938706|NCT02787005|467740877|FG001|Overall Study|Death|53|||
129938707|NCT02787005|467740878|FG002|Overall Study|Death|48|||
129938708|NCT02787005|467740879|FG003|Overall Study|Death|69|||
129938709|NCT02787005|467740880|FG004|Overall Study|Death|38|||
129938710|NCT02787005|467740876|FG000|Overall Study|Sponsor Decision|7|||
129938711|NCT02787005|467740877|FG001|Overall Study|Sponsor Decision|4|||
129938712|NCT02787005|467740878|FG002|Overall Study|Sponsor Decision|0|||
129938713|NCT02787005|467740879|FG003|Overall Study|Sponsor Decision|4|||
129938714|NCT02787005|467740880|FG004|Overall Study|Sponsor Decision|5|||
129938715|NCT02787005|467740876|FG000|Overall Study|Withdrawal by Subject|2|||
129938716|NCT02787005|467740877|FG001|Overall Study|Withdrawal by Subject|1|||
129938717|NCT02787005|467740878|FG002|Overall Study|Withdrawal by Subject|1|||
129938718|NCT02787005|467740879|FG003|Overall Study|Withdrawal by Subject|0|||
129938719|NCT02787005|467740880|FG004|Overall Study|Withdrawal by Subject|1|||
129938720|NCT02787005|467740876|FG000|Overall Study|Screen Failure|0|||
129938721|NCT02787005|467740877|FG001|Overall Study|Screen Failure|2|||
129938722|NCT02787005|467740878|FG002|Overall Study|Screen Failure|0|||
129938723|NCT02787005|467740879|FG003|Overall Study|Screen Failure|0|||
129938724|NCT02787005|467740880|FG004|Overall Study|Screen Failure|1|||
129938725|NCT02787005|467740876|FG000|Overall Study|Lost to Follow-up|0|||
129938726|NCT02787005|467740877|FG001|Overall Study|Lost to Follow-up|0|||
129938727|NCT02787005|467740878|FG002|Overall Study|Lost to Follow-up|0|||
129938728|NCT02787005|467740879|FG003|Overall Study|Lost to Follow-up|1|||
129938729|NCT02787005|467740880|FG004|Overall Study|Lost to Follow-up|0|||
129938730|NCT05580003|467740881|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938731|NCT05580003|467740882|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938732|NCT05580003|467740883|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938733|NCT05580003|467740884|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938734|NCT05580003|467740885|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938735|NCT05580003|467740886|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938736|NCT05580003|467740887|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
129938737|NCT05580003|467740888|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938738|NCT05580003|467740889|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938739|NCT05580003|467740890|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938740|NCT05580003|467740891|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938741|NCT05580003|467740892|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938742|NCT05580003|467740893|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129452884|NCT02966509|465956312|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
129452885|NCT02966509|465956311|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
129452886|NCT02966509|465956312|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
129452887|NCT02966509|465956311|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
129452888|NCT02966509|465956312|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
129452889|NCT02966509|465956311|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
129452890|NCT02966509|465956312|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
129452891|NCT00516048|465956317|FG000|Overall Study|Death|0|||
129452892|NCT00516048|465956318|FG001|Overall Study|Death|0|||
129452893|NCT00516048|465956319|FG002|Overall Study|Death|1|||
129452894|NCT00516048|465956317|FG000|Overall Study|Subject Decision|0|||
129452895|NCT00516048|465956318|FG001|Overall Study|Subject Decision|2|||
129452896|NCT00516048|465956319|FG002|Overall Study|Subject Decision|0|||
129452897|NCT00054704|465956322|FG000|Overall Study|Lack of Efficacy|2|||
129452898|NCT00054704|465956323|FG001|Overall Study|Lack of Efficacy|3|||
129452899|NCT00054704|465956322|FG000|Overall Study|Adverse Event|3|||
129452900|NCT00054704|465956323|FG001|Overall Study|Adverse Event|1|||
129452901|NCT00054704|465956322|FG000|Overall Study|Lost to Follow-up|0|||
129452902|NCT00054704|465956323|FG001|Overall Study|Lost to Follow-up|1|||
129452903|NCT00362414|465956324|FG000|Overall Study|Death|2|||
129452904|NCT00362414|465956324|FG000|Overall Study|Adverse Event|1|||
129452905|NCT00096785|465956325|FG000|Overall Study|Lost to Follow-up|1|||
129452906|NCT00096785|465956326|FG001|Overall Study|Lost to Follow-up|0|||
129452907|NCT00096785|465956325|FG000|Overall Study|Withdrawal by Subject|0|||
129452908|NCT00096785|465956326|FG001|Overall Study|Withdrawal by Subject|1|||
129452909|NCT00096785|465956325|FG000|Overall Study|Relocated|1|||
129452910|NCT00096785|465956326|FG001|Overall Study|Relocated|0|||
129452911|NCT04053868|465956327|FG000|Overall Study|Withdrawal by Subject|1|||
129452912|NCT04053868|465956328|FG001|Overall Study|Withdrawal by Subject|0|||
129452913|NCT00833053|465956331|FG000|Overall Study|Adverse Event|4|||
129452914|NCT00833053|465956332|FG001|Overall Study|Adverse Event|0|||
129452915|NCT00833053|465956331|FG000|Overall Study|Treatment Failure|3|||
129452916|NCT00833053|465956332|FG001|Overall Study|Treatment Failure|1|||
129452917|NCT00833053|465956331|FG000|Overall Study|Withdrawal by Subject|0|||
129452918|NCT00833053|465956332|FG001|Overall Study|Withdrawal by Subject|1|||
129452919|NCT00833053|465956331|FG000|Overall Study|Protocol Violation|2|||
129452920|NCT00833053|465956332|FG001|Overall Study|Protocol Violation|1|||
129452921|NCT02187471|465956335|FG000|Overall Study|Protocol Violation|4|||
129452922|NCT02187471|465956336|FG001|Overall Study|Protocol Violation|5|||
129452923|NCT02187471|465956337|FG002|Overall Study|Protocol Violation|4|||
129452924|NCT02187471|465956338|FG003|Overall Study|Protocol Violation|4|||
129452925|NCT02187471|465956335|FG000|Overall Study|Missing|0|||
129452926|NCT02187471|465956336|FG001|Overall Study|Missing|0|||
129452927|NCT02187471|465956337|FG002|Overall Study|Missing|0|||
129452928|NCT02187471|465956338|FG003|Overall Study|Missing|1|||
129452929|NCT02187471|465956335|FG000|Overall Study|Lack of Efficacy|18|||
129452930|NCT02187471|465956336|FG001|Overall Study|Lack of Efficacy|9|||
129452931|NCT02187471|465956337|FG002|Overall Study|Lack of Efficacy|13|||
129452932|NCT02187471|465956338|FG003|Overall Study|Lack of Efficacy|11|||
129452933|NCT02187471|465956335|FG000|Overall Study|Adverse Event|24|||
129938743|NCT05580003|467740894|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938744|NCT05580003|467740895|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938745|NCT05580003|467740896|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938746|NCT05580003|467740897|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938747|NCT05580003|467740898|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938748|NCT05580003|467740899|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129452934|NCT02187471|465956336|FG001|Overall Study|Adverse Event|34|||
129452935|NCT02187471|465956337|FG002|Overall Study|Adverse Event|44|||
129452936|NCT02187471|465956338|FG003|Overall Study|Adverse Event|36|||
129452937|NCT02187471|465956335|FG000|Overall Study|Withdrawal by Subject|23|||
129452938|NCT02187471|465956336|FG001|Overall Study|Withdrawal by Subject|29|||
129452939|NCT02187471|465956337|FG002|Overall Study|Withdrawal by Subject|22|||
129452940|NCT02187471|465956338|FG003|Overall Study|Withdrawal by Subject|24|||
129938749|NCT05580003|467740900|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938750|NCT05580003|467740901|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129452941|NCT02187471|465956335|FG000|Overall Study|Other|7|||
129452942|NCT02187471|465956336|FG001|Overall Study|Other|5|||
129452943|NCT02187471|465956337|FG002|Overall Study|Other|3|||
129452944|NCT02187471|465956338|FG003|Overall Study|Other|4|||
129452945|NCT02236520|465956339|FG000|Overall Study|Physician Decision|0|||
129452946|NCT02236520|465956340|FG001|Overall Study|Physician Decision|5|||
129452947|NCT02236520|465956341|FG002|Overall Study|Physician Decision|0|||
129452948|NCT02236520|465956342|FG003|Overall Study|Physician Decision|0|||
129452949|NCT02236520|465956339|FG000|Overall Study|Withdrawal by Subject|1|||
129452950|NCT02236520|465956340|FG001|Overall Study|Withdrawal by Subject|0|||
129452951|NCT02236520|465956341|FG002|Overall Study|Withdrawal by Subject|0|||
129452952|NCT02236520|465956342|FG003|Overall Study|Withdrawal by Subject|1|||
129938751|NCT05580003|467740902|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938752|NCT05580003|467740903|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938753|NCT05580003|467740904|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938754|NCT05580003|467740905|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938755|NCT05580003|467740906|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938756|NCT05580003|467740907|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938757|NCT05580003|467740908|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129938758|NCT05580003|467740881|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938759|NCT05580003|467740882|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938760|NCT05580003|467740883|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938761|NCT05580003|467740884|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938762|NCT05580003|467740885|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938763|NCT05580003|467740886|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
129938764|NCT05580003|467740887|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938765|NCT05580003|467740888|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938766|NCT05580003|467740889|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938767|NCT05580003|467740890|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938768|NCT05580003|467740891|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938769|NCT05580003|467740892|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938770|NCT05580003|467740893|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938771|NCT05580003|467740894|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938772|NCT05580003|467740895|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938773|NCT05580003|467740896|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938774|NCT05580003|467740897|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938775|NCT05580003|467740898|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938776|NCT05580003|467740899|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938777|NCT05580003|467740900|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938778|NCT05580003|467740901|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938779|NCT05580003|467740902|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938780|NCT05580003|467740903|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938781|NCT05580003|467740904|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938782|NCT05580003|467740905|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938783|NCT05580003|467740906|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938784|NCT05580003|467740907|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938785|NCT05580003|467740908|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
129938786|NCT05580003|467740881|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938787|NCT05580003|467740882|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938788|NCT05580003|467740883|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938789|NCT05580003|467740884|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
129938790|NCT05580003|467740885|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938791|NCT05580003|467740886|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938792|NCT05580003|467740887|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938793|NCT05580003|467740888|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938794|NCT05580003|467740889|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938795|NCT05580003|467740890|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938796|NCT05580003|467740891|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938797|NCT05580003|467740892|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938798|NCT05580003|467740893|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938799|NCT05580003|467740894|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938800|NCT05580003|467740895|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938801|NCT05580003|467740896|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938802|NCT05580003|467740897|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938803|NCT05580003|467740898|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938804|NCT05580003|467740899|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938805|NCT05580003|467740900|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938806|NCT05580003|467740901|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938807|NCT05580003|467740902|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938808|NCT05580003|467740903|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938809|NCT05580003|467740904|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938810|NCT05580003|467740905|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938811|NCT05580003|467740906|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938812|NCT05580003|467740907|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938813|NCT05580003|467740908|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
129938814|NCT05580003|467740881|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938815|NCT05580003|467740882|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
129938816|NCT05580003|467740883|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938817|NCT05580003|467740884|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938818|NCT05580003|467740885|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938819|NCT05580003|467740886|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938820|NCT05580003|467740887|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938821|NCT05580003|467740888|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938822|NCT05580003|467740889|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938823|NCT05580003|467740890|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938824|NCT05580003|467740891|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938825|NCT05580003|467740892|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938826|NCT05580003|467740893|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938827|NCT05580003|467740894|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938828|NCT05580003|467740895|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938829|NCT05580003|467740896|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938830|NCT05580003|467740897|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938831|NCT05580003|467740898|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938832|NCT05580003|467740899|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938833|NCT05580003|467740900|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938834|NCT05580003|467740901|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938835|NCT05580003|467740902|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938836|NCT05580003|467740903|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938837|NCT05580003|467740904|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938838|NCT05580003|467740905|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938839|NCT05580003|467740906|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938840|NCT05580003|467740907|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938841|NCT05580003|467740908|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
129938842|NCT05580003|467740881|FG000|Part 2 (up to 10 Days)|Other|0|||
129938843|NCT05580003|467740882|FG001|Part 2 (up to 10 Days)|Other|0|||
129938844|NCT05580003|467740883|FG002|Part 2 (up to 10 Days)|Other|0|||
129938845|NCT05580003|467740884|FG003|Part 2 (up to 10 Days)|Other|0|||
129938846|NCT05580003|467740885|FG004|Part 2 (up to 10 Days)|Other|0|||
129938847|NCT05580003|467740886|FG005|Part 2 (up to 10 Days)|Other|0|||
129938848|NCT05580003|467740887|FG006|Part 2 (up to 10 Days)|Other|0|||
129938849|NCT05580003|467740888|FG007|Part 2 (up to 10 Days)|Other|0|||
129938850|NCT05580003|467740889|FG008|Part 2 (up to 10 Days)|Other|0|||
129938851|NCT05580003|467740890|FG009|Part 2 (up to 10 Days)|Other|1|||
129938852|NCT05580003|467740891|FG010|Part 2 (up to 10 Days)|Other|0|||
129938853|NCT05580003|467740892|FG011|Part 2 (up to 10 Days)|Other|0|||
129938854|NCT05580003|467740893|FG012|Part 2 (up to 10 Days)|Other|0|||
129938855|NCT05580003|467740894|FG013|Part 2 (up to 10 Days)|Other|0|||
129938856|NCT05580003|467740895|FG014|Part 2 (up to 10 Days)|Other|0|||
129938857|NCT05580003|467740896|FG015|Part 2 (up to 10 Days)|Other|0|||
129938858|NCT05580003|467740897|FG016|Part 2 (up to 10 Days)|Other|0|||
129938859|NCT05580003|467740898|FG017|Part 2 (up to 10 Days)|Other|0|||
129938860|NCT05580003|467740899|FG018|Part 2 (up to 10 Days)|Other|0|||
129938861|NCT05580003|467740900|FG019|Part 2 (up to 10 Days)|Other|0|||
129938862|NCT05580003|467740901|FG020|Part 2 (up to 10 Days)|Other|0|||
129938863|NCT05580003|467740902|FG021|Part 2 (up to 10 Days)|Other|0|||
129938864|NCT05580003|467740903|FG022|Part 2 (up to 10 Days)|Other|0|||
129938865|NCT05580003|467740904|FG023|Part 2 (up to 10 Days)|Other|0|||
129938866|NCT05580003|467740905|FG024|Part 2 (up to 10 Days)|Other|0|||
129938867|NCT05580003|467740906|FG025|Part 2 (up to 10 Days)|Other|0|||
129938868|NCT05580003|467740907|FG026|Part 2 (up to 10 Days)|Other|0|||
129938869|NCT05580003|467740908|FG027|Part 2 (up to 10 Days)|Other|0|||
129938870|NCT05580003|467740881|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938871|NCT05580003|467740882|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938872|NCT05580003|467740883|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938873|NCT05580003|467740884|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938874|NCT05580003|467740885|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938875|NCT05580003|467740886|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938876|NCT05580003|467740887|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938877|NCT05580003|467740888|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938878|NCT05580003|467740889|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938879|NCT05580003|467740890|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938880|NCT05580003|467740891|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938881|NCT05580003|467740892|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938882|NCT05580003|467740893|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938883|NCT05580003|467740894|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938884|NCT05580003|467740895|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938885|NCT05580003|467740896|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938886|NCT05580003|467740897|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938887|NCT05580003|467740898|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938888|NCT05580003|467740899|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938889|NCT05580003|467740900|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
129938890|NCT05580003|467740901|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938891|NCT05580003|467740902|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938892|NCT05580003|467740903|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938893|NCT05580003|467740904|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938894|NCT05580003|467740905|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938895|NCT05580003|467740906|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938896|NCT05580003|467740907|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938897|NCT05580003|467740908|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
129938898|NCT05580003|467740881|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938899|NCT05580003|467740882|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938900|NCT05580003|467740883|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938901|NCT05580003|467740884|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938902|NCT05580003|467740885|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938903|NCT05580003|467740886|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938904|NCT05580003|467740887|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938905|NCT05580003|467740888|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938906|NCT05580003|467740889|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938907|NCT05580003|467740890|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938908|NCT05580003|467740891|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938909|NCT05580003|467740892|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938910|NCT05580003|467740893|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938911|NCT05580003|467740894|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938912|NCT05580003|467740895|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938913|NCT05580003|467740896|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938914|NCT05580003|467740897|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938915|NCT05580003|467740898|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938916|NCT05580003|467740899|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938917|NCT05580003|467740900|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938918|NCT05580003|467740901|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
129938919|NCT05580003|467740902|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938920|NCT05580003|467740903|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938921|NCT05580003|467740904|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938922|NCT05580003|467740905|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938923|NCT05580003|467740906|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938924|NCT05580003|467740907|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938925|NCT05580003|467740908|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
129938926|NCT05580003|467740881|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938927|NCT05580003|467740882|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938928|NCT05580003|467740883|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938929|NCT05580003|467740884|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938930|NCT05580003|467740885|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938931|NCT05580003|467740886|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938932|NCT05580003|467740887|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938933|NCT05580003|467740888|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938934|NCT05580003|467740889|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938935|NCT05580003|467740890|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938936|NCT05580003|467740891|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938937|NCT05580003|467740892|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938938|NCT05580003|467740893|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938939|NCT05580003|467740894|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938940|NCT05580003|467740895|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938941|NCT05580003|467740896|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938942|NCT05580003|467740897|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938943|NCT05580003|467740898|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938944|NCT05580003|467740899|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938945|NCT05580003|467740900|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938946|NCT05580003|467740901|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938947|NCT05580003|467740902|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
129938948|NCT05580003|467740903|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938949|NCT05580003|467740904|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938950|NCT05580003|467740905|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938951|NCT05580003|467740906|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938952|NCT05580003|467740907|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938953|NCT05580003|467740908|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
129938954|NCT05580003|467740881|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938955|NCT05580003|467740882|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938956|NCT05580003|467740883|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938957|NCT05580003|467740884|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938958|NCT05580003|467740885|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938959|NCT05580003|467740886|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938960|NCT05580003|467740887|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938961|NCT05580003|467740888|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938962|NCT05580003|467740889|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938963|NCT05580003|467740890|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938964|NCT05580003|467740891|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938965|NCT05580003|467740892|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938966|NCT05580003|467740893|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938967|NCT05580003|467740894|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938968|NCT05580003|467740895|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938969|NCT05580003|467740896|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938970|NCT05580003|467740897|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938971|NCT05580003|467740898|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938972|NCT05580003|467740899|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938973|NCT05580003|467740900|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938974|NCT05580003|467740901|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938975|NCT05580003|467740902|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938976|NCT05580003|467740903|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938977|NCT05580003|467740904|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938978|NCT05580003|467740905|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938979|NCT05580003|467740906|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938980|NCT05580003|467740907|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
129938981|NCT05580003|467740908|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
129938982|NCT05580003|467740881|FG000|Part 6 Period 2 (Day 1)|Other|0|||
129938983|NCT05580003|467740882|FG001|Part 6 Period 2 (Day 1)|Other|0|||
129938984|NCT05580003|467740883|FG002|Part 6 Period 2 (Day 1)|Other|0|||
129938985|NCT05580003|467740884|FG003|Part 6 Period 2 (Day 1)|Other|0|||
129938986|NCT05580003|467740885|FG004|Part 6 Period 2 (Day 1)|Other|0|||
129938987|NCT05580003|467740886|FG005|Part 6 Period 2 (Day 1)|Other|0|||
129938988|NCT05580003|467740887|FG006|Part 6 Period 2 (Day 1)|Other|0|||
129938989|NCT05580003|467740888|FG007|Part 6 Period 2 (Day 1)|Other|0|||
129938990|NCT05580003|467740889|FG008|Part 6 Period 2 (Day 1)|Other|0|||
129938991|NCT05580003|467740890|FG009|Part 6 Period 2 (Day 1)|Other|0|||
129938992|NCT05580003|467740891|FG010|Part 6 Period 2 (Day 1)|Other|0|||
129938993|NCT05580003|467740892|FG011|Part 6 Period 2 (Day 1)|Other|0|||
129938994|NCT05580003|467740893|FG012|Part 6 Period 2 (Day 1)|Other|0|||
129938995|NCT05580003|467740894|FG013|Part 6 Period 2 (Day 1)|Other|0|||
129938996|NCT05580003|467740895|FG014|Part 6 Period 2 (Day 1)|Other|0|||
129938997|NCT05580003|467740896|FG015|Part 6 Period 2 (Day 1)|Other|0|||
129938998|NCT05580003|467740897|FG016|Part 6 Period 2 (Day 1)|Other|0|||
129938999|NCT05580003|467740898|FG017|Part 6 Period 2 (Day 1)|Other|0|||
129939000|NCT05580003|467740899|FG018|Part 6 Period 2 (Day 1)|Other|0|||
129939001|NCT05580003|467740900|FG019|Part 6 Period 2 (Day 1)|Other|0|||
129939002|NCT05580003|467740901|FG020|Part 6 Period 2 (Day 1)|Other|0|||
129939003|NCT05580003|467740902|FG021|Part 6 Period 2 (Day 1)|Other|0|||
129939004|NCT05580003|467740903|FG022|Part 6 Period 2 (Day 1)|Other|0|||
129939005|NCT05580003|467740904|FG023|Part 6 Period 2 (Day 1)|Other|0|||
129939006|NCT05580003|467740905|FG024|Part 6 Period 2 (Day 1)|Other|1|||
129939007|NCT05580003|467740906|FG025|Part 6 Period 2 (Day 1)|Other|0|||
129939008|NCT05580003|467740907|FG026|Part 6 Period 2 (Day 1)|Other|0|||
129939009|NCT05580003|467740908|FG027|Part 6 Period 2 (Day 1)|Other|0|||
129939010|NCT02029235|467740909|FG000|Overall Study|Non-compliance with study meds or diary|4|||
129939011|NCT02029235|467740910|FG001|Overall Study|Non-compliance with study meds or diary|1|||
129939012|NCT00701701|467740911|FG000|Overall Study|Withdrawal by Subject|0|||
129939013|NCT00701701|467740912|FG001|Overall Study|Withdrawal by Subject|1|||
129939014|NCT00701701|467740911|FG000|Overall Study|Adverse Event|0|||
129939015|NCT00701701|467740912|FG001|Overall Study|Adverse Event|1|||
129939016|NCT00589875|467740913|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
129939017|NCT00589875|467740913|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
129939018|NCT03593226|467740930|FG000|Overall Study|Disease progression|6|||
129939019|NCT03593226|467740931|FG001|Overall Study|Disease progression|13|||
129939020|NCT03593226|467740932|FG002|Overall Study|Disease progression|5|||
129939021|NCT03593226|467740933|FG003|Overall Study|Disease progression|6|||
129939022|NCT03593226|467740930|FG000|Overall Study|Adverse Event|0|||
129939023|NCT03593226|467740931|FG001|Overall Study|Adverse Event|1|||
129939024|NCT03593226|467740932|FG002|Overall Study|Adverse Event|0|||
129939025|NCT03593226|467740933|FG003|Overall Study|Adverse Event|0|||
129939026|NCT03593226|467740930|FG000|Overall Study|Withdrawal by Subject|0|||
129939027|NCT03593226|467740931|FG001|Overall Study|Withdrawal by Subject|4|||
129939028|NCT03593226|467740932|FG002|Overall Study|Withdrawal by Subject|1|||
129939029|NCT03593226|467740933|FG003|Overall Study|Withdrawal by Subject|0|||
129939030|NCT03593226|467740930|FG000|Overall Study|Physician Decision|0|||
129939031|NCT03593226|467740931|FG001|Overall Study|Physician Decision|1|||
129939032|NCT03593226|467740932|FG002|Overall Study|Physician Decision|0|||
129939033|NCT03593226|467740933|FG003|Overall Study|Physician Decision|0|||
129939034|NCT03593226|467740930|FG000|Overall Study|Clinical disease progression|0|||
129939035|NCT03593226|467740931|FG001|Overall Study|Clinical disease progression|0|||
129939036|NCT03593226|467740932|FG002|Overall Study|Clinical disease progression|1|||
129939037|NCT03593226|467740933|FG003|Overall Study|Clinical disease progression|0|||
129939038|NCT04517435|467740934|FG000|Overall Study|Withdrawal by Subject|0|||
129939039|NCT04517435|467740935|FG001|Overall Study|Withdrawal by Subject|0|||
129939040|NCT04517435|467740936|FG002|Overall Study|Withdrawal by Subject|1|||
129939041|NCT04517435|467740934|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
129939042|NCT04517435|467740935|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
129939043|NCT04517435|467740936|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
129939044|NCT04057131|467740937|FG000|Overall Study|Protocol Violation|24|||
129939045|NCT03160885|467740938|FG000|Initial Treatment Period|Not dosed|2|||
129939046|NCT03160885|467740939|FG001|Initial Treatment Period|Not dosed|0|||
129939047|NCT03160885|467740940|FG002|Initial Treatment Period|Not dosed|0|||
129939048|NCT03160885|467740941|FG003|Initial Treatment Period|Not dosed|0|||
129939049|NCT03160885|467740942|FG004|Initial Treatment Period|Not dosed|0|||
129939050|NCT03160885|467740943|FG005|Initial Treatment Period|Not dosed|0|||
129939051|NCT03160885|467740944|FG006|Initial Treatment Period|Not dosed|0|||
129939052|NCT03160885|467740938|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
129939053|NCT03160885|467740939|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
129939054|NCT03160885|467740940|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939055|NCT03160885|467740941|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939056|NCT03160885|467740942|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939057|NCT03160885|467740943|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939058|NCT03160885|467740944|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
129939059|NCT03160885|467740938|FG000|Open-label Treatment|Not dosed|0|||
129939060|NCT03160885|467740939|FG001|Open-label Treatment|Not dosed|0|||
129939061|NCT03160885|467740940|FG002|Open-label Treatment|Not dosed|0|||
129939062|NCT03160885|467740941|FG003|Open-label Treatment|Not dosed|0|||
129939063|NCT03160885|467740942|FG004|Open-label Treatment|Not dosed|0|||
129939064|NCT03160885|467740943|FG005|Open-label Treatment|Not dosed|0|||
129939065|NCT03160885|467740944|FG006|Open-label Treatment|Not dosed|2|||
129939066|NCT03160885|467740938|FG000|Open-label Treatment|Discontinued IMP|0|||
129939067|NCT03160885|467740939|FG001|Open-label Treatment|Discontinued IMP|0|||
129939068|NCT03160885|467740940|FG002|Open-label Treatment|Discontinued IMP|0|||
129939069|NCT03160885|467740941|FG003|Open-label Treatment|Discontinued IMP|0|||
129939070|NCT03160885|467740942|FG004|Open-label Treatment|Discontinued IMP|0|||
129939071|NCT03160885|467740943|FG005|Open-label Treatment|Discontinued IMP|0|||
129939072|NCT03160885|467740944|FG006|Open-label Treatment|Discontinued IMP|131|||
129939073|NCT03160885|467740938|FG000|Open-label Treatment|Completed Week 50|0|||
129939074|NCT03160885|467740939|FG001|Open-label Treatment|Completed Week 50|0|||
129939075|NCT03160885|467740940|FG002|Open-label Treatment|Completed Week 50|0|||
129939076|NCT03160885|467740941|FG003|Open-label Treatment|Completed Week 50|0|||
129939077|NCT03160885|467740942|FG004|Open-label Treatment|Completed Week 50|0|||
129939078|NCT03160885|467740943|FG005|Open-label Treatment|Completed Week 50|0|||
129939079|NCT03160885|467740944|FG006|Open-label Treatment|Completed Week 50|4|||
129939080|NCT03160885|467740938|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939081|NCT03160885|467740939|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939082|NCT03160885|467740940|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939083|NCT03160885|467740941|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
129939084|NCT03160885|467740942|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939085|NCT03160885|467740943|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939086|NCT03160885|467740944|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
129939087|NCT03160885|467740938|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
129939088|NCT03160885|467740939|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
129939089|NCT03160885|467740940|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
129939090|NCT03160885|467740941|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
129939091|NCT03160885|467740942|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
129939092|NCT03160885|467740943|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
129939093|NCT03160885|467740944|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
129939094|NCT03160885|467740938|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129939095|NCT03160885|467740939|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129939096|NCT03160885|467740940|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
129939097|NCT03160885|467740941|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
129939098|NCT03160885|467740942|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
129939099|NCT03160885|467740943|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
129939100|NCT03160885|467740944|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
129939101|NCT03160885|467740938|FG000|Maintenance Treatment Period|Completed Week 50|0|||
129939102|NCT03160885|467740939|FG001|Maintenance Treatment Period|Completed Week 50|0|||
129939103|NCT03160885|467740940|FG002|Maintenance Treatment Period|Completed Week 50|1|||
129939104|NCT03160885|467740941|FG003|Maintenance Treatment Period|Completed Week 50|0|||
129939105|NCT03160885|467740942|FG004|Maintenance Treatment Period|Completed Week 50|0|||
129939106|NCT03160885|467740943|FG005|Maintenance Treatment Period|Completed Week 50|0|||
129939107|NCT03160885|467740944|FG006|Maintenance Treatment Period|Completed Week 50|0|||
129939108|NCT05704725|467740947|FG000|Overall Study|Lost to Follow-up|0|||
129939109|NCT05704725|467740948|FG001|Overall Study|Lost to Follow-up|1|||
129939110|NCT05704725|467740947|FG000|Overall Study|Withdrawal by Subject|1|||
129939111|NCT05704725|467740948|FG001|Overall Study|Withdrawal by Subject|0|||
129939112|NCT04484623|467740949|FG000|Overall Study|Lost to Follow-up|0|||
129939113|NCT04484623|467740950|FG001|Overall Study|Lost to Follow-up|1|||
129939114|NCT04484623|467740949|FG000|Overall Study|Protocol Deviation|1|||
129939115|NCT04484623|467740950|FG001|Overall Study|Protocol Deviation|0|||
129939116|NCT04484623|467740949|FG000|Overall Study|Physician Decision|1|||
129939117|NCT04484623|467740950|FG001|Overall Study|Physician Decision|0|||
129939118|NCT04484623|467740949|FG000|Overall Study|Withdrawal by Subject|11|||
129939119|NCT04484623|467740950|FG001|Overall Study|Withdrawal by Subject|8|||
129939120|NCT04484623|467740949|FG000|Overall Study|Ongoing|94|||
129939121|NCT04484623|467740950|FG001|Overall Study|Ongoing|84|||
129939122|NCT04551066|467740951|FG000|Overall Study|Death|5|||
129939123|NCT04551066|467740952|FG001|Overall Study|Death|3|||
129939124|NCT04551066|467740951|FG000|Overall Study|Lost to Follow-up|1|||
129939125|NCT04551066|467740952|FG001|Overall Study|Lost to Follow-up|0|||
129939126|NCT04551066|467740951|FG000|Overall Study|Sponsor Decision|103|||
129939127|NCT04551066|467740952|FG001|Overall Study|Sponsor Decision|117|||
129939128|NCT04551066|467740951|FG000|Overall Study|Withdrawal by Subject|8|||
129939129|NCT04551066|467740952|FG001|Overall Study|Withdrawal by Subject|2|||
129939130|NCT04551066|467740951|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
129939131|NCT04551066|467740952|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
129939132|NCT04551066|467740951|FG000|Overall Study|Adverse Event|2|||
129939133|NCT04551066|467740952|FG001|Overall Study|Adverse Event|0|||
129939134|NCT04551066|467740951|FG000|Overall Study|Physician Decision|2|||
129939135|NCT04551066|467740952|FG001|Overall Study|Physician Decision|0|||
129939136|NCT04551066|467740951|FG000|Overall Study|Protocol Violation|1|||
129939137|NCT04551066|467740952|FG001|Overall Study|Protocol Violation|0|||
129939138|NCT04551066|467740951|FG000|Overall Study|Lack of Efficacy|0|||
129939139|NCT04551066|467740952|FG001|Overall Study|Lack of Efficacy|1|||
129939140|NCT04551066|467740951|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
129939141|NCT04551066|467740952|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
129939142|NCT05529992|467740953|FG000|Overall Study|Withdrawal by Subject|1|||
129939143|NCT00210106|467742333|FG000|Overall Study|Death|1|||
129939144|NCT00210106|467742333|FG000|Overall Study|Protocol Violation|13|||
129939145|NCT00065182|467742338|FG000|Overall Study|Adverse Event|24|||
129939146|NCT00065182|467742339|FG001|Overall Study|Adverse Event|17|||
129939147|NCT00065182|467742338|FG000|Overall Study|Lost to Follow-up|0|||
129939148|NCT00065182|467742339|FG001|Overall Study|Lost to Follow-up|4|||
129939149|NCT00065182|467742338|FG000|Overall Study|Protocol Violation|3|||
129939150|NCT00065182|467742339|FG001|Overall Study|Protocol Violation|4|||
129939151|NCT00065182|467742338|FG000|Overall Study|Serious adverse events (SAE)|1|||
129939152|NCT00065182|467742339|FG001|Overall Study|Serious adverse events (SAE)|0|||
129939153|NCT00065182|467742338|FG000|Overall Study|Sponsor Decision|11|||
129939154|NCT00065182|467742339|FG001|Overall Study|Sponsor Decision|7|||
129939155|NCT00065182|467742338|FG000|Overall Study|Withdrawal by Subject|8|||
129939156|NCT00065182|467742339|FG001|Overall Study|Withdrawal by Subject|3|||
129939157|NCT00065182|467742338|FG000|Overall Study|No clinical benefit|1|||
129939158|NCT00065182|467742339|FG001|Overall Study|No clinical benefit|0|||
129939159|NCT00065182|467742338|FG000|Overall Study|Death|0|||
129939160|NCT00065182|467742339|FG001|Overall Study|Death|1|||
129939161|NCT00065182|467742338|FG000|Overall Study|Decline in Status|0|||
129939162|NCT00065182|467742339|FG001|Overall Study|Decline in Status|1|||
129939163|NCT04876417|467742342|FG000|Overall Study|Lost to Follow-up|5|||
129939164|NCT04876417|467742343|FG001|Overall Study|Lost to Follow-up|8|||
129939165|NCT04876417|467742344|FG002|Overall Study|Lost to Follow-up|0|||
129939166|NCT04876417|467742345|FG003|Overall Study|Lost to Follow-up|0|||
129939167|NCT03801148|467742346|FG000|Period 1 (2 Days)|Adverse Event|1|||
129939168|NCT03801148|467742347|FG001|Period 1 (2 Days)|Adverse Event|1|||
129939169|NCT03801148|467742348|FG002|Period 1 (2 Days)|Adverse Event|0|||
129939170|NCT03801148|467742349|FG003|Period 1 (2 Days)|Adverse Event|0|||
129939171|NCT03801148|467742346|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129939172|NCT03801148|467742347|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129939173|NCT03801148|467742348|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
129939174|NCT03801148|467742349|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
129939175|NCT03801148|467742346|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129939176|NCT03801148|467742347|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129939177|NCT03801148|467742348|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
129939178|NCT03801148|467742349|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
129939179|NCT03801148|467742346|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
129939180|NCT03801148|467742347|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
129939181|NCT03801148|467742348|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
129939182|NCT03801148|467742349|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
129939183|NCT00439270|467742350|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
129939184|NCT00439270|467742351|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
129939185|NCT00439270|467742352|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
129939186|NCT00439270|467742353|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
129939187|NCT00439270|467742354|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
129939188|NCT00439270|467742350|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939189|NCT00439270|467742351|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
129939190|NCT00439270|467742352|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939191|NCT00439270|467742353|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939192|NCT00439270|467742354|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
129939193|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
129939194|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
129939195|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
129939196|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
129939197|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
129939198|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939199|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939200|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939201|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
129939202|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
129939203|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939204|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939205|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939206|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
129939207|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
129939208|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939209|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939210|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939211|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
129939212|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
129939213|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129939214|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129939215|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129939216|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
129939217|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
129452953|NCT02236520|465956339|FG000|Overall Study|Pregnancy|1|||
129452954|NCT02236520|465956340|FG001|Overall Study|Pregnancy|0|||
129939218|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939219|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939220|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939221|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
129939222|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
129939223|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939224|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939225|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939226|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
129452955|NCT02236520|465956341|FG002|Overall Study|Pregnancy|0|||
129939227|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
129939228|NCT00439270|467742350|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939229|NCT00439270|467742351|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939230|NCT00439270|467742352|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939231|NCT00439270|467742353|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
129939232|NCT00439270|467742354|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
129939233|NCT01750684|467742355|FG000|Overall Study|Death|1|||
129939234|NCT01750684|467742356|FG001|Overall Study|Death|0|||
129939235|NCT01750684|467742355|FG000|Overall Study|Non-compliance with Study Drug|0|||
129939236|NCT01750684|467742356|FG001|Overall Study|Non-compliance with Study Drug|1|||
129939237|NCT01750684|467742355|FG000|Overall Study|Withdrawn by Sponsor|0|||
129939238|NCT01750684|467742356|FG001|Overall Study|Withdrawn by Sponsor|1|||
129939239|NCT01750684|467742355|FG000|Overall Study|Protocol Violation|1|||
129939240|NCT01750684|467742356|FG001|Overall Study|Protocol Violation|0|||
129939241|NCT03478969|467742357|FG000|Overall Study|Withdrawal by Subject|4|||
129939242|NCT03478969|467742358|FG001|Overall Study|Withdrawal by Subject|7|||
129939243|NCT03478969|467742359|FG002|Overall Study|Withdrawal by Subject|6|||
129939244|NCT03478969|467742357|FG000|Overall Study|Adverse Event|2|||
129939245|NCT03478969|467742358|FG001|Overall Study|Adverse Event|0|||
129939246|NCT03478969|467742359|FG002|Overall Study|Adverse Event|1|||
129939247|NCT03478969|467742357|FG000|Overall Study|Pregnancy|1|||
129939248|NCT03478969|467742358|FG001|Overall Study|Pregnancy|0|||
129939249|NCT03478969|467742359|FG002|Overall Study|Pregnancy|0|||
129939250|NCT03478969|467742357|FG000|Overall Study|Personal Reasons|1|||
129939251|NCT03478969|467742358|FG001|Overall Study|Personal Reasons|0|||
129939252|NCT03478969|467742359|FG002|Overall Study|Personal Reasons|1|||
129939253|NCT03478969|467742357|FG000|Overall Study|Covid-19|1|||
129939254|NCT03478969|467742358|FG001|Overall Study|Covid-19|4|||
129939255|NCT03478969|467742359|FG002|Overall Study|Covid-19|3|||
129939256|NCT03478969|467742357|FG000|Overall Study|Multiple Reasons|0|||
129939257|NCT03478969|467742358|FG001|Overall Study|Multiple Reasons|1|||
129939258|NCT03478969|467742359|FG002|Overall Study|Multiple Reasons|1|||
129939259|NCT03478969|467742357|FG000|Overall Study|Eligibility Criteria|0|||
129939260|NCT03478969|467742358|FG001|Overall Study|Eligibility Criteria|0|||
129939261|NCT03478969|467742359|FG002|Overall Study|Eligibility Criteria|5|||
129939262|NCT03478969|467742357|FG000|Overall Study|Lost to Follow-up|0|||
129939263|NCT03478969|467742358|FG001|Overall Study|Lost to Follow-up|0|||
129939264|NCT03478969|467742359|FG002|Overall Study|Lost to Follow-up|1|||
129939265|NCT01185600|467742360|FG000|Overall Study|Adverse Event|1|||
129939266|NCT01185600|467742361|FG001|Overall Study|Adverse Event|1|||
129939267|NCT01185600|467742360|FG000|Overall Study|Death|0|||
129939268|NCT01185600|467742361|FG001|Overall Study|Death|1|||
129939269|NCT01185600|467742360|FG000|Overall Study|Lost to Follow-up|0|||
129939270|NCT01185600|467742361|FG001|Overall Study|Lost to Follow-up|5|||
129939271|NCT01185600|467742360|FG000|Overall Study|Physician Decision|29|||
129939272|NCT01185600|467742361|FG001|Overall Study|Physician Decision|35|||
129939273|NCT01185600|467742360|FG000|Overall Study|Withdrawal by Subject|1|||
129939274|NCT01185600|467742361|FG001|Overall Study|Withdrawal by Subject|1|||
129939275|NCT01185600|467742360|FG000|Overall Study|Hold by DSMB|1|||
129939276|NCT01185600|467742361|FG001|Overall Study|Hold by DSMB|2|||
129939277|NCT01436175|467742362|FG000|Overall Study|Adverse Event|111|||
129939278|NCT01436175|467742362|FG000|Overall Study|Protocol Violation|49|||
129939279|NCT01436175|467742362|FG000|Overall Study|Withdrawal by Subject|108|||
129939280|NCT01436175|467742362|FG000|Overall Study|Lost to Follow-up|89|||
129939281|NCT01436175|467742362|FG000|Overall Study|Lack of Efficacy|24|||
129939282|NCT01436175|467742362|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
129939283|NCT01436175|467742362|FG000|Overall Study|Other|826|||
129939284|NCT05405244|467742364|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
129939285|NCT05405244|467742365|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
129939286|NCT05405244|467742364|FG000|Washout (2 Weeks)|Adverse Event|2|||
129939287|NCT05405244|467742365|FG001|Washout (2 Weeks)|Adverse Event|0|||
129939288|NCT05405244|467742364|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
129939289|NCT05405244|467742365|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
129939290|NCT03418922|467742368|FG000|Overall Study|Withdrawal by Subject|0|||
129939291|NCT03418922|467742369|FG001|Overall Study|Withdrawal by Subject|2|||
129939292|NCT03418922|467742368|FG000|Overall Study|Adverse Event|2|||
129939293|NCT03418922|467742369|FG001|Overall Study|Adverse Event|2|||
129939294|NCT03418922|467742368|FG000|Overall Study|Death|0|||
129939295|NCT03418922|467742369|FG001|Overall Study|Death|1|||
129939296|NCT03418922|467742368|FG000|Overall Study|Physician Decision|0|||
129939297|NCT03418922|467742369|FG001|Overall Study|Physician Decision|1|||
129939298|NCT03577106|467742370|FG000|Overall Study|Withdrawal by Subject|3|||
129939299|NCT00640159|467742371|FG000|Overall Study|Lost to Follow-up|2|||
129939300|NCT01500200|467742372|FG000|Stage 1|Adverse Event|1|||
129939301|NCT01500200|467742373|FG001|Stage 1|Adverse Event|4|||
129939302|NCT01500200|467742374|FG002|Stage 1|Adverse Event|5|||
129939303|NCT01500200|467742375|FG003|Stage 1|Adverse Event|0|||
129939304|NCT01500200|467742376|FG004|Stage 1|Adverse Event|0|||
129939305|NCT01500200|467742377|FG005|Stage 1|Adverse Event|0|||
129939306|NCT01500200|467742372|FG000|Stage 1|Lost to Follow-up|2|||
129939307|NCT01500200|467742373|FG001|Stage 1|Lost to Follow-up|2|||
129939308|NCT01500200|467742374|FG002|Stage 1|Lost to Follow-up|1|||
129939309|NCT01500200|467742375|FG003|Stage 1|Lost to Follow-up|0|||
129939310|NCT01500200|467742376|FG004|Stage 1|Lost to Follow-up|0|||
129939311|NCT01500200|467742377|FG005|Stage 1|Lost to Follow-up|0|||
129939312|NCT01500200|467742372|FG000|Stage 1|Withdrawal by Subject|3|||
129939313|NCT01500200|467742373|FG001|Stage 1|Withdrawal by Subject|0|||
129939314|NCT01500200|467742374|FG002|Stage 1|Withdrawal by Subject|0|||
129939315|NCT01500200|467742375|FG003|Stage 1|Withdrawal by Subject|0|||
129939316|NCT01500200|467742376|FG004|Stage 1|Withdrawal by Subject|0|||
129939317|NCT01500200|467742377|FG005|Stage 1|Withdrawal by Subject|0|||
129939318|NCT01500200|467742372|FG000|Stage 1|Noncompliance with Study Drug|1|||
129939319|NCT01500200|467742373|FG001|Stage 1|Noncompliance with Study Drug|0|||
129939320|NCT01500200|467742374|FG002|Stage 1|Noncompliance with Study Drug|0|||
129939321|NCT01500200|467742375|FG003|Stage 1|Noncompliance with Study Drug|0|||
129939322|NCT01500200|467742376|FG004|Stage 1|Noncompliance with Study Drug|0|||
129939323|NCT01500200|467742377|FG005|Stage 1|Noncompliance with Study Drug|0|||
129939324|NCT01500200|467742372|FG000|Stage 1|Physician Decision|1|||
129939325|NCT01500200|467742373|FG001|Stage 1|Physician Decision|0|||
129939326|NCT01500200|467742374|FG002|Stage 1|Physician Decision|0|||
129939327|NCT01500200|467742375|FG003|Stage 1|Physician Decision|0|||
129939328|NCT01500200|467742376|FG004|Stage 1|Physician Decision|0|||
129939329|NCT01500200|467742377|FG005|Stage 1|Physician Decision|0|||
129939330|NCT01500200|467742372|FG000|Stage 2|Adverse Event|0|||
129939331|NCT01500200|467742373|FG001|Stage 2|Adverse Event|0|||
129939332|NCT01500200|467742374|FG002|Stage 2|Adverse Event|0|||
129939333|NCT01500200|467742375|FG003|Stage 2|Adverse Event|0|||
129939334|NCT01500200|467742376|FG004|Stage 2|Adverse Event|5|||
129939335|NCT01500200|467742377|FG005|Stage 2|Adverse Event|4|||
129939336|NCT00523419|467742379|FG000|Overall Study|Adverse Event|1|||
129939337|NCT00523419|467742379|FG000|Overall Study|Withdrawal by Subject|1|||
129939338|NCT00523419|467742379|FG000|Overall Study|Physician Decision|2|||
129939339|NCT00523419|467742379|FG000|Overall Study|Progressive Disease|22|||
129939340|NCT00523419|467742379|FG000|Overall Study|Death due to Study Disease|4|||
129939341|NCT00523419|467742379|FG000|Overall Study|Death due to Adverse Event|2|||
129939342|NCT01218009|467742380|FG000|Overall Study|Protocol Violation|2|||
129939343|NCT01218009|467742381|FG001|Overall Study|Protocol Violation|1|||
129939344|NCT01218009|467742380|FG000|Overall Study|Withdrawal by Subject|3|||
129939345|NCT01218009|467742381|FG001|Overall Study|Withdrawal by Subject|1|||
129939346|NCT01218009|467742380|FG000|Overall Study|Sponsor terminated study|161|||
129939347|NCT01218009|467742381|FG001|Overall Study|Sponsor terminated study|163|||
129939348|NCT00811941|467742382|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
129939349|NCT00811941|467742383|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
129939350|NCT00811941|467742382|FG000|All Treated Patients|Adverse Event|2|||
129939351|NCT00811941|467742383|FG001|All Treated Patients|Adverse Event|43|||
129939352|NCT00811941|467742382|FG000|All Treated Patients|Lack of Efficacy|2|||
129939353|NCT00811941|467742383|FG001|All Treated Patients|Lack of Efficacy|3|||
129939354|NCT00811941|467742382|FG000|All Treated Patients|Non-compliance|1|||
129939355|NCT00811941|467742383|FG001|All Treated Patients|Non-compliance|8|||
129939356|NCT00811941|467742382|FG000|All Treated Patients|Protocol Violation|5|||
129939357|NCT00811941|467742383|FG001|All Treated Patients|Protocol Violation|17|||
129939358|NCT00811941|467742382|FG000|All Treated Patients|Withdrawal by Subject|35|||
129939359|NCT00811941|467742383|FG001|All Treated Patients|Withdrawal by Subject|94|||
129939360|NCT00811941|467742382|FG000|All Treated Patients|Lost to Follow-up|3|||
129939361|NCT00811941|467742383|FG001|All Treated Patients|Lost to Follow-up|12|||
129939362|NCT00811941|467742382|FG000|All Treated Patients|Other Reason|4|||
129939363|NCT00811941|467742383|FG001|All Treated Patients|Other Reason|14|||
129939364|NCT03802994|467742384|FG000|Overall Study|Lost to Follow-up|0|||
129939365|NCT03802994|467742385|FG001|Overall Study|Lost to Follow-up|2|||
129939366|NCT03802994|467742386|FG002|Overall Study|Lost to Follow-up|3|||
129939367|NCT03802994|467742387|FG003|Overall Study|Lost to Follow-up|2|||
129939368|NCT03802994|467742388|FG004|Overall Study|Lost to Follow-up|2|||
129939369|NCT02646618|467742392|FG000|Overall Study|Lost to Follow-up|10|||
129939370|NCT02646618|467742393|FG001|Overall Study|Lost to Follow-up|14|||
129939371|NCT00390884|467742394|FG000|Overall Study|Withdrawal by Subject|2|||
129939372|NCT00390884|467742395|FG001|Overall Study|Withdrawal by Subject|2|||
129939373|NCT04035447|467742396|FG000|Treatment Period|Lost to Follow-up|6|||
129939374|NCT04035447|467742397|FG001|Treatment Period|Lost to Follow-up|5|||
129939375|NCT04035447|467742396|FG000|Treatment Period|Physician Decision|0|||
129939376|NCT04035447|467742397|FG001|Treatment Period|Physician Decision|2|||
129939377|NCT03304587|467742398|FG000|Overall Study|Headache after intervention|0|||
129939378|NCT03304587|467742399|FG001|Overall Study|Headache after intervention|1|||
129939379|NCT03304587|467742398|FG000|Overall Study|Withdrawal by Subject|1|||
129939380|NCT03304587|467742399|FG001|Overall Study|Withdrawal by Subject|0|||
129452956|NCT02236520|465956342|FG003|Overall Study|Pregnancy|0|||
129452957|NCT01785160|465956343|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
129939381|NCT01458366|467742401|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
129939382|NCT01458366|467742402|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
129939383|NCT01458366|467742403|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
129939384|NCT01458366|467742404|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
129939385|NCT01458366|467742405|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
129939386|NCT01458366|467742401|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939387|NCT01458366|467742402|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939388|NCT01458366|467742403|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939389|NCT01458366|467742404|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
129939390|NCT01458366|467742405|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
129939391|NCT01753999|467742406|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
129939392|NCT01753999|467742407|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
129939393|NCT01753999|467742406|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
129939394|NCT01753999|467742407|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
129939395|NCT01753999|467742406|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
129939396|NCT01753999|467742407|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
129939397|NCT01753999|467742406|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
129939398|NCT01753999|467742407|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
129939399|NCT01753999|467742406|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
129939400|NCT01753999|467742407|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
129939401|NCT01753999|467742406|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
129939402|NCT01753999|467742407|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
129939403|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939404|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
129939405|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939406|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
129939407|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939408|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
129939409|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939410|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939411|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939412|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939413|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
129939414|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
129939415|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939416|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939417|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939418|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939419|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
129939420|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
129939421|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
129939422|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939423|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939424|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
129939425|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939426|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
129939427|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939428|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939429|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939430|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939431|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
129939432|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
129939433|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
129939434|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
129939435|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
129939436|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
129939437|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
129939438|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
129939439|NCT02392234|467742408|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939440|NCT02392234|467742409|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939441|NCT02392234|467742410|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
129939442|NCT02392234|467742411|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939443|NCT02392234|467742412|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
129939444|NCT02392234|467742413|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
129939445|NCT02392234|467742408|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
129939446|NCT02392234|467742409|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129452958|NCT01785160|465956343|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
129939447|NCT02392234|467742410|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939448|NCT02392234|467742411|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939449|NCT02392234|467742412|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939450|NCT02392234|467742413|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
129939451|NCT02052440|467742418|FG000|Overall Study|Withdrawal by Subject|0|||
129939452|NCT02052440|467742419|FG001|Overall Study|Withdrawal by Subject|1|||
129939453|NCT02130557|467742420|FG000|Overall Study|Withdrawal by Subject|12|||
129939454|NCT02130557|467742421|FG001|Overall Study|Withdrawal by Subject|12|||
129939455|NCT02130557|467742420|FG000|Overall Study|Investigator Request|0|||
129939456|NCT02130557|467742421|FG001|Overall Study|Investigator Request|2|||
129939457|NCT02130557|467742420|FG000|Overall Study|Deceased|14|||
129939458|NCT02130557|467742421|FG001|Overall Study|Deceased|14|||
129452959|NCT00957528|465956344|FG000|Overall Study|Protocol Violation|0|||
129939459|NCT02130557|467742420|FG000|Overall Study|Lost to Follow-up|6|||
129939460|NCT02130557|467742421|FG001|Overall Study|Lost to Follow-up|7|||
129939461|NCT02130557|467742420|FG000|Overall Study|Other|2|||
129939462|NCT02130557|467742421|FG001|Overall Study|Other|1|||
129939463|NCT02130557|467742420|FG000|Overall Study|Missing|2|||
129939464|NCT02130557|467742421|FG001|Overall Study|Missing|1|||
129939465|NCT02408887|467742422|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
129939466|NCT02408887|467742423|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
129939467|NCT02408887|467742422|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
129939468|NCT02408887|467742423|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
129939469|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129939470|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
129939471|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
129939472|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129939473|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
129939474|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
129939475|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
129939476|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
129939477|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
129939478|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
129939479|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
129939480|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
129939481|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
129939482|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
129939483|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
129939484|NCT03333109|467742425|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
129939485|NCT03333109|467742426|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
129939486|NCT03333109|467742427|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
129939487|NCT03333109|467742425|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
129939488|NCT03333109|467742426|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
129939489|NCT03333109|467742427|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
129939490|NCT03333109|467742425|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
129939491|NCT03333109|467742426|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
129939492|NCT03333109|467742427|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
129939493|NCT02078648|467742430|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
129939494|NCT02078648|467742431|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
129939495|NCT02078648|467742430|FG000|Overall Study|Adverse Event|0|||
129939496|NCT02078648|467742431|FG001|Overall Study|Adverse Event|1|||
129939497|NCT02078648|467742430|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
129939498|NCT02078648|467742431|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
129939499|NCT02078648|467742430|FG000|Overall Study|Withdrawal by Subject|3|||
129939500|NCT02078648|467742431|FG001|Overall Study|Withdrawal by Subject|1|||
129939501|NCT02078648|467742430|FG000|Overall Study|Investigator Decision|5|||
129939502|NCT02078648|467742431|FG001|Overall Study|Investigator Decision|7|||
129939503|NCT02078648|467742430|FG000|Overall Study|Death|1|||
129939504|NCT02078648|467742431|FG001|Overall Study|Death|1|||
129939505|NCT02078648|467742430|FG000|Overall Study|Undefined|0|||
129939506|NCT02078648|467742431|FG001|Overall Study|Undefined|1|||
129939507|NCT04088227|467742432|FG000|Overall Study|Withdrawal by Subject|1|||
129939508|NCT04088227|467742433|FG001|Overall Study|Withdrawal by Subject|0|||
129939509|NCT04088227|467742432|FG000|Overall Study|Surgery postponed >5weeks|1|||
129939510|NCT04088227|467742433|FG001|Overall Study|Surgery postponed >5weeks|0|||
129939511|NCT01855750|467742434|FG000|Overall Study|Death|78|||
129939512|NCT01855750|467742435|FG001|Overall Study|Death|78|||
129939513|NCT01855750|467742434|FG000|Overall Study|Lost to Follow-up|9|||
129939514|NCT01855750|467742435|FG001|Overall Study|Lost to Follow-up|23|||
129939515|NCT01855750|467742434|FG000|Overall Study|Withdrawal by Subject|35|||
129939516|NCT01855750|467742435|FG001|Overall Study|Withdrawal by Subject|28|||
129939517|NCT01855750|467742434|FG000|Overall Study|Sponsor ends the study|297|||
129939518|NCT01855750|467742435|FG001|Overall Study|Sponsor ends the study|290|||
129939519|NCT04300023|467742436|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
129939520|NCT04300023|467742437|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
129939521|NCT05525572|467742438|FG000|Overall Study|Lost to Follow-up|2|||
129939522|NCT03425682|467742439|FG000|Overall Study|Lost to Follow-up|2|||
129939523|NCT03425682|467742440|FG001|Overall Study|Lost to Follow-up|4|||
129939524|NCT03425682|467742439|FG000|Overall Study|Withdrawal by Subject|0|||
129939525|NCT03425682|467742440|FG001|Overall Study|Withdrawal by Subject|3|||
129939526|NCT03425682|467742439|FG000|Overall Study|Subject did not meet I/E|4|||
129939527|NCT03425682|467742440|FG001|Overall Study|Subject did not meet I/E|10|||
129939528|NCT03277989|467742445|FG000|Overall Study|Lost to Follow-up|6|||
129939529|NCT03277989|467742445|FG000|Overall Study|Adverse Event|6|||
129939530|NCT03277989|467742445|FG000|Overall Study|Withdrawal by Subject|3|||
129939531|NCT03277989|467742445|FG000|Overall Study|Didn't Receive Study Device|7|||
129939532|NCT03277989|467742445|FG000|Overall Study|Site Closure|26|||
129939533|NCT03277989|467742445|FG000|Overall Study|Sponsor Closure|107|||
129939534|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
129939535|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
129939536|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
129939537|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
129939538|NCT03227861|467742448|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
129939539|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
129939540|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
129939541|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
129939542|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
129939543|NCT03227861|467742448|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
129939544|NCT03516942|467742449|FG000|Registration Through Baseline Survey Com|Withdrawal by Subject|36|||
129939545|NCT03516942|467742449|FG000|Registration Through Baseline Survey Com|Death|8|||
129939546|NCT03516942|467742449|FG000|Registration Through Baseline Survey Com|Could not contact patient after enrollment|58|||
129939547|NCT03516942|467742449|FG000|T0: Baseline|LOST|13|||
129939548|NCT03516942|467742449|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
129939549|NCT03516942|467742449|FG000|T1: 3 Months Survey|Death|10|||
129939550|NCT03516942|467742449|FG000|T1: 3 Months Survey|Lost|163|||
129939551|NCT03516942|467742449|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
129939552|NCT03516942|467742449|FG000|T2: 6 Month Survey|Death|14|||
129939553|NCT03516942|467742449|FG000|T2: 6 Month Survey|Lost|180|||
129939554|NCT03516942|467742449|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
129939555|NCT03516942|467742449|FG000|T3: 12 Month Survey|Death|19|||
129939556|NCT03516942|467742449|FG000|T3: 12 Month Survey|Lost|209|||
129939557|NCT05613907|467742450|FG000|Overall Study|Lost to Follow-up|5|||
129939558|NCT05613907|467742450|FG000|Overall Study|Death|3|||
129939559|NCT05613907|467742450|FG000|Overall Study|Withdrawal by Subject|2|||
129939560|NCT05349838|467742451|FG000|Overall Study|Virological Failure|1|||
129939561|NCT05349838|467742452|FG001|Overall Study|Virological Failure|2|||
129939562|NCT05349838|467742451|FG000|Overall Study|Withdrawal by Subject|2|||
129939563|NCT05349838|467742452|FG001|Overall Study|Withdrawal by Subject|3|||
129939564|NCT05349838|467742451|FG000|Overall Study|Adverse Event|3|||
129939565|NCT05349838|467742452|FG001|Overall Study|Adverse Event|1|||
129939566|NCT05349838|467742451|FG000|Overall Study|Lost to Follow-up|1|||
129939567|NCT05349838|467742452|FG001|Overall Study|Lost to Follow-up|2|||
129939568|NCT05349838|467742451|FG000|Overall Study|Other reasons|5|||
129939569|NCT05349838|467742452|FG001|Overall Study|Other reasons|1|||
129939570|NCT05071430|467742454|FG000|Overall Study|Adverse Event|1|||
129939571|NCT05071430|467742455|FG001|Overall Study|Adverse Event|2|||
129939572|NCT05071430|467742454|FG000|Overall Study|Lost to Follow-up|4|||
129939573|NCT05071430|467742455|FG001|Overall Study|Lost to Follow-up|4|||
129939574|NCT05071430|467742454|FG000|Overall Study|Protocol Violation|1|||
129939575|NCT05071430|467742455|FG001|Overall Study|Protocol Violation|0|||
129939576|NCT05071430|467742454|FG000|Overall Study|Withdrawal by Subject|3|||
129939577|NCT05071430|467742455|FG001|Overall Study|Withdrawal by Subject|2|||
129939578|NCT05071430|467742454|FG000|Overall Study|Other|1|||
129939579|NCT05071430|467742455|FG001|Overall Study|Other|1|||
129939580|NCT00490139|467742457|FG000|Overall Study|Lost to Follow-up|249|||
129939581|NCT00490139|467742458|FG001|Overall Study|Lost to Follow-up|216|||
129939582|NCT00490139|467742459|FG002|Overall Study|Lost to Follow-up|205|||
129939583|NCT00490139|467742460|FG003|Overall Study|Lost to Follow-up|229|||
129939584|NCT00490139|467742457|FG000|Overall Study|Withdrawal by Subject|333|||
129939585|NCT00490139|467742458|FG001|Overall Study|Withdrawal by Subject|322|||
129939586|NCT00490139|467742459|FG002|Overall Study|Withdrawal by Subject|396|||
129939587|NCT00490139|467742460|FG003|Overall Study|Withdrawal by Subject|295|||
129939588|NCT00490139|467742457|FG000|Overall Study|Patient did not sign ICF 12|169|||
129939589|NCT00490139|467742458|FG001|Overall Study|Patient did not sign ICF 12|176|||
129939590|NCT00490139|467742459|FG002|Overall Study|Patient did not sign ICF 12|139|||
129939591|NCT00490139|467742460|FG003|Overall Study|Patient did not sign ICF 12|167|||
129939592|NCT00490139|467742457|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
129452960|NCT00957528|465956345|FG001|Overall Study|Protocol Violation|1|||
129452961|NCT00957528|465956346|FG002|Overall Study|Protocol Violation|0|||
129452962|NCT00957528|465956344|FG000|Overall Study|Withdrawal by Subject|0|||
129452963|NCT00957528|465956345|FG001|Overall Study|Withdrawal by Subject|0|||
129452964|NCT00957528|465956346|FG002|Overall Study|Withdrawal by Subject|1|||
129452965|NCT02081534|465956347|FG000|Overall Study|Adverse Event|5|||
129452966|NCT02081534|465956348|FG001|Overall Study|Adverse Event|4|||
129452967|NCT02081534|465956349|FG002|Overall Study|Adverse Event|3|||
129452968|NCT02081534|465956350|FG003|Overall Study|Adverse Event|10|||
129452969|NCT02081534|465956351|FG004|Overall Study|Adverse Event|2|||
129452970|NCT02081534|465956352|FG005|Overall Study|Adverse Event|8|||
129452971|NCT02081534|465956353|FG006|Overall Study|Adverse Event|2|||
129452972|NCT02081534|465956347|FG000|Overall Study|Withdrawal by Subject|0|||
129452973|NCT02081534|465956348|FG001|Overall Study|Withdrawal by Subject|1|||
129452974|NCT02081534|465956349|FG002|Overall Study|Withdrawal by Subject|1|||
129452975|NCT02081534|465956350|FG003|Overall Study|Withdrawal by Subject|1|||
129452976|NCT02081534|465956351|FG004|Overall Study|Withdrawal by Subject|1|||
129452977|NCT02081534|465956352|FG005|Overall Study|Withdrawal by Subject|0|||
129452978|NCT02081534|465956353|FG006|Overall Study|Withdrawal by Subject|1|||
129452979|NCT02081534|465956347|FG000|Overall Study|Protocol Violation|0|||
129452980|NCT02081534|465956348|FG001|Overall Study|Protocol Violation|3|||
129452981|NCT02081534|465956349|FG002|Overall Study|Protocol Violation|0|||
129452982|NCT02081534|465956350|FG003|Overall Study|Protocol Violation|0|||
129452983|NCT02081534|465956351|FG004|Overall Study|Protocol Violation|0|||
129452984|NCT02081534|465956352|FG005|Overall Study|Protocol Violation|0|||
129452985|NCT02081534|465956353|FG006|Overall Study|Protocol Violation|1|||
129452986|NCT02081534|465956347|FG000|Overall Study|Lost to Follow-up|0|||
129452987|NCT02081534|465956348|FG001|Overall Study|Lost to Follow-up|0|||
129452988|NCT02081534|465956349|FG002|Overall Study|Lost to Follow-up|0|||
129452989|NCT02081534|465956350|FG003|Overall Study|Lost to Follow-up|2|||
129452990|NCT02081534|465956351|FG004|Overall Study|Lost to Follow-up|1|||
129452991|NCT02081534|465956352|FG005|Overall Study|Lost to Follow-up|1|||
129452992|NCT02081534|465956353|FG006|Overall Study|Lost to Follow-up|0|||
129452993|NCT02289742|465956354|FG000|First Wear Period|Adverse event prior to treatment|0|||
129452994|NCT02289742|465956355|FG001|First Wear Period|Adverse event prior to treatment|1|||
129452995|NCT02289742|465956356|FG002|First Wear Period|Adverse event prior to treatment|0|||
129452996|NCT02289742|465956357|FG003|First Wear Period|Adverse event prior to treatment|0|||
129452997|NCT02289742|465956354|FG000|First Wear Period|Adverse Event|0|||
129452998|NCT02289742|465956355|FG001|First Wear Period|Adverse Event|0|||
129452999|NCT02289742|465956356|FG002|First Wear Period|Adverse Event|1|||
129453000|NCT02289742|465956357|FG003|First Wear Period|Adverse Event|0|||
129453001|NCT02289742|465956354|FG000|First Wear Period|Other prior to treatment|0|||
129453002|NCT02289742|465956355|FG001|First Wear Period|Other prior to treatment|0|||
129453003|NCT02289742|465956356|FG002|First Wear Period|Other prior to treatment|0|||
129453004|NCT02289742|465956357|FG003|First Wear Period|Other prior to treatment|1|||
129453005|NCT02289742|465956354|FG000|Third Wear Period|Adverse Event|0|||
129453006|NCT02289742|465956355|FG001|Third Wear Period|Adverse Event|1|||
129453007|NCT02289742|465956356|FG002|Third Wear Period|Adverse Event|0|||
129453008|NCT02289742|465956357|FG003|Third Wear Period|Adverse Event|0|||
129453009|NCT02289742|465956354|FG000|Third Wear Period|Reason not given|0|||
129453010|NCT02289742|465956355|FG001|Third Wear Period|Reason not given|0|||
129453011|NCT02289742|465956356|FG002|Third Wear Period|Reason not given|0|||
129453012|NCT02289742|465956357|FG003|Third Wear Period|Reason not given|1|||
129453013|NCT02181816|465956358|FG000|Overall Study|Case Report Forms Uncollected|38|||
129453014|NCT02181816|465956358|FG000|Overall Study|Protocol Deviation|21|||
129453015|NCT01365039|465956359|FG000|Overall Study|Study related symptoms and complaints|1|||
129453016|NCT01365039|465956360|FG001|Overall Study|Study related symptoms and complaints|0|||
129453017|NCT03807349|465956363|FG000|Overall Study|Early Study Termination|9|||
129453018|NCT00294060|465956364|FG000|Overall Study|Death|225|||
129453019|NCT00294060|465956364|FG000|Overall Study|Other|59|||
129453020|NCT00294060|465956364|FG000|Overall Study|Lost to Follow-up|55|||
129453021|NCT00294060|465956364|FG000|Overall Study|Withdrawal by Subject|11|||
129453022|NCT00294060|465956364|FG000|Overall Study|Physician Decision|797|||
129453023|NCT00294060|465956364|FG000|Overall Study|Medical condition|3|||
129453024|NCT00294060|465956364|FG000|Overall Study|Device explanted/not replaced|23|||
129453025|NCT01360554|465956365|FG000|Overall Study|Death|359|||
129453026|NCT01360554|465956366|FG001|Overall Study|Death|371|||
129453027|NCT01360554|465956365|FG000|Overall Study|Lost to Follow-up|4|||
129453028|NCT01360554|465956366|FG001|Overall Study|Lost to Follow-up|4|||
129453029|NCT01360554|465956365|FG000|Overall Study|Withdrawal by Subject|23|||
129453030|NCT01360554|465956366|FG001|Overall Study|Withdrawal by Subject|24|||
129453031|NCT01360554|465956365|FG000|Overall Study|Study terminated by sponsor|49|||
129453032|NCT01360554|465956366|FG001|Overall Study|Study terminated by sponsor|37|||
129453033|NCT01360554|465956365|FG000|Overall Study|Other, not specified|1|||
129453034|NCT01360554|465956366|FG001|Overall Study|Other, not specified|0|||
129453035|NCT01360554|465956365|FG000|Overall Study|Randomized but not treated.|3|||
129453036|NCT01360554|465956366|FG001|Overall Study|Randomized but not treated.|3|||
129939593|NCT00490139|467742458|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
129939594|NCT00490139|467742459|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
129939595|NCT00490139|467742460|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
129939596|NCT00490139|467742457|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
129939597|NCT00490139|467742458|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
129939598|NCT00490139|467742459|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
129939599|NCT00490139|467742460|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
129939600|NCT00490139|467742457|FG000|Overall Study|Other reasons as defined per protocol|98|||
129939601|NCT00490139|467742458|FG001|Overall Study|Other reasons as defined per protocol|84|||
129939602|NCT00490139|467742459|FG002|Overall Study|Other reasons as defined per protocol|82|||
129939603|NCT00490139|467742460|FG003|Overall Study|Other reasons as defined per protocol|105|||
129939604|NCT02798471|467742461|FG000|Overall Study|Adverse Event|7|||
129939605|NCT02798471|467742462|FG001|Overall Study|Adverse Event|2|||
129939606|NCT02798471|467742461|FG000|Overall Study|Physician Decision|3|||
129939607|NCT02798471|467742462|FG001|Overall Study|Physician Decision|7|||
129939608|NCT02798471|467742461|FG000|Overall Study|Death|2|||
129939609|NCT02798471|467742462|FG001|Overall Study|Death|3|||
129939610|NCT02798471|467742461|FG000|Overall Study|Lost to Follow-up|0|||
129939611|NCT02798471|467742462|FG001|Overall Study|Lost to Follow-up|1|||
129939612|NCT02798471|467742461|FG000|Overall Study|Other|5|||
129939613|NCT02798471|467742462|FG001|Overall Study|Other|3|||
129939614|NCT02798471|467742461|FG000|Overall Study|Subject withdrew consent|0|||
129939615|NCT02798471|467742462|FG001|Overall Study|Subject withdrew consent|6|||
129939616|NCT02798471|467742461|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
129939617|NCT02798471|467742462|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
129939618|NCT02798471|467742461|FG000|Overall Study|Randomized, but not treated|0|||
129939619|NCT02798471|467742462|FG001|Overall Study|Randomized, but not treated|2|||
129939620|NCT03752684|467743825|FG000|Overall Study|Lost to Follow-up|4|||
129939621|NCT01982682|467743828|FG000|Overall Study|Physician Decision|1|||
129939622|NCT02760654|467743829|FG000|Overall Study|Lost to Follow-up|3|||
129939623|NCT02760654|467743830|FG001|Overall Study|Lost to Follow-up|3|||
129939624|NCT02760654|467743829|FG000|Overall Study|Withdrawal by Subject|4|||
129939625|NCT02760654|467743830|FG001|Overall Study|Withdrawal by Subject|3|||
129939626|NCT00754325|467743831|FG000|Initial Treatment|Continuing Active Treatment|4|||
129939627|NCT00754325|467743832|FG001|Initial Treatment|Continuing Active Treatment|5|||
129939628|NCT00754325|467743831|FG000|Initial Treatment|Adverse Event|7|||
129939629|NCT00754325|467743832|FG001|Initial Treatment|Adverse Event|6|||
129939630|NCT00754325|467743831|FG000|Initial Treatment|Withdrawal by Subject|2|||
129939631|NCT00754325|467743832|FG001|Initial Treatment|Withdrawal by Subject|2|||
129939632|NCT00754325|467743831|FG000|Initial Treatment|Physician Decision|2|||
129939633|NCT00754325|467743832|FG001|Initial Treatment|Physician Decision|0|||
129939634|NCT00754325|467743831|FG000|Initial Treatment|Sponsor Request|0|||
129939635|NCT00754325|467743832|FG001|Initial Treatment|Sponsor Request|1|||
129939636|NCT00754325|467743831|FG000|Initial Treatment|Disease Progression|35|||
129939637|NCT00754325|467743832|FG001|Initial Treatment|Disease Progression|35|||
129939638|NCT03442777|467743833|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
129939639|NCT03442777|467743834|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
129939640|NCT03442777|467743835|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
129939641|NCT02941549|467743836|FG000|Overall Study|Adverse Event|1|||
129939642|NCT02941549|467743837|FG001|Overall Study|Adverse Event|0|||
129939643|NCT02941549|467743838|FG002|Overall Study|Adverse Event|0|||
129939644|NCT02941549|467743836|FG000|Overall Study|Withdrawal by Subject|2|||
129939645|NCT02941549|467743837|FG001|Overall Study|Withdrawal by Subject|1|||
129939646|NCT02941549|467743838|FG002|Overall Study|Withdrawal by Subject|2|||
129939647|NCT03451422|467743839|FG000|Overall Study|Lost to Follow-up|0|||
129939648|NCT03451422|467743840|FG001|Overall Study|Lost to Follow-up|0|||
129939649|NCT03451422|467743841|FG002|Overall Study|Lost to Follow-up|0|||
129939650|NCT03451422|467743842|FG003|Overall Study|Lost to Follow-up|0|||
129939651|NCT03451422|467743843|FG004|Overall Study|Lost to Follow-up|0|||
129939652|NCT03451422|467743844|FG005|Overall Study|Lost to Follow-up|1|||
129939653|NCT03451422|467743839|FG000|Overall Study|Decision by sponsor|1|||
129939654|NCT03451422|467743840|FG001|Overall Study|Decision by sponsor|0|||
129939655|NCT03451422|467743841|FG002|Overall Study|Decision by sponsor|1|||
129939656|NCT03451422|467743842|FG003|Overall Study|Decision by sponsor|0|||
129939657|NCT03451422|467743843|FG004|Overall Study|Decision by sponsor|0|||
129939658|NCT03451422|467743844|FG005|Overall Study|Decision by sponsor|0|||
129939659|NCT03451422|467743839|FG000|Overall Study|Withdrawal by Subject|0|||
129939660|NCT03451422|467743840|FG001|Overall Study|Withdrawal by Subject|0|||
129939661|NCT03451422|467743841|FG002|Overall Study|Withdrawal by Subject|2|||
129939662|NCT03451422|467743842|FG003|Overall Study|Withdrawal by Subject|3|||
129939663|NCT03451422|467743843|FG004|Overall Study|Withdrawal by Subject|2|||
129939664|NCT03451422|467743844|FG005|Overall Study|Withdrawal by Subject|1|||
129939665|NCT03601715|467743845|FG000|Second Intervention|Lost to Follow-up|1|||
129939666|NCT03601715|467743846|FG001|Second Intervention|Lost to Follow-up|1|||
129939667|NCT03601715|467743847|FG002|Second Intervention|Lost to Follow-up|0|||
129939668|NCT00918333|467743850|FG000|Overall Study|Drug not taken per protocol|1|||
129939669|NCT00918333|467743851|FG001|Overall Study|Drug not taken per protocol|0|||
129939670|NCT00918333|467743850|FG000|Overall Study|Inadequate amount of drugs provided|1|||
129939671|NCT00918333|467743851|FG001|Overall Study|Inadequate amount of drugs provided|4|||
129939672|NCT00918333|467743850|FG000|Overall Study|Ineligible|1|||
129939673|NCT00918333|467743851|FG001|Overall Study|Ineligible|0|||
129939674|NCT00918333|467743850|FG000|Overall Study|Withdrawal by Subject|0|||
129939675|NCT00918333|467743851|FG001|Overall Study|Withdrawal by Subject|1|||
129939676|NCT01313884|467743853|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
129939677|NCT00263757|467743854|FG000|Overall Study|Withdrawal by Subject|5|||
129939678|NCT00263757|467743855|FG001|Overall Study|Withdrawal by Subject|4|||
129939679|NCT00263757|467743854|FG000|Overall Study|Screen failure|0|||
129939680|NCT00263757|467743855|FG001|Overall Study|Screen failure|1|||
129939681|NCT00263757|467743854|FG000|Overall Study|Adverse Event|3|||
129939682|NCT00263757|467743855|FG001|Overall Study|Adverse Event|3|||
129939683|NCT02964741|467743856|FG000|Overall Study|Protocol Violation|1|||
129939684|NCT02964741|467743857|FG001|Overall Study|Protocol Violation|0|||
129939685|NCT02964741|467743858|FG002|Overall Study|Protocol Violation|0|||
129939686|NCT02964741|467743856|FG000|Overall Study|Withdrawal by Subject|0|||
129939687|NCT02964741|467743857|FG001|Overall Study|Withdrawal by Subject|1|||
129939688|NCT02964741|467743858|FG002|Overall Study|Withdrawal by Subject|0|||
129939689|NCT02964741|467743856|FG000|Overall Study|claustrophobia|1|||
129939690|NCT02964741|467743857|FG001|Overall Study|claustrophobia|0|||
129939691|NCT02964741|467743858|FG002|Overall Study|claustrophobia|0|||
129939692|NCT01212744|467743871|FG000|Overall Study|Withdrawal by Subject|1|||
129939693|NCT02167451|467743872|FG000|Overall Study|Withdrawal by Subject|1|||
129939694|NCT01218659|467743873|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
129939695|NCT01218659|467743874|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
129939696|NCT01218659|467743875|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
129939697|NCT01218659|467743873|FG000|18-Month Randomized Period|Did not receive study drug|0|||
129939698|NCT01218659|467743874|FG001|18-Month Randomized Period|Did not receive study drug|3|||
129939699|NCT01218659|467743875|FG002|18-Month Randomized Period|Did not receive study drug|0|||
129939700|NCT01218659|467743873|FG000|12-Month OLE|Withdrawal by Subject|0|||
129939701|NCT01218659|467743874|FG001|12-Month OLE|Withdrawal by Subject|0|||
129939702|NCT01218659|467743875|FG002|12-Month OLE|Withdrawal by Subject|2|||
129939703|NCT01218659|467743873|FG000|12-Month OLE|Physician Decision|0|||
129939704|NCT01218659|467743874|FG001|12-Month OLE|Physician Decision|0|||
129939705|NCT01218659|467743875|FG002|12-Month OLE|Physician Decision|1|||
129939706|NCT01218659|467743873|FG000|12-Month OLE|Lost to Follow-up|0|||
129939707|NCT01218659|467743874|FG001|12-Month OLE|Lost to Follow-up|0|||
129939708|NCT01218659|467743875|FG002|12-Month OLE|Lost to Follow-up|1|||
129939709|NCT01218659|467743873|FG000|12-Month OLE|Pregnancy|0|||
129939710|NCT01218659|467743874|FG001|12-Month OLE|Pregnancy|0|||
129939711|NCT01218659|467743875|FG002|12-Month OLE|Pregnancy|1|||
129939712|NCT01218659|467743873|FG000|12-Month OLE|Lack of Efficacy|0|||
129939713|NCT01218659|467743874|FG001|12-Month OLE|Lack of Efficacy|0|||
129939714|NCT01218659|467743875|FG002|12-Month OLE|Lack of Efficacy|1|||
129939715|NCT01218659|467743873|FG000|12-Month OLE|Declined to participate in the OLE|0|||
129939716|NCT01218659|467743874|FG001|12-Month OLE|Declined to participate in the OLE|0|||
129939717|NCT01218659|467743875|FG002|12-Month OLE|Declined to participate in the OLE|4|||
129939718|NCT04191824|467743882|FG000|Overall Study|Death|13|||
129939719|NCT04191824|467743883|FG001|Overall Study|Death|12|||
129939720|NCT04191824|467743882|FG000|Overall Study|Lost to Follow-up|456|||
129939721|NCT04191824|467743883|FG001|Overall Study|Lost to Follow-up|435|||
129939722|NCT04191824|467743882|FG000|Overall Study|Physician Decision|2|||
129939723|NCT04191824|467743883|FG001|Overall Study|Physician Decision|1|||
129939724|NCT04191824|467743882|FG000|Overall Study|Protocol Violation|0|||
129939725|NCT04191824|467743883|FG001|Overall Study|Protocol Violation|2|||
129939726|NCT04191824|467743882|FG000|Overall Study|Withdrawal by Subject|16|||
129939727|NCT04191824|467743883|FG001|Overall Study|Withdrawal by Subject|18|||
129939728|NCT04191824|467743882|FG000|Overall Study|Early site closure|24|||
129939729|NCT04191824|467743883|FG001|Overall Study|Early site closure|22|||
129939730|NCT01499849|467743889|FG000|Overall Study|Adverse Event|28|||
129939731|NCT01499849|467743890|FG001|Overall Study|Adverse Event|32|||
129939732|NCT01499849|467743889|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
129453037|NCT00187096|465956368|FG000|Overall Study|unacceptable toxicity|0|||
129453038|NCT00187096|465956369|FG001|Overall Study|unacceptable toxicity|0|||
129939733|NCT01499849|467743890|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
129939734|NCT01499849|467743889|FG000|Overall Study|Withdrawal by Subject|43|||
129939735|NCT01499849|467743890|FG001|Overall Study|Withdrawal by Subject|43|||
129939736|NCT01499849|467743889|FG000|Overall Study|Death|5|||
129939737|NCT01499849|467743890|FG001|Overall Study|Death|7|||
129939738|NCT01499849|467743889|FG000|Overall Study|Disease Progression|11|||
129939739|NCT01499849|467743890|FG001|Overall Study|Disease Progression|10|||
129939740|NCT01499849|467743889|FG000|Overall Study|Protocol Violation|11|||
129939741|NCT01499849|467743890|FG001|Overall Study|Protocol Violation|11|||
129939742|NCT01499849|467743889|FG000|Overall Study|Physician Decision|20|||
129939743|NCT01499849|467743890|FG001|Overall Study|Physician Decision|19|||
129939744|NCT01499849|467743889|FG000|Overall Study|Lack of Efficacy|3|||
129939745|NCT01499849|467743890|FG001|Overall Study|Lack of Efficacy|4|||
129939746|NCT01499849|467743889|FG000|Overall Study|Lost to Follow-up|6|||
129939747|NCT01499849|467743890|FG001|Overall Study|Lost to Follow-up|3|||
129939748|NCT01499849|467743889|FG000|Overall Study|Other Reasons|27|||
129939749|NCT01499849|467743890|FG001|Overall Study|Other Reasons|30|||
129939750|NCT01437319|467743891|FG000|Phase I|Lost to Follow-up|2|||
129939751|NCT01437319|467743892|FG001|Phase I|Lost to Follow-up|0|||
129939752|NCT01437319|467743893|FG002|Phase I|Lost to Follow-up|0|||
129939753|NCT01437319|467743891|FG000|Phase I|Protocol Violation|1|||
129939754|NCT01437319|467743892|FG001|Phase I|Protocol Violation|0|||
129939755|NCT01437319|467743893|FG002|Phase I|Protocol Violation|0|||
129939756|NCT01437319|467743891|FG000|Phase I|Study related symptoms/complaints|27|||
129939757|NCT01437319|467743892|FG001|Phase I|Study related symptoms/complaints|0|||
129939758|NCT01437319|467743893|FG002|Phase I|Study related symptoms/complaints|0|||
129939759|NCT01437319|467743891|FG000|Phase I|Withdrawal by Subject|25|||
129939760|NCT01437319|467743892|FG001|Phase I|Withdrawal by Subject|0|||
129939761|NCT01437319|467743893|FG002|Phase I|Withdrawal by Subject|0|||
129939762|NCT01437319|467743891|FG000|Phase II|Withdrawal by Subject|0|||
129939763|NCT01437319|467743892|FG001|Phase II|Withdrawal by Subject|8|||
129939764|NCT01437319|467743893|FG002|Phase II|Withdrawal by Subject|16|||
129939765|NCT01437319|467743891|FG000|Phase II|Lost to Follow-up|0|||
129939766|NCT01437319|467743892|FG001|Phase II|Lost to Follow-up|7|||
129939767|NCT01437319|467743893|FG002|Phase II|Lost to Follow-up|2|||
129939768|NCT01437319|467743891|FG000|Phase II|Study related symptoms/complaints|0|||
129939769|NCT01437319|467743892|FG001|Phase II|Study related symptoms/complaints|28|||
129939770|NCT01437319|467743893|FG002|Phase II|Study related symptoms/complaints|19|||
129939771|NCT01437319|467743891|FG000|Phase II|Protocol Violation|0|||
129939772|NCT01437319|467743892|FG001|Phase II|Protocol Violation|1|||
129939773|NCT01437319|467743893|FG002|Phase II|Protocol Violation|0|||
129939774|NCT00174252|467743894|FG000|Overall Study|Protocol Violation|2|||
129939775|NCT03611556|467743897|FG000|Overall Study|Death|7|||
129939776|NCT03611556|467743898|FG001|Overall Study|Death|7|||
129939777|NCT03611556|467743899|FG002|Overall Study|Death|3|||
129939778|NCT03611556|467743900|FG003|Overall Study|Death|8|||
129939779|NCT03611556|467743901|FG004|Overall Study|Death|47|||
129939780|NCT03611556|467743902|FG005|Overall Study|Death|32|||
129939781|NCT03611556|467743903|FG006|Overall Study|Death|53|||
129939782|NCT03611556|467743897|FG000|Overall Study|Withdrawal by Subject|0|||
129939783|NCT03611556|467743898|FG001|Overall Study|Withdrawal by Subject|0|||
129939784|NCT03611556|467743899|FG002|Overall Study|Withdrawal by Subject|0|||
129939785|NCT03611556|467743900|FG003|Overall Study|Withdrawal by Subject|0|||
129939786|NCT03611556|467743901|FG004|Overall Study|Withdrawal by Subject|4|||
129939787|NCT03611556|467743902|FG005|Overall Study|Withdrawal by Subject|2|||
129939788|NCT03611556|467743903|FG006|Overall Study|Withdrawal by Subject|4|||
129939789|NCT03611556|467743897|FG000|Overall Study|Sponsor decision|0|||
129939790|NCT03611556|467743898|FG001|Overall Study|Sponsor decision|0|||
129939791|NCT03611556|467743899|FG002|Overall Study|Sponsor decision|0|||
129939792|NCT03611556|467743900|FG003|Overall Study|Sponsor decision|0|||
129939793|NCT03611556|467743901|FG004|Overall Study|Sponsor decision|9|||
129939794|NCT03611556|467743902|FG005|Overall Study|Sponsor decision|4|||
129939795|NCT03611556|467743903|FG006|Overall Study|Sponsor decision|12|||
129939796|NCT03611556|467743897|FG000|Overall Study|Reasons|0|||
129939797|NCT03611556|467743898|FG001|Overall Study|Reasons|0|||
129453039|NCT00187096|465956370|FG002|Overall Study|unacceptable toxicity|1|||
129939798|NCT03611556|467743899|FG002|Overall Study|Reasons|0|||
129939799|NCT03611556|467743900|FG003|Overall Study|Reasons|0|||
129939800|NCT03611556|467743901|FG004|Overall Study|Reasons|2|||
129939801|NCT03611556|467743902|FG005|Overall Study|Reasons|0|||
129939802|NCT03611556|467743903|FG006|Overall Study|Reasons|1|||
129939803|NCT02397096|467743904|FG000|Day 1 to Week 24|Adverse Event|7|||
129939804|NCT02397096|467743905|FG001|Day 1 to Week 24|Adverse Event|1|||
129939805|NCT02397096|467743904|FG000|Day 1 to Week 24|Death|1|||
129939806|NCT02397096|467743905|FG001|Day 1 to Week 24|Death|0|||
129939807|NCT02397096|467743904|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
129939808|NCT02397096|467743905|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
129939809|NCT02397096|467743904|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
129939810|NCT02397096|467743905|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
129453040|NCT00253643|465956375|FG000|Overall Study|Withdrawal by Subject|0|||
129453041|NCT00253643|465956376|FG001|Overall Study|Withdrawal by Subject|0|||
129453042|NCT00253643|465956377|FG002|Overall Study|Withdrawal by Subject|1|||
129453043|NCT00253643|465956378|FG003|Overall Study|Withdrawal by Subject|1|||
129453044|NCT00253643|465956375|FG000|Overall Study|Non-Compliance|0|||
129453045|NCT00253643|465956376|FG001|Overall Study|Non-Compliance|0|||
129453046|NCT00253643|465956377|FG002|Overall Study|Non-Compliance|0|||
129453047|NCT00253643|465956378|FG003|Overall Study|Non-Compliance|2|||
129453048|NCT00383084|465956379|FG000|Overall Study|Withdrawal by Subject|12|||
129453049|NCT00383084|465956380|FG001|Overall Study|Withdrawal by Subject|10|||
129453050|NCT02113436|465956381|FG000|Period 1: 8 Weeks|Adverse Event|1|||
129453051|NCT02113436|465956382|FG001|Period 1: 8 Weeks|Adverse Event|0|||
129453052|NCT02113436|465956383|FG002|Period 1: 8 Weeks|Adverse Event|0|||
129453053|NCT02113436|465956384|FG003|Period 1: 8 Weeks|Adverse Event|0|||
129453054|NCT02113436|465956381|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
129453055|NCT02113436|465956382|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
129453056|NCT02113436|465956383|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
129453057|NCT02113436|465956384|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
129453058|NCT02113436|465956381|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
129453059|NCT02113436|465956382|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
129453060|NCT02113436|465956383|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
129453061|NCT02113436|465956384|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
129453062|NCT02113436|465956381|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
129453063|NCT02113436|465956382|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
129453064|NCT02113436|465956383|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
129453065|NCT02113436|465956384|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
129453066|NCT02113436|465956381|FG000|Period 2: 16 Weeks|Adverse Event|0|||
129453067|NCT02113436|465956382|FG001|Period 2: 16 Weeks|Adverse Event|0|||
129453068|NCT02113436|465956383|FG002|Period 2: 16 Weeks|Adverse Event|4|||
129939811|NCT02397096|467743904|FG000|Day 1 to Week 24|Physician Decision|2|||
129939812|NCT02397096|467743905|FG001|Day 1 to Week 24|Physician Decision|3|||
129939813|NCT02397096|467743904|FG000|Day 1 to Week 24|Protocol Violation|1|||
129939814|NCT02397096|467743905|FG001|Day 1 to Week 24|Protocol Violation|4|||
129939815|NCT02397096|467743904|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
129939816|NCT02397096|467743905|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
129939817|NCT02397096|467743904|FG000|Day 1 to Week 24|Randomized, not treated|3|||
129939818|NCT02397096|467743905|FG001|Day 1 to Week 24|Randomized, not treated|0|||
129939819|NCT02397096|467743904|FG000|Week 24 to Week 48|Adverse Event|6|||
129939820|NCT02397096|467743905|FG001|Week 24 to Week 48|Adverse Event|2|||
129939821|NCT02397096|467743904|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
129939822|NCT02397096|467743905|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
129939823|NCT02397096|467743904|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
129939824|NCT02397096|467743905|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
129939825|NCT02397096|467743904|FG000|Week 24 to Week 48|Physician Decision|2|||
129939826|NCT02397096|467743905|FG001|Week 24 to Week 48|Physician Decision|1|||
129939827|NCT02397096|467743904|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
129939828|NCT02397096|467743905|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
129939829|NCT02397096|467743904|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
129939830|NCT02397096|467743905|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
129939831|NCT02397096|467743904|FG000|Study Extension 1|Adverse Event|7|||
129453069|NCT02113436|465956384|FG003|Period 2: 16 Weeks|Adverse Event|5|||
129453070|NCT02113436|465956381|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
129453071|NCT02113436|465956382|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
129453072|NCT02113436|465956383|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
129939832|NCT02397096|467743905|FG001|Study Extension 1|Adverse Event|5|||
129939833|NCT02397096|467743904|FG000|Study Extension 1|Death|1|||
129939834|NCT02397096|467743905|FG001|Study Extension 1|Death|0|||
129939835|NCT02397096|467743904|FG000|Study Extension 1|Lack of Efficacy|2|||
129939836|NCT02397096|467743905|FG001|Study Extension 1|Lack of Efficacy|5|||
129939837|NCT02397096|467743904|FG000|Study Extension 1|Lost to Follow-up|2|||
129939838|NCT02397096|467743905|FG001|Study Extension 1|Lost to Follow-up|3|||
129939839|NCT02397096|467743904|FG000|Study Extension 1|Non-compliance with study drug|3|||
129939840|NCT02397096|467743905|FG001|Study Extension 1|Non-compliance with study drug|0|||
129939841|NCT02397096|467743904|FG000|Study Extension 1|Physician Decision|4|||
129939842|NCT02397096|467743905|FG001|Study Extension 1|Physician Decision|2|||
129939843|NCT02397096|467743904|FG000|Study Extension 1|Pregnancy|1|||
129939844|NCT02397096|467743905|FG001|Study Extension 1|Pregnancy|0|||
129939845|NCT02397096|467743904|FG000|Study Extension 1|Protocol Violation|0|||
129939846|NCT02397096|467743905|FG001|Study Extension 1|Protocol Violation|1|||
129939847|NCT02397096|467743904|FG000|Study Extension 1|Withdrawal by Subject|21|||
129939848|NCT02397096|467743905|FG001|Study Extension 1|Withdrawal by Subject|7|||
129939849|NCT02397096|467743904|FG000|Study Extension 2|Adverse Event|3|||
129939850|NCT02397096|467743905|FG001|Study Extension 2|Adverse Event|3|||
129939851|NCT02397096|467743904|FG000|Study Extension 2|Availability of study medication locally|152|||
129939852|NCT02397096|467743905|FG001|Study Extension 2|Availability of study medication locally|64|||
129939853|NCT02397096|467743904|FG000|Study Extension 2|Death|2|||
129939854|NCT02397096|467743905|FG001|Study Extension 2|Death|0|||
129939855|NCT02397096|467743904|FG000|Study Extension 2|Lack of Efficacy|1|||
129939856|NCT02397096|467743905|FG001|Study Extension 2|Lack of Efficacy|0|||
129939857|NCT02397096|467743904|FG000|Study Extension 2|Lost to Follow-up|2|||
129939858|NCT02397096|467743905|FG001|Study Extension 2|Lost to Follow-up|1|||
129939859|NCT02397096|467743904|FG000|Study Extension 2|Non-compliance with study drug|1|||
129939860|NCT02397096|467743905|FG001|Study Extension 2|Non-compliance with study drug|0|||
129939861|NCT02397096|467743904|FG000|Study Extension 2|Physician Decision|2|||
129939862|NCT02397096|467743905|FG001|Study Extension 2|Physician Decision|5|||
129939863|NCT02397096|467743904|FG000|Study Extension 2|Pregnancy|1|||
129939864|NCT02397096|467743905|FG001|Study Extension 2|Pregnancy|0|||
129939865|NCT02397096|467743904|FG000|Study Extension 2|Withdrawal by Subject|10|||
129939866|NCT02397096|467743905|FG001|Study Extension 2|Withdrawal by Subject|3|||
129939867|NCT02397096|467743904|FG000|Study Extension 3|Adverse Event|1|||
129939868|NCT02397096|467743905|FG001|Study Extension 3|Adverse Event|0|||
129939869|NCT02397096|467743904|FG000|Study Extension 3|Availability of study medication locally|11|||
129939870|NCT02397096|467743905|FG001|Study Extension 3|Availability of study medication locally|3|||
129939871|NCT02397096|467743904|FG000|Study Extension 3|Lost to Follow-up|1|||
129939872|NCT02397096|467743905|FG001|Study Extension 3|Lost to Follow-up|0|||
129939873|NCT02397096|467743904|FG000|Study Extension 3|Withdrawal by Subject|2|||
129939874|NCT02397096|467743905|FG001|Study Extension 3|Withdrawal by Subject|1|||
129939875|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
129939876|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
129939877|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
129939878|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
129939879|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
129939880|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
129939881|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
129939882|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
129939883|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
129939884|NCT00918203|467743907|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
129939885|NCT00918203|467743908|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
129939886|NCT00918203|467743909|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
129939887|NCT03488719|467743914|FG000|Overall Study|Adverse Event|0|||
129939888|NCT03488719|467743915|FG001|Overall Study|Adverse Event|4|||
129939889|NCT03488719|467743916|FG002|Overall Study|Adverse Event|2|||
129939890|NCT03488719|467743914|FG000|Overall Study|Other|0|||
129939891|NCT03488719|467743915|FG001|Overall Study|Other|0|||
129939892|NCT03488719|467743916|FG002|Overall Study|Other|5|||
129939893|NCT03477175|467743919|FG000|Overall Study|Unable to travel due to COVID-19|0|||
129939894|NCT03477175|467743920|FG001|Overall Study|Unable to travel due to COVID-19|1|||
129939895|NCT03477175|467743919|FG000|Overall Study|Physician Decision|1|||
129939896|NCT03477175|467743920|FG001|Overall Study|Physician Decision|0|||
129939897|NCT03477175|467743919|FG000|Overall Study|Transitioned to commercial drug|6|||
129939898|NCT03477175|467743920|FG001|Overall Study|Transitioned to commercial drug|6|||
129939899|NCT03477175|467743919|FG000|Overall Study|Lost to Follow-up|1|||
129939900|NCT03477175|467743920|FG001|Overall Study|Lost to Follow-up|1|||
129939901|NCT03477175|467743919|FG000|Overall Study|Withdrawal by Subject|3|||
129939902|NCT03477175|467743920|FG001|Overall Study|Withdrawal by Subject|1|||
129939903|NCT03477175|467743919|FG000|Overall Study|Adverse Event|1|||
129939904|NCT03477175|467743920|FG001|Overall Study|Adverse Event|5|||
129939905|NCT03477175|467743919|FG000|Overall Study|Disease Progression|7|||
129939906|NCT03477175|467743920|FG001|Overall Study|Disease Progression|7|||
129939907|NCT01675492|467743921|FG000|Overall Study|study completed early - product approval|42|||
129939908|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939909|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939910|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939911|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
129939912|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939913|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939914|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939915|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939916|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939917|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
129939918|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
129939919|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939920|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939921|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
129939922|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939923|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939924|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939925|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939926|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939927|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
129939928|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Death|1|||
129939929|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Death|2|||
129939930|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Death|3|||
129939931|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Death|5|||
129939932|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Death|4|||
129939933|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Death|0|||
129939934|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Death|0|||
129939935|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Death|0|||
129939936|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Death|0|||
129939937|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Death|0|||
129939938|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939939|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
129939940|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939941|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939942|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
129939943|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939944|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939945|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939946|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939947|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
129939948|NCT02401815|467743922|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
129939949|NCT02401815|467743923|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939950|NCT02401815|467743924|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939951|NCT02401815|467743925|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939952|NCT02401815|467743926|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
129939953|NCT02401815|467743927|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939954|NCT02401815|467743928|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939955|NCT02401815|467743929|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939956|NCT02401815|467743930|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939957|NCT02401815|467743931|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
129939958|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939959|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939960|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939961|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939962|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939963|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
129939964|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939965|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939966|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939967|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
129939968|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939969|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939970|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939971|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939972|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939973|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939974|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
129939975|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939976|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939977|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129939978|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939979|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939980|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939981|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939982|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939983|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
129939984|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
129939985|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939986|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939987|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
129939988|NCT02401815|467743922|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939989|NCT02401815|467743923|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939990|NCT02401815|467743924|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939991|NCT02401815|467743925|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939992|NCT02401815|467743926|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939993|NCT02401815|467743927|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
129939994|NCT02401815|467743928|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939995|NCT02401815|467743929|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939996|NCT02401815|467743930|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939997|NCT02401815|467743931|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
129939998|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129939999|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940000|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940001|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940002|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940003|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940004|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
129940005|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
129940006|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
129940007|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
129940008|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940009|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940010|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940011|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940012|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940013|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940014|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940015|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
129940016|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
129940017|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
129940018|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940019|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940020|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940021|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940022|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940023|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940024|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940025|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940026|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
129940027|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
129940028|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940029|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940030|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940031|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940032|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940033|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940034|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940035|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129453073|NCT02113436|465956384|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
129453074|NCT02113436|465956381|FG000|Period 2: 16 Weeks|Physician Decision|0|||
129453075|NCT02113436|465956382|FG001|Period 2: 16 Weeks|Physician Decision|0|||
129453076|NCT02113436|465956383|FG002|Period 2: 16 Weeks|Physician Decision|2|||
129453077|NCT02113436|465956384|FG003|Period 2: 16 Weeks|Physician Decision|0|||
129453078|NCT02113436|465956381|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
129453079|NCT02113436|465956382|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
129453080|NCT02113436|465956383|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
129453081|NCT02113436|465956384|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
129453082|NCT02159729|465956385|FG000|Overall Study|Adverse Event|0|||
129453083|NCT02159729|465956386|FG001|Overall Study|Adverse Event|1|||
129453084|NCT02159729|465956385|FG000|Overall Study|Subject's Request|13|||
129453085|NCT02159729|465956386|FG001|Overall Study|Subject's Request|10|||
129453086|NCT02159729|465956385|FG000|Overall Study|Lost to Follow-up|24|||
129453087|NCT02159729|465956386|FG001|Overall Study|Lost to Follow-up|9|||
129453088|NCT02159729|465956385|FG000|Overall Study|Non compliance|2|||
129453089|NCT02159729|465956386|FG001|Overall Study|Non compliance|0|||
129453090|NCT02159729|465956385|FG000|Overall Study|Other Unspecified|3|||
129453091|NCT02159729|465956386|FG001|Overall Study|Other Unspecified|1|||
129453092|NCT01263483|465956387|FG000|Overall Study|Adverse Event|4|||
129453093|NCT01263483|465956388|FG001|Overall Study|Adverse Event|0|||
129453094|NCT01263483|465956389|FG002|Overall Study|Adverse Event|3|||
129453095|NCT01263483|465956387|FG000|Overall Study|Withdrawal by Subject|1|||
129940036|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
129940037|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
129940038|NCT02401815|467743922|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940039|NCT02401815|467743923|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940040|NCT02401815|467743924|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940041|NCT02401815|467743925|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940042|NCT02401815|467743926|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940043|NCT02401815|467743927|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940044|NCT02401815|467743928|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940045|NCT02401815|467743929|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
129940046|NCT02401815|467743930|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
129940047|NCT02401815|467743931|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
129940048|NCT02751528|467743932|FG000|Overall Study|Withdrawal by Subject|1|||
129940049|NCT02751528|467743932|FG000|Overall Study|Adverse Event|1|||
129940050|NCT04218357|467743933|FG000|1st Allocation|Withdrawal by Subject|1|||
129940051|NCT04218357|467743934|FG001|1st Allocation|Withdrawal by Subject|0|||
129940052|NCT01958021|467743935|FG000|Treatment|Progressive disease|206|||
129940053|NCT01958021|467743936|FG001|Treatment|Progressive disease|265|||
129940054|NCT01958021|467743935|FG000|Treatment|Adverse Event|38|||
129940055|NCT01958021|467743936|FG001|Treatment|Adverse Event|10|||
129940056|NCT01958021|467743935|FG000|Treatment|Subject/guardian decision|29|||
129940057|NCT01958021|467743936|FG001|Treatment|Subject/guardian decision|25|||
129940058|NCT01958021|467743935|FG000|Treatment|Physician Decision|28|||
129940059|NCT01958021|467743936|FG001|Treatment|Physician Decision|21|||
129940060|NCT01958021|467743935|FG000|Treatment|Death|6|||
129940061|NCT01958021|467743936|FG001|Treatment|Death|1|||
129940062|NCT01958021|467743935|FG000|Treatment|Protocol deviation|3|||
129940063|NCT01958021|467743936|FG001|Treatment|Protocol deviation|1|||
129940064|NCT01958021|467743935|FG000|Treatment|Sponsor decision|24|||
129940065|NCT01958021|467743936|FG001|Treatment|Sponsor decision|11|||
129940066|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129940067|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129940068|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Death|1|||
129940069|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Death|0|||
129940070|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
129940071|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129940072|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129940073|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129940074|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
129940075|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
129940076|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
129940077|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
129940078|NCT01958021|467743935|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
129940079|NCT01958021|467743936|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
129453096|NCT01263483|465956388|FG001|Overall Study|Withdrawal by Subject|0|||
129453097|NCT01263483|465956389|FG002|Overall Study|Withdrawal by Subject|0|||
129453098|NCT01263483|465956387|FG000|Overall Study|Lack of Efficacy|2|||
129453099|NCT01263483|465956388|FG001|Overall Study|Lack of Efficacy|0|||
129453100|NCT01263483|465956389|FG002|Overall Study|Lack of Efficacy|0|||
129940080|NCT02488408|467743938|FG000|Part A|Adverse Event|2|||
129940081|NCT02488408|467743939|FG001|Part A|Adverse Event|0|||
129940082|NCT02488408|467743940|FG002|Part A|Adverse Event|0|||
129940083|NCT02488408|467743941|FG003|Part A|Adverse Event|0|||
129940084|NCT02488408|467743942|FG004|Part A|Adverse Event|0|||
129940085|NCT02488408|467743943|FG005|Part A|Adverse Event|0|||
129940086|NCT02488408|467743944|FG006|Part A|Adverse Event|0|||
129940087|NCT02488408|467743945|FG007|Part A|Adverse Event|0|||
129940088|NCT02488408|467743946|FG008|Part A|Adverse Event|0|||
129940089|NCT02488408|467743947|FG009|Part A|Adverse Event|0|||
129940090|NCT02488408|467743938|FG000|Part A|Death|1|||
129940091|NCT02488408|467743939|FG001|Part A|Death|5|||
129940092|NCT02488408|467743940|FG002|Part A|Death|0|||
129940093|NCT02488408|467743941|FG003|Part A|Death|0|||
129940094|NCT02488408|467743942|FG004|Part A|Death|3|||
129940095|NCT02488408|467743943|FG005|Part A|Death|0|||
129940096|NCT02488408|467743944|FG006|Part A|Death|0|||
129940097|NCT02488408|467743945|FG007|Part A|Death|0|||
129940098|NCT02488408|467743946|FG008|Part A|Death|0|||
129940099|NCT02488408|467743947|FG009|Part A|Death|0|||
129940100|NCT02488408|467743938|FG000|Part A|Disease Progression|2|||
129940101|NCT02488408|467743939|FG001|Part A|Disease Progression|8|||
129940102|NCT02488408|467743940|FG002|Part A|Disease Progression|2|||
129940103|NCT02488408|467743941|FG003|Part A|Disease Progression|3|||
129940104|NCT02488408|467743942|FG004|Part A|Disease Progression|4|||
129940105|NCT02488408|467743943|FG005|Part A|Disease Progression|0|||
129940106|NCT02488408|467743944|FG006|Part A|Disease Progression|0|||
129940107|NCT02488408|467743945|FG007|Part A|Disease Progression|0|||
129940108|NCT02488408|467743946|FG008|Part A|Disease Progression|0|||
129940109|NCT02488408|467743947|FG009|Part A|Disease Progression|0|||
129940110|NCT02488408|467743938|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
129940111|NCT02488408|467743939|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
129940112|NCT02488408|467743940|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
129940113|NCT02488408|467743941|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
129940114|NCT02488408|467743942|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
129940115|NCT02488408|467743943|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
129940116|NCT02488408|467743944|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
129940117|NCT02488408|467743945|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
129940118|NCT02488408|467743946|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
129940119|NCT02488408|467743947|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
129940120|NCT02488408|467743938|FG000|Part A|Investigator Decision|0|||
129940121|NCT02488408|467743939|FG001|Part A|Investigator Decision|1|||
129940122|NCT02488408|467743940|FG002|Part A|Investigator Decision|1|||
129940123|NCT02488408|467743941|FG003|Part A|Investigator Decision|0|||
129940124|NCT02488408|467743942|FG004|Part A|Investigator Decision|0|||
129940125|NCT02488408|467743943|FG005|Part A|Investigator Decision|0|||
129940126|NCT02488408|467743944|FG006|Part A|Investigator Decision|0|||
129940127|NCT02488408|467743945|FG007|Part A|Investigator Decision|0|||
129940128|NCT02488408|467743946|FG008|Part A|Investigator Decision|0|||
129940129|NCT02488408|467743947|FG009|Part A|Investigator Decision|0|||
129940130|NCT02488408|467743938|FG000|Part A|Withdrawal by Subject|0|||
129940131|NCT02488408|467743939|FG001|Part A|Withdrawal by Subject|0|||
129940132|NCT02488408|467743940|FG002|Part A|Withdrawal by Subject|2|||
129940133|NCT02488408|467743941|FG003|Part A|Withdrawal by Subject|0|||
129940134|NCT02488408|467743942|FG004|Part A|Withdrawal by Subject|0|||
129940135|NCT02488408|467743943|FG005|Part A|Withdrawal by Subject|0|||
129940136|NCT02488408|467743944|FG006|Part A|Withdrawal by Subject|0|||
129940137|NCT02488408|467743945|FG007|Part A|Withdrawal by Subject|0|||
129940138|NCT02488408|467743946|FG008|Part A|Withdrawal by Subject|0|||
129940139|NCT02488408|467743947|FG009|Part A|Withdrawal by Subject|0|||
129940140|NCT02488408|467743938|FG000|Part A|Other|1|||
129940141|NCT02488408|467743939|FG001|Part A|Other|0|||
129940142|NCT02488408|467743940|FG002|Part A|Other|0|||
129940143|NCT02488408|467743941|FG003|Part A|Other|0|||
129940144|NCT02488408|467743942|FG004|Part A|Other|0|||
129940145|NCT02488408|467743943|FG005|Part A|Other|0|||
129940146|NCT02488408|467743944|FG006|Part A|Other|0|||
129940147|NCT02488408|467743945|FG007|Part A|Other|0|||
129940148|NCT02488408|467743946|FG008|Part A|Other|0|||
129940149|NCT02488408|467743947|FG009|Part A|Other|0|||
129940150|NCT02488408|467743938|FG000|Part B|Adverse Event|0|||
129940151|NCT02488408|467743939|FG001|Part B|Adverse Event|0|||
129940152|NCT02488408|467743940|FG002|Part B|Adverse Event|0|||
129940153|NCT02488408|467743941|FG003|Part B|Adverse Event|0|||
129940154|NCT02488408|467743942|FG004|Part B|Adverse Event|0|||
129940155|NCT02488408|467743943|FG005|Part B|Adverse Event|2|||
129940156|NCT02488408|467743944|FG006|Part B|Adverse Event|2|||
129940157|NCT02488408|467743945|FG007|Part B|Adverse Event|7|||
129940158|NCT02488408|467743946|FG008|Part B|Adverse Event|2|||
129940159|NCT02488408|467743947|FG009|Part B|Adverse Event|2|||
129940160|NCT02488408|467743938|FG000|Part B|Death|0|||
129940161|NCT02488408|467743939|FG001|Part B|Death|0|||
129940162|NCT02488408|467743940|FG002|Part B|Death|0|||
129940163|NCT02488408|467743941|FG003|Part B|Death|0|||
129940164|NCT02488408|467743942|FG004|Part B|Death|0|||
129940165|NCT02488408|467743943|FG005|Part B|Death|3|||
129940166|NCT02488408|467743944|FG006|Part B|Death|1|||
129940167|NCT02488408|467743945|FG007|Part B|Death|2|||
129940168|NCT02488408|467743946|FG008|Part B|Death|2|||
129940169|NCT02488408|467743947|FG009|Part B|Death|2|||
129940170|NCT02488408|467743938|FG000|Part B|Death due to Disease Progression|0|||
129940171|NCT02488408|467743939|FG001|Part B|Death due to Disease Progression|0|||
129940172|NCT02488408|467743940|FG002|Part B|Death due to Disease Progression|0|||
129940173|NCT02488408|467743941|FG003|Part B|Death due to Disease Progression|0|||
129940174|NCT02488408|467743942|FG004|Part B|Death due to Disease Progression|0|||
129940175|NCT02488408|467743943|FG005|Part B|Death due to Disease Progression|2|||
129940176|NCT02488408|467743944|FG006|Part B|Death due to Disease Progression|2|||
129940177|NCT02488408|467743945|FG007|Part B|Death due to Disease Progression|1|||
129940178|NCT02488408|467743946|FG008|Part B|Death due to Disease Progression|1|||
129940179|NCT02488408|467743947|FG009|Part B|Death due to Disease Progression|1|||
129940180|NCT02488408|467743938|FG000|Part B|Disease Progression|0|||
129940181|NCT02488408|467743939|FG001|Part B|Disease Progression|0|||
129940182|NCT02488408|467743940|FG002|Part B|Disease Progression|0|||
129940183|NCT02488408|467743941|FG003|Part B|Disease Progression|0|||
129940184|NCT02488408|467743942|FG004|Part B|Disease Progression|0|||
129940185|NCT02488408|467743943|FG005|Part B|Disease Progression|6|||
129940186|NCT02488408|467743944|FG006|Part B|Disease Progression|9|||
129940187|NCT02488408|467743945|FG007|Part B|Disease Progression|7|||
129940188|NCT02488408|467743946|FG008|Part B|Disease Progression|9|||
129940189|NCT02488408|467743947|FG009|Part B|Disease Progression|11|||
129940190|NCT02488408|467743938|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
129940191|NCT02488408|467743939|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
129940192|NCT02488408|467743940|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
129940193|NCT02488408|467743941|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
129940194|NCT02488408|467743942|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
129940195|NCT02488408|467743943|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
129940196|NCT02488408|467743944|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
129940197|NCT02488408|467743945|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
129940198|NCT02488408|467743946|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
129940199|NCT02488408|467743947|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
129940200|NCT02488408|467743938|FG000|Part B|Investigator Decision|0|||
129940201|NCT02488408|467743939|FG001|Part B|Investigator Decision|0|||
129940202|NCT02488408|467743940|FG002|Part B|Investigator Decision|0|||
129940203|NCT02488408|467743941|FG003|Part B|Investigator Decision|0|||
129940204|NCT02488408|467743942|FG004|Part B|Investigator Decision|0|||
129940205|NCT02488408|467743943|FG005|Part B|Investigator Decision|0|||
129940206|NCT02488408|467743944|FG006|Part B|Investigator Decision|1|||
129940207|NCT02488408|467743945|FG007|Part B|Investigator Decision|0|||
129940208|NCT02488408|467743946|FG008|Part B|Investigator Decision|2|||
129940209|NCT02488408|467743947|FG009|Part B|Investigator Decision|1|||
129940210|NCT05886777|467743950|FG000|Overall Study|Lost to Follow-up|1|||
129940211|NCT05886777|467743951|FG001|Overall Study|Lost to Follow-up|0|||
129940212|NCT05886777|467743952|FG002|Overall Study|Lost to Follow-up|2|||
129940213|NCT05886777|467743953|FG003|Overall Study|Lost to Follow-up|1|||
129940214|NCT05886777|467743954|FG004|Overall Study|Lost to Follow-up|0|||
129940215|NCT05886777|467743955|FG005|Overall Study|Lost to Follow-up|2|||
129940216|NCT05886777|467743956|FG006|Overall Study|Lost to Follow-up|0|||
129940217|NCT05886777|467743950|FG000|Overall Study|Other|0|||
129940218|NCT05886777|467743951|FG001|Overall Study|Other|2|||
129940219|NCT05886777|467743952|FG002|Overall Study|Other|1|||
129940220|NCT05886777|467743953|FG003|Overall Study|Other|0|||
129940221|NCT05886777|467743954|FG004|Overall Study|Other|0|||
129940222|NCT05886777|467743955|FG005|Overall Study|Other|0|||
129940223|NCT05886777|467743956|FG006|Overall Study|Other|0|||
129940224|NCT05886777|467743950|FG000|Overall Study|Withdrawal by Subject|1|||
129940225|NCT05886777|467743951|FG001|Overall Study|Withdrawal by Subject|0|||
129940226|NCT05886777|467743952|FG002|Overall Study|Withdrawal by Subject|1|||
129940227|NCT05886777|467743953|FG003|Overall Study|Withdrawal by Subject|4|||
129940228|NCT05886777|467743954|FG004|Overall Study|Withdrawal by Subject|3|||
129940229|NCT05886777|467743955|FG005|Overall Study|Withdrawal by Subject|1|||
129940230|NCT05886777|467743956|FG006|Overall Study|Withdrawal by Subject|1|||
129940231|NCT05886777|467743950|FG000|Overall Study|Protocol Violation|0|||
129940232|NCT05886777|467743951|FG001|Overall Study|Protocol Violation|0|||
129940233|NCT05886777|467743952|FG002|Overall Study|Protocol Violation|1|||
129940234|NCT05886777|467743953|FG003|Overall Study|Protocol Violation|0|||
129940235|NCT05886777|467743954|FG004|Overall Study|Protocol Violation|0|||
129453101|NCT01263483|465956387|FG000|Overall Study|Protocol Violation|0|||
129940236|NCT05886777|467743955|FG005|Overall Study|Protocol Violation|0|||
129940237|NCT05886777|467743956|FG006|Overall Study|Protocol Violation|0|||
129940238|NCT05886777|467743950|FG000|Overall Study|No longer met eligibility criteria|0|||
129940239|NCT05886777|467743951|FG001|Overall Study|No longer met eligibility criteria|1|||
129940240|NCT05886777|467743952|FG002|Overall Study|No longer met eligibility criteria|0|||
129940241|NCT05886777|467743953|FG003|Overall Study|No longer met eligibility criteria|0|||
129940242|NCT05886777|467743954|FG004|Overall Study|No longer met eligibility criteria|0|||
129940243|NCT05886777|467743955|FG005|Overall Study|No longer met eligibility criteria|0|||
129940244|NCT05886777|467743956|FG006|Overall Study|No longer met eligibility criteria|0|||
129940245|NCT03664804|467743958|FG000|Overall Study|Withdrawal by Subject|7|||
129940246|NCT04701203|467743959|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
129940247|NCT04701203|467743960|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
129940248|NCT04701203|467743961|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
129940249|NCT04701203|467743959|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
129940250|NCT04701203|467743960|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
129940251|NCT04701203|467743961|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
129940252|NCT04701203|467743959|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
129940253|NCT04701203|467743960|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
129940254|NCT04701203|467743961|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
129940255|NCT04701203|467743959|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
129940256|NCT04701203|467743960|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
129940257|NCT04701203|467743961|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
129940258|NCT06140290|467743963|FG000|Period 1|Adverse Event|1|||
129940259|NCT06140290|467743964|FG001|Period 1|Adverse Event|0|||
129940260|NCT06140290|467743963|FG000|Period 2|Assigned but not treated|0|||
129940261|NCT06140290|467743964|FG001|Period 2|Assigned but not treated|1|||
129940262|NCT06140290|467743963|FG000|Period 2|Withdrawal by Subject|0|||
129940263|NCT06140290|467743964|FG001|Period 2|Withdrawal by Subject|1|||
129940264|NCT05293717|467743965|FG000|Overall Study|Physician Decision|1|||
129940265|NCT03762850|467745390|FG000|Overall Study|Death|0|||
129940266|NCT03762850|467745391|FG001|Overall Study|Death|1|||
129940267|NCT03762850|467745390|FG000|Overall Study|Lost to Follow-up|0|||
129940268|NCT03762850|467745391|FG001|Overall Study|Lost to Follow-up|1|||
129940269|NCT03762850|467745390|FG000|Overall Study|Physician Decision|0|||
129940270|NCT03762850|467745391|FG001|Overall Study|Physician Decision|1|||
129940271|NCT03762850|467745390|FG000|Overall Study|Withdrawal by Subject|4|||
129940272|NCT03762850|467745391|FG001|Overall Study|Withdrawal by Subject|9|||
129940273|NCT03083366|467745392|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
129940274|NCT03083366|467745393|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
129940275|NCT03083366|467745392|FG000|Enrollment Period|Lack of Efficacy|1|||
129940276|NCT03083366|467745393|FG001|Enrollment Period|Lack of Efficacy|0|||
129940277|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940278|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940279|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
129940280|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
129940281|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940282|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
129940283|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
129940284|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
129940285|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
129940286|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
129940287|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Death|0|||
129940288|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Death|0|||
129940289|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Death|0|||
129940290|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Death|0|||
129940291|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Death|0|||
129940292|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Death|0|||
129940293|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Death|0|||
129940294|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Death|0|||
129940295|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Death|1|||
129940296|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Death|0|||
129940297|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
129940298|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940299|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
129940300|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940301|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940302|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940303|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940304|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940305|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
129940306|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
129940307|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940308|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940309|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940310|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940311|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
129940312|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940313|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940314|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
129940315|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
129940316|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
129940317|NCT02036970|467745398|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940318|NCT02036970|467745399|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940319|NCT02036970|467745400|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940320|NCT02036970|467745401|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
129940321|NCT02036970|467745402|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940322|NCT02036970|467745403|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940323|NCT02036970|467745404|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940324|NCT02036970|467745405|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940325|NCT02036970|467745406|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940326|NCT02036970|467745407|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
129940327|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
129940328|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
129940329|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
129940330|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
129940331|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
129940332|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
129940333|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
129940334|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
129940335|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
129940336|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
129940337|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940338|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940339|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940340|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940341|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940342|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940343|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940344|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
129940345|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940346|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
129940347|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940348|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
129940349|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
129940350|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940351|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940352|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940353|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940354|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940355|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
129940356|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
129940357|NCT02036970|467745398|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940358|NCT02036970|467745399|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
129940359|NCT02036970|467745400|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
129940360|NCT02036970|467745401|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
129940361|NCT02036970|467745402|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940362|NCT02036970|467745403|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940363|NCT02036970|467745404|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940364|NCT02036970|467745405|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940365|NCT02036970|467745406|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
129940366|NCT02036970|467745407|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
129940367|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
129940368|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
129453102|NCT01263483|465956388|FG001|Overall Study|Protocol Violation|1|||
129453103|NCT01263483|465956389|FG002|Overall Study|Protocol Violation|1|||
129940369|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
129453104|NCT01263483|465956387|FG000|Overall Study|Participant Unavailability|0|||
129453105|NCT01263483|465956388|FG001|Overall Study|Participant Unavailability|1|||
129940370|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
129453106|NCT01263483|465956389|FG002|Overall Study|Participant Unavailability|1|||
129940371|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
129940372|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
129940373|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
129940374|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
129940375|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
129940376|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
129940377|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
129940378|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
129940379|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
129940380|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
129940381|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
129940382|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940383|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
129940384|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940385|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940386|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
129940387|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
129940388|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
129940389|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
129940390|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
129940391|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
129940392|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other|1|||
129940393|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other|0|||
129940394|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other|0|||
129940395|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other|0|||
129940396|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other|0|||
129940397|NCT02386098|467745410|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
129940398|NCT02386098|467745411|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
129940399|NCT02386098|467745412|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
129940400|NCT02386098|467745413|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
129940401|NCT02386098|467745414|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
129940402|NCT03352713|467745418|FG000|Overall Study|Lost to Follow-up|8|||
129940403|NCT03352713|467745418|FG000|Overall Study|Withdrawn by investigator|5|||
129940404|NCT03352713|467745418|FG000|Overall Study|Completed 0 EMAs|8|||
129940405|NCT03352713|467745418|FG000|Overall Study|Device incompatible/stolen|5|||
129940406|NCT01812759|467745419|FG000|Overall Study|Physician Decision|0|||
129940407|NCT01812759|467745420|FG001|Overall Study|Physician Decision|0|||
129940408|NCT01812759|467745421|FG002|Overall Study|Physician Decision|1|||
129940409|NCT00536120|467745422|FG000|Overall Study|Lost to Follow-up|1|||
129940410|NCT00536120|467745423|FG001|Overall Study|Lost to Follow-up|0|||
129940411|NCT00536120|467745422|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
129940412|NCT00536120|467745423|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
129940413|NCT00536120|467745422|FG000|Overall Study|Non-compliance|1|||
129940414|NCT00536120|467745423|FG001|Overall Study|Non-compliance|0|||
129940415|NCT00536120|467745422|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
129940416|NCT00536120|467745423|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
129940417|NCT00536120|467745422|FG000|Overall Study|Steroid Use|0|||
129940418|NCT00536120|467745423|FG001|Overall Study|Steroid Use|2|||
129940419|NCT00536120|467745422|FG000|Overall Study|Missed Study Visit|0|||
129940420|NCT00536120|467745423|FG001|Overall Study|Missed Study Visit|1|||
129940421|NCT02722434|467745424|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
129940422|NCT02722434|467745425|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
129940423|NCT02722434|467745424|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
129940424|NCT02722434|467745425|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
129940425|NCT00360269|467745426|FG000|Overall Study|Lost to Follow-up|7|||
129940426|NCT00360269|467745427|FG001|Overall Study|Lost to Follow-up|9|||
129940427|NCT00360269|467745426|FG000|Overall Study|Physician Decision|1|||
129940428|NCT00360269|467745427|FG001|Overall Study|Physician Decision|2|||
129940429|NCT00360269|467745426|FG000|Overall Study|Adverse Event|1|||
129940430|NCT00360269|467745427|FG001|Overall Study|Adverse Event|0|||
129940431|NCT00360269|467745426|FG000|Overall Study|Withdrawal by Subject|1|||
129940432|NCT00360269|467745427|FG001|Overall Study|Withdrawal by Subject|1|||
129940433|NCT00048932|467745430|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
129940434|NCT00048932|467745431|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
129940435|NCT00048932|467745432|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
129940436|NCT00048932|467745430|FG000|Double Blind Period (DB)|Adverse Event|51|||
129940437|NCT00048932|467745431|FG001|Double Blind Period (DB)|Adverse Event|19|||
129940438|NCT00048932|467745432|FG002|Double Blind Period (DB)|Adverse Event|0|||
129940439|NCT00048932|467745430|FG000|Double Blind Period (DB)|Death|5|||
129940440|NCT00048932|467745431|FG001|Double Blind Period (DB)|Death|3|||
129940441|NCT00048932|467745432|FG002|Double Blind Period (DB)|Death|0|||
129940442|NCT00048932|467745430|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
129940443|NCT00048932|467745431|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
129940444|NCT00048932|467745432|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
129940445|NCT00048932|467745430|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
129940446|NCT00048932|467745431|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
129940447|NCT00048932|467745432|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
129940448|NCT00048932|467745430|FG000|Double Blind Period (DB)|Relocation|1|||
129940449|NCT00048932|467745431|FG001|Double Blind Period (DB)|Relocation|0|||
129940450|NCT00048932|467745432|FG002|Double Blind Period (DB)|Relocation|0|||
129940451|NCT00048932|467745430|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
129940452|NCT00048932|467745431|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
129940453|NCT00048932|467745432|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
129940454|NCT00048932|467745430|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
129940455|NCT00048932|467745431|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
129940456|NCT00048932|467745432|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
129940457|NCT00048932|467745430|FG000|Double Blind Period (DB)|Pregnancy|1|||
129940458|NCT00048932|467745431|FG001|Double Blind Period (DB)|Pregnancy|0|||
129940459|NCT00048932|467745432|FG002|Double Blind Period (DB)|Pregnancy|0|||
129940460|NCT00048932|467745430|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
129940461|NCT00048932|467745431|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
129940462|NCT00048932|467745432|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
129940463|NCT00048932|467745430|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
129940464|NCT00048932|467745431|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
129940465|NCT00048932|467745432|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
129940466|NCT00048932|467745430|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
129940467|NCT00048932|467745431|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
129940468|NCT00048932|467745432|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
129940469|NCT00048932|467745430|FG000|Open Label Period (OL)|Death|0|||
129940470|NCT00048932|467745431|FG001|Open Label Period (OL)|Death|0|||
129940471|NCT00048932|467745432|FG002|Open Label Period (OL)|Death|25|||
129940472|NCT00048932|467745430|FG000|Open Label Period (OL)|Adverse Event|0|||
129940473|NCT00048932|467745431|FG001|Open Label Period (OL)|Adverse Event|0|||
129940474|NCT00048932|467745432|FG002|Open Label Period (OL)|Adverse Event|103|||
129940475|NCT00048932|467745430|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
129940476|NCT00048932|467745431|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
129940477|NCT00048932|467745432|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
129940478|NCT00048932|467745430|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
129940479|NCT00048932|467745431|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
129940480|NCT00048932|467745432|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
129940481|NCT00048932|467745430|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
129940482|NCT00048932|467745431|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
129940483|NCT00048932|467745432|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
129940484|NCT00048932|467745430|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
129940485|NCT00048932|467745431|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
129940486|NCT00048932|467745432|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
129940487|NCT00048932|467745430|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
129940488|NCT00048932|467745431|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
129940489|NCT00048932|467745432|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
129940490|NCT00048932|467745430|FG000|Open Label Period (OL)|Pregnancy|0|||
129940491|NCT00048932|467745431|FG001|Open Label Period (OL)|Pregnancy|0|||
129940492|NCT00048932|467745432|FG002|Open Label Period (OL)|Pregnancy|6|||
129940493|NCT00048932|467745430|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
129940494|NCT00048932|467745431|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
129940495|NCT00048932|467745432|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
129940496|NCT00048932|467745430|FG000|Open Label Period (OL)|Investigator Retiring|0|||
129940497|NCT00048932|467745431|FG001|Open Label Period (OL)|Investigator Retiring|0|||
129940498|NCT00048932|467745432|FG002|Open Label Period (OL)|Investigator Retiring|2|||
129940499|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
129940500|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
129940501|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
129940502|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Relocated|0|||
129940503|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Relocated|0|||
129940504|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Relocated|6|||
129940505|NCT00048932|467745430|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
129940506|NCT00048932|467745431|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
129940507|NCT00048932|467745432|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
129940508|NCT00048932|467745430|FG000|Open Label Period (OL)|Site Closure|0|||
129940509|NCT00048932|467745431|FG001|Open Label Period (OL)|Site Closure|0|||
129940510|NCT00048932|467745432|FG002|Open Label Period (OL)|Site Closure|3|||
129940511|NCT00048932|467745430|FG000|Open Label Period (OL)|Trial Terminated|0|||
129940512|NCT00048932|467745431|FG001|Open Label Period (OL)|Trial Terminated|0|||
129940513|NCT00048932|467745432|FG002|Open Label Period (OL)|Trial Terminated|1|||
129940514|NCT00048932|467745430|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
129940515|NCT00048932|467745431|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
129940516|NCT00048932|467745432|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
129940517|NCT00048932|467745430|FG000|Open Label Period (OL)|Patient Decision|0|||
129940518|NCT00048932|467745431|FG001|Open Label Period (OL)|Patient Decision|0|||
129940519|NCT00048932|467745432|FG002|Open Label Period (OL)|Patient Decision|4|||
129940520|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
129940521|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
129940522|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
129940523|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
129940524|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
129940525|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
129940526|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
129940527|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
129940528|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
129940529|NCT00048932|467745430|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
129940530|NCT00048932|467745431|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
129940531|NCT00048932|467745432|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
129940532|NCT00048932|467745430|FG000|Open Label Period (OL)|Investigator Decision|0|||
129940533|NCT00048932|467745431|FG001|Open Label Period (OL)|Investigator Decision|0|||
129940534|NCT00048932|467745432|FG002|Open Label Period (OL)|Investigator Decision|4|||
129940535|NCT00048932|467745430|FG000|Open Label Period (OL)|Site Staff Issues|0|||
129940536|NCT00048932|467745431|FG001|Open Label Period (OL)|Site Staff Issues|0|||
129940537|NCT00048932|467745432|FG002|Open Label Period (OL)|Site Staff Issues|2|||
129940538|NCT00048932|467745430|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
129940539|NCT00048932|467745431|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
129940540|NCT00048932|467745432|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
129940541|NCT00048932|467745430|FG000|Open Label Period (OL)|Participant Surgery|0|||
129940542|NCT00048932|467745431|FG001|Open Label Period (OL)|Participant Surgery|0|||
129940543|NCT00048932|467745432|FG002|Open Label Period (OL)|Participant Surgery|1|||
129940544|NCT02232737|467745433|FG000|Overall Study|Lost to Follow-up|18|||
129940545|NCT02232737|467745434|FG001|Overall Study|Lost to Follow-up|28|||
129940546|NCT02232737|467745435|FG002|Overall Study|Lost to Follow-up|33|||
129940547|NCT02232737|467745433|FG000|Overall Study|Personal reasons|7|||
129940548|NCT02232737|467745434|FG001|Overall Study|Personal reasons|8|||
129940549|NCT02232737|467745435|FG002|Overall Study|Personal reasons|14|||
129940550|NCT02232737|467745433|FG000|Overall Study|Adverse Event|6|||
129940551|NCT02232737|467745434|FG001|Overall Study|Adverse Event|3|||
129940552|NCT02232737|467745435|FG002|Overall Study|Adverse Event|8|||
129940553|NCT02232737|467745433|FG000|Overall Study|Incarcerated|2|||
129940554|NCT02232737|467745434|FG001|Overall Study|Incarcerated|1|||
129940555|NCT02232737|467745435|FG002|Overall Study|Incarcerated|2|||
129940556|NCT02232737|467745433|FG000|Overall Study|Withdrawal by Subject|0|||
129940557|NCT02232737|467745434|FG001|Overall Study|Withdrawal by Subject|1|||
129940558|NCT02232737|467745435|FG002|Overall Study|Withdrawal by Subject|2|||
129940559|NCT02232737|467745433|FG000|Overall Study|Death|0|||
129940560|NCT02232737|467745434|FG001|Overall Study|Death|1|||
129940561|NCT02232737|467745435|FG002|Overall Study|Death|1|||
129940562|NCT02232737|467745433|FG000|Overall Study|Physician Decision|1|||
129940563|NCT02232737|467745434|FG001|Overall Study|Physician Decision|3|||
129940564|NCT02232737|467745435|FG002|Overall Study|Physician Decision|1|||
129940565|NCT02232737|467745433|FG000|Overall Study|Protocol Violation|1|||
129940566|NCT02232737|467745434|FG001|Overall Study|Protocol Violation|0|||
129940567|NCT02232737|467745435|FG002|Overall Study|Protocol Violation|1|||
129940568|NCT02232737|467745433|FG000|Overall Study|Reason unknown|1|||
129940569|NCT02232737|467745434|FG001|Overall Study|Reason unknown|0|||
129940570|NCT02232737|467745435|FG002|Overall Study|Reason unknown|0|||
129940571|NCT04559698|467745436|FG000|Overall Study|Lost to Follow-up|14|||
129940572|NCT04559698|467745437|FG001|Overall Study|Lost to Follow-up|15|||
129940573|NCT04559698|467745436|FG000|Overall Study|Withdrawal by Subject|0|||
129940574|NCT04559698|467745437|FG001|Overall Study|Withdrawal by Subject|1|||
129940575|NCT04989816|467745438|FG000|Overall Study|Death|77|||
129940576|NCT04989816|467745438|FG000|Overall Study|Lost to Follow-up|3|||
129453107|NCT00326209|465956390|FG000|Overall Study|Adverse Event|28|||
129940577|NCT03437733|467745439|FG000|Overall Study|Eligibility criteria not met|0|||
129940578|NCT03437733|467745440|FG001|Overall Study|Eligibility criteria not met|3|||
129940579|NCT00786864|467745441|FG000|Overall Study|Lost to Follow-up|0|||
129940580|NCT00786864|467745442|FG001|Overall Study|Lost to Follow-up|1|||
129940581|NCT00786864|467745441|FG000|Overall Study|Sustained serious back injury|1|||
129940582|NCT00786864|467745442|FG001|Overall Study|Sustained serious back injury|0|||
129940583|NCT01641900|467745446|FG000|Overall Study|Withdrawal by Subject|2|||
129453108|NCT00326209|465956390|FG000|Overall Study|Withdrawal by Subject|22|||
129940584|NCT01641900|467745447|FG001|Overall Study|Withdrawal by Subject|2|||
129940585|NCT03220724|467745453|FG000|Overall Study|Lost to Follow-up|2|||
129940586|NCT03220724|467745454|FG001|Overall Study|Lost to Follow-up|2|||
129940587|NCT03220724|467745455|FG002|Overall Study|Lost to Follow-up|0|||
129940588|NCT03220724|467745456|FG003|Overall Study|Lost to Follow-up|3|||
129940589|NCT03220724|467745457|FG004|Overall Study|Lost to Follow-up|1|||
129940590|NCT03220724|467745458|FG005|Overall Study|Lost to Follow-up|0|||
129940591|NCT03220724|467745459|FG006|Overall Study|Lost to Follow-up|2|||
129940592|NCT03220724|467745460|FG007|Overall Study|Lost to Follow-up|1|||
129940593|NCT03220724|467745461|FG008|Overall Study|Lost to Follow-up|0|||
129940594|NCT03220724|467745453|FG000|Overall Study|Withdrawal by Subject|1|||
129940595|NCT03220724|467745454|FG001|Overall Study|Withdrawal by Subject|0|||
129940596|NCT03220724|467745455|FG002|Overall Study|Withdrawal by Subject|1|||
129940597|NCT03220724|467745456|FG003|Overall Study|Withdrawal by Subject|0|||
129940598|NCT03220724|467745457|FG004|Overall Study|Withdrawal by Subject|0|||
129940599|NCT03220724|467745458|FG005|Overall Study|Withdrawal by Subject|0|||
129940600|NCT03220724|467745459|FG006|Overall Study|Withdrawal by Subject|0|||
129940601|NCT03220724|467745460|FG007|Overall Study|Withdrawal by Subject|0|||
129940602|NCT03220724|467745461|FG008|Overall Study|Withdrawal by Subject|0|||
129940603|NCT02463448|467745462|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
129940604|NCT02463448|467745462|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
129940605|NCT02463448|467745462|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
129940606|NCT02463448|467745462|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
129940607|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
129940608|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
129940609|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
129940610|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
129940611|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
129940612|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
129940613|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
129940614|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
129940615|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
129940616|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
129940617|NCT01767467|467745466|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
129940618|NCT01767467|467745467|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
129940619|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
129940620|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
129940621|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
129940622|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
129940623|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
129940624|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
129940625|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
129940626|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
129940627|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
129940628|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
129940629|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
129940630|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
129940631|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
129940632|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
129940633|NCT01767467|467745466|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
129940634|NCT01767467|467745467|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
129940635|NCT00857766|467745468|FG000|Overall Study|Adverse Event|13|||
129940636|NCT00857766|467745469|FG001|Overall Study|Adverse Event|12|||
129940637|NCT00857766|467745468|FG000|Overall Study|Protocol Violation|11|||
129940638|NCT00857766|467745469|FG001|Overall Study|Protocol Violation|11|||
129940639|NCT00857766|467745468|FG000|Overall Study|Lost to Follow-up|1|||
129940640|NCT00857766|467745469|FG001|Overall Study|Lost to Follow-up|0|||
129940641|NCT00857766|467745468|FG000|Overall Study|Investigator Discretion|2|||
129940642|NCT00857766|467745469|FG001|Overall Study|Investigator Discretion|3|||
129940643|NCT00857766|467745468|FG000|Overall Study|Participant Withdrew Consent|4|||
129940644|NCT00857766|467745469|FG001|Overall Study|Participant Withdrew Consent|4|||
129940645|NCT01640951|467745470|FG000|Overall Study|Adverse Event|8|||
129940646|NCT01640951|467745471|FG001|Overall Study|Adverse Event|3|||
129940647|NCT01640951|467745472|FG002|Overall Study|Adverse Event|10|||
129940648|NCT01640951|467745473|FG003|Overall Study|Adverse Event|6|||
129940649|NCT01640951|467745474|FG004|Overall Study|Adverse Event|1|||
129940650|NCT01640951|467745475|FG005|Overall Study|Adverse Event|11|||
129940651|NCT01640951|467745476|FG006|Overall Study|Adverse Event|1|||
129940652|NCT01640951|467745477|FG007|Overall Study|Adverse Event|3|||
129940653|NCT01640951|467745470|FG000|Overall Study|Lack of Efficacy|20|||
129940654|NCT01640951|467745471|FG001|Overall Study|Lack of Efficacy|1|||
129940655|NCT01640951|467745472|FG002|Overall Study|Lack of Efficacy|7|||
129940656|NCT01640951|467745473|FG003|Overall Study|Lack of Efficacy|14|||
129940657|NCT01640951|467745474|FG004|Overall Study|Lack of Efficacy|0|||
129940658|NCT01640951|467745475|FG005|Overall Study|Lack of Efficacy|6|||
129940659|NCT01640951|467745476|FG006|Overall Study|Lack of Efficacy|5|||
129940660|NCT01640951|467745477|FG007|Overall Study|Lack of Efficacy|6|||
129940661|NCT01640951|467745470|FG000|Overall Study|Lost to Follow-up|1|||
129940662|NCT01640951|467745471|FG001|Overall Study|Lost to Follow-up|0|||
129940663|NCT01640951|467745472|FG002|Overall Study|Lost to Follow-up|6|||
129940664|NCT01640951|467745473|FG003|Overall Study|Lost to Follow-up|2|||
129940665|NCT01640951|467745474|FG004|Overall Study|Lost to Follow-up|2|||
129940666|NCT01640951|467745475|FG005|Overall Study|Lost to Follow-up|3|||
129940667|NCT01640951|467745476|FG006|Overall Study|Lost to Follow-up|1|||
129940668|NCT01640951|467745477|FG007|Overall Study|Lost to Follow-up|1|||
129940669|NCT01640951|467745470|FG000|Overall Study|Non-compliance with study treatment|0|||
129940670|NCT01640951|467745471|FG001|Overall Study|Non-compliance with study treatment|0|||
129940671|NCT01640951|467745472|FG002|Overall Study|Non-compliance with study treatment|1|||
129940672|NCT01640951|467745473|FG003|Overall Study|Non-compliance with study treatment|1|||
129940673|NCT01640951|467745474|FG004|Overall Study|Non-compliance with study treatment|1|||
129940674|NCT01640951|467745475|FG005|Overall Study|Non-compliance with study treatment|4|||
129940675|NCT01640951|467745476|FG006|Overall Study|Non-compliance with study treatment|1|||
129940676|NCT01640951|467745477|FG007|Overall Study|Non-compliance with study treatment|0|||
129940677|NCT01640951|467745470|FG000|Overall Study|Physician Decision|2|||
129940678|NCT01640951|467745471|FG001|Overall Study|Physician Decision|5|||
129940679|NCT01640951|467745472|FG002|Overall Study|Physician Decision|2|||
129940680|NCT01640951|467745473|FG003|Overall Study|Physician Decision|2|||
129940681|NCT01640951|467745474|FG004|Overall Study|Physician Decision|2|||
129940682|NCT01640951|467745475|FG005|Overall Study|Physician Decision|3|||
129940683|NCT01640951|467745476|FG006|Overall Study|Physician Decision|3|||
129940684|NCT01640951|467745477|FG007|Overall Study|Physician Decision|0|||
129940685|NCT01640951|467745470|FG000|Overall Study|Pregnancy|3|||
129940686|NCT01640951|467745471|FG001|Overall Study|Pregnancy|0|||
129940687|NCT01640951|467745472|FG002|Overall Study|Pregnancy|0|||
129940688|NCT01640951|467745473|FG003|Overall Study|Pregnancy|4|||
129940689|NCT01640951|467745474|FG004|Overall Study|Pregnancy|0|||
129940690|NCT01640951|467745475|FG005|Overall Study|Pregnancy|0|||
129940691|NCT01640951|467745476|FG006|Overall Study|Pregnancy|2|||
129940692|NCT01640951|467745477|FG007|Overall Study|Pregnancy|0|||
129940693|NCT01640951|467745470|FG000|Overall Study|Protocol Deviation|0|||
129940694|NCT01640951|467745471|FG001|Overall Study|Protocol Deviation|1|||
129940695|NCT01640951|467745472|FG002|Overall Study|Protocol Deviation|2|||
129940696|NCT01640951|467745473|FG003|Overall Study|Protocol Deviation|1|||
129940697|NCT01640951|467745474|FG004|Overall Study|Protocol Deviation|0|||
129940698|NCT01640951|467745475|FG005|Overall Study|Protocol Deviation|1|||
129940699|NCT01640951|467745476|FG006|Overall Study|Protocol Deviation|0|||
129940700|NCT01640951|467745477|FG007|Overall Study|Protocol Deviation|0|||
129940701|NCT01640951|467745470|FG000|Overall Study|Subject/Guardian decision|12|||
129940702|NCT01640951|467745471|FG001|Overall Study|Subject/Guardian decision|4|||
129940703|NCT01640951|467745472|FG002|Overall Study|Subject/Guardian decision|13|||
129940704|NCT01640951|467745473|FG003|Overall Study|Subject/Guardian decision|15|||
129940705|NCT01640951|467745474|FG004|Overall Study|Subject/Guardian decision|7|||
129940706|NCT01640951|467745475|FG005|Overall Study|Subject/Guardian decision|19|||
129940707|NCT01640951|467745476|FG006|Overall Study|Subject/Guardian decision|5|||
129940708|NCT01640951|467745477|FG007|Overall Study|Subject/Guardian decision|4|||
129940709|NCT01640951|467745470|FG000|Overall Study|Death|0|||
129940710|NCT01640951|467745471|FG001|Overall Study|Death|1|||
129940711|NCT01640951|467745472|FG002|Overall Study|Death|1|||
129940712|NCT01640951|467745473|FG003|Overall Study|Death|0|||
129940713|NCT01640951|467745474|FG004|Overall Study|Death|0|||
129940714|NCT01640951|467745475|FG005|Overall Study|Death|0|||
129940715|NCT01640951|467745476|FG006|Overall Study|Death|0|||
129940716|NCT01640951|467745477|FG007|Overall Study|Death|2|||
129940717|NCT03355573|467745478|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
129940718|NCT03355573|467745478|FG000|Overall Study|Sponsor's decision|1|||
129940719|NCT03355573|467745478|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
129940720|NCT03355573|467745478|FG000|Overall Study|PI's decision|2|||
129940721|NCT03355573|467745478|FG000|Overall Study|Withdrawal by Subject|23|||
129940722|NCT03355573|467745478|FG000|Overall Study|Lost to Follow-up|4|||
129940723|NCT03355573|467745478|FG000|Overall Study|Lack of Efficacy|2|||
129940724|NCT03355573|467745478|FG000|Overall Study|Adverse Event, non-fatal|17|||
129940725|NCT03355573|467745478|FG000|Overall Study|Adverse Event, serious fatal|2|||
129940726|NCT01536093|467745481|FG000|Overall Study|Death|1|||
129940727|NCT01536093|467745482|FG001|Overall Study|Death|2|||
129940728|NCT01536093|467745481|FG000|Overall Study|absence of maternal colostrum|2|||
129940729|NCT01536093|467745482|FG001|Overall Study|absence of maternal colostrum|0|||
129940730|NCT01536093|467745481|FG000|Overall Study|Withdrawal by Subject|0|||
129940731|NCT01536093|467745482|FG001|Overall Study|Withdrawal by Subject|1|||
129940732|NCT02406092|467745483|FG000|Overall Study|Screen failure|10|||
129940733|NCT02406092|467745484|FG001|Overall Study|Screen failure|7|||
129940734|NCT02406092|467745483|FG000|Overall Study|Death|22|||
129940735|NCT02406092|467745484|FG001|Overall Study|Death|5|||
129940736|NCT02406092|467745483|FG000|Overall Study|Lost to Follow-up|4|||
129940737|NCT02406092|467745484|FG001|Overall Study|Lost to Follow-up|1|||
129940738|NCT02406092|467745483|FG000|Overall Study|Adverse Event|1|||
129940739|NCT02406092|467745484|FG001|Overall Study|Adverse Event|0|||
129940740|NCT02406092|467745483|FG000|Overall Study|Withdrawal by Subject|1|||
129940741|NCT02406092|467745484|FG001|Overall Study|Withdrawal by Subject|0|||
129940742|NCT03631407|467745485|FG000|Overall Study|Withdrawal by Subject|3|||
129940743|NCT03631407|467745486|FG001|Overall Study|Withdrawal by Subject|2|||
129940744|NCT03631407|467745485|FG000|Overall Study|Sponsor Decision|0|||
129940745|NCT03631407|467745486|FG001|Overall Study|Sponsor Decision|2|||
129940746|NCT03631407|467745485|FG000|Overall Study|Death|16|||
129940747|NCT03631407|467745486|FG001|Overall Study|Death|16|||
129940748|NCT03631407|467745485|FG000|Overall Study|Randomized by mistake without study treatment|1|||
129940749|NCT03631407|467745486|FG001|Overall Study|Randomized by mistake without study treatment|0|||
129940750|NCT00942266|467745487|FG000|Overall Study|Withdrawal by Subject|1|||
129940751|NCT00942266|467745488|FG001|Overall Study|Withdrawal by Subject|0|||
129940752|NCT00942266|467745487|FG000|Overall Study|Adverse Event|2|||
129940753|NCT00942266|467745488|FG001|Overall Study|Adverse Event|1|||
129940754|NCT00942266|467745487|FG000|Overall Study|Disease Progression|38|||
129940755|NCT00942266|467745488|FG001|Overall Study|Disease Progression|11|||
129940756|NCT00942266|467745487|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
129940757|NCT00942266|467745488|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
129940758|NCT00942266|467745487|FG000|Overall Study|Intercurrent illness|0|||
129940759|NCT00942266|467745488|FG001|Overall Study|Intercurrent illness|1|||
129940760|NCT00942266|467745487|FG000|Overall Study|Physician Decision|2|||
129940761|NCT00942266|467745488|FG001|Overall Study|Physician Decision|0|||
129940762|NCT00942266|467745487|FG000|Overall Study|medical deterioration (pneumonia)|0|||
129940763|NCT00942266|467745488|FG001|Overall Study|medical deterioration (pneumonia)|1|||
129940764|NCT00756574|467745494|FG000|Overall Study|Withdrawal by Subject|9|||
129940765|NCT00756574|467745495|FG001|Overall Study|Withdrawal by Subject|7|||
129940766|NCT00756574|467745494|FG000|Overall Study|Lost to Follow-up|4|||
129940767|NCT00756574|467745495|FG001|Overall Study|Lost to Follow-up|4|||
129940768|NCT04795167|467745496|FG000|Overall Study|Death|1|||
129940769|NCT04795167|467745497|FG001|Overall Study|Death|18|||
129940770|NCT04795167|467745498|FG002|Overall Study|Death|1|||
129940771|NCT04795167|467745496|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
129940772|NCT04795167|467745497|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
129940773|NCT04795167|467745498|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
129940774|NCT03598907|467745507|FG000|Overall Study|Physician Decision|14|||
129940775|NCT03598907|467745508|FG001|Overall Study|Physician Decision|19|||
129940776|NCT05025384|467745509|FG000|Overall Study|Physician Decision|5|||
129940777|NCT05025384|467745510|FG001|Overall Study|Physician Decision|6|||
129940778|NCT03610581|467745511|FG000|Overall Study|Study terminated by sponsor|2|||
129940779|NCT03610581|467745512|FG001|Overall Study|Study terminated by sponsor|0|||
129940780|NCT03610581|467745511|FG000|Overall Study|Other|0|||
129940781|NCT03610581|467745512|FG001|Overall Study|Other|1|||
129940782|NCT03610581|467745511|FG000|Overall Study|Withdrawal by Subject|1|||
129940783|NCT03610581|467745512|FG001|Overall Study|Withdrawal by Subject|0|||
129940784|NCT00748709|467745521|FG000|Overall Study|Progressive disease|15|||
129940785|NCT00748709|467745521|FG000|Overall Study|Drug reducing Toxity|2|||
129940786|NCT00748709|467745521|FG000|Overall Study|Other Adverse Event|1|||
129940787|NCT00748709|467745521|FG000|Overall Study|Withdrawal by Subject|1|||
129940788|NCT00748709|467745521|FG000|Overall Study|Other Reasons|1|||
129940789|NCT05485805|467745526|FG000|Overall Study|Withdrawal by Subject|1|||
129940790|NCT05485805|467745527|FG001|Overall Study|Withdrawal by Subject|2|||
129940791|NCT05485805|467745528|FG002|Overall Study|Withdrawal by Subject|2|||
129940792|NCT05485805|467745529|FG003|Overall Study|Withdrawal by Subject|0|||
129940793|NCT05485805|467745530|FG004|Overall Study|Withdrawal by Subject|2|||
129940794|NCT05485805|467745526|FG000|Overall Study|Adverse Event|0|||
129940795|NCT05485805|467745527|FG001|Overall Study|Adverse Event|1|||
129940796|NCT05485805|467745528|FG002|Overall Study|Adverse Event|0|||
129940797|NCT05485805|467745529|FG003|Overall Study|Adverse Event|0|||
129940798|NCT05485805|467745530|FG004|Overall Study|Adverse Event|0|||
129940799|NCT05485805|467745526|FG000|Overall Study|Lost to Follow-up|1|||
129940800|NCT05485805|467745527|FG001|Overall Study|Lost to Follow-up|1|||
129940801|NCT05485805|467745528|FG002|Overall Study|Lost to Follow-up|3|||
129940802|NCT05485805|467745529|FG003|Overall Study|Lost to Follow-up|1|||
129940803|NCT05485805|467745530|FG004|Overall Study|Lost to Follow-up|0|||
129940804|NCT00092534|467746733|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
129940805|NCT00092534|467746734|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
129940806|NCT00092534|467746735|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129940807|NCT00092534|467746736|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129940808|NCT00092534|467746737|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
129940809|NCT00092534|467746733|FG000|Base Study Vaccination Period|Adverse Event|3|||
129940810|NCT00092534|467746734|FG001|Base Study Vaccination Period|Adverse Event|1|||
129940811|NCT00092534|467746735|FG002|Base Study Vaccination Period|Adverse Event|0|||
129940812|NCT00092534|467746736|FG003|Base Study Vaccination Period|Adverse Event|0|||
129940813|NCT00092534|467746737|FG004|Base Study Vaccination Period|Adverse Event|0|||
129940814|NCT00092534|467746733|FG000|Base Study Vaccination Period|Death|5|||
129940815|NCT00092534|467746734|FG001|Base Study Vaccination Period|Death|4|||
129940816|NCT00092534|467746735|FG002|Base Study Vaccination Period|Death|0|||
129940817|NCT00092534|467746736|FG003|Base Study Vaccination Period|Death|0|||
129940818|NCT00092534|467746737|FG004|Base Study Vaccination Period|Death|0|||
129940819|NCT00092534|467746733|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
129940820|NCT00092534|467746734|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
129940821|NCT00092534|467746735|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
129940822|NCT00092534|467746736|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
129940823|NCT00092534|467746737|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129940824|NCT00092534|467746733|FG000|Base Study Vaccination Period|Physician Decision|1|||
129940825|NCT00092534|467746734|FG001|Base Study Vaccination Period|Physician Decision|0|||
129940826|NCT00092534|467746735|FG002|Base Study Vaccination Period|Physician Decision|0|||
129940827|NCT00092534|467746736|FG003|Base Study Vaccination Period|Physician Decision|0|||
129940828|NCT00092534|467746737|FG004|Base Study Vaccination Period|Physician Decision|0|||
129940829|NCT00092534|467746733|FG000|Base Study Vaccination Period|Pregnancy|9|||
129940830|NCT00092534|467746734|FG001|Base Study Vaccination Period|Pregnancy|7|||
129940831|NCT00092534|467746735|FG002|Base Study Vaccination Period|Pregnancy|0|||
129940832|NCT00092534|467746736|FG003|Base Study Vaccination Period|Pregnancy|0|||
129940833|NCT00092534|467746737|FG004|Base Study Vaccination Period|Pregnancy|0|||
129940834|NCT00092534|467746733|FG000|Base Study Vaccination Period|Protocol Violation|2|||
129940835|NCT00092534|467746734|FG001|Base Study Vaccination Period|Protocol Violation|1|||
129940836|NCT00092534|467746735|FG002|Base Study Vaccination Period|Protocol Violation|0|||
129940837|NCT00092534|467746736|FG003|Base Study Vaccination Period|Protocol Violation|0|||
129940838|NCT00092534|467746737|FG004|Base Study Vaccination Period|Protocol Violation|0|||
129940839|NCT00092534|467746733|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
129940840|NCT00092534|467746734|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
129940841|NCT00092534|467746735|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
129940842|NCT00092534|467746736|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
129940843|NCT00092534|467746737|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129940844|NCT00092534|467746733|FG000|Base Study Vaccination Period|Moved|14|||
129940845|NCT00092534|467746734|FG001|Base Study Vaccination Period|Moved|12|||
129940846|NCT00092534|467746735|FG002|Base Study Vaccination Period|Moved|0|||
129940847|NCT00092534|467746736|FG003|Base Study Vaccination Period|Moved|0|||
129940848|NCT00092534|467746737|FG004|Base Study Vaccination Period|Moved|0|||
129940849|NCT00092534|467746733|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
129940850|NCT00092534|467746734|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940851|NCT00092534|467746735|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940852|NCT00092534|467746736|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940853|NCT00092534|467746737|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
129940854|NCT00092534|467746733|FG000|Base Study Vaccination Period|Travel|1|||
129940855|NCT00092534|467746734|FG001|Base Study Vaccination Period|Travel|0|||
129940856|NCT00092534|467746735|FG002|Base Study Vaccination Period|Travel|0|||
129940857|NCT00092534|467746736|FG003|Base Study Vaccination Period|Travel|0|||
129940858|NCT00092534|467746737|FG004|Base Study Vaccination Period|Travel|0|||
129453109|NCT00326209|465956390|FG000|Overall Study|Lack of Efficacy|31|||
129453110|NCT00326209|465956390|FG000|Overall Study|Lost to Follow-up|18|||
129940859|NCT00092534|467746733|FG000|Base Study Vaccination Period|Site Closed|0|||
129940860|NCT00092534|467746734|FG001|Base Study Vaccination Period|Site Closed|1|||
129940861|NCT00092534|467746735|FG002|Base Study Vaccination Period|Site Closed|0|||
129940862|NCT00092534|467746736|FG003|Base Study Vaccination Period|Site Closed|0|||
129940863|NCT00092534|467746737|FG004|Base Study Vaccination Period|Site Closed|0|||
129940864|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Adverse Event|2|||
129940865|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Adverse Event|4|||
129453111|NCT00326209|465956390|FG000|Overall Study|Participant non-compliant|6|||
129453112|NCT00326209|465956390|FG000|Overall Study|Sponsor closed study|173|||
129940866|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Adverse Event|0|||
129453113|NCT00326209|465956390|FG000|Overall Study|Prohibited medication use|1|||
129940867|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Adverse Event|0|||
129940868|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Adverse Event|0|||
129940869|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Death|2|||
129940870|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Death|1|||
129940871|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Death|0|||
129940872|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Death|0|||
129940873|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Death|0|||
129940874|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
129940875|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
129940876|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
129940877|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
129940878|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
129940879|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Pregnancy|6|||
129940880|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Pregnancy|10|||
129940881|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Pregnancy|0|||
129940882|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Pregnancy|0|||
129940883|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Pregnancy|0|||
129940884|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
129940885|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
129940886|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
129940887|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
129940888|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
129940889|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
129940890|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
129940891|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
129940892|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
129940893|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
129940894|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Moved|62|||
129940895|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Moved|58|||
129940896|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Moved|0|||
129940897|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Moved|0|||
129940898|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Moved|0|||
129940899|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Travel|10|||
129940900|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Travel|7|||
129940901|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Travel|0|||
129940902|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Travel|0|||
129940903|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Travel|0|||
129940904|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Site Closed|0|||
129940905|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Site Closed|2|||
129940906|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Site Closed|0|||
129940907|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Site Closed|0|||
129940908|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Site Closed|0|||
129940909|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
129940910|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
129940911|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
129940912|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
129940913|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
129940914|NCT00092534|467746733|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
129940915|NCT00092534|467746734|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
129940916|NCT00092534|467746735|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
129940917|NCT00092534|467746736|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
129940918|NCT00092534|467746737|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
129940919|NCT00092534|467746733|FG000|Base Study EXT|Lost to Follow-up|0|||
129940920|NCT00092534|467746734|FG001|Base Study EXT|Lost to Follow-up|0|||
129940921|NCT00092534|467746735|FG002|Base Study EXT|Lost to Follow-up|41|||
129940922|NCT00092534|467746736|FG003|Base Study EXT|Lost to Follow-up|0|||
129940923|NCT00092534|467746737|FG004|Base Study EXT|Lost to Follow-up|0|||
129940924|NCT00092534|467746733|FG000|Base Study EXT|Physician Decision|0|||
129940925|NCT00092534|467746734|FG001|Base Study EXT|Physician Decision|0|||
129940926|NCT00092534|467746735|FG002|Base Study EXT|Physician Decision|1|||
129940927|NCT00092534|467746736|FG003|Base Study EXT|Physician Decision|0|||
129940928|NCT00092534|467746737|FG004|Base Study EXT|Physician Decision|0|||
129940929|NCT00092534|467746733|FG000|Base Study EXT|Pregnancy|0|||
129940930|NCT00092534|467746734|FG001|Base Study EXT|Pregnancy|0|||
129940931|NCT00092534|467746735|FG002|Base Study EXT|Pregnancy|12|||
129940932|NCT00092534|467746736|FG003|Base Study EXT|Pregnancy|0|||
129940933|NCT00092534|467746737|FG004|Base Study EXT|Pregnancy|0|||
129940934|NCT00092534|467746733|FG000|Base Study EXT|Withdrawal by Subject|0|||
129940935|NCT00092534|467746734|FG001|Base Study EXT|Withdrawal by Subject|0|||
129940936|NCT00092534|467746735|FG002|Base Study EXT|Withdrawal by Subject|18|||
129940937|NCT00092534|467746736|FG003|Base Study EXT|Withdrawal by Subject|0|||
129940938|NCT00092534|467746737|FG004|Base Study EXT|Withdrawal by Subject|0|||
129940939|NCT00092534|467746733|FG000|Base Study EXT|Participant moved|0|||
129940940|NCT00092534|467746734|FG001|Base Study EXT|Participant moved|0|||
129940941|NCT00092534|467746735|FG002|Base Study EXT|Participant moved|6|||
129940942|NCT00092534|467746736|FG003|Base Study EXT|Participant moved|0|||
129940943|NCT00092534|467746737|FG004|Base Study EXT|Participant moved|0|||
129940944|NCT00092534|467746733|FG000|Base Study EXT|Travel|0|||
129940945|NCT00092534|467746734|FG001|Base Study EXT|Travel|0|||
129940946|NCT00092534|467746735|FG002|Base Study EXT|Travel|2|||
129940947|NCT00092534|467746736|FG003|Base Study EXT|Travel|0|||
129940948|NCT00092534|467746737|FG004|Base Study EXT|Travel|0|||
129940949|NCT00092534|467746733|FG000|Base Study EXT|Site closed|0|||
129940950|NCT00092534|467746734|FG001|Base Study EXT|Site closed|0|||
129940951|NCT00092534|467746735|FG002|Base Study EXT|Site closed|21|||
129940952|NCT00092534|467746736|FG003|Base Study EXT|Site closed|0|||
129940953|NCT00092534|467746737|FG004|Base Study EXT|Site closed|0|||
129940954|NCT00092534|467746733|FG000|Base Study EXT|Study ended|0|||
129940955|NCT00092534|467746734|FG001|Base Study EXT|Study ended|0|||
129940956|NCT00092534|467746735|FG002|Base Study EXT|Study ended|29|||
129940957|NCT00092534|467746736|FG003|Base Study EXT|Study ended|0|||
129940958|NCT00092534|467746737|FG004|Base Study EXT|Study ended|0|||
129940959|NCT00092534|467746733|FG000|Base Study EXT|Protocol Violation|0|||
129940960|NCT00092534|467746734|FG001|Base Study EXT|Protocol Violation|0|||
129940961|NCT00092534|467746735|FG002|Base Study EXT|Protocol Violation|15|||
129940962|NCT00092534|467746736|FG003|Base Study EXT|Protocol Violation|0|||
129940963|NCT00092534|467746737|FG004|Base Study EXT|Protocol Violation|0|||
129940964|NCT00092534|467746733|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940965|NCT00092534|467746734|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940966|NCT00092534|467746735|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940967|NCT00092534|467746736|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
129940968|NCT00092534|467746737|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
129940969|NCT03002194|467746738|FG000|Overall Study|Lost to Follow-up|6|||
129940970|NCT03002194|467746738|FG000|Overall Study|Adverse Event|1|||
129940971|NCT03002194|467746738|FG000|Overall Study|Lack of Efficacy|1|||
129940972|NCT03002194|467746738|FG000|Overall Study|Withdrawal by Subject|2|||
129940973|NCT02200705|467746748|FG000|Overall Study|Excluded|12|||
129940974|NCT02200705|467746748|FG000|Overall Study|Death|21|||
129940975|NCT02200705|467746748|FG000|Overall Study|Withdrawal by Subject|22|||
129940976|NCT02200705|467746748|FG000|Overall Study|Lost to Follow-up|13|||
129940977|NCT02200705|467746748|FG000|Overall Study|Physician Decision|5|||
129940978|NCT02200705|467746748|FG000|Overall Study|Adverse Event|2|||
129940979|NCT04162210|467746753|FG000|Overall Study|Lost to Follow-up|4|||
129940980|NCT04162210|467746754|FG001|Overall Study|Lost to Follow-up|1|||
129940981|NCT04162210|467746753|FG000|Overall Study|Withdrawal by Subject|17|||
129940982|NCT04162210|467746754|FG001|Overall Study|Withdrawal by Subject|9|||
129940983|NCT04162210|467746753|FG000|Overall Study|Ongoing|113|||
129940984|NCT04162210|467746754|FG001|Overall Study|Ongoing|59|||
129940985|NCT00371345|467746756|FG000|Overall Study|Disease Progression|21|||
129940986|NCT00371345|467746757|FG001|Overall Study|Disease Progression|35|||
129940987|NCT00371345|467746756|FG000|Overall Study|Study Drug Toxicity|1|||
129940988|NCT00371345|467746757|FG001|Overall Study|Study Drug Toxicity|7|||
129940989|NCT00371345|467746756|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
129940990|NCT00371345|467746757|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
129940991|NCT00371345|467746756|FG000|Overall Study|Participant Request|1|||
129940992|NCT00371345|467746757|FG001|Overall Study|Participant Request|1|||
129940993|NCT00371345|467746756|FG000|Overall Study|Participant Withdrew Consent|0|||
129940994|NCT00371345|467746757|FG001|Overall Study|Participant Withdrew Consent|1|||
129940995|NCT00442104|467746762|FG000|Overall Study|Adverse Event|5|||
129940996|NCT00442104|467746762|FG000|Overall Study|Death|2|||
129940997|NCT00442104|467746762|FG000|Overall Study|Lost to Follow-up|3|||
129940998|NCT00442104|467746762|FG000|Overall Study|Withdrawal by Subject|5|||
129940999|NCT00442104|467746762|FG000|Overall Study|Insufficient Clinical Response|10|||
129941000|NCT00442104|467746762|FG000|Overall Study|Other|21|||
129941001|NCT00442104|467746762|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
129941002|NCT00713596|467746763|FG000|Overall Study|Study was terminated|2|||
129941003|NCT00713596|467746764|FG001|Overall Study|Study was terminated|3|||
129941004|NCT00713596|467746765|FG002|Overall Study|Study was terminated|2|||
129941005|NCT04545619|467746766|FG000|Overall Study|due to equipment challenges|1|||
129453114|NCT00326209|465956390|FG000|Overall Study|Violation of entry criteria|1|||
129941006|NCT00463229|467746775|FG000|Overall Study|Lost to Follow-up|5|||
129941007|NCT00463229|467746776|FG001|Overall Study|Lost to Follow-up|7|||
129941008|NCT00463229|467746775|FG000|Overall Study|Death|4|||
129941009|NCT00463229|467746776|FG001|Overall Study|Death|3|||
129941010|NCT01932970|467746777|FG000|Overall Study|Withdrawal by Subject|5|||
129941011|NCT01932970|467746777|FG000|Overall Study|Death|1|||
129941012|NCT01932970|467746777|FG000|Overall Study|Lost to Follow-up|2|||
129941013|NCT01932970|467746777|FG000|Overall Study|Protocol Specified Criteria|10|||
129941014|NCT01359150|467746778|FG000|Overall Study|Lack of Efficacy|1|||
129941015|NCT01359150|467746779|FG001|Overall Study|Lack of Efficacy|1|||
129941016|NCT01359150|467746778|FG000|Overall Study|Withdrawal by Subject|1|||
129941017|NCT01359150|467746779|FG001|Overall Study|Withdrawal by Subject|1|||
129941018|NCT01359150|467746778|FG000|Overall Study|Adverse Event|4|||
129941019|NCT01359150|467746779|FG001|Overall Study|Adverse Event|3|||
129941020|NCT01359150|467746778|FG000|Overall Study|Other|1|||
129941021|NCT01359150|467746779|FG001|Overall Study|Other|0|||
129941022|NCT01787032|467746786|FG000|Overall Study|Protocol Violation|0|||
129941023|NCT01787032|467746787|FG001|Overall Study|Protocol Violation|0|||
129941024|NCT01787032|467746788|FG002|Overall Study|Protocol Violation|0|||
129941025|NCT01787032|467746789|FG003|Overall Study|Protocol Violation|0|||
129941026|NCT01787032|467746790|FG004|Overall Study|Protocol Violation|1|||
129941027|NCT01787032|467746791|FG005|Overall Study|Protocol Violation|1|||
129941028|NCT00776009|467746792|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
129941029|NCT00776009|467746793|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
129941030|NCT00776009|467746794|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
129941031|NCT00776009|467746795|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
129941032|NCT00776009|467746796|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
129941033|NCT00776009|467746797|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
129941034|NCT00776009|467746792|FG000|Period 1: First Intervention|Protocol Violation|0|||
129941035|NCT00776009|467746793|FG001|Period 1: First Intervention|Protocol Violation|1|||
129941036|NCT00776009|467746794|FG002|Period 1: First Intervention|Protocol Violation|0|||
129941037|NCT00776009|467746795|FG003|Period 1: First Intervention|Protocol Violation|0|||
129941038|NCT00776009|467746796|FG004|Period 1: First Intervention|Protocol Violation|1|||
129941039|NCT00776009|467746797|FG005|Period 1: First Intervention|Protocol Violation|0|||
129941040|NCT00776009|467746792|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941041|NCT00776009|467746793|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941042|NCT00776009|467746794|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941043|NCT00776009|467746795|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941044|NCT00776009|467746796|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
129941045|NCT00776009|467746797|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
129941046|NCT00776009|467746792|FG000|Period 2: Second Intervention|Protocol Violation|1|||
129941047|NCT00776009|467746793|FG001|Period 2: Second Intervention|Protocol Violation|0|||
129941048|NCT00776009|467746794|FG002|Period 2: Second Intervention|Protocol Violation|1|||
129941049|NCT00776009|467746795|FG003|Period 2: Second Intervention|Protocol Violation|0|||
129941050|NCT00776009|467746796|FG004|Period 2: Second Intervention|Protocol Violation|0|||
129941051|NCT00776009|467746797|FG005|Period 2: Second Intervention|Protocol Violation|0|||
129941052|NCT00776009|467746792|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
129941053|NCT00776009|467746793|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941054|NCT00776009|467746794|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941055|NCT00776009|467746795|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941056|NCT00776009|467746796|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941057|NCT00776009|467746797|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
129941058|NCT04971733|467746798|FG000|Overall Study|Adverse Event|1|||
129941059|NCT04971733|467746799|FG001|Overall Study|Adverse Event|1|||
129941060|NCT04971733|467746798|FG000|Overall Study|Subject choice|2|||
129941061|NCT04971733|467746799|FG001|Overall Study|Subject choice|0|||
129941062|NCT04971733|467746798|FG000|Overall Study|Withdrawal by Subject|1|||
129941063|NCT04971733|467746799|FG001|Overall Study|Withdrawal by Subject|0|||
129941064|NCT04971733|467746798|FG000|Overall Study|Other|1|||
129941065|NCT04971733|467746799|FG001|Overall Study|Other|0|||
129941066|NCT02816398|467746802|FG000|Overall Study|Death|5|||
129941067|NCT02816398|467746802|FG000|Overall Study|Lack of Efficacy|8|||
129941068|NCT02816398|467746802|FG000|Overall Study|Lost to Follow-up|1|||
129941069|NCT01593020|467746806|FG000|Overall Study|Adverse Event|1|||
129941070|NCT01593020|467746807|FG001|Overall Study|Adverse Event|1|||
129941071|NCT01593020|467746806|FG000|Overall Study|Death|0|||
129941072|NCT01593020|467746807|FG001|Overall Study|Death|1|||
129941073|NCT01593020|467746806|FG000|Overall Study|Ineligible|1|||
129941074|NCT01593020|467746807|FG001|Overall Study|Ineligible|0|||
129941075|NCT02972359|467746816|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
129941076|NCT02972359|467746816|FG000|Overall Study|Lack of Efficacy|1|||
129941077|NCT02972359|467746816|FG000|Overall Study|Adverse Event|4|||
129941078|NCT02972359|467746816|FG000|Overall Study|Death|1|||
129941079|NCT02972359|467746816|FG000|Overall Study|Withdrawal by Subject|30|||
129941080|NCT02972359|467746816|FG000|Overall Study|Protocol Violation|1|||
129941081|NCT02972359|467746816|FG000|Overall Study|Lost to Follow-up|26|||
129941082|NCT02972359|467746816|FG000|Overall Study|Other reasons|5|||
129941083|NCT02972359|467746816|FG000|Overall Study|Missing|1|||
129941084|NCT02063659|467746817|FG000|Double-Blind Treatment Period|Adverse Event|1|||
129941085|NCT02063659|467746818|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129941086|NCT02063659|467746819|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129941087|NCT02063659|467746820|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129941088|NCT02063659|467746817|FG000|Double-Blind Treatment Period|Physician Decision|1|||
129941089|NCT02063659|467746818|FG001|Double-Blind Treatment Period|Physician Decision|0|||
129941090|NCT02063659|467746819|FG002|Double-Blind Treatment Period|Physician Decision|0|||
129941091|NCT02063659|467746820|FG003|Double-Blind Treatment Period|Physician Decision|0|||
129941092|NCT02063659|467746817|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
129941093|NCT02063659|467746818|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
129941094|NCT02063659|467746819|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
129941095|NCT02063659|467746820|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
129941096|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
129941097|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
129941098|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
129941099|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
129941100|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129941101|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129941102|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
129941103|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
129941104|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129941105|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129941106|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
129941107|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
129941108|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
129941109|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
129941110|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
129941111|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
129941112|NCT02063659|467746817|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129941113|NCT02063659|467746818|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129941114|NCT02063659|467746819|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
129941115|NCT02063659|467746820|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
129941116|NCT01532999|467746821|FG000|Overall Study|Lost to Follow-up|14|||
129941117|NCT01532999|467746822|FG001|Overall Study|Lost to Follow-up|8|||
129941118|NCT01532999|467746821|FG000|Overall Study|Physician Decision|1|||
129941119|NCT01532999|467746822|FG001|Overall Study|Physician Decision|2|||
129941120|NCT01532999|467746821|FG000|Overall Study|Withdrawal by Subject|5|||
129941121|NCT01532999|467746822|FG001|Overall Study|Withdrawal by Subject|0|||
129941122|NCT01532999|467746821|FG000|Overall Study|Relocated|2|||
129941123|NCT01532999|467746822|FG001|Overall Study|Relocated|0|||
129941124|NCT01532999|467746821|FG000|Overall Study|should not have been randomized|1|||
129941125|NCT01532999|467746822|FG001|Overall Study|should not have been randomized|0|||
129941126|NCT01532999|467746821|FG000|Overall Study|substantial noncompliance|2|||
129941127|NCT01532999|467746822|FG001|Overall Study|substantial noncompliance|0|||
129941128|NCT01532999|467746821|FG000|Overall Study|no show for week 9 assessments|6|||
129941129|NCT01532999|467746822|FG001|Overall Study|no show for week 9 assessments|4|||
129941130|NCT01532999|467746821|FG000|Overall Study|Adverse Event|0|||
129941131|NCT01532999|467746822|FG001|Overall Study|Adverse Event|1|||
129941132|NCT01532999|467746821|FG000|Overall Study|incarcerated|0|||
129941133|NCT01532999|467746822|FG001|Overall Study|incarcerated|1|||
129941134|NCT01532999|467746821|FG000|Overall Study|New job|0|||
129941135|NCT01532999|467746822|FG001|Overall Study|New job|2|||
129941136|NCT05251363|467746825|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
129941137|NCT05251363|467746825|FG000|Overall Study After Implant Period|Death|9|||
129941138|NCT05251363|467746825|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
129941139|NCT05251363|467746825|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
129941140|NCT05251363|467746825|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
129941141|NCT05251363|467746825|FG000|Overall Study After Implant Period|Physician Decision|1|||
129941142|NCT05251363|467746825|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
129941143|NCT03835754|467746828|FG000|Overall Study|Death|4|||
129941144|NCT02830204|467746829|FG000|Overall Study|Death|9|||
129941145|NCT02830204|467746829|FG000|Overall Study|Withdrawal by Subject|1|||
129941146|NCT04686266|467746833|FG000|Overall Study|Withdrawal by Subject|0|||
129941147|NCT04686266|467746834|FG001|Overall Study|Withdrawal by Subject|1|||
129941148|NCT04445831|467746835|FG000|Overall Study|Withdrawal by Subject|2|||
129453115|NCT00326209|465956390|FG000|Overall Study|Withdrawn in error|1|||
129453116|NCT00326209|465956390|FG000|Overall Study|Pregnancy|1|||
129453117|NCT00714285|465956391|FG000|Overall Study|Lost to Follow-up|0|||
129941149|NCT04445831|467746836|FG001|Overall Study|Withdrawal by Subject|1|||
129941150|NCT04445831|467746837|FG002|Overall Study|Withdrawal by Subject|1|||
129941151|NCT04445831|467746838|FG003|Overall Study|Withdrawal by Subject|0|||
129941152|NCT04445831|467746839|FG004|Overall Study|Withdrawal by Subject|0|||
129941153|NCT04445831|467746840|FG005|Overall Study|Withdrawal by Subject|0|||
129941154|NCT04445831|467746841|FG006|Overall Study|Withdrawal by Subject|0|||
129941155|NCT04445831|467746835|FG000|Overall Study|Subject withdrawal by caregiver|0|||
129941156|NCT04445831|467746836|FG001|Overall Study|Subject withdrawal by caregiver|1|||
129941157|NCT04445831|467746837|FG002|Overall Study|Subject withdrawal by caregiver|0|||
129453118|NCT00714285|465956392|FG001|Overall Study|Lost to Follow-up|2|||
129453119|NCT00714285|465956393|FG002|Overall Study|Lost to Follow-up|0|||
129941158|NCT04445831|467746838|FG003|Overall Study|Subject withdrawal by caregiver|0|||
129941159|NCT04445831|467746839|FG004|Overall Study|Subject withdrawal by caregiver|0|||
129941160|NCT04445831|467746840|FG005|Overall Study|Subject withdrawal by caregiver|0|||
129941161|NCT04445831|467746841|FG006|Overall Study|Subject withdrawal by caregiver|0|||
129941162|NCT04306367|467746846|FG000|Overall Study|Progression of Disease|9|||
129941163|NCT04306367|467746846|FG000|Overall Study|Adverse Event|3|||
129941164|NCT04306367|467746846|FG000|Overall Study|Withdrawal by Subject|1|||
129941165|NCT04912856|467746849|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
129941166|NCT04912856|467746850|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
129941167|NCT04912856|467746849|FG000|Overall Study|Not reported in synoptic CSR.|0|||
129941168|NCT04912856|467746850|FG001|Overall Study|Not reported in synoptic CSR.|1|||
129941169|NCT05470114|467746859|FG000|Overall Study|Withdrawal by Subject|1|||
129941170|NCT05470114|467746860|FG001|Overall Study|Withdrawal by Subject|0|||
129941171|NCT05470114|467746859|FG000|Overall Study|Lost to Follow-up|1|||
129941172|NCT05470114|467746860|FG001|Overall Study|Lost to Follow-up|0|||
129941173|NCT01563185|467746861|FG000|Overall Study|Withdrawal by Subject|1|||
129941174|NCT01563185|467746861|FG000|Overall Study|Non-Compliance with study drug|1|||
129941175|NCT05864209|467748292|FG000|Overall Study|Lost to Follow-up|2|||
129941176|NCT05864209|467748293|FG001|Overall Study|Lost to Follow-up|3|||
129941177|NCT06056310|467748296|FG000|Overall Study|Other Reasons|2|||
129941178|NCT06056310|467748296|FG000|Overall Study|Sponsor Request|16|||
129941179|NCT05029284|467748299|FG000|Overall Study|Lost to Follow-up|1|||
129941180|NCT04001829|467748300|FG000|Overall Study|Never start protocol therapy|5|||
129941181|NCT04001829|467748301|FG001|Overall Study|Never start protocol therapy|5|||
129941182|NCT04001829|467748300|FG000|Overall Study|Adverse Event|11|||
129941183|NCT04001829|467748301|FG001|Overall Study|Adverse Event|7|||
129941184|NCT04001829|467748300|FG000|Overall Study|Alternative therapy|1|||
129941185|NCT04001829|467748301|FG001|Overall Study|Alternative therapy|2|||
129941186|NCT04001829|467748300|FG000|Overall Study|Disease progression/relapse|2|||
129941187|NCT04001829|467748301|FG001|Overall Study|Disease progression/relapse|1|||
129941188|NCT04001829|467748300|FG000|Overall Study|Other complicating disease|1|||
129941189|NCT04001829|467748301|FG001|Overall Study|Other complicating disease|0|||
129941190|NCT04001829|467748300|FG000|Overall Study|Withdrawal by Subject|1|||
129941191|NCT04001829|467748301|FG001|Overall Study|Withdrawal by Subject|4|||
129941192|NCT04001829|467748300|FG000|Overall Study|Ineligible|2|||
129941193|NCT04001829|467748301|FG001|Overall Study|Ineligible|2|||
129941194|NCT04001829|467748300|FG000|Overall Study|Reason missing due to delinquent data|1|||
129941195|NCT04001829|467748301|FG001|Overall Study|Reason missing due to delinquent data|0|||
129941196|NCT00985088|467748304|FG000|Overall Study|Serious Adverse Event|1|||
129941197|NCT00985088|467748305|FG001|Overall Study|Serious Adverse Event|1|||
129941198|NCT00985088|467748306|FG002|Overall Study|Serious Adverse Event|0|||
129941199|NCT00985088|467748307|FG003|Overall Study|Serious Adverse Event|0|||
129941200|NCT00985088|467748308|FG004|Overall Study|Serious Adverse Event|0|||
129941201|NCT00985088|467748309|FG005|Overall Study|Serious Adverse Event|0|||
129941202|NCT00985088|467748310|FG006|Overall Study|Serious Adverse Event|0|||
129941203|NCT00985088|467748311|FG007|Overall Study|Serious Adverse Event|1|||
129941204|NCT00985088|467748304|FG000|Overall Study|Adverse Event|0|||
129941205|NCT00985088|467748305|FG001|Overall Study|Adverse Event|0|||
129941206|NCT00985088|467748306|FG002|Overall Study|Adverse Event|1|||
129941207|NCT00985088|467748307|FG003|Overall Study|Adverse Event|0|||
129941208|NCT00985088|467748308|FG004|Overall Study|Adverse Event|0|||
129941209|NCT00985088|467748309|FG005|Overall Study|Adverse Event|0|||
129941210|NCT00985088|467748310|FG006|Overall Study|Adverse Event|0|||
129941211|NCT00985088|467748311|FG007|Overall Study|Adverse Event|0|||
129941212|NCT00985088|467748304|FG000|Overall Study|Withdrawal by Subject|4|||
129941213|NCT00985088|467748305|FG001|Overall Study|Withdrawal by Subject|0|||
129941214|NCT00985088|467748306|FG002|Overall Study|Withdrawal by Subject|0|||
129941215|NCT00985088|467748307|FG003|Overall Study|Withdrawal by Subject|1|||
129941216|NCT00985088|467748308|FG004|Overall Study|Withdrawal by Subject|3|||
129941217|NCT00985088|467748309|FG005|Overall Study|Withdrawal by Subject|2|||
129941218|NCT00985088|467748310|FG006|Overall Study|Withdrawal by Subject|1|||
129941219|NCT00985088|467748311|FG007|Overall Study|Withdrawal by Subject|2|||
129941220|NCT00985088|467748304|FG000|Overall Study|Migrated/moved from study area|0|||
129941221|NCT00985088|467748305|FG001|Overall Study|Migrated/moved from study area|0|||
129941222|NCT00985088|467748306|FG002|Overall Study|Migrated/moved from study area|1|||
129941223|NCT00985088|467748307|FG003|Overall Study|Migrated/moved from study area|0|||
129941224|NCT00985088|467748308|FG004|Overall Study|Migrated/moved from study area|0|||
129941225|NCT00985088|467748309|FG005|Overall Study|Migrated/moved from study area|0|||
129941226|NCT00985088|467748310|FG006|Overall Study|Migrated/moved from study area|0|||
129941227|NCT00985088|467748311|FG007|Overall Study|Migrated/moved from study area|1|||
129941228|NCT00985088|467748304|FG000|Overall Study|Lost to Follow-up|6|||
129941229|NCT00985088|467748305|FG001|Overall Study|Lost to Follow-up|1|||
129941230|NCT00985088|467748306|FG002|Overall Study|Lost to Follow-up|2|||
129941231|NCT00985088|467748307|FG003|Overall Study|Lost to Follow-up|6|||
129941232|NCT00985088|467748308|FG004|Overall Study|Lost to Follow-up|6|||
129941233|NCT00985088|467748309|FG005|Overall Study|Lost to Follow-up|5|||
129941234|NCT00985088|467748310|FG006|Overall Study|Lost to Follow-up|3|||
129941235|NCT00985088|467748311|FG007|Overall Study|Lost to Follow-up|2|||
129941236|NCT01737398|467748312|FG000|Overall Study|Adverse event or SAE|16|||
129941237|NCT01737398|467748313|FG001|Overall Study|Adverse event or SAE|1|||
129941238|NCT01737398|467748312|FG000|Overall Study|Stopping rule met|2|||
129941239|NCT01737398|467748313|FG001|Overall Study|Stopping rule met|1|||
129941240|NCT01737398|467748312|FG000|Overall Study|Voluntary withdrawal|2|||
129941241|NCT01737398|467748313|FG001|Overall Study|Voluntary withdrawal|3|||
129941242|NCT01737398|467748312|FG000|Overall Study|Ineligibility|1|||
129941243|NCT01737398|467748313|FG001|Overall Study|Ineligibility|0|||
129941244|NCT01737398|467748312|FG000|Overall Study|Liver transplant|1|||
129941245|NCT01737398|467748313|FG001|Overall Study|Liver transplant|0|||
129941246|NCT01737398|467748312|FG000|Overall Study|Disease progression|2|||
129941247|NCT01737398|467748313|FG001|Overall Study|Disease progression|3|||
129941248|NCT01737398|467748312|FG000|Overall Study|Sponsor's decision|2|||
129941249|NCT01737398|467748313|FG001|Overall Study|Sponsor's decision|0|||
129941250|NCT05250115|467748314|FG000|Overall Study|Premature study end|40|||
129941251|NCT05250115|467748314|FG000|Overall Study|Adverse Event|8|||
129941252|NCT05250115|467748314|FG000|Overall Study|Lost to Follow-up|7|||
129941253|NCT05250115|467748314|FG000|Overall Study|Withdrawal by Subject|6|||
129941254|NCT05250115|467748314|FG000|Overall Study|Withdrawal of informed consent|1|||
129941255|NCT05250115|467748314|FG000|Overall Study|Other|7|||
129941256|NCT01478594|467748321|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
129941257|NCT01478594|467748322|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
129941258|NCT01478594|467748321|FG000|Overall Study|Death|45|||
129941259|NCT01478594|467748322|FG001|Overall Study|Death|18|||
129941260|NCT01478594|467748321|FG000|Overall Study|Lost to Follow-up|3|||
129941261|NCT01478594|467748322|FG001|Overall Study|Lost to Follow-up|1|||
129941262|NCT01478594|467748321|FG000|Overall Study|Withdrawal by Subject|9|||
129941263|NCT01478594|467748322|FG001|Overall Study|Withdrawal by Subject|3|||
129941264|NCT01478594|467748321|FG000|Overall Study|Study Closed by Sponsor|8|||
129941265|NCT01478594|467748322|FG001|Overall Study|Study Closed by Sponsor|5|||
129941266|NCT04885998|467748323|FG000|Overall Study|Withdrawal by Subject|0|||
129941267|NCT04885998|467748324|FG001|Overall Study|Withdrawal by Subject|2|||
129941268|NCT04885998|467748325|FG002|Overall Study|Withdrawal by Subject|0|||
129941269|NCT04885998|467748326|FG003|Overall Study|Withdrawal by Subject|3|||
129941270|NCT04885998|467748323|FG000|Overall Study|Lost to Follow-up|1|||
129941271|NCT04885998|467748324|FG001|Overall Study|Lost to Follow-up|1|||
129941272|NCT04885998|467748325|FG002|Overall Study|Lost to Follow-up|0|||
129941273|NCT04885998|467748326|FG003|Overall Study|Lost to Follow-up|0|||
129941274|NCT04885998|467748323|FG000|Overall Study|Death|2|||
129941275|NCT04885998|467748324|FG001|Overall Study|Death|1|||
129941276|NCT04885998|467748325|FG002|Overall Study|Death|2|||
129941277|NCT04885998|467748326|FG003|Overall Study|Death|2|||
129941278|NCT04885998|467748323|FG000|Overall Study|Decision by sponsor|1|||
129941279|NCT04885998|467748324|FG001|Overall Study|Decision by sponsor|1|||
129941280|NCT04885998|467748325|FG002|Overall Study|Decision by sponsor|0|||
129941281|NCT04885998|467748326|FG003|Overall Study|Decision by sponsor|0|||
129941282|NCT03712371|467748328|FG000|Overall Study|Lack of Efficacy|0|||
129941283|NCT03712371|467748329|FG001|Overall Study|Lack of Efficacy|0|||
129941284|NCT03712371|467748330|FG002|Overall Study|Lack of Efficacy|0|||
129941285|NCT03712371|467748331|FG003|Overall Study|Lack of Efficacy|1|||
129941286|NCT02788981|467748334|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
129941287|NCT02788981|467748335|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
129941288|NCT04250194|467748336|FG000|Overall Study|Declined to schedule biopsy|6|||
129941289|NCT04250194|467748337|FG001|Overall Study|Declined to schedule biopsy|10|||
129941290|NCT04250194|467748336|FG000|Overall Study|Medically Unfit for Biopsy|2|||
129941291|NCT04250194|467748337|FG001|Overall Study|Medically Unfit for Biopsy|1|||
129941292|NCT04250194|467748336|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
129941293|NCT04250194|467748337|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
129941294|NCT04250194|467748336|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
129941295|NCT04250194|467748337|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
129941296|NCT04250194|467748336|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
129941297|NCT04250194|467748337|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
129941298|NCT03113409|467748342|FG000|Overall Study|Withdrawal by Subject|5|||
129941299|NCT03113409|467748343|FG001|Overall Study|Withdrawal by Subject|0|||
129941300|NCT03113409|467748344|FG002|Overall Study|Withdrawal by Subject|0|||
129941301|NCT02040870|467748345|FG000|Overall Study|Completed treatment phase|6|||
129941302|NCT02040870|467748345|FG000|Overall Study|Adverse Event|7|||
129941303|NCT02040870|467748345|FG000|Overall Study|Progressive disease|58|||
129941304|NCT02040870|467748345|FG000|Overall Study|Physician Decision|6|||
129941305|NCT02040870|467748345|FG000|Overall Study|Subject/guardian decision|10|||
129941306|NCT02040870|467748345|FG000|Overall Study|Lost to Follow-up|3|||
129941307|NCT02040870|467748345|FG000|Overall Study|Death|13|||
129941308|NCT02275611|467748348|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
129941309|NCT02275611|467748349|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
129941310|NCT02275611|467748350|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
129941311|NCT02275611|467748351|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
129941312|NCT01759862|467748357|FG000|Overall Study|Physician Decision|3|||
129941313|NCT01759862|467748358|FG001|Overall Study|Physician Decision|1|||
129941314|NCT01759862|467748357|FG000|Overall Study|Adverse Event|0|||
129941315|NCT01759862|467748358|FG001|Overall Study|Adverse Event|1|||
129941316|NCT03041233|467748361|FG000|Overall Study|Death|5|||
129941317|NCT03041233|467748361|FG000|Overall Study|Physician Decision|1|||
129941318|NCT03041233|467748361|FG000|Overall Study|Lost to Follow-up|16|||
129941319|NCT03041233|467748361|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
129941320|NCT03041233|467748361|FG000|Overall Study|Sponsor Request|1|||
129941321|NCT03041233|467748361|FG000|Overall Study|Duplicate subject|1|||
129941322|NCT03041233|467748361|FG000|Overall Study|Re-ablation|1|||
129941323|NCT03516812|467748364|FG000|Overall Study|Adverse Event|4|||
129941324|NCT03516812|467748364|FG000|Overall Study|Lack of Efficacy|2|||
129941325|NCT03890289|467748365|FG000|Overall Study|Adverse Event|1|||
129941326|NCT03890289|467748365|FG000|Overall Study|Physician Decision|1|||
129941327|NCT03890289|467748365|FG000|Overall Study|Lack of Efficacy|2|||
129941328|NCT01588951|467748369|FG000|Overall Study|Ineligible in retrospect|0|||
129941329|NCT01588951|467748370|FG001|Overall Study|Ineligible in retrospect|0|||
129941330|NCT01588951|467748371|FG002|Overall Study|Ineligible in retrospect|1|||
129941331|NCT02628626|467748372|FG000|Overall Study|Withdrawal by Subject|2|||
129941332|NCT02628626|467748373|FG001|Overall Study|Withdrawal by Subject|2|||
129941333|NCT01400958|467748376|FG000|Overall Study|Physician Decision|0|||
129941334|NCT01400958|467748377|FG001|Overall Study|Physician Decision|1|||
129941335|NCT01400958|467748376|FG000|Overall Study|Withdrawal by Subject|0|||
129941336|NCT01400958|467748377|FG001|Overall Study|Withdrawal by Subject|1|||
129941337|NCT01400958|467748376|FG000|Overall Study|Adverse Event|1|||
129941338|NCT01400958|467748377|FG001|Overall Study|Adverse Event|0|||
129941339|NCT00914966|467748378|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
129941340|NCT00914966|467748378|FG000|Step 1: 1500 Units|Physician Decision|1|||
129941341|NCT00914966|467748378|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
129941342|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941343|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
129941344|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941345|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941346|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941347|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
129941348|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
129941349|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941350|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941351|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941352|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941353|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
129941354|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941355|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941356|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
129941357|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941358|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941359|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
129941360|NCT04021862|467748379|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
129941361|NCT04021862|467748380|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
129941362|NCT04021862|467748381|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
129941363|NCT04021862|467748382|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
129941364|NCT04021862|467748383|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
129941365|NCT04021862|467748384|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
129941366|NCT04021862|467748379|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941367|NCT04021862|467748380|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941368|NCT04021862|467748381|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941369|NCT04021862|467748382|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
129941370|NCT04021862|467748383|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941371|NCT04021862|467748384|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
129941372|NCT01690624|467748385|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
129941373|NCT01690624|467748386|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
129941374|NCT01690624|467748387|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
129941375|NCT01690624|467748388|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
129941376|NCT01690624|467748385|FG000|Overall Study|Adverse event (other than DLT)|3|||
129941377|NCT01690624|467748386|FG001|Overall Study|Adverse event (other than DLT)|1|||
129941378|NCT01690624|467748387|FG002|Overall Study|Adverse event (other than DLT)|1|||
129941379|NCT01690624|467748388|FG003|Overall Study|Adverse event (other than DLT)|1|||
129941380|NCT01690624|467748385|FG000|Overall Study|Withdrawal by Subject|0|||
129941381|NCT01690624|467748386|FG001|Overall Study|Withdrawal by Subject|0|||
129941382|NCT01690624|467748387|FG002|Overall Study|Withdrawal by Subject|1|||
129941383|NCT01690624|467748388|FG003|Overall Study|Withdrawal by Subject|0|||
129941384|NCT01690624|467748385|FG000|Overall Study|Sponsor is ending trial|0|||
129941385|NCT01690624|467748386|FG001|Overall Study|Sponsor is ending trial|0|||
129941386|NCT01690624|467748387|FG002|Overall Study|Sponsor is ending trial|0|||
129941387|NCT01690624|467748388|FG003|Overall Study|Sponsor is ending trial|1|||
129941388|NCT01690624|467748385|FG000|Overall Study|Physician Decision|0|||
129941389|NCT01690624|467748386|FG001|Overall Study|Physician Decision|0|||
129941390|NCT01690624|467748387|FG002|Overall Study|Physician Decision|0|||
129941391|NCT01690624|467748388|FG003|Overall Study|Physician Decision|1|||
129941392|NCT01690624|467748385|FG000|Overall Study|Withdrawal by Subject|0|||
129941393|NCT01690624|467748386|FG001|Overall Study|Withdrawal by Subject|1|||
129941394|NCT01690624|467748387|FG002|Overall Study|Withdrawal by Subject|0|||
129941395|NCT01690624|467748388|FG003|Overall Study|Withdrawal by Subject|0|||
129941396|NCT01690624|467748385|FG000|Overall Study|Lack of Efficacy|1|||
129941397|NCT01690624|467748386|FG001|Overall Study|Lack of Efficacy|1|||
129941398|NCT01690624|467748387|FG002|Overall Study|Lack of Efficacy|3|||
129941399|NCT01690624|467748388|FG003|Overall Study|Lack of Efficacy|0|||
129941400|NCT02517268|467748390|FG000|Overall Study|Withdrawal by Subject|1|||
129941401|NCT02517268|467748391|FG001|Overall Study|Withdrawal by Subject|0|||
129941402|NCT04649047|467748398|FG000|Overall Study|Withdrawal by Subject|3|||
129941403|NCT00719888|467748399|FG000|Overall Study|Death|24|||
129941404|NCT00719888|467748400|FG001|Overall Study|Death|9|||
129941405|NCT00719888|467748399|FG000|Overall Study|Relapse|8|||
129941406|NCT00719888|467748400|FG001|Overall Study|Relapse|3|||
129941407|NCT00719888|467748399|FG000|Overall Study|Physician Decision|1|||
129941408|NCT00719888|467748400|FG001|Overall Study|Physician Decision|0|||
129941409|NCT00719888|467748399|FG000|Overall Study|Withdrawal by Subject|1|||
129941410|NCT00719888|467748400|FG001|Overall Study|Withdrawal by Subject|0|||
129941411|NCT05037513|467748401|FG000|Intervention Period|Lost to Follow-up|1|||
129941412|NCT05037513|467748402|FG001|Intervention Period|Lost to Follow-up|2|||
129941413|NCT05037513|467748401|FG000|Follow Up Period|Lost to Follow-up|16|||
129941414|NCT05037513|467748402|FG001|Follow Up Period|Lost to Follow-up|21|||
129941415|NCT05037513|467748401|FG000|Follow Up Period|Death|0|||
129941416|NCT05037513|467748402|FG001|Follow Up Period|Death|1|||
129941417|NCT05037513|467748401|FG000|Follow Up Period|Incarcerated|4|||
129941418|NCT05037513|467748402|FG001|Follow Up Period|Incarcerated|2|||
129941419|NCT03773107|467748403|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
129941420|NCT03773107|467748404|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
129941421|NCT03773107|467748405|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
129941422|NCT03773107|467748406|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
129941423|NCT02328014|467749730|FG000|Overall Study|Adverse Event|1|||
129941424|NCT02328014|467749731|FG001|Overall Study|Adverse Event|0|||
129941425|NCT02328014|467749732|FG002|Overall Study|Adverse Event|0|||
129941426|NCT02328014|467749733|FG003|Overall Study|Adverse Event|1|||
129941427|NCT02328014|467749730|FG000|Overall Study|Death|0|||
129941428|NCT02328014|467749731|FG001|Overall Study|Death|0|||
129941429|NCT02328014|467749732|FG002|Overall Study|Death|0|||
129941430|NCT02328014|467749733|FG003|Overall Study|Death|4|||
129941431|NCT02328014|467749730|FG000|Overall Study|Physician Decision|0|||
129941432|NCT02328014|467749731|FG001|Overall Study|Physician Decision|0|||
129941433|NCT02328014|467749732|FG002|Overall Study|Physician Decision|0|||
129941434|NCT02328014|467749733|FG003|Overall Study|Physician Decision|1|||
129941435|NCT02328014|467749730|FG000|Overall Study|Disease Progression|1|||
129941436|NCT02328014|467749731|FG001|Overall Study|Disease Progression|0|||
129941437|NCT02328014|467749732|FG002|Overall Study|Disease Progression|1|||
129941438|NCT02328014|467749733|FG003|Overall Study|Disease Progression|3|||
129941439|NCT02328014|467749730|FG000|Overall Study|Study Terminated by Sponsor|4|||
129941440|NCT02328014|467749731|FG001|Overall Study|Study Terminated by Sponsor|1|||
129941441|NCT02328014|467749732|FG002|Overall Study|Study Terminated by Sponsor|1|||
129941442|NCT02328014|467749733|FG003|Overall Study|Study Terminated by Sponsor|0|||
129941443|NCT02328014|467749730|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
129941444|NCT02328014|467749731|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
129941445|NCT02328014|467749732|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
129941446|NCT02328014|467749733|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
129941447|NCT02328014|467749730|FG000|Overall Study|Withdrawal by Subject|0|||
129941448|NCT02328014|467749731|FG001|Overall Study|Withdrawal by Subject|0|||
129941449|NCT02328014|467749732|FG002|Overall Study|Withdrawal by Subject|0|||
129941450|NCT02328014|467749733|FG003|Overall Study|Withdrawal by Subject|1|||
129941451|NCT01274338|467749734|FG000|Overall Study|Lack of Efficacy|72|||
129941452|NCT01274338|467749735|FG001|Overall Study|Lack of Efficacy|108|||
129941453|NCT01274338|467749736|FG002|Overall Study|Lack of Efficacy|116|||
129941454|NCT01274338|467749737|FG003|Overall Study|Lack of Efficacy|0|||
129941455|NCT01274338|467749738|FG004|Overall Study|Lack of Efficacy|0|||
129941456|NCT01274338|467749739|FG005|Overall Study|Lack of Efficacy|0|||
129941457|NCT01274338|467749734|FG000|Overall Study|Adverse Event|272|||
129941458|NCT01274338|467749735|FG001|Overall Study|Adverse Event|105|||
129941459|NCT01274338|467749736|FG002|Overall Study|Adverse Event|180|||
129941460|NCT01274338|467749737|FG003|Overall Study|Adverse Event|1|||
129941461|NCT01274338|467749738|FG004|Overall Study|Adverse Event|0|||
129941462|NCT01274338|467749739|FG005|Overall Study|Adverse Event|0|||
129941463|NCT01274338|467749734|FG000|Overall Study|Death|8|||
129941464|NCT01274338|467749735|FG001|Overall Study|Death|1|||
129941465|NCT01274338|467749736|FG002|Overall Study|Death|0|||
129941466|NCT01274338|467749737|FG003|Overall Study|Death|0|||
129941467|NCT01274338|467749738|FG004|Overall Study|Death|0|||
129941468|NCT01274338|467749739|FG005|Overall Study|Death|0|||
129941469|NCT01274338|467749734|FG000|Overall Study|Withdrawal by Subject|27|||
129941470|NCT01274338|467749735|FG001|Overall Study|Withdrawal by Subject|99|||
129941471|NCT01274338|467749736|FG002|Overall Study|Withdrawal by Subject|17|||
129941472|NCT01274338|467749737|FG003|Overall Study|Withdrawal by Subject|0|||
129941473|NCT01274338|467749738|FG004|Overall Study|Withdrawal by Subject|0|||
129941474|NCT01274338|467749739|FG005|Overall Study|Withdrawal by Subject|0|||
129941475|NCT01274338|467749734|FG000|Overall Study|Did not start treatment|8|||
129941476|NCT01274338|467749735|FG001|Overall Study|Did not start treatment|116|||
129941477|NCT01274338|467749736|FG002|Overall Study|Did not start treatment|7|||
129941478|NCT01274338|467749737|FG003|Overall Study|Did not start treatment|0|||
129941479|NCT01274338|467749738|FG004|Overall Study|Did not start treatment|0|||
129941480|NCT01274338|467749739|FG005|Overall Study|Did not start treatment|0|||
129941481|NCT01274338|467749734|FG000|Overall Study|Alternative therapy|0|||
129941482|NCT01274338|467749735|FG001|Overall Study|Alternative therapy|1|||
129941483|NCT01274338|467749736|FG002|Overall Study|Alternative therapy|0|||
129941484|NCT01274338|467749737|FG003|Overall Study|Alternative therapy|0|||
129941485|NCT01274338|467749738|FG004|Overall Study|Alternative therapy|0|||
129941486|NCT01274338|467749739|FG005|Overall Study|Alternative therapy|0|||
129941487|NCT01274338|467749734|FG000|Overall Study|Other complicating diseases|0|||
129941488|NCT01274338|467749735|FG001|Overall Study|Other complicating diseases|3|||
129941489|NCT01274338|467749736|FG002|Overall Study|Other complicating diseases|1|||
129941490|NCT01274338|467749737|FG003|Overall Study|Other complicating diseases|0|||
129941491|NCT01274338|467749738|FG004|Overall Study|Other complicating diseases|0|||
129941492|NCT01274338|467749739|FG005|Overall Study|Other complicating diseases|0|||
129941493|NCT01274338|467749734|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
129941494|NCT01274338|467749735|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941495|NCT01274338|467749736|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941496|NCT01274338|467749737|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941497|NCT01274338|467749738|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941498|NCT01274338|467749739|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
129941499|NCT01274338|467749734|FG000|Overall Study|Pregnancy|0|||
129941500|NCT01274338|467749735|FG001|Overall Study|Pregnancy|0|||
129941501|NCT01274338|467749736|FG002|Overall Study|Pregnancy|1|||
129941502|NCT01274338|467749737|FG003|Overall Study|Pregnancy|0|||
129941503|NCT01274338|467749738|FG004|Overall Study|Pregnancy|0|||
129941504|NCT01274338|467749739|FG005|Overall Study|Pregnancy|0|||
129941505|NCT01274338|467749734|FG000|Overall Study|Reason not reported|12|||
129941506|NCT01274338|467749735|FG001|Overall Study|Reason not reported|21|||
129941507|NCT01274338|467749736|FG002|Overall Study|Reason not reported|3|||
129941508|NCT01274338|467749737|FG003|Overall Study|Reason not reported|0|||
129941509|NCT01274338|467749738|FG004|Overall Study|Reason not reported|1|||
129941510|NCT01274338|467749739|FG005|Overall Study|Reason not reported|0|||
129941511|NCT05422339|467749740|FG000|Overall Study|Withdrawal by Subject|17|||
129941512|NCT05422339|467749741|FG001|Overall Study|Withdrawal by Subject|15|||
129941513|NCT03678688|467749748|FG000|Overall Study|Reason not Specified|0|||
129941514|NCT03678688|467749749|FG001|Overall Study|Reason not Specified|0|||
129941515|NCT03678688|467749750|FG002|Overall Study|Reason not Specified|3|||
129941516|NCT03678688|467749751|FG003|Overall Study|Reason not Specified|0|||
129941517|NCT03678688|467749752|FG004|Overall Study|Reason not Specified|1|||
129941518|NCT03678688|467749753|FG005|Overall Study|Reason not Specified|0|||
129941519|NCT03678688|467749754|FG006|Overall Study|Reason not Specified|0|||
129941520|NCT03678688|467749755|FG007|Overall Study|Reason not Specified|0|||
129941521|NCT03678688|467749756|FG008|Overall Study|Reason not Specified|0|||
129941522|NCT03678688|467749748|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
129941523|NCT03678688|467749749|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
129941524|NCT03678688|467749750|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
129453120|NCT00714285|465956394|FG003|Overall Study|Lost to Follow-up|1|||
129453121|NCT00714285|465956391|FG000|Overall Study|Migrated/moved from study area|0|||
129453122|NCT00714285|465956392|FG001|Overall Study|Migrated/moved from study area|1|||
129453123|NCT00714285|465956393|FG002|Overall Study|Migrated/moved from study area|0|||
129453124|NCT00714285|465956394|FG003|Overall Study|Migrated/moved from study area|0|||
129453125|NCT01372384|465956395|FG000|Overall Study|Progression of disease|3|||
129453126|NCT01131676|465956400|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
129453127|NCT01131676|465956401|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
129453128|NCT01131676|465956402|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
129453129|NCT01131676|465956400|FG000|Discontinuation From Treatment|Not treated|4|||
129453130|NCT01131676|465956401|FG001|Discontinuation From Treatment|Not treated|2|||
129453131|NCT01131676|465956402|FG002|Discontinuation From Treatment|Not treated|2|||
129453132|NCT01131676|465956400|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
129941525|NCT03678688|467749751|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
129941526|NCT03678688|467749752|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
129941527|NCT03678688|467749753|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
129941528|NCT03678688|467749754|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
129941529|NCT03678688|467749755|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
129941530|NCT03678688|467749756|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
129941531|NCT03678688|467749748|FG000|Overall Study|Covid Related Adverse Event|0|||
129941532|NCT03678688|467749749|FG001|Overall Study|Covid Related Adverse Event|0|||
129941533|NCT03678688|467749750|FG002|Overall Study|Covid Related Adverse Event|0|||
129941534|NCT03678688|467749751|FG003|Overall Study|Covid Related Adverse Event|0|||
129941535|NCT03678688|467749752|FG004|Overall Study|Covid Related Adverse Event|0|||
129941536|NCT03678688|467749753|FG005|Overall Study|Covid Related Adverse Event|3|||
129941537|NCT03678688|467749754|FG006|Overall Study|Covid Related Adverse Event|1|||
129453133|NCT01131676|465956401|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
129453134|NCT01131676|465956402|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
129941538|NCT03678688|467749755|FG007|Overall Study|Covid Related Adverse Event|1|||
129941539|NCT03678688|467749756|FG008|Overall Study|Covid Related Adverse Event|0|||
129941540|NCT03678688|467749748|FG000|Overall Study|Physician Decision|0|||
129941541|NCT03678688|467749749|FG001|Overall Study|Physician Decision|0|||
129941542|NCT03678688|467749750|FG002|Overall Study|Physician Decision|0|||
129941543|NCT03678688|467749751|FG003|Overall Study|Physician Decision|0|||
129941544|NCT03678688|467749752|FG004|Overall Study|Physician Decision|0|||
129941545|NCT03678688|467749753|FG005|Overall Study|Physician Decision|1|||
129941546|NCT03678688|467749754|FG006|Overall Study|Physician Decision|0|||
129941547|NCT03678688|467749755|FG007|Overall Study|Physician Decision|0|||
129941548|NCT03678688|467749756|FG008|Overall Study|Physician Decision|0|||
129941549|NCT03678688|467749748|FG000|Overall Study|Withdrawal by Subject|0|||
129941550|NCT03678688|467749749|FG001|Overall Study|Withdrawal by Subject|0|||
129941551|NCT03678688|467749750|FG002|Overall Study|Withdrawal by Subject|0|||
129941552|NCT03678688|467749751|FG003|Overall Study|Withdrawal by Subject|0|||
129941553|NCT03678688|467749752|FG004|Overall Study|Withdrawal by Subject|0|||
129941554|NCT03678688|467749753|FG005|Overall Study|Withdrawal by Subject|0|||
129941555|NCT03678688|467749754|FG006|Overall Study|Withdrawal by Subject|2|||
129941556|NCT03678688|467749755|FG007|Overall Study|Withdrawal by Subject|1|||
129941557|NCT03678688|467749756|FG008|Overall Study|Withdrawal by Subject|0|||
129941558|NCT01278030|467749763|FG000|Overall Study|Withdrawal by Subject|8|||
129941559|NCT01278030|467749764|FG001|Overall Study|Withdrawal by Subject|4|||
129941560|NCT00458783|467749766|FG000|Overall Study|Protocol Violation|1228|||
129941561|NCT00458783|467749767|FG001|Overall Study|Protocol Violation|1220|||
129941562|NCT04401267|467749769|FG000|Overall Study|Death|0|||
129941563|NCT04401267|467749770|FG001|Overall Study|Death|1|||
129941564|NCT04401267|467749769|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
129941565|NCT04401267|467749770|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
129941566|NCT04401267|467749769|FG000|Overall Study|Found to be Ineligible|1|||
129941567|NCT04401267|467749770|FG001|Overall Study|Found to be Ineligible|0|||
129941568|NCT03214081|467749771|FG000|Overall Study|Case Report Forms Uncollected|9|||
129941569|NCT03214081|467749771|FG000|Overall Study|Protocol Deviation|54|||
129941570|NCT02962284|467749772|FG000|Overall Study|Death|2|||
129941571|NCT02962284|467749773|FG001|Overall Study|Death|0|||
129941572|NCT02962284|467749772|FG000|Overall Study|Progressive disease|2|||
129941573|NCT02962284|467749773|FG001|Overall Study|Progressive disease|3|||
129941574|NCT02962284|467749772|FG000|Overall Study|Withdrawal by Subject|1|||
129941575|NCT02962284|467749773|FG001|Overall Study|Withdrawal by Subject|0|||
129941576|NCT05815342|467749774|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
129941577|NCT05815342|467749774|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
129941578|NCT05815342|467749774|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
129941579|NCT05815342|467749774|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
129941580|NCT05815342|467749774|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
129941581|NCT00345046|467749777|FG000|Overall Study|Protocol Violation|1|||
129941582|NCT00345046|467749778|FG001|Overall Study|Protocol Violation|1|||
129941583|NCT00345046|467749779|FG002|Overall Study|Protocol Violation|2|||
129941584|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
129941585|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
129941586|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
129941587|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Death|0|||
129941588|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Death|2|||
129941589|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Death|1|||
129941590|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
129941591|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
129941592|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
129941593|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
129941594|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
129941595|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
129941596|NCT00790569|467749780|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
129941597|NCT00790569|467749781|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
129941598|NCT00790569|467749782|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
129941599|NCT00790569|467749780|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
129941600|NCT00790569|467749781|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
129941601|NCT00790569|467749782|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
129941602|NCT03244800|467749784|FG000|Overall Study|Adverse Event|0|||
129941603|NCT03244800|467749785|FG001|Overall Study|Adverse Event|1|||
129941604|NCT03244800|467749786|FG002|Overall Study|Adverse Event|0|||
129941605|NCT03244800|467749787|FG003|Overall Study|Adverse Event|1|||
129941606|NCT03244800|467749784|FG000|Overall Study|Withdrew treatment|0|||
129941607|NCT03244800|467749785|FG001|Overall Study|Withdrew treatment|0|||
129941608|NCT03244800|467749786|FG002|Overall Study|Withdrew treatment|0|||
129941609|NCT03244800|467749787|FG003|Overall Study|Withdrew treatment|1|||
129941610|NCT02362035|467749788|FG000|Overall Study|Death|67|||
129941611|NCT02362035|467749788|FG000|Overall Study|Lost to Follow-up|3|||
129941612|NCT02362035|467749788|FG000|Overall Study|Adverse Event|1|||
129941613|NCT02362035|467749788|FG000|Overall Study|Physician Decision|1|||
129941614|NCT02362035|467749788|FG000|Overall Study|Subject started another cancer therapy|10|||
129941615|NCT02362035|467749788|FG000|Overall Study|Study terminated by sponsor|45|||
129941616|NCT02362035|467749788|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
129941617|NCT02362035|467749788|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
129941618|NCT02362035|467749788|FG000|Overall Study|Disease progression|11|||
129941619|NCT02362035|467749788|FG000|Overall Study|Withdrawal by Subject|20|||
129941620|NCT00229658|467749791|FG000|Overall Study|Administrative|2|||
129941621|NCT00229658|467749792|FG001|Overall Study|Administrative|1|||
129941622|NCT00229658|467749791|FG000|Overall Study|Investigator decision|13|||
129941623|NCT00229658|467749792|FG001|Overall Study|Investigator decision|10|||
129941624|NCT00229658|467749791|FG000|Overall Study|Other|80|||
129941625|NCT00229658|467749792|FG001|Overall Study|Other|60|||
129941626|NCT00229658|467749791|FG000|Overall Study|Lost to Follow-up|82|||
129941627|NCT00229658|467749792|FG001|Overall Study|Lost to Follow-up|55|||
129941628|NCT00229658|467749791|FG000|Overall Study|Serious Adverse Event|2|||
129941629|NCT00229658|467749792|FG001|Overall Study|Serious Adverse Event|2|||
129941630|NCT00229658|467749791|FG000|Overall Study|Withdrawal of consent|46|||
129941631|NCT00229658|467749792|FG001|Overall Study|Withdrawal of consent|39|||
129941632|NCT00249769|467749793|FG000|Overall Study|Withdrawal by Subject|1|||
129941633|NCT00249769|467749794|FG001|Overall Study|Withdrawal by Subject|10|||
129941634|NCT00249769|467749795|FG002|Overall Study|Withdrawal by Subject|6|||
129941635|NCT00249769|467749793|FG000|Overall Study|Migration from Study Area|1|||
129453135|NCT01131676|465956400|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
129453136|NCT01131676|465956401|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
129453137|NCT01131676|465956402|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
129453138|NCT01131676|465956400|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
129453139|NCT01131676|465956401|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
129453140|NCT01131676|465956402|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
129453141|NCT01131676|465956400|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
129453142|NCT01131676|465956401|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
129453143|NCT01131676|465956402|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
129453144|NCT01131676|465956400|FG000|Discontinuation From Treatment|Other than those specified|162|||
129453145|NCT01131676|465956401|FG001|Discontinuation From Treatment|Other than those specified|142|||
129453146|NCT01131676|465956402|FG002|Discontinuation From Treatment|Other than those specified|125|||
129453147|NCT01131676|465956400|FG000|Discontinuation From Treatment|Adverse Event|303|||
129453148|NCT01131676|465956401|FG001|Discontinuation From Treatment|Adverse Event|267|||
129941636|NCT00249769|467749794|FG001|Overall Study|Migration from Study Area|3|||
129941637|NCT00249769|467749795|FG002|Overall Study|Migration from Study Area|14|||
129941638|NCT00249769|467749793|FG000|Overall Study|Miscellaneous|0|||
129941639|NCT00249769|467749794|FG001|Overall Study|Miscellaneous|2|||
129941640|NCT00249769|467749795|FG002|Overall Study|Miscellaneous|2|||
129941641|NCT00249769|467749793|FG000|Overall Study|Adverse Event|0|||
129941642|NCT00249769|467749794|FG001|Overall Study|Adverse Event|0|||
129941643|NCT00249769|467749795|FG002|Overall Study|Adverse Event|1|||
129941644|NCT00249769|467749793|FG000|Overall Study|Physician Decision|0|||
129941645|NCT00249769|467749794|FG001|Overall Study|Physician Decision|0|||
129941646|NCT00249769|467749795|FG002|Overall Study|Physician Decision|2|||
129941647|NCT00249769|467749793|FG000|Overall Study|Lost to Follow-up|0|||
129941648|NCT00249769|467749794|FG001|Overall Study|Lost to Follow-up|0|||
129941649|NCT00249769|467749795|FG002|Overall Study|Lost to Follow-up|3|||
129941650|NCT01953224|467749796|FG000|Overall Study|Lost to Follow-up|1|||
129941651|NCT01953224|467749797|FG001|Overall Study|Lost to Follow-up|1|||
129941652|NCT01953224|467749796|FG000|Overall Study|Withdrawal by Subject|1|||
129941653|NCT01953224|467749797|FG001|Overall Study|Withdrawal by Subject|2|||
129941654|NCT03229408|467749798|FG000|Overall Study|Withdrawal by Subject|4|||
129941655|NCT03229408|467749799|FG001|Overall Study|Withdrawal by Subject|1|||
129941656|NCT03229408|467749798|FG000|Overall Study|Adverse Event|2|||
129941657|NCT03229408|467749799|FG001|Overall Study|Adverse Event|0|||
129941658|NCT03229408|467749798|FG000|Overall Study|Pregnancy|0|||
129941659|NCT03229408|467749799|FG001|Overall Study|Pregnancy|1|||
129941660|NCT03229408|467749798|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
129453149|NCT01131676|465956402|FG002|Discontinuation From Treatment|Adverse Event|273|||
129453150|NCT01131676|465956400|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
129453151|NCT01131676|465956401|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
129453152|NCT01131676|465956402|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
129453153|NCT01131676|465956400|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
129453154|NCT01131676|465956401|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
129453155|NCT01131676|465956402|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
129453156|NCT01131676|465956400|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
129453157|NCT01131676|465956401|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
129453158|NCT01131676|465956402|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
129453159|NCT01131676|465956400|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
129453160|NCT01131676|465956401|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
129453161|NCT01131676|465956402|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
129453162|NCT01131676|465956400|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
129453163|NCT01131676|465956401|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
129453164|NCT01131676|465956402|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
129453165|NCT01131676|465956400|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
129453166|NCT01131676|465956401|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
129453167|NCT01131676|465956402|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
129453168|NCT01816061|465956405|FG000|Overall Study|Lost to Follow-up|13|||
129453169|NCT01816061|465956406|FG001|Overall Study|Lost to Follow-up|24|||
129453170|NCT01961349|465956407|FG000|Overall Study|Withdrawal by Subject|1|||
129453171|NCT01961349|465956408|FG001|Overall Study|Withdrawal by Subject|4|||
129453172|NCT01961349|465956409|FG002|Overall Study|Withdrawal by Subject|0|||
129453173|NCT01961349|465956407|FG000|Overall Study|Adverse Event|0|||
129453174|NCT01961349|465956408|FG001|Overall Study|Adverse Event|0|||
129453175|NCT01961349|465956409|FG002|Overall Study|Adverse Event|1|||
129453176|NCT01961349|465956407|FG000|Overall Study|registration error, personal reason etc|2|||
129453177|NCT01961349|465956408|FG001|Overall Study|registration error, personal reason etc|2|||
129453178|NCT01961349|465956409|FG002|Overall Study|registration error, personal reason etc|1|||
129453179|NCT01299376|465956410|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
129453180|NCT01299376|465956411|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
129453181|NCT01299376|465956410|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
129453182|NCT01299376|465956411|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
129453183|NCT01299376|465956410|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
129453184|NCT01299376|465956411|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
129453185|NCT01299376|465956410|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
129453186|NCT01299376|465956411|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
129453187|NCT01299376|465956410|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
129453188|NCT01299376|465956411|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
129453189|NCT01299376|465956410|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
129453190|NCT01299376|465956411|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
129453191|NCT01299376|465956410|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
129453192|NCT01299376|465956411|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
129453193|NCT01299376|465956410|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
129453194|NCT01299376|465956411|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
129453195|NCT01299376|465956410|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
129453196|NCT01299376|465956411|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
129453197|NCT01299376|465956410|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
129453198|NCT01299376|465956411|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
129453199|NCT01299376|465956410|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
129453200|NCT01299376|465956411|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
129453201|NCT01431274|465956414|FG000|Overall Study|Adverse Event|51|||
129453202|NCT01431274|465956415|FG001|Overall Study|Adverse Event|37|||
129453203|NCT01431274|465956416|FG002|Overall Study|Adverse Event|43|||
129941661|NCT03229408|467749799|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
129941662|NCT04541589|467749800|FG000|Treatment Period|Adverse Event|8|||
129941663|NCT04541589|467749801|FG001|Treatment Period|Adverse Event|2|||
129941664|NCT04541589|467749800|FG000|Treatment Period|Physician Decision|3|||
129941665|NCT04541589|467749801|FG001|Treatment Period|Physician Decision|1|||
129941666|NCT04541589|467749800|FG000|Treatment Period|Subject decision|7|||
129941667|NCT04541589|467749801|FG001|Treatment Period|Subject decision|4|||
129941668|NCT04541589|467749800|FG000|Treatment Period|Withdrawal by Subject|1|||
129941669|NCT04541589|467749801|FG001|Treatment Period|Withdrawal by Subject|0|||
129941670|NCT04541589|467749800|FG000|Safety Follow-up Period|Adverse Event|2|||
129453204|NCT01431274|465956417|FG003|Overall Study|Adverse Event|30|||
129453205|NCT01431274|465956418|FG004|Overall Study|Adverse Event|37|||
129453206|NCT01431274|465956414|FG000|Overall Study|Consent withdrawn not due to AE|29|||
129453207|NCT01431274|465956415|FG001|Overall Study|Consent withdrawn not due to AE|20|||
129453208|NCT01431274|465956416|FG002|Overall Study|Consent withdrawn not due to AE|17|||
129453209|NCT01431274|465956417|FG003|Overall Study|Consent withdrawn not due to AE|20|||
129453210|NCT01431274|465956418|FG004|Overall Study|Consent withdrawn not due to AE|11|||
129453211|NCT01431274|465956414|FG000|Overall Study|Non compliant with protocol|5|||
129453212|NCT01431274|465956415|FG001|Overall Study|Non compliant with protocol|8|||
129453213|NCT01431274|465956416|FG002|Overall Study|Non compliant with protocol|4|||
129453214|NCT01431274|465956417|FG003|Overall Study|Non compliant with protocol|4|||
129453215|NCT01431274|465956418|FG004|Overall Study|Non compliant with protocol|4|||
129453216|NCT01431274|465956414|FG000|Overall Study|Lost to Follow-up|6|||
129453217|NCT01431274|465956415|FG001|Overall Study|Lost to Follow-up|7|||
129453218|NCT01431274|465956416|FG002|Overall Study|Lost to Follow-up|1|||
129453219|NCT01431274|465956417|FG003|Overall Study|Lost to Follow-up|4|||
129453220|NCT01431274|465956418|FG004|Overall Study|Lost to Follow-up|0|||
129453221|NCT01431274|465956414|FG000|Overall Study|Other reason not stated above|6|||
129453222|NCT01431274|465956415|FG001|Overall Study|Other reason not stated above|5|||
129453223|NCT01431274|465956416|FG002|Overall Study|Other reason not stated above|7|||
129453224|NCT01431274|465956417|FG003|Overall Study|Other reason not stated above|2|||
129453225|NCT01431274|465956418|FG004|Overall Study|Other reason not stated above|4|||
129453226|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
129453227|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
129453228|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Death|0|||
129453229|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Death|1|||
129453230|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
129453231|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
129453232|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
129453233|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
129453234|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
129453235|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
129453236|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
129453237|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
129453238|NCT00843518|465956419|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
129453239|NCT00843518|465956420|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
129453240|NCT00827606|465956423|FG000|Overall Study|Protocol Violation|4|||
129453241|NCT00827606|465956424|FG001|Overall Study|Protocol Violation|3|||
129453242|NCT00827606|465956423|FG000|Overall Study|Lost to Follow-up|3|||
129453243|NCT00827606|465956424|FG001|Overall Study|Lost to Follow-up|1|||
129453244|NCT00827606|465956423|FG000|Overall Study|Withdrawal by Subject|7|||
129453245|NCT00827606|465956424|FG001|Overall Study|Withdrawal by Subject|6|||
129453246|NCT00827606|465956423|FG000|Overall Study|Pregnancy|0|||
129453247|NCT00827606|465956424|FG001|Overall Study|Pregnancy|1|||
129453248|NCT00827606|465956423|FG000|Overall Study|Other|5|||
129453249|NCT00827606|465956424|FG001|Overall Study|Other|13|||
129453250|NCT00827606|465956423|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
129453251|NCT00827606|465956424|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
129453252|NCT00827606|465956423|FG000|Overall Study|Adverse Event|4|||
129453253|NCT00827606|465956424|FG001|Overall Study|Adverse Event|2|||
129453254|NCT04037748|465956429|FG000|Treatment Period 1|Withdrawal by Subject|3|||
129453255|NCT04037748|465956430|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129453256|NCT04037748|465956429|FG000|Treatment Period 1|Adverse Event|1|||
129453257|NCT04037748|465956430|FG001|Treatment Period 1|Adverse Event|1|||
129453258|NCT04037748|465956429|FG000|Treatment Period 1|Protocol Violation|4|||
129453259|NCT04037748|465956430|FG001|Treatment Period 1|Protocol Violation|5|||
129453260|NCT04037748|465956429|FG000|Treatment Period 2|Adverse Event|0|||
129453261|NCT04037748|465956430|FG001|Treatment Period 2|Adverse Event|1|||
129453262|NCT04037748|465956429|FG000|Treatment Period 2|Protocol Violation|2|||
129453263|NCT04037748|465956430|FG001|Treatment Period 2|Protocol Violation|0|||
129453264|NCT04544475|465956435|FG000|Overall Study|Withdrawal by Subject|1|||
129453265|NCT04544475|465956436|FG001|Overall Study|Withdrawal by Subject|3|||
129453266|NCT01378858|465956437|FG000|Overall Study|Withdrawal by Subject|4|||
129453267|NCT01378858|465956438|FG001|Overall Study|Withdrawal by Subject|4|||
129453268|NCT00942175|465956439|FG000|Overall Study|Adverse Event|2|||
129453269|NCT00942175|465956440|FG001|Overall Study|Adverse Event|1|||
129453270|NCT00942175|465956441|FG002|Overall Study|Adverse Event|0|||
129453271|NCT00942175|465956442|FG003|Overall Study|Adverse Event|0|||
129453272|NCT00942175|465956439|FG000|Overall Study|Protocol Violation|0|||
129453273|NCT00942175|465956440|FG001|Overall Study|Protocol Violation|1|||
129453274|NCT00942175|465956441|FG002|Overall Study|Protocol Violation|2|||
129453275|NCT00942175|465956442|FG003|Overall Study|Protocol Violation|0|||
129453276|NCT00942175|465956439|FG000|Overall Study|Pregnancy|0|||
129453277|NCT00942175|465956440|FG001|Overall Study|Pregnancy|0|||
129453278|NCT00942175|465956441|FG002|Overall Study|Pregnancy|0|||
129453279|NCT00942175|465956442|FG003|Overall Study|Pregnancy|1|||
129941671|NCT04541589|467749801|FG001|Safety Follow-up Period|Adverse Event|1|||
129941672|NCT04541589|467749800|FG000|Safety Follow-up Period|Physician Decision|1|||
129941673|NCT04541589|467749801|FG001|Safety Follow-up Period|Physician Decision|0|||
129941674|NCT04541589|467749800|FG000|Safety Follow-up Period|Subject decision|5|||
129941675|NCT04541589|467749801|FG001|Safety Follow-up Period|Subject decision|3|||
129941676|NCT04541589|467749800|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
129941677|NCT04541589|467749801|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
129941678|NCT03745313|467749802|FG000|At 30 Days Follow-up|Death|2|||
129941679|NCT03745313|467749802|FG000|At 6 Months Follow-up|Death|1|||
129941680|NCT03745313|467749802|FG000|At 6 Months Follow-up|Missed Visit|1|||
129941681|NCT03745313|467749802|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
129941682|NCT03745313|467749802|FG000|At 1 Year Follow-up|Death|2|||
129941683|NCT03745313|467749802|FG000|At 1 Year Follow-up|Missed Visit|2|||
129941684|NCT03745313|467749802|FG000|At 2 Year Follow-up|Missed Visit|1|||
129941685|NCT03389802|467749805|FG000|Overall Study|Lack of Efficacy|3|||
129941686|NCT03389802|467749806|FG001|Overall Study|Lack of Efficacy|3|||
129941687|NCT03389802|467749807|FG002|Overall Study|Lack of Efficacy|13|||
129941688|NCT03389802|467749808|FG003|Overall Study|Lack of Efficacy|6|||
129941689|NCT03389802|467749809|FG004|Overall Study|Lack of Efficacy|1|||
129941690|NCT03389802|467749805|FG000|Overall Study|Adverse Event|0|||
129941691|NCT03389802|467749806|FG001|Overall Study|Adverse Event|0|||
129941692|NCT03389802|467749807|FG002|Overall Study|Adverse Event|1|||
129941693|NCT03389802|467749808|FG003|Overall Study|Adverse Event|0|||
129941694|NCT03389802|467749809|FG004|Overall Study|Adverse Event|4|||
129941695|NCT03389802|467749805|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
129941696|NCT03389802|467749806|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
129941697|NCT03389802|467749807|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
129941698|NCT03389802|467749808|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
129941699|NCT03389802|467749809|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
129941700|NCT02426138|467749810|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129941701|NCT02426138|467749811|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129941702|NCT00274261|467749812|FG000|Overall Study|Adverse Event|19|||
129941703|NCT00274261|467749813|FG001|Overall Study|Adverse Event|11|||
129941704|NCT00274261|467749812|FG000|Overall Study|Pregnancy|114|||
129941705|NCT00274261|467749813|FG001|Overall Study|Pregnancy|83|||
129941706|NCT00274261|467749812|FG000|Overall Study|Withdrawal by Subject|179|||
129941707|NCT00274261|467749813|FG001|Overall Study|Withdrawal by Subject|126|||
129941708|NCT00274261|467749812|FG000|Overall Study|Protocol Violation|71|||
129941709|NCT00274261|467749813|FG001|Overall Study|Protocol Violation|42|||
129941710|NCT00274261|467749812|FG000|Overall Study|Lost to Follow-up|106|||
129941711|NCT00274261|467749813|FG001|Overall Study|Lost to Follow-up|75|||
129941712|NCT03362190|467749822|FG000|Overall Study|Adverse Event|0|||
129941713|NCT03362190|467749823|FG001|Overall Study|Adverse Event|0|||
129941714|NCT03362190|467749824|FG002|Overall Study|Adverse Event|0|||
129941715|NCT03362190|467749825|FG003|Overall Study|Adverse Event|1|||
129941716|NCT03362190|467749822|FG000|Overall Study|Withdrawal by Subject|0|||
129941717|NCT03362190|467749823|FG001|Overall Study|Withdrawal by Subject|0|||
129941718|NCT03362190|467749824|FG002|Overall Study|Withdrawal by Subject|0|||
129941719|NCT03362190|467749825|FG003|Overall Study|Withdrawal by Subject|1|||
129941720|NCT00687219|467749826|FG000|Overall Study|Adverse Event|8|||
129941721|NCT00687219|467749826|FG000|Overall Study|Discontinuance criteria met|7|||
129941722|NCT00687219|467749826|FG000|Overall Study|HCV-RNA positive conversion|34|||
129941723|NCT00687219|467749826|FG000|Overall Study|Withdrawal by Subject|1|||
129941724|NCT00687219|467749826|FG000|Overall Study|Lack of Efficacy|1|||
129941725|NCT01367236|467749827|FG000|Overall Study|Withdrawal by Subject|3|||
129941726|NCT01367236|467749828|FG001|Overall Study|Withdrawal by Subject|1|||
129941727|NCT02350634|467749831|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
129941728|NCT04827732|467749840|FG000|Overall Study|Did not start treatment|0|||
129941729|NCT04827732|467749841|FG001|Overall Study|Did not start treatment|1|||
129941730|NCT04827732|467749842|FG002|Overall Study|Did not start treatment|0|||
129941731|NCT04827732|467749843|FG003|Overall Study|Did not start treatment|1|||
129941732|NCT03414684|467749845|FG000|First-course Treatment|Complete response|0|||
129941733|NCT03414684|467749846|FG001|First-course Treatment|Complete response|1|||
129941734|NCT03414684|467749845|FG000|First-course Treatment|Intercurrent illness|1|||
129941735|NCT03414684|467749846|FG001|First-course Treatment|Intercurrent illness|0|||
129941736|NCT03414684|467749845|FG000|First-course Treatment|Progressive Disease|31|||
129941737|NCT03414684|467749846|FG001|First-course Treatment|Progressive Disease|32|||
129941738|NCT03414684|467749845|FG000|First-course Treatment|Adverse Event|1|||
129941739|NCT03414684|467749846|FG001|First-course Treatment|Adverse Event|2|||
129941740|NCT03414684|467749845|FG000|First-course Treatment|Physician Decision|0|||
129941741|NCT03414684|467749846|FG001|First-course Treatment|Physician Decision|1|||
129941742|NCT03414684|467749845|FG000|First-course Treatment|Withdrawal by Subject|0|||
129941743|NCT03414684|467749846|FG001|First-course Treatment|Withdrawal by Subject|1|||
129941744|NCT03414684|467749845|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
129941745|NCT03414684|467749846|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
129941746|NCT03414684|467749845|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
129941747|NCT03414684|467749846|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
129941748|NCT03414684|467749845|FG000|First-course Treatment|Still on treatment|3|||
129941749|NCT03414684|467749846|FG001|First-course Treatment|Still on treatment|0|||
129941750|NCT03414684|467749845|FG000|First-course Treatment|Never started protocol therapy|2|||
129941751|NCT03414684|467749846|FG001|First-course Treatment|Never started protocol therapy|1|||
129941752|NCT03414684|467749845|FG000|Crossover Treatment|Progressive disease|0|||
129941753|NCT03414684|467749846|FG001|Crossover Treatment|Progressive disease|12|||
129941754|NCT03414684|467749845|FG000|Crossover Treatment|Adverse Event|0|||
129941755|NCT03414684|467749846|FG001|Crossover Treatment|Adverse Event|3|||
129941756|NCT03414684|467749845|FG000|Crossover Treatment|Physician Decision|0|||
129941757|NCT03414684|467749846|FG001|Crossover Treatment|Physician Decision|1|||
129941758|NCT03414684|467749845|FG000|Crossover Treatment|Still on treatment|0|||
129941759|NCT03414684|467749846|FG001|Crossover Treatment|Still on treatment|2|||
129941760|NCT04038580|467749847|FG000|Washout 1|Death|0|||
129941761|NCT04038580|467749848|FG001|Washout 1|Death|0|||
129941762|NCT04038580|467749849|FG002|Washout 1|Death|0|||
129941763|NCT04038580|467749850|FG003|Washout 1|Death|1|||
129941764|NCT04038580|467749851|FG004|Washout 1|Death|0|||
129941765|NCT04038580|467749852|FG005|Washout 1|Death|0|||
129941766|NCT04038580|467749847|FG000|Washout 1|Withdrawal by Subject|0|||
129941767|NCT04038580|467749848|FG001|Washout 1|Withdrawal by Subject|0|||
129941768|NCT04038580|467749849|FG002|Washout 1|Withdrawal by Subject|0|||
129941769|NCT04038580|467749850|FG003|Washout 1|Withdrawal by Subject|0|||
129941770|NCT04038580|467749851|FG004|Washout 1|Withdrawal by Subject|1|||
129941771|NCT04038580|467749852|FG005|Washout 1|Withdrawal by Subject|0|||
129941772|NCT04038580|467749847|FG000|Wash-out 2|Withdrawal by Subject|1|||
129941773|NCT04038580|467749848|FG001|Wash-out 2|Withdrawal by Subject|0|||
129941774|NCT04038580|467749849|FG002|Wash-out 2|Withdrawal by Subject|0|||
129941775|NCT04038580|467749850|FG003|Wash-out 2|Withdrawal by Subject|2|||
129941776|NCT04038580|467749851|FG004|Wash-out 2|Withdrawal by Subject|0|||
129941777|NCT04038580|467749852|FG005|Wash-out 2|Withdrawal by Subject|1|||
129941778|NCT04038580|467749847|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
129941779|NCT04038580|467749848|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
129941780|NCT04038580|467749849|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
129941781|NCT04038580|467749850|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
129941782|NCT04038580|467749851|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
129941783|NCT04038580|467749852|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
129941784|NCT04038580|467749847|FG000|Wash-out 3|Withdrawal by Subject|1|||
129941785|NCT04038580|467749848|FG001|Wash-out 3|Withdrawal by Subject|0|||
129941786|NCT04038580|467749849|FG002|Wash-out 3|Withdrawal by Subject|2|||
129941787|NCT04038580|467749850|FG003|Wash-out 3|Withdrawal by Subject|0|||
129941788|NCT04038580|467749851|FG004|Wash-out 3|Withdrawal by Subject|0|||
129941789|NCT04038580|467749852|FG005|Wash-out 3|Withdrawal by Subject|0|||
129941790|NCT04577651|467749857|FG000|Overall Study|Screen Failure|7|||
129941791|NCT04577651|467749857|FG000|Overall Study|Adverse Event|1|||
129941792|NCT04577651|467749857|FG000|Overall Study|Death|1|||
129941793|NCT04577651|467749857|FG000|Overall Study|Physician Decision|1|||
129941794|NCT04577651|467749857|FG000|Overall Study|Withdrawal by Subject|3|||
129941795|NCT02278796|467750687|FG000|Overall Study|Death|2|||
129941796|NCT02278796|467750688|FG001|Overall Study|Death|3|||
129941797|NCT00357994|467750689|FG000|Overall Study|Adverse Event|1|||
129941798|NCT00357994|467750690|FG001|Overall Study|Adverse Event|2|||
129941799|NCT00357994|467750689|FG000|Overall Study|Lack of Efficacy|0|||
129941800|NCT00357994|467750690|FG001|Overall Study|Lack of Efficacy|1|||
129941801|NCT00357994|467750689|FG000|Overall Study|Protocol Violation|1|||
129941802|NCT00357994|467750690|FG001|Overall Study|Protocol Violation|0|||
129941803|NCT01613417|467750691|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
129941804|NCT01613417|467750692|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
129941805|NCT00512252|467750693|FG000|Overall Study|Lost to Follow-up|0|||
129941806|NCT00512252|467750694|FG001|Overall Study|Lost to Follow-up|0|||
129941807|NCT00512252|467750695|FG002|Overall Study|Lost to Follow-up|1|||
129941808|NCT00512252|467750693|FG000|Overall Study|Protocol Violation|0|||
129941809|NCT00512252|467750694|FG001|Overall Study|Protocol Violation|0|||
129941810|NCT00512252|467750695|FG002|Overall Study|Protocol Violation|1|||
129941811|NCT00512252|467750693|FG000|Overall Study|Death|0|||
129941812|NCT00512252|467750694|FG001|Overall Study|Death|0|||
129941813|NCT00512252|467750695|FG002|Overall Study|Death|1|||
129941814|NCT00705406|467750696|FG000|Overall Study|Lost to Follow-up|3|||
129941815|NCT00705406|467750697|FG001|Overall Study|Lost to Follow-up|3|||
129941816|NCT00705406|467750696|FG000|Overall Study|Did not receive study drug|1|||
129941817|NCT00705406|467750697|FG001|Overall Study|Did not receive study drug|2|||
129941818|NCT02357966|467750698|FG000|Overall Study|Death|0|||
129941819|NCT02357966|467750699|FG001|Overall Study|Death|0|||
129941820|NCT02357966|467750700|FG002|Overall Study|Death|1|||
129941821|NCT02357966|467750701|FG003|Overall Study|Death|0|||
129941822|NCT02357966|467750702|FG004|Overall Study|Death|2|||
129941823|NCT02357966|467750703|FG005|Overall Study|Death|0|||
129941824|NCT02357966|467750698|FG000|Overall Study|Physician Decision|1|||
129941825|NCT02357966|467750699|FG001|Overall Study|Physician Decision|0|||
129941826|NCT02357966|467750700|FG002|Overall Study|Physician Decision|0|||
129941827|NCT02357966|467750701|FG003|Overall Study|Physician Decision|0|||
129941828|NCT02357966|467750702|FG004|Overall Study|Physician Decision|1|||
129941829|NCT02357966|467750703|FG005|Overall Study|Physician Decision|0|||
129941830|NCT04652726|467750710|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
129941831|NCT04652726|467750711|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
129941832|NCT04652726|467750712|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
129941833|NCT04652726|467750710|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
129941834|NCT04652726|467750711|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
129941835|NCT04652726|467750712|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
129941836|NCT02157116|467750713|FG000|Overall Study|Withdrawal by Subject|4|||
129941837|NCT02157116|467750713|FG000|Overall Study|Physician Decision|3|||
129941838|NCT02157116|467750713|FG000|Overall Study|Failed Screening|2|||
129941839|NCT00093496|467750714|FG000|Overall Study|Protocol Violation|1|||
129941840|NCT00093496|467750715|FG001|Overall Study|Protocol Violation|3|||
129941841|NCT05014412|467750718|FG000|Overall Study|Death|11|||
129941842|NCT05014412|467750719|FG001|Overall Study|Death|7|||
129941843|NCT05014412|467750720|FG002|Overall Study|Death|4|||
129941844|NCT05014412|467750721|FG003|Overall Study|Death|7|||
129941845|NCT05014412|467750718|FG000|Overall Study|Withdrawal by Subject|1|||
129941846|NCT05014412|467750719|FG001|Overall Study|Withdrawal by Subject|1|||
129941847|NCT05014412|467750720|FG002|Overall Study|Withdrawal by Subject|1|||
129941848|NCT05014412|467750721|FG003|Overall Study|Withdrawal by Subject|2|||
129941849|NCT05014412|467750718|FG000|Overall Study|Ongoing|21|||
129941850|NCT05014412|467750719|FG001|Overall Study|Ongoing|4|||
129941851|NCT05014412|467750720|FG002|Overall Study|Ongoing|6|||
129941852|NCT05014412|467750721|FG003|Overall Study|Ongoing|20|||
129941853|NCT02101775|467750722|FG000|Overall Study|Adverse Event|4|||
129941854|NCT02101775|467750723|FG001|Overall Study|Adverse Event|0|||
129941855|NCT02101775|467750724|FG002|Overall Study|Adverse Event|0|||
129941856|NCT02101775|467750722|FG000|Overall Study|Admission to Hospital|0|||
129941857|NCT02101775|467750723|FG001|Overall Study|Admission to Hospital|1|||
129941858|NCT02101775|467750724|FG002|Overall Study|Admission to Hospital|0|||
129941859|NCT01886872|467750727|FG000|Overall Study|Ineligible|7|||
129941860|NCT01886872|467750728|FG001|Overall Study|Ineligible|4|||
129941861|NCT01886872|467750729|FG002|Overall Study|Ineligible|12|||
129941862|NCT04941482|467750730|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
129941863|NCT04941482|467750731|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
129941864|NCT04200664|467750732|FG000|Overall Study|Withdrawal by Subject|1|||
129941865|NCT04200664|467750733|FG001|Overall Study|Withdrawal by Subject|0|||
129941866|NCT04200664|467750734|FG002|Overall Study|Withdrawal by Subject|0|||
129941867|NCT02744066|467750739|FG000|Overall Study|Withdrawal by parent|0|||
129941868|NCT02744066|467750740|FG001|Overall Study|Withdrawal by parent|1|||
129941869|NCT02744066|467750739|FG000|Overall Study|Discharged from NICU prior to completion|0|||
129941870|NCT02744066|467750740|FG001|Overall Study|Discharged from NICU prior to completion|4|||
129941871|NCT02454959|467750741|FG000|Overall Study|Protocol-Specified Criteria|3|||
129941872|NCT02454959|467750741|FG000|Overall Study|Physician Decision|1|||
129941873|NCT02454959|467750741|FG000|Overall Study|Withdrawal by Subject|3|||
129941874|NCT02454959|467750741|FG000|Overall Study|Adverse Event|2|||
129941875|NCT04745676|467750742|FG000|Overall Study|Death|1|||
129941876|NCT04745676|467750743|FG001|Overall Study|Death|0|||
129941877|NCT04745676|467750744|FG002|Overall Study|Death|0|||
129941878|NCT05810285|467750756|FG000|Overall Study|Death|4|||
129941879|NCT05810285|467750757|FG001|Overall Study|Death|21|||
129941880|NCT05810285|467750756|FG000|Overall Study|Adverse Event|18|||
129941881|NCT05810285|467750757|FG001|Overall Study|Adverse Event|16|||
129941882|NCT03945773|467752084|FG000|Overall Study|Consent Withdrawn|1|||
129941883|NCT03945773|467752085|FG001|Overall Study|Consent Withdrawn|1|||
129941884|NCT03945773|467752084|FG000|Overall Study|Lost to Follow-up|1|||
129941885|NCT03945773|467752085|FG001|Overall Study|Lost to Follow-up|0|||
129941886|NCT03945773|467752084|FG000|Overall Study|Death|46|||
129941887|NCT03945773|467752085|FG001|Overall Study|Death|22|||
129941888|NCT03945773|467752084|FG000|Overall Study|Physician Decision|1|||
129941889|NCT03945773|467752085|FG001|Overall Study|Physician Decision|0|||
129941890|NCT03945773|467752084|FG000|Overall Study|Other|1|||
129941891|NCT03945773|467752085|FG001|Overall Study|Other|0|||
129941892|NCT03945773|467752084|FG000|Overall Study|Ongoing at the time of DCO|4|||
129941893|NCT03945773|467752085|FG001|Overall Study|Ongoing at the time of DCO|3|||
129941894|NCT01372085|467752092|FG000|Washout Period 2|Physician Decision|0|||
129941895|NCT01372085|467752093|FG001|Washout Period 2|Physician Decision|0|||
129941896|NCT01372085|467752094|FG002|Washout Period 2|Physician Decision|0|||
129941897|NCT01372085|467752095|FG003|Washout Period 2|Physician Decision|0|||
129941898|NCT01372085|467752096|FG004|Washout Period 2|Physician Decision|1|||
129941899|NCT01372085|467752097|FG005|Washout Period 2|Physician Decision|0|||
129941900|NCT01372085|467752098|FG006|Washout Period 2|Physician Decision|0|||
129941901|NCT01372085|467752099|FG007|Washout Period 2|Physician Decision|0|||
129941902|NCT01372085|467752100|FG008|Washout Period 2|Physician Decision|0|||
129941903|NCT01372085|467752101|FG009|Washout Period 2|Physician Decision|0|||
129941904|NCT01372085|467752092|FG000|Washout Period 3|Withdrawal by Subject|0|||
129941905|NCT01372085|467752093|FG001|Washout Period 3|Withdrawal by Subject|0|||
129941906|NCT01372085|467752094|FG002|Washout Period 3|Withdrawal by Subject|0|||
129941907|NCT01372085|467752095|FG003|Washout Period 3|Withdrawal by Subject|0|||
129941908|NCT01372085|467752096|FG004|Washout Period 3|Withdrawal by Subject|0|||
129941909|NCT01372085|467752097|FG005|Washout Period 3|Withdrawal by Subject|2|||
129941910|NCT01372085|467752098|FG006|Washout Period 3|Withdrawal by Subject|0|||
129941911|NCT01372085|467752099|FG007|Washout Period 3|Withdrawal by Subject|0|||
129941912|NCT01372085|467752100|FG008|Washout Period 3|Withdrawal by Subject|0|||
129941913|NCT01372085|467752101|FG009|Washout Period 3|Withdrawal by Subject|0|||
129941914|NCT02824198|467752102|FG000|Overall Study|Non-compliance with the protocol|5|||
129941915|NCT02824198|467752103|FG001|Overall Study|Non-compliance with the protocol|1|||
129941916|NCT02824198|467752102|FG000|Overall Study|Lost to Follow-up|5|||
129941917|NCT02824198|467752103|FG001|Overall Study|Lost to Follow-up|2|||
129941918|NCT02824198|467752102|FG000|Overall Study|Withdrawal by Subject|5|||
129941919|NCT02824198|467752103|FG001|Overall Study|Withdrawal by Subject|0|||
129941920|NCT01079806|467752106|FG000|Day 1 to Week 96|Adverse Event|0|||
129941921|NCT01079806|467752107|FG001|Day 1 to Week 96|Adverse Event|3|||
129941922|NCT01079806|467752106|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
129941923|NCT01079806|467752107|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
129941924|NCT01079806|467752106|FG000|Day 1 to Week 96|Pregnancy|0|||
129941925|NCT01079806|467752107|FG001|Day 1 to Week 96|Pregnancy|1|||
129941926|NCT01079806|467752106|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
129941927|NCT01079806|467752107|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
129941928|NCT01079806|467752106|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
129941929|NCT01079806|467752107|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
129941930|NCT01079806|467752106|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
129941931|NCT01079806|467752107|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
129941932|NCT01079806|467752106|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
129941933|NCT01079806|467752107|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
129941934|NCT01079806|467752106|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
129941935|NCT01079806|467752107|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
129941936|NCT01079806|467752106|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
129941937|NCT01079806|467752107|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
129941938|NCT01079806|467752106|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
129941939|NCT01079806|467752107|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
129941940|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
129941941|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
129941942|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
129941943|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
129941944|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
129941945|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
129941946|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
129941947|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
129941948|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129941949|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
129941950|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
129941951|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
129941952|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129941953|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
129941954|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
129941955|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
129941956|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
129941957|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
129941958|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
129941959|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
129941960|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
129941961|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
129941962|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
129941963|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
129941964|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
129941965|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
129941966|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
129941967|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
129941968|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
129941969|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
129453280|NCT00942175|465956439|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
129453281|NCT00942175|465956440|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
129453282|NCT00942175|465956441|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
129453283|NCT00942175|465956442|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
129453284|NCT00942175|465956439|FG000|Overall Study|Low Platelet Count|0|||
129453285|NCT00942175|465956440|FG001|Overall Study|Low Platelet Count|2|||
129453286|NCT00942175|465956441|FG002|Overall Study|Low Platelet Count|0|||
129453287|NCT00942175|465956442|FG003|Overall Study|Low Platelet Count|0|||
129453288|NCT02664272|465956443|FG000|Overall Study|Fluoroscopic images not made available|2|||
129941970|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941971|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941972|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941973|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941974|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
129941975|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941976|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941977|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941978|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
129941979|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129941980|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
129941981|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
129941982|NCT03732807|467752108|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941983|NCT03732807|467752109|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941984|NCT03732807|467752110|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941985|NCT03732807|467752111|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941986|NCT03732807|467752112|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941987|NCT03732807|467752113|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
129941988|NCT03732807|467752114|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
129941989|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
129941990|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
129941991|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
129941992|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
129941993|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
129941994|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
129941995|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
129941996|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
129941997|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
129941998|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
129941999|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
129942000|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
129942001|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
129942002|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
129942003|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
129942004|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
129942005|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
129942006|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
129942007|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
129942008|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
129942009|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
129942010|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942011|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
129942012|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942013|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942014|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942015|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942016|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
129942017|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942018|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
129942019|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942020|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
129942021|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
129942022|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942023|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
129942024|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
129942025|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
129942026|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942027|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942028|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
129942029|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942030|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
129942031|NCT03732807|467752108|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
129942032|NCT03732807|467752109|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
129942033|NCT03732807|467752110|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
129942034|NCT03732807|467752111|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
129942035|NCT03732807|467752112|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
129942036|NCT03732807|467752113|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
129453289|NCT03073980|465956444|FG000|Overall Study|Lost to Follow-up|10|||
129453290|NCT03073980|465956445|FG001|Overall Study|Lost to Follow-up|2|||
129453291|NCT03073980|465956446|FG002|Overall Study|Lost to Follow-up|9|||
129453292|NCT03073980|465956444|FG000|Overall Study|No post-procedure data|0|||
129453293|NCT03073980|465956445|FG001|Overall Study|No post-procedure data|0|||
129453294|NCT03073980|465956446|FG002|Overall Study|No post-procedure data|2|||
129453295|NCT00545064|465956447|FG000|Overall Study|Lost to Follow-up|3|||
129453296|NCT00545064|465956447|FG000|Overall Study|Withdrawal by Subject|2|||
129942037|NCT03732807|467752114|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
129942038|NCT01779700|467752115|FG000|Overall Study|Adverse Event|4|||
129942039|NCT01779700|467752116|FG001|Overall Study|Adverse Event|3|||
129942040|NCT01779700|467752115|FG000|Overall Study|Withdrawal by Subject|0|||
129942041|NCT01779700|467752116|FG001|Overall Study|Withdrawal by Subject|2|||
129942042|NCT00019604|467752117|FG000|Overall Study|Death|1|||
129942043|NCT00019604|467752117|FG000|Overall Study|Progressive disease|23|||
129942044|NCT00019604|467752117|FG000|Overall Study|Refused treatment|1|||
129942045|NCT00019604|467752117|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
129942046|NCT00019604|467752117|FG000|Overall Study|Going to have liver transplant|1|||
129942047|NCT00019604|467752117|FG000|Overall Study|Move to a different study|1|||
129942048|NCT00019604|467752117|FG000|Overall Study|Non compliant on systemic CH|1|||
129942049|NCT00019604|467752117|FG000|Overall Study|Non compliant|1|||
129942050|NCT00019604|467752117|FG000|Overall Study|Resectable disease|1|||
129942051|NCT00019604|467752117|FG000|Overall Study|Started new chemo regimen|1|||
129942052|NCT00019604|467752117|FG000|Overall Study|Pt going to immunotherapy study|1|||
129942053|NCT00019604|467752117|FG000|Overall Study|Too much disease|1|||
129942054|NCT00019604|467752117|FG000|Overall Study|Unable to evaluate|1|||
129942055|NCT00019604|467752117|FG000|Overall Study|Details for other not available|4|||
129942056|NCT00734578|467752120|FG000|Overall Study|Adverse Event|4|||
129942057|NCT00734578|467752121|FG001|Overall Study|Adverse Event|6|||
129942058|NCT00734578|467752122|FG002|Overall Study|Adverse Event|1|||
129942059|NCT00734578|467752120|FG000|Overall Study|Protocol Violation|8|||
129942060|NCT00734578|467752121|FG001|Overall Study|Protocol Violation|6|||
129942061|NCT00734578|467752122|FG002|Overall Study|Protocol Violation|3|||
129942062|NCT00734578|467752120|FG000|Overall Study|Withdrawal by Subject|7|||
129942063|NCT00734578|467752121|FG001|Overall Study|Withdrawal by Subject|8|||
129942064|NCT00734578|467752122|FG002|Overall Study|Withdrawal by Subject|11|||
129942065|NCT00734578|467752120|FG000|Overall Study|Lost to Follow-up|9|||
129942066|NCT00734578|467752121|FG001|Overall Study|Lost to Follow-up|3|||
129942067|NCT00734578|467752122|FG002|Overall Study|Lost to Follow-up|5|||
129942068|NCT00734578|467752120|FG000|Overall Study|Lack of Efficacy|3|||
129942069|NCT00734578|467752121|FG001|Overall Study|Lack of Efficacy|2|||
129942070|NCT00734578|467752122|FG002|Overall Study|Lack of Efficacy|5|||
129942071|NCT00734578|467752120|FG000|Overall Study|Randomized in error|1|||
129942072|NCT00734578|467752121|FG001|Overall Study|Randomized in error|0|||
129942073|NCT00734578|467752122|FG002|Overall Study|Randomized in error|0|||
129942074|NCT00734578|467752120|FG000|Overall Study|Exclusion criteria|1|||
129942075|NCT00734578|467752121|FG001|Overall Study|Exclusion criteria|0|||
129942076|NCT00734578|467752122|FG002|Overall Study|Exclusion criteria|0|||
129942077|NCT02085941|467752126|FG000|Overall Study|Lack of Efficacy|1|||
129942078|NCT02085941|467752127|FG001|Overall Study|Lack of Efficacy|0|||
129942079|NCT02085941|467752126|FG000|Overall Study|Death|6|||
129942080|NCT02085941|467752127|FG001|Overall Study|Death|1|||
129942081|NCT02085941|467752126|FG000|Overall Study|Lost to Follow-up|1|||
129942082|NCT02085941|467752127|FG001|Overall Study|Lost to Follow-up|0|||
129942083|NCT02085941|467752126|FG000|Overall Study|Physician Decision|0|||
129942084|NCT02085941|467752127|FG001|Overall Study|Physician Decision|2|||
129942085|NCT03499964|467752128|FG000|Overall Study|Lack of Efficacy|6|||
129942086|NCT03499964|467752129|FG001|Overall Study|Lack of Efficacy|26|||
129942087|NCT03499964|467752128|FG000|Overall Study|Adverse Event|1|||
129942088|NCT03499964|467752129|FG001|Overall Study|Adverse Event|0|||
129942089|NCT03499964|467752128|FG000|Overall Study|Death|1|||
129453297|NCT00545064|465956447|FG000|Overall Study|did not complete course of treatment|1|||
129942090|NCT03499964|467752129|FG001|Overall Study|Death|0|||
129942091|NCT03499964|467752128|FG000|Overall Study|Withdrawal by Subject|2|||
129942092|NCT03499964|467752129|FG001|Overall Study|Withdrawal by Subject|1|||
129942093|NCT03499964|467752128|FG000|Overall Study|Lost to Follow-up|1|||
129942094|NCT03499964|467752129|FG001|Overall Study|Lost to Follow-up|0|||
129942095|NCT03274076|467752132|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
129942096|NCT03274076|467752133|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
129942097|NCT03274076|467752134|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
129942098|NCT03274076|467752135|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
129942099|NCT03274076|467752132|FG000|24 Weeks Open Label|Adverse Event|0|||
129942100|NCT03274076|467752133|FG001|24 Weeks Open Label|Adverse Event|0|||
129942101|NCT03274076|467752134|FG002|24 Weeks Open Label|Adverse Event|2|||
129942102|NCT03274076|467752135|FG003|24 Weeks Open Label|Adverse Event|0|||
129942103|NCT03274076|467752132|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
129942104|NCT03274076|467752133|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
129942105|NCT03274076|467752134|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
129942106|NCT03274076|467752135|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
129942107|NCT00975585|467752136|FG000|Overall Study|Adverse Event|0|||
129942108|NCT00975585|467752137|FG001|Overall Study|Adverse Event|4|||
129942109|NCT00975585|467752136|FG000|Overall Study|Lost to Follow-up|3|||
129942110|NCT00975585|467752137|FG001|Overall Study|Lost to Follow-up|5|||
129942111|NCT00975585|467752136|FG000|Overall Study|Withdrawal by Subject|2|||
129942112|NCT00975585|467752137|FG001|Overall Study|Withdrawal by Subject|1|||
129942113|NCT00975585|467752136|FG000|Overall Study|Lens issue|2|||
129942114|NCT00975585|467752137|FG001|Overall Study|Lens issue|2|||
129942115|NCT00795184|467752138|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
129942116|NCT00795184|467752139|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
129942117|NCT00683800|467752141|FG000|Overall Study|Adverse Event|195|||
129942118|NCT00683800|467752142|FG001|Overall Study|Adverse Event|102|||
129942119|NCT00683800|467752141|FG000|Overall Study|Death|0|||
129942120|NCT00683800|467752142|FG001|Overall Study|Death|1|||
129942121|NCT00683800|467752141|FG000|Overall Study|Lost to Follow-up|57|||
129942122|NCT00683800|467752142|FG001|Overall Study|Lost to Follow-up|44|||
129942123|NCT00683800|467752141|FG000|Overall Study|Other|5|||
129942124|NCT00683800|467752142|FG001|Overall Study|Other|2|||
129942125|NCT00683800|467752141|FG000|Overall Study|Protocol Violation|13|||
129942126|NCT00683800|467752142|FG001|Overall Study|Protocol Violation|16|||
129942127|NCT00683800|467752141|FG000|Overall Study|Withdrawal by Subject|66|||
129942128|NCT00683800|467752142|FG001|Overall Study|Withdrawal by Subject|64|||
129942129|NCT00683800|467752141|FG000|Overall Study|Lack of Efficacy|61|||
129942130|NCT00683800|467752142|FG001|Overall Study|Lack of Efficacy|104|||
129942131|NCT00683800|467752141|FG000|Overall Study|Randomized, not treated|35|||
129942132|NCT00683800|467752142|FG001|Overall Study|Randomized, not treated|33|||
129942133|NCT00205179|467752145|FG000|Overall Study|Death|0|||
129942134|NCT00205179|467752146|FG001|Overall Study|Death|2|||
129942135|NCT00205179|467752145|FG000|Overall Study|Physician Decision|1|||
129942136|NCT00205179|467752146|FG001|Overall Study|Physician Decision|1|||
129942137|NCT00205179|467752145|FG000|Overall Study|Adverse Event|1|||
129942138|NCT00205179|467752146|FG001|Overall Study|Adverse Event|1|||
129942139|NCT00586313|467752147|FG000|Overall Study|Lack of Efficacy|2|||
129942140|NCT02079649|467752150|FG000|Overall Study|Lost to Follow-up|0|||
129942141|NCT02079649|467752151|FG001|Overall Study|Lost to Follow-up|0|||
129942142|NCT02079649|467752152|FG002|Overall Study|Lost to Follow-up|0|||
129942143|NCT02079649|467752153|FG003|Overall Study|Lost to Follow-up|1|||
129942144|NCT02079649|467752150|FG000|Overall Study|Withdrawal by Subject|0|||
129942145|NCT02079649|467752151|FG001|Overall Study|Withdrawal by Subject|0|||
129942146|NCT02079649|467752152|FG002|Overall Study|Withdrawal by Subject|0|||
129942147|NCT02079649|467752153|FG003|Overall Study|Withdrawal by Subject|1|||
129942148|NCT02079649|467752150|FG000|Overall Study|Randomization error (prior to treatment)|1|||
129942149|NCT02079649|467752151|FG001|Overall Study|Randomization error (prior to treatment)|0|||
129942150|NCT02079649|467752152|FG002|Overall Study|Randomization error (prior to treatment)|1|||
129942151|NCT02079649|467752153|FG003|Overall Study|Randomization error (prior to treatment)|0|||
129942152|NCT01953692|467752156|FG000|Overall Study|Adverse Event|5|||
129942153|NCT01953692|467752157|FG001|Overall Study|Adverse Event|2|||
129942154|NCT01953692|467752158|FG002|Overall Study|Adverse Event|4|||
129942155|NCT01953692|467752159|FG003|Overall Study|Adverse Event|2|||
129942156|NCT01953692|467752160|FG004|Overall Study|Adverse Event|1|||
129942157|NCT01953692|467752161|FG005|Overall Study|Adverse Event|2|||
129942158|NCT01953692|467752162|FG006|Overall Study|Adverse Event|0|||
129942159|NCT01953692|467752163|FG007|Overall Study|Adverse Event|0|||
129942160|NCT01953692|467752164|FG008|Overall Study|Adverse Event|0|||
129942161|NCT01953692|467752156|FG000|Overall Study|Clinical Progression|0|||
129942162|NCT01953692|467752157|FG001|Overall Study|Clinical Progression|15|||
129942163|NCT01953692|467752158|FG002|Overall Study|Clinical Progression|7|||
129942164|NCT01953692|467752159|FG003|Overall Study|Clinical Progression|5|||
129942165|NCT01953692|467752160|FG004|Overall Study|Clinical Progression|0|||
129942166|NCT01953692|467752161|FG005|Overall Study|Clinical Progression|7|||
129942167|NCT01953692|467752162|FG006|Overall Study|Clinical Progression|20|||
129942168|NCT01953692|467752163|FG007|Overall Study|Clinical Progression|3|||
129942169|NCT01953692|467752164|FG008|Overall Study|Clinical Progression|3|||
129942170|NCT01953692|467752156|FG000|Overall Study|Death|5|||
129942171|NCT01953692|467752157|FG001|Overall Study|Death|0|||
129942172|NCT01953692|467752158|FG002|Overall Study|Death|2|||
129942173|NCT01953692|467752159|FG003|Overall Study|Death|2|||
129942174|NCT01953692|467752160|FG004|Overall Study|Death|1|||
129942175|NCT01953692|467752161|FG005|Overall Study|Death|3|||
129942176|NCT01953692|467752162|FG006|Overall Study|Death|6|||
129942177|NCT01953692|467752163|FG007|Overall Study|Death|2|||
129942178|NCT01953692|467752164|FG008|Overall Study|Death|1|||
129942179|NCT01953692|467752156|FG000|Overall Study|Excluded Medication|1|||
129942180|NCT01953692|467752157|FG001|Overall Study|Excluded Medication|0|||
129942181|NCT01953692|467752158|FG002|Overall Study|Excluded Medication|0|||
129942182|NCT01953692|467752159|FG003|Overall Study|Excluded Medication|0|||
129942183|NCT01953692|467752160|FG004|Overall Study|Excluded Medication|0|||
129942184|NCT01953692|467752161|FG005|Overall Study|Excluded Medication|0|||
129942185|NCT01953692|467752162|FG006|Overall Study|Excluded Medication|0|||
129942186|NCT01953692|467752163|FG007|Overall Study|Excluded Medication|0|||
129942187|NCT01953692|467752164|FG008|Overall Study|Excluded Medication|0|||
129942188|NCT01953692|467752156|FG000|Overall Study|Lost to Follow-up|1|||
129942189|NCT01953692|467752157|FG001|Overall Study|Lost to Follow-up|0|||
129942190|NCT01953692|467752158|FG002|Overall Study|Lost to Follow-up|3|||
129942191|NCT01953692|467752159|FG003|Overall Study|Lost to Follow-up|1|||
129942192|NCT01953692|467752160|FG004|Overall Study|Lost to Follow-up|0|||
129942193|NCT01953692|467752161|FG005|Overall Study|Lost to Follow-up|1|||
129942194|NCT01953692|467752162|FG006|Overall Study|Lost to Follow-up|0|||
129942195|NCT01953692|467752163|FG007|Overall Study|Lost to Follow-up|0|||
129942196|NCT01953692|467752164|FG008|Overall Study|Lost to Follow-up|0|||
129942197|NCT01953692|467752156|FG000|Overall Study|Physician Decision|11|||
129942198|NCT01953692|467752157|FG001|Overall Study|Physician Decision|4|||
129942199|NCT01953692|467752158|FG002|Overall Study|Physician Decision|2|||
129942200|NCT01953692|467752159|FG003|Overall Study|Physician Decision|2|||
129942201|NCT01953692|467752160|FG004|Overall Study|Physician Decision|1|||
129942202|NCT01953692|467752161|FG005|Overall Study|Physician Decision|2|||
129942203|NCT01953692|467752162|FG006|Overall Study|Physician Decision|4|||
129942204|NCT01953692|467752163|FG007|Overall Study|Physician Decision|1|||
129942205|NCT01953692|467752164|FG008|Overall Study|Physician Decision|0|||
129942206|NCT01953692|467752156|FG000|Overall Study|Protocol Violation|0|||
129942207|NCT01953692|467752157|FG001|Overall Study|Protocol Violation|2|||
129942208|NCT01953692|467752158|FG002|Overall Study|Protocol Violation|1|||
129942209|NCT01953692|467752159|FG003|Overall Study|Protocol Violation|0|||
129942210|NCT01953692|467752160|FG004|Overall Study|Protocol Violation|0|||
129942211|NCT01953692|467752161|FG005|Overall Study|Protocol Violation|0|||
129942212|NCT01953692|467752162|FG006|Overall Study|Protocol Violation|0|||
129942213|NCT01953692|467752163|FG007|Overall Study|Protocol Violation|1|||
129942214|NCT01953692|467752164|FG008|Overall Study|Protocol Violation|0|||
129942215|NCT01953692|467752156|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942216|NCT01953692|467752157|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942217|NCT01953692|467752158|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942218|NCT01953692|467752159|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942219|NCT01953692|467752160|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942220|NCT01953692|467752161|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942221|NCT01953692|467752162|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942222|NCT01953692|467752163|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
129942223|NCT01953692|467752164|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
129942224|NCT01953692|467752156|FG000|Overall Study|Withdrawal by Subject|4|||
129942225|NCT01953692|467752157|FG001|Overall Study|Withdrawal by Subject|2|||
129942226|NCT01953692|467752158|FG002|Overall Study|Withdrawal by Subject|1|||
129942227|NCT01953692|467752159|FG003|Overall Study|Withdrawal by Subject|2|||
129942228|NCT01953692|467752160|FG004|Overall Study|Withdrawal by Subject|0|||
129942229|NCT01953692|467752161|FG005|Overall Study|Withdrawal by Subject|3|||
129942230|NCT01953692|467752162|FG006|Overall Study|Withdrawal by Subject|2|||
129942231|NCT01953692|467752163|FG007|Overall Study|Withdrawal by Subject|1|||
129942232|NCT01953692|467752164|FG008|Overall Study|Withdrawal by Subject|1|||
129942233|NCT01328496|467752173|FG000|Overall Study|Significant Change in Health Status|1|||
129942234|NCT01328496|467752174|FG001|Overall Study|Significant Change in Health Status|0|||
129942235|NCT05966155|467752175|FG000|Overall Study|Death|1|||
129942236|NCT05966155|467752176|FG001|Overall Study|Death|2|||
129942237|NCT05966155|467752175|FG000|Overall Study|Lost to Follow-up|63|||
129942238|NCT05966155|467752176|FG001|Overall Study|Lost to Follow-up|67|||
129942239|NCT05966155|467752175|FG000|Overall Study|Protocol Violation|1|||
129942240|NCT05966155|467752176|FG001|Overall Study|Protocol Violation|0|||
129942241|NCT05966155|467752175|FG000|Overall Study|Withdrawal by Subject|8|||
129942242|NCT05966155|467752176|FG001|Overall Study|Withdrawal by Subject|9|||
129942243|NCT05966155|467752175|FG000|Overall Study|Enrolled Erroneously|0|||
129942244|NCT05966155|467752176|FG001|Overall Study|Enrolled Erroneously|1|||
129942245|NCT05966155|467752175|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
129942246|NCT05966155|467752176|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
129942247|NCT02743819|467752177|FG000|Overall Study|Lack of Efficacy|5|||
129942248|NCT02743819|467752177|FG000|Overall Study|Death|2|||
129942249|NCT02743819|467752177|FG000|Overall Study|Adverse Event|1|||
129942250|NCT03582475|467752188|FG000|Treatment Period|Withdrawal by Subject|0|||
129942251|NCT03582475|467752189|FG001|Treatment Period|Withdrawal by Subject|1|||
129942252|NCT03582475|467752188|FG000|Follow-up Period|Withdrawal by Subject|0|||
129942253|NCT03582475|467752189|FG001|Follow-up Period|Withdrawal by Subject|1|||
129942254|NCT01706159|467752190|FG000|Overall Study|Withdrawal Criteria|2|||
129942255|NCT01706159|467752191|FG001|Overall Study|Withdrawal Criteria|1|||
129942256|NCT01706159|467752190|FG000|Overall Study|Unclassified|6|||
129942257|NCT01706159|467752191|FG001|Overall Study|Unclassified|1|||
129942258|NCT00553332|467752196|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
129942259|NCT03775486|467752197|FG000|Initial Therapy Phase|Other reason provided|0|||
129942260|NCT03775486|467752198|FG001|Initial Therapy Phase|Other reason provided|15|||
129942261|NCT03775486|467752197|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
129942262|NCT03775486|467752198|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
129942263|NCT03775486|467752197|FG000|Initial Therapy Phase|Protocol Violation|0|||
129942264|NCT03775486|467752198|FG001|Initial Therapy Phase|Protocol Violation|2|||
129942265|NCT03775486|467752197|FG000|Initial Therapy Phase|Adverse Event|0|||
129942266|NCT03775486|467752198|FG001|Initial Therapy Phase|Adverse Event|34|||
129942267|NCT03775486|467752197|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
129942268|NCT03775486|467752198|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
129942269|NCT03775486|467752197|FG000|Maintenance Phase|Withdrawal by Subject|13|||
129942270|NCT03775486|467752198|FG001|Maintenance Phase|Withdrawal by Subject|12|||
129942271|NCT03775486|467752197|FG000|Maintenance Phase|Death|44|||
129942272|NCT03775486|467752198|FG001|Maintenance Phase|Death|45|||
129942273|NCT02235298|467752200|FG000|Overall Study|Lost to Follow-up|6|||
129942274|NCT02235298|467752201|FG001|Overall Study|Lost to Follow-up|5|||
129942275|NCT02235298|467752200|FG000|Overall Study|Adverse Event|2|||
129942276|NCT02235298|467752201|FG001|Overall Study|Adverse Event|2|||
129942277|NCT02235298|467752200|FG000|Overall Study|Withdrawal by Subject|0|||
129942278|NCT02235298|467752201|FG001|Overall Study|Withdrawal by Subject|1|||
129942279|NCT03102034|467752202|FG000|Overall Study|Withdrawal by Subject|1|||
129942280|NCT03102034|467752203|FG001|Overall Study|Withdrawal by Subject|0|||
129942281|NCT01701401|467752206|FG000|Overall Study|Randomized But Not Treated|3|||
129942282|NCT01701401|467752207|FG001|Overall Study|Randomized But Not Treated|1|||
129942283|NCT01701401|467752208|FG002|Overall Study|Randomized But Not Treated|0|||
129942284|NCT01701401|467752209|FG003|Overall Study|Randomized But Not Treated|1|||
129942285|NCT01701401|467752206|FG000|Overall Study|Lost to Follow-up|5|||
129942286|NCT01701401|467752207|FG001|Overall Study|Lost to Follow-up|5|||
129942287|NCT01701401|467752208|FG002|Overall Study|Lost to Follow-up|1|||
129942288|NCT01701401|467752209|FG003|Overall Study|Lost to Follow-up|3|||
129942289|NCT01701401|467752206|FG000|Overall Study|Withdrew Consent|0|||
129942290|NCT01701401|467752207|FG001|Overall Study|Withdrew Consent|3|||
129942291|NCT01701401|467752208|FG002|Overall Study|Withdrew Consent|1|||
129942292|NCT01701401|467752209|FG003|Overall Study|Withdrew Consent|2|||
129942293|NCT01701401|467752206|FG000|Overall Study|Lack of Efficacy|1|||
129942294|NCT01701401|467752207|FG001|Overall Study|Lack of Efficacy|0|||
129942295|NCT01701401|467752208|FG002|Overall Study|Lack of Efficacy|2|||
129942296|NCT01701401|467752209|FG003|Overall Study|Lack of Efficacy|0|||
129942297|NCT01701401|467752206|FG000|Overall Study|Adverse Event|1|||
129942298|NCT01701401|467752207|FG001|Overall Study|Adverse Event|0|||
129942299|NCT01701401|467752208|FG002|Overall Study|Adverse Event|0|||
129942300|NCT01701401|467752209|FG003|Overall Study|Adverse Event|0|||
129942301|NCT01701401|467752206|FG000|Overall Study|Protocol Violation|0|||
129942302|NCT01701401|467752207|FG001|Overall Study|Protocol Violation|0|||
129942303|NCT01701401|467752208|FG002|Overall Study|Protocol Violation|1|||
129942304|NCT01701401|467752209|FG003|Overall Study|Protocol Violation|0|||
129942305|NCT05325294|467752212|FG000|Overall Study|Adverse Event|3|||
129942306|NCT05325294|467752213|FG001|Overall Study|Adverse Event|3|||
129942307|NCT05325294|467752212|FG000|Overall Study|Physician Decision|0|||
129942308|NCT05325294|467752213|FG001|Overall Study|Physician Decision|1|||
129942309|NCT05325294|467752212|FG000|Overall Study|Withdrawal by Subject|0|||
129942310|NCT05325294|467752213|FG001|Overall Study|Withdrawal by Subject|3|||
129942311|NCT05325294|467752212|FG000|Overall Study|Lost to Follow-up|1|||
129942312|NCT05325294|467752213|FG001|Overall Study|Lost to Follow-up|0|||
129942313|NCT05325294|467752212|FG000|Overall Study|Sponsor Request|0|||
129942314|NCT05325294|467752213|FG001|Overall Study|Sponsor Request|2|||
129942315|NCT00647387|467752214|FG000|Overall Study|Lost to Follow-up|6|||
129942316|NCT00647387|467752214|FG000|Overall Study|Unsuccessful implant|5|||
129942317|NCT00647387|467752214|FG000|Overall Study|Device explanted|3|||
129942318|NCT00647387|467752214|FG000|Overall Study|Other Reason|3|||
129942319|NCT00647387|467752214|FG000|Overall Study|Death|2|||
129942320|NCT02969356|467752215|FG000|Overall Study|Adverse Event|7|||
129942321|NCT02969356|467752215|FG000|Overall Study|Consent withdrawn|2|||
129942322|NCT02969356|467752215|FG000|Overall Study|Lost to Follow-up|3|||
129942323|NCT02969356|467752215|FG000|Overall Study|Did not need to be reinjected|6|||
129942324|NCT02969356|467752215|FG000|Overall Study|Personal reasons|5|||
129942325|NCT03147287|467752216|FG000|Overall Study|Randomized Not Treated|2|||
129942326|NCT03147287|467752217|FG001|Overall Study|Randomized Not Treated|1|||
129942327|NCT03147287|467752218|FG002|Overall Study|Randomized Not Treated|1|||
129942328|NCT03147287|467752216|FG000|Overall Study|Progressive Disease RECIST|31|||
129942329|NCT03147287|467752217|FG001|Overall Study|Progressive Disease RECIST|72|||
129942330|NCT03147287|467752218|FG002|Overall Study|Progressive Disease RECIST|32|||
129942331|NCT03147287|467752216|FG000|Overall Study|Progressive Disease not RECIST|13|||
129942332|NCT03147287|467752217|FG001|Overall Study|Progressive Disease not RECIST|21|||
129942333|NCT03147287|467752218|FG002|Overall Study|Progressive Disease not RECIST|13|||
129942334|NCT03147287|467752216|FG000|Overall Study|Physician Decision|1|||
129942335|NCT03147287|467752217|FG001|Overall Study|Physician Decision|2|||
129942336|NCT03147287|467752218|FG002|Overall Study|Physician Decision|1|||
129942337|NCT03147287|467752216|FG000|Overall Study|Intercurrent illness|0|||
129942338|NCT03147287|467752217|FG001|Overall Study|Intercurrent illness|1|||
129942339|NCT03147287|467752218|FG002|Overall Study|Intercurrent illness|0|||
129942340|NCT03147287|467752216|FG000|Overall Study|Withdrawal by Subject|2|||
129942341|NCT03147287|467752217|FG001|Overall Study|Withdrawal by Subject|3|||
129942342|NCT03147287|467752218|FG002|Overall Study|Withdrawal by Subject|2|||
129942343|NCT03147287|467752216|FG000|Overall Study|Patient Non-Compliance|0|||
129942344|NCT03147287|467752217|FG001|Overall Study|Patient Non-Compliance|2|||
129942345|NCT03147287|467752218|FG002|Overall Study|Patient Non-Compliance|0|||
129942346|NCT03147287|467752216|FG000|Overall Study|Patient moved|0|||
129942347|NCT03147287|467752217|FG001|Overall Study|Patient moved|1|||
129942348|NCT03147287|467752218|FG002|Overall Study|Patient moved|0|||
129942349|NCT03147287|467752216|FG000|Overall Study|Arm A crossover without PD|1|||
129942350|NCT03147287|467752217|FG001|Overall Study|Arm A crossover without PD|0|||
129942351|NCT03147287|467752218|FG002|Overall Study|Arm A crossover without PD|0|||
129942352|NCT03147287|467752216|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
129942353|NCT03147287|467752217|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
129942354|NCT03147287|467752218|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
129942355|NCT01970878|467753271|FG000|Overall Study|Withdrawal by Subject|11|||
129942356|NCT01970878|467753272|FG001|Overall Study|Withdrawal by Subject|10|||
129942357|NCT01970878|467753273|FG002|Overall Study|Withdrawal by Subject|14|||
129942358|NCT01970878|467753274|FG003|Overall Study|Withdrawal by Subject|7|||
129942359|NCT01970878|467753271|FG000|Overall Study|Lost to Follow-up|1|||
129942360|NCT01970878|467753272|FG001|Overall Study|Lost to Follow-up|3|||
129942361|NCT01970878|467753273|FG002|Overall Study|Lost to Follow-up|2|||
129942362|NCT01970878|467753274|FG003|Overall Study|Lost to Follow-up|4|||
129942363|NCT01970878|467753271|FG000|Overall Study|Administrative Reasons|1|||
129942364|NCT01970878|467753272|FG001|Overall Study|Administrative Reasons|0|||
129942365|NCT01970878|467753273|FG002|Overall Study|Administrative Reasons|0|||
129942366|NCT01970878|467753274|FG003|Overall Study|Administrative Reasons|4|||
129942367|NCT01970878|467753271|FG000|Overall Study|Lack of Efficacy|2|||
129942368|NCT01970878|467753272|FG001|Overall Study|Lack of Efficacy|1|||
129942369|NCT01970878|467753273|FG002|Overall Study|Lack of Efficacy|2|||
129942370|NCT01970878|467753274|FG003|Overall Study|Lack of Efficacy|0|||
129942371|NCT01970878|467753271|FG000|Overall Study|Adverse Event|12|||
129942372|NCT01970878|467753272|FG001|Overall Study|Adverse Event|7|||
129942373|NCT01970878|467753273|FG002|Overall Study|Adverse Event|4|||
129942374|NCT01970878|467753274|FG003|Overall Study|Adverse Event|3|||
129942375|NCT01970878|467753271|FG000|Overall Study|Protocol Specified Criteria|10|||
129942376|NCT01970878|467753272|FG001|Overall Study|Protocol Specified Criteria|4|||
129942377|NCT01970878|467753273|FG002|Overall Study|Protocol Specified Criteria|3|||
129942378|NCT01970878|467753274|FG003|Overall Study|Protocol Specified Criteria|6|||
129942379|NCT01970878|467753271|FG000|Overall Study|Physician Decision|0|||
129942380|NCT01970878|467753272|FG001|Overall Study|Physician Decision|1|||
129942381|NCT01970878|467753273|FG002|Overall Study|Physician Decision|1|||
129942382|NCT01970878|467753274|FG003|Overall Study|Physician Decision|0|||
129942383|NCT01970878|467753271|FG000|Overall Study|No Completion Status|0|||
129942384|NCT01970878|467753272|FG001|Overall Study|No Completion Status|1|||
129942385|NCT01970878|467753273|FG002|Overall Study|No Completion Status|0|||
129942386|NCT01970878|467753274|FG003|Overall Study|No Completion Status|0|||
129942387|NCT04926857|467753275|FG000|Overall Study|Withdrawal by Subject|40|||
129942388|NCT04926857|467753275|FG000|Overall Study|Death|9|||
129942389|NCT04926857|467753275|FG000|Overall Study|Study product no longer in use|44|||
129942390|NCT04926857|467753275|FG000|Overall Study|Inadequate data to address primary objective|16|||
129942391|NCT00089609|467753278|FG000|Overall Study|Withdrawal by Subject|3|||
129942392|NCT00089609|467753279|FG001|Overall Study|Withdrawal by Subject|1|||
129942393|NCT00747006|467753281|FG000|Overall Study|Adverse Event|1|||
129942394|NCT00747006|467753282|FG001|Overall Study|Adverse Event|0|||
129942395|NCT00747006|467753283|FG002|Overall Study|Adverse Event|0|||
129942396|NCT00747006|467753281|FG000|Overall Study|Lost to Follow-up|0|||
129942397|NCT00747006|467753282|FG001|Overall Study|Lost to Follow-up|1|||
129942398|NCT00747006|467753283|FG002|Overall Study|Lost to Follow-up|0|||
129942399|NCT00747006|467753281|FG000|Overall Study|Physician Decision|2|||
129942400|NCT00747006|467753282|FG001|Overall Study|Physician Decision|0|||
129942401|NCT00747006|467753283|FG002|Overall Study|Physician Decision|1|||
129942402|NCT03689946|467753284|FG000|Overall Study|Withdrawal by Subject|3|||
129942403|NCT03689946|467753284|FG000|Overall Study|Lost to Follow-up|3|||
129942404|NCT03689946|467753284|FG000|Overall Study|Data corruption|2|||
129942405|NCT04608409|467753287|FG000|Overall Study|Physician Decision|1|||
129942406|NCT04608409|467753288|FG001|Overall Study|Physician Decision|1|||
129942407|NCT04608409|467753289|FG002|Overall Study|Physician Decision|2|||
129942408|NCT00599196|467753290|FG000|Overall Study|Lack of Efficacy|22|||
129942409|NCT00599196|467753290|FG000|Overall Study|Adverse Event|93|||
129942410|NCT00599196|467753290|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
129942411|NCT00599196|467753290|FG000|Overall Study|Subject withdrew consent|43|||
129942412|NCT00599196|467753290|FG000|Overall Study|Study ended per sponsor|197|||
129942413|NCT00599196|467753290|FG000|Overall Study|Lost to Follow-up|17|||
129942414|NCT00599196|467753290|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
129942415|NCT00599196|467753290|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
129942416|NCT00599196|467753290|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
129942417|NCT00599196|467753290|FG000|Overall Study|Other: Pt Moved To Australia|1|||
129942418|NCT00599196|467753290|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
129942419|NCT00599196|467753290|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
129942420|NCT04497415|467753308|FG000|Overall Study|Lost to Follow-up|43|||
129942421|NCT04497415|467753309|FG001|Overall Study|Lost to Follow-up|27|||
129942422|NCT00853580|467753313|FG000|Overall Study|Lost to Follow-up|3|||
129942423|NCT00853580|467753314|FG001|Overall Study|Lost to Follow-up|5|||
129942424|NCT00853580|467753313|FG000|Overall Study|Protocol Violation|2|||
129942425|NCT00853580|467753314|FG001|Overall Study|Protocol Violation|1|||
129942426|NCT00853580|467753313|FG000|Overall Study|Withdrawal by Subject|2|||
129942427|NCT00853580|467753314|FG001|Overall Study|Withdrawal by Subject|8|||
129942428|NCT00853580|467753313|FG000|Overall Study|Commenced contraindicated therapy|0|||
129942429|NCT00853580|467753314|FG001|Overall Study|Commenced contraindicated therapy|2|||
129942430|NCT01700205|467753315|FG000|Overall Study|Withdrawal by Subject|13|||
129942431|NCT01700205|467753316|FG001|Overall Study|Withdrawal by Subject|13|||
129942432|NCT01700205|467753315|FG000|Overall Study|Protocol Violation|2|||
129942433|NCT01700205|467753316|FG001|Overall Study|Protocol Violation|2|||
129942434|NCT00388726|467753319|FG000|Overall Study|Adverse Event|50|||
129942435|NCT00388726|467753320|FG001|Overall Study|Adverse Event|24|||
129942436|NCT00388726|467753319|FG000|Overall Study|Progressive Disease|336|||
129942437|NCT00388726|467753320|FG001|Overall Study|Progressive Disease|153|||
129942438|NCT00388726|467753319|FG000|Overall Study|Clinical Progression|61|||
129942439|NCT00388726|467753320|FG001|Overall Study|Clinical Progression|36|||
129942440|NCT00388726|467753319|FG000|Overall Study|Withdrawal by Subject|10|||
129942441|NCT00388726|467753320|FG001|Overall Study|Withdrawal by Subject|7|||
129942442|NCT00388726|467753319|FG000|Overall Study|Administrative|6|||
129942443|NCT00388726|467753320|FG001|Overall Study|Administrative|9|||
129942444|NCT00388726|467753319|FG000|Overall Study|Physician Decision|18|||
129942445|NCT00388726|467753320|FG001|Overall Study|Physician Decision|13|||
129942446|NCT00388726|467753319|FG000|Overall Study|Death|3|||
129942447|NCT00388726|467753320|FG001|Overall Study|Death|2|||
129942448|NCT02022670|467753321|FG000|Overall Study|Adverse Event|1|||
129942449|NCT02022670|467753322|FG001|Overall Study|Adverse Event|0|||
129942450|NCT02022670|467753323|FG002|Overall Study|Adverse Event|1|||
129942451|NCT04638816|467753324|FG000|Overall Study|Withdrawal by Subject|0|||
129942452|NCT04638816|467753325|FG001|Overall Study|Withdrawal by Subject|1|||
129942453|NCT04638816|467753324|FG000|Overall Study|Lost to Follow-up|0|||
129942454|NCT04638816|467753325|FG001|Overall Study|Lost to Follow-up|1|||
129942455|NCT02251652|467753326|FG000|Overall Study|Withdrawal by Subject|1|||
129942456|NCT00983294|467753331|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
129942457|NCT00983294|467753331|FG000|Colchicine With Azithromycin|Adverse Event|1|||
129942458|NCT00853593|467753338|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
129942459|NCT00853593|467753338|FG000|Overall Study|Model 4396 lead not attempted|29|||
129942460|NCT00853593|467753338|FG000|Overall Study|Implant not attempted|4|||
129942461|NCT00600353|467753344|FG000|Overall Study|history of malignancy within 5 years|1|||
129942462|NCT00600353|467753345|FG001|Overall Study|history of malignancy within 5 years|0|||
129942463|NCT00600353|467753344|FG000|Overall Study|History of prepartive regimen|0|||
129942464|NCT00600353|467753345|FG001|Overall Study|History of prepartive regimen|1|||
129942465|NCT03683576|467753347|FG000|Overall Study|Withdrawal by Subject|2|||
129942466|NCT03683576|467753348|FG001|Overall Study|Withdrawal by Subject|0|||
129942467|NCT03683576|467753349|FG002|Overall Study|Withdrawal by Subject|8|||
129942468|NCT03683576|467753350|FG003|Overall Study|Withdrawal by Subject|3|||
129942469|NCT03683576|467753347|FG000|Overall Study|Adverse Event|3|||
129942470|NCT03683576|467753348|FG001|Overall Study|Adverse Event|0|||
129942471|NCT03683576|467753349|FG002|Overall Study|Adverse Event|0|||
129942472|NCT03683576|467753350|FG003|Overall Study|Adverse Event|4|||
129942473|NCT03683576|467753347|FG000|Overall Study|Lack of Efficacy|1|||
129942474|NCT03683576|467753348|FG001|Overall Study|Lack of Efficacy|0|||
129942475|NCT03683576|467753349|FG002|Overall Study|Lack of Efficacy|1|||
129942476|NCT03683576|467753350|FG003|Overall Study|Lack of Efficacy|1|||
129942477|NCT03683576|467753347|FG000|Overall Study|Lost to Follow-up|0|||
129942478|NCT03683576|467753348|FG001|Overall Study|Lost to Follow-up|1|||
129942479|NCT03683576|467753349|FG002|Overall Study|Lost to Follow-up|2|||
129942480|NCT03683576|467753350|FG003|Overall Study|Lost to Follow-up|0|||
129942481|NCT03683576|467753347|FG000|Overall Study|Other, Not Specified|0|||
129942482|NCT03683576|467753348|FG001|Overall Study|Other, Not Specified|2|||
129942483|NCT03683576|467753349|FG002|Overall Study|Other, Not Specified|0|||
129942484|NCT03683576|467753350|FG003|Overall Study|Other, Not Specified|0|||
129942485|NCT03683576|467753347|FG000|Overall Study|Protocol Violation|0|||
129942486|NCT03683576|467753348|FG001|Overall Study|Protocol Violation|1|||
129942487|NCT03683576|467753349|FG002|Overall Study|Protocol Violation|1|||
129942488|NCT03683576|467753350|FG003|Overall Study|Protocol Violation|0|||
129942489|NCT01827839|467753351|FG000|Overall Study|Adverse Event|1|||
129942490|NCT01827839|467753351|FG000|Overall Study|Consent Withdrawal|2|||
129942491|NCT03611075|467753355|FG000|Overall Study|Physician Decision|0|||
129942492|NCT03611075|467753356|FG001|Overall Study|Physician Decision|1|||
129942493|NCT03611075|467753357|FG002|Overall Study|Physician Decision|1|||
129942494|NCT03611075|467753358|FG003|Overall Study|Physician Decision|0|||
129942495|NCT03611075|467753359|FG004|Overall Study|Physician Decision|0|||
129942496|NCT03611075|467753360|FG005|Overall Study|Physician Decision|0|||
129942497|NCT03611075|467753361|FG006|Overall Study|Physician Decision|0|||
129942498|NCT03611075|467753362|FG007|Overall Study|Physician Decision|0|||
129942499|NCT03611075|467753363|FG008|Overall Study|Physician Decision|0|||
129942500|NCT03611075|467753355|FG000|Overall Study|Lost to Follow-up|1|||
129942501|NCT03611075|467753356|FG001|Overall Study|Lost to Follow-up|0|||
129942502|NCT03611075|467753357|FG002|Overall Study|Lost to Follow-up|0|||
129942503|NCT03611075|467753358|FG003|Overall Study|Lost to Follow-up|2|||
129942504|NCT03611075|467753359|FG004|Overall Study|Lost to Follow-up|0|||
129942505|NCT03611075|467753360|FG005|Overall Study|Lost to Follow-up|0|||
129942506|NCT03611075|467753361|FG006|Overall Study|Lost to Follow-up|0|||
129942507|NCT03611075|467753362|FG007|Overall Study|Lost to Follow-up|0|||
129942508|NCT03611075|467753363|FG008|Overall Study|Lost to Follow-up|0|||
129942509|NCT03611075|467753355|FG000|Overall Study|Withdrawal by Subject|0|||
129942510|NCT03611075|467753356|FG001|Overall Study|Withdrawal by Subject|1|||
129942511|NCT03611075|467753357|FG002|Overall Study|Withdrawal by Subject|1|||
129942512|NCT03611075|467753358|FG003|Overall Study|Withdrawal by Subject|1|||
129942513|NCT03611075|467753359|FG004|Overall Study|Withdrawal by Subject|0|||
129942514|NCT03611075|467753360|FG005|Overall Study|Withdrawal by Subject|0|||
129942515|NCT03611075|467753361|FG006|Overall Study|Withdrawal by Subject|1|||
129942516|NCT03611075|467753362|FG007|Overall Study|Withdrawal by Subject|0|||
129942517|NCT03611075|467753363|FG008|Overall Study|Withdrawal by Subject|0|||
129942518|NCT03611075|467753355|FG000|Overall Study|Reason unknown|0|||
129942519|NCT03611075|467753356|FG001|Overall Study|Reason unknown|0|||
129942520|NCT03611075|467753357|FG002|Overall Study|Reason unknown|0|||
129942521|NCT03611075|467753358|FG003|Overall Study|Reason unknown|1|||
129942522|NCT03611075|467753359|FG004|Overall Study|Reason unknown|0|||
129942523|NCT03611075|467753360|FG005|Overall Study|Reason unknown|0|||
129942524|NCT03611075|467753361|FG006|Overall Study|Reason unknown|1|||
129942525|NCT03611075|467753362|FG007|Overall Study|Reason unknown|0|||
129942526|NCT03611075|467753363|FG008|Overall Study|Reason unknown|0|||
129942527|NCT00676091|467753364|FG000|Infant Series|Parent or legal guardian request|10|||
129942528|NCT00676091|467753365|FG001|Infant Series|Parent or legal guardian request|8|||
129942529|NCT00676091|467753364|FG000|Infant Series|Protocol Violation|6|||
129942530|NCT00676091|467753365|FG001|Infant Series|Protocol Violation|3|||
129942531|NCT00676091|467753364|FG000|Infant Series|Adverse Event|2|||
129942532|NCT00676091|467753365|FG001|Infant Series|Adverse Event|3|||
129942533|NCT00676091|467753364|FG000|Infant Series|Failed to return|1|||
129942534|NCT00676091|467753365|FG001|Infant Series|Failed to return|3|||
129942535|NCT00676091|467753364|FG000|Infant Series|Lost to Follow-up|1|||
129942536|NCT00676091|467753365|FG001|Infant Series|Lost to Follow-up|0|||
129942537|NCT00676091|467753364|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
129942538|NCT00676091|467753365|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
129942539|NCT00676091|467753364|FG000|After Infant Series|Adverse Event|0|||
129942540|NCT00676091|467753365|FG001|After Infant Series|Adverse Event|1|||
129942541|NCT00676091|467753364|FG000|After Infant Series|Protocol Violation|0|||
129942542|NCT00676091|467753365|FG001|After Infant Series|Protocol Violation|1|||
129942543|NCT00676091|467753364|FG000|After Infant Series|Failed to return|1|||
129942544|NCT00676091|467753365|FG001|After Infant Series|Failed to return|1|||
129942545|NCT00676091|467753364|FG000|Toddler Dose|Failed to return|2|||
129942546|NCT00676091|467753365|FG001|Toddler Dose|Failed to return|0|||
129453298|NCT00545064|465956447|FG000|Overall Study|cancel all appointments, no rebooking|1|||
129453299|NCT00545064|465956447|FG000|Overall Study|inclement weather|1|||
129453300|NCT00501007|465956448|FG000|Overall Study|Inclusion criteria not met.|29|||
129453301|NCT00501007|465956449|FG001|Overall Study|Inclusion criteria not met.|25|||
129942547|NCT00676091|467753364|FG000|Toddler Dose|Parent or legal guardian request|1|||
129942548|NCT00676091|467753365|FG001|Toddler Dose|Parent or legal guardian request|0|||
129942549|NCT05366751|467753369|FG000|Overall Study|Adverse Event|25|||
129942550|NCT05366751|467753369|FG000|Overall Study|Physician Decision|3|||
129453302|NCT00258674|465956452|FG000|Overall Study|Death|32|||
129453303|NCT00258674|465956453|FG001|Overall Study|Death|53|||
129453304|NCT00258674|465956454|FG002|Overall Study|Death|34|||
129453305|NCT03715153|465956455|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
129453306|NCT03715153|465956456|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
129453307|NCT03715153|465956455|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
129453308|NCT03715153|465956456|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
129453309|NCT03715153|465956455|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
129453310|NCT03715153|465956456|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
129453311|NCT03715153|465956455|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
129942551|NCT05366751|467753369|FG000|Overall Study|Lost to Follow-up|2|||
129942552|NCT05366751|467753369|FG000|Overall Study|Withdrawal by Subject|14|||
129942553|NCT05366751|467753369|FG000|Overall Study|Study Terminated by Sponsor|50|||
129942554|NCT05366751|467753369|FG000|Overall Study|Site Terminated by Sponsor|3|||
129942555|NCT00491894|467753375|FG000|Overall Study|Adverse Event|14|||
129942556|NCT00491894|467753375|FG000|Overall Study|Withdrawal by Subject|5|||
129942557|NCT00491894|467753375|FG000|Overall Study|Death|3|||
129942558|NCT00491894|467753375|FG000|Overall Study|Lost to Follow-up|3|||
129942559|NCT00491894|467753375|FG000|Overall Study|Lack of Efficacy|2|||
129942560|NCT00491894|467753375|FG000|Overall Study|Other-Failed to meet any criteria|2|||
129942561|NCT00491894|467753375|FG000|Overall Study|Physician Decision|2|||
129942562|NCT00491894|467753375|FG000|Overall Study|Protocol Violation|2|||
129942563|NCT00491894|467753375|FG000|Overall Study|Other-Intake of prohibited medication|1|||
129942564|NCT04172675|467755107|FG000|Overall Study|Withdrawal by Subject|7|||
129942565|NCT04172675|467755108|FG001|Overall Study|Withdrawal by Subject|5|||
129942566|NCT04172675|467755109|FG002|Overall Study|Withdrawal by Subject|1|||
129942567|NCT04172675|467755110|FG003|Overall Study|Withdrawal by Subject|4|||
129942568|NCT05349721|467755111|FG000|Part A (24 Weeks)|Adverse Event|9|||
129942569|NCT05349721|467755112|FG001|Part A (24 Weeks)|Adverse Event|2|||
129942570|NCT05349721|467755111|FG000|Part A (24 Weeks)|Death|8|||
129942571|NCT05349721|467755112|FG001|Part A (24 Weeks)|Death|3|||
129942572|NCT05349721|467755111|FG000|Part A (24 Weeks)|Disease Progression|1|||
129942573|NCT05349721|467755112|FG001|Part A (24 Weeks)|Disease Progression|1|||
129942574|NCT05349721|467755111|FG000|Part A (24 Weeks)|Screen Failure|2|||
129942575|NCT05349721|467755112|FG001|Part A (24 Weeks)|Screen Failure|0|||
129942576|NCT05349721|467755111|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
129942577|NCT05349721|467755112|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
129942578|NCT05349721|467755111|FG000|Part A (24 Weeks)|Other Than Specified|5|||
129942579|NCT05349721|467755112|FG001|Part A (24 Weeks)|Other Than Specified|1|||
129942580|NCT05349721|467755111|FG000|Part B (28 Weeks)|Adverse Event|3|||
129942581|NCT05349721|467755112|FG001|Part B (28 Weeks)|Adverse Event|0|||
129942582|NCT05349721|467755111|FG000|Part B (28 Weeks)|Death|21|||
129942583|NCT05349721|467755112|FG001|Part B (28 Weeks)|Death|11|||
129942584|NCT05349721|467755111|FG000|Part B (28 Weeks)|Disease Progression|2|||
129942585|NCT05349721|467755112|FG001|Part B (28 Weeks)|Disease Progression|1|||
129942586|NCT05349721|467755111|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
129942587|NCT05349721|467755112|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
129942588|NCT05349721|467755111|FG000|Part B (28 Weeks)|Physician Decision|1|||
129942589|NCT05349721|467755112|FG001|Part B (28 Weeks)|Physician Decision|0|||
129942590|NCT05349721|467755111|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
129942591|NCT05349721|467755112|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
129942592|NCT05349721|467755111|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
129942593|NCT05349721|467755112|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
129942594|NCT05349721|467755111|FG000|Part B (28 Weeks)|Other Than Specified|4|||
129942595|NCT05349721|467755112|FG001|Part B (28 Weeks)|Other Than Specified|2|||
129942596|NCT05349721|467755111|FG000|Part C (108 Weeks)|Death|0|||
129453312|NCT03715153|465956456|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
129942597|NCT05349721|467755112|FG001|Part C (108 Weeks)|Death|1|||
129942598|NCT05349721|467755111|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
129942599|NCT05349721|467755112|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
129942600|NCT05349721|467755111|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
129453313|NCT03715153|465956455|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
129942601|NCT05349721|467755112|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
129942602|NCT05349721|467755111|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
129942603|NCT05349721|467755112|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
129942604|NCT03070392|467755113|FG000|Overall Study|Not Treated|7|||
129942605|NCT03070392|467755114|FG001|Overall Study|Not Treated|0|||
129453314|NCT03715153|465956456|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
129942606|NCT03070392|467755115|FG002|Overall Study|Not Treated|3|||
129942607|NCT03070392|467755116|FG003|Overall Study|Not Treated|12|||
129942608|NCT03070392|467755113|FG000|Overall Study|Death|3|||
129942609|NCT03070392|467755114|FG001|Overall Study|Death|0|||
129942610|NCT03070392|467755115|FG002|Overall Study|Death|0|||
129942611|NCT03070392|467755116|FG003|Overall Study|Death|1|||
129942612|NCT03070392|467755113|FG000|Overall Study|Withdrawal by Subject|7|||
129942613|NCT03070392|467755114|FG001|Overall Study|Withdrawal by Subject|0|||
129942614|NCT03070392|467755115|FG002|Overall Study|Withdrawal by Subject|0|||
129942615|NCT03070392|467755116|FG003|Overall Study|Withdrawal by Subject|3|||
129942616|NCT03070392|467755113|FG000|Overall Study|Physician Decision|1|||
129942617|NCT03070392|467755114|FG001|Overall Study|Physician Decision|0|||
129942618|NCT03070392|467755115|FG002|Overall Study|Physician Decision|0|||
129942619|NCT03070392|467755116|FG003|Overall Study|Physician Decision|2|||
129942620|NCT03070392|467755113|FG000|Overall Study|Progressive Disease|154|||
129942621|NCT03070392|467755114|FG001|Overall Study|Progressive Disease|6|||
129942622|NCT03070392|467755115|FG002|Overall Study|Progressive Disease|2|||
129942623|NCT03070392|467755116|FG003|Overall Study|Progressive Disease|70|||
129942624|NCT03070392|467755113|FG000|Overall Study|Adverse Event|6|||
129942625|NCT03070392|467755114|FG001|Overall Study|Adverse Event|1|||
129942626|NCT03070392|467755115|FG002|Overall Study|Adverse Event|1|||
129942627|NCT03070392|467755116|FG003|Overall Study|Adverse Event|3|||
129942628|NCT03070392|467755113|FG000|Overall Study|Alternate anticancer treatment|1|||
129942629|NCT03070392|467755114|FG001|Overall Study|Alternate anticancer treatment|0|||
129942630|NCT03070392|467755115|FG002|Overall Study|Alternate anticancer treatment|0|||
129942631|NCT03070392|467755116|FG003|Overall Study|Alternate anticancer treatment|1|||
129942632|NCT03070392|467755113|FG000|Overall Study|Ongoing|73|||
129942633|NCT03070392|467755114|FG001|Overall Study|Ongoing|0|||
129942634|NCT03070392|467755115|FG002|Overall Study|Ongoing|0|||
129942635|NCT03070392|467755116|FG003|Overall Study|Ongoing|11|||
129942636|NCT02972034|467755117|FG000|Overall Study|Death|11|||
129942637|NCT02972034|467755118|FG001|Overall Study|Death|1|||
129942638|NCT02972034|467755119|FG002|Overall Study|Death|3|||
129942639|NCT02972034|467755120|FG003|Overall Study|Death|3|||
129942640|NCT02972034|467755121|FG004|Overall Study|Death|2|||
129942641|NCT02972034|467755122|FG005|Overall Study|Death|2|||
129942642|NCT02972034|467755123|FG006|Overall Study|Death|3|||
129942643|NCT02972034|467755124|FG007|Overall Study|Death|4|||
129942644|NCT02972034|467755125|FG008|Overall Study|Death|8|||
129942645|NCT02972034|467755126|FG009|Overall Study|Death|11|||
129942646|NCT02972034|467755127|FG010|Overall Study|Death|3|||
129942647|NCT02972034|467755128|FG011|Overall Study|Death|2|||
129942648|NCT02972034|467755129|FG012|Overall Study|Death|11|||
129942649|NCT02972034|467755130|FG013|Overall Study|Death|10|||
129942650|NCT02972034|467755131|FG014|Overall Study|Death|9|||
129942651|NCT02972034|467755117|FG000|Overall Study|Lost to Follow-up|0|||
129942652|NCT02972034|467755118|FG001|Overall Study|Lost to Follow-up|0|||
129942653|NCT02972034|467755119|FG002|Overall Study|Lost to Follow-up|0|||
129942654|NCT02972034|467755120|FG003|Overall Study|Lost to Follow-up|0|||
129942655|NCT02972034|467755121|FG004|Overall Study|Lost to Follow-up|1|||
129942656|NCT02972034|467755122|FG005|Overall Study|Lost to Follow-up|0|||
129942657|NCT02972034|467755123|FG006|Overall Study|Lost to Follow-up|0|||
129942658|NCT02972034|467755124|FG007|Overall Study|Lost to Follow-up|1|||
129942659|NCT02972034|467755125|FG008|Overall Study|Lost to Follow-up|0|||
129942660|NCT02972034|467755126|FG009|Overall Study|Lost to Follow-up|0|||
129942661|NCT02972034|467755127|FG010|Overall Study|Lost to Follow-up|0|||
129942662|NCT02972034|467755128|FG011|Overall Study|Lost to Follow-up|0|||
129942663|NCT02972034|467755129|FG012|Overall Study|Lost to Follow-up|0|||
129942664|NCT02972034|467755130|FG013|Overall Study|Lost to Follow-up|0|||
129942665|NCT02972034|467755131|FG014|Overall Study|Lost to Follow-up|1|||
129453315|NCT03715153|465956455|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
129453316|NCT03715153|465956456|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
129942666|NCT02972034|467755117|FG000|Overall Study|Physician Decision|0|||
129942667|NCT02972034|467755118|FG001|Overall Study|Physician Decision|0|||
129453317|NCT01358760|465956461|FG000|Overall Study|Adverse Event|3|||
129453318|NCT01358760|465956462|FG001|Overall Study|Adverse Event|4|||
129453319|NCT01358760|465956463|FG002|Overall Study|Adverse Event|3|||
129942668|NCT02972034|467755119|FG002|Overall Study|Physician Decision|0|||
129942669|NCT02972034|467755120|FG003|Overall Study|Physician Decision|0|||
129942670|NCT02972034|467755121|FG004|Overall Study|Physician Decision|0|||
129942671|NCT02972034|467755122|FG005|Overall Study|Physician Decision|0|||
129942672|NCT02972034|467755123|FG006|Overall Study|Physician Decision|0|||
129942673|NCT02972034|467755124|FG007|Overall Study|Physician Decision|1|||
129942674|NCT02972034|467755125|FG008|Overall Study|Physician Decision|0|||
129942675|NCT02972034|467755126|FG009|Overall Study|Physician Decision|0|||
129942676|NCT02972034|467755127|FG010|Overall Study|Physician Decision|1|||
129942677|NCT02972034|467755128|FG011|Overall Study|Physician Decision|0|||
129942678|NCT02972034|467755129|FG012|Overall Study|Physician Decision|0|||
129942679|NCT02972034|467755130|FG013|Overall Study|Physician Decision|0|||
129942680|NCT02972034|467755131|FG014|Overall Study|Physician Decision|0|||
129942681|NCT02972034|467755117|FG000|Overall Study|Sponsor Decision|0|||
129942682|NCT02972034|467755118|FG001|Overall Study|Sponsor Decision|0|||
129942683|NCT02972034|467755119|FG002|Overall Study|Sponsor Decision|0|||
129942684|NCT02972034|467755120|FG003|Overall Study|Sponsor Decision|1|||
129942685|NCT02972034|467755121|FG004|Overall Study|Sponsor Decision|0|||
129942686|NCT02972034|467755122|FG005|Overall Study|Sponsor Decision|0|||
129942687|NCT02972034|467755123|FG006|Overall Study|Sponsor Decision|1|||
129942688|NCT02972034|467755124|FG007|Overall Study|Sponsor Decision|1|||
129942689|NCT02972034|467755125|FG008|Overall Study|Sponsor Decision|1|||
129942690|NCT02972034|467755126|FG009|Overall Study|Sponsor Decision|2|||
129942691|NCT02972034|467755127|FG010|Overall Study|Sponsor Decision|2|||
129942692|NCT02972034|467755128|FG011|Overall Study|Sponsor Decision|0|||
129942693|NCT02972034|467755129|FG012|Overall Study|Sponsor Decision|1|||
129942694|NCT02972034|467755130|FG013|Overall Study|Sponsor Decision|0|||
129942695|NCT02972034|467755131|FG014|Overall Study|Sponsor Decision|1|||
129942696|NCT02972034|467755117|FG000|Overall Study|Withdrawal by Subject|3|||
129942697|NCT02972034|467755118|FG001|Overall Study|Withdrawal by Subject|0|||
129942698|NCT02972034|467755119|FG002|Overall Study|Withdrawal by Subject|0|||
129942699|NCT02972034|467755120|FG003|Overall Study|Withdrawal by Subject|0|||
129942700|NCT02972034|467755121|FG004|Overall Study|Withdrawal by Subject|1|||
129942701|NCT02972034|467755122|FG005|Overall Study|Withdrawal by Subject|1|||
129942702|NCT02972034|467755123|FG006|Overall Study|Withdrawal by Subject|0|||
129942703|NCT02972034|467755124|FG007|Overall Study|Withdrawal by Subject|0|||
129942704|NCT02972034|467755125|FG008|Overall Study|Withdrawal by Subject|1|||
129942705|NCT02972034|467755126|FG009|Overall Study|Withdrawal by Subject|1|||
129942706|NCT02972034|467755127|FG010|Overall Study|Withdrawal by Subject|2|||
129942707|NCT02972034|467755128|FG011|Overall Study|Withdrawal by Subject|1|||
129942708|NCT02972034|467755129|FG012|Overall Study|Withdrawal by Subject|1|||
129942709|NCT02972034|467755130|FG013|Overall Study|Withdrawal by Subject|1|||
129942710|NCT02972034|467755131|FG014|Overall Study|Withdrawal by Subject|0|||
129942711|NCT02972034|467755117|FG000|Overall Study|Screen Failure|0|||
129942712|NCT02972034|467755118|FG001|Overall Study|Screen Failure|0|||
129942713|NCT02972034|467755119|FG002|Overall Study|Screen Failure|0|||
129942714|NCT02972034|467755120|FG003|Overall Study|Screen Failure|0|||
129942715|NCT02972034|467755121|FG004|Overall Study|Screen Failure|0|||
129942716|NCT02972034|467755122|FG005|Overall Study|Screen Failure|0|||
129942717|NCT02972034|467755123|FG006|Overall Study|Screen Failure|0|||
129942718|NCT02972034|467755124|FG007|Overall Study|Screen Failure|0|||
129942719|NCT02972034|467755125|FG008|Overall Study|Screen Failure|0|||
129942720|NCT02972034|467755126|FG009|Overall Study|Screen Failure|0|||
129942721|NCT02972034|467755127|FG010|Overall Study|Screen Failure|0|||
129942722|NCT02972034|467755128|FG011|Overall Study|Screen Failure|0|||
129942723|NCT02972034|467755129|FG012|Overall Study|Screen Failure|1|||
129942724|NCT02972034|467755130|FG013|Overall Study|Screen Failure|0|||
129942725|NCT02972034|467755131|FG014|Overall Study|Screen Failure|0|||
129942726|NCT03861052|467755132|FG000|Overall Study|Adverse Event|1|||
129942727|NCT03861052|467755133|FG001|Overall Study|Adverse Event|1|||
129942728|NCT03861052|467755134|FG002|Overall Study|Adverse Event|2|||
129942729|NCT03861052|467755135|FG003|Overall Study|Adverse Event|4|||
129942730|NCT03861052|467755132|FG000|Overall Study|Lost to Follow-up|0|||
129942731|NCT03861052|467755133|FG001|Overall Study|Lost to Follow-up|0|||
129942732|NCT03861052|467755134|FG002|Overall Study|Lost to Follow-up|0|||
129942733|NCT03861052|467755135|FG003|Overall Study|Lost to Follow-up|1|||
129942734|NCT03861052|467755132|FG000|Overall Study|Physician Decision|0|||
129942735|NCT03861052|467755133|FG001|Overall Study|Physician Decision|1|||
129942736|NCT03861052|467755134|FG002|Overall Study|Physician Decision|0|||
129942737|NCT03861052|467755135|FG003|Overall Study|Physician Decision|0|||
129942738|NCT03861052|467755132|FG000|Overall Study|Withdrawal by Subject|2|||
129942739|NCT03861052|467755133|FG001|Overall Study|Withdrawal by Subject|5|||
129942740|NCT03861052|467755134|FG002|Overall Study|Withdrawal by Subject|3|||
129942741|NCT03861052|467755135|FG003|Overall Study|Withdrawal by Subject|0|||
129942742|NCT03861052|467755132|FG000|Overall Study|Relocation to other city|1|||
129942743|NCT03861052|467755133|FG001|Overall Study|Relocation to other city|0|||
129942744|NCT03861052|467755134|FG002|Overall Study|Relocation to other city|0|||
129942745|NCT03861052|467755135|FG003|Overall Study|Relocation to other city|0|||
129942746|NCT00378898|467755136|FG000|Overall Study|Withdrawal by Subject|10|||
129942747|NCT00378898|467755137|FG001|Overall Study|Withdrawal by Subject|5|||
129942748|NCT00378898|467755136|FG000|Overall Study|Protocol Violation|1|||
129942749|NCT00378898|467755137|FG001|Overall Study|Protocol Violation|1|||
129942750|NCT02534233|467755140|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
129942751|NCT03136159|467755141|FG000|Overall Study|chorioamnionitis|2|||
129942752|NCT03136159|467755142|FG001|Overall Study|chorioamnionitis|0|||
129942753|NCT03136159|467755141|FG000|Overall Study|vertical skin incision|1|||
129942754|NCT03136159|467755142|FG001|Overall Study|vertical skin incision|0|||
129942755|NCT03136159|467755141|FG000|Overall Study|additional dressing|1|||
129942756|NCT03136159|467755142|FG001|Overall Study|additional dressing|0|||
129942757|NCT03136159|467755141|FG000|Overall Study|never got dressing placed|1|||
129453320|NCT01358760|465956461|FG000|Overall Study|Lost to Follow-up|1|||
129942758|NCT03136159|467755142|FG001|Overall Study|never got dressing placed|0|||
129453321|NCT01358760|465956462|FG001|Overall Study|Lost to Follow-up|1|||
129942759|NCT03823703|467755143|FG000|Overall Study|Sponsor request|0|||
129942760|NCT03823703|467755144|FG001|Overall Study|Sponsor request|3|||
129942761|NCT03823703|467755145|FG002|Overall Study|Sponsor request|4|||
129942762|NCT03823703|467755143|FG000|Overall Study|Adverse Event|3|||
129942763|NCT03823703|467755144|FG001|Overall Study|Adverse Event|1|||
129942764|NCT03823703|467755145|FG002|Overall Study|Adverse Event|0|||
129942765|NCT03823703|467755143|FG000|Overall Study|Withdrawal by Subject|0|||
129942766|NCT03823703|467755144|FG001|Overall Study|Withdrawal by Subject|1|||
129942767|NCT03823703|467755145|FG002|Overall Study|Withdrawal by Subject|0|||
129942768|NCT03137459|467755146|FG000|2-month Assessment|Withdrawal by Subject|13|||
129942769|NCT03137459|467755147|FG001|2-month Assessment|Withdrawal by Subject|3|||
129942770|NCT03137459|467755146|FG000|2-month Assessment|Unable to reach|42|||
129942771|NCT03137459|467755147|FG001|2-month Assessment|Unable to reach|32|||
129942772|NCT03137459|467755146|FG000|2-month Assessment|Refused assessment|7|||
129942773|NCT03137459|467755147|FG001|2-month Assessment|Refused assessment|5|||
129942774|NCT03137459|467755146|FG000|2-month Assessment|Acutely ill|6|||
129942775|NCT03137459|467755147|FG001|2-month Assessment|Acutely ill|2|||
129942776|NCT03137459|467755146|FG000|4-month Assessment|Death|4|||
129942777|NCT03137459|467755147|FG001|4-month Assessment|Death|2|||
129942778|NCT03137459|467755146|FG000|4-month Assessment|Withdrawal by Subject|4|||
129942779|NCT03137459|467755147|FG001|4-month Assessment|Withdrawal by Subject|2|||
129942780|NCT03137459|467755146|FG000|4-month Assessment|Unable to reach|44|||
129942781|NCT03137459|467755147|FG001|4-month Assessment|Unable to reach|29|||
129942782|NCT03137459|467755146|FG000|4-month Assessment|Refused assessment|24|||
129942783|NCT03137459|467755147|FG001|4-month Assessment|Refused assessment|10|||
129942784|NCT03137459|467755146|FG000|4-month Assessment|Acutely ill|2|||
129942785|NCT03137459|467755147|FG001|4-month Assessment|Acutely ill|3|||
129942786|NCT03137459|467755146|FG000|6-months|Lost to Follow-up|14|||
129942787|NCT03137459|467755147|FG001|6-months|Lost to Follow-up|11|||
129942788|NCT03137459|467755146|FG000|6-months|Death|0|||
129942789|NCT03137459|467755147|FG001|6-months|Death|2|||
129942790|NCT03137459|467755146|FG000|6-months|Refused assessment|6|||
129942791|NCT03137459|467755147|FG001|6-months|Refused assessment|3|||
129942792|NCT03137459|467755146|FG000|6-months|Acutely ill|1|||
129942793|NCT03137459|467755147|FG001|6-months|Acutely ill|1|||
129942794|NCT01732757|467755148|FG000|Overall Study|Lost to Follow-up|1|||
129942795|NCT01732757|467755149|FG001|Overall Study|Lost to Follow-up|0|||
129942796|NCT01732757|467755150|FG002|Overall Study|Lost to Follow-up|0|||
129942797|NCT00925548|467755151|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
129942798|NCT00925548|467755152|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
129942799|NCT04921358|467755153|FG000|Overall Study|Withdrawal by Subject|6|||
129942800|NCT04921358|467755154|FG001|Overall Study|Withdrawal by Subject|13|||
129942801|NCT04921358|467755153|FG000|Overall Study|Lost to Follow-up|3|||
129942802|NCT04921358|467755154|FG001|Overall Study|Lost to Follow-up|6|||
129942803|NCT04921358|467755153|FG000|Overall Study|Study Terminated by Sponsor|86|||
129942804|NCT04921358|467755154|FG001|Overall Study|Study Terminated by Sponsor|89|||
129942805|NCT04921358|467755153|FG000|Overall Study|Death|92|||
129942806|NCT04921358|467755154|FG001|Overall Study|Death|82|||
129942807|NCT02372799|467755159|FG000|Treatment Period|Adverse Event|3|||
129942808|NCT02372799|467755160|FG001|Treatment Period|Adverse Event|10|||
129942809|NCT02372799|467755161|FG002|Treatment Period|Adverse Event|6|||
129942810|NCT02372799|467755159|FG000|Treatment Period|Insufficient therapeutic response|2|||
129942811|NCT02372799|467755160|FG001|Treatment Period|Insufficient therapeutic response|2|||
129942812|NCT02372799|467755161|FG002|Treatment Period|Insufficient therapeutic response|0|||
129942813|NCT02372799|467755159|FG000|Treatment Period|Withdrawal by Subject|10|||
129942814|NCT02372799|467755160|FG001|Treatment Period|Withdrawal by Subject|10|||
129942815|NCT02372799|467755161|FG002|Treatment Period|Withdrawal by Subject|2|||
129942816|NCT02372799|467755159|FG000|Treatment Period|Lost to Follow-up|11|||
129942817|NCT02372799|467755160|FG001|Treatment Period|Lost to Follow-up|5|||
129942818|NCT02372799|467755161|FG002|Treatment Period|Lost to Follow-up|3|||
129942819|NCT02372799|467755159|FG000|Treatment Period|Protocol Violation|3|||
129942820|NCT02372799|467755160|FG001|Treatment Period|Protocol Violation|0|||
129942821|NCT02372799|467755161|FG002|Treatment Period|Protocol Violation|0|||
129942822|NCT02372799|467755159|FG000|Treatment Period|Non-compliance with study drug|4|||
129942823|NCT02372799|467755160|FG001|Treatment Period|Non-compliance with study drug|4|||
129942824|NCT02372799|467755161|FG002|Treatment Period|Non-compliance with study drug|4|||
129942825|NCT02372799|467755159|FG000|Treatment Period|Miscellaneous Reasons|1|||
129942826|NCT02372799|467755160|FG001|Treatment Period|Miscellaneous Reasons|1|||
129942827|NCT02372799|467755161|FG002|Treatment Period|Miscellaneous Reasons|0|||
129942828|NCT02372799|467755159|FG000|Down-taper Period|Lost to Follow-up|1|||
129942829|NCT02372799|467755160|FG001|Down-taper Period|Lost to Follow-up|2|||
129942830|NCT02372799|467755161|FG002|Down-taper Period|Lost to Follow-up|2|||
129942831|NCT00491400|467755162|FG000|Overall Study|Withdrawal by Subject|5|||
129942832|NCT00491400|467755163|FG001|Overall Study|Withdrawal by Subject|4|||
129942833|NCT00745875|467755164|FG000|Overall Study|Continuing study treatment|4|||
129942834|NCT00745875|467755165|FG001|Overall Study|Continuing study treatment|4|||
129942835|NCT01256359|467755168|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
129942836|NCT01256359|467755169|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
129942837|NCT01256359|467755168|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
129942838|NCT01256359|467755169|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
129942839|NCT02000752|467755170|FG000|Overall Study|Dystocic delivery|19|||
129942840|NCT02000752|467755171|FG001|Overall Study|Dystocic delivery|8|||
129942841|NCT02000752|467755170|FG000|Overall Study|Shift Changes|12|||
129942842|NCT02000752|467755171|FG001|Overall Study|Shift Changes|5|||
129942843|NCT04693637|467755172|FG000|Overall Study|Death|4|||
129942844|NCT04693637|467755172|FG000|Overall Study|Withdrawal by Subject|3|||
129942845|NCT04693637|467755172|FG000|Overall Study|Physician Decision|2|||
129942846|NCT04693637|467755172|FG000|Overall Study|Lost to Follow-up|1|||
129942847|NCT01728324|467755194|FG000|Termination of DBV|Adverse Event|14|||
129942848|NCT01728324|467755195|FG001|Termination of DBV|Adverse Event|13|||
129942849|NCT01728324|467755196|FG002|Termination of DBV|Adverse Event|4|||
129942850|NCT01728324|467755194|FG000|Termination of DBV|Lack of Efficacy|14|||
129942851|NCT01728324|467755195|FG001|Termination of DBV|Lack of Efficacy|12|||
129942852|NCT01728324|467755196|FG002|Termination of DBV|Lack of Efficacy|8|||
129942853|NCT01728324|467755194|FG000|Termination of DBV|Withdrawal by Subject|9|||
129942854|NCT01728324|467755195|FG001|Termination of DBV|Withdrawal by Subject|6|||
129942855|NCT01728324|467755196|FG002|Termination of DBV|Withdrawal by Subject|2|||
129942856|NCT01728324|467755194|FG000|Termination of DBV|Other than stated|1|||
129942857|NCT01728324|467755195|FG001|Termination of DBV|Other than stated|3|||
129942858|NCT01728324|467755196|FG002|Termination of DBV|Other than stated|0|||
129942859|NCT01728324|467755194|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
129942860|NCT01728324|467755195|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
129942861|NCT01728324|467755196|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
129942862|NCT01728324|467755194|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
129942863|NCT01728324|467755195|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
129942864|NCT01728324|467755196|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
129942865|NCT01728324|467755194|FG000|Termination of FDV|Adverse Event|14|||
129942866|NCT01728324|467755195|FG001|Termination of FDV|Adverse Event|13|||
129942867|NCT01728324|467755196|FG002|Termination of FDV|Adverse Event|4|||
129942868|NCT01728324|467755194|FG000|Termination of FDV|Lack of Efficacy|14|||
129942869|NCT01728324|467755195|FG001|Termination of FDV|Lack of Efficacy|12|||
129942870|NCT01728324|467755196|FG002|Termination of FDV|Lack of Efficacy|8|||
129942871|NCT01728324|467755194|FG000|Termination of FDV|Withdrawal by Subject|9|||
129942872|NCT01728324|467755195|FG001|Termination of FDV|Withdrawal by Subject|6|||
129942873|NCT01728324|467755196|FG002|Termination of FDV|Withdrawal by Subject|2|||
129942874|NCT01728324|467755194|FG000|Termination of FDV|Other than stated|1|||
129942875|NCT01728324|467755195|FG001|Termination of FDV|Other than stated|3|||
129942876|NCT01728324|467755196|FG002|Termination of FDV|Other than stated|0|||
129942877|NCT01728324|467755194|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
129942878|NCT01728324|467755195|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
129942879|NCT01728324|467755196|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
129942880|NCT01728324|467755194|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
129942881|NCT01728324|467755195|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
129942882|NCT01728324|467755196|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
129942883|NCT01728324|467755194|FG000|Termination of RBV|Adverse Event|15|||
129942884|NCT01728324|467755195|FG001|Termination of RBV|Adverse Event|16|||
129942885|NCT01728324|467755196|FG002|Termination of RBV|Adverse Event|5|||
129942886|NCT01728324|467755194|FG000|Termination of RBV|Lack of Efficacy|14|||
129942887|NCT01728324|467755195|FG001|Termination of RBV|Lack of Efficacy|11|||
129942888|NCT01728324|467755196|FG002|Termination of RBV|Lack of Efficacy|7|||
129942889|NCT01728324|467755194|FG000|Termination of RBV|Withdrawal by Subject|9|||
129942890|NCT01728324|467755195|FG001|Termination of RBV|Withdrawal by Subject|5|||
129942891|NCT01728324|467755196|FG002|Termination of RBV|Withdrawal by Subject|2|||
129942892|NCT01728324|467755194|FG000|Termination of RBV|Other than stated|1|||
129942893|NCT01728324|467755195|FG001|Termination of RBV|Other than stated|3|||
129942894|NCT01728324|467755196|FG002|Termination of RBV|Other than stated|1|||
129942895|NCT01728324|467755194|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
129942896|NCT01728324|467755195|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
129942897|NCT01728324|467755196|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
129942898|NCT01728324|467755194|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
129942899|NCT01728324|467755195|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
129942900|NCT01728324|467755196|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
129942901|NCT03057600|467755197|FG000|Overall Study|Adverse Event|0|||
129942902|NCT03057600|467755198|FG001|Overall Study|Adverse Event|0|||
129942903|NCT03057600|467755199|FG002|Overall Study|Adverse Event|4|||
129942904|NCT03057600|467755200|FG003|Overall Study|Adverse Event|0|||
129942905|NCT03057600|467755197|FG000|Overall Study|Radiologic Disease Progression|8|||
129942906|NCT03057600|467755198|FG001|Overall Study|Radiologic Disease Progression|7|||
129942907|NCT03057600|467755199|FG002|Overall Study|Radiologic Disease Progression|13|||
129942908|NCT03057600|467755200|FG003|Overall Study|Radiologic Disease Progression|10|||
129453322|NCT01358760|465956463|FG002|Overall Study|Lost to Follow-up|3|||
129453323|NCT01358760|465956461|FG000|Overall Study|Withdrawal by Subject|5|||
129453324|NCT01358760|465956462|FG001|Overall Study|Withdrawal by Subject|3|||
129453325|NCT01358760|465956463|FG002|Overall Study|Withdrawal by Subject|2|||
129453326|NCT01358760|465956461|FG000|Overall Study|Physician Decision|1|||
129453327|NCT01358760|465956462|FG001|Overall Study|Physician Decision|0|||
129942909|NCT03057600|467755197|FG000|Overall Study|Symptomatic Deterioration|0|||
129942910|NCT03057600|467755198|FG001|Overall Study|Symptomatic Deterioration|1|||
129942911|NCT03057600|467755199|FG002|Overall Study|Symptomatic Deterioration|1|||
129942912|NCT03057600|467755200|FG003|Overall Study|Symptomatic Deterioration|0|||
129942913|NCT03057600|467755197|FG000|Overall Study|Investigator Decision|0|||
129942914|NCT03057600|467755198|FG001|Overall Study|Investigator Decision|0|||
129942915|NCT03057600|467755199|FG002|Overall Study|Investigator Decision|1|||
129942916|NCT03057600|467755200|FG003|Overall Study|Investigator Decision|0|||
129942917|NCT03057600|467755197|FG000|Overall Study|Study Termination by Sponsor|0|||
129942918|NCT03057600|467755198|FG001|Overall Study|Study Termination by Sponsor|0|||
129942919|NCT03057600|467755199|FG002|Overall Study|Study Termination by Sponsor|0|||
129942920|NCT03057600|467755200|FG003|Overall Study|Study Termination by Sponsor|2|||
129942921|NCT03057600|467755197|FG000|Overall Study|Withdrawal by Subject|0|||
129942922|NCT03057600|467755198|FG001|Overall Study|Withdrawal by Subject|1|||
129453328|NCT01358760|465956463|FG002|Overall Study|Physician Decision|1|||
129453329|NCT01358760|465956461|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
129453330|NCT01358760|465956462|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
129942923|NCT03057600|467755199|FG002|Overall Study|Withdrawal by Subject|0|||
129942924|NCT03057600|467755200|FG003|Overall Study|Withdrawal by Subject|0|||
129942925|NCT03057600|467755197|FG000|Overall Study|Other, Not Specified|1|||
129942926|NCT03057600|467755198|FG001|Overall Study|Other, Not Specified|1|||
129942927|NCT03057600|467755199|FG002|Overall Study|Other, Not Specified|1|||
129942928|NCT03057600|467755200|FG003|Overall Study|Other, Not Specified|1|||
129942929|NCT01170208|467755201|FG000|Overall Study|Withdrawal by Subject|5|||
129942930|NCT01170208|467755202|FG001|Overall Study|Withdrawal by Subject|0|||
129942931|NCT01170208|467755203|FG002|Overall Study|Withdrawal by Subject|1|||
129942932|NCT01170208|467755201|FG000|Overall Study|Protocol Violation|1|||
129942933|NCT01170208|467755202|FG001|Overall Study|Protocol Violation|0|||
129942934|NCT01170208|467755203|FG002|Overall Study|Protocol Violation|1|||
129942935|NCT03335488|467755210|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
129942936|NCT03335488|467755211|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
129942937|NCT03335488|467755210|FG000|Safety Extension Period|Adverse Event|1|||
129942938|NCT03335488|467755211|FG001|Safety Extension Period|Adverse Event|0|||
129942939|NCT03335488|467755210|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
129942940|NCT03335488|467755211|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
129942941|NCT02113449|467755212|FG000|Overall Study|Adverse Event|4|||
129942942|NCT01160354|467755215|FG000|Overall Study|Death|0|||
129942943|NCT01160354|467755216|FG001|Overall Study|Death|1|||
129942944|NCT01160354|467755217|FG002|Overall Study|Death|1|||
129942945|NCT01822756|467755218|FG000|Overall Study|Adverse Event|0|||
129942946|NCT01822756|467755219|FG001|Overall Study|Adverse Event|0|||
129942947|NCT01822756|467755220|FG002|Overall Study|Adverse Event|0|||
129942948|NCT01822756|467755221|FG003|Overall Study|Adverse Event|2|||
129942949|NCT01822756|467755222|FG004|Overall Study|Adverse Event|0|||
129942950|NCT01822756|467755218|FG000|Overall Study|Disease progression|11|||
129942951|NCT01822756|467755219|FG001|Overall Study|Disease progression|1|||
129942952|NCT01822756|467755220|FG002|Overall Study|Disease progression|7|||
129942953|NCT01822756|467755221|FG003|Overall Study|Disease progression|2|||
129942954|NCT01822756|467755222|FG004|Overall Study|Disease progression|6|||
129942955|NCT01822756|467755218|FG000|Overall Study|Death|2|||
129942956|NCT01822756|467755219|FG001|Overall Study|Death|2|||
129942957|NCT01822756|467755220|FG002|Overall Study|Death|1|||
129942958|NCT01822756|467755221|FG003|Overall Study|Death|0|||
129942959|NCT01822756|467755222|FG004|Overall Study|Death|0|||
129942960|NCT01822756|467755218|FG000|Overall Study|Lost to Follow-up|1|||
129942961|NCT01822756|467755219|FG001|Overall Study|Lost to Follow-up|0|||
129942962|NCT01822756|467755220|FG002|Overall Study|Lost to Follow-up|1|||
129942963|NCT01822756|467755221|FG003|Overall Study|Lost to Follow-up|0|||
129942964|NCT01822756|467755222|FG004|Overall Study|Lost to Follow-up|1|||
129942965|NCT01822756|467755218|FG000|Overall Study|Physician Decision|0|||
129942966|NCT01822756|467755219|FG001|Overall Study|Physician Decision|1|||
129942967|NCT01822756|467755220|FG002|Overall Study|Physician Decision|0|||
129942968|NCT01822756|467755221|FG003|Overall Study|Physician Decision|0|||
129942969|NCT01822756|467755222|FG004|Overall Study|Physician Decision|0|||
129942970|NCT01822756|467755218|FG000|Overall Study|disease progression & patient preference|2|||
129942971|NCT01822756|467755219|FG001|Overall Study|disease progression & patient preference|0|||
129942972|NCT01822756|467755220|FG002|Overall Study|disease progression & patient preference|1|||
129942973|NCT01822756|467755221|FG003|Overall Study|disease progression & patient preference|0|||
129942974|NCT01822756|467755222|FG004|Overall Study|disease progression & patient preference|0|||
129942975|NCT00614614|467755227|FG000|Primary Vaccination Phase|Adverse Event|6|||
129942976|NCT00614614|467755228|FG001|Primary Vaccination Phase|Adverse Event|0|||
129942977|NCT00614614|467755229|FG002|Primary Vaccination Phase|Adverse Event|0|||
129942978|NCT00614614|467755230|FG003|Primary Vaccination Phase|Adverse Event|0|||
129942979|NCT00614614|467755231|FG004|Primary Vaccination Phase|Adverse Event|0|||
129942980|NCT00614614|467755227|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
129942981|NCT00614614|467755228|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
129942982|NCT00614614|467755229|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
129942983|NCT00614614|467755230|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
129942984|NCT00614614|467755231|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
129942985|NCT00614614|467755227|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
129942986|NCT00614614|467755228|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
129942987|NCT00614614|467755229|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
129942988|NCT00614614|467755230|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
129942989|NCT00614614|467755231|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
129942990|NCT00614614|467755227|FG000|Primary Vaccination Phase|Protocol Violation|9|||
129942991|NCT00614614|467755228|FG001|Primary Vaccination Phase|Protocol Violation|3|||
129942992|NCT00614614|467755229|FG002|Primary Vaccination Phase|Protocol Violation|0|||
129942993|NCT00614614|467755230|FG003|Primary Vaccination Phase|Protocol Violation|0|||
129453331|NCT01358760|465956463|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
129453332|NCT01506960|465956464|FG000|Overall Study|Did not meet angiographic criteria|47|||
129942994|NCT00614614|467755231|FG004|Primary Vaccination Phase|Protocol Violation|0|||
129942995|NCT00614614|467755227|FG000|Primary Vaccination Phase|Other|4|||
129942996|NCT00614614|467755228|FG001|Primary Vaccination Phase|Other|0|||
129942997|NCT00614614|467755229|FG002|Primary Vaccination Phase|Other|0|||
129942998|NCT00614614|467755230|FG003|Primary Vaccination Phase|Other|0|||
129942999|NCT00614614|467755231|FG004|Primary Vaccination Phase|Other|0|||
129943000|NCT00614614|467755227|FG000|Booster Vaccination Phase|Adverse Event|0|||
129943001|NCT00614614|467755228|FG001|Booster Vaccination Phase|Adverse Event|0|||
129943002|NCT00614614|467755229|FG002|Booster Vaccination Phase|Adverse Event|1|||
129943003|NCT00614614|467755230|FG003|Booster Vaccination Phase|Adverse Event|1|||
129943004|NCT00614614|467755231|FG004|Booster Vaccination Phase|Adverse Event|0|||
129943005|NCT00614614|467755227|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
129943006|NCT00614614|467755228|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
129943007|NCT00614614|467755229|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
129943008|NCT00614614|467755230|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
129943009|NCT00614614|467755231|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
129943010|NCT00614614|467755227|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
129943011|NCT00614614|467755228|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
129943012|NCT00614614|467755229|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
129943013|NCT00614614|467755230|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
129943014|NCT00614614|467755231|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
129943015|NCT00614614|467755227|FG000|Booster Vaccination Phase|Protocol Violation|0|||
129943016|NCT00614614|467755228|FG001|Booster Vaccination Phase|Protocol Violation|0|||
129943017|NCT00614614|467755229|FG002|Booster Vaccination Phase|Protocol Violation|2|||
129943018|NCT00614614|467755230|FG003|Booster Vaccination Phase|Protocol Violation|3|||
129943019|NCT00614614|467755231|FG004|Booster Vaccination Phase|Protocol Violation|0|||
129943020|NCT00614614|467755227|FG000|Booster Vaccination Phase|Other|0|||
129943021|NCT00614614|467755228|FG001|Booster Vaccination Phase|Other|1|||
129943022|NCT00614614|467755229|FG002|Booster Vaccination Phase|Other|3|||
129943023|NCT00614614|467755230|FG003|Booster Vaccination Phase|Other|2|||
129943024|NCT00614614|467755231|FG004|Booster Vaccination Phase|Other|1|||
129943025|NCT00933270|467755232|FG000|Overall Study|Withdrawal by Subject|26|||
129943026|NCT00933270|467755232|FG000|Overall Study|Insufficient Follow-up|10|||
129943027|NCT00933270|467755232|FG000|Overall Study|Lost to Follow-up|14|||
129943028|NCT00933270|467755232|FG000|Overall Study|Adverse Event|1|||
129943029|NCT00933270|467755232|FG000|Overall Study|Missed Visit|2|||
129943030|NCT00933270|467755232|FG000|Overall Study|Death|24|||
129943031|NCT00933270|467755232|FG000|Overall Study|Moved or would not return|10|||
129943032|NCT01000805|467755233|FG000|Overall Study|Adverse Event|21|||
129943033|NCT01000805|467755234|FG001|Overall Study|Adverse Event|9|||
129943034|NCT01000805|467755233|FG000|Overall Study|Lack of Efficacy|5|||
129943035|NCT01000805|467755234|FG001|Overall Study|Lack of Efficacy|16|||
129943036|NCT01000805|467755233|FG000|Overall Study|Lost to Follow-up|16|||
129943037|NCT01000805|467755234|FG001|Overall Study|Lost to Follow-up|21|||
129943038|NCT01000805|467755233|FG000|Overall Study|Physician Decision|0|||
129943039|NCT01000805|467755234|FG001|Overall Study|Physician Decision|1|||
129943040|NCT01000805|467755233|FG000|Overall Study|Protocol Violation|12|||
129943041|NCT01000805|467755234|FG001|Overall Study|Protocol Violation|8|||
129943042|NCT01000805|467755233|FG000|Overall Study|Withdrawal by Subject|16|||
129943043|NCT01000805|467755234|FG001|Overall Study|Withdrawal by Subject|6|||
129943044|NCT01000805|467755233|FG000|Overall Study|Sponsor Decision|0|||
129943045|NCT01000805|467755234|FG001|Overall Study|Sponsor Decision|1|||
129943046|NCT00989196|467755235|FG000|Treatment Period|Lost to Follow-up|1|||
129943047|NCT00989196|467755236|FG001|Treatment Period|Lost to Follow-up|0|||
129943048|NCT03476798|467755239|FG000|Overall Study|Death|1|||
129943049|NCT03476798|467755239|FG000|Overall Study|Withdrawal by Subject|2|||
129943050|NCT03476798|467755239|FG000|Overall Study|Protocol Violation|2|||
129943051|NCT05824559|467755240|FG000|Overall Study|Adverse Event|2|||
129943052|NCT05824559|467755240|FG000|Overall Study|Physician Decision|2|||
129943053|NCT05824559|467755240|FG000|Overall Study|Progressive Disease|16|||
129943054|NCT05824559|467755240|FG000|Overall Study|Study Terminated by Sponsor|1|||
129943055|NCT05824559|467755240|FG000|Overall Study|Withdrawal by Subject|2|||
129943056|NCT02409680|467755245|FG000|Overall Study|Lost to Follow-up|15|||
129943057|NCT02409680|467755246|FG001|Overall Study|Lost to Follow-up|30|||
129943058|NCT03343704|467755252|FG000|Overall Study|Refused to complete follow up|0|||
129943059|NCT03343704|467755253|FG001|Overall Study|Refused to complete follow up|1|||
129943060|NCT03343704|467755252|FG000|Overall Study|Death|0|||
129943061|NCT03343704|467755253|FG001|Overall Study|Death|1|||
129943062|NCT03343704|467755252|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
129943063|NCT03343704|467755253|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
129943064|NCT03789656|467755254|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
129943065|NCT03789656|467755255|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
129943066|NCT03789656|467755256|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
129943067|NCT03789656|467755257|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
129943068|NCT03789656|467755258|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
129943069|NCT03789656|467755254|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943070|NCT03789656|467755255|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943071|NCT03789656|467755256|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
129943072|NCT03789656|467755257|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943073|NCT03789656|467755258|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
129943074|NCT03789656|467755254|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
129943075|NCT03789656|467755255|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943076|NCT03789656|467755256|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943077|NCT03789656|467755257|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943078|NCT03789656|467755258|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
129943079|NCT03789656|467755254|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
129943080|NCT03789656|467755255|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943081|NCT03789656|467755256|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943082|NCT03789656|467755257|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943083|NCT03789656|467755258|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
129943084|NCT02434328|467755266|FG000|Overall Study|Adverse Event|9|||
129943085|NCT02434328|467755267|FG001|Overall Study|Adverse Event|4|||
129943086|NCT02434328|467755266|FG000|Overall Study|Lack of Efficacy|0|||
129943087|NCT02434328|467755267|FG001|Overall Study|Lack of Efficacy|2|||
129943088|NCT02434328|467755266|FG000|Overall Study|Physician Decision|0|||
129943089|NCT02434328|467755267|FG001|Overall Study|Physician Decision|1|||
129943090|NCT02434328|467755266|FG000|Overall Study|Withdrawal by Subject|12|||
129943091|NCT02434328|467755267|FG001|Overall Study|Withdrawal by Subject|21|||
129943092|NCT02434328|467755266|FG000|Overall Study|Death|4|||
129943093|NCT02434328|467755267|FG001|Overall Study|Death|7|||
129943094|NCT02434328|467755266|FG000|Overall Study|Lost to Follow-up|1|||
129943095|NCT02434328|467755267|FG001|Overall Study|Lost to Follow-up|6|||
129943096|NCT02434328|467755266|FG000|Overall Study|Other|4|||
129943097|NCT02434328|467755267|FG001|Overall Study|Other|1|||
129943098|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
129943099|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
129943100|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
129943101|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
129943102|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
129453333|NCT00450723|465956466|FG000|Overall Study|Physician Decision|5|||
129943103|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
129943104|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
129943105|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
129943106|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
129943107|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
129943108|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
129943109|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943110|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943111|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943112|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
129943113|NCT00302211|467755272|FG000|Double Blind Period (New Patients)|Disease progression|0|||
129943114|NCT00302211|467755273|FG001|Double Blind Period (New Patients)|Disease progression|1|||
129943115|NCT00302211|467755274|FG002|Double Blind Period (New Patients)|Disease progression|1|||
129943116|NCT00302211|467755275|FG003|Double Blind Period (New Patients)|Disease progression|0|||
129943117|NCT00302211|467755276|FG004|Double Blind Period (New Patients)|Disease progression|0|||
129943118|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
129943119|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
129943120|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
129943121|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
129943122|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
129943123|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943124|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943125|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943126|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
129943127|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
129943128|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943129|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943130|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943131|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
129943132|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
129943133|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
129943134|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
129943135|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
129943136|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
129943137|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
129943138|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Death|0|||
129943139|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Death|0|||
129943140|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Death|0|||
129943141|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Death|1|||
129943142|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Death|1|||
129943143|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943144|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943145|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943146|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
129943147|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
129943148|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943149|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943150|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943151|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
129943152|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
129943153|NCT00302211|467755272|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943154|NCT00302211|467755273|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943155|NCT00302211|467755274|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943156|NCT00302211|467755275|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
129943157|NCT00302211|467755276|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
129943158|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
129943159|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
129943160|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
129943161|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
129943162|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
129943163|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
129943164|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
129943165|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
129943166|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
129943167|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
129943168|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
129943169|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
129943170|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
129943171|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
129943172|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
129943173|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
129943174|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
129943175|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
129943176|NCT02294461|467755277|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
129943177|NCT02294461|467755278|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
129943178|NCT02294461|467755279|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
129943179|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
129943180|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
129943181|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
129943182|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
129943183|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
129943184|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
129943185|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
129943186|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
129943187|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
129943188|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
129943189|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
129943190|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
129943191|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
129943192|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
129943193|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
129943194|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
129943195|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
129943196|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
129943197|NCT02294461|467755277|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
129943198|NCT02294461|467755278|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
129943199|NCT02294461|467755279|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
129943200|NCT05432986|467755280|FG000|Overall Study|Withdrawal by Subject|2|||
129943201|NCT05432986|467755280|FG000|Overall Study|incomplete measurement|7|||
129943202|NCT03009344|467756652|FG000|Overall Study|Lack of Efficacy|5|||
129943203|NCT03009344|467756652|FG000|Overall Study|Withdrawal by Subject|1|||
129943204|NCT03009344|467756652|FG000|Overall Study|Adverse Event|1|||
129943205|NCT03116464|467756653|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
129943206|NCT00597376|467756654|FG000|Overall Study|Withdrawal by Subject|4|||
129943207|NCT00597376|467756655|FG001|Overall Study|Withdrawal by Subject|3|||
129943208|NCT00597376|467756654|FG000|Overall Study|Adverse Event|4|||
129943209|NCT00597376|467756655|FG001|Overall Study|Adverse Event|1|||
129943210|NCT01532648|467756658|FG000|Overall Study|Lost to Follow-up|3|||
129943211|NCT01532648|467756659|FG001|Overall Study|Lost to Follow-up|4|||
129943212|NCT01532648|467756658|FG000|Overall Study|Lack of Efficacy|4|||
129943213|NCT01532648|467756659|FG001|Overall Study|Lack of Efficacy|1|||
129943214|NCT01532648|467756658|FG000|Overall Study|Protocol Violation|1|||
129943215|NCT01532648|467756659|FG001|Overall Study|Protocol Violation|1|||
129943216|NCT01532648|467756658|FG000|Overall Study|Adverse Event|12|||
129943217|NCT01532648|467756659|FG001|Overall Study|Adverse Event|9|||
129943218|NCT01532648|467756658|FG000|Overall Study|Withdrawal by Subject|16|||
129943219|NCT01532648|467756659|FG001|Overall Study|Withdrawal by Subject|2|||
129943220|NCT01583166|467756660|FG000|Overall Study|Withdrawal by Subject|4|||
129943221|NCT01583166|467756661|FG001|Overall Study|Withdrawal by Subject|6|||
129943222|NCT04652869|467756666|FG000|Overall Study|Withdrawal by Subject|0|||
129943223|NCT04652869|467756667|FG001|Overall Study|Withdrawal by Subject|2|||
129943224|NCT04652869|467756668|FG002|Overall Study|Withdrawal by Subject|0|||
129943225|NCT01833455|467756669|FG000|Overall Study|Withdrawal by Subject|1|||
129943226|NCT01833455|467756670|FG001|Overall Study|Withdrawal by Subject|0|||
129943227|NCT00562094|467756671|FG000|Overall Study|Lost to Follow-up|62|||
129943228|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
129943229|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
129943230|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
129943231|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
129943232|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
129943233|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
129943234|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
129943235|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
129943236|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
129943237|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
129943238|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
129943239|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
129943240|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Other|1|||
129943241|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Other|0|||
129943242|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Other|0|||
129943243|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
129943244|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
129943245|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
129943246|NCT00887224|467756672|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
129943247|NCT00887224|467756673|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
129943248|NCT00887224|467756674|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
129943249|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
129943250|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
129943251|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
129943252|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
129943253|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
129943254|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
129943255|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
129943256|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
129943257|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
129943258|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
129943259|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
129943260|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
129943261|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Other|1|||
129943262|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Other|0|||
129943263|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Other|0|||
129943264|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
129943265|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
129943266|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
129943267|NCT00887224|467756672|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
129943268|NCT00887224|467756673|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
129943269|NCT00887224|467756674|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
129943270|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
129943271|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
129943272|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
129943273|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
129943274|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
129943275|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
129943276|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
129943277|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
129943278|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
129943279|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
129943280|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
129943281|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
129943282|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Other|30|||
129943283|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Other|0|||
129943284|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Other|0|||
129943285|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
129943286|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
129943287|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
129943288|NCT00887224|467756672|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
129943289|NCT00887224|467756673|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
129943290|NCT00887224|467756674|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
129943291|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Adverse Event|0|||
129943292|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Adverse Event|7|||
129943293|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Adverse Event|2|||
129943294|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Failed to return|0|||
129943295|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Failed to return|2|||
129943296|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Failed to return|2|||
129943297|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
129943298|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
129943299|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
129943300|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
129943301|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
129943302|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
129943303|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Other|0|||
129943304|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Other|2|||
129943305|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Other|0|||
129943306|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
129943307|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
129943308|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
129943309|NCT00887224|467756672|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
129943310|NCT00887224|467756673|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
129943311|NCT00887224|467756674|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
129943312|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
129943313|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
129943314|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
129943315|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
129943316|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
129943317|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
129943318|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
129943319|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
129943320|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
129943321|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
129943322|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
129943323|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
129943324|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
129943325|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
129943326|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
129943327|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
129943328|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
129943329|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
129943330|NCT00887224|467756672|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
129943331|NCT00887224|467756673|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
129943332|NCT00887224|467756674|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
129943333|NCT01555138|467756677|FG000|Overall Study|Death|0|||
129943334|NCT01555138|467756678|FG001|Overall Study|Death|1|||
129943335|NCT01555138|467756677|FG000|Overall Study|Lost to Follow-up|1|||
129943336|NCT01555138|467756678|FG001|Overall Study|Lost to Follow-up|0|||
129943337|NCT01555138|467756677|FG000|Overall Study|Abnormal Lab reults|1|||
129943338|NCT01555138|467756678|FG001|Overall Study|Abnormal Lab reults|3|||
129943339|NCT01555138|467756677|FG000|Overall Study|Lack of Efficacy|2|||
129943340|NCT01555138|467756678|FG001|Overall Study|Lack of Efficacy|2|||
129943341|NCT01555138|467756677|FG000|Overall Study|Protocol Violation|5|||
129943342|NCT01555138|467756678|FG001|Overall Study|Protocol Violation|3|||
129943343|NCT01555138|467756677|FG000|Overall Study|Administrative problems|8|||
129943344|NCT01555138|467756678|FG001|Overall Study|Administrative problems|0|||
129943345|NCT01555138|467756677|FG000|Overall Study|Withdrawal by Subject|16|||
129943346|NCT01555138|467756678|FG001|Overall Study|Withdrawal by Subject|15|||
129943347|NCT01555138|467756677|FG000|Overall Study|Adverse Event|14|||
129943348|NCT01555138|467756678|FG001|Overall Study|Adverse Event|14|||
129943349|NCT03883828|467756679|FG000|Overall Study|Did not start radiotherapy|1|||
129943350|NCT03883828|467756680|FG001|Overall Study|Did not start radiotherapy|2|||
129943351|NCT04938453|467756684|FG000|Washout Period 1|Adverse Event|1|||
129943352|NCT04938453|467756685|FG001|Washout Period 1|Adverse Event|0|||
129943353|NCT04938453|467756684|FG000|Washout Period 1|Physician Decision|0|||
129943354|NCT04938453|467756685|FG001|Washout Period 1|Physician Decision|1|||
129943355|NCT02095145|467756690|FG000|Overall Study|Withdrawal by Subject|1|||
129943356|NCT02095145|467756691|FG001|Overall Study|Withdrawal by Subject|0|||
129943357|NCT04237792|467756695|FG000|Treatment (Day 1)|Adverse Event|1|||
129943358|NCT04237792|467756696|FG001|Treatment (Day 1)|Adverse Event|0|||
129943359|NCT04237792|467756697|FG002|Treatment (Day 1)|Adverse Event|0|||
129943360|NCT04237792|467756698|FG003|Treatment (Day 1)|Adverse Event|0|||
129943361|NCT04237792|467756699|FG004|Treatment (Day 1)|Adverse Event|1|||
129943362|NCT04237792|467756700|FG005|Treatment (Day 1)|Adverse Event|1|||
129943363|NCT04237792|467756695|FG000|Treatment (Day 1)|Other|0|||
129943364|NCT04237792|467756696|FG001|Treatment (Day 1)|Other|0|||
129943365|NCT04237792|467756697|FG002|Treatment (Day 1)|Other|1|||
129943366|NCT04237792|467756698|FG003|Treatment (Day 1)|Other|0|||
129943367|NCT04237792|467756699|FG004|Treatment (Day 1)|Other|0|||
129943368|NCT04237792|467756700|FG005|Treatment (Day 1)|Other|1|||
129943369|NCT04237792|467756695|FG000|Treatment (Day 1)|Not treated|1|||
129943370|NCT04237792|467756696|FG001|Treatment (Day 1)|Not treated|1|||
129943371|NCT04237792|467756697|FG002|Treatment (Day 1)|Not treated|2|||
129943372|NCT04237792|467756698|FG003|Treatment (Day 1)|Not treated|1|||
129943373|NCT04237792|467756699|FG004|Treatment (Day 1)|Not treated|0|||
129943374|NCT04237792|467756700|FG005|Treatment (Day 1)|Not treated|1|||
129943375|NCT05553366|467756702|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
129943376|NCT05553366|467756703|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
129943377|NCT05553366|467756704|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
129943378|NCT05553366|467756702|FG000|Overall Study|Lost to Follow-up|3|||
129943379|NCT05553366|467756703|FG001|Overall Study|Lost to Follow-up|3|||
129943380|NCT05553366|467756704|FG002|Overall Study|Lost to Follow-up|3|||
129943381|NCT05553366|467756702|FG000|Overall Study|Other non-compliance|1|||
129943382|NCT05553366|467756703|FG001|Overall Study|Other non-compliance|1|||
129943383|NCT05553366|467756704|FG002|Overall Study|Other non-compliance|0|||
129943384|NCT05553366|467756702|FG000|Overall Study|Randomized but not dosed|0|||
129943385|NCT05553366|467756703|FG001|Overall Study|Randomized but not dosed|0|||
129943386|NCT05553366|467756704|FG002|Overall Study|Randomized but not dosed|2|||
129943387|NCT02022657|467756708|FG000|Overall Study|Withdrawal by Subject|2|||
129943388|NCT02022657|467756709|FG001|Overall Study|Withdrawal by Subject|0|||
129943389|NCT02022657|467756710|FG002|Overall Study|Withdrawal by Subject|1|||
129943390|NCT02022657|467756711|FG003|Overall Study|Withdrawal by Subject|0|||
129943391|NCT02022657|467756712|FG004|Overall Study|Withdrawal by Subject|0|||
129943392|NCT02022657|467756713|FG005|Overall Study|Withdrawal by Subject|0|||
129943393|NCT02022657|467756708|FG000|Overall Study|Physician Decision|0|||
129943394|NCT02022657|467756709|FG001|Overall Study|Physician Decision|0|||
129943395|NCT02022657|467756710|FG002|Overall Study|Physician Decision|0|||
129943396|NCT02022657|467756711|FG003|Overall Study|Physician Decision|0|||
129943397|NCT02022657|467756712|FG004|Overall Study|Physician Decision|0|||
129943398|NCT02022657|467756713|FG005|Overall Study|Physician Decision|1|||
129943399|NCT03739866|467756715|FG000|Overall Study|Lost to Follow-up|0|||
129943400|NCT03739866|467756716|FG001|Overall Study|Lost to Follow-up|0|||
129943401|NCT03739866|467756717|FG002|Overall Study|Lost to Follow-up|0|||
129943402|NCT03739866|467756718|FG003|Overall Study|Lost to Follow-up|1|||
129943403|NCT03739866|467756719|FG004|Overall Study|Lost to Follow-up|0|||
129943404|NCT03739866|467756720|FG005|Overall Study|Lost to Follow-up|0|||
129943405|NCT03739866|467756721|FG006|Overall Study|Lost to Follow-up|0|||
129943406|NCT03739866|467756722|FG007|Overall Study|Lost to Follow-up|0|||
129943407|NCT03739866|467756715|FG000|Overall Study|Enrolled but not treated|0|||
129943408|NCT03739866|467756716|FG001|Overall Study|Enrolled but not treated|0|||
129943409|NCT03739866|467756717|FG002|Overall Study|Enrolled but not treated|1|||
129943410|NCT03739866|467756718|FG003|Overall Study|Enrolled but not treated|0|||
129943411|NCT03739866|467756719|FG004|Overall Study|Enrolled but not treated|1|||
129943412|NCT03739866|467756720|FG005|Overall Study|Enrolled but not treated|0|||
129943413|NCT03739866|467756721|FG006|Overall Study|Enrolled but not treated|0|||
129943414|NCT03739866|467756722|FG007|Overall Study|Enrolled but not treated|0|||
129943415|NCT01034306|467756723|FG000|Overall Study|Adverse Event|1|||
129943416|NCT01034306|467756724|FG001|Overall Study|Adverse Event|0|||
129943417|NCT01034306|467756723|FG000|Overall Study|Lost to Follow-up|0|||
129943418|NCT01034306|467756724|FG001|Overall Study|Lost to Follow-up|1|||
129943419|NCT01034306|467756723|FG000|Overall Study|Withdrawal by Subject|2|||
129943420|NCT01034306|467756724|FG001|Overall Study|Withdrawal by Subject|2|||
129943421|NCT01034306|467756723|FG000|Overall Study|hospitalized and decided to stop|1|||
129943422|NCT01034306|467756724|FG001|Overall Study|hospitalized and decided to stop|0|||
129943423|NCT01034306|467756723|FG000|Overall Study|Noncomplience|1|||
129943424|NCT01034306|467756724|FG001|Overall Study|Noncomplience|0|||
129943425|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
129943426|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
129943427|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
129943428|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
129943429|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
129943430|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
129943431|NCT01619059|467756727|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
129943432|NCT01619059|467756728|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
129943433|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
129943434|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
129943435|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
129943436|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
129943437|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
129943438|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
129943439|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Death|1|||
129943440|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Death|0|||
129943441|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
129943442|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
129943443|NCT01619059|467756727|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
129943444|NCT01619059|467756728|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
129943445|NCT01968967|467756731|FG000|Treatment Period|Other|22|||
129943446|NCT01968967|467756732|FG001|Treatment Period|Other|22|||
129943447|NCT01968967|467756733|FG002|Treatment Period|Other|0|||
129943448|NCT01968967|467756734|FG003|Treatment Period|Other|0|||
129943449|NCT01968967|467756735|FG004|Treatment Period|Other|0|||
129943450|NCT01968967|467756731|FG000|Treatment Period|Withdrawal by Subject|71|||
129943451|NCT01968967|467756732|FG001|Treatment Period|Withdrawal by Subject|61|||
129943452|NCT01968967|467756733|FG002|Treatment Period|Withdrawal by Subject|0|||
129943453|NCT01968967|467756734|FG003|Treatment Period|Withdrawal by Subject|0|||
129943454|NCT01968967|467756735|FG004|Treatment Period|Withdrawal by Subject|0|||
129943455|NCT01968967|467756731|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
129943456|NCT01968967|467756732|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
129943457|NCT01968967|467756733|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
129943458|NCT01968967|467756734|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
129943459|NCT01968967|467756735|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
129943460|NCT01968967|467756731|FG000|Treatment Period|Lost to Follow-up|26|||
129943461|NCT01968967|467756732|FG001|Treatment Period|Lost to Follow-up|31|||
129943462|NCT01968967|467756733|FG002|Treatment Period|Lost to Follow-up|0|||
129943463|NCT01968967|467756734|FG003|Treatment Period|Lost to Follow-up|0|||
129943464|NCT01968967|467756735|FG004|Treatment Period|Lost to Follow-up|0|||
129943465|NCT01968967|467756731|FG000|Treatment Period|Protocol Violation|1|||
129943466|NCT01968967|467756732|FG001|Treatment Period|Protocol Violation|2|||
129943467|NCT01968967|467756733|FG002|Treatment Period|Protocol Violation|0|||
129943468|NCT01968967|467756734|FG003|Treatment Period|Protocol Violation|0|||
129943469|NCT01968967|467756735|FG004|Treatment Period|Protocol Violation|0|||
129943470|NCT01968967|467756731|FG000|Treatment Period|Adverse Event|9|||
129943471|NCT01968967|467756732|FG001|Treatment Period|Adverse Event|8|||
129943472|NCT01968967|467756733|FG002|Treatment Period|Adverse Event|0|||
129943473|NCT01968967|467756734|FG003|Treatment Period|Adverse Event|0|||
129943474|NCT01968967|467756735|FG004|Treatment Period|Adverse Event|0|||
129943475|NCT01968967|467756731|FG000|Treatment Period|Death|9|||
129943476|NCT01968967|467756732|FG001|Treatment Period|Death|2|||
129943477|NCT01968967|467756733|FG002|Treatment Period|Death|0|||
129943478|NCT01968967|467756734|FG003|Treatment Period|Death|0|||
129943479|NCT01968967|467756735|FG004|Treatment Period|Death|0|||
129943480|NCT01968967|467756731|FG000|Treatment Period|Randomized Not Treated|6|||
129943481|NCT01968967|467756732|FG001|Treatment Period|Randomized Not Treated|5|||
129943482|NCT01968967|467756733|FG002|Treatment Period|Randomized Not Treated|0|||
129943483|NCT01968967|467756734|FG003|Treatment Period|Randomized Not Treated|0|||
129943484|NCT01968967|467756735|FG004|Treatment Period|Randomized Not Treated|0|||
129943485|NCT01968967|467756731|FG000|Extension Period|Withdrew Consent|0|||
129943486|NCT01968967|467756732|FG001|Extension Period|Withdrew Consent|0|||
129943487|NCT01968967|467756733|FG002|Extension Period|Withdrew Consent|2|||
129943488|NCT01968967|467756734|FG003|Extension Period|Withdrew Consent|0|||
129943489|NCT01968967|467756735|FG004|Extension Period|Withdrew Consent|5|||
129943490|NCT03489369|467756736|FG000|Overall Study|Documented Progressive Disease|3|||
129943491|NCT03489369|467756737|FG001|Overall Study|Documented Progressive Disease|2|||
129943492|NCT03489369|467756738|FG002|Overall Study|Documented Progressive Disease|3|||
129943493|NCT03489369|467756739|FG003|Overall Study|Documented Progressive Disease|6|||
129943494|NCT03489369|467756736|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
129943495|NCT03489369|467756737|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
129943496|NCT03489369|467756738|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
129943497|NCT03489369|467756739|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
129943498|NCT00109031|467756745|FG000|Overall Study|Adverse Event|0|||
129943499|NCT00109031|467756746|FG001|Overall Study|Adverse Event|0|||
129943500|NCT00109031|467756747|FG002|Overall Study|Adverse Event|1|||
129943501|NCT00109031|467756748|FG003|Overall Study|Adverse Event|0|||
129943502|NCT00109031|467756745|FG000|Overall Study|Withdrawal by Subject|0|||
129943503|NCT00109031|467756746|FG001|Overall Study|Withdrawal by Subject|1|||
129943504|NCT00109031|467756747|FG002|Overall Study|Withdrawal by Subject|0|||
129943505|NCT00109031|467756748|FG003|Overall Study|Withdrawal by Subject|0|||
129943506|NCT00109031|467756745|FG000|Overall Study|Physician Decision|0|||
129943507|NCT00109031|467756746|FG001|Overall Study|Physician Decision|1|||
129943508|NCT00109031|467756747|FG002|Overall Study|Physician Decision|0|||
129943509|NCT00109031|467756748|FG003|Overall Study|Physician Decision|0|||
129943510|NCT00109031|467756745|FG000|Overall Study|Protocol Violation|0|||
129943511|NCT00109031|467756746|FG001|Overall Study|Protocol Violation|0|||
129943512|NCT00109031|467756747|FG002|Overall Study|Protocol Violation|1|||
129943513|NCT00109031|467756748|FG003|Overall Study|Protocol Violation|0|||
129943514|NCT03697603|467756749|FG000|Overall Study|Adverse Event|3|||
129943515|NCT03697603|467756750|FG001|Overall Study|Adverse Event|18|||
129943516|NCT03697603|467756751|FG002|Overall Study|Adverse Event|3|||
129943517|NCT03697603|467756749|FG000|Overall Study|Physician Decision|1|||
129943518|NCT03697603|467756750|FG001|Overall Study|Physician Decision|0|||
129943519|NCT03697603|467756751|FG002|Overall Study|Physician Decision|2|||
129943520|NCT03697603|467756749|FG000|Overall Study|Protocol Violation|3|||
129943521|NCT03697603|467756750|FG001|Overall Study|Protocol Violation|8|||
129943522|NCT03697603|467756751|FG002|Overall Study|Protocol Violation|5|||
129943523|NCT03697603|467756749|FG000|Overall Study|Withdrawal by Subject|5|||
129943524|NCT03697603|467756750|FG001|Overall Study|Withdrawal by Subject|1|||
129943525|NCT03697603|467756751|FG002|Overall Study|Withdrawal by Subject|1|||
129943526|NCT03697603|467756749|FG000|Overall Study|Protocol Violation|0|||
129943527|NCT03697603|467756750|FG001|Overall Study|Protocol Violation|0|||
129943528|NCT03697603|467756751|FG002|Overall Study|Protocol Violation|1|||
129943529|NCT02309294|467756754|FG000|Overall Study|Withdrawal by Subject|2|||
129943530|NCT03520036|467756755|FG000|Overall Study|Adverse Event|1|||
129943531|NCT03520036|467756756|FG001|Overall Study|Adverse Event|2|||
129943532|NCT03520036|467756757|FG002|Overall Study|Adverse Event|0|||
129943533|NCT03520036|467756755|FG000|Overall Study|Protocol Violation|1|||
129943534|NCT03520036|467756756|FG001|Overall Study|Protocol Violation|0|||
129943535|NCT03520036|467756757|FG002|Overall Study|Protocol Violation|0|||
129943536|NCT03520036|467756755|FG000|Overall Study|Withdrawal by Subject|0|||
129943537|NCT03520036|467756756|FG001|Overall Study|Withdrawal by Subject|1|||
129943538|NCT03520036|467756757|FG002|Overall Study|Withdrawal by Subject|4|||
129943539|NCT03520036|467756755|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
129943540|NCT03520036|467756756|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
129943541|NCT03520036|467756757|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
129943542|NCT00467272|467756760|FG000|Overall Study|Pneumonia|2|||
129943543|NCT00467272|467756760|FG000|Overall Study|Thrombophlebitis|1|||
129943544|NCT05426109|467756761|FG000|Overall Study|Withdrawal by Subject|0|||
129943545|NCT05426109|467756762|FG001|Overall Study|Withdrawal by Subject|1|||
129943546|NCT05212285|467756763|FG000|Overall Study|Lack of Efficacy|12|||
129943547|NCT05212285|467756764|FG001|Overall Study|Lack of Efficacy|8|||
129943548|NCT05212285|467756763|FG000|Overall Study|Withdrawal by Subject|8|||
129943549|NCT05212285|467756764|FG001|Overall Study|Withdrawal by Subject|1|||
129943550|NCT05212285|467756763|FG000|Overall Study|Lost to Follow-up|13|||
129943551|NCT05212285|467756764|FG001|Overall Study|Lost to Follow-up|1|||
129943552|NCT05212285|467756763|FG000|Overall Study|miss data|21|||
129943553|NCT05212285|467756764|FG001|Overall Study|miss data|2|||
129943554|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
129943555|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
129943556|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
129943557|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
129943558|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
129943559|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
129943560|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
129943561|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
129943562|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
129943563|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
129943564|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
129943565|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
129943566|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
129943567|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
129943568|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
129943569|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
129943570|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
129943571|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
129943572|NCT02222493|467756765|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
129943573|NCT02222493|467756766|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
129943574|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
129943575|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
129943576|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
129943577|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
129943578|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
129943579|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
129943580|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
129943581|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
129943582|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
129943583|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
129943584|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
129943585|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
129943586|NCT02222493|467756765|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
129943587|NCT02222493|467756766|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
129943588|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
129943589|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
129943590|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
129943591|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
129943592|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
129943593|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
129943594|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
129943595|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
129943596|NCT02222493|467756765|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
129943597|NCT02222493|467756766|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
129943598|NCT03924869|467756770|FG000|Overall Study|Death|66|||
129943599|NCT03924869|467756771|FG001|Overall Study|Death|53|||
129943600|NCT03924869|467756770|FG000|Overall Study|Lost to Follow-up|2|||
129943601|NCT03924869|467756771|FG001|Overall Study|Lost to Follow-up|0|||
129943602|NCT03924869|467756770|FG000|Overall Study|Physician Decision|0|||
129943603|NCT03924869|467756771|FG001|Overall Study|Physician Decision|3|||
129943604|NCT03924869|467756770|FG000|Overall Study|Withdrawal by Subject|5|||
129943605|NCT03924869|467756771|FG001|Overall Study|Withdrawal by Subject|1|||
129943606|NCT03924869|467756770|FG000|Overall Study|Participants Ongoing|154|||
129943607|NCT03924869|467756771|FG001|Overall Study|Participants Ongoing|164|||
129943608|NCT02542943|467756772|FG000|Overall Study|Lost to Follow-up|1|||
129943609|NCT02542943|467756773|FG001|Overall Study|Lost to Follow-up|0|||
129943610|NCT02542943|467756774|FG002|Overall Study|Lost to Follow-up|0|||
129943611|NCT02542943|467756772|FG000|Overall Study|Withdrawal by Subject|0|||
129943612|NCT02542943|467756773|FG001|Overall Study|Withdrawal by Subject|1|||
129943613|NCT02542943|467756774|FG002|Overall Study|Withdrawal by Subject|0|||
129943614|NCT05865392|467756783|FG000|Overall Study|Withdrawal by Subject|4|||
129943615|NCT05865392|467756784|FG001|Overall Study|Withdrawal by Subject|0|||
129943616|NCT05865392|467756783|FG000|Overall Study|Didn't meet inclusion criteria|4|||
129943617|NCT05865392|467756784|FG001|Overall Study|Didn't meet inclusion criteria|0|||
129943618|NCT02637063|467758048|FG000|Overall Study|Lost to Follow-up|3|||
129943619|NCT02637063|467758049|FG001|Overall Study|Lost to Follow-up|2|||
129943620|NCT02637063|467758050|FG002|Overall Study|Lost to Follow-up|3|||
129943621|NCT02637063|467758048|FG000|Overall Study|Withdrawal by Subject|2|||
129943622|NCT02637063|467758049|FG001|Overall Study|Withdrawal by Subject|2|||
129943623|NCT02637063|467758050|FG002|Overall Study|Withdrawal by Subject|3|||
129943624|NCT02310581|467758051|FG000|Overall Study|Adverse Event|1|||
129943625|NCT02310581|467758052|FG001|Overall Study|Adverse Event|1|||
129943626|NCT02310581|467758053|FG002|Overall Study|Adverse Event|1|||
129943627|NCT02310581|467758054|FG003|Overall Study|Adverse Event|0|||
129943628|NCT02310581|467758051|FG000|Overall Study|Withdrawal by Subject|2|||
129943629|NCT02310581|467758052|FG001|Overall Study|Withdrawal by Subject|1|||
129943630|NCT02310581|467758053|FG002|Overall Study|Withdrawal by Subject|0|||
129943631|NCT02310581|467758054|FG003|Overall Study|Withdrawal by Subject|1|||
129943632|NCT01673594|467758055|FG000|Overall Study|Adverse Event|3|||
129943633|NCT01673594|467758056|FG001|Overall Study|Adverse Event|1|||
129943634|NCT01673594|467758055|FG000|Overall Study|Lost to Follow-up|1|||
129943635|NCT01673594|467758056|FG001|Overall Study|Lost to Follow-up|0|||
129943636|NCT01673594|467758055|FG000|Overall Study|Physician Decision|2|||
129943637|NCT01673594|467758056|FG001|Overall Study|Physician Decision|4|||
129943638|NCT01673594|467758055|FG000|Overall Study|Withdrawal by Subject|0|||
129943639|NCT01673594|467758056|FG001|Overall Study|Withdrawal by Subject|1|||
129943640|NCT04658784|467758057|FG000|6-month Follow-up|Lost to Follow-up|2|||
129943641|NCT04658784|467758058|FG001|6-month Follow-up|Lost to Follow-up|5|||
129943642|NCT00454194|467758064|FG000|Overall Study|Adverse Event|7|||
129943643|NCT00454194|467758065|FG001|Overall Study|Adverse Event|2|||
129943644|NCT00454194|467758064|FG000|Overall Study|Withdrawal by Subject|12|||
129943645|NCT00454194|467758065|FG001|Overall Study|Withdrawal by Subject|8|||
129943646|NCT00454194|467758064|FG000|Overall Study|Other Medical Problems|1|||
129943647|NCT00454194|467758065|FG001|Overall Study|Other Medical Problems|2|||
129943648|NCT00454194|467758064|FG000|Overall Study|Other Unspecified Reason|2|||
129943649|NCT00454194|467758065|FG001|Overall Study|Other Unspecified Reason|2|||
129943650|NCT02827201|467758066|FG000|Overall Study|Death|1|||
129943651|NCT02827201|467758067|FG001|Overall Study|Death|2|||
129943652|NCT02827201|467758066|FG000|Overall Study|Patients not treated|1|||
129943653|NCT02827201|467758067|FG001|Overall Study|Patients not treated|1|||
129943654|NCT03345979|467758068|FG000|Overall Study|Withdrawal by Subject|20|||
129943655|NCT03345979|467758069|FG001|Overall Study|Withdrawal by Subject|31|||
129943656|NCT03345979|467758068|FG000|Overall Study|Adverse Event|10|||
129943657|NCT03345979|467758069|FG001|Overall Study|Adverse Event|11|||
129943658|NCT03345979|467758068|FG000|Overall Study|Lost to Follow-up|8|||
129943659|NCT03345979|467758069|FG001|Overall Study|Lost to Follow-up|9|||
129943660|NCT03345979|467758068|FG000|Overall Study|Lack of Efficacy|4|||
129943661|NCT03345979|467758069|FG001|Overall Study|Lack of Efficacy|2|||
129943662|NCT03345979|467758068|FG000|Overall Study|Protocol Violation|1|||
129943663|NCT03345979|467758069|FG001|Overall Study|Protocol Violation|3|||
129943664|NCT03345979|467758068|FG000|Overall Study|Physician Decision|0|||
129943665|NCT03345979|467758069|FG001|Overall Study|Physician Decision|2|||
129943666|NCT00620854|467758070|FG000|Washout 1|Withdrawal by Subject|0|||
129943667|NCT00620854|467758071|FG001|Washout 1|Withdrawal by Subject|0|||
129943668|NCT00620854|467758072|FG002|Washout 1|Withdrawal by Subject|1|||
129943669|NCT00620854|467758073|FG003|Washout 1|Withdrawal by Subject|1|||
129943670|NCT00620854|467758074|FG004|Washout 1|Withdrawal by Subject|0|||
129943671|NCT00620854|467758075|FG005|Washout 1|Withdrawal by Subject|0|||
129943672|NCT00487240|467758076|FG000|Overall Study|Withdrawal by Subject|12|||
129943673|NCT00487240|467758077|FG001|Overall Study|Withdrawal by Subject|6|||
129943674|NCT00487240|467758076|FG000|Overall Study|Lost to Follow-up|7|||
129943675|NCT00487240|467758077|FG001|Overall Study|Lost to Follow-up|6|||
129943676|NCT00487240|467758076|FG000|Overall Study|Adverse Event|0|||
129943677|NCT00487240|467758077|FG001|Overall Study|Adverse Event|4|||
129943678|NCT00487240|467758076|FG000|Overall Study|Protocol Violation|5|||
129943679|NCT00487240|467758077|FG001|Overall Study|Protocol Violation|5|||
129943680|NCT00487240|467758076|FG000|Overall Study|Entry Criteria Not Met|3|||
129943681|NCT00487240|467758077|FG001|Overall Study|Entry Criteria Not Met|4|||
129943682|NCT00487240|467758076|FG000|Overall Study|Sponsor Decision|2|||
129943683|NCT00487240|467758077|FG001|Overall Study|Sponsor Decision|1|||
129943684|NCT00487240|467758076|FG000|Overall Study|Physician Decision|2|||
129943685|NCT00487240|467758077|FG001|Overall Study|Physician Decision|0|||
129943686|NCT00999596|467758080|FG000|Overall Study|Statistical population not required|101|||
129943687|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
129943688|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
129943689|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Death|2|||
129943690|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
129943691|NCT01698918|467758081|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
129943692|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
129943693|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
129943694|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Death|1|||
129943695|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
129943696|NCT01698918|467758081|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
129943697|NCT02630186|467758082|FG000|Overall Study|Withdrawal by Subject|1|||
129943698|NCT00439218|467758085|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
129943699|NCT03176407|467758086|FG000|Overall Study|Protocol Violation|1|||
129943700|NCT03176407|467758086|FG000|Overall Study|human failure|1|||
129943701|NCT03176407|467758086|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
129943702|NCT01428583|467758089|FG000|Overall Study|Adverse Event|75|||
129943703|NCT01428583|467758089|FG000|Overall Study|Withdrawal by Subject|51|||
129943704|NCT01428583|467758089|FG000|Overall Study|Lack of Efficacy|37|||
129943705|NCT01428583|467758089|FG000|Overall Study|Lost to Follow-up|17|||
129943706|NCT01428583|467758089|FG000|Overall Study|Death|1|||
129943707|NCT01428583|467758089|FG000|Overall Study|Pregnancy|1|||
129943708|NCT01428583|467758089|FG000|Overall Study|Protocol Violation|1|||
129943709|NCT01428583|467758089|FG000|Overall Study|Physician Decision|12|||
129943710|NCT01428583|467758089|FG000|Overall Study|Non-compliant|25|||
129943711|NCT01428583|467758089|FG000|Overall Study|Confirmed positive urine drug test|8|||
129943712|NCT01428583|467758089|FG000|Overall Study|Sponsor's request|3|||
129943713|NCT01428583|467758089|FG000|Overall Study|Other|6|||
129943714|NCT00670488|467758090|FG000|Overall Study|Adverse Event|0|||
129943715|NCT00670488|467758091|FG001|Overall Study|Adverse Event|7|||
129943716|NCT00670488|467758092|FG002|Overall Study|Adverse Event|0|||
129943717|NCT00670488|467758093|FG003|Overall Study|Adverse Event|3|||
129943718|NCT00670488|467758094|FG004|Overall Study|Adverse Event|1|||
129943719|NCT00670488|467758095|FG005|Overall Study|Adverse Event|1|||
129943720|NCT00670488|467758096|FG006|Overall Study|Adverse Event|5|||
129943721|NCT00670488|467758097|FG007|Overall Study|Adverse Event|1|||
129943722|NCT00670488|467758098|FG008|Overall Study|Adverse Event|0|||
129453334|NCT01538628|465956467|FG000|Overall Study|Withdrawal by Subject|1|||
129943723|NCT00670488|467758099|FG009|Overall Study|Adverse Event|1|||
129943724|NCT00670488|467758090|FG000|Overall Study|Physician Decision|1|||
129943725|NCT00670488|467758091|FG001|Overall Study|Physician Decision|9|||
129943726|NCT00670488|467758092|FG002|Overall Study|Physician Decision|0|||
129943727|NCT00670488|467758093|FG003|Overall Study|Physician Decision|1|||
129943728|NCT00670488|467758094|FG004|Overall Study|Physician Decision|0|||
129943729|NCT00670488|467758095|FG005|Overall Study|Physician Decision|0|||
129943730|NCT00670488|467758096|FG006|Overall Study|Physician Decision|0|||
129943731|NCT00670488|467758097|FG007|Overall Study|Physician Decision|0|||
129943732|NCT00670488|467758098|FG008|Overall Study|Physician Decision|0|||
129943733|NCT00670488|467758099|FG009|Overall Study|Physician Decision|0|||
129943734|NCT00670488|467758090|FG000|Overall Study|Progressive Disease|2|||
129943735|NCT00670488|467758091|FG001|Overall Study|Progressive Disease|41|||
129943736|NCT00670488|467758092|FG002|Overall Study|Progressive Disease|3|||
129943737|NCT00670488|467758093|FG003|Overall Study|Progressive Disease|2|||
129943738|NCT00670488|467758094|FG004|Overall Study|Progressive Disease|2|||
129943739|NCT00670488|467758095|FG005|Overall Study|Progressive Disease|4|||
129943740|NCT00670488|467758096|FG006|Overall Study|Progressive Disease|11|||
129943741|NCT00670488|467758097|FG007|Overall Study|Progressive Disease|2|||
129943742|NCT00670488|467758098|FG008|Overall Study|Progressive Disease|2|||
129943743|NCT00670488|467758099|FG009|Overall Study|Progressive Disease|1|||
129943744|NCT00670488|467758090|FG000|Overall Study|Withdrawal by Subject|0|||
129943745|NCT00670488|467758091|FG001|Overall Study|Withdrawal by Subject|1|||
129943746|NCT00670488|467758092|FG002|Overall Study|Withdrawal by Subject|0|||
129943747|NCT00670488|467758093|FG003|Overall Study|Withdrawal by Subject|1|||
129943748|NCT00670488|467758094|FG004|Overall Study|Withdrawal by Subject|0|||
129943749|NCT00670488|467758095|FG005|Overall Study|Withdrawal by Subject|0|||
129943750|NCT00670488|467758096|FG006|Overall Study|Withdrawal by Subject|1|||
129943751|NCT00670488|467758097|FG007|Overall Study|Withdrawal by Subject|0|||
129943752|NCT00670488|467758098|FG008|Overall Study|Withdrawal by Subject|1|||
129943753|NCT00670488|467758099|FG009|Overall Study|Withdrawal by Subject|0|||
129943754|NCT01124045|467758104|FG000|Overall Study|Lost to Follow-up|0|||
129943755|NCT01124045|467758105|FG001|Overall Study|Lost to Follow-up|1|||
129943756|NCT01124045|467758104|FG000|Overall Study|Physician Decision|0|||
129943757|NCT01124045|467758105|FG001|Overall Study|Physician Decision|2|||
129943758|NCT03205566|467758110|FG000|Phase 1|Protocol Violation|1|||
129943759|NCT03205566|467758111|FG001|Phase 1|Protocol Violation|1|||
129943760|NCT00836498|467758112|FG000|Overall Study|Adverse Event|1|||
129943761|NCT00836498|467758113|FG001|Overall Study|Adverse Event|0|||
129943762|NCT00836498|467758112|FG000|Overall Study|Lost to Follow-up|1|||
129943763|NCT00836498|467758113|FG001|Overall Study|Lost to Follow-up|0|||
129943764|NCT00836498|467758112|FG000|Overall Study|Withdrawal by Subject|2|||
129943765|NCT00836498|467758113|FG001|Overall Study|Withdrawal by Subject|1|||
129943766|NCT03418545|467758114|FG000|Overall Study|Withdrawal by Participant|2|||
129943767|NCT03418545|467758115|FG001|Overall Study|Withdrawal by Participant|4|||
129943768|NCT03418545|467758114|FG000|Overall Study|Lost to Follow-up|3|||
129943769|NCT03418545|467758115|FG001|Overall Study|Lost to Follow-up|5|||
129943770|NCT03418545|467758114|FG000|Overall Study|Reason Not Specified|0|||
129943771|NCT03418545|467758115|FG001|Overall Study|Reason Not Specified|1|||
129943772|NCT03418545|467758114|FG000|Overall Study|Missing Completion Status|0|||
129943773|NCT03418545|467758115|FG001|Overall Study|Missing Completion Status|1|||
129943774|NCT02384382|467758121|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
129943775|NCT02384382|467758121|FG000|Overall Study|Death|1|||
129943776|NCT02384382|467758121|FG000|Overall Study|Adverse Event|1|||
129943777|NCT02384382|467758121|FG000|Overall Study|Disease progression|16|||
129943778|NCT03567616|467758127|FG000|Overall Study|Disease progression|4|||
129943779|NCT03567616|467758127|FG000|Overall Study|Withdrawal by Subject|1|||
129943780|NCT03567616|467758127|FG000|Overall Study|Physician Decision|1|||
129943781|NCT03567616|467758127|FG000|Overall Study|Death|1|||
129943782|NCT03567616|467758127|FG000|Overall Study|Adverse Event|1|||
129943783|NCT01074242|467758128|FG000|Overall Study|Case report before date of contract|40|||
129943784|NCT01074242|467758128|FG000|Overall Study|Lost to Follow-up|1|||
129943785|NCT01074242|467758128|FG000|Overall Study|Case report unclear|6|||
129943786|NCT01074242|467758128|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
129943787|NCT01074242|467758128|FG000|Overall Study|Duplicate Case Report Form|5|||
129943788|NCT01957163|467758134|FG000|Overall Study|Adverse Event|5|||
129943789|NCT01957163|467758135|FG001|Overall Study|Adverse Event|2|||
129943790|NCT01957163|467758136|FG002|Overall Study|Adverse Event|4|||
129943791|NCT01957163|467758134|FG000|Overall Study|Lack of Efficacy|5|||
129943792|NCT01957163|467758135|FG001|Overall Study|Lack of Efficacy|4|||
129943793|NCT01957163|467758136|FG002|Overall Study|Lack of Efficacy|9|||
129943794|NCT01957163|467758134|FG000|Overall Study|Protocol Violation|1|||
129943795|NCT01957163|467758135|FG001|Overall Study|Protocol Violation|2|||
129943796|NCT01957163|467758136|FG002|Overall Study|Protocol Violation|0|||
129943797|NCT01957163|467758134|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
129943798|NCT01957163|467758135|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
129943799|NCT01957163|467758136|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
129943800|NCT01957163|467758134|FG000|Overall Study|Lost to Follow-up|0|||
129943801|NCT01957163|467758135|FG001|Overall Study|Lost to Follow-up|1|||
129943802|NCT01957163|467758136|FG002|Overall Study|Lost to Follow-up|0|||
129943803|NCT01957163|467758134|FG000|Overall Study|Withdrawal by Subject|4|||
129943804|NCT01957163|467758135|FG001|Overall Study|Withdrawal by Subject|2|||
129943805|NCT01957163|467758136|FG002|Overall Study|Withdrawal by Subject|4|||
129943806|NCT01065779|467758139|FG000|Overall Study|Duplicate Investigation|1|||
129943807|NCT01065779|467758139|FG000|Overall Study|Investigation Before Contract Date|37|||
129943808|NCT01065779|467758139|FG000|Overall Study|Non-enrollment Period Administration|10|||
129943809|NCT01065779|467758139|FG000|Overall Study|Not Administered With Study Drug|17|||
129943810|NCT01065779|467758139|FG000|Overall Study|Failed to Follow-up|10|||
129943811|NCT01065779|467758139|FG000|Overall Study|Inclusion Criteria Violation|7|||
129943812|NCT02630966|467758140|FG000|Overall Study|Adverse Event|1|||
129943813|NCT02630966|467758141|FG001|Overall Study|Adverse Event|3|||
129943814|NCT02630966|467758140|FG000|Overall Study|Significant Protocol Deviation|0|||
129943815|NCT02630966|467758141|FG001|Overall Study|Significant Protocol Deviation|2|||
129943816|NCT02630966|467758140|FG000|Overall Study|Voluntary Withdrawal|1|||
129943817|NCT02630966|467758141|FG001|Overall Study|Voluntary Withdrawal|1|||
129943818|NCT02630966|467758140|FG000|Overall Study|Lack of Efficacy|0|||
129943819|NCT02630966|467758141|FG001|Overall Study|Lack of Efficacy|2|||
129943820|NCT00641537|467758142|FG000|96-week Period|Adverse Event|0|||
129943821|NCT00641537|467758143|FG001|96-week Period|Adverse Event|1|||
129943822|NCT00641537|467758144|FG002|96-week Period|Adverse Event|3|||
129943823|NCT00641537|467758145|FG003|96-week Period|Adverse Event|0|||
129943824|NCT00641537|467758146|FG004|96-week Period|Adverse Event|2|||
129943825|NCT00641537|467758147|FG005|96-week Period|Adverse Event|0|||
129943826|NCT00641537|467758148|FG006|96-week Period|Adverse Event|0|||
129943827|NCT00641537|467758149|FG007|96-week Period|Adverse Event|0|||
129943828|NCT00641537|467758142|FG000|96-week Period|Lost to Follow-up|3|||
129943829|NCT00641537|467758143|FG001|96-week Period|Lost to Follow-up|1|||
129943830|NCT00641537|467758144|FG002|96-week Period|Lost to Follow-up|2|||
129943831|NCT00641537|467758145|FG003|96-week Period|Lost to Follow-up|2|||
129943832|NCT00641537|467758146|FG004|96-week Period|Lost to Follow-up|4|||
129943833|NCT00641537|467758147|FG005|96-week Period|Lost to Follow-up|0|||
129943834|NCT00641537|467758148|FG006|96-week Period|Lost to Follow-up|1|||
129943835|NCT00641537|467758149|FG007|96-week Period|Lost to Follow-up|0|||
129943836|NCT00641537|467758142|FG000|96-week Period|Protocol Violation|0|||
129943837|NCT00641537|467758143|FG001|96-week Period|Protocol Violation|1|||
129943838|NCT00641537|467758144|FG002|96-week Period|Protocol Violation|0|||
129943839|NCT00641537|467758145|FG003|96-week Period|Protocol Violation|1|||
129943840|NCT00641537|467758146|FG004|96-week Period|Protocol Violation|0|||
129943841|NCT00641537|467758147|FG005|96-week Period|Protocol Violation|1|||
129943842|NCT00641537|467758148|FG006|96-week Period|Protocol Violation|0|||
129943843|NCT00641537|467758149|FG007|96-week Period|Protocol Violation|0|||
129943844|NCT00641537|467758142|FG000|96-week Period|Death|2|||
129943845|NCT00641537|467758143|FG001|96-week Period|Death|0|||
129943846|NCT00641537|467758144|FG002|96-week Period|Death|1|||
129943847|NCT00641537|467758145|FG003|96-week Period|Death|0|||
129943848|NCT00641537|467758146|FG004|96-week Period|Death|0|||
129943849|NCT00641537|467758147|FG005|96-week Period|Death|0|||
129943850|NCT00641537|467758148|FG006|96-week Period|Death|0|||
129943851|NCT00641537|467758149|FG007|96-week Period|Death|0|||
129943852|NCT00641537|467758142|FG000|96-week Period|Other|4|||
129943853|NCT00641537|467758143|FG001|96-week Period|Other|7|||
129943854|NCT00641537|467758144|FG002|96-week Period|Other|14|||
129943855|NCT00641537|467758145|FG003|96-week Period|Other|9|||
129943856|NCT00641537|467758146|FG004|96-week Period|Other|11|||
129943857|NCT00641537|467758147|FG005|96-week Period|Other|6|||
129943858|NCT00641537|467758148|FG006|96-week Period|Other|4|||
129943859|NCT00641537|467758149|FG007|96-week Period|Other|6|||
129943860|NCT00641537|467758142|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
129943861|NCT00641537|467758143|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
129943862|NCT00641537|467758144|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
129943863|NCT00641537|467758145|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
129943864|NCT00641537|467758146|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
129943865|NCT00641537|467758147|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
129943866|NCT00641537|467758148|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
129943867|NCT00641537|467758149|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
129943868|NCT00641537|467758142|FG000|24-Week Supplemental Follow-up Period|Other|0|||
129943869|NCT00641537|467758143|FG001|24-Week Supplemental Follow-up Period|Other|2|||
129943870|NCT00641537|467758144|FG002|24-Week Supplemental Follow-up Period|Other|2|||
129943871|NCT00641537|467758145|FG003|24-Week Supplemental Follow-up Period|Other|1|||
129943872|NCT00641537|467758146|FG004|24-Week Supplemental Follow-up Period|Other|3|||
129943873|NCT00641537|467758147|FG005|24-Week Supplemental Follow-up Period|Other|0|||
129943874|NCT00641537|467758148|FG006|24-Week Supplemental Follow-up Period|Other|1|||
129943875|NCT00641537|467758149|FG007|24-Week Supplemental Follow-up Period|Other|1|||
129943876|NCT01801007|467758150|FG000|Overall Study|Adverse Event|2|||
129943877|NCT01801007|467758150|FG000|Overall Study|Lost to Follow-up|4|||
129943878|NCT01801007|467758150|FG000|Overall Study|Withdrawal by Subject|5|||
129943879|NCT00665392|467758151|FG000|Overall Study|not treated|1|||
129943880|NCT01321073|467758157|FG000|Overall Study|Did not attempt implant|4|||
129943881|NCT01321073|467758157|FG000|Overall Study|Death|3|||
129943882|NCT05352230|467758166|FG000|First Intervention (3 Months)|study terminated|2|||
129943883|NCT05352230|467758167|FG001|First Intervention (3 Months)|study terminated|2|||
129943884|NCT02686658|467758168|FG000|Overall Study|Adverse Event|0|||
129943885|NCT02686658|467758169|FG001|Overall Study|Adverse Event|0|||
129943886|NCT02686658|467758170|FG002|Overall Study|Adverse Event|1|||
129943887|NCT02686658|467758171|FG003|Overall Study|Adverse Event|1|||
129943888|NCT02686658|467758172|FG004|Overall Study|Adverse Event|2|||
129943889|NCT02686658|467758173|FG005|Overall Study|Adverse Event|1|||
129943890|NCT02686658|467758168|FG000|Overall Study|Investigator decision|0|||
129943891|NCT02686658|467758169|FG001|Overall Study|Investigator decision|0|||
129943892|NCT02686658|467758170|FG002|Overall Study|Investigator decision|0|||
129943893|NCT02686658|467758171|FG003|Overall Study|Investigator decision|1|||
129943894|NCT02686658|467758172|FG004|Overall Study|Investigator decision|2|||
129943895|NCT02686658|467758173|FG005|Overall Study|Investigator decision|1|||
129943896|NCT02686658|467758168|FG000|Overall Study|Sponsor decision|1|||
129943897|NCT02686658|467758169|FG001|Overall Study|Sponsor decision|2|||
129943898|NCT02686658|467758170|FG002|Overall Study|Sponsor decision|1|||
129943899|NCT02686658|467758171|FG003|Overall Study|Sponsor decision|5|||
129943900|NCT02686658|467758172|FG004|Overall Study|Sponsor decision|13|||
129943901|NCT02686658|467758173|FG005|Overall Study|Sponsor decision|2|||
129943902|NCT02686658|467758168|FG000|Overall Study|Lost to Follow-up|0|||
129943903|NCT02686658|467758169|FG001|Overall Study|Lost to Follow-up|0|||
129943904|NCT02686658|467758170|FG002|Overall Study|Lost to Follow-up|2|||
129943905|NCT02686658|467758171|FG003|Overall Study|Lost to Follow-up|0|||
129943906|NCT02686658|467758172|FG004|Overall Study|Lost to Follow-up|0|||
129943907|NCT02686658|467758173|FG005|Overall Study|Lost to Follow-up|1|||
129943908|NCT02686658|467758168|FG000|Overall Study|Death|1|||
129943909|NCT02686658|467758169|FG001|Overall Study|Death|0|||
129943910|NCT02686658|467758170|FG002|Overall Study|Death|0|||
129943911|NCT02686658|467758171|FG003|Overall Study|Death|1|||
129943912|NCT02686658|467758172|FG004|Overall Study|Death|1|||
129943913|NCT02686658|467758173|FG005|Overall Study|Death|1|||
129943914|NCT02686658|467758168|FG000|Overall Study|Withdrawal by Subject|2|||
129943915|NCT02686658|467758169|FG001|Overall Study|Withdrawal by Subject|5|||
129943916|NCT02686658|467758170|FG002|Overall Study|Withdrawal by Subject|4|||
129943917|NCT02686658|467758171|FG003|Overall Study|Withdrawal by Subject|4|||
129943918|NCT02686658|467758172|FG004|Overall Study|Withdrawal by Subject|17|||
129943919|NCT02686658|467758173|FG005|Overall Study|Withdrawal by Subject|8|||
129943920|NCT02686658|467758168|FG000|Overall Study|Placed in hospice care|0|||
129943921|NCT02686658|467758169|FG001|Overall Study|Placed in hospice care|0|||
129943922|NCT02686658|467758170|FG002|Overall Study|Placed in hospice care|1|||
129943923|NCT02686658|467758171|FG003|Overall Study|Placed in hospice care|0|||
129943924|NCT02686658|467758172|FG004|Overall Study|Placed in hospice care|0|||
129943925|NCT02686658|467758173|FG005|Overall Study|Placed in hospice care|0|||
129943926|NCT02686658|467758168|FG000|Overall Study|Participant non-compliance|0|||
129943927|NCT02686658|467758169|FG001|Overall Study|Participant non-compliance|0|||
129943928|NCT02686658|467758170|FG002|Overall Study|Participant non-compliance|0|||
129943929|NCT02686658|467758171|FG003|Overall Study|Participant non-compliance|0|||
129943930|NCT02686658|467758172|FG004|Overall Study|Participant non-compliance|0|||
129943931|NCT02686658|467758173|FG005|Overall Study|Participant non-compliance|1|||
129943932|NCT02686658|467758168|FG000|Overall Study|Concern over coronavirus disease care|0|||
129943933|NCT02686658|467758169|FG001|Overall Study|Concern over coronavirus disease care|0|||
129943934|NCT02686658|467758170|FG002|Overall Study|Concern over coronavirus disease care|0|||
129943935|NCT02686658|467758171|FG003|Overall Study|Concern over coronavirus disease care|0|||
129943936|NCT02686658|467758172|FG004|Overall Study|Concern over coronavirus disease care|2|||
129943937|NCT02686658|467758173|FG005|Overall Study|Concern over coronavirus disease care|1|||
129943938|NCT00570505|467758174|FG000|Overall Study|Adverse Event|7|||
129943939|NCT00570505|467758174|FG000|Overall Study|Withdrawal by Subject|7|||
129943940|NCT00570505|467758174|FG000|Overall Study|Lost to Follow-up|23|||
129943941|NCT00570505|467758174|FG000|Overall Study|Other loss to follow-up|4|||
129943942|NCT04224272|467758175|FG000|Part 1 - Dose Finding|Death|4|||
129943943|NCT04224272|467758175|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
129943944|NCT04224272|467758175|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
129943945|NCT04224272|467758175|FG000|Part 2 - Dose Expansion|Death|10|||
129943946|NCT04224272|467758175|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
129943947|NCT02556918|467760090|FG000|Overall Study|Protocol Violation|5|||
129943948|NCT02556918|467760091|FG001|Overall Study|Protocol Violation|6|||
129943949|NCT02556918|467760090|FG000|Overall Study|Withdrawal by Subject|4|||
129943950|NCT02556918|467760091|FG001|Overall Study|Withdrawal by Subject|4|||
129943951|NCT00551421|467760102|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
129943952|NCT02634307|467760112|FG000|Overall Study|Adverse Event|50|||
129943953|NCT02634307|467760113|FG001|Overall Study|Adverse Event|24|||
129943954|NCT02634307|467760114|FG002|Overall Study|Adverse Event|14|||
129943955|NCT02634307|467760112|FG000|Overall Study|Lost to Follow-up|21|||
129943956|NCT02634307|467760113|FG001|Overall Study|Lost to Follow-up|5|||
129943957|NCT02634307|467760114|FG002|Overall Study|Lost to Follow-up|6|||
129943958|NCT02634307|467760112|FG000|Overall Study|Pregnancy|5|||
129943959|NCT02634307|467760113|FG001|Overall Study|Pregnancy|1|||
129943960|NCT02634307|467760114|FG002|Overall Study|Pregnancy|3|||
129943961|NCT02634307|467760112|FG000|Overall Study|Withdrawal by Subject|38|||
129943962|NCT02634307|467760113|FG001|Overall Study|Withdrawal by Subject|24|||
129943963|NCT02634307|467760114|FG002|Overall Study|Withdrawal by Subject|18|||
129943964|NCT02634307|467760112|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129943965|NCT02634307|467760113|FG001|Overall Study|Non-Compliance with Study Drug|2|||
129943966|NCT02634307|467760114|FG002|Overall Study|Non-Compliance with Study Drug|2|||
129943967|NCT02634307|467760112|FG000|Overall Study|Lack of Efficacy|1|||
129943968|NCT02634307|467760113|FG001|Overall Study|Lack of Efficacy|5|||
129943969|NCT02634307|467760114|FG002|Overall Study|Lack of Efficacy|3|||
129943970|NCT02634307|467760112|FG000|Overall Study|Physician Decision|7|||
129943971|NCT02634307|467760113|FG001|Overall Study|Physician Decision|5|||
129943972|NCT02634307|467760114|FG002|Overall Study|Physician Decision|5|||
129943973|NCT02634307|467760112|FG000|Overall Study|Reason not Specified|3|||
129943974|NCT02634307|467760113|FG001|Overall Study|Reason not Specified|5|||
129943975|NCT02634307|467760114|FG002|Overall Study|Reason not Specified|10|||
129943976|NCT02698475|467760115|FG000|Main Study Period|Lack of Efficacy|1|||
129943977|NCT02698475|467760115|FG000|Main Study Period|Protocol Violation|2|||
129943978|NCT02698475|467760115|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
129943979|NCT02698475|467760115|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
129943980|NCT02698475|467760115|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
129943981|NCT02698475|467760115|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
129943982|NCT02698475|467760115|FG000|Long-Term Extension Period|Other|1|||
129943983|NCT02132949|467760116|FG000|Overall Study|Death|7|||
129943984|NCT02132949|467760117|FG001|Overall Study|Death|13|||
129943985|NCT02132949|467760116|FG000|Overall Study|Lost to Follow-up|14|||
129943986|NCT02132949|467760117|FG001|Overall Study|Lost to Follow-up|4|||
129943987|NCT02132949|467760116|FG000|Overall Study|Withdrawal by Subject|6|||
129943988|NCT02132949|467760117|FG001|Overall Study|Withdrawal by Subject|5|||
129943989|NCT02132949|467760116|FG000|Overall Study|Noncompliance|5|||
129943990|NCT02132949|467760117|FG001|Overall Study|Noncompliance|1|||
129943991|NCT02132949|467760116|FG000|Overall Study|Physician Decision|3|||
129943992|NCT02132949|467760117|FG001|Overall Study|Physician Decision|1|||
129943993|NCT02132949|467760116|FG000|Overall Study|Disease Progression|3|||
129943994|NCT02132949|467760117|FG001|Overall Study|Disease Progression|0|||
129943995|NCT02132949|467760116|FG000|Overall Study|Adverse Event|2|||
129943996|NCT02132949|467760117|FG001|Overall Study|Adverse Event|1|||
129943997|NCT02132949|467760116|FG000|Overall Study|Withdrew Prior to Treatment|1|||
129943998|NCT02132949|467760117|FG001|Overall Study|Withdrew Prior to Treatment|2|||
129943999|NCT02132949|467760116|FG000|Overall Study|Reason Unspecified|0|||
129944000|NCT02132949|467760117|FG001|Overall Study|Reason Unspecified|1|||
129944001|NCT02148705|467760125|FG000|Overall Study|Death|2|||
129944002|NCT02148705|467760126|FG001|Overall Study|Death|0|||
129944003|NCT02148705|467760127|FG002|Overall Study|Death|0|||
129944004|NCT02148705|467760125|FG000|Overall Study|Lost to Follow-up|13|||
129944005|NCT02148705|467760126|FG001|Overall Study|Lost to Follow-up|4|||
129944006|NCT02148705|467760127|FG002|Overall Study|Lost to Follow-up|10|||
129944007|NCT02148705|467760125|FG000|Overall Study|Withdrawal by Subject|3|||
129944008|NCT02148705|467760126|FG001|Overall Study|Withdrawal by Subject|0|||
129944009|NCT02148705|467760127|FG002|Overall Study|Withdrawal by Subject|2|||
129944010|NCT02148705|467760125|FG000|Overall Study|Not Treated|0|||
129944011|NCT02148705|467760126|FG001|Overall Study|Not Treated|1|||
129944012|NCT02148705|467760127|FG002|Overall Study|Not Treated|5|||
129944013|NCT01737021|467760128|FG000|Overall Study|Lost to Follow-up|5|||
129944014|NCT01737021|467760129|FG001|Overall Study|Lost to Follow-up|3|||
129944015|NCT03865732|467760131|FG000|Overall Study|Adverse Event|0|||
129944016|NCT03865732|467760132|FG001|Overall Study|Adverse Event|1|||
129944017|NCT03392194|467760133|FG000|Overall Study|Withdrawal by Subject|1|||
129944018|NCT03392194|467760134|FG001|Overall Study|Withdrawal by Subject|2|||
129944019|NCT03392194|467760133|FG000|Overall Study|Conflicts with personal schedule|1|||
129944020|NCT03392194|467760134|FG001|Overall Study|Conflicts with personal schedule|0|||
129944021|NCT01019135|467760136|FG000|Overall Study|Did not receive allocated intervention|12|||
129944022|NCT01019135|467760137|FG001|Overall Study|Did not receive allocated intervention|6|||
129944023|NCT01019135|467760138|FG002|Overall Study|Did not receive allocated intervention|25|||
129944024|NCT01019135|467760136|FG000|Overall Study|Did not attend CR|8|||
129944025|NCT01019135|467760137|FG001|Overall Study|Did not attend CR|13|||
129944026|NCT01019135|467760138|FG002|Overall Study|Did not attend CR|6|||
129944027|NCT05124210|467760139|FG000|Overall Study|Lost to Follow-up|1|||
129944028|NCT05124210|467760140|FG001|Overall Study|Lost to Follow-up|0|||
129944029|NCT05124210|467760139|FG000|Overall Study|Withdrawal by Subject|1|||
129944030|NCT05124210|467760140|FG001|Overall Study|Withdrawal by Subject|0|||
129944031|NCT00768755|467760143|FG000|Phase 1|Death|6|||
129944032|NCT00768755|467760144|FG001|Phase 1|Death|0|||
129944033|NCT00768755|467760145|FG002|Phase 1|Death|0|||
129944034|NCT00768755|467760146|FG003|Phase 1|Death|0|||
129944035|NCT00768755|467760143|FG000|Phase 1|Other|4|||
129944036|NCT00768755|467760144|FG001|Phase 1|Other|0|||
129944037|NCT00768755|467760145|FG002|Phase 1|Other|0|||
129944038|NCT00768755|467760146|FG003|Phase 1|Other|0|||
129944039|NCT00768755|467760143|FG000|Phase 2|Death|0|||
129944040|NCT00768755|467760144|FG001|Phase 2|Death|37|||
129944041|NCT00768755|467760145|FG002|Phase 2|Death|48|||
129944042|NCT00768755|467760146|FG003|Phase 2|Death|31|||
129944043|NCT00768755|467760143|FG000|Phase 2|Protocol Violation|0|||
129944044|NCT00768755|467760144|FG001|Phase 2|Protocol Violation|2|||
129944045|NCT00768755|467760145|FG002|Phase 2|Protocol Violation|0|||
129944046|NCT00768755|467760146|FG003|Phase 2|Protocol Violation|1|||
129944047|NCT00768755|467760143|FG000|Phase 2|Lost to Follow-up|0|||
129944048|NCT00768755|467760144|FG001|Phase 2|Lost to Follow-up|1|||
129944049|NCT00768755|467760145|FG002|Phase 2|Lost to Follow-up|1|||
129944050|NCT00768755|467760146|FG003|Phase 2|Lost to Follow-up|4|||
129944051|NCT00768755|467760143|FG000|Phase 2|Withdrawal by Subject|0|||
129944052|NCT00768755|467760144|FG001|Phase 2|Withdrawal by Subject|1|||
129944053|NCT00768755|467760145|FG002|Phase 2|Withdrawal by Subject|0|||
129944054|NCT00768755|467760146|FG003|Phase 2|Withdrawal by Subject|1|||
129944055|NCT00768755|467760143|FG000|Phase 2|Other|0|||
129944056|NCT00768755|467760144|FG001|Phase 2|Other|1|||
129944057|NCT00768755|467760145|FG002|Phase 2|Other|2|||
129944058|NCT00768755|467760146|FG003|Phase 2|Other|4|||
129944059|NCT00768755|467760143|FG000|Phase 2|Study Terminated by Sponsor|0|||
129944060|NCT00768755|467760144|FG001|Phase 2|Study Terminated by Sponsor|13|||
129944061|NCT00768755|467760145|FG002|Phase 2|Study Terminated by Sponsor|7|||
129944062|NCT00768755|467760146|FG003|Phase 2|Study Terminated by Sponsor|14|||
129944063|NCT00768755|467760143|FG000|Phase 2|Randomized but not treated|0|||
129944064|NCT00768755|467760144|FG001|Phase 2|Randomized but not treated|0|||
129944065|NCT00768755|467760145|FG002|Phase 2|Randomized but not treated|0|||
129944066|NCT00768755|467760146|FG003|Phase 2|Randomized but not treated|2|||
129944067|NCT00310037|467760147|FG000|Overall Study|Adverse Event|7|||
129944068|NCT00310037|467760148|FG001|Overall Study|Adverse Event|14|||
129944069|NCT00310037|467760147|FG000|Overall Study|Withdrawal by Subject|4|||
129944070|NCT00310037|467760148|FG001|Overall Study|Withdrawal by Subject|3|||
129944071|NCT00310037|467760147|FG000|Overall Study|Progression|6|||
129944072|NCT00310037|467760148|FG001|Overall Study|Progression|0|||
129944073|NCT00310037|467760147|FG000|Overall Study|Non-protocol treatment|1|||
129944074|NCT00310037|467760148|FG001|Overall Study|Non-protocol treatment|0|||
129944075|NCT01530334|467760152|FG000|Overall Study|Adverse Event|3|||
129944076|NCT01530334|467760152|FG000|Overall Study|unknown reason|1|||
129944077|NCT01530334|467760152|FG000|Overall Study|Progressive disease|47|||
129944078|NCT01485887|467760153|FG000|Overall Study|Withdrawal by Subject|2|||
129944079|NCT01485887|467760153|FG000|Overall Study|Adverse Event|8|||
129944080|NCT01485887|467760153|FG000|Overall Study|Deterioration of primary disease|1|||
129944081|NCT01485887|467760153|FG000|Overall Study|Primary disease markedly improved|1|||
129944082|NCT00659373|467760154|FG000|Overall Study|Withdrawal by Subject|3|||
129944083|NCT00659373|467760155|FG001|Overall Study|Withdrawal by Subject|5|||
129944084|NCT00659373|467760154|FG000|Overall Study|Assessment Missed|2|||
129944085|NCT00659373|467760155|FG001|Overall Study|Assessment Missed|2|||
129944086|NCT02382640|467760156|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
129944087|NCT02382640|467760157|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
129944088|NCT02382640|467760158|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
129944089|NCT02382640|467760159|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
129453335|NCT01538628|465956468|FG001|Overall Study|Withdrawal by Subject|1|||
129453336|NCT01538628|465956467|FG000|Overall Study|Lost to Follow-up|0|||
129453337|NCT01538628|465956468|FG001|Overall Study|Lost to Follow-up|1|||
129453338|NCT00736255|465958037|FG000|Overall Study|Adverse Event|1|||
129944090|NCT03162614|467760162|FG000|Overall Study|Lost to Follow-up|2|||
129944091|NCT03162614|467760163|FG001|Overall Study|Lost to Follow-up|1|||
129944092|NCT03162614|467760164|FG002|Overall Study|Lost to Follow-up|1|||
129944093|NCT03162614|467760165|FG003|Overall Study|Lost to Follow-up|1|||
129944094|NCT03162614|467760166|FG004|Overall Study|Lost to Follow-up|2|||
129944095|NCT03162614|467760167|FG005|Overall Study|Lost to Follow-up|0|||
129944096|NCT03162614|467760162|FG000|Overall Study|Protocol Violation|0|||
129944097|NCT03162614|467760163|FG001|Overall Study|Protocol Violation|1|||
129944098|NCT03162614|467760164|FG002|Overall Study|Protocol Violation|0|||
129944099|NCT03162614|467760165|FG003|Overall Study|Protocol Violation|1|||
129944100|NCT03162614|467760166|FG004|Overall Study|Protocol Violation|0|||
129944101|NCT03162614|467760167|FG005|Overall Study|Protocol Violation|0|||
129944102|NCT03162614|467760162|FG000|Overall Study|Withdrawal by Subject|2|||
129944103|NCT03162614|467760163|FG001|Overall Study|Withdrawal by Subject|1|||
129944104|NCT03162614|467760164|FG002|Overall Study|Withdrawal by Subject|1|||
129944105|NCT03162614|467760165|FG003|Overall Study|Withdrawal by Subject|1|||
129944106|NCT03162614|467760166|FG004|Overall Study|Withdrawal by Subject|0|||
129944107|NCT03162614|467760167|FG005|Overall Study|Withdrawal by Subject|0|||
129944108|NCT03162614|467760162|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
129944109|NCT03162614|467760163|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
129944110|NCT03162614|467760164|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
129944111|NCT03162614|467760165|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
129944112|NCT03162614|467760166|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
129944113|NCT03162614|467760167|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
129944114|NCT05270460|467760170|FG000|Overall Study|Adverse Event|0|||
129944115|NCT05270460|467760171|FG001|Overall Study|Adverse Event|1|||
129944116|NCT05270460|467760172|FG002|Overall Study|Adverse Event|0|||
129944117|NCT05270460|467760170|FG000|Overall Study|Early Termination|0|||
129944118|NCT05270460|467760171|FG001|Overall Study|Early Termination|1|||
129944119|NCT05270460|467760172|FG002|Overall Study|Early Termination|0|||
129944120|NCT00380250|467760173|FG000|Overall Study|Withdrawal by Subject|39|||
129944121|NCT00380250|467760174|FG001|Overall Study|Withdrawal by Subject|28|||
129944122|NCT00380250|467760173|FG000|Overall Study|Adverse Event|20|||
129944123|NCT00380250|467760174|FG001|Overall Study|Adverse Event|9|||
129944124|NCT00380250|467760173|FG000|Overall Study|Lack of Efficacy|10|||
129944125|NCT00380250|467760174|FG001|Overall Study|Lack of Efficacy|8|||
129944126|NCT00380250|467760173|FG000|Overall Study|Protocol Violation|15|||
129944127|NCT00380250|467760174|FG001|Overall Study|Protocol Violation|5|||
129944128|NCT00380250|467760173|FG000|Overall Study|Lost to Follow-up|14|||
129944129|NCT00380250|467760174|FG001|Overall Study|Lost to Follow-up|5|||
129944130|NCT00380250|467760173|FG000|Overall Study|Physician Decision|1|||
129944131|NCT00380250|467760174|FG001|Overall Study|Physician Decision|0|||
129944132|NCT00243867|467760175|FG000|Overall Study|Adverse Event|24|||
129944133|NCT00243867|467760176|FG001|Overall Study|Adverse Event|34|||
129944134|NCT00243867|467760175|FG000|Overall Study|Lack of Efficacy|115|||
129944135|NCT00243867|467760176|FG001|Overall Study|Lack of Efficacy|78|||
129944136|NCT00243867|467760175|FG000|Overall Study|Withdrawal by Subject|11|||
129944137|NCT00243867|467760176|FG001|Overall Study|Withdrawal by Subject|23|||
129944138|NCT00243867|467760175|FG000|Overall Study|Lost to Follow-up|2|||
129944139|NCT00243867|467760176|FG001|Overall Study|Lost to Follow-up|1|||
129944140|NCT00243867|467760175|FG000|Overall Study|Physician Decision|2|||
129944141|NCT00243867|467760176|FG001|Overall Study|Physician Decision|7|||
129944142|NCT00243867|467760175|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
129944143|NCT00243867|467760176|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
129944144|NCT01638000|467760177|FG000|Overall Study|Randomized but Never Received Drug|7|||
129944145|NCT01638000|467760178|FG001|Overall Study|Randomized but Never Received Drug|10|||
129944146|NCT01638000|467760177|FG000|Overall Study|Adverse Event|14|||
129944147|NCT01638000|467760178|FG001|Overall Study|Adverse Event|16|||
129944148|NCT01638000|467760177|FG000|Overall Study|Lack of Efficacy|5|||
129944149|NCT01638000|467760178|FG001|Overall Study|Lack of Efficacy|6|||
129944150|NCT01638000|467760177|FG000|Overall Study|Protocol Violation|11|||
129944151|NCT01638000|467760178|FG001|Overall Study|Protocol Violation|13|||
129944152|NCT01638000|467760177|FG000|Overall Study|Withdrawal by Subject|21|||
129944153|NCT01638000|467760178|FG001|Overall Study|Withdrawal by Subject|24|||
129944154|NCT01638000|467760177|FG000|Overall Study|Miscellaneous|2|||
129944155|NCT01638000|467760178|FG001|Overall Study|Miscellaneous|2|||
129944156|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944157|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944158|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
129944159|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944160|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
129944161|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
129944162|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
129944163|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
129944164|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
129944165|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
129944166|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944167|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
129944168|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944169|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944170|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
129944171|NCT01683409|467760181|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
129944172|NCT01683409|467760182|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
129944173|NCT01683409|467760183|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
129944174|NCT01683409|467760184|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
129453339|NCT00736255|465958038|FG001|Overall Study|Adverse Event|0|||
129453340|NCT00736255|465958037|FG000|Overall Study|Physician Decision|1|||
129453341|NCT00736255|465958038|FG001|Overall Study|Physician Decision|0|||
129453342|NCT00736255|465958037|FG000|Overall Study|Non-compliance|1|||
129453343|NCT00736255|465958038|FG001|Overall Study|Non-compliance|1|||
129453344|NCT01717287|465958039|FG000|Overall Study|Lost to Follow-up|0|||
129453345|NCT01717287|465958040|FG001|Overall Study|Lost to Follow-up|2|||
129453346|NCT01717287|465958039|FG000|Overall Study|Protocol Violation|0|||
129453347|NCT01717287|465958040|FG001|Overall Study|Protocol Violation|1|||
129453348|NCT00404820|465958041|FG000|Overall Study|Adverse Event|4|||
129453349|NCT00404820|465958042|FG001|Overall Study|Adverse Event|16|||
129453350|NCT00404820|465958041|FG000|Overall Study|Withdrawal by Subject|5|||
129453351|NCT00404820|465958042|FG001|Overall Study|Withdrawal by Subject|3|||
129453352|NCT00404820|465958041|FG000|Overall Study|Lost to Follow-up|7|||
129453353|NCT00404820|465958042|FG001|Overall Study|Lost to Follow-up|3|||
129453354|NCT00404820|465958041|FG000|Overall Study|Administrative problems|2|||
129453355|NCT00404820|465958042|FG001|Overall Study|Administrative problems|0|||
129453356|NCT00404820|465958041|FG000|Overall Study|Death|1|||
129453357|NCT00404820|465958042|FG001|Overall Study|Death|0|||
129453358|NCT00404820|465958041|FG000|Overall Study|Other|0|||
129453359|NCT00404820|465958042|FG001|Overall Study|Other|2|||
129453360|NCT01469182|465958047|FG000|Overall Study|Adverse Event|21|||
129453361|NCT01469182|465958048|FG001|Overall Study|Adverse Event|3|||
129453362|NCT01469182|465958047|FG000|Overall Study|Lost to Follow-up|3|||
129453363|NCT01469182|465958048|FG001|Overall Study|Lost to Follow-up|0|||
129453364|NCT01469182|465958047|FG000|Overall Study|Withdrawal by Subject|4|||
129453365|NCT01469182|465958048|FG001|Overall Study|Withdrawal by Subject|1|||
129453366|NCT01469182|465958047|FG000|Overall Study|Protocol Violation|4|||
129453367|NCT01469182|465958048|FG001|Overall Study|Protocol Violation|2|||
129453368|NCT01469182|465958047|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
129453369|NCT01469182|465958048|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
129453370|NCT02687542|465958049|FG000|Overall Study|Medication error without associated AEs|0|||
129453371|NCT02687542|465958050|FG001|Overall Study|Medication error without associated AEs|0|||
129453372|NCT02687542|465958051|FG002|Overall Study|Medication error without associated AEs|0|||
129453373|NCT02687542|465958052|FG003|Overall Study|Medication error without associated AEs|0|||
129453374|NCT02687542|465958053|FG004|Overall Study|Medication error without associated AEs|1|||
129453375|NCT02687542|465958049|FG000|Overall Study|Lost to Follow-up|0|||
129453376|NCT02687542|465958050|FG001|Overall Study|Lost to Follow-up|0|||
129453377|NCT02687542|465958051|FG002|Overall Study|Lost to Follow-up|0|||
129453378|NCT02687542|465958052|FG003|Overall Study|Lost to Follow-up|0|||
129453379|NCT02687542|465958053|FG004|Overall Study|Lost to Follow-up|1|||
129453380|NCT02687542|465958049|FG000|Overall Study|Protocol Violation|0|||
129453381|NCT02687542|465958050|FG001|Overall Study|Protocol Violation|1|||
129453382|NCT02687542|465958051|FG002|Overall Study|Protocol Violation|0|||
129453383|NCT02687542|465958052|FG003|Overall Study|Protocol Violation|0|||
129453384|NCT02687542|465958053|FG004|Overall Study|Protocol Violation|0|||
129453385|NCT02687542|465958049|FG000|Overall Study|Other|5|||
129453386|NCT02687542|465958050|FG001|Overall Study|Other|9|||
129453387|NCT02687542|465958051|FG002|Overall Study|Other|10|||
129453388|NCT02687542|465958052|FG003|Overall Study|Other|6|||
129453389|NCT02687542|465958053|FG004|Overall Study|Other|5|||
129453390|NCT02687542|465958049|FG000|Overall Study|Adverse Event|3|||
129453391|NCT02687542|465958050|FG001|Overall Study|Adverse Event|1|||
129944175|NCT01683409|467760185|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
129944176|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944177|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944178|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
129944179|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944180|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
129944181|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
129944182|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
129944183|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
129944184|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
129944185|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
129453392|NCT02687542|465958051|FG002|Overall Study|Adverse Event|3|||
129453393|NCT02687542|465958052|FG003|Overall Study|Adverse Event|2|||
129453394|NCT02687542|465958053|FG004|Overall Study|Adverse Event|9|||
129453395|NCT02687542|465958049|FG000|Overall Study|Withdrawal by Subject|0|||
129944186|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
129944187|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
129453396|NCT02687542|465958050|FG001|Overall Study|Withdrawal by Subject|1|||
129453397|NCT02687542|465958051|FG002|Overall Study|Withdrawal by Subject|1|||
129944188|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
129453398|NCT02687542|465958052|FG003|Overall Study|Withdrawal by Subject|2|||
129453399|NCT02687542|465958053|FG004|Overall Study|Withdrawal by Subject|4|||
129453400|NCT01838616|465958056|FG000|Titration Period|Adverse Event|18|||
129453401|NCT01838616|465958057|FG001|Titration Period|Adverse Event|48|||
129453402|NCT01838616|465958056|FG000|Titration Period|Lack of Efficacy|5|||
129453403|NCT01838616|465958057|FG001|Titration Period|Lack of Efficacy|12|||
129453404|NCT01838616|465958056|FG000|Titration Period|Withdrawal by Subject|5|||
129453405|NCT01838616|465958057|FG001|Titration Period|Withdrawal by Subject|5|||
129453406|NCT01838616|465958056|FG000|Titration Period|Technical problems|1|||
129453407|NCT01838616|465958057|FG001|Titration Period|Technical problems|0|||
129944189|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
129944190|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
129944191|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
129944192|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944193|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944194|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944195|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
129944196|NCT01683409|467760181|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
129944197|NCT01683409|467760182|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
129944198|NCT01683409|467760183|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
129944199|NCT01683409|467760184|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
129944200|NCT01683409|467760185|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
129944201|NCT01683409|467760181|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944202|NCT01683409|467760182|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944203|NCT01683409|467760183|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944204|NCT01683409|467760184|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
129944205|NCT01683409|467760185|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
129944206|NCT01683409|467760181|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944207|NCT01683409|467760182|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944208|NCT01683409|467760183|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
129944209|NCT01683409|467760184|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944210|NCT01683409|467760185|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
129944211|NCT04218864|467760186|FG000|Overall Study|Lost to Follow-up|8|||
129944212|NCT04218864|467760187|FG001|Overall Study|Lost to Follow-up|4|||
129944213|NCT04218864|467760186|FG000|Overall Study|Withdrawal by Subject|1|||
129944214|NCT04218864|467760187|FG001|Overall Study|Withdrawal by Subject|3|||
129944215|NCT01227421|467760189|FG000|Overall Study|Lost to Follow-up|6|||
129944216|NCT01227421|467760190|FG001|Overall Study|Lost to Follow-up|7|||
129944217|NCT01227421|467760191|FG002|Overall Study|Lost to Follow-up|5|||
129944218|NCT01227421|467760189|FG000|Overall Study|Adverse Event|2|||
129944219|NCT01227421|467760190|FG001|Overall Study|Adverse Event|7|||
129944220|NCT01227421|467760191|FG002|Overall Study|Adverse Event|2|||
129944221|NCT01227421|467760189|FG000|Overall Study|Withdrawal by Subject|1|||
129944222|NCT01227421|467760190|FG001|Overall Study|Withdrawal by Subject|2|||
129944223|NCT01227421|467760191|FG002|Overall Study|Withdrawal by Subject|1|||
129944224|NCT01227421|467760189|FG000|Overall Study|Protocol Violation|1|||
129944225|NCT01227421|467760190|FG001|Overall Study|Protocol Violation|1|||
129944226|NCT01227421|467760191|FG002|Overall Study|Protocol Violation|2|||
129944227|NCT01227421|467760189|FG000|Overall Study|Randomized in error|1|||
129944228|NCT01227421|467760190|FG001|Overall Study|Randomized in error|1|||
129944229|NCT01227421|467760191|FG002|Overall Study|Randomized in error|0|||
129944230|NCT02499328|467760192|FG000|Overall Study|Withdrawal by Subject|1|||
129944231|NCT02499328|467760193|FG001|Overall Study|Withdrawal by Subject|1|||
129944232|NCT02499328|467760194|FG002|Overall Study|Withdrawal by Subject|5|||
129944233|NCT02499328|467760195|FG003|Overall Study|Withdrawal by Subject|3|||
129944234|NCT02499328|467760196|FG004|Overall Study|Withdrawal by Subject|5|||
129944235|NCT02499328|467760197|FG005|Overall Study|Withdrawal by Subject|0|||
129944236|NCT02499328|467760198|FG006|Overall Study|Withdrawal by Subject|0|||
129944237|NCT02499328|467760199|FG007|Overall Study|Withdrawal by Subject|0|||
129944238|NCT02499328|467760200|FG008|Overall Study|Withdrawal by Subject|2|||
129944239|NCT02499328|467760201|FG009|Overall Study|Withdrawal by Subject|2|||
129453408|NCT01838616|465958056|FG000|Titration Period|Other|1|||
129944240|NCT02499328|467760202|FG010|Overall Study|Withdrawal by Subject|0|||
129944241|NCT02499328|467760203|FG011|Overall Study|Withdrawal by Subject|3|||
129944242|NCT02499328|467760204|FG012|Overall Study|Withdrawal by Subject|7|||
129944243|NCT02499328|467760205|FG013|Overall Study|Withdrawal by Subject|3|||
129944244|NCT02499328|467760206|FG014|Overall Study|Withdrawal by Subject|1|||
129944245|NCT02499328|467760207|FG015|Overall Study|Withdrawal by Subject|0|||
129453409|NCT01838616|465958057|FG001|Titration Period|Other|0|||
129944246|NCT02499328|467760208|FG016|Overall Study|Withdrawal by Subject|0|||
129944247|NCT02499328|467760209|FG017|Overall Study|Withdrawal by Subject|3|||
129944248|NCT02499328|467760210|FG018|Overall Study|Withdrawal by Subject|0|||
129944249|NCT02499328|467760192|FG000|Overall Study|Lost to Follow-up|0|||
129944250|NCT02499328|467760193|FG001|Overall Study|Lost to Follow-up|1|||
129944251|NCT02499328|467760194|FG002|Overall Study|Lost to Follow-up|1|||
129944252|NCT02499328|467760195|FG003|Overall Study|Lost to Follow-up|2|||
129944253|NCT02499328|467760196|FG004|Overall Study|Lost to Follow-up|0|||
129944254|NCT02499328|467760197|FG005|Overall Study|Lost to Follow-up|0|||
129944255|NCT02499328|467760198|FG006|Overall Study|Lost to Follow-up|0|||
129944256|NCT02499328|467760199|FG007|Overall Study|Lost to Follow-up|2|||
129944257|NCT02499328|467760200|FG008|Overall Study|Lost to Follow-up|3|||
129944258|NCT02499328|467760201|FG009|Overall Study|Lost to Follow-up|0|||
129944259|NCT02499328|467760202|FG010|Overall Study|Lost to Follow-up|0|||
129944260|NCT02499328|467760203|FG011|Overall Study|Lost to Follow-up|0|||
129944261|NCT02499328|467760204|FG012|Overall Study|Lost to Follow-up|0|||
129944262|NCT02499328|467760205|FG013|Overall Study|Lost to Follow-up|0|||
129944263|NCT02499328|467760206|FG014|Overall Study|Lost to Follow-up|0|||
129944264|NCT02499328|467760207|FG015|Overall Study|Lost to Follow-up|0|||
129944265|NCT02499328|467760208|FG016|Overall Study|Lost to Follow-up|0|||
129944266|NCT02499328|467760209|FG017|Overall Study|Lost to Follow-up|0|||
129944267|NCT02499328|467760210|FG018|Overall Study|Lost to Follow-up|1|||
129944268|NCT02499328|467760192|FG000|Overall Study|Death|0|||
129944269|NCT02499328|467760193|FG001|Overall Study|Death|3|||
129944270|NCT02499328|467760194|FG002|Overall Study|Death|3|||
129944271|NCT02499328|467760195|FG003|Overall Study|Death|2|||
129944272|NCT02499328|467760196|FG004|Overall Study|Death|4|||
129944273|NCT02499328|467760197|FG005|Overall Study|Death|7|||
129944274|NCT02499328|467760198|FG006|Overall Study|Death|3|||
129944275|NCT02499328|467760199|FG007|Overall Study|Death|0|||
129944276|NCT02499328|467760200|FG008|Overall Study|Death|2|||
129944277|NCT02499328|467760201|FG009|Overall Study|Death|6|||
129944278|NCT02499328|467760202|FG010|Overall Study|Death|6|||
129944279|NCT02499328|467760203|FG011|Overall Study|Death|20|||
129944280|NCT02499328|467760204|FG012|Overall Study|Death|9|||
129944281|NCT02499328|467760205|FG013|Overall Study|Death|7|||
129944282|NCT02499328|467760206|FG014|Overall Study|Death|3|||
129944283|NCT02499328|467760207|FG015|Overall Study|Death|1|||
129944284|NCT02499328|467760208|FG016|Overall Study|Death|1|||
129944285|NCT02499328|467760209|FG017|Overall Study|Death|16|||
129944286|NCT02499328|467760210|FG018|Overall Study|Death|5|||
129944287|NCT02499328|467760192|FG000|Overall Study|"Other"|2|||
129944288|NCT02499328|467760193|FG001|Overall Study|"Other"|2|||
129944289|NCT02499328|467760194|FG002|Overall Study|"Other"|1|||
129944290|NCT02499328|467760195|FG003|Overall Study|"Other"|3|||
129944291|NCT02499328|467760196|FG004|Overall Study|"Other"|6|||
129944292|NCT02499328|467760197|FG005|Overall Study|"Other"|2|||
129944293|NCT02499328|467760198|FG006|Overall Study|"Other"|3|||
129944294|NCT02499328|467760199|FG007|Overall Study|"Other"|4|||
129944295|NCT02499328|467760200|FG008|Overall Study|"Other"|6|||
129944296|NCT02499328|467760201|FG009|Overall Study|"Other"|16|||
129944297|NCT02499328|467760202|FG010|Overall Study|"Other"|13|||
129944298|NCT02499328|467760203|FG011|Overall Study|"Other"|31|||
129944299|NCT02499328|467760204|FG012|Overall Study|"Other"|8|||
129944300|NCT02499328|467760205|FG013|Overall Study|"Other"|7|||
129944301|NCT02499328|467760206|FG014|Overall Study|"Other"|6|||
129944302|NCT02499328|467760207|FG015|Overall Study|"Other"|0|||
129944303|NCT02499328|467760208|FG016|Overall Study|"Other"|0|||
129944304|NCT02499328|467760209|FG017|Overall Study|"Other"|34|||
129944305|NCT02499328|467760210|FG018|Overall Study|"Other"|43|||
129944306|NCT02499328|467760192|FG000|Overall Study|Disease Progression|0|||
129944307|NCT02499328|467760193|FG001|Overall Study|Disease Progression|0|||
129944308|NCT02499328|467760194|FG002|Overall Study|Disease Progression|0|||
129944309|NCT02499328|467760195|FG003|Overall Study|Disease Progression|0|||
129944310|NCT02499328|467760196|FG004|Overall Study|Disease Progression|0|||
129944311|NCT02499328|467760197|FG005|Overall Study|Disease Progression|0|||
129944312|NCT02499328|467760198|FG006|Overall Study|Disease Progression|1|||
129944313|NCT02499328|467760199|FG007|Overall Study|Disease Progression|0|||
129944314|NCT02499328|467760200|FG008|Overall Study|Disease Progression|1|||
129944315|NCT02499328|467760201|FG009|Overall Study|Disease Progression|0|||
129944316|NCT02499328|467760202|FG010|Overall Study|Disease Progression|1|||
129944317|NCT02499328|467760203|FG011|Overall Study|Disease Progression|0|||
129944318|NCT02499328|467760204|FG012|Overall Study|Disease Progression|0|||
129944319|NCT02499328|467760205|FG013|Overall Study|Disease Progression|0|||
129944320|NCT02499328|467760206|FG014|Overall Study|Disease Progression|0|||
129944321|NCT02499328|467760207|FG015|Overall Study|Disease Progression|0|||
129944322|NCT02499328|467760208|FG016|Overall Study|Disease Progression|0|||
129944323|NCT02499328|467760209|FG017|Overall Study|Disease Progression|2|||
129944324|NCT02499328|467760210|FG018|Overall Study|Disease Progression|0|||
129944325|NCT02499328|467760192|FG000|Overall Study|Adverse Event|1|||
129944326|NCT02499328|467760193|FG001|Overall Study|Adverse Event|0|||
129944327|NCT02499328|467760194|FG002|Overall Study|Adverse Event|0|||
129944328|NCT02499328|467760195|FG003|Overall Study|Adverse Event|1|||
129944329|NCT02499328|467760196|FG004|Overall Study|Adverse Event|0|||
129944330|NCT02499328|467760197|FG005|Overall Study|Adverse Event|0|||
129944331|NCT02499328|467760198|FG006|Overall Study|Adverse Event|0|||
129944332|NCT02499328|467760199|FG007|Overall Study|Adverse Event|0|||
129944333|NCT02499328|467760200|FG008|Overall Study|Adverse Event|0|||
129944334|NCT02499328|467760201|FG009|Overall Study|Adverse Event|0|||
129944335|NCT02499328|467760202|FG010|Overall Study|Adverse Event|0|||
129944336|NCT02499328|467760203|FG011|Overall Study|Adverse Event|0|||
129944337|NCT02499328|467760204|FG012|Overall Study|Adverse Event|1|||
129944338|NCT02499328|467760205|FG013|Overall Study|Adverse Event|0|||
129944339|NCT02499328|467760206|FG014|Overall Study|Adverse Event|0|||
129944340|NCT02499328|467760207|FG015|Overall Study|Adverse Event|0|||
129944341|NCT02499328|467760208|FG016|Overall Study|Adverse Event|0|||
129944342|NCT02499328|467760209|FG017|Overall Study|Adverse Event|0|||
129944343|NCT02499328|467760210|FG018|Overall Study|Adverse Event|0|||
129944344|NCT00145470|467760211|FG000|Overall Study|Adverse Event|19|||
129944345|NCT00145470|467760212|FG001|Overall Study|Adverse Event|25|||
129944346|NCT00145470|467760211|FG000|Overall Study|Lack of Efficacy|27|||
129944347|NCT00145470|467760212|FG001|Overall Study|Lack of Efficacy|13|||
129944348|NCT00145470|467760211|FG000|Overall Study|Withdrawal by Subject|36|||
129944349|NCT00145470|467760212|FG001|Overall Study|Withdrawal by Subject|34|||
129944350|NCT00145470|467760211|FG000|Overall Study|Lost to Follow-up|21|||
129944351|NCT00145470|467760212|FG001|Overall Study|Lost to Follow-up|17|||
129944352|NCT00145470|467760211|FG000|Overall Study|Reason Not Reported|9|||
129944353|NCT00145470|467760212|FG001|Overall Study|Reason Not Reported|9|||
129944354|NCT04602728|467760214|FG000|Overall Study|Lost to Follow-up|4|||
129944355|NCT04602728|467760215|FG001|Overall Study|Lost to Follow-up|4|||
129944356|NCT04447027|467760218|FG000|Dose Escalation|Withdrawal by Subject|1|||
129944357|NCT04447027|467760219|FG001|Dose Escalation|Withdrawal by Subject|4|||
129944358|NCT04447027|467760220|FG002|Dose Escalation|Withdrawal by Subject|3|||
129944359|NCT04447027|467760221|FG003|Dose Escalation|Withdrawal by Subject|3|||
129944360|NCT04447027|467760222|FG004|Dose Escalation|Withdrawal by Subject|1|||
129944361|NCT04447027|467760223|FG005|Dose Escalation|Withdrawal by Subject|0|||
129944362|NCT04447027|467760224|FG006|Dose Escalation|Withdrawal by Subject|0|||
129944363|NCT04447027|467760225|FG007|Dose Escalation|Withdrawal by Subject|0|||
129944364|NCT04447027|467760226|FG008|Dose Escalation|Withdrawal by Subject|0|||
129944365|NCT04447027|467760218|FG000|Dose Escalation|Refused further treatment|0|||
129944366|NCT04447027|467760219|FG001|Dose Escalation|Refused further treatment|1|||
129944367|NCT04447027|467760220|FG002|Dose Escalation|Refused further treatment|1|||
129944368|NCT04447027|467760221|FG003|Dose Escalation|Refused further treatment|0|||
129944369|NCT04447027|467760222|FG004|Dose Escalation|Refused further treatment|0|||
129944370|NCT04447027|467760223|FG005|Dose Escalation|Refused further treatment|0|||
129944371|NCT04447027|467760224|FG006|Dose Escalation|Refused further treatment|0|||
129944372|NCT04447027|467760225|FG007|Dose Escalation|Refused further treatment|0|||
129944373|NCT04447027|467760226|FG008|Dose Escalation|Refused further treatment|0|||
129944374|NCT04447027|467760218|FG000|Dose Expansion|Withdrawal by Subject|0|||
129944375|NCT04447027|467760219|FG001|Dose Expansion|Withdrawal by Subject|0|||
129944376|NCT04447027|467760220|FG002|Dose Expansion|Withdrawal by Subject|0|||
129944377|NCT04447027|467760221|FG003|Dose Expansion|Withdrawal by Subject|0|||
129944378|NCT04447027|467760222|FG004|Dose Expansion|Withdrawal by Subject|0|||
129944379|NCT04447027|467760223|FG005|Dose Expansion|Withdrawal by Subject|2|||
129944380|NCT04447027|467760224|FG006|Dose Expansion|Withdrawal by Subject|0|||
129944381|NCT04447027|467760225|FG007|Dose Expansion|Withdrawal by Subject|2|||
129944382|NCT04447027|467760226|FG008|Dose Expansion|Withdrawal by Subject|0|||
129944383|NCT02831049|467760227|FG000|Overall Study|Lost to Follow-up|0|||
129944384|NCT02831049|467760228|FG001|Overall Study|Lost to Follow-up|0|||
129944385|NCT02831049|467760229|FG002|Overall Study|Lost to Follow-up|1|||
129944386|NCT02831049|467760227|FG000|Overall Study|Withdrawal by Subject|0|||
129944387|NCT02831049|467760228|FG001|Overall Study|Withdrawal by Subject|1|||
129944388|NCT02831049|467760229|FG002|Overall Study|Withdrawal by Subject|1|||
129944389|NCT02831049|467760227|FG000|Overall Study|Pandemic shutdown|1|||
129944390|NCT02831049|467760228|FG001|Overall Study|Pandemic shutdown|0|||
129944391|NCT02831049|467760229|FG002|Overall Study|Pandemic shutdown|0|||
129944392|NCT02609048|467760230|FG000|Overall Study|Adverse Event|3|||
129944393|NCT02609048|467760231|FG001|Overall Study|Adverse Event|0|||
129944394|NCT02609048|467760232|FG002|Overall Study|Adverse Event|0|||
129944395|NCT02609048|467760230|FG000|Overall Study|Randomized but never treated|1|||
129944396|NCT02609048|467760231|FG001|Overall Study|Randomized but never treated|1|||
129944397|NCT02609048|467760232|FG002|Overall Study|Randomized but never treated|1|||
129944398|NCT02609048|467760230|FG000|Overall Study|Withdrawal of informed consent|1|||
129453410|NCT01838616|465958056|FG000|Titration Period|Protocol Violation|0|||
129453411|NCT01838616|465958057|FG001|Titration Period|Protocol Violation|1|||
129944399|NCT02609048|467760231|FG001|Overall Study|Withdrawal of informed consent|0|||
129944400|NCT02609048|467760232|FG002|Overall Study|Withdrawal of informed consent|0|||
129944401|NCT02609048|467760230|FG000|Overall Study|Reason not specified|6|||
129944402|NCT02609048|467760231|FG001|Overall Study|Reason not specified|9|||
129453412|NCT01838616|465958056|FG000|Continuation Period|Lack of Efficacy|3|||
129453413|NCT01838616|465958057|FG001|Continuation Period|Lack of Efficacy|5|||
129453414|NCT01838616|465958056|FG000|Continuation Period|Adverse Event|8|||
129453415|NCT01838616|465958057|FG001|Continuation Period|Adverse Event|4|||
129453416|NCT01838616|465958056|FG000|Continuation Period|Protocol Violation|2|||
129453417|NCT01838616|465958057|FG001|Continuation Period|Protocol Violation|0|||
129453418|NCT01838616|465958056|FG000|Continuation Period|Lost to Follow-up|1|||
129453419|NCT01838616|465958057|FG001|Continuation Period|Lost to Follow-up|0|||
129453420|NCT01838616|465958056|FG000|Continuation Period|Withdrawal by Subject|0|||
129453421|NCT01838616|465958057|FG001|Continuation Period|Withdrawal by Subject|4|||
129453422|NCT01838616|465958056|FG000|Continuation Period|Technical problems|0|||
129453423|NCT01838616|465958057|FG001|Continuation Period|Technical problems|1|||
129453424|NCT01838616|465958056|FG000|Pick-up Arm|Lack of Efficacy|4|||
129453425|NCT01838616|465958057|FG001|Pick-up Arm|Lack of Efficacy|0|||
129453426|NCT01838616|465958056|FG000|Pick-up Arm|Adverse Event|9|||
129944403|NCT02609048|467760232|FG002|Overall Study|Reason not specified|9|||
129944404|NCT02485925|467760233|FG000|Overall Study|Withdrawal by Subject|3|||
129944405|NCT02485925|467760233|FG000|Overall Study|Death|1|||
129944406|NCT02485925|467760233|FG000|Overall Study|Lost to Follow-up|11|||
129944407|NCT05995977|467760234|FG000|Overall Study|Withdrawal by Subject|1|||
129944408|NCT05995977|467760235|FG001|Overall Study|Withdrawal by Subject|4|||
129944409|NCT05995977|467760234|FG000|Overall Study|Lost to Follow-up|2|||
129944410|NCT05995977|467760235|FG001|Overall Study|Lost to Follow-up|0|||
129944411|NCT04181788|467760236|FG000|TREATMENT|Adverse Event|0|||
129944412|NCT04181788|467760237|FG001|TREATMENT|Adverse Event|2|||
129944413|NCT04181788|467760238|FG002|TREATMENT|Adverse Event|1|||
129944414|NCT04181788|467760239|FG003|TREATMENT|Adverse Event|0|||
129944415|NCT04181788|467760240|FG004|TREATMENT|Adverse Event|1|||
129944416|NCT04181788|467760241|FG005|TREATMENT|Adverse Event|3|||
129944417|NCT04181788|467760236|FG000|TREATMENT|Death|0|||
129944418|NCT04181788|467760237|FG001|TREATMENT|Death|0|||
129944419|NCT04181788|467760238|FG002|TREATMENT|Death|0|||
129944420|NCT04181788|467760239|FG003|TREATMENT|Death|0|||
129944421|NCT04181788|467760240|FG004|TREATMENT|Death|8|||
129944422|NCT04181788|467760241|FG005|TREATMENT|Death|8|||
129944423|NCT04181788|467760236|FG000|TREATMENT|Physician Decision|0|||
129944424|NCT04181788|467760237|FG001|TREATMENT|Physician Decision|0|||
129944425|NCT04181788|467760238|FG002|TREATMENT|Physician Decision|0|||
129944426|NCT04181788|467760239|FG003|TREATMENT|Physician Decision|0|||
129944427|NCT04181788|467760240|FG004|TREATMENT|Physician Decision|0|||
129944428|NCT04181788|467760241|FG005|TREATMENT|Physician Decision|1|||
129944429|NCT04181788|467760236|FG000|TREATMENT|Progressive disease|3|||
129453427|NCT01838616|465958057|FG001|Pick-up Arm|Adverse Event|0|||
129944430|NCT04181788|467760237|FG001|TREATMENT|Progressive disease|3|||
129944431|NCT04181788|467760238|FG002|TREATMENT|Progressive disease|5|||
129944432|NCT04181788|467760239|FG003|TREATMENT|Progressive disease|7|||
129944433|NCT04181788|467760240|FG004|TREATMENT|Progressive disease|20|||
129944434|NCT04181788|467760241|FG005|TREATMENT|Progressive disease|38|||
129944435|NCT04181788|467760236|FG000|TREATMENT|Global deterioration of health status|0|||
129944436|NCT04181788|467760237|FG001|TREATMENT|Global deterioration of health status|2|||
129453428|NCT01838616|465958056|FG000|Pick-up Arm|Withdrawal by Subject|1|||
129944437|NCT04181788|467760238|FG002|TREATMENT|Global deterioration of health status|0|||
129944438|NCT04181788|467760239|FG003|TREATMENT|Global deterioration of health status|0|||
129944439|NCT04181788|467760240|FG004|TREATMENT|Global deterioration of health status|2|||
129944440|NCT04181788|467760241|FG005|TREATMENT|Global deterioration of health status|8|||
129944441|NCT04181788|467760236|FG000|TREATMENT|Withdrawal by Subject|1|||
129944442|NCT04181788|467760237|FG001|TREATMENT|Withdrawal by Subject|2|||
129944443|NCT04181788|467760238|FG002|TREATMENT|Withdrawal by Subject|0|||
129944444|NCT04181788|467760239|FG003|TREATMENT|Withdrawal by Subject|0|||
129944445|NCT04181788|467760240|FG004|TREATMENT|Withdrawal by Subject|3|||
129944446|NCT04181788|467760241|FG005|TREATMENT|Withdrawal by Subject|5|||
129944447|NCT04181788|467760236|FG000|TREATMENT|Other unspecified|0|||
129944448|NCT04181788|467760237|FG001|TREATMENT|Other unspecified|0|||
129944449|NCT04181788|467760238|FG002|TREATMENT|Other unspecified|0|||
129944450|NCT04181788|467760239|FG003|TREATMENT|Other unspecified|0|||
129944451|NCT04181788|467760240|FG004|TREATMENT|Other unspecified|0|||
129944452|NCT04181788|467760241|FG005|TREATMENT|Other unspecified|2|||
129944453|NCT04181788|467760236|FG000|TREATMENT|Ongoing|0|||
129944454|NCT04181788|467760237|FG001|TREATMENT|Ongoing|3|||
129944455|NCT04181788|467760238|FG002|TREATMENT|Ongoing|0|||
129944456|NCT04181788|467760239|FG003|TREATMENT|Ongoing|5|||
129944457|NCT04181788|467760240|FG004|TREATMENT|Ongoing|7|||
129944458|NCT04181788|467760241|FG005|TREATMENT|Ongoing|15|||
129944459|NCT04181788|467760236|FG000|FOLLOW-UP|Death|0|||
129944460|NCT04181788|467760237|FG001|FOLLOW-UP|Death|0|||
129944461|NCT04181788|467760238|FG002|FOLLOW-UP|Death|1|||
129944462|NCT04181788|467760239|FG003|FOLLOW-UP|Death|2|||
129944463|NCT04181788|467760240|FG004|FOLLOW-UP|Death|8|||
129944464|NCT04181788|467760241|FG005|FOLLOW-UP|Death|20|||
129944465|NCT04181788|467760236|FG000|FOLLOW-UP|Lost to Follow-up|0|||
129944466|NCT04181788|467760237|FG001|FOLLOW-UP|Lost to Follow-up|0|||
129944467|NCT04181788|467760238|FG002|FOLLOW-UP|Lost to Follow-up|0|||
129944468|NCT04181788|467760239|FG003|FOLLOW-UP|Lost to Follow-up|0|||
129944469|NCT04181788|467760240|FG004|FOLLOW-UP|Lost to Follow-up|0|||
129944470|NCT04181788|467760241|FG005|FOLLOW-UP|Lost to Follow-up|2|||
129944471|NCT04181788|467760236|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
129944472|NCT04181788|467760237|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
129944473|NCT04181788|467760238|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
129944474|NCT04181788|467760239|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
129944475|NCT04181788|467760240|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
129944476|NCT04181788|467760241|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
129944477|NCT04181788|467760236|FG000|FOLLOW-UP|Other unspecified|0|||
129944478|NCT04181788|467760237|FG001|FOLLOW-UP|Other unspecified|1|||
129944479|NCT04181788|467760238|FG002|FOLLOW-UP|Other unspecified|0|||
129944480|NCT04181788|467760239|FG003|FOLLOW-UP|Other unspecified|0|||
129944481|NCT04181788|467760240|FG004|FOLLOW-UP|Other unspecified|0|||
129944482|NCT04181788|467760241|FG005|FOLLOW-UP|Other unspecified|3|||
129944483|NCT04181788|467760236|FG000|FOLLOW-UP|Ongoing|0|||
129944484|NCT04181788|467760237|FG001|FOLLOW-UP|Ongoing|0|||
129944485|NCT04181788|467760238|FG002|FOLLOW-UP|Ongoing|1|||
129944486|NCT04181788|467760239|FG003|FOLLOW-UP|Ongoing|3|||
129944487|NCT04181788|467760240|FG004|FOLLOW-UP|Ongoing|2|||
129944488|NCT04181788|467760241|FG005|FOLLOW-UP|Ongoing|2|||
129944489|NCT04937504|467760242|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
129944490|NCT04937504|467760243|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
129944491|NCT04937504|467760242|FG000|9 Months Assessment|Lost to Follow-up|3|||
129944492|NCT04937504|467760243|FG001|9 Months Assessment|Lost to Follow-up|2|||
129944493|NCT04186247|467760244|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
129944494|NCT04186247|467760245|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944495|NCT04186247|467760246|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944496|NCT04186247|467760247|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944497|NCT04186247|467760248|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
129944498|NCT03662659|467760249|FG000|Pre-treatment|Participant no longer met study criteria|1|||
129944499|NCT03662659|467760250|FG001|Pre-treatment|Participant no longer met study criteria|1|||
129944500|NCT03662659|467760249|FG000|Pre-treatment|Other reasons|1|||
129944501|NCT03662659|467760250|FG001|Pre-treatment|Other reasons|0|||
129944502|NCT03662659|467760249|FG000|Treatment|Completed Treatment|0|||
129944503|NCT03662659|467760250|FG001|Treatment|Completed Treatment|2|||
129944504|NCT03662659|467760249|FG000|Treatment|Disease Progression|85|||
129944505|NCT03662659|467760250|FG001|Treatment|Disease Progression|97|||
129944506|NCT03662659|467760249|FG000|Treatment|Study Drug Toxicity|19|||
129944507|NCT03662659|467760250|FG001|Treatment|Study Drug Toxicity|9|||
129944508|NCT03662659|467760249|FG000|Treatment|Death|11|||
129944509|NCT03662659|467760250|FG001|Treatment|Death|9|||
129944510|NCT03662659|467760249|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
129944511|NCT03662659|467760250|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
129944512|NCT03662659|467760249|FG000|Treatment|Withdrawal by Subject|1|||
129944513|NCT03662659|467760250|FG001|Treatment|Withdrawal by Subject|1|||
129944514|NCT03662659|467760249|FG000|Treatment|Poor/Non-compliance|1|||
129944515|NCT03662659|467760250|FG001|Treatment|Poor/Non-compliance|0|||
129944516|NCT03662659|467760249|FG000|Treatment|Participant no longer meets study criteria|1|||
129944517|NCT03662659|467760250|FG001|Treatment|Participant no longer meets study criteria|0|||
129944518|NCT03662659|467760249|FG000|Treatment|Other reasons|10|||
129944519|NCT03662659|467760250|FG001|Treatment|Other reasons|8|||
129944520|NCT03662659|467760249|FG000|Treatment|Administrative reasons by sponsor|1|||
129944521|NCT03662659|467760250|FG001|Treatment|Administrative reasons by sponsor|0|||
129944522|NCT03662659|467760249|FG000|Treatment|maximum clinical benefit|0|||
129944523|NCT03662659|467760250|FG001|Treatment|maximum clinical benefit|2|||
129944524|NCT04118894|467760252|FG000|Overall Study|Lost to Follow-up|21|||
129944525|NCT04118894|467760252|FG000|Overall Study|Withdrawal by Subject|10|||
129944526|NCT04118894|467760252|FG000|Overall Study|Adverse Event|4|||
129944527|NCT04323800|467761730|FG000|Overall Study|Withdrawal by Subject|4|||
129944528|NCT04323800|467761731|FG001|Overall Study|Withdrawal by Subject|4|||
129944529|NCT04323800|467761730|FG000|Overall Study|Incomplete transfusion|1|||
129944530|NCT04323800|467761731|FG001|Overall Study|Incomplete transfusion|0|||
129944531|NCT04323800|467761730|FG000|Overall Study|Other|0|||
129944532|NCT04323800|467761731|FG001|Overall Study|Other|1|||
129944533|NCT04323800|467761730|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
129944534|NCT04323800|467761731|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
129944535|NCT00489554|467761732|FG000|Overall Study|Adverse Event|2|||
129944536|NCT00489554|467761732|FG000|Overall Study|Withdrawal by Subject|1|||
129944537|NCT00489554|467761732|FG000|Overall Study|Lost to Follow-up|1|||
129944538|NCT06571695|467761733|FG000|Overall Study|Lost to Follow-up|1|||
129944539|NCT06571695|467761734|FG001|Overall Study|Lost to Follow-up|6|||
129944540|NCT01380145|467761735|FG000|Overall Study|Progressive disease|4|||
129944541|NCT02038049|467761740|FG000|Overall Study|Lost to Follow-up|1|||
129944542|NCT02038049|467761741|FG001|Overall Study|Lost to Follow-up|0|||
129944543|NCT02771366|467761742|FG000|Period 1|Withdrawal by Subject|0|||
129944544|NCT02771366|467761743|FG001|Period 1|Withdrawal by Subject|2|||
129944545|NCT02771366|467761742|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
129944546|NCT02771366|467761743|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
129944547|NCT01808534|467761744|FG000|Overall Study|Disease progression|3|||
129944548|NCT01808534|467761744|FG000|Overall Study|Physician Decision|1|||
129944549|NCT01823224|467761745|FG000|Overall Study|Lost to Follow-up|5|||
129944550|NCT01823224|467761746|FG001|Overall Study|Lost to Follow-up|6|||
129944551|NCT01823224|467761745|FG000|Overall Study|didn't qualify|1|||
129944552|NCT01823224|467761746|FG001|Overall Study|didn't qualify|2|||
129944553|NCT01823224|467761745|FG000|Overall Study|pharmacy error|0|||
129944554|NCT01823224|467761746|FG001|Overall Study|pharmacy error|1|||
129944555|NCT01823224|467761745|FG000|Overall Study|missed med dose|0|||
129944556|NCT01823224|467761746|FG001|Overall Study|missed med dose|1|||
129944557|NCT01823224|467761745|FG000|Overall Study|Withdrawal by Subject|0|||
129944558|NCT01823224|467761746|FG001|Overall Study|Withdrawal by Subject|1|||
129944559|NCT03737110|467761754|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
129944560|NCT03737110|467761755|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
129944561|NCT03737110|467761756|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
129944562|NCT03737110|467761757|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
129944563|NCT03737110|467761758|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
129944564|NCT03737110|467761759|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
129944565|NCT03737110|467761754|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
129944566|NCT03737110|467761755|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944567|NCT03737110|467761756|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944568|NCT03737110|467761757|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944569|NCT03737110|467761758|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944570|NCT03737110|467761759|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
129944571|NCT03737110|467761754|FG000|Run-in (RI) Period|Adverse Event|4|||
129944572|NCT03737110|467761755|FG001|Run-in (RI) Period|Adverse Event|0|||
129944573|NCT03737110|467761756|FG002|Run-in (RI) Period|Adverse Event|0|||
129944574|NCT03737110|467761757|FG003|Run-in (RI) Period|Adverse Event|0|||
129944575|NCT03737110|467761758|FG004|Run-in (RI) Period|Adverse Event|0|||
129944576|NCT03737110|467761759|FG005|Run-in (RI) Period|Adverse Event|0|||
129944577|NCT03737110|467761754|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944578|NCT03737110|467761755|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
129979764|NCT01204710|467889468|FG000|Randomization Treatment|Lost to Follow-up|1|||
129979765|NCT01204710|467889469|FG001|Randomization Treatment|Lost to Follow-up|0|||
129979766|NCT01204710|467889468|FG000|Randomization Treatment|Withdrawal by Subject|6|||
129979767|NCT01204710|467889469|FG001|Randomization Treatment|Withdrawal by Subject|5|||
129979768|NCT01204710|467889468|FG000|Randomization Treatment|Physician Decision|3|||
129979769|NCT01204710|467889469|FG001|Randomization Treatment|Physician Decision|2|||
129979770|NCT01204710|467889468|FG000|Randomization Treatment|Entry criteria not met|0|||
129979771|NCT01204710|467889469|FG001|Randomization Treatment|Entry criteria not met|1|||
129979772|NCT01204710|467889468|FG000|Randomization Treatment|Adverse Event|4|||
129979773|NCT01204710|467889469|FG001|Randomization Treatment|Adverse Event|2|||
129979774|NCT01204710|467889468|FG000|Randomization Treatment|Sponsor Decision|0|||
129979775|NCT01204710|467889469|FG001|Randomization Treatment|Sponsor Decision|1|||
129979776|NCT01204710|467889468|FG000|Randomization Treatment|Worsening of General condition|0|||
129944579|NCT03737110|467761756|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944580|NCT03737110|467761757|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944581|NCT03737110|467761758|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944582|NCT03737110|467761759|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
129944583|NCT03737110|467761754|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944584|NCT03737110|467761755|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944585|NCT03737110|467761756|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
129944586|NCT03737110|467761757|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944587|NCT03737110|467761758|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944588|NCT03737110|467761759|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
129944589|NCT03737110|467761754|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944590|NCT03737110|467761755|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944591|NCT03737110|467761756|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944592|NCT03737110|467761757|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
129944593|NCT03737110|467761758|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944594|NCT03737110|467761759|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129944595|NCT03737110|467761754|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944596|NCT03737110|467761755|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944597|NCT03737110|467761756|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944598|NCT03737110|467761757|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
129944599|NCT03737110|467761758|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
129944600|NCT03737110|467761759|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
129944601|NCT03737110|467761754|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944602|NCT03737110|467761755|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944603|NCT03737110|467761756|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944604|NCT03737110|467761757|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944605|NCT03737110|467761758|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
129944606|NCT03737110|467761759|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
129944607|NCT02575365|467761770|FG000|Overall Study|Lost to Follow-up|4|||
129944608|NCT00273052|467761781|FG000|Overall Study|Withdrawal by Subject|16|||
129944609|NCT00273052|467761782|FG001|Overall Study|Withdrawal by Subject|19|||
129944610|NCT00273052|467761781|FG000|Overall Study|Adverse Event|21|||
129944611|NCT00273052|467761782|FG001|Overall Study|Adverse Event|19|||
129944612|NCT00273052|467761781|FG000|Overall Study|Protocol Violation|14|||
129944613|NCT00273052|467761782|FG001|Overall Study|Protocol Violation|18|||
129944614|NCT00273052|467761781|FG000|Overall Study|Lost to Follow-up|7|||
129944615|NCT00273052|467761782|FG001|Overall Study|Lost to Follow-up|25|||
129944616|NCT00273052|467761781|FG000|Overall Study|Lack of Efficacy|6|||
129944617|NCT00273052|467761782|FG001|Overall Study|Lack of Efficacy|4|||
129944618|NCT00273052|467761781|FG000|Overall Study|Non-Compliance|3|||
129944619|NCT00273052|467761782|FG001|Overall Study|Non-Compliance|1|||
129944620|NCT00273052|467761781|FG000|Overall Study|Other|2|||
129944621|NCT00273052|467761782|FG001|Overall Study|Other|0|||
129944622|NCT00273052|467761781|FG000|Overall Study|Worsening serum lipid levels|0|||
129944623|NCT00273052|467761782|FG001|Overall Study|Worsening serum lipid levels|2|||
129944624|NCT01951703|467761785|FG000|First Intervention|Withdrawal by Subject|1|||
129944625|NCT01951703|467761786|FG001|First Intervention|Withdrawal by Subject|0|||
129944626|NCT01951703|467761785|FG000|First Intervention|Subject was not compliant|1|||
129944627|NCT01951703|467761786|FG001|First Intervention|Subject was not compliant|1|||
129944628|NCT01951703|467761785|FG000|First Intervention|Physician Decision|1|||
129944629|NCT01951703|467761786|FG001|First Intervention|Physician Decision|0|||
129944630|NCT01951703|467761785|FG000|Second Intervention|Protocol Violation|0|||
129944631|NCT01951703|467761786|FG001|Second Intervention|Protocol Violation|1|||
129944632|NCT01951703|467761785|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
129944633|NCT01951703|467761786|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
129944634|NCT01009645|467761787|FG000|Overall Study|Lost to Follow-up|2|||
129944635|NCT01009645|467761788|FG001|Overall Study|Lost to Follow-up|8|||
129944636|NCT01009645|467761789|FG002|Overall Study|Lost to Follow-up|4|||
129944637|NCT01009645|467761790|FG003|Overall Study|Lost to Follow-up|5|||
129944638|NCT02708498|467761791|FG000|Overall Study|Death|20|||
129944639|NCT02708498|467761792|FG001|Overall Study|Death|19|||
129944640|NCT02708498|467761793|FG002|Overall Study|Death|0|||
129944641|NCT02708498|467761794|FG003|Overall Study|Death|0|||
129944642|NCT02708498|467761795|FG004|Overall Study|Death|1|||
129944643|NCT02708498|467761796|FG005|Overall Study|Death|0|||
129944644|NCT02708498|467761797|FG006|Overall Study|Death|0|||
129944645|NCT02708498|467761798|FG007|Overall Study|Death|0|||
129944646|NCT02708498|467761791|FG000|Overall Study|Unknown reason, missing data|0|||
129944647|NCT02708498|467761792|FG001|Overall Study|Unknown reason, missing data|0|||
129944648|NCT02708498|467761793|FG002|Overall Study|Unknown reason, missing data|62|||
129944649|NCT02708498|467761794|FG003|Overall Study|Unknown reason, missing data|51|||
129944650|NCT02708498|467761795|FG004|Overall Study|Unknown reason, missing data|195|||
129944651|NCT02708498|467761796|FG005|Overall Study|Unknown reason, missing data|132|||
129944652|NCT02708498|467761797|FG006|Overall Study|Unknown reason, missing data|0|||
129944653|NCT02708498|467761798|FG007|Overall Study|Unknown reason, missing data|0|||
129944654|NCT03052517|467761799|FG000|Overall Study|Study Terminated By Sponsor|928|||
129944655|NCT03052517|467761800|FG001|Overall Study|Study Terminated By Sponsor|938|||
129944656|NCT03052517|467761801|FG002|Overall Study|Study Terminated By Sponsor|296|||
129944657|NCT03052517|467761799|FG000|Overall Study|Subject/Guardian Decision|50|||
129944658|NCT03052517|467761800|FG001|Overall Study|Subject/Guardian Decision|45|||
129944659|NCT03052517|467761801|FG002|Overall Study|Subject/Guardian Decision|22|||
129944660|NCT03052517|467761799|FG000|Overall Study|Lack of Efficacy|23|||
129944661|NCT03052517|467761800|FG001|Overall Study|Lack of Efficacy|14|||
129944662|NCT03052517|467761801|FG002|Overall Study|Lack of Efficacy|7|||
129944663|NCT03052517|467761799|FG000|Overall Study|Adverse Event|6|||
129944664|NCT03052517|467761800|FG001|Overall Study|Adverse Event|5|||
129944665|NCT03052517|467761801|FG002|Overall Study|Adverse Event|0|||
129944666|NCT03052517|467761799|FG000|Overall Study|Physician Decision|4|||
129944667|NCT03052517|467761800|FG001|Overall Study|Physician Decision|5|||
129944668|NCT03052517|467761801|FG002|Overall Study|Physician Decision|1|||
129944669|NCT03052517|467761799|FG000|Overall Study|Death|3|||
129944670|NCT03052517|467761800|FG001|Overall Study|Death|0|||
129944671|NCT03052517|467761801|FG002|Overall Study|Death|1|||
129944672|NCT03052517|467761799|FG000|Overall Study|Lost to Follow-up|2|||
129944673|NCT03052517|467761800|FG001|Overall Study|Lost to Follow-up|4|||
129944674|NCT03052517|467761801|FG002|Overall Study|Lost to Follow-up|0|||
129944675|NCT03052517|467761799|FG000|Overall Study|Pregnancy|1|||
129944676|NCT03052517|467761800|FG001|Overall Study|Pregnancy|0|||
129944677|NCT03052517|467761801|FG002|Overall Study|Pregnancy|1|||
129944678|NCT03052517|467761799|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
129944679|NCT03052517|467761800|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
129944680|NCT03052517|467761801|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
129944681|NCT03052517|467761799|FG000|Overall Study|Technical Problems|0|||
129944682|NCT03052517|467761800|FG001|Overall Study|Technical Problems|1|||
129944683|NCT03052517|467761801|FG002|Overall Study|Technical Problems|0|||
129944684|NCT04803734|467761802|FG000|Overall Study|Withdrawal by Subject|0|||
129944685|NCT04803734|467761803|FG001|Overall Study|Withdrawal by Subject|1|||
129944686|NCT04803734|467761802|FG000|Overall Study|Protocol Violation|0|||
129944687|NCT04803734|467761803|FG001|Overall Study|Protocol Violation|1|||
129944688|NCT01640288|467761804|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
129944689|NCT01640288|467761805|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
129944690|NCT01640288|467761804|FG000|Overall Study|Screen Failure|20|||
129944691|NCT01640288|467761805|FG001|Overall Study|Screen Failure|18|||
129944692|NCT01640288|467761804|FG000|Overall Study|Withdrawn by PI|5|||
129944693|NCT01640288|467761805|FG001|Overall Study|Withdrawn by PI|0|||
129944694|NCT01640288|467761804|FG000|Overall Study|Withdrawal by Subject|1|||
129944695|NCT01640288|467761805|FG001|Overall Study|Withdrawal by Subject|0|||
129944696|NCT00195819|467761808|FG000|Double-Blind|Withdrawal by Subject|1|||
129944697|NCT00195819|467761809|FG001|Double-Blind|Withdrawal by Subject|0|||
129944698|NCT00195819|467761808|FG000|Double-Blind|Moved|1|||
129944699|NCT00195819|467761809|FG001|Double-Blind|Moved|0|||
129944700|NCT00195819|467761808|FG000|Open-label|Adverse Event|0|||
129944701|NCT00195819|467761809|FG001|Open-label|Adverse Event|9|||
129944702|NCT00195819|467761808|FG000|Open-label|Lack of Efficacy|0|||
129944703|NCT00195819|467761809|FG001|Open-label|Lack of Efficacy|2|||
129944704|NCT00195819|467761808|FG000|Open-label|Pregnancy|0|||
129944705|NCT00195819|467761809|FG001|Open-label|Pregnancy|1|||
129944706|NCT00195819|467761808|FG000|Open-label|Protocol Violation|0|||
129944707|NCT00195819|467761809|FG001|Open-label|Protocol Violation|2|||
129944708|NCT00195819|467761808|FG000|Open-label|Moved|0|||
129944709|NCT00195819|467761809|FG001|Open-label|Moved|1|||
129944710|NCT00195819|467761808|FG000|Open-label|Withdrawal by Subject|0|||
129944711|NCT00195819|467761809|FG001|Open-label|Withdrawal by Subject|5|||
129944712|NCT03298087|467761810|FG000|Overall Study|Withdrawal by Subject|4|||
129944713|NCT03781375|467761815|FG000|Double-blind Phase|Adverse Event|0|||
129944714|NCT03781375|467761816|FG001|Double-blind Phase|Adverse Event|1|||
129944715|NCT03781375|467761815|FG000|Double-blind Phase|Lack of Response|6|||
129944716|NCT03781375|467761816|FG001|Double-blind Phase|Lack of Response|2|||
129944717|NCT03781375|467761815|FG000|Double-blind Phase|Other|1|||
129944718|NCT03781375|467761816|FG001|Double-blind Phase|Other|3|||
129944719|NCT03781375|467761815|FG000|Open-label Phase|Protocol Issues|0|||
129944720|NCT03781375|467761816|FG001|Open-label Phase|Protocol Issues|1|||
129944721|NCT03781375|467761815|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
129944722|NCT03781375|467761816|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
129944723|NCT03781375|467761815|FG000|Open-label Phase|Other|2|||
129944724|NCT03781375|467761816|FG001|Open-label Phase|Other|2|||
129944725|NCT03184987|467761820|FG000|Overall Study|Withdrawal by Subject|0|||
129944726|NCT03184987|467761821|FG001|Overall Study|Withdrawal by Subject|1|||
129944727|NCT03184987|467761822|FG002|Overall Study|Withdrawal by Subject|2|||
129944728|NCT03184987|467761820|FG000|Overall Study|Physician Decision|0|||
129944729|NCT03184987|467761821|FG001|Overall Study|Physician Decision|0|||
129944730|NCT03184987|467761822|FG002|Overall Study|Physician Decision|1|||
129944731|NCT03184987|467761820|FG000|Overall Study|Adverse Event|1|||
129944732|NCT03184987|467761821|FG001|Overall Study|Adverse Event|0|||
129944733|NCT03184987|467761822|FG002|Overall Study|Adverse Event|1|||
129944734|NCT02203799|467761823|FG000|Overall Study|Withdrawal by Subject|3|||
129944735|NCT00681109|467761824|FG000|Overall Study|Lost to Follow-up|2|||
129944736|NCT00681109|467761825|FG001|Overall Study|Lost to Follow-up|6|||
129944737|NCT00681109|467761826|FG002|Overall Study|Lost to Follow-up|0|||
129944738|NCT04660799|467761827|FG000|Overall Study|Progressive Disease|1|||
129944739|NCT04660799|467761828|FG001|Overall Study|Progressive Disease|1|||
129944740|NCT04660799|467761827|FG000|Overall Study|Death|2|||
129944741|NCT04660799|467761828|FG001|Overall Study|Death|1|||
129944742|NCT04660799|467761827|FG000|Overall Study|Adverse Event|2|||
129944743|NCT04660799|467761828|FG001|Overall Study|Adverse Event|1|||
129944744|NCT04660799|467761827|FG000|Overall Study|Withdrawal by Subject|2|||
129944745|NCT04660799|467761828|FG001|Overall Study|Withdrawal by Subject|5|||
129944746|NCT02106884|467761829|FG000|Overall Study|Change of diagnosis/exclusion|0|||
129944747|NCT02106884|467761830|FG001|Overall Study|Change of diagnosis/exclusion|1|||
129944748|NCT02161458|467761831|FG000|Overall Study|Withdrawal by Subject|0|||
129944749|NCT02161458|467761832|FG001|Overall Study|Withdrawal by Subject|4|||
129944750|NCT02161458|467761833|FG002|Overall Study|Withdrawal by Subject|4|||
129944751|NCT02161458|467761834|FG003|Overall Study|Withdrawal by Subject|0|||
129944752|NCT02161458|467761831|FG000|Overall Study|Lost to Follow-up|0|||
129944753|NCT02161458|467761832|FG001|Overall Study|Lost to Follow-up|2|||
129944754|NCT02161458|467761833|FG002|Overall Study|Lost to Follow-up|1|||
129944755|NCT02161458|467761834|FG003|Overall Study|Lost to Follow-up|0|||
129944756|NCT01560429|467761837|FG000|Overall Study|Protocol Violation|3|||
129944757|NCT01560429|467761838|FG001|Overall Study|Protocol Violation|6|||
129944758|NCT00391170|467761847|FG000|Overall Study|Withdrawal by Subject|1|||
129944759|NCT00391170|467761848|FG001|Overall Study|Withdrawal by Subject|0|||
129944760|NCT00391170|467761847|FG000|Overall Study|Adverse Event|3|||
129944761|NCT00391170|467761848|FG001|Overall Study|Adverse Event|2|||
129944762|NCT00391170|467761847|FG000|Overall Study|Physician Decision|2|||
129944763|NCT00391170|467761848|FG001|Overall Study|Physician Decision|2|||
129944764|NCT03035942|467761851|FG000|Overall Study|Adverse Event|8|||
129944765|NCT03035942|467761852|FG001|Overall Study|Adverse Event|4|||
129944766|NCT03035942|467761853|FG002|Overall Study|Adverse Event|5|||
129944767|NCT02091752|467761854|FG000|Overall Study|Study terminated by Sponsor|2|||
129944768|NCT02091752|467761854|FG000|Overall Study|Adverse Event|1|||
129944769|NCT04029090|467761855|FG000|Overall Study|Protocol Violation|1|||
129944770|NCT04029090|467761856|FG001|Overall Study|Protocol Violation|0|||
129944771|NCT04029090|467761857|FG002|Overall Study|Protocol Violation|0|||
129944772|NCT04029090|467761855|FG000|Overall Study|Withdrawal by Subject|0|||
129944773|NCT04029090|467761856|FG001|Overall Study|Withdrawal by Subject|1|||
129944774|NCT04029090|467761857|FG002|Overall Study|Withdrawal by Subject|0|||
129944775|NCT02157948|467761858|FG000|Overall Study|Withdrawal by Subject|4|||
129944776|NCT02157948|467761859|FG001|Overall Study|Withdrawal by Subject|5|||
129944777|NCT02157948|467761858|FG000|Overall Study|Lost to Follow-up|3|||
129944778|NCT02157948|467761859|FG001|Overall Study|Lost to Follow-up|2|||
129944779|NCT02157948|467761858|FG000|Overall Study|Protocol Specified Criteria|2|||
129944780|NCT02157948|467761859|FG001|Overall Study|Protocol Specified Criteria|1|||
129944781|NCT02157948|467761858|FG000|Overall Study|Decision by Sponsor|0|||
129944782|NCT02157948|467761859|FG001|Overall Study|Decision by Sponsor|1|||
129944783|NCT01604824|467761860|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944784|NCT01604824|467761861|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944785|NCT01604824|467761862|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944786|NCT01604824|467761863|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944787|NCT01604824|467761864|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
129944788|NCT01604824|467761865|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
129944789|NCT01604824|467761860|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944790|NCT01604824|467761861|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944791|NCT01604824|467761862|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944792|NCT01604824|467761863|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944793|NCT01604824|467761864|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
129944794|NCT01604824|467761865|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
129944795|NCT06269003|467761878|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
129944796|NCT06269003|467761879|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
129944797|NCT06269003|467761880|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
129944798|NCT06269003|467761881|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
129944799|NCT01567852|467762841|FG000|Overall Study|Withdrawal by Subject|3|||
129944800|NCT01567852|467762842|FG001|Overall Study|Withdrawal by Subject|6|||
129944801|NCT01567852|467762841|FG000|Overall Study|ECT discontinued|1|||
129944802|NCT01567852|467762842|FG001|Overall Study|ECT discontinued|1|||
129944803|NCT02713594|467762843|FG000|Overall Study|Withdrawal by Subject|32|||
129944804|NCT02713594|467762844|FG001|Overall Study|Withdrawal by Subject|22|||
129944805|NCT02713594|467762843|FG000|Overall Study|Lost to Follow-up|358|||
129944806|NCT02713594|467762844|FG001|Overall Study|Lost to Follow-up|374|||
129944807|NCT00670449|467762845|FG000|Overall Study|Adverse Event|6|||
129944808|NCT00670449|467762846|FG001|Overall Study|Adverse Event|2|||
129944809|NCT00670449|467762847|FG002|Overall Study|Adverse Event|8|||
129944810|NCT00670449|467762848|FG003|Overall Study|Adverse Event|5|||
129944811|NCT00670449|467762845|FG000|Overall Study|Protocol Deviation|1|||
129944812|NCT00670449|467762846|FG001|Overall Study|Protocol Deviation|2|||
129944813|NCT00670449|467762847|FG002|Overall Study|Protocol Deviation|0|||
129944814|NCT00670449|467762848|FG003|Overall Study|Protocol Deviation|1|||
129944815|NCT00670449|467762845|FG000|Overall Study|Administrative Problems|0|||
129944816|NCT00670449|467762846|FG001|Overall Study|Administrative Problems|2|||
129944817|NCT00670449|467762847|FG002|Overall Study|Administrative Problems|0|||
129944818|NCT00670449|467762848|FG003|Overall Study|Administrative Problems|1|||
129944819|NCT00670449|467762845|FG000|Overall Study|Subject Withdrew Consent|0|||
129944820|NCT00670449|467762846|FG001|Overall Study|Subject Withdrew Consent|2|||
129944821|NCT00670449|467762847|FG002|Overall Study|Subject Withdrew Consent|0|||
129944822|NCT00670449|467762848|FG003|Overall Study|Subject Withdrew Consent|1|||
129944823|NCT00670449|467762845|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
129944824|NCT00670449|467762846|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129944825|NCT00670449|467762847|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
129944826|NCT00670449|467762848|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
129944827|NCT00670449|467762845|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
129944828|NCT00670449|467762846|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
129944829|NCT00670449|467762847|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129944830|NCT00670449|467762848|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
129944831|NCT04809623|467762849|FG000|Overall Study|Study Terminated by Sponsor|1|||
129944832|NCT04809623|467762850|FG001|Overall Study|Study Terminated by Sponsor|0|||
129944833|NCT02660086|467762853|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
129944834|NCT02660086|467762854|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
129944835|NCT02660086|467762853|FG000|Overall Study- 12-month|Left full-time employment|12|||
129944836|NCT02660086|467762854|FG001|Overall Study- 12-month|Left full-time employment|20|||
129944837|NCT02660086|467762853|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
129944838|NCT02660086|467762854|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
129944839|NCT02660086|467762853|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
129944840|NCT02660086|467762854|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
129944841|NCT02660086|467762853|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
129944842|NCT02660086|467762854|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
129944843|NCT02660086|467762853|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
129944844|NCT02660086|467762854|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
129944845|NCT01214200|467762858|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
129944846|NCT01214200|467762858|FG000|Overall Study|Withdrawal by Subject|2|||
129944847|NCT00667017|467762859|FG000|Overall Study|Withdrawal by Subject|1|||
129944848|NCT02605174|467762863|FG000|Overall Study|Adverse Event|0|||
129944849|NCT02605174|467762864|FG001|Overall Study|Adverse Event|0|||
129944850|NCT02605174|467762865|FG002|Overall Study|Adverse Event|1|||
129944851|NCT02605174|467762866|FG003|Overall Study|Adverse Event|0|||
129944852|NCT02605174|467762867|FG004|Overall Study|Adverse Event|4|||
129944853|NCT02605174|467762868|FG005|Overall Study|Adverse Event|0|||
129944854|NCT02605174|467762869|FG006|Overall Study|Adverse Event|0|||
129944855|NCT02605174|467762863|FG000|Overall Study|Lost to Follow-up|20|||
129944856|NCT02605174|467762864|FG001|Overall Study|Lost to Follow-up|7|||
129944857|NCT02605174|467762865|FG002|Overall Study|Lost to Follow-up|27|||
129944858|NCT02605174|467762866|FG003|Overall Study|Lost to Follow-up|10|||
129944859|NCT02605174|467762867|FG004|Overall Study|Lost to Follow-up|20|||
129944860|NCT02605174|467762868|FG005|Overall Study|Lost to Follow-up|10|||
129944861|NCT02605174|467762869|FG006|Overall Study|Lost to Follow-up|29|||
129944862|NCT02605174|467762863|FG000|Overall Study|Protocol Violation|10|||
129944863|NCT02605174|467762864|FG001|Overall Study|Protocol Violation|4|||
129944864|NCT02605174|467762865|FG002|Overall Study|Protocol Violation|14|||
129944865|NCT02605174|467762866|FG003|Overall Study|Protocol Violation|6|||
129944866|NCT02605174|467762867|FG004|Overall Study|Protocol Violation|7|||
129944867|NCT02605174|467762868|FG005|Overall Study|Protocol Violation|7|||
129944868|NCT02605174|467762869|FG006|Overall Study|Protocol Violation|12|||
129944869|NCT02605174|467762863|FG000|Overall Study|Pregnancy|1|||
129944870|NCT02605174|467762864|FG001|Overall Study|Pregnancy|0|||
129944871|NCT02605174|467762865|FG002|Overall Study|Pregnancy|0|||
129944872|NCT02605174|467762866|FG003|Overall Study|Pregnancy|2|||
129944873|NCT02605174|467762867|FG004|Overall Study|Pregnancy|0|||
129944874|NCT02605174|467762868|FG005|Overall Study|Pregnancy|0|||
129944875|NCT02605174|467762869|FG006|Overall Study|Pregnancy|0|||
129944876|NCT02605174|467762863|FG000|Overall Study|Withdrawal by Subject|9|||
129944877|NCT02605174|467762864|FG001|Overall Study|Withdrawal by Subject|6|||
129944878|NCT02605174|467762865|FG002|Overall Study|Withdrawal by Subject|14|||
129944879|NCT02605174|467762866|FG003|Overall Study|Withdrawal by Subject|11|||
129944880|NCT02605174|467762867|FG004|Overall Study|Withdrawal by Subject|6|||
129944881|NCT02605174|467762868|FG005|Overall Study|Withdrawal by Subject|4|||
129944882|NCT02605174|467762869|FG006|Overall Study|Withdrawal by Subject|15|||
129944883|NCT02605174|467762863|FG000|Overall Study|Physician Decision|2|||
129944884|NCT02605174|467762864|FG001|Overall Study|Physician Decision|0|||
129944885|NCT02605174|467762865|FG002|Overall Study|Physician Decision|0|||
129944886|NCT02605174|467762866|FG003|Overall Study|Physician Decision|0|||
129944887|NCT02605174|467762867|FG004|Overall Study|Physician Decision|0|||
129944888|NCT02605174|467762868|FG005|Overall Study|Physician Decision|0|||
129944889|NCT02605174|467762869|FG006|Overall Study|Physician Decision|3|||
129944890|NCT02605174|467762863|FG000|Overall Study|Randomization Failure|22|||
129944891|NCT02605174|467762864|FG001|Overall Study|Randomization Failure|6|||
129944892|NCT02605174|467762865|FG002|Overall Study|Randomization Failure|20|||
129944893|NCT02605174|467762866|FG003|Overall Study|Randomization Failure|7|||
129944894|NCT02605174|467762867|FG004|Overall Study|Randomization Failure|16|||
129944895|NCT02605174|467762868|FG005|Overall Study|Randomization Failure|11|||
129944896|NCT02605174|467762869|FG006|Overall Study|Randomization Failure|30|||
129944897|NCT03041090|467762870|FG000|Overall Study|technical error|0|||
129944898|NCT03041090|467762871|FG001|Overall Study|technical error|3|||
129944899|NCT03292406|467762872|FG000|Overall Study|Progressive Disease|6|||
129944900|NCT03292406|467762873|FG001|Overall Study|Progressive Disease|3|||
129944901|NCT03292406|467762874|FG002|Overall Study|Progressive Disease|4|||
129944902|NCT03292406|467762872|FG000|Overall Study|Adverse Event|7|||
129944903|NCT03292406|467762873|FG001|Overall Study|Adverse Event|1|||
129944904|NCT03292406|467762874|FG002|Overall Study|Adverse Event|4|||
129944905|NCT03292406|467762872|FG000|Overall Study|Withdrawal by Subject|0|||
129944906|NCT03292406|467762873|FG001|Overall Study|Withdrawal by Subject|7|||
129944907|NCT03292406|467762874|FG002|Overall Study|Withdrawal by Subject|2|||
129944908|NCT03292406|467762872|FG000|Overall Study|Protocol Violation|0|||
129944909|NCT03292406|467762873|FG001|Overall Study|Protocol Violation|1|||
129944910|NCT03292406|467762874|FG002|Overall Study|Protocol Violation|1|||
129944911|NCT03292406|467762872|FG000|Overall Study|Other|0|||
129944912|NCT03292406|467762873|FG001|Overall Study|Other|1|||
129944913|NCT03292406|467762874|FG002|Overall Study|Other|2|||
129944914|NCT00047385|467762875|FG000|Overall Study|Death before any screening|2|||
129944915|NCT00047385|467762876|FG001|Overall Study|Death before any screening|5|||
129944916|NCT00047385|467762875|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
129944917|NCT00047385|467762876|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
129944918|NCT00047385|467762875|FG000|Overall Study|Eligible for screening but had no screen|260|||
129944919|NCT00047385|467762876|FG001|Overall Study|Eligible for screening but had no screen|492|||
129944920|NCT03490032|467762877|FG000|Overall Study|family issue (child custody)|1|||
129944921|NCT03490032|467762878|FG001|Overall Study|family issue (child custody)|0|||
129944922|NCT03490032|467762879|FG002|Overall Study|family issue (child custody)|0|||
129944923|NCT02224755|467762880|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
129944924|NCT02224755|467762881|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
129944925|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Death|103|||
129944926|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Death|98|||
129944927|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
129944928|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
129944929|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
129944930|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
129944931|NCT02224755|467762880|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
129944932|NCT02224755|467762881|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
129944933|NCT01852045|467762882|FG000|Overall Study|Adverse Event|1|||
129944934|NCT01852045|467762883|FG001|Overall Study|Adverse Event|0|||
129944935|NCT01852045|467762884|FG002|Overall Study|Adverse Event|0|||
129944936|NCT01852045|467762882|FG000|Overall Study|Lack of Efficacy|3|||
129944937|NCT01852045|467762883|FG001|Overall Study|Lack of Efficacy|0|||
129944938|NCT01852045|467762884|FG002|Overall Study|Lack of Efficacy|0|||
129944939|NCT01852045|467762882|FG000|Overall Study|Lost to Follow-up|0|||
129944940|NCT01852045|467762883|FG001|Overall Study|Lost to Follow-up|1|||
129944941|NCT01852045|467762884|FG002|Overall Study|Lost to Follow-up|1|||
129944942|NCT01852045|467762882|FG000|Overall Study|Withdrawal by Subject|1|||
129944943|NCT01852045|467762883|FG001|Overall Study|Withdrawal by Subject|0|||
129944944|NCT01852045|467762884|FG002|Overall Study|Withdrawal by Subject|1|||
129944945|NCT01852045|467762882|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129944946|NCT01852045|467762883|FG001|Overall Study|Other Miscellaneous Reasons|3|||
129944947|NCT01852045|467762884|FG002|Overall Study|Other Miscellaneous Reasons|2|||
129944948|NCT02736188|467762885|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
129944949|NCT02736188|467762885|FG000|Overall Study|Adverse Event|1|||
129944950|NCT02736188|467762885|FG000|Overall Study|Withdrawal by Subject|1|||
129944951|NCT02736188|467762885|FG000|Overall Study|Other|6|||
129944952|NCT02007070|467762887|FG000|Overall Study|Adverse Event|4|||
129944953|NCT02007070|467762887|FG000|Overall Study|Clinical Progression|4|||
129944954|NCT02007070|467762887|FG000|Overall Study|Death|1|||
129944955|NCT02007070|467762887|FG000|Overall Study|Protocol Violation|2|||
129944956|NCT02007070|467762887|FG000|Overall Study|Physician Decision|1|||
129944957|NCT02007070|467762887|FG000|Overall Study|Progressive Disease|21|||
129944958|NCT01629589|467762890|FG000|Overall Study|Protocol Violation|4|||
129944959|NCT01629589|467762891|FG001|Overall Study|Protocol Violation|2|||
129944960|NCT01629589|467762890|FG000|Overall Study|Lost to Follow-up|2|||
129944961|NCT01629589|467762891|FG001|Overall Study|Lost to Follow-up|1|||
129944962|NCT01629589|467762890|FG000|Overall Study|Withdrawal by Subject|2|||
129944963|NCT01629589|467762891|FG001|Overall Study|Withdrawal by Subject|3|||
129944964|NCT01629589|467762890|FG000|Overall Study|Did not receive study vaccine|0|||
129944965|NCT01629589|467762891|FG001|Overall Study|Did not receive study vaccine|1|||
129944966|NCT01303510|467762892|FG000|Overall Study|Lost to Follow-up|1|||
129944967|NCT01303510|467762893|FG001|Overall Study|Lost to Follow-up|0|||
129944968|NCT00822900|467762894|FG000|Overall Study|Withdrawal by Subject|14|||
129944969|NCT00822900|467762895|FG001|Overall Study|Withdrawal by Subject|14|||
129944970|NCT00822900|467762894|FG000|Overall Study|Lost to Follow-up|9|||
129944971|NCT00822900|467762895|FG001|Overall Study|Lost to Follow-up|9|||
129944972|NCT00822900|467762894|FG000|Overall Study|Death|83|||
129944973|NCT00822900|467762895|FG001|Overall Study|Death|69|||
129944974|NCT00822900|467762894|FG000|Overall Study|Became a ward of the state|2|||
129944975|NCT00822900|467762895|FG001|Overall Study|Became a ward of the state|1|||
129944976|NCT02095678|467762896|FG000|Overall Study|Withdrawal by Subject|0|||
129944977|NCT02095678|467762897|FG001|Overall Study|Withdrawal by Subject|1|||
129944978|NCT02095678|467762896|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
129944979|NCT02095678|467762897|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
129944980|NCT02095678|467762896|FG000|Overall Study|lesion impacted by previous treatment|1|||
129944981|NCT02095678|467762897|FG001|Overall Study|lesion impacted by previous treatment|1|||
129944982|NCT02095678|467762896|FG000|Overall Study|No Confirmed Diagnosis|0|||
129944983|NCT02095678|467762897|FG001|Overall Study|No Confirmed Diagnosis|3|||
129944984|NCT02095678|467762896|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
129944985|NCT02095678|467762897|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
129944986|NCT02095678|467762896|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
129944987|NCT02095678|467762897|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
129944988|NCT00701415|467762898|FG000|Overall Study|Adverse Event|0|||
129944989|NCT00701415|467762899|FG001|Overall Study|Adverse Event|1|||
129453429|NCT01838616|465958057|FG001|Pick-up Arm|Withdrawal by Subject|0|||
129944990|NCT00701415|467762898|FG000|Overall Study|Social/family issues and needle phobia|1|||
129944991|NCT00701415|467762899|FG001|Overall Study|Social/family issues and needle phobia|0|||
129944992|NCT02066636|467762900|FG000|Overall Study|Disease progression|51|||
129944993|NCT02066636|467762901|FG001|Overall Study|Disease progression|60|||
129944994|NCT02066636|467762902|FG002|Overall Study|Disease progression|700|||
129944995|NCT02066636|467762900|FG000|Overall Study|Study drug toxicity|13|||
129944996|NCT02066636|467762901|FG001|Overall Study|Study drug toxicity|2|||
129944997|NCT02066636|467762902|FG002|Overall Study|Study drug toxicity|58|||
129944998|NCT02066636|467762900|FG000|Overall Study|Death|4|||
129944999|NCT02066636|467762901|FG001|Overall Study|Death|2|||
129945000|NCT02066636|467762902|FG002|Overall Study|Death|158|||
129945001|NCT02066636|467762900|FG000|Overall Study|Adverse event unrelated to study drug|6|||
129945002|NCT02066636|467762901|FG001|Overall Study|Adverse event unrelated to study drug|4|||
129945003|NCT02066636|467762902|FG002|Overall Study|Adverse event unrelated to study drug|45|||
129945004|NCT02066636|467762900|FG000|Overall Study|Participant request to discontinue treatment|12|||
129945005|NCT02066636|467762901|FG001|Overall Study|Participant request to discontinue treatment|12|||
129945006|NCT02066636|467762902|FG002|Overall Study|Participant request to discontinue treatment|70|||
129945007|NCT02066636|467762900|FG000|Overall Study|Participant withdrew consent|10|||
129945008|NCT02066636|467762901|FG001|Overall Study|Participant withdrew consent|18|||
129945009|NCT02066636|467762902|FG002|Overall Study|Participant withdrew consent|61|||
129945010|NCT02066636|467762900|FG000|Overall Study|Lost to Follow-up|0|||
129945011|NCT02066636|467762901|FG001|Overall Study|Lost to Follow-up|2|||
129945012|NCT02066636|467762902|FG002|Overall Study|Lost to Follow-up|2|||
129945013|NCT02066636|467762900|FG000|Overall Study|Maximum clinical benefit|2|||
129945014|NCT02066636|467762901|FG001|Overall Study|Maximum clinical benefit|2|||
129945015|NCT02066636|467762902|FG002|Overall Study|Maximum clinical benefit|3|||
129945016|NCT02066636|467762900|FG000|Overall Study|Poor/non-compliance|2|||
129945017|NCT02066636|467762901|FG001|Overall Study|Poor/non-compliance|1|||
129945018|NCT02066636|467762902|FG002|Overall Study|Poor/non-compliance|1|||
129945019|NCT02066636|467762900|FG000|Overall Study|Participant no loner meets study criteria|3|||
129945020|NCT02066636|467762901|FG001|Overall Study|Participant no loner meets study criteria|2|||
129945021|NCT02066636|467762902|FG002|Overall Study|Participant no loner meets study criteria|28|||
129945022|NCT02066636|467762900|FG000|Overall Study|Administrative reasons by sponsor|8|||
129945023|NCT02066636|467762901|FG001|Overall Study|Administrative reasons by sponsor|5|||
129945024|NCT02066636|467762902|FG002|Overall Study|Administrative reasons by sponsor|0|||
129945025|NCT02066636|467762900|FG000|Overall Study|Other reasons|16|||
129945026|NCT02066636|467762901|FG001|Overall Study|Other reasons|15|||
129945027|NCT02066636|467762902|FG002|Overall Study|Other reasons|50|||
129945028|NCT00705159|467762906|FG000|Overall Study|Withdrawal by Subject|0|||
129945029|NCT00705159|467762907|FG001|Overall Study|Withdrawal by Subject|1|||
129945030|NCT00705159|467762908|FG002|Overall Study|Withdrawal by Subject|1|||
129945031|NCT00705159|467762909|FG003|Overall Study|Withdrawal by Subject|1|||
129945032|NCT00705159|467762906|FG000|Overall Study|Protocol Violation|0|||
129945033|NCT00705159|467762907|FG001|Overall Study|Protocol Violation|1|||
129945034|NCT00705159|467762908|FG002|Overall Study|Protocol Violation|0|||
129945035|NCT00705159|467762909|FG003|Overall Study|Protocol Violation|0|||
129945036|NCT00705159|467762906|FG000|Overall Study|Adverse Event|0|||
129945037|NCT00705159|467762907|FG001|Overall Study|Adverse Event|0|||
129945038|NCT00705159|467762908|FG002|Overall Study|Adverse Event|1|||
129945039|NCT00705159|467762909|FG003|Overall Study|Adverse Event|0|||
129945040|NCT00705159|467762906|FG000|Overall Study|Lost to Follow-up|0|||
129945041|NCT00705159|467762907|FG001|Overall Study|Lost to Follow-up|0|||
129945042|NCT00705159|467762908|FG002|Overall Study|Lost to Follow-up|3|||
129945043|NCT00705159|467762909|FG003|Overall Study|Lost to Follow-up|2|||
129453430|NCT01838616|465958056|FG000|Pick-up Arm|Technical problems|1|||
129453431|NCT01838616|465958057|FG001|Pick-up Arm|Technical problems|0|||
129453432|NCT01566773|465958058|FG000|Overall Study|Protocol specified criteria|4|||
129453433|NCT01566773|465958058|FG000|Overall Study|Protocol Violation|4|||
129453434|NCT01566773|465958058|FG000|Overall Study|Withdrawal by Subject|9|||
129945044|NCT00705159|467762906|FG000|Overall Study|Screen Failure|0|||
129945045|NCT00705159|467762907|FG001|Overall Study|Screen Failure|0|||
129945046|NCT00705159|467762908|FG002|Overall Study|Screen Failure|0|||
129945047|NCT00705159|467762909|FG003|Overall Study|Screen Failure|1|||
129945048|NCT03026166|467762910|FG000|Overall Study|Death|22|||
129945049|NCT03026166|467762911|FG001|Overall Study|Death|7|||
129945050|NCT03026166|467762910|FG000|Overall Study|Physician Decision|2|||
129945051|NCT03026166|467762911|FG001|Overall Study|Physician Decision|0|||
129453435|NCT01566773|465958058|FG000|Overall Study|Administrative reason|1|||
129945052|NCT03026166|467762910|FG000|Overall Study|Withdrawal by Subject|1|||
129945053|NCT03026166|467762911|FG001|Overall Study|Withdrawal by Subject|2|||
129945054|NCT03026166|467762910|FG000|Overall Study|Lost to Follow-up|1|||
129945055|NCT03026166|467762911|FG001|Overall Study|Lost to Follow-up|0|||
129945056|NCT03026166|467762910|FG000|Overall Study|Study Terminated by Sponsor|3|||
129945057|NCT03026166|467762911|FG001|Overall Study|Study Terminated by Sponsor|3|||
129945058|NCT03026166|467762910|FG000|Overall Study|Other|1|||
129945059|NCT03026166|467762911|FG001|Overall Study|Other|0|||
129945060|NCT01989104|467762914|FG000|Overall Study|Withdrawal by Subject|3|||
129945061|NCT01989104|467762915|FG001|Overall Study|Withdrawal by Subject|0|||
129945062|NCT01989104|467762916|FG002|Overall Study|Withdrawal by Subject|0|||
129945063|NCT01989104|467762917|FG003|Overall Study|Withdrawal by Subject|0|||
129945064|NCT01989104|467762918|FG004|Overall Study|Withdrawal by Subject|0|||
129945065|NCT02833948|467762921|FG000|Overall Study|Death|2|||
129945066|NCT02833948|467762922|FG001|Overall Study|Death|3|||
129945067|NCT02833948|467762921|FG000|Overall Study|were not scanned|8|||
129945068|NCT02833948|467762922|FG001|Overall Study|were not scanned|13|||
129945069|NCT02833948|467762921|FG000|Overall Study|scans could not be evaluated|5|||
129945070|NCT02833948|467762922|FG001|Overall Study|scans could not be evaluated|2|||
129945071|NCT03539055|467762926|FG000|Overall Study|Death|4|||
129945072|NCT03539055|467762926|FG000|Overall Study|Lost to Follow-up|1|||
129945073|NCT03539055|467762926|FG000|Overall Study|Withdrawal by Subject|2|||
129945074|NCT03539055|467762926|FG000|Overall Study|Screen Fail|7|||
129945075|NCT03539055|467762926|FG000|Overall Study|Drug Intolerance|2|||
129945076|NCT04821271|467762927|FG000|Period 1|Withdrawal by Subject|2|||
129945077|NCT04821271|467762928|FG001|Period 1|Withdrawal by Subject|0|||
129945078|NCT04076059|467762929|FG000|Double Blind Phase|Progressive disease|22|||
129945079|NCT04076059|467762930|FG001|Double Blind Phase|Progressive disease|26|||
129945080|NCT04076059|467762931|FG002|Double Blind Phase|Progressive disease|0|||
129945081|NCT04076059|467762929|FG000|Double Blind Phase|Withdrawal by Subject|4|||
129945082|NCT04076059|467762930|FG001|Double Blind Phase|Withdrawal by Subject|11|||
129945083|NCT04076059|467762931|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129945084|NCT04076059|467762929|FG000|Double Blind Phase|Death|1|||
129945085|NCT04076059|467762930|FG001|Double Blind Phase|Death|1|||
129945086|NCT04076059|467762931|FG002|Double Blind Phase|Death|0|||
129945087|NCT04076059|467762929|FG000|Double Blind Phase|Lost to Follow-up|1|||
129945088|NCT04076059|467762930|FG001|Double Blind Phase|Lost to Follow-up|0|||
129945089|NCT04076059|467762931|FG002|Double Blind Phase|Lost to Follow-up|0|||
129945090|NCT04076059|467762929|FG000|Double Blind Phase|Adverse Event|5|||
129945091|NCT04076059|467762930|FG001|Double Blind Phase|Adverse Event|1|||
129945092|NCT04076059|467762931|FG002|Double Blind Phase|Adverse Event|0|||
129945093|NCT04076059|467762929|FG000|Double Blind Phase|Ongoing Participants|82|||
129945094|NCT04076059|467762930|FG001|Double Blind Phase|Ongoing Participants|18|||
129945095|NCT04076059|467762931|FG002|Double Blind Phase|Ongoing Participants|0|||
129945096|NCT04076059|467762929|FG000|Double Blind Phase|Miscellaneous|3|||
129945097|NCT04076059|467762930|FG001|Double Blind Phase|Miscellaneous|1|||
129945098|NCT04076059|467762931|FG002|Double Blind Phase|Miscellaneous|0|||
129945099|NCT04076059|467762929|FG000|Double Blind Phase|Protocol Deviation|1|||
129945100|NCT04076059|467762930|FG001|Double Blind Phase|Protocol Deviation|1|||
129945101|NCT04076059|467762931|FG002|Double Blind Phase|Protocol Deviation|0|||
129945102|NCT04076059|467762929|FG000|Double Blind Phase|Did not take study drug|1|||
129945103|NCT04076059|467762930|FG001|Double Blind Phase|Did not take study drug|1|||
129945104|NCT04076059|467762931|FG002|Double Blind Phase|Did not take study drug|0|||
129945105|NCT04076059|467762929|FG000|Open Label Phase|Progressive disease|0|||
129945106|NCT04076059|467762930|FG001|Open Label Phase|Progressive disease|0|||
129945107|NCT04076059|467762931|FG002|Open Label Phase|Progressive disease|7|||
129945108|NCT04076059|467762929|FG000|Open Label Phase|Withdrawal by Subject|0|||
129945109|NCT04076059|467762930|FG001|Open Label Phase|Withdrawal by Subject|0|||
129945110|NCT04076059|467762931|FG002|Open Label Phase|Withdrawal by Subject|3|||
129945111|NCT04076059|467762929|FG000|Open Label Phase|Death|0|||
129945112|NCT04076059|467762930|FG001|Open Label Phase|Death|0|||
129945113|NCT04076059|467762931|FG002|Open Label Phase|Death|2|||
129945114|NCT04076059|467762929|FG000|Open Label Phase|Ongoing Participants|0|||
129945115|NCT04076059|467762930|FG001|Open Label Phase|Ongoing Participants|0|||
129945116|NCT04076059|467762931|FG002|Open Label Phase|Ongoing Participants|11|||
129945117|NCT04535414|467762939|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
129945118|NCT04535414|467762940|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
129945119|NCT04535414|467762939|FG000|Overall Study|Cancelled appointment|1|||
129945120|NCT04535414|467762940|FG001|Overall Study|Cancelled appointment|0|||
129945121|NCT04535414|467762939|FG000|Overall Study|cancelled - food in stomach|2|||
129945122|NCT04535414|467762940|FG001|Overall Study|cancelled - food in stomach|0|||
129945123|NCT04535414|467762939|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
129945124|NCT04535414|467762940|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
129945125|NCT04535414|467762939|FG000|Overall Study|Withdrawal by Subject|0|||
129945126|NCT04535414|467762940|FG001|Overall Study|Withdrawal by Subject|1|||
129945127|NCT00949117|467764077|FG000|Overall Study|Lack of Efficacy|2|||
129945128|NCT00949117|467764078|FG001|Overall Study|Lack of Efficacy|3|||
129945129|NCT00949117|467764077|FG000|Overall Study|Protocol Violation|1|||
129945130|NCT00949117|467764078|FG001|Overall Study|Protocol Violation|1|||
129945131|NCT00949117|467764077|FG000|Overall Study|Adverse Event|0|||
129945132|NCT00949117|467764078|FG001|Overall Study|Adverse Event|1|||
129945133|NCT00799409|467764079|FG000|Overall Study|Withdrawal by Subject|1|||
129945134|NCT00799409|467764080|FG001|Overall Study|Withdrawal by Subject|0|||
129945135|NCT00799409|467764081|FG002|Overall Study|Withdrawal by Subject|0|||
129945136|NCT00799409|467764079|FG000|Overall Study|Lost to Follow-up|1|||
129945137|NCT00799409|467764080|FG001|Overall Study|Lost to Follow-up|0|||
129945138|NCT00799409|467764081|FG002|Overall Study|Lost to Follow-up|0|||
129945139|NCT00799409|467764079|FG000|Overall Study|Optimal Dose Not Achieved|2|||
129945140|NCT00799409|467764080|FG001|Overall Study|Optimal Dose Not Achieved|0|||
129945141|NCT00799409|467764081|FG002|Overall Study|Optimal Dose Not Achieved|0|||
129945142|NCT00799409|467764079|FG000|Overall Study|Failure to follow study protocol)|1|||
129945143|NCT00799409|467764080|FG001|Overall Study|Failure to follow study protocol)|0|||
129945144|NCT00799409|467764081|FG002|Overall Study|Failure to follow study protocol)|0|||
129945145|NCT00799409|467764079|FG000|Overall Study|Did not attend lab school day 1|1|||
129945146|NCT00799409|467764080|FG001|Overall Study|Did not attend lab school day 1|0|||
129945147|NCT00799409|467764081|FG002|Overall Study|Did not attend lab school day 1|0|||
129945148|NCT00799409|467764079|FG000|Overall Study|medication compliance|1|||
129945149|NCT00799409|467764080|FG001|Overall Study|medication compliance|0|||
129945150|NCT00799409|467764081|FG002|Overall Study|medication compliance|0|||
129945151|NCT03964974|467764082|FG000|Overall Study|Lost to Follow-up|3|||
129945152|NCT03964974|467764083|FG001|Overall Study|Lost to Follow-up|2|||
129945153|NCT03964974|467764082|FG000|Overall Study|Withdrawal by Subject|0|||
129945154|NCT03964974|467764083|FG001|Overall Study|Withdrawal by Subject|3|||
129945155|NCT01719172|467764084|FG000|Overall Study|Lost to Follow-up|1|||
129945156|NCT01719172|467764084|FG000|Overall Study|Death|1|||
129945157|NCT00587171|467764085|FG000|Overall Study|Lost to Follow-up|1|||
129945158|NCT00587171|467764086|FG001|Overall Study|Lost to Follow-up|1|||
129945159|NCT01148017|467764087|FG000|Overall Study|Withdrawal by Subject|31|||
129945160|NCT01148017|467764088|FG001|Overall Study|Withdrawal by Subject|14|||
129945161|NCT01148017|467764089|FG002|Overall Study|Withdrawal by Subject|0|||
129945162|NCT01148017|467764090|FG003|Overall Study|Withdrawal by Subject|0|||
129945163|NCT01148017|467764087|FG000|Overall Study|Lost to Follow-up|23|||
129945164|NCT01148017|467764088|FG001|Overall Study|Lost to Follow-up|10|||
129945165|NCT01148017|467764089|FG002|Overall Study|Lost to Follow-up|0|||
129945166|NCT01148017|467764090|FG003|Overall Study|Lost to Follow-up|0|||
129945167|NCT01148017|467764087|FG000|Overall Study|Inappropriate enrollment|1|||
129945168|NCT01148017|467764088|FG001|Overall Study|Inappropriate enrollment|0|||
129945169|NCT01148017|467764089|FG002|Overall Study|Inappropriate enrollment|0|||
129945170|NCT01148017|467764090|FG003|Overall Study|Inappropriate enrollment|0|||
129945171|NCT01148017|467764087|FG000|Overall Study|Administrative reason|22|||
129945172|NCT01148017|467764088|FG001|Overall Study|Administrative reason|9|||
129945173|NCT01148017|467764089|FG002|Overall Study|Administrative reason|0|||
129945174|NCT01148017|467764090|FG003|Overall Study|Administrative reason|0|||
129945175|NCT01148017|467764087|FG000|Overall Study|Unable to classify|3|||
129945176|NCT01148017|467764088|FG001|Overall Study|Unable to classify|1|||
129945177|NCT01148017|467764089|FG002|Overall Study|Unable to classify|0|||
129945178|NCT01148017|467764090|FG003|Overall Study|Unable to classify|0|||
129945179|NCT01848483|467764091|FG000|Overall Study|Death|2|||
129945180|NCT01848483|467764092|FG001|Overall Study|Death|1|||
129945181|NCT01848483|467764091|FG000|Overall Study|Lost to Follow-up|6|||
129945182|NCT01848483|467764092|FG001|Overall Study|Lost to Follow-up|8|||
129945183|NCT01848483|467764091|FG000|Overall Study|Withdrawal by Subject|1|||
129945184|NCT01848483|467764092|FG001|Overall Study|Withdrawal by Subject|0|||
129945185|NCT01848483|467764091|FG000|Overall Study|Incarceration|2|||
129945186|NCT01848483|467764092|FG001|Overall Study|Incarceration|2|||
129945187|NCT04250636|467764095|FG000|Overall Study|Lost to Follow-up|2|||
129945188|NCT01779050|467764097|FG000|Overall Study|Withdrawal by Subject|1|||
129945189|NCT01779050|467764098|FG001|Overall Study|Withdrawal by Subject|0|||
129945190|NCT02202317|467764099|FG000|Overall Study|Lost to Follow-up|1|||
129945191|NCT01353274|467764100|FG000|Overall Study|No case report form (CRF) collected|28|||
129945192|NCT01409837|467764101|FG000|Overall Study|Withdrawal by Subject|2|||
129945193|NCT01409837|467764102|FG001|Overall Study|Withdrawal by Subject|1|||
129945194|NCT01409837|467764101|FG000|Overall Study|Lost to Follow-up|1|||
129945195|NCT01409837|467764102|FG001|Overall Study|Lost to Follow-up|0|||
129945196|NCT01409837|467764101|FG000|Overall Study|Physician Decision|0|||
129945197|NCT01409837|467764102|FG001|Overall Study|Physician Decision|1|||
129945198|NCT03960645|467764103|FG000|Overall Study|Protocol Violation|1|||
129945199|NCT03960645|467764104|FG001|Overall Study|Protocol Violation|0|||
129945200|NCT00022672|467764106|FG000|Main Phase: 24 Months|Adverse Event|6|||
129945201|NCT00022672|467764107|FG001|Main Phase: 24 Months|Adverse Event|0|||
129945202|NCT00022672|467764106|FG000|Main Phase: 24 Months|Death|0|||
129945203|NCT00022672|467764107|FG001|Main Phase: 24 Months|Death|3|||
129945204|NCT00022672|467764106|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
129945205|NCT00022672|467764107|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
129945206|NCT00022672|467764106|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
129945207|NCT00022672|467764107|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
129945208|NCT00022672|467764106|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
129945209|NCT00022672|467764107|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
129945210|NCT00022672|467764106|FG000|Main Phase: 24 Months|Refused Treatment|3|||
129945211|NCT00022672|467764107|FG001|Main Phase: 24 Months|Refused Treatment|4|||
129945212|NCT00022672|467764106|FG000|Main Phase: 24 Months|Failure to Return|1|||
129945213|NCT00022672|467764107|FG001|Main Phase: 24 Months|Failure to Return|1|||
129945214|NCT00022672|467764106|FG000|Main Phase: 24 Months|Other|1|||
129945215|NCT00022672|467764107|FG001|Main Phase: 24 Months|Other|0|||
129945216|NCT00022672|467764106|FG000|Extension Phase|Adverse Event|1|||
129945217|NCT00022672|467764107|FG001|Extension Phase|Adverse Event|3|||
129945218|NCT00022672|467764106|FG000|Extension Phase|Death|0|||
129945219|NCT00022672|467764107|FG001|Extension Phase|Death|1|||
129945220|NCT00022672|467764106|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
129945221|NCT00022672|467764107|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
129945222|NCT00022672|467764106|FG000|Extension Phase|Refused Treatment|0|||
129945223|NCT00022672|467764107|FG001|Extension Phase|Refused Treatment|2|||
129945224|NCT00022672|467764106|FG000|Extension Phase|Other|1|||
129945225|NCT00022672|467764107|FG001|Extension Phase|Other|1|||
129945226|NCT00403494|467764108|FG000|Overall Study|Adverse Event|10|||
129945227|NCT00403494|467764109|FG001|Overall Study|Adverse Event|8|||
129945228|NCT00403494|467764108|FG000|Overall Study|Withdrew Consent|3|||
129945229|NCT00403494|467764109|FG001|Overall Study|Withdrew Consent|2|||
129945230|NCT00403494|467764108|FG000|Overall Study|Inappropriately enrolled|0|||
129945231|NCT00403494|467764109|FG001|Overall Study|Inappropriately enrolled|1|||
129945232|NCT00403494|467764108|FG000|Overall Study|Lost to Follow-up|0|||
129945233|NCT00403494|467764109|FG001|Overall Study|Lost to Follow-up|2|||
129945234|NCT00403494|467764108|FG000|Overall Study|Protocol noncompliance|0|||
129945235|NCT00403494|467764109|FG001|Overall Study|Protocol noncompliance|1|||
129945236|NCT00403494|467764108|FG000|Overall Study|Death|1|||
129945237|NCT00403494|467764109|FG001|Overall Study|Death|0|||
129945238|NCT00403494|467764108|FG000|Overall Study|Sponsor Request|1|||
129945239|NCT00403494|467764109|FG001|Overall Study|Sponsor Request|0|||
129945240|NCT00703092|467764110|FG000|Overall Study|Withdrawal by Subject|2|||
129945241|NCT02309515|467764111|FG000|Overall Study|Withdrawal by Subject|0|||
129945242|NCT02309515|467764112|FG001|Overall Study|Withdrawal by Subject|1|||
129945243|NCT04070105|467764116|FG000|Overall Study|Lost to Follow-up|0|||
129945244|NCT04070105|467764117|FG001|Overall Study|Lost to Follow-up|0|||
129945245|NCT04070105|467764118|FG002|Overall Study|Lost to Follow-up|0|||
129945246|NCT04070105|467764119|FG003|Overall Study|Lost to Follow-up|0|||
129945247|NCT04070105|467764120|FG004|Overall Study|Lost to Follow-up|0|||
129945248|NCT04070105|467764121|FG005|Overall Study|Lost to Follow-up|1|||
129945249|NCT05260437|467764127|FG000|Overall Study|Lost to Follow-up|5|||
129945250|NCT05260437|467764128|FG001|Overall Study|Lost to Follow-up|2|||
129945251|NCT05260437|467764129|FG002|Overall Study|Lost to Follow-up|1|||
129945252|NCT05260437|467764130|FG003|Overall Study|Lost to Follow-up|2|||
129945253|NCT05260437|467764131|FG004|Overall Study|Lost to Follow-up|2|||
129945254|NCT05260437|467764127|FG000|Overall Study|Withdrawal by Subject|3|||
129945255|NCT05260437|467764128|FG001|Overall Study|Withdrawal by Subject|0|||
129945256|NCT05260437|467764129|FG002|Overall Study|Withdrawal by Subject|4|||
129945257|NCT05260437|467764130|FG003|Overall Study|Withdrawal by Subject|5|||
129945258|NCT05260437|467764131|FG004|Overall Study|Withdrawal by Subject|0|||
129945259|NCT05260437|467764127|FG000|Overall Study|Vaccine Not Administered|0|||
129945260|NCT05260437|467764128|FG001|Overall Study|Vaccine Not Administered|1|||
129945261|NCT05260437|467764129|FG002|Overall Study|Vaccine Not Administered|0|||
129945262|NCT05260437|467764130|FG003|Overall Study|Vaccine Not Administered|0|||
129945263|NCT05260437|467764131|FG004|Overall Study|Vaccine Not Administered|0|||
129945264|NCT00910962|467764132|FG000|Overall Study|Adverse Event|5|||
129945265|NCT00910962|467764133|FG001|Overall Study|Adverse Event|20|||
129945266|NCT00910962|467764134|FG002|Overall Study|Adverse Event|17|||
129945267|NCT00910962|467764132|FG000|Overall Study|Protocol Violation|1|||
129945268|NCT00910962|467764133|FG001|Overall Study|Protocol Violation|3|||
129945269|NCT00910962|467764134|FG002|Overall Study|Protocol Violation|3|||
129945270|NCT00910962|467764132|FG000|Overall Study|Lost to Follow-up|0|||
129945271|NCT00910962|467764133|FG001|Overall Study|Lost to Follow-up|3|||
129945272|NCT00910962|467764134|FG002|Overall Study|Lost to Follow-up|1|||
129945273|NCT00910962|467764132|FG000|Overall Study|Physician Decision|0|||
129945274|NCT00910962|467764133|FG001|Overall Study|Physician Decision|6|||
129945275|NCT00910962|467764134|FG002|Overall Study|Physician Decision|6|||
129945276|NCT00910962|467764132|FG000|Overall Study|Withdrawal by Subject|25|||
129945277|NCT00910962|467764133|FG001|Overall Study|Withdrawal by Subject|32|||
129945278|NCT00910962|467764134|FG002|Overall Study|Withdrawal by Subject|32|||
129945279|NCT00910962|467764132|FG000|Overall Study|Reached defined stopping criteria|12|||
129945280|NCT00910962|467764133|FG001|Overall Study|Reached defined stopping criteria|14|||
129945281|NCT00910962|467764134|FG002|Overall Study|Reached defined stopping criteria|17|||
129945282|NCT01858688|467764135|FG000|Overall Study|Withdrawal by Subject|8|||
129945283|NCT01858688|467764135|FG000|Overall Study|Participant began another therapy|3|||
129945284|NCT01858688|467764135|FG000|Overall Study|Physician Decision|2|||
129945285|NCT01858688|467764135|FG000|Overall Study|Progressive Disease|2|||
129945286|NCT01858688|467764135|FG000|Overall Study|Reason not reproted|5|||
129945287|NCT01999335|467764136|FG000|Overall Study|Discontinued before receiving treatment|0|||
129945288|NCT01999335|467764137|FG001|Overall Study|Discontinued before receiving treatment|0|||
129945289|NCT01999335|467764138|FG002|Overall Study|Discontinued before receiving treatment|0|||
129945290|NCT01999335|467764139|FG003|Overall Study|Discontinued before receiving treatment|0|||
129945291|NCT01999335|467764140|FG004|Overall Study|Discontinued before receiving treatment|2|||
129945292|NCT00787176|467764141|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
129945293|NCT00787176|467764142|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
129945294|NCT00787176|467764143|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
129945295|NCT00787176|467764144|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
129945296|NCT01220999|467764154|FG000|Overall Study|Progressive disease|0|||
129945297|NCT01220999|467764155|FG001|Overall Study|Progressive disease|0|||
129945298|NCT01220999|467764156|FG002|Overall Study|Progressive disease|1|||
129945299|NCT01220999|467764157|FG003|Overall Study|Progressive disease|0|||
129945300|NCT01220999|467764158|FG004|Overall Study|Progressive disease|0|||
129945301|NCT03861234|467764159|FG000|Overall Study|Not treated|0|||
129945302|NCT03861234|467764160|FG001|Overall Study|Not treated|0|||
129945303|NCT03861234|467764161|FG002|Overall Study|Not treated|0|||
129453436|NCT01566773|465958058|FG000|Overall Study|Adverse Event|10|||
129945304|NCT03861234|467764162|FG003|Overall Study|Not treated|0|||
129945305|NCT03861234|467764163|FG004|Overall Study|Not treated|0|||
129945306|NCT03861234|467764164|FG005|Overall Study|Not treated|1|||
129945307|NCT03861234|467764165|FG006|Overall Study|Not treated|0|||
129945308|NCT03861234|467764166|FG007|Overall Study|Not treated|0|||
129945309|NCT03861234|467764159|FG000|Overall Study|Adverse Event|0|||
129945310|NCT03861234|467764160|FG001|Overall Study|Adverse Event|0|||
129945311|NCT03861234|467764161|FG002|Overall Study|Adverse Event|0|||
129945312|NCT03861234|467764162|FG003|Overall Study|Adverse Event|0|||
129945313|NCT03861234|467764163|FG004|Overall Study|Adverse Event|0|||
129945314|NCT03861234|467764164|FG005|Overall Study|Adverse Event|1|||
129945315|NCT03861234|467764165|FG006|Overall Study|Adverse Event|0|||
129945316|NCT03861234|467764166|FG007|Overall Study|Adverse Event|0|||
129945317|NCT03861234|467764159|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
129945318|NCT03861234|467764160|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
129945319|NCT03861234|467764161|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
129945320|NCT03861234|467764162|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
129945321|NCT03861234|467764163|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
129945322|NCT03861234|467764164|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
129945323|NCT03861234|467764165|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
129945324|NCT03861234|467764166|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
129945325|NCT03861234|467764159|FG000|Overall Study|As per sponsor decision|0|||
129945326|NCT03861234|467764160|FG001|Overall Study|As per sponsor decision|0|||
129945327|NCT03861234|467764161|FG002|Overall Study|As per sponsor decision|0|||
129945328|NCT03861234|467764162|FG003|Overall Study|As per sponsor decision|0|||
129945329|NCT03861234|467764163|FG004|Overall Study|As per sponsor decision|0|||
129945330|NCT03861234|467764164|FG005|Overall Study|As per sponsor decision|0|||
129945331|NCT03861234|467764165|FG006|Overall Study|As per sponsor decision|1|||
129945332|NCT03861234|467764166|FG007|Overall Study|As per sponsor decision|0|||
129945333|NCT03861234|467764159|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
129945334|NCT03861234|467764160|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
129945335|NCT03861234|467764161|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
129945336|NCT03861234|467764162|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
129945337|NCT03861234|467764163|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
129945338|NCT03861234|467764164|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
129945339|NCT03861234|467764165|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
129945340|NCT03861234|467764166|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
129945341|NCT02852824|467764167|FG000|Overall Study|Withdrawal by Subject|1|||
129945342|NCT02852824|467764168|FG001|Overall Study|Withdrawal by Subject|0|||
129945343|NCT02852824|467764169|FG002|Overall Study|Withdrawal by Subject|0|||
129945344|NCT02852824|467764170|FG003|Overall Study|Withdrawal by Subject|0|||
129945345|NCT02852824|467764171|FG004|Overall Study|Withdrawal by Subject|0|||
129945346|NCT02852824|467764172|FG005|Overall Study|Withdrawal by Subject|0|||
129945347|NCT02852824|467764173|FG006|Overall Study|Withdrawal by Subject|0|||
129945348|NCT02852824|467764167|FG000|Overall Study|Adverse Event|0|||
129945349|NCT02852824|467764168|FG001|Overall Study|Adverse Event|0|||
129945350|NCT02852824|467764169|FG002|Overall Study|Adverse Event|0|||
129945351|NCT02852824|467764170|FG003|Overall Study|Adverse Event|0|||
129945352|NCT02852824|467764171|FG004|Overall Study|Adverse Event|2|||
129945353|NCT02852824|467764172|FG005|Overall Study|Adverse Event|0|||
129945354|NCT02852824|467764173|FG006|Overall Study|Adverse Event|0|||
129945355|NCT03775213|467764174|FG000|Overall Study|Withdrawal by Subject|51|||
129945356|NCT03775213|467764175|FG001|Overall Study|Withdrawal by Subject|53|||
129945357|NCT03775213|467764174|FG000|Overall Study|Incomplete Survey|7|||
129945358|NCT03775213|467764175|FG001|Overall Study|Incomplete Survey|7|||
129945359|NCT00786188|467764176|FG000|Overall Study|Adverse Event|3|||
129945360|NCT00786188|467764177|FG001|Overall Study|Adverse Event|1|||
129945361|NCT00786188|467764176|FG000|Overall Study|Withdrawal by Subject|2|||
129945362|NCT00786188|467764177|FG001|Overall Study|Withdrawal by Subject|0|||
129945363|NCT02521493|467764181|FG000|Overall Study|Death|3|||
129945364|NCT02521493|467764182|FG001|Overall Study|Death|4|||
129945365|NCT02521493|467764183|FG002|Overall Study|Death|1|||
129945366|NCT02521493|467764181|FG000|Overall Study|Physician Decision|19|||
129945367|NCT02521493|467764182|FG001|Overall Study|Physician Decision|1|||
129945368|NCT02521493|467764183|FG002|Overall Study|Physician Decision|2|||
129945369|NCT02521493|467764181|FG000|Overall Study|Withdrawal by Subject|3|||
129945370|NCT02521493|467764182|FG001|Overall Study|Withdrawal by Subject|0|||
129945371|NCT02521493|467764183|FG002|Overall Study|Withdrawal by Subject|0|||
129945372|NCT02521493|467764181|FG000|Overall Study|Ineligible|0|||
129945373|NCT02521493|467764182|FG001|Overall Study|Ineligible|1|||
129945374|NCT02521493|467764183|FG002|Overall Study|Ineligible|0|||
129945375|NCT02521493|467764181|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
129945376|NCT02521493|467764182|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
129945377|NCT02521493|467764183|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
129945378|NCT02521493|467764181|FG000|Overall Study|No MRD result|0|||
129945379|NCT02521493|467764182|FG001|Overall Study|No MRD result|0|||
129945380|NCT02521493|467764183|FG002|Overall Study|No MRD result|4|||
129945381|NCT01218594|467764184|FG000|Overall Study|Death|1|||
129945382|NCT01218594|467764184|FG000|Overall Study|Withdrawal by Subject|3|||
129945383|NCT01218594|467764184|FG000|Overall Study|Adverse Event|2|||
129945384|NCT01218594|467764184|FG000|Overall Study|Physician Decision|6|||
129945385|NCT04748341|467764185|FG000|Overall Study|Lost to Follow-up|1|||
129945386|NCT04748341|467764186|FG001|Overall Study|Lost to Follow-up|1|||
129945387|NCT00452114|467764188|FG000|Overall Study|Physician Decision|3|||
129945388|NCT00452114|467764189|FG001|Overall Study|Physician Decision|3|||
129945389|NCT02334215|467764190|FG000|Overall Study|Death|1|||
129945390|NCT02334215|467764191|FG001|Overall Study|Death|1|||
129945391|NCT02334215|467764192|FG002|Overall Study|Death|0|||
129945392|NCT02334215|467764190|FG000|Overall Study|Lost to Follow-up|1|||
129945393|NCT02334215|467764191|FG001|Overall Study|Lost to Follow-up|0|||
129945394|NCT02334215|467764192|FG002|Overall Study|Lost to Follow-up|4|||
129945395|NCT02334215|467764190|FG000|Overall Study|Withdrawal by Subject|2|||
129945396|NCT02334215|467764191|FG001|Overall Study|Withdrawal by Subject|2|||
129945397|NCT02334215|467764192|FG002|Overall Study|Withdrawal by Subject|1|||
129945398|NCT02334215|467764190|FG000|Overall Study|Not released from incarceration on time|3|||
129945399|NCT02334215|467764191|FG001|Overall Study|Not released from incarceration on time|3|||
129945400|NCT02334215|467764192|FG002|Overall Study|Not released from incarceration on time|3|||
129945401|NCT02334215|467764190|FG000|Overall Study|Incarcerated|0|||
129945402|NCT02334215|467764191|FG001|Overall Study|Incarcerated|0|||
129945403|NCT02334215|467764192|FG002|Overall Study|Incarcerated|7|||
129945404|NCT03905642|467764193|FG000|Overall Study|Withdrawal by Subject|3|||
129945405|NCT03905642|467764193|FG000|Overall Study|Pregnancy|1|||
129945406|NCT03905642|467764193|FG000|Overall Study|Adverse Event|1|||
129945407|NCT03905642|467764193|FG000|Overall Study|Lack of Efficacy|1|||
129945408|NCT03905642|467764193|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
129945409|NCT03769090|467766298|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
129945410|NCT03769090|467766299|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
129945411|NCT03769090|467766300|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
129945412|NCT03769090|467766298|FG000|Overall Study|Withdrawal by Subject|52|||
129945413|NCT03769090|467766299|FG001|Overall Study|Withdrawal by Subject|62|||
129945414|NCT03769090|467766300|FG002|Overall Study|Withdrawal by Subject|74|||
129945415|NCT03769090|467766298|FG000|Overall Study|Death|4|||
129945416|NCT03769090|467766299|FG001|Overall Study|Death|2|||
129945417|NCT03769090|467766300|FG002|Overall Study|Death|2|||
129945418|NCT03769090|467766298|FG000|Overall Study|Adverse Event|7|||
129945419|NCT03769090|467766299|FG001|Overall Study|Adverse Event|7|||
129945420|NCT03769090|467766300|FG002|Overall Study|Adverse Event|8|||
129945421|NCT03769090|467766298|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
129945422|NCT03769090|467766299|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
129945423|NCT03769090|467766300|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
129945424|NCT03769090|467766298|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
129945425|NCT03769090|467766299|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
129945426|NCT03769090|467766300|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
129945427|NCT03769090|467766298|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
129945428|NCT03769090|467766299|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
129945429|NCT03769090|467766300|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
129945430|NCT03769090|467766298|FG000|Overall Study|Protocol Violation|5|||
129945431|NCT03769090|467766299|FG001|Overall Study|Protocol Violation|6|||
129945432|NCT03769090|467766300|FG002|Overall Study|Protocol Violation|8|||
129945433|NCT03769090|467766298|FG000|Overall Study|Pregnancy|1|||
129945434|NCT03769090|467766299|FG001|Overall Study|Pregnancy|0|||
129945435|NCT03769090|467766300|FG002|Overall Study|Pregnancy|3|||
129945436|NCT03769090|467766298|FG000|Overall Study|Lost to Follow-up|19|||
129945437|NCT03769090|467766299|FG001|Overall Study|Lost to Follow-up|25|||
129945438|NCT03769090|467766300|FG002|Overall Study|Lost to Follow-up|21|||
129945439|NCT03769090|467766298|FG000|Overall Study|Condition under investigation worsened|2|||
129945440|NCT03769090|467766299|FG001|Overall Study|Condition under investigation worsened|0|||
129945441|NCT03769090|467766300|FG002|Overall Study|Condition under investigation worsened|1|||
129945442|NCT03769090|467766298|FG000|Overall Study|Lack of Efficacy|1|||
129945443|NCT03769090|467766299|FG001|Overall Study|Lack of Efficacy|2|||
129945444|NCT03769090|467766300|FG002|Overall Study|Lack of Efficacy|2|||
129945445|NCT03769090|467766298|FG000|Overall Study|Other reasons|8|||
129945446|NCT03769090|467766299|FG001|Overall Study|Other reasons|12|||
129945447|NCT03769090|467766300|FG002|Overall Study|Other reasons|15|||
129945448|NCT02014402|467766304|FG000|Overall Study|Adverse Event|1|||
129945449|NCT02014402|467766305|FG001|Overall Study|Adverse Event|0|||
129945450|NCT02014402|467766306|FG002|Overall Study|Adverse Event|0|||
129945451|NCT02014402|467766307|FG003|Overall Study|Adverse Event|0|||
129945452|NCT02014402|467766304|FG000|Overall Study|Withdrawal by Subject|1|||
129945453|NCT02014402|467766305|FG001|Overall Study|Withdrawal by Subject|2|||
129945454|NCT02014402|467766306|FG002|Overall Study|Withdrawal by Subject|2|||
129945455|NCT02014402|467766307|FG003|Overall Study|Withdrawal by Subject|1|||
129945456|NCT02014402|467766304|FG000|Overall Study|Subject did not have transportation|0|||
129945457|NCT02014402|467766305|FG001|Overall Study|Subject did not have transportation|1|||
129945458|NCT02014402|467766306|FG002|Overall Study|Subject did not have transportation|0|||
129945459|NCT02014402|467766307|FG003|Overall Study|Subject did not have transportation|0|||
129945460|NCT02014402|467766304|FG000|Overall Study|Lost to Follow-up|0|||
129945461|NCT02014402|467766305|FG001|Overall Study|Lost to Follow-up|0|||
129945462|NCT02014402|467766306|FG002|Overall Study|Lost to Follow-up|1|||
129945463|NCT02014402|467766307|FG003|Overall Study|Lost to Follow-up|2|||
129945464|NCT00443820|467766308|FG000|Overall Study|Adverse Event|1|||
129945465|NCT00443820|467766309|FG001|Overall Study|Adverse Event|1|||
129945466|NCT00443820|467766310|FG002|Overall Study|Adverse Event|0|||
129945467|NCT00443820|467766311|FG003|Overall Study|Adverse Event|0|||
129945468|NCT00443820|467766308|FG000|Overall Study|Lack of Efficacy|3|||
129945469|NCT00443820|467766309|FG001|Overall Study|Lack of Efficacy|2|||
129945470|NCT00443820|467766310|FG002|Overall Study|Lack of Efficacy|1|||
129945471|NCT00443820|467766311|FG003|Overall Study|Lack of Efficacy|1|||
129945472|NCT00443820|467766308|FG000|Overall Study|Protocol Violation|2|||
129945473|NCT00443820|467766309|FG001|Overall Study|Protocol Violation|1|||
129945474|NCT00443820|467766310|FG002|Overall Study|Protocol Violation|2|||
129945475|NCT00443820|467766311|FG003|Overall Study|Protocol Violation|1|||
129945476|NCT00443820|467766308|FG000|Overall Study|Withdrawal by Subject|6|||
129945477|NCT00443820|467766309|FG001|Overall Study|Withdrawal by Subject|7|||
129945478|NCT00443820|467766310|FG002|Overall Study|Withdrawal by Subject|8|||
129945479|NCT00443820|467766311|FG003|Overall Study|Withdrawal by Subject|9|||
129945480|NCT00443820|467766308|FG000|Overall Study|Lost to Follow-up|9|||
129945481|NCT00443820|467766309|FG001|Overall Study|Lost to Follow-up|8|||
129945482|NCT00443820|467766310|FG002|Overall Study|Lost to Follow-up|6|||
129945483|NCT00443820|467766311|FG003|Overall Study|Lost to Follow-up|5|||
129945484|NCT00443820|467766308|FG000|Overall Study|Administrative problems|0|||
129945485|NCT00443820|467766309|FG001|Overall Study|Administrative problems|0|||
129945486|NCT00443820|467766310|FG002|Overall Study|Administrative problems|0|||
129945487|NCT00443820|467766311|FG003|Overall Study|Administrative problems|1|||
129945488|NCT00443820|467766308|FG000|Overall Study|Death|0|||
129945489|NCT00443820|467766309|FG001|Overall Study|Death|0|||
129945490|NCT00443820|467766310|FG002|Overall Study|Death|1|||
129945491|NCT00443820|467766311|FG003|Overall Study|Death|0|||
129945492|NCT04633200|467766312|FG000|Overall Study|Lost to Follow-up|3|||
129945493|NCT04633200|467766313|FG001|Overall Study|Lost to Follow-up|5|||
129945494|NCT03493282|467766314|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
129945495|NCT03493282|467766315|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
129945496|NCT03493282|467766316|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
129945497|NCT03493282|467766314|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
129945498|NCT03493282|467766315|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
129945499|NCT03493282|467766316|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
129945500|NCT01523392|467766317|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129945501|NCT01523392|467766318|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129945502|NCT01523392|467766317|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
129945503|NCT01523392|467766318|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
129945504|NCT01523392|467766317|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
129945505|NCT01523392|467766318|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
129945506|NCT00671853|467766320|FG000|Overall Study|Lack of Efficacy|3|||
129945507|NCT00671853|467766321|FG001|Overall Study|Lack of Efficacy|7|||
129945508|NCT00671853|467766320|FG000|Overall Study|Adverse Event|7|||
129945509|NCT00671853|467766321|FG001|Overall Study|Adverse Event|1|||
129945510|NCT00671853|467766320|FG000|Overall Study|Withdrawal by Subject|1|||
129945511|NCT00671853|467766321|FG001|Overall Study|Withdrawal by Subject|5|||
129945512|NCT00671853|467766320|FG000|Overall Study|Lost to Follow-up|8|||
129945513|NCT00671853|467766321|FG001|Overall Study|Lost to Follow-up|8|||
129945514|NCT00671853|467766320|FG000|Overall Study|Physician Decision|0|||
129945515|NCT00671853|467766321|FG001|Overall Study|Physician Decision|2|||
129945516|NCT00671853|467766320|FG000|Overall Study|Non-adherence with study procedures|1|||
129945517|NCT00671853|467766321|FG001|Overall Study|Non-adherence with study procedures|4|||
129945518|NCT01332266|467766323|FG000|Phase 1b|Death|3|||
129945519|NCT01332266|467766324|FG001|Phase 1b|Death|3|||
129945520|NCT01332266|467766325|FG002|Phase 1b|Death|2|||
129945521|NCT01332266|467766326|FG003|Phase 1b|Death|0|||
129945522|NCT01332266|467766327|FG004|Phase 1b|Death|0|||
129945523|NCT01332266|467766323|FG000|Phase 1b|Lost to Follow-up|0|||
129945524|NCT01332266|467766324|FG001|Phase 1b|Lost to Follow-up|1|||
129945525|NCT01332266|467766325|FG002|Phase 1b|Lost to Follow-up|0|||
129945526|NCT01332266|467766326|FG003|Phase 1b|Lost to Follow-up|0|||
129945527|NCT01332266|467766327|FG004|Phase 1b|Lost to Follow-up|0|||
129945528|NCT01332266|467766323|FG000|Phase 1b|Withdrawal by Subject|1|||
129945529|NCT01332266|467766324|FG001|Phase 1b|Withdrawal by Subject|1|||
129945530|NCT01332266|467766325|FG002|Phase 1b|Withdrawal by Subject|1|||
129945531|NCT01332266|467766326|FG003|Phase 1b|Withdrawal by Subject|0|||
129945532|NCT01332266|467766327|FG004|Phase 1b|Withdrawal by Subject|0|||
129945533|NCT01332266|467766323|FG000|Phase 2|Death|0|||
129945534|NCT01332266|467766324|FG001|Phase 2|Death|0|||
129945535|NCT01332266|467766325|FG002|Phase 2|Death|0|||
129945536|NCT01332266|467766326|FG003|Phase 2|Death|33|||
129945537|NCT01332266|467766327|FG004|Phase 2|Death|36|||
129945538|NCT01332266|467766323|FG000|Phase 2|Lost to Follow-up|0|||
129945539|NCT01332266|467766324|FG001|Phase 2|Lost to Follow-up|0|||
129945540|NCT01332266|467766325|FG002|Phase 2|Lost to Follow-up|0|||
129945541|NCT01332266|467766326|FG003|Phase 2|Lost to Follow-up|2|||
129945542|NCT01332266|467766327|FG004|Phase 2|Lost to Follow-up|0|||
129945543|NCT01332266|467766323|FG000|Phase 2|Physician Decision|0|||
129945544|NCT01332266|467766324|FG001|Phase 2|Physician Decision|0|||
129945545|NCT01332266|467766325|FG002|Phase 2|Physician Decision|0|||
129945546|NCT01332266|467766326|FG003|Phase 2|Physician Decision|3|||
129945547|NCT01332266|467766327|FG004|Phase 2|Physician Decision|1|||
129945548|NCT01332266|467766323|FG000|Phase 2|Symptomatic deterioration|0|||
129945549|NCT01332266|467766324|FG001|Phase 2|Symptomatic deterioration|0|||
129945550|NCT01332266|467766325|FG002|Phase 2|Symptomatic deterioration|0|||
129945551|NCT01332266|467766326|FG003|Phase 2|Symptomatic deterioration|0|||
129945552|NCT01332266|467766327|FG004|Phase 2|Symptomatic deterioration|1|||
129945553|NCT01332266|467766323|FG000|Phase 2|Progression Disease|0|||
129945554|NCT01332266|467766324|FG001|Phase 2|Progression Disease|0|||
129945555|NCT01332266|467766325|FG002|Phase 2|Progression Disease|0|||
129945556|NCT01332266|467766326|FG003|Phase 2|Progression Disease|2|||
129945557|NCT01332266|467766327|FG004|Phase 2|Progression Disease|1|||
129945558|NCT01332266|467766323|FG000|Phase 2|Withdrawal by Subject|0|||
129945559|NCT01332266|467766324|FG001|Phase 2|Withdrawal by Subject|0|||
129945560|NCT01332266|467766325|FG002|Phase 2|Withdrawal by Subject|0|||
129945561|NCT01332266|467766326|FG003|Phase 2|Withdrawal by Subject|2|||
129945562|NCT01332266|467766327|FG004|Phase 2|Withdrawal by Subject|2|||
129945563|NCT02128269|467766334|FG000|Treatment Period|Adverse Event|1|||
129945564|NCT02128269|467766334|FG000|Treatment Period|Physician Decision|1|||
129945565|NCT00878189|467766335|FG000|Overall Study|Death|0|||
129945566|NCT00878189|467766336|FG001|Overall Study|Death|1|||
129945567|NCT00878189|467766337|FG002|Overall Study|Death|0|||
129945568|NCT00878189|467766338|FG003|Overall Study|Death|1|||
129945569|NCT00878189|467766339|FG004|Overall Study|Death|0|||
129945570|NCT00878189|467766340|FG005|Overall Study|Death|0|||
129945571|NCT00878189|467766341|FG006|Overall Study|Death|0|||
129945572|NCT00878189|467766342|FG007|Overall Study|Death|0|||
129945573|NCT00878189|467766343|FG008|Overall Study|Death|1|||
129945574|NCT00878189|467766335|FG000|Overall Study|Participant Refused to Follow-up|0|||
129945575|NCT00878189|467766336|FG001|Overall Study|Participant Refused to Follow-up|0|||
129945576|NCT00878189|467766337|FG002|Overall Study|Participant Refused to Follow-up|0|||
129945577|NCT00878189|467766338|FG003|Overall Study|Participant Refused to Follow-up|0|||
129945578|NCT00878189|467766339|FG004|Overall Study|Participant Refused to Follow-up|0|||
129945579|NCT00878189|467766340|FG005|Overall Study|Participant Refused to Follow-up|4|||
129945580|NCT00878189|467766341|FG006|Overall Study|Participant Refused to Follow-up|0|||
129945581|NCT00878189|467766342|FG007|Overall Study|Participant Refused to Follow-up|0|||
129945582|NCT00878189|467766343|FG008|Overall Study|Participant Refused to Follow-up|0|||
129945583|NCT00878189|467766335|FG000|Overall Study|Other|3|||
129945584|NCT00878189|467766336|FG001|Overall Study|Other|2|||
129945585|NCT00878189|467766337|FG002|Overall Study|Other|4|||
129945586|NCT00878189|467766338|FG003|Overall Study|Other|7|||
129945587|NCT00878189|467766339|FG004|Overall Study|Other|4|||
129945588|NCT00878189|467766340|FG005|Overall Study|Other|18|||
129945589|NCT00878189|467766341|FG006|Overall Study|Other|15|||
129945590|NCT00878189|467766342|FG007|Overall Study|Other|3|||
129945591|NCT00878189|467766343|FG008|Overall Study|Other|4|||
129945592|NCT00878189|467766335|FG000|Overall Study|Lost to Follow-up|0|||
129945593|NCT00878189|467766336|FG001|Overall Study|Lost to Follow-up|0|||
129945594|NCT00878189|467766337|FG002|Overall Study|Lost to Follow-up|0|||
129945595|NCT00878189|467766338|FG003|Overall Study|Lost to Follow-up|0|||
129945596|NCT00878189|467766339|FG004|Overall Study|Lost to Follow-up|0|||
129945597|NCT00878189|467766340|FG005|Overall Study|Lost to Follow-up|1|||
129945598|NCT00878189|467766341|FG006|Overall Study|Lost to Follow-up|1|||
129945599|NCT00878189|467766342|FG007|Overall Study|Lost to Follow-up|0|||
129945600|NCT00878189|467766343|FG008|Overall Study|Lost to Follow-up|0|||
129945601|NCT00878189|467766335|FG000|Overall Study|Objection Progression or Relapse|0|||
129945602|NCT00878189|467766336|FG001|Overall Study|Objection Progression or Relapse|0|||
129945603|NCT00878189|467766337|FG002|Overall Study|Objection Progression or Relapse|0|||
129945604|NCT00878189|467766338|FG003|Overall Study|Objection Progression or Relapse|0|||
129945605|NCT00878189|467766339|FG004|Overall Study|Objection Progression or Relapse|0|||
129945606|NCT00878189|467766340|FG005|Overall Study|Objection Progression or Relapse|0|||
129945607|NCT00878189|467766341|FG006|Overall Study|Objection Progression or Relapse|0|||
129945608|NCT00878189|467766342|FG007|Overall Study|Objection Progression or Relapse|0|||
129945609|NCT00878189|467766343|FG008|Overall Study|Objection Progression or Relapse|3|||
129945610|NCT01021748|467766344|FG000|Overall Study|Adverse Event|2|||
129945611|NCT01021748|467766345|FG001|Overall Study|Adverse Event|1|||
129945612|NCT01021748|467766346|FG002|Overall Study|Adverse Event|2|||
129945613|NCT01021748|467766347|FG003|Overall Study|Adverse Event|0|||
129945614|NCT01021748|467766348|FG004|Overall Study|Adverse Event|2|||
129945615|NCT01021748|467766349|FG005|Overall Study|Adverse Event|0|||
129945616|NCT01021748|467766350|FG006|Overall Study|Adverse Event|1|||
129945617|NCT01021748|467766351|FG007|Overall Study|Adverse Event|0|||
129945618|NCT01021748|467766352|FG008|Overall Study|Adverse Event|7|||
129945619|NCT01021748|467766344|FG000|Overall Study|Physician Decision|1|||
129945620|NCT01021748|467766345|FG001|Overall Study|Physician Decision|0|||
129945621|NCT01021748|467766346|FG002|Overall Study|Physician Decision|1|||
129945622|NCT01021748|467766347|FG003|Overall Study|Physician Decision|1|||
129945623|NCT01021748|467766348|FG004|Overall Study|Physician Decision|0|||
129945624|NCT01021748|467766349|FG005|Overall Study|Physician Decision|0|||
129945625|NCT01021748|467766350|FG006|Overall Study|Physician Decision|1|||
129945626|NCT01021748|467766351|FG007|Overall Study|Physician Decision|1|||
129945627|NCT01021748|467766352|FG008|Overall Study|Physician Decision|2|||
129945628|NCT01021748|467766344|FG000|Overall Study|Progressive Disease|3|||
129945629|NCT01021748|467766345|FG001|Overall Study|Progressive Disease|3|||
129945630|NCT01021748|467766346|FG002|Overall Study|Progressive Disease|4|||
129945631|NCT01021748|467766347|FG003|Overall Study|Progressive Disease|6|||
129945632|NCT01021748|467766348|FG004|Overall Study|Progressive Disease|7|||
129945633|NCT01021748|467766349|FG005|Overall Study|Progressive Disease|3|||
129945634|NCT01021748|467766350|FG006|Overall Study|Progressive Disease|0|||
129945635|NCT01021748|467766351|FG007|Overall Study|Progressive Disease|5|||
129945636|NCT01021748|467766352|FG008|Overall Study|Progressive Disease|6|||
129945637|NCT01021748|467766344|FG000|Overall Study|Withdrawal by Subject|0|||
129945638|NCT01021748|467766345|FG001|Overall Study|Withdrawal by Subject|0|||
129945639|NCT01021748|467766346|FG002|Overall Study|Withdrawal by Subject|0|||
129945640|NCT01021748|467766347|FG003|Overall Study|Withdrawal by Subject|0|||
129945641|NCT01021748|467766348|FG004|Overall Study|Withdrawal by Subject|0|||
129945642|NCT01021748|467766349|FG005|Overall Study|Withdrawal by Subject|0|||
129945643|NCT01021748|467766350|FG006|Overall Study|Withdrawal by Subject|1|||
129945644|NCT01021748|467766351|FG007|Overall Study|Withdrawal by Subject|0|||
129945645|NCT01021748|467766352|FG008|Overall Study|Withdrawal by Subject|1|||
129945646|NCT01021748|467766344|FG000|Overall Study|Not Treated|0|||
129945647|NCT01021748|467766345|FG001|Overall Study|Not Treated|1|||
129945648|NCT01021748|467766346|FG002|Overall Study|Not Treated|0|||
129945649|NCT01021748|467766347|FG003|Overall Study|Not Treated|0|||
129945650|NCT01021748|467766348|FG004|Overall Study|Not Treated|0|||
129945651|NCT01021748|467766349|FG005|Overall Study|Not Treated|0|||
129945652|NCT01021748|467766350|FG006|Overall Study|Not Treated|0|||
129945653|NCT01021748|467766351|FG007|Overall Study|Not Treated|0|||
129945654|NCT01021748|467766352|FG008|Overall Study|Not Treated|0|||
129945655|NCT01829711|467766357|FG000|Overall Study|Lost to Follow-up|2|||
129945656|NCT01829711|467766357|FG000|Overall Study|Withdrawal by Subject|3|||
129945657|NCT01829711|467766357|FG000|Overall Study|Death|4|||
129945658|NCT01829711|467766357|FG000|Overall Study|Started new therapies|17|||
129945659|NCT01829711|467766357|FG000|Overall Study|Adverse Event|3|||
129945660|NCT01829711|467766357|FG000|Overall Study|Due to progression of disease|13|||
129945661|NCT01829711|467766357|FG000|Overall Study|Due to lack of response|1|||
129945662|NCT01480258|467766358|FG000|Infant Series|Protocol Violation|2|||
129945663|NCT01480258|467766359|FG001|Infant Series|Protocol Violation|0|||
129945664|NCT01480258|467766358|FG000|Infant Series|Physician Decision|0|||
129945665|NCT01480258|467766359|FG001|Infant Series|Physician Decision|1|||
129945666|NCT01480258|467766358|FG000|Infant Series|Not Vaccinated|3|||
129945667|NCT01480258|467766359|FG001|Infant Series|Not Vaccinated|0|||
129945668|NCT01480258|467766358|FG000|Infant Series|Adverse Event|1|||
129945669|NCT01480258|467766359|FG001|Infant Series|Adverse Event|1|||
129945670|NCT01480258|467766358|FG000|Infant Series|Withdrawal by Subject|1|||
129945671|NCT01480258|467766359|FG001|Infant Series|Withdrawal by Subject|6|||
129945672|NCT01480258|467766358|FG000|Interim Period|Lost to Follow-up|0|||
129945673|NCT01480258|467766359|FG001|Interim Period|Lost to Follow-up|2|||
129945674|NCT01480258|467766358|FG000|Interim Period|Physician Decision|1|||
129945675|NCT01480258|467766359|FG001|Interim Period|Physician Decision|0|||
129945676|NCT01480258|467766358|FG000|Interim Period|Protocol Violation|0|||
129945677|NCT01480258|467766359|FG001|Interim Period|Protocol Violation|1|||
129945678|NCT01480258|467766358|FG000|Interim Period|Withdrawal by Subject|9|||
129945679|NCT01480258|467766359|FG001|Interim Period|Withdrawal by Subject|6|||
129945680|NCT03316170|467766362|FG000|Overall Study|Death|1|||
129945681|NCT03316170|467766363|FG001|Overall Study|Death|0|||
129945682|NCT03316170|467766362|FG000|Overall Study|Lost to Follow-up|6|||
129945683|NCT03316170|467766363|FG001|Overall Study|Lost to Follow-up|7|||
129945684|NCT02169414|467766364|FG000|Overall Study|Withdrawal by Subject|1|||
129945685|NCT02169414|467766365|FG001|Overall Study|Withdrawal by Subject|0|||
129945686|NCT02169414|467766366|FG002|Overall Study|Withdrawal by Subject|0|||
129945687|NCT02169414|467766367|FG003|Overall Study|Withdrawal by Subject|0|||
129945688|NCT02169414|467766364|FG000|Overall Study|Adverse Event|0|||
129945689|NCT02169414|467766365|FG001|Overall Study|Adverse Event|1|||
129945690|NCT02169414|467766366|FG002|Overall Study|Adverse Event|0|||
129945691|NCT02169414|467766367|FG003|Overall Study|Adverse Event|0|||
129945692|NCT03374254|467766368|FG000|Overall Study|Death|5|||
129945693|NCT03374254|467766369|FG001|Overall Study|Death|16|||
129945694|NCT03374254|467766370|FG002|Overall Study|Death|13|||
129945695|NCT03374254|467766371|FG003|Overall Study|Death|11|||
129945696|NCT03374254|467766372|FG004|Overall Study|Death|9|||
129945697|NCT03374254|467766373|FG005|Overall Study|Death|12|||
129945698|NCT03374254|467766374|FG006|Overall Study|Death|11|||
129945699|NCT03374254|467766375|FG007|Overall Study|Death|6|||
129945700|NCT03374254|467766376|FG008|Overall Study|Death|7|||
129945701|NCT03374254|467766368|FG000|Overall Study|Lost to Follow-up|0|||
129945702|NCT03374254|467766369|FG001|Overall Study|Lost to Follow-up|0|||
129945703|NCT03374254|467766370|FG002|Overall Study|Lost to Follow-up|0|||
129945704|NCT03374254|467766371|FG003|Overall Study|Lost to Follow-up|0|||
129945705|NCT03374254|467766372|FG004|Overall Study|Lost to Follow-up|0|||
129945706|NCT03374254|467766373|FG005|Overall Study|Lost to Follow-up|0|||
129945707|NCT03374254|467766374|FG006|Overall Study|Lost to Follow-up|2|||
129945708|NCT03374254|467766375|FG007|Overall Study|Lost to Follow-up|0|||
129945709|NCT03374254|467766376|FG008|Overall Study|Lost to Follow-up|0|||
129945710|NCT03374254|467766368|FG000|Overall Study|Sponsor Decision|1|||
129945711|NCT03374254|467766369|FG001|Overall Study|Sponsor Decision|0|||
129945712|NCT03374254|467766370|FG002|Overall Study|Sponsor Decision|2|||
129945713|NCT03374254|467766371|FG003|Overall Study|Sponsor Decision|3|||
129945714|NCT03374254|467766372|FG004|Overall Study|Sponsor Decision|2|||
129945715|NCT03374254|467766373|FG005|Overall Study|Sponsor Decision|3|||
129945716|NCT03374254|467766374|FG006|Overall Study|Sponsor Decision|3|||
129945717|NCT03374254|467766375|FG007|Overall Study|Sponsor Decision|3|||
129945718|NCT03374254|467766376|FG008|Overall Study|Sponsor Decision|4|||
129945719|NCT03374254|467766368|FG000|Overall Study|Withdrawal by Subject|0|||
129945720|NCT03374254|467766369|FG001|Overall Study|Withdrawal by Subject|0|||
129945721|NCT03374254|467766370|FG002|Overall Study|Withdrawal by Subject|0|||
129945722|NCT03374254|467766371|FG003|Overall Study|Withdrawal by Subject|2|||
129945723|NCT03374254|467766372|FG004|Overall Study|Withdrawal by Subject|0|||
129945724|NCT03374254|467766373|FG005|Overall Study|Withdrawal by Subject|1|||
129945725|NCT03374254|467766374|FG006|Overall Study|Withdrawal by Subject|0|||
129945726|NCT03374254|467766375|FG007|Overall Study|Withdrawal by Subject|0|||
129945727|NCT03374254|467766376|FG008|Overall Study|Withdrawal by Subject|0|||
129945728|NCT00749944|467766379|FG000|Overall Study|Lost to Follow-up|2|||
129945729|NCT00749944|467766380|FG001|Overall Study|Lost to Follow-up|1|||
129945730|NCT00749944|467766379|FG000|Overall Study|Other|1|||
129945731|NCT00749944|467766380|FG001|Overall Study|Other|0|||
129945732|NCT00749944|467766379|FG000|Overall Study|Withdrawal by Subject|2|||
129945733|NCT00749944|467766380|FG001|Overall Study|Withdrawal by Subject|0|||
129945734|NCT00624377|467766383|FG000|Overall Study|Lost to Follow-up|355|||
129945735|NCT00624377|467766383|FG000|Overall Study|Withdrawal by Subject|100|||
129945736|NCT00624377|467766383|FG000|Overall Study|Adverse Event|14|||
129945737|NCT00624377|467766383|FG000|Overall Study|Other|91|||
129945738|NCT00624377|467766383|FG000|Overall Study|Non-evaluable population|84|||
129945739|NCT02404441|467766387|FG000|Phase 1 Part|Adverse Event|1|||
129945740|NCT02404441|467766388|FG001|Phase 1 Part|Adverse Event|0|||
129945741|NCT02404441|467766389|FG002|Phase 1 Part|Adverse Event|0|||
129945742|NCT02404441|467766390|FG003|Phase 1 Part|Adverse Event|0|||
129945743|NCT02404441|467766391|FG004|Phase 1 Part|Adverse Event|0|||
129945744|NCT02404441|467766392|FG005|Phase 1 Part|Adverse Event|0|||
129945745|NCT02404441|467766393|FG006|Phase 1 Part|Adverse Event|0|||
129945746|NCT02404441|467766394|FG007|Phase 1 Part|Adverse Event|0|||
129945747|NCT02404441|467766395|FG008|Phase 1 Part|Adverse Event|0|||
129945748|NCT02404441|467766396|FG009|Phase 1 Part|Adverse Event|0|||
129453437|NCT01566773|465958058|FG000|Overall Study|Physician Decision|2|||
129453438|NCT01033734|465958059|FG000|Overall Study|Withdrawal by Subject|1|||
129453439|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
129945749|NCT02404441|467766387|FG000|Phase 1 Part|Physician Decision|0|||
129945750|NCT02404441|467766388|FG001|Phase 1 Part|Physician Decision|1|||
129945751|NCT02404441|467766389|FG002|Phase 1 Part|Physician Decision|0|||
129945752|NCT02404441|467766390|FG003|Phase 1 Part|Physician Decision|0|||
129945753|NCT02404441|467766391|FG004|Phase 1 Part|Physician Decision|0|||
129945754|NCT02404441|467766392|FG005|Phase 1 Part|Physician Decision|0|||
129945755|NCT02404441|467766393|FG006|Phase 1 Part|Physician Decision|0|||
129945756|NCT02404441|467766394|FG007|Phase 1 Part|Physician Decision|0|||
129945757|NCT02404441|467766395|FG008|Phase 1 Part|Physician Decision|0|||
129945758|NCT02404441|467766396|FG009|Phase 1 Part|Physician Decision|0|||
129945759|NCT02404441|467766387|FG000|Phase 1 Part|Progressive Disease|14|||
129945760|NCT02404441|467766388|FG001|Phase 1 Part|Progressive Disease|11|||
129945761|NCT02404441|467766389|FG002|Phase 1 Part|Progressive Disease|7|||
129945762|NCT02404441|467766390|FG003|Phase 1 Part|Progressive Disease|6|||
129945763|NCT02404441|467766391|FG004|Phase 1 Part|Progressive Disease|9|||
129945764|NCT02404441|467766392|FG005|Phase 1 Part|Progressive Disease|0|||
129945765|NCT02404441|467766393|FG006|Phase 1 Part|Progressive Disease|0|||
129945766|NCT02404441|467766394|FG007|Phase 1 Part|Progressive Disease|0|||
129945767|NCT02404441|467766395|FG008|Phase 1 Part|Progressive Disease|0|||
129945768|NCT02404441|467766396|FG009|Phase 1 Part|Progressive Disease|0|||
129945769|NCT02404441|467766387|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
129945770|NCT02404441|467766388|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
129945771|NCT02404441|467766389|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
129945772|NCT02404441|467766390|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
129945773|NCT02404441|467766391|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
129945774|NCT02404441|467766392|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
129945775|NCT02404441|467766393|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
129945776|NCT02404441|467766394|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
129945777|NCT02404441|467766395|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
129945778|NCT02404441|467766396|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
129945779|NCT02404441|467766387|FG000|Phase 1 Part|Death|1|||
129945780|NCT02404441|467766388|FG001|Phase 1 Part|Death|1|||
129945781|NCT02404441|467766389|FG002|Phase 1 Part|Death|1|||
129945782|NCT02404441|467766390|FG003|Phase 1 Part|Death|0|||
129945783|NCT02404441|467766391|FG004|Phase 1 Part|Death|1|||
129945784|NCT02404441|467766392|FG005|Phase 1 Part|Death|0|||
129945785|NCT02404441|467766393|FG006|Phase 1 Part|Death|0|||
129945786|NCT02404441|467766394|FG007|Phase 1 Part|Death|0|||
129945787|NCT02404441|467766395|FG008|Phase 1 Part|Death|0|||
129945788|NCT02404441|467766396|FG009|Phase 1 Part|Death|0|||
129945789|NCT02404441|467766387|FG000|Phase 2 Part|Adverse Event|0|||
129945790|NCT02404441|467766388|FG001|Phase 2 Part|Adverse Event|0|||
129945791|NCT02404441|467766389|FG002|Phase 2 Part|Adverse Event|0|||
129945792|NCT02404441|467766390|FG003|Phase 2 Part|Adverse Event|0|||
129945793|NCT02404441|467766391|FG004|Phase 2 Part|Adverse Event|0|||
129945794|NCT02404441|467766392|FG005|Phase 2 Part|Adverse Event|2|||
129945795|NCT02404441|467766393|FG006|Phase 2 Part|Adverse Event|3|||
129945796|NCT02404441|467766394|FG007|Phase 2 Part|Adverse Event|3|||
129945797|NCT02404441|467766395|FG008|Phase 2 Part|Adverse Event|6|||
129945798|NCT02404441|467766396|FG009|Phase 2 Part|Adverse Event|1|||
129945799|NCT02404441|467766387|FG000|Phase 2 Part|Physician Decision|0|||
129945800|NCT02404441|467766388|FG001|Phase 2 Part|Physician Decision|0|||
129945801|NCT02404441|467766389|FG002|Phase 2 Part|Physician Decision|0|||
129945802|NCT02404441|467766390|FG003|Phase 2 Part|Physician Decision|0|||
129945803|NCT02404441|467766391|FG004|Phase 2 Part|Physician Decision|0|||
129945804|NCT02404441|467766392|FG005|Phase 2 Part|Physician Decision|7|||
129945805|NCT02404441|467766393|FG006|Phase 2 Part|Physician Decision|9|||
129945806|NCT02404441|467766394|FG007|Phase 2 Part|Physician Decision|2|||
129945807|NCT02404441|467766395|FG008|Phase 2 Part|Physician Decision|1|||
129945808|NCT02404441|467766396|FG009|Phase 2 Part|Physician Decision|3|||
129945809|NCT02404441|467766387|FG000|Phase 2 Part|Progressive disease|0|||
129945810|NCT02404441|467766388|FG001|Phase 2 Part|Progressive disease|0|||
129945811|NCT02404441|467766389|FG002|Phase 2 Part|Progressive disease|0|||
129945812|NCT02404441|467766390|FG003|Phase 2 Part|Progressive disease|0|||
129945813|NCT02404441|467766391|FG004|Phase 2 Part|Progressive disease|0|||
129945814|NCT02404441|467766392|FG005|Phase 2 Part|Progressive disease|43|||
129945815|NCT02404441|467766393|FG006|Phase 2 Part|Progressive disease|32|||
129945816|NCT02404441|467766394|FG007|Phase 2 Part|Progressive disease|31|||
129945817|NCT02404441|467766395|FG008|Phase 2 Part|Progressive disease|39|||
129945818|NCT02404441|467766396|FG009|Phase 2 Part|Progressive disease|27|||
129945819|NCT02404441|467766387|FG000|Phase 2 Part|Subject/guardian decision|0|||
129945820|NCT02404441|467766388|FG001|Phase 2 Part|Subject/guardian decision|0|||
129945821|NCT02404441|467766389|FG002|Phase 2 Part|Subject/guardian decision|0|||
129945822|NCT02404441|467766390|FG003|Phase 2 Part|Subject/guardian decision|0|||
129945823|NCT02404441|467766391|FG004|Phase 2 Part|Subject/guardian decision|0|||
129945824|NCT02404441|467766392|FG005|Phase 2 Part|Subject/guardian decision|3|||
129945825|NCT02404441|467766393|FG006|Phase 2 Part|Subject/guardian decision|9|||
129945826|NCT02404441|467766394|FG007|Phase 2 Part|Subject/guardian decision|0|||
129945827|NCT02404441|467766395|FG008|Phase 2 Part|Subject/guardian decision|3|||
129945828|NCT02404441|467766396|FG009|Phase 2 Part|Subject/guardian decision|2|||
129945829|NCT02404441|467766387|FG000|Phase 2 Part|Death|0|||
129945830|NCT02404441|467766388|FG001|Phase 2 Part|Death|0|||
129945831|NCT02404441|467766389|FG002|Phase 2 Part|Death|0|||
129945832|NCT02404441|467766390|FG003|Phase 2 Part|Death|0|||
129945833|NCT02404441|467766391|FG004|Phase 2 Part|Death|0|||
129945834|NCT02404441|467766392|FG005|Phase 2 Part|Death|4|||
129945835|NCT02404441|467766393|FG006|Phase 2 Part|Death|8|||
129945836|NCT02404441|467766394|FG007|Phase 2 Part|Death|4|||
129945837|NCT02404441|467766395|FG008|Phase 2 Part|Death|10|||
129945838|NCT02404441|467766396|FG009|Phase 2 Part|Death|9|||
129945839|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945840|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945841|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945842|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
129945843|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945844|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945845|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
129945846|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945847|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
129945848|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945849|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945850|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945851|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945852|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
129945853|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Death|1|||
129945854|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Death|2|||
129945855|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Death|0|||
129945856|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Death|1|||
129945857|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Death|0|||
129945858|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Death|0|||
129945859|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Death|0|||
129945860|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
129945861|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
129945862|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
129945863|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
129945864|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
129945865|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
129945866|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
129945867|NCT02234141|467766397|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945868|NCT02234141|467766398|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
129945869|NCT02234141|467766399|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945870|NCT02234141|467766400|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945871|NCT02234141|467766401|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945872|NCT02234141|467766402|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945873|NCT02234141|467766403|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
129945874|NCT02234141|467766397|FG000|Long-Term Treatment Period|Death|0|||
129945875|NCT02234141|467766398|FG001|Long-Term Treatment Period|Death|0|||
129945876|NCT02234141|467766399|FG002|Long-Term Treatment Period|Death|0|||
129945877|NCT02234141|467766400|FG003|Long-Term Treatment Period|Death|0|||
129945878|NCT02234141|467766401|FG004|Long-Term Treatment Period|Death|0|||
129945879|NCT02234141|467766402|FG005|Long-Term Treatment Period|Death|1|||
129945880|NCT02234141|467766403|FG006|Long-Term Treatment Period|Death|0|||
129945881|NCT02234141|467766397|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
129945882|NCT02234141|467766398|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
129945883|NCT02234141|467766399|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
129945884|NCT02234141|467766400|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
129945885|NCT02234141|467766401|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
129945886|NCT02234141|467766402|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
129945887|NCT02234141|467766403|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
129945888|NCT02234141|467766397|FG000|Long-Term Treatment Period|Adverse Event|4|||
129945889|NCT02234141|467766398|FG001|Long-Term Treatment Period|Adverse Event|0|||
129945890|NCT02234141|467766399|FG002|Long-Term Treatment Period|Adverse Event|5|||
129945891|NCT02234141|467766400|FG003|Long-Term Treatment Period|Adverse Event|0|||
129945892|NCT02234141|467766401|FG004|Long-Term Treatment Period|Adverse Event|1|||
129945893|NCT02234141|467766402|FG005|Long-Term Treatment Period|Adverse Event|1|||
129945894|NCT02234141|467766403|FG006|Long-Term Treatment Period|Adverse Event|1|||
129945895|NCT02234141|467766397|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
129945896|NCT02234141|467766398|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
129945897|NCT02234141|467766399|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
129945898|NCT02234141|467766400|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
129945899|NCT02234141|467766401|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
129945900|NCT02234141|467766402|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
129945901|NCT02234141|467766403|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
129945902|NCT02234141|467766397|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
129945903|NCT02234141|467766398|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
129945904|NCT02234141|467766399|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
129945905|NCT02234141|467766400|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
129945906|NCT02234141|467766401|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
129945907|NCT02234141|467766402|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
129945908|NCT02234141|467766403|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
129945909|NCT00895245|467766404|FG000|Overall Study|Lack of Efficacy|6|||
129945910|NCT04248868|467766405|FG000|Overall Study|Death|1|||
129945911|NCT04248868|467766405|FG000|Overall Study|Lost to Follow-up|3|||
129945912|NCT04248868|467766405|FG000|Overall Study|Protocol Violation|2|||
129945913|NCT02706483|467766408|FG000|Overall Study|Adverse Event|97|||
129945914|NCT02706483|467766408|FG000|Overall Study|Death|1|||
129945915|NCT02706483|467766408|FG000|Overall Study|Lack of Efficacy|39|||
129945916|NCT02706483|467766408|FG000|Overall Study|Lost to Follow-up|101|||
129945917|NCT02706483|467766408|FG000|Overall Study|Non-compliance with study drug|15|||
129945918|NCT02706483|467766408|FG000|Overall Study|Physician Decision|6|||
129945919|NCT02706483|467766408|FG000|Overall Study|Pregnancy|6|||
129945920|NCT02706483|467766408|FG000|Overall Study|Protocol Violation|18|||
129945921|NCT02706483|467766408|FG000|Overall Study|Withdrawal by Subject|136|||
129945922|NCT02706483|467766408|FG000|Overall Study|Non-compliance with visits|6|||
129945923|NCT02706483|467766408|FG000|Overall Study|Site closure|4|||
129945924|NCT02706483|467766408|FG000|Overall Study|Subject moved|1|||
129945925|NCT03131713|467766409|FG000|Overall Study|Lost to Follow-up|5|||
129945926|NCT03131713|467766410|FG001|Overall Study|Lost to Follow-up|0|||
129945927|NCT02208843|467766411|FG000|Overall Study|Clinical symptoms of progression|2|||
129945928|NCT02208843|467766411|FG000|Overall Study|Progression disease according to RECIST|24|||
129945929|NCT02208843|467766411|FG000|Overall Study|Adverse Event|12|||
129945930|NCT02208843|467766411|FG000|Overall Study|Protocol Violation|1|||
129945931|NCT02208843|467766411|FG000|Overall Study|Withdrawal by Subject|1|||
129945932|NCT02208843|467766411|FG000|Overall Study|Switched to commercial afatinib|20|||
129945933|NCT01976507|467766412|FG000|Overall Study|Adverse Event|6|||
129945934|NCT01976507|467766412|FG000|Overall Study|ablation not done, drug not given|1|||
129945935|NCT01972776|467766413|FG000|Part 1|Withdrawal by Subject|0|||
129945936|NCT01972776|467766414|FG001|Part 1|Withdrawal by Subject|0|||
129945937|NCT01972776|467766415|FG002|Part 1|Withdrawal by Subject|1|||
129945938|NCT01972776|467766416|FG003|Part 1|Withdrawal by Subject|0|||
129945939|NCT01972776|467766417|FG004|Part 1|Withdrawal by Subject|0|||
129945940|NCT01972776|467766418|FG005|Part 1|Withdrawal by Subject|0|||
129945941|NCT01972776|467766413|FG000|Part 1|Adverse Event|0|||
129945942|NCT01972776|467766414|FG001|Part 1|Adverse Event|0|||
129945943|NCT01972776|467766415|FG002|Part 1|Adverse Event|1|||
129945944|NCT01972776|467766416|FG003|Part 1|Adverse Event|1|||
129945945|NCT01972776|467766417|FG004|Part 1|Adverse Event|0|||
129945946|NCT01972776|467766418|FG005|Part 1|Adverse Event|0|||
129945947|NCT01972776|467766413|FG000|Part 2|Adverse Event|0|||
129945948|NCT01972776|467766414|FG001|Part 2|Adverse Event|0|||
129945949|NCT01972776|467766415|FG002|Part 2|Adverse Event|0|||
129945950|NCT01972776|467766416|FG003|Part 2|Adverse Event|0|||
129945951|NCT01972776|467766417|FG004|Part 2|Adverse Event|3|||
129945952|NCT01972776|467766418|FG005|Part 2|Adverse Event|0|||
129945953|NCT01972776|467766413|FG000|Part 2|Administrative problems|0|||
129945954|NCT01972776|467766414|FG001|Part 2|Administrative problems|0|||
129945955|NCT01972776|467766415|FG002|Part 2|Administrative problems|0|||
129945956|NCT01972776|467766416|FG003|Part 2|Administrative problems|0|||
129945957|NCT01972776|467766417|FG004|Part 2|Administrative problems|10|||
129945958|NCT01972776|467766418|FG005|Part 2|Administrative problems|7|||
129945959|NCT00089791|467766422|FG000|Overall Study|Physician Decision|6|||
129945960|NCT00089791|467766423|FG001|Overall Study|Physician Decision|3|||
129945961|NCT00089791|467766422|FG000|Overall Study|Adverse Event|81|||
129945962|NCT00089791|467766423|FG001|Overall Study|Adverse Event|93|||
129945963|NCT00089791|467766422|FG000|Overall Study|Withdrawal by Subject|403|||
129945964|NCT00089791|467766423|FG001|Overall Study|Withdrawal by Subject|344|||
129945965|NCT00089791|467766422|FG000|Overall Study|Death|78|||
129945966|NCT00089791|467766423|FG001|Overall Study|Death|62|||
129945967|NCT00089791|467766422|FG000|Overall Study|Disease progression|7|||
129945968|NCT00089791|467766423|FG001|Overall Study|Disease progression|3|||
129945969|NCT00089791|467766422|FG000|Overall Study|Ineligibility determined|12|||
129945970|NCT00089791|467766423|FG001|Overall Study|Ineligibility determined|9|||
129945971|NCT00089791|467766422|FG000|Overall Study|Lost to Follow-up|57|||
129945972|NCT00089791|467766423|FG001|Overall Study|Lost to Follow-up|57|||
129945973|NCT00089791|467766422|FG000|Overall Study|Noncompliance|17|||
129945974|NCT00089791|467766423|FG001|Overall Study|Noncompliance|13|||
129945975|NCT00089791|467766422|FG000|Overall Study|Other|20|||
129945976|NCT00089791|467766423|FG001|Overall Study|Other|32|||
129945977|NCT00089791|467766422|FG000|Overall Study|Protocol deviation|12|||
129453440|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
129453441|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
129453442|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
129453443|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
129453444|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
129453445|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
129453446|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
129453447|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
129453448|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
129453449|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
129453450|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
129453451|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
129453452|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
129453453|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
129453454|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
129453455|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
129945978|NCT00089791|467766423|FG001|Overall Study|Protocol deviation|10|||
129945979|NCT00089791|467766422|FG000|Overall Study|Requirement for alternative therapy|7|||
129945980|NCT00089791|467766423|FG001|Overall Study|Requirement for alternative therapy|4|||
129945981|NCT00148122|467766424|FG000|Overall Study|Withdrawal by Subject|2|||
129945982|NCT03042767|467766425|FG000|Overall Study|Lost to Follow-up|1|||
129945983|NCT03042767|467766426|FG001|Overall Study|Lost to Follow-up|2|||
129945984|NCT01543204|467766427|FG000|Overall Study|Non-compliance|1|||
129945985|NCT01543204|467766427|FG000|Overall Study|Adverse Event|1|||
129945986|NCT01543204|467766427|FG000|Overall Study|Withdrawal by Subject|4|||
129945987|NCT01543204|467766427|FG000|Overall Study|Requirement for Alternative Therapy|1|||
129945988|NCT01543204|467766427|FG000|Overall Study|Lost to Follow-up|1|||
129945989|NCT02449902|467766431|FG000|Overall Study|Adverse Event|0|||
129945990|NCT02449902|467766432|FG001|Overall Study|Adverse Event|1|||
129945991|NCT02449902|467766431|FG000|Overall Study|Withdrawal by Subject|0|||
129945992|NCT02449902|467766432|FG001|Overall Study|Withdrawal by Subject|1|||
129945993|NCT02362789|467766433|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
129945994|NCT02362789|467766434|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
129453456|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
129453457|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
129945995|NCT02362789|467766435|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
129945996|NCT02362789|467766433|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
129945997|NCT02362789|467766434|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
129945998|NCT02362789|467766435|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
129945999|NCT02362789|467766433|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
129946000|NCT02362789|467766434|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
129946001|NCT02362789|467766435|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
129946002|NCT02362789|467766433|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
129946003|NCT02362789|467766434|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
129946004|NCT02362789|467766435|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
129946005|NCT02362789|467766433|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
129946006|NCT02362789|467766434|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
129946007|NCT02362789|467766435|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
129946008|NCT03326856|467766436|FG000|Overall Study|Lost to Follow-up|1|||
129946009|NCT03326856|467766437|FG001|Overall Study|Lost to Follow-up|1|||
129946010|NCT03326856|467766438|FG002|Overall Study|Lost to Follow-up|0|||
129946011|NCT03326856|467766439|FG003|Overall Study|Lost to Follow-up|0|||
129946012|NCT03326856|467766440|FG004|Overall Study|Lost to Follow-up|0|||
129946013|NCT02037568|467766441|FG000|Overall Study|Withdrawal by Subject|17|||
129946014|NCT02037568|467766442|FG001|Overall Study|Withdrawal by Subject|24|||
129946015|NCT02037568|467766441|FG000|Overall Study|Lost to Follow-up|16|||
129946016|NCT02037568|467766442|FG001|Overall Study|Lost to Follow-up|13|||
129946017|NCT02037568|467766441|FG000|Overall Study|Screen Failure|3|||
129946018|NCT02037568|467766442|FG001|Overall Study|Screen Failure|1|||
129946019|NCT02037568|467766441|FG000|Overall Study|Patient did not receive transplant|0|||
129946020|NCT02037568|467766442|FG001|Overall Study|Patient did not receive transplant|1|||
129946021|NCT00721734|467766446|FG000|Overall Study|Progressive Disease|3|||
129946022|NCT00721734|467766447|FG001|Overall Study|Progressive Disease|10|||
129946023|NCT00721734|467766448|FG002|Overall Study|Progressive Disease|4|||
129946024|NCT00721734|467766449|FG003|Overall Study|Progressive Disease|5|||
129946025|NCT00721734|467766450|FG004|Overall Study|Progressive Disease|2|||
129946026|NCT00721734|467766446|FG000|Overall Study|Adverse Event|3|||
129946027|NCT00721734|467766447|FG001|Overall Study|Adverse Event|1|||
129946028|NCT00721734|467766448|FG002|Overall Study|Adverse Event|4|||
129946029|NCT00721734|467766449|FG003|Overall Study|Adverse Event|0|||
129946030|NCT00721734|467766450|FG004|Overall Study|Adverse Event|3|||
129946031|NCT00721734|467766446|FG000|Overall Study|Withdrawal by Subject|2|||
129946032|NCT00721734|467766447|FG001|Overall Study|Withdrawal by Subject|1|||
129946033|NCT00721734|467766448|FG002|Overall Study|Withdrawal by Subject|0|||
129946034|NCT00721734|467766449|FG003|Overall Study|Withdrawal by Subject|0|||
129946035|NCT00721734|467766450|FG004|Overall Study|Withdrawal by Subject|1|||
129946036|NCT00721734|467766446|FG000|Overall Study|Other|0|||
129946037|NCT00721734|467766447|FG001|Overall Study|Other|0|||
129946038|NCT00721734|467766448|FG002|Overall Study|Other|0|||
129946039|NCT00721734|467766449|FG003|Overall Study|Other|1|||
129946040|NCT00721734|467766450|FG004|Overall Study|Other|0|||
129946041|NCT00621842|467766451|FG000|Overall Study|Adverse Event|6|||
129946042|NCT00621842|467766451|FG000|Overall Study|Withdrawal by Subject|7|||
129946043|NCT00621842|467766451|FG000|Overall Study|Protocol Violation|4|||
129946044|NCT00621842|467766451|FG000|Overall Study|Lack of Efficacy|2|||
129946045|NCT01989689|467766453|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
129946046|NCT01989689|467766454|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
129946047|NCT01989689|467766453|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
129946048|NCT01989689|467766454|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
129946049|NCT00526994|467766455|FG000|Overall Study|Lost to Follow-up|98|||
129946050|NCT00526994|467766456|FG001|Overall Study|Lost to Follow-up|108|||
129946051|NCT00526994|467766457|FG002|Overall Study|Lost to Follow-up|96|||
129946052|NCT00526994|467766455|FG000|Overall Study|Death|4|||
129946053|NCT00526994|467766456|FG001|Overall Study|Death|3|||
129946054|NCT00526994|467766457|FG002|Overall Study|Death|3|||
129946055|NCT00526994|467766455|FG000|Overall Study|Withdrawal by Subject|2|||
129946056|NCT00526994|467766456|FG001|Overall Study|Withdrawal by Subject|7|||
129946057|NCT00526994|467766457|FG002|Overall Study|Withdrawal by Subject|5|||
129946058|NCT00526994|467766455|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
129946059|NCT00526994|467766456|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
129946060|NCT00526994|467766457|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
129946061|NCT03938272|467766458|FG000|Overall Study|Withdrawal by Subject|1|||
129946062|NCT03938272|467766459|FG001|Overall Study|Withdrawal by Subject|0|||
129946063|NCT03938272|467766458|FG000|Overall Study|Physician Decision|0|||
129946064|NCT03938272|467766459|FG001|Overall Study|Physician Decision|2|||
129946065|NCT03938272|467766458|FG000|Overall Study|Study termination by sponsor|10|||
129946066|NCT03938272|467766459|FG001|Overall Study|Study termination by sponsor|8|||
129946067|NCT03692871|467766463|FG000|Overall Study|Death|1|||
129946068|NCT03692871|467766464|FG001|Overall Study|Death|1|||
129946069|NCT03692871|467766463|FG000|Overall Study|Lost to Follow-up|24|||
129946070|NCT03692871|467766464|FG001|Overall Study|Lost to Follow-up|9|||
129946071|NCT03692871|467766463|FG000|Overall Study|Physician Decision|22|||
129946072|NCT03692871|467766464|FG001|Overall Study|Physician Decision|7|||
129946073|NCT03692871|467766463|FG000|Overall Study|Protocol Deviation|1|||
129946074|NCT03692871|467766464|FG001|Overall Study|Protocol Deviation|0|||
129946075|NCT03692871|467766463|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
129946076|NCT03692871|467766464|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
129946077|NCT02644122|467766465|FG000|Overall Study|Withdrawal by Subject|1|||
129946078|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
129946079|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
129946080|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
129946081|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
129946082|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
129946083|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
129946084|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
129946085|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
129946086|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
129946087|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
129946088|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
129946089|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
129946090|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
129946091|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
129946092|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
129946093|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
129946094|NCT03182244|467766466|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
129946095|NCT03182244|467766467|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
129946096|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
129946097|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
129946098|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
129946099|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
129946100|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
129946101|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
129946102|NCT03182244|467766466|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
129946103|NCT03182244|467766467|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
129946104|NCT00680771|467766470|FG000|Overall Study|Withdrawal by Subject|1|||
129946105|NCT00680771|467766471|FG001|Overall Study|Withdrawal by Subject|0|||
129946106|NCT00680771|467766470|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
129946107|NCT00680771|467766471|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
129946108|NCT00680771|467766470|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
129946109|NCT00680771|467766471|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
129946110|NCT01316913|467766472|FG000|Overall Study|Adverse Event|17|||
129946111|NCT01316913|467766473|FG001|Overall Study|Adverse Event|20|||
129946112|NCT01316913|467766474|FG002|Overall Study|Adverse Event|15|||
129946113|NCT01316913|467766475|FG003|Overall Study|Adverse Event|11|||
129946114|NCT01316913|467766472|FG000|Overall Study|Lack of Efficacy|22|||
129946115|NCT01316913|467766473|FG001|Overall Study|Lack of Efficacy|12|||
129946116|NCT01316913|467766474|FG002|Overall Study|Lack of Efficacy|9|||
129946117|NCT01316913|467766475|FG003|Overall Study|Lack of Efficacy|13|||
129946118|NCT01316913|467766472|FG000|Overall Study|Protocol Violation|1|||
129946119|NCT01316913|467766473|FG001|Overall Study|Protocol Violation|4|||
129946120|NCT01316913|467766474|FG002|Overall Study|Protocol Violation|4|||
129946121|NCT01316913|467766475|FG003|Overall Study|Protocol Violation|1|||
129946122|NCT01316913|467766472|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
129946123|NCT01316913|467766473|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
129946124|NCT01316913|467766474|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
129946125|NCT01316913|467766475|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
129946126|NCT01316913|467766472|FG000|Overall Study|Lost to Follow-up|0|||
129946127|NCT01316913|467766473|FG001|Overall Study|Lost to Follow-up|1|||
129946128|NCT01316913|467766474|FG002|Overall Study|Lost to Follow-up|0|||
129946129|NCT01316913|467766475|FG003|Overall Study|Lost to Follow-up|2|||
129946130|NCT01316913|467766472|FG000|Overall Study|Withdrawal by Subject|10|||
129946131|NCT01316913|467766473|FG001|Overall Study|Withdrawal by Subject|9|||
129946132|NCT01316913|467766474|FG002|Overall Study|Withdrawal by Subject|10|||
129946133|NCT01316913|467766475|FG003|Overall Study|Withdrawal by Subject|6|||
129946134|NCT01668719|467766476|FG000|Phase I|On treatment|1|||
129946135|NCT01668719|467766477|FG001|Phase I|On treatment|0|||
129946136|NCT01668719|467766478|FG002|Phase I|On treatment|0|||
129946137|NCT01668719|467766476|FG000|Phase I|Adverse Event|2|||
129946138|NCT01668719|467766477|FG001|Phase I|Adverse Event|0|||
129946139|NCT01668719|467766478|FG002|Phase I|Adverse Event|0|||
129946140|NCT01668719|467766476|FG000|Phase I|Progression/relapse|1|||
129946141|NCT01668719|467766477|FG001|Phase I|Progression/relapse|0|||
129946142|NCT01668719|467766478|FG002|Phase I|Progression/relapse|0|||
129946143|NCT01668719|467766476|FG000|Phase I|not protocol specified|2|||
129946144|NCT01668719|467766477|FG001|Phase I|not protocol specified|0|||
129946145|NCT01668719|467766478|FG002|Phase I|not protocol specified|0|||
129946146|NCT01668719|467766476|FG000|Phase II|On treatment|0|||
129946147|NCT01668719|467766477|FG001|Phase II|On treatment|4|||
129946148|NCT01668719|467766478|FG002|Phase II|On treatment|3|||
129946149|NCT01668719|467766476|FG000|Phase II|Adverse Event|0|||
129946150|NCT01668719|467766477|FG001|Phase II|Adverse Event|18|||
129946151|NCT01668719|467766478|FG002|Phase II|Adverse Event|18|||
129946152|NCT01668719|467766476|FG000|Phase II|Refusal unrelated to adverse event|0|||
129946153|NCT01668719|467766477|FG001|Phase II|Refusal unrelated to adverse event|4|||
129946154|NCT01668719|467766478|FG002|Phase II|Refusal unrelated to adverse event|1|||
129946155|NCT01668719|467766476|FG000|Phase II|Progression/relapse|0|||
129946156|NCT01668719|467766477|FG001|Phase II|Progression/relapse|13|||
129946157|NCT01668719|467766478|FG002|Phase II|Progression/relapse|17|||
129946158|NCT01668719|467766476|FG000|Phase II|Death|0|||
129946159|NCT01668719|467766477|FG001|Phase II|Death|0|||
129946160|NCT01668719|467766478|FG002|Phase II|Death|2|||
129946161|NCT01668719|467766476|FG000|Phase II|not protocol specified|0|||
129946162|NCT01668719|467766477|FG001|Phase II|not protocol specified|13|||
129946163|NCT01668719|467766478|FG002|Phase II|not protocol specified|7|||
129946164|NCT02060487|467766479|FG000|Overall Study|Other|1|||
129946165|NCT02060487|467766480|FG001|Overall Study|Other|2|||
129946166|NCT02060487|467766481|FG002|Overall Study|Other|1|||
129946167|NCT02060487|467766479|FG000|Overall Study|Lack of Efficacy|0|||
129946168|NCT02060487|467766480|FG001|Overall Study|Lack of Efficacy|1|||
129946169|NCT02060487|467766481|FG002|Overall Study|Lack of Efficacy|0|||
129946170|NCT02060487|467766479|FG000|Overall Study|Withdrawal by Subject|3|||
129946171|NCT02060487|467766480|FG001|Overall Study|Withdrawal by Subject|10|||
129946172|NCT02060487|467766481|FG002|Overall Study|Withdrawal by Subject|4|||
129946173|NCT02060487|467766479|FG000|Overall Study|Study Terminated By Sponsor|87|||
129946174|NCT02060487|467766480|FG001|Overall Study|Study Terminated By Sponsor|89|||
129946175|NCT02060487|467766481|FG002|Overall Study|Study Terminated By Sponsor|100|||
129946176|NCT02060487|467766479|FG000|Overall Study|Randomized in error|1|||
129946177|NCT02060487|467766480|FG001|Overall Study|Randomized in error|0|||
129946178|NCT02060487|467766481|FG002|Overall Study|Randomized in error|0|||
129946179|NCT02060487|467766479|FG000|Overall Study|Protocol Violation|0|||
129946180|NCT02060487|467766480|FG001|Overall Study|Protocol Violation|1|||
129946181|NCT02060487|467766481|FG002|Overall Study|Protocol Violation|1|||
129946182|NCT02060487|467766479|FG000|Overall Study|Lost to Follow-up|3|||
129946183|NCT02060487|467766480|FG001|Overall Study|Lost to Follow-up|0|||
129946184|NCT02060487|467766481|FG002|Overall Study|Lost to Follow-up|2|||
129946185|NCT02060487|467766479|FG000|Overall Study|Death|34|||
129946186|NCT02060487|467766480|FG001|Overall Study|Death|25|||
129946187|NCT02060487|467766481|FG002|Overall Study|Death|19|||
129946188|NCT02060487|467766479|FG000|Overall Study|Adverse Event|0|||
129946189|NCT02060487|467766480|FG001|Overall Study|Adverse Event|0|||
129946190|NCT02060487|467766481|FG002|Overall Study|Adverse Event|1|||
129946191|NCT00875706|467766482|FG000|Overall Study|Withdrawal by Subject|1|||
129946192|NCT00875706|467766483|FG001|Overall Study|Withdrawal by Subject|0|||
129946193|NCT00875706|467766484|FG002|Overall Study|Withdrawal by Subject|0|||
129946194|NCT02950961|467766486|FG000|Overall Study|Study had to stop due to COVID.|7|||
129946195|NCT02241785|467766489|FG000|Overall Study|Sponsor Termination|43|||
129946196|NCT02241785|467766489|FG000|Overall Study|Withdrawal by Subject|1|||
129946197|NCT02241785|467766489|FG000|Overall Study|Lost to Follow-up|2|||
129946198|NCT02241785|467766489|FG000|Overall Study|Adverse Event|1|||
129946199|NCT03055988|467766490|FG000|Period 1|Adverse Event|0|||
129946200|NCT03055988|467766491|FG001|Period 1|Adverse Event|1|||
129946201|NCT03055988|467766490|FG000|Period 1|Lost to Follow-up|1|||
129946202|NCT03055988|467766491|FG001|Period 1|Lost to Follow-up|0|||
129946203|NCT03055988|467766490|FG000|Period 1|Withdrawal by Subject|0|||
129946204|NCT03055988|467766491|FG001|Period 1|Withdrawal by Subject|4|||
129946205|NCT03055988|467766490|FG000|Period 2|Adverse Event|0|||
129946206|NCT03055988|467766491|FG001|Period 2|Adverse Event|1|||
129946207|NCT03055988|467766490|FG000|Period 2|Other than listed|1|||
129946208|NCT03055988|467766491|FG001|Period 2|Other than listed|1|||
129946209|NCT00845520|467766492|FG000|Overall Study|Death|1|||
129946210|NCT00845520|467766493|FG001|Overall Study|Death|2|||
129946211|NCT00845520|467766494|FG002|Overall Study|Death|0|||
129946212|NCT00845520|467766492|FG000|Overall Study|Lost to Follow-up|1|||
129946213|NCT00845520|467766493|FG001|Overall Study|Lost to Follow-up|0|||
129946214|NCT00845520|467766494|FG002|Overall Study|Lost to Follow-up|0|||
129946215|NCT00845520|467766492|FG000|Overall Study|Adverse Event|0|||
129946216|NCT00845520|467766493|FG001|Overall Study|Adverse Event|0|||
129946217|NCT00845520|467766494|FG002|Overall Study|Adverse Event|1|||
129946218|NCT01736475|467766495|FG000|Overall Study|Adverse Event|4|||
129946219|NCT01736475|467766496|FG001|Overall Study|Adverse Event|0|||
129946220|NCT01736475|467766495|FG000|Overall Study|Withdrawal by Subject|2|||
129946221|NCT01736475|467766496|FG001|Overall Study|Withdrawal by Subject|0|||
129946222|NCT01736475|467766495|FG000|Overall Study|Protocol Violation|4|||
129946223|NCT01736475|467766496|FG001|Overall Study|Protocol Violation|0|||
129946224|NCT01736475|467766495|FG000|Overall Study|Other - Screen failure|1|||
129946225|NCT01736475|467766496|FG001|Overall Study|Other - Screen failure|0|||
129946226|NCT01736475|467766495|FG000|Overall Study|Other - Surgical procedure|1|||
129946227|NCT01736475|467766496|FG001|Overall Study|Other - Surgical procedure|0|||
129946228|NCT02807857|467766497|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
129946229|NCT02807857|467766497|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
129946230|NCT02807857|467766497|FG000|Follow-Up Set|Withdrawal by Subject|8|||
129946231|NCT02807857|467766497|FG000|Follow-Up Set|Lost to Follow-up|7|||
129946232|NCT02807857|467766497|FG000|Follow-Up Set|Physician Decision|6|||
129946233|NCT02807857|467766497|FG000|Follow-Up Set|Adverse Event|3|||
129946234|NCT02807857|467766497|FG000|Follow-Up Set|Death|27|||
129946235|NCT02807857|467766497|FG000|Follow-Up Set|Relocation|2|||
129946236|NCT01190124|467768447|FG000|Overall Study|Death|3|||
129946237|NCT01190124|467768448|FG001|Overall Study|Death|0|||
129946238|NCT01190124|467768449|FG002|Overall Study|Death|0|||
129946239|NCT01190124|467768447|FG000|Overall Study|Therapeutic Failure|12|||
129946240|NCT01190124|467768448|FG001|Overall Study|Therapeutic Failure|0|||
129946241|NCT01190124|467768449|FG002|Overall Study|Therapeutic Failure|1|||
129946242|NCT01190124|467768447|FG000|Overall Study|Lost to Follow-up|2|||
129946243|NCT01190124|467768448|FG001|Overall Study|Lost to Follow-up|0|||
129946244|NCT01190124|467768449|FG002|Overall Study|Lost to Follow-up|0|||
129946245|NCT00070707|467768450|FG000|Overall Study|Adverse Event|1|||
129946246|NCT00070707|467768451|FG001|Overall Study|Adverse Event|2|||
129946247|NCT00070707|467768450|FG000|Overall Study|Lack of Efficacy|4|||
129946248|NCT00070707|467768451|FG001|Overall Study|Lack of Efficacy|1|||
129946249|NCT00070707|467768450|FG000|Overall Study|Protocol Violation|8|||
129946250|NCT00070707|467768451|FG001|Overall Study|Protocol Violation|4|||
129946251|NCT00070707|467768450|FG000|Overall Study|Unrelated to Study Medication|1|||
129946252|NCT00070707|467768451|FG001|Overall Study|Unrelated to Study Medication|0|||
129946253|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
129946254|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
129946255|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
129946256|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
129946257|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
129946258|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
129946259|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
129946260|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
129946261|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
129946262|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
129946263|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
129946264|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
129946265|NCT03928743|467768452|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
129946266|NCT03928743|467768453|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
129946267|NCT03928743|467768454|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
129946268|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
129946269|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
129946270|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
129946271|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
129946272|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
129946273|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
129946274|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
129946275|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
129946276|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
129946277|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
129946278|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
129946279|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
129946280|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
129946281|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
129946282|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
129946283|NCT03928743|467768452|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
129946284|NCT03928743|467768453|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
129946285|NCT03928743|467768454|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
129946286|NCT02236611|467768456|FG000|Overall Study|Adverse Event|10|||
129946287|NCT02236611|467768457|FG001|Overall Study|Adverse Event|16|||
129946288|NCT02236611|467768456|FG000|Overall Study|Lack of Efficacy|4|||
129946289|NCT02236611|467768457|FG001|Overall Study|Lack of Efficacy|7|||
129946290|NCT02236611|467768456|FG000|Overall Study|Lost to Follow-up|0|||
129946291|NCT02236611|467768457|FG001|Overall Study|Lost to Follow-up|2|||
129946292|NCT02236611|467768456|FG000|Overall Study|Protocol deviation|3|||
129946293|NCT02236611|467768457|FG001|Overall Study|Protocol deviation|5|||
129946294|NCT02236611|467768456|FG000|Overall Study|Withdrew consent|9|||
129946295|NCT02236611|467768457|FG001|Overall Study|Withdrew consent|4|||
129946296|NCT01450007|467768458|FG000|Overall Study|Late exclusion before treatment|2|||
129946297|NCT01450007|467768459|FG001|Overall Study|Late exclusion before treatment|3|||
129946298|NCT01450007|467768460|FG002|Overall Study|Late exclusion before treatment|2|||
129946299|NCT01450007|467768458|FG000|Overall Study|Protocol Violation|0|||
129946300|NCT01450007|467768459|FG001|Overall Study|Protocol Violation|1|||
129946301|NCT01450007|467768460|FG002|Overall Study|Protocol Violation|1|||
129946302|NCT01450007|467768458|FG000|Overall Study|Adverse Event|0|||
129946303|NCT01450007|467768459|FG001|Overall Study|Adverse Event|1|||
129946304|NCT01450007|467768460|FG002|Overall Study|Adverse Event|0|||
129946305|NCT03851094|467768462|FG000|Overall Study|Withdrawal by Subject|0|||
129946306|NCT03851094|467768463|FG001|Overall Study|Withdrawal by Subject|1|||
129946307|NCT03851094|467768462|FG000|Overall Study|Participant lost device|0|||
129946308|NCT03851094|467768463|FG001|Overall Study|Participant lost device|1|||
129946309|NCT03851094|467768462|FG000|Overall Study|Participant returned device|0|||
129946310|NCT03851094|467768463|FG001|Overall Study|Participant returned device|2|||
129946311|NCT01536704|467768464|FG000|Washout Period 1|Withdrawal by Subject|1|||
129946312|NCT01536704|467768465|FG001|Washout Period 1|Withdrawal by Subject|2|||
129946313|NCT01536704|467768466|FG002|Washout Period 1|Withdrawal by Subject|0|||
129946314|NCT01536704|467768467|FG003|Washout Period 1|Withdrawal by Subject|0|||
129946315|NCT01536704|467768464|FG000|Washout Period 2|Adverse Event|1|||
129946316|NCT01536704|467768465|FG001|Washout Period 2|Adverse Event|0|||
129946317|NCT01536704|467768466|FG002|Washout Period 2|Adverse Event|0|||
129946318|NCT01536704|467768467|FG003|Washout Period 2|Adverse Event|0|||
129946319|NCT01536704|467768464|FG000|Washout Period 2|Withdrawal by Subject|0|||
129946320|NCT01536704|467768465|FG001|Washout Period 2|Withdrawal by Subject|0|||
129946321|NCT01536704|467768466|FG002|Washout Period 2|Withdrawal by Subject|0|||
129946322|NCT01536704|467768467|FG003|Washout Period 2|Withdrawal by Subject|1|||
129946323|NCT01536704|467768464|FG000|Period 3|Adverse Event|0|||
129946324|NCT01536704|467768465|FG001|Period 3|Adverse Event|0|||
129946325|NCT01536704|467768466|FG002|Period 3|Adverse Event|0|||
129946326|NCT01536704|467768467|FG003|Period 3|Adverse Event|1|||
129946327|NCT01536704|467768464|FG000|Washout Period 3|Adverse Event|0|||
129946328|NCT01536704|467768465|FG001|Washout Period 3|Adverse Event|0|||
129946329|NCT01536704|467768466|FG002|Washout Period 3|Adverse Event|1|||
129946330|NCT01536704|467768467|FG003|Washout Period 3|Adverse Event|0|||
129946331|NCT02392507|467768468|FG000|Induction Regimen|Death|3|||
129946332|NCT02392507|467768468|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
129946333|NCT02392507|467768468|FG000|Induction Regimen|Physician Decision|1|||
129946334|NCT02392507|467768468|FG000|Induction Regimen|Withdrawal by Subject|2|||
129946335|NCT02392507|467768468|FG000|Maintenance Regimen|Death|1|||
129946336|NCT02392507|467768468|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
129946337|NCT00240994|467768469|FG000|Overall Study|Lost to Follow-up|1|||
129946338|NCT00240994|467768469|FG000|Overall Study|Protocol Violation|1|||
129946339|NCT00240994|467768469|FG000|Overall Study|Graft failure|1|||
129946340|NCT00923078|467768473|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
129946341|NCT00923078|467768474|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
129946342|NCT00923078|467768475|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
129946343|NCT00923078|467768473|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
129946344|NCT00923078|467768474|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
129946345|NCT00923078|467768475|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
129946346|NCT03547154|467768486|FG000|Overall Study|Disease Progression/Recurrence|6|||
129946347|NCT03547154|467768487|FG001|Overall Study|Disease Progression/Recurrence|14|||
129946348|NCT03547154|467768486|FG000|Overall Study|Adverse Event|26|||
129946349|NCT03547154|467768487|FG001|Overall Study|Adverse Event|31|||
129946350|NCT03547154|467768486|FG000|Overall Study|Protocol Violation|6|||
129946351|NCT03547154|467768487|FG001|Overall Study|Protocol Violation|1|||
129946352|NCT03547154|467768486|FG000|Overall Study|Physician Decision|4|||
129946353|NCT03547154|467768487|FG001|Overall Study|Physician Decision|3|||
129946354|NCT03547154|467768486|FG000|Overall Study|Insufficient Therapeutic Response|13|||
129946355|NCT03547154|467768487|FG001|Overall Study|Insufficient Therapeutic Response|10|||
129946356|NCT03547154|467768486|FG000|Overall Study|Withdrawal by Subject|10|||
129946357|NCT03547154|467768487|FG001|Overall Study|Withdrawal by Subject|6|||
129946358|NCT03547154|467768486|FG000|Overall Study|Not Selected|0|||
129946359|NCT03547154|467768487|FG001|Overall Study|Not Selected|1|||
129946360|NCT03547154|467768486|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
129946361|NCT03547154|467768487|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
129946362|NCT04679675|467768488|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
129979777|NCT01204710|467889469|FG001|Randomization Treatment|Worsening of General condition|1|||
129946363|NCT04679675|467768489|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
129946364|NCT04679675|467768490|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
129946365|NCT04679675|467768491|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
129946366|NCT04679675|467768488|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
129946367|NCT04679675|467768489|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
129946368|NCT04679675|467768490|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
129946369|NCT04679675|467768491|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
129946370|NCT03259568|467768492|FG000|Overall Study|Participant performance was low|3|||
129946371|NCT01794299|467768502|FG000|Overall Study|ATIR manufacturing not possible|1|||
129946372|NCT01794299|467768502|FG000|Overall Study|Death|14|||
129946373|NCT01794299|467768502|FG000|Overall Study|Graft failure|1|||
129946374|NCT01794299|467768502|FG000|Overall Study|ATIR batch rejected|2|||
129946375|NCT01794299|467768502|FG000|Overall Study|Relapse|2|||
129946376|NCT01794299|467768502|FG000|Overall Study|Discontinued from active follow-up|1|||
129946377|NCT01794299|467768502|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
129946378|NCT01029704|467768503|FG000|Overall Study|Adverse Event|0|||
129946379|NCT01029704|467768504|FG001|Overall Study|Adverse Event|0|||
129946380|NCT01029704|467768505|FG002|Overall Study|Adverse Event|0|||
129946381|NCT01029704|467768506|FG003|Overall Study|Adverse Event|0|||
129946382|NCT01029704|467768507|FG004|Overall Study|Adverse Event|0|||
129946383|NCT01029704|467768508|FG005|Overall Study|Adverse Event|0|||
129946384|NCT01029704|467768509|FG006|Overall Study|Adverse Event|1|||
129946385|NCT01029704|467768510|FG007|Overall Study|Adverse Event|1|||
129946386|NCT01029704|467768511|FG008|Overall Study|Adverse Event|0|||
129946387|NCT01029704|467768503|FG000|Overall Study|Withdrawal by Subject|0|||
129946388|NCT01029704|467768504|FG001|Overall Study|Withdrawal by Subject|0|||
129946389|NCT01029704|467768505|FG002|Overall Study|Withdrawal by Subject|0|||
129946390|NCT01029704|467768506|FG003|Overall Study|Withdrawal by Subject|0|||
129946391|NCT01029704|467768507|FG004|Overall Study|Withdrawal by Subject|2|||
129946392|NCT01029704|467768508|FG005|Overall Study|Withdrawal by Subject|1|||
129946393|NCT01029704|467768509|FG006|Overall Study|Withdrawal by Subject|1|||
129946394|NCT01029704|467768510|FG007|Overall Study|Withdrawal by Subject|1|||
129946395|NCT01029704|467768511|FG008|Overall Study|Withdrawal by Subject|0|||
129946396|NCT01029704|467768503|FG000|Overall Study|Lost to Follow-up|0|||
129946397|NCT01029704|467768504|FG001|Overall Study|Lost to Follow-up|0|||
129946398|NCT01029704|467768505|FG002|Overall Study|Lost to Follow-up|0|||
129946399|NCT01029704|467768506|FG003|Overall Study|Lost to Follow-up|0|||
129946400|NCT01029704|467768507|FG004|Overall Study|Lost to Follow-up|0|||
129946401|NCT01029704|467768508|FG005|Overall Study|Lost to Follow-up|0|||
129946402|NCT01029704|467768509|FG006|Overall Study|Lost to Follow-up|1|||
129946403|NCT01029704|467768510|FG007|Overall Study|Lost to Follow-up|1|||
129946404|NCT01029704|467768511|FG008|Overall Study|Lost to Follow-up|1|||
129946405|NCT01029704|467768503|FG000|Overall Study|Lack of Efficacy|0|||
129946406|NCT01029704|467768504|FG001|Overall Study|Lack of Efficacy|0|||
129946407|NCT01029704|467768505|FG002|Overall Study|Lack of Efficacy|0|||
129946408|NCT01029704|467768506|FG003|Overall Study|Lack of Efficacy|0|||
129946409|NCT01029704|467768507|FG004|Overall Study|Lack of Efficacy|2|||
129946410|NCT01029704|467768508|FG005|Overall Study|Lack of Efficacy|3|||
129946411|NCT01029704|467768509|FG006|Overall Study|Lack of Efficacy|1|||
129946412|NCT01029704|467768510|FG007|Overall Study|Lack of Efficacy|2|||
129946413|NCT01029704|467768511|FG008|Overall Study|Lack of Efficacy|0|||
129946414|NCT01029704|467768503|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
129946415|NCT01029704|467768504|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
129946416|NCT01029704|467768505|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
129946417|NCT01029704|467768506|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
129946418|NCT01029704|467768507|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
129946419|NCT01029704|467768508|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
129946420|NCT01029704|467768509|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
129946421|NCT01029704|467768510|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
129946422|NCT01029704|467768511|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
129946423|NCT03006393|467768512|FG000|Overall Study|Withdrawal by Subject|1|||
129946424|NCT03006393|467768513|FG001|Overall Study|Withdrawal by Subject|1|||
129946425|NCT03006393|467768512|FG000|Overall Study|Pregnancy|0|||
129946426|NCT03006393|467768513|FG001|Overall Study|Pregnancy|1|||
129946427|NCT03006393|467768512|FG000|Overall Study|Lost to Follow-up|0|||
129946428|NCT03006393|467768513|FG001|Overall Study|Lost to Follow-up|1|||
129946429|NCT01365546|467768514|FG000|Overall Study|Withdrawal by Subject|1|||
129946430|NCT01365546|467768514|FG000|Overall Study|Screen failure|9|||
129946431|NCT01365546|467768514|FG000|Overall Study|Study termination|1|||
129946432|NCT00472082|467768515|FG000|Overall Study|Study prematurely terminated|5|||
129946433|NCT03200574|467768523|FG000|Overall Study|Death|4|||
129946434|NCT03200574|467768523|FG000|Overall Study|Withdrawal by Subject|8|||
129946435|NCT03200574|467768523|FG000|Overall Study|Long-Term need for anticoagulation|1|||
129946436|NCT03200574|467768523|FG000|Overall Study|Relocation|2|||
129946437|NCT03200574|467768523|FG000|Overall Study|Lost to Follow-up|2|||
129946438|NCT04183491|467768524|FG000|Overall Study|Withdrawal by Subject|0|||
129946439|NCT04183491|467768525|FG001|Overall Study|Withdrawal by Subject|0|||
129946440|NCT04183491|467768526|FG002|Overall Study|Withdrawal by Subject|1|||
129946441|NCT04183491|467768527|FG003|Overall Study|Withdrawal by Subject|0|||
129946442|NCT04183491|467768528|FG004|Overall Study|Withdrawal by Subject|0|||
129946443|NCT04183491|467768529|FG005|Overall Study|Withdrawal by Subject|1|||
129946444|NCT04183491|467768530|FG006|Overall Study|Withdrawal by Subject|0|||
129946445|NCT00068107|467768533|FG000|Overall Study|end-stage renal disease|6|||
129946446|NCT00068107|467768533|FG000|Overall Study|Death|2|||
129946447|NCT00068107|467768533|FG000|Overall Study|Withdrawal by Subject|1|||
129946448|NCT01419184|467768536|FG000|Overall Study|Site data not available|3|||
129946449|NCT01419184|467768537|FG001|Overall Study|Site data not available|2|||
129946450|NCT01419184|467768536|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
129946451|NCT01419184|467768537|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
129946452|NCT01419184|467768536|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
129946453|NCT01419184|467768537|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
129946454|NCT01419184|467768536|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
129946455|NCT01419184|467768537|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
129946456|NCT01419184|467768536|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
129946457|NCT01419184|467768537|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
129946458|NCT01419184|467768536|FG000|Overall Study|Participant randomized, not treated|1|||
129946459|NCT01419184|467768537|FG001|Overall Study|Participant randomized, not treated|0|||
129946460|NCT03989232|467768540|FG000|Overall Study|Lost to Follow-up|3|||
129946461|NCT03989232|467768541|FG001|Overall Study|Lost to Follow-up|10|||
129946462|NCT03989232|467768540|FG000|Overall Study|Withdrawal by Subject|6|||
129946463|NCT03989232|467768541|FG001|Overall Study|Withdrawal by Subject|6|||
129946464|NCT03989232|467768540|FG000|Overall Study|Death|1|||
129946465|NCT03989232|467768541|FG001|Overall Study|Death|2|||
129946466|NCT02691702|467768548|FG000|Overall Study|Adverse Event|1|||
129946467|NCT02691702|467768549|FG001|Overall Study|Adverse Event|0|||
129946468|NCT02691702|467768550|FG002|Overall Study|Adverse Event|0|||
129946469|NCT02691702|467768551|FG003|Overall Study|Adverse Event|0|||
129946470|NCT02691702|467768552|FG004|Overall Study|Adverse Event|0|||
129946471|NCT02691702|467768553|FG005|Overall Study|Adverse Event|0|||
129946472|NCT02691702|467768554|FG006|Overall Study|Adverse Event|0|||
129946473|NCT02691702|467768555|FG007|Overall Study|Adverse Event|0|||
129946474|NCT02691702|467768556|FG008|Overall Study|Adverse Event|1|||
129946475|NCT02691702|467768557|FG009|Overall Study|Adverse Event|0|||
129946476|NCT02691702|467768558|FG010|Overall Study|Adverse Event|1|||
129946477|NCT02691702|467768548|FG000|Overall Study|Lost to Follow-up|0|||
129946478|NCT02691702|467768549|FG001|Overall Study|Lost to Follow-up|0|||
129946479|NCT02691702|467768550|FG002|Overall Study|Lost to Follow-up|1|||
129946480|NCT02691702|467768551|FG003|Overall Study|Lost to Follow-up|0|||
129946481|NCT02691702|467768552|FG004|Overall Study|Lost to Follow-up|0|||
129946482|NCT02691702|467768553|FG005|Overall Study|Lost to Follow-up|2|||
129946483|NCT02691702|467768554|FG006|Overall Study|Lost to Follow-up|0|||
129946484|NCT02691702|467768555|FG007|Overall Study|Lost to Follow-up|0|||
129946485|NCT02691702|467768556|FG008|Overall Study|Lost to Follow-up|0|||
129946486|NCT02691702|467768557|FG009|Overall Study|Lost to Follow-up|0|||
129946487|NCT02691702|467768558|FG010|Overall Study|Lost to Follow-up|1|||
129946488|NCT02691702|467768548|FG000|Overall Study|Withdrawal by Subject|1|||
129946489|NCT02691702|467768549|FG001|Overall Study|Withdrawal by Subject|1|||
129946490|NCT02691702|467768550|FG002|Overall Study|Withdrawal by Subject|0|||
129946491|NCT02691702|467768551|FG003|Overall Study|Withdrawal by Subject|0|||
129946492|NCT02691702|467768552|FG004|Overall Study|Withdrawal by Subject|0|||
129946493|NCT02691702|467768553|FG005|Overall Study|Withdrawal by Subject|1|||
129946494|NCT02691702|467768554|FG006|Overall Study|Withdrawal by Subject|2|||
129946495|NCT02691702|467768555|FG007|Overall Study|Withdrawal by Subject|0|||
129946496|NCT02691702|467768556|FG008|Overall Study|Withdrawal by Subject|0|||
129946497|NCT02691702|467768557|FG009|Overall Study|Withdrawal by Subject|0|||
129946498|NCT02691702|467768558|FG010|Overall Study|Withdrawal by Subject|0|||
129946499|NCT02691702|467768548|FG000|Overall Study|Other|0|||
129946500|NCT02691702|467768549|FG001|Overall Study|Other|0|||
129946501|NCT02691702|467768550|FG002|Overall Study|Other|0|||
129946502|NCT02691702|467768551|FG003|Overall Study|Other|0|||
129946503|NCT02691702|467768552|FG004|Overall Study|Other|0|||
129946504|NCT02691702|467768553|FG005|Overall Study|Other|0|||
129946505|NCT02691702|467768554|FG006|Overall Study|Other|1|||
129946506|NCT02691702|467768555|FG007|Overall Study|Other|0|||
129946507|NCT02691702|467768556|FG008|Overall Study|Other|1|||
129946508|NCT02691702|467768557|FG009|Overall Study|Other|0|||
129946509|NCT02691702|467768558|FG010|Overall Study|Other|0|||
129946510|NCT02691702|467768548|FG000|Overall Study|Protocol Violation|0|||
129946511|NCT02691702|467768549|FG001|Overall Study|Protocol Violation|0|||
129946512|NCT02691702|467768550|FG002|Overall Study|Protocol Violation|0|||
129946513|NCT02691702|467768551|FG003|Overall Study|Protocol Violation|0|||
129946514|NCT02691702|467768552|FG004|Overall Study|Protocol Violation|0|||
129946515|NCT02691702|467768553|FG005|Overall Study|Protocol Violation|0|||
129946516|NCT02691702|467768554|FG006|Overall Study|Protocol Violation|0|||
129946517|NCT02691702|467768555|FG007|Overall Study|Protocol Violation|0|||
129946518|NCT02691702|467768556|FG008|Overall Study|Protocol Violation|0|||
129946519|NCT02691702|467768557|FG009|Overall Study|Protocol Violation|2|||
129946520|NCT02691702|467768558|FG010|Overall Study|Protocol Violation|0|||
129946521|NCT05169684|467768559|FG000|Overall Study|Adverse Event|1|||
129946522|NCT05169684|467768560|FG001|Overall Study|Adverse Event|3|||
129946523|NCT05169684|467768559|FG000|Overall Study|Physician Decision|0|||
129946524|NCT05169684|467768560|FG001|Overall Study|Physician Decision|1|||
129946525|NCT05169684|467768559|FG000|Overall Study|Progressive Disease|1|||
129946526|NCT05169684|467768560|FG001|Overall Study|Progressive Disease|1|||
129946527|NCT05169684|467768559|FG000|Overall Study|Participant request to discontinue treatment|0|||
129946528|NCT05169684|467768560|FG001|Overall Study|Participant request to discontinue treatment|1|||
129946529|NCT05169684|467768559|FG000|Overall Study|Other Reason|0|||
129946530|NCT05169684|467768560|FG001|Overall Study|Other Reason|1|||
129946531|NCT05484661|467768561|FG000|Overall Study|Withdrawal by Subject|1|||
129946532|NCT05484661|467768562|FG001|Overall Study|Withdrawal by Subject|0|||
129946533|NCT03205488|467768568|FG000|Overall Study|Adverse Event|1|||
129946534|NCT03205488|467768569|FG001|Overall Study|Adverse Event|2|||
129946535|NCT03205488|467768570|FG002|Overall Study|Adverse Event|4|||
129946536|NCT03205488|467768568|FG000|Overall Study|Protocol Violation|0|||
129946537|NCT03205488|467768569|FG001|Overall Study|Protocol Violation|0|||
129946538|NCT03205488|467768570|FG002|Overall Study|Protocol Violation|1|||
129946539|NCT01856569|467768571|FG000|Overall Study|Other|1|||
129946540|NCT01856569|467768571|FG000|Overall Study|Changed Site/Structure|1|||
129946541|NCT01856569|467768571|FG000|Overall Study|Lost to Follow-up|3|||
129946542|NCT01856569|467768571|FG000|Overall Study|Did not met inclusion criteria|8|||
129946543|NCT03652610|467768572|FG000|Overall Study|Lost to Follow-up|1|||
129946544|NCT03652610|467768573|FG001|Overall Study|Lost to Follow-up|0|||
129946545|NCT03652610|467768572|FG000|Overall Study|Withdrawal by Subject|3|||
129946546|NCT03652610|467768573|FG001|Overall Study|Withdrawal by Subject|5|||
129946547|NCT00326183|467768574|FG000|Overall Study|Lost to Follow-up|104|||
129946548|NCT00326183|467768575|FG001|Overall Study|Lost to Follow-up|56|||
129946549|NCT00326183|467768574|FG000|Overall Study|Protocol Violation|6|||
129946550|NCT00326183|467768575|FG001|Overall Study|Protocol Violation|3|||
129946551|NCT00326183|467768574|FG000|Overall Study|Withdrawal by Subject|35|||
129946552|NCT00326183|467768575|FG001|Overall Study|Withdrawal by Subject|7|||
129946553|NCT00326183|467768574|FG000|Overall Study|Subject Moved|7|||
129946554|NCT00326183|467768575|FG001|Overall Study|Subject Moved|4|||
129946555|NCT00326183|467768574|FG000|Overall Study|Other|47|||
129946556|NCT00326183|467768575|FG001|Overall Study|Other|13|||
129946557|NCT00326183|467768574|FG000|Overall Study|Adverse Event|1|||
129946558|NCT00326183|467768575|FG001|Overall Study|Adverse Event|0|||
129946559|NCT02279732|467768577|FG000|Overall Study|Death|23|||
129946560|NCT02279732|467768578|FG001|Overall Study|Death|20|||
129946561|NCT02279732|467768577|FG000|Overall Study|Disease Progression|13|||
129946562|NCT02279732|467768578|FG001|Overall Study|Disease Progression|3|||
129946563|NCT02279732|467768577|FG000|Overall Study|Withdrawal by Subject|2|||
129946564|NCT02279732|467768578|FG001|Overall Study|Withdrawal by Subject|7|||
129946565|NCT02279732|467768577|FG000|Overall Study|Adverse Event|1|||
129946566|NCT02279732|467768578|FG001|Overall Study|Adverse Event|2|||
129946567|NCT02279732|467768577|FG000|Overall Study|Administrative Reason By Sponsor|0|||
129946568|NCT02279732|467768578|FG001|Overall Study|Administrative Reason By Sponsor|2|||
129946569|NCT02279732|467768577|FG000|Overall Study|Study Drug Toxicity|2|||
129946570|NCT02279732|467768578|FG001|Overall Study|Study Drug Toxicity|0|||
129946571|NCT02279732|467768577|FG000|Overall Study|Lost to Follow-up|0|||
129946572|NCT02279732|467768578|FG001|Overall Study|Lost to Follow-up|1|||
129946573|NCT02279732|467768577|FG000|Overall Study|Maximum Clinical Benefit|1|||
129946574|NCT02279732|467768578|FG001|Overall Study|Maximum Clinical Benefit|0|||
129946575|NCT02279732|467768577|FG000|Overall Study|Subject Requested to Discontinue|0|||
129946576|NCT02279732|467768578|FG001|Overall Study|Subject Requested to Discontinue|1|||
129946577|NCT02279732|467768577|FG000|Overall Study|Other|53|||
129946578|NCT02279732|467768578|FG001|Overall Study|Other|67|||
129946579|NCT02279732|467768577|FG000|Overall Study|Other|3|||
129946580|NCT02279732|467768578|FG001|Overall Study|Other|3|||
129946581|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
129946582|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
129946583|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
129946584|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
129946585|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
129946586|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
129946587|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
129946588|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
129946589|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Death|41|||
129946590|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Death|33|||
129946591|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Death|0|||
129946592|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Death|0|||
129946593|NCT02970318|467768579|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
129946594|NCT02970318|467768580|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
129946595|NCT02970318|467768581|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
129946596|NCT02970318|467768582|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
129946597|NCT02970318|467768579|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
129946598|NCT02970318|467768580|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
129946599|NCT02970318|467768581|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
129946600|NCT02970318|467768582|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
129946601|NCT02970318|467768579|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
129946602|NCT02970318|467768580|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
129946603|NCT02970318|467768581|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
129946604|NCT02970318|467768582|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
129946605|NCT02970318|467768579|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
129946606|NCT02970318|467768580|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
129946607|NCT02970318|467768581|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
129946608|NCT02970318|467768582|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
129946609|NCT00824408|467768583|FG000|Run-in Phase|Progressive disease|4|||
129946610|NCT00824408|467768584|FG001|Run-in Phase|Progressive disease|4|||
129946611|NCT00824408|467768585|FG002|Run-in Phase|Progressive disease|0|||
129946612|NCT00824408|467768586|FG003|Run-in Phase|Progressive disease|0|||
129946613|NCT00824408|467768587|FG004|Run-in Phase|Progressive disease|0|||
129946614|NCT00824408|467768583|FG000|Run-in Phase|Adverse Event|1|||
129946615|NCT00824408|467768584|FG001|Run-in Phase|Adverse Event|1|||
129946616|NCT00824408|467768585|FG002|Run-in Phase|Adverse Event|0|||
129946617|NCT00824408|467768586|FG003|Run-in Phase|Adverse Event|0|||
129946618|NCT00824408|467768587|FG004|Run-in Phase|Adverse Event|0|||
129946619|NCT00824408|467768583|FG000|Run-in Phase|Refused to continue medication|1|||
129946620|NCT00824408|467768584|FG001|Run-in Phase|Refused to continue medication|0|||
129946621|NCT00824408|467768585|FG002|Run-in Phase|Refused to continue medication|0|||
129946622|NCT00824408|467768586|FG003|Run-in Phase|Refused to continue medication|0|||
129946623|NCT00824408|467768587|FG004|Run-in Phase|Refused to continue medication|0|||
129946624|NCT00824408|467768583|FG000|Run-in Phase|Other reason not defined above|0|||
129946625|NCT00824408|467768584|FG001|Run-in Phase|Other reason not defined above|1|||
129946626|NCT00824408|467768585|FG002|Run-in Phase|Other reason not defined above|0|||
129946627|NCT00824408|467768586|FG003|Run-in Phase|Other reason not defined above|0|||
129946628|NCT00824408|467768587|FG004|Run-in Phase|Other reason not defined above|0|||
129946629|NCT00824408|467768583|FG000|Randomized Phase|Not treated|0|||
129946630|NCT00824408|467768584|FG001|Randomized Phase|Not treated|0|||
129946631|NCT00824408|467768585|FG002|Randomized Phase|Not treated|1|||
129946632|NCT00824408|467768586|FG003|Randomized Phase|Not treated|1|||
129946633|NCT00824408|467768587|FG004|Randomized Phase|Not treated|1|||
129946634|NCT00824408|467768583|FG000|Randomized Phase|Progressive disease|0|||
129946635|NCT00824408|467768584|FG001|Randomized Phase|Progressive disease|0|||
129946636|NCT00824408|467768585|FG002|Randomized Phase|Progressive disease|25|||
129946637|NCT00824408|467768586|FG003|Randomized Phase|Progressive disease|36|||
129946638|NCT00824408|467768587|FG004|Randomized Phase|Progressive disease|34|||
129946639|NCT00824408|467768583|FG000|Randomized Phase|Adverse Event|0|||
129946640|NCT00824408|467768584|FG001|Randomized Phase|Adverse Event|0|||
129946641|NCT00824408|467768585|FG002|Randomized Phase|Adverse Event|4|||
129946642|NCT00824408|467768586|FG003|Randomized Phase|Adverse Event|5|||
129946643|NCT00824408|467768587|FG004|Randomized Phase|Adverse Event|5|||
129946644|NCT00824408|467768583|FG000|Randomized Phase|Refused to continue medication|0|||
129946645|NCT00824408|467768584|FG001|Randomized Phase|Refused to continue medication|0|||
129946646|NCT00824408|467768585|FG002|Randomized Phase|Refused to continue medication|2|||
129946647|NCT00824408|467768586|FG003|Randomized Phase|Refused to continue medication|2|||
129946648|NCT00824408|467768587|FG004|Randomized Phase|Refused to continue medication|2|||
129946649|NCT00824408|467768583|FG000|Randomized Phase|Other reason not defined above|0|||
129946650|NCT00824408|467768584|FG001|Randomized Phase|Other reason not defined above|0|||
129946651|NCT00824408|467768585|FG002|Randomized Phase|Other reason not defined above|4|||
129946652|NCT00824408|467768586|FG003|Randomized Phase|Other reason not defined above|2|||
129946653|NCT00824408|467768587|FG004|Randomized Phase|Other reason not defined above|4|||
129946654|NCT01263496|467768596|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
129946655|NCT01263496|467768597|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946656|NCT01263496|467768598|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946657|NCT01263496|467768599|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946658|NCT01263496|467768600|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946659|NCT01263496|467768601|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946660|NCT01263496|467768602|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946661|NCT01263496|467768603|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946662|NCT01263496|467768604|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
129946663|NCT01263496|467768596|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946664|NCT01263496|467768597|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946665|NCT01263496|467768598|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946666|NCT01263496|467768599|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
129946667|NCT01263496|467768600|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
129946668|NCT01263496|467768601|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946669|NCT01263496|467768602|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946670|NCT01263496|467768603|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946671|NCT01263496|467768604|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129946672|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
129946673|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
129946674|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
129946675|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
129946676|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
129946677|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
129946678|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
129946679|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
129946680|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
129946681|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946682|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
129946683|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946684|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946685|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946686|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946687|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946688|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946689|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129946690|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946691|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129946692|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129946693|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129946694|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
129946695|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946696|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946697|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129946698|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129946699|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
129946700|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
129946701|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
129946702|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129946703|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
129946704|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129946705|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129946706|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129946707|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129946708|NCT01263496|467768596|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946709|NCT01263496|467768597|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946710|NCT01263496|467768598|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946711|NCT01263496|467768599|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946712|NCT01263496|467768600|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946713|NCT01263496|467768601|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946714|NCT01263496|467768602|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946715|NCT01263496|467768603|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
129946716|NCT01263496|467768604|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129946717|NCT02915783|467768605|FG000|Overall Study|Death|21|||
129946718|NCT02915783|467768605|FG000|Overall Study|Lost to Follow-up|1|||
129946719|NCT02915783|467768605|FG000|Overall Study|Withdrawal by Subject|2|||
129946720|NCT01528605|467768606|FG000|Overall Study|Lost to Follow-up|1|||
129946721|NCT01528605|467768607|FG001|Overall Study|Lost to Follow-up|0|||
129946722|NCT01528605|467768608|FG002|Overall Study|Lost to Follow-up|1|||
129946723|NCT01528605|467768609|FG003|Overall Study|Lost to Follow-up|1|||
129946724|NCT01528605|467768610|FG004|Overall Study|Lost to Follow-up|0|||
129946725|NCT01528605|467768611|FG005|Overall Study|Lost to Follow-up|0|||
129946726|NCT01528605|467768606|FG000|Overall Study|Death|1|||
129946727|NCT01528605|467768607|FG001|Overall Study|Death|0|||
129946728|NCT01528605|467768608|FG002|Overall Study|Death|0|||
129946729|NCT01528605|467768609|FG003|Overall Study|Death|0|||
129946730|NCT01528605|467768610|FG004|Overall Study|Death|0|||
129946731|NCT01528605|467768611|FG005|Overall Study|Death|0|||
129946732|NCT01075152|467768617|FG000|Overall Study|Withdrawal by Subject|1|||
129946733|NCT01075152|467768618|FG001|Overall Study|Withdrawal by Subject|0|||
129946734|NCT01668355|467770049|FG000|Overall Study|Death|3|||
129946735|NCT01668355|467770050|FG001|Overall Study|Death|1|||
129946736|NCT01668355|467770049|FG000|Overall Study|Withdrawal by Subject|6|||
129946737|NCT01668355|467770050|FG001|Overall Study|Withdrawal by Subject|1|||
129946738|NCT00535626|467770051|FG000|Overall Study|Death|15|||
129946739|NCT00535626|467770051|FG000|Overall Study|Lost to Follow-up|29|||
129946740|NCT00535626|467770051|FG000|Overall Study|Withdrawal by Subject|20|||
129946741|NCT00535626|467770051|FG000|Overall Study|Removal/revision of study component|8|||
129946742|NCT00535626|467770051|FG000|Overall Study|Subject terminated|31|||
129946743|NCT00535626|467770051|FG000|Overall Study|Unable to return|2|||
129946744|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
129946745|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
129946746|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
129946747|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
129946748|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
129946749|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
129946750|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
129946751|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
129946752|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
129946753|NCT01277302|467770052|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
129946754|NCT01277302|467770053|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
129946755|NCT01277302|467770054|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
129946756|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
129946757|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
129946758|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
129946759|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
129946760|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
129946761|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
129946762|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
129946763|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
129946764|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
129946765|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
129946766|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
129946767|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
129946768|NCT01277302|467770052|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
129946769|NCT01277302|467770053|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
129946770|NCT01277302|467770054|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
129946771|NCT02710669|467770055|FG000|Overall Study|Physician Decision|2|||
129946772|NCT02710669|467770056|FG001|Overall Study|Physician Decision|1|||
129946773|NCT02710669|467770057|FG002|Overall Study|Physician Decision|0|||
129946774|NCT02710669|467770055|FG000|Overall Study|Institutional delays (including COVID)|2|||
129946775|NCT02710669|467770056|FG001|Overall Study|Institutional delays (including COVID)|2|||
129946776|NCT02710669|467770057|FG002|Overall Study|Institutional delays (including COVID)|0|||
129946777|NCT02710669|467770055|FG000|Overall Study|arrived in afib/aflutter|10|||
129946778|NCT02710669|467770056|FG001|Overall Study|arrived in afib/aflutter|8|||
129946779|NCT02710669|467770057|FG002|Overall Study|arrived in afib/aflutter|2|||
129946780|NCT00731692|467770060|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
129453458|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
129946781|NCT00731692|467770061|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
129946782|NCT00731692|467770062|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
129946783|NCT00731692|467770060|FG000|Core Study (36 Months)|Physician Decision|1|||
129946784|NCT00731692|467770061|FG001|Core Study (36 Months)|Physician Decision|0|||
129946785|NCT00731692|467770062|FG002|Core Study (36 Months)|Physician Decision|2|||
129946786|NCT00731692|467770060|FG000|Core Study (36 Months)|Death|2|||
129453459|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
129453460|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
129946787|NCT00731692|467770061|FG001|Core Study (36 Months)|Death|1|||
129946788|NCT00731692|467770062|FG002|Core Study (36 Months)|Death|2|||
129946789|NCT00731692|467770060|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
129946790|NCT00731692|467770061|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
129946791|NCT00731692|467770062|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
129946792|NCT00731692|467770060|FG000|Core Study (36 Months)|Administrative|2|||
129946793|NCT00731692|467770061|FG001|Core Study (36 Months)|Administrative|2|||
129946794|NCT00731692|467770062|FG002|Core Study (36 Months)|Administrative|6|||
129946795|NCT00731692|467770060|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
129946796|NCT00731692|467770061|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
129946797|NCT00731692|467770062|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
129946798|NCT00731692|467770060|FG000|Core Study (36 Months)|Protocol Violation|4|||
129946799|NCT00731692|467770061|FG001|Core Study (36 Months)|Protocol Violation|5|||
129946800|NCT00731692|467770062|FG002|Core Study (36 Months)|Protocol Violation|8|||
129453461|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
129453462|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
129453463|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
129453464|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
129453465|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
129453466|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
129453467|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
129453468|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
129453469|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453470|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129453471|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129453472|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129453473|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453474|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129453475|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
129453476|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
129453477|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
129453478|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
129946801|NCT00731692|467770060|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
129946802|NCT00731692|467770061|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
129946803|NCT00731692|467770062|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
129946804|NCT00731692|467770060|FG000|Core Study (36 Months)|Adverse Event|25|||
129946805|NCT00731692|467770061|FG001|Core Study (36 Months)|Adverse Event|28|||
129946806|NCT00731692|467770062|FG002|Core Study (36 Months)|Adverse Event|29|||
129453479|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
129453480|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
129453481|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
129453482|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
129453483|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
129946807|NCT00731692|467770060|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
129946808|NCT00731692|467770061|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
129946809|NCT00731692|467770062|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
129946810|NCT00731692|467770060|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
129946811|NCT00731692|467770061|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
129946812|NCT00731692|467770062|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
129946813|NCT00731692|467770060|FG000|Extension Phase|Abnormal test procedure|0|||
129946814|NCT00731692|467770061|FG001|Extension Phase|Abnormal test procedure|0|||
129946815|NCT00731692|467770062|FG002|Extension Phase|Abnormal test procedure|1|||
129946816|NCT00731692|467770060|FG000|Extension Phase|Abnormal lab values|0|||
129946817|NCT00731692|467770061|FG001|Extension Phase|Abnormal lab values|0|||
129946818|NCT00731692|467770062|FG002|Extension Phase|Abnormal lab values|1|||
129946819|NCT00731692|467770060|FG000|Extension Phase|Lost to Follow-up|0|||
129946820|NCT00731692|467770061|FG001|Extension Phase|Lost to Follow-up|1|||
129946821|NCT00731692|467770062|FG002|Extension Phase|Lost to Follow-up|4|||
129453484|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
129946822|NCT00731692|467770060|FG000|Extension Phase|Withdrawal by Subject|4|||
129946823|NCT00731692|467770061|FG001|Extension Phase|Withdrawal by Subject|5|||
129946824|NCT00731692|467770062|FG002|Extension Phase|Withdrawal by Subject|3|||
129946825|NCT00731692|467770060|FG000|Extension Phase|Adverse Event|1|||
129946826|NCT00731692|467770061|FG001|Extension Phase|Adverse Event|1|||
129946827|NCT00731692|467770062|FG002|Extension Phase|Adverse Event|15|||
129946828|NCT03332589|467770063|FG000|Overall Study|Lack of Efficacy|2|||
129946829|NCT03332589|467770064|FG001|Overall Study|Lack of Efficacy|0|||
129946830|NCT03332589|467770065|FG002|Overall Study|Lack of Efficacy|0|||
129946831|NCT03332589|467770063|FG000|Overall Study|Adverse Event|1|||
129946832|NCT03332589|467770064|FG001|Overall Study|Adverse Event|0|||
129946833|NCT03332589|467770065|FG002|Overall Study|Adverse Event|0|||
129946834|NCT03332589|467770063|FG000|Overall Study|Death|1|||
129946835|NCT03332589|467770064|FG001|Overall Study|Death|0|||
129946836|NCT03332589|467770065|FG002|Overall Study|Death|0|||
129946837|NCT00108355|467770070|FG000|Overall Study|Peritonitis at index paracentesis|1|||
129946838|NCT00108355|467770071|FG001|Overall Study|Peritonitis at index paracentesis|1|||
129946839|NCT00108355|467770070|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
129946840|NCT00108355|467770071|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
129946841|NCT02002689|467770076|FG000|Overall Study|Disease Progression|7|||
129946842|NCT02002689|467770076|FG000|Overall Study|Adverse Event|3|||
129946843|NCT00087516|467770077|FG000|Overall Study|Adverse Event|10|||
129946844|NCT00087516|467770078|FG001|Overall Study|Adverse Event|10|||
129946845|NCT00087516|467770079|FG002|Overall Study|Adverse Event|3|||
129946846|NCT00087516|467770080|FG003|Overall Study|Adverse Event|6|||
129946847|NCT00087516|467770077|FG000|Overall Study|Lack of Efficacy|82|||
129946848|NCT00087516|467770078|FG001|Overall Study|Lack of Efficacy|80|||
129946849|NCT00087516|467770079|FG002|Overall Study|Lack of Efficacy|39|||
129946850|NCT00087516|467770080|FG003|Overall Study|Lack of Efficacy|29|||
129946851|NCT00087516|467770077|FG000|Overall Study|Lost to Follow-up|8|||
129946852|NCT00087516|467770078|FG001|Overall Study|Lost to Follow-up|6|||
129946853|NCT00087516|467770079|FG002|Overall Study|Lost to Follow-up|5|||
129946854|NCT00087516|467770080|FG003|Overall Study|Lost to Follow-up|5|||
129946855|NCT00087516|467770077|FG000|Overall Study|Protocol Violation|4|||
129946856|NCT00087516|467770078|FG001|Overall Study|Protocol Violation|8|||
129946857|NCT00087516|467770079|FG002|Overall Study|Protocol Violation|3|||
129946858|NCT00087516|467770080|FG003|Overall Study|Protocol Violation|6|||
129946859|NCT00087516|467770077|FG000|Overall Study|Withdrawal by Subject|16|||
129946860|NCT00087516|467770078|FG001|Overall Study|Withdrawal by Subject|27|||
129946861|NCT00087516|467770079|FG002|Overall Study|Withdrawal by Subject|11|||
129946862|NCT00087516|467770080|FG003|Overall Study|Withdrawal by Subject|12|||
129946863|NCT00087516|467770077|FG000|Overall Study|Site terminated|0|||
129946864|NCT00087516|467770078|FG001|Overall Study|Site terminated|2|||
129946865|NCT00087516|467770079|FG002|Overall Study|Site terminated|1|||
129946866|NCT00087516|467770080|FG003|Overall Study|Site terminated|0|||
129946867|NCT00087516|467770077|FG000|Overall Study|Protocol specified discontinuation|35|||
129946868|NCT00087516|467770078|FG001|Overall Study|Protocol specified discontinuation|33|||
129946869|NCT00087516|467770079|FG002|Overall Study|Protocol specified discontinuation|33|||
129946870|NCT00087516|467770080|FG003|Overall Study|Protocol specified discontinuation|26|||
129946871|NCT00087516|467770077|FG000|Overall Study|Patient moved|3|||
129946872|NCT00087516|467770078|FG001|Overall Study|Patient moved|2|||
129946873|NCT00087516|467770079|FG002|Overall Study|Patient moved|1|||
129946874|NCT00087516|467770080|FG003|Overall Study|Patient moved|0|||
129946875|NCT00087516|467770077|FG000|Overall Study|Patient was non-compliant|3|||
129946876|NCT00087516|467770078|FG001|Overall Study|Patient was non-compliant|1|||
129946877|NCT00087516|467770079|FG002|Overall Study|Patient was non-compliant|0|||
129946878|NCT00087516|467770080|FG003|Overall Study|Patient was non-compliant|0|||
129946879|NCT00087516|467770077|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
129946880|NCT00087516|467770078|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
129946881|NCT00087516|467770079|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
129946882|NCT00087516|467770080|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
129946883|NCT00087516|467770077|FG000|Overall Study|Other|0|||
129946884|NCT00087516|467770078|FG001|Overall Study|Other|0|||
129946885|NCT00087516|467770079|FG002|Overall Study|Other|1|||
129946886|NCT00087516|467770080|FG003|Overall Study|Other|0|||
129946887|NCT01128959|467770085|FG000|Lead in Period|Adverse Event|3|||
129946888|NCT01128959|467770085|FG000|Treatment Period|Adverse Event|3|||
129946889|NCT01128959|467770085|FG000|Treatment Period|Withdrawal by Subject|1|||
129946890|NCT02338999|467770086|FG000|First Intervention|Withdrawal by Subject|3|||
129946891|NCT02338999|467770087|FG001|First Intervention|Withdrawal by Subject|1|||
129946892|NCT02338999|467770086|FG000|Washout Period|Withdrawal by Subject|0|||
129946893|NCT02338999|467770087|FG001|Washout Period|Withdrawal by Subject|2|||
129946894|NCT02338999|467770086|FG000|Second Intervention|Withdrawal by Subject|0|||
129946895|NCT02338999|467770087|FG001|Second Intervention|Withdrawal by Subject|2|||
129946896|NCT02701296|467770088|FG000|Overall Study|Incomplete Data|0|||
129946897|NCT02701296|467770089|FG001|Overall Study|Incomplete Data|2|||
129946898|NCT00569166|467770090|FG000|Overall Study|Withdrawal by Subject|7|||
129946899|NCT00569166|467770091|FG001|Overall Study|Withdrawal by Subject|5|||
129946900|NCT00569166|467770092|FG002|Overall Study|Withdrawal by Subject|3|||
129946901|NCT00569166|467770090|FG000|Overall Study|Lost to Follow-up|2|||
129946902|NCT00569166|467770091|FG001|Overall Study|Lost to Follow-up|1|||
129946903|NCT00569166|467770092|FG002|Overall Study|Lost to Follow-up|1|||
129946904|NCT05005247|467770093|FG000|Overall Study|Withdrawal by Subject|0|||
129946905|NCT05005247|467770094|FG001|Overall Study|Withdrawal by Subject|1|||
129946906|NCT05005247|467770095|FG002|Overall Study|Withdrawal by Subject|0|||
129946907|NCT00308308|467770096|FG000|Overall Study|Adverse Event|17|||
129946908|NCT00308308|467770097|FG001|Overall Study|Adverse Event|2|||
129946909|NCT00308308|467770096|FG000|Overall Study|Lost to Follow-up|5|||
129946910|NCT00308308|467770097|FG001|Overall Study|Lost to Follow-up|5|||
129946911|NCT00308308|467770096|FG000|Overall Study|Physician Decision|15|||
129946912|NCT00308308|467770097|FG001|Overall Study|Physician Decision|7|||
129946913|NCT00308308|467770096|FG000|Overall Study|Protocol Violation|3|||
129946914|NCT00308308|467770097|FG001|Overall Study|Protocol Violation|14|||
129946915|NCT00308308|467770096|FG000|Overall Study|Withdrawal by Subject|47|||
129946916|NCT00308308|467770097|FG001|Overall Study|Withdrawal by Subject|19|||
129946917|NCT00308308|467770096|FG000|Overall Study|Various|7|||
129946918|NCT00308308|467770097|FG001|Overall Study|Various|5|||
129946919|NCT00308308|467770096|FG000|Overall Study|Randomized but not dosed|8|||
129946920|NCT00308308|467770097|FG001|Overall Study|Randomized but not dosed|16|||
129946921|NCT00308308|467770096|FG000|Overall Study|Other|1|||
129946922|NCT00308308|467770097|FG001|Overall Study|Other|0|||
129946923|NCT01802333|467770098|FG000|Overall Study|Ineligible|2|||
129946924|NCT01802333|467770099|FG001|Overall Study|Ineligible|6|||
129946925|NCT01802333|467770100|FG002|Overall Study|Ineligible|8|||
129946926|NCT01802333|467770098|FG000|Overall Study|Adverse Event|1|||
129946927|NCT01802333|467770099|FG001|Overall Study|Adverse Event|8|||
129946928|NCT01802333|467770100|FG002|Overall Study|Adverse Event|8|||
129946929|NCT01802333|467770098|FG000|Overall Study|Withdrawal by Subject|6|||
129946930|NCT01802333|467770099|FG001|Overall Study|Withdrawal by Subject|6|||
129946931|NCT01802333|467770100|FG002|Overall Study|Withdrawal by Subject|5|||
129946932|NCT01802333|467770098|FG000|Overall Study|Progression/relapse|1|||
129946933|NCT01802333|467770099|FG001|Overall Study|Progression/relapse|3|||
129946934|NCT01802333|467770100|FG002|Overall Study|Progression/relapse|0|||
129946935|NCT01802333|467770098|FG000|Overall Study|Death|7|||
129946936|NCT01802333|467770099|FG001|Overall Study|Death|14|||
129946937|NCT01802333|467770100|FG002|Overall Study|Death|13|||
129946938|NCT01802333|467770098|FG000|Overall Study|Other - not protocol specified|32|||
129946939|NCT01802333|467770099|FG001|Overall Study|Other - not protocol specified|22|||
129946940|NCT01802333|467770100|FG002|Overall Study|Other - not protocol specified|24|||
129946941|NCT01802333|467770098|FG000|Overall Study|Did not start treatment|0|||
129946942|NCT01802333|467770099|FG001|Overall Study|Did not start treatment|2|||
129946943|NCT01802333|467770100|FG002|Overall Study|Did not start treatment|5|||
129946944|NCT01947491|467770102|FG000|Overall Study|Lost to Follow-up|5|||
129946945|NCT01947491|467770103|FG001|Overall Study|Lost to Follow-up|3|||
129946946|NCT01947491|467770104|FG002|Overall Study|Lost to Follow-up|1|||
129946947|NCT01947491|467770105|FG003|Overall Study|Lost to Follow-up|2|||
129946948|NCT01947491|467770102|FG000|Overall Study|Lack of Efficacy|1|||
129946949|NCT01947491|467770103|FG001|Overall Study|Lack of Efficacy|0|||
129946950|NCT01947491|467770104|FG002|Overall Study|Lack of Efficacy|0|||
129946951|NCT01947491|467770105|FG003|Overall Study|Lack of Efficacy|1|||
129946952|NCT01947491|467770102|FG000|Overall Study|Protocol Violation|1|||
129946953|NCT01947491|467770103|FG001|Overall Study|Protocol Violation|0|||
129946954|NCT01947491|467770104|FG002|Overall Study|Protocol Violation|0|||
129946955|NCT01947491|467770105|FG003|Overall Study|Protocol Violation|0|||
129946956|NCT01947491|467770102|FG000|Overall Study|Withdrawal by Subject|1|||
129946957|NCT01947491|467770103|FG001|Overall Study|Withdrawal by Subject|1|||
129946958|NCT01947491|467770104|FG002|Overall Study|Withdrawal by Subject|1|||
129946959|NCT01947491|467770105|FG003|Overall Study|Withdrawal by Subject|0|||
129946960|NCT01947491|467770102|FG000|Overall Study|Worsening of condition|0|||
129946961|NCT01947491|467770103|FG001|Overall Study|Worsening of condition|1|||
129946962|NCT01947491|467770104|FG002|Overall Study|Worsening of condition|0|||
129946963|NCT01947491|467770105|FG003|Overall Study|Worsening of condition|0|||
129946964|NCT01947491|467770102|FG000|Overall Study|Adverse Event|0|||
129946965|NCT01947491|467770103|FG001|Overall Study|Adverse Event|1|||
129946966|NCT01947491|467770104|FG002|Overall Study|Adverse Event|0|||
129946967|NCT01947491|467770105|FG003|Overall Study|Adverse Event|2|||
129946968|NCT02067663|467770106|FG000|Overall Study|Lost to Follow-up|13|||
129946969|NCT02067663|467770107|FG001|Overall Study|Lost to Follow-up|14|||
129946970|NCT03137784|467770108|FG000|Overall Study|Adverse Event|1|||
129946971|NCT03137784|467770109|FG001|Overall Study|Adverse Event|1|||
129946972|NCT03137784|467770110|FG002|Overall Study|Adverse Event|0|||
129946973|NCT03137784|467770111|FG003|Overall Study|Adverse Event|0|||
129946974|NCT03137784|467770112|FG004|Overall Study|Adverse Event|0|||
129946975|NCT03137784|467770113|FG005|Overall Study|Adverse Event|0|||
129946976|NCT03137784|467770108|FG000|Overall Study|Subject/guardian decision|1|||
129946977|NCT03137784|467770109|FG001|Overall Study|Subject/guardian decision|0|||
129946978|NCT03137784|467770110|FG002|Overall Study|Subject/guardian decision|0|||
129946979|NCT03137784|467770111|FG003|Overall Study|Subject/guardian decision|0|||
129946980|NCT03137784|467770112|FG004|Overall Study|Subject/guardian decision|0|||
129946981|NCT03137784|467770113|FG005|Overall Study|Subject/guardian decision|0|||
129946982|NCT03137784|467770108|FG000|Overall Study|Non-compliance with study treatment|0|||
129946983|NCT03137784|467770109|FG001|Overall Study|Non-compliance with study treatment|0|||
129946984|NCT03137784|467770110|FG002|Overall Study|Non-compliance with study treatment|0|||
129946985|NCT03137784|467770111|FG003|Overall Study|Non-compliance with study treatment|0|||
129946986|NCT03137784|467770112|FG004|Overall Study|Non-compliance with study treatment|1|||
129946987|NCT03137784|467770113|FG005|Overall Study|Non-compliance with study treatment|0|||
129946988|NCT01437540|467770114|FG000|Overall Study|Not listed below|7|||
129946989|NCT01437540|467770115|FG001|Overall Study|Not listed below|6|||
129946990|NCT01437540|467770114|FG000|Overall Study|COPD exacerbation|13|||
129946991|NCT01437540|467770115|FG001|Overall Study|COPD exacerbation|3|||
129946992|NCT01437540|467770114|FG000|Overall Study|Lost to Follow-up|3|||
129946993|NCT01437540|467770115|FG001|Overall Study|Lost to Follow-up|5|||
129946994|NCT01437540|467770114|FG000|Overall Study|Lack of Efficacy|23|||
129946995|NCT01437540|467770115|FG001|Overall Study|Lack of Efficacy|11|||
129946996|NCT01437540|467770114|FG000|Overall Study|Protocol Violation|24|||
129946997|NCT01437540|467770115|FG001|Overall Study|Protocol Violation|12|||
129946998|NCT01437540|467770114|FG000|Overall Study|Adverse Event|26|||
129946999|NCT01437540|467770115|FG001|Overall Study|Adverse Event|13|||
129947000|NCT01437540|467770114|FG000|Overall Study|Withdrawal by Subject|31|||
129947001|NCT01437540|467770115|FG001|Overall Study|Withdrawal by Subject|15|||
129947002|NCT03142932|467770116|FG000|Overall Study|Lost to Follow-up|2|||
129947003|NCT03142932|467770117|FG001|Overall Study|Lost to Follow-up|11|||
129947004|NCT00929526|467770118|FG000|Overall Study|Withdrawal by Subject|1|||
129947005|NCT00929526|467770119|FG001|Overall Study|Withdrawal by Subject|11|||
129947006|NCT00929526|467770118|FG000|Overall Study|Lost to Follow-up|8|||
129947007|NCT00929526|467770119|FG001|Overall Study|Lost to Follow-up|12|||
129947008|NCT00929526|467770118|FG000|Overall Study|Other|8|||
129947009|NCT00929526|467770119|FG001|Overall Study|Other|6|||
129947010|NCT02547974|467770120|FG000|Overall Study|Withdrawal by Subject|1|||
129947011|NCT02547974|467770121|FG001|Overall Study|Withdrawal by Subject|0|||
129947012|NCT02547974|467770122|FG002|Overall Study|Withdrawal by Subject|0|||
129947013|NCT02547974|467770123|FG003|Overall Study|Withdrawal by Subject|0|||
129947014|NCT01393600|467770124|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
129947015|NCT01393600|467770125|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
129947016|NCT01393600|467770126|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
129947017|NCT01393600|467770127|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
129947018|NCT01393600|467770124|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
129947019|NCT01393600|467770125|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
129947020|NCT01393600|467770126|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
129947021|NCT01393600|467770127|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
129947022|NCT01393600|467770124|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
129947023|NCT01393600|467770125|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
129947024|NCT01393600|467770126|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
129947025|NCT01393600|467770127|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
129947026|NCT01393600|467770124|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
129947027|NCT01393600|467770125|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
129947028|NCT01393600|467770126|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
129947029|NCT01393600|467770127|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
129947030|NCT01393600|467770124|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
129947031|NCT01393600|467770125|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
129947032|NCT01393600|467770126|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
129947033|NCT01393600|467770127|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
129947034|NCT01393600|467770124|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
129947035|NCT01393600|467770125|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
129947036|NCT01393600|467770126|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
129947037|NCT01393600|467770127|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
129947038|NCT01393600|467770124|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
129947039|NCT01393600|467770125|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
129947040|NCT01393600|467770126|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
129947041|NCT01393600|467770127|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
129947042|NCT04766996|467770128|FG000|Overall Study|Withdrawal by Subject|1|||
129947043|NCT04766996|467770129|FG001|Overall Study|Withdrawal by Subject|0|||
129947044|NCT04766996|467770130|FG002|Overall Study|Withdrawal by Subject|13|||
129947045|NCT02988713|467770134|FG000|Overall Study|Withdrawal by Subject|1|||
129947046|NCT02988713|467770134|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
129947047|NCT01918033|467770135|FG000|Overall Study|Adverse Event|1|||
129947048|NCT01918033|467770136|FG001|Overall Study|Adverse Event|0|||
129947049|NCT01918033|467770137|FG002|Overall Study|Adverse Event|2|||
129947050|NCT01918033|467770135|FG000|Overall Study|Lost to Follow-up|0|||
129947051|NCT01918033|467770136|FG001|Overall Study|Lost to Follow-up|1|||
129947052|NCT01918033|467770137|FG002|Overall Study|Lost to Follow-up|0|||
129947053|NCT01918033|467770135|FG000|Overall Study|Protocol Violation|2|||
129947054|NCT01918033|467770136|FG001|Overall Study|Protocol Violation|0|||
129947055|NCT01918033|467770137|FG002|Overall Study|Protocol Violation|1|||
129947056|NCT01918033|467770135|FG000|Overall Study|Withdrawal by Subject|2|||
129947057|NCT01918033|467770136|FG001|Overall Study|Withdrawal by Subject|1|||
129947058|NCT01918033|467770137|FG002|Overall Study|Withdrawal by Subject|0|||
129947059|NCT00761267|467770146|FG000|Overall Study|Death|1|||
129947060|NCT00761267|467770147|FG001|Overall Study|Death|2|||
129947061|NCT00761267|467770148|FG002|Overall Study|Death|5|||
129947062|NCT00761267|467770146|FG000|Overall Study|Lost to Follow-up|0|||
129947063|NCT00761267|467770147|FG001|Overall Study|Lost to Follow-up|0|||
129947064|NCT00761267|467770148|FG002|Overall Study|Lost to Follow-up|1|||
129947065|NCT00761267|467770146|FG000|Overall Study|Randomized but not treated|1|||
129947066|NCT00761267|467770147|FG001|Overall Study|Randomized but not treated|1|||
129947067|NCT00761267|467770148|FG002|Overall Study|Randomized but not treated|0|||
129947068|NCT00761267|467770146|FG000|Overall Study|Withdrawal by Subject|0|||
129947069|NCT00761267|467770147|FG001|Overall Study|Withdrawal by Subject|1|||
129947070|NCT00761267|467770148|FG002|Overall Study|Withdrawal by Subject|0|||
129947071|NCT02538094|467770156|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
129947072|NCT02538094|467770157|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
129947073|NCT02538094|467770156|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
129947074|NCT02538094|467770157|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
129947075|NCT03288506|467770158|FG000|Overall Study|Withdrawal by Subject|52|||
129947076|NCT01323790|467770159|FG000|Overall Study|Other|3|||
129947077|NCT01323790|467770160|FG001|Overall Study|Other|2|||
129947078|NCT01323790|467770161|FG002|Overall Study|Other|1|||
129947079|NCT01323790|467770159|FG000|Overall Study|Lost to Follow-up|11|||
129947080|NCT01323790|467770160|FG001|Overall Study|Lost to Follow-up|9|||
129947081|NCT01323790|467770161|FG002|Overall Study|Lost to Follow-up|9|||
129947082|NCT01323790|467770159|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
129947083|NCT01323790|467770160|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
129947084|NCT01323790|467770161|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
129947085|NCT01323790|467770159|FG000|Overall Study|Lack of Efficacy|3|||
129947086|NCT01323790|467770160|FG001|Overall Study|Lack of Efficacy|0|||
129947087|NCT01323790|467770161|FG002|Overall Study|Lack of Efficacy|3|||
129947088|NCT01323790|467770159|FG000|Overall Study|Adverse Event|11|||
129947089|NCT01323790|467770160|FG001|Overall Study|Adverse Event|24|||
129947090|NCT01323790|467770161|FG002|Overall Study|Adverse Event|12|||
129947091|NCT01323790|467770159|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129947092|NCT01323790|467770160|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129947093|NCT01323790|467770161|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
129947094|NCT01323790|467770159|FG000|Overall Study|Withdrawal by Subject|23|||
129947095|NCT01323790|467770160|FG001|Overall Study|Withdrawal by Subject|20|||
129947096|NCT01323790|467770161|FG002|Overall Study|Withdrawal by Subject|13|||
129947097|NCT01323790|467770159|FG000|Overall Study|Did Not Receive Treatment|2|||
129947098|NCT01323790|467770160|FG001|Overall Study|Did Not Receive Treatment|0|||
129947099|NCT01323790|467770161|FG002|Overall Study|Did Not Receive Treatment|1|||
129947100|NCT01323790|467770159|FG000|Overall Study|Severe non-compliance with protocol|2|||
129947101|NCT01323790|467770160|FG001|Overall Study|Severe non-compliance with protocol|2|||
129947102|NCT01323790|467770161|FG002|Overall Study|Severe non-compliance with protocol|2|||
129947103|NCT01880736|467770162|FG000|Overall Study|Adverse Event|0|||
129947104|NCT01880736|467770163|FG001|Overall Study|Adverse Event|0|||
129947105|NCT01880736|467770164|FG002|Overall Study|Adverse Event|0|||
129947106|NCT01880736|467770165|FG003|Overall Study|Adverse Event|1|||
129947107|NCT01880736|467770162|FG000|Overall Study|Withdrawal Criteria|1|||
129947108|NCT01880736|467770163|FG001|Overall Study|Withdrawal Criteria|2|||
129947109|NCT01880736|467770164|FG002|Overall Study|Withdrawal Criteria|1|||
129947110|NCT01880736|467770165|FG003|Overall Study|Withdrawal Criteria|5|||
129947111|NCT00266656|467770169|FG000|Overall Study|Death|1|||
129947112|NCT00266656|467770170|FG001|Overall Study|Death|0|||
129947113|NCT00266656|467770169|FG000|Overall Study|Lost to Follow-up|4|||
129947114|NCT00266656|467770170|FG001|Overall Study|Lost to Follow-up|1|||
129947115|NCT00266656|467770169|FG000|Overall Study|Withdrawal by Subject|4|||
129947116|NCT00266656|467770170|FG001|Overall Study|Withdrawal by Subject|2|||
129947117|NCT00266656|467770169|FG000|Overall Study|Did Not Reach Final Height|4|||
129947118|NCT00266656|467770170|FG001|Overall Study|Did Not Reach Final Height|8|||
129947119|NCT00266656|467770169|FG000|Overall Study|Parent/Caregiver Decision|1|||
129947120|NCT00266656|467770170|FG001|Overall Study|Parent/Caregiver Decision|2|||
129947121|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
129947122|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
129947123|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
129947124|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
129947125|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
129947126|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
129947127|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
129947128|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
129947129|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
129947130|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
129947131|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
129947132|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
129947133|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
129947134|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
129947135|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
129947136|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
129947137|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
129947138|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
129947139|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
129947140|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
129947141|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
129947142|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
129947143|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
129947144|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
129947145|NCT02203032|467770171|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
129947146|NCT02203032|467770172|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
129947147|NCT02203032|467770173|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
129947148|NCT02203032|467770174|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
129947149|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
129947150|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
129947151|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
129947152|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
129947153|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
129947154|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
129947155|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
129947156|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
129947157|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
129947158|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
129947159|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
129947160|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
129947161|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
129947162|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
129947163|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
129947164|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
129947165|NCT02203032|467770171|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
129947166|NCT02203032|467770172|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
129947167|NCT02203032|467770173|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
129947168|NCT02203032|467770174|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
129947169|NCT01915914|467770175|FG000|Acute Phase|Withdrawal by Subject|4|||
129947170|NCT01915914|467770176|FG001|Acute Phase|Withdrawal by Subject|0|||
129947171|NCT01915914|467770177|FG002|Acute Phase|Withdrawal by Subject|0|||
129947172|NCT01915914|467770178|FG003|Acute Phase|Withdrawal by Subject|0|||
129947173|NCT01915914|467770175|FG000|Acute Phase|Lost to Follow-up|4|||
129947174|NCT01915914|467770176|FG001|Acute Phase|Lost to Follow-up|0|||
129947175|NCT01915914|467770177|FG002|Acute Phase|Lost to Follow-up|0|||
129947176|NCT01915914|467770178|FG003|Acute Phase|Lost to Follow-up|0|||
129947177|NCT01915914|467770175|FG000|Acute Phase|Physician Decision|1|||
129947178|NCT01915914|467770176|FG001|Acute Phase|Physician Decision|0|||
129947179|NCT01915914|467770177|FG002|Acute Phase|Physician Decision|0|||
129947180|NCT01915914|467770178|FG003|Acute Phase|Physician Decision|0|||
129947181|NCT01915914|467770175|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
129947182|NCT01915914|467770176|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
129947183|NCT01915914|467770177|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
129947184|NCT01915914|467770178|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
129947185|NCT01915914|467770175|FG000|Acute Phase|"Not Achieved treatment success"|1|||
129947186|NCT01915914|467770176|FG001|Acute Phase|"Not Achieved treatment success"|0|||
129947187|NCT01915914|467770177|FG002|Acute Phase|"Not Achieved treatment success"|0|||
129947188|NCT01915914|467770178|FG003|Acute Phase|"Not Achieved treatment success"|0|||
129947189|NCT01915914|467770175|FG000|Acute Phase|Missing|1|||
129947190|NCT01915914|467770176|FG001|Acute Phase|Missing|0|||
129947191|NCT01915914|467770177|FG002|Acute Phase|Missing|0|||
129947192|NCT01915914|467770178|FG003|Acute Phase|Missing|0|||
129947193|NCT01915914|467770175|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129947194|NCT01915914|467770176|FG001|Maintenance Phase|Withdrawal by Subject|1|||
129947195|NCT01915914|467770177|FG002|Maintenance Phase|Withdrawal by Subject|1|||
129947196|NCT01915914|467770178|FG003|Maintenance Phase|Withdrawal by Subject|0|||
129947197|NCT01915914|467770175|FG000|Maintenance Phase|Lost to Follow-up|0|||
129947198|NCT01915914|467770176|FG001|Maintenance Phase|Lost to Follow-up|4|||
129947199|NCT01915914|467770177|FG002|Maintenance Phase|Lost to Follow-up|1|||
129947200|NCT01915914|467770178|FG003|Maintenance Phase|Lost to Follow-up|0|||
129947201|NCT01915914|467770175|FG000|Maintenance Phase|Missing|0|||
129947202|NCT01915914|467770176|FG001|Maintenance Phase|Missing|1|||
129947203|NCT01915914|467770177|FG002|Maintenance Phase|Missing|0|||
129947204|NCT01915914|467770178|FG003|Maintenance Phase|Missing|0|||
129947205|NCT01915914|467770175|FG000|Follow-up Phase|Withdrawal by Subject|0|||
129947206|NCT01915914|467770176|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129947207|NCT01915914|467770177|FG002|Follow-up Phase|Withdrawal by Subject|0|||
129947208|NCT01915914|467770178|FG003|Follow-up Phase|Withdrawal by Subject|1|||
129947209|NCT01915914|467770175|FG000|Follow-up Phase|Physician Decision|0|||
129947210|NCT01915914|467770176|FG001|Follow-up Phase|Physician Decision|0|||
129947211|NCT01915914|467770177|FG002|Follow-up Phase|Physician Decision|0|||
129947212|NCT01915914|467770178|FG003|Follow-up Phase|Physician Decision|1|||
129947213|NCT02432274|467770179|FG000|Overall Study|Death|2|||
129947214|NCT02432274|467770180|FG001|Overall Study|Death|6|||
129947215|NCT02432274|467770181|FG002|Overall Study|Death|7|||
129947216|NCT02432274|467770182|FG003|Overall Study|Death|0|||
129947217|NCT02432274|467770183|FG004|Overall Study|Death|27|||
129947218|NCT02432274|467770184|FG005|Overall Study|Death|7|||
129947219|NCT02432274|467770185|FG006|Overall Study|Death|9|||
129947220|NCT02432274|467770186|FG007|Overall Study|Death|14|||
129947221|NCT02432274|467770179|FG000|Overall Study|Withdrawal of Consent|0|||
129947222|NCT02432274|467770180|FG001|Overall Study|Withdrawal of Consent|0|||
129947223|NCT02432274|467770181|FG002|Overall Study|Withdrawal of Consent|0|||
129947224|NCT02432274|467770182|FG003|Overall Study|Withdrawal of Consent|0|||
129947225|NCT02432274|467770183|FG004|Overall Study|Withdrawal of Consent|2|||
129947226|NCT02432274|467770184|FG005|Overall Study|Withdrawal of Consent|0|||
129947227|NCT02432274|467770185|FG006|Overall Study|Withdrawal of Consent|1|||
129947228|NCT02432274|467770186|FG007|Overall Study|Withdrawal of Consent|2|||
129947229|NCT00116649|467770187|FG000|Overall Study|Adverse Event|20|||
129947230|NCT00116649|467770187|FG000|Overall Study|Lack of Efficacy|1|||
129947231|NCT00116649|467770187|FG000|Overall Study|Lost to Follow-up|32|||
129947232|NCT00116649|467770187|FG000|Overall Study|Withdrawal by Subject|68|||
129947233|NCT00116649|467770187|FG000|Overall Study|Local Skin Reaction|9|||
129947234|NCT00116649|467770187|FG000|Overall Study|Various Reasons|18|||
129947235|NCT00116649|467770187|FG000|Overall Study|Protocol Specified|7|||
129947236|NCT00513071|467770188|FG000|Overall Study|Adverse Event|1|||
129947237|NCT00513071|467770188|FG000|Overall Study|Withdrawal by Subject|1|||
129947238|NCT00513071|467770188|FG000|Overall Study|Physician Decision|3|||
129947239|NCT00667732|467770189|FG000|Run -In (8 Weeks)|Adverse Event|4|||
129947240|NCT00667732|467770190|FG001|Run -In (8 Weeks)|Adverse Event|0|||
129947241|NCT00667732|467770191|FG002|Run -In (8 Weeks)|Adverse Event|0|||
129947242|NCT00667732|467770189|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
129947243|NCT00667732|467770190|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
129947244|NCT00667732|467770191|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
129947245|NCT00667732|467770189|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
129947246|NCT00667732|467770190|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
129947247|NCT00667732|467770191|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
129947248|NCT01240590|467770192|FG000|Phase I|Refused further treatment|0|||
129947249|NCT01240590|467770193|FG001|Phase I|Refused further treatment|0|||
129947250|NCT01240590|467770194|FG002|Phase I|Refused further treatment|3|||
129947251|NCT01240590|467770195|FG003|Phase I|Refused further treatment|0|||
129947252|NCT01240590|467770196|FG004|Phase I|Refused further treatment|0|||
129947253|NCT01240590|467770192|FG000|Phase II|Refused further treatment|0|||
129947254|NCT01240590|467770193|FG001|Phase II|Refused further treatment|0|||
129947255|NCT01240590|467770194|FG002|Phase II|Refused further treatment|0|||
129947256|NCT01240590|467770195|FG003|Phase II|Refused further treatment|2|||
129947257|NCT01240590|467770196|FG004|Phase II|Refused further treatment|1|||
129947258|NCT02659540|467770199|FG000|Overall Study|Adverse Event|3|||
129947259|NCT02659540|467770200|FG001|Overall Study|Adverse Event|2|||
129947260|NCT02659540|467770199|FG000|Overall Study|Death|1|||
129947261|NCT02659540|467770200|FG001|Overall Study|Death|0|||
129947262|NCT02659540|467770199|FG000|Overall Study|Progressive disease|2|||
129947263|NCT02659540|467770200|FG001|Overall Study|Progressive disease|6|||
129947264|NCT02106325|467770203|FG000|Phase 1|Lost to Follow-up|2|||
129947265|NCT02106325|467770204|FG001|Phase 1|Lost to Follow-up|2|||
129947266|NCT02106325|467770203|FG000|Phase 2|Lost to Follow-up|2|||
129947267|NCT02106325|467770204|FG001|Phase 2|Lost to Follow-up|3|||
129947268|NCT02106325|467770203|FG000|Phase 3|Lost to Follow-up|2|||
129947269|NCT02106325|467770204|FG001|Phase 3|Lost to Follow-up|1|||
129947270|NCT03890484|467770205|FG000|Overall Study|Lost to Follow-up|1|||
129947271|NCT03890484|467770206|FG001|Overall Study|Lost to Follow-up|1|||
129947272|NCT00824850|467770208|FG000|Overall Study|Withdrawal by Subject|0|||
129947273|NCT00824850|467770209|FG001|Overall Study|Withdrawal by Subject|1|||
129947274|NCT04820491|467770210|FG000|Overall Study|Withdrawal by Subject|1|||
129947275|NCT04820491|467770211|FG001|Overall Study|Withdrawal by Subject|0|||
129947276|NCT01377844|467772058|FG000|Overall Study|Withdrawal by Subject|25|||
129947277|NCT01377844|467772059|FG001|Overall Study|Withdrawal by Subject|28|||
129947278|NCT01377844|467772058|FG000|Overall Study|Protocol Violation|2|||
129947279|NCT01377844|467772059|FG001|Overall Study|Protocol Violation|3|||
129947280|NCT01377844|467772058|FG000|Overall Study|Adverse Event|3|||
129947281|NCT01377844|467772059|FG001|Overall Study|Adverse Event|0|||
129947282|NCT01377844|467772058|FG000|Overall Study|Physician Decision|6|||
129947283|NCT01377844|467772059|FG001|Overall Study|Physician Decision|3|||
129947284|NCT01377844|467772058|FG000|Overall Study|Study terminated by Sponsor|0|||
129947285|NCT01377844|467772059|FG001|Overall Study|Study terminated by Sponsor|1|||
129947286|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
129947287|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129947288|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129947289|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129947290|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
129947291|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129947292|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129947293|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129947294|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
129947295|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129947296|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129947297|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129947298|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
129947299|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129947300|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129947301|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129947302|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
129947303|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129947304|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129947305|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129947306|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
129947307|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129947308|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129947309|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129947310|NCT01185340|467772062|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
129947311|NCT01185340|467772063|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129947312|NCT01185340|467772064|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129947313|NCT01185340|467772065|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129947314|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
129947315|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
129947316|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
129947317|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
129947318|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
129947319|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
129947320|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
129947321|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
129947322|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129947323|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
129947324|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
129947325|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
129947326|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129947327|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129947328|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129947329|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129947330|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
129947331|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129947332|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
129947333|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129947334|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
129947335|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
129947336|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
129947337|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
129947338|NCT01185340|467772062|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129947339|NCT01185340|467772063|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129947340|NCT01185340|467772064|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
129947341|NCT01185340|467772065|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
129947342|NCT02065895|467772066|FG000|Overall Study|Protocol Violation|1|||
129947343|NCT02065895|467772067|FG001|Overall Study|Protocol Violation|0|||
129947344|NCT02065895|467772068|FG002|Overall Study|Protocol Violation|0|||
129947345|NCT02065895|467772069|FG003|Overall Study|Protocol Violation|1|||
129947346|NCT02065895|467772070|FG004|Overall Study|Protocol Violation|0|||
129947347|NCT02065895|467772071|FG005|Overall Study|Protocol Violation|0|||
129947348|NCT02065895|467772066|FG000|Overall Study|Scheduling conflicts|0|||
129947349|NCT02065895|467772067|FG001|Overall Study|Scheduling conflicts|1|||
129947350|NCT02065895|467772068|FG002|Overall Study|Scheduling conflicts|0|||
129947351|NCT02065895|467772069|FG003|Overall Study|Scheduling conflicts|0|||
129947352|NCT02065895|467772070|FG004|Overall Study|Scheduling conflicts|0|||
129947353|NCT02065895|467772071|FG005|Overall Study|Scheduling conflicts|0|||
129947354|NCT03469258|467772072|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
129947355|NCT03403036|467772077|FG000|Overall Study|Lack of Efficacy|5|||
129947356|NCT00484198|467772080|FG000|Overall Study|Participant Withdrew Consent|12|||
129947357|NCT00484198|467772081|FG001|Overall Study|Participant Withdrew Consent|21|||
129947358|NCT00484198|467772082|FG002|Overall Study|Participant Withdrew Consent|47|||
129947359|NCT00484198|467772083|FG003|Overall Study|Participant Withdrew Consent|59|||
129947360|NCT00484198|467772080|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
129947361|NCT00484198|467772081|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
129947362|NCT00484198|467772082|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
129947363|NCT00484198|467772083|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
129947364|NCT00484198|467772080|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
129947365|NCT00484198|467772081|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
129947366|NCT00484198|467772082|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
129947367|NCT00484198|467772083|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
129947368|NCT00484198|467772080|FG000|Overall Study|Adverse Event|3|||
129947369|NCT00484198|467772081|FG001|Overall Study|Adverse Event|11|||
129947370|NCT00484198|467772082|FG002|Overall Study|Adverse Event|32|||
129947371|NCT00484198|467772083|FG003|Overall Study|Adverse Event|31|||
129947372|NCT00484198|467772080|FG000|Overall Study|Protocol Violation|0|||
129947373|NCT00484198|467772081|FG001|Overall Study|Protocol Violation|5|||
129947374|NCT00484198|467772082|FG002|Overall Study|Protocol Violation|6|||
129947375|NCT00484198|467772083|FG003|Overall Study|Protocol Violation|8|||
129947376|NCT00484198|467772080|FG000|Overall Study|Other|7|||
129947377|NCT00484198|467772081|FG001|Overall Study|Other|10|||
129947378|NCT00484198|467772082|FG002|Overall Study|Other|31|||
129947379|NCT00484198|467772083|FG003|Overall Study|Other|28|||
129947380|NCT02958553|467772084|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
129947381|NCT02958553|467772084|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
129947382|NCT03340961|467772085|FG000|Overall Study|Adverse Event|1|||
129947383|NCT03340961|467772086|FG001|Overall Study|Adverse Event|3|||
129947384|NCT03340961|467772087|FG002|Overall Study|Adverse Event|2|||
129947385|NCT03340961|467772088|FG003|Overall Study|Adverse Event|4|||
129947386|NCT03340961|467772085|FG000|Overall Study|Lost to Follow-up|0|||
129947387|NCT03340961|467772086|FG001|Overall Study|Lost to Follow-up|1|||
129947388|NCT03340961|467772087|FG002|Overall Study|Lost to Follow-up|0|||
129947389|NCT03340961|467772088|FG003|Overall Study|Lost to Follow-up|1|||
129947390|NCT03340961|467772085|FG000|Overall Study|Withdrawal by Subject|3|||
129947391|NCT03340961|467772086|FG001|Overall Study|Withdrawal by Subject|2|||
129947392|NCT03340961|467772087|FG002|Overall Study|Withdrawal by Subject|4|||
129947393|NCT03340961|467772088|FG003|Overall Study|Withdrawal by Subject|7|||
129947394|NCT03340961|467772085|FG000|Overall Study|Use of prohibited treatment|0|||
129947395|NCT03340961|467772086|FG001|Overall Study|Use of prohibited treatment|3|||
129947396|NCT03340961|467772087|FG002|Overall Study|Use of prohibited treatment|2|||
129947397|NCT03340961|467772088|FG003|Overall Study|Use of prohibited treatment|4|||
129947398|NCT03340961|467772085|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
129947399|NCT03340961|467772086|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
129947400|NCT03340961|467772087|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
129947401|NCT03340961|467772088|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
129947402|NCT03340961|467772085|FG000|Overall Study|Subject developed an exclusion criterion|0|||
129947403|NCT03340961|467772086|FG001|Overall Study|Subject developed an exclusion criterion|1|||
129947404|NCT03340961|467772087|FG002|Overall Study|Subject developed an exclusion criterion|0|||
129947405|NCT03340961|467772088|FG003|Overall Study|Subject developed an exclusion criterion|0|||
129947406|NCT03340961|467772085|FG000|Overall Study|Protocol Violation|1|||
129947407|NCT03340961|467772086|FG001|Overall Study|Protocol Violation|0|||
129947408|NCT03340961|467772087|FG002|Overall Study|Protocol Violation|1|||
129947409|NCT03340961|467772088|FG003|Overall Study|Protocol Violation|0|||
129947410|NCT03340961|467772085|FG000|Overall Study|Adverse Event|1|||
129947411|NCT03340961|467772086|FG001|Overall Study|Adverse Event|1|||
129947412|NCT03340961|467772087|FG002|Overall Study|Adverse Event|0|||
129947413|NCT03340961|467772088|FG003|Overall Study|Adverse Event|0|||
129947414|NCT03340961|467772085|FG000|Overall Study|Lack of Efficacy|0|||
129947415|NCT03340961|467772086|FG001|Overall Study|Lack of Efficacy|0|||
129947416|NCT03340961|467772087|FG002|Overall Study|Lack of Efficacy|0|||
129947417|NCT03340961|467772088|FG003|Overall Study|Lack of Efficacy|1|||
129947418|NCT01686152|467772089|FG000|Overall Study|Withdrawal by Subject|11|||
129947419|NCT01686152|467772090|FG001|Overall Study|Withdrawal by Subject|11|||
129947420|NCT01686152|467772091|FG002|Overall Study|Withdrawal by Subject|3|||
129947421|NCT01686152|467772089|FG000|Overall Study|Drug Code Unblinded|0|||
129947422|NCT01686152|467772090|FG001|Overall Study|Drug Code Unblinded|1|||
129947423|NCT01686152|467772091|FG002|Overall Study|Drug Code Unblinded|0|||
129947424|NCT01686152|467772089|FG000|Overall Study|Protocol Violation|6|||
129947425|NCT01686152|467772090|FG001|Overall Study|Protocol Violation|1|||
129947426|NCT01686152|467772091|FG002|Overall Study|Protocol Violation|0|||
129947427|NCT01686152|467772089|FG000|Overall Study|Adverse Event|12|||
129947428|NCT01686152|467772090|FG001|Overall Study|Adverse Event|11|||
129947429|NCT01686152|467772091|FG002|Overall Study|Adverse Event|0|||
129947430|NCT01686152|467772089|FG000|Overall Study|Lack of Efficacy|0|||
129947431|NCT01686152|467772090|FG001|Overall Study|Lack of Efficacy|0|||
129947432|NCT01686152|467772091|FG002|Overall Study|Lack of Efficacy|1|||
129947433|NCT01686152|467772089|FG000|Overall Study|IP Non-compliance|5|||
129947434|NCT01686152|467772090|FG001|Overall Study|IP Non-compliance|5|||
129947435|NCT01686152|467772091|FG002|Overall Study|IP Non-compliance|0|||
129947436|NCT01686152|467772089|FG000|Overall Study|Lost to Follow-up|7|||
129947437|NCT01686152|467772090|FG001|Overall Study|Lost to Follow-up|6|||
129947438|NCT01686152|467772091|FG002|Overall Study|Lost to Follow-up|5|||
129947439|NCT01853384|467772092|FG000|Randomized|Adverse Event|5|||
129947440|NCT01853384|467772093|FG001|Randomized|Adverse Event|3|||
129947441|NCT01853384|467772092|FG000|Randomized|Death|1|||
129947442|NCT01853384|467772093|FG001|Randomized|Death|2|||
129947443|NCT01853384|467772092|FG000|Randomized|Lost to Follow-up|1|||
129947444|NCT01853384|467772093|FG001|Randomized|Lost to Follow-up|1|||
129947445|NCT01853384|467772092|FG000|Randomized|Withdrawal by Subject|5|||
129947446|NCT01853384|467772093|FG001|Randomized|Withdrawal by Subject|3|||
129947447|NCT01853384|467772092|FG000|Randomized|Sponsor Decision|47|||
129947448|NCT01853384|467772093|FG001|Randomized|Sponsor Decision|34|||
129947449|NCT01853384|467772092|FG000|Randomized|Other|3|||
129947450|NCT01853384|467772093|FG001|Randomized|Other|3|||
129947451|NCT01853384|467772092|FG000|Completed Follow up Visit 1|Early Termination|13|||
129947452|NCT01853384|467772093|FG001|Completed Follow up Visit 1|Early Termination|9|||
129947453|NCT01853384|467772092|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
129947454|NCT01853384|467772093|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
129947455|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Adverse Event|1|||
129947456|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Adverse Event|0|||
129947457|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
129947458|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
129947459|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Death|1|||
129947460|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Death|0|||
129947461|NCT01853384|467772092|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
129947462|NCT01853384|467772093|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
129947463|NCT00704340|467772094|FG000|Overall Study|Lost to Follow-up|2|||
129947464|NCT00704340|467772095|FG001|Overall Study|Lost to Follow-up|1|||
129947465|NCT00704340|467772094|FG000|Overall Study|Death|0|||
129947466|NCT00704340|467772095|FG001|Overall Study|Death|1|||
129947467|NCT04311983|467772096|FG000|Overall Study|Lost to Follow-up|421|||
129947468|NCT04311983|467772097|FG001|Overall Study|Lost to Follow-up|456|||
129947469|NCT04311983|467772096|FG000|Overall Study|Incomplete survey|7|||
129947470|NCT04311983|467772097|FG001|Overall Study|Incomplete survey|9|||
129947471|NCT04311983|467772096|FG000|Overall Study|Death|1|||
129947472|NCT04311983|467772097|FG001|Overall Study|Death|0|||
129947473|NCT01205126|467772099|FG000|Titration Phase|Adverse Event|5|||
129947474|NCT01205126|467772100|FG001|Titration Phase|Adverse Event|3|||
129947475|NCT01205126|467772099|FG000|Titration Phase|Withdrawal by Subject|5|||
129947476|NCT01205126|467772100|FG001|Titration Phase|Withdrawal by Subject|5|||
129947477|NCT01205126|467772099|FG000|Titration Phase|Lost to Follow-up|2|||
129947478|NCT01205126|467772100|FG001|Titration Phase|Lost to Follow-up|2|||
129947479|NCT01205126|467772099|FG000|Titration Phase|No stable titration dose|1|||
129947480|NCT01205126|467772100|FG001|Titration Phase|No stable titration dose|0|||
129947481|NCT01205126|467772099|FG000|Titration Phase|More than maximum dosage required|2|||
129947482|NCT01205126|467772100|FG001|Titration Phase|More than maximum dosage required|3|||
129947483|NCT01205126|467772099|FG000|Titration Phase|Other|8|||
129947484|NCT01205126|467772100|FG001|Titration Phase|Other|6|||
129947485|NCT01205126|467772099|FG000|Between Titration & Maintenance Phase|Other|0|||
129947486|NCT01205126|467772100|FG001|Between Titration & Maintenance Phase|Other|4|||
129947487|NCT01205126|467772099|FG000|Maintenance Phase|Adverse Event|3|||
129947488|NCT01205126|467772100|FG001|Maintenance Phase|Adverse Event|7|||
129947489|NCT01205126|467772099|FG000|Maintenance Phase|Death|4|||
129947490|NCT01205126|467772100|FG001|Maintenance Phase|Death|4|||
129947491|NCT01205126|467772099|FG000|Maintenance Phase|More than the maximum dosage required|5|||
129947492|NCT01205126|467772100|FG001|Maintenance Phase|More than the maximum dosage required|5|||
129947493|NCT01205126|467772099|FG000|Maintenance Phase|Prohibited drugs used|1|||
129947494|NCT01205126|467772100|FG001|Maintenance Phase|Prohibited drugs used|0|||
129947495|NCT01205126|467772099|FG000|Maintenance Phase|Other|11|||
129947496|NCT01205126|467772100|FG001|Maintenance Phase|Other|8|||
129947497|NCT01205126|467772099|FG000|Maintenance Phase|Lost to Follow-up|5|||
129947498|NCT01205126|467772100|FG001|Maintenance Phase|Lost to Follow-up|5|||
129947499|NCT01205126|467772099|FG000|Maintenance Phase|Withdrawal by Subject|8|||
129947500|NCT01205126|467772100|FG001|Maintenance Phase|Withdrawal by Subject|11|||
129947501|NCT00486954|467772101|FG000|Pilot Part|Adverse Event|4|||
129947502|NCT00486954|467772102|FG001|Pilot Part|Adverse Event|0|||
129947503|NCT00486954|467772103|FG002|Pilot Part|Adverse Event|5|||
129947504|NCT00486954|467772104|FG003|Pilot Part|Adverse Event|0|||
129947505|NCT00486954|467772105|FG004|Pilot Part|Adverse Event|0|||
129947506|NCT00486954|467772101|FG000|Pilot Part|Disease Progression|2|||
129947507|NCT00486954|467772102|FG001|Pilot Part|Disease Progression|0|||
129947508|NCT00486954|467772103|FG002|Pilot Part|Disease Progression|1|||
129947509|NCT00486954|467772104|FG003|Pilot Part|Disease Progression|0|||
129947510|NCT00486954|467772105|FG004|Pilot Part|Disease Progression|0|||
129947511|NCT00486954|467772101|FG000|Randomized Part|Lost to Follow-up|0|||
129947512|NCT00486954|467772102|FG001|Randomized Part|Lost to Follow-up|0|||
129947513|NCT00486954|467772103|FG002|Randomized Part|Lost to Follow-up|0|||
129947514|NCT00486954|467772104|FG003|Randomized Part|Lost to Follow-up|0|||
129947515|NCT00486954|467772105|FG004|Randomized Part|Lost to Follow-up|1|||
129947516|NCT00486954|467772101|FG000|Randomized Part|Withdrawal by Subject|0|||
129947517|NCT00486954|467772102|FG001|Randomized Part|Withdrawal by Subject|0|||
129947518|NCT00486954|467772103|FG002|Randomized Part|Withdrawal by Subject|0|||
129947519|NCT00486954|467772104|FG003|Randomized Part|Withdrawal by Subject|1|||
129947520|NCT00486954|467772105|FG004|Randomized Part|Withdrawal by Subject|0|||
129947521|NCT00486954|467772101|FG000|Randomized Part|Sponsor Terminated Study|0|||
129947522|NCT00486954|467772102|FG001|Randomized Part|Sponsor Terminated Study|0|||
129947523|NCT00486954|467772103|FG002|Randomized Part|Sponsor Terminated Study|0|||
129947524|NCT00486954|467772104|FG003|Randomized Part|Sponsor Terminated Study|19|||
129947525|NCT00486954|467772105|FG004|Randomized Part|Sponsor Terminated Study|13|||
129947526|NCT00638456|467772108|FG000|Overall Study|Withdrawal by Subject|6|||
129947527|NCT00638456|467772109|FG001|Overall Study|Withdrawal by Subject|2|||
129947528|NCT03236779|467772110|FG000|Overall Study|Lost to Follow-up|13|||
129947529|NCT03236779|467772111|FG001|Overall Study|Lost to Follow-up|21|||
129947530|NCT01836523|467772112|FG000|Overall Study|Adverse Event|15|||
129947531|NCT01836523|467772113|FG001|Overall Study|Adverse Event|41|||
129947532|NCT01836523|467772114|FG002|Overall Study|Adverse Event|49|||
129947533|NCT01836523|467772115|FG003|Overall Study|Adverse Event|14|||
129947534|NCT01836523|467772112|FG000|Overall Study|Protocol Violation|6|||
129947535|NCT01836523|467772113|FG001|Overall Study|Protocol Violation|3|||
129947536|NCT01836523|467772114|FG002|Overall Study|Protocol Violation|2|||
129947537|NCT01836523|467772115|FG003|Overall Study|Protocol Violation|4|||
129947538|NCT01836523|467772112|FG000|Overall Study|Met Withdrawal Criteria|13|||
129947539|NCT01836523|467772113|FG001|Overall Study|Met Withdrawal Criteria|13|||
129947540|NCT01836523|467772114|FG002|Overall Study|Met Withdrawal Criteria|21|||
129947541|NCT01836523|467772115|FG003|Overall Study|Met Withdrawal Criteria|27|||
129947542|NCT01836523|467772112|FG000|Overall Study|Unclassified|17|||
129947543|NCT01836523|467772113|FG001|Overall Study|Unclassified|28|||
129947544|NCT01836523|467772114|FG002|Overall Study|Unclassified|19|||
129947545|NCT01836523|467772115|FG003|Overall Study|Unclassified|29|||
129947546|NCT00813709|467772118|FG000|Double Blind Period|Adverse Event|4|||
129947547|NCT00813709|467772119|FG001|Double Blind Period|Adverse Event|1|||
129947548|NCT00813709|467772120|FG002|Double Blind Period|Adverse Event|4|||
129947549|NCT00813709|467772121|FG003|Double Blind Period|Adverse Event|0|||
129947550|NCT00813709|467772122|FG004|Double Blind Period|Adverse Event|0|||
129947551|NCT00813709|467772123|FG005|Double Blind Period|Adverse Event|0|||
129947552|NCT00813709|467772118|FG000|Double Blind Period|Lost to Follow-up|3|||
129947553|NCT00813709|467772119|FG001|Double Blind Period|Lost to Follow-up|2|||
129947554|NCT00813709|467772120|FG002|Double Blind Period|Lost to Follow-up|2|||
129947555|NCT00813709|467772121|FG003|Double Blind Period|Lost to Follow-up|0|||
129947556|NCT00813709|467772122|FG004|Double Blind Period|Lost to Follow-up|0|||
129947557|NCT00813709|467772123|FG005|Double Blind Period|Lost to Follow-up|0|||
129947558|NCT00813709|467772118|FG000|Double Blind Period|Switched to open label phase|9|||
129947559|NCT00813709|467772119|FG001|Double Blind Period|Switched to open label phase|26|||
129947560|NCT00813709|467772120|FG002|Double Blind Period|Switched to open label phase|18|||
129947561|NCT00813709|467772121|FG003|Double Blind Period|Switched to open label phase|0|||
129947562|NCT00813709|467772122|FG004|Double Blind Period|Switched to open label phase|0|||
129947563|NCT00813709|467772123|FG005|Double Blind Period|Switched to open label phase|0|||
129947564|NCT00813709|467772118|FG000|Double Blind Period|Randomized but not treated|1|||
129947565|NCT00813709|467772119|FG001|Double Blind Period|Randomized but not treated|3|||
129947566|NCT00813709|467772120|FG002|Double Blind Period|Randomized but not treated|1|||
129947567|NCT00813709|467772121|FG003|Double Blind Period|Randomized but not treated|0|||
129947568|NCT00813709|467772122|FG004|Double Blind Period|Randomized but not treated|0|||
129947569|NCT00813709|467772123|FG005|Double Blind Period|Randomized but not treated|0|||
129947570|NCT00813709|467772118|FG000|Double Blind Period|Other|14|||
129947571|NCT00813709|467772119|FG001|Double Blind Period|Other|9|||
129947572|NCT00813709|467772120|FG002|Double Blind Period|Other|6|||
129947573|NCT00813709|467772121|FG003|Double Blind Period|Other|0|||
129947574|NCT00813709|467772122|FG004|Double Blind Period|Other|0|||
129947575|NCT00813709|467772123|FG005|Double Blind Period|Other|0|||
129947576|NCT00813709|467772118|FG000|Open Label Period|Adverse Event|0|||
129947577|NCT00813709|467772119|FG001|Open Label Period|Adverse Event|0|||
129947578|NCT00813709|467772120|FG002|Open Label Period|Adverse Event|0|||
129947579|NCT00813709|467772121|FG003|Open Label Period|Adverse Event|5|||
129947580|NCT00813709|467772122|FG004|Open Label Period|Adverse Event|4|||
129947581|NCT00813709|467772123|FG005|Open Label Period|Adverse Event|3|||
129947582|NCT00813709|467772118|FG000|Open Label Period|Lack of Efficacy|0|||
129947583|NCT00813709|467772119|FG001|Open Label Period|Lack of Efficacy|0|||
129947584|NCT00813709|467772120|FG002|Open Label Period|Lack of Efficacy|0|||
129947585|NCT00813709|467772121|FG003|Open Label Period|Lack of Efficacy|3|||
129947586|NCT00813709|467772122|FG004|Open Label Period|Lack of Efficacy|1|||
129947587|NCT00813709|467772123|FG005|Open Label Period|Lack of Efficacy|1|||
129947588|NCT00813709|467772118|FG000|Open Label Period|Randomized but not treated|0|||
129947589|NCT00813709|467772119|FG001|Open Label Period|Randomized but not treated|0|||
129947590|NCT00813709|467772120|FG002|Open Label Period|Randomized but not treated|0|||
129947591|NCT00813709|467772121|FG003|Open Label Period|Randomized but not treated|1|||
129947592|NCT00813709|467772122|FG004|Open Label Period|Randomized but not treated|0|||
129947593|NCT00813709|467772123|FG005|Open Label Period|Randomized but not treated|1|||
129947594|NCT00813709|467772118|FG000|Open Label Period|Other|0|||
129947595|NCT00813709|467772119|FG001|Open Label Period|Other|0|||
129947596|NCT00813709|467772120|FG002|Open Label Period|Other|0|||
129947597|NCT00813709|467772121|FG003|Open Label Period|Other|11|||
129947598|NCT00813709|467772122|FG004|Open Label Period|Other|5|||
129947599|NCT00813709|467772123|FG005|Open Label Period|Other|6|||
129947600|NCT00603798|467772127|FG000|Overall Study|Adverse Event|4|||
129947601|NCT00603798|467772128|FG001|Overall Study|Adverse Event|2|||
129947602|NCT00603798|467772129|FG002|Overall Study|Adverse Event|1|||
129947603|NCT00603798|467772127|FG000|Overall Study|Withdrawal by Subject|4|||
129947604|NCT00603798|467772128|FG001|Overall Study|Withdrawal by Subject|3|||
129947605|NCT00603798|467772129|FG002|Overall Study|Withdrawal by Subject|4|||
129947606|NCT00603798|467772127|FG000|Overall Study|Lost to Follow-up|1|||
129947607|NCT00603798|467772128|FG001|Overall Study|Lost to Follow-up|0|||
129947608|NCT00603798|467772129|FG002|Overall Study|Lost to Follow-up|1|||
129947609|NCT00603798|467772127|FG000|Overall Study|Non-compliance with study procedures|0|||
129947610|NCT00603798|467772128|FG001|Overall Study|Non-compliance with study procedures|1|||
129947611|NCT00603798|467772129|FG002|Overall Study|Non-compliance with study procedures|0|||
129947612|NCT00603798|467772127|FG000|Overall Study|Not due to AE|1|||
129947613|NCT00603798|467772128|FG001|Overall Study|Not due to AE|1|||
129947614|NCT00603798|467772129|FG002|Overall Study|Not due to AE|4|||
129947615|NCT02245620|467772130|FG000|Overall Study|Physician Decision|1|||
129947616|NCT02245620|467772131|FG001|Overall Study|Physician Decision|1|||
129947617|NCT01102426|467772132|FG000|Overall Study|Randomized but not treated|4|||
129947618|NCT01102426|467772133|FG001|Overall Study|Randomized but not treated|1|||
129947619|NCT01102426|467772132|FG000|Overall Study|Adverse Events (treatment-related)|15|||
129947620|NCT01102426|467772133|FG001|Overall Study|Adverse Events (treatment-related)|8|||
129947621|NCT01102426|467772132|FG000|Overall Study|Physician Decision|9|||
129947622|NCT01102426|467772133|FG001|Overall Study|Physician Decision|6|||
129947623|NCT01102426|467772132|FG000|Overall Study|Progressive Disease|85|||
129947624|NCT01102426|467772133|FG001|Overall Study|Progressive Disease|44|||
129947625|NCT01102426|467772132|FG000|Overall Study|Adverse Events (unrelated to|9|||
129947626|NCT01102426|467772133|FG001|Overall Study|Adverse Events (unrelated to|1|||
129947627|NCT01102426|467772132|FG000|Overall Study|Patient Refusal|24|||
129947628|NCT01102426|467772133|FG001|Overall Study|Patient Refusal|12|||
129947629|NCT01102426|467772132|FG000|Overall Study|Death (due to adverse events|0|||
129947630|NCT01102426|467772133|FG001|Overall Study|Death (due to adverse events|1|||
129947631|NCT01102426|467772132|FG000|Overall Study|Death (non-related to the study|19|||
129947632|NCT01102426|467772133|FG001|Overall Study|Death (non-related to the study|8|||
129947633|NCT00889863|467772134|FG000|Part I: Open Label|Death|1|||
129947634|NCT00889863|467772135|FG001|Part I: Open Label|Death|0|||
129947635|NCT00889863|467772134|FG000|Part I: Open Label|Adverse Event|4|||
129947636|NCT00889863|467772135|FG001|Part I: Open Label|Adverse Event|0|||
129947637|NCT00889863|467772134|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
129947638|NCT00889863|467772135|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
129947639|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
129947640|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
129947641|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
129947642|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
129947643|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
129947644|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
129947645|NCT00889863|467772134|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
129947646|NCT00889863|467772135|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
129947647|NCT04361617|467772136|FG000|Overall Study|Withdrawal by Subject|0|||
129947648|NCT04361617|467772137|FG001|Overall Study|Withdrawal by Subject|1|||
129947649|NCT01393964|467772138|FG000|Overall Study|Disease Progression|4|||
129947650|NCT01393964|467772139|FG001|Overall Study|Disease Progression|3|||
129947651|NCT01393964|467772140|FG002|Overall Study|Disease Progression|5|||
129947652|NCT01393964|467772138|FG000|Overall Study|Study drug toxicity|1|||
129947653|NCT01393964|467772139|FG001|Overall Study|Study drug toxicity|0|||
129947654|NCT01393964|467772140|FG002|Overall Study|Study drug toxicity|0|||
129947655|NCT01393964|467772138|FG000|Overall Study|Withdrawal by Subject|0|||
129947656|NCT01393964|467772139|FG001|Overall Study|Withdrawal by Subject|0|||
129947657|NCT01393964|467772140|FG002|Overall Study|Withdrawal by Subject|1|||
129947658|NCT01393964|467772138|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129947659|NCT01393964|467772139|FG001|Overall Study|Adverse event unrelated to study drug|3|||
129947660|NCT01393964|467772140|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129947661|NCT01393964|467772138|FG000|Overall Study|Subject request stop study treatment|0|||
129947662|NCT01393964|467772139|FG001|Overall Study|Subject request stop study treatment|1|||
129947663|NCT01393964|467772140|FG002|Overall Study|Subject request stop study treatment|0|||
129947664|NCT01393964|467772138|FG000|Overall Study|Subject decided to move to transplant|1|||
129947665|NCT01393964|467772139|FG001|Overall Study|Subject decided to move to transplant|0|||
129947666|NCT01393964|467772140|FG002|Overall Study|Subject decided to move to transplant|0|||
129947667|NCT01393964|467772138|FG000|Overall Study|Subject switched to commercial supply|1|||
129947668|NCT01393964|467772139|FG001|Overall Study|Subject switched to commercial supply|0|||
129947669|NCT01393964|467772140|FG002|Overall Study|Subject switched to commercial supply|2|||
129947670|NCT01393964|467772138|FG000|Overall Study|Subject plateaued in terms of effect|1|||
129947671|NCT01393964|467772139|FG001|Overall Study|Subject plateaued in terms of effect|0|||
129947672|NCT01393964|467772140|FG002|Overall Study|Subject plateaued in terms of effect|0|||
129947673|NCT01393964|467772138|FG000|Overall Study|Investigator removed subject from study|0|||
129947674|NCT01393964|467772139|FG001|Overall Study|Investigator removed subject from study|1|||
129947675|NCT01393964|467772140|FG002|Overall Study|Investigator removed subject from study|0|||
129947676|NCT01393964|467772138|FG000|Overall Study|Subject converted to roll-over study|0|||
129947677|NCT01393964|467772139|FG001|Overall Study|Subject converted to roll-over study|1|||
129453485|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
129947678|NCT01393964|467772140|FG002|Overall Study|Subject converted to roll-over study|0|||
129947679|NCT01393964|467772138|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
129947680|NCT01393964|467772139|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
129947681|NCT01393964|467772140|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
129947682|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
129947683|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
129947684|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947685|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947686|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947687|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947688|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
129947689|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
129947690|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
129947691|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947692|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947693|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947694|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947695|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
129947696|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
129947697|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
129947698|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947699|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947700|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947701|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947702|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
129947703|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947704|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
129947705|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947706|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947707|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947708|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947709|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
129947710|NCT03136861|467772141|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
129947711|NCT03136861|467772142|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
129947712|NCT03136861|467772143|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947713|NCT03136861|467772144|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947714|NCT03136861|467772145|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947715|NCT03136861|467772146|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947716|NCT03136861|467772147|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
129947717|NCT03136861|467772141|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947718|NCT03136861|467772142|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947719|NCT03136861|467772143|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947720|NCT03136861|467772144|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
129947721|NCT03136861|467772145|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
129947722|NCT03136861|467772146|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
129947723|NCT03136861|467772147|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
129947724|NCT03136861|467772141|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947725|NCT03136861|467772142|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947726|NCT03136861|467772143|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
129947727|NCT03136861|467772144|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947728|NCT03136861|467772145|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947729|NCT03136861|467772146|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947730|NCT03136861|467772147|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
129947731|NCT03136861|467772141|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947732|NCT03136861|467772142|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947733|NCT03136861|467772143|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
129947734|NCT03136861|467772144|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947735|NCT03136861|467772145|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947736|NCT03136861|467772146|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947737|NCT03136861|467772147|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
129947738|NCT01584648|467772150|FG000|Overall Study|Death|136|||
129947739|NCT01584648|467772151|FG001|Overall Study|Death|146|||
129947740|NCT01584648|467772150|FG000|Overall Study|Lost to Follow-up|9|||
129947741|NCT01584648|467772151|FG001|Overall Study|Lost to Follow-up|9|||
129947742|NCT01584648|467772150|FG000|Overall Study|Investigator discretion|3|||
129947743|NCT01584648|467772151|FG001|Overall Study|Investigator discretion|2|||
129947744|NCT01584648|467772150|FG000|Overall Study|Withdrew consent|13|||
129947745|NCT01584648|467772151|FG001|Overall Study|Withdrew consent|4|||
129947746|NCT01584648|467772150|FG000|Overall Study|Study closed/terminated|50|||
129947747|NCT01584648|467772151|FG001|Overall Study|Study closed/terminated|23|||
129947748|NCT01584648|467772150|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
129947749|NCT01584648|467772151|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
129947750|NCT05376397|467772154|FG000|Overall Study|Lost to Follow-up|1|||
129947751|NCT01328756|467772155|FG000|Overall Study|Protocol Violation|4|||
129947752|NCT01328756|467772155|FG000|Overall Study|Adverse Event|39|||
129947753|NCT01328756|467772155|FG000|Overall Study|Lack of Efficacy|5|||
129947754|NCT01328756|467772155|FG000|Overall Study|Withdrawal by Subject|41|||
129947755|NCT01328756|467772155|FG000|Overall Study|Lost to Follow-up|5|||
129947756|NCT01328756|467772155|FG000|Overall Study|Other|29|||
129947757|NCT04492475|467772159|FG000|Overall Study|Enrolled but not treated|8|||
129947758|NCT04492475|467772160|FG001|Overall Study|Enrolled but not treated|8|||
129947759|NCT04492475|467772159|FG000|Overall Study|Withdrawal by Subject|4|||
129947760|NCT04492475|467772160|FG001|Overall Study|Withdrawal by Subject|0|||
129947761|NCT04492475|467772159|FG000|Overall Study|Became ineligible after enrollment|2|||
129947762|NCT04492475|467772160|FG001|Overall Study|Became ineligible after enrollment|0|||
129947763|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
129947764|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
129947765|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
129947766|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
129947767|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
129947768|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
129947769|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Adverse Event|6|||
129947770|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Adverse Event|4|||
129947771|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Adverse Event|8|||
129947772|NCT01262456|467772162|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
129947773|NCT01262456|467772163|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
129947774|NCT01262456|467772164|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
129947775|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
129947776|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
129947777|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
129947778|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
129947779|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
129947780|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
129947781|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
129947782|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
129947783|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
129947784|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
129947785|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
129947786|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
129947787|NCT01262456|467772162|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
129947788|NCT01262456|467772163|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
129947789|NCT01262456|467772164|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
129947790|NCT01860079|467772167|FG000|Overall Study|Physician Decision|14|||
129947791|NCT01860079|467772168|FG001|Overall Study|Physician Decision|22|||
129947792|NCT04867382|467772169|FG000|Overall Study|Did not complete the survey|2|||
129947793|NCT04867382|467772170|FG001|Overall Study|Did not complete the survey|1|||
129947794|NCT05445557|467772174|FG000|Double Blind Part|Lost to Follow-up|1|||
129947795|NCT00428714|467772184|FG000|Overall Study|Progressive Disease|28|||
129947796|NCT00428714|467772185|FG001|Overall Study|Progressive Disease|36|||
129947797|NCT00428714|467772184|FG000|Overall Study|Withdrawal by Subject|0|||
129947798|NCT00428714|467772185|FG001|Overall Study|Withdrawal by Subject|3|||
129947799|NCT00428714|467772184|FG000|Overall Study|Adverse Event|0|||
129947800|NCT00428714|467772185|FG001|Overall Study|Adverse Event|2|||
129947801|NCT00428714|467772184|FG000|Overall Study|Physician Decision|1|||
129947802|NCT00428714|467772185|FG001|Overall Study|Physician Decision|1|||
129947803|NCT00428714|467772184|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
129947804|NCT00428714|467772185|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
129453486|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
129947805|NCT00428714|467772184|FG000|Overall Study|Death due to other then PD|1|||
129947806|NCT00428714|467772185|FG001|Overall Study|Death due to other then PD|0|||
129947807|NCT01681511|467772186|FG000|Overall Study|No Treatment Received|1|||
129947808|NCT01681511|467772187|FG001|Overall Study|No Treatment Received|3|||
129947809|NCT01681511|467772186|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
129947810|NCT01681511|467772187|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
129947811|NCT01681511|467772186|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
129947812|NCT01681511|467772187|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
129947813|NCT01681511|467772186|FG000|Overall Study|No Daily Urine Sample Collected|0|||
129947814|NCT01681511|467772187|FG001|Overall Study|No Daily Urine Sample Collected|1|||
129947815|NCT01681511|467772186|FG000|Overall Study|No post-catheter sample collected|11|||
129947816|NCT01681511|467772187|FG001|Overall Study|No post-catheter sample collected|4|||
129947817|NCT01156675|467772188|FG000|Overall Study|Death|5|||
129947818|NCT01156675|467772189|FG001|Overall Study|Death|3|||
129947819|NCT01156675|467772190|FG002|Overall Study|Death|0|||
129947820|NCT01156675|467772188|FG000|Overall Study|No data|29|||
129947821|NCT01156675|467772189|FG001|Overall Study|No data|22|||
129947822|NCT01156675|467772190|FG002|Overall Study|No data|2|||
129947823|NCT02326220|467772204|FG000|Double-blind Treatment Period|Adverse Event|1|||
129947824|NCT02326220|467772205|FG001|Double-blind Treatment Period|Adverse Event|2|||
129947825|NCT02326220|467772206|FG002|Double-blind Treatment Period|Adverse Event|0|||
129947826|NCT02326220|467772204|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129947827|NCT02326220|467772205|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129947828|NCT02326220|467772206|FG002|Double-blind Treatment Period|Protocol Violation|0|||
129947829|NCT02326220|467772204|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129947830|NCT02326220|467772205|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129947831|NCT02326220|467772206|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129947832|NCT02326220|467772204|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
129947833|NCT02326220|467772205|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
129947834|NCT02326220|467772206|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
129947835|NCT02326220|467772204|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129947836|NCT02326220|467772205|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
129947837|NCT02326220|467772206|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
129947838|NCT02114515|467772208|FG000|Overall Study|Lost to Follow-up|52|||
129947839|NCT02114515|467772209|FG001|Overall Study|Lost to Follow-up|55|||
129947840|NCT02114515|467772208|FG000|Overall Study|Death|12|||
129947841|NCT02114515|467772209|FG001|Overall Study|Death|12|||
129947842|NCT02114515|467772208|FG000|Overall Study|Withdrawal by Subject|4|||
129947843|NCT02114515|467772209|FG001|Overall Study|Withdrawal by Subject|22|||
129947844|NCT02114515|467772208|FG000|Overall Study|Other|65|||
129947845|NCT02114515|467772209|FG001|Overall Study|Other|61|||
129947846|NCT02699099|467772210|FG000|Overall Study|Adverse Event|1|||
129947847|NCT02699099|467772211|FG001|Overall Study|Adverse Event|0|||
129947848|NCT02699099|467772212|FG002|Overall Study|Adverse Event|2|||
129947849|NCT02699099|467772210|FG000|Overall Study|Lost to Follow-up|0|||
129947850|NCT02699099|467772211|FG001|Overall Study|Lost to Follow-up|1|||
129947851|NCT02699099|467772212|FG002|Overall Study|Lost to Follow-up|0|||
129947852|NCT02699099|467772210|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
129947853|NCT02699099|467772211|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
129947854|NCT02699099|467772212|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
129947855|NCT02144285|467772215|FG000|Overall Study|Withdrawal by Subject|0|||
129947856|NCT02144285|467772216|FG001|Overall Study|Withdrawal by Subject|0|||
129947857|NCT02144285|467772217|FG002|Overall Study|Withdrawal by Subject|0|||
129947858|NCT02144285|467772218|FG003|Overall Study|Withdrawal by Subject|0|||
129947859|NCT02144285|467772219|FG004|Overall Study|Withdrawal by Subject|1|||
129947860|NCT02144285|467772220|FG005|Overall Study|Withdrawal by Subject|0|||
129947861|NCT02144285|467772221|FG006|Overall Study|Withdrawal by Subject|0|||
129947862|NCT02144285|467772222|FG007|Overall Study|Withdrawal by Subject|0|||
129947863|NCT02144285|467772223|FG008|Overall Study|Withdrawal by Subject|0|||
129947864|NCT02144285|467772224|FG009|Overall Study|Withdrawal by Subject|0|||
129947865|NCT05184062|467772226|FG000|Overall Study|Lost to Follow-up|5|||
129947866|NCT05184062|467772227|FG001|Overall Study|Lost to Follow-up|1|||
129947867|NCT05184062|467772226|FG000|Overall Study|Withdrawal by Subject|1|||
129947868|NCT05184062|467772227|FG001|Overall Study|Withdrawal by Subject|0|||
129947869|NCT03659136|467772232|FG000|Overall Study|Not treated|2|||
129947870|NCT03659136|467772233|FG001|Overall Study|Not treated|0|||
129947871|NCT03659136|467772232|FG000|Overall Study|Covid-19 related|1|||
129947872|NCT03659136|467772233|FG001|Overall Study|Covid-19 related|1|||
129947873|NCT03659136|467772232|FG000|Overall Study|Withdrawal by Subject|1|||
129947874|NCT03659136|467772233|FG001|Overall Study|Withdrawal by Subject|6|||
129947875|NCT03659136|467772232|FG000|Overall Study|Adverse Event|4|||
129947876|NCT03659136|467772233|FG001|Overall Study|Adverse Event|6|||
129947877|NCT03659136|467772232|FG000|Overall Study|Progressive disease|37|||
129947878|NCT03659136|467772233|FG001|Overall Study|Progressive disease|31|||
129947879|NCT03659136|467772232|FG000|Overall Study|Study closure|2|||
129947880|NCT03659136|467772233|FG001|Overall Study|Study closure|2|||
129947881|NCT03659136|467772232|FG000|Overall Study|Sponsor decision/recommendation|3|||
129947882|NCT03659136|467772233|FG001|Overall Study|Sponsor decision/recommendation|2|||
129947883|NCT03659136|467772232|FG000|Overall Study|Switched to other drug/therapy|2|||
129947884|NCT03659136|467772233|FG001|Overall Study|Switched to other drug/therapy|2|||
129947885|NCT03659136|467772232|FG000|Overall Study|Lack of clinical benefit|0|||
129947886|NCT03659136|467772233|FG001|Overall Study|Lack of clinical benefit|1|||
129947887|NCT03786471|467772234|FG000|Overall Study|Death|254|||
129947888|NCT03786471|467772235|FG001|Overall Study|Death|223|||
129947889|NCT03786471|467772236|FG002|Overall Study|Death|37|||
129947890|NCT03786471|467772234|FG000|Overall Study|Lost to Follow-up|63|||
129947891|NCT03786471|467772235|FG001|Overall Study|Lost to Follow-up|50|||
129947892|NCT03786471|467772236|FG002|Overall Study|Lost to Follow-up|15|||
129947893|NCT03786471|467772234|FG000|Overall Study|Withdrawal by Subject|99|||
129947894|NCT03786471|467772235|FG001|Overall Study|Withdrawal by Subject|81|||
129947895|NCT03786471|467772236|FG002|Overall Study|Withdrawal by Subject|11|||
129947896|NCT00747149|467773957|FG000|Overall Study|Adverse Event|0|||
129947897|NCT00747149|467773958|FG001|Overall Study|Adverse Event|15|||
129947898|NCT00747149|467773957|FG000|Overall Study|Lost to Follow-up|0|||
129947899|NCT00747149|467773958|FG001|Overall Study|Lost to Follow-up|10|||
129947900|NCT00747149|467773957|FG000|Overall Study|Withdrawal by Subject|0|||
129947901|NCT00747149|467773958|FG001|Overall Study|Withdrawal by Subject|6|||
129947902|NCT00747149|467773957|FG000|Overall Study|Did not receive treatment|0|||
129947903|NCT00747149|467773958|FG001|Overall Study|Did not receive treatment|1|||
129947904|NCT00747149|467773957|FG000|Overall Study|Incorrect enrollment|0|||
129947905|NCT00747149|467773958|FG001|Overall Study|Incorrect enrollment|6|||
129947906|NCT00747149|467773957|FG000|Overall Study|Severe non-compliance to protocol|0|||
129947907|NCT00747149|467773958|FG001|Overall Study|Severe non-compliance to protocol|1|||
129947908|NCT00747149|467773957|FG000|Overall Study|Not reported|1|||
129947909|NCT00747149|467773958|FG001|Overall Study|Not reported|4|||
129947910|NCT01276509|467773961|FG000|Overall Study|Adverse Event|9|||
129947911|NCT01276509|467773962|FG001|Overall Study|Adverse Event|8|||
129947912|NCT01276509|467773963|FG002|Overall Study|Adverse Event|4|||
129947913|NCT01276509|467773964|FG003|Overall Study|Adverse Event|3|||
129947914|NCT01276509|467773961|FG000|Overall Study|Lack of Efficacy|2|||
129947915|NCT01276509|467773962|FG001|Overall Study|Lack of Efficacy|1|||
129947916|NCT01276509|467773963|FG002|Overall Study|Lack of Efficacy|1|||
129947917|NCT01276509|467773964|FG003|Overall Study|Lack of Efficacy|2|||
129947918|NCT01276509|467773961|FG000|Overall Study|Pregnancy|1|||
129947919|NCT01276509|467773962|FG001|Overall Study|Pregnancy|0|||
129947920|NCT01276509|467773963|FG002|Overall Study|Pregnancy|0|||
129947921|NCT01276509|467773964|FG003|Overall Study|Pregnancy|0|||
129947922|NCT01276509|467773961|FG000|Overall Study|Withdrawal by Subject|1|||
129947923|NCT01276509|467773962|FG001|Overall Study|Withdrawal by Subject|2|||
129947924|NCT01276509|467773963|FG002|Overall Study|Withdrawal by Subject|0|||
129947925|NCT01276509|467773964|FG003|Overall Study|Withdrawal by Subject|0|||
129947926|NCT01276509|467773961|FG000|Overall Study|Other|0|||
129947927|NCT01276509|467773962|FG001|Overall Study|Other|1|||
129947928|NCT01276509|467773963|FG002|Overall Study|Other|0|||
129947929|NCT01276509|467773964|FG003|Overall Study|Other|0|||
129947930|NCT02196259|467773968|FG000|Overall Study|Researcher choice|0|||
129947931|NCT02196259|467773969|FG001|Overall Study|Researcher choice|0|||
129947932|NCT02196259|467773970|FG002|Overall Study|Researcher choice|1|||
129947933|NCT02196259|467773968|FG000|Overall Study|Partial data analysis|0|||
129947934|NCT02196259|467773969|FG001|Overall Study|Partial data analysis|3|||
129947935|NCT02196259|467773970|FG002|Overall Study|Partial data analysis|0|||
129947936|NCT02830893|467773971|FG000|Overall Study|Relocation to out of the country|1|||
129947937|NCT02830893|467773972|FG001|Overall Study|Relocation to out of the country|0|||
129947938|NCT02830893|467773971|FG000|Overall Study|Lost to Follow-up|0|||
129947939|NCT02830893|467773972|FG001|Overall Study|Lost to Follow-up|2|||
129947940|NCT02830893|467773971|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
129947941|NCT02830893|467773972|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
129947942|NCT00215943|467773973|FG000|Overall Study|Disease Progression|3|||
129947943|NCT00215943|467773974|FG001|Overall Study|Disease Progression|5|||
129947944|NCT00215943|467773973|FG000|Overall Study|Alternate therapy|0|||
129947945|NCT00215943|467773974|FG001|Overall Study|Alternate therapy|1|||
129947946|NCT00215943|467773973|FG000|Overall Study|Adverse Event|3|||
129947947|NCT00215943|467773974|FG001|Overall Study|Adverse Event|6|||
129947948|NCT00215943|467773973|FG000|Overall Study|Other disease|0|||
129947949|NCT00215943|467773974|FG001|Overall Study|Other disease|1|||
129947950|NCT00215943|467773973|FG000|Overall Study|Other complications|3|||
129947951|NCT00215943|467773974|FG001|Overall Study|Other complications|1|||
129947952|NCT00647699|467773975|FG000|Overall Study|Lost to Follow-up|5|||
129947953|NCT00647699|467773976|FG001|Overall Study|Lost to Follow-up|4|||
129947954|NCT00647699|467773975|FG000|Overall Study|Withdrawal by Subject|3|||
129947955|NCT00647699|467773976|FG001|Overall Study|Withdrawal by Subject|8|||
129947956|NCT00413283|467773977|FG000|Overall Study|Withdrawal by Subject|1|||
129947957|NCT00413283|467773978|FG001|Overall Study|Withdrawal by Subject|0|||
129947958|NCT00413283|467773979|FG002|Overall Study|Withdrawal by Subject|0|||
129947959|NCT00413283|467773980|FG003|Overall Study|Withdrawal by Subject|1|||
129947960|NCT00413283|467773977|FG000|Overall Study|Death|0|||
129947961|NCT00413283|467773978|FG001|Overall Study|Death|0|||
129947962|NCT00413283|467773979|FG002|Overall Study|Death|1|||
129947963|NCT00413283|467773980|FG003|Overall Study|Death|1|||
129947964|NCT00413283|467773977|FG000|Overall Study|Adverse Event|0|||
129947965|NCT00413283|467773978|FG001|Overall Study|Adverse Event|0|||
129947966|NCT00413283|467773979|FG002|Overall Study|Adverse Event|0|||
129947967|NCT00413283|467773980|FG003|Overall Study|Adverse Event|1|||
129947968|NCT00413283|467773977|FG000|Overall Study|Ineligibility determined|0|||
129947969|NCT00413283|467773978|FG001|Overall Study|Ineligibility determined|0|||
129947970|NCT00413283|467773979|FG002|Overall Study|Ineligibility determined|0|||
129947971|NCT00413283|467773980|FG003|Overall Study|Ineligibility determined|1|||
129947972|NCT00413283|467773977|FG000|Overall Study|Protocol deviation|0|||
129947973|NCT00413283|467773978|FG001|Overall Study|Protocol deviation|1|||
129947974|NCT00413283|467773979|FG002|Overall Study|Protocol deviation|0|||
129947975|NCT00413283|467773980|FG003|Overall Study|Protocol deviation|0|||
129947976|NCT00413283|467773977|FG000|Overall Study|Requirement for alternative therapy|0|||
129947977|NCT00413283|467773978|FG001|Overall Study|Requirement for alternative therapy|2|||
129947978|NCT00413283|467773979|FG002|Overall Study|Requirement for alternative therapy|0|||
129947979|NCT00413283|467773980|FG003|Overall Study|Requirement for alternative therapy|0|||
129947980|NCT00413283|467773977|FG000|Overall Study|Other|0|||
129947981|NCT00413283|467773978|FG001|Overall Study|Other|0|||
129947982|NCT00413283|467773979|FG002|Overall Study|Other|1|||
129947983|NCT00413283|467773980|FG003|Overall Study|Other|0|||
129947984|NCT02354417|467773981|FG000|Overall Study|Physician Decision|1|||
129947985|NCT00246129|467773982|FG000|Overall Study|Lost to Follow-up|1|||
129947986|NCT00246129|467773983|FG001|Overall Study|Lost to Follow-up|0|||
129947987|NCT00246129|467773982|FG000|Overall Study|Death|2|||
129947988|NCT00246129|467773983|FG001|Overall Study|Death|1|||
129947989|NCT00246129|467773982|FG000|Overall Study|suffered primary non-function|1|||
129947990|NCT00246129|467773983|FG001|Overall Study|suffered primary non-function|0|||
129947991|NCT00246129|467773982|FG000|Overall Study|grafts failed|3|||
129947992|NCT00246129|467773983|FG001|Overall Study|grafts failed|1|||
129947993|NCT00403845|467773993|FG000|Treatment Period 1|Subject withdrew consent|1|||
129947994|NCT00403845|467773994|FG001|Treatment Period 1|Subject withdrew consent|0|||
129947995|NCT00403845|467773995|FG002|Treatment Period 1|Subject withdrew consent|0|||
129947996|NCT00403845|467773996|FG003|Treatment Period 1|Subject withdrew consent|0|||
129947997|NCT00403845|467773993|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
129947998|NCT00403845|467773994|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
129947999|NCT00403845|467773995|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
129948000|NCT00403845|467773996|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
129948001|NCT00403845|467773993|FG000|Treatment Period 2|Subject withdrew consent|1|||
129948002|NCT00403845|467773994|FG001|Treatment Period 2|Subject withdrew consent|0|||
129948003|NCT00403845|467773995|FG002|Treatment Period 2|Subject withdrew consent|0|||
129948004|NCT00403845|467773996|FG003|Treatment Period 2|Subject withdrew consent|0|||
129948005|NCT00403845|467773993|FG000|Treatment Period 3|Subject withdrew consent|0|||
129948006|NCT00403845|467773994|FG001|Treatment Period 3|Subject withdrew consent|0|||
129948007|NCT00403845|467773995|FG002|Treatment Period 3|Subject withdrew consent|0|||
129948008|NCT00403845|467773996|FG003|Treatment Period 3|Subject withdrew consent|1|||
129948009|NCT00403845|467773993|FG000|Treatment Period 3|Adverse Event|0|||
129948010|NCT00403845|467773994|FG001|Treatment Period 3|Adverse Event|0|||
129948011|NCT00403845|467773995|FG002|Treatment Period 3|Adverse Event|0|||
129948012|NCT00403845|467773996|FG003|Treatment Period 3|Adverse Event|1|||
129948013|NCT00805792|467773997|FG000|Overall Study|Death|3|||
129948014|NCT00805792|467773997|FG000|Overall Study|Lost to Follow-up|2|||
129948015|NCT00578344|467773998|FG000|Overall Study|Insurance problems|1|||
129948016|NCT00578344|467773998|FG000|Overall Study|Graft failure|1|||
129948017|NCT02935673|467773999|FG000|Overall Study|Adverse Event|0|||
129948018|NCT02935673|467774000|FG001|Overall Study|Adverse Event|1|||
129948019|NCT02935673|467774001|FG002|Overall Study|Adverse Event|0|||
129948020|NCT02935673|467773999|FG000|Overall Study|Withdrawal by Subject|1|||
129948021|NCT02935673|467774000|FG001|Overall Study|Withdrawal by Subject|2|||
129948022|NCT02935673|467774001|FG002|Overall Study|Withdrawal by Subject|0|||
129948023|NCT04328467|467774003|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
129948024|NCT04328467|467774004|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
129948025|NCT04328467|467774005|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
129948026|NCT02753075|467774008|FG000|Overall Study|Adverse Event|2|||
129948027|NCT02753075|467774009|FG001|Overall Study|Adverse Event|1|||
129948028|NCT02753075|467774010|FG002|Overall Study|Adverse Event|0|||
129948029|NCT02753075|467774008|FG000|Overall Study|Lost to Follow-up|2|||
129948030|NCT02753075|467774009|FG001|Overall Study|Lost to Follow-up|0|||
129948031|NCT02753075|467774010|FG002|Overall Study|Lost to Follow-up|0|||
129948032|NCT02753075|467774008|FG000|Overall Study|Withdrawal of Consent|1|||
129948033|NCT02753075|467774009|FG001|Overall Study|Withdrawal of Consent|1|||
129948034|NCT02753075|467774010|FG002|Overall Study|Withdrawal of Consent|3|||
129948035|NCT02753075|467774008|FG000|Overall Study|Physician Decision|3|||
129948036|NCT02753075|467774009|FG001|Overall Study|Physician Decision|1|||
129948037|NCT02753075|467774010|FG002|Overall Study|Physician Decision|0|||
129948038|NCT02152384|467774011|FG000|Period 1|Withdrawal by Subject|0|||
129948039|NCT02152384|467774012|FG001|Period 1|Withdrawal by Subject|1|||
129948040|NCT02152384|467774011|FG000|Period 1|Adverse Event|1|||
129948041|NCT02152384|467774012|FG001|Period 1|Adverse Event|1|||
129948042|NCT03265132|467774021|FG000|Overall Study|Adverse Event|0|||
129948043|NCT03265132|467774022|FG001|Overall Study|Adverse Event|1|||
129948044|NCT03265132|467774021|FG000|Overall Study|Lack of Efficacy|0|||
129948045|NCT03265132|467774022|FG001|Overall Study|Lack of Efficacy|2|||
129948046|NCT03265132|467774021|FG000|Overall Study|Progressive disease|0|||
129948047|NCT03265132|467774022|FG001|Overall Study|Progressive disease|2|||
129948048|NCT03265132|467774021|FG000|Overall Study|Withdrawal by Subject|0|||
129948049|NCT03265132|467774022|FG001|Overall Study|Withdrawal by Subject|1|||
129948050|NCT00088166|467774023|FG000|Overall Study|Adverse Event|11|||
129948051|NCT00088166|467774024|FG001|Overall Study|Adverse Event|9|||
129948052|NCT00088166|467774023|FG000|Overall Study|Death|3|||
129948053|NCT00088166|467774024|FG001|Overall Study|Death|1|||
129948054|NCT00088166|467774023|FG000|Overall Study|Lost to Follow-up|0|||
129948055|NCT00088166|467774024|FG001|Overall Study|Lost to Follow-up|1|||
129948056|NCT00088166|467774023|FG000|Overall Study|Physician Decision|4|||
129948057|NCT00088166|467774024|FG001|Overall Study|Physician Decision|1|||
129948058|NCT00088166|467774023|FG000|Overall Study|Protocol Violation|1|||
129948059|NCT00088166|467774024|FG001|Overall Study|Protocol Violation|5|||
129948060|NCT00088166|467774023|FG000|Overall Study|Patient deterioration|29|||
129948061|NCT00088166|467774024|FG001|Overall Study|Patient deterioration|39|||
129948062|NCT00088166|467774023|FG000|Overall Study|Withdrawal by Subject|5|||
129948063|NCT00088166|467774024|FG001|Overall Study|Withdrawal by Subject|5|||
129948064|NCT02671266|467774025|FG000|Overall Study|Withdrawal by Subject|1|||
129948065|NCT02671266|467774026|FG001|Overall Study|Withdrawal by Subject|1|||
129948066|NCT00666705|467774027|FG000|Overall Study|Withdrawal by Subject|1|||
129948067|NCT00687297|467774028|FG000|Randomization|Withdrawal by Subject|2|||
129948068|NCT00687297|467774029|FG001|Randomization|Withdrawal by Subject|0|||
129948069|NCT00687297|467774028|FG000|Randomization|Withdrew before treatment, ineligible|1|||
129948070|NCT00687297|467774029|FG001|Randomization|Withdrew before treatment, ineligible|1|||
129948071|NCT00687297|467774028|FG000|Induction|Withdrawal by Subject|4|||
129948072|NCT00687297|467774029|FG001|Induction|Withdrawal by Subject|4|||
129948073|NCT00687297|467774028|FG000|Induction|Adverse Event|16|||
129948074|NCT00687297|467774029|FG001|Induction|Adverse Event|15|||
129948075|NCT00687297|467774028|FG000|Induction|Death|7|||
129948076|NCT00687297|467774029|FG001|Induction|Death|11|||
129948077|NCT00687297|467774028|FG000|Induction|Lack of Efficacy|17|||
129948078|NCT00687297|467774029|FG001|Induction|Lack of Efficacy|21|||
129948079|NCT00687297|467774028|FG000|Induction|Ineligible|0|||
129948080|NCT00687297|467774029|FG001|Induction|Ineligible|1|||
129948081|NCT00687297|467774028|FG000|Induction|Patient Noncompliance|1|||
129948082|NCT00687297|467774029|FG001|Induction|Patient Noncompliance|0|||
129948083|NCT00687297|467774028|FG000|Induction|Physician Decision|0|||
129948084|NCT00687297|467774029|FG001|Induction|Physician Decision|2|||
129948085|NCT00687297|467774028|FG000|Induction|Other|0|||
129948086|NCT00687297|467774029|FG001|Induction|Other|1|||
129948087|NCT01109979|467774030|FG000|Overall Study|Physician Decision|2|||
129948088|NCT01109979|467774031|FG001|Overall Study|Physician Decision|0|||
129948089|NCT01109979|467774030|FG000|Overall Study|Withdrawal by Subject|0|||
129948090|NCT01109979|467774031|FG001|Overall Study|Withdrawal by Subject|1|||
129948091|NCT01228734|467774032|FG000|Overall Study|Randomized, but not treated|0|||
129948092|NCT01228734|467774033|FG001|Overall Study|Randomized, but not treated|4|||
129948093|NCT03128099|467774034|FG000|Overall Study|High dose task was too long|0|||
129948094|NCT03128099|467774035|FG001|Overall Study|High dose task was too long|4|||
129948095|NCT03128099|467774036|FG002|Overall Study|High dose task was too long|0|||
129948096|NCT03128099|467774034|FG000|Overall Study|Participant got a full time job.|1|||
129948097|NCT03128099|467774035|FG001|Overall Study|Participant got a full time job.|0|||
129948098|NCT03128099|467774036|FG002|Overall Study|Participant got a full time job.|0|||
129948099|NCT03128099|467774034|FG000|Overall Study|Became homeless and lost contact|1|||
129948100|NCT03128099|467774035|FG001|Overall Study|Became homeless and lost contact|0|||
129948101|NCT03128099|467774036|FG002|Overall Study|Became homeless and lost contact|0|||
129948102|NCT03128099|467774034|FG000|Overall Study|Did not complete all the assessments|0|||
129948103|NCT03128099|467774035|FG001|Overall Study|Did not complete all the assessments|0|||
129948104|NCT03128099|467774036|FG002|Overall Study|Did not complete all the assessments|1|||
129948105|NCT03456856|467774037|FG000|Overall Study|Lost to Follow-up|2|||
129948106|NCT03456856|467774037|FG000|Overall Study|Withdrawal by Subject|1|||
129948107|NCT02542696|467774042|FG000|Overall Study|Adverse Event|167|||
129948108|NCT02542696|467774042|FG000|Overall Study|Lack of Efficacy|26|||
129948109|NCT02542696|467774042|FG000|Overall Study|Lost to Follow-up|6|||
129948110|NCT02542696|467774042|FG000|Overall Study|Withdrawal by Subject|104|||
129948111|NCT02542696|467774042|FG000|Overall Study|Protocol Violation|5|||
129948112|NCT02542696|467774042|FG000|Overall Study|Death|8|||
129948113|NCT02542696|467774042|FG000|Overall Study|DECREASED OFF TIME|1|||
129948114|NCT02542696|467774042|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
129948115|NCT02542696|467774042|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
129948116|NCT02542696|467774042|FG000|Overall Study|MEDICAL HISTORY|1|||
129948117|NCT02542696|467774042|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
129948118|NCT02542696|467774042|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
129948119|NCT02542696|467774042|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
129948120|NCT02542696|467774042|FG000|Overall Study|SPONSOR DECISION|3|||
129948121|NCT02542696|467774042|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
129948122|NCT02542696|467774042|FG000|Overall Study|SUBJECT DECISION|2|||
129948123|NCT02137785|467774046|FG000|Overall Study|Lost to Follow-up|1|||
129948124|NCT02137785|467774047|FG001|Overall Study|Lost to Follow-up|0|||
129948125|NCT02137785|467774046|FG000|Overall Study|Withdrawal by Subject|1|||
129948126|NCT02137785|467774047|FG001|Overall Study|Withdrawal by Subject|4|||
129948127|NCT02137785|467774046|FG000|Overall Study|subject moved out of state|1|||
129948128|NCT02137785|467774047|FG001|Overall Study|subject moved out of state|0|||
129948129|NCT03390166|467774048|FG000|Overall Study|Death|0|||
129948130|NCT03390166|467774049|FG001|Overall Study|Death|1|||
129948131|NCT03390166|467774048|FG000|Overall Study|Lost to Follow-up|6|||
129948132|NCT03390166|467774049|FG001|Overall Study|Lost to Follow-up|4|||
129948133|NCT03390166|467774048|FG000|Overall Study|Physician Decision|2|||
129948134|NCT03390166|467774049|FG001|Overall Study|Physician Decision|1|||
129948135|NCT03390166|467774048|FG000|Overall Study|Move from study area|3|||
129948136|NCT03390166|467774049|FG001|Overall Study|Move from study area|2|||
129948137|NCT03390166|467774048|FG000|Overall Study|To militarycamp for conscript|1|||
129948138|NCT03390166|467774049|FG001|Overall Study|To militarycamp for conscript|0|||
129948139|NCT03390166|467774048|FG000|Overall Study|To drug therapy course|0|||
129948140|NCT03390166|467774049|FG001|Overall Study|To drug therapy course|1|||
129948141|NCT03390166|467774048|FG000|Overall Study|Move to work oversea|0|||
129948142|NCT03390166|467774049|FG001|Overall Study|Move to work oversea|1|||
129948143|NCT01137682|467774050|FG000|Overall Study|Adverse Event-CORE|2|||
129948144|NCT01137682|467774051|FG001|Overall Study|Adverse Event-CORE|4|||
129948145|NCT01137682|467774052|FG002|Overall Study|Adverse Event-CORE|0|||
129948146|NCT01137682|467774050|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
129948147|NCT01137682|467774051|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
129948148|NCT01137682|467774052|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
129948149|NCT01137682|467774050|FG000|Overall Study|Administrative problems-CORE|2|||
129948150|NCT01137682|467774051|FG001|Overall Study|Administrative problems-CORE|1|||
129948151|NCT01137682|467774052|FG002|Overall Study|Administrative problems-CORE|0|||
129948152|NCT01137682|467774050|FG000|Overall Study|Protocol Violation-CORE|0|||
129948153|NCT01137682|467774051|FG001|Overall Study|Protocol Violation-CORE|1|||
129948154|NCT01137682|467774052|FG002|Overall Study|Protocol Violation-CORE|1|||
129948155|NCT01137682|467774050|FG000|Overall Study|Adverse Event-Extension|4|||
129948156|NCT01137682|467774051|FG001|Overall Study|Adverse Event-Extension|8|||
129948157|NCT01137682|467774052|FG002|Overall Study|Adverse Event-Extension|7|||
129948158|NCT01137682|467774050|FG000|Overall Study|Lack of Efficacy-Extension|15|||
129948159|NCT01137682|467774051|FG001|Overall Study|Lack of Efficacy-Extension|9|||
129948160|NCT01137682|467774052|FG002|Overall Study|Lack of Efficacy-Extension|13|||
129948161|NCT01137682|467774050|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
129948162|NCT01137682|467774051|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
129948163|NCT01137682|467774052|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
129948164|NCT01137682|467774050|FG000|Overall Study|Lost to Follow Up-Extension|0|||
129948165|NCT01137682|467774051|FG001|Overall Study|Lost to Follow Up-Extension|1|||
129948166|NCT01137682|467774052|FG002|Overall Study|Lost to Follow Up-Extension|0|||
129948167|NCT01137682|467774050|FG000|Overall Study|Administrative problems-Extension|0|||
129948168|NCT01137682|467774051|FG001|Overall Study|Administrative problems-Extension|2|||
129948169|NCT01137682|467774052|FG002|Overall Study|Administrative problems-Extension|0|||
129948170|NCT01137682|467774050|FG000|Overall Study|Death-Extension|2|||
129948171|NCT01137682|467774051|FG001|Overall Study|Death-Extension|0|||
129948172|NCT01137682|467774052|FG002|Overall Study|Death-Extension|0|||
129948173|NCT01137682|467774050|FG000|Overall Study|Protocol Violation-Extension|2|||
129948174|NCT01137682|467774051|FG001|Overall Study|Protocol Violation-Extension|1|||
129948175|NCT01137682|467774052|FG002|Overall Study|Protocol Violation-Extension|0|||
129948176|NCT01137682|467774050|FG000|Overall Study|Did not enter extension|2|||
129948177|NCT01137682|467774051|FG001|Overall Study|Did not enter extension|3|||
129948178|NCT01137682|467774052|FG002|Overall Study|Did not enter extension|2|||
129948179|NCT01137682|467774050|FG000|Overall Study|Did not receive treatment in extension|0|||
129948180|NCT01137682|467774051|FG001|Overall Study|Did not receive treatment in extension|0|||
129948181|NCT01137682|467774052|FG002|Overall Study|Did not receive treatment in extension|1|||
129948182|NCT04421456|467774054|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
129948183|NCT04421456|467774055|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
129948184|NCT04421456|467774056|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
129948185|NCT04421456|467774054|FG000|Randomized Treatment Period|Adverse Event|0|||
129948186|NCT04421456|467774055|FG001|Randomized Treatment Period|Adverse Event|1|||
129948187|NCT04421456|467774056|FG002|Randomized Treatment Period|Adverse Event|0|||
129948188|NCT04421456|467774054|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
129948189|NCT04421456|467774055|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
129948190|NCT04421456|467774056|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
129948191|NCT04421456|467774054|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
129948192|NCT04421456|467774055|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
129948193|NCT04421456|467774056|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
129948194|NCT04421456|467774054|FG000|Randomized Treatment Period|Participant non-compliance|1|||
129948195|NCT04421456|467774055|FG001|Randomized Treatment Period|Participant non-compliance|1|||
129948196|NCT04421456|467774056|FG002|Randomized Treatment Period|Participant non-compliance|2|||
129948197|NCT04421456|467774054|FG000|Randomized Treatment Period|Other|0|||
129948198|NCT04421456|467774055|FG001|Randomized Treatment Period|Other|1|||
129948199|NCT04421456|467774056|FG002|Randomized Treatment Period|Other|3|||
129948200|NCT00274287|467774057|FG000|Overall Study|Withdrawal by Subject|1|||
129948201|NCT00274287|467774057|FG000|Overall Study|subject non-compliance|1|||
129948202|NCT04617847|467774058|FG000|Overall Study|Withdrawal by Subject|1|||
129948203|NCT04617847|467774059|FG001|Overall Study|Withdrawal by Subject|0|||
129948204|NCT04617847|467774058|FG000|Overall Study|Adverse Event|0|||
129948205|NCT04617847|467774059|FG001|Overall Study|Adverse Event|2|||
129948206|NCT04617847|467774058|FG000|Overall Study|Death|0|||
129948207|NCT04617847|467774059|FG001|Overall Study|Death|1|||
129948208|NCT04617847|467774058|FG000|Overall Study|Termination of Study by Sponsor|2|||
129948209|NCT04617847|467774059|FG001|Overall Study|Termination of Study by Sponsor|21|||
129948210|NCT00244751|467774060|FG000|Overall Study|Adverse Event|7|||
129948211|NCT00244751|467774061|FG001|Overall Study|Adverse Event|7|||
129948212|NCT00244751|467774062|FG002|Overall Study|Adverse Event|5|||
129948213|NCT00244751|467774060|FG000|Overall Study|Lost to Follow-up|0|||
129948214|NCT00244751|467774061|FG001|Overall Study|Lost to Follow-up|1|||
129948215|NCT00244751|467774062|FG002|Overall Study|Lost to Follow-up|0|||
129948216|NCT00244751|467774060|FG000|Overall Study|Protocol Violation|1|||
129948217|NCT00244751|467774061|FG001|Overall Study|Protocol Violation|0|||
129948218|NCT00244751|467774062|FG002|Overall Study|Protocol Violation|1|||
129948219|NCT00244751|467774060|FG000|Overall Study|Withdrawal by Subject|7|||
129948220|NCT00244751|467774061|FG001|Overall Study|Withdrawal by Subject|5|||
129948221|NCT00244751|467774062|FG002|Overall Study|Withdrawal by Subject|3|||
129948222|NCT00244751|467774060|FG000|Overall Study|Elevated liver enzymes|1|||
129948223|NCT00244751|467774061|FG001|Overall Study|Elevated liver enzymes|0|||
129948224|NCT00244751|467774062|FG002|Overall Study|Elevated liver enzymes|0|||
129948225|NCT00244751|467774060|FG000|Overall Study|Lack of compliance with protocol|0|||
129948226|NCT00244751|467774061|FG001|Overall Study|Lack of compliance with protocol|1|||
129948227|NCT00244751|467774062|FG002|Overall Study|Lack of compliance with protocol|0|||
129948228|NCT00244751|467774060|FG000|Overall Study|Safety reasons|0|||
129948229|NCT00244751|467774061|FG001|Overall Study|Safety reasons|1|||
129948230|NCT00244751|467774062|FG002|Overall Study|Safety reasons|0|||
129948231|NCT00244751|467774060|FG000|Overall Study|Participant randomized by mistake|0|||
129948232|NCT00244751|467774061|FG001|Overall Study|Participant randomized by mistake|0|||
129948233|NCT00244751|467774062|FG002|Overall Study|Participant randomized by mistake|1|||
129948234|NCT02206607|467774065|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
129948235|NCT02206607|467774066|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
129948236|NCT02206607|467774067|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
129948237|NCT02206607|467774068|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
129948238|NCT02206607|467774069|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
129948239|NCT02206607|467774065|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
129948240|NCT02206607|467774066|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
129948241|NCT02206607|467774067|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
129948242|NCT02206607|467774068|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
129948243|NCT02206607|467774069|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
129948244|NCT04085614|467774070|FG000|Overall Study|Protocol Violation|9|||
129948245|NCT04085614|467774071|FG001|Overall Study|Protocol Violation|6|||
129948246|NCT02399449|467774072|FG000|Overall Study|Withdrawal by Subject|3|||
129948247|NCT02399449|467774073|FG001|Overall Study|Withdrawal by Subject|9|||
129948248|NCT02399449|467774072|FG000|Overall Study|Physician Decision|0|||
129948249|NCT02399449|467774073|FG001|Overall Study|Physician Decision|1|||
129948250|NCT02516202|467774074|FG000|Overall Study|Withdrawal by Subject|1|||
129948251|NCT02516202|467774075|FG001|Overall Study|Withdrawal by Subject|0|||
129948252|NCT02516202|467774076|FG002|Overall Study|Withdrawal by Subject|1|||
129948253|NCT02516202|467774074|FG000|Overall Study|Lost to Follow-up|1|||
129948254|NCT02516202|467774075|FG001|Overall Study|Lost to Follow-up|1|||
129948255|NCT02516202|467774076|FG002|Overall Study|Lost to Follow-up|1|||
129948256|NCT02516202|467774074|FG000|Overall Study|Stopped Follow-up|0|||
129948257|NCT02516202|467774075|FG001|Overall Study|Stopped Follow-up|0|||
129948258|NCT02516202|467774076|FG002|Overall Study|Stopped Follow-up|1|||
129948259|NCT00337610|467774077|FG000|Overall Study|Adverse Event|2|||
129948260|NCT00337610|467774078|FG001|Overall Study|Adverse Event|2|||
129948261|NCT00337610|467774077|FG000|Overall Study|Death|0|||
129948262|NCT00337610|467774078|FG001|Overall Study|Death|1|||
129948263|NCT00337610|467774077|FG000|Overall Study|Lack of Efficacy|6|||
129948264|NCT00337610|467774078|FG001|Overall Study|Lack of Efficacy|3|||
129948265|NCT00337610|467774077|FG000|Overall Study|Lost to Follow-up|3|||
129948266|NCT00337610|467774078|FG001|Overall Study|Lost to Follow-up|3|||
129948267|NCT00337610|467774077|FG000|Overall Study|Withdrawal by Subject|6|||
129948268|NCT00337610|467774078|FG001|Overall Study|Withdrawal by Subject|5|||
129948269|NCT03979040|467774079|FG000|Overall Study|Withdrawal by Subject|24|||
129948270|NCT03979040|467774080|FG001|Overall Study|Withdrawal by Subject|32|||
129948271|NCT03979040|467774079|FG000|Overall Study|randomized but never started treatment|32|||
129948272|NCT03979040|467774080|FG001|Overall Study|randomized but never started treatment|39|||
129948273|NCT03979040|467774079|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
129948274|NCT03979040|467774080|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
129948275|NCT03541369|467774083|FG000|Overall Study|Death|0|||
129948276|NCT03541369|467774084|FG001|Overall Study|Death|0|||
129948277|NCT03541369|467774085|FG002|Overall Study|Death|0|||
129948278|NCT03541369|467774086|FG003|Overall Study|Death|0|||
129948279|NCT03541369|467774087|FG004|Overall Study|Death|1|||
129948280|NCT03541369|467774088|FG005|Overall Study|Death|1|||
129948281|NCT03541369|467774089|FG006|Overall Study|Death|0|||
129948282|NCT03541369|467774090|FG007|Overall Study|Death|2|||
129948283|NCT03541369|467774091|FG008|Overall Study|Death|1|||
129948284|NCT03541369|467774092|FG009|Overall Study|Death|2|||
129948285|NCT03541369|467774093|FG010|Overall Study|Death|1|||
129948286|NCT03541369|467774094|FG011|Overall Study|Death|0|||
129948287|NCT03541369|467774095|FG012|Overall Study|Death|2|||
129948288|NCT03541369|467774096|FG013|Overall Study|Death|1|||
129948289|NCT03541369|467774097|FG014|Overall Study|Death|1|||
129948290|NCT03541369|467774098|FG015|Overall Study|Death|1|||
129948291|NCT03541369|467774099|FG016|Overall Study|Death|0|||
129948292|NCT03541369|467774100|FG017|Overall Study|Death|1|||
129948293|NCT03541369|467774083|FG000|Overall Study|Decision by sponsor|0|||
129948294|NCT03541369|467774084|FG001|Overall Study|Decision by sponsor|0|||
129948295|NCT03541369|467774085|FG002|Overall Study|Decision by sponsor|0|||
129948296|NCT03541369|467774086|FG003|Overall Study|Decision by sponsor|1|||
129948297|NCT03541369|467774087|FG004|Overall Study|Decision by sponsor|0|||
129948298|NCT03541369|467774088|FG005|Overall Study|Decision by sponsor|2|||
129948299|NCT03541369|467774089|FG006|Overall Study|Decision by sponsor|0|||
129948300|NCT03541369|467774090|FG007|Overall Study|Decision by sponsor|1|||
129948301|NCT03541369|467774091|FG008|Overall Study|Decision by sponsor|2|||
129453487|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
129948302|NCT03541369|467774092|FG009|Overall Study|Decision by sponsor|0|||
129948303|NCT03541369|467774093|FG010|Overall Study|Decision by sponsor|0|||
129948304|NCT03541369|467774094|FG011|Overall Study|Decision by sponsor|0|||
129948305|NCT03541369|467774095|FG012|Overall Study|Decision by sponsor|2|||
129948306|NCT03541369|467774096|FG013|Overall Study|Decision by sponsor|2|||
129948307|NCT03541369|467774097|FG014|Overall Study|Decision by sponsor|0|||
129948308|NCT03541369|467774098|FG015|Overall Study|Decision by sponsor|1|||
129948309|NCT03541369|467774099|FG016|Overall Study|Decision by sponsor|1|||
129948310|NCT03541369|467774100|FG017|Overall Study|Decision by sponsor|1|||
129948311|NCT03541369|467774083|FG000|Overall Study|Withdrawal by Subject|0|||
129948312|NCT03541369|467774084|FG001|Overall Study|Withdrawal by Subject|0|||
129948313|NCT03541369|467774085|FG002|Overall Study|Withdrawal by Subject|0|||
129948314|NCT03541369|467774086|FG003|Overall Study|Withdrawal by Subject|0|||
129948315|NCT03541369|467774087|FG004|Overall Study|Withdrawal by Subject|0|||
129948316|NCT03541369|467774088|FG005|Overall Study|Withdrawal by Subject|0|||
129948317|NCT03541369|467774089|FG006|Overall Study|Withdrawal by Subject|1|||
129948318|NCT03541369|467774090|FG007|Overall Study|Withdrawal by Subject|0|||
129948319|NCT03541369|467774091|FG008|Overall Study|Withdrawal by Subject|0|||
129948320|NCT03541369|467774092|FG009|Overall Study|Withdrawal by Subject|0|||
129948321|NCT03541369|467774093|FG010|Overall Study|Withdrawal by Subject|0|||
129948322|NCT03541369|467774094|FG011|Overall Study|Withdrawal by Subject|1|||
129948323|NCT03541369|467774095|FG012|Overall Study|Withdrawal by Subject|0|||
129948324|NCT03541369|467774096|FG013|Overall Study|Withdrawal by Subject|0|||
129948325|NCT03541369|467774097|FG014|Overall Study|Withdrawal by Subject|3|||
129948326|NCT03541369|467774098|FG015|Overall Study|Withdrawal by Subject|0|||
129948327|NCT03541369|467774099|FG016|Overall Study|Withdrawal by Subject|4|||
129948328|NCT03541369|467774100|FG017|Overall Study|Withdrawal by Subject|2|||
129948329|NCT03541369|467774083|FG000|Overall Study|Lost to Follow-up|0|||
129948330|NCT03541369|467774084|FG001|Overall Study|Lost to Follow-up|0|||
129948331|NCT03541369|467774085|FG002|Overall Study|Lost to Follow-up|0|||
129948332|NCT03541369|467774086|FG003|Overall Study|Lost to Follow-up|0|||
129948333|NCT03541369|467774087|FG004|Overall Study|Lost to Follow-up|1|||
129948334|NCT03541369|467774088|FG005|Overall Study|Lost to Follow-up|0|||
129948335|NCT03541369|467774089|FG006|Overall Study|Lost to Follow-up|0|||
129948336|NCT03541369|467774090|FG007|Overall Study|Lost to Follow-up|0|||
129948337|NCT03541369|467774091|FG008|Overall Study|Lost to Follow-up|1|||
129948338|NCT03541369|467774092|FG009|Overall Study|Lost to Follow-up|0|||
129948339|NCT03541369|467774093|FG010|Overall Study|Lost to Follow-up|0|||
129948340|NCT03541369|467774094|FG011|Overall Study|Lost to Follow-up|0|||
129948341|NCT03541369|467774095|FG012|Overall Study|Lost to Follow-up|1|||
129948342|NCT03541369|467774096|FG013|Overall Study|Lost to Follow-up|0|||
129948343|NCT03541369|467774097|FG014|Overall Study|Lost to Follow-up|0|||
129948344|NCT03541369|467774098|FG015|Overall Study|Lost to Follow-up|0|||
129948345|NCT03541369|467774099|FG016|Overall Study|Lost to Follow-up|0|||
129948346|NCT03541369|467774100|FG017|Overall Study|Lost to Follow-up|0|||
129948347|NCT01079949|467774103|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
129948348|NCT01079949|467774104|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
129948349|NCT01079949|467774103|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
129948350|NCT01079949|467774104|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
129948351|NCT01079949|467774103|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
129948352|NCT01079949|467774104|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
129948353|NCT01079949|467774103|FG000|Overall Study|Randomized but not treated|1|||
129948354|NCT01079949|467774104|FG001|Overall Study|Randomized but not treated|0|||
129948355|NCT01529632|467774105|FG000|Overall Study|Administrative problem|2|||
129948356|NCT01529632|467774106|FG001|Overall Study|Administrative problem|1|||
129948357|NCT01529632|467774105|FG000|Overall Study|Protocol Violation|0|||
129948358|NCT01529632|467774106|FG001|Overall Study|Protocol Violation|1|||
129948359|NCT01529632|467774105|FG000|Overall Study|Adverse Event|1|||
129948360|NCT01529632|467774106|FG001|Overall Study|Adverse Event|1|||
129948361|NCT04369664|467775363|FG000|Overall Study|Physician Decision|1|||
129948362|NCT04369664|467775364|FG001|Overall Study|Physician Decision|0|||
129948363|NCT05522777|467775367|FG000|Overall Study|Lack of Efficacy|1|||
129948364|NCT05522777|467775367|FG000|Overall Study|Withdrawal by Subject|1|||
129948365|NCT05487300|467775370|FG000|Overall Study|Withdrawal by Subject|1|||
129948366|NCT05487300|467775371|FG001|Overall Study|Withdrawal by Subject|0|||
129948367|NCT01286311|467775373|FG000|Overall Study|Physician did not want outreach sent|14|||
129948368|NCT01286311|467775374|FG001|Overall Study|Physician did not want outreach sent|0|||
129948369|NCT00990184|467775375|FG000|Overall Study|Physician Decision|1|||
129948370|NCT01655498|467775376|FG000|Overall Study|Unrelated health issue|2|||
129948371|NCT01655498|467775376|FG000|Overall Study|Protocol Violation|2|||
129948372|NCT01655498|467775376|FG000|Overall Study|Withdrawal by Subject|1|||
129948373|NCT00930644|467775379|FG000|Overall Study|Withdrawal by Subject|4|||
129948374|NCT00930644|467775379|FG000|Overall Study|Physician Decision|2|||
129948375|NCT00930644|467775379|FG000|Overall Study|Death|1|||
129948376|NCT00930644|467775379|FG000|Overall Study|Adverse Event|16|||
129948377|NCT03909100|467775382|FG000|Overall Study|Protocol Deviation|2|||
129948378|NCT03909100|467775382|FG000|Overall Study|Technical Problems|4|||
129948379|NCT03909100|467775382|FG000|Overall Study|Withdrawal by Subject|4|||
129948380|NCT03909100|467775382|FG000|Overall Study|Lost to Follow-up|1|||
129948381|NCT03909100|467775382|FG000|Overall Study|Reason not Specified|4|||
129948382|NCT00807599|467775383|FG000|Overall Study|Not treated on protocol study|0|||
129948383|NCT00807599|467775384|FG001|Overall Study|Not treated on protocol study|0|||
129948384|NCT00807599|467775385|FG002|Overall Study|Not treated on protocol study|2|||
129948385|NCT00807599|467775383|FG000|Overall Study|Adverse Event|0|||
129948386|NCT00807599|467775384|FG001|Overall Study|Adverse Event|0|||
129948387|NCT00807599|467775385|FG002|Overall Study|Adverse Event|5|||
129948388|NCT00807599|467775383|FG000|Overall Study|Inadequate response to induction|0|||
129948389|NCT00807599|467775384|FG001|Overall Study|Inadequate response to induction|0|||
129948390|NCT00807599|467775385|FG002|Overall Study|Inadequate response to induction|9|||
129948391|NCT00807599|467775383|FG000|Overall Study|Withdrawal by Subject|0|||
129948392|NCT00807599|467775384|FG001|Overall Study|Withdrawal by Subject|0|||
129948393|NCT00807599|467775385|FG002|Overall Study|Withdrawal by Subject|1|||
129948394|NCT01670877|467775387|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948395|NCT01670877|467775388|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
129948396|NCT01670877|467775389|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948397|NCT01670877|467775390|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948398|NCT01670877|467775391|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948399|NCT01670877|467775392|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
129948400|NCT01670877|467775387|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948401|NCT01670877|467775388|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948402|NCT01670877|467775389|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
129948403|NCT01670877|467775390|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948404|NCT01670877|467775391|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948405|NCT01670877|467775392|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
129948406|NCT01670877|467775387|FG000|Part I and Part 2|Grade 2 vomiting|0|||
129948407|NCT01670877|467775388|FG001|Part I and Part 2|Grade 2 vomiting|0|||
129948408|NCT01670877|467775389|FG002|Part I and Part 2|Grade 2 vomiting|0|||
129948409|NCT01670877|467775390|FG003|Part I and Part 2|Grade 2 vomiting|1|||
129948410|NCT01670877|467775391|FG004|Part I and Part 2|Grade 2 vomiting|0|||
129948411|NCT01670877|467775392|FG005|Part I and Part 2|Grade 2 vomiting|0|||
129948412|NCT01670877|467775387|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948413|NCT01670877|467775388|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948414|NCT01670877|467775389|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948415|NCT01670877|467775390|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
129948416|NCT01670877|467775391|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948417|NCT01670877|467775392|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
129948418|NCT01670877|467775387|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948419|NCT01670877|467775388|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948420|NCT01670877|467775389|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948421|NCT01670877|467775390|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
129948422|NCT01670877|467775391|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948423|NCT01670877|467775392|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
129948424|NCT02825550|467775394|FG000|Overall Study|Physician Decision|1|||
129948425|NCT03349476|467775398|FG000|Overall Study|Physician Decision|3|||
129948426|NCT00795639|467775399|FG000|Overall Study|Death|1|||
129948427|NCT00795639|467775400|FG001|Overall Study|Death|6|||
129948428|NCT00795639|467775399|FG000|Overall Study|Withdrawal by Subject|1|||
129948429|NCT00795639|467775400|FG001|Overall Study|Withdrawal by Subject|3|||
129948430|NCT00795639|467775399|FG000|Overall Study|Pregnancy|1|||
129948431|NCT00795639|467775400|FG001|Overall Study|Pregnancy|0|||
129948432|NCT00795639|467775399|FG000|Overall Study|Adverse Event|5|||
129948433|NCT00795639|467775400|FG001|Overall Study|Adverse Event|2|||
129948434|NCT00795639|467775399|FG000|Overall Study|Other|0|||
129948435|NCT00795639|467775400|FG001|Overall Study|Other|2|||
129948436|NCT00795639|467775399|FG000|Overall Study|Terminated by sponsor|13|||
129948437|NCT00795639|467775400|FG001|Overall Study|Terminated by sponsor|12|||
129948438|NCT00795639|467775399|FG000|Overall Study|Randomized and not treated|0|||
129948439|NCT00795639|467775400|FG001|Overall Study|Randomized and not treated|1|||
129948440|NCT00879710|467775407|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
129948441|NCT00879710|467775408|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
129948442|NCT00879710|467775409|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
129948443|NCT00879710|467775410|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
129948444|NCT00879710|467775407|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
129948445|NCT00879710|467775408|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
129948446|NCT00879710|467775409|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
129948447|NCT00879710|467775410|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
129948448|NCT00696241|467775412|FG000|Overall Study|Adverse Event|11|||
129948449|NCT00696241|467775413|FG001|Overall Study|Adverse Event|3|||
129948450|NCT00696241|467775414|FG002|Overall Study|Adverse Event|6|||
129948451|NCT00696241|467775415|FG003|Overall Study|Adverse Event|4|||
129948452|NCT00696241|467775416|FG004|Overall Study|Adverse Event|5|||
129948453|NCT00696241|467775412|FG000|Overall Study|Protocol Violation|1|||
129948454|NCT00696241|467775413|FG001|Overall Study|Protocol Violation|1|||
129948455|NCT00696241|467775414|FG002|Overall Study|Protocol Violation|2|||
129948456|NCT00696241|467775415|FG003|Overall Study|Protocol Violation|0|||
129948457|NCT00696241|467775416|FG004|Overall Study|Protocol Violation|3|||
129948458|NCT00696241|467775412|FG000|Overall Study|Lost to Follow-up|1|||
129948459|NCT00696241|467775413|FG001|Overall Study|Lost to Follow-up|4|||
129948460|NCT00696241|467775414|FG002|Overall Study|Lost to Follow-up|1|||
129948461|NCT00696241|467775415|FG003|Overall Study|Lost to Follow-up|2|||
129948462|NCT00696241|467775416|FG004|Overall Study|Lost to Follow-up|0|||
129948463|NCT00696241|467775412|FG000|Overall Study|Withdrawal by Subject|4|||
129948464|NCT00696241|467775413|FG001|Overall Study|Withdrawal by Subject|8|||
129948465|NCT00696241|467775414|FG002|Overall Study|Withdrawal by Subject|6|||
129948466|NCT00696241|467775415|FG003|Overall Study|Withdrawal by Subject|1|||
129948467|NCT00696241|467775416|FG004|Overall Study|Withdrawal by Subject|0|||
129948468|NCT00696241|467775412|FG000|Overall Study|Lack of Efficacy|1|||
129948469|NCT00696241|467775413|FG001|Overall Study|Lack of Efficacy|5|||
129948470|NCT00696241|467775414|FG002|Overall Study|Lack of Efficacy|4|||
129948471|NCT00696241|467775415|FG003|Overall Study|Lack of Efficacy|5|||
129948472|NCT00696241|467775416|FG004|Overall Study|Lack of Efficacy|3|||
129948473|NCT00696241|467775412|FG000|Overall Study|Other|6|||
129948474|NCT00696241|467775413|FG001|Overall Study|Other|1|||
129948475|NCT00696241|467775414|FG002|Overall Study|Other|5|||
129948476|NCT00696241|467775415|FG003|Overall Study|Other|2|||
129948477|NCT00696241|467775416|FG004|Overall Study|Other|1|||
129948478|NCT02102724|467775425|FG000|Overall Study|Lost to Follow-up|1|||
129948479|NCT02102724|467775426|FG001|Overall Study|Lost to Follow-up|0|||
129948480|NCT02102724|467775425|FG000|Overall Study|surgery for brain aneurysm|1|||
129948481|NCT02102724|467775426|FG001|Overall Study|surgery for brain aneurysm|1|||
129948482|NCT02203513|467775427|FG000|Overall Study|Refused further treatment|2|||
129948483|NCT02203513|467775428|FG001|Overall Study|Refused further treatment|0|||
129948484|NCT02203513|467775429|FG002|Overall Study|Refused further treatment|1|||
129948485|NCT02203513|467775430|FG003|Overall Study|Refused further treatment|0|||
129948486|NCT02203513|467775431|FG004|Overall Study|Refused further treatment|0|||
129948487|NCT02203513|467775427|FG000|Overall Study|Switched to alternative treatment|3|||
129948488|NCT02203513|467775428|FG001|Overall Study|Switched to alternative treatment|4|||
129948489|NCT02203513|467775429|FG002|Overall Study|Switched to alternative treatment|0|||
129948490|NCT02203513|467775430|FG003|Overall Study|Switched to alternative treatment|0|||
129948491|NCT02203513|467775431|FG004|Overall Study|Switched to alternative treatment|4|||
129948492|NCT02203513|467775427|FG000|Overall Study|Did not receive investigational product (IP)|0|||
129948493|NCT02203513|467775428|FG001|Overall Study|Did not receive investigational product (IP)|1|||
129948494|NCT02203513|467775429|FG002|Overall Study|Did not receive investigational product (IP)|0|||
129948495|NCT02203513|467775430|FG003|Overall Study|Did not receive investigational product (IP)|0|||
129948496|NCT02203513|467775431|FG004|Overall Study|Did not receive investigational product (IP)|0|||
129948497|NCT02203513|467775427|FG000|Overall Study|Death (unrelated to study therapy)|1|||
129948498|NCT02203513|467775428|FG001|Overall Study|Death (unrelated to study therapy)|3|||
129948499|NCT02203513|467775429|FG002|Overall Study|Death (unrelated to study therapy)|1|||
129948500|NCT02203513|467775430|FG003|Overall Study|Death (unrelated to study therapy)|0|||
129948501|NCT02203513|467775431|FG004|Overall Study|Death (unrelated to study therapy)|2|||
129948502|NCT02203513|467775427|FG000|Overall Study|Lost to Follow-up|0|||
129948503|NCT02203513|467775428|FG001|Overall Study|Lost to Follow-up|0|||
129948504|NCT02203513|467775429|FG002|Overall Study|Lost to Follow-up|1|||
129948505|NCT02203513|467775430|FG003|Overall Study|Lost to Follow-up|1|||
129948506|NCT02203513|467775431|FG004|Overall Study|Lost to Follow-up|0|||
129948507|NCT02008916|467775432|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
129948508|NCT02008916|467775433|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
129948509|NCT02008916|467775434|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
129948510|NCT02008916|467775432|FG000|Week 16 - 156|Adverse Event|4|||
129948511|NCT02008916|467775433|FG001|Week 16 - 156|Adverse Event|2|||
129948512|NCT02008916|467775434|FG002|Week 16 - 156|Adverse Event|3|||
129948513|NCT02008916|467775432|FG000|Week 16 - 156|Withdrawal by Subject|7|||
129948514|NCT02008916|467775433|FG001|Week 16 - 156|Withdrawal by Subject|3|||
129948515|NCT02008916|467775434|FG002|Week 16 - 156|Withdrawal by Subject|5|||
129948516|NCT02008916|467775432|FG000|Week 16 - 156|No longer requires treatment|0|||
129948517|NCT02008916|467775433|FG001|Week 16 - 156|No longer requires treatment|1|||
129948518|NCT02008916|467775434|FG002|Week 16 - 156|No longer requires treatment|0|||
129948519|NCT02008916|467775432|FG000|Week 16 - 156|Lost to Follow-up|5|||
129948520|NCT02008916|467775433|FG001|Week 16 - 156|Lost to Follow-up|0|||
129948521|NCT02008916|467775434|FG002|Week 16 - 156|Lost to Follow-up|0|||
129948522|NCT02008916|467775432|FG000|Week 16 - 156|Lack of Efficacy|3|||
129948523|NCT02008916|467775433|FG001|Week 16 - 156|Lack of Efficacy|5|||
129948524|NCT02008916|467775434|FG002|Week 16 - 156|Lack of Efficacy|2|||
129948525|NCT02008916|467775432|FG000|Week 16 - 156|Pregnancy|0|||
129948526|NCT02008916|467775433|FG001|Week 16 - 156|Pregnancy|1|||
129948527|NCT02008916|467775434|FG002|Week 16 - 156|Pregnancy|0|||
129948528|NCT02008916|467775432|FG000|Week 16 - 156|Physician Decision|0|||
129948529|NCT02008916|467775433|FG001|Week 16 - 156|Physician Decision|1|||
129948530|NCT02008916|467775434|FG002|Week 16 - 156|Physician Decision|0|||
129948531|NCT03803475|467775435|FG000|Overall Study|Physician Decision|1|||
129948532|NCT02513667|467775436|FG000|Overall Study|Withdrawal by Subject|0|||
129948533|NCT02513667|467775437|FG001|Overall Study|Withdrawal by Subject|1|||
129948534|NCT03347396|467775438|FG000|Part A (26 Weeks)|Adverse Event|1|||
129948535|NCT03347396|467775439|FG001|Part A (26 Weeks)|Adverse Event|0|||
129948536|NCT03347396|467775438|FG000|Part A (26 Weeks)|Death|0|||
129948537|NCT03347396|467775439|FG001|Part A (26 Weeks)|Death|1|||
129948538|NCT03347396|467775438|FG000|Part B (149 Weeks)|Adverse Event|1|||
129948539|NCT03347396|467775439|FG001|Part B (149 Weeks)|Adverse Event|1|||
129948540|NCT03347396|467775438|FG000|Part B (149 Weeks)|Death|1|||
129948541|NCT03347396|467775439|FG001|Part B (149 Weeks)|Death|0|||
129948542|NCT00392197|467775441|FG000|Overall Study|Adverse Event|4|||
129948543|NCT00392197|467775442|FG001|Overall Study|Adverse Event|12|||
129948544|NCT00392197|467775441|FG000|Overall Study|Lack of Efficacy|3|||
129948545|NCT00392197|467775442|FG001|Overall Study|Lack of Efficacy|4|||
129948546|NCT00392197|467775441|FG000|Overall Study|Lost to Follow-up|0|||
129948547|NCT00392197|467775442|FG001|Overall Study|Lost to Follow-up|1|||
129948548|NCT00392197|467775441|FG000|Overall Study|Physician Decision|3|||
129948549|NCT00392197|467775442|FG001|Overall Study|Physician Decision|2|||
129948550|NCT00392197|467775441|FG000|Overall Study|Protocol Violation|7|||
129948551|NCT00392197|467775442|FG001|Overall Study|Protocol Violation|5|||
129948552|NCT00392197|467775441|FG000|Overall Study|Withdrawal by Subject|4|||
129948553|NCT00392197|467775442|FG001|Overall Study|Withdrawal by Subject|6|||
129948554|NCT03060525|467775443|FG000|Overall Study|moved out of state|1|||
129948555|NCT03060525|467775444|FG001|Overall Study|moved out of state|1|||
129948556|NCT03060525|467775445|FG002|Overall Study|moved out of state|1|||
129948557|NCT03060525|467775446|FG003|Overall Study|moved out of state|1|||
129948558|NCT03060525|467775443|FG000|Overall Study|unable to meet time commitment required of study|2|||
129948559|NCT03060525|467775444|FG001|Overall Study|unable to meet time commitment required of study|3|||
129948560|NCT03060525|467775445|FG002|Overall Study|unable to meet time commitment required of study|3|||
129948561|NCT03060525|467775446|FG003|Overall Study|unable to meet time commitment required of study|1|||
129948562|NCT03060525|467775443|FG000|Overall Study|no longer interested in doing intervention|0|||
129948563|NCT03060525|467775444|FG001|Overall Study|no longer interested in doing intervention|0|||
129948564|NCT03060525|467775445|FG002|Overall Study|no longer interested in doing intervention|0|||
129948565|NCT03060525|467775446|FG003|Overall Study|no longer interested in doing intervention|1|||
129948566|NCT00912964|467775447|FG000|Overall Study|Eligibility criterion not met|1|||
129948567|NCT00912964|467775448|FG001|Overall Study|Eligibility criterion not met|1|||
129948568|NCT00912964|467775449|FG002|Overall Study|Eligibility criterion not met|0|||
129948569|NCT00912964|467775447|FG000|Overall Study|Adverse Event|15|||
129948570|NCT00912964|467775448|FG001|Overall Study|Adverse Event|18|||
129948571|NCT00912964|467775449|FG002|Overall Study|Adverse Event|12|||
129948572|NCT00912964|467775447|FG000|Overall Study|Lack of Efficacy|11|||
129948573|NCT00912964|467775448|FG001|Overall Study|Lack of Efficacy|4|||
129948574|NCT00912964|467775449|FG002|Overall Study|Lack of Efficacy|3|||
129948575|NCT00912964|467775447|FG000|Overall Study|Withdrawal by Subject|20|||
129948576|NCT00912964|467775448|FG001|Overall Study|Withdrawal by Subject|12|||
129948577|NCT00912964|467775449|FG002|Overall Study|Withdrawal by Subject|18|||
129948578|NCT00912964|467775447|FG000|Overall Study|Lost to Follow-up|4|||
129948579|NCT00912964|467775448|FG001|Overall Study|Lost to Follow-up|3|||
129948580|NCT00912964|467775449|FG002|Overall Study|Lost to Follow-up|3|||
129948581|NCT00912964|467775447|FG000|Overall Study|Protocol Violation|5|||
129948582|NCT00912964|467775448|FG001|Overall Study|Protocol Violation|3|||
129948583|NCT00912964|467775449|FG002|Overall Study|Protocol Violation|8|||
129948584|NCT00912964|467775447|FG000|Overall Study|Taking exclusionary medications|7|||
129948585|NCT00912964|467775448|FG001|Overall Study|Taking exclusionary medications|4|||
129948586|NCT00912964|467775449|FG002|Overall Study|Taking exclusionary medications|8|||
129948587|NCT00912964|467775447|FG000|Overall Study|Medical History|1|||
129948588|NCT00912964|467775448|FG001|Overall Study|Medical History|0|||
129948589|NCT00912964|467775449|FG002|Overall Study|Medical History|0|||
129948590|NCT00912964|467775447|FG000|Overall Study|Non-compliance with study procedures|2|||
129948591|NCT00912964|467775448|FG001|Overall Study|Non-compliance with study procedures|0|||
129948592|NCT00912964|467775449|FG002|Overall Study|Non-compliance with study procedures|0|||
129948593|NCT00912964|467775447|FG000|Overall Study|Violation of exclusion criterion|0|||
129948594|NCT00912964|467775448|FG001|Overall Study|Violation of exclusion criterion|0|||
129948595|NCT00912964|467775449|FG002|Overall Study|Violation of exclusion criterion|2|||
129948596|NCT00912964|467775447|FG000|Overall Study|Randomized but never received study drug|0|||
129948597|NCT00912964|467775448|FG001|Overall Study|Randomized but never received study drug|1|||
129948598|NCT00912964|467775449|FG002|Overall Study|Randomized but never received study drug|0|||
129948599|NCT00090519|467775450|FG000|Overall Study|Adverse Event|5|||
129948600|NCT00090519|467775451|FG001|Overall Study|Adverse Event|4|||
129948601|NCT00090519|467775450|FG000|Overall Study|Death|9|||
129948602|NCT00090519|467775451|FG001|Overall Study|Death|9|||
129948603|NCT00090519|467775450|FG000|Overall Study|Lost to Follow-up|26|||
129948604|NCT00090519|467775451|FG001|Overall Study|Lost to Follow-up|29|||
129948605|NCT00090519|467775450|FG000|Overall Study|Withdrawal by Subject|28|||
129948606|NCT00090519|467775451|FG001|Overall Study|Withdrawal by Subject|29|||
129948607|NCT00090519|467775450|FG000|Overall Study|Physician Decision|2|||
129948608|NCT00090519|467775451|FG001|Overall Study|Physician Decision|3|||
129948609|NCT00090519|467775450|FG000|Overall Study|Sponsor Decision|3|||
129948610|NCT00090519|467775451|FG001|Overall Study|Sponsor Decision|1|||
129948611|NCT02161146|467775454|FG000|Overall Study|Adverse Event|1|||
129948612|NCT02161146|467775455|FG001|Overall Study|Adverse Event|1|||
129948613|NCT02161146|467775456|FG002|Overall Study|Adverse Event|0|||
129948614|NCT02161146|467775457|FG003|Overall Study|Adverse Event|1|||
129948615|NCT02161146|467775458|FG004|Overall Study|Adverse Event|0|||
129948616|NCT02161146|467775454|FG000|Overall Study|Lost to Follow-up|0|||
129948617|NCT02161146|467775455|FG001|Overall Study|Lost to Follow-up|1|||
129948618|NCT02161146|467775456|FG002|Overall Study|Lost to Follow-up|0|||
129948619|NCT02161146|467775457|FG003|Overall Study|Lost to Follow-up|0|||
129948620|NCT02161146|467775458|FG004|Overall Study|Lost to Follow-up|0|||
129948621|NCT02161146|467775454|FG000|Overall Study|Personal Reasons|0|||
129948622|NCT02161146|467775455|FG001|Overall Study|Personal Reasons|1|||
129948623|NCT02161146|467775456|FG002|Overall Study|Personal Reasons|0|||
129948624|NCT02161146|467775457|FG003|Overall Study|Personal Reasons|2|||
129948625|NCT02161146|467775458|FG004|Overall Study|Personal Reasons|1|||
129948626|NCT02161146|467775454|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129948627|NCT02161146|467775455|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129948628|NCT02161146|467775456|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129948629|NCT02161146|467775457|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129948630|NCT02161146|467775458|FG004|Overall Study|Other Miscellaneous Reasons|0|||
129948631|NCT02189759|467775461|FG000|Overall Study|Lost to Follow-up|0|||
129948632|NCT02189759|467775462|FG001|Overall Study|Lost to Follow-up|0|||
129948633|NCT02189759|467775463|FG002|Overall Study|Lost to Follow-up|2|||
129948634|NCT02189759|467775464|FG003|Overall Study|Lost to Follow-up|5|||
129948635|NCT01294644|467775471|FG000|Overall Study|Adverse Event|2|||
129948636|NCT01294644|467775472|FG001|Overall Study|Adverse Event|0|||
129948637|NCT01294644|467775473|FG002|Overall Study|Adverse Event|1|||
129948638|NCT01294644|467775471|FG000|Overall Study|Withdrawal by Subject|3|||
129948639|NCT01294644|467775472|FG001|Overall Study|Withdrawal by Subject|7|||
129948640|NCT01294644|467775473|FG002|Overall Study|Withdrawal by Subject|4|||
129948641|NCT01294644|467775471|FG000|Overall Study|Lost to Follow-up|3|||
129948642|NCT01294644|467775472|FG001|Overall Study|Lost to Follow-up|2|||
129948643|NCT01294644|467775473|FG002|Overall Study|Lost to Follow-up|5|||
129948644|NCT01294644|467775471|FG000|Overall Study|Miscellaneous Reason|2|||
129948645|NCT01294644|467775472|FG001|Overall Study|Miscellaneous Reason|1|||
129948646|NCT01294644|467775473|FG002|Overall Study|Miscellaneous Reason|4|||
129948647|NCT01986348|467775474|FG000|Overall Study|Death|8|||
129948648|NCT01986348|467775475|FG001|Overall Study|Death|22|||
129948649|NCT01986348|467775476|FG002|Overall Study|Death|10|||
129948650|NCT01986348|467775477|FG003|Overall Study|Death|21|||
129948651|NCT01986348|467775474|FG000|Overall Study|Lost to Follow-up|0|||
129948652|NCT01986348|467775475|FG001|Overall Study|Lost to Follow-up|0|||
129948653|NCT01986348|467775476|FG002|Overall Study|Lost to Follow-up|0|||
129948654|NCT01986348|467775477|FG003|Overall Study|Lost to Follow-up|2|||
129948655|NCT01986348|467775474|FG000|Overall Study|Physician Decision|0|||
129948656|NCT01986348|467775475|FG001|Overall Study|Physician Decision|0|||
129948657|NCT01986348|467775476|FG002|Overall Study|Physician Decision|0|||
129948658|NCT01986348|467775477|FG003|Overall Study|Physician Decision|1|||
129948659|NCT01986348|467775474|FG000|Overall Study|Progressive Disease|0|||
129948660|NCT01986348|467775475|FG001|Overall Study|Progressive Disease|0|||
129948661|NCT01986348|467775476|FG002|Overall Study|Progressive Disease|2|||
129948662|NCT01986348|467775477|FG003|Overall Study|Progressive Disease|0|||
129948663|NCT01986348|467775474|FG000|Overall Study|Withdrawal by Participant|0|||
129948664|NCT01986348|467775475|FG001|Overall Study|Withdrawal by Participant|1|||
129948665|NCT01986348|467775476|FG002|Overall Study|Withdrawal by Participant|2|||
129948666|NCT01986348|467775477|FG003|Overall Study|Withdrawal by Participant|1|||
129948667|NCT01986348|467775474|FG000|Overall Study|Study Terminated by Sponsor|0|||
129948668|NCT01986348|467775475|FG001|Overall Study|Study Terminated by Sponsor|0|||
129453488|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
129948669|NCT01986348|467775476|FG002|Overall Study|Study Terminated by Sponsor|0|||
129948670|NCT01986348|467775477|FG003|Overall Study|Study Terminated by Sponsor|3|||
129948671|NCT01986348|467775474|FG000|Overall Study|Other-unspecified|0|||
129948672|NCT01986348|467775475|FG001|Overall Study|Other-unspecified|1|||
129948673|NCT01986348|467775476|FG002|Overall Study|Other-unspecified|0|||
129948674|NCT01986348|467775477|FG003|Overall Study|Other-unspecified|2|||
129948675|NCT02548585|467775478|FG000|Overall Study|Withdrawal by Subject|0|||
129948676|NCT02548585|467775479|FG001|Overall Study|Withdrawal by Subject|0|||
129948677|NCT02548585|467775480|FG002|Overall Study|Withdrawal by Subject|0|||
129948678|NCT02548585|467775481|FG003|Overall Study|Withdrawal by Subject|0|||
129948679|NCT02548585|467775482|FG004|Overall Study|Withdrawal by Subject|0|||
129948680|NCT02548585|467775483|FG005|Overall Study|Withdrawal by Subject|1|||
129948681|NCT02548585|467775484|FG006|Overall Study|Withdrawal by Subject|0|||
129948682|NCT02548585|467775478|FG000|Overall Study|Lost to Follow-up|1|||
129948683|NCT02548585|467775479|FG001|Overall Study|Lost to Follow-up|0|||
129948684|NCT02548585|467775480|FG002|Overall Study|Lost to Follow-up|0|||
129948685|NCT02548585|467775481|FG003|Overall Study|Lost to Follow-up|0|||
129948686|NCT02548585|467775482|FG004|Overall Study|Lost to Follow-up|0|||
129948687|NCT02548585|467775483|FG005|Overall Study|Lost to Follow-up|0|||
129948688|NCT02548585|467775484|FG006|Overall Study|Lost to Follow-up|0|||
129948689|NCT02548585|467775478|FG000|Overall Study|Other|1|||
129948690|NCT02548585|467775479|FG001|Overall Study|Other|0|||
129948691|NCT02548585|467775480|FG002|Overall Study|Other|0|||
129948692|NCT02548585|467775481|FG003|Overall Study|Other|2|||
129948693|NCT02548585|467775482|FG004|Overall Study|Other|3|||
129948694|NCT02548585|467775483|FG005|Overall Study|Other|0|||
129948695|NCT02548585|467775484|FG006|Overall Study|Other|1|||
129948696|NCT02548585|467775478|FG000|Overall Study|Randomized but not treated|0|||
129948697|NCT02548585|467775479|FG001|Overall Study|Randomized but not treated|0|||
129948698|NCT02548585|467775480|FG002|Overall Study|Randomized but not treated|0|||
129948699|NCT02548585|467775481|FG003|Overall Study|Randomized but not treated|0|||
129948700|NCT02548585|467775482|FG004|Overall Study|Randomized but not treated|0|||
129948701|NCT02548585|467775483|FG005|Overall Study|Randomized but not treated|1|||
129948702|NCT02548585|467775484|FG006|Overall Study|Randomized but not treated|0|||
129948703|NCT03242863|467775485|FG000|Study Week 1|Withdrawal by Subject|0|||
129948704|NCT03242863|467775486|FG001|Study Week 1|Withdrawal by Subject|1|||
129948705|NCT03242863|467775487|FG002|Study Week 1|Withdrawal by Subject|0|||
129948706|NCT03242863|467775488|FG003|Study Week 1|Withdrawal by Subject|0|||
129948707|NCT03242863|467775489|FG004|Study Week 1|Withdrawal by Subject|3|||
129948708|NCT03242863|467775490|FG005|Study Week 1|Withdrawal by Subject|0|||
129948709|NCT04919499|467775495|FG000|Overall Study|Adverse Event|0|||
129948710|NCT04919499|467775496|FG001|Overall Study|Adverse Event|0|||
129948711|NCT04919499|467775497|FG002|Overall Study|Adverse Event|0|||
129948712|NCT04919499|467775498|FG003|Overall Study|Adverse Event|0|||
129948713|NCT04919499|467775499|FG004|Overall Study|Adverse Event|2|||
129948714|NCT04919499|467775495|FG000|Overall Study|Not treated|0|||
129948715|NCT04919499|467775496|FG001|Overall Study|Not treated|0|||
129948716|NCT04919499|467775497|FG002|Overall Study|Not treated|0|||
129948717|NCT04919499|467775498|FG003|Overall Study|Not treated|1|||
129948718|NCT04919499|467775499|FG004|Overall Study|Not treated|0|||
129948719|NCT03840200|467777375|FG000|Overall Study|Death|6|||
129948720|NCT03840200|467777376|FG001|Overall Study|Death|3|||
129948721|NCT03840200|467777377|FG002|Overall Study|Death|6|||
129948722|NCT03840200|467777378|FG003|Overall Study|Death|10|||
129948723|NCT03840200|467777375|FG000|Overall Study|Reason Not Specified|2|||
129948724|NCT03840200|467777376|FG001|Overall Study|Reason Not Specified|2|||
129948725|NCT03840200|467777377|FG002|Overall Study|Reason Not Specified|1|||
129948726|NCT03840200|467777378|FG003|Overall Study|Reason Not Specified|15|||
129948727|NCT03840200|467777375|FG000|Overall Study|Physician Decision|0|||
129948728|NCT03840200|467777376|FG001|Overall Study|Physician Decision|0|||
129948729|NCT03840200|467777377|FG002|Overall Study|Physician Decision|0|||
129948730|NCT03840200|467777378|FG003|Overall Study|Physician Decision|2|||
129948731|NCT03840200|467777375|FG000|Overall Study|Progressive Disease|0|||
129948732|NCT03840200|467777376|FG001|Overall Study|Progressive Disease|0|||
129453489|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
129948733|NCT03840200|467777377|FG002|Overall Study|Progressive Disease|0|||
129948734|NCT03840200|467777378|FG003|Overall Study|Progressive Disease|1|||
129453490|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
129453491|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
129948735|NCT03840200|467777375|FG000|Overall Study|Withdrawal by Subject|0|||
129948736|NCT03840200|467777376|FG001|Overall Study|Withdrawal by Subject|1|||
129948737|NCT03840200|467777377|FG002|Overall Study|Withdrawal by Subject|0|||
129948738|NCT03840200|467777378|FG003|Overall Study|Withdrawal by Subject|2|||
129948739|NCT05006703|467777379|FG000|Overall Study|Withdrawal by Subject|1|||
129948740|NCT05006703|467777380|FG001|Overall Study|Withdrawal by Subject|0|||
129948741|NCT05006703|467777379|FG000|Overall Study|Lost to Follow-up|13|||
129948742|NCT05006703|467777380|FG001|Overall Study|Lost to Follow-up|5|||
129948743|NCT04620733|467777383|FG000|Overall Study|Adverse Event|4|||
129948744|NCT04620733|467777384|FG001|Overall Study|Adverse Event|3|||
129948745|NCT04620733|467777383|FG000|Overall Study|Withdrawal by Subject|2|||
129948746|NCT04620733|467777384|FG001|Overall Study|Withdrawal by Subject|5|||
129948747|NCT04620733|467777383|FG000|Overall Study|Lost to Follow-up|1|||
129948748|NCT04620733|467777384|FG001|Overall Study|Lost to Follow-up|1|||
129948749|NCT04620733|467777383|FG000|Overall Study|Protocol Deviation|1|||
129948750|NCT04620733|467777384|FG001|Overall Study|Protocol Deviation|1|||
129948751|NCT04620733|467777383|FG000|Overall Study|Reason Not Specified|0|||
129948752|NCT04620733|467777384|FG001|Overall Study|Reason Not Specified|1|||
129948753|NCT00264576|467777387|FG000|Overall Study|Lost to Follow-up|1|||
129948754|NCT00264576|467777388|FG001|Overall Study|Lost to Follow-up|1|||
129948755|NCT04783389|467777389|FG000|Overall Study|Withdrawal by Subject|2|||
129948756|NCT04783389|467777390|FG001|Overall Study|Withdrawal by Subject|0|||
129948757|NCT04783389|467777391|FG002|Overall Study|Withdrawal by Subject|0|||
129948758|NCT04783389|467777389|FG000|Overall Study|Termination of Study by Sponsor|10|||
129948759|NCT04783389|467777390|FG001|Overall Study|Termination of Study by Sponsor|12|||
129948760|NCT04783389|467777391|FG002|Overall Study|Termination of Study by Sponsor|14|||
129948761|NCT02164578|467777392|FG000|Treatment Period|Withdrawal by Subject|3|||
129948762|NCT02164578|467777393|FG001|Treatment Period|Withdrawal by Subject|3|||
129948763|NCT02164578|467777392|FG000|Treatment Period|Adverse Event|13|||
129948764|NCT02164578|467777393|FG001|Treatment Period|Adverse Event|6|||
129948765|NCT02164578|467777392|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
129948766|NCT02164578|467777393|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
129948767|NCT02164578|467777392|FG000|Treatment Period|Protocol Violation|0|||
129948768|NCT02164578|467777393|FG001|Treatment Period|Protocol Violation|2|||
129948769|NCT02164578|467777392|FG000|Extension Period|Withdrawal by Subject|2|||
129948770|NCT02164578|467777393|FG001|Extension Period|Withdrawal by Subject|0|||
129948771|NCT02164578|467777392|FG000|Extension Period|Adverse Event|4|||
129948772|NCT02164578|467777393|FG001|Extension Period|Adverse Event|0|||
129948773|NCT02164578|467777392|FG000|Extension Period|Expiry of study medication|1|||
129948774|NCT02164578|467777393|FG001|Extension Period|Expiry of study medication|0|||
129948775|NCT02164578|467777392|FG000|Extension Period|Protocol Violation|0|||
129948776|NCT02164578|467777393|FG001|Extension Period|Protocol Violation|1|||
129948777|NCT02507297|467777394|FG000|Overall Study|Withdrawal by Subject|1|||
129948778|NCT02507297|467777395|FG001|Overall Study|Withdrawal by Subject|0|||
129948779|NCT02507297|467777394|FG000|Overall Study|Lost to Follow-up|0|||
129948780|NCT02507297|467777395|FG001|Overall Study|Lost to Follow-up|1|||
129948781|NCT02489799|467777396|FG000|Overall Study|Lost to Follow-up|4|||
129948782|NCT02489799|467777397|FG001|Overall Study|Lost to Follow-up|1|||
129948783|NCT02489799|467777396|FG000|Overall Study|Failure to Maintain Eligibility|4|||
129948784|NCT02489799|467777397|FG001|Overall Study|Failure to Maintain Eligibility|6|||
129948785|NCT02489799|467777396|FG000|Overall Study|Withdrawal by Subject|1|||
129948786|NCT02489799|467777397|FG001|Overall Study|Withdrawal by Subject|1|||
129948787|NCT02489799|467777396|FG000|Overall Study|Death|0|||
129948788|NCT02489799|467777397|FG001|Overall Study|Death|1|||
129948789|NCT04909593|467777398|FG000|Overall Study|Withdrawal by Subject|1|||
129948790|NCT01018992|467777399|FG000|Overall Study|Adverse Event|8|||
129948791|NCT01018992|467777400|FG001|Overall Study|Adverse Event|3|||
129948792|NCT01018992|467777399|FG000|Overall Study|Withdrawal by Subject|3|||
129948793|NCT01018992|467777400|FG001|Overall Study|Withdrawal by Subject|8|||
129948794|NCT01018992|467777399|FG000|Overall Study|Protocol Violation|0|||
129948795|NCT01018992|467777400|FG001|Overall Study|Protocol Violation|4|||
129948796|NCT01018992|467777399|FG000|Overall Study|Lost to Follow-up|5|||
129948797|NCT01018992|467777400|FG001|Overall Study|Lost to Follow-up|1|||
129948798|NCT03029585|467777401|FG000|Overall Study|Death|1|||
129948799|NCT03029585|467777402|FG001|Overall Study|Death|1|||
129948800|NCT03029585|467777401|FG000|Overall Study|Withdrawal by Subject|1|||
129948801|NCT03029585|467777402|FG001|Overall Study|Withdrawal by Subject|0|||
129948802|NCT01241448|467777403|FG000|Overall Study|Adverse Event|1|||
129948803|NCT01241448|467777404|FG001|Overall Study|Adverse Event|0|||
129948804|NCT01241448|467777405|FG002|Overall Study|Adverse Event|2|||
129948805|NCT01241448|467777406|FG003|Overall Study|Adverse Event|2|||
129948806|NCT01241448|467777403|FG000|Overall Study|Lost to Follow-up|2|||
129948807|NCT01241448|467777404|FG001|Overall Study|Lost to Follow-up|1|||
129948808|NCT01241448|467777405|FG002|Overall Study|Lost to Follow-up|1|||
129948809|NCT01241448|467777406|FG003|Overall Study|Lost to Follow-up|1|||
129948810|NCT01241448|467777403|FG000|Overall Study|Physician Decision|0|||
129948811|NCT01241448|467777404|FG001|Overall Study|Physician Decision|2|||
129948812|NCT01241448|467777405|FG002|Overall Study|Physician Decision|0|||
129948813|NCT01241448|467777406|FG003|Overall Study|Physician Decision|0|||
129948814|NCT01241448|467777403|FG000|Overall Study|Protocol Violation|10|||
129948815|NCT01241448|467777404|FG001|Overall Study|Protocol Violation|5|||
129948816|NCT01241448|467777405|FG002|Overall Study|Protocol Violation|3|||
129948817|NCT01241448|467777406|FG003|Overall Study|Protocol Violation|6|||
129948818|NCT01241448|467777403|FG000|Overall Study|Sponsor Decision|17|||
129948819|NCT01241448|467777404|FG001|Overall Study|Sponsor Decision|14|||
129948820|NCT01241448|467777405|FG002|Overall Study|Sponsor Decision|12|||
129948821|NCT01241448|467777406|FG003|Overall Study|Sponsor Decision|6|||
129948822|NCT01241448|467777403|FG000|Overall Study|Withdrawal by Subject|4|||
129948823|NCT01241448|467777404|FG001|Overall Study|Withdrawal by Subject|5|||
129948824|NCT01241448|467777405|FG002|Overall Study|Withdrawal by Subject|3|||
129948825|NCT01241448|467777406|FG003|Overall Study|Withdrawal by Subject|6|||
129948826|NCT01241448|467777403|FG000|Overall Study|Excluded due to data integrity issues|3|||
129453492|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
129453493|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
129948827|NCT01241448|467777404|FG001|Overall Study|Excluded due to data integrity issues|2|||
129948828|NCT01241448|467777405|FG002|Overall Study|Excluded due to data integrity issues|2|||
129948829|NCT01241448|467777406|FG003|Overall Study|Excluded due to data integrity issues|2|||
129948830|NCT02092285|467777407|FG000|Induction Phase|Adverse Event|7|||
129948831|NCT02092285|467777407|FG000|Induction Phase|Physician Decision|4|||
129948832|NCT02092285|467777407|FG000|Induction Phase|Pregnancy|1|||
129948833|NCT02092285|467777407|FG000|Induction Phase|Relapse/Recurrence|7|||
129948834|NCT02092285|467777407|FG000|Induction Phase|Withdrawal by Subject|2|||
129948835|NCT02092285|467777407|FG000|Induction Phase|Lack of Efficacy|14|||
129948836|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
129948837|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
129948838|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
129948839|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
129948840|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
129948841|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
129948842|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
129948843|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
129948844|NCT02092285|467777407|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
129948845|NCT01825785|467777408|FG000|Overall Study|Adverse Event|0|||
129948846|NCT01825785|467777409|FG001|Overall Study|Adverse Event|0|||
129948847|NCT01825785|467777410|FG002|Overall Study|Adverse Event|0|||
129948848|NCT01825785|467777411|FG003|Overall Study|Adverse Event|0|||
129948849|NCT01825785|467777412|FG004|Overall Study|Adverse Event|1|||
129948850|NCT01825785|467777413|FG005|Overall Study|Adverse Event|0|||
129948851|NCT01825785|467777414|FG006|Overall Study|Adverse Event|0|||
129948852|NCT01825785|467777408|FG000|Overall Study|Withdrawal by Subject|0|||
129948853|NCT01825785|467777409|FG001|Overall Study|Withdrawal by Subject|0|||
129948854|NCT01825785|467777410|FG002|Overall Study|Withdrawal by Subject|0|||
129948855|NCT01825785|467777411|FG003|Overall Study|Withdrawal by Subject|0|||
129948856|NCT01825785|467777412|FG004|Overall Study|Withdrawal by Subject|1|||
129948857|NCT01825785|467777413|FG005|Overall Study|Withdrawal by Subject|1|||
129948858|NCT01825785|467777414|FG006|Overall Study|Withdrawal by Subject|0|||
129948859|NCT01304940|467777416|FG000|Overall Study|not meet symptom severity requirement|3|||
129948860|NCT01304940|467777417|FG001|Overall Study|not meet symptom severity requirement|0|||
129948861|NCT00278395|467777420|FG000|Overall Study|Adverse Event|2|||
129948862|NCT00278395|467777420|FG000|Overall Study|Nonevaluable|1|||
129948863|NCT03740737|467777421|FG000|Overall Study|Protocol deviation|13|||
129948864|NCT03740737|467777422|FG001|Overall Study|Protocol deviation|0|||
129948865|NCT03740737|467777421|FG000|Overall Study|Adverse Event|2|||
129948866|NCT03740737|467777422|FG001|Overall Study|Adverse Event|0|||
129948867|NCT03740737|467777421|FG000|Overall Study|Lost to Follow-up|1|||
129948868|NCT03740737|467777422|FG001|Overall Study|Lost to Follow-up|0|||
129948869|NCT03740737|467777421|FG000|Overall Study|Randomization failure|1|||
129948870|NCT03740737|467777422|FG001|Overall Study|Randomization failure|0|||
129948871|NCT03740737|467777421|FG000|Overall Study|Participant withdrew consent|1|||
129948872|NCT03740737|467777422|FG001|Overall Study|Participant withdrew consent|0|||
129948873|NCT03740737|467777421|FG000|Overall Study|Participant withdrew from trial|2|||
129948874|NCT03740737|467777422|FG001|Overall Study|Participant withdrew from trial|1|||
129948875|NCT01381549|467777429|FG000|Overall Study|Ineligible: No organisms isolated|0|||
129948876|NCT01381549|467777430|FG001|Overall Study|Ineligible: No organisms isolated|0|||
129948877|NCT01381549|467777431|FG002|Overall Study|Ineligible: No organisms isolated|1|||
129948878|NCT02981953|467777432|FG000|Overall Study|Death|9|||
129948879|NCT02981953|467777432|FG000|Overall Study|Withdrawal by Subject|1|||
129948880|NCT02981953|467777432|FG000|Overall Study|Withdrawal to non-compliance|1|||
129948881|NCT02889900|467777435|FG000|Overall Study|Adverse Event|11|||
129948882|NCT02889900|467777435|FG000|Overall Study|Condition under investigation worsened|32|||
129948883|NCT02889900|467777435|FG000|Overall Study|Other|5|||
129948884|NCT02889900|467777435|FG000|Overall Study|Withdrawal by Subject|7|||
129948885|NCT02889900|467777435|FG000|Overall Study|Not treated|2|||
129948886|NCT01416285|467777437|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
129948887|NCT01416285|467777438|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
129948888|NCT02784834|467777446|FG000|Overall Study|Lack of Efficacy|1|||
129948889|NCT01090739|467777447|FG000|Enrollment|Withdrawal by Subject|24|||
129948890|NCT01090739|467777447|FG000|Enrollment|Protocol Violation|14|||
129948891|NCT01090739|467777447|FG000|Enrollment|Lost to Follow-up|5|||
129948892|NCT01090739|467777447|FG000|Enrollment|Physician Decision|5|||
129948893|NCT01090739|467777447|FG000|Enrollment|Sponsor termination of site|4|||
129948894|NCT01090739|467777447|FG000|Enrollment|Study implant limit reached|2|||
129948895|NCT01090739|467777447|FG000|Enrollment|Adverse Event|1|||
129948896|NCT01090739|467777447|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
129948897|NCT01090739|467777447|FG000|12 Month Follow-up|Lost to Follow-up|1|||
129948898|NCT01090739|467777447|FG000|12 Month Follow-up|Physician Decision|1|||
129948899|NCT01090739|467777447|FG000|12 Month Follow-up|Death|1|||
129948900|NCT01090739|467777447|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
129948901|NCT01090739|467777447|FG000|24 Month Follow-up|Lost to Follow-up|1|||
129948902|NCT01090739|467777447|FG000|24 Month Follow-up|Death|1|||
129948903|NCT01090739|467777447|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
129948904|NCT01090739|467777447|FG000|36 Month Follow-up|Visit still pending|17|||
129948905|NCT00441168|467777448|FG000|Treatment Period|Death|3|||
129948906|NCT00441168|467777449|FG001|Treatment Period|Death|0|||
129948907|NCT00441168|467777448|FG000|Treatment Period|Adverse Event|1|||
129948908|NCT00441168|467777449|FG001|Treatment Period|Adverse Event|2|||
129948909|NCT00441168|467777448|FG000|Treatment Period|Progressive Disease|0|||
129948910|NCT00441168|467777449|FG001|Treatment Period|Progressive Disease|2|||
129948911|NCT00441168|467777448|FG000|Treatment Period|Protocol Violation|0|||
129948912|NCT00441168|467777449|FG001|Treatment Period|Protocol Violation|1|||
129948913|NCT00441168|467777448|FG000|Treatment Period|Lost to Follow-up|0|||
129948914|NCT00441168|467777449|FG001|Treatment Period|Lost to Follow-up|1|||
129948915|NCT00441168|467777448|FG000|Treatment Period|Withdrawal by Subject|3|||
129948916|NCT00441168|467777449|FG001|Treatment Period|Withdrawal by Subject|0|||
129948917|NCT00441168|467777448|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
129948918|NCT00441168|467777449|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
129948919|NCT00441168|467777448|FG000|Treatment Period|refractory disease|1|||
129948920|NCT00441168|467777449|FG001|Treatment Period|refractory disease|0|||
129948921|NCT00441168|467777448|FG000|Follow-up Period|Death|3|||
129948922|NCT00441168|467777449|FG001|Follow-up Period|Death|0|||
129948923|NCT00441168|467777448|FG000|Follow-up Period|Lost to Follow-up|5|||
129948924|NCT00441168|467777449|FG001|Follow-up Period|Lost to Follow-up|6|||
129948925|NCT00441168|467777448|FG000|Follow-up Period|Withdrawal by Subject|3|||
129948926|NCT00441168|467777449|FG001|Follow-up Period|Withdrawal by Subject|0|||
129948927|NCT00441168|467777448|FG000|Follow-up Period|Other|1|||
129948928|NCT00441168|467777449|FG001|Follow-up Period|Other|3|||
129948929|NCT03693989|467777450|FG000|Overall Study|Protocol Violation|3|||
129948930|NCT03693989|467777451|FG001|Overall Study|Protocol Violation|4|||
129948931|NCT03146845|467777452|FG000|Overall Study|Reference ulcer healed|1|||
129948932|NCT03146845|467777453|FG001|Overall Study|Reference ulcer healed|0|||
129948933|NCT03146845|467777452|FG000|Overall Study|Physician Decision|1|||
129948934|NCT03146845|467777453|FG001|Overall Study|Physician Decision|0|||
129948935|NCT03146845|467777452|FG000|Overall Study|Adverse Event|1|||
129948936|NCT03146845|467777453|FG001|Overall Study|Adverse Event|0|||
129948937|NCT03146845|467777452|FG000|Overall Study|Withdrawal by Subject|2|||
129948938|NCT03146845|467777453|FG001|Overall Study|Withdrawal by Subject|0|||
129948939|NCT03146845|467777452|FG000|Overall Study|Noncompliance|0|||
129948940|NCT03146845|467777453|FG001|Overall Study|Noncompliance|1|||
129948941|NCT03146845|467777452|FG000|Overall Study|Protocol Violation|0|||
129948942|NCT03146845|467777453|FG001|Overall Study|Protocol Violation|2|||
129948943|NCT03146845|467777452|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
129948944|NCT03146845|467777453|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
129948945|NCT00113529|467777456|FG000|Overall Study|Adverse Event|4|||
129948946|NCT00113529|467777456|FG000|Overall Study|Lack of Efficacy|20|||
129948947|NCT00113529|467777456|FG000|Overall Study|Decision of sponsor|6|||
129948948|NCT00113529|467777456|FG000|Overall Study|Withdrawal by Subject|4|||
129948949|NCT01535261|467777457|FG000|Overall Study|Physician Decision|8|||
129948950|NCT01535261|467777457|FG000|Overall Study|Protocol Violation|3|||
129948951|NCT01535261|467777457|FG000|Overall Study|Death|5|||
129948952|NCT01535261|467777457|FG000|Overall Study|Lost to Follow-up|8|||
129948953|NCT01535261|467777457|FG000|Overall Study|Withdrawal by Subject|14|||
129948954|NCT01535261|467777457|FG000|Overall Study|Adverse Event|12|||
129948955|NCT01757288|467777460|FG000|Overall Study|Consent withdrawal|0|||
129948956|NCT01757288|467777461|FG001|Overall Study|Consent withdrawal|4|||
129948957|NCT01757288|467777462|FG002|Overall Study|Consent withdrawal|4|||
129948958|NCT01757288|467777460|FG000|Overall Study|Patient off study, IRB hold.|0|||
129948959|NCT01757288|467777461|FG001|Overall Study|Patient off study, IRB hold.|0|||
129948960|NCT01757288|467777462|FG002|Overall Study|Patient off study, IRB hold.|1|||
129948961|NCT01757288|467777460|FG000|Overall Study|Patient death prior to starting treatment|0|||
129948962|NCT01757288|467777461|FG001|Overall Study|Patient death prior to starting treatment|0|||
129948963|NCT01757288|467777462|FG002|Overall Study|Patient death prior to starting treatment|1|||
129948964|NCT01757288|467777460|FG000|Overall Study|Wrong medication administered|0|||
129948965|NCT01757288|467777461|FG001|Overall Study|Wrong medication administered|1|||
129948966|NCT01757288|467777462|FG002|Overall Study|Wrong medication administered|0|||
129948967|NCT01757288|467777460|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
129948968|NCT01757288|467777461|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
129948969|NCT01757288|467777462|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
129948970|NCT01757288|467777460|FG000|Overall Study|Not meeting protocol constraints|0|||
129948971|NCT01757288|467777461|FG001|Overall Study|Not meeting protocol constraints|1|||
129948972|NCT01757288|467777462|FG002|Overall Study|Not meeting protocol constraints|1|||
129948973|NCT01757288|467777460|FG000|Overall Study|Multiple missed appointments|0|||
129948974|NCT01757288|467777461|FG001|Overall Study|Multiple missed appointments|1|||
129948975|NCT01757288|467777462|FG002|Overall Study|Multiple missed appointments|0|||
129948976|NCT01757288|467777460|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
129948977|NCT01757288|467777461|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
129948978|NCT01757288|467777462|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
129948979|NCT01757288|467777460|FG000|Overall Study|>2 weeks treatment break|0|||
129948980|NCT01757288|467777461|FG001|Overall Study|>2 weeks treatment break|0|||
129948981|NCT01757288|467777462|FG002|Overall Study|>2 weeks treatment break|1|||
129948982|NCT00042939|467777463|FG000|Overall Study|Adverse Event|6|||
129948983|NCT00042939|467777464|FG001|Overall Study|Adverse Event|7|||
129948984|NCT00042939|467777463|FG000|Overall Study|Death|3|||
129948985|NCT00042939|467777464|FG001|Overall Study|Death|2|||
129948986|NCT00042939|467777463|FG000|Overall Study|Withdrawal by Subject|3|||
129948987|NCT00042939|467777464|FG001|Overall Study|Withdrawal by Subject|4|||
129948988|NCT00042939|467777463|FG000|Overall Study|Other disease|1|||
129948989|NCT00042939|467777464|FG001|Overall Study|Other disease|0|||
129948990|NCT00042939|467777463|FG000|Overall Study|Ineligible|2|||
129948991|NCT00042939|467777464|FG001|Overall Study|Ineligible|2|||
129948992|NCT00042939|467777463|FG000|Overall Study|Deterioration of health|3|||
129948993|NCT00042939|467777464|FG001|Overall Study|Deterioration of health|4|||
129948994|NCT00042939|467777463|FG000|Overall Study|QOL diminished|1|||
129948995|NCT00042939|467777464|FG001|Overall Study|QOL diminished|0|||
129948996|NCT00042939|467777463|FG000|Overall Study|Rising ca 19-9|1|||
129948997|NCT00042939|467777464|FG001|Overall Study|Rising ca 19-9|0|||
129948998|NCT00042939|467777463|FG000|Overall Study|Patient non-compliance|1|||
129948999|NCT00042939|467777464|FG001|Overall Study|Patient non-compliance|0|||
129949000|NCT00042939|467777463|FG000|Overall Study|Still on treatment|1|||
129949001|NCT00042939|467777464|FG001|Overall Study|Still on treatment|0|||
129949002|NCT00042939|467777463|FG000|Overall Study|Treatment break > 4 weeks|0|||
129949003|NCT00042939|467777464|FG001|Overall Study|Treatment break > 4 weeks|1|||
129949004|NCT00042939|467777463|FG000|Overall Study|Did not start treatment|2|||
129949005|NCT00042939|467777464|FG001|Overall Study|Did not start treatment|1|||
129949006|NCT02525744|467777465|FG000|Period 1|Physician Decision|0|||
129949007|NCT02525744|467777466|FG001|Period 1|Physician Decision|0|||
129949008|NCT02525744|467777467|FG002|Period 1|Physician Decision|1|||
129949009|NCT02525744|467777468|FG003|Period 1|Physician Decision|0|||
129949010|NCT02525744|467777465|FG000|Period 3|Adverse Event|0|||
129949011|NCT02525744|467777466|FG001|Period 3|Adverse Event|1|||
129949012|NCT02525744|467777467|FG002|Period 3|Adverse Event|0|||
129949013|NCT02525744|467777468|FG003|Period 3|Adverse Event|0|||
129949014|NCT02525744|467777465|FG000|Period 4|Withdrawal by Subject|1|||
129949015|NCT02525744|467777466|FG001|Period 4|Withdrawal by Subject|0|||
129949016|NCT02525744|467777467|FG002|Period 4|Withdrawal by Subject|0|||
129949017|NCT02525744|467777468|FG003|Period 4|Withdrawal by Subject|0|||
129949018|NCT02525744|467777465|FG000|Period 5|Physician Decision|1|||
129949019|NCT02525744|467777466|FG001|Period 5|Physician Decision|0|||
129949020|NCT02525744|467777467|FG002|Period 5|Physician Decision|0|||
129949021|NCT02525744|467777468|FG003|Period 5|Physician Decision|0|||
129949022|NCT01777932|467777469|FG000|Overall Study|Disease progression|136|||
129949023|NCT01777932|467777469|FG000|Overall Study|Death|3|||
129949024|NCT01777932|467777469|FG000|Overall Study|Adverse Event|34|||
129949025|NCT01777932|467777469|FG000|Overall Study|Lost to Follow-up|3|||
129949026|NCT01777932|467777469|FG000|Overall Study|Investigator decision|10|||
129949027|NCT01777932|467777469|FG000|Overall Study|Reimbursement limit|9|||
129949028|NCT01777932|467777469|FG000|Overall Study|Patient refused further treatment|10|||
129949029|NCT02514824|467777474|FG000|Overall Study|Withdrawal by Subject|1|||
129949030|NCT02514824|467777475|FG001|Overall Study|Withdrawal by Subject|0|||
129949031|NCT02514824|467777476|FG002|Overall Study|Withdrawal by Subject|0|||
129949032|NCT02514824|467777477|FG003|Overall Study|Withdrawal by Subject|0|||
129949033|NCT02514824|467777474|FG000|Overall Study|Dose-Limiting Toxicity|0|||
129949034|NCT02514824|467777475|FG001|Overall Study|Dose-Limiting Toxicity|1|||
129949035|NCT02514824|467777476|FG002|Overall Study|Dose-Limiting Toxicity|0|||
129949036|NCT02514824|467777477|FG003|Overall Study|Dose-Limiting Toxicity|0|||
129949037|NCT01930188|467777478|FG000|Overall Study|unclassified|4|||
129949038|NCT01930188|467777479|FG001|Overall Study|unclassified|5|||
129949039|NCT01930188|467777480|FG002|Overall Study|unclassified|3|||
129949040|NCT01930188|467777478|FG000|Overall Study|Missing follow-up information|2|||
129949041|NCT01930188|467777479|FG001|Overall Study|Missing follow-up information|2|||
129949042|NCT01930188|467777480|FG002|Overall Study|Missing follow-up information|3|||
129949043|NCT01930188|467777478|FG000|Overall Study|Lost to Follow-up|5|||
129949044|NCT01930188|467777479|FG001|Overall Study|Lost to Follow-up|2|||
129949045|NCT01930188|467777480|FG002|Overall Study|Lost to Follow-up|2|||
129949046|NCT01930188|467777478|FG000|Overall Study|Death|2|||
129949047|NCT01930188|467777479|FG001|Overall Study|Death|1|||
129949048|NCT01930188|467777480|FG002|Overall Study|Death|3|||
129949049|NCT01930188|467777478|FG000|Overall Study|Withdrawal by Subject|9|||
129949050|NCT01930188|467777479|FG001|Overall Study|Withdrawal by Subject|11|||
129949051|NCT01930188|467777480|FG002|Overall Study|Withdrawal by Subject|8|||
129949052|NCT03150589|467777481|FG000|Overall Study|Withdrawal by Subject|16|||
129949053|NCT03150589|467777482|FG001|Overall Study|Withdrawal by Subject|9|||
129949054|NCT03150589|467777481|FG000|Overall Study|Adverse Event|7|||
129949055|NCT03150589|467777482|FG001|Overall Study|Adverse Event|6|||
129949056|NCT03150589|467777481|FG000|Overall Study|Protocol Violation|4|||
129949057|NCT03150589|467777482|FG001|Overall Study|Protocol Violation|3|||
129949058|NCT03150589|467777481|FG000|Overall Study|Lost to Follow-up|3|||
129949059|NCT03150589|467777482|FG001|Overall Study|Lost to Follow-up|3|||
129949060|NCT03150589|467777481|FG000|Overall Study|Death|2|||
129949061|NCT03150589|467777482|FG001|Overall Study|Death|3|||
129949062|NCT03150589|467777481|FG000|Overall Study|IP non-compliance and other reasons|12|||
129949063|NCT03150589|467777482|FG001|Overall Study|IP non-compliance and other reasons|3|||
129949064|NCT01020435|467777485|FG000|Overall Study|Lost to Follow-up|0|||
129949065|NCT01020435|467777486|FG001|Overall Study|Lost to Follow-up|1|||
129949066|NCT01000649|467777487|FG000|Overall Study|Adverse Event|5|||
129949067|NCT01000649|467777488|FG001|Overall Study|Adverse Event|1|||
129949068|NCT01000649|467777489|FG002|Overall Study|Adverse Event|2|||
129949069|NCT01000649|467777490|FG003|Overall Study|Adverse Event|4|||
129949070|NCT01000649|467777487|FG000|Overall Study|Lost to Follow-up|0|||
129949071|NCT01000649|467777488|FG001|Overall Study|Lost to Follow-up|2|||
129949072|NCT01000649|467777489|FG002|Overall Study|Lost to Follow-up|0|||
129949073|NCT01000649|467777490|FG003|Overall Study|Lost to Follow-up|2|||
129949074|NCT00346398|467777491|FG000|Overall Study|Lost to Follow-up|3|||
129949075|NCT00346398|467777492|FG001|Overall Study|Lost to Follow-up|0|||
129949076|NCT00346398|467777491|FG000|Overall Study|Withdrawal by Subject|0|||
129949077|NCT00346398|467777492|FG001|Overall Study|Withdrawal by Subject|2|||
129949078|NCT02607956|467777493|FG000|Double-Blinded Phase|Withdrew Consent|17|||
129949079|NCT02607956|467777494|FG001|Double-Blinded Phase|Withdrew Consent|19|||
129949080|NCT02607956|467777495|FG002|Double-Blinded Phase|Withdrew Consent|0|||
129949081|NCT02607956|467777496|FG003|Double-Blinded Phase|Withdrew Consent|0|||
129949082|NCT02607956|467777493|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
129949083|NCT02607956|467777494|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
129949084|NCT02607956|467777495|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
129949085|NCT02607956|467777496|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
129949086|NCT02607956|467777493|FG000|Double-Blinded Phase|Randomized but never treated|7|||
129949087|NCT02607956|467777494|FG001|Double-Blinded Phase|Randomized but never treated|5|||
129949088|NCT02607956|467777495|FG002|Double-Blinded Phase|Randomized but never treated|0|||
129949089|NCT02607956|467777496|FG003|Double-Blinded Phase|Randomized but never treated|0|||
129949090|NCT02607956|467777493|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
129949091|NCT02607956|467777494|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
129949092|NCT02607956|467777495|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
129949093|NCT02607956|467777496|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
129949094|NCT02607956|467777493|FG000|Double-Blinded Phase|Death|4|||
129949095|NCT02607956|467777494|FG001|Double-Blinded Phase|Death|4|||
129949096|NCT02607956|467777495|FG002|Double-Blinded Phase|Death|0|||
129949097|NCT02607956|467777496|FG003|Double-Blinded Phase|Death|0|||
129949098|NCT02607956|467777493|FG000|Double-Blinded Phase|Adverse Event|4|||
129949099|NCT02607956|467777494|FG001|Double-Blinded Phase|Adverse Event|3|||
129949100|NCT02607956|467777495|FG002|Double-Blinded Phase|Adverse Event|0|||
129949101|NCT02607956|467777496|FG003|Double-Blinded Phase|Adverse Event|0|||
129949102|NCT02607956|467777493|FG000|Double-Blinded Phase|Protocol Violation|3|||
129949103|NCT02607956|467777494|FG001|Double-Blinded Phase|Protocol Violation|1|||
129949104|NCT02607956|467777495|FG002|Double-Blinded Phase|Protocol Violation|0|||
129949105|NCT02607956|467777496|FG003|Double-Blinded Phase|Protocol Violation|0|||
129949106|NCT02607956|467777493|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
129949107|NCT02607956|467777494|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
129949108|NCT02607956|467777495|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
129949109|NCT02607956|467777496|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
129949110|NCT02607956|467777493|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
129949111|NCT02607956|467777494|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
129949112|NCT02607956|467777495|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
129949113|NCT02607956|467777496|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
129949114|NCT02607956|467777493|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
129949115|NCT02607956|467777494|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
129949116|NCT02607956|467777495|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
129949117|NCT02607956|467777496|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
129949118|NCT02607956|467777493|FG000|Open-Label Extension Phase|Death|0|||
129949119|NCT02607956|467777494|FG001|Open-Label Extension Phase|Death|0|||
129949120|NCT02607956|467777495|FG002|Open-Label Extension Phase|Death|1|||
129949121|NCT02607956|467777496|FG003|Open-Label Extension Phase|Death|3|||
129949122|NCT02607956|467777493|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
129949123|NCT02607956|467777494|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
129949124|NCT02607956|467777495|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
129949125|NCT02607956|467777496|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
129949126|NCT02607956|467777493|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
129949127|NCT02607956|467777494|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
129949128|NCT02607956|467777495|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
129949129|NCT02607956|467777496|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
129949130|NCT02607956|467777493|FG000|Open-Label Extension Phase|Protocol Violation|0|||
129949131|NCT02607956|467777494|FG001|Open-Label Extension Phase|Protocol Violation|0|||
129949132|NCT02607956|467777495|FG002|Open-Label Extension Phase|Protocol Violation|0|||
129949133|NCT02607956|467777496|FG003|Open-Label Extension Phase|Protocol Violation|2|||
129949134|NCT02607956|467777493|FG000|Open-Label Extension Phase|Pregnancy|0|||
129949135|NCT02607956|467777494|FG001|Open-Label Extension Phase|Pregnancy|0|||
129949136|NCT02607956|467777495|FG002|Open-Label Extension Phase|Pregnancy|0|||
129453494|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
129453495|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
129949137|NCT02607956|467777496|FG003|Open-Label Extension Phase|Pregnancy|1|||
129949138|NCT00103857|467777497|FG000|54-Week Base Study|Adverse Event|12|||
129949139|NCT00103857|467777498|FG001|54-Week Base Study|Adverse Event|9|||
129949140|NCT00103857|467777499|FG002|54-Week Base Study|Adverse Event|11|||
129949141|NCT00103857|467777500|FG003|54-Week Base Study|Adverse Event|6|||
129949142|NCT00103857|467777501|FG004|54-Week Base Study|Adverse Event|5|||
129949143|NCT00103857|467777502|FG005|54-Week Base Study|Adverse Event|11|||
129949144|NCT00103857|467777503|FG006|54-Week Base Study|Adverse Event|3|||
129949145|NCT00103857|467777497|FG000|54-Week Base Study|Death|0|||
129949146|NCT00103857|467777498|FG001|54-Week Base Study|Death|0|||
129949147|NCT00103857|467777499|FG002|54-Week Base Study|Death|0|||
129949148|NCT00103857|467777500|FG003|54-Week Base Study|Death|0|||
129949149|NCT00103857|467777501|FG004|54-Week Base Study|Death|1|||
129949150|NCT00103857|467777502|FG005|54-Week Base Study|Death|1|||
129949151|NCT00103857|467777503|FG006|54-Week Base Study|Death|0|||
129949152|NCT00103857|467777497|FG000|54-Week Base Study|Lack of Efficacy|11|||
129949153|NCT00103857|467777498|FG001|54-Week Base Study|Lack of Efficacy|14|||
129949154|NCT00103857|467777499|FG002|54-Week Base Study|Lack of Efficacy|8|||
129949155|NCT00103857|467777500|FG003|54-Week Base Study|Lack of Efficacy|4|||
129949156|NCT00103857|467777501|FG004|54-Week Base Study|Lack of Efficacy|3|||
129949157|NCT00103857|467777502|FG005|54-Week Base Study|Lack of Efficacy|14|||
129949158|NCT00103857|467777503|FG006|54-Week Base Study|Lack of Efficacy|19|||
129949159|NCT00103857|467777497|FG000|54-Week Base Study|Lost to Follow-up|5|||
129949160|NCT00103857|467777498|FG001|54-Week Base Study|Lost to Follow-up|4|||
129949161|NCT00103857|467777499|FG002|54-Week Base Study|Lost to Follow-up|7|||
129949162|NCT00103857|467777500|FG003|54-Week Base Study|Lost to Follow-up|5|||
129949163|NCT00103857|467777501|FG004|54-Week Base Study|Lost to Follow-up|10|||
129949164|NCT00103857|467777502|FG005|54-Week Base Study|Lost to Follow-up|9|||
129949165|NCT00103857|467777503|FG006|54-Week Base Study|Lost to Follow-up|3|||
129949166|NCT00103857|467777497|FG000|54-Week Base Study|Physician Decision|1|||
129949167|NCT00103857|467777498|FG001|54-Week Base Study|Physician Decision|1|||
129949168|NCT00103857|467777499|FG002|54-Week Base Study|Physician Decision|0|||
129949169|NCT00103857|467777500|FG003|54-Week Base Study|Physician Decision|0|||
129949170|NCT00103857|467777501|FG004|54-Week Base Study|Physician Decision|1|||
129949171|NCT00103857|467777502|FG005|54-Week Base Study|Physician Decision|0|||
129949172|NCT00103857|467777503|FG006|54-Week Base Study|Physician Decision|0|||
129949173|NCT00103857|467777497|FG000|54-Week Base Study|Pregnancy|1|||
129949174|NCT00103857|467777498|FG001|54-Week Base Study|Pregnancy|0|||
129949175|NCT00103857|467777499|FG002|54-Week Base Study|Pregnancy|0|||
129949176|NCT00103857|467777500|FG003|54-Week Base Study|Pregnancy|0|||
129949177|NCT00103857|467777501|FG004|54-Week Base Study|Pregnancy|1|||
129949178|NCT00103857|467777502|FG005|54-Week Base Study|Pregnancy|0|||
129949179|NCT00103857|467777503|FG006|54-Week Base Study|Pregnancy|1|||
129949180|NCT00103857|467777497|FG000|54-Week Base Study|Protocol Violation|6|||
129949181|NCT00103857|467777498|FG001|54-Week Base Study|Protocol Violation|4|||
129949182|NCT00103857|467777499|FG002|54-Week Base Study|Protocol Violation|2|||
129949183|NCT00103857|467777500|FG003|54-Week Base Study|Protocol Violation|4|||
129949184|NCT00103857|467777501|FG004|54-Week Base Study|Protocol Violation|0|||
129949185|NCT00103857|467777502|FG005|54-Week Base Study|Protocol Violation|3|||
129949186|NCT00103857|467777503|FG006|54-Week Base Study|Protocol Violation|3|||
129949187|NCT00103857|467777497|FG000|54-Week Base Study|Withdrawal by Subject|17|||
129949188|NCT00103857|467777498|FG001|54-Week Base Study|Withdrawal by Subject|16|||
129949189|NCT00103857|467777499|FG002|54-Week Base Study|Withdrawal by Subject|16|||
129949190|NCT00103857|467777500|FG003|54-Week Base Study|Withdrawal by Subject|15|||
129949191|NCT00103857|467777501|FG004|54-Week Base Study|Withdrawal by Subject|10|||
129949192|NCT00103857|467777502|FG005|54-Week Base Study|Withdrawal by Subject|15|||
129949193|NCT00103857|467777503|FG006|54-Week Base Study|Withdrawal by Subject|4|||
129949194|NCT00103857|467777497|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
129949195|NCT00103857|467777498|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
129949196|NCT00103857|467777499|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
129949197|NCT00103857|467777500|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
129949198|NCT00103857|467777501|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
129949199|NCT00103857|467777502|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
129949200|NCT00103857|467777503|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
129949201|NCT00103857|467777497|FG000|54-Week Base Study|patient moved|0|||
129949202|NCT00103857|467777498|FG001|54-Week Base Study|patient moved|1|||
129949203|NCT00103857|467777499|FG002|54-Week Base Study|patient moved|1|||
129949204|NCT00103857|467777500|FG003|54-Week Base Study|patient moved|2|||
129949205|NCT00103857|467777501|FG004|54-Week Base Study|patient moved|3|||
129949206|NCT00103857|467777502|FG005|54-Week Base Study|patient moved|1|||
129949207|NCT00103857|467777503|FG006|54-Week Base Study|patient moved|0|||
129949208|NCT00103857|467777497|FG000|54-Week Base Study|non-compliance with study procedures|1|||
129949209|NCT00103857|467777498|FG001|54-Week Base Study|non-compliance with study procedures|2|||
129949210|NCT00103857|467777499|FG002|54-Week Base Study|non-compliance with study procedures|0|||
129949211|NCT00103857|467777500|FG003|54-Week Base Study|non-compliance with study procedures|0|||
129949212|NCT00103857|467777501|FG004|54-Week Base Study|non-compliance with study procedures|0|||
129949213|NCT00103857|467777502|FG005|54-Week Base Study|non-compliance with study procedures|2|||
129949214|NCT00103857|467777503|FG006|54-Week Base Study|non-compliance with study procedures|0|||
129949215|NCT00103857|467777497|FG000|54-Week Base Study|patient incarcerated|0|||
129949216|NCT00103857|467777498|FG001|54-Week Base Study|patient incarcerated|0|||
129949217|NCT00103857|467777499|FG002|54-Week Base Study|patient incarcerated|0|||
129949218|NCT00103857|467777500|FG003|54-Week Base Study|patient incarcerated|0|||
129949219|NCT00103857|467777501|FG004|54-Week Base Study|patient incarcerated|1|||
129949220|NCT00103857|467777502|FG005|54-Week Base Study|patient incarcerated|1|||
129949221|NCT00103857|467777503|FG006|54-Week Base Study|patient incarcerated|0|||
129949222|NCT00103857|467777497|FG000|54-Week Base Study|laboratory reporting error|0|||
129949223|NCT00103857|467777498|FG001|54-Week Base Study|laboratory reporting error|0|||
129949224|NCT00103857|467777499|FG002|54-Week Base Study|laboratory reporting error|0|||
129949225|NCT00103857|467777500|FG003|54-Week Base Study|laboratory reporting error|0|||
129949226|NCT00103857|467777501|FG004|54-Week Base Study|laboratory reporting error|1|||
129949227|NCT00103857|467777502|FG005|54-Week Base Study|laboratory reporting error|0|||
129453496|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
129453497|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
129453498|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
129453499|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
129453500|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
129453501|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
129453502|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
129453503|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
129453504|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
129453505|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
129453506|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
129453507|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
129453508|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
129949228|NCT00103857|467777503|FG006|54-Week Base Study|laboratory reporting error|0|||
129949229|NCT00103857|467777497|FG000|54-Week Base Study|site error|0|||
129949230|NCT00103857|467777498|FG001|54-Week Base Study|site error|0|||
129949231|NCT00103857|467777499|FG002|54-Week Base Study|site error|0|||
129949232|NCT00103857|467777500|FG003|54-Week Base Study|site error|0|||
129949233|NCT00103857|467777501|FG004|54-Week Base Study|site error|0|||
129949234|NCT00103857|467777502|FG005|54-Week Base Study|site error|1|||
129949235|NCT00103857|467777503|FG006|54-Week Base Study|site error|0|||
129949236|NCT00103857|467777497|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
129949237|NCT00103857|467777498|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949238|NCT00103857|467777499|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949239|NCT00103857|467777500|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949240|NCT00103857|467777501|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949241|NCT00103857|467777502|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949242|NCT00103857|467777503|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
129949243|NCT00103857|467777497|FG000|50-Week Extension Study|Adverse Event|2|||
129949244|NCT00103857|467777498|FG001|50-Week Extension Study|Adverse Event|3|||
129949245|NCT00103857|467777499|FG002|50-Week Extension Study|Adverse Event|2|||
129949246|NCT00103857|467777500|FG003|50-Week Extension Study|Adverse Event|0|||
129949247|NCT00103857|467777501|FG004|50-Week Extension Study|Adverse Event|1|||
129949248|NCT00103857|467777502|FG005|50-Week Extension Study|Adverse Event|1|||
129949249|NCT00103857|467777503|FG006|50-Week Extension Study|Adverse Event|0|||
129949250|NCT00103857|467777497|FG000|50-Week Extension Study|Death|0|||
129949251|NCT00103857|467777498|FG001|50-Week Extension Study|Death|0|||
129949252|NCT00103857|467777499|FG002|50-Week Extension Study|Death|0|||
129949253|NCT00103857|467777500|FG003|50-Week Extension Study|Death|1|||
129949254|NCT00103857|467777501|FG004|50-Week Extension Study|Death|0|||
129949255|NCT00103857|467777502|FG005|50-Week Extension Study|Death|1|||
129949256|NCT00103857|467777503|FG006|50-Week Extension Study|Death|0|||
129949257|NCT00103857|467777497|FG000|50-Week Extension Study|Lack of Efficacy|26|||
129949258|NCT00103857|467777498|FG001|50-Week Extension Study|Lack of Efficacy|15|||
129949259|NCT00103857|467777499|FG002|50-Week Extension Study|Lack of Efficacy|13|||
129949260|NCT00103857|467777500|FG003|50-Week Extension Study|Lack of Efficacy|16|||
129949261|NCT00103857|467777501|FG004|50-Week Extension Study|Lack of Efficacy|8|||
129949262|NCT00103857|467777502|FG005|50-Week Extension Study|Lack of Efficacy|8|||
129949263|NCT00103857|467777503|FG006|50-Week Extension Study|Lack of Efficacy|0|||
129949264|NCT00103857|467777497|FG000|50-Week Extension Study|Lost to Follow-up|4|||
129949265|NCT00103857|467777498|FG001|50-Week Extension Study|Lost to Follow-up|0|||
129949266|NCT00103857|467777499|FG002|50-Week Extension Study|Lost to Follow-up|1|||
129453509|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
129453510|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
129453511|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
129949267|NCT00103857|467777500|FG003|50-Week Extension Study|Lost to Follow-up|4|||
129949268|NCT00103857|467777501|FG004|50-Week Extension Study|Lost to Follow-up|3|||
129949269|NCT00103857|467777502|FG005|50-Week Extension Study|Lost to Follow-up|3|||
129949270|NCT00103857|467777503|FG006|50-Week Extension Study|Lost to Follow-up|0|||
129949271|NCT00103857|467777497|FG000|50-Week Extension Study|Physician Decision|0|||
129949272|NCT00103857|467777498|FG001|50-Week Extension Study|Physician Decision|1|||
129949273|NCT00103857|467777499|FG002|50-Week Extension Study|Physician Decision|1|||
129949274|NCT00103857|467777500|FG003|50-Week Extension Study|Physician Decision|0|||
129949275|NCT00103857|467777501|FG004|50-Week Extension Study|Physician Decision|0|||
129949276|NCT00103857|467777502|FG005|50-Week Extension Study|Physician Decision|0|||
129949277|NCT00103857|467777503|FG006|50-Week Extension Study|Physician Decision|0|||
129949278|NCT00103857|467777497|FG000|50-Week Extension Study|Pregnancy|0|||
129949279|NCT00103857|467777498|FG001|50-Week Extension Study|Pregnancy|0|||
129949280|NCT00103857|467777499|FG002|50-Week Extension Study|Pregnancy|1|||
129949281|NCT00103857|467777500|FG003|50-Week Extension Study|Pregnancy|0|||
129949282|NCT00103857|467777501|FG004|50-Week Extension Study|Pregnancy|1|||
129949283|NCT00103857|467777502|FG005|50-Week Extension Study|Pregnancy|0|||
129949284|NCT00103857|467777503|FG006|50-Week Extension Study|Pregnancy|0|||
129949285|NCT00103857|467777497|FG000|50-Week Extension Study|Protocol Violation|1|||
129949286|NCT00103857|467777498|FG001|50-Week Extension Study|Protocol Violation|1|||
129949287|NCT00103857|467777499|FG002|50-Week Extension Study|Protocol Violation|1|||
129949288|NCT00103857|467777500|FG003|50-Week Extension Study|Protocol Violation|2|||
129949289|NCT00103857|467777501|FG004|50-Week Extension Study|Protocol Violation|0|||
129949290|NCT00103857|467777502|FG005|50-Week Extension Study|Protocol Violation|1|||
129949291|NCT00103857|467777503|FG006|50-Week Extension Study|Protocol Violation|0|||
129949292|NCT00103857|467777497|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
129949293|NCT00103857|467777498|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
129949294|NCT00103857|467777499|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
129949295|NCT00103857|467777500|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
129949296|NCT00103857|467777501|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
129949297|NCT00103857|467777502|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
129949298|NCT00103857|467777503|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
129949299|NCT00103857|467777497|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
129949300|NCT00103857|467777498|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
129949301|NCT00103857|467777499|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
129949302|NCT00103857|467777500|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
129949303|NCT00103857|467777501|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
129949304|NCT00103857|467777502|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
129949305|NCT00103857|467777503|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
129949306|NCT00103857|467777497|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
129949307|NCT00103857|467777498|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
129949308|NCT00103857|467777499|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
129949309|NCT00103857|467777500|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
129949310|NCT00103857|467777501|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
129949311|NCT00103857|467777502|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
129949312|NCT00103857|467777503|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
129949313|NCT00103857|467777497|FG000|50-Week Extension Study|patient moved|0|||
129949314|NCT00103857|467777498|FG001|50-Week Extension Study|patient moved|0|||
129949315|NCT00103857|467777499|FG002|50-Week Extension Study|patient moved|1|||
129949316|NCT00103857|467777500|FG003|50-Week Extension Study|patient moved|2|||
129949317|NCT00103857|467777501|FG004|50-Week Extension Study|patient moved|0|||
129949318|NCT00103857|467777502|FG005|50-Week Extension Study|patient moved|0|||
129949319|NCT00103857|467777503|FG006|50-Week Extension Study|patient moved|0|||
129949320|NCT00103857|467777497|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949321|NCT00103857|467777498|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949322|NCT00103857|467777499|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
129949323|NCT00103857|467777500|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949324|NCT00103857|467777501|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949325|NCT00103857|467777502|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949326|NCT00103857|467777503|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
129949327|NCT00103857|467777497|FG000|50-Week Extension Study|reason unspecified|0|||
129949328|NCT00103857|467777498|FG001|50-Week Extension Study|reason unspecified|0|||
129949329|NCT00103857|467777499|FG002|50-Week Extension Study|reason unspecified|0|||
129949330|NCT00103857|467777500|FG003|50-Week Extension Study|reason unspecified|0|||
129949331|NCT00103857|467777501|FG004|50-Week Extension Study|reason unspecified|1|||
129949332|NCT00103857|467777502|FG005|50-Week Extension Study|reason unspecified|0|||
129949333|NCT00103857|467777503|FG006|50-Week Extension Study|reason unspecified|0|||
129949334|NCT01005914|467777504|FG000|Overall Study|Adverse Event|4|||
129949335|NCT01005914|467777504|FG000|Overall Study|Death|4|||
129949336|NCT01005914|467777504|FG000|Overall Study|Lack of Efficacy|1|||
129949337|NCT01005914|467777504|FG000|Overall Study|Withdrawal by Subject|1|||
129949338|NCT01240785|467777506|FG000|Overall Study|Lost to Follow-up|1|||
129949339|NCT01240785|467777507|FG001|Overall Study|Lost to Follow-up|0|||
129949340|NCT01240785|467777506|FG000|Overall Study|Protocol Violation|0|||
129949341|NCT01240785|467777507|FG001|Overall Study|Protocol Violation|3|||
129949342|NCT02132195|467777510|FG000|Initial Assignment|Relapsed|14|||
129949343|NCT02132195|467777511|FG001|Initial Assignment|Relapsed|0|||
129949344|NCT02132195|467777512|FG002|Initial Assignment|Relapsed|0|||
129949345|NCT02132195|467777510|FG000|Rescue Therapy|Relapsed|0|||
129949346|NCT02132195|467777511|FG001|Rescue Therapy|Relapsed|0|||
129949347|NCT02132195|467777512|FG002|Rescue Therapy|Relapsed|7|||
129949348|NCT02132195|467777510|FG000|Rescue Therapy|Physician Decision|0|||
129949349|NCT02132195|467777511|FG001|Rescue Therapy|Physician Decision|0|||
129949350|NCT02132195|467777512|FG002|Rescue Therapy|Physician Decision|1|||
129949351|NCT02132195|467777510|FG000|Rescue Therapy|Withdrawal by Subject|0|||
129949352|NCT02132195|467777511|FG001|Rescue Therapy|Withdrawal by Subject|0|||
129949353|NCT02132195|467777512|FG002|Rescue Therapy|Withdrawal by Subject|1|||
129949354|NCT02132195|467777510|FG000|Rescue Therapy|Adverse Event|0|||
129949355|NCT02132195|467777511|FG001|Rescue Therapy|Adverse Event|0|||
129949356|NCT02132195|467777512|FG002|Rescue Therapy|Adverse Event|2|||
129949357|NCT03065400|467777513|FG000|Overall Study|Adverse Event|1|||
129949358|NCT03065400|467777513|FG000|Overall Study|Physician Decision|3|||
129949359|NCT03065400|467777513|FG000|Overall Study|Withdrawal by Subject|1|||
129949360|NCT03065400|467777513|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
129949361|NCT03072862|467777514|FG000|Overall Study|Withdrawal by Subject|4|||
129949362|NCT03072862|467777514|FG000|Overall Study|Lost to Follow-up|6|||
129949363|NCT03072862|467777514|FG000|Overall Study|Protocol Violation|4|||
129949364|NCT03072862|467777514|FG000|Overall Study|Physician Decision|2|||
129949365|NCT03072862|467777514|FG000|Overall Study|Death|1|||
129949366|NCT03072862|467777514|FG000|Overall Study|Adverse Event|1|||
129949367|NCT02613403|467777522|FG000|Overall Study|Lost to Follow-up|0|||
129949368|NCT02613403|467777523|FG001|Overall Study|Lost to Follow-up|1|||
129949369|NCT02613403|467777524|FG002|Overall Study|Lost to Follow-up|0|||
129949370|NCT02613403|467777525|FG003|Overall Study|Lost to Follow-up|0|||
129949371|NCT02613403|467777526|FG004|Overall Study|Lost to Follow-up|0|||
129949372|NCT02613403|467777522|FG000|Overall Study|Withdrawal by Subject|2|||
129949373|NCT02613403|467777523|FG001|Overall Study|Withdrawal by Subject|0|||
129949374|NCT02613403|467777524|FG002|Overall Study|Withdrawal by Subject|0|||
129949375|NCT02613403|467777525|FG003|Overall Study|Withdrawal by Subject|0|||
129949376|NCT02613403|467777526|FG004|Overall Study|Withdrawal by Subject|0|||
129949377|NCT01147471|467777527|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
129949378|NCT01147471|467777528|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
129949379|NCT01147471|467777527|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
129949380|NCT01147471|467777528|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
129949381|NCT01147471|467777527|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
129949382|NCT01147471|467777528|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
129949383|NCT01147471|467777527|FG000|3 Month Follow Up|Lost to Follow-up|1|||
129949384|NCT01147471|467777528|FG001|3 Month Follow Up|Lost to Follow-up|1|||
129949385|NCT01147471|467777527|FG000|3 Month Follow Up|Physician Decision|0|||
129949386|NCT01147471|467777528|FG001|3 Month Follow Up|Physician Decision|1|||
129949387|NCT01147471|467777527|FG000|6 Month Follow Up|Lost to Follow-up|4|||
129949388|NCT01147471|467777528|FG001|6 Month Follow Up|Lost to Follow-up|2|||
129949389|NCT00800176|467777529|FG000|Overall Study|Adverse Event|2|||
129949390|NCT00800176|467777530|FG001|Overall Study|Adverse Event|1|||
129949391|NCT00800176|467777531|FG002|Overall Study|Adverse Event|0|||
129949392|NCT00800176|467777532|FG003|Overall Study|Adverse Event|2|||
129949393|NCT00800176|467777533|FG004|Overall Study|Adverse Event|1|||
129949394|NCT00800176|467777534|FG005|Overall Study|Adverse Event|1|||
129949395|NCT00800176|467777529|FG000|Overall Study|Refused treatment|3|||
129949396|NCT00800176|467777530|FG001|Overall Study|Refused treatment|2|||
129949397|NCT00800176|467777531|FG002|Overall Study|Refused treatment|0|||
129949398|NCT00800176|467777532|FG003|Overall Study|Refused treatment|0|||
129949399|NCT00800176|467777533|FG004|Overall Study|Refused treatment|1|||
129949400|NCT00800176|467777534|FG005|Overall Study|Refused treatment|4|||
129949401|NCT00800176|467777529|FG000|Overall Study|Failure to return|3|||
129949402|NCT00800176|467777530|FG001|Overall Study|Failure to return|3|||
129949403|NCT00800176|467777531|FG002|Overall Study|Failure to return|0|||
129949404|NCT00800176|467777532|FG003|Overall Study|Failure to return|2|||
129949405|NCT00800176|467777533|FG004|Overall Study|Failure to return|0|||
129949406|NCT00800176|467777534|FG005|Overall Study|Failure to return|0|||
129949407|NCT00800176|467777529|FG000|Overall Study|Other|1|||
129949408|NCT00800176|467777530|FG001|Overall Study|Other|0|||
129949409|NCT00800176|467777531|FG002|Overall Study|Other|0|||
129949410|NCT00800176|467777532|FG003|Overall Study|Other|0|||
129949411|NCT00800176|467777533|FG004|Overall Study|Other|2|||
129949412|NCT00800176|467777534|FG005|Overall Study|Other|0|||
129949413|NCT02188459|467777540|FG000|Overall Study|Lost to Follow-up|3|||
129949414|NCT02188459|467777541|FG001|Overall Study|Lost to Follow-up|4|||
129949415|NCT02188459|467777540|FG000|Overall Study|Early Termination|0|||
129949416|NCT02188459|467777541|FG001|Overall Study|Early Termination|3|||
129949417|NCT02612285|467777542|FG000|Overall Study|Withdrawal by Subject|1|||
129949418|NCT00805441|467777543|FG000|Overall Study|Adverse Event|5|||
129949419|NCT00805441|467777544|FG001|Overall Study|Adverse Event|2|||
129949420|NCT00805441|467777543|FG000|Overall Study|Lack of Efficacy|0|||
129949421|NCT00805441|467777544|FG001|Overall Study|Lack of Efficacy|2|||
129949422|NCT00805441|467777543|FG000|Overall Study|Protocol Violation|4|||
129949423|NCT00805441|467777544|FG001|Overall Study|Protocol Violation|8|||
129949424|NCT00805441|467777543|FG000|Overall Study|Lost to Follow-up|10|||
129949425|NCT00805441|467777544|FG001|Overall Study|Lost to Follow-up|13|||
129949426|NCT00805441|467777543|FG000|Overall Study|Withdrawal by Subject|15|||
129949427|NCT00805441|467777544|FG001|Overall Study|Withdrawal by Subject|9|||
129949428|NCT00805441|467777543|FG000|Overall Study|Physician Decision|0|||
129949429|NCT00805441|467777544|FG001|Overall Study|Physician Decision|1|||
129949430|NCT00805441|467777543|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
129949431|NCT00805441|467777544|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
129949432|NCT02935894|467777546|FG000|Overall Study|Subject dismissed|1|||
129949433|NCT01898299|467777549|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
129949434|NCT01898299|467777550|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
129949435|NCT02340806|467777551|FG000|Overall Study|Protocol Violation|2|||
129949436|NCT02340806|467777552|FG001|Overall Study|Protocol Violation|0|||
129949437|NCT02340806|467777551|FG000|Overall Study|epidural catheter replaced|2|||
129949438|NCT02340806|467777552|FG001|Overall Study|epidural catheter replaced|1|||
129949439|NCT02340806|467777551|FG000|Overall Study|history of chronic pain medication|1|||
129949440|NCT02340806|467777552|FG001|Overall Study|history of chronic pain medication|0|||
129949441|NCT02340806|467777551|FG000|Overall Study|re-dose < 90 min of CSE|1|||
129949442|NCT02340806|467777552|FG001|Overall Study|re-dose < 90 min of CSE|3|||
129949443|NCT00452452|467777553|FG000|Overall Study|Protocol Violation|0|||
129949444|NCT00452452|467777554|FG001|Overall Study|Protocol Violation|0|||
129949445|NCT00452452|467777555|FG002|Overall Study|Protocol Violation|1|||
129949446|NCT00452452|467777553|FG000|Overall Study|Withdrawal by Subject|1|||
129949447|NCT00452452|467777554|FG001|Overall Study|Withdrawal by Subject|0|||
129949448|NCT00452452|467777555|FG002|Overall Study|Withdrawal by Subject|0|||
129949449|NCT00452452|467777553|FG000|Overall Study|Lost to Follow-up|1|||
129949450|NCT00452452|467777554|FG001|Overall Study|Lost to Follow-up|0|||
129949451|NCT00452452|467777555|FG002|Overall Study|Lost to Follow-up|0|||
129949452|NCT02659059|467779086|FG000|Overall Study|Other reasons|6|||
129949453|NCT02659059|467779087|FG001|Overall Study|Other reasons|1|||
129949454|NCT02659059|467779086|FG000|Overall Study|Disease Progression|143|||
129949455|NCT02659059|467779087|FG001|Overall Study|Disease Progression|16|||
129949456|NCT02659059|467779086|FG000|Overall Study|Study Drug toxicity|56|||
129949457|NCT02659059|467779087|FG001|Overall Study|Study Drug toxicity|9|||
129949458|NCT02659059|467779086|FG000|Overall Study|Death|3|||
129949459|NCT02659059|467779087|FG001|Overall Study|Death|1|||
129949460|NCT02659059|467779086|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
129949461|NCT02659059|467779087|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
129949462|NCT02659059|467779086|FG000|Overall Study|Participant request to discontinue study treatment|5|||
129949463|NCT02659059|467779087|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129949464|NCT02659059|467779086|FG000|Overall Study|Participant withdrew consent|6|||
129949465|NCT02659059|467779087|FG001|Overall Study|Participant withdrew consent|1|||
129949466|NCT03976102|467779090|FG000|Overall Study|Withdrawal by Subject|4|||
129949467|NCT03976102|467779091|FG001|Overall Study|Withdrawal by Subject|4|||
129949468|NCT03976102|467779090|FG000|Overall Study|Adverse Event|2|||
129949469|NCT03976102|467779091|FG001|Overall Study|Adverse Event|4|||
129949470|NCT03976102|467779090|FG000|Overall Study|Not related to Covid-19|9|||
129949471|NCT03976102|467779091|FG001|Overall Study|Not related to Covid-19|13|||
129949472|NCT03976102|467779090|FG000|Overall Study|Lost to Follow-up|0|||
129949473|NCT03976102|467779091|FG001|Overall Study|Lost to Follow-up|2|||
129949474|NCT03976102|467779090|FG000|Overall Study|Death|3|||
129949475|NCT03976102|467779091|FG001|Overall Study|Death|2|||
129949476|NCT03976102|467779090|FG000|Overall Study|Physician Decision|1|||
129949477|NCT03976102|467779091|FG001|Overall Study|Physician Decision|1|||
129949478|NCT00092456|467779092|FG000|Overall Study|Adverse Event|0|||
129949479|NCT00092456|467779093|FG001|Overall Study|Adverse Event|0|||
129949480|NCT00092456|467779094|FG002|Overall Study|Adverse Event|1|||
129949481|NCT00092456|467779095|FG003|Overall Study|Adverse Event|1|||
129949482|NCT00092456|467779092|FG000|Overall Study|Lost to Follow-up|2|||
129949483|NCT00092456|467779093|FG001|Overall Study|Lost to Follow-up|2|||
129949484|NCT00092456|467779094|FG002|Overall Study|Lost to Follow-up|1|||
129949485|NCT00092456|467779095|FG003|Overall Study|Lost to Follow-up|2|||
129949486|NCT00092456|467779092|FG000|Overall Study|Protocol Violation|5|||
129949487|NCT00092456|467779093|FG001|Overall Study|Protocol Violation|7|||
129949488|NCT00092456|467779094|FG002|Overall Study|Protocol Violation|8|||
129949489|NCT00092456|467779095|FG003|Overall Study|Protocol Violation|6|||
129949490|NCT00092456|467779092|FG000|Overall Study|Withdrawal by Subject|13|||
129949491|NCT00092456|467779093|FG001|Overall Study|Withdrawal by Subject|5|||
129949492|NCT00092456|467779094|FG002|Overall Study|Withdrawal by Subject|16|||
129949493|NCT00092456|467779095|FG003|Overall Study|Withdrawal by Subject|6|||
129949494|NCT00092456|467779092|FG000|Overall Study|Moved|1|||
129949495|NCT00092456|467779093|FG001|Overall Study|Moved|1|||
129949496|NCT00092456|467779094|FG002|Overall Study|Moved|0|||
129949497|NCT00092456|467779095|FG003|Overall Study|Moved|1|||
129949498|NCT00092456|467779092|FG000|Overall Study|Other|4|||
129949499|NCT00092456|467779093|FG001|Overall Study|Other|2|||
129949500|NCT00092456|467779094|FG002|Overall Study|Other|3|||
129949501|NCT00092456|467779095|FG003|Overall Study|Other|0|||
129949502|NCT02121808|467779098|FG000|Overall Study|Technical problem|3|||
129949503|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
129949504|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
129949505|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
129949506|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
129949507|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
129949508|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
129949509|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
129949510|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
129949511|NCT05066230|467779099|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
129949512|NCT05066230|467779100|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
129949513|NCT05066230|467779099|FG000|After Week 48|Adverse Event|1|||
129949514|NCT05066230|467779100|FG001|After Week 48|Adverse Event|0|||
129949515|NCT05066230|467779099|FG000|After Week 48|Non-compliance with study schedule|1|||
129949516|NCT05066230|467779100|FG001|After Week 48|Non-compliance with study schedule|0|||
129949517|NCT05066230|467779099|FG000|After Week 48|Withdrawal by Subject|0|||
129949518|NCT05066230|467779100|FG001|After Week 48|Withdrawal by Subject|1|||
129949519|NCT05066230|467779099|FG000|After Week 48|Lost to Follow-up|3|||
129949520|NCT05066230|467779100|FG001|After Week 48|Lost to Follow-up|3|||
129949521|NCT05066230|467779099|FG000|After Week 48|Sponsor Request|115|||
129949522|NCT05066230|467779100|FG001|After Week 48|Sponsor Request|111|||
129949523|NCT03924193|467779101|FG000|Overall Study|Adverse Event|10|||
129949524|NCT03924193|467779102|FG001|Overall Study|Adverse Event|0|||
129949525|NCT03924193|467779103|FG002|Overall Study|Adverse Event|10|||
129949526|NCT03924193|467779101|FG000|Overall Study|Withdrawal by Subject|5|||
129949527|NCT03924193|467779102|FG001|Overall Study|Withdrawal by Subject|10|||
129949528|NCT03924193|467779103|FG002|Overall Study|Withdrawal by Subject|2|||
129949529|NCT01322386|467779107|FG000|Overall Study|Protocol Violation|0|||
129949530|NCT01322386|467779108|FG001|Overall Study|Protocol Violation|1|||
129949531|NCT01322386|467779107|FG000|Overall Study|Physician Decision|0|||
129949532|NCT01322386|467779108|FG001|Overall Study|Physician Decision|1|||
129949533|NCT02291861|467779109|FG000|Overall Study|Adverse Event|2|||
129949534|NCT02291861|467779110|FG001|Overall Study|Adverse Event|4|||
129949535|NCT02291861|467779111|FG002|Overall Study|Adverse Event|1|||
129949536|NCT02291861|467779112|FG003|Overall Study|Adverse Event|2|||
129949537|NCT02291861|467779109|FG000|Overall Study|Death|0|||
129949538|NCT02291861|467779110|FG001|Overall Study|Death|0|||
129949539|NCT02291861|467779111|FG002|Overall Study|Death|1|||
129949540|NCT02291861|467779112|FG003|Overall Study|Death|1|||
129949541|NCT02291861|467779109|FG000|Overall Study|Protocol Violation|1|||
129949542|NCT02291861|467779110|FG001|Overall Study|Protocol Violation|0|||
129949543|NCT02291861|467779111|FG002|Overall Study|Protocol Violation|0|||
129949544|NCT02291861|467779112|FG003|Overall Study|Protocol Violation|1|||
129949545|NCT02291861|467779109|FG000|Overall Study|Withdrawal by Subject|1|||
129949546|NCT02291861|467779110|FG001|Overall Study|Withdrawal by Subject|2|||
129949547|NCT02291861|467779111|FG002|Overall Study|Withdrawal by Subject|1|||
129949548|NCT02291861|467779112|FG003|Overall Study|Withdrawal by Subject|4|||
129949549|NCT02291861|467779109|FG000|Overall Study|Noncompliance|1|||
129949550|NCT02291861|467779110|FG001|Overall Study|Noncompliance|1|||
129949551|NCT02291861|467779111|FG002|Overall Study|Noncompliance|2|||
129949552|NCT02291861|467779112|FG003|Overall Study|Noncompliance|1|||
129949553|NCT02291861|467779109|FG000|Overall Study|Lost to Follow-up|2|||
129949554|NCT02291861|467779110|FG001|Overall Study|Lost to Follow-up|1|||
129949555|NCT02291861|467779111|FG002|Overall Study|Lost to Follow-up|4|||
129949556|NCT02291861|467779112|FG003|Overall Study|Lost to Follow-up|0|||
129949557|NCT02291861|467779109|FG000|Overall Study|Other|0|||
129949558|NCT02291861|467779110|FG001|Overall Study|Other|0|||
129949559|NCT02291861|467779111|FG002|Overall Study|Other|0|||
129949560|NCT02291861|467779112|FG003|Overall Study|Other|1|||
129949561|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
129949562|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
129949563|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
129949564|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
129949565|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Death|0|||
129949566|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Death|0|||
129949567|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Death|1|||
129949568|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Death|0|||
129949569|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
129949570|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
129949571|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
129949572|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
129949573|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129949574|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
129949575|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129949576|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
129949577|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
129949578|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
129949579|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
129949580|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
129949581|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
129949582|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
129949583|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
129949584|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
129949585|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
129949586|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
129949587|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
129949588|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
129949589|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Other|2|||
129949590|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Other|0|||
129949591|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Other|0|||
129949592|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Other|0|||
129949593|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
129949594|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
129949595|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
129949596|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
129949597|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
129949598|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
129949599|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
129949600|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
129949601|NCT03845517|467779121|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
129949602|NCT03845517|467779122|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
129949603|NCT03845517|467779123|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
129949604|NCT03845517|467779124|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
129949605|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
129949606|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
129949607|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
129949608|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
129949609|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Death|0|||
129949610|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Death|0|||
129949611|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Death|1|||
129949612|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Death|1|||
129949613|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
129949614|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
129949615|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
129949616|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
129949617|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
129949618|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
129949619|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
129949620|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
129949621|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
129949622|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
129949623|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
129949624|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
129949625|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Other|1|||
129949626|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Other|0|||
129949627|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Other|1|||
129949628|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Other|0|||
129949629|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
129949630|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
129949631|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
129949632|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
129949633|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
129949634|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
129949635|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
129949636|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
129949637|NCT03845517|467779121|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
129949638|NCT03845517|467779122|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
129949639|NCT03845517|467779123|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
129949640|NCT03845517|467779124|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
129949641|NCT02410278|467779127|FG000|Run-in Period|Adverse Event|5|||
129949642|NCT02410278|467779128|FG001|Run-in Period|Adverse Event|0|||
129949643|NCT02410278|467779129|FG002|Run-in Period|Adverse Event|0|||
129949644|NCT02410278|467779127|FG000|Run-in Period|GSRS Threshold Not Met|30|||
129949645|NCT02410278|467779128|FG001|Run-in Period|GSRS Threshold Not Met|0|||
129949646|NCT02410278|467779129|FG002|Run-in Period|GSRS Threshold Not Met|0|||
129949647|NCT02410278|467779127|FG000|Run-in Period|Lost to Follow-up|1|||
129949648|NCT02410278|467779128|FG001|Run-in Period|Lost to Follow-up|0|||
129949649|NCT02410278|467779129|FG002|Run-in Period|Lost to Follow-up|0|||
129949650|NCT02410278|467779127|FG000|Run-in Period|Withdrawal by Subject|1|||
129949651|NCT02410278|467779128|FG001|Run-in Period|Withdrawal by Subject|0|||
129949652|NCT02410278|467779129|FG002|Run-in Period|Withdrawal by Subject|0|||
129949653|NCT02410278|467779127|FG000|Run-in Period|Pregnancy|1|||
129949654|NCT02410278|467779128|FG001|Run-in Period|Pregnancy|0|||
129949655|NCT02410278|467779129|FG002|Run-in Period|Pregnancy|0|||
129949656|NCT02410278|467779127|FG000|Study Treatment Period|Adverse Event|0|||
129949657|NCT02410278|467779128|FG001|Study Treatment Period|Adverse Event|6|||
129949658|NCT02410278|467779129|FG002|Study Treatment Period|Adverse Event|3|||
129949659|NCT02410278|467779127|FG000|Study Treatment Period|Physician Decision|0|||
129949660|NCT02410278|467779128|FG001|Study Treatment Period|Physician Decision|0|||
129949661|NCT02410278|467779129|FG002|Study Treatment Period|Physician Decision|1|||
129949662|NCT02410278|467779127|FG000|Study Treatment Period|Withdrawal by Subject|0|||
129949663|NCT02410278|467779128|FG001|Study Treatment Period|Withdrawal by Subject|1|||
129949664|NCT02410278|467779129|FG002|Study Treatment Period|Withdrawal by Subject|0|||
129949665|NCT02410278|467779127|FG000|Study Treatment Period|Other|0|||
129949666|NCT02410278|467779128|FG001|Study Treatment Period|Other|3|||
129949667|NCT02410278|467779129|FG002|Study Treatment Period|Other|0|||
129949668|NCT02410278|467779127|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
129949669|NCT02410278|467779128|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
129949670|NCT02410278|467779129|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
129949671|NCT03695185|467779130|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
129949672|NCT03695185|467779130|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
129949673|NCT03695185|467779130|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
129949674|NCT03695185|467779130|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
129949675|NCT03695185|467779130|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
129949676|NCT03695185|467779130|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
129949677|NCT02584257|467779131|FG000|Period 1|Withdrawal by Subject|0|||
129949678|NCT02584257|467779132|FG001|Period 1|Withdrawal by Subject|0|||
129949679|NCT02584257|467779133|FG002|Period 1|Withdrawal by Subject|0|||
129949680|NCT02584257|467779134|FG003|Period 1|Withdrawal by Subject|0|||
129949681|NCT02584257|467779135|FG004|Period 1|Withdrawal by Subject|0|||
129949682|NCT02584257|467779136|FG005|Period 1|Withdrawal by Subject|0|||
129949683|NCT02584257|467779137|FG006|Period 1|Withdrawal by Subject|1|||
129949684|NCT02584257|467779138|FG007|Period 1|Withdrawal by Subject|0|||
129949685|NCT02584257|467779139|FG008|Period 1|Withdrawal by Subject|0|||
129949686|NCT02584257|467779131|FG000|Period 2|Physician Decision|1|||
129949687|NCT02584257|467779132|FG001|Period 2|Physician Decision|0|||
129949688|NCT02584257|467779133|FG002|Period 2|Physician Decision|0|||
129949689|NCT02584257|467779134|FG003|Period 2|Physician Decision|0|||
129949690|NCT02584257|467779135|FG004|Period 2|Physician Decision|0|||
129949691|NCT02584257|467779136|FG005|Period 2|Physician Decision|0|||
129949692|NCT02584257|467779137|FG006|Period 2|Physician Decision|0|||
129949693|NCT02584257|467779138|FG007|Period 2|Physician Decision|0|||
129949694|NCT02584257|467779139|FG008|Period 2|Physician Decision|0|||
129949695|NCT02584257|467779131|FG000|Period 2|Adverse Event|0|||
129949696|NCT02584257|467779132|FG001|Period 2|Adverse Event|1|||
129949697|NCT02584257|467779133|FG002|Period 2|Adverse Event|0|||
129949698|NCT02584257|467779134|FG003|Period 2|Adverse Event|0|||
129949699|NCT02584257|467779135|FG004|Period 2|Adverse Event|0|||
129949700|NCT02584257|467779136|FG005|Period 2|Adverse Event|0|||
129949701|NCT02584257|467779137|FG006|Period 2|Adverse Event|0|||
129949702|NCT02584257|467779138|FG007|Period 2|Adverse Event|0|||
129949703|NCT02584257|467779139|FG008|Period 2|Adverse Event|0|||
129949704|NCT01912599|467779147|FG000|Overall Study|Withdrawal by Subject|0|||
129949705|NCT01912599|467779148|FG001|Overall Study|Withdrawal by Subject|1|||
129949706|NCT03386344|467779150|FG000|Overall Study|Adverse Event|6|||
129949707|NCT03386344|467779151|FG001|Overall Study|Adverse Event|3|||
129949708|NCT03386344|467779152|FG002|Overall Study|Adverse Event|1|||
129949709|NCT03386344|467779150|FG000|Overall Study|Poor Compliance to Protocol|0|||
129949710|NCT03386344|467779151|FG001|Overall Study|Poor Compliance to Protocol|1|||
129949711|NCT03386344|467779152|FG002|Overall Study|Poor Compliance to Protocol|0|||
129949712|NCT03386344|467779150|FG000|Overall Study|Study Terminated by Sponsor|101|||
129949713|NCT03386344|467779151|FG001|Overall Study|Study Terminated by Sponsor|102|||
129949714|NCT03386344|467779152|FG002|Overall Study|Study Terminated by Sponsor|106|||
129949715|NCT03386344|467779150|FG000|Overall Study|Lost to Follow-up|3|||
129949716|NCT03386344|467779151|FG001|Overall Study|Lost to Follow-up|2|||
129949717|NCT03386344|467779152|FG002|Overall Study|Lost to Follow-up|1|||
129949718|NCT03386344|467779150|FG000|Overall Study|At the Participant's own Request|7|||
129949719|NCT03386344|467779151|FG001|Overall Study|At the Participant's own Request|7|||
129949720|NCT03386344|467779152|FG002|Overall Study|At the Participant's own Request|8|||
129949721|NCT03386344|467779150|FG000|Overall Study|Reason not Specified|0|||
129949722|NCT03386344|467779151|FG001|Overall Study|Reason not Specified|1|||
129949723|NCT03386344|467779152|FG002|Overall Study|Reason not Specified|0|||
129949724|NCT01280721|467779155|FG000|Overall Study|Adverse Event|4|||
129949725|NCT01280721|467779155|FG000|Overall Study|Physician Decision|3|||
129949726|NCT01280721|467779155|FG000|Overall Study|Withdrawal by Subject|6|||
129949727|NCT01280721|467779155|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
129949728|NCT01280721|467779155|FG000|Overall Study|No tolerability for the lowest dose|2|||
129949729|NCT01180400|467779156|FG000|Overall Study|Withdrawal by Subject|5|||
129949730|NCT01180400|467779157|FG001|Overall Study|Withdrawal by Subject|6|||
129949731|NCT01180400|467779156|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129949732|NCT01180400|467779157|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
129949733|NCT01180400|467779156|FG000|Overall Study|Adverse Event|12|||
129949734|NCT01180400|467779157|FG001|Overall Study|Adverse Event|10|||
129949735|NCT01180400|467779156|FG000|Overall Study|Severe non-compliance to protocol|1|||
129949736|NCT01180400|467779157|FG001|Overall Study|Severe non-compliance to protocol|2|||
129949737|NCT01180400|467779156|FG000|Overall Study|Condition under investigation worsened|2|||
129949738|NCT01180400|467779157|FG001|Overall Study|Condition under investigation worsened|1|||
129949739|NCT01180400|467779156|FG000|Overall Study|Lack of Efficacy|2|||
129949740|NCT01180400|467779157|FG001|Overall Study|Lack of Efficacy|0|||
129949741|NCT01180400|467779156|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129949742|NCT01180400|467779157|FG001|Overall Study|Study-specific withdrawal criteria|2|||
129949743|NCT01180400|467779156|FG000|Overall Study|Lost to Follow-up|2|||
129949744|NCT01180400|467779157|FG001|Overall Study|Lost to Follow-up|3|||
129949745|NCT01180400|467779156|FG000|Overall Study|Other|0|||
129949746|NCT01180400|467779157|FG001|Overall Study|Other|1|||
129453512|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
129949747|NCT00963924|467779158|FG000|Overall Study|Adverse Event|1|||
129949748|NCT00963924|467779159|FG001|Overall Study|Adverse Event|0|||
129949749|NCT00963924|467779158|FG000|Overall Study|Withdrawal by Subject|0|||
129949750|NCT00963924|467779159|FG001|Overall Study|Withdrawal by Subject|1|||
129949751|NCT00963924|467779158|FG000|Overall Study|Changed antipsychotic|0|||
129949752|NCT00963924|467779159|FG001|Overall Study|Changed antipsychotic|1|||
129949753|NCT00963924|467779158|FG000|Overall Study|Lost to Follow-up|0|||
129949754|NCT00963924|467779159|FG001|Overall Study|Lost to Follow-up|1|||
129949755|NCT03031782|467779164|FG000|Treatment Period 1|Lack of Efficacy|3|||
129949756|NCT03031782|467779165|FG001|Treatment Period 1|Lack of Efficacy|0|||
129949757|NCT03031782|467779166|FG002|Treatment Period 1|Lack of Efficacy|0|||
129949758|NCT03031782|467779167|FG003|Treatment Period 1|Lack of Efficacy|0|||
129949759|NCT03031782|467779168|FG004|Treatment Period 1|Lack of Efficacy|0|||
129949760|NCT03031782|467779164|FG000|Treatment Period 2|Physician Decision|0|||
129949761|NCT03031782|467779165|FG001|Treatment Period 2|Physician Decision|1|||
129949762|NCT03031782|467779166|FG002|Treatment Period 2|Physician Decision|0|||
129949763|NCT03031782|467779167|FG003|Treatment Period 2|Physician Decision|0|||
129949764|NCT03031782|467779168|FG004|Treatment Period 2|Physician Decision|3|||
129949765|NCT03031782|467779164|FG000|Treatment Period 2|Lack of Efficacy|0|||
129949766|NCT03031782|467779165|FG001|Treatment Period 2|Lack of Efficacy|1|||
129949767|NCT03031782|467779166|FG002|Treatment Period 2|Lack of Efficacy|0|||
129949768|NCT03031782|467779167|FG003|Treatment Period 2|Lack of Efficacy|0|||
129949769|NCT03031782|467779168|FG004|Treatment Period 2|Lack of Efficacy|1|||
129949770|NCT03031782|467779164|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129949771|NCT03031782|467779165|FG001|Treatment Period 2|Withdrawal by Subject|3|||
129949772|NCT03031782|467779166|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129949773|NCT03031782|467779167|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129949774|NCT03031782|467779168|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129949775|NCT03031782|467779164|FG000|Treatment Period 2|Adverse Event|0|||
129949776|NCT03031782|467779165|FG001|Treatment Period 2|Adverse Event|1|||
129949777|NCT03031782|467779166|FG002|Treatment Period 2|Adverse Event|2|||
129949778|NCT03031782|467779167|FG003|Treatment Period 2|Adverse Event|0|||
129949779|NCT03031782|467779168|FG004|Treatment Period 2|Adverse Event|0|||
129949780|NCT03031782|467779164|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129949781|NCT03031782|467779165|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129949782|NCT03031782|467779166|FG002|Treatment Period 3|Withdrawal by Subject|0|||
129949783|NCT03031782|467779167|FG003|Treatment Period 3|Withdrawal by Subject|1|||
129949784|NCT03031782|467779168|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129949785|NCT02170207|467779171|FG000|Overall Study|Case report forms unavailable|5|||
129949786|NCT00886834|467779172|FG000|Overall Study|Protocol Violation|0|||
129949787|NCT00886834|467779173|FG001|Overall Study|Protocol Violation|3|||
129949788|NCT03122860|467779174|FG000|Overall Study|Discontinued Before Treatment|1|||
129949789|NCT03122860|467779175|FG001|Overall Study|Discontinued Before Treatment|1|||
129949790|NCT03122860|467779176|FG002|Overall Study|Discontinued Before Treatment|2|||
129949791|NCT03122860|467779177|FG003|Overall Study|Discontinued Before Treatment|0|||
129949792|NCT03122860|467779178|FG004|Overall Study|Discontinued Before Treatment|1|||
129949793|NCT03122860|467779179|FG005|Overall Study|Discontinued Before Treatment|0|||
129949794|NCT03122860|467779174|FG000|Overall Study|Adverse Event|1|||
129949795|NCT03122860|467779175|FG001|Overall Study|Adverse Event|0|||
129949796|NCT03122860|467779176|FG002|Overall Study|Adverse Event|1|||
129949797|NCT03122860|467779177|FG003|Overall Study|Adverse Event|1|||
129949798|NCT03122860|467779178|FG004|Overall Study|Adverse Event|0|||
129949799|NCT03122860|467779179|FG005|Overall Study|Adverse Event|0|||
129949800|NCT03122860|467779174|FG000|Overall Study|Lost to Follow-up|5|||
129949801|NCT03122860|467779175|FG001|Overall Study|Lost to Follow-up|2|||
129949802|NCT03122860|467779176|FG002|Overall Study|Lost to Follow-up|3|||
129949803|NCT03122860|467779177|FG003|Overall Study|Lost to Follow-up|3|||
129949804|NCT03122860|467779178|FG004|Overall Study|Lost to Follow-up|5|||
129949805|NCT03122860|467779179|FG005|Overall Study|Lost to Follow-up|4|||
129949806|NCT03122860|467779174|FG000|Overall Study|Subject Non-Compliance|0|||
129949807|NCT03122860|467779175|FG001|Overall Study|Subject Non-Compliance|0|||
129949808|NCT03122860|467779176|FG002|Overall Study|Subject Non-Compliance|1|||
129949809|NCT03122860|467779177|FG003|Overall Study|Subject Non-Compliance|0|||
129949810|NCT03122860|467779178|FG004|Overall Study|Subject Non-Compliance|0|||
129949811|NCT03122860|467779179|FG005|Overall Study|Subject Non-Compliance|0|||
129949812|NCT03122860|467779174|FG000|Overall Study|Withdrawal by Subject|3|||
129949813|NCT03122860|467779175|FG001|Overall Study|Withdrawal by Subject|2|||
129949814|NCT03122860|467779176|FG002|Overall Study|Withdrawal by Subject|5|||
129949815|NCT03122860|467779177|FG003|Overall Study|Withdrawal by Subject|7|||
129949816|NCT03122860|467779178|FG004|Overall Study|Withdrawal by Subject|9|||
129949817|NCT03122860|467779179|FG005|Overall Study|Withdrawal by Subject|8|||
129949818|NCT01138657|467779180|FG000|Overall Study|Adverse Event|3|||
129949819|NCT01138657|467779181|FG001|Overall Study|Adverse Event|10|||
129949820|NCT01138657|467779180|FG000|Overall Study|Lack of Efficacy|2|||
129949821|NCT01138657|467779181|FG001|Overall Study|Lack of Efficacy|1|||
129949822|NCT01138657|467779180|FG000|Overall Study|Lost to Follow-up|0|||
129949823|NCT01138657|467779181|FG001|Overall Study|Lost to Follow-up|3|||
129949824|NCT01138657|467779180|FG000|Overall Study|Miscellaneous Reasons|3|||
129949825|NCT01138657|467779181|FG001|Overall Study|Miscellaneous Reasons|4|||
129949826|NCT03875729|467779182|FG000|Overall Study|Adverse Event|0|||
129949827|NCT03875729|467779183|FG001|Overall Study|Adverse Event|5|||
129949828|NCT03875729|467779182|FG000|Overall Study|Withdrawal by Subject|8|||
129949829|NCT03875729|467779183|FG001|Overall Study|Withdrawal by Subject|11|||
129949830|NCT03875729|467779182|FG000|Overall Study|Pregnancy|0|||
129949831|NCT03875729|467779183|FG001|Overall Study|Pregnancy|1|||
129949832|NCT03875729|467779182|FG000|Overall Study|Lost to Follow-up|0|||
129949833|NCT03875729|467779183|FG001|Overall Study|Lost to Follow-up|5|||
129949834|NCT03875729|467779182|FG000|Overall Study|Personal reasons|2|||
129949835|NCT03875729|467779183|FG001|Overall Study|Personal reasons|0|||
129949836|NCT00529529|467779190|FG000|Overall Study|Adverse Event|12|||
129949837|NCT00529529|467779191|FG001|Overall Study|Adverse Event|17|||
129949838|NCT00529529|467779192|FG002|Overall Study|Adverse Event|8|||
129949839|NCT00529529|467779190|FG000|Overall Study|Subject withdrew consent|12|||
129949840|NCT00529529|467779191|FG001|Overall Study|Subject withdrew consent|9|||
129949841|NCT00529529|467779192|FG002|Overall Study|Subject withdrew consent|12|||
129949842|NCT00529529|467779190|FG000|Overall Study|Protocol deviation|8|||
129949843|NCT00529529|467779191|FG001|Overall Study|Protocol deviation|12|||
129949844|NCT00529529|467779192|FG002|Overall Study|Protocol deviation|5|||
129949845|NCT00529529|467779190|FG000|Overall Study|Lost to Follow-up|5|||
129949846|NCT00529529|467779191|FG001|Overall Study|Lost to Follow-up|3|||
129949847|NCT00529529|467779192|FG002|Overall Study|Lost to Follow-up|1|||
129949848|NCT00529529|467779190|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129949849|NCT00529529|467779191|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129949850|NCT00529529|467779192|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129949851|NCT00529529|467779190|FG000|Overall Study|Death|2|||
129949852|NCT00529529|467779191|FG001|Overall Study|Death|0|||
129949853|NCT00529529|467779192|FG002|Overall Study|Death|0|||
129949854|NCT00529529|467779190|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129949855|NCT00529529|467779191|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129949856|NCT00529529|467779192|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129949857|NCT00529529|467779190|FG000|Overall Study|Administrative problems|1|||
129949858|NCT00529529|467779191|FG001|Overall Study|Administrative problems|0|||
129949859|NCT00529529|467779192|FG002|Overall Study|Administrative problems|3|||
129949860|NCT00237809|467779195|FG000|Overall Study|Lost to Follow-up|11|||
129949861|NCT00237809|467779196|FG001|Overall Study|Lost to Follow-up|10|||
129949862|NCT00237809|467779197|FG002|Overall Study|Lost to Follow-up|9|||
129949863|NCT00237809|467779198|FG003|Overall Study|Lost to Follow-up|9|||
129949864|NCT02291549|467779201|FG000|Overall Study|Lost to Follow-up|1|||
129949865|NCT02291549|467779202|FG001|Overall Study|Lost to Follow-up|0|||
129949866|NCT02291549|467779201|FG000|Overall Study|Withdrawal by Subject|0|||
129949867|NCT02291549|467779202|FG001|Overall Study|Withdrawal by Subject|1|||
129949868|NCT02978716|467779204|FG000|Overall Study|Death|25|||
129949869|NCT02978716|467779205|FG001|Overall Study|Death|13|||
129949870|NCT02978716|467779206|FG002|Overall Study|Death|20|||
129949871|NCT02978716|467779204|FG000|Overall Study|Lost to Follow-up|0|||
129949872|NCT02978716|467779205|FG001|Overall Study|Lost to Follow-up|0|||
129949873|NCT02978716|467779206|FG002|Overall Study|Lost to Follow-up|1|||
129949874|NCT02978716|467779204|FG000|Overall Study|Withdrawal by Subject|6|||
129949875|NCT02978716|467779205|FG001|Overall Study|Withdrawal by Subject|4|||
129949876|NCT02978716|467779206|FG002|Overall Study|Withdrawal by Subject|5|||
129949877|NCT02978716|467779204|FG000|Overall Study|Sponsor terminated|2|||
129949878|NCT02978716|467779205|FG001|Overall Study|Sponsor terminated|13|||
129949879|NCT02978716|467779206|FG002|Overall Study|Sponsor terminated|9|||
129949880|NCT02978716|467779204|FG000|Overall Study|Other|1|||
129949881|NCT02978716|467779205|FG001|Overall Study|Other|3|||
129949882|NCT02978716|467779206|FG002|Overall Study|Other|0|||
129949883|NCT00960206|467779207|FG000|Overall Study|Death|7|||
129949884|NCT00960206|467779208|FG001|Overall Study|Death|4|||
129949885|NCT00960206|467779209|FG002|Overall Study|Death|1|||
129949886|NCT00960206|467779207|FG000|Overall Study|Unwilling/Unable to return|1|||
129949887|NCT00960206|467779208|FG001|Overall Study|Unwilling/Unable to return|2|||
129949888|NCT00960206|467779209|FG002|Overall Study|Unwilling/Unable to return|0|||
129949889|NCT00960206|467779207|FG000|Overall Study|Lost to Follow-up|8|||
129949890|NCT00960206|467779208|FG001|Overall Study|Lost to Follow-up|14|||
129949891|NCT00960206|467779209|FG002|Overall Study|Lost to Follow-up|8|||
129949892|NCT00960206|467779207|FG000|Overall Study|Withdrawal by Subject|2|||
129949893|NCT00960206|467779208|FG001|Overall Study|Withdrawal by Subject|4|||
129949894|NCT00960206|467779209|FG002|Overall Study|Withdrawal by Subject|0|||
129949895|NCT00960206|467779207|FG000|Overall Study|Revision of study component|2|||
129949896|NCT00960206|467779208|FG001|Overall Study|Revision of study component|2|||
129949897|NCT00960206|467779209|FG002|Overall Study|Revision of study component|2|||
129949898|NCT00960206|467779207|FG000|Overall Study|Missing 10 year data|20|||
129949899|NCT00960206|467779208|FG001|Overall Study|Missing 10 year data|1|||
129949900|NCT00960206|467779209|FG002|Overall Study|Missing 10 year data|1|||
129949901|NCT02470806|467779210|FG000|Overall Study|Lost to Follow-up|1|||
129949902|NCT02470806|467779211|FG001|Overall Study|Lost to Follow-up|1|||
129949903|NCT02470806|467779210|FG000|Overall Study|Adverse Event|5|||
129949904|NCT02470806|467779211|FG001|Overall Study|Adverse Event|2|||
129949905|NCT02470806|467779210|FG000|Overall Study|Protocol Violation|4|||
129949906|NCT02470806|467779211|FG001|Overall Study|Protocol Violation|11|||
129949907|NCT02470806|467779210|FG000|Overall Study|Physician Decision|0|||
129949908|NCT02470806|467779211|FG001|Overall Study|Physician Decision|3|||
129949909|NCT02470806|467779210|FG000|Overall Study|Withdrawal by Subject|3|||
129949910|NCT02470806|467779211|FG001|Overall Study|Withdrawal by Subject|10|||
129949911|NCT02470806|467779210|FG000|Overall Study|Lack of Efficacy|5|||
129949912|NCT02470806|467779211|FG001|Overall Study|Lack of Efficacy|15|||
129949913|NCT03075878|467779215|FG000|Overall Study|Physician Decision|1|||
129949914|NCT00853957|467779220|FG000|Overall Study|Adverse Event|9|||
129949915|NCT00853957|467779221|FG001|Overall Study|Adverse Event|3|||
129949916|NCT00853957|467779220|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129949917|NCT00853957|467779221|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129949918|NCT00853957|467779220|FG000|Overall Study|Subject withdrew consent|4|||
129949919|NCT00853957|467779221|FG001|Overall Study|Subject withdrew consent|5|||
129949920|NCT00853957|467779220|FG000|Overall Study|Lost to Follow-up|1|||
129949921|NCT00853957|467779221|FG001|Overall Study|Lost to Follow-up|6|||
129949922|NCT00853957|467779220|FG000|Overall Study|Protocol deviation|0|||
129949923|NCT00853957|467779221|FG001|Overall Study|Protocol deviation|3|||
129949924|NCT02158806|467779222|FG000|Overall Study|Death|2|||
129949925|NCT02158806|467779223|FG001|Overall Study|Death|0|||
129949926|NCT02158806|467779222|FG000|Overall Study|Withdrawal by Subject|2|||
129949927|NCT02158806|467779223|FG001|Overall Study|Withdrawal by Subject|0|||
129949928|NCT02158806|467779222|FG000|Overall Study|Lost to Follow-up|0|||
129949929|NCT02158806|467779223|FG001|Overall Study|Lost to Follow-up|3|||
129949930|NCT02158806|467779222|FG000|Overall Study|Moved out of area|0|||
129949931|NCT02158806|467779223|FG001|Overall Study|Moved out of area|1|||
129949932|NCT02158806|467779222|FG000|Overall Study|Transferred to palliative care|0|||
129949933|NCT02158806|467779223|FG001|Overall Study|Transferred to palliative care|1|||
129949934|NCT03070301|467779224|FG000|Overall Study|Progression of disease|16|||
129949935|NCT03070301|467779224|FG000|Overall Study|Physician Decision|3|||
129949936|NCT03070301|467779224|FG000|Overall Study|Withdrawal by Subject|1|||
129949937|NCT04520256|467779228|FG000|Overall Study|Lost to Follow-up|6|||
129949938|NCT04520256|467779229|FG001|Overall Study|Lost to Follow-up|4|||
129949939|NCT04520256|467779230|FG002|Overall Study|Lost to Follow-up|2|||
129949940|NCT04520256|467779231|FG003|Overall Study|Lost to Follow-up|3|||
129949941|NCT04520256|467779232|FG004|Overall Study|Lost to Follow-up|6|||
129949942|NCT04520256|467779233|FG005|Overall Study|Lost to Follow-up|6|||
129949943|NCT04520256|467779234|FG006|Overall Study|Lost to Follow-up|4|||
129949944|NCT04520256|467779235|FG007|Overall Study|Lost to Follow-up|6|||
129949945|NCT04520256|467779236|FG008|Overall Study|Lost to Follow-up|1|||
129949946|NCT04520256|467779237|FG009|Overall Study|Lost to Follow-up|3|||
129949947|NCT04520256|467779238|FG010|Overall Study|Lost to Follow-up|3|||
129949948|NCT04520256|467779239|FG011|Overall Study|Lost to Follow-up|2|||
129949949|NCT04520256|467779240|FG012|Overall Study|Lost to Follow-up|5|||
129949950|NCT04520256|467779241|FG013|Overall Study|Lost to Follow-up|3|||
129949951|NCT04520256|467779242|FG014|Overall Study|Lost to Follow-up|3|||
129949952|NCT04520256|467779243|FG015|Overall Study|Lost to Follow-up|6|||
129949953|NCT04520256|467779244|FG016|Overall Study|Lost to Follow-up|6|||
129949954|NCT04520256|467779245|FG017|Overall Study|Lost to Follow-up|4|||
129949955|NCT04520256|467779246|FG018|Overall Study|Lost to Follow-up|3|||
129949956|NCT04520256|467779247|FG019|Overall Study|Lost to Follow-up|3|||
129949957|NCT04520256|467779248|FG020|Overall Study|Lost to Follow-up|7|||
129949958|NCT04520256|467779249|FG021|Overall Study|Lost to Follow-up|3|||
129949959|NCT04520256|467779250|FG022|Overall Study|Lost to Follow-up|3|||
129949960|NCT04520256|467779251|FG023|Overall Study|Lost to Follow-up|8|||
129949961|NCT04520256|467779252|FG024|Overall Study|Lost to Follow-up|5|||
129949962|NCT04520256|467779253|FG025|Overall Study|Lost to Follow-up|4|||
129949963|NCT04520256|467779254|FG026|Overall Study|Lost to Follow-up|3|||
129949964|NCT04520256|467779255|FG027|Overall Study|Lost to Follow-up|4|||
129949965|NCT04520256|467779256|FG028|Overall Study|Lost to Follow-up|3|||
129949966|NCT04520256|467779257|FG029|Overall Study|Lost to Follow-up|4|||
129949967|NCT04520256|467779258|FG030|Overall Study|Lost to Follow-up|4|||
129949968|NCT04520256|467779259|FG031|Overall Study|Lost to Follow-up|4|||
129949969|NCT02880293|467781015|FG000|Overall Study|Inevaluable|5|||
129949970|NCT00451906|467781024|FG000|Overall Study|Adverse Event|515|||
129949971|NCT00451906|467781024|FG000|Overall Study|Lost to Follow-up|31|||
129949972|NCT00451906|467781024|FG000|Overall Study|Withdrawal by Subject|111|||
129949973|NCT00451906|467781024|FG000|Overall Study|Protocol Violation|21|||
129949974|NCT00451906|467781024|FG000|Overall Study|Progressive disease|1328|||
129949975|NCT00451906|467781024|FG000|Overall Study|Termination of the study|108|||
129949976|NCT00451906|467781024|FG000|Overall Study|Other Reasons|121|||
129949977|NCT00451906|467781024|FG000|Overall Study|Did not complete final visit|4|||
129949978|NCT03072238|467781029|FG000|Overall Study|Withdrawal by Subject|44|||
129949979|NCT03072238|467781030|FG001|Overall Study|Withdrawal by Subject|64|||
129949980|NCT03072238|467781029|FG000|Overall Study|Lost to Follow-up|14|||
129949981|NCT03072238|467781030|FG001|Overall Study|Lost to Follow-up|5|||
129949982|NCT03072238|467781029|FG000|Overall Study|Physician Decision|4|||
129949983|NCT03072238|467781030|FG001|Overall Study|Physician Decision|6|||
129949984|NCT03072238|467781029|FG000|Overall Study|Death|351|||
129949985|NCT03072238|467781030|FG001|Overall Study|Death|318|||
129949986|NCT03072238|467781029|FG000|Overall Study|Progressive Disease|3|||
129949987|NCT03072238|467781030|FG001|Overall Study|Progressive Disease|4|||
129949988|NCT03072238|467781029|FG000|Overall Study|Reason Not Specified|138|||
129949989|NCT03072238|467781030|FG001|Overall Study|Reason Not Specified|150|||
129949990|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
129949991|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
129949992|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
129949993|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
129949994|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
129949995|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
129949996|NCT01863368|467781036|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
129949997|NCT01863368|467781037|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
129949998|NCT01863368|467781036|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
129949999|NCT01863368|467781037|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
129950000|NCT01863368|467781036|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
129950001|NCT01863368|467781037|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
129950002|NCT00307489|467781038|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
129950003|NCT00307489|467781039|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
129950004|NCT00307489|467781038|FG000|Baseline Through Week 48|Physician Decision|1|||
129950005|NCT00307489|467781039|FG001|Baseline Through Week 48|Physician Decision|0|||
129950006|NCT00307489|467781038|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
129950007|NCT00307489|467781039|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
129950008|NCT00307489|467781038|FG000|Week 48 Through Week 168|Adverse Event|1|||
129950009|NCT00307489|467781039|FG001|Week 48 Through Week 168|Adverse Event|0|||
129950010|NCT00307489|467781038|FG000|Week 48 Through Week 168|Physician Decision|1|||
129950011|NCT00307489|467781039|FG001|Week 48 Through Week 168|Physician Decision|0|||
129950012|NCT00307489|467781038|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
129950013|NCT00307489|467781039|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
129950014|NCT00307489|467781038|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
129950015|NCT00307489|467781039|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
129950016|NCT00307489|467781038|FG000|Week 48 Through Week 168|Death|0|||
129950017|NCT00307489|467781039|FG001|Week 48 Through Week 168|Death|1|||
129950018|NCT00307489|467781038|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
129950019|NCT00307489|467781039|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
129950020|NCT00307489|467781038|FG000|Week 48 Through Week 168|Seroconversion|1|||
129950021|NCT00307489|467781039|FG001|Week 48 Through Week 168|Seroconversion|0|||
129950022|NCT02165202|467781040|FG000|Oral Phase|Refused further participation|5|||
129950023|NCT02165202|467781041|FG001|Oral Phase|Refused further participation|1|||
129950024|NCT02165202|467781040|FG000|Oral Phase|Study product Related Toxicity|1|||
129950025|NCT02165202|467781041|FG001|Oral Phase|Study product Related Toxicity|0|||
129950026|NCT02165202|467781040|FG000|Oral Phase|Unable to contact Participant|1|||
129950027|NCT02165202|467781041|FG001|Oral Phase|Unable to contact Participant|1|||
129950028|NCT02165202|467781040|FG000|Oral Phase|Clinical reasons|1|||
129950029|NCT02165202|467781041|FG001|Oral Phase|Clinical reasons|0|||
129950030|NCT02165202|467781040|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
129950031|NCT02165202|467781041|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
129950032|NCT02165202|467781040|FG000|Oral Phase|CMC advised termination|1|||
129950033|NCT02165202|467781041|FG001|Oral Phase|CMC advised termination|0|||
129950034|NCT02165202|467781040|FG000|Oral Phase|Relocated, no follow-up planned|1|||
129950035|NCT02165202|467781041|FG001|Oral Phase|Relocated, no follow-up planned|0|||
129950036|NCT02165202|467781040|FG000|Oral Phase|Abnormal EKG|0|||
129950037|NCT02165202|467781041|FG001|Oral Phase|Abnormal EKG|1|||
129950038|NCT02165202|467781040|FG000|Injection Phase|Abnormal Lab Value|5|||
129950039|NCT02165202|467781041|FG001|Injection Phase|Abnormal Lab Value|1|||
129950040|NCT02165202|467781040|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
129950041|NCT02165202|467781041|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
129950042|NCT02165202|467781040|FG000|Injection Phase|Unable to attend within Visit Window|1|||
129950043|NCT02165202|467781041|FG001|Injection Phase|Unable to attend within Visit Window|0|||
129950044|NCT02165202|467781040|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
129950045|NCT02165202|467781041|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
129950046|NCT02165202|467781040|FG000|Injection Phase|End of Study|2|||
129950047|NCT02165202|467781041|FG001|Injection Phase|End of Study|1|||
129950048|NCT02165202|467781040|FG000|Injection Phase|Study Product related Toxicity|1|||
129950049|NCT02165202|467781041|FG001|Injection Phase|Study Product related Toxicity|0|||
129950050|NCT02165202|467781040|FG000|Injection Phase|No longer interested|0|||
129950051|NCT02165202|467781041|FG001|Injection Phase|No longer interested|1|||
129950052|NCT02165202|467781040|FG000|Injection Phase|Participant unwilling to comply|1|||
129950053|NCT02165202|467781041|FG001|Injection Phase|Participant unwilling to comply|0|||
129950054|NCT01072149|467781047|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950055|NCT01072149|467781048|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950056|NCT01072149|467781049|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
129950057|NCT01072149|467781050|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950058|NCT01072149|467781051|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950059|NCT01072149|467781052|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950060|NCT01072149|467781053|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950061|NCT01072149|467781054|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950062|NCT01072149|467781055|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950063|NCT01072149|467781056|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950064|NCT01072149|467781057|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950065|NCT01072149|467781058|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950066|NCT01072149|467781059|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950067|NCT01072149|467781060|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950068|NCT01072149|467781061|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950069|NCT01072149|467781062|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950070|NCT01072149|467781063|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950071|NCT01072149|467781064|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
129950072|NCT01072149|467781047|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950073|NCT01072149|467781048|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950074|NCT01072149|467781049|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950075|NCT01072149|467781050|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950076|NCT01072149|467781051|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950077|NCT01072149|467781052|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950078|NCT01072149|467781053|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950079|NCT01072149|467781054|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950080|NCT01072149|467781055|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950081|NCT01072149|467781056|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950082|NCT01072149|467781057|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950083|NCT01072149|467781058|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950084|NCT01072149|467781059|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950085|NCT01072149|467781060|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950086|NCT01072149|467781061|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950087|NCT01072149|467781062|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950088|NCT01072149|467781063|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
129950089|NCT01072149|467781064|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
129950090|NCT01072149|467781047|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950091|NCT01072149|467781048|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950092|NCT01072149|467781049|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950093|NCT01072149|467781050|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950094|NCT01072149|467781051|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950095|NCT01072149|467781052|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950096|NCT01072149|467781053|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950097|NCT01072149|467781054|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950098|NCT01072149|467781055|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950099|NCT01072149|467781056|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950100|NCT01072149|467781057|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
129950101|NCT01072149|467781058|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950102|NCT01072149|467781059|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950103|NCT01072149|467781060|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950104|NCT01072149|467781061|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950105|NCT01072149|467781062|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950106|NCT01072149|467781063|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950107|NCT01072149|467781064|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
129950108|NCT01072149|467781047|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950109|NCT01072149|467781048|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
129950110|NCT01072149|467781049|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950111|NCT01072149|467781050|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950112|NCT01072149|467781051|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950113|NCT01072149|467781052|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950114|NCT01072149|467781053|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950115|NCT01072149|467781054|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950116|NCT01072149|467781055|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950117|NCT01072149|467781056|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950118|NCT01072149|467781057|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950119|NCT01072149|467781058|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950120|NCT01072149|467781059|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950121|NCT01072149|467781060|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950122|NCT01072149|467781061|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950123|NCT01072149|467781062|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950124|NCT01072149|467781063|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950125|NCT01072149|467781064|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
129950126|NCT01072149|467781047|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950127|NCT01072149|467781048|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950128|NCT01072149|467781049|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
129950129|NCT01072149|467781050|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950130|NCT01072149|467781051|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950131|NCT01072149|467781052|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950132|NCT01072149|467781053|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950133|NCT01072149|467781054|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950134|NCT01072149|467781055|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950135|NCT01072149|467781056|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950136|NCT01072149|467781057|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950137|NCT01072149|467781058|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950138|NCT01072149|467781059|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950139|NCT01072149|467781060|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950140|NCT01072149|467781061|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950141|NCT01072149|467781062|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950142|NCT01072149|467781063|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950143|NCT01072149|467781064|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
129950144|NCT01072149|467781047|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950145|NCT01072149|467781048|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950146|NCT01072149|467781049|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950147|NCT01072149|467781050|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950148|NCT01072149|467781051|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950149|NCT01072149|467781052|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950150|NCT01072149|467781053|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950151|NCT01072149|467781054|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
129950152|NCT01072149|467781055|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950153|NCT01072149|467781056|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950154|NCT01072149|467781057|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950155|NCT01072149|467781058|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950156|NCT01072149|467781059|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950157|NCT01072149|467781060|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950158|NCT01072149|467781061|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950159|NCT01072149|467781062|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950160|NCT01072149|467781063|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950161|NCT01072149|467781064|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
129950162|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
129950163|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
129950164|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
129950165|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
129950166|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
129950167|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
129950168|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
129950169|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
129950170|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
129950171|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
129950172|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
129950173|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
129950174|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
129950175|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
129950176|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
129950177|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
129950178|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
129950179|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
129950180|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950181|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950182|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950183|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950184|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950185|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950186|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950187|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950188|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950189|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950190|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950191|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950192|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950193|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950194|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950195|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
129950196|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950197|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
129950198|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
129950199|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
129950200|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
129950201|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
129950202|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
129950203|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
129950204|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
129950205|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
129950206|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
129950207|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
129950208|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
129950209|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
129950210|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
129950211|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
129950212|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
129950213|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
129950214|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
129950215|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
129950216|NCT01072149|467781047|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950217|NCT01072149|467781048|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950218|NCT01072149|467781049|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950219|NCT01072149|467781050|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950220|NCT01072149|467781051|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950221|NCT01072149|467781052|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950222|NCT01072149|467781053|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950223|NCT01072149|467781054|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950224|NCT01072149|467781055|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950225|NCT01072149|467781056|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950226|NCT01072149|467781057|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950227|NCT01072149|467781058|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950228|NCT01072149|467781059|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
129950229|NCT01072149|467781060|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950230|NCT01072149|467781061|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950231|NCT01072149|467781062|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950232|NCT01072149|467781063|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950233|NCT01072149|467781064|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
129950234|NCT01072149|467781047|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950235|NCT01072149|467781048|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950236|NCT01072149|467781049|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
129950237|NCT01072149|467781050|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950238|NCT01072149|467781051|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950239|NCT01072149|467781052|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950240|NCT01072149|467781053|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950241|NCT01072149|467781054|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950242|NCT01072149|467781055|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950243|NCT01072149|467781056|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950244|NCT01072149|467781057|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950245|NCT01072149|467781058|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950246|NCT01072149|467781059|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950247|NCT01072149|467781060|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
129950248|NCT01072149|467781061|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950249|NCT01072149|467781062|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950250|NCT01072149|467781063|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950251|NCT01072149|467781064|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
129950252|NCT00080119|467781065|FG000|Overall Study|Discontinued because of study closure|0|||
129950253|NCT00080119|467781066|FG001|Overall Study|Discontinued because of study closure|0|||
129950254|NCT00080119|467781067|FG002|Overall Study|Discontinued because of study closure|130|||
129950255|NCT00080119|467781068|FG003|Overall Study|Discontinued because of study closure|141|||
129950256|NCT00080119|467781065|FG000|Overall Study|Unable to get to clinic|24|||
129950257|NCT00080119|467781066|FG001|Overall Study|Unable to get to clinic|24|||
129950258|NCT00080119|467781067|FG002|Overall Study|Unable to get to clinic|7|||
129950259|NCT00080119|467781068|FG003|Overall Study|Unable to get to clinic|1|||
129950260|NCT00080119|467781065|FG000|Overall Study|Consent withdrawn|13|||
129950261|NCT00080119|467781066|FG001|Overall Study|Consent withdrawn|17|||
129950262|NCT00080119|467781067|FG002|Overall Study|Consent withdrawn|4|||
129950263|NCT00080119|467781068|FG003|Overall Study|Consent withdrawn|6|||
129950264|NCT00080119|467781065|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
129950265|NCT00080119|467781066|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
129950266|NCT00080119|467781067|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
129950267|NCT00080119|467781068|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
129950268|NCT00080119|467781065|FG000|Overall Study|Lost to Follow-up|16|||
129950269|NCT00080119|467781066|FG001|Overall Study|Lost to Follow-up|19|||
129950270|NCT00080119|467781067|FG002|Overall Study|Lost to Follow-up|19|||
129950271|NCT00080119|467781068|FG003|Overall Study|Lost to Follow-up|14|||
129950272|NCT01919489|467781069|FG000|Overall Study|Rejected the need of injections|4|||
129950273|NCT01919489|467781070|FG001|Overall Study|Rejected the need of injections|7|||
129950274|NCT01919489|467781069|FG000|Overall Study|Adverse Event|10|||
129950275|NCT01919489|467781070|FG001|Overall Study|Adverse Event|0|||
129950276|NCT01919489|467781069|FG000|Overall Study|Hospital readmission|2|||
129950277|NCT01919489|467781070|FG001|Overall Study|Hospital readmission|9|||
129950278|NCT01919489|467781069|FG000|Overall Study|Death|2|||
129950279|NCT01919489|467781070|FG001|Overall Study|Death|1|||
129950280|NCT01919489|467781069|FG000|Overall Study|Lost to Follow-up|38|||
129950281|NCT01919489|467781070|FG001|Overall Study|Lost to Follow-up|27|||
129950282|NCT00871494|467781072|FG000|Overall Study|Protocol Violation|5|||
129950283|NCT00871494|467781072|FG000|Overall Study|Lack of Efficacy|4|||
129950284|NCT00871494|467781072|FG000|Overall Study|Adverse Event|4|||
129950285|NCT00871494|467781072|FG000|Overall Study|Lost to Follow-up|1|||
129950286|NCT01133678|467781077|FG000|Overall Study|Death|1|||
129950287|NCT01133678|467781078|FG001|Overall Study|Death|1|||
129950288|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
129950289|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950290|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950291|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950292|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
129950293|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Adverse Event|0|||
129950294|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Adverse Event|1|||
129950295|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Adverse Event|1|||
129950296|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Adverse Event|0|||
129950297|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Adverse Event|0|||
129950298|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
129950299|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950300|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950301|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950302|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
129950303|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Physician Decision|1|||
129950304|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Physician Decision|0|||
129950305|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Physician Decision|0|||
129950306|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Physician Decision|0|||
129950307|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Physician Decision|0|||
129950308|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
129950309|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
129950310|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
129950311|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
129950312|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
129950313|NCT00446095|467781079|FG000|Phase II (8 Weeks)|Ongoing|0|||
129950314|NCT00446095|467781080|FG001|Phase II (8 Weeks)|Ongoing|0|||
129950315|NCT00446095|467781081|FG002|Phase II (8 Weeks)|Ongoing|1|||
129950316|NCT00446095|467781082|FG003|Phase II (8 Weeks)|Ongoing|0|||
129950317|NCT00446095|467781083|FG004|Phase II (8 Weeks)|Ongoing|0|||
129950318|NCT00446095|467781079|FG000|Phase I (28 Days)|Adverse Event|0|||
129950319|NCT00446095|467781080|FG001|Phase I (28 Days)|Adverse Event|0|||
129950320|NCT00446095|467781081|FG002|Phase I (28 Days)|Adverse Event|0|||
129950321|NCT00446095|467781082|FG003|Phase I (28 Days)|Adverse Event|1|||
129950322|NCT00446095|467781083|FG004|Phase I (28 Days)|Adverse Event|0|||
129950323|NCT00446095|467781079|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
129950324|NCT00446095|467781080|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
129950325|NCT00446095|467781081|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
129950326|NCT00446095|467781082|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
129950327|NCT00446095|467781083|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
129950328|NCT02574286|467781084|FG000|Overall Study|Adverse Event|3|||
129950329|NCT02574286|467781084|FG000|Overall Study|Withdrawal by Subject|2|||
129950330|NCT02764320|467781085|FG000|Overall Study|Withdrawal by Subject|35|||
129950331|NCT02764320|467781086|FG001|Overall Study|Withdrawal by Subject|38|||
129950332|NCT02764320|467781085|FG000|Overall Study|Protocol Violation|11|||
129950333|NCT02764320|467781086|FG001|Overall Study|Protocol Violation|6|||
129950334|NCT02764320|467781085|FG000|Overall Study|Adverse Event|2|||
129950335|NCT02764320|467781086|FG001|Overall Study|Adverse Event|0|||
129950336|NCT02764320|467781085|FG000|Overall Study|Health Issues unable to continue|2|||
129950337|NCT02764320|467781086|FG001|Overall Study|Health Issues unable to continue|0|||
129950338|NCT02764320|467781085|FG000|Overall Study|Did not meet inclusion criteria|1|||
129453513|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
129453514|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
129453515|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
129453516|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
129453517|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
129453518|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
129453519|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
129453520|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
129950339|NCT02764320|467781086|FG001|Overall Study|Did not meet inclusion criteria|0|||
129950340|NCT02764320|467781085|FG000|Overall Study|Subject moved|0|||
129950341|NCT02764320|467781086|FG001|Overall Study|Subject moved|2|||
129950342|NCT02764320|467781085|FG000|Overall Study|Overused medication unavailable|0|||
129950343|NCT02764320|467781086|FG001|Overall Study|Overused medication unavailable|1|||
129950344|NCT02764320|467781085|FG000|Overall Study|Seeking care outside site|0|||
129950345|NCT02764320|467781086|FG001|Overall Study|Seeking care outside site|1|||
129950346|NCT02764320|467781085|FG000|Overall Study|Technology barriers|0|||
129950347|NCT02764320|467781086|FG001|Overall Study|Technology barriers|1|||
129950348|NCT01280656|467781087|FG000|Overall Study|Adverse Event|1|||
129950349|NCT01280656|467781088|FG001|Overall Study|Adverse Event|14|||
129950350|NCT01280656|467781089|FG002|Overall Study|Adverse Event|13|||
129950351|NCT01280656|467781087|FG000|Overall Study|Lack of Efficacy|1|||
129950352|NCT01280656|467781088|FG001|Overall Study|Lack of Efficacy|22|||
129950353|NCT01280656|467781089|FG002|Overall Study|Lack of Efficacy|38|||
129950354|NCT01280656|467781087|FG000|Overall Study|Treatment shortening (RGT)|0|||
129950355|NCT01280656|467781088|FG001|Overall Study|Treatment shortening (RGT)|4|||
129950356|NCT01280656|467781089|FG002|Overall Study|Treatment shortening (RGT)|5|||
129950357|NCT01280656|467781087|FG000|Overall Study|Other|1|||
129950358|NCT01280656|467781088|FG001|Overall Study|Other|7|||
129950359|NCT01280656|467781089|FG002|Overall Study|Other|7|||
129950360|NCT01405508|467781090|FG000|Overall Study|AE, non-serious non-fatal|1|||
129453521|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
129950361|NCT01405508|467781091|FG001|Overall Study|AE, non-serious non-fatal|1|||
129950362|NCT01405508|467781092|FG002|Overall Study|AE, non-serious non-fatal|0|||
129950363|NCT01405508|467781093|FG003|Overall Study|AE, non-serious non-fatal|0|||
129950364|NCT00476957|467781094|FG000|Overall Study|Lost to Follow-up|176|||
129950365|NCT00476957|467781095|FG001|Overall Study|Lost to Follow-up|193|||
129950366|NCT02159352|467781096|FG000|Overall Study|Adverse Event|3|||
129950367|NCT02159352|467781097|FG001|Overall Study|Adverse Event|1|||
129950368|NCT02159352|467781096|FG000|Overall Study|Withdrawal by Subject|0|||
129950369|NCT02159352|467781097|FG001|Overall Study|Withdrawal by Subject|1|||
129950370|NCT01916109|467781102|FG000|Overall Study|Withdrawal by Subject|1|||
129950371|NCT00636168|467781103|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
129950372|NCT00636168|467781104|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
129950373|NCT00636168|467781103|FG000|Randomized to Study Drug|Adverse Event|1|||
129950374|NCT00636168|467781104|FG001|Randomized to Study Drug|Adverse Event|0|||
129950375|NCT00636168|467781103|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
129950376|NCT00636168|467781104|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
129950377|NCT00636168|467781103|FG000|Treated With Study Drug|Recurrence of disease|135|||
129950378|NCT00636168|467781104|FG001|Treated With Study Drug|Recurrence of disease|282|||
129950379|NCT00636168|467781103|FG000|Treated With Study Drug|Adverse Event|250|||
129950380|NCT00636168|467781104|FG001|Treated With Study Drug|Adverse Event|22|||
129950381|NCT00636168|467781103|FG000|Treated With Study Drug|Participant withdrew consent|16|||
129950382|NCT00636168|467781104|FG001|Treated With Study Drug|Participant withdrew consent|21|||
129950383|NCT00636168|467781103|FG000|Treated With Study Drug|Poor/non-compliance|1|||
129950384|NCT00636168|467781104|FG001|Treated With Study Drug|Poor/non-compliance|3|||
129950385|NCT00636168|467781103|FG000|Treated With Study Drug|Death|3|||
129950386|NCT00636168|467781104|FG001|Treated With Study Drug|Death|0|||
129950387|NCT00636168|467781103|FG000|Treated With Study Drug|Pregnancy|1|||
129950388|NCT00636168|467781104|FG001|Treated With Study Drug|Pregnancy|0|||
129950389|NCT00636168|467781103|FG000|Treated With Study Drug|No longer meets study criteria|1|||
129950390|NCT00636168|467781104|FG001|Treated With Study Drug|No longer meets study criteria|0|||
129950391|NCT00636168|467781103|FG000|Treated With Study Drug|Other reason|1|||
129950392|NCT00636168|467781104|FG001|Treated With Study Drug|Other reason|3|||
129950393|NCT00636168|467781103|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
129950394|NCT00636168|467781104|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
129950395|NCT00636168|467781103|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
129950396|NCT00636168|467781104|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
129950397|NCT00636168|467781103|FG000|Long Term Follow-Up|Death|8|||
129950398|NCT00636168|467781104|FG001|Long Term Follow-Up|Death|9|||
129950399|NCT02707952|467781105|FG000|Overall Study|Adverse Event|1|||
129950400|NCT02707952|467781106|FG001|Overall Study|Adverse Event|0|||
129950401|NCT02707952|467781107|FG002|Overall Study|Adverse Event|0|||
129950402|NCT02707952|467781108|FG003|Overall Study|Adverse Event|0|||
129950403|NCT02707952|467781105|FG000|Overall Study|Lost to Follow-up|1|||
129950404|NCT02707952|467781106|FG001|Overall Study|Lost to Follow-up|0|||
129950405|NCT02707952|467781107|FG002|Overall Study|Lost to Follow-up|0|||
129950406|NCT02707952|467781108|FG003|Overall Study|Lost to Follow-up|0|||
129950407|NCT02707952|467781105|FG000|Overall Study|Withdrawal by Subject|0|||
129950408|NCT02707952|467781106|FG001|Overall Study|Withdrawal by Subject|1|||
129950409|NCT02707952|467781107|FG002|Overall Study|Withdrawal by Subject|2|||
129950410|NCT02707952|467781108|FG003|Overall Study|Withdrawal by Subject|0|||
129950411|NCT02006641|467781109|FG000|Overall Study|Withdrawal before treatment|2|||
129950412|NCT02006641|467781110|FG001|Overall Study|Withdrawal before treatment|5|||
129950413|NCT02006641|467781111|FG002|Overall Study|Withdrawal before treatment|3|||
129950414|NCT02006641|467781109|FG000|Overall Study|Adverse Event|15|||
129950415|NCT02006641|467781110|FG001|Overall Study|Adverse Event|11|||
129950416|NCT02006641|467781111|FG002|Overall Study|Adverse Event|15|||
129950417|NCT02006641|467781109|FG000|Overall Study|Protocol Violation|0|||
129950418|NCT02006641|467781110|FG001|Overall Study|Protocol Violation|2|||
129950419|NCT02006641|467781111|FG002|Overall Study|Protocol Violation|2|||
129950420|NCT02006641|467781109|FG000|Overall Study|Lost to Follow-up|0|||
129950421|NCT02006641|467781110|FG001|Overall Study|Lost to Follow-up|1|||
129950422|NCT02006641|467781111|FG002|Overall Study|Lost to Follow-up|0|||
129950423|NCT02006641|467781109|FG000|Overall Study|Withdrawal by Subject|7|||
129950424|NCT02006641|467781110|FG001|Overall Study|Withdrawal by Subject|12|||
129950425|NCT02006641|467781111|FG002|Overall Study|Withdrawal by Subject|11|||
129950426|NCT02006641|467781109|FG000|Overall Study|Other reason: patient didn't show up|1|||
129950427|NCT02006641|467781110|FG001|Overall Study|Other reason: patient didn't show up|0|||
129950428|NCT02006641|467781111|FG002|Overall Study|Other reason: patient didn't show up|0|||
129950429|NCT02006641|467781109|FG000|Overall Study|Other reason:patient didn't want to come|0|||
129950430|NCT02006641|467781110|FG001|Overall Study|Other reason:patient didn't want to come|0|||
129950431|NCT02006641|467781111|FG002|Overall Study|Other reason:patient didn't want to come|1|||
129950432|NCT02006641|467781109|FG000|Overall Study|Other reason: patient has moved|1|||
129950433|NCT02006641|467781110|FG001|Overall Study|Other reason: patient has moved|0|||
129950434|NCT02006641|467781111|FG002|Overall Study|Other reason: patient has moved|1|||
129950435|NCT02006641|467781109|FG000|Overall Study|Other reason: caregiver in hospital|0|||
129950436|NCT02006641|467781110|FG001|Overall Study|Other reason: caregiver in hospital|1|||
129950437|NCT02006641|467781111|FG002|Overall Study|Other reason: caregiver in hospital|0|||
129950438|NCT02006641|467781109|FG000|Overall Study|Other reason: patient's wife has died|0|||
129950439|NCT02006641|467781110|FG001|Overall Study|Other reason: patient's wife has died|0|||
129950440|NCT02006641|467781111|FG002|Overall Study|Other reason: patient's wife has died|1|||
129950441|NCT02006641|467781109|FG000|Overall Study|Other reason: hospitalisation|0|||
129950442|NCT02006641|467781110|FG001|Overall Study|Other reason: hospitalisation|1|||
129950443|NCT02006641|467781111|FG002|Overall Study|Other reason: hospitalisation|0|||
129950444|NCT02006641|467781109|FG000|Overall Study|Other reason: caregiver impossibility|0|||
129453522|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
129453523|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
129453524|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
129453525|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
129453526|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
129950445|NCT02006641|467781110|FG001|Overall Study|Other reason: caregiver impossibility|0|||
129950446|NCT02006641|467781111|FG002|Overall Study|Other reason: caregiver impossibility|1|||
129950447|NCT02006641|467781109|FG000|Overall Study|Other reason: protocol non-compliance|0|||
129950448|NCT02006641|467781110|FG001|Overall Study|Other reason: protocol non-compliance|0|||
129950449|NCT02006641|467781111|FG002|Overall Study|Other reason: protocol non-compliance|1|||
129950450|NCT01287832|467781112|FG000|Overall Study|Adverse Event|1|||
129950451|NCT01287832|467781113|FG001|Overall Study|Adverse Event|0|||
129950452|NCT01287832|467781112|FG000|Overall Study|Death|0|||
129950453|NCT01287832|467781113|FG001|Overall Study|Death|1|||
129950454|NCT04749797|467781115|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
129950455|NCT04749797|467781116|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
129950456|NCT04749797|467781117|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
129950457|NCT01441596|467781118|FG000|Overall Study|Other reason not defined below|0|||
129950458|NCT01441596|467781119|FG001|Overall Study|Other reason not defined below|2|||
129950459|NCT01441596|467781120|FG002|Overall Study|Other reason not defined below|1|||
129950460|NCT01441596|467781118|FG000|Overall Study|Withdrawal by Subject|4|||
129950461|NCT01441596|467781119|FG001|Overall Study|Withdrawal by Subject|0|||
129950462|NCT01441596|467781120|FG002|Overall Study|Withdrawal by Subject|2|||
129950463|NCT01441596|467781118|FG000|Overall Study|Not treated|0|||
129950464|NCT01441596|467781119|FG001|Overall Study|Not treated|1|||
129950465|NCT01441596|467781120|FG002|Overall Study|Not treated|1|||
129950466|NCT00871715|467781123|FG000|Overall Study|Withdrawal by Subject|6|||
129950467|NCT00871715|467781124|FG001|Overall Study|Withdrawal by Subject|10|||
129950468|NCT00871715|467781125|FG002|Overall Study|Withdrawal by Subject|15|||
129950469|NCT00871715|467781123|FG000|Overall Study|Physician Decision|6|||
129950470|NCT00871715|467781124|FG001|Overall Study|Physician Decision|0|||
129950471|NCT00871715|467781125|FG002|Overall Study|Physician Decision|2|||
129950472|NCT00871715|467781123|FG000|Overall Study|Lost to Follow-up|3|||
129950473|NCT00871715|467781124|FG001|Overall Study|Lost to Follow-up|6|||
129950474|NCT00871715|467781125|FG002|Overall Study|Lost to Follow-up|9|||
129950475|NCT03015220|467781128|FG000|Overall Study|Withdrawal by Subject|3|||
129950476|NCT03015220|467781129|FG001|Overall Study|Withdrawal by Subject|2|||
129950477|NCT03015220|467781130|FG002|Overall Study|Withdrawal by Subject|2|||
129950478|NCT03015220|467781131|FG003|Overall Study|Withdrawal by Subject|2|||
129950479|NCT03015220|467781128|FG000|Overall Study|Lost to Follow-up|0|||
129950480|NCT03015220|467781129|FG001|Overall Study|Lost to Follow-up|0|||
129950481|NCT03015220|467781130|FG002|Overall Study|Lost to Follow-up|1|||
129950482|NCT03015220|467781131|FG003|Overall Study|Lost to Follow-up|0|||
129950483|NCT01670526|467781133|FG000|Overall Study|Withdrawal by Subject|3|||
129950484|NCT01670526|467781134|FG001|Overall Study|Withdrawal by Subject|1|||
129950485|NCT01670526|467781133|FG000|Overall Study|Lost to Follow-up|9|||
129950486|NCT01670526|467781134|FG001|Overall Study|Lost to Follow-up|5|||
129950487|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
129950488|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
129950489|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
129950490|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
129950491|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
129950492|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
129950493|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
129950494|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
129950495|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
129950496|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
129950497|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
129950498|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
129950499|NCT01794689|467781135|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
129950500|NCT01794689|467781136|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
129950501|NCT01794689|467781137|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
129950502|NCT01794689|467781138|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
129950503|NCT01697956|467781139|FG000|Overall Study|Protocol Violation|1|||
129950504|NCT01697956|467781140|FG001|Overall Study|Protocol Violation|1|||
129950505|NCT01970527|467781141|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
129950506|NCT01970527|467781142|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
129950507|NCT01970527|467781141|FG000|Treatment|Disease progression|0|||
129950508|NCT01970527|467781142|FG001|Treatment|Disease progression|1|||
129950509|NCT01970527|467781141|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
129950510|NCT01970527|467781142|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
129950511|NCT01970527|467781141|FG000|Treatment|Death|0|||
129950512|NCT01970527|467781142|FG001|Treatment|Death|1|||
129950513|NCT01970527|467781141|FG000|Follow-up Clinic Visit|Disease progression|1|||
129950514|NCT01970527|467781142|FG001|Follow-up Clinic Visit|Disease progression|1|||
129950515|NCT01970527|467781141|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
129950516|NCT01970527|467781142|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
129950517|NCT01970527|467781141|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
129950518|NCT01970527|467781142|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
129950519|NCT01964547|467781143|FG000|Overall Study|Adverse Event|8|||
129950520|NCT01964547|467781144|FG001|Overall Study|Adverse Event|2|||
129950521|NCT01964547|467781143|FG000|Overall Study|Withdrawal by Subject|4|||
129950522|NCT01964547|467781144|FG001|Overall Study|Withdrawal by Subject|7|||
129950523|NCT01964547|467781143|FG000|Overall Study|Lost to Follow-up|0|||
129950524|NCT01964547|467781144|FG001|Overall Study|Lost to Follow-up|1|||
129950525|NCT01964547|467781143|FG000|Overall Study|Withdrawal by Investigator|0|||
129950526|NCT01964547|467781144|FG001|Overall Study|Withdrawal by Investigator|1|||
129950527|NCT01115309|467781145|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
129950528|NCT01115309|467781145|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
129950529|NCT01115309|467781145|FG000|Long-term Follow-up|Lost to Follow-up|6|||
129950530|NCT04447287|467781146|FG000|Period 1: Run-in Period|Adverse Event|3|||
129950531|NCT04447287|467781147|FG001|Period 1: Run-in Period|Adverse Event|0|||
129453527|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
129453528|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
129453529|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
129453530|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
129453531|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
129950532|NCT04447287|467781148|FG002|Period 1: Run-in Period|Adverse Event|0|||
129950533|NCT04447287|467781146|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
129488454|NCT01277289|466080717|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
129950534|NCT04447287|467781147|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
129453532|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
129453533|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
129950535|NCT04447287|467781148|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
129950536|NCT04447287|467781146|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
129950537|NCT04447287|467781147|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
129950538|NCT04447287|467781148|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
129950539|NCT02147093|467781151|FG000|Period 1|Lost to Follow-up|0|||
129950540|NCT02147093|467781152|FG001|Period 1|Lost to Follow-up|1|||
129950541|NCT02147093|467781151|FG000|Period 2|Protocol Violation|2|||
129950542|NCT02147093|467781152|FG001|Period 2|Protocol Violation|0|||
129950543|NCT03246724|467781153|FG000|Overall Study|Withdrawal by Subject|5|||
129950544|NCT03246724|467781154|FG001|Overall Study|Withdrawal by Subject|2|||
129950545|NCT03246724|467781155|FG002|Overall Study|Withdrawal by Subject|4|||
129950546|NCT03246724|467781156|FG003|Overall Study|Withdrawal by Subject|2|||
129950547|NCT03246724|467781153|FG000|Overall Study|Ineligible on day of surgery|7|||
129950548|NCT03246724|467781154|FG001|Overall Study|Ineligible on day of surgery|2|||
129950549|NCT03246724|467781155|FG002|Overall Study|Ineligible on day of surgery|0|||
129950550|NCT03246724|467781156|FG003|Overall Study|Ineligible on day of surgery|3|||
129950551|NCT03246724|467781153|FG000|Overall Study|Study completed before surgical date|2|||
129950552|NCT03246724|467781154|FG001|Overall Study|Study completed before surgical date|1|||
129950553|NCT03246724|467781155|FG002|Overall Study|Study completed before surgical date|8|||
129950554|NCT03246724|467781156|FG003|Overall Study|Study completed before surgical date|1|||
129950555|NCT03246724|467781153|FG000|Overall Study|Transferred to other arm|0|||
129950556|NCT03246724|467781154|FG001|Overall Study|Transferred to other arm|0|||
129950557|NCT03246724|467781155|FG002|Overall Study|Transferred to other arm|1|||
129950558|NCT03246724|467781156|FG003|Overall Study|Transferred to other arm|0|||
129950559|NCT03246724|467781153|FG000|Overall Study|Unable to obtain medication timely|0|||
129950560|NCT03246724|467781154|FG001|Overall Study|Unable to obtain medication timely|2|||
129950561|NCT03246724|467781155|FG002|Overall Study|Unable to obtain medication timely|2|||
129950562|NCT03246724|467781156|FG003|Overall Study|Unable to obtain medication timely|1|||
129950563|NCT03246724|467781153|FG000|Overall Study|Re-consented to participate|0|||
129950564|NCT03246724|467781154|FG001|Overall Study|Re-consented to participate|0|||
129950565|NCT03246724|467781155|FG002|Overall Study|Re-consented to participate|0|||
129950566|NCT03246724|467781156|FG003|Overall Study|Re-consented to participate|1|||
129950567|NCT00655824|467781157|FG000|Overall Study|Adverse Event|3|||
129950568|NCT00655824|467781157|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
129950569|NCT00655824|467781157|FG000|Overall Study|Protocol Violation|1|||
129950570|NCT00655824|467781157|FG000|Overall Study|Withdrawal by Subject|4|||
129950571|NCT00655824|467781157|FG000|Overall Study|Deterioration of Trial Disease|2|||
129950572|NCT01662505|467781164|FG000|Overall Study|Progressive disease|6|||
129950573|NCT01662505|467781165|FG001|Overall Study|Progressive disease|1|||
129950574|NCT01662505|467781166|FG002|Overall Study|Progressive disease|5|||
129950575|NCT01662505|467781164|FG000|Overall Study|Refused cont. medication|0|||
129950576|NCT01662505|467781165|FG001|Overall Study|Refused cont. medication|0|||
129950577|NCT01662505|467781166|FG002|Overall Study|Refused cont. medication|1|||
129950578|NCT01662505|467781164|FG000|Overall Study|Not specified above|1|||
129950579|NCT01662505|467781165|FG001|Overall Study|Not specified above|3|||
129950580|NCT01662505|467781166|FG002|Overall Study|Not specified above|2|||
129950581|NCT02255474|467781167|FG000|Overall Study|Lost to Follow-up|1|||
129950582|NCT02255474|467781168|FG001|Overall Study|Lost to Follow-up|1|||
129950583|NCT02255474|467781169|FG002|Overall Study|Lost to Follow-up|3|||
129950584|NCT02255474|467781167|FG000|Overall Study|Withdrawal by Subject|1|||
129950585|NCT02255474|467781168|FG001|Overall Study|Withdrawal by Subject|1|||
129950586|NCT02255474|467781169|FG002|Overall Study|Withdrawal by Subject|0|||
129950587|NCT01229176|467781170|FG000|Overall Study|Withdrawal by Subject|0|||
129950588|NCT01229176|467781171|FG001|Overall Study|Withdrawal by Subject|0|||
129950589|NCT01229176|467781172|FG002|Overall Study|Withdrawal by Subject|0|||
129950590|NCT01229176|467781173|FG003|Overall Study|Withdrawal by Subject|1|||
129950591|NCT01229176|467781174|FG004|Overall Study|Withdrawal by Subject|1|||
129950592|NCT01229176|467781175|FG005|Overall Study|Withdrawal by Subject|1|||
129950593|NCT01229176|467781176|FG006|Overall Study|Withdrawal by Subject|0|||
129950594|NCT01229176|467781177|FG007|Overall Study|Withdrawal by Subject|1|||
129950595|NCT01229176|467781170|FG000|Overall Study|Lost to Follow-up|0|||
129950596|NCT01229176|467781171|FG001|Overall Study|Lost to Follow-up|3|||
129950597|NCT01229176|467781172|FG002|Overall Study|Lost to Follow-up|0|||
129950598|NCT01229176|467781173|FG003|Overall Study|Lost to Follow-up|0|||
129950599|NCT01229176|467781174|FG004|Overall Study|Lost to Follow-up|1|||
129950600|NCT01229176|467781175|FG005|Overall Study|Lost to Follow-up|1|||
129950601|NCT01229176|467781176|FG006|Overall Study|Lost to Follow-up|0|||
129950602|NCT01229176|467781177|FG007|Overall Study|Lost to Follow-up|2|||
129453534|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
129950603|NCT00882050|467781183|FG000|Overall Study|Physician Decision|1|||
129950604|NCT00882050|467781184|FG001|Overall Study|Physician Decision|0|||
129950605|NCT00882050|467781185|FG002|Overall Study|Physician Decision|0|||
129950606|NCT02367794|467781186|FG000|Overall Study|Death|252|||
129950607|NCT02367794|467781187|FG001|Overall Study|Death|245|||
129950608|NCT02367794|467781188|FG002|Overall Study|Death|243|||
129950609|NCT02367794|467781186|FG000|Overall Study|Lost to Follow-up|1|||
129950610|NCT02367794|467781187|FG001|Overall Study|Lost to Follow-up|2|||
129950611|NCT02367794|467781188|FG002|Overall Study|Lost to Follow-up|2|||
129950612|NCT02367794|467781186|FG000|Overall Study|Physician Decision|0|||
129950613|NCT02367794|467781187|FG001|Overall Study|Physician Decision|5|||
129950614|NCT02367794|467781188|FG002|Overall Study|Physician Decision|3|||
129950615|NCT02367794|467781186|FG000|Overall Study|Protocol Violation|1|||
129950616|NCT02367794|467781187|FG001|Overall Study|Protocol Violation|0|||
129950617|NCT02367794|467781188|FG002|Overall Study|Protocol Violation|1|||
129950618|NCT02367794|467781186|FG000|Overall Study|Withdrawal by Subject|25|||
129950619|NCT02367794|467781187|FG001|Overall Study|Withdrawal by Subject|12|||
129950620|NCT02367794|467781188|FG002|Overall Study|Withdrawal by Subject|20|||
129950621|NCT02367794|467781186|FG000|Overall Study|Brain metastasis|1|||
129950622|NCT02367794|467781187|FG001|Overall Study|Brain metastasis|0|||
129950623|NCT02367794|467781188|FG002|Overall Study|Brain metastasis|0|||
129950624|NCT02367794|467781186|FG000|Overall Study|Randomized in error|0|||
129950625|NCT02367794|467781187|FG001|Overall Study|Randomized in error|0|||
129950626|NCT02367794|467781188|FG002|Overall Study|Randomized in error|1|||
129950627|NCT02367794|467781186|FG000|Overall Study|Patient unable to receive carboplatin|0|||
129950628|NCT02367794|467781187|FG001|Overall Study|Patient unable to receive carboplatin|0|||
129950629|NCT02367794|467781188|FG002|Overall Study|Patient unable to receive carboplatin|1|||
129950630|NCT02367794|467781186|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
129950631|NCT02367794|467781187|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
129950632|NCT02367794|467781188|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
129950633|NCT02367794|467781186|FG000|Overall Study|Adverse Event|0|||
129950634|NCT02367794|467781187|FG001|Overall Study|Adverse Event|0|||
129950635|NCT02367794|467781188|FG002|Overall Study|Adverse Event|2|||
129950636|NCT02367794|467781186|FG000|Overall Study|Study Terminated By Sponsor|0|||
129950637|NCT02367794|467781187|FG001|Overall Study|Study Terminated By Sponsor|1|||
129950638|NCT02367794|467781188|FG002|Overall Study|Study Terminated By Sponsor|1|||
129950639|NCT02367794|467781186|FG000|Overall Study|Moved to Roll-Over Study|0|||
129950640|NCT02367794|467781187|FG001|Overall Study|Moved to Roll-Over Study|15|||
129950641|NCT02367794|467781188|FG002|Overall Study|Moved to Roll-Over Study|13|||
129950642|NCT02367794|467781186|FG000|Overall Study|Sponsor Request|60|||
129950643|NCT02367794|467781187|FG001|Overall Study|Sponsor Request|57|||
129950644|NCT02367794|467781188|FG002|Overall Study|Sponsor Request|45|||
129950645|NCT02367794|467781186|FG000|Overall Study|Moved into PTAP Study|0|||
129950646|NCT02367794|467781187|FG001|Overall Study|Moved into PTAP Study|2|||
129950647|NCT02367794|467781188|FG002|Overall Study|Moved into PTAP Study|3|||
129950648|NCT02367794|467781186|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
129950649|NCT02367794|467781187|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
129950650|NCT02367794|467781188|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
129950651|NCT02367794|467781186|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
129950652|NCT02367794|467781187|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
129950653|NCT02367794|467781188|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
129950654|NCT02367794|467781186|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
129950655|NCT02367794|467781187|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
129950656|NCT02367794|467781188|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
129950657|NCT02367794|467781186|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
129950658|NCT02367794|467781187|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
129950659|NCT02367794|467781188|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
129950660|NCT02010684|467781189|FG000|Overall Study|Lost to Follow-up|8|||
129950661|NCT02010684|467781190|FG001|Overall Study|Lost to Follow-up|18|||
129950662|NCT02010684|467781189|FG000|Overall Study|Withdrawal by Subject|4|||
129950663|NCT02010684|467781190|FG001|Overall Study|Withdrawal by Subject|5|||
129950664|NCT00091572|467781195|FG000|Overall Study|Lost to Follow-up|1|||
129950665|NCT00091572|467781196|FG001|Overall Study|Lost to Follow-up|1|||
129950666|NCT00091572|467781195|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
129950667|NCT00091572|467781196|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
129950668|NCT00091572|467781195|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
129950669|NCT00091572|467781196|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
129950670|NCT00091572|467781195|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
129950671|NCT00091572|467781196|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
129950672|NCT00091572|467781195|FG000|Overall Study|Other Reason|6|||
129950673|NCT00091572|467781196|FG001|Overall Study|Other Reason|13|||
129950674|NCT00091572|467781195|FG000|Overall Study|Ongoing (still on treatment)|8|||
129950675|NCT00091572|467781196|FG001|Overall Study|Ongoing (still on treatment)|12|||
129950676|NCT00091572|467781195|FG000|Overall Study|Major Protocol Violation|2|||
129950677|NCT00091572|467781196|FG001|Overall Study|Major Protocol Violation|0|||
129950678|NCT00091572|467781195|FG000|Overall Study|Toxicity (Related AE)|53|||
129950679|NCT00091572|467781196|FG001|Overall Study|Toxicity (Related AE)|9|||
129950680|NCT02942771|467781198|FG000|Overall Study|Adverse Event|1|||
129950681|NCT02942771|467781199|FG001|Overall Study|Adverse Event|0|||
129950682|NCT02942771|467781200|FG002|Overall Study|Adverse Event|0|||
129950683|NCT02942771|467781201|FG003|Overall Study|Adverse Event|0|||
129950684|NCT02942771|467781202|FG004|Overall Study|Adverse Event|2|||
129950685|NCT02942771|467781198|FG000|Overall Study|Lost to Follow-up|1|||
129950686|NCT02942771|467781199|FG001|Overall Study|Lost to Follow-up|0|||
129950687|NCT02942771|467781200|FG002|Overall Study|Lost to Follow-up|0|||
129950688|NCT02942771|467781201|FG003|Overall Study|Lost to Follow-up|0|||
129950689|NCT02942771|467781202|FG004|Overall Study|Lost to Follow-up|0|||
129950690|NCT02942771|467781198|FG000|Overall Study|Withdrawal by Subject|1|||
129950691|NCT02942771|467781199|FG001|Overall Study|Withdrawal by Subject|0|||
129950692|NCT02942771|467781200|FG002|Overall Study|Withdrawal by Subject|0|||
129950693|NCT02942771|467781201|FG003|Overall Study|Withdrawal by Subject|0|||
129950694|NCT02942771|467781202|FG004|Overall Study|Withdrawal by Subject|2|||
129950695|NCT01186809|467781206|FG000|Overall Study|Death|30|||
129950696|NCT04895085|467781207|FG000|Overall Study|Death|1|||
129950697|NCT04895085|467781207|FG000|Overall Study|Withdrawal by Subject|1|||
129950698|NCT04895085|467781207|FG000|Overall Study|No longer eligible: Moved from area|1|||
129950699|NCT01159600|467781212|FG000|Overall Study|Not treated|0|||
129950700|NCT01159600|467781213|FG001|Overall Study|Not treated|0|||
129950701|NCT01159600|467781214|FG002|Overall Study|Not treated|1|||
129950702|NCT01159600|467781215|FG003|Overall Study|Not treated|0|||
129950703|NCT01159600|467781216|FG004|Overall Study|Not treated|0|||
129950704|NCT01159600|467781217|FG005|Overall Study|Not treated|1|||
129950705|NCT01159600|467781218|FG006|Overall Study|Not treated|2|||
129950706|NCT01159600|467781219|FG007|Overall Study|Not treated|2|||
129950707|NCT01159600|467781212|FG000|Overall Study|Adverse Event|7|||
129950708|NCT01159600|467781213|FG001|Overall Study|Adverse Event|2|||
129950709|NCT01159600|467781214|FG002|Overall Study|Adverse Event|5|||
129950710|NCT01159600|467781215|FG003|Overall Study|Adverse Event|1|||
129950711|NCT01159600|467781216|FG004|Overall Study|Adverse Event|8|||
129950712|NCT01159600|467781217|FG005|Overall Study|Adverse Event|6|||
129950713|NCT01159600|467781218|FG006|Overall Study|Adverse Event|7|||
129950714|NCT01159600|467781219|FG007|Overall Study|Adverse Event|5|||
129950715|NCT01159600|467781212|FG000|Overall Study|Lack of Efficacy|0|||
129950716|NCT01159600|467781213|FG001|Overall Study|Lack of Efficacy|0|||
129950717|NCT01159600|467781214|FG002|Overall Study|Lack of Efficacy|0|||
129950718|NCT01159600|467781215|FG003|Overall Study|Lack of Efficacy|0|||
129950719|NCT01159600|467781216|FG004|Overall Study|Lack of Efficacy|2|||
129950720|NCT01159600|467781217|FG005|Overall Study|Lack of Efficacy|0|||
129950721|NCT01159600|467781218|FG006|Overall Study|Lack of Efficacy|0|||
129950722|NCT01159600|467781219|FG007|Overall Study|Lack of Efficacy|1|||
129950723|NCT01159600|467781212|FG000|Overall Study|Non compliant with protocol|2|||
129950724|NCT01159600|467781213|FG001|Overall Study|Non compliant with protocol|1|||
129950725|NCT01159600|467781214|FG002|Overall Study|Non compliant with protocol|0|||
129950726|NCT01159600|467781215|FG003|Overall Study|Non compliant with protocol|0|||
129950727|NCT01159600|467781216|FG004|Overall Study|Non compliant with protocol|2|||
129950728|NCT01159600|467781217|FG005|Overall Study|Non compliant with protocol|0|||
129950729|NCT01159600|467781218|FG006|Overall Study|Non compliant with protocol|2|||
129950730|NCT01159600|467781219|FG007|Overall Study|Non compliant with protocol|0|||
129950731|NCT01159600|467781212|FG000|Overall Study|Lost to Follow-up|2|||
129950732|NCT01159600|467781213|FG001|Overall Study|Lost to Follow-up|3|||
129950733|NCT01159600|467781214|FG002|Overall Study|Lost to Follow-up|4|||
129950734|NCT01159600|467781215|FG003|Overall Study|Lost to Follow-up|3|||
129950735|NCT01159600|467781216|FG004|Overall Study|Lost to Follow-up|3|||
129950736|NCT01159600|467781217|FG005|Overall Study|Lost to Follow-up|0|||
129950737|NCT01159600|467781218|FG006|Overall Study|Lost to Follow-up|3|||
129950738|NCT01159600|467781219|FG007|Overall Study|Lost to Follow-up|2|||
129950739|NCT01159600|467781212|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
129950740|NCT01159600|467781213|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
129950741|NCT01159600|467781214|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
129950742|NCT01159600|467781215|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
129950743|NCT01159600|467781216|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
129950744|NCT01159600|467781217|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
129950745|NCT01159600|467781218|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
129950746|NCT01159600|467781219|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
129950747|NCT01159600|467781212|FG000|Overall Study|Other reason not defined above|3|||
129950748|NCT01159600|467781213|FG001|Overall Study|Other reason not defined above|0|||
129950749|NCT01159600|467781214|FG002|Overall Study|Other reason not defined above|4|||
129453535|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
129950750|NCT01159600|467781215|FG003|Overall Study|Other reason not defined above|2|||
129950751|NCT01159600|467781216|FG004|Overall Study|Other reason not defined above|5|||
129950752|NCT01159600|467781217|FG005|Overall Study|Other reason not defined above|7|||
129950753|NCT01159600|467781218|FG006|Overall Study|Other reason not defined above|3|||
129950754|NCT01159600|467781219|FG007|Overall Study|Other reason not defined above|3|||
129950755|NCT04433091|467781220|FG000|Overall Study|Lost to Follow-up|1|||
129950756|NCT04433091|467781221|FG001|Overall Study|Lost to Follow-up|0|||
129950757|NCT04433091|467781220|FG000|Overall Study|Withdrawn .|2|||
129950758|NCT04433091|467781221|FG001|Overall Study|Withdrawn .|4|||
129950759|NCT04097535|467781222|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
129950760|NCT04820023|467782934|FG000|Overall Study|Death|0|||
129950761|NCT04820023|467782935|FG001|Overall Study|Death|0|||
129950762|NCT04820023|467782936|FG002|Overall Study|Death|0|||
129950763|NCT04820023|467782937|FG003|Overall Study|Death|0|||
129950764|NCT04820023|467782938|FG004|Overall Study|Death|0|||
129950765|NCT04820023|467782939|FG005|Overall Study|Death|0|||
129950766|NCT04820023|467782940|FG006|Overall Study|Death|1|||
129950767|NCT04820023|467782941|FG007|Overall Study|Death|0|||
129950768|NCT04820023|467782942|FG008|Overall Study|Death|1|||
129950769|NCT04820023|467782934|FG000|Overall Study|Withdrawal by Subject|1|||
129950770|NCT04820023|467782935|FG001|Overall Study|Withdrawal by Subject|2|||
129950771|NCT04820023|467782936|FG002|Overall Study|Withdrawal by Subject|2|||
129950772|NCT04820023|467782937|FG003|Overall Study|Withdrawal by Subject|1|||
129950773|NCT04820023|467782938|FG004|Overall Study|Withdrawal by Subject|4|||
129950774|NCT04820023|467782939|FG005|Overall Study|Withdrawal by Subject|3|||
129950775|NCT04820023|467782940|FG006|Overall Study|Withdrawal by Subject|3|||
129950776|NCT04820023|467782941|FG007|Overall Study|Withdrawal by Subject|6|||
129950777|NCT04820023|467782942|FG008|Overall Study|Withdrawal by Subject|5|||
129950778|NCT04820023|467782934|FG000|Overall Study|Progressive Disease|3|||
129950779|NCT04820023|467782935|FG001|Overall Study|Progressive Disease|0|||
129950780|NCT04820023|467782936|FG002|Overall Study|Progressive Disease|2|||
129950781|NCT04820023|467782937|FG003|Overall Study|Progressive Disease|2|||
129950782|NCT04820023|467782938|FG004|Overall Study|Progressive Disease|2|||
129950783|NCT04820023|467782939|FG005|Overall Study|Progressive Disease|0|||
129950784|NCT04820023|467782940|FG006|Overall Study|Progressive Disease|1|||
129950785|NCT04820023|467782941|FG007|Overall Study|Progressive Disease|1|||
129950786|NCT04820023|467782942|FG008|Overall Study|Progressive Disease|0|||
129950787|NCT04820023|467782934|FG000|Overall Study|New anti-cancer therapy|0|||
129950788|NCT04820023|467782935|FG001|Overall Study|New anti-cancer therapy|0|||
129950789|NCT04820023|467782936|FG002|Overall Study|New anti-cancer therapy|0|||
129950790|NCT04820023|467782937|FG003|Overall Study|New anti-cancer therapy|0|||
129950791|NCT04820023|467782938|FG004|Overall Study|New anti-cancer therapy|2|||
129950792|NCT04820023|467782939|FG005|Overall Study|New anti-cancer therapy|0|||
129950793|NCT04820023|467782940|FG006|Overall Study|New anti-cancer therapy|0|||
129950794|NCT04820023|467782941|FG007|Overall Study|New anti-cancer therapy|0|||
129950795|NCT04820023|467782942|FG008|Overall Study|New anti-cancer therapy|0|||
129950796|NCT04820023|467782934|FG000|Overall Study|Other|0|||
129950797|NCT04820023|467782935|FG001|Overall Study|Other|1|||
129950798|NCT04820023|467782936|FG002|Overall Study|Other|0|||
129950799|NCT04820023|467782937|FG003|Overall Study|Other|0|||
129950800|NCT04820023|467782938|FG004|Overall Study|Other|0|||
129950801|NCT04820023|467782939|FG005|Overall Study|Other|0|||
129950802|NCT04820023|467782940|FG006|Overall Study|Other|0|||
129950803|NCT04820023|467782941|FG007|Overall Study|Other|2|||
129950804|NCT04820023|467782942|FG008|Overall Study|Other|0|||
129950805|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
129950806|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
129950807|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
129453536|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
129453537|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
129453538|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
129453539|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
129453540|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
129453541|NCT00111800|465958060|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
129453542|NCT00111800|465958061|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
129950808|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
129950809|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
129950810|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
129950811|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
129950812|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
129950813|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
129950814|NCT01020487|467782943|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
129950815|NCT01020487|467782944|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
129950816|NCT01020487|467782945|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
129950817|NCT01020487|467782943|FG000|Part 2 Open-label Period|Adverse Event|0|||
129950818|NCT01020487|467782944|FG001|Part 2 Open-label Period|Adverse Event|4|||
129950819|NCT01020487|467782945|FG002|Part 2 Open-label Period|Adverse Event|1|||
129950820|NCT02400749|467782948|FG000|Week 0 -16|Withdrawal by Subject|5|||
129950821|NCT02400749|467782949|FG001|Week 0 -16|Withdrawal by Subject|5|||
129453543|NCT00111800|465958062|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
129950822|NCT02400749|467782948|FG000|Week 0 -16|Adverse Event|3|||
129950823|NCT02400749|467782949|FG001|Week 0 -16|Adverse Event|1|||
129950824|NCT02400749|467782948|FG000|Week 0 -16|Lost to Follow-up|2|||
129950825|NCT02400749|467782949|FG001|Week 0 -16|Lost to Follow-up|0|||
129950826|NCT02400749|467782948|FG000|Week 0 -16|Protocol Violation|1|||
129950827|NCT02400749|467782949|FG001|Week 0 -16|Protocol Violation|0|||
129950828|NCT02400749|467782948|FG000|Week 17 - 32|Withdrawal by Subject|3|||
129950829|NCT02400749|467782949|FG001|Week 17 - 32|Withdrawal by Subject|2|||
129950830|NCT02400749|467782948|FG000|Week 17 - 32|Adverse Event|2|||
129950831|NCT02400749|467782949|FG001|Week 17 - 32|Adverse Event|1|||
129950832|NCT04425252|467782952|FG000|Overall Study|Withdrawal by Subject|2|||
129950833|NCT04425252|467782953|FG001|Overall Study|Withdrawal by Subject|1|||
129950834|NCT04425252|467782952|FG000|Overall Study|Lost to Follow-up|1|||
129950835|NCT04425252|467782953|FG001|Overall Study|Lost to Follow-up|0|||
129950836|NCT04425252|467782952|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
129950837|NCT04425252|467782953|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
129950838|NCT04025762|467782958|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
129950839|NCT04025762|467782959|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
129950840|NCT01975701|467782969|FG000|Overall Study|Lost to Follow-up|1|||
129950841|NCT01975701|467782969|FG000|Overall Study|Death|23|||
129950842|NCT01975701|467782969|FG000|Overall Study|Physician Decision|1|||
129950843|NCT02446015|467782972|FG000|Overall Study|Adverse Event|0|||
129950844|NCT02446015|467782973|FG001|Overall Study|Adverse Event|1|||
129950845|NCT02446015|467782972|FG000|Overall Study|Withdrawal by Subject|1|||
129950846|NCT02446015|467782973|FG001|Overall Study|Withdrawal by Subject|0|||
129950847|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
129950848|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
129950849|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
129950850|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
129950851|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Adverse Event|7|||
129950852|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Adverse Event|8|||
129950853|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Adverse Event|8|||
129950854|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Adverse Event|9|||
129950855|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
129950856|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
129950857|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
129950858|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
129950859|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
129950860|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
129950861|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
129950862|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
129950863|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Pregnancy|0|||
129950864|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Pregnancy|2|||
129950865|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Pregnancy|2|||
129950866|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Pregnancy|0|||
129950867|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Non-compliance|1|||
129950868|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Non-compliance|0|||
129950869|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Non-compliance|0|||
129950870|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Non-compliance|3|||
129950871|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Other|3|||
129950872|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Other|0|||
129950873|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Other|3|||
129950874|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Other|2|||
129950875|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
129950876|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
129950877|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
129950878|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
129950879|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
129950880|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
129950881|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
129950882|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
129950883|NCT02143713|467782976|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
129950884|NCT02143713|467782977|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
129950885|NCT02143713|467782978|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
129950886|NCT02143713|467782979|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
129950887|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
129950888|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
129950889|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
129950890|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
129950891|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
129950892|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
129950893|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
129950894|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
129950895|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
129950896|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
129950897|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
129950898|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
129950899|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
129950900|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
129950901|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
129950902|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
129950903|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
129950904|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
129950905|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
129950906|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
129950907|NCT02143713|467782976|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
129950908|NCT02143713|467782977|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
129950909|NCT02143713|467782978|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
129950910|NCT02143713|467782979|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
129950911|NCT01768572|467782982|FG000|Overall Study|Adverse Event|7|||
129950912|NCT01768572|467782983|FG001|Overall Study|Adverse Event|8|||
129950913|NCT01768572|467782984|FG002|Overall Study|Adverse Event|4|||
129950914|NCT01768572|467782982|FG000|Overall Study|Lack of Efficacy|1|||
129950915|NCT01768572|467782983|FG001|Overall Study|Lack of Efficacy|3|||
129950916|NCT01768572|467782984|FG002|Overall Study|Lack of Efficacy|1|||
129950917|NCT01768572|467782982|FG000|Overall Study|Other, Not due to an adverse event|1|||
129950918|NCT01768572|467782983|FG001|Overall Study|Other, Not due to an adverse event|1|||
129950919|NCT01768572|467782984|FG002|Overall Study|Other, Not due to an adverse event|1|||
129950920|NCT01215253|467782985|FG000|Overall Study|Withdrawal by Subject|57|||
129950921|NCT01215253|467782986|FG001|Overall Study|Withdrawal by Subject|35|||
129950922|NCT01215253|467782985|FG000|Overall Study|Physician Decision|9|||
129950923|NCT01215253|467782986|FG001|Overall Study|Physician Decision|12|||
129950924|NCT01215253|467782985|FG000|Overall Study|Lost to Follow-up|6|||
129950925|NCT01215253|467782986|FG001|Overall Study|Lost to Follow-up|4|||
129950926|NCT01215253|467782985|FG000|Overall Study|Other|14|||
129950927|NCT01215253|467782986|FG001|Overall Study|Other|12|||
129950928|NCT03761849|467782993|FG000|Overall Study|transferred to OpenLabelExtension|35|||
129950929|NCT03761849|467782994|FG001|Overall Study|transferred to OpenLabelExtension|34|||
129950930|NCT03761849|467782995|FG002|Overall Study|transferred to OpenLabelExtension|36|||
129950931|NCT03761849|467782996|FG003|Overall Study|transferred to OpenLabelExtension|0|||
129950932|NCT03761849|467782997|FG004|Overall Study|transferred to OpenLabelExtension|0|||
129950933|NCT03761849|467782998|FG005|Overall Study|transferred to OpenLabelExtension|0|||
129950934|NCT03761849|467782993|FG000|Overall Study|Adverse Event|1|||
129950935|NCT03761849|467782994|FG001|Overall Study|Adverse Event|0|||
129950936|NCT03761849|467782995|FG002|Overall Study|Adverse Event|0|||
129950937|NCT03761849|467782996|FG003|Overall Study|Adverse Event|0|||
129950938|NCT03761849|467782997|FG004|Overall Study|Adverse Event|2|||
129950939|NCT03761849|467782998|FG005|Overall Study|Adverse Event|3|||
129950940|NCT03761849|467782993|FG000|Overall Study|Withdrawal by Subject|0|||
129950941|NCT03761849|467782994|FG001|Overall Study|Withdrawal by Subject|0|||
129950942|NCT03761849|467782995|FG002|Overall Study|Withdrawal by Subject|0|||
129950943|NCT03761849|467782996|FG003|Overall Study|Withdrawal by Subject|41|||
129950944|NCT03761849|467782997|FG004|Overall Study|Withdrawal by Subject|43|||
129950945|NCT03761849|467782998|FG005|Overall Study|Withdrawal by Subject|35|||
129950946|NCT03761849|467782993|FG000|Overall Study|Lost to Follow-up|0|||
129950947|NCT03761849|467782994|FG001|Overall Study|Lost to Follow-up|1|||
129950948|NCT03761849|467782995|FG002|Overall Study|Lost to Follow-up|0|||
129950949|NCT03761849|467782996|FG003|Overall Study|Lost to Follow-up|2|||
129950950|NCT03761849|467782997|FG004|Overall Study|Lost to Follow-up|4|||
129950951|NCT03761849|467782998|FG005|Overall Study|Lost to Follow-up|5|||
129950952|NCT03761849|467782993|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
129950953|NCT03761849|467782994|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
129950954|NCT03761849|467782995|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
129950955|NCT03761849|467782996|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
129950956|NCT03761849|467782997|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
129950957|NCT03761849|467782998|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
129950958|NCT03761849|467782993|FG000|Overall Study|Physician Decision|0|||
129950959|NCT03761849|467782994|FG001|Overall Study|Physician Decision|0|||
129950960|NCT03761849|467782995|FG002|Overall Study|Physician Decision|0|||
129950961|NCT03761849|467782996|FG003|Overall Study|Physician Decision|1|||
129950962|NCT03761849|467782997|FG004|Overall Study|Physician Decision|4|||
129950963|NCT03761849|467782998|FG005|Overall Study|Physician Decision|4|||
129453544|NCT00111800|465958063|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
129453545|NCT00111800|465958064|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
129453546|NCT00111800|465958065|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
129453547|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
129453548|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
129453549|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
129453550|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
129453551|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
129453552|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
129453553|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
129453554|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
129453555|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
129453556|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
129453557|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
129453558|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
129453559|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
129453560|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
129453561|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
129453562|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
129453563|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
129453564|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
129453565|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
129453566|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
129453567|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
129453568|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
129453569|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
129950964|NCT03761849|467782993|FG000|Overall Study|Death|0|||
129950965|NCT03761849|467782994|FG001|Overall Study|Death|0|||
129950966|NCT03761849|467782995|FG002|Overall Study|Death|0|||
129950967|NCT03761849|467782996|FG003|Overall Study|Death|1|||
129950968|NCT03761849|467782997|FG004|Overall Study|Death|1|||
129950969|NCT03761849|467782998|FG005|Overall Study|Death|3|||
129950970|NCT03761849|467782993|FG000|Overall Study|Protocol Violation|0|||
129950971|NCT03761849|467782994|FG001|Overall Study|Protocol Violation|0|||
129950972|NCT03761849|467782995|FG002|Overall Study|Protocol Violation|0|||
129950973|NCT03761849|467782996|FG003|Overall Study|Protocol Violation|2|||
129950974|NCT03761849|467782997|FG004|Overall Study|Protocol Violation|2|||
129453570|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
129453571|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453572|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453573|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
129453574|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453575|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453576|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
129453577|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
129453578|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
129453579|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
129453580|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
129950975|NCT03761849|467782998|FG005|Overall Study|Protocol Violation|1|||
129950976|NCT03761849|467782993|FG000|Overall Study|Participant could not come to site|0|||
129950977|NCT03761849|467782994|FG001|Overall Study|Participant could not come to site|0|||
129950978|NCT03761849|467782995|FG002|Overall Study|Participant could not come to site|0|||
129950979|NCT03761849|467782996|FG003|Overall Study|Participant could not come to site|0|||
129950980|NCT03761849|467782997|FG004|Overall Study|Participant could not come to site|1|||
129950981|NCT03761849|467782998|FG005|Overall Study|Participant could not come to site|0|||
129950982|NCT03761849|467782993|FG000|Overall Study|SF- safety Finding|0|||
129950983|NCT03761849|467782994|FG001|Overall Study|SF- safety Finding|0|||
129950984|NCT03761849|467782995|FG002|Overall Study|SF- safety Finding|0|||
129950985|NCT03761849|467782996|FG003|Overall Study|SF- safety Finding|0|||
129950986|NCT03761849|467782997|FG004|Overall Study|SF- safety Finding|0|||
129950987|NCT03761849|467782998|FG005|Overall Study|SF- safety Finding|1|||
129950988|NCT03761849|467782993|FG000|Overall Study|Patient did not attend visit|0|||
129950989|NCT03761849|467782994|FG001|Overall Study|Patient did not attend visit|0|||
129950990|NCT03761849|467782995|FG002|Overall Study|Patient did not attend visit|0|||
129950991|NCT03761849|467782996|FG003|Overall Study|Patient did not attend visit|0|||
129950992|NCT03761849|467782997|FG004|Overall Study|Patient did not attend visit|0|||
129950993|NCT03761849|467782998|FG005|Overall Study|Patient did not attend visit|1|||
129950994|NCT03840993|467782999|FG000|Overall Study|Adverse Event|1|||
129950995|NCT03840993|467783000|FG001|Overall Study|Adverse Event|0|||
129950996|NCT03840993|467782999|FG000|Overall Study|Lost to Follow-up|4|||
129950997|NCT03840993|467783000|FG001|Overall Study|Lost to Follow-up|0|||
129950998|NCT03840993|467782999|FG000|Overall Study|Physician Decision|0|||
129950999|NCT03840993|467783000|FG001|Overall Study|Physician Decision|1|||
129951000|NCT03840993|467782999|FG000|Overall Study|Pregnancy|0|||
129951001|NCT03840993|467783000|FG001|Overall Study|Pregnancy|1|||
129951002|NCT03840993|467782999|FG000|Overall Study|Withdrawal by Subject|1|||
129951003|NCT03840993|467783000|FG001|Overall Study|Withdrawal by Subject|3|||
129951004|NCT03840993|467782999|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
129951005|NCT03840993|467783000|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
129951006|NCT01540474|467783001|FG000|Vaccination Period|Lost to Follow-up|0|||
129951007|NCT01540474|467783002|FG001|Vaccination Period|Lost to Follow-up|1|||
129951008|NCT01540474|467783003|FG002|Vaccination Period|Lost to Follow-up|0|||
129951009|NCT01540474|467783004|FG003|Vaccination Period|Lost to Follow-up|0|||
129951010|NCT00857311|467783005|FG000|Overall Study|Lost to Follow-up|1|||
129951011|NCT00857311|467783006|FG001|Overall Study|Lost to Follow-up|0|||
129951012|NCT00857311|467783007|FG002|Overall Study|Lost to Follow-up|0|||
129951013|NCT00857311|467783008|FG003|Overall Study|Lost to Follow-up|0|||
129951014|NCT02005484|467783011|FG000|Overall Study|Death|1|||
129951015|NCT02005484|467783011|FG000|Overall Study|Disease progression|1|||
129951016|NCT02005484|467783011|FG000|Overall Study|Changed to a Different Study|1|||
129951017|NCT02005484|467783011|FG000|Overall Study|Sponsor decision|1|||
129951018|NCT01129011|467783012|FG000|Overall Study|Adverse Event|20|||
129951019|NCT01129011|467783013|FG001|Overall Study|Adverse Event|30|||
129951020|NCT01129011|467783012|FG000|Overall Study|Withdrawal by Subject|24|||
129951021|NCT01129011|467783013|FG001|Overall Study|Withdrawal by Subject|8|||
129951022|NCT01129011|467783012|FG000|Overall Study|Lost to Follow-up|6|||
129951023|NCT01129011|467783013|FG001|Overall Study|Lost to Follow-up|7|||
129951024|NCT01129011|467783012|FG000|Overall Study|Duodenal Ulcer|2|||
129951025|NCT01129011|467783013|FG001|Overall Study|Duodenal Ulcer|8|||
129951026|NCT01129011|467783012|FG000|Overall Study|misc|7|||
129951027|NCT01129011|467783013|FG001|Overall Study|misc|4|||
129951028|NCT02823574|467783017|FG000|Randomization|Disease Progression|0|||
129951029|NCT02823574|467783018|FG001|Randomization|Disease Progression|0|||
129951030|NCT02823574|467783019|FG002|Randomization|Disease Progression|1|||
129951031|NCT02823574|467783020|FG003|Randomization|Disease Progression|0|||
129951032|NCT02823574|467783017|FG000|Randomization|AE unrelated to Study Drug|1|||
129951033|NCT02823574|467783018|FG001|Randomization|AE unrelated to Study Drug|0|||
129951034|NCT02823574|467783019|FG002|Randomization|AE unrelated to Study Drug|0|||
129951035|NCT02823574|467783020|FG003|Randomization|AE unrelated to Study Drug|0|||
129951036|NCT02823574|467783017|FG000|Treatment Period|Poor/Non Compliance|1|||
129951037|NCT02823574|467783018|FG001|Treatment Period|Poor/Non Compliance|0|||
129951038|NCT02823574|467783019|FG002|Treatment Period|Poor/Non Compliance|0|||
129951039|NCT02823574|467783020|FG003|Treatment Period|Poor/Non Compliance|1|||
129951040|NCT02823574|467783017|FG000|Treatment Period|Maximum Clinical Benefit|8|||
129951041|NCT02823574|467783018|FG001|Treatment Period|Maximum Clinical Benefit|4|||
129951042|NCT02823574|467783019|FG002|Treatment Period|Maximum Clinical Benefit|7|||
129951043|NCT02823574|467783020|FG003|Treatment Period|Maximum Clinical Benefit|1|||
129951044|NCT02823574|467783017|FG000|Treatment Period|Lost to Follow-up|1|||
129951045|NCT02823574|467783018|FG001|Treatment Period|Lost to Follow-up|1|||
129951046|NCT02823574|467783019|FG002|Treatment Period|Lost to Follow-up|0|||
129951047|NCT02823574|467783020|FG003|Treatment Period|Lost to Follow-up|0|||
129951048|NCT02823574|467783017|FG000|Treatment Period|Participant withdrew consent|4|||
129951049|NCT02823574|467783018|FG001|Treatment Period|Participant withdrew consent|0|||
129951050|NCT02823574|467783019|FG002|Treatment Period|Participant withdrew consent|0|||
129951051|NCT02823574|467783020|FG003|Treatment Period|Participant withdrew consent|1|||
129951052|NCT02823574|467783017|FG000|Treatment Period|Participant request to discontinue|5|||
129951053|NCT02823574|467783018|FG001|Treatment Period|Participant request to discontinue|0|||
129951054|NCT02823574|467783019|FG002|Treatment Period|Participant request to discontinue|3|||
129951055|NCT02823574|467783020|FG003|Treatment Period|Participant request to discontinue|2|||
129951056|NCT02823574|467783017|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
129951057|NCT02823574|467783018|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
129951058|NCT02823574|467783019|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
129951059|NCT02823574|467783020|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
129951060|NCT02823574|467783017|FG000|Treatment Period|Study Drug Toxicity|11|||
129951061|NCT02823574|467783018|FG001|Treatment Period|Study Drug Toxicity|2|||
129951062|NCT02823574|467783019|FG002|Treatment Period|Study Drug Toxicity|14|||
129951063|NCT02823574|467783020|FG003|Treatment Period|Study Drug Toxicity|4|||
129951064|NCT02823574|467783017|FG000|Treatment Period|Disease Progression|113|||
129951065|NCT02823574|467783018|FG001|Treatment Period|Disease Progression|64|||
129951066|NCT02823574|467783019|FG002|Treatment Period|Disease Progression|82|||
129951067|NCT02823574|467783020|FG003|Treatment Period|Disease Progression|43|||
129951068|NCT02823574|467783017|FG000|Treatment Period|Other reasons|5|||
129951069|NCT02823574|467783018|FG001|Treatment Period|Other reasons|9|||
129951070|NCT02823574|467783019|FG002|Treatment Period|Other reasons|3|||
129951071|NCT02823574|467783020|FG003|Treatment Period|Other reasons|6|||
129951072|NCT02823574|467783017|FG000|Treatment Period|Participant no longer meets study criteria|0|||
129951073|NCT02823574|467783018|FG001|Treatment Period|Participant no longer meets study criteria|0|||
129951074|NCT02823574|467783019|FG002|Treatment Period|Participant no longer meets study criteria|1|||
129951075|NCT02823574|467783020|FG003|Treatment Period|Participant no longer meets study criteria|0|||
129951076|NCT02823574|467783017|FG000|Treatment Period|Death|0|||
129951077|NCT02823574|467783018|FG001|Treatment Period|Death|0|||
129951078|NCT02823574|467783019|FG002|Treatment Period|Death|3|||
129951079|NCT02823574|467783020|FG003|Treatment Period|Death|1|||
129951080|NCT00590759|467783021|FG000|Overall Study|Death|52|||
129951081|NCT00590759|467783021|FG000|Overall Study|Lost to Follow-up|28|||
129453581|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
129453582|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
129453583|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
129453584|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
129453585|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
129453586|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
129453587|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
129453588|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
129453589|NCT00111800|465958060|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
129453590|NCT00111800|465958061|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
129951082|NCT00417885|467783022|FG000|Overall Study|Adverse Event|1|||
129951083|NCT00417885|467783022|FG000|Overall Study|Objective Progression or Relapse|3|||
129951084|NCT00417885|467783022|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
129951085|NCT01190436|467783023|FG000|Overall Study|Lost to Follow-up|35|||
129951086|NCT01190436|467783023|FG000|Overall Study|Other|4|||
129951087|NCT02721147|467783024|FG000|Overall Study|Lost to Follow-up|2|||
129951088|NCT02721147|467783025|FG001|Overall Study|Lost to Follow-up|0|||
129951089|NCT02721147|467783026|FG002|Overall Study|Lost to Follow-up|0|||
129951090|NCT01722097|467783028|FG000|Overall Study|Patient sheets not returned|6|||
129951091|NCT01722097|467783029|FG001|Overall Study|Patient sheets not returned|5|||
129951092|NCT02009332|467783030|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951093|NCT02009332|467783031|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
129951094|NCT02009332|467783032|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951095|NCT02009332|467783033|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951096|NCT02009332|467783034|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951097|NCT02009332|467783035|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
129951098|NCT02009332|467783030|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951099|NCT02009332|467783031|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951100|NCT02009332|467783032|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951101|NCT02009332|467783033|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951102|NCT02009332|467783034|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
129951103|NCT02009332|467783035|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
129951104|NCT02009332|467783030|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951105|NCT02009332|467783031|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951106|NCT02009332|467783032|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951107|NCT02009332|467783033|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951108|NCT02009332|467783034|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
129951109|NCT02009332|467783035|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
129951110|NCT00248794|467783037|FG000|Overall Study|Lost to Follow-up|6|||
129951111|NCT00248794|467783038|FG001|Overall Study|Lost to Follow-up|8|||
129951112|NCT00248794|467783039|FG002|Overall Study|Lost to Follow-up|3|||
129951113|NCT03449979|467783040|FG000|Overall Study|Technical difficulty|0|||
129951114|NCT03449979|467783041|FG001|Overall Study|Technical difficulty|0|||
129951115|NCT03449979|467783042|FG002|Overall Study|Technical difficulty|0|||
129951116|NCT03449979|467783043|FG003|Overall Study|Technical difficulty|1|||
129951117|NCT02632747|467783044|FG000|Wash-out Period|Adverse Event|1|||
129951118|NCT02632747|467783045|FG001|Wash-out Period|Adverse Event|0|||
129951119|NCT02069379|467783046|FG000|Baseline Measurements|Lost to Follow-up|1|||
129951120|NCT02069379|467783047|FG001|Baseline Measurements|Lost to Follow-up|0|||
129951121|NCT02069379|467783048|FG002|Baseline Measurements|Lost to Follow-up|0|||
129951122|NCT02069379|467783049|FG003|Baseline Measurements|Lost to Follow-up|0|||
129951123|NCT02069379|467783046|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
129951124|NCT02069379|467783047|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
129951125|NCT02069379|467783048|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
129951126|NCT02069379|467783049|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
129951127|NCT02069379|467783046|FG000|First Treatment Arm|Lost to Follow-up|0|||
129951128|NCT02069379|467783047|FG001|First Treatment Arm|Lost to Follow-up|1|||
129951129|NCT02069379|467783048|FG002|First Treatment Arm|Lost to Follow-up|1|||
129951130|NCT02069379|467783049|FG003|First Treatment Arm|Lost to Follow-up|0|||
129951131|NCT02069379|467783046|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
129951132|NCT02069379|467783047|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
129951133|NCT02069379|467783048|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
129951134|NCT02069379|467783049|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
129951135|NCT02069379|467783046|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
129951136|NCT02069379|467783047|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
129951137|NCT02069379|467783048|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
129951138|NCT02069379|467783049|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
129951139|NCT02069379|467783046|FG000|Second Treatment Arm|Lost to Follow-up|0|||
129951140|NCT02069379|467783047|FG001|Second Treatment Arm|Lost to Follow-up|0|||
129951141|NCT02069379|467783048|FG002|Second Treatment Arm|Lost to Follow-up|1|||
129951142|NCT02069379|467783049|FG003|Second Treatment Arm|Lost to Follow-up|0|||
129951143|NCT00700999|467783052|FG000|Overall Study|Lost to Follow-up|7|||
129951144|NCT00700999|467783053|FG001|Overall Study|Lost to Follow-up|7|||
129951145|NCT00700999|467783052|FG000|Overall Study|Excluded - did not meet study criteria|0|||
129951146|NCT00700999|467783053|FG001|Overall Study|Excluded - did not meet study criteria|1|||
129951147|NCT00700999|467783052|FG000|Overall Study|Withdrawal by Subject|8|||
129951148|NCT00700999|467783053|FG001|Overall Study|Withdrawal by Subject|1|||
129951149|NCT03481725|467783054|FG000|Overall Study|Withdrawal by Subject|1|||
129951150|NCT03481725|467783055|FG001|Overall Study|Withdrawal by Subject|0|||
129951151|NCT03651271|467783056|FG000|Overall Study|Death|4|||
129951152|NCT03651271|467783057|FG001|Overall Study|Death|37|||
129951153|NCT03651271|467783058|FG002|Overall Study|Death|0|||
129951154|NCT03651271|467783059|FG003|Overall Study|Death|2|||
129951155|NCT03651271|467783060|FG004|Overall Study|Death|6|||
129951156|NCT03651271|467783056|FG000|Overall Study|Lost to Follow-up|1|||
129951157|NCT03651271|467783057|FG001|Overall Study|Lost to Follow-up|5|||
129951158|NCT03651271|467783058|FG002|Overall Study|Lost to Follow-up|0|||
129951159|NCT03651271|467783059|FG003|Overall Study|Lost to Follow-up|1|||
129951160|NCT03651271|467783060|FG004|Overall Study|Lost to Follow-up|0|||
129951161|NCT03651271|467783056|FG000|Overall Study|Physician Decision|0|||
129951162|NCT03651271|467783057|FG001|Overall Study|Physician Decision|2|||
129951163|NCT03651271|467783058|FG002|Overall Study|Physician Decision|0|||
129951164|NCT03651271|467783059|FG003|Overall Study|Physician Decision|0|||
129951165|NCT03651271|467783060|FG004|Overall Study|Physician Decision|0|||
129951166|NCT03651271|467783056|FG000|Overall Study|Withdrawal by Subject|1|||
129951167|NCT03651271|467783057|FG001|Overall Study|Withdrawal by Subject|15|||
129951168|NCT03651271|467783058|FG002|Overall Study|Withdrawal by Subject|0|||
129951169|NCT03651271|467783059|FG003|Overall Study|Withdrawal by Subject|0|||
129951170|NCT03651271|467783060|FG004|Overall Study|Withdrawal by Subject|1|||
129951171|NCT03651271|467783056|FG000|Overall Study|Patient medically unable to continue|0|||
129951172|NCT03651271|467783057|FG001|Overall Study|Patient medically unable to continue|0|||
129951173|NCT03651271|467783058|FG002|Overall Study|Patient medically unable to continue|0|||
129951174|NCT03651271|467783059|FG003|Overall Study|Patient medically unable to continue|1|||
129951175|NCT03651271|467783060|FG004|Overall Study|Patient medically unable to continue|0|||
129951176|NCT03444155|467783063|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
129951177|NCT03444155|467783064|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
129951178|NCT02877680|467783069|FG000|Overall Study|Lost to Follow-up|1|||
129951179|NCT02877680|467783070|FG001|Overall Study|Lost to Follow-up|1|||
129951180|NCT02991118|467783077|FG000|Overall Study|Death|3|||
129951181|NCT02991118|467783078|FG001|Overall Study|Death|8|||
129951182|NCT02991118|467783077|FG000|Overall Study|Protocol Violation|0|||
129951183|NCT02991118|467783078|FG001|Overall Study|Protocol Violation|3|||
129951184|NCT02991118|467783077|FG000|Overall Study|Physician Decision|0|||
129951185|NCT02991118|467783078|FG001|Overall Study|Physician Decision|1|||
129951186|NCT02991118|467783077|FG000|Overall Study|Moved out of the country|0|||
129951187|NCT02991118|467783078|FG001|Overall Study|Moved out of the country|1|||
129951188|NCT02991118|467783077|FG000|Overall Study|Adverse Event|2|||
129951189|NCT02991118|467783078|FG001|Overall Study|Adverse Event|2|||
129951190|NCT02991118|467783077|FG000|Overall Study|Withdrawal by Subject|1|||
129951191|NCT02991118|467783078|FG001|Overall Study|Withdrawal by Subject|7|||
129951192|NCT02991118|467783077|FG000|Overall Study|Could not attend study visits|0|||
129951193|NCT02991118|467783078|FG001|Overall Study|Could not attend study visits|1|||
129951194|NCT02991118|467783077|FG000|Overall Study|Lost to Follow-up|1|||
129951195|NCT02991118|467783078|FG001|Overall Study|Lost to Follow-up|9|||
129951196|NCT00595959|467783079|FG000|Overall Study|Withdrawal by Subject|1|||
129951197|NCT00595959|467783079|FG000|Overall Study|Lost to Follow-up|1|||
129951198|NCT05700851|467783085|FG000|Overall Study|Received a kidney transplant|1|||
129951199|NCT05700851|467783085|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
129951200|NCT05700851|467783085|FG000|Overall Study|Withdrawal by Subject|1|||
129951201|NCT00589628|467783086|FG000|Overall Study|Lost to Follow-up|0|||
129951202|NCT00589628|467783087|FG001|Overall Study|Lost to Follow-up|1|||
129951203|NCT00736502|467783095|FG000|Overall Study|Adverse Event|22|||
129951204|NCT00736502|467783095|FG000|Overall Study|Lack of Efficacy|16|||
129951205|NCT00736502|467783095|FG000|Overall Study|Lost to Follow-up|27|||
129951206|NCT03032198|467783096|FG000|Overall Study|Screen Fail|1|||
129951207|NCT03100370|467783097|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951208|NCT03100370|467783098|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951209|NCT03100370|467783099|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951210|NCT03100370|467783100|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129951211|NCT03100370|467783101|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951212|NCT03100370|467783102|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
129951213|NCT01307800|467783103|FG000|Overall Study|Adverse Event|9|||
129951214|NCT01307800|467783104|FG001|Overall Study|Adverse Event|8|||
129951215|NCT01307800|467783105|FG002|Overall Study|Adverse Event|10|||
129951216|NCT01307800|467783106|FG003|Overall Study|Adverse Event|14|||
129951217|NCT01307800|467783103|FG000|Overall Study|Entry Criteria Not Met|0|||
129951218|NCT01307800|467783104|FG001|Overall Study|Entry Criteria Not Met|0|||
129951219|NCT01307800|467783105|FG002|Overall Study|Entry Criteria Not Met|0|||
129951220|NCT01307800|467783106|FG003|Overall Study|Entry Criteria Not Met|2|||
129951221|NCT01307800|467783103|FG000|Overall Study|Lost to Follow-up|5|||
129951222|NCT01307800|467783104|FG001|Overall Study|Lost to Follow-up|6|||
129951223|NCT01307800|467783105|FG002|Overall Study|Lost to Follow-up|2|||
129951224|NCT01307800|467783106|FG003|Overall Study|Lost to Follow-up|8|||
129951225|NCT01307800|467783103|FG000|Overall Study|Perceived Lack of Efficacy|24|||
129951226|NCT01307800|467783104|FG001|Overall Study|Perceived Lack of Efficacy|23|||
129453591|NCT00111800|465958062|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
129453592|NCT00111800|465958063|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
129453593|NCT00111800|465958064|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
129453594|NCT00111800|465958065|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
129453595|NCT01549275|465958066|FG000|Overall Study|Lost to Follow-up|1|||
129453596|NCT01549275|465958067|FG001|Overall Study|Lost to Follow-up|0|||
129453597|NCT01111851|465958070|FG000|Overall Study|All planned PET scans were not obtained.|2|||
129453598|NCT01111851|465958071|FG001|Overall Study|All planned PET scans were not obtained.|0|||
129453599|NCT01471015|465958073|FG000|Overall Study|Death|0|||
129951227|NCT01307800|467783105|FG002|Overall Study|Perceived Lack of Efficacy|20|||
129951228|NCT01307800|467783106|FG003|Overall Study|Perceived Lack of Efficacy|33|||
129951229|NCT01307800|467783103|FG000|Overall Study|Protocol Violation|0|||
129951230|NCT01307800|467783104|FG001|Overall Study|Protocol Violation|3|||
129951231|NCT01307800|467783105|FG002|Overall Study|Protocol Violation|4|||
129951232|NCT01307800|467783106|FG003|Overall Study|Protocol Violation|5|||
129951233|NCT01307800|467783103|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
129951234|NCT01307800|467783104|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
129951235|NCT01307800|467783105|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
129951236|NCT01307800|467783106|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
129951237|NCT01307800|467783103|FG000|Overall Study|Sponsor Decision|6|||
129951238|NCT01307800|467783104|FG001|Overall Study|Sponsor Decision|9|||
129951239|NCT01307800|467783105|FG002|Overall Study|Sponsor Decision|12|||
129951240|NCT01307800|467783106|FG003|Overall Study|Sponsor Decision|28|||
129951241|NCT01307800|467783103|FG000|Overall Study|Withdrawal by Subject|10|||
129951242|NCT01307800|467783104|FG001|Overall Study|Withdrawal by Subject|11|||
129951243|NCT01307800|467783105|FG002|Overall Study|Withdrawal by Subject|8|||
129951244|NCT01307800|467783106|FG003|Overall Study|Withdrawal by Subject|15|||
129951245|NCT01307800|467783103|FG000|Overall Study|Participant Moved|0|||
129951246|NCT01307800|467783104|FG001|Overall Study|Participant Moved|2|||
129951247|NCT01307800|467783105|FG002|Overall Study|Participant Moved|1|||
129951248|NCT01307800|467783106|FG003|Overall Study|Participant Moved|3|||
129951249|NCT00689351|467783107|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
129951250|NCT00689351|467783108|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
129951251|NCT00689351|467783107|FG000|Infant Series of Dosing|Adverse Event|1|||
129951252|NCT00689351|467783108|FG001|Infant Series of Dosing|Adverse Event|0|||
129951253|NCT00689351|467783107|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
129951254|NCT00689351|467783108|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
129951255|NCT00689351|467783107|FG000|After Infant Series|Parent/legal guardian request|1|||
129951256|NCT00689351|467783108|FG001|After Infant Series|Parent/legal guardian request|0|||
129951257|NCT01766206|467783109|FG000|Overall Study|Withdrawal by Subject|22|||
129951258|NCT01766206|467783109|FG000|Overall Study|Lost to Follow-up|10|||
129951259|NCT01766206|467783109|FG000|Overall Study|Inappropriate enrollment|18|||
129951260|NCT01766206|467783109|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
129951261|NCT01884571|467783112|FG000|Overall Study|Adverse Event|1|||
129951262|NCT01884571|467783112|FG000|Overall Study|Death|2|||
129951263|NCT01884571|467783112|FG000|Overall Study|Withdrawal by Subject|2|||
129951264|NCT01884571|467783112|FG000|Overall Study|Disease progression|3|||
129951265|NCT03978130|467784771|FG000|Overall Study|Lost to Follow-up|13|||
129951266|NCT03978130|467784772|FG001|Overall Study|Lost to Follow-up|14|||
129951267|NCT03978130|467784771|FG000|Overall Study|Withdrawal by Subject|12|||
129951268|NCT03978130|467784772|FG001|Overall Study|Withdrawal by Subject|2|||
129951269|NCT03978130|467784771|FG000|Overall Study|Adverse Event|2|||
129951270|NCT03978130|467784772|FG001|Overall Study|Adverse Event|1|||
129951271|NCT01562275|467784773|FG000|Stage 1|Adverse Event|0|||
129951272|NCT01562275|467784774|FG001|Stage 1|Adverse Event|0|||
129951273|NCT01562275|467784775|FG002|Stage 1|Adverse Event|0|||
129951274|NCT01562275|467784776|FG003|Stage 1|Adverse Event|1|||
129951275|NCT01562275|467784777|FG004|Stage 1|Adverse Event|1|||
129951276|NCT01562275|467784778|FG005|Stage 1|Adverse Event|0|||
129951277|NCT01562275|467784779|FG006|Stage 1|Adverse Event|0|||
129951278|NCT01562275|467784780|FG007|Stage 1|Adverse Event|0|||
129951279|NCT01562275|467784781|FG008|Stage 1|Adverse Event|0|||
129951280|NCT01562275|467784782|FG009|Stage 1|Adverse Event|1|||
129951281|NCT01562275|467784783|FG010|Stage 1|Adverse Event|0|||
129951282|NCT01562275|467784784|FG011|Stage 1|Adverse Event|0|||
129951283|NCT01562275|467784785|FG012|Stage 1|Adverse Event|0|||
129951284|NCT01562275|467784773|FG000|Stage 1|Death|1|||
129951285|NCT01562275|467784774|FG001|Stage 1|Death|0|||
129951286|NCT01562275|467784775|FG002|Stage 1|Death|0|||
129951287|NCT01562275|467784776|FG003|Stage 1|Death|0|||
129951288|NCT01562275|467784777|FG004|Stage 1|Death|0|||
129453600|NCT01471015|465958074|FG001|Overall Study|Death|1|||
129951289|NCT01562275|467784778|FG005|Stage 1|Death|0|||
129951290|NCT01562275|467784779|FG006|Stage 1|Death|0|||
129951291|NCT01562275|467784780|FG007|Stage 1|Death|0|||
129951292|NCT01562275|467784781|FG008|Stage 1|Death|0|||
129951293|NCT01562275|467784782|FG009|Stage 1|Death|0|||
129951294|NCT01562275|467784783|FG010|Stage 1|Death|0|||
129951295|NCT01562275|467784784|FG011|Stage 1|Death|0|||
129951296|NCT01562275|467784785|FG012|Stage 1|Death|0|||
129951297|NCT01562275|467784773|FG000|Stage 1|Non Compliance|0|||
129951298|NCT01562275|467784774|FG001|Stage 1|Non Compliance|0|||
129951299|NCT01562275|467784775|FG002|Stage 1|Non Compliance|1|||
129951300|NCT01562275|467784776|FG003|Stage 1|Non Compliance|0|||
129951301|NCT01562275|467784777|FG004|Stage 1|Non Compliance|0|||
129951302|NCT01562275|467784778|FG005|Stage 1|Non Compliance|0|||
129951303|NCT01562275|467784779|FG006|Stage 1|Non Compliance|0|||
129951304|NCT01562275|467784780|FG007|Stage 1|Non Compliance|0|||
129951305|NCT01562275|467784781|FG008|Stage 1|Non Compliance|0|||
129951306|NCT01562275|467784782|FG009|Stage 1|Non Compliance|0|||
129951307|NCT01562275|467784783|FG010|Stage 1|Non Compliance|0|||
129951308|NCT01562275|467784784|FG011|Stage 1|Non Compliance|0|||
129951309|NCT01562275|467784785|FG012|Stage 1|Non Compliance|0|||
129951310|NCT01562275|467784773|FG000|Stage 1|Physician Decision|0|||
129951311|NCT01562275|467784774|FG001|Stage 1|Physician Decision|0|||
129951312|NCT01562275|467784775|FG002|Stage 1|Physician Decision|0|||
129951313|NCT01562275|467784776|FG003|Stage 1|Physician Decision|0|||
129951314|NCT01562275|467784777|FG004|Stage 1|Physician Decision|1|||
129951315|NCT01562275|467784778|FG005|Stage 1|Physician Decision|0|||
129951316|NCT01562275|467784779|FG006|Stage 1|Physician Decision|1|||
129951317|NCT01562275|467784780|FG007|Stage 1|Physician Decision|0|||
129951318|NCT01562275|467784781|FG008|Stage 1|Physician Decision|1|||
129951319|NCT01562275|467784782|FG009|Stage 1|Physician Decision|0|||
129951320|NCT01562275|467784783|FG010|Stage 1|Physician Decision|0|||
129951321|NCT01562275|467784784|FG011|Stage 1|Physician Decision|0|||
129951322|NCT01562275|467784785|FG012|Stage 1|Physician Decision|0|||
129951323|NCT01562275|467784773|FG000|Stage 1|Progression of Disease|2|||
129951324|NCT01562275|467784774|FG001|Stage 1|Progression of Disease|6|||
129951325|NCT01562275|467784775|FG002|Stage 1|Progression of Disease|2|||
129951326|NCT01562275|467784776|FG003|Stage 1|Progression of Disease|1|||
129951327|NCT01562275|467784777|FG004|Stage 1|Progression of Disease|2|||
129951328|NCT01562275|467784778|FG005|Stage 1|Progression of Disease|4|||
129951329|NCT01562275|467784779|FG006|Stage 1|Progression of Disease|1|||
129951330|NCT01562275|467784780|FG007|Stage 1|Progression of Disease|7|||
129951331|NCT01562275|467784781|FG008|Stage 1|Progression of Disease|2|||
129951332|NCT01562275|467784782|FG009|Stage 1|Progression of Disease|5|||
129951333|NCT01562275|467784783|FG010|Stage 1|Progression of Disease|3|||
129951334|NCT01562275|467784784|FG011|Stage 1|Progression of Disease|0|||
129951335|NCT01562275|467784785|FG012|Stage 1|Progression of Disease|0|||
129951336|NCT01562275|467784773|FG000|Stage 1|Withdrawal by Subject|0|||
129951337|NCT01562275|467784774|FG001|Stage 1|Withdrawal by Subject|1|||
129951338|NCT01562275|467784775|FG002|Stage 1|Withdrawal by Subject|0|||
129951339|NCT01562275|467784776|FG003|Stage 1|Withdrawal by Subject|2|||
129951340|NCT01562275|467784777|FG004|Stage 1|Withdrawal by Subject|0|||
129951341|NCT01562275|467784778|FG005|Stage 1|Withdrawal by Subject|0|||
129951342|NCT01562275|467784779|FG006|Stage 1|Withdrawal by Subject|1|||
129951343|NCT01562275|467784780|FG007|Stage 1|Withdrawal by Subject|0|||
129951344|NCT01562275|467784781|FG008|Stage 1|Withdrawal by Subject|0|||
129951345|NCT01562275|467784782|FG009|Stage 1|Withdrawal by Subject|1|||
129951346|NCT01562275|467784783|FG010|Stage 1|Withdrawal by Subject|0|||
129951347|NCT01562275|467784784|FG011|Stage 1|Withdrawal by Subject|0|||
129951348|NCT01562275|467784785|FG012|Stage 1|Withdrawal by Subject|0|||
129951349|NCT01562275|467784773|FG000|Stage 2|Death|0|||
129951350|NCT01562275|467784774|FG001|Stage 2|Death|0|||
129951351|NCT01562275|467784775|FG002|Stage 2|Death|0|||
129951352|NCT01562275|467784776|FG003|Stage 2|Death|0|||
129951353|NCT01562275|467784777|FG004|Stage 2|Death|0|||
129951354|NCT01562275|467784778|FG005|Stage 2|Death|0|||
129951355|NCT01562275|467784779|FG006|Stage 2|Death|0|||
129951356|NCT01562275|467784780|FG007|Stage 2|Death|0|||
129951357|NCT01562275|467784781|FG008|Stage 2|Death|0|||
129951358|NCT01562275|467784782|FG009|Stage 2|Death|0|||
129951359|NCT01562275|467784783|FG010|Stage 2|Death|0|||
129951360|NCT01562275|467784784|FG011|Stage 2|Death|2|||
129951361|NCT01562275|467784785|FG012|Stage 2|Death|1|||
129951362|NCT01562275|467784773|FG000|Stage 2|Progression of Disease|0|||
129951363|NCT01562275|467784774|FG001|Stage 2|Progression of Disease|0|||
129951364|NCT01562275|467784775|FG002|Stage 2|Progression of Disease|0|||
129951365|NCT01562275|467784776|FG003|Stage 2|Progression of Disease|0|||
129951366|NCT01562275|467784777|FG004|Stage 2|Progression of Disease|0|||
129951367|NCT01562275|467784778|FG005|Stage 2|Progression of Disease|0|||
129951368|NCT01562275|467784779|FG006|Stage 2|Progression of Disease|0|||
129951369|NCT01562275|467784780|FG007|Stage 2|Progression of Disease|0|||
129951370|NCT01562275|467784781|FG008|Stage 2|Progression of Disease|0|||
129951371|NCT01562275|467784782|FG009|Stage 2|Progression of Disease|0|||
129951372|NCT01562275|467784783|FG010|Stage 2|Progression of Disease|0|||
129951373|NCT01562275|467784784|FG011|Stage 2|Progression of Disease|12|||
129951374|NCT01562275|467784785|FG012|Stage 2|Progression of Disease|4|||
129951375|NCT00515112|467784787|FG000|Overall Study|Death|0|||
129951376|NCT00515112|467784788|FG001|Overall Study|Death|1|||
129951377|NCT00515112|467784787|FG000|Overall Study|The study was terminated|3|||
129951378|NCT00515112|467784788|FG001|Overall Study|The study was terminated|2|||
129951379|NCT01279447|467784789|FG000|Overall Study|Lost to Follow-up|3|||
129951380|NCT01279447|467784790|FG001|Overall Study|Lost to Follow-up|1|||
129951381|NCT01131325|467784791|FG000|Overall Study|Adverse Event|1|||
129951382|NCT01131325|467784791|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
129951383|NCT02213094|467784792|FG000|Overall Study|Adverse Event|1|||
129951384|NCT02213094|467784793|FG001|Overall Study|Adverse Event|0|||
129951385|NCT00988429|467784794|FG000|Overall Study|Adverse Event|9|||
129951386|NCT00988429|467784795|FG001|Overall Study|Adverse Event|21|||
129951387|NCT00988429|467784796|FG002|Overall Study|Adverse Event|45|||
129951388|NCT00988429|467784794|FG000|Overall Study|Lack of Efficacy|0|||
129951389|NCT00988429|467784795|FG001|Overall Study|Lack of Efficacy|0|||
129951390|NCT00988429|467784796|FG002|Overall Study|Lack of Efficacy|1|||
129951391|NCT00988429|467784794|FG000|Overall Study|Non-Compliance with Study Drug|5|||
129951392|NCT00988429|467784795|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129951393|NCT00988429|467784796|FG002|Overall Study|Non-Compliance with Study Drug|3|||
129951394|NCT00988429|467784794|FG000|Overall Study|Physician Decision|1|||
129951395|NCT00988429|467784795|FG001|Overall Study|Physician Decision|0|||
129951396|NCT00988429|467784796|FG002|Overall Study|Physician Decision|3|||
129951397|NCT00988429|467784794|FG000|Overall Study|Pregnancy|2|||
129951398|NCT00988429|467784795|FG001|Overall Study|Pregnancy|1|||
129951399|NCT00988429|467784796|FG002|Overall Study|Pregnancy|0|||
129951400|NCT00988429|467784794|FG000|Overall Study|Protocol Violation|4|||
129951401|NCT00988429|467784795|FG001|Overall Study|Protocol Violation|3|||
129951402|NCT00988429|467784796|FG002|Overall Study|Protocol Violation|3|||
129951403|NCT00988429|467784794|FG000|Overall Study|Withdrawal by Subject|7|||
129951404|NCT00988429|467784795|FG001|Overall Study|Withdrawal by Subject|7|||
129951405|NCT00988429|467784796|FG002|Overall Study|Withdrawal by Subject|12|||
129951406|NCT00988429|467784794|FG000|Overall Study|Administrative Reasons|1|||
129951407|NCT00988429|467784795|FG001|Overall Study|Administrative Reasons|2|||
129951408|NCT00988429|467784796|FG002|Overall Study|Administrative Reasons|1|||
129951409|NCT00988429|467784794|FG000|Overall Study|other reasons|8|||
129951410|NCT00988429|467784795|FG001|Overall Study|other reasons|8|||
129951411|NCT00988429|467784796|FG002|Overall Study|other reasons|1|||
129951412|NCT02964234|467784797|FG000|Overall Study|Lost to Follow-up|22|||
129951413|NCT02964234|467784798|FG001|Overall Study|Lost to Follow-up|13|||
129951414|NCT01074229|467784799|FG000|Overall Study|Lost to Follow-up|1|||
129951415|NCT01074229|467784800|FG001|Overall Study|Lost to Follow-up|0|||
129951416|NCT01074229|467784801|FG002|Overall Study|Lost to Follow-up|0|||
129951417|NCT01074229|467784799|FG000|Overall Study|Change to open surgical procedure|1|||
129951418|NCT01074229|467784800|FG001|Overall Study|Change to open surgical procedure|3|||
129951419|NCT01074229|467784801|FG002|Overall Study|Change to open surgical procedure|4|||
129951420|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
129951421|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
129951422|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
129951423|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
129951424|NCT02163499|467784804|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
129951425|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
129951426|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
129951427|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
129951428|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
129951429|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
129951430|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
129951431|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
129951432|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
129951433|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
129951434|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Death|8|||
129951435|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
129951436|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
129951437|NCT02163499|467784804|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
129951438|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
129951439|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951440|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951441|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951442|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951443|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951444|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951445|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951446|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951447|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951448|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951449|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951450|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951451|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951452|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951453|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951454|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951455|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951456|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
129951457|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951458|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951459|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951460|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951461|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951462|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
129951463|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951464|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
129951465|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951466|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951467|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951468|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951469|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951470|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951471|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951472|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951473|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951474|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951475|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
129951476|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951477|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951478|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951479|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951480|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951481|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951482|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
129951483|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951484|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951485|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951486|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951487|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951488|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951489|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951490|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951491|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951492|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951493|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951494|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
129951495|NCT01587703|467784805|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
129951496|NCT01587703|467784806|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
129951497|NCT01587703|467784807|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
129951498|NCT01587703|467784808|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
129951499|NCT01587703|467784809|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
129951500|NCT01587703|467784810|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
129951501|NCT01587703|467784811|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
129951502|NCT01587703|467784812|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
129951503|NCT01587703|467784813|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951504|NCT01587703|467784814|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951505|NCT01587703|467784815|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951506|NCT01587703|467784816|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951507|NCT01587703|467784817|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951508|NCT01587703|467784818|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951509|NCT01587703|467784819|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951510|NCT01587703|467784820|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951511|NCT01587703|467784821|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951512|NCT01587703|467784822|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951513|NCT01587703|467784823|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
129951514|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951515|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951516|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951517|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951518|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951519|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951520|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951521|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951522|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
129951523|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
129951524|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
129951525|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951526|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951527|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951528|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951529|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951530|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951531|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951532|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
129951533|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951534|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951535|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951536|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951537|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951538|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951539|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951540|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951541|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
129951542|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951543|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
129951544|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951545|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951546|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951547|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951548|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951549|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951550|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951551|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
129951552|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951553|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951554|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951555|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951556|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951557|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951558|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951559|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951560|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951561|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
129951562|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
129951563|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951564|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951565|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951566|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951567|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951568|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951569|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951570|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
129951571|NCT01587703|467784805|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951572|NCT01587703|467784806|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951573|NCT01587703|467784807|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951574|NCT01587703|467784808|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951575|NCT01587703|467784809|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951576|NCT01587703|467784810|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951577|NCT01587703|467784811|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951578|NCT01587703|467784812|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951579|NCT01587703|467784813|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
129951580|NCT01587703|467784814|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951581|NCT01587703|467784815|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951582|NCT01587703|467784816|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951583|NCT01587703|467784817|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951584|NCT01587703|467784818|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951585|NCT01587703|467784819|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951586|NCT01587703|467784820|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951587|NCT01587703|467784821|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951588|NCT01587703|467784822|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951589|NCT01587703|467784823|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
129951590|NCT01587703|467784805|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951591|NCT01587703|467784806|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951592|NCT01587703|467784807|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951593|NCT01587703|467784808|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951594|NCT01587703|467784809|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951595|NCT01587703|467784810|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951596|NCT01587703|467784811|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951597|NCT01587703|467784812|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951598|NCT01587703|467784813|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951599|NCT01587703|467784814|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951600|NCT01587703|467784815|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951601|NCT01587703|467784816|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951602|NCT01587703|467784817|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951603|NCT01587703|467784818|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951604|NCT01587703|467784819|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951605|NCT01587703|467784820|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951606|NCT01587703|467784821|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951607|NCT01587703|467784822|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
129951608|NCT01587703|467784823|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
129951609|NCT01587703|467784805|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951610|NCT01587703|467784806|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951611|NCT01587703|467784807|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951612|NCT01587703|467784808|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951613|NCT01587703|467784809|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951614|NCT01587703|467784810|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951615|NCT01587703|467784811|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951616|NCT01587703|467784812|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951617|NCT01587703|467784813|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951618|NCT01587703|467784814|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951619|NCT01587703|467784815|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951620|NCT01587703|467784816|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951621|NCT01587703|467784817|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951622|NCT01587703|467784818|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951623|NCT01587703|467784819|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951624|NCT01587703|467784820|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951625|NCT01587703|467784821|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
129951626|NCT01587703|467784822|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
129951627|NCT01587703|467784823|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
129951628|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951629|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951630|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951631|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951632|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951633|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951634|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951635|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951636|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951637|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951638|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951639|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951640|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951641|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951642|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951643|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
129951644|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951645|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951646|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
129951647|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951648|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951649|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951650|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951651|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951652|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951653|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951654|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951655|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951656|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951657|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951658|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
129951659|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951660|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951661|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
129951662|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951663|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951664|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951665|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
129951666|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951667|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951668|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951669|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951670|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951671|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951672|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951673|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951674|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951675|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951676|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951677|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
129951678|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
129951679|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
129951680|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
129951681|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
129951682|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
129951683|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951684|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
129951685|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951686|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951687|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951688|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951689|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951690|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951691|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951692|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951693|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951694|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951695|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951696|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
129951697|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
129951698|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
129951699|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
129951700|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
129951701|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
129951702|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951703|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
129951704|NCT01587703|467784805|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951705|NCT01587703|467784806|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951706|NCT01587703|467784807|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951707|NCT01587703|467784808|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951708|NCT01587703|467784809|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951709|NCT01587703|467784810|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951710|NCT01587703|467784811|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951711|NCT01587703|467784812|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951712|NCT01587703|467784813|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951713|NCT01587703|467784814|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951714|NCT01587703|467784815|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951715|NCT01587703|467784816|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
129951716|NCT01587703|467784817|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951717|NCT01587703|467784818|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951718|NCT01587703|467784819|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951719|NCT01587703|467784820|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951720|NCT01587703|467784821|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951721|NCT01587703|467784822|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951722|NCT01587703|467784823|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
129951723|NCT01799993|467784828|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
129951724|NCT01799993|467784829|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
129951725|NCT01799993|467784828|FG000|Overall Study|Death|61|||
129951726|NCT01799993|467784829|FG001|Overall Study|Death|45|||
129951727|NCT01799993|467784828|FG000|Overall Study|Withdrawal by Subject|23|||
129951728|NCT01799993|467784829|FG001|Overall Study|Withdrawal by Subject|24|||
129951729|NCT01799993|467784828|FG000|Overall Study|Lost to Follow-up|5|||
129951730|NCT01799993|467784829|FG001|Overall Study|Lost to Follow-up|8|||
129951731|NCT01799993|467784828|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
129951732|NCT01799993|467784829|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
129951733|NCT01799993|467784828|FG000|Overall Study|Protocol driven decision point|0|||
129951734|NCT01799993|467784829|FG001|Overall Study|Protocol driven decision point|3|||
129951735|NCT01799993|467784828|FG000|Overall Study|Protocol Violation|1|||
129453601|NCT01471015|465958075|FG002|Overall Study|Death|1|||
129453602|NCT01843842|465958076|FG000|Overall Study|Do not meet inclusion criteria|1|||
129951736|NCT01799993|467784829|FG001|Overall Study|Protocol Violation|1|||
129951737|NCT01799993|467784828|FG000|Overall Study|Deterioration of general conditions|2|||
129951738|NCT01799993|467784829|FG001|Overall Study|Deterioration of general conditions|0|||
129951739|NCT01799993|467784828|FG000|Overall Study|Screen failure|0|||
129951740|NCT01799993|467784829|FG001|Overall Study|Screen failure|1|||
129951741|NCT01799993|467784828|FG000|Overall Study|Adverse Event|1|||
129951742|NCT01799993|467784829|FG001|Overall Study|Adverse Event|0|||
129951743|NCT01799993|467784828|FG000|Overall Study|Lack of Efficacy|1|||
129951744|NCT01799993|467784829|FG001|Overall Study|Lack of Efficacy|0|||
129951745|NCT01799993|467784828|FG000|Overall Study|Recovery|0|||
129951746|NCT01799993|467784829|FG001|Overall Study|Recovery|1|||
129951747|NCT01799993|467784828|FG000|Overall Study|Logistical difficulties|1|||
129951748|NCT01799993|467784829|FG001|Overall Study|Logistical difficulties|0|||
129951749|NCT01799993|467784828|FG000|Overall Study|Protocol deviation|1|||
129951750|NCT01799993|467784829|FG001|Overall Study|Protocol deviation|0|||
129951751|NCT01799993|467784828|FG000|Overall Study|Non-compliance with medical device|1|||
129951752|NCT01799993|467784829|FG001|Overall Study|Non-compliance with medical device|0|||
129951753|NCT01799993|467784828|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129951754|NCT01799993|467784829|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129951755|NCT01799993|467784828|FG000|Overall Study|Other|1|||
129951756|NCT01799993|467784829|FG001|Overall Study|Other|0|||
129951757|NCT01799993|467784828|FG000|Overall Study|Subject didn't return for follow-up|0|||
129951758|NCT01799993|467784829|FG001|Overall Study|Subject didn't return for follow-up|1|||
129951759|NCT04271254|467784830|FG000|Overall Study|Withdrawal by Subject|3|||
129951760|NCT04410445|467784831|FG000|Overall Study|Lost to Follow-up|3|||
129951761|NCT04410445|467784832|FG001|Overall Study|Lost to Follow-up|9|||
129951762|NCT04410445|467784831|FG000|Overall Study|Withdrawal by Subject|27|||
129951763|NCT04410445|467784832|FG001|Overall Study|Withdrawal by Subject|15|||
129951764|NCT01320683|467784833|FG000|Overall Study|Positive antibody response|1|||
129951765|NCT01123356|467784834|FG000|Overall Study|Adverse Event|2|||
129951766|NCT01123356|467784834|FG000|Overall Study|Lack of Efficacy|4|||
129951767|NCT01123356|467784834|FG000|Overall Study|Withdrawal by Subject|1|||
129951768|NCT00759681|467784835|FG000|Overall Study|Death|2|||
129951769|NCT00759681|467784836|FG001|Overall Study|Death|5|||
129951770|NCT00759681|467784835|FG000|Overall Study|Lost to Follow-up|8|||
129951771|NCT00759681|467784836|FG001|Overall Study|Lost to Follow-up|5|||
129951772|NCT00476151|467784837|FG000|Overall Study|Adverse Event|0|||
129951773|NCT00476151|467784838|FG001|Overall Study|Adverse Event|2|||
129951774|NCT00476151|467784837|FG000|Overall Study|Protocol Violation|1|||
129951775|NCT00476151|467784838|FG001|Overall Study|Protocol Violation|3|||
129951776|NCT00476151|467784837|FG000|Overall Study|Withdrawal by Subject|2|||
129951777|NCT00476151|467784838|FG001|Overall Study|Withdrawal by Subject|0|||
129951778|NCT00476151|467784837|FG000|Overall Study|Physician Decision|0|||
129951779|NCT00476151|467784838|FG001|Overall Study|Physician Decision|2|||
129951780|NCT01113541|467784845|FG000|Overall Study|Withdrawal by Subject|1|||
129951781|NCT01113541|467784845|FG000|Overall Study|Protocol Violation|1|||
129951782|NCT01113541|467784845|FG000|Overall Study|Study Terminated by Sponsor|7|||
129951783|NCT01113541|467784845|FG000|Overall Study|Adverse Event|4|||
129951784|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
129951785|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
129951786|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951787|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951788|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951789|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951790|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
129951791|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
129951792|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
129951793|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
129951794|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951795|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951796|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951797|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
129951798|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
129951799|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951800|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
129951801|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951802|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951803|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951804|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
129951805|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951806|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
129951807|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951808|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951809|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951810|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951811|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
129951812|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
129951813|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
129951814|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
129951815|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951816|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951817|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951818|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
129951819|NCT03745651|467784846|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
129951820|NCT03745651|467784847|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
129951821|NCT03745651|467784848|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
129951822|NCT03745651|467784849|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951823|NCT03745651|467784850|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951824|NCT03745651|467784851|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951825|NCT03745651|467784852|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
129951826|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951827|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951828|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951829|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951830|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951831|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
129951832|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
129951833|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951834|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951835|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951836|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
129951837|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
129951838|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
129951839|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
129951840|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129951841|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129951842|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
129951843|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
129951844|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
129951845|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
129951846|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
129951847|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951848|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951849|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951850|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
129951851|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
129951852|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
129951853|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
129951854|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951855|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951856|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951857|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
129951858|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951859|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
129951860|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
129951861|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951862|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951863|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951864|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951865|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951866|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
129951867|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
129951868|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129951869|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129951870|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
129951871|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
129951872|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
129951873|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
129951874|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
129951875|NCT03745651|467784846|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951876|NCT03745651|467784847|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951877|NCT03745651|467784848|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951878|NCT03745651|467784849|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
129951879|NCT03745651|467784850|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
129951880|NCT03745651|467784851|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
129951881|NCT03745651|467784852|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
129951882|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
129951883|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
129453603|NCT01843842|465958077|FG001|Overall Study|Do not meet inclusion criteria|1|||
129453604|NCT02953340|465958078|FG000|Overall Study|Death|0|||
129453605|NCT02953340|465958079|FG001|Overall Study|Death|1|||
129453606|NCT02953340|465958078|FG000|Overall Study|Investigator Decision|3|||
129453607|NCT02953340|465958079|FG001|Overall Study|Investigator Decision|3|||
129453608|NCT02953340|465958078|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
129453609|NCT02953340|465958079|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
129453610|NCT02953340|465958078|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
129453611|NCT02953340|465958079|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
129453612|NCT02953340|465958078|FG000|Overall Study|Withdrawal by Subject|9|||
129453613|NCT02953340|465958079|FG001|Overall Study|Withdrawal by Subject|9|||
129453614|NCT02953340|465958078|FG000|Overall Study|Sponsor decision|0|||
129453615|NCT02953340|465958079|FG001|Overall Study|Sponsor decision|2|||
129453616|NCT02953340|465958078|FG000|Overall Study|Lost to Follow-up|3|||
129453617|NCT02953340|465958079|FG001|Overall Study|Lost to Follow-up|2|||
129453618|NCT02953340|465958078|FG000|Overall Study|Reason not specified|2|||
129453619|NCT02953340|465958079|FG001|Overall Study|Reason not specified|2|||
129453620|NCT01376778|465958080|FG000|Overall Study|Lost to Follow-up|3|||
129951884|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
129951885|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
129951886|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
129951887|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
129951888|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
129951889|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
129951890|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
129951891|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
129951892|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
129951893|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
129951894|NCT01494467|467784855|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
129951895|NCT01494467|467784856|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
129951896|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
129951897|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
129951898|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
129951899|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
129951900|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
129951901|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
129951902|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
129951903|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
129951904|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
129951905|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
129951906|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
129951907|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
129951908|NCT01494467|467784855|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
129951909|NCT01494467|467784856|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
129951910|NCT02309892|467784857|FG000|Overall Study|Physician Decision|1|||
129951911|NCT02309892|467784858|FG001|Overall Study|Physician Decision|0|||
129951912|NCT02309892|467784859|FG002|Overall Study|Physician Decision|0|||
129951913|NCT02309892|467784860|FG003|Overall Study|Physician Decision|0|||
129951914|NCT02309892|467784861|FG004|Overall Study|Physician Decision|0|||
129951915|NCT02309892|467784862|FG005|Overall Study|Physician Decision|0|||
129951916|NCT02309892|467784863|FG006|Overall Study|Physician Decision|0|||
129951917|NCT02309892|467784857|FG000|Overall Study|Adverse Event|1|||
129951918|NCT02309892|467784858|FG001|Overall Study|Adverse Event|0|||
129951919|NCT02309892|467784859|FG002|Overall Study|Adverse Event|1|||
129951920|NCT02309892|467784860|FG003|Overall Study|Adverse Event|0|||
129951921|NCT02309892|467784861|FG004|Overall Study|Adverse Event|0|||
129951922|NCT02309892|467784862|FG005|Overall Study|Adverse Event|0|||
129951923|NCT02309892|467784863|FG006|Overall Study|Adverse Event|0|||
129951924|NCT02309892|467784857|FG000|Overall Study|Progressive Disease|0|||
129951925|NCT02309892|467784858|FG001|Overall Study|Progressive Disease|1|||
129951926|NCT02309892|467784859|FG002|Overall Study|Progressive Disease|0|||
129951927|NCT02309892|467784860|FG003|Overall Study|Progressive Disease|0|||
129951928|NCT02309892|467784861|FG004|Overall Study|Progressive Disease|1|||
129951929|NCT02309892|467784862|FG005|Overall Study|Progressive Disease|0|||
129951930|NCT02309892|467784863|FG006|Overall Study|Progressive Disease|0|||
129951931|NCT02309892|467784857|FG000|Overall Study|Death|0|||
129951932|NCT02309892|467784858|FG001|Overall Study|Death|0|||
129951933|NCT02309892|467784859|FG002|Overall Study|Death|0|||
129951934|NCT02309892|467784860|FG003|Overall Study|Death|0|||
129951935|NCT02309892|467784861|FG004|Overall Study|Death|0|||
129951936|NCT02309892|467784862|FG005|Overall Study|Death|1|||
129951937|NCT02309892|467784863|FG006|Overall Study|Death|0|||
129951938|NCT03262389|467784864|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
129951939|NCT03262389|467784864|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
129951940|NCT03262389|467784864|FG000|Overall Study|opted out of PET/MR|1|||
129951941|NCT01052272|467784865|FG000|Overall Study|Death|0|||
129951942|NCT01052272|467784866|FG001|Overall Study|Death|0|||
129951943|NCT01052272|467784867|FG002|Overall Study|Death|1|||
129951944|NCT01052272|467784868|FG003|Overall Study|Death|1|||
129951945|NCT01052272|467784865|FG000|Overall Study|Physician Decision|0|||
129951946|NCT01052272|467784866|FG001|Overall Study|Physician Decision|1|||
129951947|NCT01052272|467784867|FG002|Overall Study|Physician Decision|0|||
129951948|NCT01052272|467784868|FG003|Overall Study|Physician Decision|0|||
129951949|NCT01052272|467784865|FG000|Overall Study|patient refuses follow-up|5|||
129951950|NCT01052272|467784866|FG001|Overall Study|patient refuses follow-up|4|||
129951951|NCT01052272|467784867|FG002|Overall Study|patient refuses follow-up|2|||
129951952|NCT01052272|467784868|FG003|Overall Study|patient refuses follow-up|4|||
129951953|NCT01052272|467784865|FG000|Overall Study|Withdrawal by Subject|0|||
129951954|NCT01052272|467784866|FG001|Overall Study|Withdrawal by Subject|2|||
129453621|NCT01376778|465958081|FG001|Overall Study|Lost to Follow-up|2|||
129453622|NCT00928889|465958082|FG000|Overall Study|Lost to Follow-up|3|||
129453623|NCT00928889|465958083|FG001|Overall Study|Lost to Follow-up|1|||
129951955|NCT01052272|467784867|FG002|Overall Study|Withdrawal by Subject|3|||
129951956|NCT01052272|467784868|FG003|Overall Study|Withdrawal by Subject|2|||
129951957|NCT01052272|467784865|FG000|Overall Study|placed in long-term care|0|||
129951958|NCT01052272|467784866|FG001|Overall Study|placed in long-term care|0|||
129951959|NCT01052272|467784867|FG002|Overall Study|placed in long-term care|1|||
129951960|NCT01052272|467784868|FG003|Overall Study|placed in long-term care|0|||
129951961|NCT01052272|467784865|FG000|Overall Study|decline in health|0|||
129951962|NCT01052272|467784866|FG001|Overall Study|decline in health|0|||
129951963|NCT01052272|467784867|FG002|Overall Study|decline in health|1|||
129951964|NCT01052272|467784868|FG003|Overall Study|decline in health|0|||
129951965|NCT04739306|467784869|FG000|Main Study Period|Adverse Event|6|||
129951966|NCT04739306|467784870|FG001|Main Study Period|Adverse Event|7|||
129951967|NCT04739306|467784869|FG000|Main Study Period|Lost to Follow-up|4|||
129951968|NCT04739306|467784870|FG001|Main Study Period|Lost to Follow-up|6|||
129951969|NCT04739306|467784869|FG000|Main Study Period|Physician Decision|1|||
129951970|NCT04739306|467784870|FG001|Main Study Period|Physician Decision|1|||
129951971|NCT04739306|467784869|FG000|Main Study Period|Withdrawal by Subject|8|||
129951972|NCT04739306|467784870|FG001|Main Study Period|Withdrawal by Subject|6|||
129951973|NCT04739306|467784869|FG000|Main Study Period|Protocol Violation|0|||
129951974|NCT04739306|467784870|FG001|Main Study Period|Protocol Violation|1|||
129951975|NCT04739306|467784869|FG000|Main Study Period|War in Ukraine|1|||
129951976|NCT04739306|467784870|FG001|Main Study Period|War in Ukraine|1|||
129951977|NCT01077284|467784871|FG000|Overall Study|Adverse Event|2|||
129951978|NCT01077284|467784872|FG001|Overall Study|Adverse Event|0|||
129951979|NCT01077284|467784873|FG002|Overall Study|Adverse Event|1|||
129951980|NCT01077284|467784871|FG000|Overall Study|Lost to Follow-up|1|||
129951981|NCT01077284|467784872|FG001|Overall Study|Lost to Follow-up|2|||
129951982|NCT01077284|467784873|FG002|Overall Study|Lost to Follow-up|0|||
129951983|NCT01077284|467784871|FG000|Overall Study|Withdrawal by Subject|2|||
129951984|NCT01077284|467784872|FG001|Overall Study|Withdrawal by Subject|3|||
129951985|NCT01077284|467784873|FG002|Overall Study|Withdrawal by Subject|1|||
129951986|NCT01077284|467784871|FG000|Overall Study|Other|0|||
129951987|NCT01077284|467784872|FG001|Overall Study|Other|0|||
129951988|NCT01077284|467784873|FG002|Overall Study|Other|1|||
129951989|NCT00096278|467784874|FG000|Overall Study|No follow-up data|15|||
129951990|NCT00096278|467784875|FG001|Overall Study|No follow-up data|18|||
129951991|NCT00096278|467784874|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
129951992|NCT00096278|467784875|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
129951993|NCT01894620|467784878|FG000|Overall Study|Withdrawal by Subject|0|||
129951994|NCT01894620|467784879|FG001|Overall Study|Withdrawal by Subject|1|||
129951995|NCT05104242|467784880|FG000|Overall Study|Withdrawal by Subject|1|||
129951996|NCT05104242|467784881|FG001|Overall Study|Withdrawal by Subject|5|||
129951997|NCT05104242|467784880|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
129951998|NCT05104242|467784881|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
129951999|NCT01864200|467784882|FG000|Overall Study|Lost to Follow-up|1|||
129952000|NCT01864200|467784883|FG001|Overall Study|Lost to Follow-up|3|||
129952001|NCT01864200|467784882|FG000|Overall Study|Protocol Violation|1|||
129952002|NCT01864200|467784883|FG001|Overall Study|Protocol Violation|0|||
129952003|NCT02077374|467784884|FG000|Overall Study|Withdrawal by Subject|0|||
129952004|NCT02077374|467784885|FG001|Overall Study|Withdrawal by Subject|1|||
129952005|NCT02077374|467784884|FG000|Overall Study|Protocol Violation|0|||
129952006|NCT02077374|467784885|FG001|Overall Study|Protocol Violation|1|||
129952007|NCT00424476|467784887|FG000|Overall Study|Withdrawal by Subject|7|||
129952008|NCT00424476|467784888|FG001|Overall Study|Withdrawal by Subject|6|||
129952009|NCT00424476|467784889|FG002|Overall Study|Withdrawal by Subject|3|||
129952010|NCT00424476|467784887|FG000|Overall Study|Adverse Event|19|||
129952011|NCT00424476|467784888|FG001|Overall Study|Adverse Event|16|||
129952012|NCT00424476|467784889|FG002|Overall Study|Adverse Event|15|||
129952013|NCT00424476|467784887|FG000|Overall Study|Lack of Efficacy|16|||
129952014|NCT00424476|467784888|FG001|Overall Study|Lack of Efficacy|12|||
129952015|NCT00424476|467784889|FG002|Overall Study|Lack of Efficacy|12|||
129952016|NCT00424476|467784887|FG000|Overall Study|Lack of Compliance|1|||
129952017|NCT00424476|467784888|FG001|Overall Study|Lack of Compliance|1|||
129952018|NCT00424476|467784889|FG002|Overall Study|Lack of Compliance|1|||
129952019|NCT00424476|467784887|FG000|Overall Study|Lost to Follow-up|4|||
129952020|NCT00424476|467784888|FG001|Overall Study|Lost to Follow-up|6|||
129952021|NCT00424476|467784889|FG002|Overall Study|Lost to Follow-up|3|||
129952022|NCT00424476|467784887|FG000|Overall Study|Protocol Violation|7|||
129952023|NCT00424476|467784888|FG001|Overall Study|Protocol Violation|2|||
129952024|NCT00424476|467784889|FG002|Overall Study|Protocol Violation|3|||
129952025|NCT00424476|467784887|FG000|Overall Study|Physician Decision|3|||
129952026|NCT00424476|467784888|FG001|Overall Study|Physician Decision|2|||
129952027|NCT00424476|467784889|FG002|Overall Study|Physician Decision|3|||
129952028|NCT00424476|467784887|FG000|Overall Study|Other|4|||
129952029|NCT00424476|467784888|FG001|Overall Study|Other|3|||
129952030|NCT00424476|467784889|FG002|Overall Study|Other|9|||
129952031|NCT00657709|467784890|FG000|Overall Study|AE or Death|7|||
129952032|NCT00657709|467784891|FG001|Overall Study|AE or Death|7|||
129453624|NCT00928889|465958082|FG000|Overall Study|Protocol Violation|0|||
129453625|NCT00928889|465958083|FG001|Overall Study|Protocol Violation|1|||
129453626|NCT00928889|465958082|FG000|Overall Study|Adverse Event|1|||
129453627|NCT00928889|465958083|FG001|Overall Study|Adverse Event|0|||
129453628|NCT00928889|465958082|FG000|Overall Study|Other|1|||
129453629|NCT00928889|465958083|FG001|Overall Study|Other|0|||
129453630|NCT04712110|465958084|FG000|Overall Study|Lost to Follow-up|0|||
129952033|NCT00657709|467784892|FG002|Overall Study|AE or Death|6|||
129952034|NCT00657709|467784893|FG003|Overall Study|AE or Death|7|||
129952035|NCT00657709|467784894|FG004|Overall Study|AE or Death|1|||
129952036|NCT00657709|467784890|FG000|Overall Study|Withdrawal by Subject|7|||
129952037|NCT00657709|467784891|FG001|Overall Study|Withdrawal by Subject|15|||
129952038|NCT00657709|467784892|FG002|Overall Study|Withdrawal by Subject|15|||
129952039|NCT00657709|467784893|FG003|Overall Study|Withdrawal by Subject|5|||
129952040|NCT00657709|467784894|FG004|Overall Study|Withdrawal by Subject|9|||
129952041|NCT00657709|467784890|FG000|Overall Study|Lost to Follow-up|9|||
129952042|NCT00657709|467784891|FG001|Overall Study|Lost to Follow-up|9|||
129952043|NCT00657709|467784892|FG002|Overall Study|Lost to Follow-up|7|||
129952044|NCT00657709|467784893|FG003|Overall Study|Lost to Follow-up|1|||
129952045|NCT00657709|467784894|FG004|Overall Study|Lost to Follow-up|21|||
129952046|NCT00657709|467784890|FG000|Overall Study|Protocol Violation|0|||
129952047|NCT00657709|467784891|FG001|Overall Study|Protocol Violation|2|||
129952048|NCT00657709|467784892|FG002|Overall Study|Protocol Violation|0|||
129952049|NCT00657709|467784893|FG003|Overall Study|Protocol Violation|1|||
129952050|NCT00657709|467784894|FG004|Overall Study|Protocol Violation|2|||
129952051|NCT00409747|467784895|FG000|Overall Study|Withdrawal by Subject|1|||
129952052|NCT02555397|467784898|FG000|Overall Study|Withdrawal by Subject|1|||
129952053|NCT02555397|467784899|FG001|Overall Study|Withdrawal by Subject|0|||
129952054|NCT02555397|467784900|FG002|Overall Study|Withdrawal by Subject|0|||
129952055|NCT02555397|467784901|FG003|Overall Study|Withdrawal by Subject|0|||
129952056|NCT02555397|467784902|FG004|Overall Study|Withdrawal by Subject|0|||
129952057|NCT00632736|467784906|FG000|Overall Study|Adverse Event|104|||
129952058|NCT00632736|467784906|FG000|Overall Study|Lost to Follow-up|15|||
129952059|NCT00632736|467784906|FG000|Overall Study|Protocol Violation|14|||
129952060|NCT00632736|467784906|FG000|Overall Study|Withdrawal by Subject|99|||
129952061|NCT00632736|467784906|FG000|Overall Study|Lack of Efficacy|5|||
129453631|NCT04712110|465958085|FG001|Overall Study|Lost to Follow-up|1|||
129453632|NCT04712110|465958084|FG000|Overall Study|Withdrawal by Subject|0|||
129453633|NCT04712110|465958085|FG001|Overall Study|Withdrawal by Subject|4|||
129453634|NCT04712110|465958084|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
129952062|NCT00632736|467784906|FG000|Overall Study|Sponsor terminated study|5|||
129453635|NCT04712110|465958085|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
129453636|NCT01517893|465958086|FG000|Overall Study|Withdrawal by Subject|3|||
129952063|NCT00632736|467784906|FG000|Overall Study|Non-compliance|10|||
129952064|NCT00632736|467784906|FG000|Overall Study|Other|16|||
129453637|NCT01517893|465958087|FG001|Overall Study|Withdrawal by Subject|0|||
129952065|NCT02312258|467784907|FG000|Overall Study|Lost to Follow-up|8|||
129952066|NCT02312258|467784908|FG001|Overall Study|Lost to Follow-up|8|||
129952067|NCT02312258|467784907|FG000|Overall Study|Withdrawal by Patient|49|||
129952068|NCT02312258|467784908|FG001|Overall Study|Withdrawal by Patient|76|||
129952069|NCT02312258|467784907|FG000|Overall Study|Reason not Specified|107|||
129952070|NCT02312258|467784908|FG001|Overall Study|Reason not Specified|159|||
129952071|NCT02312258|467784907|FG000|Overall Study|Missing|2|||
129952072|NCT02312258|467784908|FG001|Overall Study|Missing|1|||
129952073|NCT02312258|467784907|FG000|Overall Study|Death|115|||
129952074|NCT02312258|467784908|FG001|Overall Study|Death|181|||
129952075|NCT02892019|467784915|FG000|Overall Study|randomized but not treated|0|||
129952076|NCT02892019|467784916|FG001|Overall Study|randomized but not treated|1|||
129952077|NCT02892019|467784915|FG000|Overall Study|Withdrawal by Subject|0|||
129952078|NCT02892019|467784916|FG001|Overall Study|Withdrawal by Subject|1|||
129952079|NCT02892019|467784915|FG000|Overall Study|Adverse Event|1|||
129952080|NCT02892019|467784916|FG001|Overall Study|Adverse Event|1|||
129952081|NCT01313663|467784917|FG000|Overall Study|Study Closed/Terminated|2|||
129952082|NCT01313663|467784918|FG001|Overall Study|Study Closed/Terminated|4|||
129952083|NCT01313663|467784917|FG000|Overall Study|Lost to Follow-up|0|||
129952084|NCT01313663|467784918|FG001|Overall Study|Lost to Follow-up|1|||
129952085|NCT01313663|467784917|FG000|Overall Study|Physician Decision|0|||
129952086|NCT01313663|467784918|FG001|Overall Study|Physician Decision|2|||
129952087|NCT01313663|467784917|FG000|Overall Study|Withdrawal by Subject|2|||
129952088|NCT01313663|467784918|FG001|Overall Study|Withdrawal by Subject|1|||
129952089|NCT00946998|467786833|FG000|Overall Study|Exited prior to first outcome assessment|5|||
129952090|NCT00946998|467786834|FG001|Overall Study|Exited prior to first outcome assessment|3|||
129952091|NCT04049578|467786837|FG000|Overall Study|Physician Decision|1|||
129952092|NCT00304278|467786841|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
129952093|NCT00304278|467786841|FG000|Overall Study|PT had medical condition preventing TX|1|||
129952094|NCT01945593|467786842|FG000|Overall Study|Adverse Event|0|||
129952095|NCT01945593|467786843|FG001|Overall Study|Adverse Event|0|||
129952096|NCT01945593|467786844|FG002|Overall Study|Adverse Event|0|||
129952097|NCT01945593|467786845|FG003|Overall Study|Adverse Event|5|||
129952098|NCT01945593|467786842|FG000|Overall Study|Physician Decision|0|||
129952099|NCT01945593|467786843|FG001|Overall Study|Physician Decision|0|||
129952100|NCT01945593|467786844|FG002|Overall Study|Physician Decision|1|||
129952101|NCT01945593|467786845|FG003|Overall Study|Physician Decision|1|||
129952102|NCT01945593|467786842|FG000|Overall Study|Withdrawal by Subject|0|||
129952103|NCT01945593|467786843|FG001|Overall Study|Withdrawal by Subject|2|||
129952104|NCT01945593|467786844|FG002|Overall Study|Withdrawal by Subject|0|||
129952105|NCT01945593|467786845|FG003|Overall Study|Withdrawal by Subject|4|||
129952106|NCT01945593|467786842|FG000|Overall Study|Protocol Violation|0|||
129952107|NCT01945593|467786843|FG001|Overall Study|Protocol Violation|2|||
129952108|NCT01945593|467786844|FG002|Overall Study|Protocol Violation|1|||
129952109|NCT01945593|467786845|FG003|Overall Study|Protocol Violation|3|||
129952110|NCT01945593|467786842|FG000|Overall Study|Death|0|||
129952111|NCT01945593|467786843|FG001|Overall Study|Death|0|||
129952112|NCT01945593|467786844|FG002|Overall Study|Death|1|||
129952113|NCT01945593|467786845|FG003|Overall Study|Death|0|||
129952114|NCT01945593|467786842|FG000|Overall Study|Other: Terminated|0|||
129952115|NCT01945593|467786843|FG001|Overall Study|Other: Terminated|0|||
129952116|NCT01945593|467786844|FG002|Overall Study|Other: Terminated|0|||
129952117|NCT01945593|467786845|FG003|Overall Study|Other: Terminated|1|||
129952118|NCT01945593|467786842|FG000|Overall Study|Other: Surgical Procedure|0|||
129952119|NCT01945593|467786843|FG001|Overall Study|Other: Surgical Procedure|2|||
129952120|NCT01945593|467786844|FG002|Overall Study|Other: Surgical Procedure|0|||
129952121|NCT01945593|467786845|FG003|Overall Study|Other: Surgical Procedure|6|||
129952122|NCT01945593|467786842|FG000|Overall Study|Other: Screen Failure|0|||
129952123|NCT01945593|467786843|FG001|Overall Study|Other: Screen Failure|2|||
129952124|NCT01945593|467786844|FG002|Overall Study|Other: Screen Failure|0|||
129952125|NCT01945593|467786845|FG003|Overall Study|Other: Screen Failure|0|||
129952126|NCT00507429|467786846|FG000|Treatment Phase|Disease Progression|12|||
129952127|NCT00507429|467786847|FG001|Treatment Phase|Disease Progression|5|||
129952128|NCT00507429|467786846|FG000|Treatment Phase|Adverse Event|12|||
129952129|NCT00507429|467786847|FG001|Treatment Phase|Adverse Event|5|||
129952130|NCT00507429|467786846|FG000|Treatment Phase|Withdrawal by Subject|3|||
129952131|NCT00507429|467786847|FG001|Treatment Phase|Withdrawal by Subject|3|||
129952132|NCT00507429|467786846|FG000|Treatment Phase|Physician Decision|4|||
129952133|NCT00507429|467786847|FG001|Treatment Phase|Physician Decision|2|||
129952134|NCT00507429|467786846|FG000|Treatment Phase|Other|6|||
129952135|NCT00507429|467786847|FG001|Treatment Phase|Other|3|||
129952136|NCT00507429|467786846|FG000|Maintenance Phase|Progressive Disease|14|||
129952137|NCT00507429|467786847|FG001|Maintenance Phase|Progressive Disease|0|||
129952138|NCT00608959|467786848|FG000|Part 1|Did not meet eligibility criteria|1|||
129952139|NCT01005602|467786849|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
129952140|NCT01005602|467786850|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
129952141|NCT01248715|467786851|FG000|Overall Study|Not influenza positive|501|||
129952142|NCT01248715|467786852|FG001|Overall Study|Not influenza positive|510|||
129952143|NCT03409276|467786858|FG000|Overall Study|Withdrawal by Subject|0|||
129952144|NCT03409276|467786859|FG001|Overall Study|Withdrawal by Subject|0|||
129952145|NCT03409276|467786860|FG002|Overall Study|Withdrawal by Subject|0|||
129952146|NCT03409276|467786861|FG003|Overall Study|Withdrawal by Subject|0|||
129952147|NCT03409276|467786862|FG004|Overall Study|Withdrawal by Subject|1|||
129952148|NCT03409276|467786858|FG000|Overall Study|Lost to Follow-up|0|||
129952149|NCT03409276|467786859|FG001|Overall Study|Lost to Follow-up|0|||
129952150|NCT03409276|467786860|FG002|Overall Study|Lost to Follow-up|0|||
129952151|NCT03409276|467786861|FG003|Overall Study|Lost to Follow-up|2|||
129952152|NCT03409276|467786862|FG004|Overall Study|Lost to Follow-up|2|||
129453638|NCT02973087|465958089|FG000|Overall Study|Withdrawal by Subject|2|||
129453639|NCT02973087|465958090|FG001|Overall Study|Withdrawal by Subject|1|||
129453640|NCT02973087|465958089|FG000|Overall Study|Adverse Event|1|||
129453641|NCT02973087|465958090|FG001|Overall Study|Adverse Event|0|||
129453642|NCT02973087|465958089|FG000|Overall Study|other|1|||
129453643|NCT02973087|465958090|FG001|Overall Study|other|1|||
129453644|NCT04143009|465958091|FG000|Pilot Trial|Lost to Follow-up|0|||
129453645|NCT04143009|465958092|FG001|Pilot Trial|Lost to Follow-up|1|||
129453646|NCT04143009|465958093|FG002|Pilot Trial|Lost to Follow-up|1|||
129453647|NCT05003622|465958094|FG000|Overall Study|Progressive disease|2|||
129453648|NCT05003622|465958094|FG000|Overall Study|Withdrawal by Subject|1|||
129453649|NCT01045798|465958100|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
129453650|NCT01045798|465958101|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
129453651|NCT01045798|465958100|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
129453652|NCT01045798|465958101|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
129453653|NCT01045798|465958100|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
129453654|NCT01045798|465958101|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
129453655|NCT01045798|465958100|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
129453656|NCT01045798|465958101|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
129453657|NCT01484977|465958105|FG000|Overall Study|Adverse Event|8|||
129453658|NCT01484977|465958105|FG000|Overall Study|Lack of Efficacy|4|||
129453659|NCT01484977|465958105|FG000|Overall Study|Protocol Violation|6|||
129453660|NCT01484977|465958105|FG000|Overall Study|Lost to Follow-up|1|||
129453661|NCT01484977|465958105|FG000|Overall Study|Withdrawal by Subject|4|||
129453662|NCT01484977|465958105|FG000|Overall Study|Subject Protocol Non-compliant|1|||
129453663|NCT01484977|465958105|FG000|Overall Study|Moving Overseas|1|||
129453664|NCT01484977|465958105|FG000|Overall Study|Low White Blood Cell Count|1|||
129453665|NCT01484977|465958105|FG000|Overall Study|Lack of Compliance|1|||
129453666|NCT04857996|465958108|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
129453667|NCT04857996|465958109|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
129453668|NCT04857996|465958108|FG000|Overall Study|Lost to Follow-up|1|||
129453669|NCT04857996|465958109|FG001|Overall Study|Lost to Follow-up|3|||
129453670|NCT04857996|465958108|FG000|Overall Study|Site Closure|1|||
129453671|NCT04857996|465958109|FG001|Overall Study|Site Closure|0|||
129453672|NCT04857996|465958108|FG000|Overall Study|Withdrawal by Subject|1|||
129453673|NCT04857996|465958109|FG001|Overall Study|Withdrawal by Subject|0|||
129453674|NCT02269787|465958110|FG000|Overall Study|Lost to Follow-up|20|||
129453675|NCT02269787|465958111|FG001|Overall Study|Lost to Follow-up|6|||
129453676|NCT02269787|465958110|FG000|Overall Study|Death|2|||
129453677|NCT02269787|465958111|FG001|Overall Study|Death|3|||
129453678|NCT02269787|465958110|FG000|Overall Study|Incapacitated|0|||
129453679|NCT02269787|465958111|FG001|Overall Study|Incapacitated|1|||
129453680|NCT02228720|465958112|FG000|Open Label - Day 30|Lost to Follow-up|1|||
129453681|NCT05264740|465958119|FG000|Baseline|Withdrawal by Subject|0|||
129453682|NCT05264740|465958120|FG001|Baseline|Withdrawal by Subject|1|||
129453683|NCT05264740|465958119|FG000|Follow Up 1|Lost to Follow-up|1|||
129453684|NCT05264740|465958120|FG001|Follow Up 1|Lost to Follow-up|1|||
129453685|NCT05264740|465958119|FG000|Follow Up 1|Withdrawal by Subject|0|||
129453686|NCT05264740|465958120|FG001|Follow Up 1|Withdrawal by Subject|1|||
129453687|NCT05264740|465958119|FG000|Follow Up 2|Lost to Follow-up|1|||
129453688|NCT05264740|465958120|FG001|Follow Up 2|Lost to Follow-up|4|||
129453689|NCT05264740|465958119|FG000|Follow Up 3|Lost to Follow-up|7|||
129453690|NCT05264740|465958120|FG001|Follow Up 3|Lost to Follow-up|4|||
129453691|NCT00597753|465958123|FG000|Overall Study|Adverse Event|6|||
129453692|NCT00597753|465958124|FG001|Overall Study|Adverse Event|2|||
129453693|NCT00597753|465958123|FG000|Overall Study|Death|55|||
129453694|NCT00597753|465958124|FG001|Overall Study|Death|29|||
129453695|NCT00597753|465958123|FG000|Overall Study|Lack of Efficacy|2|||
129453696|NCT00597753|465958124|FG001|Overall Study|Lack of Efficacy|0|||
129453697|NCT00597753|465958123|FG000|Overall Study|Lost to Follow-up|10|||
129453698|NCT00597753|465958124|FG001|Overall Study|Lost to Follow-up|3|||
129453699|NCT00597753|465958123|FG000|Overall Study|Physician Decision|5|||
129453700|NCT00597753|465958124|FG001|Overall Study|Physician Decision|1|||
129453701|NCT00597753|465958123|FG000|Overall Study|Pregnancy|1|||
129453702|NCT00597753|465958124|FG001|Overall Study|Pregnancy|0|||
129453703|NCT00597753|465958123|FG000|Overall Study|Withdrawal by Subject|35|||
129453704|NCT00597753|465958124|FG001|Overall Study|Withdrawal by Subject|12|||
129453705|NCT00597753|465958123|FG000|Overall Study|Discontinued Dialysis|0|||
129952153|NCT03605745|467786864|FG000|Overall Study|Study was terminated for business reasons|47|||
129952154|NCT03344458|467786868|FG000|Overall Study|Physician Decision|1|||
129952155|NCT03344458|467786868|FG000|Overall Study|Withdrawal by Subject|16|||
129952156|NCT03344458|467786868|FG000|Overall Study|Other reasons|10|||
129952157|NCT03344458|467786868|FG000|Overall Study|Lost to Follow-up|9|||
129952158|NCT03344458|467786868|FG000|Overall Study|Protocol Violation|3|||
129952159|NCT03884478|467786869|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
129952160|NCT03884478|467786870|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
129952161|NCT03884478|467786871|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
129952162|NCT03884478|467786869|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
129952163|NCT03884478|467786870|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
129952164|NCT03884478|467786871|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
129952165|NCT03884478|467786869|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
129952166|NCT03884478|467786870|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
129952167|NCT03884478|467786871|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
129952168|NCT03884478|467786869|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
129952169|NCT03884478|467786870|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
129952170|NCT03884478|467786871|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
129453706|NCT00597753|465958124|FG001|Overall Study|Discontinued Dialysis|1|||
129453707|NCT00597753|465958123|FG000|Overall Study|Never dosed|2|||
129952171|NCT01807234|467786874|FG000|Overall Study|Lost to Follow-up|2|||
129952172|NCT01807234|467786875|FG001|Overall Study|Lost to Follow-up|5|||
129952173|NCT01807234|467786876|FG002|Overall Study|Lost to Follow-up|1|||
129453708|NCT00597753|465958124|FG001|Overall Study|Never dosed|0|||
129453709|NCT00597753|465958123|FG000|Overall Study|Noncompliance|2|||
129453710|NCT00597753|465958124|FG001|Overall Study|Noncompliance|1|||
129453711|NCT00597753|465958123|FG000|Overall Study|Relocation|17|||
129453712|NCT00597753|465958124|FG001|Overall Study|Relocation|6|||
129453713|NCT00597753|465958123|FG000|Overall Study|Renal transplant|10|||
129453714|NCT00597753|465958124|FG001|Overall Study|Renal transplant|3|||
129453715|NCT00597753|465958123|FG000|Overall Study|Site closed by sponsor|19|||
129453716|NCT00597753|465958124|FG001|Overall Study|Site closed by sponsor|7|||
129952174|NCT01807234|467786877|FG003|Overall Study|Lost to Follow-up|1|||
129952175|NCT01807234|467786878|FG004|Overall Study|Lost to Follow-up|1|||
129952176|NCT01807234|467786879|FG005|Overall Study|Lost to Follow-up|2|||
129952177|NCT01807234|467786874|FG000|Overall Study|Withdrawal by Subject|3|||
129952178|NCT01807234|467786875|FG001|Overall Study|Withdrawal by Subject|1|||
129952179|NCT01807234|467786876|FG002|Overall Study|Withdrawal by Subject|1|||
129952180|NCT01807234|467786877|FG003|Overall Study|Withdrawal by Subject|1|||
129952181|NCT01807234|467786878|FG004|Overall Study|Withdrawal by Subject|2|||
129952182|NCT01807234|467786879|FG005|Overall Study|Withdrawal by Subject|1|||
129952183|NCT01807234|467786874|FG000|Overall Study|Lack of Efficacy|0|||
129952184|NCT01807234|467786875|FG001|Overall Study|Lack of Efficacy|0|||
129952185|NCT01807234|467786876|FG002|Overall Study|Lack of Efficacy|0|||
129952186|NCT01807234|467786877|FG003|Overall Study|Lack of Efficacy|0|||
129952187|NCT01807234|467786878|FG004|Overall Study|Lack of Efficacy|1|||
129952188|NCT01807234|467786879|FG005|Overall Study|Lack of Efficacy|1|||
129952189|NCT00538629|467786880|FG000|Overall Study|At subject's request|1|||
129952190|NCT00538629|467786880|FG000|Overall Study|Adverse Event|2|||
129952191|NCT00538629|467786880|FG000|Overall Study|Lack of Efficacy|12|||
129952192|NCT00538629|467786880|FG000|Overall Study|Lost to Follow-up|6|||
129453717|NCT00597753|465958123|FG000|Overall Study|Site elected to close|2|||
129952193|NCT00538629|467786880|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
129952194|NCT04454125|467786881|FG000|Overall Study|Lost to Follow-up|0|||
129952195|NCT04454125|467786882|FG001|Overall Study|Lost to Follow-up|1|||
129952196|NCT00555620|467786888|FG000|Overall Study|Death|0|||
129952197|NCT00555620|467786889|FG001|Overall Study|Death|1|||
129952198|NCT00555620|467786890|FG002|Overall Study|Death|0|||
129952199|NCT00555620|467786891|FG003|Overall Study|Death|0|||
129952200|NCT00555620|467786892|FG004|Overall Study|Death|0|||
129952201|NCT00555620|467786893|FG005|Overall Study|Death|1|||
129952202|NCT00555620|467786888|FG000|Overall Study|Study terminated by sponsor|0|||
129952203|NCT00555620|467786889|FG001|Overall Study|Study terminated by sponsor|0|||
129952204|NCT00555620|467786890|FG002|Overall Study|Study terminated by sponsor|1|||
129952205|NCT00555620|467786891|FG003|Overall Study|Study terminated by sponsor|0|||
129952206|NCT00555620|467786892|FG004|Overall Study|Study terminated by sponsor|0|||
129952207|NCT00555620|467786893|FG005|Overall Study|Study terminated by sponsor|0|||
129952208|NCT00555620|467786888|FG000|Overall Study|Adverse Event|0|||
129952209|NCT00555620|467786889|FG001|Overall Study|Adverse Event|0|||
129952210|NCT00555620|467786890|FG002|Overall Study|Adverse Event|1|||
129952211|NCT00555620|467786891|FG003|Overall Study|Adverse Event|5|||
129952212|NCT00555620|467786892|FG004|Overall Study|Adverse Event|0|||
129952213|NCT00555620|467786893|FG005|Overall Study|Adverse Event|1|||
129952214|NCT00555620|467786888|FG000|Overall Study|Objective progression or relapse|6|||
129952215|NCT00555620|467786889|FG001|Overall Study|Objective progression or relapse|5|||
129952216|NCT00555620|467786890|FG002|Overall Study|Objective progression or relapse|12|||
129952217|NCT00555620|467786891|FG003|Overall Study|Objective progression or relapse|17|||
129952218|NCT00555620|467786892|FG004|Overall Study|Objective progression or relapse|3|||
129952219|NCT00555620|467786893|FG005|Overall Study|Objective progression or relapse|16|||
129952220|NCT00555620|467786888|FG000|Overall Study|Participant refused treatment|0|||
129952221|NCT00555620|467786889|FG001|Overall Study|Participant refused treatment|1|||
129952222|NCT00555620|467786890|FG002|Overall Study|Participant refused treatment|1|||
129952223|NCT00555620|467786891|FG003|Overall Study|Participant refused treatment|0|||
129952224|NCT00555620|467786892|FG004|Overall Study|Participant refused treatment|0|||
129952225|NCT00555620|467786893|FG005|Overall Study|Participant refused treatment|1|||
129952226|NCT00555620|467786888|FG000|Overall Study|Other|0|||
129952227|NCT00555620|467786889|FG001|Overall Study|Other|0|||
129952228|NCT00555620|467786890|FG002|Overall Study|Other|0|||
129952229|NCT00555620|467786891|FG003|Overall Study|Other|1|||
129952230|NCT00555620|467786892|FG004|Overall Study|Other|0|||
129952231|NCT00555620|467786893|FG005|Overall Study|Other|3|||
129952232|NCT00828139|467786894|FG000|Overall Study|Adverse Event|8|||
129952233|NCT00828139|467786895|FG001|Overall Study|Adverse Event|1|||
129952234|NCT00828139|467786896|FG002|Overall Study|Adverse Event|10|||
129952235|NCT00828139|467786897|FG003|Overall Study|Adverse Event|5|||
129952236|NCT00828139|467786894|FG000|Overall Study|Death|2|||
129952237|NCT00828139|467786895|FG001|Overall Study|Death|1|||
129952238|NCT00828139|467786896|FG002|Overall Study|Death|0|||
129952239|NCT00828139|467786897|FG003|Overall Study|Death|2|||
129952240|NCT00828139|467786894|FG000|Overall Study|Refusal unrelated to toxicity|3|||
129952241|NCT00828139|467786895|FG001|Overall Study|Refusal unrelated to toxicity|4|||
129952242|NCT00828139|467786896|FG002|Overall Study|Refusal unrelated to toxicity|5|||
129952243|NCT00828139|467786897|FG003|Overall Study|Refusal unrelated to toxicity|3|||
129952244|NCT00828139|467786894|FG000|Overall Study|Disease Progression|24|||
129952245|NCT00828139|467786895|FG001|Overall Study|Disease Progression|33|||
129952246|NCT00828139|467786896|FG002|Overall Study|Disease Progression|35|||
129952247|NCT00828139|467786897|FG003|Overall Study|Disease Progression|39|||
129952248|NCT00828139|467786894|FG000|Overall Study|Other|4|||
129952249|NCT00828139|467786895|FG001|Overall Study|Other|2|||
129952250|NCT00828139|467786896|FG002|Overall Study|Other|5|||
129952251|NCT00828139|467786897|FG003|Overall Study|Other|2|||
129952252|NCT01714947|467786898|FG000|Part B|Progressive Disease|3|||
129952253|NCT01922102|467786899|FG000|Overall Study|Withdrawal by Subject|7|||
129952254|NCT01922102|467786900|FG001|Overall Study|Withdrawal by Subject|3|||
129952255|NCT01922102|467786901|FG002|Overall Study|Withdrawal by Subject|7|||
129952256|NCT01922102|467786899|FG000|Overall Study|Physician Decision|0|||
129952257|NCT01922102|467786900|FG001|Overall Study|Physician Decision|2|||
129952258|NCT01922102|467786901|FG002|Overall Study|Physician Decision|1|||
129952259|NCT01922102|467786899|FG000|Overall Study|Adverse Event|1|||
129952260|NCT01922102|467786900|FG001|Overall Study|Adverse Event|2|||
129952261|NCT01922102|467786901|FG002|Overall Study|Adverse Event|0|||
129952262|NCT01922102|467786899|FG000|Overall Study|Lost to Follow-up|1|||
129453718|NCT00597753|465958124|FG001|Overall Study|Site elected to close|4|||
129453719|NCT03451851|465958125|FG000|PCP: Week 0 -16|Adverse Event|1|||
129952263|NCT01922102|467786900|FG001|Overall Study|Lost to Follow-up|0|||
129952264|NCT01922102|467786901|FG002|Overall Study|Lost to Follow-up|0|||
129952265|NCT01922102|467786899|FG000|Overall Study|Administrative problems|0|||
129952266|NCT01922102|467786900|FG001|Overall Study|Administrative problems|2|||
129952267|NCT01922102|467786901|FG002|Overall Study|Administrative problems|0|||
129952268|NCT05203822|467786902|FG000|Overall Study|Adverse Event|1|||
129952269|NCT05203822|467786902|FG000|Overall Study|Withdrawal by Subject|1|||
129952270|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
129952271|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
129952272|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
129952273|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
129952274|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
129952275|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
129952276|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
129952277|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
129952278|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
129952279|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
129952280|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
129952281|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
129952282|NCT01345253|467786903|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
129952283|NCT01345253|467786904|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
129952284|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
129952285|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
129952286|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
129952287|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
129952288|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
129952289|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
129952290|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
129952291|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
129952292|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
129952293|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
129952294|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
129952295|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
129952296|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
129952297|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
129952298|NCT01345253|467786903|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
129952299|NCT01345253|467786904|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
129952300|NCT01767376|467786911|FG000|Overall Study|Lost to Follow-up|3|||
129952301|NCT01767376|467786912|FG001|Overall Study|Lost to Follow-up|2|||
129952302|NCT01767376|467786913|FG002|Overall Study|Lost to Follow-up|0|||
129952303|NCT01767376|467786911|FG000|Overall Study|Withdrawal by Subject|1|||
129952304|NCT01767376|467786912|FG001|Overall Study|Withdrawal by Subject|1|||
129952305|NCT01767376|467786913|FG002|Overall Study|Withdrawal by Subject|0|||
129952306|NCT04175834|467786915|FG000|Overall Study|Withdrawal by Subject|1|||
129952307|NCT04175834|467786916|FG001|Overall Study|Withdrawal by Subject|0|||
129952308|NCT03209492|467786919|FG000|Overall Study|Case Report Forms Uncollected|5|||
129952309|NCT01762345|467786920|FG000|Overall Study|Adverse Event|5|||
129952310|NCT01762345|467786920|FG000|Overall Study|Protocol Violation|2|||
129952311|NCT02379078|467786921|FG000|Overall Study|Lost to Follow-up|33|||
129952312|NCT02379078|467786922|FG001|Overall Study|Lost to Follow-up|30|||
129952313|NCT02379078|467786921|FG000|Overall Study|Withdrawal by Subject|6|||
129952314|NCT02379078|467786922|FG001|Overall Study|Withdrawal by Subject|5|||
129952315|NCT04908488|467786923|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
129952316|NCT04908488|467786924|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
129952317|NCT04908488|467786923|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
129952318|NCT04908488|467786924|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
129952319|NCT02959866|467786929|FG000|Overall Study|Withdrawal by Subject|1|||
129952320|NCT00952523|467786930|FG000|Overall Study|Withdrawal by Subject|7|||
129952321|NCT01029925|467786931|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
129952322|NCT01029925|467786931|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
129952323|NCT01029925|467786931|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
129952324|NCT05265247|467786932|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
129952325|NCT05265247|467786933|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
129952326|NCT05265247|467786932|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
129952327|NCT05265247|467786933|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
129952328|NCT05265247|467786932|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
129952329|NCT05265247|467786933|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
129952330|NCT01721109|467786936|FG000|Overall Study|Lack of Efficacy|1|||
129952331|NCT01721109|467786936|FG000|Overall Study|Non- Compliance with Study Drug|3|||
129952332|NCT01721109|467786936|FG000|Overall Study|Withdrew Consent|1|||
129952333|NCT01721109|467786936|FG000|Overall Study|Lost to Follow-up|2|||
129952334|NCT00134056|467786937|FG000|Randomization|Not eligible for assigned treatment|22|||
129952335|NCT00134056|467786938|FG001|Randomization|Not eligible for assigned treatment|20|||
129952336|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
129952337|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
129952338|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
129952339|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
129952340|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
129952341|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
129952342|NCT00134056|467786937|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
129952343|NCT00134056|467786938|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
129952344|NCT00321555|467786943|FG000|Overall Study|Developed antibodies|1|||
129952345|NCT00321555|467786943|FG000|Overall Study|Switched to alternative treatment|3|||
129952346|NCT00321555|467786943|FG000|Overall Study|Physician Decision|1|||
129952347|NCT00321555|467786943|FG000|Overall Study|Disease progression on study|1|||
129952348|NCT00537914|467786944|FG000|Overall Study|Death|1|||
129952349|NCT00537914|467786944|FG000|Overall Study|Adverse Event|7|||
129952350|NCT00537914|467786944|FG000|Overall Study|Treatment failure|10|||
129952351|NCT00537914|467786944|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
129952352|NCT00537914|467786944|FG000|Overall Study|Lost to Follow-up|19|||
129952353|NCT00537914|467786944|FG000|Overall Study|Withdrawal of informed consent|59|||
129952354|NCT01468597|467786945|FG000|Overall Study|Found ineligible|17|||
129952355|NCT01468597|467786945|FG000|Overall Study|concomitant valves|12|||
129952356|NCT01468597|467786945|FG000|Overall Study|off-pump CABG|1|||
129952357|NCT01468597|467786945|FG000|Overall Study|no platelet function data|5|||
129952358|NCT02260154|467786946|FG000|Overall Study|Screening failure|2|||
129952359|NCT02561195|467786948|FG000|Vaccination 1 to 3|Adverse Event|4|||
129952360|NCT02561195|467786949|FG001|Vaccination 1 to 3|Adverse Event|5|||
129952361|NCT02561195|467786950|FG002|Vaccination 1 to 3|Adverse Event|0|||
129952362|NCT02561195|467786951|FG003|Vaccination 1 to 3|Adverse Event|3|||
129952363|NCT02561195|467786952|FG004|Vaccination 1 to 3|Adverse Event|4|||
129952364|NCT02561195|467786953|FG005|Vaccination 1 to 3|Adverse Event|0|||
129952365|NCT02561195|467786954|FG006|Vaccination 1 to 3|Adverse Event|0|||
129952366|NCT02561195|467786955|FG007|Vaccination 1 to 3|Adverse Event|0|||
129952367|NCT02561195|467786956|FG008|Vaccination 1 to 3|Adverse Event|0|||
129952368|NCT02561195|467786957|FG009|Vaccination 1 to 3|Adverse Event|0|||
129952369|NCT02561195|467786958|FG010|Vaccination 1 to 3|Adverse Event|0|||
129952370|NCT02561195|467786959|FG011|Vaccination 1 to 3|Adverse Event|0|||
129952371|NCT02561195|467786960|FG012|Vaccination 1 to 3|Adverse Event|0|||
129952372|NCT02561195|467786961|FG013|Vaccination 1 to 3|Adverse Event|0|||
129952373|NCT02561195|467786948|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
129952374|NCT02561195|467786949|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
129952375|NCT02561195|467786950|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
129952376|NCT02561195|467786951|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
129952377|NCT02561195|467786952|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
129952378|NCT02561195|467786953|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
129952379|NCT02561195|467786954|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
129952380|NCT02561195|467786955|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
129952381|NCT02561195|467786956|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
129952382|NCT02561195|467786957|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
129952383|NCT02561195|467786958|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
129952384|NCT02561195|467786959|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
129952385|NCT02561195|467786960|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
129952386|NCT02561195|467786961|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
129952387|NCT02561195|467786948|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952388|NCT02561195|467786949|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
129952389|NCT02561195|467786950|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952390|NCT02561195|467786951|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
129952391|NCT02561195|467786952|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
129952392|NCT02561195|467786953|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
129952393|NCT02561195|467786954|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952394|NCT02561195|467786955|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952395|NCT02561195|467786956|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952396|NCT02561195|467786957|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952397|NCT02561195|467786958|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952398|NCT02561195|467786959|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952399|NCT02561195|467786960|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129453720|NCT03451851|465958126|FG001|PCP: Week 0 -16|Adverse Event|0|||
129952400|NCT02561195|467786961|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
129952401|NCT02561195|467786948|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
129952402|NCT02561195|467786949|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
129952403|NCT02561195|467786950|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
129952404|NCT02561195|467786951|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
129952405|NCT02561195|467786952|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
129453721|NCT03451851|465958127|FG002|PCP: Week 0 -16|Adverse Event|0|||
129453722|NCT03451851|465958128|FG003|PCP: Week 0 -16|Adverse Event|0|||
129952406|NCT02561195|467786953|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
129952407|NCT02561195|467786954|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
129952408|NCT02561195|467786955|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
129952409|NCT02561195|467786956|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
129952410|NCT02561195|467786957|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
129952411|NCT02561195|467786958|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
129952412|NCT02561195|467786959|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
129952413|NCT02561195|467786960|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
129952414|NCT02561195|467786961|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
129952415|NCT02561195|467786948|FG000|Vaccination 1 to 3|Other|7|||
129952416|NCT02561195|467786949|FG001|Vaccination 1 to 3|Other|3|||
129952417|NCT02561195|467786950|FG002|Vaccination 1 to 3|Other|1|||
129952418|NCT02561195|467786951|FG003|Vaccination 1 to 3|Other|7|||
129952419|NCT02561195|467786952|FG004|Vaccination 1 to 3|Other|5|||
129952420|NCT02561195|467786953|FG005|Vaccination 1 to 3|Other|1|||
129952421|NCT02561195|467786954|FG006|Vaccination 1 to 3|Other|0|||
129952422|NCT02561195|467786955|FG007|Vaccination 1 to 3|Other|0|||
129952423|NCT02561195|467786956|FG008|Vaccination 1 to 3|Other|0|||
129952424|NCT02561195|467786957|FG009|Vaccination 1 to 3|Other|0|||
129952425|NCT02561195|467786958|FG010|Vaccination 1 to 3|Other|0|||
129952426|NCT02561195|467786959|FG011|Vaccination 1 to 3|Other|0|||
129952427|NCT02561195|467786960|FG012|Vaccination 1 to 3|Other|0|||
129952428|NCT02561195|467786961|FG013|Vaccination 1 to 3|Other|0|||
129453723|NCT03451851|465958129|FG004|PCP: Week 0 -16|Adverse Event|0|||
129453724|NCT03451851|465958130|FG005|PCP: Week 0 -16|Adverse Event|0|||
129453725|NCT03451851|465958131|FG006|PCP: Week 0 -16|Adverse Event|1|||
129453726|NCT03451851|465958132|FG007|PCP: Week 0 -16|Adverse Event|0|||
129453727|NCT03451851|465958125|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453728|NCT03451851|465958126|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453729|NCT03451851|465958127|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
129453730|NCT03451851|465958128|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453731|NCT03451851|465958129|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453732|NCT03451851|465958130|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453733|NCT03451851|465958131|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453734|NCT03451851|465958132|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
129453735|NCT03451851|465958125|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129453736|NCT03451851|465958126|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129453737|NCT03451851|465958127|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
129453738|NCT03451851|465958128|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129952429|NCT02561195|467786948|FG000|Vaccination 1 to 3|Protocol Violation|1|||
129952430|NCT02561195|467786949|FG001|Vaccination 1 to 3|Protocol Violation|0|||
129952431|NCT02561195|467786950|FG002|Vaccination 1 to 3|Protocol Violation|1|||
129952432|NCT02561195|467786951|FG003|Vaccination 1 to 3|Protocol Violation|2|||
129952433|NCT02561195|467786952|FG004|Vaccination 1 to 3|Protocol Violation|5|||
129952434|NCT02561195|467786953|FG005|Vaccination 1 to 3|Protocol Violation|2|||
129453739|NCT03451851|465958129|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129453740|NCT03451851|465958130|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129453741|NCT03451851|465958131|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129453742|NCT03451851|465958132|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
129453743|NCT03451851|465958125|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
129453744|NCT03451851|465958126|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
129453745|NCT03451851|465958127|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
129952435|NCT02561195|467786954|FG006|Vaccination 1 to 3|Protocol Violation|0|||
129952436|NCT02561195|467786955|FG007|Vaccination 1 to 3|Protocol Violation|0|||
129952437|NCT02561195|467786956|FG008|Vaccination 1 to 3|Protocol Violation|0|||
129952438|NCT02561195|467786957|FG009|Vaccination 1 to 3|Protocol Violation|0|||
129453746|NCT03451851|465958128|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
129453747|NCT03451851|465958129|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
129453748|NCT03451851|465958130|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
129453749|NCT03451851|465958131|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
129453750|NCT03451851|465958132|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
129453751|NCT03451851|465958125|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453752|NCT03451851|465958126|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453753|NCT03451851|465958127|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453754|NCT03451851|465958128|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453755|NCT03451851|465958129|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
129453756|NCT03451851|465958130|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453757|NCT03451851|465958131|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453758|NCT03451851|465958132|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
129453759|NCT03451851|465958125|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453760|NCT03451851|465958126|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453761|NCT03451851|465958127|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453762|NCT03451851|465958128|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453763|NCT03451851|465958129|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
129453764|NCT03451851|465958130|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453765|NCT03451851|465958131|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453766|NCT03451851|465958132|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
129453767|NCT05885737|465958133|FG000|DB Period|Adverse Event|4|||
129453768|NCT05885737|465958134|FG001|DB Period|Adverse Event|4|||
129453769|NCT05885737|465958133|FG000|DB Period|Lost to Follow-up|0|||
129453770|NCT05885737|465958134|FG001|DB Period|Lost to Follow-up|1|||
129453771|NCT05885737|465958133|FG000|DB Period|Physician Decision|2|||
129453772|NCT05885737|465958134|FG001|DB Period|Physician Decision|0|||
129453773|NCT05885737|465958133|FG000|DB Period|Withdrawal by Subject|12|||
129453774|NCT05885737|465958134|FG001|DB Period|Withdrawal by Subject|6|||
129453775|NCT05885737|465958133|FG000|DB Period|Other: Unspecified|2|||
129453776|NCT05885737|465958134|FG001|DB Period|Other: Unspecified|2|||
129453777|NCT05885737|465958133|FG000|OLE Period|Adverse Event|3|||
129453778|NCT05885737|465958134|FG001|OLE Period|Adverse Event|2|||
129453779|NCT05885737|465958133|FG000|OLE Period|Physician Decision|1|||
129453780|NCT05885737|465958134|FG001|OLE Period|Physician Decision|0|||
129453781|NCT05885737|465958133|FG000|OLE Period|Withdrawal by Subject|5|||
129453782|NCT05885737|465958134|FG001|OLE Period|Withdrawal by Subject|5|||
129453783|NCT05885737|465958133|FG000|OLE Period|Other: Unspecified|2|||
129952439|NCT02561195|467786958|FG010|Vaccination 1 to 3|Protocol Violation|0|||
129952440|NCT02561195|467786959|FG011|Vaccination 1 to 3|Protocol Violation|0|||
129952441|NCT02561195|467786960|FG012|Vaccination 1 to 3|Protocol Violation|0|||
129952442|NCT02561195|467786961|FG013|Vaccination 1 to 3|Protocol Violation|0|||
129952443|NCT02561195|467786948|FG000|Vaccination 1 to 3|Death|2|||
129952444|NCT02561195|467786949|FG001|Vaccination 1 to 3|Death|1|||
129952445|NCT02561195|467786950|FG002|Vaccination 1 to 3|Death|0|||
129952446|NCT02561195|467786951|FG003|Vaccination 1 to 3|Death|2|||
129952447|NCT02561195|467786952|FG004|Vaccination 1 to 3|Death|0|||
129952448|NCT02561195|467786953|FG005|Vaccination 1 to 3|Death|0|||
129952449|NCT02561195|467786954|FG006|Vaccination 1 to 3|Death|0|||
129952450|NCT02561195|467786955|FG007|Vaccination 1 to 3|Death|0|||
129952451|NCT02561195|467786956|FG008|Vaccination 1 to 3|Death|0|||
129952452|NCT02561195|467786957|FG009|Vaccination 1 to 3|Death|0|||
129952453|NCT02561195|467786958|FG010|Vaccination 1 to 3|Death|0|||
129952454|NCT02561195|467786959|FG011|Vaccination 1 to 3|Death|0|||
129952455|NCT02561195|467786960|FG012|Vaccination 1 to 3|Death|0|||
129952456|NCT02561195|467786961|FG013|Vaccination 1 to 3|Death|0|||
129952457|NCT02561195|467786948|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
129952458|NCT02561195|467786949|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
129952459|NCT02561195|467786950|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
129952460|NCT02561195|467786951|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
129952461|NCT02561195|467786952|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
129952462|NCT02561195|467786953|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952463|NCT02561195|467786954|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952464|NCT02561195|467786955|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952465|NCT02561195|467786956|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952466|NCT02561195|467786957|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952467|NCT02561195|467786958|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952468|NCT02561195|467786959|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952469|NCT02561195|467786960|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952470|NCT02561195|467786961|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
129952471|NCT02561195|467786948|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
129952472|NCT02561195|467786949|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
129952473|NCT02561195|467786950|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
129952474|NCT02561195|467786951|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
129952475|NCT02561195|467786952|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
129952476|NCT02561195|467786953|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
129952477|NCT02561195|467786954|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
129952478|NCT02561195|467786955|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
129952479|NCT02561195|467786956|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
129952480|NCT02561195|467786957|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
129952481|NCT02561195|467786958|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
129952482|NCT02561195|467786959|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
129952483|NCT02561195|467786960|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
129952484|NCT02561195|467786961|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
129952485|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952486|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952487|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952488|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952489|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952490|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952491|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952492|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952493|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
129952494|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
129952495|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
129952496|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
129952497|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
129952498|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
129952499|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952500|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952501|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952502|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952503|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952504|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952505|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952506|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952507|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952508|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952509|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952510|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952511|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
129952512|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
129952513|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Death|0|||
129952514|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Death|0|||
129952515|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Death|0|||
129952516|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Death|0|||
129952517|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Death|0|||
129952518|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Death|0|||
129952519|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Death|0|||
129952520|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Death|0|||
129952521|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Death|0|||
129952522|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Death|1|||
129952523|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Death|0|||
129952524|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Death|0|||
129952525|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Death|0|||
129952526|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Death|0|||
129952527|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952528|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952529|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952530|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952531|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952532|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952533|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952534|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952535|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952536|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
129952537|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
129952538|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952539|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
129952540|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
129952541|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952542|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952543|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952544|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952545|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952546|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952547|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952548|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952549|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952550|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952551|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
129952552|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
129952553|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
129952554|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
129952555|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Other|0|||
129952556|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Other|0|||
129952557|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Other|0|||
129952558|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Other|0|||
129952559|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Other|0|||
129952560|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Other|0|||
129952561|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Other|0|||
129952562|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Other|0|||
129952563|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Other|0|||
129952564|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Other|0|||
129952565|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Other|2|||
129952566|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Other|2|||
129952567|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Other|1|||
129952568|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Other|0|||
129952569|NCT02561195|467786948|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952570|NCT02561195|467786949|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952571|NCT02561195|467786950|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952572|NCT02561195|467786951|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952573|NCT02561195|467786952|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952574|NCT02561195|467786953|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952575|NCT02561195|467786954|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
129952576|NCT02561195|467786955|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952577|NCT02561195|467786956|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952578|NCT02561195|467786957|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129453784|NCT05885737|465958134|FG001|OLE Period|Other: Unspecified|1|||
129453785|NCT01444742|465959356|FG000|Overall Study|Death|1|||
129453786|NCT02535715|465959357|FG000|Overall Study|Withdrawal by Subject|0|||
129453787|NCT02535715|465959358|FG001|Overall Study|Withdrawal by Subject|0|||
129453788|NCT02535715|465959359|FG002|Overall Study|Withdrawal by Subject|1|||
129453789|NCT00909181|465959360|FG000|Overall Study|Lost to Follow-up|39|||
129453790|NCT00909181|465959361|FG001|Overall Study|Lost to Follow-up|18|||
129453791|NCT00909181|465959362|FG002|Overall Study|Lost to Follow-up|33|||
129453792|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
129453793|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
129453794|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
129453795|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
129453796|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
129453797|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
129453798|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
129453799|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
129453800|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
129453801|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
129453802|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
129453803|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
129453804|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
129453805|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
129453806|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
129453807|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
129952579|NCT02561195|467786958|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
129952580|NCT02561195|467786959|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
129453808|NCT00094770|465959363|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
129952581|NCT02561195|467786960|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
129952582|NCT02561195|467786961|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
129952583|NCT03905512|467786962|FG000|Overall Study|Withdrawal by Subject|9|||
129952584|NCT03905512|467786963|FG001|Overall Study|Withdrawal by Subject|8|||
129952585|NCT03905512|467786962|FG000|Overall Study|Adverse Event|1|||
129952586|NCT03905512|467786963|FG001|Overall Study|Adverse Event|2|||
129952587|NCT03905512|467786962|FG000|Overall Study|Lost to Follow-up|4|||
129952588|NCT03905512|467786963|FG001|Overall Study|Lost to Follow-up|3|||
129952589|NCT03905512|467786962|FG000|Overall Study|Other than Specified|7|||
129952590|NCT03905512|467786963|FG001|Overall Study|Other than Specified|4|||
129952591|NCT00866619|467786964|FG000|Overall Study|Adverse Event|112|||
129952592|NCT00866619|467786965|FG001|Overall Study|Adverse Event|106|||
129952593|NCT00866619|467786966|FG002|Overall Study|Adverse Event|47|||
129952594|NCT00866619|467786967|FG003|Overall Study|Adverse Event|44|||
129952595|NCT00866619|467786964|FG000|Overall Study|Protocol Violation|2|||
129952596|NCT00866619|467786965|FG001|Overall Study|Protocol Violation|39|||
129952597|NCT00866619|467786966|FG002|Overall Study|Protocol Violation|2|||
129952598|NCT00866619|467786967|FG003|Overall Study|Protocol Violation|17|||
129952599|NCT00866619|467786964|FG000|Overall Study|Withdrawal by Subject|587|||
129952600|NCT00866619|467786965|FG001|Overall Study|Withdrawal by Subject|295|||
129952601|NCT00866619|467786966|FG002|Overall Study|Withdrawal by Subject|272|||
129952602|NCT00866619|467786967|FG003|Overall Study|Withdrawal by Subject|144|||
129453809|NCT00094770|465959364|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
129453810|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
129952603|NCT00866619|467786964|FG000|Overall Study|Lost to Follow-up|1145|||
129952604|NCT00866619|467786965|FG001|Overall Study|Lost to Follow-up|830|||
129952605|NCT00866619|467786966|FG002|Overall Study|Lost to Follow-up|568|||
129952606|NCT00866619|467786967|FG003|Overall Study|Lost to Follow-up|425|||
129952607|NCT03560206|467786968|FG000|Overall Study|Lost to Follow-up|19|||
129453811|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
129453812|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
129453813|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
129453814|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
129952608|NCT03560206|467786969|FG001|Overall Study|Lost to Follow-up|11|||
129952609|NCT03560206|467786968|FG000|Overall Study|Withdrawal by Subject|2|||
129952610|NCT03560206|467786969|FG001|Overall Study|Withdrawal by Subject|4|||
129952611|NCT03560206|467786968|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
129952612|NCT03560206|467786969|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
129952613|NCT03560206|467786968|FG000|Overall Study|Busy schedule|14|||
129952614|NCT03560206|467786969|FG001|Overall Study|Busy schedule|2|||
129952615|NCT03560206|467786968|FG000|Overall Study|patients' new health condition such as cancer|10|||
129952616|NCT03560206|467786969|FG001|Overall Study|patients' new health condition such as cancer|1|||
129952617|NCT01199302|467786975|FG000|Overall Study|Adverse Event|1|||
129952618|NCT01199302|467786976|FG001|Overall Study|Adverse Event|1|||
129952619|NCT01199302|467786977|FG002|Overall Study|Adverse Event|2|||
129952620|NCT01199302|467786978|FG003|Overall Study|Adverse Event|0|||
129952621|NCT01199302|467786975|FG000|Overall Study|Withdrawal by Subject|2|||
129952622|NCT01199302|467786976|FG001|Overall Study|Withdrawal by Subject|2|||
129952623|NCT01199302|467786977|FG002|Overall Study|Withdrawal by Subject|3|||
129952624|NCT01199302|467786978|FG003|Overall Study|Withdrawal by Subject|0|||
129952625|NCT01199302|467786975|FG000|Overall Study|Disease Progression|3|||
129952626|NCT01199302|467786976|FG001|Overall Study|Disease Progression|4|||
129952627|NCT01199302|467786977|FG002|Overall Study|Disease Progression|4|||
129952628|NCT01199302|467786978|FG003|Overall Study|Disease Progression|2|||
129952629|NCT01199302|467786975|FG000|Overall Study|Study Termination|13|||
129952630|NCT01199302|467786976|FG001|Overall Study|Study Termination|8|||
129952631|NCT01199302|467786977|FG002|Overall Study|Study Termination|11|||
129952632|NCT01199302|467786978|FG003|Overall Study|Study Termination|9|||
129952633|NCT01199302|467786975|FG000|Overall Study|Lost to Follow-up|0|||
129952634|NCT01199302|467786976|FG001|Overall Study|Lost to Follow-up|1|||
129952635|NCT01199302|467786977|FG002|Overall Study|Lost to Follow-up|0|||
129952636|NCT01199302|467786978|FG003|Overall Study|Lost to Follow-up|0|||
129952637|NCT01199302|467786975|FG000|Overall Study|Other|1|||
129952638|NCT01199302|467786976|FG001|Overall Study|Other|0|||
129952639|NCT01199302|467786977|FG002|Overall Study|Other|0|||
129952640|NCT01199302|467786978|FG003|Overall Study|Other|0|||
129952641|NCT01634165|467786981|FG000|Period 2|Adverse Event|0|||
129952642|NCT01634165|467786982|FG001|Period 2|Adverse Event|1|||
129952643|NCT01634165|467786983|FG002|Period 2|Adverse Event|0|||
129952644|NCT01634165|467786984|FG003|Period 2|Adverse Event|0|||
129952645|NCT03820024|467786985|FG000|Overall Study|Physician Decision|1|||
129952646|NCT03820024|467786986|FG001|Overall Study|Physician Decision|2|||
129952647|NCT00760877|467788311|FG000|Overall Study|Protocol Violation|1|||
129952648|NCT00760877|467788312|FG001|Overall Study|Protocol Violation|0|||
129952649|NCT00760877|467788311|FG000|Overall Study|Non-compliance with protocol treatment|2|||
129952650|NCT00760877|467788312|FG001|Overall Study|Non-compliance with protocol treatment|1|||
129952651|NCT00760877|467788311|FG000|Overall Study|Pregnancy|1|||
129952652|NCT00760877|467788312|FG001|Overall Study|Pregnancy|4|||
129952653|NCT00760877|467788311|FG000|Overall Study|Death|2|||
129952654|NCT00760877|467788312|FG001|Overall Study|Death|1|||
129952655|NCT00760877|467788311|FG000|Overall Study|Withdrawal by Subject|7|||
129952656|NCT00760877|467788312|FG001|Overall Study|Withdrawal by Subject|3|||
129952657|NCT00760877|467788311|FG000|Overall Study|Adverse Event|19|||
129952658|NCT00760877|467788312|FG001|Overall Study|Adverse Event|12|||
129952659|NCT00760877|467788311|FG000|Overall Study|Participant diagnosed with AML|0|||
129952660|NCT00760877|467788312|FG001|Overall Study|Participant diagnosed with AML|1|||
129952661|NCT00760877|467788311|FG000|Overall Study|Participant not eligible to cross-over|0|||
129952662|NCT00760877|467788312|FG001|Overall Study|Participant not eligible to cross-over|1|||
129952663|NCT00760877|467788311|FG000|Overall Study|Physician Decision|1|||
129952664|NCT00760877|467788312|FG001|Overall Study|Physician Decision|2|||
129952665|NCT00760877|467788311|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
129952666|NCT00760877|467788312|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
129952667|NCT00760877|467788311|FG000|Overall Study|Treatment failure|1|||
129952668|NCT00760877|467788312|FG001|Overall Study|Treatment failure|0|||
129952669|NCT00711555|467788315|FG000|Overall Study|Adverse Event|3|||
129952670|NCT05379400|467788317|FG000|Overall Study|Lost to Follow-up|1|||
129952671|NCT05379400|467788318|FG001|Overall Study|Lost to Follow-up|1|||
129952672|NCT04914897|467788320|FG000|Overall Study|Withdrawal by Subject|3|||
129952673|NCT04914897|467788321|FG001|Overall Study|Withdrawal by Subject|1|||
129952674|NCT04914897|467788322|FG002|Overall Study|Withdrawal by Subject|1|||
129952675|NCT04914897|467788323|FG003|Overall Study|Withdrawal by Subject|1|||
129952676|NCT04914897|467788320|FG000|Overall Study|Poor compliance to protocol|0|||
129952677|NCT04914897|467788321|FG001|Overall Study|Poor compliance to protocol|0|||
129952678|NCT04914897|467788322|FG002|Overall Study|Poor compliance to protocol|1|||
129952679|NCT04914897|467788323|FG003|Overall Study|Poor compliance to protocol|0|||
129952680|NCT04914897|467788320|FG000|Overall Study|Progressive disease|5|||
129952681|NCT04914897|467788321|FG001|Overall Study|Progressive disease|14|||
129952682|NCT04914897|467788322|FG002|Overall Study|Progressive disease|30|||
129952683|NCT04914897|467788323|FG003|Overall Study|Progressive disease|21|||
129952684|NCT04914897|467788320|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129952685|NCT04914897|467788321|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
129952686|NCT04914897|467788322|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
129952687|NCT04914897|467788323|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
129952688|NCT04914897|467788320|FG000|Overall Study|Other|1|||
129952689|NCT04914897|467788321|FG001|Overall Study|Other|0|||
129952690|NCT04914897|467788322|FG002|Overall Study|Other|0|||
129952691|NCT04914897|467788323|FG003|Overall Study|Other|1|||
129952692|NCT03141177|467788324|FG000|Overall Study|Death|62|||
129952693|NCT03141177|467788325|FG001|Overall Study|Death|13|||
129952694|NCT03141177|467788326|FG002|Overall Study|Death|84|||
129952695|NCT03141177|467788324|FG000|Overall Study|Participant withdrew consent|9|||
129952696|NCT03141177|467788325|FG001|Overall Study|Participant withdrew consent|2|||
129952697|NCT03141177|467788326|FG002|Overall Study|Participant withdrew consent|13|||
129952698|NCT03141177|467788324|FG000|Overall Study|Not reported|1|||
129952699|NCT03141177|467788325|FG001|Overall Study|Not reported|0|||
129952700|NCT03141177|467788326|FG002|Overall Study|Not reported|1|||
129952701|NCT03141177|467788324|FG000|Overall Study|Lost to Follow-up|2|||
129952702|NCT03141177|467788325|FG001|Overall Study|Lost to Follow-up|1|||
129952703|NCT03141177|467788326|FG002|Overall Study|Lost to Follow-up|1|||
129453815|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
129453816|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
129453817|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
129453818|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
129453819|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
129453820|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
129952704|NCT03141177|467788324|FG000|Overall Study|Other reasons|4|||
129952705|NCT03141177|467788325|FG001|Overall Study|Other reasons|0|||
129952706|NCT03141177|467788326|FG002|Overall Study|Other reasons|11|||
129952707|NCT03141177|467788324|FG000|Overall Study|Participants did not start treatment period|3|||
129952708|NCT03141177|467788325|FG001|Overall Study|Participants did not start treatment period|0|||
129952709|NCT03141177|467788326|FG002|Overall Study|Participants did not start treatment period|8|||
129952710|NCT03020914|467788329|FG000|Overall Study|Surgery Cancelled|1|||
129952711|NCT03020914|467788330|FG001|Overall Study|Surgery Cancelled|0|||
129952712|NCT00409006|467788335|FG000|Overall Study|Death|15|||
129952713|NCT00409006|467788336|FG001|Overall Study|Death|6|||
129952714|NCT00409006|467788335|FG000|Overall Study|Lost to Follow-up|1|||
129952715|NCT00409006|467788336|FG001|Overall Study|Lost to Follow-up|2|||
129952716|NCT00409006|467788335|FG000|Overall Study|Withdrawal by Subject|3|||
129952717|NCT00409006|467788336|FG001|Overall Study|Withdrawal by Subject|2|||
129952718|NCT00409006|467788335|FG000|Overall Study|Physician Decision|1|||
129952719|NCT00409006|467788336|FG001|Overall Study|Physician Decision|2|||
129952720|NCT03696342|467788340|FG000|Overall Study|Lost to Follow-up|1|||
129952721|NCT03696342|467788341|FG001|Overall Study|Lost to Follow-up|0|||
129952722|NCT01877720|467788347|FG000|Overall Study|Adverse Event|1|||
129952723|NCT01877720|467788348|FG001|Overall Study|Adverse Event|0|||
129952724|NCT00447499|467788349|FG000|Overall Study|Adverse Event|1|||
129952725|NCT00447499|467788349|FG000|Overall Study|Patient Decision|4|||
129952726|NCT00447499|467788349|FG000|Overall Study|Sponsor Decision|1|||
129952727|NCT00447499|467788349|FG000|Overall Study|Physician Decision|1|||
129952728|NCT02068352|467788350|FG000|Overall Study|Lost to Follow-up|0|||
129952729|NCT02068352|467788351|FG001|Overall Study|Lost to Follow-up|2|||
129952730|NCT02068352|467788352|FG002|Overall Study|Lost to Follow-up|0|||
129952731|NCT02068352|467788350|FG000|Overall Study|Adverse Event|4|||
129952732|NCT02068352|467788351|FG001|Overall Study|Adverse Event|2|||
129952733|NCT02068352|467788352|FG002|Overall Study|Adverse Event|7|||
129952734|NCT02068352|467788350|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
129952735|NCT02068352|467788351|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
129952736|NCT02068352|467788352|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
129952737|NCT02068352|467788350|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
129952738|NCT02068352|467788351|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
129952739|NCT02068352|467788352|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
129952740|NCT02068352|467788350|FG000|Overall Study|Protocol Deviation|0|||
129952741|NCT02068352|467788351|FG001|Overall Study|Protocol Deviation|0|||
129952742|NCT02068352|467788352|FG002|Overall Study|Protocol Deviation|1|||
129952743|NCT00946088|467788353|FG000|Overall Study|Withdrawal by Subject|0|||
129952744|NCT00946088|467788354|FG001|Overall Study|Withdrawal by Subject|1|||
129952745|NCT01322347|467788355|FG000|Overall Study|Adverse Event|7|||
129952746|NCT01322347|467788356|FG001|Overall Study|Adverse Event|2|||
129952747|NCT01322347|467788355|FG000|Overall Study|Death|5|||
129952748|NCT01322347|467788356|FG001|Overall Study|Death|3|||
129952749|NCT01322347|467788355|FG000|Overall Study|Physician Decision|2|||
129952750|NCT01322347|467788356|FG001|Overall Study|Physician Decision|1|||
129952751|NCT01322347|467788355|FG000|Overall Study|Protocol Violation|5|||
129952752|NCT01322347|467788356|FG001|Overall Study|Protocol Violation|2|||
129952753|NCT01322347|467788355|FG000|Overall Study|Withdrawal by Subject|1|||
129952754|NCT01322347|467788356|FG001|Overall Study|Withdrawal by Subject|4|||
129952755|NCT01322347|467788355|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
129952756|NCT01322347|467788356|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
129952757|NCT01322347|467788355|FG000|Overall Study|blood transfusion|5|||
129952758|NCT01322347|467788356|FG001|Overall Study|blood transfusion|5|||
129952759|NCT01322347|467788355|FG000|Overall Study|sponsor decision|1|||
129952760|NCT01322347|467788356|FG001|Overall Study|sponsor decision|3|||
129952761|NCT01322347|467788355|FG000|Overall Study|ineligible|6|||
129952762|NCT01322347|467788356|FG001|Overall Study|ineligible|3|||
129952763|NCT01322347|467788355|FG000|Overall Study|kidney transplant|3|||
129952764|NCT01322347|467788356|FG001|Overall Study|kidney transplant|1|||
129952765|NCT01322347|467788355|FG000|Overall Study|study drug withheld > 12 wks|0|||
129952766|NCT01322347|467788356|FG001|Overall Study|study drug withheld > 12 wks|1|||
129952767|NCT01322347|467788355|FG000|Overall Study|moved/changed dialysis|2|||
129952768|NCT01322347|467788356|FG001|Overall Study|moved/changed dialysis|4|||
129952769|NCT04883541|467788357|FG000|Overall Study|Not attending regular yoga class|16|||
129952770|NCT04883541|467788358|FG001|Overall Study|Not attending regular yoga class|0|||
129952771|NCT04883541|467788357|FG000|Overall Study|Not attending the pregnancy school|0|||
129952772|NCT04883541|467788358|FG001|Overall Study|Not attending the pregnancy school|9|||
129952773|NCT01369147|467788360|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
129952774|NCT01369147|467788361|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
129952775|NCT01369147|467788362|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
129952776|NCT00648895|467788368|FG000|Overall Study|Lack of Efficacy|0|||
129952777|NCT00648895|467788369|FG001|Overall Study|Lack of Efficacy|1|||
129952778|NCT02865083|467788370|FG000|Overall Study|Early Termination|3|||
129952779|NCT02865083|467788371|FG001|Overall Study|Early Termination|1|||
129952780|NCT04626128|467788372|FG000|Overall Study|Withdrawal by Subject|0|||
129952781|NCT04626128|467788373|FG001|Overall Study|Withdrawal by Subject|1|||
129952782|NCT04626128|467788374|FG002|Overall Study|Withdrawal by Subject|0|||
129952783|NCT04626128|467788375|FG003|Overall Study|Withdrawal by Subject|0|||
129952784|NCT01182285|467788376|FG000|First Intervention Week 1-10|Disease progression|1|||
129952785|NCT01182285|467788377|FG001|First Intervention Week 1-10|Disease progression|0|||
129952786|NCT01182285|467788378|FG002|First Intervention Week 1-10|Disease progression|0|||
129952787|NCT01182285|467788376|FG000|First Intervention Week 1-10|Adverse Event|1|||
129952788|NCT01182285|467788377|FG001|First Intervention Week 1-10|Adverse Event|0|||
129952789|NCT01182285|467788378|FG002|First Intervention Week 1-10|Adverse Event|0|||
129952790|NCT01182285|467788376|FG000|First Intervention Week 1-10|Non-compliance|1|||
129952791|NCT01182285|467788377|FG001|First Intervention Week 1-10|Non-compliance|0|||
129952792|NCT01182285|467788378|FG002|First Intervention Week 1-10|Non-compliance|0|||
129952793|NCT01182285|467788376|FG000|Third Intervention Week 11-52|Disease Progression|0|||
129952794|NCT01182285|467788377|FG001|Third Intervention Week 11-52|Disease Progression|0|||
129952795|NCT01182285|467788378|FG002|Third Intervention Week 11-52|Disease Progression|6|||
129952796|NCT01182285|467788376|FG000|Third Intervention Week 11-52|Other|0|||
129952797|NCT01182285|467788377|FG001|Third Intervention Week 11-52|Other|0|||
129952798|NCT01182285|467788378|FG002|Third Intervention Week 11-52|Other|2|||
129952799|NCT00841321|467788379|FG000|Overall Study|Lost to Follow-up|1|||
129952800|NCT00841321|467788380|FG001|Overall Study|Lost to Follow-up|1|||
129952801|NCT00841321|467788379|FG000|Overall Study|Adverse Event|0|||
129952802|NCT00841321|467788380|FG001|Overall Study|Adverse Event|2|||
129952803|NCT00379210|467788383|FG000|Overall Study|Withdrawal by Subject|10|||
129952804|NCT00379210|467788384|FG001|Overall Study|Withdrawal by Subject|7|||
129952805|NCT01358175|467788385|FG000|Overall Study|Death|1|||
129952806|NCT01358175|467788386|FG001|Overall Study|Death|0|||
129952807|NCT01358175|467788387|FG002|Overall Study|Death|1|||
129952808|NCT01358175|467788385|FG000|Overall Study|Withdrawal by Subject|9|||
129952809|NCT01358175|467788386|FG001|Overall Study|Withdrawal by Subject|5|||
129952810|NCT01358175|467788387|FG002|Overall Study|Withdrawal by Subject|10|||
129952811|NCT01358175|467788385|FG000|Overall Study|Technical issues|0|||
129952812|NCT01358175|467788386|FG001|Overall Study|Technical issues|1|||
129952813|NCT01358175|467788387|FG002|Overall Study|Technical issues|0|||
129952814|NCT01358175|467788385|FG000|Overall Study|Pregnancy|0|||
129952815|NCT01358175|467788386|FG001|Overall Study|Pregnancy|1|||
129952816|NCT01358175|467788387|FG002|Overall Study|Pregnancy|0|||
129952817|NCT01358175|467788385|FG000|Overall Study|Physician Decision|1|||
129952818|NCT01358175|467788386|FG001|Overall Study|Physician Decision|0|||
129952819|NCT01358175|467788387|FG002|Overall Study|Physician Decision|0|||
129952820|NCT01358175|467788385|FG000|Overall Study|Non Compliance with Study Treatment|0|||
129952821|NCT01358175|467788386|FG001|Overall Study|Non Compliance with Study Treatment|1|||
129952822|NCT01358175|467788387|FG002|Overall Study|Non Compliance with Study Treatment|1|||
129952823|NCT01358175|467788385|FG000|Overall Study|Lost to Follow-up|1|||
129952824|NCT01358175|467788386|FG001|Overall Study|Lost to Follow-up|1|||
129952825|NCT01358175|467788387|FG002|Overall Study|Lost to Follow-up|3|||
129952826|NCT01358175|467788385|FG000|Overall Study|Lack of Efficacy|3|||
129952827|NCT01358175|467788386|FG001|Overall Study|Lack of Efficacy|8|||
129952828|NCT01358175|467788387|FG002|Overall Study|Lack of Efficacy|6|||
129952829|NCT01358175|467788385|FG000|Overall Study|Adverse Event|6|||
129952830|NCT01358175|467788386|FG001|Overall Study|Adverse Event|11|||
129952831|NCT01358175|467788387|FG002|Overall Study|Adverse Event|11|||
129952832|NCT01525875|467788388|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
129952833|NCT01525875|467788389|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
129952834|NCT01525875|467788388|FG000|Open-label Period|Lost to Follow-up|0|||
129952835|NCT01525875|467788389|FG001|Open-label Period|Lost to Follow-up|2|||
129952836|NCT05072795|467788390|FG000|Overall Study|Lost to Follow-up|5|||
129952837|NCT00821093|467788393|FG000|Overall Study|Adverse Event|20|||
129952838|NCT00821093|467788394|FG001|Overall Study|Adverse Event|12|||
129952839|NCT00821093|467788393|FG000|Overall Study|Withdrawal by Subject|9|||
129952840|NCT00821093|467788394|FG001|Overall Study|Withdrawal by Subject|13|||
129952841|NCT00821093|467788393|FG000|Overall Study|Lost to Follow-up|9|||
129952842|NCT00821093|467788394|FG001|Overall Study|Lost to Follow-up|3|||
129952843|NCT00821093|467788393|FG000|Overall Study|Protocol deviation|3|||
129952844|NCT00821093|467788394|FG001|Overall Study|Protocol deviation|6|||
129952845|NCT00821093|467788393|FG000|Overall Study|Abnormal laboratory value(s)|2|||
129952846|NCT00821093|467788394|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129952847|NCT00821093|467788393|FG000|Overall Study|Lack of Efficacy|2|||
129952848|NCT00821093|467788394|FG001|Overall Study|Lack of Efficacy|2|||
129952849|NCT00821093|467788393|FG000|Overall Study|Death|2|||
129952850|NCT00821093|467788394|FG001|Overall Study|Death|1|||
129952851|NCT00821093|467788393|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129952852|NCT00821093|467788394|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129952853|NCT00821093|467788393|FG000|Overall Study|Administrative problems|1|||
129952854|NCT00821093|467788394|FG001|Overall Study|Administrative problems|2|||
129952855|NCT01107912|467788395|FG000|Period 1|Adverse Event|0|||
129952856|NCT01107912|467788396|FG001|Period 1|Adverse Event|0|||
129952857|NCT01107912|467788397|FG002|Period 1|Adverse Event|0|||
129952858|NCT01107912|467788398|FG003|Period 1|Adverse Event|0|||
129952859|NCT01107912|467788399|FG004|Period 1|Adverse Event|2|||
129952860|NCT01107912|467788400|FG005|Period 1|Adverse Event|0|||
129952861|NCT01107912|467788395|FG000|Period 1|Physician Decision|0|||
129952862|NCT01107912|467788396|FG001|Period 1|Physician Decision|0|||
129952863|NCT01107912|467788397|FG002|Period 1|Physician Decision|0|||
129952864|NCT01107912|467788398|FG003|Period 1|Physician Decision|0|||
129453821|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
129453822|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
129453823|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
129453824|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
129453825|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
129453826|NCT00094770|465959363|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
129453827|NCT00094770|465959364|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
129453828|NCT00914927|465959366|FG000|Overall Study|Adverse Event|0|||
129453829|NCT00914927|465959367|FG001|Overall Study|Adverse Event|0|||
129453830|NCT00914927|465959368|FG002|Overall Study|Adverse Event|0|||
129453831|NCT00914927|465959369|FG003|Overall Study|Adverse Event|0|||
129453832|NCT00914927|465959370|FG004|Overall Study|Adverse Event|1|||
129453833|NCT00914927|465959371|FG005|Overall Study|Adverse Event|0|||
129453834|NCT00914927|465959372|FG006|Overall Study|Adverse Event|0|||
129453835|NCT00914927|465959366|FG000|Overall Study|Withdrawal by Subject|0|||
129453836|NCT00914927|465959367|FG001|Overall Study|Withdrawal by Subject|1|||
129453837|NCT00914927|465959368|FG002|Overall Study|Withdrawal by Subject|0|||
129453838|NCT00914927|465959369|FG003|Overall Study|Withdrawal by Subject|1|||
129453839|NCT00914927|465959370|FG004|Overall Study|Withdrawal by Subject|0|||
129453840|NCT00914927|465959371|FG005|Overall Study|Withdrawal by Subject|0|||
129453841|NCT00914927|465959372|FG006|Overall Study|Withdrawal by Subject|0|||
129453842|NCT00914927|465959366|FG000|Overall Study|Lost to Follow-up|0|||
129453843|NCT00914927|465959367|FG001|Overall Study|Lost to Follow-up|0|||
129453844|NCT00914927|465959368|FG002|Overall Study|Lost to Follow-up|0|||
129453845|NCT00914927|465959369|FG003|Overall Study|Lost to Follow-up|1|||
129453846|NCT00914927|465959370|FG004|Overall Study|Lost to Follow-up|0|||
129453847|NCT00914927|465959371|FG005|Overall Study|Lost to Follow-up|0|||
129453848|NCT00914927|465959372|FG006|Overall Study|Lost to Follow-up|0|||
129453849|NCT00914927|465959366|FG000|Overall Study|Administrative/Other|2|||
129453850|NCT00914927|465959367|FG001|Overall Study|Administrative/Other|1|||
129453851|NCT00914927|465959368|FG002|Overall Study|Administrative/Other|0|||
129453852|NCT00914927|465959369|FG003|Overall Study|Administrative/Other|0|||
129453853|NCT00914927|465959370|FG004|Overall Study|Administrative/Other|1|||
129453854|NCT00914927|465959371|FG005|Overall Study|Administrative/Other|0|||
129453855|NCT00914927|465959372|FG006|Overall Study|Administrative/Other|0|||
129453856|NCT04773106|465959373|FG000|Overall Study|Withdrawal by Subject|3|||
129453857|NCT04773106|465959373|FG000|Overall Study|Death|1|||
129453858|NCT02969187|465959374|FG000|Overall Study|Physician Decision|12|||
129952865|NCT01107912|467788399|FG004|Period 1|Physician Decision|1|||
129952866|NCT01107912|467788400|FG005|Period 1|Physician Decision|0|||
129952867|NCT01107912|467788395|FG000|Period 1|Withdrawal by Subject|1|||
129952868|NCT01107912|467788396|FG001|Period 1|Withdrawal by Subject|0|||
129952869|NCT01107912|467788397|FG002|Period 1|Withdrawal by Subject|0|||
129952870|NCT01107912|467788398|FG003|Period 1|Withdrawal by Subject|0|||
129952871|NCT01107912|467788399|FG004|Period 1|Withdrawal by Subject|0|||
129952872|NCT01107912|467788400|FG005|Period 1|Withdrawal by Subject|0|||
129952873|NCT01107912|467788395|FG000|Period 2|Physician Decision|0|||
129952874|NCT01107912|467788396|FG001|Period 2|Physician Decision|0|||
129952875|NCT01107912|467788397|FG002|Period 2|Physician Decision|1|||
129952876|NCT01107912|467788398|FG003|Period 2|Physician Decision|0|||
129952877|NCT01107912|467788399|FG004|Period 2|Physician Decision|0|||
129952878|NCT01107912|467788400|FG005|Period 2|Physician Decision|0|||
129952879|NCT01107912|467788395|FG000|Period 3|Adverse Event|0|||
129952880|NCT01107912|467788396|FG001|Period 3|Adverse Event|1|||
129952881|NCT01107912|467788397|FG002|Period 3|Adverse Event|1|||
129952882|NCT01107912|467788398|FG003|Period 3|Adverse Event|0|||
129952883|NCT01107912|467788399|FG004|Period 3|Adverse Event|0|||
129952884|NCT01107912|467788400|FG005|Period 3|Adverse Event|0|||
129952885|NCT01107912|467788395|FG000|Period 3|Withdrawal by Subject|0|||
129952886|NCT01107912|467788396|FG001|Period 3|Withdrawal by Subject|0|||
129952887|NCT01107912|467788397|FG002|Period 3|Withdrawal by Subject|0|||
129952888|NCT01107912|467788398|FG003|Period 3|Withdrawal by Subject|1|||
129952889|NCT01107912|467788399|FG004|Period 3|Withdrawal by Subject|0|||
129952890|NCT01107912|467788400|FG005|Period 3|Withdrawal by Subject|0|||
129453859|NCT02969187|465959375|FG001|Overall Study|Physician Decision|13|||
129453860|NCT01486927|465959376|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
129453861|NCT01486927|465959376|FG000|Overall Study|Physician Decision|1|||
129453862|NCT01486927|465959376|FG000|Overall Study|50 Exposure days not reached|2|||
129952891|NCT01124916|467788404|FG000|Overall Study|Lost to Follow-up|3|||
129952892|NCT01124916|467788405|FG001|Overall Study|Lost to Follow-up|2|||
129952893|NCT01901302|467788406|FG000|Overall Study|Adverse Event|2|||
129453863|NCT01486927|465959376|FG000|Overall Study|Withdrawal by Subject|8|||
129453864|NCT01486927|465959376|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
129952894|NCT01901302|467788407|FG001|Overall Study|Adverse Event|1|||
129952895|NCT01901302|467788406|FG000|Overall Study|Lack of Efficacy|0|||
129952896|NCT01901302|467788407|FG001|Overall Study|Lack of Efficacy|2|||
129952897|NCT01901302|467788406|FG000|Overall Study|Study Terminated by Sponsor|23|||
129453865|NCT00365456|465959377|FG000|Trial Period I (12 Months)|Adverse Event|84|||
129453866|NCT00365456|465959378|FG001|Trial Period I (12 Months)|Adverse Event|0|||
129952898|NCT01901302|467788407|FG001|Overall Study|Study Terminated by Sponsor|20|||
129952899|NCT01901302|467788406|FG000|Overall Study|Withdrawal by Subject|2|||
129952900|NCT01901302|467788407|FG001|Overall Study|Withdrawal by Subject|0|||
129952901|NCT01536795|467788416|FG000|Overall Study|Lost to Follow-up|0|||
129952902|NCT01536795|467788417|FG001|Overall Study|Lost to Follow-up|2|||
129952903|NCT01536795|467788416|FG000|Overall Study|Lack of Efficacy|1|||
129453867|NCT00365456|465959377|FG000|Trial Period I (12 Months)|Non-compliance|3|||
129453868|NCT00365456|465959378|FG001|Trial Period I (12 Months)|Non-compliance|0|||
129453869|NCT00365456|465959377|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
129952904|NCT01536795|467788417|FG001|Overall Study|Lack of Efficacy|0|||
129952905|NCT01699178|467788418|FG000|Overall Study|Adverse Event|1|||
129952906|NCT01699178|467788419|FG001|Overall Study|Adverse Event|5|||
129952907|NCT01699178|467788418|FG000|Overall Study|Lost to Follow-up|1|||
129952908|NCT01699178|467788419|FG001|Overall Study|Lost to Follow-up|6|||
129952909|NCT01699178|467788418|FG000|Overall Study|Non-compliance with Study Drug|3|||
129952910|NCT01699178|467788419|FG001|Overall Study|Non-compliance with Study Drug|1|||
129952911|NCT01699178|467788418|FG000|Overall Study|Physician Decision|1|||
129952912|NCT01699178|467788419|FG001|Overall Study|Physician Decision|0|||
129952913|NCT01699178|467788418|FG000|Overall Study|Withdrawal by Subject|4|||
129952914|NCT01699178|467788419|FG001|Overall Study|Withdrawal by Subject|12|||
129952915|NCT01699178|467788418|FG000|Overall Study|Hematocrit >54%|1|||
129952916|NCT01699178|467788419|FG001|Overall Study|Hematocrit >54%|1|||
129952917|NCT01699178|467788418|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
129952918|NCT01699178|467788419|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
129952919|NCT01699178|467788418|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
129952920|NCT01699178|467788419|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
129952921|NCT02066389|467788424|FG000|Overall Study|Adverse Event|1|||
129952922|NCT02066389|467788425|FG001|Overall Study|Adverse Event|1|||
129952923|NCT02066389|467788426|FG002|Overall Study|Adverse Event|1|||
129952924|NCT02066389|467788427|FG003|Overall Study|Adverse Event|1|||
129952925|NCT02066389|467788428|FG004|Overall Study|Adverse Event|5|||
129952926|NCT02066389|467788429|FG005|Overall Study|Adverse Event|1|||
129952927|NCT02066389|467788424|FG000|Overall Study|Withdrawal by Subject|4|||
129952928|NCT02066389|467788425|FG001|Overall Study|Withdrawal by Subject|0|||
129952929|NCT02066389|467788426|FG002|Overall Study|Withdrawal by Subject|5|||
129952930|NCT02066389|467788427|FG003|Overall Study|Withdrawal by Subject|1|||
129952931|NCT02066389|467788428|FG004|Overall Study|Withdrawal by Subject|1|||
129952932|NCT02066389|467788429|FG005|Overall Study|Withdrawal by Subject|2|||
129952933|NCT02066389|467788424|FG000|Overall Study|Lost to Follow-up|0|||
129952934|NCT02066389|467788425|FG001|Overall Study|Lost to Follow-up|0|||
129952935|NCT02066389|467788426|FG002|Overall Study|Lost to Follow-up|0|||
129952936|NCT02066389|467788427|FG003|Overall Study|Lost to Follow-up|1|||
129952937|NCT02066389|467788428|FG004|Overall Study|Lost to Follow-up|1|||
129952938|NCT02066389|467788429|FG005|Overall Study|Lost to Follow-up|1|||
129952939|NCT02066389|467788424|FG000|Overall Study|Randomized in Error|0|||
129952940|NCT02066389|467788425|FG001|Overall Study|Randomized in Error|0|||
129952941|NCT02066389|467788426|FG002|Overall Study|Randomized in Error|0|||
129952942|NCT02066389|467788427|FG003|Overall Study|Randomized in Error|0|||
129952943|NCT02066389|467788428|FG004|Overall Study|Randomized in Error|0|||
129952944|NCT02066389|467788429|FG005|Overall Study|Randomized in Error|1|||
129952945|NCT01755598|467788432|FG000|Overall Study|Other|109|||
129952946|NCT01755598|467788433|FG001|Overall Study|Other|109|||
129952947|NCT01755598|467788432|FG000|Overall Study|Lost to Follow-up|32|||
129952948|NCT01755598|467788433|FG001|Overall Study|Lost to Follow-up|43|||
129952949|NCT01755598|467788432|FG000|Overall Study|Migrated/moved from study area|76|||
129952950|NCT01755598|467788433|FG001|Overall Study|Migrated/moved from study area|65|||
129952951|NCT01755598|467788432|FG000|Overall Study|Withdrawal by Subject|22|||
129952952|NCT01755598|467788433|FG001|Overall Study|Withdrawal by Subject|31|||
129952953|NCT01755598|467788432|FG000|Overall Study|Protocol Violation|7|||
129952954|NCT01755598|467788433|FG001|Overall Study|Protocol Violation|7|||
129952955|NCT01755598|467788432|FG000|Overall Study|Adverse Event|19|||
129952956|NCT01755598|467788433|FG001|Overall Study|Adverse Event|28|||
129952957|NCT02924051|467788434|FG000|Overall Study|Withdrawal by Subject|1|||
129952958|NCT02924051|467788435|FG001|Overall Study|Withdrawal by Subject|9|||
129952959|NCT03547167|467788438|FG000|Overall Study|Withdrawal by Subject|34|||
129952960|NCT03547167|467788439|FG001|Overall Study|Withdrawal by Subject|12|||
129952961|NCT03547167|467788438|FG000|Overall Study|Screen Failure|0|||
129952962|NCT03547167|467788439|FG001|Overall Study|Screen Failure|1|||
129952963|NCT03547167|467788438|FG000|Overall Study|Lost to Follow-up|59|||
129952964|NCT03547167|467788439|FG001|Overall Study|Lost to Follow-up|15|||
129952965|NCT03547167|467788438|FG000|Overall Study|Death|4|||
129952966|NCT03547167|467788439|FG001|Overall Study|Death|2|||
129952967|NCT00645411|467788440|FG000|Overall Study|Adverse Event|0|||
129952968|NCT00645411|467788441|FG001|Overall Study|Adverse Event|0|||
129453870|NCT00365456|465959378|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
129952969|NCT00645411|467788442|FG002|Overall Study|Adverse Event|0|||
129952970|NCT00645411|467788443|FG003|Overall Study|Adverse Event|2|||
129952971|NCT00645411|467788440|FG000|Overall Study|Withdrawal by Subject|2|||
129952972|NCT00645411|467788441|FG001|Overall Study|Withdrawal by Subject|1|||
129952973|NCT00645411|467788442|FG002|Overall Study|Withdrawal by Subject|19|||
129952974|NCT00645411|467788443|FG003|Overall Study|Withdrawal by Subject|21|||
129952975|NCT00645411|467788440|FG000|Overall Study|Lost to Follow-up|10|||
129952976|NCT00645411|467788441|FG001|Overall Study|Lost to Follow-up|5|||
129952977|NCT00645411|467788442|FG002|Overall Study|Lost to Follow-up|124|||
129952978|NCT00645411|467788443|FG003|Overall Study|Lost to Follow-up|75|||
129952979|NCT00645411|467788440|FG000|Overall Study|Protocol Violation|1|||
129952980|NCT00645411|467788441|FG001|Overall Study|Protocol Violation|0|||
129952981|NCT00645411|467788442|FG002|Overall Study|Protocol Violation|1|||
129952982|NCT00645411|467788443|FG003|Overall Study|Protocol Violation|0|||
129952983|NCT00645411|467788440|FG000|Overall Study|Inappropriate enrollment|0|||
129952984|NCT00645411|467788441|FG001|Overall Study|Inappropriate enrollment|0|||
129952985|NCT00645411|467788442|FG002|Overall Study|Inappropriate enrollment|4|||
129952986|NCT00645411|467788443|FG003|Overall Study|Inappropriate enrollment|1|||
129952987|NCT00645411|467788440|FG000|Overall Study|Unable to classify|0|||
129952988|NCT00645411|467788441|FG001|Overall Study|Unable to classify|0|||
129952989|NCT00645411|467788442|FG002|Overall Study|Unable to classify|3|||
129952990|NCT00645411|467788443|FG003|Overall Study|Unable to classify|4|||
129952991|NCT03987074|467788445|FG000|Overall Study|Withdrew Consent|1|||
129952992|NCT03987074|467788446|FG001|Overall Study|Withdrew Consent|1|||
129952993|NCT03987074|467788447|FG002|Overall Study|Withdrew Consent|0|||
129952994|NCT03987074|467788448|FG003|Overall Study|Withdrew Consent|2|||
129952995|NCT03987074|467788449|FG004|Overall Study|Withdrew Consent|1|||
129952996|NCT03987074|467788445|FG000|Overall Study|Adverse Event|2|||
129952997|NCT03987074|467788446|FG001|Overall Study|Adverse Event|1|||
129952998|NCT03987074|467788447|FG002|Overall Study|Adverse Event|0|||
129952999|NCT03987074|467788448|FG003|Overall Study|Adverse Event|0|||
129953000|NCT03987074|467788449|FG004|Overall Study|Adverse Event|1|||
129953001|NCT03987074|467788445|FG000|Overall Study|Lost to Follow-up|0|||
129953002|NCT03987074|467788446|FG001|Overall Study|Lost to Follow-up|0|||
129953003|NCT03987074|467788447|FG002|Overall Study|Lost to Follow-up|1|||
129953004|NCT03987074|467788448|FG003|Overall Study|Lost to Follow-up|1|||
129953005|NCT03987074|467788449|FG004|Overall Study|Lost to Follow-up|0|||
129953006|NCT03987074|467788445|FG000|Overall Study|Investigator's Discretion|0|||
129953007|NCT03987074|467788446|FG001|Overall Study|Investigator's Discretion|0|||
129953008|NCT03987074|467788447|FG002|Overall Study|Investigator's Discretion|0|||
129953009|NCT03987074|467788448|FG003|Overall Study|Investigator's Discretion|1|||
129953010|NCT03987074|467788449|FG004|Overall Study|Investigator's Discretion|0|||
129953011|NCT01334606|467788454|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
129953012|NCT02674399|467788455|FG000|Overall Study|Lost to Follow-up|2|||
129953013|NCT02674399|467788456|FG001|Overall Study|Lost to Follow-up|0|||
129953014|NCT02138838|467788457|FG000|Overall Study|Study Closure|7|||
129953015|NCT02138838|467788458|FG001|Overall Study|Study Closure|6|||
129953016|NCT02138838|467788457|FG000|Overall Study|Withdrawal by Subject|1|||
129953017|NCT02138838|467788458|FG001|Overall Study|Withdrawal by Subject|5|||
129953018|NCT02993926|467788461|FG000|Enantone Treatment Phase|Adverse Event|1|||
129953019|NCT02993926|467788462|FG001|Enantone Treatment Phase|Adverse Event|0|||
129953020|NCT02993926|467788463|FG002|Enantone Treatment Phase|Adverse Event|0|||
129953021|NCT02993926|467788461|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
129953022|NCT02993926|467788462|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
129953023|NCT02993926|467788463|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
129953024|NCT02993926|467788461|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
129953025|NCT02993926|467788462|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
129953026|NCT02993926|467788463|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
129953027|NCT02993926|467788461|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
129953028|NCT02993926|467788462|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
129953029|NCT02993926|467788463|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
129953030|NCT01084772|467788465|FG000|Baseline|Withdrawal by Subject|7|||
129953031|NCT01084772|467788466|FG001|Baseline|Withdrawal by Subject|6|||
129953032|NCT01084772|467788465|FG000|3 Months|Death|1|||
129953033|NCT01084772|467788466|FG001|3 Months|Death|0|||
129953034|NCT01084772|467788465|FG000|3 Months|Study Termination|2|||
129953035|NCT01084772|467788466|FG001|3 Months|Study Termination|2|||
129953036|NCT01084772|467788465|FG000|1 Year|Withdrawal by Subject|0|||
129453871|NCT00365456|465959377|FG000|Trial Period I (12 Months)|Other|11|||
129953037|NCT01084772|467788466|FG001|1 Year|Withdrawal by Subject|1|||
129953038|NCT01084772|467788465|FG000|1 Year|Lost to Follow-up|3|||
129953039|NCT01084772|467788466|FG001|1 Year|Lost to Follow-up|0|||
129953040|NCT01084772|467788465|FG000|1 Year|Study Termination|0|||
129953041|NCT01084772|467788466|FG001|1 Year|Study Termination|7|||
129953042|NCT01084772|467788465|FG000|2 Years|Withdrawal by Subject|1|||
129953043|NCT01084772|467788466|FG001|2 Years|Withdrawal by Subject|0|||
129953044|NCT01084772|467788465|FG000|2 Years|Lost to Follow-up|5|||
129953045|NCT01084772|467788466|FG001|2 Years|Lost to Follow-up|2|||
129953046|NCT01084772|467788465|FG000|2 Years|Study Termination|3|||
129953047|NCT01084772|467788466|FG001|2 Years|Study Termination|2|||
129953048|NCT01867307|467788467|FG000|Overall Study|Protocol Violation|2|||
129953049|NCT01867307|467788468|FG001|Overall Study|Protocol Violation|0|||
129953050|NCT01867307|467788467|FG000|Overall Study|Other Adverse Event|1|||
129953051|NCT01867307|467788468|FG001|Overall Study|Other Adverse Event|3|||
129953052|NCT00518206|467788469|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
129953053|NCT00518206|467788470|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
129953054|NCT00518206|467788469|FG000|Overall Study|Withdrawal by Subject|2|||
129953055|NCT00518206|467788470|FG001|Overall Study|Withdrawal by Subject|0|||
129953056|NCT00518206|467788469|FG000|Overall Study|Drug Supply Issue|1|||
129953057|NCT00518206|467788470|FG001|Overall Study|Drug Supply Issue|0|||
129953058|NCT00518206|467788469|FG000|Overall Study|Reason Unknown|1|||
129953059|NCT00518206|467788470|FG001|Overall Study|Reason Unknown|0|||
129953060|NCT00518206|467788469|FG000|Overall Study|Completion Status Unknown|1|||
129953061|NCT00518206|467788470|FG001|Overall Study|Completion Status Unknown|0|||
129953062|NCT05356130|467789833|FG000|Overall Study|Withdrawal by Subject|0|||
129953063|NCT05356130|467789834|FG001|Overall Study|Withdrawal by Subject|0|||
129953064|NCT05356130|467789835|FG002|Overall Study|Withdrawal by Subject|3|||
129953065|NCT00228813|467789836|FG000|Overall Study|Death|4|||
129953066|NCT00668746|467789837|FG000|Overall Study|Lost to Follow-up|2|||
129953067|NCT00668746|467789838|FG001|Overall Study|Lost to Follow-up|1|||
129953068|NCT02109172|467789839|FG000|Overall Study|Withdrawal by Subject|1|||
129953069|NCT02109172|467789840|FG001|Overall Study|Withdrawal by Subject|0|||
129953070|NCT02109172|467789841|FG002|Overall Study|Withdrawal by Subject|0|||
129953071|NCT02109172|467789842|FG003|Overall Study|Withdrawal by Subject|1|||
129953072|NCT02109172|467789843|FG004|Overall Study|Withdrawal by Subject|0|||
129953073|NCT02109172|467789844|FG005|Overall Study|Withdrawal by Subject|0|||
129953074|NCT02109172|467789839|FG000|Overall Study|Adverse Event|0|||
129953075|NCT02109172|467789840|FG001|Overall Study|Adverse Event|0|||
129953076|NCT02109172|467789841|FG002|Overall Study|Adverse Event|1|||
129953077|NCT02109172|467789842|FG003|Overall Study|Adverse Event|0|||
129953078|NCT02109172|467789843|FG004|Overall Study|Adverse Event|0|||
129953079|NCT02109172|467789844|FG005|Overall Study|Adverse Event|1|||
129953080|NCT02109172|467789839|FG000|Overall Study|Death|0|||
129953081|NCT02109172|467789840|FG001|Overall Study|Death|0|||
129953082|NCT02109172|467789841|FG002|Overall Study|Death|0|||
129953083|NCT02109172|467789842|FG003|Overall Study|Death|0|||
129953084|NCT02109172|467789843|FG004|Overall Study|Death|1|||
129953085|NCT02109172|467789844|FG005|Overall Study|Death|0|||
129453872|NCT00365456|465959378|FG001|Trial Period I (12 Months)|Other|0|||
129953086|NCT05361304|467789852|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
129953087|NCT05361304|467789853|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
129953088|NCT05361304|467789852|FG000|Overall Study|COVID-19 Related|1|||
129953089|NCT05361304|467789853|FG001|Overall Study|COVID-19 Related|2|||
129953090|NCT05361304|467789852|FG000|Overall Study|Withdrawal by Subject|1|||
129953091|NCT05361304|467789853|FG001|Overall Study|Withdrawal by Subject|0|||
129953092|NCT01816165|467789854|FG000|Overall Study|Adverse Event|1|||
129953093|NCT01816165|467789855|FG001|Overall Study|Adverse Event|0|||
129953094|NCT01816165|467789856|FG002|Overall Study|Adverse Event|0|||
129953095|NCT01816165|467789857|FG003|Overall Study|Adverse Event|0|||
129953096|NCT03960437|467789859|FG000|Overall Study|Removed by PI|4|||
129953097|NCT03960437|467789859|FG000|Overall Study|Lost to Follow-up|2|||
129953098|NCT03960437|467789859|FG000|Overall Study|Withdrawal by Subject|1|||
129953099|NCT03960437|467789859|FG000|Overall Study|Death|2|||
129953100|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Adverse Event|0|||
129953101|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Adverse Event|0|||
129953102|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Adverse Event|0|||
129953103|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Adverse Event|5|||
129953104|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Adverse Event|0|||
129953105|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Death|0|||
129953106|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Death|0|||
129953107|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Death|0|||
129953108|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Death|1|||
129953109|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Death|0|||
129953110|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Disease Progression|1|||
129953111|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Disease Progression|1|||
129953112|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Disease Progression|0|||
129953113|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Disease Progression|10|||
129953114|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Disease Progression|1|||
129953115|NCT00473512|467789862|FG000|Period 1 (Phase 1)|Other|0|||
129953116|NCT00473512|467789863|FG001|Period 1 (Phase 1)|Other|0|||
129953117|NCT00473512|467789864|FG002|Period 1 (Phase 1)|Other|0|||
129953118|NCT00473512|467789865|FG003|Period 1 (Phase 1)|Other|1|||
129953119|NCT00473512|467789866|FG004|Period 1 (Phase 1)|Other|0|||
129953120|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Adverse Event|0|||
129953121|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Adverse Event|0|||
129953122|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Adverse Event|0|||
129953123|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Adverse Event|1|||
129953124|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Adverse Event|0|||
129953125|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Death|0|||
129953126|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Death|0|||
129953127|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Death|0|||
129953128|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Death|1|||
129953129|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Death|1|||
129953130|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Disease Progression|0|||
129953131|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Disease Progression|2|||
129953132|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Disease Progression|2|||
129953133|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Disease Progression|17|||
129953134|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Disease Progression|1|||
129953135|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953136|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953137|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953138|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
129953139|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
129953140|NCT00473512|467789862|FG000|Period 2 (Phase 2)|Other|1|||
129953141|NCT00473512|467789863|FG001|Period 2 (Phase 2)|Other|0|||
129953142|NCT00473512|467789864|FG002|Period 2 (Phase 2)|Other|0|||
129953143|NCT00473512|467789865|FG003|Period 2 (Phase 2)|Other|3|||
129953144|NCT00473512|467789866|FG004|Period 2 (Phase 2)|Other|0|||
129953145|NCT00267956|467789867|FG000|Controlled Period|Adverse Event|4|||
129953146|NCT00267956|467789868|FG001|Controlled Period|Adverse Event|1|||
129953147|NCT00267956|467789869|FG002|Controlled Period|Adverse Event|0|||
129953148|NCT00267956|467789870|FG003|Controlled Period|Adverse Event|0|||
129953149|NCT00267956|467789867|FG000|Controlled Period|Lack of Efficacy|4|||
129953150|NCT00267956|467789868|FG001|Controlled Period|Lack of Efficacy|2|||
129953151|NCT00267956|467789869|FG002|Controlled Period|Lack of Efficacy|0|||
129953152|NCT00267956|467789870|FG003|Controlled Period|Lack of Efficacy|0|||
129453873|NCT00365456|465959377|FG000|Trial Period II (12 Months)|Adverse Event|0|||
129953153|NCT00267956|467789867|FG000|Controlled Period|Lost to Follow-up|2|||
129953154|NCT00267956|467789868|FG001|Controlled Period|Lost to Follow-up|0|||
129953155|NCT00267956|467789869|FG002|Controlled Period|Lost to Follow-up|0|||
129953156|NCT00267956|467789870|FG003|Controlled Period|Lost to Follow-up|0|||
129953157|NCT00267956|467789867|FG000|Controlled Period|Withdrew consent|3|||
129953158|NCT00267956|467789868|FG001|Controlled Period|Withdrew consent|1|||
129953159|NCT00267956|467789869|FG002|Controlled Period|Withdrew consent|0|||
129953160|NCT00267956|467789870|FG003|Controlled Period|Withdrew consent|0|||
129953161|NCT00267956|467789867|FG000|After Controlled Period|Adverse Event|0|||
129953162|NCT00267956|467789868|FG001|After Controlled Period|Adverse Event|0|||
129953163|NCT00267956|467789869|FG002|After Controlled Period|Adverse Event|2|||
129953164|NCT00267956|467789870|FG003|After Controlled Period|Adverse Event|1|||
129953165|NCT00267956|467789867|FG000|After Controlled Period|Lack of Efficacy|0|||
129953166|NCT00267956|467789868|FG001|After Controlled Period|Lack of Efficacy|0|||
129953167|NCT00267956|467789869|FG002|After Controlled Period|Lack of Efficacy|1|||
129953168|NCT00267956|467789870|FG003|After Controlled Period|Lack of Efficacy|1|||
129953169|NCT00267956|467789867|FG000|After Controlled Period|Lost to Follow-up|0|||
129953170|NCT00267956|467789868|FG001|After Controlled Period|Lost to Follow-up|0|||
129953171|NCT00267956|467789869|FG002|After Controlled Period|Lost to Follow-up|1|||
129953172|NCT00267956|467789870|FG003|After Controlled Period|Lost to Follow-up|0|||
129953173|NCT00267956|467789867|FG000|After Controlled Period|Withdrew consent|0|||
129953174|NCT00267956|467789868|FG001|After Controlled Period|Withdrew consent|0|||
129953175|NCT00267956|467789869|FG002|After Controlled Period|Withdrew consent|1|||
129953176|NCT00267956|467789870|FG003|After Controlled Period|Withdrew consent|0|||
129953177|NCT01263223|467789871|FG000|Period 2|Withdrawal by Subject|0|||
129953178|NCT01263223|467789872|FG001|Period 2|Withdrawal by Subject|1|||
129953179|NCT01263223|467789871|FG000|7-day Follow-up|Withdrawal by Subject|0|||
129953180|NCT01263223|467789872|FG001|7-day Follow-up|Withdrawal by Subject|1|||
129953181|NCT01263223|467789871|FG000|7-day Follow-up|Lost to Follow-up|1|||
129953182|NCT01263223|467789872|FG001|7-day Follow-up|Lost to Follow-up|0|||
129953183|NCT02246647|467789873|FG000|Overall Study|Withdrawal by Subject|1|||
129953184|NCT02246647|467789874|FG001|Overall Study|Withdrawal by Subject|1|||
129953185|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
129953186|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
129953187|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
129953188|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
129953189|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
129953190|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
129953191|NCT03557307|467789875|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
129953192|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
129953193|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Death|3|||
129953194|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
129953195|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
129953196|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
129953197|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
129953198|NCT03557307|467789875|FG000|Period 2: Maintenance Phase|other|3|||
129953199|NCT03184519|467789876|FG000|Overall Study|Lost to Follow-up|6|||
129953200|NCT03184519|467789876|FG000|Overall Study|Physician Decision|21|||
129953201|NCT04239911|467789877|FG000|Overall Study|Lost to Follow-up|2|||
129953202|NCT04239911|467789878|FG001|Overall Study|Lost to Follow-up|1|||
129953203|NCT00584909|467789884|FG000|Overall Study|Adverse Event|4|||
129953204|NCT03345407|467789885|FG000|Overall Study|Withdrawal by Subject|11|||
129953205|NCT03345407|467789886|FG001|Overall Study|Withdrawal by Subject|1|||
129953206|NCT03345407|467789887|FG002|Overall Study|Withdrawal by Subject|5|||
129953207|NCT03345407|467789888|FG003|Overall Study|Withdrawal by Subject|6|||
129953208|NCT03345407|467789889|FG004|Overall Study|Withdrawal by Subject|3|||
129953209|NCT03345407|467789890|FG005|Overall Study|Withdrawal by Subject|6|||
129953210|NCT03345407|467789891|FG006|Overall Study|Withdrawal by Subject|16|||
129953211|NCT03345407|467789885|FG000|Overall Study|Physician Decision|3|||
129953212|NCT03345407|467789886|FG001|Overall Study|Physician Decision|1|||
129953213|NCT03345407|467789887|FG002|Overall Study|Physician Decision|0|||
129953214|NCT03345407|467789888|FG003|Overall Study|Physician Decision|0|||
129953215|NCT03345407|467789889|FG004|Overall Study|Physician Decision|1|||
129953216|NCT03345407|467789890|FG005|Overall Study|Physician Decision|2|||
129953217|NCT03345407|467789891|FG006|Overall Study|Physician Decision|3|||
129953218|NCT03345407|467789885|FG000|Overall Study|Lost to Follow-up|2|||
129953219|NCT03345407|467789886|FG001|Overall Study|Lost to Follow-up|0|||
129953220|NCT03345407|467789887|FG002|Overall Study|Lost to Follow-up|1|||
129953221|NCT03345407|467789888|FG003|Overall Study|Lost to Follow-up|0|||
129453874|NCT00365456|465959378|FG001|Trial Period II (12 Months)|Adverse Event|6|||
129453875|NCT00365456|465959377|FG000|Trial Period II (12 Months)|Non-compliance|0|||
129453876|NCT00365456|465959378|FG001|Trial Period II (12 Months)|Non-compliance|2|||
129953222|NCT03345407|467789889|FG004|Overall Study|Lost to Follow-up|1|||
129953223|NCT03345407|467789890|FG005|Overall Study|Lost to Follow-up|2|||
129953224|NCT03345407|467789891|FG006|Overall Study|Lost to Follow-up|3|||
129953225|NCT03345407|467789885|FG000|Overall Study|Protocol-defined stopping criteria|9|||
129953226|NCT03345407|467789886|FG001|Overall Study|Protocol-defined stopping criteria|0|||
129953227|NCT03345407|467789887|FG002|Overall Study|Protocol-defined stopping criteria|0|||
129953228|NCT03345407|467789888|FG003|Overall Study|Protocol-defined stopping criteria|0|||
129953229|NCT03345407|467789889|FG004|Overall Study|Protocol-defined stopping criteria|2|||
129953230|NCT03345407|467789890|FG005|Overall Study|Protocol-defined stopping criteria|1|||
129953231|NCT03345407|467789891|FG006|Overall Study|Protocol-defined stopping criteria|1|||
129453877|NCT00365456|465959377|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
129953232|NCT03345407|467789885|FG000|Overall Study|Protocol Violation|2|||
129953233|NCT03345407|467789886|FG001|Overall Study|Protocol Violation|0|||
129453878|NCT00365456|465959378|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
129453879|NCT00365456|465959377|FG000|Trial Period II (12 Months)|Other|0|||
129453880|NCT00365456|465959378|FG001|Trial Period II (12 Months)|Other|1|||
129953234|NCT03345407|467789887|FG002|Overall Study|Protocol Violation|0|||
129953235|NCT03345407|467789888|FG003|Overall Study|Protocol Violation|0|||
129453881|NCT00365456|465959377|FG000|Trial Period III (12 Months)|Adverse Event|13|||
129453882|NCT00365456|465959378|FG001|Trial Period III (12 Months)|Adverse Event|3|||
129453883|NCT00365456|465959377|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
129453884|NCT00365456|465959378|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
129453885|NCT00365456|465959377|FG000|Trial Period III (12 Months)|Other|1|||
129453886|NCT00365456|465959378|FG001|Trial Period III (12 Months)|Other|1|||
129453887|NCT03668600|465959379|FG000|Overall Study|Study Terminated by the Sponsor|157|||
129453888|NCT03668600|465959379|FG000|Overall Study|Protocol Violation|1|||
129453889|NCT03668600|465959379|FG000|Overall Study|Pregnancy|1|||
129453890|NCT03668600|465959379|FG000|Overall Study|Lost to Follow-up|7|||
129453891|NCT03668600|465959379|FG000|Overall Study|Withdrawal by Subject|56|||
129453892|NCT03668600|465959379|FG000|Overall Study|Lack of Efficacy|7|||
129453893|NCT03668600|465959379|FG000|Overall Study|Adverse Event|1|||
129453894|NCT01476475|465959381|FG000|Overall Study|Adverse Event|6|||
129453895|NCT01476475|465959382|FG001|Overall Study|Adverse Event|0|||
129453896|NCT01476475|465959381|FG000|Overall Study|Poor compliance to protocol|1|||
129453897|NCT01476475|465959382|FG001|Overall Study|Poor compliance to protocol|1|||
129453898|NCT01476475|465959381|FG000|Overall Study|Other reasons|4|||
129453899|NCT01476475|465959382|FG001|Overall Study|Other reasons|2|||
129953236|NCT03345407|467789889|FG004|Overall Study|Protocol Violation|1|||
129953237|NCT03345407|467789890|FG005|Overall Study|Protocol Violation|0|||
129953238|NCT03345407|467789891|FG006|Overall Study|Protocol Violation|3|||
129953239|NCT03345407|467789885|FG000|Overall Study|Lack of Efficacy|1|||
129953240|NCT03345407|467789886|FG001|Overall Study|Lack of Efficacy|1|||
129953241|NCT03345407|467789887|FG002|Overall Study|Lack of Efficacy|1|||
129953242|NCT03345407|467789888|FG003|Overall Study|Lack of Efficacy|1|||
129953243|NCT03345407|467789889|FG004|Overall Study|Lack of Efficacy|1|||
129953244|NCT03345407|467789890|FG005|Overall Study|Lack of Efficacy|0|||
129953245|NCT03345407|467789891|FG006|Overall Study|Lack of Efficacy|3|||
129953246|NCT03345407|467789885|FG000|Overall Study|Adverse Event|4|||
129953247|NCT03345407|467789886|FG001|Overall Study|Adverse Event|0|||
129953248|NCT03345407|467789887|FG002|Overall Study|Adverse Event|5|||
129953249|NCT03345407|467789888|FG003|Overall Study|Adverse Event|4|||
129953250|NCT03345407|467789889|FG004|Overall Study|Adverse Event|6|||
129953251|NCT03345407|467789890|FG005|Overall Study|Adverse Event|5|||
129953252|NCT03345407|467789891|FG006|Overall Study|Adverse Event|16|||
129953253|NCT02092909|467789894|FG000|Overall Study|Adverse Event|0|||
129953254|NCT02092909|467789895|FG001|Overall Study|Adverse Event|0|||
129953255|NCT02092909|467789896|FG002|Overall Study|Adverse Event|4|||
129953256|NCT02092909|467789897|FG003|Overall Study|Adverse Event|2|||
129953257|NCT02092909|467789894|FG000|Overall Study|Lack of Efficacy|0|||
129953258|NCT02092909|467789895|FG001|Overall Study|Lack of Efficacy|2|||
129953259|NCT02092909|467789896|FG002|Overall Study|Lack of Efficacy|1|||
129953260|NCT02092909|467789897|FG003|Overall Study|Lack of Efficacy|0|||
129953261|NCT02092909|467789894|FG000|Overall Study|Withdrawal by Subject|0|||
129953262|NCT02092909|467789895|FG001|Overall Study|Withdrawal by Subject|0|||
129953263|NCT02092909|467789896|FG002|Overall Study|Withdrawal by Subject|2|||
129953264|NCT02092909|467789897|FG003|Overall Study|Withdrawal by Subject|1|||
129953265|NCT02092909|467789894|FG000|Overall Study|Study terminated by Sponsor|0|||
129953266|NCT02092909|467789895|FG001|Overall Study|Study terminated by Sponsor|0|||
129953267|NCT02092909|467789896|FG002|Overall Study|Study terminated by Sponsor|0|||
129953268|NCT02092909|467789897|FG003|Overall Study|Study terminated by Sponsor|2|||
129953269|NCT02092909|467789894|FG000|Overall Study|Miscellaneous|1|||
129953270|NCT02092909|467789895|FG001|Overall Study|Miscellaneous|1|||
129953271|NCT02092909|467789896|FG002|Overall Study|Miscellaneous|2|||
129953272|NCT02092909|467789897|FG003|Overall Study|Miscellaneous|1|||
129953273|NCT00901459|467789900|FG000|Overall Study|Withdrawal by Subject|6|||
129953274|NCT04765046|467789901|FG000|Overall Study|Screen Failure|2|||
129953275|NCT04765046|467789901|FG000|Overall Study|Withdrawal by Subject|4|||
129953276|NCT04765046|467789901|FG000|Overall Study|Physician Decision|4|||
129953277|NCT04765046|467789901|FG000|Overall Study|Surgery Cancelled|8|||
129953278|NCT00753896|467789906|FG000|Overall Study|Adverse Event|4|||
129953279|NCT00753896|467789906|FG000|Overall Study|Death|1|||
129953280|NCT00753896|467789906|FG000|Overall Study|Lost to Follow-up|2|||
129953281|NCT00753896|467789906|FG000|Overall Study|Protocol Violation|1|||
129953282|NCT00753896|467789906|FG000|Overall Study|Withdrawal by Subject|4|||
129953283|NCT00753896|467789906|FG000|Overall Study|Entry Criteria Not Met|4|||
129953284|NCT00848198|467789908|FG000|Overall Study|Incomplete Case Report Forms|15|||
129953285|NCT03708744|467789912|FG000|Overall Study|Withdrawal by Subject|0|||
129953286|NCT03708744|467789913|FG001|Overall Study|Withdrawal by Subject|0|||
129953287|NCT03708744|467789914|FG002|Overall Study|Withdrawal by Subject|1|||
129953288|NCT03708744|467789915|FG003|Overall Study|Withdrawal by Subject|0|||
129953289|NCT03529942|467789916|FG000|Overall Study|Withdrawal by Subject|13|||
129453900|NCT01278745|465959383|FG000|Overall Study|Death|2|||
129453901|NCT01278745|465959384|FG001|Overall Study|Death|5|||
129453902|NCT01278745|465959385|FG002|Overall Study|Death|7|||
129953290|NCT03529942|467789916|FG000|Overall Study|Physician Decision|1|||
129953291|NCT03529942|467789916|FG000|Overall Study|Lost to Follow-up|7|||
129953292|NCT03529942|467789916|FG000|Overall Study|Needle inserted but no drug administered|1|||
129453903|NCT01278745|465959386|FG003|Overall Study|Death|0|||
129453904|NCT01278745|465959383|FG000|Overall Study|Physician Decision|1|||
129953293|NCT03529942|467789916|FG000|Overall Study|Personal reasons|1|||
129953294|NCT04930263|467789917|FG000|Overall Study|Withdrawal by Subject|3|||
129453905|NCT01278745|465959384|FG001|Overall Study|Physician Decision|0|||
129453906|NCT01278745|465959385|FG002|Overall Study|Physician Decision|0|||
129953295|NCT04930263|467789918|FG001|Overall Study|Withdrawal by Subject|5|||
129953296|NCT01989156|467789921|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
129953297|NCT01989156|467789922|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
129953298|NCT01989156|467789923|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
129953299|NCT01989156|467789921|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
129953300|NCT01989156|467789922|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
129953301|NCT01989156|467789923|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
129953302|NCT01989156|467789921|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
129953303|NCT01989156|467789922|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
129953304|NCT01989156|467789923|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
129953305|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
129953306|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
129953307|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
129953308|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
129953309|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
129953310|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
129953311|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
129953312|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
129953313|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
129953314|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
129953315|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
129953316|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
129953317|NCT01989156|467789921|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
129953318|NCT01989156|467789922|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
129953319|NCT01989156|467789923|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
129953320|NCT00850993|467789926|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
129953321|NCT00850993|467789927|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
129953322|NCT00850993|467789928|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
129953323|NCT00850993|467789929|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
129953324|NCT03839355|467789930|FG000|Overall Study|Withdrawal by Subject|1|||
129953325|NCT03839355|467789931|FG001|Overall Study|Withdrawal by Subject|0|||
129953326|NCT02009865|467789946|FG000|Overall Study|Adverse Event|0|||
129953327|NCT02009865|467789947|FG001|Overall Study|Adverse Event|2|||
129953328|NCT02009865|467789946|FG000|Overall Study|Protocol Violation|0|||
129953329|NCT02009865|467789947|FG001|Overall Study|Protocol Violation|2|||
129953330|NCT02009865|467789946|FG000|Overall Study|Withdrawal by Subject|1|||
129953331|NCT02009865|467789947|FG001|Overall Study|Withdrawal by Subject|1|||
129953332|NCT01760876|467789948|FG000|Overall Study|Non-cardiac death (head injury)|1|||
129953333|NCT01760876|467789948|FG000|Overall Study|Carcinoma of prostate|1|||
129953334|NCT01760876|467789948|FG000|Overall Study|Impaired renal function|1|||
129953335|NCT01760876|467789948|FG000|Overall Study|Major depression|1|||
129953336|NCT01760876|467789948|FG000|Overall Study|Very poor baseline OCT quality|2|||
129953337|NCT01517282|467789949|FG000|Overall Study|Consent withdrawn|0|||
129953338|NCT01517282|467789950|FG001|Overall Study|Consent withdrawn|1|||
129953339|NCT01517282|467789951|FG002|Overall Study|Consent withdrawn|1|||
129953340|NCT01517282|467789952|FG003|Overall Study|Consent withdrawn|1|||
129953341|NCT01517282|467789949|FG000|Overall Study|Physician Decision|1|||
129953342|NCT01517282|467789950|FG001|Overall Study|Physician Decision|0|||
129953343|NCT01517282|467789951|FG002|Overall Study|Physician Decision|0|||
129953344|NCT01517282|467789952|FG003|Overall Study|Physician Decision|0|||
129953345|NCT00525915|467789953|FG000|Overall Study|Non-Compliance|0|||
129953346|NCT00525915|467789954|FG001|Overall Study|Non-Compliance|1|||
129953347|NCT00525915|467789953|FG000|Overall Study|Disease Progression|5|||
129953348|NCT00525915|467789954|FG001|Overall Study|Disease Progression|6|||
129953349|NCT00525915|467789953|FG000|Overall Study|Withdrawal by Subject|1|||
129953350|NCT00525915|467789954|FG001|Overall Study|Withdrawal by Subject|0|||
129953351|NCT00525915|467789953|FG000|Overall Study|Refused Surgery|1|||
129953352|NCT00525915|467789954|FG001|Overall Study|Refused Surgery|2|||
129953353|NCT00525915|467789953|FG000|Overall Study|Unrelated illness|1|||
129953354|NCT00525915|467789954|FG001|Overall Study|Unrelated illness|0|||
129953355|NCT02332889|467789958|FG000|Overall Study|Physician Decision|1|||
129953356|NCT04198428|467790833|FG000|Overall Study|Withdrawal by Subject|150|||
129953357|NCT04198428|467790834|FG001|Overall Study|Withdrawal by Subject|156|||
129953358|NCT02011568|467790835|FG000|Overall Study|Withdrawal by Subject|8|||
129953359|NCT02011568|467790836|FG001|Overall Study|Withdrawal by Subject|10|||
129953360|NCT02011568|467790835|FG000|Overall Study|Physician Decision|1|||
129953361|NCT02011568|467790836|FG001|Overall Study|Physician Decision|3|||
129953362|NCT02409732|467790838|FG000|Overall Study|Withdrawal by Subject|4|||
129953363|NCT02409732|467790838|FG000|Overall Study|Lost to Follow-up|2|||
129953364|NCT00376259|467790839|FG000|Overall Study|Sponsor request - study termination|21|||
129953365|NCT00376259|467790840|FG001|Overall Study|Sponsor request - study termination|21|||
129953366|NCT00376259|467790839|FG000|Overall Study|Patient request|1|||
129453907|NCT01278745|465959386|FG003|Overall Study|Physician Decision|9|||
129453908|NCT01278745|465959383|FG000|Overall Study|Withdrawal by Subject|1|||
129453909|NCT01278745|465959384|FG001|Overall Study|Withdrawal by Subject|1|||
129453910|NCT01278745|465959385|FG002|Overall Study|Withdrawal by Subject|5|||
129453911|NCT01278745|465959386|FG003|Overall Study|Withdrawal by Subject|1|||
129453912|NCT01278745|465959383|FG000|Overall Study|Sponsor Decision|1|||
129453913|NCT01278745|465959384|FG001|Overall Study|Sponsor Decision|0|||
129453914|NCT01278745|465959385|FG002|Overall Study|Sponsor Decision|62|||
129453915|NCT01278745|465959386|FG003|Overall Study|Sponsor Decision|6|||
129953367|NCT00376259|467790840|FG001|Overall Study|Patient request|0|||
129953368|NCT01012999|467790841|FG000|Overall Study|Protocol Violation|1|||
129453916|NCT01278745|465959383|FG000|Overall Study|Ineligible|0|||
129453917|NCT01278745|465959384|FG001|Overall Study|Ineligible|0|||
129453918|NCT01278745|465959385|FG002|Overall Study|Ineligible|42|||
129453919|NCT01278745|465959386|FG003|Overall Study|Ineligible|61|||
129453920|NCT01278745|465959383|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
129453921|NCT01278745|465959384|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
129453922|NCT01278745|465959385|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
129453923|NCT01278745|465959386|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
129453924|NCT02700412|465959389|FG000|Overall Study|Adverse Event|6|||
129453925|NCT02700412|465959389|FG000|Overall Study|Death|1|||
129453926|NCT02700412|465959389|FG000|Overall Study|Lack of Efficacy|19|||
129453927|NCT02700412|465959389|FG000|Overall Study|Protocol Violation|5|||
129953369|NCT02069366|467790842|FG000|Overall Study|Lost to Follow-up|0|||
129953370|NCT02069366|467790843|FG001|Overall Study|Lost to Follow-up|0|||
129953371|NCT02069366|467790844|FG002|Overall Study|Lost to Follow-up|1|||
129953372|NCT02069366|467790845|FG003|Overall Study|Lost to Follow-up|0|||
129953373|NCT02069366|467790846|FG004|Overall Study|Lost to Follow-up|0|||
129953374|NCT02069366|467790847|FG005|Overall Study|Lost to Follow-up|2|||
129953375|NCT02069366|467790842|FG000|Overall Study|Protocol Violation|0|||
129953376|NCT02069366|467790843|FG001|Overall Study|Protocol Violation|0|||
129953377|NCT02069366|467790844|FG002|Overall Study|Protocol Violation|1|||
129953378|NCT02069366|467790845|FG003|Overall Study|Protocol Violation|0|||
129953379|NCT02069366|467790846|FG004|Overall Study|Protocol Violation|0|||
129953380|NCT02069366|467790847|FG005|Overall Study|Protocol Violation|0|||
129953381|NCT02069366|467790842|FG000|Overall Study|Withdrawal by Subject|1|||
129953382|NCT02069366|467790843|FG001|Overall Study|Withdrawal by Subject|0|||
129953383|NCT02069366|467790844|FG002|Overall Study|Withdrawal by Subject|1|||
129953384|NCT02069366|467790845|FG003|Overall Study|Withdrawal by Subject|2|||
129953385|NCT02069366|467790846|FG004|Overall Study|Withdrawal by Subject|0|||
129453928|NCT02700412|465959389|FG000|Overall Study|Withdrawal by Subject|2|||
129453929|NCT03374189|465959395|FG000|Overall Study|Lost to Follow-up|1|||
129453930|NCT03374189|465959396|FG001|Overall Study|Lost to Follow-up|0|||
129453931|NCT02375724|465959397|FG000|Overall Study|Lack of Efficacy|1|||
129453932|NCT02375724|465959398|FG001|Overall Study|Lack of Efficacy|1|||
129953386|NCT02069366|467790847|FG005|Overall Study|Withdrawal by Subject|0|||
129953387|NCT02256553|467790848|FG000|Period I|Adverse Event|5|||
129953388|NCT02256553|467790848|FG000|Period I|Protocol Violation|1|||
129953389|NCT02256553|467790848|FG000|Period II|Adverse Event|1|||
129953390|NCT02256553|467790848|FG000|Period II|Subject Moved|1|||
129953391|NCT02256553|467790848|FG000|Period III|Adverse Event|3|||
129953392|NCT03436797|467790849|FG000|Main Study|Withdrawal by Subject|2|||
129953393|NCT03436797|467790849|FG000|Main Study|Adverse Event|4|||
129953394|NCT03436797|467790849|FG000|Main Study|Lost to Follow-up|1|||
129953395|NCT03436797|467790849|FG000|Main Study|Death|1|||
129953396|NCT03436797|467790849|FG000|Main Study|Non-Specific|2|||
129453933|NCT02375724|465959397|FG000|Overall Study|Withdrawal by Subject|1|||
129453934|NCT02375724|465959398|FG001|Overall Study|Withdrawal by Subject|1|||
129453935|NCT02375724|465959397|FG000|Overall Study|Lost to Follow-up|1|||
129453936|NCT02375724|465959398|FG001|Overall Study|Lost to Follow-up|0|||
129453937|NCT02375724|465959397|FG000|Overall Study|Protocol Violation|1|||
129453938|NCT02375724|465959398|FG001|Overall Study|Protocol Violation|0|||
129453939|NCT02375724|465959397|FG000|Overall Study|Adverse Event|2|||
129953397|NCT03436797|467790849|FG000|Extended Dosing|Patient decision|1|||
129953398|NCT01951105|467790852|FG000|Overall Study|Adverse Event|0|||
129953399|NCT01951105|467790853|FG001|Overall Study|Adverse Event|5|||
129953400|NCT01951105|467790854|FG002|Overall Study|Adverse Event|0|||
129953401|NCT01951105|467790852|FG000|Overall Study|Lost to Follow-up|0|||
129953402|NCT01951105|467790853|FG001|Overall Study|Lost to Follow-up|1|||
129953403|NCT01951105|467790854|FG002|Overall Study|Lost to Follow-up|0|||
129953404|NCT01951105|467790852|FG000|Overall Study|Protocol Violation|1|||
129953405|NCT01951105|467790853|FG001|Overall Study|Protocol Violation|1|||
129953406|NCT01951105|467790854|FG002|Overall Study|Protocol Violation|1|||
129953407|NCT01951105|467790852|FG000|Overall Study|Withdrawal by Subject|0|||
129953408|NCT01951105|467790853|FG001|Overall Study|Withdrawal by Subject|3|||
129953409|NCT01951105|467790854|FG002|Overall Study|Withdrawal by Subject|1|||
129953410|NCT01601821|467790855|FG000|Overall Study|Death|2|||
129953411|NCT01601821|467790856|FG001|Overall Study|Death|5|||
129953412|NCT01601821|467790855|FG000|Overall Study|Protocol Violation|2|||
129953413|NCT01601821|467790856|FG001|Overall Study|Protocol Violation|2|||
129953414|NCT01601821|467790855|FG000|Overall Study|Lost to Follow-up|6|||
129953415|NCT01601821|467790856|FG001|Overall Study|Lost to Follow-up|14|||
129953416|NCT01601821|467790855|FG000|Overall Study|Withdrawal by Subject|1|||
129953417|NCT01601821|467790856|FG001|Overall Study|Withdrawal by Subject|0|||
129953418|NCT01601821|467790855|FG000|Overall Study|Graft Loss|6|||
129953419|NCT01601821|467790856|FG001|Overall Study|Graft Loss|6|||
129953420|NCT01601821|467790855|FG000|Overall Study|Study Events|7|||
129953421|NCT01601821|467790856|FG001|Overall Study|Study Events|1|||
129953422|NCT01601821|467790855|FG000|Overall Study|Other|5|||
129953423|NCT01601821|467790856|FG001|Overall Study|Other|1|||
129953424|NCT02469155|467790857|FG000|Overall Study|Adverse Event|6|||
129953425|NCT02469155|467790858|FG001|Overall Study|Adverse Event|0|||
129453940|NCT02375724|465959398|FG001|Overall Study|Adverse Event|4|||
129953426|NCT02469155|467790859|FG002|Overall Study|Adverse Event|1|||
129953427|NCT02469155|467790860|FG003|Overall Study|Adverse Event|10|||
129953428|NCT02469155|467790857|FG000|Overall Study|Lack of Efficacy|13|||
129953429|NCT02469155|467790858|FG001|Overall Study|Lack of Efficacy|10|||
129953430|NCT02469155|467790859|FG002|Overall Study|Lack of Efficacy|10|||
129953431|NCT02469155|467790860|FG003|Overall Study|Lack of Efficacy|8|||
129453941|NCT01197521|465959401|FG000|Overall Study|Not reported|24|||
129953432|NCT02469155|467790857|FG000|Overall Study|Death|0|||
129953433|NCT02469155|467790858|FG001|Overall Study|Death|0|||
129953434|NCT02469155|467790859|FG002|Overall Study|Death|0|||
129953435|NCT02469155|467790860|FG003|Overall Study|Death|1|||
129953436|NCT02469155|467790857|FG000|Overall Study|Lost to Follow-up|5|||
129953437|NCT02469155|467790858|FG001|Overall Study|Lost to Follow-up|2|||
129953438|NCT02469155|467790859|FG002|Overall Study|Lost to Follow-up|7|||
129953439|NCT02469155|467790860|FG003|Overall Study|Lost to Follow-up|2|||
129953440|NCT02469155|467790857|FG000|Overall Study|Physician Decision|0|||
129953441|NCT02469155|467790858|FG001|Overall Study|Physician Decision|0|||
129453942|NCT01197521|465959402|FG001|Overall Study|Not reported|25|||
129453943|NCT01197521|465959403|FG002|Overall Study|Not reported|21|||
129453944|NCT01197521|465959401|FG000|Overall Study|Enrolment in long term extension|42|||
129953442|NCT02469155|467790859|FG002|Overall Study|Physician Decision|1|||
129953443|NCT02469155|467790860|FG003|Overall Study|Physician Decision|0|||
129953444|NCT02469155|467790857|FG000|Overall Study|Withdrawal by Subject|34|||
129953445|NCT02469155|467790858|FG001|Overall Study|Withdrawal by Subject|30|||
129953446|NCT02469155|467790859|FG002|Overall Study|Withdrawal by Subject|20|||
129953447|NCT02469155|467790860|FG003|Overall Study|Withdrawal by Subject|37|||
129953448|NCT02469155|467790857|FG000|Overall Study|Other|3|||
129953449|NCT02469155|467790858|FG001|Overall Study|Other|3|||
129953450|NCT02469155|467790859|FG002|Overall Study|Other|2|||
129953451|NCT02469155|467790860|FG003|Overall Study|Other|10|||
129953452|NCT02469155|467790857|FG000|Overall Study|Protocol Violation|0|||
129953453|NCT02469155|467790858|FG001|Overall Study|Protocol Violation|1|||
129953454|NCT02469155|467790859|FG002|Overall Study|Protocol Violation|0|||
129953455|NCT02469155|467790860|FG003|Overall Study|Protocol Violation|1|||
129953456|NCT00442559|467790861|FG000|Overall Study|Lost to Follow-up|32|||
129953457|NCT00442559|467790862|FG001|Overall Study|Lost to Follow-up|34|||
129953458|NCT00442559|467790861|FG000|Overall Study|Protocol Violation|1|||
129953459|NCT00442559|467790862|FG001|Overall Study|Protocol Violation|1|||
129953460|NCT00442559|467790861|FG000|Overall Study|Withdrawal by Subject|1|||
129953461|NCT00442559|467790862|FG001|Overall Study|Withdrawal by Subject|0|||
129953462|NCT02604199|467790872|FG000|Overall Study|Pregnancy|0|||
129953463|NCT02604199|467790873|FG001|Overall Study|Pregnancy|0|||
129953464|NCT02604199|467790874|FG002|Overall Study|Pregnancy|0|||
129953465|NCT02604199|467790875|FG003|Overall Study|Pregnancy|1|||
129953466|NCT02604199|467790872|FG000|Overall Study|Study terminated by sponsor|0|||
129953467|NCT02604199|467790873|FG001|Overall Study|Study terminated by sponsor|2|||
129953468|NCT02604199|467790874|FG002|Overall Study|Study terminated by sponsor|0|||
129953469|NCT02604199|467790875|FG003|Overall Study|Study terminated by sponsor|2|||
129953470|NCT02604199|467790872|FG000|Overall Study|Withdrawal by Subject|0|||
129953471|NCT02604199|467790873|FG001|Overall Study|Withdrawal by Subject|1|||
129953472|NCT02604199|467790874|FG002|Overall Study|Withdrawal by Subject|0|||
129953473|NCT02604199|467790875|FG003|Overall Study|Withdrawal by Subject|0|||
129953474|NCT02812706|467790876|FG000|Phase 1|Adverse Event|0|||
129953475|NCT02812706|467790877|FG001|Phase 1|Adverse Event|2|||
129953476|NCT02812706|467790878|FG002|Phase 1|Adverse Event|0|||
129953477|NCT02812706|467790876|FG000|Phase 1|Progressive disease|3|||
129953478|NCT02812706|467790877|FG001|Phase 1|Progressive disease|3|||
129953479|NCT02812706|467790878|FG002|Phase 1|Progressive disease|0|||
129953480|NCT02812706|467790876|FG000|Phase 2|Adverse Event|0|||
129953481|NCT02812706|467790877|FG001|Phase 2|Adverse Event|0|||
129953482|NCT02812706|467790878|FG002|Phase 2|Adverse Event|2|||
129953483|NCT02812706|467790876|FG000|Phase 2|Progressive disease|0|||
129953484|NCT02812706|467790877|FG001|Phase 2|Progressive disease|0|||
129953485|NCT02812706|467790878|FG002|Phase 2|Progressive disease|22|||
129953486|NCT02812706|467790876|FG000|Phase 2|Other-Unspecified|0|||
129953487|NCT02812706|467790877|FG001|Phase 2|Other-Unspecified|0|||
129953488|NCT02812706|467790878|FG002|Phase 2|Other-Unspecified|4|||
129953489|NCT04362176|467790884|FG000|Overall Study|Lost to Follow-up|5|||
129953490|NCT04362176|467790885|FG001|Overall Study|Lost to Follow-up|8|||
129953491|NCT04362176|467790884|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
129953492|NCT04362176|467790885|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
129953493|NCT00742560|467790886|FG000|Overall Study|Adverse Event|0|||
129953494|NCT00742560|467790887|FG001|Overall Study|Adverse Event|0|||
129953495|NCT00742560|467790888|FG002|Overall Study|Adverse Event|1|||
129953496|NCT00742560|467790889|FG003|Overall Study|Adverse Event|1|||
129953497|NCT00742560|467790890|FG004|Overall Study|Adverse Event|1|||
129953498|NCT00742560|467790886|FG000|Overall Study|Death|0|||
129953499|NCT00742560|467790887|FG001|Overall Study|Death|2|||
129953500|NCT00742560|467790888|FG002|Overall Study|Death|0|||
129953501|NCT00742560|467790889|FG003|Overall Study|Death|2|||
129953502|NCT00742560|467790890|FG004|Overall Study|Death|3|||
129953503|NCT00742560|467790886|FG000|Overall Study|Subject's Decision|1|||
129953504|NCT00742560|467790887|FG001|Overall Study|Subject's Decision|0|||
129953505|NCT00742560|467790888|FG002|Overall Study|Subject's Decision|2|||
129953506|NCT00742560|467790889|FG003|Overall Study|Subject's Decision|3|||
129953507|NCT00742560|467790890|FG004|Overall Study|Subject's Decision|3|||
129953508|NCT00742560|467790886|FG000|Overall Study|Investigator's Decision|0|||
129953509|NCT00742560|467790887|FG001|Overall Study|Investigator's Decision|0|||
129953510|NCT00742560|467790888|FG002|Overall Study|Investigator's Decision|4|||
129953511|NCT00742560|467790889|FG003|Overall Study|Investigator's Decision|1|||
129953512|NCT00742560|467790890|FG004|Overall Study|Investigator's Decision|0|||
129953513|NCT00742560|467790886|FG000|Overall Study|Disease Progression|1|||
129953514|NCT00742560|467790887|FG001|Overall Study|Disease Progression|0|||
129953515|NCT00742560|467790888|FG002|Overall Study|Disease Progression|5|||
129953516|NCT00742560|467790889|FG003|Overall Study|Disease Progression|17|||
129953517|NCT00742560|467790890|FG004|Overall Study|Disease Progression|16|||
129953518|NCT00742560|467790886|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
129953519|NCT00742560|467790887|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
129953520|NCT00742560|467790888|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
129953521|NCT00742560|467790889|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
129953522|NCT00742560|467790890|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
129953523|NCT00742560|467790886|FG000|Overall Study|Other|0|||
129953524|NCT00742560|467790887|FG001|Overall Study|Other|1|||
129953525|NCT00742560|467790888|FG002|Overall Study|Other|8|||
129953526|NCT00742560|467790889|FG003|Overall Study|Other|9|||
129953527|NCT00742560|467790890|FG004|Overall Study|Other|9|||
129953528|NCT00742560|467790886|FG000|Overall Study|MIssing|0|||
129953529|NCT00742560|467790887|FG001|Overall Study|MIssing|0|||
129953530|NCT00742560|467790888|FG002|Overall Study|MIssing|0|||
129953531|NCT00742560|467790889|FG003|Overall Study|MIssing|0|||
129953532|NCT00742560|467790890|FG004|Overall Study|MIssing|1|||
129953533|NCT01426217|467790891|FG000|Overall Study|lost sample|8|||
129953534|NCT01426217|467790892|FG001|Overall Study|lost sample|14|||
129953535|NCT01812837|467790893|FG000|Overall Study|Lost to Follow-up|1|||
129953536|NCT01812837|467790894|FG001|Overall Study|Lost to Follow-up|1|||
129953537|NCT01812837|467790895|FG002|Overall Study|Lost to Follow-up|0|||
129953538|NCT01812837|467790893|FG000|Overall Study|Protocol Violation|1|||
129953539|NCT01812837|467790894|FG001|Overall Study|Protocol Violation|0|||
129953540|NCT01812837|467790895|FG002|Overall Study|Protocol Violation|0|||
129953541|NCT00658632|467790896|FG000|Overall Study|Adverse Event|13|||
129953542|NCT00658632|467790897|FG001|Overall Study|Adverse Event|11|||
129953543|NCT00658632|467790896|FG000|Overall Study|Lost to Follow-up|25|||
129953544|NCT00658632|467790897|FG001|Overall Study|Lost to Follow-up|23|||
129953545|NCT00658632|467790896|FG000|Overall Study|Withdrawal by Subject|10|||
129953546|NCT00658632|467790897|FG001|Overall Study|Withdrawal by Subject|7|||
129953547|NCT00658632|467790896|FG000|Overall Study|Lack of Efficacy|0|||
129953548|NCT00658632|467790897|FG001|Overall Study|Lack of Efficacy|1|||
129953549|NCT00658632|467790896|FG000|Overall Study|Withdrawal of consent|8|||
129953550|NCT00658632|467790897|FG001|Overall Study|Withdrawal of consent|14|||
129953551|NCT00658632|467790896|FG000|Overall Study|Pregnancy|1|||
129953552|NCT00658632|467790897|FG001|Overall Study|Pregnancy|1|||
129953553|NCT00658632|467790896|FG000|Overall Study|Other|7|||
129953554|NCT00658632|467790897|FG001|Overall Study|Other|8|||
129953555|NCT04501614|467790898|FG000|Overall Study|Study Terminated by Sponsor|6|||
129953556|NCT04501614|467790899|FG001|Overall Study|Study Terminated by Sponsor|3|||
129953557|NCT04501614|467790898|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
129953558|NCT04501614|467790899|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
129953559|NCT04529941|467790900|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
129953560|NCT04529941|467790901|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
129953561|NCT02991456|467790904|FG000|Overall Study|Adverse Event|2|||
129953562|NCT02991456|467790905|FG001|Overall Study|Adverse Event|0|||
129953563|NCT02991456|467790904|FG000|Overall Study|Lost to Follow-up|0|||
129953564|NCT02991456|467790905|FG001|Overall Study|Lost to Follow-up|2|||
129953565|NCT02991456|467790904|FG000|Overall Study|Withdrawal by Subject|1|||
129953566|NCT02991456|467790905|FG001|Overall Study|Withdrawal by Subject|0|||
129953567|NCT04016415|467790906|FG000|Overall Study|Adverse Event|2|||
129953568|NCT04016415|467790907|FG001|Overall Study|Adverse Event|1|||
129953569|NCT04016415|467790906|FG000|Overall Study|Lost to Follow-up|6|||
129953570|NCT04016415|467790907|FG001|Overall Study|Lost to Follow-up|2|||
129953571|NCT04016415|467790906|FG000|Overall Study|Physician Decision|5|||
129953572|NCT04016415|467790907|FG001|Overall Study|Physician Decision|1|||
129953573|NCT04016415|467790906|FG000|Overall Study|Pregnancy|0|||
129953574|NCT04016415|467790907|FG001|Overall Study|Pregnancy|1|||
129953575|NCT04016415|467790906|FG000|Overall Study|Withdrawal by Subject|24|||
129953576|NCT04016415|467790907|FG001|Overall Study|Withdrawal by Subject|27|||
129953577|NCT04016415|467790906|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
129953578|NCT04016415|467790907|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
129953579|NCT05615870|467790908|FG000|Overall Study|Lost to Follow-up|10|||
129953580|NCT05615870|467790909|FG001|Overall Study|Lost to Follow-up|13|||
129953581|NCT05615870|467790908|FG000|Overall Study|Physician Decision|2|||
129453945|NCT01197521|465959402|FG001|Overall Study|Enrolment in long term extension|36|||
129453946|NCT01197521|465959403|FG002|Overall Study|Enrolment in long term extension|87|||
129453947|NCT01197521|465959401|FG000|Overall Study|Severe non-compliance to protocol|1|||
129953582|NCT05615870|467790909|FG001|Overall Study|Physician Decision|0|||
129953583|NCT05615870|467790908|FG000|Overall Study|Withdrawal by Subject|0|||
129953584|NCT05615870|467790909|FG001|Overall Study|Withdrawal by Subject|2|||
129953585|NCT05615870|467790908|FG000|Overall Study|Protocol Violation|0|||
129953586|NCT05615870|467790909|FG001|Overall Study|Protocol Violation|3|||
129953587|NCT05615870|467790908|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
129953588|NCT05615870|467790909|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
129953589|NCT05615870|467790908|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
129953590|NCT05615870|467790909|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
129453948|NCT01197521|465959402|FG001|Overall Study|Severe non-compliance to protocol|3|||
129453949|NCT01197521|465959403|FG002|Overall Study|Severe non-compliance to protocol|3|||
129453950|NCT01197521|465959401|FG000|Overall Study|Lack of therapeutic response|2|||
129953591|NCT05615870|467790908|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
129953592|NCT05615870|467790909|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
129953593|NCT00070317|467790910|FG000|Overall Study|Inevaluable (Never Treated)|1|||
129953594|NCT00070317|467790910|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
129953595|NCT00070317|467790910|FG000|Overall Study|Ineligible required test not done|1|||
129953596|NCT00070317|467790910|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
129953597|NCT00070317|467790910|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
129953598|NCT01885559|467790911|FG000|Overall Study|Lost to Follow-up|15|||
129953599|NCT01885559|467790912|FG001|Overall Study|Lost to Follow-up|16|||
129953600|NCT01885559|467790911|FG000|Overall Study|Less than full participation|9|||
129953601|NCT01885559|467790912|FG001|Overall Study|Less than full participation|19|||
129953602|NCT01885559|467790911|FG000|Overall Study|Protocol Violation|0|||
129953603|NCT01885559|467790912|FG001|Overall Study|Protocol Violation|1|||
129953604|NCT00738400|467790918|FG000|Overall Study|Adverse Event|3|||
129953605|NCT00738400|467790919|FG001|Overall Study|Adverse Event|1|||
129453951|NCT01197521|465959402|FG001|Overall Study|Lack of therapeutic response|3|||
129953606|NCT00738400|467790918|FG000|Overall Study|Withdrawal by Subject|0|||
129953607|NCT00738400|467790919|FG001|Overall Study|Withdrawal by Subject|1|||
129953608|NCT00738400|467790918|FG000|Overall Study|Lack of Efficacy|0|||
129453952|NCT01197521|465959403|FG002|Overall Study|Lack of therapeutic response|4|||
129453953|NCT01197521|465959401|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
129453954|NCT01197521|465959402|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
129453955|NCT01197521|465959403|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
129453956|NCT01197521|465959401|FG000|Overall Study|Lost to Follow-up|3|||
129453957|NCT01197521|465959402|FG001|Overall Study|Lost to Follow-up|2|||
129453958|NCT01197521|465959403|FG002|Overall Study|Lost to Follow-up|2|||
129453959|NCT01197521|465959401|FG000|Overall Study|Adverse Event|25|||
129953609|NCT00738400|467790919|FG001|Overall Study|Lack of Efficacy|1|||
129953610|NCT00738400|467790918|FG000|Overall Study|Lost to Follow-up|0|||
129953611|NCT00738400|467790919|FG001|Overall Study|Lost to Follow-up|3|||
129953612|NCT00738400|467790918|FG000|Overall Study|Protocol Violation|1|||
129953613|NCT00738400|467790919|FG001|Overall Study|Protocol Violation|0|||
129953614|NCT00738400|467790918|FG000|Overall Study|Non-compliant with study medication|0|||
129953615|NCT00738400|467790919|FG001|Overall Study|Non-compliant with study medication|1|||
129953616|NCT03138499|467790920|FG000|Overall Study|Lost to Follow-up|1|||
129953617|NCT03138499|467790921|FG001|Overall Study|Lost to Follow-up|0|||
129953618|NCT03138499|467790920|FG000|Overall Study|Participants withdrew consent|1|||
129953619|NCT03138499|467790921|FG001|Overall Study|Participants withdrew consent|0|||
129953620|NCT03138499|467790920|FG000|Overall Study|Participant discontinued study before treatment|0|||
129953621|NCT03138499|467790921|FG001|Overall Study|Participant discontinued study before treatment|1|||
129953622|NCT03138499|467790920|FG000|Overall Study|Disease Progression|2|||
129953623|NCT03138499|467790921|FG001|Overall Study|Disease Progression|6|||
129953624|NCT03138499|467790920|FG000|Overall Study|Study drug toxicity|2|||
129953625|NCT03138499|467790921|FG001|Overall Study|Study drug toxicity|2|||
129953626|NCT03138499|467790920|FG000|Overall Study|Participant request to discontinue study treatment|1|||
129953627|NCT03138499|467790921|FG001|Overall Study|Participant request to discontinue study treatment|1|||
129953628|NCT03138499|467790920|FG000|Overall Study|Other reasons|2|||
129953629|NCT03138499|467790921|FG001|Overall Study|Other reasons|0|||
129953630|NCT02312245|467790922|FG000|Overall Study|Death|0|||
129953631|NCT02312245|467790923|FG001|Overall Study|Death|0|||
129953632|NCT02312245|467790924|FG002|Overall Study|Death|0|||
129953633|NCT02312245|467790925|FG003|Overall Study|Death|1|||
129953634|NCT02312245|467790922|FG000|Overall Study|Withdrawal by Subject|1|||
129953635|NCT02312245|467790923|FG001|Overall Study|Withdrawal by Subject|1|||
129953636|NCT02312245|467790924|FG002|Overall Study|Withdrawal by Subject|0|||
129953637|NCT02312245|467790925|FG003|Overall Study|Withdrawal by Subject|2|||
129953638|NCT02312245|467790922|FG000|Overall Study|Alternative Therapy|1|||
129953639|NCT02312245|467790923|FG001|Overall Study|Alternative Therapy|0|||
129953640|NCT02312245|467790924|FG002|Overall Study|Alternative Therapy|0|||
129953641|NCT02312245|467790925|FG003|Overall Study|Alternative Therapy|0|||
129953642|NCT02312245|467790922|FG000|Overall Study|Progression|0|||
129953643|NCT02312245|467790923|FG001|Overall Study|Progression|0|||
129953644|NCT02312245|467790924|FG002|Overall Study|Progression|0|||
129953645|NCT02312245|467790925|FG003|Overall Study|Progression|5|||
129953646|NCT02312245|467790922|FG000|Overall Study|Patient went to hospice|0|||
129953647|NCT02312245|467790923|FG001|Overall Study|Patient went to hospice|0|||
129953648|NCT02312245|467790924|FG002|Overall Study|Patient went to hospice|0|||
129953649|NCT02312245|467790925|FG003|Overall Study|Patient went to hospice|1|||
129953650|NCT02312245|467790922|FG000|Overall Study|Ineligible|1|||
129953651|NCT02312245|467790923|FG001|Overall Study|Ineligible|0|||
129953652|NCT02312245|467790924|FG002|Overall Study|Ineligible|0|||
129953653|NCT02312245|467790925|FG003|Overall Study|Ineligible|0|||
129953654|NCT00508144|467790926|FG000|Overall Study|Not eligible|6|||
129953655|NCT00508144|467790926|FG000|Overall Study|Death|5|||
129953656|NCT01661972|467790927|FG000|Overall Study|Adverse Event|1|||
129953657|NCT01661972|467790928|FG001|Overall Study|Adverse Event|2|||
129953658|NCT01661972|467790927|FG000|Overall Study|Death during Treatment period|1|||
129953659|NCT01661972|467790928|FG001|Overall Study|Death during Treatment period|1|||
129953660|NCT01661972|467790927|FG000|Overall Study|Withdrawal by Subject|0|||
129953661|NCT01661972|467790928|FG001|Overall Study|Withdrawal by Subject|1|||
129453960|NCT01197521|465959402|FG001|Overall Study|Adverse Event|28|||
129453961|NCT01197521|465959403|FG002|Overall Study|Adverse Event|24|||
129953662|NCT03556891|467790934|FG000|Initial Pivotal Study|Adverse Event|4|||
129953663|NCT03556891|467790934|FG000|Initial Pivotal Study|MRI Need|3|||
129953664|NCT03556891|467790934|FG000|Initial Pivotal Study|Device Failure|1|||
129953665|NCT03556891|467790934|FG000|Initial Pivotal Study|Death|1|||
129953666|NCT03556891|467790934|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
129953667|NCT03556891|467790934|FG000|Initial Pivotal Study|Missing at random|1|||
129953668|NCT03556891|467790934|FG000|Initial Pivotal Study|Missing due to COVID|1|||
129953669|NCT03556891|467790934|FG000|Initial Pivotal Study|Protocol Violation|1|||
129953670|NCT05927753|467791830|FG000|Overall Study|Withdrawal by Subject|0|||
129953671|NCT05927753|467791831|FG001|Overall Study|Withdrawal by Subject|2|||
129953672|NCT05927753|467791830|FG000|Overall Study|Physician Decision|0|||
129953673|NCT05927753|467791831|FG001|Overall Study|Physician Decision|1|||
129953674|NCT05381948|467791833|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
129953675|NCT05381948|467791834|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
129953676|NCT05381948|467791835|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
129953677|NCT05381948|467791833|FG000|Overall Study|Adverse Event: Non-ocular|0|||
129953678|NCT05381948|467791834|FG001|Overall Study|Adverse Event: Non-ocular|1|||
129953679|NCT05381948|467791835|FG002|Overall Study|Adverse Event: Non-ocular|0|||
129953680|NCT05381948|467791833|FG000|Overall Study|Lost to Follow-up|1|||
129953681|NCT05381948|467791834|FG001|Overall Study|Lost to Follow-up|0|||
129953682|NCT05381948|467791835|FG002|Overall Study|Lost to Follow-up|0|||
129953683|NCT05381948|467791833|FG000|Overall Study|Protocol Deviation|0|||
129953684|NCT05381948|467791834|FG001|Overall Study|Protocol Deviation|2|||
129953685|NCT05381948|467791835|FG002|Overall Study|Protocol Deviation|0|||
129953686|NCT05381948|467791833|FG000|Overall Study|Withdrawal by Subject|1|||
129953687|NCT05381948|467791834|FG001|Overall Study|Withdrawal by Subject|0|||
129953688|NCT05381948|467791835|FG002|Overall Study|Withdrawal by Subject|1|||
129953689|NCT05381948|467791833|FG000|Overall Study|Death|0|||
129953690|NCT05381948|467791834|FG001|Overall Study|Death|2|||
129953691|NCT05381948|467791835|FG002|Overall Study|Death|0|||
129953692|NCT05381948|467791833|FG000|Overall Study|Discontinued study without receiving study drug|0|||
129953693|NCT05381948|467791834|FG001|Overall Study|Discontinued study without receiving study drug|0|||
129953694|NCT05381948|467791835|FG002|Overall Study|Discontinued study without receiving study drug|1|||
129953695|NCT04649359|467791839|FG000|Overall Study|Withdrawal by Subject|7|||
129953696|NCT04649359|467791840|FG001|Overall Study|Withdrawal by Subject|7|||
129953697|NCT04649359|467791839|FG000|Overall Study|Death|41|||
129953698|NCT04649359|467791840|FG001|Overall Study|Death|26|||
129953699|NCT04649359|467791839|FG000|Overall Study|Ongoing in the study|75|||
129953700|NCT04649359|467791840|FG001|Overall Study|Ongoing in the study|31|||
129953701|NCT04751929|467791841|FG000|Overall Study|Withdrawal by Subject|2|||
129953702|NCT04751929|467791842|FG001|Overall Study|Withdrawal by Subject|0|||
129953703|NCT04751929|467791843|FG002|Overall Study|Withdrawal by Subject|0|||
129953704|NCT04751929|467791844|FG003|Overall Study|Withdrawal by Subject|0|||
129953705|NCT04751929|467791841|FG000|Overall Study|Rising PSA|0|||
129953706|NCT04751929|467791842|FG001|Overall Study|Rising PSA|1|||
129953707|NCT04751929|467791843|FG002|Overall Study|Rising PSA|0|||
129953708|NCT04751929|467791844|FG003|Overall Study|Rising PSA|0|||
129953709|NCT04751929|467791841|FG000|Overall Study|Adverse Event|1|||
129953710|NCT04751929|467791842|FG001|Overall Study|Adverse Event|2|||
129953711|NCT04751929|467791843|FG002|Overall Study|Adverse Event|0|||
129953712|NCT04751929|467791844|FG003|Overall Study|Adverse Event|0|||
129953713|NCT04751929|467791841|FG000|Overall Study|Progressive Disease|3|||
129953714|NCT04751929|467791842|FG001|Overall Study|Progressive Disease|4|||
129953715|NCT04751929|467791843|FG002|Overall Study|Progressive Disease|4|||
129953716|NCT04751929|467791844|FG003|Overall Study|Progressive Disease|0|||
129953717|NCT04751929|467791841|FG000|Overall Study|Death|1|||
129953718|NCT04751929|467791842|FG001|Overall Study|Death|1|||
129953719|NCT04751929|467791843|FG002|Overall Study|Death|0|||
129953720|NCT04751929|467791844|FG003|Overall Study|Death|0|||
129953721|NCT04175392|467791848|FG000|Overall Study|Withdrawal by Subject|3|||
129953722|NCT04175392|467791849|FG001|Overall Study|Withdrawal by Subject|2|||
129953723|NCT02727998|467791850|FG000|Overall Study|Lost to Follow-up|3|||
129953724|NCT02727998|467791851|FG001|Overall Study|Lost to Follow-up|3|||
129953725|NCT02727998|467791850|FG000|Overall Study|Withdrawal by Subject|0|||
129953726|NCT02727998|467791851|FG001|Overall Study|Withdrawal by Subject|1|||
129953727|NCT02105688|467791852|FG000|Part A: Double-Blind|Adverse Event|1|||
129953728|NCT02105688|467791853|FG001|Part A: Double-Blind|Adverse Event|0|||
129953729|NCT02105688|467791852|FG000|Part A: Double-Blind|Death|0|||
129953730|NCT02105688|467791853|FG001|Part A: Double-Blind|Death|1|||
129953731|NCT02105688|467791852|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
129953732|NCT02105688|467791853|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
129953733|NCT02105688|467791852|FG000|Part A: Double-Blind|Physician Decision|0|||
129953734|NCT02105688|467791853|FG001|Part A: Double-Blind|Physician Decision|1|||
129953735|NCT02105688|467791852|FG000|Part A: Double-Blind|Status Unknown|0|||
129953736|NCT02105688|467791853|FG001|Part A: Double-Blind|Status Unknown|2|||
129953737|NCT02105688|467791852|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
129953738|NCT02105688|467791853|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
129953739|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Death|2|||
129953740|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Death|1|||
129953741|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
129953742|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
129953743|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
129953744|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
129953745|NCT02105688|467791852|FG000|Part B: Observational Follow-up|Physician Decision|3|||
129953746|NCT02105688|467791853|FG001|Part B: Observational Follow-up|Physician Decision|1|||
129953747|NCT02062827|467791857|FG000|Overall Study|Death|1|||
129953748|NCT02062827|467791858|FG001|Overall Study|Death|0|||
129953749|NCT02062827|467791859|FG002|Overall Study|Death|0|||
129953750|NCT02062827|467791860|FG003|Overall Study|Death|0|||
129953751|NCT02062827|467791861|FG004|Overall Study|Death|0|||
129953752|NCT02062827|467791862|FG005|Overall Study|Death|0|||
129953753|NCT02062827|467791863|FG006|Overall Study|Death|0|||
129953754|NCT02062827|467791864|FG007|Overall Study|Death|0|||
129953755|NCT02062827|467791857|FG000|Overall Study|Withdrawal by Subject|3|||
129953756|NCT02062827|467791858|FG001|Overall Study|Withdrawal by Subject|1|||
129953757|NCT02062827|467791859|FG002|Overall Study|Withdrawal by Subject|1|||
129953758|NCT02062827|467791860|FG003|Overall Study|Withdrawal by Subject|2|||
129953759|NCT02062827|467791861|FG004|Overall Study|Withdrawal by Subject|6|||
129953760|NCT02062827|467791862|FG005|Overall Study|Withdrawal by Subject|0|||
129953761|NCT02062827|467791863|FG006|Overall Study|Withdrawal by Subject|5|||
129953762|NCT02062827|467791864|FG007|Overall Study|Withdrawal by Subject|0|||
129953763|NCT02062827|467791857|FG000|Overall Study|Screen Fail|0|||
129953764|NCT02062827|467791858|FG001|Overall Study|Screen Fail|0|||
129953765|NCT02062827|467791859|FG002|Overall Study|Screen Fail|0|||
129453962|NCT01309659|465959404|FG000|Overall Study|Protocol Violation|0|||
129453963|NCT01309659|465959405|FG001|Overall Study|Protocol Violation|1|||
129953766|NCT02062827|467791860|FG003|Overall Study|Screen Fail|0|||
129953767|NCT02062827|467791861|FG004|Overall Study|Screen Fail|0|||
129953768|NCT02062827|467791862|FG005|Overall Study|Screen Fail|0|||
129953769|NCT02062827|467791863|FG006|Overall Study|Screen Fail|0|||
129953770|NCT02062827|467791864|FG007|Overall Study|Screen Fail|8|||
129953771|NCT03166215|467791865|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
129953772|NCT03166215|467791866|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
129953773|NCT03166215|467791867|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
129953774|NCT03166215|467791865|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
129953775|NCT03166215|467791866|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
129953776|NCT03166215|467791867|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
129953777|NCT00288353|467791869|FG000|Overall Study|Lack of Efficacy|2|||
129953778|NCT00288353|467791870|FG001|Overall Study|Lack of Efficacy|2|||
129953779|NCT00288353|467791869|FG000|Overall Study|Withdrawal by Subject|5|||
129953780|NCT00288353|467791870|FG001|Overall Study|Withdrawal by Subject|5|||
129953781|NCT05008224|467791871|FG000|Overall Study|Death|3|||
129953782|NCT05008224|467791871|FG000|Overall Study|Lost to Follow-up|2|||
129953783|NCT05008224|467791871|FG000|Overall Study|Did Not Continue on Extension Study|39|||
129953784|NCT05008224|467791871|FG000|Overall Study|Transferred to Extension Study|100|||
129953785|NCT05008224|467791871|FG000|Overall Study|Withdrawal by Subject|2|||
129453964|NCT03462576|465959406|FG000|Overall Study|Protocol Violation|5|||
129453965|NCT03462576|465959407|FG001|Overall Study|Protocol Violation|11|||
129453966|NCT03462576|465959408|FG002|Overall Study|Protocol Violation|7|||
129453967|NCT03462576|465959406|FG000|Overall Study|Device Malfunction|0|||
129453968|NCT03462576|465959407|FG001|Overall Study|Device Malfunction|0|||
129453969|NCT03462576|465959408|FG002|Overall Study|Device Malfunction|1|||
129953786|NCT05234632|467791872|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
129953787|NCT05234632|467791873|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
129953788|NCT05234632|467791872|FG000|Overall Study|Withdrawal by Subject|2|||
129953789|NCT05234632|467791873|FG001|Overall Study|Withdrawal by Subject|0|||
129953790|NCT05234632|467791872|FG000|Overall Study|Adverse Event|0|||
129953791|NCT05234632|467791873|FG001|Overall Study|Adverse Event|4|||
129953792|NCT05234632|467791872|FG000|Overall Study|Physician Decision|1|||
129953793|NCT05234632|467791873|FG001|Overall Study|Physician Decision|1|||
129953794|NCT05234632|467791872|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
129953795|NCT05234632|467791873|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
129953796|NCT05234632|467791872|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
129953797|NCT05234632|467791873|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
129953798|NCT04985604|467791874|FG000|Overall Study|Death|4|||
129953799|NCT04985604|467791875|FG001|Overall Study|Death|6|||
129953800|NCT04985604|467791874|FG000|Overall Study|Withdrawal by Subject|0|||
129953801|NCT04985604|467791875|FG001|Overall Study|Withdrawal by Subject|1|||
129953802|NCT02282761|467791876|FG000|Overall Study|Death|0|||
129953803|NCT02282761|467791877|FG001|Overall Study|Death|0|||
129453970|NCT02285777|465959412|FG000|Overall Study|Withdrawal by Subject|1|||
129453971|NCT02285777|465959413|FG001|Overall Study|Withdrawal by Subject|1|||
129453972|NCT02285777|465959412|FG000|Overall Study|Lost to Follow-up|4|||
129453973|NCT02285777|465959413|FG001|Overall Study|Lost to Follow-up|2|||
129453974|NCT03962101|465959417|FG000|Overall Study|Adverse Event|1|||
129453975|NCT03962101|465959417|FG000|Overall Study|Physician Decision|2|||
129453976|NCT03962101|465959417|FG000|Overall Study|Not related to medical events|1|||
129953804|NCT02282761|467791878|FG002|Overall Study|Death|1|||
129953805|NCT02282761|467791876|FG000|Overall Study|Adverse Event|6|||
129953806|NCT02282761|467791877|FG001|Overall Study|Adverse Event|2|||
129953807|NCT02282761|467791878|FG002|Overall Study|Adverse Event|0|||
129953808|NCT02282761|467791876|FG000|Overall Study|Lack of Efficacy|11|||
129953809|NCT02282761|467791877|FG001|Overall Study|Lack of Efficacy|6|||
129953810|NCT02282761|467791878|FG002|Overall Study|Lack of Efficacy|17|||
129953811|NCT02282761|467791876|FG000|Overall Study|Lost to Follow-up|2|||
129953812|NCT02282761|467791877|FG001|Overall Study|Lost to Follow-up|2|||
129953813|NCT02282761|467791878|FG002|Overall Study|Lost to Follow-up|1|||
129953814|NCT02282761|467791876|FG000|Overall Study|Physician Decision|0|||
129453977|NCT00271596|465959424|FG000|Overall Study|Protocol Violation|1|||
129453978|NCT00271596|465959425|FG001|Overall Study|Protocol Violation|0|||
129953815|NCT02282761|467791877|FG001|Overall Study|Physician Decision|0|||
129953816|NCT02282761|467791878|FG002|Overall Study|Physician Decision|2|||
129953817|NCT02282761|467791876|FG000|Overall Study|Withdrawal by Subject|8|||
129953818|NCT02282761|467791877|FG001|Overall Study|Withdrawal by Subject|10|||
129953819|NCT02282761|467791878|FG002|Overall Study|Withdrawal by Subject|16|||
129953820|NCT02282761|467791876|FG000|Overall Study|Other|3|||
129953821|NCT02282761|467791877|FG001|Overall Study|Other|2|||
129953822|NCT02282761|467791878|FG002|Overall Study|Other|1|||
129953823|NCT02632045|467791879|FG000|Overall Study|Withdrawal by Subject|1|||
129953824|NCT02632045|467791880|FG001|Overall Study|Withdrawal by Subject|2|||
129953825|NCT05878522|467791881|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953826|NCT05878522|467791882|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953827|NCT05878522|467791883|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953828|NCT05878522|467791884|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953829|NCT05878522|467791885|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953830|NCT05878522|467791886|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953831|NCT05878522|467791887|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953832|NCT05878522|467791888|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953833|NCT05878522|467791889|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
129953834|NCT05878522|467791890|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953835|NCT05878522|467791891|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953836|NCT05878522|467791892|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
129953837|NCT05878522|467791881|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
129953838|NCT05878522|467791882|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953839|NCT05878522|467791883|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953840|NCT05878522|467791884|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953841|NCT05878522|467791885|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953842|NCT05878522|467791886|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953843|NCT05878522|467791887|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129453979|NCT00271596|465959424|FG000|Overall Study|Withdrawal by Subject|0|||
129953844|NCT05878522|467791888|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953845|NCT05878522|467791889|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953846|NCT05878522|467791890|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
129953847|NCT05878522|467791891|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953848|NCT05878522|467791892|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
129953849|NCT05878522|467791881|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953850|NCT05878522|467791882|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
129953851|NCT05878522|467791883|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953852|NCT05878522|467791884|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
129953853|NCT05878522|467791885|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953854|NCT05878522|467791886|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953855|NCT05878522|467791887|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953856|NCT05878522|467791888|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953857|NCT05878522|467791889|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953858|NCT05878522|467791890|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953859|NCT05878522|467791891|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129953860|NCT05878522|467791892|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
129453980|NCT00271596|465959425|FG001|Overall Study|Withdrawal by Subject|1|||
129953861|NCT05878522|467791881|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129453981|NCT01069172|465959427|FG000|Overall Study|Withdrawal by Subject|1|||
129453982|NCT01069172|465959428|FG001|Overall Study|Withdrawal by Subject|0|||
129953862|NCT05878522|467791882|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953863|NCT05878522|467791883|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953864|NCT05878522|467791884|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953865|NCT05878522|467791885|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
129953866|NCT05878522|467791886|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953867|NCT05878522|467791887|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953868|NCT05878522|467791888|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953869|NCT05878522|467791889|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953870|NCT05878522|467791890|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953871|NCT05878522|467791891|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953872|NCT05878522|467791892|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
129953873|NCT05263492|467791893|FG000|Overall Study|Adverse Event|1|||
129953874|NCT05263492|467791893|FG000|Overall Study|Disease progression during active treatment|3|||
129953875|NCT03345420|467791896|FG000|Overall Study|Withdrawal by Subject|1|||
129953876|NCT02252172|467791897|FG000|Overall Study|Lost to Follow-up|3|||
129953877|NCT02252172|467791898|FG001|Overall Study|Lost to Follow-up|1|||
129953878|NCT02252172|467791897|FG000|Overall Study|Ongoing|276|||
129953879|NCT02252172|467791898|FG001|Overall Study|Ongoing|298|||
129953880|NCT05216835|467791899|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953881|NCT05216835|467791900|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953882|NCT05216835|467791901|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953883|NCT05216835|467791902|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
129953884|NCT05216835|467791903|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
129953885|NCT05216835|467791904|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
129953886|NCT05216835|467791905|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
129953887|NCT05216835|467791906|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
129953888|NCT05216835|467791899|FG000|Overall Study|Death|0|||
129953889|NCT05216835|467791900|FG001|Overall Study|Death|0|||
129953890|NCT05216835|467791901|FG002|Overall Study|Death|0|||
129953891|NCT05216835|467791902|FG003|Overall Study|Death|1|||
129953892|NCT05216835|467791903|FG004|Overall Study|Death|1|||
129953893|NCT05216835|467791904|FG005|Overall Study|Death|1|||
129953894|NCT05216835|467791905|FG006|Overall Study|Death|1|||
129953895|NCT05216835|467791906|FG007|Overall Study|Death|1|||
129953896|NCT05216835|467791899|FG000|Overall Study|Physician Decision|0|||
129453983|NCT04206605|465959429|FG000|Overall Study|Adverse Event|0|||
129453984|NCT04206605|465959430|FG001|Overall Study|Adverse Event|1|||
129453985|NCT04206605|465959429|FG000|Overall Study|Withdrawal by Subject|1|||
129453986|NCT04206605|465959430|FG001|Overall Study|Withdrawal by Subject|0|||
129453987|NCT03901079|465959433|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
129453988|NCT00578136|465959434|FG000|Overall Study|Not given intervention|1|||
129453989|NCT00578136|465959435|FG001|Overall Study|Not given intervention|1|||
129453990|NCT02047253|465959436|FG000|Overall Study|Lost to Follow-up|8|||
129453991|NCT01987960|465959438|FG000|Period 1|Adverse Event|24|||
129453992|NCT01987960|465959439|FG001|Period 1|Adverse Event|0|||
129453993|NCT01987960|465959440|FG002|Period 1|Adverse Event|0|||
129453994|NCT01987960|465959441|FG003|Period 1|Adverse Event|0|||
129453995|NCT01987960|465959438|FG000|Period 1|Lack of Efficacy|4|||
129453996|NCT01987960|465959439|FG001|Period 1|Lack of Efficacy|0|||
129453997|NCT01987960|465959440|FG002|Period 1|Lack of Efficacy|0|||
129453998|NCT01987960|465959441|FG003|Period 1|Lack of Efficacy|0|||
129453999|NCT01987960|465959438|FG000|Period 1|Non-compliance with IMP|6|||
129454000|NCT01987960|465959439|FG001|Period 1|Non-compliance with IMP|0|||
129454001|NCT01987960|465959440|FG002|Period 1|Non-compliance with IMP|0|||
129454002|NCT01987960|465959441|FG003|Period 1|Non-compliance with IMP|0|||
129454003|NCT01987960|465959438|FG000|Period 1|Protocol Violation|12|||
129953897|NCT05216835|467791900|FG001|Overall Study|Physician Decision|0|||
129953898|NCT05216835|467791901|FG002|Overall Study|Physician Decision|0|||
129953899|NCT05216835|467791902|FG003|Overall Study|Physician Decision|0|||
129953900|NCT05216835|467791903|FG004|Overall Study|Physician Decision|0|||
129953901|NCT05216835|467791904|FG005|Overall Study|Physician Decision|1|||
129953902|NCT05216835|467791905|FG006|Overall Study|Physician Decision|1|||
129953903|NCT05216835|467791906|FG007|Overall Study|Physician Decision|0|||
129953904|NCT05216835|467791899|FG000|Overall Study|Study terminated by Sponsor|0|||
129454004|NCT01987960|465959439|FG001|Period 1|Protocol Violation|0|||
129454005|NCT01987960|465959440|FG002|Period 1|Protocol Violation|0|||
129454006|NCT01987960|465959441|FG003|Period 1|Protocol Violation|0|||
129454007|NCT01987960|465959438|FG000|Period 1|Withdrawal by Subject|21|||
129454008|NCT01987960|465959439|FG001|Period 1|Withdrawal by Subject|0|||
129454009|NCT01987960|465959440|FG002|Period 1|Withdrawal by Subject|0|||
129454010|NCT01987960|465959441|FG003|Period 1|Withdrawal by Subject|0|||
129454011|NCT01987960|465959438|FG000|Period 1|Lost to Follow-up|40|||
129454012|NCT01987960|465959439|FG001|Period 1|Lost to Follow-up|0|||
129953905|NCT05216835|467791900|FG001|Overall Study|Study terminated by Sponsor|0|||
129953906|NCT05216835|467791901|FG002|Overall Study|Study terminated by Sponsor|0|||
129953907|NCT05216835|467791902|FG003|Overall Study|Study terminated by Sponsor|0|||
129454013|NCT01987960|465959440|FG002|Period 1|Lost to Follow-up|0|||
129454014|NCT01987960|465959441|FG003|Period 1|Lost to Follow-up|0|||
129953908|NCT05216835|467791903|FG004|Overall Study|Study terminated by Sponsor|0|||
129953909|NCT05216835|467791904|FG005|Overall Study|Study terminated by Sponsor|0|||
129953910|NCT05216835|467791905|FG006|Overall Study|Study terminated by Sponsor|0|||
129953911|NCT05216835|467791906|FG007|Overall Study|Study terminated by Sponsor|1|||
129953912|NCT05216835|467791899|FG000|Overall Study|Withdrawal by Subject|1|||
129953913|NCT05216835|467791900|FG001|Overall Study|Withdrawal by Subject|0|||
129953914|NCT05216835|467791901|FG002|Overall Study|Withdrawal by Subject|1|||
129953915|NCT05216835|467791902|FG003|Overall Study|Withdrawal by Subject|0|||
129953916|NCT05216835|467791903|FG004|Overall Study|Withdrawal by Subject|1|||
129953917|NCT05216835|467791904|FG005|Overall Study|Withdrawal by Subject|0|||
129953918|NCT05216835|467791905|FG006|Overall Study|Withdrawal by Subject|0|||
129454015|NCT01987960|465959438|FG000|Period 1|administrative or other reason|75|||
129953919|NCT05216835|467791906|FG007|Overall Study|Withdrawal by Subject|1|||
129953920|NCT05216835|467791899|FG000|Overall Study|Other|0|||
129953921|NCT05216835|467791900|FG001|Overall Study|Other|1|||
129953922|NCT05216835|467791901|FG002|Overall Study|Other|0|||
129953923|NCT05216835|467791902|FG003|Overall Study|Other|0|||
129953924|NCT05216835|467791903|FG004|Overall Study|Other|0|||
129953925|NCT05216835|467791904|FG005|Overall Study|Other|0|||
129953926|NCT05216835|467791905|FG006|Overall Study|Other|0|||
129953927|NCT05216835|467791906|FG007|Overall Study|Other|0|||
129953928|NCT05179603|467791907|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
129953929|NCT05179603|467791907|FG000|Overall Study|Withdrawal by Subject|1|||
129953930|NCT05179603|467791907|FG000|Overall Study|Progressive disease|4|||
129953931|NCT05179603|467791907|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
129953932|NCT04551053|467791910|FG000|Overall Study|Death|10|||
129953933|NCT04551053|467791911|FG001|Overall Study|Death|9|||
129953934|NCT04551053|467791910|FG000|Overall Study|Lost to Follow-up|0|||
129953935|NCT04551053|467791911|FG001|Overall Study|Lost to Follow-up|2|||
129953936|NCT04551053|467791910|FG000|Overall Study|Study Terminated by Sponsor|57|||
129953937|NCT04551053|467791911|FG001|Overall Study|Study Terminated by Sponsor|65|||
129953938|NCT04551053|467791910|FG000|Overall Study|Withdrawal by Subject|12|||
129953939|NCT04551053|467791911|FG001|Overall Study|Withdrawal by Subject|5|||
129953940|NCT04551053|467791910|FG000|Overall Study|Adverse Event|2|||
129953941|NCT04551053|467791911|FG001|Overall Study|Adverse Event|0|||
129953942|NCT04551053|467791910|FG000|Overall Study|Lack of Efficacy|2|||
129953943|NCT04551053|467791911|FG001|Overall Study|Lack of Efficacy|1|||
129953944|NCT04551053|467791910|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
129953945|NCT04551053|467791911|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
129953946|NCT04551053|467791910|FG000|Overall Study|Splenapendectomi|1|||
129953947|NCT04551053|467791911|FG001|Overall Study|Splenapendectomi|0|||
129953948|NCT04551053|467791910|FG000|Overall Study|Medical Decision|1|||
129953949|NCT04551053|467791911|FG001|Overall Study|Medical Decision|1|||
129953950|NCT05740371|467791912|FG000|Overall Study|Death|1|||
129953951|NCT03019289|467791913|FG000|Overall Study|Adverse Event|1|||
129953952|NCT03019289|467791914|FG001|Overall Study|Adverse Event|0|||
129953953|NCT03019289|467791915|FG002|Overall Study|Adverse Event|0|||
129953954|NCT03019289|467791916|FG003|Overall Study|Adverse Event|0|||
129953955|NCT03019289|467791917|FG004|Overall Study|Adverse Event|0|||
129953956|NCT03019289|467791918|FG005|Overall Study|Adverse Event|0|||
129953957|NCT03019289|467791919|FG006|Overall Study|Adverse Event|0|||
129953958|NCT03019289|467791920|FG007|Overall Study|Adverse Event|0|||
129953959|NCT03019289|467791921|FG008|Overall Study|Adverse Event|1|||
129953960|NCT03019289|467791913|FG000|Overall Study|Other|1|||
129953961|NCT03019289|467791914|FG001|Overall Study|Other|0|||
129953962|NCT03019289|467791915|FG002|Overall Study|Other|0|||
129953963|NCT03019289|467791916|FG003|Overall Study|Other|0|||
129953964|NCT03019289|467791917|FG004|Overall Study|Other|0|||
129953965|NCT03019289|467791918|FG005|Overall Study|Other|0|||
129953966|NCT03019289|467791919|FG006|Overall Study|Other|0|||
129953967|NCT03019289|467791920|FG007|Overall Study|Other|0|||
129953968|NCT03019289|467791921|FG008|Overall Study|Other|0|||
129953969|NCT02389894|467791922|FG000|Overall Study|Death|4|||
129953970|NCT02389894|467791923|FG001|Overall Study|Death|5|||
129953971|NCT02389894|467791924|FG002|Overall Study|Death|3|||
129953972|NCT02389894|467791922|FG000|Overall Study|Withdrawal by Subject|2|||
129953973|NCT02389894|467791923|FG001|Overall Study|Withdrawal by Subject|4|||
129953974|NCT02389894|467791924|FG002|Overall Study|Withdrawal by Subject|5|||
129454016|NCT01987960|465959439|FG001|Period 1|administrative or other reason|0|||
129454017|NCT01987960|465959440|FG002|Period 1|administrative or other reason|0|||
129953975|NCT02389894|467791922|FG000|Overall Study|Lost to Follow-up|2|||
129953976|NCT02389894|467791923|FG001|Overall Study|Lost to Follow-up|1|||
129953977|NCT02389894|467791924|FG002|Overall Study|Lost to Follow-up|1|||
129953978|NCT01549951|467791925|FG000|Overall Study|Adverse Event|15|||
129953979|NCT01549951|467791925|FG000|Overall Study|Withdrawal by Subject|2|||
129953980|NCT01549951|467791925|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
129953981|NCT01549951|467791925|FG000|Overall Study|Progressive disease|29|||
129953982|NCT01549951|467791925|FG000|Overall Study|Symptomatic deterioration|1|||
129953983|NCT01549951|467791925|FG000|Overall Study|Other|2|||
129953984|NCT01123200|467791926|FG000|Overall Study|Withdrawal by Subject|1|||
129953985|NCT02819141|467791927|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
129953986|NCT02819141|467791928|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
129953987|NCT02101554|467792539|FG000|Overall Study|Protocol Violation|0|||
129953988|NCT02101554|467792540|FG001|Overall Study|Protocol Violation|1|||
129953989|NCT02101554|467792541|FG002|Overall Study|Protocol Violation|0|||
129953990|NCT02101554|467792539|FG000|Overall Study|Insufficient Clinical Response|0|||
129953991|NCT02101554|467792540|FG001|Overall Study|Insufficient Clinical Response|2|||
129953992|NCT02101554|467792541|FG002|Overall Study|Insufficient Clinical Response|0|||
129953993|NCT02101554|467792539|FG000|Overall Study|Adverse Event|2|||
129953994|NCT02101554|467792540|FG001|Overall Study|Adverse Event|1|||
129953995|NCT02101554|467792541|FG002|Overall Study|Adverse Event|1|||
129953996|NCT02101554|467792539|FG000|Overall Study|Lost to Follow-up|0|||
129953997|NCT02101554|467792540|FG001|Overall Study|Lost to Follow-up|1|||
129953998|NCT02101554|467792541|FG002|Overall Study|Lost to Follow-up|0|||
129953999|NCT02101554|467792539|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
129954000|NCT02101554|467792540|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
129954001|NCT02101554|467792541|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
129954002|NCT01075815|467792543|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
129954003|NCT01075815|467792544|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
129954004|NCT01075815|467792543|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
129954005|NCT01075815|467792544|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
129954006|NCT01075815|467792543|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
129954007|NCT01075815|467792544|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
129954008|NCT03503188|467792545|FG000|Overall Study|Non eligible in the sub study|0|||
129954009|NCT03503188|467792546|FG001|Overall Study|Non eligible in the sub study|1|||
129954010|NCT03747575|467792553|FG000|Overall Study|Withdrawal by Subject|6|||
129954011|NCT03747575|467792554|FG001|Overall Study|Withdrawal by Subject|3|||
129954012|NCT03747575|467792553|FG000|Overall Study|Lost to Follow-up|3|||
129954013|NCT03747575|467792554|FG001|Overall Study|Lost to Follow-up|3|||
129954014|NCT03747575|467792553|FG000|Overall Study|Adverse Event|0|||
129954015|NCT03747575|467792554|FG001|Overall Study|Adverse Event|1|||
129954016|NCT01052714|467792560|FG000|Overall Study|Adverse Event|6|||
129954017|NCT01052714|467792561|FG001|Overall Study|Adverse Event|3|||
129954018|NCT01052714|467792562|FG002|Overall Study|Adverse Event|0|||
129954019|NCT01052714|467792560|FG000|Overall Study|Death|1|||
129954020|NCT01052714|467792561|FG001|Overall Study|Death|2|||
129954021|NCT01052714|467792562|FG002|Overall Study|Death|0|||
129954022|NCT01052714|467792560|FG000|Overall Study|Lost to Follow-up|2|||
129954023|NCT01052714|467792561|FG001|Overall Study|Lost to Follow-up|3|||
129954024|NCT01052714|467792562|FG002|Overall Study|Lost to Follow-up|0|||
129954025|NCT01052714|467792560|FG000|Overall Study|Physician Decision|9|||
129954026|NCT01052714|467792561|FG001|Overall Study|Physician Decision|9|||
129954027|NCT01052714|467792562|FG002|Overall Study|Physician Decision|1|||
129954028|NCT01052714|467792560|FG000|Overall Study|Withdrawal by Subject|7|||
129954029|NCT01052714|467792561|FG001|Overall Study|Withdrawal by Subject|12|||
129954030|NCT01052714|467792562|FG002|Overall Study|Withdrawal by Subject|1|||
129954031|NCT03689452|467792565|FG000|Overall Study|Lost to Follow-up|1|||
129954032|NCT03689452|467792566|FG001|Overall Study|Lost to Follow-up|1|||
129954033|NCT02676778|467792568|FG000|Overall Study|Disease Progression|7|||
129954034|NCT02676778|467792569|FG001|Overall Study|Disease Progression|3|||
129954035|NCT02676778|467792570|FG002|Overall Study|Disease Progression|1|||
129954036|NCT02676778|467792568|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
129954037|NCT02676778|467792569|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
129954038|NCT02676778|467792570|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
129954039|NCT02676778|467792568|FG000|Overall Study|Withdrawal by Subject|3|||
129954040|NCT02676778|467792569|FG001|Overall Study|Withdrawal by Subject|2|||
129954041|NCT02676778|467792570|FG002|Overall Study|Withdrawal by Subject|0|||
129954042|NCT02676778|467792568|FG000|Overall Study|Other|4|||
129954043|NCT02676778|467792569|FG001|Overall Study|Other|3|||
129954044|NCT02676778|467792570|FG002|Overall Study|Other|0|||
129954045|NCT02676778|467792568|FG000|Overall Study|Adverse Event|2|||
129954046|NCT02676778|467792569|FG001|Overall Study|Adverse Event|3|||
129954047|NCT02676778|467792570|FG002|Overall Study|Adverse Event|0|||
129954048|NCT00732498|467792571|FG000|Overall Study|Ineligible|1|||
129954049|NCT00732498|467792571|FG000|Overall Study|Adverse Event|2|||
129954050|NCT00732498|467792571|FG000|Overall Study|Physician Decision|3|||
129954051|NCT03214198|467792579|FG000|Overall Study|Case Report Forms Uncollected|18|||
129954052|NCT03214198|467792579|FG000|Overall Study|Protocol Deviation|18|||
129954053|NCT04295499|467792580|FG000|Overall Study|moving out of state|1|||
129954054|NCT04295499|467792581|FG001|Overall Study|moving out of state|0|||
129954055|NCT04295499|467792580|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
129954056|NCT04295499|467792581|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
129954057|NCT03122548|467792582|FG000|Overall Study|Death|2|||
129954058|NCT03122548|467792582|FG000|Overall Study|Progression - subject went into hospice|1|||
129954059|NCT03122548|467792582|FG000|Overall Study|Study Terminated by Sponsor|2|||
129954060|NCT04448561|467792588|FG000|Overall Study|Noncompliance|1|||
129954061|NCT04448561|467792589|FG001|Overall Study|Noncompliance|0|||
129954062|NCT01730118|467793957|FG000|Dose Escalation|Death on study|5|||
129954063|NCT01730118|467793958|FG001|Dose Escalation|Death on study|7|||
129954064|NCT01730118|467793959|FG002|Dose Escalation|Death on study|2|||
129954065|NCT01730118|467793960|FG003|Dose Escalation|Death on study|6|||
129954066|NCT01730118|467793961|FG004|Dose Escalation|Death on study|0|||
129954067|NCT01730118|467793962|FG005|Dose Escalation|Death on study|0|||
129954068|NCT01730118|467793963|FG006|Dose Escalation|Death on study|0|||
129954069|NCT01730118|467793957|FG000|Dose Escalation|Died before treatment|0|||
129954070|NCT01730118|467793958|FG001|Dose Escalation|Died before treatment|0|||
129954071|NCT01730118|467793959|FG002|Dose Escalation|Died before treatment|0|||
129954072|NCT01730118|467793960|FG003|Dose Escalation|Died before treatment|0|||
129954073|NCT01730118|467793961|FG004|Dose Escalation|Died before treatment|0|||
129954074|NCT01730118|467793962|FG005|Dose Escalation|Died before treatment|0|||
129954075|NCT01730118|467793963|FG006|Dose Escalation|Died before treatment|1|||
129954076|NCT01730118|467793957|FG000|Dose Escalation|Chose to start a different treatment|1|||
129954077|NCT01730118|467793958|FG001|Dose Escalation|Chose to start a different treatment|0|||
129954078|NCT01730118|467793959|FG002|Dose Escalation|Chose to start a different treatment|0|||
129954079|NCT01730118|467793960|FG003|Dose Escalation|Chose to start a different treatment|0|||
129954080|NCT01730118|467793961|FG004|Dose Escalation|Chose to start a different treatment|0|||
129954081|NCT01730118|467793962|FG005|Dose Escalation|Chose to start a different treatment|0|||
129954082|NCT01730118|467793963|FG006|Dose Escalation|Chose to start a different treatment|0|||
129954083|NCT01730118|467793957|FG000|Dose Escalation|Withdrawal by Subject|0|||
129954084|NCT01730118|467793958|FG001|Dose Escalation|Withdrawal by Subject|0|||
129954085|NCT01730118|467793959|FG002|Dose Escalation|Withdrawal by Subject|1|||
129954086|NCT01730118|467793960|FG003|Dose Escalation|Withdrawal by Subject|0|||
129954087|NCT01730118|467793961|FG004|Dose Escalation|Withdrawal by Subject|0|||
129954088|NCT01730118|467793962|FG005|Dose Escalation|Withdrawal by Subject|0|||
129954089|NCT01730118|467793963|FG006|Dose Escalation|Withdrawal by Subject|0|||
129954090|NCT01730118|467793957|FG000|Dose Escalation|Disease progression prior to treatment|0|||
129954091|NCT01730118|467793958|FG001|Dose Escalation|Disease progression prior to treatment|0|||
129954092|NCT01730118|467793959|FG002|Dose Escalation|Disease progression prior to treatment|0|||
129954093|NCT01730118|467793960|FG003|Dose Escalation|Disease progression prior to treatment|0|||
129954094|NCT01730118|467793961|FG004|Dose Escalation|Disease progression prior to treatment|0|||
129954095|NCT01730118|467793962|FG005|Dose Escalation|Disease progression prior to treatment|0|||
129954096|NCT01730118|467793963|FG006|Dose Escalation|Disease progression prior to treatment|1|||
129954097|NCT01730118|467793957|FG000|Dose Expansion|Death|0|||
129954098|NCT01730118|467793958|FG001|Dose Expansion|Death|0|||
129954099|NCT01730118|467793959|FG002|Dose Expansion|Death|0|||
129954100|NCT01730118|467793960|FG003|Dose Expansion|Death|0|||
129954101|NCT01730118|467793961|FG004|Dose Expansion|Death|1|||
129954102|NCT01730118|467793962|FG005|Dose Expansion|Death|0|||
129954103|NCT01730118|467793963|FG006|Dose Expansion|Death|0|||
129954104|NCT01730118|467793957|FG000|Dose Expansion|Other medical condition|0|||
129954105|NCT01730118|467793958|FG001|Dose Expansion|Other medical condition|0|||
129954106|NCT01730118|467793959|FG002|Dose Expansion|Other medical condition|0|||
129954107|NCT01730118|467793960|FG003|Dose Expansion|Other medical condition|0|||
129954108|NCT01730118|467793961|FG004|Dose Expansion|Other medical condition|1|||
129954109|NCT01730118|467793962|FG005|Dose Expansion|Other medical condition|0|||
129954110|NCT01730118|467793963|FG006|Dose Expansion|Other medical condition|0|||
129954111|NCT01730118|467793957|FG000|Dose Expansion|Withdrawal by Subject|0|||
129954112|NCT01730118|467793958|FG001|Dose Expansion|Withdrawal by Subject|0|||
129954113|NCT01730118|467793959|FG002|Dose Expansion|Withdrawal by Subject|0|||
129954114|NCT01730118|467793960|FG003|Dose Expansion|Withdrawal by Subject|0|||
129954115|NCT01730118|467793961|FG004|Dose Expansion|Withdrawal by Subject|1|||
129954116|NCT01730118|467793962|FG005|Dose Expansion|Withdrawal by Subject|0|||
129954117|NCT01730118|467793963|FG006|Dose Expansion|Withdrawal by Subject|0|||
129954118|NCT01730118|467793957|FG000|Dose Expansion|Disease progression|0|||
129954119|NCT01730118|467793958|FG001|Dose Expansion|Disease progression|0|||
129954120|NCT01730118|467793959|FG002|Dose Expansion|Disease progression|0|||
129954121|NCT01730118|467793960|FG003|Dose Expansion|Disease progression|0|||
129954122|NCT01730118|467793961|FG004|Dose Expansion|Disease progression|0|||
129954123|NCT01730118|467793962|FG005|Dose Expansion|Disease progression|1|||
129954124|NCT01730118|467793963|FG006|Dose Expansion|Disease progression|0|||
129954125|NCT01730118|467793957|FG000|Dose Expansion|Inability to return|0|||
129954126|NCT01730118|467793958|FG001|Dose Expansion|Inability to return|0|||
129954127|NCT01730118|467793959|FG002|Dose Expansion|Inability to return|0|||
129954128|NCT01730118|467793960|FG003|Dose Expansion|Inability to return|0|||
129954129|NCT01730118|467793961|FG004|Dose Expansion|Inability to return|0|||
129954130|NCT01730118|467793962|FG005|Dose Expansion|Inability to return|1|||
129954131|NCT01730118|467793963|FG006|Dose Expansion|Inability to return|0|||
129954132|NCT01730118|467793957|FG000|Dose Expansion|Physician Decision|0|||
129954133|NCT01730118|467793958|FG001|Dose Expansion|Physician Decision|0|||
129954134|NCT01730118|467793959|FG002|Dose Expansion|Physician Decision|0|||
129954135|NCT01730118|467793960|FG003|Dose Expansion|Physician Decision|0|||
129954136|NCT01730118|467793961|FG004|Dose Expansion|Physician Decision|0|||
129954137|NCT01730118|467793962|FG005|Dose Expansion|Physician Decision|1|||
129954138|NCT01730118|467793963|FG006|Dose Expansion|Physician Decision|0|||
129954139|NCT00489489|467793965|FG000|Overall Study|Not treated due to protocol violation|0|||
129954140|NCT00489489|467793966|FG001|Overall Study|Not treated due to protocol violation|1|||
129954141|NCT00489489|467793967|FG002|Overall Study|Not treated due to protocol violation|1|||
129954142|NCT00489489|467793965|FG000|Overall Study|Adverse Event|1|||
129954143|NCT00489489|467793966|FG001|Overall Study|Adverse Event|1|||
129954144|NCT00489489|467793967|FG002|Overall Study|Adverse Event|1|||
129954145|NCT00489489|467793965|FG000|Overall Study|Protocol Violation|1|||
129954146|NCT00489489|467793966|FG001|Overall Study|Protocol Violation|0|||
129954147|NCT00489489|467793967|FG002|Overall Study|Protocol Violation|1|||
129954148|NCT00489489|467793965|FG000|Overall Study|Progressive disease|0|||
129954149|NCT00489489|467793966|FG001|Overall Study|Progressive disease|1|||
129954150|NCT00489489|467793967|FG002|Overall Study|Progressive disease|0|||
129954151|NCT00489489|467793965|FG000|Overall Study|Participant did not wish to continue|1|||
129954152|NCT00489489|467793966|FG001|Overall Study|Participant did not wish to continue|1|||
129954153|NCT00489489|467793967|FG002|Overall Study|Participant did not wish to continue|0|||
129954154|NCT00489489|467793965|FG000|Overall Study|Other than above|0|||
129954155|NCT00489489|467793966|FG001|Overall Study|Other than above|1|||
129954156|NCT00489489|467793967|FG002|Overall Study|Other than above|0|||
129954157|NCT04851587|467793970|FG000|Overall Study|Lost to Follow-up|18|||
129954158|NCT01350102|467793974|FG000|Overall Study|Adverse Event|0|||
129954159|NCT01350102|467793975|FG001|Overall Study|Adverse Event|0|||
129954160|NCT01350102|467793976|FG002|Overall Study|Adverse Event|1|||
129954161|NCT01350102|467793977|FG003|Overall Study|Adverse Event|0|||
129954162|NCT04523571|467793978|FG000|Received 2 Doses|Withdrawal by Subject|0|||
129954163|NCT04523571|467793979|FG001|Received 2 Doses|Withdrawal by Subject|0|||
129954164|NCT04523571|467793980|FG002|Received 2 Doses|Withdrawal by Subject|0|||
129954165|NCT04523571|467793981|FG003|Received 2 Doses|Withdrawal by Subject|1|||
129954166|NCT04523571|467793982|FG004|Received 2 Doses|Withdrawal by Subject|1|||
129954167|NCT04523571|467793983|FG005|Received 2 Doses|Withdrawal by Subject|0|||
129954168|NCT04523571|467793978|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
129954169|NCT04523571|467793979|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954170|NCT04523571|467793980|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
129954171|NCT04523571|467793981|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954172|NCT04523571|467793982|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954173|NCT04523571|467793983|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
129954174|NCT04523571|467793978|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954175|NCT04523571|467793979|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954176|NCT04523571|467793980|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954177|NCT04523571|467793981|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954178|NCT04523571|467793982|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
129954179|NCT04523571|467793983|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
129954180|NCT04523571|467793978|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
129954181|NCT04523571|467793979|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
129954182|NCT04523571|467793980|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
129954183|NCT04523571|467793981|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
129954184|NCT04523571|467793982|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
129954185|NCT04523571|467793983|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
129954186|NCT04385849|467793985|FG000|Overall Study|Lost to Follow-up|1|||
129954187|NCT04385849|467793986|FG001|Overall Study|Lost to Follow-up|0|||
129954188|NCT01375777|467793987|FG000|Overall Study|Withdrawal by Subject|0|||
129954189|NCT01375777|467793988|FG001|Overall Study|Withdrawal by Subject|2|||
129954190|NCT01375777|467793989|FG002|Overall Study|Withdrawal by Subject|1|||
129954191|NCT01375777|467793990|FG003|Overall Study|Withdrawal by Subject|0|||
129954192|NCT01375777|467793991|FG004|Overall Study|Withdrawal by Subject|1|||
129954193|NCT01375777|467793992|FG005|Overall Study|Withdrawal by Subject|1|||
129954194|NCT01375777|467793993|FG006|Overall Study|Withdrawal by Subject|1|||
129954195|NCT01375777|467793994|FG007|Overall Study|Withdrawal by Subject|2|||
129954196|NCT01375777|467793995|FG008|Overall Study|Withdrawal by Subject|1|||
129954197|NCT01375777|467793987|FG000|Overall Study|Lost to Follow-up|1|||
129954198|NCT01375777|467793988|FG001|Overall Study|Lost to Follow-up|0|||
129954199|NCT01375777|467793989|FG002|Overall Study|Lost to Follow-up|0|||
129954200|NCT01375777|467793990|FG003|Overall Study|Lost to Follow-up|0|||
129954201|NCT01375777|467793991|FG004|Overall Study|Lost to Follow-up|0|||
129954202|NCT01375777|467793992|FG005|Overall Study|Lost to Follow-up|0|||
129954203|NCT01375777|467793993|FG006|Overall Study|Lost to Follow-up|1|||
129954204|NCT01375777|467793994|FG007|Overall Study|Lost to Follow-up|0|||
129954205|NCT01375777|467793995|FG008|Overall Study|Lost to Follow-up|0|||
129954206|NCT01375777|467793987|FG000|Overall Study|Other|1|||
129954207|NCT01375777|467793988|FG001|Overall Study|Other|1|||
129954208|NCT01375777|467793989|FG002|Overall Study|Other|0|||
129954209|NCT01375777|467793990|FG003|Overall Study|Other|0|||
129954210|NCT01375777|467793991|FG004|Overall Study|Other|0|||
129954211|NCT01375777|467793992|FG005|Overall Study|Other|0|||
129954212|NCT01375777|467793993|FG006|Overall Study|Other|0|||
129954213|NCT01375777|467793994|FG007|Overall Study|Other|0|||
129954214|NCT01375777|467793995|FG008|Overall Study|Other|1|||
129954215|NCT05878990|467793996|FG000|Overall Study|Lost to Follow-up|7|||
129954216|NCT05878990|467793996|FG000|Overall Study|Withdrawal by Subject|1|||
129954217|NCT01838499|467793999|FG000|Overall Study|Protocol Violation|0|||
129954218|NCT01838499|467794000|FG001|Overall Study|Protocol Violation|1|||
129954219|NCT01838499|467793999|FG000|Overall Study|Lost to Follow-up|2|||
129954220|NCT01838499|467794000|FG001|Overall Study|Lost to Follow-up|4|||
129954221|NCT01838499|467793999|FG000|Overall Study|Lack of Efficacy|1|||
129954222|NCT01838499|467794000|FG001|Overall Study|Lack of Efficacy|2|||
129954223|NCT01838499|467793999|FG000|Overall Study|Adverse Event|2|||
129954224|NCT01838499|467794000|FG001|Overall Study|Adverse Event|1|||
129954225|NCT01838499|467793999|FG000|Overall Study|Withdrawal by Subject|19|||
129954226|NCT01838499|467794000|FG001|Overall Study|Withdrawal by Subject|9|||
129954227|NCT01136733|467794001|FG000|Phase 1b|Adverse Event|0|||
129954228|NCT01136733|467794002|FG001|Phase 1b|Adverse Event|3|||
129954229|NCT01136733|467794003|FG002|Phase 1b|Adverse Event|1|||
129954230|NCT01136733|467794004|FG003|Phase 1b|Adverse Event|0|||
129954231|NCT01136733|467794005|FG004|Phase 1b|Adverse Event|0|||
129954232|NCT01136733|467794006|FG005|Phase 1b|Adverse Event|0|||
129954233|NCT01136733|467794007|FG006|Phase 1b|Adverse Event|0|||
129954234|NCT01136733|467794001|FG000|Phase 1b|Participant Choice|0|||
129954235|NCT01136733|467794002|FG001|Phase 1b|Participant Choice|0|||
129954236|NCT01136733|467794003|FG002|Phase 1b|Participant Choice|1|||
129954237|NCT01136733|467794004|FG003|Phase 1b|Participant Choice|0|||
129954238|NCT01136733|467794005|FG004|Phase 1b|Participant Choice|0|||
129954239|NCT01136733|467794006|FG005|Phase 1b|Participant Choice|0|||
129954240|NCT01136733|467794007|FG006|Phase 1b|Participant Choice|0|||
129954241|NCT01136733|467794001|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
129954242|NCT01136733|467794002|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
129954243|NCT01136733|467794003|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
129954244|NCT01136733|467794004|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
129954245|NCT01136733|467794005|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
129954246|NCT01136733|467794006|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
129954247|NCT01136733|467794007|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
129954248|NCT01136733|467794001|FG000|Phase 1b|Clinical Progression|1|||
129954249|NCT01136733|467794002|FG001|Phase 1b|Clinical Progression|1|||
129954250|NCT01136733|467794003|FG002|Phase 1b|Clinical Progression|0|||
129954251|NCT01136733|467794004|FG003|Phase 1b|Clinical Progression|0|||
129954252|NCT01136733|467794005|FG004|Phase 1b|Clinical Progression|0|||
129954253|NCT01136733|467794006|FG005|Phase 1b|Clinical Progression|0|||
129954254|NCT01136733|467794007|FG006|Phase 1b|Clinical Progression|0|||
129954255|NCT01136733|467794001|FG000|Phase 2|Disease Progression|0|||
129954256|NCT01136733|467794002|FG001|Phase 2|Disease Progression|0|||
129954257|NCT01136733|467794003|FG002|Phase 2|Disease Progression|0|||
129954258|NCT01136733|467794004|FG003|Phase 2|Disease Progression|0|||
129954259|NCT01136733|467794005|FG004|Phase 2|Disease Progression|30|||
129954260|NCT01136733|467794006|FG005|Phase 2|Disease Progression|32|||
129954261|NCT01136733|467794007|FG006|Phase 2|Disease Progression|38|||
129954262|NCT01136733|467794001|FG000|Phase 2|Adverse Event|0|||
129954263|NCT01136733|467794002|FG001|Phase 2|Adverse Event|0|||
129954264|NCT01136733|467794003|FG002|Phase 2|Adverse Event|0|||
129954265|NCT01136733|467794004|FG003|Phase 2|Adverse Event|0|||
129954266|NCT01136733|467794005|FG004|Phase 2|Adverse Event|11|||
129954267|NCT01136733|467794006|FG005|Phase 2|Adverse Event|13|||
129954268|NCT01136733|467794007|FG006|Phase 2|Adverse Event|5|||
129954269|NCT01136733|467794001|FG000|Phase 2|Participant Choice|0|||
129954270|NCT01136733|467794002|FG001|Phase 2|Participant Choice|0|||
129954271|NCT01136733|467794003|FG002|Phase 2|Participant Choice|0|||
129954272|NCT01136733|467794004|FG003|Phase 2|Participant Choice|0|||
129954273|NCT01136733|467794005|FG004|Phase 2|Participant Choice|3|||
129954274|NCT01136733|467794006|FG005|Phase 2|Participant Choice|0|||
129954275|NCT01136733|467794007|FG006|Phase 2|Participant Choice|1|||
129954276|NCT01136733|467794001|FG000|Phase 2|Administrative-Withdrew Consent|0|||
129954277|NCT01136733|467794002|FG001|Phase 2|Administrative-Withdrew Consent|0|||
129954278|NCT01136733|467794003|FG002|Phase 2|Administrative-Withdrew Consent|0|||
129954279|NCT01136733|467794004|FG003|Phase 2|Administrative-Withdrew Consent|0|||
129954280|NCT01136733|467794005|FG004|Phase 2|Administrative-Withdrew Consent|1|||
129954281|NCT01136733|467794006|FG005|Phase 2|Administrative-Withdrew Consent|0|||
129954282|NCT01136733|467794007|FG006|Phase 2|Administrative-Withdrew Consent|0|||
129954283|NCT01136733|467794001|FG000|Phase 2|Other|0|||
129954284|NCT01136733|467794002|FG001|Phase 2|Other|0|||
129454018|NCT01987960|465959441|FG003|Period 1|administrative or other reason|0|||
129454019|NCT01987960|465959438|FG000|Period 1|Withdrawal of consent before treatment|4|||
129454020|NCT01987960|465959439|FG001|Period 1|Withdrawal of consent before treatment|0|||
129454021|NCT01987960|465959440|FG002|Period 1|Withdrawal of consent before treatment|0|||
129454022|NCT01987960|465959441|FG003|Period 1|Withdrawal of consent before treatment|0|||
129454023|NCT01987960|465959438|FG000|Period 2|Adverse Event|0|||
129454024|NCT01987960|465959439|FG001|Period 2|Adverse Event|0|||
129454025|NCT01987960|465959440|FG002|Period 2|Adverse Event|1|||
129454026|NCT01987960|465959441|FG003|Period 2|Adverse Event|0|||
129954285|NCT01136733|467794003|FG002|Phase 2|Other|0|||
129954286|NCT01136733|467794004|FG003|Phase 2|Other|0|||
129954287|NCT01136733|467794005|FG004|Phase 2|Other|6|||
129954288|NCT01136733|467794006|FG005|Phase 2|Other|7|||
129954289|NCT01136733|467794007|FG006|Phase 2|Other|6|||
129954290|NCT03360071|467794009|FG000|Overall Study|Lost to Follow-up|1|||
129954291|NCT03360071|467794010|FG001|Overall Study|Lost to Follow-up|0|||
129954292|NCT01193283|467794014|FG000|Overall Study|Death|1|||
129954293|NCT03314233|467794020|FG000|Overall Study|No longer eligible at time of delivery|1|||
129954294|NCT00168805|467794022|FG000|Overall Study|Adverse Event|7|||
129954295|NCT00168805|467794023|FG001|Overall Study|Adverse Event|11|||
129954296|NCT00168805|467794024|FG002|Overall Study|Adverse Event|16|||
129954297|NCT00168805|467794022|FG000|Overall Study|Protocol Violation|12|||
129954298|NCT00168805|467794023|FG001|Overall Study|Protocol Violation|11|||
129954299|NCT00168805|467794024|FG002|Overall Study|Protocol Violation|8|||
129954300|NCT00168805|467794022|FG000|Overall Study|Lost to Follow-up|12|||
129954301|NCT00168805|467794023|FG001|Overall Study|Lost to Follow-up|17|||
129954302|NCT00168805|467794024|FG002|Overall Study|Lost to Follow-up|11|||
129954303|NCT00168805|467794022|FG000|Overall Study|Withdrawal by Subject|16|||
129954304|NCT00168805|467794023|FG001|Overall Study|Withdrawal by Subject|18|||
129954305|NCT00168805|467794024|FG002|Overall Study|Withdrawal by Subject|21|||
129954306|NCT00168805|467794022|FG000|Overall Study|Other|24|||
129954307|NCT00168805|467794023|FG001|Overall Study|Other|21|||
129954308|NCT00168805|467794024|FG002|Overall Study|Other|22|||
129954309|NCT00168805|467794022|FG000|Treatment|Adverse Event|25|||
129954310|NCT00168805|467794023|FG001|Treatment|Adverse Event|26|||
129954311|NCT00168805|467794024|FG002|Treatment|Adverse Event|32|||
129954312|NCT00168805|467794022|FG000|Treatment|Protocol Violation|3|||
129954313|NCT00168805|467794023|FG001|Treatment|Protocol Violation|5|||
129954314|NCT00168805|467794024|FG002|Treatment|Protocol Violation|5|||
129954315|NCT00168805|467794022|FG000|Treatment|Withdrawal by Subject|3|||
129954316|NCT00168805|467794023|FG001|Treatment|Withdrawal by Subject|7|||
129954317|NCT00168805|467794024|FG002|Treatment|Withdrawal by Subject|8|||
129954318|NCT00168805|467794022|FG000|Treatment|Other|18|||
129954319|NCT00168805|467794023|FG001|Treatment|Other|18|||
129954320|NCT00168805|467794024|FG002|Treatment|Other|17|||
129954321|NCT01114217|467794025|FG000|Overall Study|Adverse Event|5|||
129954322|NCT01114217|467794026|FG001|Overall Study|Adverse Event|3|||
129954323|NCT01114217|467794025|FG000|Overall Study|Lost to Follow-up|17|||
129954324|NCT01114217|467794026|FG001|Overall Study|Lost to Follow-up|33|||
129954325|NCT01114217|467794025|FG000|Overall Study|Withdrawal by Subject|21|||
129954326|NCT01114217|467794026|FG001|Overall Study|Withdrawal by Subject|28|||
129954327|NCT01114217|467794025|FG000|Overall Study|Other-Clerical Error|3|||
129954328|NCT01114217|467794026|FG001|Overall Study|Other-Clerical Error|0|||
129954329|NCT01114217|467794025|FG000|Overall Study|Other-Early termination|6|||
129954330|NCT01114217|467794026|FG001|Overall Study|Other-Early termination|10|||
129954331|NCT01114217|467794025|FG000|Overall Study|Other-Procedure|1|||
129954332|NCT01114217|467794026|FG001|Overall Study|Other-Procedure|1|||
129954333|NCT01114217|467794025|FG000|Overall Study|Other-Pregnancy|2|||
129954334|NCT01114217|467794026|FG001|Overall Study|Other-Pregnancy|4|||
129954335|NCT01114217|467794025|FG000|Overall Study|Other-Protocol Violation|1|||
129954336|NCT01114217|467794026|FG001|Overall Study|Other-Protocol Violation|3|||
129954337|NCT01114217|467794025|FG000|Overall Study|Other-Lack of Efficacy|1|||
129954338|NCT01114217|467794026|FG001|Overall Study|Other-Lack of Efficacy|0|||
129954339|NCT01114217|467794025|FG000|Overall Study|Other-Non Compliance|2|||
129954340|NCT01114217|467794026|FG001|Overall Study|Other-Non Compliance|0|||
129954341|NCT01114217|467794025|FG000|Overall Study|Other-Physician Decision|1|||
129954342|NCT01114217|467794026|FG001|Overall Study|Other-Physician Decision|1|||
129954343|NCT01114217|467794025|FG000|Overall Study|Other-Sponsor Decision|10|||
129954344|NCT01114217|467794026|FG001|Overall Study|Other-Sponsor Decision|12|||
129954345|NCT01114217|467794025|FG000|Overall Study|Other-Study Termination|0|||
129954346|NCT01114217|467794026|FG001|Overall Study|Other-Study Termination|1|||
129454027|NCT01987960|465959438|FG000|Period 2|Withdrawal by Subject|0|||
129454028|NCT01987960|465959439|FG001|Period 2|Withdrawal by Subject|0|||
129454029|NCT01987960|465959440|FG002|Period 2|Withdrawal by Subject|1|||
129954347|NCT01114217|467794025|FG000|Overall Study|Other-Study Withdrawn|1|||
129954348|NCT01114217|467794026|FG001|Overall Study|Other-Study Withdrawn|1|||
129954349|NCT01114217|467794025|FG000|Overall Study|Other-Site Stopped Communicating|2|||
129454030|NCT01987960|465959441|FG003|Period 2|Withdrawal by Subject|0|||
129954350|NCT01114217|467794026|FG001|Overall Study|Other-Site Stopped Communicating|0|||
129954351|NCT01114217|467794025|FG000|Overall Study|Other-Lost to Follow-up|1|||
129954352|NCT01114217|467794026|FG001|Overall Study|Other-Lost to Follow-up|0|||
129954353|NCT01114217|467794025|FG000|Overall Study|Other-Withdrawal by Subject|1|||
129954354|NCT01114217|467794026|FG001|Overall Study|Other-Withdrawal by Subject|1|||
129954355|NCT01183013|467794029|FG000|Overall Study|Adverse Event|6|||
129954356|NCT01183013|467794030|FG001|Overall Study|Adverse Event|8|||
129954357|NCT01183013|467794031|FG002|Overall Study|Adverse Event|5|||
129954358|NCT01183013|467794032|FG003|Overall Study|Adverse Event|5|||
129954359|NCT01183013|467794033|FG004|Overall Study|Adverse Event|10|||
129954360|NCT01183013|467794034|FG005|Overall Study|Adverse Event|10|||
129954361|NCT01183013|467794035|FG006|Overall Study|Adverse Event|6|||
129954362|NCT01183013|467794029|FG000|Overall Study|Lack of Efficacy|3|||
129954363|NCT01183013|467794030|FG001|Overall Study|Lack of Efficacy|2|||
129954364|NCT01183013|467794031|FG002|Overall Study|Lack of Efficacy|1|||
129954365|NCT01183013|467794032|FG003|Overall Study|Lack of Efficacy|2|||
129954366|NCT01183013|467794033|FG004|Overall Study|Lack of Efficacy|1|||
129954367|NCT01183013|467794034|FG005|Overall Study|Lack of Efficacy|2|||
129954368|NCT01183013|467794035|FG006|Overall Study|Lack of Efficacy|0|||
129954369|NCT01183013|467794029|FG000|Overall Study|Protocol Violation|5|||
129954370|NCT01183013|467794030|FG001|Overall Study|Protocol Violation|2|||
129954371|NCT01183013|467794031|FG002|Overall Study|Protocol Violation|4|||
129954372|NCT01183013|467794032|FG003|Overall Study|Protocol Violation|0|||
129954373|NCT01183013|467794033|FG004|Overall Study|Protocol Violation|4|||
129954374|NCT01183013|467794034|FG005|Overall Study|Protocol Violation|3|||
129954375|NCT01183013|467794035|FG006|Overall Study|Protocol Violation|3|||
129954376|NCT01183013|467794029|FG000|Overall Study|Lost to Follow-up|7|||
129954377|NCT01183013|467794030|FG001|Overall Study|Lost to Follow-up|3|||
129954378|NCT01183013|467794031|FG002|Overall Study|Lost to Follow-up|4|||
129954379|NCT01183013|467794032|FG003|Overall Study|Lost to Follow-up|3|||
129954380|NCT01183013|467794033|FG004|Overall Study|Lost to Follow-up|2|||
129954381|NCT01183013|467794034|FG005|Overall Study|Lost to Follow-up|6|||
129954382|NCT01183013|467794035|FG006|Overall Study|Lost to Follow-up|5|||
129954383|NCT01183013|467794029|FG000|Overall Study|Withdrawal by Subject|9|||
129954384|NCT01183013|467794030|FG001|Overall Study|Withdrawal by Subject|13|||
129954385|NCT01183013|467794031|FG002|Overall Study|Withdrawal by Subject|10|||
129954386|NCT01183013|467794032|FG003|Overall Study|Withdrawal by Subject|8|||
129954387|NCT01183013|467794033|FG004|Overall Study|Withdrawal by Subject|7|||
129954388|NCT01183013|467794034|FG005|Overall Study|Withdrawal by Subject|9|||
129954389|NCT01183013|467794035|FG006|Overall Study|Withdrawal by Subject|10|||
129954390|NCT01183013|467794029|FG000|Overall Study|Reasons other than stated above|15|||
129954391|NCT01183013|467794030|FG001|Overall Study|Reasons other than stated above|11|||
129954392|NCT01183013|467794031|FG002|Overall Study|Reasons other than stated above|17|||
129954393|NCT01183013|467794032|FG003|Overall Study|Reasons other than stated above|12|||
129954394|NCT01183013|467794033|FG004|Overall Study|Reasons other than stated above|12|||
129954395|NCT01183013|467794034|FG005|Overall Study|Reasons other than stated above|15|||
129954396|NCT01183013|467794035|FG006|Overall Study|Reasons other than stated above|13|||
129954397|NCT03785210|467794036|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
129979778|NCT01204710|467889468|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
129979779|NCT01204710|467889469|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
129979780|NCT01204710|467889468|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
129979781|NCT01204710|467889469|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
129979782|NCT01204710|467889468|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
129979783|NCT01204710|467889469|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
129979784|NCT01204710|467889468|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
129979785|NCT01204710|467889469|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
129979786|NCT01276379|467889470|FG000|Overall Study|Screening failure|40|||
129979787|NCT00864253|467889471|FG000|Overall Study|Adverse Event|56|||
129979788|NCT00864253|467889472|FG001|Overall Study|Adverse Event|11|||
129979789|NCT00864253|467889471|FG000|Overall Study|Unrelated Adverse Event|3|||
129979790|NCT00864253|467889472|FG001|Overall Study|Unrelated Adverse Event|1|||
129979791|NCT00864253|467889471|FG000|Overall Study|Physician Decision|11|||
129979792|NCT00864253|467889472|FG001|Overall Study|Physician Decision|15|||
129979793|NCT00864253|467889471|FG000|Overall Study|Protocol Violation|0|||
129979794|NCT00864253|467889472|FG001|Overall Study|Protocol Violation|2|||
129979795|NCT00864253|467889471|FG000|Overall Study|Lost to Follow-up|1|||
129979796|NCT00864253|467889472|FG001|Overall Study|Lost to Follow-up|1|||
129979797|NCT00864253|467889471|FG000|Overall Study|Withdrawal by Subject|18|||
129979798|NCT00864253|467889472|FG001|Overall Study|Withdrawal by Subject|18|||
129979799|NCT00864253|467889471|FG000|Overall Study|Death|1|||
129979800|NCT00864253|467889472|FG001|Overall Study|Death|0|||
129979801|NCT00864253|467889471|FG000|Overall Study|Ongoing|2|||
129979802|NCT00864253|467889472|FG001|Overall Study|Ongoing|3|||
129979803|NCT00864253|467889471|FG000|Overall Study|Untreated|7|||
129979804|NCT00864253|467889472|FG001|Overall Study|Untreated|7|||
129979805|NCT01896726|467889473|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
129979806|NCT01896726|467889473|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
129979807|NCT01128114|467889474|FG000|Overall Study|Treatment Withdrawn|6|||
129979808|NCT01128114|467889474|FG000|Overall Study|Screening Failed|2|||
129979809|NCT00208325|467889475|FG000|Overall Study|Death|18|||
129979810|NCT00208325|467889476|FG001|Overall Study|Death|19|||
129979811|NCT00208325|467889477|FG002|Overall Study|Death|7|||
129979812|NCT00208325|467889478|FG003|Overall Study|Death|5|||
129979813|NCT00208325|467889475|FG000|Overall Study|Withdrawal by Subject|0|||
129979814|NCT00208325|467889476|FG001|Overall Study|Withdrawal by Subject|1|||
129979815|NCT00208325|467889477|FG002|Overall Study|Withdrawal by Subject|0|||
129979816|NCT00208325|467889478|FG003|Overall Study|Withdrawal by Subject|0|||
129979817|NCT00208325|467889475|FG000|Overall Study|Revision|4|||
129979818|NCT00208325|467889476|FG001|Overall Study|Revision|1|||
129979819|NCT00208325|467889477|FG002|Overall Study|Revision|0|||
129979820|NCT00208325|467889478|FG003|Overall Study|Revision|4|||
129979821|NCT00208325|467889475|FG000|Overall Study|Lost to Follow-up|1|||
129979822|NCT00208325|467889476|FG001|Overall Study|Lost to Follow-up|0|||
129979823|NCT00208325|467889477|FG002|Overall Study|Lost to Follow-up|2|||
129979824|NCT00208325|467889478|FG003|Overall Study|Lost to Follow-up|0|||
129979825|NCT00208325|467889475|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
129979826|NCT00208325|467889476|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
129979827|NCT00208325|467889477|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
129979828|NCT00208325|467889478|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
129979829|NCT00208325|467889475|FG000|Overall Study|Does not wish to Continue in Study|5|||
129979830|NCT00208325|467889476|FG001|Overall Study|Does not wish to Continue in Study|8|||
129979831|NCT00208325|467889477|FG002|Overall Study|Does not wish to Continue in Study|3|||
129979832|NCT00208325|467889478|FG003|Overall Study|Does not wish to Continue in Study|2|||
129954398|NCT03785210|467794037|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
129954399|NCT00472199|467794063|FG000|Overall Study|Adverse Event|19|||
129954400|NCT00472199|467794064|FG001|Overall Study|Adverse Event|23|||
129954401|NCT00472199|467794063|FG000|Overall Study|Lack of Efficacy|4|||
129954402|NCT00472199|467794064|FG001|Overall Study|Lack of Efficacy|25|||
129954403|NCT00472199|467794063|FG000|Overall Study|Lost to Follow-up|2|||
129954404|NCT00472199|467794064|FG001|Overall Study|Lost to Follow-up|4|||
129954405|NCT00472199|467794063|FG000|Overall Study|Protocol Violation|3|||
129954406|NCT00472199|467794064|FG001|Overall Study|Protocol Violation|2|||
129954407|NCT00472199|467794063|FG000|Overall Study|Withdrawal by Subject|6|||
129954408|NCT00472199|467794064|FG001|Overall Study|Withdrawal by Subject|5|||
129954409|NCT00472199|467794063|FG000|Overall Study|personal reason|0|||
129954410|NCT00472199|467794064|FG001|Overall Study|personal reason|1|||
129954411|NCT00472199|467794063|FG000|Overall Study|patient was asymptomatic|1|||
129954412|NCT00472199|467794064|FG001|Overall Study|patient was asymptomatic|0|||
129954413|NCT01268488|467794066|FG000|Overall Study|Adverse Event|3|||
129954414|NCT01268488|467794066|FG000|Overall Study|Physician Decision|2|||
129954415|NCT01757171|467794067|FG000|Overall Study|Adverse Event|5|||
129954416|NCT01757171|467794068|FG001|Overall Study|Adverse Event|1|||
129954417|NCT01757171|467794067|FG000|Overall Study|Disease Progression|1|||
129954418|NCT01757171|467794068|FG001|Overall Study|Disease Progression|0|||
129954419|NCT01757171|467794067|FG000|Overall Study|Hospitalization|1|||
129954420|NCT01757171|467794068|FG001|Overall Study|Hospitalization|0|||
129954421|NCT01757171|467794067|FG000|Overall Study|ECOG decline|1|||
129954422|NCT01757171|467794068|FG001|Overall Study|ECOG decline|0|||
129954423|NCT01014013|467794072|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
129954424|NCT01014013|467794073|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
129954425|NCT01014013|467794072|FG000|Overall Study|Clinical adverse experience|4|||
129954426|NCT01014013|467794073|FG001|Overall Study|Clinical adverse experience|2|||
129954427|NCT01014013|467794072|FG000|Overall Study|Laboratory adverse experience|1|||
129954428|NCT01014013|467794073|FG001|Overall Study|Laboratory adverse experience|1|||
129954429|NCT01014013|467794072|FG000|Overall Study|Protocol Violation|1|||
129954430|NCT01014013|467794073|FG001|Overall Study|Protocol Violation|3|||
129954431|NCT01014013|467794072|FG000|Overall Study|Withdrawal by Subject|7|||
129954432|NCT01014013|467794073|FG001|Overall Study|Withdrawal by Subject|4|||
129954433|NCT01014013|467794072|FG000|Overall Study|Clinical/microbiologic failure|1|||
129954434|NCT01014013|467794073|FG001|Overall Study|Clinical/microbiologic failure|2|||
129954435|NCT01014013|467794072|FG000|Overall Study|Pathogen culture = no growth|26|||
129954436|NCT01014013|467794073|FG001|Overall Study|Pathogen culture = no growth|34|||
129954437|NCT01014013|467794072|FG000|Overall Study|Negative urine culture|2|||
129954438|NCT01014013|467794073|FG001|Overall Study|Negative urine culture|0|||
129954439|NCT01014013|467794072|FG000|Overall Study|Pathogen resistant|7|||
129954440|NCT01014013|467794073|FG001|Overall Study|Pathogen resistant|4|||
129954441|NCT01014013|467794072|FG000|Overall Study|Physician Decision|0|||
129954442|NCT01014013|467794073|FG001|Overall Study|Physician Decision|1|||
129954443|NCT01014013|467794072|FG000|Overall Study|Another antibiotic therapy required|0|||
129954444|NCT01014013|467794073|FG001|Overall Study|Another antibiotic therapy required|1|||
129954445|NCT01014013|467794072|FG000|Overall Study|Appendectomy|1|||
129954446|NCT01014013|467794073|FG001|Overall Study|Appendectomy|0|||
129954447|NCT01014013|467794072|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
129954448|NCT01014013|467794073|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
129954449|NCT00316121|467794074|FG000|Overall Study|Death|1|||
129954450|NCT00316121|467794075|FG001|Overall Study|Death|0|||
129954451|NCT00316121|467794074|FG000|Overall Study|Lost to Follow-up|14|||
129954452|NCT00316121|467794075|FG001|Overall Study|Lost to Follow-up|8|||
129954453|NCT00316121|467794074|FG000|Overall Study|Withdrawal by Subject|2|||
129954454|NCT00316121|467794075|FG001|Overall Study|Withdrawal by Subject|0|||
129954455|NCT00316121|467794074|FG000|Overall Study|Reason is missing|1|||
129954456|NCT00316121|467794075|FG001|Overall Study|Reason is missing|0|||
129954457|NCT00316121|467794074|FG000|Overall Study|Subject relocated|1|||
129954458|NCT00316121|467794075|FG001|Overall Study|Subject relocated|1|||
129954459|NCT00316121|467794074|FG000|Overall Study|Subject refused to return|1|||
129954460|NCT00316121|467794075|FG001|Overall Study|Subject refused to return|0|||
129954461|NCT00316121|467794074|FG000|Overall Study|Subject no show for visit x 3|1|||
129954462|NCT00316121|467794075|FG001|Overall Study|Subject no show for visit x 3|0|||
129954463|NCT00316121|467794074|FG000|Overall Study|Subject did not have 24 month visit|1|||
129954464|NCT00316121|467794075|FG001|Overall Study|Subject did not have 24 month visit|0|||
129954465|NCT05274906|467794076|FG000|Overall Study|Withdrawal by Subject|2|||
129954466|NCT05274906|467794077|FG001|Overall Study|Withdrawal by Subject|1|||
129954467|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
129954468|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
129954469|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
129954470|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
129954471|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
129954472|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
129954473|NCT02213458|467794080|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
129954474|NCT02213458|467794081|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
129954475|NCT02213458|467794080|FG000|Overall Study|Refused re-consent|6|||
129954476|NCT02213458|467794081|FG001|Overall Study|Refused re-consent|0|||
129954477|NCT02213458|467794080|FG000|Overall Study|Lost to Follow-up|2|||
129954478|NCT02213458|467794081|FG001|Overall Study|Lost to Follow-up|2|||
129954479|NCT02213458|467794080|FG000|Overall Study|Withdrawal by Subject|26|||
129954480|NCT02213458|467794081|FG001|Overall Study|Withdrawal by Subject|8|||
129954481|NCT00910871|467794082|FG000|Overall Study|Adverse Event|5|||
129954482|NCT00910871|467794082|FG000|Overall Study|Death|12|||
129954483|NCT00910871|467794082|FG000|Overall Study|Lost to Follow-up|8|||
129954484|NCT00910871|467794082|FG000|Overall Study|Protocol Violation|11|||
129954485|NCT00910871|467794082|FG000|Overall Study|Withdrawal by Subject|12|||
129954486|NCT00910871|467794082|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
129954487|NCT00910871|467794082|FG000|Overall Study|Undefined|1|||
129954488|NCT01047306|467794083|FG000|Overall Study|Withdrawal by Subject|2|||
129954489|NCT01047306|467794084|FG001|Overall Study|Withdrawal by Subject|0|||
129954490|NCT01047306|467794083|FG000|Overall Study|Lost to Follow-up|1|||
129954491|NCT01047306|467794084|FG001|Overall Study|Lost to Follow-up|0|||
129954492|NCT04043806|467794085|FG000|Overall Study|Commercial drug is available for participants|13|||
129954493|NCT04043806|467794085|FG000|Overall Study|Physician Decision|2|||
129454031|NCT01987960|465959438|FG000|Period 2|Administrative or other reason|0|||
129954494|NCT04043806|467794085|FG000|Overall Study|Other|12|||
129954495|NCT04043806|467794085|FG000|Overall Study|Adverse Event|2|||
129954496|NCT04043806|467794085|FG000|Overall Study|Lost to Follow-up|6|||
129954497|NCT04043806|467794085|FG000|Overall Study|Other non-compliance|2|||
129954498|NCT04043806|467794085|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
129954499|NCT04043806|467794085|FG000|Overall Study|Never Dosed|1|||
129954500|NCT04799587|467794087|FG000|Overall Study|Withdrawal by Subject|0|||
129954501|NCT04799587|467794088|FG001|Overall Study|Withdrawal by Subject|1|||
129954502|NCT01613599|467794091|FG000|Overall Study|Death|9|||
129954503|NCT01613599|467794091|FG000|Overall Study|Lost to Follow-up|5|||
129454032|NCT01987960|465959439|FG001|Period 2|Administrative or other reason|5|||
129454033|NCT01987960|465959440|FG002|Period 2|Administrative or other reason|7|||
129454034|NCT01987960|465959441|FG003|Period 2|Administrative or other reason|0|||
129454035|NCT01987960|465959438|FG000|Period 3|Adverse Event|0|||
129954504|NCT01613599|467794091|FG000|Overall Study|Withdrawal by Subject|8|||
129954505|NCT01613599|467794091|FG000|Overall Study|Reason not specified|3|||
129954506|NCT00617708|467794095|FG000|Overall Study|Adverse Event|0|||
129454036|NCT01987960|465959439|FG001|Period 3|Adverse Event|0|||
129454037|NCT01987960|465959440|FG002|Period 3|Adverse Event|0|||
129454038|NCT01987960|465959441|FG003|Period 3|Adverse Event|7|||
129454039|NCT01987960|465959438|FG000|Period 3|Non-compliance with IMP|0|||
129454040|NCT01987960|465959439|FG001|Period 3|Non-compliance with IMP|0|||
129454041|NCT01987960|465959440|FG002|Period 3|Non-compliance with IMP|0|||
129454042|NCT01987960|465959441|FG003|Period 3|Non-compliance with IMP|1|||
129454043|NCT01987960|465959438|FG000|Period 3|Protocol Violation|0|||
129454044|NCT01987960|465959439|FG001|Period 3|Protocol Violation|0|||
129454045|NCT01987960|465959440|FG002|Period 3|Protocol Violation|0|||
129454046|NCT01987960|465959441|FG003|Period 3|Protocol Violation|6|||
129454047|NCT01987960|465959438|FG000|Period 3|Withdrawal by Subject|0|||
129954507|NCT00617708|467794096|FG001|Overall Study|Adverse Event|6|||
129954508|NCT00617708|467794097|FG002|Overall Study|Adverse Event|9|||
129954509|NCT00617708|467794095|FG000|Overall Study|Withdrawal by Subject|1|||
129954510|NCT00617708|467794096|FG001|Overall Study|Withdrawal by Subject|1|||
129954511|NCT00617708|467794097|FG002|Overall Study|Withdrawal by Subject|7|||
129954512|NCT00617708|467794095|FG000|Overall Study|Death|0|||
129954513|NCT00617708|467794096|FG001|Overall Study|Death|6|||
129954514|NCT00617708|467794097|FG002|Overall Study|Death|5|||
129954515|NCT00617708|467794095|FG000|Overall Study|Progression/Relapse|7|||
129954516|NCT00617708|467794096|FG001|Overall Study|Progression/Relapse|40|||
129954517|NCT00617708|467794097|FG002|Overall Study|Progression/Relapse|36|||
129954518|NCT00617708|467794095|FG000|Overall Study|Not protocol specified|1|||
129954519|NCT00617708|467794096|FG001|Overall Study|Not protocol specified|4|||
129954520|NCT00617708|467794097|FG002|Overall Study|Not protocol specified|2|||
129954521|NCT00617708|467794095|FG000|Overall Study|Not eligible|1|||
129954522|NCT00617708|467794096|FG001|Overall Study|Not eligible|3|||
129454048|NCT01987960|465959439|FG001|Period 3|Withdrawal by Subject|0|||
129454049|NCT01987960|465959440|FG002|Period 3|Withdrawal by Subject|0|||
129454050|NCT01987960|465959441|FG003|Period 3|Withdrawal by Subject|9|||
129954523|NCT00617708|467794097|FG002|Overall Study|Not eligible|5|||
129954524|NCT02058992|467794098|FG000|Overall Study|Lost to Follow-up|4|||
129954525|NCT02058992|467794098|FG000|Overall Study|Protocol Violation|92|||
129954526|NCT02058992|467794098|FG000|Overall Study|CRF Uncollected|20|||
129954527|NCT02130401|467794099|FG000|Overall Study|Poor enrollment|6|||
129454051|NCT01987960|465959438|FG000|Period 3|Lost to Follow-up|0|||
129954528|NCT03005106|467794100|FG000|Overall Study|Lost to Follow-up|16|||
129954529|NCT03005106|467794100|FG000|Overall Study|Adverse Event|1|||
129954530|NCT03005106|467794100|FG000|Overall Study|Physician Decision|1|||
129954531|NCT03005106|467794100|FG000|Overall Study|Death|2|||
129954532|NCT00321672|467794101|FG000|Overall Study|Withdrawal by Subject|5|||
129954533|NCT00321672|467794102|FG001|Overall Study|Withdrawal by Subject|1|||
129954534|NCT00321672|467794103|FG002|Overall Study|Withdrawal by Subject|2|||
129954535|NCT00321672|467794104|FG003|Overall Study|Withdrawal by Subject|0|||
129954536|NCT00321672|467794101|FG000|Overall Study|Noncompliance|1|||
129954537|NCT00321672|467794102|FG001|Overall Study|Noncompliance|2|||
129954538|NCT00321672|467794103|FG002|Overall Study|Noncompliance|1|||
129954539|NCT00321672|467794104|FG003|Overall Study|Noncompliance|0|||
129954540|NCT00321672|467794101|FG000|Overall Study|Adverse Event|1|||
129954541|NCT00321672|467794102|FG001|Overall Study|Adverse Event|1|||
129954542|NCT00321672|467794103|FG002|Overall Study|Adverse Event|0|||
129954543|NCT00321672|467794104|FG003|Overall Study|Adverse Event|0|||
129954544|NCT00321672|467794101|FG000|Overall Study|Lack of Efficacy|1|||
129454052|NCT01987960|465959439|FG001|Period 3|Lost to Follow-up|0|||
129954545|NCT00321672|467794102|FG001|Overall Study|Lack of Efficacy|1|||
129954546|NCT00321672|467794103|FG002|Overall Study|Lack of Efficacy|0|||
129954547|NCT00321672|467794104|FG003|Overall Study|Lack of Efficacy|0|||
129954548|NCT00321672|467794101|FG000|Overall Study|Lost to Follow-up|2|||
129954549|NCT00321672|467794102|FG001|Overall Study|Lost to Follow-up|0|||
129954550|NCT00321672|467794103|FG002|Overall Study|Lost to Follow-up|4|||
129954551|NCT00321672|467794104|FG003|Overall Study|Lost to Follow-up|2|||
129954552|NCT00321672|467794101|FG000|Overall Study|Death|1|||
129954553|NCT00321672|467794102|FG001|Overall Study|Death|0|||
129954554|NCT00321672|467794103|FG002|Overall Study|Death|0|||
129954555|NCT00321672|467794104|FG003|Overall Study|Death|0|||
129954556|NCT00321672|467794101|FG000|Overall Study|Too far to travel for visits|1|||
129954557|NCT00321672|467794102|FG001|Overall Study|Too far to travel for visits|0|||
129954558|NCT00321672|467794103|FG002|Overall Study|Too far to travel for visits|0|||
129954559|NCT00321672|467794104|FG003|Overall Study|Too far to travel for visits|0|||
129954560|NCT00321672|467794101|FG000|Overall Study|Incarcerated|0|||
129954561|NCT00321672|467794102|FG001|Overall Study|Incarcerated|0|||
129954562|NCT00321672|467794103|FG002|Overall Study|Incarcerated|2|||
129954563|NCT00321672|467794104|FG003|Overall Study|Incarcerated|0|||
129954564|NCT00321672|467794101|FG000|Overall Study|Moved out of state|0|||
129954565|NCT00321672|467794102|FG001|Overall Study|Moved out of state|1|||
129954566|NCT00321672|467794103|FG002|Overall Study|Moved out of state|1|||
129954567|NCT00321672|467794104|FG003|Overall Study|Moved out of state|0|||
129954568|NCT00321672|467794101|FG000|Overall Study|Protocol Violation|0|||
129954569|NCT00321672|467794102|FG001|Overall Study|Protocol Violation|0|||
129954570|NCT00321672|467794103|FG002|Overall Study|Protocol Violation|1|||
129954571|NCT00321672|467794104|FG003|Overall Study|Protocol Violation|0|||
129954572|NCT00321672|467794101|FG000|Overall Study|Diagnosis of testicular cancer|0|||
129954573|NCT00321672|467794102|FG001|Overall Study|Diagnosis of testicular cancer|1|||
129954574|NCT00321672|467794103|FG002|Overall Study|Diagnosis of testicular cancer|0|||
129954575|NCT00321672|467794104|FG003|Overall Study|Diagnosis of testicular cancer|0|||
129954576|NCT00321672|467794101|FG000|Overall Study|Extensive travel required for new job|0|||
129954577|NCT00321672|467794102|FG001|Overall Study|Extensive travel required for new job|1|||
129954578|NCT00321672|467794103|FG002|Overall Study|Extensive travel required for new job|0|||
129954579|NCT00321672|467794104|FG003|Overall Study|Extensive travel required for new job|0|||
129954580|NCT00512902|467794105|FG000|Overall Study|Adverse Event|7|||
129954581|NCT00512902|467794105|FG000|Overall Study|Lost to Follow-up|1|||
129954582|NCT00936065|467794106|FG000|Overall Study|Adverse Event|1|||
129954583|NCT00936065|467794107|FG001|Overall Study|Adverse Event|0|||
129954584|NCT00936065|467794108|FG002|Overall Study|Adverse Event|1|||
129954585|NCT00936065|467794106|FG000|Overall Study|Lack of Efficacy|1|||
129954586|NCT00936065|467794107|FG001|Overall Study|Lack of Efficacy|0|||
129954587|NCT00936065|467794108|FG002|Overall Study|Lack of Efficacy|1|||
129954588|NCT00936065|467794106|FG000|Overall Study|Lost to Follow-up|1|||
129954589|NCT00936065|467794107|FG001|Overall Study|Lost to Follow-up|0|||
129954590|NCT00936065|467794108|FG002|Overall Study|Lost to Follow-up|0|||
129954591|NCT00936065|467794106|FG000|Overall Study|Protocol Violation|1|||
129954592|NCT00936065|467794107|FG001|Overall Study|Protocol Violation|2|||
129954593|NCT00936065|467794108|FG002|Overall Study|Protocol Violation|1|||
129954594|NCT00936065|467794106|FG000|Overall Study|Withdrawal by Subject|0|||
129954595|NCT00936065|467794107|FG001|Overall Study|Withdrawal by Subject|2|||
129954596|NCT00936065|467794108|FG002|Overall Study|Withdrawal by Subject|4|||
129954597|NCT00145496|467794109|FG000|Overall Study|Adverse Event|42|||
129954598|NCT00145496|467794110|FG001|Overall Study|Adverse Event|30|||
129954599|NCT00145496|467794109|FG000|Overall Study|Lack of Efficacy|12|||
129954600|NCT00145496|467794110|FG001|Overall Study|Lack of Efficacy|7|||
129954601|NCT00145496|467794109|FG000|Overall Study|Withdrawal by Subject|32|||
129954602|NCT00145496|467794110|FG001|Overall Study|Withdrawal by Subject|26|||
129954603|NCT00145496|467794109|FG000|Overall Study|Lost to Follow-up|12|||
129954604|NCT00145496|467794110|FG001|Overall Study|Lost to Follow-up|5|||
129954605|NCT00145496|467794109|FG000|Overall Study|Other|25|||
129954606|NCT00145496|467794110|FG001|Overall Study|Other|13|||
129954607|NCT01429285|467794111|FG000|Overall Study|Protocol Violation|9|||
129954608|NCT01429285|467794112|FG001|Overall Study|Protocol Violation|4|||
129954609|NCT01429285|467794111|FG000|Overall Study|Missing Data|5|||
129954610|NCT01429285|467794112|FG001|Overall Study|Missing Data|3|||
129954611|NCT01429285|467794111|FG000|Overall Study|Erroneously Enrolled Twice|8|||
129954612|NCT01429285|467794112|FG001|Overall Study|Erroneously Enrolled Twice|2|||
129954613|NCT03394508|467794115|FG000|Overall Study|Protocol Violation|0|||
129954614|NCT03394508|467794116|FG001|Overall Study|Protocol Violation|3|||
129954615|NCT03394508|467794115|FG000|Overall Study|Lost to Follow-up|1|||
129954616|NCT03394508|467794116|FG001|Overall Study|Lost to Follow-up|0|||
129954617|NCT01288729|467794117|FG000|Overall Study|Withdrawal by Subject|1|||
129954618|NCT01288729|467794118|FG001|Overall Study|Withdrawal by Subject|0|||
129954619|NCT02135445|467794119|FG000|Overall Study|Lost to Follow-up|1|||
129954620|NCT02135445|467794120|FG001|Overall Study|Lost to Follow-up|0|||
129954621|NCT02135445|467794119|FG000|Overall Study|Withdrawal by Subject|1|||
129954622|NCT02135445|467794120|FG001|Overall Study|Withdrawal by Subject|0|||
129954623|NCT02136797|467795504|FG000|Overall Study|Not Treated|8|||
129954624|NCT03694210|467795505|FG000|Overall Study|Death|1|||
129954625|NCT03694210|467795505|FG000|Overall Study|Screen Failure|7|||
129954626|NCT03050372|467795506|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
129954627|NCT03050372|467795507|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
129954628|NCT03050372|467795506|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
129954629|NCT03050372|467795507|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
129954630|NCT02706834|467795508|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129954631|NCT02706834|467795509|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129954632|NCT02706834|467795510|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129954633|NCT02706834|467795511|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
129954634|NCT02706834|467795512|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
129954635|NCT02706834|467795513|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
129954636|NCT02706834|467795514|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
129954637|NCT02706834|467795515|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
129954638|NCT02706834|467795516|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
129954639|NCT02706834|467795517|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
129954640|NCT02706834|467795518|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
129954641|NCT02706834|467795508|FG000|Overall Study|Lost to Follow-up|0|||
129954642|NCT02706834|467795509|FG001|Overall Study|Lost to Follow-up|0|||
129954643|NCT02706834|467795510|FG002|Overall Study|Lost to Follow-up|1|||
129954644|NCT02706834|467795511|FG003|Overall Study|Lost to Follow-up|0|||
129954645|NCT02706834|467795512|FG004|Overall Study|Lost to Follow-up|0|||
129954646|NCT02706834|467795513|FG005|Overall Study|Lost to Follow-up|0|||
129954647|NCT02706834|467795514|FG006|Overall Study|Lost to Follow-up|0|||
129954648|NCT02706834|467795515|FG007|Overall Study|Lost to Follow-up|0|||
129954649|NCT02706834|467795516|FG008|Overall Study|Lost to Follow-up|0|||
129954650|NCT02706834|467795517|FG009|Overall Study|Lost to Follow-up|0|||
129954651|NCT02706834|467795518|FG010|Overall Study|Lost to Follow-up|0|||
129954652|NCT02706834|467795508|FG000|Overall Study|Voluntary Withdrawal|1|||
129979833|NCT00208325|467889475|FG000|Overall Study|Other|2|||
129979834|NCT00208325|467889476|FG001|Overall Study|Other|1|||
129979835|NCT00208325|467889477|FG002|Overall Study|Other|1|||
129979836|NCT00208325|467889478|FG003|Overall Study|Other|0|||
129979837|NCT00208325|467889475|FG000|Overall Study|Mis-Randomized|17|||
129979838|NCT00208325|467889476|FG001|Overall Study|Mis-Randomized|20|||
129979839|NCT00208325|467889477|FG002|Overall Study|Mis-Randomized|0|||
129979840|NCT00208325|467889478|FG003|Overall Study|Mis-Randomized|0|||
129979841|NCT04445987|467889479|FG000|Overall Study|Adverse Event|0|||
129979842|NCT04445987|467889480|FG001|Overall Study|Adverse Event|0|||
129979843|NCT04445987|467889481|FG002|Overall Study|Adverse Event|1|||
129979844|NCT04445987|467889482|FG003|Overall Study|Adverse Event|0|||
129979845|NCT04445987|467889483|FG004|Overall Study|Adverse Event|4|||
129979846|NCT04445987|467889484|FG005|Overall Study|Adverse Event|0|||
129979847|NCT04445987|467889479|FG000|Overall Study|Lost to Follow-up|4|||
129979848|NCT04445987|467889480|FG001|Overall Study|Lost to Follow-up|3|||
129979849|NCT04445987|467889481|FG002|Overall Study|Lost to Follow-up|1|||
129979850|NCT04445987|467889482|FG003|Overall Study|Lost to Follow-up|1|||
129979851|NCT04445987|467889483|FG004|Overall Study|Lost to Follow-up|29|||
129979852|NCT04445987|467889484|FG005|Overall Study|Lost to Follow-up|0|||
129979853|NCT04445987|467889479|FG000|Overall Study|Physician Decision|0|||
129979854|NCT04445987|467889480|FG001|Overall Study|Physician Decision|0|||
129979855|NCT04445987|467889481|FG002|Overall Study|Physician Decision|0|||
129979856|NCT04445987|467889482|FG003|Overall Study|Physician Decision|0|||
129454053|NCT01987960|465959440|FG002|Period 3|Lost to Follow-up|0|||
129954653|NCT02706834|467795509|FG001|Overall Study|Voluntary Withdrawal|0|||
129954654|NCT02706834|467795510|FG002|Overall Study|Voluntary Withdrawal|0|||
129954655|NCT02706834|467795511|FG003|Overall Study|Voluntary Withdrawal|0|||
129954656|NCT02706834|467795512|FG004|Overall Study|Voluntary Withdrawal|0|||
129954657|NCT02706834|467795513|FG005|Overall Study|Voluntary Withdrawal|0|||
129954658|NCT02706834|467795514|FG006|Overall Study|Voluntary Withdrawal|0|||
129954659|NCT02706834|467795515|FG007|Overall Study|Voluntary Withdrawal|0|||
129954660|NCT02706834|467795516|FG008|Overall Study|Voluntary Withdrawal|0|||
129954661|NCT02706834|467795517|FG009|Overall Study|Voluntary Withdrawal|1|||
129954662|NCT02706834|467795518|FG010|Overall Study|Voluntary Withdrawal|0|||
129954663|NCT02706834|467795508|FG000|Overall Study|Other Reason Not Specified|1|||
129954664|NCT02706834|467795509|FG001|Overall Study|Other Reason Not Specified|0|||
129954665|NCT02706834|467795510|FG002|Overall Study|Other Reason Not Specified|0|||
129954666|NCT02706834|467795511|FG003|Overall Study|Other Reason Not Specified|0|||
129954667|NCT02706834|467795512|FG004|Overall Study|Other Reason Not Specified|1|||
129954668|NCT02706834|467795513|FG005|Overall Study|Other Reason Not Specified|0|||
129954669|NCT02706834|467795514|FG006|Overall Study|Other Reason Not Specified|0|||
129954670|NCT02706834|467795515|FG007|Overall Study|Other Reason Not Specified|0|||
129954671|NCT02706834|467795516|FG008|Overall Study|Other Reason Not Specified|0|||
129954672|NCT02706834|467795517|FG009|Overall Study|Other Reason Not Specified|0|||
129954673|NCT02706834|467795518|FG010|Overall Study|Other Reason Not Specified|0|||
129954674|NCT00627523|467795519|FG000|Overall Study|Lack of Efficacy|1|||
129954675|NCT00627523|467795520|FG001|Overall Study|Lack of Efficacy|0|||
129954676|NCT00627523|467795519|FG000|Overall Study|Withdrawal by Subject|0|||
129954677|NCT00627523|467795520|FG001|Overall Study|Withdrawal by Subject|2|||
129954678|NCT00627523|467795519|FG000|Overall Study|Other|1|||
129954679|NCT00627523|467795520|FG001|Overall Study|Other|0|||
129954680|NCT02543294|467795523|FG000|Overall Study|Lost to Follow-up|3|||
129954681|NCT02543294|467795523|FG000|Overall Study|Physician Decision|2|||
129954682|NCT02543294|467795523|FG000|Overall Study|Withdrawal by Subject|7|||
129954683|NCT01038128|467795525|FG000|Overall Study|Lack of Efficacy|1|||
129954684|NCT01038128|467795525|FG000|Overall Study|Lost to Follow-up|1|||
129954685|NCT01038128|467795525|FG000|Overall Study|Withdrawal by Subject|2|||
129954686|NCT03672188|467795532|FG000|Overall Study|Withdrawal by Subject|0|||
129954687|NCT03672188|467795533|FG001|Overall Study|Withdrawal by Subject|0|||
129954688|NCT03672188|467795534|FG002|Overall Study|Withdrawal by Subject|0|||
129954689|NCT03672188|467795535|FG003|Overall Study|Withdrawal by Subject|3|||
129954690|NCT03672188|467795536|FG004|Overall Study|Withdrawal by Subject|0|||
129954691|NCT03672188|467795537|FG005|Overall Study|Withdrawal by Subject|0|||
129954692|NCT03672188|467795538|FG006|Overall Study|Withdrawal by Subject|0|||
129954693|NCT03672188|467795539|FG007|Overall Study|Withdrawal by Subject|0|||
129954694|NCT03672188|467795540|FG008|Overall Study|Withdrawal by Subject|0|||
129954695|NCT03672188|467795541|FG009|Overall Study|Withdrawal by Subject|0|||
129954696|NCT03672188|467795542|FG010|Overall Study|Withdrawal by Subject|0|||
129954697|NCT03672188|467795543|FG011|Overall Study|Withdrawal by Subject|0|||
129954698|NCT03672188|467795544|FG012|Overall Study|Withdrawal by Subject|0|||
129954699|NCT03672188|467795545|FG013|Overall Study|Withdrawal by Subject|0|||
129954700|NCT03672188|467795546|FG014|Overall Study|Withdrawal by Subject|0|||
129954701|NCT03672188|467795532|FG000|Overall Study|Death|0|||
129954702|NCT03672188|467795533|FG001|Overall Study|Death|0|||
129954703|NCT03672188|467795534|FG002|Overall Study|Death|0|||
129954704|NCT03672188|467795535|FG003|Overall Study|Death|0|||
129954705|NCT03672188|467795536|FG004|Overall Study|Death|0|||
129954706|NCT03672188|467795537|FG005|Overall Study|Death|0|||
129954707|NCT03672188|467795538|FG006|Overall Study|Death|0|||
129954708|NCT03672188|467795539|FG007|Overall Study|Death|0|||
129954709|NCT03672188|467795540|FG008|Overall Study|Death|0|||
129954710|NCT03672188|467795541|FG009|Overall Study|Death|0|||
129954711|NCT03672188|467795542|FG010|Overall Study|Death|0|||
129954712|NCT03672188|467795543|FG011|Overall Study|Death|0|||
129954713|NCT03672188|467795544|FG012|Overall Study|Death|1|||
129954714|NCT03672188|467795545|FG013|Overall Study|Death|0|||
129954715|NCT03672188|467795546|FG014|Overall Study|Death|0|||
129954716|NCT03672188|467795532|FG000|Overall Study|Lost to Follow-up|0|||
129954717|NCT03672188|467795533|FG001|Overall Study|Lost to Follow-up|0|||
129954718|NCT03672188|467795534|FG002|Overall Study|Lost to Follow-up|1|||
129954719|NCT03672188|467795535|FG003|Overall Study|Lost to Follow-up|0|||
129954720|NCT03672188|467795536|FG004|Overall Study|Lost to Follow-up|0|||
129954721|NCT03672188|467795537|FG005|Overall Study|Lost to Follow-up|0|||
129954722|NCT03672188|467795538|FG006|Overall Study|Lost to Follow-up|0|||
129954723|NCT03672188|467795539|FG007|Overall Study|Lost to Follow-up|0|||
129954724|NCT03672188|467795540|FG008|Overall Study|Lost to Follow-up|0|||
129954725|NCT03672188|467795541|FG009|Overall Study|Lost to Follow-up|0|||
129954726|NCT03672188|467795542|FG010|Overall Study|Lost to Follow-up|0|||
129954727|NCT03672188|467795543|FG011|Overall Study|Lost to Follow-up|0|||
129954728|NCT03672188|467795544|FG012|Overall Study|Lost to Follow-up|0|||
129954729|NCT03672188|467795545|FG013|Overall Study|Lost to Follow-up|0|||
129954730|NCT03672188|467795546|FG014|Overall Study|Lost to Follow-up|0|||
129954731|NCT03320941|467795556|FG000|Overall Study|subject/guardian decision|0|||
129954732|NCT03320941|467795557|FG001|Overall Study|subject/guardian decision|0|||
129954733|NCT03320941|467795558|FG002|Overall Study|subject/guardian decision|0|||
129954734|NCT03320941|467795559|FG003|Overall Study|subject/guardian decision|1|||
129954735|NCT03320941|467795560|FG004|Overall Study|subject/guardian decision|0|||
129454054|NCT01987960|465959441|FG003|Period 3|Lost to Follow-up|5|||
129454055|NCT01987960|465959438|FG000|Period 3|Administrative or other reason|0|||
129454056|NCT01987960|465959439|FG001|Period 3|Administrative or other reason|0|||
129454057|NCT01987960|465959440|FG002|Period 3|Administrative or other reason|0|||
129454058|NCT01987960|465959441|FG003|Period 3|Administrative or other reason|43|||
129954736|NCT03614923|467795561|FG000|Overall Study|Withdrawal by Subject|2|||
129954737|NCT03614923|467795562|FG001|Overall Study|Withdrawal by Subject|1|||
129954738|NCT03614923|467795563|FG002|Overall Study|Withdrawal by Subject|1|||
129954739|NCT03614923|467795561|FG000|Overall Study|Adverse Event|0|||
129954740|NCT03614923|467795562|FG001|Overall Study|Adverse Event|2|||
129954741|NCT03614923|467795563|FG002|Overall Study|Adverse Event|1|||
129954742|NCT03614923|467795561|FG000|Overall Study|Lost to Follow-up|1|||
129954743|NCT03614923|467795562|FG001|Overall Study|Lost to Follow-up|0|||
129954744|NCT03614923|467795563|FG002|Overall Study|Lost to Follow-up|1|||
129954745|NCT03614923|467795561|FG000|Overall Study|Lack of Efficacy|2|||
129954746|NCT03614923|467795562|FG001|Overall Study|Lack of Efficacy|0|||
129954747|NCT03614923|467795563|FG002|Overall Study|Lack of Efficacy|1|||
129954748|NCT03614923|467795561|FG000|Overall Study|Non-compliance|0|||
129954749|NCT03614923|467795562|FG001|Overall Study|Non-compliance|1|||
129954750|NCT03614923|467795563|FG002|Overall Study|Non-compliance|0|||
129954751|NCT03614923|467795561|FG000|Overall Study|Other|0|||
129954752|NCT03614923|467795562|FG001|Overall Study|Other|1|||
129954753|NCT03614923|467795563|FG002|Overall Study|Other|1|||
129954754|NCT01107353|467795564|FG000|Overall Study|Positive Drug Screen|1|||
129954755|NCT01107353|467795565|FG001|Overall Study|Positive Drug Screen|0|||
129954756|NCT01745380|467795566|FG000|Overall Study|Lost to Follow-up|1|||
129954757|NCT01745380|467795567|FG001|Overall Study|Lost to Follow-up|0|||
129954758|NCT01745380|467795566|FG000|Overall Study|Lack of Efficacy|0|||
129954759|NCT01745380|467795567|FG001|Overall Study|Lack of Efficacy|1|||
129954760|NCT01882088|467795568|FG000|Overall Study|Intolerance of esophageal manometry|1|||
129954761|NCT01882088|467795568|FG000|Overall Study|no possibility to place the catheter|1|||
129954762|NCT01882088|467795568|FG000|Overall Study|Protocol Violation|1|||
129954763|NCT01882088|467795568|FG000|Overall Study|inadequate pH-impedance tracings|2|||
129954764|NCT02368691|467795569|FG000|Overall Study|Death|13|||
129954765|NCT02368691|467795569|FG000|Overall Study|Lack of Efficacy|15|||
129954766|NCT02368691|467795569|FG000|Overall Study|Physician Decision|4|||
129954767|NCT02720198|467795570|FG000|Overall Study|Withdrawal by Subject|0|||
129954768|NCT02720198|467795571|FG001|Overall Study|Withdrawal by Subject|1|||
129954769|NCT04879823|467795572|FG000|Overall Study|Physician Decision|3|||
129954770|NCT04879823|467795573|FG001|Overall Study|Physician Decision|1|||
129954771|NCT04879823|467795572|FG000|Overall Study|Protocol Violation|2|||
129954772|NCT04879823|467795573|FG001|Overall Study|Protocol Violation|3|||
129954773|NCT04879823|467795572|FG000|Overall Study|Lost to Follow-up|43|||
129954774|NCT04879823|467795573|FG001|Overall Study|Lost to Follow-up|35|||
129954775|NCT02722278|467795578|FG000|Overall Study|Withdrawal by Subject|5|||
129954776|NCT02722278|467795579|FG001|Overall Study|Withdrawal by Subject|3|||
129954777|NCT02722278|467795578|FG000|Overall Study|Adverse Event|4|||
129954778|NCT02722278|467795579|FG001|Overall Study|Adverse Event|1|||
129954779|NCT02722278|467795578|FG000|Overall Study|Lost to Follow-up|2|||
129954780|NCT02722278|467795579|FG001|Overall Study|Lost to Follow-up|0|||
129954781|NCT02722278|467795578|FG000|Overall Study|Protocol Violation|1|||
129954782|NCT02722278|467795579|FG001|Overall Study|Protocol Violation|0|||
129954783|NCT02722278|467795578|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
129954784|NCT02722278|467795579|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
129954785|NCT02722278|467795578|FG000|Overall Study|Subject declined after tx assignment|0|||
129954786|NCT02722278|467795579|FG001|Overall Study|Subject declined after tx assignment|1|||
129954787|NCT02722278|467795578|FG000|Overall Study|Site closure not study related|0|||
129954788|NCT02722278|467795579|FG001|Overall Study|Site closure not study related|1|||
129954789|NCT00203502|467795580|FG000|Overall Study|Death|1|||
129954790|NCT02446912|467795581|FG000|Overall Study|Adverse Event|3|||
129954791|NCT02446912|467795582|FG001|Overall Study|Adverse Event|13|||
129954792|NCT02446912|467795583|FG002|Overall Study|Adverse Event|5|||
129954793|NCT02446912|467795581|FG000|Overall Study|Condition under investigation worsened|0|||
129954794|NCT02446912|467795582|FG001|Overall Study|Condition under investigation worsened|1|||
129954795|NCT02446912|467795583|FG002|Overall Study|Condition under investigation worsened|1|||
129954796|NCT02446912|467795581|FG000|Overall Study|Study-specific withdrawal criteria|1|||
129954797|NCT02446912|467795582|FG001|Overall Study|Study-specific withdrawal criteria|0|||
129954798|NCT02446912|467795583|FG002|Overall Study|Study-specific withdrawal criteria|0|||
129954799|NCT02446912|467795581|FG000|Overall Study|Lack of Efficacy|1|||
129954800|NCT02446912|467795582|FG001|Overall Study|Lack of Efficacy|4|||
129954801|NCT02446912|467795583|FG002|Overall Study|Lack of Efficacy|7|||
129954802|NCT02446912|467795581|FG000|Overall Study|Lost to Follow-up|0|||
129954803|NCT02446912|467795582|FG001|Overall Study|Lost to Follow-up|0|||
129954804|NCT02446912|467795583|FG002|Overall Study|Lost to Follow-up|2|||
129954805|NCT02446912|467795581|FG000|Overall Study|Severe non-compliance to protocol|1|||
129954806|NCT02446912|467795582|FG001|Overall Study|Severe non-compliance to protocol|0|||
129954807|NCT02446912|467795583|FG002|Overall Study|Severe non-compliance to protocol|1|||
129954808|NCT02446912|467795581|FG000|Overall Study|Withdrawal by Subject|10|||
129954809|NCT02446912|467795582|FG001|Overall Study|Withdrawal by Subject|15|||
129954810|NCT02446912|467795583|FG002|Overall Study|Withdrawal by Subject|15|||
129954811|NCT02446912|467795581|FG000|Overall Study|Miscellaneous|2|||
129954812|NCT02446912|467795582|FG001|Overall Study|Miscellaneous|2|||
129954813|NCT02446912|467795583|FG002|Overall Study|Miscellaneous|4|||
129954814|NCT00147745|467795584|FG000|Overall Study|Withdrawal by Subject|1|||
129954815|NCT00147745|467795585|FG001|Overall Study|Withdrawal by Subject|0|||
129954816|NCT00147745|467795586|FG002|Overall Study|Withdrawal by Subject|0|||
129954817|NCT00510783|467795595|FG000|Overall Study|Lost to Follow-up|29|||
129954818|NCT00510783|467795596|FG001|Overall Study|Lost to Follow-up|25|||
129954819|NCT00510783|467795595|FG000|Overall Study|Withdrawal by Subject|2|||
129954820|NCT00510783|467795596|FG001|Overall Study|Withdrawal by Subject|3|||
129954821|NCT00510783|467795595|FG000|Overall Study|Protocol Violation|0|||
129954822|NCT00510783|467795596|FG001|Overall Study|Protocol Violation|1|||
129954823|NCT02305797|467795597|FG000|Overall Study|Adverse Event|11|||
129954824|NCT02305797|467795598|FG001|Overall Study|Adverse Event|2|||
129954825|NCT02305797|467795597|FG000|Overall Study|Withdrawal by Subject|9|||
129954826|NCT02305797|467795598|FG001|Overall Study|Withdrawal by Subject|10|||
129954827|NCT02305797|467795597|FG000|Overall Study|Lack of Efficacy|6|||
129954828|NCT02305797|467795598|FG001|Overall Study|Lack of Efficacy|0|||
129954829|NCT02305797|467795597|FG000|Overall Study|Lost to Follow-up|5|||
129954830|NCT02305797|467795598|FG001|Overall Study|Lost to Follow-up|11|||
129954831|NCT02305797|467795597|FG000|Overall Study|Pregnancy|0|||
129954832|NCT02305797|467795598|FG001|Overall Study|Pregnancy|2|||
129954833|NCT02305797|467795597|FG000|Overall Study|Noncompliance|14|||
129954834|NCT02305797|467795598|FG001|Overall Study|Noncompliance|12|||
129954835|NCT02305797|467795597|FG000|Overall Study|Reason not collected|0|||
129954836|NCT02305797|467795598|FG001|Overall Study|Reason not collected|1|||
129954837|NCT00422162|467795599|FG000|Overall Study|Adverse Event|11|||
129954838|NCT00422162|467795600|FG001|Overall Study|Adverse Event|9|||
129954839|NCT00422162|467795599|FG000|Overall Study|Lack of Efficacy|4|||
129954840|NCT00422162|467795600|FG001|Overall Study|Lack of Efficacy|10|||
129979857|NCT04445987|467889483|FG004|Overall Study|Physician Decision|1|||
129979858|NCT04445987|467889484|FG005|Overall Study|Physician Decision|0|||
129979859|NCT04445987|467889479|FG000|Overall Study|Protocol Violation|1|||
129979860|NCT04445987|467889480|FG001|Overall Study|Protocol Violation|0|||
129979861|NCT04445987|467889481|FG002|Overall Study|Protocol Violation|0|||
129979862|NCT04445987|467889482|FG003|Overall Study|Protocol Violation|0|||
129979863|NCT04445987|467889483|FG004|Overall Study|Protocol Violation|2|||
129979864|NCT04445987|467889484|FG005|Overall Study|Protocol Violation|0|||
129979865|NCT04445987|467889479|FG000|Overall Study|Withdrawal by Subject|4|||
129979866|NCT04445987|467889480|FG001|Overall Study|Withdrawal by Subject|0|||
129979867|NCT04445987|467889481|FG002|Overall Study|Withdrawal by Subject|1|||
129979868|NCT04445987|467889482|FG003|Overall Study|Withdrawal by Subject|0|||
129979869|NCT04445987|467889483|FG004|Overall Study|Withdrawal by Subject|18|||
129979870|NCT04445987|467889484|FG005|Overall Study|Withdrawal by Subject|1|||
129979871|NCT04445987|467889479|FG000|Overall Study|Other reason|0|||
129979872|NCT04445987|467889480|FG001|Overall Study|Other reason|0|||
129979873|NCT04445987|467889481|FG002|Overall Study|Other reason|1|||
129979874|NCT04445987|467889482|FG003|Overall Study|Other reason|0|||
129979875|NCT04445987|467889483|FG004|Overall Study|Other reason|2|||
129979876|NCT04445987|467889484|FG005|Overall Study|Other reason|0|||
129979877|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
129979878|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
129979879|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
129979880|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
129979881|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
129979882|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
129979883|NCT01114880|467889485|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
129979884|NCT01114880|467889486|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
129979885|NCT01114880|467889485|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
129979886|NCT01114880|467889486|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
129979887|NCT01114880|467889485|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
129979888|NCT01114880|467889486|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
129979889|NCT02001064|467889492|FG000|Overall Study|Withdrawal by Subject|2|||
129979890|NCT02001064|467889493|FG001|Overall Study|Withdrawal by Subject|1|||
129979891|NCT02108964|467889498|FG000|Overall Study|Progressive disease|15|||
129979892|NCT02108964|467889499|FG001|Overall Study|Progressive disease|31|||
129979893|NCT02108964|467889500|FG002|Overall Study|Progressive disease|54|||
129979894|NCT02108964|467889501|FG003|Overall Study|Progressive disease|7|||
129979895|NCT02108964|467889502|FG004|Overall Study|Progressive disease|20|||
129979896|NCT02108964|467889503|FG005|Overall Study|Progressive disease|4|||
129979897|NCT02108964|467889504|FG006|Overall Study|Progressive disease|6|||
129979898|NCT02108964|467889505|FG007|Overall Study|Progressive disease|33|||
129979899|NCT02108964|467889498|FG000|Overall Study|Physician Decision|1|||
129979900|NCT02108964|467889499|FG001|Overall Study|Physician Decision|5|||
129979901|NCT02108964|467889500|FG002|Overall Study|Physician Decision|7|||
129979902|NCT02108964|467889501|FG003|Overall Study|Physician Decision|1|||
129979903|NCT02108964|467889502|FG004|Overall Study|Physician Decision|2|||
129979904|NCT02108964|467889503|FG005|Overall Study|Physician Decision|1|||
129979905|NCT02108964|467889504|FG006|Overall Study|Physician Decision|1|||
129979906|NCT02108964|467889505|FG007|Overall Study|Physician Decision|3|||
129979907|NCT02108964|467889498|FG000|Overall Study|Adverse Event|0|||
129979908|NCT02108964|467889499|FG001|Overall Study|Adverse Event|0|||
129979909|NCT02108964|467889500|FG002|Overall Study|Adverse Event|4|||
129979910|NCT02108964|467889501|FG003|Overall Study|Adverse Event|0|||
129979911|NCT02108964|467889502|FG004|Overall Study|Adverse Event|1|||
129979912|NCT02108964|467889503|FG005|Overall Study|Adverse Event|0|||
129979913|NCT02108964|467889504|FG006|Overall Study|Adverse Event|3|||
129979914|NCT02108964|467889505|FG007|Overall Study|Adverse Event|2|||
129979915|NCT02108964|467889498|FG000|Overall Study|Death|1|||
129979916|NCT02108964|467889499|FG001|Overall Study|Death|1|||
129979917|NCT02108964|467889500|FG002|Overall Study|Death|4|||
129979918|NCT02108964|467889501|FG003|Overall Study|Death|0|||
129979919|NCT02108964|467889502|FG004|Overall Study|Death|3|||
129979920|NCT02108964|467889503|FG005|Overall Study|Death|0|||
129979921|NCT02108964|467889504|FG006|Overall Study|Death|0|||
129979922|NCT02108964|467889505|FG007|Overall Study|Death|2|||
129979923|NCT02108964|467889498|FG000|Overall Study|Subject/Guardian decision|0|||
129979924|NCT02108964|467889499|FG001|Overall Study|Subject/Guardian decision|1|||
129979925|NCT02108964|467889500|FG002|Overall Study|Subject/Guardian decision|4|||
129979926|NCT02108964|467889501|FG003|Overall Study|Subject/Guardian decision|0|||
129979927|NCT02108964|467889502|FG004|Overall Study|Subject/Guardian decision|2|||
129979928|NCT02108964|467889503|FG005|Overall Study|Subject/Guardian decision|0|||
129979929|NCT02108964|467889504|FG006|Overall Study|Subject/Guardian decision|1|||
129979930|NCT02108964|467889505|FG007|Overall Study|Subject/Guardian decision|2|||
129979931|NCT02108964|467889498|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129954841|NCT00422162|467795599|FG000|Overall Study|Withdrawal by Subject|7|||
129954842|NCT00422162|467795600|FG001|Overall Study|Withdrawal by Subject|6|||
129954843|NCT00422162|467795599|FG000|Overall Study|Lost to Follow-up|1|||
129954844|NCT00422162|467795600|FG001|Overall Study|Lost to Follow-up|2|||
129954845|NCT00422162|467795599|FG000|Overall Study|Non-Compliant with Protocol|1|||
129954846|NCT00422162|467795600|FG001|Overall Study|Non-Compliant with Protocol|1|||
129954847|NCT00422162|467795599|FG000|Overall Study|Other|0|||
129954848|NCT00422162|467795600|FG001|Overall Study|Other|1|||
129954849|NCT00422162|467795599|FG000|Overall Study|Didn't Receive Treatment|0|||
129954850|NCT00422162|467795600|FG001|Overall Study|Didn't Receive Treatment|1|||
129954851|NCT02522299|467795601|FG000|Overall Study|Adverse Event|2|||
129954852|NCT02522299|467795602|FG001|Overall Study|Adverse Event|0|||
129954853|NCT02522299|467795601|FG000|Overall Study|Physician Decision|0|||
129954854|NCT02522299|467795602|FG001|Overall Study|Physician Decision|1|||
129954855|NCT02522299|467795601|FG000|Overall Study|Withdrawal by Subject|2|||
129954856|NCT02522299|467795602|FG001|Overall Study|Withdrawal by Subject|0|||
129954857|NCT00460577|467795605|FG000|Overall Study|Protocol Violation|2|||
129954858|NCT00460577|467795606|FG001|Overall Study|Protocol Violation|6|||
129954859|NCT01878253|467795607|FG000|Overall Study|Death|1|||
129954860|NCT01878253|467795607|FG000|Overall Study|SIdus System Removal|3|||
129954861|NCT01878253|467795607|FG000|Overall Study|Withdrawal by Subject|1|||
129954862|NCT01878253|467795607|FG000|Overall Study|Lost to Follow-up|2|||
129954863|NCT01878253|467795607|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
129954864|NCT00448344|467795612|FG000|Overall Study|Lost to Follow-up|20|||
129954865|NCT00448344|467795613|FG001|Overall Study|Lost to Follow-up|22|||
129954866|NCT00448344|467795612|FG000|Overall Study|Withdrawal by Subject|6|||
129954867|NCT00448344|467795613|FG001|Overall Study|Withdrawal by Subject|8|||
129954868|NCT00448344|467795612|FG000|Overall Study|Death|3|||
129954869|NCT00448344|467795613|FG001|Overall Study|Death|4|||
129954870|NCT00448344|467795612|FG000|Overall Study|Physician Decision|1|||
129954871|NCT00448344|467795613|FG001|Overall Study|Physician Decision|2|||
129954872|NCT00267865|467795620|FG000|Induction Treatment|Died before completing.|2|||
129954873|NCT00267865|467795620|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
129954874|NCT03686176|467795621|FG000|Overall Study|Procedure cancelled|1|||
129954875|NCT03686176|467795622|FG001|Overall Study|Procedure cancelled|0|||
129954876|NCT03686176|467795623|FG002|Overall Study|Procedure cancelled|0|||
129954877|NCT03686176|467795621|FG000|Overall Study|VR Malfunction|1|||
129954878|NCT03686176|467795622|FG001|Overall Study|VR Malfunction|0|||
129954879|NCT03686176|467795623|FG002|Overall Study|VR Malfunction|0|||
129954880|NCT03530345|467795633|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
129954881|NCT03530345|467795634|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
129954882|NCT03530345|467795633|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
129954883|NCT03530345|467795634|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
129954884|NCT03530345|467795633|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
129954885|NCT03530345|467795634|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
129954886|NCT03530345|467795633|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
129954887|NCT03530345|467795634|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
129454059|NCT00932360|465959442|FG000|Washout (One Week)|Withdrawal by Subject|0|||
129454060|NCT00932360|465959443|FG001|Washout (One Week)|Withdrawal by Subject|0|||
129454061|NCT00932360|465959444|FG002|Washout (One Week)|Withdrawal by Subject|0|||
129454062|NCT00932360|465959445|FG003|Washout (One Week)|Withdrawal by Subject|0|||
129454063|NCT00932360|465959446|FG004|Washout (One Week)|Withdrawal by Subject|2|||
129954888|NCT00644332|467797260|FG000|Overall Study|Adverse Event|11|||
129954889|NCT00644332|467797260|FG000|Overall Study|Withdrawal by Subject|6|||
129954890|NCT00644332|467797260|FG000|Overall Study|Completion Status Unknown|2|||
129954891|NCT00644332|467797260|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
129954892|NCT00644332|467797260|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
129954893|NCT00355784|467797262|FG000|Overall Study|Withdrawal by Subject|0|||
129954894|NCT00355784|467797263|FG001|Overall Study|Withdrawal by Subject|0|||
129954895|NCT00355784|467797264|FG002|Overall Study|Withdrawal by Subject|2|||
129954896|NCT03602053|467797267|FG000|Overall Study|Withdrawal by Subject|7|||
129954897|NCT03602053|467797268|FG001|Overall Study|Withdrawal by Subject|9|||
129954898|NCT03602053|467797269|FG002|Overall Study|Withdrawal by Subject|7|||
129954899|NCT03602053|467797267|FG000|Overall Study|Lost to Follow-up|5|||
129954900|NCT03602053|467797268|FG001|Overall Study|Lost to Follow-up|6|||
129954901|NCT03602053|467797269|FG002|Overall Study|Lost to Follow-up|0|||
129954902|NCT03602053|467797267|FG000|Overall Study|Protocol Violation|3|||
129954903|NCT03602053|467797268|FG001|Overall Study|Protocol Violation|0|||
129954904|NCT03602053|467797269|FG002|Overall Study|Protocol Violation|4|||
129954905|NCT03602053|467797267|FG000|Overall Study|Physician Decision|1|||
129954906|NCT03602053|467797268|FG001|Overall Study|Physician Decision|0|||
129954907|NCT03602053|467797269|FG002|Overall Study|Physician Decision|0|||
129954908|NCT03602053|467797267|FG000|Overall Study|migration|2|||
129954909|NCT03602053|467797268|FG001|Overall Study|migration|3|||
129954910|NCT03602053|467797269|FG002|Overall Study|migration|0|||
129954911|NCT03602053|467797267|FG000|Overall Study|Other|1|||
129954912|NCT03602053|467797268|FG001|Overall Study|Other|0|||
129954913|NCT03602053|467797269|FG002|Overall Study|Other|0|||
129954914|NCT00396409|467797270|FG000|Period 1 - 2007|Adverse Event|0|||
129954915|NCT00396409|467797271|FG001|Period 1 - 2007|Adverse Event|1|||
129954916|NCT00396409|467797270|FG000|Period 1 - 2007|Lack of Efficacy|0|||
129954917|NCT00396409|467797271|FG001|Period 1 - 2007|Lack of Efficacy|1|||
129954918|NCT00396409|467797270|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
129954919|NCT00396409|467797271|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
129954920|NCT00396409|467797270|FG000|Period 1 - 2007|Lost to Follow-up|2|||
129954921|NCT00396409|467797271|FG001|Period 1 - 2007|Lost to Follow-up|3|||
129954922|NCT00396409|467797270|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
129954923|NCT00396409|467797271|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
129954924|NCT00396409|467797270|FG000|Period 2 - 2008|Protocol Violation|1|||
129954925|NCT00396409|467797271|FG001|Period 2 - 2008|Protocol Violation|0|||
129954926|NCT00396409|467797270|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
129954927|NCT00396409|467797271|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
129954928|NCT00396409|467797270|FG000|Period 2 - 2008|Lost to Follow-up|3|||
129954929|NCT00396409|467797271|FG001|Period 2 - 2008|Lost to Follow-up|1|||
129954930|NCT00331799|467797272|FG000|Overall Study|Withdrawal by Subject|2|||
129954931|NCT00331799|467797272|FG000|Overall Study|Sedation|1|||
129954932|NCT04203199|467797275|FG000|First Intervention Period|Lost to Follow-up|0|||
129954933|NCT04203199|467797276|FG001|First Intervention Period|Lost to Follow-up|1|||
129954934|NCT04203199|467797275|FG000|Second Intervention Period|Medication change|1|||
129954935|NCT04203199|467797276|FG001|Second Intervention Period|Medication change|0|||
129954936|NCT01870999|467797280|FG000|Overall Study|Adverse Event|0|||
129954937|NCT01870999|467797281|FG001|Overall Study|Adverse Event|4|||
129954938|NCT01870999|467797282|FG002|Overall Study|Adverse Event|1|||
129954939|NCT01870999|467797280|FG000|Overall Study|Subject met withdrawal criteria|3|||
129954940|NCT01870999|467797281|FG001|Overall Study|Subject met withdrawal criteria|2|||
129954941|NCT01870999|467797282|FG002|Overall Study|Subject met withdrawal criteria|0|||
129954942|NCT01870999|467797280|FG000|Overall Study|Subject withdrawn by Investigator|1|||
129954943|NCT01870999|467797281|FG001|Overall Study|Subject withdrawn by Investigator|0|||
129954944|NCT01870999|467797282|FG002|Overall Study|Subject withdrawn by Investigator|0|||
129954945|NCT01870999|467797280|FG000|Overall Study|Withdrawal by Subject|0|||
129954946|NCT01870999|467797281|FG001|Overall Study|Withdrawal by Subject|2|||
129954947|NCT01870999|467797282|FG002|Overall Study|Withdrawal by Subject|5|||
129954948|NCT01870999|467797280|FG000|Overall Study|Protocol Violation|0|||
129954949|NCT01870999|467797281|FG001|Overall Study|Protocol Violation|0|||
129954950|NCT01870999|467797282|FG002|Overall Study|Protocol Violation|1|||
129954951|NCT03034772|467797283|FG000|Overall Study|Adverse Event|0|||
129954952|NCT03034772|467797284|FG001|Overall Study|Adverse Event|1|||
129954953|NCT03034772|467797283|FG000|Overall Study|Withdrawal by Subject|0|||
129954954|NCT03034772|467797284|FG001|Overall Study|Withdrawal by Subject|1|||
129954955|NCT02660034|467797285|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
129954956|NCT02660034|467797286|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
129954957|NCT02660034|467797287|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
129954958|NCT02660034|467797288|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
129954959|NCT02660034|467797289|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
129954960|NCT02660034|467797290|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
129954961|NCT02660034|467797291|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
129954962|NCT02660034|467797292|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
129954963|NCT02660034|467797293|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
129954964|NCT02660034|467797294|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
129954965|NCT02660034|467797295|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
129954966|NCT02660034|467797296|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
129954967|NCT02660034|467797297|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
129954968|NCT02660034|467797298|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
129954969|NCT02660034|467797285|FG000|Overall Study|Progressive Disease (Clinical)|7|||
129954970|NCT02660034|467797286|FG001|Overall Study|Progressive Disease (Clinical)|8|||
129954971|NCT02660034|467797287|FG002|Overall Study|Progressive Disease (Clinical)|3|||
129954972|NCT02660034|467797288|FG003|Overall Study|Progressive Disease (Clinical)|9|||
129954973|NCT02660034|467797289|FG004|Overall Study|Progressive Disease (Clinical)|3|||
129954974|NCT02660034|467797290|FG005|Overall Study|Progressive Disease (Clinical)|0|||
129954975|NCT02660034|467797291|FG006|Overall Study|Progressive Disease (Clinical)|0|||
129954976|NCT02660034|467797292|FG007|Overall Study|Progressive Disease (Clinical)|0|||
129954977|NCT02660034|467797293|FG008|Overall Study|Progressive Disease (Clinical)|0|||
129954978|NCT02660034|467797294|FG009|Overall Study|Progressive Disease (Clinical)|0|||
129954979|NCT02660034|467797295|FG010|Overall Study|Progressive Disease (Clinical)|0|||
129954980|NCT02660034|467797296|FG011|Overall Study|Progressive Disease (Clinical)|0|||
129954981|NCT02660034|467797297|FG012|Overall Study|Progressive Disease (Clinical)|0|||
129954982|NCT02660034|467797298|FG013|Overall Study|Progressive Disease (Clinical)|0|||
129954983|NCT02660034|467797285|FG000|Overall Study|Lost to Follow-up|0|||
129954984|NCT02660034|467797286|FG001|Overall Study|Lost to Follow-up|0|||
129954985|NCT02660034|467797287|FG002|Overall Study|Lost to Follow-up|1|||
129954986|NCT02660034|467797288|FG003|Overall Study|Lost to Follow-up|1|||
129954987|NCT02660034|467797289|FG004|Overall Study|Lost to Follow-up|0|||
129954988|NCT02660034|467797290|FG005|Overall Study|Lost to Follow-up|0|||
129954989|NCT02660034|467797291|FG006|Overall Study|Lost to Follow-up|0|||
129954990|NCT02660034|467797292|FG007|Overall Study|Lost to Follow-up|0|||
129954991|NCT02660034|467797293|FG008|Overall Study|Lost to Follow-up|0|||
129954992|NCT02660034|467797294|FG009|Overall Study|Lost to Follow-up|1|||
129954993|NCT02660034|467797295|FG010|Overall Study|Lost to Follow-up|1|||
129954994|NCT02660034|467797296|FG011|Overall Study|Lost to Follow-up|1|||
129954995|NCT02660034|467797297|FG012|Overall Study|Lost to Follow-up|0|||
129954996|NCT02660034|467797298|FG013|Overall Study|Lost to Follow-up|0|||
129954997|NCT02660034|467797285|FG000|Overall Study|Participant moved into special access scheme|1|||
129954998|NCT02660034|467797286|FG001|Overall Study|Participant moved into special access scheme|2|||
129954999|NCT02660034|467797287|FG002|Overall Study|Participant moved into special access scheme|0|||
129955000|NCT02660034|467797288|FG003|Overall Study|Participant moved into special access scheme|0|||
129955001|NCT02660034|467797289|FG004|Overall Study|Participant moved into special access scheme|0|||
129955002|NCT02660034|467797290|FG005|Overall Study|Participant moved into special access scheme|0|||
129955003|NCT02660034|467797291|FG006|Overall Study|Participant moved into special access scheme|0|||
129955004|NCT02660034|467797292|FG007|Overall Study|Participant moved into special access scheme|0|||
129955005|NCT02660034|467797293|FG008|Overall Study|Participant moved into special access scheme|0|||
129955006|NCT02660034|467797294|FG009|Overall Study|Participant moved into special access scheme|0|||
129955007|NCT02660034|467797295|FG010|Overall Study|Participant moved into special access scheme|0|||
129955008|NCT02660034|467797296|FG011|Overall Study|Participant moved into special access scheme|0|||
129955009|NCT02660034|467797297|FG012|Overall Study|Participant moved into special access scheme|0|||
129955010|NCT02660034|467797298|FG013|Overall Study|Participant moved into special access scheme|0|||
129955011|NCT02660034|467797285|FG000|Overall Study|Adverse Event|1|||
129955012|NCT02660034|467797286|FG001|Overall Study|Adverse Event|0|||
129955013|NCT02660034|467797287|FG002|Overall Study|Adverse Event|0|||
129955014|NCT02660034|467797288|FG003|Overall Study|Adverse Event|0|||
129955015|NCT02660034|467797289|FG004|Overall Study|Adverse Event|0|||
129955016|NCT02660034|467797290|FG005|Overall Study|Adverse Event|0|||
129955017|NCT02660034|467797291|FG006|Overall Study|Adverse Event|0|||
129955018|NCT02660034|467797292|FG007|Overall Study|Adverse Event|0|||
129955019|NCT02660034|467797293|FG008|Overall Study|Adverse Event|0|||
129955020|NCT02660034|467797294|FG009|Overall Study|Adverse Event|0|||
129955021|NCT02660034|467797295|FG010|Overall Study|Adverse Event|0|||
129955022|NCT02660034|467797296|FG011|Overall Study|Adverse Event|0|||
129955023|NCT02660034|467797297|FG012|Overall Study|Adverse Event|0|||
129955024|NCT02660034|467797298|FG013|Overall Study|Adverse Event|0|||
129454064|NCT00932360|465959447|FG005|Washout (One Week)|Withdrawal by Subject|0|||
129454065|NCT00993265|465959453|FG000|Overall Study|Adverse Event|1|||
129454066|NCT00993265|465959454|FG001|Overall Study|Adverse Event|0|||
129454067|NCT00993265|465959453|FG000|Overall Study|Changed dose of concomitant drug|2|||
129955025|NCT02660034|467797285|FG000|Overall Study|Sponsor Decision|0|||
129955026|NCT02660034|467797286|FG001|Overall Study|Sponsor Decision|1|||
129955027|NCT02660034|467797287|FG002|Overall Study|Sponsor Decision|2|||
129955028|NCT02660034|467797288|FG003|Overall Study|Sponsor Decision|2|||
129955029|NCT02660034|467797289|FG004|Overall Study|Sponsor Decision|3|||
129955030|NCT02660034|467797290|FG005|Overall Study|Sponsor Decision|0|||
129955031|NCT02660034|467797291|FG006|Overall Study|Sponsor Decision|0|||
129955032|NCT02660034|467797292|FG007|Overall Study|Sponsor Decision|0|||
129955033|NCT02660034|467797293|FG008|Overall Study|Sponsor Decision|0|||
129955034|NCT02660034|467797294|FG009|Overall Study|Sponsor Decision|0|||
129955035|NCT02660034|467797295|FG010|Overall Study|Sponsor Decision|0|||
129955036|NCT02660034|467797296|FG011|Overall Study|Sponsor Decision|0|||
129955037|NCT02660034|467797297|FG012|Overall Study|Sponsor Decision|0|||
129955038|NCT02660034|467797298|FG013|Overall Study|Sponsor Decision|1|||
129955039|NCT02660034|467797285|FG000|Overall Study|Withdrawal by Subject|0|||
129955040|NCT02660034|467797286|FG001|Overall Study|Withdrawal by Subject|0|||
129955041|NCT02660034|467797287|FG002|Overall Study|Withdrawal by Subject|0|||
129955042|NCT02660034|467797288|FG003|Overall Study|Withdrawal by Subject|0|||
129955043|NCT02660034|467797289|FG004|Overall Study|Withdrawal by Subject|0|||
129955044|NCT02660034|467797290|FG005|Overall Study|Withdrawal by Subject|0|||
129955045|NCT02660034|467797291|FG006|Overall Study|Withdrawal by Subject|1|||
129955046|NCT02660034|467797292|FG007|Overall Study|Withdrawal by Subject|1|||
129955047|NCT02660034|467797293|FG008|Overall Study|Withdrawal by Subject|1|||
129955048|NCT02660034|467797294|FG009|Overall Study|Withdrawal by Subject|0|||
129955049|NCT02660034|467797295|FG010|Overall Study|Withdrawal by Subject|0|||
129955050|NCT02660034|467797296|FG011|Overall Study|Withdrawal by Subject|1|||
129955051|NCT02660034|467797297|FG012|Overall Study|Withdrawal by Subject|2|||
129955052|NCT02660034|467797298|FG013|Overall Study|Withdrawal by Subject|0|||
129955053|NCT02660034|467797285|FG000|Overall Study|Death|0|||
129955054|NCT02660034|467797286|FG001|Overall Study|Death|0|||
129955055|NCT02660034|467797287|FG002|Overall Study|Death|0|||
129955056|NCT02660034|467797288|FG003|Overall Study|Death|0|||
129955057|NCT02660034|467797289|FG004|Overall Study|Death|0|||
129955058|NCT02660034|467797290|FG005|Overall Study|Death|13|||
129955059|NCT02660034|467797291|FG006|Overall Study|Death|14|||
129955060|NCT02660034|467797292|FG007|Overall Study|Death|10|||
129955061|NCT02660034|467797293|FG008|Overall Study|Death|9|||
129955062|NCT02660034|467797294|FG009|Overall Study|Death|21|||
129955063|NCT02660034|467797295|FG010|Overall Study|Death|17|||
129955064|NCT02660034|467797296|FG011|Overall Study|Death|15|||
129955065|NCT02660034|467797297|FG012|Overall Study|Death|18|||
129955066|NCT02660034|467797298|FG013|Overall Study|Death|7|||
129955067|NCT02660034|467797285|FG000|Overall Study|Physician Decision|0|||
129955068|NCT02660034|467797286|FG001|Overall Study|Physician Decision|0|||
129955069|NCT02660034|467797287|FG002|Overall Study|Physician Decision|0|||
129955070|NCT02660034|467797288|FG003|Overall Study|Physician Decision|0|||
129955071|NCT02660034|467797289|FG004|Overall Study|Physician Decision|0|||
129955072|NCT02660034|467797290|FG005|Overall Study|Physician Decision|0|||
129955073|NCT02660034|467797291|FG006|Overall Study|Physician Decision|0|||
129955074|NCT02660034|467797292|FG007|Overall Study|Physician Decision|0|||
129955075|NCT02660034|467797293|FG008|Overall Study|Physician Decision|0|||
129955076|NCT02660034|467797294|FG009|Overall Study|Physician Decision|0|||
129955077|NCT02660034|467797295|FG010|Overall Study|Physician Decision|0|||
129955078|NCT02660034|467797296|FG011|Overall Study|Physician Decision|0|||
129955079|NCT02660034|467797297|FG012|Overall Study|Physician Decision|0|||
129955080|NCT02660034|467797298|FG013|Overall Study|Physician Decision|1|||
129955081|NCT02660034|467797285|FG000|Overall Study|Participants transferred to LTE|0|||
129955082|NCT02660034|467797286|FG001|Overall Study|Participants transferred to LTE|0|||
129454068|NCT00993265|465959454|FG001|Overall Study|Changed dose of concomitant drug|0|||
129454069|NCT00993265|465959453|FG000|Overall Study|Non-compliant with study medication|1|||
129454070|NCT00993265|465959454|FG001|Overall Study|Non-compliant with study medication|0|||
129955083|NCT02660034|467797287|FG002|Overall Study|Participants transferred to LTE|0|||
129955084|NCT02660034|467797288|FG003|Overall Study|Participants transferred to LTE|0|||
129955085|NCT02660034|467797289|FG004|Overall Study|Participants transferred to LTE|0|||
129955086|NCT02660034|467797290|FG005|Overall Study|Participants transferred to LTE|10|||
129955087|NCT02660034|467797291|FG006|Overall Study|Participants transferred to LTE|8|||
129955088|NCT02660034|467797292|FG007|Overall Study|Participants transferred to LTE|8|||
129955089|NCT02660034|467797293|FG008|Overall Study|Participants transferred to LTE|10|||
129955090|NCT02660034|467797294|FG009|Overall Study|Participants transferred to LTE|1|||
129955091|NCT02660034|467797295|FG010|Overall Study|Participants transferred to LTE|2|||
129955092|NCT02660034|467797296|FG011|Overall Study|Participants transferred to LTE|4|||
129955093|NCT02660034|467797297|FG012|Overall Study|Participants transferred to LTE|1|||
129955094|NCT02660034|467797298|FG013|Overall Study|Participants transferred to LTE|1|||
129955095|NCT01533181|467797301|FG000|Overall Study|Disease progression pre-active treatment|0|||
129955096|NCT01533181|467797302|FG001|Overall Study|Disease progression pre-active treatment|1|||
129454071|NCT00807742|465959456|FG000|Overall Study|Death|9|||
129454072|NCT00807742|465959457|FG001|Overall Study|Death|2|||
129955097|NCT01533181|467797301|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
129955098|NCT01533181|467797302|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
129955099|NCT01837719|467797305|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
129955100|NCT01837719|467797305|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
129955101|NCT01703988|467797306|FG000|Overall Study|Investigator Judgment|0|||
129955102|NCT01703988|467797307|FG001|Overall Study|Investigator Judgment|0|||
129955103|NCT01703988|467797308|FG002|Overall Study|Investigator Judgment|0|||
129955104|NCT01703988|467797309|FG003|Overall Study|Investigator Judgment|1|||
129955105|NCT06247488|467797310|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
129955106|NCT06247488|467797311|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955107|NCT06247488|467797312|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955108|NCT06247488|467797313|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955109|NCT06247488|467797314|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955110|NCT06247488|467797315|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
129955111|NCT06247488|467797310|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955112|NCT06247488|467797311|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955113|NCT06247488|467797312|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955114|NCT06247488|467797313|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
129955115|NCT06247488|467797314|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955116|NCT06247488|467797315|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
129955117|NCT06247488|467797310|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
129955118|NCT06247488|467797311|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955119|NCT06247488|467797312|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955120|NCT06247488|467797313|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955121|NCT06247488|467797314|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955122|NCT06247488|467797315|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
129955123|NCT06247488|467797310|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955124|NCT06247488|467797311|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955125|NCT06247488|467797312|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955126|NCT06247488|467797313|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
129955127|NCT06247488|467797314|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955128|NCT06247488|467797315|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
129955129|NCT06247488|467797310|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955130|NCT06247488|467797311|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955131|NCT06247488|467797312|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955132|NCT06247488|467797313|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955133|NCT06247488|467797314|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
129955134|NCT06247488|467797315|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
129955135|NCT06247488|467797310|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
129955136|NCT06247488|467797311|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
129955137|NCT06247488|467797312|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
129955138|NCT06247488|467797313|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
129955139|NCT06247488|467797314|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
129955140|NCT06247488|467797315|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
129955141|NCT06247488|467797310|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955142|NCT06247488|467797311|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955143|NCT06247488|467797312|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955144|NCT06247488|467797313|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955145|NCT06247488|467797314|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
129955146|NCT06247488|467797315|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
129955147|NCT02995733|467797316|FG000|Overall Study|Study site closed|9|||
129955148|NCT02995733|467797317|FG001|Overall Study|Study site closed|10|||
129955149|NCT02995733|467797316|FG000|Overall Study|Death|3|||
129955150|NCT02995733|467797317|FG001|Overall Study|Death|4|||
129955151|NCT02995733|467797316|FG000|Overall Study|Withdrawal by Subject|6|||
129955152|NCT02995733|467797317|FG001|Overall Study|Withdrawal by Subject|2|||
129955153|NCT02995733|467797316|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
129955154|NCT02995733|467797317|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
129955155|NCT02995733|467797316|FG000|Overall Study|Lost to Follow-up|48|||
129955156|NCT02995733|467797317|FG001|Overall Study|Lost to Follow-up|37|||
129955157|NCT02995733|467797316|FG000|Overall Study|Other|0|||
129955158|NCT02995733|467797317|FG001|Overall Study|Other|1|||
129955159|NCT04468633|467797318|FG000|Overall Study|Withdrawal by Subject|4|||
129955160|NCT04468633|467797319|FG001|Overall Study|Withdrawal by Subject|0|||
129955161|NCT00460434|467797322|FG000|Overall Study|Lost to Follow-up|3|||
129955162|NCT00460434|467797323|FG001|Overall Study|Lost to Follow-up|7|||
129955163|NCT02465866|467797324|FG000|Period 3|Withdrawal by Subject|0|||
129955164|NCT02465866|467797325|FG001|Period 3|Withdrawal by Subject|1|||
129955165|NCT02465866|467797326|FG002|Period 3|Withdrawal by Subject|0|||
129955166|NCT02465866|467797327|FG003|Period 3|Withdrawal by Subject|0|||
129955167|NCT02023099|467797328|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
129955168|NCT02023099|467797329|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
129955169|NCT02023099|467797330|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
129955170|NCT02023099|467797328|FG000|Overall Study|Withdrawn Consent|3|||
129955171|NCT02023099|467797329|FG001|Overall Study|Withdrawn Consent|0|||
129955172|NCT02023099|467797330|FG002|Overall Study|Withdrawn Consent|1|||
129955173|NCT02023099|467797328|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
129955174|NCT02023099|467797329|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
129955175|NCT02023099|467797330|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
129955176|NCT01469819|467797331|FG000|Overall Study|Withdrawal by Subject|1|||
129955177|NCT01469819|467797331|FG000|Overall Study|Did not meet inclusionary criteria|2|||
129955178|NCT01469819|467797331|FG000|Overall Study|Could not swallow SmartPill|2|||
129955179|NCT01469819|467797331|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
129955180|NCT04057937|467797332|FG000|Placebo-controlled Phase|Adverse Event|3|||
129955181|NCT04057937|467797333|FG001|Placebo-controlled Phase|Adverse Event|0|||
129955182|NCT04057937|467797332|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
129955183|NCT04057937|467797333|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
129955184|NCT04057937|467797332|FG000|Active-treatment Phase|Pregnancy|0|||
129955185|NCT04057937|467797333|FG001|Active-treatment Phase|Pregnancy|1|||
129955186|NCT04057937|467797332|FG000|Active-treatment Phase|Physician Decision|0|||
129955187|NCT04057937|467797333|FG001|Active-treatment Phase|Physician Decision|1|||
129955188|NCT02504502|467797336|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
129955189|NCT02504502|467797337|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
129955190|NCT02504502|467797336|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
129955191|NCT02504502|467797337|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
129955192|NCT03508830|467797339|FG000|Overall Study|Withdrawal by Subject|3|||
129955193|NCT03508830|467797340|FG001|Overall Study|Withdrawal by Subject|4|||
129955194|NCT03508830|467797339|FG000|Overall Study|Physician Decision|2|||
129955195|NCT03508830|467797340|FG001|Overall Study|Physician Decision|2|||
129955196|NCT04908800|467797341|FG000|Overall Study|Adverse Event|0|||
129955197|NCT04908800|467797342|FG001|Overall Study|Adverse Event|0|||
129955198|NCT04908800|467797343|FG002|Overall Study|Adverse Event|0|||
129955199|NCT04908800|467797344|FG003|Overall Study|Adverse Event|0|||
129955200|NCT04908800|467797345|FG004|Overall Study|Adverse Event|0|||
129955201|NCT04908800|467797346|FG005|Overall Study|Adverse Event|0|||
129955202|NCT04908800|467797347|FG006|Overall Study|Adverse Event|0|||
129955203|NCT04908800|467797348|FG007|Overall Study|Adverse Event|0|||
129955204|NCT04908800|467797349|FG008|Overall Study|Adverse Event|0|||
129955205|NCT04908800|467797350|FG009|Overall Study|Adverse Event|0|||
129955206|NCT04908800|467797351|FG010|Overall Study|Adverse Event|1|||
129955207|NCT04908800|467797352|FG011|Overall Study|Adverse Event|0|||
129955208|NCT04908800|467797353|FG012|Overall Study|Adverse Event|0|||
129955209|NCT01622088|467797357|FG000|Overall Study|Adverse Event|20|||
129955210|NCT01622088|467797357|FG000|Overall Study|Lost to Follow-up|1|||
129955211|NCT01622088|467797357|FG000|Overall Study|Withdrawal by Subject|20|||
129454073|NCT00807742|465959456|FG000|Overall Study|Withdrawal by Subject|2|||
129454074|NCT00807742|465959457|FG001|Overall Study|Withdrawal by Subject|1|||
129955212|NCT01622088|467797357|FG000|Overall Study|Investigator Decision|1|||
129454075|NCT00807742|465959456|FG000|Overall Study|Lost to Follow-up|35|||
129955213|NCT01622088|467797357|FG000|Overall Study|Death|53|||
129955214|NCT01622088|467797357|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
129955215|NCT00274846|467797360|FG000|Overall Study|Did not receive adequate NK cells|1|||
129955216|NCT03045302|467797361|FG000|Overall Study|Pre-treatment adverse event|1|||
129955217|NCT05287178|467797364|FG000|Overall Study|Lost to Follow-up|2|||
129955218|NCT01648699|467797365|FG000|Overall Study|Death|1|||
129955219|NCT01648699|467797365|FG000|Overall Study|Lost to Follow-up|2|||
129955220|NCT01648699|467797365|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
129955221|NCT02267746|467797366|FG000|Overall Study|Adverse Event|0|||
129955222|NCT02267746|467797367|FG001|Overall Study|Adverse Event|2|||
129955223|NCT02267746|467797368|FG002|Overall Study|Adverse Event|1|||
129955224|NCT02267746|467797366|FG000|Overall Study|Protocol Violation|8|||
129955225|NCT02267746|467797367|FG001|Overall Study|Protocol Violation|7|||
129955226|NCT02267746|467797368|FG002|Overall Study|Protocol Violation|3|||
129955227|NCT02267746|467797366|FG000|Overall Study|Lack of Efficacy|11|||
129955228|NCT02267746|467797367|FG001|Overall Study|Lack of Efficacy|11|||
129955229|NCT02267746|467797368|FG002|Overall Study|Lack of Efficacy|15|||
129955230|NCT02267746|467797366|FG000|Overall Study|Protocol Violation|1|||
129955231|NCT02267746|467797367|FG001|Overall Study|Protocol Violation|2|||
129955232|NCT02267746|467797368|FG002|Overall Study|Protocol Violation|1|||
129955233|NCT02267746|467797366|FG000|Overall Study|Miscellaneous|1|||
129955234|NCT02267746|467797367|FG001|Overall Study|Miscellaneous|0|||
129955235|NCT02267746|467797368|FG002|Overall Study|Miscellaneous|1|||
129955236|NCT04598776|467797373|FG000|Overall Study|Protocol Violation|5|||
129955237|NCT04598776|467797373|FG000|Overall Study|Physician Decision|4|||
129955238|NCT00728884|467797374|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
129955239|NCT00728884|467797374|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
129955240|NCT00348283|467797375|FG000|Induction|Adverse Event|0|||
129955241|NCT00348283|467797376|FG001|Induction|Adverse Event|2|||
129955242|NCT00348283|467797375|FG000|Induction|Protocol Violation|0|||
129955243|NCT00348283|467797376|FG001|Induction|Protocol Violation|4|||
129955244|NCT00348283|467797375|FG000|Double Blind|Adverse Event|2|||
129955245|NCT00348283|467797376|FG001|Double Blind|Adverse Event|5|||
129955246|NCT00348283|467797375|FG000|Double Blind|Withdrawal by Subject|1|||
129955247|NCT00348283|467797376|FG001|Double Blind|Withdrawal by Subject|1|||
129955248|NCT00348283|467797375|FG000|Double Blind|Protocol Violation|0|||
129955249|NCT00348283|467797376|FG001|Double Blind|Protocol Violation|1|||
129955250|NCT00348283|467797375|FG000|Double Blind|Lack of Efficacy|2|||
129955251|NCT00348283|467797376|FG001|Double Blind|Lack of Efficacy|2|||
129955252|NCT00348283|467797375|FG000|Double Blind|Pregnancy|0|||
129955253|NCT00348283|467797376|FG001|Double Blind|Pregnancy|1|||
129955254|NCT00348283|467797375|FG000|Open Label|Adverse Event|0|||
129955255|NCT00348283|467797376|FG001|Open Label|Adverse Event|8|||
129955256|NCT00348283|467797375|FG000|Open Label|Withdrawal by Subject|0|||
129955257|NCT00348283|467797376|FG001|Open Label|Withdrawal by Subject|4|||
129955258|NCT00348283|467797375|FG000|Open Label|Lost to Follow-up|0|||
129955259|NCT00348283|467797376|FG001|Open Label|Lost to Follow-up|1|||
129955260|NCT00348283|467797375|FG000|Open Label|Lack of Efficacy|0|||
129955261|NCT00348283|467797376|FG001|Open Label|Lack of Efficacy|13|||
129955262|NCT00348283|467797375|FG000|Open Label|Administrative reasons|0|||
129955263|NCT00348283|467797376|FG001|Open Label|Administrative reasons|5|||
129955264|NCT00348283|467797375|FG000|Open Label|Subject moved to the United States|0|||
129955265|NCT00348283|467797376|FG001|Open Label|Subject moved to the United States|1|||
129955266|NCT00348283|467797375|FG000|Open Label|Pregnancy|0|||
129955267|NCT00348283|467797376|FG001|Open Label|Pregnancy|1|||
129955268|NCT00348283|467797375|FG000|Open Label|Sponsor decision|0|||
129955269|NCT00348283|467797376|FG001|Open Label|Sponsor decision|1|||
129955270|NCT06312566|467797384|FG000|Overall Study|Protocol Violation|0|||
129955271|NCT06312566|467797385|FG001|Overall Study|Protocol Violation|1|||
129955272|NCT04736472|467797386|FG000|Overall Study|Lost to Follow-up|1|||
129955273|NCT04736472|467797387|FG001|Overall Study|Lost to Follow-up|0|||
129955274|NCT04736472|467797388|FG002|Overall Study|Lost to Follow-up|0|||
129955275|NCT04736472|467797386|FG000|Overall Study|Withdrawal by Subject|2|||
129955276|NCT04736472|467797387|FG001|Overall Study|Withdrawal by Subject|0|||
129955277|NCT04736472|467797388|FG002|Overall Study|Withdrawal by Subject|0|||
129955278|NCT04736472|467797386|FG000|Overall Study|Protocol Violation|48|||
129955279|NCT04736472|467797387|FG001|Overall Study|Protocol Violation|0|||
129955280|NCT04736472|467797388|FG002|Overall Study|Protocol Violation|6|||
129955281|NCT03861078|467797389|FG000|Overall Study|COVID-19 shut down|4|||
129955282|NCT03861078|467797389|FG000|Overall Study|Lost to Follow-up|1|||
129955283|NCT03861078|467797389|FG000|Overall Study|Protocol Violation|2|||
129955284|NCT03861078|467797389|FG000|Overall Study|lack of venous access|1|||
129955285|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
129955286|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
129955287|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
129955288|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
129955289|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
129955290|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
129955291|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
129955292|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
129955293|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
129955294|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
129955295|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
129955296|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
129955297|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
129955298|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
129955299|NCT02971683|467797390|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
129955300|NCT02971683|467797391|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
129955301|NCT02971683|467797390|FG000|Open-Label|Lost to Follow-up|1|||
129955302|NCT02971683|467797391|FG001|Open-Label|Lost to Follow-up|0|||
129955303|NCT02971683|467797390|FG000|Open-Label|Participants withdrew consent|0|||
129955304|NCT02971683|467797391|FG001|Open-Label|Participants withdrew consent|2|||
129955305|NCT02971683|467797390|FG000|Open-Label|Participant request to discontinue study treatment|1|||
129955306|NCT02971683|467797391|FG001|Open-Label|Participant request to discontinue study treatment|0|||
129955307|NCT02971683|467797390|FG000|Open-Label|Lack of Efficacy|2|||
129955308|NCT02971683|467797391|FG001|Open-Label|Lack of Efficacy|0|||
129955309|NCT02971683|467797390|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
129955310|NCT02971683|467797391|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
129955311|NCT02971683|467797390|FG000|Long-Term Open Label|Participant withdrew consent|1|||
129955312|NCT02971683|467797391|FG001|Long-Term Open Label|Participant withdrew consent|0|||
129955313|NCT02971683|467797390|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
129955314|NCT02971683|467797391|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
129955315|NCT02971683|467797390|FG000|Long-Term Open Label|Adverse Event|1|||
129955316|NCT02971683|467797391|FG001|Long-Term Open Label|Adverse Event|2|||
129955317|NCT02971683|467797390|FG000|Long-Term Open Label|Lack of Efficacy|1|||
129955318|NCT02971683|467797391|FG001|Long-Term Open Label|Lack of Efficacy|1|||
129955319|NCT02268526|467797394|FG000|Overall Study|Adverse Event|0|||
129955320|NCT02268526|467797395|FG001|Overall Study|Adverse Event|2|||
129955321|NCT02268526|467797396|FG002|Overall Study|Adverse Event|1|||
129955322|NCT02268526|467797394|FG000|Overall Study|Death|1|||
129955323|NCT02268526|467797395|FG001|Overall Study|Death|11|||
129955324|NCT02268526|467797396|FG002|Overall Study|Death|0|||
129955325|NCT02268526|467797394|FG000|Overall Study|protocol deviation|0|||
129955326|NCT02268526|467797395|FG001|Overall Study|protocol deviation|1|||
129955327|NCT02268526|467797396|FG002|Overall Study|protocol deviation|0|||
129955328|NCT02268526|467797394|FG000|Overall Study|Physician Decision|0|||
129955329|NCT02268526|467797395|FG001|Overall Study|Physician Decision|0|||
129955330|NCT02268526|467797396|FG002|Overall Study|Physician Decision|1|||
129955331|NCT02268526|467797394|FG000|Overall Study|Subject/guardian decision|0|||
129955332|NCT02268526|467797395|FG001|Overall Study|Subject/guardian decision|7|||
129955333|NCT02268526|467797396|FG002|Overall Study|Subject/guardian decision|3|||
129955334|NCT00596960|467797397|FG000|Overall Study|Death|1|||
129955335|NCT00596960|467797398|FG001|Overall Study|Death|2|||
129955336|NCT00596960|467797397|FG000|Overall Study|Lost to Follow-up|6|||
129955337|NCT00596960|467797398|FG001|Overall Study|Lost to Follow-up|5|||
129955338|NCT00596960|467797397|FG000|Overall Study|Withdrawal by Subject|1|||
129955339|NCT00596960|467797398|FG001|Overall Study|Withdrawal by Subject|0|||
129955340|NCT00596960|467797397|FG000|Overall Study|Incarcerated|2|||
129955341|NCT00596960|467797398|FG001|Overall Study|Incarcerated|0|||
129955342|NCT00596960|467797397|FG000|Overall Study|Physician Decision|1|||
129955343|NCT00596960|467797398|FG001|Overall Study|Physician Decision|0|||
129955344|NCT00596960|467797397|FG000|Overall Study|Protocol Violation|0|||
129955345|NCT00596960|467797398|FG001|Overall Study|Protocol Violation|1|||
129955346|NCT00596960|467797397|FG000|Overall Study|No alcohol use data|0|||
129955347|NCT00596960|467797398|FG001|Overall Study|No alcohol use data|1|||
129955348|NCT02374476|467797401|FG000|VT Induced Ablation|Screening Failures|36|||
129955349|NCT02374476|467797402|FG001|VT Induced Ablation|Screening Failures|0|||
129955350|NCT02374476|467797403|FG002|VT Induced Ablation|Screening Failures|0|||
129955351|NCT02374476|467797401|FG000|Arm Assignment|Withdrawal by Subject|0|||
129955352|NCT02374476|467797402|FG001|Arm Assignment|Withdrawal by Subject|0|||
129955353|NCT02374476|467797403|FG002|Arm Assignment|Withdrawal by Subject|1|||
129955354|NCT03305458|467797404|FG000|Overall Study|Withdrawal by Subject|50|||
129955355|NCT03305458|467797405|FG001|Overall Study|Withdrawal by Subject|46|||
129955356|NCT03305458|467797406|FG002|Overall Study|Withdrawal by Subject|93|||
129955357|NCT03305458|467797404|FG000|Overall Study|Lost to Follow-up|85|||
129955358|NCT03305458|467797405|FG001|Overall Study|Lost to Follow-up|85|||
129955359|NCT03305458|467797406|FG002|Overall Study|Lost to Follow-up|35|||
129955360|NCT05431543|467797409|FG000|Overall Study|Medical History|1|||
129955361|NCT05431543|467797410|FG001|Overall Study|Medical History|0|||
129955362|NCT05431543|467797411|FG002|Overall Study|Medical History|0|||
129955363|NCT00440037|467797412|FG000|Overall Study|Withdrawal by Subject|6|||
129955364|NCT00440037|467797412|FG000|Overall Study|Administrative decision|3|||
129955365|NCT00990314|467797413|FG000|Overall Study|Death|2|||
129955366|NCT00990314|467797413|FG000|Overall Study|Adverse Event|2|||
129955367|NCT00990314|467797413|FG000|Overall Study|Withdrawal by Subject|3|||
129955368|NCT00990314|467797413|FG000|Overall Study|Non-Compliance|1|||
129955369|NCT00990314|467797413|FG000|Overall Study|Physician Decision|3|||
129955370|NCT00990314|467797413|FG000|Overall Study|Lack of Efficacy|1|||
129955371|NCT01636778|467797421|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
129955372|NCT01636778|467797422|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
129955373|NCT01636778|467797423|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
129955374|NCT01636778|467797421|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
129955375|NCT01636778|467797422|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
129955376|NCT01636778|467797423|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
129955377|NCT01636778|467797421|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
129955378|NCT01636778|467797422|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
129955379|NCT01636778|467797423|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
129955380|NCT01636778|467797421|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
129955381|NCT01636778|467797422|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
129955382|NCT01636778|467797423|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
129955383|NCT01636778|467797421|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
129955384|NCT01636778|467797422|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
129955385|NCT01636778|467797423|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
129955386|NCT01636778|467797421|FG000|Follow-up Period After Part 2|Other|0|||
129955387|NCT01636778|467797422|FG001|Follow-up Period After Part 2|Other|0|||
129955388|NCT01636778|467797423|FG002|Follow-up Period After Part 2|Other|1|||
129955389|NCT01636778|467797421|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
129955390|NCT01636778|467797422|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
129955391|NCT01636778|467797423|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
129955392|NCT01636778|467797421|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
129955393|NCT01636778|467797422|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
129955394|NCT01636778|467797423|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
129955395|NCT04853394|467797425|FG000|Follow-up Interviews|Lost to Follow-up|22|||
129955396|NCT04853394|467797426|FG001|Follow-up Interviews|Lost to Follow-up|15|||
129955397|NCT04212299|467797427|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
129955398|NCT04413149|467799225|FG000|Overall Study|Death|10|||
129955399|NCT04413149|467799226|FG001|Overall Study|Death|5|||
129955400|NCT04413149|467799225|FG000|Overall Study|Lung transplantation|1|||
129955401|NCT04413149|467799226|FG001|Overall Study|Lung transplantation|0|||
129955402|NCT00705614|467799227|FG000|Initial Intervention|Adverse Event|40|||
129955403|NCT00705614|467799228|FG001|Initial Intervention|Adverse Event|21|||
129955404|NCT00705614|467799227|FG000|Initial Intervention|Lost to Follow-up|310|||
129955405|NCT00705614|467799228|FG001|Initial Intervention|Lost to Follow-up|191|||
129955406|NCT00705614|467799227|FG000|Initial Intervention|Withdrawal by Subject|114|||
129955407|NCT00705614|467799228|FG001|Initial Intervention|Withdrawal by Subject|71|||
129955408|NCT00705614|467799227|FG000|Initial Intervention|Administrative Reason|51|||
129955409|NCT00705614|467799228|FG001|Initial Intervention|Administrative Reason|38|||
129955410|NCT00705614|467799227|FG000|Initial Intervention|Status completion unknown|3|||
129955411|NCT00705614|467799228|FG001|Initial Intervention|Status completion unknown|0|||
129955412|NCT00705614|467799227|FG000|Switch to Remicade|Adverse Event|0|||
129955413|NCT00705614|467799228|FG001|Switch to Remicade|Adverse Event|5|||
129955414|NCT00705614|467799227|FG000|Switch to Remicade|Lost to Follow-up|0|||
129955415|NCT00705614|467799228|FG001|Switch to Remicade|Lost to Follow-up|23|||
129955416|NCT00705614|467799227|FG000|Switch to Remicade|Withdrawal by Subject|0|||
129955417|NCT00705614|467799228|FG001|Switch to Remicade|Withdrawal by Subject|12|||
129955418|NCT00705614|467799227|FG000|Switch to Remicade|Administrative Reason|0|||
129955419|NCT00705614|467799228|FG001|Switch to Remicade|Administrative Reason|9|||
129955420|NCT00676195|467799231|FG000|Overall Study|Lost to Follow-up|1|||
129955421|NCT00676195|467799231|FG000|Overall Study|Adverse Event|1|||
129955422|NCT00676195|467799231|FG000|Overall Study|Physician Decision|1|||
129955423|NCT02661490|467799232|FG000|Overall Study|Lost to Follow-up|0|||
129955424|NCT02661490|467799233|FG001|Overall Study|Lost to Follow-up|1|||
129955425|NCT02661490|467799234|FG002|Overall Study|Lost to Follow-up|0|||
129955426|NCT02661490|467799235|FG003|Overall Study|Lost to Follow-up|0|||
129955427|NCT02661490|467799236|FG004|Overall Study|Lost to Follow-up|2|||
129955428|NCT02661490|467799232|FG000|Overall Study|Withdrawal by Subject|2|||
129955429|NCT02661490|467799233|FG001|Overall Study|Withdrawal by Subject|0|||
129955430|NCT02661490|467799234|FG002|Overall Study|Withdrawal by Subject|2|||
129955431|NCT02661490|467799235|FG003|Overall Study|Withdrawal by Subject|0|||
129955432|NCT02661490|467799236|FG004|Overall Study|Withdrawal by Subject|0|||
129955433|NCT02661490|467799232|FG000|Overall Study|Death|1|||
129955434|NCT02661490|467799233|FG001|Overall Study|Death|1|||
129955435|NCT02661490|467799234|FG002|Overall Study|Death|0|||
129955436|NCT02661490|467799235|FG003|Overall Study|Death|1|||
129955437|NCT02661490|467799236|FG004|Overall Study|Death|0|||
129955438|NCT02661490|467799232|FG000|Overall Study|Reason not Specified|0|||
129955439|NCT02661490|467799233|FG001|Overall Study|Reason not Specified|0|||
129955440|NCT02661490|467799234|FG002|Overall Study|Reason not Specified|0|||
129955441|NCT02661490|467799235|FG003|Overall Study|Reason not Specified|0|||
129955442|NCT02661490|467799236|FG004|Overall Study|Reason not Specified|1|||
129955443|NCT00814632|467799237|FG000|Overall Study|Lack of Efficacy|2|||
129955444|NCT05335005|467799238|FG000|Overall Study|Lost to Follow-up|1|||
129955445|NCT04050722|467799239|FG000|Overall Study|Withdrawal by Subject|1|||
129955446|NCT04050722|467799240|FG001|Overall Study|Withdrawal by Subject|0|||
129955447|NCT03087851|467799244|FG000|Overall Study|Withdraw on medical grounds|0|||
129955448|NCT03087851|467799245|FG001|Overall Study|Withdraw on medical grounds|1|||
129955449|NCT03087851|467799246|FG002|Overall Study|Withdraw on medical grounds|2|||
129955450|NCT00678899|467799252|FG000|Overall Study|Adverse Event|1|||
129955451|NCT03451292|467799253|FG000|Overall Study|Death|44|||
129955452|NCT03451292|467799254|FG001|Overall Study|Death|59|||
129955453|NCT03451292|467799253|FG000|Overall Study|Withdrawal by Subject|18|||
129955454|NCT03451292|467799254|FG001|Overall Study|Withdrawal by Subject|13|||
129955455|NCT03451292|467799253|FG000|Overall Study|Transplantation|18|||
129955456|NCT03451292|467799254|FG001|Overall Study|Transplantation|12|||
129955457|NCT03451292|467799253|FG000|Overall Study|Lost to Follow-up|4|||
129955458|NCT03451292|467799254|FG001|Overall Study|Lost to Follow-up|12|||
129955459|NCT03451292|467799253|FG000|Overall Study|Physician Decision|4|||
129955460|NCT03451292|467799254|FG001|Overall Study|Physician Decision|3|||
129955461|NCT03451292|467799253|FG000|Overall Study|Adverse Event|3|||
129955462|NCT03451292|467799254|FG001|Overall Study|Adverse Event|3|||
129955463|NCT03451292|467799253|FG000|Overall Study|Non-compliance with Study Drug|2|||
129955464|NCT03451292|467799254|FG001|Overall Study|Non-compliance with Study Drug|0|||
129955465|NCT01572493|467799262|FG000|Overall Study|Physician Decision|1|||
129955466|NCT01572493|467799263|FG001|Overall Study|Physician Decision|0|||
129955467|NCT01572493|467799264|FG002|Overall Study|Physician Decision|0|||
129955468|NCT01572493|467799265|FG003|Overall Study|Physician Decision|0|||
129955469|NCT01572493|467799266|FG004|Overall Study|Physician Decision|0|||
129955470|NCT01572493|467799267|FG005|Overall Study|Physician Decision|0|||
129955471|NCT01572493|467799268|FG006|Overall Study|Physician Decision|0|||
129955472|NCT01572493|467799269|FG007|Overall Study|Physician Decision|0|||
129955473|NCT01572493|467799270|FG008|Overall Study|Physician Decision|0|||
129955474|NCT01572493|467799262|FG000|Overall Study|Switched to alternative treatment|0|||
129955475|NCT01572493|467799263|FG001|Overall Study|Switched to alternative treatment|1|||
129955476|NCT01572493|467799264|FG002|Overall Study|Switched to alternative treatment|2|||
129955477|NCT01572493|467799265|FG003|Overall Study|Switched to alternative treatment|1|||
129955478|NCT01572493|467799266|FG004|Overall Study|Switched to alternative treatment|2|||
129955479|NCT01572493|467799267|FG005|Overall Study|Switched to alternative treatment|0|||
129955480|NCT01572493|467799268|FG006|Overall Study|Switched to alternative treatment|2|||
129955481|NCT01572493|467799269|FG007|Overall Study|Switched to alternative treatment|0|||
129955482|NCT01572493|467799270|FG008|Overall Study|Switched to alternative treatment|2|||
129955483|NCT01572493|467799262|FG000|Overall Study|Death|0|||
129955484|NCT01572493|467799263|FG001|Overall Study|Death|0|||
129955485|NCT01572493|467799264|FG002|Overall Study|Death|0|||
129955486|NCT01572493|467799265|FG003|Overall Study|Death|1|||
129955487|NCT01572493|467799266|FG004|Overall Study|Death|0|||
129955488|NCT01572493|467799267|FG005|Overall Study|Death|1|||
129955489|NCT01572493|467799268|FG006|Overall Study|Death|0|||
129955490|NCT01572493|467799269|FG007|Overall Study|Death|0|||
129955491|NCT01572493|467799270|FG008|Overall Study|Death|0|||
129955492|NCT01572493|467799262|FG000|Overall Study|Adverse Event|0|||
129955493|NCT01572493|467799263|FG001|Overall Study|Adverse Event|0|||
129955494|NCT01572493|467799264|FG002|Overall Study|Adverse Event|0|||
129955495|NCT01572493|467799265|FG003|Overall Study|Adverse Event|0|||
129955496|NCT01572493|467799266|FG004|Overall Study|Adverse Event|0|||
129955497|NCT01572493|467799267|FG005|Overall Study|Adverse Event|0|||
129955498|NCT01572493|467799268|FG006|Overall Study|Adverse Event|1|||
129955499|NCT01572493|467799269|FG007|Overall Study|Adverse Event|0|||
129955500|NCT01572493|467799270|FG008|Overall Study|Adverse Event|0|||
129955501|NCT01234675|467799271|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
129955502|NCT01234675|467799272|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
129955503|NCT01234675|467799271|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129955504|NCT01234675|467799272|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
129955505|NCT00609245|467799273|FG000|Overall Study|Adverse Event|1|||
129955506|NCT02889809|467799274|FG000|Overall Study|Withdrawal by Subject|30|||
129955507|NCT02889809|467799275|FG001|Overall Study|Withdrawal by Subject|21|||
129955508|NCT02889809|467799274|FG000|Overall Study|Lost to Follow-up|1|||
129955509|NCT02889809|467799275|FG001|Overall Study|Lost to Follow-up|1|||
129955510|NCT02889809|467799274|FG000|Overall Study|Site Closed|12|||
129955511|NCT02889809|467799275|FG001|Overall Study|Site Closed|11|||
129955512|NCT01090076|467799276|FG000|Overall Study|Death|1|||
129955513|NCT01090076|467799277|FG001|Overall Study|Death|1|||
129955514|NCT01090076|467799276|FG000|Overall Study|Withdrawal by Subject|0|||
129955515|NCT01090076|467799277|FG001|Overall Study|Withdrawal by Subject|1|||
129955516|NCT02798861|467799286|FG000|Overall Study|Lost to Follow-up|22|||
129955517|NCT02798861|467799286|FG000|Overall Study|Withdrawal by Subject|1|||
129955518|NCT02186015|467799287|FG000|Overall Study|Physician Decision|1|||
129955519|NCT02186015|467799288|FG001|Overall Study|Physician Decision|0|||
129955520|NCT00907517|467799289|FG000|Overall Study|Progressive Disease|3|||
129955521|NCT00907517|467799290|FG001|Overall Study|Progressive Disease|3|||
129955522|NCT00907517|467799291|FG002|Overall Study|Progressive Disease|4|||
129955523|NCT00907517|467799292|FG003|Overall Study|Progressive Disease|4|||
129955524|NCT00907517|467799293|FG004|Overall Study|Progressive Disease|4|||
129955525|NCT00907517|467799289|FG000|Overall Study|Symptomatic Deterioration|0|||
129955526|NCT00907517|467799290|FG001|Overall Study|Symptomatic Deterioration|0|||
129955527|NCT00907517|467799291|FG002|Overall Study|Symptomatic Deterioration|0|||
129955528|NCT00907517|467799292|FG003|Overall Study|Symptomatic Deterioration|0|||
129955529|NCT00907517|467799293|FG004|Overall Study|Symptomatic Deterioration|1|||
129955530|NCT01797705|467799295|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
129955531|NCT01797705|467799295|FG000|Overall Study|Withdrawal by Subject|1|||
129955532|NCT01838447|467799296|FG000|Overall Study|Change in surgical plan|1|||
129955533|NCT01838447|467799297|FG001|Overall Study|Change in surgical plan|2|||
129955534|NCT01838447|467799296|FG000|Overall Study|Withdrawal by Subject|1|||
129955535|NCT01838447|467799297|FG001|Overall Study|Withdrawal by Subject|1|||
129955536|NCT02030847|467799298|FG000|Overall Study|Death|10|||
129955537|NCT02030847|467799298|FG000|Overall Study|Disease Progression|15|||
129955538|NCT02030847|467799298|FG000|Overall Study|New Cancer Therapy|8|||
129955539|NCT02030847|467799298|FG000|Overall Study|Physician Decision|3|||
129955540|NCT02030847|467799298|FG000|Overall Study|Withdrawal by Subject|1|||
129955541|NCT01403805|467799301|FG000|Overall Study|Withdrawal by Subject|0|||
129955542|NCT01403805|467799302|FG001|Overall Study|Withdrawal by Subject|4|||
129955543|NCT01403805|467799301|FG000|Overall Study|Lost to Follow-up|0|||
129955544|NCT01403805|467799302|FG001|Overall Study|Lost to Follow-up|2|||
129955545|NCT01403805|467799301|FG000|Overall Study|Death|0|||
129955546|NCT01403805|467799302|FG001|Overall Study|Death|1|||
129955547|NCT01103141|467799303|FG000|Overall Study|Death|0|||
129955548|NCT01103141|467799304|FG001|Overall Study|Death|1|||
129955549|NCT01103141|467799303|FG000|Overall Study|Lost to Follow-up|2|||
129955550|NCT01103141|467799304|FG001|Overall Study|Lost to Follow-up|1|||
129955551|NCT01695993|467799305|FG000|Overall Study|Lost to Follow-up|2|||
129955552|NCT01695993|467799306|FG001|Overall Study|Lost to Follow-up|1|||
129955553|NCT01695993|467799307|FG002|Overall Study|Lost to Follow-up|3|||
129955554|NCT01695993|467799305|FG000|Overall Study|Withdrawal by Subject|2|||
129955555|NCT01695993|467799306|FG001|Overall Study|Withdrawal by Subject|2|||
129955556|NCT01695993|467799307|FG002|Overall Study|Withdrawal by Subject|2|||
129955557|NCT01695993|467799305|FG000|Overall Study|To ill to continue|1|||
129955558|NCT01695993|467799306|FG001|Overall Study|To ill to continue|2|||
129955559|NCT01695993|467799307|FG002|Overall Study|To ill to continue|0|||
129955560|NCT01695993|467799305|FG000|Overall Study|Changed Medical Facility|0|||
129955561|NCT01695993|467799306|FG001|Overall Study|Changed Medical Facility|0|||
129955562|NCT01695993|467799307|FG002|Overall Study|Changed Medical Facility|1|||
129955563|NCT02029521|467799309|FG000|Overall Study|Protocol Violation|1|||
129955564|NCT02029521|467799310|FG001|Overall Study|Protocol Violation|0|||
129955565|NCT02029521|467799309|FG000|Overall Study|Withdrawal by Subject|1|||
129955566|NCT02029521|467799310|FG001|Overall Study|Withdrawal by Subject|1|||
129955567|NCT01072396|467799311|FG000|Period One|Adverse Event|1|||
129955568|NCT01072396|467799312|FG001|Period One|Adverse Event|1|||
129955569|NCT01072396|467799311|FG000|Period One|Protocol Violation|2|||
129955570|NCT01072396|467799312|FG001|Period One|Protocol Violation|1|||
129955571|NCT01072396|467799311|FG000|Period One|Withdrawal by Subject|2|||
129955572|NCT01072396|467799312|FG001|Period One|Withdrawal by Subject|0|||
129955573|NCT01072396|467799311|FG000|Washout Period|Missing termination information|0|||
129955574|NCT01072396|467799312|FG001|Washout Period|Missing termination information|1|||
129955575|NCT01072396|467799311|FG000|Period Two|Adverse Event|0|||
129955576|NCT01072396|467799312|FG001|Period Two|Adverse Event|3|||
129955577|NCT01072396|467799311|FG000|Period Two|Lost to Follow-up|1|||
129955578|NCT01072396|467799312|FG001|Period Two|Lost to Follow-up|0|||
129955579|NCT00105521|467799313|FG000|Overall Study|Other|1|||
129955580|NCT00105521|467799314|FG001|Overall Study|Other|1|||
129955581|NCT00105521|467799315|FG002|Overall Study|Other|2|||
129955582|NCT00105521|467799316|FG003|Overall Study|Other|0|||
129955583|NCT00105521|467799313|FG000|Overall Study|Adverse Event|10|||
129955584|NCT00105521|467799314|FG001|Overall Study|Adverse Event|4|||
129955585|NCT00105521|467799315|FG002|Overall Study|Adverse Event|10|||
129955586|NCT00105521|467799316|FG003|Overall Study|Adverse Event|8|||
129955587|NCT00105521|467799313|FG000|Overall Study|Withdrawal by Subject|1|||
129955588|NCT00105521|467799314|FG001|Overall Study|Withdrawal by Subject|0|||
129955589|NCT00105521|467799315|FG002|Overall Study|Withdrawal by Subject|1|||
129955590|NCT00105521|467799316|FG003|Overall Study|Withdrawal by Subject|4|||
129955591|NCT00105521|467799313|FG000|Overall Study|Lack of Efficacy|0|||
129955592|NCT00105521|467799314|FG001|Overall Study|Lack of Efficacy|0|||
129955593|NCT00105521|467799315|FG002|Overall Study|Lack of Efficacy|0|||
129955594|NCT00105521|467799316|FG003|Overall Study|Lack of Efficacy|1|||
129955595|NCT00105521|467799313|FG000|Overall Study|Protocol Violation|3|||
129955596|NCT00105521|467799314|FG001|Overall Study|Protocol Violation|5|||
129955597|NCT00105521|467799315|FG002|Overall Study|Protocol Violation|4|||
129955598|NCT00105521|467799316|FG003|Overall Study|Protocol Violation|4|||
129955599|NCT00105521|467799313|FG000|Overall Study|Lost to Follow-up|0|||
129955600|NCT00105521|467799314|FG001|Overall Study|Lost to Follow-up|1|||
129955601|NCT00105521|467799315|FG002|Overall Study|Lost to Follow-up|0|||
129955602|NCT00105521|467799316|FG003|Overall Study|Lost to Follow-up|0|||
129955603|NCT02744898|467799317|FG000|Overall Study|Progressive Disease|2|||
129955604|NCT02744898|467799317|FG000|Overall Study|Physician Decision|1|||
129955605|NCT02744898|467799317|FG000|Overall Study|Toxicity|1|||
129955606|NCT03751280|467799328|FG000|Overall Study|Adverse Event|0|||
129955607|NCT03751280|467799329|FG001|Overall Study|Adverse Event|1|||
129955608|NCT03751280|467799328|FG000|Overall Study|Lost to Follow-up|3|||
129955609|NCT03751280|467799329|FG001|Overall Study|Lost to Follow-up|5|||
129955610|NCT03751280|467799328|FG000|Overall Study|Physician Decision|0|||
129955611|NCT03751280|467799329|FG001|Overall Study|Physician Decision|2|||
129955612|NCT03751280|467799328|FG000|Overall Study|Protocol Violation|0|||
129955613|NCT03751280|467799329|FG001|Overall Study|Protocol Violation|2|||
129955614|NCT03751280|467799328|FG000|Overall Study|Withdrawal by Subject|5|||
129955615|NCT03751280|467799329|FG001|Overall Study|Withdrawal by Subject|2|||
129955616|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
129955617|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
129955618|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Adverse Event|4|||
129955619|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Adverse Event|1|||
129955620|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
129955621|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
129955622|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Physician Decision|0|||
129955623|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Physician Decision|2|||
129955624|NCT02162771|467799336|FG000|Core Study Period (Part 2)|Death|1|||
129955625|NCT02162771|467799337|FG001|Core Study Period (Part 2)|Death|0|||
129955626|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
129955627|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
129955628|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
129955629|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
129955630|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Death|2|||
129955631|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Death|1|||
129955632|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
129955633|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
129955634|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
129955635|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
129955636|NCT02162771|467799336|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
129955637|NCT02162771|467799337|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
129955638|NCT01348763|467799338|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
129955639|NCT01348763|467799338|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
129955640|NCT01078571|467799339|FG000|Overall Study|Adverse Event|36|||
129955641|NCT01078571|467799339|FG000|Overall Study|Lack of effectiveness|36|||
129955642|NCT01078571|467799339|FG000|Overall Study|Reason not reported|21|||
129955643|NCT01078571|467799339|FG000|Overall Study|Withdrawal by Subject|12|||
129955644|NCT01078571|467799339|FG000|Overall Study|Lost to Follow-up|8|||
129955645|NCT01078571|467799339|FG000|Overall Study|Protocol Violation|2|||
129454076|NCT00807742|465959457|FG001|Overall Study|Lost to Follow-up|51|||
129955646|NCT03647709|467799343|FG000|Overall Study|Lost to Follow-up|5|||
129955647|NCT03647709|467799343|FG000|Overall Study|Physician Decision|6|||
129955648|NCT03647709|467799343|FG000|Overall Study|Withdrawal by Subject|3|||
129955649|NCT01257698|467799346|FG000|Overall Study|Protocol Violation|4|||
129955650|NCT01257698|467799347|FG001|Overall Study|Protocol Violation|0|||
129955651|NCT02038803|467799353|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
129454077|NCT00492752|465959458|FG000|Double Blind Treatment|Death|13|||
129955652|NCT02038803|467799353|FG000|Overall Study|Lost to Follow-up|1|||
129955653|NCT04372186|467799354|FG000|Overall Study|Death|24|||
129955654|NCT04372186|467799355|FG001|Overall Study|Death|11|||
129955655|NCT04372186|467799354|FG000|Overall Study|Transferred to a different facility for care|0|||
129955656|NCT04372186|467799355|FG001|Overall Study|Transferred to a different facility for care|2|||
129955657|NCT02116582|467799356|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
129955658|NCT02116582|467799356|FG000|Overall Study|Adverse Event|22|||
129955659|NCT02116582|467799356|FG000|Overall Study|Death|9|||
129955660|NCT02116582|467799356|FG000|Overall Study|Progressive Disease|148|||
129955661|NCT02116582|467799356|FG000|Overall Study|Protocol Violation|3|||
129955662|NCT02116582|467799356|FG000|Overall Study|Withdrawal by Subject|8|||
129955663|NCT02116582|467799356|FG000|Overall Study|Other: Miscellaneous|11|||
129955664|NCT02116582|467799356|FG000|Overall Study|Lost to Follow-up|1|||
129955665|NCT02116582|467799356|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
129955666|NCT03219216|467799357|FG000|Overall Study|Lost to Follow-up|0|||
129955667|NCT03219216|467799358|FG001|Overall Study|Lost to Follow-up|1|||
129955668|NCT02332824|467799359|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
129955669|NCT02332824|467799360|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129955670|NCT02332824|467799361|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129955671|NCT02332824|467799362|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129955672|NCT02332824|467799363|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
129955673|NCT02332824|467799364|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
129955674|NCT02332824|467799359|FG000|Overall Study|Voluntary Withdrawal|1|||
129955675|NCT02332824|467799360|FG001|Overall Study|Voluntary Withdrawal|0|||
129955676|NCT02332824|467799361|FG002|Overall Study|Voluntary Withdrawal|0|||
129955677|NCT02332824|467799362|FG003|Overall Study|Voluntary Withdrawal|0|||
129955678|NCT02332824|467799363|FG004|Overall Study|Voluntary Withdrawal|0|||
129955679|NCT02332824|467799364|FG005|Overall Study|Voluntary Withdrawal|0|||
129955680|NCT02332824|467799359|FG000|Overall Study|Inconvenient schedule|1|||
129955681|NCT02332824|467799360|FG001|Overall Study|Inconvenient schedule|1|||
129955682|NCT02332824|467799361|FG002|Overall Study|Inconvenient schedule|0|||
129955683|NCT02332824|467799362|FG003|Overall Study|Inconvenient schedule|0|||
129955684|NCT02332824|467799363|FG004|Overall Study|Inconvenient schedule|0|||
129955685|NCT02332824|467799364|FG005|Overall Study|Inconvenient schedule|0|||
129955686|NCT02332824|467799359|FG000|Overall Study|Transfer|0|||
129955687|NCT02332824|467799360|FG001|Overall Study|Transfer|0|||
129955688|NCT02332824|467799361|FG002|Overall Study|Transfer|1|||
129955689|NCT02332824|467799362|FG003|Overall Study|Transfer|1|||
129955690|NCT02332824|467799363|FG004|Overall Study|Transfer|0|||
129955691|NCT02332824|467799364|FG005|Overall Study|Transfer|0|||
129955692|NCT00498797|467799365|FG000|Overall Study|Withdrawal by Subject|4|||
129955693|NCT00498797|467799366|FG001|Overall Study|Withdrawal by Subject|2|||
129955694|NCT00498797|467799365|FG000|Overall Study|Adverse Event|12|||
129955695|NCT00498797|467799366|FG001|Overall Study|Adverse Event|5|||
129955696|NCT00498797|467799365|FG000|Overall Study|Condition under investigation worsened|19|||
129955697|NCT00498797|467799366|FG001|Overall Study|Condition under investigation worsened|21|||
129955698|NCT00498797|467799365|FG000|Overall Study|Other|3|||
129955699|NCT00498797|467799366|FG001|Overall Study|Other|1|||
129955700|NCT00914732|467799367|FG000|Overall Study|Lost to Follow-up|6|||
129955701|NCT00914732|467799368|FG001|Overall Study|Lost to Follow-up|7|||
129955702|NCT00914732|467799369|FG002|Overall Study|Lost to Follow-up|9|||
129955703|NCT00914732|467799367|FG000|Overall Study|Withdrawal by Subject|3|||
129955704|NCT00914732|467799368|FG001|Overall Study|Withdrawal by Subject|0|||
129955705|NCT00914732|467799369|FG002|Overall Study|Withdrawal by Subject|2|||
129955706|NCT00914732|467799367|FG000|Overall Study|Adverse Event|1|||
129955707|NCT00914732|467799368|FG001|Overall Study|Adverse Event|0|||
129955708|NCT00914732|467799369|FG002|Overall Study|Adverse Event|0|||
129955709|NCT01855399|467799370|FG000|6 Month|Lost to Follow-up|12|||
129955710|NCT01855399|467799371|FG001|6 Month|Lost to Follow-up|9|||
129955711|NCT01855399|467799370|FG000|6 Month|Withdrawal by Subject|8|||
129955712|NCT01855399|467799371|FG001|6 Month|Withdrawal by Subject|6|||
129454078|NCT00492752|465959459|FG001|Double Blind Treatment|Death|0|||
129454079|NCT00492752|465959460|FG002|Double Blind Treatment|Death|2|||
129955713|NCT01855399|467799370|FG000|12 Month|Lost to Follow-up|7|||
129955714|NCT01855399|467799371|FG001|12 Month|Lost to Follow-up|11|||
129454080|NCT00492752|465959461|FG003|Double Blind Treatment|Death|0|||
129454081|NCT00492752|465959458|FG000|Double Blind Treatment|Adverse Event|1|||
129955715|NCT03953079|467799372|FG000|Core Study|Withdrawal by Subject|1|||
129955716|NCT03953079|467799373|FG001|Core Study|Withdrawal by Subject|2|||
129454082|NCT00492752|465959459|FG001|Double Blind Treatment|Adverse Event|0|||
129955717|NCT03953079|467799374|FG002|Core Study|Withdrawal by Subject|1|||
129955718|NCT03953079|467799372|FG000|Core Study|COVID-19|0|||
129955719|NCT03953079|467799373|FG001|Core Study|COVID-19|1|||
129454083|NCT00492752|465959460|FG002|Double Blind Treatment|Adverse Event|0|||
129955720|NCT03953079|467799374|FG002|Core Study|COVID-19|0|||
129955721|NCT03953079|467799372|FG000|Core Study|Difficulties leaving the house|0|||
129955722|NCT03953079|467799373|FG001|Core Study|Difficulties leaving the house|1|||
129955723|NCT03953079|467799374|FG002|Core Study|Difficulties leaving the house|0|||
129955724|NCT03953079|467799372|FG000|Extension Study|Withdrawal by Subject|1|||
129955725|NCT03953079|467799373|FG001|Extension Study|Withdrawal by Subject|0|||
129955726|NCT03953079|467799374|FG002|Extension Study|Withdrawal by Subject|0|||
129955727|NCT03953079|467799372|FG000|Extension Study|Received Rescue Treatment|5|||
129955728|NCT03953079|467799373|FG001|Extension Study|Received Rescue Treatment|6|||
129955729|NCT03953079|467799374|FG002|Extension Study|Received Rescue Treatment|5|||
129955730|NCT04394624|467799375|FG000|Overall Study|Adverse Event|6|||
129955731|NCT04394624|467799376|FG001|Overall Study|Adverse Event|0|||
129955732|NCT04394624|467799375|FG000|Overall Study|Progressive disease|24|||
129955733|NCT04394624|467799376|FG001|Overall Study|Progressive disease|0|||
129955734|NCT04394624|467799375|FG000|Overall Study|Not related to COVID-19|1|||
129955735|NCT04394624|467799376|FG001|Overall Study|Not related to COVID-19|0|||
129955736|NCT00141271|467799382|FG000|Overall Study|Adverse Event|31|||
129955737|NCT00141271|467799383|FG001|Overall Study|Adverse Event|19|||
129955738|NCT00141271|467799384|FG002|Overall Study|Adverse Event|17|||
129955739|NCT00141271|467799382|FG000|Overall Study|Laboratory Abnormality|2|||
129955740|NCT00141271|467799383|FG001|Overall Study|Laboratory Abnormality|1|||
129955741|NCT00141271|467799384|FG002|Overall Study|Laboratory Abnormality|1|||
129955742|NCT00141271|467799382|FG000|Overall Study|Lack of Efficacy|7|||
129955743|NCT00141271|467799383|FG001|Overall Study|Lack of Efficacy|7|||
129955744|NCT00141271|467799384|FG002|Overall Study|Lack of Efficacy|3|||
129955745|NCT00141271|467799382|FG000|Overall Study|Lost to Follow-up|15|||
129955746|NCT00141271|467799383|FG001|Overall Study|Lost to Follow-up|15|||
129955747|NCT00141271|467799384|FG002|Overall Study|Lost to Follow-up|21|||
129955748|NCT00141271|467799382|FG000|Overall Study|Withdrawal by Subject|14|||
129955749|NCT00141271|467799383|FG001|Overall Study|Withdrawal by Subject|9|||
129955750|NCT00141271|467799384|FG002|Overall Study|Withdrawal by Subject|10|||
129955751|NCT00141271|467799382|FG000|Overall Study|Other|11|||
129955752|NCT00141271|467799383|FG001|Overall Study|Other|12|||
129955753|NCT00141271|467799384|FG002|Overall Study|Other|5|||
129955754|NCT02442622|467799387|FG000|Overall Study|Withdrawal by Subject|3|||
129955755|NCT02442622|467799388|FG001|Overall Study|Withdrawal by Subject|1|||
129955756|NCT02878590|467801245|FG000|Overall Study|Withdrawal by Subject|2|||
129955757|NCT03322514|467801246|FG000|Overall Study|Withdrawal by Subject|1|||
129955758|NCT03322514|467801247|FG001|Overall Study|Withdrawal by Subject|1|||
129955759|NCT01904019|467801251|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
129454084|NCT00492752|465959461|FG003|Double Blind Treatment|Adverse Event|0|||
129454085|NCT00492752|465959458|FG000|Double Blind Treatment|Protocol Violation|0|||
129955760|NCT01904019|467801251|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
129955761|NCT01904019|467801251|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
129955762|NCT01904019|467801251|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
129955763|NCT01904019|467801251|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
129454086|NCT00492752|465959459|FG001|Double Blind Treatment|Protocol Violation|0|||
129955764|NCT01904019|467801251|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
129955765|NCT02388932|467801256|FG000|Overall Study|Death|1|||
129955766|NCT01503515|467801257|FG000|Overall Study|Adverse Event|4|||
129955767|NCT01503515|467801258|FG001|Overall Study|Adverse Event|5|||
129955768|NCT01503515|467801257|FG000|Overall Study|Death|0|||
129955769|NCT01503515|467801258|FG001|Overall Study|Death|1|||
129955770|NCT01503515|467801257|FG000|Overall Study|Physician Decision|14|||
129955771|NCT01503515|467801258|FG001|Overall Study|Physician Decision|23|||
129955772|NCT01503515|467801257|FG000|Overall Study|Withdrawal by Subject|0|||
129955773|NCT01503515|467801258|FG001|Overall Study|Withdrawal by Subject|1|||
129454087|NCT00492752|465959460|FG002|Double Blind Treatment|Protocol Violation|1|||
129955774|NCT01503515|467801257|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
129955775|NCT01503515|467801258|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
129955776|NCT01503515|467801257|FG000|Overall Study|Ineligible|1|||
129955777|NCT01503515|467801258|FG001|Overall Study|Ineligible|1|||
129955778|NCT02123797|467801262|FG000|Baseline Intervention|Death|9|||
129955779|NCT02123797|467801263|FG001|Baseline Intervention|Death|16|||
129955780|NCT02123797|467801264|FG002|Baseline Intervention|Death|0|||
129955781|NCT02123797|467801265|FG003|Baseline Intervention|Death|0|||
129955782|NCT02123797|467801266|FG004|Baseline Intervention|Death|0|||
129955783|NCT02123797|467801262|FG000|Baseline Intervention|Withdrawal by Subject|2|||
129955784|NCT02123797|467801263|FG001|Baseline Intervention|Withdrawal by Subject|8|||
129955785|NCT02123797|467801264|FG002|Baseline Intervention|Withdrawal by Subject|0|||
129955786|NCT02123797|467801265|FG003|Baseline Intervention|Withdrawal by Subject|0|||
129955787|NCT02123797|467801266|FG004|Baseline Intervention|Withdrawal by Subject|0|||
129955788|NCT02123797|467801262|FG000|Baseline Intervention|Relocation|2|||
129955789|NCT02123797|467801263|FG001|Baseline Intervention|Relocation|0|||
129955790|NCT02123797|467801264|FG002|Baseline Intervention|Relocation|0|||
129955791|NCT02123797|467801265|FG003|Baseline Intervention|Relocation|0|||
129955792|NCT02123797|467801266|FG004|Baseline Intervention|Relocation|0|||
129955793|NCT02123797|467801262|FG000|Baseline Intervention|Out of window for initial survey|6|||
129955794|NCT02123797|467801263|FG001|Baseline Intervention|Out of window for initial survey|13|||
129955795|NCT02123797|467801264|FG002|Baseline Intervention|Out of window for initial survey|0|||
129955796|NCT02123797|467801265|FG003|Baseline Intervention|Out of window for initial survey|0|||
129955797|NCT02123797|467801266|FG004|Baseline Intervention|Out of window for initial survey|0|||
129955798|NCT02123797|467801262|FG000|Baseline Intervention|Lost to Follow-up|0|||
129955799|NCT02123797|467801263|FG001|Baseline Intervention|Lost to Follow-up|5|||
129955800|NCT02123797|467801264|FG002|Baseline Intervention|Lost to Follow-up|0|||
129454088|NCT00492752|465959461|FG003|Double Blind Treatment|Protocol Violation|0|||
129454089|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
129454090|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
129454091|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
129454092|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
129454093|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
129454094|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
129454095|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
129454096|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
129955801|NCT02123797|467801265|FG003|Baseline Intervention|Lost to Follow-up|0|||
129955802|NCT02123797|467801266|FG004|Baseline Intervention|Lost to Follow-up|0|||
129955803|NCT02123797|467801262|FG000|Baseline Intervention|Other Disease|3|||
129955804|NCT02123797|467801263|FG001|Baseline Intervention|Other Disease|0|||
129955805|NCT02123797|467801264|FG002|Baseline Intervention|Other Disease|0|||
129955806|NCT02123797|467801265|FG003|Baseline Intervention|Other Disease|0|||
129955807|NCT02123797|467801266|FG004|Baseline Intervention|Other Disease|0|||
129955808|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
129955809|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
129955810|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
129955811|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
129955812|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
129454097|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
129454098|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
129454099|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
129955813|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
129955814|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
129955815|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
129955816|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
129955817|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
129955818|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
129955819|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
129955820|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955821|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955822|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955823|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955824|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
129955825|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955826|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955827|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
129955828|NCT02123797|467801262|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
129955829|NCT02123797|467801263|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
129955830|NCT02123797|467801264|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
129955831|NCT02123797|467801265|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
129955832|NCT02123797|467801266|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
129955833|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
129955834|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
129955835|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
129955836|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
129955837|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
129955838|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
129955839|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
129955840|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
129955841|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
129955842|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
129955843|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
129955844|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
129955845|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955846|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955847|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
129955848|NCT02123797|467801262|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955849|NCT02123797|467801263|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
129955850|NCT02123797|467801264|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955851|NCT02123797|467801265|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955852|NCT02123797|467801266|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
129955853|NCT00443755|467801267|FG000|Overall Study|Withdrawal by Subject|2|||
129955854|NCT00443755|467801268|FG001|Overall Study|Withdrawal by Subject|1|||
129955855|NCT02339506|467801278|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
129955856|NCT02339506|467801279|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
129955857|NCT02339506|467801278|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
129955858|NCT02339506|467801279|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
129955859|NCT03997409|467801280|FG000|Overall Study|Protocol Violation|1|||
129955860|NCT03997409|467801281|FG001|Overall Study|Protocol Violation|1|||
129955861|NCT03997409|467801282|FG002|Overall Study|Protocol Violation|0|||
129955862|NCT03997409|467801280|FG000|Overall Study|Withdrawal by Subject|3|||
129955863|NCT03997409|467801281|FG001|Overall Study|Withdrawal by Subject|0|||
129955864|NCT03997409|467801282|FG002|Overall Study|Withdrawal by Subject|0|||
129955865|NCT03997409|467801280|FG000|Overall Study|Lost to Follow-up|0|||
129955866|NCT03997409|467801281|FG001|Overall Study|Lost to Follow-up|0|||
129955867|NCT03997409|467801282|FG002|Overall Study|Lost to Follow-up|1|||
129955868|NCT01753323|467801283|FG000|Overall Study|Lack of Efficacy|0|||
129955869|NCT01753323|467801284|FG001|Overall Study|Lack of Efficacy|0|||
129955870|NCT01753323|467801285|FG002|Overall Study|Lack of Efficacy|8|||
129955871|NCT01753323|467801283|FG000|Overall Study|Protocol deviation|1|||
129955872|NCT01753323|467801284|FG001|Overall Study|Protocol deviation|0|||
129955873|NCT01753323|467801285|FG002|Overall Study|Protocol deviation|0|||
129955874|NCT01753323|467801283|FG000|Overall Study|Adverse Event|0|||
129955875|NCT01753323|467801284|FG001|Overall Study|Adverse Event|0|||
129955876|NCT01753323|467801285|FG002|Overall Study|Adverse Event|1|||
129955877|NCT01116440|467801287|FG000|Treatment|Withdrawal by Subject|2|||
129955878|NCT01116440|467801288|FG001|Treatment|Withdrawal by Subject|2|||
129955879|NCT01116440|467801287|FG000|Treatment|Lost to Follow-up|1|||
129955880|NCT01116440|467801288|FG001|Treatment|Lost to Follow-up|1|||
129955881|NCT01116440|467801287|FG000|Treatment|Protocol Violation|0|||
129955882|NCT01116440|467801288|FG001|Treatment|Protocol Violation|2|||
129955883|NCT01116440|467801287|FG000|Treatment|Lack of Efficacy|0|||
129955884|NCT01116440|467801288|FG001|Treatment|Lack of Efficacy|1|||
129955885|NCT01116440|467801287|FG000|Treatment|Adverse Event|0|||
129955886|NCT01116440|467801288|FG001|Treatment|Adverse Event|1|||
129955887|NCT01116440|467801287|FG000|Withdrawal|Withdrawal by Subject|0|||
129955888|NCT01116440|467801288|FG001|Withdrawal|Withdrawal by Subject|1|||
129955889|NCT01116440|467801287|FG000|Withdrawal|Lost to Follow-up|0|||
129955890|NCT01116440|467801288|FG001|Withdrawal|Lost to Follow-up|1|||
129955891|NCT01116440|467801287|FG000|Follow-up|Lost to Follow-up|0|||
129955892|NCT01116440|467801288|FG001|Follow-up|Lost to Follow-up|1|||
129955893|NCT01116440|467801287|FG000|Follow-up|Withdrawal by Subject|0|||
129955894|NCT01116440|467801288|FG001|Follow-up|Withdrawal by Subject|1|||
129955895|NCT01636258|467801291|FG000|Overall Study|Lost to Follow-up|1|||
129955896|NCT01636258|467801292|FG001|Overall Study|Lost to Follow-up|0|||
129955897|NCT00116584|467801305|FG000|Overall Study|Withdrawal by Subject|1|||
129955898|NCT00116584|467801306|FG001|Overall Study|Withdrawal by Subject|0|||
129955899|NCT00116584|467801305|FG000|Overall Study|Protocol Violation|1|||
129955900|NCT00116584|467801306|FG001|Overall Study|Protocol Violation|1|||
129955901|NCT01498445|467801309|FG000|Overall Study|Lack of Efficacy|0|||
129955902|NCT01498445|467801310|FG001|Overall Study|Lack of Efficacy|0|||
129955903|NCT01498445|467801311|FG002|Overall Study|Lack of Efficacy|1|||
129955904|NCT01498445|467801312|FG003|Overall Study|Lack of Efficacy|2|||
129955905|NCT01498445|467801313|FG004|Overall Study|Lack of Efficacy|0|||
129955906|NCT01498445|467801314|FG005|Overall Study|Lack of Efficacy|0|||
129955907|NCT01498445|467801309|FG000|Overall Study|Screen Failure|0|||
129955908|NCT01498445|467801310|FG001|Overall Study|Screen Failure|0|||
129955909|NCT01498445|467801311|FG002|Overall Study|Screen Failure|0|||
129955910|NCT01498445|467801312|FG003|Overall Study|Screen Failure|0|||
129955911|NCT01498445|467801313|FG004|Overall Study|Screen Failure|1|||
129955912|NCT01498445|467801314|FG005|Overall Study|Screen Failure|1|||
129955913|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
129955914|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
129955915|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
129955916|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
129955917|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
129955918|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
129955919|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Other|3|||
129955920|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Other|0|||
129955921|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Other|0|||
129955922|NCT02592434|467801315|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
129955923|NCT02592434|467801316|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
129955924|NCT02592434|467801317|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
129955925|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
129955926|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
129955927|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
129955928|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
129955929|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
129955930|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
129955931|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Other|0|||
129955932|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Other|1|||
129955933|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Other|0|||
129955934|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
129955935|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
129955936|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
129955937|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
129955938|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
129955939|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
129955940|NCT02592434|467801315|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
129955941|NCT02592434|467801316|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
129955942|NCT02592434|467801317|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
129955943|NCT00561678|467801318|FG000|Overall Study|Withdrawal by Subject|4|||
129955944|NCT00561678|467801319|FG001|Overall Study|Withdrawal by Subject|3|||
129955945|NCT00561678|467801318|FG000|Overall Study|surgery cancelled|1|||
129955946|NCT00561678|467801319|FG001|Overall Study|surgery cancelled|1|||
129955947|NCT00561678|467801318|FG000|Overall Study|surgery rescheduled to different site|2|||
129955948|NCT00561678|467801319|FG001|Overall Study|surgery rescheduled to different site|2|||
129955949|NCT00561678|467801318|FG000|Overall Study|anesthesia provider refusal|1|||
129955950|NCT00561678|467801319|FG001|Overall Study|anesthesia provider refusal|0|||
129955951|NCT04748445|467801320|FG000|Overall Study|No longer met eligibility criteria|12|||
129955952|NCT04748445|467801320|FG000|Overall Study|Other|36|||
129955953|NCT04748445|467801320|FG000|Overall Study|Withdrawal by Subject|553|||
129955954|NCT04748445|467801320|FG000|Overall Study|Lost to Follow-up|30|||
129955955|NCT01106586|467801321|FG000|Overall Study|Adverse Event|9|||
129955956|NCT01106586|467801322|FG001|Overall Study|Adverse Event|15|||
129955957|NCT01106586|467801321|FG000|Overall Study|Death|1|||
129955958|NCT01106586|467801322|FG001|Overall Study|Death|3|||
129955959|NCT01106586|467801321|FG000|Overall Study|Pregnancy|2|||
129955960|NCT01106586|467801322|FG001|Overall Study|Pregnancy|2|||
129955961|NCT01106586|467801321|FG000|Overall Study|Lack of Efficacy|1|||
129955962|NCT01106586|467801322|FG001|Overall Study|Lack of Efficacy|0|||
129955963|NCT01106586|467801321|FG000|Overall Study|Investigator's Discretion|5|||
129955964|NCT01106586|467801322|FG001|Overall Study|Investigator's Discretion|8|||
129955965|NCT01106586|467801321|FG000|Overall Study|Withdrew Consent|18|||
129955966|NCT01106586|467801322|FG001|Overall Study|Withdrew Consent|30|||
129955967|NCT01106586|467801321|FG000|Overall Study|Lost to Follow-up|24|||
129955968|NCT01106586|467801322|FG001|Overall Study|Lost to Follow-up|20|||
129955969|NCT01106586|467801321|FG000|Overall Study|Participant Noncompliance|12|||
129955970|NCT01106586|467801322|FG001|Overall Study|Participant Noncompliance|10|||
129955971|NCT01106586|467801321|FG000|Overall Study|Protocol Violation|1|||
129955972|NCT01106586|467801322|FG001|Overall Study|Protocol Violation|0|||
129955973|NCT01106586|467801321|FG000|Overall Study|Participant Transferred to Another Study|212|||
129955974|NCT01106586|467801322|FG001|Overall Study|Participant Transferred to Another Study|197|||
129955975|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Adverse Event|3|||
129955976|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Adverse Event|0|||
129955977|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
129955978|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
129955979|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Disease Progression|23|||
129955980|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Disease Progression|22|||
129955981|NCT01379521|467801323|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
129955982|NCT01379521|467801324|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
129955983|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
129955984|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
129955985|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
129955986|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
129955987|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
129955988|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
129955989|NCT01379521|467801323|FG000|Overall Study -Treatment Period|Death|2|||
129955990|NCT01379521|467801324|FG001|Overall Study -Treatment Period|Death|1|||
129955991|NCT01379521|467801323|FG000|Post-Treatment Evaluations|Disease Progression|22|||
129955992|NCT01379521|467801324|FG001|Post-Treatment Evaluations|Disease Progression|20|||
129955993|NCT01379521|467801323|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
129955994|NCT01379521|467801324|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
129955995|NCT01379521|467801323|FG000|Post-Treatment Evaluations|Death|1|||
129955996|NCT01379521|467801324|FG001|Post-Treatment Evaluations|Death|0|||
129955997|NCT00938041|467801325|FG000|Overall Study|Lost to Follow-up|6|||
129955998|NCT00938041|467801325|FG000|Overall Study|Received Alternative Therapy|1|||
129955999|NCT00938041|467801325|FG000|Overall Study|Progressive Disease|5|||
129956000|NCT00938041|467801325|FG000|Overall Study|Death|12|||
129956001|NCT00938041|467801325|FG000|Overall Study|Adrenal Insufficiency|3|||
129956002|NCT01026103|467801326|FG000|Overall Study|Physician Decision|1|||
129956003|NCT01026103|467801326|FG000|Overall Study|did not receive study device bc of error|1|||
129956004|NCT00428441|467801327|FG000|Overall Study|Lost to Follow-up|1|||
129956005|NCT02475733|467801328|FG000|Overall Study|Withdrawal by Subject|1|||
129956006|NCT02475733|467801329|FG001|Overall Study|Withdrawal by Subject|0|||
129956007|NCT02475733|467801328|FG000|Overall Study|Physician Decision|1|||
129956008|NCT02475733|467801329|FG001|Overall Study|Physician Decision|0|||
129956009|NCT00404547|467801332|FG000|Overall Study|Adverse Event|39|||
129956010|NCT00404547|467801333|FG001|Overall Study|Adverse Event|6|||
129956011|NCT00404547|467801332|FG000|Overall Study|Withdrawal by Subject|19|||
129956012|NCT00404547|467801333|FG001|Overall Study|Withdrawal by Subject|2|||
129956013|NCT00404547|467801332|FG000|Overall Study|Protocol Violation|0|||
129956014|NCT00404547|467801333|FG001|Overall Study|Protocol Violation|1|||
129956015|NCT00404547|467801332|FG000|Overall Study|Lost to Follow-up|20|||
129956016|NCT00404547|467801333|FG001|Overall Study|Lost to Follow-up|9|||
129956017|NCT00404547|467801332|FG000|Overall Study|Lack of compliance|5|||
129956018|NCT00404547|467801333|FG001|Overall Study|Lack of compliance|1|||
129956019|NCT00404547|467801332|FG000|Overall Study|Other|4|||
129956020|NCT00404547|467801333|FG001|Overall Study|Other|0|||
129956021|NCT00404547|467801332|FG000|Overall Study|Reason not stated|3|||
129956022|NCT00404547|467801333|FG001|Overall Study|Reason not stated|6|||
129956023|NCT03906240|467801334|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
129956024|NCT03906240|467801335|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
129956025|NCT03906240|467801334|FG000|Overall Study|Lost to Follow-up|1|||
129956026|NCT03906240|467801335|FG001|Overall Study|Lost to Follow-up|0|||
129956027|NCT03906240|467801334|FG000|Overall Study|Withdrawal by Subject|0|||
129956028|NCT03906240|467801335|FG001|Overall Study|Withdrawal by Subject|1|||
129956029|NCT00296504|467801340|FG000|Interim Analysis|Withdrawal by Subject|8|||
129956030|NCT00296504|467801341|FG001|Interim Analysis|Withdrawal by Subject|0|||
129956031|NCT00296504|467801342|FG002|Interim Analysis|Withdrawal by Subject|12|||
129956032|NCT00296504|467801343|FG003|Interim Analysis|Withdrawal by Subject|0|||
129956033|NCT00296504|467801344|FG004|Interim Analysis|Withdrawal by Subject|5|||
129956034|NCT00296504|467801345|FG005|Interim Analysis|Withdrawal by Subject|5|||
129956035|NCT00296504|467801346|FG006|Interim Analysis|Withdrawal by Subject|9|||
129956036|NCT00296504|467801347|FG007|Interim Analysis|Withdrawal by Subject|3|||
129956037|NCT00296504|467801348|FG008|Interim Analysis|Withdrawal by Subject|0|||
129956038|NCT00296504|467801340|FG000|Interim Analysis|Lost to Follow-up|13|||
129956039|NCT00296504|467801341|FG001|Interim Analysis|Lost to Follow-up|3|||
129956040|NCT00296504|467801342|FG002|Interim Analysis|Lost to Follow-up|26|||
129956041|NCT00296504|467801343|FG003|Interim Analysis|Lost to Follow-up|8|||
129956042|NCT00296504|467801344|FG004|Interim Analysis|Lost to Follow-up|14|||
129956043|NCT00296504|467801345|FG005|Interim Analysis|Lost to Follow-up|4|||
129956044|NCT00296504|467801346|FG006|Interim Analysis|Lost to Follow-up|11|||
129956045|NCT00296504|467801347|FG007|Interim Analysis|Lost to Follow-up|4|||
129454100|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
129454101|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
129956046|NCT00296504|467801348|FG008|Interim Analysis|Lost to Follow-up|0|||
129956047|NCT00296504|467801340|FG000|Interim Analysis|Clinical Progression|1|||
129956048|NCT00296504|467801341|FG001|Interim Analysis|Clinical Progression|0|||
129956049|NCT00296504|467801342|FG002|Interim Analysis|Clinical Progression|1|||
129956050|NCT00296504|467801343|FG003|Interim Analysis|Clinical Progression|1|||
129956051|NCT00296504|467801344|FG004|Interim Analysis|Clinical Progression|0|||
129956052|NCT00296504|467801345|FG005|Interim Analysis|Clinical Progression|2|||
129956053|NCT00296504|467801346|FG006|Interim Analysis|Clinical Progression|1|||
129956054|NCT00296504|467801347|FG007|Interim Analysis|Clinical Progression|2|||
129956055|NCT00296504|467801348|FG008|Interim Analysis|Clinical Progression|0|||
129956056|NCT00296504|467801340|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
129956057|NCT00296504|467801341|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
129956058|NCT00296504|467801342|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
129956059|NCT00296504|467801343|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
129956060|NCT00296504|467801344|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
129956061|NCT00296504|467801345|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
129956062|NCT00296504|467801346|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
129956063|NCT00296504|467801347|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
129956064|NCT00296504|467801348|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
129956065|NCT00296504|467801340|FG000|Interim Analysis|Adverse Event|0|||
129956066|NCT00296504|467801341|FG001|Interim Analysis|Adverse Event|0|||
129956067|NCT00296504|467801342|FG002|Interim Analysis|Adverse Event|13|||
129956068|NCT00296504|467801343|FG003|Interim Analysis|Adverse Event|4|||
129956069|NCT00296504|467801344|FG004|Interim Analysis|Adverse Event|6|||
129956070|NCT00296504|467801345|FG005|Interim Analysis|Adverse Event|3|||
129956071|NCT00296504|467801346|FG006|Interim Analysis|Adverse Event|4|||
129956072|NCT00296504|467801347|FG007|Interim Analysis|Adverse Event|5|||
129956073|NCT00296504|467801348|FG008|Interim Analysis|Adverse Event|0|||
129956074|NCT00296504|467801340|FG000|Interim Analysis|Protocol Violation|0|||
129956075|NCT00296504|467801341|FG001|Interim Analysis|Protocol Violation|0|||
129956076|NCT00296504|467801342|FG002|Interim Analysis|Protocol Violation|2|||
129956077|NCT00296504|467801343|FG003|Interim Analysis|Protocol Violation|0|||
129956078|NCT00296504|467801344|FG004|Interim Analysis|Protocol Violation|1|||
129956079|NCT00296504|467801345|FG005|Interim Analysis|Protocol Violation|0|||
129956080|NCT00296504|467801346|FG006|Interim Analysis|Protocol Violation|0|||
129956081|NCT00296504|467801347|FG007|Interim Analysis|Protocol Violation|1|||
129956082|NCT00296504|467801348|FG008|Interim Analysis|Protocol Violation|0|||
129956083|NCT00296504|467801340|FG000|Interim Analysis|Insufficient CD4 Response|0|||
129956084|NCT00296504|467801341|FG001|Interim Analysis|Insufficient CD4 Response|0|||
129956085|NCT00296504|467801342|FG002|Interim Analysis|Insufficient CD4 Response|0|||
129956086|NCT00296504|467801343|FG003|Interim Analysis|Insufficient CD4 Response|0|||
129956087|NCT00296504|467801344|FG004|Interim Analysis|Insufficient CD4 Response|1|||
129956088|NCT00296504|467801345|FG005|Interim Analysis|Insufficient CD4 Response|1|||
129956089|NCT00296504|467801346|FG006|Interim Analysis|Insufficient CD4 Response|0|||
129956090|NCT00296504|467801347|FG007|Interim Analysis|Insufficient CD4 Response|0|||
129956091|NCT00296504|467801348|FG008|Interim Analysis|Insufficient CD4 Response|0|||
129956092|NCT00296504|467801340|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
129956093|NCT00296504|467801341|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
129956094|NCT00296504|467801342|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
129956095|NCT00296504|467801343|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
129956096|NCT00296504|467801344|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
129956097|NCT00296504|467801345|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
129956098|NCT00296504|467801346|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
129956099|NCT00296504|467801347|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
129956100|NCT00296504|467801348|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
129956101|NCT00296504|467801340|FG000|Interim Analysis|Pregnancy|4|||
129956102|NCT00296504|467801341|FG001|Interim Analysis|Pregnancy|1|||
129956103|NCT00296504|467801342|FG002|Interim Analysis|Pregnancy|4|||
129956104|NCT00296504|467801343|FG003|Interim Analysis|Pregnancy|2|||
129956105|NCT00296504|467801344|FG004|Interim Analysis|Pregnancy|0|||
129956106|NCT00296504|467801345|FG005|Interim Analysis|Pregnancy|1|||
129956107|NCT00296504|467801346|FG006|Interim Analysis|Pregnancy|1|||
129956108|NCT00296504|467801347|FG007|Interim Analysis|Pregnancy|1|||
129956109|NCT00296504|467801348|FG008|Interim Analysis|Pregnancy|0|||
129956110|NCT00296504|467801340|FG000|Interim Analysis|Death|1|||
129956111|NCT00296504|467801341|FG001|Interim Analysis|Death|0|||
129956112|NCT00296504|467801342|FG002|Interim Analysis|Death|3|||
129956113|NCT00296504|467801343|FG003|Interim Analysis|Death|0|||
129956114|NCT00296504|467801344|FG004|Interim Analysis|Death|0|||
129956115|NCT00296504|467801345|FG005|Interim Analysis|Death|0|||
129956116|NCT00296504|467801346|FG006|Interim Analysis|Death|0|||
129956117|NCT00296504|467801347|FG007|Interim Analysis|Death|0|||
129956118|NCT00296504|467801348|FG008|Interim Analysis|Death|0|||
129956119|NCT00296504|467801340|FG000|Interim Analysis|Participant Non-compliant|0|||
129956120|NCT00296504|467801341|FG001|Interim Analysis|Participant Non-compliant|1|||
129956121|NCT00296504|467801342|FG002|Interim Analysis|Participant Non-compliant|2|||
129956122|NCT00296504|467801343|FG003|Interim Analysis|Participant Non-compliant|1|||
129956123|NCT00296504|467801344|FG004|Interim Analysis|Participant Non-compliant|1|||
129956124|NCT00296504|467801345|FG005|Interim Analysis|Participant Non-compliant|3|||
129956125|NCT00296504|467801346|FG006|Interim Analysis|Participant Non-compliant|6|||
129956126|NCT00296504|467801347|FG007|Interim Analysis|Participant Non-compliant|2|||
129956127|NCT00296504|467801348|FG008|Interim Analysis|Participant Non-compliant|0|||
129956128|NCT00296504|467801340|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956129|NCT00296504|467801341|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956130|NCT00296504|467801342|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
129956131|NCT00296504|467801343|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956132|NCT00296504|467801344|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956133|NCT00296504|467801345|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
129956134|NCT00296504|467801346|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956135|NCT00296504|467801347|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956136|NCT00296504|467801348|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
129956137|NCT00296504|467801340|FG000|Interim Analysis|To Simplify Treatment|0|||
129956138|NCT00296504|467801341|FG001|Interim Analysis|To Simplify Treatment|0|||
129956139|NCT00296504|467801342|FG002|Interim Analysis|To Simplify Treatment|1|||
129956140|NCT00296504|467801343|FG003|Interim Analysis|To Simplify Treatment|0|||
129956141|NCT00296504|467801344|FG004|Interim Analysis|To Simplify Treatment|0|||
129956142|NCT00296504|467801345|FG005|Interim Analysis|To Simplify Treatment|0|||
129956143|NCT00296504|467801346|FG006|Interim Analysis|To Simplify Treatment|2|||
129956144|NCT00296504|467801347|FG007|Interim Analysis|To Simplify Treatment|0|||
129956145|NCT00296504|467801348|FG008|Interim Analysis|To Simplify Treatment|0|||
129956146|NCT00296504|467801340|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956147|NCT00296504|467801341|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956148|NCT00296504|467801342|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
129956149|NCT00296504|467801343|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956150|NCT00296504|467801344|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956151|NCT00296504|467801345|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956152|NCT00296504|467801346|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956153|NCT00296504|467801347|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956154|NCT00296504|467801348|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
129956155|NCT00296504|467801340|FG000|Interim Analysis|Participant Moved|1|||
129956156|NCT00296504|467801341|FG001|Interim Analysis|Participant Moved|0|||
129956157|NCT00296504|467801342|FG002|Interim Analysis|Participant Moved|1|||
129956158|NCT00296504|467801343|FG003|Interim Analysis|Participant Moved|0|||
129956159|NCT00296504|467801344|FG004|Interim Analysis|Participant Moved|0|||
129956160|NCT00296504|467801345|FG005|Interim Analysis|Participant Moved|1|||
129956161|NCT00296504|467801346|FG006|Interim Analysis|Participant Moved|1|||
129956162|NCT00296504|467801347|FG007|Interim Analysis|Participant Moved|0|||
129956163|NCT00296504|467801348|FG008|Interim Analysis|Participant Moved|0|||
129956164|NCT00296504|467801340|FG000|Interim Analysis|Participant Was Incarcerated|2|||
129956165|NCT00296504|467801341|FG001|Interim Analysis|Participant Was Incarcerated|0|||
129956166|NCT00296504|467801342|FG002|Interim Analysis|Participant Was Incarcerated|1|||
129956167|NCT00296504|467801343|FG003|Interim Analysis|Participant Was Incarcerated|0|||
129956168|NCT00296504|467801344|FG004|Interim Analysis|Participant Was Incarcerated|0|||
129956169|NCT00296504|467801345|FG005|Interim Analysis|Participant Was Incarcerated|0|||
129956170|NCT00296504|467801346|FG006|Interim Analysis|Participant Was Incarcerated|0|||
129956171|NCT00296504|467801347|FG007|Interim Analysis|Participant Was Incarcerated|0|||
129956172|NCT00296504|467801348|FG008|Interim Analysis|Participant Was Incarcerated|0|||
129956173|NCT00296504|467801340|FG000|Interim Analysis|Resistance to FPV|0|||
129956174|NCT00296504|467801341|FG001|Interim Analysis|Resistance to FPV|0|||
129956175|NCT00296504|467801342|FG002|Interim Analysis|Resistance to FPV|1|||
129956176|NCT00296504|467801343|FG003|Interim Analysis|Resistance to FPV|0|||
129956177|NCT00296504|467801344|FG004|Interim Analysis|Resistance to FPV|0|||
129956178|NCT00296504|467801345|FG005|Interim Analysis|Resistance to FPV|0|||
129956179|NCT00296504|467801346|FG006|Interim Analysis|Resistance to FPV|0|||
129956180|NCT00296504|467801347|FG007|Interim Analysis|Resistance to FPV|0|||
129956181|NCT00296504|467801348|FG008|Interim Analysis|Resistance to FPV|0|||
129956182|NCT00296504|467801340|FG000|Interim Analysis|Physician Decision|0|||
129956183|NCT00296504|467801341|FG001|Interim Analysis|Physician Decision|0|||
129956184|NCT00296504|467801342|FG002|Interim Analysis|Physician Decision|1|||
129956185|NCT00296504|467801343|FG003|Interim Analysis|Physician Decision|0|||
129956186|NCT00296504|467801344|FG004|Interim Analysis|Physician Decision|0|||
129956187|NCT00296504|467801345|FG005|Interim Analysis|Physician Decision|0|||
129956188|NCT00296504|467801346|FG006|Interim Analysis|Physician Decision|0|||
129956189|NCT00296504|467801347|FG007|Interim Analysis|Physician Decision|0|||
129956190|NCT00296504|467801348|FG008|Interim Analysis|Physician Decision|0|||
129956191|NCT00296504|467801340|FG000|Interim Analysis|Principle Investigator Discretion|2|||
129956192|NCT00296504|467801341|FG001|Interim Analysis|Principle Investigator Discretion|0|||
129956193|NCT00296504|467801342|FG002|Interim Analysis|Principle Investigator Discretion|1|||
129956194|NCT00296504|467801343|FG003|Interim Analysis|Principle Investigator Discretion|1|||
129956195|NCT00296504|467801344|FG004|Interim Analysis|Principle Investigator Discretion|0|||
129956196|NCT00296504|467801345|FG005|Interim Analysis|Principle Investigator Discretion|0|||
129956197|NCT00296504|467801346|FG006|Interim Analysis|Principle Investigator Discretion|0|||
129956198|NCT00296504|467801347|FG007|Interim Analysis|Principle Investigator Discretion|0|||
129956199|NCT00296504|467801348|FG008|Interim Analysis|Principle Investigator Discretion|0|||
129956200|NCT00296504|467801340|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
129956201|NCT00296504|467801341|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
129956202|NCT00296504|467801342|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
129956203|NCT00296504|467801343|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
129956204|NCT00296504|467801344|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
129956205|NCT00296504|467801345|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
129956206|NCT00296504|467801346|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
129956207|NCT00296504|467801347|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
129956208|NCT00296504|467801348|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
129956209|NCT00296504|467801340|FG000|Interim Analysis|Non-adherence|2|||
129956210|NCT00296504|467801341|FG001|Interim Analysis|Non-adherence|0|||
129956211|NCT00296504|467801342|FG002|Interim Analysis|Non-adherence|0|||
129956212|NCT00296504|467801343|FG003|Interim Analysis|Non-adherence|0|||
129956213|NCT00296504|467801344|FG004|Interim Analysis|Non-adherence|1|||
129956214|NCT00296504|467801345|FG005|Interim Analysis|Non-adherence|0|||
129956215|NCT00296504|467801346|FG006|Interim Analysis|Non-adherence|0|||
129956216|NCT00296504|467801347|FG007|Interim Analysis|Non-adherence|1|||
129956217|NCT00296504|467801348|FG008|Interim Analysis|Non-adherence|0|||
129956218|NCT00296504|467801340|FG000|Interim Analysis|Site Closing|1|||
129956219|NCT00296504|467801341|FG001|Interim Analysis|Site Closing|0|||
129956220|NCT00296504|467801342|FG002|Interim Analysis|Site Closing|0|||
129956221|NCT00296504|467801343|FG003|Interim Analysis|Site Closing|0|||
129956222|NCT00296504|467801344|FG004|Interim Analysis|Site Closing|0|||
129956223|NCT00296504|467801345|FG005|Interim Analysis|Site Closing|1|||
129956224|NCT00296504|467801346|FG006|Interim Analysis|Site Closing|2|||
129956225|NCT00296504|467801347|FG007|Interim Analysis|Site Closing|0|||
129956226|NCT00296504|467801348|FG008|Interim Analysis|Site Closing|0|||
129956227|NCT00296504|467801340|FG000|Interim Analysis|Lack of Personnel at Site|1|||
129956228|NCT00296504|467801341|FG001|Interim Analysis|Lack of Personnel at Site|0|||
129956229|NCT00296504|467801342|FG002|Interim Analysis|Lack of Personnel at Site|0|||
129956230|NCT00296504|467801343|FG003|Interim Analysis|Lack of Personnel at Site|0|||
129956231|NCT00296504|467801344|FG004|Interim Analysis|Lack of Personnel at Site|0|||
129956232|NCT00296504|467801345|FG005|Interim Analysis|Lack of Personnel at Site|0|||
129956233|NCT00296504|467801346|FG006|Interim Analysis|Lack of Personnel at Site|0|||
129956234|NCT00296504|467801347|FG007|Interim Analysis|Lack of Personnel at Site|0|||
129956235|NCT00296504|467801348|FG008|Interim Analysis|Lack of Personnel at Site|0|||
129956236|NCT00296504|467801340|FG000|Interim Analysis|Missed Schedule Date|1|||
129956237|NCT00296504|467801341|FG001|Interim Analysis|Missed Schedule Date|0|||
129956238|NCT00296504|467801342|FG002|Interim Analysis|Missed Schedule Date|0|||
129956239|NCT00296504|467801343|FG003|Interim Analysis|Missed Schedule Date|0|||
129956240|NCT00296504|467801344|FG004|Interim Analysis|Missed Schedule Date|0|||
129956241|NCT00296504|467801345|FG005|Interim Analysis|Missed Schedule Date|0|||
129956242|NCT00296504|467801346|FG006|Interim Analysis|Missed Schedule Date|0|||
129956243|NCT00296504|467801347|FG007|Interim Analysis|Missed Schedule Date|0|||
129956244|NCT00296504|467801348|FG008|Interim Analysis|Missed Schedule Date|0|||
129956245|NCT00296504|467801340|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
129956246|NCT00296504|467801341|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
129956247|NCT00296504|467801342|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
129956248|NCT00296504|467801343|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
129956249|NCT00296504|467801344|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
129956250|NCT00296504|467801345|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
129956251|NCT00296504|467801346|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
129956252|NCT00296504|467801347|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
129956253|NCT00296504|467801348|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
129956254|NCT00296504|467801340|FG000|Interim Analysis|Participant Stopped|0|||
129956255|NCT00296504|467801341|FG001|Interim Analysis|Participant Stopped|0|||
129956256|NCT00296504|467801342|FG002|Interim Analysis|Participant Stopped|0|||
129956257|NCT00296504|467801343|FG003|Interim Analysis|Participant Stopped|0|||
129956258|NCT00296504|467801344|FG004|Interim Analysis|Participant Stopped|1|||
129956259|NCT00296504|467801345|FG005|Interim Analysis|Participant Stopped|0|||
129956260|NCT00296504|467801346|FG006|Interim Analysis|Participant Stopped|0|||
129956261|NCT00296504|467801347|FG007|Interim Analysis|Participant Stopped|0|||
129956262|NCT00296504|467801348|FG008|Interim Analysis|Participant Stopped|0|||
129956263|NCT00296504|467801340|FG000|Interim Analysis|Physician and Participant Decision|0|||
129956264|NCT00296504|467801341|FG001|Interim Analysis|Physician and Participant Decision|0|||
129956265|NCT00296504|467801342|FG002|Interim Analysis|Physician and Participant Decision|0|||
129956266|NCT00296504|467801343|FG003|Interim Analysis|Physician and Participant Decision|0|||
129956267|NCT00296504|467801344|FG004|Interim Analysis|Physician and Participant Decision|0|||
129956268|NCT00296504|467801345|FG005|Interim Analysis|Physician and Participant Decision|1|||
129956269|NCT00296504|467801346|FG006|Interim Analysis|Physician and Participant Decision|0|||
129956270|NCT00296504|467801347|FG007|Interim Analysis|Physician and Participant Decision|0|||
129956271|NCT00296504|467801348|FG008|Interim Analysis|Physician and Participant Decision|0|||
129956272|NCT00296504|467801340|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
129956273|NCT00296504|467801341|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
129956274|NCT00296504|467801342|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
129956275|NCT00296504|467801343|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
129956276|NCT00296504|467801344|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
129956277|NCT00296504|467801345|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
129956278|NCT00296504|467801346|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
129956279|NCT00296504|467801347|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
129956280|NCT00296504|467801348|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
129956281|NCT00296504|467801340|FG000|Interim Analysis|Study Ended|0|||
129956282|NCT00296504|467801341|FG001|Interim Analysis|Study Ended|0|||
129956283|NCT00296504|467801342|FG002|Interim Analysis|Study Ended|0|||
129956284|NCT00296504|467801343|FG003|Interim Analysis|Study Ended|0|||
129956285|NCT00296504|467801344|FG004|Interim Analysis|Study Ended|0|||
129956286|NCT00296504|467801345|FG005|Interim Analysis|Study Ended|0|||
129956287|NCT00296504|467801346|FG006|Interim Analysis|Study Ended|1|||
129956288|NCT00296504|467801347|FG007|Interim Analysis|Study Ended|0|||
129956289|NCT00296504|467801348|FG008|Interim Analysis|Study Ended|0|||
129956290|NCT00296504|467801340|FG000|Interim Analysis|Participant Needed Interferon|0|||
129956291|NCT00296504|467801341|FG001|Interim Analysis|Participant Needed Interferon|0|||
129956292|NCT00296504|467801342|FG002|Interim Analysis|Participant Needed Interferon|0|||
129956293|NCT00296504|467801343|FG003|Interim Analysis|Participant Needed Interferon|0|||
129956294|NCT00296504|467801344|FG004|Interim Analysis|Participant Needed Interferon|0|||
129956295|NCT00296504|467801345|FG005|Interim Analysis|Participant Needed Interferon|0|||
129956296|NCT00296504|467801346|FG006|Interim Analysis|Participant Needed Interferon|0|||
129956297|NCT00296504|467801347|FG007|Interim Analysis|Participant Needed Interferon|1|||
129956298|NCT00296504|467801348|FG008|Interim Analysis|Participant Needed Interferon|0|||
129956299|NCT00296504|467801340|FG000|Interim Analysis|Ongoing|32|||
129956300|NCT00296504|467801341|FG001|Interim Analysis|Ongoing|12|||
129956301|NCT00296504|467801342|FG002|Interim Analysis|Ongoing|16|||
129956302|NCT00296504|467801343|FG003|Interim Analysis|Ongoing|22|||
129956303|NCT00296504|467801344|FG004|Interim Analysis|Ongoing|0|||
129956304|NCT00296504|467801345|FG005|Interim Analysis|Ongoing|0|||
129956305|NCT00296504|467801346|FG006|Interim Analysis|Ongoing|30|||
129956306|NCT00296504|467801347|FG007|Interim Analysis|Ongoing|1|||
129956307|NCT00296504|467801348|FG008|Interim Analysis|Ongoing|0|||
129956308|NCT00296504|467801340|FG000|Final Analysis|Withdrawal by Subject|0|||
129956309|NCT00296504|467801341|FG001|Final Analysis|Withdrawal by Subject|0|||
129956310|NCT00296504|467801342|FG002|Final Analysis|Withdrawal by Subject|0|||
129956311|NCT00296504|467801343|FG003|Final Analysis|Withdrawal by Subject|0|||
129956312|NCT00296504|467801344|FG004|Final Analysis|Withdrawal by Subject|0|||
129956313|NCT00296504|467801345|FG005|Final Analysis|Withdrawal by Subject|0|||
129956314|NCT00296504|467801346|FG006|Final Analysis|Withdrawal by Subject|0|||
129956315|NCT00296504|467801347|FG007|Final Analysis|Withdrawal by Subject|0|||
129956316|NCT00296504|467801348|FG008|Final Analysis|Withdrawal by Subject|1|||
129956317|NCT00296504|467801340|FG000|Final Analysis|Lost to Follow-up|0|||
129956318|NCT00296504|467801341|FG001|Final Analysis|Lost to Follow-up|0|||
129956319|NCT00296504|467801342|FG002|Final Analysis|Lost to Follow-up|0|||
129956320|NCT00296504|467801343|FG003|Final Analysis|Lost to Follow-up|0|||
129956321|NCT00296504|467801344|FG004|Final Analysis|Lost to Follow-up|0|||
129956322|NCT00296504|467801345|FG005|Final Analysis|Lost to Follow-up|0|||
129956323|NCT00296504|467801346|FG006|Final Analysis|Lost to Follow-up|0|||
129956324|NCT00296504|467801347|FG007|Final Analysis|Lost to Follow-up|0|||
129956325|NCT00296504|467801348|FG008|Final Analysis|Lost to Follow-up|5|||
129956326|NCT00296504|467801340|FG000|Final Analysis|Insufficient Viral Load Response|0|||
129956327|NCT00296504|467801341|FG001|Final Analysis|Insufficient Viral Load Response|0|||
129956328|NCT00296504|467801342|FG002|Final Analysis|Insufficient Viral Load Response|0|||
129956329|NCT00296504|467801343|FG003|Final Analysis|Insufficient Viral Load Response|0|||
129956330|NCT00296504|467801344|FG004|Final Analysis|Insufficient Viral Load Response|0|||
129956331|NCT00296504|467801345|FG005|Final Analysis|Insufficient Viral Load Response|0|||
129956332|NCT00296504|467801346|FG006|Final Analysis|Insufficient Viral Load Response|0|||
129956333|NCT00296504|467801347|FG007|Final Analysis|Insufficient Viral Load Response|0|||
129956334|NCT00296504|467801348|FG008|Final Analysis|Insufficient Viral Load Response|6|||
129956335|NCT00296504|467801340|FG000|Final Analysis|Adverse Event|0|||
129956336|NCT00296504|467801341|FG001|Final Analysis|Adverse Event|0|||
129956337|NCT00296504|467801342|FG002|Final Analysis|Adverse Event|0|||
129956338|NCT00296504|467801343|FG003|Final Analysis|Adverse Event|0|||
129956339|NCT00296504|467801344|FG004|Final Analysis|Adverse Event|0|||
129956340|NCT00296504|467801345|FG005|Final Analysis|Adverse Event|0|||
129956341|NCT00296504|467801346|FG006|Final Analysis|Adverse Event|0|||
129956342|NCT00296504|467801347|FG007|Final Analysis|Adverse Event|0|||
129956343|NCT00296504|467801348|FG008|Final Analysis|Adverse Event|2|||
129956344|NCT00296504|467801340|FG000|Final Analysis|Pregnancy|0|||
129956345|NCT00296504|467801341|FG001|Final Analysis|Pregnancy|0|||
129956346|NCT00296504|467801342|FG002|Final Analysis|Pregnancy|0|||
129956347|NCT00296504|467801343|FG003|Final Analysis|Pregnancy|0|||
129956348|NCT00296504|467801344|FG004|Final Analysis|Pregnancy|0|||
129956349|NCT00296504|467801345|FG005|Final Analysis|Pregnancy|0|||
129956350|NCT00296504|467801346|FG006|Final Analysis|Pregnancy|0|||
129956351|NCT00296504|467801347|FG007|Final Analysis|Pregnancy|0|||
129956352|NCT00296504|467801348|FG008|Final Analysis|Pregnancy|4|||
129956353|NCT00296504|467801340|FG000|Final Analysis|Tuberculosis|0|||
129956354|NCT00296504|467801341|FG001|Final Analysis|Tuberculosis|0|||
129956355|NCT00296504|467801342|FG002|Final Analysis|Tuberculosis|0|||
129956356|NCT00296504|467801343|FG003|Final Analysis|Tuberculosis|0|||
129956357|NCT00296504|467801344|FG004|Final Analysis|Tuberculosis|0|||
129956358|NCT00296504|467801345|FG005|Final Analysis|Tuberculosis|0|||
129956359|NCT00296504|467801346|FG006|Final Analysis|Tuberculosis|0|||
129956360|NCT00296504|467801347|FG007|Final Analysis|Tuberculosis|0|||
129956361|NCT00296504|467801348|FG008|Final Analysis|Tuberculosis|1|||
129956362|NCT00296504|467801340|FG000|Final Analysis|Participant Moved to Another Country|0|||
129956363|NCT00296504|467801341|FG001|Final Analysis|Participant Moved to Another Country|0|||
129956364|NCT00296504|467801342|FG002|Final Analysis|Participant Moved to Another Country|0|||
129956365|NCT00296504|467801343|FG003|Final Analysis|Participant Moved to Another Country|0|||
129956366|NCT00296504|467801344|FG004|Final Analysis|Participant Moved to Another Country|0|||
129956367|NCT00296504|467801345|FG005|Final Analysis|Participant Moved to Another Country|0|||
129956368|NCT00296504|467801346|FG006|Final Analysis|Participant Moved to Another Country|0|||
129956369|NCT00296504|467801347|FG007|Final Analysis|Participant Moved to Another Country|0|||
129956370|NCT00296504|467801348|FG008|Final Analysis|Participant Moved to Another Country|1|||
129956371|NCT00296504|467801340|FG000|Final Analysis|Poor Adherence|0|||
129956372|NCT00296504|467801341|FG001|Final Analysis|Poor Adherence|0|||
129956373|NCT00296504|467801342|FG002|Final Analysis|Poor Adherence|0|||
129956374|NCT00296504|467801343|FG003|Final Analysis|Poor Adherence|0|||
129454102|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
129454103|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
129454104|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
129454105|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
129454106|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
129454107|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
129454108|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
129454109|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
129454110|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
129454111|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
129454112|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
129454113|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
129454114|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
129454115|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
129454116|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
129454117|NCT00492752|465959458|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
129454118|NCT00492752|465959459|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
129454119|NCT00492752|465959460|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
129454120|NCT00492752|465959461|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
129454121|NCT01357655|465959462|FG000|Overall Study|Administrative Reason by Sponsor|45|||
129454122|NCT01357655|465959463|FG001|Overall Study|Administrative Reason by Sponsor|0|||
129454123|NCT01357655|465959462|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
129454124|NCT01357655|465959463|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
129454125|NCT01357655|465959462|FG000|Overall Study|Disease Progression|1|||
129956375|NCT00296504|467801344|FG004|Final Analysis|Poor Adherence|0|||
129956376|NCT00296504|467801345|FG005|Final Analysis|Poor Adherence|0|||
129956377|NCT00296504|467801346|FG006|Final Analysis|Poor Adherence|0|||
129956378|NCT00296504|467801347|FG007|Final Analysis|Poor Adherence|0|||
129956379|NCT00296504|467801348|FG008|Final Analysis|Poor Adherence|1|||
129956380|NCT00449033|467801353|FG000|Treatment Period|Adverse Event|117|||
129956381|NCT00449033|467801354|FG001|Treatment Period|Adverse Event|83|||
129956382|NCT00449033|467801353|FG000|Treatment Period|Death|21|||
129956383|NCT00449033|467801354|FG001|Treatment Period|Death|12|||
129956384|NCT00449033|467801353|FG000|Treatment Period|Lost to Follow-up|0|||
129956385|NCT00449033|467801354|FG001|Treatment Period|Lost to Follow-up|2|||
129956386|NCT00449033|467801353|FG000|Treatment Period|Physician Decision|4|||
129956387|NCT00449033|467801354|FG001|Treatment Period|Physician Decision|5|||
129956388|NCT00449033|467801353|FG000|Treatment Period|Protocol Violation|8|||
129956389|NCT00449033|467801354|FG001|Treatment Period|Protocol Violation|7|||
129956390|NCT00449033|467801353|FG000|Treatment Period|Disease Progression|231|||
129956391|NCT00449033|467801354|FG001|Treatment Period|Disease Progression|288|||
129956392|NCT00449033|467801353|FG000|Treatment Period|Consent Withdrawn|36|||
129956393|NCT00449033|467801354|FG001|Treatment Period|Consent Withdrawn|20|||
129956394|NCT00449033|467801353|FG000|Treatment Period|Amended Protocol Criteria|22|||
129956395|NCT00449033|467801354|FG001|Treatment Period|Amended Protocol Criteria|18|||
129956396|NCT00449033|467801353|FG000|Treatment Period|Non-compliance|7|||
129956397|NCT00449033|467801354|FG001|Treatment Period|Non-compliance|8|||
129956398|NCT00449033|467801353|FG000|Treatment Period|Second Malignancy|0|||
129956399|NCT00449033|467801354|FG001|Treatment Period|Second Malignancy|1|||
129956400|NCT00449033|467801353|FG000|Treatment Period|Reason Missing|0|||
129956401|NCT00449033|467801354|FG001|Treatment Period|Reason Missing|4|||
129956402|NCT00449033|467801353|FG000|Treatment Period|Treatment Ongoing|6|||
129956403|NCT00449033|467801354|FG001|Treatment Period|Treatment Ongoing|4|||
129956404|NCT00449033|467801353|FG000|Follow-up Period|Death|299|||
129956405|NCT00449033|467801354|FG001|Follow-up Period|Death|311|||
129956406|NCT00449033|467801353|FG000|Follow-up Period|Lost to Follow-up|6|||
129956407|NCT00449033|467801354|FG001|Follow-up Period|Lost to Follow-up|10|||
129454126|NCT01357655|465959463|FG001|Overall Study|Disease Progression|0|||
129454127|NCT01357655|465959462|FG000|Overall Study|Lost to Follow-up|2|||
129454128|NCT01357655|465959463|FG001|Overall Study|Lost to Follow-up|0|||
129454129|NCT01357655|465959462|FG000|Overall Study|Maximum Clinical Benefit|2|||
129454130|NCT01357655|465959463|FG001|Overall Study|Maximum Clinical Benefit|0|||
129454131|NCT01357655|465959462|FG000|Overall Study|Reason Unspecified|1|||
129454132|NCT01357655|465959463|FG001|Overall Study|Reason Unspecified|0|||
129956408|NCT00449033|467801353|FG000|Follow-up Period|Reason Missing|120|||
129956409|NCT00449033|467801354|FG001|Follow-up Period|Reason Missing|113|||
129956410|NCT04393779|467801355|FG000|Overall Study|Death|1|||
129956411|NCT04393779|467801355|FG000|Overall Study|Device reintervention or explant|4|||
129956412|NCT01190228|467801356|FG000|Overall Study|Protocol Violation|4|||
129956413|NCT01190228|467801357|FG001|Overall Study|Protocol Violation|0|||
129956414|NCT01190228|467801358|FG002|Overall Study|Protocol Violation|0|||
129454133|NCT01357655|465959462|FG000|Overall Study|Study Drug Toxicity|11|||
129454134|NCT01357655|465959463|FG001|Overall Study|Study Drug Toxicity|0|||
129454135|NCT01357655|465959462|FG000|Overall Study|Subject Withdrew Consent|1|||
129454136|NCT01357655|465959463|FG001|Overall Study|Subject Withdrew Consent|0|||
129454137|NCT00219284|465959464|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
129454138|NCT00219284|465959465|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
129454139|NCT00219284|465959464|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
129454140|NCT00219284|465959465|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
129956415|NCT01190228|467801356|FG000|Overall Study|Withdrawal by Subject|1|||
129956416|NCT01190228|467801357|FG001|Overall Study|Withdrawal by Subject|0|||
129956417|NCT01190228|467801358|FG002|Overall Study|Withdrawal by Subject|0|||
129956418|NCT02588027|467801359|FG000|Overall Study|Withdrawal by Subject|1|||
129956419|NCT02588027|467801360|FG001|Overall Study|Withdrawal by Subject|3|||
129956420|NCT02588027|467801359|FG000|Overall Study|Protocol Violation|4|||
129956421|NCT02588027|467801360|FG001|Overall Study|Protocol Violation|1|||
129956422|NCT03840148|467801363|FG000|Study Drug Disposition|Adverse Event|13|||
129956423|NCT03840148|467801364|FG001|Study Drug Disposition|Adverse Event|2|||
129956424|NCT03840148|467801363|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
129956425|NCT03840148|467801364|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
129956426|NCT03840148|467801363|FG000|Study Drug Disposition|Lack of Efficacy|3|||
129956427|NCT03840148|467801364|FG001|Study Drug Disposition|Lack of Efficacy|0|||
129956428|NCT03840148|467801363|FG000|Study Drug Disposition|Physician Decision|2|||
129956429|NCT03840148|467801364|FG001|Study Drug Disposition|Physician Decision|0|||
129956430|NCT03840148|467801363|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
129956431|NCT03840148|467801364|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
129956432|NCT03840148|467801363|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
129956433|NCT03840148|467801364|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
129956434|NCT03840148|467801363|FG000|Study Completion Disposition|Physician Decision|2|||
129956435|NCT03840148|467801364|FG001|Study Completion Disposition|Physician Decision|0|||
129956436|NCT03840148|467801363|FG000|Study Completion Disposition|Covid-19 related|2|||
129956437|NCT03840148|467801364|FG001|Study Completion Disposition|Covid-19 related|0|||
129956438|NCT03840148|467801363|FG000|Study Completion Disposition|Lost to Follow-up|1|||
129956439|NCT03840148|467801364|FG001|Study Completion Disposition|Lost to Follow-up|1|||
129956440|NCT03840148|467801363|FG000|Study Completion Disposition|Death|1|||
129956441|NCT03840148|467801364|FG001|Study Completion Disposition|Death|0|||
129956442|NCT03840148|467801363|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
129956443|NCT03840148|467801364|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
129956444|NCT03615404|467801365|FG000|Overall Study|Death|1|||
129956445|NCT03615404|467801365|FG000|Overall Study|vaccine did not pass quality assurance|1|||
129956446|NCT01774929|467801366|FG000|Overall Study|Adverse Event|3|||
129956447|NCT00603278|467801368|FG000|Overall Study|Lack of Efficacy|35|||
129956448|NCT00603278|467801369|FG001|Overall Study|Lack of Efficacy|10|||
129956449|NCT00603278|467801370|FG002|Overall Study|Lack of Efficacy|11|||
129956450|NCT00603278|467801371|FG003|Overall Study|Lack of Efficacy|8|||
129956451|NCT00603278|467801372|FG004|Overall Study|Lack of Efficacy|7|||
129956452|NCT00603278|467801373|FG005|Overall Study|Lack of Efficacy|14|||
129956453|NCT00603278|467801368|FG000|Overall Study|Adverse Event|0|||
129956454|NCT00603278|467801369|FG001|Overall Study|Adverse Event|3|||
129956455|NCT00603278|467801370|FG002|Overall Study|Adverse Event|1|||
129956456|NCT00603278|467801371|FG003|Overall Study|Adverse Event|0|||
129956457|NCT00603278|467801372|FG004|Overall Study|Adverse Event|2|||
129454141|NCT00219284|465959464|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
129454142|NCT00219284|465959465|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
129454143|NCT00219284|465959464|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
129454144|NCT00219284|465959465|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
129454145|NCT00219284|465959464|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
129956458|NCT00603278|467801373|FG005|Overall Study|Adverse Event|1|||
129956459|NCT00603278|467801368|FG000|Overall Study|Withdrawal by Subject|2|||
129956460|NCT00603278|467801369|FG001|Overall Study|Withdrawal by Subject|3|||
129956461|NCT00603278|467801370|FG002|Overall Study|Withdrawal by Subject|1|||
129956462|NCT00603278|467801371|FG003|Overall Study|Withdrawal by Subject|2|||
129956463|NCT00603278|467801372|FG004|Overall Study|Withdrawal by Subject|1|||
129956464|NCT00603278|467801373|FG005|Overall Study|Withdrawal by Subject|2|||
129956465|NCT00603278|467801368|FG000|Overall Study|Protocol Violation|3|||
129956466|NCT00603278|467801369|FG001|Overall Study|Protocol Violation|0|||
129956467|NCT00603278|467801370|FG002|Overall Study|Protocol Violation|1|||
129956468|NCT00603278|467801371|FG003|Overall Study|Protocol Violation|1|||
129956469|NCT00603278|467801372|FG004|Overall Study|Protocol Violation|0|||
129956470|NCT00603278|467801373|FG005|Overall Study|Protocol Violation|1|||
129956471|NCT00603278|467801368|FG000|Overall Study|Physician Decision|0|||
129956472|NCT00603278|467801369|FG001|Overall Study|Physician Decision|1|||
129956473|NCT00603278|467801370|FG002|Overall Study|Physician Decision|0|||
129956474|NCT00603278|467801371|FG003|Overall Study|Physician Decision|0|||
129956475|NCT00603278|467801372|FG004|Overall Study|Physician Decision|2|||
129956476|NCT00603278|467801373|FG005|Overall Study|Physician Decision|1|||
129956477|NCT00603278|467801368|FG000|Overall Study|Lost to Follow-up|1|||
129956478|NCT00603278|467801369|FG001|Overall Study|Lost to Follow-up|0|||
129956479|NCT00603278|467801370|FG002|Overall Study|Lost to Follow-up|0|||
129956480|NCT00603278|467801371|FG003|Overall Study|Lost to Follow-up|0|||
129956481|NCT00603278|467801372|FG004|Overall Study|Lost to Follow-up|1|||
129956482|NCT00603278|467801373|FG005|Overall Study|Lost to Follow-up|0|||
129956483|NCT00990821|467801380|FG000|Overall Study|Withdrawal by Subject|0|||
129956484|NCT00990821|467801381|FG001|Overall Study|Withdrawal by Subject|2|||
129956485|NCT00990821|467801382|FG002|Overall Study|Withdrawal by Subject|0|||
129956486|NCT00990821|467801383|FG003|Overall Study|Withdrawal by Subject|0|||
129956487|NCT00990821|467801384|FG004|Overall Study|Withdrawal by Subject|3|||
129956488|NCT00990821|467801385|FG005|Overall Study|Withdrawal by Subject|3|||
129956489|NCT00990821|467801386|FG006|Overall Study|Withdrawal by Subject|1|||
129956490|NCT00990821|467801387|FG007|Overall Study|Withdrawal by Subject|0|||
129956491|NCT00990821|467801388|FG008|Overall Study|Withdrawal by Subject|0|||
129956492|NCT00990821|467801389|FG009|Overall Study|Withdrawal by Subject|1|||
129956493|NCT00990821|467801390|FG010|Overall Study|Withdrawal by Subject|3|||
129956494|NCT00990821|467801391|FG011|Overall Study|Withdrawal by Subject|5|||
129956495|NCT00990821|467801392|FG012|Overall Study|Withdrawal by Subject|2|||
129956496|NCT00990821|467801393|FG013|Overall Study|Withdrawal by Subject|1|||
129956497|NCT04150250|467801394|FG000|Overall Study|Lost to Follow-up|0|||
129956498|NCT04150250|467801395|FG001|Overall Study|Lost to Follow-up|2|||
129956499|NCT01786551|467801396|FG000|Overall Study|Participant withdrew consent|2|||
129956500|NCT00308113|467801398|FG000|Overall Study|Protocol closure|0|||
129956501|NCT00308113|467801399|FG001|Overall Study|Protocol closure|0|||
129956502|NCT00308113|467801400|FG002|Overall Study|Protocol closure|0|||
129956503|NCT00308113|467801401|FG003|Overall Study|Protocol closure|1|||
129956504|NCT01123642|467801404|FG000|Overall Study|Lost to Follow-up|23|||
129956505|NCT01123642|467801404|FG000|Overall Study|Withdrawal by Subject|9|||
129956506|NCT01123642|467801404|FG000|Overall Study|ineligible at baseline assessment|36|||
129956507|NCT01184859|467802943|FG000|Period 1: Single Dose|Insufficient urine production|0|||
129956508|NCT01184859|467802944|FG001|Period 1: Single Dose|Insufficient urine production|1|||
129956509|NCT01184859|467802945|FG002|Period 1: Single Dose|Insufficient urine production|0|||
129956510|NCT01184859|467802946|FG003|Period 1: Single Dose|Insufficient urine production|0|||
129956511|NCT01184859|467802947|FG004|Period 1: Single Dose|Insufficient urine production|0|||
129956512|NCT01184859|467802943|FG000|Period 1: Single Dose|Protocol Violation|0|||
129956513|NCT01184859|467802944|FG001|Period 1: Single Dose|Protocol Violation|1|||
129956514|NCT01184859|467802945|FG002|Period 1: Single Dose|Protocol Violation|0|||
129956515|NCT01184859|467802946|FG003|Period 1: Single Dose|Protocol Violation|0|||
129956516|NCT01184859|467802947|FG004|Period 1: Single Dose|Protocol Violation|0|||
129956517|NCT01184859|467802943|FG000|Period 1: Single Dose|Adverse Event|0|||
129956518|NCT01184859|467802944|FG001|Period 1: Single Dose|Adverse Event|0|||
129956519|NCT01184859|467802945|FG002|Period 1: Single Dose|Adverse Event|0|||
129956520|NCT01184859|467802946|FG003|Period 1: Single Dose|Adverse Event|0|||
129956521|NCT01184859|467802947|FG004|Period 1: Single Dose|Adverse Event|1|||
129956522|NCT01184859|467802943|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956523|NCT01184859|467802944|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956524|NCT01184859|467802945|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956525|NCT01184859|467802946|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
129956526|NCT01184859|467802947|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
129956527|NCT01184859|467802943|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
129956528|NCT01184859|467802944|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956529|NCT01184859|467802945|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956530|NCT01184859|467802946|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956531|NCT01184859|467802947|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
129956532|NCT00961298|467802948|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
129956533|NCT00961298|467802948|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
129956534|NCT00961298|467802948|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
129956535|NCT01232569|467802949|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
129956536|NCT01232569|467802950|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129956537|NCT01232569|467802951|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129956538|NCT01232569|467802952|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
129956539|NCT01232569|467802949|FG000|Double-blind Treatment Period|Escape|2|||
129956540|NCT01232569|467802950|FG001|Double-blind Treatment Period|Escape|2|||
129956541|NCT01232569|467802951|FG002|Double-blind Treatment Period|Escape|0|||
129956542|NCT01232569|467802952|FG003|Double-blind Treatment Period|Escape|0|||
129956543|NCT01232569|467802949|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
129956544|NCT01232569|467802950|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129956545|NCT01232569|467802951|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129956546|NCT01232569|467802952|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
129956547|NCT01232569|467802949|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
129956548|NCT01232569|467802950|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
129956549|NCT01232569|467802951|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
129956550|NCT01232569|467802952|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
129956551|NCT01232569|467802949|FG000|Double-blind Treatment Period|Physician Decision|1|||
129956552|NCT01232569|467802950|FG001|Double-blind Treatment Period|Physician Decision|0|||
129956553|NCT01232569|467802951|FG002|Double-blind Treatment Period|Physician Decision|0|||
129956554|NCT01232569|467802952|FG003|Double-blind Treatment Period|Physician Decision|0|||
129956555|NCT01232569|467802949|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
129956556|NCT01232569|467802950|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
129956557|NCT01232569|467802951|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
129956558|NCT01232569|467802952|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
129956559|NCT01232569|467802949|FG000|Double-blind Treatment Period|Death|2|||
129956560|NCT01232569|467802950|FG001|Double-blind Treatment Period|Death|0|||
129956561|NCT01232569|467802951|FG002|Double-blind Treatment Period|Death|0|||
129956562|NCT01232569|467802952|FG003|Double-blind Treatment Period|Death|0|||
129956563|NCT04044352|467802953|FG000|Overall Study|Lost to Follow-up|9|||
129956564|NCT04044352|467802953|FG000|Overall Study|Withdrawal by Subject|2|||
129956565|NCT00651937|467802954|FG000|Overall Study|Withdrawal by Subject|4|||
129956566|NCT00651937|467802955|FG001|Overall Study|Withdrawal by Subject|1|||
129956567|NCT01537120|467802965|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
129956568|NCT01537120|467802965|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
129956569|NCT02514577|467802966|FG000|Overall Study|Lost to Follow-up|6|||
129956570|NCT02514577|467802967|FG001|Overall Study|Lost to Follow-up|6|||
129956571|NCT02514577|467802966|FG000|Overall Study|Protocol Violation|1|||
129956572|NCT02514577|467802967|FG001|Overall Study|Protocol Violation|0|||
129956573|NCT02514577|467802966|FG000|Overall Study|Withdrawal by Subject|6|||
129956574|NCT02514577|467802967|FG001|Overall Study|Withdrawal by Subject|6|||
129956575|NCT02514577|467802966|FG000|Overall Study|Adverse Event|1|||
129956576|NCT02514577|467802967|FG001|Overall Study|Adverse Event|1|||
129956577|NCT04816708|467802970|FG000|Overall Study|Lost to Follow-up|10|||
129956578|NCT04816708|467802971|FG001|Overall Study|Lost to Follow-up|4|||
129956579|NCT03568708|467802972|FG000|Overall Study|Withdrawal by Subject|1|||
129956580|NCT03568708|467802973|FG001|Overall Study|Withdrawal by Subject|1|||
129956581|NCT03568708|467802972|FG000|Overall Study|Lost to Follow-up|0|||
129956582|NCT03568708|467802973|FG001|Overall Study|Lost to Follow-up|1|||
129956583|NCT00511147|467802974|FG000|Overall Study|Withdrawal by Subject|1|||
129956584|NCT00511147|467802974|FG000|Overall Study|Disease progression|5|||
129956585|NCT00511147|467802974|FG000|Overall Study|Required platelet transfusion|1|||
129956586|NCT00809783|467802975|FG000|Overall Study|Death|1|||
129956587|NCT00809783|467802976|FG001|Overall Study|Death|0|||
129956588|NCT00809783|467802977|FG002|Overall Study|Death|0|||
129956589|NCT00809783|467802975|FG000|Overall Study|Adverse Event|34|||
129956590|NCT00809783|467802976|FG001|Overall Study|Adverse Event|52|||
129956591|NCT00809783|467802977|FG002|Overall Study|Adverse Event|71|||
129956592|NCT00809783|467802975|FG000|Overall Study|Lack of Efficacy|39|||
129956593|NCT00809783|467802976|FG001|Overall Study|Lack of Efficacy|52|||
129956594|NCT00809783|467802977|FG002|Overall Study|Lack of Efficacy|63|||
129956595|NCT00809783|467802975|FG000|Overall Study|Lost to Follow-up|0|||
129956596|NCT00809783|467802976|FG001|Overall Study|Lost to Follow-up|3|||
129956597|NCT00809783|467802977|FG002|Overall Study|Lost to Follow-up|4|||
129956598|NCT00809783|467802975|FG000|Overall Study|Withdrawal by Subject|47|||
129956599|NCT00809783|467802976|FG001|Overall Study|Withdrawal by Subject|72|||
129956600|NCT00809783|467802977|FG002|Overall Study|Withdrawal by Subject|64|||
129956601|NCT00809783|467802975|FG000|Overall Study|Protocol Violation|2|||
129956602|NCT00809783|467802976|FG001|Overall Study|Protocol Violation|6|||
129956603|NCT00809783|467802977|FG002|Overall Study|Protocol Violation|5|||
129956604|NCT00809783|467802975|FG000|Overall Study|Randomized, but not treated|3|||
129956605|NCT00809783|467802976|FG001|Overall Study|Randomized, but not treated|0|||
129956606|NCT00809783|467802977|FG002|Overall Study|Randomized, but not treated|2|||
129956607|NCT00809783|467802975|FG000|Overall Study|Study Terminated by Sponsor|378|||
129956608|NCT00809783|467802976|FG001|Overall Study|Study Terminated by Sponsor|626|||
129956609|NCT00809783|467802977|FG002|Overall Study|Study Terminated by Sponsor|565|||
129956610|NCT00809783|467802975|FG000|Overall Study|Other|21|||
129956611|NCT00809783|467802976|FG001|Overall Study|Other|21|||
129956612|NCT00809783|467802977|FG002|Overall Study|Other|16|||
129956613|NCT00126555|467802978|FG000|Overall Study|Withdrawal by Subject|1|||
129956614|NCT00126555|467802978|FG000|Overall Study|Adverse Event|2|||
129956615|NCT00126555|467802978|FG000|Overall Study|Progressive Disease|3|||
129956616|NCT03132753|467802981|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
129956617|NCT03132753|467802982|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
129956618|NCT03132753|467802981|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
129956619|NCT03132753|467802982|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
129956620|NCT00125853|467802983|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
129956621|NCT00125853|467802984|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
129956622|NCT02350127|467802985|FG000|4-Month Assessment|Withdrawal by Subject|10|||
129956623|NCT02350127|467802986|FG001|4-Month Assessment|Withdrawal by Subject|9|||
129956624|NCT02350127|467802985|FG000|4-Month Assessment|Death|1|||
129956625|NCT02350127|467802986|FG001|4-Month Assessment|Death|0|||
129956626|NCT02350127|467802985|FG000|8-Month Assessment|Death|1|||
129956627|NCT02350127|467802986|FG001|8-Month Assessment|Death|1|||
129956628|NCT02350127|467802985|FG000|8-Month Assessment|Withdrawal by Subject|5|||
129956629|NCT02350127|467802986|FG001|8-Month Assessment|Withdrawal by Subject|8|||
129956630|NCT01446042|467802989|FG000|Overall Study|Withdrawal by Subject|12|||
129956631|NCT01446042|467802990|FG001|Overall Study|Withdrawal by Subject|2|||
129956632|NCT01446042|467802991|FG002|Overall Study|Withdrawal by Subject|4|||
129956633|NCT01446042|467802989|FG000|Overall Study|Adverse Event|1|||
129956634|NCT01446042|467802990|FG001|Overall Study|Adverse Event|0|||
129956635|NCT01446042|467802991|FG002|Overall Study|Adverse Event|4|||
129956636|NCT01446042|467802989|FG000|Overall Study|Lost to Follow-up|5|||
129956637|NCT01446042|467802990|FG001|Overall Study|Lost to Follow-up|0|||
129956638|NCT01446042|467802991|FG002|Overall Study|Lost to Follow-up|0|||
129956639|NCT01446042|467802989|FG000|Overall Study|Other reasons|2|||
129956640|NCT01446042|467802990|FG001|Overall Study|Other reasons|1|||
129956641|NCT01446042|467802991|FG002|Overall Study|Other reasons|1|||
129956642|NCT03575572|467802993|FG000|Overall Study|Withdrawal by Subject|2|||
129956643|NCT03575572|467802993|FG000|Overall Study|Physician Decision|2|||
129956644|NCT00157209|467802994|FG000|Overall Study|Ongoing at data cut-off|10|||
129956645|NCT00157209|467802995|FG001|Overall Study|Ongoing at data cut-off|0|||
129956646|NCT03802513|467803006|FG000|Overall Study|Lost to Follow-up|1|||
129956647|NCT01770509|467803010|FG000|Overall Study|Injury|0|||
129956648|NCT01770509|467803011|FG001|Overall Study|Injury|1|||
129956649|NCT01770509|467803010|FG000|Overall Study|Lost to Follow-up|1|||
129956650|NCT01770509|467803011|FG001|Overall Study|Lost to Follow-up|2|||
129956651|NCT03928821|467803012|FG000|Overall Study|Death|0|||
129956652|NCT03928821|467803013|FG001|Overall Study|Death|1|||
129956653|NCT03928821|467803014|FG002|Overall Study|Death|0|||
129956654|NCT03928821|467803015|FG003|Overall Study|Death|0|||
129956655|NCT03928821|467803012|FG000|Overall Study|Lost to Follow-up|0|||
129956656|NCT03928821|467803013|FG001|Overall Study|Lost to Follow-up|2|||
129956657|NCT03928821|467803014|FG002|Overall Study|Lost to Follow-up|3|||
129956658|NCT03928821|467803015|FG003|Overall Study|Lost to Follow-up|0|||
129956659|NCT03928821|467803012|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129956660|NCT03928821|467803013|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129956661|NCT03928821|467803014|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
129956662|NCT03928821|467803015|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
129956663|NCT00985621|467803020|FG000|Overall Study|Adverse Event|2|||
129956664|NCT00985621|467803021|FG001|Overall Study|Adverse Event|3|||
129956665|NCT00985621|467803022|FG002|Overall Study|Adverse Event|4|||
129956666|NCT00985621|467803023|FG003|Overall Study|Adverse Event|16|||
129956667|NCT00985621|467803020|FG000|Overall Study|Lack of Efficacy|10|||
129956668|NCT00985621|467803021|FG001|Overall Study|Lack of Efficacy|6|||
129956669|NCT00985621|467803022|FG002|Overall Study|Lack of Efficacy|5|||
129956670|NCT00985621|467803023|FG003|Overall Study|Lack of Efficacy|12|||
129956671|NCT00985621|467803020|FG000|Overall Study|Lost to Follow-up|2|||
129956672|NCT00985621|467803021|FG001|Overall Study|Lost to Follow-up|3|||
129956673|NCT00985621|467803022|FG002|Overall Study|Lost to Follow-up|4|||
129956674|NCT00985621|467803023|FG003|Overall Study|Lost to Follow-up|4|||
129956675|NCT00985621|467803020|FG000|Overall Study|Study Terminated by Sponsor|89|||
129956676|NCT00985621|467803021|FG001|Overall Study|Study Terminated by Sponsor|108|||
129956677|NCT00985621|467803022|FG002|Overall Study|Study Terminated by Sponsor|99|||
129956678|NCT00985621|467803023|FG003|Overall Study|Study Terminated by Sponsor|92|||
129956679|NCT00985621|467803020|FG000|Overall Study|Protocol Violation|1|||
129956680|NCT00985621|467803021|FG001|Overall Study|Protocol Violation|1|||
129956681|NCT00985621|467803022|FG002|Overall Study|Protocol Violation|1|||
129956682|NCT00985621|467803023|FG003|Overall Study|Protocol Violation|0|||
129956683|NCT00985621|467803020|FG000|Overall Study|Withdrawal by Subject|8|||
129956684|NCT00985621|467803021|FG001|Overall Study|Withdrawal by Subject|10|||
129956685|NCT00985621|467803022|FG002|Overall Study|Withdrawal by Subject|8|||
129956686|NCT00985621|467803023|FG003|Overall Study|Withdrawal by Subject|12|||
129956687|NCT00985621|467803020|FG000|Overall Study|Other|1|||
129956688|NCT00985621|467803021|FG001|Overall Study|Other|0|||
129956689|NCT00985621|467803022|FG002|Overall Study|Other|0|||
129956690|NCT00985621|467803023|FG003|Overall Study|Other|0|||
129956691|NCT00985621|467803020|FG000|Overall Study|Randomized but not Treated|1|||
129956692|NCT00985621|467803021|FG001|Overall Study|Randomized but not Treated|0|||
129956693|NCT00985621|467803022|FG002|Overall Study|Randomized but not Treated|2|||
129956694|NCT00985621|467803023|FG003|Overall Study|Randomized but not Treated|1|||
129956695|NCT01911819|467803024|FG000|Overall Study|Adverse Event|0|||
129956696|NCT01911819|467803025|FG001|Overall Study|Adverse Event|1|||
129956697|NCT01911819|467803026|FG002|Overall Study|Adverse Event|0|||
129956698|NCT01911819|467803024|FG000|Overall Study|Withdrawal by Subject|1|||
129956699|NCT01911819|467803025|FG001|Overall Study|Withdrawal by Subject|1|||
129956700|NCT01911819|467803026|FG002|Overall Study|Withdrawal by Subject|0|||
129956701|NCT04374253|467803027|FG000|Overall Study|Adverse Event|0|||
129956702|NCT04374253|467803028|FG001|Overall Study|Adverse Event|26|||
129956703|NCT04374253|467803029|FG002|Overall Study|Adverse Event|2|||
129956704|NCT04374253|467803030|FG003|Overall Study|Adverse Event|12|||
129956705|NCT04374253|467803027|FG000|Overall Study|Study terminated by sponsor|13|||
129956706|NCT04374253|467803028|FG001|Overall Study|Study terminated by sponsor|593|||
129956707|NCT04374253|467803029|FG002|Overall Study|Study terminated by sponsor|21|||
129956708|NCT04374253|467803030|FG003|Overall Study|Study terminated by sponsor|567|||
129956709|NCT04374253|467803027|FG000|Overall Study|Withdrawal by Subject|0|||
129956710|NCT04374253|467803028|FG001|Overall Study|Withdrawal by Subject|55|||
129956711|NCT04374253|467803029|FG002|Overall Study|Withdrawal by Subject|3|||
129956712|NCT04374253|467803030|FG003|Overall Study|Withdrawal by Subject|40|||
129956713|NCT04374253|467803027|FG000|Overall Study|Physician Decision|1|||
129956714|NCT04374253|467803028|FG001|Overall Study|Physician Decision|10|||
129956715|NCT04374253|467803029|FG002|Overall Study|Physician Decision|1|||
129956716|NCT04374253|467803030|FG003|Overall Study|Physician Decision|10|||
129956717|NCT04374253|467803027|FG000|Overall Study|Protocol Violation|0|||
129956718|NCT04374253|467803028|FG001|Overall Study|Protocol Violation|0|||
129956719|NCT04374253|467803029|FG002|Overall Study|Protocol Violation|0|||
129956720|NCT04374253|467803030|FG003|Overall Study|Protocol Violation|2|||
129956721|NCT04374253|467803027|FG000|Overall Study|Death|0|||
129956722|NCT04374253|467803028|FG001|Overall Study|Death|3|||
129956723|NCT04374253|467803029|FG002|Overall Study|Death|1|||
129956724|NCT04374253|467803030|FG003|Overall Study|Death|1|||
129956725|NCT04374253|467803027|FG000|Overall Study|Lack of Efficacy|0|||
129956726|NCT04374253|467803028|FG001|Overall Study|Lack of Efficacy|0|||
129956727|NCT04374253|467803029|FG002|Overall Study|Lack of Efficacy|0|||
129956728|NCT04374253|467803030|FG003|Overall Study|Lack of Efficacy|1|||
129956729|NCT04374253|467803027|FG000|Overall Study|Lost to Follow-up|1|||
129956730|NCT04374253|467803028|FG001|Overall Study|Lost to Follow-up|1|||
129956731|NCT04374253|467803029|FG002|Overall Study|Lost to Follow-up|0|||
129956732|NCT04374253|467803030|FG003|Overall Study|Lost to Follow-up|2|||
129956733|NCT04374253|467803027|FG000|Overall Study|Reason Not Specified|0|||
129956734|NCT04374253|467803028|FG001|Overall Study|Reason Not Specified|8|||
129956735|NCT04374253|467803029|FG002|Overall Study|Reason Not Specified|0|||
129956736|NCT04374253|467803030|FG003|Overall Study|Reason Not Specified|8|||
129956737|NCT01207453|467803031|FG000|First Intervention|Adverse Event|2|||
129956738|NCT01207453|467803032|FG001|First Intervention|Adverse Event|1|||
129956739|NCT01207453|467803031|FG000|Washout|Adverse Event|1|||
129956740|NCT01207453|467803032|FG001|Washout|Adverse Event|0|||
129956741|NCT01207453|467803031|FG000|Washout|Lost to Follow-up|1|||
129956742|NCT01207453|467803032|FG001|Washout|Lost to Follow-up|0|||
129956743|NCT01207453|467803031|FG000|2nd Intervention|Adverse Event|1|||
129956744|NCT01207453|467803032|FG001|2nd Intervention|Adverse Event|2|||
129956745|NCT01207453|467803031|FG000|2nd Intervention|Lost to Follow-up|1|||
129956746|NCT01207453|467803032|FG001|2nd Intervention|Lost to Follow-up|0|||
129956747|NCT00676663|467803033|FG000|Overall Study|Death|43|||
129956748|NCT00676663|467803034|FG001|Overall Study|Death|27|||
129956749|NCT00676663|467803033|FG000|Overall Study|Withdrew Consent|1|||
129956750|NCT00676663|467803034|FG001|Overall Study|Withdrew Consent|8|||
129956751|NCT00676663|467803033|FG000|Overall Study|Lost to Follow-up|1|||
129956752|NCT00676663|467803034|FG001|Overall Study|Lost to Follow-up|3|||
129956753|NCT00580047|467803035|FG000|Overall Study|Lost to Follow-up|1|||
129956754|NCT00580047|467803036|FG001|Overall Study|Lost to Follow-up|1|||
129956755|NCT00580047|467803037|FG002|Overall Study|Lost to Follow-up|0|||
129956756|NCT00580047|467803035|FG000|Overall Study|Withdrawal by Subject|1|||
129956757|NCT00580047|467803036|FG001|Overall Study|Withdrawal by Subject|1|||
129956758|NCT00580047|467803037|FG002|Overall Study|Withdrawal by Subject|2|||
129956759|NCT00580047|467803035|FG000|Overall Study|Withdrawal by Subject|1|||
129956760|NCT00580047|467803036|FG001|Overall Study|Withdrawal by Subject|0|||
129956761|NCT00580047|467803037|FG002|Overall Study|Withdrawal by Subject|0|||
129956762|NCT04382053|467803043|FG000|Overall Study|Death|6|||
129956763|NCT04382053|467803044|FG001|Overall Study|Death|8|||
129956764|NCT04382053|467803043|FG000|Overall Study|Lost to Follow-up|0|||
129956765|NCT04382053|467803044|FG001|Overall Study|Lost to Follow-up|2|||
129956766|NCT04382053|467803043|FG000|Overall Study|Protocol Deviation|1|||
129956767|NCT04382053|467803044|FG001|Overall Study|Protocol Deviation|2|||
129956768|NCT04382053|467803043|FG000|Overall Study|Withdrawal by Subject|2|||
129956769|NCT04382053|467803044|FG001|Overall Study|Withdrawal by Subject|1|||
129956770|NCT01399905|467803048|FG000|Overall Study|Withdrawal by Subject|1|||
129956771|NCT01399905|467803049|FG001|Overall Study|Withdrawal by Subject|1|||
129956772|NCT02577315|467803052|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129956773|NCT02577315|467803053|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
129956774|NCT00417989|467803054|FG000|Overall Study|Withdrawal by Subject|13|||
129956775|NCT00417989|467803055|FG001|Overall Study|Withdrawal by Subject|13|||
129956776|NCT00417989|467803054|FG000|Overall Study|Lost to Follow-up|1|||
129956777|NCT00417989|467803055|FG001|Overall Study|Lost to Follow-up|6|||
129956778|NCT00417989|467803054|FG000|Overall Study|Protocol Violation|1|||
129956779|NCT00417989|467803055|FG001|Overall Study|Protocol Violation|0|||
129956780|NCT00417989|467803054|FG000|Overall Study|Death|0|||
129956781|NCT00417989|467803055|FG001|Overall Study|Death|1|||
129956782|NCT00417989|467803054|FG000|Overall Study|Physician Decision|5|||
129956783|NCT00417989|467803055|FG001|Overall Study|Physician Decision|2|||
129956784|NCT01945086|467803067|FG000|Overall Study|Withdrawal by Subject|1|||
129956785|NCT01945086|467803068|FG001|Overall Study|Withdrawal by Subject|0|||
129956786|NCT01945086|467803069|FG002|Overall Study|Withdrawal by Subject|1|||
129956787|NCT01945086|467803067|FG000|Overall Study|Adverse Event|0|||
129956788|NCT01945086|467803068|FG001|Overall Study|Adverse Event|0|||
129956789|NCT01945086|467803069|FG002|Overall Study|Adverse Event|1|||
129956790|NCT00170950|467803070|FG000|Overall Study|Death|236|||
129956791|NCT00170950|467803071|FG001|Overall Study|Death|274|||
129956792|NCT00170950|467803070|FG000|Overall Study|Withdrawal by Subject|496|||
129956793|NCT00170950|467803071|FG001|Overall Study|Withdrawal by Subject|498|||
129956794|NCT00170950|467803070|FG000|Overall Study|Lost to Follow-up|134|||
129956795|NCT00170950|467803071|FG001|Overall Study|Lost to Follow-up|115|||
129956796|NCT00170950|467803070|FG000|Overall Study|Missing|2|||
129956797|NCT00170950|467803071|FG001|Overall Study|Missing|1|||
129956798|NCT00170950|467803070|FG000|Overall Study|Termination Data Not Recorded|17|||
129956799|NCT00170950|467803071|FG001|Overall Study|Termination Data Not Recorded|22|||
129956800|NCT00748098|467803072|FG000|First Treatment Intervention Period|Adverse Event|1|||
129956801|NCT00748098|467803073|FG001|First Treatment Intervention Period|Adverse Event|1|||
129956802|NCT00748098|467803072|FG000|First Treatment Intervention Period|Protocol Violation|1|||
129956803|NCT00748098|467803073|FG001|First Treatment Intervention Period|Protocol Violation|0|||
129956804|NCT00748098|467803072|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
129956805|NCT00748098|467803073|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
129956806|NCT00748098|467803072|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
129956807|NCT00748098|467803073|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
129956808|NCT00748098|467803072|FG000|First Taper Period|Protocol Violation|1|||
129956809|NCT00748098|467803073|FG001|First Taper Period|Protocol Violation|0|||
129956810|NCT00748098|467803072|FG000|First Taper Period|Withdrawal by Subject|2|||
129956811|NCT00748098|467803073|FG001|First Taper Period|Withdrawal by Subject|0|||
129956812|NCT00748098|467803072|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
129956813|NCT00748098|467803073|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
129956814|NCT00748098|467803072|FG000|1-Week Washout Period|Adverse Event|0|||
129956815|NCT00748098|467803073|FG001|1-Week Washout Period|Adverse Event|1|||
129956816|NCT00748098|467803072|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
129956817|NCT00748098|467803073|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
129956818|NCT00748098|467803072|FG000|Second Treatment Intervention Period|Adverse Event|4|||
129956819|NCT00748098|467803073|FG001|Second Treatment Intervention Period|Adverse Event|1|||
129956820|NCT00748098|467803072|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
129956821|NCT00748098|467803073|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
129956822|NCT00748098|467803072|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
129956823|NCT00748098|467803073|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
129979932|NCT02108964|467889499|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979933|NCT02108964|467889500|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979934|NCT02108964|467889501|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979935|NCT02108964|467889502|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979936|NCT02108964|467889503|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979937|NCT02108964|467889504|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
129979938|NCT02108964|467889505|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
129979939|NCT03006848|467889506|FG000|Overall Study|Adverse Event|1|||
129979940|NCT03006848|467889506|FG000|Overall Study|Physician Decision|1|||
129979941|NCT03006848|467889506|FG000|Overall Study|Lack of Efficacy|16|||
129979942|NCT00384397|467889507|FG000|Overall Study|Adverse Event|0|||
129979943|NCT00384397|467889508|FG001|Overall Study|Adverse Event|1|||
129979944|NCT00384397|467889509|FG002|Overall Study|Adverse Event|2|||
129979945|NCT00384397|467889507|FG000|Overall Study|Protocol Violation|7|||
129979946|NCT00384397|467889508|FG001|Overall Study|Protocol Violation|15|||
129979947|NCT00384397|467889509|FG002|Overall Study|Protocol Violation|13|||
129979948|NCT00384397|467889507|FG000|Overall Study|Lost to Follow-up|11|||
129979949|NCT00384397|467889508|FG001|Overall Study|Lost to Follow-up|13|||
129979950|NCT00384397|467889509|FG002|Overall Study|Lost to Follow-up|3|||
129979951|NCT00384397|467889507|FG000|Overall Study|Withdrawal by Subject|14|||
129979952|NCT00384397|467889508|FG001|Overall Study|Withdrawal by Subject|17|||
129979953|NCT00384397|467889509|FG002|Overall Study|Withdrawal by Subject|15|||
129979954|NCT04372121|467889510|FG000|Overall Study|Lost to Follow-up|0|||
129979955|NCT04372121|467889511|FG001|Overall Study|Lost to Follow-up|0|||
129979956|NCT04372121|467889512|FG002|Overall Study|Lost to Follow-up|0|||
129979957|NCT04372121|467889513|FG003|Overall Study|Lost to Follow-up|1|||
129979958|NCT04372121|467889510|FG000|Overall Study|Protocol Violation|0|||
129979959|NCT04372121|467889511|FG001|Overall Study|Protocol Violation|0|||
129979960|NCT04372121|467889512|FG002|Overall Study|Protocol Violation|1|||
129956824|NCT00396097|467804510|FG000|Overall Study|Withdrawal by Subject|17|||
129956825|NCT00396097|467804511|FG001|Overall Study|Withdrawal by Subject|17|||
129956826|NCT00396097|467804510|FG000|Overall Study|Lost to Follow-up|4|||
129956827|NCT00396097|467804511|FG001|Overall Study|Lost to Follow-up|9|||
129956828|NCT00396097|467804510|FG000|Overall Study|Other|3|||
129956829|NCT00396097|467804511|FG001|Overall Study|Other|5|||
129956830|NCT00396097|467804510|FG000|Overall Study|Protocol Violation|0|||
129956831|NCT00396097|467804511|FG001|Overall Study|Protocol Violation|6|||
129956832|NCT00396097|467804510|FG000|Overall Study|Adverse Event|1|||
129956833|NCT00396097|467804511|FG001|Overall Study|Adverse Event|5|||
129956834|NCT00396097|467804510|FG000|Overall Study|Insufficient Clinical Response|1|||
129956835|NCT00396097|467804511|FG001|Overall Study|Insufficient Clinical Response|4|||
129956836|NCT03461211|467804512|FG000|Overall Study|Adverse Event|1|||
129956837|NCT03461211|467804513|FG001|Overall Study|Adverse Event|1|||
129956838|NCT03461211|467804512|FG000|Overall Study|Lack of Efficacy|0|||
129956839|NCT03461211|467804513|FG001|Overall Study|Lack of Efficacy|1|||
129956840|NCT01284634|467804514|FG000|Overall Study|Adverse Event|1|||
129956841|NCT01284634|467804515|FG001|Overall Study|Adverse Event|0|||
129956842|NCT01284634|467804516|FG002|Overall Study|Adverse Event|2|||
129956843|NCT01284634|467804517|FG003|Overall Study|Adverse Event|1|||
129956844|NCT01732588|467804518|FG000|First Intervention (7 Days)|Adverse Event|0|||
129956845|NCT01732588|467804519|FG001|First Intervention (7 Days)|Adverse Event|1|||
129956846|NCT01732588|467804520|FG002|First Intervention (7 Days)|Adverse Event|0|||
129956847|NCT00730925|467804531|FG000|Overall Study|Progressive Disease|21|||
129956848|NCT00730925|467804531|FG000|Overall Study|Dose reducing Event|2|||
129956849|NCT00730925|467804531|FG000|Overall Study|Other Averse Event|7|||
129956850|NCT00730925|467804531|FG000|Overall Study|Protocol Violation|1|||
129956851|NCT00730925|467804531|FG000|Overall Study|Withdrawal by Subject|1|||
129956852|NCT00730925|467804531|FG000|Overall Study|Switch to combination therapy|8|||
129956853|NCT00730925|467804531|FG000|Overall Study|Other|1|||
129956854|NCT00191984|467804538|FG000|Overall Study|Disease Progression|21|||
129956855|NCT00191984|467804538|FG000|Overall Study|Adverse Event|4|||
129956856|NCT00191984|467804538|FG000|Overall Study|Death|2|||
129956857|NCT00191984|467804538|FG000|Overall Study|Entry Criteria Exclusion|1|||
129956858|NCT00191984|467804538|FG000|Overall Study|Withdrawal by Subject|7|||
129956859|NCT00191984|467804538|FG000|Overall Study|Physician Decision|4|||
129956860|NCT01732627|467804539|FG000|Overall Study|Withdrawal by Subject|1|||
129956861|NCT01732627|467804540|FG001|Overall Study|Withdrawal by Subject|0|||
129956862|NCT00005908|467804543|FG000|Overall Study|Withdrawal by Subject|1|||
129956863|NCT00005908|467804544|FG001|Overall Study|Withdrawal by Subject|0|||
129956864|NCT04736602|467804547|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
129956865|NCT04736602|467804547|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
129956866|NCT02131155|467804553|FG000|Overall Study|Adverse Event|1|||
129956867|NCT02131155|467804554|FG001|Overall Study|Adverse Event|0|||
129956868|NCT02131155|467804553|FG000|Overall Study|Treatment completed|1|||
129956869|NCT02131155|467804554|FG001|Overall Study|Treatment completed|0|||
129956870|NCT02131155|467804553|FG000|Overall Study|Primary tumour recurrence|2|||
129956871|NCT02131155|467804554|FG001|Overall Study|Primary tumour recurrence|1|||
129956872|NCT02131155|467804553|FG000|Overall Study|Refused to continue study medication|1|||
129956873|NCT02131155|467804554|FG001|Overall Study|Refused to continue study medication|0|||
129956874|NCT02131155|467804553|FG000|Overall Study|Study early termination|20|||
129956875|NCT02131155|467804554|FG001|Overall Study|Study early termination|10|||
129956876|NCT01887418|467804555|FG000|Overall Study|Travelling difficulties|0|||
129956877|NCT01887418|467804556|FG001|Overall Study|Travelling difficulties|0|||
129956878|NCT01887418|467804557|FG002|Overall Study|Travelling difficulties|1|||
129956879|NCT00475735|467804558|FG000|Treatment Period 1|Adverse Event|2|||
129956880|NCT00475735|467804559|FG001|Treatment Period 1|Adverse Event|0|||
129956881|NCT00475735|467804560|FG002|Treatment Period 1|Adverse Event|0|||
129956882|NCT00475735|467804561|FG003|Treatment Period 1|Adverse Event|0|||
129956883|NCT00475735|467804562|FG004|Treatment Period 1|Adverse Event|0|||
129956884|NCT00475735|467804563|FG005|Treatment Period 1|Adverse Event|0|||
129956885|NCT00475735|467804558|FG000|Treatment Period 1|Lack of Efficacy|1|||
129956886|NCT00475735|467804559|FG001|Treatment Period 1|Lack of Efficacy|0|||
129956887|NCT00475735|467804560|FG002|Treatment Period 1|Lack of Efficacy|0|||
129956888|NCT00475735|467804561|FG003|Treatment Period 1|Lack of Efficacy|0|||
129956889|NCT00475735|467804562|FG004|Treatment Period 1|Lack of Efficacy|0|||
129956890|NCT00475735|467804563|FG005|Treatment Period 1|Lack of Efficacy|0|||
129956891|NCT00475735|467804558|FG000|Treatment Period 1|Lost to Follow-up|0|||
129956892|NCT00475735|467804559|FG001|Treatment Period 1|Lost to Follow-up|0|||
129956893|NCT00475735|467804560|FG002|Treatment Period 1|Lost to Follow-up|0|||
129956894|NCT00475735|467804561|FG003|Treatment Period 1|Lost to Follow-up|0|||
129956895|NCT00475735|467804562|FG004|Treatment Period 1|Lost to Follow-up|0|||
129956896|NCT00475735|467804563|FG005|Treatment Period 1|Lost to Follow-up|1|||
129956897|NCT00475735|467804558|FG000|Treatment Period 1|Protocol Violation|0|||
129956898|NCT00475735|467804559|FG001|Treatment Period 1|Protocol Violation|0|||
129956899|NCT00475735|467804560|FG002|Treatment Period 1|Protocol Violation|0|||
129956900|NCT00475735|467804561|FG003|Treatment Period 1|Protocol Violation|1|||
129956901|NCT00475735|467804562|FG004|Treatment Period 1|Protocol Violation|0|||
129956902|NCT00475735|467804563|FG005|Treatment Period 1|Protocol Violation|0|||
129956903|NCT00475735|467804558|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129956904|NCT00475735|467804559|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129956905|NCT00475735|467804560|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129956906|NCT00475735|467804561|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129956907|NCT00475735|467804562|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129956908|NCT00475735|467804563|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129956909|NCT00475735|467804558|FG000|Treatment Period 1|DC due to AE but continuing|0|||
129956910|NCT00475735|467804559|FG001|Treatment Period 1|DC due to AE but continuing|0|||
129956911|NCT00475735|467804560|FG002|Treatment Period 1|DC due to AE but continuing|0|||
129956912|NCT00475735|467804561|FG003|Treatment Period 1|DC due to AE but continuing|1|||
129956913|NCT00475735|467804562|FG004|Treatment Period 1|DC due to AE but continuing|2|||
129956914|NCT00475735|467804563|FG005|Treatment Period 1|DC due to AE but continuing|2|||
129956915|NCT00475735|467804558|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956916|NCT00475735|467804559|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
129956917|NCT00475735|467804560|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956918|NCT00475735|467804561|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956919|NCT00475735|467804562|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956920|NCT00475735|467804563|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
129956921|NCT00475735|467804558|FG000|Treatment Washout|Lost to Follow-up|0|||
129956922|NCT00475735|467804559|FG001|Treatment Washout|Lost to Follow-up|1|||
129956923|NCT00475735|467804560|FG002|Treatment Washout|Lost to Follow-up|0|||
129956924|NCT00475735|467804561|FG003|Treatment Washout|Lost to Follow-up|0|||
129956925|NCT00475735|467804562|FG004|Treatment Washout|Lost to Follow-up|0|||
129956926|NCT00475735|467804563|FG005|Treatment Washout|Lost to Follow-up|0|||
129956927|NCT00475735|467804558|FG000|Treatment Washout|Protocol Violation|0|||
129956928|NCT00475735|467804559|FG001|Treatment Washout|Protocol Violation|1|||
129956929|NCT00475735|467804560|FG002|Treatment Washout|Protocol Violation|0|||
129956930|NCT00475735|467804561|FG003|Treatment Washout|Protocol Violation|0|||
129956931|NCT00475735|467804562|FG004|Treatment Washout|Protocol Violation|0|||
129956932|NCT00475735|467804563|FG005|Treatment Washout|Protocol Violation|0|||
129956933|NCT00475735|467804558|FG000|Treatment Period 2|Adverse Event|0|||
129956934|NCT00475735|467804559|FG001|Treatment Period 2|Adverse Event|1|||
129956935|NCT00475735|467804560|FG002|Treatment Period 2|Adverse Event|0|||
129956936|NCT00475735|467804561|FG003|Treatment Period 2|Adverse Event|2|||
129956937|NCT00475735|467804562|FG004|Treatment Period 2|Adverse Event|0|||
129956938|NCT00475735|467804563|FG005|Treatment Period 2|Adverse Event|0|||
129956939|NCT00475735|467804558|FG000|Treatment Period 2|Lack of Efficacy|0|||
129956940|NCT00475735|467804559|FG001|Treatment Period 2|Lack of Efficacy|0|||
129956941|NCT00475735|467804560|FG002|Treatment Period 2|Lack of Efficacy|0|||
129956942|NCT00475735|467804561|FG003|Treatment Period 2|Lack of Efficacy|0|||
129956943|NCT00475735|467804562|FG004|Treatment Period 2|Lack of Efficacy|0|||
129956944|NCT00475735|467804563|FG005|Treatment Period 2|Lack of Efficacy|1|||
129956945|NCT00475735|467804558|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129956946|NCT00475735|467804559|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129956947|NCT00475735|467804560|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129956948|NCT00475735|467804561|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129956949|NCT00475735|467804562|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129956950|NCT00475735|467804563|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129956951|NCT02097056|467804567|FG000|Overall Study|Protocol Violation|2|||
129956952|NCT02097056|467804567|FG000|Overall Study|Withdrawal by Subject|15|||
129956953|NCT02097056|467804567|FG000|Overall Study|Lost to Follow-up|2|||
129956954|NCT02097056|467804567|FG000|Overall Study|Adverse Event|37|||
129956955|NCT02097056|467804567|FG000|Overall Study|Other|2|||
129956956|NCT01323309|467804568|FG000|Overall Study|Death|9|||
129956957|NCT01323309|467804569|FG001|Overall Study|Death|15|||
129956958|NCT01323309|467804570|FG002|Overall Study|Death|5|||
129956959|NCT01323309|467804568|FG000|Overall Study|Lost to Follow-up|11|||
129956960|NCT01323309|467804569|FG001|Overall Study|Lost to Follow-up|14|||
129956961|NCT01323309|467804570|FG002|Overall Study|Lost to Follow-up|24|||
129956962|NCT01323309|467804568|FG000|Overall Study|Withdrawal by Subject|14|||
129956963|NCT01323309|467804569|FG001|Overall Study|Withdrawal by Subject|14|||
129956964|NCT01323309|467804570|FG002|Overall Study|Withdrawal by Subject|18|||
129956965|NCT01323309|467804568|FG000|Overall Study|Disease progression|5|||
129956966|NCT01323309|467804569|FG001|Overall Study|Disease progression|11|||
129956967|NCT01323309|467804570|FG002|Overall Study|Disease progression|4|||
129956968|NCT03048058|467804576|FG000|Overall Study|Lost to Follow-up|4|||
129956969|NCT03048058|467804577|FG001|Overall Study|Lost to Follow-up|0|||
129956970|NCT03048058|467804576|FG000|Overall Study|Withdrawal by Subject|0|||
129956971|NCT03048058|467804577|FG001|Overall Study|Withdrawal by Subject|4|||
129956972|NCT02359552|467804592|FG000|Overall Study|Lost to Follow-up|3|||
129956973|NCT02359552|467804593|FG001|Overall Study|Lost to Follow-up|4|||
129956974|NCT01395914|467804601|FG000|Overall Study|Unrelated to study drug AE|6|||
129956975|NCT01395914|467804602|FG001|Overall Study|Unrelated to study drug AE|1|||
129956976|NCT01395914|467804601|FG000|Overall Study|Death|23|||
129454146|NCT00219284|465959465|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
129454147|NCT00219284|465959464|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
129454148|NCT00219284|465959465|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
129454149|NCT00219284|465959464|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
129454150|NCT00219284|465959465|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
129454151|NCT00219284|465959464|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
129454152|NCT00219284|465959465|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
129454153|NCT00219284|465959464|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
129454154|NCT00219284|465959465|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
129454155|NCT00609986|465959466|FG000|Overall Study|Did not receive transplant or treatment|8|||
129454156|NCT00609986|465959467|FG001|Overall Study|Did not receive transplant or treatment|3|||
129454157|NCT04722042|465959469|FG000|Overall Study|Withdrawal by Subject|2|||
129956977|NCT01395914|467804602|FG001|Overall Study|Death|17|||
129956978|NCT01395914|467804601|FG000|Overall Study|Other|9|||
129956979|NCT01395914|467804602|FG001|Overall Study|Other|3|||
129956980|NCT01395914|467804601|FG000|Overall Study|Withdrawal by patient|27|||
129956981|NCT01395914|467804602|FG001|Overall Study|Withdrawal by patient|14|||
129956982|NCT01395914|467804601|FG000|Overall Study|Study drug-related AE|1|||
129454158|NCT04722042|465959470|FG001|Overall Study|Withdrawal by Subject|1|||
129454159|NCT04722042|465959471|FG002|Overall Study|Withdrawal by Subject|0|||
129956983|NCT01395914|467804602|FG001|Overall Study|Study drug-related AE|0|||
129956984|NCT01395914|467804601|FG000|Overall Study|Lost to Follow-up|6|||
129956985|NCT01395914|467804602|FG001|Overall Study|Lost to Follow-up|2|||
129956986|NCT03023878|467804607|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
129956987|NCT03023878|467804607|FG000|Pre-Study Run-In Period|Death|1|||
129956988|NCT03023878|467804607|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
129956989|NCT03023878|467804607|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
129956990|NCT03023878|467804607|FG000|Treatment Period|Disease Progression|1|||
129956991|NCT03023878|467804607|FG000|Treatment Period|Withdrawal by Subject|1|||
129956992|NCT03023878|467804607|FG000|Treatment Period|Adverse Event|1|||
129956993|NCT03023878|467804607|FG000|Long Term Follow-Up Period|Death|2|||
129956994|NCT01247922|467804611|FG000|Overall Study|Disease progression|4|||
129956995|NCT01876823|467804614|FG000|Overall Study|Withdrawal by Subject|5|||
129956996|NCT01876823|467804614|FG000|Overall Study|Physician Decision|2|||
129956997|NCT01876823|467804614|FG000|Overall Study|Patients moved|2|||
129956998|NCT02849509|467804615|FG000|Overall Study|Worsening of disease under study|1|||
129956999|NCT02849509|467804616|FG001|Overall Study|Worsening of disease under study|1|||
129957000|NCT02849509|467804617|FG002|Overall Study|Worsening of disease under study|1|||
129957001|NCT02849509|467804615|FG000|Overall Study|Worsening of other pre-existing disease|0|||
129957002|NCT02849509|467804616|FG001|Overall Study|Worsening of other pre-existing disease|1|||
129957003|NCT02849509|467804617|FG002|Overall Study|Worsening of other pre-existing disease|2|||
129957004|NCT02849509|467804615|FG000|Overall Study|Other adverse event|36|||
129957005|NCT02849509|467804616|FG001|Overall Study|Other adverse event|41|||
129957006|NCT02849509|467804617|FG002|Overall Study|Other adverse event|8|||
129957007|NCT02849509|467804615|FG000|Overall Study|Withdrawal by Subject|6|||
129957008|NCT02849509|467804616|FG001|Overall Study|Withdrawal by Subject|17|||
129957009|NCT02849509|467804617|FG002|Overall Study|Withdrawal by Subject|12|||
129957010|NCT02849509|467804615|FG000|Overall Study|Lost to Follow-up|27|||
129957011|NCT02849509|467804616|FG001|Overall Study|Lost to Follow-up|67|||
129957012|NCT02849509|467804617|FG002|Overall Study|Lost to Follow-up|36|||
129957013|NCT02849509|467804615|FG000|Overall Study|Other, reason not specified|14|||
129957014|NCT02849509|467804616|FG001|Overall Study|Other, reason not specified|29|||
129957015|NCT02849509|467804617|FG002|Overall Study|Other, reason not specified|25|||
129957016|NCT02849509|467804615|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
129957017|NCT02849509|467804616|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
129957018|NCT02849509|467804617|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
129957019|NCT00577096|467804620|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
129957020|NCT00577096|467804621|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
129957021|NCT00577096|467804620|FG000|Short Term Participation|Withdrawal by Subject|3|||
129957022|NCT00577096|467804621|FG001|Short Term Participation|Withdrawal by Subject|5|||
129957023|NCT00577096|467804620|FG000|Short Term Participation|Death|1|||
129957024|NCT00577096|467804621|FG001|Short Term Participation|Death|1|||
129957025|NCT00832650|467804622|FG000|Overall Study|Randomized but not treated|0|||
129957026|NCT00832650|467804623|FG001|Overall Study|Randomized but not treated|0|||
129957027|NCT00832650|467804624|FG002|Overall Study|Randomized but not treated|1|||
129957028|NCT00794573|467804630|FG000|Overall Study|Death|3|||
129957029|NCT00794573|467804631|FG001|Overall Study|Death|0|||
129957030|NCT00794573|467804630|FG000|Overall Study|Withdrawal by Subject|9|||
129957031|NCT00794573|467804631|FG001|Overall Study|Withdrawal by Subject|12|||
129957032|NCT00794573|467804630|FG000|Overall Study|Lost to Follow-up|26|||
129957033|NCT00794573|467804631|FG001|Overall Study|Lost to Follow-up|33|||
129957034|NCT00257556|467804634|FG000|Overall Study|Adverse Event|1|||
129957035|NCT00257556|467804635|FG001|Overall Study|Adverse Event|4|||
129957036|NCT00257556|467804634|FG000|Overall Study|Physician Decision|6|||
129957037|NCT00257556|467804635|FG001|Overall Study|Physician Decision|0|||
129957038|NCT00257556|467804634|FG000|Overall Study|Did not meet hCG criterion|3|||
129957039|NCT00257556|467804635|FG001|Overall Study|Did not meet hCG criterion|0|||
129957040|NCT00257556|467804634|FG000|Overall Study|other reason|4|||
129957041|NCT00257556|467804635|FG001|Overall Study|other reason|6|||
129957042|NCT03849300|467804639|FG000|Overall Study|move out to different area|1|||
129957043|NCT03849300|467804640|FG001|Overall Study|move out to different area|3|||
129957044|NCT03849300|467804641|FG002|Overall Study|move out to different area|1|||
129957045|NCT03849300|467804642|FG003|Overall Study|move out to different area|4|||
129957046|NCT03849300|467804639|FG000|Overall Study|scheduling/transportation conflict|4|||
129957047|NCT03849300|467804640|FG001|Overall Study|scheduling/transportation conflict|4|||
129957048|NCT03849300|467804641|FG002|Overall Study|scheduling/transportation conflict|3|||
129957049|NCT03849300|467804642|FG003|Overall Study|scheduling/transportation conflict|2|||
129957050|NCT04839289|467804643|FG000|Overall Study|Withdrawal by Subject|1|||
129957051|NCT04839289|467804644|FG001|Overall Study|Withdrawal by Subject|0|||
129957052|NCT02418819|467804646|FG000|Overall Study|Adverse Event|0|||
129957053|NCT02418819|467804647|FG001|Overall Study|Adverse Event|0|||
129957054|NCT02418819|467804648|FG002|Overall Study|Adverse Event|1|||
129957055|NCT02418819|467804649|FG003|Overall Study|Adverse Event|0|||
129957056|NCT02418819|467804646|FG000|Overall Study|Lost to Follow-up|1|||
129957057|NCT02418819|467804647|FG001|Overall Study|Lost to Follow-up|0|||
129957058|NCT02418819|467804648|FG002|Overall Study|Lost to Follow-up|0|||
129957059|NCT02418819|467804649|FG003|Overall Study|Lost to Follow-up|0|||
129957060|NCT02418819|467804646|FG000|Overall Study|No longer meets eligibility criteria|0|||
129957061|NCT02418819|467804647|FG001|Overall Study|No longer meets eligibility criteria|0|||
129957062|NCT02418819|467804648|FG002|Overall Study|No longer meets eligibility criteria|1|||
129957063|NCT02418819|467804649|FG003|Overall Study|No longer meets eligibility criteria|0|||
129957064|NCT02418819|467804646|FG000|Overall Study|No longer willing to participate|0|||
129957065|NCT02418819|467804647|FG001|Overall Study|No longer willing to participate|0|||
129957066|NCT02418819|467804648|FG002|Overall Study|No longer willing to participate|2|||
129957067|NCT02418819|467804649|FG003|Overall Study|No longer willing to participate|1|||
129957068|NCT04743999|467804650|FG000|3-month Questionnaire|Death|1|||
129957069|NCT04743999|467804650|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
129957070|NCT04743999|467804650|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
129957071|NCT04743999|467804650|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
129957072|NCT01721759|467804651|FG000|Treatment Period|Disease Progression|85|||
129957073|NCT01721759|467804651|FG000|Treatment Period|Study drug toxicity|14|||
129957074|NCT01721759|467804651|FG000|Treatment Period|Death|1|||
129957075|NCT01721759|467804651|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
129957076|NCT01721759|467804651|FG000|Treatment Period|Participant request to withdraw|3|||
129957077|NCT01721759|467804651|FG000|Treatment Period|Other Reasons|3|||
129957078|NCT01721759|467804651|FG000|End of Study Period|Participant Withdrew Consent|5|||
129957079|NCT01721759|467804651|FG000|End of Study Period|Death|101|||
129957080|NCT01721759|467804651|FG000|End of Study Period|Lost to Follow-up|1|||
129957081|NCT01721759|467804651|FG000|End of Study Period|Other Reasons|10|||
129957082|NCT00464737|467804652|FG000|Overall Study|Adverse Event|12|||
129957083|NCT00464737|467804653|FG001|Overall Study|Adverse Event|17|||
129957084|NCT00464737|467804654|FG002|Overall Study|Adverse Event|33|||
129957085|NCT00464737|467804652|FG000|Overall Study|Lack of Efficacy|7|||
129957086|NCT00464737|467804653|FG001|Overall Study|Lack of Efficacy|7|||
129957087|NCT00464737|467804654|FG002|Overall Study|Lack of Efficacy|4|||
129957088|NCT00464737|467804652|FG000|Overall Study|Withdrawal by Subject|5|||
129957089|NCT00464737|467804653|FG001|Overall Study|Withdrawal by Subject|3|||
129957090|NCT00464737|467804654|FG002|Overall Study|Withdrawal by Subject|5|||
129957091|NCT00464737|467804652|FG000|Overall Study|Protocol Violation|1|||
129957092|NCT00464737|467804653|FG001|Overall Study|Protocol Violation|1|||
129957093|NCT00464737|467804654|FG002|Overall Study|Protocol Violation|5|||
129957094|NCT00464737|467804652|FG000|Overall Study|Non-compliance|0|||
129957095|NCT00464737|467804653|FG001|Overall Study|Non-compliance|1|||
129957096|NCT00464737|467804654|FG002|Overall Study|Non-compliance|1|||
129957097|NCT00464737|467804652|FG000|Overall Study|Lost to Follow-up|5|||
129957098|NCT00464737|467804653|FG001|Overall Study|Lost to Follow-up|2|||
129957099|NCT00464737|467804654|FG002|Overall Study|Lost to Follow-up|5|||
129957100|NCT00464737|467804652|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
129957101|NCT00464737|467804653|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
129957102|NCT00464737|467804654|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
129957103|NCT00464737|467804652|FG000|Overall Study|Other: Subject left town; family illness|1|||
129957104|NCT00464737|467804653|FG001|Overall Study|Other: Subject left town; family illness|0|||
129957105|NCT00464737|467804654|FG002|Overall Study|Other: Subject left town; family illness|0|||
129957106|NCT00464737|467804652|FG000|Overall Study|Other: Study demands too great|0|||
129957107|NCT00464737|467804653|FG001|Overall Study|Other: Study demands too great|1|||
129957108|NCT00464737|467804654|FG002|Overall Study|Other: Study demands too great|0|||
129957109|NCT00464737|467804652|FG000|Overall Study|Other: Personal family reasons|0|||
129957110|NCT00464737|467804653|FG001|Overall Study|Other: Personal family reasons|0|||
129957111|NCT00464737|467804654|FG002|Overall Study|Other: Personal family reasons|1|||
129957112|NCT00464737|467804652|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
129957113|NCT00464737|467804653|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
129957114|NCT00464737|467804654|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
129957115|NCT00925288|467806353|FG000|Overall Study|Lost to Follow-up|9|||
129957116|NCT00925288|467806354|FG001|Overall Study|Lost to Follow-up|7|||
129957117|NCT00635570|467806356|FG000|Overall Study|Lost to Follow-up|8|||
129957118|NCT00635570|467806357|FG001|Overall Study|Lost to Follow-up|8|||
129957119|NCT00635570|467806356|FG000|Overall Study|Withdrawal by Subject|1|||
129957120|NCT00635570|467806357|FG001|Overall Study|Withdrawal by Subject|1|||
129957121|NCT00635570|467806356|FG000|Overall Study|Adverse Event|2|||
129957122|NCT00635570|467806357|FG001|Overall Study|Adverse Event|0|||
129957123|NCT00635570|467806356|FG000|Overall Study|Physician Decision|1|||
129957124|NCT00635570|467806357|FG001|Overall Study|Physician Decision|0|||
129957125|NCT00635570|467806356|FG000|Overall Study|Did not complete survey|2|||
129957126|NCT00635570|467806357|FG001|Overall Study|Did not complete survey|1|||
129957127|NCT00635570|467806356|FG000|Overall Study|Early termination(No sexual activity)|1|||
129957128|NCT00635570|467806357|FG001|Overall Study|Early termination(No sexual activity)|1|||
129957129|NCT00377312|467806368|FG000|Overall Study|Adverse Event|1|||
129957130|NCT00377312|467806369|FG001|Overall Study|Adverse Event|1|||
129957131|NCT02775214|467806370|FG000|Overall Study|Withdrawal by Subject|2|||
129957132|NCT02775214|467806371|FG001|Overall Study|Withdrawal by Subject|0|||
129957133|NCT00762723|467806372|FG000|Overall Study|Study Terminated slow enrollement|5|||
129957134|NCT00762723|467806373|FG001|Overall Study|Study Terminated slow enrollement|5|||
129957135|NCT00762723|467806374|FG002|Overall Study|Study Terminated slow enrollement|3|||
129957136|NCT01145417|467806375|FG000|Overall Study|Death|1|||
129957137|NCT01145417|467806376|FG001|Overall Study|Death|0|||
129957138|NCT01145417|467806375|FG000|Overall Study|Lost to Follow-up|2|||
129957139|NCT01145417|467806376|FG001|Overall Study|Lost to Follow-up|1|||
129957140|NCT01145417|467806375|FG000|Overall Study|Withdrawal by Subject|1|||
129454160|NCT02090413|465959474|FG000|Overall Study|Adverse Event|11|||
129957141|NCT01145417|467806376|FG001|Overall Study|Withdrawal by Subject|2|||
129957142|NCT01145417|467806375|FG000|Overall Study|Pregnancy|1|||
129957143|NCT01145417|467806376|FG001|Overall Study|Pregnancy|0|||
129957144|NCT01145417|467806375|FG000|Overall Study|Adverse Event|0|||
129957145|NCT01145417|467806376|FG001|Overall Study|Adverse Event|1|||
129957146|NCT01145417|467806375|FG000|Overall Study|Study terminated by sponsor|35|||
129454161|NCT02090413|465959475|FG001|Overall Study|Adverse Event|15|||
129454162|NCT02090413|465959476|FG002|Overall Study|Adverse Event|20|||
129957147|NCT01145417|467806376|FG001|Overall Study|Study terminated by sponsor|43|||
129957148|NCT01145417|467806375|FG000|Overall Study|Other|1|||
129957149|NCT01145417|467806376|FG001|Overall Study|Other|0|||
129957150|NCT01191697|467806377|FG000|Overall Study|Death|1|||
129957151|NCT01191697|467806377|FG000|Overall Study|Physician Decision|2|||
129957152|NCT01191697|467806377|FG000|Overall Study|Pursue chemoradiation|2|||
129957153|NCT01191697|467806377|FG000|Overall Study|Break from chemotherapy|2|||
129957154|NCT01191697|467806377|FG000|Overall Study|Withdrawal by Subject|1|||
129957155|NCT01191697|467806377|FG000|Overall Study|Surveillance|1|||
129957156|NCT01191697|467806377|FG000|Overall Study|Adverse Event|2|||
129957157|NCT01191697|467806377|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
129957158|NCT01191697|467806377|FG000|Overall Study|Not completed but analyzed|25|||
129957159|NCT05372913|467806393|FG000|Overall Study|Withdrawal by Subject|0|||
129957160|NCT05372913|467806394|FG001|Overall Study|Withdrawal by Subject|2|||
129957161|NCT05372913|467806393|FG000|Overall Study|Protocol Violation|2|||
129957162|NCT05372913|467806394|FG001|Overall Study|Protocol Violation|2|||
129957163|NCT05372913|467806393|FG000|Overall Study|Adverse Event|0|||
129957164|NCT05372913|467806394|FG001|Overall Study|Adverse Event|1|||
129957165|NCT05135156|467806395|FG000|Overall Study|Lost to Follow-up|0|||
129957166|NCT05135156|467806396|FG001|Overall Study|Lost to Follow-up|0|||
129957167|NCT05135156|467806397|FG002|Overall Study|Lost to Follow-up|2|||
129957168|NCT02986659|467806398|FG000|First Intervention Period|Adverse Event|3|||
129957169|NCT02986659|467806399|FG001|First Intervention Period|Adverse Event|1|||
129957170|NCT02986659|467806398|FG000|First Intervention Period|Lost to Follow-up|1|||
129957171|NCT02986659|467806399|FG001|First Intervention Period|Lost to Follow-up|0|||
129957172|NCT02986659|467806398|FG000|First Intervention Period|Withdrawal by Subject|0|||
129957173|NCT02986659|467806399|FG001|First Intervention Period|Withdrawal by Subject|1|||
129957174|NCT02986659|467806398|FG000|Second Intervention Period|Adverse Event|0|||
129957175|NCT02986659|467806399|FG001|Second Intervention Period|Adverse Event|6|||
129957176|NCT01059526|467806402|FG000|Overall Study|Patient enrolled but not treated|20|||
129957177|NCT01059526|467806403|FG001|Overall Study|Patient enrolled but not treated|17|||
129957178|NCT01059526|467806402|FG000|Overall Study|Adverse Event|2|||
129957179|NCT01059526|467806403|FG001|Overall Study|Adverse Event|2|||
129957180|NCT01059526|467806402|FG000|Overall Study|Protocol Violation|0|||
129454163|NCT02090413|465959474|FG000|Overall Study|Flushing event|2|||
129454164|NCT02090413|465959475|FG001|Overall Study|Flushing event|0|||
129454165|NCT02090413|465959476|FG002|Overall Study|Flushing event|1|||
129454166|NCT02090413|465959474|FG000|Overall Study|Withdrawal by Subject|2|||
129957181|NCT01059526|467806403|FG001|Overall Study|Protocol Violation|1|||
129957182|NCT01059526|467806402|FG000|Overall Study|Withdrawal by Subject|3|||
129957183|NCT01059526|467806403|FG001|Overall Study|Withdrawal by Subject|1|||
129957184|NCT01059526|467806402|FG000|Overall Study|Lost to Follow-up|4|||
129957185|NCT01059526|467806403|FG001|Overall Study|Lost to Follow-up|1|||
129957186|NCT01059526|467806402|FG000|Overall Study|Patient found to be dermatographic|1|||
129957187|NCT01059526|467806403|FG001|Overall Study|Patient found to be dermatographic|0|||
129957188|NCT02720081|467806404|FG000|Overall Study|Adverse Event|0|||
129957189|NCT02720081|467806405|FG001|Overall Study|Adverse Event|3|||
129957190|NCT02720081|467806404|FG000|Overall Study|Protocol Violation|4|||
129957191|NCT02720081|467806405|FG001|Overall Study|Protocol Violation|1|||
129957192|NCT01370018|467806406|FG000|Overall Study|Did not meet criteria for analysis|1|||
129957193|NCT01525641|467806407|FG000|Overall Study|Case report form not collected|25|||
129957194|NCT01525641|467806407|FG000|Overall Study|No visit since the first visit|16|||
129957195|NCT01525641|467806407|FG000|Overall Study|Adverse Event|73|||
129957196|NCT01525641|467806407|FG000|Overall Study|Lack of Efficacy|24|||
129957197|NCT01525641|467806407|FG000|Overall Study|Improvement|5|||
129957198|NCT01525641|467806407|FG000|Overall Study|Lost to follow-up (relocation)|1|||
129957199|NCT01525641|467806407|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
129957200|NCT01525641|467806407|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
129957201|NCT01525641|467806407|FG000|Overall Study|Other than stated above|7|||
129957202|NCT03772041|467806408|FG000|Overall Study|Adverse Event|8|||
129957203|NCT03772041|467806409|FG001|Overall Study|Adverse Event|3|||
129957204|NCT03772041|467806408|FG000|Overall Study|Withdrawal by Subject|0|||
129957205|NCT03772041|467806409|FG001|Overall Study|Withdrawal by Subject|2|||
129957206|NCT03772041|467806408|FG000|Overall Study|Protocol Violation|4|||
129957207|NCT03772041|467806409|FG001|Overall Study|Protocol Violation|2|||
129957208|NCT03772041|467806408|FG000|Overall Study|Physician Decision|2|||
129957209|NCT03772041|467806409|FG001|Overall Study|Physician Decision|3|||
129957210|NCT05012397|467806414|FG000|Overall Study|Death|10|||
129957211|NCT05012397|467806414|FG000|Overall Study|Physician Decision|9|||
129957212|NCT05012397|467806414|FG000|Overall Study|Withdrawal by Subject|5|||
129957213|NCT05012397|467806414|FG000|Overall Study|Lost to Follow-up|2|||
129957214|NCT03334747|467806415|FG000|Treatment Phase|Technical problems|0|||
129957215|NCT03334747|467806416|FG001|Treatment Phase|Technical problems|0|||
129957216|NCT03334747|467806417|FG002|Treatment Phase|Technical problems|0|||
129957217|NCT03334747|467806418|FG003|Treatment Phase|Technical problems|0|||
129957218|NCT03334747|467806419|FG004|Treatment Phase|Technical problems|1|||
129957219|NCT03334747|467806420|FG005|Treatment Phase|Technical problems|0|||
129957220|NCT03334747|467806421|FG006|Treatment Phase|Technical problems|0|||
129957221|NCT03334747|467806422|FG007|Treatment Phase|Technical problems|0|||
129957222|NCT03334747|467806423|FG008|Treatment Phase|Technical problems|0|||
129957223|NCT03334747|467806415|FG000|Treatment Phase|Subject/guardian decision|1|||
129957224|NCT03334747|467806416|FG001|Treatment Phase|Subject/guardian decision|0|||
129957225|NCT03334747|467806417|FG002|Treatment Phase|Subject/guardian decision|0|||
129957226|NCT03334747|467806418|FG003|Treatment Phase|Subject/guardian decision|0|||
129957227|NCT03334747|467806419|FG004|Treatment Phase|Subject/guardian decision|0|||
129957228|NCT03334747|467806420|FG005|Treatment Phase|Subject/guardian decision|1|||
129957229|NCT03334747|467806421|FG006|Treatment Phase|Subject/guardian decision|0|||
129957230|NCT03334747|467806422|FG007|Treatment Phase|Subject/guardian decision|0|||
129957231|NCT03334747|467806423|FG008|Treatment Phase|Subject/guardian decision|0|||
129957232|NCT03334747|467806415|FG000|Follow-Up Phase|Subject/guardian decision|0|||
129957233|NCT03334747|467806416|FG001|Follow-Up Phase|Subject/guardian decision|0|||
129957234|NCT03334747|467806417|FG002|Follow-Up Phase|Subject/guardian decision|0|||
129957235|NCT03334747|467806418|FG003|Follow-Up Phase|Subject/guardian decision|0|||
129957236|NCT03334747|467806419|FG004|Follow-Up Phase|Subject/guardian decision|0|||
129957237|NCT03334747|467806420|FG005|Follow-Up Phase|Subject/guardian decision|0|||
129454167|NCT02090413|465959475|FG001|Overall Study|Withdrawal by Subject|2|||
129454168|NCT02090413|465959476|FG002|Overall Study|Withdrawal by Subject|2|||
129957238|NCT03334747|467806421|FG006|Follow-Up Phase|Subject/guardian decision|1|||
129957239|NCT03334747|467806422|FG007|Follow-Up Phase|Subject/guardian decision|0|||
129957240|NCT03334747|467806423|FG008|Follow-Up Phase|Subject/guardian decision|1|||
129454169|NCT02090413|465959474|FG000|Overall Study|Investigator Decision|1|||
129957241|NCT02567227|467806424|FG000|9 Weeks|Adverse Event|5|||
129957242|NCT02567227|467806425|FG001|9 Weeks|Adverse Event|5|||
129957243|NCT02567227|467806424|FG000|9 Weeks|Withdrawal by Subject|18|||
129957244|NCT02567227|467806425|FG001|9 Weeks|Withdrawal by Subject|8|||
129957245|NCT02567227|467806424|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
129957246|NCT02567227|467806425|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
129957247|NCT02567227|467806424|FG000|6 Month|Death|2|||
129957248|NCT02567227|467806425|FG001|6 Month|Death|0|||
129957249|NCT02567227|467806424|FG000|6 Month|Lost to Follow-up|43|||
129957250|NCT02567227|467806425|FG001|6 Month|Lost to Follow-up|40|||
129957251|NCT02567227|467806424|FG000|12 Months|Lost to Follow-up|31|||
129957252|NCT02567227|467806425|FG001|12 Months|Lost to Follow-up|32|||
129957253|NCT02567227|467806424|FG000|12 Months|Death|0|||
129957254|NCT02567227|467806425|FG001|12 Months|Death|2|||
129957255|NCT02137239|467806426|FG000|Overall Study|Discontinued Study Treatment|0|||
129957256|NCT02137239|467806427|FG001|Overall Study|Discontinued Study Treatment|3|||
129957257|NCT02137239|467806426|FG000|Overall Study|Withdrew Consent|1|||
129957258|NCT02137239|467806427|FG001|Overall Study|Withdrew Consent|1|||
129957259|NCT02137239|467806426|FG000|Overall Study|Adverse Event|2|||
129957260|NCT02137239|467806427|FG001|Overall Study|Adverse Event|2|||
129957261|NCT02498418|467806431|FG000|Overall Study|Lack of Efficacy|0|||
129957262|NCT02498418|467806432|FG001|Overall Study|Lack of Efficacy|0|||
129957263|NCT02498418|467806433|FG002|Overall Study|Lack of Efficacy|1|||
129957264|NCT02498418|467806431|FG000|Overall Study|Withdrawal by Subject|2|||
129957265|NCT02498418|467806432|FG001|Overall Study|Withdrawal by Subject|0|||
129957266|NCT02498418|467806433|FG002|Overall Study|Withdrawal by Subject|3|||
129957267|NCT02498418|467806431|FG000|Overall Study|Lost to Follow-up|0|||
129957268|NCT02498418|467806432|FG001|Overall Study|Lost to Follow-up|1|||
129957269|NCT02498418|467806433|FG002|Overall Study|Lost to Follow-up|1|||
129957270|NCT02498418|467806431|FG000|Overall Study|Participant taken prohibited medication|0|||
129957271|NCT02498418|467806432|FG001|Overall Study|Participant taken prohibited medication|1|||
129957272|NCT02498418|467806433|FG002|Overall Study|Participant taken prohibited medication|1|||
129957273|NCT00762502|467806434|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
129957274|NCT00762502|467806435|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
129957275|NCT00762502|467806436|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
129957276|NCT00762502|467806434|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
129957277|NCT00762502|467806435|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
129957278|NCT00762502|467806436|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
129957279|NCT00762502|467806434|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
129957280|NCT00762502|467806435|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
129957281|NCT00762502|467806436|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
129957282|NCT03042559|467806437|FG000|Overall Study|drop out|1|||
129957283|NCT03042559|467806438|FG001|Overall Study|drop out|1|||
129957284|NCT01536535|467806442|FG000|Overall Study|Withdrawal by Subject|10|||
129957285|NCT01536535|467806443|FG001|Overall Study|Withdrawal by Subject|5|||
129957286|NCT01536535|467806442|FG000|Overall Study|Lost to Follow-up|4|||
129957287|NCT01536535|467806443|FG001|Overall Study|Lost to Follow-up|6|||
129957288|NCT01536535|467806442|FG000|Overall Study|Physician Decision|1|||
129957289|NCT01536535|467806443|FG001|Overall Study|Physician Decision|1|||
129957290|NCT01536535|467806442|FG000|Overall Study|Participant moved|0|||
129957291|NCT01536535|467806443|FG001|Overall Study|Participant moved|1|||
129957292|NCT00385697|467806446|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
129957293|NCT00385697|467806447|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
129957294|NCT00385697|467806448|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
129957295|NCT00385697|467806449|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
129957296|NCT00385697|467806450|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
129957297|NCT00385697|467806446|FG000|Open-label Segment 1|Lost to Follow-up|1|||
129957298|NCT00385697|467806447|FG001|Open-label Segment 1|Lost to Follow-up|0|||
129957299|NCT00385697|467806448|FG002|Open-label Segment 1|Lost to Follow-up|0|||
129957300|NCT00385697|467806449|FG003|Open-label Segment 1|Lost to Follow-up|0|||
129957301|NCT00385697|467806450|FG004|Open-label Segment 1|Lost to Follow-up|0|||
129957302|NCT00385697|467806446|FG000|Double-blind Segment 2|Adverse Event|0|||
129957303|NCT00385697|467806447|FG001|Double-blind Segment 2|Adverse Event|3|||
129957304|NCT00385697|467806448|FG002|Double-blind Segment 2|Adverse Event|1|||
129957305|NCT00385697|467806449|FG003|Double-blind Segment 2|Adverse Event|0|||
129957306|NCT00385697|467806450|FG004|Double-blind Segment 2|Adverse Event|0|||
129957307|NCT00385697|467806446|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
129957308|NCT00385697|467806447|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
129957309|NCT00385697|467806448|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
129957310|NCT00385697|467806449|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
129957311|NCT00385697|467806450|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
129957312|NCT00385697|467806446|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
129957313|NCT00385697|467806447|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
129957314|NCT00385697|467806448|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
129957315|NCT00385697|467806449|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
129957316|NCT00385697|467806450|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
129957317|NCT00385697|467806446|FG000|Double-blind Segment 2|Other|0|||
129957318|NCT00385697|467806447|FG001|Double-blind Segment 2|Other|2|||
129957319|NCT00385697|467806448|FG002|Double-blind Segment 2|Other|0|||
129957320|NCT00385697|467806449|FG003|Double-blind Segment 2|Other|0|||
129957321|NCT00385697|467806450|FG004|Double-blind Segment 2|Other|0|||
129957322|NCT01485991|467806451|FG000|Overall Study|Adverse Event|0|||
129454170|NCT02090413|465959475|FG001|Overall Study|Investigator Decision|1|||
129454171|NCT02090413|465959476|FG002|Overall Study|Investigator Decision|0|||
129454172|NCT02090413|465959474|FG000|Overall Study|Other|2|||
129454173|NCT02090413|465959475|FG001|Overall Study|Other|1|||
129454174|NCT02090413|465959476|FG002|Overall Study|Other|0|||
129454175|NCT02090413|465959474|FG000|Overall Study|Lost to Follow-up|1|||
129454176|NCT02090413|465959475|FG001|Overall Study|Lost to Follow-up|1|||
129454177|NCT02090413|465959476|FG002|Overall Study|Lost to Follow-up|0|||
129454178|NCT02321930|465959481|FG000|Overall Study|Lost to Follow-up|1|||
129454179|NCT05321069|465959482|FG000|Overall Study|Adverse Event|52|||
129454180|NCT05321069|465959483|FG001|Overall Study|Adverse Event|52|||
129454181|NCT05321069|465959484|FG002|Overall Study|Adverse Event|64|||
129454182|NCT05321069|465959482|FG000|Overall Study|Protocol Violation|1|||
129454183|NCT05321069|465959483|FG001|Overall Study|Protocol Violation|1|||
129454184|NCT05321069|465959484|FG002|Overall Study|Protocol Violation|0|||
129454185|NCT05321069|465959482|FG000|Overall Study|Withdrawal by Subject|23|||
129454186|NCT05321069|465959483|FG001|Overall Study|Withdrawal by Subject|18|||
129454187|NCT05321069|465959484|FG002|Overall Study|Withdrawal by Subject|12|||
129454188|NCT05321069|465959482|FG000|Overall Study|Lost to Follow-up|1|||
129454189|NCT05321069|465959483|FG001|Overall Study|Lost to Follow-up|0|||
129454190|NCT05321069|465959484|FG002|Overall Study|Lost to Follow-up|1|||
129454191|NCT05321069|465959482|FG000|Overall Study|No reason stated by the participants|23|||
129957323|NCT01485991|467806452|FG001|Overall Study|Adverse Event|4|||
129957324|NCT01485991|467806451|FG000|Overall Study|Lost to Follow-up|13|||
129957325|NCT01485991|467806452|FG001|Overall Study|Lost to Follow-up|10|||
129957326|NCT01485991|467806451|FG000|Overall Study|Withdrawal by Subject|13|||
129957327|NCT01485991|467806452|FG001|Overall Study|Withdrawal by Subject|20|||
129957328|NCT01485991|467806451|FG000|Overall Study|randomized but not treated|6|||
129957329|NCT01485991|467806452|FG001|Overall Study|randomized but not treated|2|||
129957330|NCT02538471|467806454|FG000|Overall Study|Progression of disease|2|||
129957331|NCT01475370|467806455|FG000|Overall Study|Exacerbation of primary disease|2|||
129957332|NCT01475370|467806456|FG001|Overall Study|Exacerbation of primary disease|2|||
129957333|NCT01475370|467806457|FG002|Overall Study|Exacerbation of primary disease|2|||
129957334|NCT01475370|467806455|FG000|Overall Study|Study drug administration difficult|0|||
129957335|NCT01475370|467806456|FG001|Overall Study|Study drug administration difficult|1|||
129957336|NCT01475370|467806457|FG002|Overall Study|Study drug administration difficult|1|||
129957337|NCT01475370|467806455|FG000|Overall Study|Other than specified|1|||
129957338|NCT01475370|467806456|FG001|Overall Study|Other than specified|0|||
129957339|NCT01475370|467806457|FG002|Overall Study|Other than specified|0|||
129957340|NCT00084747|467806460|FG000|Overall Study|Relapsed|8|||
129957341|NCT00084747|467806460|FG000|Overall Study|Death|3|||
129957342|NCT00084747|467806460|FG000|Overall Study|Withdrawal by Subject|2|||
129957343|NCT02382406|467806465|FG000|Study Treatment|Disease Progression|8|||
129957344|NCT02382406|467806466|FG001|Study Treatment|Disease Progression|0|||
129957345|NCT02382406|467806467|FG002|Study Treatment|Disease Progression|20|||
129957346|NCT02382406|467806465|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
129957347|NCT02382406|467806466|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
129957348|NCT02382406|467806467|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
129957349|NCT02382406|467806465|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
129957350|NCT02382406|467806466|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
129957351|NCT02382406|467806467|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
129957352|NCT02382406|467806465|FG000|Study Treatment|symptomatic deterioration|1|||
129957353|NCT02382406|467806466|FG001|Study Treatment|symptomatic deterioration|0|||
129957354|NCT02382406|467806467|FG002|Study Treatment|symptomatic deterioration|1|||
129957355|NCT02382406|467806465|FG000|Study Treatment|Death|0|||
129957356|NCT02382406|467806466|FG001|Study Treatment|Death|0|||
129454192|NCT05321069|465959483|FG001|Overall Study|No reason stated by the participants|22|||
129454193|NCT05321069|465959484|FG002|Overall Study|No reason stated by the participants|16|||
129454194|NCT05321069|465959482|FG000|Overall Study|Lack of Efficacy|1|||
129454195|NCT05321069|465959483|FG001|Overall Study|Lack of Efficacy|1|||
129454196|NCT05321069|465959484|FG002|Overall Study|Lack of Efficacy|0|||
129454197|NCT01293968|465959485|FG000|Overall Study|non-cooperation|3|||
129454198|NCT01293968|465959486|FG001|Overall Study|non-cooperation|3|||
129454199|NCT00853749|465959487|FG000|Overall Study|Lost to Follow-up|0|||
129454200|NCT00853749|465959488|FG001|Overall Study|Lost to Follow-up|1|||
129957357|NCT02382406|467806467|FG002|Study Treatment|Death|2|||
129957358|NCT02382406|467806465|FG000|Follow up|Death|11|||
129957359|NCT02382406|467806466|FG001|Follow up|Death|0|||
129957360|NCT02382406|467806467|FG002|Follow up|Death|19|||
129957361|NCT02382406|467806465|FG000|Follow up|Symptomatic deterioration|1|||
129957362|NCT02382406|467806466|FG001|Follow up|Symptomatic deterioration|0|||
129957363|NCT02382406|467806467|FG002|Follow up|Symptomatic deterioration|1|||
129957364|NCT02382406|467806465|FG000|Follow up|Patient Refused Follow-up|1|||
129979961|NCT04372121|467889513|FG003|Overall Study|Protocol Violation|0|||
129957365|NCT02382406|467806466|FG001|Follow up|Patient Refused Follow-up|0|||
129957366|NCT02382406|467806467|FG002|Follow up|Patient Refused Follow-up|0|||
129957367|NCT02382406|467806465|FG000|Follow up|Study Terminated|1|||
129957368|NCT02382406|467806466|FG001|Follow up|Study Terminated|0|||
129957369|NCT02382406|467806467|FG002|Follow up|Study Terminated|8|||
129957370|NCT02382406|467806465|FG000|Follow up|Withdrawal by Subject|0|||
129957371|NCT02382406|467806466|FG001|Follow up|Withdrawal by Subject|0|||
129957372|NCT02382406|467806467|FG002|Follow up|Withdrawal by Subject|2|||
129957373|NCT03794609|467806470|FG000|Overall Study|Other|10|||
129957374|NCT03794609|467806470|FG000|Overall Study|Withdrawal by Subject|66|||
129957375|NCT03794609|467806470|FG000|Overall Study|The child is enrolled in an interventional study|70|||
129957376|NCT03794609|467806470|FG000|Overall Study|Inclusion/exclusion criteria|8|||
129957377|NCT03794609|467806470|FG000|Overall Study|At sponsor's request|151|||
129957378|NCT03794609|467806470|FG000|Overall Study|Physician Decision|1|||
129957379|NCT03794609|467806470|FG000|Overall Study|Lost to Follow-up|5|||
129957380|NCT04543942|467806471|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
129957381|NCT04543942|467806472|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
129957382|NCT04543942|467806471|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
129957383|NCT04543942|467806472|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
129957384|NCT04474691|467806479|FG000|Overall Study|Withdrawal by Subject|9|||
129957385|NCT00139659|467806480|FG000|Overall Study|Adverse Event|12|||
129957386|NCT00139659|467806481|FG001|Overall Study|Adverse Event|1|||
129957387|NCT00139659|467806480|FG000|Overall Study|Lack of Efficacy|1|||
129957388|NCT00139659|467806481|FG001|Overall Study|Lack of Efficacy|1|||
129957389|NCT00139659|467806480|FG000|Overall Study|Lost to Follow-up|7|||
129957390|NCT00139659|467806481|FG001|Overall Study|Lost to Follow-up|3|||
129957391|NCT00139659|467806480|FG000|Overall Study|Reason not Specified|6|||
129957392|NCT00139659|467806481|FG001|Overall Study|Reason not Specified|3|||
129957393|NCT00139659|467806480|FG000|Overall Study|Withdrawal by Subject|14|||
129957394|NCT00139659|467806481|FG001|Overall Study|Withdrawal by Subject|10|||
129957395|NCT02391116|467806483|FG000|Treatment|Withdrawal by Subject|1|||
129957396|NCT02391116|467806483|FG000|Treatment|Protocol Violation|1|||
129957397|NCT02391116|467806483|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
129957398|NCT02391116|467806483|FG000|Treatment|AE with Clinical PD|3|||
129957399|NCT02391116|467806483|FG000|Safety Follow-up|Adverse Event|1|||
129957400|NCT02391116|467806483|FG000|Safety Follow-up|Withdrawal by Subject|4|||
129957401|NCT02391116|467806483|FG000|Safety Follow-up|Switching to Other Therapy|4|||
129957402|NCT02391116|467806483|FG000|Safety Follow-up|No Follow Up|1|||
129957403|NCT02391116|467806483|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
129957404|NCT02391116|467806483|FG000|Active Follow-up|Withdrawal by Subject|1|||
129957405|NCT02391116|467806483|FG000|Active Follow-up|Switching to Other Therapy|2|||
129957406|NCT02391116|467806483|FG000|Survival Follow-up|Withdrawal by Subject|3|||
129957407|NCT02391116|467806483|FG000|Survival Follow-up|Switching to Other Therapy|1|||
129957408|NCT01261793|467806487|FG000|Overall Study|Lack of Efficacy|44|||
129957409|NCT01261793|467806488|FG001|Overall Study|Lack of Efficacy|37|||
129957410|NCT01261793|467806489|FG002|Overall Study|Lack of Efficacy|32|||
129957411|NCT01261793|467806487|FG000|Overall Study|Protocol Violation|3|||
129957412|NCT01261793|467806488|FG001|Overall Study|Protocol Violation|5|||
129957413|NCT01261793|467806489|FG002|Overall Study|Protocol Violation|6|||
129957414|NCT01261793|467806487|FG000|Overall Study|Lost to Follow-up|10|||
129957415|NCT01261793|467806488|FG001|Overall Study|Lost to Follow-up|3|||
129957416|NCT01261793|467806489|FG002|Overall Study|Lost to Follow-up|7|||
129957417|NCT01261793|467806487|FG000|Overall Study|Withdrawal by Subject|12|||
129957418|NCT01261793|467806488|FG001|Overall Study|Withdrawal by Subject|14|||
129957419|NCT01261793|467806489|FG002|Overall Study|Withdrawal by Subject|14|||
129957420|NCT01261793|467806487|FG000|Overall Study|Death|3|||
129957421|NCT01261793|467806488|FG001|Overall Study|Death|1|||
129957422|NCT01261793|467806489|FG002|Overall Study|Death|0|||
129957423|NCT01261793|467806487|FG000|Overall Study|Adverse Event|9|||
129957424|NCT01261793|467806488|FG001|Overall Study|Adverse Event|24|||
129957425|NCT01261793|467806489|FG002|Overall Study|Adverse Event|19|||
129957426|NCT01261793|467806487|FG000|Overall Study|Patient non-availability|1|||
129957427|NCT01261793|467806488|FG001|Overall Study|Patient non-availability|1|||
129957428|NCT01261793|467806489|FG002|Overall Study|Patient non-availability|1|||
129957429|NCT01261793|467806487|FG000|Overall Study|Suspected pregnancy|1|||
129957430|NCT01261793|467806488|FG001|Overall Study|Suspected pregnancy|1|||
129957431|NCT01261793|467806489|FG002|Overall Study|Suspected pregnancy|0|||
129957432|NCT01261793|467806487|FG000|Overall Study|Patient non-compliance|1|||
129957433|NCT01261793|467806488|FG001|Overall Study|Patient non-compliance|0|||
129957434|NCT01261793|467806489|FG002|Overall Study|Patient non-compliance|1|||
129957435|NCT01261793|467806487|FG000|Overall Study|Patient pregnant|1|||
129957436|NCT01261793|467806488|FG001|Overall Study|Patient pregnant|0|||
129957437|NCT01261793|467806489|FG002|Overall Study|Patient pregnant|0|||
129957438|NCT01261793|467806487|FG000|Overall Study|Outside the study area|0|||
129957439|NCT01261793|467806488|FG001|Overall Study|Outside the study area|2|||
129957440|NCT01261793|467806489|FG002|Overall Study|Outside the study area|1|||
129957441|NCT01261793|467806487|FG000|Overall Study|Lack of efficacy & patient not available|0|||
129957442|NCT01261793|467806488|FG001|Overall Study|Lack of efficacy & patient not available|1|||
129957443|NCT01261793|467806489|FG002|Overall Study|Lack of efficacy & patient not available|0|||
129957444|NCT01261793|467806487|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
129957445|NCT01261793|467806488|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
129957446|NCT01261793|467806489|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
129957447|NCT01261793|467806487|FG000|Overall Study|Randomization error|0|||
129957448|NCT01261793|467806488|FG001|Overall Study|Randomization error|1|||
129957449|NCT01261793|467806489|FG002|Overall Study|Randomization error|0|||
129957450|NCT01261793|467806487|FG000|Overall Study|Patient unable to start IV line|0|||
129957451|NCT01261793|467806488|FG001|Overall Study|Patient unable to start IV line|0|||
129957452|NCT01261793|467806489|FG002|Overall Study|Patient unable to start IV line|1|||
129957453|NCT02784535|467806490|FG000|Overall Study|Adverse Event|1|||
129957454|NCT02784535|467806491|FG001|Overall Study|Adverse Event|0|||
129957455|NCT02784535|467806490|FG000|Overall Study|Withdrawal by Subject|0|||
129957456|NCT02784535|467806491|FG001|Overall Study|Withdrawal by Subject|1|||
129957457|NCT02784535|467806490|FG000|Overall Study|Physician Decision|0|||
129957458|NCT02784535|467806491|FG001|Overall Study|Physician Decision|1|||
129957459|NCT02335242|467806495|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
129957460|NCT02335242|467806496|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
129957461|NCT02335242|467806495|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
129957462|NCT02335242|467806496|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
129957463|NCT02335242|467806495|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
129957464|NCT02335242|467806496|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
129957465|NCT00905255|467806497|FG000|Overall Study|Adverse Event|7|||
129957466|NCT00905255|467806498|FG001|Overall Study|Adverse Event|5|||
129957467|NCT00905255|467806497|FG000|Overall Study|Withdrawal by Subject|5|||
129957468|NCT00905255|467806498|FG001|Overall Study|Withdrawal by Subject|4|||
129957469|NCT00905255|467806497|FG000|Overall Study|Familial and Personal Reasons|1|||
129957470|NCT00905255|467806498|FG001|Overall Study|Familial and Personal Reasons|0|||
129957471|NCT00390806|467806501|FG000|Overall Study|Lost to Follow-up|7|||
129957472|NCT00390806|467806502|FG001|Overall Study|Lost to Follow-up|6|||
129957473|NCT00390806|467806501|FG000|Overall Study|Protocol Violation|2|||
129957474|NCT00390806|467806502|FG001|Overall Study|Protocol Violation|2|||
129957475|NCT00390806|467806501|FG000|Overall Study|Withdrawal by Subject|12|||
129957476|NCT00390806|467806502|FG001|Overall Study|Withdrawal by Subject|15|||
129957477|NCT00390806|467806501|FG000|Overall Study|Investigator Decision|4|||
129957478|NCT00390806|467806502|FG001|Overall Study|Investigator Decision|6|||
129957479|NCT00390806|467806501|FG000|Overall Study|Death|1|||
129957480|NCT00390806|467806502|FG001|Overall Study|Death|0|||
129957481|NCT00390806|467806501|FG000|Overall Study|Physician Decision|0|||
129957482|NCT00390806|467806502|FG001|Overall Study|Physician Decision|1|||
129957483|NCT00390806|467806501|FG000|Overall Study|Ongoing|4|||
129957484|NCT00390806|467806502|FG001|Overall Study|Ongoing|2|||
129957485|NCT00714688|467806503|FG000|Overall Study|Lack of Efficacy|14|||
129957486|NCT00714688|467806504|FG001|Overall Study|Lack of Efficacy|1|||
129957487|NCT00714688|467806505|FG002|Overall Study|Lack of Efficacy|4|||
129957488|NCT00714688|467806503|FG000|Overall Study|Withdrawal by Subject|4|||
129957489|NCT00714688|467806504|FG001|Overall Study|Withdrawal by Subject|3|||
129957490|NCT00714688|467806505|FG002|Overall Study|Withdrawal by Subject|3|||
129957491|NCT00714688|467806503|FG000|Overall Study|Lost to Follow-up|5|||
129957492|NCT00714688|467806504|FG001|Overall Study|Lost to Follow-up|2|||
129957493|NCT00714688|467806505|FG002|Overall Study|Lost to Follow-up|0|||
129957494|NCT00714688|467806503|FG000|Overall Study|Adverse Event|2|||
129957495|NCT00714688|467806504|FG001|Overall Study|Adverse Event|15|||
129957496|NCT00714688|467806505|FG002|Overall Study|Adverse Event|19|||
129957497|NCT00714688|467806503|FG000|Overall Study|Subject Non-compliant|3|||
129957498|NCT00714688|467806504|FG001|Overall Study|Subject Non-compliant|5|||
129957499|NCT00714688|467806505|FG002|Overall Study|Subject Non-compliant|5|||
129957500|NCT00714688|467806503|FG000|Overall Study|Ineligible to Continue the Study|0|||
129957501|NCT00714688|467806504|FG001|Overall Study|Ineligible to Continue the Study|1|||
129454201|NCT00798135|465959489|FG000|Overall Study|Disease progression, relapse|11|||
129454202|NCT00798135|465959489|FG000|Overall Study|Disease progression, refractory|1|||
129957502|NCT00714688|467806505|FG002|Overall Study|Ineligible to Continue the Study|1|||
129957503|NCT00714688|467806503|FG000|Overall Study|Sponsor's Decision|0|||
129957504|NCT00714688|467806504|FG001|Overall Study|Sponsor's Decision|2|||
129957505|NCT00714688|467806505|FG002|Overall Study|Sponsor's Decision|0|||
129957506|NCT00714688|467806503|FG000|Overall Study|Other|1|||
129957507|NCT00714688|467806504|FG001|Overall Study|Other|6|||
129957508|NCT00714688|467806505|FG002|Overall Study|Other|5|||
129957509|NCT01808144|467806507|FG000|Overall Study|Death|1|||
129957510|NCT01808144|467806508|FG001|Overall Study|Death|0|||
129957511|NCT01808144|467806507|FG000|Overall Study|Withdrawal by Subject|16|||
129957512|NCT01808144|467806508|FG001|Overall Study|Withdrawal by Subject|23|||
129957513|NCT01808144|467806507|FG000|Overall Study|Lost to Follow-up|6|||
129957514|NCT01808144|467806508|FG001|Overall Study|Lost to Follow-up|3|||
129957515|NCT01808144|467806507|FG000|Overall Study|Protocol Violation|6|||
129957516|NCT01808144|467806508|FG001|Overall Study|Protocol Violation|6|||
129957517|NCT01808144|467806507|FG000|Overall Study|Gout flare|0|||
129957518|NCT01808144|467806508|FG001|Overall Study|Gout flare|1|||
129957519|NCT01808144|467806507|FG000|Overall Study|Adverse Event|11|||
129957520|NCT01808144|467806508|FG001|Overall Study|Adverse Event|15|||
129957521|NCT00383500|467806509|FG000|Overall Study|Withdrawal by Subject|8|||
129957522|NCT00383500|467806510|FG001|Overall Study|Withdrawal by Subject|3|||
129957523|NCT00383500|467806511|FG002|Overall Study|Withdrawal by Subject|0|||
129957524|NCT00383500|467806509|FG000|Overall Study|Lost to Follow-up|0|||
129957525|NCT00383500|467806510|FG001|Overall Study|Lost to Follow-up|0|||
129957526|NCT00383500|467806511|FG002|Overall Study|Lost to Follow-up|2|||
129957527|NCT02176356|467808143|FG000|Overall Study|Screen Failure|14|||
129957528|NCT02176356|467808143|FG000|Overall Study|Lost to Follow-up|4|||
129957529|NCT02176356|467808143|FG000|Overall Study|Personal Reasons|3|||
129957530|NCT02176356|467808143|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129957531|NCT00792259|467808144|FG000|Overall Study|Poor Quality Scans|1|||
129957532|NCT00792259|467808145|FG001|Overall Study|Poor Quality Scans|0|||
129957533|NCT00792259|467808146|FG002|Overall Study|Poor Quality Scans|0|||
129957534|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
129957535|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
129957536|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
129957537|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
129957538|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
129957539|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
129957540|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
129957541|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
129957542|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
129957543|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
129957544|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
129957545|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
129957546|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
129957547|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
129957548|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
129957549|NCT00332488|467808147|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
129957550|NCT00332488|467808148|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
129957551|NCT00332488|467808149|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
129957552|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
129957553|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
129957554|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
129957555|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
129957556|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
129957557|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
129957558|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
129957559|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
129957560|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
129957561|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
129957562|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
129957563|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
129957564|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
129957565|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
129957566|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
129957567|NCT00332488|467808147|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
129957568|NCT00332488|467808148|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
129957569|NCT00332488|467808149|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
129957570|NCT00371462|467808150|FG000|Overall Study|Withdrawal by Subject|1|||
129957571|NCT00371462|467808151|FG001|Overall Study|Withdrawal by Subject|0|||
129957572|NCT00371462|467808150|FG000|Overall Study|Other|7|||
129957573|NCT00371462|467808151|FG001|Overall Study|Other|8|||
129957574|NCT03721978|467808153|FG000|Overall Study|Withdrawal by Subject|6|||
129957575|NCT03721978|467808154|FG001|Overall Study|Withdrawal by Subject|1|||
129957576|NCT03721978|467808153|FG000|Overall Study|Adverse Event|1|||
129957577|NCT03721978|467808154|FG001|Overall Study|Adverse Event|1|||
129957578|NCT03721978|467808153|FG000|Overall Study|Progressive Disease|1|||
129957579|NCT03721978|467808154|FG001|Overall Study|Progressive Disease|0|||
129957580|NCT03721978|467808153|FG000|Overall Study|Lost to Follow-up|5|||
129957581|NCT03721978|467808154|FG001|Overall Study|Lost to Follow-up|1|||
129957582|NCT03721978|467808153|FG000|Overall Study|Reason not Specified|0|||
129957583|NCT03721978|467808154|FG001|Overall Study|Reason not Specified|2|||
129957584|NCT05244226|467808155|FG000|Overall Study|Adverse Event|1|||
129957585|NCT05244226|467808156|FG001|Overall Study|Adverse Event|0|||
129957586|NCT05244226|467808157|FG002|Overall Study|Adverse Event|0|||
129957587|NCT05244226|467808155|FG000|Overall Study|Lost to Follow-up|0|||
129957588|NCT05244226|467808156|FG001|Overall Study|Lost to Follow-up|0|||
129957589|NCT05244226|467808157|FG002|Overall Study|Lost to Follow-up|1|||
129957590|NCT05244226|467808155|FG000|Overall Study|Protocol Violation|0|||
129957591|NCT05244226|467808156|FG001|Overall Study|Protocol Violation|2|||
129957592|NCT05244226|467808157|FG002|Overall Study|Protocol Violation|2|||
129957593|NCT02507687|467808158|FG000|Overall Study|Adverse Event|3|||
129957594|NCT02507687|467808159|FG001|Overall Study|Adverse Event|2|||
129957595|NCT02507687|467808160|FG002|Overall Study|Adverse Event|2|||
129957596|NCT02507687|467808161|FG003|Overall Study|Adverse Event|2|||
129957597|NCT02507687|467808158|FG000|Overall Study|Withdrawal by Subject|1|||
129957598|NCT02507687|467808159|FG001|Overall Study|Withdrawal by Subject|4|||
129957599|NCT02507687|467808160|FG002|Overall Study|Withdrawal by Subject|6|||
129454203|NCT00798135|465959489|FG000|Overall Study|Physician Decision|1|||
129454204|NCT00687440|465959490|FG000|Overall Study|Adverse Event|3|||
129454205|NCT00687440|465959490|FG000|Overall Study|Lost to Follow-up|3|||
129454206|NCT00687440|465959490|FG000|Overall Study|Lack of Efficacy|2|||
129454207|NCT00687440|465959490|FG000|Overall Study|Death|2|||
129957600|NCT02507687|467808161|FG003|Overall Study|Withdrawal by Subject|6|||
129957601|NCT02507687|467808158|FG000|Overall Study|Protocol Violation|1|||
129957602|NCT02507687|467808159|FG001|Overall Study|Protocol Violation|0|||
129957603|NCT02507687|467808160|FG002|Overall Study|Protocol Violation|2|||
129957604|NCT02507687|467808161|FG003|Overall Study|Protocol Violation|0|||
129957605|NCT02507687|467808158|FG000|Overall Study|Lost to Follow-up|0|||
129957606|NCT02507687|467808159|FG001|Overall Study|Lost to Follow-up|0|||
129957607|NCT02507687|467808160|FG002|Overall Study|Lost to Follow-up|2|||
129957608|NCT02507687|467808161|FG003|Overall Study|Lost to Follow-up|1|||
129957609|NCT02507687|467808158|FG000|Overall Study|Screen Failure|0|||
129957610|NCT02507687|467808159|FG001|Overall Study|Screen Failure|0|||
129957611|NCT02507687|467808160|FG002|Overall Study|Screen Failure|1|||
129957612|NCT02507687|467808161|FG003|Overall Study|Screen Failure|0|||
129957613|NCT02507687|467808158|FG000|Overall Study|Other, Not Specified|0|||
129957614|NCT02507687|467808159|FG001|Overall Study|Other, Not Specified|0|||
129957615|NCT02507687|467808160|FG002|Overall Study|Other, Not Specified|2|||
129957616|NCT02507687|467808161|FG003|Overall Study|Other, Not Specified|4|||
129957617|NCT00733226|467808162|FG000|Overall Study|Withdrawal by Subject|1|||
129957618|NCT00733226|467808163|FG001|Overall Study|Withdrawal by Subject|0|||
129957619|NCT00733226|467808162|FG000|Overall Study|Lost to Follow-up|2|||
129957620|NCT00733226|467808163|FG001|Overall Study|Lost to Follow-up|0|||
129957621|NCT00733226|467808162|FG000|Overall Study|moved to another place|2|||
129957622|NCT00733226|467808163|FG001|Overall Study|moved to another place|0|||
129957623|NCT03722485|467808166|FG000|Overall Study|Withdrawal by Subject|1|||
129957624|NCT03722485|467808167|FG001|Overall Study|Withdrawal by Subject|0|||
129957625|NCT03722485|467808166|FG000|Overall Study|Adverse Event|0|||
129957626|NCT03722485|467808167|FG001|Overall Study|Adverse Event|2|||
129957627|NCT03722485|467808166|FG000|Overall Study|subject discharged prior to study completion|1|||
129957628|NCT03722485|467808167|FG001|Overall Study|subject discharged prior to study completion|5|||
129957629|NCT03722485|467808166|FG000|Overall Study|eligibility criteria not met|2|||
129957630|NCT03722485|467808167|FG001|Overall Study|eligibility criteria not met|0|||
129957631|NCT00349622|467808168|FG000|Overall Study|Death|168|||
129957632|NCT00349622|467808169|FG001|Overall Study|Death|86|||
129957633|NCT00349622|467808168|FG000|Overall Study|Lost to Follow-up|5|||
129957634|NCT00349622|467808169|FG001|Overall Study|Lost to Follow-up|1|||
129957635|NCT00349622|467808168|FG000|Overall Study|Withdrawal by Subject|5|||
129957636|NCT00349622|467808169|FG001|Overall Study|Withdrawal by Subject|9|||
129957637|NCT01902381|467808170|FG000|Overall Study|Withdrawal by Subject|1|||
129957638|NCT00755716|467808175|FG000|Overall Study|Adverse Event|1|||
129957639|NCT00755716|467808176|FG001|Overall Study|Adverse Event|4|||
129454208|NCT00687440|465959490|FG000|Overall Study|Other|1|||
129454209|NCT00687440|465959490|FG000|Overall Study|Missing|1|||
129454210|NCT01392677|465959493|FG000|Overall Study|Adverse Event|3|||
129454211|NCT01392677|465959494|FG001|Overall Study|Adverse Event|1|||
129957640|NCT00755716|467808177|FG002|Overall Study|Adverse Event|1|||
129957641|NCT00755716|467808175|FG000|Overall Study|Lack of Efficacy|2|||
129957642|NCT00755716|467808176|FG001|Overall Study|Lack of Efficacy|0|||
129957643|NCT00755716|467808177|FG002|Overall Study|Lack of Efficacy|0|||
129957644|NCT00755716|467808175|FG000|Overall Study|Lost to Follow-up|5|||
129957645|NCT00755716|467808176|FG001|Overall Study|Lost to Follow-up|3|||
129957646|NCT00755716|467808177|FG002|Overall Study|Lost to Follow-up|1|||
129957647|NCT00755716|467808175|FG000|Overall Study|work schedule issues|0|||
129957648|NCT00755716|467808176|FG001|Overall Study|work schedule issues|1|||
129957649|NCT00755716|467808177|FG002|Overall Study|work schedule issues|1|||
129957650|NCT02762500|467808178|FG000|Overall Study|Lack of Efficacy|1|||
129957651|NCT02762500|467808179|FG001|Overall Study|Lack of Efficacy|0|||
129957652|NCT02762500|467808178|FG000|Overall Study|Withdrawal by Subject|1|||
129957653|NCT02762500|467808179|FG001|Overall Study|Withdrawal by Subject|1|||
129957654|NCT02762500|467808178|FG000|Overall Study|Adverse Event|0|||
129957655|NCT02762500|467808179|FG001|Overall Study|Adverse Event|2|||
129957656|NCT02229396|467808180|FG000|Overall Study|Adverse Event|6|||
129957657|NCT02229396|467808181|FG001|Overall Study|Adverse Event|12|||
129957658|NCT02229396|467808182|FG002|Overall Study|Adverse Event|12|||
129957659|NCT02229396|467808180|FG000|Overall Study|Death|2|||
129957660|NCT02229396|467808181|FG001|Overall Study|Death|3|||
129957661|NCT02229396|467808182|FG002|Overall Study|Death|1|||
129957662|NCT02229396|467808180|FG000|Overall Study|Lost to Follow-up|14|||
129957663|NCT02229396|467808181|FG001|Overall Study|Lost to Follow-up|14|||
129957664|NCT02229396|467808182|FG002|Overall Study|Lost to Follow-up|21|||
129957665|NCT02229396|467808180|FG000|Overall Study|Protocol Violation|2|||
129957666|NCT02229396|467808181|FG001|Overall Study|Protocol Violation|1|||
129957667|NCT02229396|467808182|FG002|Overall Study|Protocol Violation|0|||
129957668|NCT02229396|467808180|FG000|Overall Study|Patient Incorrectly Randomized|0|||
129957669|NCT02229396|467808181|FG001|Overall Study|Patient Incorrectly Randomized|0|||
129957670|NCT02229396|467808182|FG002|Overall Study|Patient Incorrectly Randomized|1|||
129957671|NCT02229396|467808180|FG000|Overall Study|Other|10|||
129957672|NCT02229396|467808181|FG001|Overall Study|Other|18|||
129957673|NCT02229396|467808182|FG002|Overall Study|Other|15|||
129957674|NCT02229396|467808180|FG000|Overall Study|Withdrawal by Subject|42|||
129957675|NCT02229396|467808181|FG001|Overall Study|Withdrawal by Subject|28|||
129957676|NCT02229396|467808182|FG002|Overall Study|Withdrawal by Subject|41|||
129957677|NCT02229396|467808180|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
129957678|NCT02229396|467808181|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129957679|NCT02229396|467808182|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
129957680|NCT02229396|467808180|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
129957681|NCT02229396|467808181|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
129957682|NCT02229396|467808182|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
129957683|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
129957684|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
129957685|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
129957686|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
129957687|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
129957688|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
129957689|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
129957690|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
129957691|NCT00352053|467808190|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
129957692|NCT00352053|467808191|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
129957693|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
129957694|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
129957695|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
129957696|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
129957697|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
129957698|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
129957699|NCT00352053|467808190|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
129957700|NCT00352053|467808191|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
129957701|NCT00352053|467808190|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
129957702|NCT00352053|467808191|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
129957703|NCT00352053|467808190|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
129957704|NCT00352053|467808191|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
129957705|NCT00352053|467808190|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
129957706|NCT00352053|467808191|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
129957707|NCT00352053|467808190|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
129957708|NCT00352053|467808191|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
129957709|NCT01066897|467808192|FG000|Overall Study|Withdrawal by Subject|1|||
129957710|NCT01066897|467808193|FG001|Overall Study|Withdrawal by Subject|0|||
129957711|NCT01066897|467808192|FG000|Overall Study|stopped study after developing the flu.|1|||
129957712|NCT01066897|467808193|FG001|Overall Study|stopped study after developing the flu.|0|||
129957713|NCT03275402|467808194|FG000|Overall Study|Death|17|||
129957714|NCT03275402|467808194|FG000|Overall Study|Study terminated by sponsor|21|||
129957715|NCT03275402|467808194|FG000|Overall Study|Withdrawal by Subject|1|||
129957716|NCT02402465|467808196|FG000|Overall Study|Withdrawal by Subject|0|||
129957717|NCT02402465|467808197|FG001|Overall Study|Withdrawal by Subject|0|||
129957718|NCT02402465|467808198|FG002|Overall Study|Withdrawal by Subject|0|||
129957719|NCT02402465|467808199|FG003|Overall Study|Withdrawal by Subject|0|||
129957720|NCT02402465|467808200|FG004|Overall Study|Withdrawal by Subject|0|||
129957721|NCT02402465|467808201|FG005|Overall Study|Withdrawal by Subject|1|||
129957722|NCT02402465|467808196|FG000|Overall Study|Lost to Follow-up|0|||
129957723|NCT02402465|467808197|FG001|Overall Study|Lost to Follow-up|1|||
129957724|NCT02402465|467808198|FG002|Overall Study|Lost to Follow-up|0|||
129957725|NCT02402465|467808199|FG003|Overall Study|Lost to Follow-up|0|||
129957726|NCT02402465|467808200|FG004|Overall Study|Lost to Follow-up|1|||
129957727|NCT02402465|467808201|FG005|Overall Study|Lost to Follow-up|0|||
129957728|NCT03807700|467808202|FG000|Overall Study|Withdrawal by Subject|2|||
129957729|NCT03807700|467808203|FG001|Overall Study|Withdrawal by Subject|1|||
129957730|NCT02005029|467808205|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
129957731|NCT02005029|467808206|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
129957732|NCT01675050|467808207|FG000|Period One Treatment|Withdrawal by Subject|1|||
129957733|NCT01675050|467808208|FG001|Period One Treatment|Withdrawal by Subject|0|||
129957734|NCT02625922|467808209|FG000|Overall Study|Non-availability of IMP|1|||
129957735|NCT02625922|467808210|FG001|Overall Study|Non-availability of IMP|1|||
129957736|NCT02625922|467808209|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
129957737|NCT02625922|467808210|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
129957738|NCT02282917|467808212|FG000|Overall Study|Withdrawal by Subject|1|||
129957739|NCT02282917|467808212|FG000|Overall Study|Screen Failure/Not Eligible|1|||
129957740|NCT01747629|467808213|FG000|Overall Study|Adverse Event|1|||
129957741|NCT01747629|467808214|FG001|Overall Study|Adverse Event|2|||
129454212|NCT01392677|465959493|FG000|Overall Study|Withdrawal by Subject|0|||
129454213|NCT01392677|465959494|FG001|Overall Study|Withdrawal by Subject|2|||
129454214|NCT01392677|465959493|FG000|Overall Study|Incorrect enrollment|2|||
129957742|NCT01747629|467808213|FG000|Overall Study|Withdrawal by Subject|2|||
129957743|NCT01747629|467808214|FG001|Overall Study|Withdrawal by Subject|2|||
129957744|NCT01747629|467808213|FG000|Overall Study|Noncompliance|1|||
129957745|NCT01747629|467808214|FG001|Overall Study|Noncompliance|1|||
129957746|NCT01747629|467808213|FG000|Overall Study|Inclusion criteria not met|1|||
129957747|NCT01747629|467808214|FG001|Overall Study|Inclusion criteria not met|0|||
129957748|NCT01747629|467808213|FG000|Overall Study|Not treated|1|||
129957749|NCT01747629|467808214|FG001|Overall Study|Not treated|0|||
129957750|NCT01747629|467808213|FG000|Overall Study|Other|2|||
129957751|NCT01747629|467808214|FG001|Overall Study|Other|1|||
129957752|NCT04414397|467808215|FG000|Control Period|Withdrawal by Subject|2|||
129957753|NCT04414397|467808216|FG001|Control Period|Withdrawal by Subject|2|||
129957754|NCT04414397|467808215|FG000|Control Period|Lost to Follow-up|0|||
129957755|NCT04414397|467808216|FG001|Control Period|Lost to Follow-up|4|||
129957756|NCT04414397|467808215|FG000|Control Period|Protocol deviation|0|||
129957757|NCT04414397|467808216|FG001|Control Period|Protocol deviation|1|||
129957758|NCT04414397|467808215|FG000|Post-Control Period|Withdrawal by Subject|3|||
129957759|NCT04414397|467808216|FG001|Post-Control Period|Withdrawal by Subject|6|||
129957760|NCT04414397|467808215|FG000|Post-Control Period|Lost to Follow-up|4|||
129957761|NCT04414397|467808216|FG001|Post-Control Period|Lost to Follow-up|9|||
129957762|NCT04414397|467808215|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
129957763|NCT04414397|467808216|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
129957764|NCT04414397|467808215|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
129957765|NCT04414397|467808216|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
129957766|NCT01920178|467808218|FG000|Overall Study|Lost to Follow-up|2|||
129957767|NCT01920178|467808219|FG001|Overall Study|Lost to Follow-up|1|||
129957768|NCT03562117|467808223|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
129957769|NCT03562117|467808224|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
129957770|NCT03562117|467808225|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
129957771|NCT01294358|467808226|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957772|NCT01294358|467808227|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
129957773|NCT01294358|467808228|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957774|NCT01294358|467808229|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957775|NCT01294358|467808230|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
129957776|NCT01294358|467808226|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957777|NCT01294358|467808227|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957778|NCT01294358|467808228|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
129957779|NCT01294358|467808229|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957780|NCT01294358|467808230|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
129957781|NCT01294358|467808226|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957782|NCT01294358|467808227|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957783|NCT01294358|467808228|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957784|NCT01294358|467808229|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
129957785|NCT01294358|467808230|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
129957786|NCT01294358|467808226|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957787|NCT01294358|467808227|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957788|NCT01294358|467808228|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957789|NCT01294358|467808229|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
129957790|NCT01294358|467808230|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
129957791|NCT00655668|467808240|FG000|Overall Study|Adverse Event|6|||
129957792|NCT00655668|467808240|FG000|Overall Study|Death|5|||
129957793|NCT00655668|467808240|FG000|Overall Study|Disease Progression|27|||
129957794|NCT00655668|467808240|FG000|Overall Study|Study Terminated|9|||
129957795|NCT00655668|467808240|FG000|Overall Study|Other|1|||
129957796|NCT00655668|467808240|FG000|Overall Study|New Lymphoma Treatment Started|4|||
129957797|NCT00655668|467808240|FG000|Overall Study|Withdrawal by Subject|2|||
129957798|NCT03740919|467808241|FG000|Lead-in Period|Lost to Follow-up|1|||
129957799|NCT03740919|467808242|FG001|Lead-in Period|Lost to Follow-up|0|||
129957800|NCT03740919|467808243|FG002|Lead-in Period|Lost to Follow-up|0|||
129957801|NCT03740919|467808244|FG003|Lead-in Period|Lost to Follow-up|0|||
129957802|NCT03740919|467808241|FG000|Lead-in Period|Physician Decision|2|||
129957803|NCT03740919|467808242|FG001|Lead-in Period|Physician Decision|0|||
129957804|NCT03740919|467808243|FG002|Lead-in Period|Physician Decision|0|||
129957805|NCT03740919|467808244|FG003|Lead-in Period|Physician Decision|0|||
129957806|NCT03740919|467808241|FG000|Lead-in Period|Protocol Violation|1|||
129957807|NCT03740919|467808242|FG001|Lead-in Period|Protocol Violation|0|||
129957808|NCT03740919|467808243|FG002|Lead-in Period|Protocol Violation|0|||
129957809|NCT03740919|467808244|FG003|Lead-in Period|Protocol Violation|0|||
129957810|NCT03740919|467808241|FG000|Lead-in Period|Withdrawal by Subject|10|||
129957811|NCT03740919|467808242|FG001|Lead-in Period|Withdrawal by Subject|0|||
129957812|NCT03740919|467808243|FG002|Lead-in Period|Withdrawal by Subject|0|||
129957813|NCT03740919|467808244|FG003|Lead-in Period|Withdrawal by Subject|0|||
129957814|NCT03740919|467808241|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
129957815|NCT03740919|467808242|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
129957816|NCT03740919|467808243|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
129957817|NCT03740919|467808244|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
129957818|NCT03740919|467808241|FG000|Lead-in Period|Study Task Too Burdensome|1|||
129957819|NCT03740919|467808242|FG001|Lead-in Period|Study Task Too Burdensome|0|||
129957820|NCT03740919|467808243|FG002|Lead-in Period|Study Task Too Burdensome|0|||
129957821|NCT03740919|467808244|FG003|Lead-in Period|Study Task Too Burdensome|0|||
129957822|NCT03740919|467808241|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
129957823|NCT03740919|467808242|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
129957824|NCT03740919|467808243|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
129957825|NCT03740919|467808244|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
129957826|NCT03740919|467808241|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
129957827|NCT03740919|467808242|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
129957828|NCT03740919|467808243|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
129957829|NCT03740919|467808244|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
129957830|NCT03740919|467808241|FG000|Treatment Period|Adverse Event|0|||
129957831|NCT03740919|467808242|FG001|Treatment Period|Adverse Event|0|||
129957832|NCT03740919|467808243|FG002|Treatment Period|Adverse Event|2|||
129957833|NCT03740919|467808244|FG003|Treatment Period|Adverse Event|0|||
129957834|NCT03740919|467808241|FG000|Treatment Period|Protocol Violation|0|||
129957835|NCT03740919|467808242|FG001|Treatment Period|Protocol Violation|1|||
129957836|NCT03740919|467808243|FG002|Treatment Period|Protocol Violation|0|||
129957837|NCT03740919|467808244|FG003|Treatment Period|Protocol Violation|0|||
129957838|NCT03740919|467808241|FG000|Treatment Period|Withdrawal by Subject|0|||
129957839|NCT03740919|467808242|FG001|Treatment Period|Withdrawal by Subject|7|||
129957840|NCT03740919|467808243|FG002|Treatment Period|Withdrawal by Subject|6|||
129957841|NCT03740919|467808244|FG003|Treatment Period|Withdrawal by Subject|2|||
129957842|NCT03740919|467808241|FG000|Treatment Period|Terminated by Sponsor|0|||
129957843|NCT03740919|467808242|FG001|Treatment Period|Terminated by Sponsor|1|||
129957844|NCT03740919|467808243|FG002|Treatment Period|Terminated by Sponsor|0|||
129957845|NCT03740919|467808244|FG003|Treatment Period|Terminated by Sponsor|0|||
129957846|NCT03740919|467808241|FG000|Treatment Period|Issue with Insulin Pump|0|||
129957847|NCT03740919|467808242|FG001|Treatment Period|Issue with Insulin Pump|1|||
129957848|NCT03740919|467808243|FG002|Treatment Period|Issue with Insulin Pump|0|||
129957849|NCT03740919|467808244|FG003|Treatment Period|Issue with Insulin Pump|0|||
129957850|NCT03740919|467808241|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
129957851|NCT03740919|467808242|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
129957852|NCT03740919|467808243|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
129957853|NCT03740919|467808244|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
129957854|NCT03740919|467808241|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
129957855|NCT03740919|467808242|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
129957856|NCT03740919|467808243|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
129454215|NCT01392677|465959494|FG001|Overall Study|Incorrect enrollment|3|||
129454216|NCT01392677|465959493|FG000|Overall Study|Other reason|3|||
129454217|NCT01392677|465959494|FG001|Overall Study|Other reason|2|||
129454218|NCT03996876|465959495|FG000|Overall Study|Incomplete Data|2|||
129454219|NCT03996876|465959496|FG001|Overall Study|Incomplete Data|4|||
129454220|NCT03080883|465959497|FG000|Overall Study|Withdrawal by Subject|11|||
129957857|NCT03740919|467808244|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
129957858|NCT03740919|467808241|FG000|Treatment Period|Not Completing Diary|0|||
129957859|NCT03740919|467808242|FG001|Treatment Period|Not Completing Diary|0|||
129957860|NCT03740919|467808243|FG002|Treatment Period|Not Completing Diary|1|||
129957861|NCT03740919|467808244|FG003|Treatment Period|Not Completing Diary|0|||
129957862|NCT03740919|467808241|FG000|Treatment Period|Insulin Painful to Participant|0|||
129957863|NCT03740919|467808242|FG001|Treatment Period|Insulin Painful to Participant|0|||
129957864|NCT03740919|467808243|FG002|Treatment Period|Insulin Painful to Participant|1|||
129957865|NCT03740919|467808244|FG003|Treatment Period|Insulin Painful to Participant|0|||
129957866|NCT03873038|467808247|FG000|Part 2|Withdrawal by Subject|0|||
129454221|NCT03080883|465959498|FG001|Overall Study|Withdrawal by Subject|15|||
129454222|NCT03080883|465959497|FG000|Overall Study|Adverse Event|22|||
129957867|NCT03873038|467808248|FG001|Part 2|Withdrawal by Subject|0|||
129957868|NCT03873038|467808249|FG002|Part 2|Withdrawal by Subject|0|||
129957869|NCT03873038|467808250|FG003|Part 2|Withdrawal by Subject|0|||
129454223|NCT03080883|465959498|FG001|Overall Study|Adverse Event|22|||
129454224|NCT03080883|465959497|FG000|Overall Study|Alternative Therapy|0|||
129454225|NCT03080883|465959498|FG001|Overall Study|Alternative Therapy|3|||
129454226|NCT03080883|465959497|FG000|Overall Study|Other Complicating Disease|9|||
129454227|NCT03080883|465959498|FG001|Overall Study|Other Complicating Disease|5|||
129454228|NCT03080883|465959497|FG000|Overall Study|Death|21|||
129454229|NCT03080883|465959498|FG001|Overall Study|Death|16|||
129454230|NCT03080883|465959497|FG000|Overall Study|Physician Decision|2|||
129454231|NCT03080883|465959498|FG001|Overall Study|Physician Decision|2|||
129454232|NCT03080883|465959497|FG000|Overall Study|Disease Progression|2|||
129957870|NCT03873038|467808251|FG004|Part 2|Withdrawal by Subject|0|||
129957871|NCT03873038|467808252|FG005|Part 2|Withdrawal by Subject|1|||
129957872|NCT03873038|467808247|FG000|Part 2|Unknon|0|||
129957873|NCT03873038|467808248|FG001|Part 2|Unknon|0|||
129957874|NCT03873038|467808249|FG002|Part 2|Unknon|0|||
129957875|NCT03873038|467808250|FG003|Part 2|Unknon|0|||
129957876|NCT03873038|467808251|FG004|Part 2|Unknon|1|||
129957877|NCT03873038|467808252|FG005|Part 2|Unknon|0|||
129957878|NCT04222088|467808253|FG000|Overall Study|Lost to Follow-up|5|||
129957879|NCT04222088|467808254|FG001|Overall Study|Lost to Follow-up|1|||
129957880|NCT04222088|467808253|FG000|Overall Study|Withdrawal by Subject|4|||
129957881|NCT04222088|467808254|FG001|Overall Study|Withdrawal by Subject|0|||
129957882|NCT00595764|467808255|FG000|Overall Study|Protocol Violation|24|||
129957883|NCT00595764|467808256|FG001|Overall Study|Protocol Violation|19|||
129957884|NCT00595764|467808255|FG000|Overall Study|Missed Medication >1 week|10|||
129957885|NCT00595764|467808256|FG001|Overall Study|Missed Medication >1 week|17|||
129957886|NCT00595764|467808255|FG000|Overall Study|Missed 3 PM visits|1|||
129957887|NCT00595764|467808256|FG001|Overall Study|Missed 3 PM visits|7|||
129957888|NCT00595764|467808255|FG000|Overall Study|Withdrawal by Subject|4|||
129957889|NCT00595764|467808256|FG001|Overall Study|Withdrawal by Subject|0|||
129957890|NCT01894256|467808259|FG000|Part A|Adverse Event|0|||
129957891|NCT01894256|467808260|FG001|Part A|Adverse Event|1|||
129957892|NCT01894256|467808261|FG002|Part A|Adverse Event|0|||
129957893|NCT01894256|467808259|FG000|Part B|Death|0|||
129957894|NCT01894256|467808260|FG001|Part B|Death|1|||
129957895|NCT01894256|467808261|FG002|Part B|Death|1|||
129957896|NCT01894256|467808259|FG000|Part B|Withdrawal by Subject|0|||
129957897|NCT01894256|467808260|FG001|Part B|Withdrawal by Subject|1|||
129957898|NCT01894256|467808261|FG002|Part B|Withdrawal by Subject|0|||
129957899|NCT01894256|467808259|FG000|Part B|Lack of Efficacy|15|||
129957900|NCT01894256|467808260|FG001|Part B|Lack of Efficacy|12|||
129957901|NCT01894256|467808261|FG002|Part B|Lack of Efficacy|13|||
129957902|NCT02133131|467808262|FG000|Overall Study|Adverse Event|0|||
129957903|NCT02133131|467808263|FG001|Overall Study|Adverse Event|0|||
129957904|NCT02133131|467808264|FG002|Overall Study|Adverse Event|0|||
129957905|NCT02133131|467808265|FG003|Overall Study|Adverse Event|1|||
129957906|NCT02133131|467808266|FG004|Overall Study|Adverse Event|0|||
129957907|NCT02133131|467808267|FG005|Overall Study|Adverse Event|0|||
129957908|NCT02133131|467808268|FG006|Overall Study|Adverse Event|0|||
129957909|NCT02133131|467808262|FG000|Overall Study|Lost to Follow-up|1|||
129957910|NCT02133131|467808263|FG001|Overall Study|Lost to Follow-up|0|||
129957911|NCT02133131|467808264|FG002|Overall Study|Lost to Follow-up|0|||
129957912|NCT02133131|467808265|FG003|Overall Study|Lost to Follow-up|1|||
129957913|NCT02133131|467808266|FG004|Overall Study|Lost to Follow-up|0|||
129957914|NCT02133131|467808267|FG005|Overall Study|Lost to Follow-up|0|||
129957915|NCT02133131|467808268|FG006|Overall Study|Lost to Follow-up|0|||
129957916|NCT02133131|467808262|FG000|Overall Study|Status not recorded|4|||
129957917|NCT02133131|467808263|FG001|Overall Study|Status not recorded|5|||
129957918|NCT02133131|467808264|FG002|Overall Study|Status not recorded|1|||
129957919|NCT02133131|467808265|FG003|Overall Study|Status not recorded|4|||
129957920|NCT02133131|467808266|FG004|Overall Study|Status not recorded|0|||
129957921|NCT02133131|467808267|FG005|Overall Study|Status not recorded|0|||
129957922|NCT02133131|467808268|FG006|Overall Study|Status not recorded|0|||
129957923|NCT02133131|467808262|FG000|Overall Study|Ongoing in study|0|||
129957924|NCT02133131|467808263|FG001|Overall Study|Ongoing in study|0|||
129957925|NCT02133131|467808264|FG002|Overall Study|Ongoing in study|0|||
129957926|NCT02133131|467808265|FG003|Overall Study|Ongoing in study|0|||
129957927|NCT02133131|467808266|FG004|Overall Study|Ongoing in study|15|||
129957928|NCT02133131|467808267|FG005|Overall Study|Ongoing in study|14|||
129957929|NCT02133131|467808268|FG006|Overall Study|Ongoing in study|11|||
129957930|NCT02133131|467808262|FG000|Overall Study|Protocol Violation|0|||
129957931|NCT02133131|467808263|FG001|Overall Study|Protocol Violation|0|||
129957932|NCT02133131|467808264|FG002|Overall Study|Protocol Violation|0|||
129957933|NCT02133131|467808265|FG003|Overall Study|Protocol Violation|0|||
129957934|NCT02133131|467808266|FG004|Overall Study|Protocol Violation|0|||
129957935|NCT02133131|467808267|FG005|Overall Study|Protocol Violation|0|||
129957936|NCT02133131|467808268|FG006|Overall Study|Protocol Violation|1|||
129957937|NCT01544153|467808269|FG000|Overall Study|Under 18|0|||
129957938|NCT01544153|467808270|FG001|Overall Study|Under 18|1|||
129957939|NCT01544153|467808271|FG002|Overall Study|Under 18|0|||
129957940|NCT01544153|467808272|FG003|Overall Study|Under 18|0|||
129957941|NCT01544153|467808269|FG000|Overall Study|Non-smoker|0|||
129957942|NCT01544153|467808270|FG001|Overall Study|Non-smoker|0|||
129957943|NCT01544153|467808271|FG002|Overall Study|Non-smoker|1|||
129957944|NCT01544153|467808272|FG003|Overall Study|Non-smoker|0|||
129957945|NCT04783519|467808277|FG000|Overall Study|Withdrawal by Subject|2|||
129957946|NCT04783519|467808278|FG001|Overall Study|Withdrawal by Subject|7|||
129957947|NCT04783519|467808279|FG002|Overall Study|Withdrawal by Subject|3|||
129957948|NCT04783519|467808277|FG000|Overall Study|Lost to Follow-up|9|||
129957949|NCT04783519|467808278|FG001|Overall Study|Lost to Follow-up|7|||
129957950|NCT04783519|467808279|FG002|Overall Study|Lost to Follow-up|6|||
129957951|NCT00884793|467808280|FG000|Overall Study|Withdrawal by Subject|1|||
129957952|NCT01032200|467808281|FG000|Overall Study|Death|1|||
129957953|NCT01032200|467808282|FG001|Overall Study|Death|1|||
129957954|NCT01032200|467808281|FG000|Overall Study|Withdrawal by Subject|1|||
129957955|NCT01032200|467808282|FG001|Overall Study|Withdrawal by Subject|3|||
129957956|NCT01032200|467808281|FG000|Overall Study|Toxicity|0|||
129957957|NCT01032200|467808282|FG001|Overall Study|Toxicity|2|||
129957958|NCT01032200|467808281|FG000|Overall Study|Progression|1|||
129957959|NCT01032200|467808282|FG001|Overall Study|Progression|0|||
129957960|NCT01032200|467808281|FG000|Overall Study|Multiple|1|||
129957961|NCT01032200|467808282|FG001|Overall Study|Multiple|1|||
129957962|NCT02316171|467808288|FG000|Overall Study|difficulties with urinary catheter|1|||
129957963|NCT02316171|467808289|FG001|Overall Study|difficulties with urinary catheter|0|||
129957964|NCT02316171|467808290|FG002|Overall Study|difficulties with urinary catheter|0|||
129957965|NCT02316171|467808291|FG003|Overall Study|difficulties with urinary catheter|0|||
129957966|NCT01804140|467808293|FG000|Overall Study|No sampling or biopsy procedures done|114|||
129957967|NCT01524887|467808294|FG000|Overall Study|Withdrawal by Subject|6|||
129957968|NCT01524887|467808295|FG001|Overall Study|Withdrawal by Subject|2|||
129957969|NCT01524887|467808296|FG002|Overall Study|Withdrawal by Subject|3|||
129957970|NCT01524887|467808294|FG000|Overall Study|Adverse Event|5|||
129957971|NCT01524887|467808295|FG001|Overall Study|Adverse Event|1|||
129957972|NCT01524887|467808296|FG002|Overall Study|Adverse Event|1|||
129957973|NCT01524887|467808294|FG000|Overall Study|Protocol Violation|0|||
129957974|NCT01524887|467808295|FG001|Overall Study|Protocol Violation|0|||
129957975|NCT01524887|467808296|FG002|Overall Study|Protocol Violation|1|||
129957976|NCT01524887|467808294|FG000|Overall Study|Study termination|73|||
129957977|NCT01524887|467808295|FG001|Overall Study|Study termination|87|||
129957978|NCT01524887|467808296|FG002|Overall Study|Study termination|79|||
129957979|NCT01524887|467808294|FG000|Overall Study|Withdrawal by Caregiver|0|||
129957980|NCT01524887|467808295|FG001|Overall Study|Withdrawal by Caregiver|0|||
129957981|NCT01524887|467808296|FG002|Overall Study|Withdrawal by Caregiver|2|||
129957982|NCT01524887|467808294|FG000|Overall Study|Use of prohibited medication|1|||
129957983|NCT01524887|467808295|FG001|Overall Study|Use of prohibited medication|0|||
129957984|NCT01524887|467808296|FG002|Overall Study|Use of prohibited medication|0|||
129957985|NCT02785900|467808297|FG000|Overall Study|Study Termination by Sponsor|64|||
129957986|NCT02785900|467808298|FG001|Overall Study|Study Termination by Sponsor|81|||
129957987|NCT02785900|467808297|FG000|Overall Study|Death|46|||
129957988|NCT02785900|467808298|FG001|Overall Study|Death|32|||
129957989|NCT02785900|467808297|FG000|Overall Study|Withdrawal by Subject|4|||
129957990|NCT02785900|467808298|FG001|Overall Study|Withdrawal by Subject|8|||
129957991|NCT02785900|467808297|FG000|Overall Study|Physician Decision|3|||
129957992|NCT02785900|467808298|FG001|Overall Study|Physician Decision|2|||
129957993|NCT03993054|467808299|FG000|Overall Study|PI Decision|1|||
129957994|NCT04341584|467808303|FG000|Overall Study|Withdrew consent|0|||
129957995|NCT04341584|467808304|FG001|Overall Study|Withdrew consent|2|||
129957996|NCT04341584|467808305|FG002|Overall Study|Withdrew consent|2|||
129957997|NCT04341584|467808306|FG003|Overall Study|Withdrew consent|1|||
129957998|NCT00497198|467808308|FG000|Overall Study|Adverse Event|4|||
129957999|NCT00497198|467808309|FG001|Overall Study|Adverse Event|2|||
129958000|NCT00497198|467808308|FG000|Overall Study|Physician Decision|1|||
129958001|NCT00497198|467808309|FG001|Overall Study|Physician Decision|2|||
129958002|NCT00497198|467808308|FG000|Overall Study|Withdrawal by Subject|0|||
129958003|NCT00497198|467808309|FG001|Overall Study|Withdrawal by Subject|1|||
129958004|NCT04267393|467808310|FG000|Randomization|Adverse Event|1|||
129958005|NCT04267393|467808311|FG001|Randomization|Adverse Event|0|||
129958006|NCT04267393|467808312|FG002|Randomization|Adverse Event|0|||
129958007|NCT04267393|467808310|FG000|Randomization|Administrative Reasons by Sponsor|0|||
129958008|NCT04267393|467808311|FG001|Randomization|Administrative Reasons by Sponsor|1|||
129958009|NCT04267393|467808312|FG002|Randomization|Administrative Reasons by Sponsor|0|||
129958010|NCT04267393|467808310|FG000|Treatment Period|Adverse Event|0|||
129958011|NCT04267393|467808311|FG001|Treatment Period|Adverse Event|2|||
129958012|NCT04267393|467808312|FG002|Treatment Period|Adverse Event|3|||
129958013|NCT04267393|467808310|FG000|Treatment Period|Participant Withdrew Consent|0|||
129958014|NCT04267393|467808311|FG001|Treatment Period|Participant Withdrew Consent|0|||
129958015|NCT04267393|467808312|FG002|Treatment Period|Participant Withdrew Consent|1|||
129958016|NCT04267393|467808310|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
129958017|NCT04267393|467808311|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
129958018|NCT04267393|467808312|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
129958019|NCT02799745|467808313|FG000|Overall Study|Participant moved out of state|1|||
129958020|NCT02799745|467808314|FG001|Overall Study|Participant moved out of state|0|||
129958021|NCT02799745|467808313|FG000|Overall Study|Discontinued due to planned surgery|1|||
129958022|NCT02799745|467808314|FG001|Overall Study|Discontinued due to planned surgery|0|||
129958023|NCT02799745|467808313|FG000|Overall Study|Withdrawal by Subject|16|||
129958024|NCT02799745|467808314|FG001|Overall Study|Withdrawal by Subject|25|||
129958025|NCT02799745|467808313|FG000|Overall Study|Protocol Deviation|4|||
129958026|NCT02799745|467808314|FG001|Overall Study|Protocol Deviation|5|||
129958027|NCT02799745|467808313|FG000|Overall Study|Progressive Disease|28|||
129958028|NCT02799745|467808314|FG001|Overall Study|Progressive Disease|38|||
129958029|NCT02799745|467808313|FG000|Overall Study|Lost to Follow-up|3|||
129958030|NCT02799745|467808314|FG001|Overall Study|Lost to Follow-up|2|||
129958031|NCT02799745|467808313|FG000|Overall Study|Death|3|||
129958032|NCT02799745|467808314|FG001|Overall Study|Death|0|||
129958033|NCT02799745|467808313|FG000|Overall Study|Adverse Event|0|||
129958034|NCT02799745|467808314|FG001|Overall Study|Adverse Event|1|||
129958035|NCT04853238|467808315|FG000|Overall Study|Death|4|||
129958036|NCT04853238|467808316|FG001|Overall Study|Death|0|||
129958037|NCT04853238|467808317|FG002|Overall Study|Death|2|||
129958038|NCT04853238|467808315|FG000|Overall Study|Lost to Follow-up|16|||
129958039|NCT04853238|467808316|FG001|Overall Study|Lost to Follow-up|2|||
129958040|NCT04853238|467808317|FG002|Overall Study|Lost to Follow-up|37|||
129958041|NCT04853238|467808315|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
129958042|NCT04853238|467808316|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
129958043|NCT04853238|467808317|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
129958044|NCT04853238|467808315|FG000|Overall Study|Withdrawal by Subject|6|||
129958045|NCT04853238|467808316|FG001|Overall Study|Withdrawal by Subject|0|||
129958046|NCT04853238|467808317|FG002|Overall Study|Withdrawal by Subject|21|||
129958047|NCT04853238|467808315|FG000|Overall Study|Physician Decision|0|||
129958048|NCT04853238|467808316|FG001|Overall Study|Physician Decision|0|||
129958049|NCT04853238|467808317|FG002|Overall Study|Physician Decision|2|||
129958050|NCT04853238|467808315|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
129958051|NCT04853238|467808316|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
129958052|NCT04853238|467808317|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
129958053|NCT01002547|467810293|FG000|Overall Study|Withdrawal by Subject|4|||
129958054|NCT01002547|467810294|FG001|Overall Study|Withdrawal by Subject|0|||
129958055|NCT01002547|467810295|FG002|Overall Study|Withdrawal by Subject|5|||
129958056|NCT01002547|467810293|FG000|Overall Study|Lost to Follow-up|2|||
129958057|NCT01002547|467810294|FG001|Overall Study|Lost to Follow-up|1|||
129958058|NCT01002547|467810295|FG002|Overall Study|Lost to Follow-up|1|||
129958059|NCT01002547|467810293|FG000|Overall Study|Physician Decision|1|||
129958060|NCT01002547|467810294|FG001|Overall Study|Physician Decision|0|||
129958061|NCT01002547|467810295|FG002|Overall Study|Physician Decision|0|||
129958062|NCT01002547|467810293|FG000|Overall Study|Death|0|||
129958063|NCT01002547|467810294|FG001|Overall Study|Death|2|||
129958064|NCT01002547|467810295|FG002|Overall Study|Death|2|||
129958065|NCT01002547|467810293|FG000|Overall Study|Adverse Event|1|||
129958066|NCT01002547|467810294|FG001|Overall Study|Adverse Event|0|||
129958067|NCT01002547|467810295|FG002|Overall Study|Adverse Event|0|||
129958068|NCT02093897|467810302|FG000|Overall Study|Physician Decision|1|||
129958069|NCT02093897|467810302|FG000|Overall Study|Planned age group closure - no's reached|17|||
129958070|NCT02093897|467810302|FG000|Overall Study|Adverse event, non-fatal|1|||
129958071|NCT00088452|467810303|FG000|Overall Study|Did not receive intervention|1|||
129958072|NCT00088452|467810304|FG001|Overall Study|Did not receive intervention|0|||
129958073|NCT00088452|467810305|FG002|Overall Study|Did not receive intervention|1|||
129958074|NCT02081196|467810307|FG000|Overall Study|Lost to Follow-up|1|||
129958075|NCT03098797|467810310|FG000|Part 2 Open Label Extension|Adverse Event|2|||
129958076|NCT03098797|467810311|FG001|Part 2 Open Label Extension|Adverse Event|0|||
129958077|NCT00434577|467810312|FG000|Months 0-3|Serious Adverse Event|0|||
129958078|NCT00434577|467810313|FG001|Months 0-3|Serious Adverse Event|0|||
129958079|NCT00434577|467810314|FG002|Months 0-3|Serious Adverse Event|1|||
129958080|NCT00434577|467810315|FG003|Months 0-3|Serious Adverse Event|0|||
129958081|NCT00434577|467810316|FG004|Months 0-3|Serious Adverse Event|0|||
129958082|NCT00434577|467810312|FG000|Months 0-3|Adverse Event|0|||
129958083|NCT00434577|467810313|FG001|Months 0-3|Adverse Event|1|||
129958084|NCT00434577|467810314|FG002|Months 0-3|Adverse Event|1|||
129958085|NCT00434577|467810315|FG003|Months 0-3|Adverse Event|0|||
129958086|NCT00434577|467810316|FG004|Months 0-3|Adverse Event|0|||
129958087|NCT00434577|467810312|FG000|Months 0-3|Lost to Follow-up|0|||
129958088|NCT00434577|467810313|FG001|Months 0-3|Lost to Follow-up|0|||
129958089|NCT00434577|467810314|FG002|Months 0-3|Lost to Follow-up|0|||
129958090|NCT00434577|467810315|FG003|Months 0-3|Lost to Follow-up|0|||
129958091|NCT00434577|467810316|FG004|Months 0-3|Lost to Follow-up|2|||
129958092|NCT00434577|467810312|FG000|Months 0-3|Protocol Violation|1|||
129958093|NCT00434577|467810313|FG001|Months 0-3|Protocol Violation|0|||
129958094|NCT00434577|467810314|FG002|Months 0-3|Protocol Violation|1|||
129958095|NCT00434577|467810315|FG003|Months 0-3|Protocol Violation|0|||
129958096|NCT00434577|467810316|FG004|Months 0-3|Protocol Violation|0|||
129958097|NCT00434577|467810312|FG000|Months 0-3|Withdrawal by Subject|2|||
129958098|NCT00434577|467810313|FG001|Months 0-3|Withdrawal by Subject|1|||
129958099|NCT00434577|467810314|FG002|Months 0-3|Withdrawal by Subject|1|||
129958100|NCT00434577|467810315|FG003|Months 0-3|Withdrawal by Subject|1|||
129958101|NCT00434577|467810316|FG004|Months 0-3|Withdrawal by Subject|1|||
129958102|NCT01589523|467810329|FG000|Overall Study|Withdrawal by Subject|1|||
129958103|NCT00961896|467810330|FG000|Overall Study|Abnormal laboratory value|0|||
129958104|NCT00961896|467810331|FG001|Overall Study|Abnormal laboratory value|0|||
129958105|NCT00961896|467810332|FG002|Overall Study|Abnormal laboratory value|1|||
129958106|NCT00506922|467810333|FG000|Overall Study|Physician Decision|0|||
129958107|NCT00506922|467810334|FG001|Overall Study|Physician Decision|0|||
129958108|NCT00506922|467810335|FG002|Overall Study|Physician Decision|0|||
129958109|NCT00506922|467810336|FG003|Overall Study|Physician Decision|2|||
129958110|NCT00506922|467810337|FG004|Overall Study|Physician Decision|0|||
129958111|NCT00506922|467810333|FG000|Overall Study|Withdrawal by Subject|0|||
129958112|NCT00506922|467810334|FG001|Overall Study|Withdrawal by Subject|0|||
129958113|NCT00506922|467810335|FG002|Overall Study|Withdrawal by Subject|0|||
129958114|NCT00506922|467810336|FG003|Overall Study|Withdrawal by Subject|0|||
129958115|NCT00506922|467810337|FG004|Overall Study|Withdrawal by Subject|1|||
129958116|NCT02675998|467810346|FG000|8-Week Treatment Period|Adverse Event|6|||
129958117|NCT02675998|467810347|FG001|8-Week Treatment Period|Adverse Event|5|||
129958118|NCT02675998|467810348|FG002|8-Week Treatment Period|Adverse Event|6|||
129958119|NCT02675998|467810349|FG003|8-Week Treatment Period|Adverse Event|0|||
129958120|NCT02675998|467810346|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
129958121|NCT02675998|467810347|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
129958122|NCT02675998|467810348|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
129958123|NCT02675998|467810349|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
129958124|NCT02675998|467810346|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
129958125|NCT02675998|467810347|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
129958126|NCT02675998|467810348|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
129958127|NCT02675998|467810349|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
129958128|NCT02675998|467810346|FG000|8-Week Treatment Period|Physician Decision|1|||
129958129|NCT02675998|467810347|FG001|8-Week Treatment Period|Physician Decision|0|||
129958130|NCT02675998|467810348|FG002|8-Week Treatment Period|Physician Decision|2|||
129958131|NCT02675998|467810349|FG003|8-Week Treatment Period|Physician Decision|0|||
129958132|NCT02675998|467810346|FG000|8-Week Treatment Period|GI side Effects|1|||
129958133|NCT02675998|467810347|FG001|8-Week Treatment Period|GI side Effects|4|||
129958134|NCT02675998|467810348|FG002|8-Week Treatment Period|GI side Effects|2|||
129958135|NCT02675998|467810349|FG003|8-Week Treatment Period|GI side Effects|0|||
129958136|NCT02675998|467810346|FG000|8-Week Treatment Period|Protocol Violation|1|||
129454233|NCT03080883|465959498|FG001|Overall Study|Disease Progression|8|||
129958137|NCT02675998|467810347|FG001|8-Week Treatment Period|Protocol Violation|1|||
129958138|NCT02675998|467810348|FG002|8-Week Treatment Period|Protocol Violation|1|||
129958139|NCT02675998|467810349|FG003|8-Week Treatment Period|Protocol Violation|0|||
129958140|NCT02675998|467810346|FG000|8-Week Treatment Period|Other|3|||
129958141|NCT02675998|467810347|FG001|8-Week Treatment Period|Other|1|||
129958142|NCT02675998|467810348|FG002|8-Week Treatment Period|Other|2|||
129958143|NCT02675998|467810349|FG003|8-Week Treatment Period|Other|0|||
129958144|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
129958145|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
129958146|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
129958147|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
129958148|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
129958149|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
129958150|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
129958151|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
129454234|NCT03080883|465959497|FG000|Overall Study|Lost to Follow-up|1|||
129454235|NCT03080883|465959498|FG001|Overall Study|Lost to Follow-up|1|||
129454236|NCT00388973|465960704|FG000|Overall Study|Adverse Event|16|||
129454237|NCT00388973|465960705|FG001|Overall Study|Adverse Event|6|||
129454238|NCT00388973|465960704|FG000|Overall Study|Lack of Efficacy|1|||
129454239|NCT00388973|465960705|FG001|Overall Study|Lack of Efficacy|12|||
129454240|NCT00388973|465960704|FG000|Overall Study|Protocol Violation|3|||
129454241|NCT00388973|465960705|FG001|Overall Study|Protocol Violation|0|||
129454242|NCT00388973|465960704|FG000|Overall Study|Withdrawal by Subject|14|||
129454243|NCT00388973|465960705|FG001|Overall Study|Withdrawal by Subject|17|||
129454244|NCT00388973|465960704|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
129454245|NCT00388973|465960705|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
129454246|NCT00388973|465960704|FG000|Overall Study|Did not complete 61 days of treatment|5|||
129454247|NCT00388973|465960705|FG001|Overall Study|Did not complete 61 days of treatment|4|||
129454248|NCT00388973|465960704|FG000|Overall Study|Left region|0|||
129454249|NCT00388973|465960705|FG001|Overall Study|Left region|1|||
129454250|NCT00388973|465960704|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
129454251|NCT00388973|465960705|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
129454252|NCT00346073|465960720|FG000|Overall Study|Serious Adverse Event|2|||
129454253|NCT00346073|465960721|FG001|Overall Study|Serious Adverse Event|0|||
129454254|NCT00346073|465960720|FG000|Overall Study|Lost to Follow-up|39|||
129454255|NCT00346073|465960721|FG001|Overall Study|Lost to Follow-up|24|||
129454256|NCT03703882|465960726|FG000|Overall Study|Adverse Event|1|||
129454257|NCT03703882|465960727|FG001|Overall Study|Adverse Event|0|||
129454258|NCT03703882|465960726|FG000|Overall Study|Lost to Follow-up|0|||
129454259|NCT03703882|465960727|FG001|Overall Study|Lost to Follow-up|2|||
129454260|NCT03703882|465960726|FG000|Overall Study|Non-compliance with study drug|0|||
129454261|NCT03703882|465960727|FG001|Overall Study|Non-compliance with study drug|1|||
129454262|NCT03703882|465960726|FG000|Overall Study|Physician Decision|0|||
129454263|NCT03703882|465960727|FG001|Overall Study|Physician Decision|1|||
129454264|NCT03703882|465960726|FG000|Overall Study|Progressive disease|1|||
129454265|NCT03703882|465960727|FG001|Overall Study|Progressive disease|0|||
129454266|NCT03703882|465960726|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129454267|NCT03703882|465960727|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129454268|NCT03703882|465960726|FG000|Overall Study|Starting another treatment|0|||
129454269|NCT03703882|465960727|FG001|Overall Study|Starting another treatment|1|||
129454270|NCT03703882|465960726|FG000|Overall Study|noncompliance with study procedures|0|||
129454271|NCT03703882|465960727|FG001|Overall Study|noncompliance with study procedures|1|||
129454272|NCT01617460|465960728|FG000|Overall Study|Adverse Event|10|||
129454273|NCT01617460|465960728|FG000|Overall Study|Physician Decision|16|||
129454274|NCT01617460|465960728|FG000|Overall Study|Protocol Violation|5|||
129454275|NCT01617460|465960728|FG000|Overall Study|Withdrawal by Subject|9|||
129454276|NCT04179734|465960735|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
129454277|NCT04179734|465960736|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
129454278|NCT04179734|465960735|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
129454279|NCT04179734|465960736|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
129454280|NCT01761292|465960738|FG000|Part 1|Adverse Event|1|||
129454281|NCT01761292|465960738|FG000|Part 1|not receiving treatment in Part 1|1|||
129454282|NCT01761292|465960738|FG000|Extension 1|Withdrawal by Subject|1|||
129454283|NCT00840086|465960739|FG000|Overall Study|Adverse Event|1|||
129454284|NCT00840086|465960739|FG000|Overall Study|Protocol Violation|2|||
129454285|NCT00840086|465960739|FG000|Overall Study|Lost to Follow-up|1|||
129454286|NCT03332498|465960740|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
129454287|NCT03332498|465960741|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
129454288|NCT03332498|465960742|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
129454289|NCT04036708|465960743|FG000|Overall Study|Lost to Follow-up|14|||
129454290|NCT04036708|465960744|FG001|Overall Study|Lost to Follow-up|4|||
129454291|NCT04036708|465960745|FG002|Overall Study|Lost to Follow-up|14|||
129454292|NCT04036708|465960746|FG003|Overall Study|Lost to Follow-up|4|||
129454293|NCT02349048|465960750|FG000|Overall Study|Withdrawal by Subject|4|||
129454294|NCT02349048|465960751|FG001|Overall Study|Withdrawal by Subject|0|||
129454295|NCT02349048|465960750|FG000|Overall Study|Lost to Follow-up|1|||
129454296|NCT02349048|465960751|FG001|Overall Study|Lost to Follow-up|0|||
129454297|NCT01349465|465960754|FG000|Overall Study|Adverse Event|1|||
129454298|NCT01349465|465960755|FG001|Overall Study|Adverse Event|0|||
129454299|NCT01349465|465960754|FG000|Overall Study|Death|3|||
129454300|NCT01349465|465960755|FG001|Overall Study|Death|0|||
129454301|NCT01349465|465960754|FG000|Overall Study|Lost to Follow-up|10|||
129958152|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
129454302|NCT01349465|465960755|FG001|Overall Study|Lost to Follow-up|1|||
129454303|NCT01349465|465960754|FG000|Overall Study|Withdrawal by Subject|4|||
129454304|NCT01349465|465960755|FG001|Overall Study|Withdrawal by Subject|2|||
129454305|NCT01349465|465960754|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
129454306|NCT01349465|465960755|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
129454307|NCT01648790|465960756|FG000|Treatment 3|Withdrawal by Subject|0|||
129958153|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
129958154|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
129958155|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
129958156|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
129958157|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
129958158|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
129958159|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
129958160|NCT02675998|467810346|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
129958161|NCT02675998|467810347|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
129958162|NCT02675998|467810348|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
129958163|NCT02675998|467810349|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
129958164|NCT00275301|467810350|FG000|Overall Study|Adverse Event|5|||
129958165|NCT04357964|467810351|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
129958166|NCT04357964|467810352|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
129958167|NCT04357964|467810351|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
129958168|NCT04357964|467810352|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
129958169|NCT04357964|467810351|FG000|Overall Study|Adipose sample was insufficient quality|0|||
129958170|NCT04357964|467810352|FG001|Overall Study|Adipose sample was insufficient quality|1|||
129958171|NCT00848393|467810361|FG000|Overall Study|Protocol Violation|0|||
129958172|NCT00848393|467810362|FG001|Overall Study|Protocol Violation|0|||
129958173|NCT00848393|467810363|FG002|Overall Study|Protocol Violation|1|||
129958174|NCT00848393|467810361|FG000|Overall Study|surgical complications unrelated to stud|0|||
129958175|NCT00848393|467810362|FG001|Overall Study|surgical complications unrelated to stud|0|||
129958176|NCT00848393|467810363|FG002|Overall Study|surgical complications unrelated to stud|2|||
129958177|NCT02561078|467810364|FG000|Overall Study|Adverse Event|5|||
129958178|NCT02561078|467810365|FG001|Overall Study|Adverse Event|2|||
129958179|NCT02561078|467810364|FG000|Overall Study|Death|2|||
129958180|NCT02561078|467810365|FG001|Overall Study|Death|1|||
129958181|NCT02561078|467810364|FG000|Overall Study|Lost to Follow-up|2|||
129958182|NCT02561078|467810365|FG001|Overall Study|Lost to Follow-up|6|||
129958183|NCT02561078|467810364|FG000|Overall Study|Non-Compliance with Study Drug|6|||
129958184|NCT02561078|467810365|FG001|Overall Study|Non-Compliance with Study Drug|3|||
129958185|NCT02561078|467810364|FG000|Overall Study|Physician Decision|2|||
129454308|NCT01648790|465960757|FG001|Treatment 3|Withdrawal by Subject|0|||
129454309|NCT01648790|465960758|FG002|Treatment 3|Withdrawal by Subject|0|||
129454310|NCT01648790|465960759|FG003|Treatment 3|Withdrawal by Subject|1|||
129454311|NCT01648790|465960760|FG004|Treatment 3|Withdrawal by Subject|0|||
129454312|NCT01265615|465960765|FG000|Overall Study|Protocol Violation|2|||
129454313|NCT01265615|465960766|FG001|Overall Study|Protocol Violation|2|||
129454314|NCT01265615|465960767|FG002|Overall Study|Protocol Violation|4|||
129454315|NCT01265615|465960768|FG003|Overall Study|Protocol Violation|3|||
129454316|NCT03370120|465960773|FG000|Overall Study|Adverse event, non-fatal|24|||
129454317|NCT03370120|465960773|FG000|Overall Study|Withdrawal by Subject|6|||
129454318|NCT03370120|465960773|FG000|Overall Study|Lost to Follow-up|1|||
129454319|NCT03370120|465960773|FG000|Overall Study|Lack of Efficacy|37|||
129454320|NCT03370120|465960773|FG000|Overall Study|Per sponsor's instructions|1|||
129958186|NCT02561078|467810365|FG001|Overall Study|Physician Decision|3|||
129958187|NCT02561078|467810364|FG000|Overall Study|Withdrawal by Subject|13|||
129958188|NCT02561078|467810365|FG001|Overall Study|Withdrawal by Subject|10|||
129958189|NCT00043186|467810370|FG000|Overall Study|Physician Decision|0|||
129958190|NCT00043186|467810371|FG001|Overall Study|Physician Decision|0|||
129958191|NCT00043186|467810372|FG002|Overall Study|Physician Decision|3|||
129958192|NCT00043186|467810373|FG003|Overall Study|Physician Decision|0|||
129958193|NCT00043186|467810374|FG004|Overall Study|Physician Decision|1|||
129958194|NCT00043186|467810375|FG005|Overall Study|Physician Decision|0|||
129958195|NCT00043186|467810376|FG006|Overall Study|Physician Decision|0|||
129958196|NCT00043186|467810377|FG007|Overall Study|Physician Decision|1|||
129958197|NCT00043186|467810378|FG008|Overall Study|Physician Decision|1|||
129958198|NCT00043186|467810370|FG000|Overall Study|Adverse Event|2|||
129958199|NCT00043186|467810371|FG001|Overall Study|Adverse Event|2|||
129958200|NCT00043186|467810372|FG002|Overall Study|Adverse Event|2|||
129958201|NCT00043186|467810373|FG003|Overall Study|Adverse Event|3|||
129958202|NCT00043186|467810374|FG004|Overall Study|Adverse Event|2|||
129958203|NCT00043186|467810375|FG005|Overall Study|Adverse Event|1|||
129958204|NCT00043186|467810376|FG006|Overall Study|Adverse Event|2|||
129958205|NCT00043186|467810377|FG007|Overall Study|Adverse Event|1|||
129958206|NCT00043186|467810378|FG008|Overall Study|Adverse Event|3|||
129958207|NCT00043186|467810370|FG000|Overall Study|Withdrawal by Subject|11|||
129958208|NCT00043186|467810371|FG001|Overall Study|Withdrawal by Subject|8|||
129958209|NCT00043186|467810372|FG002|Overall Study|Withdrawal by Subject|11|||
129958210|NCT00043186|467810373|FG003|Overall Study|Withdrawal by Subject|13|||
129958211|NCT00043186|467810374|FG004|Overall Study|Withdrawal by Subject|14|||
129958212|NCT00043186|467810375|FG005|Overall Study|Withdrawal by Subject|6|||
129958213|NCT00043186|467810376|FG006|Overall Study|Withdrawal by Subject|12|||
129958214|NCT00043186|467810377|FG007|Overall Study|Withdrawal by Subject|9|||
129958215|NCT00043186|467810378|FG008|Overall Study|Withdrawal by Subject|10|||
129958216|NCT00043186|467810370|FG000|Overall Study|Death|0|||
129958217|NCT00043186|467810371|FG001|Overall Study|Death|0|||
129958218|NCT00043186|467810372|FG002|Overall Study|Death|1|||
129958219|NCT00043186|467810373|FG003|Overall Study|Death|0|||
129958220|NCT00043186|467810374|FG004|Overall Study|Death|0|||
129958221|NCT00043186|467810375|FG005|Overall Study|Death|0|||
129958222|NCT00043186|467810376|FG006|Overall Study|Death|2|||
129958223|NCT00043186|467810377|FG007|Overall Study|Death|0|||
129958224|NCT00043186|467810378|FG008|Overall Study|Death|0|||
129958225|NCT00043186|467810370|FG000|Overall Study|Disease progression|1|||
129958226|NCT00043186|467810371|FG001|Overall Study|Disease progression|0|||
129958227|NCT00043186|467810372|FG002|Overall Study|Disease progression|0|||
129958228|NCT00043186|467810373|FG003|Overall Study|Disease progression|3|||
129958229|NCT00043186|467810374|FG004|Overall Study|Disease progression|0|||
129958230|NCT00043186|467810375|FG005|Overall Study|Disease progression|0|||
129958231|NCT00043186|467810376|FG006|Overall Study|Disease progression|0|||
129958232|NCT00043186|467810377|FG007|Overall Study|Disease progression|4|||
129958233|NCT00043186|467810378|FG008|Overall Study|Disease progression|0|||
129454321|NCT03370120|465960773|FG000|Overall Study|Study was terminated by parent company UCB|2|||
129454322|NCT03370120|465960773|FG000|Overall Study|The study was ended by the promoter|3|||
129958234|NCT00043186|467810370|FG000|Overall Study|Ineligibility determined|0|||
129454323|NCT03370120|465960773|FG000|Overall Study|Discontinuation of drug development|3|||
129454324|NCT03370120|465960773|FG000|Overall Study|End of project|2|||
129958235|NCT00043186|467810371|FG001|Overall Study|Ineligibility determined|0|||
129958236|NCT00043186|467810372|FG002|Overall Study|Ineligibility determined|0|||
129958237|NCT00043186|467810373|FG003|Overall Study|Ineligibility determined|0|||
129958238|NCT00043186|467810374|FG004|Overall Study|Ineligibility determined|0|||
129958239|NCT00043186|467810375|FG005|Overall Study|Ineligibility determined|0|||
129958240|NCT00043186|467810376|FG006|Overall Study|Ineligibility determined|0|||
129454325|NCT03370120|465960773|FG000|Overall Study|Premature study closure|2|||
129454326|NCT03370120|465960773|FG000|Overall Study|Premature program termination|1|||
129958241|NCT00043186|467810377|FG007|Overall Study|Ineligibility determined|0|||
129958242|NCT00043186|467810378|FG008|Overall Study|Ineligibility determined|1|||
129958243|NCT00043186|467810370|FG000|Overall Study|Lost to Follow-up|3|||
129454327|NCT03370120|465960773|FG000|Overall Study|Premature study termination|7|||
129958244|NCT00043186|467810371|FG001|Overall Study|Lost to Follow-up|5|||
129958245|NCT00043186|467810372|FG002|Overall Study|Lost to Follow-up|1|||
129958246|NCT00043186|467810373|FG003|Overall Study|Lost to Follow-up|1|||
129958247|NCT00043186|467810374|FG004|Overall Study|Lost to Follow-up|1|||
129958248|NCT00043186|467810375|FG005|Overall Study|Lost to Follow-up|1|||
129958249|NCT00043186|467810376|FG006|Overall Study|Lost to Follow-up|1|||
129958250|NCT00043186|467810377|FG007|Overall Study|Lost to Follow-up|1|||
129958251|NCT00043186|467810378|FG008|Overall Study|Lost to Follow-up|2|||
129958252|NCT00043186|467810370|FG000|Overall Study|Noncompliance|0|||
129958253|NCT00043186|467810371|FG001|Overall Study|Noncompliance|0|||
129958254|NCT00043186|467810372|FG002|Overall Study|Noncompliance|1|||
129958255|NCT00043186|467810373|FG003|Overall Study|Noncompliance|1|||
129958256|NCT00043186|467810374|FG004|Overall Study|Noncompliance|0|||
129958257|NCT00043186|467810375|FG005|Overall Study|Noncompliance|0|||
129958258|NCT00043186|467810376|FG006|Overall Study|Noncompliance|0|||
129958259|NCT00043186|467810377|FG007|Overall Study|Noncompliance|0|||
129958260|NCT00043186|467810378|FG008|Overall Study|Noncompliance|0|||
129958261|NCT00043186|467810370|FG000|Overall Study|Other|0|||
129958262|NCT00043186|467810371|FG001|Overall Study|Other|0|||
129958263|NCT00043186|467810372|FG002|Overall Study|Other|1|||
129958264|NCT00043186|467810373|FG003|Overall Study|Other|1|||
129958265|NCT00043186|467810374|FG004|Overall Study|Other|0|||
129958266|NCT00043186|467810375|FG005|Overall Study|Other|0|||
129958267|NCT00043186|467810376|FG006|Overall Study|Other|0|||
129958268|NCT00043186|467810377|FG007|Overall Study|Other|0|||
129958269|NCT00043186|467810378|FG008|Overall Study|Other|0|||
129958270|NCT00730847|467810380|FG000|Overall Study|Adverse Event|1|||
129958271|NCT00730847|467810380|FG000|Overall Study|Protocol Violation|2|||
129958272|NCT00730847|467810380|FG000|Overall Study|Withdrawal by Subject|16|||
129958273|NCT00730847|467810380|FG000|Overall Study|Lost to Follow-up|67|||
129958274|NCT00730847|467810380|FG000|Overall Study|Unknown completion status|21|||
129958275|NCT00730847|467810380|FG000|Overall Study|Other|24|||
129958276|NCT03022578|467810381|FG000|Overall Study|Adverse Event|1|||
129958277|NCT03022578|467810381|FG000|Overall Study|Lack of Efficacy|2|||
129958278|NCT03022578|467810381|FG000|Overall Study|Withdrawal by Subject|1|||
129958279|NCT03681353|467810382|FG000|Overall Study|Lost to Follow-up|2|||
129958280|NCT03681353|467810382|FG000|Overall Study|Withdrawal by Subject|3|||
129958281|NCT03681353|467810382|FG000|Overall Study|withdrawn by PI|2|||
129958282|NCT00726388|467810385|FG000|Overall Study|Withdrawal by Subject|5|||
129958283|NCT00726388|467810385|FG000|Overall Study|Adverse Event|3|||
129958284|NCT00726388|467810385|FG000|Overall Study|Lost to Follow-up|10|||
129958285|NCT00726388|467810385|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
129958286|NCT00726388|467810385|FG000|Overall Study|Other|5|||
129958287|NCT00726388|467810385|FG000|Overall Study|Enrolled, Not Treated|79|||
129958288|NCT00111839|467810386|FG000|Overall Study|Disease Progression|30|||
129958289|NCT00111839|467810387|FG001|Overall Study|Disease Progression|33|||
129958290|NCT00111839|467810388|FG002|Overall Study|Disease Progression|33|||
129958291|NCT00111839|467810386|FG000|Overall Study|Adverse Event|5|||
129958292|NCT00111839|467810387|FG001|Overall Study|Adverse Event|3|||
129958293|NCT00111839|467810388|FG002|Overall Study|Adverse Event|1|||
129958294|NCT00111839|467810386|FG000|Overall Study|Protocol Violation|2|||
129958295|NCT00111839|467810387|FG001|Overall Study|Protocol Violation|4|||
129958296|NCT00111839|467810388|FG002|Overall Study|Protocol Violation|2|||
129958297|NCT00111839|467810386|FG000|Overall Study|Death|1|||
129958298|NCT00111839|467810387|FG001|Overall Study|Death|1|||
129958299|NCT00111839|467810388|FG002|Overall Study|Death|6|||
129958300|NCT00111839|467810386|FG000|Overall Study|Withdrawal by Subject|2|||
129958301|NCT00111839|467810387|FG001|Overall Study|Withdrawal by Subject|2|||
129958302|NCT00111839|467810388|FG002|Overall Study|Withdrawal by Subject|2|||
129958303|NCT00111839|467810386|FG000|Overall Study|Lost to Follow-up|1|||
129958304|NCT00111839|467810387|FG001|Overall Study|Lost to Follow-up|0|||
129958305|NCT00111839|467810388|FG002|Overall Study|Lost to Follow-up|0|||
129958306|NCT00111839|467810386|FG000|Overall Study|Logistical Constraint|1|||
129958307|NCT00111839|467810387|FG001|Overall Study|Logistical Constraint|0|||
129958308|NCT00111839|467810388|FG002|Overall Study|Logistical Constraint|0|||
129958309|NCT00111839|467810386|FG000|Overall Study|Other|6|||
129958310|NCT00111839|467810387|FG001|Overall Study|Other|3|||
129958311|NCT00111839|467810388|FG002|Overall Study|Other|3|||
129958312|NCT00111839|467810386|FG000|Overall Study|Randomized but Not Treated|0|||
129958313|NCT00111839|467810387|FG001|Overall Study|Randomized but Not Treated|0|||
129958314|NCT00111839|467810388|FG002|Overall Study|Randomized but Not Treated|2|||
129958315|NCT01011049|467810389|FG000|Overall Study|Protocol Violation|0|||
129958316|NCT01011049|467810390|FG001|Overall Study|Protocol Violation|0|||
129958317|NCT01011049|467810391|FG002|Overall Study|Protocol Violation|2|||
129958318|NCT01011049|467810392|FG003|Overall Study|Protocol Violation|0|||
129958319|NCT01011049|467810389|FG000|Overall Study|Lost to Follow-up|1|||
129958320|NCT01011049|467810390|FG001|Overall Study|Lost to Follow-up|2|||
129958321|NCT01011049|467810391|FG002|Overall Study|Lost to Follow-up|1|||
129958322|NCT01011049|467810392|FG003|Overall Study|Lost to Follow-up|0|||
129958323|NCT01011049|467810389|FG000|Overall Study|Withdrawal by Subject|0|||
129958324|NCT01011049|467810390|FG001|Overall Study|Withdrawal by Subject|0|||
129958325|NCT01011049|467810391|FG002|Overall Study|Withdrawal by Subject|1|||
129958326|NCT01011049|467810392|FG003|Overall Study|Withdrawal by Subject|0|||
129958327|NCT00382408|467810393|FG000|Overall Study|Did not meet protocol requirement|3|||
129958328|NCT00382408|467810394|FG001|Overall Study|Did not meet protocol requirement|3|||
129958329|NCT00382408|467810393|FG000|Overall Study|Protocol Violation|2|||
129958330|NCT00382408|467810394|FG001|Overall Study|Protocol Violation|2|||
129958331|NCT00382408|467810393|FG000|Overall Study|Physician Decision|1|||
129958332|NCT00382408|467810394|FG001|Overall Study|Physician Decision|0|||
129958333|NCT00382408|467810393|FG000|Overall Study|Withdrawal by Subject|17|||
129958334|NCT00382408|467810394|FG001|Overall Study|Withdrawal by Subject|6|||
129958335|NCT00382408|467810393|FG000|Overall Study|Pregnancy|2|||
129958336|NCT00382408|467810394|FG001|Overall Study|Pregnancy|0|||
129958337|NCT00382408|467810393|FG000|Overall Study|Lost to Follow-up|19|||
129958338|NCT00382408|467810394|FG001|Overall Study|Lost to Follow-up|8|||
129958339|NCT00382408|467810393|FG000|Overall Study|Other|100|||
129958340|NCT00382408|467810394|FG001|Overall Study|Other|35|||
129958341|NCT02391545|467810398|FG000|Overall Study|Death|0|||
129958342|NCT02391545|467810399|FG001|Overall Study|Death|2|||
129958343|NCT02391545|467810398|FG000|Overall Study|Lost to Follow-up|0|||
129958344|NCT02391545|467810399|FG001|Overall Study|Lost to Follow-up|1|||
129958345|NCT02391545|467810398|FG000|Overall Study|Termination of study by sponsor|20|||
129958346|NCT02391545|467810399|FG001|Overall Study|Termination of study by sponsor|20|||
129958347|NCT02391545|467810398|FG000|Overall Study|Withdrawal by Subject|0|||
129958348|NCT02391545|467810399|FG001|Overall Study|Withdrawal by Subject|1|||
129958349|NCT02391545|467810398|FG000|Overall Study|Other Reasons|6|||
129958350|NCT02391545|467810399|FG001|Overall Study|Other Reasons|4|||
129958351|NCT04754594|467810400|FG000|Blinded Period|Withdrawal by Subject|4|||
129958352|NCT04754594|467810401|FG001|Blinded Period|Withdrawal by Subject|9|||
129958353|NCT04754594|467810402|FG002|Blinded Period|Withdrawal by Subject|0|||
129958354|NCT04754594|467810403|FG003|Blinded Period|Withdrawal by Subject|0|||
129958355|NCT04754594|467810400|FG000|Blinded Period|Protocol Violation|2|||
129958356|NCT04754594|467810401|FG001|Blinded Period|Protocol Violation|2|||
129958357|NCT04754594|467810402|FG002|Blinded Period|Protocol Violation|0|||
129958358|NCT04754594|467810403|FG003|Blinded Period|Protocol Violation|0|||
129958359|NCT04754594|467810400|FG000|Blinded Period|Lost to Follow-up|1|||
129958360|NCT04754594|467810401|FG001|Blinded Period|Lost to Follow-up|1|||
129958361|NCT04754594|467810402|FG002|Blinded Period|Lost to Follow-up|0|||
129958362|NCT04754594|467810403|FG003|Blinded Period|Lost to Follow-up|0|||
129958363|NCT04754594|467810400|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
129958364|NCT04754594|467810401|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
129958365|NCT04754594|467810402|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
129958366|NCT04754594|467810403|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
129958367|NCT04754594|467810400|FG000|Unblinded Period|Withdrawal by Subject|6|||
129958368|NCT04754594|467810401|FG001|Unblinded Period|Withdrawal by Subject|8|||
129958369|NCT04754594|467810402|FG002|Unblinded Period|Withdrawal by Subject|0|||
129958370|NCT04754594|467810403|FG003|Unblinded Period|Withdrawal by Subject|0|||
129958371|NCT04754594|467810400|FG000|Unblinded Period|Lost to Follow-up|5|||
129958372|NCT04754594|467810401|FG001|Unblinded Period|Lost to Follow-up|3|||
129958373|NCT04754594|467810402|FG002|Unblinded Period|Lost to Follow-up|0|||
129958374|NCT04754594|467810403|FG003|Unblinded Period|Lost to Follow-up|0|||
129958375|NCT04754594|467810400|FG000|Unblinded Period|Protocol Violation|2|||
129958376|NCT04754594|467810401|FG001|Unblinded Period|Protocol Violation|4|||
129958377|NCT04754594|467810402|FG002|Unblinded Period|Protocol Violation|0|||
129958378|NCT04754594|467810403|FG003|Unblinded Period|Protocol Violation|0|||
129958379|NCT04754594|467810400|FG000|Unblinded Period|Other|3|||
129958380|NCT04754594|467810401|FG001|Unblinded Period|Other|0|||
129958381|NCT04754594|467810402|FG002|Unblinded Period|Other|0|||
129958382|NCT04754594|467810403|FG003|Unblinded Period|Other|0|||
129958383|NCT04754594|467810400|FG000|Infant Participants|Withdrawal by Subject|0|||
129958384|NCT04754594|467810401|FG001|Infant Participants|Withdrawal by Subject|0|||
129958385|NCT04754594|467810402|FG002|Infant Participants|Withdrawal by Subject|9|||
129958386|NCT04754594|467810403|FG003|Infant Participants|Withdrawal by Subject|17|||
129958387|NCT04754594|467810400|FG000|Infant Participants|Lost to Follow-up|0|||
129958388|NCT04754594|467810401|FG001|Infant Participants|Lost to Follow-up|0|||
129958389|NCT04754594|467810402|FG002|Infant Participants|Lost to Follow-up|4|||
129958390|NCT04754594|467810403|FG003|Infant Participants|Lost to Follow-up|10|||
129958391|NCT04754594|467810400|FG000|Infant Participants|Death|0|||
129958392|NCT04754594|467810401|FG001|Infant Participants|Death|0|||
129958393|NCT04754594|467810402|FG002|Infant Participants|Death|1|||
129958394|NCT04754594|467810403|FG003|Infant Participants|Death|1|||
129958395|NCT04754594|467810400|FG000|Infant Participants|Other|0|||
129958396|NCT04754594|467810401|FG001|Infant Participants|Other|0|||
129958397|NCT04754594|467810402|FG002|Infant Participants|Other|1|||
129958398|NCT04754594|467810403|FG003|Infant Participants|Other|1|||
129958399|NCT03340766|467810406|FG000|Overall Study|Withdrawal by Subject|2|||
129958400|NCT03340766|467810407|FG001|Overall Study|Withdrawal by Subject|1|||
129958401|NCT03340766|467810408|FG002|Overall Study|Withdrawal by Subject|3|||
129958402|NCT03340766|467810406|FG000|Overall Study|Lost to Follow-up|0|||
129958403|NCT03340766|467810407|FG001|Overall Study|Lost to Follow-up|0|||
129958404|NCT03340766|467810408|FG002|Overall Study|Lost to Follow-up|1|||
129958405|NCT03340766|467810406|FG000|Overall Study|Death|6|||
129958406|NCT03340766|467810407|FG001|Overall Study|Death|7|||
129958407|NCT03340766|467810408|FG002|Overall Study|Death|4|||
129958408|NCT00975130|467810414|FG000|Study Part 1|Adverse Event|150|||
129958409|NCT00975130|467810415|FG001|Study Part 1|Adverse Event|0|||
129958410|NCT00975130|467810416|FG002|Study Part 1|Adverse Event|0|||
129958411|NCT00975130|467810414|FG000|Study Part 1|Lost to Follow-up|19|||
129958412|NCT00975130|467810415|FG001|Study Part 1|Lost to Follow-up|0|||
129958413|NCT00975130|467810416|FG002|Study Part 1|Lost to Follow-up|0|||
129958414|NCT00975130|467810414|FG000|Study Part 1|Withdrawal by Subject|61|||
129958415|NCT00975130|467810415|FG001|Study Part 1|Withdrawal by Subject|0|||
129958416|NCT00975130|467810416|FG002|Study Part 1|Withdrawal by Subject|0|||
129958417|NCT00975130|467810414|FG000|Study Part 1|Protocol Violation|13|||
129958418|NCT00975130|467810415|FG001|Study Part 1|Protocol Violation|0|||
129958419|NCT00975130|467810416|FG002|Study Part 1|Protocol Violation|0|||
129958420|NCT00975130|467810414|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
129958421|NCT00975130|467810415|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
129958422|NCT00975130|467810416|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
129958423|NCT00975130|467810414|FG000|Study Part 1|Administrative|4|||
129958424|NCT00975130|467810415|FG001|Study Part 1|Administrative|0|||
129958425|NCT00975130|467810416|FG002|Study Part 1|Administrative|0|||
129958426|NCT00975130|467810414|FG000|Study Part 1|Withdrew Consent|24|||
129958427|NCT00975130|467810415|FG001|Study Part 1|Withdrew Consent|0|||
129958428|NCT00975130|467810416|FG002|Study Part 1|Withdrew Consent|0|||
129958429|NCT00975130|467810414|FG000|Study Part 2|Adverse Event|0|||
129958430|NCT00975130|467810415|FG001|Study Part 2|Adverse Event|14|||
129958431|NCT00975130|467810416|FG002|Study Part 2|Adverse Event|7|||
129958432|NCT00975130|467810414|FG000|Study Part 2|Lost to Follow-up|0|||
129958433|NCT00975130|467810415|FG001|Study Part 2|Lost to Follow-up|0|||
129958434|NCT00975130|467810416|FG002|Study Part 2|Lost to Follow-up|1|||
129958435|NCT00975130|467810414|FG000|Study Part 2|Withdrawal by Subject|0|||
129958436|NCT00975130|467810415|FG001|Study Part 2|Withdrawal by Subject|13|||
129958437|NCT00975130|467810416|FG002|Study Part 2|Withdrawal by Subject|5|||
129958438|NCT00975130|467810414|FG000|Study Part 2|Withdrew Consent|0|||
129958439|NCT00975130|467810415|FG001|Study Part 2|Withdrew Consent|6|||
129958440|NCT00975130|467810416|FG002|Study Part 2|Withdrew Consent|2|||
129958441|NCT00975130|467810414|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
129958442|NCT00975130|467810415|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
129958443|NCT00975130|467810416|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
129958444|NCT00975130|467810414|FG000|Study Part 2|Administrative|0|||
129958445|NCT00975130|467810415|FG001|Study Part 2|Administrative|1|||
129958446|NCT00975130|467810416|FG002|Study Part 2|Administrative|0|||
129958447|NCT00975130|467810414|FG000|Study Part 2|Protocol Violation|0|||
129958448|NCT00975130|467810415|FG001|Study Part 2|Protocol Violation|0|||
129958449|NCT00975130|467810416|FG002|Study Part 2|Protocol Violation|1|||
129958450|NCT00734851|467810417|FG000|Overall Study|Withdrawal by Subject|2|||
129958451|NCT00734851|467810417|FG000|Overall Study|Lost to Follow-up|1|||
129958452|NCT00734851|467810417|FG000|Overall Study|Physician Decision|18|||
129958453|NCT01332318|467810423|FG000|Overall Study|Adverse Event|0|||
129958454|NCT01332318|467810424|FG001|Overall Study|Adverse Event|3|||
129958455|NCT01332318|467810425|FG002|Overall Study|Adverse Event|0|||
129958456|NCT01332318|467810426|FG003|Overall Study|Adverse Event|0|||
129958457|NCT01332318|467810423|FG000|Overall Study|Withdrawal by Subject|1|||
129958458|NCT01332318|467810424|FG001|Overall Study|Withdrawal by Subject|1|||
129958459|NCT01332318|467810425|FG002|Overall Study|Withdrawal by Subject|0|||
129958460|NCT01332318|467810426|FG003|Overall Study|Withdrawal by Subject|1|||
129958461|NCT01332318|467810423|FG000|Overall Study|Protocol Violation|1|||
129958462|NCT01332318|467810424|FG001|Overall Study|Protocol Violation|0|||
129958463|NCT01332318|467810425|FG002|Overall Study|Protocol Violation|1|||
129958464|NCT01332318|467810426|FG003|Overall Study|Protocol Violation|1|||
129958465|NCT02820298|467810427|FG000|Overall Study|Withdrawal by Subject|0|||
129958466|NCT02820298|467810428|FG001|Overall Study|Withdrawal by Subject|1|||
129958467|NCT02820298|467810427|FG000|Overall Study|Physician Decision|1|||
129958468|NCT02820298|467810428|FG001|Overall Study|Physician Decision|0|||
129958469|NCT02820298|467810427|FG000|Overall Study|Protocol Violation|0|||
129958470|NCT02820298|467810428|FG001|Overall Study|Protocol Violation|1|||
129958471|NCT01780584|467810429|FG000|Overall Study|Death|1|||
129958472|NCT01780584|467810430|FG001|Overall Study|Death|0|||
129958473|NCT01780584|467810431|FG002|Overall Study|Death|1|||
129958474|NCT01780584|467810429|FG000|Overall Study|Adverse Event|0|||
129958475|NCT01780584|467810430|FG001|Overall Study|Adverse Event|1|||
129958476|NCT01780584|467810431|FG002|Overall Study|Adverse Event|0|||
129958477|NCT01780584|467810429|FG000|Overall Study|Protocol Violation|0|||
129958478|NCT01780584|467810430|FG001|Overall Study|Protocol Violation|0|||
129958479|NCT01780584|467810431|FG002|Overall Study|Protocol Violation|1|||
129958480|NCT00727259|467810432|FG000|Overall Study|Not all questionnaires completed|1055|||
129958481|NCT01021683|467810433|FG000|Overall Study|Lack of Efficacy|12|||
129958482|NCT01021683|467810433|FG000|Overall Study|Recovery of neutrophil count|51|||
129958483|NCT01021683|467810433|FG000|Overall Study|Other|8|||
129958484|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
129958485|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
129958486|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
129958487|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
129958488|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
129958489|NCT00500539|467810434|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
129958490|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
129958491|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
129958492|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
129958493|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
129958494|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Death|1|||
129958495|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
129958496|NCT00500539|467810434|FG000|Follow-up Period (16 Weeks)|Missing|3|||
129958497|NCT00645099|467810435|FG000|Overall Study|Lack of Efficacy|15|||
129958498|NCT00645099|467810436|FG001|Overall Study|Lack of Efficacy|6|||
129958499|NCT00645099|467810435|FG000|Overall Study|Withdrawal by Subject|30|||
129958500|NCT00645099|467810436|FG001|Overall Study|Withdrawal by Subject|22|||
129958501|NCT00645099|467810435|FG000|Overall Study|Lost to Follow-up|6|||
129958502|NCT00645099|467810436|FG001|Overall Study|Lost to Follow-up|4|||
129958503|NCT00645099|467810435|FG000|Overall Study|Adverse Event|11|||
129958504|NCT00645099|467810436|FG001|Overall Study|Adverse Event|5|||
129958505|NCT00645099|467810435|FG000|Overall Study|Other|9|||
129958506|NCT00645099|467810436|FG001|Overall Study|Other|5|||
129958507|NCT01201915|467810437|FG000|Overall Study|Adverse Event|2|||
129958508|NCT01201915|467810438|FG001|Overall Study|Adverse Event|1|||
129958509|NCT01201915|467810439|FG002|Overall Study|Adverse Event|1|||
129958510|NCT01201915|467810437|FG000|Overall Study|Lost to Follow-up|0|||
129958511|NCT01201915|467810438|FG001|Overall Study|Lost to Follow-up|4|||
129958512|NCT01201915|467810439|FG002|Overall Study|Lost to Follow-up|0|||
129958513|NCT01201915|467810437|FG000|Overall Study|Physician Decision|3|||
129958514|NCT01201915|467810438|FG001|Overall Study|Physician Decision|0|||
129958515|NCT01201915|467810439|FG002|Overall Study|Physician Decision|0|||
129958516|NCT01201915|467810437|FG000|Overall Study|Subject Decision|3|||
129958517|NCT01201915|467810438|FG001|Overall Study|Subject Decision|3|||
129958518|NCT01201915|467810439|FG002|Overall Study|Subject Decision|5|||
129958519|NCT01201915|467810437|FG000|Overall Study|Target Lesion Progression|0|||
129958520|NCT01201915|467810438|FG001|Overall Study|Target Lesion Progression|3|||
129958521|NCT01201915|467810439|FG002|Overall Study|Target Lesion Progression|0|||
129958522|NCT03406507|467810440|FG000|Extension Period|Lack of Efficacy|0|||
129958523|NCT03406507|467810441|FG001|Extension Period|Lack of Efficacy|1|||
129958524|NCT00663923|467810442|FG000|Overall Study|Lost to Follow-up|2|||
129958525|NCT00547300|467810445|FG000|Overall Study|Study was Administratively Terminated|25|||
129958526|NCT00547300|467810446|FG001|Overall Study|Study was Administratively Terminated|24|||
129958527|NCT00547300|467810445|FG000|Overall Study|Did not Meet Entry Criteria|0|||
129958528|NCT00547300|467810446|FG001|Overall Study|Did not Meet Entry Criteria|2|||
129958529|NCT04380688|467810447|FG000|Overall Study|Death|2|||
129958530|NCT04380688|467810448|FG001|Overall Study|Death|2|||
129958531|NCT04380688|467810447|FG000|Overall Study|Lost to Follow-up|2|||
129958532|NCT04380688|467810448|FG001|Overall Study|Lost to Follow-up|4|||
129958533|NCT04380688|467810447|FG000|Overall Study|Withdrawal by Subject|3|||
129958534|NCT04380688|467810448|FG001|Overall Study|Withdrawal by Subject|3|||
129958535|NCT02329223|467812307|FG000|Overall Study|Withdrawal by Subject|1|||
129958536|NCT02329223|467812308|FG001|Overall Study|Withdrawal by Subject|2|||
129958537|NCT02329223|467812309|FG002|Overall Study|Withdrawal by Subject|5|||
129958538|NCT02329223|467812307|FG000|Overall Study|Physician Decision|0|||
129958539|NCT02329223|467812308|FG001|Overall Study|Physician Decision|0|||
129958540|NCT02329223|467812309|FG002|Overall Study|Physician Decision|1|||
129958541|NCT02329223|467812307|FG000|Overall Study|Adverse Event|0|||
129958542|NCT02329223|467812308|FG001|Overall Study|Adverse Event|1|||
129958543|NCT02329223|467812309|FG002|Overall Study|Adverse Event|0|||
129958544|NCT00381888|467812310|FG000|Overall Study|Death|1|||
129958545|NCT00381888|467812310|FG000|Overall Study|Withdrawal by Subject|1|||
129958546|NCT00381888|467812310|FG000|Overall Study|Physician Decision|1|||
129958547|NCT00381888|467812310|FG000|Overall Study|Protocol Violation|9|||
129958548|NCT00381888|467812310|FG000|Overall Study|Had laparoscopic surgery|2|||
129958549|NCT00381888|467812310|FG000|Overall Study|Surgery was cancelled|2|||
129958550|NCT00381888|467812310|FG000|Overall Study|Adverse Event|1|||
129958551|NCT03449134|467812311|FG000|52-Week Treatment Period|Death|2|||
129958552|NCT03449134|467812312|FG001|52-Week Treatment Period|Death|1|||
129958553|NCT03449134|467812313|FG002|52-Week Treatment Period|Death|0|||
129958554|NCT03449134|467812311|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
129958555|NCT03449134|467812312|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
129958556|NCT03449134|467812313|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
129958557|NCT03449134|467812311|FG000|52-Week Treatment Period|Physician Decision|2|||
129958558|NCT03449134|467812312|FG001|52-Week Treatment Period|Physician Decision|3|||
129958559|NCT03449134|467812313|FG002|52-Week Treatment Period|Physician Decision|3|||
129958560|NCT03449134|467812311|FG000|52-Week Treatment Period|Screen Failure|1|||
129958561|NCT03449134|467812312|FG001|52-Week Treatment Period|Screen Failure|0|||
129958562|NCT03449134|467812313|FG002|52-Week Treatment Period|Screen Failure|1|||
129958563|NCT03449134|467812311|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
129958564|NCT03449134|467812312|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
129958565|NCT03449134|467812313|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
129958566|NCT03449134|467812311|FG000|52-Week Treatment Period|Site Closure|1|||
129958567|NCT03449134|467812312|FG001|52-Week Treatment Period|Site Closure|0|||
129958568|NCT03449134|467812313|FG002|52-Week Treatment Period|Site Closure|0|||
129958569|NCT00957996|467812314|FG000|Overall Study|Death|4|||
129958570|NCT00957996|467812315|FG001|Overall Study|Death|10|||
129958571|NCT00957996|467812314|FG000|Overall Study|Lost to Follow-up|4|||
129958572|NCT00957996|467812315|FG001|Overall Study|Lost to Follow-up|7|||
129958573|NCT00957996|467812314|FG000|Overall Study|Withdrawal by Subject|9|||
129958574|NCT00957996|467812315|FG001|Overall Study|Withdrawal by Subject|2|||
129958575|NCT00957996|467812314|FG000|Overall Study|Adverse Event|2|||
129958576|NCT00957996|467812315|FG001|Overall Study|Adverse Event|1|||
129958577|NCT00957996|467812314|FG000|Overall Study|Physician Decision|1|||
129958578|NCT00957996|467812315|FG001|Overall Study|Physician Decision|1|||
129958579|NCT00957996|467812314|FG000|Overall Study|Influenza-related complication|0|||
129958580|NCT00957996|467812315|FG001|Overall Study|Influenza-related complication|1|||
129958581|NCT00957996|467812314|FG000|Overall Study|Missing|1|||
129958582|NCT00957996|467812315|FG001|Overall Study|Missing|0|||
129958583|NCT00957996|467812314|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
129958584|NCT00957996|467812315|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
129958585|NCT01580995|467812320|FG000|Overall Study|Lost to Follow-up|2|||
129958586|NCT01580995|467812321|FG001|Overall Study|Lost to Follow-up|2|||
129958587|NCT02916706|467812322|FG000|Overall Study|Adverse Event|0|||
129958588|NCT02916706|467812323|FG001|Overall Study|Adverse Event|1|||
129958589|NCT02916706|467812322|FG000|Overall Study|Lost to Follow-up|0|||
129958590|NCT02916706|467812323|FG001|Overall Study|Lost to Follow-up|1|||
129958591|NCT02916706|467812322|FG000|Overall Study|Physician Decision|1|||
129958592|NCT02916706|467812323|FG001|Overall Study|Physician Decision|0|||
129958593|NCT02916706|467812322|FG000|Overall Study|Protocol Violation|3|||
129958594|NCT02916706|467812323|FG001|Overall Study|Protocol Violation|1|||
129958595|NCT02916706|467812322|FG000|Overall Study|Withdrawal by Subject|6|||
129958596|NCT02916706|467812323|FG001|Overall Study|Withdrawal by Subject|9|||
129958597|NCT02916706|467812322|FG000|Overall Study|Other|5|||
129958598|NCT02916706|467812323|FG001|Overall Study|Other|19|||
129958599|NCT00598871|467812324|FG000|Overall Study|Adverse Event|0|||
129958600|NCT00598871|467812325|FG001|Overall Study|Adverse Event|1|||
129958601|NCT01194271|467812326|FG000|Overall Study|Withdrawal by Subject|1|||
129958602|NCT01194271|467812326|FG000|Overall Study|Ineligible, Screen Failure|1|||
129958603|NCT01194271|467812326|FG000|Overall Study|Death|1|||
129958604|NCT01983462|467812327|FG000|Overall Study|Adverse Event|1|||
129958605|NCT01983462|467812328|FG001|Overall Study|Adverse Event|0|||
129958606|NCT01983462|467812329|FG002|Overall Study|Adverse Event|0|||
129958607|NCT00381797|467812330|FG000|Overall Study|Withdrawal by Subject|1|||
129958608|NCT00381797|467812331|FG001|Overall Study|Withdrawal by Subject|1|||
129958609|NCT00381797|467812332|FG002|Overall Study|Withdrawal by Subject|0|||
129958610|NCT00381797|467812333|FG003|Overall Study|Withdrawal by Subject|0|||
129958611|NCT00381797|467812334|FG004|Overall Study|Withdrawal by Subject|2|||
129958612|NCT00381797|467812330|FG000|Overall Study|Ineligible|0|||
129958613|NCT00381797|467812331|FG001|Overall Study|Ineligible|0|||
129958614|NCT00381797|467812332|FG002|Overall Study|Ineligible|0|||
129958615|NCT00381797|467812333|FG003|Overall Study|Ineligible|1|||
129958616|NCT00381797|467812334|FG004|Overall Study|Ineligible|0|||
129958617|NCT00443898|467812335|FG000|Overall Study|Adverse Event|0|||
129958618|NCT00443898|467812336|FG001|Overall Study|Adverse Event|0|||
129958619|NCT00443898|467812337|FG002|Overall Study|Adverse Event|1|||
129958620|NCT00443898|467812338|FG003|Overall Study|Adverse Event|1|||
129958621|NCT00443898|467812335|FG000|Overall Study|Lack of Efficacy|2|||
129958622|NCT00443898|467812336|FG001|Overall Study|Lack of Efficacy|3|||
129958623|NCT00443898|467812337|FG002|Overall Study|Lack of Efficacy|3|||
129958624|NCT00443898|467812338|FG003|Overall Study|Lack of Efficacy|1|||
129958625|NCT00443898|467812335|FG000|Overall Study|Protocol Violation|1|||
129958626|NCT00443898|467812336|FG001|Overall Study|Protocol Violation|1|||
129958627|NCT00443898|467812337|FG002|Overall Study|Protocol Violation|1|||
129958628|NCT00443898|467812338|FG003|Overall Study|Protocol Violation|0|||
129958629|NCT00443898|467812335|FG000|Overall Study|Withdrawal by Subject|11|||
129958630|NCT00443898|467812336|FG001|Overall Study|Withdrawal by Subject|10|||
129958631|NCT00443898|467812337|FG002|Overall Study|Withdrawal by Subject|10|||
129958632|NCT00443898|467812338|FG003|Overall Study|Withdrawal by Subject|6|||
129958633|NCT00443898|467812335|FG000|Overall Study|Lost to Follow-up|10|||
129958634|NCT00443898|467812336|FG001|Overall Study|Lost to Follow-up|10|||
129958635|NCT00443898|467812337|FG002|Overall Study|Lost to Follow-up|14|||
129958636|NCT00443898|467812338|FG003|Overall Study|Lost to Follow-up|10|||
129958637|NCT00443898|467812335|FG000|Overall Study|Death|0|||
129958638|NCT00443898|467812336|FG001|Overall Study|Death|1|||
129958639|NCT00443898|467812337|FG002|Overall Study|Death|0|||
129958640|NCT00443898|467812338|FG003|Overall Study|Death|0|||
129958641|NCT00958711|467812339|FG000|Overall Study|Withdrawal by Subject|0|||
129958642|NCT00958711|467812340|FG001|Overall Study|Withdrawal by Subject|4|||
129958643|NCT00958711|467812339|FG000|Overall Study|Physician Decision|5|||
129958644|NCT00958711|467812340|FG001|Overall Study|Physician Decision|7|||
129958645|NCT00958711|467812339|FG000|Overall Study|Lost to Follow-up|4|||
129958646|NCT00958711|467812340|FG001|Overall Study|Lost to Follow-up|1|||
129958647|NCT00958711|467812339|FG000|Overall Study|Other|2|||
129958648|NCT00958711|467812340|FG001|Overall Study|Other|5|||
129958649|NCT00958711|467812339|FG000|Overall Study|Death|1|||
129454328|NCT03370120|465960773|FG000|Overall Study|Trial terminated by sponsor|2|||
129958650|NCT00958711|467812340|FG001|Overall Study|Death|2|||
129958651|NCT00958711|467812339|FG000|Overall Study|Adverse Event|1|||
129958652|NCT00958711|467812340|FG001|Overall Study|Adverse Event|2|||
129958653|NCT00550771|467812343|FG000|Overall Study|Adverse Event|11|||
129958654|NCT00550771|467812344|FG001|Overall Study|Adverse Event|3|||
129958655|NCT00550771|467812343|FG000|Overall Study|Discontinued for study-related reasons|0|||
129958656|NCT00550771|467812344|FG001|Overall Study|Discontinued for study-related reasons|1|||
129958657|NCT00550771|467812343|FG000|Overall Study|Physician Decision|2|||
129958658|NCT00550771|467812344|FG001|Overall Study|Physician Decision|0|||
129958659|NCT00550771|467812343|FG000|Overall Study|Withdrawal by Subject|0|||
129958660|NCT00550771|467812344|FG001|Overall Study|Withdrawal by Subject|1|||
129958661|NCT00550771|467812343|FG000|Overall Study|Protocol Violation|4|||
129958662|NCT00550771|467812344|FG001|Overall Study|Protocol Violation|5|||
129958663|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
129958664|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
129958665|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
129958666|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
129958667|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
129958668|NCT00520403|467812346|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
129958669|NCT00520403|467812346|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
129958670|NCT00520403|467812346|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
129958671|NCT02435381|467812347|FG000|Overall Study|Lost to Follow-up|2|||
129958672|NCT02435381|467812348|FG001|Overall Study|Lost to Follow-up|1|||
129958673|NCT00405912|467812351|FG000|Overall Study|Withdrawal by Subject|12|||
129958674|NCT00405912|467812352|FG001|Overall Study|Withdrawal by Subject|11|||
129958675|NCT00405912|467812353|FG002|Overall Study|Withdrawal by Subject|12|||
129958676|NCT00405912|467812351|FG000|Overall Study|Lost to Follow-up|4|||
129958677|NCT00405912|467812352|FG001|Overall Study|Lost to Follow-up|8|||
129958678|NCT00405912|467812353|FG002|Overall Study|Lost to Follow-up|4|||
129958679|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
129958680|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
129958681|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
129958682|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
129958683|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
129958684|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
129958685|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
129958686|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
129958687|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Death|6|||
129958688|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Death|2|||
129958689|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Death|2|||
129958690|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Death|9|||
129958691|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
129958692|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129958693|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129958694|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
129958695|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
129958696|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
129958697|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
129958698|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
129958699|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
129958700|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
129958701|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
129958702|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
129958703|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
129958704|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
129958705|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
129958706|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
129958707|NCT03730662|467812354|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
129958708|NCT03730662|467812355|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
129958709|NCT03730662|467812356|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
129958710|NCT03730662|467812357|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
129958711|NCT03730662|467812354|FG000|Variable Treatment Period|Adverse Event|1|||
129958712|NCT03730662|467812355|FG001|Variable Treatment Period|Adverse Event|2|||
129958713|NCT03730662|467812356|FG002|Variable Treatment Period|Adverse Event|0|||
129958714|NCT03730662|467812357|FG003|Variable Treatment Period|Adverse Event|7|||
129958715|NCT03730662|467812354|FG000|Variable Treatment Period|Death|9|||
129958716|NCT03730662|467812355|FG001|Variable Treatment Period|Death|0|||
129958717|NCT03730662|467812356|FG002|Variable Treatment Period|Death|6|||
129958718|NCT03730662|467812357|FG003|Variable Treatment Period|Death|26|||
129958719|NCT03730662|467812354|FG000|Variable Treatment Period|Lost to Follow-up|2|||
129958720|NCT03730662|467812355|FG001|Variable Treatment Period|Lost to Follow-up|1|||
129958721|NCT03730662|467812356|FG002|Variable Treatment Period|Lost to Follow-up|4|||
129958722|NCT03730662|467812357|FG003|Variable Treatment Period|Lost to Follow-up|11|||
129958723|NCT03730662|467812354|FG000|Variable Treatment Period|Personal Reason|0|||
129958724|NCT03730662|467812355|FG001|Variable Treatment Period|Personal Reason|2|||
129958725|NCT03730662|467812356|FG002|Variable Treatment Period|Personal Reason|1|||
129958726|NCT03730662|467812357|FG003|Variable Treatment Period|Personal Reason|6|||
129958727|NCT03730662|467812354|FG000|Variable Treatment Period|Physician Decision|0|||
129958728|NCT03730662|467812355|FG001|Variable Treatment Period|Physician Decision|0|||
129958729|NCT03730662|467812356|FG002|Variable Treatment Period|Physician Decision|0|||
129958730|NCT03730662|467812357|FG003|Variable Treatment Period|Physician Decision|3|||
129958731|NCT03730662|467812354|FG000|Variable Treatment Period|Protocol Violation|0|||
129958732|NCT03730662|467812355|FG001|Variable Treatment Period|Protocol Violation|1|||
129958733|NCT03730662|467812356|FG002|Variable Treatment Period|Protocol Violation|1|||
129958734|NCT03730662|467812357|FG003|Variable Treatment Period|Protocol Violation|1|||
129958735|NCT03730662|467812354|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
129958736|NCT03730662|467812355|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
129958737|NCT03730662|467812356|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
129958738|NCT03730662|467812357|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
129958739|NCT01797562|467812358|FG000|Overall Study|Protocol Violation|5|||
129958740|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
129958741|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
129958742|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
129958743|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
129958744|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Death|0|||
129958745|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Death|1|||
129958746|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
129958747|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
129958748|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
129958749|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
129958750|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
129958751|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
129958752|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
129958753|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
129958754|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
129958755|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
129958756|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
129958757|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
129958758|NCT01309243|467812359|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
129958759|NCT01309243|467812360|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
129958760|NCT01309243|467812359|FG000|Extension Phase|Lost to Follow-up|6|||
129958761|NCT01309243|467812360|FG001|Extension Phase|Lost to Follow-up|0|||
129958762|NCT00632931|467812363|FG000|Part 1, Period 1|Protocol Violation|1|||
129958763|NCT00632931|467812364|FG001|Part 1, Period 1|Protocol Violation|0|||
129958764|NCT00632931|467812365|FG002|Part 1, Period 1|Protocol Violation|0|||
129958765|NCT00632931|467812363|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
129958766|NCT00632931|467812364|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
129958767|NCT00632931|467812365|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
129958768|NCT00632931|467812363|FG000|Part 2|Adverse Event|0|||
129958769|NCT00632931|467812364|FG001|Part 2|Adverse Event|0|||
129958770|NCT00632931|467812365|FG002|Part 2|Adverse Event|3|||
129958771|NCT00632931|467812363|FG000|Part 2|Death|0|||
129958772|NCT00632931|467812364|FG001|Part 2|Death|0|||
129958773|NCT00632931|467812365|FG002|Part 2|Death|1|||
129958774|NCT00632931|467812363|FG000|Part 2|Lack of Efficacy|0|||
129958775|NCT00632931|467812364|FG001|Part 2|Lack of Efficacy|0|||
129958776|NCT00632931|467812365|FG002|Part 2|Lack of Efficacy|17|||
129958777|NCT00632931|467812363|FG000|Part 2|Withdrawal by Subject|0|||
129958778|NCT00632931|467812364|FG001|Part 2|Withdrawal by Subject|0|||
129958779|NCT00632931|467812365|FG002|Part 2|Withdrawal by Subject|3|||
129958780|NCT01441583|467812368|FG000|Overall Study|Withdrawal by Subject|1|||
129958781|NCT01441583|467812369|FG001|Overall Study|Withdrawal by Subject|1|||
129958782|NCT01441583|467812370|FG002|Overall Study|Withdrawal by Subject|1|||
129958783|NCT01441583|467812368|FG000|Overall Study|Death|1|||
129958784|NCT01441583|467812369|FG001|Overall Study|Death|0|||
129958785|NCT01441583|467812370|FG002|Overall Study|Death|4|||
129958786|NCT01441583|467812368|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
129958787|NCT01441583|467812369|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
129958788|NCT01441583|467812370|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
129958789|NCT03341312|467812371|FG000|Period 1|Withdrawal by Subject|0|||
129958790|NCT03341312|467812372|FG001|Period 1|Withdrawal by Subject|1|||
129958791|NCT03341312|467812373|FG002|Period 1|Withdrawal by Subject|0|||
129958792|NCT03341312|467812374|FG003|Period 1|Withdrawal by Subject|0|||
129958793|NCT00839306|467812375|FG000|Overall Study|Adverse Event|3|||
129958794|NCT00839306|467812376|FG001|Overall Study|Adverse Event|5|||
129958795|NCT00839306|467812375|FG000|Overall Study|Lost to Follow-up|6|||
129958796|NCT00839306|467812376|FG001|Overall Study|Lost to Follow-up|9|||
129958797|NCT00839306|467812375|FG000|Overall Study|Withdrawal by Subject|5|||
129958798|NCT00839306|467812376|FG001|Overall Study|Withdrawal by Subject|7|||
129958799|NCT00839306|467812375|FG000|Overall Study|Lack of Efficacy|5|||
129958800|NCT00839306|467812376|FG001|Overall Study|Lack of Efficacy|4|||
129958801|NCT00839306|467812375|FG000|Overall Study|Other|6|||
129958802|NCT00839306|467812376|FG001|Overall Study|Other|18|||
129958803|NCT01812707|467812377|FG000|Overall Study|Adverse Event|0|||
129958804|NCT01812707|467812378|FG001|Overall Study|Adverse Event|0|||
129958805|NCT01812707|467812379|FG002|Overall Study|Adverse Event|0|||
129958806|NCT01812707|467812380|FG003|Overall Study|Adverse Event|2|||
129958807|NCT01812707|467812377|FG000|Overall Study|Poor compliance to protocol|1|||
129958808|NCT01812707|467812378|FG001|Overall Study|Poor compliance to protocol|0|||
129958809|NCT01812707|467812379|FG002|Overall Study|Poor compliance to protocol|0|||
129958810|NCT01812707|467812380|FG003|Overall Study|Poor compliance to protocol|0|||
129958811|NCT01812707|467812377|FG000|Overall Study|Consent withdrawn by participant|1|||
129958812|NCT01812707|467812378|FG001|Overall Study|Consent withdrawn by participant|0|||
129958813|NCT01812707|467812379|FG002|Overall Study|Consent withdrawn by participant|0|||
129958814|NCT01812707|467812380|FG003|Overall Study|Consent withdrawn by participant|0|||
129958815|NCT05060237|467812381|FG000|Overall Study|Withdrawal by Subject|4|||
129958816|NCT05060237|467812381|FG000|Overall Study|Screening failure|8|||
129958817|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
129958818|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958819|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958820|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958821|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958822|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958823|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958824|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958825|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958826|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
129958827|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958828|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958829|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958830|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958831|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958832|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
129958833|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958834|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958835|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958836|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
129958837|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
129958838|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958839|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958840|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958841|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958842|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958843|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958844|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958845|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958846|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
129958847|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958848|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958849|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958850|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958851|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958852|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958853|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958854|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958855|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
129958856|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
129958857|NCT01697592|467812382|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958858|NCT01697592|467812383|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
129958859|NCT01697592|467812384|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
129958860|NCT01697592|467812385|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
129958861|NCT01697592|467812386|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958862|NCT01697592|467812387|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958863|NCT01697592|467812388|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
129958864|NCT01697592|467812389|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958865|NCT01697592|467812390|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
129958866|NCT01697592|467812391|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
129454329|NCT03370120|465960773|FG000|Overall Study|Trial discontinued by sponsor|2|||
129958867|NCT01697592|467812382|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
129958868|NCT01697592|467812383|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958869|NCT01697592|467812384|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958870|NCT01697592|467812385|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
129958871|NCT01697592|467812386|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958872|NCT01697592|467812387|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958873|NCT01697592|467812388|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129454330|NCT03370120|465960773|FG000|Overall Study|Study ended|15|||
129958874|NCT01697592|467812389|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958875|NCT01697592|467812390|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958876|NCT01697592|467812391|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
129958877|NCT01697592|467812382|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
129958878|NCT01697592|467812383|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958879|NCT01697592|467812384|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958880|NCT01697592|467812385|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958881|NCT01697592|467812386|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958882|NCT01697592|467812387|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
129958883|NCT01697592|467812388|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958884|NCT01697592|467812389|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
129958885|NCT01697592|467812390|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958886|NCT01697592|467812391|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
129958887|NCT01697592|467812382|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
129958888|NCT01697592|467812383|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958889|NCT01697592|467812384|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958890|NCT01697592|467812385|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
129958891|NCT01697592|467812386|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
129958892|NCT01697592|467812387|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958893|NCT01697592|467812388|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
129958894|NCT01697592|467812389|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
129958895|NCT01697592|467812390|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
129958896|NCT01697592|467812391|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
129958897|NCT02396758|467812392|FG000|Overall Study|Withdrawal by Subject|2|||
129958898|NCT02396758|467812393|FG001|Overall Study|Withdrawal by Subject|0|||
129958899|NCT02396758|467812394|FG002|Overall Study|Withdrawal by Subject|0|||
129958900|NCT02396758|467812395|FG003|Overall Study|Withdrawal by Subject|1|||
129958901|NCT02396758|467812392|FG000|Overall Study|Lost to Follow-up|8|||
129958902|NCT02396758|467812393|FG001|Overall Study|Lost to Follow-up|5|||
129958903|NCT02396758|467812394|FG002|Overall Study|Lost to Follow-up|3|||
129958904|NCT02396758|467812395|FG003|Overall Study|Lost to Follow-up|3|||
129958905|NCT02396758|467812392|FG000|Overall Study|Death|1|||
129958906|NCT02396758|467812393|FG001|Overall Study|Death|1|||
129958907|NCT02396758|467812394|FG002|Overall Study|Death|0|||
129958908|NCT02396758|467812395|FG003|Overall Study|Death|1|||
129958909|NCT02396758|467812392|FG000|Overall Study|Randomized but not treated|1|||
129958910|NCT02396758|467812393|FG001|Overall Study|Randomized but not treated|0|||
129958911|NCT02396758|467812394|FG002|Overall Study|Randomized but not treated|1|||
129958912|NCT02396758|467812395|FG003|Overall Study|Randomized but not treated|0|||
129958913|NCT00265096|467812396|FG000|Overall Study|Adverse Event|14|||
129958914|NCT00265096|467812397|FG001|Overall Study|Adverse Event|18|||
129958915|NCT00265096|467812398|FG002|Overall Study|Adverse Event|18|||
129958916|NCT00265096|467812396|FG000|Overall Study|Lost to Follow-up|2|||
129958917|NCT00265096|467812397|FG001|Overall Study|Lost to Follow-up|5|||
129958918|NCT00265096|467812398|FG002|Overall Study|Lost to Follow-up|3|||
129958919|NCT00265096|467812396|FG000|Overall Study|Death|0|||
129958920|NCT00265096|467812397|FG001|Overall Study|Death|1|||
129958921|NCT00265096|467812398|FG002|Overall Study|Death|2|||
129958922|NCT00265096|467812396|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
129958923|NCT00265096|467812397|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129958924|NCT00265096|467812398|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
129958925|NCT00265096|467812396|FG000|Overall Study|Other|11|||
129958926|NCT00265096|467812397|FG001|Overall Study|Other|19|||
129958927|NCT00265096|467812398|FG002|Overall Study|Other|10|||
129958928|NCT00774306|467812399|FG000|Overall Study|Adverse Event|3|||
129958929|NCT00774306|467812400|FG001|Overall Study|Adverse Event|0|||
129958930|NCT00774306|467812401|FG002|Overall Study|Adverse Event|0|||
129958931|NCT00774306|467812402|FG003|Overall Study|Adverse Event|0|||
129958932|NCT00774306|467812399|FG000|Overall Study|Protocol Violation|2|||
129958933|NCT00774306|467812400|FG001|Overall Study|Protocol Violation|0|||
129958934|NCT00774306|467812401|FG002|Overall Study|Protocol Violation|3|||
129958935|NCT00774306|467812402|FG003|Overall Study|Protocol Violation|0|||
129958936|NCT00774306|467812399|FG000|Overall Study|Withdrawal by Subject|6|||
129958937|NCT00774306|467812400|FG001|Overall Study|Withdrawal by Subject|1|||
129958938|NCT00774306|467812401|FG002|Overall Study|Withdrawal by Subject|1|||
129958939|NCT00774306|467812402|FG003|Overall Study|Withdrawal by Subject|0|||
129958940|NCT00774306|467812399|FG000|Overall Study|Lost to Follow-up|6|||
129958941|NCT00774306|467812400|FG001|Overall Study|Lost to Follow-up|0|||
129958942|NCT00774306|467812401|FG002|Overall Study|Lost to Follow-up|4|||
129958943|NCT00774306|467812402|FG003|Overall Study|Lost to Follow-up|5|||
129958944|NCT00774306|467812399|FG000|Overall Study|Death|1|||
129958945|NCT00774306|467812400|FG001|Overall Study|Death|1|||
129958946|NCT00774306|467812401|FG002|Overall Study|Death|0|||
129958947|NCT00774306|467812402|FG003|Overall Study|Death|0|||
129958948|NCT00666835|467812405|FG000|Overall Study|Withdrawal by Subject|5|||
129958949|NCT00666835|467812406|FG001|Overall Study|Withdrawal by Subject|2|||
129958950|NCT00666835|467812405|FG000|Overall Study|Lack of Efficacy|0|||
129958951|NCT00666835|467812406|FG001|Overall Study|Lack of Efficacy|1|||
129958952|NCT00666835|467812405|FG000|Overall Study|Incl./excl. not fulfilled|7|||
129958953|NCT00666835|467812406|FG001|Overall Study|Incl./excl. not fulfilled|2|||
129958954|NCT00666835|467812405|FG000|Overall Study|Adverse Event|7|||
129958955|NCT00666835|467812406|FG001|Overall Study|Adverse Event|6|||
129958956|NCT00666835|467812405|FG000|Overall Study|Protocol Violation|2|||
129958957|NCT00666835|467812406|FG001|Overall Study|Protocol Violation|0|||
129958958|NCT00666835|467812405|FG000|Overall Study|Death|15|||
129958959|NCT00666835|467812406|FG001|Overall Study|Death|4|||
129958960|NCT00666835|467812405|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
129958961|NCT00666835|467812406|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
129958962|NCT00666835|467812405|FG000|Overall Study|Hemoglobulin concentration|4|||
129958963|NCT00666835|467812406|FG001|Overall Study|Hemoglobulin concentration|3|||
129958964|NCT00666835|467812405|FG000|Overall Study|Planned operation|2|||
129958965|NCT00666835|467812406|FG001|Overall Study|Planned operation|0|||
129958966|NCT00666835|467812405|FG000|Overall Study|Physician Decision|1|||
129958967|NCT00666835|467812406|FG001|Overall Study|Physician Decision|2|||
129958968|NCT01126879|467812407|FG000|Overall Study|Progressive Disease|3|||
129958969|NCT01126879|467812408|FG001|Overall Study|Progressive Disease|1|||
129958970|NCT01126879|467812407|FG000|Overall Study|Withdrawal by Subject|1|||
129958971|NCT01126879|467812408|FG001|Overall Study|Withdrawal by Subject|0|||
129958972|NCT01126879|467812407|FG000|Overall Study|Adverse Event|0|||
129958973|NCT01126879|467812408|FG001|Overall Study|Adverse Event|1|||
129958974|NCT01126879|467812407|FG000|Overall Study|Physician Decision|1|||
129958975|NCT01126879|467812408|FG001|Overall Study|Physician Decision|0|||
129958976|NCT03319719|467812409|FG000|Overall Study|Lost to Follow-up|1|||
129958977|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
129958978|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
129958979|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
129958980|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
129958981|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
129958982|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
129958983|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
129958984|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
129958985|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
129958986|NCT00498433|467812410|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
129958987|NCT00498433|467812411|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
129958988|NCT00498433|467812412|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
129958989|NCT00744796|467812413|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
129958990|NCT03193216|467812417|FG000|Overall Study|Lost to Follow-up|1|||
129958991|NCT03193216|467812418|FG001|Overall Study|Lost to Follow-up|0|||
129958992|NCT03193216|467812417|FG000|Overall Study|Withdrawal by Subject|5|||
129958993|NCT03193216|467812418|FG001|Overall Study|Withdrawal by Subject|0|||
129958994|NCT03193216|467812417|FG000|Overall Study|Physician Decision|4|||
129958995|NCT03193216|467812418|FG001|Overall Study|Physician Decision|0|||
129958996|NCT01514864|467812419|FG000|Overall Study|Disease progression|7|||
129958997|NCT01514864|467812420|FG001|Overall Study|Disease progression|5|||
129958998|NCT01514864|467812419|FG000|Overall Study|Study drug toxicity|2|||
129958999|NCT01514864|467812420|FG001|Overall Study|Study drug toxicity|0|||
129959000|NCT02253147|467812422|FG000|Overall Study|Protocol Violation|30|||
129959001|NCT02253147|467812422|FG000|Overall Study|Did not consent to study extension|9|||
129959002|NCT02253147|467812422|FG000|Overall Study|Conditional re-treatment at W52|5|||
129959003|NCT02253147|467812422|FG000|Overall Study|Lost to Follow-up|2|||
129959004|NCT02253147|467812422|FG000|Overall Study|Withdrawal by Subject|1|||
129959005|NCT02254681|467812423|FG000|Overall Study|Lack of Efficacy|6|||
129959006|NCT02316847|467812424|FG000|Overall Study|Adverse Event|0|||
129959007|NCT02316847|467812425|FG001|Overall Study|Adverse Event|3|||
129959008|NCT02316847|467812424|FG000|Overall Study|Lost to Follow-up|0|||
129959009|NCT02316847|467812425|FG001|Overall Study|Lost to Follow-up|2|||
129959010|NCT02316847|467812424|FG000|Overall Study|Physician Decision|0|||
129959011|NCT02316847|467812425|FG001|Overall Study|Physician Decision|1|||
129959012|NCT02316847|467812424|FG000|Overall Study|Pregnancy|0|||
129959013|NCT02316847|467812425|FG001|Overall Study|Pregnancy|1|||
129959014|NCT02316847|467812424|FG000|Overall Study|Withdrawal by Subject|2|||
129959015|NCT02316847|467812425|FG001|Overall Study|Withdrawal by Subject|9|||
129959016|NCT02316847|467812424|FG000|Overall Study|Noncompliance with study drug|0|||
129959017|NCT02316847|467812425|FG001|Overall Study|Noncompliance with study drug|3|||
129959018|NCT02316847|467812424|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
129959019|NCT02316847|467812425|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
129959020|NCT02621047|467812426|FG000|Overall Study|Adverse Event|0|||
129959021|NCT02621047|467812427|FG001|Overall Study|Adverse Event|0|||
129959022|NCT02621047|467812428|FG002|Overall Study|Adverse Event|1|||
129959023|NCT02236598|467812434|FG000|Overall Study|Adverse Event|0|||
129959024|NCT02236598|467812435|FG001|Overall Study|Adverse Event|1|||
129959025|NCT02236598|467812434|FG000|Overall Study|Withdrawal by Subject|0|||
129959026|NCT02236598|467812435|FG001|Overall Study|Withdrawal by Subject|1|||
129959027|NCT01264887|467812437|FG000|Overall Study|Adverse Event|5|||
129959028|NCT01264887|467812437|FG000|Overall Study|Death|7|||
129959029|NCT01264887|467812437|FG000|Overall Study|Lack of Efficacy|5|||
129959030|NCT01264887|467812437|FG000|Overall Study|Physician Decision|4|||
129959031|NCT01264887|467812437|FG000|Overall Study|Withdrawal by Subject|6|||
129959032|NCT01264887|467812437|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
129959033|NCT01264887|467812437|FG000|Overall Study|Other|2|||
129959034|NCT02171130|467812438|FG000|Overall Study|Death|1|||
129959035|NCT02171130|467812438|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
129959036|NCT02171130|467812438|FG000|Overall Study|Discontinued; Site Termination|5|||
129959037|NCT02171130|467812438|FG000|Overall Study|Withdrawal by Subject|3|||
129959038|NCT02171130|467812438|FG000|Overall Study|Physician Decision|1|||
129959039|NCT02171130|467812438|FG000|Overall Study|Lost to Follow-up|1|||
129959040|NCT02171130|467812438|FG000|Overall Study|Met Exclusion Criteria|1|||
129959041|NCT03544229|467812439|FG000|Overall Study|Adverse Event|1|||
129959042|NCT03544229|467812440|FG001|Overall Study|Adverse Event|0|||
129959043|NCT03544229|467812441|FG002|Overall Study|Adverse Event|1|||
129959044|NCT03544229|467812442|FG003|Overall Study|Adverse Event|0|||
129959045|NCT03544229|467812439|FG000|Overall Study|Protocol Deviation|0|||
129959046|NCT03544229|467812440|FG001|Overall Study|Protocol Deviation|0|||
129959047|NCT03544229|467812441|FG002|Overall Study|Protocol Deviation|1|||
129959048|NCT03544229|467812442|FG003|Overall Study|Protocol Deviation|0|||
129959049|NCT03544229|467812439|FG000|Overall Study|Lost to Follow-up|3|||
129959050|NCT03544229|467812440|FG001|Overall Study|Lost to Follow-up|0|||
129959051|NCT03544229|467812441|FG002|Overall Study|Lost to Follow-up|0|||
129959052|NCT03544229|467812442|FG003|Overall Study|Lost to Follow-up|2|||
129959053|NCT03544229|467812439|FG000|Overall Study|Voluntary Withdrawal|2|||
129959054|NCT03544229|467812440|FG001|Overall Study|Voluntary Withdrawal|1|||
129959055|NCT03544229|467812441|FG002|Overall Study|Voluntary Withdrawal|3|||
129959056|NCT03544229|467812442|FG003|Overall Study|Voluntary Withdrawal|0|||
129959057|NCT03544229|467812439|FG000|Overall Study|Lack of Efficacy|0|||
129959058|NCT03544229|467812440|FG001|Overall Study|Lack of Efficacy|1|||
129959059|NCT03544229|467812441|FG002|Overall Study|Lack of Efficacy|0|||
129959060|NCT03544229|467812442|FG003|Overall Study|Lack of Efficacy|0|||
129959061|NCT03187353|467812444|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
129959062|NCT03187353|467812445|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
129959063|NCT03187353|467812444|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
129959064|NCT03187353|467812445|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
129959065|NCT03187353|467812444|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
129959066|NCT03187353|467812445|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
129959067|NCT03187353|467812444|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
129959068|NCT03187353|467812445|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
129959069|NCT03187353|467812444|FG000|Washout (2 Weeks)|Adverse Event|2|||
129959070|NCT03187353|467812445|FG001|Washout (2 Weeks)|Adverse Event|0|||
129959071|NCT03187353|467812444|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
129959072|NCT03187353|467812445|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
129959073|NCT01061775|467812446|FG000|Overall Study|Physician Decision|2|||
129959074|NCT01061775|467812446|FG000|Overall Study|Lost to Follow-up|1|||
129959075|NCT03303521|467812447|FG000|Overall Study|Withdrawal by Subject|2|||
129959076|NCT03303521|467812448|FG001|Overall Study|Withdrawal by Subject|0|||
129959077|NCT03303521|467812447|FG000|Overall Study|Death|1|||
129959078|NCT03303521|467812448|FG001|Overall Study|Death|0|||
129959079|NCT03303521|467812447|FG000|Overall Study|Kidney transplantation|0|||
129959080|NCT03303521|467812448|FG001|Overall Study|Kidney transplantation|1|||
129959081|NCT03303521|467812447|FG000|Overall Study|Investigational product discontinuation|0|||
129959082|NCT03303521|467812448|FG001|Overall Study|Investigational product discontinuation|1|||
129959083|NCT03303521|467812447|FG000|Overall Study|Transferred to non-study dialysis center|1|||
129959084|NCT03303521|467812448|FG001|Overall Study|Transferred to non-study dialysis center|0|||
129959085|NCT03303521|467812447|FG000|Overall Study|Non-comliance to study protocol|0|||
129959086|NCT03303521|467812448|FG001|Overall Study|Non-comliance to study protocol|1|||
129959087|NCT03303521|467812447|FG000|Overall Study|Adverse Event|1|||
129959088|NCT03303521|467812448|FG001|Overall Study|Adverse Event|0|||
129959089|NCT02642159|467812449|FG000|Overall Study|Randomized but not treated|1|||
129959090|NCT02642159|467812450|FG001|Overall Study|Randomized but not treated|0|||
129959091|NCT02642159|467812449|FG000|Overall Study|Adverse Event|10|||
129959092|NCT02642159|467812450|FG001|Overall Study|Adverse Event|4|||
129959093|NCT02642159|467812449|FG000|Overall Study|Withdrawal by Subject|9|||
129959094|NCT02642159|467812450|FG001|Overall Study|Withdrawal by Subject|1|||
129959095|NCT02642159|467812449|FG000|Overall Study|Poor compliance to study protocol|1|||
129959096|NCT02642159|467812450|FG001|Overall Study|Poor compliance to study protocol|0|||
129959097|NCT02642159|467812449|FG000|Overall Study|Other than specified above|10|||
129959098|NCT02642159|467812450|FG001|Overall Study|Other than specified above|3|||
129959099|NCT03746483|467812451|FG000|Overall Study|Adverse Event|0|||
129959100|NCT03746483|467812452|FG001|Overall Study|Adverse Event|1|||
129959101|NCT03746483|467812451|FG000|Overall Study|Lack of Efficacy|3|||
129959102|NCT03746483|467812452|FG001|Overall Study|Lack of Efficacy|2|||
129959103|NCT03746483|467812451|FG000|Overall Study|Lost to Follow-up|1|||
129959104|NCT03746483|467812452|FG001|Overall Study|Lost to Follow-up|0|||
129959105|NCT03746483|467812451|FG000|Overall Study|Protocol Violation|2|||
129959106|NCT03746483|467812452|FG001|Overall Study|Protocol Violation|0|||
129959107|NCT01951261|467812455|FG000|Overall Study|Death|1|||
129959108|NCT01951261|467812456|FG001|Overall Study|Death|0|||
129959109|NCT01951261|467812455|FG000|Overall Study|Lost to Follow-up|4|||
129959110|NCT01951261|467812456|FG001|Overall Study|Lost to Follow-up|3|||
129959111|NCT01951261|467812455|FG000|Overall Study|Protocol Violation|4|||
129959112|NCT01951261|467812456|FG001|Overall Study|Protocol Violation|3|||
129959113|NCT01924806|467812457|FG000|Overall Study|Physician Decision|2|||
129959114|NCT01924806|467812458|FG001|Overall Study|Physician Decision|1|||
129959115|NCT02205476|467812459|FG000|Overall Study|Study termination by Sponsor|7|||
129959116|NCT02205476|467812460|FG001|Overall Study|Study termination by Sponsor|3|||
129959117|NCT01313299|467812461|FG000|Overall Study|Adverse Event|3|||
129959118|NCT01313299|467812462|FG001|Overall Study|Adverse Event|1|||
129959119|NCT01313299|467812463|FG002|Overall Study|Adverse Event|1|||
129959120|NCT01313299|467812461|FG000|Overall Study|Lost to Follow-up|1|||
129959121|NCT01313299|467812462|FG001|Overall Study|Lost to Follow-up|0|||
129959122|NCT01313299|467812463|FG002|Overall Study|Lost to Follow-up|0|||
129959123|NCT01313299|467812461|FG000|Overall Study|Protocol Violation|2|||
129959124|NCT01313299|467812462|FG001|Overall Study|Protocol Violation|0|||
129959125|NCT01313299|467812463|FG002|Overall Study|Protocol Violation|0|||
129959126|NCT01313299|467812461|FG000|Overall Study|Withdrawal by Subject|1|||
129959127|NCT01313299|467812462|FG001|Overall Study|Withdrawal by Subject|0|||
129959128|NCT01313299|467812463|FG002|Overall Study|Withdrawal by Subject|2|||
129959129|NCT01313299|467812461|FG000|Overall Study|Family reason and moved out of state|0|||
129959130|NCT01313299|467812462|FG001|Overall Study|Family reason and moved out of state|2|||
129959131|NCT01313299|467812463|FG002|Overall Study|Family reason and moved out of state|0|||
129959132|NCT01313299|467812461|FG000|Overall Study|Lack of subject compliance|0|||
129959133|NCT01313299|467812462|FG001|Overall Study|Lack of subject compliance|0|||
129959134|NCT01313299|467812463|FG002|Overall Study|Lack of subject compliance|1|||
129959135|NCT04089332|467812467|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
129959136|NCT04089332|467812467|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
129959137|NCT04089332|467812467|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
129959138|NCT02256488|467812468|FG000|Overall Study|Lost to Follow-up|6|||
129959139|NCT02256488|467812469|FG001|Overall Study|Lost to Follow-up|6|||
129959140|NCT02256488|467812470|FG002|Overall Study|Lost to Follow-up|9|||
129959141|NCT02256488|467812471|FG003|Overall Study|Lost to Follow-up|3|||
129959142|NCT02256488|467812468|FG000|Overall Study|OTHER|1|||
129959143|NCT02256488|467812469|FG001|Overall Study|OTHER|0|||
129959144|NCT02256488|467812470|FG002|Overall Study|OTHER|1|||
129959145|NCT02256488|467812471|FG003|Overall Study|OTHER|1|||
129959146|NCT02256488|467812468|FG000|Overall Study|Withdrawal by Subject|1|||
129959147|NCT02256488|467812469|FG001|Overall Study|Withdrawal by Subject|0|||
129959148|NCT02256488|467812470|FG002|Overall Study|Withdrawal by Subject|0|||
129959149|NCT02256488|467812471|FG003|Overall Study|Withdrawal by Subject|2|||
129959150|NCT00240097|467812472|FG000|Part I|Adverse Event|1|||
129959151|NCT00240097|467812472|FG000|Part I|Death|1|||
129959152|NCT00240097|467812472|FG000|Part I|histology|1|||
129959153|NCT00240097|467812472|FG000|Part I|unevaluable|1|||
129959154|NCT00240097|467812472|FG000|Part II|did not continue from Part I|23|||
129959155|NCT00818519|467812473|FG000|Overall Study|Adverse Event|2|||
129959156|NCT00818519|467812474|FG001|Overall Study|Adverse Event|2|||
129959157|NCT00818519|467812473|FG000|Overall Study|Lost to Follow-up|4|||
129959158|NCT00818519|467812474|FG001|Overall Study|Lost to Follow-up|6|||
129959159|NCT00818519|467812473|FG000|Overall Study|Protocol Violation|2|||
129959160|NCT00818519|467812474|FG001|Overall Study|Protocol Violation|1|||
129959161|NCT00818519|467812473|FG000|Overall Study|Pregnancy|0|||
129959162|NCT00818519|467812474|FG001|Overall Study|Pregnancy|1|||
129959163|NCT00818519|467812473|FG000|Overall Study|Withdrawal by Subject|4|||
129959164|NCT00818519|467812474|FG001|Overall Study|Withdrawal by Subject|9|||
129959165|NCT00818519|467812473|FG000|Overall Study|participant recovered completely|1|||
129959166|NCT00818519|467812474|FG001|Overall Study|participant recovered completely|0|||
129959167|NCT00818519|467812473|FG000|Overall Study|participant will leave for long tme|1|||
129959168|NCT00818519|467812474|FG001|Overall Study|participant will leave for long tme|0|||
129959169|NCT03356145|467812477|FG000|Overall Study|Withdrawal by Subject|2|||
129959170|NCT03356145|467812478|FG001|Overall Study|Withdrawal by Subject|1|||
129959171|NCT03356145|467812477|FG000|Overall Study|Did not meet inclusion criteria|1|||
129959172|NCT03356145|467812478|FG001|Overall Study|Did not meet inclusion criteria|0|||
129959173|NCT03613454|467812479|FG000|Overall Study|Protocol Violation|1|||
129959174|NCT03613454|467812480|FG001|Overall Study|Protocol Violation|0|||
129959175|NCT03613454|467812479|FG000|Overall Study|Protocol Violation|0|||
129959176|NCT03613454|467812480|FG001|Overall Study|Protocol Violation|1|||
129959177|NCT02963922|467812481|FG000|Overall Study|Adverse Event|15|||
129959178|NCT02963922|467812482|FG001|Overall Study|Adverse Event|6|||
129959179|NCT02963922|467812481|FG000|Overall Study|Protocol deviation|6|||
129959180|NCT02963922|467812482|FG001|Overall Study|Protocol deviation|6|||
129959181|NCT02963922|467812481|FG000|Overall Study|Lack of Efficacy|1|||
129959182|NCT02963922|467812482|FG001|Overall Study|Lack of Efficacy|1|||
129959183|NCT02963922|467812481|FG000|Overall Study|Lost to Follow-up|2|||
129959184|NCT02963922|467812482|FG001|Overall Study|Lost to Follow-up|3|||
129959185|NCT02963922|467812481|FG000|Overall Study|Other|8|||
129959186|NCT02963922|467812482|FG001|Overall Study|Other|14|||
129959187|NCT01967719|467813911|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959188|NCT01967719|467813912|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
129959189|NCT01967719|467813913|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959190|NCT01967719|467813914|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
129959191|NCT01967719|467813911|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
129959192|NCT01967719|467813912|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
129959193|NCT01967719|467813913|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
129959194|NCT01967719|467813914|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
129959195|NCT00796614|467813915|FG000|Overall Study|Adverse Event|1|||
129959196|NCT00796614|467813916|FG001|Overall Study|Adverse Event|2|||
129959197|NCT00796614|467813917|FG002|Overall Study|Adverse Event|0|||
129959198|NCT00796614|467813918|FG003|Overall Study|Adverse Event|0|||
129959199|NCT00796614|467813915|FG000|Overall Study|Protocol Violation|0|||
129959200|NCT00796614|467813916|FG001|Overall Study|Protocol Violation|0|||
129959201|NCT00796614|467813917|FG002|Overall Study|Protocol Violation|2|||
129959202|NCT00796614|467813918|FG003|Overall Study|Protocol Violation|0|||
129959203|NCT00796614|467813915|FG000|Overall Study|Lost to Follow-up|2|||
129959204|NCT00796614|467813916|FG001|Overall Study|Lost to Follow-up|2|||
129959205|NCT00796614|467813917|FG002|Overall Study|Lost to Follow-up|1|||
129959206|NCT00796614|467813918|FG003|Overall Study|Lost to Follow-up|0|||
129959207|NCT00796614|467813915|FG000|Overall Study|Withdrawal by Subject|1|||
129959208|NCT00796614|467813916|FG001|Overall Study|Withdrawal by Subject|0|||
129959209|NCT00796614|467813917|FG002|Overall Study|Withdrawal by Subject|0|||
129959210|NCT00796614|467813918|FG003|Overall Study|Withdrawal by Subject|1|||
129959211|NCT00796614|467813915|FG000|Overall Study|Other than stated|1|||
129959212|NCT00796614|467813916|FG001|Overall Study|Other than stated|0|||
129959213|NCT00796614|467813917|FG002|Overall Study|Other than stated|0|||
129959214|NCT00796614|467813918|FG003|Overall Study|Other than stated|0|||
129959215|NCT01231464|467813919|FG000|Overall Study|Adverse Event|0|||
129959216|NCT01231464|467813920|FG001|Overall Study|Adverse Event|1|||
129959217|NCT01231464|467813919|FG000|Overall Study|Protocol Violation|1|||
129959218|NCT01231464|467813920|FG001|Overall Study|Protocol Violation|2|||
129959219|NCT01231464|467813919|FG000|Overall Study|Lost to Follow-up|1|||
129959220|NCT01231464|467813920|FG001|Overall Study|Lost to Follow-up|2|||
129959221|NCT01231464|467813919|FG000|Overall Study|Withdrawal by Subject|3|||
129959222|NCT01231464|467813920|FG001|Overall Study|Withdrawal by Subject|2|||
129959223|NCT01960348|467813927|FG000|Overall Study|Adverse event, not serious|2|||
129959224|NCT01960348|467813928|FG001|Overall Study|Adverse event, not serious|2|||
129959225|NCT01960348|467813927|FG000|Overall Study|Adverse event, serious fatal|6|||
129959226|NCT01960348|467813928|FG001|Overall Study|Adverse event, serious fatal|5|||
129959227|NCT01960348|467813927|FG000|Overall Study|Adverse event, serious non-fatal|0|||
129959228|NCT01960348|467813928|FG001|Overall Study|Adverse event, serious non-fatal|3|||
129959229|NCT01960348|467813927|FG000|Overall Study|Withdrawal by Subject|1|||
129959230|NCT01960348|467813928|FG001|Overall Study|Withdrawal by Subject|11|||
129959231|NCT01960348|467813927|FG000|Overall Study|Physician Decision|0|||
129959232|NCT01960348|467813928|FG001|Overall Study|Physician Decision|1|||
129959233|NCT01960348|467813927|FG000|Overall Study|Protocol Violation|1|||
129959234|NCT01960348|467813928|FG001|Overall Study|Protocol Violation|0|||
129959235|NCT02151643|467813931|FG000|Overall Study|Adverse Event|2|||
129959236|NCT02151643|467813932|FG001|Overall Study|Adverse Event|0|||
129959237|NCT02151643|467813933|FG002|Overall Study|Adverse Event|1|||
129959238|NCT02151643|467813934|FG003|Overall Study|Adverse Event|4|||
129959239|NCT02151643|467813935|FG004|Overall Study|Adverse Event|0|||
129959240|NCT02151643|467813931|FG000|Overall Study|Withdrawal by Subject|0|||
129959241|NCT02151643|467813932|FG001|Overall Study|Withdrawal by Subject|1|||
129959242|NCT02151643|467813933|FG002|Overall Study|Withdrawal by Subject|1|||
129959243|NCT02151643|467813934|FG003|Overall Study|Withdrawal by Subject|1|||
129454331|NCT03370120|465960773|FG000|Overall Study|Clinical trial has been cancelled|1|||
129454332|NCT03370120|465960773|FG000|Overall Study|End of study per sponsor decision|2|||
129454333|NCT03370120|465960773|FG000|Overall Study|Promoter's decision|2|||
129454334|NCT03370120|465960773|FG000|Overall Study|The trial has been suspended|3|||
129454335|NCT03370120|465960773|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
129454336|NCT03370120|465960773|FG000|Overall Study|Early termination by order of sponsor|2|||
129454337|NCT03370120|465960773|FG000|Overall Study|Discontinuation of the study|5|||
129454338|NCT03370120|465960773|FG000|Overall Study|End of clinical trial discontinuation|1|||
129454339|NCT03370120|465960773|FG000|Overall Study|Because the clinical trial ended halfway|4|||
129454340|NCT03370120|465960773|FG000|Overall Study|Development discontinued|5|||
129454341|NCT03370120|465960773|FG000|Overall Study|Padsenovil program closed|3|||
129454342|NCT03370120|465960773|FG000|Overall Study|End of project|2|||
129454343|NCT03370120|465960773|FG000|Overall Study|Termination of project|1|||
129454344|NCT03370120|465960773|FG000|Overall Study|The study was interrupted by sponsor|4|||
129454345|NCT03370120|465960773|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
129454346|NCT03370120|465960773|FG000|Overall Study|End of sponsor decision|1|||
129454347|NCT03370120|465960773|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
129454348|NCT03370120|465960773|FG000|Overall Study|Early termination of studies|5|||
129454349|NCT03370120|465960773|FG000|Overall Study|This study is ended early|1|||
129454350|NCT03370120|465960773|FG000|Overall Study|End of padsevonil program|2|||
129454351|NCT03370120|465960773|FG000|Overall Study|Decision of sponsor|6|||
129454352|NCT03370120|465960773|FG000|Overall Study|Asked by the sponsor|3|||
129454353|NCT03370120|465960773|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
129454354|NCT03370120|465960773|FG000|Overall Study|PI decision poor compliance from participant|1|||
129454355|NCT03370120|465960773|FG000|Overall Study|Promoter ended the study|3|||
129454356|NCT03370120|465960773|FG000|Overall Study|Premature study close by sponsor's decision|4|||
129959244|NCT02151643|467813935|FG004|Overall Study|Withdrawal by Subject|1|||
129959245|NCT02151643|467813931|FG000|Overall Study|Hyperphosphataemia|1|||
129959246|NCT02151643|467813932|FG001|Overall Study|Hyperphosphataemia|0|||
129454357|NCT03370120|465960773|FG000|Overall Study|Study terminated by sponsor|33|||
129454358|NCT03370120|465960773|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
129454359|NCT03370120|465960773|FG000|Overall Study|Sponsor decision to terminate study|63|||
129454360|NCT03370120|465960773|FG000|Overall Study|Program closure|3|||
129959247|NCT02151643|467813933|FG002|Overall Study|Hyperphosphataemia|0|||
129959248|NCT02151643|467813934|FG003|Overall Study|Hyperphosphataemia|0|||
129454361|NCT03370120|465960773|FG000|Overall Study|Study ended prematurely|1|||
129454362|NCT03370120|465960773|FG000|Overall Study|Study stopped by sponsor|2|||
129454363|NCT03370120|465960773|FG000|Overall Study|Program termination|55|||
129959249|NCT02151643|467813935|FG004|Overall Study|Hyperphosphataemia|1|||
129959250|NCT02151643|467813931|FG000|Overall Study|High Ferritin levels|3|||
129959251|NCT02151643|467813932|FG001|Overall Study|High Ferritin levels|3|||
129959252|NCT02151643|467813933|FG002|Overall Study|High Ferritin levels|2|||
129959253|NCT02151643|467813934|FG003|Overall Study|High Ferritin levels|2|||
129959254|NCT02151643|467813935|FG004|Overall Study|High Ferritin levels|1|||
129959255|NCT00508274|467813938|FG000|Overall Study|Adverse Event|5|||
129959256|NCT00508274|467813938|FG000|Overall Study|Death|7|||
129959257|NCT00508274|467813938|FG000|Overall Study|Disease progression|32|||
129959258|NCT00508274|467813938|FG000|Overall Study|Withdrawal by Subject|1|||
129959259|NCT00508274|467813938|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
129959260|NCT00508274|467813938|FG000|Overall Study|Missing|3|||
129959261|NCT03296566|467813939|FG000|Overall Study|Lost to Follow-up|19|||
129959262|NCT03296566|467813940|FG001|Overall Study|Lost to Follow-up|46|||
129959263|NCT03296566|467813939|FG000|Overall Study|Withdrawal by Subject|0|||
129959264|NCT03296566|467813940|FG001|Overall Study|Withdrawal by Subject|3|||
129959265|NCT00197106|467813941|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
129959266|NCT00197106|467813942|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
129959267|NCT00197106|467813943|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
129959268|NCT00197106|467813941|FG000|Overall Treatment Period|Lack of Efficacy|0|||
129959269|NCT00197106|467813942|FG001|Overall Treatment Period|Lack of Efficacy|1|||
129959270|NCT00197106|467813943|FG002|Overall Treatment Period|Lack of Efficacy|0|||
129959271|NCT00197106|467813941|FG000|Overall Treatment Period|Lost to Follow-up|0|||
129959272|NCT00197106|467813942|FG001|Overall Treatment Period|Lost to Follow-up|0|||
129959273|NCT00197106|467813943|FG002|Overall Treatment Period|Lost to Follow-up|2|||
129959274|NCT00197106|467813941|FG000|Overall Treatment Period|Protocol Violation|0|||
129959275|NCT00197106|467813942|FG001|Overall Treatment Period|Protocol Violation|0|||
129959276|NCT00197106|467813943|FG002|Overall Treatment Period|Protocol Violation|2|||
129959277|NCT00197106|467813941|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
129959278|NCT00197106|467813942|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
129959279|NCT00197106|467813943|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
129959280|NCT01084239|467813948|FG000|28-Day Follow-up|Lost to Follow-up|4|||
129959281|NCT01084239|467813949|FG001|28-Day Follow-up|Lost to Follow-up|9|||
129959282|NCT02679079|467813950|FG000|Overall Study|Adverse Event|2|||
129959283|NCT02679079|467813951|FG001|Overall Study|Adverse Event|0|||
129959284|NCT02679079|467813952|FG002|Overall Study|Adverse Event|2|||
129959285|NCT02679079|467813950|FG000|Overall Study|Protocol Violation|0|||
129959286|NCT02679079|467813951|FG001|Overall Study|Protocol Violation|1|||
129959287|NCT02679079|467813952|FG002|Overall Study|Protocol Violation|0|||
129959288|NCT02679079|467813950|FG000|Overall Study|Withdrawal by Subject|2|||
129959289|NCT02679079|467813951|FG001|Overall Study|Withdrawal by Subject|1|||
129959290|NCT02679079|467813952|FG002|Overall Study|Withdrawal by Subject|0|||
129959291|NCT03924947|467813953|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959292|NCT03924947|467813954|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959293|NCT03924947|467813955|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
129959294|NCT03924947|467813956|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959295|NCT03924947|467813957|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959296|NCT03924947|467813958|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
129959297|NCT04150341|467813959|FG000|Overall Study|Physician Decision|0|||
129959298|NCT04150341|467813960|FG001|Overall Study|Physician Decision|0|||
129454364|NCT03370120|465960773|FG000|Overall Study|Sponsor decision|62|||
129959299|NCT04150341|467813961|FG002|Overall Study|Physician Decision|1|||
129959300|NCT04150341|467813962|FG003|Overall Study|Physician Decision|0|||
129959301|NCT04150341|467813963|FG004|Overall Study|Physician Decision|0|||
129959302|NCT04150341|467813964|FG005|Overall Study|Physician Decision|0|||
129959303|NCT04150341|467813959|FG000|Overall Study|Adverse Event|0|||
129959304|NCT04150341|467813960|FG001|Overall Study|Adverse Event|0|||
129959305|NCT04150341|467813961|FG002|Overall Study|Adverse Event|0|||
129959306|NCT04150341|467813962|FG003|Overall Study|Adverse Event|0|||
129959307|NCT04150341|467813963|FG004|Overall Study|Adverse Event|1|||
129959308|NCT04150341|467813964|FG005|Overall Study|Adverse Event|0|||
129959309|NCT00805285|467813965|FG000|Overall Study|Lack of Efficacy|1|||
129959310|NCT00917462|467813966|FG000|Overall Study|Clinical Deterioration|1|||
129959311|NCT01631825|467813967|FG000|Overall Study|Adverse Event|42|||
129959312|NCT01631825|467813967|FG000|Overall Study|Lack of Efficacy|7|||
129959313|NCT01631825|467813967|FG000|Overall Study|Withdrawal by Subject|9|||
129959314|NCT01631825|467813967|FG000|Overall Study|Protocol Violation|4|||
129959315|NCT01631825|467813967|FG000|Overall Study|Discontinuation criteria|1|||
129959316|NCT01631825|467813967|FG000|Overall Study|Physician Decision|2|||
129959317|NCT05109117|467813968|FG000|Overall Study|Lost to Follow-up|1|||
129959318|NCT05109117|467813968|FG000|Overall Study|Discontinued for non-compliance|1|||
129959319|NCT03226353|467813969|FG000|Overall Study|Withdrawal by Subject|1|||
129959320|NCT03226353|467813969|FG000|Overall Study|Screen Failure|5|||
129959321|NCT00797511|467813971|FG000|Overall Study|Withdrawal by Subject|1|||
129959322|NCT02853305|467813972|FG000|Overall Study|Death|287|||
129959323|NCT02853305|467813973|FG001|Overall Study|Death|249|||
129959324|NCT02853305|467813974|FG002|Overall Study|Death|300|||
129959325|NCT02853305|467813972|FG000|Overall Study|Withdrawal by Subject|2|||
129959326|NCT02853305|467813973|FG001|Overall Study|Withdrawal by Subject|8|||
129959327|NCT02853305|467813974|FG002|Overall Study|Withdrawal by Subject|3|||
129959328|NCT02853305|467813972|FG000|Overall Study|Transferred to Extension Study|46|||
129959329|NCT02853305|467813973|FG001|Overall Study|Transferred to Extension Study|30|||
129959330|NCT02853305|467813974|FG002|Overall Study|Transferred to Extension Study|25|||
129959331|NCT02853305|467813972|FG000|Overall Study|Did Not Continue on Extension Study|16|||
129959332|NCT02853305|467813973|FG001|Overall Study|Did Not Continue on Extension Study|20|||
129959333|NCT02853305|467813974|FG002|Overall Study|Did Not Continue on Extension Study|24|||
129959334|NCT04772313|467813977|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
129959335|NCT04772313|467813977|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
129959336|NCT01836198|467813978|FG000|Part A, Period 2|Protocol Violation|0|||
129959337|NCT01836198|467813979|FG001|Part A, Period 2|Protocol Violation|1|||
129959338|NCT01836198|467813980|FG002|Part A, Period 2|Protocol Violation|0|||
129959339|NCT02215954|467813981|FG000|Overall Study|Adverse Event|0|||
129959340|NCT02215954|467813982|FG001|Overall Study|Adverse Event|0|||
129959341|NCT02215954|467813983|FG002|Overall Study|Adverse Event|1|||
129959342|NCT02215954|467813981|FG000|Overall Study|Withdrawal by Subject|0|||
129959343|NCT02215954|467813982|FG001|Overall Study|Withdrawal by Subject|0|||
129959344|NCT02215954|467813983|FG002|Overall Study|Withdrawal by Subject|2|||
129959345|NCT02215954|467813981|FG000|Overall Study|Not exposed|1|||
129959346|NCT02215954|467813982|FG001|Overall Study|Not exposed|1|||
129959347|NCT02215954|467813983|FG002|Overall Study|Not exposed|3|||
129959348|NCT02460562|467813984|FG000|Overall Study|Lost to Follow-up|15|||
129959349|NCT02460562|467813985|FG001|Overall Study|Lost to Follow-up|16|||
129959350|NCT01654289|467813986|FG000|Overall Study|Withdrawal by Subject|10|||
129959351|NCT01654289|467813987|FG001|Overall Study|Withdrawal by Subject|8|||
129959352|NCT01654289|467813988|FG002|Overall Study|Withdrawal by Subject|5|||
129959353|NCT01654289|467813986|FG000|Overall Study|Withdrew from intervention only|17|||
129959354|NCT01654289|467813987|FG001|Overall Study|Withdrew from intervention only|20|||
129959355|NCT01654289|467813988|FG002|Overall Study|Withdrew from intervention only|0|||
129959356|NCT04194541|467813989|FG000|Day 1 Through 13|Lost to Follow-up|3|||
129959357|NCT04194541|467813989|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
129959358|NCT04194541|467813989|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
129959359|NCT00187135|467813990|FG000|Visit One|Withdrawal by Subject|1|||
129959360|NCT00187135|467813991|FG001|Visit One|Withdrawal by Subject|0|||
129959361|NCT00187135|467813992|FG002|Visit One|Withdrawal by Subject|0|||
129959362|NCT00187135|467813993|FG003|Visit One|Withdrawal by Subject|0|||
129959363|NCT00187135|467813994|FG004|Visit One|Withdrawal by Subject|0|||
129959364|NCT00187135|467813995|FG005|Visit One|Withdrawal by Subject|1|||
129959365|NCT00187135|467813990|FG000|Visit One|Physician Decision|3|||
129959366|NCT00187135|467813991|FG001|Visit One|Physician Decision|1|||
129959367|NCT00187135|467813992|FG002|Visit One|Physician Decision|0|||
129959368|NCT00187135|467813993|FG003|Visit One|Physician Decision|0|||
129959369|NCT00187135|467813994|FG004|Visit One|Physician Decision|0|||
129959370|NCT00187135|467813995|FG005|Visit One|Physician Decision|1|||
129959371|NCT00187135|467813990|FG000|Visit Two|Death|0|||
129959372|NCT00187135|467813991|FG001|Visit Two|Death|0|||
129959373|NCT00187135|467813992|FG002|Visit Two|Death|0|||
129959374|NCT00187135|467813993|FG003|Visit Two|Death|1|||
129959375|NCT00187135|467813994|FG004|Visit Two|Death|0|||
129959376|NCT00187135|467813995|FG005|Visit Two|Death|1|||
129959377|NCT00187135|467813990|FG000|Visit Two|Physician Decision|1|||
129959378|NCT00187135|467813991|FG001|Visit Two|Physician Decision|0|||
129959379|NCT00187135|467813992|FG002|Visit Two|Physician Decision|0|||
129959380|NCT00187135|467813993|FG003|Visit Two|Physician Decision|0|||
129959381|NCT00187135|467813994|FG004|Visit Two|Physician Decision|0|||
129959382|NCT00187135|467813995|FG005|Visit Two|Physician Decision|0|||
129959383|NCT00187135|467813990|FG000|Visit Two|Withdrawal by Subject|1|||
129959384|NCT00187135|467813991|FG001|Visit Two|Withdrawal by Subject|1|||
129959385|NCT00187135|467813992|FG002|Visit Two|Withdrawal by Subject|1|||
129959386|NCT00187135|467813993|FG003|Visit Two|Withdrawal by Subject|0|||
129959387|NCT00187135|467813994|FG004|Visit Two|Withdrawal by Subject|1|||
129959388|NCT00187135|467813995|FG005|Visit Two|Withdrawal by Subject|1|||
129959389|NCT00187135|467813990|FG000|Visit Two|Study Discontinued|3|||
129959390|NCT00187135|467813991|FG001|Visit Two|Study Discontinued|2|||
129959391|NCT00187135|467813992|FG002|Visit Two|Study Discontinued|1|||
129959392|NCT00187135|467813993|FG003|Visit Two|Study Discontinued|7|||
129959393|NCT00187135|467813994|FG004|Visit Two|Study Discontinued|5|||
129959394|NCT00187135|467813995|FG005|Visit Two|Study Discontinued|6|||
129959395|NCT00187135|467813990|FG000|Visit Three|Death|0|||
129959396|NCT00187135|467813991|FG001|Visit Three|Death|0|||
129959397|NCT00187135|467813992|FG002|Visit Three|Death|1|||
129959398|NCT00187135|467813993|FG003|Visit Three|Death|0|||
129959399|NCT00187135|467813994|FG004|Visit Three|Death|1|||
129959400|NCT00187135|467813995|FG005|Visit Three|Death|0|||
129959401|NCT00187135|467813990|FG000|Visit Three|Withdrawal by Subject|0|||
129959402|NCT00187135|467813991|FG001|Visit Three|Withdrawal by Subject|1|||
129959403|NCT00187135|467813992|FG002|Visit Three|Withdrawal by Subject|1|||
129959404|NCT00187135|467813993|FG003|Visit Three|Withdrawal by Subject|2|||
129959405|NCT00187135|467813994|FG004|Visit Three|Withdrawal by Subject|0|||
129959406|NCT00187135|467813995|FG005|Visit Three|Withdrawal by Subject|0|||
129959407|NCT00187135|467813990|FG000|Visit Three|Study Discontinued|7|||
129959408|NCT00187135|467813991|FG001|Visit Three|Study Discontinued|6|||
129959409|NCT00187135|467813992|FG002|Visit Three|Study Discontinued|7|||
129959410|NCT00187135|467813993|FG003|Visit Three|Study Discontinued|7|||
129959411|NCT00187135|467813994|FG004|Visit Three|Study Discontinued|7|||
129959412|NCT00187135|467813995|FG005|Visit Three|Study Discontinued|6|||
129959413|NCT00297778|467813999|FG000|Overall Study|Adverse Event|16|||
129959414|NCT00297778|467814000|FG001|Overall Study|Adverse Event|10|||
129959415|NCT00297778|467813999|FG000|Overall Study|Withdrawal by Subject|1|||
129959416|NCT00297778|467814000|FG001|Overall Study|Withdrawal by Subject|5|||
129959417|NCT00297778|467813999|FG000|Overall Study|Lack of Efficacy|2|||
129959418|NCT00297778|467814000|FG001|Overall Study|Lack of Efficacy|1|||
129959419|NCT00297778|467813999|FG000|Overall Study|Non-compliant with trial protocol|0|||
129959420|NCT00297778|467814000|FG001|Overall Study|Non-compliant with trial protocol|3|||
129959421|NCT00297778|467813999|FG000|Overall Study|Other|0|||
129959422|NCT00297778|467814000|FG001|Overall Study|Other|1|||
129959423|NCT00679549|467814001|FG000|Overall Study|dropout|2|||
129959424|NCT00679549|467814002|FG001|Overall Study|dropout|4|||
129959425|NCT00679549|467814001|FG000|Overall Study|missing outcome echocardiograms|4|||
129959426|NCT00679549|467814002|FG001|Overall Study|missing outcome echocardiograms|5|||
129959427|NCT03280108|467814003|FG000|Overall Study|Lost to Follow-up|2|||
129959428|NCT03280108|467814004|FG001|Overall Study|Lost to Follow-up|0|||
129959429|NCT02201771|467814005|FG000|Overall Study|Death|3|||
129959430|NCT02201771|467814006|FG001|Overall Study|Death|2|||
129959431|NCT02201771|467814007|FG002|Overall Study|Death|0|||
129959432|NCT02201771|467814005|FG000|Overall Study|Protocol Violation|10|||
129959433|NCT02201771|467814006|FG001|Overall Study|Protocol Violation|8|||
129959434|NCT02201771|467814007|FG002|Overall Study|Protocol Violation|10|||
129959435|NCT01820637|467814008|FG000|Overall Study|Death|2|||
129959436|NCT01820637|467814008|FG000|Overall Study|Withdrawal by Subject|1|||
129959437|NCT00264498|467814009|FG000|Randomized Treatment|Death|0|||
129959438|NCT00264498|467814010|FG001|Randomized Treatment|Death|3|||
129959439|NCT00264498|467814009|FG000|Randomized Treatment|Withdrawal by Subject|0|||
129959440|NCT00264498|467814010|FG001|Randomized Treatment|Withdrawal by Subject|1|||
129454365|NCT03370120|465960773|FG000|Overall Study|Sponsor study closure|10|||
129454366|NCT00454857|465960775|FG000|Overall Study|Withdrawal by Subject|15|||
129454367|NCT00454857|465960775|FG000|Overall Study|Lost to Follow-up|16|||
129454368|NCT00454857|465960775|FG000|Overall Study|Noncompliance|6|||
129454369|NCT00454857|465960775|FG000|Overall Study|Death|5|||
129454370|NCT00454857|465960775|FG000|Overall Study|Other|11|||
129454371|NCT00454857|465960775|FG000|Overall Study|Reason unknown|1|||
129959441|NCT00264498|467814009|FG000|Randomized Treatment|Objective disease Progression|13|||
129959442|NCT00264498|467814010|FG001|Randomized Treatment|Objective disease Progression|14|||
129959443|NCT00264498|467814009|FG000|Randomized Treatment|Physician Decision|1|||
129959444|NCT00264498|467814010|FG001|Randomized Treatment|Physician Decision|0|||
129959445|NCT00264498|467814009|FG000|Randomized Treatment|Incorrectly randomized|1|||
129959446|NCT00264498|467814010|FG001|Randomized Treatment|Incorrectly randomized|0|||
129959447|NCT00264498|467814009|FG000|Randomized Treatment|Study Closure|1|||
129959448|NCT00264498|467814010|FG001|Randomized Treatment|Study Closure|0|||
129959449|NCT00264498|467814009|FG000|Randomized Treatment|Protocol Violation|1|||
129959450|NCT00264498|467814010|FG001|Randomized Treatment|Protocol Violation|0|||
129959451|NCT00264498|467814009|FG000|Crossover Treatment|Death|1|||
129959452|NCT00264498|467814010|FG001|Crossover Treatment|Death|3|||
129959453|NCT00264498|467814009|FG000|Crossover Treatment|Objective disease progression|4|||
129959454|NCT00264498|467814010|FG001|Crossover Treatment|Objective disease progression|5|||
129959455|NCT00264498|467814009|FG000|Crossover Treatment|Study closure|0|||
129959456|NCT00264498|467814010|FG001|Crossover Treatment|Study closure|1|||
129959457|NCT00264498|467814009|FG000|Crossover Treatment|Withdrawal by Subject|1|||
129959458|NCT00264498|467814010|FG001|Crossover Treatment|Withdrawal by Subject|0|||
129959459|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
129959460|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
129959461|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
129959462|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
129959463|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
129959464|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
129959465|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
129959466|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
129959467|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
129959468|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
129959469|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
129959470|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
129959471|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
129959472|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
129959473|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
129959474|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
129959475|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
129959476|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
129959477|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
129959478|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
129959479|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
129959480|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
129959481|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
129959482|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
129959483|NCT02269917|467814011|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
129959484|NCT02269917|467814012|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
129959485|NCT02269917|467814013|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
129959486|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129959487|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
129959488|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
129959489|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129959490|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
129959491|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
129959492|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129959493|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
129959494|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
129959495|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129959496|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
129959497|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
129959498|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
129959499|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
129959500|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
129959501|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129959502|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
129959503|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
129959504|NCT02269917|467814011|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129959505|NCT02269917|467814012|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
129959506|NCT02269917|467814013|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
129959507|NCT02383927|467814014|FG000|Overall Study|Disease Progression|8|||
129959508|NCT02383927|467814015|FG001|Overall Study|Disease Progression|8|||
129959509|NCT02383927|467814016|FG002|Overall Study|Disease Progression|15|||
129959510|NCT02383927|467814017|FG003|Overall Study|Disease Progression|4|||
129959511|NCT02383927|467814014|FG000|Overall Study|Physician Decision|0|||
129959512|NCT02383927|467814015|FG001|Overall Study|Physician Decision|0|||
129959513|NCT02383927|467814016|FG002|Overall Study|Physician Decision|2|||
129959514|NCT02383927|467814017|FG003|Overall Study|Physician Decision|0|||
129959515|NCT02383927|467814014|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
129959516|NCT02383927|467814015|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
129959517|NCT02383927|467814016|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
129959518|NCT02383927|467814017|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
129959519|NCT02383927|467814014|FG000|Overall Study|Adverse Event|4|||
129959520|NCT02383927|467814015|FG001|Overall Study|Adverse Event|1|||
129959521|NCT02383927|467814016|FG002|Overall Study|Adverse Event|3|||
129959522|NCT02383927|467814017|FG003|Overall Study|Adverse Event|5|||
129959523|NCT02383927|467814014|FG000|Overall Study|Miscellaneous|1|||
129959524|NCT02383927|467814015|FG001|Overall Study|Miscellaneous|0|||
129959525|NCT02383927|467814016|FG002|Overall Study|Miscellaneous|0|||
129959526|NCT02383927|467814017|FG003|Overall Study|Miscellaneous|1|||
129959527|NCT02383927|467814014|FG000|Overall Study|Withdrawal by Subject|0|||
129959528|NCT02383927|467814015|FG001|Overall Study|Withdrawal by Subject|1|||
129959529|NCT02383927|467814016|FG002|Overall Study|Withdrawal by Subject|4|||
129959530|NCT02383927|467814017|FG003|Overall Study|Withdrawal by Subject|0|||
129959531|NCT02865135|467814018|FG000|Overall Study|Death|0|||
129959532|NCT02865135|467814019|FG001|Overall Study|Death|1|||
129959533|NCT02865135|467814020|FG002|Overall Study|Death|0|||
129959534|NCT02865135|467814018|FG000|Overall Study|Progression|6|||
129959535|NCT02865135|467814019|FG001|Overall Study|Progression|2|||
129959536|NCT02865135|467814020|FG002|Overall Study|Progression|2|||
129959537|NCT01071317|467814021|FG000|Overall Study|Lost to Follow-up|2|||
129959538|NCT01071317|467814022|FG001|Overall Study|Lost to Follow-up|2|||
129959539|NCT02040532|467814024|FG000|Overall Study|Lost to Follow-up|1|||
129959540|NCT02040532|467814024|FG000|Overall Study|Physician Decision|4|||
129959541|NCT02040532|467814024|FG000|Overall Study|Adverse Event|4|||
129959542|NCT02040532|467814024|FG000|Overall Study|Withdrawal by Subject|3|||
129959543|NCT03640754|467814029|FG000|Overall Study|Withdrawal by Subject|1|||
129959544|NCT03640754|467814030|FG001|Overall Study|Withdrawal by Subject|0|||
129959545|NCT03640754|467814029|FG000|Overall Study|Lost to Follow-up|0|||
129959546|NCT03640754|467814030|FG001|Overall Study|Lost to Follow-up|1|||
129959547|NCT01679613|467814036|FG000|Overall Study|other than stated above|0|||
129959548|NCT01679613|467814037|FG001|Overall Study|other than stated above|1|||
129959549|NCT01679613|467814038|FG002|Overall Study|other than stated above|2|||
129959550|NCT01679613|467814039|FG003|Overall Study|other than stated above|2|||
129959551|NCT03169530|467814040|FG000|Overall Study|Study ended by NIH|15|||
129959552|NCT03169530|467814041|FG001|Overall Study|Study ended by NIH|17|||
129959553|NCT02154516|467814042|FG000|Overall Study|Withdrawal by Subject|0|||
129959554|NCT02154516|467814043|FG001|Overall Study|Withdrawal by Subject|1|||
129959555|NCT02154516|467814042|FG000|Overall Study|Lost to Follow-up|1|||
129959556|NCT02154516|467814043|FG001|Overall Study|Lost to Follow-up|0|||
129959557|NCT02154516|467814042|FG000|Overall Study|Removal/revision of device|1|||
129959558|NCT02154516|467814043|FG001|Overall Study|Removal/revision of device|0|||
129959559|NCT02154516|467814042|FG000|Overall Study|Death|2|||
129959560|NCT02154516|467814043|FG001|Overall Study|Death|1|||
129959561|NCT02965599|467814044|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
129959562|NCT02965599|467814045|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
129959563|NCT00230971|467814046|FG000|Randomization|No study drug administered|3|||
129959564|NCT00230971|467814047|FG001|Randomization|No study drug administered|3|||
129959565|NCT00230971|467814046|FG000|Baseline Participants|Lost to Follow-up|5|||
129959566|NCT00230971|467814047|FG001|Baseline Participants|Lost to Follow-up|12|||
129959567|NCT00230971|467814046|FG000|Baseline Participants|Death|6|||
129959568|NCT00230971|467814047|FG001|Baseline Participants|Death|5|||
129959569|NCT00230971|467814046|FG000|Baseline Participants|Withdrawal by Subject|7|||
129959570|NCT00230971|467814047|FG001|Baseline Participants|Withdrawal by Subject|1|||
129959571|NCT00230971|467814046|FG000|Baseline Participants|Adverse Event|1|||
129959572|NCT00230971|467814047|FG001|Baseline Participants|Adverse Event|0|||
129959573|NCT00230971|467814046|FG000|Baseline Participants|No bacteria observed|1|||
129959574|NCT00230971|467814047|FG001|Baseline Participants|No bacteria observed|0|||
129959575|NCT00230971|467814046|FG000|Baseline Participants|Failure to return|1|||
129959576|NCT00230971|467814047|FG001|Baseline Participants|Failure to return|1|||
129959577|NCT00230971|467814046|FG000|Baseline Participants|Reintervention|1|||
129959578|NCT00230971|467814047|FG001|Baseline Participants|Reintervention|0|||
129959579|NCT02956278|467815986|FG000|Overall Study|Withdrawal by Subject|6|||
129959580|NCT02956278|467815987|FG001|Overall Study|Withdrawal by Subject|2|||
129959581|NCT02956278|467815988|FG002|Overall Study|Withdrawal by Subject|0|||
129959582|NCT00509821|467815998|FG000|Study Period 1 (Induction)|Death|0|||
129959583|NCT00509821|467815999|FG001|Study Period 1 (Induction)|Death|1|||
129959584|NCT00509821|467815998|FG000|Study Period 1 (Induction)|Adverse Event|0|||
129959585|NCT00509821|467815999|FG001|Study Period 1 (Induction)|Adverse Event|2|||
129959586|NCT00509821|467815998|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
129454372|NCT04206020|465960776|FG000|Overall Study|Adverse Event|1|||
129454373|NCT04206020|465960777|FG001|Overall Study|Adverse Event|4|||
129454374|NCT04206020|465960776|FG000|Overall Study|Protocol Violation|2|||
129454375|NCT04206020|465960777|FG001|Overall Study|Protocol Violation|0|||
129959587|NCT00509821|467815999|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
129959588|NCT01816685|467816003|FG000|Overall Study|Lost to Follow-up|7|||
129959589|NCT01816685|467816004|FG001|Overall Study|Lost to Follow-up|9|||
129959590|NCT01816685|467816003|FG000|Overall Study|Surgery Cancelled|3|||
129959591|NCT01816685|467816004|FG001|Overall Study|Surgery Cancelled|2|||
129959592|NCT02720185|467816005|FG000|Overall Study|Lost to Follow-up|1|||
129959593|NCT00684203|467816006|FG000|Overall Study|Adverse Event|6|||
129959594|NCT00684203|467816007|FG001|Overall Study|Adverse Event|4|||
129959595|NCT00684203|467816008|FG002|Overall Study|Adverse Event|8|||
129959596|NCT00684203|467816009|FG003|Overall Study|Adverse Event|0|||
129959597|NCT00684203|467816010|FG004|Overall Study|Adverse Event|0|||
129959598|NCT00684203|467816011|FG005|Overall Study|Adverse Event|0|||
129959599|NCT00684203|467816006|FG000|Overall Study|Protocol-defined clinical event|3|||
129959600|NCT00684203|467816007|FG001|Overall Study|Protocol-defined clinical event|1|||
129959601|NCT00684203|467816008|FG002|Overall Study|Protocol-defined clinical event|0|||
129959602|NCT00684203|467816009|FG003|Overall Study|Protocol-defined clinical event|0|||
129959603|NCT00684203|467816010|FG004|Overall Study|Protocol-defined clinical event|0|||
129959604|NCT00684203|467816011|FG005|Overall Study|Protocol-defined clinical event|0|||
129959605|NCT00684203|467816006|FG000|Overall Study|Withdrawal by Subject|0|||
129959606|NCT00684203|467816007|FG001|Overall Study|Withdrawal by Subject|2|||
129959607|NCT00684203|467816008|FG002|Overall Study|Withdrawal by Subject|1|||
129959608|NCT00684203|467816009|FG003|Overall Study|Withdrawal by Subject|0|||
129959609|NCT00684203|467816010|FG004|Overall Study|Withdrawal by Subject|0|||
129959610|NCT00684203|467816011|FG005|Overall Study|Withdrawal by Subject|0|||
129959611|NCT00684203|467816006|FG000|Overall Study|Did not meet protocol eligibility|0|||
129959612|NCT00684203|467816007|FG001|Overall Study|Did not meet protocol eligibility|1|||
129959613|NCT00684203|467816008|FG002|Overall Study|Did not meet protocol eligibility|0|||
129959614|NCT00684203|467816009|FG003|Overall Study|Did not meet protocol eligibility|0|||
129959615|NCT00684203|467816010|FG004|Overall Study|Did not meet protocol eligibility|0|||
129959616|NCT00684203|467816011|FG005|Overall Study|Did not meet protocol eligibility|0|||
129959617|NCT03418493|467816014|FG000|Overall Study|Adverse Event|1|||
129959618|NCT03418493|467816015|FG001|Overall Study|Adverse Event|0|||
129959619|NCT03418493|467816016|FG002|Overall Study|Adverse Event|0|||
129959620|NCT03418493|467816017|FG003|Overall Study|Adverse Event|0|||
129959621|NCT03418493|467816018|FG004|Overall Study|Adverse Event|0|||
129959622|NCT03418493|467816019|FG005|Overall Study|Adverse Event|0|||
129959623|NCT03418493|467816020|FG006|Overall Study|Adverse Event|0|||
129959624|NCT03418493|467816021|FG007|Overall Study|Adverse Event|0|||
129959625|NCT03418493|467816022|FG008|Overall Study|Adverse Event|0|||
129959626|NCT03418493|467816023|FG009|Overall Study|Adverse Event|0|||
129959627|NCT03418493|467816024|FG010|Overall Study|Adverse Event|0|||
129959628|NCT03418493|467816014|FG000|Overall Study|Protocol Violation|0|||
129959629|NCT03418493|467816015|FG001|Overall Study|Protocol Violation|0|||
129959630|NCT03418493|467816016|FG002|Overall Study|Protocol Violation|0|||
129959631|NCT03418493|467816017|FG003|Overall Study|Protocol Violation|0|||
129959632|NCT03418493|467816018|FG004|Overall Study|Protocol Violation|0|||
129959633|NCT03418493|467816019|FG005|Overall Study|Protocol Violation|0|||
129959634|NCT03418493|467816020|FG006|Overall Study|Protocol Violation|0|||
129959635|NCT03418493|467816021|FG007|Overall Study|Protocol Violation|0|||
129959636|NCT03418493|467816022|FG008|Overall Study|Protocol Violation|0|||
129959637|NCT03418493|467816023|FG009|Overall Study|Protocol Violation|1|||
129959638|NCT03418493|467816024|FG010|Overall Study|Protocol Violation|0|||
129959639|NCT00719212|467816025|FG000|Overall Study|Death|41|||
129959640|NCT00719212|467816025|FG000|Overall Study|Lost to Follow-up|2|||
129959641|NCT00719212|467816025|FG000|Overall Study|Withdrawal by Subject|1|||
129959642|NCT05446714|467816026|FG000|Overall Study|Lost to Follow-up|1|||
129454376|NCT04206020|465960776|FG000|Overall Study|Withdrawal by Subject|2|||
129454377|NCT04206020|465960777|FG001|Overall Study|Withdrawal by Subject|0|||
129454378|NCT04206020|465960776|FG000|Overall Study|Lost to Follow-up|2|||
129454379|NCT04206020|465960777|FG001|Overall Study|Lost to Follow-up|0|||
129454380|NCT04206020|465960776|FG000|Overall Study|Pregnancy|0|||
129454381|NCT04206020|465960777|FG001|Overall Study|Pregnancy|1|||
129454382|NCT04206020|465960776|FG000|Overall Study|Unable to attend visits|1|||
129454383|NCT04206020|465960777|FG001|Overall Study|Unable to attend visits|2|||
129454384|NCT00632099|465960778|FG000|Overall Study|Lost to Follow-up|3|||
129454385|NCT00632099|465960779|FG001|Overall Study|Lost to Follow-up|3|||
129454386|NCT00552175|465960780|FG000|Overall Study|Lack of Efficacy|2|||
129454387|NCT00552175|465960781|FG001|Overall Study|Lack of Efficacy|0|||
129454388|NCT00552175|465960782|FG002|Overall Study|Lack of Efficacy|1|||
129454389|NCT00552175|465960780|FG000|Overall Study|Adverse Event|9|||
129454390|NCT00552175|465960781|FG001|Overall Study|Adverse Event|9|||
129454391|NCT00552175|465960782|FG002|Overall Study|Adverse Event|10|||
129454392|NCT00552175|465960780|FG000|Overall Study|Withdrawal by Subject|2|||
129454393|NCT00552175|465960781|FG001|Overall Study|Withdrawal by Subject|2|||
129454394|NCT00552175|465960782|FG002|Overall Study|Withdrawal by Subject|1|||
129454395|NCT00552175|465960780|FG000|Overall Study|Lost to Follow-up|0|||
129454396|NCT00552175|465960781|FG001|Overall Study|Lost to Follow-up|0|||
129454397|NCT00552175|465960782|FG002|Overall Study|Lost to Follow-up|1|||
129454398|NCT00552175|465960780|FG000|Overall Study|Entry Criteria Not Met|1|||
129454399|NCT00552175|465960781|FG001|Overall Study|Entry Criteria Not Met|1|||
129454400|NCT00552175|465960782|FG002|Overall Study|Entry Criteria Not Met|0|||
129454401|NCT00552175|465960780|FG000|Overall Study|Reason Not Specified|3|||
129454402|NCT00552175|465960781|FG001|Overall Study|Reason Not Specified|1|||
129454403|NCT00552175|465960782|FG002|Overall Study|Reason Not Specified|1|||
129454404|NCT04707157|465960783|FG000|Overall Study|Adverse Event|12|||
129454405|NCT04707157|465960784|FG001|Overall Study|Adverse Event|3|||
129454406|NCT04707157|465960783|FG000|Overall Study|Lost to Follow-up|2|||
129454407|NCT04707157|465960784|FG001|Overall Study|Lost to Follow-up|0|||
129454408|NCT04707157|465960783|FG000|Overall Study|Sponsor's decision|1|||
129454409|NCT04707157|465960784|FG001|Overall Study|Sponsor's decision|0|||
129454410|NCT04707157|465960783|FG000|Overall Study|Physician Decision|8|||
129454411|NCT04707157|465960784|FG001|Overall Study|Physician Decision|5|||
129454412|NCT04707157|465960783|FG000|Overall Study|Protocol Deviation|1|||
129454413|NCT04707157|465960784|FG001|Overall Study|Protocol Deviation|0|||
129454414|NCT04707157|465960783|FG000|Overall Study|Withdrawal by Subject|1|||
129454415|NCT04707157|465960784|FG001|Overall Study|Withdrawal by Subject|1|||
129454416|NCT01543828|465960785|FG000|Treatment 2|Lost to Follow-up|1|||
129454417|NCT01543828|465960786|FG001|Treatment 2|Lost to Follow-up|0|||
129454418|NCT02285998|465960787|FG000|Overall Study|Adverse Event|9|||
129454419|NCT02285998|465960788|FG001|Overall Study|Adverse Event|8|||
129454420|NCT02285998|465960787|FG000|Overall Study|Physician Decision|1|||
129454421|NCT02285998|465960788|FG001|Overall Study|Physician Decision|2|||
129454422|NCT02285998|465960787|FG000|Overall Study|Lost to Follow-up|176|||
129454423|NCT02285998|465960788|FG001|Overall Study|Lost to Follow-up|172|||
129454424|NCT02285998|465960787|FG000|Overall Study|Withdrawal by Subject|53|||
129454425|NCT02285998|465960788|FG001|Overall Study|Withdrawal by Subject|61|||
129454426|NCT02285998|465960787|FG000|Overall Study|Other Reasons|7|||
129454427|NCT02285998|465960788|FG001|Overall Study|Other Reasons|10|||
129454428|NCT04995055|465960789|FG000|Period 1|COVID-19 Related|1|||
129454429|NCT04995055|465960790|FG001|Period 1|COVID-19 Related|0|||
129454430|NCT04995055|465960789|FG000|Period 1|Withdrawal by Subject|0|||
129454431|NCT04995055|465960790|FG001|Period 1|Withdrawal by Subject|1|||
129454432|NCT04995055|465960789|FG000|Period 1|Subject discontinued due to timing|4|||
129454433|NCT04995055|465960790|FG001|Period 1|Subject discontinued due to timing|4|||
129454434|NCT01553188|465960795|FG000|Overall Study|Patient choice|1|||
129454435|NCT01553188|465960796|FG001|Overall Study|Patient choice|0|||
129454436|NCT01553188|465960797|FG002|Overall Study|Patient choice|0|||
129454437|NCT01553188|465960798|FG003|Overall Study|Patient choice|0|||
129454438|NCT01553188|465960795|FG000|Overall Study|Intercurrent illness and adverse event|0|||
129454439|NCT01553188|465960796|FG001|Overall Study|Intercurrent illness and adverse event|1|||
129454440|NCT01553188|465960797|FG002|Overall Study|Intercurrent illness and adverse event|2|||
129959643|NCT05446714|467816027|FG001|Overall Study|Lost to Follow-up|3|||
129959644|NCT05446714|467816028|FG002|Overall Study|Lost to Follow-up|2|||
129959645|NCT05446714|467816026|FG000|Overall Study|Protocol Violation|2|||
129959646|NCT05446714|467816027|FG001|Overall Study|Protocol Violation|0|||
129959647|NCT05446714|467816028|FG002|Overall Study|Protocol Violation|0|||
129959648|NCT01990313|467816029|FG000|Overall Study|Lost to Follow-up|1|||
129959649|NCT02396953|467816030|FG000|Overall Study|Withdrawal by Subject|0|||
129959650|NCT02396953|467816031|FG001|Overall Study|Withdrawal by Subject|0|||
129959651|NCT02396953|467816032|FG002|Overall Study|Withdrawal by Subject|1|||
129959652|NCT02396953|467816030|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
129959653|NCT02396953|467816031|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
129959654|NCT02396953|467816032|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
129959655|NCT02396953|467816030|FG000|Overall Study|Personal Reasons|1|||
129959656|NCT02396953|467816031|FG001|Overall Study|Personal Reasons|1|||
129959657|NCT02396953|467816032|FG002|Overall Study|Personal Reasons|0|||
129959658|NCT00329550|467816036|FG000|Overall Study|Adverse Event|3|||
129959659|NCT00329550|467816037|FG001|Overall Study|Adverse Event|4|||
129959660|NCT00329550|467816038|FG002|Overall Study|Adverse Event|2|||
129959661|NCT00329550|467816036|FG000|Overall Study|Withdrawal of Consent|1|||
129959662|NCT00329550|467816037|FG001|Overall Study|Withdrawal of Consent|0|||
129959663|NCT00329550|467816038|FG002|Overall Study|Withdrawal of Consent|1|||
129959664|NCT00329550|467816036|FG000|Overall Study|Due to Relocation|0|||
129959665|NCT00329550|467816037|FG001|Overall Study|Due to Relocation|0|||
129959666|NCT00329550|467816038|FG002|Overall Study|Due to Relocation|1|||
129959667|NCT00833898|467816048|FG000|Overall Study|Withdrawal by Subject|33|||
129959668|NCT00833898|467816049|FG001|Overall Study|Withdrawal by Subject|27|||
129959669|NCT00833898|467816048|FG000|Overall Study|Lost to Follow-up|7|||
129959670|NCT00833898|467816049|FG001|Overall Study|Lost to Follow-up|7|||
129959671|NCT00833898|467816048|FG000|Overall Study|Patient did not receive transplant|0|||
129959672|NCT00833898|467816049|FG001|Overall Study|Patient did not receive transplant|2|||
129959673|NCT01402063|467816050|FG000|Overall Study|Withdrawal by Subject|3|||
129959674|NCT01402063|467816051|FG001|Overall Study|Withdrawal by Subject|3|||
129959675|NCT02110225|467816055|FG000|Overall Study|Lost to Follow-up|0|||
129959676|NCT02110225|467816056|FG001|Overall Study|Lost to Follow-up|1|||
129959677|NCT02110225|467816057|FG002|Overall Study|Lost to Follow-up|0|||
129959678|NCT02176018|467816058|FG000|Overall Study|Adverse Event|0|||
129959679|NCT02176018|467816059|FG001|Overall Study|Adverse Event|2|||
129959680|NCT02176018|467816058|FG000|Overall Study|Lost to Follow-up|3|||
129959681|NCT02176018|467816059|FG001|Overall Study|Lost to Follow-up|1|||
129959682|NCT02176018|467816058|FG000|Overall Study|Protocol Violation|1|||
129959683|NCT02176018|467816059|FG001|Overall Study|Protocol Violation|1|||
129959684|NCT02176018|467816058|FG000|Overall Study|Withdrawal by Subject|1|||
129959685|NCT02176018|467816059|FG001|Overall Study|Withdrawal by Subject|2|||
129959686|NCT03022045|467816060|FG000|Overall Study|Adverse Event|0|||
129959687|NCT03022045|467816061|FG001|Overall Study|Adverse Event|1|||
129959688|NCT03022045|467816060|FG000|Overall Study|Withdrawal by Subject|1|||
129959689|NCT03022045|467816061|FG001|Overall Study|Withdrawal by Subject|1|||
129959690|NCT02499835|467816065|FG000|Overall Study|Withdrawal by Subject|1|||
129959691|NCT02499835|467816066|FG001|Overall Study|Withdrawal by Subject|0|||
129959692|NCT02499835|467816067|FG002|Overall Study|Withdrawal by Subject|0|||
129959693|NCT02499835|467816068|FG003|Overall Study|Withdrawal by Subject|1|||
129959694|NCT02499835|467816065|FG000|Overall Study|Physician Decision|0|||
129959695|NCT02499835|467816066|FG001|Overall Study|Physician Decision|3|||
129959696|NCT02499835|467816067|FG002|Overall Study|Physician Decision|18|||
129959697|NCT02499835|467816068|FG003|Overall Study|Physician Decision|7|||
129959698|NCT02499835|467816065|FG000|Overall Study|Adverse Event|0|||
129959699|NCT02499835|467816066|FG001|Overall Study|Adverse Event|0|||
129959700|NCT02499835|467816067|FG002|Overall Study|Adverse Event|0|||
129959701|NCT02499835|467816068|FG003|Overall Study|Adverse Event|1|||
129959702|NCT02499835|467816065|FG000|Overall Study|Disease progression|2|||
129959703|NCT02499835|467816066|FG001|Overall Study|Disease progression|1|||
129959704|NCT02499835|467816067|FG002|Overall Study|Disease progression|0|||
129959705|NCT02499835|467816068|FG003|Overall Study|Disease progression|7|||
129959706|NCT03972137|467816069|FG000|Overall Study|Lost to Follow-up|2|||
129959707|NCT03972137|467816069|FG000|Overall Study|Withdrawal by Subject|4|||
129959708|NCT00899379|467816073|FG000|Overall Study|Adverse Event|2|||
129959709|NCT00899379|467816074|FG001|Overall Study|Adverse Event|2|||
129959710|NCT00899379|467816075|FG002|Overall Study|Adverse Event|1|||
129959711|NCT00899379|467816076|FG003|Overall Study|Adverse Event|1|||
129959712|NCT00899379|467816077|FG004|Overall Study|Adverse Event|2|||
129959713|NCT00899379|467816073|FG000|Overall Study|Lack of Efficacy|0|||
129959714|NCT00899379|467816074|FG001|Overall Study|Lack of Efficacy|4|||
129959715|NCT00899379|467816075|FG002|Overall Study|Lack of Efficacy|3|||
129959716|NCT00899379|467816076|FG003|Overall Study|Lack of Efficacy|0|||
129959717|NCT00899379|467816077|FG004|Overall Study|Lack of Efficacy|1|||
129959718|NCT00899379|467816073|FG000|Overall Study|Lost to Follow-up|9|||
129959719|NCT00899379|467816074|FG001|Overall Study|Lost to Follow-up|3|||
129959720|NCT00899379|467816075|FG002|Overall Study|Lost to Follow-up|0|||
129959721|NCT00899379|467816076|FG003|Overall Study|Lost to Follow-up|6|||
129959722|NCT00899379|467816077|FG004|Overall Study|Lost to Follow-up|2|||
129959723|NCT00899379|467816073|FG000|Overall Study|Protocol Violation|0|||
129959724|NCT00899379|467816074|FG001|Overall Study|Protocol Violation|0|||
129959725|NCT00899379|467816075|FG002|Overall Study|Protocol Violation|1|||
129959726|NCT00899379|467816076|FG003|Overall Study|Protocol Violation|1|||
129959727|NCT00899379|467816077|FG004|Overall Study|Protocol Violation|0|||
129959728|NCT00899379|467816073|FG000|Overall Study|Withdrawal by Subject|2|||
129959729|NCT00899379|467816074|FG001|Overall Study|Withdrawal by Subject|4|||
129959730|NCT00899379|467816075|FG002|Overall Study|Withdrawal by Subject|2|||
129959731|NCT00899379|467816076|FG003|Overall Study|Withdrawal by Subject|3|||
129959732|NCT00899379|467816077|FG004|Overall Study|Withdrawal by Subject|6|||
129959733|NCT00899379|467816073|FG000|Overall Study|Pregnancy|0|||
129959734|NCT00899379|467816074|FG001|Overall Study|Pregnancy|0|||
129959735|NCT00899379|467816075|FG002|Overall Study|Pregnancy|1|||
129959736|NCT00899379|467816076|FG003|Overall Study|Pregnancy|0|||
129959737|NCT00899379|467816077|FG004|Overall Study|Pregnancy|1|||
129959738|NCT00899379|467816073|FG000|Overall Study|Patient Uncooperative|0|||
129959739|NCT00899379|467816074|FG001|Overall Study|Patient Uncooperative|1|||
129959740|NCT00899379|467816075|FG002|Overall Study|Patient Uncooperative|0|||
129959741|NCT00899379|467816076|FG003|Overall Study|Patient Uncooperative|1|||
129959742|NCT00899379|467816077|FG004|Overall Study|Patient Uncooperative|2|||
129959743|NCT00899379|467816073|FG000|Overall Study|Abnormal Baseline ECG|0|||
129959744|NCT00899379|467816074|FG001|Overall Study|Abnormal Baseline ECG|0|||
129959745|NCT00899379|467816075|FG002|Overall Study|Abnormal Baseline ECG|0|||
129959746|NCT00899379|467816076|FG003|Overall Study|Abnormal Baseline ECG|1|||
129959747|NCT00899379|467816077|FG004|Overall Study|Abnormal Baseline ECG|0|||
129959748|NCT00899379|467816073|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959749|NCT00899379|467816074|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959750|NCT00899379|467816075|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959751|NCT00899379|467816076|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959752|NCT00899379|467816077|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959753|NCT00899379|467816073|FG000|Overall Study|Not Completed/Entered Extn|5|||
129959754|NCT00899379|467816074|FG001|Overall Study|Not Completed/Entered Extn|1|||
129959755|NCT00899379|467816075|FG002|Overall Study|Not Completed/Entered Extn|6|||
129959756|NCT00899379|467816076|FG003|Overall Study|Not Completed/Entered Extn|4|||
129959757|NCT00899379|467816077|FG004|Overall Study|Not Completed/Entered Extn|3|||
129959758|NCT00899379|467816073|FG000|Overall Study|Study Terminated|3|||
129959759|NCT00899379|467816074|FG001|Overall Study|Study Terminated|0|||
129959760|NCT00899379|467816075|FG002|Overall Study|Study Terminated|3|||
129959761|NCT00899379|467816076|FG003|Overall Study|Study Terminated|3|||
129959762|NCT00899379|467816077|FG004|Overall Study|Study Terminated|1|||
129959763|NCT00899379|467816073|FG000|Overall Study|Lost to Follow-up|3|||
129959764|NCT00899379|467816074|FG001|Overall Study|Lost to Follow-up|1|||
129959765|NCT00899379|467816075|FG002|Overall Study|Lost to Follow-up|0|||
129959766|NCT00899379|467816076|FG003|Overall Study|Lost to Follow-up|2|||
129959767|NCT00899379|467816077|FG004|Overall Study|Lost to Follow-up|5|||
129959768|NCT00899379|467816073|FG000|Overall Study|Withdrawal by Subject|4|||
129959769|NCT00899379|467816074|FG001|Overall Study|Withdrawal by Subject|7|||
129959770|NCT00899379|467816075|FG002|Overall Study|Withdrawal by Subject|4|||
129959771|NCT00899379|467816076|FG003|Overall Study|Withdrawal by Subject|7|||
129959772|NCT00899379|467816077|FG004|Overall Study|Withdrawal by Subject|2|||
129959773|NCT00899379|467816073|FG000|Overall Study|Pregnancy|1|||
129959774|NCT00899379|467816074|FG001|Overall Study|Pregnancy|0|||
129959775|NCT00899379|467816075|FG002|Overall Study|Pregnancy|0|||
129959776|NCT00899379|467816076|FG003|Overall Study|Pregnancy|0|||
129959777|NCT00899379|467816077|FG004|Overall Study|Pregnancy|0|||
129959778|NCT00899379|467816073|FG000|Overall Study|Patient Uncooperative|0|||
129959779|NCT00899379|467816074|FG001|Overall Study|Patient Uncooperative|0|||
129959780|NCT00899379|467816075|FG002|Overall Study|Patient Uncooperative|0|||
129959781|NCT00899379|467816076|FG003|Overall Study|Patient Uncooperative|1|||
129959782|NCT00899379|467816077|FG004|Overall Study|Patient Uncooperative|0|||
129959783|NCT00899379|467816073|FG000|Overall Study|Abnormal Prestudy Labs|0|||
129959784|NCT00899379|467816074|FG001|Overall Study|Abnormal Prestudy Labs|0|||
129959785|NCT00899379|467816075|FG002|Overall Study|Abnormal Prestudy Labs|0|||
129959786|NCT00899379|467816076|FG003|Overall Study|Abnormal Prestudy Labs|0|||
129959787|NCT00899379|467816077|FG004|Overall Study|Abnormal Prestudy Labs|2|||
129959788|NCT00899379|467816073|FG000|Overall Study|Abnormal Baseline ECG|0|||
129959789|NCT00899379|467816074|FG001|Overall Study|Abnormal Baseline ECG|0|||
129959790|NCT00899379|467816075|FG002|Overall Study|Abnormal Baseline ECG|1|||
129959791|NCT00899379|467816076|FG003|Overall Study|Abnormal Baseline ECG|1|||
129959792|NCT00899379|467816077|FG004|Overall Study|Abnormal Baseline ECG|0|||
129959793|NCT00899379|467816073|FG000|Overall Study|No Attack Pretreatment|3|||
129959794|NCT00899379|467816074|FG001|Overall Study|No Attack Pretreatment|5|||
129959795|NCT00899379|467816075|FG002|Overall Study|No Attack Pretreatment|5|||
129959796|NCT00899379|467816076|FG003|Overall Study|No Attack Pretreatment|6|||
129959797|NCT00899379|467816077|FG004|Overall Study|No Attack Pretreatment|4|||
129959798|NCT00899379|467816073|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
129959799|NCT00899379|467816074|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959800|NCT00899379|467816075|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959801|NCT00899379|467816076|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959802|NCT00899379|467816077|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
129959803|NCT00899379|467816073|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
129959804|NCT00899379|467816074|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
129959805|NCT00899379|467816075|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
129959806|NCT00899379|467816076|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
129959807|NCT00899379|467816077|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
129959808|NCT03220776|467816082|FG000|Overall Study|Claustrophobia|0|||
129959809|NCT03220776|467816083|FG001|Overall Study|Claustrophobia|1|||
129959810|NCT03220776|467816084|FG002|Overall Study|Claustrophobia|1|||
129959811|NCT03220776|467816085|FG003|Overall Study|Claustrophobia|0|||
129959812|NCT03220776|467816086|FG004|Overall Study|Claustrophobia|1|||
129959813|NCT03220776|467816087|FG005|Overall Study|Claustrophobia|0|||
129959814|NCT03220776|467816082|FG000|Overall Study|MRI Equipment Failure|1|||
129959815|NCT03220776|467816083|FG001|Overall Study|MRI Equipment Failure|0|||
129959816|NCT03220776|467816084|FG002|Overall Study|MRI Equipment Failure|0|||
129959817|NCT03220776|467816085|FG003|Overall Study|MRI Equipment Failure|0|||
129959818|NCT03220776|467816086|FG004|Overall Study|MRI Equipment Failure|0|||
129959819|NCT03220776|467816087|FG005|Overall Study|MRI Equipment Failure|0|||
129959820|NCT03220776|467816082|FG000|Overall Study|Inclimate Weather|0|||
129959821|NCT03220776|467816083|FG001|Overall Study|Inclimate Weather|0|||
129959822|NCT03220776|467816084|FG002|Overall Study|Inclimate Weather|0|||
129959823|NCT03220776|467816085|FG003|Overall Study|Inclimate Weather|0|||
129959824|NCT03220776|467816086|FG004|Overall Study|Inclimate Weather|0|||
129959825|NCT03220776|467816087|FG005|Overall Study|Inclimate Weather|1|||
129959826|NCT03220776|467816082|FG000|Overall Study|Physician Decision|0|||
129959827|NCT03220776|467816083|FG001|Overall Study|Physician Decision|0|||
129959828|NCT03220776|467816084|FG002|Overall Study|Physician Decision|0|||
129959829|NCT03220776|467816085|FG003|Overall Study|Physician Decision|1|||
129959830|NCT03220776|467816086|FG004|Overall Study|Physician Decision|0|||
129959831|NCT03220776|467816087|FG005|Overall Study|Physician Decision|0|||
129959832|NCT03220776|467816082|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959833|NCT03220776|467816083|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959834|NCT03220776|467816084|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959835|NCT03220776|467816085|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
129959836|NCT03220776|467816086|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959837|NCT03220776|467816087|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
129959838|NCT03220776|467816082|FG000|Overall Study|Protocol Violation|0|||
129959839|NCT03220776|467816083|FG001|Overall Study|Protocol Violation|0|||
129959840|NCT03220776|467816084|FG002|Overall Study|Protocol Violation|0|||
129959841|NCT03220776|467816085|FG003|Overall Study|Protocol Violation|2|||
129959842|NCT03220776|467816086|FG004|Overall Study|Protocol Violation|0|||
129959843|NCT03220776|467816087|FG005|Overall Study|Protocol Violation|1|||
129959844|NCT03220776|467816082|FG000|Overall Study|Withdrawal by Subject|1|||
129959845|NCT03220776|467816083|FG001|Overall Study|Withdrawal by Subject|0|||
129959846|NCT03220776|467816084|FG002|Overall Study|Withdrawal by Subject|0|||
129959847|NCT03220776|467816085|FG003|Overall Study|Withdrawal by Subject|0|||
129959848|NCT03220776|467816086|FG004|Overall Study|Withdrawal by Subject|0|||
129959849|NCT03220776|467816087|FG005|Overall Study|Withdrawal by Subject|0|||
129959850|NCT01780545|467816089|FG000|Overall Study|Withdrawal by Subject|3|||
129959851|NCT01780545|467816090|FG001|Overall Study|Withdrawal by Subject|1|||
129959852|NCT01780545|467816089|FG000|Overall Study|Lost to Follow-up|1|||
129959853|NCT01780545|467816090|FG001|Overall Study|Lost to Follow-up|1|||
129959854|NCT03441789|467816091|FG000|Overall Study|Withdrawal by Subject|1|||
129959855|NCT03441789|467816092|FG001|Overall Study|Withdrawal by Subject|1|||
129959856|NCT03441789|467816091|FG000|Overall Study|Adverse Event|0|||
129959857|NCT03441789|467816092|FG001|Overall Study|Adverse Event|1|||
129959858|NCT03441789|467816091|FG000|Overall Study|Protocol Violation|0|||
129959859|NCT03441789|467816092|FG001|Overall Study|Protocol Violation|1|||
129959860|NCT03441789|467816091|FG000|Overall Study|Lost to Follow-up|0|||
129959861|NCT03441789|467816092|FG001|Overall Study|Lost to Follow-up|1|||
129959862|NCT02581189|467816097|FG000|Overall Study|Failure to return|36|||
129959863|NCT02581189|467816097|FG000|Overall Study|Withdrew consent|5|||
129959864|NCT02581189|467816097|FG000|Overall Study|Death|3|||
129959865|NCT02581189|467816097|FG000|Overall Study|Insufficient virological response|2|||
129959866|NCT02581189|467816097|FG000|Overall Study|Other, not specified|7|||
129959867|NCT00843115|467816098|FG000|Overall Study|Death|4|||
129959868|NCT00843115|467816098|FG000|Overall Study|Adverse Event|30|||
129959869|NCT00843115|467816098|FG000|Overall Study|Lost to Follow-up|4|||
129959870|NCT00843115|467816098|FG000|Overall Study|Withdrawal by Subject|17|||
129959871|NCT00843115|467816098|FG000|Overall Study|Family wanted meds stopped|1|||
129959872|NCT00843115|467816098|FG000|Overall Study|Family does not want continuation|1|||
129959873|NCT00843115|467816098|FG000|Overall Study|Patient forgot to take meds|1|||
129959874|NCT00843115|467816098|FG000|Overall Study|Does not meet entrance criteria|1|||
129959875|NCT00843115|467816098|FG000|Overall Study|Physician Decision|1|||
129959876|NCT00843115|467816098|FG000|Overall Study|Family discontinued meds|1|||
129959877|NCT00843115|467816098|FG000|Overall Study|patient took for 2 days then stopped|1|||
129959878|NCT00843115|467816098|FG000|Overall Study|patient never took the medication|1|||
129959879|NCT00843115|467816098|FG000|Overall Study|hospitalized due to deterioration|1|||
129959880|NCT00843115|467816098|FG000|Overall Study|week 12 not done|1|||
129959881|NCT00843115|467816098|FG000|Overall Study|Syndrome De Glissement|1|||
129959882|NCT01037413|467816099|FG000|Part A: Skin Testing|Adverse Event|1|||
129959883|NCT01037413|467816100|FG001|Part A: Skin Testing|Adverse Event|0|||
129959884|NCT01037413|467816099|FG000|Part A: Skin Testing|Protocol Violation|1|||
129959885|NCT01037413|467816100|FG001|Part A: Skin Testing|Protocol Violation|0|||
129959886|NCT01037413|467816099|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
129959887|NCT01037413|467816100|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
129959888|NCT01037413|467816099|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
129959889|NCT01037413|467816100|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
129959890|NCT00619983|467816104|FG000|Test Drug Alone|Withdrawal by Subject|1|||
129959891|NCT00619983|467816105|FG001|Test Drug Alone|Withdrawal by Subject|0|||
129959892|NCT00619983|467816106|FG002|Test Drug Alone|Withdrawal by Subject|0|||
129959893|NCT00619983|467816107|FG003|Test Drug Alone|Withdrawal by Subject|1|||
129959894|NCT00619983|467816104|FG000|Test Drug Alone|Failure of daily diary device|1|||
129959895|NCT00619983|467816105|FG001|Test Drug Alone|Failure of daily diary device|1|||
129959896|NCT00619983|467816106|FG002|Test Drug Alone|Failure of daily diary device|2|||
129959897|NCT00619983|467816107|FG003|Test Drug Alone|Failure of daily diary device|2|||
129959898|NCT03371485|467816111|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
129959899|NCT03371485|467816111|FG000|2-year Follow-up|Death|5|||
129959900|NCT02204319|467816112|FG000|Overall Study|Pregnancy|1|||
129959901|NCT02204319|467816112|FG000|Overall Study|Withdrawal by Subject|2|||
129959902|NCT01177137|467816117|FG000|Overall Study|Withdrawal by Subject|10|||
129959903|NCT01177137|467816118|FG001|Overall Study|Withdrawal by Subject|10|||
129959904|NCT01177137|467816119|FG002|Overall Study|Withdrawal by Subject|2|||
129959905|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
129959906|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
129959907|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
129959908|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
129959909|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
129959910|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
129959911|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
129959912|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129959913|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129959914|NCT02959177|467816120|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129959915|NCT02959177|467816121|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129959916|NCT02959177|467816122|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129959917|NCT02959177|467816120|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
129959918|NCT02959177|467816121|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
129959919|NCT02959177|467816122|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
129959920|NCT02959177|467816120|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
129959921|NCT02959177|467816121|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
129959922|NCT02959177|467816122|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
129959923|NCT02959177|467816120|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
129959924|NCT02959177|467816121|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
129959925|NCT02959177|467816122|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
129959926|NCT04531813|467816127|FG000|Overall Study|Protocol Violation|1|||
129959927|NCT04531813|467816127|FG000|Overall Study|Withdrawal by Subject|1|||
129959928|NCT02381652|467816132|FG000|Overall Study|Withdrawal by Subject|0|||
129959929|NCT02381652|467816133|FG001|Overall Study|Withdrawal by Subject|0|||
129959930|NCT02381652|467816134|FG002|Overall Study|Withdrawal by Subject|1|||
129959931|NCT01340300|467816135|FG000|Overall Study|Lost to Follow-up|3|||
129959932|NCT01340300|467816136|FG001|Overall Study|Lost to Follow-up|0|||
129959933|NCT01340300|467816137|FG002|Overall Study|Lost to Follow-up|5|||
129959934|NCT01340300|467816138|FG003|Overall Study|Lost to Follow-up|10|||
129959935|NCT01340300|467816135|FG000|Overall Study|Withdrawal by Subject|5|||
129959936|NCT01340300|467816136|FG001|Overall Study|Withdrawal by Subject|6|||
129959937|NCT01340300|467816137|FG002|Overall Study|Withdrawal by Subject|6|||
129959938|NCT01340300|467816138|FG003|Overall Study|Withdrawal by Subject|3|||
129959939|NCT01340300|467816135|FG000|Overall Study|Adverse Event|1|||
129959940|NCT01340300|467816136|FG001|Overall Study|Adverse Event|0|||
129959941|NCT01340300|467816137|FG002|Overall Study|Adverse Event|4|||
129959942|NCT01340300|467816138|FG003|Overall Study|Adverse Event|0|||
129959943|NCT01340300|467816135|FG000|Overall Study|Physician Decision|0|||
129959944|NCT01340300|467816136|FG001|Overall Study|Physician Decision|1|||
129959945|NCT01340300|467816137|FG002|Overall Study|Physician Decision|0|||
129959946|NCT01340300|467816138|FG003|Overall Study|Physician Decision|0|||
129959947|NCT01340300|467816135|FG000|Overall Study|Unrelated sickness|0|||
129959948|NCT01340300|467816136|FG001|Overall Study|Unrelated sickness|2|||
129959949|NCT01340300|467816137|FG002|Overall Study|Unrelated sickness|0|||
129959950|NCT01340300|467816138|FG003|Overall Study|Unrelated sickness|1|||
129959951|NCT01954771|467816142|FG000|Overall Study|Missing HbA1c of end-point|1|||
129959952|NCT01954771|467816143|FG001|Overall Study|Missing HbA1c of end-point|1|||
129959953|NCT01954771|467816144|FG002|Overall Study|Missing HbA1c of end-point|0|||
129959954|NCT01954771|467816142|FG000|Overall Study|Missing CGMS of end-point|1|||
129959955|NCT01954771|467816143|FG001|Overall Study|Missing CGMS of end-point|1|||
129959956|NCT01954771|467816144|FG002|Overall Study|Missing CGMS of end-point|0|||
129959957|NCT01954771|467816142|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
129959958|NCT01954771|467816143|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
129959959|NCT01954771|467816144|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
129959960|NCT03635775|467816145|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
129959961|NCT03635775|467816146|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
129959962|NCT03635775|467816147|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
129959963|NCT03635775|467816148|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
129959964|NCT02996097|467816150|FG000|Overall Study|Lost to Follow-up|11|||
129959965|NCT02996097|467816151|FG001|Overall Study|Lost to Follow-up|11|||
129959966|NCT00583115|467816152|FG000|Overall Study|Death|1|||
129959967|NCT01287416|467816155|FG000|Pre-post Training|Withdrawal by Subject|17|||
129959968|NCT01287416|467816156|FG001|Pre-post Training|Withdrawal by Subject|24|||
129959969|NCT01287416|467816155|FG000|Pre-post Training|Lost to Follow-up|5|||
129959970|NCT01287416|467816156|FG001|Pre-post Training|Lost to Follow-up|1|||
129959971|NCT01287416|467816155|FG000|6 Month Follow-up|Lost to Follow-up|3|||
129959972|NCT01287416|467816156|FG001|6 Month Follow-up|Lost to Follow-up|2|||
129959973|NCT02109107|467816157|FG000|Overall Study|Lost to Follow-up|2|||
129959974|NCT02506881|467816163|FG000|First Intervention (Day 1)|Protocol Violation|0|||
129959975|NCT02506881|467816164|FG001|First Intervention (Day 1)|Protocol Violation|0|||
129959976|NCT02506881|467816165|FG002|First Intervention (Day 1)|Protocol Violation|1|||
129959977|NCT02506881|467816166|FG003|First Intervention (Day 1)|Protocol Violation|0|||
129959978|NCT02506881|467816163|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
129454441|NCT01553188|465960798|FG003|Overall Study|Intercurrent illness and adverse event|0|||
129454442|NCT04744207|465960802|FG000|Treatment|Withdrawal by Subject|2|||
129454443|NCT04744207|465960803|FG001|Treatment|Withdrawal by Subject|0|||
129454444|NCT04744207|465960802|FG000|Treatment|Adverse Event|1|||
129959979|NCT02506881|467816164|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959980|NCT02506881|467816165|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959981|NCT02506881|467816166|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
129959982|NCT02506881|467816163|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
129959983|NCT02506881|467816164|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
129959984|NCT02506881|467816165|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
129959985|NCT02506881|467816166|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
129454445|NCT04744207|465960803|FG001|Treatment|Adverse Event|2|||
129959986|NCT01919398|467816167|FG000|Overall Study|Progressive Disease|0|||
129959987|NCT01919398|467816168|FG001|Overall Study|Progressive Disease|0|||
129959988|NCT01919398|467816169|FG002|Overall Study|Progressive Disease|4|||
129959989|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
129959990|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Duplication|2|||
129959991|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
129959992|NCT02016690|467816172|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
129959993|NCT02016690|467816172|FG000|Overall Study|Did not meet inclusion criteria|13|||
129959994|NCT02016690|467816172|FG000|Overall Study|Hospitalized for RSV at study start|3|||
129959995|NCT00050167|467816173|FG000|Overall Study|not eligible not invasive|1|||
129959996|NCT00050167|467816174|FG001|Overall Study|not eligible not invasive|1|||
129959997|NCT00495612|467816177|FG000|Overall Study|Lost to Follow-up|1|||
129959998|NCT00495612|467816178|FG001|Overall Study|Lost to Follow-up|0|||
129959999|NCT00495612|467816177|FG000|Overall Study|Subject's Decision to Withdraw|3|||
129960000|NCT00495612|467816178|FG001|Overall Study|Subject's Decision to Withdraw|0|||
129960001|NCT06016127|467816181|FG000|Overall Study|Withdrawal by Subject|4|||
129960002|NCT06016127|467816182|FG001|Overall Study|Withdrawal by Subject|3|||
129960003|NCT02864147|467816188|FG000|Overall Study|Withdrawal by Subject|3|||
129960004|NCT02864147|467816189|FG001|Overall Study|Withdrawal by Subject|2|||
129960005|NCT02864147|467816190|FG002|Overall Study|Withdrawal by Subject|1|||
129960006|NCT02864147|467816188|FG000|Overall Study|Lost to Follow-up|0|||
129960007|NCT02864147|467816189|FG001|Overall Study|Lost to Follow-up|4|||
129960008|NCT02864147|467816190|FG002|Overall Study|Lost to Follow-up|0|||
129960009|NCT02864147|467816188|FG000|Overall Study|Adverse Event|0|||
129960010|NCT02864147|467816189|FG001|Overall Study|Adverse Event|1|||
129960011|NCT02864147|467816190|FG002|Overall Study|Adverse Event|0|||
129960012|NCT02864147|467816188|FG000|Overall Study|Pregnancy|4|||
129960013|NCT02864147|467816189|FG001|Overall Study|Pregnancy|0|||
129960014|NCT02864147|467816190|FG002|Overall Study|Pregnancy|0|||
129960015|NCT02864147|467816188|FG000|Overall Study|Physician Decision|0|||
129960016|NCT02864147|467816189|FG001|Overall Study|Physician Decision|0|||
129960017|NCT02864147|467816190|FG002|Overall Study|Physician Decision|1|||
129960018|NCT02864147|467816188|FG000|Overall Study|Opted for excisional procedures|0|||
129960019|NCT02864147|467816189|FG001|Overall Study|Opted for excisional procedures|0|||
129960020|NCT02864147|467816190|FG002|Overall Study|Opted for excisional procedures|3|||
129960021|NCT01772147|467817778|FG000|Overall Study|Adverse Event|13|||
129960022|NCT01772147|467817779|FG001|Overall Study|Adverse Event|10|||
129960023|NCT01772147|467817780|FG002|Overall Study|Adverse Event|6|||
129960024|NCT01772147|467817778|FG000|Overall Study|Withdrew Consent|7|||
129960025|NCT01772147|467817779|FG001|Overall Study|Withdrew Consent|8|||
129960026|NCT01772147|467817780|FG002|Overall Study|Withdrew Consent|4|||
129960027|NCT01772147|467817778|FG000|Overall Study|Lost to Follow-up|1|||
129960028|NCT01772147|467817779|FG001|Overall Study|Lost to Follow-up|0|||
129960029|NCT01772147|467817780|FG002|Overall Study|Lost to Follow-up|1|||
129960030|NCT01772147|467817778|FG000|Overall Study|Protocol Deviation|2|||
129960031|NCT01772147|467817779|FG001|Overall Study|Protocol Deviation|1|||
129960032|NCT01772147|467817780|FG002|Overall Study|Protocol Deviation|1|||
129960033|NCT01772147|467817778|FG000|Overall Study|Lack of Efficacy|8|||
129960034|NCT01772147|467817779|FG001|Overall Study|Lack of Efficacy|6|||
129960035|NCT01772147|467817780|FG002|Overall Study|Lack of Efficacy|6|||
129960036|NCT02972242|467817781|FG000|Overall Study|Withdrawal by Subject|1|||
129960037|NCT02972242|467817782|FG001|Overall Study|Withdrawal by Subject|0|||
129960038|NCT04572997|467817783|FG000|Overall Study|Adverse Event|1|||
129960039|NCT00740597|467817784|FG000|Overall Study|insurance would not cover treatment|1|||
129960040|NCT00552513|467817785|FG000|Overall Study|Lost to Follow-up|5|||
129960041|NCT00552513|467817786|FG001|Overall Study|Lost to Follow-up|1|||
129960042|NCT01157351|467817787|FG000|Overall Study|Adverse Event|5|||
129960043|NCT01157351|467817788|FG001|Overall Study|Adverse Event|4|||
129960044|NCT01157351|467817787|FG000|Overall Study|Death|1|||
129960045|NCT01157351|467817788|FG001|Overall Study|Death|0|||
129960046|NCT01157351|467817787|FG000|Overall Study|Lost to Follow-up|53|||
129960047|NCT01157351|467817788|FG001|Overall Study|Lost to Follow-up|55|||
129960048|NCT01157351|467817787|FG000|Overall Study|Withdrawal by Subject|37|||
129960049|NCT01157351|467817788|FG001|Overall Study|Withdrawal by Subject|27|||
129960050|NCT01157351|467817787|FG000|Overall Study|Physician Decision|5|||
129960051|NCT01157351|467817788|FG001|Overall Study|Physician Decision|4|||
129960052|NCT01157351|467817787|FG000|Overall Study|Protocol Violation|0|||
129960053|NCT01157351|467817788|FG001|Overall Study|Protocol Violation|1|||
129960054|NCT01157351|467817787|FG000|Overall Study|Other|32|||
129960055|NCT01157351|467817788|FG001|Overall Study|Other|36|||
129960056|NCT01157351|467817787|FG000|Overall Study|Noncompliance with Study Drug|0|||
129960057|NCT01157351|467817788|FG001|Overall Study|Noncompliance with Study Drug|3|||
129960058|NCT01157351|467817787|FG000|Overall Study|Randomized but not Treated|4|||
129960059|NCT01157351|467817788|FG001|Overall Study|Randomized but not Treated|2|||
129960060|NCT00746785|467817789|FG000|Overall Study|Lost to Follow-up|29|||
129960061|NCT00746785|467817790|FG001|Overall Study|Lost to Follow-up|25|||
129960062|NCT00746785|467817791|FG002|Overall Study|Lost to Follow-up|27|||
129960063|NCT02517528|467817793|FG000|Overall Study|Withdrawal by Subject|1|||
129960064|NCT03511378|467817796|FG000|Overall Study|Withdrawal by Subject|2|||
129960065|NCT03511378|467817797|FG001|Overall Study|Withdrawal by Subject|2|||
129960066|NCT03511378|467817796|FG000|Overall Study|Patient not coming or schedule visit|1|||
129960067|NCT03511378|467817797|FG001|Overall Study|Patient not coming or schedule visit|0|||
129960068|NCT00837096|467817798|FG000|Overall Study|Physician Decision|1|||
129960069|NCT00837096|467817799|FG001|Overall Study|Physician Decision|1|||
129960070|NCT00837096|467817798|FG000|Overall Study|Not reported|9|||
129960071|NCT00837096|467817799|FG001|Overall Study|Not reported|8|||
129960072|NCT00280683|467817800|FG000|Overall Study|Withdrawal by Subject|1|||
129960073|NCT00280683|467817801|FG001|Overall Study|Withdrawal by Subject|2|||
129960074|NCT00280683|467817800|FG000|Overall Study|Adverse Event|1|||
129960075|NCT00280683|467817801|FG001|Overall Study|Adverse Event|1|||
129960076|NCT01243411|467817802|FG000|Overall Study|Withdrawal by Subject|18|||
129960077|NCT01243411|467817802|FG000|Overall Study|Lost to Follow-up|10|||
129960078|NCT01243411|467817802|FG000|Overall Study|Adverse Event|5|||
129960079|NCT01243411|467817802|FG000|Overall Study|Other|8|||
129960080|NCT00510198|467817803|FG000|Overall Study|Withdrawal by Subject|5|||
129960081|NCT00510198|467817804|FG001|Overall Study|Withdrawal by Subject|4|||
129960082|NCT03168425|467817810|FG000|Overall Study|Lost to Follow-up|5|||
129960083|NCT03168425|467817811|FG001|Overall Study|Lost to Follow-up|8|||
129960084|NCT03168425|467817810|FG000|Overall Study|unable to confirm post op opioids|2|||
129960085|NCT03168425|467817811|FG001|Overall Study|unable to confirm post op opioids|3|||
129960086|NCT04491006|467817812|FG000|Overall Study|Adverse Event|0|||
129960087|NCT04491006|467817813|FG001|Overall Study|Adverse Event|3|||
129960088|NCT04491006|467817814|FG002|Overall Study|Adverse Event|5|||
129960089|NCT04491006|467817812|FG000|Overall Study|Withdrawal by Subject|1|||
129960090|NCT04491006|467817813|FG001|Overall Study|Withdrawal by Subject|0|||
129960091|NCT04491006|467817814|FG002|Overall Study|Withdrawal by Subject|2|||
129960092|NCT01960114|467817818|FG000|Overall Study|Adverse Event|1|||
129960093|NCT01960114|467817819|FG001|Overall Study|Adverse Event|0|||
129960094|NCT01960114|467817818|FG000|Overall Study|Could not swallow study medication|0|||
129960095|NCT01960114|467817819|FG001|Overall Study|Could not swallow study medication|1|||
129960096|NCT02469077|467817820|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
129960097|NCT02469077|467817821|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
129960098|NCT02469077|467817820|FG000|Post Randomization/Intervention Period|Relocated|1|||
129960099|NCT02469077|467817821|FG001|Post Randomization/Intervention Period|Relocated|1|||
129960100|NCT02469077|467817820|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
129960101|NCT02469077|467817821|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
129960102|NCT02469077|467817820|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
129960103|NCT02469077|467817821|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
129960104|NCT01040403|467817822|FG000|Overall Study|Adverse Event|10|||
129960105|NCT01040403|467817822|FG000|Overall Study|Protocol Violation|2|||
129960106|NCT01040403|467817822|FG000|Overall Study|Lost to Follow-up|1|||
129960107|NCT01040403|467817822|FG000|Overall Study|Not treated|1|||
129960108|NCT01040403|467817822|FG000|Overall Study|Other reason not defined above|6|||
129960109|NCT01885936|467817823|FG000|Overall Study|Withdrawal by Subject|1|||
129960110|NCT01885936|467817824|FG001|Overall Study|Withdrawal by Subject|0|||
129960111|NCT03036150|467817825|FG000|Overall Study|Withdrawal by Subject|8|||
129960112|NCT03036150|467817826|FG001|Overall Study|Withdrawal by Subject|3|||
129960113|NCT03036150|467817825|FG000|Overall Study|Lost to Follow-up|2|||
129960114|NCT03036150|467817826|FG001|Overall Study|Lost to Follow-up|2|||
129960115|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|no longer interested|1|||
129960116|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|no longer interested|0|||
129960117|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
129960118|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
129960119|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
129960120|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
129960121|NCT00427778|467817827|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
129960122|NCT00427778|467817828|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
129960123|NCT00439647|467817829|FG000|Overall Study|Withdrawal by Subject|25|||
129960124|NCT00439647|467817830|FG001|Overall Study|Withdrawal by Subject|22|||
129960125|NCT00439647|467817829|FG000|Overall Study|Death|15|||
129960126|NCT00439647|467817830|FG001|Overall Study|Death|18|||
129960127|NCT00439647|467817829|FG000|Overall Study|Adverse Event|11|||
129960128|NCT00439647|467817830|FG001|Overall Study|Adverse Event|11|||
129960129|NCT00439647|467817829|FG000|Overall Study|Lost to Follow-up|4|||
129960130|NCT00439647|467817830|FG001|Overall Study|Lost to Follow-up|12|||
129960131|NCT00439647|467817829|FG000|Overall Study|Protocol Violation|3|||
129960132|NCT00439647|467817830|FG001|Overall Study|Protocol Violation|4|||
129960133|NCT00439647|467817829|FG000|Overall Study|Lack of Efficacy|0|||
129960134|NCT00439647|467817830|FG001|Overall Study|Lack of Efficacy|4|||
129960135|NCT02845375|467817831|FG000|Overall Study|upper airway obstruction|1|||
129960136|NCT02845375|467817832|FG001|Overall Study|upper airway obstruction|2|||
129960137|NCT02845375|467817833|FG002|Overall Study|upper airway obstruction|1|||
129960138|NCT03041701|467817838|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
129960139|NCT03041701|467817839|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
129960140|NCT03041701|467817840|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
129960141|NCT03041701|467817838|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
129960142|NCT03041701|467817839|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
129960143|NCT03041701|467817840|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
129960144|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
129960145|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
129960146|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
129960147|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
129960148|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
129960149|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
129960150|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
129960151|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
129960152|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
129960153|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
129960154|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
129960155|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
129960156|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
129960157|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
129960158|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
129960159|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
129960160|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
129960161|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
129960162|NCT03569475|467817841|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
129960163|NCT03569475|467817842|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
129960164|NCT03569475|467817843|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
129960165|NCT03569475|467817841|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
129960166|NCT03569475|467817842|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
129960167|NCT03569475|467817843|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
129960168|NCT03569475|467817841|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
129960169|NCT03569475|467817842|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
129960170|NCT03569475|467817843|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
129960171|NCT03638258|467817845|FG000|Overall Study|Adverse Event|1|||
129454446|NCT01066585|465960809|FG000|Overall Study|Protocol Violation|1|||
129454447|NCT01066585|465960810|FG001|Overall Study|Protocol Violation|0|||
129960172|NCT03638258|467817846|FG001|Overall Study|Adverse Event|0|||
129960173|NCT03638258|467817847|FG002|Overall Study|Adverse Event|2|||
129960174|NCT03638258|467817845|FG000|Overall Study|Lost to Follow-up|2|||
129960175|NCT03638258|467817846|FG001|Overall Study|Lost to Follow-up|4|||
129960176|NCT03638258|467817847|FG002|Overall Study|Lost to Follow-up|5|||
129960177|NCT03638258|467817845|FG000|Overall Study|Pregnancy|0|||
129960178|NCT03638258|467817846|FG001|Overall Study|Pregnancy|0|||
129960179|NCT03638258|467817847|FG002|Overall Study|Pregnancy|1|||
129960180|NCT03638258|467817845|FG000|Overall Study|Protocol Violation|0|||
129960181|NCT03638258|467817846|FG001|Overall Study|Protocol Violation|0|||
129960182|NCT03638258|467817847|FG002|Overall Study|Protocol Violation|1|||
129960183|NCT03638258|467817845|FG000|Overall Study|Withdrawal by Subject|4|||
129960184|NCT03638258|467817846|FG001|Overall Study|Withdrawal by Subject|5|||
129960185|NCT03638258|467817847|FG002|Overall Study|Withdrawal by Subject|12|||
129960186|NCT03638258|467817845|FG000|Overall Study|Lack of Efficacy|0|||
129960187|NCT03638258|467817846|FG001|Overall Study|Lack of Efficacy|0|||
129960188|NCT03638258|467817847|FG002|Overall Study|Lack of Efficacy|2|||
129960189|NCT02630706|467817848|FG000|Overall Study|Adverse Event|2|||
129960190|NCT02630706|467817849|FG001|Overall Study|Adverse Event|1|||
129960191|NCT02630706|467817850|FG002|Overall Study|Adverse Event|1|||
129960192|NCT02630706|467817848|FG000|Overall Study|Lost to Follow-up|0|||
129960193|NCT02630706|467817849|FG001|Overall Study|Lost to Follow-up|1|||
129960194|NCT02630706|467817850|FG002|Overall Study|Lost to Follow-up|2|||
129960195|NCT02630706|467817848|FG000|Overall Study|Physician Decision|1|||
129960196|NCT02630706|467817849|FG001|Overall Study|Physician Decision|1|||
129960197|NCT02630706|467817850|FG002|Overall Study|Physician Decision|0|||
129960198|NCT02630706|467817848|FG000|Overall Study|Pregnancy|0|||
129960199|NCT02630706|467817849|FG001|Overall Study|Pregnancy|1|||
129960200|NCT02630706|467817850|FG002|Overall Study|Pregnancy|0|||
129960201|NCT02630706|467817848|FG000|Overall Study|Withdrawal by Subject|4|||
129960202|NCT02630706|467817849|FG001|Overall Study|Withdrawal by Subject|5|||
129960203|NCT02630706|467817850|FG002|Overall Study|Withdrawal by Subject|7|||
129960204|NCT01527500|467817853|FG000|Part A|Administrative|11|||
129960205|NCT01527500|467817854|FG001|Part A|Administrative|7|||
129960206|NCT01527500|467817853|FG000|Part A|Adverse Event|4|||
129960207|NCT01527500|467817854|FG001|Part A|Adverse Event|2|||
129960208|NCT01527500|467817853|FG000|Part A|Death|4|||
129960209|NCT01527500|467817854|FG001|Part A|Death|1|||
129960210|NCT01527500|467817853|FG000|Part A|Lost to Follow-up|0|||
129960211|NCT01527500|467817854|FG001|Part A|Lost to Follow-up|1|||
129960212|NCT01527500|467817853|FG000|Part A|Protocol Deviation|9|||
129960213|NCT01527500|467817854|FG001|Part A|Protocol Deviation|2|||
129960214|NCT01527500|467817853|FG000|Part A|Withdrawal by Subject|2|||
129960215|NCT01527500|467817854|FG001|Part A|Withdrawal by Subject|0|||
129960216|NCT01527500|467817853|FG000|Part B|Adverse Event|1|||
129960217|NCT01527500|467817854|FG001|Part B|Adverse Event|0|||
129960218|NCT03078751|467817862|FG000|Overall Study|Adverse Event|4|||
129960219|NCT03078751|467817863|FG001|Overall Study|Adverse Event|0|||
129960220|NCT03078751|467817862|FG000|Overall Study|Physician Decision|1|||
129960221|NCT03078751|467817863|FG001|Overall Study|Physician Decision|0|||
129960222|NCT03078751|467817862|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
129960223|NCT03078751|467817863|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
129960224|NCT03078751|467817862|FG000|Overall Study|Subject/guardian decision|8|||
129960225|NCT03078751|467817863|FG001|Overall Study|Subject/guardian decision|1|||
129960226|NCT03078751|467817862|FG000|Overall Study|Untreated|0|||
129960227|NCT03078751|467817863|FG001|Overall Study|Untreated|4|||
129960228|NCT00607789|467817864|FG000|Overall Study|Adverse Event|3|||
129960229|NCT00607789|467817865|FG001|Overall Study|Adverse Event|0|||
129960230|NCT00607789|467817864|FG000|Overall Study|Lack of Efficacy|0|||
129960231|NCT00607789|467817865|FG001|Overall Study|Lack of Efficacy|1|||
129960232|NCT00607789|467817864|FG000|Overall Study|Inadequate adherence|3|||
129960233|NCT00607789|467817865|FG001|Overall Study|Inadequate adherence|0|||
129960234|NCT00607789|467817864|FG000|Overall Study|Lost to Follow-up|0|||
129960235|NCT00607789|467817865|FG001|Overall Study|Lost to Follow-up|5|||
129960236|NCT00607789|467817864|FG000|Overall Study|Withdrawal by Subject|1|||
129960237|NCT00607789|467817865|FG001|Overall Study|Withdrawal by Subject|0|||
129960238|NCT01209286|467817866|FG000|Overall Study|Adverse Event|4|||
129960239|NCT01209286|467817867|FG001|Overall Study|Adverse Event|3|||
129960240|NCT01209286|467817868|FG002|Overall Study|Adverse Event|1|||
129960241|NCT01209286|467817866|FG000|Overall Study|Hematological Relapse After Remission|0|||
129960242|NCT01209286|467817867|FG001|Overall Study|Hematological Relapse After Remission|1|||
129960243|NCT01209286|467817868|FG002|Overall Study|Hematological Relapse After Remission|1|||
129960244|NCT01209286|467817866|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
129960245|NCT01209286|467817867|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
129960246|NCT01209286|467817868|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
129960247|NCT01209286|467817866|FG000|Overall Study|Physician Decision|0|||
129960248|NCT01209286|467817867|FG001|Overall Study|Physician Decision|2|||
129960249|NCT01209286|467817868|FG002|Overall Study|Physician Decision|0|||
129960250|NCT01209286|467817866|FG000|Overall Study|Other|0|||
129960251|NCT01209286|467817867|FG001|Overall Study|Other|1|||
129960252|NCT01209286|467817868|FG002|Overall Study|Other|0|||
129960253|NCT03915951|467817869|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
129960254|NCT03915951|467817870|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
129960255|NCT03915951|467817869|FG000|Overall Study|Adverse Event|12|||
129960256|NCT03915951|467817870|FG001|Overall Study|Adverse Event|6|||
129960257|NCT03915951|467817869|FG000|Overall Study|Disease progression (radiological)|17|||
129960258|NCT03915951|467817870|FG001|Overall Study|Disease progression (radiological)|15|||
129960259|NCT03915951|467817869|FG000|Overall Study|Disease progression (clinical)|4|||
129960260|NCT03915951|467817870|FG001|Overall Study|Disease progression (clinical)|1|||
129960261|NCT03915951|467817869|FG000|Overall Study|Patient decision|0|||
129960262|NCT03915951|467817870|FG001|Overall Study|Patient decision|4|||
129960263|NCT03915951|467817869|FG000|Overall Study|Investigator decision|0|||
129960264|NCT03915951|467817870|FG001|Overall Study|Investigator decision|1|||
129960265|NCT03915951|467817869|FG000|Overall Study|Consent withdrawn|1|||
129960266|NCT03915951|467817870|FG001|Overall Study|Consent withdrawn|1|||
129960267|NCT03915951|467817869|FG000|Overall Study|Death|0|||
129960268|NCT03915951|467817870|FG001|Overall Study|Death|3|||
129960269|NCT01121185|467817874|FG000|Overall Study|Not infused|0|||
129960270|NCT01121185|467817875|FG001|Overall Study|Not infused|1|||
129960271|NCT01121185|467817874|FG000|Overall Study|Not transplanted|1|||
129960272|NCT01121185|467817875|FG001|Overall Study|Not transplanted|0|||
129960273|NCT01196741|467817876|FG000|Overall Study|Disease progression|34|||
129960274|NCT01196741|467817877|FG001|Overall Study|Disease progression|14|||
129454448|NCT01066585|465960809|FG000|Overall Study|Withdrawal by Subject|0|||
129454449|NCT01066585|465960810|FG001|Overall Study|Withdrawal by Subject|3|||
129960275|NCT01196741|467817876|FG000|Overall Study|Adverse Event|10|||
129960276|NCT01196741|467817877|FG001|Overall Study|Adverse Event|6|||
129454450|NCT00884273|465960813|FG000|Overall Study|Adverse Event|0|||
129454451|NCT00884273|465960814|FG001|Overall Study|Adverse Event|2|||
129960277|NCT01196741|467817876|FG000|Overall Study|Serious Adverse Event|3|||
129960278|NCT01196741|467817877|FG001|Overall Study|Serious Adverse Event|1|||
129960279|NCT01196741|467817876|FG000|Overall Study|Dose limiting Adverse Event|2|||
129960280|NCT01196741|467817877|FG001|Overall Study|Dose limiting Adverse Event|1|||
129960281|NCT01196741|467817876|FG000|Overall Study|Withdrawal by Subject|3|||
129960282|NCT01196741|467817877|FG001|Overall Study|Withdrawal by Subject|0|||
129960283|NCT01196741|467817876|FG000|Overall Study|Other reason|3|||
129960284|NCT01196741|467817877|FG001|Overall Study|Other reason|3|||
129960285|NCT01196741|467817876|FG000|Overall Study|Other|3|||
129960286|NCT01196741|467817877|FG001|Overall Study|Other|2|||
129960287|NCT01196741|467817876|FG000|Overall Study|Protocol Violation|2|||
129960288|NCT01196741|467817877|FG001|Overall Study|Protocol Violation|1|||
129960289|NCT01064856|467817879|FG000|Double-blind (DB) Period|Adverse Event|1|||
129960290|NCT01064856|467817880|FG001|Double-blind (DB) Period|Adverse Event|0|||
129960291|NCT01064856|467817881|FG002|Double-blind (DB) Period|Adverse Event|0|||
129960292|NCT01064856|467817882|FG003|Double-blind (DB) Period|Adverse Event|0|||
129960293|NCT01064856|467817879|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
129960294|NCT01064856|467817880|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
129960295|NCT01064856|467817881|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
129960296|NCT01064856|467817882|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
129960297|NCT01064856|467817879|FG000|Open-label (OL) Period|Adverse Event|0|||
129960298|NCT01064856|467817880|FG001|Open-label (OL) Period|Adverse Event|0|||
129960299|NCT01064856|467817881|FG002|Open-label (OL) Period|Adverse Event|12|||
129960300|NCT01064856|467817882|FG003|Open-label (OL) Period|Adverse Event|6|||
129960301|NCT01064856|467817879|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
129960302|NCT01064856|467817880|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
129960303|NCT01064856|467817881|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
129960304|NCT01064856|467817882|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
129960305|NCT01064856|467817879|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
129960306|NCT01064856|467817880|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
129960307|NCT01064856|467817881|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
129960308|NCT01064856|467817882|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
129960309|NCT01064856|467817879|FG000|Open-label (OL) Period|Other|0|||
129960310|NCT01064856|467817880|FG001|Open-label (OL) Period|Other|0|||
129960311|NCT01064856|467817881|FG002|Open-label (OL) Period|Other|7|||
129960312|NCT01064856|467817882|FG003|Open-label (OL) Period|Other|7|||
129960313|NCT01204775|467817885|FG000|Overall Study|Poor/non-compliance|0|||
129960314|NCT01204775|467817886|FG001|Overall Study|Poor/non-compliance|1|||
129960315|NCT01204775|467817885|FG000|Overall Study|Withdrawal by Subject|1|||
129960316|NCT01204775|467817886|FG001|Overall Study|Withdrawal by Subject|0|||
129960317|NCT02273180|467817887|FG000|Overall Study|Adverse Event|2|||
129960318|NCT02273180|467817888|FG001|Overall Study|Adverse Event|2|||
129960319|NCT02273180|467817887|FG000|Overall Study|Lack of Efficacy|1|||
129960320|NCT02273180|467817888|FG001|Overall Study|Lack of Efficacy|0|||
129960321|NCT02273180|467817887|FG000|Overall Study|Protocol Violation|1|||
129960322|NCT02273180|467817888|FG001|Overall Study|Protocol Violation|7|||
129960323|NCT02273180|467817887|FG000|Overall Study|Randomized but not treated|1|||
129960324|NCT02273180|467817888|FG001|Overall Study|Randomized but not treated|0|||
129960325|NCT02273180|467817887|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
129960326|NCT02273180|467817888|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
129960327|NCT02273180|467817887|FG000|Overall Study|Other than specified above|21|||
129960328|NCT02273180|467817888|FG001|Overall Study|Other than specified above|10|||
129960329|NCT00509925|467817889|FG000|Overall Study|Personal reasons|0|||
129960330|NCT00509925|467817890|FG001|Overall Study|Personal reasons|1|||
129960331|NCT03749616|467817893|FG000|Overall Study|Lost to Follow-up|4|||
129960332|NCT03749616|467817894|FG001|Overall Study|Lost to Follow-up|7|||
129960333|NCT03749616|467817893|FG000|Overall Study|Screen Failure|1|||
129960334|NCT03749616|467817894|FG001|Overall Study|Screen Failure|1|||
129960335|NCT03749616|467817893|FG000|Overall Study|Withdrawal by Subject|2|||
129960336|NCT03749616|467817894|FG001|Overall Study|Withdrawal by Subject|0|||
129960337|NCT04435522|467817897|FG000|Overall Study|Withdrawal by Subject|2|||
129960338|NCT03302559|467817898|FG000|Overall Study|Adverse Event|2|||
129960339|NCT03302559|467817898|FG000|Overall Study|Lost to Follow-up|1|||
129960340|NCT03302559|467817898|FG000|Overall Study|Withdrew Consent|3|||
129960341|NCT00951171|467817899|FG000|Overall Study|Adverse Event|2|||
129960342|NCT00951171|467817900|FG001|Overall Study|Adverse Event|0|||
129960343|NCT00919061|467817901|FG000|Overall Study|Adverse Event|1|||
129960344|NCT00919061|467817901|FG000|Overall Study|Withdrawal by Subject|1|||
129960345|NCT04130061|467817904|FG000|Overall Study|OR team forgot to request membrane|1|||
129960346|NCT04130061|467817905|FG001|Overall Study|OR team forgot to request membrane|0|||
129960347|NCT05294328|467817912|FG000|Overall Study|Adverse Event|1|||
129960348|NCT05294328|467817913|FG001|Overall Study|Adverse Event|0|||
129960349|NCT05294328|467817914|FG002|Overall Study|Adverse Event|0|||
129960350|NCT05294328|467817912|FG000|Overall Study|Physician Decision|1|||
129960351|NCT05294328|467817913|FG001|Overall Study|Physician Decision|1|||
129960352|NCT05294328|467817914|FG002|Overall Study|Physician Decision|0|||
129960353|NCT05294328|467817912|FG000|Overall Study|Withdrawal by Subject|0|||
129960354|NCT05294328|467817913|FG001|Overall Study|Withdrawal by Subject|2|||
129960355|NCT05294328|467817914|FG002|Overall Study|Withdrawal by Subject|1|||
129960356|NCT05294328|467817912|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
129960357|NCT05294328|467817913|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
129960358|NCT05294328|467817914|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
129960359|NCT02056873|467817915|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
129960360|NCT00113269|467819483|FG000|Overall Study|Not transplanted, donor issues|4|||
129960361|NCT00113269|467819484|FG001|Overall Study|Not transplanted, donor issues|0|||
129960362|NCT00113269|467819485|FG002|Overall Study|Not transplanted, donor issues|2|||
129960363|NCT00113269|467819486|FG003|Overall Study|Not transplanted, donor issues|2|||
129960364|NCT00113269|467819483|FG000|Overall Study|Not transplanted, recipient issues|2|||
129960365|NCT00113269|467819484|FG001|Overall Study|Not transplanted, recipient issues|1|||
129960366|NCT00113269|467819485|FG002|Overall Study|Not transplanted, recipient issues|7|||
129960367|NCT00113269|467819486|FG003|Overall Study|Not transplanted, recipient issues|4|||
129960368|NCT00113269|467819483|FG000|Overall Study|Early graft loss, technical|0|||
129960369|NCT00113269|467819484|FG001|Overall Study|Early graft loss, technical|0|||
129960370|NCT00113269|467819485|FG002|Overall Study|Early graft loss, technical|2|||
129960371|NCT00113269|467819486|FG003|Overall Study|Early graft loss, technical|0|||
129960372|NCT00113269|467819483|FG000|Overall Study|Death in operating room|0|||
129960373|NCT00113269|467819484|FG001|Overall Study|Death in operating room|0|||
129960374|NCT00113269|467819485|FG002|Overall Study|Death in operating room|0|||
129960375|NCT00113269|467819486|FG003|Overall Study|Death in operating room|1|||
129960376|NCT00113269|467819483|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
129960377|NCT00113269|467819484|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
129960378|NCT00113269|467819485|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
129960379|NCT00113269|467819486|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
129960380|NCT00113269|467819483|FG000|Overall Study|Adverse Event|2|||
129960381|NCT00113269|467819484|FG001|Overall Study|Adverse Event|7|||
129960382|NCT00113269|467819485|FG002|Overall Study|Adverse Event|11|||
129960383|NCT00113269|467819486|FG003|Overall Study|Adverse Event|7|||
129960384|NCT00113269|467819483|FG000|Overall Study|Withdrawal by Subject|4|||
129960385|NCT00113269|467819484|FG001|Overall Study|Withdrawal by Subject|3|||
129960386|NCT00113269|467819485|FG002|Overall Study|Withdrawal by Subject|4|||
129960387|NCT00113269|467819486|FG003|Overall Study|Withdrawal by Subject|2|||
129960388|NCT00113269|467819483|FG000|Overall Study|Graft loss|6|||
129960389|NCT00113269|467819484|FG001|Overall Study|Graft loss|6|||
129960390|NCT00113269|467819485|FG002|Overall Study|Graft loss|4|||
129960391|NCT00113269|467819486|FG003|Overall Study|Graft loss|9|||
129960392|NCT00113269|467819483|FG000|Overall Study|Protocol Violation|1|||
129960393|NCT00113269|467819484|FG001|Overall Study|Protocol Violation|0|||
129960394|NCT00113269|467819485|FG002|Overall Study|Protocol Violation|4|||
129960395|NCT00113269|467819486|FG003|Overall Study|Protocol Violation|2|||
129960396|NCT00113269|467819483|FG000|Overall Study|Lost to Follow-up|2|||
129960397|NCT00113269|467819484|FG001|Overall Study|Lost to Follow-up|3|||
129960398|NCT00113269|467819485|FG002|Overall Study|Lost to Follow-up|6|||
129960399|NCT00113269|467819486|FG003|Overall Study|Lost to Follow-up|3|||
129960400|NCT00113269|467819483|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
129960401|NCT00113269|467819484|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
129960402|NCT00113269|467819485|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
129960403|NCT00113269|467819486|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
129960404|NCT00113269|467819483|FG000|Overall Study|Discontinued due to rejection|0|||
129960405|NCT00113269|467819484|FG001|Overall Study|Discontinued due to rejection|0|||
129960406|NCT00113269|467819485|FG002|Overall Study|Discontinued due to rejection|1|||
129960407|NCT00113269|467819486|FG003|Overall Study|Discontinued due to rejection|0|||
129960408|NCT00113269|467819483|FG000|Overall Study|Moved|0|||
129960409|NCT00113269|467819484|FG001|Overall Study|Moved|1|||
129960410|NCT00113269|467819485|FG002|Overall Study|Moved|0|||
129960411|NCT00113269|467819486|FG003|Overall Study|Moved|3|||
129960412|NCT00113269|467819483|FG000|Overall Study|Received pancreas transplant|0|||
129960413|NCT00113269|467819484|FG001|Overall Study|Received pancreas transplant|0|||
129960414|NCT00113269|467819485|FG002|Overall Study|Received pancreas transplant|0|||
129960415|NCT00113269|467819486|FG003|Overall Study|Received pancreas transplant|2|||
129960416|NCT00113269|467819483|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
129960417|NCT00113269|467819484|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
129960418|NCT00113269|467819485|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
129960419|NCT00113269|467819486|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
129960420|NCT00113269|467819483|FG000|Overall Study|Did not meet eligibility criteria|1|||
129960421|NCT00113269|467819484|FG001|Overall Study|Did not meet eligibility criteria|0|||
129960422|NCT00113269|467819485|FG002|Overall Study|Did not meet eligibility criteria|0|||
129960423|NCT00113269|467819486|FG003|Overall Study|Did not meet eligibility criteria|1|||
129960424|NCT00113269|467819483|FG000|Overall Study|Unable to return for follow up|2|||
129960425|NCT00113269|467819484|FG001|Overall Study|Unable to return for follow up|1|||
129960426|NCT00113269|467819485|FG002|Overall Study|Unable to return for follow up|0|||
129960427|NCT00113269|467819486|FG003|Overall Study|Unable to return for follow up|0|||
129960428|NCT01821729|467819487|FG000|Overall Study|Withdrawal by Subject|1|||
129960429|NCT01093599|467819490|FG000|Overall Study|Lost to Follow-up|32|||
129960430|NCT01093599|467819491|FG001|Overall Study|Lost to Follow-up|46|||
129960431|NCT01703845|467819492|FG000|Overall Study|Adverse Event|1|||
129960432|NCT01703845|467819493|FG001|Overall Study|Adverse Event|0|||
129960433|NCT01703845|467819492|FG000|Overall Study|Protocol Violation|1|||
129960434|NCT01703845|467819493|FG001|Overall Study|Protocol Violation|0|||
129960435|NCT01703845|467819492|FG000|Overall Study|other than stated above|1|||
129960436|NCT01703845|467819493|FG001|Overall Study|other than stated above|0|||
129960437|NCT01644188|467819494|FG000|Overall Study|Adverse Event|44|||
129960438|NCT01644188|467819495|FG001|Overall Study|Adverse Event|20|||
129960439|NCT01644188|467819494|FG000|Overall Study|Poor compliance to protocol|26|||
129960440|NCT01644188|467819495|FG001|Overall Study|Poor compliance to protocol|14|||
129960441|NCT01644188|467819494|FG000|Overall Study|Physician Decision|1|||
129960442|NCT01644188|467819495|FG001|Overall Study|Physician Decision|3|||
129960443|NCT01644188|467819494|FG000|Overall Study|Participant moved|7|||
129960444|NCT01644188|467819495|FG001|Overall Study|Participant moved|2|||
129960445|NCT01644188|467819494|FG000|Overall Study|Related to auto-injector administration|2|||
129960446|NCT01644188|467819495|FG001|Overall Study|Related to auto-injector administration|2|||
129960447|NCT01644188|467819494|FG000|Overall Study|Consent withdrawn by participant|14|||
129960448|NCT01644188|467819495|FG001|Overall Study|Consent withdrawn by participant|7|||
129960449|NCT01644188|467819494|FG000|Overall Study|Selection criteria finally not met|2|||
129960450|NCT01644188|467819495|FG001|Overall Study|Selection criteria finally not met|0|||
129960451|NCT01644188|467819494|FG000|Overall Study|Lost to Follow-up|1|||
129960452|NCT01644188|467819495|FG001|Overall Study|Lost to Follow-up|0|||
129960453|NCT01644188|467819494|FG000|Overall Study|Death|4|||
129960454|NCT01644188|467819495|FG001|Overall Study|Death|3|||
129960455|NCT01644188|467819494|FG000|Overall Study|Last visit outside protocol visit window|14|||
129960456|NCT01644188|467819495|FG001|Overall Study|Last visit outside protocol visit window|16|||
129960457|NCT01644188|467819494|FG000|Overall Study|Site closure|1|||
129960458|NCT01644188|467819495|FG001|Overall Study|Site closure|1|||
129960459|NCT01644188|467819494|FG000|Overall Study|Other than specified above|6|||
129960460|NCT01644188|467819495|FG001|Overall Study|Other than specified above|7|||
129960461|NCT00966979|467819499|FG000|Overall Study|Death|1|||
129960462|NCT00966979|467819499|FG000|Overall Study|Lost to Follow-up|6|||
129960463|NCT00966979|467819499|FG000|Overall Study|Withdrawal by Subject|14|||
129960464|NCT00966979|467819499|FG000|Overall Study|Adverse Event|5|||
129960465|NCT00966979|467819499|FG000|Overall Study|Sponsor terminated early|49|||
129960466|NCT00966979|467819499|FG000|Overall Study|Censored because surgery not done|2|||
129960467|NCT00966979|467819499|FG000|Overall Study|Censored because study device was not implanted|14|||
129960468|NCT00966979|467819499|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
129960469|NCT04140266|467819500|FG000|Overall Study|Physician Decision|2|||
129960470|NCT04140266|467819501|FG001|Overall Study|Physician Decision|0|||
129960471|NCT04140266|467819500|FG000|Overall Study|Withdrawal by Subject|4|||
129960472|NCT04140266|467819501|FG001|Overall Study|Withdrawal by Subject|2|||
129960473|NCT03119688|467819505|FG000|Overall Study|Adverse Event|4|||
129960474|NCT03226106|467819506|FG000|Overall Study|Withdrawal by Subject|2|||
129960475|NCT03226106|467819507|FG001|Overall Study|Withdrawal by Subject|0|||
129960476|NCT03226106|467819506|FG000|Overall Study|Adverse Event|1|||
129960477|NCT03226106|467819507|FG001|Overall Study|Adverse Event|0|||
129960478|NCT03226106|467819506|FG000|Overall Study|Lost to Follow-up|2|||
129960479|NCT03226106|467819507|FG001|Overall Study|Lost to Follow-up|0|||
129960480|NCT00721214|467819508|FG000|Overall Study|Chose another center for transplant|1|||
129960481|NCT00721214|467819508|FG000|Overall Study|Death|3|||
129960482|NCT00488319|467819509|FG000|Overall Study|Adverse Event|1|||
129960483|NCT00488319|467819510|FG001|Overall Study|Adverse Event|2|||
129960484|NCT00488319|467819511|FG002|Overall Study|Adverse Event|23|||
129960485|NCT00488319|467819509|FG000|Overall Study|Lack of Efficacy|6|||
129960486|NCT00488319|467819510|FG001|Overall Study|Lack of Efficacy|12|||
129960487|NCT00488319|467819511|FG002|Overall Study|Lack of Efficacy|27|||
129960488|NCT00488319|467819509|FG000|Overall Study|Lost to Follow-up|3|||
129960489|NCT00488319|467819510|FG001|Overall Study|Lost to Follow-up|5|||
129960490|NCT00488319|467819511|FG002|Overall Study|Lost to Follow-up|16|||
129960491|NCT00488319|467819509|FG000|Overall Study|Withdrawal by Subject|5|||
129960492|NCT00488319|467819510|FG001|Overall Study|Withdrawal by Subject|20|||
129960493|NCT00488319|467819511|FG002|Overall Study|Withdrawal by Subject|44|||
129960494|NCT00488319|467819509|FG000|Overall Study|Other reasons for withdrawal|0|||
129960495|NCT00488319|467819510|FG001|Overall Study|Other reasons for withdrawal|4|||
129960496|NCT00488319|467819511|FG002|Overall Study|Other reasons for withdrawal|12|||
129960497|NCT01649557|467819512|FG000|Overall Study|Lost to Follow-up|5|||
129454452|NCT00884273|465960813|FG000|Overall Study|Protocol Violation|1|||
129454453|NCT00884273|465960814|FG001|Overall Study|Protocol Violation|3|||
129454454|NCT00884273|465960813|FG000|Overall Study|Practical reasons|1|||
129454455|NCT00884273|465960814|FG001|Overall Study|Practical reasons|0|||
129454456|NCT00078325|465960817|FG000|Overall Study|Adverse Event|15|||
129454457|NCT00078325|465960818|FG001|Overall Study|Adverse Event|10|||
129454458|NCT00078325|465960819|FG002|Overall Study|Adverse Event|5|||
129454459|NCT00078325|465960817|FG000|Overall Study|Protocol Violation|2|||
129454460|NCT00078325|465960818|FG001|Overall Study|Protocol Violation|2|||
129960498|NCT01649557|467819513|FG001|Overall Study|Lost to Follow-up|0|||
129960499|NCT01649557|467819514|FG002|Overall Study|Lost to Follow-up|3|||
129960500|NCT01649557|467819512|FG000|Overall Study|Adverse Event|7|||
129454461|NCT00078325|465960819|FG002|Overall Study|Protocol Violation|0|||
129454462|NCT00078325|465960817|FG000|Overall Study|Withdrawal by Subject|1|||
129454463|NCT00078325|465960818|FG001|Overall Study|Withdrawal by Subject|5|||
129454464|NCT00078325|465960819|FG002|Overall Study|Withdrawal by Subject|3|||
129960501|NCT01649557|467819513|FG001|Overall Study|Adverse Event|5|||
129454465|NCT00078325|465960817|FG000|Overall Study|Lost to Follow-up|0|||
129960502|NCT01649557|467819514|FG002|Overall Study|Adverse Event|1|||
129454466|NCT00078325|465960818|FG001|Overall Study|Lost to Follow-up|1|||
129454467|NCT00078325|465960819|FG002|Overall Study|Lost to Follow-up|1|||
129960503|NCT01649557|467819512|FG000|Overall Study|Met withdrawal criteria|4|||
129960504|NCT01649557|467819513|FG001|Overall Study|Met withdrawal criteria|0|||
129960505|NCT01649557|467819514|FG002|Overall Study|Met withdrawal criteria|0|||
129960506|NCT01649557|467819512|FG000|Overall Study|Physician Decision|8|||
129960507|NCT01649557|467819513|FG001|Overall Study|Physician Decision|2|||
129960508|NCT01649557|467819514|FG002|Overall Study|Physician Decision|1|||
129960509|NCT01649557|467819512|FG000|Overall Study|Withdrawal by Subject|15|||
129960510|NCT01649557|467819513|FG001|Overall Study|Withdrawal by Subject|5|||
129960511|NCT01649557|467819514|FG002|Overall Study|Withdrawal by Subject|4|||
129960512|NCT01649557|467819512|FG000|Overall Study|Protocol deviation|0|||
129960513|NCT01649557|467819513|FG001|Overall Study|Protocol deviation|2|||
129960514|NCT01649557|467819514|FG002|Overall Study|Protocol deviation|0|||
129960515|NCT01649557|467819512|FG000|Overall Study|Lack of Efficacy|5|||
129960516|NCT01649557|467819513|FG001|Overall Study|Lack of Efficacy|0|||
129960517|NCT01649557|467819514|FG002|Overall Study|Lack of Efficacy|0|||
129960518|NCT03712449|467819518|FG000|Overall Study|Withdraw Consent|0|||
129960519|NCT03712449|467819519|FG001|Overall Study|Withdraw Consent|1|||
129960520|NCT00666198|467819525|FG000|Overall Study|Protocol Violation|10|||
129454468|NCT00078325|465960817|FG000|Overall Study|Physician Decision|2|||
129960521|NCT00666198|467819525|FG000|Overall Study|No Visit After First Day of Treatment|13|||
129960522|NCT00666198|467819525|FG000|Overall Study|Safety Not Assessable|6|||
129960523|NCT00666198|467819525|FG000|Overall Study|No Drug Administration|4|||
129960524|NCT05153499|467819526|FG000|Overall Study|Withdrawal by Subject|1|||
129960525|NCT05153499|467819527|FG001|Overall Study|Withdrawal by Subject|0|||
129960526|NCT05153499|467819526|FG000|Overall Study|Clinical Hold|1|||
129960527|NCT05153499|467819527|FG001|Overall Study|Clinical Hold|0|||
129454469|NCT00078325|465960818|FG001|Overall Study|Physician Decision|0|||
129454470|NCT00078325|465960819|FG002|Overall Study|Physician Decision|1|||
129454471|NCT00078325|465960817|FG000|Overall Study|Miscellaneous|1|||
129454472|NCT00078325|465960818|FG001|Overall Study|Miscellaneous|1|||
129454473|NCT00078325|465960819|FG002|Overall Study|Miscellaneous|1|||
129454474|NCT04126083|465960820|FG000|Overall Study|Withdrawal by Subject|1|||
129454475|NCT03710486|465960821|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
129454476|NCT03710486|465960822|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
129454477|NCT03710486|465960821|FG000|Overall Study|Missing|0|||
129454478|NCT03710486|465960822|FG001|Overall Study|Missing|2|||
129454479|NCT01279850|465960823|FG000|Overall Study|Protocol Violation|50|||
129454480|NCT01279850|465960823|FG000|Overall Study|No Drug Administration Information|7|||
129454481|NCT01279850|465960823|FG000|Overall Study|No Visit After Treatment|34|||
129454482|NCT01131520|465960824|FG000|Overall Study|Computer problem|1|||
129454483|NCT01131520|465960825|FG001|Overall Study|Computer problem|0|||
129454484|NCT01131520|465960824|FG000|Overall Study|Counselor not available|0|||
129454485|NCT01131520|465960825|FG001|Overall Study|Counselor not available|3|||
129454486|NCT01131520|465960824|FG000|Overall Study|Subject changed history after enrollment|0|||
129454487|NCT01131520|465960825|FG001|Overall Study|Subject changed history after enrollment|1|||
129454488|NCT02536313|465960826|FG000|Overall Study|Lack of Efficacy|0|||
129454489|NCT02536313|465960827|FG001|Overall Study|Lack of Efficacy|1|||
129454490|NCT02437864|465960837|FG000|Overall Study|Protocol Violation|4|||
129454491|NCT02437864|465960838|FG001|Overall Study|Protocol Violation|0|||
129454492|NCT01892163|465960839|FG000|Overall Study|Death|1|||
129454493|NCT01892163|465960840|FG001|Overall Study|Death|1|||
129454494|NCT01892163|465960839|FG000|Overall Study|Lost to Follow-up|1|||
129454495|NCT01892163|465960840|FG001|Overall Study|Lost to Follow-up|0|||
129454496|NCT03302975|465960841|FG000|Overall Study|Lost to Follow-up|4|||
129454497|NCT01924182|465960842|FG000|Overall Study|Withdrawal by Subject|1|||
129454498|NCT01924182|465960843|FG001|Overall Study|Withdrawal by Subject|0|||
129454499|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
129454500|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
129454501|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
129454502|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
129454503|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
129454504|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
129454505|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
129454506|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
129454507|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to death|4|||
129454508|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to death|3|||
129454509|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
129454510|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
129454511|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
129454512|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
129454513|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
129454514|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
129454515|NCT02258451|465960845|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
129454516|NCT02258451|465960846|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
129454517|NCT02258451|465960845|FG000|Overall Study|Other reason|1|||
129454518|NCT02258451|465960846|FG001|Overall Study|Other reason|1|||
129454519|NCT02258451|465960845|FG000|Overall Study|Never treated|2|||
129454520|NCT02258451|465960846|FG001|Overall Study|Never treated|3|||
129454521|NCT04360551|465962740|FG000|Overall Study|Withdrawal by Subject|1|||
129454522|NCT04360551|465962741|FG001|Overall Study|Withdrawal by Subject|0|||
129454523|NCT00075023|465962742|FG000|Pilot Study|Physician Decision|1|||
129454524|NCT00075023|465962743|FG001|Pilot Study|Physician Decision|2|||
129454525|NCT00075023|465962742|FG000|Pilot Study|Withdrawal by Subject|1|||
129454526|NCT00075023|465962743|FG001|Pilot Study|Withdrawal by Subject|0|||
129960528|NCT05153499|467819526|FG000|Overall Study|Study Termination|6|||
129960529|NCT05153499|467819527|FG001|Overall Study|Study Termination|5|||
129960530|NCT03029234|467819531|FG000|Overall Study|Sponsor Decision|1|||
129960531|NCT03029234|467819531|FG000|Overall Study|Withdrawal by Subject|5|||
129960532|NCT03029234|467819531|FG000|Overall Study|Death|91|||
129960533|NCT03029234|467819531|FG000|Overall Study|Lost to Follow-up|2|||
129960534|NCT02166047|467819532|FG000|Overall Study|Withdrawal by Participant|0|||
129960535|NCT02166047|467819533|FG001|Overall Study|Withdrawal by Participant|1|||
129960536|NCT02166047|467819534|FG002|Overall Study|Withdrawal by Participant|2|||
129960537|NCT02166047|467819535|FG003|Overall Study|Withdrawal by Participant|0|||
129960538|NCT02166047|467819536|FG004|Overall Study|Withdrawal by Participant|0|||
129960539|NCT02166047|467819537|FG005|Overall Study|Withdrawal by Participant|0|||
129960540|NCT02166047|467819538|FG006|Overall Study|Withdrawal by Participant|1|||
129960541|NCT02166047|467819539|FG007|Overall Study|Withdrawal by Participant|0|||
129960542|NCT02166047|467819540|FG008|Overall Study|Withdrawal by Participant|0|||
129960543|NCT02166047|467819541|FG009|Overall Study|Withdrawal by Participant|0|||
129960544|NCT02166047|467819542|FG010|Overall Study|Withdrawal by Participant|0|||
129960545|NCT02166047|467819543|FG011|Overall Study|Withdrawal by Participant|0|||
129960546|NCT02166047|467819532|FG000|Overall Study|Adverse Event|0|||
129960547|NCT02166047|467819533|FG001|Overall Study|Adverse Event|0|||
129960548|NCT02166047|467819534|FG002|Overall Study|Adverse Event|0|||
129960549|NCT02166047|467819535|FG003|Overall Study|Adverse Event|0|||
129960550|NCT02166047|467819536|FG004|Overall Study|Adverse Event|1|||
129960551|NCT02166047|467819537|FG005|Overall Study|Adverse Event|0|||
129960552|NCT02166047|467819538|FG006|Overall Study|Adverse Event|1|||
129960553|NCT02166047|467819539|FG007|Overall Study|Adverse Event|0|||
129960554|NCT02166047|467819540|FG008|Overall Study|Adverse Event|0|||
129960555|NCT02166047|467819541|FG009|Overall Study|Adverse Event|0|||
129960556|NCT02166047|467819542|FG010|Overall Study|Adverse Event|2|||
129960557|NCT02166047|467819543|FG011|Overall Study|Adverse Event|0|||
129960558|NCT01649297|467819544|FG000|Overall Study|Adverse Event|5|||
129960559|NCT01649297|467819545|FG001|Overall Study|Adverse Event|5|||
129960560|NCT01649297|467819546|FG002|Overall Study|Adverse Event|4|||
129960561|NCT01649297|467819547|FG003|Overall Study|Adverse Event|13|||
129960562|NCT01649297|467819548|FG004|Overall Study|Adverse Event|1|||
129960563|NCT01649297|467819544|FG000|Overall Study|Lack of Efficacy|0|||
129960564|NCT01649297|467819545|FG001|Overall Study|Lack of Efficacy|0|||
129960565|NCT01649297|467819546|FG002|Overall Study|Lack of Efficacy|0|||
129960566|NCT01649297|467819547|FG003|Overall Study|Lack of Efficacy|0|||
129960567|NCT01649297|467819548|FG004|Overall Study|Lack of Efficacy|1|||
129960568|NCT01649297|467819544|FG000|Overall Study|Non compliant with Protocol|1|||
129960569|NCT01649297|467819545|FG001|Overall Study|Non compliant with Protocol|0|||
129960570|NCT01649297|467819546|FG002|Overall Study|Non compliant with Protocol|3|||
129960571|NCT01649297|467819547|FG003|Overall Study|Non compliant with Protocol|2|||
129960572|NCT01649297|467819548|FG004|Overall Study|Non compliant with Protocol|1|||
129960573|NCT01649297|467819544|FG000|Overall Study|Lost to Follow-up|1|||
129960574|NCT01649297|467819545|FG001|Overall Study|Lost to Follow-up|1|||
129960575|NCT01649297|467819546|FG002|Overall Study|Lost to Follow-up|4|||
129960576|NCT01649297|467819547|FG003|Overall Study|Lost to Follow-up|3|||
129960577|NCT01649297|467819548|FG004|Overall Study|Lost to Follow-up|0|||
129960578|NCT01649297|467819544|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
129960579|NCT01649297|467819545|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
129960580|NCT01649297|467819546|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
129960581|NCT01649297|467819547|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
129960582|NCT01649297|467819548|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
129960583|NCT01649297|467819544|FG000|Overall Study|For other reason|4|||
129960584|NCT01649297|467819545|FG001|Overall Study|For other reason|1|||
129960585|NCT01649297|467819546|FG002|Overall Study|For other reason|2|||
129960586|NCT01649297|467819547|FG003|Overall Study|For other reason|0|||
129960587|NCT01649297|467819548|FG004|Overall Study|For other reason|0|||
129960588|NCT01685047|467819549|FG000|Overall Study|Withdrawal by Subject|20|||
129960589|NCT01685047|467819549|FG000|Overall Study|Death|26|||
129960590|NCT01685047|467819549|FG000|Overall Study|Lost to Follow-up|8|||
129960591|NCT01685047|467819549|FG000|Overall Study|Physician Decision|25|||
129960592|NCT01685047|467819549|FG000|Overall Study|Adverse Event|5|||
129960593|NCT01685047|467819549|FG000|Overall Study|patient withdrawn by sponsor|1|||
129960594|NCT02490878|467819556|FG000|Overall Study|deemed ineligible|0|||
129960595|NCT02490878|467819557|FG001|Overall Study|deemed ineligible|1|||
129960596|NCT02490878|467819556|FG000|Overall Study|progression prior to treatment|0|||
129960597|NCT02490878|467819557|FG001|Overall Study|progression prior to treatment|1|||
129960598|NCT02490878|467819556|FG000|Overall Study|only submitted baseline QOL|0|||
129960599|NCT02490878|467819557|FG001|Overall Study|only submitted baseline QOL|1|||
129960600|NCT00451555|467819558|FG000|Overall Study|Protocol Violation|2|||
129960601|NCT00451555|467819559|FG001|Overall Study|Protocol Violation|2|||
129960602|NCT00451555|467819558|FG000|Overall Study|Adverse Event|3|||
129960603|NCT00451555|467819559|FG001|Overall Study|Adverse Event|1|||
129960604|NCT00451555|467819558|FG000|Overall Study|Withdrawal by Subject|6|||
129960605|NCT00451555|467819559|FG001|Overall Study|Withdrawal by Subject|0|||
129960606|NCT00451555|467819558|FG000|Overall Study|Physician Decision|2|||
129454527|NCT03670953|465962744|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
129454528|NCT03670953|465962745|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
129454529|NCT03670953|465962746|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
129454530|NCT03670953|465962747|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
129454531|NCT03670953|465962744|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
129454532|NCT03670953|465962745|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
129454533|NCT03670953|465962746|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
129454534|NCT03670953|465962747|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
129454535|NCT03670953|465962744|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
129454536|NCT03670953|465962745|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
129454537|NCT03670953|465962746|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
129454538|NCT03670953|465962747|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
129454539|NCT03670953|465962744|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
129454540|NCT03670953|465962745|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
129454541|NCT03670953|465962746|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
129454542|NCT03670953|465962747|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
129454543|NCT03670953|465962744|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
129454544|NCT03670953|465962745|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
129454545|NCT03670953|465962746|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
129454546|NCT03670953|465962747|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
129454547|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
129454548|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
129960607|NCT00451555|467819559|FG001|Overall Study|Physician Decision|1|||
129960608|NCT00922441|467819562|FG000|Overall Study|Protocol Violation|0|||
129454549|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
129960609|NCT00922441|467819563|FG001|Overall Study|Protocol Violation|0|||
129960610|NCT00922441|467819564|FG002|Overall Study|Protocol Violation|2|||
129960611|NCT00922441|467819562|FG000|Overall Study|Withdrawal by Subject|0|||
129960612|NCT00922441|467819563|FG001|Overall Study|Withdrawal by Subject|0|||
129960613|NCT00922441|467819564|FG002|Overall Study|Withdrawal by Subject|1|||
129960614|NCT02973477|467819567|FG000|First Intervention|Lost to Follow-up|0|||
129960615|NCT02973477|467819568|FG001|First Intervention|Lost to Follow-up|2|||
129960616|NCT02973477|467819567|FG000|Washout|Withdrawal by Subject|1|||
129960617|NCT02973477|467819568|FG001|Washout|Withdrawal by Subject|0|||
129960618|NCT02973477|467819567|FG000|Second Intervention|Lost to Follow-up|1|||
129960619|NCT02973477|467819568|FG001|Second Intervention|Lost to Follow-up|0|||
129960620|NCT00317603|467819572|FG000|Overall Study|Progressive Disease|3|||
129960621|NCT00523549|467819575|FG000|Overall Study|Adverse Event|6|||
129960622|NCT00523549|467819576|FG001|Overall Study|Adverse Event|3|||
129960623|NCT00523549|467819575|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129960624|NCT00523549|467819576|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129960625|NCT00523549|467819575|FG000|Overall Study|Protocol Deviation|3|||
129960626|NCT00523549|467819576|FG001|Overall Study|Protocol Deviation|1|||
129960627|NCT00523549|467819575|FG000|Overall Study|Patient withdrew consent|7|||
129960628|NCT00523549|467819576|FG001|Overall Study|Patient withdrew consent|6|||
129960629|NCT00523549|467819575|FG000|Overall Study|Lost to Follow-up|3|||
129960630|NCT00523549|467819576|FG001|Overall Study|Lost to Follow-up|5|||
129960631|NCT00053352|467819581|FG000|Overall Study|Lost to Follow-up|0|||
129960632|NCT00053352|467819582|FG001|Overall Study|Lost to Follow-up|1|||
129960633|NCT00053352|467819581|FG000|Overall Study|Physician Decision|11|||
129960634|NCT00053352|467819582|FG001|Overall Study|Physician Decision|1|||
129960635|NCT00053352|467819581|FG000|Overall Study|Withdrawal by Subject|1|||
129960636|NCT00053352|467819582|FG001|Overall Study|Withdrawal by Subject|0|||
129960637|NCT00053352|467819581|FG000|Overall Study|Ineligible|8|||
129960638|NCT00053352|467819582|FG001|Overall Study|Ineligible|8|||
129960639|NCT00053352|467819581|FG000|Overall Study|Disease at new site|1|||
129960640|NCT00053352|467819582|FG001|Overall Study|Disease at new site|0|||
129960641|NCT00931918|467819583|FG000|Overall Study|Adverse Event|4|||
129960642|NCT00931918|467819584|FG001|Overall Study|Adverse Event|6|||
129960643|NCT00931918|467819583|FG000|Overall Study|Progressive Disease|2|||
129960644|NCT00931918|467819584|FG001|Overall Study|Progressive Disease|1|||
129960645|NCT00931918|467819583|FG000|Overall Study|Symptomatic Deterioration|1|||
129960646|NCT00931918|467819584|FG001|Overall Study|Symptomatic Deterioration|0|||
129960647|NCT00931918|467819583|FG000|Overall Study|Withdrawal by Patient|3|||
129960648|NCT00931918|467819584|FG001|Overall Study|Withdrawal by Patient|4|||
129960649|NCT00931918|467819583|FG000|Overall Study|Other Reason not Specified|4|||
129960650|NCT00931918|467819584|FG001|Overall Study|Other Reason not Specified|4|||
129960651|NCT00931918|467819583|FG000|Overall Study|Did not receive study drug|3|||
129960652|NCT00931918|467819584|FG001|Overall Study|Did not receive study drug|2|||
129960653|NCT00570921|467819585|FG000|Overall Study|Protocol Violation|1|||
129960654|NCT00570921|467819585|FG000|Overall Study|Physician Decision|1|||
129960655|NCT00784277|467819587|FG000|IR Treatment|Adverse Event|4|||
129960656|NCT00784277|467819588|FG001|IR Treatment|Adverse Event|8|||
129960657|NCT00784277|467819589|FG002|IR Treatment|Adverse Event|19|||
129960658|NCT00784277|467819590|FG003|IR Treatment|Adverse Event|35|||
129960659|NCT00784277|467819591|FG004|IR Treatment|Adverse Event|0|||
129960660|NCT00784277|467819592|FG005|IR Treatment|Adverse Event|0|||
129960661|NCT00784277|467819593|FG006|IR Treatment|Adverse Event|0|||
129960662|NCT00784277|467819587|FG000|IR Treatment|Lack of Efficacy|4|||
129960663|NCT00784277|467819588|FG001|IR Treatment|Lack of Efficacy|4|||
129960664|NCT00784277|467819589|FG002|IR Treatment|Lack of Efficacy|1|||
129960665|NCT00784277|467819590|FG003|IR Treatment|Lack of Efficacy|0|||
129960666|NCT00784277|467819591|FG004|IR Treatment|Lack of Efficacy|0|||
129960667|NCT00784277|467819592|FG005|IR Treatment|Lack of Efficacy|0|||
129960668|NCT00784277|467819593|FG006|IR Treatment|Lack of Efficacy|0|||
129960669|NCT00784277|467819587|FG000|IR Treatment|Lost to Follow-up|1|||
129960670|NCT00784277|467819588|FG001|IR Treatment|Lost to Follow-up|0|||
129960671|NCT00784277|467819589|FG002|IR Treatment|Lost to Follow-up|1|||
129960672|NCT00784277|467819590|FG003|IR Treatment|Lost to Follow-up|0|||
129960673|NCT00784277|467819591|FG004|IR Treatment|Lost to Follow-up|0|||
129960674|NCT00784277|467819592|FG005|IR Treatment|Lost to Follow-up|0|||
129960675|NCT00784277|467819593|FG006|IR Treatment|Lost to Follow-up|0|||
129960676|NCT00784277|467819587|FG000|IR Treatment|Withdrawal by Subject|5|||
129960677|NCT00784277|467819588|FG001|IR Treatment|Withdrawal by Subject|1|||
129960678|NCT00784277|467819589|FG002|IR Treatment|Withdrawal by Subject|4|||
129960679|NCT00784277|467819590|FG003|IR Treatment|Withdrawal by Subject|6|||
129960680|NCT00784277|467819591|FG004|IR Treatment|Withdrawal by Subject|0|||
129960681|NCT00784277|467819592|FG005|IR Treatment|Withdrawal by Subject|0|||
129960682|NCT00784277|467819593|FG006|IR Treatment|Withdrawal by Subject|0|||
129960683|NCT00784277|467819587|FG000|IR Treatment|Resolution Of Pain|0|||
129960684|NCT00784277|467819588|FG001|IR Treatment|Resolution Of Pain|1|||
129960685|NCT00784277|467819589|FG002|IR Treatment|Resolution Of Pain|0|||
129960686|NCT00784277|467819590|FG003|IR Treatment|Resolution Of Pain|0|||
129960687|NCT00784277|467819591|FG004|IR Treatment|Resolution Of Pain|0|||
129960688|NCT00784277|467819592|FG005|IR Treatment|Resolution Of Pain|0|||
129454550|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
129960689|NCT00784277|467819593|FG006|IR Treatment|Resolution Of Pain|0|||
129960690|NCT00784277|467819587|FG000|IR Treatment|Other|2|||
129960691|NCT00784277|467819588|FG001|IR Treatment|Other|3|||
129960692|NCT00784277|467819589|FG002|IR Treatment|Other|3|||
129960693|NCT00784277|467819590|FG003|IR Treatment|Other|2|||
129960694|NCT00784277|467819591|FG004|IR Treatment|Other|0|||
129960695|NCT00784277|467819592|FG005|IR Treatment|Other|0|||
129960696|NCT00784277|467819593|FG006|IR Treatment|Other|0|||
129960697|NCT00784277|467819587|FG000|ER Treatment|Adverse Event|0|||
129960698|NCT00784277|467819588|FG001|ER Treatment|Adverse Event|0|||
129960699|NCT00784277|467819589|FG002|ER Treatment|Adverse Event|0|||
129960700|NCT00784277|467819590|FG003|ER Treatment|Adverse Event|0|||
129960701|NCT00784277|467819591|FG004|ER Treatment|Adverse Event|1|||
129960702|NCT00784277|467819592|FG005|ER Treatment|Adverse Event|7|||
129960703|NCT00784277|467819593|FG006|ER Treatment|Adverse Event|7|||
129960704|NCT00784277|467819587|FG000|ER Treatment|Lack of Efficacy|0|||
129960705|NCT00784277|467819588|FG001|ER Treatment|Lack of Efficacy|0|||
129960706|NCT00784277|467819589|FG002|ER Treatment|Lack of Efficacy|0|||
129960707|NCT00784277|467819590|FG003|ER Treatment|Lack of Efficacy|0|||
129960708|NCT00784277|467819591|FG004|ER Treatment|Lack of Efficacy|3|||
129960709|NCT00784277|467819592|FG005|ER Treatment|Lack of Efficacy|4|||
129960710|NCT00784277|467819593|FG006|ER Treatment|Lack of Efficacy|0|||
129960711|NCT00784277|467819587|FG000|ER Treatment|Lost to Follow-up|0|||
129960712|NCT00784277|467819588|FG001|ER Treatment|Lost to Follow-up|0|||
129960713|NCT00784277|467819589|FG002|ER Treatment|Lost to Follow-up|0|||
129960714|NCT00784277|467819590|FG003|ER Treatment|Lost to Follow-up|0|||
129960715|NCT00784277|467819591|FG004|ER Treatment|Lost to Follow-up|0|||
129960716|NCT00784277|467819592|FG005|ER Treatment|Lost to Follow-up|2|||
129960717|NCT00784277|467819593|FG006|ER Treatment|Lost to Follow-up|0|||
129960718|NCT00784277|467819587|FG000|ER Treatment|Withdrawal by Subject|0|||
129960719|NCT00784277|467819588|FG001|ER Treatment|Withdrawal by Subject|0|||
129960720|NCT00784277|467819589|FG002|ER Treatment|Withdrawal by Subject|0|||
129960721|NCT00784277|467819590|FG003|ER Treatment|Withdrawal by Subject|0|||
129960722|NCT00784277|467819591|FG004|ER Treatment|Withdrawal by Subject|2|||
129960723|NCT00784277|467819592|FG005|ER Treatment|Withdrawal by Subject|5|||
129960724|NCT00784277|467819593|FG006|ER Treatment|Withdrawal by Subject|3|||
129960725|NCT00784277|467819587|FG000|ER Treatment|Study Medication Non-Compliant|0|||
129960726|NCT00784277|467819588|FG001|ER Treatment|Study Medication Non-Compliant|0|||
129960727|NCT00784277|467819589|FG002|ER Treatment|Study Medication Non-Compliant|0|||
129960728|NCT00784277|467819590|FG003|ER Treatment|Study Medication Non-Compliant|0|||
129960729|NCT00784277|467819591|FG004|ER Treatment|Study Medication Non-Compliant|2|||
129960730|NCT00784277|467819592|FG005|ER Treatment|Study Medication Non-Compliant|3|||
129960731|NCT00784277|467819593|FG006|ER Treatment|Study Medication Non-Compliant|3|||
129960732|NCT00784277|467819587|FG000|ER Treatment|Other|0|||
129960733|NCT00784277|467819588|FG001|ER Treatment|Other|0|||
129960734|NCT00784277|467819589|FG002|ER Treatment|Other|0|||
129960735|NCT00784277|467819590|FG003|ER Treatment|Other|0|||
129960736|NCT00784277|467819591|FG004|ER Treatment|Other|1|||
129960737|NCT00784277|467819592|FG005|ER Treatment|Other|3|||
129960738|NCT00784277|467819593|FG006|ER Treatment|Other|2|||
129960739|NCT00588341|467819594|FG000|Overall Study|Withdrawal by Subject|3|||
129960740|NCT00588341|467819594|FG000|Overall Study|Not treated due to metastatic disease|1|||
129960741|NCT00588341|467819594|FG000|Overall Study|Patient ineligible|1|||
129960742|NCT00745121|467819598|FG000|Overall Study|Death|3|||
129960743|NCT00745121|467819599|FG001|Overall Study|Death|0|||
129960744|NCT00745121|467819598|FG000|Overall Study|Adverse Event|1|||
129960745|NCT00745121|467819599|FG001|Overall Study|Adverse Event|0|||
129960746|NCT00745121|467819598|FG000|Overall Study|Lost to Follow-up|1|||
129960747|NCT00745121|467819599|FG001|Overall Study|Lost to Follow-up|0|||
129960748|NCT00745121|467819598|FG000|Overall Study|Withdrawal by Subject|4|||
129960749|NCT00745121|467819599|FG001|Overall Study|Withdrawal by Subject|2|||
129960750|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
129960751|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960752|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960753|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960754|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
129960755|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
129960756|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960757|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960758|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960759|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
129960760|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
129960761|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960762|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960763|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960764|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
129960765|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
129960766|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129960767|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129960768|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129960769|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
129454551|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
129454552|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
129454553|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
129454554|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
129454555|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
129454556|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
129454557|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
129454558|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
129454559|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
129454560|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
129454561|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
129454562|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
129454563|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
129454564|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
129454565|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
129454566|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
129454567|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
129454568|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
129454569|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
129454570|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
129454571|NCT03670953|465962744|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
129454572|NCT03670953|465962745|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
129454573|NCT03670953|465962746|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
129454574|NCT03670953|465962747|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
129454575|NCT03670953|465962744|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
129454576|NCT03670953|465962745|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
129454577|NCT03670953|465962746|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
129454578|NCT03670953|465962747|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
129454579|NCT03670953|465962744|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
129454580|NCT03670953|465962745|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
129454581|NCT03670953|465962746|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
129454582|NCT03670953|465962747|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
129454583|NCT03670953|465962744|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
129454584|NCT03670953|465962745|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
129454585|NCT03670953|465962746|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
129454586|NCT03670953|465962747|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
129454587|NCT03670953|465962744|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
129454588|NCT03670953|465962745|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
129454589|NCT03670953|465962746|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
129454590|NCT03670953|465962747|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
129454591|NCT03670953|465962744|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
129454592|NCT03670953|465962745|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
129454593|NCT03670953|465962746|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
129454594|NCT03670953|465962747|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
129454595|NCT03670953|465962744|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
129454596|NCT03670953|465962745|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
129454597|NCT03670953|465962746|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
129454598|NCT03670953|465962747|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
129960770|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
129960771|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960772|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960773|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960774|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
129960775|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
129960776|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960777|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960778|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960779|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
129960780|NCT01187407|467819600|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
129960781|NCT01187407|467819601|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960782|NCT01187407|467819602|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960783|NCT01187407|467819603|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960784|NCT01187407|467819604|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
129960785|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
129960786|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
129960787|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
129960788|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
129960789|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
129960790|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
129960791|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
129960792|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
129960793|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
129960794|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
129960795|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
129960796|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
129960797|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
129960798|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
129960799|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
129960800|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129960801|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129960802|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
129960803|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
129960804|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
129960805|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
129960806|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
129960807|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
129960808|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
129960809|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
129960810|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
129960811|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
129960812|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
129960813|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
129960814|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
129960815|NCT01187407|467819600|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
129960816|NCT01187407|467819601|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129960817|NCT01187407|467819602|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129960818|NCT01187407|467819603|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
129960819|NCT01187407|467819604|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
129960820|NCT00640042|467819611|FG000|Enrollment|Did not receive study drug|83|||
129960821|NCT01363297|467819622|FG000|Overall Study|Other|0|||
129960822|NCT01363297|467819623|FG001|Overall Study|Other|0|||
129960823|NCT01363297|467819624|FG002|Overall Study|Other|0|||
129960824|NCT01363297|467819625|FG003|Overall Study|Other|0|||
129960825|NCT01363297|467819626|FG004|Overall Study|Other|1|||
129960826|NCT01363297|467819622|FG000|Overall Study|Death|3|||
129960827|NCT01363297|467819623|FG001|Overall Study|Death|6|||
129960828|NCT01363297|467819624|FG002|Overall Study|Death|6|||
129960829|NCT01363297|467819625|FG003|Overall Study|Death|10|||
129960830|NCT01363297|467819626|FG004|Overall Study|Death|30|||
129960831|NCT02515097|467819627|FG000|Overall Study|Lost to Follow-up|4|||
129960832|NCT02515097|467819628|FG001|Overall Study|Lost to Follow-up|2|||
129960833|NCT02515097|467819627|FG000|Overall Study|Withdrawal by Subject|1|||
129960834|NCT02515097|467819628|FG001|Overall Study|Withdrawal by Subject|3|||
129960835|NCT02515097|467819627|FG000|Overall Study|Adverse Event|2|||
129960836|NCT02515097|467819628|FG001|Overall Study|Adverse Event|1|||
129960837|NCT01180790|467819634|FG000|Overall Study|Adverse Event|1|||
129960838|NCT01180790|467819635|FG001|Overall Study|Adverse Event|1|||
129960839|NCT01180790|467819636|FG002|Overall Study|Adverse Event|2|||
129960840|NCT01180790|467819637|FG003|Overall Study|Adverse Event|0|||
129960841|NCT01180790|467819638|FG004|Overall Study|Adverse Event|1|||
129960842|NCT01180790|467819639|FG005|Overall Study|Adverse Event|3|||
129960843|NCT01180790|467819640|FG006|Overall Study|Adverse Event|0|||
129960844|NCT01180790|467819634|FG000|Overall Study|Withdrawal by Subject|3|||
129960845|NCT01180790|467819635|FG001|Overall Study|Withdrawal by Subject|0|||
129960846|NCT01180790|467819636|FG002|Overall Study|Withdrawal by Subject|5|||
129960847|NCT01180790|467819637|FG003|Overall Study|Withdrawal by Subject|0|||
129960848|NCT01180790|467819638|FG004|Overall Study|Withdrawal by Subject|2|||
129960849|NCT01180790|467819639|FG005|Overall Study|Withdrawal by Subject|1|||
129960850|NCT01180790|467819640|FG006|Overall Study|Withdrawal by Subject|0|||
129960851|NCT01180790|467819634|FG000|Overall Study|Lost to Follow-up|3|||
129960852|NCT01180790|467819635|FG001|Overall Study|Lost to Follow-up|1|||
129960853|NCT01180790|467819636|FG002|Overall Study|Lost to Follow-up|0|||
129960854|NCT01180790|467819637|FG003|Overall Study|Lost to Follow-up|2|||
129960855|NCT01180790|467819638|FG004|Overall Study|Lost to Follow-up|1|||
129960856|NCT01180790|467819639|FG005|Overall Study|Lost to Follow-up|0|||
129960857|NCT01180790|467819640|FG006|Overall Study|Lost to Follow-up|1|||
129960858|NCT01180790|467819634|FG000|Overall Study|Physician Decision|1|||
129960859|NCT01180790|467819635|FG001|Overall Study|Physician Decision|0|||
129960860|NCT01180790|467819636|FG002|Overall Study|Physician Decision|0|||
129960861|NCT01180790|467819637|FG003|Overall Study|Physician Decision|1|||
129960862|NCT01180790|467819638|FG004|Overall Study|Physician Decision|0|||
129960863|NCT01180790|467819639|FG005|Overall Study|Physician Decision|0|||
129960864|NCT01180790|467819640|FG006|Overall Study|Physician Decision|0|||
129960865|NCT01180790|467819634|FG000|Overall Study|Lack of Efficacy|1|||
129960866|NCT01180790|467819635|FG001|Overall Study|Lack of Efficacy|2|||
129960867|NCT01180790|467819636|FG002|Overall Study|Lack of Efficacy|5|||
129960868|NCT01180790|467819637|FG003|Overall Study|Lack of Efficacy|6|||
129960869|NCT01180790|467819638|FG004|Overall Study|Lack of Efficacy|1|||
129960870|NCT01180790|467819639|FG005|Overall Study|Lack of Efficacy|3|||
129960871|NCT01180790|467819640|FG006|Overall Study|Lack of Efficacy|0|||
129960872|NCT01180790|467819634|FG000|Overall Study|compliance|0|||
129960873|NCT01180790|467819635|FG001|Overall Study|compliance|1|||
129960874|NCT01180790|467819636|FG002|Overall Study|compliance|0|||
129960875|NCT01180790|467819637|FG003|Overall Study|compliance|0|||
129960876|NCT01180790|467819638|FG004|Overall Study|compliance|0|||
129960877|NCT01180790|467819639|FG005|Overall Study|compliance|0|||
129960878|NCT01180790|467819640|FG006|Overall Study|compliance|0|||
129960879|NCT01180790|467819634|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960880|NCT01180790|467819635|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960881|NCT01180790|467819636|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
129960882|NCT01180790|467819637|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960883|NCT01180790|467819638|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960884|NCT01180790|467819639|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960885|NCT01180790|467819640|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
129960886|NCT01568112|467819643|FG000|Overall Study|Randomized But Not Treated|0|||
129960887|NCT01568112|467819644|FG001|Overall Study|Randomized But Not Treated|1|||
129960888|NCT01568112|467819645|FG002|Overall Study|Randomized But Not Treated|0|||
129960889|NCT01568112|467819646|FG003|Overall Study|Randomized But Not Treated|0|||
129960890|NCT01568112|467819643|FG000|Overall Study|Withdrew due to Adverse Event|2|||
129960891|NCT01568112|467819644|FG001|Overall Study|Withdrew due to Adverse Event|4|||
129960892|NCT01568112|467819645|FG002|Overall Study|Withdrew due to Adverse Event|6|||
129960893|NCT01568112|467819646|FG003|Overall Study|Withdrew due to Adverse Event|3|||
129960894|NCT01568112|467819643|FG000|Overall Study|Lost to Follow-up|0|||
129960895|NCT01568112|467819644|FG001|Overall Study|Lost to Follow-up|0|||
129960896|NCT01568112|467819645|FG002|Overall Study|Lost to Follow-up|0|||
129960897|NCT01568112|467819646|FG003|Overall Study|Lost to Follow-up|1|||
129960898|NCT01568112|467819643|FG000|Overall Study|Withdrawal by Subject|2|||
129960899|NCT01568112|467819644|FG001|Overall Study|Withdrawal by Subject|3|||
129960900|NCT01568112|467819645|FG002|Overall Study|Withdrawal by Subject|0|||
129960901|NCT01568112|467819646|FG003|Overall Study|Withdrawal by Subject|7|||
129960902|NCT01568112|467819643|FG000|Overall Study|Withdrawal by Physician|1|||
129960903|NCT01568112|467819644|FG001|Overall Study|Withdrawal by Physician|0|||
129960904|NCT01568112|467819645|FG002|Overall Study|Withdrawal by Physician|1|||
129960905|NCT01568112|467819646|FG003|Overall Study|Withdrawal by Physician|1|||
129960906|NCT02544113|467821480|FG000|Overall Study|Death|3|||
129960907|NCT02544113|467821481|FG001|Overall Study|Death|4|||
129960908|NCT02847637|467821483|FG000|Overall Study|Withdrawal by Subject|0|||
129960909|NCT02847637|467821484|FG001|Overall Study|Withdrawal by Subject|1|||
129960910|NCT02847637|467821485|FG002|Overall Study|Withdrawal by Subject|1|||
129960911|NCT02847637|467821486|FG003|Overall Study|Withdrawal by Subject|0|||
129960912|NCT02847637|467821483|FG000|Overall Study|Lost to Follow-up|1|||
129960913|NCT02847637|467821484|FG001|Overall Study|Lost to Follow-up|1|||
129960914|NCT02847637|467821485|FG002|Overall Study|Lost to Follow-up|0|||
129960915|NCT02847637|467821486|FG003|Overall Study|Lost to Follow-up|0|||
129960916|NCT01746108|467821489|FG000|Overall Study|Migrated /moved from study area|0|||
129960917|NCT01746108|467821490|FG001|Overall Study|Migrated /moved from study area|1|||
129960918|NCT01746108|467821491|FG002|Overall Study|Migrated /moved from study area|0|||
129960919|NCT01746108|467821489|FG000|Overall Study|Adverse event, non-fatal|0|||
129960920|NCT01746108|467821490|FG001|Overall Study|Adverse event, non-fatal|1|||
129960921|NCT01746108|467821491|FG002|Overall Study|Adverse event, non-fatal|0|||
129960922|NCT01746108|467821489|FG000|Overall Study|Withdrawal by Subject|0|||
129960923|NCT01746108|467821490|FG001|Overall Study|Withdrawal by Subject|1|||
129960924|NCT01746108|467821491|FG002|Overall Study|Withdrawal by Subject|0|||
129960925|NCT01746108|467821489|FG000|Overall Study|Lost to Follow-up|0|||
129960926|NCT01746108|467821490|FG001|Overall Study|Lost to Follow-up|1|||
129960927|NCT01746108|467821491|FG002|Overall Study|Lost to Follow-up|0|||
129960928|NCT01388478|467821497|FG000|Overall Study|Adverse Event|4|||
129960929|NCT01388478|467821497|FG000|Overall Study|Withdrawal by Subject|1|||
129960930|NCT01990664|467821498|FG000|Overall Study|Lost to Follow-up|2|||
129960931|NCT01990664|467821499|FG001|Overall Study|Lost to Follow-up|6|||
129960932|NCT01990664|467821498|FG000|Overall Study|Withdrawal by Subject|2|||
129960933|NCT01990664|467821499|FG001|Overall Study|Withdrawal by Subject|3|||
129454599|NCT04342871|465962748|FG000|Overall Study|Death|4|||
129454600|NCT04342871|465962748|FG000|Overall Study|Clinical deterioration/illness progression|2|||
129454601|NCT04342871|465962748|FG000|Overall Study|Did not complete baseline assessments|5|||
129454602|NCT04342871|465962748|FG000|Overall Study|Lost to Follow-up|13|||
129454603|NCT00666458|465962750|FG000|Overall Study|Adverse Event|8|||
129454604|NCT00666458|465962751|FG001|Overall Study|Adverse Event|7|||
129454605|NCT00666458|465962750|FG000|Overall Study|Withdrawal by Subject|5|||
129454606|NCT00666458|465962751|FG001|Overall Study|Withdrawal by Subject|4|||
129454607|NCT00666458|465962750|FG000|Overall Study|Lost to Follow-up|0|||
129454608|NCT00666458|465962751|FG001|Overall Study|Lost to Follow-up|3|||
129454609|NCT00666458|465962750|FG000|Overall Study|Administrative reason by sponsor|1|||
129454610|NCT00666458|465962751|FG001|Overall Study|Administrative reason by sponsor|1|||
129454611|NCT00666458|465962750|FG000|Overall Study|Incorrect enrollment|7|||
129454612|NCT00666458|465962751|FG001|Overall Study|Incorrect enrollment|1|||
129454613|NCT00666458|465962750|FG000|Overall Study|Study specific discontinuation criteria|14|||
129454614|NCT00666458|465962751|FG001|Overall Study|Study specific discontinuation criteria|7|||
129454615|NCT00666458|465962750|FG000|Overall Study|Severe non-compliance to the protocol|1|||
129454616|NCT00666458|465962751|FG001|Overall Study|Severe non-compliance to the protocol|1|||
129454617|NCT00666458|465962750|FG000|Overall Study|Safety reasons|1|||
129454618|NCT00666458|465962751|FG001|Overall Study|Safety reasons|0|||
129454619|NCT00666458|465962750|FG000|Overall Study|Medical history of anemia|1|||
129454620|NCT00666458|465962751|FG001|Overall Study|Medical history of anemia|0|||
129454621|NCT02222207|465962752|FG000|Overall Study|Death|1|||
129454622|NCT02222207|465962752|FG000|Overall Study|Other reasons|2|||
129454623|NCT02222207|465962752|FG000|Overall Study|Adverse Event|1|||
129454624|NCT02982954|465962753|FG000|Overall Study|Death|55|||
129454625|NCT02982954|465962754|FG001|Overall Study|Death|29|||
129454626|NCT02982954|465962755|FG002|Overall Study|Death|15|||
129454627|NCT02982954|465962756|FG003|Overall Study|Death|20|||
129454628|NCT02982954|465962753|FG000|Overall Study|Lost to Follow-up|2|||
129454629|NCT02982954|465962754|FG001|Overall Study|Lost to Follow-up|1|||
129454630|NCT02982954|465962755|FG002|Overall Study|Lost to Follow-up|0|||
129454631|NCT02982954|465962756|FG003|Overall Study|Lost to Follow-up|0|||
129454632|NCT02982954|465962753|FG000|Overall Study|Participant withdrew consent|7|||
129454633|NCT02982954|465962754|FG001|Overall Study|Participant withdrew consent|5|||
129454634|NCT02982954|465962755|FG002|Overall Study|Participant withdrew consent|1|||
129454635|NCT02982954|465962756|FG003|Overall Study|Participant withdrew consent|1|||
129454636|NCT02982954|465962753|FG000|Overall Study|Other reasons|42|||
129454637|NCT02982954|465962754|FG001|Overall Study|Other reasons|17|||
129454638|NCT02982954|465962755|FG002|Overall Study|Other reasons|12|||
129454639|NCT02982954|465962756|FG003|Overall Study|Other reasons|3|||
129454640|NCT02982954|465962753|FG000|Overall Study|Premature site closure|0|||
129454641|NCT02982954|465962754|FG001|Overall Study|Premature site closure|0|||
129454642|NCT02982954|465962755|FG002|Overall Study|Premature site closure|0|||
129454643|NCT02982954|465962756|FG003|Overall Study|Premature site closure|1|||
129454644|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
129454645|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
129454646|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
129454647|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
129454648|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
129454649|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
129454650|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Death|2|||
129454651|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Death|0|||
129454652|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
129960934|NCT01990664|467821498|FG000|Overall Study|Protocol Violation|1|||
129960935|NCT01990664|467821499|FG001|Overall Study|Protocol Violation|0|||
129960936|NCT01990664|467821498|FG000|Overall Study|Lens Discomfort|1|||
129960937|NCT01990664|467821499|FG001|Overall Study|Lens Discomfort|1|||
129960938|NCT01990664|467821498|FG000|Overall Study|Lens Handling Difficulties|1|||
129454653|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
129454654|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
129454655|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
129454656|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
129454657|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
129454658|NCT02603120|465962757|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
129454659|NCT02603120|465962758|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
129454660|NCT02603120|465962757|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
129454661|NCT02603120|465962758|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
129454662|NCT02603120|465962757|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
129960939|NCT01990664|467821499|FG001|Overall Study|Lens Handling Difficulties|0|||
129960940|NCT01990664|467821498|FG000|Overall Study|Unsatisfactory Visual Response|0|||
129960941|NCT01990664|467821499|FG001|Overall Study|Unsatisfactory Visual Response|1|||
129960942|NCT02246218|467821500|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129960943|NCT02246218|467821501|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129454663|NCT02603120|465962758|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
129454664|NCT02603120|465962757|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
129454665|NCT02603120|465962758|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
129960944|NCT02246218|467821500|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
129960945|NCT02246218|467821501|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
129960946|NCT02246218|467821500|FG000|Overall Study|Adverse Event|1|||
129960947|NCT02246218|467821501|FG001|Overall Study|Adverse Event|1|||
129960948|NCT02246218|467821500|FG000|Overall Study|Lost to Follow-up|1|||
129960949|NCT02246218|467821501|FG001|Overall Study|Lost to Follow-up|0|||
129960950|NCT03891641|467821502|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
129960951|NCT03891641|467821503|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
129960952|NCT01093222|467821504|FG000|Overall Study|Ineligible|6|||
129960953|NCT01093222|467821504|FG000|Overall Study|Adverse Event|7|||
129960954|NCT01093222|467821504|FG000|Overall Study|Progression/relapse|24|||
129960955|NCT01093222|467821504|FG000|Overall Study|Death|2|||
129960956|NCT01093222|467821504|FG000|Overall Study|Not protocol specified|1|||
129960957|NCT02025985|467821507|FG000|Overall Study|Consent withdrawn|0|||
129960958|NCT02025985|467821508|FG001|Overall Study|Consent withdrawn|0|||
129960959|NCT02025985|467821509|FG002|Overall Study|Consent withdrawn|1|||
129960960|NCT02025985|467821510|FG003|Overall Study|Consent withdrawn|0|||
129960961|NCT02025985|467821511|FG004|Overall Study|Consent withdrawn|0|||
129960962|NCT02025985|467821507|FG000|Overall Study|Termination of study by Sponsor|4|||
129960963|NCT02025985|467821508|FG001|Overall Study|Termination of study by Sponsor|3|||
129960964|NCT02025985|467821509|FG002|Overall Study|Termination of study by Sponsor|1|||
129960965|NCT02025985|467821510|FG003|Overall Study|Termination of study by Sponsor|1|||
129960966|NCT02025985|467821511|FG004|Overall Study|Termination of study by Sponsor|3|||
129960967|NCT02025985|467821507|FG000|Overall Study|Death|21|||
129960968|NCT02025985|467821508|FG001|Overall Study|Death|20|||
129960969|NCT02025985|467821509|FG002|Overall Study|Death|23|||
129960970|NCT02025985|467821510|FG003|Overall Study|Death|20|||
129960971|NCT02025985|467821511|FG004|Overall Study|Death|17|||
129960972|NCT03723915|467821523|FG000|Screening|Failed to meet screening requirements.|2|||
129960973|NCT03723915|467821523|FG000|On Treatment|Failed to meet treatment requirements|2|||
129960974|NCT01713998|467821525|FG000|Overall Study|Lost to Follow-up|2|||
129960975|NCT01713998|467821526|FG001|Overall Study|Lost to Follow-up|0|||
129960976|NCT01713998|467821527|FG002|Overall Study|Lost to Follow-up|2|||
129960977|NCT01713998|467821525|FG000|Overall Study|Withdrawal by Subject|1|||
129960978|NCT01713998|467821526|FG001|Overall Study|Withdrawal by Subject|0|||
129960979|NCT01713998|467821527|FG002|Overall Study|Withdrawal by Subject|0|||
129960980|NCT02101268|467821528|FG000|Randomized Treatment Phase|Subject Decision|8|||
129960981|NCT02101268|467821529|FG001|Randomized Treatment Phase|Subject Decision|4|||
129960982|NCT02101268|467821530|FG002|Randomized Treatment Phase|Subject Decision|0|||
129960983|NCT02101268|467821531|FG003|Randomized Treatment Phase|Subject Decision|0|||
129960984|NCT02101268|467821528|FG000|Randomized Treatment Phase|Physician Decision|4|||
129960985|NCT02101268|467821529|FG001|Randomized Treatment Phase|Physician Decision|1|||
129960986|NCT02101268|467821530|FG002|Randomized Treatment Phase|Physician Decision|0|||
129960987|NCT02101268|467821531|FG003|Randomized Treatment Phase|Physician Decision|0|||
129960988|NCT02101268|467821528|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
129960989|NCT02101268|467821529|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
129960990|NCT02101268|467821530|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
129960991|NCT02101268|467821531|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
129960992|NCT02101268|467821528|FG000|Randomized Treatment Phase|Adverse Event|6|||
129960993|NCT02101268|467821529|FG001|Randomized Treatment Phase|Adverse Event|0|||
129960994|NCT02101268|467821530|FG002|Randomized Treatment Phase|Adverse Event|0|||
129960995|NCT02101268|467821531|FG003|Randomized Treatment Phase|Adverse Event|0|||
129960996|NCT02101268|467821528|FG000|Randomized Treatment Phase|Death|5|||
129960997|NCT02101268|467821529|FG001|Randomized Treatment Phase|Death|4|||
129960998|NCT02101268|467821530|FG002|Randomized Treatment Phase|Death|0|||
129960999|NCT02101268|467821531|FG003|Randomized Treatment Phase|Death|0|||
129961000|NCT02101268|467821528|FG000|Randomized Treatment Phase|Disease Progression|4|||
129961001|NCT02101268|467821529|FG001|Randomized Treatment Phase|Disease Progression|1|||
129961002|NCT02101268|467821530|FG002|Randomized Treatment Phase|Disease Progression|0|||
129961003|NCT02101268|467821531|FG003|Randomized Treatment Phase|Disease Progression|0|||
129961004|NCT02101268|467821528|FG000|Extended Treatment Phase|Subject Decision|0|||
129961005|NCT02101268|467821529|FG001|Extended Treatment Phase|Subject Decision|0|||
129961006|NCT02101268|467821530|FG002|Extended Treatment Phase|Subject Decision|3|||
129961007|NCT02101268|467821531|FG003|Extended Treatment Phase|Subject Decision|2|||
129961008|NCT02101268|467821528|FG000|Extended Treatment Phase|Physician Decision|0|||
129961009|NCT02101268|467821529|FG001|Extended Treatment Phase|Physician Decision|0|||
129961010|NCT02101268|467821530|FG002|Extended Treatment Phase|Physician Decision|5|||
129961011|NCT02101268|467821531|FG003|Extended Treatment Phase|Physician Decision|2|||
129961012|NCT02101268|467821528|FG000|Extended Treatment Phase|Adverse Event|0|||
129961013|NCT02101268|467821529|FG001|Extended Treatment Phase|Adverse Event|0|||
129961014|NCT02101268|467821530|FG002|Extended Treatment Phase|Adverse Event|14|||
129961015|NCT02101268|467821531|FG003|Extended Treatment Phase|Adverse Event|18|||
129961016|NCT02101268|467821528|FG000|Extended Treatment Phase|Death|0|||
129961017|NCT02101268|467821529|FG001|Extended Treatment Phase|Death|0|||
129961018|NCT02101268|467821530|FG002|Extended Treatment Phase|Death|5|||
129454666|NCT02603120|465962757|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
129454667|NCT02603120|465962758|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
129454668|NCT02603120|465962757|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
129454669|NCT02603120|465962758|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
129454670|NCT02603120|465962757|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
129454671|NCT02603120|465962758|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
129961019|NCT02101268|467821531|FG003|Extended Treatment Phase|Death|1|||
129961020|NCT02101268|467821528|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
129961021|NCT02101268|467821529|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
129961022|NCT02101268|467821530|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
129961023|NCT02101268|467821531|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
129961024|NCT02101268|467821528|FG000|Extended Treatment Phase|Disease Progression|0|||
129961025|NCT02101268|467821529|FG001|Extended Treatment Phase|Disease Progression|0|||
129961026|NCT02101268|467821530|FG002|Extended Treatment Phase|Disease Progression|13|||
129961027|NCT02101268|467821531|FG003|Extended Treatment Phase|Disease Progression|6|||
129961028|NCT02101268|467821528|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
129961029|NCT02101268|467821529|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
129961030|NCT02101268|467821530|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
129961031|NCT02101268|467821531|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
129961032|NCT00740870|467821532|FG000|Overall Study|Not Catheterized|4|||
129961033|NCT00740870|467821532|FG000|Overall Study|Further testing contraindicated implant|17|||
129454672|NCT00176605|465962761|FG000|Overall Study|Withdrawal by Subject|2|||
129454673|NCT01321710|465962762|FG000|Overall Study|Lost to Follow-up|4|||
129454674|NCT01321710|465962763|FG001|Overall Study|Lost to Follow-up|5|||
129454675|NCT01321710|465962764|FG002|Overall Study|Lost to Follow-up|0|||
129454676|NCT01227187|465962765|FG000|Overall Study|Physician Decision|0|||
129454677|NCT01227187|465962766|FG001|Overall Study|Physician Decision|0|||
129454678|NCT01227187|465962767|FG002|Overall Study|Physician Decision|0|||
129454679|NCT01227187|465962768|FG003|Overall Study|Physician Decision|1|||
129454680|NCT03577730|465962770|FG000|Overall Study|Physician Decision|3|||
129454681|NCT03577730|465962771|FG001|Overall Study|Physician Decision|1|||
129454682|NCT03577730|465962770|FG000|Overall Study|Did not receive allocated intervention|1|||
129454683|NCT03577730|465962771|FG001|Overall Study|Did not receive allocated intervention|0|||
129454684|NCT01911442|465962772|FG000|Overall Study|Adverse Event|2|||
129454685|NCT01911442|465962773|FG001|Overall Study|Adverse Event|2|||
129454686|NCT01911442|465962774|FG002|Overall Study|Adverse Event|4|||
129454687|NCT01911442|465962772|FG000|Overall Study|Lack of Efficacy|1|||
129454688|NCT01911442|465962773|FG001|Overall Study|Lack of Efficacy|1|||
129454689|NCT01911442|465962774|FG002|Overall Study|Lack of Efficacy|1|||
129454690|NCT01911442|465962772|FG000|Overall Study|Lost to Follow-up|2|||
129454691|NCT01911442|465962773|FG001|Overall Study|Lost to Follow-up|0|||
129454692|NCT01911442|465962774|FG002|Overall Study|Lost to Follow-up|1|||
129454693|NCT01911442|465962772|FG000|Overall Study|Withdrawal by Subject|1|||
129454694|NCT01911442|465962773|FG001|Overall Study|Withdrawal by Subject|0|||
129454695|NCT01911442|465962774|FG002|Overall Study|Withdrawal by Subject|6|||
129454696|NCT01911442|465962772|FG000|Overall Study|Mother's Work Schedule|0|||
129454697|NCT01911442|465962773|FG001|Overall Study|Mother's Work Schedule|1|||
129454698|NCT01911442|465962774|FG002|Overall Study|Mother's Work Schedule|0|||
129454699|NCT00122681|465962778|FG000|Overall Study|Adverse Event|20|||
129454700|NCT00122681|465962779|FG001|Overall Study|Adverse Event|16|||
129454701|NCT00122681|465962778|FG000|Overall Study|Lost to Follow-up|1080|||
129454702|NCT00122681|465962779|FG001|Overall Study|Lost to Follow-up|1097|||
129454703|NCT00122681|465962778|FG000|Overall Study|Protocol Violation|7|||
129454704|NCT00122681|465962779|FG001|Overall Study|Protocol Violation|10|||
129454705|NCT00122681|465962778|FG000|Overall Study|Withdrawal by Subject|257|||
129454706|NCT00122681|465962779|FG001|Overall Study|Withdrawal by Subject|251|||
129454707|NCT00122681|465962778|FG000|Overall Study|Personal reasons|150|||
129454708|NCT00122681|465962779|FG001|Overall Study|Personal reasons|147|||
129454709|NCT02004262|465962788|FG000|Overall Study|Death|67|||
129454710|NCT02004262|465962789|FG001|Overall Study|Death|64|||
129454711|NCT02004262|465962790|FG002|Overall Study|Death|66|||
129454712|NCT02004262|465962791|FG003|Overall Study|Death|28|||
129454713|NCT02004262|465962792|FG004|Overall Study|Death|29|||
129454714|NCT02004262|465962793|FG005|Overall Study|Death|22|||
129454715|NCT02004262|465962788|FG000|Overall Study|Withdrawal by Subject|1|||
129454716|NCT02004262|465962789|FG001|Overall Study|Withdrawal by Subject|0|||
129454717|NCT02004262|465962790|FG002|Overall Study|Withdrawal by Subject|4|||
129454718|NCT02004262|465962791|FG003|Overall Study|Withdrawal by Subject|0|||
129454719|NCT02004262|465962792|FG004|Overall Study|Withdrawal by Subject|1|||
129454720|NCT02004262|465962793|FG005|Overall Study|Withdrawal by Subject|3|||
129454721|NCT02004262|465962788|FG000|Overall Study|Lost to Follow-up|1|||
129454722|NCT02004262|465962789|FG001|Overall Study|Lost to Follow-up|1|||
129454723|NCT02004262|465962790|FG002|Overall Study|Lost to Follow-up|0|||
129454724|NCT02004262|465962791|FG003|Overall Study|Lost to Follow-up|0|||
129454725|NCT02004262|465962792|FG004|Overall Study|Lost to Follow-up|0|||
129454726|NCT02004262|465962793|FG005|Overall Study|Lost to Follow-up|0|||
129454727|NCT02004262|465962788|FG000|Overall Study|Study Terminated by Sponsor|4|||
129454728|NCT02004262|465962789|FG001|Overall Study|Study Terminated by Sponsor|3|||
129454729|NCT02004262|465962790|FG002|Overall Study|Study Terminated by Sponsor|2|||
129454730|NCT02004262|465962791|FG003|Overall Study|Study Terminated by Sponsor|1|||
129454731|NCT02004262|465962792|FG004|Overall Study|Study Terminated by Sponsor|1|||
129454732|NCT02004262|465962793|FG005|Overall Study|Study Terminated by Sponsor|5|||
129454733|NCT01923285|465962794|FG000|Overall Study|Withdrawal by Subject|7|||
129454734|NCT01923285|465962795|FG001|Overall Study|Withdrawal by Subject|6|||
129454735|NCT03200366|465962799|FG000|Patient Navigation Intervention Given|Death|0|||
129454736|NCT03200366|465962800|FG001|Patient Navigation Intervention Given|Death|2|||
129454737|NCT03200366|465962801|FG002|Patient Navigation Intervention Given|Death|0|||
129454738|NCT03200366|465962799|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
129454739|NCT03200366|465962800|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
129454740|NCT03200366|465962801|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
129454741|NCT03200366|465962799|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
129454742|NCT03200366|465962800|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
129454743|NCT03200366|465962801|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
129454744|NCT03200366|465962799|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
129454745|NCT03200366|465962800|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
129454746|NCT03200366|465962801|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
129454747|NCT03200366|465962799|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
129454748|NCT03200366|465962800|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
129454749|NCT03200366|465962801|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
129454750|NCT03200366|465962799|FG000|6 Month Post-Baseline Interview|Death|1|||
129454751|NCT03200366|465962800|FG001|6 Month Post-Baseline Interview|Death|1|||
129454752|NCT03200366|465962801|FG002|6 Month Post-Baseline Interview|Death|1|||
129454753|NCT03200366|465962799|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
129454754|NCT03200366|465962800|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
129454755|NCT03200366|465962801|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
129961034|NCT00607997|467821533|FG000|Overall Study|Lack of Efficacy|6|||
129961035|NCT00607997|467821534|FG001|Overall Study|Lack of Efficacy|20|||
129961036|NCT00607997|467821535|FG002|Overall Study|Lack of Efficacy|14|||
129961037|NCT00607997|467821536|FG003|Overall Study|Lack of Efficacy|10|||
129961038|NCT00607997|467821533|FG000|Overall Study|Death|8|||
129961039|NCT00607997|467821534|FG001|Overall Study|Death|5|||
129961040|NCT00607997|467821535|FG002|Overall Study|Death|2|||
129961041|NCT00607997|467821536|FG003|Overall Study|Death|5|||
129961042|NCT00607997|467821533|FG000|Overall Study|Adverse Event|3|||
129961043|NCT00607997|467821534|FG001|Overall Study|Adverse Event|1|||
129961044|NCT00607997|467821535|FG002|Overall Study|Adverse Event|2|||
129961045|NCT00607997|467821536|FG003|Overall Study|Adverse Event|0|||
129961046|NCT00607997|467821533|FG000|Overall Study|Physician Decision|4|||
129961047|NCT00607997|467821534|FG001|Overall Study|Physician Decision|1|||
129961048|NCT00607997|467821535|FG002|Overall Study|Physician Decision|0|||
129961049|NCT00607997|467821536|FG003|Overall Study|Physician Decision|0|||
129961050|NCT00607997|467821533|FG000|Overall Study|Relapse, recurrent illness|4|||
129961051|NCT00607997|467821534|FG001|Overall Study|Relapse, recurrent illness|0|||
129961052|NCT00607997|467821535|FG002|Overall Study|Relapse, recurrent illness|2|||
129961053|NCT00607997|467821536|FG003|Overall Study|Relapse, recurrent illness|0|||
129961054|NCT00607997|467821533|FG000|Overall Study|Other without explanation|2|||
129961055|NCT00607997|467821534|FG001|Overall Study|Other without explanation|0|||
129961056|NCT00607997|467821535|FG002|Overall Study|Other without explanation|4|||
129961057|NCT00607997|467821536|FG003|Overall Study|Other without explanation|1|||
129961058|NCT00839332|467821537|FG000|Phase 1|Disease Progression|38|||
129961059|NCT00839332|467821538|FG001|Phase 1|Disease Progression|0|||
129961060|NCT00839332|467821539|FG002|Phase 1|Disease Progression|0|||
129961061|NCT00839332|467821537|FG000|Phase 1|Adverse Event|6|||
129961062|NCT00839332|467821538|FG001|Phase 1|Adverse Event|0|||
129961063|NCT00839332|467821539|FG002|Phase 1|Adverse Event|0|||
129961064|NCT00839332|467821537|FG000|Phase 1|Withdrawal by Subject|4|||
129961065|NCT00839332|467821538|FG001|Phase 1|Withdrawal by Subject|0|||
129961066|NCT00839332|467821539|FG002|Phase 1|Withdrawal by Subject|0|||
129961067|NCT00839332|467821537|FG000|Phase 1|Physician Decision|2|||
129961068|NCT00839332|467821538|FG001|Phase 1|Physician Decision|0|||
129961069|NCT00839332|467821539|FG002|Phase 1|Physician Decision|0|||
129961070|NCT00839332|467821537|FG000|Phase 2|Protocol Violation|0|||
129961071|NCT00839332|467821538|FG001|Phase 2|Protocol Violation|1|||
129961072|NCT00839332|467821539|FG002|Phase 2|Protocol Violation|0|||
129961073|NCT00839332|467821537|FG000|Phase 2|Disease Progression|0|||
129961074|NCT00839332|467821538|FG001|Phase 2|Disease Progression|46|||
129961075|NCT00839332|467821539|FG002|Phase 2|Disease Progression|21|||
129961076|NCT00839332|467821537|FG000|Phase 2|Adverse Event|0|||
129961077|NCT00839332|467821538|FG001|Phase 2|Adverse Event|8|||
129961078|NCT00839332|467821539|FG002|Phase 2|Adverse Event|6|||
129961079|NCT00839332|467821537|FG000|Phase 2|Death|0|||
129961080|NCT00839332|467821538|FG001|Phase 2|Death|4|||
129961081|NCT00839332|467821539|FG002|Phase 2|Death|2|||
129961082|NCT00839332|467821537|FG000|Phase 2|Withdrawal by Subject|0|||
129961083|NCT00839332|467821538|FG001|Phase 2|Withdrawal by Subject|5|||
129961084|NCT00839332|467821539|FG002|Phase 2|Withdrawal by Subject|8|||
129961085|NCT00839332|467821537|FG000|Phase 2|Physician Decision|0|||
129961086|NCT00839332|467821538|FG001|Phase 2|Physician Decision|4|||
129961087|NCT00839332|467821539|FG002|Phase 2|Physician Decision|1|||
129961088|NCT00839332|467821537|FG000|Phase 2|Lost to Follow-up|0|||
129961089|NCT00839332|467821538|FG001|Phase 2|Lost to Follow-up|0|||
129961090|NCT00839332|467821539|FG002|Phase 2|Lost to Follow-up|1|||
129961091|NCT01200485|467821540|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
129961092|NCT01200485|467821541|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
129961093|NCT01200485|467821542|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
129961094|NCT01200485|467821540|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
129961095|NCT01200485|467821541|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
129961096|NCT01200485|467821542|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
129961097|NCT06080438|467821543|FG000|Overall Study|Lost to Follow-up|2|||
129961098|NCT03589300|467821544|FG000|Overall Study|Adverse Event|2|||
129961099|NCT03589300|467821544|FG000|Overall Study|Death|4|||
129961100|NCT03589300|467821544|FG000|Overall Study|Lost to Follow-up|12|||
129961101|NCT03589300|467821544|FG000|Overall Study|Withdrawal by Subject|5|||
129961102|NCT01678898|467821547|FG000|PB-102-F01|Adverse Event|0|||
129961103|NCT01678898|467821548|FG001|PB-102-F01|Adverse Event|1|||
129961104|NCT01678898|467821549|FG002|PB-102-F01|Adverse Event|0|||
129961105|NCT01678898|467821547|FG000|PB-102-F01|Physician Decision|0|||
129961106|NCT01678898|467821548|FG001|PB-102-F01|Physician Decision|1|||
129961107|NCT01678898|467821549|FG002|PB-102-F01|Physician Decision|0|||
129961108|NCT02864342|467821551|FG000|Overall Study|Eligibility Criteria Deviation|2|||
129961109|NCT02864342|467821552|FG001|Overall Study|Eligibility Criteria Deviation|3|||
129961110|NCT02864342|467821551|FG000|Overall Study|Withdrawal by Subject|4|||
129961111|NCT02864342|467821552|FG001|Overall Study|Withdrawal by Subject|2|||
129961112|NCT02864342|467821551|FG000|Overall Study|Device Technology Issue|6|||
129961113|NCT02864342|467821552|FG001|Overall Study|Device Technology Issue|7|||
129961114|NCT02864342|467821551|FG000|Overall Study|Death|0|||
129454756|NCT03200366|465962799|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
129454757|NCT03200366|465962800|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
129454758|NCT03200366|465962801|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
129454759|NCT03200366|465962799|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
129454760|NCT03200366|465962800|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
129454761|NCT03200366|465962801|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
129961115|NCT02864342|467821552|FG001|Overall Study|Death|1|||
129961116|NCT02864342|467821551|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
129961117|NCT02864342|467821552|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
129961118|NCT02864342|467821551|FG000|Overall Study|Lost to Follow-up|1|||
129961119|NCT02864342|467821552|FG001|Overall Study|Lost to Follow-up|5|||
129961120|NCT02864342|467821551|FG000|Overall Study|Lost Device|1|||
129961121|NCT02864342|467821552|FG001|Overall Study|Lost Device|0|||
129961122|NCT02864342|467821551|FG000|Overall Study|Adverse Event|1|||
129961123|NCT02864342|467821552|FG001|Overall Study|Adverse Event|0|||
129961124|NCT00776984|467821553|FG000|Overall Study|Adverse Event|8|||
129961125|NCT00776984|467821554|FG001|Overall Study|Adverse Event|2|||
129961126|NCT00776984|467821553|FG000|Overall Study|Protocol Violation|4|||
129961127|NCT00776984|467821554|FG001|Overall Study|Protocol Violation|2|||
129961128|NCT00776984|467821553|FG000|Overall Study|Lost to Follow-up|2|||
129961129|NCT00776984|467821554|FG001|Overall Study|Lost to Follow-up|0|||
129961130|NCT00776984|467821553|FG000|Overall Study|Withdrawal by Subject|12|||
129961131|NCT00776984|467821554|FG001|Overall Study|Withdrawal by Subject|7|||
129961132|NCT00776984|467821553|FG000|Overall Study|Lack of Efficacy|0|||
129961133|NCT00776984|467821554|FG001|Overall Study|Lack of Efficacy|1|||
129961134|NCT00776984|467821553|FG000|Overall Study|Other|5|||
129961135|NCT00776984|467821554|FG001|Overall Study|Other|9|||
129961136|NCT02573883|467821557|FG000|Six Month Follow Up|Lost to Follow-up|1|||
129961137|NCT02573883|467821558|FG001|Six Month Follow Up|Lost to Follow-up|0|||
129961138|NCT02573883|467821559|FG002|Six Month Follow Up|Lost to Follow-up|0|||
129961139|NCT02573883|467821560|FG003|Six Month Follow Up|Lost to Follow-up|0|||
129961140|NCT02573883|467821557|FG000|One Year Follow Up|Lost to Follow-up|2|||
129961141|NCT02573883|467821558|FG001|One Year Follow Up|Lost to Follow-up|1|||
129961142|NCT02573883|467821559|FG002|One Year Follow Up|Lost to Follow-up|0|||
129961143|NCT02573883|467821560|FG003|One Year Follow Up|Lost to Follow-up|0|||
129961144|NCT01544309|467821561|FG000|Overall Study|Withdrawal by Subject|12|||
129961145|NCT01544309|467821562|FG001|Overall Study|Withdrawal by Subject|7|||
129961146|NCT01544309|467821561|FG000|Overall Study|Protocol Violation|2|||
129961147|NCT01544309|467821562|FG001|Overall Study|Protocol Violation|1|||
129961148|NCT01544309|467821561|FG000|Overall Study|Physician Decision|4|||
129961149|NCT01544309|467821562|FG001|Overall Study|Physician Decision|1|||
129961150|NCT01544309|467821561|FG000|Overall Study|Not performed pre-dose examination|1|||
129961151|NCT01544309|467821562|FG001|Overall Study|Not performed pre-dose examination|2|||
129961152|NCT01544309|467821561|FG000|Overall Study|Administered prohibit prior medication|1|||
129961153|NCT01544309|467821562|FG001|Overall Study|Administered prohibit prior medication|0|||
129961154|NCT00118703|467821563|FG000|Overall Study|Protocol Violation|1|||
129961155|NCT00118703|467821564|FG001|Overall Study|Protocol Violation|0|||
129961156|NCT00118703|467821563|FG000|Overall Study|Adverse Event|1|||
129961157|NCT00118703|467821564|FG001|Overall Study|Adverse Event|1|||
129961158|NCT00118703|467821563|FG000|Overall Study|Participant took two different treatment|0|||
129961159|NCT00118703|467821564|FG001|Overall Study|Participant took two different treatment|1|||
129961160|NCT00118703|467821563|FG000|Overall Study|Withdrawal by Subject|2|||
129961161|NCT00118703|467821564|FG001|Overall Study|Withdrawal by Subject|5|||
129961162|NCT00118703|467821563|FG000|Overall Study|Lost to Follow-up|1|||
129961163|NCT00118703|467821564|FG001|Overall Study|Lost to Follow-up|2|||
129961164|NCT03796208|467821570|FG000|Overall Study|Withdrawal by Subject|3|||
129961165|NCT03796208|467821571|FG001|Overall Study|Withdrawal by Subject|0|||
129961166|NCT03796208|467821570|FG000|Overall Study|Loss of pregnancy|1|||
129961167|NCT03796208|467821571|FG001|Overall Study|Loss of pregnancy|1|||
129961168|NCT03796208|467821570|FG000|Overall Study|Changed prenatal clinics|0|||
129961169|NCT03796208|467821571|FG001|Overall Study|Changed prenatal clinics|5|||
129961170|NCT03796208|467821570|FG000|Overall Study|Lost to Follow-up|20|||
129961171|NCT03796208|467821571|FG001|Overall Study|Lost to Follow-up|16|||
129961172|NCT02725008|467821572|FG000|Overall Study|Lost to Follow-up|7|||
129961173|NCT02725008|467821573|FG001|Overall Study|Lost to Follow-up|9|||
129961174|NCT02725008|467821572|FG000|Overall Study|Withdrawal by Subject|2|||
129961175|NCT02725008|467821573|FG001|Overall Study|Withdrawal by Subject|2|||
129961176|NCT02725008|467821572|FG000|Overall Study|Admitted to hospital|0|||
129961177|NCT02725008|467821573|FG001|Overall Study|Admitted to hospital|1|||
129961178|NCT01560585|467821574|FG000|Overall Study|Physician Decision|3|||
129961179|NCT00519285|467821575|FG000|Overall Study|Adverse Event|127|||
129961180|NCT00519285|467821576|FG001|Overall Study|Adverse Event|266|||
129961181|NCT00519285|467821575|FG000|Overall Study|Disease progression|334|||
129961182|NCT00519285|467821576|FG001|Overall Study|Disease progression|186|||
129961183|NCT00519285|467821575|FG000|Overall Study|Physician Decision|75|||
129961184|NCT00519285|467821576|FG001|Overall Study|Physician Decision|47|||
129961185|NCT00519285|467821575|FG000|Overall Study|Participant's request|53|||
129961186|NCT00519285|467821576|FG001|Overall Study|Participant's request|84|||
129961187|NCT00519285|467821575|FG000|Overall Study|Consent withdrawn|4|||
129961188|NCT00519285|467821576|FG001|Overall Study|Consent withdrawn|5|||
129961189|NCT00519285|467821575|FG000|Overall Study|Poor compliance to protocol|5|||
129961190|NCT00519285|467821576|FG001|Overall Study|Poor compliance to protocol|7|||
129961191|NCT00519285|467821575|FG000|Overall Study|Reason unspecified|5|||
129961192|NCT00519285|467821576|FG001|Overall Study|Reason unspecified|8|||
129961193|NCT00519285|467821575|FG000|Overall Study|Not treated|8|||
129961194|NCT00519285|467821576|FG001|Overall Study|Not treated|7|||
129961195|NCT00519285|467821575|FG000|Overall Study|Treatment ongoing|1|||
129454762|NCT03200366|465962799|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
129454763|NCT03200366|465962800|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
129454764|NCT03200366|465962801|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
129454765|NCT03200366|465962799|FG000|9 Month Post-Baseline Interview|Death|1|||
129454766|NCT03200366|465962800|FG001|9 Month Post-Baseline Interview|Death|1|||
129454767|NCT03200366|465962801|FG002|9 Month Post-Baseline Interview|Death|1|||
129454768|NCT03200366|465962799|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
129454769|NCT03200366|465962800|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
129454770|NCT03200366|465962801|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
129454771|NCT03200366|465962799|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
129454772|NCT03200366|465962800|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
129454773|NCT03200366|465962801|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
129454774|NCT03200366|465962799|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
129454775|NCT03200366|465962800|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
129454776|NCT03200366|465962801|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
129454777|NCT02018822|465962802|FG000|Overall Study|filling replaced by crown|0|||
129454778|NCT02018822|465962803|FG001|Overall Study|filling replaced by crown|1|||
129454779|NCT02018822|465962804|FG002|Overall Study|filling replaced by crown|0|||
129454780|NCT02018822|465962802|FG000|Overall Study|Physician Decision|0|||
129454781|NCT02018822|465962803|FG001|Overall Study|Physician Decision|1|||
129454782|NCT02018822|465962804|FG002|Overall Study|Physician Decision|1|||
129454783|NCT02018822|465962802|FG000|Overall Study|Lost to Follow-up|6|||
129454784|NCT02018822|465962803|FG001|Overall Study|Lost to Follow-up|6|||
129454785|NCT02018822|465962804|FG002|Overall Study|Lost to Follow-up|5|||
129454786|NCT03201458|465962805|FG000|Overall Study|No longer eligible|2|||
129454787|NCT03201458|465962806|FG001|Overall Study|No longer eligible|5|||
129454788|NCT03201458|465962805|FG000|Overall Study|Health event before starting|1|||
129454789|NCT03201458|465962806|FG001|Overall Study|Health event before starting|0|||
129454790|NCT03201458|465962805|FG000|Overall Study|Physician Decision|1|||
129454791|NCT03201458|465962806|FG001|Overall Study|Physician Decision|0|||
129454792|NCT00715026|465962809|FG000|Overall Study|Withdrawal by Subject|5|||
129454793|NCT00715026|465962809|FG000|Overall Study|Lost to Follow-up|3|||
129454794|NCT00715026|465962809|FG000|Overall Study|Protocol Violation|1|||
129454795|NCT00715026|465962809|FG000|Overall Study|Surgery done on non-study consented hip|1|||
129961196|NCT00519285|467821576|FG001|Overall Study|Treatment ongoing|2|||
129454796|NCT00750737|465962810|FG000|Overall Study|Withdrawal by Subject|3|||
129454797|NCT00750737|465962811|FG001|Overall Study|Withdrawal by Subject|3|||
129454798|NCT01389752|465962815|FG000|Study Period 1|Sponsor decision|0|||
129961197|NCT01020747|467821581|FG000|Overall Study|Withdrawal by Subject|1|||
129454799|NCT01389752|465962816|FG001|Study Period 1|Sponsor decision|2|||
129454800|NCT01389752|465962815|FG000|Study Period 2|Sponsor decision|1|||
129454801|NCT01389752|465962816|FG001|Study Period 2|Sponsor decision|0|||
129454802|NCT03975920|465962822|FG000|Overall Study|Lost to Follow-up|1|||
129454803|NCT03975920|465962823|FG001|Overall Study|Lost to Follow-up|2|||
129454804|NCT03975920|465962822|FG000|Overall Study|Protocol Violation|1|||
129454805|NCT03975920|465962823|FG001|Overall Study|Protocol Violation|1|||
129454806|NCT03975920|465962822|FG000|Overall Study|Did not complete survey|2|||
129454807|NCT03975920|465962823|FG001|Overall Study|Did not complete survey|1|||
129454808|NCT04251910|465962824|FG000|Overall Study|Covid 19 lockdown|0|||
129454809|NCT04251910|465962825|FG001|Overall Study|Covid 19 lockdown|5|||
129454810|NCT04251910|465962826|FG002|Overall Study|Covid 19 lockdown|0|||
129454811|NCT04251910|465962827|FG003|Overall Study|Covid 19 lockdown|4|||
129454812|NCT04251910|465962828|FG004|Overall Study|Covid 19 lockdown|0|||
129454813|NCT04251910|465962829|FG005|Overall Study|Covid 19 lockdown|0|||
129454814|NCT04251910|465962824|FG000|Overall Study|Assisted living facility was closed|0|||
129454815|NCT04251910|465962825|FG001|Overall Study|Assisted living facility was closed|0|||
129454816|NCT04251910|465962826|FG002|Overall Study|Assisted living facility was closed|0|||
129454817|NCT04251910|465962827|FG003|Overall Study|Assisted living facility was closed|0|||
129454818|NCT04251910|465962828|FG004|Overall Study|Assisted living facility was closed|1|||
129454819|NCT04251910|465962829|FG005|Overall Study|Assisted living facility was closed|0|||
129454820|NCT00804570|465962832|FG000|Overall Study|Adverse Event|14|||
129454821|NCT00804570|465962833|FG001|Overall Study|Adverse Event|7|||
129454822|NCT00804570|465962832|FG000|Overall Study|Lack of Efficacy|0|||
129454823|NCT00804570|465962833|FG001|Overall Study|Lack of Efficacy|1|||
129454824|NCT00804570|465962832|FG000|Overall Study|Lost to Follow-up|18|||
129454825|NCT00804570|465962833|FG001|Overall Study|Lost to Follow-up|21|||
129454826|NCT00804570|465962832|FG000|Overall Study|Entry criteria not met|5|||
129454827|NCT00804570|465962833|FG001|Overall Study|Entry criteria not met|5|||
129454828|NCT00804570|465962832|FG000|Overall Study|Protocol Violation|12|||
129454829|NCT00804570|465962833|FG001|Overall Study|Protocol Violation|16|||
129454830|NCT00804570|465962832|FG000|Overall Study|Physician Decision|1|||
129454831|NCT00804570|465962833|FG001|Overall Study|Physician Decision|2|||
129454832|NCT00804570|465962832|FG000|Overall Study|Sponsor decision|1|||
129454833|NCT00804570|465962833|FG001|Overall Study|Sponsor decision|4|||
129454834|NCT00804570|465962832|FG000|Overall Study|Withdrawal by Subject|21|||
129454835|NCT00804570|465962833|FG001|Overall Study|Withdrawal by Subject|38|||
129454836|NCT00290342|465962834|FG000|Overall Study|Other|0|||
129454837|NCT00290342|465962835|FG001|Overall Study|Other|1|||
129454838|NCT00290342|465962834|FG000|Overall Study|Withdrawal by Subject|6|||
129454839|NCT00290342|465962835|FG001|Overall Study|Withdrawal by Subject|4|||
129454840|NCT00290342|465962834|FG000|Overall Study|Lost to Follow-up|1|||
129454841|NCT00290342|465962835|FG001|Overall Study|Lost to Follow-up|0|||
129454842|NCT01056510|465962838|FG000|Overall Study|Dropout Before Start of Treatment|1|||
129454843|NCT01056510|465962839|FG001|Overall Study|Dropout Before Start of Treatment|1|||
129454844|NCT01056510|465962838|FG000|Overall Study|Withdrawal by Subject|4|||
129454845|NCT01056510|465962839|FG001|Overall Study|Withdrawal by Subject|2|||
129454846|NCT01056510|465962838|FG000|Overall Study|Death|29|||
129454847|NCT01056510|465962839|FG001|Overall Study|Death|34|||
129454848|NCT01056510|465962838|FG000|Overall Study|Noncompliance|1|||
129454849|NCT01056510|465962839|FG001|Overall Study|Noncompliance|3|||
129454850|NCT01056510|465962838|FG000|Overall Study|Physician Decision|4|||
129454851|NCT01056510|465962839|FG001|Overall Study|Physician Decision|5|||
129454852|NCT01056510|465962838|FG000|Overall Study|Lost to Follow-up|5|||
129454853|NCT01056510|465962839|FG001|Overall Study|Lost to Follow-up|6|||
129454854|NCT01056510|465962838|FG000|Overall Study|Other|10|||
129454855|NCT01056510|465962839|FG001|Overall Study|Other|12|||
129454856|NCT01056510|465962838|FG000|Overall Study|Missing|0|||
129454857|NCT01056510|465962839|FG001|Overall Study|Missing|1|||
129961198|NCT02175745|467821582|FG000|Overall Study|Not Eligible|1|||
129961199|NCT01078584|467821585|FG000|Overall Study|Final Status Unknown|1073|||
129961200|NCT01078584|467821585|FG000|Overall Study|Lost to Follow-up|670|||
129961201|NCT01078584|467821585|FG000|Overall Study|Non-serious Adverse Event|577|||
129961202|NCT01078584|467821585|FG000|Overall Study|Withdrawal of Consent|244|||
129961203|NCT01078584|467821585|FG000|Overall Study|Physician Withdrew from Study|90|||
129961204|NCT01078584|467821585|FG000|Overall Study|Non-compliance|67|||
129961205|NCT01078584|467821585|FG000|Overall Study|Blood Pressure Controlled|49|||
129961206|NCT01078584|467821585|FG000|Overall Study|Physician Switched Medication|26|||
129961207|NCT01078584|467821585|FG000|Overall Study|Physician Discontinued Patient|12|||
129961208|NCT01078584|467821585|FG000|Overall Study|Lack of Efficacy|98|||
129961209|NCT01078584|467821585|FG000|Overall Study|Protocol Violation|75|||
129961210|NCT01078584|467821585|FG000|Overall Study|Serious Adverse Event|27|||
129961211|NCT01078584|467821585|FG000|Overall Study|Multiple Reasons|2|||
129961212|NCT03015181|467821586|FG000|Overall Study|Enrolled, but product never administered|1|||
129961213|NCT03015181|467821587|FG001|Overall Study|Enrolled, but product never administered|0|||
129961214|NCT03015181|467821588|FG002|Overall Study|Enrolled, but product never administered|0|||
129961215|NCT03015181|467821589|FG003|Overall Study|Enrolled, but product never administered|0|||
129961216|NCT03015181|467821590|FG004|Overall Study|Enrolled, but product never administered|0|||
129961217|NCT03015181|467821591|FG005|Overall Study|Enrolled, but product never administered|0|||
129961218|NCT03015181|467821592|FG006|Overall Study|Enrolled, but product never administered|0|||
129961219|NCT03015181|467821586|FG000|Overall Study|Withdrawal by Subject|0|||
129961220|NCT03015181|467821587|FG001|Overall Study|Withdrawal by Subject|0|||
129961221|NCT03015181|467821588|FG002|Overall Study|Withdrawal by Subject|0|||
129961222|NCT03015181|467821589|FG003|Overall Study|Withdrawal by Subject|0|||
129961223|NCT03015181|467821590|FG004|Overall Study|Withdrawal by Subject|0|||
129961224|NCT03015181|467821591|FG005|Overall Study|Withdrawal by Subject|1|||
129961225|NCT03015181|467821592|FG006|Overall Study|Withdrawal by Subject|0|||
129961226|NCT03015181|467821586|FG000|Overall Study|Physician Decision|0|||
129961227|NCT03015181|467821587|FG001|Overall Study|Physician Decision|0|||
129961228|NCT03015181|467821588|FG002|Overall Study|Physician Decision|0|||
129961229|NCT03015181|467821589|FG003|Overall Study|Physician Decision|0|||
129961230|NCT03015181|467821590|FG004|Overall Study|Physician Decision|0|||
129961231|NCT03015181|467821591|FG005|Overall Study|Physician Decision|0|||
129961232|NCT03015181|467821592|FG006|Overall Study|Physician Decision|1|||
129961233|NCT02551692|467821594|FG000|Overall Study|Lost to Follow-up|0|||
129961234|NCT02551692|467821595|FG001|Overall Study|Lost to Follow-up|1|||
129961235|NCT02551692|467821596|FG002|Overall Study|Lost to Follow-up|4|||
129961236|NCT02551692|467821594|FG000|Overall Study|Withdrawal by Subject|1|||
129961237|NCT02551692|467821595|FG001|Overall Study|Withdrawal by Subject|0|||
129961238|NCT02551692|467821596|FG002|Overall Study|Withdrawal by Subject|1|||
129961239|NCT01091519|467821597|FG000|Overall Study|Adverse Event|12|||
129961240|NCT01091519|467821598|FG001|Overall Study|Adverse Event|16|||
129961241|NCT01091519|467821597|FG000|Overall Study|Death|1|||
129961242|NCT01091519|467821598|FG001|Overall Study|Death|0|||
129961243|NCT01091519|467821597|FG000|Overall Study|Lack of Efficacy|16|||
129961244|NCT01091519|467821598|FG001|Overall Study|Lack of Efficacy|19|||
129961245|NCT01091519|467821597|FG000|Overall Study|Lost to Follow-up|14|||
129961246|NCT01091519|467821598|FG001|Overall Study|Lost to Follow-up|24|||
129961247|NCT01091519|467821597|FG000|Overall Study|Withdrawal by Subject|2|||
129961248|NCT01091519|467821598|FG001|Overall Study|Withdrawal by Subject|2|||
129961249|NCT01091519|467821597|FG000|Overall Study|Other|6|||
129961250|NCT01091519|467821598|FG001|Overall Study|Other|8|||
129961251|NCT01091519|467821597|FG000|Overall Study|Randomized not treated|4|||
129961252|NCT01091519|467821598|FG001|Overall Study|Randomized not treated|4|||
129961253|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
129961254|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
129961255|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
129961256|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Other|1|||
129961257|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Other|0|||
129961258|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Other|0|||
129961259|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Physician Decision|3|||
129961260|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Physician Decision|0|||
129961261|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Physician Decision|0|||
129961262|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
129961263|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
129961264|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
129961265|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
129961266|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
129961267|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
129961268|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Adverse Event|18|||
129961269|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Adverse Event|0|||
129961270|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Adverse Event|0|||
129961271|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
129961272|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
129961273|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
129961274|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
129961275|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
129961276|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
129961277|NCT03030599|467821601|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
129961278|NCT03030599|467821602|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
129961279|NCT03030599|467821603|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
129961280|NCT03030599|467821601|FG000|Stable Dose|Protocol deviation|3|||
129961281|NCT03030599|467821602|FG001|Stable Dose|Protocol deviation|0|||
129961282|NCT03030599|467821603|FG002|Stable Dose|Protocol deviation|0|||
129961283|NCT03030599|467821601|FG000|Stable Dose|Adverse Event|1|||
129961284|NCT03030599|467821602|FG001|Stable Dose|Adverse Event|0|||
129961285|NCT03030599|467821603|FG002|Stable Dose|Adverse Event|0|||
129961286|NCT03030599|467821601|FG000|Stable Dose|Lost to Follow-up|1|||
129961287|NCT03030599|467821602|FG001|Stable Dose|Lost to Follow-up|0|||
129961288|NCT03030599|467821603|FG002|Stable Dose|Lost to Follow-up|0|||
129961289|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
129961290|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
129961291|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
129961292|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
129961293|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
129961294|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
129961295|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
129961296|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
129961297|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
129961298|NCT03030599|467821601|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
129961299|NCT03030599|467821602|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
129961300|NCT03030599|467821603|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
129961301|NCT03030599|467821601|FG000|Open-label Extension|Adverse Event|3|||
129961302|NCT03030599|467821602|FG001|Open-label Extension|Adverse Event|0|||
129961303|NCT03030599|467821603|FG002|Open-label Extension|Adverse Event|0|||
129961304|NCT03030599|467821601|FG000|Open-label Extension|Lost to Follow-up|2|||
129961305|NCT03030599|467821602|FG001|Open-label Extension|Lost to Follow-up|0|||
129961306|NCT03030599|467821603|FG002|Open-label Extension|Lost to Follow-up|0|||
129961307|NCT03030599|467821601|FG000|Open-label Extension|Lack of Efficacy|1|||
129961308|NCT03030599|467821602|FG001|Open-label Extension|Lack of Efficacy|0|||
129961309|NCT03030599|467821603|FG002|Open-label Extension|Lack of Efficacy|0|||
129961310|NCT03030599|467821601|FG000|Open-label Extension|Other Reason|1|||
129961311|NCT03030599|467821602|FG001|Open-label Extension|Other Reason|0|||
129961312|NCT03030599|467821603|FG002|Open-label Extension|Other Reason|0|||
129961313|NCT01592383|467821604|FG000|Overall Study|Adverse Event|1|||
129961314|NCT04582864|467821605|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
129961315|NCT04582864|467821605|FG000|Overall Study|Death|1|||
129961316|NCT04167085|467821606|FG000|Baseline|Withdrawal by Subject|2|||
129961317|NCT04167085|467821607|FG001|Baseline|Withdrawal by Subject|1|||
129961318|NCT04167085|467821606|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
129961319|NCT04167085|467821607|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
129961320|NCT02481934|467821611|FG000|Overall Study|Death|2|||
129961321|NCT00942188|467821612|FG000|Overall Study|Adverse Event|0|||
129961322|NCT00942188|467821613|FG001|Overall Study|Adverse Event|3|||
129961323|NCT00942188|467821614|FG002|Overall Study|Adverse Event|2|||
129961324|NCT00942188|467821615|FG003|Overall Study|Adverse Event|0|||
129961325|NCT00942188|467821612|FG000|Overall Study|Lack of Efficacy|0|||
129961326|NCT00942188|467821613|FG001|Overall Study|Lack of Efficacy|0|||
129961327|NCT00942188|467821614|FG002|Overall Study|Lack of Efficacy|0|||
129961328|NCT00942188|467821615|FG003|Overall Study|Lack of Efficacy|1|||
129961329|NCT00942188|467821612|FG000|Overall Study|Protocol Violation|1|||
129961330|NCT00942188|467821613|FG001|Overall Study|Protocol Violation|1|||
129961331|NCT00942188|467821614|FG002|Overall Study|Protocol Violation|0|||
129961332|NCT00942188|467821615|FG003|Overall Study|Protocol Violation|0|||
129961333|NCT00942188|467821612|FG000|Overall Study|Lost to Follow-up|2|||
129961334|NCT00942188|467821613|FG001|Overall Study|Lost to Follow-up|1|||
129961335|NCT00942188|467821614|FG002|Overall Study|Lost to Follow-up|2|||
129961336|NCT00942188|467821615|FG003|Overall Study|Lost to Follow-up|0|||
129961337|NCT00942188|467821612|FG000|Overall Study|Withdrawal by Subject|1|||
129961338|NCT00942188|467821613|FG001|Overall Study|Withdrawal by Subject|3|||
129454858|NCT00243386|465962840|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
129454859|NCT00243386|465962841|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
129961339|NCT00942188|467821614|FG002|Overall Study|Withdrawal by Subject|4|||
129961340|NCT00942188|467821615|FG003|Overall Study|Withdrawal by Subject|2|||
129961341|NCT00942188|467821612|FG000|Overall Study|Physician Decision|0|||
129961342|NCT00942188|467821613|FG001|Overall Study|Physician Decision|0|||
129961343|NCT00942188|467821614|FG002|Overall Study|Physician Decision|1|||
129961344|NCT00942188|467821615|FG003|Overall Study|Physician Decision|0|||
129961345|NCT00942188|467821612|FG000|Overall Study|Sponsor Decision|0|||
129961346|NCT00942188|467821613|FG001|Overall Study|Sponsor Decision|2|||
129961347|NCT00942188|467821614|FG002|Overall Study|Sponsor Decision|0|||
129961348|NCT00942188|467821615|FG003|Overall Study|Sponsor Decision|1|||
129961349|NCT01374971|467821616|FG000|Overall Study|Withdrawal by Subject|1|||
129961350|NCT00560313|467823975|FG000|Overall Study|Adverse Events or Death|2|||
129961351|NCT00560313|467823975|FG000|Overall Study|Withdrawal by Subject|2|||
129961352|NCT00560313|467823975|FG000|Overall Study|Lost to Follow-up|1|||
129961353|NCT00560313|467823975|FG000|Overall Study|Protocol Violation|1|||
129961354|NCT00526097|467823979|FG000|Overall Study|Adverse Event|6|||
129961355|NCT00526097|467823980|FG001|Overall Study|Adverse Event|44|||
129961356|NCT00526097|467823979|FG000|Overall Study|Protocol Violation|4|||
129961357|NCT00526097|467823980|FG001|Overall Study|Protocol Violation|10|||
129961358|NCT00526097|467823979|FG000|Overall Study|Withdrawal by Subject|3|||
129961359|NCT00526097|467823980|FG001|Overall Study|Withdrawal by Subject|1|||
129961360|NCT00526097|467823979|FG000|Overall Study|Other|2|||
129961361|NCT00526097|467823980|FG001|Overall Study|Other|1|||
129961362|NCT00943618|467823981|FG000|Overall Study|Lost to Follow-up|38|||
129961363|NCT00943618|467823982|FG001|Overall Study|Lost to Follow-up|48|||
129961364|NCT00943618|467823983|FG002|Overall Study|Lost to Follow-up|20|||
129961365|NCT00943618|467823981|FG000|Overall Study|Discontinued Medication|17|||
129961366|NCT00943618|467823982|FG001|Overall Study|Discontinued Medication|29|||
129961367|NCT00943618|467823983|FG002|Overall Study|Discontinued Medication|11|||
129961368|NCT03713281|467823993|FG000|Overall Study|Lens handling difficuluties|2|||
129961369|NCT03713281|467823993|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
129961370|NCT05006417|467823996|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
129961371|NCT02158247|467823997|FG000|Overall Study|Invisible vocal cords|5|||
129961372|NCT00875615|467824006|FG000|Overall Study|Withdrawal by Subject|1|||
129961373|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
129961374|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
129961375|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
129961376|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
129961377|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
129961378|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
129961379|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
129961380|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
129961381|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
129961382|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
129961383|NCT01772823|467824007|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
129961384|NCT01772823|467824008|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
129961385|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
129961386|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
129961387|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
129961388|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
129961389|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
129961390|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
129961391|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
129961392|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
129961393|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
129961394|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
129961395|NCT01772823|467824007|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
129961396|NCT01772823|467824008|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
129961397|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
129961398|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
129961399|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
129961400|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
129961401|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
129961402|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
129961403|NCT01772823|467824007|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
129961404|NCT01772823|467824008|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
129961405|NCT00468858|467824013|FG000|Overall Study|Adverse Event|0|||
129961406|NCT00468858|467824014|FG001|Overall Study|Adverse Event|1|||
129961407|NCT00468858|467824015|FG002|Overall Study|Adverse Event|0|||
129961408|NCT00468858|467824013|FG000|Overall Study|Withdrawal by Subject|7|||
129961409|NCT00468858|467824014|FG001|Overall Study|Withdrawal by Subject|4|||
129961410|NCT00468858|467824015|FG002|Overall Study|Withdrawal by Subject|5|||
129961411|NCT00468858|467824013|FG000|Overall Study|Relocation|1|||
129961412|NCT00468858|467824014|FG001|Overall Study|Relocation|3|||
129961413|NCT00468858|467824015|FG002|Overall Study|Relocation|3|||
129961414|NCT00468858|467824013|FG000|Overall Study|Lost to Follow-up|1|||
129961415|NCT00468858|467824014|FG001|Overall Study|Lost to Follow-up|2|||
129961416|NCT00468858|467824015|FG002|Overall Study|Lost to Follow-up|5|||
129961417|NCT00468858|467824013|FG000|Overall Study|Other|0|||
129961418|NCT00468858|467824014|FG001|Overall Study|Other|0|||
129961419|NCT00468858|467824015|FG002|Overall Study|Other|1|||
129961420|NCT02741713|467824019|FG000|Overall Study|Surgery type changed intra-operatively|2|||
129961421|NCT02741713|467824020|FG001|Overall Study|Surgery type changed intra-operatively|1|||
129961422|NCT00809341|467824023|FG000|Overall Study|Physician Decision|0|||
129961423|NCT00809341|467824024|FG001|Overall Study|Physician Decision|1|||
129961424|NCT00550446|467824025|FG000|Up To Week 12|Adverse Event|2|||
129961425|NCT00550446|467824026|FG001|Up To Week 12|Adverse Event|2|||
129961426|NCT00550446|467824027|FG002|Up To Week 12|Adverse Event|0|||
129961427|NCT00550446|467824028|FG003|Up To Week 12|Adverse Event|0|||
129961428|NCT00550446|467824029|FG004|Up To Week 12|Adverse Event|2|||
129961429|NCT00550446|467824030|FG005|Up To Week 12|Adverse Event|2|||
129961430|NCT00550446|467824031|FG006|Up To Week 12|Adverse Event|1|||
129961431|NCT00550446|467824032|FG007|Up To Week 12|Adverse Event|0|||
129961432|NCT00550446|467824033|FG008|Up To Week 12|Adverse Event|0|||
129961433|NCT00550446|467824034|FG009|Up To Week 12|Adverse Event|0|||
129961434|NCT00550446|467824035|FG010|Up To Week 12|Adverse Event|0|||
129961435|NCT00550446|467824025|FG000|Up To Week 12|Lack of Efficacy|3|||
129961436|NCT00550446|467824026|FG001|Up To Week 12|Lack of Efficacy|1|||
129961437|NCT00550446|467824027|FG002|Up To Week 12|Lack of Efficacy|0|||
129961438|NCT00550446|467824028|FG003|Up To Week 12|Lack of Efficacy|1|||
129961439|NCT00550446|467824029|FG004|Up To Week 12|Lack of Efficacy|0|||
129961440|NCT00550446|467824030|FG005|Up To Week 12|Lack of Efficacy|3|||
129961441|NCT00550446|467824031|FG006|Up To Week 12|Lack of Efficacy|3|||
129961442|NCT00550446|467824032|FG007|Up To Week 12|Lack of Efficacy|0|||
129961443|NCT00550446|467824033|FG008|Up To Week 12|Lack of Efficacy|0|||
129961444|NCT00550446|467824034|FG009|Up To Week 12|Lack of Efficacy|0|||
129961445|NCT00550446|467824035|FG010|Up To Week 12|Lack of Efficacy|0|||
129961446|NCT00550446|467824025|FG000|Up To Week 12|Lost to Follow-up|0|||
129961447|NCT00550446|467824026|FG001|Up To Week 12|Lost to Follow-up|1|||
129961448|NCT00550446|467824027|FG002|Up To Week 12|Lost to Follow-up|0|||
129961449|NCT00550446|467824028|FG003|Up To Week 12|Lost to Follow-up|0|||
129961450|NCT00550446|467824029|FG004|Up To Week 12|Lost to Follow-up|1|||
129961451|NCT00550446|467824030|FG005|Up To Week 12|Lost to Follow-up|1|||
129961452|NCT00550446|467824031|FG006|Up To Week 12|Lost to Follow-up|2|||
129961453|NCT00550446|467824032|FG007|Up To Week 12|Lost to Follow-up|0|||
129961454|NCT00550446|467824033|FG008|Up To Week 12|Lost to Follow-up|0|||
129961455|NCT00550446|467824034|FG009|Up To Week 12|Lost to Follow-up|0|||
129961456|NCT00550446|467824035|FG010|Up To Week 12|Lost to Follow-up|0|||
129961457|NCT00550446|467824025|FG000|Up To Week 12|Withdrawal by Subject|2|||
129961458|NCT00550446|467824026|FG001|Up To Week 12|Withdrawal by Subject|0|||
129961459|NCT00550446|467824027|FG002|Up To Week 12|Withdrawal by Subject|3|||
129961460|NCT00550446|467824028|FG003|Up To Week 12|Withdrawal by Subject|2|||
129961461|NCT00550446|467824029|FG004|Up To Week 12|Withdrawal by Subject|0|||
129961462|NCT00550446|467824030|FG005|Up To Week 12|Withdrawal by Subject|1|||
129961463|NCT00550446|467824031|FG006|Up To Week 12|Withdrawal by Subject|3|||
129961464|NCT00550446|467824032|FG007|Up To Week 12|Withdrawal by Subject|0|||
129961465|NCT00550446|467824033|FG008|Up To Week 12|Withdrawal by Subject|0|||
129961466|NCT00550446|467824034|FG009|Up To Week 12|Withdrawal by Subject|0|||
129961467|NCT00550446|467824035|FG010|Up To Week 12|Withdrawal by Subject|0|||
129961468|NCT00550446|467824025|FG000|Up To Week 12|Other|3|||
129961469|NCT00550446|467824026|FG001|Up To Week 12|Other|0|||
129961470|NCT00550446|467824027|FG002|Up To Week 12|Other|0|||
129961471|NCT00550446|467824028|FG003|Up To Week 12|Other|0|||
129961472|NCT00550446|467824029|FG004|Up To Week 12|Other|0|||
129961473|NCT00550446|467824030|FG005|Up To Week 12|Other|1|||
129961474|NCT00550446|467824031|FG006|Up To Week 12|Other|4|||
129961475|NCT00550446|467824032|FG007|Up To Week 12|Other|0|||
129961476|NCT00550446|467824033|FG008|Up To Week 12|Other|0|||
129961477|NCT00550446|467824034|FG009|Up To Week 12|Other|0|||
129961478|NCT00550446|467824035|FG010|Up To Week 12|Other|0|||
129961479|NCT00550446|467824025|FG000|Up To Week 12|Randomized not treated|0|||
129961480|NCT00550446|467824026|FG001|Up To Week 12|Randomized not treated|1|||
129961481|NCT00550446|467824027|FG002|Up To Week 12|Randomized not treated|1|||
129961482|NCT00550446|467824028|FG003|Up To Week 12|Randomized not treated|0|||
129961483|NCT00550446|467824029|FG004|Up To Week 12|Randomized not treated|0|||
129961484|NCT00550446|467824030|FG005|Up To Week 12|Randomized not treated|0|||
129961485|NCT00550446|467824031|FG006|Up To Week 12|Randomized not treated|0|||
129961486|NCT00550446|467824032|FG007|Up To Week 12|Randomized not treated|0|||
129961487|NCT00550446|467824033|FG008|Up To Week 12|Randomized not treated|0|||
129961488|NCT00550446|467824034|FG009|Up To Week 12|Randomized not treated|0|||
129961489|NCT00550446|467824035|FG010|Up To Week 12|Randomized not treated|0|||
129961490|NCT00550446|467824025|FG000|Post Week 12|Adverse Event|2|||
129961491|NCT00550446|467824026|FG001|Post Week 12|Adverse Event|1|||
129961492|NCT00550446|467824027|FG002|Post Week 12|Adverse Event|1|||
129961493|NCT00550446|467824028|FG003|Post Week 12|Adverse Event|1|||
129961494|NCT00550446|467824029|FG004|Post Week 12|Adverse Event|1|||
129961495|NCT00550446|467824030|FG005|Post Week 12|Adverse Event|1|||
129961496|NCT00550446|467824031|FG006|Post Week 12|Adverse Event|0|||
129961497|NCT00550446|467824032|FG007|Post Week 12|Adverse Event|0|||
129961498|NCT00550446|467824033|FG008|Post Week 12|Adverse Event|0|||
129961499|NCT00550446|467824034|FG009|Post Week 12|Adverse Event|4|||
129961500|NCT00550446|467824035|FG010|Post Week 12|Adverse Event|0|||
129961501|NCT00550446|467824025|FG000|Post Week 12|Lack of Efficacy|0|||
129961502|NCT00550446|467824026|FG001|Post Week 12|Lack of Efficacy|0|||
129961503|NCT00550446|467824027|FG002|Post Week 12|Lack of Efficacy|1|||
129961504|NCT00550446|467824028|FG003|Post Week 12|Lack of Efficacy|0|||
129961505|NCT00550446|467824029|FG004|Post Week 12|Lack of Efficacy|0|||
129961506|NCT00550446|467824030|FG005|Post Week 12|Lack of Efficacy|0|||
129961507|NCT00550446|467824031|FG006|Post Week 12|Lack of Efficacy|0|||
129961508|NCT00550446|467824032|FG007|Post Week 12|Lack of Efficacy|1|||
129961509|NCT00550446|467824033|FG008|Post Week 12|Lack of Efficacy|1|||
129961510|NCT00550446|467824034|FG009|Post Week 12|Lack of Efficacy|2|||
129961511|NCT00550446|467824035|FG010|Post Week 12|Lack of Efficacy|1|||
129961512|NCT00550446|467824025|FG000|Post Week 12|Lost to Follow-up|0|||
129961513|NCT00550446|467824026|FG001|Post Week 12|Lost to Follow-up|0|||
129961514|NCT00550446|467824027|FG002|Post Week 12|Lost to Follow-up|1|||
129961515|NCT00550446|467824028|FG003|Post Week 12|Lost to Follow-up|1|||
129961516|NCT00550446|467824029|FG004|Post Week 12|Lost to Follow-up|0|||
129961517|NCT00550446|467824030|FG005|Post Week 12|Lost to Follow-up|0|||
129961518|NCT00550446|467824031|FG006|Post Week 12|Lost to Follow-up|1|||
129961519|NCT00550446|467824032|FG007|Post Week 12|Lost to Follow-up|0|||
129961520|NCT00550446|467824033|FG008|Post Week 12|Lost to Follow-up|0|||
129961521|NCT00550446|467824034|FG009|Post Week 12|Lost to Follow-up|0|||
129961522|NCT00550446|467824035|FG010|Post Week 12|Lost to Follow-up|0|||
129961523|NCT00550446|467824025|FG000|Post Week 12|Withdrawal by Subject|0|||
129961524|NCT00550446|467824026|FG001|Post Week 12|Withdrawal by Subject|0|||
129961525|NCT00550446|467824027|FG002|Post Week 12|Withdrawal by Subject|0|||
129961526|NCT00550446|467824028|FG003|Post Week 12|Withdrawal by Subject|0|||
129961527|NCT00550446|467824029|FG004|Post Week 12|Withdrawal by Subject|1|||
129961528|NCT00550446|467824030|FG005|Post Week 12|Withdrawal by Subject|0|||
129961529|NCT00550446|467824031|FG006|Post Week 12|Withdrawal by Subject|0|||
129961530|NCT00550446|467824032|FG007|Post Week 12|Withdrawal by Subject|0|||
129961531|NCT00550446|467824033|FG008|Post Week 12|Withdrawal by Subject|0|||
129961532|NCT00550446|467824034|FG009|Post Week 12|Withdrawal by Subject|0|||
129961533|NCT00550446|467824035|FG010|Post Week 12|Withdrawal by Subject|0|||
129961534|NCT00550446|467824025|FG000|Post Week 12|Other|1|||
129961535|NCT00550446|467824026|FG001|Post Week 12|Other|1|||
129961536|NCT00550446|467824027|FG002|Post Week 12|Other|0|||
129961537|NCT00550446|467824028|FG003|Post Week 12|Other|1|||
129961538|NCT00550446|467824029|FG004|Post Week 12|Other|0|||
129961539|NCT00550446|467824030|FG005|Post Week 12|Other|0|||
129961540|NCT00550446|467824031|FG006|Post Week 12|Other|1|||
129961541|NCT00550446|467824032|FG007|Post Week 12|Other|0|||
129961542|NCT00550446|467824033|FG008|Post Week 12|Other|1|||
129961543|NCT00550446|467824034|FG009|Post Week 12|Other|1|||
129961544|NCT00550446|467824035|FG010|Post Week 12|Other|0|||
129961545|NCT02716298|467824036|FG000|First Intervention (1 Month)|Lens discomfort|1|||
129961546|NCT02716298|467824037|FG001|First Intervention (1 Month)|Lens discomfort|1|||
129961547|NCT03503162|467824038|FG000|Overall Study|did not meet eligibility|1|||
129961548|NCT04952701|467824039|FG000|Control Lens|Physician Decision|4|||
129961549|NCT04952701|467824039|FG000|Test Lens|Physician Decision|1|||
129961550|NCT01670188|467824042|FG000|Overall Study|Death|0|||
129961551|NCT01670188|467824043|FG001|Overall Study|Death|1|||
129961552|NCT02212301|467824044|FG000|Period 1|Lost to Follow-up|0|||
129961553|NCT02212301|467824045|FG001|Period 1|Lost to Follow-up|1|||
129961554|NCT03927222|467824046|FG000|Overall Study|Progression|3|||
129961555|NCT03927222|467824046|FG000|Overall Study|CMV testing results inconclusive|1|||
129961556|NCT03927222|467824046|FG000|Overall Study|Unable to generate enough vaccines|1|||
129961557|NCT03927222|467824046|FG000|Overall Study|Early study termination|1|||
129961558|NCT00578318|467824051|FG000|Overall Study|Lost to Follow-up|2|||
129961559|NCT00578318|467824052|FG001|Overall Study|Lost to Follow-up|0|||
129961560|NCT00578318|467824051|FG000|Overall Study|Physician Decision|1|||
129961561|NCT00578318|467824052|FG001|Overall Study|Physician Decision|0|||
129961562|NCT00866918|467824053|FG000|Overall Study|Death|1|||
129961563|NCT00866918|467824054|FG001|Overall Study|Death|5|||
129961564|NCT00866918|467824053|FG000|Overall Study|Lack of Efficacy|1|||
129961565|NCT00866918|467824054|FG001|Overall Study|Lack of Efficacy|1|||
129961566|NCT00866918|467824053|FG000|Overall Study|Physician Decision|10|||
129961567|NCT00866918|467824054|FG001|Overall Study|Physician Decision|2|||
129961568|NCT00866918|467824053|FG000|Overall Study|Ineligible|2|||
129961569|NCT00866918|467824054|FG001|Overall Study|Ineligible|4|||
129961570|NCT00866918|467824053|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
129961571|NCT00866918|467824054|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
129961572|NCT00866918|467824053|FG000|Overall Study|Secondary malignancy|1|||
129961573|NCT00866918|467824054|FG001|Overall Study|Secondary malignancy|0|||
129961574|NCT00527514|467824056|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
129961575|NCT00527514|467824056|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
129961576|NCT00527514|467824056|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
129961577|NCT00527514|467824056|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
129961578|NCT00527514|467824056|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
129961579|NCT00527514|467824056|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
129961580|NCT00527514|467824056|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
129961581|NCT00001941|467824063|FG000|Overall Study|not treated- rapidly progressing disease|0|||
129961582|NCT00001941|467824064|FG001|Overall Study|not treated- rapidly progressing disease|0|||
129961583|NCT00001941|467824065|FG002|Overall Study|not treated- rapidly progressing disease|0|||
129961584|NCT00001941|467824066|FG003|Overall Study|not treated- rapidly progressing disease|0|||
129961585|NCT00001941|467824067|FG004|Overall Study|not treated- rapidly progressing disease|1|||
129961586|NCT01281917|467824074|FG000|Overall Study|Withdrawal by Subject|1|||
129961587|NCT01978236|467824076|FG000|Overall Study|Discontinued due to study close|2|||
129961588|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
129961589|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
129961590|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
129961591|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
129961592|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
129454860|NCT00243386|465962842|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
129454861|NCT00243386|465962840|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
129454862|NCT00243386|465962841|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
129454863|NCT00243386|465962842|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
129454864|NCT00243386|465962840|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
129454865|NCT00243386|465962841|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
129454866|NCT00243386|465962842|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
129454867|NCT00243386|465962840|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
129454868|NCT00243386|465962841|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
129454869|NCT00243386|465962842|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
129454870|NCT00243386|465962840|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
129454871|NCT00243386|465962841|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
129454872|NCT00243386|465962842|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
129961593|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
129961594|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Rejections|0|||
129961595|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Rejections|0|||
129961596|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Rejections|55|||
129961597|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
129961598|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
129961599|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
129961600|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
129961601|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
129961602|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
129961603|NCT00634920|467824078|FG000|Period 1 - Pre-Randomization|Other issues|0|||
129961604|NCT00634920|467824079|FG001|Period 1 - Pre-Randomization|Other issues|0|||
129961605|NCT00634920|467824080|FG002|Period 1 - Pre-Randomization|Other issues|6|||
129961606|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
129961607|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
129961608|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
129961609|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Rejection|11|||
129961610|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Rejection|5|||
129961611|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Rejection|0|||
129961612|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Death|2|||
129961613|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Death|5|||
129961614|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Death|0|||
129961615|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
129961616|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
129961617|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
129961618|NCT00634920|467824078|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
129961619|NCT00634920|467824079|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
129961620|NCT00634920|467824080|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
129961621|NCT00819013|467824081|FG000|Overall Study|Not meeting continuing study eligibility|2|||
129961622|NCT00819013|467824082|FG001|Overall Study|Not meeting continuing study eligibility|1|||
129961623|NCT00819013|467824083|FG002|Overall Study|Not meeting continuing study eligibility|2|||
129961624|NCT00819013|467824084|FG003|Overall Study|Not meeting continuing study eligibility|1|||
129961625|NCT00819013|467824081|FG000|Overall Study|Adverse Event|0|||
129961626|NCT00819013|467824082|FG001|Overall Study|Adverse Event|0|||
129961627|NCT00819013|467824083|FG002|Overall Study|Adverse Event|1|||
129961628|NCT00819013|467824084|FG003|Overall Study|Adverse Event|0|||
129961629|NCT00819013|467824081|FG000|Overall Study|Withdrawal by Subject|1|||
129961630|NCT00819013|467824082|FG001|Overall Study|Withdrawal by Subject|0|||
129961631|NCT00819013|467824083|FG002|Overall Study|Withdrawal by Subject|1|||
129961632|NCT00819013|467824084|FG003|Overall Study|Withdrawal by Subject|0|||
129961633|NCT00819013|467824081|FG000|Overall Study|Lost to Follow-up|0|||
129961634|NCT00819013|467824082|FG001|Overall Study|Lost to Follow-up|0|||
129961635|NCT00819013|467824083|FG002|Overall Study|Lost to Follow-up|1|||
129961636|NCT00819013|467824084|FG003|Overall Study|Lost to Follow-up|2|||
129961637|NCT00819013|467824081|FG000|Overall Study|Death|0|||
129961638|NCT00819013|467824082|FG001|Overall Study|Death|0|||
129961639|NCT00819013|467824083|FG002|Overall Study|Death|0|||
129961640|NCT00819013|467824084|FG003|Overall Study|Death|1|||
129961641|NCT00576823|467824087|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
129961642|NCT00576823|467824088|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
129961643|NCT00576823|467824089|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
129961644|NCT00576823|467824087|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
129961645|NCT00576823|467824088|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
129961646|NCT00576823|467824089|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
129961647|NCT00510146|467824090|FG000|Double-Blind Treatment|Adverse Event|30|||
129961648|NCT00510146|467824091|FG001|Double-Blind Treatment|Adverse Event|13|||
129961649|NCT00510146|467824090|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
129961650|NCT00510146|467824091|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
129961651|NCT00510146|467824090|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
129961652|NCT00510146|467824091|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
129961653|NCT00510146|467824090|FG000|Double-Blind Treatment|Physician Decision|6|||
129961654|NCT00510146|467824091|FG001|Double-Blind Treatment|Physician Decision|0|||
129961655|NCT00510146|467824090|FG000|Double-Blind Treatment|Protocol Violation|1|||
129961656|NCT00510146|467824091|FG001|Double-Blind Treatment|Protocol Violation|2|||
129961657|NCT00510146|467824090|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
129961658|NCT00510146|467824091|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
129961659|NCT00510146|467824090|FG000|Double-Blind Treatment|Clinical Relapse|0|||
129961660|NCT00510146|467824091|FG001|Double-Blind Treatment|Clinical Relapse|1|||
129961661|NCT00510146|467824090|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
129454873|NCT00243386|465962840|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
129961662|NCT00510146|467824091|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
129961663|NCT00510146|467824090|FG000|Open-Label Treatment|Adverse Event|22|||
129961664|NCT00510146|467824091|FG001|Open-Label Treatment|Adverse Event|8|||
129961665|NCT00510146|467824090|FG000|Open-Label Treatment|Death|1|||
129961666|NCT00510146|467824091|FG001|Open-Label Treatment|Death|1|||
129961667|NCT00510146|467824090|FG000|Open-Label Treatment|Lack of Efficacy|4|||
129961668|NCT00510146|467824091|FG001|Open-Label Treatment|Lack of Efficacy|0|||
129961669|NCT00510146|467824090|FG000|Open-Label Treatment|Lost to Follow-up|10|||
129961670|NCT00510146|467824091|FG001|Open-Label Treatment|Lost to Follow-up|1|||
129961671|NCT00510146|467824090|FG000|Open-Label Treatment|Physician Decision|3|||
129961672|NCT00510146|467824091|FG001|Open-Label Treatment|Physician Decision|1|||
129961673|NCT00510146|467824090|FG000|Open-Label Treatment|Protocol Violation|4|||
129961674|NCT00510146|467824091|FG001|Open-Label Treatment|Protocol Violation|2|||
129961675|NCT00510146|467824090|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
129961676|NCT00510146|467824091|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
129961677|NCT00510146|467824090|FG000|Open-Label Treatment|Clinical Relapse|1|||
129961678|NCT00510146|467824091|FG001|Open-Label Treatment|Clinical Relapse|1|||
129961679|NCT00510146|467824090|FG000|Open-Label Treatment|Sponsor Decision|2|||
129961680|NCT00510146|467824091|FG001|Open-Label Treatment|Sponsor Decision|0|||
129961681|NCT03188536|467824094|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
129961682|NCT03188536|467824094|FG000|Overall Study|Not participated/met inclusion criteria|1|||
129961683|NCT01930214|467824096|FG000|Overall Study|Death|4|||
129961684|NCT01930214|467824097|FG001|Overall Study|Death|4|||
129961685|NCT01930214|467824098|FG002|Overall Study|Death|11|||
129961686|NCT01930214|467824096|FG000|Overall Study|Lost to Follow-up|12|||
129961687|NCT01930214|467824097|FG001|Overall Study|Lost to Follow-up|13|||
129961688|NCT01930214|467824098|FG002|Overall Study|Lost to Follow-up|12|||
129961689|NCT01930214|467824096|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
129961690|NCT01930214|467824097|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
129961691|NCT01930214|467824098|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
129961692|NCT01930214|467824096|FG000|Overall Study|Physician Decision|2|||
129961693|NCT01930214|467824097|FG001|Overall Study|Physician Decision|0|||
129961694|NCT01930214|467824098|FG002|Overall Study|Physician Decision|0|||
129961695|NCT02132117|467824099|FG000|Overall Study|Adverse Event|6|||
129961696|NCT02132117|467824100|FG001|Overall Study|Adverse Event|1|||
129961697|NCT02132117|467824099|FG000|Overall Study|Lost to Follow-up|2|||
129961698|NCT02132117|467824100|FG001|Overall Study|Lost to Follow-up|2|||
129961699|NCT02132117|467824099|FG000|Overall Study|Personal Reasons|1|||
129961700|NCT02132117|467824100|FG001|Overall Study|Personal Reasons|2|||
129961701|NCT02132117|467824099|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129961702|NCT02132117|467824100|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129961703|NCT01222078|467824106|FG000|Overall Study|Early termination of the study|1|||
129961704|NCT00808899|467824108|FG000|Overall Study|Death|1|||
129961705|NCT00808899|467824108|FG000|Overall Study|Physician Decision|3|||
129961706|NCT04688086|467824113|FG000|Overall Study|Lost to Follow-up|164|||
129961707|NCT04688086|467824113|FG000|Overall Study|Imaging error;|64|||
129961708|NCT03120949|467824114|FG000|Overall Study|randomized in error|1|||
129961709|NCT03120949|467824115|FG001|Overall Study|randomized in error|0|||
129961710|NCT03120949|467824114|FG000|Overall Study|Death|13|||
129961711|NCT03120949|467824115|FG001|Overall Study|Death|13|||
129961712|NCT03120949|467824114|FG000|Overall Study|Lost to Follow-up|23|||
129961713|NCT03120949|467824115|FG001|Overall Study|Lost to Follow-up|13|||
129961714|NCT03120949|467824114|FG000|Overall Study|Withdrawal by Subject|139|||
129961715|NCT03120949|467824115|FG001|Overall Study|Withdrawal by Subject|124|||
129961716|NCT03120949|467824114|FG000|Overall Study|Covid-19|43|||
129961717|NCT03120949|467824115|FG001|Overall Study|Covid-19|34|||
129961718|NCT03120949|467824114|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
129961719|NCT03120949|467824115|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
129961720|NCT03120949|467824114|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
129961721|NCT03120949|467824115|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
129961722|NCT03120949|467824114|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
129961723|NCT03120949|467824115|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
129961724|NCT03120949|467824114|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
129961725|NCT03120949|467824115|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
129961726|NCT03120949|467824114|FG000|Overall Study|Site was closed|2|||
129961727|NCT03120949|467824115|FG001|Overall Study|Site was closed|3|||
129961728|NCT03120949|467824114|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
129961729|NCT03120949|467824115|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
129961730|NCT03120949|467824114|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
129961731|NCT03120949|467824115|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
129454874|NCT00243386|465962841|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
129454875|NCT00243386|465962842|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
129454876|NCT00243386|465962840|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
129454877|NCT00243386|465962841|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
129454878|NCT00243386|465962842|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
129454879|NCT00243386|465962840|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
129454880|NCT00243386|465962841|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
129454881|NCT00243386|465962842|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
129454882|NCT00133991|465962843|FG000|Overall Study|Death|4|||
129454883|NCT03002155|465962844|FG000|Overall Study|Lost to Follow-up|1|||
129454884|NCT03002155|465962845|FG001|Overall Study|Lost to Follow-up|2|||
129961732|NCT03120949|467824114|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
129454885|NCT03002155|465962844|FG000|Overall Study|Withdrawal by Subject|1|||
129961733|NCT03120949|467824115|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
129961734|NCT03120949|467824114|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
129961735|NCT03120949|467824115|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
129961736|NCT03120949|467824114|FG000|Overall Study|Other: Adverse Event|0|||
129961737|NCT03120949|467824115|FG001|Overall Study|Other: Adverse Event|1|||
129961738|NCT03120949|467824114|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
129961739|NCT03120949|467824115|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
129961740|NCT03120949|467824114|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
129961741|NCT03120949|467824115|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
129961742|NCT03120949|467824114|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
129961743|NCT03120949|467824115|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
129961744|NCT03120949|467824114|FG000|Overall Study|Personal Reasons|0|||
129961745|NCT03120949|467824115|FG001|Overall Study|Personal Reasons|1|||
129961746|NCT03120949|467824114|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
129961747|NCT03120949|467824115|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
129961748|NCT03120949|467824114|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
129961749|NCT03120949|467824115|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
129961750|NCT03120949|467824114|FG000|Overall Study|Compliance With Medication|0|||
129961751|NCT03120949|467824115|FG001|Overall Study|Compliance With Medication|1|||
129961752|NCT03120949|467824114|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
129961753|NCT03120949|467824115|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
129961754|NCT03120949|467824114|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
129961755|NCT03120949|467824115|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
129961756|NCT03120949|467824114|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
129961757|NCT03120949|467824115|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
129961758|NCT00988117|467824116|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
129961759|NCT00988117|467824116|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
129961760|NCT00853021|467824119|FG000|Overall Study|Adverse Event|2|||
129961761|NCT00853021|467824119|FG000|Overall Study|Withdrawal by Subject|2|||
129961762|NCT00853021|467824119|FG000|Overall Study|Death|1|||
129961763|NCT01329419|467824120|FG000|Overall Study|Protocol Violation|235|||
129961764|NCT04522778|467824123|FG000|Overall Study|Patient did not want to wear the device|1|||
129961765|NCT04522778|467824124|FG001|Overall Study|Patient did not want to wear the device|0|||
129961766|NCT04522778|467824123|FG000|Overall Study|Lost to Follow-up|0|||
129961767|NCT04522778|467824124|FG001|Overall Study|Lost to Follow-up|1|||
129961768|NCT01225159|467824125|FG000|Overall Study|Change operation|1|||
129961769|NCT01225159|467824126|FG001|Overall Study|Change operation|0|||
129961770|NCT01220856|467824130|FG000|Overall Study|graft loss|3|||
129961771|NCT01220856|467824131|FG001|Overall Study|graft loss|3|||
129961772|NCT01220856|467824130|FG000|Overall Study|Lost to Follow-up|1|||
129961773|NCT01220856|467824131|FG001|Overall Study|Lost to Follow-up|0|||
129961774|NCT04088500|467824132|FG000|Overall Study|Reason unknown|1|||
129961775|NCT04088500|467824132|FG000|Overall Study|Participant withdrew consent|1|||
129961776|NCT04088500|467824132|FG000|Overall Study|Disease progression|3|||
129961777|NCT00981578|467824133|FG000|Overall Study|Death|1|||
129961778|NCT00981578|467824133|FG000|Overall Study|Withdrawal by Subject|2|||
129961779|NCT04206384|467824134|FG000|Overall Study|Withdrawal by Subject|8|||
129961780|NCT04206384|467824134|FG000|Overall Study|Adverse Event|2|||
129961781|NCT02212197|467824135|FG000|Overall Study|Need for radiotherapy|1|||
129961782|NCT02212197|467824136|FG001|Overall Study|Need for radiotherapy|0|||
129961783|NCT02212197|467824137|FG002|Overall Study|Need for radiotherapy|0|||
129961784|NCT01177228|467824140|FG000|Overall Study|Positive tuberculosis test|0|||
129961785|NCT01177228|467824141|FG001|Overall Study|Positive tuberculosis test|1|||
129961786|NCT01177228|467824142|FG002|Overall Study|Positive tuberculosis test|0|||
129961787|NCT01177228|467824143|FG003|Overall Study|Positive tuberculosis test|0|||
129961788|NCT01177228|467824140|FG000|Overall Study|Worsening disease activity|1|||
129961789|NCT01177228|467824141|FG001|Overall Study|Worsening disease activity|0|||
129961790|NCT01177228|467824142|FG002|Overall Study|Worsening disease activity|0|||
129961791|NCT01177228|467824143|FG003|Overall Study|Worsening disease activity|0|||
129961792|NCT01177228|467824140|FG000|Overall Study|Withdrawal by Subject|0|||
129961793|NCT01177228|467824141|FG001|Overall Study|Withdrawal by Subject|1|||
129961794|NCT01177228|467824142|FG002|Overall Study|Withdrawal by Subject|0|||
129961795|NCT01177228|467824143|FG003|Overall Study|Withdrawal by Subject|0|||
129961796|NCT01494298|467824144|FG000|Overall Study|Protocol Violation|2|||
129961797|NCT01494298|467824145|FG001|Overall Study|Protocol Violation|8|||
129961798|NCT00006436|467824147|FG000|Overall Study|Refused further treatment|2|||
129961799|NCT00006436|467824147|FG000|Overall Study|Declined to participate (before treatment started)|1|||
129961800|NCT00316589|467824148|FG000|Overall Study|Withdrawal by Subject|0|||
129961801|NCT00316589|467824149|FG001|Overall Study|Withdrawal by Subject|5|||
129961802|NCT00316589|467824150|FG002|Overall Study|Withdrawal by Subject|0|||
129961803|NCT00316589|467824151|FG003|Overall Study|Withdrawal by Subject|1|||
129454886|NCT03002155|465962845|FG001|Overall Study|Withdrawal by Subject|0|||
129961804|NCT00316589|467824148|FG000|Overall Study|Subject unwilling/unable to comply|0|||
129961805|NCT00316589|467824149|FG001|Overall Study|Subject unwilling/unable to comply|6|||
129961806|NCT00316589|467824150|FG002|Overall Study|Subject unwilling/unable to comply|0|||
129961807|NCT00316589|467824151|FG003|Overall Study|Subject unwilling/unable to comply|2|||
129961808|NCT00316589|467824148|FG000|Overall Study|Adverse Event|1|||
129961809|NCT00316589|467824149|FG001|Overall Study|Adverse Event|0|||
129961810|NCT00316589|467824150|FG002|Overall Study|Adverse Event|0|||
129961811|NCT00316589|467824151|FG003|Overall Study|Adverse Event|1|||
129961812|NCT00316589|467824148|FG000|Overall Study|Physician Decision|0|||
129961813|NCT00316589|467824149|FG001|Overall Study|Physician Decision|1|||
129961814|NCT00316589|467824150|FG002|Overall Study|Physician Decision|0|||
129961815|NCT00316589|467824151|FG003|Overall Study|Physician Decision|0|||
129961816|NCT00316589|467824148|FG000|Overall Study|Other reason|0|||
129961817|NCT00316589|467824149|FG001|Overall Study|Other reason|12|||
129961818|NCT00316589|467824150|FG002|Overall Study|Other reason|1|||
129961819|NCT00316589|467824151|FG003|Overall Study|Other reason|1|||
129961820|NCT01482819|467824152|FG000|Overall Study|Lost to Follow-up|2|||
129961821|NCT00562484|467824153|FG000|Overall Study|Adverse Event|6|||
129961822|NCT00562484|467824154|FG001|Overall Study|Adverse Event|1|||
129961823|NCT00562484|467824153|FG000|Overall Study|Protocol Violation|11|||
129961824|NCT00562484|467824154|FG001|Overall Study|Protocol Violation|2|||
129961825|NCT00562484|467824153|FG000|Overall Study|Withdrawal by Subject|12|||
129961826|NCT00562484|467824154|FG001|Overall Study|Withdrawal by Subject|9|||
129961827|NCT00562484|467824153|FG000|Overall Study|Moved away from the study area|20|||
129961828|NCT00562484|467824154|FG001|Overall Study|Moved away from the study area|9|||
129961829|NCT00562484|467824153|FG000|Overall Study|Lost to Follow-up|132|||
129961830|NCT00562484|467824154|FG001|Overall Study|Lost to Follow-up|71|||
129961831|NCT00562484|467824153|FG000|Overall Study|Reason not provided or not specified|25|||
129961832|NCT00562484|467824154|FG001|Overall Study|Reason not provided or not specified|12|||
129961833|NCT00702520|467824155|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
129961834|NCT00702520|467824156|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
129961835|NCT00702520|467824157|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
129961836|NCT00702520|467824158|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
129961837|NCT00702520|467824155|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
129961838|NCT00702520|467824156|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
129961839|NCT00702520|467824157|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
129961840|NCT00702520|467824158|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
129961841|NCT00702520|467824155|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
129961842|NCT00702520|467824156|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
129961843|NCT00702520|467824157|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
129961844|NCT00702520|467824158|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
129961845|NCT00276016|467824159|FG000|Intervention 1|Withdrawal by Subject|0|||
129961846|NCT00276016|467824160|FG001|Intervention 1|Withdrawal by Subject|1|||
129961847|NCT00276016|467824161|FG002|Intervention 1|Withdrawal by Subject|0|||
129961848|NCT00276016|467824162|FG003|Intervention 1|Withdrawal by Subject|0|||
129961849|NCT00276016|467824163|FG004|Intervention 1|Withdrawal by Subject|0|||
129961850|NCT00276016|467824164|FG005|Intervention 1|Withdrawal by Subject|0|||
129961851|NCT05041439|467824165|FG000|Overall Study|Withdrawal by Subject|1|||
129961852|NCT05041439|467824166|FG001|Overall Study|Withdrawal by Subject|1|||
129961853|NCT05041439|467824165|FG000|Overall Study|Death|1|||
129961854|NCT05041439|467824166|FG001|Overall Study|Death|0|||
129961855|NCT01904136|467825592|FG000|Overall Study|Physician Decision|0|||
129961856|NCT01904136|467825593|FG001|Overall Study|Physician Decision|0|||
129961857|NCT01904136|467825594|FG002|Overall Study|Physician Decision|0|||
129961858|NCT01904136|467825595|FG003|Overall Study|Physician Decision|0|||
129961859|NCT01904136|467825596|FG004|Overall Study|Physician Decision|0|||
129961860|NCT01904136|467825597|FG005|Overall Study|Physician Decision|1|||
129961861|NCT01904136|467825598|FG006|Overall Study|Physician Decision|0|||
129961862|NCT01904136|467825599|FG007|Overall Study|Physician Decision|0|||
129961863|NCT01904136|467825600|FG008|Overall Study|Physician Decision|0|||
129961864|NCT01222533|467825609|FG000|Overall Study|Adverse Event|5|||
129961865|NCT01222533|467825609|FG000|Overall Study|Withdrawal by Subject|5|||
129961866|NCT01222533|467825609|FG000|Overall Study|Other|4|||
129961867|NCT01947517|467825610|FG000|Overall Study|Withdrawal by Subject|1|||
129961868|NCT01947517|467825611|FG001|Overall Study|Withdrawal by Subject|1|||
129454887|NCT03002155|465962844|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
129488455|NCT01277289|466080718|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
129454888|NCT03002155|465962845|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
129454889|NCT00978029|465962846|FG000|Overall Study|Adverse Event|1|||
129454890|NCT00978029|465962847|FG001|Overall Study|Adverse Event|2|||
129454891|NCT00978029|465962848|FG002|Overall Study|Adverse Event|5|||
129454892|NCT00978029|465962846|FG000|Overall Study|Withdrawal by Subject|0|||
129454893|NCT00978029|465962847|FG001|Overall Study|Withdrawal by Subject|0|||
129454894|NCT00978029|465962848|FG002|Overall Study|Withdrawal by Subject|1|||
129454895|NCT00978029|465962846|FG000|Overall Study|Protocol Violation|0|||
129454896|NCT00978029|465962847|FG001|Overall Study|Protocol Violation|1|||
129454897|NCT00978029|465962848|FG002|Overall Study|Protocol Violation|0|||
129454898|NCT00545298|465962849|FG000|Overall Study|Issues with Standard of Care|2|||
129454899|NCT00545298|465962850|FG001|Overall Study|Issues with Standard of Care|0|||
129454900|NCT00545298|465962851|FG002|Overall Study|Issues with Standard of Care|1|||
129454901|NCT01820364|465962855|FG000|Part I: LGX818|Death|1|||
129454902|NCT01820364|465962856|FG001|Part I: LGX818|Death|0|||
129454903|NCT01820364|465962855|FG000|Part I: LGX818|Administrative Problems|3|||
129454904|NCT01820364|465962856|FG001|Part I: LGX818|Administrative Problems|0|||
129454905|NCT01820364|465962855|FG000|Part I: LGX818|Adverse Event|6|||
129454906|NCT01820364|465962856|FG001|Part I: LGX818|Adverse Event|0|||
129454907|NCT01820364|465962855|FG000|Part I: LGX818|Disease Progression|4|||
129454908|NCT01820364|465962856|FG001|Part I: LGX818|Disease Progression|0|||
129454909|NCT01820364|465962855|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
129454910|NCT01820364|465962856|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
129454911|NCT01793142|465962859|FG000|Overall Study|Randomized not treated|7|||
129454912|NCT03451084|465962865|FG000|Overall Study|Withdrawal by Subject|2|||
129454913|NCT03451084|465962866|FG001|Overall Study|Withdrawal by Subject|1|||
129454914|NCT03451084|465962867|FG002|Overall Study|Withdrawal by Subject|2|||
129454915|NCT03451084|465962868|FG003|Overall Study|Withdrawal by Subject|1|||
129454916|NCT03451084|465962865|FG000|Overall Study|Disease recurrence|0|||
129454917|NCT03451084|465962866|FG001|Overall Study|Disease recurrence|2|||
129454918|NCT03451084|465962867|FG002|Overall Study|Disease recurrence|0|||
129454919|NCT03451084|465962868|FG003|Overall Study|Disease recurrence|0|||
129454920|NCT03451084|465962865|FG000|Overall Study|Lack of Efficacy|0|||
129454921|NCT03451084|465962866|FG001|Overall Study|Lack of Efficacy|3|||
129454922|NCT03451084|465962867|FG002|Overall Study|Lack of Efficacy|0|||
129454923|NCT03451084|465962868|FG003|Overall Study|Lack of Efficacy|1|||
129454924|NCT03451084|465962865|FG000|Overall Study|Death|1|||
129961869|NCT00460564|467825615|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
129961870|NCT00460564|467825616|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
129961871|NCT00460564|467825617|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961872|NCT00460564|467825618|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961873|NCT00460564|467825619|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961874|NCT00460564|467825620|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961875|NCT00460564|467825621|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961876|NCT00460564|467825622|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
129961877|NCT00460564|467825615|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
129961878|NCT00460564|467825616|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961879|NCT00460564|467825617|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961880|NCT00460564|467825618|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961881|NCT00460564|467825619|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961882|NCT00460564|467825620|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961883|NCT00460564|467825621|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961884|NCT00460564|467825622|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
129961885|NCT00460564|467825615|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961886|NCT00460564|467825616|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961887|NCT00460564|467825617|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961888|NCT00460564|467825618|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961889|NCT00460564|467825619|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
129961890|NCT00460564|467825620|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
129961891|NCT00460564|467825621|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
129961892|NCT00460564|467825622|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
129961893|NCT00460564|467825615|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961894|NCT00460564|467825616|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961895|NCT00460564|467825617|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961896|NCT00460564|467825618|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961897|NCT00460564|467825619|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
129961898|NCT00460564|467825620|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
129961899|NCT00460564|467825621|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129454925|NCT03451084|465962866|FG001|Overall Study|Death|0|||
129454926|NCT03451084|465962867|FG002|Overall Study|Death|2|||
129454927|NCT03451084|465962868|FG003|Overall Study|Death|0|||
129454928|NCT03451084|465962865|FG000|Overall Study|Physician Decision|0|||
129454929|NCT03451084|465962866|FG001|Overall Study|Physician Decision|0|||
129454930|NCT03451084|465962867|FG002|Overall Study|Physician Decision|2|||
129961900|NCT00460564|467825622|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
129961901|NCT00460564|467825615|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129454931|NCT03451084|465962868|FG003|Overall Study|Physician Decision|2|||
129454932|NCT03451084|465962865|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
129454933|NCT03451084|465962866|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
129454934|NCT03451084|465962867|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
129454935|NCT03451084|465962868|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
129454936|NCT03418129|465962869|FG000|Overall Study|Lost to Follow-up|11|||
129454937|NCT03418129|465962870|FG001|Overall Study|Lost to Follow-up|20|||
129454938|NCT03418129|465962871|FG002|Overall Study|Lost to Follow-up|15|||
129454939|NCT03418129|465962869|FG000|Overall Study|Withdrawal by Subject|3|||
129454940|NCT03418129|465962870|FG001|Overall Study|Withdrawal by Subject|6|||
129454941|NCT03418129|465962871|FG002|Overall Study|Withdrawal by Subject|4|||
129454942|NCT05376215|465962874|FG000|Overall Study|Withdrawal by Subject|2|||
129454943|NCT05376215|465962875|FG001|Overall Study|Withdrawal by Subject|1|||
129454944|NCT05376215|465962874|FG000|Overall Study|Lost to Follow-up|0|||
129454945|NCT05376215|465962875|FG001|Overall Study|Lost to Follow-up|1|||
129454946|NCT01147744|465962889|FG000|Overall Study|Protocol Violation|1|||
129454947|NCT01147744|465962890|FG001|Overall Study|Protocol Violation|0|||
129454948|NCT01147744|465962891|FG002|Overall Study|Protocol Violation|1|||
129454949|NCT01147744|465962892|FG003|Overall Study|Protocol Violation|0|||
129454950|NCT01147744|465962893|FG004|Overall Study|Protocol Violation|1|||
129454951|NCT01147744|465962894|FG005|Overall Study|Protocol Violation|3|||
129454952|NCT01147744|465962895|FG006|Overall Study|Protocol Violation|1|||
129454953|NCT01147744|465962889|FG000|Overall Study|Physician Decision|0|||
129454954|NCT01147744|465962890|FG001|Overall Study|Physician Decision|1|||
129454955|NCT01147744|465962891|FG002|Overall Study|Physician Decision|1|||
129454956|NCT01147744|465962892|FG003|Overall Study|Physician Decision|0|||
129454957|NCT01147744|465962893|FG004|Overall Study|Physician Decision|0|||
129454958|NCT01147744|465962894|FG005|Overall Study|Physician Decision|0|||
129454959|NCT01147744|465962895|FG006|Overall Study|Physician Decision|1|||
129454960|NCT01147744|465962889|FG000|Overall Study|Lack of Efficacy|11|||
129454961|NCT01147744|465962890|FG001|Overall Study|Lack of Efficacy|11|||
129454962|NCT01147744|465962891|FG002|Overall Study|Lack of Efficacy|9|||
129454963|NCT01147744|465962892|FG003|Overall Study|Lack of Efficacy|11|||
129454964|NCT01147744|465962893|FG004|Overall Study|Lack of Efficacy|13|||
129454965|NCT01147744|465962894|FG005|Overall Study|Lack of Efficacy|8|||
129454966|NCT01147744|465962895|FG006|Overall Study|Lack of Efficacy|7|||
129454967|NCT01147744|465962889|FG000|Overall Study|Adverse Event|1|||
129454968|NCT01147744|465962890|FG001|Overall Study|Adverse Event|2|||
129454969|NCT01147744|465962891|FG002|Overall Study|Adverse Event|3|||
129454970|NCT01147744|465962892|FG003|Overall Study|Adverse Event|0|||
129454971|NCT01147744|465962893|FG004|Overall Study|Adverse Event|2|||
129454972|NCT01147744|465962894|FG005|Overall Study|Adverse Event|1|||
129454973|NCT01147744|465962895|FG006|Overall Study|Adverse Event|2|||
129454974|NCT01147744|465962889|FG000|Overall Study|Withdrawal by Subject|8|||
129454975|NCT01147744|465962890|FG001|Overall Study|Withdrawal by Subject|4|||
129454976|NCT01147744|465962891|FG002|Overall Study|Withdrawal by Subject|2|||
129454977|NCT01147744|465962892|FG003|Overall Study|Withdrawal by Subject|2|||
129454978|NCT01147744|465962893|FG004|Overall Study|Withdrawal by Subject|2|||
129454979|NCT01147744|465962894|FG005|Overall Study|Withdrawal by Subject|5|||
129454980|NCT01147744|465962895|FG006|Overall Study|Withdrawal by Subject|2|||
129454981|NCT01147744|465962889|FG000|Overall Study|Lost to Follow-up|0|||
129454982|NCT01147744|465962890|FG001|Overall Study|Lost to Follow-up|1|||
129454983|NCT01147744|465962891|FG002|Overall Study|Lost to Follow-up|0|||
129454984|NCT01147744|465962892|FG003|Overall Study|Lost to Follow-up|0|||
129454985|NCT01147744|465962893|FG004|Overall Study|Lost to Follow-up|0|||
129454986|NCT01147744|465962894|FG005|Overall Study|Lost to Follow-up|0|||
129454987|NCT01147744|465962895|FG006|Overall Study|Lost to Follow-up|0|||
129454988|NCT01147744|465962889|FG000|Overall Study|Sponsor decision to amend protocol|7|||
129454989|NCT01147744|465962890|FG001|Overall Study|Sponsor decision to amend protocol|4|||
129454990|NCT01147744|465962891|FG002|Overall Study|Sponsor decision to amend protocol|2|||
129454991|NCT01147744|465962892|FG003|Overall Study|Sponsor decision to amend protocol|5|||
129454992|NCT01147744|465962893|FG004|Overall Study|Sponsor decision to amend protocol|7|||
129454993|NCT01147744|465962894|FG005|Overall Study|Sponsor decision to amend protocol|2|||
129961902|NCT00460564|467825616|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129454994|NCT01147744|465962895|FG006|Overall Study|Sponsor decision to amend protocol|6|||
129454995|NCT01147744|465962889|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129454996|NCT01147744|465962890|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129454997|NCT01147744|465962891|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129454998|NCT01147744|465962892|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129454999|NCT01147744|465962893|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129455000|NCT01147744|465962894|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129455001|NCT01147744|465962895|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129455002|NCT01342484|465962896|FG000|Overall Study|Other Reasons|1|||
129455003|NCT01342484|465962897|FG001|Overall Study|Other Reasons|0|||
129455004|NCT01342484|465962898|FG002|Overall Study|Other Reasons|0|||
129455005|NCT01342484|465962896|FG000|Overall Study|Protocol Violation|0|||
129455006|NCT01342484|465962897|FG001|Overall Study|Protocol Violation|0|||
129455007|NCT01342484|465962898|FG002|Overall Study|Protocol Violation|1|||
129455008|NCT01342484|465962896|FG000|Overall Study|Withdrawal by Subject|1|||
129455009|NCT01342484|465962897|FG001|Overall Study|Withdrawal by Subject|0|||
129961903|NCT00460564|467825617|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961904|NCT00460564|467825618|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961905|NCT00460564|467825619|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
129961906|NCT00460564|467825620|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961907|NCT00460564|467825621|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961908|NCT00460564|467825622|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
129961909|NCT00320398|467825627|FG000|Overall Study|Adverse Event|1|||
129961910|NCT00320398|467825628|FG001|Overall Study|Adverse Event|4|||
129961911|NCT00320398|467825627|FG000|Overall Study|Other|1|||
129961912|NCT00320398|467825628|FG001|Overall Study|Other|0|||
129961913|NCT00630552|467825629|FG000|Overall Study|Adverse Event|0|||
129961914|NCT00630552|467825630|FG001|Overall Study|Adverse Event|1|||
129961915|NCT00630552|467825631|FG002|Overall Study|Adverse Event|5|||
129961916|NCT00630552|467825632|FG003|Overall Study|Adverse Event|4|||
129961917|NCT00630552|467825633|FG004|Overall Study|Adverse Event|2|||
129961918|NCT00630552|467825629|FG000|Overall Study|Disease progression|5|||
129961919|NCT00630552|467825630|FG001|Overall Study|Disease progression|6|||
129961920|NCT00630552|467825631|FG002|Overall Study|Disease progression|27|||
129961921|NCT00630552|467825632|FG003|Overall Study|Disease progression|22|||
129961922|NCT00630552|467825633|FG004|Overall Study|Disease progression|31|||
129961923|NCT00630552|467825629|FG000|Overall Study|Never received IP|0|||
129961924|NCT00630552|467825630|FG001|Overall Study|Never received IP|0|||
129961925|NCT00630552|467825631|FG002|Overall Study|Never received IP|0|||
129961926|NCT00630552|467825632|FG003|Overall Study|Never received IP|2|||
129961927|NCT00630552|467825633|FG004|Overall Study|Never received IP|2|||
129961928|NCT00630552|467825629|FG000|Overall Study|Ineligibility determined|0|||
129961929|NCT00630552|467825630|FG001|Overall Study|Ineligibility determined|0|||
129961930|NCT00630552|467825631|FG002|Overall Study|Ineligibility determined|0|||
129961931|NCT00630552|467825632|FG003|Overall Study|Ineligibility determined|0|||
129961932|NCT00630552|467825633|FG004|Overall Study|Ineligibility determined|1|||
129961933|NCT00630552|467825629|FG000|Overall Study|Protocol Violation|0|||
129961934|NCT00630552|467825630|FG001|Overall Study|Protocol Violation|0|||
129961935|NCT00630552|467825631|FG002|Overall Study|Protocol Violation|0|||
129961936|NCT00630552|467825632|FG003|Overall Study|Protocol Violation|1|||
129961937|NCT00630552|467825633|FG004|Overall Study|Protocol Violation|0|||
129961938|NCT00630552|467825629|FG000|Overall Study|Physician Decision|0|||
129961939|NCT00630552|467825630|FG001|Overall Study|Physician Decision|0|||
129961940|NCT00630552|467825631|FG002|Overall Study|Physician Decision|0|||
129961941|NCT00630552|467825632|FG003|Overall Study|Physician Decision|0|||
129961942|NCT00630552|467825633|FG004|Overall Study|Physician Decision|1|||
129961943|NCT00630552|467825629|FG000|Overall Study|Death|0|||
129961944|NCT00630552|467825630|FG001|Overall Study|Death|0|||
129961945|NCT00630552|467825631|FG002|Overall Study|Death|1|||
129961946|NCT00630552|467825632|FG003|Overall Study|Death|2|||
129961947|NCT00630552|467825633|FG004|Overall Study|Death|2|||
129961948|NCT00630552|467825629|FG000|Overall Study|Withdrawal by Subject|0|||
129961949|NCT00630552|467825630|FG001|Overall Study|Withdrawal by Subject|0|||
129961950|NCT00630552|467825631|FG002|Overall Study|Withdrawal by Subject|0|||
129961951|NCT00630552|467825632|FG003|Overall Study|Withdrawal by Subject|1|||
129961952|NCT00630552|467825633|FG004|Overall Study|Withdrawal by Subject|0|||
129961953|NCT00630552|467825629|FG000|Overall Study|Other|0|||
129961954|NCT00630552|467825630|FG001|Overall Study|Other|0|||
129961955|NCT00630552|467825631|FG002|Overall Study|Other|4|||
129961956|NCT00630552|467825632|FG003|Overall Study|Other|2|||
129961957|NCT00630552|467825633|FG004|Overall Study|Other|0|||
129961958|NCT04349644|467825634|FG000|Allocation/Pretest|Lost to pretest|0|||
129961959|NCT04349644|467825635|FG001|Allocation/Pretest|Lost to pretest|3|||
129961960|NCT04349644|467825634|FG000|Posttest|Lost to posttest|0|||
129961961|NCT04349644|467825635|FG001|Posttest|Lost to posttest|8|||
129961962|NCT04349644|467825634|FG000|Posttest|Discontinued intervention|6|||
129961963|NCT04349644|467825635|FG001|Posttest|Discontinued intervention|0|||
129961964|NCT04349644|467825634|FG000|Follow-up|Lost to Follow-up|0|||
129961965|NCT04349644|467825635|FG001|Follow-up|Lost to Follow-up|2|||
129961966|NCT00983905|467825637|FG000|Theophylline Alone|Adverse Event|1|||
129961967|NCT00983905|467825637|FG000|Colchicine Alone|Adverse Event|2|||
129961968|NCT01169636|467825638|FG000|Overall Study|Adverse Event|0|||
129961969|NCT01169636|467825639|FG001|Overall Study|Adverse Event|0|||
129961970|NCT01169636|467825640|FG002|Overall Study|Adverse Event|1|||
129961971|NCT01169636|467825641|FG003|Overall Study|Adverse Event|1|||
129961972|NCT01169636|467825642|FG004|Overall Study|Adverse Event|0|||
129961973|NCT01169636|467825638|FG000|Overall Study|Screen failure|0|||
129961974|NCT01169636|467825639|FG001|Overall Study|Screen failure|0|||
129961975|NCT01169636|467825640|FG002|Overall Study|Screen failure|2|||
129961976|NCT01169636|467825641|FG003|Overall Study|Screen failure|0|||
129961977|NCT01169636|467825642|FG004|Overall Study|Screen failure|0|||
129961978|NCT01169636|467825638|FG000|Overall Study|Withdrawal by Subject|0|||
129961979|NCT01169636|467825639|FG001|Overall Study|Withdrawal by Subject|0|||
129961980|NCT01169636|467825640|FG002|Overall Study|Withdrawal by Subject|0|||
129455010|NCT01342484|465962898|FG002|Overall Study|Withdrawal by Subject|0|||
129961981|NCT01169636|467825641|FG003|Overall Study|Withdrawal by Subject|0|||
129961982|NCT01169636|467825642|FG004|Overall Study|Withdrawal by Subject|3|||
129961983|NCT02705625|467825643|FG000|Overall Study|Protocol Violation|1|||
129961984|NCT02705625|467825644|FG001|Overall Study|Protocol Violation|0|||
129961985|NCT02705625|467825645|FG002|Overall Study|Protocol Violation|0|||
129961986|NCT02705625|467825643|FG000|Overall Study|Adverse Event|6|||
129961987|NCT02705625|467825644|FG001|Overall Study|Adverse Event|5|||
129961988|NCT02705625|467825645|FG002|Overall Study|Adverse Event|2|||
129455011|NCT01840579|465962899|FG000|Overall Study|Status not recorded|0|||
129455012|NCT01840579|465962900|FG001|Overall Study|Status not recorded|0|||
129455013|NCT01840579|465962901|FG002|Overall Study|Status not recorded|2|||
129455014|NCT01840579|465962902|FG003|Overall Study|Status not recorded|3|||
129455015|NCT01840579|465962903|FG004|Overall Study|Status not recorded|4|||
129455016|NCT01840579|465962904|FG005|Overall Study|Status not recorded|3|||
129961989|NCT02705625|467825643|FG000|Overall Study|Death|0|||
129961990|NCT02705625|467825644|FG001|Overall Study|Death|0|||
129961991|NCT02705625|467825645|FG002|Overall Study|Death|1|||
129455017|NCT01840579|465962905|FG006|Overall Study|Status not recorded|0|||
129455018|NCT01840579|465962906|FG007|Overall Study|Status not recorded|3|||
129455019|NCT01840579|465962907|FG008|Overall Study|Status not recorded|3|||
129455020|NCT01840579|465962908|FG009|Overall Study|Status not recorded|3|||
129455021|NCT01840579|465962899|FG000|Overall Study|Progressive disease|3|||
129455022|NCT01840579|465962900|FG001|Overall Study|Progressive disease|5|||
129455023|NCT01840579|465962901|FG002|Overall Study|Progressive disease|0|||
129455024|NCT01840579|465962902|FG003|Overall Study|Progressive disease|0|||
129455025|NCT01840579|465962903|FG004|Overall Study|Progressive disease|0|||
129455026|NCT01840579|465962904|FG005|Overall Study|Progressive disease|0|||
129455027|NCT01840579|465962905|FG006|Overall Study|Progressive disease|0|||
129455028|NCT01840579|465962906|FG007|Overall Study|Progressive disease|0|||
129455029|NCT01840579|465962907|FG008|Overall Study|Progressive disease|0|||
129455030|NCT01840579|465962908|FG009|Overall Study|Progressive disease|0|||
129455031|NCT01840579|465962899|FG000|Overall Study|Ongoing in study|0|||
129455032|NCT01840579|465962900|FG001|Overall Study|Ongoing in study|1|||
129455033|NCT01840579|465962901|FG002|Overall Study|Ongoing in study|0|||
129455034|NCT01840579|465962902|FG003|Overall Study|Ongoing in study|0|||
129455035|NCT01840579|465962903|FG004|Overall Study|Ongoing in study|0|||
129455036|NCT01840579|465962904|FG005|Overall Study|Ongoing in study|0|||
129455037|NCT01840579|465962905|FG006|Overall Study|Ongoing in study|0|||
129455038|NCT01840579|465962906|FG007|Overall Study|Ongoing in study|0|||
129961992|NCT02705625|467825643|FG000|Overall Study|Withdrawal by Subject|1|||
129961993|NCT02705625|467825644|FG001|Overall Study|Withdrawal by Subject|4|||
129961994|NCT02705625|467825645|FG002|Overall Study|Withdrawal by Subject|5|||
129961995|NCT02705625|467825643|FG000|Overall Study|Lost to Follow-up|0|||
129455039|NCT01840579|465962907|FG008|Overall Study|Ongoing in study|0|||
129455040|NCT01840579|465962908|FG009|Overall Study|Ongoing in study|0|||
129961996|NCT02705625|467825644|FG001|Overall Study|Lost to Follow-up|0|||
129455041|NCT01840579|465962899|FG000|Overall Study|Death|0|||
129455042|NCT01840579|465962900|FG001|Overall Study|Death|0|||
129455043|NCT01840579|465962901|FG002|Overall Study|Death|0|||
129455044|NCT01840579|465962902|FG003|Overall Study|Death|0|||
129455045|NCT01840579|465962903|FG004|Overall Study|Death|0|||
129961997|NCT02705625|467825645|FG002|Overall Study|Lost to Follow-up|1|||
129961998|NCT02705625|467825643|FG000|Overall Study|Non-compliance|0|||
129961999|NCT02705625|467825644|FG001|Overall Study|Non-compliance|1|||
129962000|NCT02705625|467825645|FG002|Overall Study|Non-compliance|1|||
129962001|NCT02705625|467825643|FG000|Overall Study|Overdosing|0|||
129962002|NCT02705625|467825644|FG001|Overall Study|Overdosing|0|||
129962003|NCT02705625|467825645|FG002|Overall Study|Overdosing|1|||
129962004|NCT00494026|467825646|FG000|Overall Study|Sponsor Decision|4|||
129962005|NCT04544865|467825647|FG000|Overall Study|Death|0|||
129962006|NCT04544865|467825648|FG001|Overall Study|Death|2|||
129962007|NCT04544865|467825647|FG000|Overall Study|Lost to Follow-up|11|||
129962008|NCT04544865|467825648|FG001|Overall Study|Lost to Follow-up|7|||
129962009|NCT04544865|467825647|FG000|Overall Study|Withdrawal by Subject|0|||
129962010|NCT04544865|467825648|FG001|Overall Study|Withdrawal by Subject|1|||
129962011|NCT04544865|467825647|FG000|Overall Study|Other|0|||
129962012|NCT04544865|467825648|FG001|Overall Study|Other|1|||
129962013|NCT02815735|467825649|FG000|First Intervention (4 Weeks)|Discomfort|1|||
129962014|NCT02815735|467825650|FG001|First Intervention (4 Weeks)|Discomfort|0|||
129962015|NCT02815735|467825649|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
129962016|NCT02815735|467825650|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129962017|NCT02815735|467825649|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
129962018|NCT02815735|467825650|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
129962019|NCT02815735|467825649|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
129962020|NCT02815735|467825650|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
129962021|NCT00225277|467825656|FG000|Overall Study|Adverse Event|30|||
129962022|NCT00225277|467825657|FG001|Overall Study|Adverse Event|34|||
129962023|NCT00225277|467825656|FG000|Overall Study|Lack of Efficacy|4|||
129962024|NCT00225277|467825657|FG001|Overall Study|Lack of Efficacy|1|||
129962025|NCT00225277|467825656|FG000|Overall Study|Lost to Follow-up|4|||
129962026|NCT00225277|467825657|FG001|Overall Study|Lost to Follow-up|6|||
129962027|NCT00225277|467825656|FG000|Overall Study|Physician Decision|6|||
129962028|NCT00225277|467825657|FG001|Overall Study|Physician Decision|8|||
129962029|NCT00225277|467825656|FG000|Overall Study|Protocol Violation|6|||
129962030|NCT00225277|467825657|FG001|Overall Study|Protocol Violation|3|||
129962031|NCT00225277|467825656|FG000|Overall Study|Withdrawal by Subject|40|||
129962032|NCT00225277|467825657|FG001|Overall Study|Withdrawal by Subject|34|||
129962033|NCT00225277|467825656|FG000|Overall Study|Other|7|||
129962034|NCT00225277|467825657|FG001|Overall Study|Other|9|||
129962035|NCT04582669|467825664|FG000|Overall Study|Subject missed appointment(s).|1|||
129962036|NCT04582669|467825665|FG001|Overall Study|Subject missed appointment(s).|0|||
129962037|NCT04582669|467825666|FG002|Overall Study|Subject missed appointment(s).|1|||
129962038|NCT04582669|467825667|FG003|Overall Study|Subject missed appointment(s).|2|||
129962039|NCT04582669|467825664|FG000|Overall Study|Protocol Violation|0|||
129962040|NCT04582669|467825665|FG001|Overall Study|Protocol Violation|1|||
129962041|NCT04582669|467825666|FG002|Overall Study|Protocol Violation|1|||
129962042|NCT04582669|467825667|FG003|Overall Study|Protocol Violation|0|||
129962043|NCT00591409|467825668|FG000|Overall Study|Not Treated|0|||
129962044|NCT00591409|467825669|FG001|Overall Study|Not Treated|0|||
129962045|NCT00591409|467825670|FG002|Overall Study|Not Treated|0|||
129962046|NCT00591409|467825671|FG003|Overall Study|Not Treated|0|||
129962047|NCT00591409|467825672|FG004|Overall Study|Not Treated|1|||
129962048|NCT00591409|467825673|FG005|Overall Study|Not Treated|0|||
129962049|NCT00591409|467825674|FG006|Overall Study|Not Treated|0|||
129962050|NCT00591409|467825675|FG007|Overall Study|Not Treated|0|||
129962051|NCT00591409|467825676|FG008|Overall Study|Not Treated|0|||
129962052|NCT00591409|467825677|FG009|Overall Study|Not Treated|1|||
129962053|NCT00677092|467825678|FG000|Overall Study|Adverse Event|1|||
129962054|NCT00677092|467825678|FG000|Overall Study|Lost to Follow-up|1|||
129962055|NCT00677092|467825678|FG000|Overall Study|Withdrawal by Subject|3|||
129962056|NCT00677092|467825678|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
129962057|NCT00920699|467825679|FG000|Overall Study|Withdrawal by Subject|2|||
129962058|NCT00920699|467825680|FG001|Overall Study|Withdrawal by Subject|0|||
129962059|NCT00920699|467825681|FG002|Overall Study|Withdrawal by Subject|2|||
129962060|NCT00920699|467825679|FG000|Overall Study|no longer met eligibility|0|||
129962061|NCT00920699|467825680|FG001|Overall Study|no longer met eligibility|1|||
129962062|NCT00920699|467825681|FG002|Overall Study|no longer met eligibility|0|||
129962063|NCT00920699|467825679|FG000|Overall Study|Lost to Follow-up|0|||
129962064|NCT00920699|467825680|FG001|Overall Study|Lost to Follow-up|0|||
129962065|NCT00920699|467825681|FG002|Overall Study|Lost to Follow-up|2|||
129962066|NCT00363649|467825684|FG000|Overall Study|Withdrawal by Subject|1|||
129962067|NCT00363649|467825685|FG001|Overall Study|Withdrawal by Subject|1|||
129962068|NCT00363649|467825684|FG000|Overall Study|Adverse Event|6|||
129962069|NCT00363649|467825685|FG001|Overall Study|Adverse Event|0|||
129962070|NCT04947436|467825688|FG000|Overall Study|Lost to Follow-up|3|||
129962071|NCT04947436|467825689|FG001|Overall Study|Lost to Follow-up|7|||
129962072|NCT04947436|467825690|FG002|Overall Study|Lost to Follow-up|5|||
129962073|NCT04947436|467825688|FG000|Overall Study|Death|1|||
129962074|NCT04947436|467825689|FG001|Overall Study|Death|1|||
129962075|NCT04947436|467825690|FG002|Overall Study|Death|1|||
129962076|NCT02161185|467825692|FG000|Treatment Phase|Administrative/Other|7|||
129962077|NCT00372255|467825693|FG000|Overall Study|Withdrawn for other reasons|2|||
129962078|NCT00372255|467825694|FG001|Overall Study|Withdrawn for other reasons|1|||
129962079|NCT02970305|467825700|FG000|Overall Study|Adverse Event|10|||
129962080|NCT02970305|467825701|FG001|Overall Study|Adverse Event|6|||
129962081|NCT02970305|467825700|FG000|Overall Study|Lack of Efficacy|1|||
129962082|NCT02970305|467825701|FG001|Overall Study|Lack of Efficacy|1|||
129962083|NCT02970305|467825700|FG000|Overall Study|Noncompliance with study drug|2|||
129962084|NCT02970305|467825701|FG001|Overall Study|Noncompliance with study drug|4|||
129962085|NCT02970305|467825700|FG000|Overall Study|Protocol Violation|2|||
129455046|NCT01840579|465962904|FG005|Overall Study|Death|1|||
129455047|NCT01840579|465962905|FG006|Overall Study|Death|0|||
129455048|NCT01840579|465962906|FG007|Overall Study|Death|0|||
129962086|NCT02970305|467825701|FG001|Overall Study|Protocol Violation|2|||
129962087|NCT02970305|467825700|FG000|Overall Study|Withdrawal by Subject|12|||
129962088|NCT02970305|467825701|FG001|Overall Study|Withdrawal by Subject|11|||
129962089|NCT02970305|467825700|FG000|Overall Study|Not further specified|1|||
129962090|NCT02970305|467825701|FG001|Overall Study|Not further specified|2|||
129962091|NCT02970305|467825700|FG000|Overall Study|Lost to Follow-up|1|||
129455049|NCT01840579|465962907|FG008|Overall Study|Death|0|||
129455050|NCT01840579|465962908|FG009|Overall Study|Death|0|||
129962092|NCT02970305|467825701|FG001|Overall Study|Lost to Follow-up|2|||
129962093|NCT00983892|467825702|FG000|Overall Study|Withdrawal by Subject|10|||
129455051|NCT01840579|465962899|FG000|Overall Study|Adverse Event|0|||
129455052|NCT01840579|465962900|FG001|Overall Study|Adverse Event|1|||
129455053|NCT01840579|465962901|FG002|Overall Study|Adverse Event|0|||
129455054|NCT01840579|465962902|FG003|Overall Study|Adverse Event|0|||
129455055|NCT01840579|465962903|FG004|Overall Study|Adverse Event|0|||
129455056|NCT01840579|465962904|FG005|Overall Study|Adverse Event|0|||
129455057|NCT01840579|465962905|FG006|Overall Study|Adverse Event|0|||
129455058|NCT01840579|465962906|FG007|Overall Study|Adverse Event|0|||
129455059|NCT01840579|465962907|FG008|Overall Study|Adverse Event|0|||
129455060|NCT01840579|465962908|FG009|Overall Study|Adverse Event|0|||
129455061|NCT01840579|465962899|FG000|Overall Study|Follow-up ended by Sponsor|0|||
129455062|NCT01840579|465962900|FG001|Overall Study|Follow-up ended by Sponsor|0|||
129455063|NCT01840579|465962901|FG002|Overall Study|Follow-up ended by Sponsor|0|||
129455064|NCT01840579|465962902|FG003|Overall Study|Follow-up ended by Sponsor|0|||
129455065|NCT01840579|465962903|FG004|Overall Study|Follow-up ended by Sponsor|0|||
129455066|NCT01840579|465962904|FG005|Overall Study|Follow-up ended by Sponsor|0|||
129455067|NCT01840579|465962905|FG006|Overall Study|Follow-up ended by Sponsor|2|||
129455068|NCT01840579|465962906|FG007|Overall Study|Follow-up ended by Sponsor|0|||
129455069|NCT01840579|465962907|FG008|Overall Study|Follow-up ended by Sponsor|0|||
129455070|NCT01840579|465962908|FG009|Overall Study|Follow-up ended by Sponsor|0|||
129455071|NCT05419128|465962910|FG000|Overall Study|Withdrawal by Subject|1|||
129455072|NCT05419128|465962911|FG001|Overall Study|Withdrawal by Subject|1|||
129455073|NCT05419128|465962912|FG002|Overall Study|Withdrawal by Subject|0|||
129455074|NCT05419128|465962913|FG003|Overall Study|Withdrawal by Subject|1|||
129455075|NCT05419128|465962914|FG004|Overall Study|Withdrawal by Subject|1|||
129455076|NCT05419128|465962915|FG005|Overall Study|Withdrawal by Subject|0|||
129455077|NCT05419128|465962910|FG000|Overall Study|Lost to Follow-up|0|||
129455078|NCT05419128|465962911|FG001|Overall Study|Lost to Follow-up|0|||
129455079|NCT05419128|465962912|FG002|Overall Study|Lost to Follow-up|1|||
129455080|NCT05419128|465962913|FG003|Overall Study|Lost to Follow-up|0|||
129455081|NCT05419128|465962914|FG004|Overall Study|Lost to Follow-up|0|||
129455082|NCT05419128|465962915|FG005|Overall Study|Lost to Follow-up|1|||
129455083|NCT03834519|465962916|FG000|Overall Study|Lost to Follow-up|2|||
129455084|NCT03834519|465962917|FG001|Overall Study|Lost to Follow-up|1|||
129455085|NCT03834519|465962916|FG000|Overall Study|Withdrawal by Subject|5|||
129455086|NCT03834519|465962917|FG001|Overall Study|Withdrawal by Subject|8|||
129455087|NCT03834519|465962916|FG000|Overall Study|Death|368|||
129455088|NCT03834519|465962917|FG001|Overall Study|Death|174|||
129455089|NCT03834519|465962916|FG000|Overall Study|Physician Decision|5|||
129455090|NCT03834519|465962917|FG001|Overall Study|Physician Decision|1|||
129455091|NCT03834519|465962916|FG000|Overall Study|Sponsor decision|149|||
129455092|NCT03834519|465962917|FG001|Overall Study|Sponsor decision|80|||
129455093|NCT04066491|465962918|FG000|Overall Study|Randomized, not treated|0|||
129455094|NCT04066491|465962919|FG001|Overall Study|Randomized, not treated|0|||
129455095|NCT04066491|465962920|FG002|Overall Study|Randomized, not treated|2|||
129455096|NCT04506086|465962921|FG000|Overall Study|Withdrawal by Subject|2|||
129455097|NCT00517751|465962922|FG000|Overall Study|Death|3|||
129455098|NCT00517751|465962922|FG000|Overall Study|Withdrawal by Subject|37|||
129455099|NCT00517751|465962922|FG000|Overall Study|Lost to Follow-up|4|||
129455100|NCT00517751|465962922|FG000|Overall Study|patient not over due|6|||
129455101|NCT00517751|465962922|FG000|Overall Study|Patient not due for visit|76|||
129455102|NCT00517751|465962922|FG000|Overall Study|Missing|3|||
129455103|NCT00495820|465962923|FG000|Overall Study|Adverse Event|1|||
129455104|NCT00495820|465962924|FG001|Overall Study|Adverse Event|1|||
129455105|NCT00820950|465962925|FG000|Overall Study|Scheduling Conflict|0|||
129455106|NCT00820950|465962926|FG001|Overall Study|Scheduling Conflict|0|||
129455107|NCT00820950|465962927|FG002|Overall Study|Scheduling Conflict|0|||
129455108|NCT00820950|465962928|FG003|Overall Study|Scheduling Conflict|0|||
129455109|NCT00820950|465962929|FG004|Overall Study|Scheduling Conflict|0|||
129455110|NCT00820950|465962930|FG005|Overall Study|Scheduling Conflict|0|||
129455111|NCT00820950|465962931|FG006|Overall Study|Scheduling Conflict|1|||
129455112|NCT00820950|465962932|FG007|Overall Study|Scheduling Conflict|1|||
129455113|NCT00820950|465962933|FG008|Overall Study|Scheduling Conflict|0|||
129455114|NCT00820950|465962934|FG009|Overall Study|Scheduling Conflict|0|||
129455115|NCT00820950|465962925|FG000|Overall Study|Protocol Violation|1|||
129455116|NCT00820950|465962926|FG001|Overall Study|Protocol Violation|1|||
129455117|NCT00820950|465962927|FG002|Overall Study|Protocol Violation|0|||
129455118|NCT00820950|465962928|FG003|Overall Study|Protocol Violation|0|||
129455119|NCT00820950|465962929|FG004|Overall Study|Protocol Violation|0|||
129455120|NCT00820950|465962930|FG005|Overall Study|Protocol Violation|0|||
129455121|NCT00820950|465962931|FG006|Overall Study|Protocol Violation|0|||
129455122|NCT00820950|465962932|FG007|Overall Study|Protocol Violation|0|||
129455123|NCT00820950|465962933|FG008|Overall Study|Protocol Violation|0|||
129455124|NCT00820950|465962934|FG009|Overall Study|Protocol Violation|0|||
129455125|NCT03416153|465962935|FG000|Overall Study|Physician Decision|1|||
129455126|NCT03416153|465962936|FG001|Overall Study|Physician Decision|1|||
129455127|NCT03416153|465962935|FG000|Overall Study|Withdrawal by Subject|1|||
129455128|NCT03416153|465962936|FG001|Overall Study|Withdrawal by Subject|0|||
129455129|NCT01429584|465964530|FG000|Overall Study|Withdrawal by Subject|1|||
129455130|NCT01429584|465964531|FG001|Overall Study|Withdrawal by Subject|0|||
129455131|NCT01429584|465964530|FG000|Overall Study|Protocol Violation|0|||
129455132|NCT01429584|465964531|FG001|Overall Study|Protocol Violation|1|||
129455133|NCT03557281|465964535|FG000|Overall Study|Investigator discretion|0|||
129455134|NCT03557281|465964536|FG001|Overall Study|Investigator discretion|0|||
129455135|NCT03557281|465964537|FG002|Overall Study|Investigator discretion|1|||
129455136|NCT03557281|465964538|FG003|Overall Study|Investigator discretion|0|||
129455137|NCT03557281|465964539|FG004|Overall Study|Investigator discretion|0|||
129455138|NCT03557281|465964535|FG000|Overall Study|Withdrawal by Subject|0|||
129455139|NCT03557281|465964536|FG001|Overall Study|Withdrawal by Subject|1|||
129455140|NCT03557281|465964537|FG002|Overall Study|Withdrawal by Subject|1|||
129455141|NCT03557281|465964538|FG003|Overall Study|Withdrawal by Subject|1|||
129455142|NCT03557281|465964539|FG004|Overall Study|Withdrawal by Subject|2|||
129455143|NCT03557281|465964535|FG000|Overall Study|Randomized, but did not receive treatment|0|||
129455144|NCT03557281|465964536|FG001|Overall Study|Randomized, but did not receive treatment|0|||
129455145|NCT03557281|465964537|FG002|Overall Study|Randomized, but did not receive treatment|0|||
129455146|NCT03557281|465964538|FG003|Overall Study|Randomized, but did not receive treatment|0|||
129455147|NCT03557281|465964539|FG004|Overall Study|Randomized, but did not receive treatment|1|||
129455148|NCT01199042|465964542|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
129455149|NCT01199042|465964542|FG000|At Home (3 Months)|Lost to Follow-up|1|||
129455150|NCT01999465|465964543|FG000|Overall Study|Lost to Follow-up|0|||
129455151|NCT01999465|465964544|FG001|Overall Study|Lost to Follow-up|2|||
129455152|NCT01999465|465964543|FG000|Overall Study|Protocol Violation|0|||
129455153|NCT01999465|465964544|FG001|Overall Study|Protocol Violation|1|||
129455154|NCT02463409|465964547|FG000|Overall Study|Withdrawal by Subject|1|||
129455155|NCT02463409|465964547|FG000|Overall Study|Screen failure|1|||
129455156|NCT02819635|465964549|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
129455157|NCT02819635|465964550|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
129455158|NCT02819635|465964551|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
129455159|NCT02819635|465964552|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
129455160|NCT02819635|465964553|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
129455161|NCT02819635|465964554|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
129455162|NCT02819635|465964555|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
129962094|NCT00983892|467825703|FG001|Overall Study|Withdrawal by Subject|12|||
129962095|NCT00312845|467825704|FG000|Overall Study|Adverse Event|19|||
129962096|NCT00312845|467825705|FG001|Overall Study|Adverse Event|5|||
129962097|NCT00312845|467825704|FG000|Overall Study|Death|2|||
129962098|NCT00312845|467825705|FG001|Overall Study|Death|2|||
129962099|NCT00312845|467825704|FG000|Overall Study|Withdrawal by Subject|14|||
129962100|NCT00312845|467825705|FG001|Overall Study|Withdrawal by Subject|6|||
129962101|NCT00312845|467825704|FG000|Overall Study|Disease Progression|56|||
129962102|NCT00312845|467825705|FG001|Overall Study|Disease Progression|77|||
129962103|NCT00312845|467825704|FG000|Overall Study|Lost to Follow-up|2|||
129962104|NCT00312845|467825705|FG001|Overall Study|Lost to Follow-up|0|||
129962105|NCT00312845|467825704|FG000|Overall Study|Other|6|||
129962106|NCT00312845|467825705|FG001|Overall Study|Other|5|||
129962107|NCT03512288|467825708|FG000|Overall Study|Adverse Event|1|||
129962108|NCT03512288|467825709|FG001|Overall Study|Adverse Event|0|||
129962109|NCT03512288|467825708|FG000|Overall Study|Lost to Follow-up|12|||
129962110|NCT03512288|467825709|FG001|Overall Study|Lost to Follow-up|15|||
129962111|NCT03512288|467825708|FG000|Overall Study|Physician Decision|0|||
129962112|NCT03512288|467825709|FG001|Overall Study|Physician Decision|2|||
129962113|NCT03512288|467825708|FG000|Overall Study|Protocol Violation|6|||
129962114|NCT03512288|467825709|FG001|Overall Study|Protocol Violation|4|||
129962115|NCT03512288|467825708|FG000|Overall Study|Medication error without associated adverse event|1|||
129455163|NCT02819635|465964556|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
129455164|NCT02819635|465964557|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
129455165|NCT02819635|465964558|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
129455166|NCT02819635|465964559|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
129455167|NCT02819635|465964560|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
129962116|NCT03512288|467825709|FG001|Overall Study|Medication error without associated adverse event|0|||
129962117|NCT03512288|467825708|FG000|Overall Study|No longer met eligibility criteria|5|||
129962118|NCT03512288|467825709|FG001|Overall Study|No longer met eligibility criteria|2|||
129962119|NCT03512288|467825708|FG000|Overall Study|Withdrawal by parent/guardian|14|||
129962120|NCT03512288|467825709|FG001|Overall Study|Withdrawal by parent/guardian|18|||
129962121|NCT03512288|467825708|FG000|Overall Study|Other|1|||
129962122|NCT03512288|467825709|FG001|Overall Study|Other|1|||
129962123|NCT03512288|467825708|FG000|Overall Study|Randomized but not treated|1|||
129962124|NCT03512288|467825709|FG001|Overall Study|Randomized but not treated|1|||
129962125|NCT01208870|467825710|FG000|Overall Study|Lost to Follow-up|2|||
129962126|NCT01208870|467825711|FG001|Overall Study|Lost to Follow-up|8|||
129962127|NCT02930837|467825714|FG000|Overall Study|Adverse Event|6|||
129962128|NCT02930837|467825714|FG000|Overall Study|Lost to Follow-up|5|||
129962129|NCT02930837|467825714|FG000|Overall Study|Withdrawal by Subject|1|||
129962130|NCT01393613|467825715|FG000|Overall Study|Adverse Event|11|||
129962131|NCT01393613|467825716|FG001|Overall Study|Adverse Event|11|||
129962132|NCT01393613|467825717|FG002|Overall Study|Adverse Event|13|||
129962133|NCT01393613|467825718|FG003|Overall Study|Adverse Event|22|||
129962134|NCT01393613|467825715|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
129962135|NCT01393613|467825716|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
129962136|NCT01393613|467825717|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
129962137|NCT01393613|467825718|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
129962138|NCT01393613|467825715|FG000|Overall Study|Physician Decision|2|||
129962139|NCT01393613|467825716|FG001|Overall Study|Physician Decision|0|||
129962140|NCT01393613|467825717|FG002|Overall Study|Physician Decision|0|||
129962141|NCT01393613|467825718|FG003|Overall Study|Physician Decision|1|||
129962142|NCT01393613|467825715|FG000|Overall Study|Withdrawal by Subject|15|||
129962143|NCT01393613|467825716|FG001|Overall Study|Withdrawal by Subject|25|||
129962144|NCT01393613|467825717|FG002|Overall Study|Withdrawal by Subject|23|||
129962145|NCT01393613|467825718|FG003|Overall Study|Withdrawal by Subject|21|||
129962146|NCT01393613|467825715|FG000|Overall Study|Protocol Deviation|2|||
129962147|NCT01393613|467825716|FG001|Overall Study|Protocol Deviation|1|||
129962148|NCT01393613|467825717|FG002|Overall Study|Protocol Deviation|0|||
129962149|NCT01393613|467825718|FG003|Overall Study|Protocol Deviation|0|||
129962150|NCT01393613|467825715|FG000|Overall Study|Lack of Efficacy|9|||
129962151|NCT01393613|467825716|FG001|Overall Study|Lack of Efficacy|20|||
129962152|NCT01393613|467825717|FG002|Overall Study|Lack of Efficacy|16|||
129962153|NCT01393613|467825718|FG003|Overall Study|Lack of Efficacy|21|||
129962154|NCT03821064|467825721|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
129962155|NCT01283971|467825724|FG000|Overall Study|Adverse Event|3|||
129962156|NCT01283971|467825725|FG001|Overall Study|Adverse Event|5|||
129962157|NCT01283971|467825724|FG000|Overall Study|Insufficient therapeutic responses|3|||
129962158|NCT01283971|467825725|FG001|Overall Study|Insufficient therapeutic responses|3|||
129962159|NCT01283971|467825724|FG000|Overall Study|Protocol Violation|5|||
129962160|NCT01283971|467825725|FG001|Overall Study|Protocol Violation|1|||
129962161|NCT01283971|467825724|FG000|Overall Study|Refused treatment|3|||
129962162|NCT01283971|467825725|FG001|Overall Study|Refused treatment|1|||
129962163|NCT01283971|467825724|FG000|Overall Study|Failure to return|0|||
129962164|NCT01283971|467825725|FG001|Overall Study|Failure to return|1|||
129962165|NCT01283971|467825724|FG000|Overall Study|Administrative reasons|1|||
129962166|NCT01283971|467825725|FG001|Overall Study|Administrative reasons|1|||
129962167|NCT02598934|467825734|FG000|Overall Study|Adverse Event|11|||
129962168|NCT02598934|467825735|FG001|Overall Study|Adverse Event|13|||
129962169|NCT02598934|467825734|FG000|Overall Study|Failure to Return|3|||
129962170|NCT02598934|467825735|FG001|Overall Study|Failure to Return|3|||
129962171|NCT02598934|467825734|FG000|Overall Study|Withdrawal by Subject|2|||
129962172|NCT02598934|467825735|FG001|Overall Study|Withdrawal by Subject|3|||
129962173|NCT02598934|467825734|FG000|Overall Study|Administrative|2|||
129962174|NCT02598934|467825735|FG001|Overall Study|Administrative|1|||
129962175|NCT02598934|467825734|FG000|Overall Study|Protocol Violation|1|||
129962176|NCT02598934|467825735|FG001|Overall Study|Protocol Violation|2|||
129962177|NCT03325608|467825738|FG000|Overall Study|Lost to Follow-up|23|||
129962178|NCT03325608|467825739|FG001|Overall Study|Lost to Follow-up|23|||
129962179|NCT03325608|467825740|FG002|Overall Study|Lost to Follow-up|30|||
129962180|NCT03325608|467825741|FG003|Overall Study|Lost to Follow-up|30|||
129962181|NCT03325608|467825738|FG000|Overall Study|Death of Caregiver|0|||
129962182|NCT03325608|467825739|FG001|Overall Study|Death of Caregiver|0|||
129962183|NCT03325608|467825740|FG002|Overall Study|Death of Caregiver|2|||
129962184|NCT03325608|467825741|FG003|Overall Study|Death of Caregiver|2|||
129962185|NCT03325608|467825738|FG000|Overall Study|Death of Care Recipient|34|||
129962186|NCT03325608|467825739|FG001|Overall Study|Death of Care Recipient|34|||
129962187|NCT03325608|467825740|FG002|Overall Study|Death of Care Recipient|28|||
129962188|NCT03325608|467825741|FG003|Overall Study|Death of Care Recipient|28|||
129962189|NCT03325608|467825738|FG000|Overall Study|Withdrawal by Subject|49|||
129962190|NCT03325608|467825739|FG001|Overall Study|Withdrawal by Subject|49|||
129962191|NCT03325608|467825740|FG002|Overall Study|Withdrawal by Subject|35|||
129962192|NCT03325608|467825741|FG003|Overall Study|Withdrawal by Subject|35|||
129962193|NCT03325608|467825738|FG000|Overall Study|Ineligible|7|||
129962194|NCT03325608|467825739|FG001|Overall Study|Ineligible|7|||
129962195|NCT03325608|467825740|FG002|Overall Study|Ineligible|5|||
129962196|NCT03325608|467825741|FG003|Overall Study|Ineligible|5|||
129962197|NCT02188784|467825742|FG000|Overall Study|Death|3|||
129962198|NCT02188784|467825743|FG001|Overall Study|Death|1|||
129962199|NCT02188784|467825742|FG000|Overall Study|Lost to Follow-up|1|||
129962200|NCT02188784|467825743|FG001|Overall Study|Lost to Follow-up|0|||
129962201|NCT02188784|467825742|FG000|Overall Study|Withdrawal by Subject|3|||
129962202|NCT02188784|467825743|FG001|Overall Study|Withdrawal by Subject|9|||
129962203|NCT02188784|467825742|FG000|Overall Study|Physician Decision|2|||
129962204|NCT02188784|467825743|FG001|Overall Study|Physician Decision|3|||
129962205|NCT04944784|467825744|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
129962206|NCT04944784|467825745|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
129962207|NCT04944784|467825746|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
129962208|NCT04944784|467825747|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
129962209|NCT04944784|467825744|FG000|Double-blind Period|Adverse Event|20|||
129962210|NCT04944784|467825745|FG001|Double-blind Period|Adverse Event|4|||
129962211|NCT04944784|467825746|FG002|Double-blind Period|Adverse Event|0|||
129962212|NCT04944784|467825747|FG003|Double-blind Period|Adverse Event|0|||
129962213|NCT04944784|467825744|FG000|Double-blind Period|Withdrawal by Subject|15|||
129962214|NCT04944784|467825745|FG001|Double-blind Period|Withdrawal by Subject|4|||
129962215|NCT04944784|467825746|FG002|Double-blind Period|Withdrawal by Subject|0|||
129962216|NCT04944784|467825747|FG003|Double-blind Period|Withdrawal by Subject|0|||
129962217|NCT04944784|467825744|FG000|Double-blind Period|Death|7|||
129962218|NCT04944784|467825745|FG001|Double-blind Period|Death|2|||
129962219|NCT04944784|467825746|FG002|Double-blind Period|Death|0|||
129962220|NCT04944784|467825747|FG003|Double-blind Period|Death|0|||
129962221|NCT04944784|467825744|FG000|Double-blind Period|Physician Decision|2|||
129962222|NCT04944784|467825745|FG001|Double-blind Period|Physician Decision|1|||
129962223|NCT04944784|467825746|FG002|Double-blind Period|Physician Decision|0|||
129962224|NCT04944784|467825747|FG003|Double-blind Period|Physician Decision|0|||
129962225|NCT04944784|467825744|FG000|Double-blind Period|Lack of Efficacy|0|||
129962226|NCT04944784|467825745|FG001|Double-blind Period|Lack of Efficacy|1|||
129962227|NCT04944784|467825746|FG002|Double-blind Period|Lack of Efficacy|0|||
129962228|NCT04944784|467825747|FG003|Double-blind Period|Lack of Efficacy|0|||
129962229|NCT04944784|467825744|FG000|Double-blind Period|Sponsor Request|2|||
129962230|NCT04944784|467825745|FG001|Double-blind Period|Sponsor Request|1|||
129962231|NCT04944784|467825746|FG002|Double-blind Period|Sponsor Request|0|||
129962232|NCT04944784|467825747|FG003|Double-blind Period|Sponsor Request|0|||
129962233|NCT04944784|467825744|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
129962234|NCT04944784|467825745|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
129962235|NCT04944784|467825746|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
129962236|NCT04944784|467825747|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
129962237|NCT04944784|467825744|FG000|Double-blind Period|Participant Choice|1|||
129962238|NCT04944784|467825745|FG001|Double-blind Period|Participant Choice|1|||
129962239|NCT04944784|467825746|FG002|Double-blind Period|Participant Choice|0|||
129962240|NCT04944784|467825747|FG003|Double-blind Period|Participant Choice|0|||
129962241|NCT04944784|467825744|FG000|Double-blind Period|Progressive Disease|2|||
129962242|NCT04944784|467825745|FG001|Double-blind Period|Progressive Disease|2|||
129962243|NCT04944784|467825746|FG002|Double-blind Period|Progressive Disease|0|||
129962244|NCT04944784|467825747|FG003|Double-blind Period|Progressive Disease|0|||
129962245|NCT04944784|467825744|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
129962246|NCT04944784|467825745|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
129962247|NCT04944784|467825746|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
129962248|NCT04944784|467825747|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
129962249|NCT04944784|467825744|FG000|Active Drug Period|Adverse Event|0|||
129962250|NCT04944784|467825745|FG001|Active Drug Period|Adverse Event|0|||
129962251|NCT04944784|467825746|FG002|Active Drug Period|Adverse Event|3|||
129962252|NCT04944784|467825747|FG003|Active Drug Period|Adverse Event|6|||
129962253|NCT04944784|467825744|FG000|Active Drug Period|Withdrawal by Subject|0|||
129962254|NCT04944784|467825745|FG001|Active Drug Period|Withdrawal by Subject|0|||
129962255|NCT04944784|467825746|FG002|Active Drug Period|Withdrawal by Subject|4|||
129962256|NCT04944784|467825747|FG003|Active Drug Period|Withdrawal by Subject|7|||
129962257|NCT04944784|467825744|FG000|Active Drug Period|Death|0|||
129962258|NCT04944784|467825745|FG001|Active Drug Period|Death|0|||
129962259|NCT04944784|467825746|FG002|Active Drug Period|Death|3|||
129962260|NCT04944784|467825747|FG003|Active Drug Period|Death|4|||
129962261|NCT04944784|467825744|FG000|Active Drug Period|Lack of Efficacy|0|||
129962262|NCT04944784|467825745|FG001|Active Drug Period|Lack of Efficacy|0|||
129962263|NCT04944784|467825746|FG002|Active Drug Period|Lack of Efficacy|2|||
129962264|NCT04944784|467825747|FG003|Active Drug Period|Lack of Efficacy|2|||
129962265|NCT04944784|467825744|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
129962266|NCT04944784|467825745|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
129962267|NCT04944784|467825746|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
129962268|NCT04944784|467825747|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
129962269|NCT04944784|467825744|FG000|Active Drug Period|Participant Choice|0|||
129962270|NCT04944784|467825745|FG001|Active Drug Period|Participant Choice|0|||
129962271|NCT04944784|467825746|FG002|Active Drug Period|Participant Choice|0|||
129962272|NCT04944784|467825747|FG003|Active Drug Period|Participant Choice|1|||
129962273|NCT04944784|467825744|FG000|Active Drug Period|Progressive Disease|0|||
129962274|NCT04944784|467825745|FG001|Active Drug Period|Progressive Disease|0|||
129962275|NCT04944784|467825746|FG002|Active Drug Period|Progressive Disease|4|||
129962276|NCT04944784|467825747|FG003|Active Drug Period|Progressive Disease|4|||
129962277|NCT04944784|467825744|FG000|Active Drug Period|Lost to Follow-up|0|||
129962278|NCT04944784|467825745|FG001|Active Drug Period|Lost to Follow-up|0|||
129962279|NCT04944784|467825746|FG002|Active Drug Period|Lost to Follow-up|0|||
129962280|NCT04944784|467825747|FG003|Active Drug Period|Lost to Follow-up|1|||
129962281|NCT00853372|467827065|FG000|Overall Study|Death|30|||
129962282|NCT00853372|467827066|FG001|Overall Study|Death|26|||
129962283|NCT00853372|467827065|FG000|Overall Study|Lost to Follow-up|1|||
129962284|NCT00853372|467827066|FG001|Overall Study|Lost to Follow-up|2|||
129962285|NCT00853372|467827065|FG000|Overall Study|Full Consent Withdrawn|1|||
129962286|NCT00853372|467827066|FG001|Overall Study|Full Consent Withdrawn|1|||
129962287|NCT01268098|467827069|FG000|Overall Study|Adverse Event|1|||
129962288|NCT01268098|467827070|FG001|Overall Study|Adverse Event|0|||
129962289|NCT01929876|467827072|FG000|Period 2|Non-Compliance|1|||
129962290|NCT01845649|467827073|FG000|Overall Study|Adverse Event|7|||
129962291|NCT01845649|467827074|FG001|Overall Study|Adverse Event|10|||
129962292|NCT01845649|467827073|FG000|Overall Study|Lack of Efficacy|1|||
129962293|NCT01845649|467827074|FG001|Overall Study|Lack of Efficacy|1|||
129962294|NCT01845649|467827073|FG000|Overall Study|Lost to Follow-up|2|||
129962295|NCT01845649|467827074|FG001|Overall Study|Lost to Follow-up|2|||
129962296|NCT01845649|467827073|FG000|Overall Study|Withdrew Consent|12|||
129962297|NCT01845649|467827074|FG001|Overall Study|Withdrew Consent|4|||
129962298|NCT01845649|467827073|FG000|Overall Study|Protocol Deviation|7|||
129962299|NCT01845649|467827074|FG001|Overall Study|Protocol Deviation|4|||
129962300|NCT01845649|467827073|FG000|Overall Study|Reason not Specified|2|||
129962301|NCT01845649|467827074|FG001|Overall Study|Reason not Specified|1|||
129962302|NCT03991988|467827075|FG000|Overall Study|Withdrawal by Subject|2|||
129962303|NCT03991988|467827076|FG001|Overall Study|Withdrawal by Subject|2|||
129962304|NCT02418845|467827078|FG000|Overall Study|Lost to Follow-up|7|||
129962305|NCT02418845|467827079|FG001|Overall Study|Lost to Follow-up|2|||
129962306|NCT02418845|467827078|FG000|Overall Study|Lack of Efficacy|0|||
129962307|NCT02418845|467827079|FG001|Overall Study|Lack of Efficacy|3|||
129962308|NCT02418845|467827078|FG000|Overall Study|Physician Decision|5|||
129962309|NCT02418845|467827079|FG001|Overall Study|Physician Decision|5|||
129962310|NCT02418845|467827078|FG000|Overall Study|Protocol Violation|1|||
129962311|NCT02418845|467827079|FG001|Overall Study|Protocol Violation|0|||
129962312|NCT02418845|467827078|FG000|Overall Study|Withdrawal by Subject|3|||
129962313|NCT02418845|467827079|FG001|Overall Study|Withdrawal by Subject|2|||
129962314|NCT00487552|467827080|FG000|Overall Study|Unsuccessful magnet placements|3|||
129962315|NCT00487552|467827080|FG000|Overall Study|Death due to progressive malignancy|2|||
129962316|NCT00487552|467827080|FG000|Overall Study|Stent not placed|1|||
129962317|NCT02412111|467827081|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
129962318|NCT02412111|467827082|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
129962319|NCT02412111|467827083|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
129962320|NCT02412111|467827081|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
129962321|NCT02412111|467827082|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
129962322|NCT02412111|467827083|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
129962323|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
129962324|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
129962325|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
129962326|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
129962327|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
129962328|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
129962329|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
129962330|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
129962331|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
129962332|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
129962333|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
129962334|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
129962335|NCT02412111|467827081|FG000|Active Comparator Period (8 Weeks)|Other|0|||
129962336|NCT02412111|467827082|FG001|Active Comparator Period (8 Weeks)|Other|0|||
129962337|NCT02412111|467827083|FG002|Active Comparator Period (8 Weeks)|Other|2|||
129962338|NCT01057251|467827085|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
129962339|NCT01057251|467827086|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
129962340|NCT01057251|467827085|FG000|Overall Study|Adverse Event|4|||
129962341|NCT01057251|467827086|FG001|Overall Study|Adverse Event|2|||
129962342|NCT01057251|467827085|FG000|Overall Study|Lack of Efficacy|2|||
129962343|NCT01057251|467827086|FG001|Overall Study|Lack of Efficacy|11|||
129962344|NCT01057251|467827085|FG000|Overall Study|Protocol Violation|6|||
129962345|NCT01057251|467827086|FG001|Overall Study|Protocol Violation|2|||
129962346|NCT01057251|467827085|FG000|Overall Study|Withdrawal by Subject|4|||
129962347|NCT01057251|467827086|FG001|Overall Study|Withdrawal by Subject|5|||
129962348|NCT01057251|467827085|FG000|Overall Study|Lost to Follow-up|7|||
129962349|NCT01057251|467827086|FG001|Overall Study|Lost to Follow-up|6|||
129962350|NCT01057251|467827085|FG000|Overall Study|Other Reason|1|||
129962351|NCT01057251|467827086|FG001|Overall Study|Other Reason|1|||
129962352|NCT00784147|467827087|FG000|Overall Study|Lost to Follow-up|2|||
129962353|NCT00784147|467827088|FG001|Overall Study|Lost to Follow-up|4|||
129962354|NCT00784147|467827087|FG000|Overall Study|Withdrawal by Subject|1|||
129962355|NCT00784147|467827088|FG001|Overall Study|Withdrawal by Subject|3|||
129962356|NCT00784147|467827087|FG000|Overall Study|Physician Decision|2|||
129962357|NCT00784147|467827088|FG001|Overall Study|Physician Decision|1|||
129962358|NCT00784147|467827087|FG000|Overall Study|Protocol Violation|1|||
129962359|NCT00784147|467827088|FG001|Overall Study|Protocol Violation|1|||
129962360|NCT00784147|467827087|FG000|Overall Study|Death|2|||
129962361|NCT00784147|467827088|FG001|Overall Study|Death|0|||
129962362|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
129962363|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
129962364|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
129962365|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
129962366|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
129962367|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
129962368|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
129455168|NCT02819635|465964549|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455169|NCT02819635|465964550|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455170|NCT02819635|465964551|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455171|NCT02819635|465964552|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455172|NCT02819635|465964553|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
129455173|NCT02819635|465964554|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
129455174|NCT02819635|465964555|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
129455175|NCT02819635|465964556|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455176|NCT02819635|465964557|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455177|NCT02819635|465964558|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455178|NCT02819635|465964559|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455179|NCT02819635|465964560|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
129455180|NCT02819635|465964549|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455181|NCT02819635|465964550|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455182|NCT02819635|465964551|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455183|NCT02819635|465964552|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455184|NCT02819635|465964553|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455185|NCT02819635|465964554|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
129455186|NCT02819635|465964555|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
129962369|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
129962370|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
129962371|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
129962372|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
129962373|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
129962374|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
129962375|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
129962376|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
129962377|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
129962378|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
129962379|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
129962380|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
129962381|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
129962382|NCT02637856|467827089|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
129962383|NCT02637856|467827090|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
129962384|NCT02637856|467827089|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
129962385|NCT02637856|467827090|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
129962386|NCT02637856|467827089|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
129962387|NCT02637856|467827090|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
129962388|NCT02973802|467827097|FG000|Overall Study|Lost to Follow-up|1|||
129962389|NCT02973802|467827097|FG000|Overall Study|Withdrawal by Subject|1|||
129962390|NCT03357471|467827098|FG000|Overall Study|Adverse Event|1|||
129962391|NCT03357471|467827099|FG001|Overall Study|Adverse Event|0|||
129962392|NCT03357471|467827098|FG000|Overall Study|Lost to Follow-up|1|||
129962393|NCT03357471|467827099|FG001|Overall Study|Lost to Follow-up|0|||
129962394|NCT00706914|467827100|FG000|Overall Study|Lack of Efficacy|0|||
129962395|NCT00706914|467827101|FG001|Overall Study|Lack of Efficacy|1|||
129962396|NCT00706914|467827102|FG002|Overall Study|Lack of Efficacy|0|||
129962397|NCT00706914|467827100|FG000|Overall Study|Lost to Follow-up|1|||
129962398|NCT00706914|467827101|FG001|Overall Study|Lost to Follow-up|0|||
129962399|NCT00706914|467827102|FG002|Overall Study|Lost to Follow-up|0|||
129962400|NCT00706914|467827100|FG000|Overall Study|Adverse Event|2|||
129962401|NCT00706914|467827101|FG001|Overall Study|Adverse Event|2|||
129962402|NCT00706914|467827102|FG002|Overall Study|Adverse Event|0|||
129962403|NCT00706914|467827100|FG000|Overall Study|Protocol Violation|3|||
129962404|NCT00706914|467827101|FG001|Overall Study|Protocol Violation|1|||
129962405|NCT00706914|467827102|FG002|Overall Study|Protocol Violation|1|||
129962406|NCT00702650|467827103|FG000|Overall Study|Withdrawal by Subject|9|||
129962407|NCT00702650|467827103|FG000|Overall Study|Non-Compliance of Study Drug|3|||
129962408|NCT00702650|467827103|FG000|Overall Study|Lost to Follow-up|2|||
129962409|NCT00702650|467827103|FG000|Overall Study|Non-Compliance with Site Directives|1|||
129962410|NCT00702650|467827103|FG000|Overall Study|Sponsor Request|1|||
129962411|NCT00702650|467827103|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
129962412|NCT00702650|467827103|FG000|Overall Study|Adverse Event|3|||
129962413|NCT01850823|467827104|FG000|Overall Study|Early Visit Window|0|||
129962414|NCT01850823|467827105|FG001|Overall Study|Early Visit Window|1|||
129962415|NCT01850823|467827106|FG002|Overall Study|Early Visit Window|4|||
129962416|NCT01850823|467827104|FG000|Overall Study|Enrolled in Error|0|||
129962417|NCT01850823|467827105|FG001|Overall Study|Enrolled in Error|1|||
129962418|NCT01850823|467827106|FG002|Overall Study|Enrolled in Error|2|||
129962419|NCT01850823|467827104|FG000|Overall Study|Lack of Efficacy|1|||
129962420|NCT01850823|467827105|FG001|Overall Study|Lack of Efficacy|0|||
129962421|NCT01850823|467827106|FG002|Overall Study|Lack of Efficacy|0|||
129962422|NCT01850823|467827104|FG000|Overall Study|Lost to Follow-up|0|||
129962423|NCT01850823|467827105|FG001|Overall Study|Lost to Follow-up|0|||
129962424|NCT01850823|467827106|FG002|Overall Study|Lost to Follow-up|1|||
129962425|NCT01850823|467827104|FG000|Overall Study|Restricted Medication|0|||
129962426|NCT01850823|467827105|FG001|Overall Study|Restricted Medication|0|||
129962427|NCT01850823|467827106|FG002|Overall Study|Restricted Medication|2|||
129962428|NCT01850823|467827104|FG000|Overall Study|Significant worstening of SAR|0|||
129962429|NCT01850823|467827105|FG001|Overall Study|Significant worstening of SAR|1|||
129962430|NCT01850823|467827106|FG002|Overall Study|Significant worstening of SAR|0|||
129962431|NCT01850823|467827104|FG000|Overall Study|Withdrawal by Subject|2|||
129962432|NCT01850823|467827105|FG001|Overall Study|Withdrawal by Subject|0|||
129962433|NCT01850823|467827106|FG002|Overall Study|Withdrawal by Subject|1|||
129962434|NCT01751165|467827107|FG000|Overall Study|Adverse event, serious fatal|1|||
129962435|NCT01751165|467827108|FG001|Overall Study|Adverse event, serious fatal|0|||
129962436|NCT01751165|467827109|FG002|Overall Study|Adverse event, serious fatal|1|||
129962437|NCT01751165|467827107|FG000|Overall Study|Withdrawal by Subject|0|||
129962438|NCT01751165|467827108|FG001|Overall Study|Withdrawal by Subject|0|||
129962439|NCT01751165|467827109|FG002|Overall Study|Withdrawal by Subject|1|||
129962440|NCT01751165|467827107|FG000|Overall Study|Serious adverse event|0|||
129962441|NCT01751165|467827108|FG001|Overall Study|Serious adverse event|2|||
129962442|NCT01751165|467827109|FG002|Overall Study|Serious adverse event|0|||
129962443|NCT01751165|467827107|FG000|Overall Study|Lost to Follow-up|1|||
129962444|NCT01751165|467827108|FG001|Overall Study|Lost to Follow-up|1|||
129962445|NCT01751165|467827109|FG002|Overall Study|Lost to Follow-up|1|||
129962446|NCT00988533|467827114|FG000|Overall Study|Lost to Follow-up|3|||
129962447|NCT00943722|467827117|FG000|Base Study|Adverse Event|0|||
129962448|NCT00943722|467827118|FG001|Base Study|Adverse Event|0|||
129962449|NCT00943722|467827119|FG002|Base Study|Adverse Event|0|||
129962450|NCT00943722|467827120|FG003|Base Study|Adverse Event|1|||
129962451|NCT00943722|467827121|FG004|Base Study|Adverse Event|0|||
129962452|NCT00943722|467827122|FG005|Base Study|Adverse Event|0|||
129962453|NCT00943722|467827123|FG006|Base Study|Adverse Event|0|||
129962454|NCT00943722|467827117|FG000|Base Study|Lost to Follow-up|12|||
129962455|NCT00943722|467827118|FG001|Base Study|Lost to Follow-up|8|||
129962456|NCT00943722|467827119|FG002|Base Study|Lost to Follow-up|10|||
129962457|NCT00943722|467827120|FG003|Base Study|Lost to Follow-up|8|||
129962458|NCT00943722|467827121|FG004|Base Study|Lost to Follow-up|11|||
129962459|NCT00943722|467827122|FG005|Base Study|Lost to Follow-up|0|||
129962460|NCT00943722|467827123|FG006|Base Study|Lost to Follow-up|0|||
129962461|NCT00943722|467827117|FG000|Base Study|Physician Decision|1|||
129962462|NCT00943722|467827118|FG001|Base Study|Physician Decision|0|||
129962463|NCT00943722|467827119|FG002|Base Study|Physician Decision|0|||
129962464|NCT00943722|467827120|FG003|Base Study|Physician Decision|0|||
129962465|NCT00943722|467827121|FG004|Base Study|Physician Decision|1|||
129962466|NCT00943722|467827122|FG005|Base Study|Physician Decision|0|||
129962467|NCT00943722|467827123|FG006|Base Study|Physician Decision|0|||
129962468|NCT00943722|467827117|FG000|Base Study|Pregnancy|0|||
129962469|NCT00943722|467827118|FG001|Base Study|Pregnancy|0|||
129962470|NCT00943722|467827119|FG002|Base Study|Pregnancy|1|||
129962471|NCT00943722|467827120|FG003|Base Study|Pregnancy|0|||
129962472|NCT00943722|467827121|FG004|Base Study|Pregnancy|2|||
129962473|NCT00943722|467827122|FG005|Base Study|Pregnancy|0|||
129962474|NCT00943722|467827123|FG006|Base Study|Pregnancy|0|||
129962475|NCT00943722|467827117|FG000|Base Study|Protocol Violation|0|||
129962476|NCT00943722|467827118|FG001|Base Study|Protocol Violation|1|||
129962477|NCT00943722|467827119|FG002|Base Study|Protocol Violation|0|||
129962478|NCT00943722|467827120|FG003|Base Study|Protocol Violation|0|||
129962479|NCT00943722|467827121|FG004|Base Study|Protocol Violation|2|||
129962480|NCT00943722|467827122|FG005|Base Study|Protocol Violation|0|||
129962481|NCT00943722|467827123|FG006|Base Study|Protocol Violation|0|||
129962482|NCT00943722|467827117|FG000|Base Study|Withdrawal by Subject|12|||
129962483|NCT00943722|467827118|FG001|Base Study|Withdrawal by Subject|13|||
129962484|NCT00943722|467827119|FG002|Base Study|Withdrawal by Subject|2|||
129962485|NCT00943722|467827120|FG003|Base Study|Withdrawal by Subject|13|||
129962486|NCT00943722|467827121|FG004|Base Study|Withdrawal by Subject|8|||
129962487|NCT00943722|467827122|FG005|Base Study|Withdrawal by Subject|0|||
129962488|NCT00943722|467827123|FG006|Base Study|Withdrawal by Subject|0|||
129962489|NCT00943722|467827117|FG000|Base Study|Month 12 visit not completed|0|||
129962490|NCT00943722|467827118|FG001|Base Study|Month 12 visit not completed|0|||
129962491|NCT00943722|467827119|FG002|Base Study|Month 12 visit not completed|0|||
129962492|NCT00943722|467827120|FG003|Base Study|Month 12 visit not completed|0|||
129962493|NCT00943722|467827121|FG004|Base Study|Month 12 visit not completed|2|||
129962494|NCT00943722|467827122|FG005|Base Study|Month 12 visit not completed|0|||
129962495|NCT00943722|467827123|FG006|Base Study|Month 12 visit not completed|0|||
129962496|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Adverse Event|0|||
129962497|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Adverse Event|0|||
129962498|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Adverse Event|0|||
129962499|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Adverse Event|0|||
129962500|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Adverse Event|0|||
129962501|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Adverse Event|1|||
129962502|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Adverse Event|0|||
129962503|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962504|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962505|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962506|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962507|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
129962508|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
129962509|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
129962510|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962511|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962512|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962513|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962514|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
129962515|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
129962516|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
129962517|NCT00943722|467827117|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
129962518|NCT00943722|467827118|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
129962519|NCT00943722|467827119|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
129962520|NCT00943722|467827120|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
129962521|NCT00943722|467827121|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
129962522|NCT00943722|467827122|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
129962523|NCT00943722|467827123|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
129962524|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
129962525|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
129962526|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
129962527|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
129962528|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
129962529|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
129962530|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
129962531|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962532|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962533|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962534|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962535|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
129962536|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
129962537|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
129962538|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
129962539|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
129962540|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
129962541|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
129962542|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
129962543|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
129962544|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
129962545|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
129962546|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
129962547|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
129962548|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
129962549|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
129962550|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
129488456|NCT01277289|466080717|FG000|Overall Study|Protocol Violation|1|||
129962551|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
129962552|NCT00943722|467827117|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962553|NCT00943722|467827118|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962554|NCT00943722|467827119|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962555|NCT00943722|467827120|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129488457|NCT01277289|466080718|FG001|Overall Study|Protocol Violation|1|||
129962556|NCT00943722|467827121|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
129962557|NCT00943722|467827122|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
129962558|NCT00943722|467827123|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
129962559|NCT02895360|467827128|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
129962560|NCT02895360|467827129|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962561|NCT02895360|467827130|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962562|NCT02895360|467827131|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962563|NCT02895360|467827132|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962564|NCT02895360|467827133|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
129962565|NCT02895360|467827128|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962566|NCT02895360|467827129|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
129962567|NCT02895360|467827130|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962568|NCT02895360|467827131|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962569|NCT02895360|467827132|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962570|NCT02895360|467827133|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
129962571|NCT02895360|467827128|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962572|NCT02895360|467827129|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962573|NCT02895360|467827130|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
129962574|NCT02895360|467827131|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962575|NCT02895360|467827132|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962576|NCT02895360|467827133|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
129962577|NCT02895360|467827128|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962578|NCT02895360|467827129|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962579|NCT02895360|467827130|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
129962580|NCT02895360|467827131|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962581|NCT02895360|467827132|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962582|NCT02895360|467827133|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
129962583|NCT02895360|467827128|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962584|NCT02895360|467827129|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962585|NCT02895360|467827130|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962586|NCT02895360|467827131|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
129962587|NCT02895360|467827132|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962588|NCT02895360|467827133|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
129962589|NCT02895360|467827128|FG000|Phase 2a|Adverse Event|0|||
129962590|NCT02895360|467827129|FG001|Phase 2a|Adverse Event|0|||
129962591|NCT02895360|467827130|FG002|Phase 2a|Adverse Event|0|||
129962592|NCT02895360|467827131|FG003|Phase 2a|Adverse Event|0|||
129962593|NCT02895360|467827132|FG004|Phase 2a|Adverse Event|0|||
129962594|NCT02895360|467827133|FG005|Phase 2a|Adverse Event|1|||
129962595|NCT02895360|467827128|FG000|Phase 2a|Progressive disease|0|||
129962596|NCT02895360|467827129|FG001|Phase 2a|Progressive disease|0|||
129962597|NCT02895360|467827130|FG002|Phase 2a|Progressive disease|0|||
129962598|NCT02895360|467827131|FG003|Phase 2a|Progressive disease|0|||
129962599|NCT02895360|467827132|FG004|Phase 2a|Progressive disease|11|||
129962600|NCT02895360|467827133|FG005|Phase 2a|Progressive disease|11|||
129962601|NCT00307164|467827136|FG000|Overall Study|Death|1|||
129962602|NCT00307164|467827137|FG001|Overall Study|Death|0|||
129962603|NCT00307164|467827136|FG000|Overall Study|Severe debilitation, unable to continue|1|||
129962604|NCT00307164|467827137|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129962605|NCT00307164|467827136|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
129962606|NCT00307164|467827137|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
129962607|NCT00307164|467827136|FG000|Overall Study|Withdrawal by Subject|1|||
129962608|NCT00307164|467827137|FG001|Overall Study|Withdrawal by Subject|8|||
129962609|NCT00307164|467827136|FG000|Overall Study|Not compliant with requirements|4|||
129962610|NCT00307164|467827137|FG001|Overall Study|Not compliant with requirements|4|||
129962611|NCT00307164|467827136|FG000|Overall Study|Lost to Follow-up|6|||
129962612|NCT00307164|467827137|FG001|Overall Study|Lost to Follow-up|1|||
129962613|NCT01732926|467827139|FG000|Overall Study|Study Terminated by Sponsor|168|||
129962614|NCT01732926|467827140|FG001|Overall Study|Study Terminated by Sponsor|80|||
129962615|NCT01732926|467827139|FG000|Overall Study|Withdrawal by Subject|46|||
129962616|NCT01732926|467827140|FG001|Overall Study|Withdrawal by Subject|8|||
129962617|NCT01732926|467827139|FG000|Overall Study|Physician Decision|24|||
129962618|NCT01732926|467827140|FG001|Overall Study|Physician Decision|11|||
129962619|NCT01732926|467827139|FG000|Overall Study|Other Reason|21|||
129962620|NCT01732926|467827140|FG001|Overall Study|Other Reason|4|||
129962621|NCT01732926|467827139|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
129962622|NCT01732926|467827140|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
129962623|NCT01732926|467827139|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
129962624|NCT01732926|467827140|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
129962625|NCT02262364|467827142|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
129962626|NCT01049984|467827143|FG000|Overall Study|Withdrawal by Subject|1|||
129962627|NCT01049984|467827144|FG001|Overall Study|Withdrawal by Subject|5|||
129962628|NCT01049984|467827143|FG000|Overall Study|Protocol Violation|3|||
129962629|NCT01049984|467827144|FG001|Overall Study|Protocol Violation|4|||
129962630|NCT01049984|467827143|FG000|Overall Study|Lost to Follow-up|2|||
129962631|NCT01049984|467827144|FG001|Overall Study|Lost to Follow-up|1|||
129962632|NCT01049984|467827143|FG000|Overall Study|Adverse Event|13|||
129962633|NCT01049984|467827144|FG001|Overall Study|Adverse Event|7|||
129962634|NCT01049984|467827143|FG000|Overall Study|Treatment failure|0|||
129962635|NCT01049984|467827144|FG001|Overall Study|Treatment failure|2|||
129962636|NCT04191148|467827150|FG000|Overall Study|Withdrawal by Subject|1|||
129962637|NCT04191148|467827151|FG001|Overall Study|Withdrawal by Subject|0|||
129962638|NCT04191148|467827150|FG000|Overall Study|Adverse Event|1|||
129962639|NCT04191148|467827151|FG001|Overall Study|Adverse Event|0|||
129962640|NCT01274559|467827154|FG000|Overall Study|Adverse Event|57|||
129962641|NCT01274559|467827155|FG001|Overall Study|Adverse Event|13|||
129962642|NCT01274559|467827154|FG000|Overall Study|Death|1|||
129962643|NCT01274559|467827155|FG001|Overall Study|Death|1|||
129962644|NCT01274559|467827154|FG000|Overall Study|Lost to Follow-up|3|||
129962645|NCT01274559|467827155|FG001|Overall Study|Lost to Follow-up|3|||
129962646|NCT01274559|467827154|FG000|Overall Study|Non-compliance with Study Drug|2|||
129962647|NCT01274559|467827155|FG001|Overall Study|Non-compliance with Study Drug|4|||
129962648|NCT01274559|467827154|FG000|Overall Study|Physician Decision|2|||
129962649|NCT01274559|467827155|FG001|Overall Study|Physician Decision|1|||
129962650|NCT01274559|467827154|FG000|Overall Study|Protocol Violation|28|||
129962651|NCT01274559|467827155|FG001|Overall Study|Protocol Violation|23|||
129962652|NCT01274559|467827154|FG000|Overall Study|Study Terminated by Sponsor|79|||
129962653|NCT01274559|467827155|FG001|Overall Study|Study Terminated by Sponsor|87|||
129962654|NCT01274559|467827154|FG000|Overall Study|Withdrawal by Subject|25|||
129962655|NCT01274559|467827155|FG001|Overall Study|Withdrawal by Subject|13|||
129962656|NCT02560389|467827166|FG000|Overall Study|Lost to Follow-up|1|||
129962657|NCT02560389|467827167|FG001|Overall Study|Lost to Follow-up|2|||
129962658|NCT02560389|467827168|FG002|Overall Study|Lost to Follow-up|2|||
129962659|NCT02560389|467827166|FG000|Overall Study|Tested positive for illicit substance|0|||
129962660|NCT02560389|467827167|FG001|Overall Study|Tested positive for illicit substance|1|||
129962661|NCT02560389|467827168|FG002|Overall Study|Tested positive for illicit substance|0|||
129962662|NCT03409731|467827173|FG000|Overall Study|Withdrawal by Subject|17|||
129962663|NCT03409731|467827173|FG000|Overall Study|Death|4|||
129962664|NCT00827775|467827179|FG000|Overall Study|Withdrawal by Subject|0|||
129962665|NCT00827775|467827180|FG001|Overall Study|Withdrawal by Subject|5|||
129962666|NCT02287883|467827184|FG000|Overall Study|Death|8|||
129962667|NCT02287883|467827185|FG001|Overall Study|Death|7|||
129962668|NCT02287883|467827184|FG000|Overall Study|No longer eligible|222|||
129962669|NCT02287883|467827185|FG001|Overall Study|No longer eligible|182|||
129962670|NCT02287883|467827184|FG000|Overall Study|Non-response to survey|229|||
129962671|NCT02287883|467827185|FG001|Overall Study|Non-response to survey|237|||
129962672|NCT00802438|467827186|FG000|Overall Study|Screen Failure|20|||
129962673|NCT00802438|467827186|FG000|Overall Study|Withdrawal by Subject|7|||
129962674|NCT00802438|467827186|FG000|Overall Study|Physician Decision|1|||
129962675|NCT03175198|467827187|FG000|Overall Study|Adverse Event|480|||
129962676|NCT03175198|467827187|FG000|Overall Study|No actual visit|120|||
129962677|NCT03175198|467827187|FG000|Overall Study|Registration rule not followed|4|||
129962678|NCT03175198|467827187|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
129962679|NCT03175198|467827187|FG000|Overall Study|Other personal reason|509|||
129962680|NCT03175198|467827187|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
129962681|NCT03175198|467827187|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
129962682|NCT03175198|467827187|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
129962683|NCT03175198|467827187|FG000|Overall Study|To conduct invasive treatment of operation|53|||
129962684|NCT03175198|467827187|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
129962685|NCT01260142|467827189|FG000|Treatment Period 1|Study on hold|1|||
129455187|NCT02819635|465964556|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129962686|NCT01260142|467827190|FG001|Treatment Period 1|Study on hold|1|||
129962687|NCT01260142|467827191|FG002|Treatment Period 1|Study on hold|0|||
129962688|NCT01260142|467827192|FG003|Treatment Period 1|Study on hold|0|||
129962689|NCT01260142|467827193|FG004|Treatment Period 1|Study on hold|1|||
129455188|NCT02819635|465964557|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455189|NCT02819635|465964558|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129962690|NCT01260142|467827194|FG005|Treatment Period 1|Study on hold|2|||
129962691|NCT01260142|467827189|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962692|NCT01260142|467827190|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962693|NCT01260142|467827191|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962694|NCT01260142|467827192|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962695|NCT01260142|467827193|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
129962696|NCT01260142|467827194|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
129962697|NCT01260142|467827189|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129962698|NCT01260142|467827190|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129962699|NCT01260142|467827191|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129962700|NCT01260142|467827192|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129962701|NCT01260142|467827193|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129962702|NCT01260142|467827194|FG005|Treatment Period 1|Withdrawal by Subject|1|||
129962703|NCT00496834|467827198|FG000|Overall Study|Withdrawal by Subject|4|||
129962704|NCT00496834|467827199|FG001|Overall Study|Withdrawal by Subject|6|||
129962705|NCT00496834|467827198|FG000|Overall Study|Contraindicated medication administered|0|||
129962706|NCT00496834|467827199|FG001|Overall Study|Contraindicated medication administered|1|||
129962707|NCT00496834|467827198|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
129962708|NCT00496834|467827199|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
129962709|NCT00496834|467827198|FG000|Overall Study|Adverse Event|5|||
129962710|NCT00496834|467827199|FG001|Overall Study|Adverse Event|3|||
129962711|NCT00496834|467827198|FG000|Overall Study|IP administration violation|2|||
129962712|NCT00496834|467827199|FG001|Overall Study|IP administration violation|0|||
129962713|NCT00496834|467827198|FG000|Overall Study|Lost to Follow-up|2|||
129962714|NCT00496834|467827199|FG001|Overall Study|Lost to Follow-up|0|||
129962715|NCT00496834|467827198|FG000|Overall Study|Blood Pressure control failure|2|||
129962716|NCT00496834|467827199|FG001|Overall Study|Blood Pressure control failure|1|||
129962717|NCT01227928|467827200|FG000|Overall Study|Lost to Follow-up|4|||
129962718|NCT01227928|467827201|FG001|Overall Study|Lost to Follow-up|2|||
129962719|NCT01227928|467827200|FG000|Overall Study|Withdrawal by Subject|4|||
129962720|NCT01227928|467827201|FG001|Overall Study|Withdrawal by Subject|3|||
129962721|NCT01227928|467827200|FG000|Overall Study|Death|14|||
129962722|NCT01227928|467827201|FG001|Overall Study|Death|12|||
129962723|NCT04159805|467827204|FG000|Overall Study|Withdrawal by Subject|0|||
129962724|NCT04159805|467827205|FG001|Overall Study|Withdrawal by Subject|2|||
129962725|NCT04159805|467827206|FG002|Overall Study|Withdrawal by Subject|2|||
129962726|NCT02154347|467827207|FG000|Double-blind Period|Adverse Event|1|||
129962727|NCT02154347|467827208|FG001|Double-blind Period|Adverse Event|2|||
129962728|NCT02154347|467827207|FG000|Double-blind Period|Lack of Efficacy|1|||
129962729|NCT02154347|467827208|FG001|Double-blind Period|Lack of Efficacy|0|||
129962730|NCT02154347|467827207|FG000|Double-blind Period|Physician Decision|0|||
129962731|NCT02154347|467827208|FG001|Double-blind Period|Physician Decision|1|||
129962732|NCT02154347|467827207|FG000|Double-blind Period|Withdrawal by Subject|1|||
129962733|NCT02154347|467827208|FG001|Double-blind Period|Withdrawal by Subject|1|||
129962734|NCT02154347|467827207|FG000|Open-label Period|Adverse Event|3|||
129962735|NCT02154347|467827208|FG001|Open-label Period|Adverse Event|4|||
129962736|NCT02154347|467827207|FG000|Open-label Period|Lack of Efficacy|4|||
129962737|NCT02154347|467827208|FG001|Open-label Period|Lack of Efficacy|19|||
129962738|NCT02154347|467827207|FG000|Open-label Period|Protocol Violation|0|||
129962739|NCT02154347|467827208|FG001|Open-label Period|Protocol Violation|1|||
129962740|NCT02154347|467827207|FG000|Open-label Period|Withdrawal by Subject|0|||
129962741|NCT02154347|467827208|FG001|Open-label Period|Withdrawal by Subject|1|||
129962742|NCT02473913|467827210|FG000|Overall Study|Lost to Follow-up|3|||
129962743|NCT02473913|467827211|FG001|Overall Study|Lost to Follow-up|3|||
129962744|NCT01190449|467827214|FG000|Overall Study|Ineligible|0|||
129962745|NCT01190449|467827215|FG001|Overall Study|Ineligible|4|||
129962746|NCT02210208|467829090|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
129962747|NCT02210208|467829090|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
129962748|NCT02210208|467829090|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
129962749|NCT01171183|467829091|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
129962750|NCT01171183|467829092|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
129962751|NCT01171183|467829091|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
129962752|NCT01171183|467829092|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
129962753|NCT01171183|467829091|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
129962754|NCT01171183|467829092|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
129962755|NCT01171183|467829091|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
129962756|NCT01171183|467829092|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
129962757|NCT01171183|467829091|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
129962758|NCT01171183|467829092|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
129962759|NCT01171183|467829091|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
129962760|NCT01171183|467829092|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
129962761|NCT01066936|467829093|FG000|Overall Study|Death|2|||
129962762|NCT01066936|467829093|FG000|Overall Study|Device revised/removed|1|||
129962763|NCT01066936|467829093|FG000|Overall Study|Lost to Follow-up|3|||
129962764|NCT01066936|467829093|FG000|Overall Study|Withdrawal by Subject|4|||
129962765|NCT00362375|467829099|FG000|Overall Study|Lost to Follow-up|40|||
129962766|NCT00362375|467829100|FG001|Overall Study|Lost to Follow-up|35|||
129962767|NCT04984239|467829101|FG000|Overall Study|Lost to Follow-up|1|||
129962768|NCT04190225|467829102|FG000|Overall Study|Lost to Follow-up|2|||
129962769|NCT04190225|467829103|FG001|Overall Study|Lost to Follow-up|3|||
129962770|NCT04190225|467829102|FG000|Overall Study|Withdrawal by Subject|3|||
129962771|NCT04190225|467829103|FG001|Overall Study|Withdrawal by Subject|2|||
129962772|NCT04190225|467829102|FG000|Overall Study|Unrelated health condition|2|||
129962773|NCT04190225|467829103|FG001|Overall Study|Unrelated health condition|0|||
129962774|NCT01114139|467829105|FG000|Overall Study|Adverse Event|3|||
129962775|NCT01114139|467829106|FG001|Overall Study|Adverse Event|2|||
129962776|NCT01114139|467829105|FG000|Overall Study|Lost to Follow-up|15|||
129962777|NCT01114139|467829106|FG001|Overall Study|Lost to Follow-up|3|||
129962778|NCT01114139|467829105|FG000|Overall Study|Withdrawal by Subject|17|||
129962779|NCT01114139|467829106|FG001|Overall Study|Withdrawal by Subject|6|||
129962780|NCT01114139|467829105|FG000|Overall Study|Other-Missed 1 visit|1|||
129962781|NCT01114139|467829106|FG001|Overall Study|Other-Missed 1 visit|0|||
129962782|NCT01114139|467829105|FG000|Overall Study|Other-Protocol Violation|1|||
129962783|NCT01114139|467829106|FG001|Overall Study|Other-Protocol Violation|0|||
129962784|NCT01114139|467829105|FG000|Overall Study|Other-Out of window for study drug dose|1|||
129962785|NCT01114139|467829106|FG001|Overall Study|Other-Out of window for study drug dose|0|||
129962786|NCT01114139|467829105|FG000|Overall Study|Other-Participant falsified records|0|||
129962787|NCT01114139|467829106|FG001|Overall Study|Other-Participant falsified records|1|||
129962788|NCT01114139|467829105|FG000|Overall Study|Other-Participant went on hospice|0|||
129962789|NCT01114139|467829106|FG001|Overall Study|Other-Participant went on hospice|1|||
129962790|NCT01114139|467829105|FG000|Overall Study|Other-Physician changed treatment|1|||
129962791|NCT01114139|467829106|FG001|Overall Study|Other-Physician changed treatment|0|||
129962792|NCT01114139|467829105|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
129962793|NCT01114139|467829106|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
129962794|NCT02994784|467829107|FG000|6 Months Follow-up|Lost to Follow-up|3|||
129962795|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
129962796|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
129962797|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
129962798|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
129962799|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
129962800|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
129962801|NCT02466243|467829109|FG000|Part B Open-label Treatment Period|Missing|2|||
129962802|NCT02466243|467829110|FG001|Part B Open-label Treatment Period|Missing|2|||
129962803|NCT00477464|467829111|FG000|Overall Study|Lost to Follow-up|1|||
129962804|NCT00477464|467829111|FG000|Overall Study|Death|36|||
129962805|NCT00477464|467829111|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
129962806|NCT00639769|467829112|FG000|Overall Study|Death|2|||
129962807|NCT00639769|467829112|FG000|Overall Study|Adverse Event|7|||
129962808|NCT00639769|467829112|FG000|Overall Study|Lack of Efficacy|1|||
129962809|NCT00639769|467829112|FG000|Overall Study|Disease progression|26|||
129962810|NCT00639769|467829112|FG000|Overall Study|Withdrawal by Subject|4|||
129962811|NCT00863798|467829113|FG000|Overall Study|Adverse Event|5|||
129962812|NCT00863798|467829114|FG001|Overall Study|Adverse Event|2|||
129962813|NCT00863798|467829115|FG002|Overall Study|Adverse Event|4|||
129962814|NCT00863798|467829113|FG000|Overall Study|Participant failed to return|2|||
129962815|NCT00863798|467829114|FG001|Overall Study|Participant failed to return|1|||
129962816|NCT00863798|467829115|FG002|Overall Study|Participant failed to return|0|||
129962817|NCT00863798|467829113|FG000|Overall Study|Investigator request|1|||
129962818|NCT00863798|467829114|FG001|Overall Study|Investigator request|2|||
129962819|NCT00863798|467829115|FG002|Overall Study|Investigator request|1|||
129962820|NCT00863798|467829113|FG000|Overall Study|Lack of Efficacy|4|||
129962821|NCT00863798|467829114|FG001|Overall Study|Lack of Efficacy|3|||
129962822|NCT00863798|467829115|FG002|Overall Study|Lack of Efficacy|6|||
129962823|NCT00863798|467829113|FG000|Overall Study|Lost to Follow-up|6|||
129962824|NCT00863798|467829114|FG001|Overall Study|Lost to Follow-up|9|||
129962825|NCT00863798|467829115|FG002|Overall Study|Lost to Follow-up|5|||
129962826|NCT00863798|467829113|FG000|Overall Study|Other|2|||
129962827|NCT00863798|467829114|FG001|Overall Study|Other|3|||
129962828|NCT00863798|467829115|FG002|Overall Study|Other|1|||
129962829|NCT00863798|467829113|FG000|Overall Study|Protocol Violation|0|||
129962830|NCT00863798|467829114|FG001|Overall Study|Protocol Violation|1|||
129962831|NCT00863798|467829115|FG002|Overall Study|Protocol Violation|1|||
129962832|NCT00863798|467829113|FG000|Overall Study|Withdrawal by Subject|8|||
129962833|NCT00863798|467829114|FG001|Overall Study|Withdrawal by Subject|7|||
129962834|NCT00863798|467829115|FG002|Overall Study|Withdrawal by Subject|4|||
129962835|NCT00863798|467829113|FG000|Overall Study|Randomized not treated|4|||
129962836|NCT00863798|467829114|FG001|Overall Study|Randomized not treated|2|||
129962837|NCT00863798|467829115|FG002|Overall Study|Randomized not treated|3|||
129962838|NCT04238520|467829116|FG000|Overall Study|Withdrawal by Subject|1|||
129962839|NCT04238520|467829117|FG001|Overall Study|Withdrawal by Subject|1|||
129962840|NCT04238520|467829116|FG000|Overall Study|Lost to Follow-up|1|||
129962841|NCT04238520|467829117|FG001|Overall Study|Lost to Follow-up|2|||
129962842|NCT04238520|467829116|FG000|Overall Study|Death|0|||
129962843|NCT04238520|467829117|FG001|Overall Study|Death|2|||
129962844|NCT04238520|467829116|FG000|Overall Study|Unsafe home environment for research staff|0|||
129962845|NCT04238520|467829117|FG001|Overall Study|Unsafe home environment for research staff|1|||
129962846|NCT01470599|467829118|FG000|Overall Study|Did not meet entrance criteria|1|||
129962847|NCT01470599|467829119|FG001|Overall Study|Did not meet entrance criteria|0|||
129962848|NCT01470599|467829118|FG000|Overall Study|Lost to Follow-up|2|||
129962849|NCT01470599|467829119|FG001|Overall Study|Lost to Follow-up|1|||
129962850|NCT01470599|467829118|FG000|Overall Study|Withdrawal by Subject|3|||
129962851|NCT01470599|467829119|FG001|Overall Study|Withdrawal by Subject|4|||
129962852|NCT01470599|467829118|FG000|Overall Study|Other|1|||
129962853|NCT01470599|467829119|FG001|Overall Study|Other|0|||
129962854|NCT01470599|467829118|FG000|Overall Study|Protocol Violation|3|||
129962855|NCT01470599|467829119|FG001|Overall Study|Protocol Violation|1|||
129962856|NCT01470599|467829118|FG000|Overall Study|Adverse event related to study drug|2|||
129962857|NCT01470599|467829119|FG001|Overall Study|Adverse event related to study drug|5|||
129962858|NCT01470599|467829118|FG000|Overall Study|Insufficient clinical response|6|||
129962859|NCT01470599|467829119|FG001|Overall Study|Insufficient clinical response|27|||
129962860|NCT01470599|467829118|FG000|Overall Study|Adverse event not related to study drug|1|||
129962861|NCT01470599|467829119|FG001|Overall Study|Adverse event not related to study drug|5|||
129962862|NCT00195442|467829120|FG000|Overall Study|Less than expected therapeutic effect|38|||
129962863|NCT00195442|467829120|FG000|Overall Study|Lost to Follow-up|27|||
129962864|NCT00195442|467829120|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
129962865|NCT00195442|467829120|FG000|Overall Study|Intermittent product shortage|21|||
129962866|NCT00195442|467829120|FG000|Overall Study|Death|7|||
129962867|NCT00195442|467829120|FG000|Overall Study|No reason specified|4|||
129962868|NCT00195442|467829120|FG000|Overall Study|Poor cooperation|2|||
129962869|NCT00195442|467829120|FG000|Overall Study|Other|14|||
129962870|NCT01917006|467829121|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
129962871|NCT01917006|467829122|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
129962872|NCT01917006|467829123|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
129962873|NCT01917006|467829124|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
129962874|NCT01917006|467829125|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
129962875|NCT01917006|467829126|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
129962876|NCT01917006|467829127|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
129962877|NCT01917006|467829128|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
129962878|NCT01917006|467829121|FG000|Randomized-treatment Period|Personal Reasons|0|||
129962879|NCT01917006|467829122|FG001|Randomized-treatment Period|Personal Reasons|0|||
129962880|NCT01917006|467829123|FG002|Randomized-treatment Period|Personal Reasons|0|||
129962881|NCT01917006|467829124|FG003|Randomized-treatment Period|Personal Reasons|0|||
129962882|NCT01917006|467829125|FG004|Randomized-treatment Period|Personal Reasons|0|||
129962883|NCT01917006|467829126|FG005|Randomized-treatment Period|Personal Reasons|1|||
129962884|NCT01917006|467829127|FG006|Randomized-treatment Period|Personal Reasons|0|||
129962885|NCT01917006|467829128|FG007|Randomized-treatment Period|Personal Reasons|0|||
129962886|NCT01917006|467829121|FG000|Randomized-treatment Period|Protocol Violation|1|||
129962887|NCT01917006|467829122|FG001|Randomized-treatment Period|Protocol Violation|0|||
129962888|NCT01917006|467829123|FG002|Randomized-treatment Period|Protocol Violation|0|||
129962889|NCT01917006|467829124|FG003|Randomized-treatment Period|Protocol Violation|0|||
129962890|NCT01917006|467829125|FG004|Randomized-treatment Period|Protocol Violation|0|||
129962891|NCT01917006|467829126|FG005|Randomized-treatment Period|Protocol Violation|0|||
129962892|NCT01917006|467829127|FG006|Randomized-treatment Period|Protocol Violation|0|||
129962893|NCT01917006|467829128|FG007|Randomized-treatment Period|Protocol Violation|0|||
129962894|NCT01917006|467829121|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962895|NCT01917006|467829122|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962896|NCT01917006|467829123|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962897|NCT01917006|467829124|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962898|NCT01917006|467829125|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962899|NCT01917006|467829126|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962900|NCT01917006|467829127|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
129962901|NCT01917006|467829128|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
129962902|NCT01917006|467829121|FG000|Open-label Period|Adverse Event|0|||
129962903|NCT01917006|467829122|FG001|Open-label Period|Adverse Event|0|||
129962904|NCT01917006|467829123|FG002|Open-label Period|Adverse Event|0|||
129962905|NCT01917006|467829124|FG003|Open-label Period|Adverse Event|0|||
129962906|NCT01917006|467829125|FG004|Open-label Period|Adverse Event|0|||
129962907|NCT01917006|467829126|FG005|Open-label Period|Adverse Event|0|||
129962908|NCT01917006|467829127|FG006|Open-label Period|Adverse Event|0|||
129455190|NCT02819635|465964559|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455191|NCT02819635|465964560|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
129455192|NCT02819635|465964549|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455193|NCT02819635|465964550|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455194|NCT02819635|465964551|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455195|NCT02819635|465964552|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455196|NCT02819635|465964553|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455197|NCT02819635|465964554|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455198|NCT02819635|465964555|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
129455199|NCT02819635|465964556|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455200|NCT02819635|465964557|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455201|NCT02819635|465964558|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455202|NCT02819635|465964559|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455203|NCT02819635|465964560|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
129455204|NCT02819635|465964549|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
129455205|NCT02819635|465964550|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
129455206|NCT02819635|465964551|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
129455207|NCT02819635|465964552|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
129455208|NCT02819635|465964553|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
129455209|NCT02819635|465964554|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
129455210|NCT02819635|465964555|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
129455211|NCT02819635|465964556|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
129455212|NCT02819635|465964557|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
129455213|NCT02819635|465964558|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
129455214|NCT02819635|465964559|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
129455215|NCT02819635|465964560|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
129455216|NCT02819635|465964549|FG000|Substudy 2, Part 2|Adverse Event|0|||
129455217|NCT02819635|465964550|FG001|Substudy 2, Part 2|Adverse Event|0|||
129455218|NCT02819635|465964551|FG002|Substudy 2, Part 2|Adverse Event|0|||
129455219|NCT02819635|465964552|FG003|Substudy 2, Part 2|Adverse Event|0|||
129455220|NCT02819635|465964553|FG004|Substudy 2, Part 2|Adverse Event|0|||
129455221|NCT02819635|465964554|FG005|Substudy 2, Part 2|Adverse Event|4|||
129455222|NCT02819635|465964555|FG006|Substudy 2, Part 2|Adverse Event|0|||
129455223|NCT02819635|465964556|FG007|Substudy 2, Part 2|Adverse Event|0|||
129455224|NCT02819635|465964557|FG008|Substudy 2, Part 2|Adverse Event|0|||
129455225|NCT02819635|465964558|FG009|Substudy 2, Part 2|Adverse Event|0|||
129455226|NCT02819635|465964559|FG010|Substudy 2, Part 2|Adverse Event|0|||
129455227|NCT02819635|465964560|FG011|Substudy 2, Part 2|Adverse Event|0|||
129455228|NCT02819635|465964549|FG000|Substudy 2, Part 2|Withdrew consent|0|||
129455229|NCT02819635|465964550|FG001|Substudy 2, Part 2|Withdrew consent|0|||
129455230|NCT02819635|465964551|FG002|Substudy 2, Part 2|Withdrew consent|0|||
129455231|NCT02819635|465964552|FG003|Substudy 2, Part 2|Withdrew consent|0|||
129455232|NCT02819635|465964553|FG004|Substudy 2, Part 2|Withdrew consent|0|||
129455233|NCT02819635|465964554|FG005|Substudy 2, Part 2|Withdrew consent|3|||
129455234|NCT02819635|465964555|FG006|Substudy 2, Part 2|Withdrew consent|1|||
129455235|NCT02819635|465964556|FG007|Substudy 2, Part 2|Withdrew consent|0|||
129455236|NCT02819635|465964557|FG008|Substudy 2, Part 2|Withdrew consent|0|||
129455237|NCT02819635|465964558|FG009|Substudy 2, Part 2|Withdrew consent|0|||
129455238|NCT02819635|465964559|FG010|Substudy 2, Part 2|Withdrew consent|0|||
129455239|NCT02819635|465964560|FG011|Substudy 2, Part 2|Withdrew consent|0|||
129455240|NCT02819635|465964549|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
129455241|NCT02819635|465964550|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
129455242|NCT02819635|465964551|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
129962909|NCT01917006|467829128|FG007|Open-label Period|Adverse Event|1|||
129962910|NCT01917006|467829121|FG000|Open-label Period|Lost to Follow-up|0|||
129962911|NCT01917006|467829122|FG001|Open-label Period|Lost to Follow-up|0|||
129962912|NCT01917006|467829123|FG002|Open-label Period|Lost to Follow-up|0|||
129962913|NCT01917006|467829124|FG003|Open-label Period|Lost to Follow-up|0|||
129962914|NCT01917006|467829125|FG004|Open-label Period|Lost to Follow-up|0|||
129455243|NCT02819635|465964552|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
129455244|NCT02819635|465964553|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
129962915|NCT01917006|467829126|FG005|Open-label Period|Lost to Follow-up|0|||
129962916|NCT01917006|467829127|FG006|Open-label Period|Lost to Follow-up|0|||
129962917|NCT01917006|467829128|FG007|Open-label Period|Lost to Follow-up|1|||
129962918|NCT00847132|467829131|FG000|Overall Study|Death|1|||
129962919|NCT00847132|467829132|FG001|Overall Study|Death|1|||
129962920|NCT03596242|467829133|FG000|Overall Study|Lost to Follow-up|2|||
129962921|NCT03596242|467829134|FG001|Overall Study|Lost to Follow-up|2|||
129962922|NCT02509312|467829135|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
129962923|NCT02509312|467829136|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
129962924|NCT02509312|467829135|FG000|Overall Study|Obstetrician refusal|0|||
129962925|NCT02509312|467829136|FG001|Overall Study|Obstetrician refusal|1|||
129962926|NCT02509312|467829135|FG000|Overall Study|Patient elected for TOLAC|1|||
129962927|NCT02509312|467829136|FG001|Overall Study|Patient elected for TOLAC|0|||
129962928|NCT02509312|467829135|FG000|Overall Study|Cesarean deemed stat|1|||
129962929|NCT02509312|467829136|FG001|Overall Study|Cesarean deemed stat|0|||
129962930|NCT02509312|467829135|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
129962931|NCT02509312|467829136|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
129962932|NCT01036165|467829141|FG000|Overall Study|Adverse Event|6|||
129962933|NCT01036165|467829141|FG000|Overall Study|Lost to Follow-up|2|||
129962934|NCT01036165|467829141|FG000|Overall Study|Withdrawal by Subject|3|||
129962935|NCT01036165|467829141|FG000|Overall Study|Device Related Issues|3|||
129962936|NCT01036165|467829141|FG000|Overall Study|Problems finding proper area to inject|1|||
129962937|NCT00913523|467829148|FG000|Overall Study|Withdrawal by Subject|3|||
129962938|NCT00913523|467829149|FG001|Overall Study|Withdrawal by Subject|2|||
129962939|NCT00913523|467829150|FG002|Overall Study|Withdrawal by Subject|2|||
129962940|NCT00913523|467829148|FG000|Overall Study|Lost to Follow-up|1|||
129962941|NCT00913523|467829149|FG001|Overall Study|Lost to Follow-up|1|||
129962942|NCT00913523|467829150|FG002|Overall Study|Lost to Follow-up|1|||
129962943|NCT00913523|467829148|FG000|Overall Study|Adverse Event|1|||
129962944|NCT00913523|467829149|FG001|Overall Study|Adverse Event|0|||
129962945|NCT00913523|467829150|FG002|Overall Study|Adverse Event|0|||
129962946|NCT00913523|467829148|FG000|Overall Study|Protocol Violation|5|||
129962947|NCT00913523|467829149|FG001|Overall Study|Protocol Violation|8|||
129962948|NCT00913523|467829150|FG002|Overall Study|Protocol Violation|8|||
129962949|NCT00913523|467829148|FG000|Overall Study|Pregnancy|1|||
129962950|NCT00913523|467829149|FG001|Overall Study|Pregnancy|3|||
129962951|NCT00913523|467829150|FG002|Overall Study|Pregnancy|0|||
129962952|NCT00913523|467829148|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
129962953|NCT00913523|467829149|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
129962954|NCT00913523|467829150|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
129962955|NCT00916305|467829151|FG000|Overall Study|Lost to Follow-up|21|||
129962956|NCT00916305|467829152|FG001|Overall Study|Lost to Follow-up|27|||
129455245|NCT02819635|465964554|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
129455246|NCT02819635|465964555|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
129455247|NCT02819635|465964556|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
129455248|NCT02819635|465964557|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
129455249|NCT02819635|465964558|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
129455250|NCT02819635|465964559|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
129455251|NCT02819635|465964560|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
129455252|NCT02819635|465964549|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455253|NCT02819635|465964550|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455254|NCT02819635|465964551|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455255|NCT02819635|465964552|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129962957|NCT00916305|467829151|FG000|Overall Study|Withdrawal by Subject|0|||
129962958|NCT00916305|467829152|FG001|Overall Study|Withdrawal by Subject|1|||
129962959|NCT01844726|467829153|FG000|Overall Study|Withdrawal by Subject|0|||
129962960|NCT01844726|467829154|FG001|Overall Study|Withdrawal by Subject|1|||
129962961|NCT01844726|467829153|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
129455256|NCT02819635|465964553|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455257|NCT02819635|465964554|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455258|NCT02819635|465964555|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
129455259|NCT02819635|465964556|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455260|NCT02819635|465964557|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129962962|NCT01844726|467829154|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
129962963|NCT01475461|467829157|FG000|Run-in Period|Not meet eligibility criteria|16|||
129962964|NCT01475461|467829158|FG001|Run-in Period|Not meet eligibility criteria|0|||
129962965|NCT01475461|467829159|FG002|Run-in Period|Not meet eligibility criteria|0|||
129962966|NCT01475461|467829160|FG003|Run-in Period|Not meet eligibility criteria|0|||
129962967|NCT01475461|467829161|FG004|Run-in Period|Not meet eligibility criteria|0|||
129962968|NCT01475461|467829162|FG005|Run-in Period|Not meet eligibility criteria|0|||
129962969|NCT01475461|467829163|FG006|Run-in Period|Not meet eligibility criteria|0|||
129962970|NCT01475461|467829157|FG000|Run-in Period|Lost to Follow-up|7|||
129962971|NCT01475461|467829158|FG001|Run-in Period|Lost to Follow-up|0|||
129962972|NCT01475461|467829159|FG002|Run-in Period|Lost to Follow-up|0|||
129962973|NCT01475461|467829160|FG003|Run-in Period|Lost to Follow-up|0|||
129962974|NCT01475461|467829161|FG004|Run-in Period|Lost to Follow-up|0|||
129962975|NCT01475461|467829162|FG005|Run-in Period|Lost to Follow-up|0|||
129962976|NCT01475461|467829163|FG006|Run-in Period|Lost to Follow-up|0|||
129962977|NCT01475461|467829157|FG000|Run-in Period|Withdrawal by Subject|11|||
129962978|NCT01475461|467829158|FG001|Run-in Period|Withdrawal by Subject|0|||
129962979|NCT01475461|467829159|FG002|Run-in Period|Withdrawal by Subject|0|||
129962980|NCT01475461|467829160|FG003|Run-in Period|Withdrawal by Subject|0|||
129962981|NCT01475461|467829161|FG004|Run-in Period|Withdrawal by Subject|0|||
129962982|NCT01475461|467829162|FG005|Run-in Period|Withdrawal by Subject|0|||
129962983|NCT01475461|467829163|FG006|Run-in Period|Withdrawal by Subject|0|||
129962984|NCT01475461|467829157|FG000|Run-in Period|Other|3|||
129962985|NCT01475461|467829158|FG001|Run-in Period|Other|0|||
129962986|NCT01475461|467829159|FG002|Run-in Period|Other|0|||
129962987|NCT01475461|467829160|FG003|Run-in Period|Other|0|||
129962988|NCT01475461|467829161|FG004|Run-in Period|Other|0|||
129962989|NCT01475461|467829162|FG005|Run-in Period|Other|0|||
129962990|NCT01475461|467829163|FG006|Run-in Period|Other|0|||
129962991|NCT01475461|467829157|FG000|Run-in Period|Protocol Violation|4|||
129962992|NCT01475461|467829158|FG001|Run-in Period|Protocol Violation|0|||
129962993|NCT01475461|467829159|FG002|Run-in Period|Protocol Violation|0|||
129962994|NCT01475461|467829160|FG003|Run-in Period|Protocol Violation|0|||
129962995|NCT01475461|467829161|FG004|Run-in Period|Protocol Violation|0|||
129962996|NCT01475461|467829162|FG005|Run-in Period|Protocol Violation|0|||
129962997|NCT01475461|467829163|FG006|Run-in Period|Protocol Violation|0|||
129962998|NCT01475461|467829157|FG000|Treatment Period|Death|0|||
129962999|NCT01475461|467829158|FG001|Treatment Period|Death|0|||
129963000|NCT01475461|467829159|FG002|Treatment Period|Death|0|||
129963001|NCT01475461|467829160|FG003|Treatment Period|Death|1|||
129963002|NCT01475461|467829161|FG004|Treatment Period|Death|0|||
129963003|NCT01475461|467829162|FG005|Treatment Period|Death|0|||
129963004|NCT01475461|467829163|FG006|Treatment Period|Death|0|||
129963005|NCT01475461|467829157|FG000|Treatment Period|Lost to Follow-up|0|||
129963006|NCT01475461|467829158|FG001|Treatment Period|Lost to Follow-up|3|||
129963007|NCT01475461|467829159|FG002|Treatment Period|Lost to Follow-up|2|||
129963008|NCT01475461|467829160|FG003|Treatment Period|Lost to Follow-up|3|||
129963009|NCT01475461|467829161|FG004|Treatment Period|Lost to Follow-up|1|||
129963010|NCT01475461|467829162|FG005|Treatment Period|Lost to Follow-up|2|||
129963011|NCT01475461|467829163|FG006|Treatment Period|Lost to Follow-up|1|||
129963012|NCT01475461|467829157|FG000|Treatment Period|Withdrawal by Subject|0|||
129963013|NCT01475461|467829158|FG001|Treatment Period|Withdrawal by Subject|2|||
129963014|NCT01475461|467829159|FG002|Treatment Period|Withdrawal by Subject|2|||
129963015|NCT01475461|467829160|FG003|Treatment Period|Withdrawal by Subject|0|||
129963016|NCT01475461|467829161|FG004|Treatment Period|Withdrawal by Subject|2|||
129963017|NCT01475461|467829162|FG005|Treatment Period|Withdrawal by Subject|2|||
129963018|NCT01475461|467829163|FG006|Treatment Period|Withdrawal by Subject|0|||
129963019|NCT01475461|467829157|FG000|Treatment Period|Other|0|||
129963020|NCT01475461|467829158|FG001|Treatment Period|Other|1|||
129963021|NCT01475461|467829159|FG002|Treatment Period|Other|0|||
129963022|NCT01475461|467829160|FG003|Treatment Period|Other|0|||
129963023|NCT01475461|467829161|FG004|Treatment Period|Other|0|||
129963024|NCT01475461|467829162|FG005|Treatment Period|Other|0|||
129963025|NCT01475461|467829163|FG006|Treatment Period|Other|0|||
129963026|NCT01475461|467829157|FG000|Treatment Period|Protocol Violation|0|||
129963027|NCT01475461|467829158|FG001|Treatment Period|Protocol Violation|1|||
129963028|NCT01475461|467829159|FG002|Treatment Period|Protocol Violation|0|||
129963029|NCT01475461|467829160|FG003|Treatment Period|Protocol Violation|0|||
129963030|NCT01475461|467829161|FG004|Treatment Period|Protocol Violation|0|||
129963031|NCT01475461|467829162|FG005|Treatment Period|Protocol Violation|0|||
129963032|NCT01475461|467829163|FG006|Treatment Period|Protocol Violation|1|||
129963033|NCT01475461|467829157|FG000|Treatment Period|Lack of Efficacy|0|||
129963034|NCT01475461|467829158|FG001|Treatment Period|Lack of Efficacy|2|||
129455261|NCT02819635|465964558|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129455262|NCT02819635|465964559|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129963035|NCT01475461|467829159|FG002|Treatment Period|Lack of Efficacy|0|||
129963036|NCT01475461|467829160|FG003|Treatment Period|Lack of Efficacy|2|||
129963037|NCT01475461|467829161|FG004|Treatment Period|Lack of Efficacy|1|||
129963038|NCT01475461|467829162|FG005|Treatment Period|Lack of Efficacy|1|||
129455263|NCT02819635|465964560|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
129963039|NCT01475461|467829163|FG006|Treatment Period|Lack of Efficacy|0|||
129963040|NCT01475461|467829157|FG000|Treatment Period|Medication Error|0|||
129963041|NCT01475461|467829158|FG001|Treatment Period|Medication Error|0|||
129963042|NCT01475461|467829159|FG002|Treatment Period|Medication Error|0|||
129963043|NCT01475461|467829160|FG003|Treatment Period|Medication Error|1|||
129963044|NCT01475461|467829161|FG004|Treatment Period|Medication Error|0|||
129963045|NCT01475461|467829162|FG005|Treatment Period|Medication Error|0|||
129963046|NCT01475461|467829163|FG006|Treatment Period|Medication Error|0|||
129963047|NCT01475461|467829157|FG000|Treatment Period|Adverse Event|0|||
129963048|NCT01475461|467829158|FG001|Treatment Period|Adverse Event|0|||
129963049|NCT01475461|467829159|FG002|Treatment Period|Adverse Event|0|||
129963050|NCT01475461|467829160|FG003|Treatment Period|Adverse Event|1|||
129963051|NCT01475461|467829161|FG004|Treatment Period|Adverse Event|0|||
129963052|NCT01475461|467829162|FG005|Treatment Period|Adverse Event|0|||
129963053|NCT01475461|467829163|FG006|Treatment Period|Adverse Event|0|||
129963054|NCT02512861|467829169|FG000|Overall Study|Protocol Violation|3|||
129963055|NCT02512861|467829170|FG001|Overall Study|Protocol Violation|7|||
129963056|NCT02512861|467829169|FG000|Overall Study|Physician Decision|3|||
129963057|NCT02512861|467829170|FG001|Overall Study|Physician Decision|1|||
129963058|NCT02512861|467829169|FG000|Overall Study|Withdrawal by Subject|0|||
129963059|NCT02512861|467829170|FG001|Overall Study|Withdrawal by Subject|1|||
129963060|NCT03214250|467829173|FG000|Overall Study|Death|5|||
129963061|NCT03214250|467829174|FG001|Overall Study|Death|5|||
129963062|NCT03214250|467829175|FG002|Overall Study|Death|7|||
129963063|NCT03214250|467829176|FG003|Overall Study|Death|4|||
129963064|NCT03214250|467829177|FG004|Overall Study|Death|23|||
129963065|NCT03214250|467829178|FG005|Overall Study|Death|23|||
129963066|NCT03214250|467829179|FG006|Overall Study|Death|24|||
129963067|NCT03214250|467829173|FG000|Overall Study|Lost to Follow-up|0|||
129963068|NCT03214250|467829174|FG001|Overall Study|Lost to Follow-up|0|||
129963069|NCT03214250|467829175|FG002|Overall Study|Lost to Follow-up|0|||
129963070|NCT03214250|467829176|FG003|Overall Study|Lost to Follow-up|1|||
129963071|NCT03214250|467829177|FG004|Overall Study|Lost to Follow-up|1|||
129963072|NCT03214250|467829178|FG005|Overall Study|Lost to Follow-up|2|||
129963073|NCT03214250|467829179|FG006|Overall Study|Lost to Follow-up|0|||
129963074|NCT03214250|467829173|FG000|Overall Study|Other|0|||
129963075|NCT03214250|467829174|FG001|Overall Study|Other|0|||
129963076|NCT03214250|467829175|FG002|Overall Study|Other|0|||
129963077|NCT03214250|467829176|FG003|Overall Study|Other|0|||
129963078|NCT03214250|467829177|FG004|Overall Study|Other|1|||
129963079|NCT03214250|467829178|FG005|Overall Study|Other|1|||
129963080|NCT03214250|467829179|FG006|Overall Study|Other|2|||
129963081|NCT03214250|467829173|FG000|Overall Study|Remains on Study|2|||
129963082|NCT03214250|467829174|FG001|Overall Study|Remains on Study|2|||
129963083|NCT03214250|467829175|FG002|Overall Study|Remains on Study|0|||
129963084|NCT03214250|467829176|FG003|Overall Study|Remains on Study|1|||
129963085|NCT03214250|467829177|FG004|Overall Study|Remains on Study|7|||
129963086|NCT03214250|467829178|FG005|Overall Study|Remains on Study|5|||
129963087|NCT03214250|467829179|FG006|Overall Study|Remains on Study|3|||
129963088|NCT03214250|467829173|FG000|Overall Study|Withdrawal by Subject|0|||
129963089|NCT03214250|467829174|FG001|Overall Study|Withdrawal by Subject|0|||
129963090|NCT03214250|467829175|FG002|Overall Study|Withdrawal by Subject|1|||
129963091|NCT03214250|467829176|FG003|Overall Study|Withdrawal by Subject|2|||
129963092|NCT03214250|467829177|FG004|Overall Study|Withdrawal by Subject|5|||
129963093|NCT03214250|467829178|FG005|Overall Study|Withdrawal by Subject|0|||
129963094|NCT03214250|467829179|FG006|Overall Study|Withdrawal by Subject|2|||
129963095|NCT00292981|467829183|FG000|Overall Study|Adverse Event|1|||
129963096|NCT00292981|467829183|FG000|Overall Study|Lost to Follow-up|13|||
129963097|NCT00292981|467829183|FG000|Overall Study|Withdrawal by Subject|22|||
129963098|NCT00292981|467829183|FG000|Overall Study|Other|3|||
129963099|NCT00594178|467829184|FG000|Overall Study|Physician Decision|5|||
129963100|NCT02971228|467829187|FG000|Overall Study|Withdrawal by Subject|1|||
129963101|NCT02971228|467829188|FG001|Overall Study|Withdrawal by Subject|1|||
129963102|NCT02971228|467829189|FG002|Overall Study|Withdrawal by Subject|0|||
129963103|NCT02971228|467829190|FG003|Overall Study|Withdrawal by Subject|0|||
129963104|NCT02971228|467829191|FG004|Overall Study|Withdrawal by Subject|0|||
129963105|NCT02971228|467829187|FG000|Overall Study|Logistical challenges|0|||
129963106|NCT02971228|467829188|FG001|Overall Study|Logistical challenges|1|||
129963107|NCT02971228|467829189|FG002|Overall Study|Logistical challenges|0|||
129963108|NCT02971228|467829190|FG003|Overall Study|Logistical challenges|0|||
129963109|NCT02971228|467829191|FG004|Overall Study|Logistical challenges|0|||
129963110|NCT00905034|467829193|FG000|Overall Study|Withdrawal by Subject|1|||
129963111|NCT00394589|467829194|FG000|Overall Study|Adverse Event|2|||
129963112|NCT00394589|467829195|FG001|Overall Study|Adverse Event|1|||
129963113|NCT00394589|467829196|FG002|Overall Study|Adverse Event|2|||
129963114|NCT00394589|467829194|FG000|Overall Study|Lack of Efficacy|2|||
129963115|NCT00394589|467829195|FG001|Overall Study|Lack of Efficacy|2|||
129963116|NCT00394589|467829196|FG002|Overall Study|Lack of Efficacy|3|||
129963117|NCT00394589|467829194|FG000|Overall Study|Protocol Violation|4|||
129963118|NCT00394589|467829195|FG001|Overall Study|Protocol Violation|0|||
129963119|NCT00394589|467829196|FG002|Overall Study|Protocol Violation|2|||
129963120|NCT04081389|467829197|FG000|Overall Study|Withdrawal by Subject|0|||
129963121|NCT04081389|467829198|FG001|Overall Study|Withdrawal by Subject|0|||
129963122|NCT04081389|467829199|FG002|Overall Study|Withdrawal by Subject|1|||
129963123|NCT04081389|467829200|FG003|Overall Study|Withdrawal by Subject|0|||
129963124|NCT04016805|467829201|FG000|Overall Study|Sponsor's Discretion|30|||
129963125|NCT04016805|467829202|FG001|Overall Study|Sponsor's Discretion|6|||
129963126|NCT04016805|467829203|FG002|Overall Study|Sponsor's Discretion|5|||
129963127|NCT00545571|467829204|FG000|Overall Study|Administrative Reasons|1|||
129963128|NCT00545571|467829204|FG000|Overall Study|Adverse Event|2|||
129963129|NCT00545571|467829204|FG000|Overall Study|Death|5|||
129963130|NCT00545571|467829204|FG000|Overall Study|Lack of Efficacy|1|||
129963131|NCT00545571|467829204|FG000|Overall Study|Protocol Violation|2|||
129963132|NCT00545571|467829204|FG000|Overall Study|Refused Treatment|1|||
129963133|NCT00545571|467829204|FG000|Overall Study|Screen Failure|16|||
129963134|NCT00545571|467829204|FG000|Overall Study|Transfusion|12|||
129963135|NCT00545571|467829204|FG000|Overall Study|Early Termination of Study|24|||
129963136|NCT00545571|467829204|FG000|Overall Study|Kidney Transplantation|3|||
129963137|NCT01193218|467829205|FG000|0-12 Weeks|Adverse Event|6|||
129963138|NCT01193218|467829206|FG001|0-12 Weeks|Adverse Event|0|||
129963139|NCT01193218|467829207|FG002|0-12 Weeks|Adverse Event|1|||
129963140|NCT01193218|467829208|FG003|0-12 Weeks|Adverse Event|0|||
129963141|NCT01193218|467829209|FG004|0-12 Weeks|Adverse Event|0|||
129963142|NCT01193218|467829210|FG005|0-12 Weeks|Adverse Event|2|||
129963143|NCT01193218|467829211|FG006|0-12 Weeks|Adverse Event|2|||
129963144|NCT01193218|467829212|FG007|0-12 Weeks|Adverse Event|0|||
129963145|NCT01193218|467829205|FG000|0-12 Weeks|Protocol Violation|0|||
129963146|NCT01193218|467829206|FG001|0-12 Weeks|Protocol Violation|0|||
129963147|NCT01193218|467829207|FG002|0-12 Weeks|Protocol Violation|0|||
129963148|NCT01193218|467829208|FG003|0-12 Weeks|Protocol Violation|0|||
129963149|NCT01193218|467829209|FG004|0-12 Weeks|Protocol Violation|1|||
129963150|NCT01193218|467829210|FG005|0-12 Weeks|Protocol Violation|1|||
129963151|NCT01193218|467829211|FG006|0-12 Weeks|Protocol Violation|0|||
129963152|NCT01193218|467829212|FG007|0-12 Weeks|Protocol Violation|0|||
129963153|NCT01193218|467829205|FG000|0-12 Weeks|Withdrawal by Subject|3|||
129963154|NCT01193218|467829206|FG001|0-12 Weeks|Withdrawal by Subject|0|||
129963155|NCT01193218|467829207|FG002|0-12 Weeks|Withdrawal by Subject|2|||
129963156|NCT01193218|467829208|FG003|0-12 Weeks|Withdrawal by Subject|0|||
129963157|NCT01193218|467829209|FG004|0-12 Weeks|Withdrawal by Subject|0|||
129963158|NCT01193218|467829210|FG005|0-12 Weeks|Withdrawal by Subject|0|||
129963159|NCT01193218|467829211|FG006|0-12 Weeks|Withdrawal by Subject|1|||
129963160|NCT01193218|467829212|FG007|0-12 Weeks|Withdrawal by Subject|0|||
129963161|NCT01193218|467829205|FG000|12-52 Weeks|Adverse Event|1|||
129963162|NCT01193218|467829206|FG001|12-52 Weeks|Adverse Event|0|||
129963163|NCT01193218|467829207|FG002|12-52 Weeks|Adverse Event|1|||
129963164|NCT01193218|467829208|FG003|12-52 Weeks|Adverse Event|2|||
129963165|NCT01193218|467829209|FG004|12-52 Weeks|Adverse Event|3|||
129963166|NCT01193218|467829210|FG005|12-52 Weeks|Adverse Event|3|||
129963167|NCT01193218|467829211|FG006|12-52 Weeks|Adverse Event|1|||
129963168|NCT01193218|467829212|FG007|12-52 Weeks|Adverse Event|2|||
129963169|NCT01193218|467829205|FG000|12-52 Weeks|Lack of Efficacy|0|||
129963170|NCT01193218|467829206|FG001|12-52 Weeks|Lack of Efficacy|0|||
129963171|NCT01193218|467829207|FG002|12-52 Weeks|Lack of Efficacy|0|||
129963172|NCT01193218|467829208|FG003|12-52 Weeks|Lack of Efficacy|0|||
129963173|NCT01193218|467829209|FG004|12-52 Weeks|Lack of Efficacy|0|||
129963174|NCT01193218|467829210|FG005|12-52 Weeks|Lack of Efficacy|0|||
129963175|NCT01193218|467829211|FG006|12-52 Weeks|Lack of Efficacy|1|||
129963176|NCT01193218|467829212|FG007|12-52 Weeks|Lack of Efficacy|0|||
129963177|NCT01193218|467829205|FG000|12-52 Weeks|Withdrawal by Subject|3|||
129963178|NCT01193218|467829206|FG001|12-52 Weeks|Withdrawal by Subject|0|||
129963179|NCT01193218|467829207|FG002|12-52 Weeks|Withdrawal by Subject|3|||
129963180|NCT01193218|467829208|FG003|12-52 Weeks|Withdrawal by Subject|0|||
129963181|NCT01193218|467829209|FG004|12-52 Weeks|Withdrawal by Subject|0|||
129963182|NCT01193218|467829210|FG005|12-52 Weeks|Withdrawal by Subject|2|||
129963183|NCT01193218|467829211|FG006|12-52 Weeks|Withdrawal by Subject|1|||
129963184|NCT01193218|467829212|FG007|12-52 Weeks|Withdrawal by Subject|2|||
129963185|NCT01193218|467829205|FG000|12-52 Weeks|Other reason than above|1|||
129963186|NCT01193218|467829206|FG001|12-52 Weeks|Other reason than above|0|||
129963187|NCT01193218|467829207|FG002|12-52 Weeks|Other reason than above|0|||
129963188|NCT01193218|467829208|FG003|12-52 Weeks|Other reason than above|1|||
129963189|NCT01193218|467829209|FG004|12-52 Weeks|Other reason than above|1|||
129963190|NCT01193218|467829210|FG005|12-52 Weeks|Other reason than above|0|||
129963191|NCT01193218|467829211|FG006|12-52 Weeks|Other reason than above|0|||
129963192|NCT01193218|467829212|FG007|12-52 Weeks|Other reason than above|0|||
129963193|NCT01013740|467829213|FG000|Overall Study|Lost to Follow-up|3|||
129963194|NCT01013740|467829214|FG001|Overall Study|Lost to Follow-up|5|||
129963195|NCT01013740|467829213|FG000|Overall Study|Physician Decision|2|||
129963196|NCT01013740|467829214|FG001|Overall Study|Physician Decision|0|||
129963197|NCT01013740|467829213|FG000|Overall Study|Withdrawal by Subject|2|||
129963198|NCT01013740|467829214|FG001|Overall Study|Withdrawal by Subject|10|||
129963199|NCT01013740|467829213|FG000|Overall Study|study close / terminated : done in error|2|||
129963200|NCT01013740|467829214|FG001|Overall Study|study close / terminated : done in error|1|||
129963201|NCT01013740|467829213|FG000|Overall Study|Missing|2|||
129963202|NCT01013740|467829214|FG001|Overall Study|Missing|1|||
129963203|NCT01013740|467829213|FG000|Overall Study|Ongoing: Study records not completed|0|||
129963204|NCT01013740|467829214|FG001|Overall Study|Ongoing: Study records not completed|2|||
129963205|NCT00338949|467829215|FG000|Subject Screening|Screen failures|11|||
129963206|NCT00338949|467829216|FG001|Subject Screening|Screen failures|11|||
129963207|NCT00338949|467829215|FG000|Randomization|Withdrawal by Subject|1|||
129963208|NCT00338949|467829216|FG001|Randomization|Withdrawal by Subject|0|||
129963209|NCT00338949|467829215|FG000|Randomization|Adverse Event|0|||
129963210|NCT00338949|467829216|FG001|Randomization|Adverse Event|5|||
129963211|NCT03811834|467829217|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
129963212|NCT01242371|467829218|FG000|Overall Study|Withdrawal by Subject|2|||
129963213|NCT01242371|467829219|FG001|Overall Study|Withdrawal by Subject|2|||
129963214|NCT01242371|467829218|FG000|Overall Study|Protocol Violation|0|||
129963215|NCT01242371|467829219|FG001|Overall Study|Protocol Violation|3|||
129963216|NCT00025662|467829220|FG000|Overall Study|Withdrawal by Subject|2|||
129963217|NCT00025662|467829220|FG000|Overall Study|Technical failure of manipulation|1|||
129963218|NCT01349036|467829221|FG000|Overall Study|Disease progression|13|||
129963219|NCT01349036|467829222|FG001|Overall Study|Disease progression|22|||
129963220|NCT01349036|467829221|FG000|Overall Study|Other|1|||
129963221|NCT01349036|467829222|FG001|Overall Study|Other|0|||
129963222|NCT01349036|467829221|FG000|Overall Study|Withdrawal by Subject|0|||
129963223|NCT01349036|467829222|FG001|Overall Study|Withdrawal by Subject|2|||
129963224|NCT01215032|467829225|FG000|Overall Study|Adverse Event|3|||
129963225|NCT01215032|467829225|FG000|Overall Study|Lack of Efficacy|17|||
129963226|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
129963227|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
129963228|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
129963229|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
129963230|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
129963231|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
129963232|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
129963233|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
129963234|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
129963235|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
129963236|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
129963237|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
129963238|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
129963239|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
129963240|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
129963241|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
129963242|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
129963243|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
129963244|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
129963245|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
129963246|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
129963247|NCT01125566|467829226|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
129963248|NCT01125566|467829227|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
129963249|NCT01125566|467829228|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
129979962|NCT04372121|467889510|FG000|Overall Study|Withdrawal by Subject|3|||
129963250|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
129963251|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
129963252|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
129963253|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
129963254|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
129963255|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
129963256|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
129963257|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
129963258|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
129963259|NCT01125566|467829226|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
129963260|NCT01125566|467829227|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
129963261|NCT01125566|467829228|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
129963262|NCT03028012|467829229|FG000|Overall Study|Lost to Follow-up|2|||
129963263|NCT03028012|467829230|FG001|Overall Study|Lost to Follow-up|3|||
129963264|NCT03028012|467829231|FG002|Overall Study|Lost to Follow-up|3|||
129963265|NCT02484547|467829238|FG000|Placebo-Controlled Period|Adverse Event|10|||
129963266|NCT02484547|467829239|FG001|Placebo-Controlled Period|Adverse Event|13|||
129963267|NCT02484547|467829240|FG002|Placebo-Controlled Period|Adverse Event|20|||
129963268|NCT02484547|467829241|FG003|Placebo-Controlled Period|Adverse Event|0|||
129963269|NCT02484547|467829242|FG004|Placebo-Controlled Period|Adverse Event|0|||
129963270|NCT02484547|467829243|FG005|Placebo-Controlled Period|Adverse Event|0|||
129963271|NCT02484547|467829244|FG006|Placebo-Controlled Period|Adverse Event|0|||
129963272|NCT02484547|467829238|FG000|Placebo-Controlled Period|Change of Treatment|0|||
129963273|NCT02484547|467829239|FG001|Placebo-Controlled Period|Change of Treatment|0|||
129963274|NCT02484547|467829240|FG002|Placebo-Controlled Period|Change of Treatment|1|||
129963275|NCT02484547|467829241|FG003|Placebo-Controlled Period|Change of Treatment|0|||
129963276|NCT02484547|467829242|FG004|Placebo-Controlled Period|Change of Treatment|0|||
129963277|NCT02484547|467829243|FG005|Placebo-Controlled Period|Change of Treatment|0|||
129963278|NCT02484547|467829244|FG006|Placebo-Controlled Period|Change of Treatment|0|||
129963279|NCT02484547|467829238|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
129963280|NCT02484547|467829239|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
129963281|NCT02484547|467829240|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
129963282|NCT02484547|467829241|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
129963283|NCT02484547|467829242|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
129963284|NCT02484547|467829243|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
129963285|NCT02484547|467829244|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
129963286|NCT02484547|467829238|FG000|Placebo-Controlled Period|Death|5|||
129963287|NCT02484547|467829239|FG001|Placebo-Controlled Period|Death|0|||
129963288|NCT02484547|467829240|FG002|Placebo-Controlled Period|Death|6|||
129963289|NCT02484547|467829241|FG003|Placebo-Controlled Period|Death|0|||
129963290|NCT02484547|467829242|FG004|Placebo-Controlled Period|Death|0|||
129963291|NCT02484547|467829243|FG005|Placebo-Controlled Period|Death|0|||
129963292|NCT02484547|467829244|FG006|Placebo-Controlled Period|Death|0|||
129963293|NCT02484547|467829238|FG000|Placebo-Controlled Period|Disease Progression|2|||
129963294|NCT02484547|467829239|FG001|Placebo-Controlled Period|Disease Progression|0|||
129963295|NCT02484547|467829240|FG002|Placebo-Controlled Period|Disease Progression|1|||
129963296|NCT02484547|467829241|FG003|Placebo-Controlled Period|Disease Progression|0|||
129963297|NCT02484547|467829242|FG004|Placebo-Controlled Period|Disease Progression|0|||
129963298|NCT02484547|467829243|FG005|Placebo-Controlled Period|Disease Progression|0|||
129963299|NCT02484547|467829244|FG006|Placebo-Controlled Period|Disease Progression|0|||
129963300|NCT02484547|467829238|FG000|Placebo-Controlled Period|Investigator Decision|2|||
129963301|NCT02484547|467829239|FG001|Placebo-Controlled Period|Investigator Decision|2|||
129963302|NCT02484547|467829240|FG002|Placebo-Controlled Period|Investigator Decision|5|||
129963303|NCT02484547|467829241|FG003|Placebo-Controlled Period|Investigator Decision|0|||
129963304|NCT02484547|467829242|FG004|Placebo-Controlled Period|Investigator Decision|0|||
129963305|NCT02484547|467829243|FG005|Placebo-Controlled Period|Investigator Decision|0|||
129963306|NCT02484547|467829244|FG006|Placebo-Controlled Period|Investigator Decision|0|||
129963307|NCT02484547|467829238|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
129963308|NCT02484547|467829239|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
129963309|NCT02484547|467829240|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
129963310|NCT02484547|467829241|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
129963311|NCT02484547|467829242|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
129963312|NCT02484547|467829243|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
129963313|NCT02484547|467829244|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
129963314|NCT02484547|467829238|FG000|Placebo-Controlled Period|Relocation|1|||
129963315|NCT02484547|467829239|FG001|Placebo-Controlled Period|Relocation|1|||
129963316|NCT02484547|467829240|FG002|Placebo-Controlled Period|Relocation|1|||
129963317|NCT02484547|467829241|FG003|Placebo-Controlled Period|Relocation|0|||
129963318|NCT02484547|467829242|FG004|Placebo-Controlled Period|Relocation|0|||
129963319|NCT02484547|467829243|FG005|Placebo-Controlled Period|Relocation|0|||
129963320|NCT02484547|467829244|FG006|Placebo-Controlled Period|Relocation|0|||
129963321|NCT02484547|467829238|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
129963322|NCT02484547|467829239|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
129963323|NCT02484547|467829240|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
129963324|NCT02484547|467829241|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
129963325|NCT02484547|467829242|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
129963326|NCT02484547|467829243|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
129963327|NCT02484547|467829244|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
129963328|NCT02484547|467829238|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
129963329|NCT02484547|467829239|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129963330|NCT02484547|467829240|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129963331|NCT02484547|467829241|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963332|NCT02484547|467829242|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963333|NCT02484547|467829243|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963334|NCT02484547|467829244|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129963335|NCT02484547|467829238|FG000|Placebo-Controlled Period|Reason not Specified|216|||
129963336|NCT02484547|467829239|FG001|Placebo-Controlled Period|Reason not Specified|194|||
129963337|NCT02484547|467829240|FG002|Placebo-Controlled Period|Reason not Specified|183|||
129963338|NCT02484547|467829241|FG003|Placebo-Controlled Period|Reason not Specified|0|||
129963339|NCT02484547|467829242|FG004|Placebo-Controlled Period|Reason not Specified|0|||
129963340|NCT02484547|467829243|FG005|Placebo-Controlled Period|Reason not Specified|0|||
129963341|NCT02484547|467829244|FG006|Placebo-Controlled Period|Reason not Specified|0|||
129963342|NCT02484547|467829238|FG000|Long-Term Extension Period|Adverse Event|0|||
129963343|NCT02484547|467829239|FG001|Long-Term Extension Period|Adverse Event|0|||
129963344|NCT02484547|467829240|FG002|Long-Term Extension Period|Adverse Event|0|||
129963345|NCT02484547|467829241|FG003|Long-Term Extension Period|Adverse Event|0|||
129963346|NCT02484547|467829242|FG004|Long-Term Extension Period|Adverse Event|1|||
129963347|NCT02484547|467829243|FG005|Long-Term Extension Period|Adverse Event|3|||
129963348|NCT02484547|467829244|FG006|Long-Term Extension Period|Adverse Event|2|||
129963349|NCT02484547|467829238|FG000|Long-Term Extension Period|Death|0|||
129963350|NCT02484547|467829239|FG001|Long-Term Extension Period|Death|0|||
129963351|NCT02484547|467829240|FG002|Long-Term Extension Period|Death|0|||
129963352|NCT02484547|467829241|FG003|Long-Term Extension Period|Death|0|||
129963353|NCT02484547|467829242|FG004|Long-Term Extension Period|Death|0|||
129963354|NCT02484547|467829243|FG005|Long-Term Extension Period|Death|3|||
129963355|NCT02484547|467829244|FG006|Long-Term Extension Period|Death|0|||
129963356|NCT02484547|467829238|FG000|Long-Term Extension Period|Disease Progression|0|||
129963357|NCT02484547|467829239|FG001|Long-Term Extension Period|Disease Progression|0|||
129963358|NCT02484547|467829240|FG002|Long-Term Extension Period|Disease Progression|0|||
129963359|NCT02484547|467829241|FG003|Long-Term Extension Period|Disease Progression|0|||
129963360|NCT02484547|467829242|FG004|Long-Term Extension Period|Disease Progression|2|||
129963361|NCT02484547|467829243|FG005|Long-Term Extension Period|Disease Progression|4|||
129963362|NCT02484547|467829244|FG006|Long-Term Extension Period|Disease Progression|0|||
129963363|NCT02484547|467829238|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
129963364|NCT02484547|467829239|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
129963365|NCT02484547|467829240|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
129963366|NCT02484547|467829241|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
129963367|NCT02484547|467829242|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
129963368|NCT02484547|467829243|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
129963369|NCT02484547|467829244|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
129963370|NCT02484547|467829238|FG000|Long-Term Extension Period|Loss of Capacity|0|||
129963371|NCT02484547|467829239|FG001|Long-Term Extension Period|Loss of Capacity|0|||
129963372|NCT02484547|467829240|FG002|Long-Term Extension Period|Loss of Capacity|0|||
129963373|NCT02484547|467829241|FG003|Long-Term Extension Period|Loss of Capacity|0|||
129963374|NCT02484547|467829242|FG004|Long-Term Extension Period|Loss of Capacity|1|||
129963375|NCT02484547|467829243|FG005|Long-Term Extension Period|Loss of Capacity|0|||
129963376|NCT02484547|467829244|FG006|Long-Term Extension Period|Loss of Capacity|0|||
129963377|NCT02484547|467829238|FG000|Long-Term Extension Period|Change of Treatment|0|||
129963378|NCT02484547|467829239|FG001|Long-Term Extension Period|Change of Treatment|0|||
129963379|NCT02484547|467829240|FG002|Long-Term Extension Period|Change of Treatment|0|||
129963380|NCT02484547|467829241|FG003|Long-Term Extension Period|Change of Treatment|0|||
129963381|NCT02484547|467829242|FG004|Long-Term Extension Period|Change of Treatment|0|||
129963382|NCT02484547|467829243|FG005|Long-Term Extension Period|Change of Treatment|0|||
129963383|NCT02484547|467829244|FG006|Long-Term Extension Period|Change of Treatment|1|||
129963384|NCT02484547|467829238|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
129963385|NCT02484547|467829239|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
129963386|NCT02484547|467829240|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
129963387|NCT02484547|467829241|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
129963388|NCT02484547|467829242|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
129963389|NCT02484547|467829243|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
129963390|NCT02484547|467829244|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
129963391|NCT02484547|467829238|FG000|Long-Term Extension Period|Investigator Decision|0|||
129963392|NCT02484547|467829239|FG001|Long-Term Extension Period|Investigator Decision|0|||
129963393|NCT02484547|467829240|FG002|Long-Term Extension Period|Investigator Decision|0|||
129963394|NCT02484547|467829241|FG003|Long-Term Extension Period|Investigator Decision|2|||
129963395|NCT02484547|467829242|FG004|Long-Term Extension Period|Investigator Decision|1|||
129963396|NCT02484547|467829243|FG005|Long-Term Extension Period|Investigator Decision|0|||
129963397|NCT02484547|467829244|FG006|Long-Term Extension Period|Investigator Decision|1|||
129963398|NCT02484547|467829238|FG000|Long-Term Extension Period|Relocation|0|||
129963399|NCT02484547|467829239|FG001|Long-Term Extension Period|Relocation|0|||
129963400|NCT02484547|467829240|FG002|Long-Term Extension Period|Relocation|0|||
129963401|NCT02484547|467829241|FG003|Long-Term Extension Period|Relocation|1|||
129963402|NCT02484547|467829242|FG004|Long-Term Extension Period|Relocation|1|||
129963403|NCT02484547|467829243|FG005|Long-Term Extension Period|Relocation|0|||
129963404|NCT02484547|467829244|FG006|Long-Term Extension Period|Relocation|0|||
129963405|NCT02484547|467829238|FG000|Long-Term Extension Period|Study Visit Burden|0|||
129963406|NCT02484547|467829239|FG001|Long-Term Extension Period|Study Visit Burden|0|||
129963407|NCT02484547|467829240|FG002|Long-Term Extension Period|Study Visit Burden|0|||
129963408|NCT02484547|467829241|FG003|Long-Term Extension Period|Study Visit Burden|2|||
129963409|NCT02484547|467829242|FG004|Long-Term Extension Period|Study Visit Burden|0|||
129963410|NCT02484547|467829243|FG005|Long-Term Extension Period|Study Visit Burden|0|||
129963411|NCT02484547|467829244|FG006|Long-Term Extension Period|Study Visit Burden|3|||
129963412|NCT02484547|467829238|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963413|NCT02484547|467829239|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963414|NCT02484547|467829240|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963415|NCT02484547|467829241|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
129963416|NCT02484547|467829242|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
129963417|NCT02484547|467829243|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
129963418|NCT02484547|467829244|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
129963419|NCT02484547|467829238|FG000|Long-Term Extension Period|Reason not Specified|0|||
129963420|NCT02484547|467829239|FG001|Long-Term Extension Period|Reason not Specified|0|||
129963421|NCT02484547|467829240|FG002|Long-Term Extension Period|Reason not Specified|0|||
129963422|NCT02484547|467829241|FG003|Long-Term Extension Period|Reason not Specified|119|||
129963423|NCT02484547|467829242|FG004|Long-Term Extension Period|Reason not Specified|117|||
129963424|NCT02484547|467829243|FG005|Long-Term Extension Period|Reason not Specified|223|||
129963425|NCT02484547|467829244|FG006|Long-Term Extension Period|Reason not Specified|231|||
129963426|NCT01813305|467829245|FG000|Overall Study|Withdrawal by Subject|12|||
129963427|NCT01813305|467829246|FG001|Overall Study|Withdrawal by Subject|5|||
129963428|NCT01813305|467829245|FG000|Overall Study|Safety Concern|4|||
129963429|NCT01813305|467829246|FG001|Overall Study|Safety Concern|0|||
129963430|NCT01813305|467829245|FG000|Overall Study|Ulcer became worse|4|||
129963431|NCT01813305|467829246|FG001|Overall Study|Ulcer became worse|0|||
129963432|NCT01813305|467829245|FG000|Overall Study|Physician Decision|4|||
129963433|NCT01813305|467829246|FG001|Overall Study|Physician Decision|0|||
129963434|NCT01813305|467829245|FG000|Overall Study|Lost to Follow-up|3|||
129963435|NCT01813305|467829246|FG001|Overall Study|Lost to Follow-up|1|||
129963436|NCT01813305|467829245|FG000|Overall Study|Protocol Violation|1|||
129963437|NCT01813305|467829246|FG001|Overall Study|Protocol Violation|0|||
129963438|NCT01813305|467829245|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
129963439|NCT01813305|467829246|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
129963440|NCT01665599|467829250|FG000|Overall Study|Adverse Event|1|||
129963441|NCT01665599|467829250|FG000|Overall Study|Consent Withdrawn|1|||
129963442|NCT01665599|467829250|FG000|Overall Study|Investigator/Sponsor decision|1|||
129963443|NCT01665599|467829250|FG000|Overall Study|Death|1|||
129963444|NCT01665599|467829250|FG000|Overall Study|Lost to Follow-up|2|||
129963445|NCT01665599|467829250|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
129963446|NCT01665599|467829250|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
129963447|NCT01424189|467829251|FG000|Overall Study|Adverse Event|1|||
129963448|NCT01424189|467829252|FG001|Overall Study|Adverse Event|0|||
129963449|NCT01424189|467829251|FG000|Overall Study|Lost to Follow-up|4|||
129963450|NCT01424189|467829252|FG001|Overall Study|Lost to Follow-up|1|||
129963451|NCT01424189|467829251|FG000|Overall Study|Withdrawal by Subject|4|||
129963452|NCT01424189|467829252|FG001|Overall Study|Withdrawal by Subject|4|||
129963453|NCT01424189|467829251|FG000|Overall Study|Subject moved|1|||
129963454|NCT01424189|467829252|FG001|Overall Study|Subject moved|0|||
129963455|NCT01424189|467829251|FG000|Overall Study|Death|3|||
129963456|NCT01424189|467829252|FG001|Overall Study|Death|1|||
129963457|NCT01705145|467829253|FG000|Part B|Adverse Event|1|||
129963458|NCT01203956|467829257|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
129963459|NCT01203956|467829258|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
129455264|NCT02819635|465964549|FG000|Substudy 2, Part 2|Other, not specified|0|||
129963460|NCT00069277|467829259|FG000|Overall Study|Adverse Event|3|||
129963461|NCT00069277|467829259|FG000|Overall Study|Withdrawal by Subject|1|||
129455265|NCT02819635|465964550|FG001|Substudy 2, Part 2|Other, not specified|0|||
129963462|NCT00069277|467829259|FG000|Overall Study|Progressive Disease|15|||
129963463|NCT00069277|467829259|FG000|Overall Study|Physician Decision|2|||
129963464|NCT02230306|467829260|FG000|Overall Study|Did not receive study treatment|1|||
129963465|NCT00361842|467829261|FG000|Overall Study|Withdrawal by Subject|2|||
129963466|NCT00361842|467829262|FG001|Overall Study|Withdrawal by Subject|3|||
129963467|NCT00361842|467829261|FG000|Overall Study|Death|2|||
129963468|NCT00361842|467829262|FG001|Overall Study|Death|1|||
129963469|NCT00361842|467829261|FG000|Overall Study|Disease progression|19|||
129963470|NCT00361842|467829262|FG001|Overall Study|Disease progression|20|||
129963471|NCT00361842|467829261|FG000|Overall Study|Adverse Event|2|||
129963472|NCT00361842|467829262|FG001|Overall Study|Adverse Event|3|||
129963473|NCT00361842|467829261|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
129963474|NCT00361842|467829262|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
129963475|NCT00361842|467829261|FG000|Overall Study|Other|1|||
129963476|NCT00361842|467829262|FG001|Overall Study|Other|0|||
129963477|NCT00361842|467829261|FG000|Overall Study|Other|0|||
129963478|NCT00361842|467829262|FG001|Overall Study|Other|2|||
129963479|NCT01077622|467829263|FG000|Overall Study|Physician Decision|2|||
129963480|NCT01077622|467829263|FG000|Overall Study|Withdrawal by Subject|1|||
129963481|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
129963482|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
129963483|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
129963484|NCT00424177|467829264|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
129963485|NCT00424177|467829264|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
129963486|NCT00424177|467829264|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
129963487|NCT00424177|467829264|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
129963488|NCT00424177|467829264|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
129963489|NCT00424177|467829264|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
129963490|NCT00424177|467829264|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
129963491|NCT01502371|467829267|FG000|Overall Study|Withdrawal by Subject|1|||
129963492|NCT01502371|467829268|FG001|Overall Study|Withdrawal by Subject|2|||
129963493|NCT01502371|467829269|FG002|Overall Study|Withdrawal by Subject|1|||
129963494|NCT01502371|467829270|FG003|Overall Study|Withdrawal by Subject|1|||
129963495|NCT01502371|467829271|FG004|Overall Study|Withdrawal by Subject|1|||
129963496|NCT01502371|467829267|FG000|Overall Study|Adverse Event|2|||
129963497|NCT01502371|467829268|FG001|Overall Study|Adverse Event|1|||
129963498|NCT01502371|467829269|FG002|Overall Study|Adverse Event|0|||
129963499|NCT01502371|467829270|FG003|Overall Study|Adverse Event|4|||
129963500|NCT01502371|467829271|FG004|Overall Study|Adverse Event|3|||
129963501|NCT01502371|467829267|FG000|Overall Study|Treatment Failure|22|||
129963502|NCT01502371|467829268|FG001|Overall Study|Treatment Failure|20|||
129963503|NCT01502371|467829269|FG002|Overall Study|Treatment Failure|12|||
129963504|NCT01502371|467829270|FG003|Overall Study|Treatment Failure|19|||
129963505|NCT01502371|467829271|FG004|Overall Study|Treatment Failure|30|||
129963506|NCT01502371|467829267|FG000|Overall Study|Lack of Efficacy|3|||
129963507|NCT01502371|467829268|FG001|Overall Study|Lack of Efficacy|3|||
129963508|NCT01502371|467829269|FG002|Overall Study|Lack of Efficacy|2|||
129963509|NCT01502371|467829270|FG003|Overall Study|Lack of Efficacy|2|||
129963510|NCT01502371|467829271|FG004|Overall Study|Lack of Efficacy|4|||
129963511|NCT01502371|467829267|FG000|Overall Study|Physician Decision|3|||
129963512|NCT01502371|467829268|FG001|Overall Study|Physician Decision|0|||
129963513|NCT01502371|467829269|FG002|Overall Study|Physician Decision|0|||
129963514|NCT01502371|467829270|FG003|Overall Study|Physician Decision|0|||
129963515|NCT01502371|467829271|FG004|Overall Study|Physician Decision|1|||
129963516|NCT01502371|467829267|FG000|Overall Study|Noncompliance with Study Drug|0|||
129963517|NCT01502371|467829268|FG001|Overall Study|Noncompliance with Study Drug|0|||
129963518|NCT01502371|467829269|FG002|Overall Study|Noncompliance with Study Drug|1|||
129963519|NCT01502371|467829270|FG003|Overall Study|Noncompliance with Study Drug|2|||
129963520|NCT01502371|467829271|FG004|Overall Study|Noncompliance with Study Drug|1|||
129963521|NCT01502371|467829267|FG000|Overall Study|Technical Problems|1|||
129963522|NCT01502371|467829268|FG001|Overall Study|Technical Problems|0|||
129963523|NCT01502371|467829269|FG002|Overall Study|Technical Problems|2|||
129963524|NCT01502371|467829270|FG003|Overall Study|Technical Problems|4|||
129963525|NCT01502371|467829271|FG004|Overall Study|Technical Problems|1|||
129963526|NCT01502371|467829267|FG000|Overall Study|Protocol Violation|9|||
129963527|NCT01502371|467829268|FG001|Overall Study|Protocol Violation|5|||
129963528|NCT01502371|467829269|FG002|Overall Study|Protocol Violation|6|||
129963529|NCT01502371|467829270|FG003|Overall Study|Protocol Violation|5|||
129963530|NCT01502371|467829271|FG004|Overall Study|Protocol Violation|10|||
129963531|NCT01502371|467829267|FG000|Overall Study|Excluded Medication|0|||
129963532|NCT01502371|467829268|FG001|Overall Study|Excluded Medication|1|||
129963533|NCT01502371|467829269|FG002|Overall Study|Excluded Medication|1|||
129963534|NCT01502371|467829270|FG003|Overall Study|Excluded Medication|0|||
129963535|NCT01502371|467829271|FG004|Overall Study|Excluded Medication|1|||
129963536|NCT03282799|467829272|FG000|Overall Study|Pregnancy|1|||
129963537|NCT03282799|467829273|FG001|Overall Study|Pregnancy|0|||
129963538|NCT03282799|467829272|FG000|Overall Study|Physician Decision|1|||
129963539|NCT03282799|467829273|FG001|Overall Study|Physician Decision|0|||
129963540|NCT01726049|467830553|FG000|Overall Study|Death|1|||
129963541|NCT01726049|467830554|FG001|Overall Study|Death|1|||
129963542|NCT01726049|467830553|FG000|Overall Study|Adverse Event|4|||
129963543|NCT01726049|467830554|FG001|Overall Study|Adverse Event|1|||
129963544|NCT01726049|467830553|FG000|Overall Study|refused second HC|0|||
129963545|NCT01726049|467830554|FG001|Overall Study|refused second HC|2|||
129963546|NCT04156399|467830562|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
129963547|NCT04156399|467830562|FG000|Overall Study|study suspension due to COVID pandemic|3|||
129963548|NCT03440047|467830563|FG000|Overall Study|Withdrawal by Subject|2|||
129963549|NCT01181609|467830564|FG000|Overall Study|Adverse Event|1|||
129963550|NCT01181609|467830564|FG000|Overall Study|Withdrawal by Subject|1|||
129963551|NCT01181609|467830564|FG000|Overall Study|Lost to Follow-up|1|||
129963552|NCT01181609|467830564|FG000|Overall Study|Death|50|||
129963553|NCT01722045|467830565|FG000|Overall Study|Adverse Event|8|||
129963554|NCT01722045|467830565|FG000|Overall Study|Death|3|||
129963555|NCT01722045|467830565|FG000|Overall Study|Withdrawal by Subject|8|||
129963556|NCT01722045|467830565|FG000|Overall Study|Lost to Follow-up|4|||
129963557|NCT01722045|467830565|FG000|Overall Study|Protocol Deviation|1|||
129963558|NCT01722045|467830565|FG000|Overall Study|Physician Decision|3|||
129963559|NCT01722045|467830565|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
129963560|NCT03834623|467830575|FG000|Overall Study|Progression|0|||
129963561|NCT03834623|467830576|FG001|Overall Study|Progression|1|||
129963562|NCT00478647|467830577|FG000|Overall Study|Adverse Event|1|||
129963563|NCT00478647|467830577|FG000|Overall Study|Withdrawal by Subject|1|||
129963564|NCT00511836|467830580|FG000|Double-blind Period|Lost to Follow-up|1|||
129963565|NCT00511836|467830581|FG001|Double-blind Period|Lost to Follow-up|0|||
129963566|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
129963567|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
129963568|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
129963569|NCT01755546|467830582|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
129963570|NCT01755546|467830582|FG000|Titration Phase|Adverse Event|11|||
129963571|NCT01755546|467830582|FG000|Titration Phase|Lack of Efficacy|18|||
129963572|NCT01755546|467830582|FG000|Titration Phase|Protocol Violation|9|||
129963573|NCT01755546|467830582|FG000|Titration Phase|Lost to Follow-up|2|||
129963574|NCT01755546|467830582|FG000|Titration Phase|Other and Continuing|22|||
129963575|NCT01755546|467830582|FG000|Titration Phase|Withdrawal by Subject|8|||
129963576|NCT01755546|467830582|FG000|Long Term Treatment|Adverse Event|12|||
129963577|NCT01755546|467830582|FG000|Long Term Treatment|Lack of Efficacy|6|||
129963578|NCT01755546|467830582|FG000|Long Term Treatment|Protocol Violation|10|||
129963579|NCT01755546|467830582|FG000|Long Term Treatment|Withdrawal by Subject|35|||
129963580|NCT01755546|467830582|FG000|Long Term Treatment|Lost to Follow-up|17|||
129963581|NCT01755546|467830582|FG000|Long Term Treatment|other and ongoing|41|||
129963582|NCT04606199|467830583|FG000|Overall Study|Withdrawal by Subject|2|||
129963583|NCT02624869|467830584|FG000|Overall Study|Lost to Follow-up|0|||
129963584|NCT02624869|467830585|FG001|Overall Study|Lost to Follow-up|0|||
129963585|NCT02624869|467830586|FG002|Overall Study|Lost to Follow-up|1|||
129963586|NCT02624869|467830584|FG000|Overall Study|Withdrawal by Subject|1|||
129963587|NCT02624869|467830585|FG001|Overall Study|Withdrawal by Subject|3|||
129963588|NCT02624869|467830586|FG002|Overall Study|Withdrawal by Subject|1|||
129963589|NCT04051242|467830591|FG000|Overall Study|Withdrawal by Subject|1|||
129488458|NCT01277289|466080717|FG000|Overall Study|Adverse Event|2|||
129963590|NCT04051242|467830591|FG000|Overall Study|Physician Decision|1|||
129963591|NCT00496626|467830592|FG000|Overall Study|Lost to Follow-up|0|||
129963592|NCT00496626|467830593|FG001|Overall Study|Lost to Follow-up|1|||
129963593|NCT00496626|467830592|FG000|Overall Study|Protocol Violation|1|||
129963594|NCT00496626|467830593|FG001|Overall Study|Protocol Violation|0|||
129963595|NCT00496626|467830592|FG000|Overall Study|Withdrawal by Subject|5|||
129963596|NCT00496626|467830593|FG001|Overall Study|Withdrawal by Subject|4|||
129963597|NCT00496626|467830592|FG000|Overall Study|Relocated|0|||
129963598|NCT00496626|467830593|FG001|Overall Study|Relocated|1|||
129963599|NCT00727415|467830594|FG000|Phase I|Dose Limiting Toxicity|2|||
129963600|NCT00853229|467830596|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
129963601|NCT00853229|467830597|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
129963602|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
129963603|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
129963604|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
129963605|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
129963606|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
129963607|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
129963608|NCT03201900|467830601|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
129963609|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
129963610|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
129963611|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
129963612|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
129963613|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
129963614|NCT03201900|467830601|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
129963615|NCT00776659|467830605|FG000|Overall Study|Lost to Follow-up|15|||
129963616|NCT00776659|467830605|FG000|Overall Study|Withdrawal by Subject|10|||
129963617|NCT00776659|467830605|FG000|Overall Study|Study Terminated by Sponsor|1|||
129963618|NCT01233999|467830608|FG000|Overall Study|Withdrawal by Subject|1|||
129963619|NCT01233999|467830608|FG000|Overall Study|Lost to Follow-up|1|||
129963620|NCT01167192|467830609|FG000|Overall Study|Adverse Event|1|||
129963621|NCT01167192|467830609|FG000|Overall Study|Death|1|||
129963622|NCT01167192|467830609|FG000|Overall Study|Withdrawal by Subject|1|||
129963623|NCT01167192|467830609|FG000|Overall Study|Insurance denial|1|||
129963624|NCT00129649|467830615|FG000|Overall Study|Withdrawal by Subject|76|||
129963625|NCT00129649|467830616|FG001|Overall Study|Withdrawal by Subject|65|||
129963626|NCT00025506|467830617|FG000|Overall Study|Ineligible: clerical error|1|||
129963627|NCT00025506|467830617|FG000|Overall Study|Ineligible: wrong cell type|5|||
129963628|NCT00025506|467830617|FG000|Overall Study|Ineligible: inadequate pathology|2|||
129963629|NCT00025506|467830617|FG000|Overall Study|Never Treated|2|||
129963630|NCT01321723|467830618|FG000|Overall Study|Adverse Event|3|||
129963631|NCT01321723|467830619|FG001|Overall Study|Adverse Event|5|||
129963632|NCT01321723|467830620|FG002|Overall Study|Adverse Event|2|||
129963633|NCT01321723|467830618|FG000|Overall Study|Withdrawal by Subject|2|||
129963634|NCT01321723|467830619|FG001|Overall Study|Withdrawal by Subject|0|||
129963635|NCT01321723|467830620|FG002|Overall Study|Withdrawal by Subject|2|||
129963636|NCT00713206|467830621|FG000|Overall Study|Lost to Follow-up|4|||
129963637|NCT00713206|467830622|FG001|Overall Study|Lost to Follow-up|4|||
129963638|NCT00713206|467830621|FG000|Overall Study|Death|1|||
129963639|NCT00713206|467830622|FG001|Overall Study|Death|0|||
129963640|NCT02561806|467830623|FG000|Induction Period|Adverse Event|0|||
129963641|NCT02561806|467830624|FG001|Induction Period|Adverse Event|2|||
129963642|NCT02561806|467830623|FG000|Induction Period|Lack of Efficacy|1|||
129963643|NCT02561806|467830624|FG001|Induction Period|Lack of Efficacy|0|||
129963644|NCT02561806|467830623|FG000|Induction Period|Withdrawal by Subject|0|||
129963645|NCT02561806|467830624|FG001|Induction Period|Withdrawal by Subject|2|||
129963646|NCT02561806|467830623|FG000|Induction Period|Site staff became unblinded|1|||
129963647|NCT02561806|467830624|FG001|Induction Period|Site staff became unblinded|0|||
129963648|NCT02561806|467830623|FG000|Induction Period|Randomized but not treated|0|||
129963649|NCT02561806|467830624|FG001|Induction Period|Randomized but not treated|1|||
129963650|NCT02561806|467830623|FG000|Maintenance Period|Adverse Event|2|||
129963651|NCT02561806|467830624|FG001|Maintenance Period|Adverse Event|1|||
129963652|NCT02561806|467830623|FG000|Maintenance Period|Lack of Efficacy|3|||
129963653|NCT02561806|467830624|FG001|Maintenance Period|Lack of Efficacy|1|||
129963654|NCT02561806|467830623|FG000|Maintenance Period|Lost to Follow-up|2|||
129963655|NCT02561806|467830624|FG001|Maintenance Period|Lost to Follow-up|2|||
129963656|NCT02561806|467830623|FG000|Maintenance Period|Protocol Violation|1|||
129963657|NCT02561806|467830624|FG001|Maintenance Period|Protocol Violation|0|||
129963658|NCT02561806|467830623|FG000|Maintenance Period|Withdrawal by Subject|5|||
129963659|NCT02561806|467830624|FG001|Maintenance Period|Withdrawal by Subject|3|||
129963660|NCT02561806|467830623|FG000|Maintenance Period|Site staff became unblinded|0|||
129963661|NCT02561806|467830624|FG001|Maintenance Period|Site staff became unblinded|1|||
129963662|NCT02561806|467830623|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
129963663|NCT02561806|467830624|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
129963664|NCT02561806|467830623|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
129963665|NCT02561806|467830624|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
129963666|NCT02547441|467830625|FG000|Double-Blind Study Period|Adverse Event|4|||
129963667|NCT02547441|467830626|FG001|Double-Blind Study Period|Adverse Event|9|||
129963668|NCT02547441|467830625|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
129963669|NCT02547441|467830626|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
129963670|NCT02547441|467830625|FG000|Double-Blind Study Period|Physician Decision|1|||
129963671|NCT02547441|467830626|FG001|Double-Blind Study Period|Physician Decision|0|||
129963672|NCT02547441|467830625|FG000|Double-Blind Study Period|Protocol Violation|1|||
129963673|NCT02547441|467830626|FG001|Double-Blind Study Period|Protocol Violation|2|||
129963674|NCT02547441|467830625|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
129963675|NCT02547441|467830626|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
129963676|NCT02547441|467830625|FG000|Double-Blind Study Period|Sponsor Decision|1|||
129963677|NCT02547441|467830626|FG001|Double-Blind Study Period|Sponsor Decision|0|||
129963678|NCT02547441|467830625|FG000|Open-Label Study Period|Adverse Event|10|||
129963679|NCT02547441|467830626|FG001|Open-Label Study Period|Adverse Event|11|||
129963680|NCT02547441|467830625|FG000|Open-Label Study Period|Lack of Efficacy|3|||
129963681|NCT02547441|467830626|FG001|Open-Label Study Period|Lack of Efficacy|2|||
129963682|NCT02547441|467830625|FG000|Open-Label Study Period|Lost to Follow-up|7|||
129963683|NCT02547441|467830626|FG001|Open-Label Study Period|Lost to Follow-up|8|||
129963684|NCT02547441|467830625|FG000|Open-Label Study Period|Physician Decision|1|||
129963685|NCT02547441|467830626|FG001|Open-Label Study Period|Physician Decision|0|||
129963686|NCT02547441|467830625|FG000|Open-Label Study Period|Protocol Violation|2|||
129963687|NCT02547441|467830626|FG001|Open-Label Study Period|Protocol Violation|0|||
129963688|NCT02547441|467830625|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
129963689|NCT02547441|467830626|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
129963690|NCT02547441|467830625|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
129963691|NCT02547441|467830626|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
129963692|NCT01322009|467830627|FG000|Overall Study|Death|0|||
129963693|NCT01322009|467830628|FG001|Overall Study|Death|1|||
129963694|NCT01322009|467830627|FG000|Overall Study|Adverse Event|0|||
129963695|NCT01322009|467830628|FG001|Overall Study|Adverse Event|1|||
129963696|NCT01322009|467830627|FG000|Overall Study|ng tube discontinued|0|||
129963697|NCT01322009|467830628|FG001|Overall Study|ng tube discontinued|1|||
129963698|NCT02427958|467830634|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
129963699|NCT02427958|467830634|FG000|Overall Study|Lost to Follow-up|6|||
129963700|NCT02427958|467830634|FG000|Overall Study|Withdrawal by Subject|14|||
129963701|NCT02427958|467830634|FG000|Overall Study|Lack of Efficacy|1|||
129963702|NCT00582114|467830637|FG000|Overall Study|Death|4|||
129963703|NCT00582114|467830638|FG001|Overall Study|Death|4|||
129963704|NCT00582114|467830637|FG000|Overall Study|Kidney Transplant|3|||
129963705|NCT00582114|467830638|FG001|Overall Study|Kidney Transplant|1|||
129963706|NCT00582114|467830637|FG000|Overall Study|Lost to Follow-up|7|||
129963707|NCT00582114|467830638|FG001|Overall Study|Lost to Follow-up|6|||
129963708|NCT00582114|467830637|FG000|Overall Study|Withdrawal by Subject|8|||
129963709|NCT00582114|467830638|FG001|Overall Study|Withdrawal by Subject|16|||
129963710|NCT00582114|467830637|FG000|Overall Study|Adverse Event|1|||
129963711|NCT00582114|467830638|FG001|Overall Study|Adverse Event|1|||
129963712|NCT00582114|467830637|FG000|Overall Study|Physician Decision|0|||
129963713|NCT00582114|467830638|FG001|Overall Study|Physician Decision|6|||
129963714|NCT00582114|467830637|FG000|Overall Study|Stopped by data safety monitoring board|19|||
129963715|NCT00582114|467830638|FG001|Overall Study|Stopped by data safety monitoring board|20|||
129963716|NCT02604342|467830639|FG000|Overall Study|Death|32|||
129963717|NCT02604342|467830640|FG001|Overall Study|Death|16|||
129963718|NCT02604342|467830639|FG000|Overall Study|Progression of disease|1|||
129963719|NCT02604342|467830640|FG001|Overall Study|Progression of disease|0|||
129963720|NCT02604342|467830639|FG000|Overall Study|Withdrawal by Subject|5|||
129963721|NCT02604342|467830640|FG001|Overall Study|Withdrawal by Subject|6|||
129963722|NCT02604342|467830639|FG000|Overall Study|Other|1|||
129963723|NCT02604342|467830640|FG001|Overall Study|Other|0|||
129963724|NCT02604342|467830639|FG000|Overall Study|Study Termination by Sponsor|1|||
129963725|NCT02604342|467830640|FG001|Overall Study|Study Termination by Sponsor|0|||
129963726|NCT02604342|467830639|FG000|Overall Study|Lost to Follow-up|1|||
129963727|NCT02604342|467830640|FG001|Overall Study|Lost to Follow-up|1|||
129963728|NCT02604342|467830639|FG000|Overall Study|Physician Decision|2|||
129963729|NCT02604342|467830640|FG001|Overall Study|Physician Decision|0|||
129963730|NCT00130728|467830641|FG000|Overall Study|Death|258|||
129963731|NCT00130728|467830642|FG001|Overall Study|Death|258|||
129963732|NCT00130728|467830641|FG000|Overall Study|Lost to Follow-up|4|||
129963733|NCT00130728|467830642|FG001|Overall Study|Lost to Follow-up|0|||
129963734|NCT00130728|467830641|FG000|Overall Study|Withdrawal by Subject|0|||
129963735|NCT00130728|467830642|FG001|Overall Study|Withdrawal by Subject|2|||
129455266|NCT02819635|465964551|FG002|Substudy 2, Part 2|Other, not specified|0|||
129455267|NCT02819635|465964552|FG003|Substudy 2, Part 2|Other, not specified|0|||
129455268|NCT02819635|465964553|FG004|Substudy 2, Part 2|Other, not specified|0|||
129963736|NCT00746356|467830643|FG000|Overall Study|Withdrawal by Subject|2|||
129963737|NCT00746356|467830644|FG001|Overall Study|Withdrawal by Subject|3|||
129963738|NCT00746356|467830643|FG000|Overall Study|Death|7|||
129963739|NCT00746356|467830644|FG001|Overall Study|Death|3|||
129963740|NCT00746356|467830643|FG000|Overall Study|Lost to Follow-up|1|||
129963741|NCT00746356|467830644|FG001|Overall Study|Lost to Follow-up|0|||
129963742|NCT00746356|467830643|FG000|Overall Study|Removal of Device|0|||
129963743|NCT00746356|467830644|FG001|Overall Study|Removal of Device|1|||
129963744|NCT00746356|467830643|FG000|Overall Study|Patient relocated|1|||
129963745|NCT00746356|467830644|FG001|Overall Study|Patient relocated|0|||
129963746|NCT02881047|467830647|FG000|Overall Study|Adverse Event|1|||
129963747|NCT02881047|467830647|FG000|Overall Study|Withdrawal by Subject|1|||
129963748|NCT04814992|467830654|FG000|Overall Study|Withdrawal by Subject|6|||
129963749|NCT04814992|467830655|FG001|Overall Study|Withdrawal by Subject|3|||
129963750|NCT04814992|467830654|FG000|Overall Study|Lost to Follow-up|1|||
129963751|NCT04814992|467830655|FG001|Overall Study|Lost to Follow-up|4|||
129963752|NCT00691678|467830656|FG000|Overall Study|Adverse Event|5|||
129963753|NCT00691678|467830656|FG000|Overall Study|life events, pain|11|||
129963754|NCT01503164|467830660|FG000|Overall Study|Withdrawal by Subject|2|||
129963755|NCT01503164|467830661|FG001|Overall Study|Withdrawal by Subject|1|||
129963756|NCT01831726|467830662|FG000|Overall Study|Adverse Event|16|||
129963757|NCT01831726|467830662|FG000|Overall Study|Death|7|||
129963758|NCT01831726|467830662|FG000|Overall Study|Disease Progression|49|||
129963759|NCT01831726|467830662|FG000|Overall Study|Physician Decision|1|||
129963760|NCT01831726|467830662|FG000|Overall Study|Subject/guardian decision|7|||
129963761|NCT03049306|467830663|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
129963762|NCT03049306|467830664|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
129963763|NCT03151551|467830665|FG000|Open-Label Treatment Period|Adverse Event|0|||
129963764|NCT03151551|467830666|FG001|Open-Label Treatment Period|Adverse Event|2|||
129963765|NCT03151551|467830665|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
129963766|NCT03151551|467830666|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
129963767|NCT03151551|467830665|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
129963768|NCT03151551|467830666|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
129963769|NCT03151551|467830665|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
129963770|NCT03151551|467830666|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
129963771|NCT03151551|467830665|FG000|Open-Label Treatment Period|Physician Decision|3|||
129963772|NCT03151551|467830666|FG001|Open-Label Treatment Period|Physician Decision|0|||
129963773|NCT03151551|467830665|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
129963774|NCT03151551|467830666|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
129963775|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
129963776|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
129963777|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
129963778|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
129963779|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
129963780|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
129963781|NCT03151551|467830665|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
129963782|NCT03151551|467830666|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
129963783|NCT00514813|467830671|FG000|Overall Study|Study terminated|14|||
129963784|NCT00514813|467830672|FG001|Overall Study|Study terminated|74|||
129963785|NCT00514813|467830673|FG002|Overall Study|Study terminated|40|||
129963786|NCT00514813|467830674|FG003|Overall Study|Study terminated|2|||
129963787|NCT00514813|467830671|FG000|Overall Study|Adverse Event|0|||
129963788|NCT00514813|467830672|FG001|Overall Study|Adverse Event|2|||
129963789|NCT00514813|467830673|FG002|Overall Study|Adverse Event|2|||
129963790|NCT00514813|467830674|FG003|Overall Study|Adverse Event|0|||
129455269|NCT02819635|465964554|FG005|Substudy 2, Part 2|Other, not specified|4|||
129455270|NCT02819635|465964555|FG006|Substudy 2, Part 2|Other, not specified|8|||
129455271|NCT02819635|465964556|FG007|Substudy 2, Part 2|Other, not specified|0|||
129455272|NCT02819635|465964557|FG008|Substudy 2, Part 2|Other, not specified|0|||
129455273|NCT02819635|465964558|FG009|Substudy 2, Part 2|Other, not specified|0|||
129455274|NCT02819635|465964559|FG010|Substudy 2, Part 2|Other, not specified|0|||
129455275|NCT02819635|465964560|FG011|Substudy 2, Part 2|Other, not specified|0|||
129455276|NCT02819635|465964549|FG000|Substudy 3|Adverse Event|0|||
129455277|NCT02819635|465964550|FG001|Substudy 3|Adverse Event|0|||
129455278|NCT02819635|465964551|FG002|Substudy 3|Adverse Event|0|||
129455279|NCT02819635|465964552|FG003|Substudy 3|Adverse Event|0|||
129455280|NCT02819635|465964553|FG004|Substudy 3|Adverse Event|0|||
129455281|NCT02819635|465964554|FG005|Substudy 3|Adverse Event|0|||
129455282|NCT02819635|465964555|FG006|Substudy 3|Adverse Event|0|||
129455283|NCT02819635|465964556|FG007|Substudy 3|Adverse Event|0|||
129455284|NCT02819635|465964557|FG008|Substudy 3|Adverse Event|32|||
129455285|NCT02819635|465964558|FG009|Substudy 3|Adverse Event|3|||
129455286|NCT02819635|465964559|FG010|Substudy 3|Adverse Event|12|||
129455287|NCT02819635|465964560|FG011|Substudy 3|Adverse Event|18|||
129455288|NCT02819635|465964549|FG000|Substudy 3|Withdrew consent|0|||
129455289|NCT02819635|465964550|FG001|Substudy 3|Withdrew consent|0|||
129963791|NCT00514813|467830671|FG000|Overall Study|Protocol Violation|1|||
129963792|NCT00514813|467830672|FG001|Overall Study|Protocol Violation|0|||
129963793|NCT00514813|467830673|FG002|Overall Study|Protocol Violation|0|||
129455290|NCT02819635|465964551|FG002|Substudy 3|Withdrew consent|0|||
129455291|NCT02819635|465964552|FG003|Substudy 3|Withdrew consent|0|||
129455292|NCT02819635|465964553|FG004|Substudy 3|Withdrew consent|0|||
129963794|NCT00514813|467830674|FG003|Overall Study|Protocol Violation|0|||
129455293|NCT02819635|465964554|FG005|Substudy 3|Withdrew consent|0|||
129455294|NCT02819635|465964555|FG006|Substudy 3|Withdrew consent|0|||
129963795|NCT00514813|467830671|FG000|Overall Study|Withdrawal by Subject|0|||
129963796|NCT00514813|467830672|FG001|Overall Study|Withdrawal by Subject|1|||
129963797|NCT00514813|467830673|FG002|Overall Study|Withdrawal by Subject|0|||
129963798|NCT00514813|467830674|FG003|Overall Study|Withdrawal by Subject|0|||
129963799|NCT00514813|467830671|FG000|Overall Study|Lack of Efficacy|0|||
129963800|NCT00514813|467830672|FG001|Overall Study|Lack of Efficacy|1|||
129963801|NCT00514813|467830673|FG002|Overall Study|Lack of Efficacy|0|||
129963802|NCT00514813|467830674|FG003|Overall Study|Lack of Efficacy|0|||
129963803|NCT00514813|467830671|FG000|Overall Study|Kidney transplant|0|||
129963804|NCT00514813|467830672|FG001|Overall Study|Kidney transplant|6|||
129963805|NCT00514813|467830673|FG002|Overall Study|Kidney transplant|2|||
129963806|NCT00514813|467830674|FG003|Overall Study|Kidney transplant|0|||
129963807|NCT00514813|467830671|FG000|Overall Study|Death|0|||
129963808|NCT00514813|467830672|FG001|Overall Study|Death|2|||
129963809|NCT00514813|467830673|FG002|Overall Study|Death|3|||
129963810|NCT00514813|467830674|FG003|Overall Study|Death|2|||
129963811|NCT02979613|467830675|FG000|Double-Blind Phase|Withdrew Consent|2|||
129963812|NCT02979613|467830676|FG001|Double-Blind Phase|Withdrew Consent|4|||
129963813|NCT02979613|467830675|FG000|Double-Blind Phase|Pregnancy|2|||
129963814|NCT02979613|467830676|FG001|Double-Blind Phase|Pregnancy|2|||
129963815|NCT02979613|467830675|FG000|Double-Blind Phase|Adverse Event|2|||
129963816|NCT02979613|467830676|FG001|Double-Blind Phase|Adverse Event|0|||
129963817|NCT02979613|467830675|FG000|Double-Blind Phase|Lost to Follow-up|1|||
129963818|NCT02979613|467830676|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129963819|NCT02979613|467830675|FG000|Double-Blind Phase|Protocol Violation|1|||
129963820|NCT02979613|467830676|FG001|Double-Blind Phase|Protocol Violation|1|||
129963821|NCT02979613|467830675|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
129963822|NCT02979613|467830676|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
129963823|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
129963824|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
129963825|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
129963826|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
129963827|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Death|0|||
129963828|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Death|1|||
129963829|NCT02979613|467830675|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
129963830|NCT02979613|467830676|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
129963831|NCT00143598|467830679|FG000|Overall Study|Lost to Follow-up|23|||
129963832|NCT00143598|467830680|FG001|Overall Study|Lost to Follow-up|21|||
129963833|NCT00143598|467830679|FG000|Overall Study|Withdrawal by Subject|33|||
129963834|NCT00143598|467830680|FG001|Overall Study|Withdrawal by Subject|37|||
129963835|NCT00143598|467830679|FG000|Overall Study|Death|36|||
129963836|NCT00143598|467830680|FG001|Overall Study|Death|36|||
129963837|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
129963838|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
129963839|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
129963840|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
129963841|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
129963842|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
129963843|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
129963844|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
129963845|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
129963846|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
129963847|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
129963848|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
129963849|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
129963850|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
129963851|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
129963852|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
129963853|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
129963854|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
129963855|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
129963856|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
129963857|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
129963858|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
129963859|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
129963860|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
129963861|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
129963862|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
129963863|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
129963864|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
129963865|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
129963866|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
129963867|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
129963868|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
129963869|NCT00092521|467832325|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
129963870|NCT00092521|467832326|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
129963871|NCT00092521|467832327|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
129963872|NCT00092521|467832328|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
129963873|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
129963874|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
129963875|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
129963876|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
129963877|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
129963878|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
129963879|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
129963880|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
129963881|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
129963882|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
129963883|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
129963884|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
129963885|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Death|2|||
129963886|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Death|0|||
129963887|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Death|1|||
129963888|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Death|0|||
129963889|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
129963890|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
129963891|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
129963892|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
129963893|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
129963894|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
129963895|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
129963896|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
129963897|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
129963898|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
129963899|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
129963900|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
129963901|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Moved|32|||
129963902|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Moved|2|||
129963903|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Moved|28|||
129963904|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Moved|0|||
129963905|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
129963906|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
129963907|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
129963908|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
129963909|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Travel|2|||
129963910|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Travel|0|||
129963911|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Travel|0|||
129963912|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Travel|0|||
129963913|NCT00092521|467832325|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
129963914|NCT00092521|467832326|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
129963915|NCT00092521|467832327|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
129963916|NCT00092521|467832328|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
129963917|NCT00092521|467832325|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
129963918|NCT00092521|467832326|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
129963919|NCT00092521|467832327|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
129963920|NCT00092521|467832328|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
129963921|NCT00092521|467832325|FG000|Extension Study (Group 4)|Adverse Event|0|||
129963922|NCT00092521|467832326|FG001|Extension Study (Group 4)|Adverse Event|0|||
129963923|NCT00092521|467832327|FG002|Extension Study (Group 4)|Adverse Event|0|||
129963924|NCT00092521|467832328|FG003|Extension Study (Group 4)|Adverse Event|2|||
129963925|NCT00092521|467832325|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
129963926|NCT00092521|467832326|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
129963927|NCT00092521|467832327|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
129963928|NCT00092521|467832328|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
129963929|NCT00092521|467832325|FG000|Extension Study (Group 4)|Pregnancy|0|||
129963930|NCT00092521|467832326|FG001|Extension Study (Group 4)|Pregnancy|0|||
129963931|NCT00092521|467832327|FG002|Extension Study (Group 4)|Pregnancy|0|||
129963932|NCT00092521|467832328|FG003|Extension Study (Group 4)|Pregnancy|4|||
129963933|NCT00092521|467832325|FG000|Extension Study (Group 4)|Protocol Violation|0|||
129963934|NCT00092521|467832326|FG001|Extension Study (Group 4)|Protocol Violation|0|||
129963935|NCT00092521|467832327|FG002|Extension Study (Group 4)|Protocol Violation|0|||
129963936|NCT00092521|467832328|FG003|Extension Study (Group 4)|Protocol Violation|2|||
129963937|NCT00092521|467832325|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
129963938|NCT00092521|467832326|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
129963939|NCT00092521|467832327|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
129963940|NCT00092521|467832328|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
129963941|NCT00092521|467832325|FG000|Extension Study (Group 4)|Moved|0|||
129963942|NCT00092521|467832326|FG001|Extension Study (Group 4)|Moved|0|||
129963943|NCT00092521|467832327|FG002|Extension Study (Group 4)|Moved|0|||
129963944|NCT00092521|467832328|FG003|Extension Study (Group 4)|Moved|16|||
129963945|NCT00092521|467832325|FG000|Extension Study (Group 4)|Site Terminated|0|||
129963946|NCT00092521|467832326|FG001|Extension Study (Group 4)|Site Terminated|0|||
129963947|NCT00092521|467832327|FG002|Extension Study (Group 4)|Site Terminated|0|||
129963948|NCT00092521|467832328|FG003|Extension Study (Group 4)|Site Terminated|4|||
129963949|NCT00092521|467832325|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
129963950|NCT00092521|467832326|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
129963951|NCT00092521|467832327|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
129963952|NCT00092521|467832328|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
129963953|NCT03464383|467832329|FG000|Overall Study|Lost to Follow-up|1|||
129963954|NCT03464383|467832330|FG001|Overall Study|Lost to Follow-up|0|||
129963955|NCT03464383|467832331|FG002|Overall Study|Lost to Follow-up|0|||
129963956|NCT03464383|467832329|FG000|Overall Study|Withdrawal by Subject|0|||
129963957|NCT03464383|467832330|FG001|Overall Study|Withdrawal by Subject|1|||
129963958|NCT03464383|467832331|FG002|Overall Study|Withdrawal by Subject|0|||
129963959|NCT00605566|467832332|FG000|Overall Study|Adverse Event|1|||
129963960|NCT00605566|467832332|FG000|Overall Study|Clinical deterioration|1|||
129963961|NCT00605566|467832332|FG000|Overall Study|Poor compliance in run-in period|1|||
129963962|NCT00695136|467832340|FG000|Overall Study|Withdrawal by Subject|1|||
129963963|NCT00695136|467832340|FG000|Overall Study|unrelated adverse event|1|||
129963964|NCT02826798|467832342|FG000|Overall Study|Withdrawal by Subject|0|||
129963965|NCT02826798|467832343|FG001|Overall Study|Withdrawal by Subject|1|||
129963966|NCT02826798|467832344|FG002|Overall Study|Withdrawal by Subject|0|||
129963967|NCT02826798|467832345|FG003|Overall Study|Withdrawal by Subject|1|||
129963968|NCT02826798|467832346|FG004|Overall Study|Withdrawal by Subject|0|||
129963969|NCT02806505|467832347|FG000|Overall Study|Adverse event/intercurrent illness|1|||
129963970|NCT02806505|467832348|FG001|Overall Study|Adverse event/intercurrent illness|3|||
129963971|NCT02806505|467832347|FG000|Overall Study|Death|4|||
129963972|NCT02806505|467832348|FG001|Overall Study|Death|0|||
129963973|NCT02806505|467832347|FG000|Overall Study|Did not cooperate/refused treatment|3|||
129963974|NCT02806505|467832348|FG001|Overall Study|Did not cooperate/refused treatment|3|||
129963975|NCT02806505|467832347|FG000|Overall Study|Failure to return|0|||
129963976|NCT02806505|467832348|FG001|Overall Study|Failure to return|1|||
129963977|NCT02806505|467832347|FG000|Overall Study|Insufficient therapeutic response|2|||
129963978|NCT02806505|467832348|FG001|Overall Study|Insufficient therapeutic response|4|||
129963979|NCT01333111|467832351|FG000|Overall Study|patient undergoing major surgery|0|||
129963980|NCT01333111|467832352|FG001|Overall Study|patient undergoing major surgery|2|||
129963981|NCT01333111|467832353|FG002|Overall Study|patient undergoing major surgery|0|||
129963982|NCT01333111|467832351|FG000|Overall Study|personal reasons|0|||
129963983|NCT01333111|467832352|FG001|Overall Study|personal reasons|0|||
129963984|NCT01333111|467832353|FG002|Overall Study|personal reasons|1|||
129963985|NCT01333111|467832351|FG000|Overall Study|unclassified|1|||
129963986|NCT01333111|467832352|FG001|Overall Study|unclassified|0|||
129963987|NCT01333111|467832353|FG002|Overall Study|unclassified|0|||
129963988|NCT01333111|467832351|FG000|Overall Study|withdrawal criteria|0|||
129963989|NCT01333111|467832352|FG001|Overall Study|withdrawal criteria|1|||
129963990|NCT01333111|467832353|FG002|Overall Study|withdrawal criteria|0|||
129963991|NCT01333111|467832351|FG000|Overall Study|Non-compliance|1|||
129963992|NCT01333111|467832352|FG001|Overall Study|Non-compliance|0|||
129963993|NCT01333111|467832353|FG002|Overall Study|Non-compliance|0|||
129963994|NCT01333111|467832351|FG000|Overall Study|Ineffective therapy|0|||
129963995|NCT01333111|467832352|FG001|Overall Study|Ineffective therapy|0|||
129963996|NCT01333111|467832353|FG002|Overall Study|Ineffective therapy|1|||
129963997|NCT02161406|467832354|FG000|Overall Study|Death|2|||
129963998|NCT02161406|467832355|FG001|Overall Study|Death|1|||
129963999|NCT02161406|467832354|FG000|Overall Study|Lost to Follow-up|2|||
129964000|NCT02161406|467832355|FG001|Overall Study|Lost to Follow-up|1|||
129964001|NCT02161406|467832354|FG000|Overall Study|Withdrawal by Subject|2|||
129964002|NCT02161406|467832355|FG001|Overall Study|Withdrawal by Subject|4|||
129964003|NCT02161406|467832354|FG000|Overall Study|investigator withdrew subject|3|||
129964004|NCT02161406|467832355|FG001|Overall Study|investigator withdrew subject|1|||
129964005|NCT02161406|467832354|FG000|Overall Study|Lack of Efficacy|1|||
129964006|NCT02161406|467832355|FG001|Overall Study|Lack of Efficacy|1|||
129964007|NCT02161406|467832354|FG000|Overall Study|relocation|0|||
129964008|NCT02161406|467832355|FG001|Overall Study|relocation|1|||
129964009|NCT00664105|467832356|FG000|Overall Study|Death|3|||
129964010|NCT00664105|467832356|FG000|Overall Study|Withdrawal by Subject|5|||
129964011|NCT00664105|467832356|FG000|Overall Study|Adverse Event|9|||
129964012|NCT00664105|467832356|FG000|Overall Study|Disease progression|7|||
129964013|NCT04732871|467832357|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
129964014|NCT04732871|467832358|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
129964015|NCT04732871|467832359|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
129964016|NCT04732871|467832357|FG000|Overall Study|Lost to Follow-up|7|||
129964017|NCT04732871|467832358|FG001|Overall Study|Lost to Follow-up|4|||
129964018|NCT04732871|467832359|FG002|Overall Study|Lost to Follow-up|3|||
129964019|NCT04732871|467832357|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
129964020|NCT04732871|467832358|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
129964021|NCT04732871|467832359|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
129964022|NCT04732871|467832357|FG000|Overall Study|Migrated / moved from the study area|5|||
129964023|NCT04732871|467832358|FG001|Overall Study|Migrated / moved from the study area|0|||
129964024|NCT04732871|467832359|FG002|Overall Study|Migrated / moved from the study area|0|||
129964025|NCT04732871|467832357|FG000|Overall Study|Other|1|||
129964026|NCT04732871|467832358|FG001|Overall Study|Other|0|||
129964027|NCT04732871|467832359|FG002|Overall Study|Other|1|||
129964028|NCT04732871|467832357|FG000|Overall Study|Ongoing|6|||
129964029|NCT04732871|467832358|FG001|Overall Study|Ongoing|0|||
129964030|NCT04732871|467832359|FG002|Overall Study|Ongoing|1|||
129964031|NCT04732871|467832357|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
129964032|NCT04732871|467832358|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
129964033|NCT04732871|467832359|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
129964034|NCT02034162|467832362|FG000|Double-blind|Lost to Follow-up|3|||
129964035|NCT02034162|467832363|FG001|Double-blind|Lost to Follow-up|0|||
129964036|NCT02034162|467832364|FG002|Double-blind|Lost to Follow-up|0|||
129964037|NCT02034162|467832362|FG000|Double-blind|Physician Decision|1|||
129964038|NCT02034162|467832363|FG001|Double-blind|Physician Decision|0|||
129964039|NCT02034162|467832364|FG002|Double-blind|Physician Decision|0|||
129964040|NCT02034162|467832362|FG000|Double-blind|Protocol Violation|0|||
129964041|NCT02034162|467832363|FG001|Double-blind|Protocol Violation|1|||
129964042|NCT02034162|467832364|FG002|Double-blind|Protocol Violation|0|||
129964043|NCT02034162|467832362|FG000|Double-blind|Withdrawal by Subject|5|||
129964044|NCT02034162|467832363|FG001|Double-blind|Withdrawal by Subject|7|||
129964045|NCT02034162|467832364|FG002|Double-blind|Withdrawal by Subject|0|||
129964046|NCT03458728|467832366|FG000|Overall Study|Adverse Event|1|||
129964047|NCT03458728|467832367|FG001|Overall Study|Adverse Event|0|||
129964048|NCT03458728|467832366|FG000|Overall Study|Physician Decision|1|||
129964049|NCT03458728|467832367|FG001|Overall Study|Physician Decision|0|||
129964050|NCT03458728|467832366|FG000|Overall Study|Progressive disease - clinical assessment|1|||
129964051|NCT03458728|467832367|FG001|Overall Study|Progressive disease - clinical assessment|0|||
129964052|NCT03458728|467832366|FG000|Overall Study|Progressive disease - radiological progression|21|||
129964053|NCT03458728|467832367|FG001|Overall Study|Progressive disease - radiological progression|6|||
129964054|NCT03458728|467832366|FG000|Overall Study|Withdrawal by Subject|0|||
129964055|NCT03458728|467832367|FG001|Overall Study|Withdrawal by Subject|1|||
129964056|NCT00908349|467832371|FG000|Overall Study|Adverse Event|10|||
129964057|NCT00908349|467832371|FG000|Overall Study|Withdrawal by Subject|9|||
129964058|NCT00908349|467832371|FG000|Overall Study|Physician Decision|5|||
129964059|NCT00908349|467832371|FG000|Overall Study|Lost to Follow-up|5|||
129964060|NCT00908349|467832371|FG000|Overall Study|Various|6|||
129964061|NCT03294941|467832377|FG000|Overall Study|Withdrawal by Subject|0|||
129964062|NCT03294941|467832378|FG001|Overall Study|Withdrawal by Subject|2|||
129964063|NCT03927690|467832379|FG000|Overall Study|Withdrawal by Subject|3|||
129964064|NCT03927690|467832380|FG001|Overall Study|Withdrawal by Subject|1|||
129964065|NCT03927690|467832381|FG002|Overall Study|Withdrawal by Subject|1|||
129964066|NCT03927690|467832379|FG000|Overall Study|Adverse Event|1|||
129964067|NCT03927690|467832380|FG001|Overall Study|Adverse Event|0|||
129964068|NCT03927690|467832381|FG002|Overall Study|Adverse Event|0|||
129964069|NCT03927690|467832379|FG000|Overall Study|Death|1|||
129964070|NCT03927690|467832380|FG001|Overall Study|Death|0|||
129964071|NCT03927690|467832381|FG002|Overall Study|Death|0|||
129964072|NCT03927690|467832379|FG000|Overall Study|Lost to Follow-up|2|||
129964073|NCT03927690|467832380|FG001|Overall Study|Lost to Follow-up|2|||
129964074|NCT03927690|467832381|FG002|Overall Study|Lost to Follow-up|1|||
129964075|NCT01202409|467832385|FG000|Overall Study|Adverse Event|1|||
129964076|NCT01202409|467832385|FG000|Overall Study|Ineligible - KRAS mutants|7|||
129964077|NCT00337285|467832386|FG000|Overall Study|Withdrawal by Subject|42|||
129964078|NCT00337285|467832386|FG000|Overall Study|Lost to Follow-up|41|||
129964079|NCT00337285|467832386|FG000|Overall Study|Adverse Event|28|||
129964080|NCT00337285|467832386|FG000|Overall Study|Protocol Violation|27|||
129964081|NCT00337285|467832386|FG000|Overall Study|Lack of Efficacy|11|||
129964082|NCT00337285|467832386|FG000|Overall Study|Death|1|||
129964083|NCT00337285|467832386|FG000|Overall Study|Physician Decision|1|||
129964084|NCT00337285|467832386|FG000|Overall Study|Lack of protocol compliance|7|||
129964085|NCT01774019|467832387|FG000|Overall Study|No longer meets protocol criteria|2|||
129964086|NCT01774019|467832388|FG001|Overall Study|No longer meets protocol criteria|0|||
129964087|NCT01774019|467832387|FG000|Overall Study|Withdrawal by Subject|1|||
129964088|NCT01774019|467832388|FG001|Overall Study|Withdrawal by Subject|0|||
129964089|NCT01774019|467832387|FG000|Overall Study|Surgery delayed > 120 days|1|||
129964090|NCT01774019|467832388|FG001|Overall Study|Surgery delayed > 120 days|0|||
129964091|NCT01774019|467832387|FG000|Overall Study|Patient refused surgery|1|||
129964092|NCT01774019|467832388|FG001|Overall Study|Patient refused surgery|1|||
129964093|NCT01774019|467832387|FG000|Overall Study|Unable to implant study device|1|||
129964094|NCT01774019|467832388|FG001|Overall Study|Unable to implant study device|0|||
129964095|NCT01774019|467832387|FG000|Overall Study|Lost to Follow-up|0|||
129964096|NCT01774019|467832388|FG001|Overall Study|Lost to Follow-up|3|||
129964097|NCT00553605|467832389|FG000|Overall Study|Did not meet entrance criteria|1|||
129964098|NCT00553605|467832390|FG001|Overall Study|Did not meet entrance criteria|3|||
129964099|NCT00553605|467832389|FG000|Overall Study|Did not receive full dose|1|||
129964100|NCT00553605|467832390|FG001|Overall Study|Did not receive full dose|0|||
129964101|NCT00553605|467832389|FG000|Overall Study|Randomized but not treated|2|||
129964102|NCT00553605|467832390|FG001|Overall Study|Randomized but not treated|0|||
129964103|NCT01004185|467832391|FG000|Overall Study|Adverse Event|1|||
129964104|NCT01004185|467832392|FG001|Overall Study|Adverse Event|1|||
129964105|NCT01004185|467832391|FG000|Overall Study|Lost to Follow-up|0|||
129964106|NCT01004185|467832392|FG001|Overall Study|Lost to Follow-up|1|||
129964107|NCT01004185|467832391|FG000|Overall Study|Lack of Efficacy|2|||
129964108|NCT01004185|467832392|FG001|Overall Study|Lack of Efficacy|1|||
129964109|NCT01004185|467832391|FG000|Overall Study|Sponsor Terminated Study|4|||
129964110|NCT01004185|467832392|FG001|Overall Study|Sponsor Terminated Study|5|||
129964111|NCT01004185|467832391|FG000|Overall Study|Withdrawal by Subject|2|||
129964112|NCT01004185|467832392|FG001|Overall Study|Withdrawal by Subject|1|||
129964113|NCT03481556|467832397|FG000|Overall Study|Adverse Event|1|||
129964114|NCT03481556|467832398|FG001|Overall Study|Adverse Event|0|||
129964115|NCT03481556|467832399|FG002|Overall Study|Adverse Event|0|||
129964116|NCT03481556|467832400|FG003|Overall Study|Adverse Event|0|||
129964117|NCT03481556|467832397|FG000|Overall Study|Death|4|||
129964118|NCT03481556|467832398|FG001|Overall Study|Death|2|||
129964119|NCT03481556|467832399|FG002|Overall Study|Death|3|||
129964120|NCT03481556|467832400|FG003|Overall Study|Death|16|||
129964121|NCT03481556|467832397|FG000|Overall Study|Study Terminated by Sponsor|10|||
129964122|NCT03481556|467832398|FG001|Overall Study|Study Terminated by Sponsor|5|||
129964123|NCT03481556|467832399|FG002|Overall Study|Study Terminated by Sponsor|2|||
129964124|NCT03481556|467832400|FG003|Overall Study|Study Terminated by Sponsor|9|||
129964125|NCT03463577|467832401|FG000|Overall Study|Lost to Follow-up|238|||
129964126|NCT03463577|467832402|FG001|Overall Study|Lost to Follow-up|435|||
129964127|NCT03463577|467832403|FG002|Overall Study|Lost to Follow-up|0|||
129964128|NCT03463577|467832404|FG003|Overall Study|Lost to Follow-up|0|||
129964129|NCT03463577|467832405|FG004|Overall Study|Lost to Follow-up|0|||
129964130|NCT03463577|467832406|FG005|Overall Study|Lost to Follow-up|0|||
129964131|NCT03463577|467832401|FG000|Overall Study|With unknown pregnancy outcome|0|||
129964132|NCT03463577|467832402|FG001|Overall Study|With unknown pregnancy outcome|5|||
129964133|NCT03463577|467832403|FG002|Overall Study|With unknown pregnancy outcome|0|||
129964134|NCT03463577|467832404|FG003|Overall Study|With unknown pregnancy outcome|0|||
129964135|NCT03463577|467832405|FG004|Overall Study|With unknown pregnancy outcome|0|||
129964136|NCT03463577|467832406|FG005|Overall Study|With unknown pregnancy outcome|0|||
129964137|NCT03463577|467832401|FG000|Overall Study|Maternal death|2|||
129964138|NCT03463577|467832402|FG001|Overall Study|Maternal death|0|||
129964139|NCT03463577|467832403|FG002|Overall Study|Maternal death|0|||
129964140|NCT03463577|467832404|FG003|Overall Study|Maternal death|0|||
129964141|NCT03463577|467832405|FG004|Overall Study|Maternal death|0|||
129964142|NCT03463577|467832406|FG005|Overall Study|Maternal death|0|||
129964143|NCT03463577|467832401|FG000|Overall Study|Neonatal death|0|||
129964144|NCT03463577|467832402|FG001|Overall Study|Neonatal death|0|||
129964145|NCT03463577|467832403|FG002|Overall Study|Neonatal death|0|||
129964146|NCT03463577|467832404|FG003|Overall Study|Neonatal death|15|||
129964147|NCT03463577|467832405|FG004|Overall Study|Neonatal death|17|||
129964148|NCT03463577|467832406|FG005|Overall Study|Neonatal death|0|||
129964149|NCT01085812|467832408|FG000|Open-Label Period|Adverse Event|0|||
129964150|NCT01085812|467832409|FG001|Open-Label Period|Adverse Event|80|||
129964151|NCT01085812|467832408|FG000|Open-Label Period|Lack of Efficacy|0|||
129964152|NCT01085812|467832409|FG001|Open-Label Period|Lack of Efficacy|26|||
129964153|NCT01085812|467832408|FG000|Open-Label Period|Protocol Violation|0|||
129964154|NCT01085812|467832409|FG001|Open-Label Period|Protocol Violation|39|||
129964155|NCT01085812|467832408|FG000|Open-Label Period|Withdrawal by Subject|0|||
129964156|NCT01085812|467832409|FG001|Open-Label Period|Withdrawal by Subject|53|||
129964157|NCT01085812|467832408|FG000|Open-Label Period|Lost to Follow-up|0|||
129964158|NCT01085812|467832409|FG001|Open-Label Period|Lost to Follow-up|42|||
129964159|NCT01085812|467832408|FG000|Double-Blind Period|Adverse Event|3|||
129964160|NCT01085812|467832409|FG001|Double-Blind Period|Adverse Event|8|||
129964161|NCT01085812|467832408|FG000|Double-Blind Period|Protocol Violation|2|||
129964162|NCT01085812|467832409|FG001|Double-Blind Period|Protocol Violation|7|||
129964163|NCT01085812|467832408|FG000|Double-Blind Period|Withdrawal by Subject|11|||
129964164|NCT01085812|467832409|FG001|Double-Blind Period|Withdrawal by Subject|24|||
129964165|NCT01085812|467832408|FG000|Double-Blind Period|Lost to Follow-up|5|||
129964166|NCT01085812|467832409|FG001|Double-Blind Period|Lost to Follow-up|17|||
129964167|NCT01085812|467832408|FG000|Double-Blind Period|Other Reasons|0|||
129964168|NCT01085812|467832409|FG001|Double-Blind Period|Other Reasons|2|||
129964169|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
129964170|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
129964171|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
129964172|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
129964173|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
129964174|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
129964175|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
129964176|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
129964177|NCT01085812|467832408|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
129964178|NCT01085812|467832409|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
129964179|NCT01101997|467832410|FG000|Overall Study|Withdrawal by Subject|2|||
129964180|NCT01172639|467832413|FG000|Overall Study|Death|1|||
129964181|NCT01172639|467832414|FG001|Overall Study|Death|1|||
129964182|NCT01172639|467832415|FG002|Overall Study|Death|0|||
129964183|NCT01172639|467832416|FG003|Overall Study|Death|0|||
129964184|NCT01172639|467832417|FG004|Overall Study|Death|0|||
129964185|NCT01172639|467832413|FG000|Overall Study|Lost to Follow-up|9|||
129964186|NCT01172639|467832414|FG001|Overall Study|Lost to Follow-up|7|||
129964187|NCT01172639|467832415|FG002|Overall Study|Lost to Follow-up|11|||
129964188|NCT01172639|467832416|FG003|Overall Study|Lost to Follow-up|6|||
129964189|NCT01172639|467832417|FG004|Overall Study|Lost to Follow-up|6|||
129964190|NCT01172639|467832413|FG000|Overall Study|Withdrawal by Subject|3|||
129964191|NCT01172639|467832414|FG001|Overall Study|Withdrawal by Subject|3|||
129964192|NCT01172639|467832415|FG002|Overall Study|Withdrawal by Subject|5|||
129964193|NCT01172639|467832416|FG003|Overall Study|Withdrawal by Subject|5|||
129964194|NCT01172639|467832417|FG004|Overall Study|Withdrawal by Subject|0|||
129964195|NCT02172950|467832418|FG000|Overall Study|Physician Decision|3|||
129964196|NCT02172950|467832419|FG001|Overall Study|Physician Decision|3|||
129964197|NCT02172950|467832418|FG000|Overall Study|Lack of Efficacy|1|||
129964198|NCT02172950|467832419|FG001|Overall Study|Lack of Efficacy|0|||
129964199|NCT02172950|467832418|FG000|Overall Study|Adverse Event|4|||
129964200|NCT02172950|467832419|FG001|Overall Study|Adverse Event|1|||
129964201|NCT02172950|467832418|FG000|Overall Study|Withdrawal by Subject|10|||
129964202|NCT02172950|467832419|FG001|Overall Study|Withdrawal by Subject|0|||
129964203|NCT02172950|467832418|FG000|Overall Study|Protocol Violation|1|||
129964204|NCT02172950|467832419|FG001|Overall Study|Protocol Violation|0|||
129964205|NCT02172950|467832418|FG000|Overall Study|Lost to Follow-up|1|||
129964206|NCT02172950|467832419|FG001|Overall Study|Lost to Follow-up|0|||
129964207|NCT02172950|467832418|FG000|Overall Study|Death|1|||
129964208|NCT02172950|467832419|FG001|Overall Study|Death|0|||
129964209|NCT02172950|467832418|FG000|Overall Study|Patient traveling|1|||
129964210|NCT02172950|467832419|FG001|Overall Study|Patient traveling|0|||
129964211|NCT02172950|467832418|FG000|Overall Study|Patient went to other country|1|||
129964212|NCT02172950|467832419|FG001|Overall Study|Patient went to other country|0|||
129964213|NCT02172950|467832418|FG000|Overall Study|Patient relocated overseas|1|||
129964214|NCT02172950|467832419|FG001|Overall Study|Patient relocated overseas|1|||
129964215|NCT02172950|467832418|FG000|Overall Study|Patient moving|1|||
129964216|NCT02172950|467832419|FG001|Overall Study|Patient moving|0|||
129964217|NCT00469456|467832420|FG000|Overall Study|Adverse Event|4|||
129964218|NCT00469456|467832421|FG001|Overall Study|Adverse Event|3|||
129964219|NCT00469456|467832420|FG000|Overall Study|Protocol Violation|1|||
129964220|NCT00469456|467832421|FG001|Overall Study|Protocol Violation|0|||
129964221|NCT00469456|467832420|FG000|Overall Study|Withdrawal by Subject|4|||
129964222|NCT00469456|467832421|FG001|Overall Study|Withdrawal by Subject|1|||
129964223|NCT00611715|467832422|FG000|Overall Study|Disease Progression|24|||
129964224|NCT00611715|467832423|FG001|Overall Study|Disease Progression|4|||
129964225|NCT00611715|467832422|FG000|Overall Study|Withdrawal by Subject|5|||
129964226|NCT00611715|467832423|FG001|Overall Study|Withdrawal by Subject|1|||
129964227|NCT00611715|467832422|FG000|Overall Study|Adverse Event|9|||
129964228|NCT00611715|467832423|FG001|Overall Study|Adverse Event|1|||
129964229|NCT00611715|467832422|FG000|Overall Study|Death|1|||
129964230|NCT00611715|467832423|FG001|Overall Study|Death|0|||
129964231|NCT00611715|467832422|FG000|Overall Study|two patients are still on treatment|2|||
129964232|NCT00611715|467832423|FG001|Overall Study|two patients are still on treatment|0|||
129964233|NCT00107978|467832426|FG000|Overall Study|Adverse Event|1|||
129964234|NCT00107978|467832427|FG001|Overall Study|Adverse Event|5|||
129964235|NCT00107978|467832426|FG000|Overall Study|Death|3|||
129455295|NCT02819635|465964556|FG007|Substudy 3|Withdrew consent|0|||
129455296|NCT02819635|465964557|FG008|Substudy 3|Withdrew consent|11|||
129455297|NCT02819635|465964558|FG009|Substudy 3|Withdrew consent|1|||
129455298|NCT02819635|465964559|FG010|Substudy 3|Withdrew consent|4|||
129455299|NCT02819635|465964560|FG011|Substudy 3|Withdrew consent|9|||
129455300|NCT02819635|465964549|FG000|Substudy 3|Lost to Follow-up|0|||
129455301|NCT02819635|465964550|FG001|Substudy 3|Lost to Follow-up|0|||
129455302|NCT02819635|465964551|FG002|Substudy 3|Lost to Follow-up|0|||
129455303|NCT02819635|465964552|FG003|Substudy 3|Lost to Follow-up|0|||
129455304|NCT02819635|465964553|FG004|Substudy 3|Lost to Follow-up|0|||
129455305|NCT02819635|465964554|FG005|Substudy 3|Lost to Follow-up|0|||
129455306|NCT02819635|465964555|FG006|Substudy 3|Lost to Follow-up|0|||
129455307|NCT02819635|465964556|FG007|Substudy 3|Lost to Follow-up|0|||
129455308|NCT02819635|465964557|FG008|Substudy 3|Lost to Follow-up|1|||
129455309|NCT02819635|465964558|FG009|Substudy 3|Lost to Follow-up|0|||
129455310|NCT02819635|465964559|FG010|Substudy 3|Lost to Follow-up|1|||
129455311|NCT02819635|465964560|FG011|Substudy 3|Lost to Follow-up|1|||
129455312|NCT02819635|465964549|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455313|NCT02819635|465964550|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455314|NCT02819635|465964551|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455315|NCT02819635|465964552|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455316|NCT02819635|465964553|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455317|NCT02819635|465964554|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455318|NCT02819635|465964555|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455319|NCT02819635|465964556|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455320|NCT02819635|465964557|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455321|NCT02819635|465964558|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455322|NCT02819635|465964559|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
129455323|NCT02819635|465964560|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
129455324|NCT02819635|465964549|FG000|Substudy 3|Other, not specified|0|||
129455325|NCT02819635|465964550|FG001|Substudy 3|Other, not specified|0|||
129455326|NCT02819635|465964551|FG002|Substudy 3|Other, not specified|0|||
129455327|NCT02819635|465964552|FG003|Substudy 3|Other, not specified|0|||
129455328|NCT02819635|465964553|FG004|Substudy 3|Other, not specified|0|||
129455329|NCT02819635|465964554|FG005|Substudy 3|Other, not specified|0|||
129455330|NCT02819635|465964555|FG006|Substudy 3|Other, not specified|0|||
129455331|NCT02819635|465964556|FG007|Substudy 3|Other, not specified|0|||
129455332|NCT02819635|465964557|FG008|Substudy 3|Other, not specified|202|||
129455333|NCT02819635|465964558|FG009|Substudy 3|Other, not specified|5|||
129455334|NCT02819635|465964559|FG010|Substudy 3|Other, not specified|89|||
129455335|NCT02819635|465964560|FG011|Substudy 3|Other, not specified|39|||
129455336|NCT03179891|465964564|FG000|First Intervention|Withdrawal by Subject|1|||
129455337|NCT03179891|465964565|FG001|First Intervention|Withdrawal by Subject|1|||
129455338|NCT03179891|465964564|FG000|First Intervention|Unspecified reason|1|||
129455339|NCT03179891|465964565|FG001|First Intervention|Unspecified reason|0|||
129455340|NCT03179891|465964564|FG000|First Intervention|Protocol Violation|0|||
129455341|NCT03179891|465964565|FG001|First Intervention|Protocol Violation|1|||
129455342|NCT01438489|465964566|FG000|Overall Study|Lost to Follow-up|4|||
129455343|NCT01438489|465964567|FG001|Overall Study|Lost to Follow-up|2|||
129455344|NCT01438489|465964568|FG002|Overall Study|Lost to Follow-up|2|||
129455345|NCT01438489|465964566|FG000|Overall Study|Withdrawal by Subject|11|||
129455346|NCT01438489|465964567|FG001|Overall Study|Withdrawal by Subject|3|||
129455347|NCT01438489|465964568|FG002|Overall Study|Withdrawal by Subject|8|||
129455348|NCT01438489|465964566|FG000|Overall Study|Death|0|||
129455349|NCT01438489|465964567|FG001|Overall Study|Death|0|||
129455350|NCT01438489|465964568|FG002|Overall Study|Death|1|||
129455351|NCT01438489|465964566|FG000|Overall Study|Sponsor decision|4|||
129455352|NCT01438489|465964567|FG001|Overall Study|Sponsor decision|1|||
129455353|NCT01438489|465964568|FG002|Overall Study|Sponsor decision|4|||
129455354|NCT01438489|465964566|FG000|Overall Study|Subject choice/Subject moved|2|||
129455355|NCT01438489|465964567|FG001|Overall Study|Subject choice/Subject moved|1|||
129455356|NCT01438489|465964568|FG002|Overall Study|Subject choice/Subject moved|1|||
129455357|NCT01438489|465964566|FG000|Overall Study|Investigator decision|0|||
129455358|NCT01438489|465964567|FG001|Overall Study|Investigator decision|1|||
129455359|NCT01438489|465964568|FG002|Overall Study|Investigator decision|0|||
129455360|NCT01438489|465964566|FG000|Overall Study|AE/SAEs|2|||
129455361|NCT01438489|465964567|FG001|Overall Study|AE/SAEs|1|||
129455362|NCT01438489|465964568|FG002|Overall Study|AE/SAEs|1|||
129455363|NCT01438489|465964566|FG000|Overall Study|Received prohibited medication|1|||
129455364|NCT01438489|465964567|FG001|Overall Study|Received prohibited medication|0|||
129455365|NCT01438489|465964568|FG002|Overall Study|Received prohibited medication|0|||
129455366|NCT01438489|465964566|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
129455367|NCT01438489|465964567|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
129455368|NCT01438489|465964568|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
129455369|NCT01438489|465964566|FG000|Overall Study|Inadequate venous access|0|||
129455370|NCT01438489|465964567|FG001|Overall Study|Inadequate venous access|2|||
129455371|NCT01438489|465964568|FG002|Overall Study|Inadequate venous access|0|||
129964236|NCT00107978|467832427|FG001|Overall Study|Death|3|||
129964237|NCT00107978|467832426|FG000|Overall Study|Lost to Follow-up|20|||
129964238|NCT00107978|467832427|FG001|Overall Study|Lost to Follow-up|28|||
129964239|NCT00107978|467832426|FG000|Overall Study|Withdrawal by Subject|4|||
129964240|NCT00107978|467832427|FG001|Overall Study|Withdrawal by Subject|9|||
129964241|NCT00107978|467832426|FG000|Overall Study|Protocol Violation|0|||
129964242|NCT00107978|467832427|FG001|Overall Study|Protocol Violation|1|||
129964243|NCT00107978|467832426|FG000|Overall Study|Other|5|||
129964244|NCT00107978|467832427|FG001|Overall Study|Other|4|||
129964245|NCT02669407|467832428|FG000|Overall Study|Physician Decision|3|||
129964246|NCT00704171|467832434|FG000|Overall Study|Withdrawal by Subject|1|||
129964247|NCT00704171|467832435|FG001|Overall Study|Withdrawal by Subject|0|||
129964248|NCT01874665|467832436|FG000|Overall Study|Adverse Event|6|||
129964249|NCT01874665|467832437|FG001|Overall Study|Adverse Event|2|||
129964250|NCT01874665|467832436|FG000|Overall Study|Withdrawal by Subject|4|||
129964251|NCT01874665|467832437|FG001|Overall Study|Withdrawal by Subject|1|||
129964252|NCT01874665|467832436|FG000|Overall Study|Physician Decision|3|||
129964253|NCT01874665|467832437|FG001|Overall Study|Physician Decision|0|||
129964254|NCT01874665|467832436|FG000|Overall Study|Clinical Progressive Disease|4|||
129964255|NCT01874665|467832437|FG001|Overall Study|Clinical Progressive Disease|3|||
129964256|NCT01874665|467832436|FG000|Overall Study|Study Terminated by Sponsor|0|||
129964257|NCT01874665|467832437|FG001|Overall Study|Study Terminated by Sponsor|2|||
129964258|NCT01874665|467832436|FG000|Overall Study|Documented Progressive Disease|11|||
129964259|NCT01874665|467832437|FG001|Overall Study|Documented Progressive Disease|7|||
129964260|NCT01874665|467832436|FG000|Overall Study|Other|2|||
129964261|NCT01874665|467832437|FG001|Overall Study|Other|0|||
129964262|NCT00350298|467832438|FG000|Overall Study|Death|7|||
129964263|NCT00350298|467832439|FG001|Overall Study|Death|8|||
129964264|NCT00350298|467832438|FG000|Overall Study|Lost to Follow-up|1|||
129964265|NCT00350298|467832439|FG001|Overall Study|Lost to Follow-up|2|||
129964266|NCT00350298|467832438|FG000|Overall Study|Withdrawal by Subject|1|||
129964267|NCT00350298|467832439|FG001|Overall Study|Withdrawal by Subject|3|||
129964268|NCT03634839|467832442|FG000|First Intervention (2 Hours)|Adverse Event|0|||
129964269|NCT03634839|467832443|FG001|First Intervention (2 Hours)|Adverse Event|2|||
129964270|NCT02447432|467832446|FG000|Epoch 001|Adverse Event|1|||
129964271|NCT02447432|467832447|FG001|Epoch 001|Adverse Event|1|||
129964272|NCT02447432|467832446|FG000|Epoch 001|Withdrawal by Subject|0|||
129964273|NCT02447432|467832447|FG001|Epoch 001|Withdrawal by Subject|4|||
129964274|NCT02447432|467832446|FG000|Epoch 001|Migrated/moved from study area|3|||
129964275|NCT02447432|467832447|FG001|Epoch 001|Migrated/moved from study area|5|||
129964276|NCT02447432|467832446|FG000|Epoch 001|Lost to Follow-up|1|||
129964277|NCT02447432|467832447|FG001|Epoch 001|Lost to Follow-up|3|||
129964278|NCT00233389|467832448|FG000|Overall Study|Adverse Event|5|||
129964279|NCT00233389|467832449|FG001|Overall Study|Adverse Event|5|||
129964280|NCT00233389|467832448|FG000|Overall Study|Lack of Efficacy|11|||
129964281|NCT00233389|467832449|FG001|Overall Study|Lack of Efficacy|8|||
129964282|NCT00233389|467832448|FG000|Overall Study|Lost to Follow-up|1|||
129964283|NCT00233389|467832449|FG001|Overall Study|Lost to Follow-up|1|||
129964284|NCT00233389|467832448|FG000|Overall Study|Physician Decision|1|||
129964285|NCT00233389|467832449|FG001|Overall Study|Physician Decision|0|||
129964286|NCT00233389|467832448|FG000|Overall Study|Protocol Violation|0|||
129964287|NCT00233389|467832449|FG001|Overall Study|Protocol Violation|1|||
129964288|NCT00233389|467832448|FG000|Overall Study|Withdrawal by Subject|0|||
129964289|NCT00233389|467832449|FG001|Overall Study|Withdrawal by Subject|1|||
129964290|NCT04962698|467832454|FG000|Motor Imagery|Technical difficulty|1|||
129964291|NCT04962698|467832455|FG001|Motor Imagery|Technical difficulty|0|||
129964292|NCT04962698|467832454|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
129964293|NCT04962698|467832455|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
129964294|NCT04962698|467832454|FG000|Kinesthetic MI|Technical difficulty|1|||
129964295|NCT04962698|467832455|FG001|Kinesthetic MI|Technical difficulty|0|||
129964296|NCT04962698|467832454|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
129964297|NCT04962698|467832455|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
129964298|NCT04962698|467832454|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
129964299|NCT04962698|467832455|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
129964300|NCT04962698|467832454|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
129964301|NCT04962698|467832455|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
129964302|NCT04962698|467832454|FG000|Virtual-hand Interaction|Technical difficulty|1|||
129964303|NCT04962698|467832455|FG001|Virtual-hand Interaction|Technical difficulty|0|||
129964304|NCT04962698|467832454|FG000|Robotic Action Observation|Technical difficulty|1|||
129964305|NCT04962698|467832455|FG001|Robotic Action Observation|Technical difficulty|0|||
129964306|NCT04962698|467832454|FG000|Rest|Technical difficulty|1|||
129964307|NCT04962698|467832455|FG001|Rest|Technical difficulty|0|||
129964308|NCT04962698|467832454|FG000|Rest|Exclusion criteria met after enrollment|0|||
129964309|NCT04962698|467832455|FG001|Rest|Exclusion criteria met after enrollment|2|||
129964310|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
129455372|NCT01324232|465964569|FG000|Overall Study|Protocol Violation|0|||
129455373|NCT01324232|465964570|FG001|Overall Study|Protocol Violation|0|||
129455374|NCT01324232|465964571|FG002|Overall Study|Protocol Violation|0|||
129455375|NCT01324232|465964572|FG003|Overall Study|Protocol Violation|2|||
129455376|NCT01324232|465964569|FG000|Overall Study|Missing|0|||
129455377|NCT01324232|465964570|FG001|Overall Study|Missing|0|||
129455378|NCT01324232|465964571|FG002|Overall Study|Missing|1|||
129455379|NCT01324232|465964572|FG003|Overall Study|Missing|0|||
129455380|NCT01324232|465964569|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
129455381|NCT01324232|465964570|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
129455382|NCT01324232|465964571|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
129455383|NCT01324232|465964572|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
129455384|NCT01324232|465964569|FG000|Overall Study|Lack of Efficacy|2|||
129455385|NCT01324232|465964570|FG001|Overall Study|Lack of Efficacy|1|||
129455386|NCT01324232|465964571|FG002|Overall Study|Lack of Efficacy|2|||
129455387|NCT01324232|465964572|FG003|Overall Study|Lack of Efficacy|2|||
129455388|NCT01324232|465964569|FG000|Overall Study|Participant Refused Medication|0|||
129455389|NCT01324232|465964570|FG001|Overall Study|Participant Refused Medication|1|||
129455390|NCT01324232|465964571|FG002|Overall Study|Participant Refused Medication|0|||
129455391|NCT01324232|465964572|FG003|Overall Study|Participant Refused Medication|0|||
129455392|NCT01324232|465964569|FG000|Overall Study|Intercurrent illness|0|||
129455393|NCT01324232|465964570|FG001|Overall Study|Intercurrent illness|0|||
129455394|NCT01324232|465964571|FG002|Overall Study|Intercurrent illness|0|||
129455395|NCT01324232|465964572|FG003|Overall Study|Intercurrent illness|1|||
129455396|NCT01324232|465964569|FG000|Overall Study|Adverse Event|2|||
129455397|NCT01324232|465964570|FG001|Overall Study|Adverse Event|5|||
129455398|NCT01324232|465964571|FG002|Overall Study|Adverse Event|6|||
129455399|NCT01324232|465964572|FG003|Overall Study|Adverse Event|6|||
129455400|NCT01324232|465964569|FG000|Overall Study|Withdrawal by Subject|0|||
129455401|NCT01324232|465964570|FG001|Overall Study|Withdrawal by Subject|3|||
129455402|NCT01324232|465964571|FG002|Overall Study|Withdrawal by Subject|4|||
129455403|NCT01324232|465964572|FG003|Overall Study|Withdrawal by Subject|0|||
129455404|NCT01324232|465964569|FG000|Overall Study|Lost to Follow-up|1|||
129455405|NCT01324232|465964570|FG001|Overall Study|Lost to Follow-up|0|||
129455406|NCT01324232|465964571|FG002|Overall Study|Lost to Follow-up|0|||
129455407|NCT01324232|465964572|FG003|Overall Study|Lost to Follow-up|0|||
129455408|NCT00661531|465964573|FG000|Overall Study|Withdrawal by Subject|3|||
129964311|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
129964312|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
129964313|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
129964314|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
129964315|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
129964316|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
129964317|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
129964318|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
129964319|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
129964320|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
129964321|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
129964322|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
129964323|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
129964324|NCT01664923|467832471|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
129964325|NCT01664923|467832472|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
129964326|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
129964327|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
129964328|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
129964329|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
129964330|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
129964331|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
129964332|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
129964333|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
129964334|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
129964335|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
129964336|NCT01664923|467832471|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
129964337|NCT01664923|467832472|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
129964338|NCT01710800|467832473|FG000|Overall Study|Withdrawal by Subject|21|||
129455409|NCT03134599|465964575|FG000|Week 1|Lost to Follow-up|0|||
129455410|NCT03134599|465964576|FG001|Week 1|Lost to Follow-up|0|||
129455411|NCT03134599|465964577|FG002|Week 1|Lost to Follow-up|0|||
129455412|NCT03134599|465964578|FG003|Week 1|Lost to Follow-up|0|||
129455413|NCT03134599|465964579|FG004|Week 1|Lost to Follow-up|1|||
129455414|NCT03134599|465964580|FG005|Week 1|Lost to Follow-up|0|||
129455415|NCT03134599|465964575|FG000|Week 2|Lost to Follow-up|1|||
129455416|NCT03134599|465964576|FG001|Week 2|Lost to Follow-up|0|||
129964339|NCT01710800|467832473|FG000|Overall Study|Protocol Violation|1|||
129964340|NCT00511797|467832474|FG000|Overall Study|Adverse Event|1|||
129964341|NCT00511797|467832475|FG001|Overall Study|Adverse Event|2|||
129964342|NCT00511797|467832476|FG002|Overall Study|Adverse Event|2|||
129964343|NCT00511797|467832477|FG003|Overall Study|Adverse Event|2|||
129964344|NCT00511797|467832474|FG000|Overall Study|Lost to Follow-up|1|||
129964345|NCT00511797|467832475|FG001|Overall Study|Lost to Follow-up|0|||
129964346|NCT00511797|467832476|FG002|Overall Study|Lost to Follow-up|0|||
129964347|NCT00511797|467832477|FG003|Overall Study|Lost to Follow-up|1|||
129964348|NCT00511797|467832474|FG000|Overall Study|Pregnancy|0|||
129964349|NCT00511797|467832475|FG001|Overall Study|Pregnancy|0|||
129964350|NCT00511797|467832476|FG002|Overall Study|Pregnancy|0|||
129964351|NCT00511797|467832477|FG003|Overall Study|Pregnancy|1|||
129964352|NCT00511797|467832474|FG000|Overall Study|Protocol Violation|0|||
129964353|NCT00511797|467832475|FG001|Overall Study|Protocol Violation|2|||
129964354|NCT00511797|467832476|FG002|Overall Study|Protocol Violation|2|||
129964355|NCT00511797|467832477|FG003|Overall Study|Protocol Violation|3|||
129964356|NCT00511797|467832474|FG000|Overall Study|Withdrawal by Subject|3|||
129964357|NCT00511797|467832475|FG001|Overall Study|Withdrawal by Subject|3|||
129964358|NCT00511797|467832476|FG002|Overall Study|Withdrawal by Subject|4|||
129964359|NCT00511797|467832477|FG003|Overall Study|Withdrawal by Subject|2|||
129964360|NCT00511797|467832474|FG000|Overall Study|Never dispensed|1|||
129964361|NCT00511797|467832475|FG001|Overall Study|Never dispensed|0|||
129964362|NCT00511797|467832476|FG002|Overall Study|Never dispensed|1|||
129964363|NCT00511797|467832477|FG003|Overall Study|Never dispensed|3|||
129964364|NCT00511797|467832474|FG000|Overall Study|Study drug not taken|0|||
129964365|NCT00511797|467832475|FG001|Overall Study|Study drug not taken|1|||
129964366|NCT00511797|467832476|FG002|Overall Study|Study drug not taken|0|||
129964367|NCT00511797|467832477|FG003|Overall Study|Study drug not taken|1|||
129964368|NCT00511797|467832474|FG000|Overall Study|Partially missing diary|0|||
129964369|NCT00511797|467832475|FG001|Overall Study|Partially missing diary|0|||
129964370|NCT00511797|467832476|FG002|Overall Study|Partially missing diary|1|||
129964371|NCT00511797|467832477|FG003|Overall Study|Partially missing diary|0|||
129964372|NCT00511797|467832474|FG000|Overall Study|Other (moving etc)|1|||
129964373|NCT00511797|467832475|FG001|Overall Study|Other (moving etc)|0|||
129964374|NCT00511797|467832476|FG002|Overall Study|Other (moving etc)|1|||
129964375|NCT00511797|467832477|FG003|Overall Study|Other (moving etc)|2|||
129964376|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
129964377|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
129964378|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
129964379|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
129964380|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
129964381|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Death|1|||
129964382|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Death|0|||
129964383|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Death|0|||
129964384|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Death|0|||
129964385|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Death|0|||
129964386|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964387|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
129964388|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964389|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964390|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
129964391|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964392|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
129455417|NCT03134599|465964577|FG002|Week 2|Lost to Follow-up|0|||
129455418|NCT03134599|465964578|FG003|Week 2|Lost to Follow-up|1|||
129455419|NCT03134599|465964579|FG004|Week 2|Lost to Follow-up|1|||
129455420|NCT03134599|465964580|FG005|Week 2|Lost to Follow-up|0|||
129455421|NCT03134599|465964575|FG000|Week 3|Lost to Follow-up|0|||
129964393|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964394|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964395|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
129964396|NCT03974100|467832478|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
129964397|NCT03974100|467832479|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
129964398|NCT03974100|467832480|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
129964399|NCT03974100|467832481|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
129964400|NCT03974100|467832482|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
129964401|NCT03974100|467832478|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129964402|NCT03974100|467832479|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129964403|NCT03974100|467832480|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129455422|NCT03134599|465964576|FG001|Week 3|Lost to Follow-up|0|||
129964404|NCT03974100|467832481|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
129964405|NCT03974100|467832482|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
129964406|NCT03974100|467832478|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
129964407|NCT03974100|467832479|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
129964408|NCT03974100|467832480|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
129455423|NCT03134599|465964577|FG002|Week 3|Lost to Follow-up|0|||
129455424|NCT03134599|465964578|FG003|Week 3|Lost to Follow-up|1|||
129964409|NCT03974100|467832481|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
129964410|NCT03974100|467832482|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
129964411|NCT01560871|467832485|FG000|Overall Study|transportation issues|2|||
129964412|NCT01560871|467832486|FG001|Overall Study|transportation issues|1|||
129964413|NCT01560871|467832485|FG000|Overall Study|relocation|1|||
129964414|NCT01560871|467832486|FG001|Overall Study|relocation|0|||
129964415|NCT01560871|467832485|FG000|Overall Study|readmission to a hospital|2|||
129964416|NCT01560871|467832486|FG001|Overall Study|readmission to a hospital|1|||
129964417|NCT01560871|467832485|FG000|Overall Study|Lost to Follow-up|1|||
129964418|NCT01560871|467832486|FG001|Overall Study|Lost to Follow-up|0|||
129964419|NCT02024750|467832487|FG000|Overall Study|Withdrawal by Subject|2|||
129964420|NCT02024750|467832488|FG001|Overall Study|Withdrawal by Subject|1|||
129964421|NCT04088136|467832495|FG000|Overall Study|Withdrawal by Subject|5|||
129964422|NCT04088136|467832496|FG001|Overall Study|Withdrawal by Subject|0|||
129964423|NCT04088136|467832495|FG000|Overall Study|Lack of Efficacy|0|||
129964424|NCT04088136|467832496|FG001|Overall Study|Lack of Efficacy|1|||
129964425|NCT00934700|467832497|FG000|Overall Study|missing scan|5|||
129964426|NCT00934700|467832498|FG001|Overall Study|missing scan|9|||
129964427|NCT00934700|467832497|FG000|Overall Study|Death|8|||
129964428|NCT00934700|467832498|FG001|Overall Study|Death|3|||
129964429|NCT01075100|467832501|FG000|Overall Study|Adverse Event|15|||
129964430|NCT01075100|467832502|FG001|Overall Study|Adverse Event|18|||
129964431|NCT01075100|467832501|FG000|Overall Study|Patient Request|4|||
129964432|NCT01075100|467832502|FG001|Overall Study|Patient Request|4|||
129964433|NCT01075100|467832501|FG000|Overall Study|Investigator Request|2|||
129964434|NCT01075100|467832502|FG001|Overall Study|Investigator Request|1|||
129964435|NCT01075100|467832501|FG000|Overall Study|Disease Progression|25|||
129964436|NCT01075100|467832502|FG001|Overall Study|Disease Progression|29|||
129964437|NCT01075100|467832501|FG000|Overall Study|Other|3|||
129964438|NCT01075100|467832502|FG001|Overall Study|Other|1|||
129964439|NCT02250183|467832503|FG000|Overall Study|Withdrawal by Subject|2|||
129964440|NCT02250183|467832503|FG000|Overall Study|Adverse Event|5|||
129964441|NCT02250183|467832503|FG000|Overall Study|Lost to Follow-up|1|||
129964442|NCT05896696|467832504|FG000|Overall Study|Screening Failure|7|||
129964443|NCT05896696|467832504|FG000|Overall Study|Withdrawal by Subject|2|||
129964444|NCT03900715|467832505|FG000|Overall Study|Protocol Deviation|1|||
129964445|NCT03900715|467832505|FG000|Overall Study|Lack of Efficacy|1|||
129964446|NCT03900715|467832505|FG000|Overall Study|Progressive Disease|6|||
129964447|NCT03900715|467832505|FG000|Overall Study|Adverse Event|2|||
129964448|NCT03900715|467832505|FG000|Overall Study|Other reasons|11|||
129964449|NCT01878383|467834384|FG000|Overall Study|Lost to Follow-up|0|||
129964450|NCT01878383|467834385|FG001|Overall Study|Lost to Follow-up|1499|||
129964451|NCT03475056|467834386|FG000|Overall Study|Lost to Follow-up|0|||
129964452|NCT03475056|467834387|FG001|Overall Study|Lost to Follow-up|1|||
129964453|NCT03475056|467834386|FG000|Overall Study|Moved from Area|0|||
129964454|NCT03475056|467834387|FG001|Overall Study|Moved from Area|2|||
129964455|NCT01932762|467834390|FG000|Overall Study|Withdrawal by Subject|1|||
129964456|NCT01932762|467834391|FG001|Overall Study|Withdrawal by Subject|2|||
129964457|NCT01932762|467834392|FG002|Overall Study|Withdrawal by Subject|0|||
129964458|NCT01932762|467834393|FG003|Overall Study|Withdrawal by Subject|0|||
129964459|NCT01932762|467834390|FG000|Overall Study|Lost to Follow-up|4|||
129964460|NCT01932762|467834391|FG001|Overall Study|Lost to Follow-up|0|||
129964461|NCT01932762|467834392|FG002|Overall Study|Lost to Follow-up|0|||
129964462|NCT01932762|467834393|FG003|Overall Study|Lost to Follow-up|1|||
129964463|NCT01932762|467834390|FG000|Overall Study|Physician Decision|1|||
129964464|NCT01932762|467834391|FG001|Overall Study|Physician Decision|0|||
129964465|NCT01932762|467834392|FG002|Overall Study|Physician Decision|0|||
129964466|NCT01932762|467834393|FG003|Overall Study|Physician Decision|0|||
129964467|NCT02080403|467834396|FG000|Overall Study|Adverse Event|5|||
129964468|NCT02080403|467834397|FG001|Overall Study|Adverse Event|1|||
129964469|NCT02080403|467834396|FG000|Overall Study|Death|0|||
129964470|NCT02080403|467834397|FG001|Overall Study|Death|2|||
129964471|NCT02080403|467834396|FG000|Overall Study|Lost to Follow-up|2|||
129964472|NCT02080403|467834397|FG001|Overall Study|Lost to Follow-up|0|||
129964473|NCT02080403|467834396|FG000|Overall Study|Pregnancy|0|||
129964474|NCT02080403|467834397|FG001|Overall Study|Pregnancy|1|||
129964475|NCT02080403|467834396|FG000|Overall Study|Protocol Violation|3|||
129964476|NCT02080403|467834397|FG001|Overall Study|Protocol Violation|7|||
129455425|NCT03134599|465964579|FG004|Week 3|Lost to Follow-up|0|||
129964477|NCT02080403|467834396|FG000|Overall Study|Withdrawal by Subject|5|||
129964478|NCT02080403|467834397|FG001|Overall Study|Withdrawal by Subject|1|||
129964479|NCT01101334|467834398|FG000|Overall Study|Adverse Event|9|||
129964480|NCT01101334|467834399|FG001|Overall Study|Adverse Event|4|||
129964481|NCT01101334|467834398|FG000|Overall Study|Death|7|||
129964482|NCT01101334|467834399|FG001|Overall Study|Death|1|||
129964483|NCT01101334|467834398|FG000|Overall Study|Withdrawal by Subject|4|||
129964484|NCT01101334|467834399|FG001|Overall Study|Withdrawal by Subject|3|||
129964485|NCT01101334|467834398|FG000|Overall Study|Withdrawal by Sponsor|1|||
129964486|NCT01101334|467834399|FG001|Overall Study|Withdrawal by Sponsor|1|||
129964487|NCT01101334|467834398|FG000|Overall Study|Progressive Disease|22|||
129964488|NCT01101334|467834399|FG001|Overall Study|Progressive Disease|35|||
129964489|NCT01101334|467834398|FG000|Overall Study|Other|2|||
129964490|NCT01101334|467834399|FG001|Overall Study|Other|1|||
129964491|NCT03864341|467834402|FG000|Overall Study|Withdrawal by Subject|1|||
129964492|NCT00263211|467834404|FG000|Overall Study|Death|1|||
129964493|NCT00263211|467834405|FG001|Overall Study|Death|0|||
129964494|NCT00263211|467834404|FG000|Overall Study|Withdrawal by Subject|3|||
129964495|NCT00263211|467834405|FG001|Overall Study|Withdrawal by Subject|0|||
129964496|NCT00263211|467834404|FG000|Overall Study|Protocol Violation|1|||
129964497|NCT00263211|467834405|FG001|Overall Study|Protocol Violation|0|||
129964498|NCT00263211|467834404|FG000|Overall Study|Disease Progression|0|||
129964499|NCT00263211|467834405|FG001|Overall Study|Disease Progression|1|||
129964500|NCT00760513|467834406|FG000|Overall Study|Withdrawal by Subject|5|||
129964501|NCT00760513|467834407|FG001|Overall Study|Withdrawal by Subject|7|||
129964502|NCT01468077|467834408|FG000|Overall Study|Adverse Event|2|||
129964503|NCT01468077|467834409|FG001|Overall Study|Adverse Event|2|||
129964504|NCT01468077|467834408|FG000|Overall Study|Lack of Efficacy|1|||
129964505|NCT01468077|467834409|FG001|Overall Study|Lack of Efficacy|1|||
129964506|NCT01468077|467834408|FG000|Overall Study|Physician Decision|1|||
129964507|NCT01468077|467834409|FG001|Overall Study|Physician Decision|0|||
129964508|NCT02647788|467834415|FG000|Overall Study|Lost to Follow-up|13|||
129964509|NCT02647788|467834416|FG001|Overall Study|Lost to Follow-up|11|||
129964510|NCT02647788|467834415|FG000|Overall Study|Did not want opiate|0|||
129964511|NCT02647788|467834416|FG001|Overall Study|Did not want opiate|1|||
129964512|NCT02647788|467834415|FG000|Overall Study|Withdrawal by Subject|1|||
129964513|NCT02647788|467834416|FG001|Overall Study|Withdrawal by Subject|0|||
129964514|NCT02647788|467834415|FG000|Overall Study|Felt itchy with assigned medication|1|||
129964515|NCT02647788|467834416|FG001|Overall Study|Felt itchy with assigned medication|0|||
129964516|NCT02647788|467834415|FG000|Overall Study|Felt nauseous with assigned medication|1|||
129964517|NCT02647788|467834416|FG001|Overall Study|Felt nauseous with assigned medication|1|||
129964518|NCT01588366|467834422|FG000|Overall Study|Adverse Event|0|||
129964519|NCT01588366|467834423|FG001|Overall Study|Adverse Event|1|||
129964520|NCT01588366|467834424|FG002|Overall Study|Adverse Event|0|||
129964521|NCT01588366|467834425|FG003|Overall Study|Adverse Event|1|||
129964522|NCT01588366|467834426|FG004|Overall Study|Adverse Event|0|||
129964523|NCT01588366|467834427|FG005|Overall Study|Adverse Event|2|||
129964524|NCT00719043|467834428|FG000|Overall Study|Adverse Event|5|||
129964525|NCT00719043|467834429|FG001|Overall Study|Adverse Event|1|||
129964526|NCT00719043|467834430|FG002|Overall Study|Adverse Event|2|||
129964527|NCT00719043|467834431|FG003|Overall Study|Adverse Event|2|||
129964528|NCT00719043|467834432|FG004|Overall Study|Adverse Event|1|||
129964529|NCT00719043|467834433|FG005|Overall Study|Adverse Event|4|||
129964530|NCT00719043|467834434|FG006|Overall Study|Adverse Event|4|||
129964531|NCT00719043|467834428|FG000|Overall Study|Lost to Follow-up|14|||
129964532|NCT00719043|467834429|FG001|Overall Study|Lost to Follow-up|10|||
129964533|NCT00719043|467834430|FG002|Overall Study|Lost to Follow-up|8|||
129964534|NCT00719043|467834431|FG003|Overall Study|Lost to Follow-up|9|||
129964535|NCT00719043|467834432|FG004|Overall Study|Lost to Follow-up|10|||
129964536|NCT00719043|467834433|FG005|Overall Study|Lost to Follow-up|9|||
129964537|NCT00719043|467834434|FG006|Overall Study|Lost to Follow-up|9|||
129964538|NCT00719043|467834428|FG000|Overall Study|Protocol Violation|0|||
129964539|NCT00719043|467834429|FG001|Overall Study|Protocol Violation|0|||
129964540|NCT00719043|467834430|FG002|Overall Study|Protocol Violation|0|||
129964541|NCT00719043|467834431|FG003|Overall Study|Protocol Violation|0|||
129964542|NCT00719043|467834432|FG004|Overall Study|Protocol Violation|0|||
129964543|NCT00719043|467834433|FG005|Overall Study|Protocol Violation|1|||
129964544|NCT00719043|467834434|FG006|Overall Study|Protocol Violation|0|||
129964545|NCT00719043|467834428|FG000|Overall Study|Other|1|||
129964546|NCT00719043|467834429|FG001|Overall Study|Other|0|||
129964547|NCT00719043|467834430|FG002|Overall Study|Other|1|||
129964548|NCT00719043|467834431|FG003|Overall Study|Other|2|||
129964549|NCT00719043|467834432|FG004|Overall Study|Other|0|||
129964550|NCT00719043|467834433|FG005|Overall Study|Other|2|||
129964551|NCT00719043|467834434|FG006|Overall Study|Other|1|||
129964552|NCT00719043|467834428|FG000|Overall Study|Withdrawal by Subject|12|||
129455426|NCT03134599|465964580|FG005|Week 3|Lost to Follow-up|1|||
129964553|NCT00719043|467834429|FG001|Overall Study|Withdrawal by Subject|14|||
129964554|NCT00719043|467834430|FG002|Overall Study|Withdrawal by Subject|9|||
129964555|NCT00719043|467834431|FG003|Overall Study|Withdrawal by Subject|10|||
129964556|NCT00719043|467834432|FG004|Overall Study|Withdrawal by Subject|16|||
129964557|NCT00719043|467834433|FG005|Overall Study|Withdrawal by Subject|18|||
129964558|NCT00719043|467834434|FG006|Overall Study|Withdrawal by Subject|14|||
129964559|NCT00302159|467834435|FG000|Overall Study|pt declined before treatment started|1|||
129964560|NCT00302159|467834435|FG000|Overall Study|pt started Avastin|1|||
129964561|NCT03245619|467834436|FG000|Part A (Up to Day 22)|Physician Decision|4|||
129964562|NCT03245619|467834437|FG001|Part A (Up to Day 22)|Physician Decision|6|||
129964563|NCT03245619|467834438|FG002|Part A (Up to Day 22)|Physician Decision|6|||
129964564|NCT03245619|467834439|FG003|Part A (Up to Day 22)|Physician Decision|0|||
129964565|NCT03245619|467834440|FG004|Part A (Up to Day 22)|Physician Decision|0|||
129964566|NCT03245619|467834441|FG005|Part A (Up to Day 22)|Physician Decision|0|||
129964567|NCT03245619|467834442|FG006|Part A (Up to Day 22)|Physician Decision|0|||
129964568|NCT03245619|467834443|FG007|Part A (Up to Day 22)|Physician Decision|0|||
129964569|NCT03245619|467834444|FG008|Part A (Up to Day 22)|Physician Decision|0|||
129964570|NCT03245619|467834445|FG009|Part A (Up to Day 22)|Physician Decision|0|||
129964571|NCT03245619|467834446|FG010|Part A (Up to Day 22)|Physician Decision|0|||
129964572|NCT03245619|467834447|FG011|Part A (Up to Day 22)|Physician Decision|0|||
129964573|NCT03245619|467834448|FG012|Part A (Up to Day 22)|Physician Decision|0|||
129964574|NCT03245619|467834449|FG013|Part A (Up to Day 22)|Physician Decision|0|||
129964575|NCT03245619|467834450|FG014|Part A (Up to Day 22)|Physician Decision|0|||
129964576|NCT03245619|467834451|FG015|Part A (Up to Day 22)|Physician Decision|0|||
129964577|NCT03245619|467834452|FG016|Part A (Up to Day 22)|Physician Decision|0|||
129964578|NCT02835092|467834455|FG000|Overall Study|Withdrawal by Subject|3|||
129964579|NCT02835092|467834456|FG001|Overall Study|Withdrawal by Subject|6|||
129964580|NCT02835092|467834457|FG002|Overall Study|Withdrawal by Subject|3|||
129964581|NCT02835092|467834455|FG000|Overall Study|Lost to Follow-up|0|||
129964582|NCT02835092|467834456|FG001|Overall Study|Lost to Follow-up|2|||
129964583|NCT02835092|467834457|FG002|Overall Study|Lost to Follow-up|0|||
129964584|NCT01657877|467834459|FG000|Overall Study|Withdrawal by Subject|4|||
129964585|NCT01657877|467834459|FG000|Overall Study|Protocol Violation|6|||
129964586|NCT01657877|467834459|FG000|Overall Study|Adverse Event|2|||
129964587|NCT01657877|467834459|FG000|Overall Study|Other Reason|2|||
129964588|NCT01114672|467834461|FG000|Overall Study|Death|0|||
129964589|NCT01114672|467834462|FG001|Overall Study|Death|1|||
129964590|NCT01114672|467834461|FG000|Overall Study|Withdrawal by Subject|2|||
129964591|NCT01114672|467834462|FG001|Overall Study|Withdrawal by Subject|1|||
129964592|NCT01114672|467834461|FG000|Overall Study|Lost to Follow-up|1|||
129964593|NCT01114672|467834462|FG001|Overall Study|Lost to Follow-up|0|||
129964594|NCT01114672|467834461|FG000|Overall Study|transplanted|1|||
129964595|NCT01114672|467834462|FG001|Overall Study|transplanted|0|||
129964596|NCT02586415|467834467|FG000|Overall Study|Death|13|||
129964597|NCT02586415|467834468|FG001|Overall Study|Death|23|||
129964598|NCT02586415|467834467|FG000|Overall Study|Lost to Follow-up|1|||
129964599|NCT02586415|467834468|FG001|Overall Study|Lost to Follow-up|2|||
129964600|NCT02872311|467834469|FG000|Overall Study|Death|2|||
129964601|NCT02872311|467834470|FG001|Overall Study|Death|0|||
129964602|NCT02872311|467834471|FG002|Overall Study|Death|0|||
129964603|NCT02872311|467834472|FG003|Overall Study|Death|0|||
129964604|NCT02872311|467834473|FG004|Overall Study|Death|0|||
129964605|NCT02872311|467834469|FG000|Overall Study|Lost to Follow-up|2|||
129964606|NCT02872311|467834470|FG001|Overall Study|Lost to Follow-up|0|||
129964607|NCT02872311|467834471|FG002|Overall Study|Lost to Follow-up|0|||
129964608|NCT02872311|467834472|FG003|Overall Study|Lost to Follow-up|0|||
129964609|NCT02872311|467834473|FG004|Overall Study|Lost to Follow-up|0|||
129964610|NCT02872311|467834469|FG000|Overall Study|Protocol Violation|0|||
129964611|NCT02872311|467834470|FG001|Overall Study|Protocol Violation|2|||
129964612|NCT02872311|467834471|FG002|Overall Study|Protocol Violation|1|||
129964613|NCT02872311|467834472|FG003|Overall Study|Protocol Violation|0|||
129964614|NCT02872311|467834473|FG004|Overall Study|Protocol Violation|0|||
129964615|NCT04545476|467834474|FG000|Overall Study|Lost to Follow-up|1|||
129964616|NCT04545476|467834475|FG001|Overall Study|Lost to Follow-up|1|||
129964617|NCT04545476|467834476|FG002|Overall Study|Lost to Follow-up|0|||
129964618|NCT04545476|467834477|FG003|Overall Study|Lost to Follow-up|0|||
129964619|NCT00690378|467834478|FG000|Overall Study|Adverse Event|1|||
129964620|NCT00690378|467834479|FG001|Overall Study|Adverse Event|0|||
129964621|NCT00690378|467834478|FG000|Overall Study|Withdrawal by Subject|2|||
129964622|NCT00690378|467834479|FG001|Overall Study|Withdrawal by Subject|0|||
129964623|NCT00690378|467834478|FG000|Overall Study|Protocol Violation|1|||
129964624|NCT00690378|467834479|FG001|Overall Study|Protocol Violation|0|||
129964625|NCT00690378|467834478|FG000|Overall Study|Lost to Follow-up|2|||
129964626|NCT00690378|467834479|FG001|Overall Study|Lost to Follow-up|3|||
129964627|NCT00690378|467834478|FG000|Overall Study|Did not meet inc/exc criteria|13|||
129964628|NCT00690378|467834479|FG001|Overall Study|Did not meet inc/exc criteria|11|||
129488459|NCT01277289|466080718|FG001|Overall Study|Adverse Event|1|||
129964629|NCT00690378|467834478|FG000|Overall Study|Social problem|1|||
129964630|NCT00690378|467834479|FG001|Overall Study|Social problem|0|||
129964631|NCT02019641|467834480|FG000|10-Week Follow up|Withdrawal by investigator|2|||
129964632|NCT02019641|467834481|FG001|10-Week Follow up|Withdrawal by investigator|0|||
129964633|NCT02019641|467834482|FG002|10-Week Follow up|Withdrawal by investigator|0|||
129964634|NCT02019641|467834480|FG000|10-Week Follow up|Withdrawal by Subject|1|||
129964635|NCT02019641|467834481|FG001|10-Week Follow up|Withdrawal by Subject|1|||
129964636|NCT02019641|467834482|FG002|10-Week Follow up|Withdrawal by Subject|0|||
129964637|NCT02019641|467834480|FG000|20-Week Follow up|Withdrawal by investigator|0|||
129964638|NCT02019641|467834481|FG001|20-Week Follow up|Withdrawal by investigator|0|||
129964639|NCT02019641|467834482|FG002|20-Week Follow up|Withdrawal by investigator|1|||
129964640|NCT03318783|467834483|FG000|Overall Study|Withdrawal by Subject|0|||
129964641|NCT03318783|467834484|FG001|Overall Study|Withdrawal by Subject|1|||
129964642|NCT03318783|467834483|FG000|Overall Study|Death|0|||
129964643|NCT03318783|467834484|FG001|Overall Study|Death|1|||
129964644|NCT03410108|467834487|FG000|Overall Study|Ongoing|41|||
129964645|NCT03410108|467834487|FG000|Overall Study|Adverse Event|4|||
129964646|NCT03410108|467834487|FG000|Overall Study|Progressive Disease|58|||
129964647|NCT03410108|467834487|FG000|Overall Study|Withdrawal by Subject|1|||
129964648|NCT04035577|467834491|FG000|Overall Study|Lost to Follow-up|1|||
129964649|NCT04035577|467834491|FG000|Overall Study|Withdrawal by Subject|1|||
129964650|NCT03269695|467834492|FG000|Overall Study|Adverse Event|2|||
129964651|NCT03269695|467834493|FG001|Overall Study|Adverse Event|1|||
129964652|NCT03269695|467834492|FG000|Overall Study|Lack of Efficacy|0|||
129964653|NCT03269695|467834493|FG001|Overall Study|Lack of Efficacy|1|||
129964654|NCT03269695|467834492|FG000|Overall Study|Withdrawal by Subject|0|||
129964655|NCT03269695|467834493|FG001|Overall Study|Withdrawal by Subject|1|||
129964656|NCT00104637|467834495|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
129964657|NCT00104637|467834496|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
129964658|NCT01313624|467834497|FG000|Double-Blind Phase|Adverse Event|27|||
129964659|NCT01313624|467834498|FG001|Double-Blind Phase|Adverse Event|4|||
129964660|NCT01313624|467834497|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
129964661|NCT01313624|467834498|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
129964662|NCT01313624|467834497|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129964663|NCT01313624|467834498|FG001|Double-Blind Phase|Lost to Follow-up|2|||
129964664|NCT01313624|467834497|FG000|Double-Blind Phase|Physician Decision|1|||
129964665|NCT01313624|467834498|FG001|Double-Blind Phase|Physician Decision|0|||
129964666|NCT01313624|467834497|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129964667|NCT01313624|467834498|FG001|Double-Blind Phase|Lack of Efficacy|0|||
129964668|NCT01313624|467834497|FG000|Open-Label Phase|Adverse Event|1|||
129964669|NCT01313624|467834498|FG001|Open-Label Phase|Adverse Event|10|||
129964670|NCT01313624|467834497|FG000|Open-Label Phase|Withdrawal by Subject|2|||
129964671|NCT01313624|467834498|FG001|Open-Label Phase|Withdrawal by Subject|2|||
129964672|NCT01313624|467834497|FG000|Open-Label Phase|Lost to Follow-up|1|||
129964673|NCT01313624|467834498|FG001|Open-Label Phase|Lost to Follow-up|1|||
129964674|NCT00505414|467834499|FG000|Titration Phase|Adverse Event|0|||
129964675|NCT00505414|467834500|FG001|Titration Phase|Adverse Event|0|||
129964676|NCT00505414|467834501|FG002|Titration Phase|Adverse Event|0|||
129964677|NCT00505414|467834502|FG003|Titration Phase|Adverse Event|8|||
129964678|NCT00505414|467834503|FG004|Titration Phase|Adverse Event|3|||
129964679|NCT00505414|467834499|FG000|Titration Phase|Death|0|||
129964680|NCT00505414|467834500|FG001|Titration Phase|Death|0|||
129964681|NCT00505414|467834501|FG002|Titration Phase|Death|0|||
129964682|NCT00505414|467834502|FG003|Titration Phase|Death|2|||
129964683|NCT00505414|467834503|FG004|Titration Phase|Death|0|||
129964684|NCT00505414|467834499|FG000|Titration Phase|Lack of Efficacy|0|||
129964685|NCT00505414|467834500|FG001|Titration Phase|Lack of Efficacy|0|||
129964686|NCT00505414|467834501|FG002|Titration Phase|Lack of Efficacy|0|||
129964687|NCT00505414|467834502|FG003|Titration Phase|Lack of Efficacy|10|||
129964688|NCT00505414|467834503|FG004|Titration Phase|Lack of Efficacy|1|||
129964689|NCT00505414|467834499|FG000|Titration Phase|Protocol Violation|0|||
129964690|NCT00505414|467834500|FG001|Titration Phase|Protocol Violation|0|||
129964691|NCT00505414|467834501|FG002|Titration Phase|Protocol Violation|0|||
129964692|NCT00505414|467834502|FG003|Titration Phase|Protocol Violation|0|||
129964693|NCT00505414|467834503|FG004|Titration Phase|Protocol Violation|1|||
129964694|NCT00505414|467834499|FG000|Titration Phase|Withdrawal by Subject|0|||
129964695|NCT00505414|467834500|FG001|Titration Phase|Withdrawal by Subject|0|||
129964696|NCT00505414|467834501|FG002|Titration Phase|Withdrawal by Subject|0|||
129964697|NCT00505414|467834502|FG003|Titration Phase|Withdrawal by Subject|3|||
129964698|NCT00505414|467834503|FG004|Titration Phase|Withdrawal by Subject|4|||
129964699|NCT00505414|467834499|FG000|Titration Phase|Underlying disease and therapy required|0|||
129964700|NCT00505414|467834500|FG001|Titration Phase|Underlying disease and therapy required|0|||
129964701|NCT00505414|467834501|FG002|Titration Phase|Underlying disease and therapy required|0|||
129964702|NCT00505414|467834502|FG003|Titration Phase|Underlying disease and therapy required|7|||
129964703|NCT00505414|467834503|FG004|Titration Phase|Underlying disease and therapy required|3|||
129964704|NCT00505414|467834499|FG000|Maintenance Phase|Adverse Event|2|||
129455427|NCT04416555|465964581|FG000|Overall Study|Withdrawal by Subject|0|||
129455428|NCT04416555|465964582|FG001|Overall Study|Withdrawal by Subject|3|||
129455429|NCT01617070|465964587|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
129964705|NCT00505414|467834500|FG001|Maintenance Phase|Adverse Event|2|||
129964706|NCT00505414|467834501|FG002|Maintenance Phase|Adverse Event|3|||
129964707|NCT00505414|467834502|FG003|Maintenance Phase|Adverse Event|0|||
129964708|NCT00505414|467834503|FG004|Maintenance Phase|Adverse Event|0|||
129964709|NCT00505414|467834499|FG000|Maintenance Phase|Death|2|||
129964710|NCT00505414|467834500|FG001|Maintenance Phase|Death|0|||
129964711|NCT00505414|467834501|FG002|Maintenance Phase|Death|1|||
129964712|NCT00505414|467834502|FG003|Maintenance Phase|Death|0|||
129964713|NCT00505414|467834503|FG004|Maintenance Phase|Death|0|||
129964714|NCT00505414|467834499|FG000|Maintenance Phase|Lack of Efficacy|2|||
129964715|NCT00505414|467834500|FG001|Maintenance Phase|Lack of Efficacy|1|||
129964716|NCT00505414|467834501|FG002|Maintenance Phase|Lack of Efficacy|1|||
129964717|NCT00505414|467834502|FG003|Maintenance Phase|Lack of Efficacy|0|||
129964718|NCT00505414|467834503|FG004|Maintenance Phase|Lack of Efficacy|0|||
129964719|NCT00505414|467834499|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129964720|NCT00505414|467834500|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129964721|NCT00505414|467834501|FG002|Maintenance Phase|Withdrawal by Subject|1|||
129964722|NCT00505414|467834502|FG003|Maintenance Phase|Withdrawal by Subject|0|||
129964723|NCT00505414|467834503|FG004|Maintenance Phase|Withdrawal by Subject|0|||
129964724|NCT00505414|467834499|FG000|Maintenance Phase|underlying disease and therapy required|0|||
129964725|NCT00505414|467834500|FG001|Maintenance Phase|underlying disease and therapy required|2|||
129964726|NCT00505414|467834501|FG002|Maintenance Phase|underlying disease and therapy required|2|||
129964727|NCT00505414|467834502|FG003|Maintenance Phase|underlying disease and therapy required|0|||
129964728|NCT00505414|467834503|FG004|Maintenance Phase|underlying disease and therapy required|0|||
129964729|NCT00846768|467834504|FG000|Overall Study|Adverse Event|0|||
129964730|NCT00846768|467834505|FG001|Overall Study|Adverse Event|1|||
129964731|NCT00846768|467834506|FG002|Overall Study|Adverse Event|0|||
129964732|NCT00846768|467834507|FG003|Overall Study|Adverse Event|0|||
129964733|NCT00644878|467834508|FG000|Overall Study|Adverse Event|2|||
129964734|NCT00644878|467834508|FG000|Overall Study|Abnormal laboratory value|3|||
129964735|NCT00644878|467834508|FG000|Overall Study|Protocol deviation|2|||
129964736|NCT00644878|467834508|FG000|Overall Study|Treatment duration completed as per protocol|11|||
129964737|NCT00591591|467834513|FG000|Overall Study|Withdrawal by Subject|1|||
129964738|NCT00591591|467834514|FG001|Overall Study|Withdrawal by Subject|37|||
129964739|NCT00591591|467834513|FG000|Overall Study|Lack of Efficacy|10|||
129964740|NCT00591591|467834514|FG001|Overall Study|Lack of Efficacy|2|||
129964741|NCT01841112|467834518|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
129964742|NCT01841112|467834519|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
129964743|NCT01841112|467834520|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
129964744|NCT01841112|467834521|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
129964745|NCT01841112|467834522|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
129964746|NCT00878553|467834523|FG000|Sleep Study|Withdrawal by Subject|2|||
129964747|NCT00878553|467834524|FG001|Sleep Study|Withdrawal by Subject|0|||
129964748|NCT00878553|467834525|FG002|Sleep Study|Withdrawal by Subject|0|||
129964749|NCT00878553|467834526|FG003|Sleep Study|Withdrawal by Subject|0|||
129964750|NCT00878553|467834527|FG004|Sleep Study|Withdrawal by Subject|0|||
129964751|NCT00878553|467834523|FG000|Sleep Study|Lost to Follow-up|1|||
129964752|NCT00878553|467834524|FG001|Sleep Study|Lost to Follow-up|0|||
129964753|NCT00878553|467834525|FG002|Sleep Study|Lost to Follow-up|0|||
129964754|NCT00878553|467834526|FG003|Sleep Study|Lost to Follow-up|0|||
129964755|NCT00878553|467834527|FG004|Sleep Study|Lost to Follow-up|0|||
129964756|NCT00878553|467834523|FG000|Sleep Study|car accident|1|||
129964757|NCT00878553|467834524|FG001|Sleep Study|car accident|0|||
129964758|NCT00878553|467834525|FG002|Sleep Study|car accident|0|||
129964759|NCT00878553|467834526|FG003|Sleep Study|car accident|0|||
129964760|NCT00878553|467834527|FG004|Sleep Study|car accident|0|||
129964761|NCT00878553|467834523|FG000|Sleep Study|family emergency|1|||
129964762|NCT00878553|467834524|FG001|Sleep Study|family emergency|0|||
129964763|NCT00878553|467834525|FG002|Sleep Study|family emergency|0|||
129964764|NCT00878553|467834526|FG003|Sleep Study|family emergency|0|||
129964765|NCT00878553|467834527|FG004|Sleep Study|family emergency|0|||
129964766|NCT00878553|467834523|FG000|PK Study|Withdrawal by Subject|0|||
129964767|NCT00878553|467834524|FG001|PK Study|Withdrawal by Subject|0|||
129964768|NCT00878553|467834525|FG002|PK Study|Withdrawal by Subject|0|||
129964769|NCT00878553|467834526|FG003|PK Study|Withdrawal by Subject|1|||
129964770|NCT00878553|467834527|FG004|PK Study|Withdrawal by Subject|0|||
129964771|NCT00912223|467834528|FG000|Overall Study|Withdrawal by Subject|1|||
129964772|NCT00912223|467834528|FG000|Overall Study|Not transplanted|1|||
129964773|NCT00912223|467834528|FG000|Overall Study|Transformed disease|1|||
129964774|NCT00461123|467834529|FG000|Overall Study|Adverse Event|1|||
129964775|NCT00461123|467834530|FG001|Overall Study|Adverse Event|0|||
129964776|NCT00461123|467834529|FG000|Overall Study|Lost to Follow-up|1|||
129964777|NCT00461123|467834530|FG001|Overall Study|Lost to Follow-up|1|||
129964778|NCT00461123|467834529|FG000|Overall Study|Protocol Violation|3|||
129964779|NCT00461123|467834530|FG001|Overall Study|Protocol Violation|2|||
129964780|NCT00461123|467834529|FG000|Overall Study|Withdrawal by Subject|1|||
129964781|NCT00461123|467834530|FG001|Overall Study|Withdrawal by Subject|3|||
129964782|NCT00927901|467834531|FG000|Treatment Period 1|Subject withdrew consent|0|||
129964783|NCT00927901|467834532|FG001|Treatment Period 1|Subject withdrew consent|0|||
129964784|NCT00927901|467834533|FG002|Treatment Period 1|Subject withdrew consent|1|||
129964785|NCT00927901|467834534|FG003|Treatment Period 1|Subject withdrew consent|0|||
129964786|NCT00927901|467834531|FG000|Treatment Period 4|Adverse Event|0|||
129964787|NCT00927901|467834532|FG001|Treatment Period 4|Adverse Event|0|||
129964788|NCT00927901|467834533|FG002|Treatment Period 4|Adverse Event|0|||
129964789|NCT00927901|467834534|FG003|Treatment Period 4|Adverse Event|1|||
129964790|NCT00927901|467834531|FG000|Treatment Period 4|Subject withdrew consent|0|||
129964791|NCT00927901|467834532|FG001|Treatment Period 4|Subject withdrew consent|0|||
129964792|NCT00927901|467834533|FG002|Treatment Period 4|Subject withdrew consent|1|||
129964793|NCT00927901|467834534|FG003|Treatment Period 4|Subject withdrew consent|0|||
129964794|NCT03029819|467834535|FG000|Overall Study|Lost to Follow-up|3|||
129964795|NCT03029819|467834536|FG001|Overall Study|Lost to Follow-up|5|||
129964796|NCT03029819|467834535|FG000|Overall Study|Removed due to disruptive behavior|0|||
129964797|NCT03029819|467834536|FG001|Overall Study|Removed due to disruptive behavior|1|||
129964798|NCT03605368|467834539|FG000|Overall Study|Lost to Follow-up|2|||
129964799|NCT03605368|467834540|FG001|Overall Study|Lost to Follow-up|1|||
129964800|NCT03605368|467834541|FG002|Overall Study|Lost to Follow-up|3|||
129964801|NCT03605368|467834542|FG003|Overall Study|Lost to Follow-up|2|||
129964802|NCT03605368|467834539|FG000|Overall Study|Withdrawal by Subject|0|||
129964803|NCT03605368|467834540|FG001|Overall Study|Withdrawal by Subject|0|||
129964804|NCT03605368|467834541|FG002|Overall Study|Withdrawal by Subject|4|||
129964805|NCT03605368|467834542|FG003|Overall Study|Withdrawal by Subject|3|||
129964806|NCT02650466|467834544|FG000|Overall Study|Physician Decision|1|||
129964807|NCT02650466|467834544|FG000|Overall Study|Withdrawal by Subject|5|||
129964808|NCT02650466|467834544|FG000|Overall Study|Lost to Follow-up|1|||
129964809|NCT01837797|467834545|FG000|Period 1|Adverse Event|9|||
129964810|NCT01837797|467834546|FG001|Period 1|Adverse Event|0|||
129964811|NCT01837797|467834547|FG002|Period 1|Adverse Event|0|||
129964812|NCT01837797|467834548|FG003|Period 1|Adverse Event|0|||
129964813|NCT01837797|467834549|FG004|Period 1|Adverse Event|0|||
129964814|NCT01837797|467834545|FG000|Period 1|Withdrawal by Subject|6|||
129964815|NCT01837797|467834546|FG001|Period 1|Withdrawal by Subject|0|||
129964816|NCT01837797|467834547|FG002|Period 1|Withdrawal by Subject|0|||
129964817|NCT01837797|467834548|FG003|Period 1|Withdrawal by Subject|0|||
129964818|NCT01837797|467834549|FG004|Period 1|Withdrawal by Subject|0|||
129964819|NCT01837797|467834545|FG000|Period 1|Administrative reasons|76|||
129964820|NCT01837797|467834546|FG001|Period 1|Administrative reasons|0|||
129964821|NCT01837797|467834547|FG002|Period 1|Administrative reasons|0|||
129964822|NCT01837797|467834548|FG003|Period 1|Administrative reasons|0|||
129964823|NCT01837797|467834549|FG004|Period 1|Administrative reasons|0|||
129964824|NCT01837797|467834545|FG000|Period 1|Withdrawal of consent before treatment|1|||
129964825|NCT01837797|467834546|FG001|Period 1|Withdrawal of consent before treatment|0|||
129964826|NCT01837797|467834547|FG002|Period 1|Withdrawal of consent before treatment|0|||
129964827|NCT01837797|467834548|FG003|Period 1|Withdrawal of consent before treatment|0|||
129964828|NCT01837797|467834549|FG004|Period 1|Withdrawal of consent before treatment|0|||
129964829|NCT01837797|467834545|FG000|Period 1|Other|10|||
129964830|NCT01837797|467834546|FG001|Period 1|Other|0|||
129964831|NCT01837797|467834547|FG002|Period 1|Other|0|||
129964832|NCT01837797|467834548|FG003|Period 1|Other|0|||
129964833|NCT01837797|467834549|FG004|Period 1|Other|0|||
129964834|NCT01837797|467834545|FG000|Period 2|Administrative or other reasons|0|||
129964835|NCT01837797|467834546|FG001|Period 2|Administrative or other reasons|5|||
129964836|NCT01837797|467834547|FG002|Period 2|Administrative or other reasons|2|||
129964837|NCT01837797|467834548|FG003|Period 2|Administrative or other reasons|4|||
129964838|NCT01837797|467834549|FG004|Period 2|Administrative or other reasons|0|||
129964839|NCT01837797|467834545|FG000|Period 2|Adverse Event|0|||
129964840|NCT01837797|467834546|FG001|Period 2|Adverse Event|0|||
129964841|NCT01837797|467834547|FG002|Period 2|Adverse Event|0|||
129964842|NCT01837797|467834548|FG003|Period 2|Adverse Event|1|||
129964843|NCT01837797|467834549|FG004|Period 2|Adverse Event|0|||
129964844|NCT01837797|467834545|FG000|Period 3|Adverse Event|0|||
129964845|NCT01837797|467834546|FG001|Period 3|Adverse Event|0|||
129964846|NCT01837797|467834547|FG002|Period 3|Adverse Event|0|||
129964847|NCT01837797|467834548|FG003|Period 3|Adverse Event|0|||
129964848|NCT01837797|467834549|FG004|Period 3|Adverse Event|1|||
129964849|NCT01837797|467834545|FG000|Period 3|Administrative reasons|0|||
129964850|NCT01837797|467834546|FG001|Period 3|Administrative reasons|0|||
129964851|NCT01837797|467834547|FG002|Period 3|Administrative reasons|0|||
129964852|NCT01837797|467834548|FG003|Period 3|Administrative reasons|0|||
129964853|NCT01837797|467834549|FG004|Period 3|Administrative reasons|20|||
129964854|NCT01837797|467834545|FG000|Period 3|Other|0|||
129964855|NCT01837797|467834546|FG001|Period 3|Other|0|||
129964856|NCT01837797|467834547|FG002|Period 3|Other|0|||
129964857|NCT01837797|467834548|FG003|Period 3|Other|0|||
129964858|NCT01837797|467834549|FG004|Period 3|Other|2|||
129964859|NCT03797989|467834550|FG000|VAC069A|Withdrawal by Subject|0|||
129964860|NCT03797989|467834551|FG001|VAC069A|Withdrawal by Subject|0|||
129964861|NCT03797989|467834552|FG002|VAC069A|Withdrawal by Subject|1|||
129964862|NCT03797989|467834553|FG003|VAC069A|Withdrawal by Subject|0|||
129964863|NCT03797989|467834554|FG004|VAC069A|Withdrawal by Subject|0|||
129964864|NCT03797989|467834555|FG005|VAC069A|Withdrawal by Subject|0|||
129964865|NCT03797989|467834556|FG006|VAC069A|Withdrawal by Subject|0|||
129964866|NCT03797989|467834557|FG007|VAC069A|Withdrawal by Subject|0|||
129964867|NCT03797989|467834558|FG008|VAC069A|Withdrawal by Subject|0|||
129964868|NCT03797989|467834559|FG009|VAC069A|Withdrawal by Subject|0|||
129964869|NCT03797989|467834560|FG010|VAC069A|Withdrawal by Subject|0|||
129964870|NCT03797989|467834561|FG011|VAC069A|Withdrawal by Subject|0|||
129455430|NCT02230384|465964589|FG000|Phase 1|Lost to Follow-up|1|||
129455431|NCT02230384|465964590|FG001|Phase 1|Lost to Follow-up|0|||
129455432|NCT02230384|465964589|FG000|Phase 1|Physician Decision|0|||
129964871|NCT00604188|467834563|FG000|Overall Study|Adverse Event|1|||
129964872|NCT00604188|467834564|FG001|Overall Study|Adverse Event|4|||
129964873|NCT00604188|467834563|FG000|Overall Study|Lost to Follow-up|17|||
129964874|NCT00604188|467834564|FG001|Overall Study|Lost to Follow-up|15|||
129964875|NCT00604188|467834563|FG000|Overall Study|Withdrawal by Subject|5|||
129964876|NCT00604188|467834564|FG001|Overall Study|Withdrawal by Subject|1|||
129964877|NCT00604188|467834563|FG000|Overall Study|Non-compliance with protocol|4|||
129964878|NCT00604188|467834564|FG001|Overall Study|Non-compliance with protocol|4|||
129964879|NCT00604188|467834563|FG000|Overall Study|Did not receive study drug|0|||
129964880|NCT00604188|467834564|FG001|Overall Study|Did not receive study drug|1|||
129964881|NCT00356759|467834565|FG000|Overall Study|Death|5|||
129964882|NCT00356759|467834566|FG001|Overall Study|Death|2|||
129964883|NCT00356759|467834565|FG000|Overall Study|Withdrawal by Subject|2|||
129964884|NCT00356759|467834566|FG001|Overall Study|Withdrawal by Subject|2|||
129964885|NCT00356759|467834565|FG000|Overall Study|Adverse Event|1|||
129964886|NCT00356759|467834566|FG001|Overall Study|Adverse Event|3|||
129964887|NCT00356759|467834565|FG000|Overall Study|Lost to Follow-up|1|||
129964888|NCT00356759|467834566|FG001|Overall Study|Lost to Follow-up|1|||
129964889|NCT00356759|467834565|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
129964890|NCT00356759|467834566|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
129964891|NCT01999972|467836819|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
129964892|NCT01999972|467836820|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
129964893|NCT01999972|467836821|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
129964894|NCT01999972|467836822|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
129964895|NCT01999972|467836823|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
129964896|NCT01999972|467836824|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
129964897|NCT01999972|467836819|FG000|Dose Escalation Part|Death|0|||
129964898|NCT01999972|467836820|FG001|Dose Escalation Part|Death|1|||
129964899|NCT01999972|467836821|FG002|Dose Escalation Part|Death|0|||
129964900|NCT01999972|467836822|FG003|Dose Escalation Part|Death|0|||
129964901|NCT01999972|467836823|FG004|Dose Escalation Part|Death|0|||
129964902|NCT01999972|467836824|FG005|Dose Escalation Part|Death|0|||
129964903|NCT01999972|467836819|FG000|Dose Escalation Part|Enrolled but not treated|0|||
129964904|NCT01999972|467836820|FG001|Dose Escalation Part|Enrolled but not treated|0|||
129964905|NCT01999972|467836821|FG002|Dose Escalation Part|Enrolled but not treated|1|||
129964906|NCT01999972|467836822|FG003|Dose Escalation Part|Enrolled but not treated|1|||
129964907|NCT01999972|467836823|FG004|Dose Escalation Part|Enrolled but not treated|0|||
129964908|NCT01999972|467836824|FG005|Dose Escalation Part|Enrolled but not treated|0|||
129964909|NCT01999972|467836819|FG000|Dose Escalation Part|Disease progression|3|||
129964910|NCT01999972|467836820|FG001|Dose Escalation Part|Disease progression|2|||
129964911|NCT01999972|467836821|FG002|Dose Escalation Part|Disease progression|3|||
129964912|NCT01999972|467836822|FG003|Dose Escalation Part|Disease progression|6|||
129964913|NCT01999972|467836823|FG004|Dose Escalation Part|Disease progression|0|||
129964914|NCT01999972|467836824|FG005|Dose Escalation Part|Disease progression|0|||
129964915|NCT01999972|467836819|FG000|Dose Escalation Part|Adverse Event|0|||
129964916|NCT01999972|467836820|FG001|Dose Escalation Part|Adverse Event|0|||
129964917|NCT01999972|467836821|FG002|Dose Escalation Part|Adverse Event|0|||
129964918|NCT01999972|467836822|FG003|Dose Escalation Part|Adverse Event|2|||
129964919|NCT01999972|467836823|FG004|Dose Escalation Part|Adverse Event|0|||
129964920|NCT01999972|467836824|FG005|Dose Escalation Part|Adverse Event|0|||
129964921|NCT01999972|467836819|FG000|Dose Escalation Part|Global deterioration of health status|1|||
129964922|NCT01999972|467836820|FG001|Dose Escalation Part|Global deterioration of health status|0|||
129964923|NCT01999972|467836821|FG002|Dose Escalation Part|Global deterioration of health status|0|||
129964924|NCT01999972|467836822|FG003|Dose Escalation Part|Global deterioration of health status|1|||
129964925|NCT01999972|467836823|FG004|Dose Escalation Part|Global deterioration of health status|0|||
129964926|NCT01999972|467836824|FG005|Dose Escalation Part|Global deterioration of health status|0|||
129964927|NCT01999972|467836819|FG000|Dose Expansion Part|Death|0|||
129964928|NCT01999972|467836820|FG001|Dose Expansion Part|Death|0|||
129964929|NCT01999972|467836821|FG002|Dose Expansion Part|Death|0|||
129964930|NCT01999972|467836822|FG003|Dose Expansion Part|Death|0|||
129964931|NCT01999972|467836823|FG004|Dose Expansion Part|Death|2|||
129964932|NCT01999972|467836824|FG005|Dose Expansion Part|Death|1|||
129964933|NCT01999972|467836819|FG000|Dose Expansion Part|Disease progression|0|||
129964934|NCT01999972|467836820|FG001|Dose Expansion Part|Disease progression|0|||
129964935|NCT01999972|467836821|FG002|Dose Expansion Part|Disease progression|0|||
129964936|NCT01999972|467836822|FG003|Dose Expansion Part|Disease progression|0|||
129964937|NCT01999972|467836823|FG004|Dose Expansion Part|Disease progression|9|||
129964938|NCT01999972|467836824|FG005|Dose Expansion Part|Disease progression|3|||
129964939|NCT01999972|467836819|FG000|Dose Expansion Part|Sponsor decision|0|||
129964940|NCT01999972|467836820|FG001|Dose Expansion Part|Sponsor decision|0|||
129964941|NCT01999972|467836821|FG002|Dose Expansion Part|Sponsor decision|0|||
129964942|NCT01999972|467836822|FG003|Dose Expansion Part|Sponsor decision|0|||
129964943|NCT01999972|467836823|FG004|Dose Expansion Part|Sponsor decision|1|||
129964944|NCT01999972|467836824|FG005|Dose Expansion Part|Sponsor decision|0|||
129964945|NCT01999972|467836819|FG000|Dose Expansion Part|Adverse Event|0|||
129964946|NCT01999972|467836820|FG001|Dose Expansion Part|Adverse Event|0|||
129964947|NCT01999972|467836821|FG002|Dose Expansion Part|Adverse Event|0|||
129964948|NCT01999972|467836822|FG003|Dose Expansion Part|Adverse Event|0|||
129964949|NCT01999972|467836823|FG004|Dose Expansion Part|Adverse Event|4|||
129964950|NCT01999972|467836824|FG005|Dose Expansion Part|Adverse Event|2|||
129964951|NCT01999972|467836819|FG000|Dose Expansion Part|Participant's non-compliance|0|||
129964952|NCT01999972|467836820|FG001|Dose Expansion Part|Participant's non-compliance|0|||
129964953|NCT01999972|467836821|FG002|Dose Expansion Part|Participant's non-compliance|0|||
129964954|NCT01999972|467836822|FG003|Dose Expansion Part|Participant's non-compliance|0|||
129964955|NCT01999972|467836823|FG004|Dose Expansion Part|Participant's non-compliance|0|||
129964956|NCT01999972|467836824|FG005|Dose Expansion Part|Participant's non-compliance|1|||
129964957|NCT01999972|467836819|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
129964958|NCT01999972|467836820|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
129964959|NCT01999972|467836821|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
129964960|NCT01999972|467836822|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
129964961|NCT01999972|467836823|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
129964962|NCT01999972|467836824|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
129964963|NCT01999972|467836819|FG000|Dose Expansion Part|Changed to standard of care|0|||
129964964|NCT01999972|467836820|FG001|Dose Expansion Part|Changed to standard of care|0|||
129964965|NCT01999972|467836821|FG002|Dose Expansion Part|Changed to standard of care|0|||
129964966|NCT01999972|467836822|FG003|Dose Expansion Part|Changed to standard of care|0|||
129964967|NCT01999972|467836823|FG004|Dose Expansion Part|Changed to standard of care|1|||
129964968|NCT01999972|467836824|FG005|Dose Expansion Part|Changed to standard of care|0|||
129964969|NCT02202109|467836825|FG000|Overall Study|Lost to Follow-up|88|||
129964970|NCT02202109|467836826|FG001|Overall Study|Lost to Follow-up|87|||
129964971|NCT02202109|467836825|FG000|Overall Study|Withdrawal by Subject|2|||
129964972|NCT02202109|467836826|FG001|Overall Study|Withdrawal by Subject|0|||
129964973|NCT00612352|467836828|FG000|Overall Study|Adverse Event|1|||
129964974|NCT00612352|467836829|FG001|Overall Study|Adverse Event|0|||
129964975|NCT00612352|467836828|FG000|Overall Study|Withdrawal by Subject|3|||
129964976|NCT00612352|467836829|FG001|Overall Study|Withdrawal by Subject|5|||
129964977|NCT00612352|467836828|FG000|Overall Study|moved out of state|1|||
129964978|NCT00612352|467836829|FG001|Overall Study|moved out of state|0|||
129964979|NCT00612352|467836828|FG000|Overall Study|didn't return calls/show up on test date|4|||
129964980|NCT00612352|467836829|FG001|Overall Study|didn't return calls/show up on test date|1|||
129964981|NCT04843579|467836836|FG000|Overall Study|Adverse Event|1|||
129964982|NCT04843579|467836836|FG000|Overall Study|Disease Progression|1|||
129964983|NCT00761956|467836837|FG000|Overall Study|Lost to Follow-up|6|||
129964984|NCT00761956|467836838|FG001|Overall Study|Lost to Follow-up|11|||
129964985|NCT00761956|467836837|FG000|Overall Study|Withdrawal by Subject|3|||
129964986|NCT00761956|467836838|FG001|Overall Study|Withdrawal by Subject|8|||
129964987|NCT00761956|467836837|FG000|Overall Study|Death|0|||
129964988|NCT00761956|467836838|FG001|Overall Study|Death|1|||
129964989|NCT00761956|467836837|FG000|Overall Study|Adverse Event|26|||
129964990|NCT00761956|467836838|FG001|Overall Study|Adverse Event|34|||
129964991|NCT03024996|467836840|FG000|Overall Study|Death|57|||
129964992|NCT03024996|467836841|FG001|Overall Study|Death|55|||
129964993|NCT03024996|467836840|FG000|Overall Study|Disease relapse|1|||
129964994|NCT03024996|467836841|FG001|Overall Study|Disease relapse|0|||
129964995|NCT03024996|467836840|FG000|Overall Study|Lost to Follow-up|5|||
129964996|NCT03024996|467836841|FG001|Overall Study|Lost to Follow-up|10|||
129964997|NCT03024996|467836840|FG000|Overall Study|Other|3|||
129964998|NCT03024996|467836841|FG001|Overall Study|Other|3|||
129964999|NCT03024996|467836840|FG000|Overall Study|Physician Decision|0|||
129965000|NCT03024996|467836841|FG001|Overall Study|Physician Decision|1|||
129965001|NCT03024996|467836840|FG000|Overall Study|Study terminated by sponsor|303|||
129965002|NCT03024996|467836841|FG001|Overall Study|Study terminated by sponsor|283|||
129965003|NCT03024996|467836840|FG000|Overall Study|Withdrawal by Subject|21|||
129965004|NCT03024996|467836841|FG001|Overall Study|Withdrawal by Subject|36|||
129965005|NCT01951378|467836845|FG000|Overall Study|Study Terminated-Not completed|23|||
129965006|NCT01951378|467836846|FG001|Overall Study|Study Terminated-Not completed|17|||
129455433|NCT02230384|465964590|FG001|Phase 1|Physician Decision|1|||
129965007|NCT00464945|467836847|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
129965008|NCT00464945|467836848|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
129965009|NCT00464945|467836847|FG000|Infant Series|Protocol Violation|1|||
129455434|NCT02230384|465964589|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
129965010|NCT00464945|467836848|FG001|Infant Series|Protocol Violation|0|||
129965011|NCT00464945|467836847|FG000|Infant Series|Lost to Follow-up|1|||
129455435|NCT02230384|465964590|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
129965012|NCT00464945|467836848|FG001|Infant Series|Lost to Follow-up|0|||
129965013|NCT00464945|467836847|FG000|After Infant Series|Withdrawal by Subject|0|||
129965014|NCT00464945|467836848|FG001|After Infant Series|Withdrawal by Subject|2|||
129965015|NCT00464945|467836847|FG000|Toddler Dose|Lost to Follow-up|0|||
129965016|NCT00464945|467836848|FG001|Toddler Dose|Lost to Follow-up|1|||
129965017|NCT03065933|467836851|FG000|Overall Study|study terminated|5|||
129965018|NCT02536742|467836852|FG000|Overall Study|Did not start protocol therapy|1|||
129965019|NCT02536742|467836852|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
129965020|NCT04629443|467836853|FG000|Overall Study|Adverse Event|2|||
129965021|NCT04629443|467836854|FG001|Overall Study|Adverse Event|1|||
129965022|NCT04629443|467836855|FG002|Overall Study|Adverse Event|2|||
129965023|NCT04629443|467836853|FG000|Overall Study|Progressive Disease|2|||
129965024|NCT04629443|467836854|FG001|Overall Study|Progressive Disease|3|||
129965025|NCT04629443|467836855|FG002|Overall Study|Progressive Disease|3|||
129965026|NCT04629443|467836853|FG000|Overall Study|Physician Decision|1|||
129965027|NCT04629443|467836854|FG001|Overall Study|Physician Decision|3|||
129965028|NCT04629443|467836855|FG002|Overall Study|Physician Decision|0|||
129965029|NCT01547117|467836857|FG000|Overall Study|Physician Decision|0|||
129965030|NCT01547117|467836858|FG001|Overall Study|Physician Decision|1|||
129965031|NCT01547117|467836859|FG002|Overall Study|Physician Decision|1|||
129965032|NCT01547117|467836860|FG003|Overall Study|Physician Decision|3|||
129965033|NCT01547117|467836857|FG000|Overall Study|Withdrawal by Subject|1|||
129965034|NCT01547117|467836858|FG001|Overall Study|Withdrawal by Subject|2|||
129965035|NCT01547117|467836859|FG002|Overall Study|Withdrawal by Subject|1|||
129965036|NCT01547117|467836860|FG003|Overall Study|Withdrawal by Subject|2|||
129965037|NCT03491215|467836862|FG000|Overall Study|Death|6|||
129965038|NCT03491215|467836863|FG001|Overall Study|Death|2|||
129965039|NCT03491215|467836864|FG002|Overall Study|Death|1|||
129965040|NCT03491215|467836865|FG003|Overall Study|Death|0|||
129965041|NCT03491215|467836862|FG000|Overall Study|Physician Decision|1|||
129965042|NCT03491215|467836863|FG001|Overall Study|Physician Decision|0|||
129965043|NCT03491215|467836864|FG002|Overall Study|Physician Decision|0|||
129965044|NCT03491215|467836865|FG003|Overall Study|Physician Decision|0|||
129965045|NCT01336205|467836868|FG000|Overall Study|Other|22|||
129965046|NCT01336205|467836869|FG001|Overall Study|Other|9|||
129965047|NCT01336205|467836868|FG000|Overall Study|Lost to Follow-up|40|||
129965048|NCT01336205|467836869|FG001|Overall Study|Lost to Follow-up|20|||
129965049|NCT01336205|467836868|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
129965050|NCT01336205|467836869|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
129965051|NCT01336205|467836868|FG000|Overall Study|Lack of Efficacy|4|||
129965052|NCT01336205|467836869|FG001|Overall Study|Lack of Efficacy|0|||
129965053|NCT01336205|467836868|FG000|Overall Study|Severe noncompliance with protocol|9|||
129965054|NCT01336205|467836869|FG001|Overall Study|Severe noncompliance with protocol|2|||
129965055|NCT01336205|467836868|FG000|Overall Study|Adverse Event|56|||
129965056|NCT01336205|467836869|FG001|Overall Study|Adverse Event|6|||
129965057|NCT01336205|467836868|FG000|Overall Study|Death|1|||
129965058|NCT01336205|467836869|FG001|Overall Study|Death|1|||
129965059|NCT01336205|467836868|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
129965060|NCT01336205|467836869|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
129965061|NCT01336205|467836868|FG000|Overall Study|Withdrawal by Subject|72|||
129965062|NCT01336205|467836869|FG001|Overall Study|Withdrawal by Subject|38|||
129965063|NCT01336205|467836868|FG000|Overall Study|Did not receive treatment|4|||
129965064|NCT01336205|467836869|FG001|Overall Study|Did not receive treatment|0|||
129965065|NCT01006616|467836870|FG000|Period 1 (6 Months)|Adverse Event|10|||
129965066|NCT01006616|467836871|FG001|Period 1 (6 Months)|Adverse Event|31|||
129965067|NCT01006616|467836872|FG002|Period 1 (6 Months)|Adverse Event|37|||
129965068|NCT01006616|467836873|FG003|Period 1 (6 Months)|Adverse Event|9|||
129965069|NCT01006616|467836870|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
129455436|NCT02230384|465964589|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
129455437|NCT02230384|465964590|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
129455438|NCT02230384|465964589|FG000|Phase 2 - Switch|Adverse Event|2|||
129455439|NCT02230384|465964590|FG001|Phase 2 - Switch|Adverse Event|0|||
129455440|NCT00808236|465964591|FG000|Overall Study|Was not resuscitated|50|||
129965070|NCT01006616|467836871|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
129965071|NCT01006616|467836872|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
129965072|NCT01006616|467836873|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
129965073|NCT01006616|467836870|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
129965074|NCT01006616|467836871|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
129965075|NCT01006616|467836872|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
129965076|NCT01006616|467836873|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
129965077|NCT01006616|467836870|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
129965078|NCT01006616|467836871|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
129965079|NCT01006616|467836872|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
129965080|NCT01006616|467836873|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
129965081|NCT01006616|467836870|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
129455441|NCT00808236|465964592|FG001|Overall Study|Was not resuscitated|56|||
129455442|NCT00808236|465964591|FG000|Overall Study|Pre-defined exclusion|13|||
129965082|NCT01006616|467836871|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
129965083|NCT01006616|467836872|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
129965084|NCT01006616|467836873|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
129965085|NCT01006616|467836870|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
129965086|NCT01006616|467836871|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
129965087|NCT01006616|467836872|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
129965088|NCT01006616|467836873|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
129965089|NCT01006616|467836870|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
129965090|NCT01006616|467836871|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
129965091|NCT01006616|467836872|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
129965092|NCT01006616|467836873|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
129965093|NCT01006616|467836870|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
129965094|NCT01006616|467836871|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
129965095|NCT01006616|467836872|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
129965096|NCT01006616|467836873|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
129965097|NCT01006616|467836870|FG000|Period 1 (6 Months)|Not Treated|0|||
129965098|NCT01006616|467836871|FG001|Period 1 (6 Months)|Not Treated|0|||
129965099|NCT01006616|467836872|FG002|Period 1 (6 Months)|Not Treated|1|||
129965100|NCT01006616|467836873|FG003|Period 1 (6 Months)|Not Treated|1|||
129965101|NCT01006616|467836870|FG000|Period 2 (18 Months)|Adverse Event|6|||
129965102|NCT01006616|467836871|FG001|Period 2 (18 Months)|Adverse Event|6|||
129965103|NCT01006616|467836872|FG002|Period 2 (18 Months)|Adverse Event|6|||
129965104|NCT01006616|467836873|FG003|Period 2 (18 Months)|Adverse Event|4|||
129965105|NCT01006616|467836870|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
129965106|NCT01006616|467836871|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
129965107|NCT01006616|467836872|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
129965108|NCT01006616|467836873|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
129965109|NCT01006616|467836870|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
129965110|NCT01006616|467836871|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
129965111|NCT01006616|467836872|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
129965112|NCT01006616|467836873|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
129965113|NCT01006616|467836870|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
129965114|NCT01006616|467836871|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
129965115|NCT01006616|467836872|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
129965116|NCT01006616|467836873|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
129965117|NCT01006616|467836870|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
129965118|NCT01006616|467836871|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
129965119|NCT01006616|467836872|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
129965120|NCT01006616|467836873|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
129965121|NCT01006616|467836870|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
129965122|NCT01006616|467836871|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
129965123|NCT01006616|467836872|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
129965124|NCT01006616|467836873|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
129965125|NCT01006616|467836870|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
129965126|NCT01006616|467836871|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
129965127|NCT01006616|467836872|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
129965128|NCT01006616|467836873|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
129965129|NCT01006616|467836870|FG000|Period 2 (18 Months)|Study Terminated|63|||
129965130|NCT01006616|467836871|FG001|Period 2 (18 Months)|Study Terminated|46|||
129965131|NCT01006616|467836872|FG002|Period 2 (18 Months)|Study Terminated|44|||
129965132|NCT01006616|467836873|FG003|Period 2 (18 Months)|Study Terminated|70|||
129965133|NCT03672175|467836874|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
129965134|NCT03672175|467836875|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
129965135|NCT03672175|467836876|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
129965136|NCT03672175|467836874|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
129965137|NCT03672175|467836875|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
129965138|NCT03672175|467836876|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
129965139|NCT03672175|467836874|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
129965140|NCT03672175|467836875|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
129965141|NCT03672175|467836876|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
129965142|NCT03672175|467836874|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
129965143|NCT03672175|467836875|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
129965144|NCT03672175|467836876|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
129455443|NCT00808236|465964592|FG001|Overall Study|Pre-defined exclusion|3|||
129455444|NCT00808236|465964591|FG000|Overall Study|Lost to Follow-up|1|||
129455445|NCT00808236|465964592|FG001|Overall Study|Lost to Follow-up|1|||
129965145|NCT03672175|467836874|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
129965146|NCT03672175|467836875|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
129965147|NCT03672175|467836876|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
129965148|NCT03672175|467836874|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
129965149|NCT03672175|467836875|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
129965150|NCT03672175|467836876|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
129965151|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
129965152|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
129965153|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
129965154|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
129965155|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
129965156|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
129965157|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
129965158|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
129965159|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
129965160|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
129965161|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
129965162|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
129965163|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
129965164|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
129965165|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
129965166|NCT03672175|467836874|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
129965167|NCT03672175|467836875|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
129965168|NCT03672175|467836876|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
129965169|NCT02482935|467836877|FG000|Period 1|Withdrawal by Subject|1|||
129965170|NCT02482935|467836878|FG001|Period 1|Withdrawal by Subject|0|||
129965171|NCT03414047|467836879|FG000|Overall Study|Adverse Event|0|||
129965172|NCT03414047|467836880|FG001|Overall Study|Adverse Event|0|||
129965173|NCT03414047|467836881|FG002|Overall Study|Adverse Event|1|||
129965174|NCT03414047|467836882|FG003|Overall Study|Adverse Event|1|||
129965175|NCT03414047|467836879|FG000|Overall Study|Physician Decision|1|||
129965176|NCT03414047|467836880|FG001|Overall Study|Physician Decision|0|||
129965177|NCT03414047|467836881|FG002|Overall Study|Physician Decision|0|||
129965178|NCT03414047|467836882|FG003|Overall Study|Physician Decision|1|||
129965179|NCT03414047|467836879|FG000|Overall Study|Withdrawal by Subject|1|||
129965180|NCT03414047|467836880|FG001|Overall Study|Withdrawal by Subject|0|||
129965181|NCT03414047|467836881|FG002|Overall Study|Withdrawal by Subject|2|||
129965182|NCT03414047|467836882|FG003|Overall Study|Withdrawal by Subject|0|||
129965183|NCT01585298|467836885|FG000|Overall Study|Study completion was not documented.|1|||
129965184|NCT01585298|467836885|FG000|Overall Study|Protocol deviation|1|||
129965185|NCT01585298|467836885|FG000|Overall Study|Administrative problems|4|||
129965186|NCT01585298|467836885|FG000|Overall Study|Lost to Follow-up|2|||
129965187|NCT01585298|467836885|FG000|Overall Study|Withdrawal by Subject|4|||
129965188|NCT01585298|467836885|FG000|Overall Study|Abnormal test procedure results|1|||
129965189|NCT01585298|467836885|FG000|Overall Study|Adverse Event|24|||
129965190|NCT02777242|467836889|FG000|Overall Study|Other|2|||
129965191|NCT02777242|467836889|FG000|Overall Study|Lost to Follow-up|1|||
129965192|NCT02777242|467836889|FG000|Overall Study|Multiple|1|||
129965193|NCT02777242|467836889|FG000|Overall Study|Sponsor's request|1|||
129965194|NCT02777242|467836889|FG000|Overall Study|Withdrawal by Subject|1|||
129965195|NCT01898442|467836890|FG000|Overall Study|Hemolysis/technical problems|1|||
129965196|NCT01898442|467836891|FG001|Overall Study|Hemolysis/technical problems|2|||
129965197|NCT01898442|467836892|FG002|Overall Study|Hemolysis/technical problems|2|||
129455446|NCT00808236|465964591|FG000|Overall Study|Physician Decision|0|||
129455447|NCT00808236|465964592|FG001|Overall Study|Physician Decision|1|||
129455448|NCT00808236|465964591|FG000|Overall Study|Death|18|||
129455449|NCT00808236|465964592|FG001|Overall Study|Death|30|||
129455450|NCT00777101|465964593|FG000|Overall Study|Death|48|||
129455451|NCT00777101|465964594|FG001|Overall Study|Death|43|||
129455452|NCT00777101|465964593|FG000|Overall Study|Withdrawal by Subject|11|||
129455453|NCT00777101|465964594|FG001|Overall Study|Withdrawal by Subject|6|||
129455454|NCT00777101|465964593|FG000|Overall Study|Lost to Follow-up|2|||
129455455|NCT00777101|465964594|FG001|Overall Study|Lost to Follow-up|1|||
129455456|NCT00777101|465964593|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
129455457|NCT00777101|465964594|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
129455458|NCT00777101|465964593|FG000|Overall Study|Failed to Return|0|||
129455459|NCT00777101|465964594|FG001|Overall Study|Failed to Return|1|||
129455460|NCT00961220|465964595|FG000|Overall Study|Adverse Event|3|||
129455461|NCT00961220|465964595|FG000|Overall Study|Lack of Efficacy|1|||
129455462|NCT00961220|465964595|FG000|Overall Study|No IV access for O6BG|1|||
129455463|NCT00961220|465964595|FG000|Overall Study|O6BG no longer supplied|1|||
129455464|NCT00961220|465964595|FG000|Overall Study|Complete Response prior to 12 courses|1|||
129455465|NCT01301950|465964600|FG000|Overall Study|Surgery was cancelled by patient|0|||
129965198|NCT01898442|467836890|FG000|Overall Study|Patient vomited pills|0|||
129965199|NCT01898442|467836891|FG001|Overall Study|Patient vomited pills|0|||
129965200|NCT01898442|467836892|FG002|Overall Study|Patient vomited pills|1|||
129965201|NCT05178979|467836893|FG000|Overall Study|Death|0|||
129965202|NCT05178979|467836894|FG001|Overall Study|Death|5|||
129965203|NCT05178979|467836895|FG002|Overall Study|Death|0|||
129965204|NCT05178979|467836896|FG003|Overall Study|Death|3|||
129965205|NCT05178979|467836893|FG000|Overall Study|Adverse Event|0|||
129965206|NCT05178979|467836894|FG001|Overall Study|Adverse Event|1|||
129965207|NCT05178979|467836895|FG002|Overall Study|Adverse Event|0|||
129965208|NCT05178979|467836896|FG003|Overall Study|Adverse Event|0|||
129965209|NCT05178979|467836893|FG000|Overall Study|Lost to Follow-up|1|||
129965210|NCT05178979|467836894|FG001|Overall Study|Lost to Follow-up|8|||
129965211|NCT05178979|467836895|FG002|Overall Study|Lost to Follow-up|3|||
129965212|NCT05178979|467836896|FG003|Overall Study|Lost to Follow-up|8|||
129965213|NCT01704547|467836903|FG000|Overall Study|Physician Decision|4|||
129965214|NCT01704547|467836903|FG000|Overall Study|Withdrawal by Subject|1|||
129965215|NCT00468130|467836913|FG000|Overall Study|Adverse Event|2|||
129965216|NCT00468130|467836914|FG001|Overall Study|Adverse Event|1|||
129965217|NCT00468130|467836913|FG000|Overall Study|Withdrawal by Subject|0|||
129965218|NCT00468130|467836914|FG001|Overall Study|Withdrawal by Subject|1|||
129965219|NCT00436956|467836915|FG000|Overall Study|Not evaluable|1|||
129965220|NCT00436956|467836916|FG001|Overall Study|Not evaluable|0|||
129965221|NCT02143063|467836919|FG000|Overall Study|Lost to Follow-up|16|||
129965222|NCT02143063|467836920|FG001|Overall Study|Lost to Follow-up|28|||
129965223|NCT02143063|467836921|FG002|Overall Study|Lost to Follow-up|29|||
129965224|NCT02143063|467836919|FG000|Overall Study|Withdrawal by Subject|0|||
129965225|NCT02143063|467836920|FG001|Overall Study|Withdrawal by Subject|1|||
129965226|NCT02143063|467836921|FG002|Overall Study|Withdrawal by Subject|0|||
129965227|NCT02143063|467836919|FG000|Overall Study|Death|0|||
129965228|NCT02143063|467836920|FG001|Overall Study|Death|1|||
129965229|NCT02143063|467836921|FG002|Overall Study|Death|1|||
129965230|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
129965231|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
129965232|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
129965233|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
129965234|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
129965235|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
129965236|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
129965237|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
129965238|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
129965239|NCT01099579|467836924|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
129965240|NCT01099579|467836925|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
129965241|NCT01099579|467836926|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
129965242|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
129965243|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
129965244|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
129965245|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
129965246|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
129965247|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
129965248|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
129965249|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
129965250|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
129965251|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
129965252|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
129965253|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
129965254|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
129965255|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
129965256|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
129965257|NCT01099579|467836924|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
129965258|NCT01099579|467836925|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
129965259|NCT01099579|467836926|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
129965260|NCT00909532|467836927|FG000|Overall Study|Adverse Event|4|||
129965261|NCT00909532|467836928|FG001|Overall Study|Adverse Event|1|||
129965262|NCT00909532|467836927|FG000|Overall Study|Pregnancy|0|||
129965263|NCT00909532|467836928|FG001|Overall Study|Pregnancy|1|||
129965264|NCT00909532|467836927|FG000|Overall Study|Prohibited Medication|2|||
129965265|NCT00909532|467836928|FG001|Overall Study|Prohibited Medication|1|||
129965266|NCT00909532|467836927|FG000|Overall Study|Withdrawal of Consent|1|||
129965267|NCT00909532|467836928|FG001|Overall Study|Withdrawal of Consent|1|||
129965268|NCT00909532|467836927|FG000|Overall Study|Noncompliance with Study Requirements|0|||
129488460|NCT01277289|466080717|FG000|Overall Study|consent withdrawn|1|||
129965269|NCT00909532|467836928|FG001|Overall Study|Noncompliance with Study Requirements|2|||
129965270|NCT00909532|467836927|FG000|Overall Study|Physician Decision|1|||
129965271|NCT00909532|467836928|FG001|Overall Study|Physician Decision|0|||
129965272|NCT00909532|467836927|FG000|Overall Study|Wrong Genotype|1|||
129965273|NCT00909532|467836928|FG001|Overall Study|Wrong Genotype|0|||
129965274|NCT00909532|467836927|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
129965275|NCT00909532|467836928|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
129965276|NCT01130168|467836929|FG000|Period 1|Withdrawal by Subject|0|||
129965277|NCT01130168|467836930|FG001|Period 1|Withdrawal by Subject|1|||
129965278|NCT01130168|467836931|FG002|Period 1|Withdrawal by Subject|0|||
129965279|NCT01130168|467836932|FG003|Period 1|Withdrawal by Subject|1|||
129965280|NCT01130168|467836933|FG004|Period 1|Withdrawal by Subject|0|||
129965281|NCT01130168|467836934|FG005|Period 1|Withdrawal by Subject|0|||
129965282|NCT01130168|467836929|FG000|Period 1|Discontinued For Other Reason|0|||
129965283|NCT01130168|467836930|FG001|Period 1|Discontinued For Other Reason|0|||
129965284|NCT01130168|467836931|FG002|Period 1|Discontinued For Other Reason|1|||
129965285|NCT01130168|467836932|FG003|Period 1|Discontinued For Other Reason|1|||
129965286|NCT01130168|467836933|FG004|Period 1|Discontinued For Other Reason|0|||
129965287|NCT01130168|467836934|FG005|Period 1|Discontinued For Other Reason|0|||
129965288|NCT01130168|467836929|FG000|Period 1|Adverse Event|0|||
129965289|NCT01130168|467836930|FG001|Period 1|Adverse Event|0|||
129965290|NCT01130168|467836931|FG002|Period 1|Adverse Event|0|||
129965291|NCT01130168|467836932|FG003|Period 1|Adverse Event|1|||
129965292|NCT01130168|467836933|FG004|Period 1|Adverse Event|0|||
129965293|NCT01130168|467836934|FG005|Period 1|Adverse Event|0|||
129965294|NCT01263925|467836941|FG000|Overall Study|Protocol Violation|1|||
129965295|NCT01263925|467836942|FG001|Overall Study|Protocol Violation|0|||
129965296|NCT01263925|467836941|FG000|Overall Study|Lack of Efficacy|0|||
129965297|NCT01263925|467836942|FG001|Overall Study|Lack of Efficacy|1|||
129965298|NCT01263925|467836941|FG000|Overall Study|Adverse Event|23|||
129965299|NCT01263925|467836942|FG001|Overall Study|Adverse Event|22|||
129965300|NCT01263925|467836941|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
129965301|NCT01263925|467836942|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
129965302|NCT01263925|467836941|FG000|Overall Study|Withdrawal by Subject|6|||
129965303|NCT01263925|467836942|FG001|Overall Study|Withdrawal by Subject|8|||
129965304|NCT01263925|467836941|FG000|Overall Study|Other|4|||
129965305|NCT01263925|467836942|FG001|Overall Study|Other|4|||
129965306|NCT01263925|467836941|FG000|Overall Study|Lost to Follow-up|3|||
129965307|NCT01263925|467836942|FG001|Overall Study|Lost to Follow-up|1|||
129965308|NCT01263925|467836941|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
129965309|NCT01263925|467836942|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
129965310|NCT01263925|467836941|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
129965311|NCT01263925|467836942|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
129965312|NCT01263925|467836941|FG000|Overall Study|AE/ Withdrawal|1|||
129965313|NCT01263925|467836942|FG001|Overall Study|AE/ Withdrawal|4|||
129965314|NCT01263925|467836941|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
129965315|NCT01263925|467836942|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
129965316|NCT01263925|467836941|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
129965317|NCT01263925|467836942|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
129965318|NCT01263925|467836941|FG000|Overall Study|Withdrawal/ Not specified|0|||
129965319|NCT01263925|467836942|FG001|Overall Study|Withdrawal/ Not specified|1|||
129965320|NCT01726517|467836952|FG000|Overall Study|Withdrawal by Subject|0|||
129965321|NCT01726517|467836953|FG001|Overall Study|Withdrawal by Subject|0|||
129965322|NCT01726517|467836954|FG002|Overall Study|Withdrawal by Subject|1|||
129965323|NCT01726517|467836955|FG003|Overall Study|Withdrawal by Subject|0|||
129965324|NCT01726517|467836956|FG004|Overall Study|Withdrawal by Subject|0|||
129965325|NCT00573651|467836957|FG000|Overall Study|Lost to Follow-up|3|||
129965326|NCT00573651|467836957|FG000|Overall Study|Withdrawal by Subject|1|||
129965327|NCT03765164|467836958|FG000|Pre-intervention|Withdrawal by Subject|5|||
129965328|NCT03765164|467836959|FG001|Pre-intervention|Withdrawal by Subject|6|||
129965329|NCT03448536|467836961|FG000|Overall Study|Protocol Violation|2|||
129965330|NCT03448536|467836962|FG001|Overall Study|Protocol Violation|0|||
129965331|NCT03448536|467836961|FG000|Overall Study|Pregnancy|1|||
129965332|NCT03448536|467836962|FG001|Overall Study|Pregnancy|0|||
129965333|NCT03448536|467836961|FG000|Overall Study|Withdrawal by Subject|1|||
129965334|NCT03448536|467836962|FG001|Overall Study|Withdrawal by Subject|2|||
129965335|NCT03448536|467836961|FG000|Overall Study|Lost to Follow-up|3|||
129965336|NCT03448536|467836962|FG001|Overall Study|Lost to Follow-up|2|||
129965337|NCT03448536|467836961|FG000|Overall Study|Inadequate pain reporter|1|||
129965338|NCT03448536|467836962|FG001|Overall Study|Inadequate pain reporter|0|||
129965339|NCT03448536|467836961|FG000|Overall Study|Other|3|||
129965340|NCT03448536|467836962|FG001|Overall Study|Other|0|||
129965341|NCT03448536|467836961|FG000|Overall Study|Physician Decision|1|||
129965342|NCT03448536|467836962|FG001|Overall Study|Physician Decision|0|||
129965343|NCT04052997|467836985|FG000|Overall Study|Withdrawal by Subject|17|||
129965344|NCT04052997|467836985|FG000|Overall Study|Physician Decision|50|||
129965345|NCT04052997|467836985|FG000|Overall Study|Death|43|||
129965346|NCT04052997|467836985|FG000|Overall Study|Lost to Follow-up|5|||
129965347|NCT04052997|467836985|FG000|Overall Study|Progression of Disease|1|||
129965348|NCT01024036|467836986|FG000|Blinded Treatment|Adverse Event|1|||
129965349|NCT01024036|467836987|FG001|Blinded Treatment|Adverse Event|1|||
129965350|NCT01024036|467836986|FG000|Blinded Treatment|Lack of Efficacy|16|||
129965351|NCT01024036|467836987|FG001|Blinded Treatment|Lack of Efficacy|14|||
129965352|NCT01024036|467836986|FG000|Blinded Treatment|Physician Decision|1|||
129965353|NCT01024036|467836987|FG001|Blinded Treatment|Physician Decision|0|||
129965354|NCT01024036|467836986|FG000|Blinded Treatment|Death|0|||
129965355|NCT01024036|467836987|FG001|Blinded Treatment|Death|2|||
129965356|NCT01024036|467836986|FG000|Blinded Treatment|Withdrawal by Subject|4|||
129965357|NCT01024036|467836987|FG001|Blinded Treatment|Withdrawal by Subject|3|||
129965358|NCT01024036|467836986|FG000|Unblinded Treatment|Adverse Event|0|||
129965359|NCT01024036|467836987|FG001|Unblinded Treatment|Adverse Event|1|||
129965360|NCT01024036|467836986|FG000|Unblinded Treatment|Lack of Efficacy|0|||
129965361|NCT01024036|467836987|FG001|Unblinded Treatment|Lack of Efficacy|2|||
129965362|NCT01024036|467836986|FG000|Follow-Up Period|Lost to Follow-up|1|||
129965363|NCT01024036|467836987|FG001|Follow-Up Period|Lost to Follow-up|1|||
129965364|NCT01024036|467836986|FG000|Follow-Up Period|Withdrawal by Subject|0|||
129965365|NCT01024036|467836987|FG001|Follow-Up Period|Withdrawal by Subject|1|||
129965366|NCT01024036|467836986|FG000|Follow-Up Period|Adverse Event|4|||
129965367|NCT01024036|467836987|FG001|Follow-Up Period|Adverse Event|1|||
129965368|NCT00474383|467836997|FG000|Main Study|Adverse Event|11|||
129965369|NCT00474383|467836998|FG001|Main Study|Adverse Event|0|||
129965370|NCT00474383|467836997|FG000|Main Study|Symptomatic Deterioration|1|||
129965371|NCT00474383|467836998|FG001|Main Study|Symptomatic Deterioration|0|||
129965372|NCT00474383|467836997|FG000|Main Study|Progressive Disease|23|||
129965373|NCT00474383|467836998|FG001|Main Study|Progressive Disease|0|||
129965374|NCT00474383|467836997|FG000|Main Study|Other|1|||
129965375|NCT00474383|467836998|FG001|Main Study|Other|0|||
129965376|NCT00474383|467836997|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
129965377|NCT00474383|467836998|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
129965378|NCT00474383|467836997|FG000|Extension|Progressive Disease|0|||
129965379|NCT00474383|467836998|FG001|Extension|Progressive Disease|5|||
129965380|NCT02998918|467836999|FG000|Overall Study|Withdrawal by Subject|1|||
129965381|NCT02998918|467837000|FG001|Overall Study|Withdrawal by Subject|0|||
129965382|NCT00443599|467837008|FG000|Overall Study|Physician Decision|2|||
129965383|NCT00443599|467837009|FG001|Overall Study|Physician Decision|1|||
129965384|NCT00443599|467837008|FG000|Overall Study|Death|1|||
129965385|NCT00443599|467837009|FG001|Overall Study|Death|1|||
129965386|NCT00443599|467837008|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
129965387|NCT00443599|467837009|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
129965388|NCT04811339|467837010|FG000|Overall Study|lack of transportation not wanting to return|4|||
129965389|NCT04811339|467837011|FG001|Overall Study|lack of transportation not wanting to return|8|||
129965390|NCT04811339|467837012|FG002|Overall Study|lack of transportation not wanting to return|0|||
129965391|NCT04811339|467837010|FG000|Overall Study|Adverse Event|3|||
129965392|NCT04811339|467837011|FG001|Overall Study|Adverse Event|0|||
129965393|NCT04811339|467837012|FG002|Overall Study|Adverse Event|0|||
129965394|NCT04811339|467837010|FG000|Overall Study|Lost to Follow-up|1|||
129965395|NCT04811339|467837011|FG001|Overall Study|Lost to Follow-up|0|||
129965396|NCT04811339|467837012|FG002|Overall Study|Lost to Follow-up|0|||
129965397|NCT04811339|467837010|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
129965398|NCT04811339|467837011|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
129965399|NCT04811339|467837012|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
129965400|NCT04811339|467837010|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
129965401|NCT04811339|467837011|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
129965402|NCT04811339|467837012|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
129965403|NCT04811339|467837010|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
129965404|NCT04811339|467837011|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
129965405|NCT04811339|467837012|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
129965406|NCT04811339|467837010|FG000|Overall Study|Withdrawal by Subject|0|||
129965407|NCT04811339|467837011|FG001|Overall Study|Withdrawal by Subject|3|||
129965408|NCT04811339|467837012|FG002|Overall Study|Withdrawal by Subject|0|||
129965409|NCT04811339|467837010|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
129965410|NCT04811339|467837011|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
129965411|NCT04811339|467837012|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
129965412|NCT04811339|467837010|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
129965413|NCT04811339|467837011|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
129965414|NCT04811339|467837012|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
129965415|NCT01986114|467839001|FG000|Overall Study|Adverse Event|59|||
129965416|NCT01986114|467839001|FG000|Overall Study|Lack of Efficacy|23|||
129965417|NCT01986114|467839001|FG000|Overall Study|Withdrawal by Subject|58|||
129965418|NCT01986114|467839001|FG000|Overall Study|Noncompliance|3|||
129965419|NCT01986114|467839001|FG000|Overall Study|Protocol Violation|1|||
129965420|NCT01986114|467839001|FG000|Overall Study|Lost to Follow-up|5|||
129965421|NCT01986114|467839001|FG000|Overall Study|Other reason|7|||
129965422|NCT02808975|467839002|FG000|Overall Study|Adverse Event|3|||
129965423|NCT02808975|467839003|FG001|Overall Study|Adverse Event|4|||
129965424|NCT02808975|467839002|FG000|Overall Study|Withdrew consent|9|||
129965425|NCT02808975|467839003|FG001|Overall Study|Withdrew consent|8|||
129965426|NCT02808975|467839002|FG000|Overall Study|Lost to Follow-up|4|||
129965427|NCT02808975|467839003|FG001|Overall Study|Lost to Follow-up|6|||
129965428|NCT02808975|467839002|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
129965429|NCT02808975|467839003|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
129965430|NCT02808975|467839002|FG000|Overall Study|Other, not specified|5|||
129965431|NCT02808975|467839003|FG001|Overall Study|Other, not specified|1|||
129965432|NCT00030823|467839004|FG000|Overall Study|Withdrawal by Subject|1|||
129965433|NCT04333147|467839006|FG000|Overall Study|Adverse Event|43|||
129965434|NCT04333147|467839007|FG001|Overall Study|Adverse Event|40|||
129965435|NCT04333147|467839006|FG000|Overall Study|Lack of Efficacy|49|||
129965436|NCT04333147|467839007|FG001|Overall Study|Lack of Efficacy|48|||
129965437|NCT04333147|467839006|FG000|Overall Study|Lost to Follow-up|19|||
129965438|NCT04333147|467839007|FG001|Overall Study|Lost to Follow-up|16|||
129965439|NCT04333147|467839006|FG000|Overall Study|Physician Decision|17|||
129965440|NCT04333147|467839007|FG001|Overall Study|Physician Decision|20|||
129965441|NCT04333147|467839006|FG000|Overall Study|Withdrawal by Subject|65|||
129965442|NCT04333147|467839007|FG001|Overall Study|Withdrawal by Subject|68|||
129965443|NCT04333147|467839006|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
129965444|NCT04333147|467839007|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
129965445|NCT04333147|467839006|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
129965446|NCT04333147|467839007|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
129965447|NCT04333147|467839006|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
129965448|NCT04333147|467839007|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
129965449|NCT02106195|467839008|FG000|Overall Study|Adverse Event|2|||
129965450|NCT02106195|467839008|FG000|Overall Study|Protocol Violation|1|||
129965451|NCT03062449|467839009|FG000|Overall Study|Withdrawal by Subject|7|||
129965452|NCT03062449|467839010|FG001|Overall Study|Withdrawal by Subject|1|||
129965453|NCT04702893|467839012|FG000|Overall Study|Other reasons than listed|11|||
129965454|NCT04702893|467839012|FG000|Overall Study|Withdrawal by Subject|3|||
129965455|NCT04702893|467839012|FG000|Overall Study|Lost to Follow-up|7|||
129455466|NCT01301950|465964601|FG001|Overall Study|Surgery was cancelled by patient|1|||
129455467|NCT00825162|465964606|FG000|Overall Study|Withdrawal by Subject|11|||
129455468|NCT00825162|465964607|FG001|Overall Study|Withdrawal by Subject|13|||
129455469|NCT00825162|465964608|FG002|Overall Study|Withdrawal by Subject|3|||
129455470|NCT00825162|465964606|FG000|Overall Study|Lost to Follow-up|9|||
129455471|NCT00825162|465964607|FG001|Overall Study|Lost to Follow-up|6|||
129455472|NCT00825162|465964608|FG002|Overall Study|Lost to Follow-up|3|||
129455473|NCT00825162|465964606|FG000|Overall Study|Physician Decision|2|||
129455474|NCT00825162|465964607|FG001|Overall Study|Physician Decision|0|||
129455475|NCT00825162|465964608|FG002|Overall Study|Physician Decision|0|||
129455476|NCT00825162|465964606|FG000|Overall Study|Move away from the study area|1|||
129455477|NCT00825162|465964607|FG001|Overall Study|Move away from the study area|0|||
129455478|NCT00825162|465964608|FG002|Overall Study|Move away from the study area|0|||
129455479|NCT00825162|465964606|FG000|Overall Study|Unable to attend the study visit|5|||
129455480|NCT00825162|465964607|FG001|Overall Study|Unable to attend the study visit|2|||
129455481|NCT00825162|465964608|FG002|Overall Study|Unable to attend the study visit|0|||
129455482|NCT00964743|465964612|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
129455483|NCT00781911|465964613|FG000|Overall Study|Adverse Event|4|||
129455484|NCT00781911|465964614|FG001|Overall Study|Adverse Event|4|||
129455485|NCT00781911|465964613|FG000|Overall Study|Withdrawal by Subject|1|||
129455486|NCT00781911|465964614|FG001|Overall Study|Withdrawal by Subject|2|||
129455487|NCT00781911|465964613|FG000|Overall Study|Physician Decision|0|||
129455488|NCT00781911|465964614|FG001|Overall Study|Physician Decision|2|||
129455489|NCT00781911|465964613|FG000|Overall Study|Sponsor Decision|1|||
129455490|NCT00781911|465964614|FG001|Overall Study|Sponsor Decision|0|||
129455491|NCT03317795|465964617|FG000|Overall Study|IUD Expulsion|1|||
129455492|NCT03317795|465964618|FG001|Overall Study|IUD Expulsion|0|||
129455493|NCT03317795|465964617|FG000|Overall Study|Lost to Follow-up|1|||
129455494|NCT03317795|465964618|FG001|Overall Study|Lost to Follow-up|3|||
129455495|NCT03317795|465964617|FG000|Overall Study|Treatment change|0|||
129455496|NCT03317795|465964618|FG001|Overall Study|Treatment change|3|||
129455497|NCT03317795|465964617|FG000|Overall Study|Intolerance of medication|0|||
129455498|NCT03317795|465964618|FG001|Overall Study|Intolerance of medication|1|||
129455499|NCT01549002|465964619|FG000|Overall Study|Excessive pain|0|||
129455500|NCT01549002|465964620|FG001|Overall Study|Excessive pain|2|||
129455501|NCT01549002|465964619|FG000|Overall Study|Moderate sedation required|0|||
129455502|NCT01549002|465964620|FG001|Overall Study|Moderate sedation required|2|||
129455503|NCT02424253|465964623|FG000|Overall Study|Other, unspecified|1|||
129455504|NCT02424253|465964624|FG001|Overall Study|Other, unspecified|0|||
129455505|NCT02424253|465964623|FG000|Overall Study|Compliance problems|1|||
129455506|NCT02424253|465964624|FG001|Overall Study|Compliance problems|0|||
129965456|NCT04702893|467839012|FG000|Overall Study|Death|10|||
129965457|NCT04702893|467839012|FG000|Overall Study|Not treated|6|||
129965458|NCT00408928|467839013|FG000|Overall Study|Withdrawal by Subject|1|||
129965459|NCT00408928|467839013|FG000|Overall Study|Death|1|||
129965460|NCT00408928|467839013|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
129965461|NCT04469465|467839014|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
129455507|NCT02424253|465964623|FG000|Overall Study|Physician Decision|2|||
129965462|NCT04469465|467839015|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
129965463|NCT04469465|467839014|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
129965464|NCT04469465|467839015|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
129965465|NCT04469465|467839014|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
129965466|NCT04469465|467839015|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
129965467|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
129965468|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
129965469|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
129965470|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
129965471|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
129965472|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
129965473|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Death|0|||
129965474|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Death|1|||
129965475|NCT04469465|467839014|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
129965476|NCT04469465|467839015|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
129965477|NCT03194867|467839016|FG000|Overall Study|Incorrect completion of end of study form|0|||
129965478|NCT03194867|467839017|FG001|Overall Study|Incorrect completion of end of study form|0|||
129965479|NCT03194867|467839018|FG002|Overall Study|Incorrect completion of end of study form|1|||
129965480|NCT03194867|467839019|FG003|Overall Study|Incorrect completion of end of study form|0|||
129965481|NCT03305809|467839020|FG000|Overall Study|Adverse Event|2|||
129965482|NCT03305809|467839021|FG001|Overall Study|Adverse Event|2|||
129965483|NCT03305809|467839022|FG002|Overall Study|Adverse Event|6|||
129965484|NCT03305809|467839023|FG003|Overall Study|Adverse Event|6|||
129965485|NCT03305809|467839020|FG000|Overall Study|Death|0|||
129965486|NCT03305809|467839021|FG001|Overall Study|Death|0|||
129965487|NCT03305809|467839022|FG002|Overall Study|Death|1|||
129965488|NCT03305809|467839023|FG003|Overall Study|Death|1|||
129965489|NCT03305809|467839020|FG000|Overall Study|Lost to Follow-up|1|||
129965490|NCT03305809|467839021|FG001|Overall Study|Lost to Follow-up|2|||
129965491|NCT03305809|467839022|FG002|Overall Study|Lost to Follow-up|0|||
129965492|NCT03305809|467839023|FG003|Overall Study|Lost to Follow-up|0|||
129965493|NCT03305809|467839020|FG000|Overall Study|Sponsor Decision|1|||
129965494|NCT03305809|467839021|FG001|Overall Study|Sponsor Decision|0|||
129965495|NCT03305809|467839022|FG002|Overall Study|Sponsor Decision|1|||
129965496|NCT03305809|467839023|FG003|Overall Study|Sponsor Decision|8|||
129965497|NCT03305809|467839020|FG000|Overall Study|Physician Decision|0|||
129965498|NCT03305809|467839021|FG001|Overall Study|Physician Decision|0|||
129965499|NCT03305809|467839022|FG002|Overall Study|Physician Decision|2|||
129965500|NCT03305809|467839023|FG003|Overall Study|Physician Decision|4|||
129965501|NCT03305809|467839020|FG000|Overall Study|Progressive Disease|0|||
129965502|NCT03305809|467839021|FG001|Overall Study|Progressive Disease|0|||
129965503|NCT03305809|467839022|FG002|Overall Study|Progressive Disease|1|||
129965504|NCT03305809|467839023|FG003|Overall Study|Progressive Disease|0|||
129965505|NCT03305809|467839020|FG000|Overall Study|Protocol Violation|1|||
129965506|NCT03305809|467839021|FG001|Overall Study|Protocol Violation|0|||
129965507|NCT03305809|467839022|FG002|Overall Study|Protocol Violation|2|||
129965508|NCT03305809|467839023|FG003|Overall Study|Protocol Violation|3|||
129965509|NCT03305809|467839020|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
129965510|NCT03305809|467839021|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
129965511|NCT03305809|467839022|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
129965512|NCT03305809|467839023|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
129965513|NCT03305809|467839020|FG000|Overall Study|Withdrawal by Subject|2|||
129455508|NCT02424253|465964624|FG001|Overall Study|Physician Decision|0|||
129455509|NCT02424253|465964623|FG000|Overall Study|Lack of Efficacy|0|||
129455510|NCT02424253|465964624|FG001|Overall Study|Lack of Efficacy|7|||
129455511|NCT02424253|465964623|FG000|Overall Study|Adverse Event|2|||
129455512|NCT02424253|465964624|FG001|Overall Study|Adverse Event|0|||
129455513|NCT02424253|465964623|FG000|Overall Study|Consent withdrawn by subject|4|||
129455514|NCT02424253|465964624|FG001|Overall Study|Consent withdrawn by subject|1|||
129455515|NCT02424253|465964623|FG000|Overall Study|Lost to Follow-up|1|||
129455516|NCT02424253|465964624|FG001|Overall Study|Lost to Follow-up|1|||
129455517|NCT02290873|465964627|FG000|Overall Study|Withdrawal by Subject|0|||
129455518|NCT02290873|465964628|FG001|Overall Study|Withdrawal by Subject|1|||
129455519|NCT02290873|465964629|FG002|Overall Study|Withdrawal by Subject|1|||
129965514|NCT03305809|467839021|FG001|Overall Study|Withdrawal by Subject|4|||
129965515|NCT03305809|467839022|FG002|Overall Study|Withdrawal by Subject|5|||
129965516|NCT03305809|467839023|FG003|Overall Study|Withdrawal by Subject|2|||
129965517|NCT03305809|467839020|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
129965518|NCT03305809|467839021|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
129965519|NCT03305809|467839022|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
129965520|NCT03305809|467839023|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
129965521|NCT00816556|467839024|FG000|Overall Study|Adverse Event|1|||
129965522|NCT00816556|467839025|FG001|Overall Study|Adverse Event|1|||
129965523|NCT00816556|467839026|FG002|Overall Study|Adverse Event|1|||
129965524|NCT00816556|467839024|FG000|Overall Study|Withdrawal by Subject|1|||
129965525|NCT00816556|467839025|FG001|Overall Study|Withdrawal by Subject|1|||
129965526|NCT00816556|467839026|FG002|Overall Study|Withdrawal by Subject|1|||
129965527|NCT00816556|467839024|FG000|Overall Study|Lost to Follow-up|0|||
129965528|NCT00816556|467839025|FG001|Overall Study|Lost to Follow-up|0|||
129965529|NCT00816556|467839026|FG002|Overall Study|Lost to Follow-up|1|||
129965530|NCT03546816|467839027|FG000|Overall Study|Adverse Event|5|||
129965531|NCT03546816|467839028|FG001|Overall Study|Adverse Event|3|||
129965532|NCT03546816|467839027|FG000|Overall Study|Lack of Efficacy|2|||
129965533|NCT03546816|467839028|FG001|Overall Study|Lack of Efficacy|4|||
129965534|NCT03546816|467839027|FG000|Overall Study|Pregnancy|1|||
129965535|NCT03546816|467839028|FG001|Overall Study|Pregnancy|0|||
129965536|NCT03546816|467839027|FG000|Overall Study|Physician Decision|2|||
129965537|NCT03546816|467839028|FG001|Overall Study|Physician Decision|0|||
129965538|NCT03546816|467839027|FG000|Overall Study|Withdrawal by Subject|8|||
129965539|NCT03546816|467839028|FG001|Overall Study|Withdrawal by Subject|10|||
129965540|NCT03546816|467839027|FG000|Overall Study|Lost to Follow-up|3|||
129965541|NCT03546816|467839028|FG001|Overall Study|Lost to Follow-up|2|||
129965542|NCT02438371|467839029|FG000|Overall Study|Lost to Follow-up|3|||
129965543|NCT02438371|467839030|FG001|Overall Study|Lost to Follow-up|2|||
129965544|NCT02438371|467839029|FG000|Overall Study|Withdrawal by Subject|1|||
129965545|NCT02438371|467839030|FG001|Overall Study|Withdrawal by Subject|1|||
129965546|NCT01161446|467839031|FG000|Overall Study|Lost to Follow-up|18|||
129965547|NCT01161446|467839032|FG001|Overall Study|Lost to Follow-up|14|||
129965548|NCT01161446|467839031|FG000|Overall Study|Withdrawal by Subject|0|||
129965549|NCT01161446|467839032|FG001|Overall Study|Withdrawal by Subject|1|||
129965550|NCT01660256|467839035|FG000|Overall Study|Adverse Event|4|||
129965551|NCT01660256|467839036|FG001|Overall Study|Adverse Event|0|||
129965552|NCT01660256|467839037|FG002|Overall Study|Adverse Event|2|||
129965553|NCT01660256|467839035|FG000|Overall Study|Withdrawal by Subject|1|||
129965554|NCT01660256|467839036|FG001|Overall Study|Withdrawal by Subject|0|||
129965555|NCT01660256|467839037|FG002|Overall Study|Withdrawal by Subject|2|||
129965556|NCT01162135|467839039|FG000|Overall Study|Withdrawal by Subject|1|||
129965557|NCT01162135|467839039|FG000|Overall Study|Severe back pain|1|||
129965558|NCT01162135|467839039|FG000|Overall Study|Ineligible|1|||
129965559|NCT02088554|467839040|FG000|Overall Study|Exited before procedure|130|||
129965560|NCT02088554|467839040|FG000|Overall Study|Attempted but not implanted|31|||
129965561|NCT02088554|467839040|FG000|Overall Study|Implant not attempted|19|||
129965562|NCT02088554|467839040|FG000|Overall Study|Pending next visit|532|||
129965563|NCT02088554|467839040|FG000|Overall Study|Death|170|||
129965564|NCT02088554|467839040|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
129965565|NCT02088554|467839040|FG000|Overall Study|Lost to Follow-up|23|||
129965566|NCT02088554|467839040|FG000|Overall Study|Explanted|32|||
129965567|NCT02088554|467839040|FG000|Overall Study|Any other reason not covered by previous categories|11|||
129965568|NCT00551135|467839041|FG000|Overall Study|Adverse Event|1|||
129965569|NCT00551135|467839042|FG001|Overall Study|Adverse Event|0|||
129965570|NCT00551135|467839043|FG002|Overall Study|Adverse Event|1|||
129965571|NCT00551135|467839044|FG003|Overall Study|Adverse Event|1|||
129965572|NCT00551135|467839041|FG000|Overall Study|Lost to Follow-up|0|||
129965573|NCT00551135|467839042|FG001|Overall Study|Lost to Follow-up|0|||
129965574|NCT00551135|467839043|FG002|Overall Study|Lost to Follow-up|0|||
129965575|NCT00551135|467839044|FG003|Overall Study|Lost to Follow-up|1|||
129965576|NCT00551135|467839041|FG000|Overall Study|Other|3|||
129965577|NCT00551135|467839042|FG001|Overall Study|Other|2|||
129965578|NCT00551135|467839043|FG002|Overall Study|Other|1|||
129965579|NCT00551135|467839044|FG003|Overall Study|Other|2|||
129965580|NCT00551135|467839041|FG000|Overall Study|Withdrawal by Subject|1|||
129965581|NCT00551135|467839042|FG001|Overall Study|Withdrawal by Subject|0|||
129965582|NCT00551135|467839043|FG002|Overall Study|Withdrawal by Subject|3|||
129965583|NCT00551135|467839044|FG003|Overall Study|Withdrawal by Subject|1|||
129965584|NCT00858247|467839045|FG000|Baseline Assessment|Withdrawal by Subject|1|||
129965585|NCT00858247|467839046|FG001|Baseline Assessment|Withdrawal by Subject|1|||
129965586|NCT00858247|467839045|FG000|Baseline Assessment|Poor IV access|1|||
129965587|NCT00858247|467839046|FG001|Baseline Assessment|Poor IV access|0|||
129965588|NCT00858247|467839045|FG000|Baseline Assessment|Protocol Violation|0|||
129965589|NCT00858247|467839046|FG001|Baseline Assessment|Protocol Violation|1|||
129965590|NCT00858247|467839045|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
129965591|NCT00858247|467839046|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
129965592|NCT03898960|467839049|FG000|Overall Study|Death|10|||
129965593|NCT00548847|467839050|FG000|Overall Study|Disease progression|7|||
129965594|NCT01379703|467839051|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
129965595|NCT01379703|467839052|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
129965596|NCT01379703|467839053|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
129965597|NCT01379703|467839051|FG000|Study Start Through 9 Months|Adverse Event|0|||
129965598|NCT01379703|467839052|FG001|Study Start Through 9 Months|Adverse Event|14|||
129965599|NCT01379703|467839053|FG002|Study Start Through 9 Months|Adverse Event|10|||
129965600|NCT01379703|467839051|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
129965601|NCT01379703|467839052|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
129455520|NCT02290873|465964627|FG000|Overall Study|Nellcor device error|1|||
129455521|NCT02290873|465964628|FG001|Overall Study|Nellcor device error|0|||
129455522|NCT02290873|465964629|FG002|Overall Study|Nellcor device error|0|||
129455523|NCT02290873|465964627|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
129455524|NCT02290873|465964628|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
129455525|NCT02290873|465964629|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
129455526|NCT02290873|465964627|FG000|Overall Study|Protocol Violation|0|||
129455527|NCT02290873|465964628|FG001|Overall Study|Protocol Violation|0|||
129455528|NCT02290873|465964629|FG002|Overall Study|Protocol Violation|1|||
129455529|NCT01378104|465964630|FG000|Overall Study|Adverse Event|8|||
129455530|NCT01378104|465964631|FG001|Overall Study|Adverse Event|8|||
129455531|NCT01378104|465964630|FG000|Overall Study|Lack of Efficacy|7|||
129455532|NCT01378104|465964631|FG001|Overall Study|Lack of Efficacy|5|||
129455533|NCT01378104|465964630|FG000|Overall Study|Withdrawal by Subject|12|||
129455534|NCT01378104|465964631|FG001|Overall Study|Withdrawal by Subject|13|||
129455535|NCT03610724|465964632|FG000|Overall Study|Death|17|||
129455536|NCT03610724|465964632|FG000|Overall Study|Lost to Follow-up|1|||
129455537|NCT03610724|465964632|FG000|Overall Study|Physician Decision|1|||
129455538|NCT03610724|465964632|FG000|Overall Study|Died prior to infusion|1|||
129455539|NCT01473563|465964633|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
129455540|NCT01519765|465964634|FG000|Overall Study|Adverse Event|0|||
129965602|NCT01379703|467839053|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
129965603|NCT01379703|467839051|FG000|Study Start Through 9 Months|Treatment Failure|0|||
129965604|NCT01379703|467839052|FG001|Study Start Through 9 Months|Treatment Failure|2|||
129965605|NCT01379703|467839053|FG002|Study Start Through 9 Months|Treatment Failure|2|||
129965606|NCT01379703|467839051|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
129965607|NCT01379703|467839052|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
129965608|NCT01379703|467839053|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
129965609|NCT01379703|467839051|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
129965610|NCT01379703|467839052|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
129965611|NCT01379703|467839053|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
129965612|NCT01379703|467839051|FG000|Study Start Through 9 Months|Medication not available|0|||
129965613|NCT01379703|467839052|FG001|Study Start Through 9 Months|Medication not available|2|||
129965614|NCT01379703|467839053|FG002|Study Start Through 9 Months|Medication not available|1|||
129965615|NCT01379703|467839051|FG000|Study Start Through 9 Months|Poor general condition|0|||
129965616|NCT01379703|467839052|FG001|Study Start Through 9 Months|Poor general condition|1|||
129965617|NCT01379703|467839053|FG002|Study Start Through 9 Months|Poor general condition|0|||
129965618|NCT01379703|467839051|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
129965619|NCT01379703|467839052|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
129965620|NCT01379703|467839053|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
129965621|NCT01379703|467839051|FG000|Study Start Through 9 Months|Reason unknown|2|||
129965622|NCT01379703|467839052|FG001|Study Start Through 9 Months|Reason unknown|31|||
129965623|NCT01379703|467839053|FG002|Study Start Through 9 Months|Reason unknown|24|||
129965624|NCT01379703|467839051|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
129965625|NCT01379703|467839052|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
129965626|NCT01379703|467839053|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
129965627|NCT01379703|467839051|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
129965628|NCT01379703|467839052|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
129965629|NCT01379703|467839053|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
129965630|NCT01379703|467839051|FG000|9 Months Through 18 Months|Adverse Event|0|||
129965631|NCT01379703|467839052|FG001|9 Months Through 18 Months|Adverse Event|6|||
129965632|NCT01379703|467839053|FG002|9 Months Through 18 Months|Adverse Event|0|||
129965633|NCT01379703|467839051|FG000|9 Months Through 18 Months|Treatment failure|0|||
129965634|NCT01379703|467839052|FG001|9 Months Through 18 Months|Treatment failure|5|||
129965635|NCT01379703|467839053|FG002|9 Months Through 18 Months|Treatment failure|0|||
129965636|NCT01379703|467839051|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
129965637|NCT01379703|467839052|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
129965638|NCT01379703|467839053|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
129965639|NCT01379703|467839051|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
129455541|NCT01519765|465964635|FG001|Overall Study|Adverse Event|1|||
129455542|NCT01519765|465964634|FG000|Overall Study|Lack of Efficacy|2|||
129455543|NCT01519765|465964635|FG001|Overall Study|Lack of Efficacy|0|||
129455544|NCT01519765|465964634|FG000|Overall Study|Protocol Violation|1|||
129455545|NCT01519765|465964635|FG001|Overall Study|Protocol Violation|0|||
129455546|NCT01519765|465964634|FG000|Overall Study|Withdrawal by Subject|0|||
129455547|NCT01519765|465964635|FG001|Overall Study|Withdrawal by Subject|1|||
129965640|NCT01379703|467839052|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
129965641|NCT01379703|467839053|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
129965642|NCT01379703|467839051|FG000|9 Months Through 18 Months|Fatigue|0|||
129965643|NCT01379703|467839052|FG001|9 Months Through 18 Months|Fatigue|1|||
129965644|NCT01379703|467839053|FG002|9 Months Through 18 Months|Fatigue|0|||
129965645|NCT01379703|467839051|FG000|9 Months Through 18 Months|Reason Unknown|0|||
129965646|NCT01379703|467839052|FG001|9 Months Through 18 Months|Reason Unknown|23|||
129965647|NCT01379703|467839053|FG002|9 Months Through 18 Months|Reason Unknown|0|||
129965648|NCT01316887|467839054|FG000|Overall Study|Adverse Event|13|||
129455548|NCT02354222|465964636|FG000|Overall Study|Adverse Event|0|||
129455549|NCT02354222|465964637|FG001|Overall Study|Adverse Event|3|||
129455550|NCT02354222|465964636|FG000|Overall Study|Physician Decision|1|||
129455551|NCT02354222|465964637|FG001|Overall Study|Physician Decision|1|||
129455552|NCT02354222|465964636|FG000|Overall Study|Pregnancy|1|||
129455553|NCT02354222|465964637|FG001|Overall Study|Pregnancy|0|||
129455554|NCT02354222|465964636|FG000|Overall Study|Withdrawal by Subject|2|||
129455555|NCT02354222|465964637|FG001|Overall Study|Withdrawal by Subject|3|||
129455556|NCT02354222|465964636|FG000|Overall Study|Conflict with the stopping criteria|0|||
129455557|NCT02354222|465964637|FG001|Overall Study|Conflict with the stopping criteria|4|||
129455558|NCT00786565|465964638|FG000|Enrollment Prior to Surgery|Site Closed|3|||
129455559|NCT00786565|465964638|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
129455560|NCT00786565|465964638|FG000|Post Surgery|Abnormal macular pucker|1|||
129455561|NCT00786565|465964638|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
129455562|NCT05248295|465964649|FG000|Overall Study|found ineligible|4|||
129455563|NCT05248295|465964650|FG001|Overall Study|found ineligible|1|||
129455564|NCT05248295|465964649|FG000|Overall Study|Withdrawal by Subject|0|||
129455565|NCT05248295|465964650|FG001|Overall Study|Withdrawal by Subject|1|||
129455566|NCT05248295|465964649|FG000|Overall Study|Data loss: audio recording error|1|||
129455567|NCT05248295|465964650|FG001|Overall Study|Data loss: audio recording error|1|||
129455568|NCT03021499|465964653|FG000|Overall Study|Adverse Event|1|||
129455569|NCT03021499|465964654|FG001|Overall Study|Adverse Event|0|||
129455570|NCT03021499|465964653|FG000|Overall Study|Death|1|||
129455571|NCT03021499|465964654|FG001|Overall Study|Death|5|||
129455572|NCT03021499|465964653|FG000|Overall Study|Lack of Efficacy|0|||
129455573|NCT03021499|465964654|FG001|Overall Study|Lack of Efficacy|1|||
129455574|NCT03021499|465964653|FG000|Overall Study|Lost to Follow-up|1|||
129455575|NCT03021499|465964654|FG001|Overall Study|Lost to Follow-up|3|||
129455576|NCT03021499|465964653|FG000|Overall Study|Physician Decision|2|||
129455577|NCT03021499|465964654|FG001|Overall Study|Physician Decision|3|||
129455578|NCT03021499|465964653|FG000|Overall Study|Pregnancy|1|||
129455579|NCT03021499|465964654|FG001|Overall Study|Pregnancy|0|||
129455580|NCT03021499|465964653|FG000|Overall Study|Withdrawal by Subject|7|||
129455581|NCT03021499|465964654|FG001|Overall Study|Withdrawal by Subject|14|||
129455582|NCT03021499|465964653|FG000|Overall Study|Prohibited medication required|1|||
129455583|NCT03021499|465964654|FG001|Overall Study|Prohibited medication required|0|||
129455584|NCT03021499|465964653|FG000|Overall Study|Protocol non-compliance|1|||
129455585|NCT03021499|465964654|FG001|Overall Study|Protocol non-compliance|1|||
129455586|NCT03021499|465964653|FG000|Overall Study|None of the above|0|||
129455587|NCT03021499|465964654|FG001|Overall Study|None of the above|4|||
129455588|NCT03021499|465964653|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
129455589|NCT03021499|465964654|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
129455590|NCT01210690|465964655|FG000|Overall Study|Adverse Event|7|||
129455591|NCT01210690|465964655|FG000|Overall Study|Lack of Efficacy|12|||
129455592|NCT01210690|465964655|FG000|Overall Study|Lost to Follow-up|3|||
129455593|NCT01210690|465964655|FG000|Overall Study|Disease Remission|1|||
129455594|NCT01210690|465964655|FG000|Overall Study|Withdrawal by Subject|1|||
129455595|NCT01210690|465964655|FG000|Overall Study|Patient refused to swallow|1|||
129455596|NCT01210690|465964655|FG000|Overall Study|Patient could not take glucose|1|||
129965649|NCT01316887|467839055|FG001|Overall Study|Adverse Event|21|||
129965650|NCT01316887|467839056|FG002|Overall Study|Adverse Event|17|||
129965651|NCT01316887|467839054|FG000|Overall Study|Lack of Efficacy|9|||
129965652|NCT01316887|467839055|FG001|Overall Study|Lack of Efficacy|3|||
129965653|NCT01316887|467839056|FG002|Overall Study|Lack of Efficacy|1|||
129965654|NCT01316887|467839054|FG000|Overall Study|Protocol Violation|2|||
129965655|NCT01316887|467839055|FG001|Overall Study|Protocol Violation|6|||
129965656|NCT01316887|467839056|FG002|Overall Study|Protocol Violation|6|||
129965657|NCT01316887|467839054|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
129965658|NCT01316887|467839055|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
129965659|NCT01316887|467839056|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
129965660|NCT01316887|467839054|FG000|Overall Study|Study Closed/Terminated|2|||
129455597|NCT00470054|465964656|FG000|Overall Study|Ineligible|1|||
129455598|NCT04869345|465964663|FG000|Overall Study|Lost to Follow-up|8|||
129455599|NCT04869345|465964664|FG001|Overall Study|Lost to Follow-up|3|||
129455600|NCT00528021|465964668|FG000|Overall Study|Lack of Efficacy|17|||
129455601|NCT00528021|465964669|FG001|Overall Study|Lack of Efficacy|13|||
129455602|NCT00528021|465964670|FG002|Overall Study|Lack of Efficacy|7|||
129455603|NCT00528021|465964671|FG003|Overall Study|Lack of Efficacy|9|||
129455604|NCT04050982|465964672|FG000|Overall Study|Did not meet eligibility criteria|0|||
129455605|NCT04050982|465964673|FG001|Overall Study|Did not meet eligibility criteria|1|||
129455606|NCT04050982|465964674|FG002|Overall Study|Did not meet eligibility criteria|0|||
129455607|NCT04050982|465964672|FG000|Overall Study|Withdrawal by Subject|1|||
129455608|NCT04050982|465964673|FG001|Overall Study|Withdrawal by Subject|0|||
129965661|NCT01316887|467839055|FG001|Overall Study|Study Closed/Terminated|4|||
129965662|NCT01316887|467839056|FG002|Overall Study|Study Closed/Terminated|3|||
129965663|NCT01316887|467839054|FG000|Overall Study|Lost to Follow-up|1|||
129965664|NCT01316887|467839055|FG001|Overall Study|Lost to Follow-up|7|||
129965665|NCT01316887|467839056|FG002|Overall Study|Lost to Follow-up|5|||
129965666|NCT01316887|467839054|FG000|Overall Study|Withdrawal by Subject|8|||
129965667|NCT01316887|467839055|FG001|Overall Study|Withdrawal by Subject|16|||
129965668|NCT01316887|467839056|FG002|Overall Study|Withdrawal by Subject|15|||
129965669|NCT00813098|467839059|FG000|Overall Study|Adverse Event|2|||
129965670|NCT00813098|467839060|FG001|Overall Study|Adverse Event|4|||
129965671|NCT00813098|467839061|FG002|Overall Study|Adverse Event|1|||
129965672|NCT00813098|467839059|FG000|Overall Study|Withdrawal by Subject|0|||
129965673|NCT00813098|467839060|FG001|Overall Study|Withdrawal by Subject|1|||
129965674|NCT00813098|467839061|FG002|Overall Study|Withdrawal by Subject|0|||
129965675|NCT00813098|467839059|FG000|Overall Study|Inability to complete study procedures|1|||
129965676|NCT00813098|467839060|FG001|Overall Study|Inability to complete study procedures|0|||
129965677|NCT00813098|467839061|FG002|Overall Study|Inability to complete study procedures|0|||
129965678|NCT00813098|467839059|FG000|Overall Study|Lost to Follow-up|0|||
129965679|NCT00813098|467839060|FG001|Overall Study|Lost to Follow-up|1|||
129965680|NCT00813098|467839061|FG002|Overall Study|Lost to Follow-up|0|||
129965681|NCT00813098|467839059|FG000|Overall Study|Protocol Violation|0|||
129965682|NCT00813098|467839060|FG001|Overall Study|Protocol Violation|0|||
129965683|NCT00813098|467839061|FG002|Overall Study|Protocol Violation|1|||
129965684|NCT00813098|467839059|FG000|Overall Study|Principal Investigator decision|0|||
129965685|NCT00813098|467839060|FG001|Overall Study|Principal Investigator decision|1|||
129965686|NCT00813098|467839061|FG002|Overall Study|Principal Investigator decision|0|||
129965687|NCT00813098|467839059|FG000|Overall Study|Withdrew Consent|0|||
129965688|NCT00813098|467839060|FG001|Overall Study|Withdrew Consent|1|||
129965689|NCT00813098|467839061|FG002|Overall Study|Withdrew Consent|0|||
129965690|NCT03470545|467839064|FG000|Overall Study|Death|0|||
129965691|NCT03470545|467839065|FG001|Overall Study|Death|1|||
129965692|NCT03470545|467839064|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
129965693|NCT03470545|467839065|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
129965694|NCT03470545|467839064|FG000|Overall Study|Adverse Event|2|||
129965695|NCT03470545|467839065|FG001|Overall Study|Adverse Event|0|||
129965696|NCT03470545|467839064|FG000|Overall Study|Withdrawal by Subject|1|||
129965697|NCT03470545|467839065|FG001|Overall Study|Withdrawal by Subject|1|||
129965698|NCT03470545|467839064|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
129965699|NCT03470545|467839065|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
129965700|NCT00585975|467839066|FG000|Overall Study|Withdrawal by Subject|3|||
129965701|NCT00585975|467839067|FG001|Overall Study|Withdrawal by Subject|3|||
129965702|NCT00585975|467839066|FG000|Overall Study|Lost to Follow-up|2|||
129965703|NCT00585975|467839067|FG001|Overall Study|Lost to Follow-up|1|||
129965704|NCT00585975|467839066|FG000|Overall Study|Enrollment met/over-enrolled|10|||
129965705|NCT00585975|467839067|FG001|Overall Study|Enrollment met/over-enrolled|9|||
129965706|NCT01772563|467839068|FG000|Cycle 1|Dose limiting toxicity|2|||
129965707|NCT01772563|467839068|FG000|Cycle 1|Progressive disease|2|||
129965708|NCT01772563|467839068|FG000|Cycle 2 and Beyond|Progressive disease|17|||
129965709|NCT01772563|467839068|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
129965710|NCT01772563|467839068|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
129965711|NCT01192776|467839069|FG000|Overall Study|Death|8|||
129965712|NCT01192776|467839070|FG001|Overall Study|Death|15|||
129965713|NCT01192776|467839071|FG002|Overall Study|Death|18|||
129965714|NCT01192776|467839072|FG003|Overall Study|Death|15|||
129965715|NCT01192776|467839069|FG000|Overall Study|Lost to Follow-up|3|||
129965716|NCT01192776|467839070|FG001|Overall Study|Lost to Follow-up|6|||
129965717|NCT01192776|467839071|FG002|Overall Study|Lost to Follow-up|3|||
129455609|NCT04050982|465964674|FG002|Overall Study|Withdrawal by Subject|0|||
129455610|NCT04050982|465964672|FG000|Overall Study|Unable to enroll on platform|1|||
129455611|NCT04050982|465964673|FG001|Overall Study|Unable to enroll on platform|0|||
129455612|NCT04050982|465964674|FG002|Overall Study|Unable to enroll on platform|0|||
129455613|NCT05054114|465964675|FG000|Overall Study|Protocol Violation|13|||
129455614|NCT05054114|465964676|FG001|Overall Study|Protocol Violation|1|||
129455615|NCT05054114|465964675|FG000|Overall Study|Pregnancy|0|||
129965718|NCT01192776|467839072|FG003|Overall Study|Lost to Follow-up|5|||
129965719|NCT01086384|467839075|FG000|2-week Run-in Period|Adverse Event|1|||
129965720|NCT01086384|467839076|FG001|2-week Run-in Period|Adverse Event|0|||
129965721|NCT01086384|467839077|FG002|2-week Run-in Period|Adverse Event|0|||
129965722|NCT01086384|467839075|FG000|2-week Run-in Period|Protocol Violation|1|||
129965723|NCT01086384|467839076|FG001|2-week Run-in Period|Protocol Violation|0|||
129965724|NCT01086384|467839077|FG002|2-week Run-in Period|Protocol Violation|0|||
129965725|NCT01086384|467839075|FG000|2-week Run-in Period|Lost to Follow-up|1|||
129965726|NCT01086384|467839076|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129965727|NCT01086384|467839077|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129965728|NCT01086384|467839075|FG000|2-week Run-in Period|Physician Decision|6|||
129965729|NCT01086384|467839076|FG001|2-week Run-in Period|Physician Decision|0|||
129965730|NCT01086384|467839077|FG002|2-week Run-in Period|Physician Decision|0|||
129965731|NCT01086384|467839075|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
129965732|NCT01086384|467839076|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129965733|NCT01086384|467839077|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129965734|NCT01086384|467839075|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
129965735|NCT01086384|467839076|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
129965736|NCT01086384|467839077|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
129965737|NCT01086384|467839075|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
129965738|NCT01086384|467839076|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
129965739|NCT01086384|467839077|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
129965740|NCT01086384|467839075|FG000|2-week Run-in Period|Randomized in Error|1|||
129965741|NCT01086384|467839076|FG001|2-week Run-in Period|Randomized in Error|0|||
129965742|NCT01086384|467839077|FG002|2-week Run-in Period|Randomized in Error|0|||
129965743|NCT01086384|467839075|FG000|Treatment Period|Withdrawal by Subject|0|||
129965744|NCT01086384|467839076|FG001|Treatment Period|Withdrawal by Subject|53|||
129965745|NCT01086384|467839077|FG002|Treatment Period|Withdrawal by Subject|55|||
129965746|NCT01086384|467839075|FG000|Treatment Period|Protocol Violation|0|||
129965747|NCT01086384|467839076|FG001|Treatment Period|Protocol Violation|26|||
129965748|NCT01086384|467839077|FG002|Treatment Period|Protocol Violation|17|||
129965749|NCT01086384|467839075|FG000|Treatment Period|Lack of Efficacy|0|||
129965750|NCT01086384|467839076|FG001|Treatment Period|Lack of Efficacy|22|||
129965751|NCT01086384|467839077|FG002|Treatment Period|Lack of Efficacy|13|||
129965752|NCT01086384|467839075|FG000|Treatment Period|Adverse Event|0|||
129965753|NCT01086384|467839076|FG001|Treatment Period|Adverse Event|19|||
129965754|NCT01086384|467839077|FG002|Treatment Period|Adverse Event|15|||
129965755|NCT01086384|467839075|FG000|Treatment Period|Lost to Follow-up|0|||
129965756|NCT01086384|467839076|FG001|Treatment Period|Lost to Follow-up|11|||
129965757|NCT01086384|467839077|FG002|Treatment Period|Lost to Follow-up|9|||
129965758|NCT01086384|467839075|FG000|Treatment Period|Physician Decision|0|||
129965759|NCT01086384|467839076|FG001|Treatment Period|Physician Decision|9|||
129965760|NCT01086384|467839077|FG002|Treatment Period|Physician Decision|6|||
129965761|NCT01086384|467839075|FG000|Treatment Period|Study Closed/Terminated|0|||
129965762|NCT01086384|467839076|FG001|Treatment Period|Study Closed/Terminated|7|||
129965763|NCT01086384|467839077|FG002|Treatment Period|Study Closed/Terminated|8|||
129965764|NCT01086384|467839075|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
129965765|NCT01086384|467839076|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
129965766|NCT01086384|467839077|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
129965767|NCT01086384|467839075|FG000|Treatment Period|Received Treatment in Error|0|||
129965768|NCT01086384|467839076|FG001|Treatment Period|Received Treatment in Error|1|||
129965769|NCT01086384|467839077|FG002|Treatment Period|Received Treatment in Error|0|||
129965770|NCT01747837|467839078|FG000|Overall Study|Lost to Follow-up|5|||
129965771|NCT01747837|467839079|FG001|Overall Study|Lost to Follow-up|2|||
129965772|NCT01747837|467839078|FG000|Overall Study|Death|4|||
129965773|NCT01747837|467839079|FG001|Overall Study|Death|4|||
129965774|NCT01253447|467839081|FG000|Overall Study|Adverse Event|2|||
129965775|NCT00817336|467839082|FG000|Overall Study|Withdrawal by Subject|1|||
129965776|NCT00817336|467839083|FG001|Overall Study|Withdrawal by Subject|1|||
129965777|NCT01435798|467839084|FG000|Overall Study|Withdrawal by Subject|1|||
129965778|NCT01121913|467839087|FG000|First Intervention Period|Adverse Event|0|||
129965779|NCT01121913|467839088|FG001|First Intervention Period|Adverse Event|0|||
129965780|NCT01121913|467839089|FG002|First Intervention Period|Adverse Event|1|||
129965781|NCT01121913|467839090|FG003|First Intervention Period|Adverse Event|0|||
129965782|NCT01121913|467839087|FG000|First Washout Period|Withdrawal by Subject|1|||
129965783|NCT01121913|467839088|FG001|First Washout Period|Withdrawal by Subject|0|||
129965784|NCT01121913|467839089|FG002|First Washout Period|Withdrawal by Subject|0|||
129965785|NCT01121913|467839090|FG003|First Washout Period|Withdrawal by Subject|0|||
129965786|NCT01121913|467839087|FG000|Second Intervention Period|Adverse Event|0|||
129965787|NCT01121913|467839088|FG001|Second Intervention Period|Adverse Event|0|||
129965788|NCT01121913|467839089|FG002|Second Intervention Period|Adverse Event|1|||
129965789|NCT01121913|467839090|FG003|Second Intervention Period|Adverse Event|0|||
129965790|NCT01121913|467839087|FG000|Second Washout Period|Withdrawal by Subject|0|||
129965791|NCT01121913|467839088|FG001|Second Washout Period|Withdrawal by Subject|0|||
129965792|NCT01121913|467839089|FG002|Second Washout Period|Withdrawal by Subject|1|||
129965793|NCT01121913|467839090|FG003|Second Washout Period|Withdrawal by Subject|0|||
129965794|NCT01121913|467839087|FG000|Third Washout Period|Adverse Event|1|||
129965795|NCT01121913|467839088|FG001|Third Washout Period|Adverse Event|0|||
129965796|NCT01121913|467839089|FG002|Third Washout Period|Adverse Event|0|||
129965797|NCT01121913|467839090|FG003|Third Washout Period|Adverse Event|0|||
129965798|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965799|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965800|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
129965801|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965802|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965803|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965804|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
129965805|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
129965806|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
129455616|NCT05054114|465964676|FG001|Overall Study|Pregnancy|1|||
129455617|NCT01423851|465964680|FG000|Whole Study|Disease progression|2|||
129455618|NCT01423851|465964681|FG001|Whole Study|Disease progression|1|||
129455619|NCT01423851|465964682|FG002|Whole Study|Disease progression|1|||
129455620|NCT01423851|465964683|FG003|Whole Study|Disease progression|4|||
129455621|NCT01423851|465964684|FG004|Whole Study|Disease progression|1|||
129455622|NCT01423851|465964685|FG005|Whole Study|Disease progression|3|||
129455623|NCT01423851|465964686|FG006|Whole Study|Disease progression|1|||
129455624|NCT01423851|465964687|FG007|Whole Study|Disease progression|4|||
129455625|NCT01423851|465964688|FG008|Whole Study|Disease progression|0|||
129455626|NCT01423851|465964689|FG009|Whole Study|Disease progression|2|||
129455627|NCT01423851|465964690|FG010|Whole Study|Disease progression|10|||
129455628|NCT01423851|465964680|FG000|Whole Study|Physician Decision|0|||
129455629|NCT01423851|465964681|FG001|Whole Study|Physician Decision|1|||
129455630|NCT01423851|465964682|FG002|Whole Study|Physician Decision|2|||
129455631|NCT01423851|465964683|FG003|Whole Study|Physician Decision|0|||
129455632|NCT01423851|465964684|FG004|Whole Study|Physician Decision|2|||
129455633|NCT01423851|465964685|FG005|Whole Study|Physician Decision|0|||
129455634|NCT01423851|465964686|FG006|Whole Study|Physician Decision|2|||
129455635|NCT01423851|465964687|FG007|Whole Study|Physician Decision|1|||
129455636|NCT01423851|465964688|FG008|Whole Study|Physician Decision|3|||
129455637|NCT01423851|465964689|FG009|Whole Study|Physician Decision|4|||
129455638|NCT01423851|465964690|FG010|Whole Study|Physician Decision|12|||
129455639|NCT01423851|465964680|FG000|Whole Study|Withdrawal by Subject|1|||
129455640|NCT01423851|465964681|FG001|Whole Study|Withdrawal by Subject|1|||
129455641|NCT01423851|465964682|FG002|Whole Study|Withdrawal by Subject|0|||
129455642|NCT01423851|465964683|FG003|Whole Study|Withdrawal by Subject|0|||
129455643|NCT01423851|465964684|FG004|Whole Study|Withdrawal by Subject|0|||
129455644|NCT01423851|465964685|FG005|Whole Study|Withdrawal by Subject|0|||
129455645|NCT01423851|465964686|FG006|Whole Study|Withdrawal by Subject|0|||
129455646|NCT01423851|465964687|FG007|Whole Study|Withdrawal by Subject|0|||
129455647|NCT01423851|465964688|FG008|Whole Study|Withdrawal by Subject|2|||
129455648|NCT01423851|465964689|FG009|Whole Study|Withdrawal by Subject|0|||
129455649|NCT01423851|465964690|FG010|Whole Study|Withdrawal by Subject|4|||
129455650|NCT01423851|465964680|FG000|Whole Study|Adverse Event|0|||
129455651|NCT01423851|465964681|FG001|Whole Study|Adverse Event|0|||
129455652|NCT01423851|465964682|FG002|Whole Study|Adverse Event|0|||
129455653|NCT01423851|465964683|FG003|Whole Study|Adverse Event|2|||
129455654|NCT01423851|465964684|FG004|Whole Study|Adverse Event|0|||
129455655|NCT01423851|465964685|FG005|Whole Study|Adverse Event|0|||
129455656|NCT01423851|465964686|FG006|Whole Study|Adverse Event|0|||
129455657|NCT01423851|465964687|FG007|Whole Study|Adverse Event|3|||
129455658|NCT01423851|465964688|FG008|Whole Study|Adverse Event|3|||
129455659|NCT01423851|465964689|FG009|Whole Study|Adverse Event|2|||
129455660|NCT01423851|465964690|FG010|Whole Study|Adverse Event|3|||
129455661|NCT00980200|465966572|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
129455662|NCT00980200|465966573|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
129455663|NCT00980200|465966574|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
129455664|NCT00980200|465966575|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
129455665|NCT00980200|465966576|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
129455666|NCT00980200|465966572|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
129455667|NCT00980200|465966573|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
129455668|NCT00980200|465966574|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
129455669|NCT00980200|465966575|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
129965807|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
129965808|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
129965809|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
129965810|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
129965811|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
129965812|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
129965813|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
129965814|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965815|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965816|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
129965817|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
129965818|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965819|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965820|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965821|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
129965822|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129455670|NCT00980200|465966576|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
129455671|NCT00457015|465966577|FG000|Overall Study|Left study site against medical advice|0|||
129455672|NCT00457015|465966578|FG001|Overall Study|Left study site against medical advice|1|||
129455673|NCT00747643|465966579|FG000|Overall Study|Withdrawal by Subject|36|||
129455674|NCT00747643|465966580|FG001|Overall Study|Withdrawal by Subject|27|||
129455675|NCT00750698|465966581|FG000|Overall Study|Withdrawal by Subject|1|||
129455676|NCT00750698|465966582|FG001|Overall Study|Withdrawal by Subject|0|||
129455677|NCT00750698|465966581|FG000|Overall Study|Progressive disease|5|||
129455678|NCT00750698|465966582|FG001|Overall Study|Progressive disease|2|||
129455679|NCT02263079|465966583|FG000|Overall Study|Physician Decision|1|||
129455680|NCT02263079|465966584|FG001|Overall Study|Physician Decision|0|||
129455681|NCT02263079|465966585|FG002|Overall Study|Physician Decision|0|||
129455682|NCT02263079|465966583|FG000|Overall Study|Withdrawal by Subject|2|||
129455683|NCT02263079|465966584|FG001|Overall Study|Withdrawal by Subject|8|||
129455684|NCT02263079|465966585|FG002|Overall Study|Withdrawal by Subject|0|||
129455685|NCT00402649|465966586|FG000|Overall Study|Lost to Follow-up|1|||
129455686|NCT00402649|465966586|FG000|Overall Study|Withdrawal by Subject|1|||
129455687|NCT02554019|465966595|FG000|Overall Study|Withdrawal by Subject|1|||
129455688|NCT02554019|465966596|FG001|Overall Study|Withdrawal by Subject|0|||
129455689|NCT02554019|465966597|FG002|Overall Study|Withdrawal by Subject|2|||
129455690|NCT02554019|465966595|FG000|Overall Study|Adverse Event|1|||
129455691|NCT02554019|465966596|FG001|Overall Study|Adverse Event|0|||
129455692|NCT02554019|465966597|FG002|Overall Study|Adverse Event|0|||
129455693|NCT00916357|465966598|FG000|Period 1|Withdrawal by Subject|1|||
129455694|NCT00916357|465966599|FG001|Period 1|Withdrawal by Subject|0|||
129455695|NCT00916357|465966600|FG002|Period 1|Withdrawal by Subject|0|||
129455696|NCT00916357|465966601|FG003|Period 1|Withdrawal by Subject|0|||
129455697|NCT00916357|465966602|FG004|Period 1|Withdrawal by Subject|0|||
129455698|NCT00916357|465966603|FG005|Period 1|Withdrawal by Subject|0|||
129455699|NCT00916357|465966598|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
129455700|NCT00916357|465966599|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
129455701|NCT00916357|465966600|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
129455702|NCT00916357|465966601|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
129965823|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
129965824|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129965825|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129965826|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
129965827|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
129965828|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
129965829|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
129965830|NCT00937521|467839092|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
129965831|NCT00937521|467839093|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965832|NCT00937521|467839094|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965833|NCT00937521|467839095|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965834|NCT00937521|467839096|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965835|NCT00937521|467839097|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965836|NCT00937521|467839098|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
129965837|NCT00937521|467839099|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
129965838|NCT00937521|467839092|FG000|Booster Phase|Adverse Event|0|||
129965839|NCT00937521|467839093|FG001|Booster Phase|Adverse Event|0|||
129965840|NCT00937521|467839094|FG002|Booster Phase|Adverse Event|0|||
129965841|NCT00937521|467839095|FG003|Booster Phase|Adverse Event|0|||
129965842|NCT00937521|467839096|FG004|Booster Phase|Adverse Event|0|||
129965843|NCT00937521|467839097|FG005|Booster Phase|Adverse Event|0|||
129965844|NCT00937521|467839098|FG006|Booster Phase|Adverse Event|1|||
129965845|NCT00937521|467839099|FG007|Booster Phase|Adverse Event|0|||
129965846|NCT00937521|467839092|FG000|Booster Phase|Withdrawal by Subject|1|||
129965847|NCT00937521|467839093|FG001|Booster Phase|Withdrawal by Subject|0|||
129965848|NCT00937521|467839094|FG002|Booster Phase|Withdrawal by Subject|0|||
129965849|NCT00937521|467839095|FG003|Booster Phase|Withdrawal by Subject|1|||
129965850|NCT00937521|467839096|FG004|Booster Phase|Withdrawal by Subject|0|||
129965851|NCT00937521|467839097|FG005|Booster Phase|Withdrawal by Subject|0|||
129965852|NCT00937521|467839098|FG006|Booster Phase|Withdrawal by Subject|0|||
129965853|NCT00937521|467839099|FG007|Booster Phase|Withdrawal by Subject|2|||
129965854|NCT00937521|467839092|FG000|Booster Phase|Lost to Follow-up|2|||
129455703|NCT00916357|465966602|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
129965855|NCT00937521|467839093|FG001|Booster Phase|Lost to Follow-up|2|||
129965856|NCT00937521|467839094|FG002|Booster Phase|Lost to Follow-up|4|||
129965857|NCT00937521|467839095|FG003|Booster Phase|Lost to Follow-up|2|||
129965858|NCT00937521|467839096|FG004|Booster Phase|Lost to Follow-up|4|||
129965859|NCT00937521|467839097|FG005|Booster Phase|Lost to Follow-up|4|||
129965860|NCT00937521|467839098|FG006|Booster Phase|Lost to Follow-up|3|||
129455704|NCT00916357|465966603|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
129455705|NCT01308008|465966604|FG000|4 Weeks|Illness, disinterest, time|9|||
129455706|NCT01308008|465966605|FG001|4 Weeks|Illness, disinterest, time|2|||
129455707|NCT01417195|465966606|FG000|Overall Study|Stimulation failure|1|||
129455708|NCT01417195|465966607|FG001|Overall Study|Stimulation failure|0|||
129455709|NCT01417195|465966606|FG000|Overall Study|No embryos for transfer|0|||
129455710|NCT01417195|465966607|FG001|Overall Study|No embryos for transfer|1|||
129455711|NCT01417195|465966606|FG000|Overall Study|No transfer due to risk of OHSS|1|||
129965861|NCT00937521|467839099|FG007|Booster Phase|Lost to Follow-up|0|||
129965862|NCT00937521|467839092|FG000|Booster Phase|Administrative Reason|0|||
129965863|NCT00937521|467839093|FG001|Booster Phase|Administrative Reason|0|||
129965864|NCT00937521|467839094|FG002|Booster Phase|Administrative Reason|1|||
129965865|NCT00937521|467839095|FG003|Booster Phase|Administrative Reason|0|||
129965866|NCT00937521|467839096|FG004|Booster Phase|Administrative Reason|1|||
129965867|NCT00937521|467839097|FG005|Booster Phase|Administrative Reason|1|||
129965868|NCT00937521|467839098|FG006|Booster Phase|Administrative Reason|0|||
129965869|NCT00937521|467839099|FG007|Booster Phase|Administrative Reason|0|||
129965870|NCT00937521|467839092|FG000|Booster Phase|Protocol Deviation|0|||
129965871|NCT00937521|467839093|FG001|Booster Phase|Protocol Deviation|0|||
129965872|NCT00937521|467839094|FG002|Booster Phase|Protocol Deviation|0|||
129965873|NCT00937521|467839095|FG003|Booster Phase|Protocol Deviation|0|||
129965874|NCT00937521|467839096|FG004|Booster Phase|Protocol Deviation|0|||
129965875|NCT00937521|467839097|FG005|Booster Phase|Protocol Deviation|0|||
129965876|NCT00937521|467839098|FG006|Booster Phase|Protocol Deviation|1|||
129965877|NCT00937521|467839099|FG007|Booster Phase|Protocol Deviation|0|||
129965878|NCT01721746|467839100|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
129965879|NCT01721746|467839101|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
129965880|NCT01721746|467839100|FG000|Pre-Treatment|Withdrawal by Subject|1|||
129965881|NCT01721746|467839101|FG001|Pre-Treatment|Withdrawal by Subject|16|||
129965882|NCT01721746|467839100|FG000|Pre-Treatment|Poor/Non-compliance|1|||
129965883|NCT01721746|467839101|FG001|Pre-Treatment|Poor/Non-compliance|0|||
129965884|NCT01721746|467839100|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
129965885|NCT01721746|467839101|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
129965886|NCT01721746|467839100|FG000|Treatment|Disease Progression|192|||
129965887|NCT01721746|467839101|FG001|Treatment|Disease Progression|74|||
129965888|NCT01721746|467839100|FG000|Treatment|Study Drug Toxicity|19|||
129965889|NCT01721746|467839101|FG001|Treatment|Study Drug Toxicity|11|||
129965890|NCT01721746|467839100|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
129965891|NCT01721746|467839101|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
129965892|NCT01721746|467839100|FG000|Treatment|Participant request to discontinue Study treatment|26|||
129965893|NCT01721746|467839101|FG001|Treatment|Participant request to discontinue Study treatment|7|||
129965894|NCT01721746|467839100|FG000|Treatment|Participant withdrew consent|4|||
129965895|NCT01721746|467839101|FG001|Treatment|Participant withdrew consent|2|||
129965896|NCT01721746|467839100|FG000|Treatment|Maximum Clinical Benefit|9|||
129965897|NCT01721746|467839101|FG001|Treatment|Maximum Clinical Benefit|3|||
129965898|NCT01721746|467839100|FG000|Treatment|Poor/Non-compliance|2|||
129965899|NCT01721746|467839101|FG001|Treatment|Poor/Non-compliance|0|||
129965900|NCT01721746|467839100|FG000|Treatment|Participant no longer met Study criteria|4|||
129965901|NCT01721746|467839101|FG001|Treatment|Participant no longer met Study criteria|0|||
129965902|NCT01721746|467839100|FG000|Treatment|Other reasons|6|||
129965903|NCT01721746|467839101|FG001|Treatment|Other reasons|2|||
129965904|NCT04358068|467839102|FG000|Overall Study|Did not initiate study treatment|2|||
129965905|NCT04358068|467839103|FG001|Overall Study|Did not initiate study treatment|2|||
129965906|NCT02447718|467839104|FG000|Overall Study|Lost to Follow-up|8|||
129965907|NCT02447718|467839105|FG001|Overall Study|Lost to Follow-up|0|||
129965908|NCT02447718|467839104|FG000|Overall Study|Withdrawal by Subject|3|||
129965909|NCT02447718|467839105|FG001|Overall Study|Withdrawal by Subject|0|||
129965910|NCT02447718|467839104|FG000|Overall Study|Screen Failure|1|||
129965911|NCT02447718|467839105|FG001|Overall Study|Screen Failure|0|||
129965912|NCT00239681|467839106|FG000|Overall Study|Adverse Event|100|||
129965913|NCT00239681|467839107|FG001|Overall Study|Adverse Event|99|||
129965914|NCT00239681|467839106|FG000|Overall Study|Withdrawal by Subject|458|||
129965915|NCT00239681|467839107|FG001|Overall Study|Withdrawal by Subject|489|||
129965916|NCT00239681|467839106|FG000|Overall Study|Lost to Follow-up|28|||
129965917|NCT00239681|467839107|FG001|Overall Study|Lost to Follow-up|22|||
129965918|NCT00239681|467839106|FG000|Overall Study|Protocol Violation|4|||
129965919|NCT00239681|467839107|FG001|Overall Study|Protocol Violation|4|||
129965920|NCT00239681|467839106|FG000|Overall Study|Physician Decision|13|||
129965921|NCT00239681|467839107|FG001|Overall Study|Physician Decision|17|||
129965922|NCT00239681|467839106|FG000|Overall Study|No information chacked on CaseReportForm|90|||
129965923|NCT00239681|467839107|FG001|Overall Study|No information chacked on CaseReportForm|84|||
129965924|NCT03599622|467839108|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
129965925|NCT03599622|467839109|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
129965926|NCT03599622|467839110|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
129965927|NCT03599622|467839111|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
129965928|NCT03599622|467839108|FG000|Pre-Treatment Period|Other reasons|1|||
129965929|NCT03599622|467839109|FG001|Pre-Treatment Period|Other reasons|1|||
129965930|NCT03599622|467839110|FG002|Pre-Treatment Period|Other reasons|1|||
129965931|NCT03599622|467839111|FG003|Pre-Treatment Period|Other reasons|0|||
129965932|NCT03599622|467839108|FG000|Treatment Period|Adverse Event|11|||
129965933|NCT03599622|467839109|FG001|Treatment Period|Adverse Event|20|||
129965934|NCT03599622|467839110|FG002|Treatment Period|Adverse Event|18|||
129965935|NCT03599622|467839111|FG003|Treatment Period|Adverse Event|2|||
129965936|NCT03599622|467839108|FG000|Treatment Period|Lack of Efficacy|18|||
129965937|NCT03599622|467839109|FG001|Treatment Period|Lack of Efficacy|12|||
129965938|NCT03599622|467839110|FG002|Treatment Period|Lack of Efficacy|13|||
129965939|NCT03599622|467839111|FG003|Treatment Period|Lack of Efficacy|2|||
129965940|NCT03599622|467839108|FG000|Treatment Period|Withdrawal by Subject|5|||
129965941|NCT03599622|467839109|FG001|Treatment Period|Withdrawal by Subject|11|||
129965942|NCT03599622|467839110|FG002|Treatment Period|Withdrawal by Subject|16|||
129965943|NCT03599622|467839111|FG003|Treatment Period|Withdrawal by Subject|1|||
129965944|NCT03599622|467839108|FG000|Treatment Period|Other reasons|4|||
129965945|NCT03599622|467839109|FG001|Treatment Period|Other reasons|6|||
129965946|NCT03599622|467839110|FG002|Treatment Period|Other reasons|7|||
129965947|NCT03599622|467839111|FG003|Treatment Period|Other reasons|0|||
129965948|NCT03599622|467839108|FG000|Treatment Period|Lost to Follow-up|1|||
129965949|NCT03599622|467839109|FG001|Treatment Period|Lost to Follow-up|0|||
129965950|NCT03599622|467839110|FG002|Treatment Period|Lost to Follow-up|0|||
129965951|NCT03599622|467839111|FG003|Treatment Period|Lost to Follow-up|0|||
129965952|NCT03599622|467839108|FG000|Treatment Period|Study terminated by sponsor|7|||
129965953|NCT03599622|467839109|FG001|Treatment Period|Study terminated by sponsor|20|||
129965954|NCT03599622|467839110|FG002|Treatment Period|Study terminated by sponsor|15|||
129965955|NCT03599622|467839111|FG003|Treatment Period|Study terminated by sponsor|0|||
129965956|NCT03599622|467839108|FG000|Treatment Period|Site terminated by sponsor|0|||
129965957|NCT03599622|467839109|FG001|Treatment Period|Site terminated by sponsor|1|||
129965958|NCT03599622|467839110|FG002|Treatment Period|Site terminated by sponsor|0|||
129965959|NCT03599622|467839111|FG003|Treatment Period|Site terminated by sponsor|0|||
129965960|NCT00770588|467839112|FG000|Overall Study|Adverse Event|9|||
129965961|NCT00770588|467839113|FG001|Overall Study|Adverse Event|2|||
129965962|NCT00770588|467839112|FG000|Overall Study|Death caused by progression of disease|70|||
129965963|NCT00770588|467839113|FG001|Overall Study|Death caused by progression of disease|91|||
129965964|NCT00770588|467839112|FG000|Overall Study|Lost to Follow-up|1|||
129965965|NCT00770588|467839113|FG001|Overall Study|Lost to Follow-up|1|||
129965966|NCT00770588|467839112|FG000|Overall Study|Withdrawal by Subject|1|||
129965967|NCT00770588|467839113|FG001|Overall Study|Withdrawal by Subject|1|||
129965968|NCT01006889|467839114|FG000|Overall Study|Withdrawal by Subject|3|||
129965969|NCT00623363|467839115|FG000|Overall Study|Adverse Event|2|||
129965970|NCT00623363|467839116|FG001|Overall Study|Adverse Event|2|||
129965971|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
129965972|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
129965973|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
129965974|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
129965975|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
129965976|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
129965977|NCT00823836|467839118|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
129965978|NCT00823836|467839119|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
129965979|NCT00823836|467839118|FG000|Long-term Phase|Adverse Event|3|||
129965980|NCT00823836|467839119|FG001|Long-term Phase|Adverse Event|2|||
129965981|NCT00823836|467839118|FG000|Long-term Phase|Physician Decision|1|||
129965982|NCT00823836|467839119|FG001|Long-term Phase|Physician Decision|2|||
129965983|NCT00823836|467839118|FG000|Long-term Phase|Withdrawal by Subject|1|||
129965984|NCT00823836|467839119|FG001|Long-term Phase|Withdrawal by Subject|1|||
129965985|NCT01438840|467839121|FG000|Core Study|Adverse Event|0|||
129965986|NCT01438840|467839122|FG001|Core Study|Adverse Event|3|||
129965987|NCT01438840|467839123|FG002|Core Study|Adverse Event|0|||
129965988|NCT01438840|467839121|FG000|Core Study|Lack of Efficacy|15|||
129965989|NCT01438840|467839122|FG001|Core Study|Lack of Efficacy|7|||
129965990|NCT01438840|467839123|FG002|Core Study|Lack of Efficacy|0|||
129965991|NCT01438840|467839121|FG000|Core Study|Withdrawal of consent|1|||
129965992|NCT01438840|467839122|FG001|Core Study|Withdrawal of consent|0|||
129965993|NCT01438840|467839123|FG002|Core Study|Withdrawal of consent|0|||
129965994|NCT01438840|467839121|FG000|Extension Phase|Adverse Event|0|||
129965995|NCT01438840|467839122|FG001|Extension Phase|Adverse Event|0|||
129455712|NCT01417195|465966607|FG001|Overall Study|No transfer due to risk of OHSS|0|||
129965996|NCT01438840|467839123|FG002|Extension Phase|Adverse Event|3|||
129965997|NCT01438840|467839121|FG000|Extension Phase|Lost to Follow-up|0|||
129965998|NCT01438840|467839122|FG001|Extension Phase|Lost to Follow-up|0|||
129965999|NCT01438840|467839123|FG002|Extension Phase|Lost to Follow-up|1|||
129966000|NCT01438840|467839121|FG000|Extension Phase|Withdrawal by Subject|0|||
129966001|NCT01438840|467839122|FG001|Extension Phase|Withdrawal by Subject|0|||
129966002|NCT01438840|467839123|FG002|Extension Phase|Withdrawal by Subject|3|||
129966003|NCT01438840|467839121|FG000|Extension Phase|Lack of Efficacy|0|||
129966004|NCT01438840|467839122|FG001|Extension Phase|Lack of Efficacy|0|||
129966005|NCT01438840|467839123|FG002|Extension Phase|Lack of Efficacy|2|||
129966006|NCT01438840|467839121|FG000|Extension Phase|Other|0|||
129966007|NCT01438840|467839122|FG001|Extension Phase|Other|0|||
129966008|NCT01438840|467839123|FG002|Extension Phase|Other|1|||
129966009|NCT02062645|467839126|FG000|Overall Study|Adverse Event|2|||
129966010|NCT02062645|467839126|FG000|Overall Study|Protocol Violation|8|||
129966011|NCT02062645|467839126|FG000|Overall Study|Lost to Follow-up|5|||
129966012|NCT00798304|467839127|FG000|Overall Study|Adverse Event|0|||
129966013|NCT00798304|467839128|FG001|Overall Study|Adverse Event|1|||
129966014|NCT00798304|467839129|FG002|Overall Study|Adverse Event|1|||
129966015|NCT00798304|467839127|FG000|Overall Study|Discontinuation by Sponsor|14|||
129966016|NCT00798304|467839128|FG001|Overall Study|Discontinuation by Sponsor|21|||
129966017|NCT00798304|467839129|FG002|Overall Study|Discontinuation by Sponsor|9|||
129966018|NCT01774305|467839130|FG000|Overall Study|Physician Decision|1|||
129966019|NCT01774305|467839131|FG001|Overall Study|Physician Decision|0|||
129966020|NCT01157377|467839135|FG000|Overall Study|Lost to Follow-up|0|||
129966021|NCT01157377|467839136|FG001|Overall Study|Lost to Follow-up|0|||
129966022|NCT01157377|467839137|FG002|Overall Study|Lost to Follow-up|1|||
129966023|NCT01157377|467839138|FG003|Overall Study|Lost to Follow-up|0|||
129966024|NCT01157377|467839139|FG004|Overall Study|Lost to Follow-up|1|||
129966025|NCT01157377|467839140|FG005|Overall Study|Lost to Follow-up|1|||
129966026|NCT01157377|467839141|FG006|Overall Study|Lost to Follow-up|0|||
129966027|NCT01157377|467839135|FG000|Overall Study|Personal Reasons|2|||
129966028|NCT01157377|467839136|FG001|Overall Study|Personal Reasons|1|||
129966029|NCT01157377|467839137|FG002|Overall Study|Personal Reasons|0|||
129966030|NCT01157377|467839138|FG003|Overall Study|Personal Reasons|1|||
129966031|NCT01157377|467839139|FG004|Overall Study|Personal Reasons|0|||
129966032|NCT01157377|467839140|FG005|Overall Study|Personal Reasons|0|||
129966033|NCT01157377|467839141|FG006|Overall Study|Personal Reasons|0|||
129966034|NCT01157377|467839135|FG000|Overall Study|Protocol Violation|0|||
129966035|NCT01157377|467839136|FG001|Overall Study|Protocol Violation|0|||
129966036|NCT01157377|467839137|FG002|Overall Study|Protocol Violation|0|||
129966037|NCT01157377|467839138|FG003|Overall Study|Protocol Violation|0|||
129966038|NCT01157377|467839139|FG004|Overall Study|Protocol Violation|0|||
129966039|NCT01157377|467839140|FG005|Overall Study|Protocol Violation|1|||
129966040|NCT01157377|467839141|FG006|Overall Study|Protocol Violation|0|||
129966041|NCT01157377|467839135|FG000|Overall Study|Lack of Efficacy|0|||
129966042|NCT01157377|467839136|FG001|Overall Study|Lack of Efficacy|0|||
129966043|NCT01157377|467839137|FG002|Overall Study|Lack of Efficacy|0|||
129966044|NCT01157377|467839138|FG003|Overall Study|Lack of Efficacy|0|||
129966045|NCT01157377|467839139|FG004|Overall Study|Lack of Efficacy|0|||
129966046|NCT01157377|467839140|FG005|Overall Study|Lack of Efficacy|0|||
129966047|NCT01157377|467839141|FG006|Overall Study|Lack of Efficacy|1|||
129966048|NCT01157377|467839135|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129966049|NCT01157377|467839136|FG001|Overall Study|Other Miscellaneous Reasons|2|||
129966050|NCT01157377|467839137|FG002|Overall Study|Other Miscellaneous Reasons|0|||
129966051|NCT01157377|467839138|FG003|Overall Study|Other Miscellaneous Reasons|0|||
129966052|NCT01157377|467839139|FG004|Overall Study|Other Miscellaneous Reasons|1|||
129966053|NCT01157377|467839140|FG005|Overall Study|Other Miscellaneous Reasons|1|||
129966054|NCT01157377|467839141|FG006|Overall Study|Other Miscellaneous Reasons|1|||
129966055|NCT02760485|467839144|FG000|Phase 1|Death|3|||
129966056|NCT02760485|467839145|FG001|Phase 1|Death|6|||
129966057|NCT02760485|467839146|FG002|Phase 1|Death|0|||
129966058|NCT02760485|467839144|FG000|Phase 1|Withdrawal by Subject|2|||
129966059|NCT02760485|467839145|FG001|Phase 1|Withdrawal by Subject|0|||
129966060|NCT02760485|467839146|FG002|Phase 1|Withdrawal by Subject|0|||
129966061|NCT02760485|467839144|FG000|Phase 1|Progressive Disease|1|||
129966062|NCT02760485|467839145|FG001|Phase 1|Progressive Disease|0|||
129966063|NCT02760485|467839146|FG002|Phase 1|Progressive Disease|0|||
129966064|NCT02760485|467839144|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
129966065|NCT02760485|467839145|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
129966066|NCT02760485|467839146|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
129966067|NCT02760485|467839144|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
129966068|NCT02760485|467839145|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
129966069|NCT02760485|467839146|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
129966070|NCT02760485|467839144|FG000|Phase 2|Death|0|||
129966071|NCT02760485|467839145|FG001|Phase 2|Death|0|||
129966072|NCT02760485|467839146|FG002|Phase 2|Death|12|||
129966073|NCT02760485|467839144|FG000|Phase 2|Withdrawal by Subject|0|||
129966074|NCT02760485|467839145|FG001|Phase 2|Withdrawal by Subject|0|||
129966075|NCT02760485|467839146|FG002|Phase 2|Withdrawal by Subject|3|||
129966076|NCT02760485|467839144|FG000|Phase 2|Progressive Disease|0|||
129966077|NCT02760485|467839145|FG001|Phase 2|Progressive Disease|0|||
129966078|NCT02760485|467839146|FG002|Phase 2|Progressive Disease|1|||
129966079|NCT02760485|467839144|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
129966080|NCT02760485|467839145|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
129966081|NCT02760485|467839146|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
129966082|NCT02261285|467839147|FG000|Overall Study|Disease progression|0|||
129966083|NCT02261285|467839148|FG001|Overall Study|Disease progression|0|||
129966084|NCT02261285|467839149|FG002|Overall Study|Disease progression|1|||
129966085|NCT01702519|467839150|FG000|Washout Period|Lost to Follow-up|1|||
129966086|NCT01702519|467839151|FG001|Washout Period|Lost to Follow-up|0|||
129966087|NCT01702519|467839150|FG000|Washout Period|Withdrawal by Subject|0|||
129966088|NCT01702519|467839151|FG001|Washout Period|Withdrawal by Subject|2|||
129966089|NCT03738397|467839152|FG000|Overall Study|Adverse Event|3|||
129488461|NCT01277289|466080718|FG001|Overall Study|consent withdrawn|1|||
129966090|NCT03738397|467839153|FG001|Overall Study|Adverse Event|7|||
129966091|NCT03738397|467839152|FG000|Overall Study|Withdrawal by Subject|8|||
129966092|NCT03738397|467839153|FG001|Overall Study|Withdrawal by Subject|11|||
129966093|NCT03738397|467839152|FG000|Overall Study|Lost to Follow-up|7|||
129966094|NCT03738397|467839153|FG001|Overall Study|Lost to Follow-up|5|||
129966095|NCT03738397|467839152|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
129966096|NCT03738397|467839153|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
129966097|NCT03738397|467839152|FG000|Overall Study|Other|4|||
129966098|NCT03738397|467839153|FG001|Overall Study|Other|6|||
129966099|NCT00904722|467839156|FG000|Overall Study|Physician Decision|1|||
129966100|NCT01087814|467839157|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
129966101|NCT01087814|467839158|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
129966102|NCT01087814|467839157|FG000|Second Intervention (5 Days)|Physician Decision|1|||
129966103|NCT01087814|467839158|FG001|Second Intervention (5 Days)|Physician Decision|0|||
129966104|NCT01891890|467839159|FG000|Overall Study|Lost to Follow-up|0|||
129966105|NCT01891890|467839160|FG001|Overall Study|Lost to Follow-up|0|||
129966106|NCT01891890|467839161|FG002|Overall Study|Lost to Follow-up|1|||
129966107|NCT01891890|467839159|FG000|Overall Study|Study ended before endpoint reached|7|||
129966108|NCT01891890|467839160|FG001|Overall Study|Study ended before endpoint reached|3|||
129966109|NCT01891890|467839161|FG002|Overall Study|Study ended before endpoint reached|6|||
129966110|NCT04680637|467839162|FG000|Overall Study|Lost to Follow-up|0|||
129966111|NCT04680637|467839163|FG001|Overall Study|Lost to Follow-up|1|||
129966112|NCT04680637|467839164|FG002|Overall Study|Lost to Follow-up|0|||
129966113|NCT04680637|467839165|FG003|Overall Study|Lost to Follow-up|1|||
129966114|NCT04680637|467839162|FG000|Overall Study|Death|1|||
129966115|NCT04680637|467839163|FG001|Overall Study|Death|0|||
129966116|NCT04680637|467839164|FG002|Overall Study|Death|0|||
129966117|NCT04680637|467839165|FG003|Overall Study|Death|0|||
129966118|NCT04680637|467839162|FG000|Overall Study|Withdrawal by Subject|7|||
129966119|NCT04680637|467839163|FG001|Overall Study|Withdrawal by Subject|10|||
129966120|NCT04680637|467839164|FG002|Overall Study|Withdrawal by Subject|17|||
129966121|NCT04680637|467839165|FG003|Overall Study|Withdrawal by Subject|15|||
129966122|NCT04680637|467839162|FG000|Overall Study|Decision by Sponsor|21|||
129966123|NCT04680637|467839163|FG001|Overall Study|Decision by Sponsor|15|||
129966124|NCT04680637|467839164|FG002|Overall Study|Decision by Sponsor|7|||
129966125|NCT04680637|467839165|FG003|Overall Study|Decision by Sponsor|32|||
129966126|NCT00497874|467841029|FG000|Overall Study|Withdrawal by Subject|48|||
129966127|NCT00497874|467841030|FG001|Overall Study|Withdrawal by Subject|17|||
129966128|NCT00497874|467841029|FG000|Overall Study|Illness|8|||
129966129|NCT00497874|467841030|FG001|Overall Study|Illness|4|||
129966130|NCT00497874|467841029|FG000|Overall Study|Death|2|||
129966131|NCT00497874|467841030|FG001|Overall Study|Death|4|||
129966132|NCT00497874|467841029|FG000|Overall Study|Unable to contact|52|||
129966133|NCT00497874|467841030|FG001|Overall Study|Unable to contact|67|||
129966134|NCT00497874|467841029|FG000|Overall Study|Unable to schedule|37|||
129966135|NCT00497874|467841030|FG001|Overall Study|Unable to schedule|24|||
129966136|NCT01256671|467841034|FG000|Overall Study|Adverse Event|29|||
129966137|NCT01256671|467841034|FG000|Overall Study|Lost to Follow-up|16|||
129966138|NCT01256671|467841034|FG000|Overall Study|Withdrawal by Subject|31|||
129966139|NCT01256671|467841034|FG000|Overall Study|Physician Decision|3|||
129966140|NCT01256671|467841034|FG000|Overall Study|Lack of Efficacy|4|||
129966141|NCT01256671|467841034|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
129966142|NCT04009629|467841035|FG000|Overall Study|Withdrawal by Subject|2|||
129966143|NCT04009629|467841036|FG001|Overall Study|Withdrawal by Subject|0|||
129966144|NCT03602586|467841037|FG000|Overall Study|Withdrawal by Subject|3|||
129966145|NCT00891046|467841040|FG000|Overall Study|Protocol Violation|1|||
129966146|NCT00891046|467841041|FG001|Overall Study|Protocol Violation|1|||
129966147|NCT00891046|467841042|FG002|Overall Study|Protocol Violation|0|||
129966148|NCT00891046|467841043|FG003|Overall Study|Protocol Violation|0|||
129966149|NCT00891046|467841044|FG004|Overall Study|Protocol Violation|1|||
129966150|NCT00891046|467841040|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
129966151|NCT00891046|467841041|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129966152|NCT00891046|467841042|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
129966153|NCT00891046|467841043|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129966154|NCT00891046|467841044|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
129966155|NCT00891046|467841040|FG000|Overall Study|Administrative problems|0|||
129966156|NCT00891046|467841041|FG001|Overall Study|Administrative problems|0|||
129966157|NCT00891046|467841042|FG002|Overall Study|Administrative problems|0|||
129966158|NCT00891046|467841043|FG003|Overall Study|Administrative problems|0|||
129966159|NCT00891046|467841044|FG004|Overall Study|Administrative problems|1|||
129966160|NCT00891046|467841040|FG000|Overall Study|Participant no longer required drug|0|||
129966161|NCT00891046|467841041|FG001|Overall Study|Participant no longer required drug|2|||
129966162|NCT00891046|467841042|FG002|Overall Study|Participant no longer required drug|0|||
129966163|NCT00891046|467841043|FG003|Overall Study|Participant no longer required drug|0|||
129966164|NCT00891046|467841044|FG004|Overall Study|Participant no longer required drug|1|||
129966165|NCT00891046|467841040|FG000|Overall Study|Adverse Event|4|||
129966166|NCT00891046|467841041|FG001|Overall Study|Adverse Event|3|||
129966167|NCT00891046|467841042|FG002|Overall Study|Adverse Event|2|||
129966168|NCT00891046|467841043|FG003|Overall Study|Adverse Event|0|||
129966169|NCT00891046|467841044|FG004|Overall Study|Adverse Event|14|||
129966170|NCT00891046|467841040|FG000|Overall Study|Withdrawal by Subject|2|||
129966171|NCT00891046|467841041|FG001|Overall Study|Withdrawal by Subject|1|||
129966172|NCT00891046|467841042|FG002|Overall Study|Withdrawal by Subject|2|||
129966173|NCT00891046|467841043|FG003|Overall Study|Withdrawal by Subject|1|||
129966174|NCT00891046|467841044|FG004|Overall Study|Withdrawal by Subject|1|||
129966175|NCT00891046|467841040|FG000|Overall Study|Lost to Follow-up|0|||
129966176|NCT00891046|467841041|FG001|Overall Study|Lost to Follow-up|0|||
129966177|NCT00891046|467841042|FG002|Overall Study|Lost to Follow-up|0|||
129966178|NCT00891046|467841043|FG003|Overall Study|Lost to Follow-up|0|||
129966179|NCT00891046|467841044|FG004|Overall Study|Lost to Follow-up|1|||
129966180|NCT04523207|467841047|FG000|Overall Study|Adverse Event|5|||
129966181|NCT04523207|467841048|FG001|Overall Study|Adverse Event|1|||
129966182|NCT04523207|467841047|FG000|Overall Study|Lost to Follow-up|2|||
129966183|NCT04523207|467841048|FG001|Overall Study|Lost to Follow-up|0|||
129966184|NCT04523207|467841047|FG000|Overall Study|Withdrawal by Subject|2|||
129966185|NCT04523207|467841048|FG001|Overall Study|Withdrawal by Subject|0|||
129966186|NCT04523207|467841047|FG000|Overall Study|Progressive Disease|2|||
129966187|NCT04523207|467841048|FG001|Overall Study|Progressive Disease|1|||
129966188|NCT04523207|467841047|FG000|Overall Study|Other|7|||
129966189|NCT04523207|467841048|FG001|Overall Study|Other|1|||
129966190|NCT03113383|467841049|FG000|Overall Study|Death|4|||
129966191|NCT03113383|467841050|FG001|Overall Study|Death|0|||
129966192|NCT03568812|467841052|FG000|Overall Study|Physician Decision|0|||
129966193|NCT03568812|467841053|FG001|Overall Study|Physician Decision|1|||
129966194|NCT04014790|467841054|FG000|Overall Study|Death|4|||
129966195|NCT04014790|467841054|FG000|Overall Study|Adverse Event|1|||
129966196|NCT04014790|467841054|FG000|Overall Study|Withdrawal by Subject|1|||
129966197|NCT01010204|467841057|FG000|Overall Study|Lost to Follow-up|2|||
129966198|NCT01010204|467841058|FG001|Overall Study|Lost to Follow-up|2|||
129966199|NCT01010204|467841057|FG000|Overall Study|Adverse Event|1|||
129966200|NCT01010204|467841058|FG001|Overall Study|Adverse Event|3|||
129966201|NCT01010204|467841057|FG000|Overall Study|Withdrawal by Subject|2|||
129966202|NCT01010204|467841058|FG001|Overall Study|Withdrawal by Subject|3|||
129966203|NCT01010204|467841057|FG000|Overall Study|psychiatric hospitalization|2|||
129966204|NCT01010204|467841058|FG001|Overall Study|psychiatric hospitalization|1|||
129966205|NCT01519778|467841059|FG000|Overall Study|Withdrawal by Subject|3|||
129966206|NCT01519778|467841059|FG000|Overall Study|Lost to Follow-up|10|||
129966207|NCT01519778|467841059|FG000|Overall Study|Physician Decision|1|||
129966208|NCT02330562|467841060|FG000|Overall Study|Adverse Event|0|||
129966209|NCT02330562|467841061|FG001|Overall Study|Adverse Event|0|||
129966210|NCT02330562|467841062|FG002|Overall Study|Adverse Event|3|||
129966211|NCT02330562|467841063|FG003|Overall Study|Adverse Event|0|||
129966212|NCT02330562|467841064|FG004|Overall Study|Adverse Event|3|||
129966213|NCT02330562|467841065|FG005|Overall Study|Adverse Event|1|||
129966214|NCT02330562|467841066|FG006|Overall Study|Adverse Event|0|||
129966215|NCT02330562|467841067|FG007|Overall Study|Adverse Event|0|||
129966216|NCT02330562|467841068|FG008|Overall Study|Adverse Event|0|||
129966217|NCT02330562|467841069|FG009|Overall Study|Adverse Event|1|||
129966218|NCT02330562|467841070|FG010|Overall Study|Adverse Event|1|||
129966219|NCT02330562|467841060|FG000|Overall Study|Participant decision|1|||
129966220|NCT02330562|467841061|FG001|Overall Study|Participant decision|0|||
129966221|NCT02330562|467841062|FG002|Overall Study|Participant decision|4|||
129966222|NCT02330562|467841063|FG003|Overall Study|Participant decision|1|||
129966223|NCT02330562|467841064|FG004|Overall Study|Participant decision|5|||
129966224|NCT02330562|467841065|FG005|Overall Study|Participant decision|2|||
129966225|NCT02330562|467841066|FG006|Overall Study|Participant decision|0|||
129966226|NCT02330562|467841067|FG007|Overall Study|Participant decision|0|||
129966227|NCT02330562|467841068|FG008|Overall Study|Participant decision|0|||
129966228|NCT02330562|467841069|FG009|Overall Study|Participant decision|3|||
129966229|NCT02330562|467841070|FG010|Overall Study|Participant decision|0|||
129966230|NCT02330562|467841060|FG000|Overall Study|Disease progression|5|||
129966231|NCT02330562|467841061|FG001|Overall Study|Disease progression|3|||
129966232|NCT02330562|467841062|FG002|Overall Study|Disease progression|20|||
129966233|NCT02330562|467841063|FG003|Overall Study|Disease progression|28|||
129966234|NCT02330562|467841064|FG004|Overall Study|Disease progression|23|||
129966235|NCT02330562|467841065|FG005|Overall Study|Disease progression|7|||
129966236|NCT02330562|467841066|FG006|Overall Study|Disease progression|1|||
129966237|NCT02330562|467841067|FG007|Overall Study|Disease progression|1|||
129966238|NCT02330562|467841068|FG008|Overall Study|Disease progression|1|||
129966239|NCT02330562|467841069|FG009|Overall Study|Disease progression|0|||
129966240|NCT02330562|467841070|FG010|Overall Study|Disease progression|5|||
129966241|NCT02330562|467841060|FG000|Overall Study|Other reasons|0|||
129966242|NCT02330562|467841061|FG001|Overall Study|Other reasons|0|||
129966243|NCT02330562|467841062|FG002|Overall Study|Other reasons|0|||
129966244|NCT02330562|467841063|FG003|Overall Study|Other reasons|1|||
129966245|NCT02330562|467841064|FG004|Overall Study|Other reasons|0|||
129966246|NCT02330562|467841065|FG005|Overall Study|Other reasons|0|||
129966247|NCT02330562|467841066|FG006|Overall Study|Other reasons|0|||
129966248|NCT02330562|467841067|FG007|Overall Study|Other reasons|0|||
129966249|NCT02330562|467841068|FG008|Overall Study|Other reasons|0|||
129966250|NCT02330562|467841069|FG009|Overall Study|Other reasons|0|||
129966251|NCT02330562|467841070|FG010|Overall Study|Other reasons|0|||
129966252|NCT02330562|467841060|FG000|Overall Study|Withdrawal by Subject|0|||
129966253|NCT02330562|467841061|FG001|Overall Study|Withdrawal by Subject|0|||
129966254|NCT02330562|467841062|FG002|Overall Study|Withdrawal by Subject|0|||
129966255|NCT02330562|467841063|FG003|Overall Study|Withdrawal by Subject|0|||
129966256|NCT02330562|467841064|FG004|Overall Study|Withdrawal by Subject|0|||
129966257|NCT02330562|467841065|FG005|Overall Study|Withdrawal by Subject|0|||
129966258|NCT02330562|467841066|FG006|Overall Study|Withdrawal by Subject|0|||
129966259|NCT02330562|467841067|FG007|Overall Study|Withdrawal by Subject|0|||
129966260|NCT02330562|467841068|FG008|Overall Study|Withdrawal by Subject|0|||
129966261|NCT02330562|467841069|FG009|Overall Study|Withdrawal by Subject|1|||
129966262|NCT02330562|467841070|FG010|Overall Study|Withdrawal by Subject|0|||
129966263|NCT01657799|467841071|FG000|Overall Study|Adverse Event Related to progression|6|||
129966264|NCT01657799|467841072|FG001|Overall Study|Adverse Event Related to progression|8|||
129966265|NCT01657799|467841073|FG002|Overall Study|Adverse Event Related to progression|12|||
129966266|NCT01657799|467841071|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
129966267|NCT01657799|467841072|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
129966268|NCT01657799|467841073|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
129966269|NCT01657799|467841071|FG000|Overall Study|Withdrawal by Subject|13|||
129966270|NCT01657799|467841072|FG001|Overall Study|Withdrawal by Subject|10|||
129966271|NCT01657799|467841073|FG002|Overall Study|Withdrawal by Subject|10|||
129966272|NCT01657799|467841071|FG000|Overall Study|Lost to Follow-up|1|||
129966273|NCT01657799|467841072|FG001|Overall Study|Lost to Follow-up|0|||
129966274|NCT01657799|467841073|FG002|Overall Study|Lost to Follow-up|1|||
129966275|NCT01657799|467841071|FG000|Overall Study|Disease Progression|2|||
129966276|NCT01657799|467841072|FG001|Overall Study|Disease Progression|4|||
129966277|NCT01657799|467841073|FG002|Overall Study|Disease Progression|4|||
129966278|NCT01657799|467841071|FG000|Overall Study|Progressive Disease Clinical|7|||
129966279|NCT01657799|467841072|FG001|Overall Study|Progressive Disease Clinical|4|||
129966280|NCT01657799|467841073|FG002|Overall Study|Progressive Disease Clinical|7|||
129966281|NCT01657799|467841071|FG000|Overall Study|Radiographic & Clinical Progression|16|||
129966282|NCT01657799|467841072|FG001|Overall Study|Radiographic & Clinical Progression|11|||
129966283|NCT01657799|467841073|FG002|Overall Study|Radiographic & Clinical Progression|15|||
129966284|NCT01657799|467841071|FG000|Overall Study|Other|52|||
129966285|NCT01657799|467841072|FG001|Overall Study|Other|62|||
129966286|NCT01657799|467841073|FG002|Overall Study|Other|49|||
129966287|NCT03021551|467841074|FG000|Overall Study|Equipment Issues|2|||
129966288|NCT03021551|467841074|FG000|Overall Study|Protocol Violation|1|||
129966289|NCT01015677|467841076|FG000|Overall Study|Adverse Event|0|||
129966290|NCT01015677|467841077|FG001|Overall Study|Adverse Event|1|||
129966291|NCT01015677|467841078|FG002|Overall Study|Adverse Event|0|||
129966292|NCT01015677|467841076|FG000|Overall Study|Lack of Efficacy|0|||
129966293|NCT01015677|467841077|FG001|Overall Study|Lack of Efficacy|1|||
129966294|NCT01015677|467841078|FG002|Overall Study|Lack of Efficacy|0|||
129966295|NCT01015677|467841076|FG000|Overall Study|Protocol Violation|0|||
129966296|NCT01015677|467841077|FG001|Overall Study|Protocol Violation|1|||
129966297|NCT01015677|467841078|FG002|Overall Study|Protocol Violation|0|||
129966298|NCT01015677|467841076|FG000|Overall Study|Withdrawal by Subject|1|||
129966299|NCT01015677|467841077|FG001|Overall Study|Withdrawal by Subject|1|||
129966300|NCT01015677|467841078|FG002|Overall Study|Withdrawal by Subject|0|||
129966301|NCT01646385|467841082|FG000|Overall Study|Death|202|||
129966302|NCT01646385|467841083|FG001|Overall Study|Death|222|||
129966303|NCT01646385|467841082|FG000|Overall Study|Switched to alternate biologic|636|||
129966304|NCT01646385|467841083|FG001|Overall Study|Switched to alternate biologic|649|||
129966305|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
129966306|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
129966307|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
129966308|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
129966309|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
129966310|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
129966311|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
129966312|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
129966313|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
129966314|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
129966315|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
129966316|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
129966317|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
129966318|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
129966319|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
129966320|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
129966321|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
129966322|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
129966323|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
129966324|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
129966325|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
129966326|NCT04599855|467841084|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
129966327|NCT04599855|467841085|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
129966328|NCT04599855|467841086|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
129966329|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
129966330|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
129966331|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
129966332|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
129966333|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
129966334|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
129966335|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
129966336|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
129966337|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
129966338|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
129966339|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
129966340|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
129966341|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
129966342|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
129966343|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
129966344|NCT04599855|467841084|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
129966345|NCT04599855|467841085|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
129966346|NCT04599855|467841086|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
129966347|NCT04799418|467841087|FG000|Overall Study|Death|1|||
129966348|NCT04799418|467841088|FG001|Overall Study|Death|1|||
129966349|NCT04799418|467841087|FG000|Overall Study|Lack of Efficacy|14|||
129966350|NCT04799418|467841088|FG001|Overall Study|Lack of Efficacy|14|||
129966351|NCT04799418|467841087|FG000|Overall Study|Withdrawal by Subject|10|||
129966352|NCT04799418|467841088|FG001|Overall Study|Withdrawal by Subject|7|||
129966353|NCT04799418|467841087|FG000|Overall Study|Adverse Event|3|||
129966354|NCT04799418|467841088|FG001|Overall Study|Adverse Event|2|||
129966355|NCT03297398|467841089|FG000|Overall Study|Sponsor's decision|6|||
129966356|NCT03297398|467841090|FG001|Overall Study|Sponsor's decision|9|||
129966357|NCT03297398|467841091|FG002|Overall Study|Sponsor's decision|7|||
129966358|NCT03297398|467841089|FG000|Overall Study|Adverse Event|1|||
129966359|NCT03297398|467841090|FG001|Overall Study|Adverse Event|4|||
129966360|NCT03297398|467841091|FG002|Overall Study|Adverse Event|4|||
129966361|NCT03297398|467841089|FG000|Overall Study|Withdrawal by Subject|1|||
129966362|NCT03297398|467841090|FG001|Overall Study|Withdrawal by Subject|2|||
129966363|NCT03297398|467841091|FG002|Overall Study|Withdrawal by Subject|2|||
129966364|NCT03297398|467841089|FG000|Overall Study|Protocol Violation|0|||
129966365|NCT03297398|467841090|FG001|Overall Study|Protocol Violation|2|||
129966366|NCT03297398|467841091|FG002|Overall Study|Protocol Violation|0|||
129966367|NCT03297398|467841089|FG000|Overall Study|Physician Decision|0|||
129966368|NCT03297398|467841090|FG001|Overall Study|Physician Decision|0|||
129966369|NCT03297398|467841091|FG002|Overall Study|Physician Decision|1|||
129966370|NCT03297398|467841089|FG000|Overall Study|Lost to Follow-up|0|||
129966371|NCT03297398|467841090|FG001|Overall Study|Lost to Follow-up|0|||
129966372|NCT03297398|467841091|FG002|Overall Study|Lost to Follow-up|1|||
129966373|NCT00236184|467841096|FG000|Overall Study|Adverse Event|5|||
129966374|NCT00236184|467841097|FG001|Overall Study|Adverse Event|2|||
129966375|NCT00236184|467841096|FG000|Overall Study|Lack of Efficacy|0|||
129966376|NCT00236184|467841097|FG001|Overall Study|Lack of Efficacy|1|||
129966377|NCT00236184|467841096|FG000|Overall Study|Lost to Follow-up|3|||
129966378|NCT00236184|467841097|FG001|Overall Study|Lost to Follow-up|4|||
129966379|NCT00236184|467841096|FG000|Overall Study|Physician Decision|1|||
129966380|NCT00236184|467841097|FG001|Overall Study|Physician Decision|1|||
129966381|NCT00236184|467841096|FG000|Overall Study|Withdrawal by Subject|3|||
129966382|NCT00236184|467841097|FG001|Overall Study|Withdrawal by Subject|0|||
129966383|NCT00236184|467841096|FG000|Overall Study|Protocol Violation|3|||
129966384|NCT00236184|467841097|FG001|Overall Study|Protocol Violation|0|||
129966385|NCT00236184|467841096|FG000|Overall Study|non-compliance with study drug|2|||
129455713|NCT01417195|465966606|FG000|Overall Study|No transfer due to elevated progesterone|1|||
129966386|NCT00236184|467841097|FG001|Overall Study|non-compliance with study drug|1|||
129966387|NCT00236184|467841096|FG000|Overall Study|other|1|||
129966388|NCT00236184|467841097|FG001|Overall Study|other|2|||
129966389|NCT02312206|467841098|FG000|Overall Study|Adverse Event|3|||
129966390|NCT02312206|467841099|FG001|Overall Study|Adverse Event|6|||
129966391|NCT02312206|467841098|FG000|Overall Study|Withdrawal by Subject|6|||
129966392|NCT02312206|467841099|FG001|Overall Study|Withdrawal by Subject|6|||
129966393|NCT02312206|467841098|FG000|Overall Study|Physician Decision|7|||
129966394|NCT02312206|467841099|FG001|Overall Study|Physician Decision|6|||
129966395|NCT02312206|467841098|FG000|Overall Study|Death|31|||
129966396|NCT02312206|467841099|FG001|Overall Study|Death|36|||
129966397|NCT02312206|467841098|FG000|Overall Study|Study Terminated by Sponsor|81|||
129966398|NCT02312206|467841099|FG001|Overall Study|Study Terminated by Sponsor|74|||
129966399|NCT02312206|467841098|FG000|Overall Study|Patient transferred to hospice|0|||
129966400|NCT02312206|467841099|FG001|Overall Study|Patient transferred to hospice|1|||
129966401|NCT02312206|467841098|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
129966402|NCT02312206|467841099|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
129966403|NCT02312206|467841098|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
129966404|NCT02312206|467841099|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
129966405|NCT02312206|467841098|FG000|Overall Study|Disease Progression|1|||
129966406|NCT02312206|467841099|FG001|Overall Study|Disease Progression|0|||
129966407|NCT03082612|467841100|FG000|Overall Study|Lost to Follow-up|2|||
129966408|NCT03082612|467841101|FG001|Overall Study|Lost to Follow-up|0|||
129966409|NCT03732820|467841108|FG000|Overall Study|Death|168|||
129966410|NCT03732820|467841109|FG001|Overall Study|Death|203|||
129966411|NCT03732820|467841108|FG000|Overall Study|Other|2|||
129966412|NCT03732820|467841109|FG001|Overall Study|Other|2|||
129966413|NCT03732820|467841108|FG000|Overall Study|Failure to meet randomisation criteria|1|||
129966414|NCT03732820|467841109|FG001|Overall Study|Failure to meet randomisation criteria|1|||
129966415|NCT03732820|467841108|FG000|Overall Study|Patient decision|14|||
129966416|NCT03732820|467841109|FG001|Overall Study|Patient decision|10|||
129966417|NCT03732820|467841108|FG000|Overall Study|Screen failure|0|||
129966418|NCT03732820|467841109|FG001|Overall Study|Screen failure|1|||
129966419|NCT03732820|467841108|FG000|Overall Study|Patients ongoing study at data cut off|210|||
129966420|NCT03732820|467841109|FG001|Overall Study|Patients ongoing study at data cut off|178|||
129966421|NCT03732820|467841108|FG000|Overall Study|Lost to Follow-up|4|||
129966422|NCT03732820|467841109|FG001|Overall Study|Lost to Follow-up|2|||
129966423|NCT00992992|467841110|FG000|Overall Study|Lost to Follow-up|3|||
129966424|NCT00992992|467841110|FG000|Overall Study|Death|16|||
129966425|NCT00992992|467841110|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
129966426|NCT00992992|467841110|FG000|Overall Study|Sponsor Closed the Study|4|||
129966427|NCT00832000|467841112|FG000|Overall Study|Adverse Event|2|||
129966428|NCT00832000|467841113|FG001|Overall Study|Adverse Event|0|||
129966429|NCT00832000|467841112|FG000|Overall Study|Withdrawal by Subject|1|||
129966430|NCT00832000|467841113|FG001|Overall Study|Withdrawal by Subject|0|||
129966431|NCT00832000|467841112|FG000|Overall Study|No calls to IVR in either period|1|||
129966432|NCT00832000|467841113|FG001|Overall Study|No calls to IVR in either period|1|||
129966433|NCT00832000|467841112|FG000|Overall Study|No calls to IVR in period 2|2|||
129966434|NCT00832000|467841113|FG001|Overall Study|No calls to IVR in period 2|0|||
129966435|NCT02725567|467841115|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
129966436|NCT02725567|467841116|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
129966437|NCT02725567|467841115|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
129966438|NCT02725567|467841116|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
129966439|NCT02725567|467841115|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
129966440|NCT02725567|467841116|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
129966441|NCT00255944|467841117|FG000|Overall Study|Lost to Follow-up|797|||
129966442|NCT00255944|467841118|FG001|Overall Study|Lost to Follow-up|834|||
129966443|NCT01129115|467841119|FG000|Overall Study|Adverse Event|1|||
129966444|NCT01129115|467841120|FG001|Overall Study|Adverse Event|2|||
129966445|NCT01129115|467841121|FG002|Overall Study|Adverse Event|3|||
129966446|NCT01129115|467841122|FG003|Overall Study|Adverse Event|3|||
129966447|NCT01129115|467841119|FG000|Overall Study|Withdrawal by Subject|1|||
129966448|NCT01129115|467841120|FG001|Overall Study|Withdrawal by Subject|3|||
129966449|NCT01129115|467841121|FG002|Overall Study|Withdrawal by Subject|1|||
129966450|NCT01129115|467841122|FG003|Overall Study|Withdrawal by Subject|4|||
129966451|NCT01129115|467841119|FG000|Overall Study|Protocol Violation|0|||
129966452|NCT01129115|467841120|FG001|Overall Study|Protocol Violation|2|||
129966453|NCT01129115|467841121|FG002|Overall Study|Protocol Violation|2|||
129966454|NCT01129115|467841122|FG003|Overall Study|Protocol Violation|2|||
129966455|NCT02299427|467841124|FG000|Overall Study|Withdrawal by Subject|1|||
129966456|NCT02299427|467841125|FG001|Overall Study|Withdrawal by Subject|0|||
129966457|NCT02299427|467841124|FG000|Overall Study|Lost to Follow-up|1|||
129966458|NCT02299427|467841125|FG001|Overall Study|Lost to Follow-up|3|||
129455714|NCT01417195|465966607|FG001|Overall Study|No transfer due to elevated progesterone|0|||
129455715|NCT03357731|465966608|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
129966459|NCT02299427|467841124|FG000|Overall Study|not adherent to dog website use|21|||
129966460|NCT02299427|467841125|FG001|Overall Study|not adherent to dog website use|0|||
129455716|NCT03357731|465966609|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
129966461|NCT02108652|467841126|FG000|Overall Study|Death|253|||
129966462|NCT02108652|467841126|FG000|Overall Study|Lost to Follow-up|2|||
129966463|NCT02108652|467841126|FG000|Overall Study|Withdrawal by Subject|16|||
129966464|NCT02108652|467841126|FG000|Overall Study|Study Terminated By Sponsor|31|||
129966465|NCT02108652|467841126|FG000|Overall Study|Non-Compliance|1|||
129966466|NCT02108652|467841126|FG000|Overall Study|Physician Decision|6|||
129966467|NCT02108652|467841126|FG000|Overall Study|Progression Of Disease|1|||
129966468|NCT02564718|467841129|FG000|Overall Study|Withdrew from treatment|0|||
129966469|NCT02564718|467841130|FG001|Overall Study|Withdrew from treatment|1|||
129966470|NCT00935259|467841131|FG000|Period 1|Administrative (scheduling conflict)|1|||
129966471|NCT00935259|467841132|FG001|Period 1|Administrative (scheduling conflict)|1|||
129966472|NCT00874497|467841136|FG000|Overall Study|Lost to Follow-up|2|||
129966473|NCT00874497|467841137|FG001|Overall Study|Lost to Follow-up|4|||
129966474|NCT00874497|467841136|FG000|Overall Study|Adverse Event|9|||
129966475|NCT00874497|467841137|FG001|Overall Study|Adverse Event|4|||
129966476|NCT00874497|467841136|FG000|Overall Study|Sponsor Discontinued Trial|7|||
129966477|NCT00874497|467841137|FG001|Overall Study|Sponsor Discontinued Trial|3|||
129966478|NCT00874497|467841136|FG000|Overall Study|Met Withdrawal Criteria|4|||
129966479|NCT00874497|467841137|FG001|Overall Study|Met Withdrawal Criteria|2|||
129966480|NCT00874497|467841136|FG000|Overall Study|Physician Decision|1|||
129966481|NCT00874497|467841137|FG001|Overall Study|Physician Decision|1|||
129966482|NCT00874497|467841136|FG000|Overall Study|Withdrawal by Subject|5|||
129966483|NCT00874497|467841137|FG001|Overall Study|Withdrawal by Subject|4|||
129966484|NCT01017263|467841138|FG000|Overall Study|not eligible|12|||
129966485|NCT02980705|467841139|FG000|Overall Study|Adverse Event|0|||
129966486|NCT02980705|467841140|FG001|Overall Study|Adverse Event|1|||
129966487|NCT02980705|467841139|FG000|Overall Study|Withdrawal by Subject|6|||
129966488|NCT02980705|467841140|FG001|Overall Study|Withdrawal by Subject|9|||
129455717|NCT03357731|465966610|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
129455718|NCT03357731|465966611|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
129455719|NCT03357731|465966612|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
129455720|NCT03357731|465966613|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
129455721|NCT03357731|465966608|FG000|Overall Study|Acute bradycardia and hypotension|0|||
129455722|NCT03357731|465966609|FG001|Overall Study|Acute bradycardia and hypotension|0|||
129455723|NCT03357731|465966610|FG002|Overall Study|Acute bradycardia and hypotension|0|||
129455724|NCT03357731|465966611|FG003|Overall Study|Acute bradycardia and hypotension|1|||
129455725|NCT03357731|465966612|FG004|Overall Study|Acute bradycardia and hypotension|0|||
129455726|NCT03357731|465966613|FG005|Overall Study|Acute bradycardia and hypotension|0|||
129455727|NCT03357731|465966608|FG000|Overall Study|Adverse Event|0|||
129455728|NCT03357731|465966609|FG001|Overall Study|Adverse Event|0|||
129455729|NCT03357731|465966610|FG002|Overall Study|Adverse Event|0|||
129455730|NCT03357731|465966611|FG003|Overall Study|Adverse Event|0|||
129455731|NCT03357731|465966612|FG004|Overall Study|Adverse Event|0|||
129455732|NCT03357731|465966613|FG005|Overall Study|Adverse Event|1|||
129455733|NCT03357731|465966608|FG000|Overall Study|Hypotension|0|||
129455734|NCT03357731|465966609|FG001|Overall Study|Hypotension|0|||
129455735|NCT03357731|465966610|FG002|Overall Study|Hypotension|1|||
129455736|NCT03357731|465966611|FG003|Overall Study|Hypotension|1|||
129455737|NCT03357731|465966612|FG004|Overall Study|Hypotension|0|||
129455738|NCT03357731|465966613|FG005|Overall Study|Hypotension|0|||
129455739|NCT03357731|465966608|FG000|Overall Study|Lost to Follow-up|0|||
129455740|NCT03357731|465966609|FG001|Overall Study|Lost to Follow-up|0|||
129455741|NCT03357731|465966610|FG002|Overall Study|Lost to Follow-up|0|||
129455742|NCT03357731|465966611|FG003|Overall Study|Lost to Follow-up|1|||
129455743|NCT03357731|465966612|FG004|Overall Study|Lost to Follow-up|0|||
129455744|NCT03357731|465966613|FG005|Overall Study|Lost to Follow-up|0|||
129455745|NCT00772954|465966614|FG000|Overall Study|Adverse Event|0|||
129455746|NCT00772954|465966615|FG001|Overall Study|Adverse Event|0|||
129966489|NCT02980705|467841139|FG000|Overall Study|withdrew participation|0|||
129966490|NCT02980705|467841140|FG001|Overall Study|withdrew participation|1|||
129966491|NCT02980705|467841139|FG000|Overall Study|Lost to Follow-up|2|||
129966492|NCT02980705|467841140|FG001|Overall Study|Lost to Follow-up|0|||
129966493|NCT00263575|467841141|FG000|Titration Period|Adverse Event|14|||
129966494|NCT00263575|467841141|FG000|Titration Period|Withdrawal by Subject|10|||
129966495|NCT00263575|467841141|FG000|Titration Period|Protocol Violation|9|||
129966496|NCT00263575|467841141|FG000|Titration Period|Sponsor Decision|2|||
129966497|NCT00263575|467841141|FG000|Titration Period|Other|2|||
129966498|NCT00263575|467841141|FG000|Titration Period|Lack of Efficacy|6|||
129966499|NCT00263575|467841141|FG000|Maintence Period|Adverse Event|23|||
129966500|NCT00263575|467841141|FG000|Maintence Period|Withdrawal by Subject|8|||
129455747|NCT00772954|465966616|FG002|Overall Study|Adverse Event|1|||
129455748|NCT01773109|465966617|FG000|Overall Study|Symptomatic Progression|2|||
129455749|NCT01773109|465966617|FG000|Overall Study|Death|1|||
129455750|NCT01239342|465966618|FG000|Overall Study|Adverse Event|1|||
129455751|NCT01239342|465966619|FG001|Overall Study|Adverse Event|0|||
129455752|NCT01239342|465966618|FG000|Overall Study|Withdrawal by Subject|1|||
129455753|NCT01239342|465966619|FG001|Overall Study|Withdrawal by Subject|5|||
129455754|NCT01239342|465966618|FG000|Overall Study|Reason Unknown|1|||
129455755|NCT01239342|465966619|FG001|Overall Study|Reason Unknown|1|||
129966501|NCT00263575|467841141|FG000|Maintence Period|Protocol Violation|4|||
129966502|NCT00263575|467841141|FG000|Maintence Period|Lack of Efficacy|4|||
129966503|NCT00263575|467841141|FG000|Maintence Period|Physician Decision|6|||
129966504|NCT00263575|467841141|FG000|Maintence Period|Lost to Follow-up|1|||
129966505|NCT00263575|467841141|FG000|Maintence Period|Sponsor Decision|24|||
129966506|NCT00263575|467841141|FG000|Maintence Period|Other|7|||
129966507|NCT04353817|467841142|FG000|Overall Study|Adverse Event|0|||
129966508|NCT04353817|467841143|FG001|Overall Study|Adverse Event|1|||
129966509|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
129966510|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
129966511|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
129966512|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Death|0|||
129966513|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Death|0|||
129966514|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Death|1|||
129966515|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
129966516|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
129966517|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
129966518|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
129966519|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
129966520|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
129966521|NCT00665223|467841148|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
129966522|NCT00665223|467841149|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
129966523|NCT00665223|467841150|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
129966524|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
129966525|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
129966526|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
129966527|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Death|0|||
129966528|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Death|1|||
129966529|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Death|0|||
129455756|NCT02495844|465966620|FG000|Overall Study|Lack of Efficacy|1|||
129455757|NCT02495844|465966621|FG001|Overall Study|Lack of Efficacy|2|||
129455758|NCT02495844|465966620|FG000|Overall Study|AE, non-fatal|0|||
129455759|NCT02495844|465966621|FG001|Overall Study|AE, non-fatal|1|||
129455760|NCT02495844|465966620|FG000|Overall Study|Hepatitis Positivity|0|||
129455761|NCT02495844|465966621|FG001|Overall Study|Hepatitis Positivity|1|||
129455762|NCT02325219|465966624|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
129455763|NCT02325219|465966625|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
129455764|NCT02325219|465966626|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
129455765|NCT02325219|465966627|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
129455766|NCT02325219|465966628|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
129455767|NCT02325219|465966624|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
129455768|NCT02325219|465966625|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
129455769|NCT02325219|465966626|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129455770|NCT02325219|465966627|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129455771|NCT02325219|465966628|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
129455772|NCT02325219|465966624|FG000|Controlled Period (Week 0 - 16)|Other|0|||
129455773|NCT02325219|465966625|FG001|Controlled Period (Week 0 - 16)|Other|0|||
129455774|NCT02325219|465966626|FG002|Controlled Period (Week 0 - 16)|Other|1|||
129455775|NCT02325219|465966627|FG003|Controlled Period (Week 0 - 16)|Other|0|||
129455776|NCT02325219|465966628|FG004|Controlled Period (Week 0 - 16)|Other|0|||
129455777|NCT02325219|465966624|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
129455778|NCT02325219|465966625|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
129455779|NCT02325219|465966626|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
129455780|NCT02325219|465966627|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
129455781|NCT02325219|465966628|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
129455782|NCT02325219|465966624|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
129455783|NCT02325219|465966625|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
129455784|NCT02325219|465966626|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
129455785|NCT02325219|465966627|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
129455786|NCT02325219|465966628|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
129455787|NCT02325219|465966624|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129455788|NCT02325219|465966625|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
129966530|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
129966531|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
129966532|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
129966533|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
129455789|NCT02325219|465966626|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129455790|NCT02325219|465966627|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129455791|NCT02325219|465966628|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
129455792|NCT02918864|465966629|FG000|Overall Study|Withdrawal by Subject|1|||
129966534|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
129966535|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
129966536|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
129966537|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
129966538|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
129966539|NCT00665223|467841148|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
129966540|NCT00665223|467841149|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
129966541|NCT00665223|467841150|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
129966542|NCT00002597|467841151|FG000|Overall Study|Protocol Violation|19|||
129966543|NCT00002597|467841152|FG001|Overall Study|Protocol Violation|17|||
129966544|NCT00002597|467841151|FG000|Overall Study|Withdrawal by Subject|7|||
129966545|NCT00002597|467841152|FG001|Overall Study|Withdrawal by Subject|6|||
129966546|NCT01426113|467841153|FG000|Overall Study|Study Discontinued|1|||
129966547|NCT01426113|467841154|FG001|Overall Study|Study Discontinued|1|||
129966548|NCT01426113|467841153|FG000|Overall Study|Adverse Event|0|||
129966549|NCT01426113|467841154|FG001|Overall Study|Adverse Event|1|||
129966550|NCT02654132|467841155|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
129966551|NCT02654132|467841156|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
129966552|NCT02654132|467841155|FG000|Treatment Period|Disease progression|43|||
129966553|NCT02654132|467841156|FG001|Treatment Period|Disease progression|38|||
129966554|NCT02654132|467841155|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
129966555|NCT02654132|467841156|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
129966556|NCT02654132|467841155|FG000|Treatment Period|Other reasons|4|||
129966557|NCT02654132|467841156|FG001|Treatment Period|Other reasons|2|||
129966558|NCT02654132|467841155|FG000|Treatment Period|Study drug toxicity|2|||
129966559|NCT02654132|467841156|FG001|Treatment Period|Study drug toxicity|2|||
129966560|NCT02654132|467841155|FG000|Treatment Period|Withdrawal by Subject|2|||
129966561|NCT02654132|467841156|FG001|Treatment Period|Withdrawal by Subject|1|||
129966562|NCT02654132|467841155|FG000|Treatment Period|Maximum Clinical Benefit|0|||
129966563|NCT02654132|467841156|FG001|Treatment Period|Maximum Clinical Benefit|2|||
129966564|NCT02654132|467841155|FG000|Treatment Period|Participant request to discontinue|2|||
129966565|NCT02654132|467841156|FG001|Treatment Period|Participant request to discontinue|0|||
129966566|NCT02654132|467841155|FG000|Treatment Period|Administrative reasons by sponsor|0|||
129966567|NCT02654132|467841156|FG001|Treatment Period|Administrative reasons by sponsor|1|||
129966568|NCT02654132|467841155|FG000|Treatment Period|Death|1|||
129966569|NCT02654132|467841156|FG001|Treatment Period|Death|0|||
129966570|NCT02485899|467841158|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
129966571|NCT02485899|467841159|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129966572|NCT02485899|467841158|FG000|Overall Study|Withdrawal by Subject|1|||
129966573|NCT02485899|467841159|FG001|Overall Study|Withdrawal by Subject|0|||
129966574|NCT02485899|467841158|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
129966575|NCT02485899|467841159|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
129966576|NCT01918371|467841160|FG000|Overall Study|Missing Data|1|||
129966577|NCT01918371|467841161|FG001|Overall Study|Missing Data|1|||
129966578|NCT03517111|467841166|FG000|Enrolled|Withdrawal by Subject|0|||
129966579|NCT03517111|467841167|FG001|Enrolled|Withdrawal by Subject|1|||
129966580|NCT03517111|467841168|FG002|Enrolled|Withdrawal by Subject|0|||
129966581|NCT03517111|467841166|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
129966582|NCT03517111|467841167|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
129966583|NCT03517111|467841168|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
129966584|NCT03517111|467841166|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
129966585|NCT03517111|467841167|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
129455793|NCT02918864|465966630|FG001|Overall Study|Withdrawal by Subject|1|||
129455794|NCT02918864|465966629|FG000|Overall Study|Lost to Follow-up|3|||
129966586|NCT03517111|467841168|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
129966587|NCT03517111|467841166|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
129966588|NCT03517111|467841167|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
129966589|NCT03517111|467841168|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
129966590|NCT03517111|467841166|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
129966591|NCT03517111|467841167|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
129966592|NCT03517111|467841168|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
129966593|NCT00621192|467841169|FG000|Overall Study|Withdrawal by Subject|0|||
129966594|NCT00621192|467841170|FG001|Overall Study|Withdrawal by Subject|0|||
129966595|NCT00621192|467841171|FG002|Overall Study|Withdrawal by Subject|2|||
129966596|NCT00621192|467841172|FG003|Overall Study|Withdrawal by Subject|0|||
129966597|NCT00621192|467841169|FG000|Overall Study|Physician Decision|1|||
129966598|NCT00621192|467841170|FG001|Overall Study|Physician Decision|3|||
129966599|NCT00621192|467841171|FG002|Overall Study|Physician Decision|0|||
129966600|NCT00621192|467841172|FG003|Overall Study|Physician Decision|0|||
129966601|NCT00621192|467841169|FG000|Overall Study|Protocol Violation|1|||
129966602|NCT00621192|467841170|FG001|Overall Study|Protocol Violation|0|||
129966603|NCT00621192|467841171|FG002|Overall Study|Protocol Violation|0|||
129966604|NCT00621192|467841172|FG003|Overall Study|Protocol Violation|1|||
129966605|NCT00621192|467841169|FG000|Overall Study|Adverse Event|0|||
129966606|NCT00621192|467841170|FG001|Overall Study|Adverse Event|1|||
129966607|NCT00621192|467841171|FG002|Overall Study|Adverse Event|0|||
129966608|NCT00621192|467841172|FG003|Overall Study|Adverse Event|1|||
129966609|NCT00621192|467841169|FG000|Overall Study|Death|2|||
129966610|NCT00621192|467841170|FG001|Overall Study|Death|5|||
129966611|NCT00621192|467841171|FG002|Overall Study|Death|0|||
129966612|NCT00621192|467841172|FG003|Overall Study|Death|0|||
129966613|NCT00621192|467841169|FG000|Overall Study|Final Assessments not Completed|0|||
129966614|NCT00621192|467841170|FG001|Overall Study|Final Assessments not Completed|0|||
129966615|NCT00621192|467841171|FG002|Overall Study|Final Assessments not Completed|3|||
129966616|NCT00621192|467841172|FG003|Overall Study|Final Assessments not Completed|1|||
129966617|NCT01880437|467841173|FG000|Overall Study|Death|12|||
129966618|NCT01880437|467841174|FG001|Overall Study|Death|4|||
129966619|NCT01880437|467841175|FG002|Overall Study|Death|17|||
129966620|NCT01880437|467841173|FG000|Overall Study|Study terminated by Sponsor|3|||
129966621|NCT01880437|467841174|FG001|Overall Study|Study terminated by Sponsor|0|||
129966622|NCT01880437|467841175|FG002|Overall Study|Study terminated by Sponsor|2|||
129966623|NCT02725528|467841181|FG000|Overall Study|Lost to Follow-up|1|||
129966624|NCT02725528|467841182|FG001|Overall Study|Lost to Follow-up|4|||
129966625|NCT02725528|467841181|FG000|Overall Study|Withdrawal by Subject|0|||
129966626|NCT02725528|467841182|FG001|Overall Study|Withdrawal by Subject|1|||
129966627|NCT02569957|467841183|FG000|Overall Study|Withdrawal by Subject|0|||
129966628|NCT02569957|467841184|FG001|Overall Study|Withdrawal by Subject|1|||
129966629|NCT04354168|467841185|FG000|Overall Study|Lost to Follow-up|22|||
129966630|NCT02804399|467841190|FG000|Period 2|Adverse Event|0|||
129966631|NCT02804399|467841191|FG001|Period 2|Adverse Event|1|||
129966632|NCT04211389|467841192|FG000|Overall Study|Adverse Event|1|||
129966633|NCT04211389|467841193|FG001|Overall Study|Adverse Event|2|||
129966634|NCT04211389|467841192|FG000|Overall Study|Lost to Follow-up|15|||
129966635|NCT04211389|467841193|FG001|Overall Study|Lost to Follow-up|7|||
129966636|NCT04211389|467841192|FG000|Overall Study|Protocol Violation|0|||
129966637|NCT04211389|467841193|FG001|Overall Study|Protocol Violation|1|||
129966638|NCT04211389|467841192|FG000|Overall Study|Withdrawal by Subject|10|||
129966639|NCT04211389|467841193|FG001|Overall Study|Withdrawal by Subject|11|||
129966640|NCT01062971|467841200|FG000|Overall Study|Protocol Violation|1|||
129966641|NCT01062971|467841201|FG001|Overall Study|Protocol Violation|3|||
129966642|NCT01062971|467841200|FG000|Overall Study|Lost to Follow-up|3|||
129966643|NCT01062971|467841201|FG001|Overall Study|Lost to Follow-up|4|||
129966644|NCT01530087|467841202|FG000|Overall Study|Physician Decision|2|||
129966645|NCT05523219|467841203|FG000|Overall Study|Wrong inclusion|1|||
129966646|NCT05523219|467841203|FG000|Overall Study|Lost to Follow-up|7|||
129966647|NCT01182207|467841204|FG000|First Intervention|Positive Hepatitis Results|0|||
129966648|NCT01182207|467841205|FG001|First Intervention|Positive Hepatitis Results|1|||
129966649|NCT01182207|467841204|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
129966650|NCT01182207|467841205|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
129966651|NCT01161628|467841206|FG000|Overall Study|Death|6|||
129966652|NCT01161628|467841206|FG000|Overall Study|Lack of Efficacy|2|||
129966653|NCT02037256|467841209|FG000|Overall Study|Protocol Violation|0|||
129966654|NCT02037256|467841210|FG001|Overall Study|Protocol Violation|1|||
129966655|NCT02037256|467841209|FG000|Overall Study|Withdrawn prior to Velcade|0|||
129966656|NCT02037256|467841210|FG001|Overall Study|Withdrawn prior to Velcade|2|||
129966657|NCT04398368|467843025|FG000|Overall Study|Withdrawal by Subject|2|||
129455795|NCT02918864|465966630|FG001|Overall Study|Lost to Follow-up|2|||
129455796|NCT04766021|465966631|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
129966658|NCT00328562|467843032|FG000|Overall Study|Disease progression|1|||
129966659|NCT04486313|467843033|FG000|Overall Study|Lost to Follow-up|7|||
129966660|NCT04486313|467843034|FG001|Overall Study|Lost to Follow-up|9|||
129966661|NCT04486313|467843033|FG000|Overall Study|Withdrawal by Subject|8|||
129966662|NCT04486313|467843034|FG001|Overall Study|Withdrawal by Subject|6|||
129966663|NCT04486313|467843033|FG000|Overall Study|Physician Decision|1|||
129966664|NCT04486313|467843034|FG001|Overall Study|Physician Decision|1|||
129966665|NCT04486313|467843033|FG000|Overall Study|Death|2|||
129966666|NCT04486313|467843034|FG001|Overall Study|Death|0|||
129966667|NCT04486313|467843033|FG000|Overall Study|Protocol Violation|1|||
129966668|NCT04486313|467843034|FG001|Overall Study|Protocol Violation|1|||
129966669|NCT00412880|467843035|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
129966670|NCT00412880|467843035|FG000|Overall Study|Consent withdrawn|1|||
129966671|NCT00412880|467843035|FG000|Overall Study|Adverse Event|1|||
129966672|NCT00412880|467843035|FG000|Overall Study|Progressive disease|20|||
129966673|NCT01288209|467843036|FG000|Overall Study|Withdrawal by Subject|1|||
129966674|NCT01288209|467843037|FG001|Overall Study|Withdrawal by Subject|3|||
129966675|NCT01288209|467843036|FG000|Overall Study|Other|1|||
129966676|NCT01288209|467843037|FG001|Overall Study|Other|0|||
129966677|NCT01496365|467843038|FG000|Overall Study|Adverse Event|2|||
129966678|NCT01496365|467843039|FG001|Overall Study|Adverse Event|3|||
129966679|NCT01496365|467843040|FG002|Overall Study|Adverse Event|3|||
129966680|NCT01496365|467843041|FG003|Overall Study|Adverse Event|2|||
129966681|NCT01496365|467843042|FG004|Overall Study|Adverse Event|5|||
129966682|NCT01496365|467843043|FG005|Overall Study|Adverse Event|6|||
129966683|NCT01496365|467843044|FG006|Overall Study|Adverse Event|4|||
129966684|NCT01496365|467843038|FG000|Overall Study|Withdrawal by Subject|6|||
129966685|NCT01496365|467843039|FG001|Overall Study|Withdrawal by Subject|6|||
129966686|NCT01496365|467843040|FG002|Overall Study|Withdrawal by Subject|0|||
129966687|NCT01496365|467843041|FG003|Overall Study|Withdrawal by Subject|1|||
129966688|NCT01496365|467843042|FG004|Overall Study|Withdrawal by Subject|3|||
129966689|NCT01496365|467843043|FG005|Overall Study|Withdrawal by Subject|2|||
129966690|NCT01496365|467843044|FG006|Overall Study|Withdrawal by Subject|1|||
129966691|NCT01496365|467843038|FG000|Overall Study|Protocol Violation|2|||
129966692|NCT01496365|467843039|FG001|Overall Study|Protocol Violation|1|||
129966693|NCT01496365|467843040|FG002|Overall Study|Protocol Violation|1|||
129966694|NCT01496365|467843041|FG003|Overall Study|Protocol Violation|0|||
129966695|NCT01496365|467843042|FG004|Overall Study|Protocol Violation|0|||
129966696|NCT01496365|467843043|FG005|Overall Study|Protocol Violation|1|||
129966697|NCT01496365|467843044|FG006|Overall Study|Protocol Violation|0|||
129966698|NCT01496365|467843038|FG000|Overall Study|Lack of Efficacy|1|||
129966699|NCT01496365|467843039|FG001|Overall Study|Lack of Efficacy|0|||
129966700|NCT01496365|467843040|FG002|Overall Study|Lack of Efficacy|0|||
129966701|NCT01496365|467843041|FG003|Overall Study|Lack of Efficacy|0|||
129966702|NCT01496365|467843042|FG004|Overall Study|Lack of Efficacy|0|||
129966703|NCT01496365|467843043|FG005|Overall Study|Lack of Efficacy|1|||
129966704|NCT01496365|467843044|FG006|Overall Study|Lack of Efficacy|0|||
129966705|NCT01496365|467843038|FG000|Overall Study|Lost to Follow-up|0|||
129966706|NCT01496365|467843039|FG001|Overall Study|Lost to Follow-up|1|||
129966707|NCT01496365|467843040|FG002|Overall Study|Lost to Follow-up|0|||
129966708|NCT01496365|467843041|FG003|Overall Study|Lost to Follow-up|0|||
129966709|NCT01496365|467843042|FG004|Overall Study|Lost to Follow-up|2|||
129966710|NCT01496365|467843043|FG005|Overall Study|Lost to Follow-up|0|||
129966711|NCT01496365|467843044|FG006|Overall Study|Lost to Follow-up|0|||
129966712|NCT01496365|467843038|FG000|Overall Study|Other|4|||
129966713|NCT01496365|467843039|FG001|Overall Study|Other|4|||
129966714|NCT01496365|467843040|FG002|Overall Study|Other|2|||
129966715|NCT01496365|467843041|FG003|Overall Study|Other|1|||
129966716|NCT01496365|467843042|FG004|Overall Study|Other|3|||
129966717|NCT01496365|467843043|FG005|Overall Study|Other|0|||
129966718|NCT01496365|467843044|FG006|Overall Study|Other|1|||
129966719|NCT01843777|467843045|FG000|Overall Study|Withdrawal by Subject|1|||
129966720|NCT01843777|467843046|FG001|Overall Study|Withdrawal by Subject|0|||
129966721|NCT02165397|467843054|FG000|Overall Study|Death|7|||
129966722|NCT02165397|467843055|FG001|Overall Study|Death|10|||
129966723|NCT02165397|467843056|FG002|Overall Study|Death|8|||
129966724|NCT02165397|467843054|FG000|Overall Study|Lost to Follow-up|1|||
129966725|NCT02165397|467843055|FG001|Overall Study|Lost to Follow-up|3|||
129455797|NCT04766021|465966631|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
129966726|NCT02165397|467843056|FG002|Overall Study|Lost to Follow-up|0|||
129966727|NCT02165397|467843054|FG000|Overall Study|Withdrawal by Subject|6|||
129966728|NCT02165397|467843055|FG001|Overall Study|Withdrawal by Subject|6|||
129966729|NCT02165397|467843056|FG002|Overall Study|Withdrawal by Subject|1|||
129966730|NCT02165397|467843054|FG000|Overall Study|Other, Not Specified|0|||
129966731|NCT02165397|467843055|FG001|Overall Study|Other, Not Specified|0|||
129966732|NCT02165397|467843056|FG002|Overall Study|Other, Not Specified|1|||
129966733|NCT02250534|467843065|FG000|Overall Study|Lost to Follow-up|18|||
129966734|NCT02250534|467843066|FG001|Overall Study|Lost to Follow-up|28|||
129966735|NCT02250534|467843067|FG002|Overall Study|Lost to Follow-up|33|||
129966736|NCT02250534|467843065|FG000|Overall Study|Personal reasons|7|||
129966737|NCT02250534|467843066|FG001|Overall Study|Personal reasons|8|||
129966738|NCT02250534|467843067|FG002|Overall Study|Personal reasons|14|||
129966739|NCT02250534|467843065|FG000|Overall Study|Adverse Event|6|||
129966740|NCT02250534|467843066|FG001|Overall Study|Adverse Event|3|||
129966741|NCT02250534|467843067|FG002|Overall Study|Adverse Event|8|||
129966742|NCT02250534|467843065|FG000|Overall Study|incarcerated|2|||
129966743|NCT02250534|467843066|FG001|Overall Study|incarcerated|1|||
129966744|NCT02250534|467843067|FG002|Overall Study|incarcerated|2|||
129966745|NCT02250534|467843065|FG000|Overall Study|Withdrawal by Subject|0|||
129966746|NCT02250534|467843066|FG001|Overall Study|Withdrawal by Subject|1|||
129966747|NCT02250534|467843067|FG002|Overall Study|Withdrawal by Subject|2|||
129966748|NCT02250534|467843065|FG000|Overall Study|Death|0|||
129966749|NCT02250534|467843066|FG001|Overall Study|Death|1|||
129966750|NCT02250534|467843067|FG002|Overall Study|Death|1|||
129966751|NCT02250534|467843065|FG000|Overall Study|Physician Decision|1|||
129966752|NCT02250534|467843066|FG001|Overall Study|Physician Decision|3|||
129966753|NCT02250534|467843067|FG002|Overall Study|Physician Decision|1|||
129966754|NCT02250534|467843065|FG000|Overall Study|Protocol Violation|1|||
129966755|NCT02250534|467843066|FG001|Overall Study|Protocol Violation|0|||
129966756|NCT02250534|467843067|FG002|Overall Study|Protocol Violation|1|||
129966757|NCT02250534|467843065|FG000|Overall Study|Reason unknown|1|||
129966758|NCT02250534|467843066|FG001|Overall Study|Reason unknown|0|||
129966759|NCT02250534|467843067|FG002|Overall Study|Reason unknown|0|||
129966760|NCT00217022|467843068|FG000|Overall Study|Withdrawal by Subject|1|||
129966761|NCT00217022|467843069|FG001|Overall Study|Withdrawal by Subject|1|||
129966762|NCT01182181|467843070|FG000|First Intervention|Adverse Event|1|||
129966763|NCT01182181|467843071|FG001|First Intervention|Adverse Event|0|||
129966764|NCT01182181|467843070|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
129966765|NCT01182181|467843071|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
129455798|NCT02257372|465966637|FG000|Overall Study|Adverse Event|3|||
129966766|NCT03845075|467843072|FG000|Part 1 - DB|Withdrawal by Subject|1|||
129966767|NCT03845075|467843073|FG001|Part 1 - DB|Withdrawal by Subject|1|||
129966768|NCT03845075|467843074|FG002|Part 1 - DB|Withdrawal by Subject|0|||
129966769|NCT03845075|467843075|FG003|Part 1 - DB|Withdrawal by Subject|0|||
129966770|NCT03845075|467843072|FG000|Part 1 - DB|Adverse Event|0|||
129966771|NCT03845075|467843073|FG001|Part 1 - DB|Adverse Event|1|||
129966772|NCT03845075|467843074|FG002|Part 1 - DB|Adverse Event|0|||
129966773|NCT03845075|467843075|FG003|Part 1 - DB|Adverse Event|0|||
129966774|NCT03845075|467843072|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
129966775|NCT03845075|467843073|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
129966776|NCT03845075|467843074|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
129966777|NCT03845075|467843075|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
129966778|NCT03856047|467843076|FG000|Overall Study|Withdrawal by Subject|0|||
129966779|NCT03856047|467843077|FG001|Overall Study|Withdrawal by Subject|1|||
129966780|NCT03856047|467843078|FG002|Overall Study|Withdrawal by Subject|1|||
129966781|NCT03856047|467843079|FG003|Overall Study|Withdrawal by Subject|0|||
129966782|NCT03856047|467843080|FG004|Overall Study|Withdrawal by Subject|3|||
129966783|NCT03856047|467843081|FG005|Overall Study|Withdrawal by Subject|0|||
129966784|NCT03856047|467843082|FG006|Overall Study|Withdrawal by Subject|2|||
129966785|NCT03856047|467843076|FG000|Overall Study|Lost to Follow-up|4|||
129966786|NCT03856047|467843077|FG001|Overall Study|Lost to Follow-up|2|||
129966787|NCT03856047|467843078|FG002|Overall Study|Lost to Follow-up|3|||
129966788|NCT03856047|467843079|FG003|Overall Study|Lost to Follow-up|1|||
129966789|NCT03856047|467843080|FG004|Overall Study|Lost to Follow-up|4|||
129966790|NCT03856047|467843081|FG005|Overall Study|Lost to Follow-up|4|||
129966791|NCT03856047|467843082|FG006|Overall Study|Lost to Follow-up|4|||
129966792|NCT01278615|467843083|FG000|Overall Study|Withdrawal by Subject|2|||
129966793|NCT00905359|467843084|FG000|Overall Study|Lost to Follow-up|17|||
129966794|NCT00905359|467843085|FG001|Overall Study|Lost to Follow-up|10|||
129966795|NCT00905359|467843084|FG000|Overall Study|Death|2|||
129966796|NCT00905359|467843085|FG001|Overall Study|Death|0|||
129966797|NCT00905359|467843084|FG000|Overall Study|Withdrawal consent|5|||
129966798|NCT00905359|467843085|FG001|Overall Study|Withdrawal consent|6|||
129966799|NCT02138253|467843086|FG000|Overall Study|Adverse Event|3|||
129966800|NCT02138253|467843087|FG001|Overall Study|Adverse Event|3|||
129966801|NCT02138253|467843086|FG000|Overall Study|Lost to Follow-up|2|||
129966802|NCT02138253|467843087|FG001|Overall Study|Lost to Follow-up|1|||
129966803|NCT02138253|467843086|FG000|Overall Study|Physician Decision|2|||
129966804|NCT02138253|467843087|FG001|Overall Study|Physician Decision|0|||
129966805|NCT02138253|467843086|FG000|Overall Study|Non compliance|1|||
129966806|NCT02138253|467843087|FG001|Overall Study|Non compliance|0|||
129966807|NCT02138253|467843086|FG000|Overall Study|Withdrawal by Subject|1|||
129966808|NCT02138253|467843087|FG001|Overall Study|Withdrawal by Subject|0|||
129966809|NCT02872012|467843088|FG000|Overall Study|Withdrawal by Subject|1|||
129966810|NCT02872012|467843089|FG001|Overall Study|Withdrawal by Subject|0|||
129966811|NCT02872012|467843090|FG002|Overall Study|Withdrawal by Subject|0|||
129966812|NCT02872012|467843091|FG003|Overall Study|Withdrawal by Subject|0|||
129966813|NCT02872012|467843092|FG004|Overall Study|Withdrawal by Subject|0|||
129966814|NCT01728623|467843093|FG000|Overall Study|Disease progression|26|||
129966815|NCT01728623|467843093|FG000|Overall Study|Adverse Event|1|||
129966816|NCT01728623|467843093|FG000|Overall Study|Withdrawal by Subject|1|||
129966817|NCT00243022|467843094|FG000|Overall Study|Withdrawal by Subject|1|||
129966818|NCT00243022|467843095|FG001|Overall Study|Withdrawal by Subject|0|||
129966819|NCT00243022|467843094|FG000|Overall Study|Death|1|||
129966820|NCT00243022|467843095|FG001|Overall Study|Death|0|||
129966821|NCT00243022|467843094|FG000|Overall Study|Difficult Travel Distance|0|||
129966822|NCT00243022|467843095|FG001|Overall Study|Difficult Travel Distance|1|||
129966823|NCT04706793|467843096|FG000|Treatment|Disease worsening|10|||
129966824|NCT04706793|467843097|FG001|Treatment|Disease worsening|10|||
129966825|NCT04706793|467843096|FG000|Follow-up|Lack of Efficacy|1|||
129966826|NCT04706793|467843097|FG001|Follow-up|Lack of Efficacy|0|||
129966827|NCT04706793|467843096|FG000|Follow-up|Disease worsening|8|||
129966828|NCT04706793|467843097|FG001|Follow-up|Disease worsening|10|||
129966829|NCT04706793|467843096|FG000|Follow-up|Adverse Event|1|||
129966830|NCT04706793|467843097|FG001|Follow-up|Adverse Event|0|||
129966831|NCT03713320|467843100|FG000|Randomized Period|Adverse Event|1|||
129966832|NCT03713320|467843101|FG001|Randomized Period|Adverse Event|5|||
129966833|NCT03713320|467843102|FG002|Randomized Period|Adverse Event|0|||
129966834|NCT03713320|467843100|FG000|Randomized Period|Physician Decision|1|||
129966835|NCT03713320|467843101|FG001|Randomized Period|Physician Decision|1|||
129966836|NCT03713320|467843102|FG002|Randomized Period|Physician Decision|0|||
129966837|NCT03713320|467843100|FG000|Randomized Period|Withdrawal by Subject|4|||
129966838|NCT03713320|467843101|FG001|Randomized Period|Withdrawal by Subject|0|||
129966839|NCT03713320|467843102|FG002|Randomized Period|Withdrawal by Subject|0|||
129966840|NCT03713320|467843100|FG000|Randomized Period|Participant decision|3|||
129966841|NCT03713320|467843101|FG001|Randomized Period|Participant decision|1|||
129966842|NCT03713320|467843102|FG002|Randomized Period|Participant decision|0|||
129966843|NCT03713320|467843100|FG000|Randomized Period|Study terminated by sponsor|6|||
129966844|NCT03713320|467843101|FG001|Randomized Period|Study terminated by sponsor|3|||
129966845|NCT03713320|467843102|FG002|Randomized Period|Study terminated by sponsor|0|||
129966846|NCT03713320|467843100|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
129966847|NCT03713320|467843101|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
129966848|NCT03713320|467843102|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
129966849|NCT03713320|467843100|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
129966850|NCT03713320|467843101|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
129966851|NCT03713320|467843102|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
129966852|NCT01781832|467843103|FG000|Overall Study|Withdrawal by Subject|1|||
129966853|NCT02719743|467843104|FG000|Overall Study|Consent withdrawal|0|||
129966854|NCT02719743|467843105|FG001|Overall Study|Consent withdrawal|2|||
129966855|NCT02719743|467843106|FG002|Overall Study|Consent withdrawal|0|||
129966856|NCT02719743|467843107|FG003|Overall Study|Consent withdrawal|1|||
129966857|NCT02719743|467843108|FG004|Overall Study|Consent withdrawal|0|||
129966858|NCT02719743|467843104|FG000|Overall Study|Migrated/moved from study area|0|||
129966859|NCT02719743|467843105|FG001|Overall Study|Migrated/moved from study area|0|||
129966860|NCT02719743|467843106|FG002|Overall Study|Migrated/moved from study area|0|||
129966861|NCT02719743|467843107|FG003|Overall Study|Migrated/moved from study area|0|||
129966862|NCT02719743|467843108|FG004|Overall Study|Migrated/moved from study area|2|||
129966863|NCT02719743|467843104|FG000|Overall Study|Lost to Follow-up|1|||
129966864|NCT02719743|467843105|FG001|Overall Study|Lost to Follow-up|1|||
129966865|NCT02719743|467843106|FG002|Overall Study|Lost to Follow-up|0|||
129966866|NCT02719743|467843107|FG003|Overall Study|Lost to Follow-up|0|||
129966867|NCT02719743|467843108|FG004|Overall Study|Lost to Follow-up|0|||
129966868|NCT01209598|467843109|FG000|Overall Study|Withdrawal by Subject|1|||
129966869|NCT01209598|467843110|FG001|Overall Study|Withdrawal by Subject|0|||
129966870|NCT02601209|467843111|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
129966871|NCT02601209|467843112|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
129966872|NCT02601209|467843113|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
129966873|NCT02601209|467843114|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966874|NCT02601209|467843115|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966875|NCT02601209|467843116|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966876|NCT02601209|467843117|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966877|NCT02601209|467843118|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966878|NCT02601209|467843119|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
129966879|NCT02601209|467843111|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966880|NCT02601209|467843112|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966881|NCT02601209|467843113|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966882|NCT02601209|467843114|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966883|NCT02601209|467843115|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
129966884|NCT02601209|467843116|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
129966885|NCT02601209|467843117|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
129966886|NCT02601209|467843118|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966887|NCT02601209|467843119|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
129966888|NCT03636373|467843120|FG000|Overall Study|Study closure due to Covid-19|1|||
129966889|NCT03636373|467843121|FG001|Overall Study|Study closure due to Covid-19|0|||
129966890|NCT00572533|467843122|FG000|Overall Study|Death|4|||
129966891|NCT00572533|467843123|FG001|Overall Study|Death|1|||
129966892|NCT00572533|467843122|FG000|Overall Study|Received Kidney Transplant|2|||
129966893|NCT00572533|467843123|FG001|Overall Study|Received Kidney Transplant|1|||
129966894|NCT00572533|467843122|FG000|Overall Study|Social Issues|1|||
129966895|NCT00572533|467843123|FG001|Overall Study|Social Issues|0|||
129966896|NCT00572533|467843122|FG000|Overall Study|Transfer out of Facility|0|||
129966897|NCT00572533|467843123|FG001|Overall Study|Transfer out of Facility|1|||
129966898|NCT03772613|467843124|FG000|Overall Study|Lost to Follow-up|0|||
129966899|NCT03772613|467843125|FG001|Overall Study|Lost to Follow-up|1|||
129966900|NCT03772613|467843126|FG002|Overall Study|Lost to Follow-up|1|||
129966901|NCT01427738|467843127|FG000|Overall Study|Death|12|||
129966902|NCT01427738|467843128|FG001|Overall Study|Death|9|||
129966903|NCT01427738|467843127|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129966904|NCT01427738|467843128|FG001|Overall Study|Severe debilitation, unable to continue|1|||
129966905|NCT01427738|467843127|FG000|Overall Study|Subject unable to get to clinic|5|||
129966906|NCT01427738|467843128|FG001|Overall Study|Subject unable to get to clinic|2|||
129966907|NCT01427738|467843127|FG000|Overall Study|Withdrawal by Subject|0|||
129966908|NCT01427738|467843128|FG001|Overall Study|Withdrawal by Subject|2|||
129966909|NCT01427738|467843127|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
129966910|NCT01427738|467843128|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
129966911|NCT01427738|467843127|FG000|Overall Study|Lost to Follow-up|1|||
129966912|NCT01427738|467843128|FG001|Overall Study|Lost to Follow-up|5|||
129966913|NCT00661713|467843129|FG000|Overall Study|Death|1|||
129966914|NCT00661713|467843130|FG001|Overall Study|Death|0|||
129966915|NCT00661713|467843131|FG002|Overall Study|Death|0|||
129966916|NCT00661713|467843132|FG003|Overall Study|Death|0|||
129966917|NCT00661713|467843133|FG004|Overall Study|Death|1|||
129966918|NCT00661713|467843134|FG005|Overall Study|Death|0|||
129966919|NCT00661713|467843135|FG006|Overall Study|Death|0|||
129966920|NCT00661713|467843136|FG007|Overall Study|Death|0|||
129966921|NCT00661713|467843129|FG000|Overall Study|Unable to Classify|1|||
129966922|NCT00661713|467843130|FG001|Overall Study|Unable to Classify|0|||
129966923|NCT00661713|467843131|FG002|Overall Study|Unable to Classify|0|||
129966924|NCT00661713|467843132|FG003|Overall Study|Unable to Classify|0|||
129966925|NCT00661713|467843133|FG004|Overall Study|Unable to Classify|0|||
129966926|NCT00661713|467843134|FG005|Overall Study|Unable to Classify|0|||
129966927|NCT00661713|467843135|FG006|Overall Study|Unable to Classify|0|||
129966928|NCT00661713|467843136|FG007|Overall Study|Unable to Classify|0|||
129966929|NCT00661713|467843129|FG000|Overall Study|Protocol Violation|1|||
129966930|NCT00661713|467843130|FG001|Overall Study|Protocol Violation|6|||
129966931|NCT00661713|467843131|FG002|Overall Study|Protocol Violation|3|||
129966932|NCT00661713|467843132|FG003|Overall Study|Protocol Violation|3|||
129966933|NCT00661713|467843133|FG004|Overall Study|Protocol Violation|0|||
129966934|NCT00661713|467843134|FG005|Overall Study|Protocol Violation|2|||
129966935|NCT00661713|467843135|FG006|Overall Study|Protocol Violation|2|||
129966936|NCT00661713|467843136|FG007|Overall Study|Protocol Violation|1|||
129966937|NCT00661713|467843129|FG000|Overall Study|Withdrawal by Subject|11|||
129966938|NCT00661713|467843130|FG001|Overall Study|Withdrawal by Subject|25|||
129966939|NCT00661713|467843131|FG002|Overall Study|Withdrawal by Subject|12|||
129966940|NCT00661713|467843132|FG003|Overall Study|Withdrawal by Subject|21|||
129966941|NCT00661713|467843133|FG004|Overall Study|Withdrawal by Subject|12|||
129966942|NCT00661713|467843134|FG005|Overall Study|Withdrawal by Subject|26|||
129966943|NCT00661713|467843135|FG006|Overall Study|Withdrawal by Subject|45|||
129966944|NCT00661713|467843136|FG007|Overall Study|Withdrawal by Subject|9|||
129966945|NCT00661713|467843129|FG000|Overall Study|Lost to Follow-up|2|||
129966946|NCT00661713|467843130|FG001|Overall Study|Lost to Follow-up|7|||
129966947|NCT00661713|467843131|FG002|Overall Study|Lost to Follow-up|2|||
129966948|NCT00661713|467843132|FG003|Overall Study|Lost to Follow-up|2|||
129966949|NCT00661713|467843133|FG004|Overall Study|Lost to Follow-up|5|||
129966950|NCT00661713|467843134|FG005|Overall Study|Lost to Follow-up|7|||
129966951|NCT00661713|467843135|FG006|Overall Study|Lost to Follow-up|14|||
129966952|NCT00661713|467843136|FG007|Overall Study|Lost to Follow-up|1|||
129966953|NCT00661713|467843129|FG000|Overall Study|Administrative Reason|0|||
129966954|NCT00661713|467843130|FG001|Overall Study|Administrative Reason|1|||
129966955|NCT00661713|467843131|FG002|Overall Study|Administrative Reason|0|||
129966956|NCT00661713|467843132|FG003|Overall Study|Administrative Reason|2|||
129966957|NCT00661713|467843133|FG004|Overall Study|Administrative Reason|2|||
129966958|NCT00661713|467843134|FG005|Overall Study|Administrative Reason|2|||
129966959|NCT00661713|467843135|FG006|Overall Study|Administrative Reason|1|||
129966960|NCT00661713|467843136|FG007|Overall Study|Administrative Reason|0|||
129966961|NCT00661713|467843129|FG000|Overall Study|Adverse Event|0|||
129966962|NCT00661713|467843130|FG001|Overall Study|Adverse Event|0|||
129966963|NCT00661713|467843131|FG002|Overall Study|Adverse Event|0|||
129966964|NCT00661713|467843132|FG003|Overall Study|Adverse Event|0|||
129966965|NCT00661713|467843133|FG004|Overall Study|Adverse Event|0|||
129966966|NCT00661713|467843134|FG005|Overall Study|Adverse Event|0|||
129966967|NCT00661713|467843135|FG006|Overall Study|Adverse Event|1|||
129966968|NCT00661713|467843136|FG007|Overall Study|Adverse Event|0|||
129966969|NCT00661713|467843129|FG000|Overall Study|Inappropriate Enrollment|0|||
129966970|NCT00661713|467843130|FG001|Overall Study|Inappropriate Enrollment|0|||
129966971|NCT00661713|467843131|FG002|Overall Study|Inappropriate Enrollment|0|||
129966972|NCT00661713|467843132|FG003|Overall Study|Inappropriate Enrollment|0|||
129966973|NCT00661713|467843133|FG004|Overall Study|Inappropriate Enrollment|0|||
129966974|NCT00661713|467843134|FG005|Overall Study|Inappropriate Enrollment|0|||
129966975|NCT00661713|467843135|FG006|Overall Study|Inappropriate Enrollment|1|||
129966976|NCT00661713|467843136|FG007|Overall Study|Inappropriate Enrollment|0|||
129966977|NCT02658175|467843137|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
129966978|NCT02658175|467843138|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
129966979|NCT02658175|467843139|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
129966980|NCT02658175|467843137|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
129966981|NCT02658175|467843138|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
129966982|NCT02658175|467843139|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
129966983|NCT02658175|467843137|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
129966984|NCT02658175|467843138|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
129966985|NCT02658175|467843139|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
129966986|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
129966987|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
129966988|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
129966989|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
129966990|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
129966991|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
129966992|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
129966993|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
129966994|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
129966995|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
129966996|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
129966997|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
129966998|NCT02658175|467843137|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
129966999|NCT02658175|467843138|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
129967000|NCT02658175|467843139|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
129967001|NCT02658175|467843137|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
129967002|NCT02658175|467843138|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
129967003|NCT02658175|467843139|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
129967004|NCT02658175|467843137|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
129967005|NCT02658175|467843138|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
129967006|NCT02658175|467843139|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
129967007|NCT01801982|467843143|FG000|Overall Study|Lost to Follow-up|1|||
129967008|NCT02918292|467843144|FG000|Study Enrollment Prior to Transplant|Death|1|||
129967009|NCT02918292|467843144|FG000|Study Follow up After Transplant|Death|6|||
129967010|NCT00727506|467843145|FG000|Overall Study|Adverse Event|0|||
129967011|NCT00727506|467843146|FG001|Overall Study|Adverse Event|0|||
129967012|NCT00727506|467843147|FG002|Overall Study|Adverse Event|4|||
129967013|NCT00727506|467843148|FG003|Overall Study|Adverse Event|4|||
129967014|NCT00727506|467843149|FG004|Overall Study|Adverse Event|1|||
129967015|NCT00727506|467843150|FG005|Overall Study|Adverse Event|8|||
129967016|NCT00727506|467843145|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129967017|NCT00727506|467843146|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967018|NCT00727506|467843147|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129967019|NCT00727506|467843148|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967020|NCT00727506|467843149|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967021|NCT00727506|467843150|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129967022|NCT00727506|467843145|FG000|Overall Study|Progressive disease|4|||
129967023|NCT00727506|467843146|FG001|Overall Study|Progressive disease|7|||
129967024|NCT00727506|467843147|FG002|Overall Study|Progressive disease|9|||
129967025|NCT00727506|467843148|FG003|Overall Study|Progressive disease|28|||
129967026|NCT00727506|467843149|FG004|Overall Study|Progressive disease|38|||
129967027|NCT00727506|467843150|FG005|Overall Study|Progressive disease|28|||
129967028|NCT00727506|467843145|FG000|Overall Study|Refused to continue medication|0|||
129967029|NCT00727506|467843146|FG001|Overall Study|Refused to continue medication|1|||
129967030|NCT00727506|467843147|FG002|Overall Study|Refused to continue medication|2|||
129967031|NCT00727506|467843148|FG003|Overall Study|Refused to continue medication|3|||
129967032|NCT00727506|467843149|FG004|Overall Study|Refused to continue medication|1|||
129967033|NCT00727506|467843150|FG005|Overall Study|Refused to continue medication|2|||
129967034|NCT00727506|467843145|FG000|Overall Study|Other reason not described above|0|||
129967035|NCT00727506|467843146|FG001|Overall Study|Other reason not described above|0|||
129967036|NCT00727506|467843147|FG002|Overall Study|Other reason not described above|1|||
129967037|NCT00727506|467843148|FG003|Overall Study|Other reason not described above|4|||
129967038|NCT00727506|467843149|FG004|Overall Study|Other reason not described above|1|||
129967039|NCT00727506|467843150|FG005|Overall Study|Other reason not described above|1|||
129967040|NCT00715117|467843151|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
129967041|NCT00715117|467843152|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
129967042|NCT01482429|467843153|FG000|Care Usual|Protocol Violation|0|||
129967043|NCT01482429|467843154|FG001|Care Usual|Protocol Violation|172|||
129967044|NCT01482429|467843153|FG000|Care Usual|Lost to Follow-up|0|||
129967045|NCT01482429|467843154|FG001|Care Usual|Lost to Follow-up|1|||
129967046|NCT01482429|467843153|FG000|Protocol|Protocol Violation|275|||
129967047|NCT01482429|467843154|FG001|Protocol|Protocol Violation|0|||
129967048|NCT01214421|467843155|FG000|Overall Study|Lost to Follow-up|7|||
129967049|NCT01214421|467843156|FG001|Overall Study|Lost to Follow-up|3|||
129967050|NCT01214421|467843157|FG002|Overall Study|Lost to Follow-up|7|||
129967051|NCT01214421|467843158|FG003|Overall Study|Lost to Follow-up|3|||
129967052|NCT01214421|467843155|FG000|Overall Study|Adverse Event|16|||
129967053|NCT01214421|467843156|FG001|Overall Study|Adverse Event|35|||
129967054|NCT01214421|467843157|FG002|Overall Study|Adverse Event|14|||
129967055|NCT01214421|467843158|FG003|Overall Study|Adverse Event|3|||
129967056|NCT01214421|467843155|FG000|Overall Study|Sponsor Discontinued Site|1|||
129967057|NCT01214421|467843156|FG001|Overall Study|Sponsor Discontinued Site|2|||
129967058|NCT01214421|467843157|FG002|Overall Study|Sponsor Discontinued Site|0|||
129967059|NCT01214421|467843158|FG003|Overall Study|Sponsor Discontinued Site|0|||
129967060|NCT01214421|467843155|FG000|Overall Study|Withdrawal Criteria Met|3|||
129967061|NCT01214421|467843156|FG001|Overall Study|Withdrawal Criteria Met|0|||
129967062|NCT01214421|467843157|FG002|Overall Study|Withdrawal Criteria Met|2|||
129967063|NCT01214421|467843158|FG003|Overall Study|Withdrawal Criteria Met|1|||
129967064|NCT01214421|467843155|FG000|Overall Study|Physician Decision|2|||
129967065|NCT01214421|467843156|FG001|Overall Study|Physician Decision|0|||
129967066|NCT01214421|467843157|FG002|Overall Study|Physician Decision|4|||
129967067|NCT01214421|467843158|FG003|Overall Study|Physician Decision|0|||
129967068|NCT01214421|467843155|FG000|Overall Study|Withdrawal by Subject|21|||
129967069|NCT01214421|467843156|FG001|Overall Study|Withdrawal by Subject|18|||
129967070|NCT01214421|467843157|FG002|Overall Study|Withdrawal by Subject|11|||
129967071|NCT01214421|467843158|FG003|Overall Study|Withdrawal by Subject|2|||
129967072|NCT03561597|467843159|FG000|Overall Study|Lost to Follow-up|20|||
129967073|NCT03783689|467843161|FG000|Overall Study|Adverse Event|2|||
129967074|NCT03783689|467843162|FG001|Overall Study|Adverse Event|0|||
129455799|NCT02257372|465966638|FG001|Overall Study|Adverse Event|7|||
129455800|NCT02257372|465966637|FG000|Overall Study|Lack of Efficacy|2|||
129455801|NCT02257372|465966638|FG001|Overall Study|Lack of Efficacy|1|||
129455802|NCT02257372|465966637|FG000|Overall Study|Protocol Violation|1|||
129455803|NCT02257372|465966638|FG001|Overall Study|Protocol Violation|1|||
129455804|NCT02257372|465966637|FG000|Overall Study|Lost to Follow-up|0|||
129455805|NCT02257372|465966638|FG001|Overall Study|Lost to Follow-up|1|||
129455806|NCT02257372|465966637|FG000|Overall Study|Withdrew consent|1|||
129455807|NCT02257372|465966638|FG001|Overall Study|Withdrew consent|0|||
129455808|NCT00789529|465966639|FG000|Overall Study|Withdrawal by Subject|0|||
129455809|NCT00789529|465966640|FG001|Overall Study|Withdrawal by Subject|1|||
129455810|NCT00789529|465966639|FG000|Overall Study|Other Reason|1|||
129455811|NCT00789529|465966640|FG001|Overall Study|Other Reason|0|||
129455812|NCT02634151|465966641|FG000|Overall Study|Withdrawal by Subject|1|||
129455813|NCT02634151|465966642|FG001|Overall Study|Withdrawal by Subject|0|||
129455814|NCT02634151|465966641|FG000|Overall Study|Non-Compliance|0|||
129455815|NCT02634151|465966642|FG001|Overall Study|Non-Compliance|1|||
129455816|NCT02634151|465966641|FG000|Overall Study|Other|0|||
129455817|NCT02634151|465966642|FG001|Overall Study|Other|1|||
129455818|NCT02347098|465966643|FG000|Overall Study|Death|1|||
129455819|NCT02347098|465966644|FG001|Overall Study|Death|0|||
129455820|NCT02347098|465966643|FG000|Overall Study|Withdrawal by Subject|1|||
129455821|NCT02347098|465966644|FG001|Overall Study|Withdrawal by Subject|0|||
129455822|NCT02347098|465966643|FG000|Overall Study|Lost to Follow-up|2|||
129455823|NCT02347098|465966644|FG001|Overall Study|Lost to Follow-up|2|||
129455824|NCT02347098|465966643|FG000|Overall Study|Refuse Follow-up Visit|1|||
129967075|NCT03783689|467843161|FG000|Overall Study|Lost to Follow-up|2|||
129967076|NCT03783689|467843162|FG001|Overall Study|Lost to Follow-up|1|||
129967077|NCT03783689|467843161|FG000|Overall Study|Physician Decision|2|||
129967078|NCT03783689|467843162|FG001|Overall Study|Physician Decision|1|||
129967079|NCT03783689|467843161|FG000|Overall Study|Withdrawal by Subject|3|||
129967080|NCT03783689|467843162|FG001|Overall Study|Withdrawal by Subject|3|||
129967081|NCT02392104|467843165|FG000|Overall Study|discontinuation of warfarin|3|||
129967082|NCT02392104|467843165|FG000|Overall Study|bleeding event|1|||
129967083|NCT02392104|467843165|FG000|Overall Study|transferred care to another doctor|2|||
129967084|NCT02392104|467843165|FG000|Overall Study|INR goal range changed|1|||
129967085|NCT02392104|467843165|FG000|Overall Study|admitted to skilled nursing facility|3|||
129967086|NCT02392104|467843165|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
129967087|NCT04887506|467843166|FG000|Overall Study|Death|1|||
129967088|NCT04887506|467843167|FG001|Overall Study|Death|1|||
129967089|NCT04887506|467843166|FG000|Overall Study|Withdrawal by Subject|0|||
129967090|NCT04887506|467843167|FG001|Overall Study|Withdrawal by Subject|3|||
129967091|NCT04887506|467843166|FG000|Overall Study|Adverse Event|4|||
129967092|NCT04887506|467843167|FG001|Overall Study|Adverse Event|3|||
129967093|NCT04887506|467843166|FG000|Overall Study|Other - Not Reported|1|||
129967094|NCT04887506|467843167|FG001|Overall Study|Other - Not Reported|1|||
129967095|NCT01255761|467843168|FG000|Overall Study|Adverse Event|29|||
129967096|NCT01255761|467843169|FG001|Overall Study|Adverse Event|43|||
129967097|NCT01255761|467843168|FG000|Overall Study|Lack of Efficacy|86|||
129967098|NCT01255761|467843169|FG001|Overall Study|Lack of Efficacy|74|||
129967099|NCT01255761|467843168|FG000|Overall Study|Protocol Violation|9|||
129967100|NCT01255761|467843169|FG001|Overall Study|Protocol Violation|5|||
129967101|NCT01255761|467843168|FG000|Overall Study|Lost to Follow-up|10|||
129967102|NCT01255761|467843169|FG001|Overall Study|Lost to Follow-up|8|||
129967103|NCT01255761|467843168|FG000|Overall Study|Withdrawal by Subject|11|||
129967104|NCT01255761|467843169|FG001|Overall Study|Withdrawal by Subject|27|||
129967105|NCT01255761|467843168|FG000|Overall Study|Other Reasons|37|||
129967106|NCT01255761|467843169|FG001|Overall Study|Other Reasons|18|||
129967107|NCT05613088|467843172|FG000|Treatment|Ongoing Study Treatment|9|||
129967108|NCT05613088|467843173|FG001|Treatment|Ongoing Study Treatment|2|||
129967109|NCT05613088|467843172|FG000|Treatment|Adverse Event|3|||
129455825|NCT02347098|465966644|FG001|Overall Study|Refuse Follow-up Visit|5|||
129455826|NCT02347098|465966643|FG000|Overall Study|no visit due to illness|2|||
129455827|NCT02347098|465966644|FG001|Overall Study|no visit due to illness|1|||
129455828|NCT02187172|465966645|FG000|Overall Study|Lost to Follow-up|1|||
129967110|NCT05613088|467843173|FG001|Treatment|Adverse Event|1|||
129967111|NCT05613088|467843172|FG000|Treatment|Other Reasons|0|||
129967112|NCT05613088|467843173|FG001|Treatment|Other Reasons|1|||
129967113|NCT05613088|467843172|FG000|Treatment|Progressive Disease|58|||
129967114|NCT05613088|467843173|FG001|Treatment|Progressive Disease|26|||
129967115|NCT05613088|467843172|FG000|Treatment|Withdrawal by Subject|0|||
129967116|NCT05613088|467843173|FG001|Treatment|Withdrawal by Subject|4|||
129967117|NCT03569891|467843176|FG000|Lead-in|Ineligible during lead-in|8|||
129967118|NCT03569891|467843176|FG000|Lead-in|Withdrawal by Subject|3|||
129967119|NCT03569891|467843176|FG000|Lead-in|Risks related to COVID-19|2|||
129967120|NCT03569891|467843176|FG000|AMT-061|Adverse Event|1|||
129967121|NCT02647645|467843179|FG000|Overall Study|Lost to Follow-up|2|||
129455829|NCT02187172|465966646|FG001|Overall Study|Lost to Follow-up|2|||
129455830|NCT02187172|465966645|FG000|Overall Study|Lack of Efficacy|1|||
129967122|NCT02647645|467843180|FG001|Overall Study|Lost to Follow-up|1|||
129967123|NCT00356811|467843181|FG000|Overall Study|Death|35|||
129967124|NCT00356811|467843181|FG000|Overall Study|Lost to Follow-up|2|||
129967125|NCT00356811|467843181|FG000|Overall Study|Withdrawal by Subject|6|||
129967126|NCT00356811|467843181|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
129967127|NCT00356811|467843181|FG000|Overall Study|Study Is Terminating|3|||
129967128|NCT00356811|467843181|FG000|Overall Study|Site Closed during Follow-up|2|||
129967129|NCT02101983|467843182|FG000|Overall Study|Physician Decision|1|||
129967130|NCT02101983|467843183|FG001|Overall Study|Physician Decision|0|||
129967131|NCT03614676|467844883|FG000|Overall Study|Delivery before planned visit|2|||
129967132|NCT03614676|467844884|FG001|Overall Study|Delivery before planned visit|0|||
129967133|NCT03614676|467844883|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
129967134|NCT03614676|467844884|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
129967135|NCT03614676|467844883|FG000|Overall Study|Migrated / moved from the study area|30|||
129967136|NCT03614676|467844884|FG001|Overall Study|Migrated / moved from the study area|22|||
129967137|NCT03614676|467844883|FG000|Overall Study|Lost to Follow-up|17|||
129967138|NCT03614676|467844884|FG001|Overall Study|Lost to Follow-up|42|||
129967139|NCT03614676|467844883|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
129967140|NCT03614676|467844884|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
129967141|NCT03614676|467844883|FG000|Overall Study|Other|16|||
129967142|NCT03614676|467844884|FG001|Overall Study|Other|47|||
129967143|NCT03614676|467844883|FG000|Overall Study|Protocol Violation|0|||
129967144|NCT03614676|467844884|FG001|Overall Study|Protocol Violation|2|||
129967145|NCT03614676|467844883|FG000|Overall Study|Neonatal event of interest|0|||
129967146|NCT03614676|467844884|FG001|Overall Study|Neonatal event of interest|6|||
129967147|NCT03614676|467844883|FG000|Overall Study|Death in infant greater than 28 days old|0|||
129967148|NCT03614676|467844884|FG001|Overall Study|Death in infant greater than 28 days old|12|||
129967149|NCT03614676|467844883|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
129967150|NCT03614676|467844884|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
129967151|NCT00903760|467844885|FG000|Overall Study|Disease Progression/Death|8|||
129967152|NCT00903760|467844886|FG001|Overall Study|Disease Progression/Death|6|||
129967153|NCT00903760|467844885|FG000|Overall Study|Stem Cell Transplant|8|||
129967154|NCT00903760|467844886|FG001|Overall Study|Stem Cell Transplant|4|||
129967155|NCT00903760|467844885|FG000|Overall Study|Physician Decision|1|||
129967156|NCT00903760|467844886|FG001|Overall Study|Physician Decision|2|||
129967157|NCT00903760|467844885|FG000|Overall Study|Death|0|||
129967158|NCT00903760|467844886|FG001|Overall Study|Death|1|||
129967159|NCT00903760|467844885|FG000|Overall Study|Lost to Follow-up|1|||
129967160|NCT00903760|467844886|FG001|Overall Study|Lost to Follow-up|0|||
129967161|NCT00903760|467844885|FG000|Overall Study|Withdrawal by Subject|1|||
129967162|NCT00903760|467844886|FG001|Overall Study|Withdrawal by Subject|2|||
129967163|NCT00903760|467844885|FG000|Overall Study|Off treatment for long period|0|||
129967164|NCT00903760|467844886|FG001|Overall Study|Off treatment for long period|1|||
129967165|NCT02388347|467844887|FG000|Overall Study|Withdrawal by Subject|0|||
129967166|NCT02388347|467844888|FG001|Overall Study|Withdrawal by Subject|0|||
129967167|NCT02388347|467844889|FG002|Overall Study|Withdrawal by Subject|1|||
129967168|NCT02388347|467844890|FG003|Overall Study|Withdrawal by Subject|0|||
129967169|NCT02388347|467844891|FG004|Overall Study|Withdrawal by Subject|0|||
129967170|NCT02825251|467844893|FG000|Overall Study|Adverse Event|0|||
129967171|NCT02825251|467844894|FG001|Overall Study|Adverse Event|1|||
129967172|NCT02825251|467844893|FG000|Overall Study|Lost to Follow-up|0|||
129967173|NCT02825251|467844894|FG001|Overall Study|Lost to Follow-up|1|||
129967174|NCT02825251|467844893|FG000|Overall Study|Withdrawal by Subject|1|||
129967175|NCT02825251|467844894|FG001|Overall Study|Withdrawal by Subject|4|||
129967176|NCT02825251|467844893|FG000|Overall Study|Unclassified|2|||
129967177|NCT02825251|467844894|FG001|Overall Study|Unclassified|0|||
129967178|NCT01845805|467844895|FG000|Overall Study|Withdrawal by Subject|1|||
129967179|NCT01845805|467844896|FG001|Overall Study|Withdrawal by Subject|2|||
129967180|NCT01845805|467844895|FG000|Overall Study|Disease Progression|13|||
129967181|NCT01845805|467844896|FG001|Overall Study|Disease Progression|14|||
129967182|NCT01845805|467844895|FG000|Overall Study|Drug-related Toxicity|4|||
129967183|NCT01845805|467844896|FG001|Overall Study|Drug-related Toxicity|0|||
129967184|NCT04795336|467844898|FG000|Overall Study|Withdrawal by Subject|3|||
129967185|NCT04795336|467844899|FG001|Overall Study|Withdrawal by Subject|4|||
129967186|NCT04795336|467844900|FG002|Overall Study|Withdrawal by Subject|3|||
129967187|NCT04795336|467844901|FG003|Overall Study|Withdrawal by Subject|12|||
129967188|NCT04795336|467844898|FG000|Overall Study|Lost study logs|0|||
129967189|NCT04795336|467844899|FG001|Overall Study|Lost study logs|1|||
129967190|NCT04795336|467844900|FG002|Overall Study|Lost study logs|0|||
129967191|NCT04795336|467844901|FG003|Overall Study|Lost study logs|2|||
129967192|NCT04795336|467844898|FG000|Overall Study|Did not take study medication|2|||
129967193|NCT04795336|467844899|FG001|Overall Study|Did not take study medication|0|||
129967194|NCT04795336|467844900|FG002|Overall Study|Did not take study medication|0|||
129967195|NCT04795336|467844901|FG003|Overall Study|Did not take study medication|0|||
129967196|NCT03898700|467844902|FG000|Overall Study|Withdrawal by Subject|2|||
129967197|NCT00971997|467844903|FG000|Overall Study|Adverse Event|2|||
129967198|NCT00971997|467844903|FG000|Overall Study|Death|1|||
129967199|NCT00971997|467844903|FG000|Overall Study|Protocol Violation|4|||
129967200|NCT00971997|467844903|FG000|Overall Study|Withdrawal by Subject|5|||
129967201|NCT00971997|467844903|FG000|Overall Study|Physician Decision|7|||
129967202|NCT01266018|467844907|FG000|Overall Study|Physician Decision|1|||
129967203|NCT01266018|467844908|FG001|Overall Study|Physician Decision|0|||
129967204|NCT01266018|467844907|FG000|Overall Study|Progressive disease|0|||
129967205|NCT01266018|467844908|FG001|Overall Study|Progressive disease|1|||
129967206|NCT02684123|467844909|FG000|Phase 1|Lack of Efficacy|5|||
129967207|NCT02684123|467844910|FG001|Phase 1|Lack of Efficacy|0|||
129967208|NCT02684123|467844909|FG000|Phase 1|Adverse Event|3|||
129967209|NCT02684123|467844910|FG001|Phase 1|Adverse Event|0|||
129967210|NCT02684123|467844909|FG000|Phase 1|Lost to Follow-up|0|||
129967211|NCT02684123|467844910|FG001|Phase 1|Lost to Follow-up|1|||
129967212|NCT02684123|467844909|FG000|Phase 2|Lack of Efficacy|1|||
129967213|NCT02684123|467844910|FG001|Phase 2|Lack of Efficacy|8|||
129967214|NCT00516139|467844911|FG000|Overall Study|Adverse Event|27|||
129967215|NCT00516139|467844911|FG000|Overall Study|Lost to Follow-up|1|||
129967216|NCT00516139|467844911|FG000|Overall Study|Protocol Violation|1|||
129967217|NCT00516139|467844911|FG000|Overall Study|Withdrawal by Subject|8|||
129967218|NCT00516139|467844911|FG000|Overall Study|Lack of Efficacy|1|||
129967219|NCT00416598|467844912|FG000|Induction & Intensification|Adverse Event|38|||
129967220|NCT00416598|467844912|FG000|Induction & Intensification|Death|32|||
129967221|NCT00416598|467844912|FG000|Induction & Intensification|Withdrawal by Subject|46|||
129967222|NCT00416598|467844912|FG000|Induction & Intensification|Alternative Treatment|135|||
129967223|NCT00416598|467844912|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
129967224|NCT00416598|467844912|FG000|Induction & Intensification|Relapse/progression|29|||
129967225|NCT00416598|467844912|FG000|Induction & Intensification|Failed induction|87|||
129967226|NCT00416598|467844912|FG000|Decitabine Maintenance|Adverse Event|5|||
129967227|NCT00416598|467844912|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
129967228|NCT00416598|467844912|FG000|Decitabine Maintenance|Progression/relapse|38|||
129967229|NCT00416598|467844912|FG000|Decitabine Maintenance|Alternative treatment|2|||
129967230|NCT00416598|467844912|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
129967231|NCT02166476|467844919|FG000|Overall Study|Withdrawal by Subject|5|||
129967232|NCT02166476|467844920|FG001|Overall Study|Withdrawal by Subject|7|||
129967233|NCT02166476|467844919|FG000|Overall Study|Adverse Event|3|||
129967234|NCT02166476|467844920|FG001|Overall Study|Adverse Event|3|||
129967235|NCT02166476|467844919|FG000|Overall Study|Lost to Follow-up|5|||
129967236|NCT02166476|467844920|FG001|Overall Study|Lost to Follow-up|10|||
129967237|NCT02166476|467844919|FG000|Overall Study|Physician Decision|1|||
129967238|NCT02166476|467844920|FG001|Overall Study|Physician Decision|0|||
129967239|NCT02166476|467844919|FG000|Overall Study|Unable to Come for Visit|0|||
129967240|NCT02166476|467844920|FG001|Overall Study|Unable to Come for Visit|3|||
129967241|NCT02053610|467844925|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
129967242|NCT02053610|467844926|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
129967243|NCT02053610|467844925|FG000|Overall Study|Withdrew Consent|2|||
129967244|NCT02053610|467844926|FG001|Overall Study|Withdrew Consent|9|||
129967245|NCT02053610|467844925|FG000|Overall Study|Death|5|||
129967246|NCT02053610|467844926|FG001|Overall Study|Death|5|||
129967247|NCT02053610|467844925|FG000|Overall Study|Administrative/Other|1|||
129967248|NCT02053610|467844926|FG001|Overall Study|Administrative/Other|1|||
129967249|NCT02053610|467844925|FG000|Overall Study|Disease Progression|2|||
129967250|NCT02053610|467844926|FG001|Overall Study|Disease Progression|3|||
129967251|NCT02053610|467844925|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
129967252|NCT02053610|467844926|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
129967253|NCT02053610|467844925|FG000|Overall Study|Did not Receive Treatment|4|||
129967254|NCT02053610|467844926|FG001|Overall Study|Did not Receive Treatment|2|||
129967255|NCT02053610|467844925|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129967256|NCT02053610|467844926|FG001|Overall Study|Insufficient Therapeutic Response|1|||
129967257|NCT02053610|467844925|FG000|Overall Study|Violation of Selection Criteria|1|||
129967258|NCT02053610|467844926|FG001|Overall Study|Violation of Selection Criteria|0|||
129967259|NCT00543062|467844932|FG000|Overall Study|Withdrawal by Subject|1|||
129967260|NCT00543062|467844933|FG001|Overall Study|Withdrawal by Subject|0|||
129967261|NCT00543062|467844934|FG002|Overall Study|Withdrawal by Subject|2|||
129967262|NCT00543062|467844935|FG003|Overall Study|Withdrawal by Subject|0|||
129967263|NCT00543062|467844932|FG000|Overall Study|Adverse Event|0|||
129967264|NCT00543062|467844933|FG001|Overall Study|Adverse Event|1|||
129967265|NCT00543062|467844934|FG002|Overall Study|Adverse Event|1|||
129967266|NCT00543062|467844935|FG003|Overall Study|Adverse Event|1|||
129967267|NCT00543062|467844932|FG000|Overall Study|Protocol Violation|1|||
129967268|NCT00543062|467844933|FG001|Overall Study|Protocol Violation|0|||
129967269|NCT00543062|467844934|FG002|Overall Study|Protocol Violation|0|||
129967270|NCT00543062|467844935|FG003|Overall Study|Protocol Violation|0|||
129967271|NCT01513330|467844936|FG000|SenSura Mio First,|Adverse Event|2|||
129967272|NCT01513330|467844937|FG001|SenSura Mio First,|Adverse Event|0|||
129967273|NCT01513330|467844936|FG000|SenSura Mio First,|Lack of Efficacy|0|||
129967274|NCT01513330|467844937|FG001|SenSura Mio First,|Lack of Efficacy|1|||
129967275|NCT01513330|467844936|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
129967276|NCT01513330|467844937|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
129967277|NCT01513330|467844936|FG000|SenSura Mio First,|Other|1|||
129967278|NCT01513330|467844937|FG001|SenSura Mio First,|Other|0|||
129967279|NCT01513330|467844936|FG000|Standard Care First,|Lack of Efficacy|2|||
129967280|NCT01513330|467844937|FG001|Standard Care First,|Lack of Efficacy|2|||
129967281|NCT01513330|467844936|FG000|Standard Care First,|Withdrawal by Subject|1|||
129967282|NCT01513330|467844937|FG001|Standard Care First,|Withdrawal by Subject|2|||
129967283|NCT01513330|467844936|FG000|Standard Care First,|Other|1|||
129967284|NCT01513330|467844937|FG001|Standard Care First,|Other|0|||
129967285|NCT02232399|467844942|FG000|Overall Study|Adverse Event|1|||
129967286|NCT02232399|467844943|FG001|Overall Study|Adverse Event|0|||
129967287|NCT02232399|467844942|FG000|Overall Study|Withdrawal by Subject|0|||
129967288|NCT02232399|467844943|FG001|Overall Study|Withdrawal by Subject|1|||
129967289|NCT01777334|467844944|FG000|Overall Study|Adverse Event|18|||
129967290|NCT01777334|467844945|FG001|Overall Study|Adverse Event|14|||
129967291|NCT01777334|467844944|FG000|Overall Study|Lack of Efficacy|15|||
129967292|NCT01777334|467844945|FG001|Overall Study|Lack of Efficacy|29|||
129967293|NCT01777334|467844944|FG000|Overall Study|Protocol Violation|3|||
129967294|NCT01777334|467844945|FG001|Overall Study|Protocol Violation|7|||
129967295|NCT01777334|467844944|FG000|Overall Study|Lost to Follow-up|3|||
129967296|NCT01777334|467844945|FG001|Overall Study|Lost to Follow-up|2|||
129967297|NCT01777334|467844944|FG000|Overall Study|Withdrawal by Subject|14|||
129967298|NCT01777334|467844945|FG001|Overall Study|Withdrawal by Subject|11|||
129967299|NCT00632021|467844957|FG000|Overall Study|Withdrawal/death|4|||
129967300|NCT00632021|467844958|FG001|Overall Study|Withdrawal/death|7|||
129967301|NCT00952848|467844961|FG000|Overall Study|Withdrawal by Subject|4|||
129967302|NCT00458393|467844962|FG000|Overall Study|Withdrawal by Subject|67|||
129967303|NCT00458393|467844963|FG001|Overall Study|Withdrawal by Subject|80|||
129967304|NCT00458393|467844962|FG000|Overall Study|Physician Decision|31|||
129967305|NCT00458393|467844963|FG001|Overall Study|Physician Decision|22|||
129967306|NCT00458393|467844962|FG000|Overall Study|Relocated|77|||
129967307|NCT00458393|467844963|FG001|Overall Study|Relocated|81|||
129967308|NCT00458393|467844962|FG000|Overall Study|Lost to Follow-up|115|||
129967309|NCT00458393|467844963|FG001|Overall Study|Lost to Follow-up|92|||
129967310|NCT00458393|467844962|FG000|Overall Study|Sites marked other on the form.|19|||
129967311|NCT00458393|467844963|FG001|Overall Study|Sites marked other on the form.|20|||
129967312|NCT00857233|467844966|FG000|Overall Study|Adverse Event|24|||
129967313|NCT00857233|467844966|FG000|Overall Study|Lack of Efficacy|1|||
129967314|NCT00857233|467844966|FG000|Overall Study|Non-compliance|1|||
129967315|NCT00857233|467844966|FG000|Overall Study|Withdrawal of Consent|9|||
129967316|NCT00857233|467844966|FG000|Overall Study|Lost to Follow-up|4|||
129967317|NCT00857233|467844966|FG000|Overall Study|Nursing Home Placement|14|||
129967318|NCT00857233|467844966|FG000|Overall Study|Other Reasons|2|||
129967319|NCT01587118|467844967|FG000|Overall Study|Adverse Event|3|||
129967320|NCT01587118|467844967|FG000|Overall Study|Lost to Follow-up|2|||
129967321|NCT01587118|467844967|FG000|Overall Study|Relocation|1|||
129967322|NCT01587118|467844967|FG000|Overall Study|nonresponse|1|||
129967323|NCT00537329|467844968|FG000|Overall Study|Death|10|||
129967324|NCT00537329|467844968|FG000|Overall Study|Adverse Event|3|||
129967325|NCT00537329|467844968|FG000|Overall Study|Lack of Efficacy|2|||
129967326|NCT00537329|467844968|FG000|Overall Study|Lost to Follow-up|6|||
129967327|NCT00537329|467844968|FG000|Overall Study|Withdrawal by Subject|4|||
129967328|NCT00537329|467844968|FG000|Overall Study|Other|1|||
129967329|NCT02287233|467844970|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
129967330|NCT02287233|467844971|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
129967331|NCT02287233|467844972|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
129455831|NCT02187172|465966646|FG001|Overall Study|Lack of Efficacy|2|||
129967332|NCT02287233|467844970|FG000|Overall Study|Adverse Event Related to Progression|0|||
129967333|NCT02287233|467844971|FG001|Overall Study|Adverse Event Related to Progression|2|||
129967334|NCT02287233|467844972|FG002|Overall Study|Adverse Event Related to Progression|8|||
129967335|NCT02287233|467844970|FG000|Overall Study|Physician Decision|1|||
129967336|NCT02287233|467844971|FG001|Overall Study|Physician Decision|2|||
129967337|NCT02287233|467844972|FG002|Overall Study|Physician Decision|4|||
129967338|NCT02287233|467844970|FG000|Overall Study|Progressive Disease with Death|0|||
129967339|NCT02287233|467844971|FG001|Overall Study|Progressive Disease with Death|0|||
129967340|NCT02287233|467844972|FG002|Overall Study|Progressive Disease with Death|10|||
129967341|NCT02287233|467844970|FG000|Overall Study|Progressive Disease Without Death|2|||
129967342|NCT02287233|467844971|FG001|Overall Study|Progressive Disease Without Death|3|||
129967343|NCT02287233|467844972|FG002|Overall Study|Progressive Disease Without Death|20|||
129967344|NCT02287233|467844970|FG000|Overall Study|Withdrawal by Subject|1|||
129967345|NCT02287233|467844971|FG001|Overall Study|Withdrawal by Subject|1|||
129967346|NCT02287233|467844972|FG002|Overall Study|Withdrawal by Subject|7|||
129967347|NCT02287233|467844970|FG000|Overall Study|Other|3|||
129967348|NCT02287233|467844971|FG001|Overall Study|Other|0|||
129967349|NCT02287233|467844972|FG002|Overall Study|Other|15|||
129967350|NCT02287233|467844970|FG000|Overall Study|Did Not Receive Treatment|0|||
129967351|NCT02287233|467844971|FG001|Overall Study|Did Not Receive Treatment|0|||
129967352|NCT02287233|467844972|FG002|Overall Study|Did Not Receive Treatment|2|||
129967353|NCT00085566|467844973|FG000|Overall Study|Adverse Event|0|||
129967354|NCT00085566|467844974|FG001|Overall Study|Adverse Event|0|||
129967355|NCT00085566|467844975|FG002|Overall Study|Adverse Event|10|||
129967356|NCT00085566|467844973|FG000|Overall Study|Patient Not treated|0|||
129967357|NCT00085566|467844974|FG001|Overall Study|Patient Not treated|0|||
129967358|NCT00085566|467844975|FG002|Overall Study|Patient Not treated|3|||
129967359|NCT00085566|467844973|FG000|Overall Study|Clinical progression|0|||
129967360|NCT00085566|467844974|FG001|Overall Study|Clinical progression|0|||
129967361|NCT00085566|467844975|FG002|Overall Study|Clinical progression|1|||
129967362|NCT03174782|467844976|FG000|Overall Study|Protocol Violation|1|||
129967363|NCT03174782|467844977|FG001|Overall Study|Protocol Violation|0|||
129967364|NCT03174782|467844976|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
129967365|NCT03174782|467844977|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
129967366|NCT03178045|467844978|FG000|Overall Study|Withdrawal by Subject|5|||
129967367|NCT03178045|467844979|FG001|Overall Study|Withdrawal by Subject|7|||
129967368|NCT03178045|467844978|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
129967369|NCT03178045|467844979|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
129967370|NCT03178045|467844978|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
129967371|NCT03178045|467844979|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
129967372|NCT03432390|467844982|FG000|Apnea Period|Protocol Violation|2|||
129967373|NCT03432390|467844983|FG001|Apnea Period|Protocol Violation|2|||
129967374|NCT00547534|467844987|FG000|Overall Study|Adverse Event|7|||
129967375|NCT00547534|467844987|FG000|Overall Study|Disease Progression|4|||
129967376|NCT00763451|467844989|FG000|Overall Study|Adverse Event|4|||
129967377|NCT00763451|467844990|FG001|Overall Study|Adverse Event|6|||
129967378|NCT00763451|467844991|FG002|Overall Study|Adverse Event|19|||
129967379|NCT00763451|467844992|FG003|Overall Study|Adverse Event|14|||
129967380|NCT00763451|467844989|FG000|Overall Study|Lack of Efficacy|1|||
129967381|NCT00763451|467844990|FG001|Overall Study|Lack of Efficacy|4|||
129967382|NCT00763451|467844991|FG002|Overall Study|Lack of Efficacy|3|||
129967383|NCT00763451|467844992|FG003|Overall Study|Lack of Efficacy|2|||
129967384|NCT00763451|467844989|FG000|Overall Study|Withdrawal by Subject|1|||
129967385|NCT00763451|467844990|FG001|Overall Study|Withdrawal by Subject|6|||
129967386|NCT00763451|467844991|FG002|Overall Study|Withdrawal by Subject|9|||
129967387|NCT00763451|467844992|FG003|Overall Study|Withdrawal by Subject|7|||
129967388|NCT00763451|467844989|FG000|Overall Study|Protocol Violation|0|||
129967389|NCT00763451|467844990|FG001|Overall Study|Protocol Violation|0|||
129967390|NCT00763451|467844991|FG002|Overall Study|Protocol Violation|1|||
129967391|NCT00763451|467844992|FG003|Overall Study|Protocol Violation|0|||
129967392|NCT00763451|467844989|FG000|Overall Study|Poor Compliance to Protocol|1|||
129967393|NCT00763451|467844990|FG001|Overall Study|Poor Compliance to Protocol|1|||
129967394|NCT00763451|467844991|FG002|Overall Study|Poor Compliance to Protocol|2|||
129967395|NCT00763451|467844992|FG003|Overall Study|Poor Compliance to Protocol|2|||
129967396|NCT00763451|467844989|FG000|Overall Study|Familial and Personal Reasons|5|||
129967397|NCT00763451|467844990|FG001|Overall Study|Familial and Personal Reasons|3|||
129967398|NCT00763451|467844991|FG002|Overall Study|Familial and Personal Reasons|5|||
129967399|NCT00763451|467844992|FG003|Overall Study|Familial and Personal Reasons|4|||
129967400|NCT00763451|467844989|FG000|Overall Study|Randomized but not Treated|1|||
129967401|NCT00763451|467844990|FG001|Overall Study|Randomized but not Treated|1|||
129967402|NCT00763451|467844991|FG002|Overall Study|Randomized but not Treated|0|||
129455832|NCT02187172|465966645|FG000|Overall Study|Adverse Event|0|||
129455833|NCT02187172|465966646|FG001|Overall Study|Adverse Event|1|||
129455834|NCT02187172|465966645|FG000|Overall Study|Physician Decision|1|||
129967403|NCT00763451|467844992|FG003|Overall Study|Randomized but not Treated|0|||
129455835|NCT02187172|465966646|FG001|Overall Study|Physician Decision|1|||
129455836|NCT04640272|465966647|FG000|Overall Study|Subject moved out of area|1|||
129455837|NCT00880399|465966648|FG000|Overall Study|Adverse Event|4|||
129967404|NCT00763451|467844989|FG000|Overall Study|Study Site Reason|0|||
129967405|NCT00763451|467844990|FG001|Overall Study|Study Site Reason|1|||
129967406|NCT00763451|467844991|FG002|Overall Study|Study Site Reason|1|||
129967407|NCT00763451|467844992|FG003|Overall Study|Study Site Reason|1|||
129967408|NCT00725543|467844996|FG000|Overall Study|Adverse Event|10|||
129967409|NCT00725543|467844996|FG000|Overall Study|Lack of Efficacy|3|||
129967410|NCT00725543|467844996|FG000|Overall Study|Withdrawal by Subject|10|||
129455838|NCT00880399|465966649|FG001|Overall Study|Adverse Event|6|||
129967411|NCT00725543|467844996|FG000|Overall Study|Physician Decision|5|||
129967412|NCT00725543|467844996|FG000|Overall Study|Lost to Follow-up|4|||
129967413|NCT00725543|467844996|FG000|Overall Study|Non-compliance|2|||
129967414|NCT00725543|467844996|FG000|Overall Study|Other|119|||
129967415|NCT05594589|467844997|FG000|Overall Study|Other|0|||
129455839|NCT00880399|465966650|FG002|Overall Study|Adverse Event|5|||
129967416|NCT05594589|467844998|FG001|Overall Study|Other|1|||
129967417|NCT05594589|467844999|FG002|Overall Study|Other|0|||
129967418|NCT02168478|467845006|FG000|Overall Study|Withdrawal by Subject|1|||
129967419|NCT02168478|467845006|FG000|Overall Study|Did Not Consent to Participation|2|||
129967420|NCT02168478|467845006|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
129967421|NCT00087555|467845007|FG000|Overall Study|Adverse Event|3|||
129967422|NCT00087555|467845008|FG001|Overall Study|Adverse Event|6|||
129967423|NCT00087555|467845009|FG002|Overall Study|Adverse Event|14|||
129967424|NCT00087555|467845007|FG000|Overall Study|Lost to Follow-up|0|||
129967425|NCT00087555|467845008|FG001|Overall Study|Lost to Follow-up|1|||
129967426|NCT00087555|467845009|FG002|Overall Study|Lost to Follow-up|1|||
129967427|NCT00087555|467845007|FG000|Overall Study|Non - Compliance|1|||
129967428|NCT00087555|467845008|FG001|Overall Study|Non - Compliance|0|||
129967429|NCT00087555|467845009|FG002|Overall Study|Non - Compliance|0|||
129967430|NCT00087555|467845007|FG000|Overall Study|Protocol Violation|0|||
129967431|NCT00087555|467845008|FG001|Overall Study|Protocol Violation|0|||
129967432|NCT00087555|467845009|FG002|Overall Study|Protocol Violation|2|||
129967433|NCT00087555|467845007|FG000|Overall Study|Screen Failure|1|||
129967434|NCT00087555|467845008|FG001|Overall Study|Screen Failure|1|||
129967435|NCT00087555|467845009|FG002|Overall Study|Screen Failure|0|||
129967436|NCT00087555|467845007|FG000|Overall Study|Pregnancy|0|||
129967437|NCT00087555|467845008|FG001|Overall Study|Pregnancy|1|||
129967438|NCT00087555|467845009|FG002|Overall Study|Pregnancy|1|||
129967439|NCT00087555|467845007|FG000|Overall Study|Withdrawal by Subject|3|||
129967440|NCT00087555|467845008|FG001|Overall Study|Withdrawal by Subject|2|||
129967441|NCT00087555|467845009|FG002|Overall Study|Withdrawal by Subject|1|||
129967442|NCT00087555|467845007|FG000|Overall Study|Lack of Efficacy|2|||
129967443|NCT00087555|467845008|FG001|Overall Study|Lack of Efficacy|0|||
129967444|NCT00087555|467845009|FG002|Overall Study|Lack of Efficacy|1|||
129967445|NCT00087555|467845007|FG000|Overall Study|Non Compliance|0|||
129967446|NCT00087555|467845008|FG001|Overall Study|Non Compliance|0|||
129967447|NCT00087555|467845009|FG002|Overall Study|Non Compliance|1|||
129455840|NCT00880399|465966648|FG000|Overall Study|Lack of Efficacy|1|||
129967448|NCT00087555|467845007|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
129967449|NCT00087555|467845008|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
129967450|NCT00087555|467845009|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
129967451|NCT00087555|467845007|FG000|Overall Study|Patient wanted to go back on Med|1|||
129967452|NCT00087555|467845008|FG001|Overall Study|Patient wanted to go back on Med|0|||
129967453|NCT00087555|467845009|FG002|Overall Study|Patient wanted to go back on Med|0|||
129967454|NCT02344173|467845018|FG000|Procedure|Ablation Procedure Not Performed|7|||
129967455|NCT02344173|467845018|FG000|12-month Visit|Death|8|||
129967456|NCT02344173|467845018|FG000|12-month Visit|Withdrawal by Subject|30|||
129967457|NCT02344173|467845018|FG000|12-month Visit|Lost to Follow-up|58|||
129967458|NCT03845023|467845019|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
129967459|NCT03845023|467845020|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
129967460|NCT03845023|467845021|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
129967461|NCT03845023|467845022|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
129967462|NCT03845023|467845019|FG000|Follow-Up (14 Days)|Adverse Event|0|||
129967463|NCT03845023|467845020|FG001|Follow-Up (14 Days)|Adverse Event|0|||
129967464|NCT03845023|467845021|FG002|Follow-Up (14 Days)|Adverse Event|1|||
129967465|NCT03845023|467845022|FG003|Follow-Up (14 Days)|Adverse Event|1|||
129967466|NCT05314374|467845023|FG000|Overall Study|Adverse Event|2|||
129967467|NCT05314374|467845024|FG001|Overall Study|Adverse Event|2|||
129967468|NCT02554383|467845025|FG000|Overall Study|Ineligible|3|||
129967469|NCT02554383|467845026|FG001|Overall Study|Ineligible|2|||
129967470|NCT02554383|467845025|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
129967471|NCT02554383|467845026|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
129967472|NCT02554383|467845025|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
129967473|NCT02554383|467845026|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
129967474|NCT02554383|467845025|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
129967475|NCT02554383|467845026|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
129967476|NCT01185171|467845029|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
129967477|NCT01185171|467845029|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
129967478|NCT01185171|467845029|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
129967479|NCT01185171|467845029|FG000|Maintenance|Elevated liver transaminases|3|||
129967480|NCT01185171|467845029|FG000|Maintenance|Rush|2|||
129967481|NCT01185171|467845029|FG000|Maintenance|Diarrhea|1|||
129967482|NCT01185171|467845029|FG000|Maintenance|Xerostomia|1|||
129967483|NCT01185171|467845029|FG000|Maintenance|Nausea|1|||
129967484|NCT01185171|467845029|FG000|Maintenance|Comorbid Illness|2|||
129967485|NCT01185171|467845029|FG000|Maintenance|Withdrawal by Subject|1|||
129967486|NCT01185171|467845029|FG000|Maintenance|Disease Recurrence|1|||
129967487|NCT02581059|467845030|FG000|Study Treatment|Disease Progression|1|||
129967488|NCT02581059|467845031|FG001|Study Treatment|Disease Progression|1|||
129967489|NCT02581059|467845030|FG000|Study Treatment|Adverse Event|2|||
129967490|NCT02581059|467845031|FG001|Study Treatment|Adverse Event|1|||
129967491|NCT02581059|467845030|FG000|Study Treatment|Death|1|||
129967492|NCT02581059|467845031|FG001|Study Treatment|Death|1|||
129967493|NCT02581059|467845030|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
129967494|NCT02581059|467845031|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
129967495|NCT02581059|467845030|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
129967496|NCT02581059|467845031|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
129967497|NCT02581059|467845030|FG000|Follow up|Death|1|||
129967498|NCT02581059|467845031|FG001|Follow up|Death|3|||
129967499|NCT02581059|467845030|FG000|Follow up|study terminated|1|||
129967500|NCT02581059|467845031|FG001|Follow up|study terminated|1|||
129967501|NCT02581059|467845030|FG000|Follow up|screen failure|0|||
129967502|NCT02581059|467845031|FG001|Follow up|screen failure|1|||
129967503|NCT02581059|467845030|FG000|Follow up|Patient started new clinical trial|1|||
129967504|NCT02581059|467845031|FG001|Follow up|Patient started new clinical trial|0|||
129967505|NCT02394665|467845036|FG000|Overall Study|Physician Decision|1|||
129967506|NCT02394665|467845037|FG001|Overall Study|Physician Decision|0|||
129967507|NCT02394665|467845038|FG002|Overall Study|Physician Decision|0|||
129967508|NCT02636608|467845039|FG000|Overall Study|Failure to Return|4|||
129967509|NCT02636608|467845039|FG000|Overall Study|Insufficient Virological Response|1|||
129967510|NCT02636608|467845039|FG000|Overall Study|Death|3|||
129967511|NCT02636608|467845039|FG000|Overall Study|Other|2|||
129967512|NCT02636608|467845039|FG000|Overall Study|Did Not Receive Treatment|1|||
129967513|NCT03912532|467845040|FG000|Overall Study|Adverse Event|3|||
129967514|NCT03912532|467845041|FG001|Overall Study|Adverse Event|3|||
129967515|NCT03912532|467845042|FG002|Overall Study|Adverse Event|2|||
129967516|NCT03912532|467845043|FG003|Overall Study|Adverse Event|2|||
129967517|NCT03912532|467845040|FG000|Overall Study|Lost to Follow-up|3|||
129967518|NCT03912532|467845041|FG001|Overall Study|Lost to Follow-up|2|||
129967519|NCT03912532|467845042|FG002|Overall Study|Lost to Follow-up|1|||
129967520|NCT03912532|467845043|FG003|Overall Study|Lost to Follow-up|2|||
129455841|NCT00880399|465966649|FG001|Overall Study|Lack of Efficacy|4|||
129455842|NCT00880399|465966650|FG002|Overall Study|Lack of Efficacy|2|||
129455843|NCT00880399|465966648|FG000|Overall Study|Protocol Violation|4|||
129455844|NCT00880399|465966649|FG001|Overall Study|Protocol Violation|4|||
129455845|NCT00880399|465966650|FG002|Overall Study|Protocol Violation|6|||
129455846|NCT00880399|465966648|FG000|Overall Study|Study closed/terminated|3|||
129455847|NCT00880399|465966649|FG001|Overall Study|Study closed/terminated|7|||
129455848|NCT00880399|465966650|FG002|Overall Study|Study closed/terminated|4|||
129455849|NCT00880399|465966648|FG000|Overall Study|Lost to Follow-up|8|||
129455850|NCT00880399|465966649|FG001|Overall Study|Lost to Follow-up|5|||
129455851|NCT00880399|465966650|FG002|Overall Study|Lost to Follow-up|3|||
129455852|NCT00880399|465966648|FG000|Overall Study|Physician Decision|5|||
129455853|NCT00880399|465966649|FG001|Overall Study|Physician Decision|0|||
129455854|NCT00880399|465966650|FG002|Overall Study|Physician Decision|3|||
129455855|NCT00880399|465966648|FG000|Overall Study|Withdrawal by Subject|6|||
129455856|NCT00880399|465966649|FG001|Overall Study|Withdrawal by Subject|3|||
129455857|NCT00880399|465966650|FG002|Overall Study|Withdrawal by Subject|3|||
129455858|NCT04353284|465966655|FG000|Overall Study|Adverse Event|1|||
129455859|NCT04353284|465966656|FG001|Overall Study|Adverse Event|1|||
129455860|NCT04353284|465966655|FG000|Overall Study|Lost to Follow-up|1|||
129455861|NCT04353284|465966656|FG001|Overall Study|Lost to Follow-up|0|||
129455862|NCT00766532|465966664|FG000|Overall Study|Protocol Violation|2|||
129455863|NCT00751400|465966667|FG000|Overall Study|Lost to Follow-up|10|||
129455864|NCT00573430|465966668|FG000|Overall Study|Incorrect enrollment of randomization|0|||
129455865|NCT00573430|465966669|FG001|Overall Study|Incorrect enrollment of randomization|4|||
129455866|NCT00573430|465966670|FG002|Overall Study|Incorrect enrollment of randomization|3|||
129455867|NCT00573430|465966668|FG000|Overall Study|Adverse Event|0|||
129455868|NCT00573430|465966669|FG001|Overall Study|Adverse Event|0|||
129455869|NCT00573430|465966670|FG002|Overall Study|Adverse Event|2|||
129455870|NCT00573430|465966668|FG000|Overall Study|Withdrawal by Subject|1|||
129455871|NCT00573430|465966669|FG001|Overall Study|Withdrawal by Subject|0|||
129455872|NCT00573430|465966670|FG002|Overall Study|Withdrawal by Subject|1|||
129455873|NCT00573430|465966668|FG000|Overall Study|Protocol Violation|0|||
129455874|NCT00573430|465966669|FG001|Overall Study|Protocol Violation|1|||
129455875|NCT00573430|465966670|FG002|Overall Study|Protocol Violation|1|||
129455876|NCT00573430|465966668|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129455877|NCT00573430|465966669|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129455878|NCT00573430|465966670|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
129455879|NCT02037295|465966672|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
129455880|NCT02037295|465966673|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
129455881|NCT02037295|465966674|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
129455882|NCT02037295|465966675|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
129455883|NCT00441974|465966679|FG000|Overall Study|Adverse Event|6|||
129455884|NCT00441974|465966679|FG000|Overall Study|Consent Withdrawn|35|||
129455885|NCT00441974|465966679|FG000|Overall Study|Lost to Follow-up|80|||
129455886|NCT00441974|465966679|FG000|Overall Study|Protocol Violation|7|||
129455887|NCT01148537|465966682|FG000|Overall Study|Withdrawal by Subject|1|||
129455888|NCT01148537|465966683|FG001|Overall Study|Withdrawal by Subject|0|||
129967521|NCT03912532|467845040|FG000|Overall Study|Withdrawal by Subject|1|||
129455889|NCT01148537|465966684|FG002|Overall Study|Withdrawal by Subject|2|||
129967522|NCT03912532|467845041|FG001|Overall Study|Withdrawal by Subject|1|||
129967523|NCT03912532|467845042|FG002|Overall Study|Withdrawal by Subject|2|||
129967524|NCT03912532|467845043|FG003|Overall Study|Withdrawal by Subject|0|||
129967525|NCT03912532|467845040|FG000|Overall Study|Physician Decision|1|||
129967526|NCT03912532|467845041|FG001|Overall Study|Physician Decision|0|||
129967527|NCT03912532|467845042|FG002|Overall Study|Physician Decision|0|||
129967528|NCT03912532|467845043|FG003|Overall Study|Physician Decision|3|||
129967529|NCT03912532|467845040|FG000|Overall Study|Other|0|||
129967530|NCT03912532|467845041|FG001|Overall Study|Other|1|||
129967531|NCT03912532|467845042|FG002|Overall Study|Other|1|||
129967532|NCT03912532|467845043|FG003|Overall Study|Other|0|||
129967533|NCT03783871|467845048|FG000|Overall Study|Withdrawal by Subject|15|||
129967534|NCT03783871|467845048|FG000|Overall Study|Death|13|||
129967535|NCT03783871|467845048|FG000|Overall Study|Lost to Follow-up|2|||
129967536|NCT04594733|467845049|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
129967537|NCT04594733|467845050|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
129967538|NCT04594733|467845049|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
129967539|NCT04594733|467845050|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
129967540|NCT04594733|467845049|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
129967541|NCT04594733|467845050|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
129967542|NCT02386839|467845051|FG000|Overall Study|Death|1|||
129967543|NCT02386839|467845052|FG001|Overall Study|Death|0|||
129967544|NCT02386839|467845051|FG000|Overall Study|Withdrawal by Subject|9|||
129967545|NCT02386839|467845052|FG001|Overall Study|Withdrawal by Subject|10|||
129967546|NCT02386839|467845051|FG000|Overall Study|Lost to Follow-up|4|||
129967547|NCT02386839|467845052|FG001|Overall Study|Lost to Follow-up|4|||
129967548|NCT02386839|467845051|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
129967549|NCT02386839|467845052|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
129967550|NCT02386839|467845051|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
129967551|NCT02386839|467845052|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
129967552|NCT02386839|467845051|FG000|Overall Study|Other (unspecified)|1|||
129967553|NCT02386839|467845052|FG001|Overall Study|Other (unspecified)|0|||
129455890|NCT01148537|465966682|FG000|Overall Study|Adverse Event|2|||
129455891|NCT01148537|465966683|FG001|Overall Study|Adverse Event|0|||
129455892|NCT01148537|465966684|FG002|Overall Study|Adverse Event|1|||
129455893|NCT02770547|465966685|FG000|Overall Study|Patient non-compliant|1|||
129455894|NCT02770547|465966686|FG001|Overall Study|Patient non-compliant|0|||
129455895|NCT02770547|465966685|FG000|Overall Study|Adverse Event|0|||
129455896|NCT02770547|465966686|FG001|Overall Study|Adverse Event|1|||
129455897|NCT00393887|465966687|FG000|Overall Study|Physician Decision|5|||
129455898|NCT00393887|465966688|FG001|Overall Study|Physician Decision|0|||
129455899|NCT00393887|465966687|FG000|Overall Study|Lost to Follow-up|11|||
129455900|NCT00393887|465966688|FG001|Overall Study|Lost to Follow-up|9|||
129455901|NCT04962022|465966691|FG000|Period 1|Withdrawal by Subject|1|||
129455902|NCT04962022|465966692|FG001|Period 1|Withdrawal by Subject|0|||
129455903|NCT01146873|465966695|FG000|Overall Study|Transfer out|0|||
129455904|NCT01146873|465966696|FG001|Overall Study|Transfer out|6|||
129455905|NCT01967628|465966697|FG000|Overall Study|Withdrawal by Subject|2|||
129455906|NCT01967628|465966698|FG001|Overall Study|Withdrawal by Subject|0|||
129455907|NCT01967628|465966697|FG000|Overall Study|Unable to complete bronchoscopy|4|||
129455908|NCT01967628|465966698|FG001|Overall Study|Unable to complete bronchoscopy|6|||
129455909|NCT01967628|465966697|FG000|Overall Study|Lost to Follow-up|1|||
129455910|NCT01967628|465966698|FG001|Overall Study|Lost to Follow-up|0|||
129455911|NCT01967628|465966697|FG000|Overall Study|Low protein concentration in sample|20|||
129455912|NCT01967628|465966698|FG001|Overall Study|Low protein concentration in sample|25|||
129455913|NCT01356407|465966699|FG000|Overall Study|Lost to Follow-up|2|||
129455914|NCT01356407|465966700|FG001|Overall Study|Lost to Follow-up|0|||
129455915|NCT01356407|465966699|FG000|Overall Study|Patient Withdrew Consent|2|||
129455916|NCT01356407|465966700|FG001|Overall Study|Patient Withdrew Consent|1|||
129455917|NCT01356407|465966699|FG000|Overall Study|Could not afford IMP administration|0|||
129455918|NCT01356407|465966700|FG001|Overall Study|Could not afford IMP administration|1|||
129455919|NCT01356407|465966699|FG000|Overall Study|Not complete Endoscopy|2|||
129455920|NCT01356407|465966700|FG001|Overall Study|Not complete Endoscopy|2|||
129455921|NCT02055820|465966703|FG000|Phase I: Dose-Finding|Death|1|||
129455922|NCT02055820|465966704|FG001|Phase I: Dose-Finding|Death|0|||
129455923|NCT02055820|465966705|FG002|Phase I: Dose-Finding|Death|1|||
129455924|NCT02055820|465966706|FG003|Phase I: Dose-Finding|Death|2|||
129455925|NCT02055820|465966707|FG004|Phase I: Dose-Finding|Death|0|||
129455926|NCT02055820|465966708|FG005|Phase I: Dose-Finding|Death|1|||
129455927|NCT02055820|465966709|FG006|Phase I: Dose-Finding|Death|1|||
129455928|NCT02055820|465966710|FG007|Phase I: Dose-Finding|Death|0|||
129455929|NCT02055820|465966711|FG008|Phase I: Dose-Finding|Death|0|||
129455930|NCT02055820|465966712|FG009|Phase I: Dose-Finding|Death|0|||
129455931|NCT02055820|465966703|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455932|NCT02055820|465966704|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455933|NCT02055820|465966705|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455934|NCT02055820|465966706|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455935|NCT02055820|465966707|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455936|NCT02055820|465966708|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
129455937|NCT02055820|465966709|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455938|NCT02055820|465966710|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455939|NCT02055820|465966711|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455940|NCT02055820|465966712|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
129455941|NCT02055820|465966703|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455942|NCT02055820|465966704|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455943|NCT02055820|465966705|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455944|NCT02055820|465966706|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
129455945|NCT02055820|465966707|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455946|NCT02055820|465966708|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455947|NCT02055820|465966709|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
129455948|NCT02055820|465966710|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
129967554|NCT00826228|467847021|FG000|Overall Study|Withdrawal by Subject|1|||
129967555|NCT02820597|467847022|FG000|Overall Study|Lost to Follow-up|12|||
129967556|NCT00575042|467847023|FG000|Overall Study|Adverse Event|2|||
129967557|NCT00575042|467847023|FG000|Overall Study|Lost to Follow-up|1|||
129967558|NCT02666664|467847024|FG000|Overall Study|Physician Decision|0|||
129967559|NCT02666664|467847025|FG001|Overall Study|Physician Decision|1|||
129967560|NCT02666664|467847024|FG000|Overall Study|Protocol Violation|0|||
129967561|NCT02666664|467847025|FG001|Overall Study|Protocol Violation|2|||
129967562|NCT02666664|467847024|FG000|Overall Study|Other|0|||
129967563|NCT02666664|467847025|FG001|Overall Study|Other|1|||
129967564|NCT02666664|467847024|FG000|Overall Study|Adverse Event|12|||
129967565|NCT02666664|467847025|FG001|Overall Study|Adverse Event|37|||
129967566|NCT02666664|467847024|FG000|Overall Study|Withdrawal by participant|23|||
129967567|NCT02666664|467847025|FG001|Overall Study|Withdrawal by participant|40|||
129967568|NCT02666664|467847024|FG000|Overall Study|Sponsor decision|0|||
129967569|NCT02666664|467847025|FG001|Overall Study|Sponsor decision|1|||
129967570|NCT02666664|467847024|FG000|Overall Study|Lost to Follow-up|1|||
129967571|NCT02666664|467847025|FG001|Overall Study|Lost to Follow-up|2|||
129967572|NCT03616964|467847026|FG000|Overall Study|Adverse Event|15|||
129967573|NCT03616964|467847027|FG001|Overall Study|Adverse Event|10|||
129967574|NCT03616964|467847028|FG002|Overall Study|Adverse Event|16|||
129967575|NCT03616964|467847026|FG000|Overall Study|Death|3|||
129967576|NCT03616964|467847027|FG001|Overall Study|Death|0|||
129967577|NCT03616964|467847028|FG002|Overall Study|Death|4|||
129967578|NCT03616964|467847026|FG000|Overall Study|Lack of Efficacy|4|||
129967579|NCT03616964|467847027|FG001|Overall Study|Lack of Efficacy|8|||
129967580|NCT03616964|467847028|FG002|Overall Study|Lack of Efficacy|8|||
129967581|NCT03616964|467847026|FG000|Overall Study|Lost to Follow-up|2|||
129967582|NCT03616964|467847027|FG001|Overall Study|Lost to Follow-up|1|||
129967583|NCT03616964|467847028|FG002|Overall Study|Lost to Follow-up|3|||
129455949|NCT02055820|465966711|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455950|NCT02055820|465966712|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
129455951|NCT02055820|465966703|FG000|Phase II: Expansion|Death|0|||
129455952|NCT02055820|465966704|FG001|Phase II: Expansion|Death|0|||
129455953|NCT02055820|465966705|FG002|Phase II: Expansion|Death|0|||
129455954|NCT02055820|465966706|FG003|Phase II: Expansion|Death|0|||
129455955|NCT02055820|465966707|FG004|Phase II: Expansion|Death|33|||
129455956|NCT02055820|465966708|FG005|Phase II: Expansion|Death|0|||
129455957|NCT02055820|465966709|FG006|Phase II: Expansion|Death|0|||
129455958|NCT02055820|465966710|FG007|Phase II: Expansion|Death|0|||
129455959|NCT02055820|465966711|FG008|Phase II: Expansion|Death|0|||
129455960|NCT02055820|465966712|FG009|Phase II: Expansion|Death|0|||
129455961|NCT02055820|465966703|FG000|Phase II: Expansion|Lost to Follow-up|0|||
129455962|NCT02055820|465966704|FG001|Phase II: Expansion|Lost to Follow-up|0|||
129455963|NCT02055820|465966705|FG002|Phase II: Expansion|Lost to Follow-up|0|||
129455964|NCT02055820|465966706|FG003|Phase II: Expansion|Lost to Follow-up|0|||
129455965|NCT02055820|465966707|FG004|Phase II: Expansion|Lost to Follow-up|4|||
129455966|NCT02055820|465966708|FG005|Phase II: Expansion|Lost to Follow-up|0|||
129455967|NCT02055820|465966709|FG006|Phase II: Expansion|Lost to Follow-up|0|||
129455968|NCT02055820|465966710|FG007|Phase II: Expansion|Lost to Follow-up|0|||
129455969|NCT02055820|465966711|FG008|Phase II: Expansion|Lost to Follow-up|0|||
129455970|NCT02055820|465966712|FG009|Phase II: Expansion|Lost to Follow-up|0|||
129455971|NCT02055820|465966703|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
129455972|NCT02055820|465966704|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
129455973|NCT02055820|465966705|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
129455974|NCT02055820|465966706|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
129455975|NCT02055820|465966707|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
129455976|NCT02055820|465966708|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
129455977|NCT02055820|465966709|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
129455978|NCT02055820|465966710|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
129455979|NCT02055820|465966711|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
129455980|NCT02055820|465966712|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
129455981|NCT02614859|465966713|FG000|Overall Study|Physician Decision|0|||
129455982|NCT02614859|465966714|FG001|Overall Study|Physician Decision|1|||
129455983|NCT01157364|465966716|FG000|Overall Study|Other Reasons|1|||
129455984|NCT01157364|465966717|FG001|Overall Study|Other Reasons|1|||
129455985|NCT01157364|465966718|FG002|Overall Study|Other Reasons|2|||
129455986|NCT01157364|465966719|FG003|Overall Study|Other Reasons|1|||
129455987|NCT01157364|465966720|FG004|Overall Study|Other Reasons|0|||
129455988|NCT01157364|465966721|FG005|Overall Study|Other Reasons|0|||
129455989|NCT01157364|465966716|FG000|Overall Study|Personal Reasons|0|||
129455990|NCT01157364|465966717|FG001|Overall Study|Personal Reasons|2|||
129455991|NCT01157364|465966718|FG002|Overall Study|Personal Reasons|0|||
129455992|NCT01157364|465966719|FG003|Overall Study|Personal Reasons|0|||
129455993|NCT01157364|465966720|FG004|Overall Study|Personal Reasons|1|||
129455994|NCT01157364|465966721|FG005|Overall Study|Personal Reasons|1|||
129455995|NCT01157364|465966716|FG000|Overall Study|Lost to Follow-up|1|||
129455996|NCT01157364|465966717|FG001|Overall Study|Lost to Follow-up|0|||
129455997|NCT01157364|465966718|FG002|Overall Study|Lost to Follow-up|1|||
129455998|NCT01157364|465966719|FG003|Overall Study|Lost to Follow-up|0|||
129455999|NCT01157364|465966720|FG004|Overall Study|Lost to Follow-up|0|||
129456000|NCT01157364|465966721|FG005|Overall Study|Lost to Follow-up|0|||
129456001|NCT01157364|465966716|FG000|Overall Study|Lack of Efficacy|0|||
129456002|NCT01157364|465966717|FG001|Overall Study|Lack of Efficacy|0|||
129456003|NCT01157364|465966718|FG002|Overall Study|Lack of Efficacy|0|||
129456004|NCT01157364|465966719|FG003|Overall Study|Lack of Efficacy|1|||
129456005|NCT01157364|465966720|FG004|Overall Study|Lack of Efficacy|0|||
129456006|NCT01157364|465966721|FG005|Overall Study|Lack of Efficacy|0|||
129456007|NCT01157364|465966716|FG000|Overall Study|Adverse Event|0|||
129456008|NCT01157364|465966717|FG001|Overall Study|Adverse Event|1|||
129456009|NCT01157364|465966718|FG002|Overall Study|Adverse Event|1|||
129456010|NCT01157364|465966719|FG003|Overall Study|Adverse Event|0|||
129456011|NCT01157364|465966720|FG004|Overall Study|Adverse Event|1|||
129456012|NCT01157364|465966721|FG005|Overall Study|Adverse Event|0|||
129456013|NCT00841568|465966735|FG000|Overall Study|Adverse Event|1|||
129456014|NCT00841568|465966735|FG000|Overall Study|Death|1|||
129456015|NCT00841568|465966735|FG000|Overall Study|Withdrawal by Subject|2|||
129456016|NCT00841568|465966735|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
129456017|NCT01087775|465966736|FG000|Overall Study|failed inclusion criteria|2|||
129456018|NCT05289570|465966741|FG000|Overall Study|Physician Decision|1|||
129456019|NCT00432042|465966742|FG000|Overall Study|Protocol Violation|2|||
129456020|NCT00432042|465966743|FG001|Overall Study|Protocol Violation|0|||
129456021|NCT00432042|465966744|FG002|Overall Study|Protocol Violation|0|||
129456022|NCT00432042|465966742|FG000|Overall Study|Withdrawal by Subject|0|||
129456023|NCT00432042|465966743|FG001|Overall Study|Withdrawal by Subject|0|||
129456024|NCT00432042|465966744|FG002|Overall Study|Withdrawal by Subject|2|||
129456025|NCT00432042|465966742|FG000|Overall Study|Lost to Follow-up|5|||
129456026|NCT00432042|465966743|FG001|Overall Study|Lost to Follow-up|1|||
129456027|NCT00432042|465966744|FG002|Overall Study|Lost to Follow-up|0|||
129456028|NCT01585272|465966745|FG000|Overall Study|Adverse Event|22|||
129456029|NCT01585272|465966745|FG000|Overall Study|Protocol Violation|7|||
129456030|NCT01585272|465966745|FG000|Overall Study|Withdrawal by Subject|10|||
129456031|NCT00645593|465966746|FG000|Overall Study|Later found to be ineligible|1|||
129456032|NCT00645593|465966747|FG001|Overall Study|Later found to be ineligible|0|||
129456033|NCT00733954|465966748|FG000|Overall Study|Lost to Follow-up|5|||
129456034|NCT00733954|465966749|FG001|Overall Study|Lost to Follow-up|2|||
129456035|NCT00733954|465966748|FG000|Overall Study|Protocol Violation|1|||
129456036|NCT00733954|465966749|FG001|Overall Study|Protocol Violation|0|||
129456037|NCT00733954|465966748|FG000|Overall Study|Withdrawal by Subject|2|||
129456038|NCT00733954|465966749|FG001|Overall Study|Withdrawal by Subject|0|||
129456039|NCT02663453|465966750|FG000|Overall Study|Death|4|||
129456040|NCT02663453|465966751|FG001|Overall Study|Death|4|||
129456041|NCT02663453|465966750|FG000|Overall Study|Withdrawal by Subject|1|||
129456042|NCT02663453|465966751|FG001|Overall Study|Withdrawal by Subject|0|||
129456043|NCT01611974|465967864|FG000|Overall Study|Death|10|||
129456044|NCT01611974|465967865|FG001|Overall Study|Death|12|||
129456045|NCT01611974|465967866|FG002|Overall Study|Death|10|||
129456046|NCT01611974|465967864|FG000|Overall Study|Lost to Follow-up|0|||
129456047|NCT01611974|465967865|FG001|Overall Study|Lost to Follow-up|1|||
129456048|NCT01611974|465967866|FG002|Overall Study|Lost to Follow-up|0|||
129456049|NCT01611974|465967864|FG000|Overall Study|Physician Decision|5|||
129456050|NCT01611974|465967865|FG001|Overall Study|Physician Decision|1|||
129456051|NCT01611974|465967866|FG002|Overall Study|Physician Decision|2|||
129456052|NCT01611974|465967864|FG000|Overall Study|Withdrawal by Subject|0|||
129456053|NCT01611974|465967865|FG001|Overall Study|Withdrawal by Subject|1|||
129456054|NCT01611974|465967866|FG002|Overall Study|Withdrawal by Subject|4|||
129456055|NCT01849874|465967871|FG000|Overall Study|Death|89|||
129456056|NCT01849874|465967872|FG001|Overall Study|Death|42|||
129456057|NCT01849874|465967871|FG000|Overall Study|Withdrawal by Subject|17|||
129456058|NCT01849874|465967872|FG001|Overall Study|Withdrawal by Subject|16|||
129456059|NCT01849874|465967871|FG000|Overall Study|Lost to Follow-up|3|||
129456060|NCT01849874|465967872|FG001|Overall Study|Lost to Follow-up|2|||
129456061|NCT01849874|465967871|FG000|Overall Study|Study Termination By Sponsor|93|||
129456062|NCT01849874|465967872|FG001|Overall Study|Study Termination By Sponsor|48|||
129456063|NCT01849874|465967871|FG000|Overall Study|Completed as per protocol amendment 6|3|||
129456064|NCT01849874|465967872|FG001|Overall Study|Completed as per protocol amendment 6|0|||
129456065|NCT01849874|465967871|FG000|Overall Study|Physician Decision|7|||
129456066|NCT01849874|465967872|FG001|Overall Study|Physician Decision|1|||
129456067|NCT01849874|465967871|FG000|Overall Study|Other|16|||
129456068|NCT01849874|465967872|FG001|Overall Study|Other|4|||
129456069|NCT01230242|465967885|FG000|Overall Study|Physician Decision|2|||
129456070|NCT01230242|465967885|FG000|Overall Study|Withdrawal by Subject|1|||
129456071|NCT04329702|465967886|FG000|Overall Study|illness|3|||
129456072|NCT04329702|465967887|FG001|Overall Study|illness|4|||
129456073|NCT04329702|465967888|FG002|Overall Study|illness|0|||
129456074|NCT04329702|465967886|FG000|Overall Study|Lost to Follow-up|0|||
129456075|NCT04329702|465967887|FG001|Overall Study|Lost to Follow-up|0|||
129456076|NCT04329702|465967888|FG002|Overall Study|Lost to Follow-up|2|||
129456077|NCT04329702|465967886|FG000|Overall Study|Death|0|||
129456078|NCT04329702|465967887|FG001|Overall Study|Death|2|||
129456079|NCT04329702|465967888|FG002|Overall Study|Death|0|||
129456080|NCT01140451|465967892|FG000|Overall Study|Withdrawal by Subject|26|||
129456081|NCT01140451|465967893|FG001|Overall Study|Withdrawal by Subject|33|||
129456082|NCT01140451|465967892|FG000|Overall Study|Adverse Event|2|||
129456083|NCT01140451|465967893|FG001|Overall Study|Adverse Event|6|||
129456084|NCT01140451|465967892|FG000|Overall Study|Physician Decision|5|||
129456085|NCT01140451|465967893|FG001|Overall Study|Physician Decision|3|||
129456086|NCT01140451|465967892|FG000|Overall Study|Lost to Follow-up|2|||
129967584|NCT03616964|467847026|FG000|Overall Study|Withdrawal by Subject|18|||
129967585|NCT03616964|467847027|FG001|Overall Study|Withdrawal by Subject|14|||
129456087|NCT01140451|465967893|FG001|Overall Study|Lost to Follow-up|0|||
129456088|NCT01140451|465967892|FG000|Overall Study|Participants Planning Pregnancy|3|||
129456089|NCT01140451|465967893|FG001|Overall Study|Participants Planning Pregnancy|0|||
129456090|NCT01399788|465967895|FG000|First Intervention Period|Adverse Event|1|||
129456091|NCT01399788|465967896|FG001|First Intervention Period|Adverse Event|0|||
129456092|NCT02919436|465967897|FG000|Overall Study|Did not undergo surgery|16|||
129456093|NCT02919436|465967898|FG001|Overall Study|Did not undergo surgery|20|||
129456094|NCT02919436|465967897|FG000|Overall Study|Enrolled before trial registration|44|||
129456095|NCT02919436|465967898|FG001|Overall Study|Enrolled before trial registration|33|||
129967586|NCT03616964|467847028|FG002|Overall Study|Withdrawal by Subject|21|||
129967587|NCT03616964|467847026|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
129456096|NCT03699007|465967899|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
129456097|NCT03699007|465967900|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
129456098|NCT03699007|465967899|FG000|6-month Follow Up|Lost to Follow-up|2|||
129456099|NCT03699007|465967900|FG001|6-month Follow Up|Lost to Follow-up|3|||
129456100|NCT04718974|465967901|FG000|Overall Study|Death|0|||
129456101|NCT04718974|465967902|FG001|Overall Study|Death|2|||
129456102|NCT04718974|465967901|FG000|Overall Study|Lost to Follow-up|10|||
129967588|NCT03616964|467847027|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
129967589|NCT03616964|467847028|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
129967590|NCT03616964|467847026|FG000|Overall Study|Sponsor's Decision|1|||
129967591|NCT03616964|467847027|FG001|Overall Study|Sponsor's Decision|0|||
129967592|NCT03616964|467847028|FG002|Overall Study|Sponsor's Decision|0|||
129967593|NCT03616964|467847026|FG000|Overall Study|Physician Decision|0|||
129967594|NCT03616964|467847027|FG001|Overall Study|Physician Decision|2|||
129967595|NCT03616964|467847028|FG002|Overall Study|Physician Decision|0|||
129967596|NCT03616964|467847026|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
129967597|NCT03616964|467847027|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
129967598|NCT03616964|467847028|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
129967599|NCT03616964|467847026|FG000|Overall Study|Protocol Violation|0|||
129967600|NCT03616964|467847027|FG001|Overall Study|Protocol Violation|1|||
129967601|NCT03616964|467847028|FG002|Overall Study|Protocol Violation|0|||
129967602|NCT03616964|467847026|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
129967603|NCT03616964|467847027|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
129967604|NCT03616964|467847028|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
129967605|NCT03616964|467847026|FG000|Overall Study|Randomized but Never Treated|1|||
129967606|NCT03616964|467847027|FG001|Overall Study|Randomized but Never Treated|1|||
129967607|NCT03616964|467847028|FG002|Overall Study|Randomized but Never Treated|1|||
129967608|NCT03167151|467847031|FG000|Overall Study|Withdrawal by Subject|1|||
129967609|NCT03167151|467847032|FG001|Overall Study|Withdrawal by Subject|0|||
129967610|NCT03167151|467847033|FG002|Overall Study|Withdrawal by Subject|0|||
129967611|NCT03167151|467847031|FG000|Overall Study|No evidence of tumour at surgery|0|||
129967612|NCT03167151|467847032|FG001|Overall Study|No evidence of tumour at surgery|1|||
129967613|NCT03167151|467847033|FG002|Overall Study|No evidence of tumour at surgery|1|||
129967614|NCT01458522|467847034|FG000|Overall Study|Withdrawal by Subject|2|||
129967615|NCT01458522|467847035|FG001|Overall Study|Withdrawal by Subject|2|||
129967616|NCT01458522|467847034|FG000|Overall Study|Physician Decision|1|||
129967617|NCT01458522|467847035|FG001|Overall Study|Physician Decision|9|||
129967618|NCT04367480|467847038|FG000|Overall Study|Adverse Event|1|||
129967619|NCT04367480|467847039|FG001|Overall Study|Adverse Event|1|||
129967620|NCT04367480|467847038|FG000|Overall Study|Death|1|||
129967621|NCT04367480|467847039|FG001|Overall Study|Death|0|||
129967622|NCT04367480|467847038|FG000|Overall Study|Lost to Follow-up|1|||
129967623|NCT04367480|467847039|FG001|Overall Study|Lost to Follow-up|1|||
129967624|NCT04367480|467847038|FG000|Overall Study|Withdrawal by Subject|0|||
129967625|NCT04367480|467847039|FG001|Overall Study|Withdrawal by Subject|3|||
129967626|NCT04367480|467847038|FG000|Overall Study|App glitch during the study|1|||
129967627|NCT04367480|467847039|FG001|Overall Study|App glitch during the study|0|||
129967628|NCT04367480|467847038|FG000|Overall Study|Device Distribution Error|0|||
129967629|NCT04367480|467847039|FG001|Overall Study|Device Distribution Error|2|||
129967630|NCT04367480|467847038|FG000|Overall Study|Ineligible after Randomization|0|||
129967631|NCT04367480|467847039|FG001|Overall Study|Ineligible after Randomization|1|||
129967632|NCT04367480|467847038|FG000|Overall Study|Other Medical Reasons|0|||
129967633|NCT04367480|467847039|FG001|Overall Study|Other Medical Reasons|2|||
129967634|NCT04120376|467847040|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
129967635|NCT04120376|467847041|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
129967636|NCT02641587|467847042|FG000|Confinement Period|Adverse Event|1|||
129967637|NCT02641587|467847043|FG001|Confinement Period|Adverse Event|0|||
129967638|NCT02641587|467847042|FG000|Confinement Period|Withdrawal by Subject|2|||
129967639|NCT02641587|467847043|FG001|Confinement Period|Withdrawal by Subject|1|||
129967640|NCT02641587|467847042|FG000|Ambulatory Period|Withdrawal by Subject|1|||
129967641|NCT02641587|467847043|FG001|Ambulatory Period|Withdrawal by Subject|0|||
129967642|NCT01165177|467847044|FG000|Overall Study|Serious Adverse Event|227|||
129967643|NCT01165177|467847045|FG001|Overall Study|Serious Adverse Event|235|||
129967644|NCT01165177|467847044|FG000|Overall Study|Withdrawal by Subject|368|||
129967645|NCT01165177|467847045|FG001|Overall Study|Withdrawal by Subject|354|||
129967646|NCT01165177|467847044|FG000|Overall Study|Protocol Violation|19|||
129967647|NCT01165177|467847045|FG001|Overall Study|Protocol Violation|21|||
129967648|NCT01165177|467847044|FG000|Overall Study|Non-serious adverse event|30|||
129967649|NCT01165177|467847045|FG001|Overall Study|Non-serious adverse event|18|||
129967650|NCT01165177|467847044|FG000|Overall Study|Other unspecified reasons|47|||
129967651|NCT01165177|467847045|FG001|Overall Study|Other unspecified reasons|35|||
129967652|NCT01165177|467847044|FG000|Overall Study|Suspected HZ episode|0|||
129967653|NCT01165177|467847045|FG001|Overall Study|Suspected HZ episode|2|||
129967654|NCT01165177|467847044|FG000|Overall Study|Lost to Follow-up|183|||
129967655|NCT01165177|467847045|FG001|Overall Study|Lost to Follow-up|194|||
129967656|NCT01165177|467847044|FG000|Overall Study|Migrated/ moved from study area|48|||
129967657|NCT01165177|467847045|FG001|Overall Study|Migrated/ moved from study area|43|||
129967658|NCT00634842|467847046|FG000|Overall Study|Adverse Event|2|||
129967659|NCT00634842|467847047|FG001|Overall Study|Adverse Event|3|||
129967660|NCT00634842|467847046|FG000|Overall Study|Protocol Violation|8|||
129967661|NCT00634842|467847047|FG001|Overall Study|Protocol Violation|4|||
129456103|NCT04718974|465967902|FG001|Overall Study|Lost to Follow-up|20|||
129456104|NCT04718974|465967901|FG000|Overall Study|Transferred out|2|||
129456105|NCT04718974|465967902|FG001|Overall Study|Transferred out|4|||
129456106|NCT03259074|465967903|FG000|Overall Study|Adverse Event|9|||
129456107|NCT03259074|465967904|FG001|Overall Study|Adverse Event|12|||
129456108|NCT03259074|465967905|FG002|Overall Study|Adverse Event|8|||
129456109|NCT03259074|465967903|FG000|Overall Study|Death|1|||
129456110|NCT03259074|465967904|FG001|Overall Study|Death|1|||
129456111|NCT03259074|465967905|FG002|Overall Study|Death|3|||
129456112|NCT03259074|465967903|FG000|Overall Study|Lost to Follow-up|2|||
129456113|NCT03259074|465967904|FG001|Overall Study|Lost to Follow-up|4|||
129456114|NCT03259074|465967905|FG002|Overall Study|Lost to Follow-up|3|||
129456115|NCT03259074|465967903|FG000|Overall Study|New Therapy For Study Indication|1|||
129456116|NCT03259074|465967904|FG001|Overall Study|New Therapy For Study Indication|2|||
129456117|NCT03259074|465967905|FG002|Overall Study|New Therapy For Study Indication|2|||
129456118|NCT03259074|465967903|FG000|Overall Study|Physician Decision|4|||
129456119|NCT03259074|465967904|FG001|Overall Study|Physician Decision|12|||
129456120|NCT03259074|465967905|FG002|Overall Study|Physician Decision|10|||
129456121|NCT03259074|465967903|FG000|Overall Study|Pregnancy|1|||
129456122|NCT03259074|465967904|FG001|Overall Study|Pregnancy|1|||
129456123|NCT03259074|465967905|FG002|Overall Study|Pregnancy|0|||
129456124|NCT03259074|465967903|FG000|Overall Study|Progressive Disease|1|||
129456125|NCT03259074|465967904|FG001|Overall Study|Progressive Disease|0|||
129456126|NCT03259074|465967905|FG002|Overall Study|Progressive Disease|0|||
129456127|NCT03259074|465967903|FG000|Overall Study|Protocol Deviation|1|||
129456128|NCT03259074|465967904|FG001|Overall Study|Protocol Deviation|1|||
129456129|NCT03259074|465967905|FG002|Overall Study|Protocol Deviation|3|||
129456130|NCT03259074|465967903|FG000|Overall Study|Subject/Guardian Decision|13|||
129456131|NCT03259074|465967904|FG001|Overall Study|Subject/Guardian Decision|16|||
129456132|NCT03259074|465967905|FG002|Overall Study|Subject/Guardian Decision|14|||
129456133|NCT01780662|465967906|FG000|Overall Study|Adverse Event|1|||
129456134|NCT01780662|465967907|FG001|Overall Study|Adverse Event|0|||
129456135|NCT01780662|465967908|FG002|Overall Study|Adverse Event|2|||
129456136|NCT01780662|465967906|FG000|Overall Study|Physician Decision|0|||
129456137|NCT01780662|465967907|FG001|Overall Study|Physician Decision|5|||
129456138|NCT01780662|465967908|FG002|Overall Study|Physician Decision|7|||
129456139|NCT01780662|465967906|FG000|Overall Study|Protocol Violation|0|||
129456140|NCT01780662|465967907|FG001|Overall Study|Protocol Violation|1|||
129456141|NCT01780662|465967908|FG002|Overall Study|Protocol Violation|0|||
129456142|NCT01780662|465967906|FG000|Overall Study|Ineligible|0|||
129456143|NCT01780662|465967907|FG001|Overall Study|Ineligible|0|||
129456144|NCT01780662|465967908|FG002|Overall Study|Ineligible|1|||
129456145|NCT00053417|465967909|FG000|Overall Study|Adverse Event|1|||
129456146|NCT00053417|465967910|FG001|Overall Study|Adverse Event|0|||
129456147|NCT00053417|465967911|FG002|Overall Study|Adverse Event|1|||
129456148|NCT00053417|465967912|FG003|Overall Study|Adverse Event|5|||
129456149|NCT00053417|465967909|FG000|Overall Study|Non-Compliance|0|||
129456150|NCT00053417|465967910|FG001|Overall Study|Non-Compliance|0|||
129456151|NCT00053417|465967911|FG002|Overall Study|Non-Compliance|0|||
129456152|NCT00053417|465967912|FG003|Overall Study|Non-Compliance|1|||
129456153|NCT00053417|465967909|FG000|Overall Study|Withdrawal by Subject|0|||
129456154|NCT00053417|465967910|FG001|Overall Study|Withdrawal by Subject|1|||
129456155|NCT00053417|465967911|FG002|Overall Study|Withdrawal by Subject|0|||
129456156|NCT00053417|465967912|FG003|Overall Study|Withdrawal by Subject|0|||
129456157|NCT00053417|465967909|FG000|Overall Study|Lost to Follow-up|1|||
129456158|NCT00053417|465967910|FG001|Overall Study|Lost to Follow-up|1|||
129456159|NCT00053417|465967911|FG002|Overall Study|Lost to Follow-up|0|||
129456160|NCT00053417|465967912|FG003|Overall Study|Lost to Follow-up|0|||
129456161|NCT04081363|465967915|FG000|Overall Study|Withdrawal by Subject|1|||
129456162|NCT04081363|465967916|FG001|Overall Study|Withdrawal by Subject|0|||
129456163|NCT01227044|465967921|FG000|Overall Study|Lost to Follow-up|5|||
129456164|NCT01227044|465967922|FG001|Overall Study|Lost to Follow-up|7|||
129456165|NCT01227044|465967921|FG000|Overall Study|Discontinued Intervention|1|||
129456166|NCT01227044|465967922|FG001|Overall Study|Discontinued Intervention|2|||
129456167|NCT00583362|465967923|FG000|Overall Study|Adverse Event|44|||
129456168|NCT00583362|465967923|FG000|Overall Study|Lack of Efficacy|22|||
129456169|NCT00583362|465967923|FG000|Overall Study|Lost to Follow-up|4|||
129456170|NCT00583362|465967923|FG000|Overall Study|Non-compliance with study drug|28|||
129456171|NCT00583362|465967923|FG000|Overall Study|Pregnancy|7|||
129456172|NCT00583362|465967923|FG000|Overall Study|Miscommunication of visit window|5|||
129456173|NCT00583362|465967923|FG000|Overall Study|Current site closed|7|||
129967662|NCT00634842|467847046|FG000|Overall Study|Move to another state|1|||
129967663|NCT00634842|467847047|FG001|Overall Study|Move to another state|0|||
129456174|NCT00583362|465967923|FG000|Overall Study|Subject not dosed in LBSL99|1|||
129456175|NCT00583362|465967923|FG000|Overall Study|Subject moved out of the country/state|2|||
129456176|NCT00583362|465967923|FG000|Overall Study|Missed visits due to staff changes|1|||
129456177|NCT00583362|465967923|FG000|Overall Study|Misunderstanding of protocol|1|||
129456178|NCT00583362|465967923|FG000|Overall Study|Behavioral problems and non-compliance|1|||
129456179|NCT00583362|465967923|FG000|Overall Study|Sponsor request due to missed doses|1|||
129456180|NCT00583362|465967923|FG000|Overall Study|Physician Decision|19|||
129456181|NCT00583362|465967923|FG000|Overall Study|Protocol Violation|2|||
129456182|NCT00583362|465967923|FG000|Overall Study|Withdrawal by Subject|57|||
129456183|NCT02370615|465967928|FG000|Overall Study|Adverse Event|1|||
129456184|NCT02370615|465967929|FG001|Overall Study|Adverse Event|0|||
129456185|NCT01136655|465967930|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
129456186|NCT01136655|465967930|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
129456187|NCT01136655|465967930|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
129456188|NCT01136655|465967930|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
129456189|NCT02287623|465967934|FG000|Overall Study|Protocol Violation|0|||
129456190|NCT02287623|465967935|FG001|Overall Study|Protocol Violation|1|||
129456191|NCT02700997|465967936|FG000|Overall Study|Did not undergo CT imaging|1|||
129456192|NCT02700997|465967936|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
129456193|NCT03765138|465967941|FG000|Overall Study|Lost to Follow-up|1|||
129456194|NCT02577146|465967942|FG000|Overall Study|Lost to Follow-up|8|||
129456195|NCT02577146|465967942|FG000|Overall Study|Physician Decision|3|||
129456196|NCT02577146|465967942|FG000|Overall Study|Screen Failure|17|||
129456197|NCT01970501|465967943|FG000|Overall Study|Discontinuation of study by sponsor|16|||
129456198|NCT01970501|465967944|FG001|Overall Study|Discontinuation of study by sponsor|14|||
129456199|NCT01970501|465967943|FG000|Overall Study|Withdrawal by Subject|6|||
129456200|NCT01970501|465967944|FG001|Overall Study|Withdrawal by Subject|7|||
129456201|NCT01970501|465967943|FG000|Overall Study|Adverse Event|2|||
129456202|NCT01970501|465967944|FG001|Overall Study|Adverse Event|4|||
129456203|NCT01970501|465967943|FG000|Overall Study|Death|1|||
129456204|NCT01970501|465967944|FG001|Overall Study|Death|3|||
129456205|NCT01970501|465967943|FG000|Overall Study|Physician Decision|2|||
129456206|NCT01970501|465967944|FG001|Overall Study|Physician Decision|0|||
129456207|NCT03803059|465967946|FG000|Overall Study|Protocol Violation|2|||
129456208|NCT03803059|465967946|FG000|Overall Study|Lost to Follow-up|1|||
129456209|NCT04013529|465967949|FG000|Overall Study|Withdrawal by Subject|1|||
129456210|NCT04013529|465967950|FG001|Overall Study|Withdrawal by Subject|1|||
129456211|NCT03116698|465967951|FG000|Overall Study|Adverse Event|1|||
129456212|NCT03116698|465967952|FG001|Overall Study|Adverse Event|1|||
129456213|NCT03116698|465967953|FG002|Overall Study|Adverse Event|1|||
129456214|NCT03116698|465967954|FG003|Overall Study|Adverse Event|0|||
129456215|NCT03116698|465967951|FG000|Overall Study|Withdrawal by Subject|1|||
129456216|NCT03116698|465967952|FG001|Overall Study|Withdrawal by Subject|4|||
129456217|NCT03116698|465967953|FG002|Overall Study|Withdrawal by Subject|5|||
129456218|NCT03116698|465967954|FG003|Overall Study|Withdrawal by Subject|2|||
129456219|NCT03116698|465967951|FG000|Overall Study|Lost to Follow-up|2|||
129456220|NCT03116698|465967952|FG001|Overall Study|Lost to Follow-up|0|||
129456221|NCT03116698|465967953|FG002|Overall Study|Lost to Follow-up|0|||
129456222|NCT03116698|465967954|FG003|Overall Study|Lost to Follow-up|0|||
129456223|NCT03116698|465967951|FG000|Overall Study|Physician Decision|1|||
129456224|NCT03116698|465967952|FG001|Overall Study|Physician Decision|1|||
129456225|NCT03116698|465967953|FG002|Overall Study|Physician Decision|0|||
129456226|NCT03116698|465967954|FG003|Overall Study|Physician Decision|0|||
129456227|NCT03116698|465967951|FG000|Overall Study|Protocol Violation|1|||
129456228|NCT03116698|465967952|FG001|Overall Study|Protocol Violation|0|||
129456229|NCT03116698|465967953|FG002|Overall Study|Protocol Violation|0|||
129456230|NCT03116698|465967954|FG003|Overall Study|Protocol Violation|0|||
129456231|NCT03116698|465967951|FG000|Overall Study|Death|0|||
129456232|NCT03116698|465967952|FG001|Overall Study|Death|0|||
129456233|NCT03116698|465967953|FG002|Overall Study|Death|2|||
129456234|NCT03116698|465967954|FG003|Overall Study|Death|0|||
129456235|NCT00788372|465967955|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
129456236|NCT00788372|465967955|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
129456237|NCT00788372|465967955|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
129967664|NCT00634842|467847046|FG000|Overall Study|Inclusion criteria were not met|1|||
129967665|NCT00634842|467847047|FG001|Overall Study|Inclusion criteria were not met|0|||
129967666|NCT00634842|467847046|FG000|Overall Study|Lost to Follow-up|1|||
129967667|NCT00634842|467847047|FG001|Overall Study|Lost to Follow-up|2|||
129967668|NCT00634842|467847046|FG000|Overall Study|Physician Decision|1|||
129967669|NCT00634842|467847047|FG001|Overall Study|Physician Decision|0|||
129967670|NCT00634842|467847046|FG000|Overall Study|Withdrawal by Subject|1|||
129967671|NCT00634842|467847047|FG001|Overall Study|Withdrawal by Subject|3|||
129967672|NCT00634842|467847046|FG000|Overall Study|Lack of time and intolerance to drug|0|||
129456238|NCT00788372|465967955|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
129456239|NCT00788372|465967955|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
129456240|NCT00788372|465967955|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
129456241|NCT00788372|465967955|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
129456242|NCT03099187|465967963|FG000|Double-blind Treatment|Adverse Event|19|||
129967673|NCT00634842|467847047|FG001|Overall Study|Lack of time and intolerance to drug|1|||
129456243|NCT03099187|465967964|FG001|Double-blind Treatment|Adverse Event|1|||
129456244|NCT03099187|465967965|FG002|Double-blind Treatment|Adverse Event|0|||
129456245|NCT03099187|465967966|FG003|Double-blind Treatment|Adverse Event|0|||
129967674|NCT00634842|467847046|FG000|Overall Study|Discontinued due to injection|0|||
129967675|NCT00634842|467847047|FG001|Overall Study|Discontinued due to injection|2|||
129967676|NCT00634842|467847046|FG000|Overall Study|No need of study drug to treat diabetes|0|||
129967677|NCT00634842|467847047|FG001|Overall Study|No need of study drug to treat diabetes|1|||
129967678|NCT00634842|467847046|FG000|Overall Study|No wish to keep taking Avandia|0|||
129967679|NCT00634842|467847047|FG001|Overall Study|No wish to keep taking Avandia|1|||
129967680|NCT00634842|467847046|FG000|Overall Study|Subject off study drug for too long|0|||
129967681|NCT00634842|467847047|FG001|Overall Study|Subject off study drug for too long|1|||
129967682|NCT00810342|467847050|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
129967683|NCT00810342|467847051|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
129456246|NCT03099187|465967963|FG000|Double-blind Treatment|Death|1|||
129456247|NCT03099187|465967964|FG001|Double-blind Treatment|Death|3|||
129456248|NCT03099187|465967965|FG002|Double-blind Treatment|Death|0|||
129456249|NCT03099187|465967966|FG003|Double-blind Treatment|Death|0|||
129456250|NCT03099187|465967963|FG000|Double-blind Treatment|Lack of Efficacy|1|||
129456251|NCT03099187|465967964|FG001|Double-blind Treatment|Lack of Efficacy|0|||
129456252|NCT03099187|465967965|FG002|Double-blind Treatment|Lack of Efficacy|0|||
129456253|NCT03099187|465967966|FG003|Double-blind Treatment|Lack of Efficacy|0|||
129456254|NCT03099187|465967963|FG000|Double-blind Treatment|Physician Decision|2|||
129456255|NCT03099187|465967964|FG001|Double-blind Treatment|Physician Decision|1|||
129456256|NCT03099187|465967965|FG002|Double-blind Treatment|Physician Decision|0|||
129456257|NCT03099187|465967966|FG003|Double-blind Treatment|Physician Decision|0|||
129456258|NCT03099187|465967963|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
129456259|NCT03099187|465967964|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
129456260|NCT03099187|465967965|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
129456261|NCT03099187|465967966|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
129456262|NCT03099187|465967963|FG000|Double-blind Treatment|Lung transplantation|0|||
129456263|NCT03099187|465967964|FG001|Double-blind Treatment|Lung transplantation|1|||
129456264|NCT03099187|465967965|FG002|Double-blind Treatment|Lung transplantation|0|||
129456265|NCT03099187|465967966|FG003|Double-blind Treatment|Lung transplantation|0|||
129456266|NCT03099187|465967963|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
129456267|NCT03099187|465967964|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
129456268|NCT03099187|465967965|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
129456269|NCT03099187|465967966|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
129456270|NCT03099187|465967963|FG000|Double-blind Treatment|Disease progression|0|||
129456271|NCT03099187|465967964|FG001|Double-blind Treatment|Disease progression|1|||
129456272|NCT03099187|465967965|FG002|Double-blind Treatment|Disease progression|0|||
129456273|NCT03099187|465967966|FG003|Double-blind Treatment|Disease progression|0|||
129456274|NCT03099187|465967963|FG000|Double-blind Treatment|Randomization error|0|||
129456275|NCT03099187|465967964|FG001|Double-blind Treatment|Randomization error|2|||
129456276|NCT03099187|465967965|FG002|Double-blind Treatment|Randomization error|0|||
129456277|NCT03099187|465967966|FG003|Double-blind Treatment|Randomization error|0|||
129456278|NCT03099187|465967963|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
129456279|NCT03099187|465967964|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
129456280|NCT03099187|465967965|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
129456281|NCT03099187|465967966|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
129456282|NCT03099187|465967963|FG000|12-month Safety Follow-up|Adverse Event|0|||
129456283|NCT03099187|465967964|FG001|12-month Safety Follow-up|Adverse Event|0|||
129456284|NCT03099187|465967965|FG002|12-month Safety Follow-up|Adverse Event|5|||
129456285|NCT03099187|465967966|FG003|12-month Safety Follow-up|Adverse Event|12|||
129456286|NCT03099187|465967963|FG000|12-month Safety Follow-up|Death|0|||
129456287|NCT03099187|465967964|FG001|12-month Safety Follow-up|Death|0|||
129456288|NCT03099187|465967965|FG002|12-month Safety Follow-up|Death|7|||
129456289|NCT03099187|465967966|FG003|12-month Safety Follow-up|Death|9|||
129456290|NCT03099187|465967963|FG000|12-month Safety Follow-up|Lung transplantation|0|||
129456291|NCT03099187|465967964|FG001|12-month Safety Follow-up|Lung transplantation|0|||
129456292|NCT03099187|465967965|FG002|12-month Safety Follow-up|Lung transplantation|2|||
129456293|NCT03099187|465967966|FG003|12-month Safety Follow-up|Lung transplantation|1|||
129456294|NCT03099187|465967963|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
129456295|NCT03099187|465967964|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
129456296|NCT03099187|465967965|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
129456297|NCT03099187|465967966|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
129456298|NCT03099187|465967963|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
129456299|NCT03099187|465967964|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
129967684|NCT00810342|467847050|FG000|Month 1 Follow-up|Pregnancy|1|||
129967685|NCT00810342|467847051|FG001|Month 1 Follow-up|Pregnancy|0|||
129967686|NCT00810342|467847050|FG000|6-month Follow-up|Lost to Follow-up|18|||
129967687|NCT00810342|467847051|FG001|6-month Follow-up|Lost to Follow-up|6|||
129967688|NCT00810342|467847050|FG000|6-month Follow-up|Pregnancy|6|||
129967689|NCT00810342|467847051|FG001|6-month Follow-up|Pregnancy|2|||
129456300|NCT03099187|465967965|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
129967690|NCT00810342|467847050|FG000|12-month Followup|Pregnancy|9|||
129456301|NCT03099187|465967966|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
129456302|NCT03099187|465967963|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
129456303|NCT03099187|465967964|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
129456304|NCT03099187|465967965|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
129456305|NCT03099187|465967966|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
129456306|NCT03099187|465967963|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
129456307|NCT03099187|465967964|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
129456308|NCT03099187|465967965|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
129456309|NCT03099187|465967966|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
129456310|NCT01246583|465967967|FG000|Overall Study|Lost to Follow-up|0|||
129456311|NCT01246583|465967968|FG001|Overall Study|Lost to Follow-up|0|||
129456312|NCT01246583|465967969|FG002|Overall Study|Lost to Follow-up|0|||
129456313|NCT01246583|465967970|FG003|Overall Study|Lost to Follow-up|1|||
129456314|NCT01246583|465967967|FG000|Overall Study|Protocol Violation|0|||
129456315|NCT01246583|465967968|FG001|Overall Study|Protocol Violation|0|||
129456316|NCT01246583|465967969|FG002|Overall Study|Protocol Violation|1|||
129456317|NCT01246583|465967970|FG003|Overall Study|Protocol Violation|0|||
129456318|NCT01246583|465967967|FG000|Overall Study|Withdrawal by Subject|1|||
129456319|NCT01246583|465967968|FG001|Overall Study|Withdrawal by Subject|0|||
129456320|NCT01246583|465967969|FG002|Overall Study|Withdrawal by Subject|0|||
129456321|NCT01246583|465967970|FG003|Overall Study|Withdrawal by Subject|0|||
129456322|NCT02116777|465967971|FG000|Overall Study|Adverse Event|0|||
129456323|NCT02116777|465967972|FG001|Overall Study|Adverse Event|0|||
129456324|NCT02116777|465967973|FG002|Overall Study|Adverse Event|0|||
129456325|NCT02116777|465967974|FG003|Overall Study|Adverse Event|0|||
129456326|NCT02116777|465967975|FG004|Overall Study|Adverse Event|2|||
129456327|NCT02116777|465967976|FG005|Overall Study|Adverse Event|2|||
129456328|NCT02116777|465967977|FG006|Overall Study|Adverse Event|0|||
129456329|NCT02116777|465967971|FG000|Overall Study|Death|0|||
129456330|NCT02116777|465967972|FG001|Overall Study|Death|0|||
129456331|NCT02116777|465967973|FG002|Overall Study|Death|0|||
129456332|NCT02116777|465967974|FG003|Overall Study|Death|1|||
129456333|NCT02116777|465967975|FG004|Overall Study|Death|0|||
129456334|NCT02116777|465967976|FG005|Overall Study|Death|0|||
129456335|NCT02116777|465967977|FG006|Overall Study|Death|0|||
129456336|NCT02116777|465967971|FG000|Overall Study|Lack of Efficacy|3|||
129456337|NCT02116777|465967972|FG001|Overall Study|Lack of Efficacy|3|||
129456338|NCT02116777|465967973|FG002|Overall Study|Lack of Efficacy|3|||
129456339|NCT02116777|465967974|FG003|Overall Study|Lack of Efficacy|8|||
129456340|NCT02116777|465967975|FG004|Overall Study|Lack of Efficacy|4|||
129456341|NCT02116777|465967976|FG005|Overall Study|Lack of Efficacy|1|||
129456342|NCT02116777|465967977|FG006|Overall Study|Lack of Efficacy|9|||
129456343|NCT02116777|465967971|FG000|Overall Study|Physician Decision|0|||
129456344|NCT02116777|465967972|FG001|Overall Study|Physician Decision|0|||
129456345|NCT02116777|465967973|FG002|Overall Study|Physician Decision|0|||
129456346|NCT02116777|465967974|FG003|Overall Study|Physician Decision|2|||
129456347|NCT02116777|465967975|FG004|Overall Study|Physician Decision|0|||
129456348|NCT02116777|465967976|FG005|Overall Study|Physician Decision|0|||
129456349|NCT02116777|465967977|FG006|Overall Study|Physician Decision|0|||
129456350|NCT02116777|465967971|FG000|Overall Study|Protocol Violation|0|||
129456351|NCT02116777|465967972|FG001|Overall Study|Protocol Violation|0|||
129456352|NCT02116777|465967973|FG002|Overall Study|Protocol Violation|0|||
129456353|NCT02116777|465967974|FG003|Overall Study|Protocol Violation|1|||
129456354|NCT02116777|465967975|FG004|Overall Study|Protocol Violation|0|||
129456355|NCT02116777|465967976|FG005|Overall Study|Protocol Violation|0|||
129456356|NCT02116777|465967977|FG006|Overall Study|Protocol Violation|0|||
129456357|NCT02116777|465967971|FG000|Overall Study|Withdrawal by Subject|0|||
129456358|NCT02116777|465967972|FG001|Overall Study|Withdrawal by Subject|0|||
129456359|NCT02116777|465967973|FG002|Overall Study|Withdrawal by Subject|0|||
129456360|NCT02116777|465967974|FG003|Overall Study|Withdrawal by Subject|1|||
129456361|NCT02116777|465967975|FG004|Overall Study|Withdrawal by Subject|0|||
129456362|NCT02116777|465967976|FG005|Overall Study|Withdrawal by Subject|0|||
129456363|NCT02116777|465967977|FG006|Overall Study|Withdrawal by Subject|0|||
129488462|NCT01277289|466080717|FG000|Overall Study|premature closure of the study|4|||
129488463|NCT01277289|466080718|FG001|Overall Study|premature closure of the study|2|||
129488464|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
129488465|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
129488466|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
129488467|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
129488468|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
129488469|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
129488470|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
129488471|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
129488472|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
129488473|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
129488474|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
129456364|NCT04218201|465969896|FG000|Overall Study|Death|0|||
129456365|NCT04218201|465969897|FG001|Overall Study|Death|0|||
129456366|NCT04218201|465969898|FG002|Overall Study|Death|2|||
129456367|NCT04218201|465969899|FG003|Overall Study|Death|0|||
129456368|NCT04218201|465969896|FG000|Overall Study|Unable to contact participant|4|||
129456369|NCT04218201|465969897|FG001|Overall Study|Unable to contact participant|0|||
129456370|NCT04218201|465969898|FG002|Overall Study|Unable to contact participant|3|||
129456371|NCT04218201|465969899|FG003|Overall Study|Unable to contact participant|0|||
129456372|NCT04218201|465969896|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
129456373|NCT04218201|465969897|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
129456374|NCT04218201|465969898|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
129456375|NCT04218201|465969899|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
129456376|NCT04218201|465969896|FG000|Overall Study|Withdrawal by Subject|2|||
129456377|NCT04218201|465969897|FG001|Overall Study|Withdrawal by Subject|0|||
129456378|NCT04218201|465969898|FG002|Overall Study|Withdrawal by Subject|0|||
129456379|NCT04218201|465969899|FG003|Overall Study|Withdrawal by Subject|0|||
129456380|NCT04218201|465969896|FG000|Overall Study|PCP plans to leave practice|0|||
129456381|NCT04218201|465969897|FG001|Overall Study|PCP plans to leave practice|8|||
129456382|NCT04218201|465969898|FG002|Overall Study|PCP plans to leave practice|0|||
129456383|NCT04218201|465969899|FG003|Overall Study|PCP plans to leave practice|5|||
129456384|NCT04218201|465969896|FG000|Overall Study|Reduced panel|0|||
129456385|NCT04218201|465969897|FG001|Overall Study|Reduced panel|0|||
129456386|NCT04218201|465969898|FG002|Overall Study|Reduced panel|0|||
129456387|NCT04218201|465969899|FG003|Overall Study|Reduced panel|1|||
129456388|NCT04218201|465969896|FG000|Overall Study|No longer interested in participating|0|||
129456389|NCT04218201|465969897|FG001|Overall Study|No longer interested in participating|1|||
129456390|NCT04218201|465969898|FG002|Overall Study|No longer interested in participating|0|||
129456391|NCT04218201|465969899|FG003|Overall Study|No longer interested in participating|0|||
129456392|NCT03723707|465969906|FG000|Overall Study|Death|32|||
129456393|NCT03723707|465969907|FG001|Overall Study|Death|32|||
129456394|NCT03723707|465969906|FG000|Overall Study|Admitted to long term care|12|||
129456395|NCT03723707|465969907|FG001|Overall Study|Admitted to long term care|12|||
129456396|NCT03723707|465969906|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
129456397|NCT03723707|465969907|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
129456398|NCT03723707|465969906|FG000|Overall Study|Lost to Follow-up|40|||
129456399|NCT03723707|465969907|FG001|Overall Study|Lost to Follow-up|22|||
129456400|NCT03723707|465969906|FG000|Overall Study|Discontinued after study closure|24|||
129456401|NCT03723707|465969907|FG001|Overall Study|Discontinued after study closure|12|||
129456402|NCT05121480|465969908|FG000|Overall Study|Lack of Efficacy|2|||
129456403|NCT05121480|465969909|FG001|Overall Study|Lack of Efficacy|2|||
129456404|NCT05121480|465969910|FG002|Overall Study|Lack of Efficacy|1|||
129456405|NCT05121480|465969911|FG003|Overall Study|Lack of Efficacy|4|||
129456406|NCT05121480|465969912|FG004|Overall Study|Lack of Efficacy|0|||
129456407|NCT05121480|465969913|FG005|Overall Study|Lack of Efficacy|1|||
129456408|NCT05121480|465969914|FG006|Overall Study|Lack of Efficacy|0|||
129456409|NCT05121480|465969915|FG007|Overall Study|Lack of Efficacy|2|||
129456410|NCT05121480|465969908|FG000|Overall Study|Treatment Failure|0|||
129456411|NCT05121480|465969909|FG001|Overall Study|Treatment Failure|2|||
129456412|NCT05121480|465969910|FG002|Overall Study|Treatment Failure|0|||
129456413|NCT05121480|465969911|FG003|Overall Study|Treatment Failure|1|||
129456414|NCT05121480|465969912|FG004|Overall Study|Treatment Failure|0|||
129456415|NCT05121480|465969913|FG005|Overall Study|Treatment Failure|0|||
129456416|NCT05121480|465969914|FG006|Overall Study|Treatment Failure|0|||
129456417|NCT05121480|465969915|FG007|Overall Study|Treatment Failure|0|||
129456418|NCT05121480|465969908|FG000|Overall Study|Adverse Event|0|||
129456419|NCT05121480|465969909|FG001|Overall Study|Adverse Event|1|||
129456420|NCT05121480|465969910|FG002|Overall Study|Adverse Event|0|||
129456421|NCT05121480|465969911|FG003|Overall Study|Adverse Event|5|||
129456422|NCT05121480|465969912|FG004|Overall Study|Adverse Event|3|||
129456423|NCT05121480|465969913|FG005|Overall Study|Adverse Event|2|||
129456424|NCT05121480|465969914|FG006|Overall Study|Adverse Event|0|||
129456425|NCT05121480|465969915|FG007|Overall Study|Adverse Event|4|||
129456426|NCT05121480|465969908|FG000|Overall Study|Withdrawal by Subject|4|||
129967691|NCT00810342|467847051|FG001|12-month Followup|Pregnancy|10|||
129456427|NCT05121480|465969909|FG001|Overall Study|Withdrawal by Subject|9|||
129456428|NCT05121480|465969910|FG002|Overall Study|Withdrawal by Subject|1|||
129456429|NCT05121480|465969911|FG003|Overall Study|Withdrawal by Subject|8|||
129456430|NCT05121480|465969912|FG004|Overall Study|Withdrawal by Subject|0|||
129456431|NCT05121480|465969913|FG005|Overall Study|Withdrawal by Subject|9|||
129456432|NCT05121480|465969914|FG006|Overall Study|Withdrawal by Subject|0|||
129456433|NCT05121480|465969915|FG007|Overall Study|Withdrawal by Subject|4|||
129456434|NCT05121480|465969908|FG000|Overall Study|Non-compliance with the protocol|0|||
129456435|NCT05121480|465969909|FG001|Overall Study|Non-compliance with the protocol|0|||
129456436|NCT05121480|465969910|FG002|Overall Study|Non-compliance with the protocol|0|||
129456437|NCT05121480|465969911|FG003|Overall Study|Non-compliance with the protocol|0|||
129456438|NCT05121480|465969912|FG004|Overall Study|Non-compliance with the protocol|1|||
129456439|NCT05121480|465969913|FG005|Overall Study|Non-compliance with the protocol|6|||
129456440|NCT05121480|465969914|FG006|Overall Study|Non-compliance with the protocol|0|||
129456441|NCT05121480|465969915|FG007|Overall Study|Non-compliance with the protocol|1|||
129456442|NCT05121480|465969908|FG000|Overall Study|Lost to Follow-up|0|||
129456443|NCT05121480|465969909|FG001|Overall Study|Lost to Follow-up|4|||
129456444|NCT05121480|465969910|FG002|Overall Study|Lost to Follow-up|1|||
129456445|NCT05121480|465969911|FG003|Overall Study|Lost to Follow-up|3|||
129456446|NCT05121480|465969912|FG004|Overall Study|Lost to Follow-up|1|||
129456447|NCT05121480|465969913|FG005|Overall Study|Lost to Follow-up|1|||
129456448|NCT05121480|465969914|FG006|Overall Study|Lost to Follow-up|1|||
129456449|NCT05121480|465969915|FG007|Overall Study|Lost to Follow-up|4|||
129456450|NCT05121480|465969908|FG000|Overall Study|Physician Decision|0|||
129456451|NCT05121480|465969909|FG001|Overall Study|Physician Decision|0|||
129456452|NCT05121480|465969910|FG002|Overall Study|Physician Decision|0|||
129456453|NCT05121480|465969911|FG003|Overall Study|Physician Decision|0|||
129456454|NCT05121480|465969912|FG004|Overall Study|Physician Decision|0|||
129456455|NCT05121480|465969913|FG005|Overall Study|Physician Decision|1|||
129456456|NCT05121480|465969914|FG006|Overall Study|Physician Decision|0|||
129456457|NCT05121480|465969915|FG007|Overall Study|Physician Decision|1|||
129456458|NCT05121480|465969908|FG000|Overall Study|Other Reason|0|||
129456459|NCT05121480|465969909|FG001|Overall Study|Other Reason|0|||
129456460|NCT05121480|465969910|FG002|Overall Study|Other Reason|0|||
129456461|NCT05121480|465969911|FG003|Overall Study|Other Reason|0|||
129456462|NCT05121480|465969912|FG004|Overall Study|Other Reason|0|||
129456463|NCT05121480|465969913|FG005|Overall Study|Other Reason|1|||
129456464|NCT05121480|465969914|FG006|Overall Study|Other Reason|1|||
129456465|NCT05121480|465969915|FG007|Overall Study|Other Reason|1|||
129456466|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
129456467|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
129456468|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
129456469|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
129456470|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
129456471|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
129456472|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
129456473|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
129456474|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
129456475|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
129456476|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
129456477|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
129456478|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
129456479|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
129456480|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
129456481|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
129456482|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
129456483|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
129456484|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
129456485|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
129456486|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
129456487|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
129456488|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
129456489|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
129456490|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
129456491|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
129456492|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
129456493|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
129456494|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
129456495|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
129456496|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
129456497|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
129456498|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
129456499|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
129456500|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
129456501|NCT02831673|465969918|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
129456502|NCT02831673|465969919|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
129456503|NCT02831673|465969920|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
129456504|NCT02831673|465969921|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
129456505|NCT02831673|465969922|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
129456506|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129967692|NCT00810342|467847050|FG000|12-month Followup|Lost to Follow-up|3|||
129967693|NCT00810342|467847051|FG001|12-month Followup|Lost to Follow-up|1|||
129456507|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129456508|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
129456509|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
129456510|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
129456511|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129456512|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129456513|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
129456514|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
129456515|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
129456516|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129456517|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129456518|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129456519|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
129456520|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
129456521|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
129456522|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
129456523|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
129456524|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
129456525|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
129456526|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129456527|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129456528|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
129456529|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
129456530|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
129456531|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129456532|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129456533|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
129456534|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
129456535|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
129456536|NCT02831673|465969918|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129456537|NCT02831673|465969919|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129456538|NCT02831673|465969920|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
129456539|NCT02831673|465969921|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
129456540|NCT02831673|465969922|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
129456541|NCT02831673|465969918|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
129456542|NCT02831673|465969919|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
129456543|NCT02831673|465969920|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
129456544|NCT02831673|465969921|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
129456545|NCT02831673|465969922|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
129456546|NCT02831673|465969918|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129456547|NCT02831673|465969919|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129456548|NCT02831673|465969920|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129456549|NCT02831673|465969921|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
129456550|NCT02831673|465969922|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
129456551|NCT02831673|465969918|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129456552|NCT02831673|465969919|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129456553|NCT02831673|465969920|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129456554|NCT02831673|465969921|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
129456555|NCT02831673|465969922|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
129456556|NCT02831673|465969918|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129456557|NCT02831673|465969919|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129456558|NCT02831673|465969920|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129456559|NCT02831673|465969921|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
129456560|NCT02831673|465969922|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
129456561|NCT02831673|465969918|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129456562|NCT02831673|465969919|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129456563|NCT02831673|465969920|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129456564|NCT02831673|465969921|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
129456565|NCT02831673|465969922|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
129456566|NCT02356562|465969924|FG000|Overall Study|Withdrawal by Subject|0|||
129456567|NCT02356562|465969925|FG001|Overall Study|Withdrawal by Subject|1|||
129456568|NCT02356562|465969924|FG000|Overall Study|Re-entered treatment in a previous study|1|||
129456569|NCT02356562|465969925|FG001|Overall Study|Re-entered treatment in a previous study|0|||
129456570|NCT02356562|465969924|FG000|Overall Study|site closure|1|||
129456571|NCT02356562|465969925|FG001|Overall Study|site closure|0|||
129456572|NCT00412750|465969926|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129456573|NCT00412750|465969927|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129456574|NCT00412750|465969928|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129456575|NCT00412750|465969926|FG000|Overall Study|Administrative problems|21|||
129456576|NCT00412750|465969927|FG001|Overall Study|Administrative problems|17|||
129456577|NCT00412750|465969928|FG002|Overall Study|Administrative problems|14|||
129456578|NCT00412750|465969926|FG000|Overall Study|Adverse Event|8|||
129456579|NCT00412750|465969927|FG001|Overall Study|Adverse Event|3|||
129456580|NCT00412750|465969928|FG002|Overall Study|Adverse Event|3|||
129456581|NCT00412750|465969926|FG000|Overall Study|Lost to Follow-up|1|||
129456582|NCT00412750|465969927|FG001|Overall Study|Lost to Follow-up|0|||
129456583|NCT00412750|465969928|FG002|Overall Study|Lost to Follow-up|1|||
129456584|NCT00412750|465969926|FG000|Overall Study|Withdrawal by Subject|0|||
129456585|NCT00412750|465969927|FG001|Overall Study|Withdrawal by Subject|1|||
129456586|NCT00412750|465969928|FG002|Overall Study|Withdrawal by Subject|2|||
129456587|NCT00412750|465969926|FG000|Overall Study|Lack of Efficacy|0|||
129456588|NCT00412750|465969927|FG001|Overall Study|Lack of Efficacy|0|||
129456589|NCT00412750|465969928|FG002|Overall Study|Lack of Efficacy|3|||
129456590|NCT02830880|465969941|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
129456591|NCT02830880|465969941|FG000|Overall Study|Death|1|||
129456592|NCT02830880|465969941|FG000|Overall Study|Physician Decision|1|||
129456593|NCT03551509|465969942|FG000|Overall Study|Lost to Follow-up|0|||
129456594|NCT03551509|465969943|FG001|Overall Study|Lost to Follow-up|1|||
129456595|NCT03551509|465969944|FG002|Overall Study|Lost to Follow-up|0|||
129456596|NCT01040351|465969945|FG000|Overall Study|poor ovarian response|1|||
129456597|NCT01040351|465969946|FG001|Overall Study|poor ovarian response|2|||
129456598|NCT01230307|465969947|FG000|Overall Study|LVAD Placement|0|||
129456599|NCT01230307|465969948|FG001|Overall Study|LVAD Placement|2|||
129456600|NCT00530894|465969952|FG000|Overall Study|Death|84|||
129456601|NCT00530894|465969953|FG001|Overall Study|Death|89|||
129456602|NCT00530894|465969954|FG002|Overall Study|Death|55|||
129456603|NCT00530894|465969955|FG003|Overall Study|Death|89|||
129456604|NCT00530894|465969952|FG000|Overall Study|Lost to Follow-up|1|||
129456605|NCT00530894|465969953|FG001|Overall Study|Lost to Follow-up|3|||
129456606|NCT00530894|465969954|FG002|Overall Study|Lost to Follow-up|0|||
129456607|NCT00530894|465969955|FG003|Overall Study|Lost to Follow-up|0|||
129456608|NCT00530894|465969952|FG000|Overall Study|Withdrawal by Subject|1|||
129456609|NCT00530894|465969953|FG001|Overall Study|Withdrawal by Subject|23|||
129456610|NCT00530894|465969954|FG002|Overall Study|Withdrawal by Subject|0|||
129456611|NCT00530894|465969955|FG003|Overall Study|Withdrawal by Subject|5|||
129456612|NCT00530894|465969952|FG000|Overall Study|Alive and censored prior to 1 year|2|||
129456613|NCT00530894|465969953|FG001|Overall Study|Alive and censored prior to 1 year|0|||
129456614|NCT00530894|465969954|FG002|Overall Study|Alive and censored prior to 1 year|0|||
129456615|NCT00530894|465969955|FG003|Overall Study|Alive and censored prior to 1 year|0|||
129456616|NCT02256540|465969956|FG000|Overall Study|Withdrawal by Subject|0|||
129456617|NCT02256540|465969957|FG001|Overall Study|Withdrawal by Subject|1|||
129456618|NCT02256540|465969958|FG002|Overall Study|Withdrawal by Subject|1|||
129456619|NCT02256540|465969956|FG000|Overall Study|Back pain preventing exercise|0|||
129456620|NCT02256540|465969957|FG001|Overall Study|Back pain preventing exercise|0|||
129456621|NCT02256540|465969958|FG002|Overall Study|Back pain preventing exercise|1|||
129456622|NCT03719690|465969967|FG000|Overall Study|Withdrawal by Subject|5|||
129456623|NCT03719690|465969968|FG001|Overall Study|Withdrawal by Subject|10|||
129456624|NCT03719690|465969967|FG000|Overall Study|Death|40|||
129456625|NCT03719690|465969968|FG001|Overall Study|Death|149|||
129456626|NCT03719690|465969967|FG000|Overall Study|Miscellaneous|12|||
129456627|NCT03719690|465969968|FG001|Overall Study|Miscellaneous|56|||
129456628|NCT03719690|465969967|FG000|Overall Study|Lost to Follow-up|2|||
129456629|NCT03719690|465969968|FG001|Overall Study|Lost to Follow-up|18|||
129456630|NCT03719690|465969967|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
129456631|NCT03719690|465969968|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
129456632|NCT01918007|465969969|FG000|Overall Study|Baseline oximetry not acceptable|11|||
129456633|NCT01918007|465969970|FG001|Overall Study|Baseline oximetry not acceptable|7|||
129456634|NCT01918007|465969969|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
129967694|NCT04504630|467847053|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
129967695|NCT04504630|467847054|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
129456635|NCT01918007|465969970|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
129456636|NCT01918007|465969969|FG000|Overall Study|Lost to Follow-up|4|||
129456637|NCT01918007|465969970|FG001|Overall Study|Lost to Follow-up|7|||
129456638|NCT00960661|465969973|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
129456639|NCT00960661|465969974|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
129456640|NCT00960661|465969975|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
129456641|NCT00960661|465969973|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
129456642|NCT00960661|465969974|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
129967696|NCT04504630|467847053|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
129456643|NCT00960661|465969975|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
129456644|NCT00960661|465969973|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
129456645|NCT00960661|465969974|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
129456646|NCT00960661|465969975|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
129456647|NCT00960661|465969973|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
129456648|NCT00960661|465969974|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
129456649|NCT00960661|465969975|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
129456650|NCT00960661|465969973|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
129456651|NCT00960661|465969974|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
129456652|NCT00960661|465969975|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
129456653|NCT00960661|465969973|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
129456654|NCT00960661|465969974|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
129456655|NCT00960661|465969975|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
129456656|NCT00960661|465969973|FG000|Interventional Phase|Adverse Event|0|||
129456657|NCT00960661|465969974|FG001|Interventional Phase|Adverse Event|17|||
129456658|NCT00960661|465969975|FG002|Interventional Phase|Adverse Event|8|||
129456659|NCT00960661|465969973|FG000|Interventional Phase|Death|0|||
129456660|NCT00960661|465969974|FG001|Interventional Phase|Death|1|||
129456661|NCT00960661|465969975|FG002|Interventional Phase|Death|0|||
129456662|NCT00960661|465969973|FG000|Interventional Phase|Lost to Follow-up|0|||
129456663|NCT00960661|465969974|FG001|Interventional Phase|Lost to Follow-up|0|||
129456664|NCT00960661|465969975|FG002|Interventional Phase|Lost to Follow-up|2|||
129456665|NCT00960661|465969973|FG000|Interventional Phase|entry criteria not met|0|||
129456666|NCT00960661|465969974|FG001|Interventional Phase|entry criteria not met|3|||
129456667|NCT00960661|465969975|FG002|Interventional Phase|entry criteria not met|0|||
129456668|NCT00960661|465969973|FG000|Interventional Phase|Protocol Violation|0|||
129456669|NCT00960661|465969974|FG001|Interventional Phase|Protocol Violation|7|||
129456670|NCT00960661|465969975|FG002|Interventional Phase|Protocol Violation|2|||
129456671|NCT00960661|465969973|FG000|Interventional Phase|Withdrawal by Subject|0|||
129456672|NCT00960661|465969974|FG001|Interventional Phase|Withdrawal by Subject|18|||
129456673|NCT00960661|465969975|FG002|Interventional Phase|Withdrawal by Subject|29|||
129456674|NCT00960661|465969973|FG000|Interventional Phase|Physician Decision|0|||
129456675|NCT00960661|465969974|FG001|Interventional Phase|Physician Decision|3|||
129456676|NCT00960661|465969975|FG002|Interventional Phase|Physician Decision|5|||
129456677|NCT00960661|465969973|FG000|Interventional Phase|sponsor decision|0|||
129456678|NCT00960661|465969974|FG001|Interventional Phase|sponsor decision|1|||
129456679|NCT00960661|465969975|FG002|Interventional Phase|sponsor decision|0|||
129456680|NCT00960661|465969973|FG000|Interventional Phase|Lack of Efficacy|0|||
129456681|NCT00960661|465969974|FG001|Interventional Phase|Lack of Efficacy|2|||
129456682|NCT00960661|465969975|FG002|Interventional Phase|Lack of Efficacy|0|||
129456683|NCT02699892|465969976|FG000|Overall Study|Other|36|||
129456684|NCT00530270|465969988|FG000|Overall Study|Protocol Violation|1|||
129456685|NCT00530270|465969989|FG001|Overall Study|Protocol Violation|0|||
129456686|NCT00838331|465969994|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
129456687|NCT03972969|465969996|FG000|3-month Follow-up|Death|1|||
129456688|NCT03972969|465969997|FG001|3-month Follow-up|Death|1|||
129456689|NCT03972969|465969998|FG002|3-month Follow-up|Death|0|||
129456690|NCT03972969|465969996|FG000|6-month Follow-up|Death|1|||
129456691|NCT03972969|465969997|FG001|6-month Follow-up|Death|1|||
129456692|NCT03972969|465969998|FG002|6-month Follow-up|Death|1|||
129456693|NCT03972969|465969996|FG000|6-month Follow-up|Lost to Follow-up|2|||
129456694|NCT03972969|465969997|FG001|6-month Follow-up|Lost to Follow-up|2|||
129456695|NCT03972969|465969998|FG002|6-month Follow-up|Lost to Follow-up|2|||
129456696|NCT00264875|465969999|FG000|Overall Study|Adverse Event|6|||
129456697|NCT00264875|465969999|FG000|Overall Study|Lost to Follow-up|6|||
129456698|NCT00264875|465969999|FG000|Overall Study|Protocol Violation|11|||
129456699|NCT00264875|465969999|FG000|Overall Study|Withdrawal by Subject|7|||
129456700|NCT00183274|465970003|FG000|Phase 1: Open-Label|Adverse Event|31|||
129456701|NCT00183274|465970004|FG001|Phase 1: Open-Label|Adverse Event|0|||
129456702|NCT00183274|465970005|FG002|Phase 1: Open-Label|Adverse Event|0|||
129456703|NCT00183274|465970006|FG003|Phase 1: Open-Label|Adverse Event|0|||
129456704|NCT00183274|465970007|FG004|Phase 1: Open-Label|Adverse Event|0|||
129456705|NCT00183274|465970008|FG005|Phase 1: Open-Label|Adverse Event|0|||
129456706|NCT00183274|465970003|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
129456707|NCT00183274|465970004|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
129456708|NCT00183274|465970005|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
129456709|NCT00183274|465970006|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
129456710|NCT00183274|465970007|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
129456711|NCT00183274|465970008|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
129456712|NCT00183274|465970003|FG000|Phase 1: Open-Label|Protocol Violation|11|||
129456713|NCT00183274|465970004|FG001|Phase 1: Open-Label|Protocol Violation|0|||
129456714|NCT00183274|465970005|FG002|Phase 1: Open-Label|Protocol Violation|0|||
129456715|NCT00183274|465970006|FG003|Phase 1: Open-Label|Protocol Violation|0|||
129456716|NCT00183274|465970007|FG004|Phase 1: Open-Label|Protocol Violation|0|||
129456717|NCT00183274|465970008|FG005|Phase 1: Open-Label|Protocol Violation|0|||
129456718|NCT00183274|465970003|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
129456719|NCT00183274|465970004|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
129456720|NCT00183274|465970005|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
129456721|NCT00183274|465970006|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
129456722|NCT00183274|465970007|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
129456723|NCT00183274|465970008|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
129456724|NCT00183274|465970003|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
129456725|NCT00183274|465970004|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
129456726|NCT00183274|465970005|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
129456727|NCT00183274|465970006|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
129456728|NCT00183274|465970007|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
129456729|NCT00183274|465970008|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
129456730|NCT00183274|465970003|FG000|Phase 1: Open-Label|Other|9|||
129456731|NCT00183274|465970004|FG001|Phase 1: Open-Label|Other|0|||
129456732|NCT00183274|465970005|FG002|Phase 1: Open-Label|Other|0|||
129456733|NCT00183274|465970006|FG003|Phase 1: Open-Label|Other|0|||
129456734|NCT00183274|465970007|FG004|Phase 1: Open-Label|Other|0|||
129456735|NCT00183274|465970008|FG005|Phase 1: Open-Label|Other|0|||
129456736|NCT00183274|465970003|FG000|Phase 2: Double-Blind|Relapsed|0|||
129456737|NCT00183274|465970004|FG001|Phase 2: Double-Blind|Relapsed|8|||
129456738|NCT00183274|465970005|FG002|Phase 2: Double-Blind|Relapsed|29|||
129456739|NCT00183274|465970006|FG003|Phase 2: Double-Blind|Relapsed|0|||
129456740|NCT00183274|465970007|FG004|Phase 2: Double-Blind|Relapsed|0|||
129456741|NCT00183274|465970008|FG005|Phase 2: Double-Blind|Relapsed|0|||
129456742|NCT00183274|465970003|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
129456743|NCT00183274|465970004|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
129456744|NCT00183274|465970005|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
129456745|NCT00183274|465970006|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
129456746|NCT00183274|465970007|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
129456747|NCT00183274|465970008|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
129456748|NCT00183274|465970003|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
129456749|NCT00183274|465970004|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
129456750|NCT00183274|465970005|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
129456751|NCT00183274|465970006|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
129456752|NCT00183274|465970007|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
129456753|NCT00183274|465970008|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
129456754|NCT00183274|465970003|FG000|Phase 3: Double-Blind|Relapsed|0|||
129456755|NCT00183274|465970004|FG001|Phase 3: Double-Blind|Relapsed|0|||
129456756|NCT00183274|465970005|FG002|Phase 3: Double-Blind|Relapsed|0|||
129456757|NCT00183274|465970006|FG003|Phase 3: Double-Blind|Relapsed|1|||
129456758|NCT00183274|465970007|FG004|Phase 3: Double-Blind|Relapsed|11|||
129456759|NCT00183274|465970008|FG005|Phase 3: Double-Blind|Relapsed|2|||
129456760|NCT02409290|465970011|FG000|Overall Study|Protocol Violation|3|||
129456761|NCT02409290|465970012|FG001|Overall Study|Protocol Violation|6|||
129456762|NCT02409290|465970013|FG002|Overall Study|Protocol Violation|9|||
129456763|NCT02409290|465970014|FG003|Overall Study|Protocol Violation|4|||
129456764|NCT02409290|465970011|FG000|Overall Study|No positive culture/no baseline sample|3|||
129456765|NCT02409290|465970012|FG001|Overall Study|No positive culture/no baseline sample|9|||
129456766|NCT02409290|465970013|FG002|Overall Study|No positive culture/no baseline sample|6|||
129456767|NCT02409290|465970014|FG003|Overall Study|No positive culture/no baseline sample|5|||
129456768|NCT02409290|465970011|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
129456769|NCT02409290|465970012|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
129456770|NCT02409290|465970013|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
129456771|NCT02409290|465970014|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
129456772|NCT00708500|465970015|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
129456773|NCT00708500|465970016|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
129456774|NCT00708500|465970017|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
129456775|NCT00708500|465970015|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
129456776|NCT00708500|465970016|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
129456777|NCT00708500|465970017|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
129456778|NCT00708500|465970015|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
129456779|NCT00708500|465970016|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
129456780|NCT00708500|465970017|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
129456781|NCT00708500|465970015|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
129456782|NCT00708500|465970016|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
129456783|NCT00708500|465970017|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
129456784|NCT00708500|465970015|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
129456785|NCT00708500|465970016|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
129456786|NCT00708500|465970017|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
129456787|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
129456788|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
129456789|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
129456790|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
129456791|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
129456792|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
129456793|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
129456794|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
129456795|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
129456796|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
129456797|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
129456798|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
129456799|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
129456800|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
129456801|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
129456802|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
129456803|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
129456804|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
129456805|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
129456806|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
129456807|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
129456808|NCT00708500|465970015|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
129456809|NCT00708500|465970016|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
129456810|NCT00708500|465970017|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
129456811|NCT00708500|465970015|FG000|FOLLOWUP|Adverse Event|0|||
129456812|NCT00708500|465970016|FG001|FOLLOWUP|Adverse Event|1|||
129456813|NCT00708500|465970017|FG002|FOLLOWUP|Adverse Event|0|||
129456814|NCT00708500|465970015|FG000|FOLLOWUP|Lost to Follow-up|1|||
129456815|NCT00708500|465970016|FG001|FOLLOWUP|Lost to Follow-up|6|||
129456816|NCT00708500|465970017|FG002|FOLLOWUP|Lost to Follow-up|4|||
129456817|NCT00708500|465970015|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
129456818|NCT00708500|465970016|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
129456819|NCT00708500|465970017|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
129456820|NCT00708500|465970015|FG000|FOLLOWUP|Subject withdrew consent|31|||
129456821|NCT00708500|465970016|FG001|FOLLOWUP|Subject withdrew consent|4|||
129456822|NCT00708500|465970017|FG002|FOLLOWUP|Subject withdrew consent|5|||
129456823|NCT00708500|465970015|FG000|FOLLOWUP|Non-compliance with protocol|5|||
129456824|NCT00708500|465970016|FG001|FOLLOWUP|Non-compliance with protocol|0|||
129456825|NCT00708500|465970017|FG002|FOLLOWUP|Non-compliance with protocol|1|||
129456826|NCT00618410|465970022|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
129456827|NCT00618410|465970023|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
129456828|NCT00705783|465970029|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
129456829|NCT00705783|465970030|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
129456830|NCT00705783|465970031|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
129456831|NCT00705783|465970029|FG000|Conversion Phase|Lost to Follow-up|13|||
129456832|NCT00705783|465970030|FG001|Conversion Phase|Lost to Follow-up|0|||
129456833|NCT00705783|465970031|FG002|Conversion Phase|Lost to Follow-up|0|||
129456834|NCT00705783|465970029|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
129456835|NCT00705783|465970030|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
129456836|NCT00705783|465970031|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
129456837|NCT00705783|465970029|FG000|Conversion Phase|Withdrawn by Investigator|4|||
129456838|NCT00705783|465970030|FG001|Conversion Phase|Withdrawn by Investigator|0|||
129456839|NCT00705783|465970031|FG002|Conversion Phase|Withdrawn by Investigator|0|||
129456840|NCT00705783|465970029|FG000|Conversion Phase|Withdrew Consent|24|||
129456841|NCT00705783|465970030|FG001|Conversion Phase|Withdrew Consent|0|||
129456842|NCT00705783|465970031|FG002|Conversion Phase|Withdrew Consent|0|||
129456843|NCT00705783|465970029|FG000|Conversion Phase|Protocol Deviation|2|||
129456844|NCT00705783|465970030|FG001|Conversion Phase|Protocol Deviation|0|||
129456845|NCT00705783|465970031|FG002|Conversion Phase|Protocol Deviation|0|||
129456846|NCT00705783|465970029|FG000|Conversion Phase|Adverse Event|11|||
129456847|NCT00705783|465970030|FG001|Conversion Phase|Adverse Event|0|||
129456848|NCT00705783|465970031|FG002|Conversion Phase|Adverse Event|0|||
129456849|NCT00705783|465970029|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
129456850|NCT00705783|465970030|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
129456851|NCT00705783|465970031|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
129456852|NCT00705783|465970029|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
129456853|NCT00705783|465970030|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129456854|NCT00705783|465970031|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129456855|NCT00705783|465970029|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
129456856|NCT00705783|465970030|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
129456857|NCT00705783|465970031|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
129456858|NCT00705783|465970029|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
129456859|NCT00705783|465970030|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
129456860|NCT00705783|465970031|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
129456861|NCT00705783|465970029|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
129456862|NCT00705783|465970030|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129456863|NCT00705783|465970031|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129456864|NCT00705783|465970029|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
129456865|NCT00705783|465970030|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129456866|NCT00705783|465970031|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129456867|NCT00705783|465970029|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
129456868|NCT00705783|465970030|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
129456869|NCT00705783|465970031|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
129456870|NCT00705783|465970029|FG000|Oral Stabilization Phase|Adverse Event|14|||
129456871|NCT00705783|465970030|FG001|Oral Stabilization Phase|Adverse Event|0|||
129456872|NCT00705783|465970031|FG002|Oral Stabilization Phase|Adverse Event|0|||
129456873|NCT00705783|465970029|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
129456874|NCT00705783|465970030|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129456875|NCT00705783|465970031|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129456876|NCT00705783|465970029|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
129456877|NCT00705783|465970030|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129456878|NCT00705783|465970031|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129456879|NCT00705783|465970029|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
129456880|NCT00705783|465970030|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
129456881|NCT00705783|465970031|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
129456882|NCT00705783|465970029|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
129456883|NCT00705783|465970030|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
129456884|NCT00705783|465970031|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
129456885|NCT00705783|465970029|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
129456886|NCT00705783|465970030|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
129456887|NCT00705783|465970031|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
129456888|NCT00705783|465970029|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
129456889|NCT00705783|465970030|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
129456890|NCT00705783|465970031|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
129456891|NCT00705783|465970029|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
129456892|NCT00705783|465970030|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
129456893|NCT00705783|465970031|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
129456894|NCT00705783|465970029|FG000|Depot Stabilization Phase|Adverse Event|17|||
129456895|NCT00705783|465970030|FG001|Depot Stabilization Phase|Adverse Event|0|||
129456896|NCT00705783|465970031|FG002|Depot Stabilization Phase|Adverse Event|0|||
129456897|NCT00705783|465970029|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
129456898|NCT00705783|465970030|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129456899|NCT00705783|465970031|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129456900|NCT00705783|465970029|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
129456901|NCT00705783|465970030|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129456902|NCT00705783|465970031|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129456903|NCT00705783|465970029|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
129967697|NCT04504630|467847054|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
129967698|NCT02229578|467847078|FG000|Overall Study|Withdrawal by Subject|1|||
129967699|NCT02229578|467847079|FG001|Overall Study|Withdrawal by Subject|3|||
129456904|NCT00705783|465970030|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
129456905|NCT00705783|465970031|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
129456906|NCT00705783|465970029|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
129967700|NCT02229578|467847078|FG000|Overall Study|Protocol Violation|2|||
129967701|NCT02229578|467847079|FG001|Overall Study|Protocol Violation|0|||
129456907|NCT00705783|465970030|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
129456908|NCT00705783|465970031|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
129456909|NCT00705783|465970029|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
129456910|NCT00705783|465970030|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
129456911|NCT00705783|465970031|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
129456912|NCT00705783|465970029|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
129456913|NCT00705783|465970030|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
129456914|NCT00705783|465970031|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
129456915|NCT00705783|465970029|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
129456916|NCT00705783|465970030|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
129456917|NCT00705783|465970031|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
129456918|NCT00705783|465970029|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
129456919|NCT00705783|465970030|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
129456920|NCT00705783|465970031|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
129456921|NCT00705783|465970029|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
129456922|NCT00705783|465970030|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
129456923|NCT00705783|465970031|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
129456924|NCT00705783|465970029|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
129456925|NCT00705783|465970030|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
129456926|NCT00705783|465970031|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
129456927|NCT00705783|465970029|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
129456928|NCT00705783|465970030|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
129456929|NCT00705783|465970031|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
129456930|NCT02182687|465970032|FG000|Overall Study|Withdrawal by Subject|4|||
129456931|NCT02182687|465970033|FG001|Overall Study|Withdrawal by Subject|0|||
129456932|NCT02182687|465970032|FG000|Overall Study|Adverse Event|1|||
129456933|NCT02182687|465970033|FG001|Overall Study|Adverse Event|0|||
129456934|NCT02182687|465970032|FG000|Overall Study|Lost to Follow-up|0|||
129456935|NCT02182687|465970033|FG001|Overall Study|Lost to Follow-up|1|||
129456936|NCT02184195|465970036|FG000|Overall Study|Patient decision|5|||
129456937|NCT02184195|465970037|FG001|Overall Study|Patient decision|2|||
129456938|NCT02184195|465970036|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
129456939|NCT02184195|465970037|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
129456940|NCT02184195|465970036|FG000|Overall Study|Death|67|||
129456941|NCT02184195|465970037|FG001|Overall Study|Death|44|||
129456942|NCT02184195|465970036|FG000|Overall Study|Lost to Follow-up|1|||
129456943|NCT02184195|465970037|FG001|Overall Study|Lost to Follow-up|5|||
129456944|NCT02184195|465970036|FG000|Overall Study|Other|0|||
129456945|NCT02184195|465970037|FG001|Overall Study|Other|3|||
129456946|NCT00939783|465970040|FG000|Overall Study|Death|6|||
129456947|NCT00939783|465970040|FG000|Overall Study|Adverse Event|39|||
129456948|NCT00939783|465970040|FG000|Overall Study|Study Terminated by Sponsor|498|||
129456949|NCT00939783|465970040|FG000|Overall Study|Withdrawal by Subject|78|||
129456950|NCT00939783|465970040|FG000|Overall Study|Other|16|||
129456951|NCT00939783|465970040|FG000|Overall Study|Lost to Follow-up|8|||
129456952|NCT00939783|465970040|FG000|Overall Study|Protocol Violation|3|||
129456953|NCT00939783|465970040|FG000|Overall Study|Enrolled but not treated|1|||
129456954|NCT02255409|465970047|FG000|Overall Study|Administrative Reason|3|||
129456955|NCT02255409|465970048|FG001|Overall Study|Administrative Reason|7|||
129456956|NCT02255409|465970047|FG000|Overall Study|Withdrawal by Subject|1|||
129456957|NCT02255409|465970048|FG001|Overall Study|Withdrawal by Subject|5|||
129456958|NCT02255409|465970047|FG000|Overall Study|Lost to Follow-up|10|||
129456959|NCT02255409|465970048|FG001|Overall Study|Lost to Follow-up|19|||
129456960|NCT01251367|465970049|FG000|Overall Study|Protocol Violation|1|||
129456961|NCT01251367|465970049|FG000|Overall Study|Lack of Efficacy|2|||
129456962|NCT01251367|465970049|FG000|Overall Study|Adverse Event|19|||
129456963|NCT01251367|465970049|FG000|Overall Study|Withdrawal by Subject|36|||
129456964|NCT01251367|465970049|FG000|Overall Study|Lost to Follow-up|5|||
129456965|NCT01251367|465970049|FG000|Overall Study|Subject Required Alternative Treatment|7|||
129456966|NCT01251367|465970049|FG000|Overall Study|No Study Drug Available|1|||
129456967|NCT01251367|465970049|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
129456968|NCT01251367|465970049|FG000|Overall Study|End of Study Visit Performed in Error|1|||
129456969|NCT03775421|465970053|FG000|Overall Study|Lost to Follow-up|2|||
129456970|NCT03775421|465970053|FG000|Overall Study|Withdrawal by Subject|10|||
129456971|NCT03775421|465970053|FG000|Overall Study|Physician Decision|3|||
129456972|NCT03775421|465970053|FG000|Overall Study|Death|1|||
129456973|NCT03775421|465970053|FG000|Overall Study|Study Terminated by Sponsor|94|||
129456974|NCT03917823|465970054|FG000|Overall Study|Lost to Follow-up|1|||
129456975|NCT03917823|465970055|FG001|Overall Study|Lost to Follow-up|1|||
129456976|NCT03917823|465970054|FG000|Overall Study|Withdrawal by Subject|0|||
129456977|NCT03917823|465970055|FG001|Overall Study|Withdrawal by Subject|1|||
129456978|NCT02016820|465970056|FG000|Overall Study|Lost to Follow-up|2|||
129456979|NCT02016820|465970057|FG001|Overall Study|Lost to Follow-up|4|||
129456980|NCT00135668|465970058|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
129456981|NCT00135668|465970059|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
129456982|NCT00135668|465970060|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
129456983|NCT00135668|465970061|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
129456984|NCT00473343|465970064|FG000|Overall Study|Adverse Event|9|||
129456985|NCT00473343|465970064|FG000|Overall Study|Lost to Follow-up|8|||
129456986|NCT00473343|465970064|FG000|Overall Study|Treatment failure|27|||
129456987|NCT00473343|465970064|FG000|Overall Study|Withdrew consent|3|||
129456988|NCT00473343|465970064|FG000|Overall Study|Other un-specified reason|3|||
129456989|NCT04247061|465970067|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
129456990|NCT04247061|465970067|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
129456991|NCT04247061|465970067|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
129456992|NCT00455013|465970071|FG000|Short Term Period|Adverse Event|2|||
129456993|NCT00455013|465970072|FG001|Short Term Period|Adverse Event|5|||
129456994|NCT00455013|465970073|FG002|Short Term Period|Adverse Event|0|||
129456995|NCT00455013|465970071|FG000|Short Term Period|Withdrawal by Subject|0|||
129456996|NCT00455013|465970072|FG001|Short Term Period|Withdrawal by Subject|0|||
129456997|NCT00455013|465970073|FG002|Short Term Period|Withdrawal by Subject|1|||
129456998|NCT00455013|465970071|FG000|Short Term Period|Lack of Efficacy|4|||
129456999|NCT00455013|465970072|FG001|Short Term Period|Lack of Efficacy|0|||
129457000|NCT00455013|465970073|FG002|Short Term Period|Lack of Efficacy|0|||
129457001|NCT00455013|465970071|FG000|Short Term Period|Other|0|||
129457002|NCT00455013|465970072|FG001|Short Term Period|Other|0|||
129457003|NCT00455013|465970073|FG002|Short Term Period|Other|1|||
129457004|NCT00455013|465970071|FG000|Long Term Extension (LTE)|Adverse Event|0|||
129457005|NCT00455013|465970072|FG001|Long Term Extension (LTE)|Adverse Event|1|||
129457006|NCT00455013|465970073|FG002|Long Term Extension (LTE)|Adverse Event|1|||
129457007|NCT00455013|465970071|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
129457008|NCT00455013|465970072|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
129457009|NCT00455013|465970073|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
129457010|NCT00455013|465970071|FG000|Long Term Extension (LTE)|Death|1|||
129457011|NCT00455013|465970072|FG001|Long Term Extension (LTE)|Death|1|||
129457012|NCT00455013|465970073|FG002|Long Term Extension (LTE)|Death|0|||
129457013|NCT00455013|465970071|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
129457014|NCT00455013|465970072|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
129457015|NCT00455013|465970073|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
129457016|NCT00455013|465970071|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
129457017|NCT00455013|465970072|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
129457018|NCT00455013|465970073|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
129457019|NCT00455013|465970071|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
129457020|NCT00455013|465970072|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
129457021|NCT00455013|465970073|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
129457022|NCT00455013|465970071|FG000|Long Term Extension (LTE)|non-specified|0|||
129457023|NCT00455013|465970072|FG001|Long Term Extension (LTE)|non-specified|0|||
129457024|NCT00455013|465970073|FG002|Long Term Extension (LTE)|non-specified|1|||
129457025|NCT02739620|465970076|FG000|Overall Study|Lost to Follow-up|3|||
129457026|NCT02739620|465970077|FG001|Overall Study|Lost to Follow-up|1|||
129457027|NCT02739620|465970076|FG000|Overall Study|Adverse Event|0|||
129457028|NCT02739620|465970077|FG001|Overall Study|Adverse Event|1|||
129457029|NCT01439555|465970078|FG000|Overall Study|Protocol Violation|1|||
129457030|NCT00102960|465970080|FG000|Overall Study|Death|23|||
129457031|NCT00102960|465970081|FG001|Overall Study|Death|11|||
129457032|NCT00102960|465970082|FG002|Overall Study|Death|11|||
129457033|NCT00102960|465970080|FG000|Overall Study|Lost to Follow-up|6|||
129457034|NCT00102960|465970081|FG001|Overall Study|Lost to Follow-up|12|||
129457035|NCT00102960|465970082|FG002|Overall Study|Lost to Follow-up|16|||
129457036|NCT00102960|465970080|FG000|Overall Study|Withdrawal by Subject|1|||
129457037|NCT00102960|465970081|FG001|Overall Study|Withdrawal by Subject|0|||
129457038|NCT00102960|465970082|FG002|Overall Study|Withdrawal by Subject|1|||
129457039|NCT02646982|465971769|FG000|Overall Study|Adverse Event|1|||
129457040|NCT02646982|465971770|FG001|Overall Study|Adverse Event|1|||
129457041|NCT02646982|465971769|FG000|Overall Study|Withdrawal by Subject|2|||
129457042|NCT02646982|465971770|FG001|Overall Study|Withdrawal by Subject|1|||
129457043|NCT00713700|465971771|FG000|Overall Study|Lost to Follow-up|3|||
129457044|NCT00713700|465971771|FG000|Overall Study|Withdrawal by Subject|1|||
129457045|NCT03923426|465971773|FG000|Overall Study|Other|19|||
129457046|NCT03923426|465971773|FG000|Overall Study|Lost to Follow-up|16|||
129457047|NCT03923426|465971773|FG000|Overall Study|Death|107|||
129457048|NCT03923426|465971773|FG000|Overall Study|Incomplete response to question|13|||
129457049|NCT00769002|465971774|FG000|Overall Study|Study was not completed, no data|9|||
129457050|NCT00769002|465971775|FG001|Overall Study|Study was not completed, no data|9|||
129457051|NCT00847912|465971785|FG000|Overall Study|Protocol Violation|6|||
129457052|NCT00847912|465971786|FG001|Overall Study|Protocol Violation|7|||
129457053|NCT00847912|465971785|FG000|Overall Study|Withdrawal by Subject|3|||
129457054|NCT00847912|465971786|FG001|Overall Study|Withdrawal by Subject|6|||
129457055|NCT01732796|465971787|FG000|Overall Study|Adverse Event|16|||
129457056|NCT01732796|465971788|FG001|Overall Study|Adverse Event|16|||
129457057|NCT01732796|465971789|FG002|Overall Study|Adverse Event|4|||
129457058|NCT01732796|465971787|FG000|Overall Study|Lack of Efficacy|21|||
129457059|NCT01732796|465971788|FG001|Overall Study|Lack of Efficacy|18|||
129457060|NCT01732796|465971789|FG002|Overall Study|Lack of Efficacy|5|||
129457061|NCT01732796|465971787|FG000|Overall Study|Lost to Follow-up|2|||
129457062|NCT01732796|465971788|FG001|Overall Study|Lost to Follow-up|0|||
129457063|NCT01732796|465971789|FG002|Overall Study|Lost to Follow-up|0|||
129457064|NCT01732796|465971787|FG000|Overall Study|Withdrawal by Subject|6|||
129457065|NCT01732796|465971788|FG001|Overall Study|Withdrawal by Subject|8|||
129457066|NCT01732796|465971789|FG002|Overall Study|Withdrawal by Subject|2|||
129457067|NCT01732796|465971787|FG000|Overall Study|Other reason not defined above|1|||
129457068|NCT01732796|465971788|FG001|Overall Study|Other reason not defined above|0|||
129457069|NCT01732796|465971789|FG002|Overall Study|Other reason not defined above|2|||
129457070|NCT00732303|465971793|FG000|Overall Study|Study Terminated|2|||
129457071|NCT01074190|465971794|FG000|Overall Study|Emergency Cesarean Delivery|1|||
129457072|NCT01074190|465971795|FG001|Overall Study|Emergency Cesarean Delivery|2|||
129457073|NCT01074190|465971796|FG002|Overall Study|Emergency Cesarean Delivery|1|||
129457074|NCT01074190|465971794|FG000|Overall Study|Protocol Violation|2|||
129457075|NCT01074190|465971795|FG001|Overall Study|Protocol Violation|1|||
129457076|NCT01074190|465971796|FG002|Overall Study|Protocol Violation|0|||
129457077|NCT01074190|465971794|FG000|Overall Study|Delivered in under 90 minutes|0|||
129457078|NCT01074190|465971795|FG001|Overall Study|Delivered in under 90 minutes|2|||
129457079|NCT01074190|465971796|FG002|Overall Study|Delivered in under 90 minutes|1|||
129457080|NCT01074190|465971794|FG000|Overall Study|Subject withdrew consent|1|||
129457081|NCT01074190|465971795|FG001|Overall Study|Subject withdrew consent|1|||
129457082|NCT01074190|465971796|FG002|Overall Study|Subject withdrew consent|1|||
129457083|NCT01500278|465971803|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
129457084|NCT01500278|465971804|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
129457085|NCT01500278|465971803|FG000|Week 0 - Week 12|Protocol Violation|10|||
129457086|NCT01500278|465971804|FG001|Week 0 - Week 12|Protocol Violation|16|||
129457087|NCT01500278|465971803|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
129457088|NCT01500278|465971804|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
129457089|NCT01500278|465971803|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
129457090|NCT01500278|465971804|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
129457091|NCT01500278|465971803|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
129457092|NCT01500278|465971804|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
129457093|NCT01500278|465971803|FG000|Week 0 - Week 12|Patient decision|1|||
129457094|NCT01500278|465971804|FG001|Week 0 - Week 12|Patient decision|0|||
129457095|NCT01500278|465971803|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
129457096|NCT01500278|465971804|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
129457097|NCT01500278|465971803|FG000|Week 0 - Week 12|Investigator decision|1|||
129457098|NCT01500278|465971804|FG001|Week 0 - Week 12|Investigator decision|0|||
129457099|NCT01500278|465971803|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
129457100|NCT01500278|465971804|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
129457101|NCT01500278|465971803|FG000|Week 0 - Week 12|Sponsor decision|1|||
129457102|NCT01500278|465971804|FG001|Week 0 - Week 12|Sponsor decision|0|||
129457103|NCT01500278|465971803|FG000|Week 0 - Week 12|Personal reason|0|||
129457104|NCT01500278|465971804|FG001|Week 0 - Week 12|Personal reason|1|||
129457105|NCT01500278|465971803|FG000|Week 0 - Week 12|Other serious disease|0|||
129457106|NCT01500278|465971804|FG001|Week 0 - Week 12|Other serious disease|1|||
129457107|NCT01500278|465971803|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
129457108|NCT01500278|465971804|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
129457109|NCT01500278|465971803|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
129457110|NCT01500278|465971804|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
129457111|NCT01500278|465971803|FG000|Week 13 - Week 104|Protocol Violation|6|||
129457112|NCT01500278|465971804|FG001|Week 13 - Week 104|Protocol Violation|6|||
129457113|NCT01500278|465971803|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
129457114|NCT01500278|465971804|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
129457115|NCT01500278|465971803|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
129457116|NCT01500278|465971804|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
129457117|NCT01500278|465971803|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
129457118|NCT01500278|465971804|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
129457119|NCT01500278|465971803|FG000|Week 13 - Week 104|Non/bad compliance|7|||
129457120|NCT01500278|465971804|FG001|Week 13 - Week 104|Non/bad compliance|5|||
129457121|NCT01500278|465971803|FG000|Week 13 - Week 104|Recurrent infections|1|||
129457122|NCT01500278|465971804|FG001|Week 13 - Week 104|Recurrent infections|0|||
129457123|NCT01500278|465971803|FG000|Week 13 - Week 104|False positive test|1|||
129457124|NCT01500278|465971804|FG001|Week 13 - Week 104|False positive test|2|||
129457125|NCT01500278|465971803|FG000|Week 13 - Week 104|Sponsor request|4|||
129457126|NCT01500278|465971804|FG001|Week 13 - Week 104|Sponsor request|0|||
129457127|NCT01500278|465971803|FG000|Week 13 - Week 104|Withdrawn in error|1|||
129457128|NCT01500278|465971804|FG001|Week 13 - Week 104|Withdrawn in error|0|||
129457129|NCT01500278|465971803|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
129967702|NCT00943787|467847080|FG000|Overall Study|Physician Decision|4|||
129457130|NCT01500278|465971804|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
129457131|NCT01500278|465971803|FG000|Week 13 - Week 104|Protocol deviation|1|||
129457132|NCT01500278|465971804|FG001|Week 13 - Week 104|Protocol deviation|0|||
129457133|NCT01500278|465971803|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
129457134|NCT01500278|465971804|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
129457135|NCT01500278|465971803|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
129457136|NCT01500278|465971804|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
129457137|NCT01500278|465971803|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
129457138|NCT01500278|465971804|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
129457139|NCT01500278|465971803|FG000|Week 13 - Week 104|Relocation|0|||
129457140|NCT01500278|465971804|FG001|Week 13 - Week 104|Relocation|1|||
129457141|NCT01500278|465971803|FG000|Week 13 - Week 104|Sponsor decision|0|||
129457142|NCT01500278|465971804|FG001|Week 13 - Week 104|Sponsor decision|2|||
129457143|NCT01500278|465971803|FG000|Week 13 - Week 104|Medical monitor decision|0|||
129457144|NCT01500278|465971804|FG001|Week 13 - Week 104|Medical monitor decision|2|||
129457145|NCT01500278|465971803|FG000|Week 13 - Week 104|Personal reason|0|||
129457146|NCT01500278|465971804|FG001|Week 13 - Week 104|Personal reason|1|||
129457147|NCT01500278|465971803|FG000|Week 13 - Week 104|Not completed|0|||
129457148|NCT01500278|465971804|FG001|Week 13 - Week 104|Not completed|1|||
129457149|NCT01500278|465971803|FG000|Week 13 - Week 104|Death|2|||
129457150|NCT01500278|465971804|FG001|Week 13 - Week 104|Death|4|||
129457151|NCT01500278|465971803|FG000|Week 13 - Week 104|Adverse Event|54|||
129457152|NCT01500278|465971804|FG001|Week 13 - Week 104|Adverse Event|54|||
129457153|NCT01709435|465971808|FG000|Overall Study|Adverse Event|1|||
129457154|NCT01709435|465971809|FG001|Overall Study|Adverse Event|1|||
129457155|NCT01709435|465971810|FG002|Overall Study|Adverse Event|1|||
129457156|NCT01709435|465971811|FG003|Overall Study|Adverse Event|0|||
129457157|NCT01709435|465971812|FG004|Overall Study|Adverse Event|0|||
129457158|NCT01709435|465971813|FG005|Overall Study|Adverse Event|1|||
129457159|NCT01709435|465971808|FG000|Overall Study|Lack of Efficacy|5|||
129457160|NCT01709435|465971809|FG001|Overall Study|Lack of Efficacy|7|||
129457161|NCT01709435|465971810|FG002|Overall Study|Lack of Efficacy|2|||
129457162|NCT01709435|465971811|FG003|Overall Study|Lack of Efficacy|2|||
129457163|NCT01709435|465971812|FG004|Overall Study|Lack of Efficacy|6|||
129457164|NCT01709435|465971813|FG005|Overall Study|Lack of Efficacy|3|||
129457165|NCT01709435|465971808|FG000|Overall Study|Physician Decision|0|||
129457166|NCT01709435|465971809|FG001|Overall Study|Physician Decision|1|||
129457167|NCT01709435|465971810|FG002|Overall Study|Physician Decision|0|||
129457168|NCT01709435|465971811|FG003|Overall Study|Physician Decision|1|||
129457169|NCT01709435|465971812|FG004|Overall Study|Physician Decision|2|||
129457170|NCT01709435|465971813|FG005|Overall Study|Physician Decision|0|||
129457171|NCT01709435|465971808|FG000|Overall Study|Withdrawal by Subject|0|||
129457172|NCT01709435|465971809|FG001|Overall Study|Withdrawal by Subject|0|||
129457173|NCT01709435|465971810|FG002|Overall Study|Withdrawal by Subject|3|||
129457174|NCT01709435|465971811|FG003|Overall Study|Withdrawal by Subject|0|||
129457175|NCT01709435|465971812|FG004|Overall Study|Withdrawal by Subject|2|||
129457176|NCT01709435|465971813|FG005|Overall Study|Withdrawal by Subject|2|||
129457177|NCT01297270|465971817|FG000|Overall Study|Adverse Event|19|||
129457178|NCT01297270|465971818|FG001|Overall Study|Adverse Event|32|||
129457179|NCT01297270|465971819|FG002|Overall Study|Adverse Event|5|||
129457180|NCT01297270|465971817|FG000|Overall Study|Lack of Efficacy|15|||
129457181|NCT01297270|465971818|FG001|Overall Study|Lack of Efficacy|17|||
129457182|NCT01297270|465971819|FG002|Overall Study|Lack of Efficacy|15|||
129457183|NCT01297270|465971817|FG000|Overall Study|Lost to Follow-up|1|||
129457184|NCT01297270|465971818|FG001|Overall Study|Lost to Follow-up|2|||
129457185|NCT01297270|465971819|FG002|Overall Study|Lost to Follow-up|1|||
129457186|NCT01297270|465971817|FG000|Overall Study|Protocol Violation|0|||
129457187|NCT01297270|465971818|FG001|Overall Study|Protocol Violation|2|||
129457188|NCT01297270|465971819|FG002|Overall Study|Protocol Violation|0|||
129457189|NCT01297270|465971817|FG000|Overall Study|Withdrawal by Subject|7|||
129457190|NCT01297270|465971818|FG001|Overall Study|Withdrawal by Subject|15|||
129457191|NCT01297270|465971819|FG002|Overall Study|Withdrawal by Subject|7|||
129457192|NCT01297270|465971817|FG000|Overall Study|Other reason not defined above|3|||
129457193|NCT01297270|465971818|FG001|Overall Study|Other reason not defined above|3|||
129457194|NCT01297270|465971819|FG002|Overall Study|Other reason not defined above|1|||
129457195|NCT01297270|465971817|FG000|Overall Study|Not treated|0|||
129457196|NCT01297270|465971818|FG001|Overall Study|Not treated|1|||
129457197|NCT01297270|465971819|FG002|Overall Study|Not treated|0|||
129457198|NCT03882970|465971822|FG000|Overall Study|Adverse Event|5|||
129457199|NCT03882970|465971823|FG001|Overall Study|Adverse Event|7|||
129457200|NCT03882970|465971824|FG002|Overall Study|Adverse Event|3|||
129457201|NCT03882970|465971825|FG003|Overall Study|Adverse Event|1|||
129457202|NCT03882970|465971822|FG000|Overall Study|Death|1|||
129457203|NCT03882970|465971823|FG001|Overall Study|Death|2|||
129457204|NCT03882970|465971824|FG002|Overall Study|Death|1|||
129457205|NCT03882970|465971825|FG003|Overall Study|Death|1|||
129457206|NCT03882970|465971822|FG000|Overall Study|Lost to Follow-up|8|||
129457207|NCT03882970|465971823|FG001|Overall Study|Lost to Follow-up|9|||
129457208|NCT03882970|465971824|FG002|Overall Study|Lost to Follow-up|5|||
129457209|NCT03882970|465971825|FG003|Overall Study|Lost to Follow-up|5|||
129457210|NCT03882970|465971822|FG000|Overall Study|Physician Decision|0|||
129457211|NCT03882970|465971823|FG001|Overall Study|Physician Decision|2|||
129457212|NCT03882970|465971824|FG002|Overall Study|Physician Decision|2|||
129457213|NCT03882970|465971825|FG003|Overall Study|Physician Decision|2|||
129457214|NCT03882970|465971822|FG000|Overall Study|Protocol Violation|2|||
129457215|NCT03882970|465971823|FG001|Overall Study|Protocol Violation|0|||
129457216|NCT03882970|465971824|FG002|Overall Study|Protocol Violation|0|||
129457217|NCT03882970|465971825|FG003|Overall Study|Protocol Violation|0|||
129457218|NCT03882970|465971822|FG000|Overall Study|Withdrawal by Subject|8|||
129457219|NCT03882970|465971823|FG001|Overall Study|Withdrawal by Subject|17|||
129457220|NCT03882970|465971824|FG002|Overall Study|Withdrawal by Subject|7|||
129457221|NCT03882970|465971825|FG003|Overall Study|Withdrawal by Subject|22|||
129457222|NCT03882970|465971822|FG000|Overall Study|Personal Reason|2|||
129457223|NCT03882970|465971823|FG001|Overall Study|Personal Reason|3|||
129457224|NCT03882970|465971824|FG002|Overall Study|Personal Reason|1|||
129457225|NCT03882970|465971825|FG003|Overall Study|Personal Reason|3|||
129457226|NCT02863809|465971827|FG000|Overall Study|Adverse Event|8|||
129457227|NCT02863809|465971828|FG001|Overall Study|Adverse Event|8|||
129457228|NCT02863809|465971827|FG000|Overall Study|Withdrawal by Subject|0|||
129457229|NCT02863809|465971828|FG001|Overall Study|Withdrawal by Subject|1|||
129457230|NCT02863809|465971827|FG000|Overall Study|Lost to Follow-up|1|||
129457231|NCT02863809|465971828|FG001|Overall Study|Lost to Follow-up|1|||
129457232|NCT02863809|465971827|FG000|Overall Study|Death|1|||
129457233|NCT02863809|465971828|FG001|Overall Study|Death|0|||
129457234|NCT02830776|465971829|FG000|Overall Study|Lost to Follow-up|1|||
129457235|NCT03029143|465971830|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
129457236|NCT03029143|465971831|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
129457237|NCT03029143|465971832|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
129457238|NCT03029143|465971830|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
129457239|NCT03029143|465971831|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
129457240|NCT03029143|465971832|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
129457241|NCT03029143|465971830|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
129457242|NCT03029143|465971831|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
129457243|NCT03029143|465971832|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
129457244|NCT03029143|465971830|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
129457245|NCT03029143|465971831|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
129457246|NCT03029143|465971832|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
129457247|NCT03029143|465971830|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
129457248|NCT03029143|465971831|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
129457249|NCT03029143|465971832|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
129457250|NCT03029143|465971830|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
129457251|NCT03029143|465971831|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
129457252|NCT03029143|465971832|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
129457253|NCT03029143|465971830|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
129457254|NCT03029143|465971831|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
129457255|NCT03029143|465971832|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
129457256|NCT03029143|465971830|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129457257|NCT03029143|465971831|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129457258|NCT03029143|465971832|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
129457259|NCT03029143|465971830|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
129457260|NCT03029143|465971831|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
129457261|NCT03029143|465971832|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
129457262|NCT03029143|465971830|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129457263|NCT03029143|465971831|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
129457264|NCT03029143|465971832|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
129457265|NCT03029143|465971830|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
129457266|NCT03029143|465971831|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
129457267|NCT03029143|465971832|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
129457268|NCT00607386|465971833|FG000|Overall Study|Physician Decision|1|||
129457269|NCT00974675|465971834|FG000|Overall Study|Adverse Event|2|||
129457270|NCT00974675|465971835|FG001|Overall Study|Adverse Event|1|||
129457271|NCT00974675|465971836|FG002|Overall Study|Adverse Event|1|||
129457272|NCT00974675|465971837|FG003|Overall Study|Adverse Event|1|||
129457273|NCT00974675|465971834|FG000|Overall Study|Physician Decision|0|||
129457274|NCT00974675|465971835|FG001|Overall Study|Physician Decision|0|||
129457275|NCT00974675|465971836|FG002|Overall Study|Physician Decision|1|||
129457276|NCT00974675|465971837|FG003|Overall Study|Physician Decision|0|||
129457277|NCT00974675|465971834|FG000|Overall Study|Participant on holiday; unable to attend|0|||
129457278|NCT00974675|465971835|FG001|Overall Study|Participant on holiday; unable to attend|0|||
129457279|NCT00974675|465971836|FG002|Overall Study|Participant on holiday; unable to attend|0|||
129457280|NCT00974675|465971837|FG003|Overall Study|Participant on holiday; unable to attend|1|||
129457281|NCT02121262|465971840|FG000|Overall Study|Adverse Event|6|||
129457282|NCT02121262|465971841|FG001|Overall Study|Adverse Event|3|||
129457283|NCT02121262|465971840|FG000|Overall Study|Lack of Efficacy|3|||
129457284|NCT02121262|465971841|FG001|Overall Study|Lack of Efficacy|0|||
129457285|NCT02121262|465971840|FG000|Overall Study|Personal Reasons|19|||
129457286|NCT02121262|465971841|FG001|Overall Study|Personal Reasons|5|||
129457287|NCT02121262|465971840|FG000|Overall Study|Protocol Violation|1|||
129457288|NCT02121262|465971841|FG001|Overall Study|Protocol Violation|1|||
129457289|NCT02121262|465971840|FG000|Overall Study|Participant Dropped-out|0|||
129457290|NCT02121262|465971841|FG001|Overall Study|Participant Dropped-out|1|||
129457291|NCT02121262|465971840|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
129457292|NCT02121262|465971841|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
129457293|NCT02121262|465971840|FG000|Overall Study|Consent Withdrawn|1|||
129457294|NCT02121262|465971841|FG001|Overall Study|Consent Withdrawn|0|||
129457295|NCT02716987|465971842|FG000|Overall Study|Ligand synthesis failure|0|||
129457296|NCT02716987|465971843|FG001|Overall Study|Ligand synthesis failure|0|||
129457297|NCT02716987|465971844|FG002|Overall Study|Ligand synthesis failure|1|||
129457298|NCT02716987|465971845|FG003|Overall Study|Ligand synthesis failure|0|||
129457299|NCT02716987|465971846|FG004|Overall Study|Ligand synthesis failure|0|||
129457300|NCT02716987|465971847|FG005|Overall Study|Ligand synthesis failure|0|||
129457301|NCT02716987|465971842|FG000|Overall Study|Withdrawal by Subject|0|||
129457302|NCT02716987|465971843|FG001|Overall Study|Withdrawal by Subject|0|||
129457303|NCT02716987|465971844|FG002|Overall Study|Withdrawal by Subject|0|||
129457304|NCT02716987|465971845|FG003|Overall Study|Withdrawal by Subject|0|||
129457305|NCT02716987|465971846|FG004|Overall Study|Withdrawal by Subject|1|||
129457306|NCT02716987|465971847|FG005|Overall Study|Withdrawal by Subject|1|||
129457307|NCT02829138|465971848|FG000|Overall Study|Withdrawal by Subject|1|||
129457308|NCT02829138|465971849|FG001|Overall Study|Withdrawal by Subject|0|||
129457309|NCT01394627|465971850|FG000|First Intervention (1 Day)|poor intravenous access|0|||
129457310|NCT01394627|465971851|FG001|First Intervention (1 Day)|poor intravenous access|1|||
129457311|NCT01394627|465971850|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
129457312|NCT01394627|465971851|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
129457313|NCT01765920|465971857|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
129457314|NCT01765920|465971858|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
129457315|NCT01765920|465971857|FG000|Overall Study|Patient code disclosure|0|||
129457316|NCT01765920|465971858|FG001|Overall Study|Patient code disclosure|1|||
129457317|NCT03223428|465971859|FG000|Overall Study|No longer taking Xermelo|27|||
129457318|NCT03223428|465971859|FG000|Overall Study|Declined Consent|1|||
129457319|NCT03223428|465971859|FG000|Overall Study|Non-responders|56|||
129457320|NCT03223428|465971859|FG000|Overall Study|Withdrawal by Subject|14|||
129457321|NCT01081249|465971860|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
129457322|NCT01081249|465971861|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
129457323|NCT02025907|465971862|FG000|Overall Study|Lack of Efficacy|1|||
129457324|NCT02025907|465971863|FG001|Overall Study|Lack of Efficacy|0|||
129457325|NCT02025907|465971862|FG000|Overall Study|Withdrawal by Subject|15|||
129457326|NCT02025907|465971863|FG001|Overall Study|Withdrawal by Subject|8|||
129457327|NCT02025907|465971862|FG000|Overall Study|Protocol Violation|2|||
129457328|NCT02025907|465971863|FG001|Overall Study|Protocol Violation|0|||
129457329|NCT02025907|465971862|FG000|Overall Study|Physician Decision|2|||
129457330|NCT02025907|465971863|FG001|Overall Study|Physician Decision|0|||
129457331|NCT02025907|465971862|FG000|Overall Study|Lost to Follow-up|2|||
129457332|NCT02025907|465971863|FG001|Overall Study|Lost to Follow-up|2|||
129457333|NCT02025907|465971862|FG000|Overall Study|Adverse Event|3|||
129457334|NCT02025907|465971863|FG001|Overall Study|Adverse Event|1|||
129457335|NCT02025907|465971862|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
129457336|NCT02025907|465971863|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
129457337|NCT02411539|465971864|FG000|Overall Study|Lost to Follow-up|2|||
129967703|NCT00943787|467847080|FG000|Overall Study|Withdrawal by Subject|3|||
129457338|NCT02411539|465971865|FG001|Overall Study|Lost to Follow-up|0|||
129457339|NCT02411539|465971864|FG000|Overall Study|Confounding medical condition|0|||
129457340|NCT02411539|465971865|FG001|Overall Study|Confounding medical condition|1|||
129457341|NCT00282334|465971866|FG000|Overall Study|Withdrawal by Subject|8|||
129967704|NCT02706951|467847082|FG000|Period 1|Adverse Event|1|||
129457342|NCT00282334|465971867|FG001|Overall Study|Withdrawal by Subject|5|||
129457343|NCT03681119|465971869|FG000|Overall Study|No specific reason|4|||
129457344|NCT03681119|465971870|FG001|Overall Study|No specific reason|0|||
129457345|NCT03681119|465971869|FG000|Overall Study|Sickness|2|||
129457346|NCT03681119|465971870|FG001|Overall Study|Sickness|0|||
129457347|NCT04041284|465971873|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
129457348|NCT04041284|465971874|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
129457349|NCT04041284|465971873|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
129457350|NCT04041284|465971874|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
129967705|NCT02706951|467847083|FG001|Period 1|Adverse Event|5|||
129967706|NCT02706951|467847084|FG002|Period 1|Adverse Event|3|||
129457351|NCT04041284|465971873|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
129457352|NCT04041284|465971874|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
129457353|NCT04041284|465971873|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
129457354|NCT04041284|465971874|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
129457355|NCT04041284|465971873|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
129457356|NCT04041284|465971874|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
129457357|NCT04041284|465971873|FG000|DB Phase (12 Weeks)|Other than specified|1|||
129457358|NCT04041284|465971874|FG001|DB Phase (12 Weeks)|Other than specified|0|||
129457359|NCT04041284|465971873|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
129457360|NCT04041284|465971874|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
129457361|NCT04041284|465971873|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
129457362|NCT04041284|465971874|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
129457363|NCT04041284|465971873|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
129457364|NCT04041284|465971874|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
129457365|NCT04041284|465971873|FG000|OL Phase (12 Weeks)|Other than specified|6|||
129457366|NCT04041284|465971874|FG001|OL Phase (12 Weeks)|Other than specified|2|||
129457367|NCT00563186|465971875|FG000|Overall Study|LOS<48 hours|97|||
129457368|NCT00563186|465971876|FG001|Overall Study|LOS<48 hours|74|||
129457369|NCT00563186|465971875|FG000|Overall Study|Incomplete data|1|||
129457370|NCT00563186|465971876|FG001|Overall Study|Incomplete data|1|||
129457371|NCT00879645|465971881|FG000|Overall Study|Adverse Event|1|||
129457372|NCT00879645|465971882|FG001|Overall Study|Adverse Event|0|||
129457373|NCT00879645|465971883|FG002|Overall Study|Adverse Event|0|||
129457374|NCT00879645|465971884|FG003|Overall Study|Adverse Event|0|||
129457375|NCT03631732|465971885|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
129457376|NCT03631732|465971886|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
129457377|NCT03631732|465971885|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
129457378|NCT03631732|465971886|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
129457379|NCT03631732|465971885|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
129457380|NCT03631732|465971886|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
129457381|NCT03631732|465971885|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
129457382|NCT03631732|465971886|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
129457383|NCT03631732|465971885|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
129457384|NCT03631732|465971886|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
129457385|NCT03631732|465971885|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
129457386|NCT03631732|465971886|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
129457387|NCT03631732|465971885|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
129457388|NCT03631732|465971886|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
129457389|NCT03631732|465971885|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
129457390|NCT03631732|465971886|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
129457391|NCT03631732|465971885|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
129457392|NCT03631732|465971886|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
129457393|NCT03631732|465971885|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
129457394|NCT03631732|465971886|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
129457395|NCT00886600|465971887|FG000|Double-blind Monotherapy|Adverse Event|1|||
129457396|NCT00886600|465971888|FG001|Double-blind Monotherapy|Adverse Event|1|||
129457397|NCT00886600|465971889|FG002|Double-blind Monotherapy|Adverse Event|1|||
129457398|NCT00886600|465971890|FG003|Double-blind Monotherapy|Adverse Event|1|||
129457399|NCT00886600|465971887|FG000|Double-blind Monotherapy|Protocol Violation|0|||
129457400|NCT00886600|465971888|FG001|Double-blind Monotherapy|Protocol Violation|0|||
129457401|NCT00886600|465971889|FG002|Double-blind Monotherapy|Protocol Violation|0|||
129457402|NCT00886600|465971890|FG003|Double-blind Monotherapy|Protocol Violation|1|||
129457403|NCT00886600|465971887|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
129457404|NCT00886600|465971888|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
129457405|NCT00886600|465971889|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
129457406|NCT00886600|465971890|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
129457407|NCT00886600|465971887|FG000|Combination Therapy Period|Adverse Event|0|||
129457408|NCT00886600|465971888|FG001|Combination Therapy Period|Adverse Event|0|||
129457409|NCT00886600|465971889|FG002|Combination Therapy Period|Adverse Event|1|||
129457410|NCT00886600|465971890|FG003|Combination Therapy Period|Adverse Event|0|||
129457411|NCT00886600|465971887|FG000|Combination Therapy Period|Protocol Violation|0|||
129457412|NCT00886600|465971888|FG001|Combination Therapy Period|Protocol Violation|0|||
129457413|NCT00886600|465971889|FG002|Combination Therapy Period|Protocol Violation|1|||
129457414|NCT00886600|465971890|FG003|Combination Therapy Period|Protocol Violation|0|||
129457415|NCT01439204|465971891|FG000|Overall Study|Withdrawal by Subject|0|||
129457416|NCT01439204|465971892|FG001|Overall Study|Withdrawal by Subject|1|||
129457417|NCT01439204|465971891|FG000|Overall Study|Lost to Follow-up|0|||
129457418|NCT01439204|465971892|FG001|Overall Study|Lost to Follow-up|2|||
129457419|NCT01439204|465971891|FG000|Overall Study|No longer meets study criteria|1|||
129457420|NCT01439204|465971892|FG001|Overall Study|No longer meets study criteria|0|||
129457421|NCT01439204|465971891|FG000|Overall Study|poor/non-compliance|3|||
129457422|NCT01439204|465971892|FG001|Overall Study|poor/non-compliance|0|||
129457423|NCT04288154|465971893|FG000|Overall Study|Withdrawal by Subject|9|||
129457424|NCT04288154|465971894|FG001|Overall Study|Withdrawal by Subject|9|||
129457425|NCT02873936|465971896|FG000|Overall Study|Withdrew Consent|4|||
129457426|NCT02873936|465971897|FG001|Overall Study|Withdrew Consent|11|||
129457427|NCT02873936|465971898|FG002|Overall Study|Withdrew Consent|20|||
129457428|NCT02873936|465971896|FG000|Overall Study|Investigator's Discretion|3|||
129457429|NCT02873936|465971897|FG001|Overall Study|Investigator's Discretion|5|||
129457430|NCT02873936|465971898|FG002|Overall Study|Investigator's Discretion|4|||
129457431|NCT02873936|465971896|FG000|Overall Study|Adverse Event|3|||
129457432|NCT02873936|465971897|FG001|Overall Study|Adverse Event|5|||
129457433|NCT02873936|465971898|FG002|Overall Study|Adverse Event|3|||
129457434|NCT02873936|465971896|FG000|Overall Study|Protocol Violation|0|||
129457435|NCT02873936|465971897|FG001|Overall Study|Protocol Violation|1|||
129457436|NCT02873936|465971898|FG002|Overall Study|Protocol Violation|3|||
129457437|NCT02873936|465971896|FG000|Overall Study|Lost to Follow-up|1|||
129457438|NCT02873936|465971897|FG001|Overall Study|Lost to Follow-up|1|||
129457439|NCT02873936|465971898|FG002|Overall Study|Lost to Follow-up|1|||
129457440|NCT02873936|465971896|FG000|Overall Study|Non-compliance With Study Drug|1|||
129457441|NCT02873936|465971897|FG001|Overall Study|Non-compliance With Study Drug|0|||
129457442|NCT02873936|465971898|FG002|Overall Study|Non-compliance With Study Drug|1|||
129457443|NCT02873936|465971896|FG000|Overall Study|Randomized but not Dosed|1|||
129457444|NCT02873936|465971897|FG001|Overall Study|Randomized but not Dosed|0|||
129457445|NCT02873936|465971898|FG002|Overall Study|Randomized but not Dosed|0|||
129457446|NCT00754793|465971900|FG000|Overall Study|voluntary withdrawn from study|0|||
129457447|NCT00754793|465971901|FG001|Overall Study|voluntary withdrawn from study|1|||
129457448|NCT02943564|465971902|FG000|Overall Study|Miscellaneous Reasons|0|||
129457449|NCT02943564|465971903|FG001|Overall Study|Miscellaneous Reasons|0|||
129457450|NCT02943564|465971904|FG002|Overall Study|Miscellaneous Reasons|3|||
129457451|NCT02943564|465971902|FG000|Overall Study|Site terminated by sponsor|0|||
129457452|NCT02943564|465971903|FG001|Overall Study|Site terminated by sponsor|1|||
129457453|NCT02943564|465971904|FG002|Overall Study|Site terminated by sponsor|0|||
129457454|NCT02943564|465971902|FG000|Overall Study|Non-compliance with study drug|0|||
129457455|NCT02943564|465971903|FG001|Overall Study|Non-compliance with study drug|1|||
129457456|NCT02943564|465971904|FG002|Overall Study|Non-compliance with study drug|0|||
129457457|NCT02943564|465971902|FG000|Overall Study|Pregnancy|0|||
129457458|NCT02943564|465971903|FG001|Overall Study|Pregnancy|1|||
129457459|NCT02943564|465971904|FG002|Overall Study|Pregnancy|1|||
129457460|NCT02943564|465971902|FG000|Overall Study|Protocol Violation|2|||
129457461|NCT02943564|465971903|FG001|Overall Study|Protocol Violation|2|||
129457462|NCT02943564|465971904|FG002|Overall Study|Protocol Violation|2|||
129457463|NCT02943564|465971902|FG000|Overall Study|Lost to Follow-up|1|||
129457464|NCT02943564|465971903|FG001|Overall Study|Lost to Follow-up|0|||
129457465|NCT02943564|465971904|FG002|Overall Study|Lost to Follow-up|0|||
129457466|NCT02943564|465971902|FG000|Overall Study|Withdrawal by Subject|6|||
129457467|NCT02943564|465971903|FG001|Overall Study|Withdrawal by Subject|5|||
129457468|NCT02943564|465971904|FG002|Overall Study|Withdrawal by Subject|2|||
129457469|NCT02943564|465971902|FG000|Overall Study|Adverse Event|1|||
129457470|NCT02943564|465971903|FG001|Overall Study|Adverse Event|2|||
129457471|NCT02943564|465971904|FG002|Overall Study|Adverse Event|1|||
129457472|NCT02943564|465971902|FG000|Overall Study|Lack of Efficacy|0|||
129457473|NCT02943564|465971903|FG001|Overall Study|Lack of Efficacy|1|||
129457474|NCT02943564|465971904|FG002|Overall Study|Lack of Efficacy|0|||
129457475|NCT01073267|465971908|FG000|Overall Study|Disease Progression|3|||
129457476|NCT01225731|465971909|FG000|Part 1|Did not meet eligibility criteria|1|||
129457477|NCT01225731|465971910|FG001|Part 1|Did not meet eligibility criteria|0|||
129457478|NCT01225731|465971911|FG002|Part 1|Did not meet eligibility criteria|0|||
129457479|NCT01225731|465971912|FG003|Part 1|Did not meet eligibility criteria|0|||
129457480|NCT01225731|465971913|FG004|Part 1|Did not meet eligibility criteria|1|||
129457481|NCT01225731|465971914|FG005|Part 1|Did not meet eligibility criteria|0|||
129457482|NCT01225731|465971915|FG006|Part 1|Did not meet eligibility criteria|0|||
129457483|NCT01225731|465971916|FG007|Part 1|Did not meet eligibility criteria|0|||
129457484|NCT01225731|465971917|FG008|Part 1|Did not meet eligibility criteria|0|||
129457485|NCT01225731|465971918|FG009|Part 1|Did not meet eligibility criteria|0|||
129457486|NCT01225731|465971919|FG010|Part 1|Did not meet eligibility criteria|0|||
129457487|NCT01225731|465971920|FG011|Part 1|Did not meet eligibility criteria|0|||
129457488|NCT01225731|465971921|FG012|Part 1|Did not meet eligibility criteria|0|||
129457489|NCT01225731|465971909|FG000|Part 1|Adverse Event|1|||
129457490|NCT01225731|465971910|FG001|Part 1|Adverse Event|2|||
129457491|NCT01225731|465971911|FG002|Part 1|Adverse Event|1|||
129457492|NCT01225731|465971912|FG003|Part 1|Adverse Event|1|||
129457493|NCT01225731|465971913|FG004|Part 1|Adverse Event|1|||
129457494|NCT01225731|465971914|FG005|Part 1|Adverse Event|0|||
129457495|NCT01225731|465971915|FG006|Part 1|Adverse Event|0|||
129457496|NCT01225731|465971916|FG007|Part 1|Adverse Event|0|||
129457497|NCT01225731|465971917|FG008|Part 1|Adverse Event|0|||
129457498|NCT01225731|465971918|FG009|Part 1|Adverse Event|0|||
129457499|NCT01225731|465971919|FG010|Part 1|Adverse Event|0|||
129457500|NCT01225731|465971920|FG011|Part 1|Adverse Event|0|||
129457501|NCT01225731|465971921|FG012|Part 1|Adverse Event|0|||
129457502|NCT01225731|465971909|FG000|Part 1|Withdrawal by Subject|0|||
129457503|NCT01225731|465971910|FG001|Part 1|Withdrawal by Subject|3|||
129457504|NCT01225731|465971911|FG002|Part 1|Withdrawal by Subject|0|||
129457505|NCT01225731|465971912|FG003|Part 1|Withdrawal by Subject|0|||
129457506|NCT01225731|465971913|FG004|Part 1|Withdrawal by Subject|4|||
129457507|NCT01225731|465971914|FG005|Part 1|Withdrawal by Subject|0|||
129457508|NCT01225731|465971915|FG006|Part 1|Withdrawal by Subject|0|||
129457509|NCT01225731|465971916|FG007|Part 1|Withdrawal by Subject|0|||
129457510|NCT01225731|465971917|FG008|Part 1|Withdrawal by Subject|0|||
129457511|NCT01225731|465971918|FG009|Part 1|Withdrawal by Subject|0|||
129457512|NCT01225731|465971919|FG010|Part 1|Withdrawal by Subject|0|||
129457513|NCT01225731|465971920|FG011|Part 1|Withdrawal by Subject|0|||
129457514|NCT01225731|465971921|FG012|Part 1|Withdrawal by Subject|0|||
129457515|NCT01225731|465971909|FG000|Part 1|Protocol Violation|0|||
129457516|NCT01225731|465971910|FG001|Part 1|Protocol Violation|0|||
129457517|NCT01225731|465971911|FG002|Part 1|Protocol Violation|0|||
129457518|NCT01225731|465971912|FG003|Part 1|Protocol Violation|1|||
129457519|NCT01225731|465971913|FG004|Part 1|Protocol Violation|0|||
129457520|NCT01225731|465971914|FG005|Part 1|Protocol Violation|0|||
129457521|NCT01225731|465971915|FG006|Part 1|Protocol Violation|0|||
129457522|NCT01225731|465971916|FG007|Part 1|Protocol Violation|0|||
129457523|NCT01225731|465971917|FG008|Part 1|Protocol Violation|0|||
129457524|NCT01225731|465971918|FG009|Part 1|Protocol Violation|0|||
129457525|NCT01225731|465971919|FG010|Part 1|Protocol Violation|0|||
129457526|NCT01225731|465971920|FG011|Part 1|Protocol Violation|0|||
129457527|NCT01225731|465971921|FG012|Part 1|Protocol Violation|0|||
129457528|NCT01225731|465971909|FG000|Part 2|Protocol Violation|0|||
129457529|NCT01225731|465971910|FG001|Part 2|Protocol Violation|0|||
129457530|NCT01225731|465971911|FG002|Part 2|Protocol Violation|0|||
129457531|NCT01225731|465971912|FG003|Part 2|Protocol Violation|0|||
129457532|NCT01225731|465971913|FG004|Part 2|Protocol Violation|0|||
129457533|NCT01225731|465971914|FG005|Part 2|Protocol Violation|1|||
129457534|NCT01225731|465971915|FG006|Part 2|Protocol Violation|0|||
129457535|NCT01225731|465971916|FG007|Part 2|Protocol Violation|0|||
129457536|NCT01225731|465971917|FG008|Part 2|Protocol Violation|1|||
129457537|NCT01225731|465971918|FG009|Part 2|Protocol Violation|0|||
129457538|NCT01225731|465971919|FG010|Part 2|Protocol Violation|0|||
129457539|NCT01225731|465971920|FG011|Part 2|Protocol Violation|0|||
129457540|NCT01225731|465971921|FG012|Part 2|Protocol Violation|0|||
129457541|NCT01225731|465971909|FG000|Part 2|Adverse Event|0|||
129457542|NCT01225731|465971910|FG001|Part 2|Adverse Event|0|||
129457543|NCT01225731|465971911|FG002|Part 2|Adverse Event|0|||
129457544|NCT01225731|465971912|FG003|Part 2|Adverse Event|0|||
129457545|NCT01225731|465971913|FG004|Part 2|Adverse Event|0|||
129457546|NCT01225731|465971914|FG005|Part 2|Adverse Event|0|||
129457547|NCT01225731|465971915|FG006|Part 2|Adverse Event|4|||
129457548|NCT01225731|465971916|FG007|Part 2|Adverse Event|4|||
129457549|NCT01225731|465971917|FG008|Part 2|Adverse Event|2|||
129457550|NCT01225731|465971918|FG009|Part 2|Adverse Event|0|||
129457551|NCT01225731|465971919|FG010|Part 2|Adverse Event|0|||
129457552|NCT01225731|465971920|FG011|Part 2|Adverse Event|0|||
129457553|NCT01225731|465971921|FG012|Part 2|Adverse Event|0|||
129457554|NCT01225731|465971909|FG000|Part 2|Lack of Efficacy|0|||
129457555|NCT01225731|465971910|FG001|Part 2|Lack of Efficacy|0|||
129457556|NCT01225731|465971911|FG002|Part 2|Lack of Efficacy|0|||
129457557|NCT01225731|465971912|FG003|Part 2|Lack of Efficacy|0|||
129457558|NCT01225731|465971913|FG004|Part 2|Lack of Efficacy|0|||
129457559|NCT01225731|465971914|FG005|Part 2|Lack of Efficacy|1|||
129457560|NCT01225731|465971915|FG006|Part 2|Lack of Efficacy|0|||
129457561|NCT01225731|465971916|FG007|Part 2|Lack of Efficacy|12|||
129457562|NCT01225731|465971917|FG008|Part 2|Lack of Efficacy|3|||
129457563|NCT01225731|465971918|FG009|Part 2|Lack of Efficacy|0|||
129457564|NCT01225731|465971919|FG010|Part 2|Lack of Efficacy|0|||
129967707|NCT02706951|467847085|FG003|Period 1|Adverse Event|0|||
129457565|NCT01225731|465971920|FG011|Part 2|Lack of Efficacy|0|||
129457566|NCT01225731|465971921|FG012|Part 2|Lack of Efficacy|0|||
129457567|NCT01225731|465971909|FG000|Part 2|Pregnancy|0|||
129457568|NCT01225731|465971910|FG001|Part 2|Pregnancy|0|||
129457569|NCT01225731|465971911|FG002|Part 2|Pregnancy|0|||
129457570|NCT01225731|465971912|FG003|Part 2|Pregnancy|0|||
129457571|NCT01225731|465971913|FG004|Part 2|Pregnancy|0|||
129457572|NCT01225731|465971914|FG005|Part 2|Pregnancy|0|||
129457573|NCT01225731|465971915|FG006|Part 2|Pregnancy|1|||
129457574|NCT01225731|465971916|FG007|Part 2|Pregnancy|0|||
129457575|NCT01225731|465971917|FG008|Part 2|Pregnancy|1|||
129457576|NCT01225731|465971918|FG009|Part 2|Pregnancy|0|||
129457577|NCT01225731|465971919|FG010|Part 2|Pregnancy|0|||
129457578|NCT01225731|465971920|FG011|Part 2|Pregnancy|0|||
129457579|NCT01225731|465971921|FG012|Part 2|Pregnancy|0|||
129457580|NCT01225731|465971909|FG000|Part 2|Lost to Follow-up|0|||
129457581|NCT01225731|465971910|FG001|Part 2|Lost to Follow-up|0|||
129457582|NCT01225731|465971911|FG002|Part 2|Lost to Follow-up|0|||
129457583|NCT01225731|465971912|FG003|Part 2|Lost to Follow-up|0|||
129457584|NCT01225731|465971913|FG004|Part 2|Lost to Follow-up|0|||
129457585|NCT01225731|465971914|FG005|Part 2|Lost to Follow-up|0|||
129457586|NCT01225731|465971915|FG006|Part 2|Lost to Follow-up|0|||
129457587|NCT01225731|465971916|FG007|Part 2|Lost to Follow-up|3|||
129457588|NCT01225731|465971917|FG008|Part 2|Lost to Follow-up|1|||
129457589|NCT01225731|465971918|FG009|Part 2|Lost to Follow-up|0|||
129457590|NCT01225731|465971919|FG010|Part 2|Lost to Follow-up|0|||
129457591|NCT01225731|465971920|FG011|Part 2|Lost to Follow-up|0|||
129457592|NCT01225731|465971921|FG012|Part 2|Lost to Follow-up|0|||
129457593|NCT01225731|465971909|FG000|Part 2|Physician Decision|0|||
129457594|NCT01225731|465971910|FG001|Part 2|Physician Decision|0|||
129457595|NCT01225731|465971911|FG002|Part 2|Physician Decision|0|||
129457596|NCT01225731|465971912|FG003|Part 2|Physician Decision|0|||
129457597|NCT01225731|465971913|FG004|Part 2|Physician Decision|0|||
129457598|NCT01225731|465971914|FG005|Part 2|Physician Decision|0|||
129457599|NCT01225731|465971915|FG006|Part 2|Physician Decision|0|||
129457600|NCT01225731|465971916|FG007|Part 2|Physician Decision|2|||
129457601|NCT01225731|465971917|FG008|Part 2|Physician Decision|2|||
129457602|NCT01225731|465971918|FG009|Part 2|Physician Decision|0|||
129457603|NCT01225731|465971919|FG010|Part 2|Physician Decision|0|||
129457604|NCT01225731|465971920|FG011|Part 2|Physician Decision|0|||
129457605|NCT01225731|465971921|FG012|Part 2|Physician Decision|0|||
129457606|NCT01225731|465971909|FG000|Part 2|Withdrawal by Subject|0|||
129457607|NCT01225731|465971910|FG001|Part 2|Withdrawal by Subject|0|||
129457608|NCT01225731|465971911|FG002|Part 2|Withdrawal by Subject|0|||
129457609|NCT01225731|465971912|FG003|Part 2|Withdrawal by Subject|0|||
129457610|NCT01225731|465971913|FG004|Part 2|Withdrawal by Subject|0|||
129457611|NCT01225731|465971914|FG005|Part 2|Withdrawal by Subject|1|||
129457612|NCT01225731|465971915|FG006|Part 2|Withdrawal by Subject|3|||
129457613|NCT01225731|465971916|FG007|Part 2|Withdrawal by Subject|4|||
129457614|NCT01225731|465971917|FG008|Part 2|Withdrawal by Subject|1|||
129457615|NCT01225731|465971918|FG009|Part 2|Withdrawal by Subject|0|||
129457616|NCT01225731|465971919|FG010|Part 2|Withdrawal by Subject|0|||
129457617|NCT01225731|465971920|FG011|Part 2|Withdrawal by Subject|0|||
129457618|NCT01225731|465971921|FG012|Part 2|Withdrawal by Subject|0|||
129457619|NCT01225731|465971909|FG000|Part 3|Adverse Event|0|||
129457620|NCT01225731|465971910|FG001|Part 3|Adverse Event|0|||
129457621|NCT01225731|465971911|FG002|Part 3|Adverse Event|0|||
129457622|NCT01225731|465971912|FG003|Part 3|Adverse Event|0|||
129457623|NCT01225731|465971913|FG004|Part 3|Adverse Event|0|||
129457624|NCT01225731|465971914|FG005|Part 3|Adverse Event|0|||
129457625|NCT01225731|465971915|FG006|Part 3|Adverse Event|0|||
129457626|NCT01225731|465971916|FG007|Part 3|Adverse Event|0|||
129457627|NCT01225731|465971917|FG008|Part 3|Adverse Event|0|||
129457628|NCT01225731|465971918|FG009|Part 3|Adverse Event|0|||
129457629|NCT01225731|465971919|FG010|Part 3|Adverse Event|1|||
129457630|NCT01225731|465971920|FG011|Part 3|Adverse Event|1|||
129457631|NCT01225731|465971921|FG012|Part 3|Adverse Event|0|||
129457632|NCT01225731|465971909|FG000|Part 3|Lost to Follow-up|0|||
129457633|NCT01225731|465971910|FG001|Part 3|Lost to Follow-up|0|||
129457634|NCT01225731|465971911|FG002|Part 3|Lost to Follow-up|0|||
129457635|NCT01225731|465971912|FG003|Part 3|Lost to Follow-up|0|||
129457636|NCT01225731|465971913|FG004|Part 3|Lost to Follow-up|0|||
129457637|NCT01225731|465971914|FG005|Part 3|Lost to Follow-up|0|||
129457638|NCT01225731|465971915|FG006|Part 3|Lost to Follow-up|0|||
129457639|NCT01225731|465971916|FG007|Part 3|Lost to Follow-up|0|||
129457640|NCT01225731|465971917|FG008|Part 3|Lost to Follow-up|0|||
129457641|NCT01225731|465971918|FG009|Part 3|Lost to Follow-up|0|||
129457642|NCT01225731|465971919|FG010|Part 3|Lost to Follow-up|1|||
129457643|NCT01225731|465971920|FG011|Part 3|Lost to Follow-up|2|||
129457644|NCT01225731|465971921|FG012|Part 3|Lost to Follow-up|1|||
129457645|NCT01225731|465971909|FG000|Part 3|Physician Decision|0|||
129457646|NCT01225731|465971910|FG001|Part 3|Physician Decision|0|||
129457647|NCT01225731|465971911|FG002|Part 3|Physician Decision|0|||
129457648|NCT01225731|465971912|FG003|Part 3|Physician Decision|0|||
129457649|NCT01225731|465971913|FG004|Part 3|Physician Decision|0|||
129457650|NCT01225731|465971914|FG005|Part 3|Physician Decision|0|||
129457651|NCT01225731|465971915|FG006|Part 3|Physician Decision|0|||
129457652|NCT01225731|465971916|FG007|Part 3|Physician Decision|0|||
129457653|NCT01225731|465971917|FG008|Part 3|Physician Decision|0|||
129457654|NCT01225731|465971918|FG009|Part 3|Physician Decision|0|||
129457655|NCT01225731|465971919|FG010|Part 3|Physician Decision|0|||
129457656|NCT01225731|465971920|FG011|Part 3|Physician Decision|1|||
129457657|NCT01225731|465971921|FG012|Part 3|Physician Decision|2|||
129457658|NCT01225731|465971909|FG000|Part 3|Withdrawal by Subject|0|||
129457659|NCT01225731|465971910|FG001|Part 3|Withdrawal by Subject|0|||
129457660|NCT01225731|465971911|FG002|Part 3|Withdrawal by Subject|0|||
129457661|NCT01225731|465971912|FG003|Part 3|Withdrawal by Subject|0|||
129457662|NCT01225731|465971913|FG004|Part 3|Withdrawal by Subject|0|||
129457663|NCT01225731|465971914|FG005|Part 3|Withdrawal by Subject|0|||
129457664|NCT01225731|465971915|FG006|Part 3|Withdrawal by Subject|0|||
129457665|NCT01225731|465971916|FG007|Part 3|Withdrawal by Subject|0|||
129457666|NCT01225731|465971917|FG008|Part 3|Withdrawal by Subject|0|||
129457667|NCT01225731|465971918|FG009|Part 3|Withdrawal by Subject|0|||
129457668|NCT01225731|465971919|FG010|Part 3|Withdrawal by Subject|4|||
129457669|NCT01225731|465971920|FG011|Part 3|Withdrawal by Subject|6|||
129457670|NCT01225731|465971921|FG012|Part 3|Withdrawal by Subject|4|||
129457671|NCT00577642|465971922|FG000|Overall Study|Clinical Disease Progression|1|||
129457672|NCT00917150|465971927|FG000|Overall Study|Adverse Event|12|||
129457673|NCT00917150|465971928|FG001|Overall Study|Adverse Event|7|||
129457674|NCT00917150|465971929|FG002|Overall Study|Adverse Event|12|||
129457675|NCT00917150|465971930|FG003|Overall Study|Adverse Event|11|||
129457676|NCT00917150|465971927|FG000|Overall Study|Death|1|||
129457677|NCT00917150|465971928|FG001|Overall Study|Death|4|||
129457678|NCT00917150|465971929|FG002|Overall Study|Death|3|||
129457679|NCT00917150|465971930|FG003|Overall Study|Death|2|||
129457680|NCT00917150|465971927|FG000|Overall Study|Lost to Follow-up|1|||
129457681|NCT00917150|465971928|FG001|Overall Study|Lost to Follow-up|0|||
129457682|NCT00917150|465971929|FG002|Overall Study|Lost to Follow-up|4|||
129457683|NCT00917150|465971930|FG003|Overall Study|Lost to Follow-up|2|||
129457684|NCT00917150|465971927|FG000|Overall Study|Physician Decision|0|||
129457685|NCT00917150|465971928|FG001|Overall Study|Physician Decision|2|||
129457686|NCT00917150|465971929|FG002|Overall Study|Physician Decision|0|||
129457687|NCT00917150|465971930|FG003|Overall Study|Physician Decision|1|||
129457688|NCT00917150|465971927|FG000|Overall Study|Protocol Violation|5|||
129457689|NCT00917150|465971928|FG001|Overall Study|Protocol Violation|5|||
129457690|NCT00917150|465971929|FG002|Overall Study|Protocol Violation|3|||
129457691|NCT00917150|465971930|FG003|Overall Study|Protocol Violation|5|||
129457692|NCT00917150|465971927|FG000|Overall Study|Withdrawal by Subject|15|||
129457693|NCT00917150|465971928|FG001|Overall Study|Withdrawal by Subject|16|||
129457694|NCT00917150|465971929|FG002|Overall Study|Withdrawal by Subject|18|||
129457695|NCT00917150|465971930|FG003|Overall Study|Withdrawal by Subject|11|||
129457696|NCT00917150|465971927|FG000|Overall Study|Other than specified|3|||
129457697|NCT00917150|465971928|FG001|Overall Study|Other than specified|3|||
129457698|NCT00917150|465971929|FG002|Overall Study|Other than specified|2|||
129457699|NCT00917150|465971930|FG003|Overall Study|Other than specified|2|||
129457700|NCT00794157|465971931|FG000|Overall Study|Adverse Event|4|||
129457701|NCT00794157|465971932|FG001|Overall Study|Adverse Event|1|||
129457702|NCT00794157|465971933|FG002|Overall Study|Adverse Event|8|||
129457703|NCT00794157|465971931|FG000|Overall Study|Subject withdrew consent|2|||
129457704|NCT00794157|465971932|FG001|Overall Study|Subject withdrew consent|0|||
129457705|NCT00794157|465971933|FG002|Overall Study|Subject withdrew consent|3|||
129457706|NCT00794157|465971931|FG000|Overall Study|Lost to Follow-up|2|||
129457707|NCT00794157|465971932|FG001|Overall Study|Lost to Follow-up|0|||
129457708|NCT00794157|465971933|FG002|Overall Study|Lost to Follow-up|1|||
129457709|NCT00794157|465971931|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129457710|NCT00794157|465971932|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129457711|NCT00794157|465971933|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
129457712|NCT00794157|465971931|FG000|Overall Study|Administrative problems|1|||
129457713|NCT00794157|465971932|FG001|Overall Study|Administrative problems|7|||
129457714|NCT00794157|465971933|FG002|Overall Study|Administrative problems|4|||
129457715|NCT00794157|465971931|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129457716|NCT00794157|465971932|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129457717|NCT00794157|465971933|FG002|Overall Study|Abnormal test procedure result(s)|0|||
129457718|NCT00794157|465971931|FG000|Overall Study|Protocol deviation|0|||
129457719|NCT00794157|465971932|FG001|Overall Study|Protocol deviation|1|||
129457720|NCT00794157|465971933|FG002|Overall Study|Protocol deviation|1|||
129457721|NCT01692275|465971934|FG000|Overall Study|Lost to Follow-up|57|||
129457722|NCT01692275|465971935|FG001|Overall Study|Lost to Follow-up|48|||
129457723|NCT01692275|465971934|FG000|Overall Study|Withdrawal by Subject|9|||
129457724|NCT01692275|465971935|FG001|Overall Study|Withdrawal by Subject|11|||
129457725|NCT01624662|465971936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
129457726|NCT01624662|465971937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
129457727|NCT01624662|465971938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
129457728|NCT01624662|465971939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
129457729|NCT01624662|465971936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
129457730|NCT01624662|465971937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
129457731|NCT01624662|465971938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
129457732|NCT01624662|465971939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
129457733|NCT01624662|465971936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
129457734|NCT01624662|465971937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
129457735|NCT01624662|465971938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
129457736|NCT01624662|465971939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
129457737|NCT01624662|465971936|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
129457738|NCT01624662|465971937|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
129457739|NCT01624662|465971938|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
129457740|NCT01624662|465971939|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
129457741|NCT01624662|465971936|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
129457742|NCT01624662|465971937|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
129457743|NCT01624662|465971938|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
129457744|NCT01624662|465971939|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
129457745|NCT01624662|465971936|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
129457746|NCT01624662|465971937|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
129457747|NCT01624662|465971938|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
129457748|NCT01624662|465971939|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
129457749|NCT01624662|465971936|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
129457750|NCT01624662|465971937|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
129457751|NCT01624662|465971938|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
129457752|NCT01624662|465971939|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
129457753|NCT01135498|465973445|FG000|Overall Study|Adverse Event|20|||
129457754|NCT01135498|465973445|FG000|Overall Study|Progressive disease|38|||
129457755|NCT01135498|465973445|FG000|Overall Study|Investigator judgement|25|||
129457756|NCT01135498|465973445|FG000|Overall Study|Withdrawal by Subject|4|||
129457757|NCT01135498|465973445|FG000|Overall Study|Death|1|||
129457758|NCT01135498|465973445|FG000|Overall Study|Ongoing at time of analysis|2|||
129457759|NCT02104583|465973446|FG000|Overall Study|New ICD or CRT-D implanted|2|||
129457760|NCT02104583|465973447|FG001|Overall Study|New ICD or CRT-D implanted|0|||
129457761|NCT02104583|465973448|FG002|Overall Study|New ICD or CRT-D implanted|1|||
129457762|NCT02104583|465973449|FG003|Overall Study|New ICD or CRT-D implanted|0|||
129457763|NCT02104583|465973450|FG004|Overall Study|New ICD or CRT-D implanted|0|||
129457764|NCT02104583|465973446|FG000|Overall Study|Death|2|||
129457765|NCT02104583|465973447|FG001|Overall Study|Death|1|||
129457766|NCT02104583|465973448|FG002|Overall Study|Death|3|||
129457767|NCT02104583|465973449|FG003|Overall Study|Death|3|||
129457768|NCT02104583|465973450|FG004|Overall Study|Death|5|||
129457769|NCT02104583|465973446|FG000|Overall Study|Subject required cardiac ablation|6|||
129457770|NCT02104583|465973447|FG001|Overall Study|Subject required cardiac ablation|4|||
129457771|NCT02104583|465973448|FG002|Overall Study|Subject required cardiac ablation|4|||
129457772|NCT02104583|465973449|FG003|Overall Study|Subject required cardiac ablation|5|||
129457773|NCT02104583|465973450|FG004|Overall Study|Subject required cardiac ablation|4|||
129457774|NCT02104583|465973446|FG000|Overall Study|Subject required prohibited medication|0|||
129457775|NCT02104583|465973447|FG001|Overall Study|Subject required prohibited medication|1|||
129457776|NCT02104583|465973448|FG002|Overall Study|Subject required prohibited medication|1|||
129457777|NCT02104583|465973449|FG003|Overall Study|Subject required prohibited medication|0|||
129457778|NCT02104583|465973450|FG004|Overall Study|Subject required prohibited medication|1|||
129457779|NCT02104583|465973446|FG000|Overall Study|Withdrew Consent|3|||
129457780|NCT02104583|465973447|FG001|Overall Study|Withdrew Consent|2|||
129457781|NCT02104583|465973448|FG002|Overall Study|Withdrew Consent|0|||
129457782|NCT02104583|465973449|FG003|Overall Study|Withdrew Consent|2|||
129457783|NCT02104583|465973450|FG004|Overall Study|Withdrew Consent|1|||
129457784|NCT02104583|465973446|FG000|Overall Study|Investigator's Discretion|1|||
129457785|NCT02104583|465973447|FG001|Overall Study|Investigator's Discretion|0|||
129457786|NCT02104583|465973448|FG002|Overall Study|Investigator's Discretion|0|||
129457787|NCT02104583|465973449|FG003|Overall Study|Investigator's Discretion|0|||
129457788|NCT02104583|465973450|FG004|Overall Study|Investigator's Discretion|0|||
129457789|NCT02104583|465973446|FG000|Overall Study|Protocol Violation|0|||
129457790|NCT02104583|465973447|FG001|Overall Study|Protocol Violation|0|||
129457791|NCT02104583|465973448|FG002|Overall Study|Protocol Violation|1|||
129457792|NCT02104583|465973449|FG003|Overall Study|Protocol Violation|0|||
129457793|NCT02104583|465973450|FG004|Overall Study|Protocol Violation|0|||
129457794|NCT02104583|465973446|FG000|Overall Study|Adverse Event|3|||
129457795|NCT02104583|465973447|FG001|Overall Study|Adverse Event|3|||
129457796|NCT02104583|465973448|FG002|Overall Study|Adverse Event|6|||
129457797|NCT02104583|465973449|FG003|Overall Study|Adverse Event|6|||
129457798|NCT02104583|465973450|FG004|Overall Study|Adverse Event|1|||
129457799|NCT02104583|465973446|FG000|Overall Study|Lost to Follow-up|1|||
129457800|NCT02104583|465973447|FG001|Overall Study|Lost to Follow-up|0|||
129457801|NCT02104583|465973448|FG002|Overall Study|Lost to Follow-up|0|||
129457802|NCT02104583|465973449|FG003|Overall Study|Lost to Follow-up|0|||
129457803|NCT02104583|465973450|FG004|Overall Study|Lost to Follow-up|0|||
129457804|NCT02104583|465973446|FG000|Overall Study|Randomized but Never Treated|0|||
129457805|NCT02104583|465973447|FG001|Overall Study|Randomized but Never Treated|0|||
129457806|NCT02104583|465973448|FG002|Overall Study|Randomized but Never Treated|0|||
129457807|NCT02104583|465973449|FG003|Overall Study|Randomized but Never Treated|1|||
129457808|NCT02104583|465973450|FG004|Overall Study|Randomized but Never Treated|0|||
129457809|NCT01351389|465973451|FG000|Overall Study|Withdrawal by Subject|7|||
129457810|NCT01351389|465973452|FG001|Overall Study|Withdrawal by Subject|0|||
129457811|NCT01351389|465973451|FG000|Overall Study|did not complete intervention|23|||
129457812|NCT01351389|465973452|FG001|Overall Study|did not complete intervention|15|||
129457813|NCT00930761|465973453|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
129457814|NCT00930761|465973454|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
129457815|NCT00930761|465973453|FG000|Overall Study|less than 3 music therapy sessions|0|||
129457816|NCT00930761|465973454|FG001|Overall Study|less than 3 music therapy sessions|3|||
129457817|NCT00283595|465973455|FG000|Overall Study|Withdrawal by Subject|1|||
129457818|NCT00283595|465973456|FG001|Overall Study|Withdrawal by Subject|2|||
129457819|NCT01263639|465973457|FG000|Overall Study|Lost to Follow-up|66|||
129457820|NCT01263639|465973458|FG001|Overall Study|Lost to Follow-up|70|||
129457821|NCT01263639|465973457|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
129457822|NCT01263639|465973458|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
129457823|NCT00440947|465973459|FG000|36-Week Induction Phase|Adverse Event|16|||
129457824|NCT00440947|465973460|FG001|36-Week Induction Phase|Adverse Event|0|||
129457825|NCT00440947|465973461|FG002|36-Week Induction Phase|Adverse Event|0|||
129457826|NCT00440947|465973462|FG003|36-Week Induction Phase|Adverse Event|0|||
129457827|NCT00440947|465973463|FG004|36-Week Induction Phase|Adverse Event|0|||
129457828|NCT00440947|465973459|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
129457829|NCT00440947|465973460|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
129457830|NCT00440947|465973461|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
129457831|NCT00440947|465973462|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
129457832|NCT00440947|465973463|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
129457833|NCT00440947|465973459|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
129457834|NCT00440947|465973460|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
129457835|NCT00440947|465973461|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
129457836|NCT00440947|465973462|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
129457837|NCT00440947|465973463|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
129457838|NCT00440947|465973459|FG000|36-Week Induction Phase|Non-compliance|10|||
129457839|NCT00440947|465973460|FG001|36-Week Induction Phase|Non-compliance|0|||
129457840|NCT00440947|465973461|FG002|36-Week Induction Phase|Non-compliance|0|||
129457841|NCT00440947|465973462|FG003|36-Week Induction Phase|Non-compliance|0|||
129457842|NCT00440947|465973463|FG004|36-Week Induction Phase|Non-compliance|0|||
129457843|NCT00440947|465973459|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
129457844|NCT00440947|465973460|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
129457845|NCT00440947|465973461|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
129457846|NCT00440947|465973462|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
129457847|NCT00440947|465973463|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
129457848|NCT00440947|465973459|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
129457849|NCT00440947|465973460|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
129457850|NCT00440947|465973461|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
129457851|NCT00440947|465973462|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
129457852|NCT00440947|465973463|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
129457853|NCT00440947|465973459|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
129457854|NCT00440947|465973460|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
129457855|NCT00440947|465973461|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
129457856|NCT00440947|465973462|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
129457857|NCT00440947|465973463|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
129457858|NCT00440947|465973459|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
129457859|NCT00440947|465973460|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
129457860|NCT00440947|465973461|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
129457861|NCT00440947|465973462|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
129457862|NCT00440947|465973463|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
129457863|NCT00440947|465973459|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
129457864|NCT00440947|465973460|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
129457865|NCT00440947|465973461|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
129457866|NCT00440947|465973462|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
129457867|NCT00440947|465973463|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
129457868|NCT00440947|465973459|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
129457869|NCT00440947|465973460|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
129457870|NCT00440947|465973461|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
129457871|NCT00440947|465973462|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
129457872|NCT00440947|465973463|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
129457873|NCT00440947|465973459|FG000|36-Week Induction Phase|Incarceration|3|||
129457874|NCT00440947|465973460|FG001|36-Week Induction Phase|Incarceration|0|||
129457875|NCT00440947|465973461|FG002|36-Week Induction Phase|Incarceration|0|||
129457876|NCT00440947|465973462|FG003|36-Week Induction Phase|Incarceration|0|||
129457877|NCT00440947|465973463|FG004|36-Week Induction Phase|Incarceration|0|||
129457878|NCT00440947|465973459|FG000|36-Week Induction Phase|Pregnancy|1|||
129457879|NCT00440947|465973460|FG001|36-Week Induction Phase|Pregnancy|0|||
129457880|NCT00440947|465973461|FG002|36-Week Induction Phase|Pregnancy|0|||
129457881|NCT00440947|465973462|FG003|36-Week Induction Phase|Pregnancy|0|||
129457882|NCT00440947|465973463|FG004|36-Week Induction Phase|Pregnancy|0|||
129457883|NCT00440947|465973459|FG000|48-Week Randomization Phase|Adverse Event|0|||
129457884|NCT00440947|465973460|FG001|48-Week Randomization Phase|Adverse Event|2|||
129457885|NCT00440947|465973461|FG002|48-Week Randomization Phase|Adverse Event|5|||
129457886|NCT00440947|465973462|FG003|48-Week Randomization Phase|Adverse Event|0|||
129457887|NCT00440947|465973463|FG004|48-Week Randomization Phase|Adverse Event|0|||
129457888|NCT00440947|465973459|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
129457889|NCT00440947|465973460|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
129457890|NCT00440947|465973461|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
129457891|NCT00440947|465973462|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
129457892|NCT00440947|465973463|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
129457893|NCT00440947|465973459|FG000|48-Week Randomization Phase|Non-compliance|0|||
129457894|NCT00440947|465973460|FG001|48-Week Randomization Phase|Non-compliance|3|||
129457895|NCT00440947|465973461|FG002|48-Week Randomization Phase|Non-compliance|4|||
129457896|NCT00440947|465973462|FG003|48-Week Randomization Phase|Non-compliance|0|||
129457897|NCT00440947|465973463|FG004|48-Week Randomization Phase|Non-compliance|0|||
129457898|NCT00440947|465973459|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
129457899|NCT00440947|465973460|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
129457900|NCT00440947|465973461|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
129457901|NCT00440947|465973462|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
129457902|NCT00440947|465973463|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
129457903|NCT00440947|465973459|FG000|48-Week Randomization Phase|Protocol Violation|0|||
129457904|NCT00440947|465973460|FG001|48-Week Randomization Phase|Protocol Violation|0|||
129457905|NCT00440947|465973461|FG002|48-Week Randomization Phase|Protocol Violation|1|||
129457906|NCT00440947|465973462|FG003|48-Week Randomization Phase|Protocol Violation|0|||
129457907|NCT00440947|465973463|FG004|48-Week Randomization Phase|Protocol Violation|0|||
129457908|NCT00440947|465973459|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
129457909|NCT00440947|465973460|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
129457910|NCT00440947|465973461|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
129457911|NCT00440947|465973462|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
129457912|NCT00440947|465973463|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
129457913|NCT00440947|465973459|FG000|48-Week Randomization Phase|Pregnancy|0|||
129457914|NCT00440947|465973460|FG001|48-Week Randomization Phase|Pregnancy|0|||
129457915|NCT00440947|465973461|FG002|48-Week Randomization Phase|Pregnancy|1|||
129457916|NCT00440947|465973462|FG003|48-Week Randomization Phase|Pregnancy|0|||
129457917|NCT00440947|465973463|FG004|48-Week Randomization Phase|Pregnancy|0|||
129457918|NCT00440947|465973459|FG000|48-Week Randomization Phase|Incarceration|0|||
129457919|NCT00440947|465973460|FG001|48-Week Randomization Phase|Incarceration|3|||
129457920|NCT00440947|465973461|FG002|48-Week Randomization Phase|Incarceration|0|||
129457921|NCT00440947|465973462|FG003|48-Week Randomization Phase|Incarceration|0|||
129457922|NCT00440947|465973463|FG004|48-Week Randomization Phase|Incarceration|0|||
129457923|NCT00440947|465973459|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
129457924|NCT00440947|465973460|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
129457925|NCT00440947|465973461|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
129457926|NCT00440947|465973462|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
129457927|NCT00440947|465973463|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
129457928|NCT00440947|465973459|FG000|48-Week Randomization Phase|Physician Decision|0|||
129457929|NCT00440947|465973460|FG001|48-Week Randomization Phase|Physician Decision|2|||
129457930|NCT00440947|465973461|FG002|48-Week Randomization Phase|Physician Decision|0|||
129457931|NCT00440947|465973462|FG003|48-Week Randomization Phase|Physician Decision|0|||
129457932|NCT00440947|465973463|FG004|48-Week Randomization Phase|Physician Decision|0|||
129457933|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
129457934|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
129457935|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
129457936|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
129457937|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
129457938|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
129457939|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
129457940|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
129457941|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
129457942|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
129457943|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
129457944|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
129457945|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
129457946|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
129457947|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
129457948|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
129457949|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
129457950|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
129457951|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
129457952|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
129457953|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
129457954|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
129457955|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
129457956|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
129457957|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
129457958|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
129457959|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
129457960|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
129457961|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
129457962|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
129457963|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
129457964|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
129457965|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
129457966|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
129457967|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
129457968|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
129457969|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
129457970|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
129457971|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
129457972|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
129457973|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
129457974|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
129457975|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
129457976|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
129457977|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
129457978|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
129457979|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
129457980|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
129457981|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
129457982|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
129457983|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
129457984|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
129457985|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
129457986|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
129457987|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
129457988|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Other|0|||
129457989|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Other|0|||
129457990|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Other|0|||
129457991|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Other|1|||
129457992|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Other|0|||
129457993|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
129457994|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
129457995|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
129457996|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
129457997|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
129457998|NCT00440947|465973459|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
129457999|NCT00440947|465973460|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
129458000|NCT00440947|465973461|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
129458001|NCT00440947|465973462|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
129458002|NCT00440947|465973463|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
129458003|NCT01834274|465973466|FG000|Overall Study|Study Termination|41|||
129458004|NCT01834274|465973467|FG001|Overall Study|Study Termination|38|||
129458005|NCT01834274|465973466|FG000|Overall Study|Withdrawal by Subject|1|||
129458006|NCT01834274|465973467|FG001|Overall Study|Withdrawal by Subject|1|||
129458007|NCT01834274|465973466|FG000|Overall Study|Lost to Follow-up|3|||
129458008|NCT01834274|465973467|FG001|Overall Study|Lost to Follow-up|1|||
129458009|NCT01834274|465973466|FG000|Overall Study|Other|2|||
129458010|NCT01834274|465973467|FG001|Overall Study|Other|1|||
129458011|NCT02980224|465973473|FG000|Overall Study|Adverse Event|4|||
129458012|NCT02980224|465973474|FG001|Overall Study|Adverse Event|1|||
129458013|NCT02980224|465973473|FG000|Overall Study|Withdrawal by Subject|0|||
129458014|NCT02980224|465973474|FG001|Overall Study|Withdrawal by Subject|2|||
129458015|NCT01087905|465973475|FG000|Overall Study|Lost to Follow-up|24|||
129458016|NCT01087905|465973476|FG001|Overall Study|Lost to Follow-up|28|||
129458017|NCT01087905|465973477|FG002|Overall Study|Lost to Follow-up|18|||
129458018|NCT01087905|465973478|FG003|Overall Study|Lost to Follow-up|31|||
129458019|NCT01087905|465973479|FG004|Overall Study|Lost to Follow-up|27|||
129458020|NCT01087905|465973480|FG005|Overall Study|Lost to Follow-up|25|||
129458021|NCT01087905|465973481|FG006|Overall Study|Lost to Follow-up|20|||
129458022|NCT01087905|465973482|FG007|Overall Study|Lost to Follow-up|24|||
129458023|NCT01087905|465973475|FG000|Overall Study|Withdrawal by Subject|5|||
129458024|NCT01087905|465973476|FG001|Overall Study|Withdrawal by Subject|4|||
129458025|NCT01087905|465973477|FG002|Overall Study|Withdrawal by Subject|4|||
129458026|NCT01087905|465973478|FG003|Overall Study|Withdrawal by Subject|5|||
129458027|NCT01087905|465973479|FG004|Overall Study|Withdrawal by Subject|4|||
129458028|NCT01087905|465973480|FG005|Overall Study|Withdrawal by Subject|3|||
129458029|NCT01087905|465973481|FG006|Overall Study|Withdrawal by Subject|3|||
129458030|NCT01087905|465973482|FG007|Overall Study|Withdrawal by Subject|5|||
129458031|NCT02937818|465973483|FG000|Overall Study|Participants decision|2|||
129458032|NCT02937818|465973484|FG001|Overall Study|Participants decision|1|||
129458033|NCT02937818|465973485|FG002|Overall Study|Participants decision|1|||
129458034|NCT02937818|465973486|FG003|Overall Study|Participants decision|1|||
129458035|NCT02937818|465973483|FG000|Overall Study|Adverse Event|2|||
129458036|NCT02937818|465973484|FG001|Overall Study|Adverse Event|4|||
129458037|NCT02937818|465973485|FG002|Overall Study|Adverse Event|1|||
129458038|NCT02937818|465973486|FG003|Overall Study|Adverse Event|1|||
129458039|NCT02937818|465973483|FG000|Overall Study|Disease progression|17|||
129458040|NCT02937818|465973484|FG001|Overall Study|Disease progression|15|||
129458041|NCT02937818|465973485|FG002|Overall Study|Disease progression|7|||
129458042|NCT02937818|465973486|FG003|Overall Study|Disease progression|19|||
129458043|NCT02937818|465973483|FG000|Overall Study|Condition under investigation worsened|0|||
129458044|NCT02937818|465973484|FG001|Overall Study|Condition under investigation worsened|0|||
129458045|NCT02937818|465973485|FG002|Overall Study|Condition under investigation worsened|1|||
129458046|NCT02937818|465973486|FG003|Overall Study|Condition under investigation worsened|0|||
129458047|NCT05513625|465973487|FG000|Overall Study|Withdrawal by Subject|1|||
129458048|NCT01015768|465973488|FG000|Overall Study|Some subject data unuseable|4|||
129458049|NCT01015768|465973489|FG001|Overall Study|Some subject data unuseable|4|||
129458050|NCT03891264|465973490|FG000|Overall Study|Adverse Event|1|||
129458051|NCT03891264|465973490|FG000|Overall Study|Withdrawal by Subject|2|||
129458052|NCT03891264|465973490|FG000|Overall Study|Physician Decision|2|||
129458053|NCT01505634|465973495|FG000|Overall Study|Withdrawal by Subject|2|||
129458054|NCT01505634|465973496|FG001|Overall Study|Withdrawal by Subject|5|||
129458055|NCT01505634|465973497|FG002|Overall Study|Withdrawal by Subject|1|||
129458056|NCT01505634|465973495|FG000|Overall Study|Physician Decision|1|||
129458057|NCT01505634|465973496|FG001|Overall Study|Physician Decision|1|||
129458058|NCT01505634|465973497|FG002|Overall Study|Physician Decision|0|||
129458059|NCT01505634|465973495|FG000|Overall Study|Adverse Event|1|||
129458060|NCT01505634|465973496|FG001|Overall Study|Adverse Event|0|||
129458061|NCT01505634|465973497|FG002|Overall Study|Adverse Event|0|||
129458062|NCT01505634|465973495|FG000|Overall Study|Insufficient supply of drug at site|1|||
129458063|NCT01505634|465973496|FG001|Overall Study|Insufficient supply of drug at site|0|||
129458064|NCT01505634|465973497|FG002|Overall Study|Insufficient supply of drug at site|0|||
129458065|NCT01505634|465973495|FG000|Overall Study|Protocol Violation|2|||
129458066|NCT01505634|465973496|FG001|Overall Study|Protocol Violation|0|||
129458067|NCT01505634|465973497|FG002|Overall Study|Protocol Violation|0|||
129458068|NCT01505634|465973495|FG000|Overall Study|Lost to Follow-up|1|||
129458069|NCT01505634|465973496|FG001|Overall Study|Lost to Follow-up|4|||
129458070|NCT01505634|465973497|FG002|Overall Study|Lost to Follow-up|4|||
129458071|NCT01505634|465973495|FG000|Overall Study|Death|1|||
129458072|NCT01505634|465973496|FG001|Overall Study|Death|0|||
129458073|NCT01505634|465973497|FG002|Overall Study|Death|0|||
129458074|NCT01505634|465973495|FG000|Overall Study|In a conflict zone|0|||
129458075|NCT01505634|465973496|FG001|Overall Study|In a conflict zone|0|||
129458076|NCT01505634|465973497|FG002|Overall Study|In a conflict zone|1|||
129458077|NCT02054897|465973498|FG000|Overall Study|Withdrawal by Subject|2|||
129458078|NCT02054897|465973499|FG001|Overall Study|Withdrawal by Subject|0|||
129458079|NCT02054897|465973500|FG002|Overall Study|Withdrawal by Subject|2|||
129458080|NCT02054897|465973498|FG000|Overall Study|Missing follow-up information|3|||
129458081|NCT02054897|465973499|FG001|Overall Study|Missing follow-up information|5|||
129458082|NCT02054897|465973500|FG002|Overall Study|Missing follow-up information|3|||
129458083|NCT02054897|465973498|FG000|Overall Study|Lost to Follow-up|4|||
129458084|NCT02054897|465973499|FG001|Overall Study|Lost to Follow-up|2|||
129458085|NCT02054897|465973500|FG002|Overall Study|Lost to Follow-up|7|||
129458086|NCT02054897|465973498|FG000|Overall Study|Randomized but not exposed|1|||
129458087|NCT02054897|465973499|FG001|Overall Study|Randomized but not exposed|0|||
129458088|NCT02054897|465973500|FG002|Overall Study|Randomized but not exposed|0|||
129458089|NCT00361270|465973503|FG000|Overall Study|Death|0|||
129458090|NCT00361270|465973504|FG001|Overall Study|Death|0|||
129458091|NCT00361270|465973505|FG002|Overall Study|Death|0|||
129458092|NCT00361270|465973506|FG003|Overall Study|Death|2|||
129458093|NCT00361270|465973503|FG000|Overall Study|Lost to Follow-up|4|||
129458094|NCT00361270|465973504|FG001|Overall Study|Lost to Follow-up|1|||
129458095|NCT00361270|465973505|FG002|Overall Study|Lost to Follow-up|0|||
129458096|NCT00361270|465973506|FG003|Overall Study|Lost to Follow-up|0|||
129458097|NCT00361270|465973503|FG000|Overall Study|Physician Decision|0|||
129458098|NCT00361270|465973504|FG001|Overall Study|Physician Decision|0|||
129458099|NCT00361270|465973505|FG002|Overall Study|Physician Decision|1|||
129458100|NCT00361270|465973506|FG003|Overall Study|Physician Decision|0|||
129458101|NCT00361270|465973503|FG000|Overall Study|Protocol Violation|9|||
129458102|NCT00361270|465973504|FG001|Overall Study|Protocol Violation|4|||
129458103|NCT00361270|465973505|FG002|Overall Study|Protocol Violation|5|||
129458104|NCT00361270|465973506|FG003|Overall Study|Protocol Violation|4|||
129458105|NCT00361270|465973503|FG000|Overall Study|Withdrawal by Subject|6|||
129458106|NCT00361270|465973504|FG001|Overall Study|Withdrawal by Subject|6|||
129458107|NCT00361270|465973505|FG002|Overall Study|Withdrawal by Subject|3|||
129458108|NCT00361270|465973506|FG003|Overall Study|Withdrawal by Subject|7|||
129458109|NCT00361270|465973503|FG000|Overall Study|Afraid of Hypnosis|1|||
129458110|NCT00361270|465973504|FG001|Overall Study|Afraid of Hypnosis|2|||
129458111|NCT00361270|465973505|FG002|Overall Study|Afraid of Hypnosis|0|||
129458112|NCT00361270|465973506|FG003|Overall Study|Afraid of Hypnosis|0|||
129458113|NCT00361270|465973503|FG000|Overall Study|Problems with Transportation|4|||
129458114|NCT00361270|465973504|FG001|Overall Study|Problems with Transportation|0|||
129458115|NCT00361270|465973505|FG002|Overall Study|Problems with Transportation|0|||
129458116|NCT00361270|465973506|FG003|Overall Study|Problems with Transportation|0|||
129458117|NCT00361270|465973503|FG000|Overall Study|Adverse Event|0|||
129458118|NCT00361270|465973504|FG001|Overall Study|Adverse Event|1|||
129458119|NCT00361270|465973505|FG002|Overall Study|Adverse Event|1|||
129458120|NCT00361270|465973506|FG003|Overall Study|Adverse Event|0|||
129458121|NCT00677014|465973508|FG000|Overall Study|Lost to Follow-up|20|||
129458122|NCT00677014|465973509|FG001|Overall Study|Lost to Follow-up|12|||
129458123|NCT00677014|465973510|FG002|Overall Study|Lost to Follow-up|24|||
129458124|NCT00677014|465973508|FG000|Overall Study|Death|6|||
129458125|NCT00677014|465973509|FG001|Overall Study|Death|15|||
129458126|NCT00677014|465973510|FG002|Overall Study|Death|7|||
129458127|NCT00677014|465973508|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
129458128|NCT00677014|465973509|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
129458129|NCT00677014|465973510|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
129458130|NCT00640328|465973511|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
129458131|NCT00640328|465973512|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
129458132|NCT00640328|465973513|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
129458133|NCT00640328|465973514|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
129458134|NCT00640328|465973515|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
129458135|NCT00640328|465973516|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
129458136|NCT00640328|465973511|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
129458137|NCT00640328|465973512|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
129458138|NCT00640328|465973513|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
129458139|NCT00640328|465973514|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
129458140|NCT00640328|465973515|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
129458141|NCT00640328|465973516|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
129458142|NCT00640328|465973511|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
129458143|NCT00640328|465973512|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
129458144|NCT00640328|465973513|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
129458145|NCT00640328|465973514|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
129458146|NCT00640328|465973515|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
129458147|NCT00640328|465973516|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
129458148|NCT00640328|465973511|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
129458149|NCT00640328|465973512|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
129458150|NCT00640328|465973513|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
129458151|NCT00640328|465973514|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
129458152|NCT00640328|465973515|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
129458153|NCT00640328|465973516|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
129458154|NCT02374099|465973517|FG000|Overall Study|Adverse Event|1|||
129458155|NCT02374099|465973518|FG001|Overall Study|Adverse Event|0|||
129458156|NCT02374099|465973517|FG000|Overall Study|Progressive Disease|35|||
129458157|NCT02374099|465973518|FG001|Overall Study|Progressive Disease|40|||
129458158|NCT02374099|465973517|FG000|Overall Study|Withdrawal by Subject|5|||
129458159|NCT02374099|465973518|FG001|Overall Study|Withdrawal by Subject|1|||
129458160|NCT02374099|465973517|FG000|Overall Study|Miscellaneous|2|||
129458161|NCT02374099|465973518|FG001|Overall Study|Miscellaneous|3|||
129458162|NCT02374099|465973517|FG000|Overall Study|Randomized, but not treated|2|||
129458163|NCT02374099|465973518|FG001|Overall Study|Randomized, but not treated|1|||
129458164|NCT02374099|465973517|FG000|Overall Study|Study Terminated by Sponsor|3|||
129458165|NCT02374099|465973518|FG001|Overall Study|Study Terminated by Sponsor|4|||
129458166|NCT01326546|465973519|FG000|Overall Study|Lost to Follow-up|8|||
129458167|NCT01326546|465973520|FG001|Overall Study|Lost to Follow-up|7|||
129458168|NCT01326546|465973519|FG000|Overall Study|Protocol Violation|3|||
129458169|NCT01326546|465973520|FG001|Overall Study|Protocol Violation|4|||
129458170|NCT01326546|465973519|FG000|Overall Study|Pregnancy|0|||
129458171|NCT01326546|465973520|FG001|Overall Study|Pregnancy|1|||
129458172|NCT01326546|465973519|FG000|Overall Study|Adverse Event|1|||
129458173|NCT01326546|465973520|FG001|Overall Study|Adverse Event|0|||
129458174|NCT01326546|465973519|FG000|Overall Study|Withdrawal by Subject|5|||
129458175|NCT01326546|465973520|FG001|Overall Study|Withdrawal by Subject|1|||
129458176|NCT01033825|465973521|FG000|Overall Study|Withdrawal by Subject|2|||
129458177|NCT01033825|465973522|FG001|Overall Study|Withdrawal by Subject|3|||
129458178|NCT01033825|465973523|FG002|Overall Study|Withdrawal by Subject|2|||
129458179|NCT01033825|465973524|FG003|Overall Study|Withdrawal by Subject|1|||
129458180|NCT01033825|465973525|FG004|Overall Study|Withdrawal by Subject|1|||
129458181|NCT01033825|465973526|FG005|Overall Study|Withdrawal by Subject|0|||
129458182|NCT01033825|465973527|FG006|Overall Study|Withdrawal by Subject|0|||
129458183|NCT01033825|465973521|FG000|Overall Study|Adverse Event|0|||
129458184|NCT01033825|465973522|FG001|Overall Study|Adverse Event|0|||
129458185|NCT01033825|465973523|FG002|Overall Study|Adverse Event|0|||
129458186|NCT01033825|465973524|FG003|Overall Study|Adverse Event|1|||
129458187|NCT01033825|465973525|FG004|Overall Study|Adverse Event|0|||
129458188|NCT01033825|465973526|FG005|Overall Study|Adverse Event|0|||
129458189|NCT01033825|465973527|FG006|Overall Study|Adverse Event|0|||
129458190|NCT01033825|465973521|FG000|Overall Study|Protocol Violation|1|||
129458191|NCT01033825|465973522|FG001|Overall Study|Protocol Violation|0|||
129458192|NCT01033825|465973523|FG002|Overall Study|Protocol Violation|0|||
129458193|NCT01033825|465973524|FG003|Overall Study|Protocol Violation|0|||
129458194|NCT01033825|465973525|FG004|Overall Study|Protocol Violation|0|||
129458195|NCT01033825|465973526|FG005|Overall Study|Protocol Violation|0|||
129458196|NCT01033825|465973527|FG006|Overall Study|Protocol Violation|0|||
129458197|NCT01033825|465973521|FG000|Overall Study|Other|0|||
129458198|NCT01033825|465973522|FG001|Overall Study|Other|0|||
129458199|NCT01033825|465973523|FG002|Overall Study|Other|0|||
129458200|NCT01033825|465973524|FG003|Overall Study|Other|0|||
129458201|NCT01033825|465973525|FG004|Overall Study|Other|1|||
129458202|NCT01033825|465973526|FG005|Overall Study|Other|0|||
129458203|NCT01033825|465973527|FG006|Overall Study|Other|0|||
129458204|NCT04294719|465973528|FG000|Overall Study|Withdrawal by Subject|1|||
129458205|NCT00081159|465973529|FG000|Overall Study|Withdrawal by Subject|0|||
129458206|NCT00081159|465973530|FG001|Overall Study|Withdrawal by Subject|3|||
129458207|NCT00081159|465973529|FG000|Overall Study|Myelosuppression prior to treatment|0|||
129458208|NCT00081159|465973530|FG001|Overall Study|Myelosuppression prior to treatment|1|||
129458209|NCT00081159|465973529|FG000|Overall Study|Lost to Follow-up|2|||
129458210|NCT00081159|465973530|FG001|Overall Study|Lost to Follow-up|1|||
129458211|NCT01714687|465973531|FG000|Overall Study|Withdrawal by Subject|1|||
129458212|NCT01714687|465973532|FG001|Overall Study|Withdrawal by Subject|0|||
129458213|NCT01714687|465973531|FG000|Overall Study|Lost to Follow-up|2|||
129458214|NCT01714687|465973532|FG001|Overall Study|Lost to Follow-up|4|||
129458215|NCT01553136|465973537|FG000|Overall Study|Adverse Event|3|||
129458216|NCT01553136|465973538|FG001|Overall Study|Adverse Event|2|||
129458217|NCT01553136|465973537|FG000|Overall Study|Withdrawal by Subject|2|||
129458218|NCT01553136|465973538|FG001|Overall Study|Withdrawal by Subject|3|||
129458219|NCT01553136|465973537|FG000|Overall Study|Lost to Follow-up|4|||
129458220|NCT01553136|465973538|FG001|Overall Study|Lost to Follow-up|10|||
129458221|NCT01553136|465973537|FG000|Overall Study|Physician Decision|2|||
129458222|NCT01553136|465973538|FG001|Overall Study|Physician Decision|3|||
129458223|NCT01553136|465973537|FG000|Overall Study|Scheduling Difficulties|5|||
129458224|NCT01553136|465973538|FG001|Overall Study|Scheduling Difficulties|4|||
129458225|NCT01100437|465973539|FG000|Titration/Stabilization|Adverse Event|0|||
129458226|NCT01100437|465973540|FG001|Titration/Stabilization|Adverse Event|0|||
129458227|NCT01100437|465973541|FG002|Titration/Stabilization|Adverse Event|4|||
129458228|NCT01100437|465973539|FG000|Titration/Stabilization|Non-compliance|0|||
129458229|NCT01100437|465973540|FG001|Titration/Stabilization|Non-compliance|0|||
129458230|NCT01100437|465973541|FG002|Titration/Stabilization|Non-compliance|1|||
129458231|NCT01100437|465973539|FG000|Titration/Stabilization|Sponsor canceled study|0|||
129458232|NCT01100437|465973540|FG001|Titration/Stabilization|Sponsor canceled study|0|||
129458233|NCT01100437|465973541|FG002|Titration/Stabilization|Sponsor canceled study|1|||
129458234|NCT01100437|465973539|FG000|Maintenance|Withdrawal by Subject|0|||
129458235|NCT01100437|465973540|FG001|Maintenance|Withdrawal by Subject|0|||
129458236|NCT01100437|465973541|FG002|Maintenance|Withdrawal by Subject|1|||
129458237|NCT01100437|465973539|FG000|Maintenance|Sponsor termination of study|0|||
129458238|NCT01100437|465973540|FG001|Maintenance|Sponsor termination of study|0|||
129458239|NCT01100437|465973541|FG002|Maintenance|Sponsor termination of study|1|||
129458240|NCT00894556|465973544|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
129458241|NCT00894556|465973545|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
129458242|NCT00894556|465973546|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
129458243|NCT00894556|465973547|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
129458244|NCT00894556|465973544|FG000|Treatment Phase|Lost to Follow-up|2|||
129458245|NCT00894556|465973545|FG001|Treatment Phase|Lost to Follow-up|3|||
129458246|NCT00894556|465973546|FG002|Treatment Phase|Lost to Follow-up|1|||
129458247|NCT00894556|465973547|FG003|Treatment Phase|Lost to Follow-up|0|||
129458248|NCT00894556|465973544|FG000|Treatment Phase|Lack of Qualifying Event|2|||
129458249|NCT00894556|465973545|FG001|Treatment Phase|Lack of Qualifying Event|1|||
129458250|NCT00894556|465973546|FG002|Treatment Phase|Lack of Qualifying Event|0|||
129458251|NCT00894556|465973547|FG003|Treatment Phase|Lack of Qualifying Event|0|||
129458252|NCT03077685|465973550|FG000|Overall Study|Lost to Follow-up|0|||
129458253|NCT03077685|465973551|FG001|Overall Study|Lost to Follow-up|0|||
129458254|NCT03077685|465973552|FG002|Overall Study|Lost to Follow-up|0|||
129458255|NCT03077685|465973553|FG003|Overall Study|Lost to Follow-up|0|||
129458256|NCT03077685|465973554|FG004|Overall Study|Lost to Follow-up|1|||
129458257|NCT03077685|465973550|FG000|Overall Study|Death|0|||
129458258|NCT03077685|465973551|FG001|Overall Study|Death|0|||
129458259|NCT03077685|465973552|FG002|Overall Study|Death|1|||
129458260|NCT03077685|465973553|FG003|Overall Study|Death|1|||
129458261|NCT03077685|465973554|FG004|Overall Study|Death|3|||
129458262|NCT03077685|465973550|FG000|Overall Study|Withdrawal by Subject|0|||
129458263|NCT03077685|465973551|FG001|Overall Study|Withdrawal by Subject|0|||
129458264|NCT03077685|465973552|FG002|Overall Study|Withdrawal by Subject|0|||
129458265|NCT03077685|465973553|FG003|Overall Study|Withdrawal by Subject|2|||
129458266|NCT03077685|465973554|FG004|Overall Study|Withdrawal by Subject|1|||
129458267|NCT03077685|465973550|FG000|Overall Study|Physician Decision|0|||
129458268|NCT03077685|465973551|FG001|Overall Study|Physician Decision|0|||
129458269|NCT03077685|465973552|FG002|Overall Study|Physician Decision|1|||
129458270|NCT03077685|465973553|FG003|Overall Study|Physician Decision|0|||
129458271|NCT03077685|465973554|FG004|Overall Study|Physician Decision|3|||
129458272|NCT03077685|465973550|FG000|Overall Study|Disease Progression|1|||
129458273|NCT03077685|465973551|FG001|Overall Study|Disease Progression|0|||
129458274|NCT03077685|465973552|FG002|Overall Study|Disease Progression|0|||
129458275|NCT03077685|465973553|FG003|Overall Study|Disease Progression|2|||
129458276|NCT03077685|465973554|FG004|Overall Study|Disease Progression|1|||
129458277|NCT03077685|465973550|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
129458278|NCT03077685|465973551|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
129458279|NCT03077685|465973552|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
129458280|NCT03077685|465973553|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
129458281|NCT03077685|465973554|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
129458282|NCT03077685|465973550|FG000|Overall Study|Subject entered hospice care|0|||
129458283|NCT03077685|465973551|FG001|Overall Study|Subject entered hospice care|0|||
129458284|NCT03077685|465973552|FG002|Overall Study|Subject entered hospice care|0|||
129458285|NCT03077685|465973553|FG003|Overall Study|Subject entered hospice care|0|||
129458286|NCT03077685|465973554|FG004|Overall Study|Subject entered hospice care|1|||
129458287|NCT01979536|465973555|FG000|Overall Study|Physician Decision|2|||
129458288|NCT01979536|465973556|FG001|Overall Study|Physician Decision|3|||
129458289|NCT01979536|465973555|FG000|Overall Study|Withdrawal by Subject|0|||
129458290|NCT01979536|465973556|FG001|Overall Study|Withdrawal by Subject|1|||
129458291|NCT01979536|465973555|FG000|Overall Study|Refusal|0|||
129458292|NCT01979536|465973556|FG001|Overall Study|Refusal|1|||
129458293|NCT01979536|465973555|FG000|Overall Study|Relapse|0|||
129458294|NCT01979536|465973556|FG001|Overall Study|Relapse|1|||
129458295|NCT01979536|465973555|FG000|Overall Study|Study terminated by Sponsor|0|||
129458296|NCT01979536|465973556|FG001|Overall Study|Study terminated by Sponsor|1|||
129458297|NCT01979536|465973555|FG000|Overall Study|Did not start treatment|0|||
129458298|NCT01979536|465973556|FG001|Overall Study|Did not start treatment|1|||
129458299|NCT02581202|465973572|FG000|Overall Study|Lack of Efficacy|2|||
129458300|NCT02581202|465973572|FG000|Overall Study|Withdrawal by Subject|4|||
129458301|NCT02581202|465973572|FG000|Overall Study|Lost to Follow-up|5|||
129458302|NCT02581202|465973572|FG000|Overall Study|Pregnancy|3|||
129458303|NCT01806779|465973573|FG000|Overall Study|Physician Decision|2|||
129458304|NCT01806779|465973574|FG001|Overall Study|Physician Decision|0|||
129458305|NCT01806779|465973575|FG002|Overall Study|Physician Decision|1|||
129458306|NCT01806779|465973573|FG000|Overall Study|Lack of Efficacy|1|||
129458307|NCT01806779|465973574|FG001|Overall Study|Lack of Efficacy|1|||
129458308|NCT01806779|465973575|FG002|Overall Study|Lack of Efficacy|0|||
129458309|NCT01806779|465973573|FG000|Overall Study|Lost to Follow-up|19|||
129458310|NCT01806779|465973574|FG001|Overall Study|Lost to Follow-up|20|||
129458311|NCT01806779|465973575|FG002|Overall Study|Lost to Follow-up|0|||
129458312|NCT01806779|465973573|FG000|Overall Study|Withdrawal by Subject|20|||
129458313|NCT01806779|465973574|FG001|Overall Study|Withdrawal by Subject|23|||
129458314|NCT01806779|465973575|FG002|Overall Study|Withdrawal by Subject|22|||
129458315|NCT02595450|465973578|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
129458316|NCT02595450|465973578|FG000|Overall Study|Enrolled, but not treated|8|||
129458317|NCT04294901|465973580|FG000|Overall Study|Death|86|||
129458318|NCT04294901|465973581|FG001|Overall Study|Death|110|||
129458319|NCT04294901|465973580|FG000|Overall Study|Provider did not have historical control patients|581|||
129458320|NCT04294901|465973581|FG001|Overall Study|Provider did not have historical control patients|0|||
129458321|NCT04294901|465973580|FG000|Overall Study|Provider did not have intervention patients|0|||
129458322|NCT04294901|465973581|FG001|Overall Study|Provider did not have intervention patients|98|||
129458323|NCT01934556|465973584|FG000|Overall Study|Withdrawal by Subject|0|||
129458324|NCT01934556|465973585|FG001|Overall Study|Withdrawal by Subject|1|||
129458325|NCT01934556|465973586|FG002|Overall Study|Withdrawal by Subject|1|||
129458326|NCT01934556|465973584|FG000|Overall Study|Lost to Follow-up|4|||
129458327|NCT01934556|465973585|FG001|Overall Study|Lost to Follow-up|10|||
129458328|NCT01934556|465973586|FG002|Overall Study|Lost to Follow-up|7|||
129458329|NCT01934556|465973584|FG000|Overall Study|Death|1|||
129458330|NCT01934556|465973585|FG001|Overall Study|Death|5|||
129458331|NCT01934556|465973586|FG002|Overall Study|Death|2|||
129458332|NCT05038020|465973590|FG000|Overall Study|Early Termination|3|||
129458333|NCT05038020|465973591|FG001|Overall Study|Early Termination|0|||
129967708|NCT02706951|467847086|FG004|Period 1|Adverse Event|0|||
129967709|NCT02706951|467847082|FG000|Period 1|Withdrawal by Subject|10|||
129458334|NCT03770260|465975100|FG000|Overall Study|Disease progression|0|||
129458335|NCT03770260|465975101|FG001|Overall Study|Disease progression|1|||
129458336|NCT03770260|465975102|FG002|Overall Study|Disease progression|0|||
129458337|NCT03770260|465975103|FG003|Overall Study|Disease progression|0|||
129458338|NCT02484911|465975104|FG000|Overall Study|Withdrawal by Subject|2|||
129458339|NCT02484911|465975105|FG001|Overall Study|Withdrawal by Subject|1|||
129458340|NCT02484911|465975104|FG000|Overall Study|Protocol Violation|2|||
129458341|NCT02484911|465975105|FG001|Overall Study|Protocol Violation|1|||
129458342|NCT01652885|465975110|FG000|Overall Study|Adverse Event|1|||
129458343|NCT00075400|465975111|FG000|Overall Study|Ineligible: wrong primary|1|||
129458344|NCT00075400|465975111|FG000|Overall Study|Never treated|2|||
129458345|NCT00490568|465975112|FG000|Overall Study|Adverse Event|116|||
129458346|NCT00490568|465975112|FG000|Overall Study|Lost to Follow-up|13|||
129458347|NCT00490568|465975112|FG000|Overall Study|Protocol Violation|45|||
129458348|NCT00490568|465975112|FG000|Overall Study|Withdrawal by Subject|135|||
129458349|NCT00490568|465975112|FG000|Overall Study|Still in the study at termination|974|||
129458350|NCT00490568|465975112|FG000|Overall Study|Other|1|||
129458351|NCT00490568|465975112|FG000|Overall Study|Exclusion criteria met|1|||
129458352|NCT00490568|465975112|FG000|Overall Study|Caregiver related|20|||
129458353|NCT00490568|465975112|FG000|Overall Study|Abnormal ECG|25|||
129458354|NCT00490568|465975112|FG000|Overall Study|Participant refused follow-up|9|||
129458355|NCT00490568|465975112|FG000|Overall Study|Legal representative withdrew consent|1|||
129967710|NCT02706951|467847083|FG001|Period 1|Withdrawal by Subject|6|||
129458356|NCT00490568|465975112|FG000|Overall Study|Disease progression|4|||
129458357|NCT00490568|465975112|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
129458358|NCT00490568|465975112|FG000|Overall Study|Investigator decision|3|||
129458359|NCT00490568|465975112|FG000|Overall Study|Non-Compliance|7|||
129458360|NCT00490568|465975112|FG000|Overall Study|Efficacy related|3|||
129458361|NCT00490568|465975112|FG000|Overall Study|Participant died|1|||
129458362|NCT00490568|465975112|FG000|Overall Study|Participant withdrawal due to surgery|1|||
129967711|NCT02706951|467847084|FG002|Period 1|Withdrawal by Subject|6|||
129458363|NCT01395394|465975113|FG000|Baseline Study Visit|Protocol Violation|1|||
129458364|NCT01395394|465975114|FG001|Baseline Study Visit|Protocol Violation|0|||
129458365|NCT01395394|465975115|FG002|Baseline Study Visit|Protocol Violation|0|||
129458366|NCT03451773|465975118|FG000|Overall Study|Death on study|1|||
129458367|NCT03451773|465975119|FG001|Overall Study|Death on study|5|||
129458368|NCT03451773|465975118|FG000|Overall Study|Death during follow-up period|0|||
129458369|NCT03451773|465975119|FG001|Overall Study|Death during follow-up period|1|||
129458370|NCT03468855|465975120|FG000|Overall Study|Adverse Event|2|||
129458371|NCT03468855|465975120|FG000|Overall Study|Lost to Follow-up|5|||
129458372|NCT03468855|465975120|FG000|Overall Study|Withdrawal by Subject|3|||
129458373|NCT03468855|465975120|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
129458374|NCT01908101|465975121|FG000|Overall Study|Physician Decision|1|||
129458375|NCT01908101|465975121|FG000|Overall Study|Withdrawal by Subject|1|||
129458376|NCT01908101|465975121|FG000|Overall Study|Incorrect Diagnosis|2|||
129458377|NCT01908101|465975121|FG000|Overall Study|Incorrect Starting Dose|1|||
129458378|NCT01908101|465975121|FG000|Overall Study|Did not complete the first cycle|4|||
129458379|NCT00477165|465975122|FG000|Overall Study|Adverse Event|7|||
129458380|NCT00477165|465975123|FG001|Overall Study|Adverse Event|2|||
129458381|NCT00105443|465975124|FG000|Double-Blind Treatment|Adverse Event|1|||
129458382|NCT00105443|465975125|FG001|Double-Blind Treatment|Adverse Event|0|||
129458383|NCT00105443|465975126|FG002|Double-Blind Treatment|Adverse Event|0|||
129458384|NCT00105443|465975127|FG003|Double-Blind Treatment|Adverse Event|0|||
129458385|NCT00105443|465975124|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
129458386|NCT00105443|465975125|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
129458387|NCT00105443|465975126|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
129458388|NCT00105443|465975127|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
129458389|NCT00105443|465975124|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
129458390|NCT00105443|465975125|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
129458391|NCT00105443|465975126|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
129458392|NCT00105443|465975127|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
129458393|NCT00105443|465975124|FG000|Double-Blind Treatment|Physician Decision|1|||
129458394|NCT00105443|465975125|FG001|Double-Blind Treatment|Physician Decision|0|||
129458395|NCT00105443|465975126|FG002|Double-Blind Treatment|Physician Decision|2|||
129458396|NCT00105443|465975127|FG003|Double-Blind Treatment|Physician Decision|0|||
129458397|NCT00105443|465975124|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
129458398|NCT00105443|465975125|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
129458399|NCT00105443|465975126|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
129458400|NCT00105443|465975127|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
129458401|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
129458402|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
129458403|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
129458404|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
129458405|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
129458406|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
129458407|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
129458408|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
129458409|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
129458410|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
129458411|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
129458412|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
129458413|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
129458414|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
129458415|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
129458416|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
129458417|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
129458418|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
129458419|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
129458420|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
129458421|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
129458422|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
129458423|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
129458424|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
129458425|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
129458426|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
129458427|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
129458428|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
129458429|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
129458430|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
129458431|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
129458432|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
129458433|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
129458434|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
129458435|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
129458436|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
129458437|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
129458438|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
129458439|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
129458440|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
129458441|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
129458442|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
129458443|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
129458444|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
129458445|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
129458446|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
129458447|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
129458448|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
129458449|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
129458450|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
129458451|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
129458452|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
129458453|NCT00105443|465975124|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
129458454|NCT00105443|465975125|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
129458455|NCT00105443|465975126|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
129458456|NCT00105443|465975127|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
129458457|NCT02135692|465975128|FG000|Overall Study|Adverse Event|3|||
129458458|NCT02135692|465975128|FG000|Overall Study|Lack of Efficacy|2|||
129458459|NCT02135692|465975128|FG000|Overall Study|Protocol Violation|2|||
129458460|NCT02135692|465975128|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
129458461|NCT02135692|465975128|FG000|Overall Study|Product commercially available|159|||
129458462|NCT02135692|465975128|FG000|Overall Study|Study closed/terminated|153|||
129458463|NCT02135692|465975128|FG000|Overall Study|Lost to Follow-up|4|||
129458464|NCT02135692|465975128|FG000|Overall Study|Withdrawal by Subject|15|||
129458465|NCT01157078|465975129|FG000|Overall Study|Withdrawal by Subject|12|||
129458466|NCT01157078|465975130|FG001|Overall Study|Withdrawal by Subject|14|||
129458467|NCT01157078|465975129|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129458468|NCT01157078|465975130|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129458469|NCT01157078|465975129|FG000|Overall Study|Adverse Event|6|||
129458470|NCT01157078|465975130|FG001|Overall Study|Adverse Event|6|||
129458471|NCT01157078|465975129|FG000|Overall Study|Severe non-compliance to protocol|2|||
129458472|NCT01157078|465975130|FG001|Overall Study|Severe non-compliance to protocol|4|||
129458473|NCT01157078|465975129|FG000|Overall Study|Condition under investigation worsened|0|||
129458474|NCT01157078|465975130|FG001|Overall Study|Condition under investigation worsened|1|||
129458475|NCT01157078|465975129|FG000|Overall Study|Lack of Efficacy|2|||
129458476|NCT01157078|465975130|FG001|Overall Study|Lack of Efficacy|0|||
129458477|NCT01157078|465975129|FG000|Overall Study|Study-specific withdrawal criteria|2|||
129458478|NCT01157078|465975130|FG001|Overall Study|Study-specific withdrawal criteria|2|||
129458479|NCT01157078|465975129|FG000|Overall Study|Lost to Follow-up|7|||
129458480|NCT01157078|465975130|FG001|Overall Study|Lost to Follow-up|5|||
129458481|NCT01157078|465975129|FG000|Overall Study|Other|2|||
129458482|NCT01157078|465975130|FG001|Overall Study|Other|4|||
129458483|NCT04429061|465975133|FG000|Overall Study|Lost to Follow-up|62|||
129458484|NCT04429061|465975134|FG001|Overall Study|Lost to Follow-up|87|||
129458485|NCT04429061|465975133|FG000|Overall Study|Withdrawal by Subject|3|||
129458486|NCT04429061|465975134|FG001|Overall Study|Withdrawal by Subject|4|||
129458487|NCT00879229|465975141|FG000|Overall Study|Study terminated by Sponsor|13|||
129458488|NCT00879229|465975142|FG001|Overall Study|Study terminated by Sponsor|12|||
129458489|NCT00879229|465975141|FG000|Overall Study|Death|4|||
129458490|NCT00879229|465975142|FG001|Overall Study|Death|2|||
129458491|NCT00879229|465975141|FG000|Overall Study|Adverse Event|2|||
129458492|NCT00879229|465975142|FG001|Overall Study|Adverse Event|0|||
129458493|NCT00879229|465975141|FG000|Overall Study|Withdrawal by Subject|1|||
129458494|NCT00879229|465975142|FG001|Overall Study|Withdrawal by Subject|0|||
129458495|NCT00879229|465975141|FG000|Overall Study|Clinical status did not improve|1|||
129458496|NCT00879229|465975142|FG001|Overall Study|Clinical status did not improve|0|||
129458497|NCT00879229|465975141|FG000|Overall Study|Other|1|||
129458498|NCT00879229|465975142|FG001|Overall Study|Other|0|||
129458499|NCT01097746|465975143|FG000|Overall Study|Adverse Event|4|||
129458500|NCT01097746|465975143|FG000|Overall Study|taken off study before any treatment given|1|||
129458501|NCT00631371|465975150|FG000|Overall Study|Lost to Follow-up|24|||
129458502|NCT00631371|465975151|FG001|Overall Study|Lost to Follow-up|19|||
129458503|NCT00631371|465975150|FG000|Overall Study|Other reason|5|||
129458504|NCT00631371|465975151|FG001|Overall Study|Other reason|12|||
129458505|NCT00631371|465975150|FG000|Overall Study|subject request|38|||
129458506|NCT00631371|465975151|FG001|Overall Study|subject request|45|||
129458507|NCT00631371|465975150|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
129458508|NCT00631371|465975151|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
129458509|NCT00631371|465975150|FG000|Overall Study|Death|263|||
129458510|NCT00631371|465975151|FG001|Overall Study|Death|239|||
129458511|NCT00390546|465975152|FG000|Overall Study|Renal impairment|1|||
129458512|NCT00390546|465975153|FG001|Overall Study|Renal impairment|0|||
129458513|NCT00390546|465975152|FG000|Overall Study|Physician Decision|5|||
129458514|NCT00390546|465975153|FG001|Overall Study|Physician Decision|5|||
129458515|NCT00812214|465975159|FG000|Overall Study|Lost to Follow-up|3|||
129458516|NCT00812214|465975160|FG001|Overall Study|Lost to Follow-up|1|||
129458517|NCT02145741|465975161|FG000|Overall Study|Progressive disease|3|||
129458518|NCT02145741|465975162|FG001|Overall Study|Progressive disease|6|||
129458519|NCT02145741|465975163|FG002|Overall Study|Progressive disease|6|||
129458520|NCT02145741|465975161|FG000|Overall Study|quality issue with the administered drug|3|||
129458521|NCT02145741|465975162|FG001|Overall Study|quality issue with the administered drug|0|||
129458522|NCT02145741|465975163|FG002|Overall Study|quality issue with the administered drug|0|||
129458523|NCT01192022|465975164|FG000|Overall Study|Withdrawal of Consent|3|||
129458524|NCT01192022|465975165|FG001|Overall Study|Withdrawal of Consent|1|||
129458525|NCT01192022|465975166|FG002|Overall Study|Withdrawal of Consent|0|||
129458526|NCT01192022|465975167|FG003|Overall Study|Withdrawal of Consent|0|||
129458527|NCT01192022|465975168|FG004|Overall Study|Withdrawal of Consent|0|||
129458528|NCT01192022|465975164|FG000|Overall Study|Lost to Follow-up|4|||
129458529|NCT01192022|465975165|FG001|Overall Study|Lost to Follow-up|2|||
129458530|NCT01192022|465975166|FG002|Overall Study|Lost to Follow-up|1|||
129458531|NCT01192022|465975167|FG003|Overall Study|Lost to Follow-up|1|||
129458532|NCT01192022|465975168|FG004|Overall Study|Lost to Follow-up|0|||
129458533|NCT01192022|465975164|FG000|Overall Study|Adverse Event|1|||
129458534|NCT01192022|465975165|FG001|Overall Study|Adverse Event|0|||
129458535|NCT01192022|465975166|FG002|Overall Study|Adverse Event|0|||
129458536|NCT01192022|465975167|FG003|Overall Study|Adverse Event|0|||
129458537|NCT01192022|465975168|FG004|Overall Study|Adverse Event|0|||
129458538|NCT01192022|465975164|FG000|Overall Study|Fatal Adverse Event|4|||
129458539|NCT01192022|465975165|FG001|Overall Study|Fatal Adverse Event|6|||
129458540|NCT01192022|465975166|FG002|Overall Study|Fatal Adverse Event|0|||
129458541|NCT01192022|465975167|FG003|Overall Study|Fatal Adverse Event|0|||
129458542|NCT01192022|465975168|FG004|Overall Study|Fatal Adverse Event|1|||
129458543|NCT01192022|465975164|FG000|Overall Study|Physician withdrew-patient hardship|1|||
129458544|NCT01192022|465975165|FG001|Overall Study|Physician withdrew-patient hardship|0|||
129458545|NCT01192022|465975166|FG002|Overall Study|Physician withdrew-patient hardship|0|||
129458546|NCT01192022|465975167|FG003|Overall Study|Physician withdrew-patient hardship|0|||
129458547|NCT01192022|465975168|FG004|Overall Study|Physician withdrew-patient hardship|0|||
129458548|NCT01192022|465975164|FG000|Overall Study|Patient too sick from chemotherapy|0|||
129458549|NCT01192022|465975165|FG001|Overall Study|Patient too sick from chemotherapy|1|||
129458550|NCT01192022|465975166|FG002|Overall Study|Patient too sick from chemotherapy|0|||
129458551|NCT01192022|465975167|FG003|Overall Study|Patient too sick from chemotherapy|0|||
129458552|NCT01192022|465975168|FG004|Overall Study|Patient too sick from chemotherapy|0|||
129458553|NCT01192022|465975164|FG000|Overall Study|Patient needed surgery|0|||
129458554|NCT01192022|465975165|FG001|Overall Study|Patient needed surgery|1|||
129458555|NCT01192022|465975166|FG002|Overall Study|Patient needed surgery|0|||
129458556|NCT01192022|465975167|FG003|Overall Study|Patient needed surgery|0|||
129458557|NCT01192022|465975168|FG004|Overall Study|Patient needed surgery|0|||
129458558|NCT01192022|465975164|FG000|Overall Study|Parents did not allow all follow up|0|||
129458559|NCT01192022|465975165|FG001|Overall Study|Parents did not allow all follow up|0|||
129458560|NCT01192022|465975166|FG002|Overall Study|Parents did not allow all follow up|0|||
129458561|NCT01192022|465975167|FG003|Overall Study|Parents did not allow all follow up|1|||
129458562|NCT01192022|465975168|FG004|Overall Study|Parents did not allow all follow up|0|||
129458563|NCT00129766|465975170|FG000|Overall Study|Death|3|||
129458564|NCT00129766|465975171|FG001|Overall Study|Death|8|||
129458565|NCT00129766|465975170|FG000|Overall Study|Withdrawal of consent|31|||
129458566|NCT00129766|465975171|FG001|Overall Study|Withdrawal of consent|30|||
129458567|NCT00129766|465975170|FG000|Overall Study|Lost to Follow-up|26|||
129458568|NCT00129766|465975171|FG001|Overall Study|Lost to Follow-up|21|||
129458569|NCT00781456|465975173|FG000|Overall Study|Adverse Event|3|||
129458570|NCT00781456|465975174|FG001|Overall Study|Adverse Event|3|||
129458571|NCT00781456|465975173|FG000|Overall Study|Withdrawal by Subject|3|||
129458572|NCT00781456|465975174|FG001|Overall Study|Withdrawal by Subject|5|||
129458573|NCT00781456|465975173|FG000|Overall Study|Protocol Violation|4|||
129458574|NCT00781456|465975174|FG001|Overall Study|Protocol Violation|1|||
129458575|NCT00781456|465975173|FG000|Overall Study|Noncompliance With Protocol|1|||
129458576|NCT00781456|465975174|FG001|Overall Study|Noncompliance With Protocol|1|||
129458577|NCT00781456|465975173|FG000|Overall Study|Lost to Follow-up|10|||
129458578|NCT00781456|465975174|FG001|Overall Study|Lost to Follow-up|5|||
129458579|NCT00781456|465975173|FG000|Overall Study|Other Reason, Unknown|0|||
129458580|NCT00781456|465975174|FG001|Overall Study|Other Reason, Unknown|1|||
129458581|NCT01594853|465975175|FG000|Overall Study|Withdrawal by Subject|1|||
129458582|NCT01594853|465975176|FG001|Overall Study|Withdrawal by Subject|1|||
129458583|NCT01594853|465975175|FG000|Overall Study|Lost to Follow-up|1|||
129458584|NCT01594853|465975176|FG001|Overall Study|Lost to Follow-up|1|||
129458585|NCT01594853|465975175|FG000|Overall Study|noncompliance with exercise|0|||
129458586|NCT01594853|465975176|FG001|Overall Study|noncompliance with exercise|1|||
129458587|NCT04091087|465975177|FG000|Overall Study|Not treated|1|||
129458588|NCT04091087|465975178|FG001|Overall Study|Not treated|0|||
129458589|NCT04091087|465975177|FG000|Overall Study|Adverse Event|4|||
129458590|NCT04091087|465975178|FG001|Overall Study|Adverse Event|4|||
129458591|NCT04091087|465975177|FG000|Overall Study|Protocol Violation|0|||
129458592|NCT04091087|465975178|FG001|Overall Study|Protocol Violation|1|||
129458593|NCT04091087|465975177|FG000|Overall Study|Withdrawal by Subject|5|||
129967712|NCT02706951|467847085|FG003|Period 1|Withdrawal by Subject|0|||
129458594|NCT04091087|465975178|FG001|Overall Study|Withdrawal by Subject|2|||
129458595|NCT05440539|465975179|FG000|Overall Study|Lost to Follow-up|4|||
129458596|NCT05440539|465975180|FG001|Overall Study|Lost to Follow-up|4|||
129458597|NCT05440539|465975179|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
129458598|NCT05440539|465975180|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
129458599|NCT03808077|465975181|FG000|Overall Study|Physician Decision|2|||
129458600|NCT03808077|465975182|FG001|Overall Study|Physician Decision|3|||
129458601|NCT03808077|465975181|FG000|Overall Study|Withdrawal by Subject|1|||
129458602|NCT03808077|465975182|FG001|Overall Study|Withdrawal by Subject|0|||
129458603|NCT03808077|465975181|FG000|Overall Study|Equipment Issues|2|||
129458604|NCT03808077|465975182|FG001|Overall Study|Equipment Issues|1|||
129458605|NCT04152161|465975183|FG000|Overall Study|Death|0|||
129458606|NCT04152161|465975184|FG001|Overall Study|Death|1|||
129458607|NCT04152161|465975183|FG000|Overall Study|Physician Decision|0|||
129458608|NCT04152161|465975184|FG001|Overall Study|Physician Decision|1|||
129458609|NCT04152161|465975183|FG000|Overall Study|Lost to Follow-up|9|||
129458610|NCT04152161|465975184|FG001|Overall Study|Lost to Follow-up|3|||
129458611|NCT04152161|465975183|FG000|Overall Study|Protocol Violation|1|||
129458612|NCT04152161|465975184|FG001|Overall Study|Protocol Violation|0|||
129458613|NCT04152161|465975183|FG000|Overall Study|Withdrawal by Subject|29|||
129458614|NCT04152161|465975184|FG001|Overall Study|Withdrawal by Subject|28|||
129458615|NCT04152161|465975183|FG000|Overall Study|Sponsor termination of study|750|||
129458616|NCT04152161|465975184|FG001|Overall Study|Sponsor termination of study|755|||
129458617|NCT04152161|465975183|FG000|Overall Study|Other|20|||
129458618|NCT04152161|465975184|FG001|Overall Study|Other|18|||
129458619|NCT03246958|465975185|FG000|Overall Study|Withdrawal by Subject|0|||
129458620|NCT03246958|465975186|FG001|Overall Study|Withdrawal by Subject|1|||
129458621|NCT03246958|465975187|FG002|Overall Study|Withdrawal by Subject|0|||
129458622|NCT03246958|465975188|FG003|Overall Study|Withdrawal by Subject|0|||
129458623|NCT03246958|465975189|FG004|Overall Study|Withdrawal by Subject|0|||
129458624|NCT03246958|465975190|FG005|Overall Study|Withdrawal by Subject|1|||
129458625|NCT03246958|465975191|FG006|Overall Study|Withdrawal by Subject|0|||
129458626|NCT03246958|465975185|FG000|Overall Study|Progression|13|||
129458627|NCT03246958|465975186|FG001|Overall Study|Progression|9|||
129458628|NCT03246958|465975187|FG002|Overall Study|Progression|3|||
129458629|NCT03246958|465975188|FG003|Overall Study|Progression|2|||
129458630|NCT03246958|465975189|FG004|Overall Study|Progression|1|||
129458631|NCT03246958|465975190|FG005|Overall Study|Progression|2|||
129458632|NCT03246958|465975191|FG006|Overall Study|Progression|1|||
129458633|NCT03246958|465975185|FG000|Overall Study|Adverse Event|2|||
129458634|NCT03246958|465975186|FG001|Overall Study|Adverse Event|2|||
129458635|NCT03246958|465975187|FG002|Overall Study|Adverse Event|0|||
129458636|NCT03246958|465975188|FG003|Overall Study|Adverse Event|1|||
129458637|NCT03246958|465975189|FG004|Overall Study|Adverse Event|1|||
129458638|NCT03246958|465975190|FG005|Overall Study|Adverse Event|0|||
129458639|NCT03246958|465975191|FG006|Overall Study|Adverse Event|2|||
129458640|NCT03246958|465975185|FG000|Overall Study|Death|0|||
129458641|NCT03246958|465975186|FG001|Overall Study|Death|1|||
129458642|NCT03246958|465975187|FG002|Overall Study|Death|0|||
129458643|NCT03246958|465975188|FG003|Overall Study|Death|0|||
129458644|NCT03246958|465975189|FG004|Overall Study|Death|0|||
129458645|NCT03246958|465975190|FG005|Overall Study|Death|0|||
129458646|NCT03246958|465975191|FG006|Overall Study|Death|0|||
129458647|NCT03246958|465975185|FG000|Overall Study|Physician Decision|0|||
129458648|NCT03246958|465975186|FG001|Overall Study|Physician Decision|0|||
129458649|NCT03246958|465975187|FG002|Overall Study|Physician Decision|0|||
129458650|NCT03246958|465975188|FG003|Overall Study|Physician Decision|1|||
129458651|NCT03246958|465975189|FG004|Overall Study|Physician Decision|0|||
129458652|NCT03246958|465975190|FG005|Overall Study|Physician Decision|0|||
129458653|NCT03246958|465975191|FG006|Overall Study|Physician Decision|0|||
129458654|NCT03246958|465975185|FG000|Overall Study|Never start treatment|1|||
129458655|NCT03246958|465975186|FG001|Overall Study|Never start treatment|0|||
129458656|NCT03246958|465975187|FG002|Overall Study|Never start treatment|0|||
129458657|NCT03246958|465975188|FG003|Overall Study|Never start treatment|0|||
129458658|NCT03246958|465975189|FG004|Overall Study|Never start treatment|0|||
129458659|NCT03246958|465975190|FG005|Overall Study|Never start treatment|0|||
129458660|NCT03246958|465975191|FG006|Overall Study|Never start treatment|0|||
129458661|NCT03246958|465975185|FG000|Overall Study|Over enrollment|0|||
129458662|NCT03246958|465975186|FG001|Overall Study|Over enrollment|2|||
129458663|NCT03246958|465975187|FG002|Overall Study|Over enrollment|0|||
129458664|NCT03246958|465975188|FG003|Overall Study|Over enrollment|0|||
129458665|NCT03246958|465975189|FG004|Overall Study|Over enrollment|0|||
129458666|NCT03246958|465975190|FG005|Overall Study|Over enrollment|0|||
129458667|NCT03246958|465975191|FG006|Overall Study|Over enrollment|0|||
129458668|NCT01379274|465975192|FG000|Overall Study|funding withdrawn|1|||
129458669|NCT03287219|465975193|FG000|Overall Study|Protocol Violation|0|||
129458670|NCT03287219|465975194|FG001|Overall Study|Protocol Violation|2|||
129458671|NCT00631020|465975195|FG000|Overall Study|Lost to Follow-up|7|||
129458672|NCT00631020|465975195|FG000|Overall Study|Incarcerated|1|||
129458673|NCT03221751|465975196|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
129967713|NCT02706951|467847086|FG004|Period 1|Withdrawal by Subject|0|||
129458674|NCT03221751|465975197|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
129458675|NCT03571646|465975198|FG000|Overall Study|Adverse Event|1|||
129458676|NCT03571646|465975199|FG001|Overall Study|Adverse Event|0|||
129458677|NCT03571646|465975198|FG000|Overall Study|Withdrawal by Subject|1|||
129458678|NCT03571646|465975199|FG001|Overall Study|Withdrawal by Subject|1|||
129458679|NCT03548935|465975200|FG000|Overall Study|Withdrawal by Subject|26|||
129458680|NCT03548935|465975201|FG001|Overall Study|Withdrawal by Subject|17|||
129458681|NCT03548935|465975200|FG000|Overall Study|Lost to Follow-up|39|||
129458682|NCT03548935|465975201|FG001|Overall Study|Lost to Follow-up|28|||
129458683|NCT03548935|465975200|FG000|Overall Study|Death|1|||
129458684|NCT03548935|465975201|FG001|Overall Study|Death|1|||
129458685|NCT04677959|465975202|FG000|Overall Study|Adverse Event|1|||
129458686|NCT04677959|465975203|FG001|Overall Study|Adverse Event|9|||
129458687|NCT04677959|465975202|FG000|Overall Study|Withdrawal by Subject|2|||
129458688|NCT04677959|465975203|FG001|Overall Study|Withdrawal by Subject|15|||
129458689|NCT04677959|465975202|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129458690|NCT04677959|465975203|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129458691|NCT04677959|465975202|FG000|Overall Study|Non-compliance with study drug|0|||
129458692|NCT04677959|465975203|FG001|Overall Study|Non-compliance with study drug|2|||
129458693|NCT04677959|465975202|FG000|Overall Study|Protocol deviation|0|||
129458694|NCT04677959|465975203|FG001|Overall Study|Protocol deviation|11|||
129458695|NCT04677959|465975202|FG000|Overall Study|Lost to Follow-up|9|||
129458696|NCT04677959|465975203|FG001|Overall Study|Lost to Follow-up|13|||
129458697|NCT04677959|465975202|FG000|Overall Study|Other than specified|0|||
129458698|NCT04677959|465975203|FG001|Overall Study|Other than specified|8|||
129458699|NCT00763815|465975204|FG000|Overall Study|Adverse Event|14|||
129458700|NCT00763815|465975205|FG001|Overall Study|Adverse Event|29|||
129458701|NCT00763815|465975204|FG000|Overall Study|Lack of Efficacy|10|||
129458702|NCT00763815|465975205|FG001|Overall Study|Lack of Efficacy|11|||
129458703|NCT00763815|465975204|FG000|Overall Study|Poor Compliance to Protocol|6|||
129458704|NCT00763815|465975205|FG001|Overall Study|Poor Compliance to Protocol|6|||
129458705|NCT00763815|465975204|FG000|Overall Study|Lost to Follow-up|2|||
129458706|NCT00763815|465975205|FG001|Overall Study|Lost to Follow-up|4|||
129458707|NCT00763815|465975204|FG000|Overall Study|Early Termination|1|||
129458708|NCT00763815|465975205|FG001|Overall Study|Early Termination|0|||
129458709|NCT00763815|465975204|FG000|Overall Study|Familial and Personal Reasons|9|||
129458710|NCT00763815|465975205|FG001|Overall Study|Familial and Personal Reasons|16|||
129458711|NCT00763815|465975204|FG000|Overall Study|Physician Decision|1|||
129458712|NCT00763815|465975205|FG001|Overall Study|Physician Decision|0|||
129458713|NCT00763815|465975204|FG000|Overall Study|Withdrawal by Subject|7|||
129458714|NCT00763815|465975205|FG001|Overall Study|Withdrawal by Subject|12|||
129458715|NCT00763815|465975204|FG000|Overall Study|Protocol Violation|2|||
129458716|NCT00763815|465975205|FG001|Overall Study|Protocol Violation|5|||
129458717|NCT00763815|465975204|FG000|Overall Study|Sponsor's Decision|0|||
129458718|NCT00763815|465975205|FG001|Overall Study|Sponsor's Decision|1|||
129458719|NCT01970995|465975206|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
129458720|NCT01970995|465975207|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
129458721|NCT01970995|465975208|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
129458722|NCT01970995|465975206|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
129458723|NCT01970995|465975207|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
129458724|NCT01970995|465975208|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
129458725|NCT01576549|465975209|FG000|Overall Study|Sponsor Decision|2|||
129458726|NCT00586495|465975210|FG000|Treatment Period|Adverse Event|11|||
129458727|NCT00586495|465975210|FG000|Treatment Period|Death|1|||
129458728|NCT00586495|465975210|FG000|Treatment Period|Protocol Violation|1|||
129458729|NCT00586495|465975210|FG000|Treatment Period|Withdrawal by Subject|1|||
129458730|NCT00586495|465975210|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
129458731|NCT00586495|465975210|FG000|Treatment Period|Switch to commercial drug|10|||
129458732|NCT00586495|465975210|FG000|Follow-up|Death|40|||
129458733|NCT00586495|465975210|FG000|Follow-up|Lost to Follow-up|1|||
129458734|NCT00586495|465975210|FG000|Follow-up|Withdrawal by Subject|4|||
129458735|NCT00586495|465975210|FG000|Follow-up|Protocol driven decision point|37|||
129458736|NCT00586495|465975210|FG000|Follow-up|Switch to commercial drug|10|||
129458737|NCT01265797|465975227|FG000|Run-in Month|Withdrawal by Subject|0|||
129458738|NCT01265797|465975228|FG001|Run-in Month|Withdrawal by Subject|4|||
129458739|NCT01265797|465975227|FG000|Run-in Month|1st seizure during run-in month|0|||
129458740|NCT01265797|465975228|FG001|Run-in Month|1st seizure during run-in month|1|||
129458741|NCT01265797|465975227|FG000|Blinded Month|Lack of Efficacy|5|||
129458742|NCT01265797|465975228|FG001|Blinded Month|Lack of Efficacy|0|||
129458743|NCT01265797|465975227|FG000|Blinded Month|Lost to Follow-up|1|||
129458744|NCT01265797|465975228|FG001|Blinded Month|Lost to Follow-up|0|||
129458745|NCT01265797|465975227|FG000|Blinded Month|Protocol Violation|2|||
129458746|NCT01265797|465975228|FG001|Blinded Month|Protocol Violation|1|||
129458747|NCT01265797|465975227|FG000|Blinded Month|Adverse Event|2|||
129458748|NCT01265797|465975228|FG001|Blinded Month|Adverse Event|0|||
129458749|NCT01265797|465975227|FG000|Blinded Month|Diary data incomplete|0|||
129458750|NCT01265797|465975228|FG001|Blinded Month|Diary data incomplete|1|||
129458751|NCT01265797|465975227|FG000|Open Label Month|Lost to Follow-up|0|||
129458752|NCT01265797|465975228|FG001|Open Label Month|Lost to Follow-up|1|||
129458753|NCT02813694|465975229|FG000|Overall Study|Physician Decision|0|||
129458754|NCT02813694|465975230|FG001|Overall Study|Physician Decision|1|||
129458755|NCT02813694|465975229|FG000|Overall Study|Withdrawal by Subject|10|||
129458756|NCT02813694|465975230|FG001|Overall Study|Withdrawal by Subject|9|||
129458757|NCT02813694|465975229|FG000|Overall Study|Lost to Follow-up|1|||
129458758|NCT02813694|465975230|FG001|Overall Study|Lost to Follow-up|1|||
129458759|NCT02813694|465975229|FG000|Overall Study|Death|3|||
129458760|NCT02813694|465975230|FG001|Overall Study|Death|3|||
129458761|NCT02813694|465975229|FG000|Overall Study|Randomized- did not receive study drug|2|||
129458762|NCT02813694|465975230|FG001|Overall Study|Randomized- did not receive study drug|0|||
129458763|NCT02813694|465975229|FG000|Overall Study|Patient hospitalized|1|||
129458764|NCT02813694|465975230|FG001|Overall Study|Patient hospitalized|0|||
129458765|NCT00606320|465975233|FG000|Overall Study|Adverse Event|3|||
129458766|NCT00606320|465975233|FG000|Overall Study|Lack of Efficacy|5|||
129458767|NCT00606320|465975233|FG000|Overall Study|Physician Decision|7|||
129458768|NCT00606320|465975233|FG000|Overall Study|Protocol Violation|8|||
129458769|NCT00606320|465975233|FG000|Overall Study|Withdrawal by Subject|10|||
129458770|NCT00606320|465975233|FG000|Overall Study|Progression to depressive phase|4|||
129458771|NCT02595723|465975234|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
129458772|NCT02595723|465975235|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
129458773|NCT02595723|465975236|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
129458774|NCT02595723|465975234|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
129458775|NCT02595723|465975235|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
129458776|NCT02595723|465975236|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
129458777|NCT04839380|465975237|FG000|Overall Study|Withdrawal by Subject|2|||
129458778|NCT04839380|465975237|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
129458779|NCT01347554|465975238|FG000|Overall Study|Lack of Efficacy|7|||
129458780|NCT01347554|465975239|FG001|Overall Study|Lack of Efficacy|11|||
129458781|NCT00004259|465975241|FG000|Overall Study|Protocol Violation|1|||
129458782|NCT00004259|465975242|FG001|Overall Study|Protocol Violation|2|||
129458783|NCT00004259|465975243|FG002|Overall Study|Protocol Violation|0|||
129458784|NCT00004259|465975244|FG003|Overall Study|Protocol Violation|0|||
129458785|NCT00004259|465975241|FG000|Overall Study|Withdrawal by Subject|0|||
129458786|NCT00004259|465975242|FG001|Overall Study|Withdrawal by Subject|2|||
129458787|NCT00004259|465975243|FG002|Overall Study|Withdrawal by Subject|0|||
129458788|NCT00004259|465975244|FG003|Overall Study|Withdrawal by Subject|0|||
129458789|NCT00996944|465975245|FG000|Double-blind Treatment Period|Adverse Event|2|||
129458790|NCT00996944|465975246|FG001|Double-blind Treatment Period|Adverse Event|1|||
129458791|NCT00996944|465975245|FG000|Double-blind Treatment Period|Protocol Violation|1|||
129458792|NCT00996944|465975246|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129458793|NCT00996944|465975245|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
129458794|NCT00996944|465975246|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
129458795|NCT00996944|465975245|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129458796|NCT00996944|465975246|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
129458797|NCT00996944|465975245|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
129458798|NCT00996944|465975246|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
129458799|NCT00769184|465975247|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
129458800|NCT00769184|465975248|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
129458801|NCT00769184|465975247|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
129458802|NCT00769184|465975248|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
129458803|NCT00769184|465975247|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
129458804|NCT00769184|465975248|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
129458805|NCT00385255|465975249|FG000|Overall Study|Serious Adverse Event|1|||
129458806|NCT00385255|465975250|FG001|Overall Study|Serious Adverse Event|2|||
129458807|NCT00385255|465975249|FG000|Overall Study|Protocol Violation|0|||
129458808|NCT00385255|465975250|FG001|Overall Study|Protocol Violation|4|||
129458809|NCT00385255|465975249|FG000|Overall Study|Withdrawal by Subject|0|||
129458810|NCT00385255|465975250|FG001|Overall Study|Withdrawal by Subject|8|||
129458811|NCT00385255|465975249|FG000|Overall Study|Migrated/moved from study area|0|||
129458812|NCT00385255|465975250|FG001|Overall Study|Migrated/moved from study area|1|||
129458813|NCT00385255|465975249|FG000|Overall Study|Lost to Follow-up|20|||
129458814|NCT00385255|465975250|FG001|Overall Study|Lost to Follow-up|58|||
129458815|NCT02443883|465975251|FG000|Overall Study|Adverse Event|0|||
129458816|NCT02443883|465975252|FG001|Overall Study|Adverse Event|1|||
129458817|NCT02443883|465975253|FG002|Overall Study|Adverse Event|0|||
129458818|NCT02443883|465975254|FG003|Overall Study|Adverse Event|0|||
129458819|NCT02443883|465975251|FG000|Overall Study|Lost to Follow-up|3|||
129458820|NCT02443883|465975252|FG001|Overall Study|Lost to Follow-up|2|||
129458821|NCT02443883|465975253|FG002|Overall Study|Lost to Follow-up|1|||
129458822|NCT02443883|465975254|FG003|Overall Study|Lost to Follow-up|0|||
129458823|NCT02443883|465975251|FG000|Overall Study|Physician Decision|1|||
129458824|NCT02443883|465975252|FG001|Overall Study|Physician Decision|1|||
129458825|NCT02443883|465975253|FG002|Overall Study|Physician Decision|0|||
129458826|NCT02443883|465975254|FG003|Overall Study|Physician Decision|3|||
129458827|NCT02443883|465975251|FG000|Overall Study|Withdrawal by Subject|1|||
129458828|NCT02443883|465975252|FG001|Overall Study|Withdrawal by Subject|0|||
129458829|NCT02443883|465975253|FG002|Overall Study|Withdrawal by Subject|0|||
129458830|NCT02443883|465975254|FG003|Overall Study|Withdrawal by Subject|2|||
129458831|NCT02443883|465975251|FG000|Overall Study|Randomized, but never treated|1|||
129458832|NCT02443883|465975252|FG001|Overall Study|Randomized, but never treated|0|||
129458833|NCT02443883|465975253|FG002|Overall Study|Randomized, but never treated|0|||
129458834|NCT02443883|465975254|FG003|Overall Study|Randomized, but never treated|0|||
129458835|NCT00205855|465975270|FG000|Overall Study|Only received temporary implants|16|||
129458836|NCT00205855|465975270|FG000|Overall Study|Withdrawal by Subject|5|||
129458837|NCT00506883|465975271|FG000|Overall Study|Lost to Follow-up|1|||
129458838|NCT00506883|465975272|FG001|Overall Study|Lost to Follow-up|1|||
129458839|NCT00506883|465975273|FG002|Overall Study|Lost to Follow-up|1|||
129458840|NCT00506883|465975271|FG000|Overall Study|Withdrawal by Subject|1|||
129458841|NCT00506883|465975272|FG001|Overall Study|Withdrawal by Subject|0|||
129458842|NCT00506883|465975273|FG002|Overall Study|Withdrawal by Subject|1|||
129458843|NCT00506883|465975271|FG000|Overall Study|Lack of Efficacy|0|||
129458844|NCT00506883|465975272|FG001|Overall Study|Lack of Efficacy|1|||
129458845|NCT00506883|465975273|FG002|Overall Study|Lack of Efficacy|1|||
129458846|NCT00506883|465975271|FG000|Overall Study|Other|5|||
129458847|NCT00506883|465975272|FG001|Overall Study|Other|1|||
129458848|NCT00506883|465975273|FG002|Overall Study|Other|1|||
129458849|NCT01445951|465975274|FG000|Overall Study|Adverse Event|16|||
129458850|NCT01445951|465975275|FG001|Overall Study|Adverse Event|9|||
129458851|NCT01445951|465975276|FG002|Overall Study|Adverse Event|0|||
129458852|NCT01445951|465975274|FG000|Overall Study|Protocol Violation|2|||
129458853|NCT01445951|465975275|FG001|Overall Study|Protocol Violation|2|||
129458854|NCT01445951|465975276|FG002|Overall Study|Protocol Violation|2|||
129458855|NCT01445951|465975274|FG000|Overall Study|Withdrawal by Subject|21|||
129458856|NCT01445951|465975275|FG001|Overall Study|Withdrawal by Subject|16|||
129458857|NCT01445951|465975276|FG002|Overall Study|Withdrawal by Subject|8|||
129458858|NCT01445951|465975274|FG000|Overall Study|Physician Decision|3|||
129458859|NCT01445951|465975275|FG001|Overall Study|Physician Decision|1|||
129458860|NCT01445951|465975276|FG002|Overall Study|Physician Decision|0|||
129458861|NCT01445951|465975274|FG000|Overall Study|Lost to Follow-up|1|||
129458862|NCT01445951|465975275|FG001|Overall Study|Lost to Follow-up|2|||
129458863|NCT01445951|465975276|FG002|Overall Study|Lost to Follow-up|4|||
129458864|NCT01445951|465975274|FG000|Overall Study|Pregnancy|0|||
129458865|NCT01445951|465975275|FG001|Overall Study|Pregnancy|1|||
129458866|NCT01445951|465975276|FG002|Overall Study|Pregnancy|4|||
129458867|NCT01445951|465975274|FG000|Overall Study|Death|0|||
129458868|NCT01445951|465975275|FG001|Overall Study|Death|0|||
129458869|NCT01445951|465975276|FG002|Overall Study|Death|1|||
129458870|NCT01445951|465975274|FG000|Overall Study|Non-compliance with study drug|1|||
129458871|NCT01445951|465975275|FG001|Overall Study|Non-compliance with study drug|2|||
129458872|NCT01445951|465975276|FG002|Overall Study|Non-compliance with study drug|0|||
129458873|NCT01445951|465975274|FG000|Overall Study|Non-compliance with protocol|0|||
129458874|NCT01445951|465975275|FG001|Overall Study|Non-compliance with protocol|1|||
129458875|NCT01445951|465975276|FG002|Overall Study|Non-compliance with protocol|0|||
129458876|NCT01445951|465975274|FG000|Overall Study|Sponsor decision - subject travel|0|||
129458877|NCT01445951|465975275|FG001|Overall Study|Sponsor decision - subject travel|1|||
129458878|NCT01445951|465975276|FG002|Overall Study|Sponsor decision - subject travel|0|||
129458879|NCT01445951|465975274|FG000|Overall Study|Cough|0|||
129458880|NCT01445951|465975275|FG001|Overall Study|Cough|1|||
129458881|NCT01445951|465975276|FG002|Overall Study|Cough|0|||
129458882|NCT03921424|465975278|FG000|Overall Study|Lost to Follow-up|0|||
129458883|NCT03921424|465975279|FG001|Overall Study|Lost to Follow-up|1|||
129458884|NCT03921424|465975278|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
129458885|NCT03921424|465975279|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
129458886|NCT04649255|465977019|FG000|Overall Study|Death|9|||
129458887|NCT04649255|465977019|FG000|Overall Study|Withdrawal by Subject|1|||
129458888|NCT04129528|465977020|FG000|Overall Study|Adverse Event|1|||
129458889|NCT04129528|465977021|FG001|Overall Study|Adverse Event|0|||
129458890|NCT04129528|465977020|FG000|Overall Study|Physician Decision|1|||
129458891|NCT04129528|465977021|FG001|Overall Study|Physician Decision|1|||
129458892|NCT04129528|465977020|FG000|Overall Study|Withdrawal by Subject|1|||
129458893|NCT04129528|465977021|FG001|Overall Study|Withdrawal by Subject|1|||
129458894|NCT01964352|465977022|FG000|Overall Study|Adverse Event|13|||
129458895|NCT01964352|465977023|FG001|Overall Study|Adverse Event|3|||
129458896|NCT01964352|465977024|FG002|Overall Study|Adverse Event|4|||
129458897|NCT01964352|465977025|FG003|Overall Study|Adverse Event|3|||
129458898|NCT01964352|465977022|FG000|Overall Study|Lack of Efficacy|6|||
129458899|NCT01964352|465977023|FG001|Overall Study|Lack of Efficacy|0|||
129458900|NCT01964352|465977024|FG002|Overall Study|Lack of Efficacy|0|||
129458901|NCT01964352|465977025|FG003|Overall Study|Lack of Efficacy|0|||
129458902|NCT01964352|465977022|FG000|Overall Study|Protocol Violation|2|||
129458903|NCT01964352|465977023|FG001|Overall Study|Protocol Violation|4|||
129458904|NCT01964352|465977024|FG002|Overall Study|Protocol Violation|0|||
129458905|NCT01964352|465977025|FG003|Overall Study|Protocol Violation|2|||
129458906|NCT01964352|465977022|FG000|Overall Study|Lost to Follow-up|1|||
129458907|NCT01964352|465977023|FG001|Overall Study|Lost to Follow-up|0|||
129458908|NCT01964352|465977024|FG002|Overall Study|Lost to Follow-up|0|||
129458909|NCT01964352|465977025|FG003|Overall Study|Lost to Follow-up|1|||
129458910|NCT01964352|465977022|FG000|Overall Study|Withdrawal by Subject|4|||
129458911|NCT01964352|465977023|FG001|Overall Study|Withdrawal by Subject|2|||
129458912|NCT01964352|465977024|FG002|Overall Study|Withdrawal by Subject|1|||
129458913|NCT01964352|465977025|FG003|Overall Study|Withdrawal by Subject|0|||
129458914|NCT01964352|465977022|FG000|Overall Study|Other than stated above|0|||
129458915|NCT01964352|465977023|FG001|Overall Study|Other than stated above|2|||
129458916|NCT01964352|465977024|FG002|Overall Study|Other than stated above|1|||
129458917|NCT01964352|465977025|FG003|Overall Study|Other than stated above|2|||
129458918|NCT00513409|465977032|FG000|Overall Study|Adverse Event|0|||
129458919|NCT00513409|465977033|FG001|Overall Study|Adverse Event|1|||
129458920|NCT00513409|465977032|FG000|Overall Study|Withdrawal by Subject|0|||
129458921|NCT00513409|465977033|FG001|Overall Study|Withdrawal by Subject|2|||
129458922|NCT00513409|465977032|FG000|Overall Study|Lost to Follow-up|0|||
129458923|NCT00513409|465977033|FG001|Overall Study|Lost to Follow-up|1|||
129458924|NCT00513409|465977032|FG000|Overall Study|Physician Decision|1|||
129458925|NCT00513409|465977033|FG001|Overall Study|Physician Decision|0|||
129458926|NCT00513409|465977032|FG000|Overall Study|Visit 3 not done|1|||
129458927|NCT00513409|465977033|FG001|Overall Study|Visit 3 not done|2|||
129458928|NCT03189446|465977035|FG000|Overall Study|Adverse Event|2|||
129458929|NCT03189446|465977035|FG000|Overall Study|Withdrawal by Subject|2|||
129458930|NCT03189446|465977035|FG000|Overall Study|Physician Decision|1|||
129458931|NCT05634577|465977036|FG000|Overall Study|Lost to Follow-up|1|||
129458932|NCT05634577|465977036|FG000|Overall Study|Withdrawal by Subject|1|||
129458933|NCT04839978|465977037|FG000|Overall Study|Lost to Follow-up|135|||
129458934|NCT04839978|465977038|FG001|Overall Study|Lost to Follow-up|147|||
129458935|NCT03865706|465977039|FG000|Overall Study|Death|0|||
129458936|NCT03865706|465977040|FG001|Overall Study|Death|3|||
129458937|NCT03865706|465977041|FG002|Overall Study|Death|1|||
129458938|NCT04677712|465977043|FG000|Overall Study|Lost to Follow-up|0|||
129458939|NCT04677712|465977044|FG001|Overall Study|Lost to Follow-up|1|||
129458940|NCT04677712|465977045|FG002|Overall Study|Lost to Follow-up|0|||
129458941|NCT04677712|465977046|FG003|Overall Study|Lost to Follow-up|0|||
129458942|NCT04677712|465977047|FG004|Overall Study|Lost to Follow-up|0|||
129458943|NCT04677712|465977048|FG005|Overall Study|Lost to Follow-up|0|||
129458944|NCT00711100|465977049|FG000|Overall Study|Lack of Efficacy|5|||
129458945|NCT00711100|465977049|FG000|Overall Study|Withdrawal by Subject|8|||
129458946|NCT00783094|465977050|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
129458947|NCT00783094|465977051|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
129458948|NCT00783094|465977052|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
129458949|NCT00783094|465977050|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
129458950|NCT00783094|465977051|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
129458951|NCT00783094|465977052|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
129458952|NCT00783094|465977050|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
129458953|NCT00783094|465977051|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
129458954|NCT00783094|465977052|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
129458955|NCT00783094|465977050|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
129458956|NCT00783094|465977051|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
129458957|NCT00783094|465977052|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
129458958|NCT00783094|465977050|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
129458959|NCT00783094|465977051|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
129458960|NCT00783094|465977052|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
129458961|NCT00783094|465977050|FG000|Open-Label Extension Period|Adverse Event|12|||
129458962|NCT00783094|465977051|FG001|Open-Label Extension Period|Adverse Event|7|||
129458963|NCT00783094|465977052|FG002|Open-Label Extension Period|Adverse Event|16|||
129458964|NCT00783094|465977050|FG000|Open-Label Extension Period|Death|0|||
129458965|NCT00783094|465977051|FG001|Open-Label Extension Period|Death|0|||
129458966|NCT00783094|465977052|FG002|Open-Label Extension Period|Death|1|||
129458967|NCT00783094|465977050|FG000|Open-Label Extension Period|Protocol Violation|4|||
129458968|NCT00783094|465977051|FG001|Open-Label Extension Period|Protocol Violation|5|||
129458969|NCT00783094|465977052|FG002|Open-Label Extension Period|Protocol Violation|7|||
129458970|NCT00783094|465977050|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
129458971|NCT00783094|465977051|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
129967714|NCT02706951|467847082|FG000|Period 1|Lost to Follow-up|0|||
129458972|NCT00783094|465977052|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
129458973|NCT00783094|465977050|FG000|Open-Label Extension Period|Physician Decision|4|||
129458974|NCT00783094|465977051|FG001|Open-Label Extension Period|Physician Decision|2|||
129458975|NCT00783094|465977052|FG002|Open-Label Extension Period|Physician Decision|3|||
129458976|NCT00783094|465977050|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
129458977|NCT00783094|465977051|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
129458978|NCT00783094|465977052|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
129967715|NCT02706951|467847083|FG001|Period 1|Lost to Follow-up|4|||
129967716|NCT02706951|467847084|FG002|Period 1|Lost to Follow-up|1|||
129967717|NCT02706951|467847085|FG003|Period 1|Lost to Follow-up|0|||
129967718|NCT02706951|467847086|FG004|Period 1|Lost to Follow-up|0|||
129967719|NCT02706951|467847082|FG000|Period 1|Other|2|||
129967720|NCT02706951|467847083|FG001|Period 1|Other|1|||
129967721|NCT02706951|467847084|FG002|Period 1|Other|0|||
129967722|NCT02706951|467847085|FG003|Period 1|Other|0|||
129967723|NCT02706951|467847086|FG004|Period 1|Other|0|||
129967724|NCT02706951|467847082|FG000|Period 2|Adverse Event|0|||
129967725|NCT02706951|467847083|FG001|Period 2|Adverse Event|0|||
129967726|NCT02706951|467847084|FG002|Period 2|Adverse Event|0|||
129967727|NCT02706951|467847085|FG003|Period 2|Adverse Event|25|||
129967728|NCT02706951|467847086|FG004|Period 2|Adverse Event|34|||
129967729|NCT02706951|467847082|FG000|Period 2|Withdrawal by Subject|0|||
129967730|NCT02706951|467847083|FG001|Period 2|Withdrawal by Subject|0|||
129967731|NCT02706951|467847084|FG002|Period 2|Withdrawal by Subject|0|||
129967732|NCT02706951|467847085|FG003|Period 2|Withdrawal by Subject|38|||
129967733|NCT02706951|467847086|FG004|Period 2|Withdrawal by Subject|44|||
129967734|NCT02706951|467847082|FG000|Period 2|Lost to Follow-up|0|||
129967735|NCT02706951|467847083|FG001|Period 2|Lost to Follow-up|0|||
129967736|NCT02706951|467847084|FG002|Period 2|Lost to Follow-up|0|||
129967737|NCT02706951|467847085|FG003|Period 2|Lost to Follow-up|17|||
129967738|NCT02706951|467847086|FG004|Period 2|Lost to Follow-up|9|||
129967739|NCT02706951|467847082|FG000|Period 2|COVID-19 Related|0|||
129967740|NCT02706951|467847083|FG001|Period 2|COVID-19 Related|0|||
129967741|NCT02706951|467847084|FG002|Period 2|COVID-19 Related|0|||
129967742|NCT02706951|467847085|FG003|Period 2|COVID-19 Related|1|||
129967743|NCT02706951|467847086|FG004|Period 2|COVID-19 Related|2|||
129458979|NCT02513329|465977053|FG000|Overall Study|Lost to Follow-up|5|||
129458980|NCT02513329|465977054|FG001|Overall Study|Lost to Follow-up|2|||
129458981|NCT01294670|465977055|FG000|Overall Study|Not treated|1|||
129458982|NCT01294670|465977056|FG001|Overall Study|Not treated|0|||
129458983|NCT01294670|465977057|FG002|Overall Study|Not treated|0|||
129458984|NCT01294670|465977058|FG003|Overall Study|Not treated|0|||
129458985|NCT01294670|465977059|FG004|Overall Study|Not treated|0|||
129458986|NCT03703102|465977061|FG000|Overall Study|Adverse Event|4|||
129458987|NCT03703102|465977062|FG001|Overall Study|Adverse Event|3|||
129458988|NCT03703102|465977063|FG002|Overall Study|Adverse Event|7|||
129458989|NCT03703102|465977064|FG003|Overall Study|Adverse Event|3|||
129458990|NCT03703102|465977065|FG004|Overall Study|Adverse Event|13|||
129458991|NCT03703102|465977061|FG000|Overall Study|Lack of Efficacy|4|||
129458992|NCT03703102|465977062|FG001|Overall Study|Lack of Efficacy|0|||
129458993|NCT03703102|465977063|FG002|Overall Study|Lack of Efficacy|1|||
129458994|NCT03703102|465977064|FG003|Overall Study|Lack of Efficacy|4|||
129458995|NCT03703102|465977065|FG004|Overall Study|Lack of Efficacy|1|||
129458996|NCT03703102|465977061|FG000|Overall Study|Lost to Follow-up|0|||
129458997|NCT03703102|465977062|FG001|Overall Study|Lost to Follow-up|0|||
129458998|NCT03703102|465977063|FG002|Overall Study|Lost to Follow-up|1|||
129458999|NCT03703102|465977064|FG003|Overall Study|Lost to Follow-up|2|||
129459000|NCT03703102|465977065|FG004|Overall Study|Lost to Follow-up|2|||
129459001|NCT03703102|465977061|FG000|Overall Study|Physician Decision|2|||
129459002|NCT03703102|465977062|FG001|Overall Study|Physician Decision|2|||
129459003|NCT03703102|465977063|FG002|Overall Study|Physician Decision|2|||
129459004|NCT03703102|465977064|FG003|Overall Study|Physician Decision|2|||
129459005|NCT03703102|465977065|FG004|Overall Study|Physician Decision|4|||
129459006|NCT03703102|465977061|FG000|Overall Study|Withdrawal by Subject|7|||
129459007|NCT03703102|465977062|FG001|Overall Study|Withdrawal by Subject|5|||
129967744|NCT02706951|467847082|FG000|Period 2|Other|0|||
129967745|NCT02706951|467847083|FG001|Period 2|Other|0|||
129967746|NCT02706951|467847084|FG002|Period 2|Other|0|||
129967747|NCT02706951|467847085|FG003|Period 2|Other|37|||
129967748|NCT02706951|467847086|FG004|Period 2|Other|31|||
129967749|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
129967750|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
129967751|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
129459008|NCT03703102|465977063|FG002|Overall Study|Withdrawal by Subject|5|||
129459009|NCT03703102|465977064|FG003|Overall Study|Withdrawal by Subject|5|||
129459010|NCT03703102|465977065|FG004|Overall Study|Withdrawal by Subject|9|||
129459011|NCT03703102|465977061|FG000|Overall Study|Ineligibility|0|||
129459012|NCT03703102|465977062|FG001|Overall Study|Ineligibility|0|||
129459013|NCT03703102|465977063|FG002|Overall Study|Ineligibility|1|||
129459014|NCT03703102|465977064|FG003|Overall Study|Ineligibility|0|||
129459015|NCT03703102|465977065|FG004|Overall Study|Ineligibility|0|||
129967752|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
129967753|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
129967754|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
129967755|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
129967756|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
129459016|NCT03703102|465977061|FG000|Overall Study|Protocol Deviation|4|||
129459017|NCT03703102|465977062|FG001|Overall Study|Protocol Deviation|4|||
129459018|NCT03703102|465977063|FG002|Overall Study|Protocol Deviation|3|||
129459019|NCT03703102|465977064|FG003|Overall Study|Protocol Deviation|0|||
129459020|NCT03703102|465977065|FG004|Overall Study|Protocol Deviation|0|||
129459021|NCT03703102|465977061|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129459022|NCT03703102|465977062|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129459023|NCT03703102|465977063|FG002|Overall Study|Non-Compliance with Study Drug|2|||
129459024|NCT03703102|465977064|FG003|Overall Study|Non-Compliance with Study Drug|1|||
129459025|NCT03703102|465977065|FG004|Overall Study|Non-Compliance with Study Drug|4|||
129459026|NCT00876187|465977066|FG000|Overall Study|Adverse Event|14|||
129459027|NCT00876187|465977067|FG001|Overall Study|Adverse Event|12|||
129459028|NCT00876187|465977068|FG002|Overall Study|Adverse Event|19|||
129459029|NCT00876187|465977069|FG003|Overall Study|Adverse Event|29|||
129459030|NCT00876187|465977070|FG004|Overall Study|Adverse Event|10|||
129459031|NCT00876187|465977066|FG000|Overall Study|Lack of Efficacy|59|||
129459032|NCT00876187|465977067|FG001|Overall Study|Lack of Efficacy|34|||
129459033|NCT00876187|465977068|FG002|Overall Study|Lack of Efficacy|45|||
129459034|NCT00876187|465977069|FG003|Overall Study|Lack of Efficacy|34|||
129459035|NCT00876187|465977070|FG004|Overall Study|Lack of Efficacy|59|||
129459036|NCT00876187|465977066|FG000|Overall Study|Lost to Follow-up|9|||
129459037|NCT00876187|465977067|FG001|Overall Study|Lost to Follow-up|10|||
129459038|NCT00876187|465977068|FG002|Overall Study|Lost to Follow-up|8|||
129459039|NCT00876187|465977069|FG003|Overall Study|Lost to Follow-up|8|||
129459040|NCT00876187|465977070|FG004|Overall Study|Lost to Follow-up|11|||
129459041|NCT00876187|465977066|FG000|Overall Study|Protocol Violation|6|||
129459042|NCT00876187|465977067|FG001|Overall Study|Protocol Violation|7|||
129459043|NCT00876187|465977068|FG002|Overall Study|Protocol Violation|7|||
129459044|NCT00876187|465977069|FG003|Overall Study|Protocol Violation|6|||
129459045|NCT00876187|465977070|FG004|Overall Study|Protocol Violation|3|||
129459046|NCT00876187|465977066|FG000|Overall Study|Withdrawal by Subject|16|||
129459047|NCT00876187|465977067|FG001|Overall Study|Withdrawal by Subject|26|||
129459048|NCT00876187|465977068|FG002|Overall Study|Withdrawal by Subject|32|||
129459049|NCT00876187|465977069|FG003|Overall Study|Withdrawal by Subject|38|||
129459050|NCT00876187|465977070|FG004|Overall Study|Withdrawal by Subject|37|||
129459051|NCT00876187|465977066|FG000|Overall Study|Entered extension study|101|||
129459052|NCT00876187|465977067|FG001|Overall Study|Entered extension study|120|||
129459053|NCT00876187|465977068|FG002|Overall Study|Entered extension study|156|||
129459054|NCT00876187|465977069|FG003|Overall Study|Entered extension study|151|||
129459055|NCT00876187|465977070|FG004|Overall Study|Entered extension study|144|||
129459056|NCT00876187|465977066|FG000|Overall Study|Randomized but not treated|3|||
129459057|NCT00876187|465977067|FG001|Overall Study|Randomized but not treated|1|||
129459058|NCT00876187|465977068|FG002|Overall Study|Randomized but not treated|3|||
129459059|NCT00876187|465977069|FG003|Overall Study|Randomized but not treated|2|||
129459060|NCT00876187|465977070|FG004|Overall Study|Randomized but not treated|3|||
129459061|NCT00876187|465977066|FG000|Overall Study|Other|2|||
129459062|NCT00876187|465977067|FG001|Overall Study|Other|5|||
129459063|NCT00876187|465977068|FG002|Overall Study|Other|9|||
129459064|NCT00876187|465977069|FG003|Overall Study|Other|7|||
129459065|NCT00876187|465977070|FG004|Overall Study|Other|4|||
129459066|NCT01650636|465977071|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
129459067|NCT01650636|465977072|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
129459068|NCT01650636|465977071|FG000|Washout up to 5 Months|Physician Decision|2|||
129459069|NCT01650636|465977072|FG001|Washout up to 5 Months|Physician Decision|2|||
129459070|NCT01650636|465977071|FG000|Washout up to 5 Months|Death|1|||
129459071|NCT01650636|465977072|FG001|Washout up to 5 Months|Death|0|||
129459072|NCT01650636|465977071|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
129459073|NCT01650636|465977072|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
129459074|NCT01650636|465977071|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
129459075|NCT01650636|465977072|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
129459076|NCT01650636|465977071|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
129459077|NCT01650636|465977072|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
129459078|NCT03363321|465977074|FG000|Overall Study|Withdrawal by Subject|0|||
129459079|NCT03363321|465977075|FG001|Overall Study|Withdrawal by Subject|1|||
129459080|NCT03363321|465977076|FG002|Overall Study|Withdrawal by Subject|0|||
129459081|NCT03363321|465977077|FG003|Overall Study|Withdrawal by Subject|1|||
129459082|NCT03363321|465977078|FG004|Overall Study|Withdrawal by Subject|0|||
129459083|NCT01577186|465977079|FG000|Overall Study|Adverse Event|23|||
129459084|NCT01577186|465977079|FG000|Overall Study|Death|1|||
129459085|NCT01577186|465977079|FG000|Overall Study|Lost to Follow-up|28|||
129459086|NCT01577186|465977079|FG000|Overall Study|Withdrawal by Subject|35|||
129459087|NCT01577186|465977079|FG000|Overall Study|Insufficient Response|18|||
129459088|NCT01577186|465977079|FG000|Overall Study|Ineligible to Continue|15|||
129459089|NCT01577186|465977079|FG000|Overall Study|Non-Compliant|8|||
129459090|NCT01577186|465977079|FG000|Overall Study|Other|2|||
129459091|NCT02915523|465977083|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
129459092|NCT02915523|465977084|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
129459093|NCT02915523|465977085|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
129459094|NCT02915523|465977086|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
129459095|NCT02915523|465977083|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
129459096|NCT02915523|465977084|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
129459097|NCT02915523|465977085|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
129459098|NCT02915523|465977086|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
129459099|NCT02915523|465977083|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
129459100|NCT02915523|465977084|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
129459101|NCT02915523|465977085|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
129459102|NCT02915523|465977086|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
129459103|NCT02915523|465977083|FG000|Expansion Phase (Phase 2)|Death|0|||
129459104|NCT02915523|465977084|FG001|Expansion Phase (Phase 2)|Death|0|||
129459105|NCT02915523|465977085|FG002|Expansion Phase (Phase 2)|Death|26|||
129459106|NCT02915523|465977086|FG003|Expansion Phase (Phase 2)|Death|53|||
129459107|NCT02915523|465977083|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
129459108|NCT02915523|465977084|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
129459109|NCT02915523|465977085|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
129459110|NCT02915523|465977086|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
129459111|NCT02915523|465977083|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
129459112|NCT02915523|465977084|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
129459113|NCT02915523|465977085|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
129459114|NCT02915523|465977086|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
129459115|NCT02915523|465977083|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
129459116|NCT02915523|465977084|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
129459117|NCT02915523|465977085|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
129459118|NCT02915523|465977086|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
129459119|NCT00957008|465977087|FG000|Overall Study|Withdrawal by Subject|13|||
129459120|NCT00957008|465977088|FG001|Overall Study|Withdrawal by Subject|10|||
129459121|NCT00957008|465977089|FG002|Overall Study|Withdrawal by Subject|12|||
129459122|NCT00957008|465977090|FG003|Overall Study|Withdrawal by Subject|16|||
129459123|NCT00957008|465977087|FG000|Overall Study|Lost to Follow-up|3|||
129459124|NCT00957008|465977088|FG001|Overall Study|Lost to Follow-up|1|||
129459125|NCT00957008|465977089|FG002|Overall Study|Lost to Follow-up|3|||
129459126|NCT00957008|465977090|FG003|Overall Study|Lost to Follow-up|4|||
129459127|NCT00957008|465977087|FG000|Overall Study|Physician Decision|1|||
129459128|NCT00957008|465977088|FG001|Overall Study|Physician Decision|0|||
129459129|NCT00957008|465977089|FG002|Overall Study|Physician Decision|1|||
129459130|NCT00957008|465977090|FG003|Overall Study|Physician Decision|1|||
129459131|NCT00957008|465977087|FG000|Overall Study|Relocated; Family conflict|4|||
129459132|NCT00957008|465977088|FG001|Overall Study|Relocated; Family conflict|1|||
129459133|NCT00957008|465977089|FG002|Overall Study|Relocated; Family conflict|1|||
129459134|NCT00957008|465977090|FG003|Overall Study|Relocated; Family conflict|3|||
129459135|NCT05630937|465977094|FG000|Overall Study|Study terminated by sponsor|1|||
129459136|NCT05630937|465977095|FG001|Overall Study|Study terminated by sponsor|1|||
129459137|NCT05630937|465977096|FG002|Overall Study|Study terminated by sponsor|8|||
129459138|NCT05630937|465977097|FG003|Overall Study|Study terminated by sponsor|0|||
129459139|NCT05630937|465977094|FG000|Overall Study|Lost to Follow-up|0|||
129459140|NCT05630937|465977095|FG001|Overall Study|Lost to Follow-up|0|||
129459141|NCT05630937|465977096|FG002|Overall Study|Lost to Follow-up|1|||
129459142|NCT05630937|465977097|FG003|Overall Study|Lost to Follow-up|0|||
129459143|NCT05630937|465977094|FG000|Overall Study|Enrolled but not treated|0|||
129459144|NCT05630937|465977095|FG001|Overall Study|Enrolled but not treated|0|||
129459145|NCT05630937|465977096|FG002|Overall Study|Enrolled but not treated|0|||
129459146|NCT05630937|465977097|FG003|Overall Study|Enrolled but not treated|1|||
129459147|NCT01604265|465977101|FG000|Overall Study|Adverse Event|1|||
129459148|NCT01604265|465977102|FG001|Overall Study|Adverse Event|0|||
129459149|NCT01604265|465977101|FG000|Overall Study|Withdrawal by Subject|1|||
129459150|NCT01604265|465977102|FG001|Overall Study|Withdrawal by Subject|0|||
129459151|NCT02706873|465977103|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
129459152|NCT02706873|465977104|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
129459153|NCT02706873|465977105|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
129459154|NCT02706873|465977106|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
129459155|NCT02706873|465977103|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
129459156|NCT02706873|465977104|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
129459157|NCT02706873|465977105|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
129459158|NCT02706873|465977106|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
129459159|NCT02706873|465977103|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
129459160|NCT02706873|465977104|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
129459161|NCT02706873|465977105|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
129459162|NCT02706873|465977106|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
129459163|NCT02706873|465977103|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
129459164|NCT02706873|465977104|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
129459165|NCT02706873|465977105|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
129459166|NCT02706873|465977106|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
129459167|NCT02706873|465977103|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
129459168|NCT02706873|465977104|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
129459169|NCT02706873|465977105|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
129459170|NCT02706873|465977106|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
129459171|NCT02706873|465977103|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
129459172|NCT02706873|465977104|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
129459173|NCT02706873|465977105|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
129459174|NCT02706873|465977106|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
129459175|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
129459176|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
129459177|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
129459178|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
129459179|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
129459180|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
129459181|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
129459182|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
129459183|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
129459184|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
129459185|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
129459186|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
129459187|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
129459188|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
129459189|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
129459190|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
129459191|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
129459192|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
129459193|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
129459194|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
129459195|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
129459196|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
129459197|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
129459198|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
129459199|NCT02706873|465977103|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
129459200|NCT02706873|465977104|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
129459201|NCT02706873|465977105|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
129459202|NCT02706873|465977106|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
129459203|NCT00464334|465977112|FG000|Overall Study|Adverse Event|0|||
129459204|NCT00464334|465977113|FG001|Overall Study|Adverse Event|0|||
129459205|NCT00464334|465977114|FG002|Overall Study|Adverse Event|0|||
129459206|NCT00464334|465977115|FG003|Overall Study|Adverse Event|1|||
129459207|NCT00464334|465977116|FG004|Overall Study|Adverse Event|1|||
129459208|NCT00464334|465977117|FG005|Overall Study|Adverse Event|1|||
129459209|NCT00464334|465977118|FG006|Overall Study|Adverse Event|0|||
129459210|NCT00464334|465977119|FG007|Overall Study|Adverse Event|0|||
129459211|NCT00464334|465977120|FG008|Overall Study|Adverse Event|2|||
129459212|NCT00464334|465977121|FG009|Overall Study|Adverse Event|1|||
129459213|NCT00464334|465977122|FG010|Overall Study|Adverse Event|2|||
129459214|NCT00464334|465977112|FG000|Overall Study|Lack of Efficacy|0|||
129459215|NCT00464334|465977113|FG001|Overall Study|Lack of Efficacy|1|||
129459216|NCT00464334|465977114|FG002|Overall Study|Lack of Efficacy|0|||
129459217|NCT00464334|465977115|FG003|Overall Study|Lack of Efficacy|0|||
129459218|NCT00464334|465977116|FG004|Overall Study|Lack of Efficacy|0|||
129459219|NCT00464334|465977117|FG005|Overall Study|Lack of Efficacy|0|||
129459220|NCT00464334|465977118|FG006|Overall Study|Lack of Efficacy|0|||
129459221|NCT00464334|465977119|FG007|Overall Study|Lack of Efficacy|0|||
129459222|NCT00464334|465977120|FG008|Overall Study|Lack of Efficacy|0|||
129459223|NCT00464334|465977121|FG009|Overall Study|Lack of Efficacy|0|||
129459224|NCT00464334|465977122|FG010|Overall Study|Lack of Efficacy|0|||
129459225|NCT00464334|465977112|FG000|Overall Study|Lost to Follow-up|0|||
129459226|NCT00464334|465977113|FG001|Overall Study|Lost to Follow-up|0|||
129459227|NCT00464334|465977114|FG002|Overall Study|Lost to Follow-up|1|||
129459228|NCT00464334|465977115|FG003|Overall Study|Lost to Follow-up|0|||
129459229|NCT00464334|465977116|FG004|Overall Study|Lost to Follow-up|1|||
129459230|NCT00464334|465977117|FG005|Overall Study|Lost to Follow-up|0|||
129459231|NCT00464334|465977118|FG006|Overall Study|Lost to Follow-up|1|||
129459232|NCT00464334|465977119|FG007|Overall Study|Lost to Follow-up|0|||
129459233|NCT00464334|465977120|FG008|Overall Study|Lost to Follow-up|0|||
129459234|NCT00464334|465977121|FG009|Overall Study|Lost to Follow-up|0|||
129459235|NCT00464334|465977122|FG010|Overall Study|Lost to Follow-up|2|||
129459236|NCT00464334|465977112|FG000|Overall Study|Progressive Disease|0|||
129459237|NCT00464334|465977113|FG001|Overall Study|Progressive Disease|0|||
129459238|NCT00464334|465977114|FG002|Overall Study|Progressive Disease|0|||
129459239|NCT00464334|465977115|FG003|Overall Study|Progressive Disease|0|||
129459240|NCT00464334|465977116|FG004|Overall Study|Progressive Disease|0|||
129459241|NCT00464334|465977117|FG005|Overall Study|Progressive Disease|1|||
129459242|NCT00464334|465977118|FG006|Overall Study|Progressive Disease|0|||
129459243|NCT00464334|465977119|FG007|Overall Study|Progressive Disease|0|||
129459244|NCT00464334|465977120|FG008|Overall Study|Progressive Disease|1|||
129459245|NCT00464334|465977121|FG009|Overall Study|Progressive Disease|0|||
129459246|NCT00464334|465977122|FG010|Overall Study|Progressive Disease|0|||
129459247|NCT00464334|465977112|FG000|Overall Study|Study Terminated by Sponsor|0|||
129459248|NCT00464334|465977113|FG001|Overall Study|Study Terminated by Sponsor|0|||
129459249|NCT00464334|465977114|FG002|Overall Study|Study Terminated by Sponsor|0|||
129459250|NCT00464334|465977115|FG003|Overall Study|Study Terminated by Sponsor|1|||
129459251|NCT00464334|465977116|FG004|Overall Study|Study Terminated by Sponsor|0|||
129459252|NCT00464334|465977117|FG005|Overall Study|Study Terminated by Sponsor|0|||
129459253|NCT00464334|465977118|FG006|Overall Study|Study Terminated by Sponsor|0|||
129459254|NCT00464334|465977119|FG007|Overall Study|Study Terminated by Sponsor|0|||
129459255|NCT00464334|465977120|FG008|Overall Study|Study Terminated by Sponsor|0|||
129459256|NCT00464334|465977121|FG009|Overall Study|Study Terminated by Sponsor|0|||
129459257|NCT00464334|465977122|FG010|Overall Study|Study Terminated by Sponsor|0|||
129459258|NCT00464334|465977112|FG000|Overall Study|Withdrawal by Subject|1|||
129459259|NCT00464334|465977113|FG001|Overall Study|Withdrawal by Subject|7|||
129459260|NCT00464334|465977114|FG002|Overall Study|Withdrawal by Subject|4|||
129459261|NCT00464334|465977115|FG003|Overall Study|Withdrawal by Subject|2|||
129459262|NCT00464334|465977116|FG004|Overall Study|Withdrawal by Subject|2|||
129459263|NCT00464334|465977117|FG005|Overall Study|Withdrawal by Subject|2|||
129459264|NCT00464334|465977118|FG006|Overall Study|Withdrawal by Subject|2|||
129459265|NCT00464334|465977119|FG007|Overall Study|Withdrawal by Subject|1|||
129459266|NCT00464334|465977120|FG008|Overall Study|Withdrawal by Subject|3|||
129459267|NCT00464334|465977121|FG009|Overall Study|Withdrawal by Subject|0|||
129459268|NCT00464334|465977122|FG010|Overall Study|Withdrawal by Subject|0|||
129459269|NCT00794677|465977131|FG000|First Intervention|Withdrawal by Subject|2|||
129459270|NCT00794677|465977132|FG001|First Intervention|Withdrawal by Subject|0|||
129459271|NCT01422915|465977133|FG000|Overall Study|Adverse Event|1|||
129459272|NCT01152021|465977134|FG000|Overall Study|Adverse Event|4|||
129459273|NCT01152021|465977135|FG001|Overall Study|Adverse Event|4|||
129459274|NCT01152021|465977134|FG000|Overall Study|Study drug had expired|1|||
129459275|NCT01152021|465977135|FG001|Overall Study|Study drug had expired|0|||
129459276|NCT01152021|465977134|FG000|Overall Study|Physician Decision|1|||
129459277|NCT01152021|465977135|FG001|Overall Study|Physician Decision|1|||
129459278|NCT01152021|465977134|FG000|Overall Study|No access to study drug in Pharmacy|0|||
129459279|NCT01152021|465977135|FG001|Overall Study|No access to study drug in Pharmacy|1|||
129459280|NCT01627860|465977138|FG000|Overall Study|Adverse Event|9|||
129459281|NCT01627860|465977139|FG001|Overall Study|Adverse Event|4|||
129459282|NCT01627860|465977138|FG000|Overall Study|Withdrawal by Subject|2|||
129459283|NCT01627860|465977139|FG001|Overall Study|Withdrawal by Subject|1|||
129459284|NCT01627860|465977138|FG000|Overall Study|Seizure frequency doubled|0|||
129459285|NCT01627860|465977139|FG001|Overall Study|Seizure frequency doubled|1|||
129459286|NCT01627860|465977138|FG000|Overall Study|Protocol Violation|1|||
129459287|NCT01627860|465977139|FG001|Overall Study|Protocol Violation|0|||
129459288|NCT00889265|465977145|FG000|Overall Study|Adverse Event|1|||
129459289|NCT00889265|465977145|FG000|Overall Study|Lost to Follow-up|5|||
129459290|NCT00889265|465977145|FG000|Overall Study|Protocol Violation|1|||
129459291|NCT00531752|465977149|FG000|First Double-blind Intervention Period|Adverse Event|2|||
129459292|NCT00531752|465977150|FG001|First Double-blind Intervention Period|Adverse Event|0|||
129459293|NCT00531752|465977151|FG002|First Double-blind Intervention Period|Adverse Event|1|||
129459294|NCT00531752|465977152|FG003|First Double-blind Intervention Period|Adverse Event|1|||
129459295|NCT00531752|465977149|FG000|First Double-blind Intervention Period|Other|1|||
129459296|NCT00531752|465977150|FG001|First Double-blind Intervention Period|Other|4|||
129459297|NCT00531752|465977151|FG002|First Double-blind Intervention Period|Other|4|||
129459298|NCT00531752|465977152|FG003|First Double-blind Intervention Period|Other|0|||
129459299|NCT00531752|465977149|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
129459300|NCT00531752|465977150|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
129459301|NCT00531752|465977151|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
129459302|NCT00531752|465977152|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
129459303|NCT00531752|465977149|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
129459304|NCT00531752|465977150|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
129459305|NCT00531752|465977151|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
129459306|NCT00531752|465977152|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
129459307|NCT00531752|465977149|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
129459308|NCT00531752|465977150|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
129459309|NCT00531752|465977151|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
129459310|NCT00531752|465977152|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
129459311|NCT00531752|465977149|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
129459312|NCT00531752|465977150|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
129459313|NCT00531752|465977151|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
129459314|NCT00531752|465977152|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
129459315|NCT00531752|465977149|FG000|Second Double-blind Intervention Period|Other|1|||
129459316|NCT00531752|465977150|FG001|Second Double-blind Intervention Period|Other|1|||
129459317|NCT00531752|465977151|FG002|Second Double-blind Intervention Period|Other|0|||
129459318|NCT00531752|465977152|FG003|Second Double-blind Intervention Period|Other|0|||
129459319|NCT00531752|465977149|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
129459320|NCT00531752|465977150|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
129459321|NCT00531752|465977151|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
129459322|NCT00531752|465977152|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
129459323|NCT00531752|465977149|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
129459324|NCT00531752|465977150|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
129459325|NCT00531752|465977151|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
129459326|NCT00531752|465977152|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
129459327|NCT00401375|465977153|FG000|Overall Study|Protocol Violation|2|||
129459328|NCT00401375|465977154|FG001|Overall Study|Protocol Violation|2|||
129459329|NCT00401375|465977155|FG002|Overall Study|Protocol Violation|1|||
129459330|NCT00401375|465977153|FG000|Overall Study|Adverse Event|6|||
129459331|NCT00401375|465977154|FG001|Overall Study|Adverse Event|11|||
129459332|NCT00401375|465977155|FG002|Overall Study|Adverse Event|10|||
129459333|NCT00401375|465977153|FG000|Overall Study|Withdrawal by Subject|9|||
129459334|NCT00401375|465977154|FG001|Overall Study|Withdrawal by Subject|7|||
129459335|NCT00401375|465977155|FG002|Overall Study|Withdrawal by Subject|7|||
129459336|NCT00401375|465977153|FG000|Overall Study|Lost to Follow-up|0|||
129459337|NCT00401375|465977154|FG001|Overall Study|Lost to Follow-up|1|||
129459338|NCT00401375|465977155|FG002|Overall Study|Lost to Follow-up|1|||
129459339|NCT00401375|465977153|FG000|Overall Study|Other than specified|2|||
129459340|NCT00401375|465977154|FG001|Overall Study|Other than specified|1|||
129459341|NCT00401375|465977155|FG002|Overall Study|Other than specified|3|||
129459342|NCT00401375|465977153|FG000|Overall Study|Randomized but not treated|3|||
129459343|NCT00401375|465977154|FG001|Overall Study|Randomized but not treated|3|||
129459344|NCT00401375|465977155|FG002|Overall Study|Randomized but not treated|3|||
129459345|NCT00950664|465977156|FG000|First Intervention|Lost to Follow-up|1|||
129459346|NCT00950664|465977157|FG001|First Intervention|Lost to Follow-up|3|||
129459347|NCT00950664|465977156|FG000|First Intervention|Withdrawal by Subject|2|||
129459348|NCT00950664|465977157|FG001|First Intervention|Withdrawal by Subject|2|||
129459349|NCT02821715|465977158|FG000|Overall Study|Protocol Violation|1|||
129459350|NCT02821715|465977159|FG001|Overall Study|Protocol Violation|0|||
129459351|NCT02821715|465977160|FG002|Overall Study|Protocol Violation|0|||
129459352|NCT02821715|465977161|FG003|Overall Study|Protocol Violation|0|||
129459353|NCT02821715|465977162|FG004|Overall Study|Protocol Violation|0|||
129459354|NCT02821715|465977163|FG005|Overall Study|Protocol Violation|0|||
129459355|NCT03152019|465977164|FG000|Overall Study|Adverse Event|0|||
129459356|NCT03152019|465977165|FG001|Overall Study|Adverse Event|1|||
129459357|NCT00254501|465977171|FG000|Overall Study|Lost to Follow-up|1|||
129459358|NCT00254501|465977172|FG001|Overall Study|Lost to Follow-up|1|||
129459359|NCT00923130|465977173|FG000|Overall Study|Stopped treatment due to progression|17|||
129459360|NCT00923130|465977173|FG000|Overall Study|Death|1|||
129459361|NCT00923130|465977173|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
129459362|NCT00923130|465977173|FG000|Overall Study|Switched to alternative treatment|2|||
129459363|NCT00923130|465977173|FG000|Overall Study|Refused further treatment|2|||
129459364|NCT04194528|465977181|FG000|Overall Study|Adverse Event|1|||
129459365|NCT04682405|465978560|FG000|Overall Study|Adverse Event|0|||
129459366|NCT04682405|465978561|FG001|Overall Study|Adverse Event|1|||
129459367|NCT00522431|465978562|FG000|Overall Study|Adverse Event|5|||
129459368|NCT00522431|465978562|FG000|Overall Study|Protocol Violation|2|||
129459369|NCT00522431|465978562|FG000|Overall Study|Withdrawal by Subject|2|||
129459370|NCT00522431|465978562|FG000|Overall Study|Subject non-compliance|1|||
129459371|NCT00522431|465978562|FG000|Overall Study|Other/unknown|1|||
129459372|NCT01049035|465978565|FG000|Overall Study|Serious adverse event|0|||
129459373|NCT01049035|465978566|FG001|Overall Study|Serious adverse event|1|||
129459374|NCT01049035|465978567|FG002|Overall Study|Serious adverse event|1|||
129459375|NCT01049035|465978568|FG003|Overall Study|Serious adverse event|2|||
129459376|NCT01049035|465978569|FG004|Overall Study|Serious adverse event|0|||
129459377|NCT01049035|465978570|FG005|Overall Study|Serious adverse event|0|||
129459378|NCT01049035|465978571|FG006|Overall Study|Serious adverse event|0|||
129459379|NCT01049035|465978565|FG000|Overall Study|Other adverse event (AE)|0|||
129459380|NCT01049035|465978566|FG001|Overall Study|Other adverse event (AE)|0|||
129459381|NCT01049035|465978567|FG002|Overall Study|Other adverse event (AE)|0|||
129459382|NCT01049035|465978568|FG003|Overall Study|Other adverse event (AE)|1|||
129459383|NCT01049035|465978569|FG004|Overall Study|Other adverse event (AE)|0|||
129459384|NCT01049035|465978570|FG005|Overall Study|Other adverse event (AE)|0|||
129459385|NCT01049035|465978571|FG006|Overall Study|Other adverse event (AE)|0|||
129459386|NCT01049035|465978565|FG000|Overall Study|Non-compliance with the protocol|12|||
129459387|NCT01049035|465978566|FG001|Overall Study|Non-compliance with the protocol|6|||
129459388|NCT01049035|465978567|FG002|Overall Study|Non-compliance with the protocol|14|||
129459389|NCT01049035|465978568|FG003|Overall Study|Non-compliance with the protocol|5|||
129459390|NCT01049035|465978569|FG004|Overall Study|Non-compliance with the protocol|3|||
129459391|NCT01049035|465978570|FG005|Overall Study|Non-compliance with the protocol|4|||
129459392|NCT01049035|465978571|FG006|Overall Study|Non-compliance with the protocol|10|||
129459393|NCT01049035|465978565|FG000|Overall Study|Lost to Follow-up|5|||
129459394|NCT01049035|465978566|FG001|Overall Study|Lost to Follow-up|4|||
129459395|NCT01049035|465978567|FG002|Overall Study|Lost to Follow-up|4|||
129459396|NCT01049035|465978568|FG003|Overall Study|Lost to Follow-up|1|||
129459397|NCT01049035|465978569|FG004|Overall Study|Lost to Follow-up|0|||
129459398|NCT01049035|465978570|FG005|Overall Study|Lost to Follow-up|3|||
129459399|NCT01049035|465978571|FG006|Overall Study|Lost to Follow-up|3|||
129459400|NCT01049035|465978565|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
129459401|NCT01049035|465978566|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
129459402|NCT01049035|465978567|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
129459403|NCT01049035|465978568|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
129459404|NCT01049035|465978569|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
129459405|NCT01049035|465978570|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
129459406|NCT01049035|465978571|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
129459407|NCT02095535|465978572|FG000|Recruitment|Protocol Violation|2|||
129459408|NCT00623480|465978573|FG000|Overall Study|Lost to Follow-up|0|||
129459409|NCT00623480|465978574|FG001|Overall Study|Lost to Follow-up|1|||
129459410|NCT00623480|465978573|FG000|Overall Study|Withdrawal by Subject|2|||
129459411|NCT00623480|465978574|FG001|Overall Study|Withdrawal by Subject|4|||
129459412|NCT00623480|465978573|FG000|Overall Study|Lack of Efficacy|1|||
129459413|NCT00623480|465978574|FG001|Overall Study|Lack of Efficacy|0|||
129459414|NCT00623480|465978573|FG000|Overall Study|Non-compliant with study medication|4|||
129459415|NCT00623480|465978574|FG001|Overall Study|Non-compliant with study medication|0|||
129459416|NCT00623480|465978573|FG000|Overall Study|Protocol Violation|0|||
129459417|NCT00623480|465978574|FG001|Overall Study|Protocol Violation|1|||
129459418|NCT00623480|465978573|FG000|Overall Study|Site closed by sponsor|0|||
129459419|NCT00623480|465978574|FG001|Overall Study|Site closed by sponsor|1|||
129459420|NCT03709654|465978575|FG000|Overall Study|Lost to Follow-up|1|||
129459421|NCT03709654|465978576|FG001|Overall Study|Lost to Follow-up|1|||
129459422|NCT03709654|465978575|FG000|Overall Study|Withdrawal by Subject|1|||
129459423|NCT03709654|465978576|FG001|Overall Study|Withdrawal by Subject|1|||
129459424|NCT03709654|465978575|FG000|Overall Study|Adverse Event|1|||
129459425|NCT03709654|465978576|FG001|Overall Study|Adverse Event|0|||
129459426|NCT01902966|465978577|FG000|Overall Study|Death|1|||
129459427|NCT01902966|465978577|FG000|Overall Study|Physician Decision|1|||
129459428|NCT01902966|465978577|FG000|Overall Study|Withdrawal by Subject|1|||
129459429|NCT02631200|465978580|FG000|First Period|Death|1|||
129459430|NCT02631200|465978581|FG001|First Period|Death|2|||
129459431|NCT02631200|465978580|FG000|First Period|Patient ill-health|2|||
129459432|NCT02631200|465978581|FG001|First Period|Patient ill-health|4|||
129459433|NCT02631200|465978580|FG000|First Period|Withdrawal by Subject|4|||
129459434|NCT02631200|465978581|FG001|First Period|Withdrawal by Subject|1|||
129459435|NCT02631200|465978580|FG000|Deferred Period|Death|0|||
129459436|NCT02631200|465978581|FG001|Deferred Period|Death|1|||
129459437|NCT02631200|465978580|FG000|Deferred Period|Received kidney transplant|0|||
129459438|NCT02631200|465978581|FG001|Deferred Period|Received kidney transplant|1|||
129459439|NCT02631200|465978580|FG000|Deferred Period|Withdrawal by Subject|0|||
129459440|NCT02631200|465978581|FG001|Deferred Period|Withdrawal by Subject|2|||
129459441|NCT02631200|465978580|FG000|Deferred Period|Lost to Follow-up|0|||
129459442|NCT02631200|465978581|FG001|Deferred Period|Lost to Follow-up|1|||
129459443|NCT01081912|465978582|FG000|Conversion/Titration|Adverse Event|47|||
129459444|NCT01081912|465978583|FG001|Conversion/Titration|Adverse Event|0|||
129459445|NCT01081912|465978584|FG002|Conversion/Titration|Adverse Event|0|||
129459446|NCT01081912|465978582|FG000|Conversion/Titration|Lack of Efficacy|17|||
129459447|NCT01081912|465978583|FG001|Conversion/Titration|Lack of Efficacy|0|||
129459448|NCT01081912|465978584|FG002|Conversion/Titration|Lack of Efficacy|0|||
129459449|NCT01081912|465978582|FG000|Conversion/Titration|Lost to Follow-up|5|||
129459450|NCT01081912|465978583|FG001|Conversion/Titration|Lost to Follow-up|0|||
129459451|NCT01081912|465978584|FG002|Conversion/Titration|Lost to Follow-up|0|||
129459452|NCT01081912|465978582|FG000|Conversion/Titration|Physician Decision|2|||
129459453|NCT01081912|465978583|FG001|Conversion/Titration|Physician Decision|0|||
129459454|NCT01081912|465978584|FG002|Conversion/Titration|Physician Decision|0|||
129459455|NCT01081912|465978582|FG000|Conversion/Titration|Protocol Violation|67|||
129459456|NCT01081912|465978583|FG001|Conversion/Titration|Protocol Violation|0|||
129967757|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
129459457|NCT01081912|465978584|FG002|Conversion/Titration|Protocol Violation|0|||
129459458|NCT01081912|465978582|FG000|Conversion/Titration|Withdrawal by Subject|23|||
129459459|NCT01081912|465978583|FG001|Conversion/Titration|Withdrawal by Subject|0|||
129459460|NCT01081912|465978584|FG002|Conversion/Titration|Withdrawal by Subject|0|||
129459461|NCT01081912|465978582|FG000|Conversion/Titration|Non-Compliance|47|||
129459462|NCT01081912|465978583|FG001|Conversion/Titration|Non-Compliance|0|||
129459463|NCT01081912|465978584|FG002|Conversion/Titration|Non-Compliance|0|||
129459464|NCT01081912|465978582|FG000|Maintenance Treatment|Adverse Event|0|||
129459465|NCT01081912|465978583|FG001|Maintenance Treatment|Adverse Event|2|||
129459466|NCT01081912|465978584|FG002|Maintenance Treatment|Adverse Event|12|||
129459467|NCT01081912|465978582|FG000|Maintenance Treatment|Lack of Efficacy|0|||
129459468|NCT01081912|465978583|FG001|Maintenance Treatment|Lack of Efficacy|14|||
129459469|NCT01081912|465978584|FG002|Maintenance Treatment|Lack of Efficacy|64|||
129459470|NCT01081912|465978582|FG000|Maintenance Treatment|Lost to Follow-up|0|||
129459471|NCT01081912|465978583|FG001|Maintenance Treatment|Lost to Follow-up|1|||
129459472|NCT01081912|465978584|FG002|Maintenance Treatment|Lost to Follow-up|0|||
129459473|NCT01081912|465978582|FG000|Maintenance Treatment|Physician Decision|0|||
129459474|NCT01081912|465978583|FG001|Maintenance Treatment|Physician Decision|0|||
129459475|NCT01081912|465978584|FG002|Maintenance Treatment|Physician Decision|1|||
129459476|NCT01081912|465978582|FG000|Maintenance Treatment|Protocol Violation|0|||
129459477|NCT01081912|465978583|FG001|Maintenance Treatment|Protocol Violation|1|||
129459478|NCT01081912|465978584|FG002|Maintenance Treatment|Protocol Violation|2|||
129459479|NCT01081912|465978582|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
129459480|NCT01081912|465978583|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
129459481|NCT01081912|465978584|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
129459482|NCT01081912|465978582|FG000|Maintenance Treatment|Non-Compliance|0|||
129459483|NCT01081912|465978583|FG001|Maintenance Treatment|Non-Compliance|4|||
129459484|NCT01081912|465978584|FG002|Maintenance Treatment|Non-Compliance|7|||
129459485|NCT01081912|465978582|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
129459486|NCT01081912|465978583|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
129459487|NCT01081912|465978584|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
129459488|NCT02083380|465978588|FG000|Overall Study|Lack of Efficacy|68|||
129459489|NCT02083380|465978589|FG001|Overall Study|Lack of Efficacy|79|||
129459490|NCT02083380|465978590|FG002|Overall Study|Lack of Efficacy|64|||
129459491|NCT02083380|465978588|FG000|Overall Study|Withdrawal by Subject|9|||
129459492|NCT02083380|465978589|FG001|Overall Study|Withdrawal by Subject|3|||
129459493|NCT02083380|465978590|FG002|Overall Study|Withdrawal by Subject|7|||
129459494|NCT02083380|465978588|FG000|Overall Study|Physician Decision|1|||
129459495|NCT02083380|465978589|FG001|Overall Study|Physician Decision|6|||
129459496|NCT02083380|465978590|FG002|Overall Study|Physician Decision|3|||
129459497|NCT02083380|465978588|FG000|Overall Study|Adverse Event|0|||
129459498|NCT02083380|465978589|FG001|Overall Study|Adverse Event|0|||
129459499|NCT02083380|465978590|FG002|Overall Study|Adverse Event|1|||
129459500|NCT02083380|465978588|FG000|Overall Study|Lost to Follow-up|5|||
129459501|NCT02083380|465978589|FG001|Overall Study|Lost to Follow-up|3|||
129459502|NCT02083380|465978590|FG002|Overall Study|Lost to Follow-up|3|||
129459503|NCT02083380|465978588|FG000|Overall Study|Other|8|||
129459504|NCT02083380|465978589|FG001|Overall Study|Other|4|||
129459505|NCT02083380|465978590|FG002|Overall Study|Other|6|||
129459506|NCT00001379|465978591|FG000|Initial Treatment|Disease progression|21|||
129459507|NCT00001379|465978592|FG001|Initial Treatment|Disease progression|3|||
129459508|NCT00001379|465978593|FG002|Initial Treatment|Disease progression|0|||
129459509|NCT00001379|465978594|FG003|Initial Treatment|Disease progression|0|||
129459510|NCT00001379|465978591|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
129459511|NCT00001379|465978592|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
129459512|NCT00001379|465978593|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
129459513|NCT00001379|465978594|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
129459514|NCT00001379|465978591|FG000|Initial Treatment|Received alternative treatment|2|||
129459515|NCT00001379|465978592|FG001|Initial Treatment|Received alternative treatment|1|||
129459516|NCT00001379|465978593|FG002|Initial Treatment|Received alternative treatment|0|||
129459517|NCT00001379|465978594|FG003|Initial Treatment|Received alternative treatment|0|||
129459518|NCT00001379|465978591|FG000|Initial Treatment|Refused further treatment|2|||
129459519|NCT00001379|465978592|FG001|Initial Treatment|Refused further treatment|0|||
129459520|NCT00001379|465978593|FG002|Initial Treatment|Refused further treatment|0|||
129459521|NCT00001379|465978594|FG003|Initial Treatment|Refused further treatment|0|||
129459522|NCT00001379|465978591|FG000|Initial Treatment|Did not receive protocol treatment|0|||
129459523|NCT00001379|465978592|FG001|Initial Treatment|Did not receive protocol treatment|0|||
129459524|NCT00001379|465978593|FG002|Initial Treatment|Did not receive protocol treatment|5|||
129459525|NCT00001379|465978594|FG003|Initial Treatment|Did not receive protocol treatment|0|||
129459526|NCT00001379|465978591|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
129459527|NCT00001379|465978592|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
129459528|NCT00001379|465978593|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
129459529|NCT00001379|465978594|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
129459530|NCT00001379|465978591|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
129459531|NCT00001379|465978592|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
129459532|NCT00001379|465978593|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
129459533|NCT00001379|465978594|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
129459534|NCT00001379|465978591|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
129459535|NCT00001379|465978592|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
129459536|NCT00001379|465978593|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
129459537|NCT00001379|465978594|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
129459538|NCT00001379|465978591|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
129459539|NCT00001379|465978592|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
129967758|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
129967759|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
129459540|NCT00001379|465978593|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
129459541|NCT00001379|465978594|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
129459542|NCT00001379|465978591|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
129459543|NCT00001379|465978592|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
129459544|NCT00001379|465978593|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
129459545|NCT00001379|465978594|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
129459546|NCT00405067|465978600|FG000|Overall Study|Adverse Event|4|||
129459547|NCT00405067|465978601|FG001|Overall Study|Adverse Event|9|||
129459548|NCT00405067|465978602|FG002|Overall Study|Adverse Event|4|||
129459549|NCT00405067|465978600|FG000|Overall Study|Lost to Follow-up|0|||
129459550|NCT00405067|465978601|FG001|Overall Study|Lost to Follow-up|0|||
129459551|NCT00405067|465978602|FG002|Overall Study|Lost to Follow-up|1|||
129459552|NCT01560780|465978603|FG000|Overall Study|Death|2|||
129459553|NCT01560780|465978604|FG001|Overall Study|Death|1|||
129459554|NCT01560780|465978603|FG000|Overall Study|Patient Preference|11|||
129459555|NCT01560780|465978604|FG001|Overall Study|Patient Preference|11|||
129459556|NCT01032915|465978605|FG000|Overall Study|Adverse Event|2|||
129459557|NCT01032915|465978606|FG001|Overall Study|Adverse Event|2|||
129459558|NCT01032915|465978607|FG002|Overall Study|Adverse Event|1|||
129459559|NCT01032915|465978608|FG003|Overall Study|Adverse Event|1|||
129459560|NCT01032915|465978605|FG000|Overall Study|Abnormal test procedure result|0|||
129459561|NCT01032915|465978606|FG001|Overall Study|Abnormal test procedure result|0|||
129459562|NCT01032915|465978607|FG002|Overall Study|Abnormal test procedure result|1|||
129459563|NCT01032915|465978608|FG003|Overall Study|Abnormal test procedure result|0|||
129459564|NCT01032915|465978605|FG000|Overall Study|Withdrawal by Subject|0|||
129459565|NCT01032915|465978606|FG001|Overall Study|Withdrawal by Subject|3|||
129459566|NCT01032915|465978607|FG002|Overall Study|Withdrawal by Subject|1|||
129459567|NCT01032915|465978608|FG003|Overall Study|Withdrawal by Subject|1|||
129459568|NCT01032915|465978605|FG000|Overall Study|Administrative reasons|5|||
129459569|NCT01032915|465978606|FG001|Overall Study|Administrative reasons|6|||
129459570|NCT01032915|465978607|FG002|Overall Study|Administrative reasons|4|||
129459571|NCT01032915|465978608|FG003|Overall Study|Administrative reasons|4|||
129459572|NCT01032915|465978605|FG000|Overall Study|Protocol Violation|1|||
129459573|NCT01032915|465978606|FG001|Overall Study|Protocol Violation|0|||
129967760|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
129967761|NCT01216072|467847087|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
129967762|NCT01216072|467847088|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
129967763|NCT01216072|467847087|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
129967764|NCT01216072|467847088|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
129967765|NCT01216072|467847087|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
129967766|NCT01216072|467847088|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
129967767|NCT01216072|467847087|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
129967768|NCT01216072|467847088|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
129967769|NCT04294667|467847089|FG000|Overall Study|Lack of Efficacy|4|||
129967770|NCT04294667|467847090|FG001|Overall Study|Lack of Efficacy|4|||
129967771|NCT04294667|467847089|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
129967772|NCT04294667|467847090|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
129967773|NCT04294667|467847089|FG000|Overall Study|Patient has a Renal Flare|1|||
129967774|NCT04294667|467847090|FG001|Overall Study|Patient has a Renal Flare|0|||
129967775|NCT04294667|467847089|FG000|Overall Study|SLE Worsening|0|||
129967776|NCT04294667|467847090|FG001|Overall Study|SLE Worsening|1|||
129967777|NCT04294667|467847089|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
129967778|NCT04294667|467847090|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
129967779|NCT04294667|467847089|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
129967780|NCT04294667|467847090|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
129459574|NCT01032915|465978607|FG002|Overall Study|Protocol Violation|0|||
129459575|NCT01032915|465978608|FG003|Overall Study|Protocol Violation|1|||
129459576|NCT00915681|465978609|FG000|Overall Study|Screening failures|46|||
129459577|NCT00811135|465978610|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
129459578|NCT00811135|465978610|FG000|Overall Study|Death|3|||
129459579|NCT00811135|465978610|FG000|Overall Study|Protocol Violation|2|||
129967781|NCT04294667|467847089|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
129967782|NCT04294667|467847090|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
129967783|NCT04294667|467847089|FG000|Overall Study|Subject Moved to Another State|0|||
129967784|NCT04294667|467847090|FG001|Overall Study|Subject Moved to Another State|1|||
129459580|NCT00811135|465978610|FG000|Overall Study|Violation of Selection Criteria|1|||
129459581|NCT00811135|465978610|FG000|Overall Study|Refused Treatment|1|||
129459582|NCT00811135|465978610|FG000|Overall Study|Withdrawal by Subject|3|||
129459583|NCT00811135|465978610|FG000|Overall Study|Administrative/Other Unspecified|11|||
129459584|NCT00811135|465978610|FG000|Overall Study|Ongoing|59|||
129459585|NCT01118351|465978611|FG000|Overall Study|Adverse Event|3|||
129459586|NCT01118351|465978611|FG000|Overall Study|Withdrawal by Subject|1|||
129967785|NCT04294667|467847089|FG000|Overall Study|Adverse event, serious fatal|0|||
129967786|NCT04294667|467847090|FG001|Overall Study|Adverse event, serious fatal|1|||
129967787|NCT04294667|467847089|FG000|Overall Study|Adverse event, non-fatal|3|||
129967788|NCT04294667|467847090|FG001|Overall Study|Adverse event, non-fatal|4|||
129967789|NCT02599688|467847091|FG000|Overall Study|Lack of Efficacy|1|||
129967790|NCT02599688|467847091|FG000|Overall Study|Withdrawal by Subject|1|||
129967791|NCT02599688|467847091|FG000|Overall Study|Termination by Sponsor|2|||
129967792|NCT01841697|467847092|FG000|Overall Study|Death|0|||
129967793|NCT01841697|467847093|FG001|Overall Study|Death|1|||
129967794|NCT01841697|467847092|FG000|Overall Study|Lost to Follow-up|4|||
129967795|NCT01841697|467847093|FG001|Overall Study|Lost to Follow-up|1|||
129967796|NCT01841697|467847092|FG000|Overall Study|Withdrawal by Subject|16|||
129967797|NCT01841697|467847093|FG001|Overall Study|Withdrawal by Subject|16|||
129967798|NCT00756457|467847094|FG000|Overall Study|Lost to Follow-up|1|||
129967799|NCT00756457|467847095|FG001|Overall Study|Lost to Follow-up|2|||
129967800|NCT01777490|467847096|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
129967801|NCT01777490|467847097|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
129967802|NCT01777490|467847098|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
129967803|NCT01777490|467847099|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
129967804|NCT00822770|467847100|FG000|Overall Study|Not treated|1|||
129967805|NCT00822770|467847101|FG001|Overall Study|Not treated|0|||
129967806|NCT00822770|467847100|FG000|Overall Study|Complication/Incomplete treatment|1|||
129967807|NCT00822770|467847101|FG001|Overall Study|Complication/Incomplete treatment|0|||
129459587|NCT00845728|465978623|FG000|Overall Study|Abnormal laboratory value (s)|2|||
129459588|NCT00845728|465978624|FG001|Overall Study|Abnormal laboratory value (s)|2|||
129459589|NCT00845728|465978623|FG000|Overall Study|Patient's inability to use the device|4|||
129459590|NCT00845728|465978624|FG001|Overall Study|Patient's inability to use the device|6|||
129459591|NCT00845728|465978623|FG000|Overall Study|Abnormal test procedure result (s)|7|||
129459592|NCT00845728|465978624|FG001|Overall Study|Abnormal test procedure result (s)|2|||
129459593|NCT00845728|465978623|FG000|Overall Study|Lost to Follow-up|22|||
129459594|NCT00845728|465978624|FG001|Overall Study|Lost to Follow-up|13|||
129459595|NCT00845728|465978623|FG000|Overall Study|Death|24|||
129459596|NCT00845728|465978624|FG001|Overall Study|Death|26|||
129967808|NCT00822770|467847100|FG000|Overall Study|Death|1|||
129967809|NCT00822770|467847101|FG001|Overall Study|Death|1|||
129967810|NCT02818998|467847102|FG000|Overall Study|Adverse Event|3|||
129967811|NCT02818998|467847103|FG001|Overall Study|Adverse Event|2|||
129967812|NCT02818998|467847104|FG002|Overall Study|Adverse Event|1|||
129967813|NCT02818998|467847102|FG000|Overall Study|Lost to Follow-up|4|||
129967814|NCT02818998|467847103|FG001|Overall Study|Lost to Follow-up|1|||
129459597|NCT00845728|465978623|FG000|Overall Study|Administrative Problems|34|||
129459598|NCT00845728|465978624|FG001|Overall Study|Administrative Problems|26|||
129967815|NCT02818998|467847104|FG002|Overall Study|Lost to Follow-up|2|||
129967816|NCT02818998|467847102|FG000|Overall Study|Withdrawal by sponsor|0|||
129967817|NCT02818998|467847103|FG001|Overall Study|Withdrawal by sponsor|1|||
129967818|NCT02818998|467847104|FG002|Overall Study|Withdrawal by sponsor|1|||
129967819|NCT02818998|467847102|FG000|Overall Study|Death|3|||
129967820|NCT02818998|467847103|FG001|Overall Study|Death|6|||
129967821|NCT02818998|467847104|FG002|Overall Study|Death|8|||
129967822|NCT02818998|467847102|FG000|Overall Study|Withdrawal by Subject|7|||
129967823|NCT02818998|467847103|FG001|Overall Study|Withdrawal by Subject|6|||
129967824|NCT02818998|467847104|FG002|Overall Study|Withdrawal by Subject|6|||
129967825|NCT02818998|467847102|FG000|Overall Study|Physician Decision|1|||
129967826|NCT02818998|467847103|FG001|Overall Study|Physician Decision|0|||
129967827|NCT02818998|467847104|FG002|Overall Study|Physician Decision|0|||
129967828|NCT01101061|467847105|FG000|Overall Study|Adverse Event|0|||
129967829|NCT01101061|467847106|FG001|Overall Study|Adverse Event|0|||
129967830|NCT01101061|467847107|FG002|Overall Study|Adverse Event|1|||
129459599|NCT00845728|465978623|FG000|Overall Study|Protocol Violation|36|||
129967831|NCT01101061|467847108|FG003|Overall Study|Adverse Event|0|||
129967832|NCT01101061|467847109|FG004|Overall Study|Adverse Event|0|||
129967833|NCT01101061|467847110|FG005|Overall Study|Adverse Event|0|||
129967834|NCT05043883|467847111|FG000|Overall Study|Minimum required measurements could not be taken|4|||
129459600|NCT00845728|465978624|FG001|Overall Study|Protocol Violation|24|||
129459601|NCT00845728|465978623|FG000|Overall Study|Lack of Efficacy|51|||
129459602|NCT00845728|465978624|FG001|Overall Study|Lack of Efficacy|39|||
129459603|NCT00845728|465978623|FG000|Overall Study|Adverse Event|101|||
129459604|NCT00845728|465978624|FG001|Overall Study|Adverse Event|96|||
129967835|NCT02049515|467847112|FG000|Overall Study|Adverse Event|46|||
129967836|NCT02049515|467847113|FG001|Overall Study|Adverse Event|2|||
129967837|NCT02049515|467847112|FG000|Overall Study|Protocol-specified Disease Progression|23|||
129967838|NCT02049515|467847113|FG001|Overall Study|Protocol-specified Disease Progression|2|||
129967839|NCT02049515|467847112|FG000|Overall Study|Death|6|||
129967840|NCT02049515|467847113|FG001|Overall Study|Death|0|||
129967841|NCT02049515|467847112|FG000|Overall Study|Physician Decision|5|||
129967842|NCT02049515|467847113|FG001|Overall Study|Physician Decision|1|||
129967843|NCT02049515|467847112|FG000|Overall Study|Withdrawal by Subject|3|||
129967844|NCT02049515|467847113|FG001|Overall Study|Withdrawal by Subject|0|||
129967845|NCT02049515|467847112|FG000|Overall Study|Termination of the Study by Sponsor|2|||
129967846|NCT02049515|467847113|FG001|Overall Study|Termination of the Study by Sponsor|0|||
129967847|NCT02049515|467847112|FG000|Overall Study|Protocol Violation|1|||
129967848|NCT02049515|467847113|FG001|Overall Study|Protocol Violation|1|||
129967849|NCT02049515|467847112|FG000|Overall Study|Clinical Deterioration|1|||
129967850|NCT02049515|467847113|FG001|Overall Study|Clinical Deterioration|0|||
129967851|NCT02049515|467847112|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
129967852|NCT02049515|467847113|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
129967853|NCT02049515|467847112|FG000|Overall Study|Treatment Interruption >42 Days|1|||
129967854|NCT02049515|467847113|FG001|Overall Study|Treatment Interruption >42 Days|0|||
129967855|NCT02049515|467847112|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
129967856|NCT02049515|467847113|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
129967857|NCT00224029|467847114|FG000|Overall Study|Lost to Follow-up|1|||
129967858|NCT00224029|467847114|FG000|Overall Study|Withdrawal by Subject|4|||
129967859|NCT00224029|467847114|FG000|Overall Study|Other|1|||
129967860|NCT01390441|467847115|FG000|Treatment Period|Protocol Violation|0|||
129967861|NCT01390441|467847116|FG001|Treatment Period|Protocol Violation|1|||
129967862|NCT01390441|467847117|FG002|Treatment Period|Protocol Violation|0|||
129967863|NCT01390441|467847118|FG003|Treatment Period|Protocol Violation|0|||
129967864|NCT01390441|467847119|FG004|Treatment Period|Protocol Violation|0|||
129967865|NCT01390441|467847115|FG000|Treatment Period|Physician Decision|0|||
129967866|NCT01390441|467847116|FG001|Treatment Period|Physician Decision|0|||
129967867|NCT01390441|467847117|FG002|Treatment Period|Physician Decision|0|||
129967868|NCT01390441|467847118|FG003|Treatment Period|Physician Decision|1|||
129967869|NCT01390441|467847119|FG004|Treatment Period|Physician Decision|0|||
129967870|NCT01390441|467847115|FG000|Treatment Period|Lack of Efficacy|0|||
129967871|NCT01390441|467847116|FG001|Treatment Period|Lack of Efficacy|0|||
129967872|NCT01390441|467847117|FG002|Treatment Period|Lack of Efficacy|0|||
129967873|NCT01390441|467847118|FG003|Treatment Period|Lack of Efficacy|0|||
129967874|NCT01390441|467847119|FG004|Treatment Period|Lack of Efficacy|1|||
129967875|NCT01390441|467847115|FG000|Treatment Period|Unknown due to early stopping of study|0|||
129967876|NCT01390441|467847116|FG001|Treatment Period|Unknown due to early stopping of study|0|||
129967877|NCT01390441|467847117|FG002|Treatment Period|Unknown due to early stopping of study|8|||
129967878|NCT01390441|467847118|FG003|Treatment Period|Unknown due to early stopping of study|11|||
129967879|NCT01390441|467847119|FG004|Treatment Period|Unknown due to early stopping of study|7|||
129967880|NCT01390441|467847115|FG000|Treatment Period|Adverse Event|0|||
129967881|NCT01390441|467847116|FG001|Treatment Period|Adverse Event|0|||
129967882|NCT01390441|467847117|FG002|Treatment Period|Adverse Event|1|||
129967883|NCT01390441|467847118|FG003|Treatment Period|Adverse Event|1|||
129967884|NCT01390441|467847119|FG004|Treatment Period|Adverse Event|2|||
129967885|NCT01390441|467847115|FG000|Treatment Period|Withdrawal by Subject|0|||
129967886|NCT01390441|467847116|FG001|Treatment Period|Withdrawal by Subject|0|||
129967887|NCT01390441|467847117|FG002|Treatment Period|Withdrawal by Subject|1|||
129967888|NCT01390441|467847118|FG003|Treatment Period|Withdrawal by Subject|0|||
129967889|NCT01390441|467847119|FG004|Treatment Period|Withdrawal by Subject|1|||
129967890|NCT01390441|467847115|FG000|Treatment Period|Lost to Follow-up|1|||
129967891|NCT01390441|467847116|FG001|Treatment Period|Lost to Follow-up|0|||
129967892|NCT01390441|467847117|FG002|Treatment Period|Lost to Follow-up|0|||
129967893|NCT01390441|467847118|FG003|Treatment Period|Lost to Follow-up|0|||
129967894|NCT01390441|467847119|FG004|Treatment Period|Lost to Follow-up|0|||
129967895|NCT01390441|467847115|FG000|Extension Period|Protocol Violation|3|||
129967896|NCT01390441|467847116|FG001|Extension Period|Protocol Violation|1|||
129967897|NCT01390441|467847117|FG002|Extension Period|Protocol Violation|0|||
129967898|NCT01390441|467847118|FG003|Extension Period|Protocol Violation|1|||
129967899|NCT01390441|467847119|FG004|Extension Period|Protocol Violation|0|||
129967900|NCT01407276|467847120|FG000|Overall Study|Withdrawal by Subject|0|||
129967901|NCT01407276|467847121|FG001|Overall Study|Withdrawal by Subject|0|||
129967902|NCT01407276|467847122|FG002|Overall Study|Withdrawal by Subject|0|||
129967903|NCT01407276|467847123|FG003|Overall Study|Withdrawal by Subject|0|||
129967904|NCT01407276|467847124|FG004|Overall Study|Withdrawal by Subject|0|||
129459605|NCT00845728|465978623|FG000|Overall Study|Withdrawal by Subject|105|||
129459606|NCT00845728|465978624|FG001|Overall Study|Withdrawal by Subject|108|||
129967905|NCT01407276|467847125|FG005|Overall Study|Withdrawal by Subject|0|||
129967906|NCT01407276|467847126|FG006|Overall Study|Withdrawal by Subject|0|||
129967907|NCT01407276|467847127|FG007|Overall Study|Withdrawal by Subject|1|||
129967908|NCT02635386|467847128|FG000|Overall Study|Pregnancy|2|||
129967909|NCT02635386|467847129|FG001|Overall Study|Pregnancy|0|||
129967910|NCT02635386|467847130|FG002|Overall Study|Pregnancy|0|||
129967911|NCT02635386|467847131|FG003|Overall Study|Pregnancy|0|||
129967912|NCT02635386|467847132|FG004|Overall Study|Pregnancy|2|||
129967913|NCT02635386|467847128|FG000|Overall Study|Withdrawal by Subject|1|||
129967914|NCT02635386|467847129|FG001|Overall Study|Withdrawal by Subject|1|||
129967915|NCT02635386|467847130|FG002|Overall Study|Withdrawal by Subject|0|||
129459607|NCT04951037|465978627|FG000|Overall Study|Lost to Follow-up|16|||
129967916|NCT02635386|467847131|FG003|Overall Study|Withdrawal by Subject|1|||
129967917|NCT02635386|467847132|FG004|Overall Study|Withdrawal by Subject|0|||
129967918|NCT02635386|467847128|FG000|Overall Study|Physician Decision|0|||
129967919|NCT02635386|467847129|FG001|Overall Study|Physician Decision|1|||
129967920|NCT02635386|467847130|FG002|Overall Study|Physician Decision|0|||
129967921|NCT02635386|467847131|FG003|Overall Study|Physician Decision|0|||
129967922|NCT02635386|467847132|FG004|Overall Study|Physician Decision|0|||
129967923|NCT02635386|467847128|FG000|Overall Study|Moved Out of State|0|||
129967924|NCT02635386|467847129|FG001|Overall Study|Moved Out of State|1|||
129967925|NCT02635386|467847130|FG002|Overall Study|Moved Out of State|0|||
129967926|NCT02635386|467847131|FG003|Overall Study|Moved Out of State|0|||
129967927|NCT02635386|467847132|FG004|Overall Study|Moved Out of State|0|||
129967928|NCT02635386|467847128|FG000|Overall Study|Noncompliant|0|||
129967929|NCT02635386|467847129|FG001|Overall Study|Noncompliant|2|||
129967930|NCT02635386|467847130|FG002|Overall Study|Noncompliant|1|||
129967931|NCT02635386|467847131|FG003|Overall Study|Noncompliant|1|||
129967932|NCT02635386|467847132|FG004|Overall Study|Noncompliant|1|||
129967933|NCT02635386|467847128|FG000|Overall Study|side effects|0|||
129967934|NCT02635386|467847129|FG001|Overall Study|side effects|0|||
129967935|NCT02635386|467847130|FG002|Overall Study|side effects|1|||
129967936|NCT02635386|467847131|FG003|Overall Study|side effects|4|||
129967937|NCT02635386|467847132|FG004|Overall Study|side effects|6|||
129967938|NCT02635386|467847128|FG000|Overall Study|needed other major surgery|0|||
129967939|NCT02635386|467847129|FG001|Overall Study|needed other major surgery|1|||
129967940|NCT02635386|467847130|FG002|Overall Study|needed other major surgery|0|||
129967941|NCT02635386|467847131|FG003|Overall Study|needed other major surgery|0|||
129967942|NCT02635386|467847132|FG004|Overall Study|needed other major surgery|0|||
129967943|NCT02635386|467847128|FG000|Overall Study|Other medical problems not drug related|0|||
129967944|NCT02635386|467847129|FG001|Overall Study|Other medical problems not drug related|0|||
129967945|NCT02635386|467847130|FG002|Overall Study|Other medical problems not drug related|0|||
129967946|NCT02635386|467847131|FG003|Overall Study|Other medical problems not drug related|1|||
129967947|NCT02635386|467847132|FG004|Overall Study|Other medical problems not drug related|0|||
129967948|NCT00778921|467847136|FG000|Overall Study|Adverse Event|9|||
129967949|NCT00778921|467847137|FG001|Overall Study|Adverse Event|10|||
129967950|NCT00778921|467847138|FG002|Overall Study|Adverse Event|14|||
129967951|NCT00778921|467847136|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
129967952|NCT00778921|467847137|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
129967953|NCT00778921|467847138|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
129967954|NCT00778921|467847136|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
129967955|NCT00778921|467847137|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
129967956|NCT00778921|467847138|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
129967957|NCT00778921|467847136|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
129967958|NCT00778921|467847137|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
129967959|NCT00778921|467847138|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
129967960|NCT00778921|467847136|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
129967961|NCT00778921|467847137|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
129967962|NCT00778921|467847138|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
129967963|NCT00778921|467847136|FG000|Overall Study|Patient withdrew request|3|||
129967964|NCT00778921|467847137|FG001|Overall Study|Patient withdrew request|1|||
129967965|NCT00778921|467847138|FG002|Overall Study|Patient withdrew request|6|||
129967966|NCT00778921|467847136|FG000|Overall Study|Lost to Follow-up|0|||
129967967|NCT00778921|467847137|FG001|Overall Study|Lost to Follow-up|2|||
129967968|NCT00778921|467847138|FG002|Overall Study|Lost to Follow-up|1|||
129967969|NCT00778921|467847136|FG000|Overall Study|Administrative Problems|1|||
129967970|NCT00778921|467847137|FG001|Overall Study|Administrative Problems|2|||
129967971|NCT00778921|467847138|FG002|Overall Study|Administrative Problems|0|||
129967972|NCT00778921|467847136|FG000|Overall Study|Protocol Violation|3|||
129967973|NCT00778921|467847137|FG001|Overall Study|Protocol Violation|0|||
129967974|NCT00778921|467847138|FG002|Overall Study|Protocol Violation|2|||
129967975|NCT00778921|467847136|FG000|Overall Study|Not treated|0|||
129967976|NCT00778921|467847137|FG001|Overall Study|Not treated|2|||
129967977|NCT00778921|467847138|FG002|Overall Study|Not treated|2|||
129967978|NCT04805073|467847139|FG000|Overall Study|study personnel not available|2|||
129967979|NCT04805073|467847140|FG001|Overall Study|study personnel not available|0|||
129967980|NCT04805073|467847139|FG000|Overall Study|spinal anesthesia failure|0|||
129967981|NCT04805073|467847140|FG001|Overall Study|spinal anesthesia failure|1|||
129967982|NCT04805073|467847139|FG000|Overall Study|Lost to Follow-up|0|||
129967983|NCT04805073|467847140|FG001|Overall Study|Lost to Follow-up|2|||
129967984|NCT01163474|467847141|FG000|Overall Study|Withdrawal by Subject|1|||
129967985|NCT01163474|467847141|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
129967986|NCT01163474|467847141|FG000|Overall Study|Lost to Follow-up|3|||
129967987|NCT01078922|467847149|FG000|Overall Study|Adverse Event|1|||
129967988|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
129967989|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
129967990|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
129967991|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
129967992|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
129967993|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
129967994|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
129967995|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
129967996|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
129967997|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
129967998|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
129967999|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
129968000|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Other|4|||
129968001|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Other|4|||
129968002|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Other|2|||
129968003|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Other|2|||
129968004|NCT02706847|467847152|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
129968005|NCT02706847|467847153|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
129968006|NCT02706847|467847154|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
129968007|NCT02706847|467847155|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
129968008|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
129968009|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
129968010|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
129968011|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
129968012|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
129968013|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
129968014|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
129968015|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
129968016|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
129968017|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
129968018|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
129968019|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
129968020|NCT02706847|467847152|FG000|Period 1: Week 12 to Week 24|Other|1|||
129968021|NCT02706847|467847153|FG001|Period 1: Week 12 to Week 24|Other|0|||
129968022|NCT02706847|467847154|FG002|Period 1: Week 12 to Week 24|Other|1|||
129968023|NCT02706847|467847155|FG003|Period 1: Week 12 to Week 24|Other|4|||
129968024|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
129968025|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
129968026|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
129968027|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
129968028|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
129968029|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
129968030|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
129968031|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
129968032|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
129968033|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
129968034|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
129968035|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
129968036|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
129968037|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
129968038|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
129968039|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
129968040|NCT02706847|467847152|FG000|Period 2: Week 24 to Week 260|Other|8|||
129968041|NCT02706847|467847153|FG001|Period 2: Week 24 to Week 260|Other|5|||
129968042|NCT02706847|467847154|FG002|Period 2: Week 24 to Week 260|Other|15|||
129968043|NCT02706847|467847155|FG003|Period 2: Week 24 to Week 260|Other|15|||
129968044|NCT01174264|467847156|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
129968045|NCT01174264|467847157|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
129968046|NCT01174264|467847158|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
129968047|NCT01174264|467847156|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
129968048|NCT01174264|467847157|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
129968049|NCT01174264|467847158|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
129968050|NCT01174264|467847156|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
129968051|NCT01174264|467847157|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
129968052|NCT01174264|467847158|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
129968053|NCT02058836|467847162|FG000|Overall Study|Withdrawal by Subject|1|||
129968054|NCT02058836|467847163|FG001|Overall Study|Withdrawal by Subject|1|||
129968055|NCT00267098|467847164|FG000|Overall Study|Death|0|||
129968056|NCT00267098|467847165|FG001|Overall Study|Death|0|||
129968057|NCT00267098|467847166|FG002|Overall Study|Death|57|||
129968058|NCT00267098|467847167|FG003|Overall Study|Death|66|||
129968059|NCT00267098|467847168|FG004|Overall Study|Death|14|||
129968060|NCT00267098|467847169|FG005|Overall Study|Death|23|||
129968061|NCT00267098|467847170|FG006|Overall Study|Death|28|||
129968062|NCT00267098|467847171|FG007|Overall Study|Death|9|||
129968063|NCT00267098|467847164|FG000|Overall Study|Lost to Follow-up|0|||
129968064|NCT00267098|467847165|FG001|Overall Study|Lost to Follow-up|0|||
129968065|NCT00267098|467847166|FG002|Overall Study|Lost to Follow-up|6|||
129968066|NCT00267098|467847167|FG003|Overall Study|Lost to Follow-up|5|||
129968067|NCT00267098|467847168|FG004|Overall Study|Lost to Follow-up|2|||
129968068|NCT00267098|467847169|FG005|Overall Study|Lost to Follow-up|3|||
129968069|NCT00267098|467847170|FG006|Overall Study|Lost to Follow-up|1|||
129968070|NCT00267098|467847171|FG007|Overall Study|Lost to Follow-up|1|||
129968071|NCT00267098|467847164|FG000|Overall Study|Withdrawal by Subject|8|||
129968072|NCT00267098|467847165|FG001|Overall Study|Withdrawal by Subject|0|||
129968073|NCT00267098|467847166|FG002|Overall Study|Withdrawal by Subject|24|||
129968074|NCT00267098|467847167|FG003|Overall Study|Withdrawal by Subject|21|||
129968075|NCT00267098|467847168|FG004|Overall Study|Withdrawal by Subject|12|||
129968076|NCT00267098|467847169|FG005|Overall Study|Withdrawal by Subject|9|||
129968077|NCT00267098|467847170|FG006|Overall Study|Withdrawal by Subject|12|||
129968078|NCT00267098|467847171|FG007|Overall Study|Withdrawal by Subject|5|||
129968079|NCT00267098|467847164|FG000|Overall Study|Physician Decision|5|||
129968080|NCT00267098|467847165|FG001|Overall Study|Physician Decision|0|||
129968081|NCT00267098|467847166|FG002|Overall Study|Physician Decision|7|||
129968082|NCT00267098|467847167|FG003|Overall Study|Physician Decision|11|||
129968083|NCT00267098|467847168|FG004|Overall Study|Physician Decision|5|||
129968084|NCT00267098|467847169|FG005|Overall Study|Physician Decision|4|||
129968085|NCT00267098|467847170|FG006|Overall Study|Physician Decision|3|||
129968086|NCT00267098|467847171|FG007|Overall Study|Physician Decision|0|||
129968087|NCT00267098|467847164|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
129968088|NCT00267098|467847165|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968089|NCT00267098|467847166|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968090|NCT00267098|467847167|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968091|NCT00267098|467847168|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
129968092|NCT00267098|467847169|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968093|NCT00267098|467847170|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968094|NCT00267098|467847171|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129968095|NCT00267098|467847164|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968096|NCT00267098|467847165|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
129968097|NCT00267098|467847166|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968098|NCT00267098|467847167|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968099|NCT00267098|467847168|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968100|NCT00267098|467847169|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968101|NCT00267098|467847170|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968102|NCT00267098|467847171|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
129968103|NCT00267098|467847164|FG000|Overall Study|Site closure|0|||
129968104|NCT00267098|467847165|FG001|Overall Study|Site closure|0|||
129968105|NCT00267098|467847166|FG002|Overall Study|Site closure|0|||
129968106|NCT00267098|467847167|FG003|Overall Study|Site closure|1|||
129968107|NCT00267098|467847168|FG004|Overall Study|Site closure|0|||
129968108|NCT00267098|467847169|FG005|Overall Study|Site closure|1|||
129968109|NCT00267098|467847170|FG006|Overall Study|Site closure|1|||
129968110|NCT00267098|467847171|FG007|Overall Study|Site closure|0|||
129968111|NCT00267098|467847164|FG000|Overall Study|Explanted Medtronic device|0|||
129968112|NCT00267098|467847165|FG001|Overall Study|Explanted Medtronic device|0|||
129968113|NCT00267098|467847166|FG002|Overall Study|Explanted Medtronic device|0|||
129968114|NCT00267098|467847167|FG003|Overall Study|Explanted Medtronic device|1|||
129968115|NCT00267098|467847168|FG004|Overall Study|Explanted Medtronic device|0|||
129968116|NCT00267098|467847169|FG005|Overall Study|Explanted Medtronic device|0|||
129968117|NCT00267098|467847170|FG006|Overall Study|Explanted Medtronic device|0|||
129459608|NCT04951037|465978627|FG000|Overall Study|Withdrawal by Subject|5|||
129459609|NCT04951037|465978627|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
129459610|NCT02599961|465978631|FG000|Overall Study|Withdrawal by Subject|1|||
129459611|NCT02599961|465978631|FG000|Overall Study|Subject Non-Compliance|2|||
129968118|NCT00267098|467847171|FG007|Overall Study|Explanted Medtronic device|0|||
129968119|NCT00267098|467847164|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968120|NCT00267098|467847165|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968121|NCT00267098|467847166|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968122|NCT00267098|467847167|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129459612|NCT02599961|465978631|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
129968123|NCT00267098|467847168|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
129968124|NCT00267098|467847169|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968125|NCT00267098|467847170|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968126|NCT00267098|467847171|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
129968127|NCT00267098|467847164|FG000|Overall Study|Subject listed for heart transplant|0|||
129968128|NCT00267098|467847165|FG001|Overall Study|Subject listed for heart transplant|0|||
129968129|NCT00267098|467847166|FG002|Overall Study|Subject listed for heart transplant|0|||
129968130|NCT00267098|467847167|FG003|Overall Study|Subject listed for heart transplant|0|||
129968131|NCT00267098|467847168|FG004|Overall Study|Subject listed for heart transplant|0|||
129968132|NCT00267098|467847169|FG005|Overall Study|Subject listed for heart transplant|0|||
129968133|NCT00267098|467847170|FG006|Overall Study|Subject listed for heart transplant|1|||
129968134|NCT00267098|467847171|FG007|Overall Study|Subject listed for heart transplant|0|||
129968135|NCT00267098|467847164|FG000|Overall Study|Sponsor withdrew subject|0|||
129968136|NCT00267098|467847165|FG001|Overall Study|Sponsor withdrew subject|0|||
129968137|NCT00267098|467847166|FG002|Overall Study|Sponsor withdrew subject|0|||
129968138|NCT00267098|467847167|FG003|Overall Study|Sponsor withdrew subject|1|||
129968139|NCT00267098|467847168|FG004|Overall Study|Sponsor withdrew subject|0|||
129968140|NCT00267098|467847169|FG005|Overall Study|Sponsor withdrew subject|0|||
129968141|NCT00267098|467847170|FG006|Overall Study|Sponsor withdrew subject|0|||
129968142|NCT00267098|467847171|FG007|Overall Study|Sponsor withdrew subject|0|||
129968143|NCT02689453|467847176|FG000|Overall Study|Progressive disease|0|||
129968144|NCT02689453|467847177|FG001|Overall Study|Progressive disease|1|||
129968145|NCT02689453|467847178|FG002|Overall Study|Progressive disease|1|||
129968146|NCT02688530|467847179|FG000|Overall Study|Withdrawal by Subject|0|||
129968147|NCT02688530|467847180|FG001|Overall Study|Withdrawal by Subject|1|||
129968148|NCT02688530|467847181|FG002|Overall Study|Withdrawal by Subject|0|||
129968149|NCT02688530|467847182|FG003|Overall Study|Withdrawal by Subject|0|||
129968150|NCT02688530|467847179|FG000|Overall Study|Lost to Follow-up|0|||
129968151|NCT02688530|467847180|FG001|Overall Study|Lost to Follow-up|0|||
129968152|NCT02688530|467847181|FG002|Overall Study|Lost to Follow-up|2|||
129968153|NCT02688530|467847182|FG003|Overall Study|Lost to Follow-up|0|||
129968154|NCT01658020|467847183|FG000|Overall Study|Adverse Event|3|||
129968155|NCT01658020|467847184|FG001|Overall Study|Adverse Event|3|||
129968156|NCT01658020|467847183|FG000|Overall Study|Lost to Follow-up|1|||
129968157|NCT01658020|467847184|FG001|Overall Study|Lost to Follow-up|0|||
129968158|NCT01658020|467847183|FG000|Overall Study|Withdrawal by Subject|4|||
129968159|NCT01658020|467847184|FG001|Overall Study|Withdrawal by Subject|5|||
129968160|NCT01658020|467847183|FG000|Overall Study|Protocol Violation|0|||
129968161|NCT01658020|467847184|FG001|Overall Study|Protocol Violation|1|||
129968162|NCT04206085|467847185|FG000|Overall Study|Lost to Follow-up|0|||
129968163|NCT04206085|467847186|FG001|Overall Study|Lost to Follow-up|1|||
129968164|NCT04206085|467847187|FG002|Overall Study|Lost to Follow-up|0|||
129968165|NCT04206085|467847185|FG000|Overall Study|Lost to Follow-up|0|||
129968166|NCT04206085|467847186|FG001|Overall Study|Lost to Follow-up|0|||
129968167|NCT04206085|467847187|FG002|Overall Study|Lost to Follow-up|1|||
129968168|NCT00815919|467847190|FG000|Overall Study|Unrelated Fungal Infection|1|||
129968169|NCT00815919|467847190|FG000|Overall Study|AML Relapse|1|||
129968170|NCT00815919|467847190|FG000|Overall Study|Lack of Efficacy|2|||
129968171|NCT01466790|467847193|FG000|Overall Study|Adverse Event|1|||
129968172|NCT01466790|467847194|FG001|Overall Study|Adverse Event|0|||
129968173|NCT01466790|467847195|FG002|Overall Study|Adverse Event|0|||
129968174|NCT01466790|467847196|FG003|Overall Study|Adverse Event|0|||
129968175|NCT01466790|467847197|FG004|Overall Study|Adverse Event|2|||
129968176|NCT01466790|467847198|FG005|Overall Study|Adverse Event|0|||
129968177|NCT01466790|467847199|FG006|Overall Study|Adverse Event|0|||
129968178|NCT01466790|467847200|FG007|Overall Study|Adverse Event|0|||
129968179|NCT01466790|467847193|FG000|Overall Study|Lost to Follow-up|2|||
129968180|NCT01466790|467847194|FG001|Overall Study|Lost to Follow-up|0|||
129968181|NCT01466790|467847195|FG002|Overall Study|Lost to Follow-up|0|||
129968182|NCT01466790|467847196|FG003|Overall Study|Lost to Follow-up|0|||
129968183|NCT01466790|467847197|FG004|Overall Study|Lost to Follow-up|0|||
129968184|NCT01466790|467847198|FG005|Overall Study|Lost to Follow-up|0|||
129968185|NCT01466790|467847199|FG006|Overall Study|Lost to Follow-up|0|||
129968186|NCT01466790|467847200|FG007|Overall Study|Lost to Follow-up|0|||
129968187|NCT01466790|467847193|FG000|Overall Study|Withdrawal by Subject|1|||
129968188|NCT01466790|467847194|FG001|Overall Study|Withdrawal by Subject|1|||
129968189|NCT01466790|467847195|FG002|Overall Study|Withdrawal by Subject|0|||
129968190|NCT01466790|467847196|FG003|Overall Study|Withdrawal by Subject|0|||
129968191|NCT01466790|467847197|FG004|Overall Study|Withdrawal by Subject|1|||
129968192|NCT01466790|467847198|FG005|Overall Study|Withdrawal by Subject|0|||
129968193|NCT01466790|467847199|FG006|Overall Study|Withdrawal by Subject|1|||
129968194|NCT01466790|467847200|FG007|Overall Study|Withdrawal by Subject|1|||
129968195|NCT01251887|467847201|FG000|Overall Study|Scheduling conflict|1|||
129968196|NCT01251887|467847202|FG001|Overall Study|Scheduling conflict|2|||
129968197|NCT01251887|467847203|FG002|Overall Study|Scheduling conflict|2|||
129968198|NCT01251887|467847201|FG000|Overall Study|Physician Decision|0|||
129968199|NCT01251887|467847202|FG001|Overall Study|Physician Decision|1|||
129968200|NCT01251887|467847203|FG002|Overall Study|Physician Decision|0|||
129968201|NCT04650698|467848584|FG000|Overall Study|Protocol Violation|2|||
129968202|NCT04650698|467848585|FG001|Overall Study|Protocol Violation|1|||
129459613|NCT02599961|465978631|FG000|Overall Study|Other, Not Specified|3|||
129459614|NCT00143312|465978632|FG000|Overall Study|Death|11|||
129459615|NCT00143312|465978632|FG000|Overall Study|Adverse Event|2|||
129459616|NCT00143312|465978632|FG000|Overall Study|Lost to Follow-up|1|||
129459617|NCT00143312|465978632|FG000|Overall Study|Other|1|||
129459618|NCT00143312|465978632|FG000|Overall Study|Withdrawal by Subject|1|||
129459619|NCT01029366|465978633|FG000|Overall Study|Withdrawal by Subject|1|||
129459620|NCT01029366|465978634|FG001|Overall Study|Withdrawal by Subject|0|||
129459621|NCT01029366|465978633|FG000|Overall Study|Death|1|||
129459622|NCT01029366|465978634|FG001|Overall Study|Death|1|||
129459623|NCT01029366|465978633|FG000|Overall Study|disease progression|2|||
129459624|NCT01029366|465978634|FG001|Overall Study|disease progression|0|||
129459625|NCT01029366|465978633|FG000|Overall Study|manufacturing failure|0|||
129459626|NCT01029366|465978634|FG001|Overall Study|manufacturing failure|1|||
129459627|NCT00906087|465978640|FG000|Initial Washout|Withdrawal by Subject|1|||
129459628|NCT00906087|465978640|FG000|Initial Washout|Physician Decision|1|||
129459629|NCT00513500|465978654|FG000|Overall Study|Lost to Follow-up|35|||
129968203|NCT04650698|467848584|FG000|Overall Study|Withdrawal by Subject|0|||
129968204|NCT04650698|467848585|FG001|Overall Study|Withdrawal by Subject|1|||
129968205|NCT00307047|467848586|FG000|Overall Study|Lost to Follow-up|35|||
129968206|NCT00307047|467848587|FG001|Overall Study|Lost to Follow-up|24|||
129968207|NCT00307047|467848586|FG000|Overall Study|Withdrawal by Subject|6|||
129968208|NCT00307047|467848587|FG001|Overall Study|Withdrawal by Subject|6|||
129968209|NCT00307047|467848586|FG000|Overall Study|Physician Decision|1|||
129968210|NCT00307047|467848587|FG001|Overall Study|Physician Decision|2|||
129968211|NCT00307047|467848586|FG000|Overall Study|Lost to follow-up for other reasons|0|||
129968212|NCT00307047|467848587|FG001|Overall Study|Lost to follow-up for other reasons|1|||
129968213|NCT00307047|467848586|FG000|Overall Study|All death, all MI, all Revascularization|27|||
129968214|NCT00307047|467848587|FG001|Overall Study|All death, all MI, all Revascularization|16|||
129968215|NCT03778294|467848588|FG000|Overall Study|Death|1|||
129968216|NCT03778294|467848588|FG000|Overall Study|Issues with insurance|1|||
129968217|NCT03778294|467848588|FG000|Overall Study|disease progression before treatment|2|||
129968218|NCT00487825|467848592|FG000|Overall Study|Adverse Event|2|||
129968219|NCT00487825|467848593|FG001|Overall Study|Adverse Event|2|||
129968220|NCT00487825|467848592|FG000|Overall Study|Lack of Efficacy|1|||
129968221|NCT00487825|467848593|FG001|Overall Study|Lack of Efficacy|1|||
129968222|NCT00487825|467848592|FG000|Overall Study|Other|3|||
129968223|NCT00487825|467848593|FG001|Overall Study|Other|2|||
129968224|NCT02104505|467848594|FG000|First Intervention (14 Days)|Adverse Event|2|||
129968225|NCT02104505|467848595|FG001|First Intervention (14 Days)|Adverse Event|0|||
129968226|NCT02104505|467848594|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
129968227|NCT02104505|467848595|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
129968228|NCT02104505|467848594|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
129968229|NCT02104505|467848595|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
129968230|NCT02104505|467848594|FG000|First Intervention (14 Days)|exclusionary condition|0|||
129968231|NCT02104505|467848595|FG001|First Intervention (14 Days)|exclusionary condition|1|||
129968232|NCT02104505|467848594|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
129968233|NCT02104505|467848595|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
129968234|NCT02104505|467848594|FG000|Second Intervention (14 Days)|Adverse Event|2|||
129968235|NCT02104505|467848595|FG001|Second Intervention (14 Days)|Adverse Event|0|||
129968236|NCT01639742|467848598|FG000|Overall Study|Study Ongoing|17|||
129968237|NCT01639742|467848598|FG000|Overall Study|Lost to Follow-up|1|||
129968238|NCT01190644|467848599|FG000|Overall Study|Death|2|||
129968239|NCT01190644|467848599|FG000|Overall Study|Disease progression|1|||
129968240|NCT02366143|467848600|FG000|Overall Study|Death|307|||
129968241|NCT02366143|467848601|FG001|Overall Study|Death|278|||
129968242|NCT02366143|467848602|FG002|Overall Study|Death|280|||
129968243|NCT02366143|467848600|FG000|Overall Study|Lost to Follow-up|2|||
129968244|NCT02366143|467848601|FG001|Overall Study|Lost to Follow-up|4|||
129968245|NCT02366143|467848602|FG002|Overall Study|Lost to Follow-up|2|||
129968246|NCT02366143|467848600|FG000|Overall Study|Physician Decision|1|||
129968247|NCT02366143|467848601|FG001|Overall Study|Physician Decision|2|||
129968248|NCT02366143|467848602|FG002|Overall Study|Physician Decision|1|||
129968249|NCT02366143|467848600|FG000|Overall Study|Protocol Violation|0|||
129968250|NCT02366143|467848601|FG001|Overall Study|Protocol Violation|0|||
129968251|NCT02366143|467848602|FG002|Overall Study|Protocol Violation|2|||
129968252|NCT02366143|467848600|FG000|Overall Study|Withdrawal by Subject|16|||
129968253|NCT02366143|467848601|FG001|Overall Study|Withdrawal by Subject|17|||
129968254|NCT02366143|467848602|FG002|Overall Study|Withdrawal by Subject|22|||
129968255|NCT02366143|467848600|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
129968256|NCT02366143|467848601|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
129968257|NCT02366143|467848602|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
129968258|NCT02366143|467848600|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
129968259|NCT02366143|467848601|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
129968260|NCT02366143|467848602|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
129459630|NCT00513500|465978655|FG001|Overall Study|Lost to Follow-up|39|||
129968261|NCT02366143|467848600|FG000|Overall Study|Randomization Error|1|||
129968262|NCT02366143|467848601|FG001|Overall Study|Randomization Error|0|||
129968263|NCT02366143|467848602|FG002|Overall Study|Randomization Error|0|||
129968264|NCT02366143|467848600|FG000|Overall Study|PI Move and Site Closure|1|||
129968265|NCT02366143|467848601|FG001|Overall Study|PI Move and Site Closure|0|||
129968266|NCT02366143|467848602|FG002|Overall Study|PI Move and Site Closure|1|||
129968267|NCT02366143|467848600|FG000|Overall Study|Study Terminated By Sponsor|0|||
129968268|NCT02366143|467848601|FG001|Overall Study|Study Terminated By Sponsor|0|||
129968269|NCT02366143|467848602|FG002|Overall Study|Study Terminated By Sponsor|2|||
129968270|NCT02366143|467848600|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
129968271|NCT02366143|467848601|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
129968272|NCT02366143|467848602|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
129968273|NCT02366143|467848600|FG000|Overall Study|Patient moved to roll-over study|1|||
129968274|NCT02366143|467848601|FG001|Overall Study|Patient moved to roll-over study|19|||
129968275|NCT02366143|467848602|FG002|Overall Study|Patient moved to roll-over study|28|||
129968276|NCT02366143|467848600|FG000|Overall Study|Patient moved to commercial stock|0|||
129968277|NCT02366143|467848601|FG001|Overall Study|Patient moved to commercial stock|0|||
129968278|NCT02366143|467848602|FG002|Overall Study|Patient moved to commercial stock|1|||
129968279|NCT02366143|467848600|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
129968280|NCT02366143|467848601|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
129968281|NCT02366143|467848602|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
129968282|NCT02366143|467848600|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
129968283|NCT02366143|467848601|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
129968284|NCT02366143|467848602|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
129968285|NCT02366143|467848600|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
129968286|NCT02366143|467848601|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
129968287|NCT02366143|467848602|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
129968288|NCT02366143|467848600|FG000|Overall Study|Requester's instructions|1|||
129968289|NCT02366143|467848601|FG001|Overall Study|Requester's instructions|1|||
129968290|NCT02366143|467848602|FG002|Overall Study|Requester's instructions|1|||
129968291|NCT02366143|467848600|FG000|Overall Study|Uneligible|0|||
129968292|NCT02366143|467848601|FG001|Overall Study|Uneligible|1|||
129968293|NCT02366143|467848602|FG002|Overall Study|Uneligible|0|||
129968294|NCT02366143|467848600|FG000|Overall Study|Post Trial Migration|0|||
129968295|NCT02366143|467848601|FG001|Overall Study|Post Trial Migration|1|||
129968296|NCT02366143|467848602|FG002|Overall Study|Post Trial Migration|0|||
129968297|NCT02366143|467848600|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
129968298|NCT02366143|467848601|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
129968299|NCT02366143|467848602|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
129968300|NCT02366143|467848600|FG000|Overall Study|Patient switched to PTAP|0|||
129968301|NCT02366143|467848601|FG001|Overall Study|Patient switched to PTAP|1|||
129968302|NCT02366143|467848602|FG002|Overall Study|Patient switched to PTAP|0|||
129968303|NCT02366143|467848600|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
129968304|NCT02366143|467848601|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
129968305|NCT02366143|467848602|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
129968306|NCT04411186|467848603|FG000|Overall Study|Withdrawn due to protocol violation|0|||
129968307|NCT04411186|467848604|FG001|Overall Study|Withdrawn due to protocol violation|1|||
129968308|NCT01053247|467848605|FG000|Overall Study|Withdrawal by Subject|9|||
129968309|NCT01053247|467848606|FG001|Overall Study|Withdrawal by Subject|4|||
129968310|NCT01053247|467848607|FG002|Overall Study|Withdrawal by Subject|15|||
129968311|NCT01053247|467848605|FG000|Overall Study|Lack of Efficacy|1|||
129968312|NCT01053247|467848606|FG001|Overall Study|Lack of Efficacy|0|||
129968313|NCT01053247|467848607|FG002|Overall Study|Lack of Efficacy|1|||
129968314|NCT01053247|467848605|FG000|Overall Study|Protocol Violation|2|||
129968315|NCT01053247|467848606|FG001|Overall Study|Protocol Violation|1|||
129968316|NCT01053247|467848607|FG002|Overall Study|Protocol Violation|2|||
129968317|NCT01053247|467848605|FG000|Overall Study|Lost to Follow-up|8|||
129968318|NCT01053247|467848606|FG001|Overall Study|Lost to Follow-up|5|||
129968319|NCT01053247|467848607|FG002|Overall Study|Lost to Follow-up|7|||
129968320|NCT01053247|467848605|FG000|Overall Study|Adverse Event|0|||
129968321|NCT01053247|467848606|FG001|Overall Study|Adverse Event|9|||
129968322|NCT01053247|467848607|FG002|Overall Study|Adverse Event|3|||
129968323|NCT00701909|467848610|FG000|Overall Study|Withdrawal by Subject|0|||
129968324|NCT00701909|467848611|FG001|Overall Study|Withdrawal by Subject|1|||
129968325|NCT03023722|467848616|FG000|Overall Study|No follow-up assessment|4|||
129968326|NCT01385748|467848617|FG000|Overall Study|Withdrawal by Subject|7|||
129968327|NCT01385748|467848618|FG001|Overall Study|Withdrawal by Subject|4|||
129968328|NCT01385748|467848619|FG002|Overall Study|Withdrawal by Subject|5|||
129968329|NCT01385748|467848617|FG000|Overall Study|Noncompliance|3|||
129968330|NCT01385748|467848618|FG001|Overall Study|Noncompliance|1|||
129968331|NCT01385748|467848619|FG002|Overall Study|Noncompliance|6|||
129968332|NCT01385748|467848617|FG000|Overall Study|Other|1|||
129968333|NCT01385748|467848618|FG001|Overall Study|Other|7|||
129968334|NCT01385748|467848619|FG002|Overall Study|Other|1|||
129968335|NCT01385748|467848617|FG000|Overall Study|Adverse Event|4|||
129968336|NCT01385748|467848618|FG001|Overall Study|Adverse Event|2|||
129968337|NCT01385748|467848619|FG002|Overall Study|Adverse Event|1|||
129968338|NCT00589303|467848626|FG000|Overall Study|Withdrawal by Subject|2|||
129968339|NCT00589303|467848627|FG001|Overall Study|Withdrawal by Subject|1|||
129968340|NCT00730015|467848630|FG000|Overall Study|Adverse Event|11|||
129968341|NCT00730015|467848631|FG001|Overall Study|Adverse Event|10|||
129968342|NCT00730015|467848632|FG002|Overall Study|Adverse Event|8|||
129968343|NCT00730015|467848630|FG000|Overall Study|Protocol Violation|2|||
129968344|NCT00730015|467848631|FG001|Overall Study|Protocol Violation|6|||
129968345|NCT00730015|467848632|FG002|Overall Study|Protocol Violation|4|||
129968346|NCT00730015|467848630|FG000|Overall Study|Withdrawal by Subject|12|||
129968347|NCT00730015|467848631|FG001|Overall Study|Withdrawal by Subject|12|||
129968348|NCT00730015|467848632|FG002|Overall Study|Withdrawal by Subject|8|||
129968349|NCT00730015|467848630|FG000|Overall Study|Lost to Follow-up|4|||
129968350|NCT00730015|467848631|FG001|Overall Study|Lost to Follow-up|10|||
129968351|NCT00730015|467848632|FG002|Overall Study|Lost to Follow-up|3|||
129968352|NCT00730015|467848630|FG000|Overall Study|Lack of Efficacy|1|||
129968353|NCT00730015|467848631|FG001|Overall Study|Lack of Efficacy|2|||
129968354|NCT00730015|467848632|FG002|Overall Study|Lack of Efficacy|8|||
129968355|NCT00730015|467848630|FG000|Overall Study|Other Reason|1|||
129968356|NCT00730015|467848631|FG001|Overall Study|Other Reason|0|||
129968357|NCT00730015|467848632|FG002|Overall Study|Other Reason|1|||
129968358|NCT01663506|467848633|FG000|Overall Study|Lack of Efficacy|3|||
129968359|NCT01663506|467848633|FG000|Overall Study|Consent Withdrawal by Subject|1|||
129968360|NCT01663506|467848633|FG000|Overall Study|Lost to Follow-up|1|||
129968361|NCT01663506|467848633|FG000|Overall Study|Adverse Event|1|||
129968362|NCT01663506|467848633|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
129968363|NCT01234883|467848634|FG000|Overall Study|Early treatment release|8|||
129968364|NCT01234883|467848635|FG001|Overall Study|Early treatment release|10|||
129968365|NCT01234883|467848634|FG000|Overall Study|Parent/guardian withdrew consent|1|||
129968366|NCT01234883|467848635|FG001|Overall Study|Parent/guardian withdrew consent|2|||
129968367|NCT01234883|467848634|FG000|Overall Study|Technical difficulties with IV infusion|0|||
129968368|NCT01234883|467848635|FG001|Overall Study|Technical difficulties with IV infusion|1|||
129968369|NCT01234883|467848634|FG000|Overall Study|Inclusion/exclusion failure|1|||
129968370|NCT01234883|467848635|FG001|Overall Study|Inclusion/exclusion failure|0|||
129968371|NCT04351269|467848636|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
129968372|NCT04351269|467848637|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
129968373|NCT04351269|467848638|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
129968374|NCT04351269|467848636|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
129968375|NCT04351269|467848637|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
129968376|NCT04351269|467848638|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
129968377|NCT04351269|467848636|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
129968378|NCT04351269|467848637|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
129968379|NCT04351269|467848638|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
129968380|NCT04351269|467848636|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
129968381|NCT04351269|467848637|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
129968382|NCT04351269|467848638|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
129968383|NCT04351269|467848636|FG000|Overall Study|Lost to Follow-up|1|||
129968384|NCT04351269|467848637|FG001|Overall Study|Lost to Follow-up|3|||
129968385|NCT04351269|467848638|FG002|Overall Study|Lost to Follow-up|0|||
129968386|NCT03210519|467848639|FG000|Overall Study|Adverse Event|2|||
129968387|NCT03210519|467848640|FG001|Overall Study|Adverse Event|0|||
129968388|NCT02270671|467848643|FG000|Overall Study|Withdrawal by Subject|1|||
129968389|NCT02270671|467848644|FG001|Overall Study|Withdrawal by Subject|1|||
129968390|NCT02270671|467848643|FG000|Overall Study|Protocol Violation|0|||
129968391|NCT02270671|467848644|FG001|Overall Study|Protocol Violation|1|||
129968392|NCT02270671|467848643|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
129968393|NCT02270671|467848644|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
129968394|NCT02270671|467848643|FG000|Overall Study|Lost to Follow-up|2|||
129968395|NCT02270671|467848644|FG001|Overall Study|Lost to Follow-up|1|||
129968396|NCT00174447|467848654|FG000|Overall Study|Adverse Event|19|||
129968397|NCT00174447|467848654|FG000|Overall Study|Withdrawal by Subject|15|||
129968398|NCT00174447|467848654|FG000|Overall Study|Protocol Violation|1|||
129968399|NCT00174447|467848654|FG000|Overall Study|Lack of Efficacy|1|||
129968400|NCT00174447|467848654|FG000|Overall Study|Administrative reason/Other|2|||
129968401|NCT01437423|467848655|FG000|Overall Study|Lost to Follow-up|12|||
129968402|NCT01437423|467848655|FG000|Overall Study|Off label usage|3|||
129968403|NCT00633945|467848656|FG000|Overall Study|Physician Decision|2|||
129968404|NCT01271504|467848657|FG000|Overall Study|Death|7|||
129968405|NCT01271504|467848658|FG001|Overall Study|Death|6|||
129968406|NCT01271504|467848659|FG002|Overall Study|Death|32|||
129968407|NCT01271504|467848660|FG003|Overall Study|Death|32|||
129968408|NCT01271504|467848657|FG000|Overall Study|Lost to Follow-up|0|||
129968409|NCT01271504|467848658|FG001|Overall Study|Lost to Follow-up|1|||
129968410|NCT01271504|467848659|FG002|Overall Study|Lost to Follow-up|3|||
129968411|NCT01271504|467848660|FG003|Overall Study|Lost to Follow-up|1|||
129968412|NCT01271504|467848657|FG000|Overall Study|Protocol Violation|0|||
129968413|NCT01271504|467848658|FG001|Overall Study|Protocol Violation|0|||
129968414|NCT01271504|467848659|FG002|Overall Study|Protocol Violation|0|||
129968415|NCT01271504|467848660|FG003|Overall Study|Protocol Violation|2|||
129968416|NCT01271504|467848657|FG000|Overall Study|Administrative Reasons|0|||
129968417|NCT01271504|467848658|FG001|Overall Study|Administrative Reasons|0|||
129968418|NCT01271504|467848659|FG002|Overall Study|Administrative Reasons|6|||
129968419|NCT01271504|467848660|FG003|Overall Study|Administrative Reasons|5|||
129968420|NCT01271504|467848657|FG000|Overall Study|Withdrawal by Subject|0|||
129968421|NCT01271504|467848658|FG001|Overall Study|Withdrawal by Subject|0|||
129968422|NCT01271504|467848659|FG002|Overall Study|Withdrawal by Subject|1|||
129968423|NCT01271504|467848660|FG003|Overall Study|Withdrawal by Subject|3|||
129968424|NCT01271504|467848657|FG000|Overall Study|Other|0|||
129968425|NCT01271504|467848658|FG001|Overall Study|Other|1|||
129968426|NCT01271504|467848659|FG002|Overall Study|Other|2|||
129968427|NCT01271504|467848660|FG003|Overall Study|Other|0|||
129968428|NCT03865953|467848661|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
129968429|NCT03865953|467848662|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
129968430|NCT03865953|467848661|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
129968431|NCT03865953|467848662|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
129968432|NCT03865953|467848661|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
129968433|NCT03865953|467848662|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
129968434|NCT02353871|467848667|FG000|Overall Study|Protocol deviation|0|||
129968435|NCT02353871|467848668|FG001|Overall Study|Protocol deviation|1|||
129968436|NCT02353871|467848667|FG000|Overall Study|Consent withdrawn|1|||
129968437|NCT02353871|467848668|FG001|Overall Study|Consent withdrawn|8|||
129968438|NCT02353871|467848667|FG000|Overall Study|Lost to Follow-up|2|||
129968439|NCT02353871|467848668|FG001|Overall Study|Lost to Follow-up|0|||
129968440|NCT00115336|467848669|FG000|Overall Study|Hospital discharge before study drug|0|||
129968441|NCT00115336|467848670|FG001|Overall Study|Hospital discharge before study drug|1|||
129968442|NCT01191008|467848684|FG000|Overall Study|Protocol Violation|7|||
129968443|NCT01191008|467848684|FG000|Overall Study|Lost to Follow-up|8|||
129968444|NCT04905849|467848687|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
129968445|NCT04905849|467848688|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
129968446|NCT00838929|467848693|FG000|Overall Study|Protocol Violation|0|||
129968447|NCT00838929|467848694|FG001|Overall Study|Protocol Violation|1|||
129968448|NCT00838929|467848695|FG002|Overall Study|Protocol Violation|0|||
129968449|NCT00838929|467848693|FG000|Overall Study|Disease progression|0|||
129968450|NCT00838929|467848694|FG001|Overall Study|Disease progression|2|||
129968451|NCT00838929|467848695|FG002|Overall Study|Disease progression|1|||
129968452|NCT04913948|467848703|FG000|Overall Study|Withdrawal by Subject|2|||
129968453|NCT04913948|467848703|FG000|Overall Study|Sample processing issues|1|||
129968454|NCT04913948|467848703|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
129968455|NCT01068210|467848706|FG000|Overall Study|Lost to Follow-up|1|||
129968456|NCT01068210|467848707|FG001|Overall Study|Lost to Follow-up|2|||
129968457|NCT01068210|467848708|FG002|Overall Study|Lost to Follow-up|2|||
129968458|NCT01068210|467848709|FG003|Overall Study|Lost to Follow-up|1|||
129968459|NCT01068210|467848706|FG000|Overall Study|Second cancer|0|||
129968460|NCT01068210|467848707|FG001|Overall Study|Second cancer|1|||
129968461|NCT01068210|467848708|FG002|Overall Study|Second cancer|0|||
129968462|NCT01068210|467848709|FG003|Overall Study|Second cancer|0|||
129968463|NCT01068210|467848706|FG000|Overall Study|Disease progression|0|||
129968464|NCT01068210|467848707|FG001|Overall Study|Disease progression|0|||
129968465|NCT01068210|467848708|FG002|Overall Study|Disease progression|0|||
129968466|NCT01068210|467848709|FG003|Overall Study|Disease progression|2|||
129968467|NCT04199052|467848710|FG000|Overall Study|Lost to Follow-up|11|||
129968468|NCT04199052|467848711|FG001|Overall Study|Lost to Follow-up|18|||
129968469|NCT00699842|467848712|FG000|Overall Study|Death|0|||
129968470|NCT00699842|467848713|FG001|Overall Study|Death|1|||
129968471|NCT00699842|467848714|FG002|Overall Study|Death|0|||
129968472|NCT03522389|467848715|FG000|Overall Study|Lost to Follow-up|1|||
129968473|NCT03522389|467848716|FG001|Overall Study|Lost to Follow-up|1|||
129968474|NCT03522389|467848717|FG002|Overall Study|Lost to Follow-up|2|||
129968475|NCT03522389|467848715|FG000|Overall Study|had herniated nucleus pulposus|0|||
129968476|NCT03522389|467848716|FG001|Overall Study|had herniated nucleus pulposus|1|||
129968477|NCT03522389|467848717|FG002|Overall Study|had herniated nucleus pulposus|0|||
129968478|NCT03522389|467848715|FG000|Overall Study|go to work in other province|1|||
129968479|NCT03522389|467848716|FG001|Overall Study|go to work in other province|0|||
129968480|NCT03522389|467848717|FG002|Overall Study|go to work in other province|0|||
129968481|NCT04750577|467848718|FG000|Overall Study|Adverse Event|2|||
129968482|NCT04750577|467848719|FG001|Overall Study|Adverse Event|10|||
129968483|NCT04750577|467848720|FG002|Overall Study|Adverse Event|8|||
129968484|NCT04750577|467848721|FG003|Overall Study|Adverse Event|1|||
129968485|NCT04750577|467848718|FG000|Overall Study|Change of residence|0|||
129968486|NCT04750577|467848719|FG001|Overall Study|Change of residence|0|||
129968487|NCT04750577|467848720|FG002|Overall Study|Change of residence|1|||
129968488|NCT04750577|467848721|FG003|Overall Study|Change of residence|0|||
129968489|NCT04750577|467848718|FG000|Overall Study|Burden of study procedures|0|||
129968490|NCT04750577|467848719|FG001|Overall Study|Burden of study procedures|2|||
129968491|NCT04750577|467848720|FG002|Overall Study|Burden of study procedures|2|||
129968492|NCT04750577|467848721|FG003|Overall Study|Burden of study procedures|0|||
129968493|NCT04750577|467848718|FG000|Overall Study|Prematurely discontinued|0|||
129968494|NCT04750577|467848719|FG001|Overall Study|Prematurely discontinued|0|||
129968495|NCT04750577|467848720|FG002|Overall Study|Prematurely discontinued|0|||
129968496|NCT04750577|467848721|FG003|Overall Study|Prematurely discontinued|2|||
129968497|NCT04750577|467848718|FG000|Overall Study|Protocol deviation|1|||
129968498|NCT04750577|467848719|FG001|Overall Study|Protocol deviation|1|||
129968499|NCT04750577|467848720|FG002|Overall Study|Protocol deviation|1|||
129968500|NCT04750577|467848721|FG003|Overall Study|Protocol deviation|1|||
129968501|NCT04750577|467848718|FG000|Overall Study|Other than listed|3|||
129968502|NCT04750577|467848719|FG001|Overall Study|Other than listed|2|||
129968503|NCT04750577|467848720|FG002|Overall Study|Other than listed|2|||
129968504|NCT04750577|467848721|FG003|Overall Study|Other than listed|1|||
129968505|NCT04750577|467848718|FG000|Overall Study|Not treated|0|||
129968506|NCT04750577|467848719|FG001|Overall Study|Not treated|0|||
129968507|NCT04750577|467848720|FG002|Overall Study|Not treated|0|||
129968508|NCT04750577|467848721|FG003|Overall Study|Not treated|2|||
129968509|NCT04599907|467848726|FG000|Overall Study|Withdrawal by Subject|1|||
129968510|NCT04599907|467848727|FG001|Overall Study|Withdrawal by Subject|7|||
129968511|NCT04599907|467848728|FG002|Overall Study|Withdrawal by Subject|6|||
129968512|NCT04599907|467848726|FG000|Overall Study|Lost to Follow-up|0|||
129968513|NCT04599907|467848727|FG001|Overall Study|Lost to Follow-up|1|||
129968514|NCT04599907|467848728|FG002|Overall Study|Lost to Follow-up|0|||
129968515|NCT03668223|467848730|FG000|Overall Study|Death|10|||
129968516|NCT03668223|467848731|FG001|Overall Study|Death|5|||
129968517|NCT03668223|467848730|FG000|Overall Study|Lost to Follow-up|12|||
129968518|NCT03668223|467848731|FG001|Overall Study|Lost to Follow-up|12|||
129968519|NCT03668223|467848730|FG000|Overall Study|Withdrawal by Subject|8|||
129968520|NCT03668223|467848731|FG001|Overall Study|Withdrawal by Subject|3|||
129968521|NCT01103232|467848732|FG000|Overall Study|Withdrawal by Subject|1|||
129968522|NCT01103232|467848733|FG001|Overall Study|Withdrawal by Subject|1|||
129968523|NCT01103232|467848732|FG000|Overall Study|Protocol Violation|0|||
129968524|NCT01103232|467848733|FG001|Overall Study|Protocol Violation|1|||
129968525|NCT05347485|467848736|FG000|Overall Study|Death|14|||
129968526|NCT05347485|467848736|FG000|Overall Study|Lost to Follow-up|2|||
129968527|NCT05347485|467848736|FG000|Overall Study|Withdrawal by Subject|13|||
129968528|NCT05347485|467848736|FG000|Overall Study|Progressive Disease|1|||
129968529|NCT05347485|467848736|FG000|Overall Study|Study Terminated by Sponsor|49|||
129968530|NCT05347485|467848736|FG000|Overall Study|Other|1|||
129968531|NCT05347485|467848736|FG000|Overall Study|Enrolled (consented) but not treated|4|||
129968532|NCT05347485|467848736|FG000|Overall Study|Disease Relapse|2|||
129968533|NCT04886518|467848737|FG000|Overall Study|Noncompliance with study drug|1|||
129968534|NCT04886518|467848738|FG001|Overall Study|Noncompliance with study drug|0|||
129968535|NCT04886518|467848739|FG002|Overall Study|Noncompliance with study drug|0|||
129968536|NCT04886518|467848737|FG000|Overall Study|Adverse Event|0|||
129968537|NCT04886518|467848738|FG001|Overall Study|Adverse Event|1|||
129968538|NCT04886518|467848739|FG002|Overall Study|Adverse Event|0|||
129459631|NCT00513500|465978654|FG000|Overall Study|Death|2|||
129459632|NCT00513500|465978655|FG001|Overall Study|Death|1|||
129459633|NCT00513500|465978654|FG000|Overall Study|Hospitalized|4|||
129459634|NCT00513500|465978655|FG001|Overall Study|Hospitalized|14|||
129459635|NCT00749996|465978658|FG000|Overall Study|Lost to Follow-up|7|||
129459636|NCT00749996|465978659|FG001|Overall Study|Lost to Follow-up|4|||
129459637|NCT00749996|465978658|FG000|Overall Study|Withdrawal by Subject|5|||
129459638|NCT00749996|465978659|FG001|Overall Study|Withdrawal by Subject|4|||
129459639|NCT00749996|465978658|FG000|Overall Study|Protocol Violation|2|||
129459640|NCT00749996|465978659|FG001|Overall Study|Protocol Violation|3|||
129459641|NCT00749996|465978658|FG000|Overall Study|Physician Decision|2|||
129459642|NCT00749996|465978659|FG001|Overall Study|Physician Decision|0|||
129459643|NCT00749996|465978658|FG000|Overall Study|Pregnancy|0|||
129459644|NCT00749996|465978659|FG001|Overall Study|Pregnancy|2|||
129459645|NCT00749996|465978658|FG000|Overall Study|Adverse Event|1|||
129459646|NCT00749996|465978659|FG001|Overall Study|Adverse Event|0|||
129459647|NCT00749996|465978658|FG000|Overall Study|Death|1|||
129459648|NCT00749996|465978659|FG001|Overall Study|Death|0|||
129459649|NCT00517829|465978660|FG000|Overall Study|Adverse Event|22|||
129459650|NCT00517829|465978661|FG001|Overall Study|Adverse Event|34|||
129459651|NCT00517829|465978660|FG000|Overall Study|Disease Progression|39|||
129459652|NCT00517829|465978661|FG001|Overall Study|Disease Progression|32|||
129459653|NCT00517829|465978660|FG000|Overall Study|Patient Request|6|||
129459654|NCT00517829|465978661|FG001|Overall Study|Patient Request|5|||
129459655|NCT00517829|465978660|FG000|Overall Study|Investigator Request|5|||
129968539|NCT04886518|467848737|FG000|Overall Study|Withdrawal by Subject|1|||
129968540|NCT04886518|467848738|FG001|Overall Study|Withdrawal by Subject|0|||
129968541|NCT04886518|467848739|FG002|Overall Study|Withdrawal by Subject|0|||
129968542|NCT03733899|467848740|FG000|Period 1|Protocol Violation|0|||
129968543|NCT03733899|467848741|FG001|Period 1|Protocol Violation|0|||
129968544|NCT03733899|467848742|FG002|Period 1|Protocol Violation|0|||
129968545|NCT03733899|467848743|FG003|Period 1|Protocol Violation|0|||
129968546|NCT03733899|467848744|FG004|Period 1|Protocol Violation|0|||
129968547|NCT03733899|467848745|FG005|Period 1|Protocol Violation|1|||
129968548|NCT03733899|467848740|FG000|Period 2|Unscuccessful Treatment|0|||
129968549|NCT03733899|467848741|FG001|Period 2|Unscuccessful Treatment|1|||
129968550|NCT03733899|467848742|FG002|Period 2|Unscuccessful Treatment|0|||
129968551|NCT03733899|467848743|FG003|Period 2|Unscuccessful Treatment|0|||
129459656|NCT00517829|465978661|FG001|Overall Study|Investigator Request|3|||
129459657|NCT00517829|465978660|FG000|Overall Study|Other|3|||
129459658|NCT00517829|465978661|FG001|Overall Study|Other|1|||
129459659|NCT00606086|465978662|FG000|Overall Study|Adverse Event|1|||
129459660|NCT00606086|465978663|FG001|Overall Study|Adverse Event|1|||
129459661|NCT00606086|465978662|FG000|Overall Study|Lost to Follow-up|4|||
129459662|NCT00606086|465978663|FG001|Overall Study|Lost to Follow-up|8|||
129459663|NCT00606086|465978662|FG000|Overall Study|Protocol Violation|1|||
129459664|NCT00606086|465978663|FG001|Overall Study|Protocol Violation|0|||
129459665|NCT00606086|465978662|FG000|Overall Study|Withdrawal by Subject|5|||
129459666|NCT00606086|465978663|FG001|Overall Study|Withdrawal by Subject|3|||
129459667|NCT00606086|465978662|FG000|Overall Study|Non-compliance|0|||
129459668|NCT00606086|465978663|FG001|Overall Study|Non-compliance|1|||
129459669|NCT00606086|465978662|FG000|Overall Study|Randomized, not treated|1|||
129459670|NCT00606086|465978663|FG001|Overall Study|Randomized, not treated|2|||
129459671|NCT00796315|465978670|FG000|Overall Study|Protocol Violation|0|||
129459672|NCT00796315|465978671|FG001|Overall Study|Protocol Violation|1|||
129459673|NCT00796315|465978672|FG002|Overall Study|Protocol Violation|0|||
129459674|NCT00689871|465978679|FG000|Overall Study|Lost to Follow-up|123|||
129459675|NCT00689871|465978680|FG001|Overall Study|Lost to Follow-up|13|||
129459676|NCT00689871|465978681|FG002|Overall Study|Lost to Follow-up|37|||
129459677|NCT00689871|465978682|FG003|Overall Study|Lost to Follow-up|1|||
129968552|NCT03733899|467848744|FG004|Period 2|Unscuccessful Treatment|0|||
129968553|NCT03733899|467848745|FG005|Period 2|Unscuccessful Treatment|0|||
129968554|NCT03733899|467848740|FG000|Period 3|Withdrawal by Subject|1|||
129968555|NCT03733899|467848741|FG001|Period 3|Withdrawal by Subject|0|||
129968556|NCT03733899|467848742|FG002|Period 3|Withdrawal by Subject|0|||
129968557|NCT03733899|467848743|FG003|Period 3|Withdrawal by Subject|0|||
129968558|NCT03733899|467848744|FG004|Period 3|Withdrawal by Subject|0|||
129459678|NCT00689871|465978679|FG000|Overall Study|Explanted of All Study Devices|36|||
129459679|NCT00689871|465978680|FG001|Overall Study|Explanted of All Study Devices|25|||
129459680|NCT00689871|465978681|FG002|Overall Study|Explanted of All Study Devices|29|||
129459681|NCT00689871|465978682|FG003|Overall Study|Explanted of All Study Devices|3|||
129459682|NCT00689871|465978679|FG000|Overall Study|Withdrawal by Subject|13|||
129459683|NCT00689871|465978680|FG001|Overall Study|Withdrawal by Subject|3|||
129459684|NCT00689871|465978681|FG002|Overall Study|Withdrawal by Subject|4|||
129459685|NCT00689871|465978682|FG003|Overall Study|Withdrawal by Subject|1|||
129459686|NCT00689871|465978679|FG000|Overall Study|Death|1|||
129459687|NCT00689871|465978680|FG001|Overall Study|Death|10|||
129459688|NCT00689871|465978681|FG002|Overall Study|Death|2|||
129968559|NCT03733899|467848745|FG005|Period 3|Withdrawal by Subject|0|||
129968560|NCT02354651|467850484|FG000|Overall Study|Withdrawal by Subject|2|||
129459689|NCT00689871|465978682|FG003|Overall Study|Death|2|||
129459690|NCT00689871|465978679|FG000|Overall Study|Physician Decision|2|||
129459691|NCT00689871|465978680|FG001|Overall Study|Physician Decision|1|||
129459692|NCT00689871|465978681|FG002|Overall Study|Physician Decision|1|||
129459693|NCT00689871|465978682|FG003|Overall Study|Physician Decision|0|||
129459694|NCT00542269|465978685|FG000|Overall Study|Adverse Event|10|||
129459695|NCT00542269|465978686|FG001|Overall Study|Adverse Event|4|||
129968561|NCT02354651|467850484|FG000|Overall Study|Physician Decision|1|||
129968562|NCT01377389|467850485|FG000|Overall Study|Withdrawal by Subject|1|||
129968563|NCT01377389|467850485|FG000|Overall Study|Screen failure|2|||
129968564|NCT03382561|467850486|FG000|Overall Study|Disease progression|47|||
129968565|NCT03382561|467850487|FG001|Overall Study|Disease progression|6|||
129968566|NCT03382561|467850486|FG000|Overall Study|Adverse Event|10|||
129968567|NCT03382561|467850487|FG001|Overall Study|Adverse Event|2|||
129968568|NCT03382561|467850486|FG000|Overall Study|Death|8|||
129968569|NCT03382561|467850487|FG001|Overall Study|Death|3|||
129968570|NCT03382561|467850486|FG000|Overall Study|Withdrawal by Subject|6|||
129968571|NCT03382561|467850487|FG001|Overall Study|Withdrawal by Subject|5|||
129968572|NCT03382561|467850486|FG000|Overall Study|Alternative therapy|2|||
129968573|NCT03382561|467850487|FG001|Overall Study|Alternative therapy|8|||
129968574|NCT03382561|467850486|FG000|Overall Study|Never started treatment|3|||
129968575|NCT03382561|467850487|FG001|Overall Study|Never started treatment|6|||
129459696|NCT00542269|465978687|FG002|Overall Study|Adverse Event|5|||
129459697|NCT00542269|465978685|FG000|Overall Study|Protocol Violation|1|||
129968576|NCT03382561|467850486|FG000|Overall Study|Lack of Efficacy|0|||
129968577|NCT03382561|467850487|FG001|Overall Study|Lack of Efficacy|1|||
129459698|NCT00542269|465978686|FG001|Overall Study|Protocol Violation|1|||
129968578|NCT03382561|467850486|FG000|Overall Study|Physician Decision|0|||
129968579|NCT03382561|467850487|FG001|Overall Study|Physician Decision|1|||
129968580|NCT03382561|467850486|FG000|Overall Study|Other complicating disease|0|||
129968581|NCT03382561|467850487|FG001|Overall Study|Other complicating disease|1|||
129968582|NCT01131104|467850488|FG000|Overall Study|Withdrawal by Subject|3|||
129968583|NCT01131104|467850488|FG000|Overall Study|Physician Decision|4|||
129968584|NCT01131104|467850488|FG000|Overall Study|Information Not Available|5|||
129968585|NCT01131104|467850488|FG000|Overall Study|No Information on Index Date of Onset|1|||
129968586|NCT01245140|467850489|FG000|Overall Study|Adverse Event|1|||
129968587|NCT01245140|467850490|FG001|Overall Study|Adverse Event|3|||
129968588|NCT01245140|467850489|FG000|Overall Study|Lack of Efficacy|2|||
129968589|NCT01245140|467850490|FG001|Overall Study|Lack of Efficacy|4|||
129968590|NCT01245140|467850489|FG000|Overall Study|Protocol Violation|0|||
129968591|NCT01245140|467850490|FG001|Overall Study|Protocol Violation|1|||
129968592|NCT01245140|467850489|FG000|Overall Study|Withdrawal by Subject|0|||
129968593|NCT01245140|467850490|FG001|Overall Study|Withdrawal by Subject|1|||
129968594|NCT01245140|467850489|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
129968595|NCT01245140|467850490|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
129968596|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968597|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
129968598|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
129968599|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
129968600|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968601|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968602|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968603|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
129968604|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968605|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
129968606|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
129968607|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
129968608|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968609|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968610|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968611|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
129968612|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
129968613|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968614|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968615|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968616|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968617|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968618|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968619|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
129968620|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
129968621|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968622|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968623|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968624|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968625|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968626|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968627|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
129968628|NCT04836559|467850491|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968629|NCT04836559|467850492|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968630|NCT04836559|467850493|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968631|NCT04836559|467850494|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
129968632|NCT04836559|467850495|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968633|NCT04836559|467850496|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968634|NCT04836559|467850497|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968635|NCT04836559|467850498|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
129968636|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968637|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968638|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968639|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
129968640|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
129968641|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
129968642|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
129968643|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
129968644|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968645|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968646|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968647|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
129968648|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
129968649|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
129968650|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
129968651|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
129968652|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968653|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968654|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968655|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968656|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
129968657|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
129968658|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
129968659|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
129968660|NCT04836559|467850491|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968661|NCT04836559|467850492|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968662|NCT04836559|467850493|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968663|NCT04836559|467850494|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968664|NCT04836559|467850495|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968665|NCT04836559|467850496|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968666|NCT04836559|467850497|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
129968667|NCT04836559|467850498|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
129968668|NCT00334542|467850499|FG000|Overall Study|Adverse Event|3|||
129968669|NCT00334542|467850499|FG000|Overall Study|Withdrawal by Subject|1|||
129968670|NCT00334542|467850499|FG000|Overall Study|New cancer diagnosis|1|||
129968671|NCT02370251|467850500|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
129968672|NCT02370251|467850500|FG000|Overall Study|Death|4|||
129968673|NCT00013611|467850501|FG000|Overall Study|Lost to Follow-up|91|||
129968674|NCT00013611|467850502|FG001|Overall Study|Lost to Follow-up|100|||
129968675|NCT01150045|467850503|FG000|Overall Study|Protocol Violation|0|||
129968676|NCT01150045|467850504|FG001|Overall Study|Protocol Violation|1|||
129968677|NCT01150045|467850505|FG002|Overall Study|Protocol Violation|0|||
129968678|NCT01150045|467850506|FG003|Overall Study|Protocol Violation|1|||
129968679|NCT02094898|467850513|FG000|Overall Study|Clinical Worsening|2|||
129968680|NCT02094898|467850513|FG000|Overall Study|Adverse Event|2|||
129968681|NCT02094898|467850513|FG000|Overall Study|Lack of Efficacy|1|||
129968682|NCT05382039|467850514|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
129968683|NCT05382039|467850515|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
129968684|NCT05382039|467850516|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
129968685|NCT05382039|467850514|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
129968686|NCT05382039|467850515|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
129968687|NCT05382039|467850516|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
129968688|NCT05382039|467850514|FG000|Overall Study|waiting for confirmation|0|||
129459699|NCT00542269|465978687|FG002|Overall Study|Protocol Violation|0|||
129968689|NCT05382039|467850515|FG001|Overall Study|waiting for confirmation|0|||
129968690|NCT05382039|467850516|FG002|Overall Study|waiting for confirmation|1|||
129968691|NCT01432626|467850517|FG000|Overall Study|LV function recovered|2|||
129968692|NCT01432626|467850517|FG000|Overall Study|Withdrawal by Subject|2|||
129968693|NCT01432626|467850517|FG000|Overall Study|Only 1 image competed|2|||
129968694|NCT01432626|467850517|FG000|Overall Study|Imaging agent not available|1|||
129968695|NCT05878873|467850520|FG000|Overall Study|Lost to Follow-up|2|||
129968696|NCT05878873|467850521|FG001|Overall Study|Lost to Follow-up|0|||
129459700|NCT00542269|465978685|FG000|Overall Study|Withdrawal by Subject|1|||
129459701|NCT00542269|465978686|FG001|Overall Study|Withdrawal by Subject|0|||
129459702|NCT00542269|465978687|FG002|Overall Study|Withdrawal by Subject|0|||
129968697|NCT00882115|467850523|FG000|Overall Study|Withdrawal by Subject|3|||
129968698|NCT00882115|467850523|FG000|Overall Study|did not respond to DEP challe|6|||
129968699|NCT02552147|467850524|FG000|First Intervention (7 Days)|Protocol Violation|1|||
129968700|NCT02552147|467850525|FG001|First Intervention (7 Days)|Protocol Violation|0|||
129968701|NCT02552147|467850524|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
129968702|NCT02552147|467850525|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
129459703|NCT00542269|465978685|FG000|Overall Study|Administrative problems|1|||
129968703|NCT01547598|467850526|FG000|Overall Study|Withdrew consent|1|||
129968704|NCT01547598|467850527|FG001|Overall Study|Withdrew consent|1|||
129459704|NCT00542269|465978686|FG001|Overall Study|Administrative problems|1|||
129968705|NCT01547598|467850526|FG000|Overall Study|Lost to Follow-up|1|||
129968706|NCT01547598|467850527|FG001|Overall Study|Lost to Follow-up|1|||
129968707|NCT01547598|467850526|FG000|Overall Study|Adverse Event|1|||
129968708|NCT01547598|467850527|FG001|Overall Study|Adverse Event|1|||
129968709|NCT01547598|467850526|FG000|Overall Study|Protocol Violation|1|||
129968710|NCT01547598|467850527|FG001|Overall Study|Protocol Violation|1|||
129968711|NCT01547598|467850526|FG000|Overall Study|Other Miscellaneous Reasons|2|||
129968712|NCT01547598|467850527|FG001|Overall Study|Other Miscellaneous Reasons|1|||
129968713|NCT02229227|467850528|FG000|Overall Study|Adverse Event|14|||
129968714|NCT02229227|467850529|FG001|Overall Study|Adverse Event|9|||
129968715|NCT02229227|467850528|FG000|Overall Study|Lack of Efficacy|3|||
129968716|NCT02229227|467850529|FG001|Overall Study|Lack of Efficacy|3|||
129968717|NCT02229227|467850528|FG000|Overall Study|Protocol Violation|6|||
129968718|NCT02229227|467850529|FG001|Overall Study|Protocol Violation|8|||
129968719|NCT02229227|467850528|FG000|Overall Study|Protocol defined stopping criteria|1|||
129968720|NCT02229227|467850529|FG001|Overall Study|Protocol defined stopping criteria|3|||
129968721|NCT02229227|467850528|FG000|Overall Study|Lost to Follow-up|3|||
129968722|NCT02229227|467850529|FG001|Overall Study|Lost to Follow-up|3|||
129968723|NCT02229227|467850528|FG000|Overall Study|Study terminated by sponsor|11|||
129968724|NCT02229227|467850529|FG001|Overall Study|Study terminated by sponsor|11|||
129968725|NCT02229227|467850528|FG000|Overall Study|Withdrawal by Subject|8|||
129968726|NCT02229227|467850529|FG001|Overall Study|Withdrawal by Subject|12|||
129968727|NCT02229227|467850528|FG000|Overall Study|Other|0|||
129968728|NCT02229227|467850529|FG001|Overall Study|Other|1|||
129968729|NCT02229227|467850528|FG000|Overall Study|Physician Decision|5|||
129968730|NCT02229227|467850529|FG001|Overall Study|Physician Decision|12|||
129968731|NCT04071301|467850530|FG000|Overall Study|Withdrawal by Subject|6|||
129968732|NCT04071301|467850530|FG000|Overall Study|Death|1|||
129968733|NCT02125279|467850531|FG000|Overall Study|Lack of Efficacy|2|||
129968734|NCT02125279|467850531|FG000|Overall Study|Withdrawal by Subject|6|||
129968735|NCT02125279|467850531|FG000|Overall Study|Protocol Violation|1|||
129968736|NCT02125279|467850531|FG000|Overall Study|Lost to Follow-up|4|||
129968737|NCT01850589|467850537|FG000|Overall Study|Withdrawal by Subject|8|||
129968738|NCT01850589|467850538|FG001|Overall Study|Withdrawal by Subject|0|||
129968739|NCT04468230|467850543|FG000|Overall Study|Adverse Event|2|||
129968740|NCT03721705|467850546|FG000|Overall Study|Adverse Event|2|||
129968741|NCT03721705|467850547|FG001|Overall Study|Adverse Event|0|||
129968742|NCT03721705|467850546|FG000|Overall Study|Withdrawal by Subject|4|||
129968743|NCT03721705|467850547|FG001|Overall Study|Withdrawal by Subject|10|||
129968744|NCT03721705|467850546|FG000|Overall Study|No Suitable Study Partner|1|||
129968745|NCT03721705|467850547|FG001|Overall Study|No Suitable Study Partner|0|||
129968746|NCT03721705|467850546|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
129968747|NCT03721705|467850547|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
129968748|NCT03721705|467850546|FG000|Overall Study|Death|0|||
129968749|NCT03721705|467850547|FG001|Overall Study|Death|1|||
129968750|NCT01790295|467850548|FG000|Overall Study|Adverse Event|1|||
129968751|NCT01790295|467850548|FG000|Overall Study|Death|4|||
129968752|NCT01790295|467850548|FG000|Overall Study|Lack of Efficacy|2|||
129968753|NCT01790295|467850548|FG000|Overall Study|Study closure|4|||
129968754|NCT03721172|467850551|FG000|Placebo-controlled Phase|Adverse Event|7|||
129968755|NCT03721172|467850552|FG001|Placebo-controlled Phase|Adverse Event|7|||
129968756|NCT03721172|467850553|FG002|Placebo-controlled Phase|Adverse Event|0|||
129968757|NCT03721172|467850551|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
129968758|NCT03721172|467850552|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
129968759|NCT03721172|467850553|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
129968760|NCT03721172|467850551|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
129968761|NCT03721172|467850552|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
129968762|NCT03721172|467850553|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
129968763|NCT03721172|467850551|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
129968764|NCT03721172|467850552|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
129968765|NCT03721172|467850553|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
129968766|NCT03721172|467850551|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
129968767|NCT03721172|467850552|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
129968768|NCT03721172|467850553|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
129968769|NCT03721172|467850551|FG000|Placebo-controlled Phase|Other|3|||
129968770|NCT03721172|467850552|FG001|Placebo-controlled Phase|Other|0|||
129968771|NCT03721172|467850553|FG002|Placebo-controlled Phase|Other|0|||
129968772|NCT03721172|467850551|FG000|Apremilast Extension Phase|Adverse Event|0|||
129968773|NCT03721172|467850552|FG001|Apremilast Extension Phase|Adverse Event|0|||
129968774|NCT03721172|467850553|FG002|Apremilast Extension Phase|Adverse Event|10|||
129968775|NCT03721172|467850551|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
129968776|NCT03721172|467850552|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
129968777|NCT03721172|467850553|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
129968778|NCT03721172|467850551|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
129968779|NCT03721172|467850552|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
129968780|NCT03721172|467850553|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
129968781|NCT03721172|467850551|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
129968782|NCT03721172|467850552|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
129968783|NCT03721172|467850553|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
129968784|NCT03721172|467850551|FG000|Apremilast Extension Phase|Protocol Violation|0|||
129968785|NCT03721172|467850552|FG001|Apremilast Extension Phase|Protocol Violation|0|||
129968786|NCT03721172|467850553|FG002|Apremilast Extension Phase|Protocol Violation|1|||
129968787|NCT03721172|467850551|FG000|Apremilast Extension Phase|Physician Decision|0|||
129968788|NCT03721172|467850552|FG001|Apremilast Extension Phase|Physician Decision|0|||
129968789|NCT03721172|467850553|FG002|Apremilast Extension Phase|Physician Decision|1|||
129968790|NCT03721172|467850551|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
129968791|NCT03721172|467850552|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
129968792|NCT03721172|467850553|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
129968793|NCT03721172|467850551|FG000|Apremilast Extension Phase|Other|0|||
129968794|NCT03721172|467850552|FG001|Apremilast Extension Phase|Other|0|||
129968795|NCT03721172|467850553|FG002|Apremilast Extension Phase|Other|3|||
129968796|NCT03721172|467850551|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
129968797|NCT03721172|467850552|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
129968798|NCT03721172|467850553|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
129968799|NCT00420784|467850554|FG000|Overall Study|Adverse Event|11|||
129968800|NCT00420784|467850555|FG001|Overall Study|Adverse Event|29|||
129968801|NCT00420784|467850556|FG002|Overall Study|Adverse Event|10|||
129968802|NCT00420784|467850557|FG003|Overall Study|Adverse Event|5|||
129968803|NCT00420784|467850554|FG000|Overall Study|Withdrawal by Subject|0|||
129968804|NCT00420784|467850555|FG001|Overall Study|Withdrawal by Subject|1|||
129968805|NCT00420784|467850556|FG002|Overall Study|Withdrawal by Subject|0|||
129968806|NCT00420784|467850557|FG003|Overall Study|Withdrawal by Subject|0|||
129968807|NCT00420784|467850554|FG000|Overall Study|Lost to Follow-up|0|||
129968808|NCT00420784|467850555|FG001|Overall Study|Lost to Follow-up|0|||
129968809|NCT00420784|467850556|FG002|Overall Study|Lost to Follow-up|2|||
129968810|NCT00420784|467850557|FG003|Overall Study|Lost to Follow-up|1|||
129968811|NCT00420784|467850554|FG000|Overall Study|Virologic Stopping Rule|17|||
129968812|NCT00420784|467850555|FG001|Overall Study|Virologic Stopping Rule|26|||
129968813|NCT00420784|467850556|FG002|Overall Study|Virologic Stopping Rule|41|||
129968814|NCT00420784|467850557|FG003|Overall Study|Virologic Stopping Rule|67|||
129968815|NCT00420784|467850554|FG000|Overall Study|Other|1|||
129968816|NCT00420784|467850555|FG001|Overall Study|Other|2|||
129968817|NCT00420784|467850556|FG002|Overall Study|Other|0|||
129968818|NCT00420784|467850557|FG003|Overall Study|Other|5|||
129968819|NCT02402322|467850560|FG000|Pretreatment|Withdrawal by Subject|3|||
129968820|NCT02402322|467850561|FG001|Pretreatment|Withdrawal by Subject|1|||
129968821|NCT02402322|467850562|FG002|Pretreatment|Withdrawal by Subject|1|||
129968822|NCT02402322|467850560|FG000|Follow-up|Withdrawal by Subject|6|||
129968823|NCT02402322|467850561|FG001|Follow-up|Withdrawal by Subject|3|||
129968824|NCT02402322|467850562|FG002|Follow-up|Withdrawal by Subject|24|||
129968825|NCT04593823|467850563|FG000|Overall Study|Withdrawal by Subject|1|||
129968826|NCT04593823|467850564|FG001|Overall Study|Withdrawal by Subject|1|||
129968827|NCT04593823|467850563|FG000|Overall Study|Lost to Follow-up|0|||
129968828|NCT04593823|467850564|FG001|Overall Study|Lost to Follow-up|1|||
129968829|NCT02472145|467850565|FG000|Overall Study|Death|10|||
129968830|NCT02472145|467850566|FG001|Overall Study|Death|101|||
129968831|NCT02472145|467850567|FG002|Overall Study|Death|99|||
129968832|NCT02472145|467850565|FG000|Overall Study|Lost to Follow-up|0|||
129968833|NCT02472145|467850566|FG001|Overall Study|Lost to Follow-up|1|||
129968834|NCT02472145|467850567|FG002|Overall Study|Lost to Follow-up|0|||
129968835|NCT02472145|467850565|FG000|Overall Study|Withdrawal by Subject|0|||
129968836|NCT02472145|467850566|FG001|Overall Study|Withdrawal by Subject|9|||
129968837|NCT02472145|467850567|FG002|Overall Study|Withdrawal by Subject|13|||
129968838|NCT02472145|467850565|FG000|Overall Study|Sponsor decision|0|||
129968839|NCT02472145|467850566|FG001|Overall Study|Sponsor decision|3|||
129968840|NCT02472145|467850567|FG002|Overall Study|Sponsor decision|2|||
129968841|NCT02472145|467850565|FG000|Overall Study|Other|0|||
129968842|NCT02472145|467850566|FG001|Overall Study|Other|45|||
129968843|NCT02472145|467850567|FG002|Overall Study|Other|43|||
129968844|NCT01080326|467850568|FG000|Overall Study|Patient deterioration prior to procedure|3|||
129968845|NCT01080326|467850568|FG000|Overall Study|Surgeon decision|1|||
129968846|NCT01318876|467850569|FG000|Day 8 Survey|email address invalid|96|||
129968847|NCT01318876|467850569|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
129968848|NCT01318876|467850569|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
129968849|NCT01296555|467850570|FG000|Overall Study|Adverse Event|0|||
129968850|NCT01296555|467850571|FG001|Overall Study|Adverse Event|0|||
129968851|NCT01296555|467850572|FG002|Overall Study|Adverse Event|1|||
129968852|NCT01296555|467850573|FG003|Overall Study|Adverse Event|1|||
129968853|NCT01296555|467850574|FG004|Overall Study|Adverse Event|2|||
129968854|NCT01296555|467850575|FG005|Overall Study|Adverse Event|4|||
129968855|NCT01296555|467850576|FG006|Overall Study|Adverse Event|1|||
129968856|NCT01296555|467850577|FG007|Overall Study|Adverse Event|4|||
129968857|NCT01296555|467850578|FG008|Overall Study|Adverse Event|3|||
129968858|NCT01296555|467850579|FG009|Overall Study|Adverse Event|1|||
129968859|NCT01296555|467850580|FG010|Overall Study|Adverse Event|0|||
129968860|NCT01296555|467850581|FG011|Overall Study|Adverse Event|4|||
129968861|NCT01296555|467850582|FG012|Overall Study|Adverse Event|1|||
129968862|NCT01296555|467850583|FG013|Overall Study|Adverse Event|4|||
129968863|NCT01296555|467850584|FG014|Overall Study|Adverse Event|0|||
129968864|NCT01296555|467850585|FG015|Overall Study|Adverse Event|0|||
129968865|NCT01296555|467850586|FG016|Overall Study|Adverse Event|0|||
129968866|NCT01296555|467850587|FG017|Overall Study|Adverse Event|0|||
129968867|NCT01296555|467850588|FG018|Overall Study|Adverse Event|0|||
129968868|NCT01296555|467850589|FG019|Overall Study|Adverse Event|1|||
129968869|NCT01296555|467850590|FG020|Overall Study|Adverse Event|0|||
129968870|NCT01296555|467850591|FG021|Overall Study|Adverse Event|0|||
129968871|NCT01296555|467850592|FG022|Overall Study|Adverse Event|0|||
129968872|NCT01296555|467850593|FG023|Overall Study|Adverse Event|0|||
129968873|NCT01296555|467850594|FG024|Overall Study|Adverse Event|0|||
129968874|NCT01296555|467850595|FG025|Overall Study|Adverse Event|0|||
129968875|NCT01296555|467850596|FG026|Overall Study|Adverse Event|0|||
129459705|NCT00542269|465978687|FG002|Overall Study|Administrative problems|1|||
129459706|NCT00814892|465978692|FG000|Overall Study|Disease Progression|1|||
129459707|NCT00814892|465978692|FG000|Overall Study|Study Termination|1|||
129459708|NCT00845650|465978693|FG000|Overall Study|Withdrawal by Subject|0|||
129968876|NCT01296555|467850597|FG027|Overall Study|Adverse Event|0|||
129968877|NCT01296555|467850598|FG028|Overall Study|Adverse Event|0|||
129968878|NCT01296555|467850570|FG000|Overall Study|Reason Not Specified|0|||
129968879|NCT01296555|467850571|FG001|Overall Study|Reason Not Specified|0|||
129968880|NCT01296555|467850572|FG002|Overall Study|Reason Not Specified|0|||
129968881|NCT01296555|467850573|FG003|Overall Study|Reason Not Specified|0|||
129968882|NCT01296555|467850574|FG004|Overall Study|Reason Not Specified|0|||
129968883|NCT01296555|467850575|FG005|Overall Study|Reason Not Specified|0|||
129968884|NCT01296555|467850576|FG006|Overall Study|Reason Not Specified|0|||
129968885|NCT01296555|467850577|FG007|Overall Study|Reason Not Specified|0|||
129968886|NCT01296555|467850578|FG008|Overall Study|Reason Not Specified|0|||
129968887|NCT01296555|467850579|FG009|Overall Study|Reason Not Specified|0|||
129968888|NCT01296555|467850580|FG010|Overall Study|Reason Not Specified|0|||
129968889|NCT01296555|467850581|FG011|Overall Study|Reason Not Specified|0|||
129968890|NCT01296555|467850582|FG012|Overall Study|Reason Not Specified|0|||
129459709|NCT00845650|465978694|FG001|Overall Study|Withdrawal by Subject|0|||
129968891|NCT01296555|467850583|FG013|Overall Study|Reason Not Specified|1|||
129968892|NCT01296555|467850584|FG014|Overall Study|Reason Not Specified|2|||
129968893|NCT01296555|467850585|FG015|Overall Study|Reason Not Specified|3|||
129968894|NCT01296555|467850586|FG016|Overall Study|Reason Not Specified|7|||
129968895|NCT01296555|467850587|FG017|Overall Study|Reason Not Specified|4|||
129968896|NCT01296555|467850588|FG018|Overall Study|Reason Not Specified|3|||
129968897|NCT01296555|467850589|FG019|Overall Study|Reason Not Specified|7|||
129968898|NCT01296555|467850590|FG020|Overall Study|Reason Not Specified|11|||
129968899|NCT01296555|467850591|FG021|Overall Study|Reason Not Specified|5|||
129968900|NCT01296555|467850592|FG022|Overall Study|Reason Not Specified|5|||
129968901|NCT01296555|467850593|FG023|Overall Study|Reason Not Specified|7|||
129459710|NCT00845650|465978695|FG002|Overall Study|Withdrawal by Subject|0|||
129459711|NCT00845650|465978696|FG003|Overall Study|Withdrawal by Subject|0|||
129459712|NCT00845650|465978697|FG004|Overall Study|Withdrawal by Subject|2|||
129459713|NCT00845650|465978698|FG005|Overall Study|Withdrawal by Subject|0|||
129968902|NCT01296555|467850594|FG024|Overall Study|Reason Not Specified|2|||
129968903|NCT01296555|467850595|FG025|Overall Study|Reason Not Specified|2|||
129968904|NCT01296555|467850596|FG026|Overall Study|Reason Not Specified|19|||
129968905|NCT01296555|467850597|FG027|Overall Study|Reason Not Specified|11|||
129968906|NCT01296555|467850598|FG028|Overall Study|Reason Not Specified|9|||
129968907|NCT01296555|467850570|FG000|Overall Study|Physician Decision|0|||
129968908|NCT01296555|467850571|FG001|Overall Study|Physician Decision|0|||
129968909|NCT01296555|467850572|FG002|Overall Study|Physician Decision|0|||
129968910|NCT01296555|467850573|FG003|Overall Study|Physician Decision|0|||
129968911|NCT01296555|467850574|FG004|Overall Study|Physician Decision|1|||
129968912|NCT01296555|467850575|FG005|Overall Study|Physician Decision|0|||
129968913|NCT01296555|467850576|FG006|Overall Study|Physician Decision|0|||
129968914|NCT01296555|467850577|FG007|Overall Study|Physician Decision|0|||
129968915|NCT01296555|467850578|FG008|Overall Study|Physician Decision|0|||
129968916|NCT01296555|467850579|FG009|Overall Study|Physician Decision|0|||
129459714|NCT00845650|465978693|FG000|Overall Study|Lost to Follow-up|0|||
129459715|NCT00845650|465978694|FG001|Overall Study|Lost to Follow-up|0|||
129459716|NCT00845650|465978695|FG002|Overall Study|Lost to Follow-up|3|||
129968917|NCT01296555|467850580|FG010|Overall Study|Physician Decision|0|||
129968918|NCT01296555|467850581|FG011|Overall Study|Physician Decision|0|||
129968919|NCT01296555|467850582|FG012|Overall Study|Physician Decision|0|||
129968920|NCT01296555|467850583|FG013|Overall Study|Physician Decision|1|||
129968921|NCT01296555|467850584|FG014|Overall Study|Physician Decision|0|||
129968922|NCT01296555|467850585|FG015|Overall Study|Physician Decision|0|||
129968923|NCT01296555|467850586|FG016|Overall Study|Physician Decision|0|||
129968924|NCT01296555|467850587|FG017|Overall Study|Physician Decision|0|||
129968925|NCT01296555|467850588|FG018|Overall Study|Physician Decision|0|||
129968926|NCT01296555|467850589|FG019|Overall Study|Physician Decision|1|||
129968927|NCT01296555|467850590|FG020|Overall Study|Physician Decision|0|||
129968928|NCT01296555|467850591|FG021|Overall Study|Physician Decision|0|||
129968929|NCT01296555|467850592|FG022|Overall Study|Physician Decision|0|||
129968930|NCT01296555|467850593|FG023|Overall Study|Physician Decision|0|||
129968931|NCT01296555|467850594|FG024|Overall Study|Physician Decision|0|||
129968932|NCT01296555|467850595|FG025|Overall Study|Physician Decision|0|||
129968933|NCT01296555|467850596|FG026|Overall Study|Physician Decision|0|||
129968934|NCT01296555|467850597|FG027|Overall Study|Physician Decision|0|||
129968935|NCT01296555|467850598|FG028|Overall Study|Physician Decision|0|||
129968936|NCT01296555|467850570|FG000|Overall Study|Progressive Disease|6|||
129968937|NCT01296555|467850571|FG001|Overall Study|Progressive Disease|3|||
129968938|NCT01296555|467850572|FG002|Overall Study|Progressive Disease|3|||
129968939|NCT01296555|467850573|FG003|Overall Study|Progressive Disease|7|||
129968940|NCT01296555|467850574|FG004|Overall Study|Progressive Disease|6|||
129968941|NCT01296555|467850575|FG005|Overall Study|Progressive Disease|16|||
129968942|NCT01296555|467850576|FG006|Overall Study|Progressive Disease|16|||
129968943|NCT01296555|467850577|FG007|Overall Study|Progressive Disease|8|||
129968944|NCT01296555|467850578|FG008|Overall Study|Progressive Disease|7|||
129968945|NCT01296555|467850579|FG009|Overall Study|Progressive Disease|18|||
129968946|NCT01296555|467850580|FG010|Overall Study|Progressive Disease|7|||
129968947|NCT01296555|467850581|FG011|Overall Study|Progressive Disease|14|||
129968948|NCT01296555|467850582|FG012|Overall Study|Progressive Disease|5|||
129968949|NCT01296555|467850583|FG013|Overall Study|Progressive Disease|12|||
129968950|NCT01296555|467850584|FG014|Overall Study|Progressive Disease|1|||
129968951|NCT01296555|467850585|FG015|Overall Study|Progressive Disease|1|||
129968952|NCT01296555|467850586|FG016|Overall Study|Progressive Disease|0|||
129968953|NCT01296555|467850587|FG017|Overall Study|Progressive Disease|0|||
129968954|NCT01296555|467850588|FG018|Overall Study|Progressive Disease|0|||
129968955|NCT01296555|467850589|FG019|Overall Study|Progressive Disease|1|||
129968956|NCT01296555|467850590|FG020|Overall Study|Progressive Disease|0|||
129968957|NCT01296555|467850591|FG021|Overall Study|Progressive Disease|0|||
129968958|NCT01296555|467850592|FG022|Overall Study|Progressive Disease|0|||
129968959|NCT01296555|467850593|FG023|Overall Study|Progressive Disease|0|||
129968960|NCT01296555|467850594|FG024|Overall Study|Progressive Disease|1|||
129968961|NCT01296555|467850595|FG025|Overall Study|Progressive Disease|0|||
129968962|NCT01296555|467850596|FG026|Overall Study|Progressive Disease|5|||
129968963|NCT01296555|467850597|FG027|Overall Study|Progressive Disease|1|||
129968964|NCT01296555|467850598|FG028|Overall Study|Progressive Disease|0|||
129968965|NCT01296555|467850570|FG000|Overall Study|Protocol Violation|0|||
129968966|NCT01296555|467850571|FG001|Overall Study|Protocol Violation|0|||
129968967|NCT01296555|467850572|FG002|Overall Study|Protocol Violation|0|||
129968968|NCT01296555|467850573|FG003|Overall Study|Protocol Violation|0|||
129968969|NCT01296555|467850574|FG004|Overall Study|Protocol Violation|0|||
129968970|NCT01296555|467850575|FG005|Overall Study|Protocol Violation|0|||
129968971|NCT01296555|467850576|FG006|Overall Study|Protocol Violation|0|||
129968972|NCT01296555|467850577|FG007|Overall Study|Protocol Violation|0|||
129968973|NCT01296555|467850578|FG008|Overall Study|Protocol Violation|0|||
129968974|NCT01296555|467850579|FG009|Overall Study|Protocol Violation|0|||
129968975|NCT01296555|467850580|FG010|Overall Study|Protocol Violation|0|||
129968976|NCT01296555|467850581|FG011|Overall Study|Protocol Violation|0|||
129968977|NCT01296555|467850582|FG012|Overall Study|Protocol Violation|0|||
129968978|NCT01296555|467850583|FG013|Overall Study|Protocol Violation|1|||
129968979|NCT01296555|467850584|FG014|Overall Study|Protocol Violation|0|||
129968980|NCT01296555|467850585|FG015|Overall Study|Protocol Violation|0|||
129968981|NCT01296555|467850586|FG016|Overall Study|Protocol Violation|0|||
129968982|NCT01296555|467850587|FG017|Overall Study|Protocol Violation|0|||
129968983|NCT01296555|467850588|FG018|Overall Study|Protocol Violation|0|||
129968984|NCT01296555|467850589|FG019|Overall Study|Protocol Violation|0|||
129968985|NCT01296555|467850590|FG020|Overall Study|Protocol Violation|0|||
129968986|NCT01296555|467850591|FG021|Overall Study|Protocol Violation|0|||
129968987|NCT01296555|467850592|FG022|Overall Study|Protocol Violation|0|||
129968988|NCT01296555|467850593|FG023|Overall Study|Protocol Violation|0|||
129968989|NCT01296555|467850594|FG024|Overall Study|Protocol Violation|0|||
129968990|NCT01296555|467850595|FG025|Overall Study|Protocol Violation|0|||
129968991|NCT01296555|467850596|FG026|Overall Study|Protocol Violation|0|||
129968992|NCT01296555|467850597|FG027|Overall Study|Protocol Violation|0|||
129968993|NCT01296555|467850598|FG028|Overall Study|Protocol Violation|0|||
129968994|NCT01296555|467850570|FG000|Overall Study|Study Terminated By Sponsor|0|||
129968995|NCT01296555|467850571|FG001|Overall Study|Study Terminated By Sponsor|0|||
129968996|NCT01296555|467850572|FG002|Overall Study|Study Terminated By Sponsor|0|||
129968997|NCT01296555|467850573|FG003|Overall Study|Study Terminated By Sponsor|0|||
129968998|NCT01296555|467850574|FG004|Overall Study|Study Terminated By Sponsor|0|||
129968999|NCT01296555|467850575|FG005|Overall Study|Study Terminated By Sponsor|0|||
129969000|NCT01296555|467850576|FG006|Overall Study|Study Terminated By Sponsor|0|||
129969001|NCT01296555|467850577|FG007|Overall Study|Study Terminated By Sponsor|0|||
129969002|NCT01296555|467850578|FG008|Overall Study|Study Terminated By Sponsor|0|||
129969003|NCT01296555|467850579|FG009|Overall Study|Study Terminated By Sponsor|0|||
129969004|NCT01296555|467850580|FG010|Overall Study|Study Terminated By Sponsor|0|||
129969005|NCT01296555|467850581|FG011|Overall Study|Study Terminated By Sponsor|0|||
129969006|NCT01296555|467850582|FG012|Overall Study|Study Terminated By Sponsor|0|||
129969007|NCT01296555|467850583|FG013|Overall Study|Study Terminated By Sponsor|0|||
129969008|NCT01296555|467850584|FG014|Overall Study|Study Terminated By Sponsor|0|||
129969009|NCT01296555|467850585|FG015|Overall Study|Study Terminated By Sponsor|0|||
129969010|NCT01296555|467850586|FG016|Overall Study|Study Terminated By Sponsor|0|||
129969011|NCT01296555|467850587|FG017|Overall Study|Study Terminated By Sponsor|0|||
129969012|NCT01296555|467850588|FG018|Overall Study|Study Terminated By Sponsor|0|||
129969013|NCT01296555|467850589|FG019|Overall Study|Study Terminated By Sponsor|0|||
129969014|NCT01296555|467850590|FG020|Overall Study|Study Terminated By Sponsor|0|||
129969015|NCT01296555|467850591|FG021|Overall Study|Study Terminated By Sponsor|0|||
129969016|NCT01296555|467850592|FG022|Overall Study|Study Terminated By Sponsor|0|||
129459717|NCT00845650|465978696|FG003|Overall Study|Lost to Follow-up|1|||
129459718|NCT00845650|465978697|FG004|Overall Study|Lost to Follow-up|0|||
129459719|NCT00845650|465978698|FG005|Overall Study|Lost to Follow-up|1|||
129459720|NCT00845650|465978693|FG000|Overall Study|Sponsor hold on dosing|0|||
129459721|NCT00845650|465978694|FG001|Overall Study|Sponsor hold on dosing|0|||
129459722|NCT00845650|465978695|FG002|Overall Study|Sponsor hold on dosing|0|||
129459723|NCT00845650|465978696|FG003|Overall Study|Sponsor hold on dosing|0|||
129459724|NCT00845650|465978697|FG004|Overall Study|Sponsor hold on dosing|1|||
129459725|NCT00845650|465978698|FG005|Overall Study|Sponsor hold on dosing|1|||
129459726|NCT00845650|465978693|FG000|Overall Study|Unable to access IV line|1|||
129459727|NCT00845650|465978694|FG001|Overall Study|Unable to access IV line|0|||
129459728|NCT00845650|465978695|FG002|Overall Study|Unable to access IV line|0|||
129459729|NCT00845650|465978696|FG003|Overall Study|Unable to access IV line|0|||
129459730|NCT00845650|465978697|FG004|Overall Study|Unable to access IV line|0|||
129459731|NCT00845650|465978698|FG005|Overall Study|Unable to access IV line|0|||
129459732|NCT00159861|465978699|FG000|Core Study - 16 Weeks|Death|3|||
129459733|NCT00159861|465978700|FG001|Core Study - 16 Weeks|Death|0|||
129459734|NCT00159861|465978699|FG000|Core Study - 16 Weeks|Adverse Event|12|||
129459735|NCT00159861|465978700|FG001|Core Study - 16 Weeks|Adverse Event|6|||
129459736|NCT00159861|465978699|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
129969017|NCT01296555|467850593|FG023|Overall Study|Study Terminated By Sponsor|0|||
129969018|NCT01296555|467850594|FG024|Overall Study|Study Terminated By Sponsor|0|||
129969019|NCT01296555|467850595|FG025|Overall Study|Study Terminated By Sponsor|1|||
129969020|NCT01296555|467850596|FG026|Overall Study|Study Terminated By Sponsor|0|||
129969021|NCT01296555|467850597|FG027|Overall Study|Study Terminated By Sponsor|0|||
129969022|NCT01296555|467850598|FG028|Overall Study|Study Terminated By Sponsor|0|||
129969023|NCT01296555|467850570|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969024|NCT01296555|467850571|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969025|NCT01296555|467850572|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969026|NCT01296555|467850573|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129459737|NCT00159861|465978700|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
129459738|NCT00159861|465978699|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
129969027|NCT01296555|467850574|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969028|NCT01296555|467850575|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969029|NCT01296555|467850576|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969030|NCT01296555|467850577|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969031|NCT01296555|467850578|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969032|NCT01296555|467850579|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969033|NCT01296555|467850580|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129459739|NCT00159861|465978700|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
129459740|NCT00159861|465978699|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
129459741|NCT00159861|465978700|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
129459742|NCT00159861|465978699|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
129459743|NCT00159861|465978700|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
129969034|NCT01296555|467850581|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969035|NCT01296555|467850582|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129459744|NCT00159861|465978699|FG000|Extension Study - up to 3 Years|Death|24|||
129969036|NCT01296555|467850583|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969037|NCT01296555|467850584|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129459745|NCT00159861|465978700|FG001|Extension Study - up to 3 Years|Death|28|||
129459746|NCT00159861|465978699|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
129459747|NCT00159861|465978700|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
129969038|NCT01296555|467850585|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969039|NCT01296555|467850586|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969040|NCT01296555|467850587|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969041|NCT01296555|467850588|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969042|NCT01296555|467850589|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
129969043|NCT01296555|467850590|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969044|NCT01296555|467850591|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969045|NCT01296555|467850592|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969046|NCT01296555|467850593|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969047|NCT01296555|467850594|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969048|NCT01296555|467850595|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969049|NCT01296555|467850596|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969050|NCT01296555|467850597|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969051|NCT01296555|467850598|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
129969052|NCT01296555|467850570|FG000|Overall Study|Death|0|||
129969053|NCT01296555|467850571|FG001|Overall Study|Death|0|||
129969054|NCT01296555|467850572|FG002|Overall Study|Death|0|||
129969055|NCT01296555|467850573|FG003|Overall Study|Death|2|||
129969056|NCT01296555|467850574|FG004|Overall Study|Death|1|||
129969057|NCT01296555|467850575|FG005|Overall Study|Death|0|||
129969058|NCT01296555|467850576|FG006|Overall Study|Death|2|||
129969059|NCT01296555|467850577|FG007|Overall Study|Death|0|||
129969060|NCT01296555|467850578|FG008|Overall Study|Death|0|||
129969061|NCT01296555|467850579|FG009|Overall Study|Death|1|||
129969062|NCT01296555|467850580|FG010|Overall Study|Death|0|||
129969063|NCT01296555|467850581|FG011|Overall Study|Death|1|||
129969064|NCT01296555|467850582|FG012|Overall Study|Death|0|||
129969065|NCT01296555|467850583|FG013|Overall Study|Death|2|||
129969066|NCT01296555|467850584|FG014|Overall Study|Death|27|||
129969067|NCT01296555|467850585|FG015|Overall Study|Death|15|||
129969068|NCT01296555|467850586|FG016|Overall Study|Death|11|||
129969069|NCT01296555|467850587|FG017|Overall Study|Death|11|||
129969070|NCT01296555|467850588|FG018|Overall Study|Death|17|||
129969071|NCT01296555|467850589|FG019|Overall Study|Death|12|||
129969072|NCT01296555|467850590|FG020|Overall Study|Death|13|||
129969073|NCT01296555|467850591|FG021|Overall Study|Death|12|||
129969074|NCT01296555|467850592|FG022|Overall Study|Death|12|||
129969075|NCT01296555|467850593|FG023|Overall Study|Death|13|||
129969076|NCT01296555|467850594|FG024|Overall Study|Death|7|||
129969077|NCT01296555|467850595|FG025|Overall Study|Death|7|||
129969078|NCT01296555|467850596|FG026|Overall Study|Death|35|||
129969079|NCT01296555|467850597|FG027|Overall Study|Death|92|||
129969080|NCT01296555|467850598|FG028|Overall Study|Death|44|||
129969081|NCT01296555|467850570|FG000|Overall Study|Lost to Follow-up|0|||
129969082|NCT01296555|467850571|FG001|Overall Study|Lost to Follow-up|0|||
129969083|NCT01296555|467850572|FG002|Overall Study|Lost to Follow-up|0|||
129969084|NCT01296555|467850573|FG003|Overall Study|Lost to Follow-up|0|||
129969085|NCT01296555|467850574|FG004|Overall Study|Lost to Follow-up|0|||
129969086|NCT01296555|467850575|FG005|Overall Study|Lost to Follow-up|0|||
129459748|NCT00159861|465978699|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
129459749|NCT00159861|465978700|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
129459750|NCT00159861|465978699|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
129459751|NCT00159861|465978700|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
129459752|NCT00159861|465978699|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
129459753|NCT00159861|465978700|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
129459754|NCT04489888|465978701|FG000|Overall Study|Death|75|||
129459755|NCT04489888|465978701|FG000|Overall Study|Sponsor Decision|26|||
129459756|NCT03349099|465978702|FG000|Overall Study|Physician Decision|3|||
129459757|NCT03349099|465978703|FG001|Overall Study|Physician Decision|4|||
129459758|NCT03349099|465978702|FG000|Overall Study|Stone migrated from the kidney|1|||
129969087|NCT01296555|467850576|FG006|Overall Study|Lost to Follow-up|0|||
129969088|NCT01296555|467850577|FG007|Overall Study|Lost to Follow-up|0|||
129969089|NCT01296555|467850578|FG008|Overall Study|Lost to Follow-up|0|||
129969090|NCT01296555|467850579|FG009|Overall Study|Lost to Follow-up|0|||
129969091|NCT01296555|467850580|FG010|Overall Study|Lost to Follow-up|0|||
129969092|NCT01296555|467850581|FG011|Overall Study|Lost to Follow-up|0|||
129969093|NCT01296555|467850582|FG012|Overall Study|Lost to Follow-up|0|||
129969094|NCT01296555|467850583|FG013|Overall Study|Lost to Follow-up|0|||
129969095|NCT01296555|467850584|FG014|Overall Study|Lost to Follow-up|2|||
129459759|NCT03349099|465978703|FG001|Overall Study|Stone migrated from the kidney|0|||
129969096|NCT01296555|467850585|FG015|Overall Study|Lost to Follow-up|1|||
129969097|NCT01296555|467850586|FG016|Overall Study|Lost to Follow-up|0|||
129969098|NCT01296555|467850587|FG017|Overall Study|Lost to Follow-up|2|||
129969099|NCT01296555|467850588|FG018|Overall Study|Lost to Follow-up|0|||
129969100|NCT01296555|467850589|FG019|Overall Study|Lost to Follow-up|2|||
129969101|NCT01296555|467850590|FG020|Overall Study|Lost to Follow-up|3|||
129969102|NCT01296555|467850591|FG021|Overall Study|Lost to Follow-up|2|||
129969103|NCT01296555|467850592|FG022|Overall Study|Lost to Follow-up|0|||
129969104|NCT01296555|467850593|FG023|Overall Study|Lost to Follow-up|0|||
129969105|NCT01296555|467850594|FG024|Overall Study|Lost to Follow-up|0|||
129969106|NCT01296555|467850595|FG025|Overall Study|Lost to Follow-up|0|||
129459760|NCT00278993|465978704|FG000|Overall Study|Adverse Event|24|||
129459761|NCT00278993|465978704|FG000|Overall Study|Withdrawal by Subject|5|||
129459762|NCT00278993|465978704|FG000|Overall Study|Progressive Disease|65|||
129459763|NCT00278993|465978704|FG000|Overall Study|Physician Decision|9|||
129459764|NCT00278993|465978704|FG000|Overall Study|Not Otherwise Specified|4|||
129459765|NCT01430455|465978706|FG000|Overall Study|Withdrawal by Subject|1|||
129459766|NCT01430455|465978706|FG000|Overall Study|Switched to follow-up phase|1|||
129459767|NCT03829657|465978708|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
129459768|NCT03829657|465978709|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
129459769|NCT03829657|465978710|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
129459770|NCT03829657|465978711|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
129459771|NCT03829657|465978712|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
129459772|NCT03829657|465978708|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
129459773|NCT03829657|465978709|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
129459774|NCT03829657|465978710|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
129459775|NCT03829657|465978711|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
129459776|NCT03829657|465978712|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
129459777|NCT03829657|465978708|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
129459778|NCT03829657|465978709|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
129459779|NCT03829657|465978710|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
129459780|NCT03829657|465978711|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
129459781|NCT03829657|465978712|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
129459782|NCT03829657|465978708|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
129459783|NCT03829657|465978709|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
129459784|NCT03829657|465978710|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
129459785|NCT03829657|465978711|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
129459786|NCT03829657|465978712|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
129459787|NCT03829657|465978708|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
129459788|NCT03829657|465978709|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
129459789|NCT03829657|465978710|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
129459790|NCT03829657|465978711|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
129459791|NCT03829657|465978712|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
129969107|NCT01296555|467850596|FG026|Overall Study|Lost to Follow-up|3|||
129969108|NCT01296555|467850597|FG027|Overall Study|Lost to Follow-up|13|||
129969109|NCT01296555|467850598|FG028|Overall Study|Lost to Follow-up|5|||
129969110|NCT01296555|467850570|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129969111|NCT01296555|467850571|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129969112|NCT01296555|467850572|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129969113|NCT01296555|467850573|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129969114|NCT01296555|467850574|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129969115|NCT01296555|467850575|FG005|Overall Study|Non-Compliance With Study Drug|0|||
129969116|NCT01296555|467850576|FG006|Overall Study|Non-Compliance With Study Drug|0|||
129969117|NCT01296555|467850577|FG007|Overall Study|Non-Compliance With Study Drug|1|||
129969118|NCT01296555|467850578|FG008|Overall Study|Non-Compliance With Study Drug|0|||
129969119|NCT01296555|467850579|FG009|Overall Study|Non-Compliance With Study Drug|0|||
129969120|NCT01296555|467850580|FG010|Overall Study|Non-Compliance With Study Drug|0|||
129969121|NCT01296555|467850581|FG011|Overall Study|Non-Compliance With Study Drug|0|||
129969122|NCT01296555|467850582|FG012|Overall Study|Non-Compliance With Study Drug|0|||
129969123|NCT01296555|467850583|FG013|Overall Study|Non-Compliance With Study Drug|0|||
129969124|NCT01296555|467850584|FG014|Overall Study|Non-Compliance With Study Drug|0|||
129969125|NCT01296555|467850585|FG015|Overall Study|Non-Compliance With Study Drug|0|||
129969126|NCT01296555|467850586|FG016|Overall Study|Non-Compliance With Study Drug|0|||
129969127|NCT01296555|467850587|FG017|Overall Study|Non-Compliance With Study Drug|0|||
129969128|NCT01296555|467850588|FG018|Overall Study|Non-Compliance With Study Drug|0|||
129969129|NCT01296555|467850589|FG019|Overall Study|Non-Compliance With Study Drug|0|||
129969130|NCT01296555|467850590|FG020|Overall Study|Non-Compliance With Study Drug|0|||
129969131|NCT01296555|467850591|FG021|Overall Study|Non-Compliance With Study Drug|0|||
129969132|NCT01296555|467850592|FG022|Overall Study|Non-Compliance With Study Drug|0|||
129969133|NCT01296555|467850593|FG023|Overall Study|Non-Compliance With Study Drug|0|||
129459792|NCT03829657|465978708|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
129969134|NCT01296555|467850594|FG024|Overall Study|Non-Compliance With Study Drug|0|||
129969135|NCT01296555|467850595|FG025|Overall Study|Non-Compliance With Study Drug|0|||
129969136|NCT01296555|467850596|FG026|Overall Study|Non-Compliance With Study Drug|0|||
129969137|NCT01296555|467850597|FG027|Overall Study|Non-Compliance With Study Drug|0|||
129969138|NCT01296555|467850598|FG028|Overall Study|Non-Compliance With Study Drug|0|||
129969139|NCT01296555|467850570|FG000|Overall Study|Withdrawal by Subject|0|||
129969140|NCT01296555|467850571|FG001|Overall Study|Withdrawal by Subject|0|||
129969141|NCT01296555|467850572|FG002|Overall Study|Withdrawal by Subject|0|||
129969142|NCT01296555|467850573|FG003|Overall Study|Withdrawal by Subject|0|||
129969143|NCT01296555|467850574|FG004|Overall Study|Withdrawal by Subject|1|||
129969144|NCT01296555|467850575|FG005|Overall Study|Withdrawal by Subject|0|||
129969145|NCT01296555|467850576|FG006|Overall Study|Withdrawal by Subject|1|||
129969146|NCT01296555|467850577|FG007|Overall Study|Withdrawal by Subject|0|||
129969147|NCT01296555|467850578|FG008|Overall Study|Withdrawal by Subject|0|||
129969148|NCT01296555|467850579|FG009|Overall Study|Withdrawal by Subject|0|||
129969149|NCT01296555|467850580|FG010|Overall Study|Withdrawal by Subject|1|||
129969150|NCT01296555|467850581|FG011|Overall Study|Withdrawal by Subject|1|||
129969151|NCT01296555|467850582|FG012|Overall Study|Withdrawal by Subject|0|||
129969152|NCT01296555|467850583|FG013|Overall Study|Withdrawal by Subject|0|||
129969153|NCT01296555|467850584|FG014|Overall Study|Withdrawal by Subject|3|||
129969154|NCT01296555|467850585|FG015|Overall Study|Withdrawal by Subject|0|||
129969155|NCT01296555|467850586|FG016|Overall Study|Withdrawal by Subject|2|||
129969156|NCT01296555|467850587|FG017|Overall Study|Withdrawal by Subject|1|||
129969157|NCT01296555|467850588|FG018|Overall Study|Withdrawal by Subject|0|||
129969158|NCT01296555|467850589|FG019|Overall Study|Withdrawal by Subject|1|||
129969159|NCT01296555|467850590|FG020|Overall Study|Withdrawal by Subject|1|||
129969160|NCT01296555|467850591|FG021|Overall Study|Withdrawal by Subject|1|||
129969161|NCT01296555|467850592|FG022|Overall Study|Withdrawal by Subject|3|||
129969162|NCT01296555|467850593|FG023|Overall Study|Withdrawal by Subject|0|||
129969163|NCT01296555|467850594|FG024|Overall Study|Withdrawal by Subject|0|||
129969164|NCT01296555|467850595|FG025|Overall Study|Withdrawal by Subject|0|||
129969165|NCT01296555|467850596|FG026|Overall Study|Withdrawal by Subject|8|||
129969166|NCT01296555|467850597|FG027|Overall Study|Withdrawal by Subject|4|||
129969167|NCT01296555|467850598|FG028|Overall Study|Withdrawal by Subject|2|||
129459793|NCT03829657|465978709|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
129459794|NCT03829657|465978710|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
129459795|NCT03829657|465978711|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
129459796|NCT03829657|465978712|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
129459797|NCT03829657|465978708|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
129459798|NCT03829657|465978709|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
129459799|NCT03829657|465978710|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
129459800|NCT03829657|465978711|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
129459801|NCT03829657|465978712|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
129459802|NCT03829657|465978708|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
129459803|NCT03829657|465978709|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
129459804|NCT03829657|465978710|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
129459805|NCT03829657|465978711|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
129969168|NCT03000348|467850603|FG000|Overall Study|Adverse Event|1|||
129969169|NCT03000348|467850604|FG001|Overall Study|Adverse Event|1|||
129969170|NCT03000348|467850605|FG002|Overall Study|Adverse Event|1|||
129969171|NCT03000348|467850606|FG003|Overall Study|Adverse Event|1|||
129969172|NCT03000348|467850607|FG004|Overall Study|Adverse Event|1|||
129969173|NCT03000348|467850608|FG005|Overall Study|Adverse Event|1|||
129969174|NCT03000348|467850603|FG000|Overall Study|Lost to Follow-up|0|||
129969175|NCT03000348|467850604|FG001|Overall Study|Lost to Follow-up|0|||
129969176|NCT03000348|467850605|FG002|Overall Study|Lost to Follow-up|1|||
129969177|NCT03000348|467850606|FG003|Overall Study|Lost to Follow-up|0|||
129969178|NCT03000348|467850607|FG004|Overall Study|Lost to Follow-up|0|||
129969179|NCT03000348|467850608|FG005|Overall Study|Lost to Follow-up|0|||
129969180|NCT03000348|467850603|FG000|Overall Study|Withdrawal by Subject|0|||
129969181|NCT03000348|467850604|FG001|Overall Study|Withdrawal by Subject|1|||
129969182|NCT03000348|467850605|FG002|Overall Study|Withdrawal by Subject|0|||
129969183|NCT03000348|467850606|FG003|Overall Study|Withdrawal by Subject|0|||
129969184|NCT03000348|467850607|FG004|Overall Study|Withdrawal by Subject|0|||
129969185|NCT03000348|467850608|FG005|Overall Study|Withdrawal by Subject|0|||
129459806|NCT03829657|465978712|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
129969186|NCT03000348|467850603|FG000|Overall Study|Consent|0|||
129969187|NCT03000348|467850604|FG001|Overall Study|Consent|0|||
129969188|NCT03000348|467850605|FG002|Overall Study|Consent|0|||
129969189|NCT03000348|467850606|FG003|Overall Study|Consent|0|||
129969190|NCT03000348|467850607|FG004|Overall Study|Consent|1|||
129969191|NCT03000348|467850608|FG005|Overall Study|Consent|0|||
129969192|NCT03000348|467850603|FG000|Overall Study|Failure to expectorate sputum|1|||
129969193|NCT03000348|467850604|FG001|Overall Study|Failure to expectorate sputum|0|||
129969194|NCT03000348|467850605|FG002|Overall Study|Failure to expectorate sputum|1|||
129969195|NCT03000348|467850606|FG003|Overall Study|Failure to expectorate sputum|0|||
129969196|NCT03000348|467850607|FG004|Overall Study|Failure to expectorate sputum|1|||
129969197|NCT03000348|467850608|FG005|Overall Study|Failure to expectorate sputum|0|||
129969198|NCT03000348|467850603|FG000|Overall Study|No gram negative|1|||
129969199|NCT03000348|467850604|FG001|Overall Study|No gram negative|2|||
129969200|NCT03000348|467850605|FG002|Overall Study|No gram negative|1|||
129969201|NCT03000348|467850606|FG003|Overall Study|No gram negative|1|||
129969202|NCT03000348|467850607|FG004|Overall Study|No gram negative|1|||
129969203|NCT03000348|467850608|FG005|Overall Study|No gram negative|1|||
129969204|NCT03000348|467850603|FG000|Overall Study|Patient had no transport|0|||
129969205|NCT03000348|467850604|FG001|Overall Study|Patient had no transport|0|||
129969206|NCT03000348|467850605|FG002|Overall Study|Patient had no transport|0|||
129969207|NCT03000348|467850606|FG003|Overall Study|Patient had no transport|1|||
129969208|NCT03000348|467850607|FG004|Overall Study|Patient had no transport|0|||
129969209|NCT03000348|467850608|FG005|Overall Study|Patient had no transport|0|||
129969210|NCT03000348|467850603|FG000|Overall Study|Dosing|0|||
129969211|NCT03000348|467850604|FG001|Overall Study|Dosing|0|||
129969212|NCT03000348|467850605|FG002|Overall Study|Dosing|0|||
129969213|NCT03000348|467850606|FG003|Overall Study|Dosing|0|||
129969214|NCT03000348|467850607|FG004|Overall Study|Dosing|1|||
129969215|NCT03000348|467850608|FG005|Overall Study|Dosing|0|||
129969216|NCT04042077|467850609|FG000|Overall Study|Adverse Event|0|||
129969217|NCT04042077|467850610|FG001|Overall Study|Adverse Event|1|||
129969218|NCT04042077|467850609|FG000|Overall Study|Death|2|||
129969219|NCT04042077|467850610|FG001|Overall Study|Death|1|||
129969220|NCT04042077|467850609|FG000|Overall Study|Physician Decision|2|||
129969221|NCT04042077|467850610|FG001|Overall Study|Physician Decision|0|||
129969222|NCT04042077|467850609|FG000|Overall Study|Withdrawal by Subject|3|||
129969223|NCT04042077|467850610|FG001|Overall Study|Withdrawal by Subject|2|||
129969224|NCT04042077|467850609|FG000|Overall Study|Lack of Efficacy|0|||
129969225|NCT04042077|467850610|FG001|Overall Study|Lack of Efficacy|1|||
129969226|NCT00745498|467850612|FG000|Overall Study|Lost to Follow-up|1|||
129969227|NCT00745498|467850613|FG001|Overall Study|Lost to Follow-up|1|||
129969228|NCT00745498|467850614|FG002|Overall Study|Lost to Follow-up|3|||
129969229|NCT00745498|467850612|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
129969230|NCT00745498|467850613|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
129969231|NCT00745498|467850614|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
129969232|NCT00745498|467850612|FG000|Overall Study|Non-PDR related VH|0|||
129969233|NCT00745498|467850613|FG001|Overall Study|Non-PDR related VH|1|||
129969234|NCT00745498|467850614|FG002|Overall Study|Non-PDR related VH|1|||
129969235|NCT00745498|467850612|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
129969236|NCT00745498|467850613|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
129969237|NCT00745498|467850614|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
129969238|NCT02031536|467850618|FG000|Overall Study|ineligible|1|||
129969239|NCT02031536|467850619|FG001|Overall Study|ineligible|0|||
129969240|NCT01827046|467850624|FG000|Overall Study|Lost to Follow-up|1|||
129969241|NCT01827046|467850625|FG001|Overall Study|Lost to Follow-up|5|||
129969242|NCT01827046|467850624|FG000|Overall Study|Withdrawal by Subject|0|||
129969243|NCT01827046|467850625|FG001|Overall Study|Withdrawal by Subject|4|||
129969244|NCT01294436|467850626|FG000|Overall Study|Adverse Event|10|||
129969245|NCT01294436|467850627|FG001|Overall Study|Adverse Event|17|||
129969246|NCT01294436|467850626|FG000|Overall Study|Withdrawal by Subject|11|||
129969247|NCT01294436|467850627|FG001|Overall Study|Withdrawal by Subject|28|||
129969248|NCT01294436|467850626|FG000|Overall Study|subject no longer meets study criteria|5|||
129969249|NCT01294436|467850627|FG001|Overall Study|subject no longer meets study criteria|20|||
129969250|NCT01294436|467850626|FG000|Overall Study|poor/non-compliance|2|||
129969251|NCT01294436|467850627|FG001|Overall Study|poor/non-compliance|5|||
129969252|NCT00585078|467850630|FG000|Overall Study|Withdrawal by Subject|4|||
129969253|NCT00585078|467850630|FG000|Overall Study|Poor performance status|1|||
129969254|NCT00585078|467850630|FG000|Overall Study|Disease Progression|24|||
129969255|NCT00585078|467850630|FG000|Overall Study|Adverse Event|10|||
129969256|NCT00585078|467850630|FG000|Overall Study|Death|1|||
129969257|NCT02781311|467850633|FG000|Overall Study|Adverse Event|2|||
129969258|NCT02781311|467850634|FG001|Overall Study|Adverse Event|6|||
129969259|NCT02781311|467850635|FG002|Overall Study|Adverse Event|1|||
129969260|NCT02781311|467850633|FG000|Overall Study|Withdrawal of Consent|11|||
129969261|NCT02781311|467850634|FG001|Overall Study|Withdrawal of Consent|12|||
129969262|NCT02781311|467850635|FG002|Overall Study|Withdrawal of Consent|2|||
129969263|NCT02781311|467850633|FG000|Overall Study|Lost to Follow-up|11|||
129969264|NCT02781311|467850634|FG001|Overall Study|Lost to Follow-up|8|||
129969265|NCT02781311|467850635|FG002|Overall Study|Lost to Follow-up|1|||
129969266|NCT02781311|467850633|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129969267|NCT02781311|467850634|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129969268|NCT02781311|467850635|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129969269|NCT01056263|467850638|FG000|Overall Study|Adverse Event|12|||
129969270|NCT01056263|467850638|FG000|Overall Study|Death|1|||
129969271|NCT01056263|467850638|FG000|Overall Study|Withdrawal by Subject|1|||
129969272|NCT01056263|467850638|FG000|Overall Study|Lack of Efficacy|29|||
129969273|NCT01056263|467850638|FG000|Overall Study|Progressive disease|2|||
129969274|NCT01056263|467850638|FG000|Overall Study|Neoplasm progression|1|||
129969275|NCT01056263|467850638|FG000|Overall Study|Objective progression or relapse|1|||
129969276|NCT01056263|467850638|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
129969277|NCT02257918|467850639|FG000|Overall Study|Lost to Follow-up|4|||
129969278|NCT02257918|467850640|FG001|Overall Study|Lost to Follow-up|1|||
129969279|NCT02257918|467850641|FG002|Overall Study|Lost to Follow-up|0|||
129969280|NCT02257918|467850639|FG000|Overall Study|Withdrawal by Subject|0|||
129969281|NCT02257918|467850640|FG001|Overall Study|Withdrawal by Subject|0|||
129969282|NCT02257918|467850641|FG002|Overall Study|Withdrawal by Subject|1|||
129969283|NCT02257918|467850639|FG000|Overall Study|Pregnancy|0|||
129969284|NCT02257918|467850640|FG001|Overall Study|Pregnancy|0|||
129969285|NCT02257918|467850641|FG002|Overall Study|Pregnancy|1|||
129969286|NCT03371823|467850645|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
129969287|NCT03371823|467850646|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
129969288|NCT01263054|467850650|FG000|Overall Study|Death|1|||
129969289|NCT01263054|467850651|FG001|Overall Study|Death|0|||
129969290|NCT01263054|467850650|FG000|Overall Study|Lost to Follow-up|2|||
129969291|NCT01263054|467850651|FG001|Overall Study|Lost to Follow-up|2|||
129969292|NCT01263054|467850650|FG000|Overall Study|Withdrawal by Subject|1|||
129969293|NCT01263054|467850651|FG001|Overall Study|Withdrawal by Subject|3|||
129969294|NCT01263054|467850650|FG000|Overall Study|Qualification Violation|1|||
129969295|NCT01263054|467850651|FG001|Overall Study|Qualification Violation|0|||
129969296|NCT01263054|467850650|FG000|Overall Study|Other|0|||
129969297|NCT01263054|467850651|FG001|Overall Study|Other|1|||
129969298|NCT02242643|467850652|FG000|Overall Study|Protocol Violation|1|||
129969299|NCT02242643|467850653|FG001|Overall Study|Protocol Violation|2|||
129969300|NCT02242643|467850652|FG000|Overall Study|Withdrawal by Subject|15|||
129969301|NCT02242643|467850653|FG001|Overall Study|Withdrawal by Subject|10|||
129969302|NCT02242643|467850652|FG000|Overall Study|Migrated/moved from study area|1|||
129969303|NCT02242643|467850653|FG001|Overall Study|Migrated/moved from study area|3|||
129969304|NCT02242643|467850652|FG000|Overall Study|Lost to Follow-up|54|||
129969305|NCT02242643|467850653|FG001|Overall Study|Lost to Follow-up|61|||
129969306|NCT02242643|467850652|FG000|Overall Study|Child placed in foster care by family|0|||
129969307|NCT02242643|467850653|FG001|Overall Study|Child placed in foster care by family|1|||
129969308|NCT02242643|467850652|FG000|Overall Study|Non-compliance|1|||
129969309|NCT02242643|467850653|FG001|Overall Study|Non-compliance|0|||
129969310|NCT02242643|467850652|FG000|Overall Study|Consent withdrawal by parent|1|||
129969311|NCT02242643|467850653|FG001|Overall Study|Consent withdrawal by parent|0|||
129969312|NCT02242643|467850652|FG000|Overall Study|Protocol requirements not followed|1|||
129969313|NCT02242643|467850653|FG001|Overall Study|Protocol requirements not followed|0|||
129969314|NCT02242643|467850652|FG000|Overall Study|Language barrier|1|||
129969315|NCT02242643|467850653|FG001|Overall Study|Language barrier|0|||
129969316|NCT02242643|467850652|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
129969317|NCT02242643|467850653|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
129969318|NCT02282059|467850660|FG000|Overall Study|Other|15|||
129969319|NCT02282059|467850661|FG001|Overall Study|Other|3|||
129969320|NCT02282059|467850660|FG000|Overall Study|Participant refused further follow-up|8|||
129969321|NCT02282059|467850661|FG001|Overall Study|Participant refused further follow-up|4|||
129969322|NCT02282059|467850660|FG000|Overall Study|Lost to Follow-up|19|||
129969323|NCT02282059|467850661|FG001|Overall Study|Lost to Follow-up|3|||
129969324|NCT02282059|467850660|FG000|Overall Study|Death|40|||
129969325|NCT02282059|467850661|FG001|Overall Study|Death|8|||
129969326|NCT05093504|467850662|FG000|Overall Study|Death|0|||
129969327|NCT05093504|467850663|FG001|Overall Study|Death|1|||
129969328|NCT02035696|467852892|FG000|Overall Study|Lost to Follow-up|0|||
129969329|NCT02035696|467852893|FG001|Overall Study|Lost to Follow-up|3|||
129969330|NCT02035696|467852894|FG002|Overall Study|Lost to Follow-up|1|||
129969331|NCT02035696|467852895|FG003|Overall Study|Lost to Follow-up|2|||
129969332|NCT02035696|467852892|FG000|Overall Study|Withdrawal by Subject|3|||
129969333|NCT02035696|467852893|FG001|Overall Study|Withdrawal by Subject|0|||
129969334|NCT02035696|467852894|FG002|Overall Study|Withdrawal by Subject|2|||
129969335|NCT02035696|467852895|FG003|Overall Study|Withdrawal by Subject|1|||
129969336|NCT01090011|467852896|FG000|Overall Study|Progressive disease|128|||
129969337|NCT01090011|467852896|FG000|Overall Study|Adverse Event|32|||
129969338|NCT01090011|467852896|FG000|Overall Study|Protocol Violation|1|||
129969339|NCT01090011|467852896|FG000|Overall Study|Refusal to start/continue medication|5|||
129969340|NCT01090011|467852896|FG000|Overall Study|Other reason not defined above|5|||
129459807|NCT03829657|465978708|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
129969341|NCT00379769|467852897|FG000|Main Study|Death|57|||
129969342|NCT00379769|467852898|FG001|Main Study|Death|67|||
129969343|NCT00379769|467852899|FG002|Main Study|Death|54|||
129969344|NCT00379769|467852900|FG003|Main Study|Death|72|||
129969345|NCT00379769|467852901|FG004|Main Study|Death|0|||
129969346|NCT00379769|467852902|FG005|Main Study|Death|0|||
129969347|NCT00379769|467852897|FG000|Main Study|Adverse Event|5|||
129969348|NCT00379769|467852898|FG001|Main Study|Adverse Event|8|||
129969349|NCT00379769|467852899|FG002|Main Study|Adverse Event|10|||
129969350|NCT00379769|467852900|FG003|Main Study|Adverse Event|11|||
129969351|NCT00379769|467852901|FG004|Main Study|Adverse Event|0|||
129969352|NCT00379769|467852902|FG005|Main Study|Adverse Event|0|||
129969353|NCT00379769|467852897|FG000|Main Study|Lost to Follow-up|29|||
129969354|NCT00379769|467852898|FG001|Main Study|Lost to Follow-up|29|||
129969355|NCT00379769|467852899|FG002|Main Study|Lost to Follow-up|25|||
129969356|NCT00379769|467852900|FG003|Main Study|Lost to Follow-up|26|||
129969357|NCT00379769|467852901|FG004|Main Study|Lost to Follow-up|0|||
129969358|NCT00379769|467852902|FG005|Main Study|Lost to Follow-up|0|||
129969359|NCT00379769|467852897|FG000|Main Study|Withdrawal by Subject|46|||
129969360|NCT00379769|467852898|FG001|Main Study|Withdrawal by Subject|56|||
129969361|NCT00379769|467852899|FG002|Main Study|Withdrawal by Subject|72|||
129969362|NCT00379769|467852900|FG003|Main Study|Withdrawal by Subject|70|||
129969363|NCT00379769|467852901|FG004|Main Study|Withdrawal by Subject|0|||
129969364|NCT00379769|467852902|FG005|Main Study|Withdrawal by Subject|0|||
129969365|NCT00379769|467852897|FG000|Main Study|Moved to survival status follow-up only|27|||
129969366|NCT00379769|467852898|FG001|Main Study|Moved to survival status follow-up only|25|||
129969367|NCT00379769|467852899|FG002|Main Study|Moved to survival status follow-up only|32|||
129969368|NCT00379769|467852900|FG003|Main Study|Moved to survival status follow-up only|36|||
129969369|NCT00379769|467852901|FG004|Main Study|Moved to survival status follow-up only|0|||
129969370|NCT00379769|467852902|FG005|Main Study|Moved to survival status follow-up only|0|||
129969371|NCT00379769|467852897|FG000|Main Study|Participant moved|3|||
129969372|NCT00379769|467852898|FG001|Main Study|Participant moved|2|||
129969373|NCT00379769|467852899|FG002|Main Study|Participant moved|3|||
129969374|NCT00379769|467852900|FG003|Main Study|Participant moved|3|||
129969375|NCT00379769|467852901|FG004|Main Study|Participant moved|0|||
129969376|NCT00379769|467852902|FG005|Main Study|Participant moved|0|||
129969377|NCT00379769|467852897|FG000|Main Study|Poor compliance|3|||
129969378|NCT00379769|467852898|FG001|Main Study|Poor compliance|2|||
129969379|NCT00379769|467852899|FG002|Main Study|Poor compliance|2|||
129969380|NCT00379769|467852900|FG003|Main Study|Poor compliance|1|||
129969381|NCT00379769|467852901|FG004|Main Study|Poor compliance|0|||
129969382|NCT00379769|467852902|FG005|Main Study|Poor compliance|0|||
129969383|NCT00379769|467852897|FG000|Main Study|Prohibited glucose lowering medication|0|||
129969384|NCT00379769|467852898|FG001|Main Study|Prohibited glucose lowering medication|3|||
129969385|NCT00379769|467852899|FG002|Main Study|Prohibited glucose lowering medication|0|||
129969386|NCT00379769|467852900|FG003|Main Study|Prohibited glucose lowering medication|1|||
129969387|NCT00379769|467852901|FG004|Main Study|Prohibited glucose lowering medication|0|||
129969388|NCT00379769|467852902|FG005|Main Study|Prohibited glucose lowering medication|0|||
129969389|NCT00379769|467852897|FG000|Main Study|Site closed|4|||
129969390|NCT00379769|467852898|FG001|Main Study|Site closed|4|||
129969391|NCT00379769|467852899|FG002|Main Study|Site closed|4|||
129969392|NCT00379769|467852900|FG003|Main Study|Site closed|8|||
129969393|NCT00379769|467852901|FG004|Main Study|Site closed|0|||
129969394|NCT00379769|467852902|FG005|Main Study|Site closed|0|||
129969395|NCT00379769|467852897|FG000|Main Study|Entry criteria violation|0|||
129969396|NCT00379769|467852898|FG001|Main Study|Entry criteria violation|0|||
129969397|NCT00379769|467852899|FG002|Main Study|Entry criteria violation|1|||
129969398|NCT00379769|467852900|FG003|Main Study|Entry criteria violation|1|||
129969399|NCT00379769|467852901|FG004|Main Study|Entry criteria violation|0|||
129969400|NCT00379769|467852902|FG005|Main Study|Entry criteria violation|0|||
129969401|NCT00379769|467852897|FG000|Main Study|Participant did not take study drug|0|||
129969402|NCT00379769|467852898|FG001|Main Study|Participant did not take study drug|0|||
129969403|NCT00379769|467852899|FG002|Main Study|Participant did not take study drug|1|||
129969404|NCT00379769|467852900|FG003|Main Study|Participant did not take study drug|0|||
129969405|NCT00379769|467852901|FG004|Main Study|Participant did not take study drug|0|||
129969406|NCT00379769|467852902|FG005|Main Study|Participant did not take study drug|0|||
129969407|NCT00379769|467852897|FG000|Main Study|Physician Decision|2|||
129969408|NCT00379769|467852898|FG001|Main Study|Physician Decision|2|||
129969409|NCT00379769|467852899|FG002|Main Study|Physician Decision|1|||
129969410|NCT00379769|467852900|FG003|Main Study|Physician Decision|1|||
129969411|NCT00379769|467852901|FG004|Main Study|Physician Decision|0|||
129969412|NCT00379769|467852902|FG005|Main Study|Physician Decision|0|||
129969413|NCT00379769|467852897|FG000|Main Study|Participant completed study at visit 27|1|||
129969414|NCT00379769|467852898|FG001|Main Study|Participant completed study at visit 27|0|||
129969415|NCT00379769|467852899|FG002|Main Study|Participant completed study at visit 27|0|||
129969416|NCT00379769|467852900|FG003|Main Study|Participant completed study at visit 27|0|||
129969417|NCT00379769|467852901|FG004|Main Study|Participant completed study at visit 27|0|||
129969418|NCT00379769|467852902|FG005|Main Study|Participant completed study at visit 27|0|||
129969419|NCT00379769|467852897|FG000|Main Study|Personal reasons|1|||
129969420|NCT00379769|467852898|FG001|Main Study|Personal reasons|0|||
129969421|NCT00379769|467852899|FG002|Main Study|Personal reasons|0|||
129969422|NCT00379769|467852900|FG003|Main Study|Personal reasons|0|||
129969423|NCT00379769|467852901|FG004|Main Study|Personal reasons|0|||
129969424|NCT00379769|467852902|FG005|Main Study|Personal reasons|0|||
129969425|NCT00379769|467852897|FG000|Main Study|Risk of heart failure|0|||
129969426|NCT00379769|467852898|FG001|Main Study|Risk of heart failure|1|||
129969427|NCT00379769|467852899|FG002|Main Study|Risk of heart failure|0|||
129969428|NCT00379769|467852900|FG003|Main Study|Risk of heart failure|0|||
129969429|NCT00379769|467852901|FG004|Main Study|Risk of heart failure|0|||
129969430|NCT00379769|467852902|FG005|Main Study|Risk of heart failure|0|||
129969431|NCT00379769|467852897|FG000|Main Study|Investigator refused to log temperature|0|||
129969432|NCT00379769|467852898|FG001|Main Study|Investigator refused to log temperature|0|||
129969433|NCT00379769|467852899|FG002|Main Study|Investigator refused to log temperature|1|||
129969434|NCT00379769|467852900|FG003|Main Study|Investigator refused to log temperature|0|||
129969435|NCT00379769|467852901|FG004|Main Study|Investigator refused to log temperature|0|||
129969436|NCT00379769|467852902|FG005|Main Study|Investigator refused to log temperature|0|||
129969437|NCT00379769|467852897|FG000|Main Study|Reason unspecified|0|||
129969438|NCT00379769|467852898|FG001|Main Study|Reason unspecified|0|||
129969439|NCT00379769|467852899|FG002|Main Study|Reason unspecified|1|||
129459808|NCT03829657|465978709|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
129459809|NCT03829657|465978710|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
129459810|NCT03829657|465978711|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
129459811|NCT03829657|465978712|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
129459812|NCT03829657|465978708|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
129459813|NCT03829657|465978709|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
129459814|NCT03829657|465978710|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
129459815|NCT03829657|465978711|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
129459816|NCT03829657|465978712|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
129969440|NCT00379769|467852900|FG003|Main Study|Reason unspecified|0|||
129969441|NCT00379769|467852901|FG004|Main Study|Reason unspecified|0|||
129969442|NCT00379769|467852902|FG005|Main Study|Reason unspecified|0|||
129969443|NCT00379769|467852897|FG000|Observational Follow-up|Death|0|||
129969444|NCT00379769|467852898|FG001|Observational Follow-up|Death|0|||
129969445|NCT00379769|467852899|FG002|Observational Follow-up|Death|0|||
129969446|NCT00379769|467852900|FG003|Observational Follow-up|Death|0|||
129969447|NCT00379769|467852901|FG004|Observational Follow-up|Death|78|||
129969448|NCT00379769|467852902|FG005|Observational Follow-up|Death|70|||
129969449|NCT00379769|467852897|FG000|Observational Follow-up|Adverse Event|0|||
129969450|NCT00379769|467852898|FG001|Observational Follow-up|Adverse Event|0|||
129969451|NCT00379769|467852899|FG002|Observational Follow-up|Adverse Event|0|||
129969452|NCT00379769|467852900|FG003|Observational Follow-up|Adverse Event|0|||
129969453|NCT00379769|467852901|FG004|Observational Follow-up|Adverse Event|1|||
129969454|NCT00379769|467852902|FG005|Observational Follow-up|Adverse Event|0|||
129969455|NCT00379769|467852897|FG000|Observational Follow-up|Lost to Follow-up|0|||
129969456|NCT00379769|467852898|FG001|Observational Follow-up|Lost to Follow-up|0|||
129969457|NCT00379769|467852899|FG002|Observational Follow-up|Lost to Follow-up|0|||
129969458|NCT00379769|467852900|FG003|Observational Follow-up|Lost to Follow-up|0|||
129969459|NCT00379769|467852901|FG004|Observational Follow-up|Lost to Follow-up|25|||
129969460|NCT00379769|467852902|FG005|Observational Follow-up|Lost to Follow-up|27|||
129969461|NCT00379769|467852897|FG000|Observational Follow-up|Withdrawal by Subject|0|||
129969462|NCT00379769|467852898|FG001|Observational Follow-up|Withdrawal by Subject|0|||
129969463|NCT00379769|467852899|FG002|Observational Follow-up|Withdrawal by Subject|0|||
129969464|NCT00379769|467852900|FG003|Observational Follow-up|Withdrawal by Subject|0|||
129969465|NCT00379769|467852901|FG004|Observational Follow-up|Withdrawal by Subject|12|||
129969466|NCT00379769|467852902|FG005|Observational Follow-up|Withdrawal by Subject|12|||
129969467|NCT00379769|467852897|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969468|NCT00379769|467852898|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969469|NCT00379769|467852899|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969470|NCT00379769|467852900|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
129969471|NCT00379769|467852901|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
129969472|NCT00379769|467852902|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
129969473|NCT00379769|467852897|FG000|Observational Follow-up|Physician Decision|0|||
129969474|NCT00379769|467852898|FG001|Observational Follow-up|Physician Decision|0|||
129969475|NCT00379769|467852899|FG002|Observational Follow-up|Physician Decision|0|||
129969476|NCT00379769|467852900|FG003|Observational Follow-up|Physician Decision|0|||
129969477|NCT00379769|467852901|FG004|Observational Follow-up|Physician Decision|8|||
129969478|NCT00379769|467852902|FG005|Observational Follow-up|Physician Decision|8|||
129969479|NCT00379769|467852897|FG000|Observational Follow-up|Site Closed Early|0|||
129969480|NCT00379769|467852898|FG001|Observational Follow-up|Site Closed Early|0|||
129459817|NCT01014689|465978713|FG000|Overall Study|Lack of Efficacy|0|||
129459818|NCT01014689|465978714|FG001|Overall Study|Lack of Efficacy|1|||
129459819|NCT01014689|465978713|FG000|Overall Study|Adverse Event|3|||
129459820|NCT01014689|465978714|FG001|Overall Study|Adverse Event|0|||
129969481|NCT00379769|467852899|FG002|Observational Follow-up|Site Closed Early|0|||
129969482|NCT00379769|467852900|FG003|Observational Follow-up|Site Closed Early|0|||
129969483|NCT00379769|467852901|FG004|Observational Follow-up|Site Closed Early|6|||
129969484|NCT00379769|467852902|FG005|Observational Follow-up|Site Closed Early|7|||
129969485|NCT00379769|467852897|FG000|Observational Follow-up|Participant Moved|0|||
129969486|NCT00379769|467852898|FG001|Observational Follow-up|Participant Moved|0|||
129969487|NCT00379769|467852899|FG002|Observational Follow-up|Participant Moved|0|||
129969488|NCT00379769|467852900|FG003|Observational Follow-up|Participant Moved|0|||
129969489|NCT00379769|467852901|FG004|Observational Follow-up|Participant Moved|0|||
129969490|NCT00379769|467852902|FG005|Observational Follow-up|Participant Moved|1|||
129969491|NCT00379769|467852897|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969492|NCT00379769|467852898|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969493|NCT00379769|467852899|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969494|NCT00379769|467852900|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
129969495|NCT00379769|467852901|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
129969496|NCT00379769|467852902|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
129969497|NCT01689363|467852907|FG000|Overall Study|Protocol Violation|0|||
129969498|NCT01689363|467852908|FG001|Overall Study|Protocol Violation|1|||
129969499|NCT01689363|467852909|FG002|Overall Study|Protocol Violation|0|||
129969500|NCT01689363|467852910|FG003|Overall Study|Protocol Violation|0|||
129969501|NCT01689363|467852911|FG004|Overall Study|Protocol Violation|0|||
129969502|NCT01689363|467852912|FG005|Overall Study|Protocol Violation|0|||
129969503|NCT01689363|467852913|FG006|Overall Study|Protocol Violation|0|||
129969504|NCT01689363|467852914|FG007|Overall Study|Protocol Violation|0|||
129969505|NCT02859064|467852915|FG000|Overall Study|Progressive Disease|3|||
129969506|NCT02859064|467852915|FG000|Overall Study|Physician Decision|1|||
129969507|NCT02859064|467852915|FG000|Overall Study|Withdrawal by Subject|1|||
129969508|NCT02859064|467852915|FG000|Overall Study|Death|1|||
129969509|NCT00321685|467852916|FG000|Overall Study|Adverse Event|18|||
129969510|NCT00321685|467852916|FG000|Overall Study|Death|2|||
129969511|NCT00321685|467852916|FG000|Overall Study|Withdrawal by Subject|8|||
129969512|NCT00321685|467852916|FG000|Overall Study|Alternative therapy|1|||
129969513|NCT00321685|467852916|FG000|Overall Study|Complicating disese|1|||
129969514|NCT00321685|467852916|FG000|Overall Study|Other|5|||
129969515|NCT00321685|467852916|FG000|Overall Study|Not start protocol therapy|2|||
129969516|NCT00321685|467852916|FG000|Overall Study|Ineligible|2|||
129969517|NCT00127842|467852917|FG000|Overall Study|Adverse Event|15|||
129969518|NCT00127842|467852917|FG000|Overall Study|Withdrawal by Subject|3|||
129969519|NCT00127842|467852917|FG000|Overall Study|Lost to Follow-up|1|||
129969520|NCT00127842|467852917|FG000|Overall Study|Lack of Efficacy|12|||
129969521|NCT00127842|467852917|FG000|Overall Study|Noncompliance|2|||
129969522|NCT00127842|467852917|FG000|Overall Study|Protocol Violation|1|||
129969523|NCT00127842|467852917|FG000|Overall Study|Other|5|||
129969524|NCT01638390|467852920|FG000|Overall Study|screening failures|21|||
129969525|NCT01536587|467852921|FG000|Overall Study|Adverse Event|2|||
129969526|NCT01434680|467852922|FG000|Overall Study|Withdrawal by Subject|1|||
129969527|NCT01434680|467852923|FG001|Overall Study|Withdrawal by Subject|0|||
129969528|NCT01434680|467852924|FG002|Overall Study|Withdrawal by Subject|2|||
129969529|NCT01434680|467852925|FG003|Overall Study|Withdrawal by Subject|0|||
129969530|NCT01434680|467852922|FG000|Overall Study|Lost to Follow-up|1|||
129969531|NCT01434680|467852923|FG001|Overall Study|Lost to Follow-up|1|||
129969532|NCT01434680|467852924|FG002|Overall Study|Lost to Follow-up|0|||
129969533|NCT01434680|467852925|FG003|Overall Study|Lost to Follow-up|0|||
129969534|NCT01434680|467852922|FG000|Overall Study|Protocol Violation|1|||
129969535|NCT01434680|467852923|FG001|Overall Study|Protocol Violation|1|||
129969536|NCT01434680|467852924|FG002|Overall Study|Protocol Violation|0|||
129969537|NCT01434680|467852925|FG003|Overall Study|Protocol Violation|0|||
129969538|NCT05765435|467852928|FG000|Overall Study|Lost to Follow-up|0|||
129969539|NCT05765435|467852929|FG001|Overall Study|Lost to Follow-up|1|||
129969540|NCT05765435|467852930|FG002|Overall Study|Lost to Follow-up|0|||
129969541|NCT05765435|467852928|FG000|Overall Study|Withdrawal by Subject|0|||
129969542|NCT05765435|467852929|FG001|Overall Study|Withdrawal by Subject|0|||
129969543|NCT05765435|467852930|FG002|Overall Study|Withdrawal by Subject|1|||
129969544|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
129969545|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
129969546|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
129969547|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
129969548|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
129969549|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
129969550|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
129969551|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
129969552|NCT00781937|467852939|FG000|Main Trial Period Through Week 56|Unclassified|10|||
129969553|NCT00781937|467852940|FG001|Main Trial Period Through Week 56|Unclassified|15|||
129459821|NCT01014689|465978713|FG000|Overall Study|Withdrawal by Subject|5|||
129459822|NCT01014689|465978714|FG001|Overall Study|Withdrawal by Subject|4|||
129459823|NCT01014689|465978713|FG000|Overall Study|Protocol Violation|1|||
129459824|NCT01014689|465978714|FG001|Overall Study|Protocol Violation|1|||
129969554|NCT00781937|467852939|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
129969555|NCT00781937|467852940|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
129969556|NCT00781937|467852939|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
129969557|NCT00781937|467852940|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
129969558|NCT04698915|467852941|FG000|Overall Study|Adverse Event|2|||
129459825|NCT01014689|465978713|FG000|Overall Study|Lost to Follow-up|3|||
129969559|NCT04698915|467852942|FG001|Overall Study|Adverse Event|0|||
129969560|NCT04698915|467852941|FG000|Overall Study|Death|23|||
129969561|NCT04698915|467852942|FG001|Overall Study|Death|20|||
129969562|NCT04698915|467852941|FG000|Overall Study|Physician Decision|1|||
129969563|NCT04698915|467852942|FG001|Overall Study|Physician Decision|1|||
129969564|NCT04698915|467852941|FG000|Overall Study|Lost to Follow-up|1|||
129969565|NCT04698915|467852942|FG001|Overall Study|Lost to Follow-up|0|||
129969566|NCT04698915|467852941|FG000|Overall Study|Study Terminated by Sponsor|55|||
129969567|NCT04698915|467852942|FG001|Overall Study|Study Terminated by Sponsor|60|||
129969568|NCT04698915|467852941|FG000|Overall Study|Withdrawal by Subject|2|||
129969569|NCT04698915|467852942|FG001|Overall Study|Withdrawal by Subject|3|||
129969570|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Death|2|||
129969571|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Death|2|||
129969572|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Death|3|||
129459826|NCT01014689|465978714|FG001|Overall Study|Lost to Follow-up|7|||
129459827|NCT01014689|465978713|FG000|Overall Study|Pregnancy|1|||
129459828|NCT01014689|465978714|FG001|Overall Study|Pregnancy|0|||
129459829|NCT00609791|465980374|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
129459830|NCT01394939|465980379|FG000|Overall Study|Adverse Event|1|||
129459831|NCT01394939|465980380|FG001|Overall Study|Adverse Event|3|||
129459832|NCT01394939|465980381|FG002|Overall Study|Adverse Event|0|||
129459833|NCT01394939|465980382|FG003|Overall Study|Adverse Event|2|||
129459834|NCT01394939|465980379|FG000|Overall Study|Death|0|||
129459835|NCT01394939|465980380|FG001|Overall Study|Death|2|||
129459836|NCT01394939|465980381|FG002|Overall Study|Death|0|||
129459837|NCT01394939|465980382|FG003|Overall Study|Death|0|||
129459838|NCT01394939|465980379|FG000|Overall Study|Physician Decision|0|||
129459839|NCT01394939|465980380|FG001|Overall Study|Physician Decision|1|||
129459840|NCT01394939|465980381|FG002|Overall Study|Physician Decision|0|||
129459841|NCT01394939|465980382|FG003|Overall Study|Physician Decision|0|||
129459842|NCT01394939|465980379|FG000|Overall Study|Withdrawal by Subject|0|||
129459843|NCT01394939|465980380|FG001|Overall Study|Withdrawal by Subject|2|||
129459844|NCT01394939|465980381|FG002|Overall Study|Withdrawal by Subject|0|||
129459845|NCT01394939|465980382|FG003|Overall Study|Withdrawal by Subject|2|||
129459846|NCT01394939|465980379|FG000|Overall Study|Others|0|||
129459847|NCT01394939|465980380|FG001|Overall Study|Others|2|||
129459848|NCT01394939|465980381|FG002|Overall Study|Others|0|||
129459849|NCT01394939|465980382|FG003|Overall Study|Others|3|||
129459850|NCT00150592|465980385|FG000|Overall Study|Adverse Event|4|||
129459851|NCT00150592|465980386|FG001|Overall Study|Adverse Event|1|||
129459852|NCT00150592|465980385|FG000|Overall Study|Protocol Violation|1|||
129459853|NCT00150592|465980386|FG001|Overall Study|Protocol Violation|0|||
129459854|NCT00150592|465980385|FG000|Overall Study|Withdrawal by Subject|1|||
129459855|NCT00150592|465980386|FG001|Overall Study|Withdrawal by Subject|2|||
129459856|NCT00150592|465980385|FG000|Overall Study|Non-compliance|1|||
129459857|NCT00150592|465980386|FG001|Overall Study|Non-compliance|0|||
129459858|NCT00874120|465980391|FG000|First Intervention|Adverse Event|0|||
129459859|NCT00874120|465980392|FG001|First Intervention|Adverse Event|1|||
129459860|NCT00874120|465980391|FG000|First Intervention|Withdrawal by Subject|2|||
129459861|NCT00874120|465980392|FG001|First Intervention|Withdrawal by Subject|0|||
129459862|NCT00874120|465980391|FG000|First Intervention|Lost to Follow-up|0|||
129459863|NCT00874120|465980392|FG001|First Intervention|Lost to Follow-up|1|||
129459864|NCT00874120|465980391|FG000|First Intervention|Protocol Violation|3|||
129459865|NCT00874120|465980392|FG001|First Intervention|Protocol Violation|0|||
129459866|NCT00874120|465980391|FG000|First Intervention|positive drug test|1|||
129459867|NCT00874120|465980392|FG001|First Intervention|positive drug test|0|||
129459868|NCT00874120|465980391|FG000|Second Intervention|Withdrawal by Subject|1|||
129459869|NCT00874120|465980392|FG001|Second Intervention|Withdrawal by Subject|0|||
129459870|NCT00874120|465980391|FG000|Second Intervention|Protocol Violation|1|||
129459871|NCT00874120|465980392|FG001|Second Intervention|Protocol Violation|0|||
129459872|NCT01823679|465980393|FG000|Overall Study|Death|1|||
129459873|NCT03927105|465980394|FG000|Overall Study|Death|1|||
129459874|NCT03927105|465980394|FG000|Overall Study|In observation for potential re-treatment|2|||
129459875|NCT03927105|465980394|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
129459876|NCT05594173|465980398|FG000|Overall Study|Adverse Event|1|||
129459877|NCT05594173|465980398|FG000|Overall Study|COVID-19 Pandemic|2|||
129459878|NCT00647556|465980399|FG000|Overall Study|Adverse Event|0|||
129459879|NCT00647556|465980400|FG001|Overall Study|Adverse Event|1|||
129459880|NCT00647556|465980399|FG000|Overall Study|Lost to Follow-up|1|||
129459881|NCT00647556|465980400|FG001|Overall Study|Lost to Follow-up|0|||
129459882|NCT00647556|465980399|FG000|Overall Study|Protocol Violation|0|||
129459883|NCT00647556|465980400|FG001|Overall Study|Protocol Violation|1|||
129459884|NCT00647556|465980399|FG000|Overall Study|Withdrawal by Subject|1|||
129459885|NCT00647556|465980400|FG001|Overall Study|Withdrawal by Subject|0|||
129459886|NCT00647556|465980399|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
129459887|NCT00647556|465980400|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
129459888|NCT01877187|465980401|FG000|Overall Study|Death|2|||
129459889|NCT01877187|465980401|FG000|Overall Study|Withdrawal by Subject|4|||
129459890|NCT01877187|465980401|FG000|Overall Study|Lost to Follow-up|3|||
129459891|NCT01877187|465980401|FG000|Overall Study|Declining clinical status|11|||
129459892|NCT01877187|465980401|FG000|Overall Study|Liver transplant|2|||
129969573|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Death|2|||
129969574|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Death|6|||
129459893|NCT03776175|465980403|FG000|Treatment Period (42 Days)|Adverse Event|0|||
129459894|NCT03776175|465980404|FG001|Treatment Period (42 Days)|Adverse Event|1|||
129459895|NCT03776175|465980405|FG002|Treatment Period (42 Days)|Adverse Event|1|||
129459896|NCT03776175|465980406|FG003|Treatment Period (42 Days)|Adverse Event|0|||
129459897|NCT03776175|465980403|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
129459898|NCT03776175|465980404|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
129459899|NCT03776175|465980405|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
129459900|NCT03776175|465980406|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
129459901|NCT03776175|465980403|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
129459902|NCT03776175|465980404|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
129459903|NCT03776175|465980405|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
129459904|NCT03776175|465980406|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
129459905|NCT03776175|465980403|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
129459906|NCT03776175|465980404|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
129459907|NCT03776175|465980405|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
129459908|NCT03776175|465980406|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
129459909|NCT03776175|465980403|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
129459910|NCT03776175|465980404|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
129459911|NCT03776175|465980405|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
129459912|NCT03776175|465980406|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
129459913|NCT03776175|465980403|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
129459914|NCT03776175|465980404|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
129459915|NCT03776175|465980405|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
129459916|NCT03776175|465980406|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
129459917|NCT02412787|465980407|FG000|Overall Study|Withdrawal by Subject|9|||
129459918|NCT02412787|465980407|FG000|Overall Study|Participation Terminated by Investigator|1|||
129459919|NCT02412787|465980407|FG000|Overall Study|Site Terminated by Sponsor|21|||
129459920|NCT02412787|465980407|FG000|Overall Study|Technical Problems|1|||
129459921|NCT02412787|465980407|FG000|Overall Study|Reason Not Specified|1|||
129459922|NCT02311153|465980408|FG000|Overall Study|Lost to Follow-up|5|||
129459923|NCT02311153|465980409|FG001|Overall Study|Lost to Follow-up|7|||
129459924|NCT00414453|465980415|FG000|Overall Study|Abnormal lab work|16|||
129459925|NCT00290433|465980416|FG000|Overall Study|Disease Progression|13|||
129459926|NCT00290433|465980416|FG000|Overall Study|Adverse Event|14|||
129459927|NCT00290433|465980416|FG000|Overall Study|Withdrawal by Subject|1|||
129459928|NCT00290433|465980416|FG000|Overall Study|Non-Compliance|1|||
129459929|NCT00290433|465980416|FG000|Overall Study|Congestive Heart Failure|1|||
129459930|NCT00290433|465980416|FG000|Overall Study|Transplant in CR|5|||
129459931|NCT00290433|465980416|FG000|Overall Study|Unrelated Infection/Death|1|||
129459932|NCT03031301|465980418|FG000|Overall Study|Protocol Violation|4|||
129459933|NCT03031301|465980419|FG001|Overall Study|Protocol Violation|8|||
129459934|NCT03031301|465980418|FG000|Overall Study|Withdrawal by Subject|7|||
129459935|NCT03031301|465980419|FG001|Overall Study|Withdrawal by Subject|4|||
129459936|NCT03031301|465980418|FG000|Overall Study|Lost to Follow-up|4|||
129459937|NCT03031301|465980419|FG001|Overall Study|Lost to Follow-up|12|||
129459938|NCT03031301|465980418|FG000|Overall Study|Noncompliance|1|||
129459939|NCT03031301|465980419|FG001|Overall Study|Noncompliance|3|||
129459940|NCT03031301|465980418|FG000|Overall Study|Technical issue|1|||
129459941|NCT03031301|465980419|FG001|Overall Study|Technical issue|1|||
129459942|NCT03031301|465980418|FG000|Overall Study|Adverse Event|1|||
129459943|NCT03031301|465980419|FG001|Overall Study|Adverse Event|0|||
129459944|NCT02429414|465980420|FG000|Overall Study|Physician Decision|0|||
129459945|NCT02429414|465980421|FG001|Overall Study|Physician Decision|1|||
129459946|NCT03245450|465980422|FG000|Overall Study|Radiological disease progression|3|||
129459947|NCT03245450|465980423|FG001|Overall Study|Radiological disease progression|3|||
129459948|NCT03245450|465980424|FG002|Overall Study|Radiological disease progression|2|||
129459949|NCT03245450|465980425|FG003|Overall Study|Radiological disease progression|2|||
129459950|NCT03245450|465980426|FG004|Overall Study|Radiological disease progression|7|||
129459951|NCT03245450|465980427|FG005|Overall Study|Radiological disease progression|6|||
129459952|NCT03245450|465980428|FG006|Overall Study|Radiological disease progression|6|||
129459953|NCT03245450|465980422|FG000|Overall Study|Clinical disease progression|0|||
129459954|NCT03245450|465980423|FG001|Overall Study|Clinical disease progression|0|||
129459955|NCT03245450|465980424|FG002|Overall Study|Clinical disease progression|1|||
129459956|NCT03245450|465980425|FG003|Overall Study|Clinical disease progression|0|||
129969575|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Death|5|||
129969576|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Death|3|||
129459957|NCT03245450|465980426|FG004|Overall Study|Clinical disease progression|0|||
129459958|NCT03245450|465980427|FG005|Overall Study|Clinical disease progression|2|||
129459959|NCT03245450|465980428|FG006|Overall Study|Clinical disease progression|0|||
129459960|NCT03245450|465980422|FG000|Overall Study|Other|0|||
129459961|NCT03245450|465980423|FG001|Overall Study|Other|0|||
129459962|NCT03245450|465980424|FG002|Overall Study|Other|0|||
129459963|NCT03245450|465980425|FG003|Overall Study|Other|1|||
129459964|NCT03245450|465980426|FG004|Overall Study|Other|1|||
129459965|NCT03245450|465980427|FG005|Overall Study|Other|1|||
129459966|NCT03245450|465980428|FG006|Overall Study|Other|1|||
129459967|NCT03245450|465980422|FG000|Overall Study|Withdrawal by Subject|0|||
129459968|NCT03245450|465980423|FG001|Overall Study|Withdrawal by Subject|1|||
129459969|NCT03245450|465980424|FG002|Overall Study|Withdrawal by Subject|0|||
129459970|NCT03245450|465980425|FG003|Overall Study|Withdrawal by Subject|0|||
129459971|NCT03245450|465980426|FG004|Overall Study|Withdrawal by Subject|0|||
129459972|NCT03245450|465980427|FG005|Overall Study|Withdrawal by Subject|0|||
129459973|NCT03245450|465980428|FG006|Overall Study|Withdrawal by Subject|0|||
129459974|NCT03245450|465980422|FG000|Overall Study|Adverse Event|0|||
129459975|NCT03245450|465980423|FG001|Overall Study|Adverse Event|0|||
129459976|NCT03245450|465980424|FG002|Overall Study|Adverse Event|0|||
129459977|NCT03245450|465980425|FG003|Overall Study|Adverse Event|0|||
129459978|NCT03245450|465980426|FG004|Overall Study|Adverse Event|1|||
129459979|NCT03245450|465980427|FG005|Overall Study|Adverse Event|0|||
129459980|NCT03245450|465980428|FG006|Overall Study|Adverse Event|2|||
129459981|NCT01784861|465980433|FG000|Overall Study|Adverse Event|0|||
129459982|NCT01784861|465980434|FG001|Overall Study|Adverse Event|0|||
129459983|NCT01784861|465980435|FG002|Overall Study|Adverse Event|1|||
129459984|NCT01784861|465980436|FG003|Overall Study|Adverse Event|2|||
129459985|NCT01784861|465980437|FG004|Overall Study|Adverse Event|1|||
129459986|NCT01784861|465980438|FG005|Overall Study|Adverse Event|0|||
129459987|NCT01784861|465980433|FG000|Overall Study|Withdrawal by Subject|0|||
129459988|NCT01784861|465980434|FG001|Overall Study|Withdrawal by Subject|0|||
129459989|NCT01784861|465980435|FG002|Overall Study|Withdrawal by Subject|0|||
129459990|NCT01784861|465980436|FG003|Overall Study|Withdrawal by Subject|1|||
129459991|NCT01784861|465980437|FG004|Overall Study|Withdrawal by Subject|0|||
129459992|NCT01784861|465980438|FG005|Overall Study|Withdrawal by Subject|0|||
129459993|NCT01784861|465980433|FG000|Overall Study|Physician Decision|0|||
129459994|NCT01784861|465980434|FG001|Overall Study|Physician Decision|0|||
129459995|NCT01784861|465980435|FG002|Overall Study|Physician Decision|0|||
129459996|NCT01784861|465980436|FG003|Overall Study|Physician Decision|2|||
129459997|NCT01784861|465980437|FG004|Overall Study|Physician Decision|0|||
129459998|NCT01784861|465980438|FG005|Overall Study|Physician Decision|1|||
129459999|NCT03948178|465980441|FG000|Overall Study|Protocol Violation|1|||
129460000|NCT03948178|465980441|FG000|Overall Study|Lost to Follow-up|2|||
129460001|NCT03948178|465980441|FG000|Overall Study|Withdrawal by Subject|2|||
129460002|NCT03948178|465980441|FG000|Overall Study|Reason not known|2|||
129460003|NCT03948178|465980441|FG000|Overall Study|Personal reason|14|||
129460004|NCT03948178|465980441|FG000|Overall Study|Disease progression|30|||
129460005|NCT03948178|465980441|FG000|Overall Study|Adverse Event|12|||
129460006|NCT03948178|465980441|FG000|Overall Study|Sponsor terminated study|164|||
129460007|NCT02432235|465980442|FG000|Overall Study|Death|1|||
129460008|NCT02432235|465980443|FG001|Overall Study|Death|1|||
129460009|NCT02432235|465980444|FG002|Overall Study|Death|2|||
129460010|NCT02432235|465980445|FG003|Overall Study|Death|2|||
129460011|NCT02432235|465980446|FG004|Overall Study|Death|1|||
129460012|NCT02432235|465980447|FG005|Overall Study|Death|3|||
129460013|NCT02432235|465980448|FG006|Overall Study|Death|11|||
129460014|NCT02432235|465980449|FG007|Overall Study|Death|15|||
129460015|NCT02432235|465980450|FG008|Overall Study|Death|15|||
129460016|NCT02432235|465980451|FG009|Overall Study|Death|3|||
129460017|NCT02432235|465980452|FG010|Overall Study|Death|1|||
129460018|NCT02432235|465980453|FG011|Overall Study|Death|0|||
129460019|NCT02432235|465980442|FG000|Overall Study|Withdrawal by Subject|0|||
129460020|NCT02432235|465980443|FG001|Overall Study|Withdrawal by Subject|1|||
129460021|NCT02432235|465980444|FG002|Overall Study|Withdrawal by Subject|0|||
129460022|NCT02432235|465980445|FG003|Overall Study|Withdrawal by Subject|0|||
129460023|NCT02432235|465980446|FG004|Overall Study|Withdrawal by Subject|0|||
129460024|NCT02432235|465980447|FG005|Overall Study|Withdrawal by Subject|2|||
129460025|NCT02432235|465980448|FG006|Overall Study|Withdrawal by Subject|5|||
129460026|NCT02432235|465980449|FG007|Overall Study|Withdrawal by Subject|3|||
129460027|NCT02432235|465980450|FG008|Overall Study|Withdrawal by Subject|1|||
129460028|NCT02432235|465980451|FG009|Overall Study|Withdrawal by Subject|0|||
129460029|NCT02432235|465980452|FG010|Overall Study|Withdrawal by Subject|0|||
129460030|NCT02432235|465980453|FG011|Overall Study|Withdrawal by Subject|0|||
129460031|NCT02432235|465980442|FG000|Overall Study|Lost to Follow-up|0|||
129460032|NCT02432235|465980443|FG001|Overall Study|Lost to Follow-up|0|||
129460033|NCT02432235|465980444|FG002|Overall Study|Lost to Follow-up|0|||
129460034|NCT02432235|465980445|FG003|Overall Study|Lost to Follow-up|0|||
129460035|NCT02432235|465980446|FG004|Overall Study|Lost to Follow-up|0|||
129460036|NCT02432235|465980447|FG005|Overall Study|Lost to Follow-up|1|||
129460037|NCT02432235|465980448|FG006|Overall Study|Lost to Follow-up|0|||
129460038|NCT02432235|465980449|FG007|Overall Study|Lost to Follow-up|0|||
129460039|NCT02432235|465980450|FG008|Overall Study|Lost to Follow-up|1|||
129460040|NCT02432235|465980451|FG009|Overall Study|Lost to Follow-up|0|||
129460041|NCT02432235|465980452|FG010|Overall Study|Lost to Follow-up|0|||
129460042|NCT02432235|465980453|FG011|Overall Study|Lost to Follow-up|0|||
129460043|NCT02432235|465980442|FG000|Overall Study|Miscellaneous|0|||
129460044|NCT02432235|465980443|FG001|Overall Study|Miscellaneous|0|||
129460045|NCT02432235|465980444|FG002|Overall Study|Miscellaneous|0|||
129460046|NCT02432235|465980445|FG003|Overall Study|Miscellaneous|0|||
129460047|NCT02432235|465980446|FG004|Overall Study|Miscellaneous|1|||
129460048|NCT02432235|465980447|FG005|Overall Study|Miscellaneous|6|||
129460049|NCT02432235|465980448|FG006|Overall Study|Miscellaneous|2|||
129460050|NCT02432235|465980449|FG007|Overall Study|Miscellaneous|2|||
129460051|NCT02432235|465980450|FG008|Overall Study|Miscellaneous|4|||
129460052|NCT02432235|465980451|FG009|Overall Study|Miscellaneous|0|||
129460053|NCT02432235|465980452|FG010|Overall Study|Miscellaneous|0|||
129460054|NCT02432235|465980453|FG011|Overall Study|Miscellaneous|1|||
129460055|NCT00382993|465980454|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
129460056|NCT00382993|465980455|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
129460057|NCT00382993|465980454|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
129460058|NCT00382993|465980455|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
129460059|NCT00382993|465980454|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
129460060|NCT00382993|465980455|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
129460061|NCT00382993|465980454|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
129460062|NCT00382993|465980455|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
129460063|NCT00382993|465980454|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
129460064|NCT00382993|465980455|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
129460065|NCT00382993|465980454|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
129460066|NCT00382993|465980455|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
129460067|NCT00382993|465980454|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
129460068|NCT00382993|465980455|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
129460069|NCT00382993|465980454|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
129460070|NCT00382993|465980455|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
129460071|NCT00382993|465980454|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
129460072|NCT00382993|465980455|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
129460073|NCT00382993|465980454|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
129460074|NCT00382993|465980455|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
129460075|NCT01965262|465980468|FG000|Second Intervention (7 Days)|Discontinued|0|||
129460076|NCT01965262|465980469|FG001|Second Intervention (7 Days)|Discontinued|1|||
129460077|NCT01965262|465980468|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
129460078|NCT01965262|465980469|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
129460079|NCT01965262|465980468|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
129460080|NCT01965262|465980469|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
129460081|NCT02898259|465980470|FG000|Overall Study|Adverse Event|0|||
129460082|NCT02898259|465980471|FG001|Overall Study|Adverse Event|0|||
129460083|NCT02898259|465980472|FG002|Overall Study|Adverse Event|1|||
129460084|NCT02898259|465980473|FG003|Overall Study|Adverse Event|0|||
129460085|NCT02898259|465980474|FG004|Overall Study|Adverse Event|0|||
129460086|NCT02898259|465980470|FG000|Overall Study|Lack of Efficacy|1|||
129460087|NCT02898259|465980471|FG001|Overall Study|Lack of Efficacy|1|||
129460088|NCT02898259|465980472|FG002|Overall Study|Lack of Efficacy|3|||
129460089|NCT02898259|465980473|FG003|Overall Study|Lack of Efficacy|0|||
129460090|NCT02898259|465980474|FG004|Overall Study|Lack of Efficacy|0|||
129460091|NCT02898259|465980470|FG000|Overall Study|Lost to Follow-up|0|||
129460092|NCT02898259|465980471|FG001|Overall Study|Lost to Follow-up|0|||
129460093|NCT02898259|465980472|FG002|Overall Study|Lost to Follow-up|1|||
129460094|NCT02898259|465980473|FG003|Overall Study|Lost to Follow-up|0|||
129460095|NCT02898259|465980474|FG004|Overall Study|Lost to Follow-up|0|||
129460096|NCT02898259|465980470|FG000|Overall Study|Transformation before study began|0|||
129460097|NCT02898259|465980471|FG001|Overall Study|Transformation before study began|0|||
129460098|NCT02898259|465980472|FG002|Overall Study|Transformation before study began|0|||
129460099|NCT02898259|465980473|FG003|Overall Study|Transformation before study began|1|||
129460100|NCT02898259|465980474|FG004|Overall Study|Transformation before study began|0|||
129460101|NCT01046877|465980475|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
129460102|NCT01046877|465980475|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
129460103|NCT03016325|465980476|FG000|Treatment Period|Participant withdrew consent|0|||
129460104|NCT03016325|465980477|FG001|Treatment Period|Participant withdrew consent|1|||
129460105|NCT03016325|465980478|FG002|Treatment Period|Participant withdrew consent|0|||
129460106|NCT03016325|465980479|FG003|Treatment Period|Participant withdrew consent|0|||
129460107|NCT03016325|465980480|FG004|Treatment Period|Participant withdrew consent|0|||
129460108|NCT03016325|465980481|FG005|Treatment Period|Participant withdrew consent|0|||
129460109|NCT03016325|465980482|FG006|Treatment Period|Participant withdrew consent|0|||
129460110|NCT03016325|465980483|FG007|Treatment Period|Participant withdrew consent|0|||
129460111|NCT03016325|465980476|FG000|Treatment Period|Death|0|||
129460112|NCT03016325|465980477|FG001|Treatment Period|Death|0|||
129460113|NCT03016325|465980478|FG002|Treatment Period|Death|0|||
129460114|NCT03016325|465980479|FG003|Treatment Period|Death|0|||
129460115|NCT03016325|465980480|FG004|Treatment Period|Death|2|||
129460116|NCT03016325|465980481|FG005|Treatment Period|Death|0|||
129460117|NCT03016325|465980482|FG006|Treatment Period|Death|0|||
129460118|NCT03016325|465980483|FG007|Treatment Period|Death|0|||
129460119|NCT03016325|465980476|FG000|Treatment Period|Participant refuses assessments|0|||
129460120|NCT03016325|465980477|FG001|Treatment Period|Participant refuses assessments|0|||
129460121|NCT03016325|465980478|FG002|Treatment Period|Participant refuses assessments|1|||
129460122|NCT03016325|465980479|FG003|Treatment Period|Participant refuses assessments|0|||
129969577|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Death|2|||
129460123|NCT03016325|465980480|FG004|Treatment Period|Participant refuses assessments|0|||
129460124|NCT03016325|465980481|FG005|Treatment Period|Participant refuses assessments|0|||
129460125|NCT03016325|465980482|FG006|Treatment Period|Participant refuses assessments|0|||
129460126|NCT03016325|465980483|FG007|Treatment Period|Participant refuses assessments|0|||
129460127|NCT03016325|465980476|FG000|32-Day Follow-Up Period|Death|2|||
129460128|NCT03016325|465980477|FG001|32-Day Follow-Up Period|Death|0|||
129460129|NCT03016325|465980478|FG002|32-Day Follow-Up Period|Death|5|||
129460130|NCT03016325|465980479|FG003|32-Day Follow-Up Period|Death|6|||
129460131|NCT03016325|465980480|FG004|32-Day Follow-Up Period|Death|3|||
129460132|NCT03016325|465980481|FG005|32-Day Follow-Up Period|Death|0|||
129460133|NCT03016325|465980482|FG006|32-Day Follow-Up Period|Death|0|||
129460134|NCT03016325|465980483|FG007|32-Day Follow-Up Period|Death|0|||
129460135|NCT03016325|465980476|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
129460136|NCT03016325|465980477|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
129460137|NCT03016325|465980478|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
129460138|NCT03016325|465980479|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
129460139|NCT03016325|465980480|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
129460140|NCT03016325|465980481|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
129460141|NCT03016325|465980482|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
129460142|NCT03016325|465980483|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
129460143|NCT03016325|465980476|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
129460144|NCT03016325|465980477|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
129460145|NCT03016325|465980478|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
129460146|NCT03016325|465980479|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
129460147|NCT03016325|465980480|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
129460148|NCT03016325|465980481|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
129460149|NCT03016325|465980482|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
129460150|NCT03016325|465980483|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
129460151|NCT03016325|465980476|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
129460152|NCT03016325|465980477|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
129460153|NCT03016325|465980478|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
129460154|NCT03016325|465980479|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
129460155|NCT03016325|465980480|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
129460156|NCT03016325|465980481|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
129460157|NCT03016325|465980482|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
129460158|NCT03016325|465980483|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
129460159|NCT03016325|465980476|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
129460160|NCT03016325|465980477|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
129460161|NCT03016325|465980478|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
129460162|NCT03016325|465980479|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
129460163|NCT03016325|465980480|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
129460164|NCT03016325|465980481|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
129460165|NCT03016325|465980482|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
129460166|NCT03016325|465980483|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
129460167|NCT03016325|465980476|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460168|NCT03016325|465980477|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460169|NCT03016325|465980478|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
129460170|NCT03016325|465980479|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460171|NCT03016325|465980480|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460172|NCT03016325|465980481|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460173|NCT03016325|465980482|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460174|NCT03016325|465980483|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
129460175|NCT03016325|465980476|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460176|NCT03016325|465980477|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
129460177|NCT03016325|465980478|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460178|NCT03016325|465980479|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460179|NCT03016325|465980480|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460180|NCT03016325|465980481|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460181|NCT03016325|465980482|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460182|NCT03016325|465980483|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
129460183|NCT03016325|465980476|FG000|182-Day Follow-Up Period|Death|3|||
129460184|NCT03016325|465980477|FG001|182-Day Follow-Up Period|Death|3|||
129460185|NCT03016325|465980478|FG002|182-Day Follow-Up Period|Death|11|||
129460186|NCT03016325|465980479|FG003|182-Day Follow-Up Period|Death|12|||
129460187|NCT03016325|465980480|FG004|182-Day Follow-Up Period|Death|9|||
129460188|NCT03016325|465980481|FG005|182-Day Follow-Up Period|Death|0|||
129460189|NCT03016325|465980482|FG006|182-Day Follow-Up Period|Death|0|||
129460190|NCT03016325|465980483|FG007|182-Day Follow-Up Period|Death|1|||
129460191|NCT03016325|465980476|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
129460192|NCT03016325|465980477|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460193|NCT03016325|465980478|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460194|NCT03016325|465980479|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460195|NCT03016325|465980480|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460196|NCT03016325|465980481|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460197|NCT03016325|465980482|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460198|NCT03016325|465980483|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
129460199|NCT03016325|465980476|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
129460200|NCT03016325|465980477|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
129460201|NCT03016325|465980478|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
129460202|NCT03016325|465980479|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
129460203|NCT03016325|465980480|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
129460204|NCT03016325|465980481|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
129460205|NCT03016325|465980482|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
129460206|NCT03016325|465980483|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
129460207|NCT03016325|465980476|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460208|NCT03016325|465980477|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460209|NCT03016325|465980478|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460210|NCT03016325|465980479|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460211|NCT03016325|465980480|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
129460212|NCT03016325|465980481|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460213|NCT03016325|465980482|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460214|NCT03016325|465980483|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
129460215|NCT03016325|465980476|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460216|NCT03016325|465980477|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460217|NCT03016325|465980478|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460218|NCT03016325|465980479|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460219|NCT03016325|465980480|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
129460220|NCT03016325|465980481|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460221|NCT03016325|465980482|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460222|NCT03016325|465980483|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
129460223|NCT03016325|465980476|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460224|NCT03016325|465980477|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460225|NCT03016325|465980478|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460226|NCT03016325|465980479|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
129460227|NCT03016325|465980480|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460228|NCT03016325|465980481|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460229|NCT03016325|465980482|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460230|NCT03016325|465980483|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
129460231|NCT03016325|465980476|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460232|NCT03016325|465980477|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
129460233|NCT03016325|465980478|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460234|NCT03016325|465980479|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460235|NCT03016325|465980480|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460236|NCT03016325|465980481|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460237|NCT03016325|465980482|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460238|NCT03016325|465980483|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
129460239|NCT03016325|465980476|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
129460240|NCT03016325|465980477|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
129460241|NCT03016325|465980478|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
129460242|NCT03016325|465980479|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
129460243|NCT03016325|465980480|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
129460244|NCT03016325|465980481|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
129460245|NCT03016325|465980482|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
129460246|NCT03016325|465980483|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
129460247|NCT02970292|465980484|FG000|Overall Study|Physician Decision|1|||
129460248|NCT02970292|465980485|FG001|Overall Study|Physician Decision|1|||
129460249|NCT02970292|465980484|FG000|Overall Study|Withdrawal by Subject|11|||
129460250|NCT02970292|465980485|FG001|Overall Study|Withdrawal by Subject|5|||
129460251|NCT02970292|465980484|FG000|Overall Study|Noncompliance with study drug|2|||
129460252|NCT02970292|465980485|FG001|Overall Study|Noncompliance with study drug|2|||
129460253|NCT02970292|465980484|FG000|Overall Study|Adverse Event|5|||
129460254|NCT02970292|465980485|FG001|Overall Study|Adverse Event|0|||
129460255|NCT02970292|465980484|FG000|Overall Study|Lack of Efficacy|1|||
129460256|NCT02970292|465980485|FG001|Overall Study|Lack of Efficacy|0|||
129460257|NCT02970292|465980484|FG000|Overall Study|Lost to Follow-up|1|||
129460258|NCT02970292|465980485|FG001|Overall Study|Lost to Follow-up|0|||
129460259|NCT02970292|465980484|FG000|Overall Study|Protocol Violation|2|||
129460260|NCT02970292|465980485|FG001|Overall Study|Protocol Violation|0|||
129460261|NCT02970292|465980484|FG000|Overall Study|Other|1|||
129460262|NCT02970292|465980485|FG001|Overall Study|Other|0|||
129460263|NCT01902290|465980488|FG000|Overall Study|Withdrawal by Subject|19|||
129460264|NCT01902290|465980489|FG001|Overall Study|Withdrawal by Subject|27|||
129460265|NCT01902290|465980488|FG000|Overall Study|Lost to Follow-up|2|||
129460266|NCT01902290|465980489|FG001|Overall Study|Lost to Follow-up|2|||
129460267|NCT01902290|465980488|FG000|Overall Study|Death|1|||
129460268|NCT01902290|465980489|FG001|Overall Study|Death|0|||
129460269|NCT01902290|465980488|FG000|Overall Study|Sponsor Decision|26|||
129460270|NCT01902290|465980489|FG001|Overall Study|Sponsor Decision|24|||
129460271|NCT03215771|465980491|FG000|Overall Study|Withdrawal by Subject|2|||
129460272|NCT03215771|465980491|FG000|Overall Study|Physician Decision|1|||
129460273|NCT02039375|465980492|FG000|Overall Study|Lost to Follow-up|2|||
129460274|NCT04770389|465980493|FG000|Overall Study|Adverse Event|1|||
129460275|NCT04770389|465980494|FG001|Overall Study|Adverse Event|2|||
129460276|NCT04770389|465980495|FG002|Overall Study|Adverse Event|0|||
129460277|NCT04770389|465980496|FG003|Overall Study|Adverse Event|1|||
129460278|NCT04770389|465980493|FG000|Overall Study|Withdrawal by Subject|0|||
129460279|NCT04770389|465980494|FG001|Overall Study|Withdrawal by Subject|2|||
129460280|NCT04770389|465980495|FG002|Overall Study|Withdrawal by Subject|1|||
129460281|NCT04770389|465980496|FG003|Overall Study|Withdrawal by Subject|0|||
129460282|NCT04770389|465980493|FG000|Overall Study|Failed attempt to draw blood|1|||
129460283|NCT04770389|465980494|FG001|Overall Study|Failed attempt to draw blood|0|||
129460284|NCT04770389|465980495|FG002|Overall Study|Failed attempt to draw blood|0|||
129460285|NCT04770389|465980496|FG003|Overall Study|Failed attempt to draw blood|0|||
129460286|NCT04770389|465980493|FG000|Overall Study|Left the country|0|||
129460287|NCT04770389|465980494|FG001|Overall Study|Left the country|0|||
129460288|NCT04770389|465980495|FG002|Overall Study|Left the country|1|||
129460289|NCT04770389|465980496|FG003|Overall Study|Left the country|2|||
129460290|NCT04770389|465980493|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
129460291|NCT04770389|465980494|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
129460292|NCT04770389|465980495|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
129460293|NCT04770389|465980496|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
129460294|NCT04770389|465980493|FG000|Overall Study|Lost to Follow-up|0|||
129460295|NCT04770389|465980494|FG001|Overall Study|Lost to Follow-up|0|||
129460296|NCT04770389|465980495|FG002|Overall Study|Lost to Follow-up|0|||
129460297|NCT04770389|465980496|FG003|Overall Study|Lost to Follow-up|1|||
129460298|NCT04770389|465980493|FG000|Overall Study|Moved away from study site|0|||
129460299|NCT04770389|465980494|FG001|Overall Study|Moved away from study site|1|||
129460300|NCT04770389|465980495|FG002|Overall Study|Moved away from study site|0|||
129460301|NCT04770389|465980496|FG003|Overall Study|Moved away from study site|0|||
129460302|NCT03873714|465980497|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
129460303|NCT03028870|465980498|FG000|Overall Study|Adverse Event|7|||
129460304|NCT03028870|465980499|FG001|Overall Study|Adverse Event|4|||
129460305|NCT03028870|465980500|FG002|Overall Study|Adverse Event|3|||
129460306|NCT03028870|465980501|FG003|Overall Study|Adverse Event|3|||
129460307|NCT03028870|465980498|FG000|Overall Study|Withdrawal by Subject|1|||
129460308|NCT03028870|465980499|FG001|Overall Study|Withdrawal by Subject|1|||
129460309|NCT03028870|465980500|FG002|Overall Study|Withdrawal by Subject|1|||
129460310|NCT03028870|465980501|FG003|Overall Study|Withdrawal by Subject|2|||
129460311|NCT03028870|465980498|FG000|Overall Study|Lost to Follow-up|1|||
129460312|NCT03028870|465980499|FG001|Overall Study|Lost to Follow-up|0|||
129460313|NCT03028870|465980500|FG002|Overall Study|Lost to Follow-up|0|||
129460314|NCT03028870|465980501|FG003|Overall Study|Lost to Follow-up|0|||
129460315|NCT03028870|465980498|FG000|Overall Study|Lack of Efficacy|3|||
129460316|NCT03028870|465980499|FG001|Overall Study|Lack of Efficacy|0|||
129460317|NCT03028870|465980500|FG002|Overall Study|Lack of Efficacy|0|||
129460318|NCT03028870|465980501|FG003|Overall Study|Lack of Efficacy|0|||
129460319|NCT03028870|465980498|FG000|Overall Study|Administrative|5|||
129460320|NCT03028870|465980499|FG001|Overall Study|Administrative|5|||
129460321|NCT03028870|465980500|FG002|Overall Study|Administrative|12|||
129460322|NCT03028870|465980501|FG003|Overall Study|Administrative|4|||
129460323|NCT00708123|465980502|FG000|Period 1|Protocol Violation|0|||
129460324|NCT00708123|465980503|FG001|Period 1|Protocol Violation|1|||
129460325|NCT00708123|465980504|FG002|Period 1|Protocol Violation|0|||
129460326|NCT00708123|465980505|FG003|Period 1|Protocol Violation|1|||
129460327|NCT00708123|465980506|FG004|Period 1|Protocol Violation|0|||
129460328|NCT00708123|465980502|FG000|Period 1|Adverse Event|0|||
129460329|NCT00708123|465980503|FG001|Period 1|Adverse Event|0|||
129460330|NCT00708123|465980504|FG002|Period 1|Adverse Event|1|||
129460331|NCT00708123|465980505|FG003|Period 1|Adverse Event|0|||
129460332|NCT00708123|465980506|FG004|Period 1|Adverse Event|0|||
129460333|NCT00708123|465980502|FG000|Period 2|Protocol Violation|0|||
129460334|NCT00708123|465980503|FG001|Period 2|Protocol Violation|0|||
129460335|NCT00708123|465980504|FG002|Period 2|Protocol Violation|0|||
129460336|NCT00708123|465980505|FG003|Period 2|Protocol Violation|1|||
129460337|NCT00708123|465980506|FG004|Period 2|Protocol Violation|0|||
129460338|NCT00708123|465980502|FG000|Period 2|Other Reason|1|||
129460339|NCT00708123|465980503|FG001|Period 2|Other Reason|0|||
129460340|NCT00708123|465980504|FG002|Period 2|Other Reason|0|||
129460341|NCT00708123|465980505|FG003|Period 2|Other Reason|0|||
129460342|NCT00708123|465980506|FG004|Period 2|Other Reason|0|||
129460343|NCT00708123|465980502|FG000|Period 3|Lost to Follow-up|0|||
129460344|NCT00708123|465980503|FG001|Period 3|Lost to Follow-up|0|||
129460345|NCT00708123|465980504|FG002|Period 3|Lost to Follow-up|1|||
129460346|NCT00708123|465980505|FG003|Period 3|Lost to Follow-up|1|||
129460347|NCT00708123|465980506|FG004|Period 3|Lost to Follow-up|0|||
129460348|NCT00708123|465980502|FG000|Period 4|Protocol Violation|0|||
129460349|NCT00708123|465980503|FG001|Period 4|Protocol Violation|1|||
129460350|NCT00708123|465980504|FG002|Period 4|Protocol Violation|0|||
129460351|NCT00708123|465980505|FG003|Period 4|Protocol Violation|0|||
129460352|NCT00708123|465980506|FG004|Period 4|Protocol Violation|0|||
129460353|NCT00250835|465980507|FG000|Overall Study|Withdrawal by Subject|1|||
129460354|NCT01187953|465980508|FG000|Overall Study|Death|11|||
129460355|NCT01187953|465980509|FG001|Overall Study|Death|13|||
129460356|NCT01187953|465980508|FG000|Overall Study|Adverse Event|1|||
129460357|NCT01187953|465980509|FG001|Overall Study|Adverse Event|2|||
129460358|NCT01187953|465980508|FG000|Overall Study|Lost to Follow-up|0|||
129460359|NCT01187953|465980509|FG001|Overall Study|Lost to Follow-up|3|||
129460360|NCT01187953|465980508|FG000|Overall Study|Withdrawal by Subject|3|||
129460361|NCT01187953|465980509|FG001|Overall Study|Withdrawal by Subject|3|||
129460362|NCT00333359|465980511|FG000|Overall Study|Adverse Event|29|||
129460363|NCT00333359|465980512|FG001|Overall Study|Adverse Event|35|||
129460364|NCT00333359|465980511|FG000|Overall Study|Withdrawal by Subject|19|||
129460365|NCT00333359|465980512|FG001|Overall Study|Withdrawal by Subject|37|||
129460366|NCT00333359|465980511|FG000|Overall Study|Physician Decision|2|||
129460367|NCT00333359|465980512|FG001|Overall Study|Physician Decision|2|||
129460368|NCT00333359|465980511|FG000|Overall Study|Protocol Non-compliance|2|||
129460369|NCT00333359|465980512|FG001|Overall Study|Protocol Non-compliance|8|||
129460370|NCT00333359|465980511|FG000|Overall Study|Lost to Follow-up|15|||
129460371|NCT00333359|465980512|FG001|Overall Study|Lost to Follow-up|25|||
129460372|NCT00333359|465980511|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
129460373|NCT00333359|465980512|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
129460374|NCT00333359|465980511|FG000|Overall Study|Treatment Failure|3|||
129460375|NCT00333359|465980512|FG001|Overall Study|Treatment Failure|8|||
129460376|NCT00333359|465980511|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
129460377|NCT00333359|465980512|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
129460378|NCT02867995|465980514|FG000|Overall Study|Withdrawal by Subject|0|||
129460379|NCT02867995|465980515|FG001|Overall Study|Withdrawal by Subject|1|||
129460380|NCT02867995|465980514|FG000|Overall Study|Lost to Follow-up|0|||
129460381|NCT02867995|465980515|FG001|Overall Study|Lost to Follow-up|2|||
129460382|NCT04099251|465983782|FG000|Pre-Treatment|Other reasons|1|||
129460383|NCT04099251|465983783|FG001|Pre-Treatment|Other reasons|0|||
129460384|NCT04099251|465983782|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
129460385|NCT04099251|465983783|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
129460386|NCT04099251|465983782|FG000|Blinded Treatment Phase|Other reasons|16|||
129460387|NCT04099251|465983783|FG001|Blinded Treatment Phase|Other reasons|7|||
129460388|NCT04099251|465983782|FG000|Blinded Treatment Phase|Disease recurrence|26|||
129460389|NCT04099251|465983783|FG001|Blinded Treatment Phase|Disease recurrence|41|||
129460390|NCT04099251|465983782|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
129460391|NCT04099251|465983783|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
129460392|NCT04099251|465983782|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
129460393|NCT04099251|465983783|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
129460394|NCT04099251|465983782|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
129460395|NCT04099251|465983783|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
129460396|NCT04099251|465983782|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
129460397|NCT04099251|465983783|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
129460398|NCT04099251|465983782|FG000|Blinded Treatment Phase|Death|6|||
129460399|NCT04099251|465983783|FG001|Blinded Treatment Phase|Death|2|||
129460400|NCT04099251|465983782|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
129460401|NCT04099251|465983783|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
129460402|NCT04099251|465983782|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
129460403|NCT04099251|465983783|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
129460404|NCT04099251|465983782|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
129460405|NCT04099251|465983783|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
129460406|NCT04099251|465983782|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
129460407|NCT04099251|465983783|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
129460408|NCT04099251|465983782|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
129460409|NCT04099251|465983783|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
129460410|NCT04099251|465983782|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
129460411|NCT04099251|465983783|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
129460412|NCT04099251|465983782|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
129460413|NCT04099251|465983783|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
129460414|NCT04099251|465983782|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
129460415|NCT04099251|465983783|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
129460416|NCT04099251|465983782|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
129460417|NCT04099251|465983783|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
129460418|NCT05032157|465983784|FG000|Overall Study|Adverse Event|12|||
129460419|NCT05032157|465983785|FG001|Overall Study|Adverse Event|7|||
129460420|NCT05032157|465983784|FG000|Overall Study|Pregnancy|0|||
129460421|NCT05032157|465983785|FG001|Overall Study|Pregnancy|2|||
129460422|NCT05032157|465983784|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129460423|NCT05032157|465983785|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
129460424|NCT05032157|465983784|FG000|Overall Study|Protocol Deviation|8|||
129460425|NCT05032157|465983785|FG001|Overall Study|Protocol Deviation|4|||
129460426|NCT05032157|465983784|FG000|Overall Study|Lost to Follow-up|1|||
129460427|NCT05032157|465983785|FG001|Overall Study|Lost to Follow-up|3|||
129460428|NCT05032157|465983784|FG000|Overall Study|Physician Decision|7|||
129460429|NCT05032157|465983785|FG001|Overall Study|Physician Decision|2|||
129460430|NCT05032157|465983784|FG000|Overall Study|Patient Decision|38|||
129460431|NCT05032157|465983785|FG001|Overall Study|Patient Decision|19|||
129460432|NCT03047980|465983786|FG000|Overall Study|Adverse Event|1|||
129460433|NCT02164981|465983787|FG000|Started|Withdrawal by Subject|2|||
129460434|NCT02164981|465983788|FG001|Started|Withdrawal by Subject|1|||
129460435|NCT02164981|465983789|FG002|Started|Withdrawal by Subject|0|||
129460436|NCT02164981|465983787|FG000|Started|Protocol Violation|2|||
129460437|NCT02164981|465983788|FG001|Started|Protocol Violation|0|||
129460438|NCT02164981|465983789|FG002|Started|Protocol Violation|0|||
129460439|NCT02164981|465983787|FG000|Started|Adverse Event|1|||
129460440|NCT02164981|465983788|FG001|Started|Adverse Event|2|||
129460441|NCT02164981|465983789|FG002|Started|Adverse Event|0|||
129460442|NCT02164981|465983787|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
129460443|NCT02164981|465983788|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
129460444|NCT02164981|465983789|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
129460445|NCT02164981|465983787|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
129460446|NCT02164981|465983788|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
129460447|NCT02164981|465983789|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
129460448|NCT02164981|465983787|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
129460449|NCT02164981|465983788|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
129460450|NCT02164981|465983789|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
129460451|NCT02404103|465983790|FG000|Overall Study|Adverse Event|1|||
129460452|NCT02404103|465983791|FG001|Overall Study|Adverse Event|0|||
129460453|NCT02404103|465983790|FG000|Overall Study|Lost to Follow-up|3|||
129460454|NCT02404103|465983791|FG001|Overall Study|Lost to Follow-up|3|||
129460455|NCT01995071|465983792|FG000|Overall Study|Adverse Event|0|||
129460456|NCT01995071|465983793|FG001|Overall Study|Adverse Event|0|||
129460457|NCT01995071|465983794|FG002|Overall Study|Adverse Event|0|||
129460458|NCT01995071|465983795|FG003|Overall Study|Adverse Event|0|||
129460459|NCT01995071|465983796|FG004|Overall Study|Adverse Event|0|||
129460460|NCT01995071|465983797|FG005|Overall Study|Adverse Event|0|||
129460461|NCT01995071|465983798|FG006|Overall Study|Adverse Event|1|||
129460462|NCT01995071|465983799|FG007|Overall Study|Adverse Event|0|||
129460463|NCT01995071|465983800|FG008|Overall Study|Adverse Event|0|||
129460464|NCT01995071|465983801|FG009|Overall Study|Adverse Event|0|||
129460465|NCT01995071|465983802|FG010|Overall Study|Adverse Event|0|||
129460466|NCT01995071|465983803|FG011|Overall Study|Adverse Event|0|||
129460467|NCT01995071|465983792|FG000|Overall Study|Moved|0|||
129460468|NCT01995071|465983793|FG001|Overall Study|Moved|0|||
129460469|NCT01995071|465983794|FG002|Overall Study|Moved|1|||
129460470|NCT01995071|465983795|FG003|Overall Study|Moved|0|||
129460471|NCT01995071|465983796|FG004|Overall Study|Moved|1|||
129460472|NCT01995071|465983797|FG005|Overall Study|Moved|0|||
129460473|NCT01995071|465983798|FG006|Overall Study|Moved|0|||
129460474|NCT01995071|465983799|FG007|Overall Study|Moved|0|||
129460475|NCT01995071|465983800|FG008|Overall Study|Moved|0|||
129460476|NCT01995071|465983801|FG009|Overall Study|Moved|0|||
129460477|NCT01995071|465983802|FG010|Overall Study|Moved|1|||
129460478|NCT01995071|465983803|FG011|Overall Study|Moved|0|||
129460479|NCT01995071|465983792|FG000|Overall Study|Lost to Follow-up|1|||
129460480|NCT01995071|465983793|FG001|Overall Study|Lost to Follow-up|0|||
129460481|NCT01995071|465983794|FG002|Overall Study|Lost to Follow-up|0|||
129460482|NCT01995071|465983795|FG003|Overall Study|Lost to Follow-up|0|||
129460483|NCT01995071|465983796|FG004|Overall Study|Lost to Follow-up|0|||
129460484|NCT01995071|465983797|FG005|Overall Study|Lost to Follow-up|0|||
129460485|NCT01995071|465983798|FG006|Overall Study|Lost to Follow-up|0|||
129460486|NCT01995071|465983799|FG007|Overall Study|Lost to Follow-up|1|||
129460487|NCT01995071|465983800|FG008|Overall Study|Lost to Follow-up|1|||
129460488|NCT01995071|465983801|FG009|Overall Study|Lost to Follow-up|0|||
129460489|NCT01995071|465983802|FG010|Overall Study|Lost to Follow-up|0|||
129460490|NCT01995071|465983803|FG011|Overall Study|Lost to Follow-up|0|||
129460491|NCT01995071|465983792|FG000|Overall Study|Incarcerated|0|||
129460492|NCT01995071|465983793|FG001|Overall Study|Incarcerated|0|||
129460493|NCT01995071|465983794|FG002|Overall Study|Incarcerated|0|||
129460494|NCT01995071|465983795|FG003|Overall Study|Incarcerated|0|||
129460495|NCT01995071|465983796|FG004|Overall Study|Incarcerated|0|||
129460496|NCT01995071|465983797|FG005|Overall Study|Incarcerated|0|||
129460497|NCT01995071|465983798|FG006|Overall Study|Incarcerated|0|||
129460498|NCT01995071|465983799|FG007|Overall Study|Incarcerated|1|||
129460499|NCT01995071|465983800|FG008|Overall Study|Incarcerated|0|||
129460500|NCT01995071|465983801|FG009|Overall Study|Incarcerated|0|||
129460501|NCT01995071|465983802|FG010|Overall Study|Incarcerated|0|||
129460502|NCT01995071|465983803|FG011|Overall Study|Incarcerated|0|||
129460503|NCT01783678|465983804|FG000|Overall Study|Randomized but Not Treated|0|||
129460504|NCT01783678|465983805|FG001|Overall Study|Randomized but Not Treated|0|||
129460505|NCT01783678|465983806|FG002|Overall Study|Randomized but Not Treated|0|||
129460506|NCT01783678|465983807|FG003|Overall Study|Randomized but Not Treated|1|||
129460507|NCT01783678|465983808|FG004|Overall Study|Randomized but Not Treated|0|||
129460508|NCT01783678|465983809|FG005|Overall Study|Randomized but Not Treated|0|||
129460509|NCT01783678|465983804|FG000|Overall Study|Lack of Efficacy|1|||
129460510|NCT01783678|465983805|FG001|Overall Study|Lack of Efficacy|13|||
129460511|NCT01783678|465983806|FG002|Overall Study|Lack of Efficacy|1|||
129460512|NCT01783678|465983807|FG003|Overall Study|Lack of Efficacy|3|||
129460513|NCT01783678|465983808|FG004|Overall Study|Lack of Efficacy|6|||
129460514|NCT01783678|465983809|FG005|Overall Study|Lack of Efficacy|5|||
129460515|NCT01783678|465983804|FG000|Overall Study|Lost to Follow-up|0|||
129460516|NCT01783678|465983805|FG001|Overall Study|Lost to Follow-up|4|||
129460517|NCT01783678|465983806|FG002|Overall Study|Lost to Follow-up|0|||
129460518|NCT01783678|465983807|FG003|Overall Study|Lost to Follow-up|2|||
129460519|NCT01783678|465983808|FG004|Overall Study|Lost to Follow-up|1|||
129460520|NCT01783678|465983809|FG005|Overall Study|Lost to Follow-up|0|||
129460521|NCT01783678|465983804|FG000|Overall Study|Withdrew Consent|1|||
129460522|NCT01783678|465983805|FG001|Overall Study|Withdrew Consent|1|||
129460523|NCT01783678|465983806|FG002|Overall Study|Withdrew Consent|0|||
129460524|NCT01783678|465983807|FG003|Overall Study|Withdrew Consent|2|||
129460525|NCT01783678|465983808|FG004|Overall Study|Withdrew Consent|0|||
129460526|NCT01783678|465983809|FG005|Overall Study|Withdrew Consent|0|||
129460527|NCT00328627|465983810|FG000|Overall Study|Hyperglycemic Rescue|41|||
129460528|NCT00328627|465983811|FG001|Overall Study|Hyperglycemic Rescue|18|||
129460529|NCT00328627|465983812|FG002|Overall Study|Hyperglycemic Rescue|16|||
129460530|NCT00328627|465983813|FG003|Overall Study|Hyperglycemic Rescue|13|||
129460531|NCT00328627|465983814|FG004|Overall Study|Hyperglycemic Rescue|6|||
129969578|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Death|3|||
129969579|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Death|1|||
129969580|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Death|5|||
129969581|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Death|7|||
129969582|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Death|11|||
129969583|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Death|0|||
129969584|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Death|0|||
129969585|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Death|0|||
129969586|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Death|0|||
129969587|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Death|0|||
129969588|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Death|0|||
129969589|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
129969590|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969591|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969592|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
129969593|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
129969594|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
129969595|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969596|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
129969597|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969598|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
129969599|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129460532|NCT00328627|465983815|FG005|Overall Study|Hyperglycemic Rescue|5|||
129460533|NCT00328627|465983816|FG006|Overall Study|Hyperglycemic Rescue|19|||
129460534|NCT00328627|465983817|FG007|Overall Study|Hyperglycemic Rescue|6|||
129460535|NCT00328627|465983818|FG008|Overall Study|Hyperglycemic Rescue|6|||
129460536|NCT00328627|465983819|FG009|Overall Study|Hyperglycemic Rescue|11|||
129460537|NCT00328627|465983820|FG010|Overall Study|Hyperglycemic Rescue|3|||
129969600|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129460538|NCT00328627|465983821|FG011|Overall Study|Hyperglycemic Rescue|2|||
129460539|NCT00328627|465983810|FG000|Overall Study|Adverse Event|3|||
129460540|NCT00328627|465983811|FG001|Overall Study|Adverse Event|1|||
129460541|NCT00328627|465983812|FG002|Overall Study|Adverse Event|2|||
129460542|NCT00328627|465983813|FG003|Overall Study|Adverse Event|3|||
129460543|NCT00328627|465983814|FG004|Overall Study|Adverse Event|1|||
129460544|NCT00328627|465983815|FG005|Overall Study|Adverse Event|2|||
129460545|NCT00328627|465983816|FG006|Overall Study|Adverse Event|1|||
129460546|NCT00328627|465983817|FG007|Overall Study|Adverse Event|2|||
129460547|NCT00328627|465983818|FG008|Overall Study|Adverse Event|0|||
129460548|NCT00328627|465983819|FG009|Overall Study|Adverse Event|7|||
129460549|NCT00328627|465983820|FG010|Overall Study|Adverse Event|5|||
129460550|NCT00328627|465983821|FG011|Overall Study|Adverse Event|4|||
129460551|NCT00328627|465983810|FG000|Overall Study|Protocol Violation|2|||
129460552|NCT00328627|465983811|FG001|Overall Study|Protocol Violation|2|||
129460553|NCT00328627|465983812|FG002|Overall Study|Protocol Violation|2|||
129460554|NCT00328627|465983813|FG003|Overall Study|Protocol Violation|8|||
129460555|NCT00328627|465983814|FG004|Overall Study|Protocol Violation|5|||
129460556|NCT00328627|465983815|FG005|Overall Study|Protocol Violation|5|||
129460557|NCT00328627|465983816|FG006|Overall Study|Protocol Violation|6|||
129460558|NCT00328627|465983817|FG007|Overall Study|Protocol Violation|2|||
129460559|NCT00328627|465983818|FG008|Overall Study|Protocol Violation|1|||
129460560|NCT00328627|465983819|FG009|Overall Study|Protocol Violation|4|||
129460561|NCT00328627|465983820|FG010|Overall Study|Protocol Violation|6|||
129460562|NCT00328627|465983821|FG011|Overall Study|Protocol Violation|2|||
129460563|NCT00328627|465983810|FG000|Overall Study|Lost to Follow-up|4|||
129460564|NCT00328627|465983811|FG001|Overall Study|Lost to Follow-up|2|||
129460565|NCT00328627|465983812|FG002|Overall Study|Lost to Follow-up|2|||
129460566|NCT00328627|465983813|FG003|Overall Study|Lost to Follow-up|4|||
129460567|NCT00328627|465983814|FG004|Overall Study|Lost to Follow-up|0|||
129460568|NCT00328627|465983815|FG005|Overall Study|Lost to Follow-up|2|||
129460569|NCT00328627|465983816|FG006|Overall Study|Lost to Follow-up|3|||
129460570|NCT00328627|465983817|FG007|Overall Study|Lost to Follow-up|0|||
129460571|NCT00328627|465983818|FG008|Overall Study|Lost to Follow-up|3|||
129460572|NCT00328627|465983819|FG009|Overall Study|Lost to Follow-up|2|||
129460573|NCT00328627|465983820|FG010|Overall Study|Lost to Follow-up|0|||
129460574|NCT00328627|465983821|FG011|Overall Study|Lost to Follow-up|1|||
129460575|NCT00328627|465983810|FG000|Overall Study|Withdrawal by Subject|5|||
129460576|NCT00328627|465983811|FG001|Overall Study|Withdrawal by Subject|4|||
129460577|NCT00328627|465983812|FG002|Overall Study|Withdrawal by Subject|5|||
129460578|NCT00328627|465983813|FG003|Overall Study|Withdrawal by Subject|6|||
129460579|NCT00328627|465983814|FG004|Overall Study|Withdrawal by Subject|2|||
129460580|NCT00328627|465983815|FG005|Overall Study|Withdrawal by Subject|5|||
129460581|NCT00328627|465983816|FG006|Overall Study|Withdrawal by Subject|4|||
129460582|NCT00328627|465983817|FG007|Overall Study|Withdrawal by Subject|4|||
129460583|NCT00328627|465983818|FG008|Overall Study|Withdrawal by Subject|4|||
129460584|NCT00328627|465983819|FG009|Overall Study|Withdrawal by Subject|5|||
129460585|NCT00328627|465983820|FG010|Overall Study|Withdrawal by Subject|2|||
129460586|NCT00328627|465983821|FG011|Overall Study|Withdrawal by Subject|7|||
129460587|NCT00328627|465983810|FG000|Overall Study|Pregnancy|0|||
129460588|NCT00328627|465983811|FG001|Overall Study|Pregnancy|1|||
129460589|NCT00328627|465983812|FG002|Overall Study|Pregnancy|0|||
129460590|NCT00328627|465983813|FG003|Overall Study|Pregnancy|0|||
129460591|NCT00328627|465983814|FG004|Overall Study|Pregnancy|0|||
129460592|NCT00328627|465983815|FG005|Overall Study|Pregnancy|0|||
129460593|NCT00328627|465983816|FG006|Overall Study|Pregnancy|0|||
129460594|NCT00328627|465983817|FG007|Overall Study|Pregnancy|0|||
129460595|NCT00328627|465983818|FG008|Overall Study|Pregnancy|0|||
129460596|NCT00328627|465983819|FG009|Overall Study|Pregnancy|0|||
129460597|NCT00328627|465983820|FG010|Overall Study|Pregnancy|0|||
129460598|NCT00328627|465983821|FG011|Overall Study|Pregnancy|0|||
129460599|NCT00328627|465983810|FG000|Overall Study|Physician Decision|4|||
129460600|NCT00328627|465983811|FG001|Overall Study|Physician Decision|3|||
129460601|NCT00328627|465983812|FG002|Overall Study|Physician Decision|1|||
129460602|NCT00328627|465983813|FG003|Overall Study|Physician Decision|2|||
129460603|NCT00328627|465983814|FG004|Overall Study|Physician Decision|1|||
129460604|NCT00328627|465983815|FG005|Overall Study|Physician Decision|1|||
129460605|NCT00328627|465983816|FG006|Overall Study|Physician Decision|1|||
129460606|NCT00328627|465983817|FG007|Overall Study|Physician Decision|0|||
129460607|NCT00328627|465983818|FG008|Overall Study|Physician Decision|3|||
129460608|NCT00328627|465983819|FG009|Overall Study|Physician Decision|2|||
129460609|NCT00328627|465983820|FG010|Overall Study|Physician Decision|1|||
129460610|NCT00328627|465983821|FG011|Overall Study|Physician Decision|0|||
129460611|NCT00328627|465983810|FG000|Overall Study|Other|0|||
129460612|NCT00328627|465983811|FG001|Overall Study|Other|0|||
129460613|NCT00328627|465983812|FG002|Overall Study|Other|0|||
129460614|NCT00328627|465983813|FG003|Overall Study|Other|1|||
129460615|NCT00328627|465983814|FG004|Overall Study|Other|0|||
129460616|NCT00328627|465983815|FG005|Overall Study|Other|0|||
129460617|NCT00328627|465983816|FG006|Overall Study|Other|1|||
129460618|NCT00328627|465983817|FG007|Overall Study|Other|0|||
129460619|NCT00328627|465983818|FG008|Overall Study|Other|0|||
129460620|NCT00328627|465983819|FG009|Overall Study|Other|1|||
129460621|NCT00328627|465983820|FG010|Overall Study|Other|1|||
129460622|NCT00328627|465983821|FG011|Overall Study|Other|0|||
129460623|NCT03311711|465983822|FG000|Overall Study|Death|1|||
129460624|NCT03311711|465983823|FG001|Overall Study|Death|0|||
129460625|NCT03311711|465983824|FG002|Overall Study|Death|0|||
129460626|NCT03311711|465983825|FG003|Overall Study|Death|0|||
129460627|NCT03311711|465983826|FG004|Overall Study|Death|0|||
129460628|NCT03311711|465983827|FG005|Overall Study|Death|0|||
129460629|NCT03311711|465983828|FG006|Overall Study|Death|1|||
129460630|NCT03311711|465983829|FG007|Overall Study|Death|0|||
129460631|NCT03311711|465983830|FG008|Overall Study|Death|1|||
129460632|NCT03311711|465983831|FG009|Overall Study|Death|0|||
129460633|NCT03311711|465983822|FG000|Overall Study|Death of dyad partner|0|||
129460634|NCT03311711|465983823|FG001|Overall Study|Death of dyad partner|1|||
129460635|NCT03311711|465983824|FG002|Overall Study|Death of dyad partner|0|||
129460636|NCT03311711|465983825|FG003|Overall Study|Death of dyad partner|0|||
129460637|NCT03311711|465983826|FG004|Overall Study|Death of dyad partner|0|||
129460638|NCT03311711|465983827|FG005|Overall Study|Death of dyad partner|0|||
129460639|NCT03311711|465983828|FG006|Overall Study|Death of dyad partner|0|||
129460640|NCT03311711|465983829|FG007|Overall Study|Death of dyad partner|1|||
129460641|NCT03311711|465983830|FG008|Overall Study|Death of dyad partner|0|||
129460642|NCT03311711|465983831|FG009|Overall Study|Death of dyad partner|1|||
129460643|NCT03311711|465983822|FG000|Overall Study|Lost to Follow-up|2|||
129460644|NCT03311711|465983823|FG001|Overall Study|Lost to Follow-up|2|||
129460645|NCT03311711|465983824|FG002|Overall Study|Lost to Follow-up|0|||
129460646|NCT03311711|465983825|FG003|Overall Study|Lost to Follow-up|0|||
129460647|NCT03311711|465983826|FG004|Overall Study|Lost to Follow-up|0|||
129460648|NCT03311711|465983827|FG005|Overall Study|Lost to Follow-up|0|||
129460649|NCT03311711|465983828|FG006|Overall Study|Lost to Follow-up|1|||
129460650|NCT03311711|465983829|FG007|Overall Study|Lost to Follow-up|1|||
129460651|NCT03311711|465983830|FG008|Overall Study|Lost to Follow-up|0|||
129460652|NCT03311711|465983831|FG009|Overall Study|Lost to Follow-up|0|||
129460653|NCT03311711|465983822|FG000|Overall Study|Withdrawal by Subject|1|||
129460654|NCT03311711|465983823|FG001|Overall Study|Withdrawal by Subject|1|||
129460655|NCT03311711|465983824|FG002|Overall Study|Withdrawal by Subject|0|||
129460656|NCT03311711|465983825|FG003|Overall Study|Withdrawal by Subject|0|||
129460657|NCT03311711|465983826|FG004|Overall Study|Withdrawal by Subject|0|||
129460658|NCT03311711|465983827|FG005|Overall Study|Withdrawal by Subject|0|||
129460659|NCT03311711|465983828|FG006|Overall Study|Withdrawal by Subject|3|||
129460660|NCT03311711|465983829|FG007|Overall Study|Withdrawal by Subject|3|||
129460661|NCT03311711|465983830|FG008|Overall Study|Withdrawal by Subject|0|||
129460662|NCT03311711|465983831|FG009|Overall Study|Withdrawal by Subject|0|||
129460663|NCT01339559|465983833|FG000|Overall Study|Adverse Event|92|||
129460664|NCT01339559|465983833|FG000|Overall Study|Death|5|||
129460665|NCT01339559|465983833|FG000|Overall Study|Lack of Efficacy|164|||
129460666|NCT01339559|465983833|FG000|Overall Study|Lost to Follow-up|22|||
129460667|NCT01339559|465983833|FG000|Overall Study|Subject choice|89|||
129460668|NCT01339559|465983833|FG000|Overall Study|Protocol Violation|15|||
129460669|NCT01339559|465983833|FG000|Overall Study|Study closure at site|1|||
129460670|NCT01339559|465983833|FG000|Overall Study|Incarcerated|2|||
129460671|NCT01339559|465983833|FG000|Overall Study|Epilepsy surgery|1|||
129460672|NCT01339559|465983833|FG000|Overall Study|Pregnancy planned|2|||
129460673|NCT01339559|465983833|FG000|Overall Study|Left the country|1|||
129460674|NCT01339559|465983833|FG000|Overall Study|Investigator decision|2|||
129460675|NCT01339559|465983833|FG000|Overall Study|Patient didn't wish to continue|1|||
129460676|NCT01339559|465983833|FG000|Overall Study|PI decision|1|||
129460677|NCT01137773|465983834|FG000|Overall Study|Death|3|||
129460678|NCT01137773|465983835|FG001|Overall Study|Death|3|||
129460679|NCT01137773|465983834|FG000|Overall Study|Lost to Follow-up|6|||
129460680|NCT01137773|465983835|FG001|Overall Study|Lost to Follow-up|0|||
129460681|NCT03548051|465983836|FG000|Overall Study|Death|1|||
129460682|NCT03548051|465983837|FG001|Overall Study|Death|1|||
129460683|NCT03548051|465983836|FG000|Overall Study|Withdrawal by Subject|1|||
129460684|NCT03548051|465983837|FG001|Overall Study|Withdrawal by Subject|0|||
129460685|NCT01745146|465983838|FG000|Overall Study|Withdrawal by Subject|1|||
129460686|NCT01745146|465983839|FG001|Overall Study|Withdrawal by Subject|3|||
129460687|NCT01745146|465983838|FG000|Overall Study|Lost to Follow-up|2|||
129460688|NCT01745146|465983839|FG001|Overall Study|Lost to Follow-up|0|||
129460689|NCT00488982|465983840|FG000|Course 1|Physician Decision|0|||
129460690|NCT00488982|465983841|FG001|Course 1|Physician Decision|2|||
129460691|NCT00488982|465983842|FG002|Course 1|Physician Decision|4|||
129460692|NCT00488982|465983840|FG000|Course 1|Withdrawal by Subject|0|||
129460693|NCT00488982|465983841|FG001|Course 1|Withdrawal by Subject|8|||
129460694|NCT00488982|465983842|FG002|Course 1|Withdrawal by Subject|2|||
129460695|NCT00488982|465983840|FG000|Course 1|nonprotocol therapy|0|||
129460696|NCT00488982|465983841|FG001|Course 1|nonprotocol therapy|2|||
129460697|NCT00488982|465983842|FG002|Course 1|nonprotocol therapy|2|||
129460698|NCT00488982|465983840|FG000|Course 1|Adverse Event|0|||
129460699|NCT00488982|465983841|FG001|Course 1|Adverse Event|0|||
129460700|NCT00488982|465983842|FG002|Course 1|Adverse Event|6|||
129460701|NCT03273166|465983848|FG000|Overall Study|Withdrawn prior to Completion|31|||
129460702|NCT02669017|465983849|FG000|Overall Study|Death|1|||
129460703|NCT02669017|465983850|FG001|Overall Study|Death|2|||
129460704|NCT02669017|465983851|FG002|Overall Study|Death|2|||
129460705|NCT02669017|465983852|FG003|Overall Study|Death|3|||
129460706|NCT02669017|465983853|FG004|Overall Study|Death|8|||
129460707|NCT02669017|465983854|FG005|Overall Study|Death|18|||
129460708|NCT02669017|465983855|FG006|Overall Study|Death|10|||
129460709|NCT02669017|465983856|FG007|Overall Study|Death|47|||
129460710|NCT02669017|465983857|FG008|Overall Study|Death|20|||
129460711|NCT02669017|465983849|FG000|Overall Study|Withdrawal by Subject|0|||
129460712|NCT02669017|465983850|FG001|Overall Study|Withdrawal by Subject|0|||
129460713|NCT02669017|465983851|FG002|Overall Study|Withdrawal by Subject|0|||
129460714|NCT02669017|465983852|FG003|Overall Study|Withdrawal by Subject|1|||
129460715|NCT02669017|465983853|FG004|Overall Study|Withdrawal by Subject|2|||
129460716|NCT02669017|465983854|FG005|Overall Study|Withdrawal by Subject|0|||
129460717|NCT02669017|465983855|FG006|Overall Study|Withdrawal by Subject|0|||
129460718|NCT02669017|465983856|FG007|Overall Study|Withdrawal by Subject|2|||
129460719|NCT02669017|465983857|FG008|Overall Study|Withdrawal by Subject|2|||
129460720|NCT02669017|465983849|FG000|Overall Study|Lost to Follow-up|0|||
129460721|NCT02669017|465983850|FG001|Overall Study|Lost to Follow-up|0|||
129460722|NCT02669017|465983851|FG002|Overall Study|Lost to Follow-up|0|||
129460723|NCT02669017|465983852|FG003|Overall Study|Lost to Follow-up|0|||
129460724|NCT02669017|465983853|FG004|Overall Study|Lost to Follow-up|0|||
129460725|NCT02669017|465983854|FG005|Overall Study|Lost to Follow-up|0|||
129460726|NCT02669017|465983855|FG006|Overall Study|Lost to Follow-up|0|||
129460727|NCT02669017|465983856|FG007|Overall Study|Lost to Follow-up|0|||
129460728|NCT02669017|465983857|FG008|Overall Study|Lost to Follow-up|1|||
129460729|NCT02669017|465983849|FG000|Overall Study|Miscellaneous|0|||
129460730|NCT02669017|465983850|FG001|Overall Study|Miscellaneous|0|||
129460731|NCT02669017|465983851|FG002|Overall Study|Miscellaneous|0|||
129460732|NCT02669017|465983852|FG003|Overall Study|Miscellaneous|0|||
129460733|NCT02669017|465983853|FG004|Overall Study|Miscellaneous|2|||
129460734|NCT02669017|465983854|FG005|Overall Study|Miscellaneous|1|||
129460735|NCT02669017|465983855|FG006|Overall Study|Miscellaneous|1|||
129460736|NCT02669017|465983856|FG007|Overall Study|Miscellaneous|13|||
129460737|NCT02669017|465983857|FG008|Overall Study|Miscellaneous|2|||
129460738|NCT02559687|465983865|FG000|Overall Study|Death|112|||
129460739|NCT02559687|465983865|FG000|Overall Study|Sponsor Decision|5|||
129460740|NCT02559687|465983865|FG000|Overall Study|Withdrawal by Subject|4|||
129460741|NCT00790907|465983872|FG000|Overall Study|Adverse Event|9|||
129460742|NCT00790907|465983873|FG001|Overall Study|Adverse Event|7|||
129460743|NCT00790907|465983874|FG002|Overall Study|Adverse Event|6|||
129460744|NCT00790907|465983872|FG000|Overall Study|Physician Decision|304|||
129460745|NCT00790907|465983873|FG001|Overall Study|Physician Decision|271|||
129969601|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
129969602|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969603|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969604|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969605|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969606|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969607|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
129969608|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969609|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969610|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969611|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969612|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969613|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969614|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969615|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969616|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969617|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969618|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969619|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129460746|NCT00790907|465983874|FG002|Overall Study|Physician Decision|255|||
129460747|NCT00790907|465983872|FG000|Overall Study|Withdrawal by Subject|1|||
129460748|NCT00790907|465983873|FG001|Overall Study|Withdrawal by Subject|7|||
129460749|NCT00790907|465983874|FG002|Overall Study|Withdrawal by Subject|5|||
129460750|NCT00790907|465983872|FG000|Overall Study|Bleeding Event|11|||
129969620|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
129969621|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129460751|NCT00790907|465983873|FG001|Overall Study|Bleeding Event|16|||
129460752|NCT00790907|465983874|FG002|Overall Study|Bleeding Event|21|||
129460753|NCT00790907|465983872|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
129460754|NCT00790907|465983873|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
129460755|NCT00790907|465983874|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
129460756|NCT00790907|465983872|FG000|Overall Study|Qualifying Condition Not Present|29|||
129460757|NCT00790907|465983873|FG001|Overall Study|Qualifying Condition Not Present|14|||
129460758|NCT00790907|465983874|FG002|Overall Study|Qualifying Condition Not Present|16|||
129460759|NCT00790907|465983872|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
129969622|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969623|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969624|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969625|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969626|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
129969627|NCT03520075|467852943|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969628|NCT03520075|467852944|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969629|NCT03520075|467852945|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969630|NCT03520075|467852946|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969631|NCT03520075|467852947|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969632|NCT03520075|467852948|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969633|NCT03520075|467852949|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969634|NCT03520075|467852950|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969635|NCT03520075|467852951|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969636|NCT03520075|467852952|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
129969637|NCT03520075|467852953|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969638|NCT03520075|467852954|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969639|NCT03520075|467852955|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
129969640|NCT03520075|467852956|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969641|NCT03520075|467852957|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969642|NCT03520075|467852958|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969643|NCT03520075|467852959|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969644|NCT03520075|467852960|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969645|NCT03520075|467852961|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
129969646|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Death|0|||
129969647|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Death|0|||
129969648|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Death|0|||
129969649|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Death|0|||
129969650|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Death|0|||
129969651|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Death|0|||
129969652|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Death|0|||
129969653|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Death|0|||
129969654|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Death|0|||
129969655|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Death|0|||
129969656|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Death|0|||
129969657|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Death|0|||
129969658|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Death|0|||
129969659|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Death|20|||
129969660|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Death|13|||
129969661|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Death|9|||
129969662|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Death|5|||
129969663|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Death|14|||
129969664|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Death|12|||
129969665|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969666|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969667|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969668|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969669|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969670|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969671|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969672|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969673|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969674|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969675|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969676|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969677|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969678|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
129969679|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
129969680|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
129969681|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
129460760|NCT00790907|465983873|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
129969682|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
129969683|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
129969684|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969685|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969686|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969687|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969688|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969689|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969690|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969691|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969692|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969693|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969694|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969695|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969696|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969697|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969698|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
129969699|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
129969700|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969701|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
129969702|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
129969703|NCT03520075|467852943|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969704|NCT03520075|467852944|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969705|NCT03520075|467852945|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969706|NCT03520075|467852946|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969707|NCT03520075|467852947|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969708|NCT03520075|467852948|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969709|NCT03520075|467852949|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969710|NCT03520075|467852950|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969711|NCT03520075|467852951|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969712|NCT03520075|467852952|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969713|NCT03520075|467852953|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969714|NCT03520075|467852954|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969715|NCT03520075|467852955|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969716|NCT03520075|467852956|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
129969717|NCT03520075|467852957|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969718|NCT03520075|467852958|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969719|NCT03520075|467852959|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
129969720|NCT03520075|467852960|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
129969721|NCT03520075|467852961|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
129969722|NCT00126659|467852962|FG000|Overall Study|Adverse Event|0|||
129969723|NCT00126659|467852963|FG001|Overall Study|Adverse Event|0|||
129969724|NCT00126659|467852964|FG002|Overall Study|Adverse Event|2|||
129969725|NCT02367352|467852965|FG000|Overall Study|Progressive disease|7|||
129969726|NCT02367352|467852966|FG001|Overall Study|Progressive disease|0|||
129969727|NCT02367352|467852967|FG002|Overall Study|Progressive disease|0|||
129969728|NCT02367352|467852965|FG000|Overall Study|Participant Received Alternative Therapy|1|||
129969729|NCT02367352|467852966|FG001|Overall Study|Participant Received Alternative Therapy|0|||
129969730|NCT02367352|467852967|FG002|Overall Study|Participant Received Alternative Therapy|0|||
129969731|NCT02367352|467852965|FG000|Overall Study|Adverse Event|1|||
129969732|NCT02367352|467852966|FG001|Overall Study|Adverse Event|0|||
129969733|NCT02367352|467852967|FG002|Overall Study|Adverse Event|0|||
129969734|NCT01375751|467852972|FG000|Overall Study|Other|0|||
129969735|NCT01375751|467852973|FG001|Overall Study|Other|1|||
129969736|NCT01375751|467852974|FG002|Overall Study|Other|0|||
129969737|NCT02980523|467852975|FG000|Overall Study|Lost to Follow-up|1|||
129969738|NCT02980523|467852976|FG001|Overall Study|Lost to Follow-up|4|||
129969739|NCT02980523|467852977|FG002|Overall Study|Lost to Follow-up|1|||
129969740|NCT02980523|467852978|FG003|Overall Study|Lost to Follow-up|2|||
129969741|NCT02980523|467852979|FG004|Overall Study|Lost to Follow-up|1|||
129969742|NCT02980523|467852975|FG000|Overall Study|Excluded from analysis|1|||
129969743|NCT02980523|467852976|FG001|Overall Study|Excluded from analysis|3|||
129969744|NCT02980523|467852977|FG002|Overall Study|Excluded from analysis|1|||
129969745|NCT02980523|467852978|FG003|Overall Study|Excluded from analysis|1|||
129969746|NCT02980523|467852979|FG004|Overall Study|Excluded from analysis|1|||
129969747|NCT02980523|467852975|FG000|Overall Study|Lack of Efficacy|1|||
129969748|NCT02980523|467852976|FG001|Overall Study|Lack of Efficacy|4|||
129969749|NCT02980523|467852977|FG002|Overall Study|Lack of Efficacy|4|||
129969750|NCT02980523|467852978|FG003|Overall Study|Lack of Efficacy|5|||
129969751|NCT02980523|467852979|FG004|Overall Study|Lack of Efficacy|8|||
129969752|NCT02980523|467852975|FG000|Overall Study|Did not receive intervention|0|||
129969753|NCT02980523|467852976|FG001|Overall Study|Did not receive intervention|0|||
129969754|NCT02980523|467852977|FG002|Overall Study|Did not receive intervention|0|||
129969755|NCT02980523|467852978|FG003|Overall Study|Did not receive intervention|1|||
129969756|NCT02980523|467852979|FG004|Overall Study|Did not receive intervention|0|||
129969757|NCT02375347|467852980|FG000|Overall Study|Protocol Violation|1|||
129969758|NCT05186311|467852984|FG000|Part A: Serum|Withdrawal by Subject|1|||
129969759|NCT02417441|467852993|FG000|Overall Study|Inconclusive due to missing data|52|||
129969760|NCT02417441|467852994|FG001|Overall Study|Inconclusive due to missing data|19|||
129969761|NCT00983853|467852995|FG000|Overall Study|Lost to Follow-up|1|||
129969762|NCT00983853|467852996|FG001|Overall Study|Lost to Follow-up|1|||
129969763|NCT00983853|467852997|FG002|Overall Study|Lost to Follow-up|2|||
129969764|NCT00983853|467852998|FG003|Overall Study|Lost to Follow-up|2|||
129969765|NCT00983853|467852999|FG004|Overall Study|Lost to Follow-up|2|||
129969766|NCT00983853|467853000|FG005|Overall Study|Lost to Follow-up|1|||
129969767|NCT00983853|467852995|FG000|Overall Study|Withdrawal by Subject|0|||
129969768|NCT00983853|467852996|FG001|Overall Study|Withdrawal by Subject|0|||
129969769|NCT00983853|467852997|FG002|Overall Study|Withdrawal by Subject|1|||
129969770|NCT00983853|467852998|FG003|Overall Study|Withdrawal by Subject|0|||
129969771|NCT00983853|467852999|FG004|Overall Study|Withdrawal by Subject|1|||
129969772|NCT00983853|467853000|FG005|Overall Study|Withdrawal by Subject|0|||
129969773|NCT00983853|467852995|FG000|Overall Study|Unable to come to study follow-up visits|0|||
129969774|NCT00983853|467852996|FG001|Overall Study|Unable to come to study follow-up visits|1|||
129969775|NCT00983853|467852997|FG002|Overall Study|Unable to come to study follow-up visits|0|||
129969776|NCT00983853|467852998|FG003|Overall Study|Unable to come to study follow-up visits|0|||
129969777|NCT00983853|467852999|FG004|Overall Study|Unable to come to study follow-up visits|0|||
129969778|NCT00983853|467853000|FG005|Overall Study|Unable to come to study follow-up visits|0|||
129969779|NCT03603639|467853001|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969780|NCT03603639|467853002|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969781|NCT03603639|467853003|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969782|NCT03603639|467853004|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
129969783|NCT03603639|467853005|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969784|NCT03603639|467853006|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
129969785|NCT03603639|467853001|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
129969786|NCT03603639|467853002|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
129969787|NCT03603639|467853003|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
129969788|NCT03603639|467853004|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
129969789|NCT03603639|467853005|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
129969790|NCT03603639|467853006|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
129969791|NCT01628692|467853008|FG000|Overall Study|Lack of Efficacy|4|||
129969792|NCT01628692|467853009|FG001|Overall Study|Lack of Efficacy|4|||
129969793|NCT01628692|467853010|FG002|Overall Study|Lack of Efficacy|5|||
129969794|NCT01628692|467853011|FG003|Overall Study|Lack of Efficacy|1|||
129969795|NCT01628692|467853012|FG004|Overall Study|Lack of Efficacy|4|||
129969796|NCT01628692|467853013|FG005|Overall Study|Lack of Efficacy|7|||
129969797|NCT01628692|467853008|FG000|Overall Study|Adverse Event|2|||
129969798|NCT01628692|467853009|FG001|Overall Study|Adverse Event|0|||
129969799|NCT01628692|467853010|FG002|Overall Study|Adverse Event|2|||
129969800|NCT01628692|467853011|FG003|Overall Study|Adverse Event|0|||
129969801|NCT01628692|467853012|FG004|Overall Study|Adverse Event|0|||
129969802|NCT01628692|467853013|FG005|Overall Study|Adverse Event|0|||
129969803|NCT01628692|467853008|FG000|Overall Study|Withdrawal by Subject|0|||
129969804|NCT01628692|467853009|FG001|Overall Study|Withdrawal by Subject|1|||
129969805|NCT01628692|467853010|FG002|Overall Study|Withdrawal by Subject|1|||
129969806|NCT01628692|467853011|FG003|Overall Study|Withdrawal by Subject|0|||
129969807|NCT01628692|467853012|FG004|Overall Study|Withdrawal by Subject|0|||
129969808|NCT01628692|467853013|FG005|Overall Study|Withdrawal by Subject|0|||
129969809|NCT01628692|467853008|FG000|Overall Study|Death|0|||
129969810|NCT01628692|467853009|FG001|Overall Study|Death|1|||
129969811|NCT01628692|467853010|FG002|Overall Study|Death|0|||
129969812|NCT01628692|467853011|FG003|Overall Study|Death|0|||
129969813|NCT01628692|467853012|FG004|Overall Study|Death|0|||
129969814|NCT01628692|467853013|FG005|Overall Study|Death|0|||
129460761|NCT00790907|465983874|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
129460762|NCT00790907|465983872|FG000|Overall Study|Did Not Receive Study Drug|10|||
129460763|NCT00790907|465983873|FG001|Overall Study|Did Not Receive Study Drug|0|||
129460764|NCT00790907|465983874|FG002|Overall Study|Did Not Receive Study Drug|0|||
129460765|NCT01888640|465983875|FG000|Overall Study|Lost to Follow-up|1|||
129460766|NCT01888640|465983876|FG001|Overall Study|Lost to Follow-up|2|||
129460767|NCT01888640|465983877|FG002|Overall Study|Lost to Follow-up|0|||
129460768|NCT01888640|465983875|FG000|Overall Study|Withdrawal by Subject|15|||
129460769|NCT01888640|465983876|FG001|Overall Study|Withdrawal by Subject|11|||
129969815|NCT01628692|467853008|FG000|Overall Study|Poor compliance/noncompliance|1|||
129969816|NCT01628692|467853009|FG001|Overall Study|Poor compliance/noncompliance|0|||
129969817|NCT01628692|467853010|FG002|Overall Study|Poor compliance/noncompliance|0|||
129969818|NCT01628692|467853011|FG003|Overall Study|Poor compliance/noncompliance|0|||
129969819|NCT01628692|467853012|FG004|Overall Study|Poor compliance/noncompliance|0|||
129969820|NCT01628692|467853013|FG005|Overall Study|Poor compliance/noncompliance|0|||
129969821|NCT01628692|467853008|FG000|Overall Study|Administrative reason by sponsor|0|||
129969822|NCT01628692|467853009|FG001|Overall Study|Administrative reason by sponsor|0|||
129969823|NCT01628692|467853010|FG002|Overall Study|Administrative reason by sponsor|0|||
129969824|NCT01628692|467853011|FG003|Overall Study|Administrative reason by sponsor|0|||
129969825|NCT01628692|467853012|FG004|Overall Study|Administrative reason by sponsor|0|||
129460770|NCT01888640|465983877|FG002|Overall Study|Withdrawal by Subject|4|||
129969826|NCT01628692|467853013|FG005|Overall Study|Administrative reason by sponsor|1|||
129969827|NCT01628692|467853008|FG000|Overall Study|Completed 12 Week only|0|||
129969828|NCT01628692|467853009|FG001|Overall Study|Completed 12 Week only|0|||
129969829|NCT01628692|467853010|FG002|Overall Study|Completed 12 Week only|0|||
129969830|NCT01628692|467853011|FG003|Overall Study|Completed 12 Week only|0|||
129969831|NCT01628692|467853012|FG004|Overall Study|Completed 12 Week only|0|||
129969832|NCT01628692|467853013|FG005|Overall Study|Completed 12 Week only|1|||
129969833|NCT00723125|467853015|FG000|Overall Study|Met Dx|1|||
129969834|NCT00723125|467853016|FG001|Overall Study|Met Dx|0|||
129969835|NCT00723125|467853015|FG000|Overall Study|Withdrawal by Subject|15|||
129969836|NCT00723125|467853016|FG001|Overall Study|Withdrawal by Subject|6|||
129969837|NCT00723125|467853015|FG000|Overall Study|Adverse Event|2|||
129969838|NCT00723125|467853016|FG001|Overall Study|Adverse Event|0|||
129969839|NCT02196077|467853017|FG000|Overall Study|Adverse Event|4|||
129969840|NCT02196077|467853017|FG000|Overall Study|Lack of Efficacy|1|||
129969841|NCT02196077|467853017|FG000|Overall Study|Withdrawal by Subject|14|||
129969842|NCT02196077|467853017|FG000|Overall Study|Physician Decision|1|||
129969843|NCT02196077|467853017|FG000|Overall Study|Lost to Follow-up|3|||
129969844|NCT02196077|467853017|FG000|Overall Study|Protocol Violation|24|||
129969845|NCT00003477|467853032|FG000|Overall Study|Not evalauable|4|||
129969846|NCT01236352|467853033|FG000|Overall Study|Death|0|||
129969847|NCT01236352|467853034|FG001|Overall Study|Death|0|||
129969848|NCT01236352|467853035|FG002|Overall Study|Death|0|||
129969849|NCT01236352|467853036|FG003|Overall Study|Death|0|||
129969850|NCT01236352|467853037|FG004|Overall Study|Death|0|||
129969851|NCT01236352|467853038|FG005|Overall Study|Death|0|||
129969852|NCT01236352|467853039|FG006|Overall Study|Death|0|||
129969853|NCT01236352|467853040|FG007|Overall Study|Death|1|||
129969854|NCT01236352|467853041|FG008|Overall Study|Death|0|||
129969855|NCT01236352|467853042|FG009|Overall Study|Death|0|||
129969856|NCT01236352|467853043|FG010|Overall Study|Death|0|||
129969857|NCT01236352|467853033|FG000|Overall Study|Withdrawal by Subject|0|||
129969858|NCT01236352|467853034|FG001|Overall Study|Withdrawal by Subject|0|||
129969859|NCT01236352|467853035|FG002|Overall Study|Withdrawal by Subject|0|||
129969860|NCT01236352|467853036|FG003|Overall Study|Withdrawal by Subject|0|||
129969861|NCT01236352|467853037|FG004|Overall Study|Withdrawal by Subject|0|||
129969862|NCT01236352|467853038|FG005|Overall Study|Withdrawal by Subject|0|||
129969863|NCT01236352|467853039|FG006|Overall Study|Withdrawal by Subject|0|||
129969864|NCT01236352|467853040|FG007|Overall Study|Withdrawal by Subject|0|||
129969865|NCT01236352|467853041|FG008|Overall Study|Withdrawal by Subject|0|||
129969866|NCT01236352|467853042|FG009|Overall Study|Withdrawal by Subject|2|||
129969867|NCT01236352|467853043|FG010|Overall Study|Withdrawal by Subject|1|||
129969868|NCT01236352|467853033|FG000|Overall Study|Adverse Event|0|||
129969869|NCT01236352|467853034|FG001|Overall Study|Adverse Event|0|||
129969870|NCT01236352|467853035|FG002|Overall Study|Adverse Event|0|||
129969871|NCT01236352|467853036|FG003|Overall Study|Adverse Event|0|||
129969872|NCT01236352|467853037|FG004|Overall Study|Adverse Event|0|||
129969873|NCT01236352|467853038|FG005|Overall Study|Adverse Event|0|||
129969874|NCT01236352|467853039|FG006|Overall Study|Adverse Event|2|||
129969875|NCT01236352|467853040|FG007|Overall Study|Adverse Event|0|||
129969876|NCT01236352|467853041|FG008|Overall Study|Adverse Event|0|||
129969877|NCT01236352|467853042|FG009|Overall Study|Adverse Event|4|||
129969878|NCT01236352|467853043|FG010|Overall Study|Adverse Event|1|||
129969879|NCT01236352|467853033|FG000|Overall Study|Study drug toxicity|0|||
129460771|NCT01888640|465983875|FG000|Overall Study|Minimum dose not met|10|||
129460772|NCT01888640|465983876|FG001|Overall Study|Minimum dose not met|16|||
129460773|NCT01888640|465983877|FG002|Overall Study|Minimum dose not met|0|||
129460774|NCT01888640|465983875|FG000|Overall Study|Given wrong unit (placebo)|1|||
129460775|NCT01888640|465983876|FG001|Overall Study|Given wrong unit (placebo)|0|||
129460776|NCT01888640|465983877|FG002|Overall Study|Given wrong unit (placebo)|0|||
129460777|NCT01888640|465983875|FG000|Overall Study|Excluded for prior TENS|0|||
129460778|NCT01888640|465983876|FG001|Overall Study|Excluded for prior TENS|1|||
129460779|NCT01888640|465983877|FG002|Overall Study|Excluded for prior TENS|0|||
129969880|NCT01236352|467853034|FG001|Overall Study|Study drug toxicity|0|||
129969881|NCT01236352|467853035|FG002|Overall Study|Study drug toxicity|0|||
129969882|NCT01236352|467853036|FG003|Overall Study|Study drug toxicity|0|||
129460780|NCT01888640|465983875|FG000|Overall Study|Researcher Termination of Participant|0|||
129460781|NCT01888640|465983876|FG001|Overall Study|Researcher Termination of Participant|1|||
129969883|NCT01236352|467853037|FG004|Overall Study|Study drug toxicity|0|||
129969884|NCT01236352|467853038|FG005|Overall Study|Study drug toxicity|1|||
129969885|NCT01236352|467853039|FG006|Overall Study|Study drug toxicity|1|||
129969886|NCT01236352|467853040|FG007|Overall Study|Study drug toxicity|0|||
129969887|NCT01236352|467853041|FG008|Overall Study|Study drug toxicity|0|||
129969888|NCT01236352|467853042|FG009|Overall Study|Study drug toxicity|2|||
129969889|NCT01236352|467853043|FG010|Overall Study|Study drug toxicity|2|||
129969890|NCT01236352|467853033|FG000|Overall Study|Disease progression|1|||
129460782|NCT01888640|465983877|FG002|Overall Study|Researcher Termination of Participant|1|||
129969891|NCT01236352|467853034|FG001|Overall Study|Disease progression|2|||
129969892|NCT01236352|467853035|FG002|Overall Study|Disease progression|1|||
129460783|NCT00109707|465983878|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
129460784|NCT00109707|465983879|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
129460785|NCT00109707|465983880|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
129460786|NCT00109707|465983878|FG000|Overall Study|Abnormal laboratory values|1|||
129460787|NCT00109707|465983879|FG001|Overall Study|Abnormal laboratory values|0|||
129460788|NCT00109707|465983880|FG002|Overall Study|Abnormal laboratory values|0|||
129460789|NCT00109707|465983878|FG000|Overall Study|Administrative problems|2|||
129460790|NCT00109707|465983879|FG001|Overall Study|Administrative problems|0|||
129460791|NCT00109707|465983880|FG002|Overall Study|Administrative problems|1|||
129460792|NCT00109707|465983878|FG000|Overall Study|Adverse Event|10|||
129460793|NCT00109707|465983879|FG001|Overall Study|Adverse Event|2|||
129460794|NCT00109707|465983880|FG002|Overall Study|Adverse Event|3|||
129460795|NCT00109707|465983878|FG000|Overall Study|Death|4|||
129460796|NCT00109707|465983879|FG001|Overall Study|Death|0|||
129460797|NCT00109707|465983880|FG002|Overall Study|Death|0|||
129460798|NCT00109707|465983878|FG000|Overall Study|Disease progression|12|||
129460799|NCT00109707|465983879|FG001|Overall Study|Disease progression|4|||
129460800|NCT00109707|465983880|FG002|Overall Study|Disease progression|3|||
129460801|NCT00109707|465983878|FG000|Overall Study|Lost to Follow-up|3|||
129460802|NCT00109707|465983879|FG001|Overall Study|Lost to Follow-up|0|||
129460803|NCT00109707|465983880|FG002|Overall Study|Lost to Follow-up|0|||
129460804|NCT00109707|465983878|FG000|Overall Study|Protocol Violation|1|||
129460805|NCT00109707|465983879|FG001|Overall Study|Protocol Violation|0|||
129460806|NCT00109707|465983880|FG002|Overall Study|Protocol Violation|0|||
129460807|NCT00109707|465983878|FG000|Overall Study|Patient withdrew consent|6|||
129460808|NCT00109707|465983879|FG001|Overall Study|Patient withdrew consent|1|||
129460809|NCT00109707|465983880|FG002|Overall Study|Patient withdrew consent|0|||
129460810|NCT02250274|465983882|FG000|Overall Study|Insufficient blood draw amount|7|||
129460811|NCT02250274|465983883|FG001|Overall Study|Insufficient blood draw amount|6|||
129969893|NCT01236352|467853036|FG003|Overall Study|Disease progression|2|||
129460812|NCT01277549|465983884|FG000|Overall Study|Failed to meet eligibility criteria|13|||
129460813|NCT01277549|465983885|FG001|Overall Study|Failed to meet eligibility criteria|9|||
129969894|NCT01236352|467853037|FG004|Overall Study|Disease progression|2|||
129969895|NCT01236352|467853038|FG005|Overall Study|Disease progression|2|||
129969896|NCT01236352|467853039|FG006|Overall Study|Disease progression|1|||
129969897|NCT01236352|467853040|FG007|Overall Study|Disease progression|3|||
129460814|NCT01277549|465983884|FG000|Overall Study|Withdrawal by Subject|1|||
129460815|NCT01277549|465983885|FG001|Overall Study|Withdrawal by Subject|3|||
129460816|NCT01277549|465983884|FG000|Overall Study|Protocol Violation|10|||
129460817|NCT01277549|465983885|FG001|Overall Study|Protocol Violation|1|||
129460818|NCT01277549|465983884|FG000|Overall Study|Physician Decision|2|||
129460819|NCT01277549|465983885|FG001|Overall Study|Physician Decision|1|||
129460820|NCT00446511|465983888|FG000|Overall Study|Adverse Event|7|||
129460821|NCT00446511|465983889|FG001|Overall Study|Adverse Event|2|||
129460822|NCT00446511|465983890|FG002|Overall Study|Adverse Event|3|||
129460823|NCT00446511|465983891|FG003|Overall Study|Adverse Event|1|||
129460824|NCT00446511|465983888|FG000|Overall Study|Protocol Violation|0|||
129969898|NCT01236352|467853041|FG008|Overall Study|Disease progression|2|||
129969899|NCT01236352|467853042|FG009|Overall Study|Disease progression|2|||
129969900|NCT01236352|467853043|FG010|Overall Study|Disease progression|2|||
129969901|NCT01236352|467853033|FG000|Overall Study|Poor/Non-compliance|1|||
129969902|NCT01236352|467853034|FG001|Overall Study|Poor/Non-compliance|0|||
129969903|NCT01236352|467853035|FG002|Overall Study|Poor/Non-compliance|0|||
129969904|NCT01236352|467853036|FG003|Overall Study|Poor/Non-compliance|0|||
129969905|NCT01236352|467853037|FG004|Overall Study|Poor/Non-compliance|0|||
129969906|NCT01236352|467853038|FG005|Overall Study|Poor/Non-compliance|0|||
129969907|NCT01236352|467853039|FG006|Overall Study|Poor/Non-compliance|0|||
129969908|NCT01236352|467853040|FG007|Overall Study|Poor/Non-compliance|0|||
129969909|NCT01236352|467853041|FG008|Overall Study|Poor/Non-compliance|0|||
129969910|NCT01236352|467853042|FG009|Overall Study|Poor/Non-compliance|0|||
129969911|NCT01236352|467853043|FG010|Overall Study|Poor/Non-compliance|0|||
129460825|NCT00446511|465983889|FG001|Overall Study|Protocol Violation|0|||
129460826|NCT00446511|465983890|FG002|Overall Study|Protocol Violation|0|||
129460827|NCT00446511|465983891|FG003|Overall Study|Protocol Violation|1|||
129969912|NCT01236352|467853033|FG000|Overall Study|Maximum clinical benefit|1|||
129969913|NCT01236352|467853034|FG001|Overall Study|Maximum clinical benefit|1|||
129969914|NCT01236352|467853035|FG002|Overall Study|Maximum clinical benefit|1|||
129460828|NCT00446511|465983888|FG000|Overall Study|Withdrawal by Subject|0|||
129460829|NCT00446511|465983889|FG001|Overall Study|Withdrawal by Subject|0|||
129460830|NCT00446511|465983890|FG002|Overall Study|Withdrawal by Subject|0|||
129460831|NCT00446511|465983891|FG003|Overall Study|Withdrawal by Subject|3|||
129460832|NCT00446511|465983888|FG000|Overall Study|Administrative Problems|3|||
129460833|NCT00446511|465983889|FG001|Overall Study|Administrative Problems|0|||
129460834|NCT00446511|465983890|FG002|Overall Study|Administrative Problems|4|||
129460835|NCT00446511|465983891|FG003|Overall Study|Administrative Problems|1|||
129460836|NCT01618214|465983892|FG000|Overall Study|Adverse Event|3|||
129969915|NCT01236352|467853036|FG003|Overall Study|Maximum clinical benefit|0|||
129460837|NCT01618214|465983893|FG001|Overall Study|Adverse Event|1|||
129460838|NCT01618214|465983892|FG000|Overall Study|Lack of Efficacy|1|||
129460839|NCT01618214|465983893|FG001|Overall Study|Lack of Efficacy|1|||
129460840|NCT01618214|465983892|FG000|Overall Study|Protocol Violation|1|||
129460841|NCT01618214|465983893|FG001|Overall Study|Protocol Violation|4|||
129460842|NCT01618214|465983892|FG000|Overall Study|Withdrawal Criteria|1|||
129460843|NCT01618214|465983893|FG001|Overall Study|Withdrawal Criteria|2|||
129460844|NCT01618214|465983892|FG000|Overall Study|Unclassified|4|||
129460845|NCT01618214|465983893|FG001|Overall Study|Unclassified|5|||
129460846|NCT03436862|465983894|FG000|Overall Study|Adverse Event|4|||
129460847|NCT03436862|465983894|FG000|Overall Study|Progressive Disease|2|||
129460848|NCT02228590|465983896|FG000|Overall Study|Withdrawal by Subject|1|||
129460849|NCT00391222|465983897|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
129460850|NCT00391222|465983898|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
129460851|NCT00391222|465983899|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
129460852|NCT00391222|465983900|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
129460853|NCT00391222|465983897|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
129460854|NCT00391222|465983898|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
129460855|NCT00391222|465983899|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
129460856|NCT00391222|465983900|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
129460857|NCT00391222|465983897|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
129460858|NCT00391222|465983898|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
129460859|NCT00391222|465983899|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
129460860|NCT00391222|465983900|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
129460861|NCT00391222|465983897|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
129460862|NCT00391222|465983898|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
129460863|NCT00391222|465983899|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
129460864|NCT00391222|465983900|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
129460865|NCT00391222|465983897|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
129460866|NCT00391222|465983898|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
129460867|NCT00391222|465983899|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
129460868|NCT00391222|465983900|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
129460869|NCT00391222|465983897|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
129460870|NCT00391222|465983898|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
129460871|NCT00391222|465983899|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
129460872|NCT00391222|465983900|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
129460873|NCT00391222|465983897|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
129460874|NCT00391222|465983898|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
129460875|NCT00391222|465983899|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
129460876|NCT00391222|465983900|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
129460877|NCT00391222|465983897|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
129460878|NCT00391222|465983898|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
129460879|NCT00391222|465983899|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
129460880|NCT00391222|465983900|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
129460881|NCT00391222|465983897|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
129460882|NCT00391222|465983898|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
129460883|NCT00391222|465983899|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
129460884|NCT00391222|465983900|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
129460885|NCT00391222|465983897|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
129460886|NCT00391222|465983898|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
129460887|NCT00391222|465983899|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
129460888|NCT00391222|465983900|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
129460889|NCT00391222|465983897|FG000|Period III (Double-Blind Treatment)|Other|6|||
129460890|NCT00391222|465983898|FG001|Period III (Double-Blind Treatment)|Other|1|||
129460891|NCT00391222|465983899|FG002|Period III (Double-Blind Treatment)|Other|6|||
129460892|NCT00391222|465983900|FG003|Period III (Double-Blind Treatment)|Other|0|||
129460893|NCT04486950|465983904|FG000|Overall Study|Lost to Follow-up|0|||
129460894|NCT04486950|465983905|FG001|Overall Study|Lost to Follow-up|0|||
129460895|NCT04486950|465983906|FG002|Overall Study|Lost to Follow-up|0|||
129460896|NCT04486950|465983907|FG003|Overall Study|Lost to Follow-up|0|||
129460897|NCT04486950|465983908|FG004|Overall Study|Lost to Follow-up|0|||
129460898|NCT04486950|465983909|FG005|Overall Study|Lost to Follow-up|1|||
129460899|NCT04486950|465983910|FG006|Overall Study|Lost to Follow-up|0|||
129460900|NCT00550680|465983915|FG000|Overall Study|Administrative Reasons|1|||
129460901|NCT00550680|465983915|FG000|Overall Study|Adverse Event|5|||
129460902|NCT00550680|465983915|FG000|Overall Study|Death|3|||
129460903|NCT00550680|465983915|FG000|Overall Study|Early Improvement|1|||
129460904|NCT00550680|465983915|FG000|Overall Study|Lost to Follow-up|3|||
129460905|NCT00550680|465983915|FG000|Overall Study|Lack of Efficacy|1|||
129460906|NCT00550680|465983915|FG000|Overall Study|Other|10|||
129460907|NCT00550680|465983915|FG000|Overall Study|Protocol Violation|7|||
129460908|NCT00550680|465983915|FG000|Overall Study|Refused Treatment|19|||
129460909|NCT00550680|465983915|FG000|Overall Study|Screen Failure|6|||
129460910|NCT01119248|465983916|FG000|Overall Study|Physician Decision|5|||
129460911|NCT00562354|465983917|FG000|Overall Study|Physician Decision|0|||
129460912|NCT00562354|465983918|FG001|Overall Study|Physician Decision|1|||
129460913|NCT00562354|465983917|FG000|Overall Study|Lost to Follow-up|0|||
129460914|NCT00562354|465983918|FG001|Overall Study|Lost to Follow-up|1|||
129460915|NCT00317109|465983919|FG000|Overall Study|Withdrawal by Subject|2|||
129460916|NCT00317109|465983920|FG001|Overall Study|Withdrawal by Subject|0|||
129460917|NCT00317109|465983919|FG000|Overall Study|Migated/moved from study area|1|||
129460918|NCT00317109|465983920|FG001|Overall Study|Migated/moved from study area|0|||
129460919|NCT03693625|465983922|FG000|Overall Study|Adverse Event|2|||
129460920|NCT03693625|465983923|FG001|Overall Study|Adverse Event|0|||
129460921|NCT03693625|465983922|FG000|Overall Study|Study Terminated By Sponsor|20|||
129460922|NCT03693625|465983923|FG001|Overall Study|Study Terminated By Sponsor|7|||
129460923|NCT03693625|465983922|FG000|Overall Study|Withdrawal by Subject|1|||
129460924|NCT03693625|465983923|FG001|Overall Study|Withdrawal by Subject|1|||
129460925|NCT01508702|465983924|FG000|Overall Study|Adverse Event|7|||
129460926|NCT01508702|465983925|FG001|Overall Study|Adverse Event|3|||
129460927|NCT01508702|465983924|FG000|Overall Study|Gout flare|2|||
129460928|NCT01508702|465983925|FG001|Overall Study|Gout flare|0|||
129460929|NCT01508702|465983924|FG000|Overall Study|Protocol Violation|2|||
129460930|NCT01508702|465983925|FG001|Overall Study|Protocol Violation|1|||
129460931|NCT01508702|465983924|FG000|Overall Study|Lost to Follow-up|1|||
129460932|NCT01508702|465983925|FG001|Overall Study|Lost to Follow-up|2|||
129460933|NCT01508702|465983924|FG000|Overall Study|Withdrawal by Subject|11|||
129460934|NCT01508702|465983925|FG001|Overall Study|Withdrawal by Subject|7|||
129460935|NCT01883635|465983927|FG000|Overall Study|Withdrawal by Subject|4|||
129460936|NCT01883635|465983928|FG001|Overall Study|Withdrawal by Subject|0|||
129460937|NCT01464307|465983932|FG000|Main Period|Death|0|||
129460938|NCT01464307|465983933|FG001|Main Period|Death|1|||
129460939|NCT01464307|465983932|FG000|Main Period|Adverse Event|6|||
129969916|NCT01236352|467853037|FG004|Overall Study|Maximum clinical benefit|2|||
129969917|NCT01236352|467853038|FG005|Overall Study|Maximum clinical benefit|0|||
129969918|NCT01236352|467853039|FG006|Overall Study|Maximum clinical benefit|3|||
129969919|NCT01236352|467853040|FG007|Overall Study|Maximum clinical benefit|1|||
129969920|NCT01236352|467853041|FG008|Overall Study|Maximum clinical benefit|1|||
129969921|NCT01236352|467853042|FG009|Overall Study|Maximum clinical benefit|4|||
129969922|NCT01236352|467853043|FG010|Overall Study|Maximum clinical benefit|2|||
129969923|NCT01236352|467853033|FG000|Overall Study|Subject request to discontinue treatment|0|||
129969924|NCT01236352|467853034|FG001|Overall Study|Subject request to discontinue treatment|0|||
129969925|NCT01236352|467853035|FG002|Overall Study|Subject request to discontinue treatment|1|||
129969926|NCT01236352|467853036|FG003|Overall Study|Subject request to discontinue treatment|1|||
129969927|NCT01236352|467853037|FG004|Overall Study|Subject request to discontinue treatment|0|||
129969928|NCT01236352|467853038|FG005|Overall Study|Subject request to discontinue treatment|1|||
129969929|NCT01236352|467853039|FG006|Overall Study|Subject request to discontinue treatment|0|||
129969930|NCT01236352|467853040|FG007|Overall Study|Subject request to discontinue treatment|0|||
129969931|NCT01236352|467853041|FG008|Overall Study|Subject request to discontinue treatment|0|||
129969932|NCT01236352|467853042|FG009|Overall Study|Subject request to discontinue treatment|1|||
129969933|NCT01236352|467853043|FG010|Overall Study|Subject request to discontinue treatment|4|||
129969934|NCT01236352|467853033|FG000|Overall Study|Subject to receive drug via EAP|1|||
129969935|NCT01236352|467853034|FG001|Overall Study|Subject to receive drug via EAP|1|||
129969936|NCT01236352|467853035|FG002|Overall Study|Subject to receive drug via EAP|1|||
129969937|NCT01236352|467853036|FG003|Overall Study|Subject to receive drug via EAP|0|||
129969938|NCT01236352|467853037|FG004|Overall Study|Subject to receive drug via EAP|0|||
129969939|NCT01236352|467853038|FG005|Overall Study|Subject to receive drug via EAP|0|||
129969940|NCT01236352|467853039|FG006|Overall Study|Subject to receive drug via EAP|0|||
129969941|NCT01236352|467853040|FG007|Overall Study|Subject to receive drug via EAP|2|||
129969942|NCT01236352|467853041|FG008|Overall Study|Subject to receive drug via EAP|0|||
129969943|NCT01236352|467853042|FG009|Overall Study|Subject to receive drug via EAP|4|||
129969944|NCT01236352|467853043|FG010|Overall Study|Subject to receive drug via EAP|0|||
129969945|NCT01236352|467853033|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
129969946|NCT01236352|467853034|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
129969947|NCT01236352|467853035|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
129969948|NCT01236352|467853036|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
129460940|NCT01464307|465983933|FG001|Main Period|Adverse Event|1|||
129460941|NCT01464307|465983932|FG000|Main Period|Lack of Efficacy|2|||
129460942|NCT01464307|465983933|FG001|Main Period|Lack of Efficacy|0|||
129460943|NCT01464307|465983932|FG000|Main Period|Withdrawal by Subject|5|||
129460944|NCT01464307|465983933|FG001|Main Period|Withdrawal by Subject|2|||
129460945|NCT01464307|465983932|FG000|Main Period|Predefined discontinuation criteria|2|||
129460946|NCT01464307|465983933|FG001|Main Period|Predefined discontinuation criteria|1|||
129460947|NCT01464307|465983932|FG000|Open-Label Extension Period|Adverse Event|15|||
129460948|NCT01464307|465983933|FG001|Open-Label Extension Period|Adverse Event|0|||
129460949|NCT01464307|465983932|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
129460950|NCT01464307|465983933|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
129460951|NCT01464307|465983932|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
129460952|NCT01464307|465983933|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
129460953|NCT01464307|465983932|FG000|Open-Label Extension Period|Death|1|||
129460954|NCT01464307|465983933|FG001|Open-Label Extension Period|Death|0|||
129460955|NCT01464307|465983932|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
129460956|NCT01464307|465983933|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
129460957|NCT01464307|465983932|FG000|Open-Label Extension Period|Non-compliance|9|||
129460958|NCT01464307|465983933|FG001|Open-Label Extension Period|Non-compliance|0|||
129460959|NCT01464307|465983932|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
129460960|NCT01464307|465983933|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
129460961|NCT00761514|465983936|FG000|Overall Study|Adverse Event|1|||
129460962|NCT00761514|465983936|FG000|Overall Study|Withdrawal by Subject|2|||
129460963|NCT00761514|465983936|FG000|Overall Study|Lost to Follow-up|1|||
129460964|NCT00761514|465983936|FG000|Overall Study|Health insurance didn't cover study drug|1|||
129460965|NCT00761514|465983936|FG000|Overall Study|Problem complying with study visit|1|||
129460966|NCT00761514|465983936|FG000|Overall Study|Unable to pay for medications|1|||
129460967|NCT02457637|465983937|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
129460968|NCT04942925|465983940|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
129460969|NCT04942925|465983941|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
129969949|NCT01236352|467853037|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
129969950|NCT01236352|467853038|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
129969951|NCT01236352|467853039|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
129969952|NCT01236352|467853040|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
129969953|NCT01236352|467853041|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
129969954|NCT01236352|467853042|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
129969955|NCT01236352|467853043|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
129969956|NCT01236352|467853033|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969957|NCT01236352|467853034|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129460970|NCT04942925|465983940|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
129460971|NCT04942925|465983941|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
129460972|NCT01273883|465983942|FG000|First Intervention|Adverse Event|2|||
129460973|NCT01273883|465983943|FG001|First Intervention|Adverse Event|1|||
129460974|NCT01273883|465983942|FG000|Second Intervention|Lost to Follow-up|1|||
129460975|NCT01273883|465983943|FG001|Second Intervention|Lost to Follow-up|1|||
129460976|NCT01273883|465983942|FG000|Second Intervention|Lack of Efficacy|1|||
129460977|NCT01273883|465983943|FG001|Second Intervention|Lack of Efficacy|0|||
129460978|NCT02124564|465983950|FG000|Treatment Period|Adverse Event|2|||
129460979|NCT02124564|465983950|FG000|Treatment Period|Lack of Efficacy|3|||
129460980|NCT02124564|465983950|FG000|Treatment Period|Withdrawal by Subject|2|||
129460981|NCT03885089|465983951|FG000|Overall Study|No informed consent for publication of study results|2|||
129460982|NCT02043548|465983957|FG000|Overall Study|Lack of Efficacy|1|||
129460983|NCT02043548|465983958|FG001|Overall Study|Lack of Efficacy|0|||
129460984|NCT02043548|465983957|FG000|Overall Study|Adverse Event|0|||
129460985|NCT02043548|465983958|FG001|Overall Study|Adverse Event|1|||
129460986|NCT01425008|465983967|FG000|Dose Escalation Phase|Progressive Disease|2|||
129460987|NCT01425008|465983968|FG001|Dose Escalation Phase|Progressive Disease|3|||
129460988|NCT01425008|465983969|FG002|Dose Escalation Phase|Progressive Disease|2|||
129460989|NCT01425008|465983970|FG003|Dose Escalation Phase|Progressive Disease|3|||
129460990|NCT01425008|465983971|FG004|Dose Escalation Phase|Progressive Disease|5|||
129460991|NCT01425008|465983972|FG005|Dose Escalation Phase|Progressive Disease|4|||
129460992|NCT01425008|465983973|FG006|Dose Escalation Phase|Progressive Disease|0|||
129460993|NCT01425008|465983974|FG007|Dose Escalation Phase|Progressive Disease|2|||
129460994|NCT01425008|465983975|FG008|Dose Escalation Phase|Progressive Disease|6|||
129460995|NCT01425008|465983976|FG009|Dose Escalation Phase|Progressive Disease|2|||
129460996|NCT01425008|465983977|FG010|Dose Escalation Phase|Progressive Disease|0|||
129460997|NCT01425008|465983978|FG011|Dose Escalation Phase|Progressive Disease|0|||
129460998|NCT01425008|465983979|FG012|Dose Escalation Phase|Progressive Disease|0|||
129460999|NCT01425008|465983980|FG013|Dose Escalation Phase|Progressive Disease|0|||
129461000|NCT01425008|465983981|FG014|Dose Escalation Phase|Progressive Disease|0|||
129461001|NCT01425008|465983982|FG015|Dose Escalation Phase|Progressive Disease|0|||
129461002|NCT01425008|465983983|FG016|Dose Escalation Phase|Progressive Disease|0|||
129461003|NCT01425008|465983984|FG017|Dose Escalation Phase|Progressive Disease|0|||
129461004|NCT01425008|465983985|FG018|Dose Escalation Phase|Progressive Disease|0|||
129461005|NCT01425008|465983967|FG000|Dose Escalation Phase|Adverse Event|2|||
129461006|NCT01425008|465983968|FG001|Dose Escalation Phase|Adverse Event|0|||
129969958|NCT01236352|467853035|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969959|NCT01236352|467853036|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129461007|NCT01425008|465983969|FG002|Dose Escalation Phase|Adverse Event|0|||
129461008|NCT01425008|465983970|FG003|Dose Escalation Phase|Adverse Event|0|||
129461009|NCT01425008|465983971|FG004|Dose Escalation Phase|Adverse Event|0|||
129969960|NCT01236352|467853037|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969961|NCT01236352|467853038|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969962|NCT01236352|467853039|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969963|NCT01236352|467853040|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969964|NCT01236352|467853041|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969965|NCT01236352|467853042|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
129969966|NCT01236352|467853043|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
129969967|NCT01236352|467853033|FG000|Overall Study|Lack of response to drug|0|||
129969968|NCT01236352|467853034|FG001|Overall Study|Lack of response to drug|0|||
129969969|NCT01236352|467853035|FG002|Overall Study|Lack of response to drug|0|||
129969970|NCT01236352|467853036|FG003|Overall Study|Lack of response to drug|0|||
129969971|NCT01236352|467853037|FG004|Overall Study|Lack of response to drug|0|||
129969972|NCT01236352|467853038|FG005|Overall Study|Lack of response to drug|0|||
129969973|NCT01236352|467853039|FG006|Overall Study|Lack of response to drug|0|||
129969974|NCT01236352|467853040|FG007|Overall Study|Lack of response to drug|0|||
129969975|NCT01236352|467853041|FG008|Overall Study|Lack of response to drug|0|||
129969976|NCT01236352|467853042|FG009|Overall Study|Lack of response to drug|1|||
129969977|NCT01236352|467853043|FG010|Overall Study|Lack of response to drug|1|||
129969978|NCT01236352|467853033|FG000|Overall Study|Patient transferred to IST|0|||
129461010|NCT01425008|465983972|FG005|Dose Escalation Phase|Adverse Event|2|||
129461011|NCT01425008|465983973|FG006|Dose Escalation Phase|Adverse Event|0|||
129461012|NCT01425008|465983974|FG007|Dose Escalation Phase|Adverse Event|0|||
129461013|NCT01425008|465983975|FG008|Dose Escalation Phase|Adverse Event|2|||
129461014|NCT01425008|465983976|FG009|Dose Escalation Phase|Adverse Event|0|||
129461015|NCT01425008|465983977|FG010|Dose Escalation Phase|Adverse Event|0|||
129461016|NCT01425008|465983978|FG011|Dose Escalation Phase|Adverse Event|0|||
129461017|NCT01425008|465983979|FG012|Dose Escalation Phase|Adverse Event|0|||
129461018|NCT01425008|465983980|FG013|Dose Escalation Phase|Adverse Event|0|||
129461019|NCT01425008|465983981|FG014|Dose Escalation Phase|Adverse Event|0|||
129461020|NCT01425008|465983982|FG015|Dose Escalation Phase|Adverse Event|0|||
129461021|NCT01425008|465983983|FG016|Dose Escalation Phase|Adverse Event|0|||
129461022|NCT01425008|465983984|FG017|Dose Escalation Phase|Adverse Event|0|||
129461023|NCT01425008|465983985|FG018|Dose Escalation Phase|Adverse Event|0|||
129461024|NCT01425008|465983967|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461025|NCT01425008|465983968|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461026|NCT01425008|465983969|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461027|NCT01425008|465983970|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461028|NCT01425008|465983971|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
129461029|NCT01425008|465983972|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461030|NCT01425008|465983973|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
129461031|NCT01425008|465983974|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
129461032|NCT01425008|465983975|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
129461033|NCT01425008|465983976|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461034|NCT01425008|465983977|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461035|NCT01425008|465983978|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461036|NCT01425008|465983979|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461037|NCT01425008|465983980|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461038|NCT01425008|465983981|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461039|NCT01425008|465983982|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461040|NCT01425008|465983983|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461041|NCT01425008|465983984|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461042|NCT01425008|465983985|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129461043|NCT01425008|465983967|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129461044|NCT01425008|465983968|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129461045|NCT01425008|465983969|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129461046|NCT01425008|465983970|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129461047|NCT01425008|465983971|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
129461048|NCT01425008|465983972|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
129461049|NCT01425008|465983973|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
129461050|NCT01425008|465983974|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
129461051|NCT01425008|465983975|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
129461052|NCT01425008|465983976|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
129461053|NCT01425008|465983977|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
129461054|NCT01425008|465983978|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
129461055|NCT01425008|465983979|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
129461056|NCT01425008|465983980|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
129461057|NCT01425008|465983981|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
129461058|NCT01425008|465983982|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
129969979|NCT01236352|467853034|FG001|Overall Study|Patient transferred to IST|0|||
129969980|NCT01236352|467853035|FG002|Overall Study|Patient transferred to IST|0|||
129461059|NCT01425008|465983983|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
129461060|NCT01425008|465983984|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
129461061|NCT01425008|465983985|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
129461062|NCT01425008|465983967|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461063|NCT01425008|465983968|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461064|NCT01425008|465983969|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
129461065|NCT01425008|465983970|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461066|NCT01425008|465983971|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461067|NCT01425008|465983972|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
129969981|NCT01236352|467853036|FG003|Overall Study|Patient transferred to IST|0|||
129969982|NCT01236352|467853037|FG004|Overall Study|Patient transferred to IST|0|||
129969983|NCT01236352|467853038|FG005|Overall Study|Patient transferred to IST|0|||
129969984|NCT01236352|467853039|FG006|Overall Study|Patient transferred to IST|0|||
129969985|NCT01236352|467853040|FG007|Overall Study|Patient transferred to IST|0|||
129969986|NCT01236352|467853041|FG008|Overall Study|Patient transferred to IST|0|||
129969987|NCT01236352|467853042|FG009|Overall Study|Patient transferred to IST|2|||
129969988|NCT01236352|467853043|FG010|Overall Study|Patient transferred to IST|6|||
129969989|NCT01575873|467853044|FG000|Overall Study|Withdrawal by Subject|15|||
129969990|NCT01575873|467853045|FG001|Overall Study|Withdrawal by Subject|20|||
129969991|NCT01575873|467853046|FG002|Overall Study|Withdrawal by Subject|34|||
129969992|NCT01575873|467853047|FG003|Overall Study|Withdrawal by Subject|34|||
129969993|NCT01575873|467853044|FG000|Overall Study|Adverse Event|7|||
129969994|NCT01575873|467853045|FG001|Overall Study|Adverse Event|7|||
129969995|NCT01575873|467853046|FG002|Overall Study|Adverse Event|9|||
129969996|NCT01575873|467853047|FG003|Overall Study|Adverse Event|12|||
129969997|NCT01575873|467853044|FG000|Overall Study|Lost to Follow-up|1|||
129969998|NCT01575873|467853045|FG001|Overall Study|Lost to Follow-up|3|||
129969999|NCT01575873|467853046|FG002|Overall Study|Lost to Follow-up|13|||
129970000|NCT01575873|467853047|FG003|Overall Study|Lost to Follow-up|5|||
129970001|NCT01575873|467853044|FG000|Overall Study|Death|3|||
129970002|NCT01575873|467853045|FG001|Overall Study|Death|2|||
129970003|NCT01575873|467853046|FG002|Overall Study|Death|8|||
129970004|NCT01575873|467853047|FG003|Overall Study|Death|9|||
129970005|NCT01575873|467853044|FG000|Overall Study|Noncompliance|1|||
129970006|NCT01575873|467853045|FG001|Overall Study|Noncompliance|2|||
129970007|NCT01575873|467853046|FG002|Overall Study|Noncompliance|4|||
129970008|NCT01575873|467853047|FG003|Overall Study|Noncompliance|3|||
129970009|NCT01575873|467853044|FG000|Overall Study|Administrative decision|1|||
129970010|NCT01575873|467853045|FG001|Overall Study|Administrative decision|1|||
129970011|NCT01575873|467853046|FG002|Overall Study|Administrative decision|1|||
129970012|NCT01575873|467853047|FG003|Overall Study|Administrative decision|0|||
129970013|NCT01575873|467853044|FG000|Overall Study|Protocol deviation|0|||
129970014|NCT01575873|467853045|FG001|Overall Study|Protocol deviation|1|||
129970015|NCT01575873|467853046|FG002|Overall Study|Protocol deviation|0|||
129970016|NCT01575873|467853047|FG003|Overall Study|Protocol deviation|1|||
129970017|NCT01575873|467853044|FG000|Overall Study|Requirement for Alternative Therapy|0|||
129970018|NCT01575873|467853045|FG001|Overall Study|Requirement for Alternative Therapy|0|||
129970019|NCT01575873|467853046|FG002|Overall Study|Requirement for Alternative Therapy|1|||
129970020|NCT01575873|467853047|FG003|Overall Study|Requirement for Alternative Therapy|1|||
129970021|NCT01575873|467853044|FG000|Overall Study|Other|0|||
129970022|NCT01575873|467853045|FG001|Overall Study|Other|0|||
129970023|NCT01575873|467853046|FG002|Overall Study|Other|4|||
129970024|NCT01575873|467853047|FG003|Overall Study|Other|2|||
129970025|NCT00965497|467853048|FG000|Overall Study|Physician Decision|1|||
129970026|NCT00246090|467853053|FG000|Overall Study|Adverse Event|25|||
129970027|NCT00246090|467853053|FG000|Overall Study|Withdrawal by Subject|7|||
129970028|NCT00246090|467853053|FG000|Overall Study|Progressive Disease|212|||
129970029|NCT00246090|467853053|FG000|Overall Study|Clinical Progression|30|||
129970030|NCT00246090|467853053|FG000|Overall Study|Physician Decision|11|||
129970031|NCT00246090|467853053|FG000|Overall Study|Not Otherwise Specified|10|||
129970032|NCT02734004|467853054|FG000|Overall Study|Death|36|||
129970033|NCT02734004|467853055|FG001|Overall Study|Death|24|||
129970034|NCT02734004|467853056|FG002|Overall Study|Death|26|||
129970035|NCT02734004|467853057|FG003|Overall Study|Death|35|||
129461068|NCT01425008|465983973|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461069|NCT01425008|465983974|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461070|NCT01425008|465983975|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
129970036|NCT02734004|467853058|FG004|Overall Study|Death|13|||
129970037|NCT02734004|467853059|FG005|Overall Study|Death|17|||
129970038|NCT02734004|467853060|FG006|Overall Study|Death|20|||
129970039|NCT02734004|467853054|FG000|Overall Study|Lost to Follow-up|1|||
129970040|NCT02734004|467853055|FG001|Overall Study|Lost to Follow-up|1|||
129970041|NCT02734004|467853056|FG002|Overall Study|Lost to Follow-up|0|||
129970042|NCT02734004|467853057|FG003|Overall Study|Lost to Follow-up|0|||
129970043|NCT02734004|467853058|FG004|Overall Study|Lost to Follow-up|1|||
129970044|NCT02734004|467853059|FG005|Overall Study|Lost to Follow-up|0|||
129970045|NCT02734004|467853060|FG006|Overall Study|Lost to Follow-up|0|||
129970046|NCT02734004|467853054|FG000|Overall Study|Withdrawal by Subject|3|||
129970047|NCT02734004|467853055|FG001|Overall Study|Withdrawal by Subject|1|||
129970048|NCT02734004|467853056|FG002|Overall Study|Withdrawal by Subject|1|||
129970049|NCT02734004|467853057|FG003|Overall Study|Withdrawal by Subject|1|||
129970050|NCT02734004|467853058|FG004|Overall Study|Withdrawal by Subject|3|||
129970051|NCT02734004|467853059|FG005|Overall Study|Withdrawal by Subject|0|||
129970052|NCT02734004|467853060|FG006|Overall Study|Withdrawal by Subject|2|||
129970053|NCT02734004|467853054|FG000|Overall Study|Other|0|||
129970054|NCT02734004|467853055|FG001|Overall Study|Other|8|||
129970055|NCT02734004|467853056|FG002|Overall Study|Other|7|||
129970056|NCT02734004|467853057|FG003|Overall Study|Other|4|||
129970057|NCT02734004|467853058|FG004|Overall Study|Other|34|||
129970058|NCT02734004|467853059|FG005|Overall Study|Other|14|||
129970059|NCT02734004|467853060|FG006|Overall Study|Other|10|||
129970060|NCT01536171|467853061|FG000|Overall Study|Withdrawal by Subject|1|||
129970061|NCT01018732|467853062|FG000|Overall Study|Lost to Follow-up|0|||
129970062|NCT01018732|467853063|FG001|Overall Study|Lost to Follow-up|0|||
129970063|NCT01018732|467853064|FG002|Overall Study|Lost to Follow-up|3|||
129970064|NCT01018732|467853062|FG000|Overall Study|Protocol Violation|1|||
129970065|NCT01018732|467853063|FG001|Overall Study|Protocol Violation|1|||
129970066|NCT01018732|467853064|FG002|Overall Study|Protocol Violation|0|||
129970067|NCT01018732|467853062|FG000|Overall Study|Inappropriate Enrollment|0|||
129970068|NCT01018732|467853063|FG001|Overall Study|Inappropriate Enrollment|1|||
129970069|NCT01018732|467853064|FG002|Overall Study|Inappropriate Enrollment|0|||
129970070|NCT01018732|467853062|FG000|Overall Study|Unable to Classify|0|||
129970071|NCT01018732|467853063|FG001|Overall Study|Unable to Classify|0|||
129461071|NCT01425008|465983976|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
129461072|NCT01425008|465983977|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461073|NCT01425008|465983978|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461074|NCT01425008|465983979|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
129970072|NCT01018732|467853064|FG002|Overall Study|Unable to Classify|1|||
129970073|NCT05990387|467853065|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
129970074|NCT05990387|467853066|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
129970075|NCT01806389|467853067|FG000|Overall Study|Withdrawal by Subject|4|||
129970076|NCT00936598|467853070|FG000|Overall Study|Withdrawal by Subject|1|||
129970077|NCT00936598|467853071|FG001|Overall Study|Withdrawal by Subject|0|||
129970078|NCT00936598|467853070|FG000|Overall Study|Ineligible after consent|1|||
129970079|NCT00936598|467853071|FG001|Overall Study|Ineligible after consent|0|||
129970080|NCT01310699|467853072|FG000|Overall Study|Patients did not complete tandem.|4|||
129970081|NCT01310699|467853073|FG001|Overall Study|Patients did not complete tandem.|6|||
129970082|NCT00926575|467853074|FG000|Overall Study|Adverse Event|1|||
129970083|NCT00926575|467853075|FG001|Overall Study|Adverse Event|1|||
129970084|NCT00926575|467853074|FG000|Overall Study|Death|4|||
129970085|NCT00926575|467853075|FG001|Overall Study|Death|4|||
129970086|NCT00926575|467853074|FG000|Overall Study|Lost to Follow-up|1|||
129970087|NCT00926575|467853075|FG001|Overall Study|Lost to Follow-up|1|||
129970088|NCT00926575|467853074|FG000|Overall Study|Physician Decision|1|||
129970089|NCT00926575|467853075|FG001|Overall Study|Physician Decision|2|||
129970090|NCT00926575|467853074|FG000|Overall Study|Protocol Violation|1|||
129970091|NCT00926575|467853075|FG001|Overall Study|Protocol Violation|0|||
129461075|NCT01425008|465983980|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461076|NCT01425008|465983981|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461077|NCT01425008|465983982|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461078|NCT01425008|465983983|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461079|NCT01425008|465983984|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461080|NCT01425008|465983985|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
129461081|NCT01425008|465983967|FG000|Dose Escalation Phase|Other|0|||
129461082|NCT01425008|465983968|FG001|Dose Escalation Phase|Other|0|||
129461083|NCT01425008|465983969|FG002|Dose Escalation Phase|Other|0|||
129461084|NCT01425008|465983970|FG003|Dose Escalation Phase|Other|0|||
129461085|NCT01425008|465983971|FG004|Dose Escalation Phase|Other|0|||
129461086|NCT01425008|465983972|FG005|Dose Escalation Phase|Other|0|||
129461087|NCT01425008|465983973|FG006|Dose Escalation Phase|Other|0|||
129461088|NCT01425008|465983974|FG007|Dose Escalation Phase|Other|0|||
129461089|NCT01425008|465983975|FG008|Dose Escalation Phase|Other|1|||
129461090|NCT01425008|465983976|FG009|Dose Escalation Phase|Other|0|||
129461091|NCT01425008|465983977|FG010|Dose Escalation Phase|Other|0|||
129970092|NCT00926575|467853074|FG000|Overall Study|Withdrawal by Subject|8|||
129970093|NCT00926575|467853075|FG001|Overall Study|Withdrawal by Subject|9|||
129970094|NCT02201901|467853078|FG000|Overall Study|Randomized but never treated|0|||
129970095|NCT02201901|467853079|FG001|Overall Study|Randomized but never treated|1|||
129970096|NCT02201901|467853080|FG002|Overall Study|Randomized but never treated|0|||
129970097|NCT02201901|467853078|FG000|Overall Study|Lack of Efficacy|7|||
129970098|NCT02201901|467853079|FG001|Overall Study|Lack of Efficacy|1|||
129970099|NCT02201901|467853080|FG002|Overall Study|Lack of Efficacy|6|||
129461092|NCT01425008|465983978|FG011|Dose Escalation Phase|Other|0|||
129970100|NCT02201901|467853078|FG000|Overall Study|Death|3|||
129970101|NCT02201901|467853079|FG001|Overall Study|Death|3|||
129970102|NCT02201901|467853080|FG002|Overall Study|Death|3|||
129970103|NCT02201901|467853078|FG000|Overall Study|Lost to Follow-up|2|||
129970104|NCT02201901|467853079|FG001|Overall Study|Lost to Follow-up|3|||
129970105|NCT02201901|467853080|FG002|Overall Study|Lost to Follow-up|2|||
129970106|NCT02201901|467853078|FG000|Overall Study|Withdrew Consent|2|||
129461093|NCT01425008|465983979|FG012|Dose Escalation Phase|Other|0|||
129461094|NCT01425008|465983980|FG013|Dose Escalation Phase|Other|0|||
129970107|NCT02201901|467853079|FG001|Overall Study|Withdrew Consent|0|||
129970108|NCT02201901|467853080|FG002|Overall Study|Withdrew Consent|2|||
129970109|NCT02201901|467853078|FG000|Overall Study|Adverse Event|1|||
129970110|NCT02201901|467853079|FG001|Overall Study|Adverse Event|1|||
129970111|NCT02201901|467853080|FG002|Overall Study|Adverse Event|0|||
129970112|NCT02633397|467853082|FG000|Overall Study|Adverse Event|8|||
129970113|NCT02633397|467853083|FG001|Overall Study|Adverse Event|8|||
129970114|NCT02633397|467853082|FG000|Overall Study|Study Burden|4|||
129970115|NCT02633397|467853083|FG001|Overall Study|Study Burden|1|||
129970116|NCT02633397|467853082|FG000|Overall Study|Treatment interruption|2|||
129970117|NCT02633397|467853083|FG001|Overall Study|Treatment interruption|5|||
129461095|NCT01425008|465983981|FG014|Dose Escalation Phase|Other|0|||
129461096|NCT01425008|465983982|FG015|Dose Escalation Phase|Other|0|||
129461097|NCT01425008|465983983|FG016|Dose Escalation Phase|Other|0|||
129461098|NCT01425008|465983984|FG017|Dose Escalation Phase|Other|0|||
129461099|NCT01425008|465983985|FG018|Dose Escalation Phase|Other|0|||
129461100|NCT01425008|465983967|FG000|Dose Expansion Phase|Progressive Disease|0|||
129461101|NCT01425008|465983968|FG001|Dose Expansion Phase|Progressive Disease|0|||
129461102|NCT01425008|465983969|FG002|Dose Expansion Phase|Progressive Disease|0|||
129461103|NCT01425008|465983970|FG003|Dose Expansion Phase|Progressive Disease|0|||
129461104|NCT01425008|465983971|FG004|Dose Expansion Phase|Progressive Disease|0|||
129461105|NCT01425008|465983972|FG005|Dose Expansion Phase|Progressive Disease|0|||
129970118|NCT02633397|467853082|FG000|Overall Study|Death|2|||
129970119|NCT02633397|467853083|FG001|Overall Study|Death|2|||
129970120|NCT02633397|467853082|FG000|Overall Study|Physician Decision|0|||
129970121|NCT02633397|467853083|FG001|Overall Study|Physician Decision|1|||
129970122|NCT03595878|467853084|FG000|Overall Study|Death|2|||
129970123|NCT03595878|467853085|FG001|Overall Study|Death|1|||
129970124|NCT03595878|467853086|FG002|Overall Study|Death|0|||
129970125|NCT03595878|467853084|FG000|Overall Study|Disease progression|2|||
129970126|NCT03595878|467853085|FG001|Overall Study|Disease progression|1|||
129970127|NCT03595878|467853086|FG002|Overall Study|Disease progression|2|||
129970128|NCT03494985|467853087|FG000|Overall Study|Adverse Event|3|||
129970129|NCT03494985|467853088|FG001|Overall Study|Adverse Event|2|||
129970130|NCT03494985|467853089|FG002|Overall Study|Adverse Event|3|||
129970131|NCT03494985|467853090|FG003|Overall Study|Adverse Event|0|||
129970132|NCT03494985|467853087|FG000|Overall Study|Other (Withdrawal of consent)|2|||
129970133|NCT03494985|467853088|FG001|Overall Study|Other (Withdrawal of consent)|3|||
129970134|NCT03494985|467853089|FG002|Overall Study|Other (Withdrawal of consent)|2|||
129970135|NCT03494985|467853090|FG003|Overall Study|Other (Withdrawal of consent)|5|||
129970136|NCT03494985|467853087|FG000|Overall Study|Other (Not specified)|0|||
129970137|NCT03494985|467853088|FG001|Overall Study|Other (Not specified)|1|||
129970138|NCT03494985|467853089|FG002|Overall Study|Other (Not specified)|1|||
129970139|NCT03494985|467853090|FG003|Overall Study|Other (Not specified)|0|||
129970140|NCT03036124|467853091|FG000|Overall Study|Lost to Follow-up|0|||
129970141|NCT03036124|467853092|FG001|Overall Study|Lost to Follow-up|2|||
129970142|NCT03036124|467853091|FG000|Overall Study|Withdrawal by Subject|5|||
129970143|NCT03036124|467853092|FG001|Overall Study|Withdrawal by Subject|4|||
129970144|NCT02394925|467853093|FG000|Overall Study|Adverse Event|1|||
129970145|NCT02394925|467853093|FG000|Overall Study|Lens Discomfort|3|||
129970146|NCT02394925|467853093|FG000|Overall Study|Lens handling difficulities|5|||
129970147|NCT02394925|467853093|FG000|Overall Study|Lost to Follow-up|9|||
129970148|NCT02394925|467853093|FG000|Overall Study|Protocol Violation|5|||
129970149|NCT02394925|467853093|FG000|Overall Study|No longer meet eligibility criteria|1|||
129970150|NCT02394925|467853093|FG000|Overall Study|Unsatisfactory Visual Response|5|||
129461106|NCT01425008|465983973|FG006|Dose Expansion Phase|Progressive Disease|0|||
129461107|NCT01425008|465983974|FG007|Dose Expansion Phase|Progressive Disease|0|||
129461108|NCT01425008|465983975|FG008|Dose Expansion Phase|Progressive Disease|0|||
129970151|NCT00966264|467854585|FG000|Overall Study|Lost to Follow-up|4|||
129970152|NCT00966264|467854586|FG001|Overall Study|Lost to Follow-up|3|||
129970153|NCT01246999|467854587|FG000|Overall Study|Lost to Follow-up|0|||
129970154|NCT01246999|467854588|FG001|Overall Study|Lost to Follow-up|1|||
129970155|NCT01246999|467854589|FG002|Overall Study|Lost to Follow-up|0|||
129461109|NCT01425008|465983976|FG009|Dose Expansion Phase|Progressive Disease|0|||
129970156|NCT01246999|467854590|FG003|Overall Study|Lost to Follow-up|0|||
129461110|NCT01425008|465983977|FG010|Dose Expansion Phase|Progressive Disease|10|||
129970157|NCT01246999|467854587|FG000|Overall Study|Withdrawal by Subject|0|||
129970158|NCT01246999|467854588|FG001|Overall Study|Withdrawal by Subject|0|||
129461111|NCT01425008|465983978|FG011|Dose Expansion Phase|Progressive Disease|4|||
129970159|NCT01246999|467854589|FG002|Overall Study|Withdrawal by Subject|0|||
129970160|NCT01246999|467854590|FG003|Overall Study|Withdrawal by Subject|2|||
129970161|NCT01867047|467854591|FG000|Overall Study|Lost to Follow-up|3|||
129970162|NCT01867047|467854592|FG001|Overall Study|Lost to Follow-up|3|||
129461112|NCT01425008|465983979|FG012|Dose Expansion Phase|Progressive Disease|12|||
129970163|NCT01867047|467854591|FG000|Overall Study|Withdrawal by Subject|2|||
129970164|NCT01867047|467854592|FG001|Overall Study|Withdrawal by Subject|0|||
129970165|NCT01867047|467854591|FG000|Overall Study|Physician Decision|2|||
129970166|NCT01867047|467854592|FG001|Overall Study|Physician Decision|0|||
129970167|NCT01867047|467854591|FG000|Overall Study|surgery not indicated in protocol|1|||
129970168|NCT01867047|467854592|FG001|Overall Study|surgery not indicated in protocol|2|||
129970169|NCT04596995|467854593|FG000|Overall Study|Lack of Efficacy|8|||
129970170|NCT04596995|467854593|FG000|Overall Study|Lost to Follow-up|3|||
129970171|NCT04596995|467854593|FG000|Overall Study|Withdrawal by Subject|12|||
129970172|NCT04596995|467854593|FG000|Overall Study|Sponsor decision|3|||
129970173|NCT04596995|467854593|FG000|Overall Study|Enrolled in managed access program|3|||
129970174|NCT00590564|467854595|FG000|Overall Study|Withdrawal by Subject|4|||
129970175|NCT00590564|467854595|FG000|Overall Study|Lost to Follow-up|6|||
129970176|NCT00590564|467854595|FG000|Overall Study|Protocol Violation|1|||
129970177|NCT00590564|467854595|FG000|Overall Study|Patient Found to be Ineligible|1|||
129970178|NCT00590564|467854595|FG000|Overall Study|Patient Non-compliance|6|||
129970179|NCT03020069|467854599|FG000|Overall Study|Lost to Follow-up|0|||
129970180|NCT03020069|467854600|FG001|Overall Study|Lost to Follow-up|1|||
129970181|NCT01907906|467854604|FG000|Overall Study|Withdrawal by Subject|1|||
129970182|NCT01907906|467854605|FG001|Overall Study|Withdrawal by Subject|0|||
129970183|NCT01907906|467854604|FG000|Overall Study|Physician Decision|3|||
129970184|NCT01907906|467854605|FG001|Overall Study|Physician Decision|1|||
129970185|NCT02786004|467854606|FG000|Overall Study|Withdrawal by Subject|0|||
129970186|NCT02786004|467854607|FG001|Overall Study|Withdrawal by Subject|1|||
129970187|NCT01013961|467854611|FG000|Overall Study|Adverse Event|2|||
129970188|NCT01013961|467854612|FG001|Overall Study|Adverse Event|2|||
129970189|NCT01013961|467854611|FG000|Overall Study|Withdrawal by Subject|1|||
129970190|NCT01013961|467854612|FG001|Overall Study|Withdrawal by Subject|0|||
129970191|NCT01013961|467854611|FG000|Overall Study|Physician Decision|0|||
129970192|NCT01013961|467854612|FG001|Overall Study|Physician Decision|1|||
129970193|NCT00559377|467854613|FG000|Overall Study|Withdrawal by Subject|9|||
129970194|NCT00940875|467854614|FG000|Treatment Phase|Adverse Event|9|||
129970195|NCT00940875|467854615|FG001|Treatment Phase|Adverse Event|3|||
129970196|NCT00940875|467854614|FG000|Treatment Phase|Death|3|||
129970197|NCT00940875|467854615|FG001|Treatment Phase|Death|5|||
129970198|NCT00940875|467854614|FG000|Treatment Phase|Lack of Efficacy|1|||
129970199|NCT00940875|467854615|FG001|Treatment Phase|Lack of Efficacy|0|||
129970200|NCT00940875|467854614|FG000|Treatment Phase|Withdrawal by Subject|3|||
129461113|NCT01425008|465983980|FG013|Dose Expansion Phase|Progressive Disease|1|||
129461114|NCT01425008|465983981|FG014|Dose Expansion Phase|Progressive Disease|5|||
129461115|NCT01425008|465983982|FG015|Dose Expansion Phase|Progressive Disease|8|||
129461116|NCT01425008|465983983|FG016|Dose Expansion Phase|Progressive Disease|9|||
129461117|NCT01425008|465983984|FG017|Dose Expansion Phase|Progressive Disease|2|||
129461118|NCT01425008|465983985|FG018|Dose Expansion Phase|Progressive Disease|10|||
129461119|NCT01425008|465983967|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
129461120|NCT01425008|465983968|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
129461121|NCT01425008|465983969|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
129461122|NCT01425008|465983970|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
129461123|NCT01425008|465983971|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
129461124|NCT01425008|465983972|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
129461125|NCT01425008|465983973|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
129461126|NCT01425008|465983974|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
129461127|NCT01425008|465983975|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
129461128|NCT01425008|465983976|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
129461129|NCT01425008|465983977|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
129461130|NCT01425008|465983978|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
129461131|NCT01425008|465983979|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
129461132|NCT01425008|465983980|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
129461133|NCT01425008|465983981|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
129461134|NCT01425008|465983982|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
129461135|NCT01425008|465983983|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
129970201|NCT00940875|467854615|FG001|Treatment Phase|Withdrawal by Subject|0|||
129970202|NCT00940875|467854614|FG000|Treatment Phase|Disease progression|9|||
129970203|NCT00940875|467854615|FG001|Treatment Phase|Disease progression|11|||
129970204|NCT00940875|467854614|FG000|Treatment Phase|Physician Decision|1|||
129970205|NCT00940875|467854615|FG001|Treatment Phase|Physician Decision|0|||
129970206|NCT00940875|467854614|FG000|Post-Study Treatment|Death|0|||
129970207|NCT00940875|467854615|FG001|Post-Study Treatment|Death|1|||
129970208|NCT00940875|467854614|FG000|Post-Study Treatment|Disease Progression|0|||
129970209|NCT00940875|467854615|FG001|Post-Study Treatment|Disease Progression|2|||
129970210|NCT00490945|467854616|FG000|Overall Study|Adverse Event|0|||
129970211|NCT00490945|467854617|FG001|Overall Study|Adverse Event|1|||
129970212|NCT00490945|467854618|FG002|Overall Study|Adverse Event|0|||
129970213|NCT00490945|467854619|FG003|Overall Study|Adverse Event|0|||
129970214|NCT00490945|467854620|FG004|Overall Study|Adverse Event|0|||
129970215|NCT02879383|467854628|FG000|First 24 Weeks|Physician Decision|0|||
129970216|NCT02879383|467854629|FG001|First 24 Weeks|Physician Decision|1|||
129970217|NCT02879383|467854630|FG002|First 24 Weeks|Physician Decision|0|||
129970218|NCT02879383|467854631|FG003|First 24 Weeks|Physician Decision|0|||
129970219|NCT03016598|467854641|FG000|Overall Study|Lost to Follow-up|0|||
129970220|NCT03016598|467854642|FG001|Overall Study|Lost to Follow-up|2|||
129970221|NCT02947100|467854643|FG000|Overall Study|study terminated early|3|||
129970222|NCT02947100|467854643|FG000|Overall Study|did not meet inclusion criteria|1|||
129970223|NCT00742326|467854646|FG000|Overall Study|Physician Decision|0|||
129970224|NCT00742326|467854647|FG001|Overall Study|Physician Decision|1|||
129970225|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
129970226|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
129970227|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
129970228|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
129970229|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
129970230|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
129970231|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
129970232|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
129970233|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
129970234|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
129970235|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
129970236|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
129461136|NCT01425008|465983984|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
129461137|NCT01425008|465983985|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
129461138|NCT01425008|465983967|FG000|Dose Expansion Phase|Other|0|||
129461139|NCT01425008|465983968|FG001|Dose Expansion Phase|Other|0|||
129461140|NCT01425008|465983969|FG002|Dose Expansion Phase|Other|0|||
129461141|NCT01425008|465983970|FG003|Dose Expansion Phase|Other|0|||
129461142|NCT01425008|465983971|FG004|Dose Expansion Phase|Other|0|||
129461143|NCT01425008|465983972|FG005|Dose Expansion Phase|Other|0|||
129461144|NCT01425008|465983973|FG006|Dose Expansion Phase|Other|0|||
129970237|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
129461145|NCT01425008|465983974|FG007|Dose Expansion Phase|Other|0|||
129461146|NCT01425008|465983975|FG008|Dose Expansion Phase|Other|0|||
129461147|NCT01425008|465983976|FG009|Dose Expansion Phase|Other|0|||
129970238|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
129970239|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
129970240|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
129970241|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
129970242|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
129970243|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Missing|2|||
129970244|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Missing|1|||
129970245|NCT00443209|467854649|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
129970246|NCT00443209|467854650|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
129970247|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
129970248|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
129970249|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
129970250|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
129461148|NCT01425008|465983977|FG010|Dose Expansion Phase|Other|0|||
129461149|NCT01425008|465983978|FG011|Dose Expansion Phase|Other|0|||
129461150|NCT01425008|465983979|FG012|Dose Expansion Phase|Other|1|||
129461151|NCT01425008|465983980|FG013|Dose Expansion Phase|Other|0|||
129461152|NCT01425008|465983981|FG014|Dose Expansion Phase|Other|0|||
129461153|NCT01425008|465983982|FG015|Dose Expansion Phase|Other|0|||
129461154|NCT01425008|465983983|FG016|Dose Expansion Phase|Other|2|||
129461155|NCT01425008|465983984|FG017|Dose Expansion Phase|Other|0|||
129461156|NCT01425008|465983985|FG018|Dose Expansion Phase|Other|4|||
129461157|NCT01425008|465983967|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
129970251|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
129970252|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
129970253|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
129970254|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
129970255|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
129970256|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
129970257|NCT00443209|467854649|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
129970258|NCT00443209|467854650|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
129970259|NCT00409409|467854651|FG000|Overall Study|Adverse Event|7|||
129970260|NCT00409409|467854652|FG001|Overall Study|Adverse Event|2|||
129970261|NCT00409409|467854651|FG000|Overall Study|Withdrawal by Subject|1|||
129970262|NCT00409409|467854652|FG001|Overall Study|Withdrawal by Subject|1|||
129970263|NCT00409409|467854651|FG000|Overall Study|Any other reason not above-mentioned|0|||
129970264|NCT00409409|467854652|FG001|Overall Study|Any other reason not above-mentioned|1|||
129970265|NCT03635086|467854656|FG000|Overall Study|Withdrawal of consent|0|||
129970266|NCT03635086|467854657|FG001|Overall Study|Withdrawal of consent|0|||
129970267|NCT03635086|467854658|FG002|Overall Study|Withdrawal of consent|1|||
129970268|NCT03635086|467854659|FG003|Overall Study|Withdrawal of consent|0|||
129970269|NCT03635086|467854660|FG004|Overall Study|Withdrawal of consent|0|||
129970270|NCT03635086|467854656|FG000|Overall Study|Adverse Event|0|||
129970271|NCT03635086|467854657|FG001|Overall Study|Adverse Event|1|||
129970272|NCT03635086|467854658|FG002|Overall Study|Adverse Event|0|||
129970273|NCT03635086|467854659|FG003|Overall Study|Adverse Event|0|||
129970274|NCT03635086|467854660|FG004|Overall Study|Adverse Event|0|||
129970275|NCT03635086|467854656|FG000|Overall Study|Lost to Follow-up|1|||
129970276|NCT03635086|467854657|FG001|Overall Study|Lost to Follow-up|0|||
129970277|NCT03635086|467854658|FG002|Overall Study|Lost to Follow-up|0|||
129970278|NCT03635086|467854659|FG003|Overall Study|Lost to Follow-up|0|||
129970279|NCT03635086|467854660|FG004|Overall Study|Lost to Follow-up|0|||
129970280|NCT00478205|467854661|FG000|Overall Study|Adverse Event|182|||
129970281|NCT00478205|467854662|FG001|Overall Study|Adverse Event|39|||
129970282|NCT00478205|467854661|FG000|Overall Study|Medication Non-compliance|9|||
129970283|NCT00478205|467854662|FG001|Overall Study|Medication Non-compliance|4|||
129970284|NCT00478205|467854661|FG000|Overall Study|Protocol Violation|15|||
129970285|NCT00478205|467854662|FG001|Overall Study|Protocol Violation|5|||
129970286|NCT00478205|467854661|FG000|Overall Study|Request of Investigator or Sponsor|4|||
129970287|NCT00478205|467854662|FG001|Overall Study|Request of Investigator or Sponsor|5|||
129970288|NCT00478205|467854661|FG000|Overall Study|Withdrawal by Subject|61|||
129970289|NCT00478205|467854662|FG001|Overall Study|Withdrawal by Subject|22|||
129970290|NCT00478205|467854661|FG000|Overall Study|Lack of Efficacy|1|||
129970291|NCT00478205|467854662|FG001|Overall Study|Lack of Efficacy|0|||
129461158|NCT01425008|465983968|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461159|NCT01425008|465983969|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
129970292|NCT00478205|467854661|FG000|Overall Study|Other|24|||
129970293|NCT00478205|467854662|FG001|Overall Study|Other|12|||
129970294|NCT01012947|467854663|FG000|Overall Study|Lost to Follow-up|131|||
129970295|NCT01012947|467854664|FG001|Overall Study|Lost to Follow-up|135|||
129970296|NCT01012947|467854665|FG002|Overall Study|Lost to Follow-up|130|||
129970297|NCT01012947|467854666|FG003|Overall Study|Lost to Follow-up|118|||
129970298|NCT01012947|467854667|FG004|Overall Study|Lost to Follow-up|142|||
129970299|NCT04016272|467854670|FG000|Overall Study|Withdrawal by Subject|1|||
129970300|NCT04016272|467854671|FG001|Overall Study|Withdrawal by Subject|2|||
129970301|NCT00825305|467854672|FG000|Overall Study|Adverse Event|1|||
129970302|NCT00825305|467854673|FG001|Overall Study|Adverse Event|1|||
129970303|NCT00825305|467854672|FG000|Overall Study|Withdrawal by Subject|6|||
129970304|NCT00825305|467854673|FG001|Overall Study|Withdrawal by Subject|12|||
129970305|NCT00825305|467854672|FG000|Overall Study|Inappropriate inclusion|1|||
129970306|NCT00825305|467854673|FG001|Overall Study|Inappropriate inclusion|0|||
129970307|NCT00825305|467854672|FG000|Overall Study|Protocol Violation|9|||
129970308|NCT00825305|467854673|FG001|Overall Study|Protocol Violation|9|||
129970309|NCT00825305|467854672|FG000|Overall Study|Can not be classified|0|||
129970310|NCT00825305|467854673|FG001|Overall Study|Can not be classified|1|||
129461160|NCT01425008|465983970|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461161|NCT01425008|465983971|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461162|NCT01425008|465983972|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461163|NCT01425008|465983973|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461164|NCT01425008|465983974|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461165|NCT01425008|465983975|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
129970311|NCT01850030|467854676|FG000|Overall Study|Adverse Event|64|||
129970312|NCT01850030|467854677|FG001|Overall Study|Adverse Event|82|||
129970313|NCT01850030|467854676|FG000|Overall Study|Lack of Efficacy|3|||
129970314|NCT01850030|467854677|FG001|Overall Study|Lack of Efficacy|1|||
129970315|NCT01850030|467854676|FG000|Overall Study|Lost to Follow-up|5|||
129970316|NCT01850030|467854677|FG001|Overall Study|Lost to Follow-up|5|||
129970317|NCT01850030|467854676|FG000|Overall Study|Withdrawal by Subject|3|||
129970318|NCT01850030|467854677|FG001|Overall Study|Withdrawal by Subject|4|||
129970319|NCT01850030|467854676|FG000|Overall Study|Protocol Violation|24|||
129970320|NCT01850030|467854677|FG001|Overall Study|Protocol Violation|28|||
129970321|NCT01850030|467854676|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
129970322|NCT01850030|467854677|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
129970323|NCT02638103|467854678|FG000|Overall Study|Adverse Event|13|||
129970324|NCT02638103|467854679|FG001|Overall Study|Adverse Event|12|||
129970325|NCT02638103|467854680|FG002|Overall Study|Adverse Event|19|||
129970326|NCT02638103|467854681|FG003|Overall Study|Adverse Event|12|||
129970327|NCT02638103|467854678|FG000|Overall Study|Withdrawal by Subject|43|||
129970328|NCT02638103|467854679|FG001|Overall Study|Withdrawal by Subject|53|||
129970329|NCT02638103|467854680|FG002|Overall Study|Withdrawal by Subject|30|||
129970330|NCT02638103|467854681|FG003|Overall Study|Withdrawal by Subject|61|||
129970331|NCT02638103|467854678|FG000|Overall Study|Protocol Violation|1|||
129970332|NCT02638103|467854679|FG001|Overall Study|Protocol Violation|2|||
129970333|NCT02638103|467854680|FG002|Overall Study|Protocol Violation|1|||
129970334|NCT02638103|467854681|FG003|Overall Study|Protocol Violation|4|||
129970335|NCT02638103|467854678|FG000|Overall Study|Pregnancy|2|||
129970336|NCT02638103|467854679|FG001|Overall Study|Pregnancy|3|||
129970337|NCT02638103|467854680|FG002|Overall Study|Pregnancy|0|||
129970338|NCT02638103|467854681|FG003|Overall Study|Pregnancy|1|||
129970339|NCT02638103|467854678|FG000|Overall Study|Non-compliance to Study Procedures|2|||
129970340|NCT02638103|467854679|FG001|Overall Study|Non-compliance to Study Procedures|1|||
129970341|NCT02638103|467854680|FG002|Overall Study|Non-compliance to Study Procedures|1|||
129970342|NCT02638103|467854681|FG003|Overall Study|Non-compliance to Study Procedures|1|||
129970343|NCT02638103|467854678|FG000|Overall Study|Lost to Follow-up|26|||
129970344|NCT02638103|467854679|FG001|Overall Study|Lost to Follow-up|33|||
129970345|NCT02638103|467854680|FG002|Overall Study|Lost to Follow-up|20|||
129970346|NCT02638103|467854681|FG003|Overall Study|Lost to Follow-up|37|||
129970347|NCT02638103|467854678|FG000|Overall Study|Lack of Efficacy|14|||
129970348|NCT02638103|467854679|FG001|Overall Study|Lack of Efficacy|10|||
129970349|NCT02638103|467854680|FG002|Overall Study|Lack of Efficacy|12|||
129970350|NCT02638103|467854681|FG003|Overall Study|Lack of Efficacy|22|||
129970351|NCT02638103|467854678|FG000|Overall Study|Other than specified|5|||
129970352|NCT02638103|467854679|FG001|Overall Study|Other than specified|4|||
129970353|NCT02638103|467854680|FG002|Overall Study|Other than specified|2|||
129970354|NCT02638103|467854681|FG003|Overall Study|Other than specified|4|||
129970355|NCT02165826|467854690|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
129970356|NCT02165826|467854691|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
129970357|NCT02165826|467854692|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
129970358|NCT02165826|467854690|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
129970359|NCT02165826|467854691|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
129461166|NCT01425008|465983976|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461167|NCT01425008|465983977|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
129461168|NCT01425008|465983978|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
129461169|NCT01425008|465983979|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461170|NCT01425008|465983980|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461171|NCT01425008|465983981|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
129970360|NCT02165826|467854692|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
129970361|NCT02165826|467854690|FG000|Main Treatment Period|Lost to Follow-up|4|||
129970362|NCT02165826|467854691|FG001|Main Treatment Period|Lost to Follow-up|2|||
129970363|NCT02165826|467854692|FG002|Main Treatment Period|Lost to Follow-up|1|||
129970364|NCT02165826|467854690|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
129970365|NCT02165826|467854691|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
129461172|NCT01425008|465983982|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
129970366|NCT02165826|467854692|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
129970367|NCT02165826|467854690|FG000|Main Treatment Period|Lack of Efficacy|2|||
129970368|NCT02165826|467854691|FG001|Main Treatment Period|Lack of Efficacy|0|||
129970369|NCT02165826|467854692|FG002|Main Treatment Period|Lack of Efficacy|0|||
129970370|NCT02165826|467854690|FG000|Main Treatment Period|Reason Not Specified|8|||
129970371|NCT02165826|467854691|FG001|Main Treatment Period|Reason Not Specified|5|||
129970372|NCT02165826|467854692|FG002|Main Treatment Period|Reason Not Specified|16|||
129970373|NCT02165826|467854690|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
129970374|NCT02165826|467854691|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
129970375|NCT02165826|467854692|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
129970376|NCT02165826|467854690|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
129970377|NCT02165826|467854691|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
129970378|NCT02165826|467854692|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
129970379|NCT02165826|467854690|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
129970380|NCT02165826|467854691|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
129970381|NCT02165826|467854692|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
129970382|NCT02165826|467854690|FG000|Down-Titration Period|Reason Not Specified|1|||
129970383|NCT02165826|467854691|FG001|Down-Titration Period|Reason Not Specified|0|||
129970384|NCT02165826|467854692|FG002|Down-Titration Period|Reason Not Specified|2|||
129970385|NCT04547023|467854695|FG000|Overall Study|Did Not Receive Intervention|3|||
129970386|NCT04547023|467854696|FG001|Overall Study|Did Not Receive Intervention|2|||
129970387|NCT04547023|467854695|FG000|Overall Study|Lost to Follow-up|1|||
129461173|NCT01425008|465983983|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
129461174|NCT01425008|465983984|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
129461175|NCT01425008|465983985|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
129461176|NCT01425008|465983967|FG000|Dose Expansion Phase|Adverse Event|0|||
129970388|NCT04547023|467854696|FG001|Overall Study|Lost to Follow-up|1|||
129970389|NCT01262092|467854697|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
129970390|NCT01262092|467854698|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
129970391|NCT01262092|467854697|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
129970392|NCT01262092|467854698|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
129970393|NCT01262092|467854697|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
129970394|NCT01262092|467854698|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
129970395|NCT01262092|467854697|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
129461177|NCT01425008|465983968|FG001|Dose Expansion Phase|Adverse Event|0|||
129461178|NCT01425008|465983969|FG002|Dose Expansion Phase|Adverse Event|0|||
129461179|NCT01425008|465983970|FG003|Dose Expansion Phase|Adverse Event|0|||
129461180|NCT01425008|465983971|FG004|Dose Expansion Phase|Adverse Event|0|||
129461181|NCT01425008|465983972|FG005|Dose Expansion Phase|Adverse Event|0|||
129461182|NCT01425008|465983973|FG006|Dose Expansion Phase|Adverse Event|0|||
129461183|NCT01425008|465983974|FG007|Dose Expansion Phase|Adverse Event|0|||
129461184|NCT01425008|465983975|FG008|Dose Expansion Phase|Adverse Event|0|||
129461185|NCT01425008|465983976|FG009|Dose Expansion Phase|Adverse Event|0|||
129461186|NCT01425008|465983977|FG010|Dose Expansion Phase|Adverse Event|2|||
129461187|NCT01425008|465983978|FG011|Dose Expansion Phase|Adverse Event|3|||
129461188|NCT01425008|465983979|FG012|Dose Expansion Phase|Adverse Event|3|||
129461189|NCT01425008|465983980|FG013|Dose Expansion Phase|Adverse Event|0|||
129461190|NCT01425008|465983981|FG014|Dose Expansion Phase|Adverse Event|1|||
129461191|NCT01425008|465983982|FG015|Dose Expansion Phase|Adverse Event|1|||
129461192|NCT01425008|465983983|FG016|Dose Expansion Phase|Adverse Event|5|||
129970396|NCT01262092|467854698|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
129970397|NCT03784820|467854699|FG000|Overall Study|Lost to Follow-up|5|||
129970398|NCT03784820|467854700|FG001|Overall Study|Lost to Follow-up|5|||
129970399|NCT03784820|467854701|FG002|Overall Study|Lost to Follow-up|3|||
129461193|NCT01425008|465983984|FG017|Dose Expansion Phase|Adverse Event|0|||
129461194|NCT01425008|465983985|FG018|Dose Expansion Phase|Adverse Event|3|||
129970400|NCT03784820|467854702|FG003|Overall Study|Lost to Follow-up|3|||
129970401|NCT04147858|467854703|FG000|Overall Study|Adverse Event|6|||
129970402|NCT04147858|467854704|FG001|Overall Study|Adverse Event|6|||
129970403|NCT04147858|467854705|FG002|Overall Study|Adverse Event|6|||
129970404|NCT04147858|467854703|FG000|Overall Study|Lack of Efficacy|3|||
129970405|NCT04147858|467854704|FG001|Overall Study|Lack of Efficacy|3|||
129970406|NCT04147858|467854705|FG002|Overall Study|Lack of Efficacy|1|||
129970407|NCT04147858|467854703|FG000|Overall Study|Lost to Follow-up|1|||
129461195|NCT01425008|465983967|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
129461196|NCT01425008|465983968|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
129461197|NCT01425008|465983969|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
129970408|NCT04147858|467854704|FG001|Overall Study|Lost to Follow-up|6|||
129970409|NCT04147858|467854705|FG002|Overall Study|Lost to Follow-up|2|||
129461198|NCT01425008|465983970|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
129461199|NCT01425008|465983971|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
129461200|NCT01425008|465983972|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
129970410|NCT04147858|467854703|FG000|Overall Study|Withdrawal by Subject|3|||
129970411|NCT04147858|467854704|FG001|Overall Study|Withdrawal by Subject|4|||
129970412|NCT04147858|467854705|FG002|Overall Study|Withdrawal by Subject|10|||
129970413|NCT04147858|467854703|FG000|Overall Study|Subject Noncompliance, Other|4|||
129970414|NCT04147858|467854704|FG001|Overall Study|Subject Noncompliance, Other|3|||
129970415|NCT04147858|467854705|FG002|Overall Study|Subject Noncompliance, Other|1|||
129970416|NCT00365547|467854712|FG000|Overall Study|Insurance did not cover Avastin|1|||
129970417|NCT00365547|467854712|FG000|Overall Study|Screen failure|1|||
129970418|NCT00365547|467854712|FG000|Overall Study|Withdrawal by Subject|1|||
129970419|NCT03170518|467854713|FG000|Overall Study|Lost to Follow-up|4|||
129970420|NCT03170518|467854714|FG001|Overall Study|Lost to Follow-up|1|||
129970421|NCT03170518|467854715|FG002|Overall Study|Lost to Follow-up|0|||
129970422|NCT03170518|467854713|FG000|Overall Study|Physician Decision|1|||
129970423|NCT03170518|467854714|FG001|Overall Study|Physician Decision|0|||
129970424|NCT03170518|467854715|FG002|Overall Study|Physician Decision|0|||
129970425|NCT03170518|467854713|FG000|Overall Study|Withdrawal by Subject|4|||
129970426|NCT03170518|467854714|FG001|Overall Study|Withdrawal by Subject|5|||
129970427|NCT03170518|467854715|FG002|Overall Study|Withdrawal by Subject|2|||
129970428|NCT03170518|467854713|FG000|Overall Study|Site terminated by sponsor|0|||
129970429|NCT03170518|467854714|FG001|Overall Study|Site terminated by sponsor|1|||
129970430|NCT03170518|467854715|FG002|Overall Study|Site terminated by sponsor|0|||
129970431|NCT03170518|467854713|FG000|Overall Study|Non-compliance with study drug|1|||
129970432|NCT03170518|467854714|FG001|Overall Study|Non-compliance with study drug|0|||
129970433|NCT03170518|467854715|FG002|Overall Study|Non-compliance with study drug|1|||
129970434|NCT03170518|467854713|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129970435|NCT03170518|467854714|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129970436|NCT03170518|467854715|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129970437|NCT04428476|467854716|FG000|Overall Study|Withdrawal by Subject|1|||
129970438|NCT04428476|467854716|FG000|Overall Study|Still on treatment|12|||
129970439|NCT00546078|467854717|FG000|Overall Study|Lost to Follow-up|1|||
129970440|NCT00546078|467854718|FG001|Overall Study|Lost to Follow-up|3|||
129970441|NCT00546078|467854717|FG000|Overall Study|Withdrawal by Subject|2|||
129970442|NCT00546078|467854718|FG001|Overall Study|Withdrawal by Subject|3|||
129970443|NCT00546078|467854717|FG000|Overall Study|Other reason|1|||
129970444|NCT00546078|467854718|FG001|Overall Study|Other reason|1|||
129970445|NCT03023423|467854721|FG000|Overall Study|Death|5|||
129970446|NCT03023423|467854722|FG001|Overall Study|Death|12|||
129970447|NCT03023423|467854723|FG002|Overall Study|Death|20|||
129970448|NCT03023423|467854721|FG000|Overall Study|Other|0|||
129970449|NCT03023423|467854722|FG001|Overall Study|Other|2|||
129970450|NCT03023423|467854723|FG002|Overall Study|Other|2|||
129970451|NCT03023423|467854721|FG000|Overall Study|Ongoing|2|||
129970452|NCT03023423|467854722|FG001|Overall Study|Ongoing|32|||
129970453|NCT03023423|467854723|FG002|Overall Study|Ongoing|24|||
129970454|NCT03512197|467854724|FG000|Overall Study|Guardian decision|1|||
129970455|NCT03512197|467854725|FG001|Overall Study|Guardian decision|1|||
129970456|NCT03512197|467854724|FG000|Overall Study|Lack of Efficacy|19|||
129970457|NCT03512197|467854725|FG001|Overall Study|Lack of Efficacy|11|||
129970458|NCT03512197|467854724|FG000|Overall Study|New Therapy for Study Indication|16|||
129970459|NCT03512197|467854725|FG001|Overall Study|New Therapy for Study Indication|16|||
129970460|NCT03512197|467854724|FG000|Overall Study|Physician Decision|60|||
129970461|NCT03512197|467854725|FG001|Overall Study|Physician Decision|60|||
129970462|NCT03512197|467854724|FG000|Overall Study|Protocol Violation|0|||
129970463|NCT03512197|467854725|FG001|Overall Study|Protocol Violation|2|||
129970464|NCT03512197|467854724|FG000|Overall Study|Terminated by Sponsored|46|||
129970465|NCT03512197|467854725|FG001|Overall Study|Terminated by Sponsored|50|||
129970466|NCT03512197|467854724|FG000|Overall Study|Subject Decision|15|||
129970467|NCT03512197|467854725|FG001|Overall Study|Subject Decision|12|||
129970468|NCT03512197|467854724|FG000|Overall Study|Withdrawal of informed consent|20|||
129970469|NCT03512197|467854725|FG001|Overall Study|Withdrawal of informed consent|14|||
129970470|NCT03512197|467854724|FG000|Overall Study|Adverse Event|30|||
129970471|NCT03512197|467854725|FG001|Overall Study|Adverse Event|34|||
129970472|NCT03512197|467854724|FG000|Overall Study|Death|14|||
129970473|NCT03512197|467854725|FG001|Overall Study|Death|9|||
129970474|NCT03512197|467854724|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
129970475|NCT03512197|467854725|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
129970476|NCT03512197|467854724|FG000|Overall Study|Missing|3|||
129970477|NCT03512197|467854725|FG001|Overall Study|Missing|13|||
129970478|NCT03842436|467854726|FG000|Overall Study|Lost to Follow-up|1|||
129970479|NCT00490698|467854727|FG000|Overall Study|Withdrawal by Subject|1|||
129970480|NCT00490698|467854727|FG000|Overall Study|Disease Progression|7|||
129970481|NCT00490698|467854727|FG000|Overall Study|Physician Decision|2|||
129970482|NCT03358238|467854733|FG000|Overall Study|Withdrawal by Subject|0|||
129970483|NCT03358238|467854734|FG001|Overall Study|Withdrawal by Subject|1|||
129970484|NCT01431950|467854735|FG000|Overall Study|Study Site Closed/Terminated|7|||
129970485|NCT01431950|467854736|FG001|Overall Study|Study Site Closed/Terminated|3|||
129970486|NCT01431950|467854735|FG000|Overall Study|Withdrawal by Subject|4|||
129970487|NCT01431950|467854736|FG001|Overall Study|Withdrawal by Subject|3|||
129970488|NCT01431950|467854735|FG000|Overall Study|Protocol Violation|2|||
129970489|NCT01431950|467854736|FG001|Overall Study|Protocol Violation|3|||
129970490|NCT01431950|467854735|FG000|Overall Study|Adverse Event|2|||
129970491|NCT01431950|467854736|FG001|Overall Study|Adverse Event|2|||
129970492|NCT01431950|467854735|FG000|Overall Study|Physician Decision|2|||
129970493|NCT01431950|467854736|FG001|Overall Study|Physician Decision|1|||
129970494|NCT01431950|467854735|FG000|Overall Study|Lack of Efficacy|2|||
129970495|NCT01431950|467854736|FG001|Overall Study|Lack of Efficacy|1|||
129970496|NCT01431950|467854735|FG000|Overall Study|Lost to Follow-up|0|||
129970497|NCT01431950|467854736|FG001|Overall Study|Lost to Follow-up|1|||
129970498|NCT01431950|467854735|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129461201|NCT01425008|465983973|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
129461202|NCT01425008|465983974|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
129970499|NCT01431950|467854736|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129970500|NCT01439867|467856524|FG000|Overall Study|Non-compliance|0|||
129970501|NCT01439867|467856525|FG001|Overall Study|Non-compliance|1|||
129970502|NCT01439867|467856524|FG000|Overall Study|Withdrawal by Subject|1|||
129970503|NCT01439867|467856525|FG001|Overall Study|Withdrawal by Subject|2|||
129970504|NCT01439867|467856524|FG000|Overall Study|Administrative Decision|4|||
129970505|NCT01439867|467856525|FG001|Overall Study|Administrative Decision|5|||
129970506|NCT01439867|467856524|FG000|Overall Study|Protocol-specified Criteria|1|||
129970507|NCT01439867|467856525|FG001|Overall Study|Protocol-specified Criteria|0|||
129970508|NCT00863512|467856526|FG000|Overall Study|Adverse Event|2|||
129970509|NCT00863512|467856527|FG001|Overall Study|Adverse Event|0|||
129970510|NCT00863512|467856526|FG000|Overall Study|Withdrawal by Subject|11|||
129970511|NCT00863512|467856527|FG001|Overall Study|Withdrawal by Subject|0|||
129970512|NCT00863512|467856526|FG000|Overall Study|Physician Decision|1|||
129970513|NCT00863512|467856527|FG001|Overall Study|Physician Decision|0|||
129970514|NCT02037477|467856528|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
129970515|NCT02037477|467856529|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
129970516|NCT02037477|467856530|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
129970517|NCT02037477|467856531|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
129970518|NCT02635360|467856532|FG000|Overall Study|Adverse Event|0|||
129970519|NCT02635360|467856533|FG001|Overall Study|Adverse Event|3|||
129970520|NCT02635360|467856532|FG000|Overall Study|Withdrawal by Subject|2|||
129970521|NCT02635360|467856533|FG001|Overall Study|Withdrawal by Subject|0|||
129970522|NCT02635360|467856532|FG000|Overall Study|Non-Compliance|3|||
129970523|NCT02635360|467856533|FG001|Overall Study|Non-Compliance|1|||
129970524|NCT02635360|467856532|FG000|Overall Study|Disease Progression|0|||
129970525|NCT02635360|467856533|FG001|Overall Study|Disease Progression|2|||
129970526|NCT02635360|467856532|FG000|Overall Study|Lost to Follow-up|1|||
129970527|NCT02635360|467856533|FG001|Overall Study|Lost to Follow-up|1|||
129970528|NCT04978350|467856534|FG000|Overall Study|Lost to Follow-up|6|||
129970529|NCT00983749|467856537|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
129970530|NCT00983749|467856538|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
129970531|NCT01952847|467856539|FG000|Overall Study|Ineligible|1|||
129970532|NCT01952847|467856540|FG001|Overall Study|Ineligible|0|||
129970533|NCT01952847|467856541|FG002|Overall Study|Ineligible|0|||
129970534|NCT01952847|467856542|FG003|Overall Study|Ineligible|0|||
129970535|NCT01952847|467856539|FG000|Overall Study|Lack of Insurance Coverage|0|||
129970536|NCT01952847|467856540|FG001|Overall Study|Lack of Insurance Coverage|1|||
129970537|NCT01952847|467856541|FG002|Overall Study|Lack of Insurance Coverage|0|||
129461203|NCT01425008|465983975|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
129970538|NCT01952847|467856542|FG003|Overall Study|Lack of Insurance Coverage|0|||
129461204|NCT01425008|465983976|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
129461205|NCT01425008|465983977|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
129461206|NCT01425008|465983978|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
129970539|NCT01952847|467856539|FG000|Overall Study|Withdrawal by Subject|1|||
129461207|NCT01425008|465983979|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
129461208|NCT01425008|465983980|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
129461209|NCT01425008|465983981|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
129461210|NCT01425008|465983982|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
129970540|NCT01952847|467856540|FG001|Overall Study|Withdrawal by Subject|1|||
129970541|NCT01952847|467856541|FG002|Overall Study|Withdrawal by Subject|0|||
129970542|NCT01952847|467856542|FG003|Overall Study|Withdrawal by Subject|1|||
129970543|NCT02577003|467856545|FG000|Overall Study|Adverse Event|2|||
129970544|NCT02577003|467856546|FG001|Overall Study|Adverse Event|4|||
129970545|NCT02577003|467856545|FG000|Overall Study|Withdrawal by Subject|0|||
129970546|NCT02577003|467856546|FG001|Overall Study|Withdrawal by Subject|1|||
129970547|NCT03334253|467856548|FG000|Overall Study|Withdrawal by Subject|1|||
129970548|NCT03334253|467856549|FG001|Overall Study|Withdrawal by Subject|0|||
129970549|NCT03334253|467856548|FG000|Overall Study|Lost to Follow-up|4|||
129970550|NCT03334253|467856549|FG001|Overall Study|Lost to Follow-up|3|||
129970551|NCT03334253|467856548|FG000|Overall Study|Moved residence|2|||
129970552|NCT03334253|467856549|FG001|Overall Study|Moved residence|2|||
129461211|NCT01425008|465983983|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
129970553|NCT00203047|467856550|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
129970554|NCT00203047|467856551|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
129970555|NCT00203047|467856550|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
129970556|NCT00203047|467856551|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
129970557|NCT00203047|467856550|FG000|Overall Study|Withdrawal by Subject|13|||
129970558|NCT00203047|467856551|FG001|Overall Study|Withdrawal by Subject|47|||
129970559|NCT00203047|467856550|FG000|Overall Study|Teva requested participant withdrawal|1|||
129970560|NCT00203047|467856551|FG001|Overall Study|Teva requested participant withdrawal|1|||
129970561|NCT00203047|467856550|FG000|Overall Study|Physician Decision|8|||
129970562|NCT00203047|467856551|FG001|Overall Study|Physician Decision|7|||
129970563|NCT00203047|467856550|FG000|Overall Study|Non-compliance|4|||
129970564|NCT00203047|467856551|FG001|Overall Study|Non-compliance|8|||
129970565|NCT00203047|467856550|FG000|Overall Study|Protocol Violation|1|||
129970566|NCT00203047|467856551|FG001|Overall Study|Protocol Violation|0|||
129970567|NCT00203047|467856550|FG000|Overall Study|Lost to Follow-up|11|||
129970568|NCT00203047|467856551|FG001|Overall Study|Lost to Follow-up|5|||
129970569|NCT00203047|467856550|FG000|Overall Study|Adverse Event|8|||
129970570|NCT00203047|467856551|FG001|Overall Study|Adverse Event|18|||
129970571|NCT00203047|467856550|FG000|Overall Study|Death|1|||
129970572|NCT00203047|467856551|FG001|Overall Study|Death|2|||
129970573|NCT00203047|467856550|FG000|Overall Study|Pregnancy|3|||
129970574|NCT00203047|467856551|FG001|Overall Study|Pregnancy|0|||
129970575|NCT00203047|467856550|FG000|Overall Study|Other|5|||
129970576|NCT00203047|467856551|FG001|Overall Study|Other|5|||
129970577|NCT00340704|467856552|FG000|PK Study|Adverse Event|0|||
129970578|NCT00340704|467856553|FG001|PK Study|Adverse Event|1|||
129970579|NCT00340704|467856554|FG002|PK Study|Adverse Event|0|||
129970580|NCT00340704|467856555|FG003|PK Study|Adverse Event|0|||
129970581|NCT00340704|467856556|FG004|PK Study|Adverse Event|0|||
129970582|NCT00340704|467856557|FG005|PK Study|Adverse Event|0|||
129970583|NCT00340704|467856558|FG006|PK Study|Adverse Event|0|||
129970584|NCT00340704|467856559|FG007|PK Study|Adverse Event|0|||
129970585|NCT00340704|467856560|FG008|PK Study|Adverse Event|0|||
129970586|NCT00340704|467856552|FG000|PK Study|Not treated|0|||
129970587|NCT00340704|467856553|FG001|PK Study|Not treated|0|||
129970588|NCT00340704|467856554|FG002|PK Study|Not treated|1|||
129970589|NCT00340704|467856555|FG003|PK Study|Not treated|0|||
129970590|NCT00340704|467856556|FG004|PK Study|Not treated|0|||
129970591|NCT00340704|467856557|FG005|PK Study|Not treated|0|||
129970592|NCT00340704|467856558|FG006|PK Study|Not treated|0|||
129970593|NCT00340704|467856559|FG007|PK Study|Not treated|0|||
129970594|NCT00340704|467856560|FG008|PK Study|Not treated|0|||
129970595|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970596|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970597|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970598|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
129970599|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
129970600|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970601|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
129970602|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
129970603|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
129970604|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970605|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970606|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970607|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970608|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970609|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
129970610|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970611|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970612|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
129970613|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970614|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970615|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970616|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970617|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
129970618|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
129970619|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970620|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970621|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
129970622|NCT00340704|467856552|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970623|NCT00340704|467856553|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970624|NCT00340704|467856554|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970625|NCT00340704|467856555|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970626|NCT00340704|467856556|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
129970627|NCT00340704|467856557|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
129970628|NCT00340704|467856558|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
129970629|NCT00340704|467856559|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
129970630|NCT00340704|467856560|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
129970631|NCT00121667|467856561|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
129970632|NCT00121667|467856562|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
129970633|NCT00121667|467856563|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
129970634|NCT00121667|467856564|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
129970635|NCT00121667|467856561|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
129970636|NCT00121667|467856562|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
129970637|NCT00121667|467856563|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
129970638|NCT00121667|467856564|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
129970639|NCT00121667|467856561|FG000|Short Term (ST) Period|Adverse Event|5|||
129970640|NCT00121667|467856562|FG001|Short Term (ST) Period|Adverse Event|6|||
129970641|NCT00121667|467856563|FG002|Short Term (ST) Period|Adverse Event|5|||
129970642|NCT00121667|467856564|FG003|Short Term (ST) Period|Adverse Event|3|||
129970643|NCT00121667|467856561|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
129970644|NCT00121667|467856562|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
129970645|NCT00121667|467856563|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
129970646|NCT00121667|467856564|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
129970647|NCT00121667|467856561|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
129970648|NCT00121667|467856562|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
129970649|NCT00121667|467856563|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
129970650|NCT00121667|467856564|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
129970651|NCT00121667|467856561|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
129970652|NCT00121667|467856562|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
129970653|NCT00121667|467856563|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
129970654|NCT00121667|467856564|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
129970655|NCT00121667|467856561|FG000|Short Term (ST) Period|Other Reason|3|||
129970656|NCT00121667|467856562|FG001|Short Term (ST) Period|Other Reason|0|||
129970657|NCT00121667|467856563|FG002|Short Term (ST) Period|Other Reason|0|||
129970658|NCT00121667|467856564|FG003|Short Term (ST) Period|Other Reason|0|||
129970659|NCT00121667|467856561|FG000|Short Term (ST) Period|Death|0|||
129970660|NCT00121667|467856562|FG001|Short Term (ST) Period|Death|0|||
129970661|NCT00121667|467856563|FG002|Short Term (ST) Period|Death|0|||
129970662|NCT00121667|467856564|FG003|Short Term (ST) Period|Death|1|||
129970663|NCT00121667|467856561|FG000|Short Term (ST) Period|Pregnancy|0|||
129970664|NCT00121667|467856562|FG001|Short Term (ST) Period|Pregnancy|0|||
129970665|NCT00121667|467856563|FG002|Short Term (ST) Period|Pregnancy|0|||
129970666|NCT00121667|467856564|FG003|Short Term (ST) Period|Pregnancy|1|||
129970667|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
129970668|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
129970669|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
129970670|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
129970671|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
129970672|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
129970673|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
129970674|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
129970675|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
129461212|NCT01425008|465983984|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
129461213|NCT01425008|465983985|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
129461214|NCT01425008|465983967|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461215|NCT01425008|465983968|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461216|NCT01425008|465983969|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461217|NCT01425008|465983970|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461218|NCT01425008|465983971|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461219|NCT01425008|465983972|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461220|NCT01425008|465983973|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461221|NCT01425008|465983974|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461222|NCT01425008|465983975|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129970676|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
129461223|NCT01425008|465983976|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461224|NCT01425008|465983977|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461225|NCT01425008|465983978|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461226|NCT01425008|465983979|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461227|NCT01425008|465983980|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461228|NCT01425008|465983981|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461229|NCT01425008|465983982|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461230|NCT01425008|465983983|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461231|NCT01425008|465983984|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129461232|NCT01425008|465983985|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
129461233|NCT00805480|465983988|FG000|Overall Study|Withdrawal by Subject|13|||
129461234|NCT00805480|465983989|FG001|Overall Study|Withdrawal by Subject|5|||
129461235|NCT00805480|465983990|FG002|Overall Study|Withdrawal by Subject|11|||
129461236|NCT00805480|465983991|FG003|Overall Study|Withdrawal by Subject|5|||
129461237|NCT00805480|465983988|FG000|Overall Study|Lost to Follow-up|1|||
129461238|NCT00805480|465983989|FG001|Overall Study|Lost to Follow-up|2|||
129461239|NCT00805480|465983990|FG002|Overall Study|Lost to Follow-up|0|||
129461240|NCT00805480|465983991|FG003|Overall Study|Lost to Follow-up|0|||
129461241|NCT00805480|465983988|FG000|Overall Study|Adverse Event|0|||
129461242|NCT00805480|465983989|FG001|Overall Study|Adverse Event|0|||
129461243|NCT00805480|465983990|FG002|Overall Study|Adverse Event|1|||
129461244|NCT00805480|465983991|FG003|Overall Study|Adverse Event|0|||
129461245|NCT00562588|465983992|FG000|Overall Study|Adverse Event|40|||
129461246|NCT00562588|465983993|FG001|Overall Study|Adverse Event|58|||
129461247|NCT00562588|465983992|FG000|Overall Study|Protocol Violation|30|||
129461248|NCT00562588|465983993|FG001|Overall Study|Protocol Violation|26|||
129461249|NCT00562588|465983992|FG000|Overall Study|Lost to Follow-up|12|||
129461250|NCT00562588|465983993|FG001|Overall Study|Lost to Follow-up|4|||
129461251|NCT00562588|465983992|FG000|Overall Study|Withdrawal by Subject|10|||
129461252|NCT00562588|465983993|FG001|Overall Study|Withdrawal by Subject|9|||
129461253|NCT00562588|465983992|FG000|Overall Study|Other|0|||
129461254|NCT00562588|465983993|FG001|Overall Study|Other|2|||
129461255|NCT03315871|465983997|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
129461256|NCT03315871|465983998|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
129461257|NCT03315871|465983999|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
129461258|NCT03315871|465983997|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
129461259|NCT03315871|465983998|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
129461260|NCT03315871|465983999|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
129461261|NCT03315871|465983997|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
129461262|NCT03315871|465983998|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
129461263|NCT03315871|465983999|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
129461264|NCT03315871|465983997|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
129461265|NCT03315871|465983998|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
129461266|NCT03315871|465983999|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
129461267|NCT03315871|465983997|FG000|PROSTVAC + CV301|Progressive disease|0|||
129461268|NCT03315871|465983998|FG001|PROSTVAC + CV301|Progressive disease|0|||
129461269|NCT03315871|465983999|FG002|PROSTVAC + CV301|Progressive disease|1|||
129461270|NCT03315871|465983997|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
129461271|NCT03315871|465983998|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
129461272|NCT03315871|465983999|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
129461273|NCT00880893|465985745|FG000|Overall Study|Protocol Violation|13|||
129461274|NCT00880893|465985746|FG001|Overall Study|Protocol Violation|1|||
129461275|NCT00880893|465985745|FG000|Overall Study|Withdrawal by Subject|15|||
129461276|NCT00880893|465985746|FG001|Overall Study|Withdrawal by Subject|11|||
129461277|NCT00880893|465985745|FG000|Overall Study|Lost to Follow-up|76|||
129461278|NCT00880893|465985746|FG001|Overall Study|Lost to Follow-up|33|||
129461279|NCT00880893|465985745|FG000|Overall Study|Serious adverse event|3|||
129461280|NCT00880893|465985746|FG001|Overall Study|Serious adverse event|0|||
129461281|NCT01623271|465985751|FG000|Overall Study|Withdrawal by Subject|2|||
129461282|NCT03548558|465985756|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
129461283|NCT03548558|465985757|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
129461284|NCT03548558|465985758|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
129461285|NCT03548558|465985759|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
129461286|NCT03548558|465985760|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
129461287|NCT03548558|465985761|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
129461288|NCT03548558|465985762|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
129461289|NCT03548558|465985756|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
129461290|NCT03548558|465985757|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
129461291|NCT03548558|465985758|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
129461292|NCT03548558|465985759|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
129461293|NCT03548558|465985760|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
129461294|NCT03548558|465985761|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
129461295|NCT03548558|465985762|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
129461296|NCT03548558|465985756|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
129970677|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
129970678|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
129461297|NCT03548558|465985757|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
129461298|NCT03548558|465985758|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
129461299|NCT03548558|465985759|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
129970679|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
129970680|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
129970681|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
129970682|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
129970683|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
129970684|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
129970685|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
129970686|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
129970687|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
129970688|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
129970689|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
129970690|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
129970691|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
129970692|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
129970693|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
129970694|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
129970695|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
129970696|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
129970697|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
129970698|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
129970699|NCT00121667|467856561|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
129970700|NCT00121667|467856562|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
129970701|NCT00121667|467856563|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
129970702|NCT00121667|467856564|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
129970703|NCT01453023|467856565|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
129970704|NCT01453023|467856566|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
129970705|NCT01453023|467856565|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
129970706|NCT01453023|467856566|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
129970707|NCT01453023|467856565|FG000|Treatment Period 2|Protocol Violation|0|||
129970708|NCT01453023|467856566|FG001|Treatment Period 2|Protocol Violation|1|||
129970709|NCT02413593|467856582|FG000|Overall Study|Lost to Follow-up|3|||
129970710|NCT02413593|467856582|FG000|Overall Study|Adverse Event|1|||
129970711|NCT01807182|467856583|FG000|Overall Study|Death|1|||
129970712|NCT01807182|467856583|FG000|Overall Study|New therapy|1|||
129970713|NCT01807182|467856583|FG000|Overall Study|Moved to hospice care|1|||
129970714|NCT03513068|467856585|FG000|Overall Study|Death|1|||
129970715|NCT03513068|467856586|FG001|Overall Study|Death|0|||
129970716|NCT03513068|467856585|FG000|Overall Study|Withdrawal by Subject|4|||
129970717|NCT03513068|467856586|FG001|Overall Study|Withdrawal by Subject|6|||
129970718|NCT01791413|467856587|FG000|Overall Study|Lost to Follow-up|5|||
129970719|NCT01791413|467856588|FG001|Overall Study|Lost to Follow-up|1|||
129970720|NCT00250432|467856590|FG000|Overall Study|Adverse Event|25|||
129461300|NCT03548558|465985760|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
129461301|NCT03548558|465985761|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
129461302|NCT03548558|465985762|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
129461303|NCT03548558|465985756|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
129461304|NCT03548558|465985757|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
129461305|NCT03548558|465985758|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
129461306|NCT03548558|465985759|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
129461307|NCT03548558|465985760|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
129461308|NCT03548558|465985761|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
129461309|NCT03548558|465985762|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
129461310|NCT03548558|465985756|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
129461311|NCT03548558|465985757|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
129461312|NCT03548558|465985758|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
129461313|NCT03548558|465985759|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
129461314|NCT03548558|465985760|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
129461315|NCT03548558|465985761|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
129461316|NCT03548558|465985762|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
129461317|NCT03548558|465985756|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
129461318|NCT03548558|465985757|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
129461319|NCT03548558|465985758|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
129461320|NCT03548558|465985759|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
129461321|NCT03548558|465985760|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
129461322|NCT03548558|465985761|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
129461323|NCT03548558|465985762|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
129461324|NCT01289015|465985765|FG000|Overall Study|Protocol Violation|12|||
129461325|NCT01289015|465985766|FG001|Overall Study|Protocol Violation|9|||
129461326|NCT01289015|465985765|FG000|Overall Study|Adverse Event|3|||
129461327|NCT01289015|465985766|FG001|Overall Study|Adverse Event|0|||
129461328|NCT01289015|465985765|FG000|Overall Study|Lost to Follow-up|33|||
129461329|NCT01289015|465985766|FG001|Overall Study|Lost to Follow-up|17|||
129461330|NCT01289015|465985765|FG000|Overall Study|Withdrawal by Subject|17|||
129461331|NCT01289015|465985766|FG001|Overall Study|Withdrawal by Subject|8|||
129461332|NCT01289015|465985765|FG000|Overall Study|Disease progression|1|||
129461333|NCT01289015|465985766|FG001|Overall Study|Disease progression|0|||
129461334|NCT01289015|465985765|FG000|Overall Study|Negative baseline culture and others|33|||
129461335|NCT01289015|465985766|FG001|Overall Study|Negative baseline culture and others|20|||
129461336|NCT03509350|465985775|FG000|Overall Study|Withdrawal by Subject|0|||
129461337|NCT03509350|465985776|FG001|Overall Study|Withdrawal by Subject|2|||
129461338|NCT01425203|465985779|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
129461339|NCT01425203|465985780|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
129461340|NCT01425203|465985781|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
129461341|NCT01425203|465985779|FG000|Treatment Phase|Failure at futility timepoint|8|||
129461342|NCT01425203|465985780|FG001|Treatment Phase|Failure at futility timepoint|27|||
129461343|NCT01425203|465985781|FG002|Treatment Phase|Failure at futility timepoint|0|||
129461344|NCT01425203|465985779|FG000|Treatment Phase|Other virologic failure criteria|5|||
129461345|NCT01425203|465985780|FG001|Treatment Phase|Other virologic failure criteria|3|||
129461346|NCT01425203|465985781|FG002|Treatment Phase|Other virologic failure criteria|0|||
129461347|NCT01425203|465985779|FG000|Treatment Phase|Unidentified reasons|11|||
129461348|NCT01425203|465985780|FG001|Treatment Phase|Unidentified reasons|5|||
129461349|NCT01425203|465985781|FG002|Treatment Phase|Unidentified reasons|0|||
129461350|NCT01425203|465985779|FG000|Treatment Phase|Did not receive treatment|0|||
129461351|NCT01425203|465985780|FG001|Treatment Phase|Did not receive treatment|1|||
129461352|NCT01425203|465985781|FG002|Treatment Phase|Did not receive treatment|0|||
129461353|NCT01425203|465985779|FG000|Crossover Phase|Failure at futility timepoint|0|||
129461354|NCT01425203|465985780|FG001|Crossover Phase|Failure at futility timepoint|0|||
129461355|NCT01425203|465985781|FG002|Crossover Phase|Failure at futility timepoint|3|||
129461356|NCT01425203|465985779|FG000|Crossover Phase|Other virologic failure criteria|0|||
129461357|NCT01425203|465985780|FG001|Crossover Phase|Other virologic failure criteria|0|||
129461358|NCT01425203|465985781|FG002|Crossover Phase|Other virologic failure criteria|3|||
129461359|NCT00535132|465985782|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
129461360|NCT00535132|465985783|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
129461361|NCT00535132|465985782|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
129461362|NCT00535132|465985783|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
129461363|NCT02590588|465985784|FG000|Overall Study|Adverse Event|1|||
129461364|NCT01780831|465985787|FG000|Overall Study|Withdrawal by Subject|0|||
129461365|NCT01780831|465985788|FG001|Overall Study|Withdrawal by Subject|0|||
129461366|NCT01780831|465985789|FG002|Overall Study|Withdrawal by Subject|4|||
129461367|NCT01780831|465985790|FG003|Overall Study|Withdrawal by Subject|0|||
129461368|NCT01780831|465985787|FG000|Overall Study|Lost to Follow-up|0|||
129461369|NCT01780831|465985788|FG001|Overall Study|Lost to Follow-up|0|||
129461370|NCT01780831|465985789|FG002|Overall Study|Lost to Follow-up|0|||
129461371|NCT01780831|465985790|FG003|Overall Study|Lost to Follow-up|1|||
129461372|NCT00267748|465985794|FG000|Non-randomized Period|Progressive disease|10|||
129461373|NCT00267748|465985795|FG001|Non-randomized Period|Progressive disease|0|||
129461374|NCT00267748|465985796|FG002|Non-randomized Period|Progressive disease|0|||
129461375|NCT00267748|465985794|FG000|Non-randomized Period|Adverse Event|8|||
129461376|NCT00267748|465985795|FG001|Non-randomized Period|Adverse Event|0|||
129461377|NCT00267748|465985796|FG002|Non-randomized Period|Adverse Event|0|||
129461378|NCT00267748|465985794|FG000|Non-randomized Period|Death|1|||
129461379|NCT00267748|465985795|FG001|Non-randomized Period|Death|0|||
129461380|NCT00267748|465985796|FG002|Non-randomized Period|Death|0|||
129461381|NCT00267748|465985794|FG000|Non-randomized Period|Participant not willing to participate|1|||
129461382|NCT00267748|465985795|FG001|Non-randomized Period|Participant not willing to participate|0|||
129461383|NCT00267748|465985796|FG002|Non-randomized Period|Participant not willing to participate|0|||
129461384|NCT00267748|465985794|FG000|Non-randomized Period|Other|3|||
129461385|NCT00267748|465985795|FG001|Non-randomized Period|Other|0|||
129461386|NCT00267748|465985796|FG002|Non-randomized Period|Other|0|||
129461387|NCT00267748|465985794|FG000|Randomized Period|Death|0|||
129461388|NCT00267748|465985795|FG001|Randomized Period|Death|2|||
129461389|NCT00267748|465985796|FG002|Randomized Period|Death|3|||
129461390|NCT00267748|465985794|FG000|Randomized Period|Adverse Event|0|||
129461391|NCT00267748|465985795|FG001|Randomized Period|Adverse Event|23|||
129461392|NCT00267748|465985796|FG002|Randomized Period|Adverse Event|25|||
129461393|NCT00267748|465985794|FG000|Randomized Period|Global deterioration of health status|0|||
129461394|NCT00267748|465985795|FG001|Randomized Period|Global deterioration of health status|6|||
129461395|NCT00267748|465985796|FG002|Randomized Period|Global deterioration of health status|7|||
129461396|NCT00267748|465985794|FG000|Randomized Period|Lost to Follow-up|0|||
129461397|NCT00267748|465985795|FG001|Randomized Period|Lost to Follow-up|1|||
129461398|NCT00267748|465985796|FG002|Randomized Period|Lost to Follow-up|0|||
129461399|NCT00267748|465985794|FG000|Randomized Period|Objective progression or relapse|0|||
129461400|NCT00267748|465985795|FG001|Randomized Period|Objective progression or relapse|77|||
129461401|NCT00267748|465985796|FG002|Randomized Period|Objective progression or relapse|86|||
129461402|NCT00267748|465985794|FG000|Randomized Period|Withdrawal by Subject|0|||
129461403|NCT00267748|465985795|FG001|Randomized Period|Withdrawal by Subject|9|||
129461404|NCT00267748|465985796|FG002|Randomized Period|Withdrawal by Subject|2|||
129461405|NCT00267748|465985794|FG000|Randomized Period|Other|0|||
129461406|NCT00267748|465985795|FG001|Randomized Period|Other|9|||
129461407|NCT00267748|465985796|FG002|Randomized Period|Other|6|||
129461408|NCT00267748|465985794|FG000|Randomized Period|randomized but not treated|0|||
129461409|NCT00267748|465985795|FG001|Randomized Period|randomized but not treated|0|||
129461410|NCT00267748|465985796|FG002|Randomized Period|randomized but not treated|3|||
129461411|NCT01294800|465985797|FG000|Overall Study|Adverse Event|7|||
129461412|NCT01294800|465985798|FG001|Overall Study|Adverse Event|6|||
129461413|NCT01294800|465985799|FG002|Overall Study|Adverse Event|12|||
129461414|NCT01294800|465985800|FG003|Overall Study|Adverse Event|5|||
129461415|NCT01294800|465985797|FG000|Overall Study|Subject Withdrew Consent|2|||
129461416|NCT01294800|465985798|FG001|Overall Study|Subject Withdrew Consent|2|||
129461417|NCT01294800|465985799|FG002|Overall Study|Subject Withdrew Consent|2|||
129461418|NCT01294800|465985800|FG003|Overall Study|Subject Withdrew Consent|11|||
129461419|NCT01294800|465985797|FG000|Overall Study|Lost to Follow-up|0|||
129461420|NCT01294800|465985798|FG001|Overall Study|Lost to Follow-up|0|||
129461421|NCT01294800|465985799|FG002|Overall Study|Lost to Follow-up|1|||
129461422|NCT01294800|465985800|FG003|Overall Study|Lost to Follow-up|0|||
129461423|NCT01294800|465985797|FG000|Overall Study|Non-compliance With Protocol|0|||
129461424|NCT01294800|465985798|FG001|Overall Study|Non-compliance With Protocol|1|||
129461425|NCT01294800|465985799|FG002|Overall Study|Non-compliance With Protocol|1|||
129461426|NCT01294800|465985800|FG003|Overall Study|Non-compliance With Protocol|0|||
129461427|NCT01294800|465985797|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
129461428|NCT01294800|465985798|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
129461429|NCT01294800|465985799|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
129461430|NCT01294800|465985800|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
129461431|NCT01827670|465985804|FG000|Overall Study|Withdrawal of Consent|3|||
129461432|NCT01827670|465985805|FG001|Overall Study|Withdrawal of Consent|2|||
129461433|NCT01827670|465985804|FG000|Overall Study|Lost to Follow-up|0|||
129461434|NCT01827670|465985805|FG001|Overall Study|Lost to Follow-up|1|||
129461435|NCT02941627|465985806|FG000|Overall Study|Death|1|||
129461436|NCT02941627|465985806|FG000|Overall Study|Surgical failure|1|||
129461437|NCT02941627|465985806|FG000|Overall Study|cholesteatoma prevented implantation|1|||
129461438|NCT03594227|465985807|FG000|Overall Study|Adverse Event|2|||
129461439|NCT03594227|465985808|FG001|Overall Study|Adverse Event|1|||
129461440|NCT03594227|465985809|FG002|Overall Study|Adverse Event|0|||
129461441|NCT03594227|465985810|FG003|Overall Study|Adverse Event|2|||
129461442|NCT03594227|465985807|FG000|Overall Study|Lost to Follow-up|1|||
129461443|NCT03594227|465985808|FG001|Overall Study|Lost to Follow-up|1|||
129461444|NCT03594227|465985809|FG002|Overall Study|Lost to Follow-up|1|||
129461445|NCT03594227|465985810|FG003|Overall Study|Lost to Follow-up|0|||
129461446|NCT03594227|465985807|FG000|Overall Study|Withdrawal by Subject|1|||
129461447|NCT03594227|465985808|FG001|Overall Study|Withdrawal by Subject|1|||
129461448|NCT03594227|465985809|FG002|Overall Study|Withdrawal by Subject|1|||
129461449|NCT03594227|465985810|FG003|Overall Study|Withdrawal by Subject|1|||
129461450|NCT03594227|465985807|FG000|Overall Study|Pregnancy|0|||
129461451|NCT03594227|465985808|FG001|Overall Study|Pregnancy|1|||
129461452|NCT03594227|465985809|FG002|Overall Study|Pregnancy|0|||
129461453|NCT03594227|465985810|FG003|Overall Study|Pregnancy|0|||
129461454|NCT03594227|465985807|FG000|Overall Study|Sponsor Decision|0|||
129461455|NCT03594227|465985808|FG001|Overall Study|Sponsor Decision|0|||
129461456|NCT03594227|465985809|FG002|Overall Study|Sponsor Decision|0|||
129461457|NCT03594227|465985810|FG003|Overall Study|Sponsor Decision|1|||
129461458|NCT03594227|465985807|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
129461459|NCT03594227|465985808|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
129461460|NCT03594227|465985809|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
129461461|NCT03594227|465985810|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
129461462|NCT02199080|465985817|FG000|Overall Study|Protocol Violation|12|||
129461463|NCT01097863|465985820|FG000|Overall Study|Discomfort|1|||
129461464|NCT01097863|465985821|FG001|Overall Study|Discomfort|0|||
129461465|NCT01097863|465985822|FG002|Overall Study|Discomfort|1|||
129461466|NCT01097863|465985820|FG000|Overall Study|Did not return for final visit|0|||
129461467|NCT01097863|465985821|FG001|Overall Study|Did not return for final visit|0|||
129461468|NCT01097863|465985822|FG002|Overall Study|Did not return for final visit|1|||
129461469|NCT00574275|465985823|FG000|Overall Study|Randomized but not treated|2|||
129461470|NCT00574275|465985824|FG001|Overall Study|Randomized but not treated|3|||
129461471|NCT00574275|465985823|FG000|Overall Study|Adverse Event|32|||
129461472|NCT00574275|465985824|FG001|Overall Study|Adverse Event|76|||
129461473|NCT00574275|465985823|FG000|Overall Study|Disease progression|160|||
129461474|NCT00574275|465985824|FG001|Overall Study|Disease progression|146|||
129461475|NCT00574275|465985823|FG000|Overall Study|Lost to Follow-up|2|||
129461476|NCT00574275|465985824|FG001|Overall Study|Lost to Follow-up|1|||
129461477|NCT00574275|465985823|FG000|Overall Study|Study stopped based on DMC decision|62|||
129461478|NCT00574275|465985824|FG001|Overall Study|Study stopped based on DMC decision|23|||
129461479|NCT00574275|465985823|FG000|Overall Study|Withdrawal by Subject|15|||
129461480|NCT00574275|465985824|FG001|Overall Study|Withdrawal by Subject|17|||
129461481|NCT00574275|465985823|FG000|Overall Study|Error calculating tumor measurement|1|||
129461482|NCT00574275|465985824|FG001|Overall Study|Error calculating tumor measurement|0|||
129461483|NCT00574275|465985823|FG000|Overall Study|Physician Decision|1|||
129461484|NCT00574275|465985824|FG001|Overall Study|Physician Decision|1|||
129461485|NCT00574275|465985823|FG000|Overall Study|Protocol Violation|0|||
129461486|NCT00574275|465985824|FG001|Overall Study|Protocol Violation|1|||
129461487|NCT00574275|465985823|FG000|Overall Study|Patient and Investigator decision|0|||
129461488|NCT00574275|465985824|FG001|Overall Study|Patient and Investigator decision|1|||
129461489|NCT00574275|465985823|FG000|Overall Study|Insurance change|0|||
129461490|NCT00574275|465985824|FG001|Overall Study|Insurance change|1|||
129461491|NCT00574275|465985823|FG000|Overall Study|Operation for curative intent|0|||
129461492|NCT00574275|465985824|FG001|Overall Study|Operation for curative intent|1|||
129461493|NCT02703311|465985826|FG000|Overall Study|Death|5|||
129461494|NCT02703311|465985826|FG000|Overall Study|Withdrawal by Subject|3|||
129461495|NCT00960843|465985827|FG000|Overall Study|Lost to Follow-up|2|||
129461496|NCT00960843|465985828|FG001|Overall Study|Lost to Follow-up|0|||
129461497|NCT00960843|465985827|FG000|Overall Study|Protocol Violation|0|||
129461498|NCT00960843|465985828|FG001|Overall Study|Protocol Violation|4|||
129461499|NCT00960843|465985827|FG000|Overall Study|Repeated needle dislodgment|0|||
129461500|NCT00960843|465985828|FG001|Overall Study|Repeated needle dislodgment|1|||
129461501|NCT00652366|465985829|FG000|Overall Study|Adverse Event|8|||
129461502|NCT00652366|465985830|FG001|Overall Study|Adverse Event|4|||
129461503|NCT00652366|465985831|FG002|Overall Study|Adverse Event|7|||
129461504|NCT00652366|465985832|FG003|Overall Study|Adverse Event|17|||
129461505|NCT00652366|465985833|FG004|Overall Study|Adverse Event|13|||
129461506|NCT00652366|465985829|FG000|Overall Study|Death|5|||
129461507|NCT00652366|465985830|FG001|Overall Study|Death|4|||
129461508|NCT00652366|465985831|FG002|Overall Study|Death|1|||
129461509|NCT00652366|465985832|FG003|Overall Study|Death|8|||
129461510|NCT00652366|465985833|FG004|Overall Study|Death|5|||
129461511|NCT00652366|465985829|FG000|Overall Study|Lack of Efficacy|84|||
129461512|NCT00652366|465985830|FG001|Overall Study|Lack of Efficacy|58|||
129461513|NCT00652366|465985831|FG002|Overall Study|Lack of Efficacy|53|||
129461514|NCT00652366|465985832|FG003|Overall Study|Lack of Efficacy|133|||
129461515|NCT00652366|465985833|FG004|Overall Study|Lack of Efficacy|13|||
129461516|NCT00652366|465985829|FG000|Overall Study|Violation of Selection Criteria|0|||
129461517|NCT00652366|465985830|FG001|Overall Study|Violation of Selection Criteria|0|||
129461518|NCT00652366|465985831|FG002|Overall Study|Violation of Selection Criteria|1|||
129461519|NCT00652366|465985832|FG003|Overall Study|Violation of Selection Criteria|0|||
129461520|NCT00652366|465985833|FG004|Overall Study|Violation of Selection Criteria|0|||
129461521|NCT00652366|465985829|FG000|Overall Study|Protocol Violation|1|||
129461522|NCT00652366|465985830|FG001|Overall Study|Protocol Violation|0|||
129461523|NCT00652366|465985831|FG002|Overall Study|Protocol Violation|0|||
129461524|NCT00652366|465985832|FG003|Overall Study|Protocol Violation|0|||
129461525|NCT00652366|465985833|FG004|Overall Study|Protocol Violation|0|||
129461526|NCT00652366|465985829|FG000|Overall Study|Refused treatment|3|||
129461527|NCT00652366|465985830|FG001|Overall Study|Refused treatment|7|||
129461528|NCT00652366|465985831|FG002|Overall Study|Refused treatment|6|||
129461529|NCT00652366|465985832|FG003|Overall Study|Refused treatment|17|||
129461530|NCT00652366|465985833|FG004|Overall Study|Refused treatment|5|||
129461531|NCT00652366|465985829|FG000|Overall Study|Other|5|||
129461532|NCT00652366|465985830|FG001|Overall Study|Other|2|||
129461533|NCT00652366|465985831|FG002|Overall Study|Other|3|||
129461534|NCT00652366|465985832|FG003|Overall Study|Other|4|||
129461535|NCT00652366|465985833|FG004|Overall Study|Other|0|||
129461536|NCT02069899|465985838|FG000|Overall Study|Adverse Event|6|||
129461537|NCT02069899|465985839|FG001|Overall Study|Adverse Event|0|||
129461538|NCT02069899|465985840|FG002|Overall Study|Adverse Event|1|||
129461539|NCT02069899|465985838|FG000|Overall Study|Withdrawal by Participant|2|||
129461540|NCT02069899|465985839|FG001|Overall Study|Withdrawal by Participant|0|||
129461541|NCT02069899|465985840|FG002|Overall Study|Withdrawal by Participant|0|||
129461542|NCT02069899|465985838|FG000|Overall Study|Lost to Follow-up|1|||
129461543|NCT02069899|465985839|FG001|Overall Study|Lost to Follow-up|0|||
129461544|NCT02069899|465985840|FG002|Overall Study|Lost to Follow-up|1|||
129461545|NCT02069899|465985838|FG000|Overall Study|Other|4|||
129461546|NCT02069899|465985839|FG001|Overall Study|Other|0|||
129461547|NCT02069899|465985840|FG002|Overall Study|Other|0|||
129461548|NCT02069899|465985838|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
129461549|NCT02069899|465985839|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
129461550|NCT02069899|465985840|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
129461551|NCT02069899|465985838|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
129461552|NCT02069899|465985839|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
129461553|NCT02069899|465985840|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
129461554|NCT00490451|465985843|FG000|Overall Study|Adverse Event|3|||
129461555|NCT00490451|465985844|FG001|Overall Study|Adverse Event|3|||
129461556|NCT00490451|465985843|FG000|Overall Study|Death|3|||
129461557|NCT00490451|465985844|FG001|Overall Study|Death|1|||
129461558|NCT00490451|465985843|FG000|Overall Study|Withdrawal by Subject|2|||
129461559|NCT00490451|465985844|FG001|Overall Study|Withdrawal by Subject|0|||
129461560|NCT00490451|465985843|FG000|Overall Study|Investigator Decision|1|||
129461561|NCT00490451|465985844|FG001|Overall Study|Investigator Decision|0|||
129461562|NCT00490451|465985843|FG000|Overall Study|Protocol Violation|1|||
129461563|NCT00490451|465985844|FG001|Overall Study|Protocol Violation|0|||
129461564|NCT00490451|465985843|FG000|Overall Study|Progressive Disease|53|||
129461565|NCT00490451|465985844|FG001|Overall Study|Progressive Disease|34|||
129461566|NCT01181011|465985845|FG000|Overall Study|Adverse Event|2|||
129461567|NCT01181011|465985845|FG000|Overall Study|Lost to Follow-up|1|||
129461568|NCT00137111|465985846|FG000|Total Therapy|Death|35|||
129461569|NCT00137111|465985847|FG001|Total Therapy|Death|0|||
129461570|NCT00137111|465985848|FG002|Total Therapy|Death|0|||
129461571|NCT00137111|465985849|FG003|Total Therapy|Death|0|||
129461572|NCT00137111|465985846|FG000|Total Therapy|Non Compliance|5|||
129461573|NCT00137111|465985847|FG001|Total Therapy|Non Compliance|0|||
129461574|NCT00137111|465985848|FG002|Total Therapy|Non Compliance|0|||
129461575|NCT00137111|465985849|FG003|Total Therapy|Non Compliance|0|||
129461576|NCT04703075|465985850|FG000|Overall Study|Adverse Event|11|||
129461577|NCT04703075|465985851|FG001|Overall Study|Adverse Event|7|||
129461578|NCT04703075|465985850|FG000|Overall Study|Lost to Follow-up|6|||
129461579|NCT04703075|465985851|FG001|Overall Study|Lost to Follow-up|12|||
129461580|NCT04703075|465985850|FG000|Overall Study|Physician Decision|3|||
129461581|NCT04703075|465985851|FG001|Overall Study|Physician Decision|0|||
129461582|NCT04703075|465985850|FG000|Overall Study|Moved|0|||
129461583|NCT04703075|465985851|FG001|Overall Study|Moved|2|||
129461584|NCT04703075|465985850|FG000|Overall Study|Index INH Resistant|0|||
129461585|NCT04703075|465985851|FG001|Overall Study|Index INH Resistant|1|||
129461586|NCT04703075|465985850|FG000|Overall Study|Lack of Efficacy|6|||
129461587|NCT04703075|465985851|FG001|Overall Study|Lack of Efficacy|18|||
129461588|NCT01967550|465985852|FG000|Overall Study|Withdrawal by Subject|1|||
129461589|NCT01967550|465985853|FG001|Overall Study|Withdrawal by Subject|0|||
129461590|NCT01967550|465985852|FG000|Overall Study|Adverse Event|2|||
129461591|NCT01967550|465985853|FG001|Overall Study|Adverse Event|0|||
129461592|NCT01967550|465985852|FG000|Overall Study|Protocol Violation|2|||
129461593|NCT01967550|465985853|FG001|Overall Study|Protocol Violation|1|||
129461594|NCT01967550|465985852|FG000|Overall Study|Non Compliance|0|||
129461595|NCT01967550|465985853|FG001|Overall Study|Non Compliance|1|||
129461596|NCT02425826|465985858|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
129461597|NCT02425826|465985859|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
129461598|NCT02425826|465985860|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
129461599|NCT02425826|465985858|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
129461600|NCT02425826|465985859|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
129461601|NCT02425826|465985860|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
129461602|NCT02425826|465985858|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
129461603|NCT02425826|465985859|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
129970721|NCT00250432|467856591|FG001|Overall Study|Adverse Event|29|||
129461604|NCT02425826|465985860|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
129461605|NCT02425826|465985858|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
129461606|NCT02425826|465985859|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
129461607|NCT02425826|465985860|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
129461608|NCT02425826|465985858|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
129461609|NCT02425826|465985859|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
129461610|NCT02425826|465985860|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
129461611|NCT02425826|465985858|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
129461612|NCT02425826|465985859|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
129461613|NCT02425826|465985860|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
129461614|NCT02425826|465985858|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
129461615|NCT02425826|465985859|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
129461616|NCT02425826|465985860|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
129461617|NCT02425826|465985858|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
129461618|NCT02425826|465985859|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
129461619|NCT02425826|465985860|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
129461620|NCT02425826|465985858|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
129461621|NCT02425826|465985859|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
129461622|NCT02425826|465985860|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
129461623|NCT02425826|465985858|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
129461624|NCT02425826|465985859|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
129461625|NCT02425826|465985860|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
129461626|NCT02500121|465985864|FG000|Overall Study|Lost to Follow-up|0|||
129461627|NCT02500121|465985865|FG001|Overall Study|Lost to Follow-up|1|||
129461628|NCT02500121|465985864|FG000|Overall Study|Withdrawal by Subject|1|||
129461629|NCT02500121|465985865|FG001|Overall Study|Withdrawal by Subject|1|||
129461630|NCT02500121|465985864|FG000|Overall Study|Death|26|||
129461631|NCT02500121|465985865|FG001|Overall Study|Death|24|||
129461632|NCT00852995|465985866|FG000|Overall Study|Adverse Event|1|||
129461633|NCT00852995|465985867|FG001|Overall Study|Adverse Event|0|||
129461634|NCT00852995|465985868|FG002|Overall Study|Adverse Event|4|||
129970722|NCT00250432|467856590|FG000|Overall Study|Lack of Efficacy|2|||
129970723|NCT00250432|467856591|FG001|Overall Study|Lack of Efficacy|1|||
129970724|NCT00250432|467856590|FG000|Overall Study|Lost to Follow-up|6|||
129970725|NCT00250432|467856591|FG001|Overall Study|Lost to Follow-up|5|||
129970726|NCT00250432|467856590|FG000|Overall Study|Patient Moved|0|||
129970727|NCT00250432|467856591|FG001|Overall Study|Patient Moved|1|||
129970728|NCT00250432|467856590|FG000|Overall Study|Protocol Violation|0|||
129970729|NCT00250432|467856591|FG001|Overall Study|Protocol Violation|3|||
129970730|NCT00250432|467856590|FG000|Overall Study|Withdrawal by Subject|6|||
129970731|NCT00250432|467856591|FG001|Overall Study|Withdrawal by Subject|2|||
129970732|NCT00250432|467856590|FG000|Overall Study|Pt died out of posttherapy report period|6|||
129970733|NCT00250432|467856591|FG001|Overall Study|Pt died out of posttherapy report period|5|||
129970734|NCT00250432|467856590|FG000|Overall Study|Pt was considered untreatable|0|||
129970735|NCT00250432|467856591|FG001|Overall Study|Pt was considered untreatable|1|||
129970736|NCT00658606|467856592|FG000|Overall Study|Adverse Event|2|||
129970737|NCT00658606|467856593|FG001|Overall Study|Adverse Event|1|||
129970738|NCT00658606|467856592|FG000|Overall Study|Lack of Efficacy|6|||
129970739|NCT00658606|467856593|FG001|Overall Study|Lack of Efficacy|3|||
129970740|NCT00658606|467856592|FG000|Overall Study|Lost to Follow-up|1|||
129970741|NCT00658606|467856593|FG001|Overall Study|Lost to Follow-up|0|||
129970742|NCT00658606|467856592|FG000|Overall Study|Withdrawal by Subject|7|||
129970743|NCT00658606|467856593|FG001|Overall Study|Withdrawal by Subject|16|||
129970744|NCT00658606|467856592|FG000|Overall Study|Lack of Compliance|0|||
129970745|NCT00658606|467856593|FG001|Overall Study|Lack of Compliance|3|||
129970746|NCT00583947|467856594|FG000|Cross-over Period|Adverse Event|2|||
129970747|NCT00583947|467856595|FG001|Cross-over Period|Adverse Event|0|||
129970748|NCT00583947|467856594|FG000|Cross-over Period|Withdrawal by Subject|2|||
129970749|NCT00583947|467856595|FG001|Cross-over Period|Withdrawal by Subject|0|||
129970750|NCT00583947|467856594|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
129970751|NCT00583947|467856595|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
129970752|NCT00583947|467856594|FG000|Cross-over Period|Other|1|||
129461635|NCT00852995|465985869|FG003|Overall Study|Adverse Event|0|||
129461636|NCT00852995|465985870|FG004|Overall Study|Adverse Event|0|||
129970753|NCT00583947|467856595|FG001|Cross-over Period|Other|1|||
129970754|NCT02559310|467856597|FG000|Overall Study|Death|4|||
129970755|NCT02559310|467856598|FG001|Overall Study|Death|3|||
129970756|NCT02559310|467856597|FG000|Overall Study|Lost to Follow-up|5|||
129461637|NCT00852995|465985866|FG000|Overall Study|Lost to Follow-up|0|||
129970757|NCT02559310|467856598|FG001|Overall Study|Lost to Follow-up|3|||
129970758|NCT02559310|467856597|FG000|Overall Study|Physician Decision|2|||
129970759|NCT02559310|467856598|FG001|Overall Study|Physician Decision|1|||
129970760|NCT02559310|467856597|FG000|Overall Study|Withdrawal by Subject|13|||
129970761|NCT02559310|467856598|FG001|Overall Study|Withdrawal by Subject|9|||
129461638|NCT00852995|465985867|FG001|Overall Study|Lost to Follow-up|1|||
129461639|NCT00852995|465985868|FG002|Overall Study|Lost to Follow-up|1|||
129461640|NCT00852995|465985869|FG003|Overall Study|Lost to Follow-up|0|||
129461641|NCT00852995|465985870|FG004|Overall Study|Lost to Follow-up|0|||
129461642|NCT00852995|465985866|FG000|Overall Study|Withdrawal by Subject|4|||
129461643|NCT00852995|465985867|FG001|Overall Study|Withdrawal by Subject|0|||
129461644|NCT00852995|465985868|FG002|Overall Study|Withdrawal by Subject|0|||
129461645|NCT00852995|465985869|FG003|Overall Study|Withdrawal by Subject|1|||
129461646|NCT00852995|465985870|FG004|Overall Study|Withdrawal by Subject|2|||
129461647|NCT00852995|465985866|FG000|Overall Study|Non-Compliance|0|||
129461648|NCT00852995|465985867|FG001|Overall Study|Non-Compliance|0|||
129461649|NCT00852995|465985868|FG002|Overall Study|Non-Compliance|0|||
129461650|NCT00852995|465985869|FG003|Overall Study|Non-Compliance|2|||
129461651|NCT00852995|465985870|FG004|Overall Study|Non-Compliance|0|||
129461652|NCT00852995|465985866|FG000|Overall Study|Progressive Disease|1|||
129461653|NCT00852995|465985867|FG001|Overall Study|Progressive Disease|0|||
129461654|NCT00852995|465985868|FG002|Overall Study|Progressive Disease|0|||
129461655|NCT00852995|465985869|FG003|Overall Study|Progressive Disease|2|||
129461656|NCT00852995|465985870|FG004|Overall Study|Progressive Disease|1|||
129461657|NCT00852995|465985866|FG000|Overall Study|Physician Decision|1|||
129461658|NCT00852995|465985867|FG001|Overall Study|Physician Decision|0|||
129461659|NCT00852995|465985868|FG002|Overall Study|Physician Decision|0|||
129461660|NCT00852995|465985869|FG003|Overall Study|Physician Decision|0|||
129970762|NCT02559310|467856597|FG000|Overall Study|Sponsor Decision|0|||
129970763|NCT02559310|467856598|FG001|Overall Study|Sponsor Decision|1|||
129461661|NCT00852995|465985870|FG004|Overall Study|Physician Decision|0|||
129461662|NCT00852995|465985866|FG000|Overall Study|Protocol Violation|0|||
129461663|NCT00852995|465985867|FG001|Overall Study|Protocol Violation|0|||
129461664|NCT00852995|465985868|FG002|Overall Study|Protocol Violation|0|||
129461665|NCT00852995|465985869|FG003|Overall Study|Protocol Violation|0|||
129461666|NCT00852995|465985870|FG004|Overall Study|Protocol Violation|1|||
129461667|NCT00852995|465985866|FG000|Overall Study|Moved Out of Area|1|||
129461668|NCT00852995|465985867|FG001|Overall Study|Moved Out of Area|0|||
129461669|NCT00852995|465985868|FG002|Overall Study|Moved Out of Area|0|||
129461670|NCT00852995|465985869|FG003|Overall Study|Moved Out of Area|0|||
129461671|NCT00852995|465985870|FG004|Overall Study|Moved Out of Area|0|||
129461672|NCT01836783|465985872|FG000|Overall Study|Withdrawal by Subject|0|||
129461673|NCT01836783|465985873|FG001|Overall Study|Withdrawal by Subject|2|||
129461674|NCT04518462|465985875|FG000|Overall Study|Withdrawal by Subject|0|||
129461675|NCT04518462|465985876|FG001|Overall Study|Withdrawal by Subject|0|||
129461676|NCT04518462|465985877|FG002|Overall Study|Withdrawal by Subject|1|||
129461677|NCT04518462|465985875|FG000|Overall Study|Physician Decision|1|||
129461678|NCT04518462|465985876|FG001|Overall Study|Physician Decision|1|||
129461679|NCT04518462|465985877|FG002|Overall Study|Physician Decision|0|||
129461680|NCT04418076|465985881|FG000|Overall Study|Death|1|||
129461681|NCT04418076|465985882|FG001|Overall Study|Death|0|||
129461682|NCT04418076|465985883|FG002|Overall Study|Death|0|||
129461683|NCT04418076|465985884|FG003|Overall Study|Death|0|||
129461684|NCT04418076|465985881|FG000|Overall Study|Lost to Follow-up|2|||
129461685|NCT04418076|465985882|FG001|Overall Study|Lost to Follow-up|5|||
129461686|NCT04418076|465985883|FG002|Overall Study|Lost to Follow-up|1|||
129461687|NCT04418076|465985884|FG003|Overall Study|Lost to Follow-up|2|||
129461688|NCT04418076|465985881|FG000|Overall Study|Withdrawal by Subject|1|||
129461689|NCT04418076|465985882|FG001|Overall Study|Withdrawal by Subject|0|||
129970764|NCT02559310|467856597|FG000|Overall Study|Randomized but not treated|3|||
129970765|NCT02559310|467856598|FG001|Overall Study|Randomized but not treated|2|||
129461690|NCT04418076|465985883|FG002|Overall Study|Withdrawal by Subject|1|||
129461691|NCT04418076|465985884|FG003|Overall Study|Withdrawal by Subject|1|||
129461692|NCT04418076|465985881|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
129461693|NCT04418076|465985882|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
129461694|NCT04418076|465985883|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
129461695|NCT04418076|465985884|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
129461696|NCT01471782|465985885|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
129461697|NCT01471782|465985886|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
129461698|NCT01471782|465985887|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
129461699|NCT01471782|465985888|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
129461700|NCT01471782|465985889|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
129461701|NCT01471782|465985890|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
129461702|NCT01471782|465985885|FG000|Overall Study|Lack of Efficacy|1|||
129461703|NCT01471782|465985886|FG001|Overall Study|Lack of Efficacy|2|||
129461704|NCT01471782|465985887|FG002|Overall Study|Lack of Efficacy|1|||
129461705|NCT01471782|465985888|FG003|Overall Study|Lack of Efficacy|1|||
129461706|NCT01471782|465985889|FG004|Overall Study|Lack of Efficacy|5|||
129461707|NCT01471782|465985890|FG005|Overall Study|Lack of Efficacy|18|||
129461708|NCT01471782|465985885|FG000|Overall Study|Adverse Event|1|||
129461709|NCT01471782|465985886|FG001|Overall Study|Adverse Event|1|||
129461710|NCT01471782|465985887|FG002|Overall Study|Adverse Event|2|||
129461711|NCT01471782|465985888|FG003|Overall Study|Adverse Event|2|||
129461712|NCT01471782|465985889|FG004|Overall Study|Adverse Event|3|||
129461713|NCT01471782|465985890|FG005|Overall Study|Adverse Event|1|||
129461714|NCT01471782|465985885|FG000|Overall Study|Other|0|||
129461715|NCT01471782|465985886|FG001|Overall Study|Other|0|||
129461716|NCT01471782|465985887|FG002|Overall Study|Other|1|||
129461717|NCT01471782|465985888|FG003|Overall Study|Other|1|||
129461718|NCT01471782|465985889|FG004|Overall Study|Other|6|||
129461719|NCT01471782|465985890|FG005|Overall Study|Other|5|||
129461720|NCT01471782|465985885|FG000|Overall Study|Change of Chemotherapy|1|||
129461721|NCT01471782|465985886|FG001|Overall Study|Change of Chemotherapy|1|||
129461722|NCT01471782|465985887|FG002|Overall Study|Change of Chemotherapy|0|||
129461723|NCT01471782|465985888|FG003|Overall Study|Change of Chemotherapy|0|||
129461724|NCT01471782|465985889|FG004|Overall Study|Change of Chemotherapy|1|||
129461725|NCT01471782|465985890|FG005|Overall Study|Change of Chemotherapy|4|||
129461726|NCT01471782|465985885|FG000|Overall Study|Disease Relapse|0|||
129461727|NCT01471782|465985886|FG001|Overall Study|Disease Relapse|0|||
129461728|NCT01471782|465985887|FG002|Overall Study|Disease Relapse|0|||
129461729|NCT01471782|465985888|FG003|Overall Study|Disease Relapse|1|||
129461730|NCT01471782|465985889|FG004|Overall Study|Disease Relapse|2|||
129461731|NCT01471782|465985890|FG005|Overall Study|Disease Relapse|1|||
129461732|NCT01471782|465985885|FG000|Overall Study|Physician Decision|0|||
129461733|NCT01471782|465985886|FG001|Overall Study|Physician Decision|0|||
129461734|NCT01471782|465985887|FG002|Overall Study|Physician Decision|0|||
129461735|NCT01471782|465985888|FG003|Overall Study|Physician Decision|0|||
129461736|NCT01471782|465985889|FG004|Overall Study|Physician Decision|3|||
129461737|NCT01471782|465985890|FG005|Overall Study|Physician Decision|8|||
129461738|NCT01471782|465985885|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129461739|NCT01471782|465985886|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129461740|NCT01471782|465985887|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129461741|NCT01471782|465985888|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129461742|NCT01471782|465985889|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
129461743|NCT01471782|465985890|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129461744|NCT01471782|465985885|FG000|Overall Study|Death|0|||
129461745|NCT01471782|465985886|FG001|Overall Study|Death|0|||
129461746|NCT01471782|465985887|FG002|Overall Study|Death|0|||
129461747|NCT01471782|465985888|FG003|Overall Study|Death|0|||
129461748|NCT01471782|465985889|FG004|Overall Study|Death|0|||
129461749|NCT01471782|465985890|FG005|Overall Study|Death|1|||
129461750|NCT01314716|465985891|FG000|Double-Blind Phase|Randomized but not treated|1|||
129461751|NCT01314716|465985892|FG001|Double-Blind Phase|Randomized but not treated|1|||
129461752|NCT01314716|465985891|FG000|Double-Blind Phase|Adverse Event|10|||
129461753|NCT01314716|465985892|FG001|Double-Blind Phase|Adverse Event|4|||
129461754|NCT01314716|465985891|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
129461755|NCT01314716|465985892|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
129461756|NCT01314716|465985891|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129461757|NCT01314716|465985892|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129461758|NCT01314716|465985891|FG000|Double-Blind Phase|Sponsor request|1|||
129461759|NCT01314716|465985892|FG001|Double-Blind Phase|Sponsor request|2|||
129461760|NCT01314716|465985891|FG000|Double-Blind Phase|Physician Decision|0|||
129461761|NCT01314716|465985892|FG001|Double-Blind Phase|Physician Decision|1|||
129461762|NCT01314716|465985891|FG000|Open-Label Phase|Adverse Event|4|||
129461763|NCT01314716|465985892|FG001|Open-Label Phase|Adverse Event|6|||
129461764|NCT01314716|465985891|FG000|Open-Label Phase|Withdrawal by Subject|1|||
129461765|NCT01314716|465985892|FG001|Open-Label Phase|Withdrawal by Subject|2|||
129461766|NCT01314716|465985891|FG000|Open-Label Phase|Physician Decision|5|||
129461767|NCT01314716|465985892|FG001|Open-Label Phase|Physician Decision|4|||
129461768|NCT00112905|465987544|FG000|Overall Study|Adverse Event|4|||
129461769|NCT00112905|465987544|FG000|Overall Study|Death|1|||
129461770|NCT00112905|465987544|FG000|Overall Study|Ineligibility|5|||
129461771|NCT00112905|465987544|FG000|Overall Study|Alternative treatment|1|||
129461772|NCT00112905|465987544|FG000|Overall Study|performance status was deteiorating|1|||
129461773|NCT02600507|465987545|FG000|Overall Study|Adverse Event|3|||
129461774|NCT02600507|465987546|FG001|Overall Study|Adverse Event|15|||
129461775|NCT02600507|465987547|FG002|Overall Study|Adverse Event|5|||
129461776|NCT02600507|465987545|FG000|Overall Study|Lack of Efficacy|3|||
129461777|NCT02600507|465987546|FG001|Overall Study|Lack of Efficacy|8|||
129461778|NCT02600507|465987547|FG002|Overall Study|Lack of Efficacy|5|||
129461779|NCT02600507|465987545|FG000|Overall Study|Lost to Follow-up|3|||
129461780|NCT02600507|465987546|FG001|Overall Study|Lost to Follow-up|5|||
129461781|NCT02600507|465987547|FG002|Overall Study|Lost to Follow-up|2|||
129461782|NCT02600507|465987545|FG000|Overall Study|Protocol Violation|12|||
129461783|NCT02600507|465987546|FG001|Overall Study|Protocol Violation|4|||
129461784|NCT02600507|465987547|FG002|Overall Study|Protocol Violation|4|||
129461785|NCT02600507|465987545|FG000|Overall Study|Physician Decision|1|||
129461786|NCT02600507|465987546|FG001|Overall Study|Physician Decision|0|||
129461787|NCT02600507|465987547|FG002|Overall Study|Physician Decision|1|||
129461788|NCT02600507|465987545|FG000|Overall Study|Withdrawal by Subject|7|||
129461789|NCT02600507|465987546|FG001|Overall Study|Withdrawal by Subject|11|||
129970766|NCT01740154|467856599|FG000|Overall Study|Adverse Event|1|||
129970767|NCT00469859|467856600|FG000|Overall Study|Inevaluable|0|||
129970768|NCT00469859|467856601|FG001|Overall Study|Inevaluable|2|||
129461790|NCT02600507|465987547|FG002|Overall Study|Withdrawal by Subject|7|||
129461791|NCT02600507|465987545|FG000|Overall Study|Other|0|||
129461792|NCT02600507|465987546|FG001|Overall Study|Other|1|||
129461793|NCT02600507|465987547|FG002|Overall Study|Other|1|||
129461794|NCT00621504|465987553|FG000|Overall Study|Adverse Event|1|||
129461795|NCT00621504|465987554|FG001|Overall Study|Adverse Event|3|||
129461796|NCT00621504|465987553|FG000|Overall Study|At the request of sponsor/investigator|1|||
129461797|NCT00621504|465987554|FG001|Overall Study|At the request of sponsor/investigator|0|||
129461798|NCT00621504|465987553|FG000|Overall Study|Withdrew consent|9|||
129461799|NCT00621504|465987554|FG001|Overall Study|Withdrew consent|6|||
129461800|NCT00621504|465987553|FG000|Overall Study|Lost to Follow-up|8|||
129461801|NCT00621504|465987554|FG001|Overall Study|Lost to Follow-up|10|||
129461802|NCT00621504|465987553|FG000|Overall Study|Other|1|||
129461803|NCT00621504|465987554|FG001|Overall Study|Other|0|||
129461804|NCT00621504|465987553|FG000|Overall Study|Death|6|||
129461805|NCT00621504|465987554|FG001|Overall Study|Death|6|||
129461806|NCT00605085|465987555|FG000|Overall Study|Withdrawal by Subject|8|||
129461807|NCT00605085|465987556|FG001|Overall Study|Withdrawal by Subject|5|||
129461808|NCT00605085|465987555|FG000|Overall Study|Adverse Event|9|||
129461809|NCT00605085|465987556|FG001|Overall Study|Adverse Event|5|||
129461810|NCT00605085|465987555|FG000|Overall Study|Pregnancy|2|||
129461811|NCT00605085|465987556|FG001|Overall Study|Pregnancy|0|||
129461812|NCT00605085|465987555|FG000|Overall Study|Protocol Violation|3|||
129461813|NCT00605085|465987556|FG001|Overall Study|Protocol Violation|2|||
129461814|NCT00605085|465987555|FG000|Overall Study|Lost to Follow-up|10|||
129461815|NCT00605085|465987556|FG001|Overall Study|Lost to Follow-up|5|||
129461816|NCT00605085|465987555|FG000|Overall Study|administrative reasons|18|||
129461817|NCT00605085|465987556|FG001|Overall Study|administrative reasons|8|||
129461818|NCT03257267|465987561|FG000|Overall Study|Adverse Event|17|||
129461819|NCT03257267|465987562|FG001|Overall Study|Adverse Event|7|||
129461820|NCT03257267|465987561|FG000|Overall Study|Death|96|||
129461821|NCT03257267|465987562|FG001|Overall Study|Death|98|||
129461822|NCT03257267|465987561|FG000|Overall Study|Lost to Follow-up|2|||
129461823|NCT03257267|465987562|FG001|Overall Study|Lost to Follow-up|2|||
129461824|NCT03257267|465987561|FG000|Overall Study|Non-compliance with Study Drug|0|||
129461825|NCT03257267|465987562|FG001|Overall Study|Non-compliance with Study Drug|2|||
129461826|NCT03257267|465987561|FG000|Overall Study|Participant Decision|35|||
129461827|NCT03257267|465987562|FG001|Overall Study|Participant Decision|43|||
129461828|NCT03257267|465987561|FG000|Overall Study|Sponsor Decision|1|||
129461829|NCT03257267|465987562|FG001|Overall Study|Sponsor Decision|0|||
129461830|NCT03257267|465987561|FG000|Overall Study|Physician Decision|1|||
129461831|NCT03257267|465987562|FG001|Overall Study|Physician Decision|3|||
129461832|NCT03257267|465987561|FG000|Overall Study|Disease Progression|109|||
129461833|NCT03257267|465987562|FG001|Overall Study|Disease Progression|121|||
129461834|NCT03257267|465987561|FG000|Overall Study|Withdrawal by Subject|8|||
129461835|NCT03257267|465987562|FG001|Overall Study|Withdrawal by Subject|26|||
129461836|NCT03257267|465987561|FG000|Overall Study|Other|0|||
129461837|NCT03257267|465987562|FG001|Overall Study|Other|2|||
129461838|NCT01979523|465987563|FG000|Overall Study|Withdrawal by Subject|1|||
129461839|NCT01979523|465987564|FG001|Overall Study|Withdrawal by Subject|0|||
129461840|NCT00706134|465987565|FG000|Overall Study|Adverse Event|8|||
129461841|NCT00706134|465987566|FG001|Overall Study|Adverse Event|7|||
129461842|NCT00706134|465987567|FG002|Overall Study|Adverse Event|2|||
129461843|NCT00706134|465987568|FG003|Overall Study|Adverse Event|3|||
129461844|NCT00706134|465987565|FG000|Overall Study|Lost to Follow-up|0|||
129461845|NCT00706134|465987566|FG001|Overall Study|Lost to Follow-up|1|||
129970769|NCT05226130|467856602|FG000|Overall Study|Lost to Follow-up|0|||
129970770|NCT05226130|467856603|FG001|Overall Study|Lost to Follow-up|1|||
129970771|NCT05226130|467856602|FG000|Overall Study|Not treatment adherent|0|||
129461846|NCT00706134|465987567|FG002|Overall Study|Lost to Follow-up|0|||
129461847|NCT00706134|465987568|FG003|Overall Study|Lost to Follow-up|0|||
129461848|NCT00706134|465987565|FG000|Overall Study|Protocol Violation|0|||
129461849|NCT00706134|465987566|FG001|Overall Study|Protocol Violation|6|||
129461850|NCT00706134|465987567|FG002|Overall Study|Protocol Violation|0|||
129461851|NCT00706134|465987568|FG003|Overall Study|Protocol Violation|3|||
129461852|NCT00706134|465987565|FG000|Overall Study|Withdrawal by Subject|1|||
129461853|NCT00706134|465987566|FG001|Overall Study|Withdrawal by Subject|2|||
129461854|NCT00706134|465987567|FG002|Overall Study|Withdrawal by Subject|1|||
129461855|NCT00706134|465987568|FG003|Overall Study|Withdrawal by Subject|0|||
129461856|NCT00706134|465987565|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
129461857|NCT00706134|465987566|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129461858|NCT00706134|465987567|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
129461859|NCT00706134|465987568|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
129461860|NCT00706134|465987565|FG000|Overall Study|Did not meet study criteria|2|||
129461861|NCT00706134|465987566|FG001|Overall Study|Did not meet study criteria|0|||
129461862|NCT00706134|465987567|FG002|Overall Study|Did not meet study criteria|0|||
129461863|NCT00706134|465987568|FG003|Overall Study|Did not meet study criteria|0|||
129461864|NCT01982292|465987569|FG000|Overall Study|Adverse Event|2|||
129461865|NCT01982292|465987570|FG001|Overall Study|Adverse Event|0|||
129461866|NCT01982292|465987569|FG000|Overall Study|Death|1|||
129461867|NCT01982292|465987570|FG001|Overall Study|Death|0|||
129461868|NCT01982292|465987569|FG000|Overall Study|Lost to Follow-up|2|||
129461869|NCT01982292|465987570|FG001|Overall Study|Lost to Follow-up|0|||
129461870|NCT01982292|465987569|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
129461871|NCT01982292|465987570|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
129461872|NCT01982292|465987569|FG000|Overall Study|Protocol Deviation|1|||
129461873|NCT01982292|465987570|FG001|Overall Study|Protocol Deviation|0|||
129461874|NCT01982292|465987569|FG000|Overall Study|Patient/Guardian Decision|3|||
129461875|NCT01982292|465987570|FG001|Overall Study|Patient/Guardian Decision|1|||
129461876|NCT01982292|465987569|FG000|Overall Study|Technical Problems|2|||
129461877|NCT01982292|465987570|FG001|Overall Study|Technical Problems|0|||
129461878|NCT00746252|465987573|FG000|Overall Study|weight gain >7.5 %|1|||
129461879|NCT00746252|465987574|FG001|Overall Study|weight gain >7.5 %|2|||
129461880|NCT00082888|465987575|FG000|Overall Study|Ineligible|1|||
129461881|NCT00082888|465987576|FG001|Overall Study|Ineligible|0|||
129461882|NCT00082888|465987577|FG002|Overall Study|Ineligible|0|||
129461883|NCT01659320|465987579|FG000|Overall Study|Withdrawal by Subject|2|||
129461884|NCT01659320|465987579|FG000|Overall Study|Physician Decision|1|||
129461885|NCT01870401|465987580|FG000|Overall Study|Death|48|||
129461886|NCT01870401|465987581|FG001|Overall Study|Death|24|||
129461887|NCT01870401|465987580|FG000|Overall Study|Withdrawal by Subject|39|||
129461888|NCT01870401|465987581|FG001|Overall Study|Withdrawal by Subject|26|||
129461889|NCT01870401|465987580|FG000|Overall Study|Lost to Follow-up|19|||
129461890|NCT01870401|465987581|FG001|Overall Study|Lost to Follow-up|14|||
129461891|NCT01870401|465987580|FG000|Overall Study|Other|9|||
129461892|NCT01870401|465987581|FG001|Overall Study|Other|7|||
129461893|NCT01870401|465987580|FG000|Overall Study|On-going in the Study|35|||
129461894|NCT01870401|465987581|FG001|Overall Study|On-going in the Study|25|||
129461895|NCT02684981|465987582|FG000|Overall Study|Permanently discontinued the treatment|157|||
129461896|NCT02684981|465987583|FG001|Overall Study|Permanently discontinued the treatment|161|||
129461897|NCT02684981|465987584|FG002|Overall Study|Permanently discontinued the treatment|110|||
129461898|NCT02684981|465987582|FG000|Overall Study|Other|83|||
129461899|NCT02684981|465987583|FG001|Overall Study|Other|49|||
129461900|NCT02684981|465987584|FG002|Overall Study|Other|17|||
129461901|NCT04623242|465987585|FG000|Overall Study|Withdrawal by Subject|7|||
129461902|NCT04623242|465987586|FG001|Overall Study|Withdrawal by Subject|12|||
129461903|NCT04623242|465987587|FG002|Overall Study|Withdrawal by Subject|5|||
129461904|NCT04623242|465987588|FG003|Overall Study|Withdrawal by Subject|7|||
129461905|NCT04623242|465987589|FG004|Overall Study|Withdrawal by Subject|0|||
129461906|NCT04623242|465987585|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
129461907|NCT04623242|465987586|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
129461908|NCT04623242|465987587|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
129461909|NCT04623242|465987588|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
129461910|NCT04623242|465987589|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
129461911|NCT04623242|465987585|FG000|Overall Study|Subject unblinded to mutation status|0|||
129461912|NCT04623242|465987586|FG001|Overall Study|Subject unblinded to mutation status|0|||
129461913|NCT04623242|465987587|FG002|Overall Study|Subject unblinded to mutation status|0|||
129461914|NCT04623242|465987588|FG003|Overall Study|Subject unblinded to mutation status|13|||
129461915|NCT04623242|465987589|FG004|Overall Study|Subject unblinded to mutation status|0|||
129461916|NCT00820898|465987590|FG000|Overall Study|Inelgible - wrong primary site|1|||
129461917|NCT00493870|465987593|FG000|Overall Study|Lost to Follow-up|12|||
129461918|NCT00493870|465987594|FG001|Overall Study|Lost to Follow-up|15|||
129461919|NCT00272038|465987595|FG000|Overall Study|withdrew before they received 2 cycles|7|||
129461920|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
129461921|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
129461922|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
129461923|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
129461924|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
129461925|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
129461926|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
129461927|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
129461928|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
129461929|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
129461930|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
129461931|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
129461932|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
129461933|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
129461934|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
129461935|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
129461936|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
129461937|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
129461938|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
129461939|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
129461940|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
129461941|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
129461942|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
129461943|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
129461944|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
129461945|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
129461946|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
129461947|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
129461948|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
129461949|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
129461950|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
129461951|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
129461952|NCT03605680|465987596|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
129461953|NCT03605680|465987597|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
129461954|NCT03605680|465987598|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
129461955|NCT03605680|465987599|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
129461956|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
129461957|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
129461958|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
129461959|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
129461960|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
129461961|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
129461962|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
129461963|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
129461964|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129461965|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129461966|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129461967|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
129461968|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
129461969|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
129461970|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
129461971|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
129461972|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
129461973|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
129461974|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
129461975|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
129461976|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
129461977|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
129461978|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
129461979|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
129461980|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
129461981|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
129461982|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
129461983|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
129461984|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
129461985|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
129461986|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
129461987|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
129461988|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
129461989|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
129461990|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
129461991|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
129461992|NCT03605680|465987596|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
129461993|NCT03605680|465987597|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
129461994|NCT03605680|465987598|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
129461995|NCT03605680|465987599|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
129461996|NCT02721355|465987600|FG000|Overall Study|Lost to Follow-up|6|||
129461997|NCT02721355|465987601|FG001|Overall Study|Lost to Follow-up|1|||
129461998|NCT01652287|465987602|FG000|Overall Study|Withdrawal by Subject|2|||
129461999|NCT01652287|465987603|FG001|Overall Study|Withdrawal by Subject|0|||
129462000|NCT00527605|465987604|FG000|Overall Study|Adverse Event|3|||
129462001|NCT00527605|465987605|FG001|Overall Study|Adverse Event|0|||
129462002|NCT00527605|465987604|FG000|Overall Study|Withdrawal by Subject|3|||
129462003|NCT00527605|465987605|FG001|Overall Study|Withdrawal by Subject|7|||
129462004|NCT00527605|465987604|FG000|Overall Study|Lost to Follow-up|6|||
129462005|NCT00527605|465987605|FG001|Overall Study|Lost to Follow-up|2|||
129462006|NCT00527605|465987604|FG000|Overall Study|Protocol Violation|1|||
129462007|NCT00527605|465987605|FG001|Overall Study|Protocol Violation|2|||
129462008|NCT00763139|465987606|FG000|Overall Study|Adverse Event|4|||
129462009|NCT00763139|465987607|FG001|Overall Study|Adverse Event|2|||
129462010|NCT00763139|465987606|FG000|Overall Study|Withdrawal by Subject|0|||
129462011|NCT00763139|465987607|FG001|Overall Study|Withdrawal by Subject|1|||
129462012|NCT00763139|465987606|FG000|Overall Study|med change not allowed by protocol|1|||
129462013|NCT00763139|465987607|FG001|Overall Study|med change not allowed by protocol|0|||
129462014|NCT01592760|465987608|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
129462015|NCT01592760|465987609|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
129462016|NCT01592760|465987610|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
129462017|NCT04312009|465987611|FG000|Overall Study|Withdrawal by Subject|2|||
129462018|NCT04312009|465987612|FG001|Overall Study|Withdrawal by Subject|1|||
129462019|NCT00179309|465987621|FG000|Treatment|Toxicity|2|||
129462020|NCT00179309|465987622|FG001|Treatment|Toxicity|3|||
129462021|NCT00179309|465987621|FG000|Treatment|Withdrawal by Subject|1|||
129462022|NCT00179309|465987622|FG001|Treatment|Withdrawal by Subject|2|||
129462023|NCT00179309|465987621|FG000|Treatment|Allergy|1|||
129462024|NCT00179309|465987622|FG001|Treatment|Allergy|0|||
129462025|NCT01678144|465987625|FG000|Stage 1: MAR Classic|Adverse Event|1|||
129462026|NCT01709149|465987629|FG000|Open-label Lead-in Phase|Adverse Event|109|||
129462027|NCT01709149|465987630|FG001|Open-label Lead-in Phase|Adverse Event|0|||
129462028|NCT01709149|465987631|FG002|Open-label Lead-in Phase|Adverse Event|0|||
129462029|NCT01709149|465987629|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
129462030|NCT01709149|465987630|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
129462031|NCT01709149|465987631|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
129462032|NCT01709149|465987629|FG000|Open-label Lead-in Phase|Death|1|||
129462033|NCT01709149|465987630|FG001|Open-label Lead-in Phase|Death|0|||
129462034|NCT01709149|465987631|FG002|Open-label Lead-in Phase|Death|0|||
129462035|NCT01709149|465987629|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
129462036|NCT01709149|465987630|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
129462037|NCT01709149|465987631|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
129462038|NCT01709149|465987629|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
129462039|NCT01709149|465987630|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
129462040|NCT01709149|465987631|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
129462041|NCT01709149|465987629|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
129462042|NCT01709149|465987630|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
129462043|NCT01709149|465987631|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
129462044|NCT01709149|465987629|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
129462045|NCT01709149|465987630|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
129462046|NCT01709149|465987631|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
129462047|NCT01709149|465987629|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
129462048|NCT01709149|465987630|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
129462049|NCT01709149|465987631|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
129462050|NCT01709149|465987629|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
129462051|NCT01709149|465987630|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
129462052|NCT01709149|465987631|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
129462053|NCT01709149|465987629|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129462054|NCT01709149|465987630|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
129462055|NCT01709149|465987631|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
129462056|NCT02797808|465987632|FG000|Overall Study|Withdrawal by Subject|1|||
129462057|NCT02797808|465987633|FG001|Overall Study|Withdrawal by Subject|1|||
129462058|NCT02797808|465987632|FG000|Overall Study|Physician Decision|6|||
129462059|NCT02797808|465987633|FG001|Overall Study|Physician Decision|2|||
129462060|NCT02192827|465987634|FG000|Overall Study|Lost to Follow-up|25|||
129462061|NCT02192827|465987635|FG001|Overall Study|Lost to Follow-up|27|||
129462062|NCT02192827|465987634|FG000|Overall Study|Given additional steroids with admission|13|||
129462063|NCT02192827|465987635|FG001|Overall Study|Given additional steroids with admission|11|||
129462064|NCT05098041|465987638|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
129462065|NCT00797732|465987645|FG000|Overall Study|Withdrawal by Subject|3|||
129462066|NCT00797732|465987646|FG001|Overall Study|Withdrawal by Subject|3|||
129462067|NCT00797732|465987647|FG002|Overall Study|Withdrawal by Subject|0|||
129462068|NCT00797732|465987645|FG000|Overall Study|Lost to Follow-up|1|||
129462069|NCT00797732|465987646|FG001|Overall Study|Lost to Follow-up|0|||
129462070|NCT00797732|465987647|FG002|Overall Study|Lost to Follow-up|0|||
129462071|NCT00797732|465987645|FG000|Overall Study|Death|1|||
129462072|NCT00797732|465987646|FG001|Overall Study|Death|0|||
129462073|NCT00797732|465987647|FG002|Overall Study|Death|0|||
129462074|NCT00797732|465987645|FG000|Overall Study|Not meet inclusion criteria|0|||
129462075|NCT00797732|465987646|FG001|Overall Study|Not meet inclusion criteria|0|||
129462076|NCT00797732|465987647|FG002|Overall Study|Not meet inclusion criteria|7|||
129462077|NCT00797732|465987645|FG000|Overall Study|Excluded due to time constraints|0|||
129462078|NCT00797732|465987646|FG001|Overall Study|Excluded due to time constraints|0|||
129462079|NCT00797732|465987647|FG002|Overall Study|Excluded due to time constraints|24|||
129462080|NCT00797732|465987645|FG000|Overall Study|Refused to Participate|0|||
129462081|NCT00797732|465987646|FG001|Overall Study|Refused to Participate|0|||
129462082|NCT00797732|465987647|FG002|Overall Study|Refused to Participate|123|||
129462083|NCT00401752|465987648|FG000|Overall Study|Adverse Event|2|||
129462084|NCT00401752|465987649|FG001|Overall Study|Adverse Event|5|||
129462085|NCT00401752|465987648|FG000|Overall Study|Withdrawal by Subject|2|||
129462086|NCT00401752|465987649|FG001|Overall Study|Withdrawal by Subject|6|||
129462087|NCT00401752|465987648|FG000|Overall Study|Lost to Follow-up|1|||
129462088|NCT00401752|465987649|FG001|Overall Study|Lost to Follow-up|4|||
129462089|NCT00401752|465987648|FG000|Overall Study|Development of any exclusion criteria|4|||
129462090|NCT00401752|465987649|FG001|Overall Study|Development of any exclusion criteria|2|||
129462091|NCT00401752|465987648|FG000|Overall Study|Physician Decision|1|||
129462092|NCT00401752|465987649|FG001|Overall Study|Physician Decision|1|||
129462093|NCT01895322|465987650|FG000|Overall Study|Adverse Event|1|||
129462094|NCT01895322|465987650|FG000|Overall Study|Withdrawal by Subject|2|||
129462095|NCT01895322|465987650|FG000|Overall Study|Protocol Violation|10|||
129462096|NCT02275338|465987651|FG000|Overall Study|Adverse Event|15|||
129462097|NCT02275338|465987651|FG000|Overall Study|Lack of Efficacy|3|||
129462098|NCT02275338|465987651|FG000|Overall Study|Withdrawal by Subject|4|||
129462099|NCT02275338|465987651|FG000|Overall Study|Disease progression (death)|1|||
129462100|NCT02275338|465987651|FG000|Overall Study|Ineligible to start Phase 2|4|||
129462101|NCT02275338|465987651|FG000|Overall Study|Reason not specified|5|||
129462102|NCT02275338|465987651|FG000|Overall Study|Does not meet entry criteria|1|||
129462103|NCT01857869|465987654|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
129462104|NCT01857869|465987655|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
129462105|NCT01857869|465987656|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
129462106|NCT01857869|465987657|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
129462107|NCT01857869|465987658|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
129462108|NCT01857869|465987659|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
129462109|NCT01857869|465987660|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
129462110|NCT01857869|465987661|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
129462111|NCT01857869|465987662|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
129462112|NCT01857869|465987663|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
129462113|NCT01857869|465987654|FG000|Primary/Challenge Phase|Pregnancy|1|||
129462114|NCT01857869|465987655|FG001|Primary/Challenge Phase|Pregnancy|0|||
129462115|NCT01857869|465987656|FG002|Primary/Challenge Phase|Pregnancy|0|||
129462116|NCT01857869|465987657|FG003|Primary/Challenge Phase|Pregnancy|0|||
129462117|NCT01857869|465987658|FG004|Primary/Challenge Phase|Pregnancy|0|||
129462118|NCT01857869|465987659|FG005|Primary/Challenge Phase|Pregnancy|0|||
129462119|NCT01857869|465987660|FG006|Primary/Challenge Phase|Pregnancy|0|||
129462120|NCT01857869|465987661|FG007|Primary/Challenge Phase|Pregnancy|0|||
129462121|NCT01857869|465987662|FG008|Primary/Challenge Phase|Pregnancy|0|||
129462122|NCT01857869|465987663|FG009|Primary/Challenge Phase|Pregnancy|0|||
129462123|NCT01857869|465987654|FG000|Primary/Challenge Phase|Protocol Violation|1|||
129462124|NCT01857869|465987655|FG001|Primary/Challenge Phase|Protocol Violation|0|||
129462125|NCT01857869|465987656|FG002|Primary/Challenge Phase|Protocol Violation|0|||
129462126|NCT01857869|465987657|FG003|Primary/Challenge Phase|Protocol Violation|0|||
129462127|NCT01857869|465987658|FG004|Primary/Challenge Phase|Protocol Violation|0|||
129462128|NCT01857869|465987659|FG005|Primary/Challenge Phase|Protocol Violation|0|||
129462129|NCT01857869|465987660|FG006|Primary/Challenge Phase|Protocol Violation|0|||
129462130|NCT01857869|465987661|FG007|Primary/Challenge Phase|Protocol Violation|0|||
129462131|NCT01857869|465987662|FG008|Primary/Challenge Phase|Protocol Violation|0|||
129462132|NCT01857869|465987663|FG009|Primary/Challenge Phase|Protocol Violation|0|||
129462133|NCT01857869|465987654|FG000|Primary/Challenge Phase|Other|1|||
129462134|NCT01857869|465987655|FG001|Primary/Challenge Phase|Other|1|||
129462135|NCT01857869|465987656|FG002|Primary/Challenge Phase|Other|0|||
129462136|NCT01857869|465987657|FG003|Primary/Challenge Phase|Other|0|||
129462137|NCT01857869|465987658|FG004|Primary/Challenge Phase|Other|0|||
129970772|NCT05226130|467856603|FG001|Overall Study|Not treatment adherent|2|||
129970773|NCT03358472|467856604|FG000|Overall Study|Death|6|||
129970774|NCT03358472|467856605|FG001|Overall Study|Death|3|||
129462138|NCT01857869|465987659|FG005|Primary/Challenge Phase|Other|0|||
129462139|NCT01857869|465987660|FG006|Primary/Challenge Phase|Other|0|||
129462140|NCT01857869|465987661|FG007|Primary/Challenge Phase|Other|0|||
129462141|NCT01857869|465987662|FG008|Primary/Challenge Phase|Other|0|||
129462142|NCT01857869|465987663|FG009|Primary/Challenge Phase|Other|0|||
129462143|NCT01857869|465987654|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462144|NCT01857869|465987655|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462145|NCT01857869|465987656|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129970775|NCT03358472|467856606|FG002|Overall Study|Death|10|||
129970776|NCT03358472|467856604|FG000|Overall Study|Physician Decision|0|||
129462146|NCT01857869|465987657|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
129462147|NCT01857869|465987658|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462148|NCT01857869|465987659|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462149|NCT01857869|465987660|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462150|NCT01857869|465987661|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462151|NCT01857869|465987662|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462152|NCT01857869|465987663|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
129462153|NCT01857869|465987654|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462154|NCT01857869|465987655|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462155|NCT01857869|465987656|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462156|NCT01857869|465987657|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
129462157|NCT01857869|465987658|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462158|NCT01857869|465987659|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462159|NCT01857869|465987660|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462160|NCT01857869|465987661|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462161|NCT01857869|465987662|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462162|NCT01857869|465987663|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
129462163|NCT04607733|465987669|FG000|Overall Study|Lost to Follow-up|1|||
129462164|NCT04607733|465987670|FG001|Overall Study|Lost to Follow-up|0|||
129462165|NCT04607733|465987671|FG002|Overall Study|Lost to Follow-up|0|||
129462166|NCT04607733|465987672|FG003|Overall Study|Lost to Follow-up|1|||
129462167|NCT04607733|465987673|FG004|Overall Study|Lost to Follow-up|1|||
129462168|NCT04607733|465987674|FG005|Overall Study|Lost to Follow-up|0|||
129462169|NCT04607733|465987669|FG000|Overall Study|Withdrawal by Subject|0|||
129462170|NCT04607733|465987670|FG001|Overall Study|Withdrawal by Subject|0|||
129462171|NCT04607733|465987671|FG002|Overall Study|Withdrawal by Subject|0|||
129462172|NCT04607733|465987672|FG003|Overall Study|Withdrawal by Subject|0|||
129462173|NCT04607733|465987673|FG004|Overall Study|Withdrawal by Subject|1|||
129462174|NCT04607733|465987674|FG005|Overall Study|Withdrawal by Subject|0|||
129462175|NCT03603496|465987709|FG000|Overall Study|Death|19|||
129462176|NCT03603496|465987710|FG001|Overall Study|Death|24|||
129462177|NCT03603496|465987709|FG000|Overall Study|Lost to Follow-up|141|||
129462178|NCT03603496|465987710|FG001|Overall Study|Lost to Follow-up|141|||
129462179|NCT03603496|465987709|FG000|Overall Study|Withdrawal by Subject|26|||
129462180|NCT03603496|465987710|FG001|Overall Study|Withdrawal by Subject|20|||
129462181|NCT00774345|465987711|FG000|Pre-treatment|Other reasons|2|||
129462182|NCT00774345|465987712|FG001|Pre-treatment|Other reasons|0|||
129462183|NCT00774345|465987711|FG000|Treatment|Adverse Event|61|||
129462184|NCT00774345|465987712|FG001|Treatment|Adverse Event|15|||
129462185|NCT00774345|465987711|FG000|Treatment|Progressive Disease without histologic transformation|51|||
129462186|NCT00774345|465987712|FG001|Treatment|Progressive Disease without histologic transformation|111|||
129462187|NCT00774345|465987711|FG000|Treatment|Progressive Disease with histologic transformation|4|||
129462188|NCT00774345|465987712|FG001|Treatment|Progressive Disease with histologic transformation|2|||
129462189|NCT00774345|465987711|FG000|Treatment|Withdrawal by Subject|5|||
129462190|NCT00774345|465987712|FG001|Treatment|Withdrawal by Subject|2|||
129462191|NCT00774345|465987711|FG000|Treatment|Lost to Follow-up|1|||
129462192|NCT00774345|465987712|FG001|Treatment|Lost to Follow-up|1|||
129462193|NCT00774345|465987711|FG000|Treatment|Death|4|||
129462194|NCT00774345|465987712|FG001|Treatment|Death|0|||
129462195|NCT00774345|465987711|FG000|Treatment|Other Reasons|32|||
129462196|NCT00774345|465987712|FG001|Treatment|Other Reasons|26|||
129462197|NCT00835237|465987713|FG000|Overall Study|Lost to Follow-up|4|||
129462198|NCT00835237|465987714|FG001|Overall Study|Lost to Follow-up|0|||
129462199|NCT00835237|465987713|FG000|Overall Study|Withdrawal by Subject|2|||
129462200|NCT00835237|465987714|FG001|Overall Study|Withdrawal by Subject|0|||
129462201|NCT01265550|465987715|FG000|Pre Randomization|Withdrawal by Subject|0|||
129462202|NCT01265550|465987716|FG001|Pre Randomization|Withdrawal by Subject|0|||
129462203|NCT01265550|465987717|FG002|Pre Randomization|Withdrawal by Subject|0|||
129462204|NCT01265550|465987718|FG003|Pre Randomization|Withdrawal by Subject|70|||
129462205|NCT01265550|465987715|FG000|Pre Randomization|Technical Exclusions|0|||
129462206|NCT01265550|465987716|FG001|Pre Randomization|Technical Exclusions|0|||
129462207|NCT01265550|465987717|FG002|Pre Randomization|Technical Exclusions|0|||
129462208|NCT01265550|465987718|FG003|Pre Randomization|Technical Exclusions|54|||
129462209|NCT01265550|465987715|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
129462210|NCT01265550|465987716|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
129462211|NCT01265550|465987717|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
129462212|NCT01265550|465987718|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
129462213|NCT01265550|465987715|FG000|Pre Randomization|Non-GERD organic disorders|0|||
129462214|NCT01265550|465987716|FG001|Pre Randomization|Non-GERD organic disorders|0|||
129462215|NCT01265550|465987717|FG002|Pre Randomization|Non-GERD organic disorders|0|||
129462216|NCT01265550|465987718|FG003|Pre Randomization|Non-GERD organic disorders|23|||
129462217|NCT01265550|465987715|FG000|Pre Randomization|Functional heartburn|0|||
129462218|NCT01265550|465987716|FG001|Pre Randomization|Functional heartburn|0|||
129462219|NCT01265550|465987717|FG002|Pre Randomization|Functional heartburn|0|||
129462220|NCT01265550|465987718|FG003|Pre Randomization|Functional heartburn|99|||
129462221|NCT00623428|465987721|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
129462222|NCT00623428|465987722|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
129462223|NCT00623428|465987721|FG000|Treatment Period|Death|0|||
129462224|NCT00623428|465987722|FG001|Treatment Period|Death|1|||
129462225|NCT00623428|465987721|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
129462226|NCT00623428|465987722|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
129462227|NCT00623428|465987721|FG000|Treatment Period|Insufficient therapeutic response|0|||
129462228|NCT00623428|465987722|FG001|Treatment Period|Insufficient therapeutic response|2|||
129462229|NCT00623428|465987721|FG000|Treatment Period|Other|0|||
129462230|NCT00623428|465987722|FG001|Treatment Period|Other|1|||
129462231|NCT00623428|465987721|FG000|Treatment Period|Withdrawal by Subject|0|||
129462232|NCT00623428|465987722|FG001|Treatment Period|Withdrawal by Subject|1|||
129462233|NCT00623428|465987721|FG000|Follow-up Period|Relapse post-treatment|11|||
129462234|NCT00623428|465987722|FG001|Follow-up Period|Relapse post-treatment|3|||
129462235|NCT00623428|465987721|FG000|Follow-up Period|Failure to return|10|||
129462236|NCT00623428|465987722|FG001|Follow-up Period|Failure to return|2|||
129462237|NCT00623428|465987721|FG000|Follow-up Period|Patient withdrew consent|5|||
129462238|NCT00623428|465987722|FG001|Follow-up Period|Patient withdrew consent|4|||
129462239|NCT00623428|465987721|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
129462240|NCT00623428|465987722|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
129462241|NCT00623428|465987721|FG000|Follow-up Period|Did not cooperate|0|||
129462242|NCT00623428|465987722|FG001|Follow-up Period|Did not cooperate|3|||
129462243|NCT00623428|465987721|FG000|Follow-up Period|Reason not specified|1|||
129462244|NCT00623428|465987722|FG001|Follow-up Period|Reason not specified|1|||
129462245|NCT00623428|465987721|FG000|Follow-up Period|Death|0|||
129462246|NCT00623428|465987722|FG001|Follow-up Period|Death|1|||
129462247|NCT01929408|465987725|FG000|Overall Study|received HCT as initial treatment|8|||
129462248|NCT02788747|465987726|FG000|Overall Study|Adverse Event|1|||
129462249|NCT02788747|465987727|FG001|Overall Study|Adverse Event|0|||
129462250|NCT02788747|465987728|FG002|Overall Study|Adverse Event|0|||
129462251|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
129462252|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
129462253|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
129462254|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
129462255|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
129462256|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
129462257|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
129462258|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
129462259|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
129462260|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
129462261|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
129462262|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
129462263|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
129462264|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
129462265|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
129462266|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
129462267|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
129462268|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
129462269|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
129462270|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
129462271|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
129462272|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
129462273|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
129462274|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
129462275|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
129462276|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
129462277|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
129462278|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
129462279|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
129462280|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
129462281|NCT00784654|465987729|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
129462282|NCT00784654|465987730|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
129462283|NCT00784654|465987731|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
129462284|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
129462285|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
129462286|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
129462287|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
129462288|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
129462289|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
129462290|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129462291|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
129462292|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
129462293|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
129462294|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
129462295|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
129462296|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Adverse Event|0|||
129462297|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Adverse Event|1|||
129462298|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Adverse Event|1|||
129462299|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
129462300|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
129462301|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
129462302|NCT00784654|465987729|FG000|Randomized Withdrawal Period|Family reasons|0|||
129462303|NCT00784654|465987730|FG001|Randomized Withdrawal Period|Family reasons|0|||
129462304|NCT00784654|465987731|FG002|Randomized Withdrawal Period|Family reasons|1|||
129462305|NCT00262873|465987732|FG000|Overall Study|Adverse Event|3|||
129462306|NCT00262873|465987732|FG000|Overall Study|Withdrawal by Subject|5|||
129462307|NCT00844753|465987733|FG000|Overall Study|Lack of Efficacy|1|||
129462308|NCT00844753|465987734|FG001|Overall Study|Lack of Efficacy|0|||
129462309|NCT00844753|465987735|FG002|Overall Study|Lack of Efficacy|2|||
129462310|NCT00844753|465987736|FG003|Overall Study|Lack of Efficacy|2|||
129462311|NCT00844753|465987733|FG000|Overall Study|Adverse Event|3|||
129462312|NCT00844753|465987734|FG001|Overall Study|Adverse Event|2|||
129462313|NCT00844753|465987735|FG002|Overall Study|Adverse Event|5|||
129462314|NCT00844753|465987736|FG003|Overall Study|Adverse Event|5|||
129462315|NCT00844753|465987733|FG000|Overall Study|Lost to Follow-up|1|||
129462316|NCT00844753|465987734|FG001|Overall Study|Lost to Follow-up|1|||
129462317|NCT00844753|465987735|FG002|Overall Study|Lost to Follow-up|0|||
129462318|NCT00844753|465987736|FG003|Overall Study|Lost to Follow-up|1|||
129462319|NCT00844753|465987733|FG000|Overall Study|could not swallow medication|2|||
129462320|NCT00844753|465987734|FG001|Overall Study|could not swallow medication|0|||
129462321|NCT00844753|465987735|FG002|Overall Study|could not swallow medication|0|||
129462322|NCT00844753|465987736|FG003|Overall Study|could not swallow medication|0|||
129462323|NCT00844753|465987733|FG000|Overall Study|Withdrawal by Subject|1|||
129462324|NCT00844753|465987734|FG001|Overall Study|Withdrawal by Subject|0|||
129462325|NCT00844753|465987735|FG002|Overall Study|Withdrawal by Subject|0|||
129462326|NCT00844753|465987736|FG003|Overall Study|Withdrawal by Subject|3|||
129462327|NCT01452152|465987737|FG000|Overall Study|Study termination by sponsor|5|||
129462328|NCT01452152|465987738|FG001|Overall Study|Study termination by sponsor|0|||
129462329|NCT01452152|465987739|FG002|Overall Study|Study termination by sponsor|4|||
129462330|NCT04311502|465989139|FG000|Overall Study|Death|1|||
129462331|NCT04311502|465989140|FG001|Overall Study|Death|1|||
129462332|NCT04311502|465989141|FG002|Overall Study|Death|1|||
129462333|NCT04311502|465989139|FG000|Overall Study|Lost to Follow-up|2|||
129462334|NCT04311502|465989140|FG001|Overall Study|Lost to Follow-up|3|||
129462335|NCT04311502|465989141|FG002|Overall Study|Lost to Follow-up|0|||
129462336|NCT04311502|465989139|FG000|Overall Study|Participant is in prison|1|||
129462337|NCT04311502|465989140|FG001|Overall Study|Participant is in prison|0|||
129462338|NCT04311502|465989141|FG002|Overall Study|Participant is in prison|0|||
129462339|NCT04311502|465989139|FG000|Overall Study|Participant moved out of country|1|||
129462340|NCT04311502|465989140|FG001|Overall Study|Participant moved out of country|0|||
129462341|NCT04311502|465989141|FG002|Overall Study|Participant moved out of country|0|||
129462342|NCT04311502|465989139|FG000|Overall Study|Withdrawal by Subject|2|||
129462343|NCT04311502|465989140|FG001|Overall Study|Withdrawal by Subject|0|||
129462344|NCT04311502|465989141|FG002|Overall Study|Withdrawal by Subject|0|||
129462345|NCT04311502|465989139|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
129462346|NCT04311502|465989140|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
129462347|NCT04311502|465989141|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
129462348|NCT03040999|465989142|FG000|Overall Study|Lost to Follow-up|2|||
129462349|NCT03040999|465989143|FG001|Overall Study|Lost to Follow-up|2|||
129462350|NCT03040999|465989142|FG000|Overall Study|Withdrawal by Subject|12|||
129462351|NCT03040999|465989143|FG001|Overall Study|Withdrawal by Subject|13|||
129462352|NCT03040999|465989142|FG000|Overall Study|Death|155|||
129462353|NCT03040999|465989143|FG001|Overall Study|Death|171|||
129462354|NCT03040999|465989142|FG000|Overall Study|Physician Decision|0|||
129462355|NCT03040999|465989143|FG001|Overall Study|Physician Decision|3|||
129462356|NCT03657043|465989144|FG000|Overall Study|Withdrawal by Subject|1|||
129462357|NCT03657043|465989145|FG001|Overall Study|Withdrawal by Subject|1|||
129462358|NCT03657043|465989146|FG002|Overall Study|Withdrawal by Subject|0|||
129462359|NCT03657043|465989147|FG003|Overall Study|Withdrawal by Subject|0|||
129462360|NCT03657043|465989148|FG004|Overall Study|Withdrawal by Subject|4|||
129970777|NCT03358472|467856605|FG001|Overall Study|Physician Decision|1|||
129970778|NCT03358472|467856606|FG002|Overall Study|Physician Decision|0|||
129970779|NCT03358472|467856604|FG000|Overall Study|Withdrawal by Subject|0|||
129970780|NCT03358472|467856605|FG001|Overall Study|Withdrawal by Subject|0|||
129970781|NCT03358472|467856606|FG002|Overall Study|Withdrawal by Subject|1|||
129970782|NCT03358472|467856604|FG000|Overall Study|On-going at clinical cut off date|9|||
129970783|NCT03358472|467856605|FG001|Overall Study|On-going at clinical cut off date|6|||
129462361|NCT03657043|465989144|FG000|Overall Study|Study closure by Sponsor|0|||
129462362|NCT03657043|465989145|FG001|Overall Study|Study closure by Sponsor|2|||
129462363|NCT03657043|465989146|FG002|Overall Study|Study closure by Sponsor|0|||
129462364|NCT03657043|465989147|FG003|Overall Study|Study closure by Sponsor|0|||
129462365|NCT03657043|465989148|FG004|Overall Study|Study closure by Sponsor|17|||
129462366|NCT03657043|465989144|FG000|Overall Study|Lost to Follow-up|0|||
129462367|NCT03657043|465989145|FG001|Overall Study|Lost to Follow-up|0|||
129462368|NCT03657043|465989146|FG002|Overall Study|Lost to Follow-up|0|||
129462369|NCT03657043|465989147|FG003|Overall Study|Lost to Follow-up|0|||
129462370|NCT03657043|465989148|FG004|Overall Study|Lost to Follow-up|4|||
129462371|NCT03657043|465989144|FG000|Overall Study|Death|6|||
129462372|NCT03657043|465989145|FG001|Overall Study|Death|5|||
129462373|NCT03657043|465989146|FG002|Overall Study|Death|0|||
129462374|NCT03657043|465989147|FG003|Overall Study|Death|0|||
129462375|NCT03657043|465989148|FG004|Overall Study|Death|53|||
129462376|NCT03657043|465989144|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
129462377|NCT03657043|465989145|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
129462378|NCT03657043|465989146|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
129462379|NCT03657043|465989147|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
129462380|NCT03657043|465989148|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
129462381|NCT03657043|465989144|FG000|Overall Study|Adverse Event|0|||
129462382|NCT03657043|465989145|FG001|Overall Study|Adverse Event|0|||
129462383|NCT03657043|465989146|FG002|Overall Study|Adverse Event|0|||
129462384|NCT03657043|465989147|FG003|Overall Study|Adverse Event|0|||
129462385|NCT03657043|465989148|FG004|Overall Study|Adverse Event|2|||
129462386|NCT03657043|465989144|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
129462387|NCT03657043|465989145|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
129462388|NCT03657043|465989146|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
129462389|NCT03657043|465989147|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
129462390|NCT03657043|465989148|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
129462391|NCT03657043|465989144|FG000|Overall Study|Withdrawal - declined follow-up|0|||
129462392|NCT03657043|465989145|FG001|Overall Study|Withdrawal - declined follow-up|0|||
129462393|NCT03657043|465989146|FG002|Overall Study|Withdrawal - declined follow-up|0|||
129462394|NCT03657043|465989147|FG003|Overall Study|Withdrawal - declined follow-up|0|||
129462395|NCT03657043|465989148|FG004|Overall Study|Withdrawal - declined follow-up|1|||
129462396|NCT02627495|465989151|FG000|Overall Study|Withdrawal by Subject|4|||
129462397|NCT01736579|465989152|FG000|Overall Study|Termination of Study by Sponsor|2|||
129462398|NCT01736579|465989153|FG001|Overall Study|Termination of Study by Sponsor|2|||
129462399|NCT02543528|465989161|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
129462400|NCT02543528|465989162|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
129462401|NCT02543528|465989163|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
129462402|NCT02543528|465989164|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
129462403|NCT02543528|465989165|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
129462404|NCT02543528|465989161|FG000|Adaptation Period|Lens Handling Difficultes|0|||
129462405|NCT02543528|465989162|FG001|Adaptation Period|Lens Handling Difficultes|0|||
129462406|NCT02543528|465989163|FG002|Adaptation Period|Lens Handling Difficultes|0|||
129462407|NCT02543528|465989164|FG003|Adaptation Period|Lens Handling Difficultes|0|||
129462408|NCT02543528|465989165|FG004|Adaptation Period|Lens Handling Difficultes|8|||
129462409|NCT02543528|465989161|FG000|Adaptation Period|Lost to Follow-up|0|||
129462410|NCT02543528|465989162|FG001|Adaptation Period|Lost to Follow-up|0|||
129462411|NCT02543528|465989163|FG002|Adaptation Period|Lost to Follow-up|0|||
129462412|NCT02543528|465989164|FG003|Adaptation Period|Lost to Follow-up|0|||
129462413|NCT02543528|465989165|FG004|Adaptation Period|Lost to Follow-up|14|||
129462414|NCT02543528|465989161|FG000|Adaptation Period|Adverse Event|0|||
129462415|NCT02543528|465989162|FG001|Adaptation Period|Adverse Event|0|||
129462416|NCT02543528|465989163|FG002|Adaptation Period|Adverse Event|0|||
129462417|NCT02543528|465989164|FG003|Adaptation Period|Adverse Event|0|||
129462418|NCT02543528|465989165|FG004|Adaptation Period|Adverse Event|2|||
129970784|NCT03358472|467856606|FG002|Overall Study|On-going at clinical cut off date|5|||
129970785|NCT02520310|467856607|FG000|At 6 Months Clinical Follow-up|Death|1|||
129970786|NCT02520310|467856607|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
129462419|NCT02543528|465989161|FG000|Extended Wear Period|Adverse Event|17|||
129462420|NCT02543528|465989162|FG001|Extended Wear Period|Adverse Event|11|||
129462421|NCT02543528|465989163|FG002|Extended Wear Period|Adverse Event|16|||
129462422|NCT02543528|465989164|FG003|Extended Wear Period|Adverse Event|3|||
129462423|NCT02543528|465989165|FG004|Extended Wear Period|Adverse Event|0|||
129462424|NCT02543528|465989161|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
129462425|NCT02543528|465989162|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
129970787|NCT02520310|467856607|FG000|AT 3 Year Clinical Follow-up|Death|2|||
129462426|NCT02543528|465989163|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
129462427|NCT02543528|465989164|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
129462428|NCT02543528|465989165|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
129970788|NCT02520310|467856607|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
129970789|NCT02520310|467856607|FG000|AT 4 Year Clinical Follow-up|Death|1|||
129462429|NCT02543528|465989161|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
129462430|NCT02543528|465989162|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
129462431|NCT02543528|465989163|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
129462432|NCT02543528|465989164|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
129462433|NCT02543528|465989165|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
129462434|NCT02543528|465989161|FG000|Extended Wear Period|Lost to Follow-up|0|||
129462435|NCT02543528|465989162|FG001|Extended Wear Period|Lost to Follow-up|1|||
129462436|NCT02543528|465989163|FG002|Extended Wear Period|Lost to Follow-up|2|||
129462437|NCT02543528|465989164|FG003|Extended Wear Period|Lost to Follow-up|1|||
129462438|NCT02543528|465989165|FG004|Extended Wear Period|Lost to Follow-up|0|||
129462439|NCT02543528|465989161|FG000|Extended Wear Period|Withdrawal by Subject|10|||
129462440|NCT02543528|465989162|FG001|Extended Wear Period|Withdrawal by Subject|9|||
129462441|NCT02543528|465989163|FG002|Extended Wear Period|Withdrawal by Subject|4|||
129462442|NCT02543528|465989164|FG003|Extended Wear Period|Withdrawal by Subject|5|||
129462443|NCT02543528|465989165|FG004|Extended Wear Period|Withdrawal by Subject|0|||
129462444|NCT02049944|465989166|FG000|Overall Study|Protocol Violation|2|||
129462445|NCT01408147|465989167|FG000|Overall Study|Withdrawal by Subject|0|||
129462446|NCT01408147|465989168|FG001|Overall Study|Withdrawal by Subject|1|||
129462447|NCT01765673|465989169|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
129462448|NCT01042600|465989170|FG000|Overall Study|Ineligible|1|||
129462449|NCT01042600|465989171|FG001|Overall Study|Ineligible|0|||
129462450|NCT04541004|465989172|FG000|Overall Study|Adverse Event|2|||
129462451|NCT05048719|465989173|FG000|Overall Study|Withdrawal by Subject|2|||
129462452|NCT05048719|465989174|FG001|Overall Study|Withdrawal by Subject|1|||
129462453|NCT05048719|465989175|FG002|Overall Study|Withdrawal by Subject|3|||
129462454|NCT05048719|465989176|FG003|Overall Study|Withdrawal by Subject|1|||
129462455|NCT05048719|465989177|FG004|Overall Study|Withdrawal by Subject|0|||
129462456|NCT05048719|465989178|FG005|Overall Study|Withdrawal by Subject|2|||
129462457|NCT05048719|465989179|FG006|Overall Study|Withdrawal by Subject|1|||
129462458|NCT05048719|465989180|FG007|Overall Study|Withdrawal by Subject|1|||
129462459|NCT05048719|465989181|FG008|Overall Study|Withdrawal by Subject|0|||
129462460|NCT05048719|465989173|FG000|Overall Study|Death|1|||
129462461|NCT05048719|465989174|FG001|Overall Study|Death|0|||
129462462|NCT05048719|465989175|FG002|Overall Study|Death|0|||
129462463|NCT05048719|465989176|FG003|Overall Study|Death|0|||
129462464|NCT05048719|465989177|FG004|Overall Study|Death|0|||
129462465|NCT05048719|465989178|FG005|Overall Study|Death|0|||
129462466|NCT05048719|465989179|FG006|Overall Study|Death|0|||
129462467|NCT05048719|465989180|FG007|Overall Study|Death|0|||
129462468|NCT05048719|465989181|FG008|Overall Study|Death|0|||
129462469|NCT05048719|465989173|FG000|Overall Study|Adverse Event|0|||
129462470|NCT05048719|465989174|FG001|Overall Study|Adverse Event|1|||
129462471|NCT05048719|465989175|FG002|Overall Study|Adverse Event|2|||
129462472|NCT05048719|465989176|FG003|Overall Study|Adverse Event|0|||
129462473|NCT05048719|465989177|FG004|Overall Study|Adverse Event|1|||
129462474|NCT05048719|465989178|FG005|Overall Study|Adverse Event|0|||
129462475|NCT05048719|465989179|FG006|Overall Study|Adverse Event|0|||
129462476|NCT05048719|465989180|FG007|Overall Study|Adverse Event|0|||
129462477|NCT05048719|465989181|FG008|Overall Study|Adverse Event|0|||
129462478|NCT05048719|465989173|FG000|Overall Study|Lost to Follow-up|0|||
129462479|NCT05048719|465989174|FG001|Overall Study|Lost to Follow-up|0|||
129462480|NCT05048719|465989175|FG002|Overall Study|Lost to Follow-up|1|||
129462481|NCT05048719|465989176|FG003|Overall Study|Lost to Follow-up|3|||
129462482|NCT05048719|465989177|FG004|Overall Study|Lost to Follow-up|1|||
129462483|NCT05048719|465989178|FG005|Overall Study|Lost to Follow-up|1|||
129462484|NCT05048719|465989179|FG006|Overall Study|Lost to Follow-up|1|||
129462485|NCT05048719|465989180|FG007|Overall Study|Lost to Follow-up|1|||
129462486|NCT05048719|465989181|FG008|Overall Study|Lost to Follow-up|0|||
129462487|NCT05048719|465989173|FG000|Overall Study|Physician Decision|0|||
129462488|NCT05048719|465989174|FG001|Overall Study|Physician Decision|0|||
129462489|NCT05048719|465989175|FG002|Overall Study|Physician Decision|0|||
129462490|NCT05048719|465989176|FG003|Overall Study|Physician Decision|0|||
129970790|NCT02520310|467856607|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
129462491|NCT05048719|465989177|FG004|Overall Study|Physician Decision|0|||
129462492|NCT05048719|465989178|FG005|Overall Study|Physician Decision|0|||
129462493|NCT05048719|465989179|FG006|Overall Study|Physician Decision|0|||
129462494|NCT05048719|465989180|FG007|Overall Study|Physician Decision|1|||
129462495|NCT05048719|465989181|FG008|Overall Study|Physician Decision|1|||
129462496|NCT05048719|465989173|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
129462497|NCT05048719|465989174|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462498|NCT05048719|465989175|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462499|NCT05048719|465989176|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462500|NCT05048719|465989177|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462501|NCT05048719|465989178|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462502|NCT05048719|465989179|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462503|NCT05048719|465989180|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462504|NCT05048719|465989181|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
129462505|NCT05048719|465989173|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462506|NCT05048719|465989174|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
129462507|NCT05048719|465989175|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462508|NCT05048719|465989176|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462509|NCT05048719|465989177|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462510|NCT05048719|465989178|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462511|NCT05048719|465989179|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462512|NCT05048719|465989180|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462513|NCT05048719|465989181|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
129462514|NCT05048719|465989173|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462515|NCT05048719|465989174|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
129462516|NCT05048719|465989175|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462517|NCT05048719|465989176|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462518|NCT05048719|465989177|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462519|NCT05048719|465989178|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462520|NCT05048719|465989179|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462521|NCT05048719|465989180|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462522|NCT05048719|465989181|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
129462523|NCT05048719|465989173|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462524|NCT05048719|465989174|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462525|NCT05048719|465989175|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462526|NCT05048719|465989176|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
129462527|NCT05048719|465989177|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462528|NCT05048719|465989178|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462529|NCT05048719|465989179|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462530|NCT05048719|465989180|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462531|NCT05048719|465989181|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
129462532|NCT05048719|465989173|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462533|NCT05048719|465989174|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462534|NCT05048719|465989175|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462535|NCT05048719|465989176|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462536|NCT05048719|465989177|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462537|NCT05048719|465989178|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
129462538|NCT05048719|465989179|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462539|NCT05048719|465989180|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462540|NCT05048719|465989181|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
129462541|NCT02229552|465989183|FG000|Baseline|Withdrawal by Subject|6|||
129462542|NCT02229552|465989183|FG000|1-year Follow up|Withdrawal by Subject|7|||
129462543|NCT02229552|465989183|FG000|1-year Follow up|Lost to Follow-up|18|||
129462544|NCT02229552|465989183|FG000|2-Year Follow up|Withdrawal by Subject|9|||
129462545|NCT02229552|465989183|FG000|2-Year Follow up|Lost to Follow-up|17|||
129462546|NCT04872101|465989184|FG000|Overall Study|Withdrawal by Subject|10|||
129462547|NCT04872101|465989185|FG001|Overall Study|Withdrawal by Subject|16|||
129462548|NCT04872101|465989184|FG000|Overall Study|Lack of Efficacy|6|||
129462549|NCT04872101|465989185|FG001|Overall Study|Lack of Efficacy|14|||
129462550|NCT04872101|465989184|FG000|Overall Study|Adverse Event|1|||
129462551|NCT04872101|465989185|FG001|Overall Study|Adverse Event|6|||
129462552|NCT04872101|465989184|FG000|Overall Study|Lost to Follow-up|2|||
129462553|NCT04872101|465989185|FG001|Overall Study|Lost to Follow-up|1|||
129462554|NCT04872101|465989184|FG000|Overall Study|Pregnancy|2|||
129462555|NCT04872101|465989185|FG001|Overall Study|Pregnancy|0|||
129462556|NCT04872101|465989184|FG000|Overall Study|Prohibited Medication|1|||
129462557|NCT04872101|465989185|FG001|Overall Study|Prohibited Medication|0|||
129462558|NCT04872101|465989184|FG000|Overall Study|Not dosed|1|||
129462559|NCT04872101|465989185|FG001|Overall Study|Not dosed|0|||
129462560|NCT00971945|465989186|FG000|Overall Study|Progressive Disease|3|||
129462561|NCT00971945|465989186|FG000|Overall Study|Change in treatment policy|1|||
129462562|NCT00971945|465989186|FG000|Overall Study|Other reasons|2|||
129462563|NCT03354663|465989187|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
129462564|NCT03354663|465989187|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
129462565|NCT03354663|465989187|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
129462566|NCT03354663|465989187|FG000|Completed 30-day Visit|Missed Visit|1|||
129462567|NCT03691974|465989188|FG000|Overall Study|Physician Decision|1|||
129462568|NCT03691974|465989189|FG001|Overall Study|Physician Decision|0|||
129462569|NCT03691974|465989188|FG000|Overall Study|Adverse Event|1|||
129462570|NCT03691974|465989189|FG001|Overall Study|Adverse Event|0|||
129462571|NCT03691974|465989188|FG000|Overall Study|Withdrawal by Subject|11|||
129462572|NCT03691974|465989189|FG001|Overall Study|Withdrawal by Subject|9|||
129462573|NCT03691974|465989188|FG000|Overall Study|Protocol Violation|1|||
129462574|NCT03691974|465989189|FG001|Overall Study|Protocol Violation|0|||
129462575|NCT03691974|465989188|FG000|Overall Study|Lost to Follow-up|8|||
129462576|NCT03691974|465989189|FG001|Overall Study|Lost to Follow-up|7|||
129462577|NCT02239939|465989190|FG000|Overall Study|Adverse Event|1|||
129462578|NCT02239939|465989191|FG001|Overall Study|Adverse Event|0|||
129462579|NCT02239939|465989190|FG000|Overall Study|Withdrawal by Subject|1|||
129462580|NCT02239939|465989191|FG001|Overall Study|Withdrawal by Subject|1|||
129462581|NCT02239939|465989190|FG000|Overall Study|Lost to Follow-up|0|||
129462582|NCT02239939|465989191|FG001|Overall Study|Lost to Follow-up|1|||
129462583|NCT03325673|465989200|FG000|Overall Study|Adverse Event|4|||
129462584|NCT03325673|465989201|FG001|Overall Study|Adverse Event|0|||
129462585|NCT01514682|465989202|FG000|Overall Study|Withdrawal by Subject|2|||
129462586|NCT01514682|465989203|FG001|Overall Study|Withdrawal by Subject|3|||
129462587|NCT01514682|465989202|FG000|Overall Study|Physician Decision|4|||
129462588|NCT01514682|465989203|FG001|Overall Study|Physician Decision|3|||
129462589|NCT00590590|465989204|FG000|Overall Study|Lack of Efficacy|1|||
129462590|NCT00590590|465989205|FG001|Overall Study|Lack of Efficacy|2|||
129462591|NCT00590590|465989206|FG002|Overall Study|Lack of Efficacy|0|||
129462592|NCT00590590|465989204|FG000|Overall Study|Adverse Event|1|||
129462593|NCT00590590|465989205|FG001|Overall Study|Adverse Event|0|||
129462594|NCT00590590|465989206|FG002|Overall Study|Adverse Event|0|||
129462595|NCT00590590|465989204|FG000|Overall Study|Protocol Violation|0|||
129462596|NCT00590590|465989205|FG001|Overall Study|Protocol Violation|0|||
129462597|NCT00590590|465989206|FG002|Overall Study|Protocol Violation|2|||
129462598|NCT00590590|465989204|FG000|Overall Study|Lost to Follow-up|4|||
129462599|NCT00590590|465989205|FG001|Overall Study|Lost to Follow-up|1|||
129462600|NCT00590590|465989206|FG002|Overall Study|Lost to Follow-up|2|||
129462601|NCT00590590|465989204|FG000|Overall Study|Withdrawal by Subject|0|||
129462602|NCT00590590|465989205|FG001|Overall Study|Withdrawal by Subject|1|||
129462603|NCT00590590|465989206|FG002|Overall Study|Withdrawal by Subject|1|||
129462604|NCT00590590|465989204|FG000|Overall Study|Did not complete due to study closure|1|||
129462605|NCT00590590|465989205|FG001|Overall Study|Did not complete due to study closure|1|||
129462606|NCT00590590|465989206|FG002|Overall Study|Did not complete due to study closure|1|||
129462607|NCT00590590|465989204|FG000|Overall Study|Did not complete study|0|||
129462608|NCT00590590|465989205|FG001|Overall Study|Did not complete study|1|||
129462609|NCT00590590|465989206|FG002|Overall Study|Did not complete study|0|||
129462610|NCT02105454|465989209|FG000|Overall Study|Withdrawal by Subject|1|||
129462611|NCT00356278|465989210|FG000|Overall Study|Withdrawal by Subject|25|||
129462612|NCT00356278|465989211|FG001|Overall Study|Withdrawal by Subject|15|||
129462613|NCT00356278|465989212|FG002|Overall Study|Withdrawal by Subject|19|||
129462614|NCT00883337|465989213|FG000|Core Treatment Period|Adverse Event|9|||
129462615|NCT00883337|465989214|FG001|Core Treatment Period|Adverse Event|12|||
129462616|NCT00883337|465989215|FG002|Core Treatment Period|Adverse Event|22|||
129462617|NCT00883337|465989213|FG000|Core Treatment Period|Lack of Efficacy|7|||
129462618|NCT00883337|465989214|FG001|Core Treatment Period|Lack of Efficacy|4|||
129462619|NCT00883337|465989215|FG002|Core Treatment Period|Lack of Efficacy|2|||
129462620|NCT00883337|465989213|FG000|Core Treatment Period|Lost to Follow-up|1|||
129462621|NCT00883337|465989214|FG001|Core Treatment Period|Lost to Follow-up|1|||
129462622|NCT00883337|465989215|FG002|Core Treatment Period|Lost to Follow-up|0|||
129462623|NCT00883337|465989213|FG000|Core Treatment Period|Withdrawal by Subject|2|||
129462624|NCT00883337|465989214|FG001|Core Treatment Period|Withdrawal by Subject|2|||
129970791|NCT01340014|467856608|FG000|Period 1, First 7 Days|Adverse Event|1|||
129462625|NCT00883337|465989215|FG002|Core Treatment Period|Withdrawal by Subject|6|||
129462626|NCT00883337|465989213|FG000|Core Treatment Period|Wish to be pregnant|1|||
129462627|NCT00883337|465989214|FG001|Core Treatment Period|Wish to be pregnant|2|||
129462628|NCT00883337|465989215|FG002|Core Treatment Period|Wish to be pregnant|1|||
129462629|NCT00883337|465989213|FG000|Core Treatment Period|Poor compliance to protocol|0|||
129462630|NCT00883337|465989214|FG001|Core Treatment Period|Poor compliance to protocol|0|||
129462631|NCT00883337|465989215|FG002|Core Treatment Period|Poor compliance to protocol|1|||
129462632|NCT00883337|465989213|FG000|Core Treatment Period|Other than above|0|||
129462633|NCT00883337|465989214|FG001|Core Treatment Period|Other than above|1|||
129462634|NCT00883337|465989215|FG002|Core Treatment Period|Other than above|1|||
129462635|NCT00883337|465989213|FG000|Extension Treatment Period|Adverse Event|8|||
129462636|NCT00883337|465989214|FG001|Extension Treatment Period|Adverse Event|5|||
129462637|NCT00883337|465989215|FG002|Extension Treatment Period|Adverse Event|5|||
129462638|NCT00883337|465989213|FG000|Extension Treatment Period|Lack of Efficacy|8|||
129970792|NCT01340014|467856609|FG001|Period 1, First 7 Days|Adverse Event|0|||
129462639|NCT00883337|465989214|FG001|Extension Treatment Period|Lack of Efficacy|8|||
129462640|NCT00883337|465989215|FG002|Extension Treatment Period|Lack of Efficacy|8|||
129462641|NCT00883337|465989213|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
129462642|NCT00883337|465989214|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
129462643|NCT00883337|465989215|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
129462644|NCT00883337|465989213|FG000|Extension Treatment Period|Lost to Follow-up|1|||
129462645|NCT00883337|465989214|FG001|Extension Treatment Period|Lost to Follow-up|0|||
129462646|NCT00883337|465989215|FG002|Extension Treatment Period|Lost to Follow-up|0|||
129462647|NCT00883337|465989213|FG000|Extension Treatment Period|Other than above|10|||
129462648|NCT00883337|465989214|FG001|Extension Treatment Period|Other than above|9|||
129462649|NCT00883337|465989215|FG002|Extension Treatment Period|Other than above|5|||
129462650|NCT02363686|465989219|FG000|Overall Study|Withdrawal by Subject|22|||
129462651|NCT02363686|465989219|FG000|Overall Study|incomplete FEES examinations|13|||
129462652|NCT01485627|465989222|FG000|Overall Study|Patient withdrew|6|||
129462653|NCT01485627|465989223|FG001|Overall Study|Patient withdrew|5|||
129462654|NCT01485627|465989222|FG000|Overall Study|Patient died|3|||
129462655|NCT01485627|465989223|FG001|Overall Study|Patient died|1|||
129462656|NCT01485627|465989222|FG000|Overall Study|Patient lost to followup|0|||
129462657|NCT01485627|465989223|FG001|Overall Study|Patient lost to followup|1|||
129462658|NCT01485627|465989222|FG000|Overall Study|Caregiver withdrew|3|||
129462659|NCT01485627|465989223|FG001|Overall Study|Caregiver withdrew|3|||
129462660|NCT01485627|465989222|FG000|Overall Study|Caregiver lost to follow up|11|||
129462661|NCT01485627|465989223|FG001|Overall Study|Caregiver lost to follow up|12|||
129462662|NCT01485627|465989222|FG000|Overall Study|Caregiver died|1|||
129462663|NCT01485627|465989223|FG001|Overall Study|Caregiver died|0|||
129462664|NCT01485627|465989222|FG000|Overall Study|caregiver was not bereaved|42|||
129462665|NCT01485627|465989223|FG001|Overall Study|caregiver was not bereaved|35|||
129462666|NCT02264990|465989228|FG000|Overall Study|Death|255|||
129462667|NCT02264990|465989229|FG001|Overall Study|Death|250|||
129462668|NCT02264990|465989228|FG000|Overall Study|Withdrawal by Subject|4|||
129462669|NCT02264990|465989229|FG001|Overall Study|Withdrawal by Subject|5|||
129462670|NCT02264990|465989228|FG000|Overall Study|Lost to Follow-up|1|||
129462671|NCT02264990|465989229|FG001|Overall Study|Lost to Follow-up|3|||
129462672|NCT02264990|465989228|FG000|Overall Study|Other|0|||
129462673|NCT02264990|465989229|FG001|Overall Study|Other|1|||
129462674|NCT01662895|465989238|FG000|Overall Study|Lost to Follow-up|0|||
129462675|NCT01662895|465989239|FG001|Overall Study|Lost to Follow-up|1|||
129462676|NCT00075504|465989247|FG000|Overall Study|Withdrawal by Subject|9|||
129462677|NCT00075504|465989248|FG001|Overall Study|Withdrawal by Subject|7|||
129462678|NCT01692301|465989250|FG000|Overall Study|Adverse Event|15|||
129462679|NCT01692301|465989251|FG001|Overall Study|Adverse Event|12|||
129462680|NCT01692301|465989250|FG000|Overall Study|Death|1|||
129462681|NCT01692301|465989251|FG001|Overall Study|Death|2|||
129462682|NCT01692301|465989250|FG000|Overall Study|Lack of Efficacy|0|||
129462683|NCT01692301|465989251|FG001|Overall Study|Lack of Efficacy|5|||
129462684|NCT01692301|465989250|FG000|Overall Study|Non-compliance with study treatment|1|||
129462685|NCT01692301|465989251|FG001|Overall Study|Non-compliance with study treatment|2|||
129462686|NCT01692301|465989250|FG000|Overall Study|Protocol deviation|9|||
129462687|NCT01692301|465989251|FG001|Overall Study|Protocol deviation|2|||
129462688|NCT01692301|465989250|FG000|Overall Study|Patient/guardian decision|16|||
129462689|NCT01692301|465989251|FG001|Overall Study|Patient/guardian decision|15|||
129462690|NCT01692301|465989250|FG000|Overall Study|Technical problems|0|||
129462691|NCT01692301|465989251|FG001|Overall Study|Technical problems|1|||
129462692|NCT01692301|465989250|FG000|Overall Study|Physician Decision|2|||
129462693|NCT01692301|465989251|FG001|Overall Study|Physician Decision|2|||
129462694|NCT01692301|465989250|FG000|Overall Study|Lost to Follow-up|1|||
129462695|NCT01692301|465989251|FG001|Overall Study|Lost to Follow-up|1|||
129462696|NCT01142726|465989252|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
129462697|NCT01142726|465989253|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
129462698|NCT01142726|465989254|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
129462699|NCT01142726|465989252|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
129462700|NCT01142726|465989253|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
129462701|NCT01142726|465989254|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
129462702|NCT01142726|465989252|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
129462703|NCT01142726|465989253|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
129462704|NCT01142726|465989254|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
129462705|NCT01142726|465989252|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
129462706|NCT01142726|465989253|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
129462707|NCT01142726|465989254|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
129462708|NCT01142726|465989252|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
129462709|NCT01142726|465989253|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
129462710|NCT01142726|465989254|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
129462711|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
129462712|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
129462713|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
129462714|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
129462715|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
129462716|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
129462717|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
129462718|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
129462719|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
129462720|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
129462721|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
129462722|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
129462723|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
129462724|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
129462725|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
129462726|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
129462727|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
129462728|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
129462729|NCT01142726|465989252|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
129462730|NCT01142726|465989253|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
129462731|NCT01142726|465989254|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
129462732|NCT01142726|465989252|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
129462733|NCT01142726|465989253|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
129462734|NCT01142726|465989254|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
129462735|NCT01142726|465989252|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
129462736|NCT01142726|465989253|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
129462737|NCT01142726|465989254|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
129462738|NCT01142726|465989252|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
129462739|NCT01142726|465989253|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
129462740|NCT01142726|465989254|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
129462741|NCT01142726|465989252|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
129462742|NCT01142726|465989253|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
129462743|NCT01142726|465989254|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
129462744|NCT01568593|465989255|FG000|Overall Study|Lack of Efficacy|4|||
129462745|NCT01568593|465989256|FG001|Overall Study|Lack of Efficacy|1|||
129462746|NCT01568593|465989255|FG000|Overall Study|Adverse Event|3|||
129462747|NCT01568593|465989256|FG001|Overall Study|Adverse Event|2|||
129462748|NCT02109484|465989257|FG000|Overall Study|Lost to Follow-up|0|||
129462749|NCT02109484|465989258|FG001|Overall Study|Lost to Follow-up|0|||
129462750|NCT02109484|465989259|FG002|Overall Study|Lost to Follow-up|0|||
129462751|NCT02109484|465989260|FG003|Overall Study|Lost to Follow-up|1|||
129462752|NCT02109484|465989261|FG004|Overall Study|Lost to Follow-up|1|||
129462753|NCT02109484|465989262|FG005|Overall Study|Lost to Follow-up|0|||
129462754|NCT02109484|465989263|FG006|Overall Study|Lost to Follow-up|1|||
129462755|NCT02109484|465989264|FG007|Overall Study|Lost to Follow-up|0|||
129462756|NCT02109484|465989257|FG000|Overall Study|Withdrawal by Subject|0|||
129462757|NCT02109484|465989258|FG001|Overall Study|Withdrawal by Subject|0|||
129462758|NCT02109484|465989259|FG002|Overall Study|Withdrawal by Subject|0|||
129462759|NCT02109484|465989260|FG003|Overall Study|Withdrawal by Subject|0|||
129462760|NCT02109484|465989261|FG004|Overall Study|Withdrawal by Subject|1|||
129462761|NCT02109484|465989262|FG005|Overall Study|Withdrawal by Subject|1|||
129462762|NCT02109484|465989263|FG006|Overall Study|Withdrawal by Subject|1|||
129462763|NCT02109484|465989264|FG007|Overall Study|Withdrawal by Subject|0|||
129462764|NCT02109484|465989257|FG000|Overall Study|Physician Decision|0|||
129462765|NCT02109484|465989258|FG001|Overall Study|Physician Decision|0|||
129462766|NCT02109484|465989259|FG002|Overall Study|Physician Decision|0|||
129462767|NCT02109484|465989260|FG003|Overall Study|Physician Decision|0|||
129462768|NCT02109484|465989261|FG004|Overall Study|Physician Decision|2|||
129462769|NCT02109484|465989262|FG005|Overall Study|Physician Decision|0|||
129462770|NCT02109484|465989263|FG006|Overall Study|Physician Decision|0|||
129462771|NCT02109484|465989264|FG007|Overall Study|Physician Decision|0|||
129462772|NCT02109484|465989257|FG000|Overall Study|Death|0|||
129462773|NCT02109484|465989258|FG001|Overall Study|Death|0|||
129462774|NCT02109484|465989259|FG002|Overall Study|Death|0|||
129462775|NCT02109484|465989260|FG003|Overall Study|Death|0|||
129462776|NCT02109484|465989261|FG004|Overall Study|Death|0|||
129462777|NCT02109484|465989262|FG005|Overall Study|Death|0|||
129462778|NCT02109484|465989263|FG006|Overall Study|Death|0|||
129462779|NCT02109484|465989264|FG007|Overall Study|Death|2|||
129462780|NCT02109484|465989257|FG000|Overall Study|Moved away from study area|0|||
129462781|NCT02109484|465989258|FG001|Overall Study|Moved away from study area|0|||
129462782|NCT02109484|465989259|FG002|Overall Study|Moved away from study area|0|||
129462783|NCT02109484|465989260|FG003|Overall Study|Moved away from study area|0|||
129462784|NCT02109484|465989261|FG004|Overall Study|Moved away from study area|0|||
129462785|NCT02109484|465989262|FG005|Overall Study|Moved away from study area|0|||
129462786|NCT02109484|465989263|FG006|Overall Study|Moved away from study area|1|||
129462787|NCT02109484|465989264|FG007|Overall Study|Moved away from study area|1|||
129462788|NCT02111993|465989269|FG000|Overall Study|Physician Decision|5|||
129462789|NCT02111993|465989270|FG001|Overall Study|Physician Decision|4|||
129462790|NCT00293579|465989271|FG000|Overall Study|Withdrawal by Subject|1|||
129462791|NCT01180660|465989278|FG000|Overall Study|Changed to open surgery|1|||
129462792|NCT01180660|465989279|FG001|Overall Study|Changed to open surgery|0|||
129462793|NCT01318109|465989282|FG000|Overall Study|Adverse Event|0|||
129462794|NCT01318109|465989283|FG001|Overall Study|Adverse Event|2|||
129462795|NCT01318109|465989284|FG002|Overall Study|Adverse Event|0|||
129462796|NCT01318109|465989282|FG000|Overall Study|Withdrawal by Subject|1|||
129462797|NCT01318109|465989283|FG001|Overall Study|Withdrawal by Subject|0|||
129462798|NCT01318109|465989284|FG002|Overall Study|Withdrawal by Subject|0|||
129462799|NCT01318109|465989282|FG000|Overall Study|Schedule Conflict|0|||
129462800|NCT01318109|465989283|FG001|Overall Study|Schedule Conflict|1|||
129462801|NCT01318109|465989284|FG002|Overall Study|Schedule Conflict|0|||
129462802|NCT01328951|465989285|FG000|Overall Study|Disease Progression|17|||
129462803|NCT01328951|465989286|FG001|Overall Study|Disease Progression|14|||
129462804|NCT01328951|465989285|FG000|Overall Study|Adverse Event|2|||
129462805|NCT01328951|465989286|FG001|Overall Study|Adverse Event|0|||
129462806|NCT01328951|465989285|FG000|Overall Study|Death|243|||
129462807|NCT01328951|465989286|FG001|Overall Study|Death|258|||
129462808|NCT01328951|465989285|FG000|Overall Study|Lost to Follow-up|6|||
129462809|NCT01328951|465989286|FG001|Overall Study|Lost to Follow-up|7|||
129462810|NCT01328951|465989285|FG000|Overall Study|Withdrawal by Subject|6|||
129462811|NCT01328951|465989286|FG001|Overall Study|Withdrawal by Subject|6|||
129462812|NCT01328951|465989285|FG000|Overall Study|Study Closed by the Sponsor|36|||
129462813|NCT01328951|465989286|FG001|Overall Study|Study Closed by the Sponsor|31|||
129462814|NCT01328951|465989285|FG000|Overall Study|Other|11|||
129462815|NCT01328951|465989286|FG001|Overall Study|Other|6|||
129462816|NCT04042103|465989289|FG000|Overall Study|Lost to Follow-up|1|||
129462817|NCT04042103|465989289|FG000|Overall Study|Withdrawal by Subject|1|||
129462818|NCT01003210|465989290|FG000|Overall Study|Lost to Follow-up|1|||
129462819|NCT01003210|465989291|FG001|Overall Study|Lost to Follow-up|3|||
129462820|NCT00271817|465989292|FG000|Part 1|Adverse Event|68|||
129462821|NCT00271817|465989293|FG001|Part 1|Adverse Event|25|||
129462822|NCT00271817|465989294|FG002|Part 1|Adverse Event|156|||
129462823|NCT00271817|465989292|FG000|Part 1|Lost to Follow-up|6|||
129462824|NCT00271817|465989293|FG001|Part 1|Lost to Follow-up|8|||
129462825|NCT00271817|465989294|FG002|Part 1|Lost to Follow-up|24|||
129462826|NCT00271817|465989292|FG000|Part 1|Protocol Violation|5|||
129462827|NCT00271817|465989293|FG001|Part 1|Protocol Violation|4|||
129462828|NCT00271817|465989294|FG002|Part 1|Protocol Violation|7|||
129462829|NCT00271817|465989292|FG000|Part 1|Patient Moved|3|||
129462830|NCT00271817|465989293|FG001|Part 1|Patient Moved|1|||
129462831|NCT00271817|465989294|FG002|Part 1|Patient Moved|5|||
129462832|NCT00271817|465989292|FG000|Part 1|Withdrawal by Subject|23|||
129462833|NCT00271817|465989293|FG001|Part 1|Withdrawal by Subject|17|||
129462834|NCT00271817|465989294|FG002|Part 1|Withdrawal by Subject|45|||
129462835|NCT00271817|465989292|FG000|Part 1|LDL < 50 mg/dL|1|||
129462836|NCT00271817|465989293|FG001|Part 1|LDL < 50 mg/dL|4|||
129462837|NCT00271817|465989294|FG002|Part 1|LDL < 50 mg/dL|48|||
129462838|NCT00271817|465989292|FG000|Part 2|Adverse Event|0|||
129462839|NCT00271817|465989293|FG001|Part 2|Adverse Event|17|||
129462840|NCT00271817|465989294|FG002|Part 2|Adverse Event|33|||
129462841|NCT00271817|465989292|FG000|Part 2|Lack of Efficacy|0|||
129462842|NCT00271817|465989293|FG001|Part 2|Lack of Efficacy|1|||
129462843|NCT00271817|465989294|FG002|Part 2|Lack of Efficacy|6|||
129462844|NCT00271817|465989292|FG000|Part 2|Lost to Follow-up|0|||
129462845|NCT00271817|465989293|FG001|Part 2|Lost to Follow-up|6|||
129462846|NCT00271817|465989294|FG002|Part 2|Lost to Follow-up|18|||
129462847|NCT00271817|465989292|FG000|Part 2|Protocol Violation|0|||
129462848|NCT00271817|465989293|FG001|Part 2|Protocol Violation|3|||
129462849|NCT00271817|465989294|FG002|Part 2|Protocol Violation|5|||
129462850|NCT00271817|465989292|FG000|Part 2|Patient Moved|0|||
129462851|NCT00271817|465989293|FG001|Part 2|Patient Moved|0|||
129462852|NCT00271817|465989294|FG002|Part 2|Patient Moved|5|||
129462853|NCT00271817|465989292|FG000|Part 2|Withdrawal by Subject|0|||
129462854|NCT00271817|465989293|FG001|Part 2|Withdrawal by Subject|2|||
129462855|NCT00271817|465989294|FG002|Part 2|Withdrawal by Subject|13|||
129462856|NCT00271817|465989292|FG000|Part 2|LDL < 50 mg/dL|0|||
129462857|NCT00271817|465989293|FG001|Part 2|LDL < 50 mg/dL|3|||
129462858|NCT00271817|465989294|FG002|Part 2|LDL < 50 mg/dL|4|||
129462859|NCT03124563|465989295|FG000|Overall Study|Lost to Follow-up|1|||
129462860|NCT03124563|465989296|FG001|Overall Study|Lost to Follow-up|1|||
129462861|NCT03124563|465989295|FG000|Overall Study|Withdrawal by Subject|1|||
129462862|NCT03124563|465989296|FG001|Overall Study|Withdrawal by Subject|1|||
129462863|NCT02068547|465990650|FG000|Overall Study|Lost to Follow-up|3|||
129462864|NCT02068547|465990651|FG001|Overall Study|Lost to Follow-up|3|||
129462865|NCT02068547|465990650|FG000|Overall Study|Physician Decision|1|||
129462866|NCT02068547|465990651|FG001|Overall Study|Physician Decision|0|||
129462867|NCT01391000|465990652|FG000|Overall Study|Lost to Follow-up|2|||
129462868|NCT01391000|465990653|FG001|Overall Study|Lost to Follow-up|0|||
129462869|NCT00817531|465990654|FG000|Overall Study|Adverse Event|1|||
129462870|NCT00817531|465990654|FG000|Overall Study|Lack of Efficacy|1|||
129462871|NCT00132132|465990658|FG000|Overall Study|Lost to Follow-up|7|||
129462872|NCT00132132|465990659|FG001|Overall Study|Lost to Follow-up|2|||
129462873|NCT03468309|465990666|FG000|Overall Study|Lost to Follow-up|4|||
129462874|NCT03468309|465990666|FG000|Overall Study|Withdrawal by Subject|2|||
129462875|NCT01496885|465990670|FG000|Overall Study|Lost to Follow-up|13|||
129462876|NCT01496885|465990670|FG000|Overall Study|Withdrawal by Subject|7|||
129462877|NCT01496885|465990670|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
129462878|NCT01496885|465990670|FG000|Overall Study|Death|1|||
129462879|NCT03446885|465990671|FG000|Overall Study|Lost to Follow-up|1|||
129462880|NCT03446885|465990672|FG001|Overall Study|Lost to Follow-up|0|||
129462881|NCT03446885|465990671|FG000|Overall Study|Did not complete entire visit|1|||
129462882|NCT03446885|465990672|FG001|Overall Study|Did not complete entire visit|0|||
129462883|NCT00252057|465990679|FG000|Overall Study|Withdrawal by Subject|2|||
129462884|NCT00252057|465990680|FG001|Overall Study|Withdrawal by Subject|5|||
129462885|NCT00252057|465990679|FG000|Overall Study|Death|1|||
129462886|NCT00252057|465990680|FG001|Overall Study|Death|2|||
129462887|NCT00252057|465990679|FG000|Overall Study|Participant previously enrolled|0|||
129462888|NCT00252057|465990680|FG001|Overall Study|Participant previously enrolled|1|||
129462889|NCT01098071|465990681|FG000|Overall Study|Surgery (adenoidectomy)|2|||
129462890|NCT01098071|465990681|FG000|Overall Study|Lost to Follow-up|13|||
129462891|NCT01665807|465990686|FG000|Overall Study|Withdrawal by Subject|2|||
129462892|NCT01665807|465990687|FG001|Overall Study|Withdrawal by Subject|0|||
129462893|NCT01665807|465990688|FG002|Overall Study|Withdrawal by Subject|1|||
129462894|NCT02728830|465990689|FG000|Overall Study|Exclusionary Surgery|9|||
129462895|NCT02728830|465990689|FG000|Overall Study|Exclusionary Pathology|6|||
129462896|NCT02728830|465990689|FG000|Overall Study|Physician Decision|3|||
129462897|NCT02728830|465990689|FG000|Overall Study|Withdrawal by Subject|2|||
129462898|NCT02728830|465990689|FG000|Overall Study|Lost to Follow-up|1|||
129462899|NCT02728830|465990689|FG000|Overall Study|Exclusionary Lab Values|1|||
129462900|NCT02728830|465990689|FG000|Overall Study|Contraindicated Illness|1|||
129462901|NCT02728830|465990689|FG000|Overall Study|Language Barrier|1|||
129462902|NCT01081795|465990690|FG000|Overall Study|Adverse Event|18|||
129462903|NCT01081795|465990691|FG001|Overall Study|Adverse Event|23|||
129462904|NCT01081795|465990692|FG002|Overall Study|Adverse Event|6|||
129462905|NCT01081795|465990690|FG000|Overall Study|Lack of Efficacy|7|||
129462906|NCT01081795|465990691|FG001|Overall Study|Lack of Efficacy|5|||
129462907|NCT01081795|465990692|FG002|Overall Study|Lack of Efficacy|19|||
129462908|NCT01081795|465990690|FG000|Overall Study|Subject's schedule|1|||
129462909|NCT01081795|465990691|FG001|Overall Study|Subject's schedule|1|||
129462910|NCT01081795|465990692|FG002|Overall Study|Subject's schedule|2|||
129462911|NCT01081795|465990690|FG000|Overall Study|Revocation of informed consent|2|||
129462912|NCT01081795|465990691|FG001|Overall Study|Revocation of informed consent|0|||
129462913|NCT01081795|465990692|FG002|Overall Study|Revocation of informed consent|0|||
129462914|NCT01081795|465990690|FG000|Overall Study|Ineligible for participation|1|||
129462915|NCT01081795|465990691|FG001|Overall Study|Ineligible for participation|0|||
129462916|NCT01081795|465990692|FG002|Overall Study|Ineligible for participation|0|||
129462917|NCT01081795|465990690|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
129462918|NCT01081795|465990691|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
129462919|NCT01081795|465990692|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
129462920|NCT01081795|465990690|FG000|Overall Study|Using drug with restricted days of use|2|||
129462921|NCT01081795|465990691|FG001|Overall Study|Using drug with restricted days of use|3|||
129462922|NCT01081795|465990692|FG002|Overall Study|Using drug with restricted days of use|2|||
129462923|NCT01081795|465990690|FG000|Overall Study|Other|1|||
129462924|NCT01081795|465990691|FG001|Overall Study|Other|2|||
129462925|NCT01081795|465990692|FG002|Overall Study|Other|0|||
129970793|NCT01340014|467856608|FG000|Period 1, First 7 Days|Personal Reasons|1|||
129970794|NCT01340014|467856609|FG001|Period 1, First 7 Days|Personal Reasons|0|||
129970795|NCT01340014|467856608|FG000|Period 2, Second 7 Days|Adverse Event|0|||
129970796|NCT01340014|467856609|FG001|Period 2, Second 7 Days|Adverse Event|1|||
129970797|NCT04535544|467856611|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
129970798|NCT04535544|467856612|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
129970799|NCT04535544|467856613|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
129970800|NCT04535544|467856614|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
129970801|NCT04535544|467856611|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
129462926|NCT00143455|465990693|FG000|Cohort 1|Adverse Event|8|||
129462927|NCT00143455|465990694|FG001|Cohort 1|Adverse Event|4|||
129462928|NCT00143455|465990695|FG002|Cohort 1|Adverse Event|0|||
129462929|NCT00143455|465990696|FG003|Cohort 1|Adverse Event|0|||
129462930|NCT00143455|465990693|FG000|Cohort 1|Death|5|||
129462931|NCT00143455|465990694|FG001|Cohort 1|Death|2|||
129462932|NCT00143455|465990695|FG002|Cohort 1|Death|0|||
129462933|NCT00143455|465990696|FG003|Cohort 1|Death|0|||
129462934|NCT00143455|465990693|FG000|Cohort 1|Progressive Disease|0|||
129462935|NCT00143455|465990694|FG001|Cohort 1|Progressive Disease|6|||
129970802|NCT04535544|467856612|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
129970803|NCT04535544|467856613|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
129970804|NCT04535544|467856614|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
129970805|NCT04535544|467856611|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
129970806|NCT04535544|467856612|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
129970807|NCT04535544|467856613|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
129970808|NCT04535544|467856614|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
129970809|NCT04535544|467856611|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
129970810|NCT04535544|467856612|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
129970811|NCT04535544|467856613|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
129970812|NCT04535544|467856614|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
129970813|NCT04535544|467856611|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
129970814|NCT04535544|467856612|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
129970815|NCT04535544|467856613|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
129970816|NCT04535544|467856614|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
129970817|NCT04535544|467856611|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
129970818|NCT04535544|467856612|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
129462936|NCT00143455|465990695|FG002|Cohort 1|Progressive Disease|0|||
129462937|NCT00143455|465990696|FG003|Cohort 1|Progressive Disease|0|||
129462938|NCT00143455|465990693|FG000|Cohort 1|Withdrawal by Subject|1|||
129462939|NCT00143455|465990694|FG001|Cohort 1|Withdrawal by Subject|4|||
129462940|NCT00143455|465990695|FG002|Cohort 1|Withdrawal by Subject|0|||
129462941|NCT00143455|465990696|FG003|Cohort 1|Withdrawal by Subject|0|||
129462942|NCT00143455|465990693|FG000|Cohort 1|Randomized But Not Treated|0|||
129462943|NCT00143455|465990694|FG001|Cohort 1|Randomized But Not Treated|1|||
129462944|NCT00143455|465990695|FG002|Cohort 1|Randomized But Not Treated|0|||
129462945|NCT00143455|465990696|FG003|Cohort 1|Randomized But Not Treated|0|||
129462946|NCT00143455|465990693|FG000|Cohort 2|Adverse Event|0|||
129462947|NCT00143455|465990694|FG001|Cohort 2|Adverse Event|0|||
129462948|NCT00143455|465990695|FG002|Cohort 2|Adverse Event|42|||
129462949|NCT00143455|465990696|FG003|Cohort 2|Adverse Event|30|||
129462950|NCT00143455|465990693|FG000|Cohort 2|No Longer Required Study Treatment|0|||
129462951|NCT00143455|465990694|FG001|Cohort 2|No Longer Required Study Treatment|0|||
129462952|NCT00143455|465990695|FG002|Cohort 2|No Longer Required Study Treatment|1|||
129462953|NCT00143455|465990696|FG003|Cohort 2|No Longer Required Study Treatment|0|||
129462954|NCT00143455|465990693|FG000|Cohort 2|Protocol Violation|0|||
129462955|NCT00143455|465990694|FG001|Cohort 2|Protocol Violation|0|||
129462956|NCT00143455|465990695|FG002|Cohort 2|Protocol Violation|1|||
129462957|NCT00143455|465990696|FG003|Cohort 2|Protocol Violation|1|||
129462958|NCT00143455|465990693|FG000|Cohort 2|Lost to Follow-up|0|||
129462959|NCT00143455|465990694|FG001|Cohort 2|Lost to Follow-up|0|||
129462960|NCT00143455|465990695|FG002|Cohort 2|Lost to Follow-up|1|||
129462961|NCT00143455|465990696|FG003|Cohort 2|Lost to Follow-up|4|||
129462962|NCT00143455|465990693|FG000|Cohort 2|Death|0|||
129462963|NCT00143455|465990694|FG001|Cohort 2|Death|0|||
129462964|NCT00143455|465990695|FG002|Cohort 2|Death|20|||
129462965|NCT00143455|465990696|FG003|Cohort 2|Death|12|||
129462966|NCT00143455|465990693|FG000|Cohort 2|Progressive Disease|0|||
129462967|NCT00143455|465990694|FG001|Cohort 2|Progressive Disease|0|||
129462968|NCT00143455|465990695|FG002|Cohort 2|Progressive Disease|20|||
129462969|NCT00143455|465990696|FG003|Cohort 2|Progressive Disease|27|||
129462970|NCT00143455|465990693|FG000|Cohort 2|Withdrawal by Subject|0|||
129462971|NCT00143455|465990694|FG001|Cohort 2|Withdrawal by Subject|0|||
129462972|NCT00143455|465990695|FG002|Cohort 2|Withdrawal by Subject|13|||
129462973|NCT00143455|465990696|FG003|Cohort 2|Withdrawal by Subject|12|||
129462974|NCT00143455|465990693|FG000|Cohort 2|Other|0|||
129462975|NCT00143455|465990694|FG001|Cohort 2|Other|0|||
129462976|NCT00143455|465990695|FG002|Cohort 2|Other|7|||
129462977|NCT00143455|465990696|FG003|Cohort 2|Other|6|||
129462978|NCT00143455|465990693|FG000|Cohort 2|Randomized But Not Treated|0|||
129462979|NCT00143455|465990694|FG001|Cohort 2|Randomized But Not Treated|0|||
129462980|NCT00143455|465990695|FG002|Cohort 2|Randomized But Not Treated|1|||
129462981|NCT00143455|465990696|FG003|Cohort 2|Randomized But Not Treated|1|||
129462982|NCT03713944|465990697|FG000|Study Treatment|Patient non-compliance|1|||
129462983|NCT03713944|465990697|FG000|Study Treatment|Alternative Cancer Therapy|3|||
129462984|NCT03713944|465990697|FG000|Study Treatment|Disease Progression|18|||
129462985|NCT03713944|465990697|FG000|Study Treatment|AE/Side Effects/Complications|2|||
129462986|NCT03713944|465990697|FG000|Study Treatment|Death|2|||
129462987|NCT03713944|465990697|FG000|Study Treatment|Withdrawal by Subject|1|||
129462988|NCT03713944|465990697|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
129462989|NCT03713944|465990697|FG000|Study Treatment|Symptomatic Deterioration|2|||
129462990|NCT03713944|465990697|FG000|Follow up|Withdrawal by Subject|2|||
129462991|NCT03713944|465990697|FG000|Follow up|Death|11|||
129462992|NCT03713944|465990697|FG000|Follow up|Study Terminated|3|||
129462993|NCT00419380|465990700|FG000|Overall Study|Lack of Efficacy|1|||
129462994|NCT00419380|465990701|FG001|Overall Study|Lack of Efficacy|7|||
129462995|NCT00419380|465990700|FG000|Overall Study|Physician Decision|0|||
129462996|NCT00419380|465990701|FG001|Overall Study|Physician Decision|1|||
129462997|NCT00419380|465990700|FG000|Overall Study|Lost to Follow-up|0|||
129462998|NCT00419380|465990701|FG001|Overall Study|Lost to Follow-up|1|||
129462999|NCT00419380|465990700|FG000|Overall Study|Withdrawal by Subject|0|||
129463000|NCT00419380|465990701|FG001|Overall Study|Withdrawal by Subject|1|||
129463001|NCT03127384|465990704|FG000|Overall Study|Lost to Follow-up|4|||
129463002|NCT03127384|465990704|FG000|Overall Study|Subject request|2|||
129463003|NCT01026831|465990706|FG000|Overall Study|Adverse Event|4|||
129463004|NCT01026831|465990707|FG001|Overall Study|Adverse Event|3|||
129463005|NCT01026831|465990706|FG000|Overall Study|Lost to Follow-up|2|||
129463006|NCT01026831|465990707|FG001|Overall Study|Lost to Follow-up|0|||
129463007|NCT01026831|465990706|FG000|Overall Study|Physician Decision|1|||
129463008|NCT01026831|465990707|FG001|Overall Study|Physician Decision|1|||
129463009|NCT01026831|465990706|FG000|Overall Study|Protocol Violation|0|||
129463010|NCT01026831|465990707|FG001|Overall Study|Protocol Violation|2|||
129463011|NCT01026831|465990706|FG000|Overall Study|Withdrawal by Subject|7|||
129463012|NCT01026831|465990707|FG001|Overall Study|Withdrawal by Subject|5|||
129463013|NCT04417894|465990708|FG000|Overall Study|Lost to Follow-up|3|||
129463014|NCT04417894|465990709|FG001|Overall Study|Lost to Follow-up|0|||
129463015|NCT04417894|465990708|FG000|Overall Study|Withdrawal by Subject|7|||
129463016|NCT04417894|465990709|FG001|Overall Study|Withdrawal by Subject|6|||
129463017|NCT04417894|465990708|FG000|Overall Study|Lack of Efficacy|3|||
129463018|NCT04417894|465990709|FG001|Overall Study|Lack of Efficacy|1|||
129463019|NCT03861559|465990710|FG000|Overall Study|Adverse Event|0|||
129463020|NCT03861559|465990711|FG001|Overall Study|Adverse Event|2|||
129463021|NCT03861559|465990710|FG000|Overall Study|Treatment failure|0|||
129463022|NCT03861559|465990711|FG001|Overall Study|Treatment failure|2|||
129463023|NCT03861559|465990710|FG000|Overall Study|Noncompliance|1|||
129463024|NCT03861559|465990711|FG001|Overall Study|Noncompliance|1|||
129463025|NCT03861559|465990710|FG000|Overall Study|Did not meet eligibility requirements|1|||
129463026|NCT03861559|465990711|FG001|Overall Study|Did not meet eligibility requirements|0|||
129463027|NCT03652662|465990712|FG000|Overall Study|Withdrawal by Subject|2|||
129463028|NCT03652662|465990713|FG001|Overall Study|Withdrawal by Subject|1|||
129463029|NCT03652662|465990712|FG000|Overall Study|Lost to Follow-up|1|||
129463030|NCT03652662|465990713|FG001|Overall Study|Lost to Follow-up|0|||
129463031|NCT00487539|465990714|FG000|Overall Study|Adverse Event|3|||
129463032|NCT00487539|465990715|FG001|Overall Study|Adverse Event|2|||
129463033|NCT00487539|465990716|FG002|Overall Study|Adverse Event|1|||
129463034|NCT00487539|465990717|FG003|Overall Study|Adverse Event|1|||
129463035|NCT00487539|465990714|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129463036|NCT00487539|465990715|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129463037|NCT00487539|465990716|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129463038|NCT00487539|465990717|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
129463039|NCT00487539|465990714|FG000|Overall Study|Other|3|||
129463040|NCT00487539|465990715|FG001|Overall Study|Other|1|||
129463041|NCT00487539|465990716|FG002|Overall Study|Other|2|||
129463042|NCT00487539|465990717|FG003|Overall Study|Other|2|||
129463043|NCT03440814|465990718|FG000|Overall Study|Adverse Event|2|||
129463044|NCT03440814|465990719|FG001|Overall Study|Adverse Event|1|||
129463045|NCT03440814|465990718|FG000|Overall Study|Lost to Follow-up|2|||
129463046|NCT03440814|465990719|FG001|Overall Study|Lost to Follow-up|0|||
129463047|NCT03440814|465990718|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
129463048|NCT03440814|465990719|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
129463049|NCT00879697|465990720|FG000|Overall Study|Physician Decision|2|||
129463050|NCT00879697|465990721|FG001|Overall Study|Physician Decision|2|||
129463051|NCT02751502|465990722|FG000|Overall Study|Lack of funding|4|||
129463052|NCT00088374|465990723|FG000|Overall Study|patient did not receive any 17AAG|1|||
129463053|NCT00088374|465990723|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
129463054|NCT02678390|465990724|FG000|AE (1 Day)|Withdrawal by Subject|0|||
129463055|NCT02678390|465990725|FG001|AE (1 Day)|Withdrawal by Subject|1|||
129463056|NCT03499028|465990726|FG000|Overall Study|Lost to Follow-up|12|||
129463057|NCT03499028|465990727|FG001|Overall Study|Lost to Follow-up|9|||
129463058|NCT03499028|465990726|FG000|Overall Study|Withdrawal by Subject|5|||
129463059|NCT03499028|465990727|FG001|Overall Study|Withdrawal by Subject|8|||
129463060|NCT03499028|465990726|FG000|Overall Study|Unplanned SNF discharge|5|||
129463061|NCT03499028|465990727|FG001|Overall Study|Unplanned SNF discharge|8|||
129463062|NCT00498173|465990728|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
129463063|NCT00498173|465990729|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
129463064|NCT00498173|465990730|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
129463065|NCT03595553|465990731|FG000|Overall Study|Withdrawal by Subject|20|||
129463066|NCT03595553|465990732|FG001|Overall Study|Withdrawal by Subject|8|||
129463067|NCT03595553|465990731|FG000|Overall Study|Physician Decision|3|||
129463068|NCT03595553|465990732|FG001|Overall Study|Physician Decision|2|||
129463069|NCT03595553|465990731|FG000|Overall Study|Adverse Event|2|||
129463070|NCT03595553|465990732|FG001|Overall Study|Adverse Event|5|||
129463071|NCT03595553|465990731|FG000|Overall Study|Death|24|||
129463072|NCT03595553|465990732|FG001|Overall Study|Death|22|||
129463073|NCT03595553|465990731|FG000|Overall Study|Lost to Follow-up|6|||
129463074|NCT03595553|465990732|FG001|Overall Study|Lost to Follow-up|7|||
129463075|NCT03595553|465990731|FG000|Overall Study|Other as indicated in CSR|3|||
129463076|NCT03595553|465990732|FG001|Overall Study|Other as indicated in CSR|3|||
129463077|NCT03595553|465990731|FG000|Overall Study|Sponsor Decision|0|||
129463078|NCT03595553|465990732|FG001|Overall Study|Sponsor Decision|1|||
129463079|NCT01110200|465990733|FG000|Overall Study|Adverse Event|28|||
129463080|NCT01110200|465990734|FG001|Overall Study|Adverse Event|28|||
129463081|NCT01110200|465990733|FG000|Overall Study|Withdrawal by Subject|25|||
129463082|NCT01110200|465990734|FG001|Overall Study|Withdrawal by Subject|32|||
129463083|NCT01110200|465990733|FG000|Overall Study|Lack of Efficacy|16|||
129463084|NCT01110200|465990734|FG001|Overall Study|Lack of Efficacy|25|||
129463085|NCT01110200|465990733|FG000|Overall Study|Protocol Violation|14|||
129463086|NCT01110200|465990734|FG001|Overall Study|Protocol Violation|12|||
129463087|NCT01110200|465990733|FG000|Overall Study|Physician Decision|13|||
129463088|NCT01110200|465990734|FG001|Overall Study|Physician Decision|17|||
129463089|NCT01110200|465990733|FG000|Overall Study|Lost to Follow-up|10|||
129463090|NCT01110200|465990734|FG001|Overall Study|Lost to Follow-up|7|||
129463091|NCT01437397|465990735|FG000|Overall Study|Lost to Follow-up|9|||
129463092|NCT01437397|465990736|FG001|Overall Study|Lost to Follow-up|4|||
129463093|NCT01437397|465990737|FG002|Overall Study|Lost to Follow-up|2|||
129463094|NCT01437397|465990738|FG003|Overall Study|Lost to Follow-up|4|||
129463095|NCT01437397|465990739|FG004|Overall Study|Lost to Follow-up|5|||
129463096|NCT01437397|465990735|FG000|Overall Study|Withdrawal by Subject|11|||
129463097|NCT01437397|465990736|FG001|Overall Study|Withdrawal by Subject|12|||
129463098|NCT01437397|465990737|FG002|Overall Study|Withdrawal by Subject|24|||
129463099|NCT01437397|465990738|FG003|Overall Study|Withdrawal by Subject|11|||
129463100|NCT01437397|465990739|FG004|Overall Study|Withdrawal by Subject|22|||
129463101|NCT01437397|465990735|FG000|Overall Study|Protocol Violation|10|||
129463102|NCT01437397|465990736|FG001|Overall Study|Protocol Violation|12|||
129463103|NCT01437397|465990737|FG002|Overall Study|Protocol Violation|13|||
129463104|NCT01437397|465990738|FG003|Overall Study|Protocol Violation|21|||
129463105|NCT01437397|465990739|FG004|Overall Study|Protocol Violation|19|||
129463106|NCT01437397|465990735|FG000|Overall Study|Lack of Efficacy|5|||
129463107|NCT01437397|465990736|FG001|Overall Study|Lack of Efficacy|4|||
129463108|NCT01437397|465990737|FG002|Overall Study|Lack of Efficacy|8|||
129463109|NCT01437397|465990738|FG003|Overall Study|Lack of Efficacy|10|||
129463110|NCT01437397|465990739|FG004|Overall Study|Lack of Efficacy|20|||
129463111|NCT01437397|465990735|FG000|Overall Study|Adverse Event|21|||
129463112|NCT01437397|465990736|FG001|Overall Study|Adverse Event|22|||
129463113|NCT01437397|465990737|FG002|Overall Study|Adverse Event|16|||
129463114|NCT01437397|465990738|FG003|Overall Study|Adverse Event|14|||
129463115|NCT01437397|465990739|FG004|Overall Study|Adverse Event|21|||
129463116|NCT01437397|465990735|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
129463117|NCT01437397|465990736|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
129463118|NCT01437397|465990737|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
129463119|NCT01437397|465990738|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
129463120|NCT01437397|465990739|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
129463121|NCT00903175|465990740|FG000|Period 1 - First Line|Adverse Event|36|||
129463122|NCT00903175|465990741|FG001|Period 1 - First Line|Adverse Event|50|||
129463123|NCT00903175|465990740|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
129463124|NCT00903175|465990741|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
129463125|NCT00903175|465990740|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
129463126|NCT00903175|465990741|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
129463127|NCT00903175|465990740|FG000|Period 1 - First Line|Protocol Violation|3|||
129463128|NCT00903175|465990741|FG001|Period 1 - First Line|Protocol Violation|3|||
129463129|NCT00903175|465990740|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
129463130|NCT00903175|465990741|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
129463131|NCT00903175|465990740|FG000|Period 1 - First Line|Administrative problems|12|||
129463132|NCT00903175|465990741|FG001|Period 1 - First Line|Administrative problems|13|||
129463133|NCT00903175|465990740|FG000|Period 1 - First Line|Death|17|||
129463134|NCT00903175|465990741|FG001|Period 1 - First Line|Death|10|||
129463135|NCT00903175|465990740|FG000|Period 2 - Second Line|Missing|1|||
129463136|NCT00903175|465990741|FG001|Period 2 - Second Line|Missing|0|||
129463137|NCT00903175|465990740|FG000|Period 2 - Second Line|Adverse Event|16|||
129463138|NCT00903175|465990741|FG001|Period 2 - Second Line|Adverse Event|20|||
129463139|NCT00903175|465990740|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
129463140|NCT00903175|465990741|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
129463141|NCT00903175|465990740|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
129463142|NCT00903175|465990741|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
129463143|NCT00903175|465990740|FG000|Period 2 - Second Line|Administrative problems|19|||
129463144|NCT00903175|465990741|FG001|Period 2 - Second Line|Administrative problems|9|||
129463145|NCT00903175|465990740|FG000|Period 2 - Second Line|Death|5|||
129463146|NCT00903175|465990741|FG001|Period 2 - Second Line|Death|2|||
129463147|NCT01687712|465990742|FG000|Cycle 1|Not Biochemically Pregnant|386|||
129463148|NCT01687712|465990743|FG001|Cycle 1|Not Biochemically Pregnant|348|||
129463149|NCT01687712|465990742|FG000|Cycle 1|Early Pregnancy Loss|43|||
129463150|NCT01687712|465990743|FG001|Cycle 1|Early Pregnancy Loss|60|||
129463151|NCT01687712|465990742|FG000|Cycle 1|Ectopic Pregnancy|5|||
129463152|NCT01687712|465990743|FG001|Cycle 1|Ectopic Pregnancy|5|||
129463153|NCT01687712|465990742|FG000|Cycle 1|Heterotropic Pregnancy|1|||
129463154|NCT01687712|465990743|FG001|Cycle 1|Heterotropic Pregnancy|0|||
129463155|NCT01687712|465990742|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
129463156|NCT01687712|465990743|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
129463157|NCT01687712|465990742|FG000|Cycle 1|Abortion|3|||
129463158|NCT01687712|465990743|FG001|Cycle 1|Abortion|0|||
129463159|NCT01687712|465990742|FG000|Cycle 1|Intrauterine Fetal Death|0|||
129463160|NCT01687712|465990743|FG001|Cycle 1|Intrauterine Fetal Death|1|||
129463161|NCT01687712|465990742|FG000|Cycle 1|Lost to Follow-up|1|||
129463162|NCT01687712|465990743|FG001|Cycle 1|Lost to Follow-up|1|||
129463163|NCT01687712|465990742|FG000|Cycle 2|Not Biochemically Pregnant|74|||
129463164|NCT01687712|465990743|FG001|Cycle 2|Not Biochemically Pregnant|77|||
129463165|NCT01687712|465990742|FG000|Cycle 2|Early Pregnancy Loss|18|||
129463166|NCT01687712|465990743|FG001|Cycle 2|Early Pregnancy Loss|16|||
129463167|NCT01687712|465990742|FG000|Cycle 2|Ectopic Pregnancy|0|||
129463168|NCT01687712|465990743|FG001|Cycle 2|Ectopic Pregnancy|1|||
129463169|NCT01687712|465990742|FG000|Cycle 2|Still Birth|1|||
129463170|NCT01687712|465990743|FG001|Cycle 2|Still Birth|0|||
129463171|NCT01687712|465990742|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
129463172|NCT01687712|465990743|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
129463173|NCT01687712|465990742|FG000|Cycle 3|Not Biochemically Pregnant|21|||
129463174|NCT01687712|465990743|FG001|Cycle 3|Not Biochemically Pregnant|22|||
129463175|NCT01687712|465990742|FG000|Cycle 3|Early Pregnancy Loss|1|||
129463176|NCT01687712|465990743|FG001|Cycle 3|Early Pregnancy Loss|2|||
129463177|NCT01687712|465990742|FG000|Cycle 3|Ectopic Pregnancy|1|||
129463178|NCT01687712|465990743|FG001|Cycle 3|Ectopic Pregnancy|0|||
129463179|NCT01687712|465990742|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
129463180|NCT01687712|465990743|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
129463181|NCT03074474|465990748|FG000|Overall Study|Lost to Follow-up|10|||
129463182|NCT03074474|465990748|FG000|Overall Study|Withdrawal by Subject|10|||
129463183|NCT03074474|465990748|FG000|Overall Study|Death|4|||
129463184|NCT03074474|465990748|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
129463185|NCT01035905|465990751|FG000|Overall Study|Lack of Efficacy|1|||
129463186|NCT01035905|465990752|FG001|Overall Study|Lack of Efficacy|1|||
129463187|NCT00371865|465990753|FG000|Overall Study|Lack of Efficacy|0|||
129463188|NCT00371865|465990754|FG001|Overall Study|Lack of Efficacy|2|||
129463189|NCT00371865|465990753|FG000|Overall Study|Protocol Violation|3|||
129463190|NCT00371865|465990754|FG001|Overall Study|Protocol Violation|2|||
129463191|NCT00371865|465990753|FG000|Overall Study|Withdrawal by Subject|12|||
129463192|NCT00371865|465990754|FG001|Overall Study|Withdrawal by Subject|10|||
129463193|NCT02508194|465990755|FG000|Overall Study|Death|5|||
129463194|NCT02508194|465990756|FG001|Overall Study|Death|3|||
129463195|NCT02508194|465990755|FG000|Overall Study|Lost to Follow-up|25|||
129463196|NCT02508194|465990756|FG001|Overall Study|Lost to Follow-up|18|||
129463197|NCT02508194|465990755|FG000|Overall Study|Withdrawal by Subject|20|||
129463198|NCT02508194|465990756|FG001|Overall Study|Withdrawal by Subject|18|||
129463199|NCT02508194|465990755|FG000|Overall Study|Error in Randomization|1|||
129463200|NCT02508194|465990756|FG001|Overall Study|Error in Randomization|3|||
129463201|NCT02508194|465990755|FG000|Overall Study|Principal Investigator Decision|1|||
129463202|NCT02508194|465990756|FG001|Overall Study|Principal Investigator Decision|2|||
129463203|NCT01632566|465990758|FG000|Overall Study|Withdrawal by Subject|0|||
129463204|NCT01632566|465990759|FG001|Overall Study|Withdrawal by Subject|1|||
129463205|NCT01632566|465990760|FG002|Overall Study|Withdrawal by Subject|0|||
129463206|NCT01632566|465990761|FG003|Overall Study|Withdrawal by Subject|0|||
129463207|NCT01632566|465990762|FG004|Overall Study|Withdrawal by Subject|0|||
129463208|NCT01632566|465990758|FG000|Overall Study|Sponsor Decision|0|||
129463209|NCT01632566|465990759|FG001|Overall Study|Sponsor Decision|2|||
129463210|NCT01632566|465990760|FG002|Overall Study|Sponsor Decision|9|||
129463211|NCT01632566|465990761|FG003|Overall Study|Sponsor Decision|2|||
129463212|NCT01632566|465990762|FG004|Overall Study|Sponsor Decision|2|||
129463213|NCT02158091|465990764|FG000|Overall Study|DLT|2|||
129463214|NCT02158091|465990765|FG001|Overall Study|DLT|1|||
129463215|NCT02158091|465990766|FG002|Overall Study|DLT|0|||
129463216|NCT03977467|465990767|FG000|Overall Study|Disease Progression|1|||
129463217|NCT03977467|465990768|FG001|Overall Study|Disease Progression|1|||
129463218|NCT03977467|465990769|FG002|Overall Study|Disease Progression|30|||
129463219|NCT03977467|465990770|FG003|Overall Study|Disease Progression|0|||
129463220|NCT03977467|465990767|FG000|Overall Study|Adverse Event|0|||
129463221|NCT03977467|465990768|FG001|Overall Study|Adverse Event|1|||
129463222|NCT03977467|465990769|FG002|Overall Study|Adverse Event|0|||
129463223|NCT03977467|465990770|FG003|Overall Study|Adverse Event|0|||
129463224|NCT03977467|465990767|FG000|Overall Study|Death|0|||
129463225|NCT03977467|465990768|FG001|Overall Study|Death|0|||
129463226|NCT03977467|465990769|FG002|Overall Study|Death|3|||
129463227|NCT03977467|465990770|FG003|Overall Study|Death|0|||
129463228|NCT03977467|465990767|FG000|Overall Study|Lack of Efficacy|0|||
129463229|NCT03977467|465990768|FG001|Overall Study|Lack of Efficacy|0|||
129463230|NCT03977467|465990769|FG002|Overall Study|Lack of Efficacy|1|||
129970819|NCT04535544|467856613|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
129970820|NCT04535544|467856614|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
129970821|NCT04535544|467856611|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
129970822|NCT04535544|467856612|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
129463231|NCT03977467|465990770|FG003|Overall Study|Lack of Efficacy|0|||
129463232|NCT03977467|465990767|FG000|Overall Study|Withdrawal by Subject|2|||
129463233|NCT03977467|465990768|FG001|Overall Study|Withdrawal by Subject|1|||
129463234|NCT03977467|465990769|FG002|Overall Study|Withdrawal by Subject|4|||
129463235|NCT03977467|465990770|FG003|Overall Study|Withdrawal by Subject|0|||
129463236|NCT03977467|465990767|FG000|Overall Study|Study Terminated|1|||
129463237|NCT03977467|465990768|FG001|Overall Study|Study Terminated|0|||
129463238|NCT03977467|465990769|FG002|Overall Study|Study Terminated|0|||
129463239|NCT03977467|465990770|FG003|Overall Study|Study Terminated|1|||
129463240|NCT05913232|465990771|FG000|Overall Study|Adverse Event|0|||
129463241|NCT05913232|465990772|FG001|Overall Study|Adverse Event|2|||
129970823|NCT04535544|467856613|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
129970824|NCT04535544|467856614|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
129970825|NCT04535544|467856611|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
129970826|NCT04535544|467856612|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
129970827|NCT04535544|467856613|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
129970828|NCT04535544|467856614|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
129970829|NCT05131477|467856621|FG000|PART 1|Withdrawal by Subject|2|||
129970830|NCT05131477|467856622|FG001|PART 1|Withdrawal by Subject|9|||
129463242|NCT05913232|465990773|FG002|Overall Study|Adverse Event|1|||
129463243|NCT05913232|465990774|FG003|Overall Study|Adverse Event|1|||
129463244|NCT04153188|465990778|FG000|Overall Study|Lost to Follow-up|1|||
129463245|NCT04153188|465990779|FG001|Overall Study|Lost to Follow-up|1|||
129463246|NCT04153188|465990778|FG000|Overall Study|Withdrawal by Subject|2|||
129463247|NCT04153188|465990779|FG001|Overall Study|Withdrawal by Subject|0|||
129463248|NCT04153188|465990778|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
129463249|NCT04153188|465990779|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
129463250|NCT00264238|465990781|FG000|Overall Study|Protocol Violation|1|||
129463251|NCT00700271|465990782|FG000|Overall Study|Adverse Event|4|||
129463252|NCT00700271|465990783|FG001|Overall Study|Adverse Event|6|||
129463253|NCT00700271|465990782|FG000|Overall Study|Protocol Violation|1|||
129463254|NCT00700271|465990783|FG001|Overall Study|Protocol Violation|0|||
129463255|NCT00700271|465990782|FG000|Overall Study|Administrative Reasons|1|||
129463256|NCT00700271|465990783|FG001|Overall Study|Administrative Reasons|0|||
129463257|NCT00700271|465990782|FG000|Overall Study|Withdrawal by Subject|6|||
129463258|NCT00700271|465990783|FG001|Overall Study|Withdrawal by Subject|4|||
129463259|NCT00700271|465990782|FG000|Overall Study|Lost to Follow-up|2|||
129463260|NCT00700271|465990783|FG001|Overall Study|Lost to Follow-up|2|||
129463261|NCT00861744|465990784|FG000|Overall Study|Adverse Event|0|||
129463262|NCT00861744|465990785|FG001|Overall Study|Adverse Event|0|||
129463263|NCT00861744|465990786|FG002|Overall Study|Adverse Event|0|||
129463264|NCT00861744|465990787|FG003|Overall Study|Adverse Event|1|||
129463265|NCT00861744|465990784|FG000|Overall Study|Lost to Follow-up|7|||
129463266|NCT00861744|465990785|FG001|Overall Study|Lost to Follow-up|19|||
129463267|NCT00861744|465990786|FG002|Overall Study|Lost to Follow-up|17|||
129463268|NCT00861744|465990787|FG003|Overall Study|Lost to Follow-up|12|||
129463269|NCT00861744|465990784|FG000|Overall Study|Withdrawal by Subject|10|||
129463270|NCT00861744|465990785|FG001|Overall Study|Withdrawal by Subject|6|||
129463271|NCT00861744|465990786|FG002|Overall Study|Withdrawal by Subject|6|||
129463272|NCT00861744|465990787|FG003|Overall Study|Withdrawal by Subject|19|||
129463273|NCT00861744|465990784|FG000|Overall Study|Protocol Violation|0|||
129463274|NCT00861744|465990785|FG001|Overall Study|Protocol Violation|1|||
129463275|NCT00861744|465990786|FG002|Overall Study|Protocol Violation|0|||
129463276|NCT00861744|465990787|FG003|Overall Study|Protocol Violation|0|||
129463277|NCT00861744|465990784|FG000|Overall Study|Migration from study area|0|||
129463278|NCT00861744|465990785|FG001|Overall Study|Migration from study area|3|||
129463279|NCT00861744|465990786|FG002|Overall Study|Migration from study area|1|||
129463280|NCT00861744|465990787|FG003|Overall Study|Migration from study area|0|||
129463281|NCT00861744|465990784|FG000|Overall Study|Blood draws|0|||
129463282|NCT00861744|465990785|FG001|Overall Study|Blood draws|0|||
129463283|NCT00861744|465990786|FG002|Overall Study|Blood draws|0|||
129463284|NCT00861744|465990787|FG003|Overall Study|Blood draws|1|||
129463285|NCT05107765|465990788|FG000|Overall Study|Lost to Follow-up|4|||
129463286|NCT05107765|465990789|FG001|Overall Study|Lost to Follow-up|1|||
129970831|NCT05131477|467856623|FG002|PART 1|Withdrawal by Subject|6|||
129970832|NCT05131477|467856624|FG003|PART 1|Withdrawal by Subject|2|||
129970833|NCT05131477|467856625|FG004|PART 1|Withdrawal by Subject|8|||
129970834|NCT05131477|467856626|FG005|PART 1|Withdrawal by Subject|0|||
129463287|NCT05107765|465990788|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
129970835|NCT05131477|467856627|FG006|PART 1|Withdrawal by Subject|0|||
129970836|NCT05131477|467856628|FG007|PART 1|Withdrawal by Subject|0|||
129463288|NCT05107765|465990789|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
129463289|NCT05107765|465990788|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
129463290|NCT05107765|465990789|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
129463291|NCT01411085|465990792|FG000|Overall Study|Physician Decision|1|||
129463292|NCT01411085|465990792|FG000|Overall Study|Protocol Violation|1|||
129463293|NCT01411085|465990792|FG000|Overall Study|Adverse Event|1|||
129463294|NCT03809611|465990793|FG000|Overall Study|Withdrawal by Subject|1|||
129463295|NCT03809611|465990794|FG001|Overall Study|Withdrawal by Subject|1|||
129463296|NCT02193074|465990795|FG000|Overall Study|Withdrawal by Subject|1|||
129463297|NCT02193074|465990796|FG001|Overall Study|Withdrawal by Subject|2|||
129463298|NCT02193074|465990795|FG000|Overall Study|Adverse Event|16|||
129463299|NCT02193074|465990796|FG001|Overall Study|Adverse Event|13|||
129463300|NCT01534533|465990797|FG000|Overall Study|Lost to Follow-up|3|||
129463301|NCT01534533|465990798|FG001|Overall Study|Lost to Follow-up|0|||
129463302|NCT01534533|465990799|FG002|Overall Study|Lost to Follow-up|4|||
129463303|NCT01534533|465990800|FG003|Overall Study|Lost to Follow-up|3|||
129463304|NCT01534533|465990797|FG000|Overall Study|Withdrawal by Subject|5|||
129463305|NCT01534533|465990798|FG001|Overall Study|Withdrawal by Subject|3|||
129463306|NCT01534533|465990799|FG002|Overall Study|Withdrawal by Subject|4|||
129463307|NCT01534533|465990800|FG003|Overall Study|Withdrawal by Subject|1|||
129463308|NCT03368170|465992362|FG000|Overall Study|Adverse Event|2|||
129463309|NCT03368170|465992363|FG001|Overall Study|Adverse Event|1|||
129463310|NCT01662440|465992368|FG000|Overall Study|Adverse Event|1|||
129463311|NCT01662440|465992369|FG001|Overall Study|Adverse Event|0|||
129463312|NCT01662440|465992370|FG002|Overall Study|Adverse Event|0|||
129463313|NCT01662440|465992371|FG003|Overall Study|Adverse Event|1|||
129463314|NCT01662440|465992368|FG000|Overall Study|Death|0|||
129463315|NCT01662440|465992369|FG001|Overall Study|Death|1|||
129463316|NCT01662440|465992370|FG002|Overall Study|Death|0|||
129463317|NCT01662440|465992371|FG003|Overall Study|Death|0|||
129463318|NCT01662440|465992368|FG000|Overall Study|Lost to Follow-up|2|||
129463319|NCT01662440|465992369|FG001|Overall Study|Lost to Follow-up|2|||
129463320|NCT01662440|465992370|FG002|Overall Study|Lost to Follow-up|4|||
129463321|NCT01662440|465992371|FG003|Overall Study|Lost to Follow-up|1|||
129463322|NCT01662440|465992368|FG000|Overall Study|Subject moved to another country.|0|||
129463323|NCT01662440|465992369|FG001|Overall Study|Subject moved to another country.|1|||
129463324|NCT01662440|465992370|FG002|Overall Study|Subject moved to another country.|0|||
129463325|NCT01662440|465992371|FG003|Overall Study|Subject moved to another country.|0|||
129463326|NCT01662440|465992368|FG000|Overall Study|Protocol Violation|1|||
129463327|NCT01662440|465992369|FG001|Overall Study|Protocol Violation|0|||
129463328|NCT01662440|465992370|FG002|Overall Study|Protocol Violation|0|||
129463329|NCT01662440|465992371|FG003|Overall Study|Protocol Violation|0|||
129463330|NCT01662440|465992368|FG000|Overall Study|Withdrawal by Subject|5|||
129463331|NCT01662440|465992369|FG001|Overall Study|Withdrawal by Subject|2|||
129463332|NCT01662440|465992370|FG002|Overall Study|Withdrawal by Subject|2|||
129463333|NCT01662440|465992371|FG003|Overall Study|Withdrawal by Subject|2|||
129463334|NCT01661140|465992372|FG000|Open-Label Period|Adverse Event|44|||
129463335|NCT01661140|465992373|FG001|Open-Label Period|Adverse Event|0|||
129463336|NCT01661140|465992374|FG002|Open-Label Period|Adverse Event|0|||
129463337|NCT01661140|465992372|FG000|Open-Label Period|Protocol Violation|3|||
129463338|NCT01661140|465992373|FG001|Open-Label Period|Protocol Violation|0|||
129463339|NCT01661140|465992374|FG002|Open-Label Period|Protocol Violation|0|||
129463340|NCT01661140|465992372|FG000|Open-Label Period|Withdrawal by Subject|5|||
129463341|NCT01661140|465992373|FG001|Open-Label Period|Withdrawal by Subject|0|||
129463342|NCT01661140|465992374|FG002|Open-Label Period|Withdrawal by Subject|0|||
129463343|NCT01661140|465992372|FG000|Open-Label Period|Investigator Decision|3|||
129463344|NCT01661140|465992373|FG001|Open-Label Period|Investigator Decision|0|||
129463345|NCT01661140|465992374|FG002|Open-Label Period|Investigator Decision|0|||
129463346|NCT01661140|465992372|FG000|Open-Label Period|Death|1|||
129463347|NCT01661140|465992373|FG001|Open-Label Period|Death|0|||
129463348|NCT01661140|465992374|FG002|Open-Label Period|Death|0|||
129463349|NCT01661140|465992372|FG000|Open-Label Period|Administrative/Other|1|||
129463350|NCT01661140|465992373|FG001|Open-Label Period|Administrative/Other|0|||
129463351|NCT01661140|465992374|FG002|Open-Label Period|Administrative/Other|0|||
129463352|NCT01661140|465992372|FG000|Open-Label Period|Sponsor termination|16|||
129463353|NCT01661140|465992373|FG001|Open-Label Period|Sponsor termination|0|||
129463354|NCT01661140|465992374|FG002|Open-Label Period|Sponsor termination|0|||
129463355|NCT01661140|465992372|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
129463356|NCT01661140|465992373|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
129463357|NCT01661140|465992374|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
129463358|NCT01661140|465992372|FG000|Open-Label Period|Lost to Follow-up|2|||
129970837|NCT05131477|467856629|FG008|PART 1|Withdrawal by Subject|0|||
129970838|NCT05131477|467856630|FG009|PART 1|Withdrawal by Subject|0|||
129463359|NCT01661140|465992373|FG001|Open-Label Period|Lost to Follow-up|0|||
129463360|NCT01661140|465992374|FG002|Open-Label Period|Lost to Follow-up|0|||
129463361|NCT01661140|465992372|FG000|Double-Blind Period|Refused Treatment|0|||
129463362|NCT01661140|465992373|FG001|Double-Blind Period|Refused Treatment|0|||
129463363|NCT01661140|465992374|FG002|Double-Blind Period|Refused Treatment|1|||
129463364|NCT01661140|465992372|FG000|Double-Blind Period|Adverse Event|0|||
129463365|NCT01661140|465992373|FG001|Double-Blind Period|Adverse Event|16|||
129463366|NCT01661140|465992374|FG002|Double-Blind Period|Adverse Event|18|||
129463367|NCT01661140|465992372|FG000|Double-Blind Period|Protocol Violation|0|||
129463368|NCT01661140|465992373|FG001|Double-Blind Period|Protocol Violation|2|||
129463369|NCT01661140|465992374|FG002|Double-Blind Period|Protocol Violation|3|||
129463370|NCT01661140|465992372|FG000|Double-Blind Period|Withdrawal by Subject|0|||
129463371|NCT01661140|465992373|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129463372|NCT01661140|465992374|FG002|Double-Blind Period|Withdrawal by Subject|3|||
129463373|NCT01661140|465992372|FG000|Double-Blind Period|Investigator's Decision|0|||
129463374|NCT01661140|465992373|FG001|Double-Blind Period|Investigator's Decision|1|||
129463375|NCT01661140|465992374|FG002|Double-Blind Period|Investigator's Decision|2|||
129463376|NCT01661140|465992372|FG000|Double-Blind Period|Sponsor Termination|0|||
129463377|NCT01661140|465992373|FG001|Double-Blind Period|Sponsor Termination|14|||
129463378|NCT01661140|465992374|FG002|Double-Blind Period|Sponsor Termination|17|||
129463379|NCT01661140|465992372|FG000|Double-Blind Period|Administrative/Other|0|||
129463380|NCT01661140|465992373|FG001|Double-Blind Period|Administrative/Other|7|||
129463381|NCT01661140|465992374|FG002|Double-Blind Period|Administrative/Other|6|||
129463382|NCT02787850|465992377|FG000|Overall Study|Withdrawal by Subject|0|||
129463383|NCT02787850|465992378|FG001|Overall Study|Withdrawal by Subject|1|||
129463384|NCT00494091|465992381|FG000|Overall Study|Death|5|||
129463385|NCT00494091|465992382|FG001|Overall Study|Death|54|||
129463386|NCT00494091|465992381|FG000|Overall Study|Lost to Follow-up|0|||
129463387|NCT00494091|465992382|FG001|Overall Study|Lost to Follow-up|4|||
129463388|NCT00494091|465992381|FG000|Overall Study|Other|1|||
129463389|NCT00494091|465992382|FG001|Overall Study|Other|11|||
129463390|NCT00494091|465992381|FG000|Overall Study|Withdrawal by Subject|0|||
129463391|NCT00494091|465992382|FG001|Overall Study|Withdrawal by Subject|7|||
129463392|NCT02921971|465992383|FG000|Overall Study|Adverse Event|1|||
129463393|NCT02921971|465992384|FG001|Overall Study|Adverse Event|2|||
129463394|NCT02921971|465992383|FG000|Overall Study|Lack of Efficacy|3|||
129463395|NCT02921971|465992384|FG001|Overall Study|Lack of Efficacy|1|||
129463396|NCT02921971|465992383|FG000|Overall Study|Other than specified above|2|||
129463397|NCT02921971|465992384|FG001|Overall Study|Other than specified above|1|||
129463398|NCT00452699|465992385|FG000|Overall Study|Adverse Event|10|||
129463399|NCT00452699|465992386|FG001|Overall Study|Adverse Event|3|||
129463400|NCT00452699|465992385|FG000|Overall Study|Lack of Efficacy|6|||
129463401|NCT00452699|465992386|FG001|Overall Study|Lack of Efficacy|4|||
129463402|NCT00452699|465992385|FG000|Overall Study|Lost to Follow-up|6|||
129463403|NCT00452699|465992386|FG001|Overall Study|Lost to Follow-up|9|||
129463404|NCT00452699|465992385|FG000|Overall Study|Protocol Violation|21|||
129463405|NCT00452699|465992386|FG001|Overall Study|Protocol Violation|25|||
129463406|NCT00452699|465992385|FG000|Overall Study|Withdrawal by Subject|26|||
129463407|NCT00452699|465992386|FG001|Overall Study|Withdrawal by Subject|25|||
129463408|NCT00452699|465992385|FG000|Overall Study|Other|12|||
129463409|NCT00452699|465992386|FG001|Overall Study|Other|7|||
129463410|NCT00326898|465992387|FG000|Overall Study|Disease progression|52|||
129463411|NCT00326898|465992388|FG001|Overall Study|Disease progression|54|||
129463412|NCT00326898|465992389|FG002|Overall Study|Disease progression|102|||
129463413|NCT00326898|465992387|FG000|Overall Study|Adverse Event|124|||
129463414|NCT00326898|465992388|FG001|Overall Study|Adverse Event|128|||
129463415|NCT00326898|465992389|FG002|Overall Study|Adverse Event|33|||
129463416|NCT00326898|465992387|FG000|Overall Study|Death|2|||
129463417|NCT00326898|465992388|FG001|Overall Study|Death|0|||
129463418|NCT00326898|465992389|FG002|Overall Study|Death|0|||
129463419|NCT00326898|465992387|FG000|Overall Study|Withdrawal by Subject|134|||
129463420|NCT00326898|465992388|FG001|Overall Study|Withdrawal by Subject|128|||
129463421|NCT00326898|465992389|FG002|Overall Study|Withdrawal by Subject|32|||
129463422|NCT00326898|465992387|FG000|Overall Study|Alternative therapy|1|||
129463423|NCT00326898|465992388|FG001|Overall Study|Alternative therapy|0|||
129463424|NCT00326898|465992389|FG002|Overall Study|Alternative therapy|0|||
129463425|NCT00326898|465992387|FG000|Overall Study|Other complicating disease|5|||
129970839|NCT05131477|467856631|FG010|PART 1|Withdrawal by Subject|0|||
129970840|NCT05131477|467856632|FG011|PART 1|Withdrawal by Subject|0|||
129970841|NCT05131477|467856633|FG012|PART 1|Withdrawal by Subject|0|||
129970842|NCT05131477|467856634|FG013|PART 1|Withdrawal by Subject|0|||
129970843|NCT05131477|467856621|FG000|PART 1|Physician Decision|1|||
129970844|NCT05131477|467856622|FG001|PART 1|Physician Decision|0|||
129970845|NCT05131477|467856623|FG002|PART 1|Physician Decision|0|||
129463426|NCT00326898|465992388|FG001|Overall Study|Other complicating disease|5|||
129463427|NCT00326898|465992389|FG002|Overall Study|Other complicating disease|4|||
129463428|NCT00326898|465992387|FG000|Overall Study|Other/Missing/Unknown|33|||
129463429|NCT00326898|465992388|FG001|Overall Study|Other/Missing/Unknown|28|||
129463430|NCT00326898|465992389|FG002|Overall Study|Other/Missing/Unknown|32|||
129463431|NCT03847987|465992390|FG000|Overall Study|Lost to Follow-up|1|||
129463432|NCT03847987|465992391|FG001|Overall Study|Lost to Follow-up|0|||
129463433|NCT03847987|465992390|FG000|Overall Study|Adverse Event|2|||
129970846|NCT05131477|467856624|FG003|PART 1|Physician Decision|0|||
129463434|NCT03847987|465992391|FG001|Overall Study|Adverse Event|0|||
129463435|NCT01637142|465992400|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
129463436|NCT02111564|465992401|FG000|Overall Study|Death|109|||
129463437|NCT02111564|465992402|FG001|Overall Study|Death|120|||
129463438|NCT02111564|465992401|FG000|Overall Study|Lost to Follow-up|2|||
129463439|NCT02111564|465992402|FG001|Overall Study|Lost to Follow-up|3|||
129463440|NCT02111564|465992401|FG000|Overall Study|Withdrawal by Subject|20|||
129970847|NCT05131477|467856625|FG004|PART 1|Physician Decision|0|||
129463441|NCT02111564|465992402|FG001|Overall Study|Withdrawal by Subject|20|||
129463442|NCT00687362|465992403|FG000|Overall Study|Protocol Violation|2|||
129463443|NCT00687362|465992403|FG000|Overall Study|Withdrawal by Subject|1|||
129463444|NCT02354703|465992404|FG000|Overall Study|Withdrawal by Subject|1|||
129463445|NCT02354703|465992405|FG001|Overall Study|Withdrawal by Subject|1|||
129463446|NCT02354703|465992406|FG002|Overall Study|Withdrawal by Subject|1|||
129463447|NCT02354703|465992407|FG003|Overall Study|Withdrawal by Subject|1|||
129463448|NCT02354703|465992404|FG000|Overall Study|Lost to Follow-up|2|||
129463449|NCT02354703|465992405|FG001|Overall Study|Lost to Follow-up|7|||
129463450|NCT02354703|465992406|FG002|Overall Study|Lost to Follow-up|9|||
129463451|NCT02354703|465992407|FG003|Overall Study|Lost to Follow-up|2|||
129463452|NCT02354703|465992404|FG000|Overall Study|Adverse Event|0|||
129463453|NCT02354703|465992405|FG001|Overall Study|Adverse Event|0|||
129463454|NCT02354703|465992406|FG002|Overall Study|Adverse Event|1|||
129463455|NCT02354703|465992407|FG003|Overall Study|Adverse Event|0|||
129463456|NCT05499559|465992412|FG000|Overall Study|Lost to Follow-up|467|||
129463457|NCT04986202|465992413|FG000|Overall Study|Death|10|||
129463458|NCT04986202|465992414|FG001|Overall Study|Death|3|||
129463459|NCT04986202|465992415|FG002|Overall Study|Death|10|||
129463460|NCT04986202|465992413|FG000|Overall Study|Physician Decision|3|||
129463461|NCT04986202|465992414|FG001|Overall Study|Physician Decision|1|||
129463462|NCT04986202|465992415|FG002|Overall Study|Physician Decision|2|||
129463463|NCT04986202|465992413|FG000|Overall Study|Withdrawal by Subject|4|||
129463464|NCT04986202|465992414|FG001|Overall Study|Withdrawal by Subject|2|||
129463465|NCT04986202|465992415|FG002|Overall Study|Withdrawal by Subject|4|||
129463466|NCT02468648|465992416|FG000|Overall Study|Death|1|||
129463467|NCT02118792|465992417|FG000|Overall Study|Withdrawal by Subject|6|||
129463468|NCT02118792|465992418|FG001|Overall Study|Withdrawal by Subject|3|||
129463469|NCT02118792|465992417|FG000|Overall Study|Lost to Follow-up|4|||
129463470|NCT02118792|465992418|FG001|Overall Study|Lost to Follow-up|4|||
129463471|NCT02118792|465992417|FG000|Overall Study|Adverse Event|5|||
129463472|NCT02118792|465992418|FG001|Overall Study|Adverse Event|4|||
129463473|NCT02118792|465992417|FG000|Overall Study|Withdrawal by parent/guardian|14|||
129463474|NCT02118792|465992418|FG001|Overall Study|Withdrawal by parent/guardian|20|||
129463475|NCT02118792|465992417|FG000|Overall Study|Other|1|||
129463476|NCT02118792|465992418|FG001|Overall Study|Other|6|||
129463477|NCT02118792|465992417|FG000|Overall Study|Randomised but not treated|1|||
129463478|NCT02118792|465992418|FG001|Overall Study|Randomised but not treated|0|||
129463479|NCT05131204|465992419|FG000|Overall Study|Sponsor request|2|||
129463480|NCT05131204|465992420|FG001|Overall Study|Sponsor request|1|||
129463481|NCT01415752|465992431|FG000|Induction (Step 1)|Ineligible|4|||
129463482|NCT01415752|465992432|FG001|Induction (Step 1)|Ineligible|3|||
129463483|NCT01415752|465992433|FG002|Induction (Step 1)|Ineligible|4|||
129463484|NCT01415752|465992434|FG003|Induction (Step 1)|Ineligible|4|||
129463485|NCT01415752|465992431|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
129463486|NCT01415752|465992432|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
129463487|NCT01415752|465992433|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
129463488|NCT01415752|465992434|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
129463489|NCT01415752|465992431|FG000|Maintenance (Step 2)|Adverse Event|3|||
129463490|NCT01415752|465992432|FG001|Maintenance (Step 2)|Adverse Event|4|||
129463491|NCT01415752|465992433|FG002|Maintenance (Step 2)|Adverse Event|9|||
129463492|NCT01415752|465992434|FG003|Maintenance (Step 2)|Adverse Event|6|||
129463493|NCT01415752|465992431|FG000|Maintenance (Step 2)|Death|1|||
129463494|NCT01415752|465992432|FG001|Maintenance (Step 2)|Death|1|||
129463495|NCT01415752|465992433|FG002|Maintenance (Step 2)|Death|2|||
129463496|NCT01415752|465992434|FG003|Maintenance (Step 2)|Death|0|||
129463497|NCT01415752|465992431|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
129463498|NCT01415752|465992432|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
129463499|NCT01415752|465992433|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
129463500|NCT01415752|465992434|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
129463501|NCT01415752|465992431|FG000|Maintenance (Step 2)|Alternative therapy|0|||
129463502|NCT01415752|465992432|FG001|Maintenance (Step 2)|Alternative therapy|1|||
129463503|NCT01415752|465992433|FG002|Maintenance (Step 2)|Alternative therapy|0|||
129463504|NCT01415752|465992434|FG003|Maintenance (Step 2)|Alternative therapy|0|||
129463505|NCT01415752|465992431|FG000|Maintenance (Step 2)|Other reasons|3|||
129463506|NCT01415752|465992432|FG001|Maintenance (Step 2)|Other reasons|6|||
129463507|NCT01415752|465992433|FG002|Maintenance (Step 2)|Other reasons|4|||
129463508|NCT01415752|465992434|FG003|Maintenance (Step 2)|Other reasons|6|||
129463509|NCT01415752|465992431|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
129463510|NCT01415752|465992432|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
129463511|NCT01415752|465992433|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
129463512|NCT01415752|465992434|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
129463513|NCT01415752|465992431|FG000|Maintenance (Step 2)|ineligible|1|||
129463514|NCT01415752|465992432|FG001|Maintenance (Step 2)|ineligible|1|||
129463515|NCT01415752|465992433|FG002|Maintenance (Step 2)|ineligible|1|||
129463516|NCT01415752|465992434|FG003|Maintenance (Step 2)|ineligible|0|||
129463517|NCT01415752|465992431|FG000|Maintenance (Step 2)|Missing|4|||
129463518|NCT01415752|465992432|FG001|Maintenance (Step 2)|Missing|1|||
129463519|NCT01415752|465992433|FG002|Maintenance (Step 2)|Missing|4|||
129970848|NCT05131477|467856626|FG005|PART 1|Physician Decision|0|||
129970849|NCT05131477|467856627|FG006|PART 1|Physician Decision|0|||
129970850|NCT05131477|467856628|FG007|PART 1|Physician Decision|0|||
129463520|NCT01415752|465992434|FG003|Maintenance (Step 2)|Missing|3|||
129463521|NCT01903837|465992436|FG000|Part A|Withdrawal by Subject|4|||
129463522|NCT01903837|465992437|FG001|Part A|Withdrawal by Subject|9|||
129463523|NCT01903837|465992438|FG002|Part A|Withdrawal by Subject|8|||
129463524|NCT01903837|465992439|FG003|Part A|Withdrawal by Subject|5|||
129970851|NCT05131477|467856629|FG008|PART 1|Physician Decision|0|||
129463525|NCT01903837|465992436|FG000|Part A|Adverse Event|3|||
129463526|NCT01903837|465992437|FG001|Part A|Adverse Event|6|||
129463527|NCT01903837|465992438|FG002|Part A|Adverse Event|9|||
129463528|NCT01903837|465992439|FG003|Part A|Adverse Event|6|||
129463529|NCT01903837|465992436|FG000|Part A|Lost to Follow-up|9|||
129463530|NCT01903837|465992437|FG001|Part A|Lost to Follow-up|7|||
129463531|NCT01903837|465992438|FG002|Part A|Lost to Follow-up|7|||
129463532|NCT01903837|465992439|FG003|Part A|Lost to Follow-up|2|||
129463533|NCT01903837|465992436|FG000|Part A|Non-compliance with study drug|1|||
129463534|NCT01903837|465992437|FG001|Part A|Non-compliance with study drug|4|||
129463535|NCT01903837|465992438|FG002|Part A|Non-compliance with study drug|4|||
129463536|NCT01903837|465992439|FG003|Part A|Non-compliance with study drug|0|||
129463537|NCT01903837|465992436|FG000|Part A|Physician Decision|1|||
129463538|NCT01903837|465992437|FG001|Part A|Physician Decision|1|||
129463539|NCT01903837|465992438|FG002|Part A|Physician Decision|0|||
129463540|NCT01903837|465992439|FG003|Part A|Physician Decision|0|||
129463541|NCT01903837|465992436|FG000|Part A|Protocol Violation|1|||
129463542|NCT01903837|465992437|FG001|Part A|Protocol Violation|1|||
129463543|NCT01903837|465992438|FG002|Part A|Protocol Violation|0|||
129463544|NCT01903837|465992439|FG003|Part A|Protocol Violation|0|||
129463545|NCT01903837|465992436|FG000|Part B|Lost to Follow-up|0|||
129463546|NCT01903837|465992437|FG001|Part B|Lost to Follow-up|3|||
129463547|NCT01903837|465992438|FG002|Part B|Lost to Follow-up|3|||
129463548|NCT01903837|465992439|FG003|Part B|Lost to Follow-up|4|||
129463549|NCT01903837|465992436|FG000|Part B|Withdrawal by Subject|1|||
129463550|NCT01903837|465992437|FG001|Part B|Withdrawal by Subject|2|||
129463551|NCT01903837|465992438|FG002|Part B|Withdrawal by Subject|0|||
129463552|NCT01903837|465992439|FG003|Part B|Withdrawal by Subject|3|||
129463553|NCT01903837|465992436|FG000|Part B|Adverse Event|3|||
129463554|NCT01903837|465992437|FG001|Part B|Adverse Event|0|||
129463555|NCT01903837|465992438|FG002|Part B|Adverse Event|2|||
129463556|NCT01903837|465992439|FG003|Part B|Adverse Event|0|||
129463557|NCT01903837|465992436|FG000|Part B|Non-compliance with study drug|2|||
129463558|NCT01903837|465992437|FG001|Part B|Non-compliance with study drug|0|||
129463559|NCT01903837|465992438|FG002|Part B|Non-compliance with study drug|0|||
129463560|NCT01903837|465992439|FG003|Part B|Non-compliance with study drug|1|||
129463561|NCT01903837|465992436|FG000|Part B|Incarceration|2|||
129463562|NCT01903837|465992437|FG001|Part B|Incarceration|0|||
129463563|NCT01903837|465992438|FG002|Part B|Incarceration|0|||
129463564|NCT01903837|465992439|FG003|Part B|Incarceration|1|||
129463565|NCT01903837|465992436|FG000|Part B|Physician Decision|1|||
129463566|NCT01903837|465992437|FG001|Part B|Physician Decision|0|||
129463567|NCT01903837|465992438|FG002|Part B|Physician Decision|0|||
129463568|NCT01903837|465992439|FG003|Part B|Physician Decision|2|||
129463569|NCT01903837|465992436|FG000|Part B|Lack of Efficacy|0|||
129463570|NCT01903837|465992437|FG001|Part B|Lack of Efficacy|1|||
129463571|NCT01903837|465992438|FG002|Part B|Lack of Efficacy|0|||
129463572|NCT01903837|465992439|FG003|Part B|Lack of Efficacy|0|||
129463573|NCT00705939|465992441|FG000|Overall Study|Protocol Violation|0|||
129463574|NCT00705939|465992442|FG001|Overall Study|Protocol Violation|0|||
129463575|NCT00705939|465992443|FG002|Overall Study|Protocol Violation|1|||
129463576|NCT00705939|465992441|FG000|Overall Study|Withdrawal by Subject|0|||
129463577|NCT00705939|465992442|FG001|Overall Study|Withdrawal by Subject|1|||
129463578|NCT00705939|465992443|FG002|Overall Study|Withdrawal by Subject|3|||
129463579|NCT00705939|465992441|FG000|Overall Study|Physician Decision|0|||
129463580|NCT00705939|465992442|FG001|Overall Study|Physician Decision|1|||
129463581|NCT00705939|465992443|FG002|Overall Study|Physician Decision|0|||
129463582|NCT05048342|465992444|FG000|Overall Study|Adverse Event|1|||
129463583|NCT05048342|465992444|FG000|Overall Study|Subject decision|2|||
129463584|NCT01441063|465992445|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
129463585|NCT01441063|465992445|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
129463586|NCT04372927|465992446|FG000|Overall Study|Death|1|||
129463587|NCT00661271|465992447|FG000|Overall Study|Lost to Follow-up|28|||
129463588|NCT00661271|465992448|FG001|Overall Study|Lost to Follow-up|25|||
129463589|NCT01707693|465992450|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
129463590|NCT01707693|465992451|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
129463591|NCT01707693|465992450|FG000|Overall Study Allocation|Protocol Violation|4|||
129463592|NCT01707693|465992451|FG001|Overall Study Allocation|Protocol Violation|3|||
129463593|NCT01707693|465992450|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
129463594|NCT01707693|465992451|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
129463595|NCT01707693|465992450|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
129463596|NCT01707693|465992451|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
129463597|NCT01325428|465992452|FG000|Part A|Progressive disease according to RECIST|9|||
129463598|NCT01325428|465992452|FG000|Part A|Clinical signs, symptoms of progression|2|||
129463599|NCT01325428|465992452|FG000|Part A|Other adverse event|1|||
129463600|NCT01325428|465992452|FG000|Part A|Refused continue taking trial medication|2|||
129463601|NCT01325428|465992452|FG000|Part A|Other reason not defined above|2|||
129463602|NCT01325428|465992452|FG000|Part B|Refused continue taking trial medication|2|||
129463603|NCT01325428|465992452|FG000|Part B|Other reason not defined above|1|||
129463604|NCT03847610|465992453|FG000|Overall Study|Withdrawal by Subject|1|||
129463605|NCT03099707|465992454|FG000|Overall Study|Withdrawal by Subject|0|||
129463606|NCT03099707|465992455|FG001|Overall Study|Withdrawal by Subject|3|||
129463607|NCT03099707|465992454|FG000|Overall Study|Lost to Follow-up|0|||
129463608|NCT03099707|465992455|FG001|Overall Study|Lost to Follow-up|1|||
129463609|NCT01445769|465992456|FG000|Overall Study|Consent Withdrawn|2|||
129463610|NCT01445769|465992456|FG000|Overall Study|Disease Progression|1|||
129463611|NCT01445769|465992456|FG000|Overall Study|Lost to Follow-up|5|||
129463612|NCT00343889|465992479|FG000|Overall Study|Lost to Follow-up|2|||
129463613|NCT00343889|465992480|FG001|Overall Study|Lost to Follow-up|0|||
129463614|NCT00343889|465992479|FG000|Overall Study|Withdrawal by Subject|0|||
129463615|NCT00343889|465992480|FG001|Overall Study|Withdrawal by Subject|1|||
129463616|NCT00343889|465992479|FG000|Overall Study|Protocol Violation|1|||
129463617|NCT00343889|465992480|FG001|Overall Study|Protocol Violation|0|||
129463618|NCT01294579|465992483|FG000|Overall Study|Disease progression|12|||
129463619|NCT01294579|465992483|FG000|Overall Study|Adverse Event|11|||
129463620|NCT01294579|465992483|FG000|Overall Study|Study closed/terminated|3|||
129463621|NCT01294579|465992483|FG000|Overall Study|Lost to Follow-up|1|||
129463622|NCT01294579|465992483|FG000|Overall Study|Physician Decision|3|||
129463623|NCT01294579|465992483|FG000|Overall Study|Withdrawal by Subject|5|||
129463624|NCT01967537|465992486|FG000|Overall Study|Withdrawal by Subject|52|||
129463625|NCT01967537|465992486|FG000|Overall Study|Refuse treatment|2|||
129463626|NCT01967537|465992486|FG000|Overall Study|Lost to Follow-up|6|||
129463627|NCT01079182|465992487|FG000|Overall Study|Lost to Follow-up|1634|||
129463628|NCT01079182|465992487|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
129463629|NCT01079182|465992487|FG000|Overall Study|Lack of Efficacy|514|||
129463630|NCT01079182|465992487|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
129463631|NCT01079182|465992487|FG000|Overall Study|Reasons not Evaluated|271|||
129463632|NCT05130463|465992488|FG000|Overall Study|Unspecified reasons|2|||
129463633|NCT05130463|465992488|FG000|Overall Study|off-label indication dose|435|||
129463634|NCT03461757|465992489|FG000|Overall Study|Adverse Event|1|||
129463635|NCT03461757|465992490|FG001|Overall Study|Adverse Event|0|||
129463636|NCT03461757|465992489|FG000|Overall Study|Lost to Follow-up|13|||
129463637|NCT03461757|465992490|FG001|Overall Study|Lost to Follow-up|7|||
129463638|NCT03461757|465992489|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
129970852|NCT05131477|467856630|FG009|PART 1|Physician Decision|0|||
129970853|NCT05131477|467856631|FG010|PART 1|Physician Decision|0|||
129970854|NCT05131477|467856632|FG011|PART 1|Physician Decision|0|||
129970855|NCT05131477|467856633|FG012|PART 1|Physician Decision|0|||
129970856|NCT05131477|467856634|FG013|PART 1|Physician Decision|0|||
129970857|NCT05131477|467856621|FG000|PART 1|Adverse Event|3|||
129970858|NCT05131477|467856622|FG001|PART 1|Adverse Event|5|||
129970859|NCT05131477|467856623|FG002|PART 1|Adverse Event|1|||
129970860|NCT05131477|467856624|FG003|PART 1|Adverse Event|6|||
129970861|NCT05131477|467856625|FG004|PART 1|Adverse Event|4|||
129970862|NCT05131477|467856626|FG005|PART 1|Adverse Event|0|||
129970863|NCT05131477|467856627|FG006|PART 1|Adverse Event|0|||
129970864|NCT05131477|467856628|FG007|PART 1|Adverse Event|0|||
129970865|NCT05131477|467856629|FG008|PART 1|Adverse Event|0|||
129970866|NCT05131477|467856630|FG009|PART 1|Adverse Event|0|||
129970867|NCT05131477|467856631|FG010|PART 1|Adverse Event|0|||
129970868|NCT05131477|467856632|FG011|PART 1|Adverse Event|0|||
129970869|NCT05131477|467856633|FG012|PART 1|Adverse Event|0|||
129970870|NCT05131477|467856634|FG013|PART 1|Adverse Event|0|||
129970871|NCT05131477|467856621|FG000|PART 1|unclassified|1|||
129970872|NCT05131477|467856622|FG001|PART 1|unclassified|1|||
129970873|NCT05131477|467856623|FG002|PART 1|unclassified|0|||
129970874|NCT05131477|467856624|FG003|PART 1|unclassified|0|||
129970875|NCT05131477|467856625|FG004|PART 1|unclassified|4|||
129970876|NCT05131477|467856626|FG005|PART 1|unclassified|0|||
129970877|NCT05131477|467856627|FG006|PART 1|unclassified|0|||
129970878|NCT05131477|467856628|FG007|PART 1|unclassified|0|||
129970879|NCT05131477|467856629|FG008|PART 1|unclassified|0|||
129970880|NCT05131477|467856630|FG009|PART 1|unclassified|0|||
129970881|NCT05131477|467856631|FG010|PART 1|unclassified|0|||
129970882|NCT05131477|467856632|FG011|PART 1|unclassified|0|||
129970883|NCT05131477|467856633|FG012|PART 1|unclassified|0|||
129970884|NCT05131477|467856634|FG013|PART 1|unclassified|0|||
129970885|NCT05131477|467856621|FG000|PART 1|Randomized and not treated|0|||
129463639|NCT03461757|465992490|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
129463640|NCT03461757|465992489|FG000|Overall Study|Non-compliance with study treatment|0|||
129463641|NCT03461757|465992490|FG001|Overall Study|Non-compliance with study treatment|1|||
129463642|NCT03461757|465992489|FG000|Overall Study|Pregnancy|2|||
129463643|NCT03461757|465992490|FG001|Overall Study|Pregnancy|0|||
129463644|NCT03461757|465992489|FG000|Overall Study|Protocol Violation|1|||
129463645|NCT03461757|465992490|FG001|Overall Study|Protocol Violation|1|||
129970886|NCT05131477|467856622|FG001|PART 1|Randomized and not treated|0|||
129970887|NCT05131477|467856623|FG002|PART 1|Randomized and not treated|0|||
129970888|NCT05131477|467856624|FG003|PART 1|Randomized and not treated|1|||
129970889|NCT05131477|467856625|FG004|PART 1|Randomized and not treated|1|||
129970890|NCT05131477|467856626|FG005|PART 1|Randomized and not treated|0|||
129970891|NCT05131477|467856627|FG006|PART 1|Randomized and not treated|0|||
129970892|NCT05131477|467856628|FG007|PART 1|Randomized and not treated|0|||
129970893|NCT05131477|467856629|FG008|PART 1|Randomized and not treated|0|||
129970894|NCT05131477|467856630|FG009|PART 1|Randomized and not treated|0|||
129970895|NCT05131477|467856631|FG010|PART 1|Randomized and not treated|0|||
129970896|NCT05131477|467856632|FG011|PART 1|Randomized and not treated|0|||
129970897|NCT05131477|467856633|FG012|PART 1|Randomized and not treated|0|||
129970898|NCT05131477|467856634|FG013|PART 1|Randomized and not treated|0|||
129970899|NCT05131477|467856621|FG000|PART 1|Protocol Violation|2|||
129970900|NCT05131477|467856622|FG001|PART 1|Protocol Violation|0|||
129970901|NCT05131477|467856623|FG002|PART 1|Protocol Violation|0|||
129970902|NCT05131477|467856624|FG003|PART 1|Protocol Violation|1|||
129970903|NCT05131477|467856625|FG004|PART 1|Protocol Violation|0|||
129970904|NCT05131477|467856626|FG005|PART 1|Protocol Violation|0|||
129970905|NCT05131477|467856627|FG006|PART 1|Protocol Violation|0|||
129970906|NCT05131477|467856628|FG007|PART 1|Protocol Violation|0|||
129970907|NCT05131477|467856629|FG008|PART 1|Protocol Violation|0|||
129970908|NCT05131477|467856630|FG009|PART 1|Protocol Violation|0|||
129970909|NCT05131477|467856631|FG010|PART 1|Protocol Violation|0|||
129970910|NCT05131477|467856632|FG011|PART 1|Protocol Violation|0|||
129970911|NCT05131477|467856633|FG012|PART 1|Protocol Violation|0|||
129970912|NCT05131477|467856634|FG013|PART 1|Protocol Violation|0|||
129970913|NCT05131477|467856621|FG000|PART 1|Lack of Efficacy|0|||
129970914|NCT05131477|467856622|FG001|PART 1|Lack of Efficacy|1|||
129970915|NCT05131477|467856623|FG002|PART 1|Lack of Efficacy|1|||
129970916|NCT05131477|467856624|FG003|PART 1|Lack of Efficacy|2|||
129970917|NCT05131477|467856625|FG004|PART 1|Lack of Efficacy|5|||
129970918|NCT05131477|467856626|FG005|PART 1|Lack of Efficacy|0|||
129970919|NCT05131477|467856627|FG006|PART 1|Lack of Efficacy|0|||
129970920|NCT05131477|467856628|FG007|PART 1|Lack of Efficacy|0|||
129970921|NCT05131477|467856629|FG008|PART 1|Lack of Efficacy|0|||
129970922|NCT05131477|467856630|FG009|PART 1|Lack of Efficacy|0|||
129970923|NCT05131477|467856631|FG010|PART 1|Lack of Efficacy|0|||
129970924|NCT05131477|467856632|FG011|PART 1|Lack of Efficacy|0|||
129970925|NCT05131477|467856633|FG012|PART 1|Lack of Efficacy|0|||
129970926|NCT05131477|467856634|FG013|PART 1|Lack of Efficacy|0|||
129970927|NCT05131477|467856621|FG000|PART 2|Withdrawal by Subject|0|||
129970928|NCT05131477|467856622|FG001|PART 2|Withdrawal by Subject|0|||
129970929|NCT05131477|467856623|FG002|PART 2|Withdrawal by Subject|0|||
129970930|NCT05131477|467856624|FG003|PART 2|Withdrawal by Subject|0|||
129970931|NCT05131477|467856625|FG004|PART 2|Withdrawal by Subject|0|||
129970932|NCT05131477|467856626|FG005|PART 2|Withdrawal by Subject|0|||
129970933|NCT05131477|467856627|FG006|PART 2|Withdrawal by Subject|2|||
129970934|NCT05131477|467856628|FG007|PART 2|Withdrawal by Subject|0|||
129970935|NCT05131477|467856629|FG008|PART 2|Withdrawal by Subject|0|||
129970936|NCT05131477|467856630|FG009|PART 2|Withdrawal by Subject|0|||
129970937|NCT05131477|467856631|FG010|PART 2|Withdrawal by Subject|2|||
129970938|NCT05131477|467856632|FG011|PART 2|Withdrawal by Subject|0|||
129970939|NCT05131477|467856633|FG012|PART 2|Withdrawal by Subject|2|||
129970940|NCT05131477|467856634|FG013|PART 2|Withdrawal by Subject|2|||
129970941|NCT05131477|467856621|FG000|PART 2|Other|0|||
129970942|NCT05131477|467856622|FG001|PART 2|Other|0|||
129970943|NCT05131477|467856623|FG002|PART 2|Other|0|||
129970944|NCT05131477|467856624|FG003|PART 2|Other|0|||
129970945|NCT05131477|467856625|FG004|PART 2|Other|0|||
129970946|NCT05131477|467856626|FG005|PART 2|Other|0|||
129970947|NCT05131477|467856627|FG006|PART 2|Other|0|||
129463646|NCT03461757|465992489|FG000|Overall Study|Withdrawal by Subject|7|||
129463647|NCT03461757|465992490|FG001|Overall Study|Withdrawal by Subject|7|||
129463648|NCT03461757|465992489|FG000|Overall Study|Other Reasons|1|||
129463649|NCT03461757|465992490|FG001|Overall Study|Other Reasons|4|||
129463650|NCT00720109|465992496|FG000|Induction Period|Did not meet eligibility criteria|3|||
129463651|NCT00720109|465992497|FG001|Induction Period|Did not meet eligibility criteria|0|||
129463652|NCT00720109|465992498|FG002|Induction Period|Did not meet eligibility criteria|0|||
129463653|NCT00720109|465992496|FG000|Induction Period|Bone Marrow Transplant|2|||
129463654|NCT00720109|465992497|FG001|Induction Period|Bone Marrow Transplant|0|||
129463655|NCT00720109|465992498|FG002|Induction Period|Bone Marrow Transplant|0|||
129463656|NCT00720109|465992496|FG000|Induction Period|Physician Decision|1|||
129970948|NCT05131477|467856628|FG007|PART 2|Other|0|||
129970949|NCT05131477|467856629|FG008|PART 2|Other|1|||
129970950|NCT05131477|467856630|FG009|PART 2|Other|1|||
129970951|NCT05131477|467856631|FG010|PART 2|Other|0|||
129970952|NCT05131477|467856632|FG011|PART 2|Other|0|||
129970953|NCT05131477|467856633|FG012|PART 2|Other|1|||
129970954|NCT05131477|467856634|FG013|PART 2|Other|0|||
129970955|NCT05131477|467856621|FG000|PART 2|Lack of Efficacy|0|||
129970956|NCT05131477|467856622|FG001|PART 2|Lack of Efficacy|0|||
129463657|NCT00720109|465992497|FG001|Induction Period|Physician Decision|0|||
129463658|NCT00720109|465992498|FG002|Induction Period|Physician Decision|0|||
129463659|NCT00720109|465992496|FG000|Risk Stratification Period|Adverse Event|0|||
129463660|NCT00720109|465992497|FG001|Risk Stratification Period|Adverse Event|1|||
129463661|NCT00720109|465992498|FG002|Risk Stratification Period|Adverse Event|0|||
129463662|NCT00720109|465992496|FG000|Risk Stratification Period|Physician Decision|0|||
129463663|NCT00720109|465992497|FG001|Risk Stratification Period|Physician Decision|2|||
129463664|NCT00720109|465992498|FG002|Risk Stratification Period|Physician Decision|1|||
129463665|NCT00720109|465992496|FG000|Risk Stratification Period|Bone marrow transplant|0|||
129463666|NCT00720109|465992497|FG001|Risk Stratification Period|Bone marrow transplant|9|||
129463667|NCT00720109|465992498|FG002|Risk Stratification Period|Bone marrow transplant|7|||
129463668|NCT00720109|465992496|FG000|Risk Stratification Period|Disease progression or relapse|0|||
129463669|NCT00720109|465992497|FG001|Risk Stratification Period|Disease progression or relapse|2|||
129463670|NCT00720109|465992498|FG002|Risk Stratification Period|Disease progression or relapse|0|||
129463671|NCT00720109|465992496|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
129463672|NCT00720109|465992497|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
129463673|NCT00720109|465992498|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
129463674|NCT00903929|465992499|FG000|Overall Study|Withdrawal by Subject|0|||
129463675|NCT00903929|465992500|FG001|Overall Study|Withdrawal by Subject|0|||
129463676|NCT00903929|465992501|FG002|Overall Study|Withdrawal by Subject|1|||
129463677|NCT00903929|465992502|FG003|Overall Study|Withdrawal by Subject|2|||
129463678|NCT00903929|465992499|FG000|Overall Study|Adverse Event|0|||
129463679|NCT00903929|465992500|FG001|Overall Study|Adverse Event|0|||
129463680|NCT00903929|465992501|FG002|Overall Study|Adverse Event|0|||
129463681|NCT00903929|465992502|FG003|Overall Study|Adverse Event|1|||
129463682|NCT00512798|465992503|FG000|Overall Study|Death|0|||
129463683|NCT00512798|465992504|FG001|Overall Study|Death|3|||
129463684|NCT00512798|465992503|FG000|Overall Study|Adverse Event|2|||
129463685|NCT00512798|465992504|FG001|Overall Study|Adverse Event|4|||
129463686|NCT00512798|465992503|FG000|Overall Study|Progression of disease|14|||
129463687|NCT00512798|465992504|FG001|Overall Study|Progression of disease|20|||
129463688|NCT00512798|465992503|FG000|Overall Study|Withdrawal by Subject|3|||
129463689|NCT00512798|465992504|FG001|Overall Study|Withdrawal by Subject|0|||
129463690|NCT02926950|465992512|FG000|Overall Study|Adverse Event|4|||
129463691|NCT02926950|465992513|FG001|Overall Study|Adverse Event|6|||
129463692|NCT02926950|465992512|FG000|Overall Study|At the participant's own request|21|||
129463693|NCT02926950|465992513|FG001|Overall Study|At the participant's own request|25|||
129463694|NCT02926950|465992512|FG000|Overall Study|Reason not Specified|17|||
129463695|NCT02926950|465992513|FG001|Overall Study|Reason not Specified|9|||
129463696|NCT02926950|465992512|FG000|Overall Study|Lost to Follow-up|7|||
129463697|NCT02926950|465992513|FG001|Overall Study|Lost to Follow-up|8|||
129463698|NCT02396589|465992514|FG000|Intervention|Lost to Follow-up|1|||
129463699|NCT02396589|465992515|FG001|Intervention|Lost to Follow-up|0|||
129463700|NCT02396589|465992514|FG000|6 Month Follow-up|change in health status|0|||
129463701|NCT02396589|465992515|FG001|6 Month Follow-up|change in health status|1|||
129463702|NCT02396589|465992514|FG000|9 Month Follow-up|Death|0|||
129463703|NCT02396589|465992515|FG001|9 Month Follow-up|Death|1|||
129463704|NCT02396589|465992514|FG000|12 Month Follow up|Lost to Follow-up|0|||
129463705|NCT02396589|465992515|FG001|12 Month Follow up|Lost to Follow-up|2|||
129463706|NCT04341948|465992516|FG000|Overall Study|Adverse Event|0|||
129463707|NCT04341948|465992517|FG001|Overall Study|Adverse Event|1|||
129463708|NCT04341948|465992516|FG000|Overall Study|Lost to Follow-up|6|||
129463709|NCT04341948|465992517|FG001|Overall Study|Lost to Follow-up|1|||
129463710|NCT04341948|465992516|FG000|Overall Study|Physician Decision|1|||
129463711|NCT04341948|465992517|FG001|Overall Study|Physician Decision|2|||
129463712|NCT04341948|465992516|FG000|Overall Study|Withdrawal by Participant|6|||
129463713|NCT04341948|465992517|FG001|Overall Study|Withdrawal by Participant|3|||
129463714|NCT04341948|465992516|FG000|Overall Study|Lack of compliance by Participant|1|||
129463715|NCT04341948|465992517|FG001|Overall Study|Lack of compliance by Participant|0|||
129463716|NCT01761266|465994079|FG000|Overall Study|Death|415|||
129463717|NCT01761266|465994080|FG001|Overall Study|Death|402|||
129463718|NCT01761266|465994079|FG000|Overall Study|Lost to Follow-up|8|||
129463719|NCT01761266|465994080|FG001|Overall Study|Lost to Follow-up|12|||
129463720|NCT01761266|465994079|FG000|Overall Study|Withdrawal by Subject|14|||
129970957|NCT05131477|467856623|FG002|PART 2|Lack of Efficacy|0|||
129970958|NCT05131477|467856624|FG003|PART 2|Lack of Efficacy|0|||
129970959|NCT05131477|467856625|FG004|PART 2|Lack of Efficacy|0|||
129970960|NCT05131477|467856626|FG005|PART 2|Lack of Efficacy|1|||
129970961|NCT05131477|467856627|FG006|PART 2|Lack of Efficacy|1|||
129970962|NCT05131477|467856628|FG007|PART 2|Lack of Efficacy|0|||
129463721|NCT01761266|465994080|FG001|Overall Study|Withdrawal by Subject|10|||
129463722|NCT01761266|465994079|FG000|Overall Study|Sponsor Decision|41|||
129463723|NCT01761266|465994080|FG001|Overall Study|Sponsor Decision|52|||
129970963|NCT05131477|467856629|FG008|PART 2|Lack of Efficacy|3|||
129970964|NCT05131477|467856630|FG009|PART 2|Lack of Efficacy|0|||
129970965|NCT05131477|467856631|FG010|PART 2|Lack of Efficacy|1|||
129970966|NCT05131477|467856632|FG011|PART 2|Lack of Efficacy|0|||
129970967|NCT05131477|467856633|FG012|PART 2|Lack of Efficacy|2|||
129970968|NCT05131477|467856634|FG013|PART 2|Lack of Efficacy|0|||
129970969|NCT05131477|467856621|FG000|PART 2|Unclassified|0|||
129970970|NCT05131477|467856622|FG001|PART 2|Unclassified|0|||
129970971|NCT05131477|467856623|FG002|PART 2|Unclassified|0|||
129970972|NCT05131477|467856624|FG003|PART 2|Unclassified|0|||
129463724|NCT01284114|465994081|FG000|Overall Study|viral infection|1|||
129463725|NCT01284114|465994081|FG000|Overall Study|From the results of ALLTITUDE study|1|||
129463726|NCT01284114|465994081|FG000|Overall Study|Symptomatic hypotension|1|||
129463727|NCT01284114|465994081|FG000|Overall Study|dizziness|1|||
129463728|NCT03445000|465994082|FG000|Overall Study|Disease progression|8|||
129463729|NCT03445000|465994082|FG000|Overall Study|Adverse Event|3|||
129463730|NCT03445000|465994082|FG000|Overall Study|Death|2|||
129463731|NCT03445000|465994082|FG000|Overall Study|Physician Decision|1|||
129463732|NCT03409744|465994083|FG000|Overall Study|Death|2|||
129463733|NCT03409744|465994083|FG000|Overall Study|Physician Decision|5|||
129463734|NCT03409744|465994083|FG000|Overall Study|Pregnancy|1|||
129463735|NCT03409744|465994083|FG000|Overall Study|Lost to Follow-up|1|||
129463736|NCT03409744|465994083|FG000|Overall Study|Protocol Violation|1|||
129463737|NCT00264004|465994084|FG000|Overall Study|Adverse Event|2|||
129463738|NCT00264004|465994085|FG001|Overall Study|Adverse Event|3|||
129463739|NCT00264004|465994086|FG002|Overall Study|Adverse Event|6|||
129463740|NCT00264004|465994087|FG003|Overall Study|Adverse Event|4|||
129463741|NCT00264004|465994084|FG000|Overall Study|Withdrawal by Subject|0|||
129463742|NCT00264004|465994085|FG001|Overall Study|Withdrawal by Subject|1|||
129463743|NCT00264004|465994086|FG002|Overall Study|Withdrawal by Subject|2|||
129463744|NCT00264004|465994087|FG003|Overall Study|Withdrawal by Subject|2|||
129463745|NCT00264004|465994084|FG000|Overall Study|Other|2|||
129463746|NCT00264004|465994085|FG001|Overall Study|Other|2|||
129463747|NCT00264004|465994086|FG002|Overall Study|Other|0|||
129463748|NCT00264004|465994087|FG003|Overall Study|Other|3|||
129463749|NCT00264004|465994084|FG000|Overall Study|Development study specific disc. crit.|1|||
129463750|NCT00264004|465994085|FG001|Overall Study|Development study specific disc. crit.|0|||
129463751|NCT00264004|465994086|FG002|Overall Study|Development study specific disc. crit.|1|||
129463752|NCT00264004|465994087|FG003|Overall Study|Development study specific disc. crit.|0|||
129463753|NCT00264004|465994084|FG000|Overall Study|Cond. under inv. worsened|9|||
129463754|NCT00264004|465994085|FG001|Overall Study|Cond. under inv. worsened|5|||
129463755|NCT00264004|465994086|FG002|Overall Study|Cond. under inv. worsened|3|||
129463756|NCT00264004|465994087|FG003|Overall Study|Cond. under inv. worsened|4|||
129463757|NCT00264004|465994084|FG000|Overall Study|Not treated|3|||
129463758|NCT00264004|465994085|FG001|Overall Study|Not treated|0|||
129463759|NCT00264004|465994086|FG002|Overall Study|Not treated|2|||
129463760|NCT00264004|465994087|FG003|Overall Study|Not treated|2|||
129463761|NCT00691483|465994088|FG000|Overall Study|Adverse Event|14|||
129463762|NCT00691483|465994089|FG001|Overall Study|Adverse Event|6|||
129463763|NCT00691483|465994088|FG000|Overall Study|Lost to Follow-up|17|||
129463764|NCT00691483|465994089|FG001|Overall Study|Lost to Follow-up|10|||
129463765|NCT00691483|465994088|FG000|Overall Study|Withdrawal by Subject|24|||
129463766|NCT00691483|465994089|FG001|Overall Study|Withdrawal by Subject|7|||
129463767|NCT00691483|465994088|FG000|Overall Study|Other known cause|6|||
129463768|NCT00691483|465994089|FG001|Overall Study|Other known cause|1|||
129463769|NCT00691483|465994088|FG000|Overall Study|Randomized by not treated|7|||
129463770|NCT00691483|465994089|FG001|Overall Study|Randomized by not treated|1|||
129463771|NCT00049673|465994091|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
129463772|NCT00049673|465994092|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
129463773|NCT02475681|465994093|FG000|Overall Study|Death|16|||
129463774|NCT02475681|465994094|FG001|Overall Study|Death|6|||
129463775|NCT02475681|465994095|FG002|Overall Study|Death|9|||
129463776|NCT02475681|465994093|FG000|Overall Study|Physician Decision|0|||
129463777|NCT02475681|465994094|FG001|Overall Study|Physician Decision|3|||
129463778|NCT02475681|465994095|FG002|Overall Study|Physician Decision|1|||
129463779|NCT02475681|465994093|FG000|Overall Study|Withdrawal by Subject|12|||
129463780|NCT02475681|465994094|FG001|Overall Study|Withdrawal by Subject|6|||
129463781|NCT02475681|465994095|FG002|Overall Study|Withdrawal by Subject|9|||
129463782|NCT02475681|465994093|FG000|Overall Study|Lost to Follow-up|2|||
129463783|NCT02475681|465994094|FG001|Overall Study|Lost to Follow-up|1|||
129463784|NCT02475681|465994095|FG002|Overall Study|Lost to Follow-up|3|||
129463785|NCT02475681|465994093|FG000|Overall Study|Ongoing in Study|0|||
129463786|NCT02475681|465994094|FG001|Overall Study|Ongoing in Study|163|||
129463787|NCT02475681|465994095|FG002|Overall Study|Ongoing in Study|157|||
129463788|NCT02475681|465994093|FG000|Overall Study|Reasons other than above listed|2|||
129463789|NCT02475681|465994094|FG001|Overall Study|Reasons other than above listed|0|||
129463790|NCT02475681|465994095|FG002|Overall Study|Reasons other than above listed|0|||
129463791|NCT01535729|465994096|FG000|Overall Study|Withdrawal by Subject|2|||
129463792|NCT01535729|465994096|FG000|Overall Study|Disease progression|230|||
129463793|NCT01535729|465994096|FG000|Overall Study|Discontinued treatment|25|||
129970973|NCT05131477|467856625|FG004|PART 2|Unclassified|0|||
129970974|NCT05131477|467856626|FG005|PART 2|Unclassified|0|||
129970975|NCT05131477|467856627|FG006|PART 2|Unclassified|0|||
129970976|NCT05131477|467856628|FG007|PART 2|Unclassified|0|||
129463794|NCT01535729|465994096|FG000|Overall Study|Lost to Follow-up|8|||
129463795|NCT01535729|465994096|FG000|Overall Study|Death|52|||
129463796|NCT01535729|465994096|FG000|Overall Study|Other|19|||
129463797|NCT01535729|465994096|FG000|Overall Study|Did not sign informed consent|1|||
129463798|NCT01535729|465994096|FG000|Overall Study|No previous chemotherapy|33|||
129463799|NCT01535729|465994096|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
129463800|NCT01535729|465994096|FG000|Overall Study|Protocol Violation|11|||
129463801|NCT01535729|465994096|FG000|Overall Study|Screening failure|1|||
129463802|NCT01535729|465994096|FG000|Overall Study|Not treated|9|||
129463803|NCT01535729|465994096|FG000|Overall Study|No participant record available|5|||
129463804|NCT01262365|465994097|FG000|Overall Study|Lack of Efficacy|35|||
129463805|NCT01262365|465994098|FG001|Overall Study|Lack of Efficacy|30|||
129463806|NCT01262365|465994099|FG002|Overall Study|Lack of Efficacy|47|||
129463807|NCT01262365|465994097|FG000|Overall Study|Protocol Violation|3|||
129463808|NCT01262365|465994098|FG001|Overall Study|Protocol Violation|1|||
129463809|NCT01262365|465994099|FG002|Overall Study|Protocol Violation|1|||
129463810|NCT01262365|465994097|FG000|Overall Study|Lost to Follow-up|3|||
129463811|NCT01262365|465994098|FG001|Overall Study|Lost to Follow-up|7|||
129463812|NCT01262365|465994099|FG002|Overall Study|Lost to Follow-up|6|||
129463813|NCT01262365|465994097|FG000|Overall Study|Withdrawal by Subject|17|||
129463814|NCT01262365|465994098|FG001|Overall Study|Withdrawal by Subject|22|||
129463815|NCT01262365|465994099|FG002|Overall Study|Withdrawal by Subject|22|||
129463816|NCT01262365|465994097|FG000|Overall Study|Death|1|||
129463817|NCT01262365|465994098|FG001|Overall Study|Death|2|||
129463818|NCT01262365|465994099|FG002|Overall Study|Death|1|||
129463819|NCT01262365|465994097|FG000|Overall Study|Adverse Event|26|||
129463820|NCT01262365|465994098|FG001|Overall Study|Adverse Event|16|||
129463821|NCT01262365|465994099|FG002|Overall Study|Adverse Event|11|||
129463822|NCT01262365|465994097|FG000|Overall Study|sponsor decision|1|||
129463823|NCT01262365|465994098|FG001|Overall Study|sponsor decision|1|||
129463824|NCT01262365|465994099|FG002|Overall Study|sponsor decision|0|||
129463825|NCT01262365|465994097|FG000|Overall Study|Randomization error|1|||
129463826|NCT01262365|465994098|FG001|Overall Study|Randomization error|0|||
129463827|NCT01262365|465994099|FG002|Overall Study|Randomization error|2|||
129463828|NCT01262365|465994097|FG000|Overall Study|Non-compliance|1|||
129463829|NCT01262365|465994098|FG001|Overall Study|Non-compliance|0|||
129463830|NCT01262365|465994099|FG002|Overall Study|Non-compliance|2|||
129463831|NCT01262365|465994097|FG000|Overall Study|Suspected pregnancy|1|||
129463832|NCT01262365|465994098|FG001|Overall Study|Suspected pregnancy|0|||
129463833|NCT01262365|465994099|FG002|Overall Study|Suspected pregnancy|0|||
129463834|NCT01262365|465994097|FG000|Overall Study|Patient pregnant|1|||
129463835|NCT01262365|465994098|FG001|Overall Study|Patient pregnant|0|||
129463836|NCT01262365|465994099|FG002|Overall Study|Patient pregnant|1|||
129463837|NCT01262365|465994097|FG000|Overall Study|Toxicity related to study drug|0|||
129463838|NCT01262365|465994098|FG001|Overall Study|Toxicity related to study drug|1|||
129463839|NCT01262365|465994099|FG002|Overall Study|Toxicity related to study drug|0|||
129463840|NCT01262365|465994097|FG000|Overall Study|Cannot tolerate the protocol|0|||
129463841|NCT01262365|465994098|FG001|Overall Study|Cannot tolerate the protocol|1|||
129463842|NCT01262365|465994099|FG002|Overall Study|Cannot tolerate the protocol|0|||
129463843|NCT01262365|465994097|FG000|Overall Study|Patient unavailable|0|||
129463844|NCT01262365|465994098|FG001|Overall Study|Patient unavailable|0|||
129463845|NCT01262365|465994099|FG002|Overall Study|Patient unavailable|1|||
129463846|NCT02322710|465994100|FG000|Overall Study|No efficacy assessment post-baseline|0|||
129463847|NCT02322710|465994101|FG001|Overall Study|No efficacy assessment post-baseline|1|||
129463848|NCT02322710|465994100|FG000|Overall Study|Protocol Violation|20|||
129463849|NCT02322710|465994101|FG001|Overall Study|Protocol Violation|25|||
129463850|NCT04161131|465994102|FG000|Overall Study|Ineligible|2|||
129463851|NCT04161131|465994102|FG000|Overall Study|Lost to Follow-up|4|||
129463852|NCT03733392|465994103|FG000|Overall Study|Withdrawal by Subject|11|||
129463853|NCT03733392|465994104|FG001|Overall Study|Withdrawal by Subject|1|||
129463854|NCT03733392|465994103|FG000|Overall Study|Death|1|||
129463855|NCT03733392|465994104|FG001|Overall Study|Death|0|||
129463856|NCT03733392|465994103|FG000|Overall Study|Lost to Follow-up|5|||
129463857|NCT03733392|465994104|FG001|Overall Study|Lost to Follow-up|0|||
129463858|NCT03733392|465994103|FG000|Overall Study|Protocol Violation|0|||
129463859|NCT03733392|465994104|FG001|Overall Study|Protocol Violation|1|||
129463860|NCT03733392|465994103|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
129463861|NCT03733392|465994104|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
129463862|NCT03733392|465994103|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
129463863|NCT03733392|465994104|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
129463864|NCT03733392|465994103|FG000|Overall Study|Patient Non-Compliance|2|||
129463865|NCT03733392|465994104|FG001|Overall Study|Patient Non-Compliance|1|||
129463866|NCT03733392|465994103|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
129463867|NCT03733392|465994104|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
129463868|NCT03733392|465994103|FG000|Overall Study|Withdrawal prior to procedure|5|||
129463869|NCT03733392|465994104|FG001|Overall Study|Withdrawal prior to procedure|2|||
129463870|NCT02615990|465994107|FG000|Overall Study|study terminated|1|||
129463871|NCT02615990|465994108|FG001|Overall Study|study terminated|1|||
129463872|NCT01363986|465994109|FG000|Overall Study|Disease progression|1|||
129463873|NCT00130832|465994110|FG000|Overall Study|Adverse Event|1|||
129463874|NCT00130832|465994111|FG001|Overall Study|Adverse Event|1|||
129463875|NCT00130832|465994110|FG000|Overall Study|Lost to Follow-up|1|||
129463876|NCT00130832|465994111|FG001|Overall Study|Lost to Follow-up|2|||
129463877|NCT00130832|465994110|FG000|Overall Study|Protocol Violation|6|||
129463878|NCT00130832|465994111|FG001|Overall Study|Protocol Violation|8|||
129463879|NCT00130832|465994110|FG000|Overall Study|Withdrawal by Subject|6|||
129463880|NCT00130832|465994111|FG001|Overall Study|Withdrawal by Subject|1|||
129463881|NCT00130832|465994110|FG000|Overall Study|Moved|2|||
129463882|NCT00130832|465994111|FG001|Overall Study|Moved|2|||
129463883|NCT00130832|465994110|FG000|Overall Study|Other|0|||
129463884|NCT00130832|465994111|FG001|Overall Study|Other|3|||
129463885|NCT03905863|465994112|FG000|Overall Study|Adverse Event|2|||
129463886|NCT03905863|465994113|FG001|Overall Study|Adverse Event|4|||
129463887|NCT03905863|465994112|FG000|Overall Study|Withdrawal by Subject|2|||
129463888|NCT03905863|465994113|FG001|Overall Study|Withdrawal by Subject|2|||
129463889|NCT03905863|465994112|FG000|Overall Study|Physician Decision|0|||
129463890|NCT03905863|465994113|FG001|Overall Study|Physician Decision|3|||
129463891|NCT03905863|465994112|FG000|Overall Study|Lost to Follow-up|1|||
129463892|NCT03905863|465994113|FG001|Overall Study|Lost to Follow-up|0|||
129463893|NCT03905863|465994112|FG000|Overall Study|Protocol Violation|0|||
129463894|NCT03905863|465994113|FG001|Overall Study|Protocol Violation|2|||
129463895|NCT03905863|465994112|FG000|Overall Study|Death|0|||
129463896|NCT03905863|465994113|FG001|Overall Study|Death|1|||
129463897|NCT02944448|465994115|FG000|Overall Study|Adverse Event|37|||
129463898|NCT02944448|465994116|FG001|Overall Study|Adverse Event|6|||
129463899|NCT02944448|465994115|FG000|Overall Study|Lack of Efficacy|8|||
129463900|NCT02944448|465994116|FG001|Overall Study|Lack of Efficacy|5|||
129463901|NCT02944448|465994115|FG000|Overall Study|Lost to Follow-up|3|||
129463902|NCT02944448|465994116|FG001|Overall Study|Lost to Follow-up|1|||
129463903|NCT02944448|465994115|FG000|Overall Study|Protocol Violation|25|||
129463904|NCT02944448|465994116|FG001|Overall Study|Protocol Violation|7|||
129463905|NCT02944448|465994115|FG000|Overall Study|Withdrawal by Subject|14|||
129463906|NCT02944448|465994116|FG001|Overall Study|Withdrawal by Subject|4|||
129463907|NCT02944448|465994115|FG000|Overall Study|Sponsor did not supply drug in time|0|||
129463908|NCT02944448|465994116|FG001|Overall Study|Sponsor did not supply drug in time|1|||
129463909|NCT02944448|465994115|FG000|Overall Study|Noncompliant with dosing|1|||
129463910|NCT02944448|465994116|FG001|Overall Study|Noncompliant with dosing|0|||
129463911|NCT02944448|465994115|FG000|Overall Study|Abnormal laboratory values|1|||
129463912|NCT02944448|465994116|FG001|Overall Study|Abnormal laboratory values|0|||
129463913|NCT00925015|465994119|FG000|Overall Study|Adverse Event|1|||
129463914|NCT00925015|465994120|FG001|Overall Study|Adverse Event|2|||
129463915|NCT00925015|465994121|FG002|Overall Study|Adverse Event|1|||
129463916|NCT00925015|465994119|FG000|Overall Study|Physician Decision|0|||
129463917|NCT00925015|465994120|FG001|Overall Study|Physician Decision|1|||
129463918|NCT00925015|465994121|FG002|Overall Study|Physician Decision|0|||
129463919|NCT00925015|465994119|FG000|Overall Study|Progressive Disease|7|||
129463920|NCT00925015|465994120|FG001|Overall Study|Progressive Disease|3|||
129463921|NCT00925015|465994121|FG002|Overall Study|Progressive Disease|4|||
129463922|NCT00925015|465994119|FG000|Overall Study|Withdrawal by Subject|0|||
129463923|NCT00925015|465994120|FG001|Overall Study|Withdrawal by Subject|0|||
129463924|NCT00925015|465994121|FG002|Overall Study|Withdrawal by Subject|1|||
129463925|NCT04681170|465994122|FG000|Stratified Enrolment & run-in|Death|1|||
129463926|NCT04681170|465994123|FG001|Stratified Enrolment & run-in|Death|0|||
129463927|NCT04681170|465994122|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
129463928|NCT04681170|465994123|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
129463929|NCT04681170|465994122|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
129463930|NCT04681170|465994123|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
129970977|NCT05131477|467856629|FG008|PART 2|Unclassified|0|||
129970978|NCT05131477|467856630|FG009|PART 2|Unclassified|0|||
129970979|NCT05131477|467856631|FG010|PART 2|Unclassified|1|||
129970980|NCT05131477|467856632|FG011|PART 2|Unclassified|0|||
129463931|NCT04681170|465994122|FG000|Open Label Efficacy Phase|Adverse Event|0|||
129463932|NCT04681170|465994123|FG001|Open Label Efficacy Phase|Adverse Event|2|||
129463933|NCT04681170|465994122|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
129463934|NCT04681170|465994123|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
129463935|NCT04681170|465994122|FG000|Open Label Safety Phase|AEs and none compliance|0|||
129970981|NCT05131477|467856633|FG012|PART 2|Unclassified|0|||
129970982|NCT05131477|467856634|FG013|PART 2|Unclassified|0|||
129463936|NCT04681170|465994123|FG001|Open Label Safety Phase|AEs and none compliance|1|||
129463937|NCT02787863|465994124|FG000|Overall Study|Death|1|||
129463938|NCT02787863|465994125|FG001|Overall Study|Death|0|||
129463939|NCT02787863|465994126|FG002|Overall Study|Death|1|||
129463940|NCT02787863|465994127|FG003|Overall Study|Death|0|||
129463941|NCT02787863|465994128|FG004|Overall Study|Death|0|||
129463942|NCT02787863|465994129|FG005|Overall Study|Death|0|||
129463943|NCT02787863|465994130|FG006|Overall Study|Death|0|||
129463944|NCT02787863|465994131|FG007|Overall Study|Death|0|||
129463945|NCT02787863|465994124|FG000|Overall Study|Withdrawal by Subject|0|||
129463946|NCT02787863|465994125|FG001|Overall Study|Withdrawal by Subject|1|||
129463947|NCT02787863|465994126|FG002|Overall Study|Withdrawal by Subject|1|||
129463948|NCT02787863|465994127|FG003|Overall Study|Withdrawal by Subject|0|||
129463949|NCT02787863|465994128|FG004|Overall Study|Withdrawal by Subject|0|||
129463950|NCT02787863|465994129|FG005|Overall Study|Withdrawal by Subject|0|||
129463951|NCT02787863|465994130|FG006|Overall Study|Withdrawal by Subject|0|||
129463952|NCT02787863|465994131|FG007|Overall Study|Withdrawal by Subject|0|||
129463953|NCT01368835|465994132|FG000|Overall Study|Inclusion criteria/photography quality|22|||
129463954|NCT01368835|465994132|FG000|Overall Study|Lost to Follow-up|11|||
129463955|NCT03118297|465994133|FG000|Overall Study|Lost to Follow-up|0|||
129463956|NCT03118297|465994134|FG001|Overall Study|Lost to Follow-up|2|||
129463957|NCT02754726|465994135|FG000|Overall Study|Progressive Disease by RECIST|13|||
129463958|NCT02754726|465994135|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
129463959|NCT02754726|465994135|FG000|Overall Study|Clinical Disease Progression|5|||
129463960|NCT02754726|465994135|FG000|Overall Study|Adverse Event|3|||
129463961|NCT02754726|465994135|FG000|Overall Study|Withdrawal by Subject|1|||
129463962|NCT02754726|465994135|FG000|Overall Study|Tolerability|1|||
129463963|NCT01885000|465994136|FG000|Overall Study|Adverse Event|1|||
129463964|NCT01885000|465994137|FG001|Overall Study|Adverse Event|0|||
129463965|NCT01885000|465994136|FG000|Overall Study|Withdrawal by Subject|1|||
129463966|NCT01885000|465994137|FG001|Overall Study|Withdrawal by Subject|1|||
129463967|NCT01885000|465994136|FG000|Overall Study|Protocol Violation|0|||
129463968|NCT01885000|465994137|FG001|Overall Study|Protocol Violation|1|||
129463969|NCT03124784|465994138|FG000|Overall Study|Adverse Event|1|||
129463970|NCT03124784|465994138|FG000|Overall Study|Computer/Equip Malfunction|1|||
129463971|NCT01777152|465994143|FG000|Overall Study|Withdrawal by Subject|22|||
129463972|NCT01777152|465994144|FG001|Overall Study|Withdrawal by Subject|16|||
129463973|NCT01777152|465994143|FG000|Overall Study|Lost to Follow-up|3|||
129463974|NCT01777152|465994144|FG001|Overall Study|Lost to Follow-up|5|||
129463975|NCT01777152|465994143|FG000|Overall Study|Death|68|||
129463976|NCT01777152|465994144|FG001|Overall Study|Death|89|||
129463977|NCT01777152|465994143|FG000|Overall Study|Not eligible, no study drug received|1|||
129463978|NCT01777152|465994144|FG001|Overall Study|Not eligible, no study drug received|0|||
129463979|NCT01777152|465994143|FG000|Overall Study|Change of diagnosis|1|||
129463980|NCT01777152|465994144|FG001|Overall Study|Change of diagnosis|0|||
129463981|NCT02469090|465994147|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
129463982|NCT02469090|465994148|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
129463983|NCT02469090|465994149|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
129463984|NCT02469090|465994147|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
129463985|NCT02469090|465994148|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
129463986|NCT02469090|465994149|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
129463987|NCT02469090|465994147|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
129463988|NCT02469090|465994148|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
129463989|NCT02469090|465994149|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
129463990|NCT02469090|465994147|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
129463991|NCT02469090|465994148|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
129463992|NCT02469090|465994149|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
129463993|NCT02469090|465994147|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
129463994|NCT02469090|465994148|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
129463995|NCT02469090|465994149|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
129463996|NCT02469090|465994147|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
129463997|NCT02469090|465994148|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
129463998|NCT02469090|465994149|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
129463999|NCT02469090|465994147|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
129464000|NCT02469090|465994148|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
129464001|NCT02469090|465994149|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
129464002|NCT02469090|465994147|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
129464003|NCT02469090|465994148|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
129464004|NCT02469090|465994149|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
129970983|NCT05131477|467856621|FG000|PART 2|Re-randomized and not treated|0|||
129970984|NCT05131477|467856622|FG001|PART 2|Re-randomized and not treated|0|||
129464005|NCT01391507|465994150|FG000|Overall Study|Death|0|||
129464006|NCT01391507|465994151|FG001|Overall Study|Death|0|||
129464007|NCT01391507|465994152|FG002|Overall Study|Death|0|||
129464008|NCT01391507|465994153|FG003|Overall Study|Death|1|||
129464009|NCT01391507|465994150|FG000|Overall Study|Adverse Event|1|||
129464010|NCT01391507|465994151|FG001|Overall Study|Adverse Event|1|||
129464011|NCT01391507|465994152|FG002|Overall Study|Adverse Event|2|||
129464012|NCT01391507|465994153|FG003|Overall Study|Adverse Event|2|||
129464013|NCT01391507|465994150|FG000|Overall Study|Withdrawal by Subject|1|||
129464014|NCT01391507|465994151|FG001|Overall Study|Withdrawal by Subject|2|||
129464015|NCT01391507|465994152|FG002|Overall Study|Withdrawal by Subject|1|||
129464016|NCT01391507|465994153|FG003|Overall Study|Withdrawal by Subject|1|||
129464017|NCT01391507|465994150|FG000|Overall Study|Lack of Efficacy|0|||
129464018|NCT01391507|465994151|FG001|Overall Study|Lack of Efficacy|0|||
129464019|NCT01391507|465994152|FG002|Overall Study|Lack of Efficacy|0|||
129464020|NCT01391507|465994153|FG003|Overall Study|Lack of Efficacy|1|||
129464021|NCT01391507|465994150|FG000|Overall Study|Protocol Violation|2|||
129464022|NCT01391507|465994151|FG001|Overall Study|Protocol Violation|1|||
129464023|NCT01391507|465994152|FG002|Overall Study|Protocol Violation|1|||
129464024|NCT01391507|465994153|FG003|Overall Study|Protocol Violation|2|||
129464025|NCT02926209|465994157|FG000|Study Cohort|Poor Bowel Preparation|1|||
129464026|NCT02926209|465994158|FG001|Study Cohort|Poor Bowel Preparation|0|||
129464027|NCT01926782|465994159|FG000|Overall Study|Participant moved|2|||
129464028|NCT01926782|465994160|FG001|Overall Study|Participant moved|0|||
129464029|NCT01926782|465994161|FG002|Overall Study|Participant moved|1|||
129464030|NCT01926782|465994162|FG003|Overall Study|Participant moved|1|||
129464031|NCT01926782|465994163|FG004|Overall Study|Participant moved|0|||
129464032|NCT01926782|465994164|FG005|Overall Study|Participant moved|3|||
129464033|NCT01926782|465994159|FG000|Overall Study|Physician Decision|0|||
129464034|NCT01926782|465994160|FG001|Overall Study|Physician Decision|2|||
129464035|NCT01926782|465994161|FG002|Overall Study|Physician Decision|1|||
129464036|NCT01926782|465994162|FG003|Overall Study|Physician Decision|1|||
129464037|NCT01926782|465994163|FG004|Overall Study|Physician Decision|0|||
129464038|NCT01926782|465994164|FG005|Overall Study|Physician Decision|0|||
129464039|NCT01926782|465994159|FG000|Overall Study|Other than specified|2|||
129464040|NCT01926782|465994160|FG001|Overall Study|Other than specified|3|||
129464041|NCT01926782|465994161|FG002|Overall Study|Other than specified|5|||
129464042|NCT01926782|465994162|FG003|Overall Study|Other than specified|12|||
129464043|NCT01926782|465994163|FG004|Overall Study|Other than specified|4|||
129464044|NCT01926782|465994164|FG005|Overall Study|Other than specified|11|||
129464045|NCT01926782|465994159|FG000|Overall Study|Adverse Event|13|||
129464046|NCT01926782|465994160|FG001|Overall Study|Adverse Event|4|||
129464047|NCT01926782|465994161|FG002|Overall Study|Adverse Event|17|||
129464048|NCT01926782|465994162|FG003|Overall Study|Adverse Event|4|||
129464049|NCT01926782|465994163|FG004|Overall Study|Adverse Event|3|||
129970985|NCT05131477|467856623|FG002|PART 2|Re-randomized and not treated|0|||
129970986|NCT05131477|467856624|FG003|PART 2|Re-randomized and not treated|0|||
129464050|NCT01926782|465994164|FG005|Overall Study|Adverse Event|14|||
129464051|NCT01926782|465994159|FG000|Overall Study|Poor compliance to protocol|5|||
129464052|NCT01926782|465994160|FG001|Overall Study|Poor compliance to protocol|3|||
129464053|NCT01926782|465994161|FG002|Overall Study|Poor compliance to protocol|8|||
129464054|NCT01926782|465994162|FG003|Overall Study|Poor compliance to protocol|0|||
129464055|NCT01926782|465994163|FG004|Overall Study|Poor compliance to protocol|1|||
129464056|NCT01926782|465994164|FG005|Overall Study|Poor compliance to protocol|6|||
129464057|NCT01926782|465994159|FG000|Overall Study|Randomized and not treated|0|||
129464058|NCT01926782|465994160|FG001|Overall Study|Randomized and not treated|0|||
129970987|NCT05131477|467856625|FG004|PART 2|Re-randomized and not treated|0|||
129970988|NCT05131477|467856626|FG005|PART 2|Re-randomized and not treated|0|||
129970989|NCT05131477|467856627|FG006|PART 2|Re-randomized and not treated|0|||
129970990|NCT05131477|467856628|FG007|PART 2|Re-randomized and not treated|1|||
129970991|NCT05131477|467856629|FG008|PART 2|Re-randomized and not treated|0|||
129970992|NCT05131477|467856630|FG009|PART 2|Re-randomized and not treated|0|||
129970993|NCT05131477|467856631|FG010|PART 2|Re-randomized and not treated|1|||
129970994|NCT05131477|467856632|FG011|PART 2|Re-randomized and not treated|0|||
129970995|NCT05131477|467856633|FG012|PART 2|Re-randomized and not treated|1|||
129970996|NCT05131477|467856634|FG013|PART 2|Re-randomized and not treated|1|||
129970997|NCT02194829|467856635|FG000|Overall Study|Adverse Event|2|||
129970998|NCT02194829|467856636|FG001|Overall Study|Adverse Event|2|||
129970999|NCT02194829|467856635|FG000|Overall Study|Death|0|||
129971000|NCT02194829|467856636|FG001|Overall Study|Death|1|||
129971001|NCT02194829|467856635|FG000|Overall Study|Disease progression|0|||
129971002|NCT02194829|467856636|FG001|Overall Study|Disease progression|1|||
129971003|NCT02194829|467856635|FG000|Overall Study|Withdrawal by Subject|0|||
129971004|NCT02194829|467856636|FG001|Overall Study|Withdrawal by Subject|1|||
129464059|NCT01926782|465994161|FG002|Overall Study|Randomized and not treated|0|||
129464060|NCT01926782|465994162|FG003|Overall Study|Randomized and not treated|1|||
129464061|NCT01926782|465994163|FG004|Overall Study|Randomized and not treated|0|||
129464062|NCT01926782|465994164|FG005|Overall Study|Randomized and not treated|0|||
129464063|NCT01926782|465994159|FG000|Overall Study|Withdrawal by Subject|6|||
129464064|NCT01926782|465994160|FG001|Overall Study|Withdrawal by Subject|1|||
129464065|NCT01926782|465994161|FG002|Overall Study|Withdrawal by Subject|8|||
129464066|NCT01926782|465994162|FG003|Overall Study|Withdrawal by Subject|1|||
129464067|NCT01926782|465994163|FG004|Overall Study|Withdrawal by Subject|0|||
129464068|NCT01926782|465994164|FG005|Overall Study|Withdrawal by Subject|5|||
129971005|NCT02194829|467856635|FG000|Overall Study|Never started protocol therapy|0|||
129971006|NCT02194829|467856636|FG001|Overall Study|Never started protocol therapy|1|||
129971007|NCT05101993|467856641|FG000|Overall Study|Withdrawal by Subject|1|||
129971008|NCT01124838|467856642|FG000|Overall Study|Miscellaneous|4|||
129971009|NCT01124838|467856643|FG001|Overall Study|Miscellaneous|2|||
129971010|NCT01124838|467856642|FG000|Overall Study|Adverse Event|7|||
129971011|NCT01124838|467856643|FG001|Overall Study|Adverse Event|11|||
129971012|NCT01124838|467856642|FG000|Overall Study|Lack of Efficacy|2|||
129464069|NCT01926782|465994159|FG000|Overall Study|Related to study drug administration|0|||
129464070|NCT01926782|465994160|FG001|Overall Study|Related to study drug administration|0|||
129464071|NCT01926782|465994161|FG002|Overall Study|Related to study drug administration|0|||
129464072|NCT01926782|465994162|FG003|Overall Study|Related to study drug administration|0|||
129464073|NCT01926782|465994163|FG004|Overall Study|Related to study drug administration|0|||
129464074|NCT01926782|465994164|FG005|Overall Study|Related to study drug administration|2|||
129464075|NCT02462473|465994167|FG000|Overall Study|Death|1|||
129464076|NCT02462473|465994167|FG000|Overall Study|Other|3|||
129464077|NCT00430508|465994168|FG000|Overall Study|Adverse Event|2|||
129464078|NCT00430508|465994169|FG001|Overall Study|Adverse Event|3|||
129464079|NCT00430508|465994170|FG002|Overall Study|Adverse Event|5|||
129464080|NCT00430508|465994171|FG003|Overall Study|Adverse Event|3|||
129464081|NCT00430508|465994168|FG000|Overall Study|Withdrawal by Subject|0|||
129464082|NCT00430508|465994169|FG001|Overall Study|Withdrawal by Subject|1|||
129464083|NCT00430508|465994170|FG002|Overall Study|Withdrawal by Subject|1|||
129464084|NCT00430508|465994171|FG003|Overall Study|Withdrawal by Subject|1|||
129464085|NCT00430508|465994168|FG000|Overall Study|responder at visit 4|0|||
129464086|NCT00430508|465994169|FG001|Overall Study|responder at visit 4|0|||
129464087|NCT00430508|465994170|FG002|Overall Study|responder at visit 4|2|||
129464088|NCT00430508|465994171|FG003|Overall Study|responder at visit 4|0|||
129464089|NCT00430508|465994168|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
129464090|NCT00430508|465994169|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
129464091|NCT00430508|465994170|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
129464092|NCT00430508|465994171|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
129464093|NCT00430508|465994168|FG000|Overall Study|Other|1|||
129464094|NCT00430508|465994169|FG001|Overall Study|Other|1|||
129464095|NCT00430508|465994170|FG002|Overall Study|Other|3|||
129464096|NCT00430508|465994171|FG003|Overall Study|Other|0|||
129464097|NCT04673786|465994177|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
129464098|NCT04673786|465994178|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
129464099|NCT04673786|465994179|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
129464100|NCT04673786|465994177|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
129464101|NCT04673786|465994178|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
129464102|NCT04673786|465994179|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
129464103|NCT04673786|465994177|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
129464104|NCT04673786|465994178|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
129464105|NCT04673786|465994179|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
129464106|NCT04673786|465994177|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
129464107|NCT04673786|465994178|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
129464108|NCT04673786|465994179|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
129464109|NCT04673786|465994177|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
129464110|NCT04673786|465994178|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
129464111|NCT04673786|465994179|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
129464112|NCT04673786|465994177|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
129464113|NCT04673786|465994178|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
129464114|NCT04673786|465994179|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
129464115|NCT03298022|465994180|FG000|Overall Study|Lack of Efficacy|4|||
129464116|NCT03298022|465994180|FG000|Overall Study|Withdrawal by Subject|7|||
129464117|NCT03298022|465994180|FG000|Overall Study|Adverse Event|1|||
129464118|NCT03298022|465994180|FG000|Overall Study|disease relapse|1|||
129464119|NCT01422239|465994183|FG000|Overall Study|Lost to Follow-up|4|||
129464120|NCT01422239|465994184|FG001|Overall Study|Lost to Follow-up|3|||
129464121|NCT01400451|465994185|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
129464122|NCT01400451|465994186|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
129464123|NCT01400451|465994187|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
129971013|NCT01124838|467856643|FG001|Overall Study|Lack of Efficacy|0|||
129971014|NCT01124838|467856642|FG000|Overall Study|Withdrawal by Subject|3|||
129971015|NCT01124838|467856643|FG001|Overall Study|Withdrawal by Subject|2|||
129971016|NCT01124838|467856642|FG000|Overall Study|Lost to Follow-up|2|||
129971017|NCT01124838|467856643|FG001|Overall Study|Lost to Follow-up|0|||
129971018|NCT04297618|467856644|FG000|Overall Study|Adverse Event|1|||
129971019|NCT04297618|467856644|FG000|Overall Study|Withdrawal by Subject|1|||
129971020|NCT06719986|467856645|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
129971021|NCT06719986|467856646|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
129971022|NCT06719986|467856647|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
129971023|NCT06719986|467856645|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
129971024|NCT06719986|467856646|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
129971025|NCT06719986|467856647|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
129971026|NCT02600897|467856649|FG000|Overall Study|Death|1|||
129971027|NCT02600897|467856650|FG001|Overall Study|Death|2|||
129971028|NCT02600897|467856651|FG002|Overall Study|Death|1|||
129971029|NCT02600897|467856652|FG003|Overall Study|Death|2|||
129971030|NCT02600897|467856653|FG004|Overall Study|Death|3|||
129971031|NCT02600897|467856654|FG005|Overall Study|Death|2|||
129971032|NCT02600897|467856655|FG006|Overall Study|Death|10|||
129971033|NCT02600897|467856656|FG007|Overall Study|Death|7|||
129971034|NCT02600897|467856657|FG008|Overall Study|Death|20|||
129971035|NCT02600897|467856649|FG000|Overall Study|Lost to Follow-up|1|||
129971036|NCT02600897|467856650|FG001|Overall Study|Lost to Follow-up|0|||
129971037|NCT02600897|467856651|FG002|Overall Study|Lost to Follow-up|0|||
129971038|NCT02600897|467856652|FG003|Overall Study|Lost to Follow-up|0|||
129971039|NCT02600897|467856653|FG004|Overall Study|Lost to Follow-up|0|||
129971040|NCT02600897|467856654|FG005|Overall Study|Lost to Follow-up|0|||
129971041|NCT02600897|467856655|FG006|Overall Study|Lost to Follow-up|0|||
129971042|NCT02600897|467856656|FG007|Overall Study|Lost to Follow-up|1|||
129971043|NCT02600897|467856657|FG008|Overall Study|Lost to Follow-up|0|||
129971044|NCT02600897|467856649|FG000|Overall Study|Withdrawal by Subject|0|||
129971045|NCT02600897|467856650|FG001|Overall Study|Withdrawal by Subject|0|||
129971046|NCT02600897|467856651|FG002|Overall Study|Withdrawal by Subject|0|||
129971047|NCT02600897|467856652|FG003|Overall Study|Withdrawal by Subject|0|||
129971048|NCT02600897|467856653|FG004|Overall Study|Withdrawal by Subject|0|||
129971049|NCT02600897|467856654|FG005|Overall Study|Withdrawal by Subject|0|||
129971050|NCT02600897|467856655|FG006|Overall Study|Withdrawal by Subject|0|||
129971051|NCT02600897|467856656|FG007|Overall Study|Withdrawal by Subject|4|||
129971052|NCT02600897|467856657|FG008|Overall Study|Withdrawal by Subject|2|||
129464124|NCT01400451|465994185|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
129464125|NCT01400451|465994186|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
129464126|NCT01400451|465994187|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
129464127|NCT01400451|465994185|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
129464128|NCT01400451|465994186|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
129464129|NCT01400451|465994187|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
129464130|NCT01400451|465994185|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
129464131|NCT01400451|465994186|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
129464132|NCT01400451|465994187|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
129464133|NCT01400451|465994185|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
129464134|NCT01400451|465994186|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
129464135|NCT01400451|465994187|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
129464136|NCT01627899|465994194|FG000|Overall Study|Study terminated early by sponsor.|5|||
129464137|NCT04158648|465994200|FG000|Overall Study|Ongoing in the Study|69|||
129464138|NCT04158648|465994200|FG000|Overall Study|Withdrawal by Subject|4|||
129464139|NCT04209855|465994201|FG000|Overall Study|Death|161|||
129464140|NCT04209855|465994202|FG001|Overall Study|Death|177|||
129464141|NCT04209855|465994201|FG000|Overall Study|PI Discretion|1|||
129971053|NCT02600897|467856649|FG000|Overall Study|Reason Not Specified|0|||
129971054|NCT02600897|467856650|FG001|Overall Study|Reason Not Specified|0|||
129464142|NCT04209855|465994202|FG001|Overall Study|PI Discretion|1|||
129464143|NCT04209855|465994201|FG000|Overall Study|Lost to Follow-up|5|||
129464144|NCT04209855|465994202|FG001|Overall Study|Lost to Follow-up|2|||
129464145|NCT04209855|465994201|FG000|Overall Study|Withdrew consent|10|||
129464146|NCT04209855|465994202|FG001|Overall Study|Withdrew consent|24|||
129464147|NCT04209855|465994201|FG000|Overall Study|Sponsor decision|44|||
129464148|NCT04209855|465994202|FG001|Overall Study|Sponsor decision|18|||
129464149|NCT04209855|465994201|FG000|Overall Study|Other than specified|6|||
129464150|NCT04209855|465994202|FG001|Overall Study|Other than specified|4|||
129971055|NCT02600897|467856651|FG002|Overall Study|Reason Not Specified|0|||
129971056|NCT02600897|467856652|FG003|Overall Study|Reason Not Specified|0|||
129971057|NCT02600897|467856653|FG004|Overall Study|Reason Not Specified|0|||
129971058|NCT02600897|467856654|FG005|Overall Study|Reason Not Specified|0|||
129971059|NCT02600897|467856655|FG006|Overall Study|Reason Not Specified|0|||
129971060|NCT02600897|467856656|FG007|Overall Study|Reason Not Specified|0|||
129971061|NCT02600897|467856657|FG008|Overall Study|Reason Not Specified|1|||
129464151|NCT01250379|465994205|FG000|Overall Study|Death|141|||
129464152|NCT01250379|465994206|FG001|Overall Study|Death|148|||
129464153|NCT01250379|465994205|FG000|Overall Study|Withdrawal by Subject|32|||
129464154|NCT01250379|465994206|FG001|Overall Study|Withdrawal by Subject|20|||
129464155|NCT01250379|465994205|FG000|Overall Study|Physician Decision|11|||
129464156|NCT01250379|465994206|FG001|Overall Study|Physician Decision|3|||
129464157|NCT01250379|465994205|FG000|Overall Study|Protocol Violation|2|||
129464158|NCT01250379|465994206|FG001|Overall Study|Protocol Violation|8|||
129464159|NCT01250379|465994205|FG000|Overall Study|Lost to Follow-up|9|||
129464160|NCT01250379|465994206|FG001|Overall Study|Lost to Follow-up|6|||
129464161|NCT01250379|465994205|FG000|Overall Study|Adverse Event|5|||
129464162|NCT01250379|465994206|FG001|Overall Study|Adverse Event|4|||
129464163|NCT01250379|465994205|FG000|Overall Study|Other|0|||
129464164|NCT01250379|465994206|FG001|Overall Study|Other|4|||
129464165|NCT01250379|465994205|FG000|Overall Study|Participant noncompliance|2|||
129464166|NCT01250379|465994206|FG001|Overall Study|Participant noncompliance|0|||
129464167|NCT05902364|465994207|FG000|Overall Study|Adverse Event|1|||
129464168|NCT05902364|465994208|FG001|Overall Study|Adverse Event|0|||
129464169|NCT01984268|465994210|FG000|Overall Study|Study Terminated|15|||
129464170|NCT04899232|465994211|FG000|Screening Period|Physician Decision|1|||
129464171|NCT04899232|465994212|FG001|Screening Period|Physician Decision|0|||
129464172|NCT04899232|465994213|FG002|Screening Period|Physician Decision|0|||
129464173|NCT04899232|465994211|FG000|Screening Period|Withdrawal by Subject|1|||
129464174|NCT04899232|465994212|FG001|Screening Period|Withdrawal by Subject|0|||
129464175|NCT04899232|465994213|FG002|Screening Period|Withdrawal by Subject|0|||
129464176|NCT04899232|465994211|FG000|Screening Period|Participant discharged before receiving intervention|3|||
129464177|NCT04899232|465994212|FG001|Screening Period|Participant discharged before receiving intervention|0|||
129464178|NCT04899232|465994213|FG002|Screening Period|Participant discharged before receiving intervention|0|||
129464179|NCT03110224|465994214|FG000|Overall Study|Death|3|||
129464180|NCT03110224|465994214|FG000|Overall Study|Lost to Follow-up|132|||
129464181|NCT03110224|465994214|FG000|Overall Study|Physician Decision|2|||
129464182|NCT03110224|465994214|FG000|Overall Study|Site Closed by Physician|35|||
129464183|NCT03110224|465994214|FG000|Overall Study|Site Closed by Sponsor|202|||
129464184|NCT03110224|465994214|FG000|Overall Study|Withdrawal by Subject|9|||
129464185|NCT04818593|465994215|FG000|Overall Study|Low Oocyte Yield|8|||
129464186|NCT04818593|465994216|FG001|Overall Study|Low Oocyte Yield|8|||
129464187|NCT04818593|465994215|FG000|Overall Study|Not ICSI Insemination|7|||
129464188|NCT04818593|465994216|FG001|Overall Study|Not ICSI Insemination|7|||
129464189|NCT04818593|465994215|FG000|Overall Study|Poor Sperm Quality|2|||
129464190|NCT04818593|465994216|FG001|Overall Study|Poor Sperm Quality|2|||
129464191|NCT04818593|465994215|FG000|Overall Study|Withdrawal by Subject|2|||
129464192|NCT04818593|465994216|FG001|Overall Study|Withdrawal by Subject|2|||
129464193|NCT04818593|465994215|FG000|Overall Study|Conversion to IUI due to low response|1|||
129464194|NCT04818593|465994216|FG001|Overall Study|Conversion to IUI due to low response|1|||
129464195|NCT01564862|465994217|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
129464196|NCT01564862|465994218|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
129464197|NCT01564862|465994219|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
129464198|NCT01564862|465994217|FG000|Overall Study|Major Protocol Deviation|3|||
129464199|NCT01564862|465994218|FG001|Overall Study|Major Protocol Deviation|3|||
129464200|NCT01564862|465994219|FG002|Overall Study|Major Protocol Deviation|4|||
129464201|NCT01564862|465994217|FG000|Overall Study|Lost to Follow-up|10|||
129464202|NCT01564862|465994218|FG001|Overall Study|Lost to Follow-up|8|||
129464203|NCT01564862|465994219|FG002|Overall Study|Lost to Follow-up|6|||
129464204|NCT01564862|465994217|FG000|Overall Study|Voluntary Withdrawal|9|||
129464205|NCT01564862|465994218|FG001|Overall Study|Voluntary Withdrawal|6|||
129464206|NCT01564862|465994219|FG002|Overall Study|Voluntary Withdrawal|8|||
129464207|NCT01564862|465994217|FG000|Overall Study|Lack of Efficacy|1|||
129464208|NCT01564862|465994218|FG001|Overall Study|Lack of Efficacy|5|||
129464209|NCT01564862|465994219|FG002|Overall Study|Lack of Efficacy|6|||
129464210|NCT01564862|465994217|FG000|Overall Study|Other reason(s)|1|||
129464211|NCT01564862|465994218|FG001|Overall Study|Other reason(s)|0|||
129464212|NCT01564862|465994219|FG002|Overall Study|Other reason(s)|0|||
129464213|NCT02028455|465994220|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
129464214|NCT02028455|465994221|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
129464215|NCT02028455|465994222|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
129464216|NCT02028455|465994223|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
129464217|NCT02028455|465994224|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
129464218|NCT02028455|465994225|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
129464219|NCT02028455|465994226|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
129464220|NCT02028455|465994227|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
129464221|NCT02028455|465994220|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
129464222|NCT02028455|465994221|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
129464223|NCT02028455|465994222|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
129464224|NCT02028455|465994223|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
129464225|NCT02028455|465994224|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
129464226|NCT02028455|465994225|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
129464227|NCT02028455|465994226|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
129464228|NCT02028455|465994227|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
129464229|NCT02028455|465994220|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
129464230|NCT02028455|465994221|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
129464231|NCT02028455|465994222|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
129464232|NCT02028455|465994223|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
129464233|NCT02028455|465994224|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
129464234|NCT02028455|465994225|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
129464235|NCT02028455|465994226|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
129464236|NCT02028455|465994227|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
129464237|NCT02028455|465994220|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
129464238|NCT02028455|465994221|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
129464239|NCT02028455|465994222|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
129464240|NCT02028455|465994223|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
129464241|NCT02028455|465994224|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
129464242|NCT02028455|465994225|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
129464243|NCT02028455|465994226|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
129464244|NCT02028455|465994227|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
129464245|NCT04705051|465995496|FG000|Overall Study|Enrolled but not treated|1|||
129464246|NCT04705051|465995496|FG000|Overall Study|Study terminated by sponsor|23|||
129464247|NCT02740478|465995502|FG000|Overall Study|Withdrawal by Subject|1|||
129464248|NCT04316585|465995503|FG000|Overall Study|Adverse Event|2|||
129464249|NCT04316585|465995504|FG001|Overall Study|Adverse Event|1|||
129464250|NCT04316585|465995503|FG000|Overall Study|Lost to Follow-up|1|||
129464251|NCT04316585|465995504|FG001|Overall Study|Lost to Follow-up|0|||
129464252|NCT04316585|465995503|FG000|Overall Study|Withdrawal by Subject|2|||
129464253|NCT04316585|465995504|FG001|Overall Study|Withdrawal by Subject|3|||
129464254|NCT04316585|465995503|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
129464255|NCT04316585|465995504|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
129464256|NCT04316585|465995503|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
129464257|NCT04316585|465995504|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
129464258|NCT02792842|465995508|FG000|Overall Study|Adverse Event|4|||
129464259|NCT02792842|465995509|FG001|Overall Study|Adverse Event|2|||
129464260|NCT02792842|465995510|FG002|Overall Study|Adverse Event|3|||
129464261|NCT02792842|465995508|FG000|Overall Study|Withdrawal by Subject|0|||
129464262|NCT02792842|465995509|FG001|Overall Study|Withdrawal by Subject|1|||
129464263|NCT02792842|465995510|FG002|Overall Study|Withdrawal by Subject|2|||
129464264|NCT02792842|465995508|FG000|Overall Study|Lost to Follow-up|0|||
129464265|NCT02792842|465995509|FG001|Overall Study|Lost to Follow-up|0|||
129464266|NCT02792842|465995510|FG002|Overall Study|Lost to Follow-up|1|||
129464267|NCT02792842|465995508|FG000|Overall Study|Schedule delay|0|||
129464268|NCT02792842|465995509|FG001|Overall Study|Schedule delay|1|||
129464269|NCT02792842|465995510|FG002|Overall Study|Schedule delay|1|||
129464270|NCT00493038|465995519|FG000|Treatment|Adverse Event|8|||
129464271|NCT00493038|465995520|FG001|Treatment|Adverse Event|4|||
129464272|NCT00493038|465995519|FG000|Treatment|Lost to Follow-up|5|||
129464273|NCT00493038|465995520|FG001|Treatment|Lost to Follow-up|3|||
129464274|NCT00493038|465995519|FG000|Treatment|Withdrawal by Subject|11|||
129464275|NCT00493038|465995520|FG001|Treatment|Withdrawal by Subject|12|||
129464276|NCT00493038|465995519|FG000|Treatment|Other|0|||
129464277|NCT00493038|465995520|FG001|Treatment|Other|1|||
129464278|NCT00493038|465995519|FG000|Follow-up|Lost to Follow-up|1|||
129464279|NCT00493038|465995520|FG001|Follow-up|Lost to Follow-up|0|||
129464280|NCT03345472|465995521|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
129464281|NCT03345472|465995521|FG000|Implant to 3 Months|Physician Decision|1|||
129464282|NCT03345472|465995521|FG000|Implant to 3 Months|Adverse Event|1|||
129971062|NCT02726945|467856658|FG000|Overall Study|Withdrawal by Subject|0|||
129971063|NCT02726945|467856659|FG001|Overall Study|Withdrawal by Subject|0|||
129464283|NCT03345472|465995521|FG000|3 Months to 12 Months|Physician Decision|3|||
129464284|NCT03345472|465995521|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
129464285|NCT03345472|465995521|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
129464286|NCT03345472|465995521|FG000|3 Months to 12 Months|Adverse Event|1|||
129464287|NCT03345472|465995521|FG000|3 Months to 12 Months|Death|1|||
129464288|NCT01847885|465995522|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
129464289|NCT01847885|465995523|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
129464290|NCT01847885|465995524|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
129464291|NCT01847885|465995522|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
129971064|NCT02726945|467856660|FG002|Overall Study|Withdrawal by Subject|1|||
129464292|NCT01847885|465995523|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
129464293|NCT01847885|465995524|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
129464294|NCT01847885|465995522|FG000|Initial Enrollment (Consented)|Screen failure|39|||
129464295|NCT01847885|465995523|FG001|Initial Enrollment (Consented)|Screen failure|0|||
129464296|NCT01847885|465995524|FG002|Initial Enrollment (Consented)|Screen failure|0|||
129464297|NCT01847885|465995522|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
129464298|NCT01847885|465995523|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
129464299|NCT01847885|465995524|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
129464300|NCT01847885|465995522|FG000|Randomization|Protocol Violation|0|||
129464301|NCT01847885|465995523|FG001|Randomization|Protocol Violation|1|||
129464302|NCT01847885|465995524|FG002|Randomization|Protocol Violation|0|||
129464303|NCT01847885|465995522|FG000|Randomization|Withdrawal by Subject|0|||
129464304|NCT01847885|465995523|FG001|Randomization|Withdrawal by Subject|0|||
129464305|NCT01847885|465995524|FG002|Randomization|Withdrawal by Subject|2|||
129464306|NCT01847885|465995522|FG000|Randomization|Screen Failure|0|||
129464307|NCT01847885|465995523|FG001|Randomization|Screen Failure|3|||
129464308|NCT01847885|465995524|FG002|Randomization|Screen Failure|0|||
129464309|NCT00070941|465995525|FG000|Overall Study|Adverse Event|10|||
129464310|NCT00070941|465995526|FG001|Overall Study|Adverse Event|8|||
129464311|NCT00070941|465995527|FG002|Overall Study|Adverse Event|4|||
129464312|NCT00094055|465995528|FG000|Overall Study|Adverse Event|11|||
129464313|NCT00094055|465995528|FG000|Overall Study|Death|4|||
129464314|NCT00094055|465995528|FG000|Overall Study|Lack of Efficacy|17|||
129464315|NCT00094055|465995528|FG000|Overall Study|Lost to Follow-up|2|||
129464316|NCT00094055|465995528|FG000|Overall Study|progressive disease|2|||
129464317|NCT00094055|465995528|FG000|Overall Study|clinical progression|1|||
129464318|NCT00094055|465995528|FG000|Overall Study|roll-over to another study|14|||
129464319|NCT00094055|465995528|FG000|Overall Study|Withdrawal by Subject|9|||
129464320|NCT01536860|465995529|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
129464321|NCT01536860|465995530|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
129464322|NCT01536860|465995531|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
129464323|NCT01164722|465995532|FG000|Overall Study|Adverse Event|0|||
129464324|NCT01164722|465995533|FG001|Overall Study|Adverse Event|1|||
129464325|NCT01164722|465995532|FG000|Overall Study|Withdrawal by Subject|3|||
129464326|NCT01164722|465995533|FG001|Overall Study|Withdrawal by Subject|4|||
129464327|NCT01164722|465995532|FG000|Overall Study|Lost to Follow-up|3|||
129464328|NCT01164722|465995533|FG001|Overall Study|Lost to Follow-up|6|||
129464329|NCT01164722|465995532|FG000|Overall Study|met protocol criteria for non-treatment|11|||
129464330|NCT01164722|465995533|FG001|Overall Study|met protocol criteria for non-treatment|1|||
129464331|NCT01164722|465995532|FG000|Overall Study|enrolled on other study, concomitant med|1|||
129464332|NCT01164722|465995533|FG001|Overall Study|enrolled on other study, concomitant med|3|||
129464333|NCT02682901|465995534|FG000|Overall Study|Adverse Event|10|||
129464334|NCT02682901|465995535|FG001|Overall Study|Adverse Event|3|||
129464335|NCT02682901|465995534|FG000|Overall Study|Lack of Efficacy|0|||
129464336|NCT02682901|465995535|FG001|Overall Study|Lack of Efficacy|1|||
129464337|NCT01276236|465995536|FG000|Overall Study|Lack of Efficacy|2|||
129464338|NCT01276236|465995536|FG000|Overall Study|Withdrawal by Subject|4|||
129464339|NCT00044512|465995537|FG000|Follow Up|Lost to Follow-up|2|||
129464340|NCT02799069|465995539|FG000|Overall Study|Adverse Event|0|||
129464341|NCT02799069|465995540|FG001|Overall Study|Adverse Event|2|||
129464342|NCT02799069|465995541|FG002|Overall Study|Adverse Event|2|||
129464343|NCT02799069|465995539|FG000|Overall Study|Lack of Efficacy|2|||
129464344|NCT02799069|465995540|FG001|Overall Study|Lack of Efficacy|0|||
129464345|NCT02799069|465995541|FG002|Overall Study|Lack of Efficacy|0|||
129464346|NCT02799069|465995539|FG000|Overall Study|Lost to Follow-up|1|||
129464347|NCT02799069|465995540|FG001|Overall Study|Lost to Follow-up|1|||
129464348|NCT02799069|465995541|FG002|Overall Study|Lost to Follow-up|0|||
129464349|NCT02799069|465995539|FG000|Overall Study|Withdrawal by Subject|4|||
129464350|NCT02799069|465995540|FG001|Overall Study|Withdrawal by Subject|4|||
129464351|NCT02799069|465995541|FG002|Overall Study|Withdrawal by Subject|3|||
129464352|NCT02799069|465995539|FG000|Overall Study|Protocol Violation|1|||
129464353|NCT02799069|465995540|FG001|Overall Study|Protocol Violation|0|||
129464354|NCT02799069|465995541|FG002|Overall Study|Protocol Violation|2|||
129464355|NCT00357500|465995558|FG000|Overall Study|Adverse Event|3|||
129464356|NCT00357500|465995558|FG000|Overall Study|Withdrawal by Subject|5|||
129464357|NCT00357500|465995558|FG000|Overall Study|Progressive Disease|65|||
129464358|NCT00357500|465995558|FG000|Overall Study|Not Started Protocol Therapy|4|||
129464359|NCT02695628|465995559|FG000|Overall Study|Withdrawal by Subject|1|||
129464360|NCT02573155|465995560|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
129464361|NCT02573155|465995561|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
129464362|NCT02573155|465995560|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
129464363|NCT02573155|465995561|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
129464364|NCT02573155|465995560|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
129464365|NCT02573155|465995561|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
129464366|NCT02573155|465995560|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
129464367|NCT02573155|465995561|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
129464368|NCT02573155|465995560|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
129464369|NCT02573155|465995561|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
129464370|NCT02573155|465995560|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
129464371|NCT02573155|465995561|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
129464372|NCT02573155|465995560|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
129464373|NCT02573155|465995561|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
129464374|NCT02573155|465995560|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
129464375|NCT02573155|465995561|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
129464376|NCT00516737|465995565|FG000|Overall Study|Lost to Follow-up|2|||
129464377|NCT00516737|465995566|FG001|Overall Study|Lost to Follow-up|0|||
129464378|NCT00516737|465995565|FG000|Overall Study|Physician Decision|0|||
129464379|NCT00516737|465995566|FG001|Overall Study|Physician Decision|1|||
129464380|NCT00516737|465995565|FG000|Overall Study|Withdrawal by Subject|0|||
129464381|NCT00516737|465995566|FG001|Overall Study|Withdrawal by Subject|1|||
129464382|NCT00516737|465995565|FG000|Overall Study|Lack of Qualifying Event|9|||
129464383|NCT00516737|465995566|FG001|Overall Study|Lack of Qualifying Event|6|||
129464384|NCT01844895|465995567|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
129464385|NCT01844895|465995567|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
129464386|NCT01844895|465995567|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
129464387|NCT01844895|465995567|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
129464388|NCT01844895|465995567|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
129464389|NCT01844895|465995567|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
129464390|NCT01844895|465995567|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
129464391|NCT00511355|465995569|FG000|Overall Study|Adverse Event|4|||
129464392|NCT00511355|465995570|FG001|Overall Study|Adverse Event|4|||
129464393|NCT00511355|465995569|FG000|Overall Study|Pregnancy Wish|1|||
129464394|NCT00511355|465995570|FG001|Overall Study|Pregnancy Wish|0|||
129464395|NCT00511355|465995569|FG000|Overall Study|Lost to Follow-up|2|||
129464396|NCT00511355|465995570|FG001|Overall Study|Lost to Follow-up|1|||
129464397|NCT00511355|465995569|FG000|Overall Study|Other Reason|0|||
129464398|NCT00511355|465995570|FG001|Overall Study|Other Reason|1|||
129464399|NCT00511355|465995569|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
129464400|NCT00511355|465995570|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
129464401|NCT00511355|465995569|FG000|Overall Study|Withdrawal of informed consent|0|||
129464402|NCT00511355|465995570|FG001|Overall Study|Withdrawal of informed consent|1|||
129464403|NCT00511355|465995569|FG000|Overall Study|Other reason pre-treatment|0|||
129464404|NCT00511355|465995570|FG001|Overall Study|Other reason pre-treatment|1|||
129464405|NCT00454805|465995573|FG000|Overall Study|Withdrawal by Subject|9|||
129464406|NCT00454805|465995574|FG001|Overall Study|Withdrawal by Subject|2|||
129464407|NCT00454805|465995573|FG000|Overall Study|Death|0|||
129464408|NCT00454805|465995574|FG001|Overall Study|Death|2|||
129464409|NCT00454805|465995573|FG000|Overall Study|Disease progression|16|||
129464410|NCT00454805|465995574|FG001|Overall Study|Disease progression|19|||
129464411|NCT00454805|465995573|FG000|Overall Study|In order to begin radiotherapy|1|||
129464412|NCT00454805|465995574|FG001|Overall Study|In order to begin radiotherapy|0|||
129464413|NCT01358864|465995590|FG000|Overall Study|Adverse Event|0|||
129464414|NCT01358864|465995591|FG001|Overall Study|Adverse Event|6|||
129464415|NCT01358864|465995592|FG002|Overall Study|Adverse Event|9|||
129464416|NCT01358864|465995593|FG003|Overall Study|Adverse Event|0|||
129464417|NCT01358864|465995594|FG004|Overall Study|Adverse Event|4|||
129464418|NCT01358864|465995595|FG005|Overall Study|Adverse Event|8|||
129464419|NCT01358864|465995596|FG006|Overall Study|Adverse Event|12|||
129464420|NCT01358864|465995597|FG007|Overall Study|Adverse Event|7|||
129464421|NCT01358864|465995590|FG000|Overall Study|Lack of Efficacy|26|||
129464422|NCT01358864|465995591|FG001|Overall Study|Lack of Efficacy|3|||
129464423|NCT01358864|465995592|FG002|Overall Study|Lack of Efficacy|4|||
129464424|NCT01358864|465995593|FG003|Overall Study|Lack of Efficacy|19|||
129464425|NCT01358864|465995594|FG004|Overall Study|Lack of Efficacy|7|||
129464426|NCT01358864|465995595|FG005|Overall Study|Lack of Efficacy|4|||
129464427|NCT01358864|465995596|FG006|Overall Study|Lack of Efficacy|49|||
129464428|NCT01358864|465995597|FG007|Overall Study|Lack of Efficacy|44|||
129464429|NCT01358864|465995590|FG000|Overall Study|Lost to Follow-up|0|||
129464430|NCT01358864|465995591|FG001|Overall Study|Lost to Follow-up|0|||
129464431|NCT01358864|465995592|FG002|Overall Study|Lost to Follow-up|1|||
129464432|NCT01358864|465995593|FG003|Overall Study|Lost to Follow-up|0|||
129464433|NCT01358864|465995594|FG004|Overall Study|Lost to Follow-up|0|||
129464434|NCT01358864|465995595|FG005|Overall Study|Lost to Follow-up|0|||
129464435|NCT01358864|465995596|FG006|Overall Study|Lost to Follow-up|0|||
129464436|NCT01358864|465995597|FG007|Overall Study|Lost to Follow-up|1|||
129464437|NCT01358864|465995590|FG000|Overall Study|Withdrawal by Subject|3|||
129464438|NCT01358864|465995591|FG001|Overall Study|Withdrawal by Subject|4|||
129464439|NCT01358864|465995592|FG002|Overall Study|Withdrawal by Subject|2|||
129464440|NCT01358864|465995593|FG003|Overall Study|Withdrawal by Subject|0|||
129464441|NCT01358864|465995594|FG004|Overall Study|Withdrawal by Subject|0|||
129464442|NCT01358864|465995595|FG005|Overall Study|Withdrawal by Subject|1|||
129464443|NCT01358864|465995596|FG006|Overall Study|Withdrawal by Subject|1|||
129464444|NCT01358864|465995597|FG007|Overall Study|Withdrawal by Subject|3|||
129464445|NCT01358864|465995590|FG000|Overall Study|Other reason not defined above|2|||
129464446|NCT01358864|465995591|FG001|Overall Study|Other reason not defined above|0|||
129464447|NCT01358864|465995592|FG002|Overall Study|Other reason not defined above|0|||
129464448|NCT01358864|465995593|FG003|Overall Study|Other reason not defined above|0|||
129464449|NCT01358864|465995594|FG004|Overall Study|Other reason not defined above|0|||
129464450|NCT01358864|465995595|FG005|Overall Study|Other reason not defined above|0|||
129464451|NCT01358864|465995596|FG006|Overall Study|Other reason not defined above|2|||
129464452|NCT01358864|465995597|FG007|Overall Study|Other reason not defined above|0|||
129464453|NCT01358864|465995590|FG000|Overall Study|Not treated|0|||
129464454|NCT01358864|465995591|FG001|Overall Study|Not treated|0|||
129464455|NCT01358864|465995592|FG002|Overall Study|Not treated|0|||
129464456|NCT01358864|465995593|FG003|Overall Study|Not treated|0|||
129464457|NCT01358864|465995594|FG004|Overall Study|Not treated|0|||
129464458|NCT01358864|465995595|FG005|Overall Study|Not treated|0|||
129464459|NCT01358864|465995596|FG006|Overall Study|Not treated|1|||
129464460|NCT01358864|465995597|FG007|Overall Study|Not treated|0|||
129464461|NCT02289950|465995598|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
129464462|NCT02289950|465995599|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
129464463|NCT02289950|465995598|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
129464464|NCT02289950|465995599|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
129464465|NCT02289950|465995598|FG000|Overall Study|Lost to Follow-up|1|||
129464466|NCT02289950|465995599|FG001|Overall Study|Lost to Follow-up|0|||
129464467|NCT02289950|465995598|FG000|Overall Study|Physician Decision|9|||
129464468|NCT02289950|465995599|FG001|Overall Study|Physician Decision|3|||
129464469|NCT02289950|465995598|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
129464470|NCT02289950|465995599|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
129464471|NCT02289950|465995598|FG000|Overall Study|Withdrawal by Subject|1|||
129464472|NCT02289950|465995599|FG001|Overall Study|Withdrawal by Subject|3|||
129464473|NCT02289950|465995598|FG000|Overall Study|Test article held for greater than 28 days|0|||
129464474|NCT02289950|465995599|FG001|Overall Study|Test article held for greater than 28 days|1|||
129464475|NCT02289950|465995598|FG000|Overall Study|Adverse Event|11|||
129464476|NCT02289950|465995599|FG001|Overall Study|Adverse Event|3|||
129464477|NCT02289950|465995598|FG000|Overall Study|Death|1|||
129464478|NCT02289950|465995599|FG001|Overall Study|Death|1|||
129464479|NCT02289950|465995598|FG000|Overall Study|Other|5|||
129464480|NCT02289950|465995599|FG001|Overall Study|Other|2|||
129464481|NCT02289950|465995598|FG000|Overall Study|Not Treated|2|||
129464482|NCT02289950|465995599|FG001|Overall Study|Not Treated|1|||
129464483|NCT00644787|465995602|FG000|Period 1: Titration Phase|Adverse Event|11|||
129464484|NCT00644787|465995603|FG001|Period 1: Titration Phase|Adverse Event|0|||
129464485|NCT00644787|465995604|FG002|Period 1: Titration Phase|Adverse Event|0|||
129464486|NCT00644787|465995602|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
129464487|NCT00644787|465995603|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
129464488|NCT00644787|465995604|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
129464489|NCT00644787|465995602|FG000|Period 1: Titration Phase|Physician Decision|1|||
129464490|NCT00644787|465995603|FG001|Period 1: Titration Phase|Physician Decision|0|||
129464491|NCT00644787|465995604|FG002|Period 1: Titration Phase|Physician Decision|0|||
129464492|NCT00644787|465995602|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
129464493|NCT00644787|465995603|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
129464494|NCT00644787|465995604|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
129464495|NCT00644787|465995602|FG000|Period 1: Titration Phase|Worsening of complications|1|||
129464496|NCT00644787|465995603|FG001|Period 1: Titration Phase|Worsening of complications|0|||
129464497|NCT00644787|465995604|FG002|Period 1: Titration Phase|Worsening of complications|0|||
129464498|NCT00644787|465995602|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
129464499|NCT00644787|465995603|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
129971065|NCT02726945|467856658|FG000|Overall Study|Elected to have total knee replacement|0|||
129971066|NCT02726945|467856659|FG001|Overall Study|Elected to have total knee replacement|1|||
129971067|NCT02726945|467856660|FG002|Overall Study|Elected to have total knee replacement|0|||
129971068|NCT05992922|467856661|FG000|Overall Study|Adverse Event|6|||
129971069|NCT05992922|467856662|FG001|Overall Study|Adverse Event|0|||
129464500|NCT00644787|465995604|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
129464501|NCT00644787|465995602|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
129464502|NCT00644787|465995603|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
129464503|NCT00644787|465995604|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
129464504|NCT00644787|465995602|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
129971070|NCT05992922|467856661|FG000|Overall Study|Sponsor Termination of Study|14|||
129971071|NCT05992922|467856662|FG001|Overall Study|Sponsor Termination of Study|20|||
129464505|NCT00644787|465995603|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
129971072|NCT02172911|467858387|FG000|Overall Study|Serious Adverse Event|0|||
129464506|NCT00644787|465995604|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
129464507|NCT00644787|465995602|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
129464508|NCT00644787|465995603|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
129464509|NCT00644787|465995604|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
129464510|NCT00644787|465995602|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
129464511|NCT00644787|465995603|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
129464512|NCT00644787|465995604|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
129464513|NCT00644787|465995602|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
129464514|NCT00644787|465995603|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
129464515|NCT00644787|465995604|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
129464516|NCT00644787|465995602|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
129464517|NCT00644787|465995603|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
129464518|NCT00644787|465995604|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
129464519|NCT01489527|465995605|FG000|Overall Study|Pregnancy|9|||
129464520|NCT01489527|465995606|FG001|Overall Study|Pregnancy|14|||
129464521|NCT01489527|465995605|FG000|Overall Study|Participant moved|6|||
129464522|NCT01489527|465995606|FG001|Overall Study|Participant moved|7|||
129464523|NCT01489527|465995605|FG000|Overall Study|Withdrawal by Subject|0|||
129464524|NCT01489527|465995606|FG001|Overall Study|Withdrawal by Subject|4|||
129464525|NCT01489527|465995605|FG000|Overall Study|Lost to Follow-up|5|||
129464526|NCT01489527|465995606|FG001|Overall Study|Lost to Follow-up|1|||
129464527|NCT01489527|465995605|FG000|Overall Study|Procedures|1|||
129464528|NCT01489527|465995606|FG001|Overall Study|Procedures|0|||
129464529|NCT01489527|465995605|FG000|Overall Study|Not compliant|1|||
129464530|NCT01489527|465995606|FG001|Overall Study|Not compliant|0|||
129464531|NCT00936208|465995608|FG000|Overall Study|Protocol Violation|37|||
129464532|NCT00936208|465995609|FG001|Overall Study|Protocol Violation|22|||
129464533|NCT01344876|465995612|FG000|Overall Study|Adverse Event|0|||
129464534|NCT01344876|465995613|FG001|Overall Study|Adverse Event|0|||
129464535|NCT01344876|465995614|FG002|Overall Study|Adverse Event|0|||
129464536|NCT01344876|465995615|FG003|Overall Study|Adverse Event|0|||
129464537|NCT01344876|465995616|FG004|Overall Study|Adverse Event|1|||
129464538|NCT01344876|465995612|FG000|Overall Study|Withdrawal by Subject|0|||
129464539|NCT01344876|465995613|FG001|Overall Study|Withdrawal by Subject|0|||
129464540|NCT01344876|465995614|FG002|Overall Study|Withdrawal by Subject|1|||
129464541|NCT01344876|465995615|FG003|Overall Study|Withdrawal by Subject|0|||
129464542|NCT01344876|465995616|FG004|Overall Study|Withdrawal by Subject|0|||
129464543|NCT01344876|465995612|FG000|Overall Study|Definite progression of primary disease|1|||
129464544|NCT01344876|465995613|FG001|Overall Study|Definite progression of primary disease|0|||
129464545|NCT01344876|465995614|FG002|Overall Study|Definite progression of primary disease|0|||
129464546|NCT01344876|465995615|FG003|Overall Study|Definite progression of primary disease|3|||
129464547|NCT01344876|465995616|FG004|Overall Study|Definite progression of primary disease|0|||
129464548|NCT04428424|465995617|FG000|Overall Study|Does not meet entrance criteria|132|||
129464549|NCT04428424|465995617|FG000|Overall Study|Lost to Follow-up|115|||
129464550|NCT05036083|465995621|FG000|Overall Study|Physician Decision|1|||
129464551|NCT05036083|465995621|FG000|Overall Study|Withdrawal by Subject|1|||
129464552|NCT05036083|465995621|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
129464553|NCT05036083|465995621|FG000|Overall Study|IV not sustainable|1|||
129464554|NCT04622046|465995622|FG000|Intervention Period|Adverse Event|1|||
129464555|NCT04622046|465995622|FG000|Intervention Period|Withdrawal by Subject|2|||
129464556|NCT04622046|465995622|FG000|Extension Period|Ongoing in the Extension Period|21|||
129971073|NCT02172911|467858388|FG001|Overall Study|Serious Adverse Event|1|||
129971074|NCT02172911|467858387|FG000|Overall Study|Progression of Disease|0|||
129971075|NCT02172911|467858388|FG001|Overall Study|Progression of Disease|1|||
129971076|NCT02172911|467858387|FG000|Overall Study|Loss of insurance coverage|1|||
129971077|NCT02172911|467858388|FG001|Overall Study|Loss of insurance coverage|0|||
129464557|NCT01844986|465995623|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
129464558|NCT01844986|465995624|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
129464559|NCT01844986|465995623|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
129464560|NCT01844986|465995624|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
129464561|NCT01844986|465995623|FG000|Overall Study (Global Cohort)|Death|55|||
129464562|NCT01844986|465995624|FG001|Overall Study (Global Cohort)|Death|26|||
129464563|NCT01844986|465995623|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
129464564|NCT01844986|465995624|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
129464565|NCT01844986|465995623|FG000|Overall Study (China Cohort)|Death|10|||
129464566|NCT01844986|465995624|FG001|Overall Study (China Cohort)|Death|6|||
129464567|NCT02968810|465997593|FG000|Overall Study|Lost to Follow-up|1|||
129971078|NCT02737826|467858389|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
129971079|NCT02737826|467858390|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
129971080|NCT02737826|467858391|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
129971081|NCT00129935|467858392|FG000|Overall Study|Adverse Event|18|||
129971082|NCT00129935|467858393|FG001|Overall Study|Adverse Event|56|||
129971083|NCT00129935|467858392|FG000|Overall Study|Death|1|||
129464568|NCT02968810|465997594|FG001|Overall Study|Lost to Follow-up|0|||
129464569|NCT02968810|465997593|FG000|Overall Study|Physician Decision|1|||
129464570|NCT02968810|465997594|FG001|Overall Study|Physician Decision|0|||
129464571|NCT02968810|465997593|FG000|Overall Study|Withdrawal by Subject|1|||
129464572|NCT02968810|465997594|FG001|Overall Study|Withdrawal by Subject|3|||
129464573|NCT02968810|465997593|FG000|Overall Study|Disease Progression|0|||
129464574|NCT02968810|465997594|FG001|Overall Study|Disease Progression|1|||
129464575|NCT01790503|465997597|FG000|Overall Study|Adverse Event|1|||
129464576|NCT01790503|465997598|FG001|Overall Study|Adverse Event|0|||
129464577|NCT01790503|465997599|FG002|Overall Study|Adverse Event|0|||
129464578|NCT01790503|465997600|FG003|Overall Study|Adverse Event|0|||
129464579|NCT01790503|465997601|FG004|Overall Study|Adverse Event|0|||
129464580|NCT01790503|465997602|FG005|Overall Study|Adverse Event|2|||
129464581|NCT01790503|465997603|FG006|Overall Study|Adverse Event|0|||
129464582|NCT01790503|465997604|FG007|Overall Study|Adverse Event|0|||
129464583|NCT01790503|465997605|FG008|Overall Study|Adverse Event|2|||
129464584|NCT01790503|465997606|FG009|Overall Study|Adverse Event|4|||
129464585|NCT01790503|465997607|FG010|Overall Study|Adverse Event|7|||
129464586|NCT01790503|465997597|FG000|Overall Study|Withdrawal by Subject|0|||
129464587|NCT01790503|465997598|FG001|Overall Study|Withdrawal by Subject|0|||
129464588|NCT01790503|465997599|FG002|Overall Study|Withdrawal by Subject|1|||
129464589|NCT01790503|465997600|FG003|Overall Study|Withdrawal by Subject|1|||
129464590|NCT01790503|465997601|FG004|Overall Study|Withdrawal by Subject|1|||
129464591|NCT01790503|465997602|FG005|Overall Study|Withdrawal by Subject|2|||
129464592|NCT01790503|465997603|FG006|Overall Study|Withdrawal by Subject|1|||
129464593|NCT01790503|465997604|FG007|Overall Study|Withdrawal by Subject|0|||
129464594|NCT01790503|465997605|FG008|Overall Study|Withdrawal by Subject|0|||
129464595|NCT01790503|465997606|FG009|Overall Study|Withdrawal by Subject|0|||
129464596|NCT01790503|465997607|FG010|Overall Study|Withdrawal by Subject|1|||
129464597|NCT01790503|465997597|FG000|Overall Study|Disease progression|2|||
129464598|NCT01790503|465997598|FG001|Overall Study|Disease progression|1|||
129464599|NCT01790503|465997599|FG002|Overall Study|Disease progression|0|||
129464600|NCT01790503|465997600|FG003|Overall Study|Disease progression|1|||
129464601|NCT01790503|465997601|FG004|Overall Study|Disease progression|2|||
129464602|NCT01790503|465997602|FG005|Overall Study|Disease progression|1|||
129464603|NCT01790503|465997603|FG006|Overall Study|Disease progression|0|||
129464604|NCT01790503|465997604|FG007|Overall Study|Disease progression|1|||
129971084|NCT00129935|467858393|FG001|Overall Study|Death|1|||
129971085|NCT00129935|467858392|FG000|Overall Study|Withdrawal by Subject|7|||
129971086|NCT00129935|467858393|FG001|Overall Study|Withdrawal by Subject|20|||
129971087|NCT00129935|467858392|FG000|Overall Study|Protocol Violation|0|||
129971088|NCT00129935|467858393|FG001|Overall Study|Protocol Violation|4|||
129971089|NCT00129935|467858392|FG000|Overall Study|Physician Decision|3|||
129971090|NCT00129935|467858393|FG001|Overall Study|Physician Decision|4|||
129971091|NCT00129935|467858392|FG000|Overall Study|Recurrence|1|||
129971092|NCT00129935|467858393|FG001|Overall Study|Recurrence|3|||
129971093|NCT00129935|467858392|FG000|Overall Study|Second primary|0|||
129971094|NCT00129935|467858393|FG001|Overall Study|Second primary|1|||
129971095|NCT00129935|467858392|FG000|Overall Study|Other|3|||
129971096|NCT00129935|467858393|FG001|Overall Study|Other|2|||
129971097|NCT00129935|467858392|FG000|Overall Study|Crossed to the other arm|2|||
129971098|NCT00129935|467858393|FG001|Overall Study|Crossed to the other arm|1|||
129971099|NCT00129935|467858392|FG000|Overall Study|Incorrect study treatment|1|||
129971100|NCT00129935|467858393|FG001|Overall Study|Incorrect study treatment|0|||
129971101|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
129971102|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
129971103|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
129971104|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Death|4|||
129464605|NCT01790503|465997605|FG008|Overall Study|Disease progression|0|||
129464606|NCT01790503|465997606|FG009|Overall Study|Disease progression|17|||
129971105|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Death|2|||
129971106|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Death|3|||
129971107|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
129971108|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
129971109|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
129971110|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
129971111|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
129971112|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
129464607|NCT01790503|465997607|FG010|Overall Study|Disease progression|7|||
129464608|NCT01790503|465997597|FG000|Overall Study|Protocol Violation|0|||
129464609|NCT01790503|465997598|FG001|Overall Study|Protocol Violation|0|||
129971113|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
129464610|NCT01790503|465997599|FG002|Overall Study|Protocol Violation|0|||
129464611|NCT01790503|465997600|FG003|Overall Study|Protocol Violation|0|||
129464612|NCT01790503|465997601|FG004|Overall Study|Protocol Violation|0|||
129464613|NCT01790503|465997602|FG005|Overall Study|Protocol Violation|0|||
129464614|NCT01790503|465997603|FG006|Overall Study|Protocol Violation|0|||
129464615|NCT01790503|465997604|FG007|Overall Study|Protocol Violation|0|||
129464616|NCT01790503|465997605|FG008|Overall Study|Protocol Violation|0|||
129464617|NCT01790503|465997606|FG009|Overall Study|Protocol Violation|1|||
129464618|NCT01790503|465997607|FG010|Overall Study|Protocol Violation|0|||
129464619|NCT01790503|465997597|FG000|Overall Study|Physician Decision|0|||
129464620|NCT01790503|465997598|FG001|Overall Study|Physician Decision|0|||
129464621|NCT01790503|465997599|FG002|Overall Study|Physician Decision|0|||
129464622|NCT01790503|465997600|FG003|Overall Study|Physician Decision|0|||
129464623|NCT01790503|465997601|FG004|Overall Study|Physician Decision|0|||
129464624|NCT01790503|465997602|FG005|Overall Study|Physician Decision|0|||
129464625|NCT01790503|465997603|FG006|Overall Study|Physician Decision|0|||
129464626|NCT01790503|465997604|FG007|Overall Study|Physician Decision|0|||
129464627|NCT01790503|465997605|FG008|Overall Study|Physician Decision|0|||
129464628|NCT01790503|465997606|FG009|Overall Study|Physician Decision|1|||
129464629|NCT01790503|465997607|FG010|Overall Study|Physician Decision|1|||
129464630|NCT01790503|465997597|FG000|Overall Study|Death|0|||
129464631|NCT01790503|465997598|FG001|Overall Study|Death|0|||
129464632|NCT01790503|465997599|FG002|Overall Study|Death|0|||
129464633|NCT01790503|465997600|FG003|Overall Study|Death|0|||
129464634|NCT01790503|465997601|FG004|Overall Study|Death|0|||
129464635|NCT01790503|465997602|FG005|Overall Study|Death|0|||
129464636|NCT01790503|465997603|FG006|Overall Study|Death|0|||
129464637|NCT01790503|465997604|FG007|Overall Study|Death|0|||
129464638|NCT01790503|465997605|FG008|Overall Study|Death|0|||
129464639|NCT01790503|465997606|FG009|Overall Study|Death|1|||
129464640|NCT01790503|465997607|FG010|Overall Study|Death|0|||
129464641|NCT01790503|465997597|FG000|Overall Study|Non Compliance|0|||
129464642|NCT01790503|465997598|FG001|Overall Study|Non Compliance|0|||
129464643|NCT01790503|465997599|FG002|Overall Study|Non Compliance|0|||
129464644|NCT01790503|465997600|FG003|Overall Study|Non Compliance|0|||
129464645|NCT01790503|465997601|FG004|Overall Study|Non Compliance|1|||
129464646|NCT01790503|465997602|FG005|Overall Study|Non Compliance|0|||
129464647|NCT01790503|465997603|FG006|Overall Study|Non Compliance|0|||
129464648|NCT01790503|465997604|FG007|Overall Study|Non Compliance|0|||
129464649|NCT01790503|465997605|FG008|Overall Study|Non Compliance|0|||
129464650|NCT01790503|465997606|FG009|Overall Study|Non Compliance|0|||
129464651|NCT01790503|465997607|FG010|Overall Study|Non Compliance|0|||
129464652|NCT01790503|465997597|FG000|Overall Study|Other|0|||
129464653|NCT01790503|465997598|FG001|Overall Study|Other|0|||
129464654|NCT01790503|465997599|FG002|Overall Study|Other|0|||
129464655|NCT01790503|465997600|FG003|Overall Study|Other|0|||
129464656|NCT01790503|465997601|FG004|Overall Study|Other|1|||
129464657|NCT01790503|465997602|FG005|Overall Study|Other|0|||
129464658|NCT01790503|465997603|FG006|Overall Study|Other|0|||
129464659|NCT01790503|465997604|FG007|Overall Study|Other|0|||
129464660|NCT01790503|465997605|FG008|Overall Study|Other|1|||
129464661|NCT01790503|465997606|FG009|Overall Study|Other|2|||
129464662|NCT01790503|465997607|FG010|Overall Study|Other|0|||
129464663|NCT00699348|465997608|FG000|Overall Study|Death|6|||
129464664|NCT00699348|465997608|FG000|Overall Study|Adverse Event|15|||
129464665|NCT00699348|465997608|FG000|Overall Study|Withdrawal by Subject|11|||
129464666|NCT00699348|465997608|FG000|Overall Study|Protocol Violation|10|||
129464667|NCT00699348|465997608|FG000|Overall Study|Lack of Efficacy|8|||
129464668|NCT00699348|465997608|FG000|Overall Study|Failure to return|1|||
129464669|NCT00699348|465997608|FG000|Overall Study|Blood transfusion|24|||
129464670|NCT00699348|465997608|FG000|Overall Study|Renal transplantation|10|||
129464671|NCT00699348|465997608|FG000|Overall Study|Other|5|||
129464672|NCT03269344|465997609|FG000|Overall Study|Protocol Violation|4|||
129971114|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
129971115|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
129971116|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
129464673|NCT03269344|465997610|FG001|Overall Study|Protocol Violation|3|||
129464674|NCT02597855|465997613|FG000|Overall Study|Lost to Follow-up|2|||
129464675|NCT02597855|465997614|FG001|Overall Study|Lost to Follow-up|1|||
129464676|NCT03704194|465997620|FG000|Overall Study|Withdrawal by Subject|0|||
129464677|NCT03704194|465997621|FG001|Overall Study|Withdrawal by Subject|1|||
129464678|NCT00223496|465997624|FG000|Overall Study|screen failure|9|||
129464679|NCT00223496|465997624|FG000|Overall Study|Lost to Follow-up|4|||
129464680|NCT00223496|465997624|FG000|Overall Study|Lack of Efficacy|6|||
129464681|NCT00223496|465997624|FG000|Overall Study|Withdrawal by Subject|1|||
129464682|NCT00223496|465997624|FG000|Overall Study|Physician Decision|2|||
129464683|NCT00559507|465997625|FG000|Overall Study|Not treated, patient ineligible|3|||
129464684|NCT02889796|465997626|FG000|Overall Study|Withdrew Consent|18|||
129464685|NCT02889796|465997627|FG001|Overall Study|Withdrew Consent|29|||
129464686|NCT02889796|465997628|FG002|Overall Study|Withdrew Consent|20|||
129464687|NCT02889796|465997629|FG003|Overall Study|Withdrew Consent|1|||
129464688|NCT02889796|465997630|FG004|Overall Study|Withdrew Consent|2|||
129464689|NCT02889796|465997631|FG005|Overall Study|Withdrew Consent|35|||
129464690|NCT02889796|465997626|FG000|Overall Study|Investigator's Discretion|10|||
129464691|NCT02889796|465997627|FG001|Overall Study|Investigator's Discretion|9|||
129464692|NCT02889796|465997628|FG002|Overall Study|Investigator's Discretion|10|||
129464693|NCT02889796|465997629|FG003|Overall Study|Investigator's Discretion|3|||
129464694|NCT02889796|465997630|FG004|Overall Study|Investigator's Discretion|0|||
129464695|NCT02889796|465997631|FG005|Overall Study|Investigator's Discretion|15|||
129464696|NCT02889796|465997626|FG000|Overall Study|Adverse Event|17|||
129464697|NCT02889796|465997627|FG001|Overall Study|Adverse Event|8|||
129464698|NCT02889796|465997628|FG002|Overall Study|Adverse Event|8|||
129464699|NCT02889796|465997629|FG003|Overall Study|Adverse Event|4|||
129464700|NCT02889796|465997630|FG004|Overall Study|Adverse Event|1|||
129464701|NCT02889796|465997631|FG005|Overall Study|Adverse Event|7|||
129464702|NCT02889796|465997626|FG000|Overall Study|Lost to Follow-up|5|||
129464703|NCT02889796|465997627|FG001|Overall Study|Lost to Follow-up|7|||
129464704|NCT02889796|465997628|FG002|Overall Study|Lost to Follow-up|2|||
129464705|NCT02889796|465997629|FG003|Overall Study|Lost to Follow-up|0|||
129464706|NCT02889796|465997630|FG004|Overall Study|Lost to Follow-up|2|||
129464707|NCT02889796|465997631|FG005|Overall Study|Lost to Follow-up|6|||
129464708|NCT02889796|465997626|FG000|Overall Study|Protocol Violation|0|||
129464709|NCT02889796|465997627|FG001|Overall Study|Protocol Violation|1|||
129464710|NCT02889796|465997628|FG002|Overall Study|Protocol Violation|3|||
129464711|NCT02889796|465997629|FG003|Overall Study|Protocol Violation|0|||
129464712|NCT02889796|465997630|FG004|Overall Study|Protocol Violation|0|||
129464713|NCT02889796|465997631|FG005|Overall Study|Protocol Violation|4|||
129464714|NCT02889796|465997626|FG000|Overall Study|Non-compliance With Study Drug|0|||
129464715|NCT02889796|465997627|FG001|Overall Study|Non-compliance With Study Drug|2|||
129464716|NCT02889796|465997628|FG002|Overall Study|Non-compliance With Study Drug|0|||
129464717|NCT02889796|465997629|FG003|Overall Study|Non-compliance With Study Drug|0|||
129464718|NCT02889796|465997630|FG004|Overall Study|Non-compliance With Study Drug|1|||
129464719|NCT02889796|465997631|FG005|Overall Study|Non-compliance With Study Drug|2|||
129464720|NCT02889796|465997626|FG000|Overall Study|Death|1|||
129464721|NCT02889796|465997627|FG001|Overall Study|Death|1|||
129464722|NCT02889796|465997628|FG002|Overall Study|Death|0|||
129464723|NCT02889796|465997629|FG003|Overall Study|Death|1|||
129464724|NCT02889796|465997630|FG004|Overall Study|Death|0|||
129464725|NCT02889796|465997631|FG005|Overall Study|Death|1|||
129464726|NCT02889796|465997626|FG000|Overall Study|Pregnancy|0|||
129464727|NCT02889796|465997627|FG001|Overall Study|Pregnancy|1|||
129464728|NCT02889796|465997628|FG002|Overall Study|Pregnancy|1|||
129464729|NCT02889796|465997629|FG003|Overall Study|Pregnancy|0|||
129464730|NCT02889796|465997630|FG004|Overall Study|Pregnancy|0|||
129464731|NCT02889796|465997631|FG005|Overall Study|Pregnancy|0|||
129464732|NCT02889796|465997626|FG000|Overall Study|Randomized but not Dosed|2|||
129464733|NCT02889796|465997627|FG001|Overall Study|Randomized but not Dosed|0|||
129464734|NCT02889796|465997628|FG002|Overall Study|Randomized but not Dosed|0|||
129464735|NCT02889796|465997629|FG003|Overall Study|Randomized but not Dosed|0|||
129464736|NCT02889796|465997630|FG004|Overall Study|Randomized but not Dosed|0|||
129464737|NCT02889796|465997631|FG005|Overall Study|Randomized but not Dosed|2|||
129464738|NCT01407926|465997637|FG000|Overall Study|Lost to Follow-up|55|||
129464739|NCT02814565|465997638|FG000|Overall Study|Lack of Efficacy|0|||
129464740|NCT02814565|465997639|FG001|Overall Study|Lack of Efficacy|1|||
129464741|NCT02814565|465997638|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
129464742|NCT02814565|465997639|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
129464743|NCT04656652|465997640|FG000|Overall Study|Lost to Follow-up|2|||
129464744|NCT04656652|465997641|FG001|Overall Study|Lost to Follow-up|2|||
129464745|NCT04656652|465997640|FG000|Overall Study|Death|213|||
129464746|NCT04656652|465997641|FG001|Overall Study|Death|212|||
129464747|NCT04656652|465997640|FG000|Overall Study|Other|1|||
129464748|NCT04656652|465997641|FG001|Overall Study|Other|0|||
129464749|NCT04656652|465997640|FG000|Overall Study|Withdrawal by Subject|15|||
129464750|NCT04656652|465997641|FG001|Overall Study|Withdrawal by Subject|29|||
129464751|NCT01414257|465997644|FG000|Overall Study|No Visit After First Day of Treatment|12|||
129464752|NCT01414257|465997644|FG000|Overall Study|Protocol Violation|10|||
129464753|NCT02479802|465997645|FG000|Overall Study|Lost to Follow-up|1|||
129464754|NCT02479802|465997645|FG000|Overall Study|Adverse Event|1|||
129464755|NCT01882907|465997646|FG000|Overall Study|Adverse Event|3|||
129464756|NCT01882907|465997647|FG001|Overall Study|Adverse Event|1|||
129464757|NCT01882907|465997646|FG000|Overall Study|Lack of Efficacy|0|||
129464758|NCT01882907|465997647|FG001|Overall Study|Lack of Efficacy|3|||
129464759|NCT01882907|465997646|FG000|Overall Study|Lost to Follow-up|1|||
129464760|NCT01882907|465997647|FG001|Overall Study|Lost to Follow-up|4|||
129464761|NCT01882907|465997646|FG000|Overall Study|Protocol Violation|10|||
129464762|NCT01882907|465997647|FG001|Overall Study|Protocol Violation|14|||
129464763|NCT01882907|465997646|FG000|Overall Study|Withdrawal by Subject|0|||
129464764|NCT01882907|465997647|FG001|Overall Study|Withdrawal by Subject|6|||
129464765|NCT01978093|465997648|FG000|Overall Study|Death|1|||
129464766|NCT01978093|465997649|FG001|Overall Study|Death|0|||
129464767|NCT01978093|465997648|FG000|Overall Study|Adverse Event|0|||
129464768|NCT01978093|465997649|FG001|Overall Study|Adverse Event|5|||
129464769|NCT01978093|465997648|FG000|Overall Study|Protocol Violation|8|||
129464770|NCT01978093|465997649|FG001|Overall Study|Protocol Violation|2|||
129464771|NCT01978093|465997648|FG000|Overall Study|Withdrawal by Subject|29|||
129464772|NCT01978093|465997649|FG001|Overall Study|Withdrawal by Subject|25|||
129464773|NCT01978093|465997648|FG000|Overall Study|Lost to Follow-up|11|||
129464774|NCT01978093|465997649|FG001|Overall Study|Lost to Follow-up|15|||
129464775|NCT01978093|465997648|FG000|Overall Study|Migrated/moved from study area|11|||
129464776|NCT01978093|465997649|FG001|Overall Study|Migrated/moved from study area|13|||
129464777|NCT01978093|465997648|FG000|Overall Study|Loss of kaiser coverage|4|||
129464778|NCT01978093|465997649|FG001|Overall Study|Loss of kaiser coverage|10|||
129464779|NCT01978093|465997648|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
129464780|NCT01978093|465997649|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
129464781|NCT01978093|465997648|FG000|Overall Study|Mother lost custody of child|0|||
129464782|NCT01978093|465997649|FG001|Overall Study|Mother lost custody of child|1|||
129464783|NCT01978093|465997648|FG000|Overall Study|Child was in care of grandmother|0|||
129464784|NCT01978093|465997649|FG001|Overall Study|Child was in care of grandmother|1|||
129464785|NCT01978093|465997648|FG000|Overall Study|N/A for vaccine administration|0|||
129464786|NCT01978093|465997649|FG001|Overall Study|N/A for vaccine administration|1|||
129464787|NCT01784965|465997653|FG000|Overall Study|Withdrawal by Subject|6|||
129464788|NCT01784965|465997654|FG001|Overall Study|Withdrawal by Subject|3|||
129464789|NCT01784965|465997653|FG000|Overall Study|Adverse Event|0|||
129464790|NCT01784965|465997654|FG001|Overall Study|Adverse Event|8|||
129464791|NCT01604512|465997655|FG000|Overall Study|Withdrawal by Subject|3|||
129464792|NCT01604512|465997655|FG000|Overall Study|Not treated|4|||
129464793|NCT01100944|465997659|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
129464794|NCT01100944|465997660|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
129464795|NCT01100944|465997661|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
129464796|NCT01100944|465997659|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
129464797|NCT01100944|465997660|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
129464798|NCT01100944|465997661|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
129464799|NCT01100944|465997659|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
129464800|NCT01100944|465997660|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
129464801|NCT01100944|465997661|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
129464802|NCT01100944|465997659|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
129464803|NCT01100944|465997660|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
129464804|NCT01100944|465997661|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
129464805|NCT00577993|465997664|FG000|Overall Study|Adverse Event|1|||
129464806|NCT00577993|465997665|FG001|Overall Study|Adverse Event|0|||
129464807|NCT00577993|465997666|FG002|Overall Study|Adverse Event|0|||
129464808|NCT00577993|465997664|FG000|Overall Study|Death|0|||
129464809|NCT00577993|465997665|FG001|Overall Study|Death|1|||
129464810|NCT00577993|465997666|FG002|Overall Study|Death|1|||
129464811|NCT00577993|465997664|FG000|Overall Study|Lack of Efficacy|0|||
129464812|NCT00577993|465997665|FG001|Overall Study|Lack of Efficacy|1|||
129464813|NCT00577993|465997666|FG002|Overall Study|Lack of Efficacy|0|||
129464814|NCT00577993|465997664|FG000|Overall Study|Protocol Violation|2|||
129464815|NCT00577993|465997665|FG001|Overall Study|Protocol Violation|3|||
129464816|NCT00577993|465997666|FG002|Overall Study|Protocol Violation|0|||
129464817|NCT00577993|465997664|FG000|Overall Study|Withdrawal by Subject|1|||
129464818|NCT00577993|465997665|FG001|Overall Study|Withdrawal by Subject|0|||
129464819|NCT00577993|465997666|FG002|Overall Study|Withdrawal by Subject|2|||
129464820|NCT00577993|465997664|FG000|Overall Study|Conversion|2|||
129464821|NCT00577993|465997665|FG001|Overall Study|Conversion|5|||
129464822|NCT00577993|465997666|FG002|Overall Study|Conversion|0|||
129464823|NCT00577993|465997664|FG000|Overall Study|Uninsured|1|||
129464824|NCT00577993|465997665|FG001|Overall Study|Uninsured|0|||
129464825|NCT00577993|465997666|FG002|Overall Study|Uninsured|0|||
129464826|NCT04029519|465997668|FG000|Overall Study|Protocol Violation|1|||
129464827|NCT04029519|465997668|FG000|Overall Study|Withdrawal by Subject|3|||
129464828|NCT04029519|465997668|FG000|Overall Study|Lost to Follow-up|1|||
129464829|NCT00411554|465997674|FG000|Overall Study|Adverse Event|2|||
129464830|NCT00411554|465997675|FG001|Overall Study|Adverse Event|4|||
129464831|NCT00411554|465997674|FG000|Overall Study|Lack of Efficacy|2|||
129464832|NCT00411554|465997675|FG001|Overall Study|Lack of Efficacy|5|||
129464833|NCT00411554|465997674|FG000|Overall Study|Withdrawal by Subject|3|||
129464834|NCT00411554|465997675|FG001|Overall Study|Withdrawal by Subject|0|||
129464835|NCT00411554|465997674|FG000|Overall Study|Patient Moved|1|||
129464836|NCT00411554|465997675|FG001|Overall Study|Patient Moved|0|||
129464837|NCT00699907|465997676|FG000|Overall Study|Withdrawal by Subject|2|||
129464838|NCT00699907|465997677|FG001|Overall Study|Withdrawal by Subject|1|||
129464839|NCT00699907|465997678|FG002|Overall Study|Withdrawal by Subject|0|||
129464840|NCT00699907|465997676|FG000|Overall Study|No usable sample|0|||
129464841|NCT00699907|465997677|FG001|Overall Study|No usable sample|9|||
129464842|NCT00699907|465997678|FG002|Overall Study|No usable sample|8|||
129464843|NCT02161211|465997679|FG000|Overall Study|Lost to Follow-up|21|||
129464844|NCT02161211|465997680|FG001|Overall Study|Lost to Follow-up|27|||
129464845|NCT02161211|465997681|FG002|Overall Study|Lost to Follow-up|21|||
129464846|NCT02161211|465997679|FG000|Overall Study|Dropped|12|||
129464847|NCT02161211|465997680|FG001|Overall Study|Dropped|5|||
129464848|NCT02161211|465997681|FG002|Overall Study|Dropped|9|||
129464849|NCT03728309|465997682|FG000|Overall Study|Randomized but not Treated|0|||
129464850|NCT03728309|465997683|FG001|Overall Study|Randomized but not Treated|1|||
129464851|NCT03728309|465997682|FG000|Overall Study|Adverse Event|0|||
129464852|NCT03728309|465997683|FG001|Overall Study|Adverse Event|1|||
129464853|NCT03728309|465997682|FG000|Overall Study|Withdrawal by Subject|2|||
129464854|NCT03728309|465997683|FG001|Overall Study|Withdrawal by Subject|8|||
129464855|NCT03728309|465997682|FG000|Overall Study|Lost to Follow-up|9|||
129464856|NCT03728309|465997683|FG001|Overall Study|Lost to Follow-up|10|||
129464857|NCT03728309|465997682|FG000|Overall Study|Protocol Deviation|0|||
129464858|NCT03728309|465997683|FG001|Overall Study|Protocol Deviation|1|||
129464859|NCT03728309|465997682|FG000|Overall Study|Due to COVID|1|||
129464860|NCT03728309|465997683|FG001|Overall Study|Due to COVID|3|||
129464861|NCT00953758|465997686|FG000|Overall Study|Death|2|||
129464862|NCT00953758|465997687|FG001|Overall Study|Death|0|||
129464863|NCT00953758|465997688|FG002|Overall Study|Death|1|||
129464864|NCT00953758|465997689|FG003|Overall Study|Death|1|||
129464865|NCT00953758|465997690|FG004|Overall Study|Death|1|||
129464866|NCT00953758|465997691|FG005|Overall Study|Death|1|||
129464867|NCT00953758|465997692|FG006|Overall Study|Death|1|||
129464868|NCT00953758|465997693|FG007|Overall Study|Death|3|||
129464869|NCT00953758|465997694|FG008|Overall Study|Death|1|||
129464870|NCT00953758|465997695|FG009|Overall Study|Death|0|||
129464871|NCT00953758|465997686|FG000|Overall Study|Participant refused further follow-up|0|||
129464872|NCT00953758|465997687|FG001|Overall Study|Participant refused further follow-up|0|||
129464873|NCT00953758|465997688|FG002|Overall Study|Participant refused further follow-up|1|||
129464874|NCT00953758|465997689|FG003|Overall Study|Participant refused further follow-up|0|||
129464875|NCT00953758|465997690|FG004|Overall Study|Participant refused further follow-up|3|||
129464876|NCT00953758|465997691|FG005|Overall Study|Participant refused further follow-up|0|||
129464877|NCT00953758|465997692|FG006|Overall Study|Participant refused further follow-up|0|||
129464878|NCT00953758|465997693|FG007|Overall Study|Participant refused further follow-up|0|||
129464879|NCT00953758|465997694|FG008|Overall Study|Participant refused further follow-up|1|||
129464880|NCT00953758|465997695|FG009|Overall Study|Participant refused further follow-up|0|||
129464881|NCT00953758|465997686|FG000|Overall Study|Lost to Follow-up|0|||
129464882|NCT00953758|465997687|FG001|Overall Study|Lost to Follow-up|0|||
129464883|NCT00953758|465997688|FG002|Overall Study|Lost to Follow-up|0|||
129464884|NCT00953758|465997689|FG003|Overall Study|Lost to Follow-up|1|||
129464885|NCT00953758|465997690|FG004|Overall Study|Lost to Follow-up|0|||
129464886|NCT00953758|465997691|FG005|Overall Study|Lost to Follow-up|0|||
129464887|NCT00953758|465997692|FG006|Overall Study|Lost to Follow-up|0|||
129464888|NCT00953758|465997693|FG007|Overall Study|Lost to Follow-up|1|||
129464889|NCT00953758|465997694|FG008|Overall Study|Lost to Follow-up|0|||
129464890|NCT00953758|465997695|FG009|Overall Study|Lost to Follow-up|1|||
129464891|NCT00953758|465997686|FG000|Overall Study|Physician Decision|0|||
129464892|NCT00953758|465997687|FG001|Overall Study|Physician Decision|0|||
129464893|NCT00953758|465997688|FG002|Overall Study|Physician Decision|0|||
129464894|NCT00953758|465997689|FG003|Overall Study|Physician Decision|0|||
129464895|NCT00953758|465997690|FG004|Overall Study|Physician Decision|1|||
129464896|NCT00953758|465997691|FG005|Overall Study|Physician Decision|0|||
129464897|NCT00953758|465997692|FG006|Overall Study|Physician Decision|0|||
129464898|NCT00953758|465997693|FG007|Overall Study|Physician Decision|0|||
129464899|NCT00953758|465997694|FG008|Overall Study|Physician Decision|0|||
129464900|NCT00953758|465997695|FG009|Overall Study|Physician Decision|0|||
129464901|NCT00953758|465997686|FG000|Overall Study|Disease progression|0|||
129464902|NCT00953758|465997687|FG001|Overall Study|Disease progression|0|||
129464903|NCT00953758|465997688|FG002|Overall Study|Disease progression|0|||
129464904|NCT00953758|465997689|FG003|Overall Study|Disease progression|0|||
129464905|NCT00953758|465997690|FG004|Overall Study|Disease progression|1|||
129464906|NCT00953758|465997691|FG005|Overall Study|Disease progression|0|||
129464907|NCT00953758|465997692|FG006|Overall Study|Disease progression|0|||
129464908|NCT00953758|465997693|FG007|Overall Study|Disease progression|0|||
129464909|NCT00953758|465997694|FG008|Overall Study|Disease progression|0|||
129464910|NCT00953758|465997695|FG009|Overall Study|Disease progression|0|||
129464911|NCT00953758|465997686|FG000|Overall Study|Participant went for transplant|0|||
129464912|NCT00953758|465997687|FG001|Overall Study|Participant went for transplant|0|||
129464913|NCT00953758|465997688|FG002|Overall Study|Participant went for transplant|0|||
129464914|NCT00953758|465997689|FG003|Overall Study|Participant went for transplant|0|||
129464915|NCT00953758|465997690|FG004|Overall Study|Participant went for transplant|0|||
129464916|NCT00953758|465997691|FG005|Overall Study|Participant went for transplant|0|||
129464917|NCT00953758|465997692|FG006|Overall Study|Participant went for transplant|0|||
129464918|NCT00953758|465997693|FG007|Overall Study|Participant went for transplant|0|||
129464919|NCT00953758|465997694|FG008|Overall Study|Participant went for transplant|1|||
129464920|NCT00953758|465997695|FG009|Overall Study|Participant went for transplant|0|||
129464921|NCT00999908|465997696|FG000|Treatment Period 1|Subject withdrew consent|2|||
129464922|NCT00999908|465997697|FG001|Treatment Period 1|Subject withdrew consent|0|||
129464923|NCT00999908|465997698|FG002|Treatment Period 1|Subject withdrew consent|0|||
129464924|NCT00999908|465997696|FG000|Treatment Period 2|Protocol Violation|1|||
129464925|NCT00999908|465997697|FG001|Treatment Period 2|Protocol Violation|0|||
129464926|NCT00999908|465997698|FG002|Treatment Period 2|Protocol Violation|0|||
129464927|NCT01543087|465997703|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
129464928|NCT01543087|465997704|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
129464929|NCT01543087|465997705|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
129464930|NCT01543087|465997706|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
129464931|NCT01543087|465997707|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
129464932|NCT01543087|465997708|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
129464933|NCT01543087|465997703|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
129464934|NCT01543087|465997704|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
129464935|NCT01543087|465997705|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
129464936|NCT01543087|465997706|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
129464937|NCT01543087|465997707|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
129464938|NCT01543087|465997708|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
129464939|NCT01543087|465997703|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
129464940|NCT01543087|465997704|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
129464941|NCT01543087|465997705|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
129464942|NCT01543087|465997706|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
129464943|NCT01543087|465997707|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
129464944|NCT01543087|465997708|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
129464945|NCT01543087|465997703|FG000|Stage 1 (48 Months)|Other than specified|5|||
129464946|NCT01543087|465997704|FG001|Stage 1 (48 Months)|Other than specified|0|||
129464947|NCT01543087|465997705|FG002|Stage 1 (48 Months)|Other than specified|9|||
129464948|NCT01543087|465997706|FG003|Stage 1 (48 Months)|Other than specified|0|||
129464949|NCT01543087|465997707|FG004|Stage 1 (48 Months)|Other than specified|0|||
129464950|NCT01543087|465997708|FG005|Stage 1 (48 Months)|Other than specified|0|||
129464951|NCT01543087|465997703|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
129464952|NCT01543087|465997704|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
129464953|NCT01543087|465997705|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
129464954|NCT01543087|465997706|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
129464955|NCT01543087|465997707|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
129464956|NCT01543087|465997708|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
129464957|NCT01543087|465997703|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
129464958|NCT01543087|465997704|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
129464959|NCT01543087|465997705|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
129464960|NCT01543087|465997706|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
129464961|NCT01543087|465997707|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
129464962|NCT01543087|465997708|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
129464963|NCT01543087|465997703|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
129464964|NCT01543087|465997704|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
129464965|NCT01543087|465997705|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
129464966|NCT01543087|465997706|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
129464967|NCT01543087|465997707|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
129464968|NCT01543087|465997708|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
129464969|NCT00706030|465997709|FG000|Overall Study|Disease Progression|4|||
129464970|NCT00706030|465997710|FG001|Overall Study|Disease Progression|6|||
129464971|NCT00706030|465997711|FG002|Overall Study|Disease Progression|46|||
129464972|NCT00706030|465997712|FG003|Overall Study|Disease Progression|12|||
129464973|NCT00706030|465997709|FG000|Overall Study|Adverse Event|1|||
129464974|NCT00706030|465997710|FG001|Overall Study|Adverse Event|0|||
129464975|NCT00706030|465997711|FG002|Overall Study|Adverse Event|4|||
129464976|NCT00706030|465997712|FG003|Overall Study|Adverse Event|2|||
129464977|NCT00706030|465997709|FG000|Overall Study|Withdrawal by Subject|1|||
129464978|NCT00706030|465997710|FG001|Overall Study|Withdrawal by Subject|0|||
129464979|NCT00706030|465997711|FG002|Overall Study|Withdrawal by Subject|2|||
129464980|NCT00706030|465997712|FG003|Overall Study|Withdrawal by Subject|0|||
129464981|NCT00706030|465997709|FG000|Overall Study|Physician Decision|0|||
129464982|NCT00706030|465997710|FG001|Overall Study|Physician Decision|0|||
129464983|NCT00706030|465997711|FG002|Overall Study|Physician Decision|2|||
129464984|NCT00706030|465997712|FG003|Overall Study|Physician Decision|0|||
129464985|NCT00706030|465997709|FG000|Overall Study|Not recorded|0|||
129464986|NCT00706030|465997710|FG001|Overall Study|Not recorded|0|||
129464987|NCT00706030|465997711|FG002|Overall Study|Not recorded|2|||
129464988|NCT00706030|465997712|FG003|Overall Study|Not recorded|0|||
129464989|NCT00706030|465997709|FG000|Overall Study|Protocol Violation|0|||
129464990|NCT00706030|465997710|FG001|Overall Study|Protocol Violation|0|||
129464991|NCT00706030|465997711|FG002|Overall Study|Protocol Violation|1|||
129464992|NCT00706030|465997712|FG003|Overall Study|Protocol Violation|1|||
129464993|NCT00706030|465997709|FG000|Overall Study|Failed to return|0|||
129464994|NCT00706030|465997710|FG001|Overall Study|Failed to return|0|||
129464995|NCT00706030|465997711|FG002|Overall Study|Failed to return|1|||
129464996|NCT00706030|465997712|FG003|Overall Study|Failed to return|0|||
129464997|NCT00706030|465997709|FG000|Overall Study|Symptomatic Deterioration|0|||
129464998|NCT00706030|465997710|FG001|Overall Study|Symptomatic Deterioration|0|||
129464999|NCT00706030|465997711|FG002|Overall Study|Symptomatic Deterioration|1|||
129465000|NCT00706030|465997712|FG003|Overall Study|Symptomatic Deterioration|0|||
129465001|NCT00706030|465997709|FG000|Overall Study|No treatment received|0|||
129465002|NCT00706030|465997710|FG001|Overall Study|No treatment received|0|||
129465003|NCT00706030|465997711|FG002|Overall Study|No treatment received|0|||
129465004|NCT00706030|465997712|FG003|Overall Study|No treatment received|1|||
129465005|NCT00706030|465997709|FG000|Overall Study|Death|0|||
129465006|NCT00706030|465997710|FG001|Overall Study|Death|0|||
129465007|NCT00706030|465997711|FG002|Overall Study|Death|1|||
129465008|NCT00706030|465997712|FG003|Overall Study|Death|0|||
129465009|NCT05779072|465997714|FG000|Overall Study|Lost to Follow-up|0|||
129465010|NCT05779072|465997715|FG001|Overall Study|Lost to Follow-up|1|||
129465011|NCT05779072|465997714|FG000|Overall Study|Withdrawal by Subject|1|||
129465012|NCT05779072|465997715|FG001|Overall Study|Withdrawal by Subject|5|||
129465013|NCT03870555|465997716|FG000|Period 3 (2 Days)|Adverse Event|1|||
129465014|NCT03870555|465997717|FG001|Period 3 (2 Days)|Adverse Event|0|||
129465015|NCT03870555|465997718|FG002|Period 3 (2 Days)|Adverse Event|0|||
129465016|NCT03694925|465997719|FG000|Overall Study|Inadequate laboratory testing|0|||
129465017|NCT03694925|465997720|FG001|Overall Study|Inadequate laboratory testing|3|||
129465018|NCT03694925|465997721|FG002|Overall Study|Inadequate laboratory testing|0|||
129465019|NCT03167073|465997727|FG000|Overall Study|Stillbirth|1|||
129465020|NCT03167073|465997728|FG001|Overall Study|Stillbirth|0|||
129465021|NCT01681433|465997729|FG000|Overall Study|Lack of Efficacy|23|||
129465022|NCT01681433|465997730|FG001|Overall Study|Lack of Efficacy|23|||
129465023|NCT01681433|465997729|FG000|Overall Study|Withdrawal by Subject|5|||
129465024|NCT01681433|465997730|FG001|Overall Study|Withdrawal by Subject|5|||
129465025|NCT01681433|465997729|FG000|Overall Study|Protocol Violation|2|||
129465026|NCT01681433|465997730|FG001|Overall Study|Protocol Violation|0|||
129465027|NCT01681433|465997729|FG000|Overall Study|Adverse Event|2|||
129465028|NCT01681433|465997730|FG001|Overall Study|Adverse Event|4|||
129465029|NCT01681433|465997729|FG000|Overall Study|Lost to Follow-up|0|||
129465030|NCT01681433|465997730|FG001|Overall Study|Lost to Follow-up|1|||
129465031|NCT02301403|465997731|FG000|Overall Study|Withdrawal by Subject|28|||
129465032|NCT02301403|465997732|FG001|Overall Study|Withdrawal by Subject|41|||
129465033|NCT03064841|465997733|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
129465034|NCT03064841|465997733|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
129465035|NCT03064841|465997733|FG000|Overall Study|Screen failure|2|||
129465036|NCT03434977|465997734|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
129465037|NCT03434977|465997735|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
129465038|NCT00217087|465997736|FG000|Overall Study|decided to have esophagectomy|1|||
129465039|NCT00217087|465997737|FG001|Overall Study|decided to have esophagectomy|2|||
129465040|NCT00217087|465997736|FG000|Overall Study|completed less than 12 months return|10|||
129465041|NCT00217087|465997737|FG001|Overall Study|completed less than 12 months return|18|||
129465042|NCT03920670|465997738|FG000|Overall Study|Protocol Violation|2|||
129465043|NCT03920670|465997739|FG001|Overall Study|Protocol Violation|2|||
129465044|NCT03920670|465997738|FG000|Overall Study|Adverse Event|1|||
129465045|NCT03920670|465997739|FG001|Overall Study|Adverse Event|0|||
129465046|NCT03208231|465997745|FG000|Overall Study|Death|1|||
129465047|NCT03208231|465997746|FG001|Overall Study|Death|2|||
129465048|NCT03208231|465997745|FG000|Overall Study|Moved and unable to get to clinic|1|||
129465049|NCT03208231|465997746|FG001|Overall Study|Moved and unable to get to clinic|0|||
129465050|NCT03208231|465997745|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
129465051|NCT03208231|465997746|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
129465052|NCT04347239|465997760|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
129465053|NCT04347239|465997761|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
129465054|NCT04347239|465997762|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
129465055|NCT04347239|465997760|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
129465056|NCT04347239|465997761|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
129465057|NCT04347239|465997762|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
129465058|NCT04770779|465997763|FG000|Overall Study|Randomized, never treated|0|||
129465059|NCT04770779|465997764|FG001|Overall Study|Randomized, never treated|1|||
129979963|NCT04372121|467889511|FG001|Overall Study|Withdrawal by Subject|1|||
129465060|NCT04770779|465997763|FG000|Overall Study|Adverse Event|9|||
129465061|NCT04770779|465997764|FG001|Overall Study|Adverse Event|1|||
129465062|NCT04770779|465997763|FG000|Overall Study|Withdrawal by Subject|7|||
129465063|NCT04770779|465997764|FG001|Overall Study|Withdrawal by Subject|1|||
129465064|NCT04770779|465997763|FG000|Overall Study|Pregnancy|0|||
129465065|NCT04770779|465997764|FG001|Overall Study|Pregnancy|1|||
129465066|NCT03692052|465997765|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
129465067|NCT03692052|465997765|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
129465068|NCT03692052|465997765|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
129465069|NCT03692052|465997765|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
129465070|NCT05600309|465997766|FG000|Overall Study|Death|41|||
129465071|NCT05600309|465997767|FG001|Overall Study|Death|38|||
129465072|NCT05600309|465997766|FG000|Overall Study|Sponsor Decision|9|||
129465073|NCT05600309|465997767|FG001|Overall Study|Sponsor Decision|6|||
129465074|NCT02270242|465997769|FG000|Overall Study|Withdrawal by Subject|18|||
129465075|NCT02270242|465997770|FG001|Overall Study|Withdrawal by Subject|25|||
129465076|NCT02270242|465997769|FG000|Overall Study|Lost to Follow-up|41|||
129465077|NCT02270242|465997770|FG001|Overall Study|Lost to Follow-up|27|||
129465078|NCT02270242|465997769|FG000|Overall Study|Physician Decision|0|||
129465079|NCT02270242|465997770|FG001|Overall Study|Physician Decision|1|||
129465080|NCT02321436|465997771|FG000|Overall Study|Withdrawal by Subject|1|||
129465081|NCT02321436|465997772|FG001|Overall Study|Withdrawal by Subject|0|||
129465082|NCT02321436|465997771|FG000|Overall Study|Lost to Follow-up|0|||
129465083|NCT02321436|465997772|FG001|Overall Study|Lost to Follow-up|1|||
129465084|NCT03355300|465997773|FG000|Overall Study|Physician Decision|0|||
129465085|NCT03355300|465997774|FG001|Overall Study|Physician Decision|1|||
129465086|NCT03355300|465997773|FG000|Overall Study|Lack of Efficacy|2|||
129465087|NCT03355300|465997774|FG001|Overall Study|Lack of Efficacy|1|||
129465088|NCT03355300|465997773|FG000|Overall Study|Other reason|1|||
129465089|NCT03355300|465997774|FG001|Overall Study|Other reason|0|||
129465090|NCT03048422|465997775|FG000|Overall Study|Death|1|||
129465091|NCT03048422|465997776|FG001|Overall Study|Death|0|||
129465092|NCT03048422|465997777|FG002|Overall Study|Death|0|||
129465093|NCT03048422|465997775|FG000|Overall Study|Lost to Follow-up|5|||
129465094|NCT03048422|465997776|FG001|Overall Study|Lost to Follow-up|0|||
129465095|NCT03048422|465997777|FG002|Overall Study|Lost to Follow-up|1|||
129465096|NCT03048422|465997775|FG000|Overall Study|Withdrawal by Subject|5|||
129465097|NCT03048422|465997776|FG001|Overall Study|Withdrawal by Subject|7|||
129465098|NCT03048422|465997777|FG002|Overall Study|Withdrawal by Subject|4|||
129465099|NCT03048422|465997775|FG000|Overall Study|Moved|3|||
129465100|NCT03048422|465997776|FG001|Overall Study|Moved|2|||
129465101|NCT03048422|465997777|FG002|Overall Study|Moved|2|||
129465102|NCT03048422|465997775|FG000|Overall Study|Noncompliant with Study Requirements|2|||
129465103|NCT03048422|465997776|FG001|Overall Study|Noncompliant with Study Requirements|1|||
129465104|NCT03048422|465997777|FG002|Overall Study|Noncompliant with Study Requirements|2|||
129465105|NCT03048422|465997775|FG000|Overall Study|Not Able to Get to Clinic|1|||
129465106|NCT03048422|465997776|FG001|Overall Study|Not Able to Get to Clinic|0|||
129465107|NCT03048422|465997777|FG002|Overall Study|Not Able to Get to Clinic|0|||
129465108|NCT04137887|465999965|FG000|Overall Study|Death|102|||
129465109|NCT04137887|465999966|FG001|Overall Study|Death|92|||
129465110|NCT04137887|465999965|FG000|Overall Study|Withdrawal by Subject|2|||
129465111|NCT04137887|465999966|FG001|Overall Study|Withdrawal by Subject|3|||
129465112|NCT04137887|465999965|FG000|Overall Study|Randomized but not treated|0|||
129465113|NCT04137887|465999966|FG001|Overall Study|Randomized but not treated|1|||
129465114|NCT02605642|465999970|FG000|Overall Study|Other|11|||
129465115|NCT02605642|465999971|FG001|Overall Study|Other|1|||
129465116|NCT02605642|465999970|FG000|Overall Study|Participant non-compliance|2|||
129465117|NCT02605642|465999971|FG001|Overall Study|Participant non-compliance|4|||
129465118|NCT02605642|465999970|FG000|Overall Study|Physician Decision|10|||
129465119|NCT02605642|465999971|FG001|Overall Study|Physician Decision|0|||
129465120|NCT02605642|465999970|FG000|Overall Study|Lost to Follow-up|12|||
129465121|NCT02605642|465999971|FG001|Overall Study|Lost to Follow-up|1|||
129465122|NCT02605642|465999970|FG000|Overall Study|Adverse Event|14|||
129465123|NCT02605642|465999971|FG001|Overall Study|Adverse Event|2|||
129465124|NCT02605642|465999970|FG000|Overall Study|Withdrawal by Subject|23|||
129465125|NCT02605642|465999971|FG001|Overall Study|Withdrawal by Subject|2|||
129465126|NCT02605642|465999970|FG000|Overall Study|Lack of response|24|||
129465127|NCT02605642|465999971|FG001|Overall Study|Lack of response|11|||
129465128|NCT00984204|465999980|FG000|Overall Study|Death|1|||
129465129|NCT00984204|465999980|FG000|Overall Study|Lost to Follow-up|4|||
129465130|NCT00984204|465999980|FG000|Overall Study|Lack of Efficacy|10|||
129465131|NCT01449708|465999982|FG000|Overall Study|Protocol Violation|0|||
129465132|NCT01449708|465999983|FG001|Overall Study|Protocol Violation|1|||
129465133|NCT01449708|465999982|FG000|Overall Study|surgical complication|1|||
129465134|NCT01449708|465999983|FG001|Overall Study|surgical complication|2|||
129465135|NCT01449708|465999982|FG000|Overall Study|respiratory failure|1|||
129465136|NCT01449708|465999983|FG001|Overall Study|respiratory failure|0|||
129465137|NCT05702515|465999984|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
129465138|NCT03757988|465999985|FG000|Overall Study|Withdrawal by Subject|1|||
129465139|NCT01491178|465999988|FG000|Overall Study|Adverse Event|1016|||
129465140|NCT01491178|465999988|FG000|Overall Study|Improvement of NVAF|210|||
129465141|NCT01491178|465999988|FG000|Overall Study|To conduct invasive treatment|59|||
129465142|NCT01491178|465999988|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
129465143|NCT01491178|465999988|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
129971117|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
129465144|NCT01491178|465999988|FG000|Overall Study|To take a contraindication|20|||
129465145|NCT01491178|465999988|FG000|Overall Study|Other than specified above|657|||
129465146|NCT05689047|465999989|FG000|Overall Study|Lost to Follow-up|0|||
129465147|NCT05689047|465999990|FG001|Overall Study|Lost to Follow-up|1|||
129465148|NCT05689047|465999989|FG000|Overall Study|Protocol Deviation|1|||
129465149|NCT05689047|465999990|FG001|Overall Study|Protocol Deviation|0|||
129465150|NCT03132636|465999991|FG000|Overall Study|Adverse Event|1|||
129465151|NCT03132636|465999992|FG001|Overall Study|Adverse Event|2|||
129465152|NCT03132636|465999991|FG000|Overall Study|Death|4|||
129465153|NCT03132636|465999992|FG001|Overall Study|Death|7|||
129465154|NCT03132636|465999991|FG000|Overall Study|Lost to Follow-up|3|||
129465155|NCT03132636|465999992|FG001|Overall Study|Lost to Follow-up|2|||
129465156|NCT03132636|465999991|FG000|Overall Study|Non compliance with protocol by participant|1|||
129465157|NCT03132636|465999992|FG001|Overall Study|Non compliance with protocol by participant|1|||
129465158|NCT03132636|465999991|FG000|Overall Study|Subject decision|1|||
129465159|NCT03132636|465999992|FG001|Overall Study|Subject decision|9|||
129465160|NCT03132636|465999991|FG000|Overall Study|Sponsor decision|0|||
129465161|NCT03132636|465999992|FG001|Overall Study|Sponsor decision|1|||
129465162|NCT03132636|465999991|FG000|Overall Study|Physician Decision|1|||
129465163|NCT03132636|465999992|FG001|Overall Study|Physician Decision|0|||
129465164|NCT03132636|465999991|FG000|Overall Study|Progressive disease|33|||
129465165|NCT03132636|465999992|FG001|Overall Study|Progressive disease|36|||
129465166|NCT03132636|465999991|FG000|Overall Study|Withdrawal of consent|2|||
129465167|NCT03132636|465999992|FG001|Overall Study|Withdrawal of consent|5|||
129465168|NCT03132636|465999991|FG000|Overall Study|Did not re-consent|1|||
129465169|NCT03132636|465999992|FG001|Overall Study|Did not re-consent|0|||
129465170|NCT03132636|465999991|FG000|Overall Study|Lost insurance coverage|1|||
129465171|NCT03132636|465999992|FG001|Overall Study|Lost insurance coverage|0|||
129465172|NCT03132636|465999991|FG000|Overall Study|Related to radiological outcomes|0|||
129465173|NCT03132636|465999992|FG001|Overall Study|Related to radiological outcomes|1|||
129465174|NCT03132636|465999991|FG000|Overall Study|Unable to come to site for continued visits|0|||
129465175|NCT03132636|465999992|FG001|Overall Study|Unable to come to site for continued visits|1|||
129465176|NCT03286842|465999996|FG000|Overall Study|Patients rolled over to another study|80|||
129465177|NCT03178487|465999997|FG000|Period 1|Adverse Event|1|||
129465178|NCT03178487|465999998|FG001|Period 1|Adverse Event|2|||
129465179|NCT03178487|465999997|FG000|Period 1|Withdrawal by Subject|2|||
129465180|NCT03178487|465999998|FG001|Period 1|Withdrawal by Subject|1|||
129465181|NCT03178487|465999997|FG000|Period 1|Lost to Follow-up|1|||
129465182|NCT03178487|465999998|FG001|Period 1|Lost to Follow-up|0|||
129465183|NCT03178487|465999997|FG000|Period 1|Other|0|||
129465184|NCT03178487|465999998|FG001|Period 1|Other|1|||
129465185|NCT03178487|465999997|FG000|Period 2|Adverse Event|4|||
129465186|NCT03178487|465999998|FG001|Period 2|Adverse Event|4|||
129465187|NCT03178487|465999997|FG000|Period 2|Withdrawal by Subject|6|||
129465188|NCT03178487|465999998|FG001|Period 2|Withdrawal by Subject|6|||
129465189|NCT03178487|465999997|FG000|Period 2|Lost to Follow-up|2|||
129465190|NCT03178487|465999998|FG001|Period 2|Lost to Follow-up|2|||
129465191|NCT03178487|465999997|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
129465192|NCT03178487|465999998|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
129465193|NCT03178487|465999997|FG000|Period 2|Other|8|||
129465194|NCT03178487|465999998|FG001|Period 2|Other|7|||
129465195|NCT01453855|465999999|FG000|Overall Study|Adverse Event|3|||
129465196|NCT01453855|466000000|FG001|Overall Study|Adverse Event|4|||
129465197|NCT01453855|465999999|FG000|Overall Study|Lost to Follow-up|2|||
129465198|NCT01453855|466000000|FG001|Overall Study|Lost to Follow-up|1|||
129465199|NCT01453855|465999999|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
129465200|NCT01453855|466000000|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
129465201|NCT01453855|465999999|FG000|Overall Study|Noncompliance|1|||
129465202|NCT01453855|466000000|FG001|Overall Study|Noncompliance|0|||
129465203|NCT01453855|465999999|FG000|Overall Study|Inadequate Control of IOP|1|||
129465204|NCT01453855|466000000|FG001|Overall Study|Inadequate Control of IOP|5|||
129465205|NCT01453855|465999999|FG000|Overall Study|Other|0|||
129465206|NCT01453855|466000000|FG001|Overall Study|Other|1|||
129465207|NCT01562548|466000003|FG000|Overall Study|Lost to Follow-up|0|||
129465208|NCT01562548|466000004|FG001|Overall Study|Lost to Follow-up|0|||
129465209|NCT01562548|466000005|FG002|Overall Study|Lost to Follow-up|1|||
129465210|NCT01562548|466000006|FG003|Overall Study|Lost to Follow-up|0|||
129465211|NCT01496066|466000007|FG000|Overall Study|Lost to Follow-up|8|||
129465212|NCT01496066|466000008|FG001|Overall Study|Lost to Follow-up|5|||
129465213|NCT01496066|466000007|FG000|Overall Study|Explant|3|||
129465214|NCT01496066|466000008|FG001|Overall Study|Explant|0|||
129465215|NCT01496066|466000007|FG000|Overall Study|Death|1|||
129465216|NCT01496066|466000008|FG001|Overall Study|Death|4|||
129465217|NCT03237065|466000009|FG000|Overall Study|Adverse Event|0|||
129465218|NCT03237065|466000010|FG001|Overall Study|Adverse Event|2|||
129465219|NCT03237065|466000009|FG000|Overall Study|Protocol Violation|0|||
129465220|NCT03237065|466000010|FG001|Overall Study|Protocol Violation|1|||
129465221|NCT03237065|466000009|FG000|Overall Study|Withdrawal by Subject|3|||
129465222|NCT03237065|466000010|FG001|Overall Study|Withdrawal by Subject|0|||
129465223|NCT03237065|466000009|FG000|Overall Study|Lost to Follow-up|1|||
129465224|NCT03237065|466000010|FG001|Overall Study|Lost to Follow-up|0|||
129465225|NCT03237065|466000009|FG000|Overall Study|Unable to obtain venous access|0|||
129465226|NCT03237065|466000010|FG001|Overall Study|Unable to obtain venous access|1|||
129465227|NCT00209339|466000011|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
129465228|NCT00209339|466000011|FG000|At 12 Months Follow-up|Death|1|||
129465229|NCT00209339|466000011|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
129465230|NCT00209339|466000011|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
129465231|NCT00209339|466000011|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
129465232|NCT00209339|466000011|FG000|At 24 Months Follow-up|Death|1|||
129465233|NCT00209339|466000011|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
129465234|NCT00209339|466000011|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
129465235|NCT00209339|466000011|FG000|At 4 Years Follow-up|Death|1|||
129465236|NCT00209339|466000011|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
129465237|NCT00209339|466000011|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
129465238|NCT00209339|466000011|FG000|At 5 Years Follow-up|Death|1|||
129465239|NCT01587079|466000012|FG000|Overall Study|Protocol-specified criteria|9|||
129465240|NCT01587079|466000012|FG000|Overall Study|Protocol Violation|5|||
129465241|NCT01587079|466000012|FG000|Overall Study|Lost to Follow-up|2|||
129465242|NCT01587079|466000012|FG000|Overall Study|Physician Decision|2|||
129465243|NCT01587079|466000012|FG000|Overall Study|Withdrawal by Subject|7|||
129465244|NCT01587079|466000012|FG000|Overall Study|Adverse Event|14|||
129465245|NCT01764633|466000013|FG000|Overall Study|Withdrawal by Subject|105|||
129465246|NCT01764633|466000014|FG001|Overall Study|Withdrawal by Subject|88|||
129465247|NCT01764633|466000013|FG000|Overall Study|Lost to Follow-up|13|||
129465248|NCT01764633|466000014|FG001|Overall Study|Lost to Follow-up|5|||
129465249|NCT00704964|466000015|FG000|Overall Study|Not completed on time|328|||
129465250|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
129465251|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
129465252|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
129465253|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
129465254|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
129465255|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
129465256|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
129465257|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
129465258|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
129971118|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
129971119|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
129971120|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
129971121|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
129971122|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
129971123|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
129971124|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
129971125|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
129465259|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
129465260|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
129465261|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
129465262|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
129465263|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
129465264|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
129465265|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
129465266|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
129465267|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
129465268|NCT04418765|466000016|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
129465269|NCT04418765|466000017|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
129465270|NCT04418765|466000018|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
129465271|NCT04418765|466000016|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
129465272|NCT04418765|466000017|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
129465273|NCT04418765|466000018|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
129465274|NCT04418765|466000016|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
129465275|NCT04418765|466000017|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
129465276|NCT04418765|466000018|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
129971126|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
129971127|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
129971128|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
129971129|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
129971130|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
129465277|NCT04418765|466000016|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
129465278|NCT04418765|466000017|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
129465279|NCT04418765|466000018|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
129465280|NCT04418765|466000016|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
129465281|NCT04418765|466000017|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
129465282|NCT04418765|466000018|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
129465283|NCT04418765|466000016|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
129465284|NCT04418765|466000017|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
129465285|NCT04418765|466000018|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
129465286|NCT04418765|466000016|FG000|Extension Period (48 Weeks)|Other than specified|0|||
129465287|NCT04418765|466000017|FG001|Extension Period (48 Weeks)|Other than specified|5|||
129465288|NCT04418765|466000018|FG002|Extension Period (48 Weeks)|Other than specified|2|||
129465289|NCT01121393|466000019|FG000|Overall Study|Progressive disease|201|||
129465290|NCT01121393|466000020|FG001|Overall Study|Progressive disease|20|||
129465291|NCT01121393|466000019|FG000|Overall Study|Other Adverse events|24|||
129465292|NCT01121393|466000020|FG001|Overall Study|Other Adverse events|45|||
129465293|NCT01121393|466000019|FG000|Overall Study|Non-compliant with protocol|0|||
129465294|NCT01121393|466000020|FG001|Overall Study|Non-compliant with protocol|3|||
129465295|NCT01121393|466000019|FG000|Overall Study|Lost to Follow-up|1|||
129465296|NCT01121393|466000020|FG001|Overall Study|Lost to Follow-up|0|||
129465297|NCT01121393|466000019|FG000|Overall Study|Refused cont. medication|7|||
129465298|NCT01121393|466000020|FG001|Overall Study|Refused cont. medication|7|||
129465299|NCT01121393|466000019|FG000|Overall Study|Not treated|3|||
129465300|NCT01121393|466000020|FG001|Overall Study|Not treated|9|||
129465301|NCT01121393|466000019|FG000|Overall Study|Other than listed|6|||
129465302|NCT01121393|466000020|FG001|Overall Study|Other than listed|0|||
129465303|NCT02574637|466000024|FG000|Double-blind Period|Adverse Event|1|||
129465304|NCT02574637|466000025|FG001|Double-blind Period|Adverse Event|0|||
129465305|NCT02574637|466000026|FG002|Double-blind Period|Adverse Event|0|||
129465306|NCT02574637|466000027|FG003|Double-blind Period|Adverse Event|0|||
129465307|NCT02574637|466000028|FG004|Double-blind Period|Adverse Event|0|||
129465308|NCT02574637|466000029|FG005|Double-blind Period|Adverse Event|0|||
129465309|NCT02574637|466000030|FG006|Double-blind Period|Adverse Event|0|||
129465310|NCT02574637|466000031|FG007|Double-blind Period|Adverse Event|0|||
129465311|NCT02574637|466000032|FG008|Double-blind Period|Adverse Event|0|||
129465312|NCT02574637|466000033|FG009|Double-blind Period|Adverse Event|0|||
129465313|NCT02574637|466000024|FG000|Double-blind Period|Lack of Efficacy|0|||
129465314|NCT02574637|466000025|FG001|Double-blind Period|Lack of Efficacy|0|||
129465315|NCT02574637|466000026|FG002|Double-blind Period|Lack of Efficacy|2|||
129465316|NCT02574637|466000027|FG003|Double-blind Period|Lack of Efficacy|0|||
129465317|NCT02574637|466000028|FG004|Double-blind Period|Lack of Efficacy|0|||
129465318|NCT02574637|466000029|FG005|Double-blind Period|Lack of Efficacy|0|||
129465319|NCT02574637|466000030|FG006|Double-blind Period|Lack of Efficacy|0|||
129465320|NCT02574637|466000031|FG007|Double-blind Period|Lack of Efficacy|0|||
129465321|NCT02574637|466000032|FG008|Double-blind Period|Lack of Efficacy|0|||
129465322|NCT02574637|466000033|FG009|Double-blind Period|Lack of Efficacy|0|||
129465323|NCT02574637|466000024|FG000|Double-blind Period|Protocol Deviation|1|||
129465324|NCT02574637|466000025|FG001|Double-blind Period|Protocol Deviation|0|||
129465325|NCT02574637|466000026|FG002|Double-blind Period|Protocol Deviation|0|||
129465326|NCT02574637|466000027|FG003|Double-blind Period|Protocol Deviation|0|||
129465327|NCT02574637|466000028|FG004|Double-blind Period|Protocol Deviation|0|||
129465328|NCT02574637|466000029|FG005|Double-blind Period|Protocol Deviation|0|||
129465329|NCT02574637|466000030|FG006|Double-blind Period|Protocol Deviation|0|||
129465330|NCT02574637|466000031|FG007|Double-blind Period|Protocol Deviation|0|||
129465331|NCT02574637|466000032|FG008|Double-blind Period|Protocol Deviation|0|||
129465332|NCT02574637|466000033|FG009|Double-blind Period|Protocol Deviation|0|||
129465333|NCT02574637|466000024|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
129465334|NCT02574637|466000025|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
129465335|NCT02574637|466000026|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
129465336|NCT02574637|466000027|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
129465337|NCT02574637|466000028|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
129465338|NCT02574637|466000029|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
129465339|NCT02574637|466000030|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
129465340|NCT02574637|466000031|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
129465341|NCT02574637|466000032|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
129465342|NCT02574637|466000033|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
129465343|NCT02574637|466000024|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
129465344|NCT02574637|466000025|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
129971131|NCT02783573|467858394|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
129971132|NCT02783573|467858395|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
129971133|NCT02783573|467858396|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
129465345|NCT02574637|466000026|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
129465346|NCT02574637|466000027|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
129465347|NCT02574637|466000028|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
129465348|NCT02574637|466000029|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
129465349|NCT02574637|466000030|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
129465350|NCT02574637|466000031|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
129465351|NCT02574637|466000032|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
129465352|NCT02574637|466000033|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
129465353|NCT02574637|466000024|FG000|Double-blind Period|Reason Not Specified|0|||
129465354|NCT02574637|466000025|FG001|Double-blind Period|Reason Not Specified|0|||
129465355|NCT02574637|466000026|FG002|Double-blind Period|Reason Not Specified|0|||
129465356|NCT02574637|466000027|FG003|Double-blind Period|Reason Not Specified|1|||
129465357|NCT02574637|466000028|FG004|Double-blind Period|Reason Not Specified|0|||
129465358|NCT02574637|466000029|FG005|Double-blind Period|Reason Not Specified|0|||
129465359|NCT02574637|466000030|FG006|Double-blind Period|Reason Not Specified|0|||
129465360|NCT02574637|466000031|FG007|Double-blind Period|Reason Not Specified|0|||
129465361|NCT02574637|466000032|FG008|Double-blind Period|Reason Not Specified|0|||
129465362|NCT02574637|466000033|FG009|Double-blind Period|Reason Not Specified|0|||
129465363|NCT02574637|466000024|FG000|Open-label (OL) Period|Adverse Event|0|||
129465364|NCT02574637|466000025|FG001|Open-label (OL) Period|Adverse Event|0|||
129465365|NCT02574637|466000026|FG002|Open-label (OL) Period|Adverse Event|0|||
129465366|NCT02574637|466000027|FG003|Open-label (OL) Period|Adverse Event|0|||
129465367|NCT02574637|466000028|FG004|Open-label (OL) Period|Adverse Event|0|||
129465368|NCT02574637|466000029|FG005|Open-label (OL) Period|Adverse Event|0|||
129465369|NCT02574637|466000030|FG006|Open-label (OL) Period|Adverse Event|0|||
129465370|NCT02574637|466000031|FG007|Open-label (OL) Period|Adverse Event|0|||
129465371|NCT02574637|466000032|FG008|Open-label (OL) Period|Adverse Event|1|||
129465372|NCT02574637|466000033|FG009|Open-label (OL) Period|Adverse Event|0|||
129465373|NCT02574637|466000024|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
129465374|NCT02574637|466000025|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
129465375|NCT02574637|466000026|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
129465376|NCT02574637|466000027|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
129465377|NCT02574637|466000028|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
129465378|NCT02574637|466000029|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
129465379|NCT02574637|466000030|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
129465380|NCT02574637|466000031|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
129465381|NCT02574637|466000032|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
129465382|NCT02574637|466000033|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
129465383|NCT02574637|466000024|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
129465384|NCT02574637|466000025|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
129465385|NCT02574637|466000026|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
129465386|NCT02574637|466000027|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
129465387|NCT02574637|466000028|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
129465388|NCT02574637|466000029|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
129465389|NCT02574637|466000030|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
129465390|NCT02574637|466000031|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
129465391|NCT02574637|466000032|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
129465392|NCT02574637|466000033|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
129465393|NCT04016311|466000034|FG000|Overall Study|Withdrawal by Subject|1|||
129465394|NCT04016311|466000035|FG001|Overall Study|Withdrawal by Subject|0|||
129465395|NCT02064387|466000037|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465396|NCT02064387|466000038|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465397|NCT02064387|466000039|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465398|NCT02064387|466000040|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465399|NCT02064387|466000041|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465400|NCT02064387|466000042|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465401|NCT02064387|466000043|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465402|NCT02064387|466000044|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
129465403|NCT02064387|466000045|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465404|NCT02064387|466000046|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
129465405|NCT02064387|466000047|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465406|NCT02064387|466000048|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
129465407|NCT02064387|466000037|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465408|NCT02064387|466000038|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465409|NCT02064387|466000039|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465410|NCT02064387|466000040|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465411|NCT02064387|466000041|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465412|NCT02064387|466000042|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465413|NCT02064387|466000043|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465414|NCT02064387|466000044|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
129465415|NCT02064387|466000045|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465416|NCT02064387|466000046|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465417|NCT02064387|466000047|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465418|NCT02064387|466000048|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
129465419|NCT02064387|466000037|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465420|NCT02064387|466000038|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465421|NCT02064387|466000039|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465422|NCT02064387|466000040|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465423|NCT02064387|466000041|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465424|NCT02064387|466000042|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465425|NCT02064387|466000043|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465426|NCT02064387|466000044|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465427|NCT02064387|466000045|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
129465428|NCT02064387|466000046|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465429|NCT02064387|466000047|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465430|NCT02064387|466000048|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
129465431|NCT02064387|466000037|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
129465432|NCT02064387|466000038|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
129465433|NCT02064387|466000039|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
129465434|NCT02064387|466000040|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
129465435|NCT02064387|466000041|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
129465436|NCT02064387|466000042|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
129465437|NCT02064387|466000043|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
129465438|NCT02064387|466000044|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
129465439|NCT02064387|466000045|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
129465440|NCT02064387|466000046|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
129465441|NCT02064387|466000047|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
129465442|NCT02064387|466000048|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
129465443|NCT02064387|466000037|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465444|NCT02064387|466000038|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465445|NCT02064387|466000039|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465446|NCT02064387|466000040|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465447|NCT02064387|466000041|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465448|NCT02064387|466000042|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465449|NCT02064387|466000043|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465450|NCT02064387|466000044|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465451|NCT02064387|466000045|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465452|NCT02064387|466000046|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465453|NCT02064387|466000047|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
129465454|NCT02064387|466000048|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
129465455|NCT02706730|466000049|FG000|Overall Study|Adverse Event|3|||
129465456|NCT02706730|466000049|FG000|Overall Study|Lack of Efficacy|5|||
129465457|NCT02706730|466000049|FG000|Overall Study|Withdrawal by Subject|11|||
129465458|NCT02706730|466000049|FG000|Overall Study|Study Terminated by Sponsor|11|||
129465459|NCT02706730|466000049|FG000|Overall Study|Subject chose not to receive injection|3|||
129465460|NCT02499029|466000050|FG000|Overall Study|Lost to Follow-up|2|||
129465461|NCT02499029|466000051|FG001|Overall Study|Lost to Follow-up|2|||
129465462|NCT02499029|466000050|FG000|Overall Study|Physician Decision|2|||
129465463|NCT02499029|466000051|FG001|Overall Study|Physician Decision|1|||
129465464|NCT02499029|466000050|FG000|Overall Study|Death|1|||
129465465|NCT02499029|466000051|FG001|Overall Study|Death|0|||
129465466|NCT01999582|466000052|FG000|Overall Study|Withdrawal by Subject|0|||
129465467|NCT01999582|466000053|FG001|Overall Study|Withdrawal by Subject|0|||
129465468|NCT01999582|466000054|FG002|Overall Study|Withdrawal by Subject|0|||
129465469|NCT01999582|466000055|FG003|Overall Study|Withdrawal by Subject|1|||
129465470|NCT01999582|466000056|FG004|Overall Study|Withdrawal by Subject|0|||
129465471|NCT01999582|466000057|FG005|Overall Study|Withdrawal by Subject|0|||
129465472|NCT01999582|466000052|FG000|Overall Study|Adverse Event|0|||
129465473|NCT01999582|466000053|FG001|Overall Study|Adverse Event|0|||
129465474|NCT01999582|466000054|FG002|Overall Study|Adverse Event|3|||
129465475|NCT01999582|466000055|FG003|Overall Study|Adverse Event|0|||
129465476|NCT01999582|466000056|FG004|Overall Study|Adverse Event|1|||
129465477|NCT01999582|466000057|FG005|Overall Study|Adverse Event|0|||
129465478|NCT01999582|466000052|FG000|Overall Study|Other Reasons|1|||
129465479|NCT01999582|466000053|FG001|Overall Study|Other Reasons|0|||
129465480|NCT01999582|466000054|FG002|Overall Study|Other Reasons|3|||
129465481|NCT01999582|466000055|FG003|Overall Study|Other Reasons|1|||
129465482|NCT01999582|466000056|FG004|Overall Study|Other Reasons|1|||
129465483|NCT01999582|466000057|FG005|Overall Study|Other Reasons|2|||
129465484|NCT01999582|466000052|FG000|Overall Study|Protocol Violation|1|||
129971134|NCT02783573|467858394|FG000|Delayed-Start Period|Sponsor Decision|0|||
129971135|NCT02783573|467858395|FG001|Delayed-Start Period|Sponsor Decision|17|||
129971136|NCT02783573|467858396|FG002|Delayed-Start Period|Sponsor Decision|12|||
129971137|NCT00233480|467858397|FG000|Overall Study|Underwent status II heart transplant|0|||
129971138|NCT00233480|467858398|FG001|Overall Study|Underwent status II heart transplant|1|||
129971139|NCT00581893|467858399|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
129971140|NCT00581893|467858400|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
129971141|NCT02797522|467858408|FG000|Overall Study|Study Terminated by Sponsor|0|||
129465485|NCT01999582|466000053|FG001|Overall Study|Protocol Violation|0|||
129465486|NCT01999582|466000054|FG002|Overall Study|Protocol Violation|0|||
129465487|NCT01999582|466000055|FG003|Overall Study|Protocol Violation|0|||
129465488|NCT01999582|466000056|FG004|Overall Study|Protocol Violation|0|||
129465489|NCT01999582|466000057|FG005|Overall Study|Protocol Violation|1|||
129465490|NCT01999582|466000052|FG000|Overall Study|Lack of Efficacy|1|||
129465491|NCT01999582|466000053|FG001|Overall Study|Lack of Efficacy|3|||
129465492|NCT01999582|466000054|FG002|Overall Study|Lack of Efficacy|0|||
129465493|NCT01999582|466000055|FG003|Overall Study|Lack of Efficacy|1|||
129465494|NCT01999582|466000056|FG004|Overall Study|Lack of Efficacy|0|||
129465495|NCT01999582|466000057|FG005|Overall Study|Lack of Efficacy|0|||
129465496|NCT03889639|466000060|FG000|Overall Study|Withdrawal by Subject|0|||
129465497|NCT03889639|466000061|FG001|Overall Study|Withdrawal by Subject|0|||
129465498|NCT03889639|466000062|FG002|Overall Study|Withdrawal by Subject|0|||
129465499|NCT03889639|466000063|FG003|Overall Study|Withdrawal by Subject|0|||
129465500|NCT03889639|466000064|FG004|Overall Study|Withdrawal by Subject|0|||
129465501|NCT03889639|466000065|FG005|Overall Study|Withdrawal by Subject|0|||
129465502|NCT03889639|466000066|FG006|Overall Study|Withdrawal by Subject|0|||
129465503|NCT03889639|466000067|FG007|Overall Study|Withdrawal by Subject|1|||
129465504|NCT01703858|466000068|FG000|Overall Study|Withdrawal by Subject|0|||
129465505|NCT01703858|466000069|FG001|Overall Study|Withdrawal by Subject|1|||
129465506|NCT01703858|466000070|FG002|Overall Study|Withdrawal by Subject|0|||
129465507|NCT00927095|466000071|FG000|Overall Study|Adverse Event|3|||
129465508|NCT00927095|466000072|FG001|Overall Study|Adverse Event|1|||
129465509|NCT00927095|466000073|FG002|Overall Study|Adverse Event|0|||
129465510|NCT00927095|466000071|FG000|Overall Study|Withdrawal by Subject|2|||
129465511|NCT00927095|466000072|FG001|Overall Study|Withdrawal by Subject|1|||
129465512|NCT00927095|466000073|FG002|Overall Study|Withdrawal by Subject|1|||
129465513|NCT00927095|466000071|FG000|Overall Study|Physician Decision|1|||
129465514|NCT00927095|466000072|FG001|Overall Study|Physician Decision|2|||
129465515|NCT00927095|466000073|FG002|Overall Study|Physician Decision|1|||
129465516|NCT01290692|466000074|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
129465517|NCT02556255|466000075|FG000|Overall Study|Lost to Follow-up|4|||
129465518|NCT00993031|466000079|FG000|Overall Study|Death|0|||
129465519|NCT00993031|466000080|FG001|Overall Study|Death|1|||
129465520|NCT00993031|466000079|FG000|Overall Study|Physician Decision|0|||
129465521|NCT00993031|466000080|FG001|Overall Study|Physician Decision|2|||
129465522|NCT00993031|466000079|FG000|Overall Study|Withdrawal by Subject|3|||
129465523|NCT00993031|466000080|FG001|Overall Study|Withdrawal by Subject|3|||
129465524|NCT00993031|466000079|FG000|Overall Study|Lost to Follow-up|19|||
129465525|NCT00993031|466000080|FG001|Overall Study|Lost to Follow-up|13|||
129465526|NCT03115151|466000081|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
129465527|NCT03115151|466000082|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
129465528|NCT03115151|466000081|FG000|Overall Study|Epidural catheter removal|1|||
129465529|NCT03115151|466000082|FG001|Overall Study|Epidural catheter removal|0|||
129465530|NCT03115151|466000081|FG000|Overall Study|Withdrawal by Subject|0|||
129465531|NCT03115151|466000082|FG001|Overall Study|Withdrawal by Subject|1|||
129465532|NCT03115151|466000081|FG000|Overall Study|Intervention not received according to the protocol.|1|||
129465533|NCT03115151|466000082|FG001|Overall Study|Intervention not received according to the protocol.|1|||
129465534|NCT03115151|466000081|FG000|Overall Study|Physician Decision|1|||
129465535|NCT03115151|466000082|FG001|Overall Study|Physician Decision|0|||
129465536|NCT03115151|466000081|FG000|Overall Study|Randomization not applied|1|||
129465537|NCT03115151|466000082|FG001|Overall Study|Randomization not applied|1|||
129465538|NCT00730639|466000093|FG000|Overall Study|Adverse Event|3|||
129465539|NCT00730639|466000094|FG001|Overall Study|Adverse Event|0|||
129465540|NCT00730639|466000095|FG002|Overall Study|Adverse Event|9|||
129465541|NCT00730639|466000096|FG003|Overall Study|Adverse Event|8|||
129465542|NCT00730639|466000097|FG004|Overall Study|Adverse Event|23|||
129465543|NCT00730639|466000093|FG000|Overall Study|Complete Response|0|||
129465544|NCT00730639|466000094|FG001|Overall Study|Complete Response|0|||
129465545|NCT00730639|466000095|FG002|Overall Study|Complete Response|2|||
129465546|NCT00730639|466000096|FG003|Overall Study|Complete Response|2|||
129465547|NCT00730639|466000097|FG004|Overall Study|Complete Response|1|||
129465548|NCT00730639|466000093|FG000|Overall Study|Completed Maximum Cycles|0|||
129465549|NCT00730639|466000094|FG001|Overall Study|Completed Maximum Cycles|0|||
129465550|NCT00730639|466000095|FG002|Overall Study|Completed Maximum Cycles|11|||
129465551|NCT00730639|466000096|FG003|Overall Study|Completed Maximum Cycles|3|||
129465552|NCT00730639|466000097|FG004|Overall Study|Completed Maximum Cycles|6|||
129465553|NCT00730639|466000093|FG000|Overall Study|Death|0|||
129465554|NCT00730639|466000094|FG001|Overall Study|Death|0|||
129465555|NCT00730639|466000095|FG002|Overall Study|Death|0|||
129465556|NCT00730639|466000096|FG003|Overall Study|Death|0|||
129465557|NCT00730639|466000097|FG004|Overall Study|Death|2|||
129465558|NCT00730639|466000093|FG000|Overall Study|Disease Progression|12|||
129465559|NCT00730639|466000094|FG001|Overall Study|Disease Progression|13|||
129465560|NCT00730639|466000095|FG002|Overall Study|Disease Progression|48|||
129465561|NCT00730639|466000096|FG003|Overall Study|Disease Progression|32|||
129465562|NCT00730639|466000097|FG004|Overall Study|Disease Progression|88|||
129465563|NCT00730639|466000093|FG000|Overall Study|non-specified|0|||
129465564|NCT00730639|466000094|FG001|Overall Study|non-specified|0|||
129465565|NCT00730639|466000095|FG002|Overall Study|non-specified|4|||
129465566|NCT00730639|466000096|FG003|Overall Study|non-specified|2|||
129465567|NCT00730639|466000097|FG004|Overall Study|non-specified|3|||
129465568|NCT00730639|466000093|FG000|Overall Study|Protocol Violation|0|||
129465569|NCT00730639|466000094|FG001|Overall Study|Protocol Violation|0|||
129465570|NCT00730639|466000095|FG002|Overall Study|Protocol Violation|1|||
129465571|NCT00730639|466000096|FG003|Overall Study|Protocol Violation|0|||
129465572|NCT00730639|466000097|FG004|Overall Study|Protocol Violation|0|||
129465573|NCT00730639|466000093|FG000|Overall Study|Withdrawal by Subject|0|||
129465574|NCT00730639|466000094|FG001|Overall Study|Withdrawal by Subject|0|||
129465575|NCT00730639|466000095|FG002|Overall Study|Withdrawal by Subject|6|||
129465576|NCT00730639|466000096|FG003|Overall Study|Withdrawal by Subject|3|||
129465577|NCT00730639|466000097|FG004|Overall Study|Withdrawal by Subject|4|||
129465578|NCT00730639|466000093|FG000|Overall Study|Treatment on-going|2|||
129465579|NCT00730639|466000094|FG001|Overall Study|Treatment on-going|5|||
129465580|NCT00730639|466000095|FG002|Overall Study|Treatment on-going|5|||
129465581|NCT00730639|466000096|FG003|Overall Study|Treatment on-going|4|||
129465582|NCT00730639|466000097|FG004|Overall Study|Treatment on-going|4|||
129465583|NCT02665286|466000098|FG000|Overall Study|Lost to Follow-up|3|||
129465584|NCT02665286|466000099|FG001|Overall Study|Lost to Follow-up|2|||
129465585|NCT02665286|466000100|FG002|Overall Study|Lost to Follow-up|1|||
129465586|NCT04820309|466000108|FG000|Overall Study|Adverse Event|96|||
129465587|NCT04820309|466000108|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
129465588|NCT04820309|466000108|FG000|Overall Study|Consent Withdrawn|93|||
129465589|NCT04820309|466000108|FG000|Overall Study|failure to adhere to protocol|32|||
129465590|NCT04820309|466000108|FG000|Overall Study|alcohol or drug use|6|||
129465591|NCT04820309|466000108|FG000|Overall Study|Lost to Follow-up|46|||
129465592|NCT04820309|466000108|FG000|Overall Study|Death|2|||
129465593|NCT04820309|466000108|FG000|Overall Study|Pregnancy|1|||
129465594|NCT04820309|466000108|FG000|Overall Study|Other reasons|12|||
129465595|NCT00980538|466000115|FG000|Overall Study|Lost to Follow-up|20|||
129465596|NCT00980538|466000115|FG000|Overall Study|Sponsor's Decision|4|||
129465597|NCT00980538|466000115|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
129465598|NCT00980538|466000115|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
129465599|NCT00980538|466000115|FG000|Overall Study|Switch to Commercially Available Medication|25|||
129465600|NCT00980538|466000115|FG000|Overall Study|Participant Non-Compliant|9|||
129465601|NCT00980538|466000115|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
129465602|NCT00980538|466000115|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
129465603|NCT00980538|466000115|FG000|Overall Study|Other|60|||
129465604|NCT00980538|466000115|FG000|Overall Study|Other|1|||
129465605|NCT02482129|466000116|FG000|Overall Study|Adverse Event-prior to treatment|0|||
129465606|NCT02482129|466000117|FG001|Overall Study|Adverse Event-prior to treatment|1|||
129465607|NCT02482129|466000116|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
129465608|NCT02482129|466000117|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
129465609|NCT02482129|466000116|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
129465610|NCT02482129|466000117|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
129465611|NCT02482129|466000116|FG000|Overall Study|Criteria not met-prior to treatment|1|||
129465612|NCT02482129|466000117|FG001|Overall Study|Criteria not met-prior to treatment|0|||
129465613|NCT02482129|466000116|FG000|Overall Study|Adverse Event|1|||
129465614|NCT02482129|466000117|FG001|Overall Study|Adverse Event|0|||
129465615|NCT02482129|466000116|FG000|Overall Study|Withdrawal by Subject|2|||
129465616|NCT02482129|466000117|FG001|Overall Study|Withdrawal by Subject|0|||
129465617|NCT02482129|466000116|FG000|Overall Study|Criteria not met|1|||
129465618|NCT02482129|466000117|FG001|Overall Study|Criteria not met|0|||
129465619|NCT03505021|466000118|FG000|Overall Study|Protocol Violation|1|||
129465620|NCT03505021|466000119|FG001|Overall Study|Protocol Violation|0|||
129465621|NCT03505021|466000118|FG000|Overall Study|Death|9|||
129465622|NCT03505021|466000119|FG001|Overall Study|Death|8|||
129465623|NCT03505021|466000118|FG000|Overall Study|Consent withdrawn by subject|6|||
129465624|NCT03505021|466000119|FG001|Overall Study|Consent withdrawn by subject|1|||
129465625|NCT03505021|466000118|FG000|Overall Study|Lost to Follow-up|5|||
129465626|NCT03505021|466000119|FG001|Overall Study|Lost to Follow-up|3|||
129465627|NCT03505021|466000118|FG000|Overall Study|Adverse Event|26|||
129465628|NCT03505021|466000119|FG001|Overall Study|Adverse Event|9|||
129465629|NCT03505021|466000118|FG000|Overall Study|Disease progression|33|||
129465630|NCT03505021|466000119|FG001|Overall Study|Disease progression|17|||
129465631|NCT03505021|466000118|FG000|Overall Study|Other|11|||
129465632|NCT03505021|466000119|FG001|Overall Study|Other|5|||
129465633|NCT03505021|466000118|FG000|Overall Study|Personal reason|21|||
129465634|NCT03505021|466000119|FG001|Overall Study|Personal reason|12|||
129465635|NCT03087955|466001878|FG000|Overall Study|Death|4|||
129465636|NCT03087955|466001879|FG001|Overall Study|Death|0|||
129465637|NCT03087955|466001878|FG000|Overall Study|Lack of Efficacy|2|||
129465638|NCT03087955|466001879|FG001|Overall Study|Lack of Efficacy|0|||
129465639|NCT03087955|466001878|FG000|Overall Study|Lost to Follow-up|1|||
129465640|NCT03087955|466001879|FG001|Overall Study|Lost to Follow-up|0|||
129465641|NCT02392429|466001880|FG000|Screening|Screen failure|15|||
129465642|NCT02392429|466001880|FG000|Enrolled Participants|Ineligible due to disease|3|||
129465643|NCT02392429|466001880|FG000|Enrolled Participants|Withdrawal by Subject|4|||
129465644|NCT02392429|466001880|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
129465645|NCT02392429|466001880|FG000|Evaluable|Death|5|||
129465646|NCT02392429|466001880|FG000|Evaluable|Withdrawal by Subject|1|||
129465647|NCT02392429|466001880|FG000|Evaluable|Adverse Event|1|||
129465648|NCT02392429|466001880|FG000|Evaluable|remission bone marrow biopsy|3|||
129465649|NCT03266016|466001884|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
129465650|NCT03266016|466001885|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
129465651|NCT03266016|466001886|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
129465652|NCT03266016|466001887|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
129465653|NCT03266016|466001884|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
129465654|NCT03266016|466001885|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
129465655|NCT03266016|466001886|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
129465656|NCT03266016|466001887|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
129465657|NCT00482014|466001888|FG000|Overall Study|Withdrawal by Subject|1|||
129465658|NCT00482014|466001889|FG001|Overall Study|Withdrawal by Subject|2|||
129465659|NCT00482014|466001890|FG002|Overall Study|Withdrawal by Subject|3|||
129465660|NCT00482014|466001891|FG003|Overall Study|Withdrawal by Subject|4|||
129465661|NCT00482014|466001888|FG000|Overall Study|Adverse Event|3|||
129465662|NCT00482014|466001889|FG001|Overall Study|Adverse Event|0|||
129465663|NCT00482014|466001890|FG002|Overall Study|Adverse Event|2|||
129465664|NCT00482014|466001891|FG003|Overall Study|Adverse Event|8|||
129465665|NCT00482014|466001888|FG000|Overall Study|Death|1|||
129465666|NCT00482014|466001889|FG001|Overall Study|Death|2|||
129465667|NCT00482014|466001890|FG002|Overall Study|Death|1|||
129465668|NCT00482014|466001891|FG003|Overall Study|Death|4|||
129465669|NCT00482014|466001888|FG000|Overall Study|Lack of Efficacy|1|||
129465670|NCT00482014|466001889|FG001|Overall Study|Lack of Efficacy|0|||
129465671|NCT00482014|466001890|FG002|Overall Study|Lack of Efficacy|4|||
129465672|NCT00482014|466001891|FG003|Overall Study|Lack of Efficacy|6|||
129465673|NCT00482014|466001888|FG000|Overall Study|Sponsor Decision|1|||
129465674|NCT00482014|466001889|FG001|Overall Study|Sponsor Decision|2|||
129465675|NCT00482014|466001890|FG002|Overall Study|Sponsor Decision|1|||
129465676|NCT00482014|466001891|FG003|Overall Study|Sponsor Decision|1|||
129465677|NCT03686397|466001892|FG000|Overall Study|Lack of Efficacy|3|||
129465678|NCT03686397|466001893|FG001|Overall Study|Lack of Efficacy|5|||
129465679|NCT03686397|466001892|FG000|Overall Study|Adverse Event|0|||
129465680|NCT03686397|466001893|FG001|Overall Study|Adverse Event|1|||
129465681|NCT03686397|466001892|FG000|Overall Study|Protocol Violation|0|||
129465682|NCT03686397|466001893|FG001|Overall Study|Protocol Violation|1|||
129465683|NCT03686397|466001892|FG000|Overall Study|Withdrawal by Subject|0|||
129465684|NCT03686397|466001893|FG001|Overall Study|Withdrawal by Subject|1|||
129465685|NCT03686397|466001892|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
129465686|NCT03686397|466001893|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
129465687|NCT01241708|466001894|FG000|Overall Study|Withdrawal by Subject|6|||
129465688|NCT01241708|466001894|FG000|Overall Study|Screen Failure|6|||
129465689|NCT01241708|466001894|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
129465690|NCT01241708|466001894|FG000|Overall Study|Lost to Follow-up|5|||
129465691|NCT04183335|466001895|FG000|Overall Study|Adverse Event|1|||
129465692|NCT04183335|466001896|FG001|Overall Study|Adverse Event|0|||
129465693|NCT04183335|466001895|FG000|Overall Study|Withdrawal by Subject|12|||
129465694|NCT04183335|466001896|FG001|Overall Study|Withdrawal by Subject|3|||
129465695|NCT01268293|466001901|FG000|Overall Study|Disease progression|7|||
129465696|NCT01268293|466001901|FG000|Overall Study|Adverse Event|1|||
129465697|NCT01268293|466001901|FG000|Overall Study|Subject choice|1|||
129465698|NCT01396005|466001906|FG000|Overall Study|Withdrawal by Subject|0|||
129465699|NCT01396005|466001907|FG001|Overall Study|Withdrawal by Subject|1|||
129465700|NCT01396005|466001906|FG000|Overall Study|Non-compliance with protocol|0|||
129465701|NCT01396005|466001907|FG001|Overall Study|Non-compliance with protocol|1|||
129465702|NCT00424827|466001908|FG000|Overall Study|Adverse Event|1|||
129465703|NCT03806127|466001911|FG000|Overall Study|Withdrawal by Subject|4|||
129465704|NCT03806127|466001912|FG001|Overall Study|Withdrawal by Subject|5|||
129465705|NCT03806127|466001911|FG000|Overall Study|Protocol Violation|3|||
129465706|NCT03806127|466001912|FG001|Overall Study|Protocol Violation|1|||
129465707|NCT03806127|466001911|FG000|Overall Study|Adverse Event|3|||
129465708|NCT03806127|466001912|FG001|Overall Study|Adverse Event|0|||
129465709|NCT03806127|466001911|FG000|Overall Study|Unable to Complete Procedures|0|||
129465710|NCT03806127|466001912|FG001|Overall Study|Unable to Complete Procedures|1|||
129465711|NCT03806127|466001911|FG000|Overall Study|Pregnancy|0|||
129465712|NCT03806127|466001912|FG001|Overall Study|Pregnancy|1|||
129465713|NCT03806127|466001911|FG000|Overall Study|Lost to Follow-up|5|||
129465714|NCT03806127|466001912|FG001|Overall Study|Lost to Follow-up|1|||
129465715|NCT03806127|466001911|FG000|Overall Study|Physician Decision|1|||
129465716|NCT03806127|466001912|FG001|Overall Study|Physician Decision|1|||
129465717|NCT03806127|466001911|FG000|Overall Study|Could Not Come Due to Covid|1|||
129465718|NCT03806127|466001912|FG001|Overall Study|Could Not Come Due to Covid|0|||
129465719|NCT03806127|466001911|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
129465720|NCT03806127|466001912|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
129465721|NCT03806127|466001911|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
129465722|NCT03806127|466001912|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
129465723|NCT03806127|466001911|FG000|Overall Study|Covid 19 Restrictions|2|||
129465724|NCT03806127|466001912|FG001|Overall Study|Covid 19 Restrictions|0|||
129465725|NCT03806127|466001911|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
129465726|NCT03806127|466001912|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
129465727|NCT03806127|466001911|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
129465728|NCT03806127|466001912|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
129465729|NCT01467492|466001913|FG000|Overall Study|Withdrawal by Subject|6|||
129465730|NCT01467492|466001914|FG001|Overall Study|Withdrawal by Subject|4|||
129465731|NCT01467492|466001913|FG000|Overall Study|Study Terminated by Sponsor|6|||
129465732|NCT01467492|466001914|FG001|Overall Study|Study Terminated by Sponsor|4|||
129465733|NCT01467492|466001913|FG000|Overall Study|Adverse Event|4|||
129465734|NCT01467492|466001914|FG001|Overall Study|Adverse Event|3|||
129465735|NCT01467492|466001913|FG000|Overall Study|Lost to Follow-up|3|||
129465736|NCT01467492|466001914|FG001|Overall Study|Lost to Follow-up|2|||
129465737|NCT01467492|466001913|FG000|Overall Study|Undefined|2|||
129465738|NCT01467492|466001914|FG001|Overall Study|Undefined|0|||
129465739|NCT01467492|466001913|FG000|Overall Study|Enrolled But Not Treated|1|||
129465740|NCT01467492|466001914|FG001|Overall Study|Enrolled But Not Treated|0|||
129465741|NCT03823391|466001915|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
129465742|NCT03823391|466001916|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
129465743|NCT03823391|466001915|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
129465744|NCT03823391|466001916|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
129465745|NCT02450487|466001918|FG000|Overall Study|Lost to Follow-up|3|||
129465746|NCT01790048|466001919|FG000|Overall Study|Incorrect Age|9|||
129465747|NCT01790048|466001920|FG001|Overall Study|Incorrect Age|14|||
129465748|NCT01790048|466001919|FG000|Overall Study|data entry error|0|||
129465749|NCT01790048|466001920|FG001|Overall Study|data entry error|1|||
129465750|NCT01790048|466001919|FG000|Overall Study|Other|0|||
129465751|NCT01790048|466001920|FG001|Overall Study|Other|2|||
129465752|NCT01790048|466001919|FG000|Overall Study|SAM at Enrollment|2|||
129465753|NCT01790048|466001920|FG001|Overall Study|SAM at Enrollment|0|||
129465754|NCT01790048|466001919|FG000|Overall Study|Measurement error|1|||
129465755|NCT01790048|466001920|FG001|Overall Study|Measurement error|0|||
129465756|NCT00159432|466001921|FG000|Overall Study|Adverse Event|1|||
129465757|NCT00159432|466001921|FG000|Overall Study|Death|1|||
129465758|NCT00159432|466001921|FG000|Overall Study|Lack of Efficacy|8|||
129465759|NCT04537208|466001924|FG000|Overall Study|Adverse Event|0|||
129465760|NCT04537208|466001925|FG001|Overall Study|Adverse Event|0|||
129465761|NCT04537208|466001926|FG002|Overall Study|Adverse Event|0|||
129465762|NCT04537208|466001927|FG003|Overall Study|Adverse Event|0|||
129465763|NCT04537208|466001928|FG004|Overall Study|Adverse Event|0|||
129465764|NCT04537208|466001929|FG005|Overall Study|Adverse Event|0|||
129465765|NCT04537208|466001930|FG006|Overall Study|Adverse Event|0|||
129465766|NCT04537208|466001931|FG007|Overall Study|Adverse Event|0|||
129465767|NCT04537208|466001932|FG008|Overall Study|Adverse Event|1|||
129465768|NCT04537208|466001933|FG009|Overall Study|Adverse Event|0|||
129465769|NCT04537208|466001934|FG010|Overall Study|Adverse Event|0|||
129465770|NCT04537208|466001924|FG000|Overall Study|Protocol deviation|0|||
129465771|NCT04537208|466001925|FG001|Overall Study|Protocol deviation|0|||
129465772|NCT04537208|466001926|FG002|Overall Study|Protocol deviation|2|||
129465773|NCT04537208|466001927|FG003|Overall Study|Protocol deviation|0|||
129465774|NCT04537208|466001928|FG004|Overall Study|Protocol deviation|0|||
129465775|NCT04537208|466001929|FG005|Overall Study|Protocol deviation|2|||
129465776|NCT04537208|466001930|FG006|Overall Study|Protocol deviation|4|||
129465777|NCT04537208|466001931|FG007|Overall Study|Protocol deviation|0|||
129465778|NCT04537208|466001932|FG008|Overall Study|Protocol deviation|1|||
129465779|NCT04537208|466001933|FG009|Overall Study|Protocol deviation|0|||
129465780|NCT04537208|466001934|FG010|Overall Study|Protocol deviation|2|||
129465781|NCT04537208|466001924|FG000|Overall Study|Withdrawal by Subject|4|||
129465782|NCT04537208|466001925|FG001|Overall Study|Withdrawal by Subject|2|||
129465783|NCT04537208|466001926|FG002|Overall Study|Withdrawal by Subject|1|||
129465784|NCT04537208|466001927|FG003|Overall Study|Withdrawal by Subject|3|||
129465785|NCT04537208|466001928|FG004|Overall Study|Withdrawal by Subject|5|||
129465786|NCT04537208|466001929|FG005|Overall Study|Withdrawal by Subject|1|||
129465787|NCT04537208|466001930|FG006|Overall Study|Withdrawal by Subject|6|||
129465788|NCT04537208|466001931|FG007|Overall Study|Withdrawal by Subject|1|||
129465789|NCT04537208|466001932|FG008|Overall Study|Withdrawal by Subject|7|||
129465790|NCT04537208|466001933|FG009|Overall Study|Withdrawal by Subject|2|||
129465791|NCT04537208|466001934|FG010|Overall Study|Withdrawal by Subject|4|||
129465792|NCT04537208|466001924|FG000|Overall Study|Lost to Follow-up|4|||
129465793|NCT04537208|466001925|FG001|Overall Study|Lost to Follow-up|1|||
129465794|NCT04537208|466001926|FG002|Overall Study|Lost to Follow-up|3|||
129465795|NCT04537208|466001927|FG003|Overall Study|Lost to Follow-up|4|||
129465796|NCT04537208|466001928|FG004|Overall Study|Lost to Follow-up|3|||
129465797|NCT04537208|466001929|FG005|Overall Study|Lost to Follow-up|2|||
129465798|NCT04537208|466001930|FG006|Overall Study|Lost to Follow-up|3|||
129465799|NCT04537208|466001931|FG007|Overall Study|Lost to Follow-up|2|||
129465800|NCT04537208|466001932|FG008|Overall Study|Lost to Follow-up|7|||
129465801|NCT04537208|466001933|FG009|Overall Study|Lost to Follow-up|2|||
129465802|NCT04537208|466001934|FG010|Overall Study|Lost to Follow-up|2|||
129465803|NCT05030311|466001935|FG000|Overall Study|Technical problems|0|||
129465804|NCT05030311|466001936|FG001|Overall Study|Technical problems|1|||
129465805|NCT05030311|466001935|FG000|Overall Study|Withdrawal by Subject|31|||
129465806|NCT05030311|466001936|FG001|Overall Study|Withdrawal by Subject|17|||
129465807|NCT05030311|466001935|FG000|Overall Study|Adverse Event|13|||
129465808|NCT05030311|466001936|FG001|Overall Study|Adverse Event|5|||
129465809|NCT05030311|466001935|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129465810|NCT05030311|466001936|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129465811|NCT05030311|466001935|FG000|Overall Study|Physician Decision|5|||
129465812|NCT05030311|466001936|FG001|Overall Study|Physician Decision|2|||
129465813|NCT05030311|466001935|FG000|Overall Study|Lost to Follow-up|5|||
129465814|NCT05030311|466001936|FG001|Overall Study|Lost to Follow-up|1|||
129465815|NCT05030311|466001935|FG000|Overall Study|Protocol Violation|4|||
129465816|NCT05030311|466001936|FG001|Overall Study|Protocol Violation|4|||
129465817|NCT03042468|466001938|FG000|Overall Study|Death|0|||
129465818|NCT03042468|466001939|FG001|Overall Study|Death|1|||
129465819|NCT03042468|466001940|FG002|Overall Study|Death|1|||
129465820|NCT03042468|466001941|FG003|Overall Study|Death|0|||
129465821|NCT03042468|466001942|FG004|Overall Study|Death|0|||
129465822|NCT03042468|466001943|FG005|Overall Study|Death|0|||
129465823|NCT03042468|466001938|FG000|Overall Study|Withdrawal by Subject|0|||
129465824|NCT03042468|466001939|FG001|Overall Study|Withdrawal by Subject|0|||
129465825|NCT03042468|466001940|FG002|Overall Study|Withdrawal by Subject|0|||
129465826|NCT03042468|466001941|FG003|Overall Study|Withdrawal by Subject|0|||
129465827|NCT03042468|466001942|FG004|Overall Study|Withdrawal by Subject|0|||
129465828|NCT03042468|466001943|FG005|Overall Study|Withdrawal by Subject|1|||
129465829|NCT03042468|466001938|FG000|Overall Study|Lost to Follow-up|0|||
129465830|NCT03042468|466001939|FG001|Overall Study|Lost to Follow-up|0|||
129465831|NCT03042468|466001940|FG002|Overall Study|Lost to Follow-up|0|||
129465832|NCT03042468|466001941|FG003|Overall Study|Lost to Follow-up|0|||
129465833|NCT03042468|466001942|FG004|Overall Study|Lost to Follow-up|1|||
129465834|NCT03042468|466001943|FG005|Overall Study|Lost to Follow-up|1|||
129465835|NCT00253630|466001944|FG000|Overall Study|ineligible|2|||
129465836|NCT00429858|466001945|FG000|Overall Study|Withdrawal by Subject|1|||
129465837|NCT00429858|466001945|FG000|Overall Study|Study Termination|1|||
129465838|NCT01239160|466001947|FG000|Overall Study|Lost to Follow-up|3|||
129465839|NCT01239160|466001948|FG001|Overall Study|Lost to Follow-up|5|||
129465840|NCT01239160|466001949|FG002|Overall Study|Lost to Follow-up|0|||
129465841|NCT01239160|466001947|FG000|Overall Study|Withdrawal by Subject|17|||
129465842|NCT01239160|466001948|FG001|Overall Study|Withdrawal by Subject|6|||
129465843|NCT01239160|466001949|FG002|Overall Study|Withdrawal by Subject|2|||
129971142|NCT02797522|467858409|FG001|Overall Study|Study Terminated by Sponsor|0|||
129971143|NCT02797522|467858410|FG002|Overall Study|Study Terminated by Sponsor|0|||
129971144|NCT02797522|467858411|FG003|Overall Study|Study Terminated by Sponsor|0|||
129971145|NCT02797522|467858412|FG004|Overall Study|Study Terminated by Sponsor|0|||
129971146|NCT02797522|467858413|FG005|Overall Study|Study Terminated by Sponsor|0|||
129971147|NCT02797522|467858414|FG006|Overall Study|Study Terminated by Sponsor|0|||
129971148|NCT02797522|467858415|FG007|Overall Study|Study Terminated by Sponsor|4|||
129971149|NCT02797522|467858416|FG008|Overall Study|Study Terminated by Sponsor|2|||
129971150|NCT02797522|467858417|FG009|Overall Study|Study Terminated by Sponsor|4|||
129971151|NCT02797522|467858418|FG010|Overall Study|Study Terminated by Sponsor|1|||
129971152|NCT00725712|467858419|FG000|Overall Study|Withdrawal by Subject|2|||
129971153|NCT00725712|467858420|FG001|Overall Study|Withdrawal by Subject|1|||
129971154|NCT00725712|467858419|FG000|Overall Study|Protocol Violation|1|||
129971155|NCT00725712|467858420|FG001|Overall Study|Protocol Violation|0|||
129971156|NCT00725712|467858419|FG000|Overall Study|Progressive disease|37|||
129971157|NCT00725712|467858420|FG001|Overall Study|Progressive disease|16|||
129971158|NCT00725712|467858419|FG000|Overall Study|Clinical progression not based on RECIST|0|||
129971159|NCT00725712|467858420|FG001|Overall Study|Clinical progression not based on RECIST|3|||
129465844|NCT01239160|466001947|FG000|Overall Study|Physician Decision|5|||
129465845|NCT01239160|466001948|FG001|Overall Study|Physician Decision|7|||
129465846|NCT01239160|466001949|FG002|Overall Study|Physician Decision|2|||
129465847|NCT01239160|466001947|FG000|Overall Study|Early Termination Due to Study Closure|0|||
129465848|NCT01239160|466001948|FG001|Overall Study|Early Termination Due to Study Closure|1|||
129465849|NCT01239160|466001949|FG002|Overall Study|Early Termination Due to Study Closure|6|||
129465850|NCT02268058|466001950|FG000|Overall Study|Protocol Violation|1|||
129465851|NCT02268058|466001951|FG001|Overall Study|Protocol Violation|0|||
129971160|NCT00725712|467858419|FG000|Overall Study|Adverse Event|5|||
129971161|NCT00725712|467858420|FG001|Overall Study|Adverse Event|5|||
129971162|NCT00725712|467858419|FG000|Overall Study|Death|2|||
129971163|NCT00725712|467858420|FG001|Overall Study|Death|0|||
129971164|NCT00725712|467858419|FG000|Overall Study|Other: Death|1|||
129971165|NCT00725712|467858420|FG001|Overall Study|Other: Death|0|||
129971166|NCT00725712|467858419|FG000|Overall Study|Hospitalized, unable to continue|0|||
129971167|NCT00725712|467858420|FG001|Overall Study|Hospitalized, unable to continue|1|||
129971168|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
129971169|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
129971170|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
129971171|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
129971172|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
129971173|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
129971174|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
129465852|NCT02268058|466001952|FG002|Overall Study|Protocol Violation|0|||
129465853|NCT02268058|466001953|FG003|Overall Study|Protocol Violation|0|||
129465854|NCT04781816|466001959|FG000|Overall Study|Adverse Event|0|||
129465855|NCT04781816|466001960|FG001|Overall Study|Adverse Event|1|||
129465856|NCT04781816|466001959|FG000|Overall Study|Withdrawal by Subject|1|||
129465857|NCT04781816|466001960|FG001|Overall Study|Withdrawal by Subject|1|||
129465858|NCT04781816|466001959|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
129465859|NCT04781816|466001960|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
129465860|NCT01789970|466001961|FG000|Open-label Titration Period|Adverse Event|68|||
129465861|NCT01789970|466001962|FG001|Open-label Titration Period|Adverse Event|0|||
129465862|NCT01789970|466001963|FG002|Open-label Titration Period|Adverse Event|0|||
129465863|NCT01789970|466001961|FG000|Open-label Titration Period|Lack of Efficacy|31|||
129465864|NCT01789970|466001962|FG001|Open-label Titration Period|Lack of Efficacy|0|||
129465865|NCT01789970|466001963|FG002|Open-label Titration Period|Lack of Efficacy|0|||
129971175|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
129465866|NCT01789970|466001961|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
129465867|NCT01789970|466001962|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
129465868|NCT01789970|466001963|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
129465869|NCT01789970|466001961|FG000|Open-label Titration Period|Protocol Violation|18|||
129465870|NCT01789970|466001962|FG001|Open-label Titration Period|Protocol Violation|0|||
129465871|NCT01789970|466001963|FG002|Open-label Titration Period|Protocol Violation|0|||
129465872|NCT01789970|466001961|FG000|Open-label Titration Period|Lost to Follow-up|5|||
129465873|NCT01789970|466001962|FG001|Open-label Titration Period|Lost to Follow-up|0|||
129465874|NCT01789970|466001963|FG002|Open-label Titration Period|Lost to Follow-up|0|||
129465875|NCT01789970|466001961|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
129465876|NCT01789970|466001962|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
129465877|NCT01789970|466001963|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
129465878|NCT01789970|466001961|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
129465879|NCT01789970|466001962|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
129465880|NCT01789970|466001963|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
129465881|NCT01789970|466001961|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
129465882|NCT01789970|466001962|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
129465883|NCT01789970|466001963|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
129465884|NCT01789970|466001961|FG000|Open-label Titration Period|Pregnancy|2|||
129465885|NCT01789970|466001962|FG001|Open-label Titration Period|Pregnancy|0|||
129465886|NCT01789970|466001963|FG002|Open-label Titration Period|Pregnancy|0|||
129465887|NCT01789970|466001961|FG000|Open-label Titration Period|Other|76|||
129465888|NCT01789970|466001962|FG001|Open-label Titration Period|Other|0|||
129465889|NCT01789970|466001963|FG002|Open-label Titration Period|Other|0|||
129465890|NCT01789970|466001961|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
129465891|NCT01789970|466001962|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
129465892|NCT01789970|466001963|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
129465893|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
129465894|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
129465895|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
129465896|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
129465897|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
129465898|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
129465899|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
129465900|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
129465901|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
129465902|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
129465903|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
129971176|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
129971177|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
129971178|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
129465904|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
129465905|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
129465906|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
129465907|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
129465908|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
129465909|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
129465910|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
129465911|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
129465912|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
129465913|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
129465914|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
129465915|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
129465916|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
129465917|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
129465918|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
129465919|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
129465920|NCT01789970|466001961|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
129465921|NCT01789970|466001962|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
129465922|NCT01789970|466001963|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
129465923|NCT02217566|466001966|FG000|Overall Study|Lost to Follow-up|2|||
129465924|NCT02217566|466001966|FG000|Overall Study|Death|3|||
129465925|NCT02217566|466001966|FG000|Overall Study|Early study termination|6|||
129465926|NCT02296242|466001967|FG000|Overall Study|Death|1|||
129465927|NCT02296242|466001968|FG001|Overall Study|Death|1|||
129465928|NCT02296242|466001969|FG002|Overall Study|Death|1|||
129465929|NCT02296242|466001970|FG003|Overall Study|Death|1|||
129465930|NCT02296242|466001971|FG004|Overall Study|Death|1|||
129465931|NCT02296242|466001967|FG000|Overall Study|Withdrawal by Subject|0|||
129465932|NCT02296242|466001968|FG001|Overall Study|Withdrawal by Subject|0|||
129465933|NCT02296242|466001969|FG002|Overall Study|Withdrawal by Subject|1|||
129465934|NCT02296242|466001970|FG003|Overall Study|Withdrawal by Subject|1|||
129465935|NCT02296242|466001971|FG004|Overall Study|Withdrawal by Subject|3|||
129465936|NCT02296242|466001967|FG000|Overall Study|Disease Progression|1|||
129465937|NCT02296242|466001968|FG001|Overall Study|Disease Progression|3|||
129465938|NCT02296242|466001969|FG002|Overall Study|Disease Progression|2|||
129465939|NCT02296242|466001970|FG003|Overall Study|Disease Progression|8|||
129465940|NCT02296242|466001971|FG004|Overall Study|Disease Progression|11|||
129465941|NCT02296242|466001967|FG000|Overall Study|Unacceptable Toxicity|0|||
129465942|NCT02296242|466001968|FG001|Overall Study|Unacceptable Toxicity|0|||
129465943|NCT02296242|466001969|FG002|Overall Study|Unacceptable Toxicity|0|||
129465944|NCT02296242|466001970|FG003|Overall Study|Unacceptable Toxicity|0|||
129465945|NCT02296242|466001971|FG004|Overall Study|Unacceptable Toxicity|1|||
129465946|NCT02296242|466001967|FG000|Overall Study|Patient Condition Changed|0|||
129465947|NCT02296242|466001968|FG001|Overall Study|Patient Condition Changed|0|||
129465948|NCT02296242|466001969|FG002|Overall Study|Patient Condition Changed|2|||
129465949|NCT02296242|466001970|FG003|Overall Study|Patient Condition Changed|0|||
129465950|NCT02296242|466001971|FG004|Overall Study|Patient Condition Changed|1|||
129465951|NCT02296242|466001967|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
129465952|NCT02296242|466001968|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
129465953|NCT02296242|466001969|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
129465954|NCT02296242|466001970|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
129465955|NCT02296242|466001971|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
129465956|NCT02296242|466001967|FG000|Overall Study|Lost to Follow-up|1|||
129465957|NCT02296242|466001968|FG001|Overall Study|Lost to Follow-up|0|||
129465958|NCT02296242|466001969|FG002|Overall Study|Lost to Follow-up|0|||
129465959|NCT02296242|466001970|FG003|Overall Study|Lost to Follow-up|0|||
129465960|NCT02296242|466001971|FG004|Overall Study|Lost to Follow-up|0|||
129465961|NCT02296242|466001967|FG000|Overall Study|Need for Hydroxyurea|2|||
129465962|NCT02296242|466001968|FG001|Overall Study|Need for Hydroxyurea|0|||
129465963|NCT02296242|466001969|FG002|Overall Study|Need for Hydroxyurea|0|||
129465964|NCT02296242|466001970|FG003|Overall Study|Need for Hydroxyurea|0|||
129465965|NCT02296242|466001971|FG004|Overall Study|Need for Hydroxyurea|0|||
129465966|NCT02296242|466001967|FG000|Overall Study|Screened for Other Protocol|0|||
129465967|NCT02296242|466001968|FG001|Overall Study|Screened for Other Protocol|1|||
129465968|NCT02296242|466001969|FG002|Overall Study|Screened for Other Protocol|0|||
129465969|NCT02296242|466001970|FG003|Overall Study|Screened for Other Protocol|0|||
129465970|NCT02296242|466001971|FG004|Overall Study|Screened for Other Protocol|0|||
129465971|NCT02296242|466001967|FG000|Overall Study|Physician Decision|0|||
129465972|NCT02296242|466001968|FG001|Overall Study|Physician Decision|1|||
129465973|NCT02296242|466001969|FG002|Overall Study|Physician Decision|0|||
129465974|NCT02296242|466001970|FG003|Overall Study|Physician Decision|1|||
129465975|NCT02296242|466001971|FG004|Overall Study|Physician Decision|0|||
129465976|NCT02296242|466001967|FG000|Overall Study|Alternative Treatment|0|||
129465977|NCT02296242|466001968|FG001|Overall Study|Alternative Treatment|0|||
129465978|NCT02296242|466001969|FG002|Overall Study|Alternative Treatment|0|||
129465979|NCT02296242|466001970|FG003|Overall Study|Alternative Treatment|1|||
129465980|NCT02296242|466001971|FG004|Overall Study|Alternative Treatment|0|||
129465981|NCT02296242|466001967|FG000|Overall Study|Adverse Event|0|||
129465982|NCT02296242|466001968|FG001|Overall Study|Adverse Event|0|||
129465983|NCT02296242|466001969|FG002|Overall Study|Adverse Event|0|||
129465984|NCT02296242|466001970|FG003|Overall Study|Adverse Event|1|||
129465985|NCT02296242|466001971|FG004|Overall Study|Adverse Event|0|||
129465986|NCT02296242|466001967|FG000|Overall Study|Lack of Efficacy|0|||
129465987|NCT02296242|466001968|FG001|Overall Study|Lack of Efficacy|0|||
129465988|NCT02296242|466001969|FG002|Overall Study|Lack of Efficacy|0|||
129465989|NCT02296242|466001970|FG003|Overall Study|Lack of Efficacy|0|||
129465990|NCT02296242|466001971|FG004|Overall Study|Lack of Efficacy|3|||
129465991|NCT01639833|466001972|FG000|Overall Study|Death|4|||
129465992|NCT01639833|466001973|FG001|Overall Study|Death|2|||
129465993|NCT01639833|466001972|FG000|Overall Study|Withdrawal by Subject|2|||
129465994|NCT01639833|466001973|FG001|Overall Study|Withdrawal by Subject|2|||
129465995|NCT03033745|466001982|FG000|Overall Study|Protocol Violation|0|||
129465996|NCT03033745|466001983|FG001|Overall Study|Protocol Violation|0|||
129465997|NCT03033745|466001984|FG002|Overall Study|Protocol Violation|1|||
129465998|NCT03033745|466001982|FG000|Overall Study|Adverse Event|1|||
129465999|NCT03033745|466001983|FG001|Overall Study|Adverse Event|0|||
129466000|NCT03033745|466001984|FG002|Overall Study|Adverse Event|1|||
129466001|NCT03033745|466001982|FG000|Overall Study|Withdrawal by Subject|0|||
129466002|NCT03033745|466001983|FG001|Overall Study|Withdrawal by Subject|1|||
129466003|NCT03033745|466001984|FG002|Overall Study|Withdrawal by Subject|0|||
129466004|NCT00608985|466001985|FG000|Overall Study|Adverse Event|2|||
129466005|NCT00608985|466001986|FG001|Overall Study|Adverse Event|7|||
129466006|NCT00608985|466001987|FG002|Overall Study|Adverse Event|4|||
129466007|NCT00608985|466001988|FG003|Overall Study|Adverse Event|6|||
129466008|NCT00608985|466001985|FG000|Overall Study|Administrative/Other|7|||
129466009|NCT00608985|466001986|FG001|Overall Study|Administrative/Other|4|||
129466010|NCT00608985|466001987|FG002|Overall Study|Administrative/Other|1|||
129466011|NCT00608985|466001988|FG003|Overall Study|Administrative/Other|2|||
129466012|NCT00608985|466001985|FG000|Overall Study|Withdrawal of Consent|5|||
129466013|NCT00608985|466001986|FG001|Overall Study|Withdrawal of Consent|1|||
129466014|NCT00608985|466001987|FG002|Overall Study|Withdrawal of Consent|1|||
129466015|NCT00608985|466001988|FG003|Overall Study|Withdrawal of Consent|1|||
129466016|NCT00608985|466001985|FG000|Overall Study|Lost to Follow-up|2|||
129466017|NCT00608985|466001986|FG001|Overall Study|Lost to Follow-up|1|||
129466018|NCT00608985|466001987|FG002|Overall Study|Lost to Follow-up|0|||
129466019|NCT00608985|466001988|FG003|Overall Study|Lost to Follow-up|0|||
129466020|NCT02436876|466002000|FG000|Overall Study|Lost to Follow-up|0|||
129466021|NCT02436876|466002001|FG001|Overall Study|Lost to Follow-up|1|||
129466022|NCT02436876|466002002|FG002|Overall Study|Lost to Follow-up|1|||
129466023|NCT02436876|466002003|FG003|Overall Study|Lost to Follow-up|1|||
129466024|NCT02436876|466002000|FG000|Overall Study|Withdrawal by Subject|1|||
129466025|NCT02436876|466002001|FG001|Overall Study|Withdrawal by Subject|0|||
129466026|NCT02436876|466002002|FG002|Overall Study|Withdrawal by Subject|0|||
129466027|NCT02436876|466002003|FG003|Overall Study|Withdrawal by Subject|1|||
129466028|NCT02436876|466002000|FG000|Overall Study|Physician Decision|0|||
129466029|NCT02436876|466002001|FG001|Overall Study|Physician Decision|2|||
129466030|NCT02436876|466002002|FG002|Overall Study|Physician Decision|1|||
129466031|NCT02436876|466002003|FG003|Overall Study|Physician Decision|0|||
129466032|NCT02436876|466002000|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
129466033|NCT02436876|466002001|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
129466034|NCT02436876|466002002|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
129466035|NCT02436876|466002003|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
129466036|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
129466037|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
129466038|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
129466039|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
129466040|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129466041|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129466042|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
129971179|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
129466043|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129466044|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
129466045|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129466046|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129466047|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129466048|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
129466049|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
129466050|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
129466051|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
129466052|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
129466053|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
129466054|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
129466055|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
129466056|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
129466057|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
129466058|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
129466059|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
129466060|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
129466061|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
129466062|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
129466063|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
129466064|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
129466065|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
129466066|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
129466067|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
129466068|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
129466069|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
129466070|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
129466071|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
129466072|NCT03403205|466002005|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
129466073|NCT03403205|466002006|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
129466074|NCT03403205|466002007|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
129466075|NCT03403205|466002008|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
129466076|NCT03403205|466002009|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
129466077|NCT03403205|466002010|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
129466078|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
129466079|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
129466080|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
129466081|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
129466082|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
129466083|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
129466084|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
129466085|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
129466086|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
129466087|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
129466088|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
129466089|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
129466090|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Death|1|||
129466091|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Death|0|||
129466092|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Death|0|||
129466093|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Death|0|||
129466094|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Death|0|||
129466095|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Death|0|||
129466096|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
129466097|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
129466098|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
129466099|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
129466100|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
129466101|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
129466102|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
129466103|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
129466104|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
129466105|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
129466106|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
129466107|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
129466108|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
129466109|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
129466110|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
129466111|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
129466112|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
129466113|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
129466114|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
129466115|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
129466116|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
129466117|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
129466118|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
129466119|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
129466120|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
129466121|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
129466122|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
129466123|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
129466124|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
129466125|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
129466126|NCT03403205|466002005|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
129466127|NCT03403205|466002006|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
129466128|NCT03403205|466002007|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
129466129|NCT03403205|466002008|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
129466130|NCT03403205|466002009|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
129466131|NCT03403205|466002010|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
129466132|NCT01834729|466002011|FG000|Overall Study|Did not return bowel diaries|0|||
129466133|NCT01834729|466002012|FG001|Overall Study|Did not return bowel diaries|0|||
129466134|NCT01834729|466002013|FG002|Overall Study|Did not return bowel diaries|3|||
129466135|NCT01834729|466002014|FG003|Overall Study|Did not return bowel diaries|0|||
129466136|NCT01834729|466002011|FG000|Overall Study|Withdrawal by Subject|1|||
129466137|NCT01834729|466002012|FG001|Overall Study|Withdrawal by Subject|1|||
129466138|NCT01834729|466002013|FG002|Overall Study|Withdrawal by Subject|0|||
129466139|NCT01834729|466002014|FG003|Overall Study|Withdrawal by Subject|0|||
129466140|NCT01834729|466002011|FG000|Overall Study|Adverse Event|0|||
129466141|NCT01834729|466002012|FG001|Overall Study|Adverse Event|0|||
129466142|NCT01834729|466002013|FG002|Overall Study|Adverse Event|0|||
129466143|NCT01834729|466002014|FG003|Overall Study|Adverse Event|2|||
129466144|NCT02971670|466002015|FG000|Overall Study|Withdrawal by Subject|4|||
129466145|NCT02971670|466002016|FG001|Overall Study|Withdrawal by Subject|1|||
129466146|NCT02971670|466002017|FG002|Overall Study|Withdrawal by Subject|1|||
129466147|NCT02971670|466002018|FG003|Overall Study|Withdrawal by Subject|2|||
129466148|NCT00288080|466002019|FG000|Overall Study|Withdrawal by Subject|1|||
129466149|NCT00288080|466002020|FG001|Overall Study|Withdrawal by Subject|3|||
129466150|NCT00288080|466002019|FG000|Overall Study|Protocol Violation|25|||
129466151|NCT00288080|466002020|FG001|Overall Study|Protocol Violation|20|||
129466152|NCT02387580|466002024|FG000|Overall Study|Withdrawal by Subject|0|||
129466153|NCT02387580|466002025|FG001|Overall Study|Withdrawal by Subject|0|||
129466154|NCT02387580|466002026|FG002|Overall Study|Withdrawal by Subject|0|||
129466155|NCT02387580|466002027|FG003|Overall Study|Withdrawal by Subject|1|||
129466156|NCT02387580|466002028|FG004|Overall Study|Withdrawal by Subject|0|||
129466157|NCT02387580|466002029|FG005|Overall Study|Withdrawal by Subject|0|||
129466158|NCT02340663|466002031|FG000|Overall Study|Lost to Follow-up|1|||
129466159|NCT02340663|466002032|FG001|Overall Study|Lost to Follow-up|0|||
129466160|NCT02340663|466002031|FG000|Overall Study|Protocol Violation|1|||
129466161|NCT02340663|466002032|FG001|Overall Study|Protocol Violation|0|||
129466162|NCT02340663|466002031|FG000|Overall Study|Withdrawal by Subject|3|||
129466163|NCT02340663|466002032|FG001|Overall Study|Withdrawal by Subject|1|||
129466164|NCT02979431|466002033|FG000|Overall Study|Parent/guardian withdrew consent|2|||
129466165|NCT02979431|466002034|FG001|Overall Study|Parent/guardian withdrew consent|1|||
129466166|NCT02979431|466002035|FG002|Overall Study|Parent/guardian withdrew consent|1|||
129466167|NCT02979431|466002036|FG003|Overall Study|Parent/guardian withdrew consent|1|||
129466168|NCT02979431|466002033|FG000|Overall Study|Randomized but received no study drug|1|||
129466169|NCT02979431|466002034|FG001|Overall Study|Randomized but received no study drug|1|||
129466170|NCT02979431|466002035|FG002|Overall Study|Randomized but received no study drug|0|||
129466171|NCT02979431|466002036|FG003|Overall Study|Randomized but received no study drug|0|||
129466172|NCT02979431|466002033|FG000|Overall Study|Adverse Event|0|||
129466173|NCT02979431|466002034|FG001|Overall Study|Adverse Event|0|||
129466174|NCT02979431|466002035|FG002|Overall Study|Adverse Event|1|||
129466175|NCT02979431|466002036|FG003|Overall Study|Adverse Event|0|||
129466176|NCT02979431|466002033|FG000|Overall Study|Subject left country after Day14|1|||
129466177|NCT02979431|466002034|FG001|Overall Study|Subject left country after Day14|0|||
129466178|NCT02979431|466002035|FG002|Overall Study|Subject left country after Day14|0|||
129466179|NCT02979431|466002036|FG003|Overall Study|Subject left country after Day14|0|||
129466180|NCT01656434|466002037|FG000|Overall Study|Adverse Event|199|||
129466181|NCT01656434|466002038|FG001|Overall Study|Adverse Event|63|||
129466182|NCT01656434|466002037|FG000|Overall Study|Enrollment terminated at trial site|2|||
129466183|NCT01656434|466002038|FG001|Overall Study|Enrollment terminated at trial site|0|||
129466184|NCT01656434|466002037|FG000|Overall Study|Lost to Follow-up|309|||
129466185|NCT01656434|466002038|FG001|Overall Study|Lost to Follow-up|76|||
129466186|NCT01656434|466002037|FG000|Overall Study|Site discontinued study participation|24|||
129466187|NCT01656434|466002038|FG001|Overall Study|Site discontinued study participation|9|||
129466188|NCT01656434|466002037|FG000|Overall Study|Screen failure|2|||
129466189|NCT01656434|466002038|FG001|Overall Study|Screen failure|0|||
129466190|NCT01656434|466002037|FG000|Overall Study|Protocol Violation|7|||
129466191|NCT01656434|466002038|FG001|Overall Study|Protocol Violation|0|||
129466192|NCT01656434|466002037|FG000|Overall Study|Pregnancy wish|18|||
129466193|NCT01656434|466002038|FG001|Overall Study|Pregnancy wish|6|||
129466194|NCT01656434|466002037|FG000|Overall Study|Pregnancy|45|||
129466195|NCT01656434|466002038|FG001|Overall Study|Pregnancy|10|||
129466196|NCT01656434|466002037|FG000|Overall Study|Physician Decision|7|||
129466197|NCT01656434|466002038|FG001|Overall Study|Physician Decision|2|||
129466198|NCT01656434|466002037|FG000|Overall Study|Non-compliance with study drug|48|||
129466199|NCT01656434|466002038|FG001|Overall Study|Non-compliance with study drug|9|||
129466200|NCT01656434|466002037|FG000|Overall Study|Study terminated by sponsor|1501|||
129466201|NCT01656434|466002038|FG001|Overall Study|Study terminated by sponsor|348|||
129466202|NCT01656434|466002037|FG000|Overall Study|Participant discontinued; drug related|13|||
129466203|NCT01656434|466002038|FG001|Overall Study|Participant discontinued; drug related|4|||
129466204|NCT01656434|466002037|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
129466205|NCT01656434|466002038|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
129466206|NCT01656434|466002037|FG000|Overall Study|Non-compliance with protocol|39|||
129466207|NCT01656434|466002038|FG001|Overall Study|Non-compliance with protocol|15|||
129466208|NCT01656434|466002037|FG000|Overall Study|Participant moved|40|||
129466209|NCT01656434|466002038|FG001|Overall Study|Participant moved|12|||
129466210|NCT01656434|466002037|FG000|Overall Study|Participant withdrew consent|28|||
129466211|NCT01656434|466002038|FG001|Overall Study|Participant withdrew consent|9|||
129466212|NCT01656434|466002037|FG000|Overall Study|Withdrawal by Subject|64|||
129466213|NCT01656434|466002038|FG001|Overall Study|Withdrawal by Subject|7|||
129466214|NCT06098729|466002043|FG000|Overall Study|Withdrawal by Subject|1|||
129466215|NCT03033875|466002049|FG000|Overall Study|Withdrawal by Subject|5|||
129466216|NCT03033875|466002050|FG001|Overall Study|Withdrawal by Subject|9|||
129466217|NCT03033875|466002051|FG002|Overall Study|Withdrawal by Subject|4|||
129466218|NCT03033875|466002049|FG000|Overall Study|Other|14|||
129466219|NCT03033875|466002050|FG001|Overall Study|Other|15|||
129466220|NCT03033875|466002051|FG002|Overall Study|Other|8|||
129466221|NCT01972074|466002054|FG000|Overall Study|Adverse Event|4|||
129971180|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
129971181|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
129971182|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
129971183|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
129971184|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
129466222|NCT01972074|466002055|FG001|Overall Study|Adverse Event|1|||
129466223|NCT01972074|466002056|FG002|Overall Study|Adverse Event|0|||
129466224|NCT01972074|466002054|FG000|Overall Study|Lack of Efficacy|1|||
129466225|NCT01972074|466002055|FG001|Overall Study|Lack of Efficacy|1|||
129466226|NCT01972074|466002056|FG002|Overall Study|Lack of Efficacy|0|||
129466227|NCT01972074|466002054|FG000|Overall Study|Lost to Follow-up|0|||
129466228|NCT01972074|466002055|FG001|Overall Study|Lost to Follow-up|1|||
129466229|NCT01972074|466002056|FG002|Overall Study|Lost to Follow-up|1|||
129466230|NCT01972074|466002054|FG000|Overall Study|Withdrawal by Subject|1|||
129466231|NCT01972074|466002055|FG001|Overall Study|Withdrawal by Subject|1|||
129466232|NCT01972074|466002056|FG002|Overall Study|Withdrawal by Subject|1|||
129466233|NCT01972074|466002054|FG000|Overall Study|Scanner Unavailable|0|||
129466234|NCT01972074|466002055|FG001|Overall Study|Scanner Unavailable|0|||
129466235|NCT01972074|466002056|FG002|Overall Study|Scanner Unavailable|1|||
129466236|NCT05574062|466002057|FG000|Pre Run-In|Screening failure|3|||
129466237|NCT05574062|466002058|FG001|Pre Run-In|Screening failure|0|||
129466238|NCT05574062|466002059|FG002|Pre Run-In|Screening failure|0|||
129466239|NCT05574062|466002060|FG003|Pre Run-In|Screening failure|0|||
129466240|NCT05574062|466002061|FG004|Pre Run-In|Screening failure|0|||
129466241|NCT05574062|466002057|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
129466242|NCT05574062|466002058|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
129466243|NCT05574062|466002059|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
129971185|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
129971186|NCT00132678|467858421|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
129971187|NCT00132678|467858422|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
129466244|NCT05574062|466002060|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
129466245|NCT05574062|466002061|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
129466246|NCT05574062|466002057|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
129466247|NCT05574062|466002058|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
129466248|NCT05574062|466002059|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
129466249|NCT05574062|466002060|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
129466250|NCT05574062|466002061|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
129466251|NCT05574062|466002057|FG000|Continuation Phase Period 1|Physician Decision|1|||
129466252|NCT05574062|466002058|FG001|Continuation Phase Period 1|Physician Decision|0|||
129466253|NCT05574062|466002059|FG002|Continuation Phase Period 1|Physician Decision|0|||
129466254|NCT05574062|466002060|FG003|Continuation Phase Period 1|Physician Decision|0|||
129466255|NCT05574062|466002061|FG004|Continuation Phase Period 1|Physician Decision|0|||
129466256|NCT05574062|466002057|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
129466257|NCT05574062|466002058|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
129466258|NCT05574062|466002059|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
129466259|NCT05574062|466002060|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
129466260|NCT05574062|466002061|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
129466261|NCT05574062|466002057|FG000|Continuation Phase Period 1|Adverse Event|1|||
129466262|NCT05574062|466002058|FG001|Continuation Phase Period 1|Adverse Event|0|||
129466263|NCT05574062|466002059|FG002|Continuation Phase Period 1|Adverse Event|0|||
129466264|NCT05574062|466002060|FG003|Continuation Phase Period 1|Adverse Event|0|||
129466265|NCT05574062|466002061|FG004|Continuation Phase Period 1|Adverse Event|0|||
129466266|NCT05574062|466002057|FG000|Continuation Phase Period 1|Death|1|||
129466267|NCT05574062|466002058|FG001|Continuation Phase Period 1|Death|0|||
129466268|NCT05574062|466002059|FG002|Continuation Phase Period 1|Death|0|||
129466269|NCT05574062|466002060|FG003|Continuation Phase Period 1|Death|0|||
129466270|NCT05574062|466002061|FG004|Continuation Phase Period 1|Death|0|||
129466271|NCT05574062|466002057|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
129466272|NCT05574062|466002058|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
129466273|NCT05574062|466002059|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
129466274|NCT05574062|466002060|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
129466275|NCT05574062|466002061|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
129466276|NCT03864653|466002064|FG000|Overall Study|Withdrawal by Subject|1|||
129466277|NCT00546052|466002067|FG000|Overall Study|Adverse Event|47|||
129466278|NCT00546052|466002067|FG000|Overall Study|Lost to Follow-up|144|||
129466279|NCT00546052|466002067|FG000|Overall Study|Protocol Violation|9|||
129466280|NCT00546052|466002067|FG000|Overall Study|Withdrawal by Subject|20|||
129466281|NCT00546052|466002067|FG000|Overall Study|Non Compliance|7|||
129466282|NCT01928381|466002068|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
129466283|NCT01928381|466002069|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
129466284|NCT01928381|466002070|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
129466285|NCT01928381|466002071|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
129466286|NCT01928381|466002072|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
129466287|NCT01928381|466002073|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
129466288|NCT01928381|466002074|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
129466289|NCT01928381|466002068|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
129466290|NCT01928381|466002069|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
129466291|NCT01928381|466002070|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
129466292|NCT01928381|466002071|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
129466293|NCT01928381|466002072|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
129466294|NCT01928381|466002073|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
129466295|NCT01928381|466002074|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
129466296|NCT01928381|466002068|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
129466297|NCT01928381|466002069|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
129466298|NCT01928381|466002070|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
129466299|NCT01928381|466002071|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
129466300|NCT01928381|466002072|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
129466301|NCT01928381|466002073|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
129466302|NCT01928381|466002074|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
129466303|NCT01928381|466002068|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
129466304|NCT01928381|466002069|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
129466305|NCT01928381|466002070|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
129466306|NCT01928381|466002071|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
129466307|NCT01928381|466002072|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
129466308|NCT01928381|466002073|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
129466309|NCT01928381|466002074|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
129466310|NCT01928381|466002068|FG000|Part 1 - Pain Training|Protocol Violation|1|||
129466311|NCT01928381|466002069|FG001|Part 1 - Pain Training|Protocol Violation|0|||
129466312|NCT01928381|466002070|FG002|Part 1 - Pain Training|Protocol Violation|0|||
129466313|NCT01928381|466002071|FG003|Part 1 - Pain Training|Protocol Violation|0|||
129466314|NCT01928381|466002072|FG004|Part 1 - Pain Training|Protocol Violation|0|||
129466315|NCT01928381|466002073|FG005|Part 1 - Pain Training|Protocol Violation|0|||
129466316|NCT01928381|466002074|FG006|Part 1 - Pain Training|Protocol Violation|0|||
129466317|NCT01928381|466002068|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
129466318|NCT01928381|466002069|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
129466319|NCT01928381|466002070|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
129466320|NCT01928381|466002071|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
129466321|NCT01928381|466002072|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
129466322|NCT01928381|466002073|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
129466323|NCT01928381|466002074|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
129466324|NCT01928381|466002068|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
129466325|NCT01928381|466002069|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
129466326|NCT01928381|466002070|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
129466327|NCT01928381|466002071|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
129466328|NCT01928381|466002072|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
129466329|NCT01928381|466002073|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
129466330|NCT01928381|466002074|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
129466331|NCT01928381|466002068|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
129466332|NCT01928381|466002069|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
129466333|NCT01928381|466002070|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
129466334|NCT01928381|466002071|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
129466335|NCT01928381|466002072|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
129466336|NCT01928381|466002073|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
129466337|NCT01928381|466002074|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
129466338|NCT01928381|466002068|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
129466339|NCT01928381|466002069|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
129466340|NCT01928381|466002070|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
129466341|NCT01928381|466002071|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
129466342|NCT01928381|466002072|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
129466343|NCT01928381|466002073|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
129466344|NCT01928381|466002074|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
129466345|NCT01928381|466002068|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
129466346|NCT01928381|466002069|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
129466347|NCT01928381|466002070|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
129466348|NCT01928381|466002071|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
129466349|NCT01928381|466002072|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
129466350|NCT01928381|466002073|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
129466351|NCT01928381|466002074|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
129466352|NCT01928381|466002068|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
129466353|NCT01928381|466002069|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
129466354|NCT01928381|466002070|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
129466355|NCT01928381|466002071|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
129466356|NCT01928381|466002072|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
129466357|NCT01928381|466002073|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
129466358|NCT01928381|466002074|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
129466359|NCT01928381|466002068|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
129466360|NCT01928381|466002069|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
129466361|NCT01928381|466002070|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
129466362|NCT01928381|466002071|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
129466363|NCT01928381|466002072|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
129466364|NCT01928381|466002073|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
129466365|NCT01928381|466002074|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
129466366|NCT01928381|466002068|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
129466367|NCT01928381|466002069|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
129466368|NCT01928381|466002070|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
129466369|NCT01928381|466002071|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
129466370|NCT01928381|466002072|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
129466371|NCT01928381|466002073|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
129466372|NCT01928381|466002074|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
129466373|NCT01928381|466002068|FG000|Washout First Intervention|Protocol Violation|0|||
129466374|NCT01928381|466002069|FG001|Washout First Intervention|Protocol Violation|0|||
129466375|NCT01928381|466002070|FG002|Washout First Intervention|Protocol Violation|0|||
129466376|NCT01928381|466002071|FG003|Washout First Intervention|Protocol Violation|0|||
129466377|NCT01928381|466002072|FG004|Washout First Intervention|Protocol Violation|1|||
129466378|NCT01928381|466002073|FG005|Washout First Intervention|Protocol Violation|0|||
129466379|NCT01928381|466002074|FG006|Washout First Intervention|Protocol Violation|0|||
129466380|NCT01928381|466002068|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
129466381|NCT01928381|466002069|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
129466382|NCT01928381|466002070|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
129466383|NCT01928381|466002071|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
129466384|NCT01928381|466002072|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
129466385|NCT01928381|466002073|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
129466386|NCT01928381|466002074|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
129466387|NCT01928381|466002068|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
129466388|NCT01928381|466002069|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
129466389|NCT01928381|466002070|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
129466390|NCT01928381|466002071|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
129466391|NCT01928381|466002072|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
129466392|NCT01928381|466002073|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
129466393|NCT01928381|466002074|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
129466394|NCT03406897|466002075|FG000|Overall Study|Lost to Follow-up|1|||
129466395|NCT03406897|466002076|FG001|Overall Study|Lost to Follow-up|2|||
129466396|NCT03406897|466002075|FG000|Overall Study|Withdrawal by Subject|4|||
129466397|NCT03406897|466002076|FG001|Overall Study|Withdrawal by Subject|4|||
129466398|NCT03406897|466002075|FG000|Overall Study|Physician Decision|0|||
129466399|NCT03406897|466002076|FG001|Overall Study|Physician Decision|1|||
129466400|NCT04441905|466004041|FG000|Overall Study|Lost to Follow-up|1|||
129466401|NCT04441905|466004042|FG001|Overall Study|Lost to Follow-up|0|||
129466402|NCT04441905|466004043|FG002|Overall Study|Lost to Follow-up|0|||
129466403|NCT04441905|466004044|FG003|Overall Study|Lost to Follow-up|0|||
129466404|NCT04441905|466004045|FG004|Overall Study|Lost to Follow-up|0|||
129466405|NCT04441905|466004046|FG005|Overall Study|Lost to Follow-up|0|||
129466406|NCT04441905|466004041|FG000|Overall Study|Enrolled but treatment not administered|0|||
129466407|NCT04441905|466004042|FG001|Overall Study|Enrolled but treatment not administered|1|||
129466408|NCT04441905|466004043|FG002|Overall Study|Enrolled but treatment not administered|0|||
129466409|NCT04441905|466004044|FG003|Overall Study|Enrolled but treatment not administered|0|||
129466410|NCT04441905|466004045|FG004|Overall Study|Enrolled but treatment not administered|0|||
129466411|NCT04441905|466004046|FG005|Overall Study|Enrolled but treatment not administered|0|||
129466412|NCT04441905|466004041|FG000|Overall Study|Became ineligible after enrollment|0|||
129466413|NCT04441905|466004042|FG001|Overall Study|Became ineligible after enrollment|0|||
129466414|NCT04441905|466004043|FG002|Overall Study|Became ineligible after enrollment|0|||
129466415|NCT04441905|466004044|FG003|Overall Study|Became ineligible after enrollment|0|||
129466416|NCT04441905|466004045|FG004|Overall Study|Became ineligible after enrollment|1|||
129466417|NCT04441905|466004046|FG005|Overall Study|Became ineligible after enrollment|0|||
129466418|NCT04770753|466004047|FG000|Overall Study|Randomized, never treated|1|||
129466419|NCT04770753|466004048|FG001|Overall Study|Randomized, never treated|1|||
129466420|NCT04770753|466004047|FG000|Overall Study|Withdrawal by Subject|3|||
129466421|NCT04770753|466004048|FG001|Overall Study|Withdrawal by Subject|1|||
129466422|NCT04770753|466004047|FG000|Overall Study|Adverse Event|2|||
129466423|NCT04770753|466004048|FG001|Overall Study|Adverse Event|0|||
129466424|NCT04770753|466004047|FG000|Overall Study|Pregnancy|1|||
129466425|NCT04770753|466004048|FG001|Overall Study|Pregnancy|0|||
129466426|NCT04770753|466004047|FG000|Overall Study|Other un-specified|1|||
129466427|NCT04770753|466004048|FG001|Overall Study|Other un-specified|0|||
129466428|NCT02775851|466004049|FG000|Overall Study|Adverse Event|1|||
129466429|NCT02775851|466004050|FG001|Overall Study|Adverse Event|10|||
129466430|NCT02775851|466004049|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
129466431|NCT02775851|466004050|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
129466432|NCT02775851|466004049|FG000|Overall Study|Progression/Relapse|0|||
129466433|NCT02775851|466004050|FG001|Overall Study|Progression/Relapse|4|||
129466434|NCT02775851|466004049|FG000|Overall Study|Other - Not Protocol Specified|0|||
129466435|NCT02775851|466004050|FG001|Overall Study|Other - Not Protocol Specified|7|||
129466436|NCT02775851|466004049|FG000|Overall Study|Withdrawal by Subject|1|||
129466437|NCT02775851|466004050|FG001|Overall Study|Withdrawal by Subject|0|||
129466438|NCT00598975|466004053|FG000|Overall Study|Adverse Event|1|||
129466439|NCT00598975|466004054|FG001|Overall Study|Adverse Event|1|||
129466440|NCT00598975|466004053|FG000|Overall Study|Brain metastases|1|||
129466441|NCT00598975|466004054|FG001|Overall Study|Brain metastases|0|||
129466442|NCT00598975|466004053|FG000|Overall Study|Withdrawal by Subject|1|||
129466443|NCT00598975|466004054|FG001|Overall Study|Withdrawal by Subject|1|||
129466444|NCT00598975|466004053|FG000|Overall Study|Withdrawal of consent|0|||
129466445|NCT00598975|466004054|FG001|Overall Study|Withdrawal of consent|1|||
129466446|NCT00598975|466004053|FG000|Overall Study|Disease progression|8|||
129466447|NCT00598975|466004054|FG001|Overall Study|Disease progression|3|||
129466448|NCT00598975|466004053|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
129466449|NCT00598975|466004054|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
129466450|NCT01178138|466004055|FG000|Overall Study|Lost to Follow-up|8|||
129466451|NCT01178138|466004055|FG000|Overall Study|Withdrawal by Subject|7|||
129466452|NCT01178138|466004055|FG000|Overall Study|Physician Decision|8|||
129466453|NCT01934140|466004059|FG000|Persistence Phase (Year 6-10)|Other|24|||
129466454|NCT01934140|466004060|FG001|Persistence Phase (Year 6-10)|Other|6|||
129466455|NCT01934140|466004059|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
129466456|NCT01934140|466004060|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
129466457|NCT01934140|466004059|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
129466458|NCT01934140|466004060|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
129466459|NCT01934140|466004059|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
129466460|NCT01934140|466004060|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
129466461|NCT01934140|466004059|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
129466462|NCT01934140|466004060|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
129466463|NCT01934140|466004059|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
129466464|NCT01934140|466004060|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
129466465|NCT01934140|466004059|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
129466466|NCT01934140|466004060|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
129466467|NCT01934140|466004059|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
129466468|NCT01934140|466004060|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
129466469|NCT00618748|466004066|FG000|Overall Study|Adverse Event|4|||
129466470|NCT00618748|466004067|FG001|Overall Study|Adverse Event|3|||
129466471|NCT00618748|466004068|FG002|Overall Study|Adverse Event|8|||
129466472|NCT00618748|466004066|FG000|Overall Study|Physician Decision|3|||
129466473|NCT00618748|466004067|FG001|Overall Study|Physician Decision|1|||
129466474|NCT00618748|466004068|FG002|Overall Study|Physician Decision|1|||
129466475|NCT00618748|466004066|FG000|Overall Study|Withdrawal by Subject|4|||
129466476|NCT00618748|466004067|FG001|Overall Study|Withdrawal by Subject|1|||
129466477|NCT00618748|466004068|FG002|Overall Study|Withdrawal by Subject|5|||
129466478|NCT02595879|466004069|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
129466479|NCT02595879|466004070|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
129466480|NCT04294459|466004071|FG000|Overall Study|Adverse Event|0|||
129466481|NCT04294459|466004072|FG001|Overall Study|Adverse Event|1|||
129466482|NCT01534676|466004073|FG000|Overall Study|Study closed due to poor enrollment|2|||
129466483|NCT01534676|466004074|FG001|Overall Study|Study closed due to poor enrollment|1|||
129466484|NCT02908880|466004076|FG000|Overall Study|Lost to Follow-up|4|||
129466485|NCT02908880|466004076|FG000|Overall Study|Explantation of the device|1|||
129466486|NCT02908880|466004076|FG000|Overall Study|Withdrawal by Subject|17|||
129466487|NCT02908880|466004076|FG000|Overall Study|Death|5|||
129466488|NCT02421887|466004077|FG000|Overall Study|Lost to Follow-up|5|||
129466489|NCT02421887|466004078|FG001|Overall Study|Lost to Follow-up|0|||
129466490|NCT02421887|466004077|FG000|Overall Study|Withdrawal by Subject|8|||
129466491|NCT02421887|466004078|FG001|Overall Study|Withdrawal by Subject|5|||
129466492|NCT02421887|466004077|FG000|Overall Study|Physician Decision|2|||
129466493|NCT02421887|466004078|FG001|Overall Study|Physician Decision|4|||
129466494|NCT02421887|466004077|FG000|Overall Study|Adverse Event|2|||
129466495|NCT02421887|466004078|FG001|Overall Study|Adverse Event|0|||
129466496|NCT03946670|466004084|FG000|Overall Study|Progressive Disease|26|||
129466497|NCT03946670|466004085|FG001|Overall Study|Progressive Disease|23|||
129466498|NCT03946670|466004084|FG000|Overall Study|Adverse Event|7|||
129466499|NCT03946670|466004085|FG001|Overall Study|Adverse Event|9|||
129466500|NCT03946670|466004084|FG000|Overall Study|Death|5|||
129466501|NCT03946670|466004085|FG001|Overall Study|Death|6|||
129466502|NCT03946670|466004084|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
129466503|NCT03946670|466004085|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
129466504|NCT03946670|466004084|FG000|Overall Study|Subject Decision|4|||
129466505|NCT03946670|466004085|FG001|Overall Study|Subject Decision|4|||
129466506|NCT03946670|466004084|FG000|Overall Study|Physician Decision|3|||
129466507|NCT03946670|466004085|FG001|Overall Study|Physician Decision|3|||
129466508|NCT03946670|466004084|FG000|Overall Study|New Therapy for Study Indication|1|||
129466509|NCT03946670|466004085|FG001|Overall Study|New Therapy for Study Indication|0|||
129466510|NCT03946670|466004084|FG000|Overall Study|Not treated|1|||
129466511|NCT03946670|466004085|FG001|Overall Study|Not treated|1|||
129466512|NCT03083886|466004086|FG000|Overall Study|Withdrawal by Subject|51|||
129466513|NCT03083886|466004087|FG001|Overall Study|Withdrawal by Subject|73|||
129466514|NCT03083886|466004088|FG002|Overall Study|Withdrawal by Subject|104|||
129466515|NCT03083886|466004086|FG000|Overall Study|Missing Baseline data|43|||
129466516|NCT03083886|466004087|FG001|Overall Study|Missing Baseline data|42|||
129466517|NCT03083886|466004088|FG002|Overall Study|Missing Baseline data|31|||
129466518|NCT03083886|466004086|FG000|Overall Study|Investigator terminated|1|||
129466519|NCT03083886|466004087|FG001|Overall Study|Investigator terminated|6|||
129466520|NCT03083886|466004088|FG002|Overall Study|Investigator terminated|3|||
129466521|NCT04161495|466004089|FG000|Overall Study|Withdrawal by Subject|3|||
129466522|NCT04161495|466004090|FG001|Overall Study|Withdrawal by Subject|0|||
129466523|NCT04161495|466004089|FG000|Overall Study|Protocol Violation|1|||
129466524|NCT04161495|466004090|FG001|Overall Study|Protocol Violation|0|||
129466525|NCT04161495|466004089|FG000|Overall Study|Prohibited concomitant medication|3|||
129466526|NCT04161495|466004090|FG001|Overall Study|Prohibited concomitant medication|0|||
129466527|NCT04161495|466004089|FG000|Overall Study|Adverse Event|1|||
129466528|NCT04161495|466004090|FG001|Overall Study|Adverse Event|0|||
129466529|NCT04161495|466004089|FG000|Overall Study|Other - Unspecified|1|||
129466530|NCT04161495|466004090|FG001|Overall Study|Other - Unspecified|0|||
129466531|NCT04161495|466004089|FG000|Overall Study|Death|0|||
129466532|NCT04161495|466004090|FG001|Overall Study|Death|1|||
129466533|NCT03655756|466004091|FG000|Overall Study|Death|1|||
129466534|NCT02062658|466004092|FG000|Overall Study|Withdrawal by Subject|1|||
129466535|NCT02062658|466004092|FG000|Overall Study|Lack of Efficacy|1|||
129466536|NCT02161562|466004093|FG000|Overall Study|Withdrawal by Subject|5|||
129466537|NCT02161562|466004094|FG001|Overall Study|Withdrawal by Subject|8|||
129466538|NCT02161562|466004093|FG000|Overall Study|Protocol Violation|9|||
129466539|NCT02161562|466004094|FG001|Overall Study|Protocol Violation|4|||
129466540|NCT02161562|466004093|FG000|Overall Study|Pregnancy|1|||
129466541|NCT02161562|466004094|FG001|Overall Study|Pregnancy|2|||
129466542|NCT02161562|466004093|FG000|Overall Study|Lost to Follow-up|3|||
129466543|NCT02161562|466004094|FG001|Overall Study|Lost to Follow-up|1|||
129466544|NCT02161562|466004093|FG000|Overall Study|Lack of Efficacy|4|||
129466545|NCT02161562|466004094|FG001|Overall Study|Lack of Efficacy|1|||
129466546|NCT02161562|466004093|FG000|Overall Study|Adverse Event|1|||
129466547|NCT02161562|466004094|FG001|Overall Study|Adverse Event|1|||
129466548|NCT02161562|466004093|FG000|Overall Study|Participant moved back to home country|1|||
129466549|NCT02161562|466004094|FG001|Overall Study|Participant moved back to home country|0|||
129466550|NCT02161562|466004093|FG000|Overall Study|Withdrew due to being out of the country|1|||
129466551|NCT02161562|466004094|FG001|Overall Study|Withdrew due to being out of the country|0|||
129466552|NCT02161562|466004093|FG000|Overall Study|Participant moved out of province|1|||
129466553|NCT02161562|466004094|FG001|Overall Study|Participant moved out of province|0|||
129466554|NCT02475655|466004095|FG000|Overall Study|Lost to Follow-up|0|||
129466555|NCT02475655|466004096|FG001|Overall Study|Lost to Follow-up|1|||
129466556|NCT00643994|466004098|FG000|Overall Study|Death|24|||
129466557|NCT00643994|466004098|FG000|Overall Study|Lost to Follow-up|72|||
129466558|NCT02450578|466004115|FG000|Overall Study|ECG abnormality so not treated|1|||
129466559|NCT02450578|466004116|FG001|Overall Study|ECG abnormality so not treated|0|||
129466560|NCT02450578|466004117|FG002|Overall Study|ECG abnormality so not treated|0|||
129466561|NCT02450578|466004118|FG003|Overall Study|ECG abnormality so not treated|0|||
129466562|NCT00441545|466004119|FG000|First Intervention|Adverse Event|6|||
129466563|NCT00441545|466004120|FG001|First Intervention|Adverse Event|5|||
129466564|NCT00441545|466004119|FG000|First Intervention|Protocol Violation|2|||
129466565|NCT00441545|466004120|FG001|First Intervention|Protocol Violation|2|||
129466566|NCT00441545|466004119|FG000|First Intervention|Withdrawal by Subject|3|||
129466567|NCT00441545|466004120|FG001|First Intervention|Withdrawal by Subject|3|||
129466568|NCT00441545|466004119|FG000|First Intervention|Kidney transplant|1|||
129466569|NCT00441545|466004120|FG001|First Intervention|Kidney transplant|1|||
129466570|NCT00441545|466004119|FG000|First Intervention|Lack of Efficacy|2|||
129466571|NCT00441545|466004120|FG001|First Intervention|Lack of Efficacy|0|||
129466572|NCT00441545|466004119|FG000|First Intervention|Subject exceeded safety criteria|0|||
129466573|NCT00441545|466004120|FG001|First Intervention|Subject exceeded safety criteria|1|||
129466574|NCT00441545|466004119|FG000|First Intervention|Subject met an exclusionary criteria|1|||
129466575|NCT00441545|466004120|FG001|First Intervention|Subject met an exclusionary criteria|0|||
129466576|NCT00441545|466004119|FG000|First Intervention|Extended hospitalization|1|||
129466577|NCT00441545|466004120|FG001|First Intervention|Extended hospitalization|0|||
129466578|NCT00441545|466004119|FG000|First Intervention|Site error|1|||
129466579|NCT00441545|466004120|FG001|First Intervention|Site error|0|||
129466580|NCT00441545|466004119|FG000|First Intervention|Sponsor's request|1|||
129466581|NCT00441545|466004120|FG001|First Intervention|Sponsor's request|0|||
129466582|NCT00441545|466004119|FG000|Second Intervention|Adverse Event|5|||
129466583|NCT00441545|466004120|FG001|Second Intervention|Adverse Event|2|||
129466584|NCT00441545|466004119|FG000|Second Intervention|Protocol Violation|4|||
129466585|NCT00441545|466004120|FG001|Second Intervention|Protocol Violation|1|||
129466586|NCT00441545|466004119|FG000|Second Intervention|Withdrawal by Subject|1|||
129466587|NCT00441545|466004120|FG001|Second Intervention|Withdrawal by Subject|1|||
129466588|NCT00441545|466004119|FG000|Second Intervention|Kidney Transplant|1|||
129466589|NCT00441545|466004120|FG001|Second Intervention|Kidney Transplant|1|||
129466590|NCT00441545|466004119|FG000|Second Intervention|Lack of Efficacy|0|||
129466591|NCT00441545|466004120|FG001|Second Intervention|Lack of Efficacy|1|||
129466592|NCT00441545|466004119|FG000|Second Intervention|Subject exceeded safety criteria|1|||
129466593|NCT00441545|466004120|FG001|Second Intervention|Subject exceeded safety criteria|0|||
129466594|NCT00441545|466004119|FG000|Second Intervention|Subject moved|0|||
129466595|NCT00441545|466004120|FG001|Second Intervention|Subject moved|1|||
129466596|NCT02347176|466004121|FG000|Overall Study|Lost to Follow-up|2|||
129466597|NCT02347176|466004122|FG001|Overall Study|Lost to Follow-up|3|||
129466598|NCT02347176|466004123|FG002|Overall Study|Lost to Follow-up|1|||
129466599|NCT02347176|466004124|FG003|Overall Study|Lost to Follow-up|1|||
129466600|NCT02347176|466004121|FG000|Overall Study|Withdrawal by Subject|9|||
129466601|NCT02347176|466004122|FG001|Overall Study|Withdrawal by Subject|5|||
129466602|NCT02347176|466004123|FG002|Overall Study|Withdrawal by Subject|5|||
129466603|NCT02347176|466004124|FG003|Overall Study|Withdrawal by Subject|3|||
129466604|NCT02347176|466004121|FG000|Overall Study|Other|1|||
129466605|NCT02347176|466004122|FG001|Overall Study|Other|2|||
129466606|NCT02347176|466004123|FG002|Overall Study|Other|2|||
129466607|NCT02347176|466004124|FG003|Overall Study|Other|0|||
129466608|NCT02474082|466004125|FG000|Overall Study|Adverse Event|2|||
129466609|NCT02474082|466004126|FG001|Overall Study|Adverse Event|32|||
129466610|NCT02474082|466004125|FG000|Overall Study|Withdrawal of informed consent|1|||
129466611|NCT02474082|466004126|FG001|Overall Study|Withdrawal of informed consent|11|||
129466612|NCT02474082|466004125|FG000|Overall Study|Lost to Follow-up|2|||
129466613|NCT02474082|466004126|FG001|Overall Study|Lost to Follow-up|2|||
129466614|NCT02474082|466004125|FG000|Overall Study|Dose tapering not achieved|0|||
129466615|NCT02474082|466004126|FG001|Overall Study|Dose tapering not achieved|4|||
129466616|NCT02474082|466004125|FG000|Overall Study|Participant/guardian decision|1|||
129466617|NCT02474082|466004126|FG001|Overall Study|Participant/guardian decision|2|||
129466618|NCT02474082|466004125|FG000|Overall Study|Non-compliance with study treatment|0|||
129466619|NCT02474082|466004126|FG001|Overall Study|Non-compliance with study treatment|2|||
129466620|NCT02474082|466004125|FG000|Overall Study|Protocol deviation|0|||
129466621|NCT02474082|466004126|FG001|Overall Study|Protocol deviation|1|||
129466622|NCT01127165|466004133|FG000|Overall Study|Adverse Event|2|||
129466623|NCT01127165|466004134|FG001|Overall Study|Adverse Event|2|||
129466624|NCT01127165|466004133|FG000|Overall Study|Lack of Efficacy|10|||
129466625|NCT01127165|466004134|FG001|Overall Study|Lack of Efficacy|8|||
129466626|NCT01127165|466004133|FG000|Overall Study|Lost to Follow-up|3|||
129466627|NCT01127165|466004134|FG001|Overall Study|Lost to Follow-up|5|||
129466628|NCT01127165|466004133|FG000|Overall Study|Withdrawal by Subject|1|||
129466629|NCT01127165|466004134|FG001|Overall Study|Withdrawal by Subject|3|||
129466630|NCT01127165|466004133|FG000|Overall Study|Protocol Violation|0|||
129466631|NCT01127165|466004134|FG001|Overall Study|Protocol Violation|1|||
129466632|NCT01064167|466004135|FG000|Overall Study|Protocol Violation|14|||
129466633|NCT01064167|466004136|FG001|Overall Study|Protocol Violation|15|||
129466634|NCT00725075|466004137|FG000|Overall Study|Use of Excluded Medication|0|||
129466635|NCT00725075|466004138|FG001|Overall Study|Use of Excluded Medication|1|||
129466636|NCT00725075|466004139|FG002|Overall Study|Use of Excluded Medication|0|||
129466637|NCT00725075|466004137|FG000|Overall Study|Protocol Violation|0|||
129466638|NCT00725075|466004138|FG001|Overall Study|Protocol Violation|0|||
129466639|NCT00725075|466004139|FG002|Overall Study|Protocol Violation|1|||
129466640|NCT00725075|466004137|FG000|Overall Study|Lost to Follow-up|1|||
129466641|NCT00725075|466004138|FG001|Overall Study|Lost to Follow-up|0|||
129466642|NCT00725075|466004139|FG002|Overall Study|Lost to Follow-up|0|||
129466643|NCT00725075|466004137|FG000|Overall Study|Withdrawal by Subject|4|||
129466644|NCT00725075|466004138|FG001|Overall Study|Withdrawal by Subject|5|||
129466645|NCT00725075|466004139|FG002|Overall Study|Withdrawal by Subject|4|||
129466646|NCT00725075|466004137|FG000|Overall Study|Adverse Event|2|||
129466647|NCT00725075|466004138|FG001|Overall Study|Adverse Event|1|||
129466648|NCT00725075|466004139|FG002|Overall Study|Adverse Event|1|||
129466649|NCT00725075|466004137|FG000|Overall Study|Worsening of Disease|2|||
129466650|NCT00725075|466004138|FG001|Overall Study|Worsening of Disease|1|||
129466651|NCT00725075|466004139|FG002|Overall Study|Worsening of Disease|2|||
129466652|NCT00725075|466004137|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
129466653|NCT00725075|466004138|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
129466654|NCT00725075|466004139|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
129466655|NCT00725075|466004137|FG000|Overall Study|Other|1|||
129466656|NCT00725075|466004138|FG001|Overall Study|Other|0|||
129466657|NCT00725075|466004139|FG002|Overall Study|Other|0|||
129466658|NCT03984305|466004140|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
129466659|NCT03984305|466004141|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
129466660|NCT03984305|466004140|FG000|Overall Study|Withdrawal by Subject|3|||
129466661|NCT03984305|466004141|FG001|Overall Study|Withdrawal by Subject|3|||
129466662|NCT03984305|466004140|FG000|Overall Study|Lost to Follow-up|1|||
129466663|NCT03984305|466004141|FG001|Overall Study|Lost to Follow-up|0|||
129466664|NCT00087646|466004142|FG000|Overall Study|Adverse Event|37|||
129466665|NCT00087646|466004143|FG001|Overall Study|Adverse Event|6|||
129466666|NCT00087646|466004144|FG002|Overall Study|Adverse Event|18|||
129466667|NCT00087646|466004145|FG003|Overall Study|Adverse Event|20|||
129466668|NCT00087646|466004142|FG000|Overall Study|Death|0|||
129466669|NCT00087646|466004143|FG001|Overall Study|Death|1|||
129466670|NCT00087646|466004144|FG002|Overall Study|Death|0|||
129466671|NCT00087646|466004145|FG003|Overall Study|Death|0|||
129466672|NCT00087646|466004142|FG000|Overall Study|Withdrawal by Subject|6|||
129466673|NCT00087646|466004143|FG001|Overall Study|Withdrawal by Subject|1|||
129466674|NCT00087646|466004144|FG002|Overall Study|Withdrawal by Subject|2|||
129466675|NCT00087646|466004145|FG003|Overall Study|Withdrawal by Subject|2|||
129466676|NCT00087646|466004142|FG000|Overall Study|Insufficient therapeutic response|64|||
129466677|NCT00087646|466004143|FG001|Overall Study|Insufficient therapeutic response|24|||
129466678|NCT00087646|466004144|FG002|Overall Study|Insufficient therapeutic response|38|||
129466679|NCT00087646|466004145|FG003|Overall Study|Insufficient therapeutic response|51|||
129466680|NCT00087646|466004142|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
129466681|NCT00087646|466004143|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
129466682|NCT00087646|466004144|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
129466683|NCT00087646|466004145|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
129466684|NCT00087646|466004142|FG000|Overall Study|Failure to Return|5|||
129466685|NCT00087646|466004143|FG001|Overall Study|Failure to Return|2|||
129466686|NCT00087646|466004144|FG002|Overall Study|Failure to Return|2|||
129466687|NCT00087646|466004145|FG003|Overall Study|Failure to Return|3|||
129466688|NCT00087646|466004142|FG000|Overall Study|Administrative/Other|6|||
129466689|NCT00087646|466004143|FG001|Overall Study|Administrative/Other|1|||
129466690|NCT00087646|466004144|FG002|Overall Study|Administrative/Other|1|||
129466691|NCT00087646|466004145|FG003|Overall Study|Administrative/Other|2|||
129466692|NCT00087646|466004142|FG000|Overall Study|Other Protocol Violation|3|||
129466693|NCT00087646|466004143|FG001|Overall Study|Other Protocol Violation|1|||
129466694|NCT00087646|466004144|FG002|Overall Study|Other Protocol Violation|0|||
129466695|NCT00087646|466004145|FG003|Overall Study|Other Protocol Violation|0|||
129466696|NCT00087646|466004142|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
129466697|NCT00087646|466004143|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
129466698|NCT00087646|466004144|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
129466699|NCT00087646|466004145|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
129466700|NCT01235962|466004146|FG000|Overall Study|Withdrawal by Subject|20|||
129466701|NCT01235962|466004147|FG001|Overall Study|Withdrawal by Subject|19|||
129466702|NCT01235962|466004148|FG002|Overall Study|Withdrawal by Subject|62|||
129466703|NCT01235962|466004149|FG003|Overall Study|Withdrawal by Subject|49|||
129466704|NCT01235962|466004146|FG000|Overall Study|Lost to Follow-up|21|||
129466705|NCT01235962|466004147|FG001|Overall Study|Lost to Follow-up|16|||
129466706|NCT01235962|466004148|FG002|Overall Study|Lost to Follow-up|47|||
129466707|NCT01235962|466004149|FG003|Overall Study|Lost to Follow-up|32|||
129466708|NCT01235962|466004146|FG000|Overall Study|Physician Decision|5|||
129466709|NCT01235962|466004147|FG001|Overall Study|Physician Decision|0|||
129466710|NCT01235962|466004148|FG002|Overall Study|Physician Decision|9|||
129466711|NCT01235962|466004149|FG003|Overall Study|Physician Decision|5|||
129466712|NCT01580397|466004150|FG000|Overall Study|Lack of Efficacy|14|||
129466713|NCT02902120|466004152|FG000|Overall Study|Lack of Efficacy|1|||
129466714|NCT02004873|466004153|FG000|Overall Study|Implant unsuccessful|6|||
129466715|NCT02004873|466004153|FG000|Overall Study|Awaiting 6-month visit|390|||
129466716|NCT02004873|466004153|FG000|Overall Study|Missed 6-month visit|4|||
129466717|NCT02004873|466004153|FG000|Overall Study|Death|23|||
129466718|NCT02004873|466004153|FG000|Overall Study|Withdrawal by Subject|1|||
129466719|NCT01353703|466004154|FG000|Overall Study|Migrated/moved from study area|1|||
129466720|NCT01353703|466004155|FG001|Overall Study|Migrated/moved from study area|0|||
129466721|NCT04925752|466004173|FG000|Overall Study|Still on Study|1826|||
129466722|NCT04925752|466004174|FG001|Overall Study|Still on Study|926|||
129466723|NCT04925752|466004173|FG000|Overall Study|Withdrew Consent|128|||
129466724|NCT04925752|466004174|FG001|Overall Study|Withdrew Consent|59|||
129466725|NCT04925752|466004173|FG000|Overall Study|Lost to Follow-up|73|||
129466726|NCT04925752|466004174|FG001|Overall Study|Lost to Follow-up|47|||
129466727|NCT04925752|466004173|FG000|Overall Study|Randomized but Never Treated|12|||
129466728|NCT04925752|466004174|FG001|Overall Study|Randomized but Never Treated|9|||
129466729|NCT04925752|466004173|FG000|Overall Study|Hiv-1 Infection|6|||
129466730|NCT04925752|466004174|FG001|Overall Study|Hiv-1 Infection|7|||
129466731|NCT04925752|466004173|FG000|Overall Study|Investigator's discretion|8|||
129466732|NCT04925752|466004174|FG001|Overall Study|Investigator's discretion|5|||
129466733|NCT04925752|466004173|FG000|Overall Study|Non-compliance with Study Drug|8|||
129466734|NCT04925752|466004174|FG001|Overall Study|Non-compliance with Study Drug|5|||
129466735|NCT04925752|466004173|FG000|Overall Study|Adverse Event|5|||
129466736|NCT04925752|466004174|FG001|Overall Study|Adverse Event|2|||
129466737|NCT04925752|466004173|FG000|Overall Study|Death|4|||
129466738|NCT04925752|466004174|FG001|Overall Study|Death|2|||
129466739|NCT04925752|466004173|FG000|Overall Study|Protocol Violation|1|||
129466740|NCT04925752|466004174|FG001|Overall Study|Protocol Violation|3|||
129466741|NCT04925752|466004173|FG000|Overall Study|Withdrew Assent|1|||
129466742|NCT04925752|466004174|FG001|Overall Study|Withdrew Assent|0|||
129466743|NCT03467958|466004175|FG000|Overall Study|Adverse Event|20|||
129466744|NCT03467958|466004176|FG001|Overall Study|Adverse Event|32|||
129466745|NCT03467958|466004177|FG002|Overall Study|Adverse Event|5|||
129466746|NCT03467958|466004178|FG003|Overall Study|Adverse Event|3|||
129466747|NCT03467958|466004179|FG004|Overall Study|Adverse Event|3|||
129466748|NCT03467958|466004180|FG005|Overall Study|Adverse Event|3|||
129466749|NCT03467958|466004181|FG006|Overall Study|Adverse Event|6|||
129466750|NCT03467958|466004182|FG007|Overall Study|Adverse Event|5|||
129466751|NCT03467958|466004183|FG008|Overall Study|Adverse Event|0|||
129466752|NCT03467958|466004175|FG000|Overall Study|Lack of Efficacy|59|||
129466753|NCT03467958|466004176|FG001|Overall Study|Lack of Efficacy|120|||
129466754|NCT03467958|466004177|FG002|Overall Study|Lack of Efficacy|6|||
129466755|NCT03467958|466004178|FG003|Overall Study|Lack of Efficacy|9|||
129466756|NCT03467958|466004179|FG004|Overall Study|Lack of Efficacy|8|||
129466757|NCT03467958|466004180|FG005|Overall Study|Lack of Efficacy|9|||
129466758|NCT03467958|466004181|FG006|Overall Study|Lack of Efficacy|11|||
129466759|NCT03467958|466004182|FG007|Overall Study|Lack of Efficacy|9|||
129466760|NCT03467958|466004183|FG008|Overall Study|Lack of Efficacy|3|||
129466761|NCT03467958|466004175|FG000|Overall Study|Lost to Follow-up|1|||
129466762|NCT03467958|466004176|FG001|Overall Study|Lost to Follow-up|2|||
129466763|NCT03467958|466004177|FG002|Overall Study|Lost to Follow-up|1|||
129466764|NCT03467958|466004178|FG003|Overall Study|Lost to Follow-up|0|||
129466765|NCT03467958|466004179|FG004|Overall Study|Lost to Follow-up|4|||
129466766|NCT03467958|466004180|FG005|Overall Study|Lost to Follow-up|0|||
129466767|NCT03467958|466004181|FG006|Overall Study|Lost to Follow-up|0|||
129466768|NCT03467958|466004182|FG007|Overall Study|Lost to Follow-up|0|||
129466769|NCT03467958|466004183|FG008|Overall Study|Lost to Follow-up|0|||
129466770|NCT03467958|466004175|FG000|Overall Study|Other reasons|8|||
129466771|NCT03467958|466004176|FG001|Overall Study|Other reasons|14|||
129466772|NCT03467958|466004177|FG002|Overall Study|Other reasons|2|||
129466773|NCT03467958|466004178|FG003|Overall Study|Other reasons|1|||
129466774|NCT03467958|466004179|FG004|Overall Study|Other reasons|4|||
129466775|NCT03467958|466004180|FG005|Overall Study|Other reasons|0|||
129466776|NCT03467958|466004181|FG006|Overall Study|Other reasons|1|||
129466777|NCT03467958|466004182|FG007|Overall Study|Other reasons|0|||
129466778|NCT03467958|466004183|FG008|Overall Study|Other reasons|1|||
129466779|NCT03467958|466004175|FG000|Overall Study|Pregnancy|1|||
129466780|NCT03467958|466004176|FG001|Overall Study|Pregnancy|0|||
129466781|NCT03467958|466004177|FG002|Overall Study|Pregnancy|0|||
129466782|NCT03467958|466004178|FG003|Overall Study|Pregnancy|0|||
129466783|NCT03467958|466004179|FG004|Overall Study|Pregnancy|0|||
129466784|NCT03467958|466004180|FG005|Overall Study|Pregnancy|1|||
129466785|NCT03467958|466004181|FG006|Overall Study|Pregnancy|0|||
129466786|NCT03467958|466004182|FG007|Overall Study|Pregnancy|0|||
129466787|NCT03467958|466004183|FG008|Overall Study|Pregnancy|0|||
129466788|NCT03467958|466004175|FG000|Overall Study|Study terminated by sponsor|65|||
129466789|NCT03467958|466004176|FG001|Overall Study|Study terminated by sponsor|117|||
129466790|NCT03467958|466004177|FG002|Overall Study|Study terminated by sponsor|45|||
129466791|NCT03467958|466004178|FG003|Overall Study|Study terminated by sponsor|64|||
129466792|NCT03467958|466004179|FG004|Overall Study|Study terminated by sponsor|66|||
129466793|NCT03467958|466004180|FG005|Overall Study|Study terminated by sponsor|17|||
129466794|NCT03467958|466004181|FG006|Overall Study|Study terminated by sponsor|11|||
129466795|NCT03467958|466004182|FG007|Overall Study|Study terminated by sponsor|5|||
129466796|NCT03467958|466004183|FG008|Overall Study|Study terminated by sponsor|5|||
129466797|NCT03467958|466004175|FG000|Overall Study|Withdrawal by Subject|25|||
129466798|NCT03467958|466004176|FG001|Overall Study|Withdrawal by Subject|44|||
129466799|NCT03467958|466004177|FG002|Overall Study|Withdrawal by Subject|7|||
129466800|NCT03467958|466004178|FG003|Overall Study|Withdrawal by Subject|8|||
129466801|NCT03467958|466004179|FG004|Overall Study|Withdrawal by Subject|6|||
129466802|NCT03467958|466004180|FG005|Overall Study|Withdrawal by Subject|8|||
129466803|NCT03467958|466004181|FG006|Overall Study|Withdrawal by Subject|4|||
129466804|NCT03467958|466004182|FG007|Overall Study|Withdrawal by Subject|1|||
129466805|NCT03467958|466004183|FG008|Overall Study|Withdrawal by Subject|4|||
129466806|NCT02925156|466004185|FG000|Overall Study|Lost to Follow-up|27|||
129466807|NCT02925156|466004186|FG001|Overall Study|Lost to Follow-up|53|||
129466808|NCT02925156|466004187|FG002|Overall Study|Lost to Follow-up|51|||
129466809|NCT02925156|466004188|FG003|Overall Study|Lost to Follow-up|59|||
129466810|NCT02925156|466004189|FG004|Overall Study|Lost to Follow-up|89|||
129466811|NCT02925156|466004190|FG005|Overall Study|Lost to Follow-up|107|||
129466812|NCT02925156|466004191|FG006|Overall Study|Lost to Follow-up|34|||
129466813|NCT02925156|466004192|FG007|Overall Study|Lost to Follow-up|36|||
129466814|NCT02925156|466004193|FG008|Overall Study|Lost to Follow-up|73|||
129466815|NCT02925156|466004194|FG009|Overall Study|Lost to Follow-up|34|||
129466816|NCT00866307|466004195|FG000|Induction|Adverse Event|5|||
129466817|NCT00866307|466004196|FG001|Induction|Adverse Event|0|||
129466818|NCT00866307|466004197|FG002|Induction|Adverse Event|0|||
129466819|NCT00866307|466004195|FG000|Induction|Death|2|||
129466820|NCT00866307|466004196|FG001|Induction|Death|0|||
129466821|NCT00866307|466004197|FG002|Induction|Death|0|||
129466822|NCT00866307|466004195|FG000|Induction|Physician Decision|5|||
129466823|NCT00866307|466004196|FG001|Induction|Physician Decision|0|||
129466824|NCT00866307|466004197|FG002|Induction|Physician Decision|0|||
129466825|NCT00866307|466004195|FG000|Induction|Progressive Disease|1|||
129466826|NCT00866307|466004196|FG001|Induction|Progressive Disease|0|||
129466827|NCT00866307|466004197|FG002|Induction|Progressive Disease|0|||
129466828|NCT00866307|466004195|FG000|Induction|Identification of Patients with Day 29 M|3|||
129466829|NCT00866307|466004196|FG001|Induction|Identification of Patients with Day 29 M|0|||
129466830|NCT00866307|466004197|FG002|Induction|Identification of Patients with Day 29 M|0|||
129466831|NCT00866307|466004195|FG000|Induction|Inadequate cytognetic samples th|1|||
129466832|NCT00866307|466004196|FG001|Induction|Inadequate cytognetic samples th|0|||
129466833|NCT00866307|466004197|FG002|Induction|Inadequate cytognetic samples th|0|||
129466834|NCT00866307|466004195|FG000|Induction|Improper post-induction consent|2|||
129466835|NCT00866307|466004196|FG001|Induction|Improper post-induction consent|0|||
129466836|NCT00866307|466004197|FG002|Induction|Improper post-induction consent|0|||
129466837|NCT00866307|466004195|FG000|Induction|Study was closed at the time|1|||
129466838|NCT00866307|466004196|FG001|Induction|Study was closed at the time|0|||
129466839|NCT00866307|466004197|FG002|Induction|Study was closed at the time|0|||
129466840|NCT00866307|466004195|FG000|Consolidation/Maintenance|Adverse Event|0|||
129466841|NCT00866307|466004196|FG001|Consolidation/Maintenance|Adverse Event|0|||
129466842|NCT00866307|466004197|FG002|Consolidation/Maintenance|Adverse Event|8|||
129466843|NCT00866307|466004195|FG000|Consolidation/Maintenance|Death|0|||
129466844|NCT00866307|466004196|FG001|Consolidation/Maintenance|Death|0|||
129466845|NCT00866307|466004197|FG002|Consolidation/Maintenance|Death|1|||
129466846|NCT00866307|466004195|FG000|Consolidation/Maintenance|Physician Decision|0|||
129466847|NCT00866307|466004196|FG001|Consolidation/Maintenance|Physician Decision|3|||
129466848|NCT00866307|466004197|FG002|Consolidation/Maintenance|Physician Decision|2|||
129466849|NCT00866307|466004195|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
129466850|NCT00866307|466004196|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
129466851|NCT00866307|466004197|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
129466852|NCT00866307|466004195|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
129466853|NCT00866307|466004196|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
129466854|NCT00866307|466004197|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
129466855|NCT00866307|466004195|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
129466856|NCT00866307|466004196|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
129466857|NCT00866307|466004197|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
129466858|NCT00866307|466004195|FG000|Consolidation/Maintenance|Therapy error|0|||
129466859|NCT00866307|466004196|FG001|Consolidation/Maintenance|Therapy error|1|||
129466860|NCT00866307|466004197|FG002|Consolidation/Maintenance|Therapy error|0|||
129466861|NCT00866307|466004195|FG000|Consolidation/Maintenance|Non-compliance|0|||
129466862|NCT00866307|466004196|FG001|Consolidation/Maintenance|Non-compliance|0|||
129466863|NCT00866307|466004197|FG002|Consolidation/Maintenance|Non-compliance|1|||
129466864|NCT00866307|466004195|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
129466865|NCT00866307|466004196|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
129466866|NCT00866307|466004197|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
129466867|NCT02286947|466004200|FG000|Overall Study|Withdrawal by Subject|2|||
129466868|NCT01060059|466004203|FG000|Overall Study|Adverse Event|1|||
129466869|NCT01060059|466004204|FG001|Overall Study|Adverse Event|1|||
129466870|NCT01060059|466004203|FG000|Overall Study|Death|2|||
129466871|NCT01060059|466004204|FG001|Overall Study|Death|3|||
129466872|NCT01060059|466004203|FG000|Overall Study|Lost to Follow-up|18|||
129466873|NCT01060059|466004204|FG001|Overall Study|Lost to Follow-up|34|||
129466874|NCT01060059|466004203|FG000|Overall Study|entry criteria not met|4|||
129466875|NCT01060059|466004204|FG001|Overall Study|entry criteria not met|3|||
129466876|NCT01060059|466004203|FG000|Overall Study|Withdrawal by Subject|35|||
129466877|NCT01060059|466004204|FG001|Overall Study|Withdrawal by Subject|23|||
129466878|NCT01060059|466004203|FG000|Overall Study|lack of glycemic control|2|||
129466879|NCT01060059|466004204|FG001|Overall Study|lack of glycemic control|1|||
129466880|NCT01060059|466004203|FG000|Overall Study|lack of compliance|5|||
129466881|NCT01060059|466004204|FG001|Overall Study|lack of compliance|2|||
129466882|NCT01614093|466004205|FG000|Overall Study|Withdrawal by Subject|1|||
129466883|NCT00848354|466004206|FG000|Phase 1|Adverse Event|5|||
129466884|NCT00848354|466004207|FG001|Phase 1|Adverse Event|4|||
129466885|NCT00848354|466004206|FG000|Phase 1|Discontinuation of study by sponsor|2|||
129466886|NCT00848354|466004207|FG001|Phase 1|Discontinuation of study by sponsor|1|||
129466887|NCT00848354|466004206|FG000|Phase 1|Failed to return|0|||
129466888|NCT00848354|466004207|FG001|Phase 1|Failed to return|1|||
129466889|NCT00848354|466004206|FG000|Phase 1|Lost to Follow-up|1|||
129466890|NCT00848354|466004207|FG001|Phase 1|Lost to Follow-up|1|||
129466891|NCT00848354|466004206|FG000|Phase 1|Unspecified Reason|1|||
129466892|NCT00848354|466004207|FG001|Phase 1|Unspecified Reason|1|||
129466893|NCT00848354|466004206|FG000|Phase 1|Protocol Violation|1|||
129466894|NCT00848354|466004207|FG001|Phase 1|Protocol Violation|1|||
129466895|NCT00848354|466004206|FG000|Phase 1|Withdrawal by Subject|2|||
129466896|NCT00848354|466004207|FG001|Phase 1|Withdrawal by Subject|4|||
129466897|NCT00848354|466004206|FG000|Phase 1|Lack of Efficacy|0|||
129466898|NCT00848354|466004207|FG001|Phase 1|Lack of Efficacy|1|||
129466899|NCT00848354|466004206|FG000|Phase 2 Year 1|Adverse Event|7|||
129466900|NCT00848354|466004207|FG001|Phase 2 Year 1|Adverse Event|2|||
129466901|NCT00848354|466004206|FG000|Phase 2 Year 1|Death|1|||
129466902|NCT00848354|466004207|FG001|Phase 2 Year 1|Death|0|||
129466903|NCT00848354|466004206|FG000|Phase 2 Year 1|Failed to Return|1|||
129466904|NCT00848354|466004207|FG001|Phase 2 Year 1|Failed to Return|1|||
129466905|NCT00848354|466004206|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
129466906|NCT00848354|466004207|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
129466907|NCT00848354|466004206|FG000|Phase 2 Year 1|Unspecified Reason|3|||
129466908|NCT00848354|466004207|FG001|Phase 2 Year 1|Unspecified Reason|0|||
129466909|NCT00848354|466004206|FG000|Phase 2 Year 1|Protocol Violation|4|||
129466910|NCT00848354|466004207|FG001|Phase 2 Year 1|Protocol Violation|1|||
129466911|NCT00848354|466004206|FG000|Phase 2 Year 1|Subject Request|1|||
129466912|NCT00848354|466004207|FG001|Phase 2 Year 1|Subject Request|2|||
129466913|NCT00848354|466004206|FG000|Phase 2 Year 2|Adverse Event|12|||
129466914|NCT00848354|466004207|FG001|Phase 2 Year 2|Adverse Event|2|||
129466915|NCT00848354|466004206|FG000|Phase 2 Year 2|Death|2|||
129466916|NCT00848354|466004207|FG001|Phase 2 Year 2|Death|0|||
129466917|NCT00848354|466004206|FG000|Phase 2 Year 2|Failed to return|3|||
129466918|NCT00848354|466004207|FG001|Phase 2 Year 2|Failed to return|0|||
129466919|NCT00848354|466004206|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
129466920|NCT00848354|466004207|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
129466921|NCT00848354|466004206|FG000|Phase 2 Year 2|Unspecified Reason|1|||
129466922|NCT00848354|466004207|FG001|Phase 2 Year 2|Unspecified Reason|0|||
129466923|NCT00848354|466004206|FG000|Phase 2 Year 2|Protocol Violation|1|||
129466924|NCT00848354|466004207|FG001|Phase 2 Year 2|Protocol Violation|1|||
129466925|NCT00848354|466004206|FG000|Phase 2 Year 2|Subject Request|1|||
129466926|NCT00848354|466004207|FG001|Phase 2 Year 2|Subject Request|1|||
129466927|NCT00848354|466004206|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
129466928|NCT00848354|466004207|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
129466929|NCT01777581|466004208|FG000|Overall Study|Lost to Follow-up|1|||
129466930|NCT01777581|466004209|FG001|Overall Study|Lost to Follow-up|1|||
129466931|NCT01777581|466004208|FG000|Overall Study|Adverse Event|2|||
129466932|NCT01777581|466004209|FG001|Overall Study|Adverse Event|0|||
129466933|NCT01777581|466004208|FG000|Overall Study|Lack of Efficacy|0|||
129466934|NCT01777581|466004209|FG001|Overall Study|Lack of Efficacy|1|||
129466935|NCT04202679|466004212|FG000|Overall Study|Adverse Event|2|||
129466936|NCT04202679|466004213|FG001|Overall Study|Adverse Event|0|||
129466937|NCT04202679|466004212|FG000|Overall Study|Poor compliance to protocol|1|||
129466938|NCT04202679|466004213|FG001|Overall Study|Poor compliance to protocol|0|||
129466939|NCT04202679|466004212|FG000|Overall Study|Withdrawal by Subject|23|||
129466940|NCT04202679|466004213|FG001|Overall Study|Withdrawal by Subject|6|||
129466941|NCT03718143|466006297|FG000|Overall Study|Death|1|||
129466942|NCT03718143|466006298|FG001|Overall Study|Death|0|||
129466943|NCT03718143|466006299|FG002|Overall Study|Death|0|||
129466944|NCT03718143|466006297|FG000|Overall Study|Progression of Disease|1|||
129466945|NCT03718143|466006298|FG001|Overall Study|Progression of Disease|0|||
129466946|NCT03718143|466006299|FG002|Overall Study|Progression of Disease|0|||
129466947|NCT03718143|466006297|FG000|Overall Study|Withdrawal of Informed Consent|1|||
129466948|NCT03718143|466006298|FG001|Overall Study|Withdrawal of Informed Consent|2|||
129466949|NCT03718143|466006299|FG002|Overall Study|Withdrawal of Informed Consent|1|||
129466950|NCT05064059|466006300|FG000|Overall Study|Death|199|||
129466951|NCT05064059|466006301|FG001|Overall Study|Death|196|||
129466952|NCT05064059|466006300|FG000|Overall Study|Physician Decision|4|||
129466953|NCT05064059|466006301|FG001|Overall Study|Physician Decision|2|||
129466954|NCT05064059|466006300|FG000|Overall Study|Sponsor Decision|14|||
129466955|NCT05064059|466006301|FG001|Overall Study|Sponsor Decision|11|||
129466956|NCT05064059|466006300|FG000|Overall Study|Withdrawal by Subject|4|||
129466957|NCT05064059|466006301|FG001|Overall Study|Withdrawal by Subject|11|||
129466958|NCT00805740|466006302|FG000|Overall Study|Death|7|||
129466959|NCT00805740|466006303|FG001|Overall Study|Death|4|||
129466960|NCT00805740|466006302|FG000|Overall Study|Withdrawal by Subject|1|||
129466961|NCT00805740|466006303|FG001|Overall Study|Withdrawal by Subject|0|||
129466962|NCT00805740|466006302|FG000|Overall Study|Lost to Follow-up|1|||
129466963|NCT00805740|466006303|FG001|Overall Study|Lost to Follow-up|0|||
129466964|NCT00805740|466006302|FG000|Overall Study|Randomized, but not treated|2|||
129466965|NCT00805740|466006303|FG001|Overall Study|Randomized, but not treated|0|||
129466966|NCT00200850|466006308|FG000|Overall Study|relocation|1|||
129466967|NCT00200850|466006309|FG001|Overall Study|relocation|0|||
129466968|NCT00200850|466006310|FG002|Overall Study|relocation|1|||
129466969|NCT00200850|466006308|FG000|Overall Study|too busy|1|||
129466970|NCT00200850|466006309|FG001|Overall Study|too busy|0|||
129466971|NCT00200850|466006310|FG002|Overall Study|too busy|0|||
129466972|NCT00200850|466006308|FG000|Overall Study|Pregnancy|0|||
129466973|NCT00200850|466006309|FG001|Overall Study|Pregnancy|0|||
129466974|NCT00200850|466006310|FG002|Overall Study|Pregnancy|1|||
129466975|NCT00200850|466006308|FG000|Overall Study|Poor adherence|0|||
129466976|NCT00200850|466006309|FG001|Overall Study|Poor adherence|0|||
129466977|NCT00200850|466006310|FG002|Overall Study|Poor adherence|1|||
129466978|NCT00200850|466006308|FG000|Overall Study|optic neuritis|0|||
129466979|NCT00200850|466006309|FG001|Overall Study|optic neuritis|0|||
129466980|NCT00200850|466006310|FG002|Overall Study|optic neuritis|1|||
129466981|NCT00200850|466006308|FG000|Overall Study|Adverse Event|1|||
129466982|NCT00200850|466006309|FG001|Overall Study|Adverse Event|1|||
129466983|NCT00200850|466006310|FG002|Overall Study|Adverse Event|2|||
129466984|NCT05227690|466006316|FG000|Overall Study|Adverse Event|5|||
129466985|NCT05227690|466006317|FG001|Overall Study|Adverse Event|6|||
129466986|NCT05227690|466006318|FG002|Overall Study|Adverse Event|10|||
129466987|NCT05227690|466006316|FG000|Overall Study|Lack of Efficacy|2|||
129466988|NCT05227690|466006317|FG001|Overall Study|Lack of Efficacy|4|||
129466989|NCT05227690|466006318|FG002|Overall Study|Lack of Efficacy|1|||
129466990|NCT05227690|466006316|FG000|Overall Study|Physician Decision|6|||
129466991|NCT05227690|466006317|FG001|Overall Study|Physician Decision|0|||
129466992|NCT05227690|466006318|FG002|Overall Study|Physician Decision|4|||
129466993|NCT05227690|466006316|FG000|Overall Study|Withdrawal of consent|28|||
129466994|NCT05227690|466006317|FG001|Overall Study|Withdrawal of consent|27|||
129466995|NCT05227690|466006318|FG002|Overall Study|Withdrawal of consent|21|||
129466996|NCT05227690|466006316|FG000|Overall Study|Other, not specified|2|||
129466997|NCT05227690|466006317|FG001|Overall Study|Other, not specified|2|||
129466998|NCT05227690|466006318|FG002|Overall Study|Other, not specified|1|||
129466999|NCT02770326|466006321|FG000|Overall Study|Death|3|||
129467000|NCT02770326|466006321|FG000|Overall Study|Lost to Follow-up|1|||
129467001|NCT04033367|466006322|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
129467002|NCT04033367|466006323|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
129467003|NCT04033367|466006322|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
129467004|NCT04033367|466006323|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
129467005|NCT04033367|466006322|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
129467006|NCT04033367|466006323|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
129467007|NCT04033367|466006322|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
129467008|NCT04033367|466006323|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
129467009|NCT02723201|466006324|FG000|Second Intervention Period|Protocol Violation|1|||
129467010|NCT02723201|466006325|FG001|Second Intervention Period|Protocol Violation|0|||
129467011|NCT02723201|466006326|FG002|Second Intervention Period|Protocol Violation|0|||
129467012|NCT02723201|466006324|FG000|Second Intervention Period|Adverse Event|1|||
129467013|NCT02723201|466006325|FG001|Second Intervention Period|Adverse Event|0|||
129467014|NCT02723201|466006326|FG002|Second Intervention Period|Adverse Event|0|||
129467015|NCT03472560|466006327|FG000|Overall Study|Subject transfer to continuation protocol|0|||
129467016|NCT03472560|466006328|FG001|Overall Study|Subject transfer to continuation protocol|1|||
129467017|NCT03472560|466006327|FG000|Overall Study|Withdrawal by Subject|4|||
129467018|NCT03472560|466006328|FG001|Overall Study|Withdrawal by Subject|0|||
129467019|NCT03472560|466006327|FG000|Overall Study|Progressive disease|24|||
129467020|NCT03472560|466006328|FG001|Overall Study|Progressive disease|8|||
129467021|NCT03472560|466006327|FG000|Overall Study|Physician Decision|1|||
129467022|NCT03472560|466006328|FG001|Overall Study|Physician Decision|0|||
129467023|NCT03472560|466006327|FG000|Overall Study|Death|7|||
129467024|NCT03472560|466006328|FG001|Overall Study|Death|4|||
129467025|NCT03472560|466006327|FG000|Overall Study|Adverse Event|5|||
129467026|NCT03472560|466006328|FG001|Overall Study|Adverse Event|3|||
129467027|NCT03472560|466006327|FG000|Overall Study|Global deterioration of health status|0|||
129467028|NCT03472560|466006328|FG001|Overall Study|Global deterioration of health status|4|||
129467029|NCT02634580|466006329|FG000|Double-blind Treatment Period|Subject Request|1|||
129467030|NCT02634580|466006330|FG001|Double-blind Treatment Period|Subject Request|0|||
129467031|NCT02634580|466006331|FG002|Double-blind Treatment Period|Subject Request|1|||
129467032|NCT02634580|466006332|FG003|Double-blind Treatment Period|Subject Request|1|||
129467033|NCT02634580|466006329|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
129467034|NCT02634580|466006330|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
129467035|NCT02634580|466006331|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
129467036|NCT02634580|466006332|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
129467037|NCT00491179|466006333|FG000|Overall Study|Adverse Event|5|||
129467038|NCT00491179|466006334|FG001|Overall Study|Adverse Event|1|||
129467039|NCT00491179|466006333|FG000|Overall Study|Withdrawal by Subject|2|||
129467040|NCT00491179|466006334|FG001|Overall Study|Withdrawal by Subject|1|||
129467041|NCT04269395|466006335|FG000|Overall Study|Lost to Follow-up|1|||
129467042|NCT04269395|466006336|FG001|Overall Study|Lost to Follow-up|0|||
129467043|NCT04269395|466006335|FG000|Overall Study|Study terminated by Sponsor|13|||
129467044|NCT04269395|466006336|FG001|Overall Study|Study terminated by Sponsor|10|||
129467045|NCT01285908|466006337|FG000|Baseline Measurement|unable to insert catheter|1|||
129467046|NCT01285908|466006338|FG001|Baseline Measurement|unable to insert catheter|0|||
129467047|NCT01285908|466006339|FG002|Baseline Measurement|unable to insert catheter|0|||
129467048|NCT01285908|466006337|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
129467049|NCT01285908|466006338|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
129467050|NCT01285908|466006339|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
129467051|NCT01285908|466006337|FG000|Baseline Measurement|unable to tolerate procedure|1|||
129467052|NCT01285908|466006338|FG001|Baseline Measurement|unable to tolerate procedure|0|||
129467053|NCT01285908|466006339|FG002|Baseline Measurement|unable to tolerate procedure|0|||
129467054|NCT03529773|466006340|FG000|Overall Study|Adverse Event|0|||
129467055|NCT03529773|466006341|FG001|Overall Study|Adverse Event|0|||
129467056|NCT03529773|466006342|FG002|Overall Study|Adverse Event|0|||
129467057|NCT03529773|466006343|FG003|Overall Study|Adverse Event|0|||
129467058|NCT03529773|466006344|FG004|Overall Study|Adverse Event|0|||
129467059|NCT03529773|466006345|FG005|Overall Study|Adverse Event|0|||
129467060|NCT03529773|466006346|FG006|Overall Study|Adverse Event|0|||
129467061|NCT03529773|466006347|FG007|Overall Study|Adverse Event|0|||
129467062|NCT03529773|466006348|FG008|Overall Study|Adverse Event|0|||
129467063|NCT03529773|466006349|FG009|Overall Study|Adverse Event|0|||
129971188|NCT00132678|467858423|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
129971189|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Death|2|||
129971190|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Death|0|||
129971191|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Death|0|||
129971192|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
129467064|NCT03529773|466006350|FG010|Overall Study|Adverse Event|0|||
129467065|NCT03529773|466006351|FG011|Overall Study|Adverse Event|0|||
129467066|NCT03529773|466006352|FG012|Overall Study|Adverse Event|0|||
129467067|NCT03529773|466006353|FG013|Overall Study|Adverse Event|0|||
129467068|NCT03529773|466006354|FG014|Overall Study|Adverse Event|0|||
129467069|NCT03529773|466006355|FG015|Overall Study|Adverse Event|0|||
129467070|NCT03529773|466006356|FG016|Overall Study|Adverse Event|0|||
129467071|NCT03529773|466006357|FG017|Overall Study|Adverse Event|0|||
129467072|NCT03529773|466006358|FG018|Overall Study|Adverse Event|0|||
129467073|NCT03529773|466006359|FG019|Overall Study|Adverse Event|0|||
129467074|NCT03529773|466006360|FG020|Overall Study|Adverse Event|0|||
129467075|NCT03529773|466006361|FG021|Overall Study|Adverse Event|0|||
129467076|NCT03529773|466006362|FG022|Overall Study|Adverse Event|0|||
129467077|NCT03529773|466006363|FG023|Overall Study|Adverse Event|0|||
129467078|NCT03529773|466006364|FG024|Overall Study|Adverse Event|0|||
129467079|NCT03529773|466006365|FG025|Overall Study|Adverse Event|0|||
129467080|NCT03529773|466006366|FG026|Overall Study|Adverse Event|0|||
129467081|NCT03529773|466006367|FG027|Overall Study|Adverse Event|0|||
129467082|NCT03529773|466006368|FG028|Overall Study|Adverse Event|0|||
129467083|NCT03529773|466006369|FG029|Overall Study|Adverse Event|0|||
129467084|NCT03529773|466006370|FG030|Overall Study|Adverse Event|1|||
129467085|NCT03529773|466006371|FG031|Overall Study|Adverse Event|0|||
129467086|NCT03529773|466006372|FG032|Overall Study|Adverse Event|0|||
129467087|NCT03529773|466006373|FG033|Overall Study|Adverse Event|0|||
129467088|NCT03529773|466006374|FG034|Overall Study|Adverse Event|0|||
129467089|NCT03529773|466006375|FG035|Overall Study|Adverse Event|1|||
129467090|NCT03529773|466006376|FG036|Overall Study|Adverse Event|0|||
129467091|NCT03529773|466006377|FG037|Overall Study|Adverse Event|0|||
129467092|NCT03529773|466006378|FG038|Overall Study|Adverse Event|1|||
129467093|NCT03529773|466006379|FG039|Overall Study|Adverse Event|1|||
129467094|NCT03529773|466006340|FG000|Overall Study|Death|0|||
129467095|NCT03529773|466006341|FG001|Overall Study|Death|0|||
129467096|NCT03529773|466006342|FG002|Overall Study|Death|0|||
129467097|NCT03529773|466006343|FG003|Overall Study|Death|0|||
129467098|NCT03529773|466006344|FG004|Overall Study|Death|0|||
129467099|NCT03529773|466006345|FG005|Overall Study|Death|0|||
129467100|NCT03529773|466006346|FG006|Overall Study|Death|0|||
129467101|NCT03529773|466006347|FG007|Overall Study|Death|0|||
129467102|NCT03529773|466006348|FG008|Overall Study|Death|0|||
129467103|NCT03529773|466006349|FG009|Overall Study|Death|0|||
129467104|NCT03529773|466006350|FG010|Overall Study|Death|0|||
129467105|NCT03529773|466006351|FG011|Overall Study|Death|0|||
129467106|NCT03529773|466006352|FG012|Overall Study|Death|1|||
129467107|NCT03529773|466006353|FG013|Overall Study|Death|0|||
129467108|NCT03529773|466006354|FG014|Overall Study|Death|0|||
129467109|NCT03529773|466006355|FG015|Overall Study|Death|0|||
129467110|NCT03529773|466006356|FG016|Overall Study|Death|0|||
129467111|NCT03529773|466006357|FG017|Overall Study|Death|0|||
129467112|NCT03529773|466006358|FG018|Overall Study|Death|0|||
129467113|NCT03529773|466006359|FG019|Overall Study|Death|1|||
129467114|NCT03529773|466006360|FG020|Overall Study|Death|0|||
129467115|NCT03529773|466006361|FG021|Overall Study|Death|0|||
129467116|NCT03529773|466006362|FG022|Overall Study|Death|1|||
129467117|NCT03529773|466006363|FG023|Overall Study|Death|0|||
129467118|NCT03529773|466006364|FG024|Overall Study|Death|0|||
129467119|NCT03529773|466006365|FG025|Overall Study|Death|0|||
129467120|NCT03529773|466006366|FG026|Overall Study|Death|0|||
129467121|NCT03529773|466006367|FG027|Overall Study|Death|0|||
129467122|NCT03529773|466006368|FG028|Overall Study|Death|0|||
129467123|NCT03529773|466006369|FG029|Overall Study|Death|0|||
129467124|NCT03529773|466006370|FG030|Overall Study|Death|0|||
129467125|NCT03529773|466006371|FG031|Overall Study|Death|0|||
129467126|NCT03529773|466006372|FG032|Overall Study|Death|0|||
129971193|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
129971194|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
129971195|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
129467127|NCT03529773|466006373|FG033|Overall Study|Death|1|||
129467128|NCT03529773|466006374|FG034|Overall Study|Death|1|||
129467129|NCT03529773|466006375|FG035|Overall Study|Death|0|||
129467130|NCT03529773|466006376|FG036|Overall Study|Death|1|||
129467131|NCT03529773|466006377|FG037|Overall Study|Death|0|||
129467132|NCT03529773|466006378|FG038|Overall Study|Death|0|||
129467133|NCT03529773|466006379|FG039|Overall Study|Death|0|||
129467134|NCT03529773|466006340|FG000|Overall Study|Lost to Follow-up|0|||
129467135|NCT03529773|466006341|FG001|Overall Study|Lost to Follow-up|0|||
129467136|NCT03529773|466006342|FG002|Overall Study|Lost to Follow-up|1|||
129467137|NCT03529773|466006343|FG003|Overall Study|Lost to Follow-up|0|||
129467138|NCT03529773|466006344|FG004|Overall Study|Lost to Follow-up|1|||
129467139|NCT03529773|466006345|FG005|Overall Study|Lost to Follow-up|1|||
129467140|NCT03529773|466006346|FG006|Overall Study|Lost to Follow-up|0|||
129467141|NCT03529773|466006347|FG007|Overall Study|Lost to Follow-up|0|||
129467142|NCT03529773|466006348|FG008|Overall Study|Lost to Follow-up|0|||
129467143|NCT03529773|466006349|FG009|Overall Study|Lost to Follow-up|0|||
129467144|NCT03529773|466006350|FG010|Overall Study|Lost to Follow-up|0|||
129467145|NCT03529773|466006351|FG011|Overall Study|Lost to Follow-up|0|||
129467146|NCT03529773|466006352|FG012|Overall Study|Lost to Follow-up|0|||
129467147|NCT03529773|466006353|FG013|Overall Study|Lost to Follow-up|1|||
129467148|NCT03529773|466006354|FG014|Overall Study|Lost to Follow-up|4|||
129467149|NCT03529773|466006355|FG015|Overall Study|Lost to Follow-up|1|||
129467150|NCT03529773|466006356|FG016|Overall Study|Lost to Follow-up|1|||
129467151|NCT03529773|466006357|FG017|Overall Study|Lost to Follow-up|0|||
129467152|NCT03529773|466006358|FG018|Overall Study|Lost to Follow-up|1|||
129467153|NCT03529773|466006359|FG019|Overall Study|Lost to Follow-up|1|||
129467154|NCT03529773|466006360|FG020|Overall Study|Lost to Follow-up|2|||
129467155|NCT03529773|466006361|FG021|Overall Study|Lost to Follow-up|4|||
129467156|NCT03529773|466006362|FG022|Overall Study|Lost to Follow-up|3|||
129467157|NCT03529773|466006363|FG023|Overall Study|Lost to Follow-up|4|||
129467158|NCT03529773|466006364|FG024|Overall Study|Lost to Follow-up|3|||
129467159|NCT03529773|466006365|FG025|Overall Study|Lost to Follow-up|5|||
129467160|NCT03529773|466006366|FG026|Overall Study|Lost to Follow-up|5|||
129467161|NCT03529773|466006367|FG027|Overall Study|Lost to Follow-up|0|||
129467162|NCT03529773|466006368|FG028|Overall Study|Lost to Follow-up|0|||
129467163|NCT03529773|466006369|FG029|Overall Study|Lost to Follow-up|0|||
129467164|NCT03529773|466006370|FG030|Overall Study|Lost to Follow-up|1|||
129467165|NCT03529773|466006371|FG031|Overall Study|Lost to Follow-up|0|||
129467166|NCT03529773|466006372|FG032|Overall Study|Lost to Follow-up|0|||
129467167|NCT03529773|466006373|FG033|Overall Study|Lost to Follow-up|1|||
129467168|NCT03529773|466006374|FG034|Overall Study|Lost to Follow-up|1|||
129467169|NCT03529773|466006375|FG035|Overall Study|Lost to Follow-up|0|||
129467170|NCT03529773|466006376|FG036|Overall Study|Lost to Follow-up|0|||
129467171|NCT03529773|466006377|FG037|Overall Study|Lost to Follow-up|3|||
129467172|NCT03529773|466006378|FG038|Overall Study|Lost to Follow-up|1|||
129467173|NCT03529773|466006379|FG039|Overall Study|Lost to Follow-up|1|||
129467174|NCT03529773|466006340|FG000|Overall Study|No longer meets eligibility criteria|0|||
129467175|NCT03529773|466006341|FG001|Overall Study|No longer meets eligibility criteria|0|||
129467176|NCT03529773|466006342|FG002|Overall Study|No longer meets eligibility criteria|0|||
129467177|NCT03529773|466006343|FG003|Overall Study|No longer meets eligibility criteria|0|||
129467178|NCT03529773|466006344|FG004|Overall Study|No longer meets eligibility criteria|0|||
129467179|NCT03529773|466006345|FG005|Overall Study|No longer meets eligibility criteria|0|||
129467180|NCT03529773|466006346|FG006|Overall Study|No longer meets eligibility criteria|0|||
129467181|NCT03529773|466006347|FG007|Overall Study|No longer meets eligibility criteria|0|||
129467182|NCT03529773|466006348|FG008|Overall Study|No longer meets eligibility criteria|0|||
129467183|NCT03529773|466006349|FG009|Overall Study|No longer meets eligibility criteria|0|||
129467184|NCT03529773|466006350|FG010|Overall Study|No longer meets eligibility criteria|0|||
129467185|NCT03529773|466006351|FG011|Overall Study|No longer meets eligibility criteria|0|||
129467186|NCT03529773|466006352|FG012|Overall Study|No longer meets eligibility criteria|0|||
129467187|NCT03529773|466006353|FG013|Overall Study|No longer meets eligibility criteria|0|||
129467188|NCT03529773|466006354|FG014|Overall Study|No longer meets eligibility criteria|0|||
129467189|NCT03529773|466006355|FG015|Overall Study|No longer meets eligibility criteria|0|||
129467190|NCT03529773|466006356|FG016|Overall Study|No longer meets eligibility criteria|0|||
129467191|NCT03529773|466006357|FG017|Overall Study|No longer meets eligibility criteria|0|||
129467192|NCT03529773|466006358|FG018|Overall Study|No longer meets eligibility criteria|0|||
129467193|NCT03529773|466006359|FG019|Overall Study|No longer meets eligibility criteria|0|||
129467194|NCT03529773|466006360|FG020|Overall Study|No longer meets eligibility criteria|0|||
129467195|NCT03529773|466006361|FG021|Overall Study|No longer meets eligibility criteria|0|||
129467196|NCT03529773|466006362|FG022|Overall Study|No longer meets eligibility criteria|1|||
129467197|NCT03529773|466006363|FG023|Overall Study|No longer meets eligibility criteria|0|||
129467198|NCT03529773|466006364|FG024|Overall Study|No longer meets eligibility criteria|0|||
129467199|NCT03529773|466006365|FG025|Overall Study|No longer meets eligibility criteria|0|||
129467200|NCT03529773|466006366|FG026|Overall Study|No longer meets eligibility criteria|0|||
129467201|NCT03529773|466006367|FG027|Overall Study|No longer meets eligibility criteria|0|||
129467202|NCT03529773|466006368|FG028|Overall Study|No longer meets eligibility criteria|0|||
129467203|NCT03529773|466006369|FG029|Overall Study|No longer meets eligibility criteria|0|||
129467204|NCT03529773|466006370|FG030|Overall Study|No longer meets eligibility criteria|0|||
129467205|NCT03529773|466006371|FG031|Overall Study|No longer meets eligibility criteria|0|||
129467206|NCT03529773|466006372|FG032|Overall Study|No longer meets eligibility criteria|0|||
129467207|NCT03529773|466006373|FG033|Overall Study|No longer meets eligibility criteria|0|||
129467208|NCT03529773|466006374|FG034|Overall Study|No longer meets eligibility criteria|0|||
129467209|NCT03529773|466006375|FG035|Overall Study|No longer meets eligibility criteria|0|||
129467210|NCT03529773|466006376|FG036|Overall Study|No longer meets eligibility criteria|0|||
129467211|NCT03529773|466006377|FG037|Overall Study|No longer meets eligibility criteria|0|||
129467212|NCT03529773|466006378|FG038|Overall Study|No longer meets eligibility criteria|1|||
129467213|NCT03529773|466006379|FG039|Overall Study|No longer meets eligibility criteria|0|||
129467214|NCT03529773|466006340|FG000|Overall Study|Other|0|||
129467215|NCT03529773|466006341|FG001|Overall Study|Other|0|||
129467216|NCT03529773|466006342|FG002|Overall Study|Other|0|||
129467217|NCT03529773|466006343|FG003|Overall Study|Other|0|||
129467218|NCT03529773|466006344|FG004|Overall Study|Other|0|||
129467219|NCT03529773|466006345|FG005|Overall Study|Other|0|||
129467220|NCT03529773|466006346|FG006|Overall Study|Other|0|||
129467221|NCT03529773|466006347|FG007|Overall Study|Other|0|||
129467222|NCT03529773|466006348|FG008|Overall Study|Other|0|||
129467223|NCT03529773|466006349|FG009|Overall Study|Other|0|||
129467224|NCT03529773|466006350|FG010|Overall Study|Other|0|||
129467225|NCT03529773|466006351|FG011|Overall Study|Other|0|||
129467226|NCT03529773|466006352|FG012|Overall Study|Other|1|||
129467227|NCT03529773|466006353|FG013|Overall Study|Other|0|||
129467228|NCT03529773|466006354|FG014|Overall Study|Other|2|||
129467229|NCT03529773|466006355|FG015|Overall Study|Other|0|||
129467230|NCT03529773|466006356|FG016|Overall Study|Other|0|||
129467231|NCT03529773|466006357|FG017|Overall Study|Other|3|||
129467232|NCT03529773|466006358|FG018|Overall Study|Other|0|||
129467233|NCT03529773|466006359|FG019|Overall Study|Other|0|||
129467234|NCT03529773|466006360|FG020|Overall Study|Other|1|||
129467235|NCT03529773|466006361|FG021|Overall Study|Other|0|||
129467236|NCT03529773|466006362|FG022|Overall Study|Other|1|||
129467237|NCT03529773|466006363|FG023|Overall Study|Other|0|||
129467238|NCT03529773|466006364|FG024|Overall Study|Other|3|||
129467239|NCT03529773|466006365|FG025|Overall Study|Other|2|||
129467240|NCT03529773|466006366|FG026|Overall Study|Other|2|||
129467241|NCT03529773|466006367|FG027|Overall Study|Other|0|||
129467242|NCT03529773|466006368|FG028|Overall Study|Other|0|||
129467243|NCT03529773|466006369|FG029|Overall Study|Other|0|||
129467244|NCT03529773|466006370|FG030|Overall Study|Other|0|||
129467245|NCT03529773|466006371|FG031|Overall Study|Other|0|||
129467246|NCT03529773|466006372|FG032|Overall Study|Other|0|||
129467247|NCT03529773|466006373|FG033|Overall Study|Other|0|||
129467248|NCT03529773|466006374|FG034|Overall Study|Other|1|||
129467249|NCT03529773|466006375|FG035|Overall Study|Other|1|||
129467250|NCT03529773|466006376|FG036|Overall Study|Other|0|||
129467251|NCT03529773|466006377|FG037|Overall Study|Other|0|||
129467252|NCT03529773|466006378|FG038|Overall Study|Other|0|||
129467253|NCT03529773|466006379|FG039|Overall Study|Other|0|||
129467254|NCT03529773|466006340|FG000|Overall Study|Physician Decision|0|||
129467255|NCT03529773|466006341|FG001|Overall Study|Physician Decision|0|||
129467256|NCT03529773|466006342|FG002|Overall Study|Physician Decision|0|||
129467257|NCT03529773|466006343|FG003|Overall Study|Physician Decision|0|||
129467258|NCT03529773|466006344|FG004|Overall Study|Physician Decision|0|||
129467259|NCT03529773|466006345|FG005|Overall Study|Physician Decision|0|||
129467260|NCT03529773|466006346|FG006|Overall Study|Physician Decision|0|||
129467261|NCT03529773|466006347|FG007|Overall Study|Physician Decision|0|||
129467262|NCT03529773|466006348|FG008|Overall Study|Physician Decision|0|||
129467263|NCT03529773|466006349|FG009|Overall Study|Physician Decision|0|||
129467264|NCT03529773|466006350|FG010|Overall Study|Physician Decision|0|||
129467265|NCT03529773|466006351|FG011|Overall Study|Physician Decision|0|||
129467266|NCT03529773|466006352|FG012|Overall Study|Physician Decision|0|||
129467267|NCT03529773|466006353|FG013|Overall Study|Physician Decision|0|||
129467268|NCT03529773|466006354|FG014|Overall Study|Physician Decision|0|||
129467269|NCT03529773|466006355|FG015|Overall Study|Physician Decision|0|||
129467270|NCT03529773|466006356|FG016|Overall Study|Physician Decision|0|||
129467271|NCT03529773|466006357|FG017|Overall Study|Physician Decision|0|||
129467272|NCT03529773|466006358|FG018|Overall Study|Physician Decision|0|||
129467273|NCT03529773|466006359|FG019|Overall Study|Physician Decision|1|||
129467274|NCT03529773|466006360|FG020|Overall Study|Physician Decision|1|||
129467275|NCT03529773|466006361|FG021|Overall Study|Physician Decision|0|||
129467276|NCT03529773|466006362|FG022|Overall Study|Physician Decision|0|||
129467277|NCT03529773|466006363|FG023|Overall Study|Physician Decision|0|||
129467278|NCT03529773|466006364|FG024|Overall Study|Physician Decision|0|||
129467279|NCT03529773|466006365|FG025|Overall Study|Physician Decision|0|||
129467280|NCT03529773|466006366|FG026|Overall Study|Physician Decision|0|||
129467281|NCT03529773|466006367|FG027|Overall Study|Physician Decision|0|||
129467282|NCT03529773|466006368|FG028|Overall Study|Physician Decision|0|||
129467283|NCT03529773|466006369|FG029|Overall Study|Physician Decision|0|||
129467284|NCT03529773|466006370|FG030|Overall Study|Physician Decision|0|||
129467285|NCT03529773|466006371|FG031|Overall Study|Physician Decision|0|||
129467286|NCT03529773|466006372|FG032|Overall Study|Physician Decision|0|||
129467287|NCT03529773|466006373|FG033|Overall Study|Physician Decision|0|||
129467288|NCT03529773|466006374|FG034|Overall Study|Physician Decision|0|||
129467289|NCT03529773|466006375|FG035|Overall Study|Physician Decision|0|||
129467290|NCT03529773|466006376|FG036|Overall Study|Physician Decision|0|||
129467291|NCT03529773|466006377|FG037|Overall Study|Physician Decision|0|||
129467292|NCT03529773|466006378|FG038|Overall Study|Physician Decision|0|||
129467293|NCT03529773|466006379|FG039|Overall Study|Physician Decision|0|||
129467294|NCT03529773|466006340|FG000|Overall Study|Protocol Violation|0|||
129467295|NCT03529773|466006341|FG001|Overall Study|Protocol Violation|0|||
129467296|NCT03529773|466006342|FG002|Overall Study|Protocol Violation|0|||
129467297|NCT03529773|466006343|FG003|Overall Study|Protocol Violation|0|||
129467298|NCT03529773|466006344|FG004|Overall Study|Protocol Violation|0|||
129467299|NCT03529773|466006345|FG005|Overall Study|Protocol Violation|0|||
129467300|NCT03529773|466006346|FG006|Overall Study|Protocol Violation|0|||
129467301|NCT03529773|466006347|FG007|Overall Study|Protocol Violation|0|||
129467302|NCT03529773|466006348|FG008|Overall Study|Protocol Violation|0|||
129467303|NCT03529773|466006349|FG009|Overall Study|Protocol Violation|0|||
129467304|NCT03529773|466006350|FG010|Overall Study|Protocol Violation|0|||
129467305|NCT03529773|466006351|FG011|Overall Study|Protocol Violation|0|||
129467306|NCT03529773|466006352|FG012|Overall Study|Protocol Violation|0|||
129467307|NCT03529773|466006353|FG013|Overall Study|Protocol Violation|0|||
129467308|NCT03529773|466006354|FG014|Overall Study|Protocol Violation|0|||
129467309|NCT03529773|466006355|FG015|Overall Study|Protocol Violation|0|||
129467310|NCT03529773|466006356|FG016|Overall Study|Protocol Violation|0|||
129467311|NCT03529773|466006357|FG017|Overall Study|Protocol Violation|0|||
129467312|NCT03529773|466006358|FG018|Overall Study|Protocol Violation|0|||
129467313|NCT03529773|466006359|FG019|Overall Study|Protocol Violation|0|||
129467314|NCT03529773|466006360|FG020|Overall Study|Protocol Violation|0|||
129467315|NCT03529773|466006361|FG021|Overall Study|Protocol Violation|0|||
129467316|NCT03529773|466006362|FG022|Overall Study|Protocol Violation|0|||
129467317|NCT03529773|466006363|FG023|Overall Study|Protocol Violation|0|||
129467318|NCT03529773|466006364|FG024|Overall Study|Protocol Violation|0|||
129467319|NCT03529773|466006365|FG025|Overall Study|Protocol Violation|0|||
129467320|NCT03529773|466006366|FG026|Overall Study|Protocol Violation|0|||
129467321|NCT03529773|466006367|FG027|Overall Study|Protocol Violation|0|||
129467322|NCT03529773|466006368|FG028|Overall Study|Protocol Violation|0|||
129467323|NCT03529773|466006369|FG029|Overall Study|Protocol Violation|0|||
129467324|NCT03529773|466006370|FG030|Overall Study|Protocol Violation|1|||
129467325|NCT03529773|466006371|FG031|Overall Study|Protocol Violation|0|||
129467326|NCT03529773|466006372|FG032|Overall Study|Protocol Violation|0|||
129467327|NCT03529773|466006373|FG033|Overall Study|Protocol Violation|0|||
129467328|NCT03529773|466006374|FG034|Overall Study|Protocol Violation|0|||
129467329|NCT03529773|466006375|FG035|Overall Study|Protocol Violation|0|||
129467330|NCT03529773|466006376|FG036|Overall Study|Protocol Violation|0|||
129467331|NCT03529773|466006377|FG037|Overall Study|Protocol Violation|0|||
129467332|NCT03529773|466006378|FG038|Overall Study|Protocol Violation|0|||
129467333|NCT03529773|466006379|FG039|Overall Study|Protocol Violation|0|||
129467334|NCT03529773|466006340|FG000|Overall Study|Withdrawal by Subject|0|||
129467335|NCT03529773|466006341|FG001|Overall Study|Withdrawal by Subject|0|||
129467336|NCT03529773|466006342|FG002|Overall Study|Withdrawal by Subject|0|||
129467337|NCT03529773|466006343|FG003|Overall Study|Withdrawal by Subject|0|||
129467338|NCT03529773|466006344|FG004|Overall Study|Withdrawal by Subject|0|||
129467339|NCT03529773|466006345|FG005|Overall Study|Withdrawal by Subject|0|||
129467340|NCT03529773|466006346|FG006|Overall Study|Withdrawal by Subject|0|||
129467341|NCT03529773|466006347|FG007|Overall Study|Withdrawal by Subject|1|||
129467342|NCT03529773|466006348|FG008|Overall Study|Withdrawal by Subject|0|||
129467343|NCT03529773|466006349|FG009|Overall Study|Withdrawal by Subject|1|||
129467344|NCT03529773|466006350|FG010|Overall Study|Withdrawal by Subject|1|||
129467345|NCT03529773|466006351|FG011|Overall Study|Withdrawal by Subject|0|||
129467346|NCT03529773|466006352|FG012|Overall Study|Withdrawal by Subject|0|||
129467347|NCT03529773|466006353|FG013|Overall Study|Withdrawal by Subject|0|||
129467348|NCT03529773|466006354|FG014|Overall Study|Withdrawal by Subject|0|||
129467349|NCT03529773|466006355|FG015|Overall Study|Withdrawal by Subject|3|||
129467350|NCT03529773|466006356|FG016|Overall Study|Withdrawal by Subject|0|||
129467351|NCT03529773|466006357|FG017|Overall Study|Withdrawal by Subject|2|||
129467352|NCT03529773|466006358|FG018|Overall Study|Withdrawal by Subject|3|||
129467353|NCT03529773|466006359|FG019|Overall Study|Withdrawal by Subject|1|||
129467354|NCT03529773|466006360|FG020|Overall Study|Withdrawal by Subject|3|||
129467355|NCT03529773|466006361|FG021|Overall Study|Withdrawal by Subject|1|||
129467356|NCT03529773|466006362|FG022|Overall Study|Withdrawal by Subject|1|||
129467357|NCT03529773|466006363|FG023|Overall Study|Withdrawal by Subject|2|||
129467358|NCT03529773|466006364|FG024|Overall Study|Withdrawal by Subject|2|||
129467359|NCT03529773|466006365|FG025|Overall Study|Withdrawal by Subject|4|||
129467360|NCT03529773|466006366|FG026|Overall Study|Withdrawal by Subject|2|||
129467361|NCT03529773|466006367|FG027|Overall Study|Withdrawal by Subject|1|||
129467362|NCT03529773|466006368|FG028|Overall Study|Withdrawal by Subject|1|||
129467363|NCT03529773|466006369|FG029|Overall Study|Withdrawal by Subject|0|||
129467364|NCT03529773|466006370|FG030|Overall Study|Withdrawal by Subject|0|||
129467365|NCT03529773|466006371|FG031|Overall Study|Withdrawal by Subject|0|||
129467366|NCT03529773|466006372|FG032|Overall Study|Withdrawal by Subject|0|||
129467367|NCT03529773|466006373|FG033|Overall Study|Withdrawal by Subject|0|||
129467368|NCT03529773|466006374|FG034|Overall Study|Withdrawal by Subject|1|||
129467369|NCT03529773|466006375|FG035|Overall Study|Withdrawal by Subject|2|||
129467370|NCT03529773|466006376|FG036|Overall Study|Withdrawal by Subject|0|||
129467371|NCT03529773|466006377|FG037|Overall Study|Withdrawal by Subject|2|||
129467372|NCT03529773|466006378|FG038|Overall Study|Withdrawal by Subject|1|||
129467373|NCT03529773|466006379|FG039|Overall Study|Withdrawal by Subject|1|||
129467374|NCT03529773|466006340|FG000|Overall Study|Screen Failure|0|||
129467375|NCT03529773|466006341|FG001|Overall Study|Screen Failure|0|||
129467376|NCT03529773|466006342|FG002|Overall Study|Screen Failure|0|||
129467377|NCT03529773|466006343|FG003|Overall Study|Screen Failure|0|||
129467378|NCT03529773|466006344|FG004|Overall Study|Screen Failure|0|||
129467379|NCT03529773|466006345|FG005|Overall Study|Screen Failure|0|||
129467380|NCT03529773|466006346|FG006|Overall Study|Screen Failure|0|||
129467381|NCT03529773|466006347|FG007|Overall Study|Screen Failure|0|||
129467382|NCT03529773|466006348|FG008|Overall Study|Screen Failure|0|||
129467383|NCT03529773|466006349|FG009|Overall Study|Screen Failure|0|||
129467384|NCT03529773|466006350|FG010|Overall Study|Screen Failure|0|||
129467385|NCT03529773|466006351|FG011|Overall Study|Screen Failure|0|||
129467386|NCT03529773|466006352|FG012|Overall Study|Screen Failure|0|||
129467387|NCT03529773|466006353|FG013|Overall Study|Screen Failure|0|||
129467388|NCT03529773|466006354|FG014|Overall Study|Screen Failure|0|||
129467389|NCT03529773|466006355|FG015|Overall Study|Screen Failure|0|||
129467390|NCT03529773|466006356|FG016|Overall Study|Screen Failure|0|||
129467391|NCT03529773|466006357|FG017|Overall Study|Screen Failure|0|||
129467392|NCT03529773|466006358|FG018|Overall Study|Screen Failure|0|||
129467393|NCT03529773|466006359|FG019|Overall Study|Screen Failure|0|||
129467394|NCT03529773|466006360|FG020|Overall Study|Screen Failure|0|||
129467395|NCT03529773|466006361|FG021|Overall Study|Screen Failure|0|||
129467396|NCT03529773|466006362|FG022|Overall Study|Screen Failure|0|||
129467397|NCT03529773|466006363|FG023|Overall Study|Screen Failure|0|||
129467398|NCT03529773|466006364|FG024|Overall Study|Screen Failure|0|||
129467399|NCT03529773|466006365|FG025|Overall Study|Screen Failure|0|||
129467400|NCT03529773|466006366|FG026|Overall Study|Screen Failure|0|||
129467401|NCT03529773|466006367|FG027|Overall Study|Screen Failure|0|||
129467402|NCT03529773|466006368|FG028|Overall Study|Screen Failure|0|||
129467403|NCT03529773|466006369|FG029|Overall Study|Screen Failure|0|||
129467404|NCT03529773|466006370|FG030|Overall Study|Screen Failure|0|||
129467405|NCT03529773|466006371|FG031|Overall Study|Screen Failure|0|||
129467406|NCT03529773|466006372|FG032|Overall Study|Screen Failure|0|||
129467407|NCT03529773|466006373|FG033|Overall Study|Screen Failure|0|||
129467408|NCT03529773|466006374|FG034|Overall Study|Screen Failure|0|||
129467409|NCT03529773|466006375|FG035|Overall Study|Screen Failure|0|||
129467410|NCT03529773|466006376|FG036|Overall Study|Screen Failure|1|||
129467411|NCT03529773|466006377|FG037|Overall Study|Screen Failure|1|||
129467412|NCT03529773|466006378|FG038|Overall Study|Screen Failure|0|||
129467413|NCT03529773|466006379|FG039|Overall Study|Screen Failure|1|||
129467414|NCT03529773|466006340|FG000|Overall Study|Randomized but not vaccinated|0|||
129467415|NCT03529773|466006341|FG001|Overall Study|Randomized but not vaccinated|0|||
129467416|NCT03529773|466006342|FG002|Overall Study|Randomized but not vaccinated|0|||
129467417|NCT03529773|466006343|FG003|Overall Study|Randomized but not vaccinated|0|||
129467418|NCT03529773|466006344|FG004|Overall Study|Randomized but not vaccinated|0|||
129467419|NCT03529773|466006345|FG005|Overall Study|Randomized but not vaccinated|0|||
129467420|NCT03529773|466006346|FG006|Overall Study|Randomized but not vaccinated|0|||
129467421|NCT03529773|466006347|FG007|Overall Study|Randomized but not vaccinated|0|||
129467422|NCT03529773|466006348|FG008|Overall Study|Randomized but not vaccinated|0|||
129467423|NCT03529773|466006349|FG009|Overall Study|Randomized but not vaccinated|0|||
129467424|NCT03529773|466006350|FG010|Overall Study|Randomized but not vaccinated|0|||
129467425|NCT03529773|466006351|FG011|Overall Study|Randomized but not vaccinated|0|||
129467426|NCT03529773|466006352|FG012|Overall Study|Randomized but not vaccinated|0|||
129467427|NCT03529773|466006353|FG013|Overall Study|Randomized but not vaccinated|0|||
129467428|NCT03529773|466006354|FG014|Overall Study|Randomized but not vaccinated|0|||
129467429|NCT03529773|466006355|FG015|Overall Study|Randomized but not vaccinated|0|||
129467430|NCT03529773|466006356|FG016|Overall Study|Randomized but not vaccinated|0|||
129467431|NCT03529773|466006357|FG017|Overall Study|Randomized but not vaccinated|1|||
129467432|NCT03529773|466006358|FG018|Overall Study|Randomized but not vaccinated|0|||
129467433|NCT03529773|466006359|FG019|Overall Study|Randomized but not vaccinated|0|||
129467434|NCT03529773|466006360|FG020|Overall Study|Randomized but not vaccinated|0|||
129467435|NCT03529773|466006361|FG021|Overall Study|Randomized but not vaccinated|0|||
129467436|NCT03529773|466006362|FG022|Overall Study|Randomized but not vaccinated|0|||
129467437|NCT03529773|466006363|FG023|Overall Study|Randomized but not vaccinated|0|||
129467438|NCT03529773|466006364|FG024|Overall Study|Randomized but not vaccinated|0|||
129467439|NCT03529773|466006365|FG025|Overall Study|Randomized but not vaccinated|0|||
129467440|NCT03529773|466006366|FG026|Overall Study|Randomized but not vaccinated|0|||
129467441|NCT03529773|466006367|FG027|Overall Study|Randomized but not vaccinated|1|||
129467442|NCT03529773|466006368|FG028|Overall Study|Randomized but not vaccinated|0|||
129467443|NCT03529773|466006369|FG029|Overall Study|Randomized but not vaccinated|0|||
129467444|NCT03529773|466006370|FG030|Overall Study|Randomized but not vaccinated|0|||
129467445|NCT03529773|466006371|FG031|Overall Study|Randomized but not vaccinated|0|||
129467446|NCT03529773|466006372|FG032|Overall Study|Randomized but not vaccinated|0|||
129467447|NCT03529773|466006373|FG033|Overall Study|Randomized but not vaccinated|0|||
129467448|NCT03529773|466006374|FG034|Overall Study|Randomized but not vaccinated|0|||
129467449|NCT03529773|466006375|FG035|Overall Study|Randomized but not vaccinated|0|||
129467450|NCT03529773|466006376|FG036|Overall Study|Randomized but not vaccinated|0|||
129467451|NCT03529773|466006377|FG037|Overall Study|Randomized but not vaccinated|0|||
129467452|NCT03529773|466006378|FG038|Overall Study|Randomized but not vaccinated|0|||
129467453|NCT03529773|466006379|FG039|Overall Study|Randomized but not vaccinated|0|||
129467454|NCT01537211|466006380|FG000|Overall Study|Lost to Follow-up|0|||
129467455|NCT01537211|466006381|FG001|Overall Study|Lost to Follow-up|1|||
129467456|NCT00257010|466006385|FG000|Overall Study|Lack of Efficacy|11|||
129467457|NCT00257010|466006385|FG000|Overall Study|Lost to Follow-up|53|||
129467458|NCT00257010|466006385|FG000|Overall Study|Withdrawal by Subject|34|||
129467459|NCT00257010|466006385|FG000|Overall Study|Adverse Event|10|||
129467460|NCT00257010|466006385|FG000|Overall Study|various|11|||
129467461|NCT00257010|466006385|FG000|Overall Study|no headache reported|9|||
129467462|NCT00323557|466006386|FG000|Overall Study|Physician Decision|1|||
129467463|NCT00323557|466006387|FG001|Overall Study|Physician Decision|0|||
129467464|NCT00197054|466006388|FG000|Overall Study|Withdrawal by Subject|9|||
129467465|NCT00197054|466006389|FG001|Overall Study|Withdrawal by Subject|3|||
129971196|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
129971197|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
129467466|NCT00197054|466006390|FG002|Overall Study|Withdrawal by Subject|3|||
129467467|NCT00197054|466006388|FG000|Overall Study|Moved from area|7|||
129467468|NCT00197054|466006389|FG001|Overall Study|Moved from area|14|||
129467469|NCT00197054|466006390|FG002|Overall Study|Moved from area|9|||
129467470|NCT00197054|466006388|FG000|Overall Study|Lost to Follow-up|1|||
129467471|NCT00197054|466006389|FG001|Overall Study|Lost to Follow-up|4|||
129467472|NCT00197054|466006390|FG002|Overall Study|Lost to Follow-up|0|||
129467473|NCT00662792|466006393|FG000|Period 1|Personal Reasons|0|||
129467474|NCT00662792|466006394|FG001|Period 1|Personal Reasons|0|||
129467475|NCT00662792|466006395|FG002|Period 1|Personal Reasons|1|||
129467476|NCT00662792|466006396|FG003|Period 1|Personal Reasons|0|||
129467477|NCT00662792|466006393|FG000|Period 1|Refused continuing medication|0|||
129467478|NCT00662792|466006394|FG001|Period 1|Refused continuing medication|1|||
129467479|NCT00662792|466006395|FG002|Period 1|Refused continuing medication|1|||
129467480|NCT00662792|466006396|FG003|Period 1|Refused continuing medication|0|||
129467481|NCT00662792|466006393|FG000|Period 1|Lost to Follow-up|1|||
129467482|NCT00662792|466006394|FG001|Period 1|Lost to Follow-up|0|||
129467483|NCT00662792|466006395|FG002|Period 1|Lost to Follow-up|0|||
129467484|NCT00662792|466006396|FG003|Period 1|Lost to Follow-up|0|||
129467485|NCT00662792|466006393|FG000|Period 1|Other adverse event (AE)|0|||
129467486|NCT00662792|466006394|FG001|Period 1|Other adverse event (AE)|2|||
129467487|NCT00662792|466006395|FG002|Period 1|Other adverse event (AE)|0|||
129467488|NCT00662792|466006396|FG003|Period 1|Other adverse event (AE)|0|||
129467489|NCT00662792|466006393|FG000|Period 1|Worsening of disease under study (AE)|1|||
129467490|NCT00662792|466006394|FG001|Period 1|Worsening of disease under study (AE)|3|||
129467491|NCT00662792|466006395|FG002|Period 1|Worsening of disease under study (AE)|2|||
129467492|NCT00662792|466006396|FG003|Period 1|Worsening of disease under study (AE)|0|||
129467493|NCT00662792|466006393|FG000|Period 1|Not treated|0|||
129467494|NCT00662792|466006394|FG001|Period 1|Not treated|1|||
129467495|NCT00662792|466006395|FG002|Period 1|Not treated|0|||
129467496|NCT00662792|466006396|FG003|Period 1|Not treated|0|||
129467497|NCT00662792|466006393|FG000|Period 2|Worsening of disease under study|1|||
129467498|NCT00662792|466006394|FG001|Period 2|Worsening of disease under study|0|||
129467499|NCT00662792|466006395|FG002|Period 2|Worsening of disease under study|0|||
129467500|NCT00662792|466006396|FG003|Period 2|Worsening of disease under study|3|||
129467501|NCT00662792|466006393|FG000|Period 3|Refused continuing medication|1|||
129467502|NCT00662792|466006394|FG001|Period 3|Refused continuing medication|0|||
129467503|NCT00662792|466006395|FG002|Period 3|Refused continuing medication|1|||
129467504|NCT00662792|466006396|FG003|Period 3|Refused continuing medication|0|||
129467505|NCT00662792|466006393|FG000|Period 3|Other adverse event (AE)|0|||
129467506|NCT00662792|466006394|FG001|Period 3|Other adverse event (AE)|0|||
129467507|NCT00662792|466006395|FG002|Period 3|Other adverse event (AE)|1|||
129467508|NCT00662792|466006396|FG003|Period 3|Other adverse event (AE)|1|||
129467509|NCT00662792|466006393|FG000|Period 4|Refused continuing medication|0|||
129467510|NCT00662792|466006394|FG001|Period 4|Refused continuing medication|1|||
129467511|NCT00662792|466006395|FG002|Period 4|Refused continuing medication|0|||
129467512|NCT00662792|466006396|FG003|Period 4|Refused continuing medication|0|||
129467513|NCT00662792|466006393|FG000|Period 4|Other adverse event (AE)|1|||
129467514|NCT00662792|466006394|FG001|Period 4|Other adverse event (AE)|0|||
129467515|NCT00662792|466006395|FG002|Period 4|Other adverse event (AE)|0|||
129467516|NCT00662792|466006396|FG003|Period 4|Other adverse event (AE)|0|||
129467517|NCT00662792|466006393|FG000|Period 4|Worsening of disease under study (AE)|0|||
129467518|NCT00662792|466006394|FG001|Period 4|Worsening of disease under study (AE)|0|||
129467519|NCT00662792|466006395|FG002|Period 4|Worsening of disease under study (AE)|0|||
129467520|NCT00662792|466006396|FG003|Period 4|Worsening of disease under study (AE)|1|||
129467521|NCT01699087|466006398|FG000|Overall Study|Lost to Follow-up|7|||
129467522|NCT01699087|466006398|FG000|Overall Study|Screen failure (prior to treatment)|15|||
129467523|NCT01699087|466006398|FG000|Overall Study|Unable to make future visits|2|||
129467524|NCT03021642|466006401|FG000|Washout Period (21 Days)|Adverse Event|1|||
129467525|NCT03021642|466006402|FG001|Washout Period (21 Days)|Adverse Event|1|||
129467526|NCT00756938|466006403|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
129467527|NCT00756938|466006404|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
129467528|NCT00756938|466006405|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
129467529|NCT00756938|466006406|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
129971198|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
129971199|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
129971200|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
129971201|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
129971202|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
129467530|NCT00756938|466006403|FG000|12-week Base Study|Protocol Violation|0|||
129467531|NCT00756938|466006404|FG001|12-week Base Study|Protocol Violation|0|||
129467532|NCT00756938|466006405|FG002|12-week Base Study|Protocol Violation|1|||
129467533|NCT00756938|466006406|FG003|12-week Base Study|Protocol Violation|0|||
129467534|NCT00756938|466006403|FG000|12-week Base Study|Lost to Follow-up|1|||
129467535|NCT00756938|466006404|FG001|12-week Base Study|Lost to Follow-up|0|||
129467536|NCT00756938|466006405|FG002|12-week Base Study|Lost to Follow-up|0|||
129467537|NCT00756938|466006406|FG003|12-week Base Study|Lost to Follow-up|0|||
129467538|NCT00756938|466006403|FG000|Optional Extension|Lack of Efficacy|0|||
129467539|NCT00756938|466006404|FG001|Optional Extension|Lack of Efficacy|0|||
129467540|NCT00756938|466006405|FG002|Optional Extension|Lack of Efficacy|0|||
129467541|NCT00756938|466006406|FG003|Optional Extension|Lack of Efficacy|1|||
129467542|NCT00756938|466006403|FG000|Optional Extension|End of Study|0|||
129467543|NCT00756938|466006404|FG001|Optional Extension|End of Study|0|||
129971203|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
129971204|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
129971205|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
129971206|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
129971207|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
129971208|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
129971209|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
129971210|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
129971211|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
129971212|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
129971213|NCT00132678|467858421|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
129971214|NCT00132678|467858422|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
129971215|NCT00132678|467858423|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
129971216|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
129971217|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
129971218|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
129971219|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
129971220|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
129971221|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
129971222|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
129971223|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
129971224|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
129971225|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
129971226|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
129971227|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
129971228|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
129971229|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
129971230|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
129971231|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
129971232|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
129971233|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
129971234|NCT00132678|467858421|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
129971235|NCT00132678|467858422|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
129971236|NCT00132678|467858423|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
129971237|NCT01367847|467858424|FG000|Overall Study|Withdrawal by Subject|2|||
129971238|NCT01367847|467858425|FG001|Overall Study|Withdrawal by Subject|2|||
129971239|NCT02056626|467858426|FG000|Overall Study|patient did not follow directions|3|||
129971240|NCT02056626|467858427|FG001|Overall Study|patient did not follow directions|1|||
129971241|NCT02056626|467858428|FG002|Overall Study|patient did not follow directions|0|||
129971242|NCT02056626|467858429|FG003|Overall Study|patient did not follow directions|0|||
129971243|NCT01454739|467858433|FG000|Overall Study|Protocol Violation|2|||
129971244|NCT01454739|467858434|FG001|Overall Study|Protocol Violation|3|||
129971245|NCT01454739|467858433|FG000|Overall Study|Withdrawal by Subject|2|||
129971246|NCT01454739|467858434|FG001|Overall Study|Withdrawal by Subject|6|||
129971247|NCT01454739|467858433|FG000|Overall Study|Other|3|||
129971248|NCT01454739|467858434|FG001|Overall Study|Other|5|||
129971249|NCT01454739|467858433|FG000|Overall Study|Physician Decision|0|||
129971250|NCT01454739|467858434|FG001|Overall Study|Physician Decision|5|||
129971251|NCT01454739|467858433|FG000|Overall Study|Lost to Follow-up|0|||
129467544|NCT00756938|466006405|FG002|Optional Extension|End of Study|0|||
129467545|NCT00756938|466006406|FG003|Optional Extension|End of Study|11|||
129467546|NCT00756938|466006403|FG000|Optional Extension|Protocol-specific criteria met|0|||
129971252|NCT01454739|467858434|FG001|Overall Study|Lost to Follow-up|1|||
129971253|NCT01454739|467858433|FG000|Overall Study|Adverse Event|0|||
129971254|NCT01454739|467858434|FG001|Overall Study|Adverse Event|1|||
129971255|NCT01784523|467858437|FG000|Overall Study|Study closed early|7|||
129467547|NCT00756938|466006404|FG001|Optional Extension|Protocol-specific criteria met|0|||
129971256|NCT01784523|467858438|FG001|Overall Study|Study closed early|4|||
129467548|NCT00756938|466006405|FG002|Optional Extension|Protocol-specific criteria met|0|||
129467549|NCT00756938|466006406|FG003|Optional Extension|Protocol-specific criteria met|9|||
129467550|NCT00756938|466006403|FG000|Optional Extension|Physician Decision|0|||
129467551|NCT00756938|466006404|FG001|Optional Extension|Physician Decision|0|||
129467552|NCT00756938|466006405|FG002|Optional Extension|Physician Decision|0|||
129467553|NCT00756938|466006406|FG003|Optional Extension|Physician Decision|3|||
129467554|NCT00756938|466006403|FG000|Optional Extension|Lost to Follow-up|0|||
129467555|NCT00756938|466006404|FG001|Optional Extension|Lost to Follow-up|0|||
129467556|NCT00756938|466006405|FG002|Optional Extension|Lost to Follow-up|0|||
129467557|NCT00756938|466006406|FG003|Optional Extension|Lost to Follow-up|1|||
129467558|NCT00756938|466006403|FG000|Optional Extension|Protocol Violation|0|||
129467559|NCT00756938|466006404|FG001|Optional Extension|Protocol Violation|0|||
129467560|NCT00756938|466006405|FG002|Optional Extension|Protocol Violation|0|||
129467561|NCT00756938|466006406|FG003|Optional Extension|Protocol Violation|1|||
129467562|NCT00756938|466006403|FG000|Optional Extension|Withdrawal by Subject|0|||
129467563|NCT00756938|466006404|FG001|Optional Extension|Withdrawal by Subject|0|||
129467564|NCT00756938|466006405|FG002|Optional Extension|Withdrawal by Subject|0|||
129467565|NCT00756938|466006406|FG003|Optional Extension|Withdrawal by Subject|10|||
129467566|NCT00756938|466006403|FG000|Optional Extension|Adverse Event|0|||
129467567|NCT00756938|466006404|FG001|Optional Extension|Adverse Event|0|||
129467568|NCT00756938|466006405|FG002|Optional Extension|Adverse Event|0|||
129467569|NCT00756938|466006406|FG003|Optional Extension|Adverse Event|1|||
129467570|NCT00090545|466006407|FG000|Overall Study|Disease progression on study|21|||
129467571|NCT00090545|466006408|FG001|Overall Study|Disease progression on study|17|||
129467572|NCT00090545|466006407|FG000|Overall Study|Refused further treatment|1|||
129467573|NCT00090545|466006408|FG001|Overall Study|Refused further treatment|4|||
129467574|NCT00090545|466006407|FG000|Overall Study|Death|0|||
129467575|NCT00090545|466006408|FG001|Overall Study|Death|1|||
129467576|NCT00090545|466006407|FG000|Overall Study|Adverse Event|0|||
129467577|NCT00090545|466006408|FG001|Overall Study|Adverse Event|2|||
129467578|NCT00797823|466006412|FG000|First Period (Initial Randomization)|Physician Decision|1|||
129467579|NCT00797823|466006413|FG001|First Period (Initial Randomization)|Physician Decision|0|||
129467580|NCT00797823|466006414|FG002|First Period (Initial Randomization)|Physician Decision|0|||
129467581|NCT02809833|466006415|FG000|Overall Study|Death|3|||
129467582|NCT02809833|466006415|FG000|Overall Study|Intolerance|54|||
129467583|NCT02809833|466006415|FG000|Overall Study|Lack of Efficacy|89|||
129467584|NCT02809833|466006415|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
129467585|NCT02809833|466006415|FG000|Overall Study|Noncompliance|1|||
129467586|NCT02809833|466006415|FG000|Overall Study|Withdrawal by Subject|34|||
129467587|NCT02809833|466006415|FG000|Overall Study|Lost to Follow-up|35|||
129467588|NCT02809833|466006415|FG000|Overall Study|Adverse Event (AE)|24|||
129467589|NCT02809833|466006415|FG000|Overall Study|Other|5|||
129467590|NCT02809833|466006415|FG000|Overall Study|Missing Information|52|||
129467591|NCT00523991|466006416|FG000|Overall Study|Adverse Event|6|||
129467592|NCT00523991|466006417|FG001|Overall Study|Adverse Event|5|||
129467593|NCT00523991|466006416|FG000|Overall Study|Protocol Violation|1|||
129467594|NCT00523991|466006417|FG001|Overall Study|Protocol Violation|4|||
129467595|NCT00523991|466006416|FG000|Overall Study|Lost to Follow-up|4|||
129467596|NCT00523991|466006417|FG001|Overall Study|Lost to Follow-up|1|||
129467597|NCT00523991|466006416|FG000|Overall Study|Withdrawal by Subject|7|||
129467598|NCT00523991|466006417|FG001|Overall Study|Withdrawal by Subject|17|||
129467599|NCT00523991|466006416|FG000|Overall Study|Other reason (not specified)|3|||
129467600|NCT00523991|466006417|FG001|Overall Study|Other reason (not specified)|0|||
129467601|NCT00193063|466006418|FG000|Overall Study|Lack of Efficacy|3|||
129467602|NCT00193063|466006418|FG000|Overall Study|Adverse Event|1|||
129467603|NCT00744874|466006421|FG000|Overall Study|Lost to Follow-up|1|||
129467604|NCT00744874|466006421|FG000|Overall Study|Withdrawal by Subject|1|||
129467605|NCT00744874|466006421|FG000|Overall Study|Study Device not available at procedure|1|||
129467606|NCT00744874|466006421|FG000|Overall Study|Unable to accomodate schedule|1|||
129467607|NCT00763321|466006425|FG000|Open-label Period|Adverse Event|24|||
129467608|NCT00763321|466006426|FG001|Open-label Period|Adverse Event|0|||
129467609|NCT00763321|466006427|FG002|Open-label Period|Adverse Event|0|||
129467610|NCT00763321|466006425|FG000|Open-label Period|Lost to Follow-up|14|||
129467611|NCT00763321|466006426|FG001|Open-label Period|Lost to Follow-up|0|||
129467612|NCT00763321|466006427|FG002|Open-label Period|Lost to Follow-up|0|||
129467613|NCT00763321|466006425|FG000|Open-label Period|Withdrawal by Subject|7|||
129467614|NCT00763321|466006426|FG001|Open-label Period|Withdrawal by Subject|0|||
129467615|NCT00763321|466006427|FG002|Open-label Period|Withdrawal by Subject|0|||
129467616|NCT00763321|466006425|FG000|Open-label Period|Subject noncompliant|7|||
129467617|NCT00763321|466006426|FG001|Open-label Period|Subject noncompliant|0|||
129467618|NCT00763321|466006427|FG002|Open-label Period|Subject noncompliant|0|||
129467619|NCT00763321|466006425|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
129467620|NCT00763321|466006426|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
129467621|NCT00763321|466006427|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
129467622|NCT00763321|466006425|FG000|Open-label Period|Lack of Efficacy|2|||
129467623|NCT00763321|466006426|FG001|Open-label Period|Lack of Efficacy|0|||
129467624|NCT00763321|466006427|FG002|Open-label Period|Lack of Efficacy|0|||
129467625|NCT00763321|466006425|FG000|Open-label Period|Other|4|||
129467626|NCT00763321|466006426|FG001|Open-label Period|Other|0|||
129467627|NCT00763321|466006427|FG002|Open-label Period|Other|0|||
129467628|NCT00763321|466006425|FG000|Double-blind Period|Lack of Efficacy|0|||
129467629|NCT00763321|466006426|FG001|Double-blind Period|Lack of Efficacy|9|||
129467630|NCT00763321|466006427|FG002|Double-blind Period|Lack of Efficacy|17|||
129467631|NCT00763321|466006425|FG000|Double-blind Period|Adverse Event|0|||
129467632|NCT00763321|466006426|FG001|Double-blind Period|Adverse Event|4|||
129467633|NCT00763321|466006427|FG002|Double-blind Period|Adverse Event|4|||
129467634|NCT00763321|466006425|FG000|Double-blind Period|Lost to Follow-up|0|||
129467635|NCT00763321|466006426|FG001|Double-blind Period|Lost to Follow-up|4|||
129467636|NCT00763321|466006427|FG002|Double-blind Period|Lost to Follow-up|2|||
129467637|NCT00763321|466006425|FG000|Double-blind Period|Withdrawal by Subject|0|||
129467638|NCT00763321|466006426|FG001|Double-blind Period|Withdrawal by Subject|2|||
129467639|NCT00763321|466006427|FG002|Double-blind Period|Withdrawal by Subject|3|||
129467640|NCT00763321|466006425|FG000|Double-blind Period|Other|0|||
129467641|NCT00763321|466006426|FG001|Double-blind Period|Other|2|||
129467642|NCT00763321|466006427|FG002|Double-blind Period|Other|3|||
129467643|NCT03175549|466006428|FG000|Overall Study|Lost to Follow-up|2|||
129467644|NCT03175549|466006429|FG001|Overall Study|Lost to Follow-up|2|||
129467645|NCT03175549|466006428|FG000|Overall Study|Medication non-compliance|2|||
129467646|NCT03175549|466006429|FG001|Overall Study|Medication non-compliance|2|||
129467647|NCT02435849|466006430|FG000|Overall Study|Death|23|||
129467648|NCT02435849|466006431|FG001|Overall Study|Death|0|||
129467649|NCT02435849|466006430|FG000|Overall Study|Lack of Efficacy|10|||
129467650|NCT02435849|466006431|FG001|Overall Study|Lack of Efficacy|0|||
129467651|NCT02435849|466006430|FG000|Overall Study|New therapy for study indication|8|||
129467652|NCT02435849|466006431|FG001|Overall Study|New therapy for study indication|0|||
129467653|NCT02435849|466006430|FG000|Overall Study|Subject/guardian decision|5|||
129467654|NCT02435849|466006431|FG001|Overall Study|Subject/guardian decision|1|||
129467655|NCT02435849|466006430|FG000|Overall Study|Lost to Follow-up|1|||
129467656|NCT02435849|466006431|FG001|Overall Study|Lost to Follow-up|0|||
129467657|NCT02435849|466006430|FG000|Overall Study|Physician Decision|1|||
129467658|NCT02435849|466006431|FG001|Overall Study|Physician Decision|0|||
129467659|NCT02486757|466006432|FG000|Overall Study|Lost to Follow-up|1|||
129467660|NCT01017952|466006433|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
129467661|NCT01017952|466006434|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129467662|NCT01017952|466006435|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129467663|NCT01017952|466006436|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129467664|NCT01017952|466006437|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129467665|NCT01017952|466006433|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
129467666|NCT01017952|466006434|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
129467667|NCT01017952|466006435|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
129467668|NCT01017952|466006436|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
129467669|NCT01017952|466006437|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
129467670|NCT01017952|466006433|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
129467671|NCT01017952|466006434|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
129467672|NCT01017952|466006435|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
129467673|NCT01017952|466006436|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
129467674|NCT01017952|466006437|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
129467675|NCT01017952|466006433|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
129467676|NCT01017952|466006434|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129467677|NCT01017952|466006435|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129467678|NCT01017952|466006436|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129467679|NCT01017952|466006437|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129467680|NCT01017952|466006433|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
129467681|NCT01017952|466006434|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
129467682|NCT01017952|466006435|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
129467683|NCT01017952|466006436|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
129467684|NCT01017952|466006437|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
129971257|NCT04340947|467858439|FG000|7-day Washout Period|Lost to Follow-up|5|||
129971258|NCT04340947|467858440|FG001|7-day Washout Period|Lost to Follow-up|4|||
129467685|NCT01017952|466006433|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
129467686|NCT01017952|466006434|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129467687|NCT01017952|466006435|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129467688|NCT01017952|466006436|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129467689|NCT01017952|466006437|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129467690|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
129467691|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
129467692|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
129467693|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
129971259|NCT01124097|467858444|FG000|Overall Study|Withdrawal by Subject|4|||
129971260|NCT01124097|467858445|FG001|Overall Study|Withdrawal by Subject|3|||
129467694|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
129467695|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129467696|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
129467697|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
129467698|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
129467699|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
129467700|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
129467701|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
129467702|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
129467703|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
129467704|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
129467705|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
129467706|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
129467707|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
129467708|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
129467709|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
129467710|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129467711|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
129467712|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
129467713|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
129467714|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
129467715|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129467716|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
129467717|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
129467718|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129467719|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129467720|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129467721|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
129467722|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
129467723|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
129467724|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
129467725|NCT01017952|466006433|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
129467726|NCT01017952|466006434|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
129467727|NCT01017952|466006435|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
129467728|NCT01017952|466006436|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
129971261|NCT01124097|467858446|FG002|Overall Study|Withdrawal by Subject|2|||
129971262|NCT01124097|467858447|FG003|Overall Study|Withdrawal by Subject|3|||
129971263|NCT01124097|467858444|FG000|Overall Study|Lack of Efficacy|2|||
129971264|NCT01124097|467858445|FG001|Overall Study|Lack of Efficacy|3|||
129971265|NCT01124097|467858446|FG002|Overall Study|Lack of Efficacy|1|||
129971266|NCT01124097|467858447|FG003|Overall Study|Lack of Efficacy|3|||
129971267|NCT01124097|467858444|FG000|Overall Study|Adverse Event|24|||
129971268|NCT01124097|467858445|FG001|Overall Study|Adverse Event|15|||
129971269|NCT01124097|467858446|FG002|Overall Study|Adverse Event|15|||
129971270|NCT01124097|467858447|FG003|Overall Study|Adverse Event|7|||
129971271|NCT01124097|467858444|FG000|Overall Study|Protocol Violation|2|||
129971272|NCT01124097|467858445|FG001|Overall Study|Protocol Violation|0|||
129971273|NCT01124097|467858446|FG002|Overall Study|Protocol Violation|2|||
129467729|NCT01017952|466006437|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
129467730|NCT01298492|466006438|FG000|Overall Study|Death|2|||
129467731|NCT01298492|466006438|FG000|Overall Study|Insufficient Clinical Response|22|||
129467732|NCT01298492|466006438|FG000|Overall Study|Lost to Follow-up|12|||
129467733|NCT01298492|466006438|FG000|Overall Study|Withdrawal by Subject|47|||
129467734|NCT01298492|466006438|FG000|Overall Study|Other (Unspecified)|7|||
129467735|NCT01298492|466006438|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
129467736|NCT01298492|466006438|FG000|Overall Study|Protocol Violation|2|||
129467737|NCT01298492|466006438|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
129467738|NCT01298492|466006438|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
129467739|NCT00352105|466006439|FG000|Overall Study|Death|5|||
129467740|NCT00352105|466006439|FG000|Overall Study|Withdrawal by Subject|5|||
129467741|NCT00352105|466006439|FG000|Overall Study|Lack of Efficacy|9|||
129467742|NCT00352105|466006439|FG000|Overall Study|Adverse Event|19|||
129467743|NCT00352105|466006439|FG000|Overall Study|Protocol Violation|2|||
129467744|NCT01405053|466006440|FG000|Overall Study|Adverse Event|3|||
129467745|NCT01405053|466006441|FG001|Overall Study|Adverse Event|0|||
129467746|NCT01405053|466006440|FG000|Overall Study|Lost to Follow-up|0|||
129467747|NCT01405053|466006441|FG001|Overall Study|Lost to Follow-up|1|||
129467748|NCT01405053|466006440|FG000|Overall Study|Participant choice|2|||
129467749|NCT01405053|466006441|FG001|Overall Study|Participant choice|1|||
129467750|NCT01405053|466006440|FG000|Overall Study|Inadequate therapeutic effect|2|||
129467751|NCT01405053|466006441|FG001|Overall Study|Inadequate therapeutic effect|1|||
129467752|NCT01405053|466006440|FG000|Overall Study|Withdrawal by Subject|3|||
129467753|NCT01405053|466006441|FG001|Overall Study|Withdrawal by Subject|4|||
129467754|NCT01405053|466006440|FG000|Overall Study|Other|0|||
129467755|NCT01405053|466006441|FG001|Overall Study|Other|1|||
129467756|NCT01913483|466006449|FG000|Overall Study|Withdrawal by Subject|1|||
129467757|NCT01913483|466006450|FG001|Overall Study|Withdrawal by Subject|2|||
129467758|NCT01913483|466006449|FG000|Overall Study|Lost to Follow-up|6|||
129467759|NCT01913483|466006450|FG001|Overall Study|Lost to Follow-up|3|||
129467760|NCT01913483|466006449|FG000|Overall Study|Death|14|||
129467761|NCT01913483|466006450|FG001|Overall Study|Death|17|||
129467762|NCT00915343|466006451|FG000|Part B - Open Label Period|Treatment switch|0|||
129467763|NCT00915343|466006452|FG001|Part B - Open Label Period|Treatment switch|0|||
129467764|NCT00915343|466006453|FG002|Part B - Open Label Period|Treatment switch|1|||
129467765|NCT00915343|466006451|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
129467766|NCT00915343|466006452|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
129467767|NCT00915343|466006453|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
129467768|NCT01920711|466006454|FG000|Overall Study|Death|347|||
129467769|NCT01920711|466006455|FG001|Overall Study|Death|356|||
129467770|NCT01920711|466006454|FG000|Overall Study|Lost to Follow-up|13|||
129467771|NCT01920711|466006455|FG001|Overall Study|Lost to Follow-up|14|||
129467772|NCT01920711|466006454|FG000|Overall Study|Withdrawal by Subject|4|||
129467773|NCT01920711|466006455|FG001|Overall Study|Withdrawal by Subject|3|||
129467774|NCT01145066|466006456|FG000|Overall Study|To resume NSAIDs|2|||
129467775|NCT01145066|466006457|FG001|Overall Study|To resume NSAIDs|2|||
129467776|NCT01145066|466006458|FG002|Overall Study|To resume NSAIDs|1|||
129467777|NCT01145066|466006456|FG000|Overall Study|Non-related surgery|0|||
129467778|NCT01145066|466006457|FG001|Overall Study|Non-related surgery|0|||
129467779|NCT01145066|466006458|FG002|Overall Study|Non-related surgery|1|||
129467780|NCT01145066|466006456|FG000|Overall Study|Withdrawal by Subject|0|||
129467781|NCT01145066|466006457|FG001|Overall Study|Withdrawal by Subject|0|||
129467782|NCT01145066|466006458|FG002|Overall Study|Withdrawal by Subject|2|||
129467783|NCT01145066|466006456|FG000|Overall Study|To start new med|1|||
129467784|NCT01145066|466006457|FG001|Overall Study|To start new med|0|||
129467785|NCT01145066|466006458|FG002|Overall Study|To start new med|0|||
129467786|NCT01145066|466006456|FG000|Overall Study|problems swallowing capsule|1|||
129467787|NCT01145066|466006457|FG001|Overall Study|problems swallowing capsule|0|||
129467788|NCT01145066|466006458|FG002|Overall Study|problems swallowing capsule|0|||
129467789|NCT01145066|466006456|FG000|Overall Study|Abdominal discomfort|0|||
129467790|NCT01145066|466006457|FG001|Overall Study|Abdominal discomfort|1|||
129467791|NCT01145066|466006458|FG002|Overall Study|Abdominal discomfort|0|||
129467792|NCT01145066|466006456|FG000|Overall Study|Low platelet count|0|||
129467793|NCT01145066|466006457|FG001|Overall Study|Low platelet count|1|||
129467794|NCT01145066|466006458|FG002|Overall Study|Low platelet count|0|||
129467795|NCT03687502|466006463|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
129467796|NCT03687502|466006463|FG000|Overall Study|Lumason not available|1|||
129467797|NCT01724528|466006467|FG000|Overall Study|Death|3|||
129467798|NCT01724528|466006468|FG001|Overall Study|Death|0|||
129467799|NCT01724528|466006467|FG000|Overall Study|Withdrawal by Subject|0|||
129467800|NCT01724528|466006468|FG001|Overall Study|Withdrawal by Subject|2|||
129467801|NCT01724528|466006467|FG000|Overall Study|Protocol Violation|0|||
129467802|NCT01724528|466006468|FG001|Overall Study|Protocol Violation|1|||
129467803|NCT01724528|466006467|FG000|Overall Study|Patient refused to attend last visit|1|||
129467804|NCT01724528|466006468|FG001|Overall Study|Patient refused to attend last visit|0|||
129467805|NCT01634555|466006472|FG000|Overall Study|Adverse Event|3|||
129467806|NCT01634555|466006472|FG000|Overall Study|Physician Decision|1|||
129467807|NCT06228586|466006473|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
129467808|NCT06228586|466006474|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
129467809|NCT01227902|466007848|FG000|Overall Study|Adverse Event|12|||
129467810|NCT01227902|466007849|FG001|Overall Study|Adverse Event|8|||
129467811|NCT01227902|466007850|FG002|Overall Study|Adverse Event|11|||
129467812|NCT01227902|466007851|FG003|Overall Study|Adverse Event|4|||
129467813|NCT01227902|466007848|FG000|Overall Study|Lack of Efficacy|1|||
129467814|NCT01227902|466007849|FG001|Overall Study|Lack of Efficacy|2|||
129467815|NCT01227902|466007850|FG002|Overall Study|Lack of Efficacy|2|||
129467816|NCT01227902|466007851|FG003|Overall Study|Lack of Efficacy|1|||
129467817|NCT01227902|466007848|FG000|Overall Study|Protocol Violation|1|||
129467818|NCT01227902|466007849|FG001|Overall Study|Protocol Violation|0|||
129467819|NCT01227902|466007850|FG002|Overall Study|Protocol Violation|0|||
129467820|NCT01227902|466007851|FG003|Overall Study|Protocol Violation|0|||
129467821|NCT01227902|466007848|FG000|Overall Study|Lost to Follow-up|0|||
129467822|NCT01227902|466007849|FG001|Overall Study|Lost to Follow-up|0|||
129467823|NCT01227902|466007850|FG002|Overall Study|Lost to Follow-up|1|||
129467824|NCT01227902|466007851|FG003|Overall Study|Lost to Follow-up|2|||
129467825|NCT01227902|466007848|FG000|Overall Study|Physician Decision|0|||
129467826|NCT01227902|466007849|FG001|Overall Study|Physician Decision|1|||
129467827|NCT01227902|466007850|FG002|Overall Study|Physician Decision|1|||
129467828|NCT01227902|466007851|FG003|Overall Study|Physician Decision|0|||
129467829|NCT01227902|466007848|FG000|Overall Study|Withdrawal by Subject|4|||
129467830|NCT01227902|466007849|FG001|Overall Study|Withdrawal by Subject|2|||
129467831|NCT01227902|466007850|FG002|Overall Study|Withdrawal by Subject|4|||
129467832|NCT01227902|466007851|FG003|Overall Study|Withdrawal by Subject|3|||
129971274|NCT01124097|467858447|FG003|Overall Study|Protocol Violation|1|||
129971275|NCT01124097|467858444|FG000|Overall Study|Physician Decision|2|||
129971276|NCT01124097|467858445|FG001|Overall Study|Physician Decision|1|||
129971277|NCT01124097|467858446|FG002|Overall Study|Physician Decision|0|||
129467833|NCT01299766|466007853|FG000|Overall Study|Death|5|||
129467834|NCT01299766|466007854|FG001|Overall Study|Death|4|||
129467835|NCT01299766|466007853|FG000|Overall Study|Withdrawal by Subject|29|||
129467836|NCT01299766|466007854|FG001|Overall Study|Withdrawal by Subject|19|||
129467837|NCT00403260|466007859|FG000|Overall Study|Adverse Event|5|||
129467838|NCT00403260|466007860|FG001|Overall Study|Adverse Event|4|||
129467839|NCT00403260|466007859|FG000|Overall Study|Withdrawal by Subject|5|||
129467840|NCT00403260|466007860|FG001|Overall Study|Withdrawal by Subject|6|||
129467841|NCT00403260|466007859|FG000|Overall Study|Lost to Follow-up|49|||
129467842|NCT00403260|466007860|FG001|Overall Study|Lost to Follow-up|25|||
129467843|NCT00403260|466007859|FG000|Overall Study|Re-appearance of P. falciparum|34|||
129467844|NCT00403260|466007860|FG001|Overall Study|Re-appearance of P. falciparum|25|||
129467845|NCT00403260|466007859|FG000|Overall Study|P. vivax infection|26|||
129467846|NCT00403260|466007860|FG001|Overall Study|P. vivax infection|4|||
129467847|NCT00403260|466007859|FG000|Overall Study|Mixed infection with P. vivax|2|||
129467848|NCT00403260|466007860|FG001|Overall Study|Mixed infection with P. vivax|0|||
129467849|NCT00403260|466007859|FG000|Overall Study|Mixed infection with P. falciparum|1|||
129467850|NCT00403260|466007860|FG001|Overall Study|Mixed infection with P. falciparum|0|||
129467851|NCT00403260|466007859|FG000|Overall Study|P. vivax infection at screening|1|||
129467852|NCT00403260|466007860|FG001|Overall Study|P. vivax infection at screening|0|||
129467853|NCT00403260|466007859|FG000|Overall Study|P. ovale infection|1|||
129467854|NCT00403260|466007860|FG001|Overall Study|P. ovale infection|0|||
129467855|NCT00403260|466007859|FG000|Overall Study|Gametocyte re-appearance|1|||
129467856|NCT00403260|466007860|FG001|Overall Study|Gametocyte re-appearance|1|||
129467857|NCT00403260|466007859|FG000|Overall Study|Withdrawn from study accidentally|0|||
129467858|NCT00403260|466007860|FG001|Overall Study|Withdrawn from study accidentally|1|||
129467859|NCT01354028|466007861|FG000|Overall Study|Physician Decision|0|||
129467860|NCT01354028|466007862|FG001|Overall Study|Physician Decision|2|||
129467861|NCT01354028|466007861|FG000|Overall Study|Discharged before study start|2|||
129467862|NCT01354028|466007862|FG001|Overall Study|Discharged before study start|2|||
129467863|NCT01354028|466007861|FG000|Overall Study|No quiet alert state|0|||
129467864|NCT01354028|466007862|FG001|Overall Study|No quiet alert state|1|||
129971278|NCT01124097|467858447|FG003|Overall Study|Physician Decision|0|||
129971279|NCT01677299|467858448|FG000|Overall Study|Adverse Event|0|||
129971280|NCT01677299|467858449|FG001|Overall Study|Adverse Event|2|||
129467865|NCT00935883|466007865|FG000|Treatment Period|Physician Decision|1|||
129467866|NCT00935883|466007866|FG001|Treatment Period|Physician Decision|0|||
129467867|NCT00935883|466007865|FG000|Treatment Period|Withdrawal by Subject|0|||
129971281|NCT01677299|467858450|FG002|Overall Study|Adverse Event|1|||
129467868|NCT00935883|466007866|FG001|Treatment Period|Withdrawal by Subject|2|||
129467869|NCT02971202|466007875|FG000|Overall Study|Pregnancy|1|||
129467870|NCT02971202|466007876|FG001|Overall Study|Pregnancy|0|||
129467871|NCT02971202|466007877|FG002|Overall Study|Pregnancy|0|||
129467872|NCT02971202|466007875|FG000|Overall Study|screen fail after consent|1|||
129467873|NCT02971202|466007876|FG001|Overall Study|screen fail after consent|0|||
129467874|NCT02971202|466007877|FG002|Overall Study|screen fail after consent|1|||
129971282|NCT01677299|467858451|FG003|Overall Study|Adverse Event|0|||
129467875|NCT01946178|466007878|FG000|Overall Study|Pregnancy|1|||
129467876|NCT01946178|466007878|FG000|Overall Study|Lost to Follow-up|1|||
129467877|NCT01505894|466007879|FG000|Overall Study|Adverse Event|1|||
129467878|NCT01505894|466007880|FG001|Overall Study|Adverse Event|0|||
129467879|NCT01505894|466007881|FG002|Overall Study|Adverse Event|0|||
129467880|NCT01505894|466007882|FG003|Overall Study|Adverse Event|0|||
129467881|NCT01505894|466007883|FG004|Overall Study|Adverse Event|0|||
129467882|NCT01505894|466007884|FG005|Overall Study|Adverse Event|0|||
129467883|NCT01505894|466007885|FG006|Overall Study|Adverse Event|0|||
129467884|NCT01505894|466007886|FG007|Overall Study|Adverse Event|0|||
129467885|NCT01505894|466007887|FG008|Overall Study|Adverse Event|0|||
129467886|NCT01505894|466007879|FG000|Overall Study|Other than specified|0|||
129467887|NCT01505894|466007880|FG001|Overall Study|Other than specified|0|||
129467888|NCT01505894|466007881|FG002|Overall Study|Other than specified|0|||
129467889|NCT01505894|466007882|FG003|Overall Study|Other than specified|0|||
129467890|NCT01505894|466007883|FG004|Overall Study|Other than specified|1|||
129467891|NCT01505894|466007884|FG005|Overall Study|Other than specified|0|||
129467892|NCT01505894|466007885|FG006|Overall Study|Other than specified|0|||
129467893|NCT01505894|466007886|FG007|Overall Study|Other than specified|0|||
129467894|NCT01505894|466007887|FG008|Overall Study|Other than specified|0|||
129467895|NCT01622569|466007888|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
129467896|NCT01622569|466007889|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
129467897|NCT01622569|466007890|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
129467898|NCT01622569|466007891|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
129467899|NCT01622569|466007888|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
129467900|NCT01622569|466007889|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
129467901|NCT01622569|466007890|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
129467902|NCT01622569|466007891|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
129467903|NCT01622569|466007888|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
129467904|NCT01622569|466007889|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
129467905|NCT01622569|466007890|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
129467906|NCT01622569|466007891|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
129467907|NCT01622569|466007888|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
129467908|NCT01622569|466007889|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
129467909|NCT01622569|466007890|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
129467910|NCT01622569|466007891|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
129467911|NCT01622569|466007888|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
129467912|NCT01622569|466007889|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
129467913|NCT01622569|466007890|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
129467914|NCT01622569|466007891|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
129467915|NCT01622569|466007888|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
129467916|NCT01622569|466007889|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
129467917|NCT01622569|466007890|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
129467918|NCT01622569|466007891|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
129467919|NCT01622569|466007888|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
129467920|NCT01622569|466007889|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
129467921|NCT01622569|466007890|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
129467922|NCT01622569|466007891|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
129467923|NCT01622569|466007888|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
129467924|NCT01622569|466007889|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
129467925|NCT01622569|466007890|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
129467926|NCT01622569|466007891|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
129467927|NCT01001702|466007892|FG000|Overall Study|Lost to Follow-up|7|||
129467928|NCT01001702|466007892|FG000|Overall Study|Adverse Event|7|||
129467929|NCT01001702|466007892|FG000|Overall Study|Sponsor Discontinued Study|4|||
129467930|NCT01001702|466007892|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
129467931|NCT01001702|466007892|FG000|Overall Study|Investigator withdrew Subject|10|||
129467932|NCT01001702|466007892|FG000|Overall Study|Withdrawal by Subject|19|||
129467933|NCT01001702|466007892|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
129467934|NCT00584233|466007895|FG000|Overall Study|Withdrawal by Subject|5|||
129467935|NCT00584233|466007895|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
129467936|NCT02222714|466007896|FG000|Overall Study|Death|0|||
129467937|NCT02222714|466007897|FG001|Overall Study|Death|2|||
129971283|NCT01677299|467858448|FG000|Overall Study|Withdrawal by Subject|0|||
129971284|NCT01677299|467858449|FG001|Overall Study|Withdrawal by Subject|1|||
129971285|NCT01677299|467858450|FG002|Overall Study|Withdrawal by Subject|0|||
129467938|NCT02222714|466007898|FG002|Overall Study|Death|3|||
129467939|NCT02222714|466007899|FG003|Overall Study|Death|4|||
129467940|NCT02222714|466007900|FG004|Overall Study|Death|6|||
129467941|NCT02222714|466007896|FG000|Overall Study|Withdrawal by Subject|0|||
129467942|NCT02222714|466007897|FG001|Overall Study|Withdrawal by Subject|0|||
129467943|NCT02222714|466007898|FG002|Overall Study|Withdrawal by Subject|1|||
129467944|NCT02222714|466007899|FG003|Overall Study|Withdrawal by Subject|0|||
129467945|NCT02222714|466007900|FG004|Overall Study|Withdrawal by Subject|1|||
129467946|NCT01940484|466007901|FG000|Overall Study|Withdrawal by Subject|3|||
129467947|NCT01940484|466007901|FG000|Overall Study|Underwent transplantation|4|||
129467948|NCT01940484|466007901|FG000|Overall Study|Death|2|||
129467949|NCT01940484|466007901|FG000|Overall Study|Adverse Event|1|||
129467950|NCT01340209|466007902|FG000|Overall Study|Adverse Event|1|||
129467951|NCT01340209|466007903|FG001|Overall Study|Adverse Event|1|||
129467952|NCT01340209|466007904|FG002|Overall Study|Adverse Event|2|||
129467953|NCT01340209|466007902|FG000|Overall Study|Protocol Violation|1|||
129467954|NCT01340209|466007903|FG001|Overall Study|Protocol Violation|2|||
129467955|NCT01340209|466007904|FG002|Overall Study|Protocol Violation|1|||
129467956|NCT01340209|466007902|FG000|Overall Study|Withdrawal by Subject|0|||
129467957|NCT01340209|466007903|FG001|Overall Study|Withdrawal by Subject|0|||
129467958|NCT01340209|466007904|FG002|Overall Study|Withdrawal by Subject|1|||
129467959|NCT01340209|466007902|FG000|Overall Study|Other reason not defined above|3|||
129467960|NCT01340209|466007903|FG001|Overall Study|Other reason not defined above|5|||
129467961|NCT01340209|466007904|FG002|Overall Study|Other reason not defined above|4|||
129467962|NCT04142983|466007907|FG000|Overall Study|Lost to Follow-up|73|||
129467963|NCT04142983|466007907|FG000|Overall Study|Withdrawal by Subject|10|||
129467964|NCT04142983|466007907|FG000|Overall Study|Physician Decision|1|||
129467965|NCT04142983|466007907|FG000|Overall Study|Adverse Event|1|||
129467966|NCT04142983|466007907|FG000|Overall Study|No longer eligible|4|||
129467967|NCT04142983|466007907|FG000|Overall Study|Screen Failure|10|||
129467968|NCT02918019|466007913|FG000|Overall Study|Death|0|||
129467969|NCT02918019|466007914|FG001|Overall Study|Death|0|||
129467970|NCT02918019|466007915|FG002|Overall Study|Death|1|||
129467971|NCT02918019|466007916|FG003|Overall Study|Death|0|||
129467972|NCT02918019|466007913|FG000|Overall Study|Lost to Follow-up|1|||
129467973|NCT02918019|466007914|FG001|Overall Study|Lost to Follow-up|1|||
129467974|NCT02918019|466007915|FG002|Overall Study|Lost to Follow-up|0|||
129467975|NCT02918019|466007916|FG003|Overall Study|Lost to Follow-up|1|||
129467976|NCT02918019|466007913|FG000|Overall Study|Principal investigator request|0|||
129467977|NCT02918019|466007914|FG001|Overall Study|Principal investigator request|0|||
129467978|NCT02918019|466007915|FG002|Overall Study|Principal investigator request|0|||
129467979|NCT02918019|466007916|FG003|Overall Study|Principal investigator request|1|||
129467980|NCT02918019|466007913|FG000|Overall Study|Physician Decision|1|||
129467981|NCT02918019|466007914|FG001|Overall Study|Physician Decision|3|||
129467982|NCT02918019|466007915|FG002|Overall Study|Physician Decision|2|||
129467983|NCT02918019|466007916|FG003|Overall Study|Physician Decision|0|||
129467984|NCT02918019|466007913|FG000|Overall Study|Protocol deviation|1|||
129467985|NCT02918019|466007914|FG001|Overall Study|Protocol deviation|1|||
129467986|NCT02918019|466007915|FG002|Overall Study|Protocol deviation|0|||
129467987|NCT02918019|466007916|FG003|Overall Study|Protocol deviation|2|||
129467988|NCT02918019|466007913|FG000|Overall Study|Withdrawal by Subject|3|||
129467989|NCT02918019|466007914|FG001|Overall Study|Withdrawal by Subject|4|||
129467990|NCT02918019|466007915|FG002|Overall Study|Withdrawal by Subject|6|||
129467991|NCT02918019|466007916|FG003|Overall Study|Withdrawal by Subject|4|||
129467992|NCT02918019|466007913|FG000|Overall Study|Adverse Event|0|||
129467993|NCT02918019|466007914|FG001|Overall Study|Adverse Event|1|||
129467994|NCT02918019|466007915|FG002|Overall Study|Adverse Event|0|||
129467995|NCT02918019|466007916|FG003|Overall Study|Adverse Event|1|||
129467996|NCT01212185|466007917|FG000|Overall Study|Protocol Violation|2|||
129467997|NCT01212185|466007918|FG001|Overall Study|Protocol Violation|1|||
129467998|NCT00094757|466007919|FG000|Overall Study|Adverse Event|11|||
129467999|NCT00094757|466007920|FG001|Overall Study|Adverse Event|9|||
129468000|NCT00094757|466007921|FG002|Overall Study|Adverse Event|6|||
129468001|NCT00094757|466007919|FG000|Overall Study|Lack of Efficacy|11|||
129468002|NCT00094757|466007920|FG001|Overall Study|Lack of Efficacy|15|||
129468003|NCT00094757|466007921|FG002|Overall Study|Lack of Efficacy|8|||
129971286|NCT01677299|467858451|FG003|Overall Study|Withdrawal by Subject|1|||
129971287|NCT00193479|467858452|FG000|Induction Chemotherapy|Adverse Event|2|||
129971288|NCT00193479|467858452|FG000|Induction Chemotherapy|Disease Progression|1|||
129468004|NCT00094757|466007919|FG000|Overall Study|Lost to Follow-up|3|||
129468005|NCT00094757|466007920|FG001|Overall Study|Lost to Follow-up|5|||
129468006|NCT00094757|466007921|FG002|Overall Study|Lost to Follow-up|6|||
129468007|NCT00094757|466007919|FG000|Overall Study|Patient Moved|2|||
129468008|NCT00094757|466007920|FG001|Overall Study|Patient Moved|1|||
129468009|NCT00094757|466007921|FG002|Overall Study|Patient Moved|1|||
129468010|NCT00094757|466007919|FG000|Overall Study|Protocol Violation|8|||
129468011|NCT00094757|466007920|FG001|Overall Study|Protocol Violation|5|||
129468012|NCT00094757|466007921|FG002|Overall Study|Protocol Violation|3|||
129468013|NCT00094757|466007919|FG000|Overall Study|Withdrawal by Subject|14|||
129468014|NCT00094757|466007920|FG001|Overall Study|Withdrawal by Subject|21|||
129468015|NCT00094757|466007921|FG002|Overall Study|Withdrawal by Subject|5|||
129468016|NCT00094757|466007919|FG000|Overall Study|Other|3|||
129468017|NCT00094757|466007920|FG001|Overall Study|Other|3|||
129468018|NCT00094757|466007921|FG002|Overall Study|Other|1|||
129468019|NCT00094757|466007919|FG000|Overall Study|Protocol specified discontinuation|1|||
129468020|NCT00094757|466007920|FG001|Overall Study|Protocol specified discontinuation|3|||
129468021|NCT00094757|466007921|FG002|Overall Study|Protocol specified discontinuation|0|||
129468022|NCT04317274|466007922|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
129468023|NCT04317274|466007923|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
129468024|NCT04317274|466007924|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
129468025|NCT04317274|466007925|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
129468026|NCT02568046|466007926|FG000|Overall Study|Adverse Event|0|||
129468027|NCT02568046|466007927|FG001|Overall Study|Adverse Event|1|||
129468028|NCT02568046|466007926|FG000|Overall Study|Death|2|||
129468029|NCT02568046|466007927|FG001|Overall Study|Death|0|||
129468030|NCT02568046|466007926|FG000|Overall Study|Progressive Disease|1|||
129468031|NCT02568046|466007927|FG001|Overall Study|Progressive Disease|0|||
129468032|NCT02568046|466007926|FG000|Overall Study|Withdrawal by Subject|2|||
129468033|NCT02568046|466007927|FG001|Overall Study|Withdrawal by Subject|1|||
129468034|NCT02568046|466007926|FG000|Overall Study|Other Events|0|||
129468035|NCT02568046|466007927|FG001|Overall Study|Other Events|1|||
129468036|NCT03403192|466007928|FG000|Overall Study|Lost to Follow-up|1|||
129468037|NCT03403192|466007929|FG001|Overall Study|Lost to Follow-up|2|||
129468038|NCT03403192|466007930|FG002|Overall Study|Lost to Follow-up|0|||
129468039|NCT03403192|466007931|FG003|Overall Study|Lost to Follow-up|0|||
129468040|NCT03403192|466007928|FG000|Overall Study|Unable to respond|0|||
129468041|NCT03403192|466007929|FG001|Overall Study|Unable to respond|1|||
129468042|NCT03403192|466007930|FG002|Overall Study|Unable to respond|0|||
129468043|NCT03403192|466007931|FG003|Overall Study|Unable to respond|0|||
129468044|NCT03403192|466007928|FG000|Overall Study|Incomplete|3|||
129468045|NCT03403192|466007929|FG001|Overall Study|Incomplete|1|||
129468046|NCT03403192|466007930|FG002|Overall Study|Incomplete|3|||
129468047|NCT03403192|466007931|FG003|Overall Study|Incomplete|6|||
129468048|NCT00379795|466007932|FG000|Overall Study|Death|31|||
129468049|NCT00379795|466007933|FG001|Overall Study|Death|8|||
129468050|NCT00379795|466007934|FG002|Overall Study|Death|6|||
129468051|NCT00379795|466007935|FG003|Overall Study|Death|4|||
129468052|NCT00379795|466007936|FG004|Overall Study|Death|7|||
129468053|NCT00379795|466007932|FG000|Overall Study|Adverse Event|17|||
129468054|NCT00379795|466007933|FG001|Overall Study|Adverse Event|3|||
129468055|NCT00379795|466007934|FG002|Overall Study|Adverse Event|3|||
129468056|NCT00379795|466007935|FG003|Overall Study|Adverse Event|1|||
129468057|NCT00379795|466007936|FG004|Overall Study|Adverse Event|4|||
129468058|NCT00379795|466007932|FG000|Overall Study|Lost to Follow-up|8|||
129468059|NCT00379795|466007933|FG001|Overall Study|Lost to Follow-up|1|||
129468060|NCT00379795|466007934|FG002|Overall Study|Lost to Follow-up|2|||
129468061|NCT00379795|466007935|FG003|Overall Study|Lost to Follow-up|1|||
129468062|NCT00379795|466007936|FG004|Overall Study|Lost to Follow-up|4|||
129468063|NCT00379795|466007932|FG000|Overall Study|Physician Decision|25|||
129468064|NCT00379795|466007933|FG001|Overall Study|Physician Decision|0|||
129468065|NCT00379795|466007934|FG002|Overall Study|Physician Decision|2|||
129468066|NCT00379795|466007935|FG003|Overall Study|Physician Decision|2|||
129468067|NCT00379795|466007936|FG004|Overall Study|Physician Decision|2|||
129468068|NCT00379795|466007932|FG000|Overall Study|Withdrawal by Subject|94|||
129468069|NCT00379795|466007933|FG001|Overall Study|Withdrawal by Subject|11|||
129468070|NCT00379795|466007934|FG002|Overall Study|Withdrawal by Subject|19|||
129468071|NCT00379795|466007935|FG003|Overall Study|Withdrawal by Subject|7|||
129468072|NCT00379795|466007936|FG004|Overall Study|Withdrawal by Subject|14|||
129468073|NCT00379795|466007932|FG000|Overall Study|Subject non-compliance|7|||
129468074|NCT00379795|466007933|FG001|Overall Study|Subject non-compliance|2|||
129468075|NCT00379795|466007934|FG002|Overall Study|Subject non-compliance|0|||
129468076|NCT00379795|466007935|FG003|Overall Study|Subject non-compliance|0|||
129468077|NCT00379795|466007936|FG004|Overall Study|Subject non-compliance|1|||
129468078|NCT00379795|466007932|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
129468079|NCT00379795|466007933|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
129468080|NCT00379795|466007934|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
129468081|NCT00379795|466007935|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
129468082|NCT00379795|466007936|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
129468083|NCT00379795|466007932|FG000|Overall Study|Subjects condition mandated intervention|34|||
129468084|NCT00379795|466007933|FG001|Overall Study|Subjects condition mandated intervention|9|||
129468085|NCT00379795|466007934|FG002|Overall Study|Subjects condition mandated intervention|7|||
129468086|NCT00379795|466007935|FG003|Overall Study|Subjects condition mandated intervention|5|||
129468087|NCT00379795|466007936|FG004|Overall Study|Subjects condition mandated intervention|7|||
129468088|NCT00379795|466007932|FG000|Overall Study|Sponsor's decision|257|||
129468089|NCT00379795|466007933|FG001|Overall Study|Sponsor's decision|17|||
129468090|NCT00379795|466007934|FG002|Overall Study|Sponsor's decision|54|||
129468091|NCT00379795|466007935|FG003|Overall Study|Sponsor's decision|47|||
129468092|NCT00379795|466007936|FG004|Overall Study|Sponsor's decision|10|||
129468093|NCT04849780|466007937|FG000|Period 1|Covid-19 Related|1|||
129468094|NCT04849780|466007938|FG001|Period 1|Covid-19 Related|0|||
129468095|NCT04849780|466007937|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
129468096|NCT04849780|466007938|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
129468097|NCT04849780|466007937|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
129468098|NCT04849780|466007938|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
129468099|NCT02551159|466007939|FG000|Overall Study|Death|352|||
129468100|NCT02551159|466007940|FG001|Overall Study|Death|174|||
129468101|NCT02551159|466007941|FG002|Overall Study|Death|161|||
129468102|NCT02551159|466007939|FG000|Overall Study|Withdrawal by Subject|8|||
129468103|NCT02551159|466007940|FG001|Overall Study|Withdrawal by Subject|5|||
129468104|NCT02551159|466007941|FG002|Overall Study|Withdrawal by Subject|16|||
129468105|NCT02551159|466007939|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
129468106|NCT02551159|466007940|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
129468107|NCT02551159|466007941|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
129468108|NCT02175680|466007942|FG000|Overall Study|non-compliance|1|||
129468109|NCT02175680|466007942|FG000|Overall Study|other non-medical reason|1|||
129468110|NCT01665144|466007943|FG000|Core Part|Withdrawal by Subject|96|||
129468111|NCT01665144|466007944|FG001|Core Part|Withdrawal by Subject|77|||
129468112|NCT01665144|466007945|FG002|Core Part|Withdrawal by Subject|0|||
129468113|NCT01665144|466007943|FG000|Core Part|Adverse Event|45|||
129468114|NCT01665144|466007944|FG001|Core Part|Adverse Event|18|||
129468115|NCT01665144|466007945|FG002|Core Part|Adverse Event|0|||
129468116|NCT01665144|466007943|FG000|Core Part|Lack of Efficacy|16|||
129468117|NCT01665144|466007944|FG001|Core Part|Lack of Efficacy|11|||
129468118|NCT01665144|466007945|FG002|Core Part|Lack of Efficacy|0|||
129468119|NCT01665144|466007943|FG000|Core Part|Lost to Follow-up|9|||
129468120|NCT01665144|466007944|FG001|Core Part|Lost to Follow-up|8|||
129468121|NCT01665144|466007945|FG002|Core Part|Lost to Follow-up|0|||
129468122|NCT01665144|466007943|FG000|Core Part|Physician Decision|13|||
129468123|NCT01665144|466007944|FG001|Core Part|Physician Decision|1|||
129468124|NCT01665144|466007945|FG002|Core Part|Physician Decision|0|||
129468125|NCT01665144|466007943|FG000|Core Part|Progressive disease|8|||
129468126|NCT01665144|466007944|FG001|Core Part|Progressive disease|4|||
129468127|NCT01665144|466007945|FG002|Core Part|Progressive disease|0|||
129468128|NCT01665144|466007943|FG000|Core Part|Non-compliance with study treatment|5|||
129468129|NCT01665144|466007944|FG001|Core Part|Non-compliance with study treatment|0|||
129468130|NCT01665144|466007945|FG002|Core Part|Non-compliance with study treatment|0|||
129468131|NCT01665144|466007943|FG000|Core Part|Death|3|||
129468132|NCT01665144|466007944|FG001|Core Part|Death|1|||
129468133|NCT01665144|466007945|FG002|Core Part|Death|0|||
129468134|NCT01665144|466007943|FG000|Core Part|Protocol deviation|3|||
129468135|NCT01665144|466007944|FG001|Core Part|Protocol deviation|1|||
129468136|NCT01665144|466007945|FG002|Core Part|Protocol deviation|0|||
129468137|NCT01665144|466007943|FG000|Core Part|New therapy for study indication|2|||
129468138|NCT01665144|466007944|FG001|Core Part|New therapy for study indication|1|||
129468139|NCT01665144|466007945|FG002|Core Part|New therapy for study indication|0|||
129468140|NCT01665144|466007943|FG000|Core Part|Technical problems|2|||
129468141|NCT01665144|466007944|FG001|Core Part|Technical problems|0|||
129468142|NCT01665144|466007945|FG002|Core Part|Technical problems|0|||
129468143|NCT01665144|466007943|FG000|Extension Part|Patient/guardian decision|180|||
129468144|NCT01665144|466007944|FG001|Extension Part|Patient/guardian decision|0|||
129468145|NCT01665144|466007945|FG002|Extension Part|Patient/guardian decision|98|||
129468146|NCT01665144|466007943|FG000|Extension Part|Adverse Event|104|||
129468147|NCT01665144|466007944|FG001|Extension Part|Adverse Event|0|||
129468148|NCT01665144|466007945|FG002|Extension Part|Adverse Event|59|||
129468149|NCT01665144|466007943|FG000|Extension Part|Study closed early|42|||
129468150|NCT01665144|466007944|FG001|Extension Part|Study closed early|0|||
129468151|NCT01665144|466007945|FG002|Extension Part|Study closed early|19|||
129468152|NCT01665144|466007943|FG000|Extension Part|Progressive disease|36|||
129468153|NCT01665144|466007944|FG001|Extension Part|Progressive disease|0|||
129468154|NCT01665144|466007945|FG002|Extension Part|Progressive disease|14|||
129468155|NCT01665144|466007943|FG000|Extension Part|Lack of Efficacy|37|||
129468156|NCT01665144|466007944|FG001|Extension Part|Lack of Efficacy|0|||
129468157|NCT01665144|466007945|FG002|Extension Part|Lack of Efficacy|12|||
129468158|NCT01665144|466007943|FG000|Extension Part|Physician Decision|29|||
129468159|NCT01665144|466007944|FG001|Extension Part|Physician Decision|0|||
129468160|NCT01665144|466007945|FG002|Extension Part|Physician Decision|13|||
129468161|NCT01665144|466007943|FG000|Extension Part|Technical problems|20|||
129468162|NCT01665144|466007944|FG001|Extension Part|Technical problems|0|||
129468163|NCT01665144|466007945|FG002|Extension Part|Technical problems|8|||
129468164|NCT01665144|466007943|FG000|Extension Part|Death|20|||
129468165|NCT01665144|466007944|FG001|Extension Part|Death|0|||
129468166|NCT01665144|466007945|FG002|Extension Part|Death|4|||
129468167|NCT01665144|466007943|FG000|Extension Part|Missing|12|||
129468168|NCT01665144|466007944|FG001|Extension Part|Missing|0|||
129468169|NCT01665144|466007945|FG002|Extension Part|Missing|6|||
129468170|NCT01665144|466007943|FG000|Extension Part|Lost to Follow-up|9|||
129468171|NCT01665144|466007944|FG001|Extension Part|Lost to Follow-up|0|||
129468172|NCT01665144|466007945|FG002|Extension Part|Lost to Follow-up|5|||
129971289|NCT00193479|467858452|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
129971290|NCT00193479|467858452|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
129971291|NCT00872001|467858454|FG000|Overall Study|Adverse Event|34|||
129971292|NCT00872001|467858455|FG001|Overall Study|Adverse Event|23|||
129971293|NCT00872001|467858454|FG000|Overall Study|Protocol Defined Clinical Event|5|||
129971294|NCT00872001|467858455|FG001|Overall Study|Protocol Defined Clinical Event|7|||
129971295|NCT00872001|467858454|FG000|Overall Study|Lost to Follow-up|13|||
129971296|NCT00872001|467858455|FG001|Overall Study|Lost to Follow-up|12|||
129971297|NCT00872001|467858454|FG000|Overall Study|Withdrawal by Subject|18|||
129971298|NCT00872001|467858455|FG001|Overall Study|Withdrawal by Subject|30|||
129971299|NCT00872001|467858454|FG000|Overall Study|Protocol Violation|5|||
129971300|NCT00872001|467858455|FG001|Overall Study|Protocol Violation|8|||
129468173|NCT01665144|466007943|FG000|Extension Part|New therapy for study indication|3|||
129468174|NCT01665144|466007944|FG001|Extension Part|New therapy for study indication|0|||
129468175|NCT01665144|466007945|FG002|Extension Part|New therapy for study indication|2|||
129468176|NCT01665144|466007943|FG000|Extension Part|Protocol deviation|3|||
129468177|NCT01665144|466007944|FG001|Extension Part|Protocol deviation|0|||
129468178|NCT01665144|466007945|FG002|Extension Part|Protocol deviation|0|||
129468179|NCT02302963|466007946|FG000|Overall Study|Withdrawal by Subject|2|||
129468180|NCT02302963|466007947|FG001|Overall Study|Withdrawal by Subject|1|||
129468181|NCT02302963|466007946|FG000|Overall Study|Steroid injection|0|||
129468182|NCT02302963|466007947|FG001|Overall Study|Steroid injection|1|||
129468183|NCT02302963|466007946|FG000|Overall Study|Physician Decision|1|||
129468184|NCT02302963|466007947|FG001|Overall Study|Physician Decision|0|||
129468185|NCT01816243|466007948|FG000|Overall Study|Adverse Event|6|||
129468186|NCT01816243|466007948|FG000|Overall Study|Lost to Follow-up|1|||
129468187|NCT01816243|466007948|FG000|Overall Study|Lack of Efficacy|1|||
129468188|NCT01816243|466007948|FG000|Overall Study|Not eligible for the study|1|||
129468189|NCT01816243|466007948|FG000|Overall Study|Amputation|3|||
129468190|NCT00911989|466007951|FG000|Overall Study|Adverse Event|1|||
129468191|NCT02937350|466007953|FG000|Overall Study|Withdrawal by Subject|0|||
129468192|NCT02937350|466007954|FG001|Overall Study|Withdrawal by Subject|1|||
129468193|NCT02937350|466007955|FG002|Overall Study|Withdrawal by Subject|0|||
129468194|NCT04811716|466007959|FG000|Overall Study|Withdrawal by Subject|2|||
129468195|NCT04811716|466007960|FG001|Overall Study|Withdrawal by Subject|0|||
129468196|NCT00429585|466007966|FG000|Overall Study|Death|1|||
129468197|NCT00429585|466007967|FG001|Overall Study|Death|0|||
129468198|NCT00429585|466007966|FG000|Overall Study|Lost to Follow-up|27|||
129468199|NCT00429585|466007967|FG001|Overall Study|Lost to Follow-up|20|||
129468200|NCT00429585|466007966|FG000|Overall Study|Physician Decision|2|||
129468201|NCT00429585|466007967|FG001|Overall Study|Physician Decision|0|||
129468202|NCT05280756|466009745|FG000|Overall Study|Lost to Follow-up|1|||
129468203|NCT05280756|466009746|FG001|Overall Study|Lost to Follow-up|1|||
129468204|NCT02527707|466009752|FG000|Overall Study|Adverse Event|1|||
129468205|NCT02527707|466009752|FG000|Overall Study|Adverse Event|1|||
129468206|NCT00930059|466009753|FG000|Overall Study|Death|1|||
129468207|NCT00930059|466009754|FG001|Overall Study|Death|0|||
129468208|NCT00930059|466009753|FG000|Overall Study|Did not meet entrance criteria|1|||
129468209|NCT00930059|466009754|FG001|Overall Study|Did not meet entrance criteria|1|||
129468210|NCT00930059|466009753|FG000|Overall Study|Withdrawal by Subject|3|||
129468211|NCT00930059|466009754|FG001|Overall Study|Withdrawal by Subject|4|||
129468212|NCT00930059|466009753|FG000|Overall Study|Other|1|||
129468213|NCT00930059|466009754|FG001|Overall Study|Other|0|||
129468214|NCT00930059|466009753|FG000|Overall Study|1 site terminated by sponsor|1|||
129468215|NCT00930059|466009754|FG001|Overall Study|1 site terminated by sponsor|1|||
129468216|NCT00930059|466009753|FG000|Overall Study|Adverse Event|1|||
129468217|NCT00930059|466009754|FG001|Overall Study|Adverse Event|6|||
129468218|NCT04002310|466009757|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
129468219|NCT04002310|466009758|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
129468220|NCT04002310|466009759|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
129468221|NCT04002310|466009760|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
129468222|NCT04002310|466009761|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
129468223|NCT00542997|466009762|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
129468224|NCT00542997|466009762|FG000|Wash in / Wash Out Period|Adverse Event|3|||
129468225|NCT00542997|466009762|FG000|Efficacy Period|Adverse Event|3|||
129468226|NCT03064763|466009766|FG000|Overall Study|Lost to Follow-up|1|||
129468227|NCT03064763|466009766|FG000|Overall Study|Death|8|||
129468228|NCT00808444|466009775|FG000|Overall Study|Withdrawal by Subject|1|||
129468229|NCT00808444|466009776|FG001|Overall Study|Withdrawal by Subject|0|||
129468230|NCT00808444|466009775|FG000|Overall Study|Lost to Follow-up|0|||
129468231|NCT00808444|466009776|FG001|Overall Study|Lost to Follow-up|1|||
129468232|NCT01461044|466009777|FG000|Overall Study|Death|58|||
129468233|NCT01461044|466009778|FG001|Overall Study|Death|35|||
129468234|NCT01461044|466009777|FG000|Overall Study|Lost to Follow-up|12|||
129468235|NCT01461044|466009778|FG001|Overall Study|Lost to Follow-up|5|||
129468236|NCT00716976|466009779|FG000|Overall Study|Adverse Event|2|||
129468237|NCT00716976|466009780|FG001|Overall Study|Adverse Event|0|||
129468238|NCT00716976|466009779|FG000|Overall Study|Death|1|||
129468239|NCT00716976|466009780|FG001|Overall Study|Death|0|||
129468240|NCT00716976|466009779|FG000|Overall Study|Physician Decision|2|||
129468241|NCT00716976|466009780|FG001|Overall Study|Physician Decision|2|||
129468242|NCT00716976|466009779|FG000|Overall Study|Withdrawal by Subject|5|||
129468243|NCT00716976|466009780|FG001|Overall Study|Withdrawal by Subject|1|||
129468244|NCT00716976|466009779|FG000|Overall Study|Premature discontinuation cisplatin|5|||
129468245|NCT00716976|466009780|FG001|Overall Study|Premature discontinuation cisplatin|4|||
129468246|NCT00716976|466009779|FG000|Overall Study|Radiation during protocol|1|||
129468247|NCT00716976|466009780|FG001|Overall Study|Radiation during protocol|0|||
129468248|NCT00716976|466009779|FG000|Overall Study|Ineligibles|4|||
129468249|NCT00716976|466009780|FG001|Overall Study|Ineligibles|2|||
129468250|NCT00122135|466009781|FG000|Overall Study|Withdrawal by Subject|3|||
129468251|NCT00122135|466009782|FG001|Overall Study|Withdrawal by Subject|0|||
129468252|NCT03068325|466009783|FG000|Overall Study|Lost to Follow-up|5|||
129468253|NCT00975156|466009784|FG000|Overall Study|Protocol Violation|0|||
129468254|NCT00975156|466009785|FG001|Overall Study|Protocol Violation|1|||
129468255|NCT00454779|466009790|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
129468256|NCT00454779|466009791|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
129468257|NCT00454779|466009790|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
129468258|NCT00454779|466009791|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
129468259|NCT00454779|466009790|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
129468260|NCT00454779|466009791|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
129468261|NCT00454779|466009790|FG000|First-line Treatment Phase|Protocol Violation|0|||
129468262|NCT00454779|466009791|FG001|First-line Treatment Phase|Protocol Violation|1|||
129468263|NCT00454779|466009790|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
129468264|NCT00454779|466009791|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
129468265|NCT00454779|466009790|FG000|First-line Treatment Phase|Ongoing|1|||
129468266|NCT00454779|466009791|FG001|First-line Treatment Phase|Ongoing|0|||
129468267|NCT00454779|466009790|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
129468268|NCT00454779|466009791|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
129468269|NCT00454779|466009790|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
129468270|NCT00454779|466009791|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
129468271|NCT00454779|466009790|FG000|Second-line Treatment Phase|Ongoing|0|||
129468272|NCT00454779|466009791|FG001|Second-line Treatment Phase|Ongoing|1|||
129468273|NCT05425563|466009792|FG000|Overall Study|Withdrawal by Subject|17|||
129468274|NCT00634569|466009795|FG000|Overall Study|Withdrawal by Subject|0|||
129468275|NCT00634569|466009796|FG001|Overall Study|Withdrawal by Subject|4|||
129468276|NCT00634569|466009795|FG000|Overall Study|Physician Decision|0|||
129468277|NCT00634569|466009796|FG001|Overall Study|Physician Decision|1|||
129468278|NCT01163786|466009797|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
129468279|NCT01163786|466009797|FG000|Treatment With Bortezomib|Adverse Event|2|||
129468280|NCT01163786|466009797|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
129468281|NCT03222349|466009798|FG000|Overall Study|Treatment B not done|5|||
129468282|NCT03222349|466009799|FG001|Overall Study|Treatment B not done|0|||
129468283|NCT03222349|466009798|FG000|Overall Study|Lost to Follow-up|1|||
129468284|NCT03222349|466009799|FG001|Overall Study|Lost to Follow-up|2|||
129468285|NCT03222349|466009798|FG000|Overall Study|Withdrawal by Subject|1|||
129468286|NCT03222349|466009799|FG001|Overall Study|Withdrawal by Subject|0|||
129468287|NCT03222349|466009798|FG000|Overall Study|Treatment A not done|0|||
129468288|NCT03222349|466009799|FG001|Overall Study|Treatment A not done|5|||
129468289|NCT03222349|466009798|FG000|Overall Study|Study terminated by sponsor|1|||
129468290|NCT03222349|466009799|FG001|Overall Study|Study terminated by sponsor|0|||
129468291|NCT01808612|466009806|FG000|Treatment Period|Adverse Event|8|||
129468292|NCT01808612|466009807|FG001|Treatment Period|Adverse Event|4|||
129468293|NCT01808612|466009808|FG002|Treatment Period|Adverse Event|3|||
129468294|NCT01808612|466009806|FG000|Treatment Period|Lost to Follow-up|2|||
129468295|NCT01808612|466009807|FG001|Treatment Period|Lost to Follow-up|2|||
129468296|NCT01808612|466009808|FG002|Treatment Period|Lost to Follow-up|1|||
129468297|NCT01808612|466009806|FG000|Treatment Period|Protocol Violation|1|||
129468298|NCT01808612|466009807|FG001|Treatment Period|Protocol Violation|0|||
129468299|NCT01808612|466009808|FG002|Treatment Period|Protocol Violation|0|||
129468300|NCT01808612|466009806|FG000|Treatment Period|Withdrawal by Subject|1|||
129971301|NCT00872001|467858454|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
129971302|NCT00872001|467858455|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
129468301|NCT01808612|466009807|FG001|Treatment Period|Withdrawal by Subject|0|||
129468302|NCT01808612|466009808|FG002|Treatment Period|Withdrawal by Subject|4|||
129468303|NCT01808612|466009806|FG000|Treatment Period|Physician Decision|1|||
129468304|NCT01808612|466009807|FG001|Treatment Period|Physician Decision|0|||
129468305|NCT01808612|466009808|FG002|Treatment Period|Physician Decision|4|||
129468306|NCT01808612|466009806|FG000|Treatment Period|Sponsor Decision|1|||
129468307|NCT01808612|466009807|FG001|Treatment Period|Sponsor Decision|0|||
129468308|NCT01808612|466009808|FG002|Treatment Period|Sponsor Decision|0|||
129468309|NCT01808612|466009806|FG000|Treatment Period|Lack of Efficacy|1|||
129468310|NCT01808612|466009807|FG001|Treatment Period|Lack of Efficacy|1|||
129971303|NCT00872001|467858454|FG000|Overall Study|Administrative|23|||
129971304|NCT00872001|467858455|FG001|Overall Study|Administrative|15|||
129971305|NCT02030002|467858456|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
129971306|NCT02030002|467858456|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
129971307|NCT02030002|467858456|FG000|Follow-up|Lost to Follow-up|2|||
129971308|NCT03482752|467858462|FG000|Overall Study|Withdrawal by Subject|2|||
129971309|NCT03482752|467858462|FG000|Overall Study|Lost to Follow-up|1|||
129468311|NCT01808612|466009808|FG002|Treatment Period|Lack of Efficacy|2|||
129468312|NCT01808612|466009806|FG000|Discontinuation Period|Adverse Event|1|||
129468313|NCT01808612|466009807|FG001|Discontinuation Period|Adverse Event|0|||
129468314|NCT01808612|466009808|FG002|Discontinuation Period|Adverse Event|0|||
129468315|NCT01808612|466009806|FG000|Discontinuation Period|Physician Decision|1|||
129971310|NCT03482752|467858462|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
129971311|NCT01080300|467858463|FG000|Overall Study|Adverse Event|49|||
129971312|NCT01080300|467858464|FG001|Overall Study|Adverse Event|35|||
129971313|NCT01080300|467858463|FG000|Overall Study|Lack of Efficacy|12|||
129971314|NCT01080300|467858464|FG001|Overall Study|Lack of Efficacy|15|||
129971315|NCT01080300|467858463|FG000|Overall Study|Protocol Violation|7|||
129971316|NCT01080300|467858464|FG001|Overall Study|Protocol Violation|13|||
129971317|NCT01080300|467858463|FG000|Overall Study|Lost to Follow-up|10|||
129971318|NCT01080300|467858464|FG001|Overall Study|Lost to Follow-up|6|||
129971319|NCT01080300|467858463|FG000|Overall Study|Death|0|||
129971320|NCT01080300|467858464|FG001|Overall Study|Death|1|||
129971321|NCT01080300|467858463|FG000|Overall Study|Withdrawal by Subject|12|||
129971322|NCT01080300|467858464|FG001|Overall Study|Withdrawal by Subject|28|||
129971323|NCT01080300|467858463|FG000|Overall Study|Reasons not specified|4|||
129971324|NCT01080300|467858464|FG001|Overall Study|Reasons not specified|6|||
129971325|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
129971326|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
129971327|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
129971328|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
129971329|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
129971330|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
129971331|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
129971332|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
129971333|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
129468316|NCT01808612|466009807|FG001|Discontinuation Period|Physician Decision|0|||
129468317|NCT01808612|466009808|FG002|Discontinuation Period|Physician Decision|0|||
129468318|NCT01808612|466009806|FG000|Discontinuation Period|Lost to Follow-up|0|||
129468319|NCT01808612|466009807|FG001|Discontinuation Period|Lost to Follow-up|1|||
129468320|NCT01808612|466009808|FG002|Discontinuation Period|Lost to Follow-up|0|||
129468321|NCT04823949|466009809|FG000|Overall Study|Withdrawal by Subject|0|||
129468322|NCT04823949|466009810|FG001|Overall Study|Withdrawal by Subject|4|||
129468323|NCT04823949|466009809|FG000|Overall Study|Physician Decision|0|||
129468324|NCT04823949|466009810|FG001|Overall Study|Physician Decision|1|||
129468325|NCT01700192|466009812|FG000|Overall Study|Adverse Event|73|||
129468326|NCT01700192|466009813|FG001|Overall Study|Adverse Event|18|||
129468327|NCT01700192|466009812|FG000|Overall Study|Lack of Efficacy|1|||
129468328|NCT01700192|466009813|FG001|Overall Study|Lack of Efficacy|0|||
129468329|NCT01700192|466009812|FG000|Overall Study|Lost to Follow-up|42|||
129468330|NCT01700192|466009813|FG001|Overall Study|Lost to Follow-up|29|||
129468331|NCT01700192|466009812|FG000|Overall Study|Noncompliance with study drug|0|||
129468332|NCT01700192|466009813|FG001|Overall Study|Noncompliance with study drug|5|||
129468333|NCT01700192|466009812|FG000|Overall Study|Physician Decision|2|||
129468334|NCT01700192|466009813|FG001|Overall Study|Physician Decision|3|||
129468335|NCT01700192|466009812|FG000|Overall Study|Pregnancy|1|||
129971334|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
129971335|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
129971336|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
129971337|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
129971338|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
129971339|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
129971340|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
129971341|NCT04210843|467858466|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
129971342|NCT04210843|467858467|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
129971343|NCT04210843|467858466|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
129971344|NCT04210843|467858467|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
129971345|NCT04210843|467858466|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
129468336|NCT01700192|466009813|FG001|Overall Study|Pregnancy|4|||
129468337|NCT01700192|466009812|FG000|Overall Study|Progressive disease|1|||
129468338|NCT01700192|466009813|FG001|Overall Study|Progressive disease|0|||
129468339|NCT01700192|466009812|FG000|Overall Study|Protocol Violation|3|||
129971346|NCT04210843|467858467|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
129971347|NCT04210843|467858466|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
129468340|NCT01700192|466009813|FG001|Overall Study|Protocol Violation|4|||
129468341|NCT01700192|466009812|FG000|Overall Study|Technical problems|0|||
129468342|NCT01700192|466009813|FG001|Overall Study|Technical problems|1|||
129468343|NCT01700192|466009812|FG000|Overall Study|Withdrawal by Subject|56|||
129468344|NCT01700192|466009813|FG001|Overall Study|Withdrawal by Subject|64|||
129468345|NCT01700192|466009812|FG000|Overall Study|Never received study drug|1|||
129468346|NCT01700192|466009813|FG001|Overall Study|Never received study drug|0|||
129468347|NCT02793232|466009814|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468348|NCT02793232|466009815|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468349|NCT02793232|466009816|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468350|NCT02793232|466009817|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468351|NCT02793232|466009818|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
129468352|NCT02793232|466009819|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468353|NCT02793232|466009820|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
129468354|NCT02793232|466009821|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468355|NCT02793232|466009822|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
129468356|NCT00268242|466009823|FG000|Overall Study|Death|1|||
129468357|NCT00993928|466009824|FG000|Overall Study|Withdrawal by Subject|4|||
129468358|NCT00993928|466009825|FG001|Overall Study|Withdrawal by Subject|7|||
129468359|NCT00993928|466009824|FG000|Overall Study|ineligible|1|||
129468360|NCT00993928|466009825|FG001|Overall Study|ineligible|0|||
129468361|NCT03979274|466009826|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129468362|NCT03979274|466009827|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129468363|NCT03551743|466009830|FG000|Overall Study|Adverse Event|1|||
129468364|NCT03551743|466009831|FG001|Overall Study|Adverse Event|0|||
129468365|NCT03551743|466009832|FG002|Overall Study|Adverse Event|0|||
129468366|NCT03551743|466009833|FG003|Overall Study|Adverse Event|0|||
129468367|NCT03551743|466009830|FG000|Overall Study|Withdrawal by Subject|1|||
129468368|NCT03551743|466009831|FG001|Overall Study|Withdrawal by Subject|0|||
129468369|NCT03551743|466009832|FG002|Overall Study|Withdrawal by Subject|0|||
129468370|NCT03551743|466009833|FG003|Overall Study|Withdrawal by Subject|0|||
129468371|NCT02319044|466009834|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
129468372|NCT02319044|466009835|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
129468373|NCT02319044|466009836|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
129468374|NCT02319044|466009834|FG000|Overall Study|Withdrawal by Subject|3|||
129468375|NCT02319044|466009835|FG001|Overall Study|Withdrawal by Subject|3|||
129468376|NCT02319044|466009836|FG002|Overall Study|Withdrawal by Subject|6|||
129468377|NCT02319044|466009834|FG000|Overall Study|Condition under investigation worsened|100|||
129468378|NCT02319044|466009835|FG001|Overall Study|Condition under investigation worsened|50|||
129468379|NCT02319044|466009836|FG002|Overall Study|Condition under investigation worsened|46|||
129468380|NCT02319044|466009834|FG000|Overall Study|Adverse Event|17|||
129468381|NCT02319044|466009835|FG001|Overall Study|Adverse Event|2|||
129468382|NCT02319044|466009836|FG002|Overall Study|Adverse Event|8|||
129468383|NCT02319044|466009834|FG000|Overall Study|Study specific discontinuation criteria|2|||
129468384|NCT02319044|466009835|FG001|Overall Study|Study specific discontinuation criteria|2|||
129468385|NCT02319044|466009836|FG002|Overall Study|Study specific discontinuation criteria|1|||
129468386|NCT02319044|466009834|FG000|Overall Study|Not treated|0|||
129468387|NCT02319044|466009835|FG001|Overall Study|Not treated|2|||
129468388|NCT02319044|466009836|FG002|Overall Study|Not treated|2|||
129468389|NCT02317562|466009837|FG000|Overall Study|Physician Decision|1|||
129468390|NCT02317562|466009837|FG000|Overall Study|early termination of the study|8|||
129468391|NCT02317562|466009837|FG000|Overall Study|Lack of Efficacy|4|||
129468392|NCT02317562|466009837|FG000|Overall Study|Withdrawal by Subject|1|||
129468393|NCT00626093|466009838|FG000|Overall Study|Lost to Follow-up|5|||
129468394|NCT00626093|466009838|FG000|Overall Study|Death|1|||
129468395|NCT00626093|466009838|FG000|Overall Study|Physician Decision|4|||
129468396|NCT00626093|466009838|FG000|Overall Study|Withdrawal by Subject|6|||
129468397|NCT00626093|466009838|FG000|Overall Study|Protocol Violation|1|||
129468398|NCT00626093|466009838|FG000|Overall Study|One of the required devices not implante|6|||
129468399|NCT00603915|466009839|FG000|Overall Study|Physician Decision|1|||
129468400|NCT03891901|466009840|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
129468401|NCT03891901|466009841|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468402|NCT03891901|466009842|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468403|NCT03891901|466009843|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468404|NCT03891901|466009844|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468405|NCT03891901|466009845|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468406|NCT03891901|466009846|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468407|NCT03891901|466009847|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468408|NCT03891901|466009848|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
129468409|NCT03891901|466009840|FG000|Overall Study|Adverse Event|2|||
129468410|NCT03891901|466009841|FG001|Overall Study|Adverse Event|2|||
129468411|NCT03891901|466009842|FG002|Overall Study|Adverse Event|0|||
129468412|NCT03891901|466009843|FG003|Overall Study|Adverse Event|0|||
129468413|NCT03891901|466009844|FG004|Overall Study|Adverse Event|0|||
129468414|NCT03891901|466009845|FG005|Overall Study|Adverse Event|0|||
129468415|NCT03891901|466009846|FG006|Overall Study|Adverse Event|0|||
129468416|NCT03891901|466009847|FG007|Overall Study|Adverse Event|0|||
129468417|NCT03891901|466009848|FG008|Overall Study|Adverse Event|0|||
129468418|NCT03891901|466009840|FG000|Overall Study|Poor venous access|1|||
129468419|NCT03891901|466009841|FG001|Overall Study|Poor venous access|0|||
129468420|NCT03891901|466009842|FG002|Overall Study|Poor venous access|0|||
129468421|NCT03891901|466009843|FG003|Overall Study|Poor venous access|0|||
129468422|NCT03891901|466009844|FG004|Overall Study|Poor venous access|0|||
129468423|NCT03891901|466009845|FG005|Overall Study|Poor venous access|0|||
129468424|NCT03891901|466009846|FG006|Overall Study|Poor venous access|0|||
129468425|NCT03891901|466009847|FG007|Overall Study|Poor venous access|0|||
129468426|NCT03891901|466009848|FG008|Overall Study|Poor venous access|0|||
129468427|NCT03891901|466009840|FG000|Overall Study|Withdrawal by Subject|0|||
129468428|NCT03891901|466009841|FG001|Overall Study|Withdrawal by Subject|2|||
129468429|NCT03891901|466009842|FG002|Overall Study|Withdrawal by Subject|0|||
129468430|NCT03891901|466009843|FG003|Overall Study|Withdrawal by Subject|0|||
129468431|NCT03891901|466009844|FG004|Overall Study|Withdrawal by Subject|0|||
129468432|NCT03891901|466009845|FG005|Overall Study|Withdrawal by Subject|0|||
129468433|NCT03891901|466009846|FG006|Overall Study|Withdrawal by Subject|0|||
129468434|NCT03891901|466009847|FG007|Overall Study|Withdrawal by Subject|0|||
129468435|NCT03891901|466009848|FG008|Overall Study|Withdrawal by Subject|0|||
129468436|NCT03434379|466009849|FG000|Global Period|Lost to Follow-up|3|||
129468437|NCT03434379|466009850|FG001|Global Period|Lost to Follow-up|6|||
129468438|NCT03434379|466009851|FG002|Global Period|Lost to Follow-up|0|||
129468439|NCT03434379|466009852|FG003|Global Period|Lost to Follow-up|0|||
129468440|NCT03434379|466009849|FG000|Global Period|Death|115|||
129468441|NCT03434379|466009850|FG001|Global Period|Death|228|||
129468442|NCT03434379|466009851|FG002|Global Period|Death|0|||
129468443|NCT03434379|466009852|FG003|Global Period|Death|0|||
129468444|NCT03434379|466009849|FG000|Global Period|Withdrawal by Subject|20|||
129468445|NCT03434379|466009850|FG001|Global Period|Withdrawal by Subject|21|||
129468446|NCT03434379|466009851|FG002|Global Period|Withdrawal by Subject|0|||
129468447|NCT03434379|466009852|FG003|Global Period|Withdrawal by Subject|0|||
129468448|NCT03434379|466009849|FG000|Global Period|Reason Unspecified|0|||
129468449|NCT03434379|466009850|FG001|Global Period|Reason Unspecified|1|||
129971348|NCT04210843|467858467|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
129971349|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
129971350|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
129971351|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
129971352|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
129971353|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
129971354|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
129971355|NCT04210843|467858466|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
129971356|NCT04210843|467858467|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
129971357|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
129971358|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
129971359|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
129971360|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
129971361|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
129971362|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
129971363|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
129971364|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
129971365|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
129971366|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
129971367|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
129971368|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
129971369|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
129971370|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
129468450|NCT03434379|466009851|FG002|Global Period|Reason Unspecified|0|||
129468451|NCT03434379|466009852|FG003|Global Period|Reason Unspecified|0|||
129468452|NCT03434379|466009849|FG000|Global Period|Study Ended by Sponsor|26|||
129468453|NCT03434379|466009850|FG001|Global Period|Study Ended by Sponsor|80|||
129468454|NCT03434379|466009851|FG002|Global Period|Study Ended by Sponsor|0|||
129468455|NCT03434379|466009852|FG003|Global Period|Study Ended by Sponsor|0|||
129468456|NCT03434379|466009849|FG000|Global Period|Physician Decision|1|||
129468457|NCT03434379|466009850|FG001|Global Period|Physician Decision|0|||
129468458|NCT03434379|466009851|FG002|Global Period|Physician Decision|0|||
129468459|NCT03434379|466009852|FG003|Global Period|Physician Decision|0|||
129468460|NCT03434379|466009849|FG000|China Extension Period|Lost to Follow-up|0|||
129468461|NCT03434379|466009850|FG001|China Extension Period|Lost to Follow-up|0|||
129468462|NCT03434379|466009851|FG002|China Extension Period|Lost to Follow-up|2|||
129468463|NCT03434379|466009852|FG003|China Extension Period|Lost to Follow-up|3|||
129468464|NCT03434379|466009849|FG000|China Extension Period|Death|0|||
129468465|NCT03434379|466009850|FG001|China Extension Period|Death|0|||
129468466|NCT03434379|466009851|FG002|China Extension Period|Death|46|||
129468467|NCT03434379|466009852|FG003|China Extension Period|Death|88|||
129468468|NCT03434379|466009849|FG000|China Extension Period|Withdrawal by Subject|0|||
129468469|NCT03434379|466009850|FG001|China Extension Period|Withdrawal by Subject|0|||
129468470|NCT03434379|466009851|FG002|China Extension Period|Withdrawal by Subject|8|||
129468471|NCT03434379|466009852|FG003|China Extension Period|Withdrawal by Subject|6|||
129468472|NCT03434379|466009849|FG000|China Extension Period|Study Ended by Sponsor|0|||
129468473|NCT03434379|466009850|FG001|China Extension Period|Study Ended by Sponsor|0|||
129971371|NCT04210843|467858466|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
129971372|NCT04210843|467858467|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
129971373|NCT01776008|467858468|FG000|Overall Study|ineligible|2|||
129971374|NCT00150618|467858470|FG000|Overall Study|Adverse Event|2|||
129971375|NCT00150618|467858471|FG001|Overall Study|Adverse Event|2|||
129971376|NCT00150618|467858472|FG002|Overall Study|Adverse Event|6|||
129971377|NCT00150618|467858473|FG003|Overall Study|Adverse Event|9|||
129971378|NCT00150618|467858474|FG004|Overall Study|Adverse Event|5|||
129971379|NCT00150618|467858470|FG000|Overall Study|Withdrawal by Subject|6|||
129971380|NCT00150618|467858471|FG001|Overall Study|Withdrawal by Subject|8|||
129971381|NCT00150618|467858472|FG002|Overall Study|Withdrawal by Subject|8|||
129971382|NCT00150618|467858473|FG003|Overall Study|Withdrawal by Subject|4|||
129971383|NCT00150618|467858474|FG004|Overall Study|Withdrawal by Subject|5|||
129971384|NCT00150618|467858470|FG000|Overall Study|Lost to Follow-up|4|||
129468474|NCT03434379|466009851|FG002|China Extension Period|Study Ended by Sponsor|5|||
129468475|NCT03434379|466009852|FG003|China Extension Period|Study Ended by Sponsor|36|||
129468476|NCT02026063|466009855|FG000|Overall Study|Physician Decision|0|||
129468477|NCT02026063|466009856|FG001|Overall Study|Physician Decision|10|||
129468478|NCT02026063|466009855|FG000|Overall Study|Noncompliance with Study Drug|1|||
129468479|NCT02026063|466009856|FG001|Overall Study|Noncompliance with Study Drug|1|||
129468480|NCT02026063|466009855|FG000|Overall Study|Withdrawal of Consent|1|||
129468481|NCT02026063|466009856|FG001|Overall Study|Withdrawal of Consent|6|||
129468482|NCT02026063|466009855|FG000|Overall Study|Adverse Event|5|||
129468483|NCT02026063|466009856|FG001|Overall Study|Adverse Event|20|||
129468484|NCT02026063|466009855|FG000|Overall Study|Lack of Efficacy|0|||
129468485|NCT02026063|466009856|FG001|Overall Study|Lack of Efficacy|4|||
129468486|NCT02026063|466009855|FG000|Overall Study|Lost to Follow-up|0|||
129468487|NCT02026063|466009856|FG001|Overall Study|Lost to Follow-up|1|||
129468488|NCT02026063|466009855|FG000|Overall Study|Reason not Specified|2|||
129468489|NCT02026063|466009856|FG001|Overall Study|Reason not Specified|7|||
129468490|NCT02154087|466009857|FG000|Overall Study|Study Termination|1|||
129468491|NCT01116544|466009859|FG000|Overall Study|Protocol Violation|1|||
129468492|NCT01116544|466009860|FG001|Overall Study|Protocol Violation|0|||
129468493|NCT01116544|466009859|FG000|Overall Study|Withdrawal by Subject|1|||
129468494|NCT01116544|466009860|FG001|Overall Study|Withdrawal by Subject|1|||
129468495|NCT00486278|466009861|FG000|Overall Study|Adverse Event|5|||
129468496|NCT00486278|466009861|FG000|Overall Study|Withdrawal by Subject|2|||
129468497|NCT00486278|466009861|FG000|Overall Study|Physician Decision|2|||
129468498|NCT04556617|466009866|FG000|Overall Study|progressive disease|0|||
129468499|NCT04556617|466009867|FG001|Overall Study|progressive disease|2|||
129468500|NCT04556617|466009868|FG002|Overall Study|progressive disease|2|||
129468501|NCT04556617|466009869|FG003|Overall Study|progressive disease|1|||
129468502|NCT04556617|466009870|FG004|Overall Study|progressive disease|1|||
129468503|NCT04556617|466009866|FG000|Overall Study|Physician Decision|0|||
129468504|NCT04556617|466009867|FG001|Overall Study|Physician Decision|0|||
129971385|NCT00150618|467858471|FG001|Overall Study|Lost to Follow-up|1|||
129971386|NCT00150618|467858472|FG002|Overall Study|Lost to Follow-up|5|||
129971387|NCT00150618|467858473|FG003|Overall Study|Lost to Follow-up|8|||
129971388|NCT00150618|467858474|FG004|Overall Study|Lost to Follow-up|4|||
129971389|NCT00150618|467858470|FG000|Overall Study|Protocol Violation|1|||
129971390|NCT00150618|467858471|FG001|Overall Study|Protocol Violation|0|||
129971391|NCT00150618|467858472|FG002|Overall Study|Protocol Violation|0|||
129468505|NCT04556617|466009868|FG002|Overall Study|Physician Decision|2|||
129468506|NCT04556617|466009869|FG003|Overall Study|Physician Decision|0|||
129468507|NCT04556617|466009870|FG004|Overall Study|Physician Decision|0|||
129468508|NCT04556617|466009866|FG000|Overall Study|Adverse Event|0|||
129468509|NCT04556617|466009867|FG001|Overall Study|Adverse Event|0|||
129971392|NCT00150618|467858473|FG003|Overall Study|Protocol Violation|0|||
129971393|NCT00150618|467858474|FG004|Overall Study|Protocol Violation|1|||
129468510|NCT04556617|466009868|FG002|Overall Study|Adverse Event|2|||
129468511|NCT04556617|466009869|FG003|Overall Study|Adverse Event|3|||
129468512|NCT04556617|466009870|FG004|Overall Study|Adverse Event|0|||
129468513|NCT04556617|466009866|FG000|Overall Study|Withdrawal by Subject|0|||
129468514|NCT04556617|466009867|FG001|Overall Study|Withdrawal by Subject|2|||
129468515|NCT04556617|466009868|FG002|Overall Study|Withdrawal by Subject|1|||
129468516|NCT04556617|466009869|FG003|Overall Study|Withdrawal by Subject|1|||
129468517|NCT04556617|466009870|FG004|Overall Study|Withdrawal by Subject|0|||
129468518|NCT04556617|466009866|FG000|Overall Study|PSA increase|0|||
129468519|NCT04556617|466009867|FG001|Overall Study|PSA increase|1|||
129468520|NCT04556617|466009868|FG002|Overall Study|PSA increase|0|||
129468521|NCT04556617|466009869|FG003|Overall Study|PSA increase|0|||
129468522|NCT04556617|466009870|FG004|Overall Study|PSA increase|0|||
129468523|NCT04556617|466009866|FG000|Overall Study|Sponsor study termination|1|||
129468524|NCT04556617|466009867|FG001|Overall Study|Sponsor study termination|0|||
129468525|NCT04556617|466009868|FG002|Overall Study|Sponsor study termination|0|||
129468526|NCT04556617|466009869|FG003|Overall Study|Sponsor study termination|0|||
129468527|NCT04556617|466009870|FG004|Overall Study|Sponsor study termination|0|||
129468528|NCT04949841|466009871|FG000|Overall Study|Adverse Event|7|||
129468529|NCT04949841|466009871|FG000|Overall Study|Death|1|||
129468530|NCT04949841|466009871|FG000|Overall Study|Withdrawal by Subject|52|||
129468531|NCT04949841|466009871|FG000|Overall Study|Pregnancy|4|||
129468532|NCT04949841|466009871|FG000|Overall Study|Lost to Follow-up|9|||
129468533|NCT04949841|466009871|FG000|Overall Study|Lack of Efficacy|55|||
129468534|NCT04949841|466009871|FG000|Overall Study|Various reasons|9|||
129468535|NCT03179436|466009872|FG000|Overall Study|Withdrawal by Subject|1|||
129468536|NCT03179436|466009873|FG001|Overall Study|Withdrawal by Subject|0|||
129468537|NCT03179436|466009874|FG002|Overall Study|Withdrawal by Subject|0|||
129468538|NCT03179436|466009875|FG003|Overall Study|Withdrawal by Subject|4|||
129468539|NCT03179436|466009876|FG004|Overall Study|Withdrawal by Subject|2|||
129468540|NCT03179436|466009877|FG005|Overall Study|Withdrawal by Subject|2|||
129468541|NCT03179436|466009878|FG006|Overall Study|Withdrawal by Subject|5|||
129468542|NCT03179436|466009879|FG007|Overall Study|Withdrawal by Subject|0|||
129468543|NCT03179436|466009880|FG008|Overall Study|Withdrawal by Subject|3|||
129468544|NCT03179436|466009881|FG009|Overall Study|Withdrawal by Subject|0|||
129468545|NCT03179436|466009882|FG010|Overall Study|Withdrawal by Subject|0|||
129468546|NCT03179436|466009883|FG011|Overall Study|Withdrawal by Subject|0|||
129468547|NCT03179436|466009872|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129468548|NCT03179436|466009873|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129468549|NCT03179436|466009874|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129468550|NCT03179436|466009875|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129468551|NCT03179436|466009876|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129468552|NCT03179436|466009877|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
129468553|NCT03179436|466009878|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
129468554|NCT03179436|466009879|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
129468555|NCT03179436|466009880|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
129468556|NCT03179436|466009881|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
129468557|NCT03179436|466009882|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
129468558|NCT03179436|466009883|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
129468559|NCT03179436|466009872|FG000|Overall Study|Sponsor Decision|0|||
129468560|NCT03179436|466009873|FG001|Overall Study|Sponsor Decision|0|||
129468561|NCT03179436|466009874|FG002|Overall Study|Sponsor Decision|1|||
129468562|NCT03179436|466009875|FG003|Overall Study|Sponsor Decision|3|||
129468563|NCT03179436|466009876|FG004|Overall Study|Sponsor Decision|9|||
129468564|NCT03179436|466009877|FG005|Overall Study|Sponsor Decision|7|||
129468565|NCT03179436|466009878|FG006|Overall Study|Sponsor Decision|2|||
129468566|NCT03179436|466009879|FG007|Overall Study|Sponsor Decision|4|||
129468567|NCT03179436|466009880|FG008|Overall Study|Sponsor Decision|23|||
129468568|NCT03179436|466009881|FG009|Overall Study|Sponsor Decision|6|||
129468569|NCT03179436|466009882|FG010|Overall Study|Sponsor Decision|7|||
129468570|NCT03179436|466009883|FG011|Overall Study|Sponsor Decision|5|||
129468571|NCT03179436|466009872|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468572|NCT03179436|466009873|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
129468573|NCT03179436|466009874|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468574|NCT03179436|466009875|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468575|NCT03179436|466009876|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468576|NCT03179436|466009877|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
129468577|NCT03179436|466009878|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
129971394|NCT00150618|467858470|FG000|Overall Study|Lack of Efficacy|1|||
129971395|NCT00150618|467858471|FG001|Overall Study|Lack of Efficacy|4|||
129468578|NCT03179436|466009879|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468579|NCT03179436|466009880|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468580|NCT03179436|466009881|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468581|NCT03179436|466009882|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468582|NCT03179436|466009883|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
129468583|NCT03179436|466009872|FG000|Overall Study|Lost to Follow-up|1|||
129468584|NCT03179436|466009873|FG001|Overall Study|Lost to Follow-up|0|||
129468585|NCT03179436|466009874|FG002|Overall Study|Lost to Follow-up|0|||
129468586|NCT03179436|466009875|FG003|Overall Study|Lost to Follow-up|1|||
129468587|NCT03179436|466009876|FG004|Overall Study|Lost to Follow-up|0|||
129468588|NCT03179436|466009877|FG005|Overall Study|Lost to Follow-up|1|||
129468589|NCT03179436|466009878|FG006|Overall Study|Lost to Follow-up|0|||
129468590|NCT03179436|466009879|FG007|Overall Study|Lost to Follow-up|0|||
129468591|NCT03179436|466009880|FG008|Overall Study|Lost to Follow-up|1|||
129468592|NCT03179436|466009881|FG009|Overall Study|Lost to Follow-up|1|||
129468593|NCT03179436|466009882|FG010|Overall Study|Lost to Follow-up|0|||
129468594|NCT03179436|466009883|FG011|Overall Study|Lost to Follow-up|0|||
129468595|NCT03179436|466009872|FG000|Overall Study|Death|12|||
129468596|NCT03179436|466009873|FG001|Overall Study|Death|17|||
129468597|NCT03179436|466009874|FG002|Overall Study|Death|7|||
129468598|NCT03179436|466009875|FG003|Overall Study|Death|32|||
129468599|NCT03179436|466009876|FG004|Overall Study|Death|29|||
129468600|NCT03179436|466009877|FG005|Overall Study|Death|30|||
129468601|NCT03179436|466009878|FG006|Overall Study|Death|33|||
129468602|NCT03179436|466009879|FG007|Overall Study|Death|9|||
129468603|NCT03179436|466009880|FG008|Overall Study|Death|84|||
129468604|NCT03179436|466009881|FG009|Overall Study|Death|33|||
129468605|NCT03179436|466009882|FG010|Overall Study|Death|22|||
129468606|NCT03179436|466009883|FG011|Overall Study|Death|15|||
129468607|NCT05168267|466009884|FG000|Overall Study|Withdrawal by Subject|2|||
129468608|NCT05168267|466009885|FG001|Overall Study|Withdrawal by Subject|1|||
129468609|NCT05168267|466009884|FG000|Overall Study|Withdrawn by Therapist|1|||
129468610|NCT05168267|466009885|FG001|Overall Study|Withdrawn by Therapist|1|||
129468611|NCT05168267|466009884|FG000|Overall Study|Left Facility|1|||
129468612|NCT05168267|466009885|FG001|Overall Study|Left Facility|0|||
129468613|NCT05702736|466009886|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
129468614|NCT05702736|466009887|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
129468615|NCT05702736|466009886|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
129468616|NCT05702736|466009887|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
129468617|NCT00803179|466009890|FG000|Overall Study|Lost to Follow-up|3|||
129468618|NCT01877083|466009891|FG000|Treatment Phase|Disease Progression|10|||
129468619|NCT01877083|466009891|FG000|Treatment Phase|Clinical Progression|1|||
129468620|NCT01877083|466009891|FG000|Treatment Phase|Adverse Event|6|||
129468621|NCT01877083|466009891|FG000|Treatment Phase|Withdrawal by Subject|2|||
129468622|NCT01877083|466009891|FG000|Treatment Phase|Lost to Follow-up|1|||
129468623|NCT01877083|466009891|FG000|Extension Phase|Disease Progression|3|||
129468624|NCT01877083|466009891|FG000|Extension Phase|Adverse Event|2|||
129468625|NCT00500682|466009892|FG000|Overall Study|Adverse Event|37|||
129468626|NCT00500682|466009893|FG001|Overall Study|Adverse Event|29|||
129468627|NCT00500682|466009892|FG000|Overall Study|Death|25|||
129468628|NCT00500682|466009893|FG001|Overall Study|Death|16|||
129468629|NCT00500682|466009892|FG000|Overall Study|Lost to Follow-up|11|||
129468630|NCT00500682|466009893|FG001|Overall Study|Lost to Follow-up|11|||
129468631|NCT00500682|466009892|FG000|Overall Study|Physician Decision|6|||
129468632|NCT00500682|466009893|FG001|Overall Study|Physician Decision|10|||
129468633|NCT00500682|466009892|FG000|Overall Study|Pregnancy|2|||
129468634|NCT00500682|466009893|FG001|Overall Study|Pregnancy|0|||
129468635|NCT00500682|466009892|FG000|Overall Study|Protocol Violation|1|||
129468636|NCT00500682|466009893|FG001|Overall Study|Protocol Violation|3|||
129468637|NCT00500682|466009892|FG000|Overall Study|Withdrawal by Subject|80|||
129468638|NCT00500682|466009893|FG001|Overall Study|Withdrawal by Subject|74|||
129468639|NCT00500682|466009892|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
129468640|NCT00500682|466009893|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
129468641|NCT01582308|466009894|FG000|Period 1|Withdrawal by Subject|0|||
129468642|NCT01582308|466009895|FG001|Period 1|Withdrawal by Subject|0|||
129468643|NCT01582308|466009896|FG002|Period 1|Withdrawal by Subject|0|||
129468644|NCT01582308|466009897|FG003|Period 1|Withdrawal by Subject|0|||
129468645|NCT01582308|466009898|FG004|Period 1|Withdrawal by Subject|0|||
129468646|NCT01582308|466009899|FG005|Period 1|Withdrawal by Subject|0|||
129468647|NCT01582308|466009900|FG006|Period 1|Withdrawal by Subject|1|||
129468648|NCT01582308|466009901|FG007|Period 1|Withdrawal by Subject|0|||
129468649|NCT01582308|466009902|FG008|Period 1|Withdrawal by Subject|0|||
129468650|NCT01582308|466009903|FG009|Period 1|Withdrawal by Subject|0|||
129468651|NCT01582308|466009894|FG000|10-day Washout Following Period 1|Physician Decision|0|||
129468652|NCT01582308|466009895|FG001|10-day Washout Following Period 1|Physician Decision|0|||
129468653|NCT01582308|466009896|FG002|10-day Washout Following Period 1|Physician Decision|0|||
129468654|NCT01582308|466009897|FG003|10-day Washout Following Period 1|Physician Decision|0|||
129468655|NCT01582308|466009898|FG004|10-day Washout Following Period 1|Physician Decision|1|||
129468656|NCT01582308|466009899|FG005|10-day Washout Following Period 1|Physician Decision|0|||
129468657|NCT01582308|466009900|FG006|10-day Washout Following Period 1|Physician Decision|0|||
129468658|NCT01582308|466009901|FG007|10-day Washout Following Period 1|Physician Decision|0|||
129468659|NCT01582308|466009902|FG008|10-day Washout Following Period 1|Physician Decision|0|||
129468660|NCT01582308|466009903|FG009|10-day Washout Following Period 1|Physician Decision|0|||
129468661|NCT01582308|466009894|FG000|Period 4|Physician Decision|1|||
129468662|NCT01582308|466009895|FG001|Period 4|Physician Decision|0|||
129468663|NCT01582308|466009896|FG002|Period 4|Physician Decision|0|||
129468664|NCT01582308|466009897|FG003|Period 4|Physician Decision|0|||
129468665|NCT01582308|466009898|FG004|Period 4|Physician Decision|0|||
129468666|NCT01582308|466009899|FG005|Period 4|Physician Decision|1|||
129468667|NCT01582308|466009900|FG006|Period 4|Physician Decision|0|||
129468668|NCT01582308|466009901|FG007|Period 4|Physician Decision|0|||
129468669|NCT01582308|466009902|FG008|Period 4|Physician Decision|0|||
129468670|NCT01582308|466009903|FG009|Period 4|Physician Decision|1|||
129468671|NCT00772668|466009908|FG000|Overall Study|Physician Decision|3|||
129468672|NCT01182428|466009909|FG000|Overall Study|Physician Decision|1|||
129468673|NCT01182428|466009910|FG001|Overall Study|Physician Decision|0|||
129468674|NCT01182428|466009909|FG000|Overall Study|Lost to Follow-up|9|||
129468675|NCT01182428|466009910|FG001|Overall Study|Lost to Follow-up|1|||
129468676|NCT01182428|466009909|FG000|Overall Study|Withdrawal by Subject|1|||
129468677|NCT01182428|466009910|FG001|Overall Study|Withdrawal by Subject|0|||
129468678|NCT00684957|466009911|FG000|Overall Study|Withdrawal by Subject|1|||
129468679|NCT00684957|466009912|FG001|Overall Study|Withdrawal by Subject|1|||
129468680|NCT00684957|466009911|FG000|Overall Study|Lost to Follow-up|1|||
129468681|NCT00684957|466009912|FG001|Overall Study|Lost to Follow-up|0|||
129468682|NCT04484285|466011307|FG000|Overall Study|Unable to operate stimulator|3|||
129468683|NCT04484285|466011308|FG001|Overall Study|Unable to operate stimulator|0|||
129468684|NCT00768898|466011309|FG000|Overall Study|Unrelated injury|1|||
129468685|NCT00768898|466011309|FG000|Overall Study|Headache|1|||
129468686|NCT02949128|466011310|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
129468687|NCT02949128|466011310|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
129468688|NCT02949128|466011310|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
129468689|NCT02949128|466011310|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
129468690|NCT02949128|466011310|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
129468691|NCT02949128|466011310|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
129468692|NCT02949128|466011310|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
129468693|NCT02949128|466011310|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
129468694|NCT02949128|466011310|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
129468695|NCT02949128|466011310|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
129468696|NCT03160560|466011313|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
129468697|NCT03160560|466011314|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129468698|NCT03160560|466011315|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129468699|NCT03160560|466011316|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
129468700|NCT03160560|466011313|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
129468701|NCT03160560|466011314|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
129468702|NCT03160560|466011315|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
129468703|NCT03160560|466011316|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
129468704|NCT00667576|466011317|FG000|Overall Study|Withdrawal by Subject|1|||
129468705|NCT00667576|466011318|FG001|Overall Study|Withdrawal by Subject|0|||
129468706|NCT00667576|466011319|FG002|Overall Study|Withdrawal by Subject|1|||
129468707|NCT00667576|466011320|FG003|Overall Study|Withdrawal by Subject|1|||
129468708|NCT00667576|466011321|FG004|Overall Study|Withdrawal by Subject|1|||
129468709|NCT00667576|466011317|FG000|Overall Study|Adverse Event|1|||
129468710|NCT00667576|466011318|FG001|Overall Study|Adverse Event|1|||
129468711|NCT00667576|466011319|FG002|Overall Study|Adverse Event|0|||
129468712|NCT00667576|466011320|FG003|Overall Study|Adverse Event|0|||
129468713|NCT00667576|466011321|FG004|Overall Study|Adverse Event|0|||
129468714|NCT00667576|466011317|FG000|Overall Study|Lost to Follow-up|0|||
129468715|NCT00667576|466011318|FG001|Overall Study|Lost to Follow-up|0|||
129468716|NCT00667576|466011319|FG002|Overall Study|Lost to Follow-up|1|||
129468717|NCT00667576|466011320|FG003|Overall Study|Lost to Follow-up|0|||
129468718|NCT00667576|466011321|FG004|Overall Study|Lost to Follow-up|0|||
129468719|NCT00667576|466011317|FG000|Overall Study|Protocol Violation|0|||
129468720|NCT00667576|466011318|FG001|Overall Study|Protocol Violation|0|||
129468721|NCT00667576|466011319|FG002|Overall Study|Protocol Violation|0|||
129468722|NCT00667576|466011320|FG003|Overall Study|Protocol Violation|1|||
129468723|NCT00667576|466011321|FG004|Overall Study|Protocol Violation|0|||
129468724|NCT00667576|466011317|FG000|Overall Study|Physician Decision|0|||
129468725|NCT00667576|466011318|FG001|Overall Study|Physician Decision|0|||
129468726|NCT00667576|466011319|FG002|Overall Study|Physician Decision|0|||
129468727|NCT00667576|466011320|FG003|Overall Study|Physician Decision|1|||
129971396|NCT00150618|467858472|FG002|Overall Study|Lack of Efficacy|7|||
129468728|NCT00667576|466011321|FG004|Overall Study|Physician Decision|0|||
129468729|NCT00667576|466011317|FG000|Overall Study|Missed Visit|0|||
129971397|NCT00150618|467858473|FG003|Overall Study|Lack of Efficacy|4|||
129468730|NCT00667576|466011318|FG001|Overall Study|Missed Visit|0|||
129468731|NCT00667576|466011319|FG002|Overall Study|Missed Visit|0|||
129468732|NCT00667576|466011320|FG003|Overall Study|Missed Visit|1|||
129971398|NCT00150618|467858474|FG004|Overall Study|Lack of Efficacy|6|||
129468733|NCT00667576|466011321|FG004|Overall Study|Missed Visit|0|||
129468734|NCT01390389|466011322|FG000|Overall Study|Withdrawal by Subject|2|||
129468735|NCT01390389|466011323|FG001|Overall Study|Withdrawal by Subject|0|||
129468736|NCT01390389|466011322|FG000|Overall Study|Screen Fail|2|||
129468737|NCT01390389|466011323|FG001|Overall Study|Screen Fail|1|||
129468738|NCT02002975|466011326|FG000|Overall Study|Case Report Forms Uncollected|135|||
129468739|NCT02002975|466011326|FG000|Overall Study|Protocol Deviation|437|||
129468740|NCT01430442|466011327|FG000|Overall Study|Subject Withdrew Consent|3|||
129468741|NCT01430442|466011328|FG001|Overall Study|Subject Withdrew Consent|0|||
129468742|NCT01430442|466011329|FG002|Overall Study|Subject Withdrew Consent|1|||
129468743|NCT01430442|466011330|FG003|Overall Study|Subject Withdrew Consent|0|||
129468744|NCT01430442|466011331|FG004|Overall Study|Subject Withdrew Consent|2|||
129468745|NCT01430442|466011332|FG005|Overall Study|Subject Withdrew Consent|1|||
129468746|NCT01430442|466011333|FG006|Overall Study|Subject Withdrew Consent|5|||
129468747|NCT01430442|466011334|FG007|Overall Study|Subject Withdrew Consent|2|||
129468748|NCT01430442|466011327|FG000|Overall Study|Lost to Follow-up|2|||
129468749|NCT01430442|466011328|FG001|Overall Study|Lost to Follow-up|0|||
129468750|NCT01430442|466011329|FG002|Overall Study|Lost to Follow-up|1|||
129468751|NCT01430442|466011330|FG003|Overall Study|Lost to Follow-up|2|||
129468752|NCT01430442|466011331|FG004|Overall Study|Lost to Follow-up|2|||
129468753|NCT01430442|466011332|FG005|Overall Study|Lost to Follow-up|1|||
129468754|NCT01430442|466011333|FG006|Overall Study|Lost to Follow-up|5|||
129468755|NCT01430442|466011334|FG007|Overall Study|Lost to Follow-up|1|||
129468756|NCT01430442|466011327|FG000|Overall Study|Pregnancy|1|||
129468757|NCT01430442|466011328|FG001|Overall Study|Pregnancy|0|||
129468758|NCT01430442|466011329|FG002|Overall Study|Pregnancy|0|||
129468759|NCT01430442|466011330|FG003|Overall Study|Pregnancy|0|||
129468760|NCT01430442|466011331|FG004|Overall Study|Pregnancy|0|||
129468761|NCT01430442|466011332|FG005|Overall Study|Pregnancy|1|||
129468762|NCT01430442|466011333|FG006|Overall Study|Pregnancy|0|||
129468763|NCT01430442|466011334|FG007|Overall Study|Pregnancy|0|||
129468764|NCT01430442|466011327|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
129468765|NCT01430442|466011328|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
129468766|NCT01430442|466011329|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
129468767|NCT01430442|466011330|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
129468768|NCT01430442|466011331|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
129468769|NCT01430442|466011332|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
129468770|NCT01430442|466011333|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
129468771|NCT01430442|466011334|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
129468772|NCT01641939|466011335|FG000|Overall Study|Death|90|||
129468773|NCT01641939|466011336|FG001|Overall Study|Death|187|||
129468774|NCT01641939|466011337|FG002|Overall Study|Death|61|||
129468775|NCT01641939|466011335|FG000|Overall Study|Lost to Follow-up|3|||
129468776|NCT01641939|466011336|FG001|Overall Study|Lost to Follow-up|2|||
129468777|NCT01641939|466011337|FG002|Overall Study|Lost to Follow-up|1|||
129468778|NCT01641939|466011335|FG000|Overall Study|Withdrawal by Subject|14|||
129468779|NCT01641939|466011336|FG001|Overall Study|Withdrawal by Subject|11|||
129468780|NCT01641939|466011337|FG002|Overall Study|Withdrawal by Subject|5|||
129468781|NCT01641939|466011335|FG000|Overall Study|Study Terminated by Sponsor|10|||
129468782|NCT01641939|466011336|FG001|Overall Study|Study Terminated by Sponsor|28|||
129468783|NCT01641939|466011337|FG002|Overall Study|Study Terminated by Sponsor|3|||
129468784|NCT00772629|466011338|FG000|Overall Study|Subject was not vaccinated|1|||
129468785|NCT00772629|466011339|FG001|Overall Study|Subject was not vaccinated|0|||
129468786|NCT05162066|466011343|FG000|Overall Study|Adverse Event|1|||
129468787|NCT05162066|466011344|FG001|Overall Study|Adverse Event|0|||
129468788|NCT05162066|466011345|FG002|Overall Study|Adverse Event|0|||
129468789|NCT05162066|466011343|FG000|Overall Study|Perceived lack of efficacy|1|||
129468790|NCT05162066|466011344|FG001|Overall Study|Perceived lack of efficacy|0|||
129468791|NCT05162066|466011345|FG002|Overall Study|Perceived lack of efficacy|0|||
129468792|NCT01072344|466011346|FG000|Overall Study|Relasped-reached end point|7|||
129468793|NCT01072344|466011347|FG001|Overall Study|Relasped-reached end point|12|||
129468794|NCT01072344|466011346|FG000|Overall Study|Protocol Violation|1|||
129468795|NCT01072344|466011347|FG001|Overall Study|Protocol Violation|2|||
129468796|NCT01072344|466011346|FG000|Overall Study|Lost to Follow-up|3|||
129468797|NCT01072344|466011347|FG001|Overall Study|Lost to Follow-up|4|||
129468798|NCT01871090|466011348|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
129468799|NCT01871090|466011349|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
129468800|NCT01871090|466011348|FG000|Overall Study|Interrogation not completed correctly|1|||
129468801|NCT01871090|466011349|FG001|Overall Study|Interrogation not completed correctly|0|||
129468802|NCT01871090|466011348|FG000|Overall Study|Subject Non-Compliance|0|||
129468803|NCT01871090|466011349|FG001|Overall Study|Subject Non-Compliance|1|||
129468804|NCT00168831|466011358|FG000|Overall Study|Adverse Event|36|||
129468805|NCT00168831|466011359|FG001|Overall Study|Adverse Event|47|||
129468806|NCT00168831|466011360|FG002|Overall Study|Adverse Event|74|||
129468807|NCT00168831|466011358|FG000|Overall Study|Lost to Follow-up|5|||
129468808|NCT00168831|466011359|FG001|Overall Study|Lost to Follow-up|6|||
129468809|NCT00168831|466011360|FG002|Overall Study|Lost to Follow-up|4|||
129468810|NCT00168831|466011358|FG000|Overall Study|Withdrawal by Subject|7|||
129468811|NCT00168831|466011359|FG001|Overall Study|Withdrawal by Subject|14|||
129468812|NCT00168831|466011360|FG002|Overall Study|Withdrawal by Subject|19|||
129468813|NCT00168831|466011358|FG000|Overall Study|Protocol Violation|6|||
129468814|NCT00168831|466011359|FG001|Overall Study|Protocol Violation|11|||
129468815|NCT00168831|466011360|FG002|Overall Study|Protocol Violation|11|||
129468816|NCT00168831|466011358|FG000|Overall Study|Other|6|||
129468817|NCT00168831|466011359|FG001|Overall Study|Other|3|||
129468818|NCT00168831|466011360|FG002|Overall Study|Other|6|||
129468819|NCT02009878|466011364|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
129468820|NCT02009878|466011365|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
129468821|NCT02009878|466011366|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
129468822|NCT03106779|466011369|FG000|Overall Study|Lack of Efficacy|33|||
129468823|NCT03106779|466011370|FG001|Overall Study|Lack of Efficacy|24|||
129468824|NCT03106779|466011369|FG000|Overall Study|Adverse Event|8|||
129468825|NCT03106779|466011370|FG001|Overall Study|Adverse Event|16|||
129468826|NCT03106779|466011369|FG000|Overall Study|Physician Decision|10|||
129468827|NCT03106779|466011370|FG001|Overall Study|Physician Decision|6|||
129468828|NCT03106779|466011369|FG000|Overall Study|Patient/guardian decision|4|||
129468829|NCT03106779|466011370|FG001|Overall Study|Patient/guardian decision|3|||
129468830|NCT03106779|466011369|FG000|Overall Study|Progressive disease|1|||
129468831|NCT03106779|466011370|FG001|Overall Study|Progressive disease|3|||
129971399|NCT00150618|467858470|FG000|Overall Study|No study meds|0|||
129468832|NCT03106779|466011369|FG000|Overall Study|Lost to Follow-up|1|||
129468833|NCT03106779|466011370|FG001|Overall Study|Lost to Follow-up|2|||
129468834|NCT03106779|466011369|FG000|Overall Study|Death|1|||
129468835|NCT03106779|466011370|FG001|Overall Study|Death|0|||
129468836|NCT03106779|466011369|FG000|Overall Study|Protocol Violation|1|||
129468837|NCT03106779|466011370|FG001|Overall Study|Protocol Violation|0|||
129468838|NCT03106779|466011369|FG000|Overall Study|Not treated|1|||
129468839|NCT03106779|466011370|FG001|Overall Study|Not treated|0|||
129468840|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
129468841|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
129468842|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
129468843|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
129468844|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
129468845|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
129468846|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
129468847|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
129468848|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
129468849|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
129468850|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
129468851|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
129468852|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
129468853|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
129468854|NCT02288247|466011371|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
129468855|NCT02288247|466011372|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
129468856|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
129468857|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
129468858|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
129468859|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
129468860|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
129468861|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
129468862|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
129468863|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
129468864|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
129468865|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
129468866|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
129468867|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
129468868|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
129468869|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
129468870|NCT02288247|466011371|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
129468871|NCT02288247|466011372|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
129468872|NCT04093531|466011373|FG000|Overall Study|failed screening|4|||
129468873|NCT03634800|466011374|FG000|Overall Study|Adverse Event|1|||
129468874|NCT03634800|466011374|FG000|Overall Study|Disease Progression|4|||
129468875|NCT03634800|466011374|FG000|Overall Study|Withdrawal by Subject|1|||
129468876|NCT00343512|466011377|FG000|Overall Study|Withdrawal by Subject|2|||
129468877|NCT00684515|466011380|FG000|Overall Study|Adverse Event|3|||
129468878|NCT00684515|466011381|FG001|Overall Study|Adverse Event|3|||
129468879|NCT00684515|466011382|FG002|Overall Study|Adverse Event|1|||
129468880|NCT00684515|466011380|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
129468881|NCT00684515|466011381|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
129468882|NCT00684515|466011382|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
129468883|NCT04428411|466011383|FG000|Overall Study|Lost to Follow-up|114|||
129468884|NCT00272987|466011384|FG000|Overall Study|Adverse Event|1|||
129468885|NCT00272987|466011385|FG001|Overall Study|Adverse Event|0|||
129468886|NCT00272987|466011386|FG002|Overall Study|Adverse Event|0|||
129468887|NCT00272987|466011384|FG000|Overall Study|Lost to Follow-up|3|||
129468888|NCT00272987|466011385|FG001|Overall Study|Lost to Follow-up|1|||
129468889|NCT00272987|466011386|FG002|Overall Study|Lost to Follow-up|1|||
129468890|NCT00272987|466011384|FG000|Overall Study|Withdrawal by Subject|1|||
129468891|NCT00272987|466011385|FG001|Overall Study|Withdrawal by Subject|0|||
129468892|NCT00272987|466011386|FG002|Overall Study|Withdrawal by Subject|3|||
129468893|NCT00272987|466011384|FG000|Overall Study|Sponsor Terminated study|0|||
129468894|NCT00272987|466011385|FG001|Overall Study|Sponsor Terminated study|1|||
129468895|NCT00272987|466011386|FG002|Overall Study|Sponsor Terminated study|1|||
129468896|NCT00272987|466011384|FG000|Overall Study|Disease progression|1|||
129468897|NCT00272987|466011385|FG001|Overall Study|Disease progression|1|||
129468898|NCT00272987|466011386|FG002|Overall Study|Disease progression|2|||
129468899|NCT00272987|466011384|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
129468900|NCT00272987|466011385|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
129468901|NCT00272987|466011386|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
129971400|NCT00150618|467858471|FG001|Overall Study|No study meds|0|||
129468902|NCT00272987|466011384|FG000|Overall Study|Death|1|||
129468903|NCT00272987|466011385|FG001|Overall Study|Death|0|||
129468904|NCT00272987|466011386|FG002|Overall Study|Death|0|||
129468905|NCT00939692|466011387|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
129468906|NCT00939692|466011388|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
129468907|NCT00939692|466011387|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
129468908|NCT00939692|466011388|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
129468909|NCT00408694|466011389|FG000|Overall Study|Ineligible|1|||
129468910|NCT00408694|466011389|FG000|Overall Study|No protocol treatment|1|||
129971401|NCT00150618|467858472|FG002|Overall Study|No study meds|0|||
129971402|NCT00150618|467858473|FG003|Overall Study|No study meds|0|||
129971403|NCT00150618|467858474|FG004|Overall Study|No study meds|2|||
129971404|NCT00150618|467858470|FG000|Overall Study|Physician Decision|0|||
129971405|NCT00150618|467858471|FG001|Overall Study|Physician Decision|2|||
129971406|NCT00150618|467858472|FG002|Overall Study|Physician Decision|0|||
129971407|NCT00150618|467858473|FG003|Overall Study|Physician Decision|0|||
129971408|NCT00150618|467858474|FG004|Overall Study|Physician Decision|1|||
129971409|NCT00150618|467858470|FG000|Overall Study|Lack of compliance|2|||
129971410|NCT00150618|467858471|FG001|Overall Study|Lack of compliance|1|||
129971411|NCT00150618|467858472|FG002|Overall Study|Lack of compliance|1|||
129971412|NCT00150618|467858473|FG003|Overall Study|Lack of compliance|0|||
129971413|NCT00150618|467858474|FG004|Overall Study|Lack of compliance|1|||
129468911|NCT03543410|466011395|FG000|Overall Study|Adverse Event|10|||
129468912|NCT03543410|466011396|FG001|Overall Study|Adverse Event|8|||
129468913|NCT03543410|466011397|FG002|Overall Study|Adverse Event|2|||
129468914|NCT03543410|466011395|FG000|Overall Study|Lack of Efficacy|0|||
129468915|NCT03543410|466011396|FG001|Overall Study|Lack of Efficacy|1|||
129468916|NCT03543410|466011397|FG002|Overall Study|Lack of Efficacy|0|||
129468917|NCT03543410|466011395|FG000|Overall Study|Lost to Follow-up|0|||
129468918|NCT03543410|466011396|FG001|Overall Study|Lost to Follow-up|1|||
129468919|NCT03543410|466011397|FG002|Overall Study|Lost to Follow-up|0|||
129468920|NCT03543410|466011395|FG000|Overall Study|Withdrawal by Subject|5|||
129468921|NCT03543410|466011396|FG001|Overall Study|Withdrawal by Subject|2|||
129468922|NCT03543410|466011397|FG002|Overall Study|Withdrawal by Subject|8|||
129468923|NCT03543410|466011395|FG000|Overall Study|Protocol Violation|0|||
129468924|NCT03543410|466011396|FG001|Overall Study|Protocol Violation|1|||
129468925|NCT03543410|466011397|FG002|Overall Study|Protocol Violation|0|||
129468926|NCT03543410|466011395|FG000|Overall Study|Due to COVID-19|4|||
129468927|NCT03543410|466011396|FG001|Overall Study|Due to COVID-19|0|||
129468928|NCT03543410|466011397|FG002|Overall Study|Due to COVID-19|2|||
129468929|NCT03543410|466011395|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
129468930|NCT03543410|466011396|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
129468931|NCT03543410|466011397|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
129468932|NCT03543410|466011395|FG000|Overall Study|Not Due to COVID-19|2|||
129468933|NCT03543410|466011396|FG001|Overall Study|Not Due to COVID-19|0|||
129468934|NCT03543410|466011397|FG002|Overall Study|Not Due to COVID-19|1|||
129468935|NCT02883244|466011398|FG000|Overall Study|Lost to Follow-up|0|||
129971414|NCT00150618|467858470|FG000|Overall Study|Abnormal ECG|1|||
129971415|NCT00150618|467858471|FG001|Overall Study|Abnormal ECG|0|||
129971416|NCT00150618|467858472|FG002|Overall Study|Abnormal ECG|0|||
129971417|NCT00150618|467858473|FG003|Overall Study|Abnormal ECG|0|||
129971418|NCT00150618|467858474|FG004|Overall Study|Abnormal ECG|0|||
129971419|NCT00150618|467858470|FG000|Overall Study|Sponsor's decision|0|||
129971420|NCT00150618|467858471|FG001|Overall Study|Sponsor's decision|0|||
129971421|NCT00150618|467858472|FG002|Overall Study|Sponsor's decision|0|||
129971422|NCT00150618|467858473|FG003|Overall Study|Sponsor's decision|1|||
129971423|NCT00150618|467858474|FG004|Overall Study|Sponsor's decision|0|||
129971424|NCT00762476|467858475|FG000|Overall Study|Adverse Event|7|||
129971425|NCT00762476|467858476|FG001|Overall Study|Adverse Event|1|||
129971426|NCT00762476|467858475|FG000|Overall Study|Lost to Follow-up|2|||
129971427|NCT00762476|467858476|FG001|Overall Study|Lost to Follow-up|0|||
129971428|NCT00762476|467858475|FG000|Overall Study|Protocol Violation|5|||
129971429|NCT00762476|467858476|FG001|Overall Study|Protocol Violation|6|||
129971430|NCT00762476|467858475|FG000|Overall Study|Physician Decision|2|||
129971431|NCT00762476|467858476|FG001|Overall Study|Physician Decision|14|||
129971432|NCT00762476|467858475|FG000|Overall Study|Withdrawal by Subject|6|||
129971433|NCT00762476|467858476|FG001|Overall Study|Withdrawal by Subject|12|||
129971434|NCT00762476|467858475|FG000|Overall Study|antibiotic use|0|||
129971435|NCT00762476|467858476|FG001|Overall Study|antibiotic use|1|||
129971436|NCT00762476|467858475|FG000|Overall Study|non-compliance with study visits|0|||
129971437|NCT00762476|467858476|FG001|Overall Study|non-compliance with study visits|2|||
129971438|NCT00762476|467858475|FG000|Overall Study|Seasonal allergies|1|||
129971439|NCT00762476|467858476|FG001|Overall Study|Seasonal allergies|0|||
129468936|NCT02883244|466011399|FG001|Overall Study|Lost to Follow-up|1|||
129468937|NCT02435914|466011400|FG000|Overall Study|Ocular Adverse Event|1|||
129468938|NCT02435914|466011401|FG001|Overall Study|Ocular Adverse Event|0|||
129468939|NCT02435914|466011402|FG002|Overall Study|Ocular Adverse Event|0|||
129468940|NCT02435914|466011403|FG003|Overall Study|Ocular Adverse Event|0|||
129971440|NCT02878603|467858477|FG000|Overall Study|Lost to Follow-up|4|||
129971441|NCT02878603|467858478|FG001|Overall Study|Lost to Follow-up|1|||
129971442|NCT02878603|467858477|FG000|Overall Study|Withdrawal by Subject|1|||
129971443|NCT02878603|467858478|FG001|Overall Study|Withdrawal by Subject|1|||
129971444|NCT02878603|467858477|FG000|Overall Study|Death|1|||
129971445|NCT02878603|467858478|FG001|Overall Study|Death|0|||
129971446|NCT02878603|467858477|FG000|Overall Study|Physician Decision|0|||
129971447|NCT02878603|467858478|FG001|Overall Study|Physician Decision|3|||
129971448|NCT02838134|467858479|FG000|Overall Study|Lost to Follow-up|1|||
129971449|NCT02838134|467858480|FG001|Overall Study|Lost to Follow-up|2|||
129971450|NCT02838134|467858479|FG000|Overall Study|logistic problems|1|||
129971451|NCT02838134|467858480|FG001|Overall Study|logistic problems|1|||
129971452|NCT04674189|467858481|FG000|Overall Study|Adverse Event|0|||
129971453|NCT04674189|467858482|FG001|Overall Study|Adverse Event|0|||
129971454|NCT04674189|467858483|FG002|Overall Study|Adverse Event|1|||
129971455|NCT04674189|467858481|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
129971456|NCT04674189|467858482|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
129971457|NCT04674189|467858483|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
129971458|NCT04674189|467858481|FG000|Overall Study|Physician Decision|1|||
129468941|NCT02435914|466011400|FG000|Overall Study|Withdrawal by Subject|0|||
129468942|NCT02435914|466011401|FG001|Overall Study|Withdrawal by Subject|1|||
129468943|NCT02435914|466011402|FG002|Overall Study|Withdrawal by Subject|0|||
129468944|NCT02435914|466011403|FG003|Overall Study|Withdrawal by Subject|0|||
129468945|NCT02435914|466011400|FG000|Overall Study|Other Miscellaneous Reason|0|||
129468946|NCT02435914|466011401|FG001|Overall Study|Other Miscellaneous Reason|0|||
129468947|NCT02435914|466011402|FG002|Overall Study|Other Miscellaneous Reason|1|||
129468948|NCT02435914|466011403|FG003|Overall Study|Other Miscellaneous Reason|0|||
129468949|NCT00880256|466011409|FG000|Overall Study|Lost to Follow-up|28|||
129468950|NCT04871711|466011418|FG000|Overall Study|Withdrawal by Subject|11|||
129468951|NCT04871711|466011419|FG001|Overall Study|Withdrawal by Subject|5|||
129468952|NCT04871711|466011418|FG000|Overall Study|Lack of Efficacy|5|||
129468953|NCT04871711|466011419|FG001|Overall Study|Lack of Efficacy|7|||
129468954|NCT04871711|466011418|FG000|Overall Study|Adverse Event|2|||
129468955|NCT04871711|466011419|FG001|Overall Study|Adverse Event|6|||
129468956|NCT04871711|466011418|FG000|Overall Study|Various reasons|2|||
129468957|NCT04871711|466011419|FG001|Overall Study|Various reasons|1|||
129468958|NCT04871711|466011418|FG000|Overall Study|Lost to Follow-up|0|||
129468959|NCT04871711|466011419|FG001|Overall Study|Lost to Follow-up|2|||
129468960|NCT00573794|466011433|FG000|Overall Study|Adverse Event|81|||
129468961|NCT00573794|466011433|FG000|Overall Study|Withdrew Consent|90|||
129468962|NCT00573794|466011433|FG000|Overall Study|Lost to Follow-up|13|||
129468963|NCT00573794|466011433|FG000|Overall Study|Protocol Violation|6|||
129468964|NCT00573794|466011433|FG000|Overall Study|Lack of Efficacy|94|||
129468965|NCT00573794|466011433|FG000|Overall Study|Other|46|||
129468966|NCT02183519|466011434|FG000|Overall Study|computer error|3|||
129468967|NCT02183519|466011435|FG001|Overall Study|computer error|0|||
129468968|NCT02183519|466011434|FG000|Overall Study|Did not respond to cough inducter|0|||
129468969|NCT02183519|466011435|FG001|Overall Study|Did not respond to cough inducter|3|||
129468970|NCT00695565|466011436|FG000|Overall Study|Lost to Follow-up|4|||
129468971|NCT00695565|466011437|FG001|Overall Study|Lost to Follow-up|4|||
129468972|NCT00695565|466011436|FG000|Overall Study|Adverse Event|3|||
129468973|NCT00695565|466011437|FG001|Overall Study|Adverse Event|1|||
129468974|NCT00695565|466011436|FG000|Overall Study|Protocol Violation|3|||
129468975|NCT00695565|466011437|FG001|Overall Study|Protocol Violation|1|||
129468976|NCT00695565|466011436|FG000|Overall Study|Withdrawal by Subject|1|||
129468977|NCT00695565|466011437|FG001|Overall Study|Withdrawal by Subject|1|||
129468978|NCT00695565|466011436|FG000|Overall Study|Lack of Efficacy|1|||
129468979|NCT00695565|466011437|FG001|Overall Study|Lack of Efficacy|1|||
129468980|NCT00695565|466011436|FG000|Overall Study|Subject did not follow instructions|1|||
129468981|NCT00695565|466011437|FG001|Overall Study|Subject did not follow instructions|1|||
129971459|NCT04674189|467858482|FG001|Overall Study|Physician Decision|0|||
129971460|NCT04674189|467858483|FG002|Overall Study|Physician Decision|0|||
129971461|NCT04674189|467858481|FG000|Overall Study|Withdrawal by Participant|83|||
129971462|NCT04674189|467858482|FG001|Overall Study|Withdrawal by Participant|71|||
129971463|NCT04674189|467858483|FG002|Overall Study|Withdrawal by Participant|142|||
129971464|NCT04674189|467858481|FG000|Overall Study|Lost to Follow-up|55|||
129971465|NCT04674189|467858482|FG001|Overall Study|Lost to Follow-up|53|||
129971466|NCT04674189|467858483|FG002|Overall Study|Lost to Follow-up|44|||
129468982|NCT02419508|466011440|FG000|Overall Study|Adverse Event|9|||
129468983|NCT02419508|466011441|FG001|Overall Study|Adverse Event|3|||
129468984|NCT02419508|466011440|FG000|Overall Study|Withdrawal by Subject|1|||
129468985|NCT02419508|466011441|FG001|Overall Study|Withdrawal by Subject|0|||
129468986|NCT02419508|466011440|FG000|Overall Study|Other - Reason not specified|0|||
129468987|NCT02419508|466011441|FG001|Overall Study|Other - Reason not specified|1|||
129468988|NCT03110900|466011442|FG000|Overall Study|Sponsor withdrew|1|||
129468989|NCT03110900|466011443|FG001|Overall Study|Sponsor withdrew|1|||
129468990|NCT02531646|466011451|FG000|Overall Study|equip. image processing issue|5|||
129468991|NCT02531646|466011452|FG001|Overall Study|equip. image processing issue|1|||
129468992|NCT02531646|466011453|FG002|Overall Study|equip. image processing issue|0|||
129468993|NCT02320487|466011457|FG000|Overall Study|Reason not Specified|1|||
129971467|NCT04674189|467858481|FG000|Overall Study|Miscellaneous|27|||
129971468|NCT04674189|467858482|FG001|Overall Study|Miscellaneous|23|||
129971469|NCT04674189|467858483|FG002|Overall Study|Miscellaneous|207|||
129971470|NCT04674189|467858481|FG000|Overall Study|Did Not Receive Treatment|3|||
129971471|NCT04674189|467858482|FG001|Overall Study|Did Not Receive Treatment|1|||
129971472|NCT04674189|467858483|FG002|Overall Study|Did Not Receive Treatment|2|||
129971473|NCT01564277|467858484|FG000|Overall Study|Protocol Violation|0|||
129971474|NCT01564277|467858485|FG001|Overall Study|Protocol Violation|1|||
129971475|NCT01564277|467858484|FG000|Overall Study|Physician Decision|1|||
129971476|NCT01564277|467858485|FG001|Overall Study|Physician Decision|0|||
129971477|NCT01637077|467858486|FG000|Overall Study|Cancel|1|||
129971478|NCT01637077|467858487|FG001|Overall Study|Cancel|1|||
129971479|NCT01637077|467858486|FG000|Overall Study|Withdrawal by Subject|1|||
129971480|NCT01637077|467858487|FG001|Overall Study|Withdrawal by Subject|0|||
129971481|NCT01637077|467858486|FG000|Overall Study|No cycle 1 questionnaire data|2|||
129971482|NCT01637077|467858487|FG001|Overall Study|No cycle 1 questionnaire data|0|||
129971483|NCT02595372|467858488|FG000|Overall Study|Adverse Event|6|||
129971484|NCT02595372|467858488|FG000|Overall Study|Physician Decision|2|||
129971485|NCT02595372|467858488|FG000|Overall Study|Disease Progression|1|||
129971486|NCT00794924|467858489|FG000|Overall Study|Lost to Follow-up|6|||
129971487|NCT00794924|467858490|FG001|Overall Study|Lost to Follow-up|8|||
129971488|NCT00794924|467858489|FG000|Overall Study|Withdrawal by Subject|48|||
129971489|NCT00794924|467858490|FG001|Overall Study|Withdrawal by Subject|60|||
129971490|NCT00794924|467858489|FG000|Overall Study|Adverse Event|6|||
129971491|NCT00794924|467858490|FG001|Overall Study|Adverse Event|2|||
129971492|NCT01594970|467858491|FG000|Overall Study|Non-Adverse Event Related|4|||
129971493|NCT01594970|467858492|FG001|Overall Study|Non-Adverse Event Related|5|||
129971494|NCT01594970|467858493|FG002|Overall Study|Non-Adverse Event Related|6|||
129971495|NCT01594970|467858491|FG000|Overall Study|Adverse Event|17|||
129971496|NCT01594970|467858492|FG001|Overall Study|Adverse Event|23|||
129971497|NCT01594970|467858493|FG002|Overall Study|Adverse Event|23|||
129971498|NCT01594970|467858491|FG000|Overall Study|Lost to Follow-up|54|||
129971499|NCT01594970|467858492|FG001|Overall Study|Lost to Follow-up|54|||
129971500|NCT01594970|467858493|FG002|Overall Study|Lost to Follow-up|37|||
129971501|NCT00953615|467858494|FG000|Overall Study|Adverse Event|1|||
129971502|NCT01299480|467858495|FG000|Overall Study|No longer willing to participate|19|||
129971503|NCT01299480|467858496|FG001|Overall Study|No longer willing to participate|17|||
129971504|NCT01299480|467858497|FG002|Overall Study|No longer willing to participate|14|||
129971505|NCT01299480|467858498|FG003|Overall Study|No longer willing to participate|13|||
129971506|NCT01299480|467858499|FG004|Overall Study|No longer willing to participate|10|||
129971507|NCT01299480|467858495|FG000|Overall Study|Protocol Violation|7|||
129971508|NCT01299480|467858496|FG001|Overall Study|Protocol Violation|5|||
129971509|NCT01299480|467858497|FG002|Overall Study|Protocol Violation|8|||
129971510|NCT01299480|467858498|FG003|Overall Study|Protocol Violation|1|||
129971511|NCT01299480|467858499|FG004|Overall Study|Protocol Violation|1|||
129971512|NCT01299480|467858495|FG000|Overall Study|Withdrawal by Subject|3|||
129971513|NCT01299480|467858496|FG001|Overall Study|Withdrawal by Subject|4|||
129971514|NCT01299480|467858497|FG002|Overall Study|Withdrawal by Subject|7|||
129971515|NCT01299480|467858498|FG003|Overall Study|Withdrawal by Subject|3|||
129971516|NCT01299480|467858499|FG004|Overall Study|Withdrawal by Subject|4|||
129971517|NCT01299480|467858495|FG000|Overall Study|Adverse Event|6|||
129971518|NCT01299480|467858496|FG001|Overall Study|Adverse Event|4|||
129971519|NCT01299480|467858497|FG002|Overall Study|Adverse Event|5|||
129971520|NCT01299480|467858498|FG003|Overall Study|Adverse Event|4|||
129971521|NCT01299480|467858499|FG004|Overall Study|Adverse Event|0|||
129971522|NCT01299480|467858495|FG000|Overall Study|Withdrawal due to pregnancy|0|||
129468994|NCT02320487|466011457|FG000|Overall Study|Physician Decision|5|||
129468995|NCT02320487|466011457|FG000|Overall Study|Withdrawal by Subject|1|||
129468996|NCT02320487|466011457|FG000|Overall Study|Death|3|||
129468997|NCT02320487|466011457|FG000|Overall Study|Adverse Event|11|||
129468998|NCT04439175|466013510|FG000|Overall Study|Never started treatment|4|||
129468999|NCT04439175|466013510|FG000|Overall Study|Ineligible|5|||
129469000|NCT04439175|466013510|FG000|Overall Study|Adverse Event|6|||
129469001|NCT04439175|466013510|FG000|Overall Study|Death|4|||
129469002|NCT04439175|466013510|FG000|Overall Study|Disease progression|44|||
129469003|NCT04439175|466013510|FG000|Overall Study|Withdrawal by Subject|4|||
129469004|NCT04439175|466013510|FG000|Overall Study|Alternative Therapy|1|||
129469005|NCT04439175|466013510|FG000|Overall Study|Other|2|||
129971523|NCT01299480|467858496|FG001|Overall Study|Withdrawal due to pregnancy|1|||
129469006|NCT02363478|466013511|FG000|Overall Study|Lost to Follow-up|4|||
129469007|NCT02363478|466013511|FG000|Overall Study|Adverse Event|4|||
129469008|NCT02152345|466013512|FG000|Overall Study|Case Cancellations|2|||
129971524|NCT01299480|467858497|FG002|Overall Study|Withdrawal due to pregnancy|1|||
129971525|NCT01299480|467858498|FG003|Overall Study|Withdrawal due to pregnancy|0|||
129971526|NCT01299480|467858499|FG004|Overall Study|Withdrawal due to pregnancy|0|||
129971527|NCT01299480|467858495|FG000|Overall Study|Physician Decision|1|||
129469009|NCT02152345|466013513|FG001|Overall Study|Case Cancellations|4|||
129971528|NCT01299480|467858496|FG001|Overall Study|Physician Decision|1|||
129971529|NCT01299480|467858497|FG002|Overall Study|Physician Decision|0|||
129971530|NCT01299480|467858498|FG003|Overall Study|Physician Decision|2|||
129469010|NCT02152345|466013512|FG000|Overall Study|Withdrawal by Subject|2|||
129469011|NCT02152345|466013513|FG001|Overall Study|Withdrawal by Subject|1|||
129469012|NCT02554929|466013514|FG000|Overall Study|Lost to Follow-up|4|||
129469013|NCT02554929|466013515|FG001|Overall Study|Lost to Follow-up|4|||
129971531|NCT01299480|467858499|FG004|Overall Study|Physician Decision|0|||
129971532|NCT01299480|467858495|FG000|Overall Study|Lost to Follow-up|3|||
129971533|NCT01299480|467858496|FG001|Overall Study|Lost to Follow-up|1|||
129971534|NCT01299480|467858497|FG002|Overall Study|Lost to Follow-up|2|||
129971535|NCT01299480|467858498|FG003|Overall Study|Lost to Follow-up|1|||
129971536|NCT01299480|467858499|FG004|Overall Study|Lost to Follow-up|2|||
129971537|NCT01299480|467858495|FG000|Overall Study|Other|3|||
129971538|NCT01299480|467858496|FG001|Overall Study|Other|2|||
129971539|NCT01299480|467858497|FG002|Overall Study|Other|3|||
129971540|NCT01299480|467858498|FG003|Overall Study|Other|0|||
129971541|NCT01299480|467858499|FG004|Overall Study|Other|3|||
129971542|NCT01299480|467858495|FG000|Overall Study|Started, but not vaccinated|0|||
129971543|NCT01299480|467858496|FG001|Overall Study|Started, but not vaccinated|0|||
129971544|NCT01299480|467858497|FG002|Overall Study|Started, but not vaccinated|1|||
129469014|NCT02554929|466013514|FG000|Overall Study|Withdrawal by Subject|2|||
129469015|NCT02554929|466013515|FG001|Overall Study|Withdrawal by Subject|8|||
129469016|NCT01916980|466013516|FG000|Overall Study|Adverse Event|4|||
129469017|NCT01916980|466013517|FG001|Overall Study|Adverse Event|2|||
129469018|NCT01916980|466013516|FG000|Overall Study|Lack of Efficacy|2|||
129469019|NCT01916980|466013517|FG001|Overall Study|Lack of Efficacy|2|||
129469020|NCT01916980|466013516|FG000|Overall Study|Withdrawal by Subject|1|||
129469021|NCT01916980|466013517|FG001|Overall Study|Withdrawal by Subject|0|||
129469022|NCT02324270|466013518|FG000|Overall Study|Withdrawal by Subject|0|||
129469023|NCT02324270|466013519|FG001|Overall Study|Withdrawal by Subject|1|||
129469024|NCT02324270|466013520|FG002|Overall Study|Withdrawal by Subject|0|||
129469025|NCT02324270|466013518|FG000|Overall Study|Lost to Follow-up|4|||
129469026|NCT02324270|466013519|FG001|Overall Study|Lost to Follow-up|3|||
129469027|NCT02324270|466013520|FG002|Overall Study|Lost to Follow-up|4|||
129469028|NCT02324270|466013518|FG000|Overall Study|Protocol Violation|0|||
129469029|NCT02324270|466013519|FG001|Overall Study|Protocol Violation|1|||
129469030|NCT02324270|466013520|FG002|Overall Study|Protocol Violation|1|||
129469031|NCT02324270|466013518|FG000|Overall Study|Non Compliance with Study Drug|1|||
129469032|NCT02324270|466013519|FG001|Overall Study|Non Compliance with Study Drug|2|||
129469033|NCT02324270|466013520|FG002|Overall Study|Non Compliance with Study Drug|0|||
129469034|NCT00546364|466013521|FG000|Overall Study|Disease progression|5|||
129469035|NCT00546364|466013522|FG001|Overall Study|Disease progression|11|||
129469036|NCT00546364|466013523|FG002|Overall Study|Disease progression|8|||
129469037|NCT00546364|466013521|FG000|Overall Study|Completed and off treatment|1|||
129469038|NCT00546364|466013522|FG001|Overall Study|Completed and off treatment|0|||
129469039|NCT00546364|466013523|FG002|Overall Study|Completed and off treatment|2|||
129469040|NCT00546364|466013521|FG000|Overall Study|Administrative reason by sponsor|1|||
129469041|NCT00546364|466013522|FG001|Overall Study|Administrative reason by sponsor|0|||
129469042|NCT00546364|466013523|FG002|Overall Study|Administrative reason by sponsor|0|||
129469043|NCT00546364|466013521|FG000|Overall Study|Poor compliance/noncompliance|0|||
129469044|NCT00546364|466013522|FG001|Overall Study|Poor compliance/noncompliance|0|||
129469045|NCT00546364|466013523|FG002|Overall Study|Poor compliance/noncompliance|1|||
129469046|NCT00546364|466013521|FG000|Overall Study|No longer meets study criteria|1|||
129469047|NCT00546364|466013522|FG001|Overall Study|No longer meets study criteria|1|||
129469048|NCT00546364|466013523|FG002|Overall Study|No longer meets study criteria|0|||
129469049|NCT00546364|466013521|FG000|Overall Study|Withdrawal by Subject|5|||
129469050|NCT00546364|466013522|FG001|Overall Study|Withdrawal by Subject|6|||
129469051|NCT00546364|466013523|FG002|Overall Study|Withdrawal by Subject|3|||
129469052|NCT00546364|466013521|FG000|Overall Study|Prior taxotere|1|||
129469053|NCT00546364|466013522|FG001|Overall Study|Prior taxotere|0|||
129469054|NCT00546364|466013523|FG002|Overall Study|Prior taxotere|0|||
129469055|NCT00546364|466013521|FG000|Overall Study|Mixed response|1|||
129469056|NCT00546364|466013522|FG001|Overall Study|Mixed response|0|||
129469057|NCT00546364|466013523|FG002|Overall Study|Mixed response|0|||
129469058|NCT00546364|466013521|FG000|Overall Study|Palliative treatment|1|||
129971545|NCT01299480|467858498|FG003|Overall Study|Started, but not vaccinated|1|||
129971546|NCT01299480|467858499|FG004|Overall Study|Started, but not vaccinated|0|||
129469059|NCT00546364|466013522|FG001|Overall Study|Palliative treatment|0|||
129469060|NCT00546364|466013523|FG002|Overall Study|Palliative treatment|1|||
129469061|NCT00546364|466013521|FG000|Overall Study|Target lesions resected|1|||
129469062|NCT00546364|466013522|FG001|Overall Study|Target lesions resected|0|||
129469063|NCT00546364|466013523|FG002|Overall Study|Target lesions resected|0|||
129469064|NCT00546364|466013521|FG000|Overall Study|Physician Decision|0|||
129469065|NCT00546364|466013522|FG001|Overall Study|Physician Decision|0|||
129469066|NCT00546364|466013523|FG002|Overall Study|Physician Decision|1|||
129469067|NCT00546364|466013521|FG000|Overall Study|Sponsor decision|0|||
129971547|NCT02296892|467858500|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
129469068|NCT00546364|466013522|FG001|Overall Study|Sponsor decision|0|||
129971548|NCT02296892|467858501|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
129469069|NCT00546364|466013523|FG002|Overall Study|Sponsor decision|1|||
129469070|NCT03593915|466013525|FG000|Overall Study|Adverse Event|0|||
129469071|NCT03593915|466013526|FG001|Overall Study|Adverse Event|0|||
129469072|NCT03593915|466013527|FG002|Overall Study|Adverse Event|0|||
129469073|NCT03593915|466013528|FG003|Overall Study|Adverse Event|1|||
129469074|NCT03593915|466013529|FG004|Overall Study|Adverse Event|0|||
129469075|NCT03593915|466013530|FG005|Overall Study|Adverse Event|0|||
129469076|NCT03593915|466013525|FG000|Overall Study|Physician Decision|0|||
129469077|NCT03593915|466013526|FG001|Overall Study|Physician Decision|0|||
129469078|NCT03593915|466013527|FG002|Overall Study|Physician Decision|0|||
129469079|NCT03593915|466013528|FG003|Overall Study|Physician Decision|0|||
129469080|NCT03593915|466013529|FG004|Overall Study|Physician Decision|0|||
129469081|NCT03593915|466013530|FG005|Overall Study|Physician Decision|1|||
129469082|NCT02894840|466013531|FG000|Overall Study|Lost to Follow-up|1|||
129469083|NCT02894840|466013532|FG001|Overall Study|Lost to Follow-up|0|||
129469084|NCT02894840|466013533|FG002|Overall Study|Lost to Follow-up|3|||
129469085|NCT02894840|466013534|FG003|Overall Study|Lost to Follow-up|0|||
129469086|NCT00167245|466013536|FG000|Overall Study|Lost to Follow-up|20|||
129469087|NCT00167245|466013537|FG001|Overall Study|Lost to Follow-up|31|||
129469088|NCT00167245|466013536|FG000|Overall Study|Withdrawal by Subject|5|||
129469089|NCT00167245|466013537|FG001|Overall Study|Withdrawal by Subject|8|||
129469090|NCT00167245|466013536|FG000|Overall Study|Incarcerated|3|||
129469091|NCT00167245|466013537|FG001|Overall Study|Incarcerated|2|||
129469092|NCT00167245|466013536|FG000|Overall Study|Drowsy|1|||
129469093|NCT00167245|466013537|FG001|Overall Study|Drowsy|0|||
129469094|NCT00804687|466013540|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
129469095|NCT00804687|466013541|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
129469096|NCT00804687|466013542|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
129469097|NCT00804687|466013543|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
129469098|NCT00804687|466013544|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
129469099|NCT00804687|466013545|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
129469100|NCT00804687|466013540|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
129469101|NCT00804687|466013541|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
129469102|NCT00804687|466013542|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
129469103|NCT00804687|466013543|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
129469104|NCT00804687|466013544|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
129469105|NCT00804687|466013545|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
129469106|NCT00804687|466013540|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
129469107|NCT00804687|466013541|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
129469108|NCT00804687|466013542|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
129469109|NCT00804687|466013543|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
129469110|NCT00804687|466013544|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
129469111|NCT00804687|466013545|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
129469112|NCT00804687|466013540|FG000|Period 5: Treatment Period|Positive drug test|1|||
129469113|NCT00804687|466013541|FG001|Period 5: Treatment Period|Positive drug test|0|||
129469114|NCT00804687|466013542|FG002|Period 5: Treatment Period|Positive drug test|0|||
129469115|NCT00804687|466013543|FG003|Period 5: Treatment Period|Positive drug test|0|||
129469116|NCT00804687|466013544|FG004|Period 5: Treatment Period|Positive drug test|0|||
129469117|NCT00804687|466013545|FG005|Period 5: Treatment Period|Positive drug test|0|||
129469118|NCT00688909|466013548|FG000|Overall Study|Adverse Event|28|||
129469119|NCT00688909|466013548|FG000|Overall Study|Patient withdrew consent|2|||
129469120|NCT00688909|466013548|FG000|Overall Study|Administrative problems|1|||
129469121|NCT00688909|466013548|FG000|Overall Study|Protocol Violation|2|||
129469122|NCT01220414|466013549|FG000|Overall Study|Withdrawal by Subject|1|||
129469123|NCT01220414|466013550|FG001|Overall Study|Withdrawal by Subject|0|||
129469124|NCT01220414|466013551|FG002|Overall Study|Withdrawal by Subject|0|||
129469125|NCT01220414|466013552|FG003|Overall Study|Withdrawal by Subject|1|||
129469126|NCT02415712|466013556|FG000|Overall Study|Protocol Violation|16|||
129469127|NCT01668654|466013557|FG000|Overall Study|Study Closed/Terminated|3|||
129469128|NCT01668654|466013557|FG000|Overall Study|Withdrawal by Subject|1|||
129469129|NCT04557384|466013558|FG000|Overall Study|Study Terminated by Sponsor|1|||
129469130|NCT04557384|466013558|FG000|Overall Study|Death|1|||
129469131|NCT02397473|466013560|FG000|Treatment Phase|Adverse Event|1|||
129469132|NCT02397473|466013561|FG001|Treatment Phase|Adverse Event|2|||
129469133|NCT02397473|466013560|FG000|Treatment Phase|Lack of Efficacy|8|||
129469134|NCT02397473|466013561|FG001|Treatment Phase|Lack of Efficacy|1|||
129469135|NCT02397473|466013560|FG000|Treatment Phase|Lost to Follow-up|1|||
129469136|NCT02397473|466013561|FG001|Treatment Phase|Lost to Follow-up|0|||
129469137|NCT02397473|466013560|FG000|Treatment Phase|Withdrawal by Subject|2|||
129469138|NCT02397473|466013561|FG001|Treatment Phase|Withdrawal by Subject|1|||
129469139|NCT02397473|466013560|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
129469140|NCT02397473|466013561|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
129469141|NCT02397473|466013560|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
129469142|NCT02397473|466013561|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
129469143|NCT02397473|466013560|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
129469144|NCT02397473|466013561|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
129469145|NCT02397473|466013560|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
129469146|NCT02397473|466013561|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
129469147|NCT02397473|466013560|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
129469148|NCT02397473|466013561|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
129469149|NCT02658448|466013564|FG000|Overall Study|Lost to Follow-up|1|||
129469150|NCT04652804|466013565|FG000|Overall Study|Ineligible post randomization|1|||
129469151|NCT04652804|466013566|FG001|Overall Study|Ineligible post randomization|0|||
129469152|NCT04652804|466013567|FG002|Overall Study|Ineligible post randomization|1|||
129469153|NCT04652804|466013568|FG003|Overall Study|Ineligible post randomization|0|||
129469154|NCT04652804|466013569|FG004|Overall Study|Ineligible post randomization|1|||
129469155|NCT04652804|466013570|FG005|Overall Study|Ineligible post randomization|1|||
129469156|NCT04652804|466013565|FG000|Overall Study|Missing SVR lab results|2|||
129469157|NCT04652804|466013566|FG001|Overall Study|Missing SVR lab results|0|||
129469158|NCT04652804|466013567|FG002|Overall Study|Missing SVR lab results|0|||
129469159|NCT04652804|466013568|FG003|Overall Study|Missing SVR lab results|0|||
129469160|NCT04652804|466013569|FG004|Overall Study|Missing SVR lab results|0|||
129469161|NCT04652804|466013570|FG005|Overall Study|Missing SVR lab results|0|||
129469162|NCT00364689|466013574|FG000|Overall Study|Lost to Follow-up|1|||
129469163|NCT00191451|466013580|FG000|Overall Study|Withdrawal by Subject|2|||
129469164|NCT00191451|466013581|FG001|Overall Study|Withdrawal by Subject|3|||
129469165|NCT00191451|466013582|FG002|Overall Study|Withdrawal by Subject|5|||
129469166|NCT00191451|466013580|FG000|Overall Study|Physician Decision|2|||
129469167|NCT00191451|466013581|FG001|Overall Study|Physician Decision|9|||
129469168|NCT00191451|466013582|FG002|Overall Study|Physician Decision|6|||
129469169|NCT00191451|466013580|FG000|Overall Study|Sponsor Decision|1|||
129469170|NCT00191451|466013581|FG001|Overall Study|Sponsor Decision|0|||
129469171|NCT00191451|466013582|FG002|Overall Study|Sponsor Decision|0|||
129469172|NCT00191451|466013580|FG000|Overall Study|Ineligible|0|||
129469173|NCT00191451|466013581|FG001|Overall Study|Ineligible|1|||
129469174|NCT00191451|466013582|FG002|Overall Study|Ineligible|0|||
129469175|NCT00191451|466013580|FG000|Overall Study|Reason Not Specified|2|||
129469176|NCT00191451|466013581|FG001|Overall Study|Reason Not Specified|1|||
129469177|NCT00191451|466013582|FG002|Overall Study|Reason Not Specified|3|||
129469178|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
129469179|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
129469180|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
129469181|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
129469182|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
129469183|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
129469184|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
129469185|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
129469186|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
129469187|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
129469188|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
129469189|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
129469190|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
129469191|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
129469192|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
129469193|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
129469194|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
129469195|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
129469196|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
129469197|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
129469198|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
129469199|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
129469200|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
129469201|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
129469202|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Death|2|||
129469203|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Death|1|||
129469204|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Death|2|||
129469205|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Graft loss|0|||
129469206|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Graft loss|2|||
129469207|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Graft loss|0|||
129469208|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
129469209|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
129469210|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
129469211|NCT01114529|466013586|FG000|Completed Study Medication at Month 24|Missing|2|||
129971549|NCT02296892|467858502|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
129469212|NCT01114529|466013587|FG001|Completed Study Medication at Month 24|Missing|0|||
129469213|NCT01114529|466013588|FG002|Completed Study Medication at Month 24|Missing|0|||
129469214|NCT01114529|466013586|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
129469215|NCT01114529|466013587|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
129469216|NCT01114529|466013588|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
129469217|NCT01114529|466013586|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
129469218|NCT01114529|466013587|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
129469219|NCT01114529|466013588|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
129469220|NCT01114529|466013586|FG000|Completed Study Phase at Month 24|Death|8|||
129469221|NCT01114529|466013587|FG001|Completed Study Phase at Month 24|Death|5|||
129469222|NCT01114529|466013588|FG002|Completed Study Phase at Month 24|Death|4|||
129469223|NCT01114529|466013586|FG000|Completed Study Phase at Month 24|Other|2|||
129469224|NCT01114529|466013587|FG001|Completed Study Phase at Month 24|Other|0|||
129469225|NCT01114529|466013588|FG002|Completed Study Phase at Month 24|Other|0|||
129469226|NCT01114529|466013586|FG000|Completed Study Phase at Month 24|Missing|2|||
129469227|NCT01114529|466013587|FG001|Completed Study Phase at Month 24|Missing|0|||
129469228|NCT01114529|466013588|FG002|Completed Study Phase at Month 24|Missing|0|||
129469229|NCT00132730|466013591|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
129469230|NCT00132730|466013592|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
129469231|NCT00132730|466013593|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
129469232|NCT00132730|466013594|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
129469233|NCT00132730|466013595|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
129469234|NCT00132730|466013596|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
129469235|NCT00132730|466013591|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
129469236|NCT00132730|466013592|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
129469237|NCT00132730|466013593|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
129469238|NCT00132730|466013594|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
129469239|NCT00132730|466013595|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
129469240|NCT00132730|466013596|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
129469241|NCT00132730|466013591|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
129469242|NCT00132730|466013592|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
129469243|NCT00132730|466013593|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
129469244|NCT00132730|466013594|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
129469245|NCT00132730|466013595|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
129469246|NCT00132730|466013596|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
129469247|NCT00132730|466013591|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
129469248|NCT00132730|466013592|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
129469249|NCT00132730|466013593|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
129469250|NCT00132730|466013594|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
129469251|NCT00132730|466013595|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
129469252|NCT00132730|466013596|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
129469253|NCT00132730|466013591|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
129469254|NCT00132730|466013592|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
129469255|NCT00132730|466013593|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
129469256|NCT00132730|466013594|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
129469257|NCT00132730|466013595|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
129469258|NCT00132730|466013596|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
129469259|NCT00132730|466013591|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
129469260|NCT00132730|466013592|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
129469261|NCT00132730|466013593|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
129469262|NCT00132730|466013594|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
129469263|NCT00132730|466013595|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
129469264|NCT00132730|466013596|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
129469265|NCT00132730|466013591|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
129469266|NCT00132730|466013592|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
129469267|NCT00132730|466013593|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
129469268|NCT00132730|466013594|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
129469269|NCT00132730|466013595|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
129469270|NCT00132730|466013596|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
129469271|NCT00132730|466013591|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
129469272|NCT00132730|466013592|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
129469273|NCT00132730|466013593|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
129469274|NCT00132730|466013594|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
129971550|NCT02296892|467858500|FG000|Overall Study|Lost to Follow-up|5|||
129971551|NCT02296892|467858501|FG001|Overall Study|Lost to Follow-up|0|||
129469275|NCT00132730|466013595|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
129469276|NCT00132730|466013596|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
129469277|NCT00132730|466013591|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
129469278|NCT00132730|466013592|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
129469279|NCT00132730|466013593|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
129469280|NCT00132730|466013594|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
129469281|NCT00132730|466013595|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
129469282|NCT00132730|466013596|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
129469283|NCT00132730|466013591|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
129469284|NCT00132730|466013592|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
129469285|NCT00132730|466013593|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
129469286|NCT00132730|466013594|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
129469287|NCT00132730|466013595|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
129469288|NCT00132730|466013596|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
129469289|NCT00132730|466013591|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
129469290|NCT00132730|466013592|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
129469291|NCT00132730|466013593|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
129469292|NCT00132730|466013594|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
129971552|NCT02296892|467858502|FG002|Overall Study|Lost to Follow-up|1|||
129469293|NCT00132730|466013595|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
129469294|NCT00132730|466013596|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
129469295|NCT00132730|466013591|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
129469296|NCT00132730|466013592|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
129469297|NCT00132730|466013593|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
129469298|NCT00132730|466013594|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
129469299|NCT00132730|466013595|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
129469300|NCT00132730|466013596|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
129469301|NCT01554579|466013597|FG000|Overall Study|Adverse Event|6|||
129469302|NCT01554579|466013598|FG001|Overall Study|Adverse Event|25|||
129469303|NCT01554579|466013597|FG000|Overall Study|Lack of Efficacy|2|||
129469304|NCT01554579|466013598|FG001|Overall Study|Lack of Efficacy|1|||
129469305|NCT01554579|466013597|FG000|Overall Study|Withdrawal by Subject|2|||
129469306|NCT01554579|466013598|FG001|Overall Study|Withdrawal by Subject|1|||
129469307|NCT01192347|466013599|FG000|Overall Study|Death|3|||
129469308|NCT01192347|466013599|FG000|Overall Study|Lost to Follow-up|3|||
129469309|NCT01192347|466013599|FG000|Overall Study|Withdrawal by Subject|1|||
129469310|NCT01192347|466013599|FG000|Overall Study|Adverse Event|1|||
129469311|NCT01192347|466013599|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
129469312|NCT01192347|466013599|FG000|Overall Study|Patient seen in different hospital|1|||
129469313|NCT01192347|466013599|FG000|Overall Study|Patient not visiting hospital regularly|1|||
129469314|NCT01192347|466013599|FG000|Overall Study|Patient did not show up for visits|1|||
129469315|NCT02623335|466013600|FG000|Overall Study|Death|8|||
129469316|NCT02623335|466013601|FG001|Overall Study|Death|7|||
129469317|NCT02623335|466013600|FG000|Overall Study|Lost to Follow-up|15|||
129469318|NCT02623335|466013601|FG001|Overall Study|Lost to Follow-up|23|||
129469319|NCT02623335|466013600|FG000|Overall Study|Withdrawal by Subject|2|||
129469320|NCT02623335|466013601|FG001|Overall Study|Withdrawal by Subject|5|||
129469321|NCT02623335|466013600|FG000|Overall Study|Protocol Violation|2|||
129469322|NCT02623335|466013601|FG001|Overall Study|Protocol Violation|1|||
129469323|NCT03739528|466013602|FG000|Overall Study|Not treated|8|||
129469324|NCT03739528|466013603|FG001|Overall Study|Not treated|12|||
129469325|NCT03739528|466013602|FG000|Overall Study|Treatment and study discontinued|6|||
129469326|NCT03739528|466013603|FG001|Overall Study|Treatment and study discontinued|2|||
129469327|NCT03739528|466013602|FG000|Overall Study|Treatment discontinued + study completed|1|||
129469328|NCT03739528|466013603|FG001|Overall Study|Treatment discontinued + study completed|3|||
129469329|NCT01046695|466013604|FG000|Overall Study|Subject had a pacemaker|0|||
129469330|NCT01046695|466013605|FG001|Overall Study|Subject had a pacemaker|1|||
129469331|NCT01046695|466013604|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
129469332|NCT01046695|466013605|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
129469333|NCT03072160|466013606|FG000|Overall Study|Adverse Event|3|||
129469334|NCT03072160|466013607|FG001|Overall Study|Adverse Event|1|||
129469335|NCT03072160|466013606|FG000|Overall Study|Refused further treatment|6|||
129469336|NCT03072160|466013607|FG001|Overall Study|Refused further treatment|1|||
129469337|NCT03072160|466013606|FG000|Overall Study|Physician Decision|1|||
129469338|NCT03072160|466013607|FG001|Overall Study|Physician Decision|0|||
129469339|NCT03072160|466013606|FG000|Overall Study|Disease progression on study|1|||
129469340|NCT03072160|466013607|FG001|Overall Study|Disease progression on study|1|||
129469341|NCT03072160|466013606|FG000|Overall Study|No contact|0|||
129971553|NCT02336425|467858505|FG000|Overall Study|Study terminated.|2|||
129971554|NCT02336425|467858506|FG001|Overall Study|Study terminated.|2|||
129469342|NCT03072160|466013607|FG001|Overall Study|No contact|1|||
129469343|NCT01463098|466013608|FG000|Part A (11 Days)|Participant Choice|2|||
129469344|NCT01463098|466013609|FG001|Part A (11 Days)|Participant Choice|0|||
129469345|NCT01463098|466013610|FG002|Part A (11 Days)|Participant Choice|0|||
129469346|NCT01463098|466013611|FG003|Part A (11 Days)|Participant Choice|0|||
129469347|NCT01463098|466013612|FG004|Part A (11 Days)|Participant Choice|0|||
129469348|NCT01463098|466013613|FG005|Part A (11 Days)|Participant Choice|0|||
129469349|NCT01463098|466013614|FG006|Part A (11 Days)|Participant Choice|0|||
129469350|NCT01463098|466013615|FG007|Part A (11 Days)|Participant Choice|0|||
129469351|NCT01463098|466013616|FG008|Part A (11 Days)|Participant Choice|1|||
129469352|NCT01463098|466013617|FG009|Part A (11 Days)|Participant Choice|0|||
129469353|NCT01463098|466013618|FG010|Part A (11 Days)|Participant Choice|0|||
129469354|NCT01463098|466013619|FG011|Part A (11 Days)|Participant Choice|0|||
129469355|NCT01463098|466013620|FG012|Part A (11 Days)|Participant Choice|0|||
129469356|NCT01463098|466013621|FG013|Part A (11 Days)|Participant Choice|0|||
129469357|NCT01463098|466013608|FG000|Part A (11 Days)|Lost to Follow-up|0|||
129469358|NCT01463098|466013609|FG001|Part A (11 Days)|Lost to Follow-up|0|||
129469359|NCT01463098|466013610|FG002|Part A (11 Days)|Lost to Follow-up|0|||
129469360|NCT01463098|466013611|FG003|Part A (11 Days)|Lost to Follow-up|0|||
129469361|NCT01463098|466013612|FG004|Part A (11 Days)|Lost to Follow-up|1|||
129469362|NCT01463098|466013613|FG005|Part A (11 Days)|Lost to Follow-up|0|||
129469363|NCT01463098|466013614|FG006|Part A (11 Days)|Lost to Follow-up|0|||
129469364|NCT01463098|466013615|FG007|Part A (11 Days)|Lost to Follow-up|0|||
129469365|NCT01463098|466013616|FG008|Part A (11 Days)|Lost to Follow-up|0|||
129469366|NCT01463098|466013617|FG009|Part A (11 Days)|Lost to Follow-up|0|||
129469367|NCT01463098|466013618|FG010|Part A (11 Days)|Lost to Follow-up|0|||
129469368|NCT01463098|466013619|FG011|Part A (11 Days)|Lost to Follow-up|0|||
129469369|NCT01463098|466013620|FG012|Part A (11 Days)|Lost to Follow-up|0|||
129469370|NCT01463098|466013621|FG013|Part A (11 Days)|Lost to Follow-up|0|||
129469371|NCT01463098|466013608|FG000|Part B (11 Days)|Participant Choice|0|||
129469372|NCT01463098|466013609|FG001|Part B (11 Days)|Participant Choice|0|||
129469373|NCT01463098|466013610|FG002|Part B (11 Days)|Participant Choice|0|||
129469374|NCT01463098|466013611|FG003|Part B (11 Days)|Participant Choice|0|||
129469375|NCT01463098|466013612|FG004|Part B (11 Days)|Participant Choice|0|||
129469376|NCT01463098|466013613|FG005|Part B (11 Days)|Participant Choice|0|||
129469377|NCT01463098|466013614|FG006|Part B (11 Days)|Participant Choice|0|||
129469378|NCT01463098|466013615|FG007|Part B (11 Days)|Participant Choice|0|||
129469379|NCT01463098|466013616|FG008|Part B (11 Days)|Participant Choice|0|||
129469380|NCT01463098|466013617|FG009|Part B (11 Days)|Participant Choice|0|||
129469381|NCT01463098|466013618|FG010|Part B (11 Days)|Participant Choice|0|||
129469382|NCT01463098|466013619|FG011|Part B (11 Days)|Participant Choice|1|||
129469383|NCT01463098|466013620|FG012|Part B (11 Days)|Participant Choice|0|||
129469384|NCT01463098|466013621|FG013|Part B (11 Days)|Participant Choice|0|||
129469385|NCT01528787|466013626|FG000|Overall Study|Withdrawal by Subject|0|||
129971555|NCT02336425|467858507|FG002|Overall Study|Study terminated.|3|||
129971556|NCT02336425|467858508|FG003|Overall Study|Study terminated.|3|||
129971557|NCT00978562|467858509|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
129971558|NCT01782690|467858510|FG000|Overall Study|Not reported|7|||
129971559|NCT01782690|467858510|FG000|Overall Study|Toxicity of gemcitabine|1|||
129971560|NCT01782690|467858510|FG000|Overall Study|Toxicity of erlotinib|1|||
129971561|NCT01782690|467858510|FG000|Overall Study|Lost to Follow-up|31|||
129971562|NCT01782690|467858510|FG000|Overall Study|Withdrawal of informed consent|2|||
129971563|NCT01782690|467858510|FG000|Overall Study|Absent rash|9|||
129971564|NCT01782690|467858510|FG000|Overall Study|Physician Decision|13|||
129971565|NCT01782690|467858510|FG000|Overall Study|Patient's wish|21|||
129971566|NCT01782690|467858510|FG000|Overall Study|Tumor progression|74|||
129971567|NCT01782690|467858510|FG000|Overall Study|Death|133|||
129971568|NCT01782690|467858510|FG000|Overall Study|Study completion unknown|7|||
129971569|NCT04946942|467858512|FG000|Overall Study|Lost to Follow-up|6|||
129971570|NCT04946942|467858513|FG001|Overall Study|Lost to Follow-up|2|||
129971571|NCT04946942|467858514|FG002|Overall Study|Lost to Follow-up|0|||
129971572|NCT04907357|467858515|FG000|Overall Study|Death|0|||
129971573|NCT04907357|467858516|FG001|Overall Study|Death|1|||
129971574|NCT04907357|467858515|FG000|Overall Study|Lost to Follow-up|9|||
129971575|NCT04907357|467858516|FG001|Overall Study|Lost to Follow-up|18|||
129971576|NCT04907357|467858515|FG000|Overall Study|Physician Decision|1|||
129971577|NCT04907357|467858516|FG001|Overall Study|Physician Decision|0|||
129469386|NCT01528787|466013627|FG001|Overall Study|Withdrawal by Subject|0|||
129469387|NCT01528787|466013628|FG002|Overall Study|Withdrawal by Subject|0|||
129469388|NCT01528787|466013629|FG003|Overall Study|Withdrawal by Subject|1|||
129469389|NCT01528787|466013626|FG000|Overall Study|Family Emergency|0|||
129971578|NCT04907357|467858515|FG000|Overall Study|Withdrawal by Subject|0|||
129971579|NCT04907357|467858516|FG001|Overall Study|Withdrawal by Subject|1|||
129971580|NCT04907357|467858515|FG000|Overall Study|Unable to attend visits|1|||
129971581|NCT04907357|467858516|FG001|Overall Study|Unable to attend visits|0|||
129971582|NCT04907357|467858515|FG000|Overall Study|Incarcerated|1|||
129971583|NCT04907357|467858516|FG001|Overall Study|Incarcerated|1|||
129971584|NCT04277507|467858518|FG000|Overall Study|Lost to Follow-up|17|||
129971585|NCT04277507|467858518|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
129971586|NCT04277507|467858518|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
129971587|NCT04277507|467858518|FG000|Overall Study|Withdrawal by Subject|3|||
129469390|NCT01528787|466013627|FG001|Overall Study|Family Emergency|0|||
129469391|NCT01528787|466013628|FG002|Overall Study|Family Emergency|1|||
129469392|NCT01528787|466013629|FG003|Overall Study|Family Emergency|0|||
129469393|NCT03433781|466013635|FG000|Overall Study|Progression of Disease|1|||
129469394|NCT03433781|466013636|FG001|Overall Study|Progression of Disease|0|||
129469395|NCT03433781|466013637|FG002|Overall Study|Progression of Disease|0|||
129469396|NCT03433781|466013635|FG000|Overall Study|Physician Decision|0|||
129469397|NCT03433781|466013636|FG001|Overall Study|Physician Decision|1|||
129469398|NCT03433781|466013637|FG002|Overall Study|Physician Decision|0|||
129469399|NCT03261531|466013638|FG000|Overall Study|Withdrawal by Subject|4|||
129469400|NCT00666926|466013640|FG000|Overall Study|Adverse Event|0|||
129469401|NCT00666926|466013641|FG001|Overall Study|Adverse Event|0|||
129469402|NCT00666926|466013642|FG002|Overall Study|Adverse Event|0|||
129469403|NCT00666926|466013643|FG003|Overall Study|Adverse Event|0|||
129469404|NCT00666926|466013644|FG004|Overall Study|Adverse Event|0|||
129469405|NCT00666926|466013645|FG005|Overall Study|Adverse Event|0|||
129469406|NCT00666926|466013646|FG006|Overall Study|Adverse Event|0|||
129469407|NCT00666926|466013647|FG007|Overall Study|Adverse Event|0|||
129469408|NCT00666926|466013648|FG008|Overall Study|Adverse Event|0|||
129469409|NCT00666926|466013649|FG009|Overall Study|Adverse Event|2|||
129469410|NCT00666926|466013650|FG010|Overall Study|Adverse Event|2|||
129469411|NCT00666926|466013651|FG011|Overall Study|Adverse Event|2|||
129469412|NCT00666926|466013652|FG012|Overall Study|Adverse Event|0|||
129469413|NCT00666926|466013653|FG013|Overall Study|Adverse Event|1|||
129469414|NCT00666926|466013654|FG014|Overall Study|Adverse Event|0|||
129469415|NCT00666926|466013655|FG015|Overall Study|Adverse Event|0|||
129469416|NCT00666926|466013640|FG000|Overall Study|Laboratory abnormality|0|||
129469417|NCT00666926|466013641|FG001|Overall Study|Laboratory abnormality|0|||
129469418|NCT00666926|466013642|FG002|Overall Study|Laboratory abnormality|0|||
129469419|NCT00666926|466013643|FG003|Overall Study|Laboratory abnormality|0|||
129469420|NCT00666926|466013644|FG004|Overall Study|Laboratory abnormality|0|||
129469421|NCT00666926|466013645|FG005|Overall Study|Laboratory abnormality|0|||
129469422|NCT00666926|466013646|FG006|Overall Study|Laboratory abnormality|0|||
129469423|NCT00666926|466013647|FG007|Overall Study|Laboratory abnormality|0|||
129469424|NCT00666926|466013648|FG008|Overall Study|Laboratory abnormality|0|||
129469425|NCT00666926|466013649|FG009|Overall Study|Laboratory abnormality|0|||
129469426|NCT00666926|466013650|FG010|Overall Study|Laboratory abnormality|1|||
129469427|NCT00666926|466013651|FG011|Overall Study|Laboratory abnormality|0|||
129469428|NCT00666926|466013652|FG012|Overall Study|Laboratory abnormality|0|||
129469429|NCT00666926|466013653|FG013|Overall Study|Laboratory abnormality|0|||
129469430|NCT00666926|466013654|FG014|Overall Study|Laboratory abnormality|0|||
129469431|NCT00666926|466013655|FG015|Overall Study|Laboratory abnormality|1|||
129469432|NCT00666926|466013640|FG000|Overall Study|Lack of Efficacy|0|||
129469433|NCT00666926|466013641|FG001|Overall Study|Lack of Efficacy|0|||
129469434|NCT00666926|466013642|FG002|Overall Study|Lack of Efficacy|0|||
129469435|NCT00666926|466013643|FG003|Overall Study|Lack of Efficacy|0|||
129469436|NCT00666926|466013644|FG004|Overall Study|Lack of Efficacy|0|||
129469437|NCT00666926|466013645|FG005|Overall Study|Lack of Efficacy|1|||
129469438|NCT00666926|466013646|FG006|Overall Study|Lack of Efficacy|0|||
129469439|NCT00666926|466013647|FG007|Overall Study|Lack of Efficacy|0|||
129469440|NCT00666926|466013648|FG008|Overall Study|Lack of Efficacy|0|||
129469441|NCT00666926|466013649|FG009|Overall Study|Lack of Efficacy|0|||
129469442|NCT00666926|466013650|FG010|Overall Study|Lack of Efficacy|0|||
129469443|NCT00666926|466013651|FG011|Overall Study|Lack of Efficacy|1|||
129469444|NCT00666926|466013652|FG012|Overall Study|Lack of Efficacy|0|||
129469445|NCT00666926|466013653|FG013|Overall Study|Lack of Efficacy|0|||
129469446|NCT00666926|466013654|FG014|Overall Study|Lack of Efficacy|0|||
129469447|NCT00666926|466013655|FG015|Overall Study|Lack of Efficacy|0|||
129469448|NCT00666926|466013640|FG000|Overall Study|Lost to Follow-up|0|||
129469449|NCT00666926|466013641|FG001|Overall Study|Lost to Follow-up|0|||
129469450|NCT00666926|466013642|FG002|Overall Study|Lost to Follow-up|0|||
129469451|NCT00666926|466013643|FG003|Overall Study|Lost to Follow-up|1|||
129469452|NCT00666926|466013644|FG004|Overall Study|Lost to Follow-up|0|||
129469453|NCT00666926|466013645|FG005|Overall Study|Lost to Follow-up|0|||
129469454|NCT00666926|466013646|FG006|Overall Study|Lost to Follow-up|0|||
129469455|NCT00666926|466013647|FG007|Overall Study|Lost to Follow-up|0|||
129469456|NCT00666926|466013648|FG008|Overall Study|Lost to Follow-up|0|||
129469457|NCT00666926|466013649|FG009|Overall Study|Lost to Follow-up|0|||
129469458|NCT00666926|466013650|FG010|Overall Study|Lost to Follow-up|0|||
129469459|NCT00666926|466013651|FG011|Overall Study|Lost to Follow-up|0|||
129469460|NCT00666926|466013652|FG012|Overall Study|Lost to Follow-up|0|||
129469461|NCT00666926|466013653|FG013|Overall Study|Lost to Follow-up|0|||
129469462|NCT00666926|466013654|FG014|Overall Study|Lost to Follow-up|0|||
129469463|NCT00666926|466013655|FG015|Overall Study|Lost to Follow-up|0|||
129469464|NCT00666926|466013640|FG000|Overall Study|Other|2|||
129469465|NCT00666926|466013641|FG001|Overall Study|Other|4|||
129469466|NCT00666926|466013642|FG002|Overall Study|Other|3|||
129469467|NCT00666926|466013643|FG003|Overall Study|Other|3|||
129469468|NCT00666926|466013644|FG004|Overall Study|Other|3|||
129469469|NCT00666926|466013645|FG005|Overall Study|Other|3|||
129469470|NCT00666926|466013646|FG006|Overall Study|Other|4|||
129469471|NCT00666926|466013647|FG007|Overall Study|Other|0|||
129469472|NCT00666926|466013648|FG008|Overall Study|Other|3|||
129469473|NCT00666926|466013649|FG009|Overall Study|Other|5|||
129469474|NCT00666926|466013650|FG010|Overall Study|Other|3|||
129469475|NCT00666926|466013651|FG011|Overall Study|Other|26|||
129971588|NCT04277507|467858518|FG000|Overall Study|Death due to COVID-19|1|||
129971589|NCT04277507|467858518|FG000|Overall Study|Data missing for full evaluation|5|||
129971590|NCT00738283|467858524|FG000|Overall Study|Death|1|||
129971591|NCT00738283|467858524|FG000|Overall Study|Transfer to another facility|2|||
129971592|NCT00738283|467858524|FG000|Overall Study|Discharge home prior to end of study|1|||
129971593|NCT00486252|467858525|FG000|Overall Study|Adverse Event|7|||
129971594|NCT00486252|467858525|FG000|Overall Study|Lack of Efficacy|9|||
129971595|NCT00486252|467858525|FG000|Overall Study|Lost to Follow-up|24|||
129971596|NCT00486252|467858525|FG000|Overall Study|Other|18|||
129971597|NCT01261247|467858528|FG000|Overall Study|Ineligible|2|||
129971598|NCT01210651|467858529|FG000|Overall Study|Lost to Follow-up|1|||
129971599|NCT01210651|467858530|FG001|Overall Study|Lost to Follow-up|1|||
129971600|NCT01210651|467858529|FG000|Overall Study|schedule conflicts|1|||
129971601|NCT01210651|467858530|FG001|Overall Study|schedule conflicts|5|||
129971602|NCT01210651|467858529|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
129971603|NCT01210651|467858530|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
129971604|NCT01210651|467858529|FG000|Overall Study|Withdrawal by Subject|1|||
129971605|NCT01210651|467858530|FG001|Overall Study|Withdrawal by Subject|1|||
129971606|NCT01210651|467858529|FG000|Overall Study|Injury outside study|2|||
129971607|NCT01210651|467858530|FG001|Overall Study|Injury outside study|0|||
129971608|NCT02592707|467858531|FG000|Overall Study|Consent Withdrawn|0|||
129971609|NCT02592707|467858532|FG001|Overall Study|Consent Withdrawn|1|||
129469476|NCT00666926|466013652|FG012|Overall Study|Other|3|||
129469477|NCT00666926|466013653|FG013|Overall Study|Other|2|||
129469478|NCT00666926|466013654|FG014|Overall Study|Other|4|||
129469479|NCT00666926|466013655|FG015|Overall Study|Other|4|||
129469480|NCT00666926|466013640|FG000|Overall Study|Withdrawal by Subject|0|||
129469481|NCT00666926|466013641|FG001|Overall Study|Withdrawal by Subject|0|||
129469482|NCT00666926|466013642|FG002|Overall Study|Withdrawal by Subject|0|||
129469483|NCT00666926|466013643|FG003|Overall Study|Withdrawal by Subject|0|||
129469484|NCT00666926|466013644|FG004|Overall Study|Withdrawal by Subject|0|||
129469485|NCT00666926|466013645|FG005|Overall Study|Withdrawal by Subject|0|||
129469486|NCT00666926|466013646|FG006|Overall Study|Withdrawal by Subject|0|||
129469487|NCT00666926|466013647|FG007|Overall Study|Withdrawal by Subject|1|||
129469488|NCT00666926|466013648|FG008|Overall Study|Withdrawal by Subject|0|||
129469489|NCT00666926|466013649|FG009|Overall Study|Withdrawal by Subject|3|||
129469490|NCT00666926|466013650|FG010|Overall Study|Withdrawal by Subject|0|||
129469491|NCT00666926|466013651|FG011|Overall Study|Withdrawal by Subject|3|||
129469492|NCT00666926|466013652|FG012|Overall Study|Withdrawal by Subject|0|||
129469493|NCT00666926|466013653|FG013|Overall Study|Withdrawal by Subject|1|||
129469494|NCT00666926|466013654|FG014|Overall Study|Withdrawal by Subject|3|||
129469495|NCT00666926|466013655|FG015|Overall Study|Withdrawal by Subject|3|||
129469496|NCT00666926|466013640|FG000|Overall Study|Death|0|||
129469497|NCT00666926|466013641|FG001|Overall Study|Death|0|||
129469498|NCT00666926|466013642|FG002|Overall Study|Death|0|||
129469499|NCT00666926|466013643|FG003|Overall Study|Death|0|||
129469500|NCT00666926|466013644|FG004|Overall Study|Death|0|||
129971610|NCT02592707|467858533|FG002|Overall Study|Consent Withdrawn|2|||
129971611|NCT02592707|467858534|FG003|Overall Study|Consent Withdrawn|0|||
129971612|NCT02592707|467858531|FG000|Overall Study|Death|1|||
129971613|NCT02592707|467858532|FG001|Overall Study|Death|0|||
129469501|NCT00666926|466013645|FG005|Overall Study|Death|0|||
129469502|NCT00666926|466013646|FG006|Overall Study|Death|0|||
129469503|NCT00666926|466013647|FG007|Overall Study|Death|0|||
129469504|NCT00666926|466013648|FG008|Overall Study|Death|0|||
129469505|NCT00666926|466013649|FG009|Overall Study|Death|0|||
129469506|NCT00666926|466013650|FG010|Overall Study|Death|0|||
129469507|NCT00666926|466013651|FG011|Overall Study|Death|1|||
129469508|NCT00666926|466013652|FG012|Overall Study|Death|0|||
129971614|NCT02592707|467858533|FG002|Overall Study|Death|0|||
129469509|NCT00666926|466013653|FG013|Overall Study|Death|0|||
129469510|NCT00666926|466013654|FG014|Overall Study|Death|0|||
129469511|NCT00666926|466013655|FG015|Overall Study|Death|0|||
129971615|NCT02592707|467858534|FG003|Overall Study|Death|0|||
129971616|NCT02592707|467858531|FG000|Overall Study|Progressive Disease|4|||
129971617|NCT02592707|467858532|FG001|Overall Study|Progressive Disease|4|||
129971618|NCT02592707|467858533|FG002|Overall Study|Progressive Disease|3|||
129971619|NCT02592707|467858534|FG003|Overall Study|Progressive Disease|3|||
129469512|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
129469513|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
129469514|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
129469515|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Death|28|||
129469516|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Death|0|||
129469517|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Death|0|||
129469518|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
129469519|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
129469520|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
129469521|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
129469522|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
129971620|NCT02592707|467858531|FG000|Overall Study|Other|0|||
129971621|NCT02592707|467858532|FG001|Overall Study|Other|0|||
129971622|NCT02592707|467858533|FG002|Overall Study|Other|1|||
129971623|NCT02592707|467858534|FG003|Overall Study|Other|2|||
129971624|NCT02592707|467858531|FG000|Overall Study|Never entered LTFU period|1|||
129971625|NCT02592707|467858532|FG001|Overall Study|Never entered LTFU period|0|||
129971626|NCT02592707|467858533|FG002|Overall Study|Never entered LTFU period|0|||
129971627|NCT02592707|467858534|FG003|Overall Study|Never entered LTFU period|2|||
129971628|NCT04124471|467858535|FG000|Overall Study|screen failure|1|||
129971629|NCT04855734|467858536|FG000|Overall Study|Lost to Follow-up|2|||
129971630|NCT04855734|467858537|FG001|Overall Study|Lost to Follow-up|2|||
129971631|NCT04577573|467858538|FG000|Overall Study|Technical - invalid protocol|0|||
129971632|NCT04577573|467858539|FG001|Overall Study|Technical - invalid protocol|2|||
129971633|NCT04577573|467858540|FG002|Overall Study|Technical - invalid protocol|0|||
129971634|NCT02065882|467858541|FG000|Part I: PK/PD|Screening failure|5|||
129971635|NCT02065882|467858541|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
129971636|NCT02065882|467858541|FG000|Part I: PK/PD|Adverse Event|1|||
129971637|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Screening failure|7|||
129971638|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
129971639|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
129971640|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
129971641|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
129971642|NCT02065882|467858541|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
129971643|NCT06840769|467858542|FG000|Overall Study|Withdrawal by Subject|1|||
129971644|NCT06840769|467858543|FG001|Overall Study|Withdrawal by Subject|0|||
129971645|NCT06840769|467858544|FG002|Overall Study|Withdrawal by Subject|0|||
129971646|NCT06840769|467858545|FG003|Overall Study|Withdrawal by Subject|0|||
129971647|NCT06840769|467858546|FG004|Overall Study|Withdrawal by Subject|0|||
129971648|NCT00592293|467860260|FG000|Overall Study|Withdrawal by Subject|1|||
129971649|NCT01606319|467860261|FG000|Overall Study|Lost to Follow-up|17|||
129971650|NCT01606319|467860262|FG001|Overall Study|Lost to Follow-up|14|||
129971651|NCT01606319|467860261|FG000|Overall Study|Withdrawal by Subject|9|||
129971652|NCT01606319|467860262|FG001|Overall Study|Withdrawal by Subject|12|||
129971653|NCT01606319|467860261|FG000|Overall Study|Physician Decision|1|||
129971654|NCT01606319|467860262|FG001|Overall Study|Physician Decision|2|||
129971655|NCT01606319|467860261|FG000|Overall Study|Lack of Efficacy|6|||
129971656|NCT01606319|467860262|FG001|Overall Study|Lack of Efficacy|8|||
129971657|NCT01606319|467860261|FG000|Overall Study|Adverse Event|1|||
129971658|NCT01606319|467860262|FG001|Overall Study|Adverse Event|4|||
129971659|NCT01594827|467860264|FG000|Overall Study|Adverse Event|1|||
129971660|NCT01594827|467860265|FG001|Overall Study|Adverse Event|0|||
129971661|NCT01594827|467860264|FG000|Overall Study|Physician Decision|3|||
129971662|NCT01594827|467860265|FG001|Overall Study|Physician Decision|0|||
129971663|NCT01821937|467860267|FG000|Overall Study|Adverse Event|0|||
129971664|NCT01821937|467860268|FG001|Overall Study|Adverse Event|3|||
129971665|NCT02153905|467860269|FG000|Overall Study|Death|1|||
129971666|NCT02153905|467860270|FG001|Overall Study|Death|0|||
129971667|NCT01516749|467860275|FG000|Active Therapy|Lost to Follow-up|1|||
129971668|NCT01516749|467860275|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
129971669|NCT00351377|467860276|FG000|Overall Study|Adverse Event|5|||
129971670|NCT00351377|467860276|FG000|Overall Study|Death|1|||
129971671|NCT00351377|467860276|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129971672|NCT01607879|467860277|FG000|Overall Study|Death|1|||
129971673|NCT01607879|467860278|FG001|Overall Study|Death|0|||
129971674|NCT03994731|467860284|FG000|Pegloticase + IMM Period|Death|2|||
129971675|NCT03994731|467860285|FG001|Pegloticase + IMM Period|Death|0|||
129971676|NCT03994731|467860284|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
129971677|NCT03994731|467860285|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
129971678|NCT03994731|467860284|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
129971679|NCT03994731|467860285|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
129971680|NCT00609947|467860290|FG000|Overall Study|Death|1|||
129971681|NCT02406248|467860291|FG000|Overall Study|Death|7|||
129971682|NCT02406248|467860291|FG000|Overall Study|Withdrawal by Subject|2|||
129971683|NCT00790205|467860292|FG000|Overall Study|Lost to Follow-up|61|||
129971684|NCT00790205|467860293|FG001|Overall Study|Lost to Follow-up|71|||
129971685|NCT00790205|467860292|FG000|Overall Study|Withdrawal by Subject|299|||
129971686|NCT00790205|467860293|FG001|Overall Study|Withdrawal by Subject|363|||
129971687|NCT01304498|467860294|FG000|Overall Study|Adverse Event|1|||
129971688|NCT01304498|467860295|FG001|Overall Study|Adverse Event|1|||
129971689|NCT01304498|467860294|FG000|Overall Study|Withdrawal by Subject|2|||
129469523|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
129469524|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
129469525|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
129469526|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
129469527|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
129469528|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
129469529|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
129469530|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
129971690|NCT01304498|467860295|FG001|Overall Study|Withdrawal by Subject|3|||
129971691|NCT01304498|467860294|FG000|Overall Study|Protocol Violation|1|||
129971692|NCT01304498|467860295|FG001|Overall Study|Protocol Violation|0|||
129971693|NCT01304498|467860294|FG000|Overall Study|Lost to Follow-up|2|||
129971694|NCT01304498|467860295|FG001|Overall Study|Lost to Follow-up|1|||
129971695|NCT01834586|467860304|FG000|Overall Study|Adverse Event|1|||
129971696|NCT01667549|467860305|FG000|Overall Study|Withdrawal by Subject|3|||
129971697|NCT01667549|467860306|FG001|Overall Study|Withdrawal by Subject|5|||
129971698|NCT01667549|467860307|FG002|Overall Study|Withdrawal by Subject|7|||
129971699|NCT01667549|467860308|FG003|Overall Study|Withdrawal by Subject|6|||
129971700|NCT01667549|467860309|FG004|Overall Study|Withdrawal by Subject|1|||
129971701|NCT02844777|467860310|FG000|Overall Study|Withdrawal by Subject|2|||
129971702|NCT02844777|467860311|FG001|Overall Study|Withdrawal by Subject|0|||
129971703|NCT02844777|467860312|FG002|Overall Study|Withdrawal by Subject|0|||
129971704|NCT02127125|467860313|FG000|Overall Study|Lost to Follow-up|0|||
129971705|NCT02127125|467860314|FG001|Overall Study|Lost to Follow-up|0|||
129971706|NCT02127125|467860315|FG002|Overall Study|Lost to Follow-up|0|||
129971707|NCT02127125|467860316|FG003|Overall Study|Lost to Follow-up|0|||
129971708|NCT02127125|467860317|FG004|Overall Study|Lost to Follow-up|2|||
129971709|NCT02127125|467860318|FG005|Overall Study|Lost to Follow-up|1|||
129971710|NCT02127125|467860319|FG006|Overall Study|Lost to Follow-up|0|||
129971711|NCT02127125|467860320|FG007|Overall Study|Lost to Follow-up|0|||
129971712|NCT02127125|467860321|FG008|Overall Study|Lost to Follow-up|0|||
129971713|NCT02127125|467860313|FG000|Overall Study|Withdrawal by Subject|0|||
129971714|NCT02127125|467860314|FG001|Overall Study|Withdrawal by Subject|0|||
129971715|NCT02127125|467860315|FG002|Overall Study|Withdrawal by Subject|0|||
129971716|NCT02127125|467860316|FG003|Overall Study|Withdrawal by Subject|1|||
129971717|NCT02127125|467860317|FG004|Overall Study|Withdrawal by Subject|0|||
129971718|NCT02127125|467860318|FG005|Overall Study|Withdrawal by Subject|0|||
129971719|NCT02127125|467860319|FG006|Overall Study|Withdrawal by Subject|0|||
129971720|NCT02127125|467860320|FG007|Overall Study|Withdrawal by Subject|0|||
129971721|NCT02127125|467860321|FG008|Overall Study|Withdrawal by Subject|0|||
129971722|NCT02127125|467860313|FG000|Overall Study|Physician Decision|0|||
129971723|NCT02127125|467860314|FG001|Overall Study|Physician Decision|0|||
129971724|NCT02127125|467860315|FG002|Overall Study|Physician Decision|1|||
129971725|NCT02127125|467860316|FG003|Overall Study|Physician Decision|0|||
129971726|NCT02127125|467860317|FG004|Overall Study|Physician Decision|1|||
129971727|NCT02127125|467860318|FG005|Overall Study|Physician Decision|2|||
129469531|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
129469532|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
129469533|NCT00820755|466013656|FG000|Period 1: Combination Therapy Phase|Other|11|||
129469534|NCT00820755|466013657|FG001|Period 1: Combination Therapy Phase|Other|0|||
129469535|NCT00820755|466013658|FG002|Period 1: Combination Therapy Phase|Other|0|||
129469536|NCT00820755|466013656|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
129469537|NCT00820755|466013657|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
129469538|NCT00820755|466013658|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
129469539|NCT01725750|466013663|FG000|Overall Study|Adverse Event|1|||
129469540|NCT01725750|466013664|FG001|Overall Study|Adverse Event|0|||
129469541|NCT01725750|466013663|FG000|Overall Study|Lost to Follow-up|1|||
129469542|NCT01725750|466013664|FG001|Overall Study|Lost to Follow-up|1|||
129469543|NCT01725750|466013663|FG000|Overall Study|Withdrawal by Subject|0|||
129469544|NCT01725750|466013664|FG001|Overall Study|Withdrawal by Subject|9|||
129469545|NCT02542072|466013665|FG000|First Intervention (1 Month)|Adverse Event|1|||
129469546|NCT02542072|466013666|FG001|First Intervention (1 Month)|Adverse Event|1|||
129469547|NCT02542072|466013665|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
129469548|NCT02542072|466013666|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
129469549|NCT02542072|466013665|FG000|First Intervention (1 Month)|Lens discomfort|1|||
129469550|NCT02542072|466013666|FG001|First Intervention (1 Month)|Lens discomfort|2|||
129971728|NCT02127125|467860319|FG006|Overall Study|Physician Decision|0|||
129971729|NCT02127125|467860320|FG007|Overall Study|Physician Decision|0|||
129971730|NCT02127125|467860321|FG008|Overall Study|Physician Decision|0|||
129971731|NCT02353468|467860323|FG000|Overall Study|Study terminated|3|||
129971732|NCT02493946|467860324|FG000|DB Period|Withdrawal by Subject|8|||
129971733|NCT02493946|467860325|FG001|DB Period|Withdrawal by Subject|5|||
129971734|NCT02493946|467860326|FG002|DB Period|Withdrawal by Subject|0|||
129971735|NCT02493946|467860324|FG000|Open Label Period|Withdrawal by Subject|0|||
129971736|NCT02493946|467860325|FG001|Open Label Period|Withdrawal by Subject|0|||
129469551|NCT02542072|466013665|FG000|First Intervention (1 Month)|Protocol Violation|1|||
129469552|NCT02542072|466013666|FG001|First Intervention (1 Month)|Protocol Violation|0|||
129469553|NCT02542072|466013665|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
129469554|NCT02542072|466013666|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
129469555|NCT02542072|466013665|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
129469556|NCT02542072|466013666|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
129469557|NCT00654498|466013671|FG000|Overall Study|Not Treated|1|||
129469558|NCT00654498|466013672|FG001|Overall Study|Not Treated|0|||
129469559|NCT00654498|466013671|FG000|Overall Study|Adverse Event|6|||
129469560|NCT00654498|466013672|FG001|Overall Study|Adverse Event|1|||
129469561|NCT00654498|466013671|FG000|Overall Study|Protocol Violation|1|||
129469562|NCT00654498|466013672|FG001|Overall Study|Protocol Violation|1|||
129469563|NCT00654498|466013671|FG000|Overall Study|Lost to Follow-up|1|||
129469564|NCT00654498|466013672|FG001|Overall Study|Lost to Follow-up|5|||
129469565|NCT00654498|466013671|FG000|Overall Study|Withdrawal by Subject|1|||
129469566|NCT00654498|466013672|FG001|Overall Study|Withdrawal by Subject|0|||
129469567|NCT00654498|466013671|FG000|Overall Study|Other reason not defined above|4|||
129469568|NCT00654498|466013672|FG001|Overall Study|Other reason not defined above|5|||
129469569|NCT01738971|466013683|FG000|Overall Study|Lost to Follow-up|19|||
129469570|NCT01738971|466013684|FG001|Overall Study|Lost to Follow-up|30|||
129469571|NCT01738971|466013685|FG002|Overall Study|Lost to Follow-up|17|||
129469572|NCT01031446|466013686|FG000|Overall Study|Disease Progression|38|||
129469573|NCT01031446|466013686|FG000|Overall Study|Adverse Event|9|||
129469574|NCT01031446|466013686|FG000|Overall Study|Physician Decision|4|||
129469575|NCT01031446|466013686|FG000|Overall Study|Withdrawal by Subject|3|||
129469576|NCT01031446|466013686|FG000|Overall Study|Still on treatment|1|||
129469577|NCT03631706|466013689|FG000|Overall Study|Randomized, not treated|1|||
129469578|NCT03631706|466013690|FG001|Overall Study|Randomized, not treated|0|||
129469579|NCT05888103|466015223|FG000|Overall Study|Participant decision|3|||
129469580|NCT05888103|466015224|FG001|Overall Study|Participant decision|3|||
129469581|NCT00680836|466015225|FG000|Overall Study|Withdrawal by Subject|3|||
129469582|NCT00680836|466015226|FG001|Overall Study|Withdrawal by Subject|0|||
129469583|NCT00680836|466015225|FG000|Overall Study|Lost to Follow-up|3|||
129469584|NCT00680836|466015226|FG001|Overall Study|Lost to Follow-up|1|||
129469585|NCT00680836|466015225|FG000|Overall Study|Physician Decision|2|||
129469586|NCT00680836|466015226|FG001|Overall Study|Physician Decision|1|||
129469587|NCT03786432|466015227|FG000|Overall Study|Screen Failure after consent|1|||
129469588|NCT03786432|466015227|FG000|Overall Study|Lost to Follow-up|4|||
129469589|NCT03786432|466015227|FG000|Overall Study|did not complete 12 month CT scan|1|||
129469590|NCT03968419|466015228|FG000|Treatment Period|Adverse Event|0|||
129469591|NCT03968419|466015229|FG001|Treatment Period|Adverse Event|0|||
129469592|NCT03968419|466015230|FG002|Treatment Period|Adverse Event|1|||
129469593|NCT03968419|466015228|FG000|Safety Follow-up Period|Death|3|||
129469594|NCT03968419|466015229|FG001|Safety Follow-up Period|Death|2|||
129469595|NCT03968419|466015230|FG002|Safety Follow-up Period|Death|1|||
129469596|NCT03968419|466015228|FG000|Safety Follow-up Period|Subject Decision|2|||
129469597|NCT03968419|466015229|FG001|Safety Follow-up Period|Subject Decision|1|||
129469598|NCT03968419|466015230|FG002|Safety Follow-up Period|Subject Decision|0|||
129469599|NCT05512949|466015231|FG000|Overall Study|Lost to Follow-up|4|||
129469600|NCT05512949|466015232|FG001|Overall Study|Lost to Follow-up|6|||
129469601|NCT05512949|466015233|FG002|Overall Study|Lost to Follow-up|2|||
129469602|NCT05512949|466015231|FG000|Overall Study|Protocol Violation|0|||
129469603|NCT05512949|466015232|FG001|Overall Study|Protocol Violation|0|||
129469604|NCT05512949|466015233|FG002|Overall Study|Protocol Violation|1|||
129469605|NCT05512949|466015231|FG000|Overall Study|Withdrawal by Subject|1|||
129469606|NCT05512949|466015232|FG001|Overall Study|Withdrawal by Subject|1|||
129469607|NCT05512949|466015233|FG002|Overall Study|Withdrawal by Subject|2|||
129469608|NCT05512949|466015231|FG000|Overall Study|Completion status unknown|1|||
129469609|NCT05512949|466015232|FG001|Overall Study|Completion status unknown|3|||
129469610|NCT05512949|466015233|FG002|Overall Study|Completion status unknown|0|||
129971737|NCT02493946|467860326|FG002|Open Label Period|Withdrawal by Subject|74|||
129971738|NCT02493946|467860324|FG000|Open Label Period|Adverse Event|0|||
129971739|NCT02493946|467860325|FG001|Open Label Period|Adverse Event|0|||
129971740|NCT02493946|467860326|FG002|Open Label Period|Adverse Event|4|||
129971741|NCT02493946|467860324|FG000|Open Label Period|Lost to Follow-up|0|||
129469611|NCT01583179|466015234|FG000|Overall Study|Screen failure|1|||
129469612|NCT01583179|466015235|FG001|Overall Study|Screen failure|2|||
129469613|NCT00568555|466015238|FG000|Overall Study|Withdrawal by Subject|1|||
129469614|NCT00568555|466015239|FG001|Overall Study|Withdrawal by Subject|1|||
129469615|NCT00860158|466015247|FG000|Overall Study|Study Terminated|1|||
129469616|NCT00669617|466015249|FG000|Period 1|Withdrawal by Subject|0|||
129469617|NCT00669617|466015250|FG001|Period 1|Withdrawal by Subject|0|||
129469618|NCT00669617|466015251|FG002|Period 1|Withdrawal by Subject|1|||
129469619|NCT00669617|466015252|FG003|Period 1|Withdrawal by Subject|0|||
129469620|NCT00669617|466015253|FG004|Period 1|Withdrawal by Subject|0|||
129971742|NCT02493946|467860325|FG001|Open Label Period|Lost to Follow-up|0|||
129971743|NCT02493946|467860326|FG002|Open Label Period|Lost to Follow-up|1|||
129971744|NCT02493946|467860324|FG000|Open Label Period|Investigator decision, non-compliance|0|||
129971745|NCT02493946|467860325|FG001|Open Label Period|Investigator decision, non-compliance|0|||
129971746|NCT02493946|467860326|FG002|Open Label Period|Investigator decision, non-compliance|2|||
129971747|NCT02493946|467860324|FG000|Open Label Period|Investigator decision, non-availability|0|||
129971748|NCT02493946|467860325|FG001|Open Label Period|Investigator decision, non-availability|0|||
129971749|NCT02493946|467860326|FG002|Open Label Period|Investigator decision, non-availability|1|||
129971750|NCT02493946|467860324|FG000|Open Label Period|Pregnancy|0|||
129971751|NCT02493946|467860325|FG001|Open Label Period|Pregnancy|0|||
129971752|NCT02493946|467860326|FG002|Open Label Period|Pregnancy|3|||
129971753|NCT02493946|467860324|FG000|Open Label Period|Site error|0|||
129971754|NCT02493946|467860325|FG001|Open Label Period|Site error|0|||
129971755|NCT02493946|467860326|FG002|Open Label Period|Site error|1|||
129971756|NCT00848484|467860327|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
129469621|NCT00669617|466015249|FG000|Period 1|Protocol Deviation|0|||
129469622|NCT00669617|466015250|FG001|Period 1|Protocol Deviation|0|||
129469623|NCT00669617|466015251|FG002|Period 1|Protocol Deviation|0|||
129469624|NCT00669617|466015252|FG003|Period 1|Protocol Deviation|0|||
129469625|NCT00669617|466015253|FG004|Period 1|Protocol Deviation|1|||
129971757|NCT00848484|467860328|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
129971758|NCT00848484|467860327|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
129971759|NCT00848484|467860328|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
129971760|NCT00848484|467860327|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
129971761|NCT00848484|467860328|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
129971762|NCT00848484|467860327|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
129971763|NCT00848484|467860328|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
129971764|NCT00848484|467860327|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
129971765|NCT00848484|467860328|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
129971766|NCT03017742|467860335|FG000|Overall Study|Protocol Violation|36|||
129971767|NCT03017742|467860335|FG000|Overall Study|Withdrawal by Subject|37|||
129971768|NCT02975102|467860336|FG000|Overall Study|Adverse Event|2|||
129971769|NCT02975102|467860337|FG001|Overall Study|Adverse Event|1|||
129469626|NCT00669617|466015249|FG000|Period 3|Lost to Follow-up|1|||
129469627|NCT00669617|466015250|FG001|Period 3|Lost to Follow-up|0|||
129469628|NCT00669617|466015251|FG002|Period 3|Lost to Follow-up|0|||
129469629|NCT00669617|466015252|FG003|Period 3|Lost to Follow-up|0|||
129469630|NCT00669617|466015253|FG004|Period 3|Lost to Follow-up|0|||
129469631|NCT05499520|466015254|FG000|Overall Study|Lost to Follow-up|0|||
129469632|NCT05499520|466015255|FG001|Overall Study|Lost to Follow-up|0|||
129469633|NCT05499520|466015256|FG002|Overall Study|Lost to Follow-up|38|||
129469634|NCT05499520|466015257|FG003|Overall Study|Lost to Follow-up|41|||
129469635|NCT05499520|466015258|FG004|Overall Study|Lost to Follow-up|46|||
129469636|NCT05499520|466015259|FG005|Overall Study|Lost to Follow-up|0|||
129469637|NCT05499520|466015260|FG006|Overall Study|Lost to Follow-up|31|||
129469638|NCT05499520|466015261|FG007|Overall Study|Lost to Follow-up|45|||
129469639|NCT05499520|466015262|FG008|Overall Study|Lost to Follow-up|42|||
129469640|NCT05499520|466015263|FG009|Overall Study|Lost to Follow-up|0|||
129469641|NCT05499520|466015264|FG010|Overall Study|Lost to Follow-up|0|||
129469642|NCT05499520|466015265|FG011|Overall Study|Lost to Follow-up|37|||
129469643|NCT05499520|466015266|FG012|Overall Study|Lost to Follow-up|53|||
129469644|NCT05499520|466015267|FG013|Overall Study|Lost to Follow-up|49|||
129469645|NCT05499520|466015268|FG014|Overall Study|Lost to Follow-up|0|||
129469646|NCT05499520|466015269|FG015|Overall Study|Lost to Follow-up|36|||
129469647|NCT05499520|466015270|FG016|Overall Study|Lost to Follow-up|58|||
129469648|NCT05499520|466015271|FG017|Overall Study|Lost to Follow-up|53|||
129469649|NCT00700180|466015272|FG000|Overall Study|Death|99|||
129469650|NCT00700180|466015273|FG001|Overall Study|Death|114|||
129469651|NCT00700180|466015272|FG000|Overall Study|Alive on treatment|5|||
129469652|NCT00700180|466015273|FG001|Overall Study|Alive on treatment|3|||
129469653|NCT00700180|466015272|FG000|Overall Study|Alive in follow-up|46|||
129469654|NCT00700180|466015273|FG001|Overall Study|Alive in follow-up|27|||
129469655|NCT00700180|466015272|FG000|Overall Study|Lost to Follow-up|4|||
129469656|NCT00700180|466015273|FG001|Overall Study|Lost to Follow-up|5|||
129469657|NCT01613326|466015274|FG000|Overall Study|Adverse Event|7|||
129469658|NCT01613326|466015275|FG001|Overall Study|Adverse Event|5|||
129469659|NCT01613326|466015274|FG000|Overall Study|Withdrawal by Subject|3|||
129469660|NCT01613326|466015275|FG001|Overall Study|Withdrawal by Subject|4|||
129469661|NCT01613326|466015274|FG000|Overall Study|Abnormal test procedure result(s)|2|||
129469662|NCT01613326|466015275|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129469663|NCT01613326|466015274|FG000|Overall Study|inability to use device|1|||
129469664|NCT01613326|466015275|FG001|Overall Study|inability to use device|0|||
129469665|NCT01613326|466015274|FG000|Overall Study|Lack of Efficacy|0|||
129469666|NCT01613326|466015275|FG001|Overall Study|Lack of Efficacy|1|||
129469667|NCT01613326|466015274|FG000|Overall Study|Lost to Follow-up|0|||
129469668|NCT01613326|466015275|FG001|Overall Study|Lost to Follow-up|1|||
129469669|NCT01613326|466015274|FG000|Overall Study|Administrative|0|||
129469670|NCT01613326|466015275|FG001|Overall Study|Administrative|2|||
129469671|NCT01613326|466015274|FG000|Overall Study|Protocol Violation|0|||
129469672|NCT01613326|466015275|FG001|Overall Study|Protocol Violation|1|||
129469673|NCT03980938|466015276|FG000|Treatment Period 1|Study Terminated|1|||
129469674|NCT03980938|466015277|FG001|Treatment Period 1|Study Terminated|1|||
129469675|NCT03980938|466015276|FG000|Treatment Period 2|Study Terminated|2|||
129469676|NCT03980938|466015277|FG001|Treatment Period 2|Study Terminated|2|||
129469677|NCT00840827|466015278|FG000|Overall Study|Adverse Event|1|||
129469678|NCT00840827|466015278|FG000|Overall Study|Lack of Efficacy|4|||
129469679|NCT00840827|466015278|FG000|Overall Study|Physician Decision|1|||
129469680|NCT01445535|466015279|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
129469681|NCT01445535|466015280|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
129469682|NCT01445535|466015281|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
129469683|NCT01445535|466015282|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
129469684|NCT01445535|466015279|FG000|Overall Study|Disease progression|1|||
129469685|NCT01445535|466015280|FG001|Overall Study|Disease progression|0|||
129971770|NCT01727505|467860339|FG000|First 24 Hours|Adverse Event|0|||
129971771|NCT01727505|467860340|FG001|First 24 Hours|Adverse Event|1|||
129971772|NCT01727505|467860339|FG000|Second 24 Hours|Missing data|0|||
129971773|NCT01727505|467860340|FG001|Second 24 Hours|Missing data|1|||
129971774|NCT01441635|467860344|FG000|Overall Study|Adverse Event|4|||
129971775|NCT01441635|467860345|FG001|Overall Study|Adverse Event|3|||
129971776|NCT01441635|467860346|FG002|Overall Study|Adverse Event|1|||
129971777|NCT01441635|467860347|FG003|Overall Study|Adverse Event|5|||
129971778|NCT01441635|467860348|FG004|Overall Study|Adverse Event|1|||
129971779|NCT01441635|467860349|FG005|Overall Study|Adverse Event|2|||
129971780|NCT01441635|467860350|FG006|Overall Study|Adverse Event|2|||
129971781|NCT01441635|467860351|FG007|Overall Study|Adverse Event|2|||
129971782|NCT01441635|467860352|FG008|Overall Study|Adverse Event|1|||
129971783|NCT01441635|467860353|FG009|Overall Study|Adverse Event|0|||
129971784|NCT01441635|467860344|FG000|Overall Study|Withdrawal by Subject|1|||
129971785|NCT01441635|467860345|FG001|Overall Study|Withdrawal by Subject|1|||
129971786|NCT01441635|467860346|FG002|Overall Study|Withdrawal by Subject|0|||
129971787|NCT01441635|467860347|FG003|Overall Study|Withdrawal by Subject|1|||
129971788|NCT01441635|467860348|FG004|Overall Study|Withdrawal by Subject|0|||
129971789|NCT01441635|467860349|FG005|Overall Study|Withdrawal by Subject|0|||
129971790|NCT01441635|467860350|FG006|Overall Study|Withdrawal by Subject|2|||
129971791|NCT01441635|467860351|FG007|Overall Study|Withdrawal by Subject|0|||
129971792|NCT01441635|467860352|FG008|Overall Study|Withdrawal by Subject|1|||
129971793|NCT01441635|467860353|FG009|Overall Study|Withdrawal by Subject|1|||
129971794|NCT01441635|467860344|FG000|Overall Study|Lost to Follow-up|0|||
129971795|NCT01441635|467860345|FG001|Overall Study|Lost to Follow-up|1|||
129971796|NCT01441635|467860346|FG002|Overall Study|Lost to Follow-up|1|||
129971797|NCT01441635|467860347|FG003|Overall Study|Lost to Follow-up|1|||
129971798|NCT01441635|467860348|FG004|Overall Study|Lost to Follow-up|1|||
129971799|NCT01441635|467860349|FG005|Overall Study|Lost to Follow-up|3|||
129971800|NCT01441635|467860350|FG006|Overall Study|Lost to Follow-up|1|||
129971801|NCT01441635|467860351|FG007|Overall Study|Lost to Follow-up|1|||
129971802|NCT01441635|467860352|FG008|Overall Study|Lost to Follow-up|0|||
129971803|NCT01441635|467860353|FG009|Overall Study|Lost to Follow-up|1|||
129971804|NCT01441635|467860344|FG000|Overall Study|Noncompliance|0|||
129971805|NCT01441635|467860345|FG001|Overall Study|Noncompliance|1|||
129971806|NCT01441635|467860346|FG002|Overall Study|Noncompliance|0|||
129971807|NCT01441635|467860347|FG003|Overall Study|Noncompliance|0|||
129971808|NCT01441635|467860348|FG004|Overall Study|Noncompliance|0|||
129971809|NCT01441635|467860349|FG005|Overall Study|Noncompliance|0|||
129971810|NCT01441635|467860350|FG006|Overall Study|Noncompliance|1|||
129971811|NCT01441635|467860351|FG007|Overall Study|Noncompliance|0|||
129971812|NCT01441635|467860352|FG008|Overall Study|Noncompliance|0|||
129971813|NCT01441635|467860353|FG009|Overall Study|Noncompliance|0|||
129971814|NCT01441635|467860344|FG000|Overall Study|Surgery or Invasive Intervention|0|||
129971815|NCT01441635|467860345|FG001|Overall Study|Surgery or Invasive Intervention|0|||
129971816|NCT01441635|467860346|FG002|Overall Study|Surgery or Invasive Intervention|1|||
129971817|NCT01441635|467860347|FG003|Overall Study|Surgery or Invasive Intervention|0|||
129971818|NCT01441635|467860348|FG004|Overall Study|Surgery or Invasive Intervention|0|||
129971819|NCT01441635|467860349|FG005|Overall Study|Surgery or Invasive Intervention|0|||
129971820|NCT01441635|467860350|FG006|Overall Study|Surgery or Invasive Intervention|0|||
129971821|NCT01441635|467860351|FG007|Overall Study|Surgery or Invasive Intervention|0|||
129971822|NCT01441635|467860352|FG008|Overall Study|Surgery or Invasive Intervention|0|||
129971823|NCT01441635|467860353|FG009|Overall Study|Surgery or Invasive Intervention|0|||
129971824|NCT01441635|467860344|FG000|Overall Study|Received Exclusionary Medication|1|||
129971825|NCT01441635|467860345|FG001|Overall Study|Received Exclusionary Medication|0|||
129971826|NCT01441635|467860346|FG002|Overall Study|Received Exclusionary Medication|0|||
129971827|NCT01441635|467860347|FG003|Overall Study|Received Exclusionary Medication|0|||
129971828|NCT01441635|467860348|FG004|Overall Study|Received Exclusionary Medication|0|||
129469686|NCT01445535|466015281|FG002|Overall Study|Disease progression|1|||
129971829|NCT01441635|467860349|FG005|Overall Study|Received Exclusionary Medication|0|||
129971830|NCT01441635|467860350|FG006|Overall Study|Received Exclusionary Medication|0|||
129971831|NCT01441635|467860351|FG007|Overall Study|Received Exclusionary Medication|0|||
129971832|NCT01441635|467860352|FG008|Overall Study|Received Exclusionary Medication|0|||
129971833|NCT01441635|467860353|FG009|Overall Study|Received Exclusionary Medication|0|||
129971834|NCT01441635|467860344|FG000|Overall Study|Other|0|||
129971835|NCT01441635|467860345|FG001|Overall Study|Other|0|||
129971836|NCT01441635|467860346|FG002|Overall Study|Other|0|||
129971837|NCT01441635|467860347|FG003|Overall Study|Other|0|||
129971838|NCT01441635|467860348|FG004|Overall Study|Other|0|||
129971839|NCT01441635|467860349|FG005|Overall Study|Other|0|||
129971840|NCT01441635|467860350|FG006|Overall Study|Other|0|||
129971841|NCT01441635|467860351|FG007|Overall Study|Other|1|||
129971842|NCT01441635|467860352|FG008|Overall Study|Other|0|||
129971843|NCT01441635|467860353|FG009|Overall Study|Other|0|||
129971844|NCT03274895|467860356|FG000|Overall Study|Lack of Efficacy|1|||
129971845|NCT03274895|467860357|FG001|Overall Study|Lack of Efficacy|0|||
129971846|NCT03274895|467860356|FG000|Overall Study|Adverse Event|8|||
129971847|NCT03274895|467860357|FG001|Overall Study|Adverse Event|7|||
129971848|NCT03274895|467860356|FG000|Overall Study|Lost to Follow-up|1|||
129971849|NCT03274895|467860357|FG001|Overall Study|Lost to Follow-up|0|||
129971850|NCT03274895|467860356|FG000|Overall Study|Diagnosis not confirmed|3|||
129971851|NCT03274895|467860357|FG001|Overall Study|Diagnosis not confirmed|4|||
129971852|NCT01969851|467860366|FG000|Overall Study|Adverse Event|0|||
129971853|NCT01969851|467860367|FG001|Overall Study|Adverse Event|0|||
129971854|NCT01969851|467860368|FG002|Overall Study|Adverse Event|3|||
129971855|NCT01969851|467860366|FG000|Overall Study|Lack of Efficacy|0|||
129971856|NCT01969851|467860367|FG001|Overall Study|Lack of Efficacy|3|||
129971857|NCT01969851|467860368|FG002|Overall Study|Lack of Efficacy|1|||
129971858|NCT01969851|467860366|FG000|Overall Study|Withdrawal by Subject|1|||
129971859|NCT01969851|467860367|FG001|Overall Study|Withdrawal by Subject|0|||
129971860|NCT01969851|467860368|FG002|Overall Study|Withdrawal by Subject|1|||
129971861|NCT01969851|467860366|FG000|Overall Study|No effective dose in Titration period|0|||
129971862|NCT01969851|467860367|FG001|Overall Study|No effective dose in Titration period|0|||
129971863|NCT01969851|467860368|FG002|Overall Study|No effective dose in Titration period|1|||
129971864|NCT01969851|467860366|FG000|Overall Study|Sponsor decision|0|||
129971865|NCT01969851|467860367|FG001|Overall Study|Sponsor decision|0|||
129971866|NCT01969851|467860368|FG002|Overall Study|Sponsor decision|1|||
129971867|NCT02389764|467860375|FG000|Overall Study|Lack of Efficacy|9|||
129971868|NCT00617929|467860376|FG000|Overall Study|Physician Decision|1|||
129971869|NCT02498236|467860377|FG000|Overall Study|Did not show for testing|1|||
129971870|NCT02498236|467860378|FG001|Overall Study|Did not show for testing|0|||
129971871|NCT02498236|467860379|FG002|Overall Study|Did not show for testing|0|||
129971872|NCT02498236|467860380|FG003|Overall Study|Did not show for testing|0|||
129971873|NCT02498236|467860381|FG004|Overall Study|Did not show for testing|0|||
129971874|NCT02498236|467860382|FG005|Overall Study|Did not show for testing|0|||
129971875|NCT02498236|467860383|FG006|Overall Study|Did not show for testing|0|||
129971876|NCT02498236|467860384|FG007|Overall Study|Did not show for testing|1|||
129971877|NCT02498236|467860377|FG000|Overall Study|Equipment failure|0|||
129971878|NCT02498236|467860378|FG001|Overall Study|Equipment failure|0|||
129971879|NCT02498236|467860379|FG002|Overall Study|Equipment failure|0|||
129971880|NCT02498236|467860380|FG003|Overall Study|Equipment failure|0|||
129971881|NCT02498236|467860381|FG004|Overall Study|Equipment failure|0|||
129971882|NCT02498236|467860382|FG005|Overall Study|Equipment failure|0|||
129971883|NCT02498236|467860383|FG006|Overall Study|Equipment failure|1|||
129971884|NCT02498236|467860384|FG007|Overall Study|Equipment failure|0|||
129971885|NCT02498236|467860377|FG000|Overall Study|Withdrawal by Subject|0|||
129971886|NCT02498236|467860378|FG001|Overall Study|Withdrawal by Subject|0|||
129971887|NCT02498236|467860379|FG002|Overall Study|Withdrawal by Subject|0|||
129971888|NCT02498236|467860380|FG003|Overall Study|Withdrawal by Subject|0|||
129971889|NCT02498236|467860381|FG004|Overall Study|Withdrawal by Subject|1|||
129971890|NCT02498236|467860382|FG005|Overall Study|Withdrawal by Subject|0|||
129971891|NCT02498236|467860383|FG006|Overall Study|Withdrawal by Subject|0|||
129971892|NCT02498236|467860384|FG007|Overall Study|Withdrawal by Subject|0|||
129971893|NCT01814072|467860385|FG000|Overall Study|Lost to Follow-up|2|||
129971894|NCT01814072|467860386|FG001|Overall Study|Lost to Follow-up|2|||
129971895|NCT01814072|467860387|FG002|Overall Study|Lost to Follow-up|2|||
129971896|NCT01814072|467860388|FG003|Overall Study|Lost to Follow-up|0|||
129971897|NCT01814072|467860389|FG004|Overall Study|Lost to Follow-up|2|||
129971898|NCT01814072|467860390|FG005|Overall Study|Lost to Follow-up|3|||
129971899|NCT01814072|467860391|FG006|Overall Study|Lost to Follow-up|3|||
129971900|NCT01814072|467860392|FG007|Overall Study|Lost to Follow-up|1|||
129971901|NCT01814072|467860393|FG008|Overall Study|Lost to Follow-up|2|||
129971902|NCT01814072|467860394|FG009|Overall Study|Lost to Follow-up|3|||
129971903|NCT01814072|467860395|FG010|Overall Study|Lost to Follow-up|1|||
129971904|NCT01814072|467860396|FG011|Overall Study|Lost to Follow-up|2|||
129971905|NCT01814072|467860397|FG012|Overall Study|Lost to Follow-up|2|||
129971906|NCT01814072|467860398|FG013|Overall Study|Lost to Follow-up|1|||
129971907|NCT01814072|467860399|FG014|Overall Study|Lost to Follow-up|2|||
129971908|NCT01814072|467860400|FG015|Overall Study|Lost to Follow-up|1|||
129971909|NCT01814072|467860401|FG016|Overall Study|Lost to Follow-up|3|||
129971910|NCT01814072|467860402|FG017|Overall Study|Lost to Follow-up|1|||
129971911|NCT01814072|467860403|FG018|Overall Study|Lost to Follow-up|3|||
129971912|NCT01814072|467860404|FG019|Overall Study|Lost to Follow-up|3|||
129971913|NCT01814072|467860405|FG020|Overall Study|Lost to Follow-up|2|||
129971914|NCT01814072|467860406|FG021|Overall Study|Lost to Follow-up|1|||
129971915|NCT01814072|467860407|FG022|Overall Study|Lost to Follow-up|3|||
129971916|NCT01814072|467860408|FG023|Overall Study|Lost to Follow-up|1|||
129971917|NCT01814072|467860409|FG024|Overall Study|Lost to Follow-up|4|||
129971918|NCT01814072|467860410|FG025|Overall Study|Lost to Follow-up|1|||
129971919|NCT01814072|467860411|FG026|Overall Study|Lost to Follow-up|1|||
129971920|NCT01814072|467860412|FG027|Overall Study|Lost to Follow-up|2|||
129971921|NCT01814072|467860413|FG028|Overall Study|Lost to Follow-up|3|||
129971922|NCT01814072|467860414|FG029|Overall Study|Lost to Follow-up|3|||
129971923|NCT01814072|467860415|FG030|Overall Study|Lost to Follow-up|2|||
129971924|NCT01814072|467860416|FG031|Overall Study|Lost to Follow-up|0|||
129971925|NCT01814072|467860385|FG000|Overall Study|Withdrawal by Subject|2|||
129971926|NCT01814072|467860386|FG001|Overall Study|Withdrawal by Subject|0|||
129971927|NCT01814072|467860387|FG002|Overall Study|Withdrawal by Subject|1|||
129971928|NCT01814072|467860388|FG003|Overall Study|Withdrawal by Subject|0|||
129971929|NCT01814072|467860389|FG004|Overall Study|Withdrawal by Subject|2|||
129971930|NCT01814072|467860390|FG005|Overall Study|Withdrawal by Subject|3|||
129971931|NCT01814072|467860391|FG006|Overall Study|Withdrawal by Subject|1|||
129971932|NCT01814072|467860392|FG007|Overall Study|Withdrawal by Subject|0|||
129971933|NCT01814072|467860393|FG008|Overall Study|Withdrawal by Subject|1|||
129971934|NCT01814072|467860394|FG009|Overall Study|Withdrawal by Subject|2|||
129971935|NCT01814072|467860395|FG010|Overall Study|Withdrawal by Subject|0|||
129971936|NCT01814072|467860396|FG011|Overall Study|Withdrawal by Subject|0|||
129971937|NCT01814072|467860397|FG012|Overall Study|Withdrawal by Subject|1|||
129971938|NCT01814072|467860398|FG013|Overall Study|Withdrawal by Subject|1|||
129971939|NCT01814072|467860399|FG014|Overall Study|Withdrawal by Subject|1|||
129971940|NCT01814072|467860400|FG015|Overall Study|Withdrawal by Subject|1|||
129971941|NCT01814072|467860401|FG016|Overall Study|Withdrawal by Subject|0|||
129971942|NCT01814072|467860402|FG017|Overall Study|Withdrawal by Subject|0|||
129971943|NCT01814072|467860403|FG018|Overall Study|Withdrawal by Subject|0|||
129971944|NCT01814072|467860404|FG019|Overall Study|Withdrawal by Subject|2|||
129971945|NCT01814072|467860405|FG020|Overall Study|Withdrawal by Subject|0|||
129971946|NCT01814072|467860406|FG021|Overall Study|Withdrawal by Subject|0|||
129971947|NCT01814072|467860407|FG022|Overall Study|Withdrawal by Subject|1|||
129971948|NCT01814072|467860408|FG023|Overall Study|Withdrawal by Subject|0|||
129971949|NCT01814072|467860409|FG024|Overall Study|Withdrawal by Subject|2|||
129971950|NCT01814072|467860410|FG025|Overall Study|Withdrawal by Subject|1|||
129971951|NCT01814072|467860411|FG026|Overall Study|Withdrawal by Subject|1|||
129971952|NCT01814072|467860412|FG027|Overall Study|Withdrawal by Subject|2|||
129971953|NCT01814072|467860413|FG028|Overall Study|Withdrawal by Subject|1|||
129971954|NCT01814072|467860414|FG029|Overall Study|Withdrawal by Subject|0|||
129971955|NCT01814072|467860415|FG030|Overall Study|Withdrawal by Subject|0|||
129971956|NCT01814072|467860416|FG031|Overall Study|Withdrawal by Subject|0|||
129971957|NCT00383123|467860417|FG000|Overall Study|Adverse Event|1|||
129971958|NCT00383123|467860418|FG001|Overall Study|Adverse Event|0|||
129971959|NCT00383123|467860417|FG000|Overall Study|Lost to Follow-up|68|||
129971960|NCT00383123|467860418|FG001|Overall Study|Lost to Follow-up|61|||
129971961|NCT00383123|467860417|FG000|Overall Study|Protocol Violation|5|||
129971962|NCT00383123|467860418|FG001|Overall Study|Protocol Violation|1|||
129971963|NCT00383123|467860417|FG000|Overall Study|Withdrawal by Subject|27|||
129971964|NCT00383123|467860418|FG001|Overall Study|Withdrawal by Subject|18|||
129971965|NCT00383123|467860417|FG000|Overall Study|Other reason|10|||
129971966|NCT00383123|467860418|FG001|Overall Study|Other reason|6|||
129971967|NCT03566979|467860419|FG000|Overall Study|Withdrawal by Subject|2|||
129971968|NCT03566979|467860420|FG001|Overall Study|Withdrawal by Subject|0|||
129971969|NCT03566979|467860421|FG002|Overall Study|Withdrawal by Subject|1|||
129971970|NCT03566979|467860422|FG003|Overall Study|Withdrawal by Subject|1|||
129971971|NCT03566979|467860419|FG000|Overall Study|Lost to Follow-up|2|||
129971972|NCT03566979|467860420|FG001|Overall Study|Lost to Follow-up|7|||
129971973|NCT03566979|467860421|FG002|Overall Study|Lost to Follow-up|9|||
129469687|NCT01445535|466015282|FG003|Overall Study|Disease progression|0|||
129469688|NCT01445535|466015279|FG000|Overall Study|PI discretion|0|||
129971974|NCT03566979|467860422|FG003|Overall Study|Lost to Follow-up|5|||
129971975|NCT03566979|467860419|FG000|Overall Study|Adverse Event|1|||
129971976|NCT03566979|467860420|FG001|Overall Study|Adverse Event|0|||
129971977|NCT03566979|467860421|FG002|Overall Study|Adverse Event|0|||
129971978|NCT03566979|467860422|FG003|Overall Study|Adverse Event|0|||
129971979|NCT01011868|467860423|FG000|After Week 18 Follow-up|Adverse Event|8|||
129971980|NCT01011868|467860424|FG001|After Week 18 Follow-up|Adverse Event|6|||
129971981|NCT01011868|467860425|FG002|After Week 18 Follow-up|Adverse Event|13|||
129971982|NCT01011868|467860423|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
129971983|NCT01011868|467860424|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
129971984|NCT01011868|467860425|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
129971985|NCT01011868|467860423|FG000|After Week 18 Follow-up|Protocol Violation|1|||
129971986|NCT01011868|467860424|FG001|After Week 18 Follow-up|Protocol Violation|1|||
129971987|NCT01011868|467860425|FG002|After Week 18 Follow-up|Protocol Violation|1|||
129971988|NCT01011868|467860423|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
129971989|NCT01011868|467860424|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
129971990|NCT01011868|467860425|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
129971991|NCT01011868|467860423|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
129971992|NCT01011868|467860424|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
129971993|NCT01011868|467860425|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
129971994|NCT01011868|467860423|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
129971995|NCT01011868|467860424|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
129971996|NCT01011868|467860425|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
129971997|NCT01011868|467860423|FG000|After Week 78 Follow-up|Adverse Event|14|||
129971998|NCT01011868|467860424|FG001|After Week 78 Follow-up|Adverse Event|18|||
129971999|NCT01011868|467860425|FG002|After Week 78 Follow-up|Adverse Event|21|||
129972000|NCT01011868|467860423|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
129972001|NCT01011868|467860424|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
129972002|NCT01011868|467860425|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
129972003|NCT01011868|467860423|FG000|After Week 78 Follow-up|Protocol Violation|9|||
129972004|NCT01011868|467860424|FG001|After Week 78 Follow-up|Protocol Violation|1|||
129972005|NCT01011868|467860425|FG002|After Week 78 Follow-up|Protocol Violation|2|||
129972006|NCT01011868|467860423|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
129972007|NCT01011868|467860424|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
129972008|NCT01011868|467860425|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
129972009|NCT01011868|467860423|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
129972010|NCT01011868|467860424|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
129972011|NCT01011868|467860425|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
129972012|NCT01011868|467860423|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
129972013|NCT01011868|467860424|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
129972014|NCT01011868|467860425|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
129972015|NCT01948076|467860426|FG000|Overall Study|Withdrawal by Subject|0|||
129972016|NCT01948076|467860427|FG001|Overall Study|Withdrawal by Subject|1|||
129972017|NCT03732677|467860431|FG000|Overall Study|Terminated the study|154|||
129972018|NCT03732677|467860432|FG001|Overall Study|Terminated the study|197|||
129972019|NCT03732677|467860431|FG000|Overall Study|Continuing study off treatment|379|||
129972020|NCT03732677|467860432|FG001|Overall Study|Continuing study off treatment|333|||
129972021|NCT04013971|467860433|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
129972022|NCT04013971|467860434|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
129972023|NCT04013971|467860433|FG000|Overall Study|Missing biomechanical data|0|||
129972024|NCT04013971|467860434|FG001|Overall Study|Missing biomechanical data|1|||
129972025|NCT00344032|467860440|FG000|Overall Study|Adverse Event|0|||
129972026|NCT00344032|467860441|FG001|Overall Study|Adverse Event|1|||
129972027|NCT00344032|467860440|FG000|Overall Study|Withdrawal by Subject|6|||
129972028|NCT00344032|467860441|FG001|Overall Study|Withdrawal by Subject|2|||
129972029|NCT00344032|467860440|FG000|Overall Study|Lost to Follow-up|4|||
129972030|NCT00344032|467860441|FG001|Overall Study|Lost to Follow-up|6|||
129972031|NCT00344032|467860440|FG000|Overall Study|Physician Decision|4|||
129972032|NCT00344032|467860441|FG001|Overall Study|Physician Decision|1|||
129972033|NCT04949802|467862842|FG000|Overall Study|Lost to Follow-up|3|||
129972034|NCT02473965|467862843|FG000|Overall Study|Adverse Event|6|||
129972035|NCT02473965|467862844|FG001|Overall Study|Adverse Event|4|||
129972036|NCT02473965|467862843|FG000|Overall Study|MG worsening|4|||
129972037|NCT02473965|467862844|FG001|Overall Study|MG worsening|1|||
129972038|NCT02473965|467862843|FG000|Overall Study|Withdrawal by Subject|2|||
129972039|NCT02473965|467862844|FG001|Overall Study|Withdrawal by Subject|3|||
129972040|NCT02473965|467862843|FG000|Overall Study|Physician Decision|0|||
129972041|NCT02473965|467862844|FG001|Overall Study|Physician Decision|2|||
129972042|NCT03192462|467862845|FG000|Overall Study|Death|13|||
129972043|NCT03192462|467862846|FG001|Overall Study|Death|11|||
129972044|NCT03192462|467862847|FG002|Overall Study|Death|9|||
129972045|NCT03192462|467862845|FG000|Overall Study|Lost to Follow-up|0|||
129972046|NCT03192462|467862846|FG001|Overall Study|Lost to Follow-up|1|||
129972047|NCT03192462|467862847|FG002|Overall Study|Lost to Follow-up|0|||
129972048|NCT03192462|467862845|FG000|Overall Study|On follow up|0|||
129972049|NCT03192462|467862846|FG001|Overall Study|On follow up|0|||
129972050|NCT03192462|467862847|FG002|Overall Study|On follow up|3|||
129972051|NCT03816761|467862848|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972052|NCT03816761|467862849|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972053|NCT03816761|467862850|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972054|NCT03816761|467862851|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972055|NCT03816761|467862852|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
129972056|NCT03816761|467862853|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
129972057|NCT03816761|467862848|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
129972058|NCT03816761|467862849|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
129972059|NCT03816761|467862850|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
129972060|NCT03816761|467862851|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
129972061|NCT03816761|467862852|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
129972062|NCT03816761|467862853|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
129972063|NCT02419417|467862854|FG000|Overall Study|Disease progression|5|||
129972064|NCT02419417|467862855|FG001|Overall Study|Disease progression|4|||
129972065|NCT02419417|467862856|FG002|Overall Study|Disease progression|13|||
129972066|NCT02419417|467862857|FG003|Overall Study|Disease progression|10|||
129972067|NCT02419417|467862858|FG004|Overall Study|Disease progression|10|||
129972068|NCT02419417|467862859|FG005|Overall Study|Disease progression|3|||
129972069|NCT02419417|467862860|FG006|Overall Study|Disease progression|4|||
129972070|NCT02419417|467862861|FG007|Overall Study|Disease progression|5|||
129972071|NCT02419417|467862862|FG008|Overall Study|Disease progression|13|||
129972072|NCT02419417|467862863|FG009|Overall Study|Disease progression|9|||
129972073|NCT02419417|467862864|FG010|Overall Study|Disease progression|0|||
129972074|NCT02419417|467862854|FG000|Overall Study|Study drug toxicity|0|||
129972075|NCT02419417|467862855|FG001|Overall Study|Study drug toxicity|0|||
129972076|NCT02419417|467862856|FG002|Overall Study|Study drug toxicity|0|||
129972077|NCT02419417|467862857|FG003|Overall Study|Study drug toxicity|0|||
129972078|NCT02419417|467862858|FG004|Overall Study|Study drug toxicity|1|||
129972079|NCT02419417|467862859|FG005|Overall Study|Study drug toxicity|0|||
129972080|NCT02419417|467862860|FG006|Overall Study|Study drug toxicity|0|||
129972081|NCT02419417|467862861|FG007|Overall Study|Study drug toxicity|0|||
129972082|NCT02419417|467862862|FG008|Overall Study|Study drug toxicity|0|||
129972083|NCT02419417|467862863|FG009|Overall Study|Study drug toxicity|0|||
129972084|NCT02419417|467862864|FG010|Overall Study|Study drug toxicity|0|||
129972085|NCT02419417|467862854|FG000|Overall Study|Adverse event unrelated to study drug|0|||
129972086|NCT02419417|467862855|FG001|Overall Study|Adverse event unrelated to study drug|0|||
129972087|NCT02419417|467862856|FG002|Overall Study|Adverse event unrelated to study drug|0|||
129972088|NCT02419417|467862857|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129972089|NCT02419417|467862858|FG004|Overall Study|Adverse event unrelated to study drug|2|||
129972090|NCT02419417|467862859|FG005|Overall Study|Adverse event unrelated to study drug|1|||
129972091|NCT02419417|467862860|FG006|Overall Study|Adverse event unrelated to study drug|0|||
129972092|NCT02419417|467862861|FG007|Overall Study|Adverse event unrelated to study drug|1|||
129972093|NCT02419417|467862862|FG008|Overall Study|Adverse event unrelated to study drug|0|||
129972094|NCT02419417|467862863|FG009|Overall Study|Adverse event unrelated to study drug|0|||
129972095|NCT02419417|467862864|FG010|Overall Study|Adverse event unrelated to study drug|0|||
129972096|NCT02419417|467862854|FG000|Overall Study|Participant request to discontinue|0|||
129972097|NCT02419417|467862855|FG001|Overall Study|Participant request to discontinue|0|||
129972098|NCT02419417|467862856|FG002|Overall Study|Participant request to discontinue|0|||
129972099|NCT02419417|467862857|FG003|Overall Study|Participant request to discontinue|0|||
129972100|NCT02419417|467862858|FG004|Overall Study|Participant request to discontinue|0|||
129972101|NCT02419417|467862859|FG005|Overall Study|Participant request to discontinue|0|||
129972102|NCT02419417|467862860|FG006|Overall Study|Participant request to discontinue|0|||
129972103|NCT02419417|467862861|FG007|Overall Study|Participant request to discontinue|0|||
129972104|NCT02419417|467862862|FG008|Overall Study|Participant request to discontinue|0|||
129972105|NCT02419417|467862863|FG009|Overall Study|Participant request to discontinue|1|||
129972106|NCT02419417|467862864|FG010|Overall Study|Participant request to discontinue|0|||
129972107|NCT02419417|467862854|FG000|Overall Study|Withdrawal by Subject|0|||
129972108|NCT02419417|467862855|FG001|Overall Study|Withdrawal by Subject|0|||
129972109|NCT02419417|467862856|FG002|Overall Study|Withdrawal by Subject|0|||
129972110|NCT02419417|467862857|FG003|Overall Study|Withdrawal by Subject|0|||
129972111|NCT02419417|467862858|FG004|Overall Study|Withdrawal by Subject|0|||
129972112|NCT02419417|467862859|FG005|Overall Study|Withdrawal by Subject|0|||
129972113|NCT02419417|467862860|FG006|Overall Study|Withdrawal by Subject|0|||
129972114|NCT02419417|467862861|FG007|Overall Study|Withdrawal by Subject|0|||
129972115|NCT02419417|467862862|FG008|Overall Study|Withdrawal by Subject|0|||
129972116|NCT02419417|467862863|FG009|Overall Study|Withdrawal by Subject|0|||
129972117|NCT02419417|467862864|FG010|Overall Study|Withdrawal by Subject|1|||
129972118|NCT01240551|467862865|FG000|Overall Study|Refused further treatment|3|||
129972119|NCT01240551|467862866|FG001|Overall Study|Refused further treatment|2|||
129972120|NCT01240551|467862865|FG000|Overall Study|Lost to Follow-up|1|||
129972121|NCT01240551|467862866|FG001|Overall Study|Lost to Follow-up|1|||
129972122|NCT00078377|467862870|FG000|Overall Study|Adverse Event|2|||
129972123|NCT00078377|467862871|FG001|Overall Study|Adverse Event|5|||
129972124|NCT00078377|467862872|FG002|Overall Study|Adverse Event|1|||
129972125|NCT00078377|467862870|FG000|Overall Study|Lack of Efficacy|2|||
129972126|NCT00078377|467862871|FG001|Overall Study|Lack of Efficacy|0|||
129972127|NCT00078377|467862872|FG002|Overall Study|Lack of Efficacy|2|||
129972128|NCT00078377|467862870|FG000|Overall Study|Lost to Follow-up|0|||
129972129|NCT00078377|467862871|FG001|Overall Study|Lost to Follow-up|1|||
129972130|NCT00078377|467862872|FG002|Overall Study|Lost to Follow-up|1|||
129972131|NCT00078377|467862870|FG000|Overall Study|Physician Decision|2|||
129972132|NCT00078377|467862871|FG001|Overall Study|Physician Decision|0|||
129972133|NCT00078377|467862872|FG002|Overall Study|Physician Decision|0|||
129972134|NCT00078377|467862870|FG000|Overall Study|Withdrawal by Subject|3|||
129972135|NCT00078377|467862871|FG001|Overall Study|Withdrawal by Subject|4|||
129972136|NCT00078377|467862872|FG002|Overall Study|Withdrawal by Subject|4|||
129972137|NCT00078377|467862870|FG000|Overall Study|Miscellaneous|2|||
129972138|NCT00078377|467862871|FG001|Overall Study|Miscellaneous|6|||
129972139|NCT00078377|467862872|FG002|Overall Study|Miscellaneous|1|||
129972140|NCT01200342|467862873|FG000|Overall Study|Disease Progression|1|||
129972141|NCT00953147|467862874|FG000|Overall Study|Adverse Event|8|||
129972142|NCT00953147|467862875|FG001|Overall Study|Adverse Event|16|||
129972143|NCT00953147|467862876|FG002|Overall Study|Adverse Event|6|||
129972144|NCT00953147|467862874|FG000|Overall Study|Protocol Violation|2|||
129972145|NCT00953147|467862875|FG001|Overall Study|Protocol Violation|8|||
129972146|NCT00953147|467862876|FG002|Overall Study|Protocol Violation|4|||
129972147|NCT00953147|467862874|FG000|Overall Study|Withdrawal by Subject|13|||
129972148|NCT00953147|467862875|FG001|Overall Study|Withdrawal by Subject|15|||
129972149|NCT00953147|467862876|FG002|Overall Study|Withdrawal by Subject|12|||
129972150|NCT00953147|467862874|FG000|Overall Study|Lost to Follow-up|8|||
129972151|NCT00953147|467862875|FG001|Overall Study|Lost to Follow-up|9|||
129972152|NCT00953147|467862876|FG002|Overall Study|Lost to Follow-up|4|||
129972153|NCT00953147|467862874|FG000|Overall Study|Physician Decision|2|||
129972154|NCT00953147|467862875|FG001|Overall Study|Physician Decision|7|||
129972155|NCT00953147|467862876|FG002|Overall Study|Physician Decision|3|||
129972156|NCT00953147|467862874|FG000|Overall Study|Other|4|||
129972157|NCT00953147|467862875|FG001|Overall Study|Other|11|||
129972158|NCT00953147|467862876|FG002|Overall Study|Other|13|||
129972159|NCT01484431|467862877|FG000|Period 1: High Dose|Physician Decision|0|||
129972160|NCT01484431|467862878|FG001|Period 1: High Dose|Physician Decision|1|||
129972161|NCT01484431|467862879|FG002|Period 1: High Dose|Physician Decision|0|||
129972162|NCT01484431|467862877|FG000|Period 2|Death|0|||
129972163|NCT01484431|467862878|FG001|Period 2|Death|1|||
129972164|NCT01484431|467862879|FG002|Period 2|Death|1|||
129972165|NCT01484431|467862877|FG000|Period 2|Physician Decision|0|||
129972166|NCT01484431|467862878|FG001|Period 2|Physician Decision|0|||
129972167|NCT01484431|467862879|FG002|Period 2|Physician Decision|1|||
129972168|NCT01484431|467862877|FG000|Period 2|Non-Compliance with Study Drug|1|||
129972169|NCT01484431|467862878|FG001|Period 2|Non-Compliance with Study Drug|0|||
129972170|NCT01484431|467862879|FG002|Period 2|Non-Compliance with Study Drug|0|||
129972171|NCT02763215|467862882|FG000|Overall Study|Participants withdrew from study|3|||
129972172|NCT02763215|467862882|FG000|Overall Study|Missed visit|1|||
129972173|NCT02763215|467862882|FG000|Overall Study|Visit outside visit-window|1|||
129972174|NCT02763215|467862882|FG000|Overall Study|Death|1|||
129972175|NCT02763215|467862882|FG000|Overall Study|Lost to Follow-up|1|||
129972176|NCT00475644|467862883|FG000|Overall Study|Protocol Violation|13|||
129972177|NCT01411241|467862884|FG000|Overall Study|Protocol Violation|0|||
129972178|NCT01411241|467862885|FG001|Overall Study|Protocol Violation|5|||
129972179|NCT01411241|467862884|FG000|Overall Study|Withdrawal by Subject|9|||
129972180|NCT01411241|467862885|FG001|Overall Study|Withdrawal by Subject|10|||
129972181|NCT01411241|467862884|FG000|Overall Study|Serious Adverse Event|0|||
129972182|NCT01411241|467862885|FG001|Overall Study|Serious Adverse Event|3|||
129972183|NCT01411241|467862884|FG000|Overall Study|Lost to Follow-up|2|||
129972184|NCT01411241|467862885|FG001|Overall Study|Lost to Follow-up|4|||
129972185|NCT02980042|467862890|FG000|Overall Study|Lost to Follow-up|5|||
129972186|NCT02980042|467862891|FG001|Overall Study|Lost to Follow-up|0|||
129972187|NCT02980042|467862890|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
129972188|NCT02980042|467862891|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
129972189|NCT01020877|467862894|FG000|Second Intervention|Withdrawal by Subject|1|||
129972190|NCT01020877|467862895|FG001|Second Intervention|Withdrawal by Subject|0|||
129972191|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
129972192|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
129972193|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
129972194|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
129972195|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
129972196|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
129972197|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
129972198|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
129972199|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
129972200|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
129972201|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
129972202|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
129972203|NCT00790400|467862896|FG000|Double-blind Period (Core Phase)|Death|1|||
129972204|NCT00790400|467862897|FG001|Double-blind Period (Core Phase)|Death|0|||
129972205|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
129972206|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
129972207|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
129972208|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
129972209|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
129972210|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
129972211|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
129972212|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
129972213|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
129972214|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
129972215|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Death|1|||
129972216|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Death|0|||
129972217|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
129972218|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
129972219|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
129972220|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
129469689|NCT01445535|466015280|FG001|Overall Study|PI discretion|0|||
129469690|NCT01445535|466015281|FG002|Overall Study|PI discretion|0|||
129972221|NCT00790400|467862896|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
129972222|NCT00790400|467862897|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
129972223|NCT00078338|467862899|FG000|Overall Study|Adverse Event|31|||
129972224|NCT00078338|467862900|FG001|Overall Study|Adverse Event|24|||
129972225|NCT00078338|467862899|FG000|Overall Study|Lost to Follow-up|17|||
129972226|NCT00078338|467862900|FG001|Overall Study|Lost to Follow-up|2|||
129972227|NCT00078338|467862899|FG000|Overall Study|Protocol Violation|2|||
129972228|NCT00078338|467862900|FG001|Overall Study|Protocol Violation|2|||
129972229|NCT00078338|467862899|FG000|Overall Study|Disease Progression|4|||
129972230|NCT00078338|467862900|FG001|Overall Study|Disease Progression|7|||
129972231|NCT00078338|467862899|FG000|Overall Study|Other|28|||
129972232|NCT00078338|467862900|FG001|Overall Study|Other|16|||
129972233|NCT00078338|467862899|FG000|Overall Study|Subjects randomized, but not treated|3|||
129972234|NCT00078338|467862900|FG001|Overall Study|Subjects randomized, but not treated|3|||
129972235|NCT01483144|467862901|FG000|Overall Study|Adverse Event|9|||
129972236|NCT01483144|467862902|FG001|Overall Study|Adverse Event|4|||
129972237|NCT01483144|467862903|FG002|Overall Study|Adverse Event|6|||
129972238|NCT01483144|467862901|FG000|Overall Study|Withdrawal by Subject|0|||
129972239|NCT01483144|467862902|FG001|Overall Study|Withdrawal by Subject|2|||
129972240|NCT01483144|467862903|FG002|Overall Study|Withdrawal by Subject|5|||
129972241|NCT01483144|467862901|FG000|Overall Study|Physician Decision|1|||
129972242|NCT01483144|467862902|FG001|Overall Study|Physician Decision|0|||
129972243|NCT01483144|467862903|FG002|Overall Study|Physician Decision|0|||
129972244|NCT01483144|467862901|FG000|Overall Study|Lost to Follow-up|2|||
129972245|NCT01483144|467862902|FG001|Overall Study|Lost to Follow-up|4|||
129972246|NCT01483144|467862903|FG002|Overall Study|Lost to Follow-up|1|||
129972247|NCT01483144|467862901|FG000|Overall Study|Protocol Violation|3|||
129972248|NCT01483144|467862902|FG001|Overall Study|Protocol Violation|3|||
129972249|NCT01483144|467862903|FG002|Overall Study|Protocol Violation|3|||
129972250|NCT03258723|467862906|FG000|Overall Study|COVID Interruption of study|54|||
129972251|NCT03258723|467862906|FG000|Overall Study|Lost to Follow-up|8|||
129972252|NCT01107899|467862910|FG000|Overall Study|Physician Decision|5|||
129972253|NCT01107899|467862911|FG001|Overall Study|Physician Decision|0|||
129972254|NCT01107899|467862912|FG002|Overall Study|Physician Decision|3|||
129972255|NCT01107899|467862910|FG000|Overall Study|Withdrawal by Subject|0|||
129972256|NCT01107899|467862911|FG001|Overall Study|Withdrawal by Subject|0|||
129972257|NCT01107899|467862912|FG002|Overall Study|Withdrawal by Subject|1|||
129972258|NCT00974259|467862913|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
129972259|NCT00974259|467862914|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
129972260|NCT00944229|467862917|FG000|Overall Study|Withdrawal by Subject|11|||
129972261|NCT00944229|467862917|FG000|Overall Study|Physician Decision|14|||
129972262|NCT04292470|467862918|FG000|Overall Study|Withdrawal by Subject|0|||
129972263|NCT04292470|467862919|FG001|Overall Study|Withdrawal by Subject|1|||
129972264|NCT02906020|467862937|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
129972265|NCT02906020|467862938|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
129972266|NCT02906020|467862939|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
129972267|NCT02906020|467862940|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
129972268|NCT02906020|467862941|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
129972269|NCT02906020|467862942|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
129972270|NCT02906020|467862943|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
129972271|NCT02906020|467862944|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
129972272|NCT02906020|467862945|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
129972273|NCT02906020|467862946|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
129972274|NCT02906020|467862947|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
129972275|NCT02906020|467862948|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
129972276|NCT02906020|467862949|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
129972277|NCT02906020|467862950|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
129972278|NCT02906020|467862951|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
129469691|NCT01445535|466015282|FG003|Overall Study|PI discretion|1|||
129972279|NCT02906020|467862952|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
129972280|NCT02906020|467862937|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972281|NCT02906020|467862938|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972282|NCT02906020|467862939|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972283|NCT02906020|467862940|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972284|NCT02906020|467862941|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972285|NCT02906020|467862942|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972286|NCT02906020|467862943|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972287|NCT02906020|467862944|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972288|NCT02906020|467862945|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
129972289|NCT02906020|467862946|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
129972290|NCT02906020|467862947|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972291|NCT02906020|467862948|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129469692|NCT03569202|466015285|FG000|Part 3|Physician Decision|1|||
129469693|NCT03569202|466015286|FG001|Part 3|Physician Decision|0|||
129972292|NCT02906020|467862949|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972293|NCT02906020|467862950|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972294|NCT02906020|467862951|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972295|NCT02906020|467862952|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
129972296|NCT02906020|467862937|FG000|Part 2: Double-blind Treatment Period|Other|0|||
129972297|NCT02906020|467862938|FG001|Part 2: Double-blind Treatment Period|Other|0|||
129972298|NCT02906020|467862939|FG002|Part 2: Double-blind Treatment Period|Other|0|||
129972299|NCT02906020|467862940|FG003|Part 2: Double-blind Treatment Period|Other|0|||
129972300|NCT02906020|467862941|FG004|Part 2: Double-blind Treatment Period|Other|0|||
129972301|NCT02906020|467862942|FG005|Part 2: Double-blind Treatment Period|Other|0|||
129972302|NCT02906020|467862943|FG006|Part 2: Double-blind Treatment Period|Other|0|||
129972303|NCT02906020|467862944|FG007|Part 2: Double-blind Treatment Period|Other|0|||
129972304|NCT02906020|467862945|FG008|Part 2: Double-blind Treatment Period|Other|6|||
129972305|NCT02906020|467862946|FG009|Part 2: Double-blind Treatment Period|Other|10|||
129972306|NCT02906020|467862947|FG010|Part 2: Double-blind Treatment Period|Other|0|||
129972307|NCT02906020|467862948|FG011|Part 2: Double-blind Treatment Period|Other|0|||
129972308|NCT02906020|467862949|FG012|Part 2: Double-blind Treatment Period|Other|0|||
129972309|NCT02906020|467862950|FG013|Part 2: Double-blind Treatment Period|Other|0|||
129972310|NCT02906020|467862951|FG014|Part 2: Double-blind Treatment Period|Other|0|||
129972311|NCT02906020|467862952|FG015|Part 2: Double-blind Treatment Period|Other|0|||
129972312|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972313|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972314|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972315|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972316|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972317|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972318|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972319|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972320|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972321|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972322|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972323|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972324|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
129972325|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
129972326|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972327|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
129972328|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972329|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972330|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972331|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972332|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972333|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972334|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972335|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972336|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972337|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972338|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972339|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972340|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
129972341|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
129972342|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
129972343|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
129469694|NCT03569202|466015285|FG000|Part 3|Other|1|||
129972344|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972345|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129469695|NCT03569202|466015286|FG001|Part 3|Other|1|||
129469696|NCT00420511|466015287|FG000|Overall Study|Adverse Event|1|||
129469697|NCT00420511|466015288|FG001|Overall Study|Adverse Event|1|||
129469698|NCT00420511|466015287|FG000|Overall Study|Lost to Follow-up|1|||
129469699|NCT00420511|466015288|FG001|Overall Study|Lost to Follow-up|0|||
129972346|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972347|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972348|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972349|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972350|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972351|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972352|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972353|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972354|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972355|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972356|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
129972357|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
129972358|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972359|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
129972360|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972361|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972362|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972363|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972364|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972365|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972366|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972367|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972368|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972369|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972370|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972371|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972372|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
129972373|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
129972374|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972375|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
129972376|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972377|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972378|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972379|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972380|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972381|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972382|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972383|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972384|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972385|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972386|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972387|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
129972388|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
129972389|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
129972390|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
129972391|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
129972392|NCT02906020|467862937|FG000|Part 2: Long-term Follow-up Period|Other|0|||
129972393|NCT02906020|467862938|FG001|Part 2: Long-term Follow-up Period|Other|0|||
129972394|NCT02906020|467862939|FG002|Part 2: Long-term Follow-up Period|Other|0|||
129972395|NCT02906020|467862940|FG003|Part 2: Long-term Follow-up Period|Other|0|||
129972396|NCT02906020|467862941|FG004|Part 2: Long-term Follow-up Period|Other|0|||
129972397|NCT02906020|467862942|FG005|Part 2: Long-term Follow-up Period|Other|0|||
129972398|NCT02906020|467862943|FG006|Part 2: Long-term Follow-up Period|Other|0|||
129972399|NCT02906020|467862944|FG007|Part 2: Long-term Follow-up Period|Other|0|||
129972400|NCT02906020|467862945|FG008|Part 2: Long-term Follow-up Period|Other|0|||
129972401|NCT02906020|467862946|FG009|Part 2: Long-term Follow-up Period|Other|0|||
129972402|NCT02906020|467862947|FG010|Part 2: Long-term Follow-up Period|Other|0|||
129972403|NCT02906020|467862948|FG011|Part 2: Long-term Follow-up Period|Other|0|||
129469700|NCT01337973|466015289|FG000|Overall Study|Lost to Follow-up|2|||
129972404|NCT02906020|467862949|FG012|Part 2: Long-term Follow-up Period|Other|13|||
129972405|NCT02906020|467862950|FG013|Part 2: Long-term Follow-up Period|Other|8|||
129972406|NCT02906020|467862951|FG014|Part 2: Long-term Follow-up Period|Other|3|||
129972407|NCT02906020|467862952|FG015|Part 2: Long-term Follow-up Period|Other|2|||
129972408|NCT01810939|467862953|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
129972409|NCT01810939|467862954|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
129972410|NCT01810939|467862955|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
129972411|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol Violation|2|||
129972412|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol Violation|0|||
129972413|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol Violation|0|||
129972414|NCT01810939|467862953|FG000|Part A Treatment Period|Adverse Event|10|||
129972415|NCT01810939|467862954|FG001|Part A Treatment Period|Adverse Event|0|||
129972416|NCT01810939|467862955|FG002|Part A Treatment Period|Adverse Event|0|||
129972417|NCT01810939|467862953|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
129972418|NCT01810939|467862954|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
129972419|NCT01810939|467862955|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
129972420|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
129972421|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
129972422|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
129972423|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
129972424|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
129972425|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
129972426|NCT01810939|467862953|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
129972427|NCT01810939|467862954|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
129972428|NCT01810939|467862955|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
129972429|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
129972430|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
129972431|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
129972432|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
129972433|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
129972434|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
129972435|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
129972436|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
129972437|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
129972438|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
129972439|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
129972440|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
129972441|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
129972442|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
129972443|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
129972444|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
129972445|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
129972446|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
129972447|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
129972448|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
129972449|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
129972450|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
129972451|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
129972452|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
129972453|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
129972454|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
129972455|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
129972456|NCT01810939|467862953|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
129972457|NCT01810939|467862954|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
129972458|NCT01810939|467862955|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
129972459|NCT01375673|467862956|FG000|Overall Study|Withdrawal by Subject|0|||
129972460|NCT01375673|467862957|FG001|Overall Study|Withdrawal by Subject|1|||
129972461|NCT02179177|467862958|FG000|Overall Study|Lost to Follow-up|1|||
129972462|NCT02179177|467862959|FG001|Overall Study|Lost to Follow-up|1|||
129972463|NCT02179177|467862958|FG000|Overall Study|Withdrawal by Subject|1|||
129972464|NCT02179177|467862959|FG001|Overall Study|Withdrawal by Subject|1|||
129972465|NCT03845140|467862966|FG000|Overall Study|Participant travelled outside study area|0|||
129972466|NCT03845140|467862967|FG001|Overall Study|Participant travelled outside study area|1|||
129972467|NCT03845140|467862968|FG002|Overall Study|Participant travelled outside study area|0|||
129972468|NCT03845140|467862969|FG003|Overall Study|Participant travelled outside study area|0|||
129972469|NCT03845140|467862970|FG004|Overall Study|Participant travelled outside study area|0|||
129972470|NCT03845140|467862971|FG005|Overall Study|Participant travelled outside study area|0|||
129972471|NCT01592045|467862972|FG000|Overall Study|Disease Progression|1|||
129972472|NCT01592045|467862973|FG001|Overall Study|Disease Progression|1|||
129972473|NCT01592045|467862972|FG000|Overall Study|Adverse Event|1|||
129972474|NCT01592045|467862973|FG001|Overall Study|Adverse Event|1|||
129972475|NCT01592045|467862972|FG000|Overall Study|Withdrawal by Subject|1|||
129972476|NCT01592045|467862973|FG001|Overall Study|Withdrawal by Subject|0|||
129972477|NCT01592045|467862972|FG000|Overall Study|Moved out of country|2|||
129972478|NCT01592045|467862973|FG001|Overall Study|Moved out of country|0|||
129972479|NCT03812029|467862977|FG000|Overall Study|Protocol Violation|1|||
129972480|NCT03812029|467862978|FG001|Overall Study|Protocol Violation|0|||
129972481|NCT03812029|467862979|FG002|Overall Study|Protocol Violation|0|||
129972482|NCT03812029|467862980|FG003|Overall Study|Protocol Violation|1|||
129972483|NCT03812029|467862981|FG004|Overall Study|Protocol Violation|0|||
129972484|NCT03812029|467862977|FG000|Overall Study|Withdrawal by Subject|1|||
129972485|NCT03812029|467862978|FG001|Overall Study|Withdrawal by Subject|0|||
129972486|NCT03812029|467862979|FG002|Overall Study|Withdrawal by Subject|0|||
129972487|NCT03812029|467862980|FG003|Overall Study|Withdrawal by Subject|2|||
129972488|NCT03812029|467862981|FG004|Overall Study|Withdrawal by Subject|2|||
129972489|NCT03812029|467862977|FG000|Overall Study|Stopping rules|0|||
129972490|NCT03812029|467862978|FG001|Overall Study|Stopping rules|1|||
129972491|NCT03812029|467862979|FG002|Overall Study|Stopping rules|0|||
129972492|NCT03812029|467862980|FG003|Overall Study|Stopping rules|0|||
129972493|NCT03812029|467862981|FG004|Overall Study|Stopping rules|0|||
129972494|NCT03812029|467862977|FG000|Overall Study|Adverse Event|0|||
129469701|NCT01337973|466015290|FG001|Overall Study|Lost to Follow-up|4|||
129469702|NCT01337973|466015291|FG002|Overall Study|Lost to Follow-up|3|||
129469703|NCT01337973|466015289|FG000|Overall Study|Death|1|||
129469704|NCT01337973|466015290|FG001|Overall Study|Death|2|||
129469705|NCT01337973|466015291|FG002|Overall Study|Death|1|||
129469706|NCT01337973|466015289|FG000|Overall Study|Withdrawal by Subject|10|||
129469707|NCT01337973|466015290|FG001|Overall Study|Withdrawal by Subject|8|||
129972495|NCT03812029|467862978|FG001|Overall Study|Adverse Event|9|||
129972496|NCT03812029|467862979|FG002|Overall Study|Adverse Event|0|||
129972497|NCT03812029|467862980|FG003|Overall Study|Adverse Event|3|||
129972498|NCT03812029|467862981|FG004|Overall Study|Adverse Event|5|||
129972499|NCT03812029|467862977|FG000|Overall Study|Lost to Follow-up|0|||
129972500|NCT03812029|467862978|FG001|Overall Study|Lost to Follow-up|0|||
129972501|NCT03812029|467862979|FG002|Overall Study|Lost to Follow-up|0|||
129972502|NCT03812029|467862980|FG003|Overall Study|Lost to Follow-up|0|||
129972503|NCT03812029|467862981|FG004|Overall Study|Lost to Follow-up|3|||
129972504|NCT03149042|467862982|FG000|Overall Study|Invasive FFR not performed|21|||
129972505|NCT03149042|467862982|FG000|Overall Study|Poor CT Image Quality|1|||
129972506|NCT03149042|467862982|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
129972507|NCT02643628|467862983|FG000|Overall Study|Lost to Follow-up|1|||
129972508|NCT02643628|467862984|FG001|Overall Study|Lost to Follow-up|4|||
129972509|NCT02643628|467862983|FG000|Overall Study|Withdrawal by Subject|0|||
129972510|NCT02643628|467862984|FG001|Overall Study|Withdrawal by Subject|1|||
129972511|NCT02643628|467862983|FG000|Overall Study|Relocated out of state|0|||
129972512|NCT02643628|467862984|FG001|Overall Study|Relocated out of state|1|||
129972513|NCT04092452|467862985|FG000|Overall Study|Adverse Event|1|||
129972514|NCT04092452|467862986|FG001|Overall Study|Adverse Event|3|||
129972515|NCT04092452|467862987|FG002|Overall Study|Adverse Event|3|||
129972516|NCT04092452|467862988|FG003|Overall Study|Adverse Event|7|||
129972517|NCT04092452|467862985|FG000|Overall Study|Lack of Efficacy|1|||
129972518|NCT04092452|467862986|FG001|Overall Study|Lack of Efficacy|1|||
129972519|NCT04092452|467862987|FG002|Overall Study|Lack of Efficacy|1|||
129972520|NCT04092452|467862988|FG003|Overall Study|Lack of Efficacy|0|||
129972521|NCT04092452|467862985|FG000|Overall Study|Lost to Follow-up|4|||
129972522|NCT04092452|467862986|FG001|Overall Study|Lost to Follow-up|3|||
129972523|NCT04092452|467862987|FG002|Overall Study|Lost to Follow-up|5|||
129972524|NCT04092452|467862988|FG003|Overall Study|Lost to Follow-up|1|||
129972525|NCT04092452|467862985|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129972526|NCT04092452|467862986|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129972527|NCT04092452|467862987|FG002|Overall Study|Non-Compliance With Study Drug|1|||
129972528|NCT04092452|467862988|FG003|Overall Study|Non-Compliance With Study Drug|1|||
129972529|NCT04092452|467862985|FG000|Overall Study|Physician Decision|1|||
129972530|NCT04092452|467862986|FG001|Overall Study|Physician Decision|0|||
129972531|NCT04092452|467862987|FG002|Overall Study|Physician Decision|1|||
129972532|NCT04092452|467862988|FG003|Overall Study|Physician Decision|0|||
129972533|NCT04092452|467862985|FG000|Overall Study|Pregnancy|2|||
129972534|NCT04092452|467862986|FG001|Overall Study|Pregnancy|0|||
129972535|NCT04092452|467862987|FG002|Overall Study|Pregnancy|0|||
129972536|NCT04092452|467862988|FG003|Overall Study|Pregnancy|0|||
129972537|NCT04092452|467862985|FG000|Overall Study|Protocol Deviation|1|||
129972538|NCT04092452|467862986|FG001|Overall Study|Protocol Deviation|0|||
129972539|NCT04092452|467862987|FG002|Overall Study|Protocol Deviation|0|||
129972540|NCT04092452|467862988|FG003|Overall Study|Protocol Deviation|0|||
129469708|NCT01337973|466015291|FG002|Overall Study|Withdrawal by Subject|4|||
129972541|NCT04092452|467862985|FG000|Overall Study|Withdrawal by Subject|3|||
129972542|NCT04092452|467862986|FG001|Overall Study|Withdrawal by Subject|10|||
129972543|NCT04092452|467862987|FG002|Overall Study|Withdrawal by Subject|3|||
129972544|NCT04092452|467862988|FG003|Overall Study|Withdrawal by Subject|5|||
129972545|NCT04092452|467862985|FG000|Overall Study|Other|0|||
129972546|NCT04092452|467862986|FG001|Overall Study|Other|0|||
129972547|NCT04092452|467862987|FG002|Overall Study|Other|1|||
129972548|NCT04092452|467862988|FG003|Overall Study|Other|2|||
129469709|NCT01337973|466015289|FG000|Overall Study|missing data on primary outcome|3|||
129469710|NCT01337973|466015290|FG001|Overall Study|missing data on primary outcome|1|||
129469711|NCT01337973|466015291|FG002|Overall Study|missing data on primary outcome|3|||
129469712|NCT02494596|466015293|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129469713|NCT02494596|466015294|FG001|Overall Study|Insufficient Therapeutic Response|3|||
129469714|NCT02494596|466015295|FG002|Overall Study|Insufficient Therapeutic Response|1|||
129469715|NCT02494596|466015293|FG000|Overall Study|Adverse Event|0|||
129469716|NCT02494596|466015294|FG001|Overall Study|Adverse Event|1|||
129469717|NCT02494596|466015295|FG002|Overall Study|Adverse Event|0|||
129469718|NCT02494596|466015293|FG000|Overall Study|Refused Treatment|0|||
129469719|NCT02494596|466015294|FG001|Overall Study|Refused Treatment|1|||
129469720|NCT02494596|466015295|FG002|Overall Study|Refused Treatment|0|||
129469721|NCT00254566|466015296|FG000|Overall Study|Death|1|||
129469722|NCT00254566|466015297|FG001|Overall Study|Death|0|||
129469723|NCT00254566|466015296|FG000|Overall Study|Adverse Event|5|||
129469724|NCT00254566|466015297|FG001|Overall Study|Adverse Event|4|||
129469725|NCT00254566|466015296|FG000|Overall Study|Lack of Efficacy|12|||
129469726|NCT00254566|466015297|FG001|Overall Study|Lack of Efficacy|9|||
129469727|NCT00254566|466015296|FG000|Overall Study|Other|1|||
129469728|NCT00254566|466015297|FG001|Overall Study|Other|5|||
129469729|NCT00254566|466015296|FG000|Overall Study|Withdrawal by Subject|5|||
129469730|NCT00254566|466015297|FG001|Overall Study|Withdrawal by Subject|6|||
129469731|NCT00254566|466015296|FG000|Overall Study|Lost to Follow-up|7|||
129469732|NCT00254566|466015297|FG001|Overall Study|Lost to Follow-up|2|||
129469733|NCT00059202|466015298|FG000|Overall Study|Withdrawal by Subject|5|||
129469734|NCT00059202|466015299|FG001|Overall Study|Withdrawal by Subject|9|||
129469735|NCT00059202|466015298|FG000|Overall Study|Protocol Violation|1|||
129469736|NCT00059202|466015299|FG001|Overall Study|Protocol Violation|3|||
129469737|NCT00059202|466015298|FG000|Overall Study|drug toxicity|0|||
129469738|NCT00059202|466015299|FG001|Overall Study|drug toxicity|3|||
129469739|NCT00584194|466015303|FG000|Overall Study|Other|135|||
129972549|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
129972550|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
129972551|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
129972552|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
129972553|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
129972554|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
129972555|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Death|0|||
129972556|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Death|0|||
129972557|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Death|1|||
129972558|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Death|0|||
129972559|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Death|0|||
129972560|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Death|0|||
129972561|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
129972562|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
129972563|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
129972564|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
129972565|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
129972566|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
129972567|NCT03355209|467862989|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
129972568|NCT03355209|467862990|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
129972569|NCT03355209|467862991|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
129972570|NCT03355209|467862992|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129972571|NCT03355209|467862993|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129972572|NCT03355209|467862994|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
129972573|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
129972574|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
129972575|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
129469740|NCT02624492|466015305|FG000|Overall Study|Adverse Event|2|||
129469741|NCT02624492|466015306|FG001|Overall Study|Adverse Event|2|||
129972576|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
129469742|NCT02624492|466015307|FG002|Overall Study|Adverse Event|2|||
129469743|NCT02624492|466015305|FG000|Overall Study|Progressive disease|0|||
129469744|NCT02624492|466015306|FG001|Overall Study|Progressive disease|2|||
129469745|NCT02624492|466015307|FG002|Overall Study|Progressive disease|3|||
129972577|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
129972578|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
129972579|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972580|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
129972581|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972582|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972583|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972584|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
129972585|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
129972586|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
129972587|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
129972588|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
129972589|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
129972590|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
129972591|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
129972592|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
129972593|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
129972594|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
129972595|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
129972596|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
129972597|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
129972598|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
129972599|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
129972600|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129972601|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
129972602|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129972603|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972604|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972605|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972606|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
129972607|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
129972608|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
129972609|NCT03355209|467862989|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
129972610|NCT03355209|467862990|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972611|NCT03355209|467862991|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
129972612|NCT03355209|467862992|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972613|NCT03355209|467862993|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972614|NCT03355209|467862994|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
129972615|NCT01825577|467862996|FG000|Overall Study|Physician Decision|2|||
129972616|NCT01825577|467862996|FG000|Overall Study|Withdrawal by Subject|1|||
129972617|NCT01825577|467862996|FG000|Overall Study|Withdrawn by family members|2|||
129972618|NCT01825577|467862996|FG000|Overall Study|Lack of Efficacy|3|||
129972619|NCT00358644|467862997|FG000|Overall Study|Progressive Disease|21|||
129972620|NCT00358644|467862997|FG000|Overall Study|Adverse Event|7|||
129972621|NCT00358644|467862997|FG000|Overall Study|Death|11|||
129972622|NCT00358644|467862997|FG000|Overall Study|Withdrawal by Subject|4|||
129972623|NCT00358644|467862997|FG000|Overall Study|Physician Decision|6|||
129972624|NCT00358644|467862997|FG000|Overall Study|Patient not eligible for study|1|||
129972625|NCT01358331|467862998|FG000|Overall Study|Lost to Follow-up|0|||
129972626|NCT01358331|467862999|FG001|Overall Study|Lost to Follow-up|0|||
129972627|NCT01358331|467863000|FG002|Overall Study|Lost to Follow-up|0|||
129972628|NCT01358331|467863001|FG003|Overall Study|Lost to Follow-up|1|||
129972629|NCT01358331|467863002|FG004|Overall Study|Lost to Follow-up|0|||
129972630|NCT01358331|467863003|FG005|Overall Study|Lost to Follow-up|0|||
129972631|NCT01358331|467862998|FG000|Overall Study|Withdrawal by Subject|0|||
129972632|NCT01358331|467862999|FG001|Overall Study|Withdrawal by Subject|0|||
129972633|NCT01358331|467863000|FG002|Overall Study|Withdrawal by Subject|0|||
129972634|NCT01358331|467863001|FG003|Overall Study|Withdrawal by Subject|1|||
129972635|NCT01358331|467863002|FG004|Overall Study|Withdrawal by Subject|1|||
129972636|NCT01358331|467863003|FG005|Overall Study|Withdrawal by Subject|1|||
129972637|NCT01358331|467862998|FG000|Overall Study|Adverse Events|1|||
129972638|NCT01358331|467862999|FG001|Overall Study|Adverse Events|1|||
129972639|NCT01358331|467863000|FG002|Overall Study|Adverse Events|1|||
129972640|NCT01358331|467863001|FG003|Overall Study|Adverse Events|0|||
129972641|NCT01358331|467863002|FG004|Overall Study|Adverse Events|1|||
129972642|NCT01358331|467863003|FG005|Overall Study|Adverse Events|5|||
129972643|NCT01358331|467862998|FG000|Overall Study|Symptomatic Deterioration|0|||
129972644|NCT01358331|467862999|FG001|Overall Study|Symptomatic Deterioration|0|||
129972645|NCT01358331|467863000|FG002|Overall Study|Symptomatic Deterioration|0|||
129972646|NCT01358331|467863001|FG003|Overall Study|Symptomatic Deterioration|0|||
129972647|NCT01358331|467863002|FG004|Overall Study|Symptomatic Deterioration|1|||
129972648|NCT01358331|467863003|FG005|Overall Study|Symptomatic Deterioration|0|||
129972649|NCT01358331|467862998|FG000|Overall Study|Participants did not wish to continue|0|||
129972650|NCT01358331|467862999|FG001|Overall Study|Participants did not wish to continue|0|||
129972651|NCT01358331|467863000|FG002|Overall Study|Participants did not wish to continue|0|||
129972652|NCT01358331|467863001|FG003|Overall Study|Participants did not wish to continue|0|||
129972653|NCT01358331|467863002|FG004|Overall Study|Participants did not wish to continue|1|||
129972654|NCT01358331|467863003|FG005|Overall Study|Participants did not wish to continue|0|||
129972655|NCT01358331|467862998|FG000|Overall Study|Progress of disease under investigation|1|||
129972656|NCT01358331|467862999|FG001|Overall Study|Progress of disease under investigation|2|||
129972657|NCT01358331|467863000|FG002|Overall Study|Progress of disease under investigation|3|||
129972658|NCT01358331|467863001|FG003|Overall Study|Progress of disease under investigation|1|||
129972659|NCT01358331|467863002|FG004|Overall Study|Progress of disease under investigation|3|||
129972660|NCT01358331|467863003|FG005|Overall Study|Progress of disease under investigation|0|||
129972661|NCT03327831|467863004|FG000|Overall Study|Lost to Follow-up|2|||
129972662|NCT03332784|467863005|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972663|NCT03332784|467863006|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
129972664|NCT03332784|467863007|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972665|NCT03332784|467863008|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972666|NCT03332784|467863009|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972667|NCT03332784|467863010|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972668|NCT03332784|467863011|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972669|NCT03332784|467863012|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972670|NCT03332784|467863013|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972671|NCT03332784|467863014|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972672|NCT03332784|467863015|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972673|NCT03332784|467863016|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972674|NCT03332784|467863017|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972675|NCT03332784|467863018|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972676|NCT03332784|467863019|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
129972677|NCT03332784|467863020|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972678|NCT03332784|467863021|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972679|NCT03332784|467863022|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972680|NCT03332784|467863023|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972681|NCT03332784|467863024|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
129972682|NCT00401258|467863025|FG000|Overall Study|Adverse Event|7|||
129972683|NCT01430468|467863032|FG000|Overall Study|Physician Decision|2|||
129972684|NCT01430468|467863033|FG001|Overall Study|Physician Decision|1|||
129972685|NCT01430468|467863032|FG000|Overall Study|Withdrawal by Subject|5|||
129972686|NCT01430468|467863033|FG001|Overall Study|Withdrawal by Subject|5|||
129972687|NCT04982575|467863043|FG000|Overall Study|Withdrawal by Subject|2|||
129972688|NCT04982575|467863044|FG001|Overall Study|Withdrawal by Subject|0|||
129972689|NCT04982575|467863045|FG002|Overall Study|Withdrawal by Subject|2|||
129972690|NCT01151423|467863046|FG000|Overall Study|Study terminated by Sponsor|9|||
129972691|NCT01151423|467863047|FG001|Overall Study|Study terminated by Sponsor|10|||
129972692|NCT01151423|467863046|FG000|Overall Study|Protocol Violation|0|||
129972693|NCT01151423|467863047|FG001|Overall Study|Protocol Violation|1|||
129972694|NCT01151423|467863046|FG000|Overall Study|Physician Decision|1|||
129972695|NCT01151423|467863047|FG001|Overall Study|Physician Decision|1|||
129972696|NCT01151423|467863046|FG000|Overall Study|Pregnancy|0|||
129972697|NCT01151423|467863047|FG001|Overall Study|Pregnancy|1|||
129972698|NCT01151423|467863046|FG000|Overall Study|Death|0|||
129972699|NCT01151423|467863047|FG001|Overall Study|Death|1|||
129972700|NCT01151423|467863046|FG000|Overall Study|Adverse Event|3|||
129972701|NCT01151423|467863047|FG001|Overall Study|Adverse Event|0|||
129972702|NCT01151423|467863046|FG000|Overall Study|Withdrawal by Subject|1|||
129972703|NCT01151423|467863047|FG001|Overall Study|Withdrawal by Subject|3|||
129972704|NCT01151423|467863046|FG000|Overall Study|Lost to Follow-up|1|||
129972705|NCT01151423|467863047|FG001|Overall Study|Lost to Follow-up|0|||
129972706|NCT01151423|467863046|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
129972707|NCT01151423|467863047|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
129972708|NCT01151423|467863046|FG000|Overall Study|Participated in other clinical trial|1|||
129972709|NCT01151423|467863047|FG001|Overall Study|Participated in other clinical trial|0|||
129972710|NCT01183390|467865457|FG000|First Intervention|Adverse Event|0|||
129972711|NCT01183390|467865458|FG001|First Intervention|Adverse Event|1|||
129972712|NCT02358668|467865459|FG000|Overall Study|Adverse Event|2|||
129972713|NCT02358668|467865460|FG001|Overall Study|Adverse Event|0|||
129972714|NCT02358668|467865461|FG002|Overall Study|Adverse Event|0|||
129972715|NCT02358668|467865459|FG000|Overall Study|Withdrawal by Subject|0|||
129972716|NCT02358668|467865460|FG001|Overall Study|Withdrawal by Subject|1|||
129972717|NCT02358668|467865461|FG002|Overall Study|Withdrawal by Subject|0|||
129972718|NCT02568397|467865462|FG000|Period 2|Withdrawal by Subject|0|||
129972719|NCT02568397|467865463|FG001|Period 2|Withdrawal by Subject|1|||
129972720|NCT02568397|467865462|FG000|Period 2|Physician Decision|0|||
129972721|NCT02568397|467865463|FG001|Period 2|Physician Decision|1|||
129972722|NCT01317875|467865464|FG000|Overall Study|Other|0|||
129972723|NCT01317875|467865465|FG001|Overall Study|Other|0|||
129972724|NCT01317875|467865466|FG002|Overall Study|Other|1|||
129972725|NCT01317875|467865467|FG003|Overall Study|Other|0|||
129972726|NCT01317875|467865468|FG004|Overall Study|Other|0|||
129972727|NCT01317875|467865469|FG005|Overall Study|Other|0|||
129972728|NCT01317875|467865470|FG006|Overall Study|Other|0|||
129972729|NCT01317875|467865471|FG007|Overall Study|Other|0|||
129972730|NCT01317875|467865472|FG008|Overall Study|Other|0|||
129972731|NCT01317875|467865473|FG009|Overall Study|Other|0|||
129972732|NCT01317875|467865464|FG000|Overall Study|Noncompliance with study drug|0|||
129972733|NCT01317875|467865465|FG001|Overall Study|Noncompliance with study drug|0|||
129972734|NCT01317875|467865466|FG002|Overall Study|Noncompliance with study drug|1|||
129972735|NCT01317875|467865467|FG003|Overall Study|Noncompliance with study drug|0|||
129972736|NCT01317875|467865468|FG004|Overall Study|Noncompliance with study drug|0|||
129972737|NCT01317875|467865469|FG005|Overall Study|Noncompliance with study drug|0|||
129972738|NCT01317875|467865470|FG006|Overall Study|Noncompliance with study drug|0|||
129972739|NCT01317875|467865471|FG007|Overall Study|Noncompliance with study drug|0|||
129972740|NCT01317875|467865472|FG008|Overall Study|Noncompliance with study drug|0|||
129972741|NCT01317875|467865473|FG009|Overall Study|Noncompliance with study drug|0|||
129972742|NCT01317875|467865464|FG000|Overall Study|Progressive Disease|1|||
129972743|NCT01317875|467865465|FG001|Overall Study|Progressive Disease|0|||
129972744|NCT01317875|467865466|FG002|Overall Study|Progressive Disease|2|||
129972745|NCT01317875|467865467|FG003|Overall Study|Progressive Disease|0|||
129972746|NCT01317875|467865468|FG004|Overall Study|Progressive Disease|1|||
129972747|NCT01317875|467865469|FG005|Overall Study|Progressive Disease|0|||
129972748|NCT01317875|467865470|FG006|Overall Study|Progressive Disease|0|||
129972749|NCT01317875|467865471|FG007|Overall Study|Progressive Disease|1|||
129972750|NCT01317875|467865472|FG008|Overall Study|Progressive Disease|0|||
129972751|NCT01317875|467865473|FG009|Overall Study|Progressive Disease|0|||
129972752|NCT01317875|467865464|FG000|Overall Study|Withdrawal by Subject|0|||
129972753|NCT01317875|467865465|FG001|Overall Study|Withdrawal by Subject|0|||
129972754|NCT01317875|467865466|FG002|Overall Study|Withdrawal by Subject|0|||
129972755|NCT01317875|467865467|FG003|Overall Study|Withdrawal by Subject|0|||
129972756|NCT01317875|467865468|FG004|Overall Study|Withdrawal by Subject|1|||
129972757|NCT01317875|467865469|FG005|Overall Study|Withdrawal by Subject|0|||
129972758|NCT01317875|467865470|FG006|Overall Study|Withdrawal by Subject|0|||
129972759|NCT01317875|467865471|FG007|Overall Study|Withdrawal by Subject|3|||
129972760|NCT01317875|467865472|FG008|Overall Study|Withdrawal by Subject|0|||
129972761|NCT01317875|467865473|FG009|Overall Study|Withdrawal by Subject|0|||
129972762|NCT01317875|467865464|FG000|Overall Study|Physician Decision|0|||
129972763|NCT01317875|467865465|FG001|Overall Study|Physician Decision|1|||
129972764|NCT01317875|467865466|FG002|Overall Study|Physician Decision|1|||
129972765|NCT01317875|467865467|FG003|Overall Study|Physician Decision|0|||
129972766|NCT01317875|467865468|FG004|Overall Study|Physician Decision|2|||
129972767|NCT01317875|467865469|FG005|Overall Study|Physician Decision|0|||
129972768|NCT01317875|467865470|FG006|Overall Study|Physician Decision|0|||
129972769|NCT01317875|467865471|FG007|Overall Study|Physician Decision|2|||
129972770|NCT01317875|467865472|FG008|Overall Study|Physician Decision|0|||
129972771|NCT01317875|467865473|FG009|Overall Study|Physician Decision|0|||
129972772|NCT01317875|467865464|FG000|Overall Study|Death|0|||
129972773|NCT01317875|467865465|FG001|Overall Study|Death|0|||
129972774|NCT01317875|467865466|FG002|Overall Study|Death|2|||
129972775|NCT01317875|467865467|FG003|Overall Study|Death|1|||
129972776|NCT01317875|467865468|FG004|Overall Study|Death|0|||
129972777|NCT01317875|467865469|FG005|Overall Study|Death|1|||
129972778|NCT01317875|467865470|FG006|Overall Study|Death|0|||
129972779|NCT01317875|467865471|FG007|Overall Study|Death|4|||
129972780|NCT01317875|467865472|FG008|Overall Study|Death|0|||
129972781|NCT01317875|467865473|FG009|Overall Study|Death|0|||
129972782|NCT01317875|467865464|FG000|Overall Study|Adverse Event|2|||
129972783|NCT01317875|467865465|FG001|Overall Study|Adverse Event|1|||
129972784|NCT01317875|467865466|FG002|Overall Study|Adverse Event|2|||
129972785|NCT01317875|467865467|FG003|Overall Study|Adverse Event|1|||
129972786|NCT01317875|467865468|FG004|Overall Study|Adverse Event|5|||
129972787|NCT01317875|467865469|FG005|Overall Study|Adverse Event|1|||
129972788|NCT01317875|467865470|FG006|Overall Study|Adverse Event|2|||
129972789|NCT01317875|467865471|FG007|Overall Study|Adverse Event|5|||
129972790|NCT01317875|467865472|FG008|Overall Study|Adverse Event|0|||
129972791|NCT01317875|467865473|FG009|Overall Study|Adverse Event|0|||
129972792|NCT01381575|467865474|FG000|Overall Study|Serious Adverse Event|1|||
129972793|NCT01381575|467865475|FG001|Overall Study|Serious Adverse Event|0|||
129972794|NCT01381575|467865476|FG002|Overall Study|Serious Adverse Event|0|||
129972795|NCT01381575|467865474|FG000|Overall Study|Non-Serious Adverse Event|0|||
129972796|NCT01381575|467865475|FG001|Overall Study|Non-Serious Adverse Event|0|||
129972797|NCT01381575|467865476|FG002|Overall Study|Non-Serious Adverse Event|1|||
129972798|NCT01381575|467865474|FG000|Overall Study|Protocol Violation|0|||
129972799|NCT01381575|467865475|FG001|Overall Study|Protocol Violation|1|||
129972800|NCT01381575|467865476|FG002|Overall Study|Protocol Violation|1|||
129972801|NCT01381575|467865474|FG000|Overall Study|Withdrawal by Subject|15|||
129972802|NCT01381575|467865475|FG001|Overall Study|Withdrawal by Subject|9|||
129972803|NCT01381575|467865476|FG002|Overall Study|Withdrawal by Subject|7|||
129972804|NCT01381575|467865474|FG000|Overall Study|Migrated/moved from study area|2|||
129972805|NCT01381575|467865475|FG001|Overall Study|Migrated/moved from study area|12|||
129972806|NCT01381575|467865476|FG002|Overall Study|Migrated/moved from study area|2|||
129972807|NCT01381575|467865474|FG000|Overall Study|Lost to Follow-up|8|||
129972808|NCT01381575|467865475|FG001|Overall Study|Lost to Follow-up|17|||
129972809|NCT01381575|467865476|FG002|Overall Study|Lost to Follow-up|9|||
129972810|NCT01443403|467865477|FG000|Overall Study|Adverse Event|1|||
129972811|NCT01443403|467865478|FG001|Overall Study|Adverse Event|1|||
129972812|NCT01443403|467865479|FG002|Overall Study|Adverse Event|4|||
129972813|NCT01443403|467865480|FG003|Overall Study|Adverse Event|5|||
129972814|NCT01443403|467865477|FG000|Overall Study|Withdrawal by Subject|0|||
129972815|NCT01443403|467865478|FG001|Overall Study|Withdrawal by Subject|1|||
129972816|NCT01443403|467865479|FG002|Overall Study|Withdrawal by Subject|2|||
129972817|NCT01443403|467865480|FG003|Overall Study|Withdrawal by Subject|1|||
129972818|NCT01443403|467865477|FG000|Overall Study|Lost to Follow-up|0|||
129972819|NCT01443403|467865478|FG001|Overall Study|Lost to Follow-up|0|||
129972820|NCT01443403|467865479|FG002|Overall Study|Lost to Follow-up|0|||
129972821|NCT01443403|467865480|FG003|Overall Study|Lost to Follow-up|1|||
129972822|NCT01443403|467865477|FG000|Overall Study|Protocol Violation|2|||
129972823|NCT01443403|467865478|FG001|Overall Study|Protocol Violation|1|||
129972824|NCT01443403|467865479|FG002|Overall Study|Protocol Violation|1|||
129972825|NCT01443403|467865480|FG003|Overall Study|Protocol Violation|1|||
129972826|NCT01443403|467865477|FG000|Overall Study|Use of Prohibited Treatment|2|||
129972827|NCT01443403|467865478|FG001|Overall Study|Use of Prohibited Treatment|3|||
129972828|NCT01443403|467865479|FG002|Overall Study|Use of Prohibited Treatment|0|||
129972829|NCT01443403|467865480|FG003|Overall Study|Use of Prohibited Treatment|0|||
129972830|NCT01443403|467865477|FG000|Overall Study|Other - Miscellaneous|1|||
129972831|NCT01443403|467865478|FG001|Overall Study|Other - Miscellaneous|0|||
129972832|NCT01443403|467865479|FG002|Overall Study|Other - Miscellaneous|0|||
129972833|NCT01443403|467865480|FG003|Overall Study|Other - Miscellaneous|1|||
129972834|NCT04546217|467865483|FG000|Overall Study|Withdrawal by Subject|2|||
129972835|NCT04546217|467865484|FG001|Overall Study|Withdrawal by Subject|0|||
129972836|NCT04546217|467865483|FG000|Overall Study|Uncontrolled hypertension|1|||
129972837|NCT04546217|467865484|FG001|Overall Study|Uncontrolled hypertension|0|||
129972838|NCT02550938|467865485|FG000|Overall Study|Lost to Follow-up|8|||
129972839|NCT02550938|467865486|FG001|Overall Study|Lost to Follow-up|7|||
129972840|NCT02550938|467865487|FG002|Overall Study|Lost to Follow-up|12|||
129972841|NCT02550938|467865488|FG003|Overall Study|Lost to Follow-up|11|||
129972842|NCT02514239|467865492|FG000|Overall Study|Refused to continue trial medication|0|||
129972843|NCT02514239|467865493|FG001|Overall Study|Refused to continue trial medication|0|||
129972844|NCT02514239|467865494|FG002|Overall Study|Refused to continue trial medication|0|||
129972845|NCT02514239|467865495|FG003|Overall Study|Refused to continue trial medication|0|||
129972846|NCT02514239|467865496|FG004|Overall Study|Refused to continue trial medication|0|||
129972847|NCT02514239|467865497|FG005|Overall Study|Refused to continue trial medication|0|||
129972848|NCT02514239|467865498|FG006|Overall Study|Refused to continue trial medication|0|||
129972849|NCT02514239|467865499|FG007|Overall Study|Refused to continue trial medication|0|||
129972850|NCT02514239|467865500|FG008|Overall Study|Refused to continue trial medication|0|||
129972851|NCT02514239|467865501|FG009|Overall Study|Refused to continue trial medication|1|||
129972852|NCT02514239|467865492|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972853|NCT02514239|467865493|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972854|NCT02514239|467865494|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972855|NCT02514239|467865495|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972856|NCT02514239|467865496|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972857|NCT02514239|467865497|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972858|NCT02514239|467865498|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972859|NCT02514239|467865499|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
129972860|NCT02514239|467865500|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
129972861|NCT02514239|467865501|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
129972862|NCT02514239|467865492|FG000|Overall Study|Not treated|0|||
129972863|NCT02514239|467865493|FG001|Overall Study|Not treated|1|||
129972864|NCT02514239|467865494|FG002|Overall Study|Not treated|0|||
129972865|NCT02514239|467865495|FG003|Overall Study|Not treated|0|||
129972866|NCT02514239|467865496|FG004|Overall Study|Not treated|0|||
129972867|NCT02514239|467865497|FG005|Overall Study|Not treated|0|||
129469746|NCT03555266|466015313|FG000|Overall Study|Protocol Violation|6|||
129469747|NCT03555266|466015314|FG001|Overall Study|Protocol Violation|4|||
129972868|NCT02514239|467865498|FG006|Overall Study|Not treated|0|||
129972869|NCT02514239|467865499|FG007|Overall Study|Not treated|0|||
129972870|NCT02514239|467865500|FG008|Overall Study|Not treated|0|||
129972871|NCT02514239|467865501|FG009|Overall Study|Not treated|0|||
129972872|NCT02514239|467865492|FG000|Overall Study|Other Adverse Events|2|||
129972873|NCT02514239|467865493|FG001|Overall Study|Other Adverse Events|0|||
129972874|NCT02514239|467865494|FG002|Overall Study|Other Adverse Events|0|||
129972875|NCT02514239|467865495|FG003|Overall Study|Other Adverse Events|1|||
129972876|NCT02514239|467865496|FG004|Overall Study|Other Adverse Events|0|||
129972877|NCT02514239|467865497|FG005|Overall Study|Other Adverse Events|1|||
129972878|NCT02514239|467865498|FG006|Overall Study|Other Adverse Events|0|||
129972879|NCT02514239|467865499|FG007|Overall Study|Other Adverse Events|1|||
129972880|NCT02514239|467865500|FG008|Overall Study|Other Adverse Events|2|||
129972881|NCT02514239|467865501|FG009|Overall Study|Other Adverse Events|0|||
129972882|NCT02514239|467865492|FG000|Overall Study|Progressive disease|3|||
129972883|NCT02514239|467865493|FG001|Overall Study|Progressive disease|3|||
129972884|NCT02514239|467865494|FG002|Overall Study|Progressive disease|2|||
129972885|NCT02514239|467865495|FG003|Overall Study|Progressive disease|2|||
129972886|NCT02514239|467865496|FG004|Overall Study|Progressive disease|3|||
129972887|NCT02514239|467865497|FG005|Overall Study|Progressive disease|3|||
129972888|NCT02514239|467865498|FG006|Overall Study|Progressive disease|4|||
129972889|NCT02514239|467865499|FG007|Overall Study|Progressive disease|2|||
129972890|NCT02514239|467865500|FG008|Overall Study|Progressive disease|5|||
129972891|NCT02514239|467865501|FG009|Overall Study|Progressive disease|0|||
129972892|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
129972893|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
129972894|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
129972895|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
129972896|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
129972897|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
129972898|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
129972899|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
129972900|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
129972901|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
129972902|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
129972903|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
129972904|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
129972905|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
129972906|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972907|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972908|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972909|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972910|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972911|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
129972912|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
129972913|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
129972914|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
129972915|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
129972916|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
129972917|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
129972918|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
129972919|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
129972920|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972921|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972922|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972923|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972924|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
129972925|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972926|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129972927|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972928|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
129972929|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972930|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972931|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972932|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972933|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
129972934|NCT01888874|467865502|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972935|NCT01888874|467865503|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
129972936|NCT01888874|467865504|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972937|NCT01888874|467865505|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972938|NCT01888874|467865506|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972939|NCT01888874|467865507|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
129972940|NCT01888874|467865508|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
129972941|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
129972942|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
129972943|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
129469748|NCT02167945|466015315|FG000|Overall Study|Adverse Event|16|||
129972944|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129972945|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
129972946|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129972947|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129972948|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972949|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972950|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972951|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972952|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
129972953|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972954|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
129972955|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972956|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972957|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
129972958|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972959|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972960|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
129972961|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
129972962|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972963|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972964|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
129972965|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972966|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972967|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972968|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
129972969|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
129972970|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
129972971|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
129972972|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
129972973|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
129972974|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
129972975|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
129972976|NCT01888874|467865502|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972977|NCT01888874|467865503|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
129972978|NCT01888874|467865504|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972979|NCT01888874|467865505|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972980|NCT01888874|467865506|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972981|NCT01888874|467865507|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
129972982|NCT01888874|467865508|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
129972983|NCT00953771|467865510|FG000|Overall Study|Death|1|||
129972984|NCT00953771|467865511|FG001|Overall Study|Death|0|||
129972985|NCT00884650|467865514|FG000|Overall Study|Did not return complete pain diaries|7|||
129972986|NCT00884650|467865515|FG001|Overall Study|Did not return complete pain diaries|7|||
129972987|NCT00884650|467865514|FG000|Overall Study|Admitted Post-Op|1|||
129972988|NCT00884650|467865515|FG001|Overall Study|Admitted Post-Op|0|||
129972989|NCT00884650|467865514|FG000|Overall Study|Femoral Stress Fracture|1|||
129972990|NCT00884650|467865515|FG001|Overall Study|Femoral Stress Fracture|0|||
129972991|NCT00884650|467865514|FG000|Overall Study|Pain Pump Complication|0|||
129972992|NCT00884650|467865515|FG001|Overall Study|Pain Pump Complication|1|||
129469749|NCT02167945|466015315|FG000|Overall Study|Withdrew Consent|42|||
129469750|NCT02167945|466015315|FG000|Overall Study|Lost to Follow-up|122|||
129469751|NCT02167945|466015315|FG000|Overall Study|COVID-19 logistical restrictions|6|||
129469752|NCT02167945|466015315|FG000|Overall Study|Other, not specified|63|||
129469753|NCT02239263|466015316|FG000|Overall Study|Protocol Violation|6|||
129469754|NCT01058096|466015318|FG000|Double-blind Treatment Phase|Adverse Event|11|||
129469755|NCT01058096|466015319|FG001|Double-blind Treatment Phase|Adverse Event|15|||
129469756|NCT01058096|466015318|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
129469757|NCT01058096|466015319|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
129469758|NCT01058096|466015318|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
129469759|NCT01058096|466015319|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
129469760|NCT01058096|466015318|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
129469761|NCT01058096|466015319|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
129469762|NCT01058096|466015318|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
129469763|NCT01058096|466015319|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
129469764|NCT01058096|466015318|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
129469765|NCT01058096|466015319|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
129469766|NCT04276207|466015320|FG000|Period 1|Withdrawal by Subject|0|||
129972993|NCT00979953|467865516|FG000|Overall Study|Adverse Event|5|||
129469767|NCT04276207|466015321|FG001|Period 1|Withdrawal by Subject|1|||
129469768|NCT04451330|466015322|FG000|Overall Study|Adverse Event|1|||
129972994|NCT00979953|467865517|FG001|Overall Study|Adverse Event|2|||
129972995|NCT00979953|467865518|FG002|Overall Study|Adverse Event|17|||
129972996|NCT00979953|467865519|FG003|Overall Study|Adverse Event|4|||
129972997|NCT00979953|467865516|FG000|Overall Study|Lack of Efficacy|1|||
129972998|NCT00979953|467865517|FG001|Overall Study|Lack of Efficacy|2|||
129972999|NCT00979953|467865518|FG002|Overall Study|Lack of Efficacy|0|||
129973000|NCT00979953|467865519|FG003|Overall Study|Lack of Efficacy|0|||
129973001|NCT00979953|467865516|FG000|Overall Study|Lost to Follow-up|1|||
129973002|NCT00979953|467865517|FG001|Overall Study|Lost to Follow-up|1|||
129973003|NCT00979953|467865518|FG002|Overall Study|Lost to Follow-up|1|||
129973004|NCT00979953|467865519|FG003|Overall Study|Lost to Follow-up|0|||
129973005|NCT00979953|467865516|FG000|Overall Study|Withdrawal by Subject|0|||
129973006|NCT00979953|467865517|FG001|Overall Study|Withdrawal by Subject|0|||
129973007|NCT00979953|467865518|FG002|Overall Study|Withdrawal by Subject|2|||
129973008|NCT00979953|467865519|FG003|Overall Study|Withdrawal by Subject|1|||
129973009|NCT00979953|467865516|FG000|Overall Study|Protocol Violation|1|||
129973010|NCT00979953|467865517|FG001|Overall Study|Protocol Violation|0|||
129973011|NCT00979953|467865518|FG002|Overall Study|Protocol Violation|2|||
129973012|NCT00979953|467865519|FG003|Overall Study|Protocol Violation|2|||
129469769|NCT04451330|466015323|FG001|Overall Study|Adverse Event|2|||
129469770|NCT04451330|466015322|FG000|Overall Study|Lost to Follow-up|5|||
129469771|NCT04451330|466015323|FG001|Overall Study|Lost to Follow-up|0|||
129469772|NCT04451330|466015322|FG000|Overall Study|Withdrawal by Subject|3|||
129469773|NCT04451330|466015323|FG001|Overall Study|Withdrawal by Subject|1|||
129469774|NCT04451330|466015322|FG000|Overall Study|Withdrawal by parent/guardian|1|||
129469775|NCT04451330|466015323|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129469776|NCT04451330|466015322|FG000|Overall Study|Other than specified|0|||
129469777|NCT04451330|466015323|FG001|Overall Study|Other than specified|1|||
129469778|NCT02769624|466015324|FG000|Overall Study|Lost to Follow-up|0|||
129469779|NCT02769624|466015325|FG001|Overall Study|Lost to Follow-up|1|||
129469780|NCT05099640|466015326|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
129469781|NCT05099640|466015327|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
129469782|NCT05099640|466015328|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
129469783|NCT05099640|466015326|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
129469784|NCT05099640|466015327|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
129469785|NCT05099640|466015328|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
129469786|NCT05099640|466015326|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
129469787|NCT05099640|466015327|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
129469788|NCT05099640|466015328|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
129469789|NCT05099640|466015326|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
129469790|NCT05099640|466015327|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
129469791|NCT05099640|466015328|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
129973013|NCT04052425|467865522|FG000|24-Week Double-blind Period|Adverse Event|0|||
129973014|NCT04052425|467865523|FG001|24-Week Double-blind Period|Adverse Event|1|||
129973015|NCT04052425|467865524|FG002|24-Week Double-blind Period|Adverse Event|0|||
129973016|NCT04052425|467865525|FG003|24-Week Double-blind Period|Adverse Event|0|||
129973017|NCT04052425|467865522|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
129973018|NCT04052425|467865523|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
129973019|NCT04052425|467865524|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
129973020|NCT04052425|467865525|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
129973021|NCT04052425|467865522|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
129973022|NCT04052425|467865523|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
129973023|NCT04052425|467865524|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
129973024|NCT04052425|467865525|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
129973025|NCT04052425|467865522|FG000|24-Week Double-blind Period|Physician Decision|1|||
129973026|NCT04052425|467865523|FG001|24-Week Double-blind Period|Physician Decision|0|||
129973027|NCT04052425|467865524|FG002|24-Week Double-blind Period|Physician Decision|0|||
129973028|NCT04052425|467865525|FG003|24-Week Double-blind Period|Physician Decision|0|||
129973029|NCT04052425|467865522|FG000|24-Week Double-blind Period|Protocol Violation|1|||
129973030|NCT04052425|467865523|FG001|24-Week Double-blind Period|Protocol Violation|0|||
129973031|NCT04052425|467865524|FG002|24-Week Double-blind Period|Protocol Violation|0|||
129973032|NCT04052425|467865525|FG003|24-Week Double-blind Period|Protocol Violation|0|||
129973033|NCT04052425|467865522|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
129973034|NCT04052425|467865523|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
129973035|NCT04052425|467865524|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
129469792|NCT05099640|466015326|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
129469793|NCT05099640|466015327|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
129469794|NCT05099640|466015328|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
129973036|NCT04052425|467865525|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
129973037|NCT04052425|467865522|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
129973038|NCT04052425|467865523|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
129469795|NCT05099640|466015326|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
129469796|NCT05099640|466015327|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
129469797|NCT05099640|466015328|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
129469798|NCT00179959|466015329|FG000|Overall Study|Lost to Follow-up|3|||
129469799|NCT00179959|466015330|FG001|Overall Study|Lost to Follow-up|1|||
129469800|NCT00179959|466015329|FG000|Overall Study|Withdrawal by Subject|3|||
129469801|NCT00179959|466015330|FG001|Overall Study|Withdrawal by Subject|2|||
129469802|NCT00448708|466015331|FG000|Overall Study|Death|21|||
129469803|NCT00448708|466015332|FG001|Overall Study|Death|17|||
129469804|NCT00448708|466015331|FG000|Overall Study|Withdrawal by Subject|8|||
129973039|NCT04052425|467865524|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
129973040|NCT04052425|467865525|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
129973041|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
129973042|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
129973043|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
129973044|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
129973045|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
129973046|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
129973047|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
129973048|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
129973049|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129973050|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
129973051|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
129973052|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
129973053|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
129973054|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
129973055|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
129973056|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
129973057|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129973058|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
129973059|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
129973060|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
129973061|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
129973062|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
129973063|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
129973064|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
129973065|NCT04052425|467865522|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
129973066|NCT04052425|467865523|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
129973067|NCT04052425|467865524|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
129973068|NCT04052425|467865525|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
129973069|NCT04334278|467865526|FG000|Overall Study|Lost to Follow-up|0|||
129973070|NCT04334278|467865527|FG001|Overall Study|Lost to Follow-up|3|||
129973071|NCT04334278|467865526|FG000|Overall Study|Withdrawal by Subject|4|||
129973072|NCT04334278|467865527|FG001|Overall Study|Withdrawal by Subject|2|||
129973073|NCT04829747|467865530|FG000|Overall Study|Protocol Violation|1|||
129973074|NCT02615509|467865533|FG000|Overall Study|Lost to Follow-up|134|||
129973075|NCT02615509|467865533|FG000|Overall Study|Death|4|||
129973076|NCT02615509|467865533|FG000|Overall Study|Withdrawal by Subject|8|||
129973077|NCT00425607|467865534|FG000|Overall Study|Death|1|||
129469805|NCT00448708|466015332|FG001|Overall Study|Withdrawal by Subject|4|||
129469806|NCT00448708|466015331|FG000|Overall Study|Lost to Follow-up|6|||
129469807|NCT00448708|466015332|FG001|Overall Study|Lost to Follow-up|8|||
129469808|NCT00448708|466015331|FG000|Overall Study|not listed|0|||
129469809|NCT00448708|466015332|FG001|Overall Study|not listed|2|||
129469810|NCT04178772|466015333|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
129973078|NCT00425607|467865534|FG000|Overall Study|Withdrawal by Subject|1|||
129973079|NCT00079339|467865535|FG000|Overall Study|Adverse Event|1|||
129973080|NCT00079339|467865536|FG001|Overall Study|Adverse Event|7|||
129973081|NCT00079339|467865537|FG002|Overall Study|Adverse Event|2|||
129973082|NCT00079339|467865535|FG000|Overall Study|Death|1|||
129973083|NCT00079339|467865536|FG001|Overall Study|Death|0|||
129973084|NCT00079339|467865537|FG002|Overall Study|Death|0|||
129973085|NCT00079339|467865535|FG000|Overall Study|Non-compliance|0|||
129973086|NCT00079339|467865536|FG001|Overall Study|Non-compliance|0|||
129973087|NCT00079339|467865537|FG002|Overall Study|Non-compliance|1|||
129973088|NCT00079339|467865535|FG000|Overall Study|Withdrawal by Subject|0|||
129973089|NCT00079339|467865536|FG001|Overall Study|Withdrawal by Subject|4|||
129973090|NCT00079339|467865537|FG002|Overall Study|Withdrawal by Subject|1|||
129973091|NCT00079339|467865535|FG000|Overall Study|Disease progression|3|||
129469811|NCT04178772|466015333|FG000|Overall Study|study terminated early due to COVID-19|7|||
129469812|NCT00713219|466015336|FG000|Overall Study|Death|1|||
129973092|NCT00079339|467865536|FG001|Overall Study|Disease progression|28|||
129973093|NCT00079339|467865537|FG002|Overall Study|Disease progression|2|||
129973094|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
129973095|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
129973096|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
129469813|NCT00713219|466015336|FG000|Overall Study|Protocol Violation|1|||
129469814|NCT00091832|466015339|FG000|Overall Study|Physician Decision|1|||
129469815|NCT00091832|466015340|FG001|Overall Study|Physician Decision|0|||
129469816|NCT00091832|466015341|FG002|Overall Study|Physician Decision|0|||
129469817|NCT00091832|466015342|FG003|Overall Study|Physician Decision|0|||
129469818|NCT00091832|466015343|FG004|Overall Study|Physician Decision|0|||
129469819|NCT00091832|466015344|FG005|Overall Study|Physician Decision|0|||
129469820|NCT00091832|466015339|FG000|Overall Study|Adverse Event|0|||
129469821|NCT00091832|466015340|FG001|Overall Study|Adverse Event|0|||
129469822|NCT00091832|466015341|FG002|Overall Study|Adverse Event|0|||
129469823|NCT00091832|466015342|FG003|Overall Study|Adverse Event|1|||
129469824|NCT00091832|466015343|FG004|Overall Study|Adverse Event|3|||
129469825|NCT00091832|466015344|FG005|Overall Study|Adverse Event|0|||
129469826|NCT00091832|466015339|FG000|Overall Study|Withdrawal by Subject|4|||
129469827|NCT00091832|466015340|FG001|Overall Study|Withdrawal by Subject|5|||
129469828|NCT00091832|466015341|FG002|Overall Study|Withdrawal by Subject|0|||
129469829|NCT00091832|466015342|FG003|Overall Study|Withdrawal by Subject|1|||
129469830|NCT00091832|466015343|FG004|Overall Study|Withdrawal by Subject|3|||
129469831|NCT00091832|466015344|FG005|Overall Study|Withdrawal by Subject|1|||
129469832|NCT00091832|466015339|FG000|Overall Study|Death|6|||
129469833|NCT00091832|466015340|FG001|Overall Study|Death|4|||
129469834|NCT00091832|466015341|FG002|Overall Study|Death|5|||
129469835|NCT00091832|466015342|FG003|Overall Study|Death|8|||
129469836|NCT00091832|466015343|FG004|Overall Study|Death|5|||
129469837|NCT00091832|466015344|FG005|Overall Study|Death|6|||
129469838|NCT00091832|466015339|FG000|Overall Study|Disease Progression|2|||
129469839|NCT00091832|466015340|FG001|Overall Study|Disease Progression|0|||
129469840|NCT00091832|466015341|FG002|Overall Study|Disease Progression|0|||
129469841|NCT00091832|466015342|FG003|Overall Study|Disease Progression|1|||
129469842|NCT00091832|466015343|FG004|Overall Study|Disease Progression|1|||
129469843|NCT00091832|466015344|FG005|Overall Study|Disease Progression|2|||
129469844|NCT00091832|466015339|FG000|Overall Study|Ineligibility Determined|0|||
129469845|NCT00091832|466015340|FG001|Overall Study|Ineligibility Determined|0|||
129469846|NCT00091832|466015341|FG002|Overall Study|Ineligibility Determined|1|||
129469847|NCT00091832|466015342|FG003|Overall Study|Ineligibility Determined|0|||
129469848|NCT00091832|466015343|FG004|Overall Study|Ineligibility Determined|1|||
129469849|NCT00091832|466015344|FG005|Overall Study|Ineligibility Determined|0|||
129469850|NCT00091832|466015339|FG000|Overall Study|Lost to Follow-up|1|||
129469851|NCT00091832|466015340|FG001|Overall Study|Lost to Follow-up|0|||
129469852|NCT00091832|466015341|FG002|Overall Study|Lost to Follow-up|3|||
129469853|NCT00091832|466015342|FG003|Overall Study|Lost to Follow-up|3|||
129469854|NCT00091832|466015343|FG004|Overall Study|Lost to Follow-up|2|||
129469855|NCT00091832|466015344|FG005|Overall Study|Lost to Follow-up|1|||
129469856|NCT00091832|466015339|FG000|Overall Study|Noncompliance|0|||
129469857|NCT00091832|466015340|FG001|Overall Study|Noncompliance|1|||
129469858|NCT00091832|466015341|FG002|Overall Study|Noncompliance|0|||
129469859|NCT00091832|466015342|FG003|Overall Study|Noncompliance|0|||
129469860|NCT00091832|466015343|FG004|Overall Study|Noncompliance|0|||
129469861|NCT00091832|466015344|FG005|Overall Study|Noncompliance|0|||
129469862|NCT00091832|466015339|FG000|Overall Study|Other|0|||
129469863|NCT00091832|466015340|FG001|Overall Study|Other|1|||
129469864|NCT00091832|466015341|FG002|Overall Study|Other|2|||
129469865|NCT00091832|466015342|FG003|Overall Study|Other|0|||
129469866|NCT00091832|466015343|FG004|Overall Study|Other|0|||
129469867|NCT00091832|466015344|FG005|Overall Study|Other|0|||
129469868|NCT00091832|466015339|FG000|Overall Study|Protocol Violation|0|||
129469869|NCT00091832|466015340|FG001|Overall Study|Protocol Violation|0|||
129469870|NCT00091832|466015341|FG002|Overall Study|Protocol Violation|1|||
129973097|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
129973098|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
129469871|NCT00091832|466015342|FG003|Overall Study|Protocol Violation|0|||
129469872|NCT00091832|466015343|FG004|Overall Study|Protocol Violation|0|||
129469873|NCT00091832|466015344|FG005|Overall Study|Protocol Violation|1|||
129469874|NCT00464178|466015345|FG000|Overall Study|Protocol Violation|1|||
129469875|NCT00464178|466015345|FG000|Overall Study|Withdrawal by Subject|1|||
129469876|NCT00946309|466015348|FG000|Overall Study|Protocol Violation|1|||
129469877|NCT00946309|466015349|FG001|Overall Study|Protocol Violation|0|||
129973099|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
129469878|NCT00946309|466015348|FG000|Overall Study|Lost to Follow-up|0|||
129469879|NCT00946309|466015349|FG001|Overall Study|Lost to Follow-up|1|||
129469880|NCT00946309|466015348|FG000|Overall Study|Procedure cancelled/discontinued|0|||
129469881|NCT00946309|466015349|FG001|Overall Study|Procedure cancelled/discontinued|3|||
129469882|NCT01469000|466015354|FG000|Overall Study|Withdrawal by Subject|16|||
129469883|NCT01469000|466015355|FG001|Overall Study|Withdrawal by Subject|3|||
129469884|NCT01469000|466015354|FG000|Overall Study|Sponsor Decision|4|||
129469885|NCT01469000|466015355|FG001|Overall Study|Sponsor Decision|1|||
129973100|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
129973101|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
129973102|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
129973103|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
129973104|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
129973105|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
129973106|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129469886|NCT00686647|466015363|FG000|Overall Study|Lost to Follow-up|1|||
129469887|NCT00686647|466015363|FG000|Overall Study|Death|1|||
129469888|NCT05501119|466015372|FG000|Overall Study|Withdrawal by Subject|2|||
129469889|NCT05501119|466015372|FG000|Overall Study|Lost to Follow-up|5|||
129469890|NCT01356589|466015376|FG000|Overall Study|Enrolled, but not treated|3|||
129469891|NCT01356589|466015376|FG000|Overall Study|Dose data not recorded|2|||
129469892|NCT01462266|466015377|FG000|Overall Study|Adverse Event|7|||
129469893|NCT01462266|466015378|FG001|Overall Study|Adverse Event|6|||
129469894|NCT01462266|466015377|FG000|Overall Study|Death|2|||
129469895|NCT01462266|466015378|FG001|Overall Study|Death|1|||
129469896|NCT01462266|466015377|FG000|Overall Study|Lack of Efficacy|0|||
129469897|NCT01462266|466015378|FG001|Overall Study|Lack of Efficacy|2|||
129469898|NCT01462266|466015377|FG000|Overall Study|Lost to Follow-up|4|||
129973107|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973108|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
129973109|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973110|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973111|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
129973112|NCT02563548|467865538|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973113|NCT02563548|467865539|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973114|NCT02563548|467865540|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
129973115|NCT02563548|467865541|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
129469899|NCT01462266|466015378|FG001|Overall Study|Lost to Follow-up|3|||
129469900|NCT01462266|466015377|FG000|Overall Study|Non-compliance with study drug|3|||
129469901|NCT01462266|466015378|FG001|Overall Study|Non-compliance with study drug|0|||
129469902|NCT01462266|466015377|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
129469903|NCT01462266|466015378|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
129469904|NCT01462266|466015377|FG000|Overall Study|Physician Decision|2|||
129469905|NCT01462266|466015378|FG001|Overall Study|Physician Decision|5|||
129469906|NCT01462266|466015377|FG000|Overall Study|Protocol Violation|1|||
129469907|NCT01462266|466015378|FG001|Overall Study|Protocol Violation|3|||
129469908|NCT01462266|466015377|FG000|Overall Study|Withdrawal by Subject|7|||
129469909|NCT01462266|466015378|FG001|Overall Study|Withdrawal by Subject|2|||
129469910|NCT01462266|466015377|FG000|Overall Study|Screen failure|1|||
129469911|NCT01462266|466015378|FG001|Overall Study|Screen failure|1|||
129469912|NCT01106846|466015379|FG000|Overall Study|Change in surgical procedure|0|||
129469913|NCT01106846|466015380|FG001|Overall Study|Change in surgical procedure|1|||
129469914|NCT02447848|466015389|FG000|Overall Study|Patient discharged|3|||
129469915|NCT02447848|466015389|FG000|Overall Study|Lack of Efficacy|4|||
129469916|NCT02447848|466015389|FG000|Overall Study|Withdrawal by Subject|4|||
129469917|NCT04698629|466015391|FG000|Overall Study|Adverse Event|1|||
129469918|NCT03344003|466015392|FG000|Overall Study|Switched to alternative treatment|1|||
129469919|NCT03344003|466015393|FG001|Overall Study|Switched to alternative treatment|0|||
129469920|NCT03344003|466015392|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
129469921|NCT03344003|466015393|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
129469922|NCT01171820|466017184|FG000|Overall Study|Death|3|||
129469923|NCT01171820|466017185|FG001|Overall Study|Death|3|||
129469924|NCT01171820|466017184|FG000|Overall Study|Lost to Follow-up|0|||
129469925|NCT01171820|466017185|FG001|Overall Study|Lost to Follow-up|1|||
129469926|NCT01171820|466017184|FG000|Overall Study|Withdrawal by Subject|2|||
129469927|NCT01171820|466017185|FG001|Overall Study|Withdrawal by Subject|0|||
129469928|NCT01171820|466017184|FG000|Overall Study|Physician Decision|0|||
129469929|NCT01171820|466017185|FG001|Overall Study|Physician Decision|1|||
129469930|NCT01171820|466017184|FG000|Overall Study|1-Year Missed Visit|1|||
129469931|NCT01171820|466017185|FG001|Overall Study|1-Year Missed Visit|1|||
129469932|NCT03969875|466017186|FG000|Overall Study|did not receive allocated intervention|3|||
129469933|NCT03969875|466017187|FG001|Overall Study|did not receive allocated intervention|3|||
129469934|NCT03969875|466017188|FG002|Overall Study|did not receive allocated intervention|4|||
129469935|NCT03969875|466017186|FG000|Overall Study|Protocol Violation|4|||
129469936|NCT03969875|466017187|FG001|Overall Study|Protocol Violation|2|||
129469937|NCT03969875|466017188|FG002|Overall Study|Protocol Violation|2|||
129469938|NCT01307033|466017189|FG000|8-week Double-blind Period|Adverse Event|2|||
129469939|NCT01307033|466017190|FG001|8-week Double-blind Period|Adverse Event|0|||
129469940|NCT01307033|466017191|FG002|8-week Double-blind Period|Adverse Event|0|||
129469941|NCT01307033|466017192|FG003|8-week Double-blind Period|Adverse Event|0|||
129469942|NCT01307033|466017189|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
129469943|NCT01307033|466017190|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
129469944|NCT01307033|466017191|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
129469945|NCT01307033|466017192|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
129469946|NCT01307033|466017189|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
129469947|NCT01307033|466017190|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
129469948|NCT01307033|466017191|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
129469949|NCT01307033|466017192|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
129469950|NCT01307033|466017189|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
129469951|NCT01307033|466017190|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
129973116|NCT02563548|467865542|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973117|NCT02563548|467865543|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
129973118|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973119|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973120|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973121|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
129973122|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
129973123|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
129973124|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973125|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973126|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973127|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
129973128|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
129973129|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
129973130|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973131|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973132|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973133|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973134|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
129973135|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
129973136|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973137|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973138|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973139|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
129973140|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
129973141|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
129973142|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973143|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973144|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973145|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973146|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
129973147|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
129973148|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973149|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973150|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973151|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973152|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
129973153|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
129973154|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973155|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973156|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973157|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973158|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
129973159|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
129973160|NCT02563548|467865538|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973161|NCT02563548|467865539|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973162|NCT02563548|467865540|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973163|NCT02563548|467865541|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129973164|NCT02563548|467865542|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
129973165|NCT02563548|467865543|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
129469952|NCT01307033|466017191|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
129469953|NCT01307033|466017192|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
129469954|NCT01307033|466017189|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
129973166|NCT00520845|467865544|FG000|Overall Study|Death|3|||
129973167|NCT00520845|467865544|FG000|Overall Study|Adverse Event|4|||
129973168|NCT00520845|467865544|FG000|Overall Study|Disease Progression, relapse|13|||
129973169|NCT00520845|467865544|FG000|Overall Study|Withdrawal by Subject|1|||
129973170|NCT00520845|467865544|FG000|Overall Study|Alternative Therapy|1|||
129973171|NCT03274453|467865545|FG000|Overall Study|Lost to Follow-up|2|||
129973172|NCT03274453|467865546|FG001|Overall Study|Lost to Follow-up|5|||
129973173|NCT03274453|467865547|FG002|Overall Study|Lost to Follow-up|4|||
129973174|NCT03274453|467865548|FG003|Overall Study|Lost to Follow-up|1|||
129973175|NCT03274453|467865545|FG000|Overall Study|Physician Decision|2|||
129973176|NCT03274453|467865546|FG001|Overall Study|Physician Decision|0|||
129973177|NCT03274453|467865547|FG002|Overall Study|Physician Decision|0|||
129973178|NCT03274453|467865548|FG003|Overall Study|Physician Decision|3|||
129973179|NCT03274453|467865545|FG000|Overall Study|Surgery Cancelled|0|||
129973180|NCT03274453|467865546|FG001|Overall Study|Surgery Cancelled|1|||
129973181|NCT03274453|467865547|FG002|Overall Study|Surgery Cancelled|0|||
129973182|NCT03274453|467865548|FG003|Overall Study|Surgery Cancelled|0|||
129973183|NCT01732549|467865550|FG000|Overall Study|Adverse Event|13|||
129973184|NCT01732549|467865551|FG001|Overall Study|Adverse Event|3|||
129973185|NCT01732549|467865550|FG000|Overall Study|Consent withdrawn|13|||
129973186|NCT01732549|467865551|FG001|Overall Study|Consent withdrawn|6|||
129973187|NCT01732549|467865550|FG000|Overall Study|Disease progression|37|||
129973188|NCT01732549|467865551|FG001|Overall Study|Disease progression|50|||
129973189|NCT01732549|467865550|FG000|Overall Study|Other|8|||
129973190|NCT01732549|467865551|FG001|Overall Study|Other|14|||
129973191|NCT00945672|467865553|FG000|Overall Study|Withdrawal by Subject|0|||
129973192|NCT00945672|467865554|FG001|Overall Study|Withdrawal by Subject|0|||
129973193|NCT00945672|467865555|FG002|Overall Study|Withdrawal by Subject|0|||
129973194|NCT00945672|467865556|FG003|Overall Study|Withdrawal by Subject|1|||
129973195|NCT01681992|467865561|FG000|Overall Study|Adverse Event|3|||
129973196|NCT01681992|467865562|FG001|Overall Study|Adverse Event|2|||
129973197|NCT01681992|467865563|FG002|Overall Study|Adverse Event|3|||
129973198|NCT01681992|467865561|FG000|Overall Study|Lost to Follow-up|36|||
129973199|NCT01681992|467865562|FG001|Overall Study|Lost to Follow-up|38|||
129973200|NCT01681992|467865563|FG002|Overall Study|Lost to Follow-up|53|||
129973201|NCT01681992|467865561|FG000|Overall Study|As Per Sponsor Decision|0|||
129973202|NCT01681992|467865562|FG001|Overall Study|As Per Sponsor Decision|0|||
129973203|NCT01681992|467865563|FG002|Overall Study|As Per Sponsor Decision|1|||
129973204|NCT01681992|467865561|FG000|Overall Study|Protocol Violation|0|||
129973205|NCT01681992|467865562|FG001|Overall Study|Protocol Violation|0|||
129973206|NCT01681992|467865563|FG002|Overall Study|Protocol Violation|1|||
129973207|NCT01681992|467865561|FG000|Overall Study|Withdrawal by Subject|27|||
129973208|NCT01681992|467865562|FG001|Overall Study|Withdrawal by Subject|30|||
129973209|NCT01681992|467865563|FG002|Overall Study|Withdrawal by Subject|25|||
129973210|NCT00447590|467865564|FG000|Overall Study|Withdrawal by Subject|26|||
129973211|NCT00447590|467865564|FG000|Overall Study|Lost to Follow-up|24|||
129973212|NCT00447590|467865564|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
129973213|NCT01967069|467865565|FG000|Overall Study|Adverse Event|2|||
129973214|NCT01967069|467865566|FG001|Overall Study|Adverse Event|2|||
129973215|NCT01967069|467865565|FG000|Overall Study|Lost to Follow-up|5|||
129973216|NCT01967069|467865566|FG001|Overall Study|Lost to Follow-up|2|||
129973217|NCT01967069|467865565|FG000|Overall Study|Withdrawal by Subject|1|||
129973218|NCT01967069|467865566|FG001|Overall Study|Withdrawal by Subject|3|||
129973219|NCT01967069|467865565|FG000|Overall Study|Lack of Efficacy|0|||
129973220|NCT01967069|467865566|FG001|Overall Study|Lack of Efficacy|1|||
129973221|NCT01661205|467865570|FG000|Overall Study|Physician Decision|2|||
129973222|NCT03111095|467865574|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
129973223|NCT03111095|467865575|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
129973224|NCT03111095|467865574|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
129973225|NCT03111095|467865575|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
129973226|NCT00504075|467865576|FG000|Overall Study|Adverse Event|1|||
129973227|NCT00504075|467865576|FG000|Overall Study|Lost to Follow-up|5|||
129973228|NCT00504075|467865576|FG000|Overall Study|Withdrawal by Subject|1|||
129973229|NCT00504075|467865576|FG000|Overall Study|Required other therapeutic intervention|1|||
129973230|NCT04245345|467865592|FG000|Overall Study|Death|1|||
129973231|NCT04245345|467865592|FG000|Overall Study|Exited prior to implant|5|||
129973232|NCT04245345|467865592|FG000|Overall Study|Exited prior to 1-month|9|||
129973233|NCT04245345|467865592|FG000|Overall Study|Missed 1-month visit|3|||
129973234|NCT04245345|467865592|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
129973235|NCT04245345|467865592|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
129973236|NCT00732992|467865593|FG000|Overall Study|Adverse Event|1|||
129973237|NCT00732992|467865594|FG001|Overall Study|Adverse Event|1|||
129973238|NCT00732992|467865593|FG000|Overall Study|Objective Progression or Relapse|3|||
129973239|NCT00732992|467865594|FG001|Overall Study|Objective Progression or Relapse|5|||
129973240|NCT00732992|467865593|FG000|Overall Study|Global Deterioration of Health Status|1|||
129973241|NCT00732992|467865594|FG001|Overall Study|Global Deterioration of Health Status|0|||
129973242|NCT00732992|467865593|FG000|Overall Study|Withdrawal by Subject|1|||
129973243|NCT00732992|467865594|FG001|Overall Study|Withdrawal by Subject|0|||
129973244|NCT02344342|467865595|FG000|Overall Study|Industry partner dropped out|11|||
129973245|NCT02344342|467865596|FG001|Overall Study|Industry partner dropped out|9|||
129973246|NCT02344342|467865597|FG002|Overall Study|Industry partner dropped out|14|||
129973247|NCT02344342|467865598|FG003|Overall Study|Industry partner dropped out|10|||
129973248|NCT03690427|467865603|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
129973249|NCT03690427|467865604|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
129973250|NCT02609672|467865608|FG000|Overall Study|Lost to Follow-up|3|||
129973251|NCT02609672|467865609|FG001|Overall Study|Lost to Follow-up|1|||
129973252|NCT02956837|467865611|FG000|Overall Study|Serious Adverse Events|0|||
129973253|NCT02956837|467865612|FG001|Overall Study|Serious Adverse Events|1|||
129973254|NCT02956837|467865613|FG002|Overall Study|Serious Adverse Events|0|||
129973255|NCT02956837|467865614|FG003|Overall Study|Serious Adverse Events|0|||
129973256|NCT02956837|467865611|FG000|Overall Study|Withdrawal by Subject|0|||
129973257|NCT02956837|467865612|FG001|Overall Study|Withdrawal by Subject|1|||
129973258|NCT02956837|467865613|FG002|Overall Study|Withdrawal by Subject|0|||
129973259|NCT02956837|467865614|FG003|Overall Study|Withdrawal by Subject|3|||
129973260|NCT02956837|467865611|FG000|Overall Study|Lost to Follow-up|0|||
129973261|NCT02956837|467865612|FG001|Overall Study|Lost to Follow-up|1|||
129973262|NCT02956837|467865613|FG002|Overall Study|Lost to Follow-up|2|||
129973263|NCT02956837|467865614|FG003|Overall Study|Lost to Follow-up|0|||
129973264|NCT02597712|467865615|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
129973265|NCT02597712|467865616|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
129973266|NCT02597712|467865615|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
129973267|NCT02597712|467865616|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
129973268|NCT02597712|467865615|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
129973269|NCT02597712|467865616|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
129973270|NCT02637323|467865617|FG000|Overall Study|Lost to Follow-up|2|||
129973271|NCT02637323|467865618|FG001|Overall Study|Lost to Follow-up|0|||
129973272|NCT02637323|467865617|FG000|Overall Study|Protocol Violation|0|||
129973273|NCT02637323|467865618|FG001|Overall Study|Protocol Violation|1|||
129973274|NCT00513708|467865619|FG000|Overall Study|Lost to Follow-up|4|||
129973275|NCT00513708|467865620|FG001|Overall Study|Lost to Follow-up|4|||
129973276|NCT00513708|467865621|FG002|Overall Study|Lost to Follow-up|4|||
129973277|NCT01162486|467865622|FG000|Overall Study|low ANC|1|||
129973278|NCT01162486|467865623|FG001|Overall Study|low ANC|0|||
129973279|NCT01162486|467865624|FG002|Overall Study|low ANC|0|||
129973280|NCT01162486|467865625|FG003|Overall Study|low ANC|0|||
129973281|NCT01162486|467865626|FG004|Overall Study|low ANC|0|||
129973282|NCT01162486|467865622|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
129973283|NCT01162486|467865623|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973284|NCT01162486|467865624|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973285|NCT01162486|467865625|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973286|NCT01162486|467865626|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
129973287|NCT01162486|467865622|FG000|Overall Study|elevated LFTs|0|||
129973288|NCT01162486|467865623|FG001|Overall Study|elevated LFTs|0|||
129973289|NCT01162486|467865624|FG002|Overall Study|elevated LFTs|1|||
129973290|NCT01162486|467865625|FG003|Overall Study|elevated LFTs|0|||
129973291|NCT01162486|467865626|FG004|Overall Study|elevated LFTs|0|||
129973292|NCT01162486|467865622|FG000|Overall Study|Pregnancy|0|||
129973293|NCT01162486|467865623|FG001|Overall Study|Pregnancy|0|||
129973294|NCT01162486|467865624|FG002|Overall Study|Pregnancy|0|||
129973295|NCT01162486|467865625|FG003|Overall Study|Pregnancy|1|||
129973296|NCT01162486|467865626|FG004|Overall Study|Pregnancy|0|||
129973297|NCT00760747|467865633|FG000|Study Period II|Adverse Event|3|||
129973298|NCT00760747|467865634|FG001|Study Period II|Adverse Event|4|||
129973299|NCT00760747|467865633|FG000|Study Period II|Lack of Efficacy|0|||
129973300|NCT00760747|467865634|FG001|Study Period II|Lack of Efficacy|6|||
129973301|NCT00760747|467865633|FG000|Study Period II|Parent/Caregiver Decision|3|||
129973302|NCT00760747|467865634|FG001|Study Period II|Parent/Caregiver Decision|0|||
129973303|NCT00760747|467865633|FG000|Study Period II|Protocol Violation|6|||
129973304|NCT00760747|467865634|FG001|Study Period II|Protocol Violation|3|||
129973305|NCT00760747|467865633|FG000|Study Period II|Withdrawal by Subject|1|||
129973306|NCT00760747|467865634|FG001|Study Period II|Withdrawal by Subject|0|||
129973307|NCT00760747|467865633|FG000|Study Period II|No drug administered|0|||
129973308|NCT00760747|467865634|FG001|Study Period II|No drug administered|1|||
129973309|NCT00760747|467865633|FG000|Study Period III|Adverse Event|1|||
129973310|NCT00760747|467865634|FG001|Study Period III|Adverse Event|0|||
129973311|NCT00760747|467865633|FG000|Study Period III|Lack of Efficacy|1|||
129973312|NCT00760747|467865634|FG001|Study Period III|Lack of Efficacy|0|||
129973313|NCT00760747|467865633|FG000|Study Period III|Parent/Caregiver Decision|0|||
129973314|NCT00760747|467865634|FG001|Study Period III|Parent/Caregiver Decision|1|||
129973315|NCT00760747|467865633|FG000|Study Period III|Protocol Violation|1|||
129973316|NCT00760747|467865634|FG001|Study Period III|Protocol Violation|1|||
129973317|NCT00760747|467865633|FG000|Study Period III|Physician Decision|0|||
129973318|NCT00760747|467865634|FG001|Study Period III|Physician Decision|1|||
129469955|NCT01307033|466017190|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
129973319|NCT01443923|467865635|FG000|Overall Study|Adverse Event|1|||
129973320|NCT01443923|467865636|FG001|Overall Study|Adverse Event|0|||
129973321|NCT00108745|467865637|FG000|Overall Study|Withdrawal by Subject|19|||
129973322|NCT00108745|467865638|FG001|Overall Study|Withdrawal by Subject|12|||
129973323|NCT00108745|467865639|FG002|Overall Study|Withdrawal by Subject|12|||
129973324|NCT00108745|467865637|FG000|Overall Study|Never Treated|8|||
129973325|NCT00108745|467865638|FG001|Overall Study|Never Treated|10|||
129973326|NCT00108745|467865639|FG002|Overall Study|Never Treated|12|||
129973327|NCT00108745|467865637|FG000|Overall Study|Ineligible|7|||
129973328|NCT00108745|467865638|FG001|Overall Study|Ineligible|13|||
129973329|NCT00108745|467865639|FG002|Overall Study|Ineligible|13|||
129973330|NCT01889069|467865640|FG000|Overall Study|Death|18|||
129973331|NCT01889069|467865640|FG000|Overall Study|Progression of Disease|14|||
129973332|NCT01889069|467865640|FG000|Overall Study|Lost to Follow-up|6|||
129973333|NCT01889069|467865640|FG000|Overall Study|Other|4|||
129973334|NCT01889069|467865640|FG000|Overall Study|Consent Withdrawal|3|||
129973335|NCT01426347|467865642|FG000|Overall Study|Lost to Follow-up|0|||
129973336|NCT01426347|467865643|FG001|Overall Study|Lost to Follow-up|3|||
129973337|NCT01426347|467865642|FG000|Overall Study|Protocol Violation|2|||
129973338|NCT01426347|467865643|FG001|Overall Study|Protocol Violation|0|||
129973339|NCT01426347|467865642|FG000|Overall Study|Withdrawal by Subject|5|||
129973340|NCT01426347|467865643|FG001|Overall Study|Withdrawal by Subject|0|||
129973341|NCT00455741|467865644|FG000|Overall Study|Physician Decision|0|||
129973342|NCT00455741|467865645|FG001|Overall Study|Physician Decision|1|||
129973343|NCT01245374|467865648|FG000|Overall Study|Protocol Violation|1|||
129973344|NCT01245374|467865648|FG000|Overall Study|Withdrawal by Subject|3|||
129973345|NCT00935532|467865649|FG000|Overall Study|Adverse Event|11|||
129973346|NCT00935532|467865650|FG001|Overall Study|Adverse Event|6|||
129973347|NCT00935532|467865649|FG000|Overall Study|Death|1|||
129973348|NCT00935532|467865650|FG001|Overall Study|Death|0|||
129973349|NCT00935532|467865649|FG000|Overall Study|Lost to Follow-up|1|||
129973350|NCT00935532|467865650|FG001|Overall Study|Lost to Follow-up|0|||
129973351|NCT00935532|467865649|FG000|Overall Study|Physician Decision|1|||
129973352|NCT00935532|467865650|FG001|Overall Study|Physician Decision|2|||
129973353|NCT00935532|467865649|FG000|Overall Study|Protocol Violation|2|||
129973354|NCT00935532|467865650|FG001|Overall Study|Protocol Violation|1|||
129973355|NCT00935532|467865649|FG000|Overall Study|Subject Decision|2|||
129973356|NCT00935532|467865650|FG001|Overall Study|Subject Decision|1|||
129973357|NCT00935532|467865649|FG000|Overall Study|Sponsor Decision|0|||
129973358|NCT00935532|467865650|FG001|Overall Study|Sponsor Decision|1|||
129973359|NCT00935532|467865649|FG000|Overall Study|Loss Glucose Control|4|||
129973360|NCT00935532|467865650|FG001|Overall Study|Loss Glucose Control|0|||
129973361|NCT04954326|467865651|FG000|Overall Study|Protocol Violation|0|||
129973362|NCT04954326|467865652|FG001|Overall Study|Protocol Violation|1|||
129973363|NCT04954326|467865651|FG000|Overall Study|Death|0|||
129973364|NCT04954326|467865652|FG001|Overall Study|Death|2|||
129973365|NCT04954326|467865651|FG000|Overall Study|Physician Decision|0|||
129973366|NCT04954326|467865652|FG001|Overall Study|Physician Decision|1|||
129973367|NCT00475228|467865653|FG000|Overall Study|Lost to Follow-up|17|||
129973368|NCT00475228|467865654|FG001|Overall Study|Lost to Follow-up|17|||
129973369|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Adverse Event|2|||
129973370|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Adverse Event|0|||
129973371|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Adverse Event|0|||
129973372|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Adverse Event|0|||
129973373|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
129973374|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
129973375|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
129973376|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
129973377|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
129973378|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
129973379|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
129973380|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
129973381|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Physician Decision|1|||
129973382|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Physician Decision|0|||
129973383|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Physician Decision|0|||
129973384|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Physician Decision|0|||
129973385|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Pregnancy|1|||
129973386|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Pregnancy|0|||
129973387|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Pregnancy|0|||
129973388|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Pregnancy|0|||
129973389|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
129973390|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
129973391|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129973392|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
129973393|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
129973394|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
129973395|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
129973396|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
129973397|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
129973398|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
129973399|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
129973400|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
129973401|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
129973402|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
129973403|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
129973404|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
129973405|NCT04057573|467867776|FG000|24-Week Double-Blind Period|Not Treated|1|||
129973406|NCT04057573|467867777|FG001|24-Week Double-Blind Period|Not Treated|0|||
129973407|NCT04057573|467867778|FG002|24-Week Double-Blind Period|Not Treated|0|||
129973408|NCT04057573|467867779|FG003|24-Week Double-Blind Period|Not Treated|0|||
129973409|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
129973410|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
129973411|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
129973412|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
129973413|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
129973414|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
129973415|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
129973416|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
129973417|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
129973418|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
129973419|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
129973420|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
129973421|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
129973422|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
129973423|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
129973424|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
129973425|NCT04057573|467867776|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
129973426|NCT04057573|467867777|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
129973427|NCT04057573|467867778|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
129973428|NCT04057573|467867779|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
129973429|NCT01730950|467867784|FG000|Overall Study|Protocol Violation|6|||
129973430|NCT01730950|467867785|FG001|Overall Study|Protocol Violation|6|||
129973431|NCT00667459|467867786|FG000|Overall Study|Death|0|||
129973432|NCT00667459|467867787|FG001|Overall Study|Death|2|||
129973433|NCT00667459|467867786|FG000|Overall Study|Lost to Follow-up|8|||
129973434|NCT00667459|467867787|FG001|Overall Study|Lost to Follow-up|43|||
129973435|NCT00474526|467867788|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
129973436|NCT00474526|467867789|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
129973437|NCT00474526|467867790|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
129973438|NCT00474526|467867791|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
129973439|NCT00474526|467867792|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
129973440|NCT00474526|467867793|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
129973441|NCT00474526|467867794|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
129973442|NCT00474526|467867795|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
129973443|NCT00474526|467867796|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
129973444|NCT00474526|467867797|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
129973445|NCT00474526|467867798|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
129973446|NCT00474526|467867799|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
129973447|NCT00474526|467867800|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
129973448|NCT00474526|467867801|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
129973449|NCT00474526|467867802|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
129973450|NCT00474526|467867803|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
129973451|NCT00474526|467867804|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
129973452|NCT00474526|467867788|FG000|Overall Study|Adverse Event|2|||
129973453|NCT00474526|467867789|FG001|Overall Study|Adverse Event|0|||
129973454|NCT00474526|467867790|FG002|Overall Study|Adverse Event|2|||
129973455|NCT00474526|467867791|FG003|Overall Study|Adverse Event|4|||
129973456|NCT00474526|467867792|FG004|Overall Study|Adverse Event|2|||
129973457|NCT00474526|467867793|FG005|Overall Study|Adverse Event|1|||
129973458|NCT00474526|467867794|FG006|Overall Study|Adverse Event|1|||
129973459|NCT00474526|467867795|FG007|Overall Study|Adverse Event|0|||
129973460|NCT00474526|467867796|FG008|Overall Study|Adverse Event|0|||
129973461|NCT00474526|467867797|FG009|Overall Study|Adverse Event|0|||
129973462|NCT00474526|467867798|FG010|Overall Study|Adverse Event|0|||
129973463|NCT00474526|467867799|FG011|Overall Study|Adverse Event|0|||
129973464|NCT00474526|467867800|FG012|Overall Study|Adverse Event|0|||
129973465|NCT00474526|467867801|FG013|Overall Study|Adverse Event|0|||
129973466|NCT00474526|467867802|FG014|Overall Study|Adverse Event|1|||
129973467|NCT00474526|467867803|FG015|Overall Study|Adverse Event|1|||
129973468|NCT00474526|467867804|FG016|Overall Study|Adverse Event|0|||
129973469|NCT00474526|467867788|FG000|Overall Study|Death|0|||
129973470|NCT00474526|467867789|FG001|Overall Study|Death|0|||
129973471|NCT00474526|467867790|FG002|Overall Study|Death|0|||
129973472|NCT00474526|467867791|FG003|Overall Study|Death|0|||
129973473|NCT00474526|467867792|FG004|Overall Study|Death|0|||
129973474|NCT00474526|467867793|FG005|Overall Study|Death|0|||
129973475|NCT00474526|467867794|FG006|Overall Study|Death|0|||
129973476|NCT00474526|467867795|FG007|Overall Study|Death|0|||
129973477|NCT00474526|467867796|FG008|Overall Study|Death|0|||
129973478|NCT00474526|467867797|FG009|Overall Study|Death|0|||
129973479|NCT00474526|467867798|FG010|Overall Study|Death|0|||
129973480|NCT00474526|467867799|FG011|Overall Study|Death|0|||
129973481|NCT00474526|467867800|FG012|Overall Study|Death|0|||
129973482|NCT00474526|467867801|FG013|Overall Study|Death|3|||
129973483|NCT00474526|467867802|FG014|Overall Study|Death|0|||
129973484|NCT00474526|467867803|FG015|Overall Study|Death|0|||
129973485|NCT00474526|467867804|FG016|Overall Study|Death|0|||
129973486|NCT00474526|467867788|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973487|NCT00474526|467867789|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
129973488|NCT00474526|467867790|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973489|NCT00474526|467867791|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
129973490|NCT00474526|467867792|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
129973491|NCT00474526|467867793|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973492|NCT00474526|467867794|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973493|NCT00474526|467867795|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973494|NCT00474526|467867796|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973495|NCT00474526|467867797|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973496|NCT00474526|467867798|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973497|NCT00474526|467867799|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973498|NCT00474526|467867800|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973499|NCT00474526|467867801|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
129973500|NCT00474526|467867802|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
129973501|NCT00474526|467867803|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973502|NCT00474526|467867804|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
129973503|NCT00474526|467867788|FG000|Overall Study|Lost to Follow-up|8|||
129973504|NCT00474526|467867789|FG001|Overall Study|Lost to Follow-up|6|||
129973505|NCT00474526|467867790|FG002|Overall Study|Lost to Follow-up|13|||
129973506|NCT00474526|467867791|FG003|Overall Study|Lost to Follow-up|29|||
129973507|NCT00474526|467867792|FG004|Overall Study|Lost to Follow-up|11|||
129973508|NCT00474526|467867793|FG005|Overall Study|Lost to Follow-up|5|||
129973509|NCT00474526|467867794|FG006|Overall Study|Lost to Follow-up|8|||
129973510|NCT00474526|467867795|FG007|Overall Study|Lost to Follow-up|1|||
129973511|NCT00474526|467867796|FG008|Overall Study|Lost to Follow-up|0|||
129973512|NCT00474526|467867797|FG009|Overall Study|Lost to Follow-up|6|||
129973513|NCT00474526|467867798|FG010|Overall Study|Lost to Follow-up|2|||
129973514|NCT00474526|467867799|FG011|Overall Study|Lost to Follow-up|4|||
129973515|NCT00474526|467867800|FG012|Overall Study|Lost to Follow-up|6|||
129973516|NCT00474526|467867801|FG013|Overall Study|Lost to Follow-up|74|||
129973517|NCT00474526|467867802|FG014|Overall Study|Lost to Follow-up|29|||
129973518|NCT00474526|467867803|FG015|Overall Study|Lost to Follow-up|4|||
129973519|NCT00474526|467867804|FG016|Overall Study|Lost to Follow-up|5|||
129973520|NCT00474526|467867788|FG000|Overall Study|Protocol Violation|2|||
129973521|NCT00474526|467867789|FG001|Overall Study|Protocol Violation|6|||
129973522|NCT00474526|467867790|FG002|Overall Study|Protocol Violation|4|||
129973523|NCT00474526|467867791|FG003|Overall Study|Protocol Violation|12|||
129973524|NCT00474526|467867792|FG004|Overall Study|Protocol Violation|3|||
129973525|NCT00474526|467867793|FG005|Overall Study|Protocol Violation|1|||
129973526|NCT00474526|467867794|FG006|Overall Study|Protocol Violation|3|||
129973527|NCT00474526|467867795|FG007|Overall Study|Protocol Violation|0|||
129973528|NCT00474526|467867796|FG008|Overall Study|Protocol Violation|0|||
129973529|NCT00474526|467867797|FG009|Overall Study|Protocol Violation|4|||
129973530|NCT00474526|467867798|FG010|Overall Study|Protocol Violation|2|||
129973531|NCT00474526|467867799|FG011|Overall Study|Protocol Violation|2|||
129973532|NCT00474526|467867800|FG012|Overall Study|Protocol Violation|4|||
129973533|NCT00474526|467867801|FG013|Overall Study|Protocol Violation|19|||
129973534|NCT00474526|467867802|FG014|Overall Study|Protocol Violation|9|||
129973535|NCT00474526|467867803|FG015|Overall Study|Protocol Violation|6|||
129973536|NCT00474526|467867804|FG016|Overall Study|Protocol Violation|2|||
129973537|NCT00474526|467867788|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
129973538|NCT00474526|467867789|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
129973539|NCT00474526|467867790|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
129973540|NCT00474526|467867791|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
129973541|NCT00474526|467867792|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
129973542|NCT00474526|467867793|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
129973543|NCT00474526|467867794|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
129973544|NCT00474526|467867795|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
129973545|NCT00474526|467867796|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
129973546|NCT00474526|467867797|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
129973547|NCT00474526|467867798|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
129973548|NCT00474526|467867799|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
129973549|NCT00474526|467867800|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
129973550|NCT00474526|467867801|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
129973551|NCT00474526|467867802|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
129973552|NCT00474526|467867803|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
129973553|NCT00474526|467867804|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
129973554|NCT00474526|467867788|FG000|Overall Study|Withdrawal by Subject|9|||
129973555|NCT00474526|467867789|FG001|Overall Study|Withdrawal by Subject|24|||
129973556|NCT00474526|467867790|FG002|Overall Study|Withdrawal by Subject|21|||
129973557|NCT00474526|467867791|FG003|Overall Study|Withdrawal by Subject|52|||
129973558|NCT00474526|467867792|FG004|Overall Study|Withdrawal by Subject|38|||
129973559|NCT00474526|467867793|FG005|Overall Study|Withdrawal by Subject|6|||
129973560|NCT00474526|467867794|FG006|Overall Study|Withdrawal by Subject|12|||
129973561|NCT00474526|467867795|FG007|Overall Study|Withdrawal by Subject|4|||
129973562|NCT00474526|467867796|FG008|Overall Study|Withdrawal by Subject|4|||
129973563|NCT00474526|467867797|FG009|Overall Study|Withdrawal by Subject|13|||
129973564|NCT00474526|467867798|FG010|Overall Study|Withdrawal by Subject|5|||
129973565|NCT00474526|467867799|FG011|Overall Study|Withdrawal by Subject|4|||
129973566|NCT00474526|467867800|FG012|Overall Study|Withdrawal by Subject|4|||
129973567|NCT00474526|467867801|FG013|Overall Study|Withdrawal by Subject|37|||
129973568|NCT00474526|467867802|FG014|Overall Study|Withdrawal by Subject|22|||
129973569|NCT00474526|467867803|FG015|Overall Study|Withdrawal by Subject|1|||
129973570|NCT00474526|467867804|FG016|Overall Study|Withdrawal by Subject|1|||
129973571|NCT01251770|467867807|FG000|Overall Study|Protocol Violation|13|||
129973572|NCT01251770|467867808|FG001|Overall Study|Protocol Violation|7|||
129973573|NCT02460575|467867812|FG000|Overall Study|Lost to Follow-up|1|||
129973574|NCT02460575|467867813|FG001|Overall Study|Lost to Follow-up|0|||
129973575|NCT04307940|467867814|FG000|Overall Study|Adverse Event|1|||
129973576|NCT04307940|467867815|FG001|Overall Study|Adverse Event|0|||
129973577|NCT04307940|467867816|FG002|Overall Study|Adverse Event|0|||
129973578|NCT04307940|467867814|FG000|Overall Study|Withdrawal by Subject|2|||
129973579|NCT04307940|467867815|FG001|Overall Study|Withdrawal by Subject|3|||
129973580|NCT04307940|467867816|FG002|Overall Study|Withdrawal by Subject|1|||
129973581|NCT04307940|467867814|FG000|Overall Study|Lost to Follow-up|2|||
129973582|NCT04307940|467867815|FG001|Overall Study|Lost to Follow-up|0|||
129973583|NCT04307940|467867816|FG002|Overall Study|Lost to Follow-up|1|||
129973584|NCT05543174|467867817|FG000|Overall Study|Ongoing|7|||
129973585|NCT01270828|467867818|FG000|Pregabalin CR SB|Reason Unspecified|0|||
129973586|NCT01270828|467867819|FG001|Pregabalin CR SB|Reason Unspecified|0|||
129973587|NCT01270828|467867820|FG002|Pregabalin CR SB|Reason Unspecified|8|||
129973588|NCT01270828|467867818|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
129973589|NCT01270828|467867819|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
129973590|NCT01270828|467867820|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
129973591|NCT01270828|467867818|FG000|Pregabalin CR SB|Related adverse event|0|||
129973592|NCT01270828|467867819|FG001|Pregabalin CR SB|Related adverse event|0|||
129973593|NCT01270828|467867820|FG002|Pregabalin CR SB|Related adverse event|46|||
129973594|NCT01270828|467867818|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
129973595|NCT01270828|467867819|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
129973596|NCT01270828|467867820|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
129973597|NCT01270828|467867818|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
129973598|NCT01270828|467867819|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
129973599|NCT01270828|467867820|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
129973600|NCT01270828|467867818|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
129973601|NCT01270828|467867819|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
129973602|NCT01270828|467867820|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
129973603|NCT01270828|467867818|FG000|Pregabalin CR SB|Unrelated AE|0|||
129973604|NCT01270828|467867819|FG001|Pregabalin CR SB|Unrelated AE|0|||
129973605|NCT01270828|467867820|FG002|Pregabalin CR SB|Unrelated AE|8|||
129973606|NCT01270828|467867818|FG000|Pregabalin CR SB|Protocol Violation|0|||
129973607|NCT01270828|467867819|FG001|Pregabalin CR SB|Protocol Violation|0|||
129973608|NCT01270828|467867820|FG002|Pregabalin CR SB|Protocol Violation|8|||
129973609|NCT01270828|467867818|FG000|Double Blind Phase|Death|0|||
129973610|NCT01270828|467867819|FG001|Double Blind Phase|Death|1|||
129469956|NCT01307033|466017191|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
129973611|NCT01270828|467867820|FG002|Double Blind Phase|Death|0|||
129973612|NCT01270828|467867818|FG000|Double Blind Phase|Protocol Violation|0|||
129973613|NCT01270828|467867819|FG001|Double Blind Phase|Protocol Violation|1|||
129973614|NCT01270828|467867820|FG002|Double Blind Phase|Protocol Violation|0|||
129973615|NCT01270828|467867818|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
129973616|NCT01270828|467867819|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
129973617|NCT01270828|467867820|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
129973618|NCT01270828|467867818|FG000|Double Blind Phase|Reason Unspecified|7|||
129973619|NCT01270828|467867819|FG001|Double Blind Phase|Reason Unspecified|4|||
129973620|NCT01270828|467867820|FG002|Double Blind Phase|Reason Unspecified|0|||
129973621|NCT01270828|467867818|FG000|Double Blind Phase|Withdrawal by Subject|6|||
129973622|NCT01270828|467867819|FG001|Double Blind Phase|Withdrawal by Subject|15|||
129973623|NCT01270828|467867820|FG002|Double Blind Phase|Withdrawal by Subject|0|||
129973624|NCT01270828|467867818|FG000|Double Blind Phase|Lost to Follow-up|1|||
129973625|NCT01270828|467867819|FG001|Double Blind Phase|Lost to Follow-up|2|||
129973626|NCT01270828|467867820|FG002|Double Blind Phase|Lost to Follow-up|0|||
129973627|NCT01270828|467867818|FG000|Double Blind Phase|Lack of Efficacy|2|||
129973628|NCT01270828|467867819|FG001|Double Blind Phase|Lack of Efficacy|11|||
129973629|NCT01270828|467867820|FG002|Double Blind Phase|Lack of Efficacy|0|||
129973630|NCT01270828|467867818|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
129973631|NCT01270828|467867819|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
129973632|NCT01270828|467867820|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
129973633|NCT01270828|467867818|FG000|Double Blind Phase|Adverse event related to study drug|5|||
129973634|NCT01270828|467867819|FG001|Double Blind Phase|Adverse event related to study drug|7|||
129973635|NCT01270828|467867820|FG002|Double Blind Phase|Adverse event related to study drug|0|||
129973636|NCT02963090|467867821|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
129973637|NCT02963090|467867822|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
129973638|NCT04497389|467867823|FG000|Overall Study|Withdrawal by Subject|1|||
129973639|NCT04497389|467867824|FG001|Overall Study|Withdrawal by Subject|0|||
129973640|NCT03322540|467867826|FG000|Overall Study|Death|21|||
129973641|NCT03322540|467867827|FG001|Overall Study|Death|28|||
129973642|NCT03322540|467867826|FG000|Overall Study|Lost to Follow-up|0|||
129973643|NCT03322540|467867827|FG001|Overall Study|Lost to Follow-up|1|||
129973644|NCT03322540|467867826|FG000|Overall Study|Physician Decision|7|||
129973645|NCT03322540|467867827|FG001|Overall Study|Physician Decision|6|||
129973646|NCT03322540|467867826|FG000|Overall Study|Withdrawal by Subject|3|||
129973647|NCT03322540|467867827|FG001|Overall Study|Withdrawal by Subject|1|||
129469957|NCT01307033|466017192|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
129469958|NCT01307033|466017189|FG000|44-week Open-label Extension|Adverse Event|0|||
129469959|NCT01307033|466017190|FG001|44-week Open-label Extension|Adverse Event|0|||
129469960|NCT01307033|466017191|FG002|44-week Open-label Extension|Adverse Event|2|||
129469961|NCT01307033|466017192|FG003|44-week Open-label Extension|Adverse Event|1|||
129469962|NCT01307033|466017189|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
129469963|NCT01307033|466017190|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
129469964|NCT01307033|466017191|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
129469965|NCT01307033|466017192|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
129469966|NCT01307033|466017189|FG000|44-week Open-label Extension|Physician Decision|0|||
129469967|NCT01307033|466017190|FG001|44-week Open-label Extension|Physician Decision|0|||
129469968|NCT01307033|466017191|FG002|44-week Open-label Extension|Physician Decision|1|||
129469969|NCT01307033|466017192|FG003|44-week Open-label Extension|Physician Decision|0|||
129469970|NCT01307033|466017189|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
129469971|NCT01307033|466017190|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
129469972|NCT01307033|466017191|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
129469973|NCT01307033|466017192|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
129469974|NCT01307033|466017189|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
129469975|NCT01307033|466017190|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
129469976|NCT01307033|466017191|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
129469977|NCT01307033|466017192|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
129469978|NCT01307033|466017189|FG000|44-week Open-label Extension|Death|0|||
129469979|NCT01307033|466017190|FG001|44-week Open-label Extension|Death|0|||
129469980|NCT01307033|466017191|FG002|44-week Open-label Extension|Death|0|||
129469981|NCT01307033|466017192|FG003|44-week Open-label Extension|Death|1|||
129469982|NCT01231555|466017193|FG000|Overall Study|Study terminated|8|||
129469983|NCT01231555|466017194|FG001|Overall Study|Study terminated|5|||
129469984|NCT01231555|466017195|FG002|Overall Study|Study terminated|8|||
129469985|NCT01231555|466017193|FG000|Overall Study|Withdrawal by Subject|0|||
129469986|NCT01231555|466017194|FG001|Overall Study|Withdrawal by Subject|2|||
129469987|NCT01231555|466017195|FG002|Overall Study|Withdrawal by Subject|0|||
129469988|NCT00927368|466017200|FG000|Overall Study|enrollment in another study|1|||
129469989|NCT00927368|466017201|FG001|Overall Study|enrollment in another study|1|||
129469990|NCT00927368|466017202|FG002|Overall Study|enrollment in another study|2|||
129469991|NCT00927368|466017200|FG000|Overall Study|Lost to Follow-up|4|||
129469992|NCT00927368|466017201|FG001|Overall Study|Lost to Follow-up|0|||
129469993|NCT00927368|466017202|FG002|Overall Study|Lost to Follow-up|0|||
129469994|NCT00927368|466017200|FG000|Overall Study|equipment failure|1|||
129469995|NCT00927368|466017201|FG001|Overall Study|equipment failure|0|||
129469996|NCT00927368|466017202|FG002|Overall Study|equipment failure|0|||
129469997|NCT00927368|466017200|FG000|Overall Study|ineligible post randomization|0|||
129469998|NCT00927368|466017201|FG001|Overall Study|ineligible post randomization|3|||
129469999|NCT00927368|466017202|FG002|Overall Study|ineligible post randomization|1|||
129470000|NCT00927368|466017200|FG000|Overall Study|cancellation of surgery|0|||
129470001|NCT00927368|466017201|FG001|Overall Study|cancellation of surgery|1|||
129470002|NCT00927368|466017202|FG002|Overall Study|cancellation of surgery|2|||
129973648|NCT03322540|467867826|FG000|Overall Study|Study terminated by sponsor|0|||
129470003|NCT00331409|466017203|FG000|Overall Study|Lack of Efficacy|4|||
129470004|NCT00234039|466017204|FG000|Overall Study|Adverse Event|2|||
129470005|NCT00234039|466017204|FG000|Overall Study|Progression/relapse|34|||
129470006|NCT00234039|466017204|FG000|Overall Study|Other - Not Protocol Specified|3|||
129470007|NCT00234039|466017204|FG000|Overall Study|Ineligible|9|||
129470008|NCT00234039|466017204|FG000|Overall Study|No Protocol Treatment Received|2|||
129470009|NCT03683394|466017205|FG000|Overall Study|Withdrawal by Subject|4|||
129470010|NCT03683394|466017206|FG001|Overall Study|Withdrawal by Subject|8|||
129470011|NCT03683394|466017205|FG000|Overall Study|Lost to Follow-up|7|||
129470012|NCT03683394|466017206|FG001|Overall Study|Lost to Follow-up|0|||
129470013|NCT03683394|466017205|FG000|Overall Study|Death|3|||
129470014|NCT03683394|466017206|FG001|Overall Study|Death|1|||
129470015|NCT00559273|466017207|FG000|Correction Period (20 Weeks)|Death|3|||
129470016|NCT00559273|466017208|FG001|Correction Period (20 Weeks)|Death|4|||
129470017|NCT00559273|466017207|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
129470018|NCT00559273|466017208|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
129470019|NCT00559273|466017207|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
129470020|NCT00559273|466017208|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
129470021|NCT00559273|466017207|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
129470022|NCT00559273|466017208|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
129470023|NCT00559273|466017207|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
129470024|NCT00559273|466017208|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
129470025|NCT00559273|466017207|FG000|Evaluation Period (8 Weeks)|Death|1|||
129470026|NCT00559273|466017208|FG001|Evaluation Period (8 Weeks)|Death|3|||
129470027|NCT00559273|466017207|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
129470028|NCT00559273|466017208|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
129470029|NCT00559273|466017207|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
129470030|NCT00559273|466017208|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
129470031|NCT00559273|466017207|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
129470032|NCT00559273|466017208|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
129470033|NCT00395967|466017209|FG000|Treatment Period|Failed Mobilization|1|||
129470034|NCT00395967|466017209|FG000|Follow-up Period|Death|1|||
129470035|NCT00395967|466017209|FG000|Follow-up Period|Lost to Follow-up|1|||
129470036|NCT01109940|466017214|FG000|Overall Study|Administrative problems|2|||
129470037|NCT01109940|466017215|FG001|Overall Study|Administrative problems|0|||
129470038|NCT01109940|466017216|FG002|Overall Study|Administrative problems|0|||
129470039|NCT01109940|466017217|FG003|Overall Study|Administrative problems|0|||
129470040|NCT01109940|466017214|FG000|Overall Study|Serious Adverse Event|2|||
129470041|NCT01109940|466017215|FG001|Overall Study|Serious Adverse Event|1|||
129470042|NCT01109940|466017216|FG002|Overall Study|Serious Adverse Event|0|||
129470043|NCT01109940|466017217|FG003|Overall Study|Serious Adverse Event|0|||
129470044|NCT01109940|466017214|FG000|Overall Study|Lost to Follow-up|1|||
129470045|NCT01109940|466017215|FG001|Overall Study|Lost to Follow-up|0|||
129470046|NCT01109940|466017216|FG002|Overall Study|Lost to Follow-up|0|||
129470047|NCT01109940|466017217|FG003|Overall Study|Lost to Follow-up|0|||
129470048|NCT01109940|466017214|FG000|Overall Study|Patient withdrew consent|1|||
129470049|NCT01109940|466017215|FG001|Overall Study|Patient withdrew consent|1|||
129470050|NCT01109940|466017216|FG002|Overall Study|Patient withdrew consent|0|||
129470051|NCT01109940|466017217|FG003|Overall Study|Patient withdrew consent|0|||
129470052|NCT01109940|466017214|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129470053|NCT01109940|466017215|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129470054|NCT01109940|466017216|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
129470055|NCT01109940|466017217|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129470056|NCT03653390|466017218|FG000|Overall Study|Lost to Follow-up|12|||
129470057|NCT03653390|466017219|FG001|Overall Study|Lost to Follow-up|8|||
129470058|NCT03653390|466017220|FG002|Overall Study|Lost to Follow-up|7|||
129470059|NCT03653390|466017218|FG000|Overall Study|Withdrawal by Subject|6|||
129470060|NCT03653390|466017219|FG001|Overall Study|Withdrawal by Subject|1|||
129470061|NCT03653390|466017220|FG002|Overall Study|Withdrawal by Subject|1|||
129470062|NCT03653390|466017218|FG000|Overall Study|Death|1|||
129470063|NCT03653390|466017219|FG001|Overall Study|Death|0|||
129470064|NCT03653390|466017220|FG002|Overall Study|Death|0|||
129470065|NCT03653390|466017218|FG000|Overall Study|Paper Survey Lost|1|||
129470066|NCT03653390|466017219|FG001|Overall Study|Paper Survey Lost|0|||
129470067|NCT03653390|466017220|FG002|Overall Study|Paper Survey Lost|0|||
129470068|NCT03118947|466017221|FG000|Overall Study|Adverse Event|7|||
129470069|NCT03118947|466017221|FG000|Overall Study|Death|3|||
129470070|NCT03118947|466017221|FG000|Overall Study|Lack of Efficacy|4|||
129470071|NCT03118947|466017221|FG000|Overall Study|Non-compliance with study drug|1|||
129470072|NCT03118947|466017221|FG000|Overall Study|Protocol Violation|2|||
129470073|NCT03118947|466017221|FG000|Overall Study|Withdrawal by Subject|3|||
129470074|NCT03118947|466017221|FG000|Overall Study|Withdrawal by caregiver|3|||
129470075|NCT03118947|466017221|FG000|Overall Study|Change in patient's living situation|4|||
129470076|NCT03118947|466017221|FG000|Overall Study|Lost to Follow-up|2|||
129470077|NCT01262976|466017224|FG000|Up to Month 2|Serious Adverse Event|0|||
129470078|NCT01262976|466017225|FG001|Up to Month 2|Serious Adverse Event|0|||
129470079|NCT01262976|466017226|FG002|Up to Month 2|Serious Adverse Event|1|||
129470080|NCT01262976|466017227|FG003|Up to Month 2|Serious Adverse Event|0|||
129470081|NCT01262976|466017228|FG004|Up to Month 2|Serious Adverse Event|0|||
129470082|NCT01262976|466017229|FG005|Up to Month 2|Serious Adverse Event|0|||
129470083|NCT01262976|466017224|FG000|Up to Month 2|Withdrawal by Subject|1|||
129470084|NCT01262976|466017225|FG001|Up to Month 2|Withdrawal by Subject|0|||
129470085|NCT01262976|466017226|FG002|Up to Month 2|Withdrawal by Subject|0|||
129470086|NCT01262976|466017227|FG003|Up to Month 2|Withdrawal by Subject|0|||
129470087|NCT01262976|466017228|FG004|Up to Month 2|Withdrawal by Subject|0|||
129470088|NCT01262976|466017229|FG005|Up to Month 2|Withdrawal by Subject|0|||
129470089|NCT01262976|466017224|FG000|Up to Month 2|Migrated/moved from study area|0|||
129470090|NCT01262976|466017225|FG001|Up to Month 2|Migrated/moved from study area|1|||
129470091|NCT01262976|466017226|FG002|Up to Month 2|Migrated/moved from study area|0|||
129470092|NCT01262976|466017227|FG003|Up to Month 2|Migrated/moved from study area|0|||
129470093|NCT01262976|466017228|FG004|Up to Month 2|Migrated/moved from study area|1|||
129470094|NCT01262976|466017229|FG005|Up to Month 2|Migrated/moved from study area|1|||
129470095|NCT01262976|466017224|FG000|Up to Month 2|Lost to Follow-up|1|||
129470096|NCT01262976|466017225|FG001|Up to Month 2|Lost to Follow-up|0|||
129470097|NCT01262976|466017226|FG002|Up to Month 2|Lost to Follow-up|0|||
129470098|NCT01262976|466017227|FG003|Up to Month 2|Lost to Follow-up|1|||
129470099|NCT01262976|466017228|FG004|Up to Month 2|Lost to Follow-up|1|||
129470100|NCT01262976|466017229|FG005|Up to Month 2|Lost to Follow-up|1|||
129470101|NCT01262976|466017224|FG000|Up to Month 2|Other|1|||
129470102|NCT01262976|466017225|FG001|Up to Month 2|Other|0|||
129470103|NCT01262976|466017226|FG002|Up to Month 2|Other|0|||
129470104|NCT01262976|466017227|FG003|Up to Month 2|Other|1|||
129470105|NCT01262976|466017228|FG004|Up to Month 2|Other|0|||
129470106|NCT01262976|466017229|FG005|Up to Month 2|Other|2|||
129470107|NCT01262976|466017224|FG000|Up to Month 7|Serious Adverse Event|0|||
129470108|NCT01262976|466017225|FG001|Up to Month 7|Serious Adverse Event|0|||
129470109|NCT01262976|466017226|FG002|Up to Month 7|Serious Adverse Event|2|||
129470110|NCT01262976|466017227|FG003|Up to Month 7|Serious Adverse Event|0|||
129470111|NCT01262976|466017228|FG004|Up to Month 7|Serious Adverse Event|0|||
129470112|NCT01262976|466017229|FG005|Up to Month 7|Serious Adverse Event|0|||
129470113|NCT01262976|466017224|FG000|Up to Month 7|Withdrawal by Subject|1|||
129470114|NCT01262976|466017225|FG001|Up to Month 7|Withdrawal by Subject|0|||
129470115|NCT01262976|466017226|FG002|Up to Month 7|Withdrawal by Subject|0|||
129470116|NCT01262976|466017227|FG003|Up to Month 7|Withdrawal by Subject|0|||
129470117|NCT01262976|466017228|FG004|Up to Month 7|Withdrawal by Subject|0|||
129470118|NCT01262976|466017229|FG005|Up to Month 7|Withdrawal by Subject|0|||
129470119|NCT01262976|466017224|FG000|Up to Month 7|Migrated/moved from study area|0|||
129470120|NCT01262976|466017225|FG001|Up to Month 7|Migrated/moved from study area|0|||
129470121|NCT01262976|466017226|FG002|Up to Month 7|Migrated/moved from study area|1|||
129470122|NCT01262976|466017227|FG003|Up to Month 7|Migrated/moved from study area|3|||
129470123|NCT01262976|466017228|FG004|Up to Month 7|Migrated/moved from study area|1|||
129470124|NCT01262976|466017229|FG005|Up to Month 7|Migrated/moved from study area|1|||
129470125|NCT01262976|466017224|FG000|Up to Month 7|Lost to Follow-up|1|||
129470126|NCT01262976|466017225|FG001|Up to Month 7|Lost to Follow-up|0|||
129470127|NCT01262976|466017226|FG002|Up to Month 7|Lost to Follow-up|1|||
129470128|NCT01262976|466017227|FG003|Up to Month 7|Lost to Follow-up|3|||
129470129|NCT01262976|466017228|FG004|Up to Month 7|Lost to Follow-up|1|||
129470130|NCT01262976|466017229|FG005|Up to Month 7|Lost to Follow-up|3|||
129470131|NCT01262976|466017224|FG000|Up to Month 7|Other|3|||
129470132|NCT01262976|466017225|FG001|Up to Month 7|Other|0|||
129470133|NCT01262976|466017226|FG002|Up to Month 7|Other|2|||
129470134|NCT01262976|466017227|FG003|Up to Month 7|Other|0|||
129470135|NCT01262976|466017228|FG004|Up to Month 7|Other|0|||
129470136|NCT01262976|466017229|FG005|Up to Month 7|Other|0|||
129470137|NCT01262976|466017224|FG000|Up to Year 1|Serious Adverse Event|0|||
129470138|NCT01262976|466017225|FG001|Up to Year 1|Serious Adverse Event|0|||
129470139|NCT01262976|466017226|FG002|Up to Year 1|Serious Adverse Event|2|||
129470140|NCT01262976|466017227|FG003|Up to Year 1|Serious Adverse Event|0|||
129470141|NCT01262976|466017228|FG004|Up to Year 1|Serious Adverse Event|0|||
129470142|NCT01262976|466017229|FG005|Up to Year 1|Serious Adverse Event|0|||
129470143|NCT01262976|466017224|FG000|Up to Year 1|Withdrawal by Subject|1|||
129470144|NCT01262976|466017225|FG001|Up to Year 1|Withdrawal by Subject|0|||
129470145|NCT01262976|466017226|FG002|Up to Year 1|Withdrawal by Subject|0|||
129470146|NCT01262976|466017227|FG003|Up to Year 1|Withdrawal by Subject|0|||
129470147|NCT01262976|466017228|FG004|Up to Year 1|Withdrawal by Subject|0|||
129470148|NCT01262976|466017229|FG005|Up to Year 1|Withdrawal by Subject|0|||
129470149|NCT01262976|466017224|FG000|Up to Year 1|Migrated/moved from study area|1|||
129470150|NCT01262976|466017225|FG001|Up to Year 1|Migrated/moved from study area|0|||
129470151|NCT01262976|466017226|FG002|Up to Year 1|Migrated/moved from study area|0|||
129470152|NCT01262976|466017227|FG003|Up to Year 1|Migrated/moved from study area|3|||
129470153|NCT01262976|466017228|FG004|Up to Year 1|Migrated/moved from study area|3|||
129470154|NCT01262976|466017229|FG005|Up to Year 1|Migrated/moved from study area|2|||
129470155|NCT01262976|466017224|FG000|Up to Year 1|Lost to Follow-up|4|||
129470156|NCT01262976|466017225|FG001|Up to Year 1|Lost to Follow-up|0|||
129470157|NCT01262976|466017226|FG002|Up to Year 1|Lost to Follow-up|0|||
129470158|NCT01262976|466017227|FG003|Up to Year 1|Lost to Follow-up|1|||
129470159|NCT01262976|466017228|FG004|Up to Year 1|Lost to Follow-up|6|||
129470160|NCT01262976|466017229|FG005|Up to Year 1|Lost to Follow-up|5|||
129470161|NCT01262976|466017224|FG000|Up to Year 1|Other|3|||
129470162|NCT01262976|466017225|FG001|Up to Year 1|Other|1|||
129470163|NCT01262976|466017226|FG002|Up to Year 1|Other|0|||
129470164|NCT01262976|466017227|FG003|Up to Year 1|Other|0|||
129470165|NCT01262976|466017228|FG004|Up to Year 1|Other|2|||
129470166|NCT01262976|466017229|FG005|Up to Year 1|Other|1|||
129470167|NCT01262976|466017224|FG000|Up to Year 1|Subjects with unknown completion status|0|||
129470168|NCT01262976|466017225|FG001|Up to Year 1|Subjects with unknown completion status|0|||
129470169|NCT01262976|466017226|FG002|Up to Year 1|Subjects with unknown completion status|1|||
129470170|NCT01262976|466017227|FG003|Up to Year 1|Subjects with unknown completion status|0|||
129470171|NCT01262976|466017228|FG004|Up to Year 1|Subjects with unknown completion status|0|||
129470172|NCT01262976|466017229|FG005|Up to Year 1|Subjects with unknown completion status|1|||
129470173|NCT01262976|466017224|FG000|Up to Year 2|Serious Adverse Event|0|||
129470174|NCT01262976|466017225|FG001|Up to Year 2|Serious Adverse Event|0|||
129470175|NCT01262976|466017226|FG002|Up to Year 2|Serious Adverse Event|2|||
129470176|NCT01262976|466017227|FG003|Up to Year 2|Serious Adverse Event|0|||
129470177|NCT01262976|466017228|FG004|Up to Year 2|Serious Adverse Event|0|||
129470178|NCT01262976|466017229|FG005|Up to Year 2|Serious Adverse Event|0|||
129470179|NCT01262976|466017224|FG000|Up to Year 2|Withdrawal by Subject|1|||
129470180|NCT01262976|466017225|FG001|Up to Year 2|Withdrawal by Subject|0|||
129470181|NCT01262976|466017226|FG002|Up to Year 2|Withdrawal by Subject|0|||
129470182|NCT01262976|466017227|FG003|Up to Year 2|Withdrawal by Subject|0|||
129470183|NCT01262976|466017228|FG004|Up to Year 2|Withdrawal by Subject|0|||
129470184|NCT01262976|466017229|FG005|Up to Year 2|Withdrawal by Subject|0|||
129470185|NCT01262976|466017224|FG000|Up to Year 2|Migrated/moved from study area|0|||
129470186|NCT01262976|466017225|FG001|Up to Year 2|Migrated/moved from study area|0|||
129470187|NCT01262976|466017226|FG002|Up to Year 2|Migrated/moved from study area|0|||
129470188|NCT01262976|466017227|FG003|Up to Year 2|Migrated/moved from study area|2|||
129470189|NCT01262976|466017228|FG004|Up to Year 2|Migrated/moved from study area|1|||
129470190|NCT01262976|466017229|FG005|Up to Year 2|Migrated/moved from study area|2|||
129470191|NCT01262976|466017224|FG000|Up to Year 2|Lost to Follow-up|1|||
129470192|NCT01262976|466017225|FG001|Up to Year 2|Lost to Follow-up|1|||
129470193|NCT01262976|466017226|FG002|Up to Year 2|Lost to Follow-up|2|||
129470194|NCT01262976|466017227|FG003|Up to Year 2|Lost to Follow-up|2|||
129470195|NCT01262976|466017228|FG004|Up to Year 2|Lost to Follow-up|3|||
129470196|NCT01262976|466017229|FG005|Up to Year 2|Lost to Follow-up|3|||
129470197|NCT01262976|466017224|FG000|Up to Year 2|Subjects with unknown completion status|0|||
129470198|NCT01262976|466017225|FG001|Up to Year 2|Subjects with unknown completion status|0|||
129470199|NCT01262976|466017226|FG002|Up to Year 2|Subjects with unknown completion status|1|||
129470200|NCT01262976|466017227|FG003|Up to Year 2|Subjects with unknown completion status|0|||
129470201|NCT01262976|466017228|FG004|Up to Year 2|Subjects with unknown completion status|0|||
129470202|NCT01262976|466017229|FG005|Up to Year 2|Subjects with unknown completion status|0|||
129470203|NCT01262976|466017224|FG000|Up to Year 2|Other|3|||
129470204|NCT01262976|466017225|FG001|Up to Year 2|Other|0|||
129470205|NCT01262976|466017226|FG002|Up to Year 2|Other|0|||
129470206|NCT01262976|466017227|FG003|Up to Year 2|Other|0|||
129470207|NCT01262976|466017228|FG004|Up to Year 2|Other|0|||
129470208|NCT01262976|466017229|FG005|Up to Year 2|Other|0|||
129470209|NCT01262976|466017224|FG000|Up to Year 3|Serious Adverse Event|0|||
129470210|NCT01262976|466017225|FG001|Up to Year 3|Serious Adverse Event|0|||
129470211|NCT01262976|466017226|FG002|Up to Year 3|Serious Adverse Event|2|||
129470212|NCT01262976|466017227|FG003|Up to Year 3|Serious Adverse Event|0|||
129470213|NCT01262976|466017228|FG004|Up to Year 3|Serious Adverse Event|0|||
129470214|NCT01262976|466017229|FG005|Up to Year 3|Serious Adverse Event|0|||
129973649|NCT03322540|467867827|FG001|Overall Study|Study terminated by sponsor|1|||
129470215|NCT01262976|466017224|FG000|Up to Year 3|Withdrawal by Subject|1|||
129470216|NCT01262976|466017225|FG001|Up to Year 3|Withdrawal by Subject|0|||
129470217|NCT01262976|466017226|FG002|Up to Year 3|Withdrawal by Subject|0|||
129470218|NCT01262976|466017227|FG003|Up to Year 3|Withdrawal by Subject|0|||
129470219|NCT01262976|466017228|FG004|Up to Year 3|Withdrawal by Subject|0|||
129470220|NCT01262976|466017229|FG005|Up to Year 3|Withdrawal by Subject|0|||
129470221|NCT01262976|466017224|FG000|Up to Year 3|Migrated/moved from study area|0|||
129470222|NCT01262976|466017225|FG001|Up to Year 3|Migrated/moved from study area|0|||
129470223|NCT01262976|466017226|FG002|Up to Year 3|Migrated/moved from study area|0|||
129470224|NCT01262976|466017227|FG003|Up to Year 3|Migrated/moved from study area|2|||
129470225|NCT01262976|466017228|FG004|Up to Year 3|Migrated/moved from study area|1|||
129470226|NCT01262976|466017229|FG005|Up to Year 3|Migrated/moved from study area|1|||
129470227|NCT01262976|466017224|FG000|Up to Year 3|Lost to Follow-up|2|||
129470228|NCT01262976|466017225|FG001|Up to Year 3|Lost to Follow-up|2|||
129470229|NCT01262976|466017226|FG002|Up to Year 3|Lost to Follow-up|4|||
129470230|NCT01262976|466017227|FG003|Up to Year 3|Lost to Follow-up|3|||
129470231|NCT01262976|466017228|FG004|Up to Year 3|Lost to Follow-up|1|||
129470232|NCT01262976|466017229|FG005|Up to Year 3|Lost to Follow-up|3|||
129470233|NCT01262976|466017224|FG000|Up to Year 3|Subjects with unknown completion status|0|||
129470234|NCT01262976|466017225|FG001|Up to Year 3|Subjects with unknown completion status|0|||
129470235|NCT01262976|466017226|FG002|Up to Year 3|Subjects with unknown completion status|1|||
129470236|NCT01262976|466017227|FG003|Up to Year 3|Subjects with unknown completion status|0|||
129470237|NCT01262976|466017228|FG004|Up to Year 3|Subjects with unknown completion status|0|||
129470238|NCT01262976|466017229|FG005|Up to Year 3|Subjects with unknown completion status|0|||
129470239|NCT01262976|466017224|FG000|Up to Year 3|Other|3|||
129470240|NCT01262976|466017225|FG001|Up to Year 3|Other|0|||
129470241|NCT01262976|466017226|FG002|Up to Year 3|Other|0|||
129470242|NCT01262976|466017227|FG003|Up to Year 3|Other|0|||
129470243|NCT01262976|466017228|FG004|Up to Year 3|Other|0|||
129470244|NCT01262976|466017229|FG005|Up to Year 3|Other|0|||
129470245|NCT02690194|466017232|FG000|Overall Study|Withdrawal by Subject|1|||
129470246|NCT02690194|466017233|FG001|Overall Study|Withdrawal by Subject|4|||
129470247|NCT02690194|466017234|FG002|Overall Study|Withdrawal by Subject|0|||
129470248|NCT02400255|466017237|FG000|Overall Study|Relapse|4|||
129470249|NCT02400255|466017238|FG001|Overall Study|Relapse|1|||
129470250|NCT02400255|466017239|FG002|Overall Study|Relapse|1|||
129470251|NCT02400255|466017240|FG003|Overall Study|Relapse|2|||
129470252|NCT02400255|466017237|FG000|Overall Study|Adverse Event|6|||
129470253|NCT02400255|466017238|FG001|Overall Study|Adverse Event|3|||
129470254|NCT02400255|466017239|FG002|Overall Study|Adverse Event|0|||
129470255|NCT02400255|466017240|FG003|Overall Study|Adverse Event|0|||
129470256|NCT02400255|466017237|FG000|Overall Study|Physician Decision|6|||
129470257|NCT02400255|466017238|FG001|Overall Study|Physician Decision|0|||
129470258|NCT02400255|466017239|FG002|Overall Study|Physician Decision|0|||
129470259|NCT02400255|466017240|FG003|Overall Study|Physician Decision|0|||
129470260|NCT02400255|466017237|FG000|Overall Study|Loss of insurance|1|||
129470261|NCT02400255|466017238|FG001|Overall Study|Loss of insurance|0|||
129470262|NCT02400255|466017239|FG002|Overall Study|Loss of insurance|0|||
129470263|NCT02400255|466017240|FG003|Overall Study|Loss of insurance|0|||
129470264|NCT01961544|466017241|FG000|Overall Study|Protocol Violation|1|||
129470265|NCT01961544|466017241|FG000|Overall Study|Withdrawal by Subject|7|||
129470266|NCT01961544|466017241|FG000|Overall Study|Adverse Event|1|||
129470267|NCT01961544|466017241|FG000|Overall Study|Physician Decision|2|||
129470268|NCT01961544|466017241|FG000|Overall Study|Poor Tolerance|1|||
129470269|NCT01961544|466017241|FG000|Overall Study|Aggravation of Steral Pain|1|||
129470270|NCT03665285|466017242|FG000|Overall Study|Started New Anticancer Treatment|1|||
129470271|NCT03665285|466017243|FG001|Overall Study|Started New Anticancer Treatment|1|||
129470272|NCT03665285|466017244|FG002|Overall Study|Started New Anticancer Treatment|2|||
129470273|NCT03665285|466017245|FG003|Overall Study|Started New Anticancer Treatment|4|||
129470274|NCT03665285|466017246|FG004|Overall Study|Started New Anticancer Treatment|1|||
129470275|NCT03665285|466017247|FG005|Overall Study|Started New Anticancer Treatment|1|||
129470276|NCT03665285|466017248|FG006|Overall Study|Started New Anticancer Treatment|2|||
129470277|NCT03665285|466017249|FG007|Overall Study|Started New Anticancer Treatment|15|||
129470278|NCT03665285|466017250|FG008|Overall Study|Started New Anticancer Treatment|1|||
129470279|NCT03665285|466017242|FG000|Overall Study|Disease Progression|0|||
129470280|NCT03665285|466017243|FG001|Overall Study|Disease Progression|0|||
129470281|NCT03665285|466017244|FG002|Overall Study|Disease Progression|3|||
129470282|NCT03665285|466017245|FG003|Overall Study|Disease Progression|1|||
129470283|NCT03665285|466017246|FG004|Overall Study|Disease Progression|0|||
129470284|NCT03665285|466017247|FG005|Overall Study|Disease Progression|0|||
129470285|NCT03665285|466017248|FG006|Overall Study|Disease Progression|0|||
129470286|NCT03665285|466017249|FG007|Overall Study|Disease Progression|7|||
129470287|NCT03665285|466017250|FG008|Overall Study|Disease Progression|1|||
129470288|NCT03665285|466017242|FG000|Overall Study|Hospice|0|||
129470289|NCT03665285|466017243|FG001|Overall Study|Hospice|0|||
129470290|NCT03665285|466017244|FG002|Overall Study|Hospice|0|||
129470291|NCT03665285|466017245|FG003|Overall Study|Hospice|0|||
129470292|NCT03665285|466017246|FG004|Overall Study|Hospice|0|||
129470293|NCT03665285|466017247|FG005|Overall Study|Hospice|0|||
129973650|NCT03054337|467867833|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
129973651|NCT03054337|467867834|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
129470294|NCT03665285|466017248|FG006|Overall Study|Hospice|0|||
129470295|NCT03665285|466017249|FG007|Overall Study|Hospice|2|||
129470296|NCT03665285|466017250|FG008|Overall Study|Hospice|0|||
129470297|NCT03665285|466017242|FG000|Overall Study|Withdrawal by Subject|0|||
129470298|NCT03665285|466017243|FG001|Overall Study|Withdrawal by Subject|0|||
129470299|NCT03665285|466017244|FG002|Overall Study|Withdrawal by Subject|0|||
129470300|NCT03665285|466017245|FG003|Overall Study|Withdrawal by Subject|0|||
129470301|NCT03665285|466017246|FG004|Overall Study|Withdrawal by Subject|1|||
129470302|NCT03665285|466017247|FG005|Overall Study|Withdrawal by Subject|0|||
129470303|NCT03665285|466017248|FG006|Overall Study|Withdrawal by Subject|0|||
129470304|NCT03665285|466017249|FG007|Overall Study|Withdrawal by Subject|2|||
129973652|NCT03054337|467867835|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
129973653|NCT03054337|467867836|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
129973654|NCT03054337|467867837|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
129470305|NCT03665285|466017250|FG008|Overall Study|Withdrawal by Subject|0|||
129470306|NCT03665285|466017242|FG000|Overall Study|Physician Decision|0|||
129470307|NCT03665285|466017243|FG001|Overall Study|Physician Decision|0|||
129470308|NCT03665285|466017244|FG002|Overall Study|Physician Decision|0|||
129470309|NCT03665285|466017245|FG003|Overall Study|Physician Decision|0|||
129470310|NCT03665285|466017246|FG004|Overall Study|Physician Decision|0|||
129470311|NCT03665285|466017247|FG005|Overall Study|Physician Decision|0|||
129470312|NCT03665285|466017248|FG006|Overall Study|Physician Decision|0|||
129470313|NCT03665285|466017249|FG007|Overall Study|Physician Decision|2|||
129470314|NCT03665285|466017250|FG008|Overall Study|Physician Decision|0|||
129470315|NCT00354601|466017251|FG000|Overall Study|Protocol Violation|1|||
129470316|NCT00354601|466017251|FG000|Overall Study|progression|1|||
129470317|NCT03603652|466017252|FG000|Overall Study|Death|2|||
129470318|NCT03213366|466017257|FG000|Overall Study|Lost to Follow-up|9|||
129470319|NCT03213366|466017258|FG001|Overall Study|Lost to Follow-up|4|||
129470320|NCT02532855|466017259|FG000|Overall Study|Lost to Follow-up|4|||
129470321|NCT02532855|466017260|FG001|Overall Study|Lost to Follow-up|3|||
129470322|NCT02532855|466017259|FG000|Overall Study|Withdrawal by Subject|4|||
129470323|NCT02532855|466017260|FG001|Overall Study|Withdrawal by Subject|8|||
129470324|NCT01727258|466017261|FG000|Overall Study|Adverse Event|0|||
129470325|NCT01727258|466017262|FG001|Overall Study|Adverse Event|2|||
129470326|NCT01727258|466017263|FG002|Overall Study|Adverse Event|0|||
129470327|NCT01727258|466017261|FG000|Overall Study|Noncompliance with Study Drug|0|||
129470328|NCT01727258|466017262|FG001|Overall Study|Noncompliance with Study Drug|0|||
129470329|NCT01727258|466017263|FG002|Overall Study|Noncompliance with Study Drug|1|||
129470330|NCT01727258|466017261|FG000|Overall Study|Withdrawal by Subject|1|||
129470331|NCT01727258|466017262|FG001|Overall Study|Withdrawal by Subject|1|||
129470332|NCT01727258|466017263|FG002|Overall Study|Withdrawal by Subject|0|||
129470333|NCT01727258|466017261|FG000|Overall Study|Lost to Follow-up|1|||
129470334|NCT01727258|466017262|FG001|Overall Study|Lost to Follow-up|0|||
129470335|NCT01727258|466017263|FG002|Overall Study|Lost to Follow-up|0|||
129470336|NCT01960855|466017264|FG000|Overall Study|Subject noncompliant|1|||
129470337|NCT01960855|466017265|FG001|Overall Study|Subject noncompliant|0|||
129470338|NCT01960855|466017266|FG002|Overall Study|Subject noncompliant|0|||
129470339|NCT01960855|466017267|FG003|Overall Study|Subject noncompliant|0|||
129470340|NCT01960855|466017268|FG004|Overall Study|Subject noncompliant|0|||
129470341|NCT01960855|466017264|FG000|Overall Study|Adverse Event|2|||
129470342|NCT01960855|466017265|FG001|Overall Study|Adverse Event|0|||
129470343|NCT01960855|466017266|FG002|Overall Study|Adverse Event|6|||
129470344|NCT01960855|466017267|FG003|Overall Study|Adverse Event|2|||
129470345|NCT01960855|466017268|FG004|Overall Study|Adverse Event|2|||
129470346|NCT01960855|466017264|FG000|Overall Study|Lack of Efficacy|1|||
129470347|NCT01960855|466017265|FG001|Overall Study|Lack of Efficacy|1|||
129470348|NCT01960855|466017266|FG002|Overall Study|Lack of Efficacy|0|||
129470349|NCT01960855|466017267|FG003|Overall Study|Lack of Efficacy|0|||
129470350|NCT01960855|466017268|FG004|Overall Study|Lack of Efficacy|0|||
129470351|NCT01960855|466017264|FG000|Overall Study|Other|2|||
129470352|NCT01960855|466017265|FG001|Overall Study|Other|1|||
129470353|NCT01960855|466017266|FG002|Overall Study|Other|1|||
129470354|NCT01960855|466017267|FG003|Overall Study|Other|1|||
129470355|NCT01960855|466017268|FG004|Overall Study|Other|0|||
129470356|NCT01960855|466017264|FG000|Overall Study|Consent withdrawn by subject|3|||
129973655|NCT03054337|467867838|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
129973656|NCT03004404|467867844|FG000|Period 2|Adverse Event|0|||
129973657|NCT03004404|467867845|FG001|Period 2|Adverse Event|0|||
129470357|NCT01960855|466017265|FG001|Overall Study|Consent withdrawn by subject|1|||
129973658|NCT03004404|467867846|FG002|Period 2|Adverse Event|0|||
129973659|NCT03004404|467867847|FG003|Period 2|Adverse Event|0|||
129973660|NCT03004404|467867848|FG004|Period 2|Adverse Event|0|||
129973661|NCT03004404|467867849|FG005|Period 2|Adverse Event|0|||
129973662|NCT03004404|467867850|FG006|Period 2|Adverse Event|0|||
129973663|NCT03004404|467867851|FG007|Period 2|Adverse Event|0|||
129973664|NCT03004404|467867852|FG008|Period 2|Adverse Event|1|||
129973665|NCT03004404|467867853|FG009|Period 2|Adverse Event|0|||
129973666|NCT03004404|467867854|FG010|Period 2|Adverse Event|0|||
129973667|NCT03004404|467867855|FG011|Period 2|Adverse Event|0|||
129470358|NCT01960855|466017266|FG002|Overall Study|Consent withdrawn by subject|2|||
129470359|NCT01960855|466017267|FG003|Overall Study|Consent withdrawn by subject|1|||
129470360|NCT01960855|466017268|FG004|Overall Study|Consent withdrawn by subject|1|||
129470361|NCT01960855|466017264|FG000|Overall Study|Lost to Follow-up|2|||
129470362|NCT01960855|466017265|FG001|Overall Study|Lost to Follow-up|1|||
129470363|NCT01960855|466017266|FG002|Overall Study|Lost to Follow-up|0|||
129470364|NCT01960855|466017267|FG003|Overall Study|Lost to Follow-up|0|||
129470365|NCT01960855|466017268|FG004|Overall Study|Lost to Follow-up|2|||
129973668|NCT03004404|467867856|FG012|Period 2|Adverse Event|0|||
129470366|NCT02058147|466017269|FG000|Overall Study|Randomized but not treated|0|||
129470367|NCT02058147|466017270|FG001|Overall Study|Randomized but not treated|0|||
129470368|NCT02058147|466017271|FG002|Overall Study|Randomized but not treated|1|||
129470369|NCT02058147|466017269|FG000|Overall Study|Adverse Event|12|||
129470370|NCT02058147|466017270|FG001|Overall Study|Adverse Event|9|||
129470371|NCT02058147|466017271|FG002|Overall Study|Adverse Event|21|||
129470372|NCT02058147|466017269|FG000|Overall Study|Lack of Efficacy|1|||
129470373|NCT02058147|466017270|FG001|Overall Study|Lack of Efficacy|0|||
129470374|NCT02058147|466017271|FG002|Overall Study|Lack of Efficacy|3|||
129470375|NCT02058147|466017269|FG000|Overall Study|Poor compliance to protocol|8|||
129470376|NCT02058147|466017270|FG001|Overall Study|Poor compliance to protocol|9|||
129470377|NCT02058147|466017271|FG002|Overall Study|Poor compliance to protocol|4|||
129470378|NCT02058147|466017269|FG000|Overall Study|Other than specified|8|||
129470379|NCT02058147|466017270|FG001|Overall Study|Other than specified|9|||
129470380|NCT02058147|466017271|FG002|Overall Study|Other than specified|0|||
129470381|NCT03604445|466017278|FG000|Overall Study|Death|0|||
129470382|NCT03604445|466017279|FG001|Overall Study|Death|0|||
129470383|NCT03604445|466017280|FG002|Overall Study|Death|0|||
129470384|NCT03604445|466017281|FG003|Overall Study|Death|0|||
129470385|NCT03604445|466017282|FG004|Overall Study|Death|0|||
129470386|NCT03604445|466017283|FG005|Overall Study|Death|0|||
129470387|NCT03604445|466017284|FG006|Overall Study|Death|0|||
129470388|NCT03604445|466017285|FG007|Overall Study|Death|0|||
129470389|NCT03604445|466017286|FG008|Overall Study|Death|1|||
129470390|NCT03604445|466017278|FG000|Overall Study|Withdrawal by Subject|0|||
129470391|NCT03604445|466017279|FG001|Overall Study|Withdrawal by Subject|0|||
129470392|NCT03604445|466017280|FG002|Overall Study|Withdrawal by Subject|0|||
129470393|NCT03604445|466017281|FG003|Overall Study|Withdrawal by Subject|0|||
129470394|NCT03604445|466017282|FG004|Overall Study|Withdrawal by Subject|0|||
129470395|NCT03604445|466017283|FG005|Overall Study|Withdrawal by Subject|0|||
129470396|NCT03604445|466017284|FG006|Overall Study|Withdrawal by Subject|1|||
129470397|NCT03604445|466017285|FG007|Overall Study|Withdrawal by Subject|0|||
129470398|NCT03604445|466017286|FG008|Overall Study|Withdrawal by Subject|0|||
129470399|NCT03604445|466017278|FG000|Overall Study|Missing visit|0|||
129470400|NCT03604445|466017279|FG001|Overall Study|Missing visit|0|||
129470401|NCT03604445|466017280|FG002|Overall Study|Missing visit|0|||
129470402|NCT03604445|466017281|FG003|Overall Study|Missing visit|0|||
129973669|NCT03004404|467867857|FG013|Period 2|Adverse Event|0|||
129470403|NCT03604445|466017282|FG004|Overall Study|Missing visit|0|||
129470404|NCT03604445|466017283|FG005|Overall Study|Missing visit|1|||
129470405|NCT03604445|466017284|FG006|Overall Study|Missing visit|0|||
129470406|NCT03604445|466017285|FG007|Overall Study|Missing visit|1|||
129470407|NCT03604445|466017286|FG008|Overall Study|Missing visit|0|||
129470408|NCT03604445|466017278|FG000|Overall Study|Adverse Event|0|||
129470409|NCT03604445|466017279|FG001|Overall Study|Adverse Event|0|||
129470410|NCT03604445|466017280|FG002|Overall Study|Adverse Event|0|||
129470411|NCT03604445|466017281|FG003|Overall Study|Adverse Event|1|||
129470412|NCT03604445|466017282|FG004|Overall Study|Adverse Event|0|||
129470413|NCT03604445|466017283|FG005|Overall Study|Adverse Event|0|||
129470414|NCT03604445|466017284|FG006|Overall Study|Adverse Event|0|||
129470415|NCT03604445|466017285|FG007|Overall Study|Adverse Event|0|||
129470416|NCT03604445|466017286|FG008|Overall Study|Adverse Event|1|||
129470417|NCT01360645|466017291|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
129470418|NCT01360645|466017292|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
129470419|NCT01360645|466017293|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
129973670|NCT03004404|467867858|FG014|Period 2|Adverse Event|0|||
129973671|NCT03004404|467867859|FG015|Period 2|Adverse Event|1|||
129973672|NCT03933462|467867860|FG000|Overall Study|Adverse Event|2|||
129973673|NCT03933462|467867861|FG001|Overall Study|Adverse Event|0|||
129973674|NCT01099917|467867866|FG000|Overall Study|Adverse Event|3|||
129973675|NCT01099917|467867866|FG000|Overall Study|Not Treated|24|||
129973676|NCT00706654|467867873|FG000|Conversion Phase|Lost to Follow-up|4|||
129973677|NCT00706654|467867874|FG001|Conversion Phase|Lost to Follow-up|0|||
129973678|NCT00706654|467867875|FG002|Conversion Phase|Lost to Follow-up|0|||
129470420|NCT01360645|466017294|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
129470421|NCT01360645|466017291|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
129470422|NCT01360645|466017292|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
129470423|NCT01360645|466017293|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
129470424|NCT01360645|466017294|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
129470425|NCT01360645|466017291|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
129470426|NCT01360645|466017292|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
129470427|NCT01360645|466017293|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
129973679|NCT00706654|467867876|FG003|Conversion Phase|Lost to Follow-up|0|||
129470428|NCT01360645|466017294|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
129973680|NCT00706654|467867873|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
129973681|NCT00706654|467867874|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
129470429|NCT01360645|466017291|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
129470430|NCT01360645|466017292|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
129470431|NCT01360645|466017293|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
129470432|NCT01360645|466017294|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
129470433|NCT01360645|466017291|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
129470434|NCT01360645|466017292|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
129470435|NCT01360645|466017293|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
129470436|NCT01360645|466017294|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
129470437|NCT01360645|466017291|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
129470438|NCT01360645|466017292|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
129470439|NCT01360645|466017293|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
129470440|NCT01360645|466017294|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
129470441|NCT01360645|466017291|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
129470442|NCT01360645|466017292|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
129470443|NCT01360645|466017293|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
129470444|NCT01360645|466017294|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
129470445|NCT01360645|466017291|FG000|Phase B (6 Weeks)|Adverse Event|0|||
129470446|NCT01360645|466017292|FG001|Phase B (6 Weeks)|Adverse Event|6|||
129470447|NCT01360645|466017293|FG002|Phase B (6 Weeks)|Adverse Event|0|||
129470448|NCT01360645|466017294|FG003|Phase B (6 Weeks)|Adverse Event|0|||
129470449|NCT01360645|466017291|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129470450|NCT01360645|466017292|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
129470451|NCT01360645|466017293|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
129470452|NCT01360645|466017294|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
129470453|NCT01360645|466017291|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
129470454|NCT01360645|466017292|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
129470455|NCT01360645|466017293|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
129470456|NCT01360645|466017294|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
129470457|NCT01360645|466017291|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
129470458|NCT01360645|466017292|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
129470459|NCT01360645|466017293|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
129470460|NCT01360645|466017294|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
129470461|NCT01360645|466017291|FG000|Phase A+|Lost to Follow-up|0|||
129470462|NCT01360645|466017292|FG001|Phase A+|Lost to Follow-up|0|||
129470463|NCT01360645|466017293|FG002|Phase A+|Lost to Follow-up|0|||
129470464|NCT01360645|466017294|FG003|Phase A+|Lost to Follow-up|7|||
129470465|NCT01360645|466017291|FG000|Phase A+|Adverse Event|0|||
129470466|NCT01360645|466017292|FG001|Phase A+|Adverse Event|0|||
129470467|NCT01360645|466017293|FG002|Phase A+|Adverse Event|0|||
129470468|NCT01360645|466017294|FG003|Phase A+|Adverse Event|2|||
129470469|NCT01360645|466017291|FG000|Phase A+|Met Withdrawal Criteria|0|||
129470470|NCT01360645|466017292|FG001|Phase A+|Met Withdrawal Criteria|0|||
129470471|NCT01360645|466017293|FG002|Phase A+|Met Withdrawal Criteria|0|||
129470472|NCT01360645|466017294|FG003|Phase A+|Met Withdrawal Criteria|4|||
129470473|NCT01360645|466017291|FG000|Phase A+|Physician Decision|0|||
129470474|NCT01360645|466017292|FG001|Phase A+|Physician Decision|0|||
129973682|NCT00706654|467867875|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
129973683|NCT00706654|467867876|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
129973684|NCT00706654|467867873|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
129973685|NCT00706654|467867874|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
129973686|NCT00706654|467867875|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
129973687|NCT00706654|467867876|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
129973688|NCT00706654|467867873|FG000|Conversion Phase|Withdrawn by Investigator|14|||
129973689|NCT00706654|467867874|FG001|Conversion Phase|Withdrawn by Investigator|0|||
129470475|NCT01360645|466017293|FG002|Phase A+|Physician Decision|0|||
129470476|NCT01360645|466017294|FG003|Phase A+|Physician Decision|2|||
129470477|NCT01360645|466017291|FG000|Phase A+|Withdrawal by Subject|0|||
129470478|NCT01360645|466017292|FG001|Phase A+|Withdrawal by Subject|0|||
129470479|NCT01360645|466017293|FG002|Phase A+|Withdrawal by Subject|0|||
129470480|NCT01360645|466017294|FG003|Phase A+|Withdrawal by Subject|5|||
129470481|NCT01360645|466017291|FG000|Phase A+|Protocol Deviation|0|||
129470482|NCT01360645|466017292|FG001|Phase A+|Protocol Deviation|0|||
129470483|NCT01360645|466017293|FG002|Phase A+|Protocol Deviation|0|||
129470484|NCT01360645|466017294|FG003|Phase A+|Protocol Deviation|4|||
129470485|NCT01014585|466017295|FG000|Overall Study|Adverse Event|0|||
129470486|NCT01014585|466017296|FG001|Overall Study|Adverse Event|2|||
129973690|NCT00706654|467867875|FG002|Conversion Phase|Withdrawn by Investigator|0|||
129973691|NCT00706654|467867876|FG003|Conversion Phase|Withdrawn by Investigator|0|||
129470487|NCT01014585|466017297|FG002|Overall Study|Adverse Event|0|||
129470488|NCT01014585|466017298|FG003|Overall Study|Adverse Event|3|||
129470489|NCT01014585|466017295|FG000|Overall Study|Withdrawal by Subject|2|||
129470490|NCT01014585|466017296|FG001|Overall Study|Withdrawal by Subject|0|||
129470491|NCT01014585|466017297|FG002|Overall Study|Withdrawal by Subject|1|||
129973692|NCT00706654|467867873|FG000|Conversion Phase|Withdrew Consent|38|||
129470492|NCT01014585|466017298|FG003|Overall Study|Withdrawal by Subject|3|||
129470493|NCT01014585|466017295|FG000|Overall Study|Lost to Follow-up|0|||
129470494|NCT01014585|466017296|FG001|Overall Study|Lost to Follow-up|0|||
129470495|NCT01014585|466017297|FG002|Overall Study|Lost to Follow-up|0|||
129470496|NCT01014585|466017298|FG003|Overall Study|Lost to Follow-up|2|||
129470497|NCT01014585|466017295|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
129470498|NCT01014585|466017296|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
129470499|NCT01014585|466017297|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
129470500|NCT01014585|466017298|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
129470501|NCT00773279|466017302|FG000|Period 1|Adverse Event|2|||
129470502|NCT00773279|466017303|FG001|Period 1|Adverse Event|1|||
129470503|NCT00773279|466017302|FG000|Period 1|Lack of Efficacy|0|||
129470504|NCT00773279|466017303|FG001|Period 1|Lack of Efficacy|2|||
129470505|NCT00773279|466017302|FG000|Period 1|Unclassified|5|||
129470506|NCT00773279|466017303|FG001|Period 1|Unclassified|1|||
129470507|NCT00773279|466017302|FG000|Period 2|Adverse Event|0|||
129470508|NCT00773279|466017303|FG001|Period 2|Adverse Event|1|||
129470509|NCT00773279|466017302|FG000|Period 2|Lack of Efficacy|1|||
129470510|NCT00773279|466017303|FG001|Period 2|Lack of Efficacy|0|||
129470511|NCT00773279|466017302|FG000|Period 2|Protocol Violation|0|||
129470512|NCT00773279|466017303|FG001|Period 2|Protocol Violation|3|||
129470513|NCT00773279|466017302|FG000|Period 2|Unclassified|2|||
129470514|NCT00773279|466017303|FG001|Period 2|Unclassified|2|||
129470515|NCT02817087|466017304|FG000|Overall Study|Withdrawal by Subject|2|||
129470516|NCT02817087|466017305|FG001|Overall Study|Withdrawal by Subject|0|||
129470517|NCT00508391|466017306|FG000|First Treatment|Withdrawal by Subject|6|||
129470518|NCT00508391|466017307|FG001|First Treatment|Withdrawal by Subject|3|||
129470519|NCT00508391|466017306|FG000|Second Treatment|Withdrawal by Subject|2|||
129470520|NCT00508391|466017307|FG001|Second Treatment|Withdrawal by Subject|0|||
129470521|NCT00802360|466017308|FG000|Overall Study|Stimulation failure|4|||
129470522|NCT00802360|466017309|FG001|Overall Study|Stimulation failure|0|||
129470523|NCT00802360|466017310|FG002|Overall Study|Stimulation failure|3|||
129470524|NCT00802360|466017311|FG003|Overall Study|Stimulation failure|3|||
129470525|NCT00802360|466017308|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
129470526|NCT00802360|466017309|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
129470527|NCT00802360|466017310|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
129470528|NCT00802360|466017311|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
129470529|NCT00802360|466017308|FG000|Overall Study|Cycle cancelled|0|||
129470530|NCT00802360|466017309|FG001|Overall Study|Cycle cancelled|1|||
129470531|NCT00802360|466017310|FG002|Overall Study|Cycle cancelled|1|||
129470532|NCT00802360|466017311|FG003|Overall Study|Cycle cancelled|1|||
129973693|NCT00706654|467867874|FG001|Conversion Phase|Withdrew Consent|0|||
129973694|NCT00706654|467867875|FG002|Conversion Phase|Withdrew Consent|0|||
129973695|NCT00706654|467867876|FG003|Conversion Phase|Withdrew Consent|0|||
129973696|NCT00706654|467867873|FG000|Conversion Phase|Adverse Event|18|||
129470533|NCT00802360|466017308|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
129470534|NCT00802360|466017309|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
129470535|NCT00802360|466017310|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
129973697|NCT00706654|467867874|FG001|Conversion Phase|Adverse Event|0|||
129973698|NCT00706654|467867875|FG002|Conversion Phase|Adverse Event|0|||
129973699|NCT00706654|467867876|FG003|Conversion Phase|Adverse Event|0|||
129973700|NCT00706654|467867873|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
129470536|NCT00802360|466017311|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
129470537|NCT00802360|466017308|FG000|Overall Study|No positive serum pregnancy|17|||
129470538|NCT00802360|466017309|FG001|Overall Study|No positive serum pregnancy|20|||
129470539|NCT00802360|466017310|FG002|Overall Study|No positive serum pregnancy|14|||
129470540|NCT00802360|466017311|FG003|Overall Study|No positive serum pregnancy|10|||
129470541|NCT00802360|466017308|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
129470542|NCT00802360|466017309|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129470543|NCT00802360|466017310|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
129470544|NCT00802360|466017311|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
129470545|NCT00802360|466017308|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
129470546|NCT00802360|466017309|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
129973701|NCT00706654|467867874|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
129470547|NCT00802360|466017310|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
129470548|NCT00802360|466017311|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
129470549|NCT00802360|466017308|FG000|Overall Study|Other|2|||
129470550|NCT00802360|466017309|FG001|Overall Study|Other|3|||
129470551|NCT00802360|466017310|FG002|Overall Study|Other|6|||
129470552|NCT00802360|466017311|FG003|Overall Study|Other|3|||
129470553|NCT02041962|466017312|FG000|Overall Study|Lost Aetna Coverage|43|||
129470554|NCT02041962|466017313|FG001|Overall Study|Lost Aetna Coverage|40|||
129470555|NCT02041962|466017312|FG000|Overall Study|Death|1|||
129973702|NCT00706654|467867875|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
129973703|NCT00706654|467867876|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
129470556|NCT02041962|466017313|FG001|Overall Study|Death|1|||
129470557|NCT02041962|466017312|FG000|Overall Study|Lost to Follow-up|37|||
129470558|NCT02041962|466017313|FG001|Overall Study|Lost to Follow-up|32|||
129470559|NCT02041962|466017312|FG000|Overall Study|Withdrawal by Subject|0|||
129470560|NCT02041962|466017313|FG001|Overall Study|Withdrawal by Subject|11|||
129470561|NCT01225562|466017314|FG000|Overall Study|Withdrawal by Subject|52|||
129973704|NCT00706654|467867873|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
129973705|NCT00706654|467867874|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129973706|NCT00706654|467867875|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129973707|NCT00706654|467867876|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
129973708|NCT00706654|467867873|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
129973709|NCT00706654|467867874|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
129973710|NCT00706654|467867875|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
129973711|NCT00706654|467867876|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
129973712|NCT00706654|467867873|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
129973713|NCT00706654|467867874|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
129973714|NCT00706654|467867875|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
129470562|NCT01225562|466017315|FG001|Overall Study|Withdrawal by Subject|50|||
129470563|NCT01225562|466017316|FG002|Overall Study|Withdrawal by Subject|52|||
129470564|NCT01225562|466017314|FG000|Overall Study|Lost to Follow-up|3|||
129470565|NCT01225562|466017315|FG001|Overall Study|Lost to Follow-up|6|||
129470566|NCT01225562|466017316|FG002|Overall Study|Lost to Follow-up|1|||
129470567|NCT01481896|466017317|FG000|Overall Study|Lost to Follow-up|12|||
129470568|NCT02251912|466017320|FG000|Overall Study|Withdrawal by Subject|2|||
129470569|NCT02251912|466017321|FG001|Overall Study|Withdrawal by Subject|3|||
129470570|NCT02251912|466017320|FG000|Overall Study|Adverse Event|0|||
129470571|NCT02251912|466017321|FG001|Overall Study|Adverse Event|2|||
129470572|NCT01818726|466017322|FG000|Overall Study|Administrative reasons|5|||
129470573|NCT01818726|466017323|FG001|Overall Study|Administrative reasons|1|||
129470574|NCT01818726|466017322|FG000|Overall Study|Withdrawal by Subject|0|||
129470575|NCT01818726|466017323|FG001|Overall Study|Withdrawal by Subject|1|||
129470576|NCT01818726|466017322|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
129470577|NCT01818726|466017323|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
129470578|NCT01162421|466017324|FG000|Overall Study|Did not receive study drug|2|||
129470579|NCT01162421|466017325|FG001|Overall Study|Did not receive study drug|1|||
129470580|NCT01162421|466017324|FG000|Overall Study|Adverse Event|2|||
129470581|NCT01162421|466017325|FG001|Overall Study|Adverse Event|5|||
129470582|NCT01162421|466017324|FG000|Overall Study|Lost to Follow-up|0|||
129470583|NCT01162421|466017325|FG001|Overall Study|Lost to Follow-up|2|||
129470584|NCT01162421|466017324|FG000|Overall Study|Lack of Efficacy|2|||
129470585|NCT01162421|466017325|FG001|Overall Study|Lack of Efficacy|2|||
129470586|NCT01162421|466017324|FG000|Overall Study|Other|2|||
129470587|NCT01162421|466017325|FG001|Overall Study|Other|3|||
129470588|NCT03336502|466017326|FG000|Overall Study|Physician Decision|0|||
129470589|NCT03336502|466017327|FG001|Overall Study|Physician Decision|1|||
129470590|NCT03336502|466017326|FG000|Overall Study|Prohibited Drugs|1|||
129470591|NCT03336502|466017327|FG001|Overall Study|Prohibited Drugs|1|||
129470592|NCT03336502|466017326|FG000|Overall Study|Death|1|||
129470593|NCT03336502|466017327|FG001|Overall Study|Death|2|||
129470594|NCT03336502|466017326|FG000|Overall Study|Adverse Event|2|||
129470595|NCT03336502|466017327|FG001|Overall Study|Adverse Event|5|||
129470596|NCT00480857|466017328|FG000|Overall Study|Lack of Efficacy|2|||
129973715|NCT00706654|467867876|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
129973716|NCT00706654|467867873|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
129470597|NCT00611247|466017329|FG000|Overall Study|Death|1|||
129470598|NCT00611247|466017330|FG001|Overall Study|Death|5|||
129470599|NCT00611247|466017329|FG000|Overall Study|Lack of Efficacy|1|||
129470600|NCT00611247|466017330|FG001|Overall Study|Lack of Efficacy|16|||
129470601|NCT01107444|466017331|FG000|Overall Study|Withdrawal by Subject|8|||
129470602|NCT01107444|466017332|FG001|Overall Study|Withdrawal by Subject|12|||
129470603|NCT01107444|466017331|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
129470604|NCT01107444|466017332|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
129470605|NCT01948830|466017333|FG000|Overall Study|Physician Decision|1|||
129470606|NCT01948830|466017334|FG001|Overall Study|Physician Decision|3|||
129470607|NCT01948830|466017333|FG000|Overall Study|Protocol deviation|1|||
129470608|NCT01948830|466017334|FG001|Overall Study|Protocol deviation|2|||
129470609|NCT01948830|466017333|FG000|Overall Study|Lost to Follow-up|5|||
129470610|NCT01948830|466017334|FG001|Overall Study|Lost to Follow-up|4|||
129470611|NCT01948830|466017333|FG000|Overall Study|Withdrawal by Subject|14|||
129470612|NCT01948830|466017334|FG001|Overall Study|Withdrawal by Subject|17|||
129470613|NCT01948830|466017333|FG000|Overall Study|Adverse Event|9|||
129470614|NCT01948830|466017334|FG001|Overall Study|Adverse Event|2|||
129470615|NCT01948830|466017333|FG000|Overall Study|Death|3|||
129470616|NCT01948830|466017334|FG001|Overall Study|Death|4|||
129470617|NCT01890421|466017335|FG000|Overall Study|Adverse Event|1|||
129470618|NCT01890421|466017335|FG000|Overall Study|Other reason|10|||
129470619|NCT01557166|466017344|FG000|Overall Study|Adverse Event|20|||
129470620|NCT01557166|466017345|FG001|Overall Study|Adverse Event|6|||
129470621|NCT01557166|466017344|FG000|Overall Study|Lack of Efficacy|2|||
129470622|NCT01557166|466017345|FG001|Overall Study|Lack of Efficacy|1|||
129470623|NCT01557166|466017344|FG000|Overall Study|Protocol Violation|8|||
129470624|NCT01557166|466017345|FG001|Overall Study|Protocol Violation|5|||
129470625|NCT01557166|466017344|FG000|Overall Study|Withdrawn consent|12|||
129470626|NCT01557166|466017345|FG001|Overall Study|Withdrawn consent|20|||
129470627|NCT01557166|466017344|FG000|Overall Study|Target dose not tolerated|1|||
129470628|NCT01557166|466017345|FG001|Overall Study|Target dose not tolerated|0|||
129470629|NCT01557166|466017344|FG000|Overall Study|Psychiatric disorder|1|||
129470630|NCT01557166|466017345|FG001|Overall Study|Psychiatric disorder|0|||
129470631|NCT01557166|466017344|FG000|Overall Study|Unclassified|2|||
129470632|NCT01557166|466017345|FG001|Overall Study|Unclassified|5|||
129973717|NCT00706654|467867874|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129973718|NCT00706654|467867875|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129973719|NCT00706654|467867876|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
129973720|NCT00706654|467867873|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
129973721|NCT00706654|467867874|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129973722|NCT00706654|467867875|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129470633|NCT04506294|466017346|FG000|Overall Study|Lost to Follow-up|70|||
129470634|NCT04506294|466017347|FG001|Overall Study|Lost to Follow-up|20|||
129470635|NCT04506294|466017346|FG000|Overall Study|Withdrawal by Subject|16|||
129470636|NCT04506294|466017347|FG001|Overall Study|Withdrawal by Subject|2|||
129470637|NCT01465659|466017348|FG000|Completed 1 Cycle of Treatment|Death|0|||
129470638|NCT01465659|466017349|FG001|Completed 1 Cycle of Treatment|Death|1|||
129470639|NCT01465659|466017350|FG002|Completed 1 Cycle of Treatment|Death|0|||
129470640|NCT01465659|466017351|FG003|Completed 1 Cycle of Treatment|Death|0|||
129470641|NCT01465659|466017348|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
129470642|NCT01465659|466017349|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
129470643|NCT01465659|466017350|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
129470644|NCT01465659|466017351|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
129973723|NCT00706654|467867876|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
129973724|NCT00706654|467867873|FG000|Oral Stabilization Phase|Withdrew consent|55|||
129973725|NCT00706654|467867874|FG001|Oral Stabilization Phase|Withdrew consent|0|||
129973726|NCT00706654|467867875|FG002|Oral Stabilization Phase|Withdrew consent|0|||
129973727|NCT00706654|467867876|FG003|Oral Stabilization Phase|Withdrew consent|0|||
129973728|NCT00706654|467867873|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
129470645|NCT01465659|466017348|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
129470646|NCT01465659|466017349|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
129470647|NCT01465659|466017350|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
129470648|NCT01465659|466017351|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
129973729|NCT00706654|467867874|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
129973730|NCT00706654|467867875|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
129973731|NCT00706654|467867876|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
129973732|NCT00706654|467867873|FG000|Oral Stabilization Phase|Adverse Event|21|||
129973733|NCT00706654|467867874|FG001|Oral Stabilization Phase|Adverse Event|0|||
129470649|NCT01465659|466017348|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
129470650|NCT01465659|466017349|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
129470651|NCT01465659|466017350|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
129470652|NCT01465659|466017351|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
129973734|NCT00706654|467867875|FG002|Oral Stabilization Phase|Adverse Event|0|||
129973735|NCT00706654|467867876|FG003|Oral Stabilization Phase|Adverse Event|0|||
129973736|NCT00706654|467867873|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
129973737|NCT00706654|467867874|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129973738|NCT00706654|467867875|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129470653|NCT01465659|466017348|FG000|Completed Follow for 1 Year|Death|6|||
129470654|NCT01465659|466017349|FG001|Completed Follow for 1 Year|Death|3|||
129470655|NCT01465659|466017350|FG002|Completed Follow for 1 Year|Death|2|||
129470656|NCT01465659|466017351|FG003|Completed Follow for 1 Year|Death|4|||
129470657|NCT02445586|466017352|FG000|Overall Study|Death|14|||
129470658|NCT02445586|466017352|FG000|Overall Study|Withdrawal by Subject|13|||
129470659|NCT02445586|466017352|FG000|Overall Study|Disease Progression|10|||
129470660|NCT02445586|466017352|FG000|Overall Study|Protocol Violation|1|||
129470661|NCT02445586|466017352|FG000|Overall Study|Medical Condition|1|||
129470662|NCT00428597|466017353|FG000|Overall Study|Randomized but not treated|3|||
129470663|NCT00428597|466017354|FG001|Overall Study|Randomized but not treated|3|||
129470664|NCT00428597|466017353|FG000|Overall Study|Objective Progression or Relapse|19|||
129470665|NCT00428597|466017354|FG001|Overall Study|Objective Progression or Relapse|47|||
129470666|NCT00428597|466017353|FG000|Overall Study|Study Terminated by Sponsor|41|||
129470667|NCT00428597|466017354|FG001|Overall Study|Study Terminated by Sponsor|16|||
129470668|NCT00428597|466017353|FG000|Overall Study|Adverse Event|15|||
129470669|NCT00428597|466017354|FG001|Overall Study|Adverse Event|7|||
129470670|NCT00428597|466017353|FG000|Overall Study|Global Deterioration of Health Status|1|||
129470671|NCT00428597|466017354|FG001|Overall Study|Global Deterioration of Health Status|5|||
129470672|NCT00428597|466017353|FG000|Overall Study|Protocol Violation|2|||
129470673|NCT00428597|466017354|FG001|Overall Study|Protocol Violation|1|||
129470674|NCT00428597|466017353|FG000|Overall Study|Withdrawal by Subject|2|||
129470675|NCT00428597|466017354|FG001|Overall Study|Withdrawal by Subject|1|||
129470676|NCT00428597|466017353|FG000|Overall Study|Other|1|||
129470677|NCT00428597|466017354|FG001|Overall Study|Other|1|||
129470678|NCT00428597|466017353|FG000|Overall Study|Lost to Follow-up|0|||
129470679|NCT00428597|466017354|FG001|Overall Study|Lost to Follow-up|1|||
129470680|NCT00428597|466017353|FG000|Overall Study|Pregnancy|1|||
129470681|NCT00428597|466017354|FG001|Overall Study|Pregnancy|0|||
129470682|NCT00428597|466017353|FG000|Overall Study|Death|1|||
129470683|NCT00428597|466017354|FG001|Overall Study|Death|3|||
129470684|NCT01961115|466017359|FG000|Overall Study|Disease Progression|1|||
129470685|NCT01961115|466017360|FG001|Overall Study|Disease Progression|0|||
129470686|NCT01961115|466017361|FG002|Overall Study|Disease Progression|3|||
129470687|NCT01961115|466017359|FG000|Overall Study|Adverse Event|1|||
129470688|NCT01961115|466017360|FG001|Overall Study|Adverse Event|0|||
129470689|NCT01961115|466017361|FG002|Overall Study|Adverse Event|1|||
129470690|NCT00578643|466017362|FG000|Overall Study|Death|1|||
129470691|NCT00578643|466017362|FG000|Overall Study|Lost to Follow-up|1|||
129470692|NCT03828487|466017363|FG000|Overall Study|Physician Decision|1|||
129470693|NCT01990261|466017364|FG000|Overall Study|Death Before Treatment Start|2|||
129470694|NCT01990261|466017364|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
129470695|NCT01990261|466017364|FG000|Overall Study|Death From other Causes|1|||
129470696|NCT01990261|466017364|FG000|Overall Study|Disease Progression (PD)|8|||
129470697|NCT01990261|466017364|FG000|Overall Study|PD Before Treatment Start|1|||
129973739|NCT00706654|467867876|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
129973740|NCT00706654|467867873|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
129973741|NCT00706654|467867874|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129973742|NCT00706654|467867875|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129973743|NCT00706654|467867876|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
129973744|NCT00706654|467867873|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
129973745|NCT00706654|467867874|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
129973746|NCT00706654|467867875|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
129470698|NCT01990261|466017364|FG000|Overall Study|Dossier not Approved|1|||
129470699|NCT01990261|466017364|FG000|Overall Study|Lost to Follow-up|2|||
129470700|NCT01445678|466017366|FG000|Overall Study|Adverse Event|12|||
129470701|NCT01445678|466017367|FG001|Overall Study|Adverse Event|8|||
129470702|NCT01445678|466017366|FG000|Overall Study|Lack of Efficacy|0|||
129470703|NCT01445678|466017367|FG001|Overall Study|Lack of Efficacy|2|||
129470704|NCT01445678|466017366|FG000|Overall Study|Lost to Follow-up|8|||
129470705|NCT01445678|466017367|FG001|Overall Study|Lost to Follow-up|5|||
129470706|NCT01445678|466017366|FG000|Overall Study|Protocol Violation|1|||
129470707|NCT01445678|466017367|FG001|Overall Study|Protocol Violation|1|||
129470708|NCT01445678|466017366|FG000|Overall Study|Withdrawal by Subject|9|||
129470709|NCT01445678|466017367|FG001|Overall Study|Withdrawal by Subject|5|||
129470710|NCT02307370|466017368|FG000|Overall Study|Death|5|||
129470711|NCT02307370|466017368|FG000|Overall Study|Lost to Follow-up|1|||
129470712|NCT02307370|466017368|FG000|Overall Study|Withdrawal by Subject|1|||
129470713|NCT02307370|466017368|FG000|Overall Study|Declined Addendum ICF|6|||
129470714|NCT02307370|466017368|FG000|Overall Study|No response during telephone contact|5|||
129470715|NCT02307370|466017368|FG000|Overall Study|Protocol Violation|1|||
129470716|NCT05847686|466020148|FG000|Overall Study|Withdrawal by Subject|3|||
129470717|NCT06272370|466020149|FG000|Overall Study|Lost to Follow-up|0|||
129470718|NCT06272370|466020150|FG001|Overall Study|Lost to Follow-up|3|||
129470719|NCT06272370|466020151|FG002|Overall Study|Lost to Follow-up|1|||
129470720|NCT06272370|466020152|FG003|Overall Study|Lost to Follow-up|1|||
129470721|NCT00352534|466020154|FG000|Initial Staging|Ineligible|8|||
129470722|NCT00352534|466020155|FG001|Initial Staging|Ineligible|9|||
129470723|NCT00352534|466020156|FG002|Initial Staging|Ineligible|0|||
129470724|NCT00352534|466020157|FG003|Initial Staging|Ineligible|0|||
129470725|NCT00352534|466020158|FG004|Initial Staging|Ineligible|0|||
129470726|NCT00352534|466020159|FG005|Initial Staging|Ineligible|0|||
129470727|NCT00352534|466020160|FG006|Initial Staging|Ineligible|0|||
129470728|NCT00352534|466020154|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
129470729|NCT00352534|466020155|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
129470730|NCT00352534|466020156|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
129470731|NCT00352534|466020157|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
129470732|NCT00352534|466020158|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
129470733|NCT00352534|466020159|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
129470734|NCT00352534|466020160|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
129470735|NCT00352534|466020154|FG000|Final Risk Group Assignment|Physician Decision|0|||
129470736|NCT00352534|466020155|FG001|Final Risk Group Assignment|Physician Decision|0|||
129470737|NCT00352534|466020156|FG002|Final Risk Group Assignment|Physician Decision|0|||
129470738|NCT00352534|466020157|FG003|Final Risk Group Assignment|Physician Decision|0|||
129470739|NCT00352534|466020158|FG004|Final Risk Group Assignment|Physician Decision|0|||
129470740|NCT00352534|466020159|FG005|Final Risk Group Assignment|Physician Decision|8|||
129470741|NCT00352534|466020160|FG006|Final Risk Group Assignment|Physician Decision|0|||
129470742|NCT00352534|466020154|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
129470743|NCT00352534|466020155|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
129470744|NCT00352534|466020156|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
129470745|NCT00352534|466020157|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
129470746|NCT00352534|466020158|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
129470747|NCT00352534|466020159|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
129470748|NCT00352534|466020160|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
129470749|NCT00352534|466020154|FG000|Final Risk Group Assignment|Ineligible|0|||
129470750|NCT00352534|466020155|FG001|Final Risk Group Assignment|Ineligible|0|||
129470751|NCT00352534|466020156|FG002|Final Risk Group Assignment|Ineligible|3|||
129470752|NCT00352534|466020157|FG003|Final Risk Group Assignment|Ineligible|1|||
129470753|NCT00352534|466020158|FG004|Final Risk Group Assignment|Ineligible|0|||
129470754|NCT00352534|466020159|FG005|Final Risk Group Assignment|Ineligible|13|||
129470755|NCT00352534|466020160|FG006|Final Risk Group Assignment|Ineligible|0|||
129470756|NCT00352534|466020154|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
129470757|NCT00352534|466020155|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
129470758|NCT00352534|466020156|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
129470759|NCT00352534|466020157|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
129470760|NCT00352534|466020158|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
129470761|NCT00352534|466020159|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
129470762|NCT00352534|466020160|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
129470763|NCT00352534|466020154|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
129470764|NCT00352534|466020155|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
129470765|NCT00352534|466020156|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
129470766|NCT00352534|466020157|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
129470767|NCT00352534|466020158|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
129470768|NCT00352534|466020159|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
129470769|NCT00352534|466020160|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
129470770|NCT00352534|466020154|FG000|Final Risk Group Assignment|Death|0|||
129470771|NCT00352534|466020155|FG001|Final Risk Group Assignment|Death|0|||
129470772|NCT00352534|466020156|FG002|Final Risk Group Assignment|Death|0|||
129470773|NCT00352534|466020157|FG003|Final Risk Group Assignment|Death|0|||
129470774|NCT00352534|466020158|FG004|Final Risk Group Assignment|Death|0|||
129470775|NCT00352534|466020159|FG005|Final Risk Group Assignment|Death|2|||
129470776|NCT00352534|466020160|FG006|Final Risk Group Assignment|Death|0|||
129470777|NCT01602341|466020161|FG000|Overall Study|Adverse Event|0|||
129470778|NCT01602341|466020162|FG001|Overall Study|Adverse Event|1|||
129470779|NCT04439279|466020163|FG000|Overall Study|Adverse Event|7|||
129470780|NCT04439279|466020163|FG000|Overall Study|Death|4|||
129470781|NCT04439279|466020163|FG000|Overall Study|Disease progression|17|||
129470782|NCT04439279|466020163|FG000|Overall Study|Complicating disease|3|||
129470783|NCT04439279|466020163|FG000|Overall Study|Withdrawal by Subject|2|||
129470784|NCT04439279|466020163|FG000|Overall Study|Ineligible|1|||
129470785|NCT04439279|466020163|FG000|Overall Study|Treatment still ongoing|1|||
129470786|NCT03521791|466020164|FG000|Overall Study|Protocol Violation|7|||
129973747|NCT00706654|467867876|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
129973748|NCT00706654|467867873|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
129973749|NCT00706654|467867874|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
129973750|NCT00706654|467867875|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
129973751|NCT00706654|467867876|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
129973752|NCT00706654|467867873|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
129973753|NCT00706654|467867874|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
129973754|NCT00706654|467867875|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
129973755|NCT00706654|467867876|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
129973756|NCT00706654|467867873|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
129973757|NCT00706654|467867874|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
129973758|NCT00706654|467867875|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
129973759|NCT00706654|467867876|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
129973760|NCT00706654|467867873|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
129973761|NCT00706654|467867874|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
129973762|NCT00706654|467867875|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
129973763|NCT00706654|467867876|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
129973764|NCT00706654|467867873|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
129973765|NCT00706654|467867874|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
129470787|NCT03521791|466020165|FG001|Overall Study|Protocol Violation|17|||
129470788|NCT02090855|466020166|FG000|Overall Study|no evaluable Standard of Truth results|2|||
129470789|NCT03038308|466020168|FG000|Overall Study|Surgical resection|1|||
129470790|NCT03038308|466020168|FG000|Overall Study|Withdrawal by Subject|2|||
129470791|NCT03038308|466020168|FG000|Overall Study|Lost to Follow-up|1|||
129973766|NCT00706654|467867875|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
129973767|NCT00706654|467867876|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
129470792|NCT00544869|466020170|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
129470793|NCT00544869|466020171|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
129470794|NCT00544869|466020172|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
129470795|NCT00544869|466020170|FG000|Overall Study|Adverse Event|6|||
129470796|NCT00544869|466020171|FG001|Overall Study|Adverse Event|1|||
129470797|NCT00544869|466020172|FG002|Overall Study|Adverse Event|0|||
129470798|NCT00544869|466020170|FG000|Overall Study|Lack of Efficacy|1|||
129470799|NCT00544869|466020171|FG001|Overall Study|Lack of Efficacy|1|||
129470800|NCT00544869|466020172|FG002|Overall Study|Lack of Efficacy|0|||
129470801|NCT00544869|466020170|FG000|Overall Study|Physician Decision|2|||
129470802|NCT00544869|466020171|FG001|Overall Study|Physician Decision|0|||
129470803|NCT00544869|466020172|FG002|Overall Study|Physician Decision|0|||
129470804|NCT01777763|466020183|FG000|Overall Study|Adverse Event|2|||
129470805|NCT01777763|466020184|FG001|Overall Study|Adverse Event|32|||
129470806|NCT01777763|466020183|FG000|Overall Study|Protocol Violation|1|||
129470807|NCT01777763|466020184|FG001|Overall Study|Protocol Violation|7|||
129470808|NCT01777763|466020183|FG000|Overall Study|Withdrawal by Subject|0|||
129470809|NCT01777763|466020184|FG001|Overall Study|Withdrawal by Subject|2|||
129470810|NCT01777763|466020183|FG000|Overall Study|Treatment Failure|1|||
129470811|NCT01777763|466020184|FG001|Overall Study|Treatment Failure|6|||
129470812|NCT00925600|466020193|FG000|Overall Study|Withdrawal by Subject|16|||
129470813|NCT00925600|466020194|FG001|Overall Study|Withdrawal by Subject|14|||
129470814|NCT00925600|466020193|FG000|Overall Study|Death|4|||
129470815|NCT00925600|466020194|FG001|Overall Study|Death|3|||
129470816|NCT00925600|466020193|FG000|Overall Study|Lost to Follow-up|2|||
129470817|NCT00925600|466020194|FG001|Overall Study|Lost to Follow-up|2|||
129470818|NCT00925600|466020193|FG000|Overall Study|Disease Progression|1|||
129470819|NCT00925600|466020194|FG001|Overall Study|Disease Progression|3|||
129470820|NCT00925600|466020193|FG000|Overall Study|Administrative Decision|1|||
129470821|NCT00925600|466020194|FG001|Overall Study|Administrative Decision|1|||
129470822|NCT00925600|466020193|FG000|Overall Study|Noncompliance|2|||
129470823|NCT00925600|466020194|FG001|Overall Study|Noncompliance|0|||
129470824|NCT00925600|466020193|FG000|Overall Study|Ineligibility Determined|2|||
129470825|NCT00925600|466020194|FG001|Overall Study|Ineligibility Determined|0|||
129470826|NCT00925600|466020193|FG000|Overall Study|Protocol Deviation|0|||
129470827|NCT00925600|466020194|FG001|Overall Study|Protocol Deviation|1|||
129470828|NCT00925600|466020193|FG000|Overall Study|Requirement for Alternative Therapy|0|||
129470829|NCT00925600|466020194|FG001|Overall Study|Requirement for Alternative Therapy|1|||
129470830|NCT00925600|466020193|FG000|Overall Study|Other|3|||
129470831|NCT00925600|466020194|FG001|Overall Study|Other|1|||
129470832|NCT00925600|466020193|FG000|Overall Study|Adverse Event|1|||
129470833|NCT00925600|466020194|FG001|Overall Study|Adverse Event|2|||
129470834|NCT01974817|466020197|FG000|Overall Study|Death|4|||
129470835|NCT01974817|466020197|FG000|Overall Study|Lost to Follow-up|2|||
129470836|NCT01974817|466020197|FG000|Overall Study|Protocol Violation|2|||
129470837|NCT01246206|466020198|FG000|Overall Study|Patient did not receive study regiments.|1|||
129470838|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
129470839|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
129470840|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
129470841|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
129470842|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
129470843|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
129470844|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
129470845|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
129470846|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
129973768|NCT00706654|467867873|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
129973769|NCT00706654|467867874|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
129470847|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
129470848|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
129470849|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
129470850|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
129470851|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
129470852|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
129470853|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
129470854|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
129470855|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
129470856|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
129470857|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
129470858|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
129470859|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
129470860|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
129470861|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
129488475|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
129470862|NCT04660643|466020199|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
129470863|NCT04660643|466020200|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
129470864|NCT04660643|466020201|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
129470865|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
129470866|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
129470867|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
129470868|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
129470869|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
129470870|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
129470871|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
129973770|NCT00706654|467867875|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
129973771|NCT00706654|467867876|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
129973772|NCT00706654|467867873|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
129973773|NCT00706654|467867874|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
129470872|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
129470873|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
129470874|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
129470875|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
129470876|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
129470877|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
129470878|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
129470879|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
129470880|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
129470881|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
129470882|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
129470883|NCT04660643|466020199|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
129470884|NCT04660643|466020200|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
129470885|NCT04660643|466020201|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
129470886|NCT03988907|466020202|FG000|Overall Study|Unable to complete visit|0|||
129470887|NCT03988907|466020203|FG001|Overall Study|Unable to complete visit|1|||
129470888|NCT02810964|466020204|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
129470889|NCT02810964|466020205|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
129470890|NCT02810964|466020204|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
129470891|NCT02810964|466020205|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
129470892|NCT02810964|466020204|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
129470893|NCT02810964|466020205|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
129470894|NCT02810964|466020204|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
129470895|NCT02810964|466020205|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
129470896|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
129470897|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
129470898|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
129470899|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129470900|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129470901|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129470902|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129973774|NCT00706654|467867875|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
129973775|NCT00706654|467867876|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
129973776|NCT01001390|467867882|FG000|Overall Study|Failure to wear AFO device|2|||
129973777|NCT01001390|467867883|FG001|Overall Study|Failure to wear AFO device|0|||
129973778|NCT01151215|467867884|FG000|Overall Study|Worsening of condition under study|1|||
129973779|NCT01151215|467867885|FG001|Overall Study|Worsening of condition under study|1|||
129973780|NCT01151215|467867886|FG002|Overall Study|Worsening of condition under study|1|||
129973781|NCT01151215|467867884|FG000|Overall Study|Death|16|||
129973782|NCT01151215|467867885|FG001|Overall Study|Death|20|||
129973783|NCT01151215|467867886|FG002|Overall Study|Death|11|||
129973784|NCT01151215|467867884|FG000|Overall Study|Lost to Follow-up|0|||
129973785|NCT01151215|467867885|FG001|Overall Study|Lost to Follow-up|0|||
129973786|NCT01151215|467867886|FG002|Overall Study|Lost to Follow-up|3|||
129973787|NCT01151215|467867884|FG000|Overall Study|Withdrawal by Subject|3|||
129973788|NCT01151215|467867885|FG001|Overall Study|Withdrawal by Subject|1|||
129973789|NCT01151215|467867886|FG002|Overall Study|Withdrawal by Subject|2|||
129973790|NCT01151215|467867884|FG000|Overall Study|Disease progression|0|||
129973791|NCT01151215|467867885|FG001|Overall Study|Disease progression|1|||
129973792|NCT01151215|467867886|FG002|Overall Study|Disease progression|1|||
129973793|NCT01151215|467867884|FG000|Overall Study|Safety as judged by the investigator|0|||
129973794|NCT01151215|467867885|FG001|Overall Study|Safety as judged by the investigator|0|||
129973795|NCT01151215|467867886|FG002|Overall Study|Safety as judged by the investigator|1|||
129973796|NCT01721954|467867889|FG000|Overall Study|Death|58|||
129973797|NCT01721954|467867890|FG001|Overall Study|Death|64|||
129973798|NCT01721954|467867889|FG000|Overall Study|Withdrawal by Subject|8|||
129973799|NCT01721954|467867890|FG001|Overall Study|Withdrawal by Subject|4|||
129973800|NCT01721954|467867889|FG000|Overall Study|Adverse Event|2|||
129973801|NCT01721954|467867890|FG001|Overall Study|Adverse Event|0|||
129973802|NCT01721954|467867889|FG000|Overall Study|Lost to Follow-up|2|||
129973803|NCT01721954|467867890|FG001|Overall Study|Lost to Follow-up|1|||
129973804|NCT03392168|467867891|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
129973805|NCT03392168|467867892|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
129973806|NCT03392168|467867893|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
129973807|NCT03392168|467867894|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
129973808|NCT03392168|467867891|FG000|Period 2: Cohort 2|Other|0|||
129973809|NCT03392168|467867892|FG001|Period 2: Cohort 2|Other|1|||
129973810|NCT03392168|467867893|FG002|Period 2: Cohort 2|Other|0|||
129973811|NCT03392168|467867894|FG003|Period 2: Cohort 2|Other|0|||
129973812|NCT00368875|467867899|FG000|Overall Study|Adverse Event|0|||
129973813|NCT00368875|467867900|FG001|Overall Study|Adverse Event|12|||
129973814|NCT00368875|467867899|FG000|Overall Study|Progressive disease|3|||
129973815|NCT00368875|467867900|FG001|Overall Study|Progressive disease|27|||
129973816|NCT00368875|467867899|FG000|Overall Study|Withdrawal by Subject|2|||
129973817|NCT00368875|467867900|FG001|Overall Study|Withdrawal by Subject|6|||
129973818|NCT00368875|467867899|FG000|Overall Study|Other Reason|0|||
129973819|NCT00368875|467867900|FG001|Overall Study|Other Reason|2|||
129973820|NCT00368875|467867899|FG000|Overall Study|Alternative Therapy|1|||
129973821|NCT00368875|467867900|FG001|Overall Study|Alternative Therapy|1|||
129973822|NCT01305239|467867901|FG000|Overall Study|Adverse Event|22|||
129973823|NCT01305239|467867901|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
129973824|NCT03229486|467867902|FG000|Overall Study|Protocol Violation|0|||
129973825|NCT03229486|467867903|FG001|Overall Study|Protocol Violation|1|||
129973826|NCT01461005|467867907|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
129973827|NCT04160988|467867912|FG000|Overall Study|poor image quality|28|||
129973828|NCT00844597|467867913|FG000|Overall Study|Adverse Event|0|||
129973829|NCT00844597|467867914|FG001|Overall Study|Adverse Event|0|||
129973830|NCT00844597|467867915|FG002|Overall Study|Adverse Event|0|||
129973831|NCT00844597|467867916|FG003|Overall Study|Adverse Event|1|||
129973832|NCT00844597|467867917|FG004|Overall Study|Adverse Event|0|||
129973833|NCT00844597|467867918|FG005|Overall Study|Adverse Event|0|||
129973834|NCT02670122|467867919|FG000|Overall Study|Lost to Follow-up|4|||
129470903|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129470904|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
129470905|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
129470906|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
129470907|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129470908|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129470909|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129470910|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129470911|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129470912|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
129470913|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
129470914|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
129470915|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129470916|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129470917|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129470918|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129470919|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129470920|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
129470921|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
129470922|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
129470923|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129470924|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129470925|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129470926|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129470927|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129470928|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
129470929|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
129470930|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
129470931|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129973835|NCT02762903|467867925|FG000|Overall Study|Lost to Follow-up|0|||
129973836|NCT02762903|467867926|FG001|Overall Study|Lost to Follow-up|1|||
129973837|NCT01228175|467867927|FG000|Overall Study|Lost to Follow-up|64|||
129470932|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129470933|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129470934|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129470935|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129470936|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
129470937|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
129470938|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129470939|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129470940|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129470941|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129470942|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129470943|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129470944|NCT01097629|466020216|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
129470945|NCT01097629|466020217|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
129470946|NCT01097629|466020218|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
129470947|NCT01097629|466020219|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129470948|NCT01097629|466020220|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129470949|NCT01097629|466020221|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129470950|NCT01097629|466020222|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129470951|NCT01097629|466020223|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129470952|NCT01097629|466020216|FG000|DB RO Phase|Withdrawal by Subject|0|||
129470953|NCT01097629|466020217|FG001|DB RO Phase|Withdrawal by Subject|0|||
129470954|NCT01097629|466020218|FG002|DB RO Phase|Withdrawal by Subject|0|||
129470955|NCT01097629|466020219|FG003|DB RO Phase|Withdrawal by Subject|0|||
129470956|NCT01097629|466020220|FG004|DB RO Phase|Withdrawal by Subject|0|||
129470957|NCT01097629|466020221|FG005|DB RO Phase|Withdrawal by Subject|0|||
129470958|NCT01097629|466020222|FG006|DB RO Phase|Withdrawal by Subject|0|||
129470959|NCT01097629|466020223|FG007|DB RO Phase|Withdrawal by Subject|1|||
129470960|NCT01097629|466020216|FG000|DB RO Phase|Protocol Violation|0|||
129470961|NCT01097629|466020217|FG001|DB RO Phase|Protocol Violation|0|||
129470962|NCT01097629|466020218|FG002|DB RO Phase|Protocol Violation|0|||
129470963|NCT01097629|466020219|FG003|DB RO Phase|Protocol Violation|1|||
129470964|NCT01097629|466020220|FG004|DB RO Phase|Protocol Violation|0|||
129470965|NCT01097629|466020221|FG005|DB RO Phase|Protocol Violation|1|||
129470966|NCT01097629|466020222|FG006|DB RO Phase|Protocol Violation|1|||
129470967|NCT01097629|466020223|FG007|DB RO Phase|Protocol Violation|0|||
129470968|NCT01097629|466020216|FG000|DB RO Phase|Lost to Follow-up|0|||
129470969|NCT01097629|466020217|FG001|DB RO Phase|Lost to Follow-up|0|||
129470970|NCT01097629|466020218|FG002|DB RO Phase|Lost to Follow-up|0|||
129470971|NCT01097629|466020219|FG003|DB RO Phase|Lost to Follow-up|0|||
129470972|NCT01097629|466020220|FG004|DB RO Phase|Lost to Follow-up|0|||
129470973|NCT01097629|466020221|FG005|DB RO Phase|Lost to Follow-up|0|||
129470974|NCT01097629|466020222|FG006|DB RO Phase|Lost to Follow-up|2|||
129470975|NCT01097629|466020223|FG007|DB RO Phase|Lost to Follow-up|0|||
129470976|NCT00947531|466020225|FG000|Overall Study|Withdrawal by Subject|10|||
129470977|NCT00947531|466020226|FG001|Overall Study|Withdrawal by Subject|7|||
129470978|NCT00947531|466020225|FG000|Overall Study|Administrative Reason|0|||
129470979|NCT00947531|466020226|FG001|Overall Study|Administrative Reason|1|||
129470980|NCT00947531|466020225|FG000|Overall Study|Adverse Event|2|||
129470981|NCT00947531|466020226|FG001|Overall Study|Adverse Event|2|||
129470982|NCT00947531|466020225|FG000|Overall Study|Lack of Efficacy|1|||
129470983|NCT00947531|466020226|FG001|Overall Study|Lack of Efficacy|0|||
129470984|NCT00947531|466020225|FG000|Overall Study|Other|1|||
129470985|NCT00947531|466020226|FG001|Overall Study|Other|1|||
129470986|NCT01773421|466020228|FG000|Treatment Phase|Other|0|||
129470987|NCT01773421|466020229|FG001|Treatment Phase|Other|0|||
129470988|NCT01773421|466020230|FG002|Treatment Phase|Other|2|||
129470989|NCT01773421|466020231|FG003|Treatment Phase|Other|0|||
129470990|NCT01773421|466020232|FG004|Treatment Phase|Other|0|||
129470991|NCT01773421|466020233|FG005|Treatment Phase|Other|0|||
129470992|NCT01773421|466020234|FG006|Treatment Phase|Other|0|||
129470993|NCT01773421|466020228|FG000|Treatment Phase|Adverse Event|0|||
129470994|NCT01773421|466020229|FG001|Treatment Phase|Adverse Event|0|||
129470995|NCT01773421|466020230|FG002|Treatment Phase|Adverse Event|3|||
129470996|NCT01773421|466020231|FG003|Treatment Phase|Adverse Event|1|||
129470997|NCT01773421|466020232|FG004|Treatment Phase|Adverse Event|0|||
129470998|NCT01773421|466020233|FG005|Treatment Phase|Adverse Event|0|||
129470999|NCT01773421|466020234|FG006|Treatment Phase|Adverse Event|0|||
129471000|NCT01773421|466020228|FG000|Treatment Phase|Withdrawal by Subject|0|||
129471001|NCT01773421|466020229|FG001|Treatment Phase|Withdrawal by Subject|0|||
129471002|NCT01773421|466020230|FG002|Treatment Phase|Withdrawal by Subject|1|||
129471003|NCT01773421|466020231|FG003|Treatment Phase|Withdrawal by Subject|1|||
129471004|NCT01773421|466020232|FG004|Treatment Phase|Withdrawal by Subject|0|||
129471005|NCT01773421|466020233|FG005|Treatment Phase|Withdrawal by Subject|0|||
129471006|NCT01773421|466020234|FG006|Treatment Phase|Withdrawal by Subject|0|||
129471007|NCT01773421|466020228|FG000|Extension Phase|Other|0|||
129471008|NCT01773421|466020229|FG001|Extension Phase|Other|0|||
129471009|NCT01773421|466020230|FG002|Extension Phase|Other|0|||
129471010|NCT01773421|466020231|FG003|Extension Phase|Other|0|||
129471011|NCT01773421|466020232|FG004|Extension Phase|Other|1|||
129471012|NCT01773421|466020233|FG005|Extension Phase|Other|2|||
129471013|NCT01773421|466020234|FG006|Extension Phase|Other|0|||
129471014|NCT01773421|466020228|FG000|Extension Phase|Adverse Event|0|||
129471015|NCT01773421|466020229|FG001|Extension Phase|Adverse Event|0|||
129471016|NCT01773421|466020230|FG002|Extension Phase|Adverse Event|0|||
129471017|NCT01773421|466020231|FG003|Extension Phase|Adverse Event|0|||
129471018|NCT01773421|466020232|FG004|Extension Phase|Adverse Event|2|||
129471019|NCT01773421|466020233|FG005|Extension Phase|Adverse Event|0|||
129471020|NCT01773421|466020234|FG006|Extension Phase|Adverse Event|0|||
129471021|NCT03502330|466020235|FG000|Overall Study|Adverse Event|2|||
129471022|NCT03502330|466020236|FG001|Overall Study|Adverse Event|1|||
129471023|NCT03502330|466020237|FG002|Overall Study|Adverse Event|0|||
129471024|NCT03502330|466020238|FG003|Overall Study|Adverse Event|0|||
129471025|NCT03502330|466020239|FG004|Overall Study|Adverse Event|1|||
129471026|NCT03502330|466020240|FG005|Overall Study|Adverse Event|0|||
129471027|NCT03502330|466020241|FG006|Overall Study|Adverse Event|1|||
129471028|NCT03502330|466020242|FG007|Overall Study|Adverse Event|1|||
129471029|NCT03502330|466020243|FG008|Overall Study|Adverse Event|0|||
129471030|NCT03502330|466020235|FG000|Overall Study|Lack of Efficacy|1|||
129471031|NCT03502330|466020236|FG001|Overall Study|Lack of Efficacy|5|||
129471032|NCT03502330|466020237|FG002|Overall Study|Lack of Efficacy|3|||
129471033|NCT03502330|466020238|FG003|Overall Study|Lack of Efficacy|5|||
129471034|NCT03502330|466020239|FG004|Overall Study|Lack of Efficacy|1|||
129973838|NCT01228175|467867928|FG001|Overall Study|Lost to Follow-up|50|||
129973839|NCT01228175|467867927|FG000|Overall Study|Withdrawal by Subject|1|||
129973840|NCT01228175|467867928|FG001|Overall Study|Withdrawal by Subject|2|||
129973841|NCT01228175|467867927|FG000|Overall Study|Physician Decision|1|||
129973842|NCT01228175|467867928|FG001|Overall Study|Physician Decision|1|||
129973843|NCT00243074|467867929|FG000|Overall Study|Ineligible|6|||
129973844|NCT00243074|467867929|FG000|Overall Study|Adverse Event|6|||
129973845|NCT00243074|467867929|FG000|Overall Study|Withdrawal by Subject|2|||
129973846|NCT00243074|467867929|FG000|Overall Study|Lack of Efficacy|36|||
129973847|NCT00243074|467867929|FG000|Overall Study|Death|2|||
129471035|NCT03502330|466020240|FG005|Overall Study|Lack of Efficacy|5|||
129471036|NCT03502330|466020241|FG006|Overall Study|Lack of Efficacy|5|||
129471037|NCT03502330|466020242|FG007|Overall Study|Lack of Efficacy|6|||
129471038|NCT03502330|466020243|FG008|Overall Study|Lack of Efficacy|0|||
129471039|NCT03502330|466020235|FG000|Overall Study|Physician Decision|0|||
129471040|NCT03502330|466020236|FG001|Overall Study|Physician Decision|0|||
129471041|NCT03502330|466020237|FG002|Overall Study|Physician Decision|0|||
129471042|NCT03502330|466020238|FG003|Overall Study|Physician Decision|0|||
129471043|NCT03502330|466020239|FG004|Overall Study|Physician Decision|1|||
129471044|NCT03502330|466020240|FG005|Overall Study|Physician Decision|0|||
129471045|NCT03502330|466020241|FG006|Overall Study|Physician Decision|0|||
129471046|NCT03502330|466020242|FG007|Overall Study|Physician Decision|0|||
129973848|NCT00243074|467867929|FG000|Overall Study|not protocol specified|1|||
129973849|NCT00243074|467867929|FG000|Overall Study|Did not receive any treatment|1|||
129973850|NCT00664534|467867930|FG000|Overall Study|Adverse Event|2|||
129973851|NCT00664534|467867931|FG001|Overall Study|Adverse Event|3|||
129973852|NCT00664534|467867930|FG000|Overall Study|Lost to Follow-up|6|||
129973853|NCT00664534|467867931|FG001|Overall Study|Lost to Follow-up|10|||
129973854|NCT00664534|467867930|FG000|Overall Study|Protocol Violation|10|||
129973855|NCT00664534|467867931|FG001|Overall Study|Protocol Violation|8|||
129973856|NCT00664534|467867930|FG000|Overall Study|Withdrawal by Subject|7|||
129973857|NCT00664534|467867931|FG001|Overall Study|Withdrawal by Subject|6|||
129973858|NCT00664534|467867930|FG000|Overall Study|Physician Decision|8|||
129973859|NCT00664534|467867931|FG001|Overall Study|Physician Decision|0|||
129973860|NCT00664534|467867930|FG000|Overall Study|Sponsor decision|8|||
129973861|NCT00664534|467867931|FG001|Overall Study|Sponsor decision|6|||
129973862|NCT03041792|467867934|FG000|Overall Study|Adverse Event|4|||
129973863|NCT03041792|467867935|FG001|Overall Study|Adverse Event|0|||
129973864|NCT03041792|467867934|FG000|Overall Study|Death in the family|0|||
129973865|NCT03041792|467867935|FG001|Overall Study|Death in the family|2|||
129973866|NCT03041792|467867934|FG000|Overall Study|Randomized but not treated|0|||
129973867|NCT03041792|467867935|FG001|Overall Study|Randomized but not treated|1|||
129973868|NCT04978090|467867936|FG000|Overall Study|unable to adequately fit device|2|||
129471047|NCT03502330|466020243|FG008|Overall Study|Physician Decision|0|||
129471048|NCT03502330|466020235|FG000|Overall Study|Withdrawal by Subject|0|||
129471049|NCT03502330|466020236|FG001|Overall Study|Withdrawal by Subject|0|||
129471050|NCT03502330|466020237|FG002|Overall Study|Withdrawal by Subject|0|||
129973869|NCT02227992|467867937|FG000|Overall Study|Lost to Follow-up|1|||
129973870|NCT02227992|467867938|FG001|Overall Study|Lost to Follow-up|1|||
129973871|NCT00996606|467867941|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
129471051|NCT03502330|466020238|FG003|Overall Study|Withdrawal by Subject|0|||
129471052|NCT03502330|466020239|FG004|Overall Study|Withdrawal by Subject|0|||
129471053|NCT03502330|466020240|FG005|Overall Study|Withdrawal by Subject|1|||
129973872|NCT00996606|467867941|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129973873|NCT00996606|467867941|FG000|Overall Study|Protocol Violation|1|||
129973874|NCT00996606|467867941|FG000|Overall Study|Withdrawal by Subject|3|||
129973875|NCT00632502|467867943|FG000|Overall Study|Adverse Event|0|||
129973876|NCT00632502|467867944|FG001|Overall Study|Adverse Event|1|||
129973877|NCT00632502|467867943|FG000|Overall Study|Randomized not treated|3|||
129973878|NCT00632502|467867944|FG001|Overall Study|Randomized not treated|0|||
129973879|NCT03075527|467867945|FG000|Overall Study|Death|1|||
129973880|NCT03075527|467867945|FG000|Overall Study|Withdrawal by Subject|1|||
129973881|NCT03075527|467867945|FG000|Overall Study|Physician Decision|3|||
129973882|NCT03075527|467867945|FG000|Overall Study|Progression/Relapse|14|||
129973883|NCT00681668|467867946|FG000|Overall Study|Protocol Violation|1|||
129973884|NCT00681668|467867946|FG000|Overall Study|Withdrawal by Subject|1|||
129973885|NCT02209181|467867947|FG000|Overall Study|Adverse Event|1|||
129973886|NCT02209181|467867948|FG001|Overall Study|Adverse Event|0|||
129973887|NCT02209181|467867949|FG002|Overall Study|Adverse Event|1|||
129973888|NCT02209181|467867950|FG003|Overall Study|Adverse Event|0|||
129973889|NCT02209181|467867947|FG000|Overall Study|Withdrawal by Subject|0|||
129973890|NCT02209181|467867948|FG001|Overall Study|Withdrawal by Subject|1|||
129973891|NCT02209181|467867949|FG002|Overall Study|Withdrawal by Subject|0|||
129973892|NCT02209181|467867950|FG003|Overall Study|Withdrawal by Subject|0|||
129973893|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
129973894|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
129973895|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
129973896|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
129973897|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
129973898|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973899|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973900|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973901|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
129973902|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
129973903|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
129973904|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
129973905|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
129973906|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
129973907|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
129973908|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Death|1|||
129973909|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Death|0|||
129973910|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Death|0|||
129973911|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Death|0|||
129973912|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Death|0|||
129973913|NCT04641962|467867956|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
129973914|NCT04641962|467867957|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
129973915|NCT04641962|467867958|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
129973916|NCT04641962|467867959|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
129471054|NCT03502330|466020241|FG006|Overall Study|Withdrawal by Subject|0|||
129471055|NCT03502330|466020242|FG007|Overall Study|Withdrawal by Subject|1|||
129471056|NCT03502330|466020243|FG008|Overall Study|Withdrawal by Subject|0|||
129973917|NCT04641962|467867960|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
129973918|NCT04641962|467867956|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
129973919|NCT04641962|467867957|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
129973920|NCT04641962|467867958|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
129973921|NCT04641962|467867959|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
129973922|NCT04641962|467867960|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
129973923|NCT04641962|467867956|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129973924|NCT04641962|467867957|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129973925|NCT04641962|467867958|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
129973926|NCT04641962|467867959|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129973927|NCT04641962|467867960|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
129471057|NCT03502330|466020235|FG000|Overall Study|Death|0|||
129471058|NCT03502330|466020236|FG001|Overall Study|Death|0|||
129471059|NCT03502330|466020237|FG002|Overall Study|Death|0|||
129471060|NCT03502330|466020238|FG003|Overall Study|Death|0|||
129471061|NCT03502330|466020239|FG004|Overall Study|Death|0|||
129471062|NCT03502330|466020240|FG005|Overall Study|Death|0|||
129471063|NCT03502330|466020241|FG006|Overall Study|Death|2|||
129471064|NCT03502330|466020242|FG007|Overall Study|Death|0|||
129471065|NCT03502330|466020243|FG008|Overall Study|Death|0|||
129471066|NCT02804763|466020244|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
129471067|NCT02804763|466020245|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
129471068|NCT02804763|466020246|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
129973928|NCT00862836|467867961|FG000|Overall Study|Withdrawal by Subject|1|||
129973929|NCT06926673|467867962|FG000|Overall Study|Lost to Follow-up|0|||
129973930|NCT06926673|467867963|FG001|Overall Study|Lost to Follow-up|0|||
129973931|NCT06926673|467867964|FG002|Overall Study|Lost to Follow-up|0|||
129973932|NCT06926673|467867965|FG003|Overall Study|Lost to Follow-up|1|||
129973933|NCT06926673|467867966|FG004|Overall Study|Lost to Follow-up|0|||
129973934|NCT06926673|467867967|FG005|Overall Study|Lost to Follow-up|0|||
129973935|NCT06926673|467867968|FG006|Overall Study|Lost to Follow-up|0|||
129471069|NCT02804763|466020247|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
129471070|NCT02804763|466020244|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
129471071|NCT02804763|466020245|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
129471072|NCT02804763|466020246|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
129471073|NCT02804763|466020247|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
129471074|NCT02804763|466020244|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
129471075|NCT02804763|466020245|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
129471076|NCT02804763|466020246|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
129471077|NCT02804763|466020247|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
129471078|NCT02804763|466020244|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
129471079|NCT02804763|466020245|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
129471080|NCT02804763|466020246|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
129471081|NCT02804763|466020247|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
129471082|NCT02804763|466020244|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
129471083|NCT02804763|466020245|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
129471084|NCT02804763|466020246|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
129471085|NCT02804763|466020247|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
129471086|NCT02804763|466020244|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
129471087|NCT02804763|466020245|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
129471088|NCT02804763|466020246|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
129471089|NCT02804763|466020247|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
129471090|NCT04656990|466020248|FG000|Baseline|pandemic|20|||
129471091|NCT04656990|466020249|FG001|Baseline|pandemic|24|||
129471092|NCT04656990|466020248|FG000|Follow Up Period|Lost to Follow-up|61|||
129471093|NCT04656990|466020249|FG001|Follow Up Period|Lost to Follow-up|73|||
129471094|NCT00282243|466020250|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
129471095|NCT00282243|466020250|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
129471096|NCT00282243|466020250|FG000|Extension Treatment Period|Adverse Event|15|||
129471097|NCT00282243|466020250|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
129471098|NCT00282243|466020250|FG000|Extension Treatment Period|Non-compliance|2|||
129471099|NCT00282243|466020250|FG000|Extension Treatment Period|Physician Decision|1|||
129471100|NCT01070329|466020251|FG000|Overall Study|Adverse Event|13|||
129471101|NCT01070329|466020252|FG001|Overall Study|Adverse Event|10|||
129471102|NCT01070329|466020251|FG000|Overall Study|Lost to Follow-up|22|||
129471103|NCT01070329|466020252|FG001|Overall Study|Lost to Follow-up|12|||
129471104|NCT01070329|466020251|FG000|Overall Study|Withdrawal by Subject|9|||
129471105|NCT01070329|466020252|FG001|Overall Study|Withdrawal by Subject|11|||
129471106|NCT01070329|466020251|FG000|Overall Study|Protocol Violation|3|||
129471107|NCT01070329|466020252|FG001|Overall Study|Protocol Violation|8|||
129471108|NCT01070329|466020251|FG000|Overall Study|Lack of Efficacy|2|||
129471109|NCT01070329|466020252|FG001|Overall Study|Lack of Efficacy|6|||
129471110|NCT01070329|466020251|FG000|Overall Study|Physician Decision|2|||
129471111|NCT01070329|466020252|FG001|Overall Study|Physician Decision|1|||
129471112|NCT01070329|466020251|FG000|Overall Study|Entry Criteria Not Met|1|||
129471113|NCT01070329|466020252|FG001|Overall Study|Entry Criteria Not Met|0|||
129471114|NCT01070329|466020251|FG000|Overall Study|Sponsor Decision|0|||
129471115|NCT01070329|466020252|FG001|Overall Study|Sponsor Decision|1|||
129471116|NCT02863848|466020253|FG000|Overall Study|Lost to Follow-up|1|||
129471117|NCT02863848|466020254|FG001|Overall Study|Lost to Follow-up|1|||
129471118|NCT02863848|466020253|FG000|Overall Study|Protocol Violation|1|||
129471119|NCT02863848|466020254|FG001|Overall Study|Protocol Violation|2|||
129471120|NCT03588741|466020255|FG000|Overall Study|Withdrawal by Subject|1|||
129471121|NCT00548548|466020256|FG000|Overall Study|Death|345|||
129471122|NCT00548548|466020257|FG001|Overall Study|Death|348|||
129471123|NCT00548548|466020256|FG000|Overall Study|Lost to Follow-up|17|||
129471124|NCT00548548|466020257|FG001|Overall Study|Lost to Follow-up|18|||
129471125|NCT01705691|466020258|FG000|Overall Study|Death|1|||
129471126|NCT01705691|466020259|FG001|Overall Study|Death|2|||
129471127|NCT01705691|466020258|FG000|Overall Study|Withdrawal by Subject|1|||
129471128|NCT01705691|466020259|FG001|Overall Study|Withdrawal by Subject|2|||
129471129|NCT01705691|466020258|FG000|Overall Study|Lost to Follow-up|1|||
129471130|NCT01705691|466020259|FG001|Overall Study|Lost to Follow-up|1|||
129471131|NCT01705691|466020258|FG000|Overall Study|Other|0|||
129471132|NCT01705691|466020259|FG001|Overall Study|Other|1|||
129471133|NCT02913313|466020260|FG000|Overall Study|DISEASE PROGRESSION|1|||
129471134|NCT02913313|466020261|FG001|Overall Study|DISEASE PROGRESSION|2|||
129471135|NCT02913313|466020262|FG002|Overall Study|DISEASE PROGRESSION|2|||
129471136|NCT02913313|466020263|FG003|Overall Study|DISEASE PROGRESSION|4|||
129973936|NCT06926673|467867962|FG000|Overall Study|Physician Decision|0|||
129471137|NCT02913313|466020264|FG004|Overall Study|DISEASE PROGRESSION|6|||
129973937|NCT06926673|467867963|FG001|Overall Study|Physician Decision|0|||
129471138|NCT02913313|466020265|FG005|Overall Study|DISEASE PROGRESSION|4|||
129471139|NCT02913313|466020266|FG006|Overall Study|DISEASE PROGRESSION|19|||
129471140|NCT02913313|466020267|FG007|Overall Study|DISEASE PROGRESSION|3|||
129471141|NCT02913313|466020268|FG008|Overall Study|DISEASE PROGRESSION|4|||
129973938|NCT06926673|467867964|FG002|Overall Study|Physician Decision|0|||
129973939|NCT06926673|467867965|FG003|Overall Study|Physician Decision|0|||
129973940|NCT06926673|467867966|FG004|Overall Study|Physician Decision|0|||
129973941|NCT06926673|467867967|FG005|Overall Study|Physician Decision|0|||
129973942|NCT06926673|467867968|FG006|Overall Study|Physician Decision|1|||
129973943|NCT06926673|467867962|FG000|Overall Study|Withdrawal by Subject|0|||
129973944|NCT06926673|467867963|FG001|Overall Study|Withdrawal by Subject|3|||
129973945|NCT06926673|467867964|FG002|Overall Study|Withdrawal by Subject|2|||
129973946|NCT06926673|467867965|FG003|Overall Study|Withdrawal by Subject|1|||
129973947|NCT06926673|467867966|FG004|Overall Study|Withdrawal by Subject|0|||
129471142|NCT02913313|466020269|FG009|Overall Study|DISEASE PROGRESSION|4|||
129471143|NCT02913313|466020270|FG010|Overall Study|DISEASE PROGRESSION|11|||
129471144|NCT02913313|466020271|FG011|Overall Study|DISEASE PROGRESSION|5|||
129471145|NCT02913313|466020272|FG012|Overall Study|DISEASE PROGRESSION|14|||
129471146|NCT02913313|466020273|FG013|Overall Study|DISEASE PROGRESSION|3|||
129471147|NCT02913313|466020260|FG000|Overall Study|Not Reported|0|||
129471148|NCT02913313|466020261|FG001|Overall Study|Not Reported|0|||
129471149|NCT02913313|466020262|FG002|Overall Study|Not Reported|0|||
129471150|NCT02913313|466020263|FG003|Overall Study|Not Reported|0|||
129471151|NCT02913313|466020264|FG004|Overall Study|Not Reported|1|||
129471152|NCT02913313|466020265|FG005|Overall Study|Not Reported|0|||
129471153|NCT02913313|466020266|FG006|Overall Study|Not Reported|0|||
129471154|NCT02913313|466020267|FG007|Overall Study|Not Reported|0|||
129471155|NCT02913313|466020268|FG008|Overall Study|Not Reported|0|||
129471156|NCT02913313|466020269|FG009|Overall Study|Not Reported|0|||
129471157|NCT02913313|466020270|FG010|Overall Study|Not Reported|4|||
129471158|NCT02913313|466020271|FG011|Overall Study|Not Reported|0|||
129471159|NCT02913313|466020272|FG012|Overall Study|Not Reported|0|||
129471160|NCT02913313|466020273|FG013|Overall Study|Not Reported|0|||
129471161|NCT02913313|466020260|FG000|Overall Study|Other reasons|0|||
129471162|NCT02913313|466020261|FG001|Overall Study|Other reasons|0|||
129471163|NCT02913313|466020262|FG002|Overall Study|Other reasons|0|||
129471164|NCT02913313|466020263|FG003|Overall Study|Other reasons|0|||
129471165|NCT02913313|466020264|FG004|Overall Study|Other reasons|1|||
129471166|NCT02913313|466020265|FG005|Overall Study|Other reasons|0|||
129471167|NCT02913313|466020266|FG006|Overall Study|Other reasons|0|||
129471168|NCT02913313|466020267|FG007|Overall Study|Other reasons|0|||
129471169|NCT02913313|466020268|FG008|Overall Study|Other reasons|0|||
129471170|NCT02913313|466020269|FG009|Overall Study|Other reasons|0|||
129471171|NCT02913313|466020270|FG010|Overall Study|Other reasons|1|||
129471172|NCT02913313|466020271|FG011|Overall Study|Other reasons|0|||
129471173|NCT02913313|466020272|FG012|Overall Study|Other reasons|0|||
129471174|NCT02913313|466020273|FG013|Overall Study|Other reasons|0|||
129471175|NCT02913313|466020260|FG000|Overall Study|Withdrawal by Subject|0|||
129471176|NCT02913313|466020261|FG001|Overall Study|Withdrawal by Subject|0|||
129471177|NCT02913313|466020262|FG002|Overall Study|Withdrawal by Subject|1|||
129471178|NCT02913313|466020263|FG003|Overall Study|Withdrawal by Subject|0|||
129471179|NCT02913313|466020264|FG004|Overall Study|Withdrawal by Subject|0|||
129471180|NCT02913313|466020265|FG005|Overall Study|Withdrawal by Subject|0|||
129471181|NCT02913313|466020266|FG006|Overall Study|Withdrawal by Subject|1|||
129471182|NCT02913313|466020267|FG007|Overall Study|Withdrawal by Subject|1|||
129471183|NCT02913313|466020268|FG008|Overall Study|Withdrawal by Subject|0|||
129471184|NCT02913313|466020269|FG009|Overall Study|Withdrawal by Subject|0|||
129471185|NCT02913313|466020270|FG010|Overall Study|Withdrawal by Subject|1|||
129471186|NCT02913313|466020271|FG011|Overall Study|Withdrawal by Subject|0|||
129471187|NCT02913313|466020272|FG012|Overall Study|Withdrawal by Subject|0|||
129471188|NCT02913313|466020273|FG013|Overall Study|Withdrawal by Subject|0|||
129471189|NCT02913313|466020260|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471190|NCT02913313|466020261|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129973948|NCT06926673|467867967|FG005|Overall Study|Withdrawal by Subject|2|||
129973949|NCT06926673|467867968|FG006|Overall Study|Withdrawal by Subject|0|||
129471191|NCT02913313|466020262|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471192|NCT02913313|466020263|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471193|NCT02913313|466020264|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471194|NCT02913313|466020265|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471195|NCT02913313|466020266|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471196|NCT02913313|466020267|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471197|NCT02913313|466020268|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471198|NCT02913313|466020269|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471199|NCT02913313|466020270|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
129973950|NCT03374488|467869575|FG000|Overall Study|Death|13|||
129973951|NCT03374488|467869576|FG001|Overall Study|Death|13|||
129973952|NCT03374488|467869575|FG000|Overall Study|Withdrawal by Subject|3|||
129471200|NCT02913313|466020271|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
129471201|NCT02913313|466020272|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
129471202|NCT02913313|466020273|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
129471203|NCT02913313|466020260|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
129471204|NCT02913313|466020261|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
129471205|NCT02913313|466020262|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
129471206|NCT02913313|466020263|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
129471207|NCT02913313|466020264|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
129471208|NCT02913313|466020265|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
129471209|NCT02913313|466020266|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
129471210|NCT02913313|466020267|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
129471211|NCT02913313|466020268|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
129471212|NCT02913313|466020269|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
129471213|NCT02913313|466020270|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
129471214|NCT02913313|466020271|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
129471215|NCT02913313|466020272|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
129471216|NCT02913313|466020273|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
129471217|NCT04088409|466020274|FG000|Part A|Withdrawal by Subject|2|||
129471218|NCT04088409|466020275|FG001|Part A|Withdrawal by Subject|1|||
129471219|NCT04088409|466020274|FG000|Part A|Did Not Meet Randomization Criteria|2|||
129471220|NCT04088409|466020275|FG001|Part A|Did Not Meet Randomization Criteria|0|||
129471221|NCT04088409|466020274|FG000|Part A|Lack of Efficacy|9|||
129471222|NCT04088409|466020275|FG001|Part A|Lack of Efficacy|0|||
129471223|NCT04088409|466020274|FG000|Part A|Lost to Follow-up|1|||
129471224|NCT04088409|466020275|FG001|Part A|Lost to Follow-up|0|||
129471225|NCT04088409|466020274|FG000|Part A|Adverse Event|1|||
129471226|NCT04088409|466020275|FG001|Part A|Adverse Event|0|||
129471227|NCT04088409|466020274|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
129471228|NCT04088409|466020275|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
129471229|NCT04088409|466020274|FG000|Part B|Ongoing Treatment|10|||
129471230|NCT04088409|466020275|FG001|Part B|Ongoing Treatment|0|||
129471231|NCT04233229|466020276|FG000|Overall Study|Withdrawal by Subject|0|||
129471232|NCT04233229|466020277|FG001|Overall Study|Withdrawal by Subject|1|||
129471233|NCT04233229|466020276|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
129471234|NCT04233229|466020277|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
129471235|NCT04233229|466020276|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
129471236|NCT04233229|466020277|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
129471237|NCT02614079|466020280|FG000|Overall Study|Withdrawal by Subject|1|||
129471238|NCT03370770|466020281|FG000|Overall Study|Patient was followed in another hospital center|1|||
129471239|NCT03370770|466020281|FG000|Overall Study|Progressive Disease|98|||
129471240|NCT03370770|466020281|FG000|Overall Study|Adverse Event|2|||
129471241|NCT03370770|466020281|FG000|Overall Study|Death|5|||
129471242|NCT04426695|466020284|FG000|Overall Study|Death|2|||
129471243|NCT04426695|466020285|FG001|Overall Study|Death|0|||
129471244|NCT04426695|466020286|FG002|Overall Study|Death|1|||
129471245|NCT04426695|466020287|FG003|Overall Study|Death|27|||
129471246|NCT04426695|466020288|FG004|Overall Study|Death|25|||
129471247|NCT04426695|466020289|FG005|Overall Study|Death|21|||
129471248|NCT04426695|466020290|FG006|Overall Study|Death|42|||
129471249|NCT04426695|466020291|FG007|Overall Study|Death|23|||
129471250|NCT04426695|466020292|FG008|Overall Study|Death|37|||
129471251|NCT04426695|466020293|FG009|Overall Study|Death|14|||
129471252|NCT04426695|466020294|FG010|Overall Study|Death|8|||
129471253|NCT04426695|466020295|FG011|Overall Study|Death|7|||
129471254|NCT04426695|466020296|FG012|Overall Study|Death|13|||
129471255|NCT04426695|466020297|FG013|Overall Study|Death|25|||
129471256|NCT04426695|466020298|FG014|Overall Study|Death|19|||
129471257|NCT04426695|466020299|FG015|Overall Study|Death|7|||
129471258|NCT04426695|466020300|FG016|Overall Study|Death|8|||
129471259|NCT04426695|466020301|FG017|Overall Study|Death|4|||
129471260|NCT04426695|466020284|FG000|Overall Study|Lost to Follow-up|2|||
129471261|NCT04426695|466020285|FG001|Overall Study|Lost to Follow-up|4|||
129471262|NCT04426695|466020286|FG002|Overall Study|Lost to Follow-up|1|||
129471263|NCT04426695|466020287|FG003|Overall Study|Lost to Follow-up|19|||
129471264|NCT04426695|466020288|FG004|Overall Study|Lost to Follow-up|10|||
129471265|NCT04426695|466020289|FG005|Overall Study|Lost to Follow-up|14|||
129471266|NCT04426695|466020290|FG006|Overall Study|Lost to Follow-up|5|||
129471267|NCT04426695|466020291|FG007|Overall Study|Lost to Follow-up|14|||
129471268|NCT04426695|466020292|FG008|Overall Study|Lost to Follow-up|10|||
129471269|NCT04426695|466020293|FG009|Overall Study|Lost to Follow-up|11|||
129471270|NCT04426695|466020294|FG010|Overall Study|Lost to Follow-up|12|||
129471271|NCT04426695|466020295|FG011|Overall Study|Lost to Follow-up|6|||
129471272|NCT04426695|466020296|FG012|Overall Study|Lost to Follow-up|2|||
129471273|NCT04426695|466020297|FG013|Overall Study|Lost to Follow-up|2|||
129471274|NCT04426695|466020298|FG014|Overall Study|Lost to Follow-up|2|||
129471275|NCT04426695|466020299|FG015|Overall Study|Lost to Follow-up|0|||
129471276|NCT04426695|466020300|FG016|Overall Study|Lost to Follow-up|0|||
129471277|NCT04426695|466020301|FG017|Overall Study|Lost to Follow-up|0|||
129471278|NCT04426695|466020284|FG000|Overall Study|Participant Decision|1|||
129471279|NCT04426695|466020285|FG001|Overall Study|Participant Decision|2|||
129471280|NCT04426695|466020286|FG002|Overall Study|Participant Decision|2|||
129471281|NCT04426695|466020287|FG003|Overall Study|Participant Decision|12|||
129471282|NCT04426695|466020288|FG004|Overall Study|Participant Decision|18|||
129471283|NCT04426695|466020289|FG005|Overall Study|Participant Decision|22|||
129471284|NCT04426695|466020290|FG006|Overall Study|Participant Decision|13|||
129471285|NCT04426695|466020291|FG007|Overall Study|Participant Decision|13|||
129471286|NCT04426695|466020292|FG008|Overall Study|Participant Decision|10|||
129471287|NCT04426695|466020293|FG009|Overall Study|Participant Decision|15|||
129471288|NCT04426695|466020294|FG010|Overall Study|Participant Decision|16|||
129471289|NCT04426695|466020295|FG011|Overall Study|Participant Decision|17|||
129471290|NCT04426695|466020296|FG012|Overall Study|Participant Decision|2|||
129471291|NCT04426695|466020297|FG013|Overall Study|Participant Decision|1|||
129471292|NCT04426695|466020298|FG014|Overall Study|Participant Decision|2|||
129471293|NCT04426695|466020299|FG015|Overall Study|Participant Decision|0|||
129471294|NCT04426695|466020300|FG016|Overall Study|Participant Decision|0|||
129471295|NCT04426695|466020301|FG017|Overall Study|Participant Decision|0|||
129471296|NCT04426695|466020284|FG000|Overall Study|Adverse Event|0|||
129471297|NCT04426695|466020285|FG001|Overall Study|Adverse Event|0|||
129471298|NCT04426695|466020286|FG002|Overall Study|Adverse Event|0|||
129471299|NCT04426695|466020287|FG003|Overall Study|Adverse Event|0|||
129471300|NCT04426695|466020288|FG004|Overall Study|Adverse Event|0|||
129471301|NCT04426695|466020289|FG005|Overall Study|Adverse Event|0|||
129471302|NCT04426695|466020290|FG006|Overall Study|Adverse Event|0|||
129471303|NCT04426695|466020291|FG007|Overall Study|Adverse Event|1|||
129471304|NCT04426695|466020292|FG008|Overall Study|Adverse Event|0|||
129471305|NCT04426695|466020293|FG009|Overall Study|Adverse Event|0|||
129471306|NCT04426695|466020294|FG010|Overall Study|Adverse Event|1|||
129471307|NCT04426695|466020295|FG011|Overall Study|Adverse Event|1|||
129471308|NCT04426695|466020296|FG012|Overall Study|Adverse Event|0|||
129471309|NCT04426695|466020297|FG013|Overall Study|Adverse Event|0|||
129471310|NCT04426695|466020298|FG014|Overall Study|Adverse Event|0|||
129471311|NCT04426695|466020299|FG015|Overall Study|Adverse Event|0|||
129471312|NCT04426695|466020300|FG016|Overall Study|Adverse Event|0|||
129471313|NCT04426695|466020301|FG017|Overall Study|Adverse Event|0|||
129471314|NCT04426695|466020284|FG000|Overall Study|Sponsor Request|0|||
129471315|NCT04426695|466020285|FG001|Overall Study|Sponsor Request|0|||
129471316|NCT04426695|466020286|FG002|Overall Study|Sponsor Request|0|||
129471317|NCT04426695|466020287|FG003|Overall Study|Sponsor Request|0|||
129471318|NCT04426695|466020288|FG004|Overall Study|Sponsor Request|0|||
129471319|NCT04426695|466020289|FG005|Overall Study|Sponsor Request|0|||
129471320|NCT04426695|466020290|FG006|Overall Study|Sponsor Request|1|||
129471321|NCT04426695|466020291|FG007|Overall Study|Sponsor Request|0|||
129471322|NCT04426695|466020292|FG008|Overall Study|Sponsor Request|0|||
129471323|NCT04426695|466020293|FG009|Overall Study|Sponsor Request|0|||
129471324|NCT04426695|466020294|FG010|Overall Study|Sponsor Request|0|||
129471325|NCT04426695|466020295|FG011|Overall Study|Sponsor Request|0|||
129471326|NCT04426695|466020296|FG012|Overall Study|Sponsor Request|0|||
129471327|NCT04426695|466020297|FG013|Overall Study|Sponsor Request|0|||
129471328|NCT04426695|466020298|FG014|Overall Study|Sponsor Request|0|||
129471329|NCT04426695|466020299|FG015|Overall Study|Sponsor Request|0|||
129471330|NCT04426695|466020300|FG016|Overall Study|Sponsor Request|0|||
129471331|NCT04426695|466020301|FG017|Overall Study|Sponsor Request|0|||
129471332|NCT04426695|466020284|FG000|Overall Study|Physician Decision|0|||
129471333|NCT04426695|466020285|FG001|Overall Study|Physician Decision|0|||
129471334|NCT04426695|466020286|FG002|Overall Study|Physician Decision|0|||
129471335|NCT04426695|466020287|FG003|Overall Study|Physician Decision|0|||
129471336|NCT04426695|466020288|FG004|Overall Study|Physician Decision|0|||
129471337|NCT04426695|466020289|FG005|Overall Study|Physician Decision|0|||
129471338|NCT04426695|466020290|FG006|Overall Study|Physician Decision|0|||
129471339|NCT04426695|466020291|FG007|Overall Study|Physician Decision|0|||
129471340|NCT04426695|466020292|FG008|Overall Study|Physician Decision|0|||
129471341|NCT04426695|466020293|FG009|Overall Study|Physician Decision|1|||
129471342|NCT04426695|466020294|FG010|Overall Study|Physician Decision|0|||
129471343|NCT04426695|466020295|FG011|Overall Study|Physician Decision|0|||
129471344|NCT04426695|466020296|FG012|Overall Study|Physician Decision|1|||
129973953|NCT03374488|467869576|FG001|Overall Study|Withdrawal by Subject|1|||
129973954|NCT03374488|467869575|FG000|Overall Study|Physician Decision|3|||
129471345|NCT04426695|466020297|FG013|Overall Study|Physician Decision|0|||
129471346|NCT04426695|466020298|FG014|Overall Study|Physician Decision|0|||
129471347|NCT04426695|466020299|FG015|Overall Study|Physician Decision|0|||
129471348|NCT04426695|466020300|FG016|Overall Study|Physician Decision|0|||
129471349|NCT04426695|466020301|FG017|Overall Study|Physician Decision|0|||
129471350|NCT04426695|466020284|FG000|Overall Study|Randomized but Never Treated|3|||
129471351|NCT04426695|466020285|FG001|Overall Study|Randomized but Never Treated|1|||
129471352|NCT04426695|466020286|FG002|Overall Study|Randomized but Never Treated|0|||
129471353|NCT04426695|466020287|FG003|Overall Study|Randomized but Never Treated|4|||
129471354|NCT04426695|466020288|FG004|Overall Study|Randomized but Never Treated|5|||
129973955|NCT03374488|467869576|FG001|Overall Study|Physician Decision|0|||
129973956|NCT03104075|467869577|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
129973957|NCT03104075|467869578|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
129973958|NCT04024462|467869579|FG000|Overall Study|Withdrawal by Subject|6|||
129973959|NCT04024462|467869580|FG001|Overall Study|Withdrawal by Subject|7|||
129973960|NCT04024462|467869579|FG000|Overall Study|Progressive Disease|0|||
129973961|NCT04024462|467869580|FG001|Overall Study|Progressive Disease|1|||
129973962|NCT04024462|467869579|FG000|Overall Study|Adverse Event|0|||
129973963|NCT04024462|467869580|FG001|Overall Study|Adverse Event|1|||
129973964|NCT04024462|467869579|FG000|Overall Study|Death|0|||
129973965|NCT04024462|467869580|FG001|Overall Study|Death|1|||
129973966|NCT04024462|467869579|FG000|Overall Study|Lost to Follow-up|1|||
129973967|NCT04024462|467869580|FG001|Overall Study|Lost to Follow-up|0|||
129973968|NCT04024462|467869579|FG000|Overall Study|Ongoing in the Study|94|||
129973969|NCT04024462|467869580|FG001|Overall Study|Ongoing in the Study|89|||
129973970|NCT04896008|467869581|FG000|Overall Study|Ongoing|70|||
129973971|NCT04896008|467869582|FG001|Overall Study|Ongoing|38|||
129973972|NCT04896008|467869581|FG000|Overall Study|Adverse Event|0|||
129973973|NCT04896008|467869582|FG001|Overall Study|Adverse Event|2|||
129973974|NCT04896008|467869581|FG000|Overall Study|Death|5|||
129973975|NCT04896008|467869582|FG001|Overall Study|Death|10|||
129973976|NCT04896008|467869581|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
129973977|NCT04896008|467869582|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
129973978|NCT04896008|467869581|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
129973979|NCT04896008|467869582|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
129973980|NCT04896008|467869581|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
129973981|NCT04896008|467869582|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
129973982|NCT04896008|467869581|FG000|Overall Study|Withdrawal by Subject|1|||
129973983|NCT04896008|467869582|FG001|Overall Study|Withdrawal by Subject|4|||
129973984|NCT04896008|467869581|FG000|Overall Study|Investigator Decision|2|||
129973985|NCT04896008|467869582|FG001|Overall Study|Investigator Decision|0|||
129973986|NCT04896008|467869581|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
129973987|NCT04896008|467869582|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
129973988|NCT00709228|467869594|FG000|Overall Study|Not treated|14|||
129973989|NCT00709228|467869594|FG000|Overall Study|Eligibility criteria not met|281|||
129973990|NCT00709228|467869594|FG000|Overall Study|Adverse events|2|||
129973991|NCT00709228|467869594|FG000|Overall Study|Discontinued treatment|14|||
129973992|NCT00709228|467869594|FG000|Overall Study|Did not enter follow-up|4|||
129973993|NCT00709228|467869594|FG000|Overall Study|Discontinued follow-up|5|||
129973994|NCT00709228|467869594|FG000|Overall Study|Disease progression|1|||
129973995|NCT00709228|467869594|FG000|Overall Study|Lost to Follow-up|6|||
129973996|NCT00709228|467869594|FG000|Overall Study|Non-compliance|5|||
129973997|NCT02870972|467869595|FG000|Overall Study|Adverse Event|1|||
129973998|NCT02870972|467869596|FG001|Overall Study|Adverse Event|0|||
129973999|NCT02870972|467869597|FG002|Overall Study|Adverse Event|0|||
129974000|NCT02870972|467869598|FG003|Overall Study|Adverse Event|0|||
129974001|NCT02870972|467869599|FG004|Overall Study|Adverse Event|0|||
129974002|NCT00789360|467869602|FG000|Overall Study|Protocol Violation|3|||
129974003|NCT00789360|467869603|FG001|Overall Study|Protocol Violation|1|||
129974004|NCT04400487|467869604|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129974005|NCT04400487|467869604|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
129974006|NCT04400487|467869604|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
129974007|NCT00022659|467869605|FG000|Overall Study|Ineligible: wrong primary|1|||
129974008|NCT00022659|467869605|FG000|Overall Study|Never treated|1|||
129974009|NCT03559062|467869606|FG000|Overall Study|Other|0|||
129974010|NCT03559062|467869607|FG001|Overall Study|Other|1|||
129974011|NCT03559062|467869608|FG002|Overall Study|Other|0|||
129974012|NCT03445533|467869609|FG000|Overall Study|Progressive Disease|48|||
129471355|NCT04426695|466020289|FG005|Overall Study|Randomized but Never Treated|5|||
129471356|NCT04426695|466020290|FG006|Overall Study|Randomized but Never Treated|4|||
129471357|NCT04426695|466020291|FG007|Overall Study|Randomized but Never Treated|6|||
129471358|NCT04426695|466020292|FG008|Overall Study|Randomized but Never Treated|6|||
129471359|NCT04426695|466020293|FG009|Overall Study|Randomized but Never Treated|3|||
129471360|NCT04426695|466020294|FG010|Overall Study|Randomized but Never Treated|3|||
129471361|NCT04426695|466020295|FG011|Overall Study|Randomized but Never Treated|6|||
129471362|NCT04426695|466020296|FG012|Overall Study|Randomized but Never Treated|1|||
129471363|NCT04426695|466020297|FG013|Overall Study|Randomized but Never Treated|2|||
129974013|NCT03445533|467869610|FG001|Overall Study|Progressive Disease|81|||
129974014|NCT03445533|467869609|FG000|Overall Study|Adverse Event|60|||
129974015|NCT03445533|467869610|FG001|Overall Study|Adverse Event|64|||
129974016|NCT03445533|467869609|FG000|Overall Study|Death|9|||
129974017|NCT03445533|467869610|FG001|Overall Study|Death|19|||
129974018|NCT03445533|467869609|FG000|Overall Study|Miscellaneous|0|||
129974019|NCT03445533|467869610|FG001|Overall Study|Miscellaneous|16|||
129974020|NCT03445533|467869609|FG000|Overall Study|Withdrawal by Subject|3|||
129974021|NCT03445533|467869610|FG001|Overall Study|Withdrawal by Subject|4|||
129974022|NCT03445533|467869609|FG000|Overall Study|Physician Decision|1|||
129974023|NCT03445533|467869610|FG001|Overall Study|Physician Decision|3|||
129974024|NCT03445533|467869609|FG000|Overall Study|Sponsor Decision|0|||
129974025|NCT03445533|467869610|FG001|Overall Study|Sponsor Decision|1|||
129974026|NCT03445533|467869609|FG000|Overall Study|Lost to Follow-up|0|||
129974027|NCT03445533|467869610|FG001|Overall Study|Lost to Follow-up|1|||
129974028|NCT03445533|467869609|FG000|Overall Study|Never Received any Study Treatment|7|||
129974029|NCT03445533|467869610|FG001|Overall Study|Never Received any Study Treatment|4|||
129974030|NCT00968526|467869611|FG000|Overall Study|Adverse Event|2|||
129974031|NCT00968526|467869612|FG001|Overall Study|Adverse Event|0|||
129974032|NCT00968526|467869611|FG000|Overall Study|Migrated/moved from study area|1|||
129974033|NCT00968526|467869612|FG001|Overall Study|Migrated/moved from study area|0|||
129974034|NCT02493062|467869613|FG000|Overall Study|Physician Decision|12|||
129974035|NCT03926195|467869614|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
129974036|NCT03926195|467869615|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
129974037|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
129974038|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
129974039|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
129974040|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
129974041|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
129974042|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
129974043|NCT03926195|467869614|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
129974044|NCT03926195|467869615|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
129974045|NCT03926195|467869614|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
129974046|NCT03926195|467869615|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
129974047|NCT01327612|467869617|FG000|Overall Study|Withdrawal by Subject|0|||
129974048|NCT01327612|467869618|FG001|Overall Study|Withdrawal by Subject|0|||
129974049|NCT01327612|467869619|FG002|Overall Study|Withdrawal by Subject|0|||
129974050|NCT01327612|467869620|FG003|Overall Study|Withdrawal by Subject|0|||
129974051|NCT01327612|467869621|FG004|Overall Study|Withdrawal by Subject|0|||
129974052|NCT01327612|467869622|FG005|Overall Study|Withdrawal by Subject|1|||
129974053|NCT01327612|467869623|FG006|Overall Study|Withdrawal by Subject|0|||
129974054|NCT01327612|467869617|FG000|Overall Study|Disease Progression|1|||
129974055|NCT01327612|467869618|FG001|Overall Study|Disease Progression|1|||
129974056|NCT01327612|467869619|FG002|Overall Study|Disease Progression|1|||
129974057|NCT01327612|467869620|FG003|Overall Study|Disease Progression|0|||
129974058|NCT01327612|467869621|FG004|Overall Study|Disease Progression|1|||
129974059|NCT01327612|467869622|FG005|Overall Study|Disease Progression|2|||
129974060|NCT01327612|467869623|FG006|Overall Study|Disease Progression|2|||
129974061|NCT01327612|467869617|FG000|Overall Study|Administrative Decision|0|||
129974062|NCT01327612|467869618|FG001|Overall Study|Administrative Decision|0|||
129974063|NCT01327612|467869619|FG002|Overall Study|Administrative Decision|0|||
129974064|NCT01327612|467869620|FG003|Overall Study|Administrative Decision|1|||
129974065|NCT01327612|467869621|FG004|Overall Study|Administrative Decision|0|||
129974066|NCT01327612|467869622|FG005|Overall Study|Administrative Decision|0|||
129974067|NCT01327612|467869623|FG006|Overall Study|Administrative Decision|0|||
129974068|NCT01327612|467869617|FG000|Overall Study|Death|0|||
129974069|NCT01327612|467869618|FG001|Overall Study|Death|0|||
129974070|NCT01327612|467869619|FG002|Overall Study|Death|0|||
129974071|NCT01327612|467869620|FG003|Overall Study|Death|0|||
129974072|NCT01327612|467869621|FG004|Overall Study|Death|1|||
129974073|NCT01327612|467869622|FG005|Overall Study|Death|0|||
129974074|NCT01327612|467869623|FG006|Overall Study|Death|0|||
129974075|NCT00426127|467869624|FG000|Overall Study|Adverse Event|1|||
129974076|NCT00426127|467869624|FG000|Overall Study|Removed due to disease progression|1|||
129974077|NCT05569421|467869625|FG000|Overall Study|Withdrawal by Subject|1|||
129974078|NCT05569421|467869626|FG001|Overall Study|Withdrawal by Subject|0|||
129974079|NCT05569421|467869627|FG002|Overall Study|Withdrawal by Subject|0|||
129974080|NCT01689857|467869628|FG000|Overall Study|Lost to Follow-up|5|||
129974081|NCT01689857|467869629|FG001|Overall Study|Lost to Follow-up|2|||
129471364|NCT04426695|466020298|FG014|Overall Study|Randomized but Never Treated|0|||
129471365|NCT04426695|466020299|FG015|Overall Study|Randomized but Never Treated|0|||
129471366|NCT04426695|466020300|FG016|Overall Study|Randomized but Never Treated|0|||
129471367|NCT04426695|466020301|FG017|Overall Study|Randomized but Never Treated|0|||
129471368|NCT01552681|466020302|FG000|Overall Study|Withdrawal by Subject|4|||
129471369|NCT01552681|466020303|FG001|Overall Study|Withdrawal by Subject|0|||
129471370|NCT01552681|466020302|FG000|Overall Study|Physician Decision|1|||
129974082|NCT05105087|467869630|FG000|Overall Study|Withdrawal by Subject|2|||
129974083|NCT05105087|467869630|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
129974084|NCT03738475|467869631|FG000|Overall Study|Participant Non-Compliance|1|||
129974085|NCT03738475|467869632|FG001|Overall Study|Participant Non-Compliance|0|||
129974086|NCT00737477|467869633|FG000|Overall Study|Adverse Event|9|||
129974087|NCT00737477|467869633|FG000|Overall Study|Death|9|||
129974088|NCT00737477|467869633|FG000|Overall Study|Treatment Refusal|1|||
129974089|NCT00737477|467869633|FG000|Overall Study|Withdrawal by Subject|1|||
129974090|NCT00737477|467869633|FG000|Overall Study|Renal Transplantation|10|||
129974091|NCT00737477|467869633|FG000|Overall Study|Other|4|||
129974092|NCT00581477|467869634|FG000|Overall Study|Physician Decision|2|||
129974093|NCT03106753|467869635|FG000|Overall Study|Withdrawal by Subject|0|||
129974094|NCT03106753|467869636|FG001|Overall Study|Withdrawal by Subject|1|||
129974095|NCT01853475|467869643|FG000|Overall Study|Withdrawal by Subject|0|||
129974096|NCT01853475|467869644|FG001|Overall Study|Withdrawal by Subject|1|||
129974097|NCT01853475|467869645|FG002|Overall Study|Withdrawal by Subject|0|||
129974098|NCT01023958|467869650|FG000|Overall Study|Progressive disease|48|||
129974099|NCT01023958|467869650|FG000|Overall Study|Other adverse event|1|||
129974100|NCT01023958|467869650|FG000|Overall Study|Refused to continue medication|1|||
129974101|NCT02159040|467869651|FG000|Overall Study|Death|1|||
129974102|NCT03080493|467869652|FG000|Overall Study|Did not provide NRS pain results|1|||
129974103|NCT03080493|467869653|FG001|Overall Study|Did not provide NRS pain results|0|||
129471371|NCT01552681|466020303|FG001|Overall Study|Physician Decision|0|||
129471372|NCT01552681|466020302|FG000|Overall Study|Subject moved away|0|||
129471373|NCT01552681|466020303|FG001|Overall Study|Subject moved away|1|||
129471374|NCT01987908|466020304|FG000|Placebo Lead-in Period|Adverse Event|2|||
129471375|NCT01987908|466020305|FG001|Placebo Lead-in Period|Adverse Event|0|||
129974104|NCT03080493|467869652|FG000|Overall Study|Adverse Event|0|||
129974105|NCT03080493|467869653|FG001|Overall Study|Adverse Event|1|||
129974106|NCT03080493|467869652|FG000|Overall Study|Randomization error (parity group)|0|||
129974107|NCT03080493|467869653|FG001|Overall Study|Randomization error (parity group)|1|||
129974108|NCT00755417|467869655|FG000|Overall Study|Adverse Event|28|||
129974109|NCT00755417|467869656|FG001|Overall Study|Adverse Event|20|||
129471376|NCT01987908|466020306|FG002|Placebo Lead-in Period|Adverse Event|0|||
129471377|NCT01987908|466020304|FG000|Placebo Lead-in Period|Physician Decision|2|||
129471378|NCT01987908|466020305|FG001|Placebo Lead-in Period|Physician Decision|0|||
129471379|NCT01987908|466020306|FG002|Placebo Lead-in Period|Physician Decision|0|||
129471380|NCT01987908|466020304|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
129471381|NCT01987908|466020305|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
129471382|NCT01987908|466020306|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
129471383|NCT01987908|466020304|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
129471384|NCT01987908|466020305|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
129471385|NCT01987908|466020306|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
129471386|NCT01987908|466020304|FG000|Treatment Period|Adverse Event|0|||
129471387|NCT01987908|466020305|FG001|Treatment Period|Adverse Event|1|||
129471388|NCT01987908|466020306|FG002|Treatment Period|Adverse Event|1|||
129471389|NCT01987908|466020304|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
129974110|NCT00755417|467869657|FG002|Overall Study|Adverse Event|7|||
129974111|NCT00755417|467869655|FG000|Overall Study|Lack of Efficacy|8|||
129974112|NCT00755417|467869656|FG001|Overall Study|Lack of Efficacy|4|||
129974113|NCT00755417|467869657|FG002|Overall Study|Lack of Efficacy|9|||
129974114|NCT00755417|467869655|FG000|Overall Study|Protocol Violation|2|||
129974115|NCT00755417|467869656|FG001|Overall Study|Protocol Violation|1|||
129974116|NCT00755417|467869657|FG002|Overall Study|Protocol Violation|1|||
129974117|NCT00755417|467869655|FG000|Overall Study|Lost to Follow-up|3|||
129974118|NCT00755417|467869656|FG001|Overall Study|Lost to Follow-up|0|||
129974119|NCT00755417|467869657|FG002|Overall Study|Lost to Follow-up|1|||
129471390|NCT01987908|466020305|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
129471391|NCT01987908|466020306|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
129471392|NCT01987908|466020304|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
129974120|NCT00755417|467869655|FG000|Overall Study|Withdrawal by Subject|12|||
129974121|NCT00755417|467869656|FG001|Overall Study|Withdrawal by Subject|12|||
129974122|NCT00755417|467869657|FG002|Overall Study|Withdrawal by Subject|12|||
129974123|NCT00755417|467869655|FG000|Overall Study|Not specified or missing data|9|||
129974124|NCT00755417|467869656|FG001|Overall Study|Not specified or missing data|18|||
129974125|NCT00755417|467869657|FG002|Overall Study|Not specified or missing data|12|||
129974126|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
129974127|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
129974128|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
129974129|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|Death|1|||
129974130|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|Death|0|||
129974131|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|Death|0|||
129974132|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
129974133|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
129974134|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
129974135|NCT02362503|467869658|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
129974136|NCT02362503|467869659|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
129974137|NCT02362503|467869660|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
129974138|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
129974139|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
129974140|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
129974141|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
129974142|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
129974143|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
129974144|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
129974145|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
129974146|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
129974147|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
129974148|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
129974149|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
129974150|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
129974151|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
129974152|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
129974153|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
129974154|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
129974155|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
129974156|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
129974157|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
129974158|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
129974159|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
129974160|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
129974161|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
129974162|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
129974163|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
129974164|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
129974165|NCT02362503|467869658|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
129974166|NCT02362503|467869659|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
129974167|NCT02362503|467869660|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
129974168|NCT02803593|467869661|FG000|Overall Study|Lost to Follow-up|17|||
129974169|NCT02803593|467869662|FG001|Overall Study|Lost to Follow-up|35|||
129974170|NCT05143138|467869663|FG000|Overall Study|Death|5|||
129974171|NCT05143138|467869664|FG001|Overall Study|Death|35|||
129974172|NCT05143138|467869665|FG002|Overall Study|Death|1|||
129974173|NCT05143138|467869663|FG000|Overall Study|Lost to Follow-up|2|||
129974174|NCT05143138|467869664|FG001|Overall Study|Lost to Follow-up|4|||
129974175|NCT05143138|467869665|FG002|Overall Study|Lost to Follow-up|0|||
129974176|NCT05143138|467869663|FG000|Overall Study|withdrawal|1|||
129974177|NCT05143138|467869664|FG001|Overall Study|withdrawal|1|||
129974178|NCT05143138|467869665|FG002|Overall Study|withdrawal|0|||
129974179|NCT02195479|467869668|FG000|Overall Study|Lost to Follow-up|18|||
129974180|NCT02195479|467869669|FG001|Overall Study|Lost to Follow-up|15|||
129974181|NCT02195479|467869668|FG000|Overall Study|Death|217|||
129974182|NCT02195479|467869669|FG001|Overall Study|Death|171|||
129974183|NCT02195479|467869668|FG000|Overall Study|Physician Decision|1|||
129974184|NCT02195479|467869669|FG001|Overall Study|Physician Decision|0|||
129974185|NCT02195479|467869668|FG000|Overall Study|Withdrawal by Subject|30|||
129974186|NCT02195479|467869669|FG001|Overall Study|Withdrawal by Subject|30|||
129974187|NCT02195479|467869668|FG000|Overall Study|Other|3|||
129974188|NCT02195479|467869669|FG001|Overall Study|Other|4|||
129974189|NCT02195479|467869668|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
129974190|NCT02195479|467869669|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
129974191|NCT03443414|467869670|FG000|Overall Study|Adverse Event|6|||
129974192|NCT03443414|467869671|FG001|Overall Study|Adverse Event|0|||
129974193|NCT03443414|467869672|FG002|Overall Study|Adverse Event|4|||
129974194|NCT03443414|467869673|FG003|Overall Study|Adverse Event|2|||
129974195|NCT03443414|467869674|FG004|Overall Study|Adverse Event|3|||
129974196|NCT03443414|467869670|FG000|Overall Study|Withdrawal by Subject|3|||
129974197|NCT03443414|467869671|FG001|Overall Study|Withdrawal by Subject|2|||
129974198|NCT03443414|467869672|FG002|Overall Study|Withdrawal by Subject|2|||
129974199|NCT03443414|467869673|FG003|Overall Study|Withdrawal by Subject|2|||
129974200|NCT03443414|467869674|FG004|Overall Study|Withdrawal by Subject|1|||
129974201|NCT03443414|467869670|FG000|Overall Study|Death|0|||
129974202|NCT03443414|467869671|FG001|Overall Study|Death|1|||
129974203|NCT03443414|467869672|FG002|Overall Study|Death|0|||
129974204|NCT03443414|467869673|FG003|Overall Study|Death|1|||
129974205|NCT03443414|467869674|FG004|Overall Study|Death|0|||
129974206|NCT03443414|467869670|FG000|Overall Study|Reason not specified|2|||
129974207|NCT03443414|467869671|FG001|Overall Study|Reason not specified|0|||
129974208|NCT03443414|467869672|FG002|Overall Study|Reason not specified|0|||
129974209|NCT03443414|467869673|FG003|Overall Study|Reason not specified|0|||
129974210|NCT03443414|467869674|FG004|Overall Study|Reason not specified|1|||
129974211|NCT03325777|467869677|FG000|Overall Study|Lost to Follow-up|9|||
129974212|NCT03325777|467869678|FG001|Overall Study|Lost to Follow-up|12|||
129974213|NCT02522728|467869681|FG000|Overall Study|Withdrawal by Subject|6|||
129974214|NCT02522728|467869682|FG001|Overall Study|Withdrawal by Subject|6|||
129974215|NCT02522728|467869681|FG000|Overall Study|Death|4|||
129974216|NCT02522728|467869682|FG001|Overall Study|Death|3|||
129974217|NCT02522728|467869681|FG000|Overall Study|Adverse Event|2|||
129974218|NCT02522728|467869682|FG001|Overall Study|Adverse Event|1|||
129974219|NCT02522728|467869681|FG000|Overall Study|Did not receive randomized study device|0|||
129974220|NCT02522728|467869682|FG001|Overall Study|Did not receive randomized study device|1|||
129974221|NCT01485120|467869688|FG000|Overall Study|Withdrawal by Subject|2|||
129974222|NCT00422734|467869689|FG000|Overall Study|Physician Decision|1|||
129974223|NCT00422734|467869690|FG001|Overall Study|Physician Decision|1|||
129974224|NCT00422734|467869689|FG000|Overall Study|Protocol Violation|1|||
129974225|NCT00422734|467869690|FG001|Overall Study|Protocol Violation|6|||
129974226|NCT00422734|467869689|FG000|Overall Study|Withdrawal by Subject|12|||
129974227|NCT00422734|467869690|FG001|Overall Study|Withdrawal by Subject|8|||
129974228|NCT00422734|467869689|FG000|Overall Study|Adverse Event|0|||
129974229|NCT00422734|467869690|FG001|Overall Study|Adverse Event|3|||
129974230|NCT00422734|467869689|FG000|Overall Study|Partner Decision|0|||
129974231|NCT00422734|467869690|FG001|Overall Study|Partner Decision|3|||
129974232|NCT01081886|467869691|FG000|Overall Study|Study termination|11|||
129974233|NCT01081886|467869692|FG001|Overall Study|Study termination|13|||
129974234|NCT02567708|467869693|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
129974235|NCT02567708|467869694|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
129974236|NCT02567708|467869693|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
129974237|NCT02567708|467869694|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
129974238|NCT02567708|467869693|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
129974239|NCT02567708|467869694|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
129974240|NCT02567708|467869693|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
129974241|NCT02567708|467869694|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
129974242|NCT04148651|467869695|FG000|Overall Study|Lost to Follow-up|2|||
129974243|NCT05262751|467869696|FG000|Washout Period 2|Adverse Event|1|||
129974244|NCT05262751|467869697|FG001|Washout Period 2|Adverse Event|0|||
129974245|NCT05262751|467869698|FG002|Washout Period 2|Adverse Event|0|||
129974246|NCT05262751|467869699|FG003|Washout Period 2|Adverse Event|0|||
129974247|NCT05262751|467869700|FG004|Washout Period 2|Adverse Event|0|||
129974248|NCT05262751|467869701|FG005|Washout Period 2|Adverse Event|0|||
129974249|NCT05262751|467869696|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
129974250|NCT05262751|467869697|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
129974251|NCT05262751|467869698|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
129974252|NCT05262751|467869699|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
129974253|NCT05262751|467869700|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
129974254|NCT05262751|467869701|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
129974255|NCT01154140|467869703|FG000|Overall Study|Death|71|||
129974256|NCT01154140|467869704|FG001|Overall Study|Death|81|||
129471393|NCT01987908|466020305|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
129471394|NCT01987908|466020306|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
129471395|NCT00189462|466020307|FG000|Overall Study|Lack of Efficacy|5|||
129471396|NCT00189462|466020308|FG001|Overall Study|Lack of Efficacy|1|||
129471397|NCT00189462|466020307|FG000|Overall Study|Lost to Follow-up|18|||
129974257|NCT01154140|467869703|FG000|Overall Study|Lost to Follow-up|4|||
129974258|NCT01154140|467869704|FG001|Overall Study|Lost to Follow-up|5|||
129471398|NCT00189462|466020308|FG001|Overall Study|Lost to Follow-up|20|||
129471399|NCT01262625|466020309|FG000|Overall Study|Administrative Error|1|||
129471400|NCT01262625|466020310|FG001|Overall Study|Administrative Error|1|||
129974259|NCT01154140|467869703|FG000|Overall Study|Withdrawal by Subject|12|||
129974260|NCT01154140|467869704|FG001|Overall Study|Withdrawal by Subject|13|||
129974261|NCT01154140|467869703|FG000|Overall Study|Other|3|||
129974262|NCT01154140|467869704|FG001|Overall Study|Other|1|||
129974263|NCT01154140|467869703|FG000|Overall Study|Randomized but not treated|1|||
129974264|NCT01154140|467869704|FG001|Overall Study|Randomized but not treated|2|||
129974265|NCT02992691|467869708|FG000|Overall Study|Adverse Event|2|||
129974266|NCT02992691|467869708|FG000|Overall Study|Withdrawal by Subject|1|||
129471401|NCT01262625|466020309|FG000|Overall Study|Site Closed|1|||
129471402|NCT01262625|466020310|FG001|Overall Study|Site Closed|0|||
129471403|NCT02789657|466020311|FG000|Overall Study|Withdrawal by Subject|2|||
129471404|NCT02789657|466020312|FG001|Overall Study|Withdrawal by Subject|0|||
129471405|NCT02789657|466020313|FG002|Overall Study|Withdrawal by Subject|0|||
129471406|NCT02789657|466020314|FG003|Overall Study|Withdrawal by Subject|0|||
129471407|NCT00236080|466020315|FG000|Overall Study|Adverse Event|0|||
129471408|NCT00236080|466020316|FG001|Overall Study|Adverse Event|0|||
129471409|NCT00236080|466020317|FG002|Overall Study|Adverse Event|3|||
129471410|NCT00236080|466020318|FG003|Overall Study|Adverse Event|1|||
129471411|NCT00236080|466020319|FG004|Overall Study|Adverse Event|0|||
129471412|NCT00236080|466020315|FG000|Overall Study|Lost to Follow-up|0|||
129471413|NCT00236080|466020316|FG001|Overall Study|Lost to Follow-up|1|||
129471414|NCT00236080|466020317|FG002|Overall Study|Lost to Follow-up|0|||
129471415|NCT00236080|466020318|FG003|Overall Study|Lost to Follow-up|0|||
129471416|NCT00236080|466020319|FG004|Overall Study|Lost to Follow-up|0|||
129471417|NCT00236080|466020315|FG000|Overall Study|Physician Decision|1|||
129471418|NCT00236080|466020316|FG001|Overall Study|Physician Decision|0|||
129471419|NCT00236080|466020317|FG002|Overall Study|Physician Decision|1|||
129471420|NCT00236080|466020318|FG003|Overall Study|Physician Decision|1|||
129471421|NCT00236080|466020319|FG004|Overall Study|Physician Decision|1|||
129471422|NCT00236080|466020315|FG000|Overall Study|Withdrawal by Subject|1|||
129471423|NCT00236080|466020316|FG001|Overall Study|Withdrawal by Subject|0|||
129471424|NCT00236080|466020317|FG002|Overall Study|Withdrawal by Subject|0|||
129471425|NCT00236080|466020318|FG003|Overall Study|Withdrawal by Subject|0|||
129471426|NCT00236080|466020319|FG004|Overall Study|Withdrawal by Subject|0|||
129471427|NCT00236080|466020315|FG000|Overall Study|Miscellaneous|0|||
129471428|NCT00236080|466020316|FG001|Overall Study|Miscellaneous|0|||
129471429|NCT00236080|466020317|FG002|Overall Study|Miscellaneous|1|||
129471430|NCT00236080|466020318|FG003|Overall Study|Miscellaneous|0|||
129471431|NCT00236080|466020319|FG004|Overall Study|Miscellaneous|0|||
129471432|NCT03882424|466020320|FG000|Overall Study|Lost to Follow-up|3|||
129471433|NCT03882424|466020321|FG001|Overall Study|Lost to Follow-up|0|||
129471434|NCT03882424|466020322|FG002|Overall Study|Lost to Follow-up|0|||
129471435|NCT03882424|466020320|FG000|Overall Study|schedule conflict|1|||
129471436|NCT03882424|466020321|FG001|Overall Study|schedule conflict|0|||
129471437|NCT03882424|466020322|FG002|Overall Study|schedule conflict|0|||
129471438|NCT01214044|466020323|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
129471439|NCT01214044|466020323|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
129471440|NCT01214044|466020323|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
129471441|NCT01214044|466020323|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
129471442|NCT01214044|466020323|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
129471443|NCT01214044|466020323|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
129471444|NCT02772757|466020327|FG000|Overall Study|Withdrawal by Subject|1|||
129471445|NCT02772757|466020328|FG001|Overall Study|Withdrawal by Subject|0|||
129471446|NCT02772757|466020329|FG002|Overall Study|Withdrawal by Subject|1|||
129471447|NCT02772757|466020327|FG000|Overall Study|Protocol Violation|0|||
129471448|NCT02772757|466020328|FG001|Overall Study|Protocol Violation|0|||
129471449|NCT02772757|466020329|FG002|Overall Study|Protocol Violation|1|||
129471450|NCT02772757|466020327|FG000|Overall Study|Physician Decision|0|||
129471451|NCT02772757|466020328|FG001|Overall Study|Physician Decision|3|||
129471452|NCT02772757|466020329|FG002|Overall Study|Physician Decision|3|||
129471453|NCT04698525|466020330|FG000|Overall Study|Lost to Follow-up|1|||
129471454|NCT04698525|466020331|FG001|Overall Study|Lost to Follow-up|2|||
129471455|NCT04698525|466020330|FG000|Overall Study|Three suffered of Covid-19|2|||
129471456|NCT04698525|466020331|FG001|Overall Study|Three suffered of Covid-19|1|||
129471457|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Adverse Event|21|||
129471458|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Adverse Event|6|||
129471459|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
129471460|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
129471461|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
129471462|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
129471463|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
129471464|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
129471465|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Physician Decision|0|||
129471466|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Physician Decision|3|||
129471467|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
129471468|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
129471469|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
129471470|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
129471471|NCT00510276|466020335|FG000|Acute Double-Blind Phase|Subject Decision|26|||
129471472|NCT00510276|466020336|FG001|Acute Double-Blind Phase|Subject Decision|28|||
129471473|NCT00510276|466020335|FG000|Extension Open-Label Phase|Adverse Event|9|||
129471474|NCT00510276|466020336|FG001|Extension Open-Label Phase|Adverse Event|18|||
129471475|NCT00510276|466020335|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
129471476|NCT00510276|466020336|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
129471477|NCT00510276|466020335|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
129471478|NCT00510276|466020336|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
129471479|NCT00510276|466020335|FG000|Extension Open-Label Phase|Physician Decision|2|||
129471480|NCT00510276|466020336|FG001|Extension Open-Label Phase|Physician Decision|3|||
129471481|NCT00510276|466020335|FG000|Extension Open-Label Phase|Protocol Violation|0|||
129471482|NCT00510276|466020336|FG001|Extension Open-Label Phase|Protocol Violation|1|||
129471483|NCT00510276|466020335|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
129471484|NCT00510276|466020336|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
129471485|NCT00510276|466020335|FG000|Extension Open-Label Phase|Subject Decision|7|||
129471486|NCT00510276|466020336|FG001|Extension Open-Label Phase|Subject Decision|9|||
129471487|NCT00441792|466020339|FG000|Overall Study|Lost to Follow-up|0|||
129471488|NCT00441792|466020340|FG001|Overall Study|Lost to Follow-up|2|||
129471489|NCT00130286|466020347|FG000|Overall Study|Withdrawal by Subject|0|||
129471490|NCT00130286|466020348|FG001|Overall Study|Withdrawal by Subject|1|||
129471491|NCT00130286|466020349|FG002|Overall Study|Withdrawal by Subject|2|||
129471492|NCT00130286|466020350|FG003|Overall Study|Withdrawal by Subject|2|||
129471493|NCT00130286|466020347|FG000|Overall Study|Adverse Event|0|||
129471494|NCT00130286|466020348|FG001|Overall Study|Adverse Event|0|||
129471495|NCT00130286|466020349|FG002|Overall Study|Adverse Event|2|||
129471496|NCT00130286|466020350|FG003|Overall Study|Adverse Event|0|||
129471497|NCT00130286|466020347|FG000|Overall Study|Missing lab specimens|0|||
129471498|NCT00130286|466020348|FG001|Overall Study|Missing lab specimens|2|||
129471499|NCT00130286|466020349|FG002|Overall Study|Missing lab specimens|0|||
129471500|NCT00130286|466020350|FG003|Overall Study|Missing lab specimens|0|||
129471501|NCT02154425|466020351|FG000|Screening Period|Adverse Event|1|||
129471502|NCT02908516|466020358|FG000|Overall Study|Study Terminated|3|||
129471503|NCT02908516|466020359|FG001|Overall Study|Study Terminated|3|||
129471504|NCT00565617|466020360|FG000|Overall Study|Withdrawal by Subject|1|||
129471505|NCT01133171|466020361|FG000|Overall Study|Withdrawal by Subject|1|||
129471506|NCT01133171|466020362|FG001|Overall Study|Withdrawal by Subject|2|||
129471507|NCT01133171|466020363|FG002|Overall Study|Withdrawal by Subject|0|||
129471508|NCT02526550|466020364|FG000|Overall Study|Lost to Follow-up|1|||
129471509|NCT03969888|466020367|FG000|Overall Study|Never Received Study Drug|0|||
129471510|NCT03969888|466020368|FG001|Overall Study|Never Received Study Drug|0|||
129471511|NCT03969888|466020369|FG002|Overall Study|Never Received Study Drug|1|||
129471512|NCT03969888|466020370|FG003|Overall Study|Never Received Study Drug|0|||
129471513|NCT03969888|466020371|FG004|Overall Study|Never Received Study Drug|0|||
129471514|NCT03969888|466020372|FG005|Overall Study|Never Received Study Drug|0|||
129471515|NCT03969888|466020373|FG006|Overall Study|Never Received Study Drug|1|||
129471516|NCT03969888|466020374|FG007|Overall Study|Never Received Study Drug|0|||
129471517|NCT03969888|466020367|FG000|Overall Study|Reason Not Specified|0|||
129471518|NCT03969888|466020368|FG001|Overall Study|Reason Not Specified|0|||
129471519|NCT03969888|466020369|FG002|Overall Study|Reason Not Specified|0|||
129471520|NCT03969888|466020370|FG003|Overall Study|Reason Not Specified|0|||
129471521|NCT03969888|466020371|FG004|Overall Study|Reason Not Specified|0|||
129471522|NCT03969888|466020372|FG005|Overall Study|Reason Not Specified|0|||
129471523|NCT03969888|466020373|FG006|Overall Study|Reason Not Specified|0|||
129471524|NCT03969888|466020374|FG007|Overall Study|Reason Not Specified|1|||
129471525|NCT01446419|466020378|FG000|Overall Study|Death|1|||
129471526|NCT01446419|466020379|FG001|Overall Study|Death|0|||
129471527|NCT01446419|466020378|FG000|Overall Study|Withdrawal by Subject|1|||
129471528|NCT01446419|466020379|FG001|Overall Study|Withdrawal by Subject|1|||
129471529|NCT01446419|466020378|FG000|Overall Study|Terminated per protocol|3|||
129471530|NCT01446419|466020379|FG001|Overall Study|Terminated per protocol|0|||
129471531|NCT02867761|466020380|FG000|Overall Study|Participant withdrawn by investigator|0|||
129471532|NCT02867761|466020381|FG001|Overall Study|Participant withdrawn by investigator|1|||
129471533|NCT02867761|466020380|FG000|Overall Study|Lost to Follow-up|25|||
129471534|NCT02867761|466020381|FG001|Overall Study|Lost to Follow-up|18|||
129471535|NCT02867761|466020380|FG000|Overall Study|Unable to complete protocol|3|||
129471536|NCT02867761|466020381|FG001|Overall Study|Unable to complete protocol|7|||
129471537|NCT01931059|466020383|FG000|Day 1|Pregnancy|0|||
129471538|NCT01931059|466020384|FG001|Day 1|Pregnancy|1|||
129471539|NCT01931059|466020383|FG000|Day3|Lost to Follow-up|1|||
129974267|NCT04276051|467869709|FG000|Overall Study|Lost to Follow-up|0|||
129471540|NCT01931059|466020384|FG001|Day3|Lost to Follow-up|0|||
129471541|NCT00769119|466020385|FG000|Overall Study|Voluntary discontinuation|0|||
129471542|NCT00769119|466020386|FG001|Overall Study|Voluntary discontinuation|2|||
129471543|NCT00769119|466020385|FG000|Overall Study|Adverse Event|1|||
129471544|NCT00769119|466020386|FG001|Overall Study|Adverse Event|1|||
129471545|NCT00769119|466020385|FG000|Overall Study|Disallowed medication|1|||
129471546|NCT00769119|466020386|FG001|Overall Study|Disallowed medication|0|||
129471547|NCT01078805|466020388|FG000|Overall Study|Clinically significant abnormal lab|5|||
129471548|NCT01078805|466020388|FG000|Overall Study|Death|134|||
129471549|NCT01078805|466020388|FG000|Overall Study|Lost to Follow-up|676|||
129471550|NCT01078805|466020388|FG000|Overall Study|Physician Decision|169|||
129471551|NCT01078805|466020388|FG000|Overall Study|Serious adverse event|26|||
129471552|NCT01078805|466020388|FG000|Overall Study|Sponsor decision|46|||
129471553|NCT01078805|466020388|FG000|Overall Study|Withdrawal by Subject|739|||
129471554|NCT01078805|466020388|FG000|Overall Study|Other|173|||
129471555|NCT01078805|466020388|FG000|Overall Study|Didn't take study drug|82|||
129471556|NCT00865020|466020396|FG000|Overall Study|Withdrawal by Subject|22|||
129471557|NCT00865020|466020397|FG001|Overall Study|Withdrawal by Subject|16|||
129471558|NCT00865020|466020396|FG000|Overall Study|Adverse Event|9|||
129974268|NCT04276051|467869710|FG001|Overall Study|Lost to Follow-up|1|||
129974269|NCT04276051|467869709|FG000|Overall Study|Physician Decision|0|||
129974270|NCT04276051|467869710|FG001|Overall Study|Physician Decision|1|||
129974271|NCT04276051|467869709|FG000|Overall Study|Withdrawal by Subject|1|||
129974272|NCT04276051|467869710|FG001|Overall Study|Withdrawal by Subject|1|||
129974273|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
129974274|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
129974275|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
129974276|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
129974277|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
129974278|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
129974279|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
129974280|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
129974281|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
129974282|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
129974283|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
129974284|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
129974285|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
129974286|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
129974287|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
129974288|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
129974289|NCT00392925|467869711|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
129471559|NCT00865020|466020397|FG001|Overall Study|Adverse Event|14|||
129471560|NCT00865020|466020396|FG000|Overall Study|Abnormal test procedure result(s)|6|||
129471561|NCT00865020|466020397|FG001|Overall Study|Abnormal test procedure result(s)|8|||
129471562|NCT00865020|466020396|FG000|Overall Study|Lost to Follow-up|6|||
129471563|NCT00865020|466020397|FG001|Overall Study|Lost to Follow-up|4|||
129471564|NCT00865020|466020396|FG000|Overall Study|Protocol deviation|4|||
129471565|NCT00865020|466020397|FG001|Overall Study|Protocol deviation|1|||
129471566|NCT00865020|466020396|FG000|Overall Study|Administrative problems|0|||
129471567|NCT00865020|466020397|FG001|Overall Study|Administrative problems|2|||
129471568|NCT00865020|466020396|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129471569|NCT00865020|466020397|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129471570|NCT00865020|466020396|FG000|Overall Study|Death|0|||
129471571|NCT00865020|466020397|FG001|Overall Study|Death|1|||
129471572|NCT00865020|466020396|FG000|Overall Study|Randomized but discontinued|2|||
129471573|NCT00865020|466020397|FG001|Overall Study|Randomized but discontinued|4|||
129471574|NCT03641560|466020398|FG000|Overall Study|Withdrawal by Subject|6|||
129471575|NCT03641560|466020398|FG000|Overall Study|Progressive disease|40|||
129471576|NCT03641560|466020398|FG000|Overall Study|Death|6|||
129471577|NCT05900115|466022184|FG000|Overall Study|Lost to Follow-up|129|||
129471578|NCT05900115|466022185|FG001|Overall Study|Lost to Follow-up|98|||
129471579|NCT00388947|466022186|FG000|Overall Study|Protocol Violation|47|||
129471580|NCT04187092|466022187|FG000|Overall Study|Lost to Follow-up|1|||
129471581|NCT04187092|466022188|FG001|Overall Study|Lost to Follow-up|1|||
129471582|NCT04187092|466022187|FG000|Overall Study|Withdrawal by Subject|1|||
129471583|NCT04187092|466022188|FG001|Overall Study|Withdrawal by Subject|1|||
129471584|NCT04187092|466022187|FG000|Overall Study|Adverse Event|0|||
129471585|NCT04187092|466022188|FG001|Overall Study|Adverse Event|1|||
129471586|NCT00619502|466022192|FG000|Overall Study|Lost to Follow-up|8|||
129471587|NCT00619502|466022193|FG001|Overall Study|Lost to Follow-up|10|||
129471588|NCT00771472|466022194|FG000|Overall Study|Physician Decision|2|||
129974290|NCT00392925|467869712|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
129471589|NCT00771472|466022195|FG001|Overall Study|Physician Decision|3|||
129471590|NCT00771472|466022194|FG000|Overall Study|Progressive Disease|3|||
129471591|NCT00771472|466022195|FG001|Overall Study|Progressive Disease|1|||
129471592|NCT00771472|466022194|FG000|Overall Study|Protocol Violation|1|||
129471593|NCT00771472|466022195|FG001|Overall Study|Protocol Violation|0|||
129471594|NCT00880750|466022198|FG000|First Intervention|Adverse Event|1|||
129471595|NCT00880750|466022199|FG001|First Intervention|Adverse Event|0|||
129471596|NCT00880750|466022198|FG000|First Intervention|Unable to collect urine|4|||
129471597|NCT00880750|466022199|FG001|First Intervention|Unable to collect urine|0|||
129471598|NCT00880750|466022198|FG000|First Intervention|Non-compliance with meals|0|||
129471599|NCT00880750|466022199|FG001|First Intervention|Non-compliance with meals|1|||
129974291|NCT00392925|467869713|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
129471600|NCT00880750|466022198|FG000|First Intervention|Withdrawal by Subject|2|||
129471601|NCT00880750|466022199|FG001|First Intervention|Withdrawal by Subject|0|||
129471602|NCT00880750|466022198|FG000|First Intervention|Lost to Follow-up|2|||
129471603|NCT00880750|466022199|FG001|First Intervention|Lost to Follow-up|0|||
129471604|NCT00880750|466022198|FG000|Second Intervention|Withdrawal by Subject|2|||
129471605|NCT00880750|466022199|FG001|Second Intervention|Withdrawal by Subject|2|||
129471606|NCT00880750|466022198|FG000|Second Intervention|Protocol Violation|1|||
129471607|NCT00880750|466022199|FG001|Second Intervention|Protocol Violation|0|||
129471608|NCT00880750|466022198|FG000|Second Intervention|Unable to collect urine|1|||
129471609|NCT00880750|466022199|FG001|Second Intervention|Unable to collect urine|0|||
129471610|NCT00483327|466022200|FG000|Overall Study|Adverse Event|1|||
129471611|NCT00483327|466022200|FG000|Overall Study|Withdrawal by Subject|3|||
129471612|NCT00483327|466022200|FG000|Overall Study|Lost to Follow-up|4|||
129471613|NCT00483327|466022200|FG000|Overall Study|Patient Non Compliance|2|||
129471614|NCT00670007|466022201|FG000|Overall Study|Drug abuse|1|||
129471615|NCT00670007|466022201|FG000|Overall Study|Lung transplant|1|||
129471616|NCT00670007|466022201|FG000|Overall Study|Travel/Vacation|1|||
129471617|NCT00670007|466022201|FG000|Overall Study|Adverse event, serious fatal|1|||
129471618|NCT00670007|466022201|FG000|Overall Study|Adverse Event|1|||
129471619|NCT00670007|466022201|FG000|Overall Study|Withdrawal by Subject|4|||
129471620|NCT00618722|466022202|FG000|Overall Study|Refusal of Treatment|0|||
129471621|NCT00618722|466022203|FG001|Overall Study|Refusal of Treatment|0|||
129471622|NCT00618722|466022204|FG002|Overall Study|Refusal of Treatment|1|||
129471623|NCT00618722|466022205|FG003|Overall Study|Refusal of Treatment|0|||
129471624|NCT00618722|466022202|FG000|Overall Study|Patient Request|1|||
129471625|NCT00618722|466022203|FG001|Overall Study|Patient Request|1|||
129471626|NCT00618722|466022204|FG002|Overall Study|Patient Request|1|||
129471627|NCT00618722|466022205|FG003|Overall Study|Patient Request|1|||
129471628|NCT00618722|466022202|FG000|Overall Study|Inability to Complete Study Procedure|0|||
129471629|NCT00618722|466022203|FG001|Overall Study|Inability to Complete Study Procedure|1|||
129471630|NCT00618722|466022204|FG002|Overall Study|Inability to Complete Study Procedure|0|||
129471631|NCT00618722|466022205|FG003|Overall Study|Inability to Complete Study Procedure|0|||
129471632|NCT00618722|466022202|FG000|Overall Study|Lost to Follow-up|2|||
129471633|NCT00618722|466022203|FG001|Overall Study|Lost to Follow-up|0|||
129471634|NCT00618722|466022204|FG002|Overall Study|Lost to Follow-up|0|||
129471635|NCT00618722|466022205|FG003|Overall Study|Lost to Follow-up|2|||
129471636|NCT00618722|466022202|FG000|Overall Study|Miscellaneous Reasons|0|||
129471637|NCT00618722|466022203|FG001|Overall Study|Miscellaneous Reasons|0|||
129471638|NCT00618722|466022204|FG002|Overall Study|Miscellaneous Reasons|1|||
129471639|NCT00618722|466022205|FG003|Overall Study|Miscellaneous Reasons|1|||
129471640|NCT00200057|466022208|FG000|Overall Study|Lack of Efficacy|3|||
129471641|NCT00200057|466022208|FG000|Overall Study|Exited due to terminal illness of PI|2|||
129471642|NCT00200057|466022208|FG000|Overall Study|Withdrawal by Subject|1|||
129471643|NCT00200057|466022208|FG000|Overall Study|Change in medical condition|1|||
129471644|NCT00200057|466022208|FG000|Overall Study|Infection|1|||
129471645|NCT00200057|466022208|FG000|Overall Study|Death|1|||
129471646|NCT00778830|466022209|FG000|Overall Study|Ongoing at data cut-off|0|||
129471647|NCT00778830|466022210|FG001|Overall Study|Ongoing at data cut-off|1|||
129471648|NCT01891643|466022211|FG000|Overall Study|Adverse event unrelated to study drug|2|||
129471649|NCT01891643|466022212|FG001|Overall Study|Adverse event unrelated to study drug|5|||
129471650|NCT01891643|466022211|FG000|Overall Study|Disease Progression|4|||
129471651|NCT01891643|466022212|FG001|Overall Study|Disease Progression|3|||
129471652|NCT01891643|466022211|FG000|Overall Study|Study Drug Toxicity|3|||
129471653|NCT01891643|466022212|FG001|Overall Study|Study Drug Toxicity|0|||
129471654|NCT01891643|466022211|FG000|Overall Study|Maximum Clinical Benefit|0|||
129471655|NCT01891643|466022212|FG001|Overall Study|Maximum Clinical Benefit|1|||
129471656|NCT01891643|466022211|FG000|Overall Study|Poor/Non-compliance|0|||
129471657|NCT01891643|466022212|FG001|Overall Study|Poor/Non-compliance|1|||
129471658|NCT01891643|466022211|FG000|Overall Study|Participant request to discontinue|1|||
129471659|NCT01891643|466022212|FG001|Overall Study|Participant request to discontinue|0|||
129471660|NCT02965716|466022213|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129471661|NCT02965716|466022214|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
129471662|NCT02965716|466022213|FG000|Overall Study|Progression/Relapse|8|||
129471663|NCT02965716|466022214|FG001|Overall Study|Progression/Relapse|16|||
129471664|NCT02965716|466022213|FG000|Overall Study|Death|1|||
129471665|NCT02965716|466022214|FG001|Overall Study|Death|0|||
129471666|NCT02965716|466022213|FG000|Overall Study|Not Protocol Specified|1|||
129471667|NCT02965716|466022214|FG001|Overall Study|Not Protocol Specified|3|||
129471668|NCT04047797|466022215|FG000|Overall Study|Progressive Disease|1|||
129471669|NCT03523351|466022216|FG000|Overall Study|Death|13|||
129471670|NCT03523351|466022217|FG001|Overall Study|Death|11|||
129471671|NCT03523351|466022216|FG000|Overall Study|Lost to Follow-up|2|||
129471672|NCT03523351|466022217|FG001|Overall Study|Lost to Follow-up|3|||
129471673|NCT03523351|466022216|FG000|Overall Study|Withdrawal by Subject|4|||
129471674|NCT03523351|466022217|FG001|Overall Study|Withdrawal by Subject|0|||
129471675|NCT03523351|466022216|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
129471676|NCT03523351|466022217|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
129471677|NCT00132041|466022225|FG000|Baseline|Ineligible|6|||
129471678|NCT00132041|466022225|FG000|3 Months Post Ablation|Transplant|1|||
129471679|NCT00132041|466022225|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
129471680|NCT00132041|466022225|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
129471681|NCT00132041|466022225|FG000|6 Months Post Ablation|Death|2|||
129471682|NCT00132041|466022225|FG000|6 Months Post Ablation|Transplant|6|||
129471683|NCT00132041|466022225|FG000|9 Months Post Ablation|Death|1|||
129471684|NCT00132041|466022225|FG000|9 Months Post Ablation|Transplant|1|||
129471685|NCT00132041|466022225|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
129471686|NCT00132041|466022225|FG000|12 Months Post Ablation|Death|1|||
129471687|NCT00132041|466022225|FG000|12 Months Post Ablation|Transplant|1|||
129471688|NCT00132041|466022225|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
129471689|NCT00132041|466022225|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
129471690|NCT00132041|466022225|FG000|15 Months Post Ablation|Death|1|||
129471691|NCT00132041|466022225|FG000|15 Months Post Ablation|Transplant|5|||
129471692|NCT00132041|466022225|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
129471693|NCT00132041|466022225|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
129471694|NCT00132041|466022225|FG000|18 Months Post Ablation|Transplant|1|||
129471695|NCT00132041|466022225|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
129471696|NCT00132041|466022225|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
129471697|NCT03609619|466022226|FG000|Overall Study|Adverse Event|1|||
129471698|NCT03609619|466022227|FG001|Overall Study|Adverse Event|0|||
129471699|NCT03609619|466022226|FG000|Overall Study|Lack of Efficacy|1|||
129471700|NCT03609619|466022227|FG001|Overall Study|Lack of Efficacy|2|||
129471701|NCT03609619|466022226|FG000|Overall Study|Protocol Violation|5|||
129471702|NCT03609619|466022227|FG001|Overall Study|Protocol Violation|0|||
129471703|NCT03609619|466022226|FG000|Overall Study|Withdrawal by Subject|2|||
129471704|NCT03609619|466022227|FG001|Overall Study|Withdrawal by Subject|3|||
129471705|NCT03609619|466022226|FG000|Overall Study|Lost to Follow-up|1|||
129471706|NCT03609619|466022227|FG001|Overall Study|Lost to Follow-up|1|||
129471707|NCT02327260|466022228|FG000|Overall Study|Lost to Follow-up|2|||
129471708|NCT02327260|466022229|FG001|Overall Study|Lost to Follow-up|3|||
129471709|NCT02327260|466022230|FG002|Overall Study|Lost to Follow-up|2|||
129471710|NCT02327260|466022228|FG000|Overall Study|invalid phone number|1|||
129471711|NCT02327260|466022229|FG001|Overall Study|invalid phone number|1|||
129471712|NCT02327260|466022230|FG002|Overall Study|invalid phone number|0|||
129471713|NCT02327260|466022228|FG000|Overall Study|non-adherence to protocol|2|||
129471714|NCT02327260|466022229|FG001|Overall Study|non-adherence to protocol|0|||
129471715|NCT02327260|466022230|FG002|Overall Study|non-adherence to protocol|0|||
129471716|NCT02327260|466022228|FG000|Overall Study|cognitive concerns|1|||
129471717|NCT02327260|466022229|FG001|Overall Study|cognitive concerns|0|||
129471718|NCT02327260|466022230|FG002|Overall Study|cognitive concerns|0|||
129471719|NCT02472847|466022232|FG000|Overall Study|Withdrawal by Subject|1|||
129471720|NCT02472847|466022233|FG001|Overall Study|Withdrawal by Subject|5|||
129471721|NCT00623831|466022236|FG000|Overall Study|Withdrawal by Subject|1|||
129471722|NCT00623831|466022237|FG001|Overall Study|Withdrawal by Subject|0|||
129471723|NCT00623831|466022236|FG000|Overall Study|Progressive Disease|0|||
129471724|NCT00623831|466022237|FG001|Overall Study|Progressive Disease|1|||
129471725|NCT00270894|466022238|FG000|Overall Study|Adverse Event|1|||
129471726|NCT00270894|466022238|FG000|Overall Study|Withdrawal by Subject|1|||
129471727|NCT01748071|466022241|FG000|Overall Study|Adverse Event|2|||
129471728|NCT01748071|466022242|FG001|Overall Study|Adverse Event|2|||
129471729|NCT01748071|466022243|FG002|Overall Study|Adverse Event|0|||
129471730|NCT00793793|466022244|FG000|Overall Study|Adverse Event|0|||
129471731|NCT00793793|466022245|FG001|Overall Study|Adverse Event|0|||
129471732|NCT00793793|466022246|FG002|Overall Study|Adverse Event|1|||
129471733|NCT00793793|466022247|FG003|Overall Study|Adverse Event|1|||
129471734|NCT00793793|466022248|FG004|Overall Study|Adverse Event|0|||
129471735|NCT00793793|466022249|FG005|Overall Study|Adverse Event|1|||
129471736|NCT00793793|466022250|FG006|Overall Study|Adverse Event|2|||
129471737|NCT00793793|466022251|FG007|Overall Study|Adverse Event|0|||
129471738|NCT00793793|466022252|FG008|Overall Study|Adverse Event|0|||
129471739|NCT00793793|466022253|FG009|Overall Study|Adverse Event|0|||
129471740|NCT00793793|466022254|FG010|Overall Study|Adverse Event|0|||
129471741|NCT00793793|466022255|FG011|Overall Study|Adverse Event|2|||
129471742|NCT00793793|466022244|FG000|Overall Study|Protocol Violation|0|||
129471743|NCT00793793|466022245|FG001|Overall Study|Protocol Violation|0|||
129471744|NCT00793793|466022246|FG002|Overall Study|Protocol Violation|0|||
129471745|NCT00793793|466022247|FG003|Overall Study|Protocol Violation|1|||
129471746|NCT00793793|466022248|FG004|Overall Study|Protocol Violation|0|||
129471747|NCT00793793|466022249|FG005|Overall Study|Protocol Violation|0|||
129471748|NCT00793793|466022250|FG006|Overall Study|Protocol Violation|0|||
129471749|NCT00793793|466022251|FG007|Overall Study|Protocol Violation|0|||
129471750|NCT00793793|466022252|FG008|Overall Study|Protocol Violation|0|||
129471751|NCT00793793|466022253|FG009|Overall Study|Protocol Violation|0|||
129471752|NCT00793793|466022254|FG010|Overall Study|Protocol Violation|0|||
129471753|NCT00793793|466022255|FG011|Overall Study|Protocol Violation|0|||
129471754|NCT00793793|466022244|FG000|Overall Study|Lost to Follow-up|0|||
129471755|NCT00793793|466022245|FG001|Overall Study|Lost to Follow-up|0|||
129471756|NCT00793793|466022246|FG002|Overall Study|Lost to Follow-up|1|||
129471757|NCT00793793|466022247|FG003|Overall Study|Lost to Follow-up|0|||
129471758|NCT00793793|466022248|FG004|Overall Study|Lost to Follow-up|0|||
129471759|NCT00793793|466022249|FG005|Overall Study|Lost to Follow-up|0|||
129471760|NCT00793793|466022250|FG006|Overall Study|Lost to Follow-up|0|||
129471761|NCT00793793|466022251|FG007|Overall Study|Lost to Follow-up|0|||
129471762|NCT00793793|466022252|FG008|Overall Study|Lost to Follow-up|1|||
129471763|NCT00793793|466022253|FG009|Overall Study|Lost to Follow-up|3|||
129471764|NCT00793793|466022254|FG010|Overall Study|Lost to Follow-up|1|||
129471765|NCT00793793|466022255|FG011|Overall Study|Lost to Follow-up|0|||
129471766|NCT00793793|466022244|FG000|Overall Study|Withdrawal by Subject|0|||
129471767|NCT00793793|466022245|FG001|Overall Study|Withdrawal by Subject|0|||
129471768|NCT00793793|466022246|FG002|Overall Study|Withdrawal by Subject|0|||
129471769|NCT00793793|466022247|FG003|Overall Study|Withdrawal by Subject|0|||
129471770|NCT00793793|466022248|FG004|Overall Study|Withdrawal by Subject|1|||
129471771|NCT00793793|466022249|FG005|Overall Study|Withdrawal by Subject|0|||
129471772|NCT00793793|466022250|FG006|Overall Study|Withdrawal by Subject|0|||
129471773|NCT00793793|466022251|FG007|Overall Study|Withdrawal by Subject|0|||
129471774|NCT00793793|466022252|FG008|Overall Study|Withdrawal by Subject|1|||
129471775|NCT00793793|466022253|FG009|Overall Study|Withdrawal by Subject|0|||
129471776|NCT00793793|466022254|FG010|Overall Study|Withdrawal by Subject|0|||
129471777|NCT00793793|466022255|FG011|Overall Study|Withdrawal by Subject|0|||
129471778|NCT00793793|466022244|FG000|Overall Study|reason not specified|0|||
129471779|NCT00793793|466022245|FG001|Overall Study|reason not specified|1|||
129471780|NCT00793793|466022246|FG002|Overall Study|reason not specified|0|||
129471781|NCT00793793|466022247|FG003|Overall Study|reason not specified|1|||
129471782|NCT00793793|466022248|FG004|Overall Study|reason not specified|1|||
129471783|NCT00793793|466022249|FG005|Overall Study|reason not specified|1|||
129471784|NCT00793793|466022250|FG006|Overall Study|reason not specified|2|||
129471785|NCT00793793|466022251|FG007|Overall Study|reason not specified|0|||
129471786|NCT00793793|466022252|FG008|Overall Study|reason not specified|7|||
129471787|NCT00793793|466022253|FG009|Overall Study|reason not specified|6|||
129471788|NCT00793793|466022254|FG010|Overall Study|reason not specified|2|||
129471789|NCT00793793|466022255|FG011|Overall Study|reason not specified|4|||
129471790|NCT00950170|466022256|FG000|Overall Study|Parent/Legal Guardian Request|1|||
129471791|NCT00950170|466022256|FG000|Overall Study|Adverse Event|2|||
129471792|NCT00950170|466022256|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
129471793|NCT02522767|466022257|FG000|Double-blind|Withdrawal by Subject|8|||
129471794|NCT02522767|466022258|FG001|Double-blind|Withdrawal by Subject|11|||
129471795|NCT02522767|466022257|FG000|Double-blind|Lost to Follow-up|1|||
129471796|NCT02522767|466022258|FG001|Double-blind|Lost to Follow-up|0|||
129471797|NCT02522767|466022257|FG000|Double-blind|Adverse Event|1|||
129471798|NCT02522767|466022258|FG001|Double-blind|Adverse Event|10|||
129471799|NCT02522767|466022257|FG000|Double-blind|Protocol Violation|0|||
129471800|NCT02522767|466022258|FG001|Double-blind|Protocol Violation|1|||
129471801|NCT02522767|466022257|FG000|Double-blind|Lack of Efficacy|0|||
129471802|NCT02522767|466022258|FG001|Double-blind|Lack of Efficacy|2|||
129471803|NCT02522767|466022257|FG000|Double-blind|Protocol Deviation|1|||
129471804|NCT02522767|466022258|FG001|Double-blind|Protocol Deviation|0|||
129471805|NCT02522767|466022257|FG000|Open-label|Withdrawal by Subject|2|||
129471806|NCT02522767|466022258|FG001|Open-label|Withdrawal by Subject|3|||
129471807|NCT02522767|466022257|FG000|Open-label|Lost to Follow-up|0|||
129471808|NCT02522767|466022258|FG001|Open-label|Lost to Follow-up|1|||
129471809|NCT02522767|466022257|FG000|Open-label|Adverse Event|2|||
129471810|NCT02522767|466022258|FG001|Open-label|Adverse Event|1|||
129471811|NCT02522767|466022257|FG000|Open-label|Lack of Efficacy|1|||
129471812|NCT02522767|466022258|FG001|Open-label|Lack of Efficacy|1|||
129471813|NCT02522767|466022257|FG000|Open-label|Protocol Violation|0|||
129471814|NCT02522767|466022258|FG001|Open-label|Protocol Violation|1|||
129471815|NCT00841763|466022259|FG000|Overall Study|Withdrawal by Subject|60|||
129471816|NCT00841763|466022260|FG001|Overall Study|Withdrawal by Subject|17|||
129471817|NCT00841763|466022261|FG002|Overall Study|Withdrawal by Subject|4|||
129471818|NCT00841763|466022262|FG003|Overall Study|Withdrawal by Subject|1|||
129471819|NCT00841763|466022259|FG000|Overall Study|Adverse Event|9|||
129471820|NCT00841763|466022260|FG001|Overall Study|Adverse Event|10|||
129471821|NCT00841763|466022261|FG002|Overall Study|Adverse Event|3|||
129471822|NCT00841763|466022262|FG003|Overall Study|Adverse Event|2|||
129471823|NCT00841763|466022259|FG000|Overall Study|Lost to Follow-up|63|||
129471824|NCT00841763|466022260|FG001|Overall Study|Lost to Follow-up|25|||
129471825|NCT00841763|466022261|FG002|Overall Study|Lost to Follow-up|0|||
129471826|NCT00841763|466022262|FG003|Overall Study|Lost to Follow-up|0|||
129471827|NCT00841763|466022259|FG000|Overall Study|Protocol Violation|20|||
129471828|NCT00841763|466022260|FG001|Overall Study|Protocol Violation|3|||
129471829|NCT00841763|466022261|FG002|Overall Study|Protocol Violation|1|||
129471830|NCT00841763|466022262|FG003|Overall Study|Protocol Violation|0|||
129471831|NCT00841763|466022259|FG000|Overall Study|Administrative Reasons|3|||
129471832|NCT00841763|466022260|FG001|Overall Study|Administrative Reasons|1|||
129471833|NCT00841763|466022261|FG002|Overall Study|Administrative Reasons|0|||
129471834|NCT00841763|466022262|FG003|Overall Study|Administrative Reasons|0|||
129471835|NCT00841763|466022259|FG000|Overall Study|Unable to Classify|7|||
129471836|NCT00841763|466022260|FG001|Overall Study|Unable to Classify|1|||
129471837|NCT00841763|466022261|FG002|Overall Study|Unable to Classify|0|||
129471838|NCT00841763|466022262|FG003|Overall Study|Unable to Classify|0|||
129471839|NCT02631538|466022263|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
129471840|NCT02631538|466022264|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
129471841|NCT02631538|466022265|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
129471842|NCT02631538|466022266|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
129471843|NCT02631538|466022263|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
129471844|NCT02631538|466022264|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
129471845|NCT02631538|466022265|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
129471846|NCT02631538|466022266|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
129471847|NCT02631538|466022263|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
129471848|NCT02631538|466022264|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
129471849|NCT02631538|466022265|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
129471850|NCT02631538|466022266|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
129471851|NCT02631538|466022263|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
129471852|NCT02631538|466022264|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
129471853|NCT02631538|466022265|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
129471854|NCT02631538|466022266|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
129471855|NCT02631538|466022263|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
129471856|NCT02631538|466022264|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
129471857|NCT02631538|466022265|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
129471858|NCT02631538|466022266|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
129471859|NCT02631538|466022263|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
129471860|NCT02631538|466022264|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
129471861|NCT02631538|466022265|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
129471862|NCT02631538|466022266|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
129471863|NCT00648167|466022267|FG000|Overall Study|Adverse Event|6|||
129471864|NCT00648167|466022267|FG000|Overall Study|unable to swallow tablets|1|||
129471865|NCT01482910|466022272|FG000|Overall Study|Adverse Event|6|||
129471866|NCT01482910|466022273|FG001|Overall Study|Adverse Event|5|||
129471867|NCT01482910|466022272|FG000|Overall Study|Lost to Follow-up|0|||
129471868|NCT01482910|466022273|FG001|Overall Study|Lost to Follow-up|1|||
129471869|NCT01482910|466022272|FG000|Overall Study|Protocol Violation|1|||
129471870|NCT01482910|466022273|FG001|Overall Study|Protocol Violation|1|||
129471871|NCT01482910|466022272|FG000|Overall Study|Withdrawal by Subject|7|||
129471872|NCT01482910|466022273|FG001|Overall Study|Withdrawal by Subject|2|||
129471873|NCT01482910|466022272|FG000|Overall Study|Death|1|||
129471874|NCT01482910|466022273|FG001|Overall Study|Death|0|||
129471875|NCT00440726|466022274|FG000|Phase 1|Dose-Limiting Toxicity|0|||
129471876|NCT00440726|466022275|FG001|Phase 1|Dose-Limiting Toxicity|1|||
129471877|NCT00440726|466022276|FG002|Phase 1|Dose-Limiting Toxicity|0|||
129471878|NCT00440726|466022274|FG000|Phase 1|Physician Decision|1|||
129471879|NCT00440726|466022275|FG001|Phase 1|Physician Decision|0|||
129471880|NCT00440726|466022276|FG002|Phase 1|Physician Decision|0|||
129471881|NCT00440726|466022274|FG000|Phase 2|Death|0|||
129471882|NCT00440726|466022275|FG001|Phase 2|Death|0|||
129471883|NCT00440726|466022276|FG002|Phase 2|Death|1|||
129471884|NCT00440726|466022274|FG000|Phase 2|Adverse Event|0|||
129471885|NCT00440726|466022275|FG001|Phase 2|Adverse Event|0|||
129471886|NCT00440726|466022276|FG002|Phase 2|Adverse Event|1|||
129471887|NCT00110019|466022278|FG000|Overall Study|Lack of Efficacy|253|||
129471888|NCT00110019|466022279|FG001|Overall Study|Lack of Efficacy|285|||
129471889|NCT00110019|466022278|FG000|Overall Study|Adverse Event|61|||
129471890|NCT00110019|466022279|FG001|Overall Study|Adverse Event|40|||
129471891|NCT00110019|466022278|FG000|Overall Study|Death|13|||
129471892|NCT00110019|466022279|FG001|Overall Study|Death|15|||
129471893|NCT00110019|466022278|FG000|Overall Study|Withdrawal by Subject|21|||
129471894|NCT00110019|466022279|FG001|Overall Study|Withdrawal by Subject|9|||
129471895|NCT00110019|466022278|FG000|Overall Study|alternative therapy|5|||
129471896|NCT00110019|466022279|FG001|Overall Study|alternative therapy|1|||
129471897|NCT00110019|466022278|FG000|Overall Study|complicating disease|1|||
129471898|NCT00110019|466022279|FG001|Overall Study|complicating disease|1|||
129471899|NCT00110019|466022278|FG000|Overall Study|symptom deterioration|13|||
129471900|NCT00110019|466022279|FG001|Overall Study|symptom deterioration|16|||
129471901|NCT00110019|466022278|FG000|Overall Study|Not start protocol therapy|17|||
129471902|NCT00110019|466022279|FG001|Overall Study|Not start protocol therapy|16|||
129471903|NCT00110019|466022278|FG000|Overall Study|other reasons|22|||
129471904|NCT00110019|466022279|FG001|Overall Study|other reasons|30|||
129471905|NCT04303000|466022282|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
129471906|NCT04303000|466022283|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
129471907|NCT04303000|466022284|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
129471908|NCT00849667|466022285|FG000|Overall Study|Withdrawal by Subject|16|||
129471909|NCT00849667|466022286|FG001|Overall Study|Withdrawal by Subject|33|||
129471910|NCT00849667|466022287|FG002|Overall Study|Withdrawal by Subject|35|||
129471911|NCT00849667|466022285|FG000|Overall Study|Lost to Follow-up|8|||
129471912|NCT00849667|466022286|FG001|Overall Study|Lost to Follow-up|8|||
129471913|NCT00849667|466022287|FG002|Overall Study|Lost to Follow-up|8|||
129471914|NCT00849667|466022285|FG000|Overall Study|Adverse Event|1|||
129471915|NCT00849667|466022286|FG001|Overall Study|Adverse Event|2|||
129471916|NCT00849667|466022287|FG002|Overall Study|Adverse Event|0|||
129471917|NCT00849667|466022285|FG000|Overall Study|Other|18|||
129471918|NCT00849667|466022286|FG001|Overall Study|Other|19|||
129471919|NCT00849667|466022287|FG002|Overall Study|Other|18|||
129471920|NCT00849667|466022285|FG000|Overall Study|Progressive disease|119|||
129471921|NCT00849667|466022286|FG001|Overall Study|Progressive disease|100|||
129471922|NCT00849667|466022287|FG002|Overall Study|Progressive disease|112|||
129471923|NCT00849667|466022285|FG000|Overall Study|Sponsor decision|208|||
129471924|NCT00849667|466022286|FG001|Overall Study|Sponsor decision|204|||
129471925|NCT00849667|466022287|FG002|Overall Study|Sponsor decision|190|||
129471926|NCT00849667|466022285|FG000|Overall Study|Investigator discretion|0|||
129471927|NCT00849667|466022286|FG001|Overall Study|Investigator discretion|0|||
129471928|NCT00849667|466022287|FG002|Overall Study|Investigator discretion|1|||
129471929|NCT03486392|466022293|FG000|Overall Study|Lost to Follow-up|0|||
129471930|NCT03486392|466022294|FG001|Overall Study|Lost to Follow-up|0|||
129471931|NCT03486392|466022295|FG002|Overall Study|Lost to Follow-up|8|||
129471932|NCT03486392|466022296|FG003|Overall Study|Lost to Follow-up|5|||
129471933|NCT03486392|466022297|FG004|Overall Study|Lost to Follow-up|2|||
129471934|NCT03486392|466022293|FG000|Overall Study|Withdrawal by Subject|3|||
129471935|NCT03486392|466022294|FG001|Overall Study|Withdrawal by Subject|0|||
129471936|NCT03486392|466022295|FG002|Overall Study|Withdrawal by Subject|6|||
129471937|NCT03486392|466022296|FG003|Overall Study|Withdrawal by Subject|4|||
129471938|NCT03486392|466022297|FG004|Overall Study|Withdrawal by Subject|1|||
129471939|NCT03486392|466022293|FG000|Overall Study|Death|0|||
129471940|NCT03486392|466022294|FG001|Overall Study|Death|0|||
129471941|NCT03486392|466022295|FG002|Overall Study|Death|0|||
129471942|NCT03486392|466022296|FG003|Overall Study|Death|0|||
129471943|NCT03486392|466022297|FG004|Overall Study|Death|1|||
129471944|NCT00888355|466022304|FG000|Overall Study|Adverse Event|10|||
129471945|NCT00888355|466022305|FG001|Overall Study|Adverse Event|0|||
129471946|NCT00888355|466022306|FG002|Overall Study|Adverse Event|3|||
129471947|NCT00888355|466022307|FG003|Overall Study|Adverse Event|3|||
129471948|NCT00888355|466022304|FG000|Overall Study|Lack of Efficacy|9|||
129471949|NCT00888355|466022305|FG001|Overall Study|Lack of Efficacy|2|||
129471950|NCT00888355|466022306|FG002|Overall Study|Lack of Efficacy|5|||
129471951|NCT00888355|466022307|FG003|Overall Study|Lack of Efficacy|2|||
129471952|NCT00888355|466022304|FG000|Overall Study|Lost to Follow-up|0|||
129471953|NCT00888355|466022305|FG001|Overall Study|Lost to Follow-up|2|||
129471954|NCT00888355|466022306|FG002|Overall Study|Lost to Follow-up|2|||
129471955|NCT00888355|466022307|FG003|Overall Study|Lost to Follow-up|0|||
129471956|NCT00888355|466022304|FG000|Overall Study|Protocol Violation|3|||
129471957|NCT00888355|466022305|FG001|Overall Study|Protocol Violation|2|||
129471958|NCT00888355|466022306|FG002|Overall Study|Protocol Violation|1|||
129471959|NCT00888355|466022307|FG003|Overall Study|Protocol Violation|2|||
129471960|NCT00888355|466022304|FG000|Overall Study|Withdrawal by Subject|0|||
129471961|NCT00888355|466022305|FG001|Overall Study|Withdrawal by Subject|3|||
129471962|NCT00888355|466022306|FG002|Overall Study|Withdrawal by Subject|1|||
129471963|NCT00888355|466022307|FG003|Overall Study|Withdrawal by Subject|3|||
129471964|NCT01551693|466022309|FG000|Overall Study|Disease Progression|1|||
129471965|NCT01551693|466022310|FG001|Overall Study|Disease Progression|0|||
129471966|NCT01551693|466022309|FG000|Overall Study|Adverse Event|0|||
129471967|NCT01551693|466022310|FG001|Overall Study|Adverse Event|1|||
129471968|NCT01551693|466022309|FG000|Overall Study|Withdrawal by Subject|0|||
129471969|NCT01551693|466022310|FG001|Overall Study|Withdrawal by Subject|1|||
129471970|NCT02211261|466022312|FG000|Overall Study|Withdrawal by Subject|0|||
129471971|NCT02211261|466022313|FG001|Overall Study|Withdrawal by Subject|0|||
129471972|NCT02211261|466022314|FG002|Overall Study|Withdrawal by Subject|1|||
129471973|NCT02211261|466022315|FG003|Overall Study|Withdrawal by Subject|0|||
129471974|NCT02211261|466022316|FG004|Overall Study|Withdrawal by Subject|2|||
129471975|NCT02211261|466022317|FG005|Overall Study|Withdrawal by Subject|0|||
129471976|NCT02211261|466022318|FG006|Overall Study|Withdrawal by Subject|0|||
129471977|NCT02211261|466022319|FG007|Overall Study|Withdrawal by Subject|0|||
129471978|NCT02211261|466022320|FG008|Overall Study|Withdrawal by Subject|0|||
129471979|NCT02211261|466022321|FG009|Overall Study|Withdrawal by Subject|0|||
129471980|NCT02211261|466022322|FG010|Overall Study|Withdrawal by Subject|0|||
129471981|NCT02211261|466022312|FG000|Overall Study|Other|0|||
129471982|NCT02211261|466022313|FG001|Overall Study|Other|0|||
129471983|NCT02211261|466022314|FG002|Overall Study|Other|0|||
129471984|NCT02211261|466022315|FG003|Overall Study|Other|0|||
129471985|NCT02211261|466022316|FG004|Overall Study|Other|0|||
129471986|NCT02211261|466022317|FG005|Overall Study|Other|1|||
129471987|NCT02211261|466022318|FG006|Overall Study|Other|0|||
129471988|NCT02211261|466022319|FG007|Overall Study|Other|0|||
129471989|NCT02211261|466022320|FG008|Overall Study|Other|0|||
129471990|NCT02211261|466022321|FG009|Overall Study|Other|2|||
129471991|NCT02211261|466022322|FG010|Overall Study|Other|0|||
129471992|NCT02211261|466022312|FG000|Overall Study|Lost to Follow-up|0|||
129471993|NCT02211261|466022313|FG001|Overall Study|Lost to Follow-up|0|||
129471994|NCT02211261|466022314|FG002|Overall Study|Lost to Follow-up|0|||
129471995|NCT02211261|466022315|FG003|Overall Study|Lost to Follow-up|0|||
129974292|NCT00392925|467869714|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
129974293|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
129974294|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
129974295|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
129471996|NCT02211261|466022316|FG004|Overall Study|Lost to Follow-up|0|||
129471997|NCT02211261|466022317|FG005|Overall Study|Lost to Follow-up|0|||
129471998|NCT02211261|466022318|FG006|Overall Study|Lost to Follow-up|0|||
129471999|NCT02211261|466022319|FG007|Overall Study|Lost to Follow-up|1|||
129472000|NCT02211261|466022320|FG008|Overall Study|Lost to Follow-up|0|||
129472001|NCT02211261|466022321|FG009|Overall Study|Lost to Follow-up|0|||
129472002|NCT02211261|466022322|FG010|Overall Study|Lost to Follow-up|0|||
129472003|NCT04897867|466022323|FG000|Overall Study|Withdrawal of Consent|1|||
129472004|NCT04897867|466022323|FG000|Overall Study|Pregnancy|1|||
129472005|NCT04897867|466022323|FG000|Overall Study|Lost to Follow-up|7|||
129472006|NCT04897867|466022323|FG000|Overall Study|Reason not Specified|2|||
129472007|NCT01171612|466022328|FG000|Overall Study|Lost to Follow-up|51|||
129472008|NCT00243659|466022329|FG000|Overall Study|Withdrawal by Subject|1|||
129472009|NCT00243659|466022330|FG001|Overall Study|Withdrawal by Subject|1|||
129472010|NCT00243659|466022329|FG000|Overall Study|Protocol Violation|1|||
129472011|NCT00243659|466022330|FG001|Overall Study|Protocol Violation|2|||
129472012|NCT03310970|466022331|FG000|Overall Study|Withdrawal by Subject|0|||
129472013|NCT03310970|466022332|FG001|Overall Study|Withdrawal by Subject|1|||
129472014|NCT03430986|466022333|FG000|24-week Control Period|Adverse Event|1|||
129472015|NCT03430986|466022334|FG001|24-week Control Period|Adverse Event|0|||
129974296|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
129472016|NCT03430986|466022333|FG000|24-week Control Period|Lost to Follow-up|2|||
129472017|NCT03430986|466022334|FG001|24-week Control Period|Lost to Follow-up|2|||
129472018|NCT03430986|466022333|FG000|24-week Control Period|Withdrawal by Participant|5|||
129472019|NCT03430986|466022334|FG001|24-week Control Period|Withdrawal by Participant|0|||
129472020|NCT03430986|466022333|FG000|24-week Control Period|Protocol Deviation|0|||
129472021|NCT03430986|466022334|FG001|24-week Control Period|Protocol Deviation|2|||
129472022|NCT03430986|466022333|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
129472023|NCT03430986|466022334|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
129472024|NCT03430986|466022333|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
129472025|NCT03430986|466022334|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
129472026|NCT01609842|466022336|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
129472027|NCT01609842|466022337|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
129472028|NCT02474329|466022338|FG000|Overall Study|Withdraw or did not contribute data.|13|||
129472029|NCT01475734|466023966|FG000|Overall Study|Withdrawal by Subject|1|||
129974297|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
129974298|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
129974299|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
129974300|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
129974301|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
129974302|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
129974303|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
129974304|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
129974305|NCT00392925|467869711|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
129974306|NCT00392925|467869712|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
129974307|NCT00392925|467869713|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
129974308|NCT00392925|467869714|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
129974309|NCT02579772|467869715|FG000|Overall Study|Withdrawal by Subject|0|||
129974310|NCT02579772|467869716|FG001|Overall Study|Withdrawal by Subject|1|||
129974311|NCT02579772|467869715|FG000|Overall Study|Usage of additional antioxidants|1|||
129974312|NCT02579772|467869716|FG001|Overall Study|Usage of additional antioxidants|0|||
129974313|NCT02579772|467869715|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
129974314|NCT02579772|467869716|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
129974315|NCT03128671|467869717|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
129974316|NCT03128671|467869718|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
129974317|NCT03128671|467869717|FG000|Allocation|Death|1|||
129974318|NCT03128671|467869718|FG001|Allocation|Death|0|||
129974319|NCT03128671|467869717|FG000|Allocation|Withdrawal by Subject|4|||
129974320|NCT03128671|467869718|FG001|Allocation|Withdrawal by Subject|0|||
129974321|NCT03128671|467869717|FG000|Intervention|Withdrawal by Subject|11|||
129974322|NCT03128671|467869718|FG001|Intervention|Withdrawal by Subject|10|||
129974323|NCT03128671|467869717|FG000|Intervention|Palliative/hospice care initiated|9|||
129974324|NCT03128671|467869718|FG001|Intervention|Palliative/hospice care initiated|10|||
129974325|NCT03128671|467869717|FG000|Intervention|Death|13|||
129974326|NCT03128671|467869718|FG001|Intervention|Death|11|||
129974327|NCT03128671|467869717|FG000|Intervention|Interrupted by hurricane|1|||
129974328|NCT03128671|467869718|FG001|Intervention|Interrupted by hurricane|0|||
129974329|NCT03128671|467869717|FG000|Intervention|Physician Decision|2|||
129974330|NCT03128671|467869718|FG001|Intervention|Physician Decision|3|||
129974331|NCT04463680|467869719|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
129974332|NCT04463680|467869719|FG000|Overall Study|Not eligible due to implant duration of use|1|||
129974333|NCT04463680|467869719|FG000|Overall Study|Withdrawal by Subject|3|||
129974334|NCT05239598|467869722|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
129974335|NCT05239598|467869723|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
129974336|NCT05239598|467869722|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
129974337|NCT05239598|467869723|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
129472030|NCT01475734|466023967|FG001|Overall Study|Withdrawal by Subject|0|||
129472031|NCT01475734|466023966|FG000|Overall Study|Protocol Violation|1|||
129472032|NCT01475734|466023967|FG001|Overall Study|Protocol Violation|0|||
129472033|NCT01475734|466023966|FG000|Overall Study|Physician Decision|0|||
129472034|NCT01475734|466023967|FG001|Overall Study|Physician Decision|1|||
129472035|NCT00956943|466023971|FG000|Overall Study|Lost to Follow-up|9|||
129472036|NCT00956943|466023972|FG001|Overall Study|Lost to Follow-up|10|||
129472037|NCT02613208|466023973|FG000|Overall Study|Withdrawal by Subject|1|||
129472038|NCT02613208|466023973|FG000|Overall Study|Change of address|2|||
129472039|NCT02613208|466023973|FG000|Overall Study|Physician Decision|2|||
129472040|NCT02613208|466023973|FG000|Overall Study|Lost to Follow-up|5|||
129472041|NCT02613208|466023973|FG000|Overall Study|Death|37|||
129472042|NCT02663895|466023974|FG000|Overall Study|Adverse Event|3|||
129472043|NCT02663895|466023974|FG000|Overall Study|Physician Decision|2|||
129974338|NCT04147195|467869728|FG000|Overall Study|Adverse Event|0|||
129974339|NCT04147195|467869729|FG001|Overall Study|Adverse Event|3|||
129974340|NCT04147195|467869728|FG000|Overall Study|Study Terminated by Sponsor|4|||
129974341|NCT04147195|467869729|FG001|Overall Study|Study Terminated by Sponsor|2|||
129472044|NCT02663895|466023974|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
129472045|NCT02663895|466023974|FG000|Overall Study|Withdrawal by Subject|1|||
129472046|NCT01400932|466023978|FG000|Overall Study|Adverse Event|10|||
129472047|NCT01400932|466023979|FG001|Overall Study|Adverse Event|5|||
129472048|NCT01400932|466023978|FG000|Overall Study|Lack of Efficacy|0|||
129472049|NCT01400932|466023979|FG001|Overall Study|Lack of Efficacy|3|||
129472050|NCT01400932|466023978|FG000|Overall Study|Withdrawal by Subject|2|||
129472051|NCT01400932|466023979|FG001|Overall Study|Withdrawal by Subject|6|||
129472052|NCT01400932|466023978|FG000|Overall Study|Lost to Follow-up|1|||
129472053|NCT01400932|466023979|FG001|Overall Study|Lost to Follow-up|0|||
129472054|NCT01400932|466023978|FG000|Overall Study|Protocol Deviation|0|||
129472055|NCT01400932|466023979|FG001|Overall Study|Protocol Deviation|1|||
129472056|NCT01400932|466023978|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129472057|NCT01400932|466023979|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
129472058|NCT03244059|466023981|FG000|Specific Aim 1|Physician Decision|1|||
129472059|NCT03244059|466023982|FG001|Specific Aim 1|Physician Decision|0|||
129472060|NCT03244059|466023981|FG000|Specific Aim 2|Physician Decision|1|||
129472061|NCT03244059|466023982|FG001|Specific Aim 2|Physician Decision|0|||
129472062|NCT01276821|466023983|FG000|Overall Study|Protocol Violation|0|||
129472063|NCT01276821|466023984|FG001|Overall Study|Protocol Violation|1|||
129472064|NCT00605267|466023985|FG000|Overall Study|Adverse Event|0|||
129472065|NCT00605267|466023986|FG001|Overall Study|Adverse Event|1|||
129472066|NCT00605267|466023985|FG000|Overall Study|Lack of Efficacy|1|||
129472067|NCT00605267|466023986|FG001|Overall Study|Lack of Efficacy|5|||
129472068|NCT00605267|466023985|FG000|Overall Study|Withdrawal by Subject|2|||
129472069|NCT00605267|466023986|FG001|Overall Study|Withdrawal by Subject|3|||
129472070|NCT02939131|466023987|FG000|Overall Study|Unable to get to clinic|6|||
129472071|NCT02939131|466023988|FG001|Overall Study|Unable to get to clinic|4|||
129974342|NCT04147195|467869728|FG000|Overall Study|Withdrawal by Subject|0|||
129974343|NCT04147195|467869729|FG001|Overall Study|Withdrawal by Subject|1|||
129974344|NCT05823012|467869730|FG000|Titration Period|Adverse Event|1|||
129974345|NCT05823012|467869730|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
129974346|NCT05823012|467869730|FG000|Maintenance Period|Adverse Event|1|||
129974347|NCT05823012|467869730|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
129974348|NCT05823012|467869730|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
129974349|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Adverse Event|10|||
129974350|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Adverse Event|9|||
129974351|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Adverse Event|7|||
129974352|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
129974353|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
129974354|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
129974355|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
129974356|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
129974357|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
129974358|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Physician Decision|7|||
129974359|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Physician Decision|3|||
129974360|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Physician Decision|2|||
129974361|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Pregnancy|2|||
129974362|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Pregnancy|1|||
129974363|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Pregnancy|3|||
129974364|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
129974365|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
129974366|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
129974367|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
129974368|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
129974369|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
129974370|NCT02614183|467869731|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
129974371|NCT02614183|467869732|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
129974372|NCT02614183|467869733|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
129974373|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
129472072|NCT02939131|466023987|FG000|Overall Study|Lost to Follow-up|2|||
129472073|NCT02939131|466023988|FG001|Overall Study|Lost to Follow-up|4|||
129472074|NCT02939131|466023987|FG000|Overall Study|severe debilitation|1|||
129472075|NCT02939131|466023988|FG001|Overall Study|severe debilitation|0|||
129472076|NCT02939131|466023987|FG000|Overall Study|Other|0|||
129472077|NCT02939131|466023988|FG001|Overall Study|Other|1|||
129472078|NCT02939131|466023987|FG000|Overall Study|not willing to adhere to protocol|2|||
129472079|NCT02939131|466023988|FG001|Overall Study|not willing to adhere to protocol|0|||
129472080|NCT01254669|466023989|FG000|Overall Study|Withdrawal by Subject|0|||
129472081|NCT01254669|466023990|FG001|Overall Study|Withdrawal by Subject|1|||
129974374|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
129974375|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
129472082|NCT01254669|466023989|FG000|Overall Study|time constraint|2|||
129974376|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
129974377|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
129974378|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
129974379|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
129974380|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
129974381|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
129974382|NCT02614183|467869731|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
129974383|NCT02614183|467869732|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
129974384|NCT02614183|467869733|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
129974385|NCT01920477|467871378|FG000|Overall Study|Adverse Event|0|||
129974386|NCT01920477|467871379|FG001|Overall Study|Adverse Event|1|||
129974387|NCT01920477|467871378|FG000|Overall Study|Lack of Efficacy|1|||
129974388|NCT01920477|467871379|FG001|Overall Study|Lack of Efficacy|0|||
129974389|NCT01920477|467871378|FG000|Overall Study|Study closed/terminated|14|||
129974390|NCT01920477|467871379|FG001|Overall Study|Study closed/terminated|15|||
129974391|NCT01920477|467871378|FG000|Overall Study|Withdrawal by Subject|0|||
129974392|NCT01920477|467871379|FG001|Overall Study|Withdrawal by Subject|1|||
129974393|NCT01681277|467871382|FG000|Overall Study|Adverse Event|1|||
129974394|NCT01681277|467871383|FG001|Overall Study|Adverse Event|0|||
129974395|NCT01681277|467871384|FG002|Overall Study|Adverse Event|0|||
129974396|NCT01681277|467871385|FG003|Overall Study|Adverse Event|0|||
129974397|NCT01681277|467871386|FG004|Overall Study|Adverse Event|0|||
129974398|NCT02113124|467871387|FG000|Overall Study|Unable to retrieve blood sample|1|||
129974399|NCT02113124|467871388|FG001|Overall Study|Unable to retrieve blood sample|1|||
129974400|NCT02271984|467871394|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974401|NCT02271984|467871395|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974402|NCT02271984|467871396|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974403|NCT02271984|467871397|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974404|NCT02271984|467871398|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974405|NCT02271984|467871399|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
129974406|NCT02271984|467871400|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974407|NCT02271984|467871401|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
129974408|NCT02271984|467871402|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974409|NCT02271984|467871403|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974410|NCT02271984|467871404|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974411|NCT02271984|467871405|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
129974412|NCT02521363|467871406|FG000|Overall Study|Withdrawal by Subject|1|||
129974413|NCT02521363|467871407|FG001|Overall Study|Withdrawal by Subject|2|||
129974414|NCT04624243|467871408|FG000|Overall Study|Death|0|||
129974415|NCT04624243|467871409|FG001|Overall Study|Death|1|||
129974416|NCT04624243|467871410|FG002|Overall Study|Death|0|||
129974417|NCT04624243|467871411|FG003|Overall Study|Death|0|||
129974418|NCT04624243|467871412|FG004|Overall Study|Death|0|||
129974419|NCT04624243|467871408|FG000|Overall Study|Lost to Follow-up|2|||
129974420|NCT04624243|467871409|FG001|Overall Study|Lost to Follow-up|3|||
129974421|NCT04624243|467871410|FG002|Overall Study|Lost to Follow-up|7|||
129974422|NCT04624243|467871411|FG003|Overall Study|Lost to Follow-up|1|||
129974423|NCT04624243|467871412|FG004|Overall Study|Lost to Follow-up|3|||
129974424|NCT04624243|467871408|FG000|Overall Study|Physician Decision|3|||
129974425|NCT04624243|467871409|FG001|Overall Study|Physician Decision|8|||
129974426|NCT04624243|467871410|FG002|Overall Study|Physician Decision|15|||
129974427|NCT04624243|467871411|FG003|Overall Study|Physician Decision|2|||
129974428|NCT04624243|467871412|FG004|Overall Study|Physician Decision|11|||
129974429|NCT04624243|467871408|FG000|Overall Study|Withdrawal by Subject|19|||
129974430|NCT04624243|467871409|FG001|Overall Study|Withdrawal by Subject|44|||
129974431|NCT04624243|467871410|FG002|Overall Study|Withdrawal by Subject|40|||
129974432|NCT04624243|467871411|FG003|Overall Study|Withdrawal by Subject|21|||
129974433|NCT04624243|467871412|FG004|Overall Study|Withdrawal by Subject|39|||
129974434|NCT04624243|467871408|FG000|Overall Study|Miscellaneous|3|||
129974435|NCT04624243|467871409|FG001|Overall Study|Miscellaneous|12|||
129974436|NCT04624243|467871410|FG002|Overall Study|Miscellaneous|9|||
129974437|NCT04624243|467871411|FG003|Overall Study|Miscellaneous|4|||
129974438|NCT04624243|467871412|FG004|Overall Study|Miscellaneous|6|||
129974439|NCT01923662|467871413|FG000|Overall Study|Withdrawal by Subject|1|||
129974440|NCT01294397|467871414|FG000|Overall Study|Withdrawal by Subject|1|||
129974441|NCT01294397|467871414|FG000|Overall Study|Administrative Decision|1|||
129974442|NCT01939353|467871415|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
129974443|NCT01939353|467871415|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
129974444|NCT01939353|467871415|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
129974445|NCT01939353|467871415|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
129974446|NCT01939353|467871415|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
129974447|NCT05048238|467871423|FG000|Overall Study|Withdrawal by Subject|1|||
129974448|NCT01730378|467871424|FG000|Overall Study|Lost to Follow-up|1|||
129974449|NCT01730378|467871425|FG001|Overall Study|Lost to Follow-up|0|||
129974450|NCT00874731|467871427|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
129974451|NCT00874731|467871428|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
129974452|NCT00874731|467871429|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
129974453|NCT00874731|467871427|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
129974454|NCT00874731|467871428|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
129974455|NCT00874731|467871429|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
129974456|NCT00874731|467871427|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
129974457|NCT00874731|467871428|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
129974458|NCT00874731|467871429|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
129974459|NCT00955708|467871430|FG000|Overall Study|Death|269|||
129974460|NCT00955708|467871430|FG000|Overall Study|Lost to Follow-up|72|||
129974461|NCT00955708|467871430|FG000|Overall Study|Physician Decision|36|||
129974462|NCT00955708|467871430|FG000|Overall Study|Protocol Violation|134|||
129974463|NCT00955708|467871430|FG000|Overall Study|Registry Conclusion|186|||
129974464|NCT00955708|467871430|FG000|Overall Study|Product removed from service|94|||
129974465|NCT00955708|467871430|FG000|Overall Study|Patient Refused to participate further|116|||
129974466|NCT00955708|467871430|FG000|Overall Study|Closure of study location|60|||
129974467|NCT00955708|467871430|FG000|Overall Study|Patient changed care provider/moved|91|||
129974468|NCT01016262|467871433|FG000|Double-blind Phase|Adverse Event|0|||
129974469|NCT01016262|467871434|FG001|Double-blind Phase|Adverse Event|0|||
129974470|NCT01016262|467871435|FG002|Double-blind Phase|Adverse Event|1|||
129974471|NCT01016262|467871436|FG003|Double-blind Phase|Adverse Event|0|||
129974472|NCT01016262|467871437|FG004|Double-blind Phase|Adverse Event|0|||
129974473|NCT01016262|467871438|FG005|Double-blind Phase|Adverse Event|0|||
129974474|NCT01016262|467871433|FG000|Double-blind Phase|Lack of Efficacy|1|||
129974475|NCT01016262|467871434|FG001|Double-blind Phase|Lack of Efficacy|0|||
129974476|NCT01016262|467871435|FG002|Double-blind Phase|Lack of Efficacy|5|||
129974477|NCT01016262|467871436|FG003|Double-blind Phase|Lack of Efficacy|0|||
129974478|NCT01016262|467871437|FG004|Double-blind Phase|Lack of Efficacy|0|||
129974479|NCT01016262|467871438|FG005|Double-blind Phase|Lack of Efficacy|0|||
129974480|NCT01016262|467871433|FG000|Double-blind Phase|Disease Progression|0|||
129974481|NCT01016262|467871434|FG001|Double-blind Phase|Disease Progression|1|||
129974482|NCT01016262|467871435|FG002|Double-blind Phase|Disease Progression|2|||
129974483|NCT01016262|467871436|FG003|Double-blind Phase|Disease Progression|0|||
129974484|NCT01016262|467871437|FG004|Double-blind Phase|Disease Progression|0|||
129974485|NCT01016262|467871438|FG005|Double-blind Phase|Disease Progression|0|||
129974486|NCT01016262|467871433|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
129974487|NCT01016262|467871434|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
129974488|NCT01016262|467871435|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
129974489|NCT01016262|467871436|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
129974490|NCT01016262|467871437|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
129472083|NCT01254669|466023990|FG001|Overall Study|time constraint|2|||
129472084|NCT01254669|466023989|FG000|Overall Study|called to clinic during intervention|1|||
129472085|NCT01254669|466023990|FG001|Overall Study|called to clinic during intervention|1|||
129472086|NCT02720757|466023991|FG000|Overall Study|Other reason|5|||
129472087|NCT02720757|466023991|FG000|Overall Study|Loss of contact|4|||
129472088|NCT02720757|466023991|FG000|Overall Study|Informed consent withdrawal|1|||
129472089|NCT02720757|466023991|FG000|Overall Study|Patients wish to withdraw|2|||
129472090|NCT02720757|466023991|FG000|Overall Study|Missing|3|||
129472091|NCT02720757|466023991|FG000|Overall Study|General exclusion|3|||
129472092|NCT00988247|466023992|FG000|Overall Study|Adverse Event|17|||
129472093|NCT00988247|466023993|FG001|Overall Study|Adverse Event|3|||
129472094|NCT00988247|466023992|FG000|Overall Study|Withdrawal by Subject|44|||
129472095|NCT00988247|466023993|FG001|Overall Study|Withdrawal by Subject|13|||
129472096|NCT00988247|466023992|FG000|Overall Study|Pregnancy|1|||
129472097|NCT00988247|466023993|FG001|Overall Study|Pregnancy|2|||
129472098|NCT00988247|466023992|FG000|Overall Study|Lost to Follow-up|11|||
129472099|NCT00988247|466023993|FG001|Overall Study|Lost to Follow-up|2|||
129472100|NCT00988247|466023992|FG000|Overall Study|Protocol Violation|4|||
129472101|NCT00988247|466023993|FG001|Overall Study|Protocol Violation|5|||
129472102|NCT00988247|466023992|FG000|Overall Study|Sponsor requested withdrawal|3|||
129472103|NCT00988247|466023993|FG001|Overall Study|Sponsor requested withdrawal|1|||
129472104|NCT00988247|466023992|FG000|Overall Study|Other|3|||
129472105|NCT00988247|466023993|FG001|Overall Study|Other|0|||
129472106|NCT02661594|466023994|FG000|Overall Study|Protocol Violation|1|||
129472107|NCT02661594|466023995|FG001|Overall Study|Protocol Violation|0|||
129472108|NCT02661594|466023996|FG002|Overall Study|Protocol Violation|1|||
129974491|NCT01016262|467871438|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
129472109|NCT02661594|466023997|FG003|Overall Study|Protocol Violation|0|||
129472110|NCT04173741|466023998|FG000|Overall Study|IVC measurement cannot be done|1|||
129472111|NCT04173741|466023999|FG001|Overall Study|IVC measurement cannot be done|1|||
129974492|NCT01016262|467871433|FG000|Open-Label Phase|Adverse Event|0|||
129974493|NCT01016262|467871434|FG001|Open-Label Phase|Adverse Event|0|||
129974494|NCT01016262|467871435|FG002|Open-Label Phase|Adverse Event|0|||
129974495|NCT01016262|467871436|FG003|Open-Label Phase|Adverse Event|1|||
129974496|NCT01016262|467871437|FG004|Open-Label Phase|Adverse Event|0|||
129472112|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129974497|NCT01016262|467871438|FG005|Open-Label Phase|Adverse Event|0|||
129974498|NCT01016262|467871433|FG000|Open-Label Phase|Lost to Follow-up|0|||
129974499|NCT01016262|467871434|FG001|Open-Label Phase|Lost to Follow-up|0|||
129974500|NCT01016262|467871435|FG002|Open-Label Phase|Lost to Follow-up|0|||
129974501|NCT01016262|467871436|FG003|Open-Label Phase|Lost to Follow-up|0|||
129974502|NCT01016262|467871437|FG004|Open-Label Phase|Lost to Follow-up|1|||
129974503|NCT01016262|467871438|FG005|Open-Label Phase|Lost to Follow-up|0|||
129974504|NCT01016262|467871433|FG000|Open-Label Phase|Lack of Efficacy|0|||
129974505|NCT01016262|467871434|FG001|Open-Label Phase|Lack of Efficacy|0|||
129974506|NCT01016262|467871435|FG002|Open-Label Phase|Lack of Efficacy|0|||
129974507|NCT01016262|467871436|FG003|Open-Label Phase|Lack of Efficacy|1|||
129974508|NCT01016262|467871437|FG004|Open-Label Phase|Lack of Efficacy|0|||
129974509|NCT01016262|467871438|FG005|Open-Label Phase|Lack of Efficacy|0|||
129974510|NCT01016262|467871433|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974511|NCT01016262|467871434|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974512|NCT01016262|467871435|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974513|NCT01016262|467871436|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974514|NCT01016262|467871437|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
129974515|NCT01016262|467871438|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
129974516|NCT01736540|467871439|FG000|Overall Study|Did not complete scan within 45 days|2|||
129974517|NCT01736540|467871439|FG000|Overall Study|Death|1|||
129974518|NCT01736540|467871439|FG000|Overall Study|Abnormal test procedure|1|||
129974519|NCT01736540|467871439|FG000|Overall Study|Withdrawal by Subject|5|||
129974520|NCT01736540|467871439|FG000|Overall Study|Protocol Violation|1|||
129974521|NCT01736540|467871439|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
129974522|NCT01736540|467871439|FG000|Overall Study|No show for MRI appointment|1|||
129974523|NCT01736540|467871439|FG000|Overall Study|Unable to make MRI appointment|3|||
129974524|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
129974525|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
129974526|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
129974527|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
129974528|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
129974529|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
129974530|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
129974531|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
129974532|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
129974533|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
129974534|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
129974535|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
129974536|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
129974537|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
129974538|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
129974539|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
129974540|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
129974541|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
129974542|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
129974543|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
129472113|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
129472114|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472115|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472116|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472117|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
129472118|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
129472119|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
129472120|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
129472121|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
129472122|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
129472123|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
129472124|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472125|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
129472126|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
129472127|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
129472128|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
129472129|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
129974544|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
129974545|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
129974546|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
129974547|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
129974548|NCT00479882|467871440|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
129974549|NCT00479882|467871441|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
129974550|NCT00479882|467871442|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
129974551|NCT00479882|467871443|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
129974552|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
129974553|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
129974554|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
129974555|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
129974556|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
129974557|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
129974558|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
129974559|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
129974560|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
129974561|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
129974562|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
129974563|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
129974564|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
129974565|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
129974566|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
129974567|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
129974568|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
129974569|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
129974570|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
129974571|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
129974572|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
129974573|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
129974574|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
129974575|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
129974576|NCT00479882|467871440|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
129974577|NCT00479882|467871441|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
129974578|NCT00479882|467871442|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
129974579|NCT00479882|467871443|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
129974580|NCT01132820|467871444|FG000|Overall Study|Ineligible: wrong cell type|1|||
129974581|NCT01132820|467871444|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
129974582|NCT01132820|467871444|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
129974583|NCT01132820|467871444|FG000|Overall Study|Never treated|1|||
129974584|NCT01132820|467871444|FG000|Overall Study|Inadequate data|1|||
129974585|NCT01370655|467871447|FG000|Period 1|Adverse Event|2|||
129974586|NCT01370655|467871448|FG001|Period 1|Adverse Event|0|||
129974587|NCT01370655|467871449|FG002|Period 1|Adverse Event|0|||
129974588|NCT01370655|467871450|FG003|Period 1|Adverse Event|0|||
129974589|NCT01370655|467871451|FG004|Period 1|Adverse Event|0|||
129974590|NCT01370655|467871452|FG005|Period 1|Adverse Event|0|||
129974591|NCT01370655|467871453|FG006|Period 1|Adverse Event|1|||
129974592|NCT01370655|467871454|FG007|Period 1|Adverse Event|0|||
129974593|NCT01370655|467871455|FG008|Period 1|Adverse Event|0|||
129974594|NCT01370655|467871456|FG009|Period 1|Adverse Event|0|||
129974595|NCT01370655|467871457|FG010|Period 1|Adverse Event|0|||
129974596|NCT01370655|467871458|FG011|Period 1|Adverse Event|0|||
129974597|NCT01370655|467871447|FG000|Period 2|Adverse Event|0|||
129974598|NCT01370655|467871448|FG001|Period 2|Adverse Event|0|||
129974599|NCT01370655|467871449|FG002|Period 2|Adverse Event|1|||
129974600|NCT01370655|467871450|FG003|Period 2|Adverse Event|0|||
129974601|NCT01370655|467871451|FG004|Period 2|Adverse Event|1|||
129974602|NCT01370655|467871452|FG005|Period 2|Adverse Event|0|||
129974603|NCT01370655|467871453|FG006|Period 2|Adverse Event|0|||
129974604|NCT01370655|467871454|FG007|Period 2|Adverse Event|1|||
129472130|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
129472131|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
129472132|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129974605|NCT01370655|467871455|FG008|Period 2|Adverse Event|0|||
129974606|NCT01370655|467871456|FG009|Period 2|Adverse Event|0|||
129974607|NCT01370655|467871457|FG010|Period 2|Adverse Event|0|||
129974608|NCT01370655|467871458|FG011|Period 2|Adverse Event|0|||
129974609|NCT01370655|467871447|FG000|Period 2|met protocol specified stopping criteria|0|||
129974610|NCT01370655|467871448|FG001|Period 2|met protocol specified stopping criteria|0|||
129974611|NCT01370655|467871449|FG002|Period 2|met protocol specified stopping criteria|1|||
129974612|NCT01370655|467871450|FG003|Period 2|met protocol specified stopping criteria|0|||
129974613|NCT01370655|467871451|FG004|Period 2|met protocol specified stopping criteria|0|||
129974614|NCT01370655|467871452|FG005|Period 2|met protocol specified stopping criteria|0|||
129974615|NCT01370655|467871453|FG006|Period 2|met protocol specified stopping criteria|1|||
129974616|NCT01370655|467871454|FG007|Period 2|met protocol specified stopping criteria|0|||
129974617|NCT01370655|467871455|FG008|Period 2|met protocol specified stopping criteria|1|||
129974618|NCT01370655|467871456|FG009|Period 2|met protocol specified stopping criteria|0|||
129974619|NCT01370655|467871457|FG010|Period 2|met protocol specified stopping criteria|1|||
129974620|NCT01370655|467871458|FG011|Period 2|met protocol specified stopping criteria|0|||
129974621|NCT01370655|467871447|FG000|Period 2|Withdrawal by Subject|0|||
129974622|NCT01370655|467871448|FG001|Period 2|Withdrawal by Subject|0|||
129974623|NCT01370655|467871449|FG002|Period 2|Withdrawal by Subject|0|||
129974624|NCT01370655|467871450|FG003|Period 2|Withdrawal by Subject|0|||
129974625|NCT01370655|467871451|FG004|Period 2|Withdrawal by Subject|0|||
129974626|NCT01370655|467871452|FG005|Period 2|Withdrawal by Subject|0|||
129974627|NCT01370655|467871453|FG006|Period 2|Withdrawal by Subject|0|||
129974628|NCT01370655|467871454|FG007|Period 2|Withdrawal by Subject|0|||
129974629|NCT01370655|467871455|FG008|Period 2|Withdrawal by Subject|1|||
129974630|NCT01370655|467871456|FG009|Period 2|Withdrawal by Subject|0|||
129974631|NCT01370655|467871457|FG010|Period 2|Withdrawal by Subject|0|||
129974632|NCT01370655|467871458|FG011|Period 2|Withdrawal by Subject|0|||
129974633|NCT05000216|467871460|FG000|Stage 1|Lost to Follow-up|0|||
129974634|NCT05000216|467871461|FG001|Stage 1|Lost to Follow-up|0|||
129974635|NCT05000216|467871462|FG002|Stage 1|Lost to Follow-up|0|||
129974636|NCT05000216|467871463|FG003|Stage 1|Lost to Follow-up|0|||
129974637|NCT05000216|467871464|FG004|Stage 1|Lost to Follow-up|0|||
129974638|NCT05000216|467871465|FG005|Stage 1|Lost to Follow-up|0|||
129974639|NCT05000216|467871466|FG006|Stage 1|Lost to Follow-up|1|||
129974640|NCT05000216|467871467|FG007|Stage 1|Lost to Follow-up|1|||
129974641|NCT05000216|467871468|FG008|Stage 1|Lost to Follow-up|0|||
129974642|NCT05000216|467871469|FG009|Stage 1|Lost to Follow-up|2|||
129974643|NCT05000216|467871470|FG010|Stage 1|Lost to Follow-up|3|||
129974644|NCT05000216|467871471|FG011|Stage 1|Lost to Follow-up|0|||
129974645|NCT05000216|467871472|FG012|Stage 1|Lost to Follow-up|0|||
129974646|NCT05000216|467871473|FG013|Stage 1|Lost to Follow-up|0|||
129974647|NCT05000216|467871474|FG014|Stage 1|Lost to Follow-up|0|||
129974648|NCT05000216|467871475|FG015|Stage 1|Lost to Follow-up|0|||
129974649|NCT05000216|467871476|FG016|Stage 1|Lost to Follow-up|0|||
129974650|NCT05000216|467871477|FG017|Stage 1|Lost to Follow-up|0|||
129974651|NCT05000216|467871478|FG018|Stage 1|Lost to Follow-up|0|||
129974652|NCT05000216|467871479|FG019|Stage 1|Lost to Follow-up|0|||
129974653|NCT05000216|467871480|FG020|Stage 1|Lost to Follow-up|0|||
129974654|NCT05000216|467871481|FG021|Stage 1|Lost to Follow-up|0|||
129974655|NCT05000216|467871460|FG000|Stage 1|Physician Decision|0|||
129974656|NCT05000216|467871461|FG001|Stage 1|Physician Decision|0|||
129974657|NCT05000216|467871462|FG002|Stage 1|Physician Decision|0|||
129974658|NCT05000216|467871463|FG003|Stage 1|Physician Decision|0|||
129974659|NCT05000216|467871464|FG004|Stage 1|Physician Decision|0|||
129974660|NCT05000216|467871465|FG005|Stage 1|Physician Decision|0|||
129974661|NCT05000216|467871466|FG006|Stage 1|Physician Decision|0|||
129974662|NCT05000216|467871467|FG007|Stage 1|Physician Decision|1|||
129974663|NCT05000216|467871468|FG008|Stage 1|Physician Decision|1|||
129974664|NCT05000216|467871469|FG009|Stage 1|Physician Decision|0|||
129974665|NCT05000216|467871470|FG010|Stage 1|Physician Decision|0|||
129974666|NCT05000216|467871471|FG011|Stage 1|Physician Decision|0|||
129974667|NCT05000216|467871472|FG012|Stage 1|Physician Decision|0|||
129974668|NCT05000216|467871473|FG013|Stage 1|Physician Decision|0|||
129974669|NCT05000216|467871474|FG014|Stage 1|Physician Decision|0|||
129974670|NCT05000216|467871475|FG015|Stage 1|Physician Decision|0|||
129974671|NCT05000216|467871476|FG016|Stage 1|Physician Decision|0|||
129974672|NCT05000216|467871477|FG017|Stage 1|Physician Decision|0|||
129974673|NCT05000216|467871478|FG018|Stage 1|Physician Decision|0|||
129974674|NCT05000216|467871479|FG019|Stage 1|Physician Decision|0|||
129974675|NCT05000216|467871480|FG020|Stage 1|Physician Decision|0|||
129974676|NCT05000216|467871481|FG021|Stage 1|Physician Decision|0|||
129974677|NCT05000216|467871460|FG000|Stage 1|Withdrawal by Subject|0|||
129974678|NCT05000216|467871461|FG001|Stage 1|Withdrawal by Subject|1|||
129974679|NCT05000216|467871462|FG002|Stage 1|Withdrawal by Subject|0|||
129974680|NCT05000216|467871463|FG003|Stage 1|Withdrawal by Subject|0|||
129974681|NCT05000216|467871464|FG004|Stage 1|Withdrawal by Subject|0|||
129974682|NCT05000216|467871465|FG005|Stage 1|Withdrawal by Subject|0|||
129974683|NCT05000216|467871466|FG006|Stage 1|Withdrawal by Subject|0|||
129974684|NCT05000216|467871467|FG007|Stage 1|Withdrawal by Subject|0|||
129974685|NCT05000216|467871468|FG008|Stage 1|Withdrawal by Subject|0|||
129974686|NCT05000216|467871469|FG009|Stage 1|Withdrawal by Subject|3|||
129974687|NCT05000216|467871470|FG010|Stage 1|Withdrawal by Subject|10|||
129974688|NCT05000216|467871471|FG011|Stage 1|Withdrawal by Subject|0|||
129974689|NCT05000216|467871472|FG012|Stage 1|Withdrawal by Subject|0|||
129974690|NCT05000216|467871473|FG013|Stage 1|Withdrawal by Subject|0|||
129974691|NCT05000216|467871474|FG014|Stage 1|Withdrawal by Subject|0|||
129974692|NCT05000216|467871475|FG015|Stage 1|Withdrawal by Subject|0|||
129974693|NCT05000216|467871476|FG016|Stage 1|Withdrawal by Subject|0|||
129974694|NCT05000216|467871477|FG017|Stage 1|Withdrawal by Subject|0|||
129974695|NCT05000216|467871478|FG018|Stage 1|Withdrawal by Subject|0|||
129974696|NCT05000216|467871479|FG019|Stage 1|Withdrawal by Subject|0|||
129974697|NCT05000216|467871480|FG020|Stage 1|Withdrawal by Subject|0|||
129974698|NCT05000216|467871481|FG021|Stage 1|Withdrawal by Subject|0|||
129974699|NCT05000216|467871460|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
129974700|NCT05000216|467871461|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
129974701|NCT05000216|467871462|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
129974702|NCT05000216|467871463|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
129974703|NCT05000216|467871464|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
129974704|NCT05000216|467871465|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
129974705|NCT05000216|467871466|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
129974706|NCT05000216|467871467|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
129974707|NCT05000216|467871468|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
129974708|NCT05000216|467871469|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
129974709|NCT05000216|467871470|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
129974710|NCT05000216|467871471|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
129974711|NCT05000216|467871472|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
129974712|NCT05000216|467871473|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
129974713|NCT05000216|467871474|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
129974714|NCT05000216|467871475|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
129974715|NCT05000216|467871476|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
129974716|NCT05000216|467871477|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
129974717|NCT05000216|467871478|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
129974718|NCT05000216|467871479|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
129974719|NCT05000216|467871480|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
129974720|NCT05000216|467871481|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
129974721|NCT05000216|467871460|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974722|NCT05000216|467871461|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974723|NCT05000216|467871462|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974724|NCT05000216|467871463|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974725|NCT05000216|467871464|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974726|NCT05000216|467871465|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974727|NCT05000216|467871466|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974728|NCT05000216|467871467|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974729|NCT05000216|467871468|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
129974730|NCT05000216|467871469|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974731|NCT05000216|467871470|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974732|NCT05000216|467871471|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974733|NCT05000216|467871472|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974734|NCT05000216|467871473|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974735|NCT05000216|467871474|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974736|NCT05000216|467871475|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974737|NCT05000216|467871476|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974738|NCT05000216|467871477|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974739|NCT05000216|467871478|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974740|NCT05000216|467871479|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974741|NCT05000216|467871480|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974742|NCT05000216|467871481|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
129974743|NCT05000216|467871460|FG000|Stage 1|Other|0|||
129974744|NCT05000216|467871461|FG001|Stage 1|Other|0|||
129974745|NCT05000216|467871462|FG002|Stage 1|Other|0|||
129974746|NCT05000216|467871463|FG003|Stage 1|Other|0|||
129974747|NCT05000216|467871464|FG004|Stage 1|Other|1|||
129974748|NCT05000216|467871465|FG005|Stage 1|Other|0|||
129974749|NCT05000216|467871466|FG006|Stage 1|Other|0|||
129974750|NCT05000216|467871467|FG007|Stage 1|Other|2|||
129472133|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472134|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472135|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
129472136|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472137|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
129472138|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
129472139|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
129472140|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
129472141|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
129974751|NCT05000216|467871468|FG008|Stage 1|Other|0|||
129974752|NCT05000216|467871469|FG009|Stage 1|Other|0|||
129974753|NCT05000216|467871470|FG010|Stage 1|Other|1|||
129974754|NCT05000216|467871471|FG011|Stage 1|Other|1|||
129974755|NCT05000216|467871472|FG012|Stage 1|Other|0|||
129974756|NCT05000216|467871473|FG013|Stage 1|Other|0|||
129974757|NCT05000216|467871474|FG014|Stage 1|Other|0|||
129974758|NCT05000216|467871475|FG015|Stage 1|Other|0|||
129974759|NCT05000216|467871476|FG016|Stage 1|Other|0|||
129974760|NCT05000216|467871477|FG017|Stage 1|Other|0|||
129974761|NCT05000216|467871478|FG018|Stage 1|Other|0|||
129974762|NCT05000216|467871479|FG019|Stage 1|Other|0|||
129974763|NCT05000216|467871480|FG020|Stage 1|Other|0|||
129974764|NCT05000216|467871481|FG021|Stage 1|Other|0|||
129472142|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
129472143|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
129472144|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
129472145|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
129472146|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
129472147|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
129472148|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
129472149|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
129472150|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
129472151|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
129472152|NCT00289913|466024000|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
129472153|NCT00289913|466024001|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472154|NCT00289913|466024002|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
129472155|NCT00289913|466024003|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472156|NCT00289913|466024004|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472157|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472158|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472159|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
129472160|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472161|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472162|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
129472163|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
129472164|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
129472165|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
129472166|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
129472167|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
129472168|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
129472169|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
129472170|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
129472171|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
129472172|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
129472173|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
129472174|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
129472175|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472176|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472177|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
129472178|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129974765|NCT05000216|467871460|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
129974766|NCT05000216|467871461|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
129974767|NCT05000216|467871462|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
129974768|NCT05000216|467871463|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
129974769|NCT05000216|467871464|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
129974770|NCT05000216|467871465|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
129974771|NCT05000216|467871466|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
129974772|NCT05000216|467871467|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
129974773|NCT05000216|467871468|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
129974774|NCT05000216|467871469|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
129974775|NCT05000216|467871470|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
129974776|NCT05000216|467871471|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
129974777|NCT05000216|467871472|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
129974778|NCT05000216|467871473|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
129974779|NCT05000216|467871474|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
129974780|NCT05000216|467871475|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
129472179|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
129472180|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472181|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129974781|NCT05000216|467871476|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
129974782|NCT05000216|467871477|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
129472182|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
129472183|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
129472184|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
129472185|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
129974783|NCT05000216|467871478|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
129974784|NCT05000216|467871479|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
129472186|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
129472187|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
129472188|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
129472189|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
129472190|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
129472191|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
129472192|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
129472193|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
129472194|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
129472195|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
129472196|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
129472197|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
129472198|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
129472199|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
129472200|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
129472201|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
129472202|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
129472203|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
129472204|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
129472205|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
129472206|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
129472207|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
129472208|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
129472209|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
129472210|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
129472211|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
129472212|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
129472213|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
129472214|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
129472215|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
129472216|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
129472217|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
129472218|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
129472219|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
129472220|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
129472221|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
129472222|NCT00289913|466024000|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
129472223|NCT00289913|466024001|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
129472224|NCT00289913|466024002|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
129472225|NCT00289913|466024003|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
129472226|NCT00289913|466024004|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
129472227|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472228|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
129472229|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472230|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472231|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
129472232|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
129472233|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
129472234|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
129472235|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
129472236|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
129472237|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472238|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472239|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472240|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
129472241|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
129472242|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472243|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472244|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472245|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
129472246|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
129974785|NCT05000216|467871480|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
129974786|NCT05000216|467871481|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
129974787|NCT05000216|467871460|FG000|Stage 2|Lost to Follow-up|0|||
129472247|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
129472248|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
129472249|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
129472250|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
129472251|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
129472252|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
129472253|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
129472254|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
129472255|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
129472256|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
129472257|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
129472258|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
129472259|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
129472260|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
129472261|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
129472262|NCT00289913|466024000|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472263|NCT00289913|466024001|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
129472264|NCT00289913|466024002|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472265|NCT00289913|466024003|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472266|NCT00289913|466024004|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
129472267|NCT00214461|466024007|FG000|Overall Study|Adverse Event|0|||
129472268|NCT00214461|466024008|FG001|Overall Study|Adverse Event|0|||
129472269|NCT00214461|466024009|FG002|Overall Study|Adverse Event|1|||
129472270|NCT00214461|466024010|FG003|Overall Study|Adverse Event|1|||
129472271|NCT00214461|466024007|FG000|Overall Study|Withdrawal by Subject|0|||
129472272|NCT00214461|466024008|FG001|Overall Study|Withdrawal by Subject|0|||
129472273|NCT00214461|466024009|FG002|Overall Study|Withdrawal by Subject|1|||
129472274|NCT00214461|466024010|FG003|Overall Study|Withdrawal by Subject|0|||
129472275|NCT03502187|466024011|FG000|Overall Study|Withdrawal by Subject|4|||
129974788|NCT05000216|467871461|FG001|Stage 2|Lost to Follow-up|0|||
129974789|NCT05000216|467871462|FG002|Stage 2|Lost to Follow-up|0|||
129472276|NCT03502187|466024012|FG001|Overall Study|Withdrawal by Subject|3|||
129472277|NCT03502187|466024013|FG002|Overall Study|Withdrawal by Subject|3|||
129472278|NCT03502187|466024011|FG000|Overall Study|Lost to Follow-up|5|||
129472279|NCT03502187|466024012|FG001|Overall Study|Lost to Follow-up|4|||
129472280|NCT03502187|466024013|FG002|Overall Study|Lost to Follow-up|5|||
129472281|NCT02908100|466024015|FG000|Overall Study|Adverse Event|7|||
129472282|NCT02908100|466024016|FG001|Overall Study|Adverse Event|6|||
129472283|NCT02908100|466024017|FG002|Overall Study|Adverse Event|9|||
129472284|NCT02908100|466024015|FG000|Overall Study|Death|2|||
129472285|NCT02908100|466024016|FG001|Overall Study|Death|0|||
129974790|NCT05000216|467871463|FG003|Stage 2|Lost to Follow-up|0|||
129974791|NCT05000216|467871464|FG004|Stage 2|Lost to Follow-up|0|||
129974792|NCT05000216|467871465|FG005|Stage 2|Lost to Follow-up|0|||
129974793|NCT05000216|467871466|FG006|Stage 2|Lost to Follow-up|0|||
129974794|NCT05000216|467871467|FG007|Stage 2|Lost to Follow-up|0|||
129974795|NCT05000216|467871468|FG008|Stage 2|Lost to Follow-up|0|||
129974796|NCT05000216|467871469|FG009|Stage 2|Lost to Follow-up|0|||
129974797|NCT05000216|467871470|FG010|Stage 2|Lost to Follow-up|0|||
129974798|NCT05000216|467871471|FG011|Stage 2|Lost to Follow-up|0|||
129974799|NCT05000216|467871472|FG012|Stage 2|Lost to Follow-up|0|||
129974800|NCT05000216|467871473|FG013|Stage 2|Lost to Follow-up|0|||
129974801|NCT05000216|467871474|FG014|Stage 2|Lost to Follow-up|0|||
129974802|NCT05000216|467871475|FG015|Stage 2|Lost to Follow-up|0|||
129974803|NCT05000216|467871476|FG016|Stage 2|Lost to Follow-up|4|||
129974804|NCT05000216|467871477|FG017|Stage 2|Lost to Follow-up|0|||
129974805|NCT05000216|467871478|FG018|Stage 2|Lost to Follow-up|0|||
129974806|NCT05000216|467871479|FG019|Stage 2|Lost to Follow-up|0|||
129974807|NCT05000216|467871480|FG020|Stage 2|Lost to Follow-up|0|||
129974808|NCT05000216|467871481|FG021|Stage 2|Lost to Follow-up|0|||
129974809|NCT05000216|467871460|FG000|Stage 2|Physician Decision|0|||
129974810|NCT05000216|467871461|FG001|Stage 2|Physician Decision|0|||
129974811|NCT05000216|467871462|FG002|Stage 2|Physician Decision|0|||
129974812|NCT05000216|467871463|FG003|Stage 2|Physician Decision|0|||
129472286|NCT02908100|466024017|FG002|Overall Study|Death|0|||
129472287|NCT02908100|466024015|FG000|Overall Study|Lack of Efficacy|2|||
129472288|NCT02908100|466024016|FG001|Overall Study|Lack of Efficacy|3|||
129472289|NCT02908100|466024017|FG002|Overall Study|Lack of Efficacy|3|||
129472290|NCT02908100|466024015|FG000|Overall Study|Lost to Follow-up|0|||
129472291|NCT02908100|466024016|FG001|Overall Study|Lost to Follow-up|1|||
129974813|NCT05000216|467871464|FG004|Stage 2|Physician Decision|0|||
129974814|NCT05000216|467871465|FG005|Stage 2|Physician Decision|0|||
129974815|NCT05000216|467871466|FG006|Stage 2|Physician Decision|0|||
129974816|NCT05000216|467871467|FG007|Stage 2|Physician Decision|0|||
129974817|NCT05000216|467871468|FG008|Stage 2|Physician Decision|0|||
129974818|NCT05000216|467871469|FG009|Stage 2|Physician Decision|0|||
129974819|NCT05000216|467871470|FG010|Stage 2|Physician Decision|0|||
129974820|NCT05000216|467871471|FG011|Stage 2|Physician Decision|0|||
129974821|NCT05000216|467871472|FG012|Stage 2|Physician Decision|1|||
129974822|NCT05000216|467871473|FG013|Stage 2|Physician Decision|0|||
129974823|NCT05000216|467871474|FG014|Stage 2|Physician Decision|0|||
129974824|NCT05000216|467871475|FG015|Stage 2|Physician Decision|0|||
129974825|NCT05000216|467871476|FG016|Stage 2|Physician Decision|0|||
129974826|NCT05000216|467871477|FG017|Stage 2|Physician Decision|0|||
129974827|NCT05000216|467871478|FG018|Stage 2|Physician Decision|0|||
129974828|NCT05000216|467871479|FG019|Stage 2|Physician Decision|0|||
129974829|NCT05000216|467871480|FG020|Stage 2|Physician Decision|0|||
129974830|NCT05000216|467871481|FG021|Stage 2|Physician Decision|0|||
129974831|NCT05000216|467871460|FG000|Stage 2|Withdrawal by Subject|0|||
129974832|NCT05000216|467871461|FG001|Stage 2|Withdrawal by Subject|0|||
129974833|NCT05000216|467871462|FG002|Stage 2|Withdrawal by Subject|0|||
129974834|NCT05000216|467871463|FG003|Stage 2|Withdrawal by Subject|0|||
129974835|NCT05000216|467871464|FG004|Stage 2|Withdrawal by Subject|0|||
129974836|NCT05000216|467871465|FG005|Stage 2|Withdrawal by Subject|0|||
129974837|NCT05000216|467871466|FG006|Stage 2|Withdrawal by Subject|0|||
129974838|NCT05000216|467871467|FG007|Stage 2|Withdrawal by Subject|0|||
129974839|NCT05000216|467871468|FG008|Stage 2|Withdrawal by Subject|0|||
129974840|NCT05000216|467871469|FG009|Stage 2|Withdrawal by Subject|0|||
129974841|NCT05000216|467871470|FG010|Stage 2|Withdrawal by Subject|0|||
129974842|NCT05000216|467871471|FG011|Stage 2|Withdrawal by Subject|0|||
129974843|NCT05000216|467871472|FG012|Stage 2|Withdrawal by Subject|0|||
129974844|NCT05000216|467871473|FG013|Stage 2|Withdrawal by Subject|0|||
129974845|NCT05000216|467871474|FG014|Stage 2|Withdrawal by Subject|2|||
129974846|NCT05000216|467871475|FG015|Stage 2|Withdrawal by Subject|0|||
129974847|NCT05000216|467871476|FG016|Stage 2|Withdrawal by Subject|9|||
129974848|NCT05000216|467871477|FG017|Stage 2|Withdrawal by Subject|0|||
129974849|NCT05000216|467871478|FG018|Stage 2|Withdrawal by Subject|0|||
129974850|NCT05000216|467871479|FG019|Stage 2|Withdrawal by Subject|0|||
129974851|NCT05000216|467871480|FG020|Stage 2|Withdrawal by Subject|0|||
129974852|NCT05000216|467871481|FG021|Stage 2|Withdrawal by Subject|0|||
129974853|NCT05000216|467871460|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
129974854|NCT05000216|467871461|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
129974855|NCT05000216|467871462|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
129974856|NCT05000216|467871463|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
129974857|NCT05000216|467871464|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
129974858|NCT05000216|467871465|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
129974859|NCT05000216|467871466|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
129974860|NCT05000216|467871467|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
129974861|NCT05000216|467871468|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
129974862|NCT05000216|467871469|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
129974863|NCT05000216|467871470|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
129974864|NCT05000216|467871471|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
129974865|NCT05000216|467871472|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
129974866|NCT05000216|467871473|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
129974867|NCT05000216|467871474|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
129974868|NCT05000216|467871475|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
129974869|NCT05000216|467871476|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
129974870|NCT05000216|467871477|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
129974871|NCT05000216|467871478|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
129974872|NCT05000216|467871479|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
129974873|NCT05000216|467871480|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
129974874|NCT05000216|467871481|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
129974875|NCT05000216|467871460|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974876|NCT05000216|467871461|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974877|NCT05000216|467871462|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974878|NCT05000216|467871463|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974879|NCT05000216|467871464|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974880|NCT05000216|467871465|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974881|NCT05000216|467871466|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974882|NCT05000216|467871467|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974883|NCT05000216|467871468|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974884|NCT05000216|467871469|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974885|NCT05000216|467871470|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974886|NCT05000216|467871471|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974887|NCT05000216|467871472|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974888|NCT05000216|467871473|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974889|NCT05000216|467871474|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
129974890|NCT05000216|467871475|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974891|NCT05000216|467871476|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
129974892|NCT05000216|467871477|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974893|NCT05000216|467871478|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974894|NCT05000216|467871479|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974895|NCT05000216|467871480|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974896|NCT05000216|467871481|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
129974897|NCT05000216|467871460|FG000|Stage 2|Other reason|0|||
129974898|NCT05000216|467871461|FG001|Stage 2|Other reason|0|||
129974899|NCT05000216|467871462|FG002|Stage 2|Other reason|0|||
129974900|NCT05000216|467871463|FG003|Stage 2|Other reason|0|||
129974901|NCT05000216|467871464|FG004|Stage 2|Other reason|0|||
129974902|NCT05000216|467871465|FG005|Stage 2|Other reason|0|||
129974903|NCT05000216|467871466|FG006|Stage 2|Other reason|0|||
129974904|NCT05000216|467871467|FG007|Stage 2|Other reason|0|||
129974905|NCT05000216|467871468|FG008|Stage 2|Other reason|0|||
129974906|NCT05000216|467871469|FG009|Stage 2|Other reason|0|||
129974907|NCT05000216|467871470|FG010|Stage 2|Other reason|0|||
129974908|NCT05000216|467871471|FG011|Stage 2|Other reason|0|||
129974909|NCT05000216|467871472|FG012|Stage 2|Other reason|0|||
129974910|NCT05000216|467871473|FG013|Stage 2|Other reason|0|||
129974911|NCT05000216|467871474|FG014|Stage 2|Other reason|0|||
129974912|NCT05000216|467871475|FG015|Stage 2|Other reason|0|||
129974913|NCT05000216|467871476|FG016|Stage 2|Other reason|1|||
129974914|NCT05000216|467871477|FG017|Stage 2|Other reason|0|||
129974915|NCT05000216|467871478|FG018|Stage 2|Other reason|0|||
129974916|NCT05000216|467871479|FG019|Stage 2|Other reason|0|||
129974917|NCT05000216|467871480|FG020|Stage 2|Other reason|0|||
129974918|NCT05000216|467871481|FG021|Stage 2|Other reason|0|||
129974919|NCT05000216|467871460|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
129974920|NCT05000216|467871461|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
129974921|NCT05000216|467871462|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
129974922|NCT05000216|467871463|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
129974923|NCT05000216|467871464|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
129974924|NCT05000216|467871465|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
129974925|NCT05000216|467871466|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
129974926|NCT05000216|467871467|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
129974927|NCT05000216|467871468|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
129974928|NCT05000216|467871469|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
129974929|NCT05000216|467871470|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
129472292|NCT02908100|466024017|FG002|Overall Study|Lost to Follow-up|2|||
129472293|NCT02908100|466024015|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129472294|NCT02908100|466024016|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129472295|NCT02908100|466024017|FG002|Overall Study|Non-Compliance With Study Drug|2|||
129472296|NCT02908100|466024015|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
129472297|NCT02908100|466024016|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
129472298|NCT02908100|466024017|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
129472299|NCT02908100|466024015|FG000|Overall Study|Physician Decision|0|||
129472300|NCT02908100|466024016|FG001|Overall Study|Physician Decision|1|||
129472301|NCT02908100|466024017|FG002|Overall Study|Physician Decision|0|||
129472302|NCT02908100|466024015|FG000|Overall Study|Pregnancy|1|||
129472303|NCT02908100|466024016|FG001|Overall Study|Pregnancy|2|||
129472304|NCT02908100|466024017|FG002|Overall Study|Pregnancy|0|||
129472305|NCT02908100|466024015|FG000|Overall Study|Withdrawal by Subject|8|||
129472306|NCT02908100|466024016|FG001|Overall Study|Withdrawal by Subject|7|||
129472307|NCT02908100|466024017|FG002|Overall Study|Withdrawal by Subject|5|||
129472308|NCT02908100|466024015|FG000|Overall Study|Randomised in Error|1|||
129472309|NCT02908100|466024016|FG001|Overall Study|Randomised in Error|0|||
129472310|NCT02908100|466024017|FG002|Overall Study|Randomised in Error|0|||
129472311|NCT00400400|466024018|FG000|Overall Study|Adverse Event|9|||
129472312|NCT00400400|466024019|FG001|Overall Study|Adverse Event|8|||
129472313|NCT00400400|466024018|FG000|Overall Study|Protocol Violation|2|||
129472314|NCT00400400|466024019|FG001|Overall Study|Protocol Violation|0|||
129472315|NCT00400400|466024018|FG000|Overall Study|Withdrawal by Subject|1|||
129472316|NCT00400400|466024019|FG001|Overall Study|Withdrawal by Subject|3|||
129472317|NCT00400400|466024018|FG000|Overall Study|Administrative Problem|1|||
129472318|NCT00400400|466024019|FG001|Overall Study|Administrative Problem|0|||
129472319|NCT00400400|466024018|FG000|Overall Study|Lost to Follow-up|0|||
129472320|NCT00400400|466024019|FG001|Overall Study|Lost to Follow-up|1|||
129472321|NCT00400400|466024018|FG000|Overall Study|Did not receive study drug|1|||
129472322|NCT00400400|466024019|FG001|Overall Study|Did not receive study drug|3|||
129472323|NCT01688050|466024020|FG000|Overall Study|Death|7|||
129472324|NCT01688050|466024020|FG000|Overall Study|Conversion to open repair|1|||
129472325|NCT01688050|466024020|FG000|Overall Study|Lost to Follow-up|13|||
129974930|NCT05000216|467871471|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
129974931|NCT05000216|467871472|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
129974932|NCT05000216|467871473|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
129472326|NCT01688050|466024020|FG000|Overall Study|Withdrawal by Subject|10|||
129974933|NCT05000216|467871474|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
129974934|NCT05000216|467871475|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
129472327|NCT01731678|466024037|FG000|Overall Study|Withdrawal by Subject|3|||
129472328|NCT01731678|466024037|FG000|Overall Study|Did not meet inclusion criteria|1|||
129472329|NCT01731678|466024037|FG000|Overall Study|RMT too high, making TMS difficult|3|||
129974935|NCT05000216|467871476|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
129974936|NCT05000216|467871477|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
129974937|NCT05000216|467871478|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
129974938|NCT05000216|467871479|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
129974939|NCT05000216|467871480|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
129974940|NCT05000216|467871481|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
129974941|NCT05000216|467871460|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974942|NCT05000216|467871461|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974943|NCT05000216|467871462|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974944|NCT05000216|467871463|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974945|NCT05000216|467871464|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974946|NCT05000216|467871465|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974947|NCT05000216|467871466|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974948|NCT05000216|467871467|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974949|NCT05000216|467871468|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974950|NCT05000216|467871469|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974951|NCT05000216|467871470|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974952|NCT05000216|467871471|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974953|NCT05000216|467871472|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974954|NCT05000216|467871473|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974955|NCT05000216|467871474|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974956|NCT05000216|467871475|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
129974957|NCT05000216|467871476|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974958|NCT05000216|467871477|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974959|NCT05000216|467871478|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974960|NCT05000216|467871479|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974961|NCT05000216|467871480|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974962|NCT05000216|467871481|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
129974963|NCT05000216|467871460|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974964|NCT05000216|467871461|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974965|NCT05000216|467871462|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974966|NCT05000216|467871463|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974967|NCT05000216|467871464|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974968|NCT05000216|467871465|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974969|NCT05000216|467871466|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974970|NCT05000216|467871467|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974971|NCT05000216|467871468|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974972|NCT05000216|467871469|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974973|NCT05000216|467871470|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974974|NCT05000216|467871471|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974975|NCT05000216|467871472|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974976|NCT05000216|467871473|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
129974977|NCT05000216|467871474|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974978|NCT05000216|467871475|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
129974979|NCT05000216|467871476|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974980|NCT05000216|467871477|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974981|NCT05000216|467871478|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
129974982|NCT05000216|467871479|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974983|NCT05000216|467871480|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974984|NCT05000216|467871481|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
129974985|NCT02057575|467871483|FG000|Overall Study|Adverse Event|0|||
129974986|NCT02057575|467871484|FG001|Overall Study|Adverse Event|2|||
129974987|NCT02057575|467871485|FG002|Overall Study|Adverse Event|0|||
129974988|NCT02057575|467871486|FG003|Overall Study|Adverse Event|1|||
129974989|NCT02057575|467871483|FG000|Overall Study|Withdrawal by Subject|1|||
129974990|NCT02057575|467871484|FG001|Overall Study|Withdrawal by Subject|0|||
129974991|NCT02057575|467871485|FG002|Overall Study|Withdrawal by Subject|0|||
129974992|NCT02057575|467871486|FG003|Overall Study|Withdrawal by Subject|0|||
129974993|NCT02057575|467871483|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
129974994|NCT02057575|467871484|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
129974995|NCT02057575|467871485|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
129974996|NCT02057575|467871486|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
129974997|NCT02057575|467871483|FG000|Overall Study|Protocol Violation|0|||
129974998|NCT02057575|467871484|FG001|Overall Study|Protocol Violation|1|||
129974999|NCT02057575|467871485|FG002|Overall Study|Protocol Violation|0|||
129975000|NCT02057575|467871486|FG003|Overall Study|Protocol Violation|0|||
129975001|NCT00332462|467871487|FG000|Overall Study|Adverse Event|5|||
129975002|NCT00332462|467871487|FG000|Overall Study|Abnormal Lab Value|1|||
129975003|NCT00332462|467871487|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129975004|NCT00332462|467871487|FG000|Overall Study|no longer requires study drug|1|||
129975005|NCT00332462|467871487|FG000|Overall Study|Death|3|||
129975006|NCT00332462|467871487|FG000|Overall Study|Graft Loss|2|||
129975007|NCT01643044|467871488|FG000|Overall Study|Lost to Follow-up|1|||
129975008|NCT01643044|467871489|FG001|Overall Study|Lost to Follow-up|1|||
129975009|NCT01643044|467871488|FG000|Overall Study|Miscarried baby|2|||
129975010|NCT01643044|467871489|FG001|Overall Study|Miscarried baby|2|||
129975011|NCT01643044|467871488|FG000|Overall Study|Delivered outside of hospital|1|||
129975012|NCT01643044|467871489|FG001|Overall Study|Delivered outside of hospital|2|||
129975013|NCT01735175|467871490|FG000|Overall Study|Withdrawal by Subject|9|||
129975014|NCT01735175|467871491|FG001|Overall Study|Withdrawal by Subject|2|||
129975015|NCT01735175|467871490|FG000|Overall Study|Lost to Follow-up|4|||
129975016|NCT01735175|467871491|FG001|Overall Study|Lost to Follow-up|2|||
129975017|NCT01735175|467871490|FG000|Overall Study|Death|3|||
129975018|NCT01735175|467871491|FG001|Overall Study|Death|2|||
129975019|NCT01735175|467871490|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
129975020|NCT01735175|467871491|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
129975021|NCT00659880|467871492|FG000|Overall Study|Lost to Follow-up|5|||
129975022|NCT01886287|467871493|FG000|Overall Study|Radiographic disease progression|1|||
129975023|NCT01886287|467871493|FG000|Overall Study|Clinical progression due to disease|1|||
129975024|NCT01031628|467871494|FG000|Overall Study|Study terminated early|0|||
129975025|NCT01031628|467871495|FG001|Overall Study|Study terminated early|1|||
129975026|NCT01031628|467871496|FG002|Overall Study|Study terminated early|3|||
129975027|NCT01031628|467871497|FG003|Overall Study|Study terminated early|0|||
129975028|NCT01266161|467871501|FG000|Overall Study|Ineligible|1|||
129975029|NCT01266161|467871502|FG001|Overall Study|Ineligible|0|||
129975030|NCT01266161|467871501|FG000|Overall Study|Lack of Efficacy|0|||
129472330|NCT02649634|466024038|FG000|Overall Study|Withdrawal by Subject|3|||
129472331|NCT02649634|466024039|FG001|Overall Study|Withdrawal by Subject|5|||
129472332|NCT02649634|466024038|FG000|Overall Study|Lost to Follow-up|0|||
129472333|NCT02649634|466024039|FG001|Overall Study|Lost to Follow-up|1|||
129975031|NCT01266161|467871502|FG001|Overall Study|Lack of Efficacy|1|||
129975032|NCT01266161|467871501|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
129975033|NCT01266161|467871502|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
129975034|NCT02990468|467871503|FG000|Phase 2: MTD|Change in treatment|0|||
129975035|NCT02990468|467871504|FG001|Phase 2: MTD|Change in treatment|0|||
129975036|NCT02990468|467871505|FG002|Phase 2: MTD|Change in treatment|1|||
129975037|NCT01436305|467871507|FG000|Overall Study|Death|1|||
129975038|NCT01436305|467871508|FG001|Overall Study|Death|0|||
129975039|NCT01436305|467871509|FG002|Overall Study|Death|0|||
129975040|NCT01436305|467871507|FG000|Overall Study|Lost to Follow-up|0|||
129975041|NCT01436305|467871508|FG001|Overall Study|Lost to Follow-up|1|||
129975042|NCT01436305|467871509|FG002|Overall Study|Lost to Follow-up|0|||
129975043|NCT01436305|467871507|FG000|Overall Study|Withdrawal by Subject|1|||
129975044|NCT01436305|467871508|FG001|Overall Study|Withdrawal by Subject|3|||
129975045|NCT01436305|467871509|FG002|Overall Study|Withdrawal by Subject|0|||
129975046|NCT01602510|467871514|FG000|Open Label Phase|Adverse Event|46|||
129975047|NCT01602510|467871515|FG001|Open Label Phase|Adverse Event|0|||
129975048|NCT01602510|467871516|FG002|Open Label Phase|Adverse Event|0|||
129975049|NCT01602510|467871514|FG000|Open Label Phase|Lack of Efficacy|22|||
129975050|NCT01602510|467871515|FG001|Open Label Phase|Lack of Efficacy|0|||
129975051|NCT01602510|467871516|FG002|Open Label Phase|Lack of Efficacy|0|||
129975052|NCT01602510|467871514|FG000|Open Label Phase|Protocol Violation|15|||
129975053|NCT01602510|467871515|FG001|Open Label Phase|Protocol Violation|0|||
129975054|NCT01602510|467871516|FG002|Open Label Phase|Protocol Violation|0|||
129975055|NCT01602510|467871514|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
129975056|NCT01602510|467871515|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
129975057|NCT01602510|467871516|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
129975058|NCT01602510|467871514|FG000|Open Label Phase|Lost to Follow-up|22|||
129975059|NCT01602510|467871515|FG001|Open Label Phase|Lost to Follow-up|0|||
129975060|NCT01602510|467871516|FG002|Open Label Phase|Lost to Follow-up|0|||
129975061|NCT01602510|467871514|FG000|Open Label Phase|Physician Decision|19|||
129975062|NCT01602510|467871515|FG001|Open Label Phase|Physician Decision|0|||
129975063|NCT01602510|467871516|FG002|Open Label Phase|Physician Decision|0|||
129975064|NCT01602510|467871514|FG000|Open Label Phase|Withdrawal by Subject|57|||
129975065|NCT01602510|467871515|FG001|Open Label Phase|Withdrawal by Subject|0|||
129975066|NCT01602510|467871516|FG002|Open Label Phase|Withdrawal by Subject|0|||
129975067|NCT01602510|467871514|FG000|Randomized Phase|Adverse Event|0|||
129472334|NCT01318122|466024040|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129975068|NCT01602510|467871515|FG001|Randomized Phase|Adverse Event|2|||
129975069|NCT01602510|467871516|FG002|Randomized Phase|Adverse Event|6|||
129975070|NCT01602510|467871514|FG000|Randomized Phase|Lack of Efficacy|0|||
129975071|NCT01602510|467871515|FG001|Randomized Phase|Lack of Efficacy|4|||
129472335|NCT01318122|466024041|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
129472336|NCT01318122|466024042|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
129975072|NCT01602510|467871516|FG002|Randomized Phase|Lack of Efficacy|4|||
129975073|NCT01602510|467871514|FG000|Randomized Phase|Protocol Violation|0|||
129975074|NCT01602510|467871515|FG001|Randomized Phase|Protocol Violation|3|||
129975075|NCT01602510|467871516|FG002|Randomized Phase|Protocol Violation|3|||
129975076|NCT01602510|467871514|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
129975077|NCT01602510|467871515|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
129975078|NCT01602510|467871516|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
129975079|NCT01602510|467871514|FG000|Randomized Phase|Lost to Follow-up|0|||
129975080|NCT01602510|467871515|FG001|Randomized Phase|Lost to Follow-up|1|||
129975081|NCT01602510|467871516|FG002|Randomized Phase|Lost to Follow-up|3|||
129975082|NCT01602510|467871514|FG000|Randomized Phase|Physician Decision|0|||
129975083|NCT01602510|467871515|FG001|Randomized Phase|Physician Decision|0|||
129975084|NCT01602510|467871516|FG002|Randomized Phase|Physician Decision|2|||
129975085|NCT01602510|467871514|FG000|Randomized Phase|Withdrawal by Subject|0|||
129975086|NCT01602510|467871515|FG001|Randomized Phase|Withdrawal by Subject|6|||
129975087|NCT01602510|467871516|FG002|Randomized Phase|Withdrawal by Subject|7|||
129975088|NCT03519204|467871517|FG000|Overall Study|Lost to Follow-up|3|||
129975089|NCT03519204|467871518|FG001|Overall Study|Lost to Follow-up|8|||
129975090|NCT03519204|467871517|FG000|Overall Study|Withdrawal by Subject|9|||
129975091|NCT03519204|467871518|FG001|Overall Study|Withdrawal by Subject|7|||
129975092|NCT03519204|467871517|FG000|Overall Study|Other Miscellaneous Reasons|1|||
129975093|NCT03519204|467871518|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129975094|NCT01424813|467871523|FG000|Overall Study|Withdrawal by Subject|3|||
129975095|NCT01424813|467871524|FG001|Overall Study|Withdrawal by Subject|0|||
129975096|NCT01424813|467871523|FG000|Overall Study|Protocol Violation|1|||
129975097|NCT01424813|467871524|FG001|Overall Study|Protocol Violation|0|||
129975098|NCT01424813|467871523|FG000|Overall Study|Other|1|||
129975099|NCT01424813|467871524|FG001|Overall Study|Other|2|||
129975100|NCT04991753|467873263|FG000|Overall Study|Withdrawal by Subject|0|||
129975101|NCT04991753|467873264|FG001|Overall Study|Withdrawal by Subject|1|||
129975102|NCT03299049|467873265|FG000|Overall Study|On-going|486|||
129975103|NCT03299049|467873266|FG001|Overall Study|On-going|481|||
129975104|NCT03299049|467873265|FG000|Overall Study|Withdrawal by Subject|6|||
129975105|NCT03299049|467873266|FG001|Overall Study|Withdrawal by Subject|21|||
129975106|NCT03299049|467873265|FG000|Overall Study|Physician Decision|5|||
129975107|NCT03299049|467873266|FG001|Overall Study|Physician Decision|1|||
129975108|NCT03299049|467873265|FG000|Overall Study|Lost to Follow-up|2|||
129975109|NCT03299049|467873266|FG001|Overall Study|Lost to Follow-up|0|||
129975110|NCT03299049|467873265|FG000|Overall Study|Pregnancy|1|||
129975111|NCT03299049|467873266|FG001|Overall Study|Pregnancy|3|||
129975112|NCT03299049|467873265|FG000|Overall Study|Protocol Violation|1|||
129975113|NCT03299049|467873266|FG001|Overall Study|Protocol Violation|1|||
129975114|NCT03299049|467873265|FG000|Overall Study|Lack of Efficacy|9|||
129975115|NCT03299049|467873266|FG001|Overall Study|Lack of Efficacy|3|||
129975116|NCT03299049|467873265|FG000|Overall Study|Adverse Event|12|||
129975117|NCT03299049|467873266|FG001|Overall Study|Adverse Event|13|||
129975118|NCT01901419|467873267|FG000|Overall Study|Protocol Violation|2|||
129975119|NCT01901419|467873268|FG001|Overall Study|Protocol Violation|6|||
129975120|NCT01901419|467873267|FG000|Overall Study|unavailable researchers|6|||
129975121|NCT01901419|467873268|FG001|Overall Study|unavailable researchers|3|||
129975122|NCT01667926|467873273|FG000|Overall Study|Withdrawal by Subject|1|||
129975123|NCT01667926|467873274|FG001|Overall Study|Withdrawal by Subject|2|||
129975124|NCT01667926|467873275|FG002|Overall Study|Withdrawal by Subject|2|||
129975125|NCT01667926|467873273|FG000|Overall Study|Physician Decision|0|||
129975126|NCT01667926|467873274|FG001|Overall Study|Physician Decision|0|||
129975127|NCT01667926|467873275|FG002|Overall Study|Physician Decision|1|||
129975128|NCT01667926|467873273|FG000|Overall Study|Time committment|0|||
129975129|NCT01667926|467873274|FG001|Overall Study|Time committment|0|||
129975130|NCT01667926|467873275|FG002|Overall Study|Time committment|2|||
129975131|NCT01667926|467873273|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
129975132|NCT01667926|467873274|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
129975133|NCT01667926|467873275|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
129975134|NCT01667926|467873273|FG000|Overall Study|Lost to Follow-up|1|||
129975135|NCT01667926|467873274|FG001|Overall Study|Lost to Follow-up|2|||
129975136|NCT01667926|467873275|FG002|Overall Study|Lost to Follow-up|1|||
129975137|NCT01667926|467873273|FG000|Overall Study|Side effects|3|||
129975138|NCT01667926|467873274|FG001|Overall Study|Side effects|0|||
129975139|NCT01667926|467873275|FG002|Overall Study|Side effects|0|||
129975140|NCT02412735|467873276|FG000|Overall Study|Adverse Event|0|||
129975141|NCT02412735|467873277|FG001|Overall Study|Adverse Event|1|||
129975142|NCT02412735|467873278|FG002|Overall Study|Adverse Event|2|||
129975143|NCT02412735|467873276|FG000|Overall Study|Withdrawal by Subject|23|||
129975144|NCT02412735|467873277|FG001|Overall Study|Withdrawal by Subject|27|||
129975145|NCT02412735|467873278|FG002|Overall Study|Withdrawal by Subject|22|||
129975146|NCT02412735|467873276|FG000|Overall Study|Investigator Decision|3|||
129975147|NCT02412735|467873277|FG001|Overall Study|Investigator Decision|3|||
129975148|NCT02412735|467873278|FG002|Overall Study|Investigator Decision|2|||
129975149|NCT02412735|467873276|FG000|Overall Study|Lost to Follow-up|17|||
129975150|NCT02412735|467873277|FG001|Overall Study|Lost to Follow-up|11|||
129975151|NCT02412735|467873278|FG002|Overall Study|Lost to Follow-up|18|||
129975152|NCT02412735|467873276|FG000|Overall Study|Reason not Specified|3|||
129975153|NCT02412735|467873277|FG001|Overall Study|Reason not Specified|2|||
129975154|NCT02412735|467873278|FG002|Overall Study|Reason not Specified|2|||
129975155|NCT04043143|467873279|FG000|Overall Study|Lost to Follow-up|5|||
129975156|NCT04043143|467873280|FG001|Overall Study|Lost to Follow-up|5|||
129975157|NCT04043143|467873279|FG000|Overall Study|screen failure|1|||
129975158|NCT04043143|467873280|FG001|Overall Study|screen failure|0|||
129975159|NCT03480932|467873281|FG000|Overall Study|Death|1|||
129975160|NCT03480932|467873282|FG001|Overall Study|Death|1|||
129975161|NCT03480932|467873283|FG002|Overall Study|Death|0|||
129975162|NCT03480932|467873281|FG000|Overall Study|Lost to Follow-up|0|||
129975163|NCT03480932|467873282|FG001|Overall Study|Lost to Follow-up|2|||
129975164|NCT03480932|467873283|FG002|Overall Study|Lost to Follow-up|3|||
129975165|NCT03480932|467873281|FG000|Overall Study|Incarcerated|2|||
129975166|NCT03480932|467873282|FG001|Overall Study|Incarcerated|2|||
129975167|NCT03480932|467873283|FG002|Overall Study|Incarcerated|2|||
129975168|NCT04703192|467873287|FG000|Overall Study|Withdrawal by Subject|2|||
129975169|NCT04703192|467873288|FG001|Overall Study|Withdrawal by Subject|0|||
129975170|NCT04703192|467873287|FG000|Overall Study|Death|3|||
129975171|NCT04703192|467873288|FG001|Overall Study|Death|1|||
129975172|NCT04703192|467873287|FG000|Overall Study|Adverse Event|13|||
129975173|NCT04703192|467873288|FG001|Overall Study|Adverse Event|2|||
129472337|NCT01318122|466024043|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
129472338|NCT01318122|466024040|FG000|Enrolled - Long-Term Extension Study|Other|1|||
129472339|NCT01318122|466024041|FG001|Enrolled - Long-Term Extension Study|Other|0|||
129472340|NCT01318122|466024042|FG002|Enrolled - Long-Term Extension Study|Other|0|||
129975174|NCT04703192|467873287|FG000|Overall Study|Progressive or Relapsed Disease|46|||
129975175|NCT04703192|467873288|FG001|Overall Study|Progressive or Relapsed Disease|7|||
129975176|NCT04703192|467873287|FG000|Overall Study|Clinical Progression|19|||
129975177|NCT04703192|467873288|FG001|Overall Study|Clinical Progression|8|||
129975178|NCT04703192|467873287|FG000|Overall Study|Lost to Follow-up|1|||
129975179|NCT04703192|467873288|FG001|Overall Study|Lost to Follow-up|0|||
129975180|NCT04703192|467873287|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
129975181|NCT04703192|467873288|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
129975182|NCT04703192|467873287|FG000|Overall Study|Other|5|||
129975183|NCT04703192|467873288|FG001|Overall Study|Other|1|||
129975184|NCT00678301|467873289|FG000|Overall Study|Non-compliance with study procedures|0|||
129975185|NCT00678301|467873290|FG001|Overall Study|Non-compliance with study procedures|1|||
129472341|NCT01318122|466024043|FG003|Enrolled - Long-Term Extension Study|Other|0|||
129472342|NCT01318122|466024040|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
129472343|NCT01318122|466024041|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
129472344|NCT01318122|466024042|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
129472345|NCT01318122|466024043|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
129472346|NCT01318122|466024040|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
129975186|NCT00678301|467873289|FG000|Overall Study|Adverse Event|1|||
129975187|NCT00678301|467873290|FG001|Overall Study|Adverse Event|0|||
129975188|NCT00678301|467873289|FG000|Overall Study|Withdrawal by Subject|4|||
129975189|NCT00678301|467873290|FG001|Overall Study|Withdrawal by Subject|0|||
129975190|NCT00678301|467873289|FG000|Overall Study|Lost to Follow-up|3|||
129975191|NCT00678301|467873290|FG001|Overall Study|Lost to Follow-up|1|||
129975192|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
129975193|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
129975194|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
129975195|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
129975196|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129975197|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
129975198|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
129975199|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129975200|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129975201|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129975202|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129975203|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129975204|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
129975205|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
129975206|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129975207|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
129975208|NCT01263509|467873301|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
129975209|NCT01263509|467873302|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
129975210|NCT01263509|467873303|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
129975211|NCT01263509|467873304|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
129975212|NCT05071053|467873305|FG000|Overall Study|Progressive disease|30|||
129975213|NCT05071053|467873305|FG000|Overall Study|Adverse Event|5|||
129975214|NCT01572740|467873306|FG000|Overall Study|Adverse Event|1|||
129975215|NCT01572740|467873307|FG001|Overall Study|Adverse Event|1|||
129975216|NCT01572740|467873306|FG000|Overall Study|Withdrawal by Subject|1|||
129975217|NCT01572740|467873307|FG001|Overall Study|Withdrawal by Subject|1|||
129975218|NCT01572740|467873306|FG000|Overall Study|unclassified|4|||
129975219|NCT01572740|467873307|FG001|Overall Study|unclassified|3|||
129975220|NCT01289210|467873308|FG000|Overall Study|Adverse Event|1|||
129975221|NCT01818531|467873309|FG000|Overall Study|Withdrawn for case delay after block|1|||
129975222|NCT01818531|467873310|FG001|Overall Study|Withdrawn for case delay after block|0|||
129975223|NCT01818531|467873309|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
129975224|NCT01818531|467873310|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
129975225|NCT01818531|467873309|FG000|Overall Study|Withdrawn for failure to place block|0|||
129975226|NCT01818531|467873310|FG001|Overall Study|Withdrawn for failure to place block|1|||
129975227|NCT01110408|467873313|FG000|Overall Study|Protocol Violation|1|||
129975228|NCT01110408|467873314|FG001|Overall Study|Protocol Violation|0|||
129975229|NCT01465763|467873315|FG000|Overall Study|Withdrawal by Subject|4|||
129975230|NCT01465763|467873316|FG001|Overall Study|Withdrawal by Subject|0|||
129975231|NCT01465763|467873317|FG002|Overall Study|Withdrawal by Subject|1|||
129975232|NCT01465763|467873315|FG000|Overall Study|Insufficient Clinical Response|11|||
129975233|NCT01465763|467873316|FG001|Overall Study|Insufficient Clinical Response|0|||
129975234|NCT01465763|467873317|FG002|Overall Study|Insufficient Clinical Response|1|||
129975235|NCT01465763|467873315|FG000|Overall Study|Adverse Event|9|||
129975236|NCT01465763|467873316|FG001|Overall Study|Adverse Event|0|||
129975237|NCT01465763|467873317|FG002|Overall Study|Adverse Event|1|||
129975238|NCT01465763|467873315|FG000|Overall Study|Other|2|||
129975239|NCT01465763|467873316|FG001|Overall Study|Other|0|||
129975240|NCT01465763|467873317|FG002|Overall Study|Other|0|||
129975241|NCT01465763|467873315|FG000|Overall Study|Protocol Violation|4|||
129975242|NCT01465763|467873316|FG001|Overall Study|Protocol Violation|1|||
129975243|NCT01465763|467873317|FG002|Overall Study|Protocol Violation|1|||
129975244|NCT01465763|467873315|FG000|Overall Study|Death|1|||
129975245|NCT01465763|467873316|FG001|Overall Study|Death|0|||
129975246|NCT01465763|467873317|FG002|Overall Study|Death|0|||
129975247|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
129975248|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
129975249|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
129975250|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
129975251|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975252|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975253|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975254|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975255|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975256|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975257|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975258|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
129975259|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
129975260|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
129975261|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
129975262|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
129975263|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975264|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975265|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129472347|NCT01318122|466024041|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129472348|NCT01318122|466024042|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129472349|NCT01318122|466024043|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
129472350|NCT01318122|466024040|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
129472351|NCT01318122|466024041|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
129472352|NCT01318122|466024042|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
129975266|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975267|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975268|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975269|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975270|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
129975271|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
129975272|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
129975273|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
129975274|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
129975275|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975276|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975277|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975278|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975279|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975280|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975281|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129975282|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
129472353|NCT01318122|466024043|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
129975283|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
129975284|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
129975285|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
129975286|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
129975287|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975288|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975289|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975290|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975291|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975292|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975293|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975294|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
129975295|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975296|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975297|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
129975298|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
129975299|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975300|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975301|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975302|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975303|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975304|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975305|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975306|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
129975307|NCT01646177|467873318|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
129975308|NCT01646177|467873319|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
129975309|NCT01646177|467873320|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
129975310|NCT01646177|467873321|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975311|NCT01646177|467873322|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975312|NCT01646177|467873323|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975313|NCT01646177|467873324|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975314|NCT01646177|467873325|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975315|NCT01646177|467873326|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975316|NCT01646177|467873327|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975317|NCT01646177|467873328|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975318|NCT01646177|467873329|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
129975319|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975320|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975321|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975322|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975323|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
129975324|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
129975325|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
129975326|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
129975327|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975328|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975329|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975330|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
129975331|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975332|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975333|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975334|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975335|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
129975336|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
129975337|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
129975338|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
129975339|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975340|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975341|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975342|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
129975343|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975344|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975345|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975346|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975347|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
129975348|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
129975349|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
129975350|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
129975351|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975352|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975353|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975354|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
129975355|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975356|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975357|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975358|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975359|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
129975360|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
129975361|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
129975362|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
129975363|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129472354|NCT01318122|466024040|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129472355|NCT01318122|466024041|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
129472356|NCT01318122|466024042|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
129472357|NCT01318122|466024043|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
129472358|NCT01486199|466024044|FG000|Two Year Period Between Study Days|Physician Decision|1|||
129472359|NCT01486199|466024045|FG001|Two Year Period Between Study Days|Physician Decision|0|||
129975364|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975365|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975366|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
129975367|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975368|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975369|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975370|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975371|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
129975372|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
129975373|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
129975374|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
129975375|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975376|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975377|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975378|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
129975379|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975380|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975381|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975382|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975383|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
129975384|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
129975385|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975386|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
129472360|NCT02471716|466024047|FG000|Overall Study|Withdrawal by Subject|0|||
129472361|NCT02471716|466024048|FG001|Overall Study|Withdrawal by Subject|1|||
129472362|NCT02471716|466024049|FG002|Overall Study|Withdrawal by Subject|0|||
129472363|NCT02471716|466024050|FG003|Overall Study|Withdrawal by Subject|2|||
129472364|NCT02471716|466024051|FG004|Overall Study|Withdrawal by Subject|5|||
129472365|NCT02471716|466024047|FG000|Overall Study|Study Terminiated by sponsor|0|||
129472366|NCT02471716|466024048|FG001|Overall Study|Study Terminiated by sponsor|0|||
129472367|NCT02471716|466024049|FG002|Overall Study|Study Terminiated by sponsor|0|||
129472368|NCT02471716|466024050|FG003|Overall Study|Study Terminiated by sponsor|1|||
129472369|NCT02471716|466024051|FG004|Overall Study|Study Terminiated by sponsor|0|||
129472370|NCT02471716|466024047|FG000|Overall Study|Lost to Follow-up|0|||
129472371|NCT02471716|466024048|FG001|Overall Study|Lost to Follow-up|0|||
129472372|NCT02471716|466024049|FG002|Overall Study|Lost to Follow-up|0|||
129472373|NCT02471716|466024050|FG003|Overall Study|Lost to Follow-up|3|||
129472374|NCT02471716|466024051|FG004|Overall Study|Lost to Follow-up|2|||
129472375|NCT02471716|466024047|FG000|Overall Study|Death|0|||
129472376|NCT02471716|466024048|FG001|Overall Study|Death|0|||
129472377|NCT02471716|466024049|FG002|Overall Study|Death|0|||
129472378|NCT02471716|466024050|FG003|Overall Study|Death|1|||
129472379|NCT02471716|466024051|FG004|Overall Study|Death|0|||
129472380|NCT02471716|466024047|FG000|Overall Study|Other|0|||
129472381|NCT02471716|466024048|FG001|Overall Study|Other|0|||
129472382|NCT02471716|466024049|FG002|Overall Study|Other|0|||
129472383|NCT02471716|466024050|FG003|Overall Study|Other|8|||
129472384|NCT02471716|466024051|FG004|Overall Study|Other|9|||
129975387|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975388|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975389|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975390|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
129975391|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975392|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975393|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975394|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975395|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
129975396|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
129975397|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
129975398|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
129975399|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975400|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975401|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975402|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
129975403|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
129975404|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
129975405|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
129975406|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
129975407|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
129975408|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
129975409|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
129975410|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
129975411|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
129975412|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
129975413|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
129975414|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
129975415|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975416|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975417|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975418|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975419|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
129975420|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
129975421|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
129975422|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
129975423|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975424|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975425|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975426|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
129975427|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975428|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975429|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975430|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975431|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975432|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975433|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975434|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
129975435|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975436|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129472385|NCT01737931|466024056|FG000|Overall Study|Withdrawal by Subject|0|||
129472386|NCT01737931|466024057|FG001|Overall Study|Withdrawal by Subject|1|||
129472387|NCT01737931|466024058|FG002|Overall Study|Withdrawal by Subject|1|||
129975437|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975438|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
129975439|NCT01646177|467873318|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975440|NCT01646177|467873319|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975441|NCT01646177|467873320|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129472388|NCT01737931|466024056|FG000|Overall Study|Physician Decision|0|||
129975442|NCT01646177|467873321|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129472389|NCT01737931|466024057|FG001|Overall Study|Physician Decision|1|||
129472390|NCT01737931|466024058|FG002|Overall Study|Physician Decision|0|||
129975443|NCT01646177|467873322|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975444|NCT01646177|467873323|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
129975445|NCT01646177|467873324|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
129975446|NCT01646177|467873325|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
129975447|NCT01646177|467873326|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975448|NCT01646177|467873327|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975449|NCT01646177|467873328|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975450|NCT01646177|467873329|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
129975451|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975452|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975453|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975454|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975455|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975456|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975457|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975458|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
129975459|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
129975460|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
129975461|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
129975462|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
129975463|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975464|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975465|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975466|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975467|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975468|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975469|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975470|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
129975471|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
129975472|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
129975473|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
129975474|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
129975475|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975476|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975477|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975478|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975479|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975480|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975481|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975482|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
129975483|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
129975484|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
129975485|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
129975486|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
129975487|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975488|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975489|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975490|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975491|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975492|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975493|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975494|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
129975495|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
129975496|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
129472391|NCT03183128|466024059|FG000|Overall Study|Adverse Event|1|||
129975497|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
129975498|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
129975499|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975500|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975501|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975502|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975503|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975504|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129472392|NCT03183128|466024060|FG001|Overall Study|Adverse Event|2|||
129472393|NCT03183128|466024059|FG000|Overall Study|Withdrawal by Subject|1|||
129472394|NCT03183128|466024060|FG001|Overall Study|Withdrawal by Subject|8|||
129472395|NCT03183128|466024059|FG000|Overall Study|Protocol Violation|2|||
129975505|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975506|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
129975507|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
129975508|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
129975509|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
129975510|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
129975511|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975512|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975513|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975514|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975515|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975516|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975517|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975518|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
129975519|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
129975520|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
129975521|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
129975522|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
129975523|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975524|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975525|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975526|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975527|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975528|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975529|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975530|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975531|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
129975532|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
129975533|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
129975534|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
129975535|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975536|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975537|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975538|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975539|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975540|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975541|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975542|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975543|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
129975544|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
129975545|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
129975546|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
129975547|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975548|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975549|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975550|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129472396|NCT03183128|466024060|FG001|Overall Study|Protocol Violation|0|||
129472397|NCT03183128|466024059|FG000|Overall Study|Lack of Efficacy|4|||
129472398|NCT03183128|466024060|FG001|Overall Study|Lack of Efficacy|27|||
129472399|NCT03183128|466024059|FG000|Overall Study|Lost to Follow-up|1|||
129472400|NCT03183128|466024060|FG001|Overall Study|Lost to Follow-up|0|||
129472401|NCT03183128|466024059|FG000|Overall Study|Death|2|||
129472402|NCT03183128|466024060|FG001|Overall Study|Death|0|||
129472403|NCT03183128|466024059|FG000|Overall Study|Physician Decision|1|||
129975551|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975552|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129472404|NCT03183128|466024060|FG001|Overall Study|Physician Decision|0|||
129472405|NCT00364182|466024061|FG000|First Intervention|Secondary prophylaxis|1|||
129975553|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975554|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975555|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
129975556|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
129975557|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
129472406|NCT00364182|466024062|FG001|First Intervention|Secondary prophylaxis|0|||
129472407|NCT00364182|466024063|FG002|First Intervention|Secondary prophylaxis|0|||
129975558|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
129975559|NCT01646177|467873318|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975560|NCT01646177|467873319|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975561|NCT01646177|467873320|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975562|NCT01646177|467873321|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975563|NCT01646177|467873322|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975564|NCT01646177|467873323|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975565|NCT01646177|467873324|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975566|NCT01646177|467873325|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975567|NCT01646177|467873326|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975568|NCT01646177|467873327|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
129975569|NCT01646177|467873328|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
129975570|NCT01646177|467873329|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
129975571|NCT02920970|467873330|FG000|First Intervention|Protocol Violation|0|||
129975572|NCT02920970|467873331|FG001|First Intervention|Protocol Violation|1|||
129975573|NCT02920970|467873330|FG000|First Intervention|Adverse Event|0|||
129975574|NCT02920970|467873331|FG001|First Intervention|Adverse Event|1|||
129975575|NCT02920970|467873330|FG000|Second Intervention|Poor Lens Fit|1|||
129975576|NCT02920970|467873331|FG001|Second Intervention|Poor Lens Fit|0|||
129975577|NCT01711853|467873334|FG000|Overall Study|Not treated|3|||
129975578|NCT01374568|467873336|FG000|Overall Study|Lab unable to analyze BTM|0|||
129975579|NCT01374568|467873337|FG001|Overall Study|Lab unable to analyze BTM|2|||
129975580|NCT01912404|467873338|FG000|Overall Study|Due to personal reasons|1|||
129975581|NCT01912404|467873339|FG001|Overall Study|Due to personal reasons|0|||
129975582|NCT02269423|467873344|FG000|Overall Study|Discontinued due to change in residence|0|||
129975583|NCT02269423|467873345|FG001|Overall Study|Discontinued due to change in residence|1|||
129975584|NCT02269423|467873346|FG002|Overall Study|Discontinued due to change in residence|0|||
129975585|NCT02269423|467873347|FG003|Overall Study|Discontinued due to change in residence|1|||
129975586|NCT00755105|467873350|FG000|Overall Study|Withdrawal by Subject|9|||
129975587|NCT00755105|467873351|FG001|Overall Study|Withdrawal by Subject|11|||
129975588|NCT00755105|467873352|FG002|Overall Study|Withdrawal by Subject|4|||
129975589|NCT01281839|467873353|FG000|Overall Study|Lost to Follow-up|6|||
129975590|NCT01281839|467873354|FG001|Overall Study|Lost to Follow-up|3|||
129975591|NCT01281839|467873353|FG000|Overall Study|Withdrawal by Subject|4|||
129472408|NCT00364182|466024061|FG000|First Intervention|Withdrawal by Subject|2|||
129472409|NCT00364182|466024062|FG001|First Intervention|Withdrawal by Subject|0|||
129472410|NCT00364182|466024063|FG002|First Intervention|Withdrawal by Subject|0|||
129472411|NCT00364182|466024061|FG000|Second Intervention|non-compliance|0|||
129472412|NCT00364182|466024062|FG001|Second Intervention|non-compliance|1|||
129472413|NCT00364182|466024063|FG002|Second Intervention|non-compliance|1|||
129472414|NCT00364182|466024061|FG000|Second Intervention|Protocol Violation|0|||
129472415|NCT00364182|466024062|FG001|Second Intervention|Protocol Violation|1|||
129975592|NCT01281839|467873354|FG001|Overall Study|Withdrawal by Subject|10|||
129975593|NCT01281839|467873353|FG000|Overall Study|Reason not specified|0|||
129975594|NCT01281839|467873354|FG001|Overall Study|Reason not specified|1|||
129975595|NCT01518153|467873355|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
129472416|NCT00364182|466024063|FG002|Second Intervention|Protocol Violation|0|||
129472417|NCT00364182|466024061|FG000|Second Intervention|Adverse Event|0|||
129472418|NCT00364182|466024062|FG001|Second Intervention|Adverse Event|0|||
129472419|NCT00364182|466024063|FG002|Second Intervention|Adverse Event|1|||
129472420|NCT00364182|466024061|FG000|Third Intervention|non-compliance|0|||
129472421|NCT00364182|466024062|FG001|Third Intervention|non-compliance|1|||
129472422|NCT00364182|466024063|FG002|Third Intervention|non-compliance|0|||
129472423|NCT00364182|466024061|FG000|Third Intervention|Lost to Follow-up|0|||
129472424|NCT00364182|466024062|FG001|Third Intervention|Lost to Follow-up|0|||
129472425|NCT00364182|466024063|FG002|Third Intervention|Lost to Follow-up|1|||
129472426|NCT02921425|466024064|FG000|Overall Study|Protocol Violation|9|||
129472427|NCT01227967|466024065|FG000|Overall Study|Protocol Violation|3|||
129975596|NCT01518153|467873356|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
129975597|NCT01518153|467873357|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
129975598|NCT01518153|467873355|FG000|Stem Cell Transplant|Death|2|||
129472428|NCT01227967|466024066|FG001|Overall Study|Protocol Violation|1|||
129975599|NCT01518153|467873356|FG001|Stem Cell Transplant|Death|0|||
129975600|NCT01518153|467873357|FG002|Stem Cell Transplant|Death|0|||
129975601|NCT01518153|467873355|FG000|Stem Cell Transplant|Secondary graft failure|1|||
129975602|NCT01518153|467873356|FG001|Stem Cell Transplant|Secondary graft failure|0|||
129975603|NCT01518153|467873357|FG002|Stem Cell Transplant|Secondary graft failure|0|||
129975604|NCT01518153|467873355|FG000|Stem Cell Transplant|Adverse Event|1|||
129472429|NCT01227967|466024065|FG000|Overall Study|Death|0|||
129472430|NCT01227967|466024066|FG001|Overall Study|Death|1|||
129472431|NCT01227967|466024065|FG000|Overall Study|Lost to Follow-up|8|||
129472432|NCT01227967|466024066|FG001|Overall Study|Lost to Follow-up|3|||
129472433|NCT01227967|466024065|FG000|Overall Study|Withdrawal by Subject|4|||
129975605|NCT01518153|467873356|FG001|Stem Cell Transplant|Adverse Event|0|||
129975606|NCT01518153|467873357|FG002|Stem Cell Transplant|Adverse Event|0|||
129975607|NCT01518153|467873355|FG000|Donor Lymphocyte Infusion|Death|0|||
129975608|NCT01518153|467873356|FG001|Donor Lymphocyte Infusion|Death|2|||
129975609|NCT01518153|467873357|FG002|Donor Lymphocyte Infusion|Death|1|||
129975610|NCT00600613|467873358|FG000|Overall Study|Protocol Deviation|1|||
129975611|NCT01509547|467873361|FG000|Overall Study|Lost to Follow-up|24|||
129975612|NCT01509547|467873362|FG001|Overall Study|Lost to Follow-up|14|||
129975613|NCT01509547|467873361|FG000|Overall Study|Withdrawal by Subject|11|||
129975614|NCT01509547|467873362|FG001|Overall Study|Withdrawal by Subject|24|||
129975615|NCT01509547|467873361|FG000|Overall Study|Physician Decision|0|||
129975616|NCT01509547|467873362|FG001|Overall Study|Physician Decision|1|||
129975617|NCT00402051|467873367|FG000|Overall Study|Progressive Disease|13|||
129975618|NCT00402051|467873368|FG001|Overall Study|Progressive Disease|20|||
129975619|NCT00402051|467873367|FG000|Overall Study|Adverse Event|11|||
129975620|NCT00402051|467873368|FG001|Overall Study|Adverse Event|4|||
129975621|NCT00402051|467873367|FG000|Overall Study|Physician Decision|7|||
129975622|NCT00402051|467873368|FG001|Overall Study|Physician Decision|3|||
129975623|NCT00402051|467873367|FG000|Overall Study|Withdrawal by Subject|3|||
129975624|NCT00402051|467873368|FG001|Overall Study|Withdrawal by Subject|3|||
129975625|NCT00402051|467873367|FG000|Overall Study|Death - Related to Study Drug|1|||
129975626|NCT00402051|467873368|FG001|Overall Study|Death - Related to Study Drug|2|||
129975627|NCT00402051|467873367|FG000|Overall Study|Death Due to Study Disease|2|||
129975628|NCT00402051|467873368|FG001|Overall Study|Death Due to Study Disease|1|||
129975629|NCT00402051|467873367|FG000|Overall Study|Death Due to Adverse Event|0|||
129975630|NCT00402051|467873368|FG001|Overall Study|Death Due to Adverse Event|2|||
129975631|NCT00402051|467873367|FG000|Overall Study|Lost to Follow-up|1|||
129975632|NCT00402051|467873368|FG001|Overall Study|Lost to Follow-up|0|||
129975633|NCT02514551|467873369|FG000|Overall Study|Lost to Follow-up|0|||
129975634|NCT02514551|467873370|FG001|Overall Study|Lost to Follow-up|1|||
129975635|NCT02514551|467873369|FG000|Overall Study|Participant Never Treated|0|||
129975636|NCT02514551|467873370|FG001|Overall Study|Participant Never Treated|2|||
129975637|NCT00570908|467873385|FG000|Overall Study|Adverse Event|5|||
129975638|NCT00570908|467873385|FG000|Overall Study|Withdrawal by Subject|2|||
129975639|NCT01213524|467873386|FG000|Baseline|Withdrawal by Subject|5|||
129975640|NCT01213524|467873386|FG000|Baseline|high breath alcohol levels|1|||
129975641|NCT01213524|467873386|FG000|Baseline|Physician Decision|1|||
129975642|NCT01213524|467873386|FG000|Session 2|Withdrawal by Subject|5|||
129975643|NCT01213524|467873386|FG000|Session 3|Withdrawal by Subject|4|||
129975644|NCT01213524|467873386|FG000|Session 4|Physician Decision|1|||
129975645|NCT01213524|467873386|FG000|Session 4|Withdrawal by Subject|2|||
129975646|NCT05415748|467873395|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
129975647|NCT05415748|467873396|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
129975648|NCT05415748|467873397|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
129975649|NCT05415748|467873398|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
129975650|NCT05415748|467873395|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
129975651|NCT05415748|467873396|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
129975652|NCT05415748|467873397|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
129975653|NCT05415748|467873398|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
129975654|NCT06152224|467873401|FG000|Overall Study|Withdrawal by Subject|1|||
129975655|NCT06152224|467873402|FG001|Overall Study|Withdrawal by Subject|0|||
129975656|NCT06152224|467873401|FG000|Overall Study|Lost to Follow-up|0|||
129975657|NCT06152224|467873402|FG001|Overall Study|Lost to Follow-up|1|||
129975658|NCT06152224|467873401|FG000|Overall Study|On Follow Up|18|||
129975659|NCT06152224|467873402|FG001|Overall Study|On Follow Up|18|||
129975660|NCT00281320|467873405|FG000|Overall Study|Adverse Event|12|||
129975661|NCT00281320|467873406|FG001|Overall Study|Adverse Event|9|||
129975662|NCT00281320|467873405|FG000|Overall Study|Lack of Efficacy|4|||
129975663|NCT00281320|467873406|FG001|Overall Study|Lack of Efficacy|3|||
129472434|NCT01227967|466024066|FG001|Overall Study|Withdrawal by Subject|3|||
129472435|NCT01227967|466024065|FG000|Overall Study|Physician Decision|0|||
129472436|NCT01227967|466024066|FG001|Overall Study|Physician Decision|1|||
129472437|NCT01227967|466024065|FG000|Overall Study|Never Started Treatment|0|||
129472438|NCT01227967|466024066|FG001|Overall Study|Never Started Treatment|4|||
129472439|NCT01227967|466024065|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
129975664|NCT00281320|467873405|FG000|Overall Study|Withdrawal by Subject|5|||
129975665|NCT00281320|467873406|FG001|Overall Study|Withdrawal by Subject|6|||
129975666|NCT00281320|467873405|FG000|Overall Study|Lost to Follow-up|1|||
129975667|NCT00281320|467873406|FG001|Overall Study|Lost to Follow-up|2|||
129975668|NCT00281320|467873405|FG000|Overall Study|Other|3|||
129975669|NCT00281320|467873406|FG001|Overall Study|Other|1|||
129975670|NCT01447576|467873415|FG000|Overall Study|Lost to Follow-up|52|||
129975671|NCT01447576|467873415|FG000|Overall Study|Adverse Event|127|||
129472440|NCT01227967|466024066|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
129975672|NCT01447576|467873415|FG000|Overall Study|Participant met withdrawal criteria|40|||
129975673|NCT01447576|467873415|FG000|Overall Study|Withdrawal by Subject|100|||
129472441|NCT03403400|466024067|FG000|Overall Study|Lost to Follow-up|1|||
129975674|NCT01447576|467873415|FG000|Overall Study|Protocol deviation|83|||
129975675|NCT01447576|467873415|FG000|Overall Study|Lack of Efficacy|68|||
129975676|NCT01447576|467873415|FG000|Overall Study|Physician Decision|6|||
129975677|NCT00975676|467873416|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
129975678|NCT00975676|467873417|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
129975679|NCT02548078|467873418|FG000|Overall Study|Serious adverse event/Adverse event|1|||
129975680|NCT02548078|467873419|FG001|Overall Study|Serious adverse event/Adverse event|0|||
129975681|NCT02548078|467873418|FG000|Overall Study|Moved from study area|3|||
129975682|NCT02548078|467873419|FG001|Overall Study|Moved from study area|3|||
129975683|NCT02548078|467873418|FG000|Overall Study|Lost to Follow-up|1|||
129975684|NCT02548078|467873419|FG001|Overall Study|Lost to Follow-up|3|||
129975685|NCT02998476|467873425|FG000|Overall Study|Lost to Follow-up|1|||
129975686|NCT02998476|467873426|FG001|Overall Study|Lost to Follow-up|0|||
129975687|NCT02998476|467873425|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
129975688|NCT02998476|467873426|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
129975689|NCT02998476|467873425|FG000|Overall Study|Withdrawal by Subject|1|||
129975690|NCT02998476|467873426|FG001|Overall Study|Withdrawal by Subject|2|||
129975691|NCT02998476|467873425|FG000|Overall Study|Death|45|||
129975692|NCT02998476|467873426|FG001|Overall Study|Death|2|||
129975693|NCT02998476|467873425|FG000|Overall Study|Other|6|||
129975694|NCT02998476|467873426|FG001|Overall Study|Other|1|||
129975695|NCT03277352|467873427|FG000|Overall Study|Study Terminated By Sponsor|2|||
129975696|NCT03277352|467873427|FG000|Overall Study|Withdrawal by Subject|4|||
129975697|NCT03277352|467873427|FG000|Overall Study|Death|4|||
129975698|NCT01435772|467873428|FG000|Overall Study|Adverse Event|1|||
129975699|NCT01435772|467873429|FG001|Overall Study|Adverse Event|0|||
129975700|NCT01435772|467873430|FG002|Overall Study|Adverse Event|2|||
129975701|NCT01435772|467873428|FG000|Overall Study|Withdrawal by Subject|0|||
129472442|NCT03403400|466024068|FG001|Overall Study|Lost to Follow-up|0|||
129472443|NCT03403400|466024069|FG002|Overall Study|Lost to Follow-up|1|||
129472444|NCT03403400|466024067|FG000|Overall Study|Hospitalization|1|||
129975702|NCT01435772|467873429|FG001|Overall Study|Withdrawal by Subject|1|||
129975703|NCT01435772|467873430|FG002|Overall Study|Withdrawal by Subject|3|||
129975704|NCT01435772|467873428|FG000|Overall Study|Other - study termination|2|||
129975705|NCT01435772|467873429|FG001|Overall Study|Other - study termination|2|||
129975706|NCT01435772|467873430|FG002|Overall Study|Other - study termination|10|||
129975707|NCT03238963|467873431|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
129975708|NCT03238963|467873432|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
129975709|NCT03238963|467873431|FG000|Overall Study|Withdrawal by Subject|1|||
129975710|NCT03238963|467873432|FG001|Overall Study|Withdrawal by Subject|1|||
129975711|NCT03238963|467873431|FG000|Overall Study|Lost to Follow-up|1|||
129472445|NCT03403400|466024068|FG001|Overall Study|Hospitalization|0|||
129472446|NCT03403400|466024069|FG002|Overall Study|Hospitalization|0|||
129472447|NCT03403400|466024067|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
129472448|NCT03403400|466024068|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
129472449|NCT03403400|466024069|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
129472450|NCT01384292|466024073|FG000|Part B|Severe non-compliance to protocol|1|||
129975712|NCT03238963|467873432|FG001|Overall Study|Lost to Follow-up|0|||
129975713|NCT03238963|467873431|FG000|Overall Study|Protocol Violation|1|||
129975714|NCT03238963|467873432|FG001|Overall Study|Protocol Violation|1|||
129975715|NCT03238963|467873431|FG000|Overall Study|Adverse Event|1|||
129975716|NCT03238963|467873432|FG001|Overall Study|Adverse Event|0|||
129975717|NCT03838731|467875649|FG000|Overall Study|Pregnancy|0|||
129975718|NCT03838731|467875650|FG001|Overall Study|Pregnancy|1|||
129975719|NCT03838731|467875649|FG000|Overall Study|Withdrawal of consent|1|||
129975720|NCT03838731|467875650|FG001|Overall Study|Withdrawal of consent|0|||
129975721|NCT01088984|467875653|FG000|Phase 1|Death|2|||
129975722|NCT01088984|467875654|FG001|Phase 1|Death|1|||
129975723|NCT01088984|467875653|FG000|Phase 1|Disease Progression|2|||
129975724|NCT01088984|467875654|FG001|Phase 1|Disease Progression|4|||
129975725|NCT01088984|467875653|FG000|Phase 1|Other|1|||
129975726|NCT01088984|467875654|FG001|Phase 1|Other|1|||
129975727|NCT01088984|467875653|FG000|Phase 2|Death|0|||
129975728|NCT01088984|467875654|FG001|Phase 2|Death|5|||
129975729|NCT01088984|467875653|FG000|Phase 2|Withdrawal by Subject|0|||
129975730|NCT01088984|467875654|FG001|Phase 2|Withdrawal by Subject|1|||
129975731|NCT01088984|467875653|FG000|Phase 2|DIsease Progression|0|||
129975732|NCT01088984|467875654|FG001|Phase 2|DIsease Progression|25|||
129472451|NCT01384292|466024074|FG001|Part B|Severe non-compliance to protocol|0|||
129975733|NCT01088984|467875653|FG000|Phase 2|Other|0|||
129975734|NCT01088984|467875654|FG001|Phase 2|Other|1|||
129975735|NCT04707664|467875655|FG000|Overall Study|Adverse Event|2|||
129975736|NCT04707664|467875656|FG001|Overall Study|Adverse Event|0|||
129975737|NCT04707664|467875655|FG000|Overall Study|Death|1|||
129975738|NCT04707664|467875656|FG001|Overall Study|Death|2|||
129975739|NCT04707664|467875655|FG000|Overall Study|Withdrawal by Subject|13|||
129975740|NCT04707664|467875656|FG001|Overall Study|Withdrawal by Subject|21|||
129975741|NCT04707664|467875655|FG000|Overall Study|Lost to Follow-up|11|||
129975742|NCT04707664|467875656|FG001|Overall Study|Lost to Follow-up|13|||
129975743|NCT04707664|467875655|FG000|Overall Study|Not treated|2|||
129975744|NCT04707664|467875656|FG001|Overall Study|Not treated|0|||
129975745|NCT00699153|467875657|FG000|Overall Study|Lost to Follow-up|1|||
129975746|NCT00699153|467875658|FG001|Overall Study|Lost to Follow-up|0|||
129975747|NCT00699153|467875657|FG000|Overall Study|Adverse Event|0|||
129975748|NCT00699153|467875658|FG001|Overall Study|Adverse Event|2|||
129975749|NCT00699153|467875657|FG000|Overall Study|Protocol Violation|1|||
129975750|NCT00699153|467875658|FG001|Overall Study|Protocol Violation|0|||
129975751|NCT00699153|467875657|FG000|Overall Study|Travel Problem|1|||
129975752|NCT00699153|467875658|FG001|Overall Study|Travel Problem|0|||
129975753|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
129975754|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
129975755|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
129975756|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
129975757|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Death|13|||
129975758|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Death|12|||
129975759|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Progression|257|||
129975760|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Progression|218|||
129975761|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
129975762|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
129975763|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
129975764|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
129975765|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
129975766|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
129975767|NCT01006980|467875662|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
129975768|NCT01006980|467875663|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
129975769|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
129975770|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
129975771|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
129975772|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
129975773|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
129975774|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
129975775|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
129975776|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
129975777|NCT01006980|467875662|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
129975778|NCT01006980|467875663|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
129975779|NCT02706405|467875672|FG000|Overall Study|Death|3|||
129975780|NCT02706405|467875673|FG001|Overall Study|Death|2|||
129975781|NCT02706405|467875674|FG002|Overall Study|Death|0|||
129975782|NCT02706405|467875675|FG003|Overall Study|Death|1|||
129975783|NCT02706405|467875676|FG004|Overall Study|Death|0|||
129975784|NCT02706405|467875677|FG005|Overall Study|Death|0|||
129975785|NCT02706405|467875678|FG006|Overall Study|Death|3|||
129975786|NCT02706405|467875679|FG007|Overall Study|Death|4|||
129975787|NCT02706405|467875672|FG000|Overall Study|Disease progression|0|||
129975788|NCT02706405|467875673|FG001|Overall Study|Disease progression|0|||
129975789|NCT02706405|467875674|FG002|Overall Study|Disease progression|0|||
129975790|NCT02706405|467875675|FG003|Overall Study|Disease progression|0|||
129975791|NCT02706405|467875676|FG004|Overall Study|Disease progression|0|||
129975792|NCT02706405|467875677|FG005|Overall Study|Disease progression|0|||
129975793|NCT02706405|467875678|FG006|Overall Study|Disease progression|0|||
129975794|NCT02706405|467875679|FG007|Overall Study|Disease progression|1|||
129975795|NCT02706405|467875672|FG000|Overall Study|Pt moved to new therapy|0|||
129975796|NCT02706405|467875673|FG001|Overall Study|Pt moved to new therapy|0|||
129975797|NCT02706405|467875674|FG002|Overall Study|Pt moved to new therapy|0|||
129975798|NCT02706405|467875675|FG003|Overall Study|Pt moved to new therapy|0|||
129975799|NCT02706405|467875676|FG004|Overall Study|Pt moved to new therapy|0|||
129975800|NCT02706405|467875677|FG005|Overall Study|Pt moved to new therapy|1|||
129975801|NCT02706405|467875678|FG006|Overall Study|Pt moved to new therapy|0|||
129472452|NCT01384292|466024075|FG002|Part B|Severe non-compliance to protocol|0|||
129472453|NCT04062214|466024076|FG000|Week 12|Death|1|||
129472454|NCT04062214|466024077|FG001|Week 12|Death|1|||
129975802|NCT02706405|467875679|FG007|Overall Study|Pt moved to new therapy|1|||
129975803|NCT02706405|467875672|FG000|Overall Study|Physician Decision|1|||
129975804|NCT02706405|467875673|FG001|Overall Study|Physician Decision|0|||
129975805|NCT02706405|467875674|FG002|Overall Study|Physician Decision|0|||
129975806|NCT02706405|467875675|FG003|Overall Study|Physician Decision|0|||
129975807|NCT02706405|467875676|FG004|Overall Study|Physician Decision|0|||
129975808|NCT02706405|467875677|FG005|Overall Study|Physician Decision|0|||
129975809|NCT02706405|467875678|FG006|Overall Study|Physician Decision|0|||
129975810|NCT02706405|467875679|FG007|Overall Study|Physician Decision|0|||
129975811|NCT01228318|467875680|FG000|Overall Study|Clinic no show to receive intervention|1|||
129472455|NCT04062214|466024076|FG000|Week 12|Withdrawal by Subject|14|||
129472456|NCT04062214|466024077|FG001|Week 12|Withdrawal by Subject|13|||
129975812|NCT01228318|467875681|FG001|Overall Study|Clinic no show to receive intervention|0|||
129975813|NCT01228318|467875680|FG000|Overall Study|Unable to contact|2|||
129975814|NCT01228318|467875681|FG001|Overall Study|Unable to contact|5|||
129975815|NCT01228318|467875680|FG000|Overall Study|Moved|0|||
129975816|NCT01228318|467875681|FG001|Overall Study|Moved|2|||
129975817|NCT01228318|467875680|FG000|Overall Study|Incarcerated|1|||
129975818|NCT01228318|467875681|FG001|Overall Study|Incarcerated|0|||
129975819|NCT01182441|467875686|FG000|Overall Study|Patient Still in Follow-up|152|||
129975820|NCT01182441|467875687|FG001|Overall Study|Patient Still in Follow-up|72|||
129975821|NCT01182441|467875686|FG000|Overall Study|Death|37|||
129975822|NCT01182441|467875687|FG001|Overall Study|Death|25|||
129975823|NCT01182441|467875686|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
129975824|NCT01182441|467875687|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
129975825|NCT01182441|467875686|FG000|Overall Study|Lost to Follow-up|5|||
129975826|NCT01182441|467875687|FG001|Overall Study|Lost to Follow-up|8|||
129975827|NCT01182441|467875686|FG000|Overall Study|Withdrawal by Subject|6|||
129975828|NCT01182441|467875687|FG001|Overall Study|Withdrawal by Subject|13|||
129975829|NCT01182441|467875686|FG000|Overall Study|Implant Not Attempted|4|||
129975830|NCT01182441|467875687|FG001|Overall Study|Implant Not Attempted|0|||
129975831|NCT01182441|467875686|FG000|Overall Study|Adverse Event|2|||
129975832|NCT01182441|467875687|FG001|Overall Study|Adverse Event|0|||
129975833|NCT01182441|467875686|FG000|Overall Study|Physician Decision|1|||
129975834|NCT01182441|467875687|FG001|Overall Study|Physician Decision|1|||
129975835|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
129975836|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
129975837|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129975838|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
129975839|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129975840|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129975841|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
129975842|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
129975843|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129975844|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129975845|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
129975846|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129975847|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
129975848|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
129975849|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129975850|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
129975851|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
129975852|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
129975853|NCT00603525|467875688|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
129975854|NCT00603525|467875689|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
129975855|NCT00603525|467875690|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
129975856|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
129975857|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
129975858|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
129975859|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
129975860|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
129975861|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
129975862|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
129975863|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
129975864|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
129975865|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
129975866|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
129975867|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
129975868|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
129975869|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
129975870|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
129975871|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
129975872|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
129975873|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
129975874|NCT00603525|467875688|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
129975875|NCT00603525|467875689|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
129975876|NCT00603525|467875690|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
129975877|NCT00603525|467875688|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
129975878|NCT00603525|467875689|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
129975879|NCT00603525|467875690|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
129975880|NCT02304705|467875691|FG000|Overall Study|Withdrawal by Subject|2|||
129975881|NCT02304705|467875692|FG001|Overall Study|Withdrawal by Subject|0|||
129975882|NCT02304705|467875691|FG000|Overall Study|Physician Decision|2|||
129975883|NCT02304705|467875692|FG001|Overall Study|Physician Decision|4|||
129975884|NCT02304705|467875691|FG000|Overall Study|Death|0|||
129975885|NCT02304705|467875692|FG001|Overall Study|Death|1|||
129975886|NCT02304705|467875691|FG000|Overall Study|Lost to Follow-up|0|||
129975887|NCT02304705|467875692|FG001|Overall Study|Lost to Follow-up|2|||
129975888|NCT01195948|467875693|FG000|Overall Study|Lost to Follow-up|0|||
129975889|NCT01195948|467875694|FG001|Overall Study|Lost to Follow-up|1|||
129975890|NCT01195948|467875695|FG002|Overall Study|Lost to Follow-up|2|||
129975891|NCT00770029|467875696|FG000|Overall Study|Lost to Follow-up|2|||
129975892|NCT00770029|467875697|FG001|Overall Study|Lost to Follow-up|0|||
129975893|NCT00770029|467875696|FG000|Overall Study|Withdrawal by Subject|3|||
129975894|NCT00770029|467875697|FG001|Overall Study|Withdrawal by Subject|3|||
129975895|NCT00770029|467875696|FG000|Overall Study|Adverse Event|1|||
129975896|NCT00770029|467875697|FG001|Overall Study|Adverse Event|0|||
129975897|NCT02124811|467875698|FG000|Overall Study|Early termination|2|||
129975898|NCT02124811|467875699|FG001|Overall Study|Early termination|2|||
129975899|NCT02124811|467875698|FG000|Overall Study|Withdrawal by Subject|1|||
129975900|NCT02124811|467875699|FG001|Overall Study|Withdrawal by Subject|0|||
129975901|NCT01757197|467875702|FG000|Overall Study|Death|2|||
129975902|NCT01174446|467875706|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
129975903|NCT01174446|467875707|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
129975904|NCT01174446|467875708|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
129975905|NCT01174446|467875709|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
129975906|NCT01174446|467875706|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
129975907|NCT01174446|467875707|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
129975908|NCT01174446|467875708|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
129975909|NCT01174446|467875709|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
129975910|NCT01174446|467875706|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
129975911|NCT01174446|467875707|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
129975912|NCT01174446|467875708|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
129975913|NCT01174446|467875709|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
129975914|NCT01174446|467875706|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
129975915|NCT01174446|467875707|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
129975916|NCT01174446|467875708|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
129975917|NCT01174446|467875709|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
129975918|NCT01077128|467875710|FG000|Overall Study|Adverse Event|8|||
129975919|NCT01077128|467875710|FG000|Overall Study|Lack of Efficacy|1|||
129975920|NCT01077128|467875710|FG000|Overall Study|Disease exacerbation|1|||
129975921|NCT01077128|467875710|FG000|Overall Study|Adverse event and consent withdrawal|1|||
129975922|NCT01077128|467875710|FG000|Overall Study|Adverse event and disease exacerbation|1|||
129975923|NCT01077128|467875710|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
129975924|NCT01077128|467875710|FG000|Overall Study|Other|54|||
129975925|NCT00847626|467875713|FG000|Overall Study|Adverse Event|10|||
129975926|NCT00847626|467875714|FG001|Overall Study|Adverse Event|10|||
129975927|NCT00847626|467875715|FG002|Overall Study|Adverse Event|6|||
129975928|NCT00847626|467875716|FG003|Overall Study|Adverse Event|19|||
129975929|NCT00847626|467875717|FG004|Overall Study|Adverse Event|11|||
129975930|NCT00847626|467875718|FG005|Overall Study|Adverse Event|22|||
129975931|NCT00847626|467875719|FG006|Overall Study|Adverse Event|4|||
129975932|NCT00847626|467875720|FG007|Overall Study|Adverse Event|6|||
129975933|NCT00847626|467875721|FG008|Overall Study|Adverse Event|3|||
129975934|NCT00847626|467875722|FG009|Overall Study|Adverse Event|6|||
129975935|NCT00847626|467875723|FG010|Overall Study|Adverse Event|6|||
129975936|NCT00847626|467875713|FG000|Overall Study|Protocol Violation|2|||
129975937|NCT00847626|467875714|FG001|Overall Study|Protocol Violation|1|||
129975938|NCT00847626|467875715|FG002|Overall Study|Protocol Violation|2|||
129975939|NCT00847626|467875716|FG003|Overall Study|Protocol Violation|1|||
129975940|NCT00847626|467875717|FG004|Overall Study|Protocol Violation|1|||
129975941|NCT00847626|467875718|FG005|Overall Study|Protocol Violation|1|||
129975942|NCT00847626|467875719|FG006|Overall Study|Protocol Violation|1|||
129975943|NCT00847626|467875720|FG007|Overall Study|Protocol Violation|1|||
129975944|NCT00847626|467875721|FG008|Overall Study|Protocol Violation|0|||
129975945|NCT00847626|467875722|FG009|Overall Study|Protocol Violation|1|||
129975946|NCT00847626|467875723|FG010|Overall Study|Protocol Violation|1|||
129975947|NCT00847626|467875713|FG000|Overall Study|Lost to Follow-up|0|||
129975948|NCT00847626|467875714|FG001|Overall Study|Lost to Follow-up|1|||
129472457|NCT04062214|466024076|FG000|Week 12|Lost to Follow-up|55|||
129472458|NCT04062214|466024077|FG001|Week 12|Lost to Follow-up|68|||
129472459|NCT04062214|466024076|FG000|Week 12|Intermittent missing|31|||
129975949|NCT00847626|467875715|FG002|Overall Study|Lost to Follow-up|1|||
129975950|NCT00847626|467875716|FG003|Overall Study|Lost to Follow-up|1|||
129975951|NCT00847626|467875717|FG004|Overall Study|Lost to Follow-up|0|||
129975952|NCT00847626|467875718|FG005|Overall Study|Lost to Follow-up|3|||
129975953|NCT00847626|467875719|FG006|Overall Study|Lost to Follow-up|1|||
129975954|NCT00847626|467875720|FG007|Overall Study|Lost to Follow-up|3|||
129975955|NCT00847626|467875721|FG008|Overall Study|Lost to Follow-up|1|||
129975956|NCT00847626|467875722|FG009|Overall Study|Lost to Follow-up|0|||
129975957|NCT00847626|467875723|FG010|Overall Study|Lost to Follow-up|1|||
129975958|NCT00847626|467875713|FG000|Overall Study|Withdrawal by Subject|5|||
129975959|NCT00847626|467875714|FG001|Overall Study|Withdrawal by Subject|5|||
129975960|NCT00847626|467875715|FG002|Overall Study|Withdrawal by Subject|3|||
129975961|NCT00847626|467875716|FG003|Overall Study|Withdrawal by Subject|8|||
129472460|NCT04062214|466024077|FG001|Week 12|Intermittent missing|29|||
129472461|NCT04062214|466024076|FG000|Week 36|Withdrawal by Subject|4|||
129472462|NCT04062214|466024077|FG001|Week 36|Withdrawal by Subject|5|||
129472463|NCT04062214|466024076|FG000|Week 36|Lost to Follow-up|50|||
129472464|NCT04062214|466024077|FG001|Week 36|Lost to Follow-up|46|||
129472465|NCT04062214|466024076|FG000|Week 36|Death|0|||
129472466|NCT04062214|466024077|FG001|Week 36|Death|1|||
129472467|NCT04666038|466024078|FG000|Overall Study|Progressive Disease|2|||
129472468|NCT04666038|466024079|FG001|Overall Study|Progressive Disease|0|||
129472469|NCT04666038|466024078|FG000|Overall Study|Death|38|||
129472470|NCT04666038|466024079|FG001|Overall Study|Death|32|||
129472471|NCT04666038|466024078|FG000|Overall Study|Withdrawal by Subject|10|||
129472472|NCT04666038|466024079|FG001|Overall Study|Withdrawal by Subject|19|||
129472473|NCT04666038|466024078|FG000|Overall Study|Lost to Follow-up|0|||
129472474|NCT04666038|466024079|FG001|Overall Study|Lost to Follow-up|2|||
129472475|NCT04666038|466024078|FG000|Overall Study|On Study Treatment|46|||
129975962|NCT00847626|467875717|FG004|Overall Study|Withdrawal by Subject|12|||
129975963|NCT00847626|467875718|FG005|Overall Study|Withdrawal by Subject|9|||
129975964|NCT00847626|467875719|FG006|Overall Study|Withdrawal by Subject|8|||
129975965|NCT00847626|467875720|FG007|Overall Study|Withdrawal by Subject|4|||
129975966|NCT00847626|467875721|FG008|Overall Study|Withdrawal by Subject|4|||
129975967|NCT00847626|467875722|FG009|Overall Study|Withdrawal by Subject|5|||
129975968|NCT00847626|467875723|FG010|Overall Study|Withdrawal by Subject|2|||
129975969|NCT00847626|467875713|FG000|Overall Study|Lack of Efficacy|3|||
129975970|NCT00847626|467875714|FG001|Overall Study|Lack of Efficacy|1|||
129975971|NCT00847626|467875715|FG002|Overall Study|Lack of Efficacy|0|||
129975972|NCT00847626|467875716|FG003|Overall Study|Lack of Efficacy|1|||
129975973|NCT00847626|467875717|FG004|Overall Study|Lack of Efficacy|2|||
129975974|NCT00847626|467875718|FG005|Overall Study|Lack of Efficacy|0|||
129975975|NCT00847626|467875719|FG006|Overall Study|Lack of Efficacy|6|||
129975976|NCT00847626|467875720|FG007|Overall Study|Lack of Efficacy|2|||
129975977|NCT00847626|467875721|FG008|Overall Study|Lack of Efficacy|5|||
129975978|NCT00847626|467875722|FG009|Overall Study|Lack of Efficacy|1|||
129975979|NCT00847626|467875723|FG010|Overall Study|Lack of Efficacy|7|||
129975980|NCT00847626|467875713|FG000|Overall Study|Other|1|||
129975981|NCT00847626|467875714|FG001|Overall Study|Other|5|||
129975982|NCT00847626|467875715|FG002|Overall Study|Other|4|||
129975983|NCT00847626|467875716|FG003|Overall Study|Other|1|||
129975984|NCT00847626|467875717|FG004|Overall Study|Other|2|||
129975985|NCT00847626|467875718|FG005|Overall Study|Other|2|||
129975986|NCT00847626|467875719|FG006|Overall Study|Other|2|||
129975987|NCT00847626|467875720|FG007|Overall Study|Other|3|||
129975988|NCT00847626|467875721|FG008|Overall Study|Other|1|||
129975989|NCT00847626|467875722|FG009|Overall Study|Other|1|||
129975990|NCT00847626|467875723|FG010|Overall Study|Other|3|||
129975991|NCT03057847|467875724|FG000|Overall Study|Lost to Follow-up|16|||
129975992|NCT01706705|467875726|FG000|Overall Study|Death|1|||
129975993|NCT01706705|467875726|FG000|Overall Study|Lack of Efficacy|13|||
129975994|NCT01706705|467875726|FG000|Overall Study|Non-clinical|6|||
129975995|NCT05627258|467875727|FG000|Overall Study|Lost to Follow-up|1|||
129975996|NCT05627258|467875728|FG001|Overall Study|Lost to Follow-up|0|||
129975997|NCT05627258|467875729|FG002|Overall Study|Lost to Follow-up|0|||
129975998|NCT05627258|467875730|FG003|Overall Study|Lost to Follow-up|0|||
129975999|NCT05627258|467875731|FG004|Overall Study|Lost to Follow-up|0|||
129976000|NCT05627258|467875732|FG005|Overall Study|Lost to Follow-up|0|||
129976001|NCT05627258|467875727|FG000|Overall Study|Withdrawal by Subject|0|||
129976002|NCT05627258|467875728|FG001|Overall Study|Withdrawal by Subject|0|||
129976003|NCT05627258|467875729|FG002|Overall Study|Withdrawal by Subject|0|||
129976004|NCT05627258|467875730|FG003|Overall Study|Withdrawal by Subject|0|||
129976005|NCT05627258|467875731|FG004|Overall Study|Withdrawal by Subject|2|||
129472476|NCT04666038|466024079|FG001|Overall Study|On Study Treatment|5|||
129472477|NCT04666038|466024078|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
129472478|NCT04666038|466024079|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
129472479|NCT01282229|466024090|FG000|Overall Study|Protocol Violation|2|||
129976006|NCT05627258|467875732|FG005|Overall Study|Withdrawal by Subject|0|||
129976007|NCT05627258|467875727|FG000|Overall Study|Enrolled, but product not administered|1|||
129976008|NCT05627258|467875728|FG001|Overall Study|Enrolled, but product not administered|0|||
129976009|NCT05627258|467875729|FG002|Overall Study|Enrolled, but product not administered|0|||
129976010|NCT05627258|467875730|FG003|Overall Study|Enrolled, but product not administered|0|||
129976011|NCT05627258|467875731|FG004|Overall Study|Enrolled, but product not administered|0|||
129976012|NCT05627258|467875732|FG005|Overall Study|Enrolled, but product not administered|0|||
129976013|NCT05627258|467875727|FG000|Overall Study|Other subject illness/injury|1|||
129976014|NCT05627258|467875728|FG001|Overall Study|Other subject illness/injury|0|||
129976015|NCT05627258|467875729|FG002|Overall Study|Other subject illness/injury|0|||
129472480|NCT03094195|466024098|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
129472481|NCT03094195|466024099|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
129472482|NCT03094195|466024100|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
129472483|NCT03094195|466024101|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129472484|NCT03094195|466024102|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129472485|NCT03094195|466024103|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129472486|NCT03094195|466024104|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129472487|NCT03094195|466024105|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
129472488|NCT03094195|466024098|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
129472489|NCT03094195|466024099|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
129472490|NCT03094195|466024100|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
129472491|NCT03094195|466024101|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129472492|NCT03094195|466024102|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129472493|NCT03094195|466024103|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129472494|NCT03094195|466024104|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129472495|NCT03094195|466024105|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
129472496|NCT03094195|466024098|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472497|NCT03094195|466024099|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472498|NCT03094195|466024100|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
129472499|NCT03094195|466024101|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472500|NCT03094195|466024102|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472501|NCT03094195|466024103|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472502|NCT03094195|466024104|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472503|NCT03094195|466024105|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
129472504|NCT03094195|466024098|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129472505|NCT03094195|466024099|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
129472506|NCT03094195|466024100|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
129472507|NCT03094195|466024101|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129472508|NCT03094195|466024102|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129472509|NCT03094195|466024103|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129976016|NCT05627258|467875730|FG003|Overall Study|Other subject illness/injury|0|||
129976017|NCT05627258|467875731|FG004|Overall Study|Other subject illness/injury|0|||
129976018|NCT05627258|467875732|FG005|Overall Study|Other subject illness/injury|0|||
129976019|NCT05627258|467875727|FG000|Overall Study|Subject moved from area|0|||
129472510|NCT03094195|466024104|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129472511|NCT03094195|466024105|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
129472512|NCT03887130|466024109|FG000|Overall Study|Progressive disease|23|||
129472513|NCT03887130|466024110|FG001|Overall Study|Progressive disease|14|||
129472514|NCT03887130|466024111|FG002|Overall Study|Progressive disease|7|||
129472515|NCT03887130|466024109|FG000|Overall Study|Protocol Violation|3|||
129472516|NCT03887130|466024110|FG001|Overall Study|Protocol Violation|1|||
129472517|NCT03887130|466024111|FG002|Overall Study|Protocol Violation|2|||
129472518|NCT03887130|466024109|FG000|Overall Study|Drug related toxicity|7|||
129472519|NCT03887130|466024110|FG001|Overall Study|Drug related toxicity|7|||
129472520|NCT03887130|466024111|FG002|Overall Study|Drug related toxicity|13|||
129472521|NCT03887130|466024109|FG000|Overall Study|Non drug related toxicity|3|||
129472522|NCT03887130|466024110|FG001|Overall Study|Non drug related toxicity|0|||
129472523|NCT03887130|466024111|FG002|Overall Study|Non drug related toxicity|0|||
129472524|NCT03887130|466024109|FG000|Overall Study|Death|2|||
129472525|NCT03887130|466024110|FG001|Overall Study|Death|2|||
129472526|NCT03887130|466024111|FG002|Overall Study|Death|1|||
129472527|NCT03887130|466024109|FG000|Overall Study|Withdrawal by Subject|7|||
129472528|NCT03887130|466024110|FG001|Overall Study|Withdrawal by Subject|6|||
129472529|NCT03887130|466024111|FG002|Overall Study|Withdrawal by Subject|11|||
129472530|NCT03887130|466024109|FG000|Overall Study|other reason|6|||
129472531|NCT03887130|466024110|FG001|Overall Study|other reason|20|||
129472532|NCT03887130|466024111|FG002|Overall Study|other reason|17|||
129472533|NCT04082663|466024112|FG000|Overall Study|Adverse Event|6|||
129472534|NCT04082663|466024112|FG000|Overall Study|Lost to Follow-up|1|||
129472535|NCT02440581|466024113|FG000|Overall Study|Death|0|||
129472536|NCT02440581|466024114|FG001|Overall Study|Death|0|||
129472537|NCT02440581|466024115|FG002|Overall Study|Death|7|||
129472538|NCT02440581|466024116|FG003|Overall Study|Death|5|||
129472539|NCT02440581|466024113|FG000|Overall Study|Transplanted|1|||
129976020|NCT05627258|467875728|FG001|Overall Study|Subject moved from area|0|||
129976021|NCT05627258|467875729|FG002|Overall Study|Subject moved from area|1|||
129472540|NCT02440581|466024114|FG001|Overall Study|Transplanted|0|||
129472541|NCT02440581|466024115|FG002|Overall Study|Transplanted|3|||
129472542|NCT02440581|466024116|FG003|Overall Study|Transplanted|2|||
129472543|NCT02440581|466024113|FG000|Overall Study|Withdrawal by Subject|4|||
129472544|NCT02440581|466024114|FG001|Overall Study|Withdrawal by Subject|11|||
129472545|NCT02440581|466024115|FG002|Overall Study|Withdrawal by Subject|3|||
129472546|NCT02440581|466024116|FG003|Overall Study|Withdrawal by Subject|7|||
129472547|NCT03186989|466024117|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472548|NCT03186989|466024118|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472549|NCT03186989|466024119|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
129472550|NCT03186989|466024120|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
129472551|NCT03186989|466024121|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
129472552|NCT03186989|466024122|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472553|NCT03186989|466024123|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472554|NCT03186989|466024124|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472555|NCT03186989|466024125|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472556|NCT03186989|466024126|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472557|NCT03186989|466024127|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
129472558|NCT03186989|466024117|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472559|NCT03186989|466024118|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472560|NCT03186989|466024119|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472561|NCT03186989|466024120|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472562|NCT03186989|466024121|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472563|NCT03186989|466024122|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
129472564|NCT03186989|466024123|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472565|NCT03186989|466024124|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472566|NCT03186989|466024125|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472567|NCT03186989|466024126|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472568|NCT03186989|466024127|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
129472569|NCT03186989|466024117|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472570|NCT03186989|466024118|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472571|NCT03186989|466024119|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472572|NCT03186989|466024120|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472573|NCT03186989|466024121|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472574|NCT03186989|466024122|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472575|NCT03186989|466024123|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
129472576|NCT03186989|466024124|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472577|NCT03186989|466024125|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129472578|NCT03186989|466024126|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129976022|NCT05627258|467875730|FG003|Overall Study|Subject moved from area|0|||
129976023|NCT05627258|467875731|FG004|Overall Study|Subject moved from area|0|||
129976024|NCT05627258|467875732|FG005|Overall Study|Subject moved from area|0|||
129976025|NCT02138786|467875733|FG000|Overall Study|Adverse Event|0|||
129976026|NCT02138786|467875734|FG001|Overall Study|Adverse Event|2|||
129976027|NCT02138786|467875735|FG002|Overall Study|Adverse Event|1|||
129976028|NCT02138786|467875733|FG000|Overall Study|Death|1|||
129976029|NCT02138786|467875734|FG001|Overall Study|Death|7|||
129976030|NCT02138786|467875735|FG002|Overall Study|Death|2|||
129976031|NCT02138786|467875733|FG000|Overall Study|Disease Progression|1|||
129976032|NCT02138786|467875734|FG001|Overall Study|Disease Progression|1|||
129976033|NCT02138786|467875735|FG002|Overall Study|Disease Progression|3|||
129976034|NCT02138786|467875733|FG000|Overall Study|Withdrawal by Subject|1|||
129976035|NCT02138786|467875734|FG001|Overall Study|Withdrawal by Subject|2|||
129976036|NCT02138786|467875735|FG002|Overall Study|Withdrawal by Subject|0|||
129976037|NCT02138786|467875733|FG000|Overall Study|Patient's Wish|0|||
129976038|NCT02138786|467875734|FG001|Overall Study|Patient's Wish|2|||
129976039|NCT02138786|467875735|FG002|Overall Study|Patient's Wish|0|||
129976040|NCT02138786|467875733|FG000|Overall Study|Sponsor Terminated Study|0|||
129976041|NCT02138786|467875734|FG001|Overall Study|Sponsor Terminated Study|1|||
129976042|NCT02138786|467875735|FG002|Overall Study|Sponsor Terminated Study|1|||
129976043|NCT02138786|467875733|FG000|Overall Study|Non-Compliance|0|||
129976044|NCT02138786|467875734|FG001|Overall Study|Non-Compliance|0|||
129976045|NCT02138786|467875735|FG002|Overall Study|Non-Compliance|1|||
129976046|NCT02088957|467875736|FG000|Overall Study|Lack of Efficacy|1|||
129976047|NCT02088957|467875737|FG001|Overall Study|Lack of Efficacy|0|||
129976048|NCT01199068|467875738|FG000|Overall Study|Unacceptable toxicity|0|||
129976049|NCT01199068|467875739|FG001|Overall Study|Unacceptable toxicity|0|||
129976050|NCT01199068|467875740|FG002|Overall Study|Unacceptable toxicity|2|||
129976051|NCT01199068|467875738|FG000|Overall Study|Progressive disease|3|||
129976052|NCT01199068|467875739|FG001|Overall Study|Progressive disease|3|||
129976053|NCT01199068|467875740|FG002|Overall Study|Progressive disease|6|||
129976054|NCT01199068|467875738|FG000|Overall Study|Withdrawal by Subject|0|||
129976055|NCT01199068|467875739|FG001|Overall Study|Withdrawal by Subject|0|||
129976056|NCT01199068|467875740|FG002|Overall Study|Withdrawal by Subject|1|||
129976057|NCT03338296|467875741|FG000|Overall Study|Adverse Event|0|||
129976058|NCT03338296|467875742|FG001|Overall Study|Adverse Event|1|||
129976059|NCT03338296|467875741|FG000|Overall Study|Withdrawal by Subject|14|||
129976060|NCT03338296|467875742|FG001|Overall Study|Withdrawal by Subject|13|||
129976061|NCT03338296|467875741|FG000|Overall Study|Lost to Follow-up|10|||
129976062|NCT03338296|467875742|FG001|Overall Study|Lost to Follow-up|10|||
129976063|NCT03338296|467875741|FG000|Overall Study|Study Terminated by Sponsor|77|||
129976064|NCT03338296|467875742|FG001|Overall Study|Study Terminated by Sponsor|76|||
129976065|NCT03338296|467875741|FG000|Overall Study|Other|2|||
129976066|NCT03338296|467875742|FG001|Overall Study|Other|7|||
129976067|NCT03338296|467875741|FG000|Overall Study|Missing|0|||
129976068|NCT03338296|467875742|FG001|Overall Study|Missing|1|||
129976069|NCT02687035|467875747|FG000|Overall Study|Withdrawal by Subject|1|||
129976070|NCT02687035|467875747|FG000|Overall Study|Death|87|||
129976071|NCT02687035|467875747|FG000|Overall Study|Lost to Follow-up|1|||
129976072|NCT02687035|467875747|FG000|Overall Study|Missed Visit|87|||
129976073|NCT02687035|467875747|FG000|Overall Study|Did not receive Study Device|8|||
129976074|NCT00667394|467875748|FG000|Overall Study|Adverse Event|3|||
129976075|NCT00667394|467875749|FG001|Overall Study|Adverse Event|0|||
129976076|NCT00667394|467875748|FG000|Overall Study|Progressive disease|1|||
129976077|NCT00667394|467875749|FG001|Overall Study|Progressive disease|0|||
129976078|NCT04076943|467875751|FG000|Overall Study|Withdrawal by Subject|12|||
129976079|NCT04076943|467875751|FG000|Overall Study|Adverse Event|1|||
129976080|NCT04076943|467875751|FG000|Overall Study|Progressive Disease|2|||
129976081|NCT04076943|467875751|FG000|Overall Study|Death|13|||
129976082|NCT04076943|467875751|FG000|Overall Study|Other than specified|6|||
129976083|NCT02224703|467875757|FG000|Overall Study|Adverse Event|0|||
129976084|NCT02224703|467875758|FG001|Overall Study|Adverse Event|5|||
129976085|NCT02224703|467875759|FG002|Overall Study|Adverse Event|0|||
129976086|NCT02224703|467875757|FG000|Overall Study|Withdrawn by investigator|1|||
129976087|NCT02224703|467875758|FG001|Overall Study|Withdrawn by investigator|0|||
129976088|NCT02224703|467875759|FG002|Overall Study|Withdrawn by investigator|0|||
129976089|NCT02224703|467875757|FG000|Overall Study|Advised by medical monitor|1|||
129976090|NCT02224703|467875758|FG001|Overall Study|Advised by medical monitor|0|||
129976091|NCT02224703|467875759|FG002|Overall Study|Advised by medical monitor|0|||
129976092|NCT02224703|467875757|FG000|Overall Study|Withdrawn by parent/guardian|0|||
129976093|NCT02224703|467875758|FG001|Overall Study|Withdrawn by parent/guardian|1|||
129976094|NCT02224703|467875759|FG002|Overall Study|Withdrawn by parent/guardian|0|||
129976095|NCT02224703|467875757|FG000|Overall Study|Lack of Efficacy|1|||
129976096|NCT02224703|467875758|FG001|Overall Study|Lack of Efficacy|0|||
129976097|NCT02224703|467875759|FG002|Overall Study|Lack of Efficacy|0|||
129976098|NCT02922023|467875760|FG000|Overall Study|Lost to Follow-up|2|||
129976099|NCT02922023|467875761|FG001|Overall Study|Lost to Follow-up|0|||
129976100|NCT03596762|467875762|FG000|Overall Study|Protocol Violation|0|||
129976101|NCT03596762|467875763|FG001|Overall Study|Protocol Violation|0|||
129976102|NCT03596762|467875764|FG002|Overall Study|Protocol Violation|0|||
129976103|NCT03596762|467875765|FG003|Overall Study|Protocol Violation|0|||
129976104|NCT03596762|467875766|FG004|Overall Study|Protocol Violation|1|||
129976105|NCT03596762|467875762|FG000|Overall Study|Adverse Event|2|||
129976106|NCT03596762|467875763|FG001|Overall Study|Adverse Event|0|||
129976107|NCT03596762|467875764|FG002|Overall Study|Adverse Event|1|||
129976108|NCT03596762|467875765|FG003|Overall Study|Adverse Event|0|||
129976109|NCT03596762|467875766|FG004|Overall Study|Adverse Event|5|||
129976110|NCT03596762|467875762|FG000|Overall Study|Withdrawal by Subject|2|||
129976111|NCT03596762|467875763|FG001|Overall Study|Withdrawal by Subject|1|||
129976112|NCT03596762|467875764|FG002|Overall Study|Withdrawal by Subject|0|||
129976113|NCT03596762|467875765|FG003|Overall Study|Withdrawal by Subject|1|||
129976114|NCT03596762|467875766|FG004|Overall Study|Withdrawal by Subject|1|||
129976115|NCT02593123|467875767|FG000|Overall Study|Physician Decision|2|||
129976116|NCT02593123|467875768|FG001|Overall Study|Physician Decision|1|||
129976117|NCT02593123|467875767|FG000|Overall Study|Relapse|1|||
129976118|NCT02593123|467875768|FG001|Overall Study|Relapse|1|||
129472579|NCT03186989|466024127|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
129976119|NCT01261000|467875771|FG000|Overall Study|Screen failure|1|||
129976120|NCT00504777|467875772|FG000|Overall Study|Adverse Event|1|||
129976121|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
129976122|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
129976123|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
129976124|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
129976125|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
129976126|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
129976127|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
129976128|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
129976129|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
129976130|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
129976131|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976132|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976133|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
129976134|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
129976135|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976136|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976137|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976138|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
129976139|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
129976140|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976141|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976142|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976143|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
129976144|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976145|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976146|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976147|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
129976148|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
129976149|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
129976150|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
129976151|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
129976152|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
129976153|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129976154|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129472580|NCT03186989|466024117|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472581|NCT03186989|466024118|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472582|NCT03186989|466024119|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472583|NCT03186989|466024120|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472584|NCT03186989|466024121|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472585|NCT03186989|466024122|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
129472586|NCT03186989|466024123|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
129472587|NCT03186989|466024124|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472588|NCT03186989|466024125|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
129472589|NCT03186989|466024126|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472590|NCT03186989|466024127|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
129472591|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
129472592|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
129472593|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
129472594|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129472595|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129472596|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129472597|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129472598|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129472599|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
129472600|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
129472601|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
129472602|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
129472603|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129472604|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129472605|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129472606|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129472607|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129472608|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
129472609|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
129472610|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
129472611|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472612|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472613|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472614|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472615|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472616|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472617|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
129472618|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
129472619|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
129472620|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
129976155|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129976156|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
129976157|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
129976158|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
129976159|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
129976160|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
129472621|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129472622|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129472623|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129472624|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129472625|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129472626|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
129472627|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
129472628|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
129472629|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472630|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472631|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472632|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472633|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472634|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472635|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
129472636|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472637|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472638|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
129472639|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472640|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472641|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472642|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472643|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472644|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
129472645|NCT01583374|466024128|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472646|NCT01583374|466024129|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
129472647|NCT01583374|466024130|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472648|NCT01583374|466024131|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472649|NCT01583374|466024132|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472650|NCT01583374|466024133|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472651|NCT01583374|466024134|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472652|NCT01583374|466024135|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472653|NCT01583374|466024136|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
129472654|NCT01583374|466024128|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472655|NCT01583374|466024129|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472656|NCT01583374|466024130|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472657|NCT01583374|466024131|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472658|NCT01583374|466024132|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472659|NCT01583374|466024133|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472660|NCT01583374|466024134|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472661|NCT01583374|466024135|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
129472662|NCT01583374|466024136|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
129472663|NCT01583374|466024128|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
129472664|NCT01583374|466024129|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
129472665|NCT01583374|466024130|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
129472666|NCT01583374|466024131|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
129472667|NCT01583374|466024132|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
129472668|NCT01583374|466024133|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
129472669|NCT01583374|466024134|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
129472670|NCT01583374|466024135|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
129472671|NCT01583374|466024136|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
129472672|NCT01583374|466024128|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
129472673|NCT01583374|466024129|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
129472674|NCT01583374|466024130|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
129472675|NCT01583374|466024131|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
129472676|NCT01583374|466024132|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
129976161|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
129976162|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976163|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976164|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976165|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
129976166|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
129976167|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
129472677|NCT01583374|466024133|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
129472678|NCT01583374|466024134|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
129976168|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
129976169|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
129976170|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
129472679|NCT01583374|466024135|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
129472680|NCT01583374|466024136|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
129472681|NCT01583374|466024128|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
129472682|NCT01583374|466024129|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
129472683|NCT01583374|466024130|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
129472684|NCT01583374|466024131|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
129472685|NCT01583374|466024132|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
129472686|NCT01583374|466024133|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
129472687|NCT01583374|466024134|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
129472688|NCT01583374|466024135|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
129472689|NCT01583374|466024136|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
129472690|NCT01583374|466024128|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129472691|NCT01583374|466024129|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129472692|NCT01583374|466024130|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
129472693|NCT01583374|466024131|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129472694|NCT01583374|466024132|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
129472695|NCT01583374|466024133|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
129472696|NCT01583374|466024134|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129472697|NCT01583374|466024135|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129472698|NCT01583374|466024136|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
129472699|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
129472700|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
129472701|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
129472702|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
129472703|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
129472704|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
129472705|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
129472706|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
129472707|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
129472708|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
129472709|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
129472710|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
129472711|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
129472712|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
129472713|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
129472714|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
129472715|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
129472716|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
129472717|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
129472718|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
129472719|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
129472720|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
129472721|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
129472722|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
129472723|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
129472724|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
129472725|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
129472726|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
129472727|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
129472728|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
129472729|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
129472730|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
129472731|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
129472732|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
129472733|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
129472734|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
129472735|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472736|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472737|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472738|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472739|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
129472740|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472741|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
129472742|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472743|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
129472744|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
129472745|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
129472746|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
129472747|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
129472748|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
129472749|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
129472750|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
129472751|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
129472752|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
129472753|NCT01583374|466024128|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
129472754|NCT01583374|466024129|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
129472755|NCT01583374|466024130|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
129472756|NCT01583374|466024131|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
129472757|NCT01583374|466024132|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
129472758|NCT01583374|466024133|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
129472759|NCT01583374|466024134|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
129472760|NCT01583374|466024135|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
129472761|NCT01583374|466024136|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
129472762|NCT04188197|466025675|FG000|Overall Study|Lost to Follow-up|4|||
129472763|NCT04188197|466025676|FG001|Overall Study|Lost to Follow-up|1|||
129472764|NCT04188197|466025675|FG000|Overall Study|Withdrawal by Subject|1|||
129472765|NCT04188197|466025676|FG001|Overall Study|Withdrawal by Subject|1|||
129472766|NCT04188197|466025675|FG000|Overall Study|Pregnancy|0|||
129472767|NCT04188197|466025676|FG001|Overall Study|Pregnancy|1|||
129472768|NCT02107703|466025679|FG000|Overall Study|Withdrawal by Subject|46|||
129472769|NCT02107703|466025680|FG001|Overall Study|Withdrawal by Subject|21|||
129472770|NCT02107703|466025679|FG000|Overall Study|Lost to Follow-up|20|||
129472771|NCT02107703|466025680|FG001|Overall Study|Lost to Follow-up|9|||
129472772|NCT02107703|466025679|FG000|Overall Study|On study treatment/follow up|48|||
129472773|NCT02107703|466025680|FG001|Overall Study|On study treatment/follow up|5|||
129472774|NCT02911688|466025683|FG000|Washout|Lost to Follow-up|1|||
129472775|NCT02911688|466025684|FG001|Washout|Lost to Follow-up|1|||
129472776|NCT02911688|466025683|FG000|Washout|Withdrawal by Subject|0|||
129472777|NCT02911688|466025684|FG001|Washout|Withdrawal by Subject|1|||
129472778|NCT00883493|466025685|FG000|Overall Study|Adverse Event|11|||
129472779|NCT00883493|466025686|FG001|Overall Study|Adverse Event|12|||
129472780|NCT00883493|466025685|FG000|Overall Study|Lack of Efficacy|4|||
129472781|NCT00883493|466025686|FG001|Overall Study|Lack of Efficacy|3|||
129472782|NCT00883493|466025685|FG000|Overall Study|Lost to Follow-up|7|||
129472783|NCT00883493|466025686|FG001|Overall Study|Lost to Follow-up|6|||
129472784|NCT00883493|466025685|FG000|Overall Study|Withdrawal by Subject|11|||
129472785|NCT00883493|466025686|FG001|Overall Study|Withdrawal by Subject|20|||
129472786|NCT00883493|466025685|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
129472787|NCT00883493|466025686|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
129472788|NCT00883493|466025685|FG000|Overall Study|Study specific disc. criteria|2|||
129472789|NCT00883493|466025686|FG001|Overall Study|Study specific disc. criteria|0|||
129472790|NCT00883493|466025685|FG000|Overall Study|Other|5|||
129472791|NCT00883493|466025686|FG001|Overall Study|Other|3|||
129472792|NCT01084551|466025687|FG000|Overall Study|Adverse Event|2|||
129472793|NCT01084551|466025688|FG001|Overall Study|Adverse Event|9|||
129472794|NCT01084551|466025689|FG002|Overall Study|Adverse Event|4|||
129472795|NCT01084551|466025687|FG000|Overall Study|Lack of Efficacy|2|||
129472796|NCT01084551|466025688|FG001|Overall Study|Lack of Efficacy|0|||
129472797|NCT01084551|466025689|FG002|Overall Study|Lack of Efficacy|1|||
129472798|NCT01084551|466025687|FG000|Overall Study|Withdrawal by Subject|2|||
129472799|NCT01084551|466025688|FG001|Overall Study|Withdrawal by Subject|1|||
129472800|NCT01084551|466025689|FG002|Overall Study|Withdrawal by Subject|0|||
129472801|NCT01084551|466025687|FG000|Overall Study|Protocol Violation|2|||
129472802|NCT01084551|466025688|FG001|Overall Study|Protocol Violation|4|||
129472803|NCT01084551|466025689|FG002|Overall Study|Protocol Violation|0|||
129472804|NCT01084551|466025687|FG000|Overall Study|Lost to Follow-up|0|||
129472805|NCT01084551|466025688|FG001|Overall Study|Lost to Follow-up|0|||
129472806|NCT01084551|466025689|FG002|Overall Study|Lost to Follow-up|3|||
129472807|NCT01084551|466025687|FG000|Overall Study|Physician Decision|1|||
129472808|NCT01084551|466025688|FG001|Overall Study|Physician Decision|0|||
129472809|NCT01084551|466025689|FG002|Overall Study|Physician Decision|0|||
129472810|NCT00463476|466025692|FG000|Overall Study|Withdrawal by Subject|1|||
129472811|NCT00463476|466025693|FG001|Overall Study|Withdrawal by Subject|2|||
129472812|NCT00463476|466025692|FG000|Overall Study|Lost to Follow-up|1|||
129472813|NCT00463476|466025693|FG001|Overall Study|Lost to Follow-up|1|||
129472814|NCT01169779|466025698|FG000|Overall Study|Adverse Event|3|||
129472815|NCT01169779|466025699|FG001|Overall Study|Adverse Event|11|||
129472816|NCT01169779|466025698|FG000|Overall Study|Lack of Efficacy|1|||
129472817|NCT01169779|466025699|FG001|Overall Study|Lack of Efficacy|0|||
129472818|NCT01169779|466025698|FG000|Overall Study|Protocol Violation|1|||
129472819|NCT01169779|466025699|FG001|Overall Study|Protocol Violation|1|||
129472820|NCT01169779|466025698|FG000|Overall Study|Withdrawal by Subject|3|||
129472821|NCT01169779|466025699|FG001|Overall Study|Withdrawal by Subject|2|||
129472822|NCT01169779|466025698|FG000|Overall Study|Familial and personal reasons|3|||
129472823|NCT01169779|466025699|FG001|Overall Study|Familial and personal reasons|3|||
129472824|NCT01279057|466025701|FG000|Overall Study|Adverse Event|1|||
129472825|NCT01279057|466025702|FG001|Overall Study|Adverse Event|0|||
129472826|NCT01279057|466025703|FG002|Overall Study|Adverse Event|1|||
129472827|NCT01279057|466025701|FG000|Overall Study|Insufficient therapeutic response|0|||
129472828|NCT01279057|466025702|FG001|Overall Study|Insufficient therapeutic response|0|||
129472829|NCT01279057|466025703|FG002|Overall Study|Insufficient therapeutic response|1|||
129472830|NCT01279057|466025701|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
129472831|NCT01279057|466025702|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
129472832|NCT01279057|466025703|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
129472833|NCT01279057|466025701|FG000|Overall Study|Withdrew consent|2|||
129472834|NCT01279057|466025702|FG001|Overall Study|Withdrew consent|0|||
129472835|NCT01279057|466025703|FG002|Overall Study|Withdrew consent|1|||
129472836|NCT01279057|466025701|FG000|Overall Study|Pregnancy|0|||
129472837|NCT01279057|466025702|FG001|Overall Study|Pregnancy|1|||
129472838|NCT01279057|466025703|FG002|Overall Study|Pregnancy|0|||
129472839|NCT01279057|466025701|FG000|Overall Study|Other|3|||
129472840|NCT01279057|466025702|FG001|Overall Study|Other|3|||
129472841|NCT01279057|466025703|FG002|Overall Study|Other|0|||
129472842|NCT01427309|466025705|FG000|Overall Study|Lost to Follow-up|130|||
129472843|NCT01427309|466025706|FG001|Overall Study|Lost to Follow-up|145|||
129472844|NCT01427309|466025707|FG002|Overall Study|Lost to Follow-up|122|||
129472845|NCT01427309|466025708|FG003|Overall Study|Lost to Follow-up|135|||
129472846|NCT01427309|466025705|FG000|Overall Study|Protocol Violation|42|||
129472847|NCT01427309|466025706|FG001|Overall Study|Protocol Violation|69|||
129472848|NCT01427309|466025707|FG002|Overall Study|Protocol Violation|125|||
129472849|NCT01427309|466025708|FG003|Overall Study|Protocol Violation|124|||
129472850|NCT01427309|466025705|FG000|Overall Study|Adverse Event|0|||
129472851|NCT01427309|466025706|FG001|Overall Study|Adverse Event|0|||
129472852|NCT01427309|466025707|FG002|Overall Study|Adverse Event|3|||
129472853|NCT01427309|466025708|FG003|Overall Study|Adverse Event|1|||
129472854|NCT01427309|466025705|FG000|Overall Study|Serious adverse event|52|||
129472855|NCT01427309|466025706|FG001|Overall Study|Serious adverse event|45|||
129472856|NCT01427309|466025707|FG002|Overall Study|Serious adverse event|50|||
129472857|NCT01427309|466025708|FG003|Overall Study|Serious adverse event|61|||
129472858|NCT01427309|466025705|FG000|Overall Study|Withdrawal by Subject|148|||
129472859|NCT01427309|466025706|FG001|Overall Study|Withdrawal by Subject|148|||
129472860|NCT01427309|466025707|FG002|Overall Study|Withdrawal by Subject|61|||
129472861|NCT01427309|466025708|FG003|Overall Study|Withdrawal by Subject|55|||
129472862|NCT03617705|466025711|FG000|Overall Study|Withdrawal by Subject|2|||
129472863|NCT03617705|466025711|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
129472864|NCT03617705|466025711|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
129472865|NCT01061008|466025712|FG000|Overall Study|Badiocephalic fistula failed|3|||
129472866|NCT01061008|466025713|FG001|Overall Study|Badiocephalic fistula failed|2|||
129472867|NCT01061008|466025712|FG000|Overall Study|Death|1|||
129472868|NCT01061008|466025713|FG001|Overall Study|Death|0|||
129472869|NCT01061008|466025712|FG000|Overall Study|Withdrawal by Subject|1|||
129472870|NCT01061008|466025713|FG001|Overall Study|Withdrawal by Subject|3|||
129472871|NCT01061008|466025712|FG000|Overall Study|Unable to exercise following surgery|1|||
129472872|NCT01061008|466025713|FG001|Overall Study|Unable to exercise following surgery|0|||
129472873|NCT01061008|466025712|FG000|Overall Study|Adverse Event|0|||
129472874|NCT01061008|466025713|FG001|Overall Study|Adverse Event|1|||
129472875|NCT02024971|466025714|FG000|Overall Study|Data Not Available|30|||
129472876|NCT02024971|466025714|FG000|Overall Study|Lost to Follow-up|6|||
129472877|NCT01299727|466025718|FG000|Overall Study|Withdrawal by Subject|1|||
129976171|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
129472878|NCT01299727|466025719|FG001|Overall Study|Withdrawal by Subject|0|||
129976172|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
129976173|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
129472879|NCT01299727|466025720|FG002|Overall Study|Withdrawal by Subject|0|||
129472880|NCT01299727|466025718|FG000|Overall Study|Adverse Event|0|||
129472881|NCT01299727|466025719|FG001|Overall Study|Adverse Event|0|||
129472882|NCT01299727|466025720|FG002|Overall Study|Adverse Event|1|||
129472883|NCT01299727|466025718|FG000|Overall Study|Completed the Treatment Period|3|||
129472884|NCT01299727|466025719|FG001|Overall Study|Completed the Treatment Period|4|||
129472885|NCT01299727|466025720|FG002|Overall Study|Completed the Treatment Period|3|||
129472886|NCT00944034|466025725|FG000|Overall Study|Inappropriate enrollment|0|||
129472887|NCT00944034|466025726|FG001|Overall Study|Inappropriate enrollment|1|||
129472888|NCT00944034|466025727|FG002|Overall Study|Inappropriate enrollment|0|||
129472889|NCT00944034|466025728|FG003|Overall Study|Inappropriate enrollment|1|||
129976174|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
129472890|NCT00944034|466025729|FG004|Overall Study|Inappropriate enrollment|2|||
129472891|NCT00944034|466025730|FG005|Overall Study|Inappropriate enrollment|1|||
129472892|NCT00944034|466025731|FG006|Overall Study|Inappropriate enrollment|0|||
129472893|NCT00944034|466025732|FG007|Overall Study|Inappropriate enrollment|0|||
129472894|NCT00944034|466025733|FG008|Overall Study|Inappropriate enrollment|1|||
129472895|NCT00944034|466025734|FG009|Overall Study|Inappropriate enrollment|1|||
129472896|NCT00944034|466025735|FG010|Overall Study|Inappropriate enrollment|0|||
129472897|NCT00944034|466025736|FG011|Overall Study|Inappropriate enrollment|0|||
129472898|NCT00944034|466025725|FG000|Overall Study|Withdrawal by Subject|3|||
129472899|NCT00944034|466025726|FG001|Overall Study|Withdrawal by Subject|2|||
129472900|NCT00944034|466025727|FG002|Overall Study|Withdrawal by Subject|6|||
129472901|NCT00944034|466025728|FG003|Overall Study|Withdrawal by Subject|2|||
129472902|NCT00944034|466025729|FG004|Overall Study|Withdrawal by Subject|5|||
129472903|NCT00944034|466025730|FG005|Overall Study|Withdrawal by Subject|8|||
129472904|NCT00944034|466025731|FG006|Overall Study|Withdrawal by Subject|2|||
129472905|NCT00944034|466025732|FG007|Overall Study|Withdrawal by Subject|2|||
129472906|NCT00944034|466025733|FG008|Overall Study|Withdrawal by Subject|3|||
129472907|NCT00944034|466025734|FG009|Overall Study|Withdrawal by Subject|4|||
129472908|NCT00944034|466025735|FG010|Overall Study|Withdrawal by Subject|0|||
129472909|NCT00944034|466025736|FG011|Overall Study|Withdrawal by Subject|4|||
129472910|NCT00944034|466025725|FG000|Overall Study|Lost to Follow-up|0|||
129472911|NCT00944034|466025726|FG001|Overall Study|Lost to Follow-up|4|||
129472912|NCT00944034|466025727|FG002|Overall Study|Lost to Follow-up|2|||
129472913|NCT00944034|466025728|FG003|Overall Study|Lost to Follow-up|0|||
129472914|NCT00944034|466025729|FG004|Overall Study|Lost to Follow-up|5|||
129472915|NCT00944034|466025730|FG005|Overall Study|Lost to Follow-up|7|||
129472916|NCT00944034|466025731|FG006|Overall Study|Lost to Follow-up|0|||
129472917|NCT00944034|466025732|FG007|Overall Study|Lost to Follow-up|1|||
129472918|NCT00944034|466025733|FG008|Overall Study|Lost to Follow-up|5|||
129472919|NCT00944034|466025734|FG009|Overall Study|Lost to Follow-up|1|||
129472920|NCT00944034|466025735|FG010|Overall Study|Lost to Follow-up|1|||
129472921|NCT00944034|466025736|FG011|Overall Study|Lost to Follow-up|0|||
129472922|NCT00944034|466025725|FG000|Overall Study|Death|0|||
129472923|NCT00944034|466025726|FG001|Overall Study|Death|0|||
129472924|NCT00944034|466025727|FG002|Overall Study|Death|1|||
129472925|NCT00944034|466025728|FG003|Overall Study|Death|0|||
129472926|NCT00944034|466025729|FG004|Overall Study|Death|0|||
129472927|NCT00944034|466025730|FG005|Overall Study|Death|0|||
129472928|NCT00944034|466025731|FG006|Overall Study|Death|0|||
129472929|NCT00944034|466025732|FG007|Overall Study|Death|0|||
129472930|NCT00944034|466025733|FG008|Overall Study|Death|0|||
129472931|NCT00944034|466025734|FG009|Overall Study|Death|0|||
129472932|NCT00944034|466025735|FG010|Overall Study|Death|0|||
129472933|NCT00944034|466025736|FG011|Overall Study|Death|0|||
129472934|NCT00944034|466025725|FG000|Overall Study|Protocol Violation|2|||
129472935|NCT00944034|466025726|FG001|Overall Study|Protocol Violation|0|||
129472936|NCT00944034|466025727|FG002|Overall Study|Protocol Violation|0|||
129472937|NCT00944034|466025728|FG003|Overall Study|Protocol Violation|1|||
129472938|NCT00944034|466025729|FG004|Overall Study|Protocol Violation|2|||
129472939|NCT00944034|466025730|FG005|Overall Study|Protocol Violation|3|||
129472940|NCT00944034|466025731|FG006|Overall Study|Protocol Violation|0|||
129472941|NCT00944034|466025732|FG007|Overall Study|Protocol Violation|1|||
129472942|NCT00944034|466025733|FG008|Overall Study|Protocol Violation|1|||
129472943|NCT00944034|466025734|FG009|Overall Study|Protocol Violation|4|||
129472944|NCT00944034|466025735|FG010|Overall Study|Protocol Violation|0|||
129472945|NCT00944034|466025736|FG011|Overall Study|Protocol Violation|0|||
129472946|NCT00944034|466025725|FG000|Overall Study|Unable to classify|0|||
129472947|NCT00944034|466025726|FG001|Overall Study|Unable to classify|0|||
129472948|NCT00944034|466025727|FG002|Overall Study|Unable to classify|0|||
129472949|NCT00944034|466025728|FG003|Overall Study|Unable to classify|0|||
129472950|NCT00944034|466025729|FG004|Overall Study|Unable to classify|0|||
129472951|NCT00944034|466025730|FG005|Overall Study|Unable to classify|1|||
129472952|NCT00944034|466025731|FG006|Overall Study|Unable to classify|1|||
129472953|NCT00944034|466025732|FG007|Overall Study|Unable to classify|1|||
129472954|NCT00944034|466025733|FG008|Overall Study|Unable to classify|0|||
129472955|NCT00944034|466025734|FG009|Overall Study|Unable to classify|0|||
129472956|NCT00944034|466025735|FG010|Overall Study|Unable to classify|0|||
129472957|NCT00944034|466025736|FG011|Overall Study|Unable to classify|0|||
129472958|NCT00944034|466025725|FG000|Overall Study|Administrative reason|0|||
129472959|NCT00944034|466025726|FG001|Overall Study|Administrative reason|0|||
129472960|NCT00944034|466025727|FG002|Overall Study|Administrative reason|0|||
129472961|NCT00944034|466025728|FG003|Overall Study|Administrative reason|0|||
129472962|NCT00944034|466025729|FG004|Overall Study|Administrative reason|0|||
129472963|NCT00944034|466025730|FG005|Overall Study|Administrative reason|0|||
129472964|NCT00944034|466025731|FG006|Overall Study|Administrative reason|1|||
129472965|NCT00944034|466025732|FG007|Overall Study|Administrative reason|0|||
129472966|NCT00944034|466025733|FG008|Overall Study|Administrative reason|0|||
129472967|NCT00944034|466025734|FG009|Overall Study|Administrative reason|0|||
129472968|NCT00944034|466025735|FG010|Overall Study|Administrative reason|0|||
129472969|NCT00944034|466025736|FG011|Overall Study|Administrative reason|0|||
129472970|NCT00531960|466025739|FG000|Overall Study|Adverse Event|5|||
129472971|NCT00531960|466025740|FG001|Overall Study|Adverse Event|4|||
129472972|NCT00531960|466025739|FG000|Overall Study|Death|3|||
129472973|NCT00531960|466025740|FG001|Overall Study|Death|2|||
129472974|NCT00531960|466025739|FG000|Overall Study|Lack of Efficacy|42|||
129472975|NCT00531960|466025740|FG001|Overall Study|Lack of Efficacy|41|||
129472976|NCT00531960|466025739|FG000|Overall Study|Violation of Selection Criteria|2|||
129472977|NCT00531960|466025740|FG001|Overall Study|Violation of Selection Criteria|0|||
129472978|NCT00531960|466025739|FG000|Overall Study|Refused Treatment|5|||
129472979|NCT00531960|466025740|FG001|Overall Study|Refused Treatment|6|||
129472980|NCT00531960|466025739|FG000|Overall Study|Other|4|||
129472981|NCT00531960|466025740|FG001|Overall Study|Other|10|||
129472982|NCT01500057|466025741|FG000|Overall Study|Lost to Follow-up|6|||
129472983|NCT01500057|466025742|FG001|Overall Study|Lost to Follow-up|4|||
129472984|NCT00330187|466025750|FG000|Overall Study|Lost to Follow-up|12|||
129472985|NCT00330187|466025751|FG001|Overall Study|Lost to Follow-up|13|||
129472986|NCT00330187|466025752|FG002|Overall Study|Lost to Follow-up|14|||
129472987|NCT00330187|466025753|FG003|Overall Study|Lost to Follow-up|10|||
129472988|NCT00330187|466025750|FG000|Overall Study|Withdrawal by Subject|8|||
129472989|NCT00330187|466025751|FG001|Overall Study|Withdrawal by Subject|5|||
129472990|NCT00330187|466025752|FG002|Overall Study|Withdrawal by Subject|4|||
129472991|NCT00330187|466025753|FG003|Overall Study|Withdrawal by Subject|4|||
129472992|NCT03258814|466025754|FG000|Overall Study|Early Termination|4|||
129472993|NCT03258814|466025755|FG001|Overall Study|Early Termination|3|||
129472994|NCT03258814|466025756|FG002|Overall Study|Early Termination|10|||
129472995|NCT01413958|466025757|FG000|Overall Study|Lost to Follow-up|0|||
129472996|NCT01413958|466025758|FG001|Overall Study|Lost to Follow-up|1|||
129472997|NCT01900002|466025759|FG000|Overall Study|Withdrawal by Subject|2|||
129472998|NCT01900002|466025759|FG000|Overall Study|ineligible for Y-90|4|||
129472999|NCT01573910|466025766|FG000|Overall Study|Adverse Event|4|||
129473000|NCT01573910|466025767|FG001|Overall Study|Adverse Event|4|||
129473001|NCT01573910|466025766|FG000|Overall Study|Lost to Follow-up|2|||
129473002|NCT01573910|466025767|FG001|Overall Study|Lost to Follow-up|1|||
129473003|NCT01573910|466025766|FG000|Overall Study|Withdrawal by Subject|0|||
129473004|NCT01573910|466025767|FG001|Overall Study|Withdrawal by Subject|1|||
129473005|NCT01573910|466025766|FG000|Overall Study|Protocol Violation|3|||
129473006|NCT01573910|466025767|FG001|Overall Study|Protocol Violation|0|||
129473007|NCT01573910|466025766|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
129473008|NCT01573910|466025767|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
129473009|NCT02601573|466025777|FG000|Overall Study|Lost to Follow-up|0|||
129473010|NCT02601573|466025778|FG001|Overall Study|Lost to Follow-up|3|||
129473011|NCT02601573|466025779|FG002|Overall Study|Lost to Follow-up|1|||
129473012|NCT02601573|466025780|FG003|Overall Study|Lost to Follow-up|0|||
129473013|NCT02601573|466025781|FG004|Overall Study|Lost to Follow-up|2|||
129473014|NCT02601573|466025777|FG000|Overall Study|Withdrawal by Subject|0|||
129473015|NCT02601573|466025778|FG001|Overall Study|Withdrawal by Subject|1|||
129473016|NCT02601573|466025779|FG002|Overall Study|Withdrawal by Subject|0|||
129473017|NCT02601573|466025780|FG003|Overall Study|Withdrawal by Subject|1|||
129473018|NCT02601573|466025781|FG004|Overall Study|Withdrawal by Subject|0|||
129473019|NCT00974220|466025782|FG000|Treatment Period 1|Adverse Event|2|||
129473020|NCT00974220|466025783|FG001|Treatment Period 1|Adverse Event|1|||
129473021|NCT00974220|466025782|FG000|Treatment Period 1|noncompliant subjects|0|||
129473022|NCT00974220|466025783|FG001|Treatment Period 1|noncompliant subjects|1|||
129473023|NCT01763164|466025784|FG000|Treatment Phase|Participant/Guardian decision|26|||
129473024|NCT01763164|466025785|FG001|Treatment Phase|Participant/Guardian decision|14|||
129473025|NCT01763164|466025784|FG000|Treatment Phase|Protocol Violation|1|||
129473026|NCT01763164|466025785|FG001|Treatment Phase|Protocol Violation|1|||
129473027|NCT01763164|466025784|FG000|Treatment Phase|Progressive Disease|142|||
129473028|NCT01763164|466025785|FG001|Treatment Phase|Progressive Disease|76|||
129473029|NCT01763164|466025784|FG000|Treatment Phase|Physician Decision|24|||
129473030|NCT01763164|466025785|FG001|Treatment Phase|Physician Decision|13|||
129473031|NCT01763164|466025784|FG000|Treatment Phase|Death|10|||
129473032|NCT01763164|466025785|FG001|Treatment Phase|Death|1|||
129473033|NCT01763164|466025784|FG000|Treatment Phase|Adverse Event|66|||
129976175|NCT00477490|467875773|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
129473034|NCT01763164|466025785|FG001|Treatment Phase|Adverse Event|8|||
129473035|NCT01763164|466025784|FG000|Treatment Phase|Randomized but not Treated|0|||
129473036|NCT01763164|466025785|FG001|Treatment Phase|Randomized but not Treated|19|||
129473037|NCT01763164|466025784|FG000|Treatment Phase|Other|0|||
129473038|NCT01763164|466025785|FG001|Treatment Phase|Other|1|||
129473039|NCT01763164|466025784|FG000|Follow up Phase|New therapy for study indication|12|||
129473040|NCT01763164|466025785|FG001|Follow up Phase|New therapy for study indication|3|||
129473041|NCT01763164|466025784|FG000|Follow up Phase|Death|21|||
129473042|NCT01763164|466025785|FG001|Follow up Phase|Death|4|||
129473043|NCT01763164|466025784|FG000|Follow up Phase|Subject/guardian decision|9|||
129473044|NCT01763164|466025785|FG001|Follow up Phase|Subject/guardian decision|2|||
129473045|NCT01763164|466025784|FG000|Follow up Phase|Progressive disease|127|||
129473046|NCT01763164|466025785|FG001|Follow up Phase|Progressive disease|62|||
129473047|NCT01763164|466025784|FG000|Follow up Phase|Physician Decision|10|||
129473048|NCT01763164|466025785|FG001|Follow up Phase|Physician Decision|3|||
129473049|NCT01763164|466025784|FG000|Follow up Phase|Lost to Follow-up|1|||
129473050|NCT01763164|466025785|FG001|Follow up Phase|Lost to Follow-up|0|||
129473051|NCT01763164|466025784|FG000|Follow up Phase|Adverse Event|17|||
129473052|NCT01763164|466025785|FG001|Follow up Phase|Adverse Event|1|||
129473053|NCT01273064|466025788|FG000|Overall Study|Adverse Event|5|||
129473054|NCT01273064|466025789|FG001|Overall Study|Adverse Event|1|||
129473055|NCT01273064|466025790|FG002|Overall Study|Adverse Event|3|||
129473056|NCT01273064|466025791|FG003|Overall Study|Adverse Event|2|||
129473057|NCT01273064|466025792|FG004|Overall Study|Adverse Event|1|||
129473058|NCT01273064|466025788|FG000|Overall Study|Withdrawal by Subject|4|||
129473059|NCT01273064|466025789|FG001|Overall Study|Withdrawal by Subject|2|||
129473060|NCT01273064|466025790|FG002|Overall Study|Withdrawal by Subject|2|||
129473061|NCT01273064|466025791|FG003|Overall Study|Withdrawal by Subject|2|||
129473062|NCT01273064|466025792|FG004|Overall Study|Withdrawal by Subject|0|||
129473063|NCT01273064|466025788|FG000|Overall Study|Study Termination|13|||
129473064|NCT01273064|466025789|FG001|Overall Study|Study Termination|27|||
129473065|NCT01273064|466025790|FG002|Overall Study|Study Termination|26|||
129473066|NCT01273064|466025791|FG003|Overall Study|Study Termination|16|||
129473067|NCT01273064|466025792|FG004|Overall Study|Study Termination|8|||
129473068|NCT01273064|466025788|FG000|Overall Study|Lost to Follow-up|1|||
129473069|NCT01273064|466025789|FG001|Overall Study|Lost to Follow-up|0|||
129473070|NCT01273064|466025790|FG002|Overall Study|Lost to Follow-up|0|||
129473071|NCT01273064|466025791|FG003|Overall Study|Lost to Follow-up|0|||
129473072|NCT01273064|466025792|FG004|Overall Study|Lost to Follow-up|0|||
129473073|NCT01273064|466025788|FG000|Overall Study|Physician Decision|0|||
129473074|NCT01273064|466025789|FG001|Overall Study|Physician Decision|0|||
129473075|NCT01273064|466025790|FG002|Overall Study|Physician Decision|0|||
129473076|NCT01273064|466025791|FG003|Overall Study|Physician Decision|0|||
129473077|NCT01273064|466025792|FG004|Overall Study|Physician Decision|1|||
129473078|NCT00291551|466025793|FG000|Overall Study|Death|7|||
129473079|NCT00291551|466025793|FG000|Overall Study|Withdrawal by Subject|6|||
129473080|NCT02658812|466025794|FG000|Overall Study|Disease Progression|7|||
129473081|NCT02658812|466025794|FG000|Overall Study|Unrelated to study treatment|1|||
129473082|NCT02658812|466025794|FG000|Overall Study|Adverse Event|1|||
129473083|NCT01512264|466025795|FG000|Overall Study|Lost to Follow-up|0|||
129473084|NCT01512264|466025796|FG001|Overall Study|Lost to Follow-up|0|||
129473085|NCT01512264|466025797|FG002|Overall Study|Lost to Follow-up|0|||
129473086|NCT01512264|466025798|FG003|Overall Study|Lost to Follow-up|1|||
129473087|NCT02411747|466025799|FG000|Overall Study|Withdrawal by Subject|1|||
129473088|NCT02411747|466025800|FG001|Overall Study|Withdrawal by Subject|0|||
129473089|NCT02411747|466025799|FG000|Overall Study|Protocol Violation|2|||
129473090|NCT02411747|466025800|FG001|Overall Study|Protocol Violation|4|||
129473091|NCT00996203|466025801|FG000|Overall Study|Adverse Event|3|||
129473092|NCT00996203|466025801|FG000|Overall Study|Lost to Follow-up|1|||
129473093|NCT00996203|466025801|FG000|Overall Study|Lack of Efficacy|1|||
129473094|NCT00996203|466025801|FG000|Overall Study|Protocol Violation|2|||
129473095|NCT03686969|466025803|FG000|Overall Study|Study terminated|1|||
129473096|NCT03686969|466025804|FG001|Overall Study|Study terminated|0|||
129473097|NCT00848120|466025805|FG000|Overall Study|Adverse Event|1|||
129473098|NCT00560755|466025806|FG000|Overall Study|Protocol Violation|15|||
129473099|NCT00560755|466025806|FG000|Overall Study|Withdrawal by Subject|26|||
129473100|NCT00560755|466025806|FG000|Overall Study|Lost to Follow-up|9|||
129473101|NCT00560755|466025806|FG000|Overall Study|Adverse Event|8|||
129473102|NCT00560755|466025806|FG000|Overall Study|Physician Decision|2|||
129473103|NCT01988090|466025812|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
129473104|NCT01988090|466025813|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
129473105|NCT01988090|466025812|FG000|Start Treament After Randomization|Protocol Violation|0|||
129473106|NCT01988090|466025813|FG001|Start Treament After Randomization|Protocol Violation|1|||
129473107|NCT01988090|466025812|FG000|Complete Study After Start|Withdrawal by Subject|2|||
129473108|NCT01988090|466025813|FG001|Complete Study After Start|Withdrawal by Subject|0|||
129473109|NCT01988090|466025812|FG000|Complete Study After Start|Protocol Violation|1|||
129473110|NCT01988090|466025813|FG001|Complete Study After Start|Protocol Violation|1|||
129473111|NCT01439945|466025818|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
129473112|NCT01439945|466025819|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
129473113|NCT01439945|466025820|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
129473114|NCT01439945|466025821|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
129473115|NCT01439945|466025818|FG000|Double-Blind Treatment Phase|Ineligible|1|||
129473116|NCT01439945|466025819|FG001|Double-Blind Treatment Phase|Ineligible|2|||
129473117|NCT01439945|466025820|FG002|Double-Blind Treatment Phase|Ineligible|0|||
129473118|NCT01439945|466025821|FG003|Double-Blind Treatment Phase|Ineligible|1|||
129473119|NCT00705263|466025822|FG000|Overall Study|Withdrawal by Subject|2|||
129473120|NCT01752023|466025823|FG000|Overall Study|Physician Decision|2|||
129473121|NCT01752023|466025824|FG001|Overall Study|Physician Decision|1|||
129473122|NCT01292057|466025830|FG000|Overall Study|Protocol Violation|1|||
129473123|NCT01292057|466025831|FG001|Overall Study|Protocol Violation|1|||
129473124|NCT01292057|466025830|FG000|Overall Study|Lost to Follow-up|1|||
129473125|NCT01292057|466025831|FG001|Overall Study|Lost to Follow-up|1|||
129473126|NCT01506882|466025834|FG000|Overall Study|Lack of Efficacy|4|||
129473127|NCT01506882|466025835|FG001|Overall Study|Lack of Efficacy|3|||
129473128|NCT01506882|466025834|FG000|Overall Study|Lost to Follow-up|1|||
129473129|NCT01506882|466025835|FG001|Overall Study|Lost to Follow-up|0|||
129473130|NCT01506882|466025834|FG000|Overall Study|Withdrawal by Subject|9|||
129473131|NCT01506882|466025835|FG001|Overall Study|Withdrawal by Subject|3|||
129473132|NCT01506882|466025834|FG000|Overall Study|SAE, non-fatal|2|||
129473133|NCT01506882|466025835|FG001|Overall Study|SAE, non-fatal|0|||
129473134|NCT01506882|466025834|FG000|Overall Study|AE, non-serious non-fatal|3|||
129473135|NCT01506882|466025835|FG001|Overall Study|AE, non-serious non-fatal|1|||
129473136|NCT01506882|466025834|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
129473137|NCT01506882|466025835|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
129473138|NCT01506882|466025834|FG000|Overall Study|Other Reason|2|||
129473139|NCT01506882|466025835|FG001|Overall Study|Other Reason|0|||
129473140|NCT00821678|466025840|FG000|Overall Study|Withdrawal by Subject|8|||
129473141|NCT00821678|466025841|FG001|Overall Study|Withdrawal by Subject|0|||
129473142|NCT00821678|466025840|FG000|Overall Study|Lost to Follow-up|13|||
129473143|NCT00821678|466025841|FG001|Overall Study|Lost to Follow-up|12|||
129473144|NCT00821678|466025840|FG000|Overall Study|Death|0|||
129473145|NCT00821678|466025841|FG001|Overall Study|Death|2|||
129473146|NCT00376961|466027761|FG000|Initial Registration|Adverse Event|1|||
129473147|NCT00376961|466027762|FG001|Initial Registration|Adverse Event|0|||
129473148|NCT00376961|466027761|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
129473149|NCT00376961|466027762|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
129473150|NCT00376961|466027761|FG000|Initial Registration|Progression/relapse|1|||
129473151|NCT00376961|466027762|FG001|Initial Registration|Progression/relapse|0|||
129473152|NCT00376961|466027761|FG000|Initial Registration|Ineligible|3|||
129473153|NCT00376961|466027762|FG001|Initial Registration|Ineligible|0|||
129473154|NCT00376961|466027761|FG000|Maintenance|Adverse Event|0|||
129473155|NCT00376961|466027762|FG001|Maintenance|Adverse Event|1|||
129473156|NCT00376961|466027761|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
129473157|NCT00376961|466027762|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
129473158|NCT00376961|466027761|FG000|Maintenance|Progression/relapse|0|||
129473159|NCT00376961|466027762|FG001|Maintenance|Progression/relapse|18|||
129473160|NCT00376961|466027761|FG000|Maintenance|Ineligible|0|||
129473161|NCT00376961|466027762|FG001|Maintenance|Ineligible|3|||
129473162|NCT01059448|466027764|FG000|Overall Study|Adverse Event|1|||
129473163|NCT01059448|466027765|FG001|Overall Study|Adverse Event|3|||
129473164|NCT01059448|466027766|FG002|Overall Study|Adverse Event|0|||
129473165|NCT01059448|466027767|FG003|Overall Study|Adverse Event|1|||
129473166|NCT01059448|466027764|FG000|Overall Study|Withdrawal by Subject|2|||
129473167|NCT01059448|466027765|FG001|Overall Study|Withdrawal by Subject|0|||
129473168|NCT01059448|466027766|FG002|Overall Study|Withdrawal by Subject|2|||
129473169|NCT01059448|466027767|FG003|Overall Study|Withdrawal by Subject|4|||
129473170|NCT01059448|466027764|FG000|Overall Study|Disease Progression|2|||
129473171|NCT01059448|466027765|FG001|Overall Study|Disease Progression|1|||
129473172|NCT01059448|466027766|FG002|Overall Study|Disease Progression|4|||
129473173|NCT01059448|466027767|FG003|Overall Study|Disease Progression|2|||
129473174|NCT01059448|466027764|FG000|Overall Study|Administrative Decision|43|||
129473175|NCT01059448|466027765|FG001|Overall Study|Administrative Decision|49|||
129473176|NCT01059448|466027766|FG002|Overall Study|Administrative Decision|45|||
129473177|NCT01059448|466027767|FG003|Overall Study|Administrative Decision|46|||
129473178|NCT01059448|466027764|FG000|Overall Study|Lost to Follow-up|0|||
129473179|NCT01059448|466027765|FG001|Overall Study|Lost to Follow-up|0|||
129473180|NCT01059448|466027766|FG002|Overall Study|Lost to Follow-up|2|||
129473181|NCT01059448|466027767|FG003|Overall Study|Lost to Follow-up|0|||
129473182|NCT01059448|466027764|FG000|Overall Study|Death|0|||
129976176|NCT00477490|467875774|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
129976177|NCT00477490|467875775|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
129976178|NCT00477490|467875776|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
129976179|NCT00477490|467875777|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
129976180|NCT00477490|467875778|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
129976181|NCT00477490|467875779|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
129473183|NCT01059448|466027765|FG001|Overall Study|Death|1|||
129473184|NCT01059448|466027766|FG002|Overall Study|Death|0|||
129473185|NCT01059448|466027767|FG003|Overall Study|Death|0|||
129473186|NCT01059448|466027764|FG000|Overall Study|Other|1|||
129473187|NCT01059448|466027765|FG001|Overall Study|Other|1|||
129473188|NCT01059448|466027766|FG002|Overall Study|Other|0|||
129473189|NCT01059448|466027767|FG003|Overall Study|Other|1|||
129976182|NCT00477490|467875780|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
129976183|NCT00477490|467875781|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
129473190|NCT02591615|466027768|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
129473191|NCT02591615|466027769|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
129473192|NCT02591615|466027770|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
129473193|NCT02591615|466027771|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
129473194|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
129473195|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
129473196|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
129473197|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
129473198|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
129473199|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
129473200|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
129473201|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
129473202|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
129473203|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
129473204|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
129473205|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
129473206|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
129473207|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
129473208|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
129473209|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
129473210|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
129473211|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
129473212|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
129473213|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
129473214|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
129473215|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
129473216|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
129473217|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
129473218|NCT02591615|466027768|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
129473219|NCT02591615|466027769|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
129473220|NCT02591615|466027770|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
129473221|NCT02591615|466027771|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
129473222|NCT02591615|466027768|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
129473223|NCT02591615|466027769|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
129473224|NCT02591615|466027770|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
129473225|NCT02591615|466027771|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
129473226|NCT02591615|466027768|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
129473227|NCT02591615|466027769|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
129976184|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
129976185|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
129976186|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
129976187|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
129976188|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
129976189|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
129976190|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
129976191|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
129976192|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
129473228|NCT02591615|466027770|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
129473229|NCT02591615|466027771|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
129473230|NCT02591615|466027768|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
129473231|NCT02591615|466027769|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
129473232|NCT02591615|466027770|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
129473233|NCT02591615|466027771|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
129473234|NCT02591615|466027768|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
129473235|NCT02591615|466027769|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
129473236|NCT02591615|466027770|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
129473237|NCT02591615|466027771|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
129473238|NCT02591615|466027768|FG000|Maintenance MK-3475|Adverse Event|0|||
129473239|NCT02591615|466027769|FG001|Maintenance MK-3475|Adverse Event|3|||
129976193|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
129976194|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
129976195|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
129473240|NCT02591615|466027770|FG002|Maintenance MK-3475|Adverse Event|1|||
129473241|NCT02591615|466027771|FG003|Maintenance MK-3475|Adverse Event|2|||
129473242|NCT02591615|466027768|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
129473243|NCT02591615|466027769|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
129473244|NCT02591615|466027770|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
129473245|NCT02591615|466027771|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
129473246|NCT02591615|466027768|FG000|Maintenance MK-3475|Death|0|||
129473247|NCT02591615|466027769|FG001|Maintenance MK-3475|Death|1|||
129473248|NCT02591615|466027770|FG002|Maintenance MK-3475|Death|1|||
129473249|NCT02591615|466027771|FG003|Maintenance MK-3475|Death|0|||
129473250|NCT02591615|466027768|FG000|Maintenance MK-3475|Physician discretion|0|||
129473251|NCT02591615|466027769|FG001|Maintenance MK-3475|Physician discretion|0|||
129473252|NCT02591615|466027770|FG002|Maintenance MK-3475|Physician discretion|1|||
129473253|NCT02591615|466027771|FG003|Maintenance MK-3475|Physician discretion|0|||
129473254|NCT02591615|466027768|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
129473255|NCT02591615|466027769|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
129473256|NCT02591615|466027770|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
129473257|NCT02591615|466027771|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
129473258|NCT02591615|466027768|FG000|Maintenance MK-3475|In active treatment|2|||
129473259|NCT02591615|466027769|FG001|Maintenance MK-3475|In active treatment|0|||
129473260|NCT02591615|466027770|FG002|Maintenance MK-3475|In active treatment|0|||
129473261|NCT02591615|466027771|FG003|Maintenance MK-3475|In active treatment|1|||
129473262|NCT00809328|466027772|FG000|Overall Study|Lack of Efficacy|18|||
129473263|NCT00809328|466027772|FG000|Overall Study|Adverse Event|6|||
129473264|NCT00809328|466027772|FG000|Overall Study|Protocol Violation|3|||
129473265|NCT00809328|466027772|FG000|Overall Study|Withdrawal by Subject|2|||
129473266|NCT06441877|466027775|FG000|Overall Study|Withdrawal by Subject|0|||
129473267|NCT06441877|466027776|FG001|Overall Study|Withdrawal by Subject|2|||
129473268|NCT06441877|466027777|FG002|Overall Study|Withdrawal by Subject|0|||
129473269|NCT06441877|466027778|FG003|Overall Study|Withdrawal by Subject|0|||
129473270|NCT00066690|466027779|FG000|Overall Study|Adverse Event|145|||
129473271|NCT00066690|466027780|FG001|Overall Study|Adverse Event|58|||
129473272|NCT00066690|466027781|FG002|Overall Study|Adverse Event|126|||
129473273|NCT00066690|466027779|FG000|Overall Study|Death|3|||
129473274|NCT00066690|466027780|FG001|Overall Study|Death|0|||
129473275|NCT00066690|466027781|FG002|Overall Study|Death|2|||
129473276|NCT00066690|466027779|FG000|Overall Study|Lack of Efficacy|114|||
129473277|NCT00066690|466027780|FG001|Overall Study|Lack of Efficacy|110|||
129473278|NCT00066690|466027781|FG002|Overall Study|Lack of Efficacy|76|||
129473279|NCT00066690|466027779|FG000|Overall Study|Lost to Follow-up|40|||
129473280|NCT00066690|466027780|FG001|Overall Study|Lost to Follow-up|21|||
129473281|NCT00066690|466027781|FG002|Overall Study|Lost to Follow-up|29|||
129473282|NCT00066690|466027779|FG000|Overall Study|Withdrawal by Subject|50|||
129473283|NCT00066690|466027780|FG001|Overall Study|Withdrawal by Subject|55|||
129473284|NCT00066690|466027781|FG002|Overall Study|Withdrawal by Subject|49|||
129473285|NCT00066690|466027779|FG000|Overall Study|Treatment Ongoing|246|||
129473286|NCT00066690|466027780|FG001|Overall Study|Treatment Ongoing|278|||
129473287|NCT00066690|466027781|FG002|Overall Study|Treatment Ongoing|282|||
129473288|NCT03706365|466027785|FG000|Overall Study|Lost to Follow-up|7|||
129473289|NCT03706365|466027786|FG001|Overall Study|Lost to Follow-up|0|||
129473290|NCT03706365|466027785|FG000|Overall Study|Withdrawal by Subject|17|||
129473291|NCT03706365|466027786|FG001|Overall Study|Withdrawal by Subject|15|||
129473292|NCT03706365|466027785|FG000|Overall Study|On Study Treatment|51|||
129473293|NCT03706365|466027786|FG001|Overall Study|On Study Treatment|51|||
129473294|NCT03116113|466027787|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473295|NCT03116113|466027788|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473296|NCT03116113|466027789|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473297|NCT03116113|466027790|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473298|NCT03116113|466027791|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473299|NCT03116113|466027792|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473300|NCT03116113|466027793|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
129473301|NCT03116113|466027794|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
129473302|NCT03116113|466027795|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
129473303|NCT02159807|466027796|FG000|Overall Study|Adverse Event|0|||
129473304|NCT02159807|466027797|FG001|Overall Study|Adverse Event|0|||
129473305|NCT02159807|466027798|FG002|Overall Study|Adverse Event|1|||
129473306|NCT02159807|466027796|FG000|Overall Study|No CSF|1|||
129473307|NCT02159807|466027797|FG001|Overall Study|No CSF|1|||
129473308|NCT02159807|466027798|FG002|Overall Study|No CSF|1|||
129976196|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129976197|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129976198|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129473309|NCT02159807|466027796|FG000|Overall Study|elevated blood pressure|0|||
129473310|NCT02159807|466027797|FG001|Overall Study|elevated blood pressure|0|||
129473311|NCT02159807|466027798|FG002|Overall Study|elevated blood pressure|1|||
129473312|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
129473313|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
129473314|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
129473315|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
129976199|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129473316|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
129473317|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
129473318|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
129473319|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
129473320|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129473321|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
129473322|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129473323|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
129473324|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
129473325|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129473326|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129473327|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
129473328|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
129473329|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
129473330|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
129473331|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
129473332|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
129473333|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
129473334|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
129473335|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
129473336|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
129473337|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
129473338|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
129473339|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
129473340|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
129473341|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
129473342|NCT05195528|466027800|FG000|Placebo-controlled Treatment Period|Other|0|||
129473343|NCT05195528|466027801|FG001|Placebo-controlled Treatment Period|Other|0|||
129473344|NCT05195528|466027802|FG002|Placebo-controlled Treatment Period|Other|1|||
129473345|NCT05195528|466027803|FG003|Placebo-controlled Treatment Period|Other|0|||
129473346|NCT05195528|466027804|FG004|Placebo-controlled Treatment Period|Other|0|||
129473347|NCT05195528|466027800|FG000|Extension Period|PTE or AE or SAE|0|||
129473348|NCT05195528|466027801|FG001|Extension Period|PTE or AE or SAE|4|||
129473349|NCT05195528|466027802|FG002|Extension Period|PTE or AE or SAE|5|||
129473350|NCT05195528|466027803|FG003|Extension Period|PTE or AE or SAE|4|||
129473351|NCT05195528|466027804|FG004|Extension Period|PTE or AE or SAE|4|||
129473352|NCT05195528|466027800|FG000|Extension Period|Protocol Violation|0|||
129473353|NCT05195528|466027801|FG001|Extension Period|Protocol Violation|2|||
129473354|NCT05195528|466027802|FG002|Extension Period|Protocol Violation|1|||
129473355|NCT05195528|466027803|FG003|Extension Period|Protocol Violation|0|||
129473356|NCT05195528|466027804|FG004|Extension Period|Protocol Violation|1|||
129473357|NCT05195528|466027800|FG000|Extension Period|Lost to Follow-up|0|||
129473358|NCT05195528|466027801|FG001|Extension Period|Lost to Follow-up|6|||
129473359|NCT05195528|466027802|FG002|Extension Period|Lost to Follow-up|13|||
129473360|NCT05195528|466027803|FG003|Extension Period|Lost to Follow-up|3|||
129473361|NCT05195528|466027804|FG004|Extension Period|Lost to Follow-up|7|||
129473362|NCT05195528|466027800|FG000|Extension Period|Withdrawal by Subject|0|||
129473363|NCT05195528|466027801|FG001|Extension Period|Withdrawal by Subject|12|||
129473364|NCT05195528|466027802|FG002|Extension Period|Withdrawal by Subject|9|||
129473365|NCT05195528|466027803|FG003|Extension Period|Withdrawal by Subject|6|||
129473366|NCT05195528|466027804|FG004|Extension Period|Withdrawal by Subject|5|||
129473367|NCT05195528|466027800|FG000|Extension Period|Lack of Efficacy|0|||
129473368|NCT05195528|466027801|FG001|Extension Period|Lack of Efficacy|3|||
129473369|NCT05195528|466027802|FG002|Extension Period|Lack of Efficacy|0|||
129473370|NCT05195528|466027803|FG003|Extension Period|Lack of Efficacy|0|||
129473371|NCT05195528|466027804|FG004|Extension Period|Lack of Efficacy|2|||
129473372|NCT05195528|466027800|FG000|Extension Period|Not Treated|0|||
129473373|NCT05195528|466027801|FG001|Extension Period|Not Treated|0|||
129473374|NCT05195528|466027802|FG002|Extension Period|Not Treated|2|||
129473375|NCT05195528|466027803|FG003|Extension Period|Not Treated|3|||
129473376|NCT05195528|466027804|FG004|Extension Period|Not Treated|0|||
129473377|NCT05195528|466027800|FG000|Extension Period|Other|0|||
129473378|NCT05195528|466027801|FG001|Extension Period|Other|1|||
129473379|NCT05195528|466027802|FG002|Extension Period|Other|1|||
129473380|NCT05195528|466027803|FG003|Extension Period|Other|0|||
129473381|NCT05195528|466027804|FG004|Extension Period|Other|0|||
129473382|NCT01552902|466027805|FG000|Overall Study|Adverse Event|1|||
129473383|NCT01552902|466027806|FG001|Overall Study|Adverse Event|15|||
129473384|NCT01552902|466027807|FG002|Overall Study|Adverse Event|14|||
129473385|NCT01552902|466027805|FG000|Overall Study|Protocol Violation|3|||
129473386|NCT01552902|466027806|FG001|Overall Study|Protocol Violation|3|||
129473387|NCT01552902|466027807|FG002|Overall Study|Protocol Violation|3|||
129473388|NCT01552902|466027805|FG000|Overall Study|Lack of Efficacy|4|||
129976200|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
129473389|NCT01552902|466027806|FG001|Overall Study|Lack of Efficacy|3|||
129473390|NCT01552902|466027807|FG002|Overall Study|Lack of Efficacy|1|||
129473391|NCT01552902|466027805|FG000|Overall Study|Withdrawal by Subject|1|||
129473392|NCT01552902|466027806|FG001|Overall Study|Withdrawal by Subject|9|||
129473393|NCT01552902|466027807|FG002|Overall Study|Withdrawal by Subject|6|||
129473394|NCT01552902|466027805|FG000|Overall Study|Lost to Follow-up|1|||
129473395|NCT01552902|466027806|FG001|Overall Study|Lost to Follow-up|3|||
129473396|NCT01552902|466027807|FG002|Overall Study|Lost to Follow-up|6|||
129473397|NCT01552902|466027805|FG000|Overall Study|Other|3|||
129473398|NCT01552902|466027806|FG001|Overall Study|Other|4|||
129473399|NCT01552902|466027807|FG002|Overall Study|Other|3|||
129473400|NCT02487108|466027813|FG000|Overall Study|Adverse Event|1|||
129473401|NCT02487108|466027814|FG001|Overall Study|Adverse Event|6|||
129473402|NCT02487108|466027815|FG002|Overall Study|Adverse Event|12|||
129473403|NCT02487108|466027816|FG003|Overall Study|Adverse Event|6|||
129473404|NCT02487108|466027813|FG000|Overall Study|Withdrawal by Subject|8|||
129473405|NCT02487108|466027814|FG001|Overall Study|Withdrawal by Subject|5|||
129473406|NCT02487108|466027815|FG002|Overall Study|Withdrawal by Subject|5|||
129473407|NCT02487108|466027816|FG003|Overall Study|Withdrawal by Subject|0|||
129473408|NCT02487108|466027813|FG000|Overall Study|Non-compliance to study medication|3|||
129473409|NCT02487108|466027814|FG001|Overall Study|Non-compliance to study medication|2|||
129473410|NCT02487108|466027815|FG002|Overall Study|Non-compliance to study medication|5|||
129473411|NCT02487108|466027816|FG003|Overall Study|Non-compliance to study medication|4|||
129473412|NCT02487108|466027813|FG000|Overall Study|Protocol Violation|1|||
129473413|NCT02487108|466027814|FG001|Overall Study|Protocol Violation|1|||
129473414|NCT02487108|466027815|FG002|Overall Study|Protocol Violation|2|||
129473415|NCT02487108|466027816|FG003|Overall Study|Protocol Violation|0|||
129473416|NCT02487108|466027813|FG000|Overall Study|Non-compliance to study procedures|0|||
129473417|NCT02487108|466027814|FG001|Overall Study|Non-compliance to study procedures|0|||
129473418|NCT02487108|466027815|FG002|Overall Study|Non-compliance to study procedures|0|||
129473419|NCT02487108|466027816|FG003|Overall Study|Non-compliance to study procedures|1|||
129473420|NCT02487108|466027813|FG000|Overall Study|Other than specified|3|||
129473421|NCT02487108|466027814|FG001|Overall Study|Other than specified|2|||
129473422|NCT02487108|466027815|FG002|Overall Study|Other than specified|2|||
129473423|NCT02487108|466027816|FG003|Overall Study|Other than specified|0|||
129473424|NCT02367521|466027817|FG000|Overall Study|severe headache after intervention|2|||
129473425|NCT02367521|466027818|FG001|Overall Study|severe headache after intervention|0|||
129473426|NCT02367521|466027817|FG000|Overall Study|unable to find transportation|2|||
129473427|NCT02367521|466027818|FG001|Overall Study|unable to find transportation|0|||
129473428|NCT00600171|466027819|FG000|Overall Study|Adverse Event|0|||
129473429|NCT00600171|466027820|FG001|Overall Study|Adverse Event|1|||
129473430|NCT00600171|466027821|FG002|Overall Study|Adverse Event|0|||
129473431|NCT00600171|466027822|FG003|Overall Study|Adverse Event|0|||
129473432|NCT00600171|466027823|FG004|Overall Study|Adverse Event|1|||
129473433|NCT00600171|466027824|FG005|Overall Study|Adverse Event|0|||
129473434|NCT00600171|466027819|FG000|Overall Study|Lack of Efficacy|9|||
129473435|NCT00600171|466027820|FG001|Overall Study|Lack of Efficacy|12|||
129473436|NCT00600171|466027821|FG002|Overall Study|Lack of Efficacy|3|||
129473437|NCT00600171|466027822|FG003|Overall Study|Lack of Efficacy|5|||
129473438|NCT00600171|466027823|FG004|Overall Study|Lack of Efficacy|4|||
129473439|NCT00600171|466027824|FG005|Overall Study|Lack of Efficacy|0|||
129473440|NCT00600171|466027819|FG000|Overall Study|Protocol Violation|1|||
129473441|NCT00600171|466027820|FG001|Overall Study|Protocol Violation|2|||
129473442|NCT00600171|466027821|FG002|Overall Study|Protocol Violation|0|||
129473443|NCT00600171|466027822|FG003|Overall Study|Protocol Violation|1|||
129473444|NCT00600171|466027823|FG004|Overall Study|Protocol Violation|0|||
129473445|NCT00600171|466027824|FG005|Overall Study|Protocol Violation|0|||
129473446|NCT00600171|466027819|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
129473447|NCT00600171|466027820|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129473448|NCT00600171|466027821|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
129473449|NCT00600171|466027822|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
129473450|NCT00600171|466027823|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
129976201|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
129473451|NCT00600171|466027824|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
129473452|NCT00600171|466027819|FG000|Overall Study|Withdrawal by Subject|3|||
129473453|NCT00600171|466027820|FG001|Overall Study|Withdrawal by Subject|0|||
129473454|NCT00600171|466027821|FG002|Overall Study|Withdrawal by Subject|0|||
129473455|NCT00600171|466027822|FG003|Overall Study|Withdrawal by Subject|1|||
129473456|NCT00600171|466027823|FG004|Overall Study|Withdrawal by Subject|1|||
129473457|NCT00600171|466027824|FG005|Overall Study|Withdrawal by Subject|1|||
129473458|NCT00600171|466027819|FG000|Overall Study|Physician Decision|0|||
129473459|NCT00600171|466027820|FG001|Overall Study|Physician Decision|1|||
129473460|NCT00600171|466027821|FG002|Overall Study|Physician Decision|0|||
129473461|NCT00600171|466027822|FG003|Overall Study|Physician Decision|1|||
129473462|NCT00600171|466027823|FG004|Overall Study|Physician Decision|0|||
129473463|NCT00600171|466027824|FG005|Overall Study|Physician Decision|2|||
129473464|NCT00600171|466027819|FG000|Overall Study|Lost to Follow-up|0|||
129473465|NCT00600171|466027820|FG001|Overall Study|Lost to Follow-up|0|||
129473466|NCT00600171|466027821|FG002|Overall Study|Lost to Follow-up|0|||
129473467|NCT00600171|466027822|FG003|Overall Study|Lost to Follow-up|1|||
129473468|NCT00600171|466027823|FG004|Overall Study|Lost to Follow-up|0|||
129473469|NCT00600171|466027824|FG005|Overall Study|Lost to Follow-up|0|||
129473470|NCT00542191|466027828|FG000|Overall Study|Death|3|||
129473471|NCT00469612|466027829|FG000|Overall Study|Study terminated before data collected|2|||
129473472|NCT00469612|466027830|FG001|Overall Study|Study terminated before data collected|0|||
129473473|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
129473474|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
129473475|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
129473476|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
129473477|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
129473478|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
129473479|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
129473480|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
129473481|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
129473482|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
129473483|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
129473484|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
129473485|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
129473486|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
129473487|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
129473488|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
129473489|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
129473490|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
129473491|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
129473492|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
129473493|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
129473494|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
129473495|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
129473496|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
129473497|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
129473498|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
129473499|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
129473500|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
129473501|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
129473502|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
129473503|NCT00849017|466027831|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
129473504|NCT00849017|466027832|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
129473505|NCT00849017|466027833|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
129473506|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
129473507|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
129473508|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
129473509|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
129473510|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
129473511|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
129473512|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
129473513|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
129473514|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
129473515|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
129473516|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
129473517|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
129473518|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
129473519|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
129473520|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
129473521|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
129473522|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
129976202|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129473523|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
129473524|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
129473525|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
129473526|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
129473527|NCT00849017|466027831|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
129473528|NCT00849017|466027832|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
129473529|NCT00849017|466027833|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
129473530|NCT03075163|466027838|FG000|Overall Study|not eligible for treatment limb|138|||
129473531|NCT03075163|466027839|FG001|Overall Study|not eligible for treatment limb|138|||
129473532|NCT00110994|466027840|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
129473533|NCT00110994|466027841|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
129473534|NCT00110994|466027840|FG000|Double-blind (DB) Treatment|Death|1|||
129473535|NCT00110994|466027841|FG001|Double-blind (DB) Treatment|Death|0|||
129473536|NCT00110994|466027840|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
129473537|NCT00110994|466027841|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
129473538|NCT00110994|466027840|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
129473539|NCT00110994|466027841|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
129473540|NCT00110994|466027840|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
129473541|NCT00110994|466027841|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
129473542|NCT00110994|466027840|FG000|Double-blind (DB) Treatment|other reasons|2|||
129473543|NCT00110994|466027841|FG001|Double-blind (DB) Treatment|other reasons|3|||
129473544|NCT00110994|466027840|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
129473545|NCT00110994|466027841|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
129473546|NCT00110994|466027840|FG000|Active Follow-up|Other reasons|0|||
129473547|NCT00110994|466027841|FG001|Active Follow-up|Other reasons|2|||
129473548|NCT00110994|466027840|FG000|Long Term Follow-up|Death|19|||
129473549|NCT00110994|466027841|FG001|Long Term Follow-up|Death|17|||
129473550|NCT01570244|466027842|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
129473551|NCT04134494|466027846|FG000|Overall Study|Lost to Follow-up|2|||
129473552|NCT00781365|466027847|FG000|Overall Study|Withdrawal by Subject|13|||
129473553|NCT00781365|466027848|FG001|Overall Study|Withdrawal by Subject|8|||
129473554|NCT00781365|466027847|FG000|Overall Study|Did Not Attend Visit|20|||
129473555|NCT00781365|466027848|FG001|Overall Study|Did Not Attend Visit|28|||
129473556|NCT00781365|466027847|FG000|Overall Study|Language barrier|1|||
129473557|NCT00781365|466027848|FG001|Overall Study|Language barrier|0|||
129473558|NCT01879410|466027849|FG000|Overall Study|Adverse Event|9|||
129473559|NCT01879410|466027850|FG001|Overall Study|Adverse Event|14|||
129473560|NCT01879410|466027849|FG000|Overall Study|Lack of Efficacy|4|||
129473561|NCT01879410|466027850|FG001|Overall Study|Lack of Efficacy|6|||
129473562|NCT01879410|466027849|FG000|Overall Study|Protocol Violation|1|||
129473563|NCT01879410|466027850|FG001|Overall Study|Protocol Violation|7|||
129473564|NCT01879410|466027849|FG000|Overall Study|Lost to Follow-up|2|||
129473565|NCT01879410|466027850|FG001|Overall Study|Lost to Follow-up|1|||
129473566|NCT01879410|466027849|FG000|Overall Study|Withdrawal by Subject|7|||
129473567|NCT01879410|466027850|FG001|Overall Study|Withdrawal by Subject|8|||
129473568|NCT01879410|466027849|FG000|Overall Study|Randomised in Error|1|||
129473569|NCT01879410|466027850|FG001|Overall Study|Randomised in Error|2|||
129473570|NCT01756456|466027858|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
129473571|NCT01756456|466027859|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
129473572|NCT01756456|466027860|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
129473573|NCT01756456|466027861|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
129473574|NCT01756456|466027862|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
129473575|NCT01756456|466027863|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
129473576|NCT01756456|466027858|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
129473577|NCT01756456|466027859|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
129473578|NCT01756456|466027860|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
129473579|NCT01756456|466027861|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
129473580|NCT01756456|466027862|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
129473581|NCT01756456|466027863|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
129473582|NCT01756456|466027858|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
129473583|NCT01756456|466027859|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
129473584|NCT01756456|466027860|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
129473585|NCT01756456|466027861|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
129473586|NCT01756456|466027862|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
129473587|NCT01756456|466027863|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
129473588|NCT01756456|466027858|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
129473589|NCT01756456|466027859|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
129473590|NCT01756456|466027860|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
129473591|NCT01756456|466027861|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
129473592|NCT01756456|466027862|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
129473593|NCT01756456|466027863|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
129473594|NCT01756456|466027858|FG000|Treatment Period: Phase I/II|Other causes|0|||
129473595|NCT01756456|466027859|FG001|Treatment Period: Phase I/II|Other causes|0|||
129473596|NCT01756456|466027860|FG002|Treatment Period: Phase I/II|Other causes|0|||
129473597|NCT01756456|466027861|FG003|Treatment Period: Phase I/II|Other causes|1|||
129473598|NCT01756456|466027862|FG004|Treatment Period: Phase I/II|Other causes|2|||
129473599|NCT01756456|466027863|FG005|Treatment Period: Phase I/II|Other causes|2|||
129473600|NCT01756456|466027858|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
129473601|NCT01756456|466027859|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
129473602|NCT01756456|466027860|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
129473603|NCT01756456|466027861|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
129473604|NCT01756456|466027862|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
129473605|NCT01756456|466027863|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
129473606|NCT01756456|466027858|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
129473607|NCT01756456|466027859|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
129473608|NCT01756456|466027860|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
129473609|NCT01756456|466027861|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
129473610|NCT01756456|466027862|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
129473611|NCT01756456|466027863|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
129473612|NCT01756456|466027858|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
129473613|NCT01756456|466027859|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
129473614|NCT01756456|466027860|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
129473615|NCT01756456|466027861|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
129473616|NCT01756456|466027862|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
129473617|NCT01756456|466027863|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
129473618|NCT01756456|466027858|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
129473619|NCT01756456|466027859|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
129473620|NCT01756456|466027860|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
129473621|NCT01756456|466027861|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
129473622|NCT01756456|466027862|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
129473623|NCT01756456|466027863|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
129473624|NCT01756456|466027858|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
129473625|NCT01756456|466027859|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
129473626|NCT01756456|466027860|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
129473627|NCT01756456|466027861|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
129473628|NCT01756456|466027862|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
129473629|NCT01756456|466027863|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
129473630|NCT01756456|466027858|FG000|Follow Up Period Phase I/II|Other causes|0|||
129473631|NCT01756456|466027859|FG001|Follow Up Period Phase I/II|Other causes|0|||
129473632|NCT01756456|466027860|FG002|Follow Up Period Phase I/II|Other causes|0|||
129473633|NCT01756456|466027861|FG003|Follow Up Period Phase I/II|Other causes|1|||
129473634|NCT01756456|466027862|FG004|Follow Up Period Phase I/II|Other causes|3|||
129473635|NCT01756456|466027863|FG005|Follow Up Period Phase I/II|Other causes|5|||
129473636|NCT04525703|466027866|FG000|Overall Study|Lost to Follow-up|6|||
129473637|NCT04525703|466027867|FG001|Overall Study|Lost to Follow-up|15|||
129473638|NCT04525703|466027868|FG002|Overall Study|Lost to Follow-up|8|||
129473639|NCT01375764|466027870|FG000|Overall Study|Lost to Follow-up|0|||
129473640|NCT01375764|466027871|FG001|Overall Study|Lost to Follow-up|1|||
129473641|NCT01375764|466027872|FG002|Overall Study|Lost to Follow-up|0|||
129473642|NCT01375764|466027873|FG003|Overall Study|Lost to Follow-up|0|||
129473643|NCT01375764|466027874|FG004|Overall Study|Lost to Follow-up|0|||
129473644|NCT01375764|466027870|FG000|Overall Study|Withdrawal by Subject|2|||
129473645|NCT01375764|466027871|FG001|Overall Study|Withdrawal by Subject|0|||
129473646|NCT01375764|466027872|FG002|Overall Study|Withdrawal by Subject|0|||
129473647|NCT01375764|466027873|FG003|Overall Study|Withdrawal by Subject|0|||
129473648|NCT01375764|466027874|FG004|Overall Study|Withdrawal by Subject|1|||
129473649|NCT01375764|466027870|FG000|Overall Study|Other|0|||
129473650|NCT01375764|466027871|FG001|Overall Study|Other|0|||
129473651|NCT01375764|466027872|FG002|Overall Study|Other|0|||
129473652|NCT01375764|466027873|FG003|Overall Study|Other|1|||
129473653|NCT01375764|466027874|FG004|Overall Study|Other|0|||
129473654|NCT03595280|466027875|FG000|Overall Study|Lost to Follow-up|6|||
129473655|NCT03595280|466027876|FG001|Overall Study|Lost to Follow-up|9|||
129473656|NCT03595280|466027877|FG002|Overall Study|Lost to Follow-up|15|||
129473657|NCT00854828|466027878|FG000|Overall Study|Death|1|||
129473658|NCT00854828|466027879|FG001|Overall Study|Death|0|||
129473659|NCT00854828|466027880|FG002|Overall Study|Death|0|||
129473660|NCT00854828|466027881|FG003|Overall Study|Death|0|||
129473661|NCT00854828|466027878|FG000|Overall Study|Withdrawal by Subject|1|||
129473662|NCT00854828|466027879|FG001|Overall Study|Withdrawal by Subject|1|||
129473663|NCT00854828|466027880|FG002|Overall Study|Withdrawal by Subject|0|||
129473664|NCT00854828|466027881|FG003|Overall Study|Withdrawal by Subject|9|||
129473665|NCT00854828|466027878|FG000|Overall Study|Missed 24mo visit|1|||
129473666|NCT00854828|466027879|FG001|Overall Study|Missed 24mo visit|1|||
129473667|NCT00854828|466027880|FG002|Overall Study|Missed 24mo visit|8|||
129473668|NCT00854828|466027881|FG003|Overall Study|Missed 24mo visit|8|||
129473669|NCT04957290|466027883|FG000|Overall Study|Progressive disease|3|||
129473670|NCT04957290|466027884|FG001|Overall Study|Progressive disease|3|||
129473671|NCT04957290|466027885|FG002|Overall Study|Progressive disease|2|||
129473672|NCT04957290|466027886|FG003|Overall Study|Progressive disease|0|||
129473673|NCT04957290|466027887|FG004|Overall Study|Progressive disease|0|||
129473674|NCT04957290|466027888|FG005|Overall Study|Progressive disease|0|||
129473675|NCT04957290|466027883|FG000|Overall Study|Withdrawal by Subject|1|||
129473676|NCT04957290|466027884|FG001|Overall Study|Withdrawal by Subject|0|||
129473677|NCT04957290|466027885|FG002|Overall Study|Withdrawal by Subject|1|||
129473678|NCT04957290|466027886|FG003|Overall Study|Withdrawal by Subject|0|||
129473679|NCT04957290|466027887|FG004|Overall Study|Withdrawal by Subject|0|||
129473680|NCT04957290|466027888|FG005|Overall Study|Withdrawal by Subject|0|||
129473681|NCT04957290|466027883|FG000|Overall Study|Death|0|||
129473682|NCT04957290|466027884|FG001|Overall Study|Death|2|||
129473683|NCT04957290|466027885|FG002|Overall Study|Death|1|||
129473684|NCT04957290|466027886|FG003|Overall Study|Death|0|||
129473685|NCT04957290|466027887|FG004|Overall Study|Death|0|||
129473686|NCT04957290|466027888|FG005|Overall Study|Death|0|||
129473687|NCT04957290|466027883|FG000|Overall Study|non compliance with study drug|0|||
129473688|NCT04957290|466027884|FG001|Overall Study|non compliance with study drug|1|||
129473689|NCT04957290|466027885|FG002|Overall Study|non compliance with study drug|0|||
129473690|NCT04957290|466027886|FG003|Overall Study|non compliance with study drug|0|||
129473691|NCT04957290|466027887|FG004|Overall Study|non compliance with study drug|0|||
129473692|NCT04957290|466027888|FG005|Overall Study|non compliance with study drug|0|||
129473693|NCT04957290|466027883|FG000|Overall Study|none specified.|0|||
129473694|NCT04957290|466027884|FG001|Overall Study|none specified.|1|||
129473695|NCT04957290|466027885|FG002|Overall Study|none specified.|2|||
129473696|NCT04957290|466027886|FG003|Overall Study|none specified.|0|||
129473697|NCT04957290|466027887|FG004|Overall Study|none specified.|0|||
129473698|NCT04957290|466027888|FG005|Overall Study|none specified.|0|||
129473699|NCT04957290|466027883|FG000|Overall Study|unacceptable toxicity|0|||
129473700|NCT04957290|466027884|FG001|Overall Study|unacceptable toxicity|0|||
129473701|NCT04957290|466027885|FG002|Overall Study|unacceptable toxicity|1|||
129473702|NCT04957290|466027886|FG003|Overall Study|unacceptable toxicity|0|||
129473703|NCT04957290|466027887|FG004|Overall Study|unacceptable toxicity|0|||
129473704|NCT04957290|466027888|FG005|Overall Study|unacceptable toxicity|0|||
129473705|NCT04957290|466027883|FG000|Overall Study|Adverse Event|0|||
129473706|NCT04957290|466027884|FG001|Overall Study|Adverse Event|0|||
129473707|NCT04957290|466027885|FG002|Overall Study|Adverse Event|1|||
129473708|NCT04957290|466027886|FG003|Overall Study|Adverse Event|0|||
129473709|NCT04957290|466027887|FG004|Overall Study|Adverse Event|0|||
129473710|NCT04957290|466027888|FG005|Overall Study|Adverse Event|0|||
129473711|NCT04957290|466027883|FG000|Overall Study|study terminated by sponsor|0|||
129473712|NCT04957290|466027884|FG001|Overall Study|study terminated by sponsor|0|||
129473713|NCT04957290|466027885|FG002|Overall Study|study terminated by sponsor|2|||
129473714|NCT04957290|466027886|FG003|Overall Study|study terminated by sponsor|0|||
129473715|NCT04957290|466027887|FG004|Overall Study|study terminated by sponsor|0|||
129473716|NCT04957290|466027888|FG005|Overall Study|study terminated by sponsor|0|||
129473717|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473718|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473719|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473720|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
129473721|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473722|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
129473723|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473724|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473725|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473726|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473727|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473728|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473729|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473730|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473731|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473732|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473733|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473734|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473735|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473736|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473737|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473738|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473739|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
129473740|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
129473741|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
129473742|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
129473743|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
129473744|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
129473745|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
129473746|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
129473747|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473748|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473749|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473750|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473751|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473752|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473753|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473754|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473755|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473756|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473757|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473758|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473759|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473760|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473761|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473762|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
129473763|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
129473764|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
129473765|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
129473766|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
129473767|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
129473768|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
129473769|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
129473770|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
129473771|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473772|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473773|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473774|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473775|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473776|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473777|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473778|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473779|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473780|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473781|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473782|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473783|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473784|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473785|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
129473786|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473787|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473788|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
129473789|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473790|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
129473791|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473792|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473793|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473794|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473795|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473796|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473797|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473798|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473799|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473800|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473801|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473802|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473803|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473804|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473805|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473806|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473807|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473808|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
129473809|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
129473810|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473811|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473812|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
129473813|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473814|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473815|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473816|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473817|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473818|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473819|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473820|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473821|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473822|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473823|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473824|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473825|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473826|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473827|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473828|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473829|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473830|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473831|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
129473832|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473833|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473834|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
129473835|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473836|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473837|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473838|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473839|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473840|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473841|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473842|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473843|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473844|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473845|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473846|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473847|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473848|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473849|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473850|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473851|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473852|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473853|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473854|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
129473855|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473856|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473857|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
129473858|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473859|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473860|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473861|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473862|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473863|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473864|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473865|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473866|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473867|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473868|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473869|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473870|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473871|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473872|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473873|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473874|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473875|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473876|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473877|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
129473878|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473879|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473880|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473881|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
129473882|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473883|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473884|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473885|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473886|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473887|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473888|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473889|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473890|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473891|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473892|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473893|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473894|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473895|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473896|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473897|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473898|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473899|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473900|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
129473901|NCT00896532|466027889|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473902|NCT00896532|466027890|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
129473903|NCT00896532|466027891|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473904|NCT00896532|466027892|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
129473905|NCT00896532|466027893|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
129473906|NCT00896532|466027894|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473907|NCT00896532|466027895|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473908|NCT00896532|466027896|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473909|NCT00896532|466027897|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473910|NCT00896532|466027898|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473911|NCT00896532|466027899|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473912|NCT00896532|466027900|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473913|NCT00896532|466027901|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473914|NCT00896532|466027902|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473915|NCT00896532|466027903|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473916|NCT00896532|466027904|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473917|NCT00896532|466027905|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473918|NCT00896532|466027906|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473919|NCT00896532|466027907|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473920|NCT00896532|466027908|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473921|NCT00896532|466027909|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473922|NCT00896532|466027910|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473923|NCT00896532|466027911|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
129473924|NCT00896532|466027889|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473925|NCT00896532|466027890|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473926|NCT00896532|466027891|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473927|NCT00896532|466027892|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473928|NCT00896532|466027893|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473929|NCT00896532|466027894|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473930|NCT00896532|466027895|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473931|NCT00896532|466027896|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473932|NCT00896532|466027897|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
129473933|NCT00896532|466027898|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473934|NCT00896532|466027899|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473935|NCT00896532|466027900|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473936|NCT00896532|466027901|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473937|NCT00896532|466027902|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473938|NCT00896532|466027903|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473939|NCT00896532|466027904|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473940|NCT00896532|466027905|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473941|NCT00896532|466027906|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473942|NCT00896532|466027907|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473943|NCT00896532|466027908|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473944|NCT00896532|466027909|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473945|NCT00896532|466027910|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473946|NCT00896532|466027911|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
129473947|NCT00896532|466027889|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473948|NCT00896532|466027890|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473949|NCT00896532|466027891|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473950|NCT00896532|466027892|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473951|NCT00896532|466027893|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473952|NCT00896532|466027894|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473953|NCT00896532|466027895|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473954|NCT00896532|466027896|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473955|NCT00896532|466027897|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473956|NCT00896532|466027898|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473957|NCT00896532|466027899|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473958|NCT00896532|466027900|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473959|NCT00896532|466027901|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
129473960|NCT00896532|466027902|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473961|NCT00896532|466027903|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473962|NCT00896532|466027904|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473963|NCT00896532|466027905|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473964|NCT00896532|466027906|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473965|NCT00896532|466027907|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473966|NCT00896532|466027908|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473967|NCT00896532|466027909|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473968|NCT00896532|466027910|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473969|NCT00896532|466027911|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
129473970|NCT00896532|466027889|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473971|NCT00896532|466027890|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473972|NCT00896532|466027891|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473973|NCT00896532|466027892|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473974|NCT00896532|466027893|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473975|NCT00896532|466027894|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473976|NCT00896532|466027895|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473977|NCT00896532|466027896|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473978|NCT00896532|466027897|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473979|NCT00896532|466027898|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473980|NCT00896532|466027899|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
129473981|NCT00896532|466027900|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473982|NCT00896532|466027901|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
129473983|NCT00896532|466027902|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473984|NCT00896532|466027903|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473985|NCT00896532|466027904|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473986|NCT00896532|466027905|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473987|NCT00896532|466027906|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473988|NCT00896532|466027907|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473989|NCT00896532|466027908|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473990|NCT00896532|466027909|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473991|NCT00896532|466027910|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473992|NCT00896532|466027911|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
129473993|NCT00896532|466027889|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129473994|NCT00896532|466027890|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129473995|NCT00896532|466027891|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129473996|NCT00896532|466027892|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129473997|NCT00896532|466027893|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129473998|NCT00896532|466027894|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129473999|NCT00896532|466027895|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474000|NCT00896532|466027896|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474001|NCT00896532|466027897|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474002|NCT00896532|466027898|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474003|NCT00896532|466027899|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474004|NCT00896532|466027900|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474005|NCT00896532|466027901|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
129474006|NCT00896532|466027902|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
129474007|NCT00896532|466027903|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474008|NCT00896532|466027904|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474009|NCT00896532|466027905|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474010|NCT00896532|466027906|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474011|NCT00896532|466027907|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474012|NCT00896532|466027908|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474013|NCT00896532|466027909|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474014|NCT00896532|466027910|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474015|NCT00896532|466027911|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
129474016|NCT00896532|466027889|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
129474017|NCT00896532|466027890|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
129474018|NCT00896532|466027891|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
129474019|NCT00896532|466027892|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
129474020|NCT00896532|466027893|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
129474021|NCT00896532|466027894|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
129474022|NCT00896532|466027895|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
129474023|NCT00896532|466027896|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
129474024|NCT00896532|466027897|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
129474025|NCT00896532|466027898|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
129474026|NCT00896532|466027899|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
129474027|NCT00896532|466027900|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
129474028|NCT00896532|466027901|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
129474029|NCT00896532|466027902|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
129474030|NCT00896532|466027903|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
129474031|NCT00896532|466027904|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
129474032|NCT00896532|466027905|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
129474033|NCT00896532|466027906|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
129474034|NCT00896532|466027907|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
129474035|NCT00896532|466027908|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
129474036|NCT00896532|466027909|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
129474037|NCT00896532|466027910|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
129474038|NCT00896532|466027911|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
129474039|NCT00896532|466027889|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474040|NCT00896532|466027890|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474041|NCT00896532|466027891|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474042|NCT00896532|466027892|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474043|NCT00896532|466027893|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474044|NCT00896532|466027894|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474045|NCT00896532|466027895|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474046|NCT00896532|466027896|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474047|NCT00896532|466027897|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474048|NCT00896532|466027898|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474049|NCT00896532|466027899|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474050|NCT00896532|466027900|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474051|NCT00896532|466027901|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474052|NCT00896532|466027902|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474053|NCT00896532|466027903|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474054|NCT00896532|466027904|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
129474055|NCT00896532|466027905|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
129474056|NCT00896532|466027906|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474057|NCT00896532|466027907|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474058|NCT00896532|466027908|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474059|NCT00896532|466027909|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474060|NCT00896532|466027910|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474061|NCT00896532|466027911|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
129474062|NCT00896532|466027889|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474063|NCT00896532|466027890|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474064|NCT00896532|466027891|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474065|NCT00896532|466027892|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474066|NCT00896532|466027893|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474067|NCT00896532|466027894|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474068|NCT00896532|466027895|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474069|NCT00896532|466027896|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474070|NCT00896532|466027897|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474071|NCT00896532|466027898|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474072|NCT00896532|466027899|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474073|NCT00896532|466027900|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474074|NCT00896532|466027901|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474075|NCT00896532|466027902|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474076|NCT00896532|466027903|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474077|NCT00896532|466027904|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
129474078|NCT00896532|466027905|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
129474079|NCT00896532|466027906|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
129474080|NCT00896532|466027907|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474081|NCT00896532|466027908|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474082|NCT00896532|466027909|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474083|NCT00896532|466027910|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474084|NCT00896532|466027911|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
129474085|NCT00896532|466027889|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474086|NCT00896532|466027890|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474087|NCT00896532|466027891|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474088|NCT00896532|466027892|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474089|NCT00896532|466027893|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474090|NCT00896532|466027894|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474091|NCT00896532|466027895|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474092|NCT00896532|466027896|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474093|NCT00896532|466027897|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474094|NCT00896532|466027898|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474095|NCT00896532|466027899|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474096|NCT00896532|466027900|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474097|NCT00896532|466027901|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474098|NCT00896532|466027902|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474099|NCT00896532|466027903|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474100|NCT00896532|466027904|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474101|NCT00896532|466027905|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
129474102|NCT00896532|466027906|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474103|NCT00896532|466027907|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474104|NCT00896532|466027908|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474105|NCT00896532|466027909|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474106|NCT00896532|466027910|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474107|NCT00896532|466027911|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
129474108|NCT00896532|466027889|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
129474109|NCT00896532|466027890|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
129474110|NCT00896532|466027891|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
129474111|NCT00896532|466027892|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
129474112|NCT00896532|466027893|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
129474113|NCT00896532|466027894|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
129474114|NCT00896532|466027895|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
129474115|NCT00896532|466027896|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
129474116|NCT00896532|466027897|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
129474117|NCT00896532|466027898|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
129474118|NCT00896532|466027899|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
129474119|NCT00896532|466027900|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
129474120|NCT00896532|466027901|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
129474121|NCT00896532|466027902|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
129474122|NCT00896532|466027903|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
129474123|NCT00896532|466027904|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
129474124|NCT00896532|466027905|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
129474125|NCT00896532|466027906|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
129474126|NCT00896532|466027907|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
129474127|NCT00896532|466027908|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
129474128|NCT00896532|466027909|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
129474129|NCT00896532|466027910|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
129474130|NCT00896532|466027911|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
129474131|NCT00896532|466027889|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474132|NCT00896532|466027890|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474133|NCT00896532|466027891|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474134|NCT00896532|466027892|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474135|NCT00896532|466027893|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474136|NCT00896532|466027894|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474137|NCT00896532|466027895|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474138|NCT00896532|466027896|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474139|NCT00896532|466027897|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474140|NCT00896532|466027898|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474141|NCT00896532|466027899|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474142|NCT00896532|466027900|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474143|NCT00896532|466027901|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474144|NCT00896532|466027902|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474145|NCT00896532|466027903|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474146|NCT00896532|466027904|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474147|NCT00896532|466027905|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
129474148|NCT00896532|466027906|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474149|NCT00896532|466027907|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474150|NCT00896532|466027908|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474151|NCT00896532|466027909|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474152|NCT00896532|466027910|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474153|NCT00896532|466027911|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
129474154|NCT00896532|466027889|FG000|Months 48-72: Follow-on Phase|Death|0|||
129474155|NCT00896532|466027890|FG001|Months 48-72: Follow-on Phase|Death|0|||
129474156|NCT00896532|466027891|FG002|Months 48-72: Follow-on Phase|Death|0|||
129474157|NCT00896532|466027892|FG003|Months 48-72: Follow-on Phase|Death|0|||
129474158|NCT00896532|466027893|FG004|Months 48-72: Follow-on Phase|Death|0|||
129474159|NCT00896532|466027894|FG005|Months 48-72: Follow-on Phase|Death|0|||
129474160|NCT00896532|466027895|FG006|Months 48-72: Follow-on Phase|Death|0|||
129474161|NCT00896532|466027896|FG007|Months 48-72: Follow-on Phase|Death|0|||
129474162|NCT00896532|466027897|FG008|Months 48-72: Follow-on Phase|Death|0|||
129474163|NCT00896532|466027898|FG009|Months 48-72: Follow-on Phase|Death|0|||
129474164|NCT00896532|466027899|FG010|Months 48-72: Follow-on Phase|Death|0|||
129474165|NCT00896532|466027900|FG011|Months 48-72: Follow-on Phase|Death|0|||
129474166|NCT00896532|466027901|FG012|Months 48-72: Follow-on Phase|Death|0|||
129474167|NCT00896532|466027902|FG013|Months 48-72: Follow-on Phase|Death|0|||
129474168|NCT00896532|466027903|FG014|Months 48-72: Follow-on Phase|Death|0|||
129474169|NCT00896532|466027904|FG015|Months 48-72: Follow-on Phase|Death|0|||
129474170|NCT00896532|466027905|FG016|Months 48-72: Follow-on Phase|Death|0|||
129474171|NCT00896532|466027906|FG017|Months 48-72: Follow-on Phase|Death|0|||
129474172|NCT00896532|466027907|FG018|Months 48-72: Follow-on Phase|Death|1|||
129474173|NCT00896532|466027908|FG019|Months 48-72: Follow-on Phase|Death|0|||
129474174|NCT00896532|466027909|FG020|Months 48-72: Follow-on Phase|Death|0|||
129474175|NCT00896532|466027910|FG021|Months 48-72: Follow-on Phase|Death|0|||
129474176|NCT00896532|466027911|FG022|Months 48-72: Follow-on Phase|Death|0|||
129474177|NCT00896532|466027889|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474178|NCT00896532|466027890|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474179|NCT00896532|466027891|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474180|NCT00896532|466027892|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474181|NCT00896532|466027893|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474182|NCT00896532|466027894|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474183|NCT00896532|466027895|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474184|NCT00896532|466027896|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474185|NCT00896532|466027897|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474186|NCT00896532|466027898|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474187|NCT00896532|466027899|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474188|NCT00896532|466027900|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474189|NCT00896532|466027901|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474190|NCT00896532|466027902|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474191|NCT00896532|466027903|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474192|NCT00896532|466027904|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474193|NCT00896532|466027905|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474194|NCT00896532|466027906|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474195|NCT00896532|466027907|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474196|NCT00896532|466027908|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474197|NCT00896532|466027909|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474198|NCT00896532|466027910|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
129474199|NCT00896532|466027911|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
129474200|NCT00896532|466027889|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474201|NCT00896532|466027890|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474202|NCT00896532|466027891|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474203|NCT00896532|466027892|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474204|NCT00896532|466027893|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474205|NCT00896532|466027894|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474206|NCT00896532|466027895|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474207|NCT00896532|466027896|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474208|NCT00896532|466027897|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474209|NCT00896532|466027898|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474210|NCT00896532|466027899|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474211|NCT00896532|466027900|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474212|NCT00896532|466027901|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474213|NCT00896532|466027902|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474214|NCT00896532|466027903|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474215|NCT00896532|466027904|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474216|NCT00896532|466027905|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474217|NCT00896532|466027906|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474218|NCT00896532|466027907|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474219|NCT00896532|466027908|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474220|NCT00896532|466027909|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474221|NCT00896532|466027910|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
129474222|NCT00896532|466027911|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
129474223|NCT02149810|466027912|FG000|Overall Study|Physician Decision|1|||
129474224|NCT02149810|466027913|FG001|Overall Study|Physician Decision|2|||
129474225|NCT02149810|466027912|FG000|Overall Study|Lost to Follow-up|2|||
129474226|NCT02149810|466027913|FG001|Overall Study|Lost to Follow-up|1|||
129474227|NCT02149810|466027912|FG000|Overall Study|Withdrawal by Subject|5|||
129474228|NCT02149810|466027913|FG001|Overall Study|Withdrawal by Subject|1|||
129474229|NCT01176916|466027914|FG000|Overall Study|Adverse Event|61|||
129474230|NCT01176916|466027914|FG000|Overall Study|Death|1|||
129474231|NCT01176916|466027914|FG000|Overall Study|Lost to Follow-up|15|||
129474232|NCT01176916|466027914|FG000|Overall Study|Objective progression or relapse|17|||
129474233|NCT01176916|466027914|FG000|Overall Study|Protocol Violation|24|||
129474234|NCT01176916|466027914|FG000|Overall Study|Withdrawal by Subject|37|||
129474235|NCT01176916|466027914|FG000|Overall Study|Other|6|||
129474236|NCT01176916|466027914|FG000|Overall Study|Withdrawal prior to Treatment|6|||
129474237|NCT03158220|466027915|FG000|Overall Study|Screen Failure|0|||
129474238|NCT03158220|466027916|FG001|Overall Study|Screen Failure|1|||
129474239|NCT03158220|466027915|FG000|Overall Study|Withdrawal by Subject|8|||
129474240|NCT03158220|466027916|FG001|Overall Study|Withdrawal by Subject|9|||
129474241|NCT03158220|466027915|FG000|Overall Study|Status unknown|0|||
129474242|NCT03158220|466027916|FG001|Overall Study|Status unknown|1|||
129474243|NCT03158220|466027915|FG000|Overall Study|Lost to Follow-up|8|||
129474244|NCT03158220|466027916|FG001|Overall Study|Lost to Follow-up|5|||
129474245|NCT03158220|466027915|FG000|Overall Study|Physician Decision|1|||
129474246|NCT03158220|466027916|FG001|Overall Study|Physician Decision|0|||
129474247|NCT01015833|466027917|FG000|Overall Study|Death|1|||
129474248|NCT01015833|466027918|FG001|Overall Study|Death|0|||
129474249|NCT01015833|466027917|FG000|Overall Study|Withdrawal by Subject|3|||
129474250|NCT01015833|466027918|FG001|Overall Study|Withdrawal by Subject|2|||
129474251|NCT01015833|466027917|FG000|Overall Study|Adverse Event|0|||
129474252|NCT01015833|466027918|FG001|Overall Study|Adverse Event|1|||
129474253|NCT01015833|466027917|FG000|Overall Study|Physician Decision|2|||
129474254|NCT01015833|466027918|FG001|Overall Study|Physician Decision|0|||
129474255|NCT01015833|466027917|FG000|Overall Study|Symptomatic deterioration|0|||
129474256|NCT01015833|466027918|FG001|Overall Study|Symptomatic deterioration|1|||
129474257|NCT01015833|466027917|FG000|Overall Study|Other|5|||
129474258|NCT01015833|466027918|FG001|Overall Study|Other|1|||
129474259|NCT01015833|466027917|FG000|Overall Study|Motor Vehicle Accidents|1|||
129474260|NCT01015833|466027918|FG001|Overall Study|Motor Vehicle Accidents|0|||
129976203|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
129474261|NCT01015833|466027917|FG000|Overall Study|Did not start treatment|1|||
129474262|NCT01015833|466027918|FG001|Overall Study|Did not start treatment|0|||
129474263|NCT01671280|466027919|FG000|Overall Study|Withdrawal by Subject|2|||
129474264|NCT01959165|466027920|FG000|Overall Study|Adverse Event|0|||
129474265|NCT01959165|466027921|FG001|Overall Study|Adverse Event|0|||
129474266|NCT01959165|466027922|FG002|Overall Study|Adverse Event|0|||
129474267|NCT01959165|466027923|FG003|Overall Study|Adverse Event|1|||
129474268|NCT01959165|466027920|FG000|Overall Study|Lack of Efficacy|1|||
129474269|NCT01959165|466027921|FG001|Overall Study|Lack of Efficacy|0|||
129474270|NCT01959165|466027922|FG002|Overall Study|Lack of Efficacy|0|||
129474271|NCT01959165|466027923|FG003|Overall Study|Lack of Efficacy|0|||
129474272|NCT01959165|466027920|FG000|Overall Study|overdose|0|||
129474273|NCT01959165|466027921|FG001|Overall Study|overdose|0|||
129474274|NCT01959165|466027922|FG002|Overall Study|overdose|0|||
129474275|NCT01959165|466027923|FG003|Overall Study|overdose|1|||
129474276|NCT01959165|466027920|FG000|Overall Study|Welfare recipient|0|||
129474277|NCT01959165|466027921|FG001|Overall Study|Welfare recipient|1|||
129474278|NCT01959165|466027922|FG002|Overall Study|Welfare recipient|0|||
129474279|NCT01959165|466027923|FG003|Overall Study|Welfare recipient|0|||
129474280|NCT02899156|466027939|FG000|Overall Study|Death|1|||
129474281|NCT02899156|466027940|FG001|Overall Study|Death|0|||
129474282|NCT02899156|466027939|FG000|Overall Study|Physician Decision|0|||
129474283|NCT02899156|466027940|FG001|Overall Study|Physician Decision|1|||
129474284|NCT00787787|466027943|FG000|Overall Study|Lack of Efficacy|4|||
129474285|NCT00787787|466027943|FG000|Overall Study|Adverse Event|3|||
129474286|NCT05032950|466027945|FG000|Overall Study|Adverse Event|0|||
129474287|NCT05032950|466027946|FG001|Overall Study|Adverse Event|0|||
129474288|NCT05032950|466027947|FG002|Overall Study|Adverse Event|1|||
129474289|NCT05032950|466027948|FG003|Overall Study|Adverse Event|1|||
129474290|NCT05032950|466027949|FG004|Overall Study|Adverse Event|0|||
129474291|NCT05032950|466027950|FG005|Overall Study|Adverse Event|0|||
129474292|NCT02959814|466027952|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
129474293|NCT02959814|466027952|FG000|Overall Study|Excluded based on anatomical criteria|2|||
129474294|NCT02959814|466027952|FG000|Overall Study|Protocol Violation|7|||
129474295|NCT02959814|466027952|FG000|Overall Study|FFR not measured|2|||
129474296|NCT02959814|466027952|FG000|Overall Study|In-procedure QFR not computed|6|||
129474297|NCT02959814|466027952|FG000|Overall Study|Excluded by FFR core-lab|24|||
129474298|NCT02116621|466027953|FG000|Baseline|Withdrawal by Subject|0|||
129474299|NCT02116621|466027954|FG001|Baseline|Withdrawal by Subject|4|||
129474300|NCT02116621|466027953|FG000|Three Month Follow-up|Death|1|||
129474301|NCT02116621|466027954|FG001|Three Month Follow-up|Death|1|||
129474302|NCT02116621|466027953|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
129474303|NCT02116621|466027954|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
129474304|NCT02116621|466027953|FG000|Three Month Follow-up|Lost to Follow-up|0|||
129474305|NCT02116621|466027954|FG001|Three Month Follow-up|Lost to Follow-up|1|||
129474306|NCT02116621|466027953|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
129474307|NCT02116621|466027954|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
129474308|NCT02116621|466027953|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
129474309|NCT02116621|466027954|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
129474310|NCT02116621|466027953|FG000|Six Month Follow-up|Lost to Follow-up|2|||
129474311|NCT02116621|466027954|FG001|Six Month Follow-up|Lost to Follow-up|1|||
129474312|NCT02116621|466027953|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
129474313|NCT02116621|466027954|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
129474314|NCT02116621|466027953|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
129474315|NCT02116621|466027954|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
129474316|NCT02116621|466027953|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
129474317|NCT02116621|466027954|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
129474318|NCT02116621|466027953|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
129474319|NCT02116621|466027954|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
129474320|NCT02116621|466027953|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
129474321|NCT02116621|466027954|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
129474322|NCT00961961|466027955|FG000|Phase I|Withdrawal by Subject|7|||
129474323|NCT00961961|466027956|FG001|Phase I|Withdrawal by Subject|0|||
129474324|NCT00961961|466027957|FG002|Phase I|Withdrawal by Subject|0|||
129474325|NCT00961961|466027958|FG003|Phase I|Withdrawal by Subject|0|||
129474326|NCT00961961|466027955|FG000|Phase I|Lost to Follow-up|10|||
129474327|NCT00961961|466027956|FG001|Phase I|Lost to Follow-up|0|||
129474328|NCT00961961|466027957|FG002|Phase I|Lost to Follow-up|0|||
129474329|NCT00961961|466027958|FG003|Phase I|Lost to Follow-up|0|||
129474330|NCT00961961|466027955|FG000|Phase I|Lack of Efficacy|94|||
129474331|NCT00961961|466027956|FG001|Phase I|Lack of Efficacy|0|||
129474332|NCT00961961|466027957|FG002|Phase I|Lack of Efficacy|0|||
129474333|NCT00961961|466027958|FG003|Phase I|Lack of Efficacy|0|||
129474334|NCT00961961|466027955|FG000|Phase I|Adverse Event|7|||
129474335|NCT00961961|466027956|FG001|Phase I|Adverse Event|0|||
129474336|NCT00961961|466027957|FG002|Phase I|Adverse Event|0|||
129474337|NCT00961961|466027958|FG003|Phase I|Adverse Event|0|||
129976204|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
129474338|NCT00961961|466027955|FG000|Phase I|Physician Decision|8|||
129474339|NCT00961961|466027956|FG001|Phase I|Physician Decision|0|||
129474340|NCT00961961|466027957|FG002|Phase I|Physician Decision|0|||
129474341|NCT00961961|466027958|FG003|Phase I|Physician Decision|0|||
129474342|NCT00961961|466027955|FG000|Phase II|Lost to Follow-up|0|||
129474343|NCT00961961|466027956|FG001|Phase II|Lost to Follow-up|0|||
129474344|NCT00961961|466027957|FG002|Phase II|Lost to Follow-up|10|||
129474345|NCT00961961|466027958|FG003|Phase II|Lost to Follow-up|7|||
129474346|NCT00961961|466027955|FG000|Phase II|Adverse Event|0|||
129474347|NCT00961961|466027956|FG001|Phase II|Adverse Event|0|||
129474348|NCT00961961|466027957|FG002|Phase II|Adverse Event|0|||
129474349|NCT00961961|466027958|FG003|Phase II|Adverse Event|1|||
129474350|NCT00961961|466027955|FG000|Phase II|Physician Decision|0|||
129474351|NCT00961961|466027956|FG001|Phase II|Physician Decision|0|||
129474352|NCT00961961|466027957|FG002|Phase II|Physician Decision|1|||
129474353|NCT00961961|466027958|FG003|Phase II|Physician Decision|0|||
129474354|NCT00961961|466027955|FG000|Phase II|Withdrawal by Subject|0|||
129474355|NCT00961961|466027956|FG001|Phase II|Withdrawal by Subject|0|||
129474356|NCT00961961|466027957|FG002|Phase II|Withdrawal by Subject|1|||
129474357|NCT00961961|466027958|FG003|Phase II|Withdrawal by Subject|0|||
129474358|NCT01412957|466027959|FG000|Overall Study|Withdrawal by Subject|6|||
129474359|NCT01412957|466027960|FG001|Overall Study|Withdrawal by Subject|22|||
129474360|NCT01412957|466027959|FG000|Overall Study|Lost to Follow-up|7|||
129474361|NCT01412957|466027960|FG001|Overall Study|Lost to Follow-up|2|||
129474362|NCT01412957|466027959|FG000|Overall Study|Death|136|||
129474363|NCT01412957|466027960|FG001|Overall Study|Death|133|||
129474364|NCT04722991|466027966|FG000|Overall Study|Adverse Event|12|||
129474365|NCT04722991|466027967|FG001|Overall Study|Adverse Event|4|||
129474366|NCT04722991|466027966|FG000|Overall Study|Death|2|||
129474367|NCT04722991|466027967|FG001|Overall Study|Death|0|||
129474368|NCT04722991|466027966|FG000|Overall Study|Lost to Follow-up|1|||
129474369|NCT04722991|466027967|FG001|Overall Study|Lost to Follow-up|1|||
129474370|NCT04722991|466027966|FG000|Overall Study|Withdrawal cirterion met|2|||
129474371|NCT04722991|466027967|FG001|Overall Study|Withdrawal cirterion met|2|||
129474372|NCT04722991|466027966|FG000|Overall Study|Other|1|||
129474373|NCT04722991|466027967|FG001|Overall Study|Other|0|||
129474374|NCT04722991|466027966|FG000|Overall Study|Non-compliance|0|||
129474375|NCT04722991|466027967|FG001|Overall Study|Non-compliance|1|||
129474376|NCT04722991|466027966|FG000|Overall Study|Withdrawal by Subject|0|||
129474377|NCT04722991|466027967|FG001|Overall Study|Withdrawal by Subject|1|||
129474378|NCT00413959|466027968|FG000|Overall Study|Pt had only one cycle.|1|||
129474379|NCT04343651|466027972|FG000|Overall Study|Physician Decision|2|||
129474380|NCT04343651|466027973|FG001|Overall Study|Physician Decision|1|||
129474381|NCT04343651|466027972|FG000|Overall Study|Lost to Follow-up|2|||
129474382|NCT04343651|466027973|FG001|Overall Study|Lost to Follow-up|1|||
129474383|NCT04343651|466027972|FG000|Overall Study|Protocol Violation|4|||
129474384|NCT04343651|466027973|FG001|Overall Study|Protocol Violation|6|||
129474385|NCT04343651|466027972|FG000|Overall Study|Missing|3|||
129474386|NCT04343651|466027973|FG001|Overall Study|Missing|9|||
129474387|NCT04343651|466027972|FG000|Overall Study|Withdrawal by Subject|0|||
129474388|NCT04343651|466027973|FG001|Overall Study|Withdrawal by Subject|4|||
129474389|NCT04343651|466027972|FG000|Overall Study|Death|0|||
129474390|NCT04343651|466027973|FG001|Overall Study|Death|1|||
129474391|NCT04343651|466027972|FG000|Overall Study|Did not start treatment|1|||
129474392|NCT04343651|466027973|FG001|Overall Study|Did not start treatment|1|||
129474393|NCT04343651|466027972|FG000|Overall Study|Patient did not complete visits 3-6|0|||
129474394|NCT04343651|466027973|FG001|Overall Study|Patient did not complete visits 3-6|1|||
129474395|NCT02246621|466027974|FG000|Overall Study|Withdrawal by Subject|28|||
129474396|NCT02246621|466027975|FG001|Overall Study|Withdrawal by Subject|16|||
129474397|NCT02246621|466027974|FG000|Overall Study|Lost to Follow-up|1|||
129474398|NCT02246621|466027975|FG001|Overall Study|Lost to Follow-up|0|||
129474399|NCT02246621|466027974|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
129474400|NCT02246621|466027975|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
129474401|NCT01459614|466027976|FG000|Overall Study|Adverse Event|1|||
129474402|NCT01459614|466027977|FG001|Overall Study|Adverse Event|0|||
129474403|NCT04574999|466029890|FG000|Overall Study|Adverse Event|1|||
129474404|NCT04574999|466029891|FG001|Overall Study|Adverse Event|0|||
129474405|NCT04574999|466029890|FG000|Overall Study|Lack of Efficacy|2|||
129474406|NCT04574999|466029891|FG001|Overall Study|Lack of Efficacy|3|||
129474407|NCT04574999|466029890|FG000|Overall Study|Protocol Violation|1|||
129474408|NCT04574999|466029891|FG001|Overall Study|Protocol Violation|0|||
129474409|NCT04574999|466029890|FG000|Overall Study|Withdrawal by Subject|2|||
129474410|NCT04574999|466029891|FG001|Overall Study|Withdrawal by Subject|2|||
129474411|NCT04574999|466029890|FG000|Overall Study|Lost to Follow-up|1|||
129474412|NCT04574999|466029891|FG001|Overall Study|Lost to Follow-up|0|||
129474413|NCT04574999|466029890|FG000|Overall Study|Personal problems|1|||
129474414|NCT04574999|466029891|FG001|Overall Study|Personal problems|0|||
129474415|NCT04574999|466029890|FG000|Overall Study|Previous planned surgery|1|||
129474416|NCT04574999|466029891|FG001|Overall Study|Previous planned surgery|0|||
129976205|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129474417|NCT00008385|466029894|FG000|Overall Study|Off treatment reasons not reported|79|||
129474418|NCT00008385|466029895|FG001|Overall Study|Off treatment reasons not reported|70|||
129474419|NCT00008385|466029894|FG000|Overall Study|Progressive disease|52|||
129474420|NCT00008385|466029895|FG001|Overall Study|Progressive disease|117|||
129474421|NCT00008385|466029894|FG000|Overall Study|Adverse Event|8|||
129474422|NCT00008385|466029895|FG001|Overall Study|Adverse Event|20|||
129474423|NCT00008385|466029894|FG000|Overall Study|Death|12|||
129474424|NCT00008385|466029895|FG001|Overall Study|Death|18|||
129976206|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
129976207|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129474425|NCT00008385|466029894|FG000|Overall Study|Withdrawal by Subject|67|||
129474426|NCT00008385|466029895|FG001|Overall Study|Withdrawal by Subject|157|||
129474427|NCT00008385|466029894|FG000|Overall Study|Start non-protocol therapy|3|||
129474428|NCT00008385|466029895|FG001|Overall Study|Start non-protocol therapy|1|||
129474429|NCT00008385|466029894|FG000|Overall Study|Other complicating disease|17|||
129474430|NCT00008385|466029895|FG001|Overall Study|Other complicating disease|30|||
129474431|NCT00008385|466029894|FG000|Overall Study|Maximum dose reached|0|||
129474432|NCT00008385|466029895|FG001|Overall Study|Maximum dose reached|2|||
129474433|NCT00008385|466029894|FG000|Overall Study|Other|105|||
129474434|NCT00008385|466029895|FG001|Overall Study|Other|212|||
129474435|NCT00008385|466029894|FG000|Overall Study|Not start protocol therapy|44|||
129474436|NCT00008385|466029895|FG001|Overall Study|Not start protocol therapy|175|||
129474437|NCT00582556|466029896|FG000|Overall Study|Withdrawal by Subject|0|||
129474438|NCT00582556|466029897|FG001|Overall Study|Withdrawal by Subject|1|||
129474439|NCT00582556|466029898|FG002|Overall Study|Withdrawal by Subject|1|||
129474440|NCT00582556|466029896|FG000|Overall Study|Physician Decision|0|||
129474441|NCT00582556|466029897|FG001|Overall Study|Physician Decision|0|||
129474442|NCT00582556|466029898|FG002|Overall Study|Physician Decision|1|||
129474443|NCT01993888|466029901|FG000|Overall Study|Death|1|||
129474444|NCT01993888|466029902|FG001|Overall Study|Death|1|||
129474445|NCT01993888|466029901|FG000|Overall Study|Lost to Follow-up|1|||
129474446|NCT01993888|466029902|FG001|Overall Study|Lost to Follow-up|1|||
129474447|NCT01993888|466029901|FG000|Overall Study|Withdrawal by Subject|0|||
129474448|NCT01993888|466029902|FG001|Overall Study|Withdrawal by Subject|1|||
129474449|NCT00832819|466029903|FG000|Overall Study|Adverse Event|0|||
129474450|NCT00832819|466029904|FG001|Overall Study|Adverse Event|1|||
129474451|NCT00832819|466029905|FG002|Overall Study|Adverse Event|0|||
129474452|NCT00832819|466029903|FG000|Overall Study|Protocol Violation|0|||
129474453|NCT00832819|466029904|FG001|Overall Study|Protocol Violation|0|||
129474454|NCT00832819|466029905|FG002|Overall Study|Protocol Violation|1|||
129474455|NCT00317044|466029906|FG000|Overall Study|Protocol Violation|28|||
129474456|NCT00317044|466029907|FG001|Overall Study|Protocol Violation|22|||
129474457|NCT00317044|466029908|FG002|Overall Study|Protocol Violation|20|||
129474458|NCT00317044|466029906|FG000|Overall Study|Adverse Event|4|||
129474459|NCT00317044|466029907|FG001|Overall Study|Adverse Event|7|||
129474460|NCT00317044|466029908|FG002|Overall Study|Adverse Event|4|||
129474461|NCT00317044|466029906|FG000|Overall Study|Withdrawal by Subject|10|||
129474462|NCT00317044|466029907|FG001|Overall Study|Withdrawal by Subject|7|||
129474463|NCT00317044|466029908|FG002|Overall Study|Withdrawal by Subject|12|||
129474464|NCT00317044|466029906|FG000|Overall Study|Lost to Follow-up|0|||
129474465|NCT00317044|466029907|FG001|Overall Study|Lost to Follow-up|2|||
129474466|NCT00317044|466029908|FG002|Overall Study|Lost to Follow-up|3|||
129474467|NCT00317044|466029906|FG000|Overall Study|Multiple Reasons|6|||
129474468|NCT00317044|466029907|FG001|Overall Study|Multiple Reasons|2|||
129474469|NCT00317044|466029908|FG002|Overall Study|Multiple Reasons|6|||
129474470|NCT05742984|466029909|FG000|Overall Study|Adverse Event|0|||
129474471|NCT05742984|466029910|FG001|Overall Study|Adverse Event|0|||
129474472|NCT05742984|466029911|FG002|Overall Study|Adverse Event|1|||
129474473|NCT05742984|466029912|FG003|Overall Study|Adverse Event|0|||
129474474|NCT05742984|466029913|FG004|Overall Study|Adverse Event|1|||
129474475|NCT05742984|466029914|FG005|Overall Study|Adverse Event|1|||
129474476|NCT05742984|466029909|FG000|Overall Study|Withdrawal by Subject|0|||
129474477|NCT05742984|466029910|FG001|Overall Study|Withdrawal by Subject|1|||
129474478|NCT05742984|466029911|FG002|Overall Study|Withdrawal by Subject|0|||
129474479|NCT05742984|466029912|FG003|Overall Study|Withdrawal by Subject|0|||
129474480|NCT05742984|466029913|FG004|Overall Study|Withdrawal by Subject|0|||
129474481|NCT05742984|466029914|FG005|Overall Study|Withdrawal by Subject|2|||
129474482|NCT00379340|466029915|FG000|Overall Study|Death|0|||
129474483|NCT00379340|466029916|FG001|Overall Study|Death|0|||
129474484|NCT00379340|466029917|FG002|Overall Study|Death|0|||
129474485|NCT00379340|466029918|FG003|Overall Study|Death|2|||
129474486|NCT00379340|466029919|FG004|Overall Study|Death|0|||
129474487|NCT00379340|466029915|FG000|Overall Study|Lack of Efficacy|6|||
129474488|NCT00379340|466029916|FG001|Overall Study|Lack of Efficacy|1|||
129474489|NCT00379340|466029917|FG002|Overall Study|Lack of Efficacy|0|||
129474490|NCT00379340|466029918|FG003|Overall Study|Lack of Efficacy|4|||
129474491|NCT00379340|466029919|FG004|Overall Study|Lack of Efficacy|3|||
129474492|NCT00379340|466029915|FG000|Overall Study|Physician Decision|6|||
129474493|NCT00379340|466029916|FG001|Overall Study|Physician Decision|2|||
129474494|NCT00379340|466029917|FG002|Overall Study|Physician Decision|1|||
129474495|NCT00379340|466029918|FG003|Overall Study|Physician Decision|2|||
129474496|NCT00379340|466029919|FG004|Overall Study|Physician Decision|3|||
129474497|NCT00379340|466029915|FG000|Overall Study|Withdrawal by Subject|0|||
129474498|NCT00379340|466029916|FG001|Overall Study|Withdrawal by Subject|0|||
129474499|NCT00379340|466029917|FG002|Overall Study|Withdrawal by Subject|0|||
129474500|NCT00379340|466029918|FG003|Overall Study|Withdrawal by Subject|1|||
129474501|NCT00379340|466029919|FG004|Overall Study|Withdrawal by Subject|0|||
129474502|NCT00379340|466029915|FG000|Overall Study|Refusal of further protocol therapy|1|||
129474503|NCT00379340|466029916|FG001|Overall Study|Refusal of further protocol therapy|0|||
129474504|NCT00379340|466029917|FG002|Overall Study|Refusal of further protocol therapy|1|||
129976208|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
129474505|NCT00379340|466029918|FG003|Overall Study|Refusal of further protocol therapy|1|||
129474506|NCT00379340|466029919|FG004|Overall Study|Refusal of further protocol therapy|7|||
129474507|NCT00379340|466029915|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
129474508|NCT00379340|466029916|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
129474509|NCT00379340|466029917|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
129474510|NCT00379340|466029918|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
129474511|NCT00379340|466029919|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
129474512|NCT00379340|466029915|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
129474513|NCT00379340|466029916|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
129474514|NCT00379340|466029917|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
129474515|NCT00379340|466029918|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
129474516|NCT00379340|466029919|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
129474517|NCT02162862|466029923|FG000|Overall Study|Lost to Follow-up|0|||
129474518|NCT02162862|466029924|FG001|Overall Study|Lost to Follow-up|11|||
129474519|NCT02162862|466029925|FG002|Overall Study|Lost to Follow-up|0|||
129474520|NCT02162862|466029923|FG000|Overall Study|Subject did not feel the med was needed|0|||
129474521|NCT02162862|466029924|FG001|Overall Study|Subject did not feel the med was needed|0|||
129474522|NCT02162862|466029925|FG002|Overall Study|Subject did not feel the med was needed|4|||
129474523|NCT00430755|466029928|FG000|Overall Study|Withdrawal by Subject|53|||
129474524|NCT00103012|466029931|FG000|Overall Study|Withdrawal by Subject|2|||
129474525|NCT00103012|466029932|FG001|Overall Study|Withdrawal by Subject|1|||
129474526|NCT00103012|466029933|FG002|Overall Study|Withdrawal by Subject|2|||
129474527|NCT00103012|466029931|FG000|Overall Study|Pregnancy|1|||
129474528|NCT00103012|466029932|FG001|Overall Study|Pregnancy|0|||
129474529|NCT00103012|466029933|FG002|Overall Study|Pregnancy|0|||
129474530|NCT00103012|466029931|FG000|Overall Study|Adverse Event|0|||
129474531|NCT00103012|466029932|FG001|Overall Study|Adverse Event|0|||
129474532|NCT00103012|466029933|FG002|Overall Study|Adverse Event|1|||
129474533|NCT00103012|466029931|FG000|Overall Study|Subject non-compliant with medications|0|||
129474534|NCT00103012|466029932|FG001|Overall Study|Subject non-compliant with medications|0|||
129474535|NCT00103012|466029933|FG002|Overall Study|Subject non-compliant with medications|1|||
129474536|NCT05019131|466029941|FG000|Overall Study|Lost to Follow-up|0|||
129474537|NCT05019131|466029942|FG001|Overall Study|Lost to Follow-up|3|||
129474538|NCT04684420|466029943|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129474539|NCT04684420|466029944|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
129474540|NCT04684420|466029945|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
129474541|NCT04684420|466029946|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
129474542|NCT04684420|466029943|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
129474543|NCT04684420|466029944|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
129474544|NCT04684420|466029945|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
129474545|NCT04684420|466029946|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
129474546|NCT03480802|466029948|FG000|Overall Study|Lost to Follow-up|5|||
129474547|NCT03480802|466029949|FG001|Overall Study|Lost to Follow-up|1|||
129474548|NCT03480802|466029948|FG000|Overall Study|Withdrawal by Subject|2|||
129474549|NCT03480802|466029949|FG001|Overall Study|Withdrawal by Subject|1|||
129474550|NCT03480802|466029948|FG000|Overall Study|Relocated|0|||
129474551|NCT03480802|466029949|FG001|Overall Study|Relocated|1|||
129474552|NCT01703000|466029950|FG000|Overall Study|Death|1|||
129474553|NCT03822884|466029951|FG000|Overall Study|Withdrawal by Subject|0|||
129474554|NCT03822884|466029952|FG001|Overall Study|Withdrawal by Subject|0|||
129474555|NCT03822884|466029953|FG002|Overall Study|Withdrawal by Subject|0|||
129474556|NCT03822884|466029954|FG003|Overall Study|Withdrawal by Subject|0|||
129474557|NCT03822884|466029955|FG004|Overall Study|Withdrawal by Subject|1|||
129474558|NCT03822884|466029956|FG005|Overall Study|Withdrawal by Subject|0|||
129474559|NCT00432237|466029962|FG000|Overall Study|Adverse Event|0|||
129474560|NCT00432237|466029963|FG001|Overall Study|Adverse Event|0|||
129474561|NCT00432237|466029964|FG002|Overall Study|Adverse Event|0|||
129474562|NCT00432237|466029965|FG003|Overall Study|Adverse Event|1|||
129474563|NCT00432237|466029962|FG000|Overall Study|Lack of Efficacy|0|||
129474564|NCT00432237|466029963|FG001|Overall Study|Lack of Efficacy|0|||
129474565|NCT00432237|466029964|FG002|Overall Study|Lack of Efficacy|0|||
129474566|NCT00432237|466029965|FG003|Overall Study|Lack of Efficacy|1|||
129474567|NCT00432237|466029962|FG000|Overall Study|Lost to Follow-up|10|||
129474568|NCT00432237|466029963|FG001|Overall Study|Lost to Follow-up|10|||
129474569|NCT00432237|466029964|FG002|Overall Study|Lost to Follow-up|18|||
129474570|NCT00432237|466029965|FG003|Overall Study|Lost to Follow-up|18|||
129474571|NCT00432237|466029962|FG000|Overall Study|Physician Decision|1|||
129474572|NCT00432237|466029963|FG001|Overall Study|Physician Decision|3|||
129474573|NCT00432237|466029964|FG002|Overall Study|Physician Decision|2|||
129474574|NCT00432237|466029965|FG003|Overall Study|Physician Decision|1|||
129474575|NCT00432237|466029962|FG000|Overall Study|Pregnancy|0|||
129474576|NCT00432237|466029963|FG001|Overall Study|Pregnancy|1|||
129474577|NCT00432237|466029964|FG002|Overall Study|Pregnancy|0|||
129474578|NCT00432237|466029965|FG003|Overall Study|Pregnancy|0|||
129474579|NCT00432237|466029962|FG000|Overall Study|Protocol Violation|13|||
129474580|NCT00432237|466029963|FG001|Overall Study|Protocol Violation|10|||
129474581|NCT00432237|466029964|FG002|Overall Study|Protocol Violation|11|||
129474582|NCT00432237|466029965|FG003|Overall Study|Protocol Violation|8|||
129474583|NCT00432237|466029962|FG000|Overall Study|Withdrawal by Subject|5|||
129474584|NCT00432237|466029963|FG001|Overall Study|Withdrawal by Subject|6|||
129474585|NCT00432237|466029964|FG002|Overall Study|Withdrawal by Subject|9|||
129474586|NCT00432237|466029965|FG003|Overall Study|Withdrawal by Subject|11|||
129474587|NCT00432237|466029962|FG000|Overall Study|Lack of Qualifying Event|38|||
129474588|NCT00432237|466029963|FG001|Overall Study|Lack of Qualifying Event|71|||
129474589|NCT00432237|466029964|FG002|Overall Study|Lack of Qualifying Event|69|||
129474590|NCT00432237|466029965|FG003|Overall Study|Lack of Qualifying Event|84|||
129474591|NCT01354132|466029966|FG000|Randomization|Physician Decision|1|||
129474592|NCT01354132|466029967|FG001|Randomization|Physician Decision|0|||
129474593|NCT01354132|466029966|FG000|Randomization|Withdrawal by Subject|0|||
129474594|NCT01354132|466029967|FG001|Randomization|Withdrawal by Subject|1|||
129474595|NCT01354132|466029966|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
129474596|NCT01354132|466029967|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
129474597|NCT01354132|466029966|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
129474598|NCT01354132|466029967|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
129474599|NCT01354132|466029966|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
129474600|NCT01354132|466029967|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
129474601|NCT00603239|466029968|FG000|Overall Study|Adverse Event|4|||
129474602|NCT00603239|466029969|FG001|Overall Study|Adverse Event|1|||
129474603|NCT00603239|466029968|FG000|Overall Study|Entry criteria not met|0|||
129474604|NCT00603239|466029969|FG001|Overall Study|Entry criteria not met|1|||
129474605|NCT00603239|466029968|FG000|Overall Study|Loss of glucose control|3|||
129474606|NCT00603239|466029969|FG001|Overall Study|Loss of glucose control|0|||
129474607|NCT00603239|466029968|FG000|Overall Study|Lost to Follow-up|2|||
129474608|NCT00603239|466029969|FG001|Overall Study|Lost to Follow-up|1|||
129474609|NCT00603239|466029968|FG000|Overall Study|Physician Decision|2|||
129474610|NCT00603239|466029969|FG001|Overall Study|Physician Decision|0|||
129474611|NCT00603239|466029968|FG000|Overall Study|Protocol Violation|2|||
129474612|NCT00603239|466029969|FG001|Overall Study|Protocol Violation|0|||
129474613|NCT00603239|466029968|FG000|Overall Study|Subject decision|2|||
129474614|NCT00603239|466029969|FG001|Overall Study|Subject decision|1|||
129474615|NCT02357420|466029970|FG000|Overall Study|Adverse Event|3|||
129474616|NCT02357420|466029971|FG001|Overall Study|Adverse Event|3|||
129474617|NCT02357420|466029972|FG002|Overall Study|Adverse Event|8|||
129474618|NCT02357420|466029973|FG003|Overall Study|Adverse Event|9|||
129474619|NCT02357420|466029970|FG000|Overall Study|Investigator Decision|1|||
129474620|NCT02357420|466029971|FG001|Overall Study|Investigator Decision|0|||
129474621|NCT02357420|466029972|FG002|Overall Study|Investigator Decision|0|||
129474622|NCT02357420|466029973|FG003|Overall Study|Investigator Decision|0|||
129474623|NCT02357420|466029970|FG000|Overall Study|Prohibited Medication|1|||
129474624|NCT02357420|466029971|FG001|Overall Study|Prohibited Medication|1|||
129474625|NCT02357420|466029972|FG002|Overall Study|Prohibited Medication|0|||
129474626|NCT02357420|466029973|FG003|Overall Study|Prohibited Medication|0|||
129474627|NCT02357420|466029970|FG000|Overall Study|Protocol Non-compliance|0|||
129474628|NCT02357420|466029971|FG001|Overall Study|Protocol Non-compliance|0|||
129474629|NCT02357420|466029972|FG002|Overall Study|Protocol Non-compliance|0|||
129474630|NCT02357420|466029973|FG003|Overall Study|Protocol Non-compliance|1|||
129474631|NCT02357420|466029970|FG000|Overall Study|Withdrawn Consent|4|||
129474632|NCT02357420|466029971|FG001|Overall Study|Withdrawn Consent|8|||
129474633|NCT02357420|466029972|FG002|Overall Study|Withdrawn Consent|6|||
129474634|NCT02357420|466029973|FG003|Overall Study|Withdrawn Consent|6|||
129474635|NCT02357420|466029970|FG000|Overall Study|Lost to Follow-up|3|||
129474636|NCT02357420|466029971|FG001|Overall Study|Lost to Follow-up|0|||
129474637|NCT02357420|466029972|FG002|Overall Study|Lost to Follow-up|2|||
129474638|NCT02357420|466029973|FG003|Overall Study|Lost to Follow-up|3|||
129474639|NCT00928070|466029976|FG000|Overall Study|Lost to Follow-up|1|||
129474640|NCT00928070|466029977|FG001|Overall Study|Lost to Follow-up|2|||
129474641|NCT00928070|466029976|FG000|Overall Study|Withdrawal by Subject|10|||
129474642|NCT00928070|466029977|FG001|Overall Study|Withdrawal by Subject|3|||
129474643|NCT00928070|466029976|FG000|Overall Study|Adverse Event|14|||
129474644|NCT00928070|466029977|FG001|Overall Study|Adverse Event|26|||
129474645|NCT00928070|466029976|FG000|Overall Study|Lack of Efficacy|9|||
129474646|NCT00928070|466029977|FG001|Overall Study|Lack of Efficacy|5|||
129474647|NCT00928070|466029976|FG000|Overall Study|Did not meet entrance criteria|16|||
129474648|NCT00928070|466029977|FG001|Overall Study|Did not meet entrance criteria|9|||
129474649|NCT00928070|466029976|FG000|Overall Study|Protocol Violation|6|||
129474650|NCT00928070|466029977|FG001|Overall Study|Protocol Violation|5|||
129474651|NCT00928070|466029976|FG000|Overall Study|Randomized but not treated|2|||
129474652|NCT00928070|466029977|FG001|Overall Study|Randomized but not treated|2|||
129474653|NCT00928070|466029976|FG000|Overall Study|Other|5|||
129474654|NCT00928070|466029977|FG001|Overall Study|Other|5|||
129474655|NCT00191854|466029978|FG000|Overall Study|Death|26|||
129474656|NCT00191854|466029979|FG001|Overall Study|Death|23|||
129474657|NCT00191854|466029980|FG002|Overall Study|Death|29|||
129474658|NCT00191854|466029978|FG000|Overall Study|Lost to Follow-up|7|||
129474659|NCT00191854|466029979|FG001|Overall Study|Lost to Follow-up|5|||
129474660|NCT00191854|466029980|FG002|Overall Study|Lost to Follow-up|5|||
129474661|NCT00191854|466029978|FG000|Overall Study|Withdrawal by Subject|4|||
129474662|NCT00191854|466029979|FG001|Overall Study|Withdrawal by Subject|2|||
129474663|NCT00191854|466029980|FG002|Overall Study|Withdrawal by Subject|3|||
129474664|NCT00191854|466029978|FG000|Overall Study|Sponsor Decision|0|||
129474665|NCT00191854|466029979|FG001|Overall Study|Sponsor Decision|0|||
129474666|NCT00191854|466029980|FG002|Overall Study|Sponsor Decision|1|||
129474667|NCT00191854|466029978|FG000|Overall Study|Screen Failure|0|||
129474668|NCT00191854|466029979|FG001|Overall Study|Screen Failure|0|||
129976209|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129976210|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
129976211|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976212|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976213|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976214|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976215|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
129976216|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129474669|NCT00191854|466029980|FG002|Overall Study|Screen Failure|1|||
129474670|NCT05254418|466029984|FG000|Overall Study|Adverse Event|2|||
129474671|NCT06118385|466029985|FG000|Overall Study|Protocol Violation|0|||
129474672|NCT06118385|466029986|FG001|Overall Study|Protocol Violation|0|||
129474673|NCT06118385|466029987|FG002|Overall Study|Protocol Violation|0|||
129474674|NCT06118385|466029988|FG003|Overall Study|Protocol Violation|0|||
129474675|NCT06118385|466029989|FG004|Overall Study|Protocol Violation|0|||
129474676|NCT06118385|466029990|FG005|Overall Study|Protocol Violation|0|||
129474677|NCT06118385|466029991|FG006|Overall Study|Protocol Violation|0|||
129474678|NCT06118385|466029992|FG007|Overall Study|Protocol Violation|0|||
129474679|NCT06118385|466029993|FG008|Overall Study|Protocol Violation|1|||
129474680|NCT06118385|466029994|FG009|Overall Study|Protocol Violation|0|||
129474681|NCT06118385|466029995|FG010|Overall Study|Protocol Violation|0|||
129474682|NCT06118385|466029996|FG011|Overall Study|Protocol Violation|0|||
129474683|NCT06118385|466029985|FG000|Overall Study|Out-of-range blood tests|0|||
129474684|NCT06118385|466029986|FG001|Overall Study|Out-of-range blood tests|0|||
129474685|NCT06118385|466029987|FG002|Overall Study|Out-of-range blood tests|0|||
129474686|NCT06118385|466029988|FG003|Overall Study|Out-of-range blood tests|0|||
129474687|NCT06118385|466029989|FG004|Overall Study|Out-of-range blood tests|0|||
129474688|NCT06118385|466029990|FG005|Overall Study|Out-of-range blood tests|0|||
129474689|NCT06118385|466029991|FG006|Overall Study|Out-of-range blood tests|0|||
129474690|NCT06118385|466029992|FG007|Overall Study|Out-of-range blood tests|0|||
129474691|NCT06118385|466029993|FG008|Overall Study|Out-of-range blood tests|1|||
129474692|NCT06118385|466029994|FG009|Overall Study|Out-of-range blood tests|0|||
129474693|NCT06118385|466029995|FG010|Overall Study|Out-of-range blood tests|0|||
129474694|NCT06118385|466029996|FG011|Overall Study|Out-of-range blood tests|0|||
129474695|NCT01323478|466029997|FG000|Overall Study|Adverse Event|7|||
129474696|NCT01323478|466029997|FG000|Overall Study|Lack of Efficacy|4|||
129474697|NCT01323478|466029997|FG000|Overall Study|Non-compliance With Study Product|3|||
129474698|NCT01323478|466029997|FG000|Overall Study|Protocol Violation|1|||
129474699|NCT01323478|466029997|FG000|Overall Study|Withdrawal of Consent|1|||
129474700|NCT01323478|466029997|FG000|Overall Study|Administrative or Other Reasons|8|||
129474701|NCT02411448|466029998|FG000|Overall Study|Withdrawal by Subject|1|||
129474702|NCT02411448|466029999|FG001|Overall Study|Withdrawal by Subject|14|||
129474703|NCT02411448|466030000|FG002|Overall Study|Withdrawal by Subject|9|||
129976217|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
129976218|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
129474704|NCT02411448|466029998|FG000|Overall Study|Other|0|||
129474705|NCT02411448|466029999|FG001|Overall Study|Other|2|||
129474706|NCT02411448|466030000|FG002|Overall Study|Other|0|||
129474707|NCT02411448|466029998|FG000|Overall Study|Did not receive study treatment|0|||
129474708|NCT02411448|466029999|FG001|Overall Study|Did not receive study treatment|3|||
129474709|NCT02411448|466030000|FG002|Overall Study|Did not receive study treatment|0|||
129474710|NCT02411448|466029998|FG000|Overall Study|Alive on study treatment|3|||
129474711|NCT02411448|466029999|FG001|Overall Study|Alive on study treatment|64|||
129474712|NCT02411448|466030000|FG002|Overall Study|Alive on study treatment|43|||
129474713|NCT02771522|466030003|FG000|Overall Study|Lost to Follow-up|3|||
129474714|NCT02771522|466030003|FG000|Overall Study|Withdrawal by Subject|2|||
129474715|NCT02771522|466030003|FG000|Overall Study|No white spot lesions|3|||
129474716|NCT05655377|466030006|FG000|Overall Study|Withdrawal by Subject|2|||
129474717|NCT01256177|466030007|FG000|Overall Study|Withdrawal by Subject|23|||
129474718|NCT01256177|466030008|FG001|Overall Study|Withdrawal by Subject|22|||
129474719|NCT01256177|466030007|FG000|Overall Study|Lost to Follow-up|2|||
129474720|NCT01256177|466030008|FG001|Overall Study|Lost to Follow-up|2|||
129474721|NCT01256177|466030007|FG000|Overall Study|Adverse Event|8|||
129474722|NCT01256177|466030008|FG001|Overall Study|Adverse Event|9|||
129474723|NCT01256177|466030007|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
129474724|NCT01256177|466030008|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
129474725|NCT01256177|466030007|FG000|Overall Study|Condition under Investigation Worsened|1|||
129474726|NCT01256177|466030008|FG001|Overall Study|Condition under Investigation Worsened|0|||
129474727|NCT01256177|466030007|FG000|Overall Study|Lack of Efficacy|11|||
129474728|NCT01256177|466030008|FG001|Overall Study|Lack of Efficacy|2|||
129474729|NCT01256177|466030007|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
129474730|NCT01256177|466030008|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
129474731|NCT03624946|466030012|FG000|Overall Study|Lost to Follow-up|0|||
129474732|NCT03624946|466030013|FG001|Overall Study|Lost to Follow-up|1|||
129474733|NCT00553462|466030014|FG000|Overall Study|Adverse Event|4|||
129474734|NCT00553462|466030014|FG000|Overall Study|Progression|4|||
129474735|NCT00553462|466030014|FG000|Overall Study|Withdrawal by Subject|5|||
129474736|NCT00553462|466030014|FG000|Overall Study|Physician Decision|1|||
129474737|NCT01869348|466030015|FG000|Overall Study|Withdrawal by Subject|1|||
129474738|NCT01869348|466030016|FG001|Overall Study|Withdrawal by Subject|1|||
129474739|NCT01728779|466030017|FG000|Overall Study|Withdrawal by Subject|1|||
129474740|NCT00624520|466030018|FG000|Overall Study|Withdrawal by Subject|12|||
129474741|NCT00624520|466030019|FG001|Overall Study|Withdrawal by Subject|7|||
129474742|NCT00624520|466030018|FG000|Overall Study|Death|0|||
129474743|NCT00624520|466030019|FG001|Overall Study|Death|1|||
129474744|NCT01925209|466030020|FG000|Treatment Epoch|Physician Decision|1|||
129474745|NCT01925209|466030021|FG001|Treatment Epoch|Physician Decision|0|||
129474746|NCT01925209|466030022|FG002|Treatment Epoch|Physician Decision|0|||
129474747|NCT01925209|466030023|FG003|Treatment Epoch|Physician Decision|0|||
129474748|NCT01925209|466030020|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
129474749|NCT01925209|466030021|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
129474750|NCT01925209|466030022|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
129474751|NCT01925209|466030023|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
129474752|NCT01925209|466030020|FG000|Treatment Epoch|Death|1|||
129474753|NCT01925209|466030021|FG001|Treatment Epoch|Death|0|||
129474754|NCT01925209|466030022|FG002|Treatment Epoch|Death|0|||
129474755|NCT01925209|466030023|FG003|Treatment Epoch|Death|0|||
129474756|NCT01925209|466030020|FG000|Treatment Epoch|Protocol deviation|0|||
129474757|NCT01925209|466030021|FG001|Treatment Epoch|Protocol deviation|0|||
129474758|NCT01925209|466030022|FG002|Treatment Epoch|Protocol deviation|1|||
129474759|NCT01925209|466030023|FG003|Treatment Epoch|Protocol deviation|1|||
129474760|NCT01925209|466030020|FG000|Treatment Epoch|Withdrawal by Subject|4|||
129474761|NCT01925209|466030021|FG001|Treatment Epoch|Withdrawal by Subject|3|||
129474762|NCT01925209|466030022|FG002|Treatment Epoch|Withdrawal by Subject|3|||
129474763|NCT01925209|466030023|FG003|Treatment Epoch|Withdrawal by Subject|2|||
129474764|NCT01925209|466030020|FG000|Treatment Epoch|Adverse Event|3|||
129474765|NCT01925209|466030021|FG001|Treatment Epoch|Adverse Event|5|||
129474766|NCT01925209|466030022|FG002|Treatment Epoch|Adverse Event|3|||
129474767|NCT01925209|466030023|FG003|Treatment Epoch|Adverse Event|1|||
129474768|NCT01925209|466030020|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
129474769|NCT01925209|466030021|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
129474770|NCT01925209|466030022|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
129474771|NCT01925209|466030023|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
129474772|NCT01925209|466030020|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
129474773|NCT01925209|466030021|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
129474774|NCT01925209|466030022|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
129474775|NCT01925209|466030023|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
129474776|NCT01925209|466030020|FG000|Follow-up|Adverse Event|1|||
129474777|NCT01925209|466030021|FG001|Follow-up|Adverse Event|4|||
129474778|NCT01925209|466030022|FG002|Follow-up|Adverse Event|0|||
129474779|NCT01925209|466030023|FG003|Follow-up|Adverse Event|1|||
129474780|NCT01925209|466030020|FG000|Follow-up|Physician Decision|0|||
129474781|NCT01925209|466030021|FG001|Follow-up|Physician Decision|0|||
129474782|NCT01925209|466030022|FG002|Follow-up|Physician Decision|1|||
129474783|NCT01925209|466030023|FG003|Follow-up|Physician Decision|0|||
129474784|NCT01925209|466030020|FG000|Follow-up|Non-compliance with study treatment|0|||
129474785|NCT01925209|466030021|FG001|Follow-up|Non-compliance with study treatment|0|||
129474786|NCT01925209|466030022|FG002|Follow-up|Non-compliance with study treatment|0|||
129474787|NCT01925209|466030023|FG003|Follow-up|Non-compliance with study treatment|1|||
129474788|NCT01925209|466030020|FG000|Follow-up|Withdrawal by Subject|0|||
129474789|NCT01925209|466030021|FG001|Follow-up|Withdrawal by Subject|2|||
129474790|NCT01925209|466030022|FG002|Follow-up|Withdrawal by Subject|0|||
129474791|NCT01925209|466030023|FG003|Follow-up|Withdrawal by Subject|2|||
129474792|NCT02796755|466030024|FG000|Overall Study|Adverse Event|2|||
129474793|NCT02796755|466030025|FG001|Overall Study|Adverse Event|0|||
129474794|NCT04398732|466030029|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
129474795|NCT00556426|466030030|FG000|Overall Study|Withdrawal by Subject|3|||
129474796|NCT00556426|466030030|FG000|Overall Study|Death|6|||
129474797|NCT01596257|466030034|FG000|Overall Study|Inadequate Collection|23|||
129474798|NCT01596257|466030035|FG001|Overall Study|Inadequate Collection|19|||
129474799|NCT00792298|466030039|FG000|Treatment Period 1|Adverse Event|0|||
129474800|NCT00792298|466030040|FG001|Treatment Period 1|Adverse Event|1|||
129474801|NCT00792298|466030041|FG002|Treatment Period 1|Adverse Event|0|||
129474802|NCT00792298|466030042|FG003|Treatment Period 1|Adverse Event|1|||
129474803|NCT00792298|466030043|FG004|Treatment Period 1|Adverse Event|0|||
129474804|NCT00792298|466030044|FG005|Treatment Period 1|Adverse Event|1|||
129474805|NCT00792298|466030045|FG006|Treatment Period 1|Adverse Event|1|||
129474806|NCT00792298|466030046|FG007|Treatment Period 1|Adverse Event|0|||
129474807|NCT00792298|466030039|FG000|Treatment Period 1|Lack of Efficacy|0|||
129474808|NCT00792298|466030040|FG001|Treatment Period 1|Lack of Efficacy|0|||
129474809|NCT00792298|466030041|FG002|Treatment Period 1|Lack of Efficacy|1|||
129474810|NCT00792298|466030042|FG003|Treatment Period 1|Lack of Efficacy|0|||
129474811|NCT00792298|466030043|FG004|Treatment Period 1|Lack of Efficacy|0|||
129474812|NCT00792298|466030044|FG005|Treatment Period 1|Lack of Efficacy|0|||
129474813|NCT00792298|466030045|FG006|Treatment Period 1|Lack of Efficacy|0|||
129474814|NCT00792298|466030046|FG007|Treatment Period 1|Lack of Efficacy|0|||
129474815|NCT00792298|466030039|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129474816|NCT00792298|466030040|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129474817|NCT00792298|466030041|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129474818|NCT00792298|466030042|FG003|Treatment Period 1|Withdrawal by Subject|2|||
129474819|NCT00792298|466030043|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129474820|NCT00792298|466030044|FG005|Treatment Period 1|Withdrawal by Subject|2|||
129474821|NCT00792298|466030045|FG006|Treatment Period 1|Withdrawal by Subject|1|||
129474822|NCT00792298|466030046|FG007|Treatment Period 1|Withdrawal by Subject|0|||
129474823|NCT00792298|466030039|FG000|Treatment Period 1|Lost to Follow-up|0|||
129474824|NCT00792298|466030040|FG001|Treatment Period 1|Lost to Follow-up|0|||
129474825|NCT00792298|466030041|FG002|Treatment Period 1|Lost to Follow-up|0|||
129474826|NCT00792298|466030042|FG003|Treatment Period 1|Lost to Follow-up|0|||
129474827|NCT00792298|466030043|FG004|Treatment Period 1|Lost to Follow-up|0|||
129474828|NCT00792298|466030044|FG005|Treatment Period 1|Lost to Follow-up|0|||
129474829|NCT00792298|466030045|FG006|Treatment Period 1|Lost to Follow-up|1|||
129474830|NCT00792298|466030046|FG007|Treatment Period 1|Lost to Follow-up|0|||
129474831|NCT00792298|466030039|FG000|Treatment Period 1|Physician Decision|0|||
129474832|NCT00792298|466030040|FG001|Treatment Period 1|Physician Decision|0|||
129474833|NCT00792298|466030041|FG002|Treatment Period 1|Physician Decision|0|||
129474834|NCT00792298|466030042|FG003|Treatment Period 1|Physician Decision|1|||
129474835|NCT00792298|466030043|FG004|Treatment Period 1|Physician Decision|0|||
129474836|NCT00792298|466030044|FG005|Treatment Period 1|Physician Decision|0|||
129474837|NCT00792298|466030045|FG006|Treatment Period 1|Physician Decision|1|||
129474838|NCT00792298|466030046|FG007|Treatment Period 1|Physician Decision|0|||
129474839|NCT00792298|466030039|FG000|Treatment Period 1|Protocol Violation|0|||
129474840|NCT00792298|466030040|FG001|Treatment Period 1|Protocol Violation|0|||
129474841|NCT00792298|466030041|FG002|Treatment Period 1|Protocol Violation|0|||
129474842|NCT00792298|466030042|FG003|Treatment Period 1|Protocol Violation|0|||
129474843|NCT00792298|466030043|FG004|Treatment Period 1|Protocol Violation|0|||
129474844|NCT00792298|466030044|FG005|Treatment Period 1|Protocol Violation|0|||
129474845|NCT00792298|466030045|FG006|Treatment Period 1|Protocol Violation|0|||
129474846|NCT00792298|466030046|FG007|Treatment Period 1|Protocol Violation|1|||
129474847|NCT00792298|466030039|FG000|Washout|Adverse Event|0|||
129474848|NCT00792298|466030040|FG001|Washout|Adverse Event|0|||
129474849|NCT00792298|466030041|FG002|Washout|Adverse Event|0|||
129474850|NCT00792298|466030042|FG003|Washout|Adverse Event|0|||
129474851|NCT00792298|466030043|FG004|Washout|Adverse Event|0|||
129474852|NCT00792298|466030044|FG005|Washout|Adverse Event|1|||
129474853|NCT00792298|466030045|FG006|Washout|Adverse Event|0|||
129474854|NCT00792298|466030046|FG007|Washout|Adverse Event|0|||
129474855|NCT00792298|466030039|FG000|Washout|Withdrawal by Subject|0|||
129474856|NCT00792298|466030040|FG001|Washout|Withdrawal by Subject|0|||
129474857|NCT00792298|466030041|FG002|Washout|Withdrawal by Subject|1|||
129474858|NCT00792298|466030042|FG003|Washout|Withdrawal by Subject|0|||
129474859|NCT00792298|466030043|FG004|Washout|Withdrawal by Subject|0|||
129474860|NCT00792298|466030044|FG005|Washout|Withdrawal by Subject|1|||
129474861|NCT00792298|466030045|FG006|Washout|Withdrawal by Subject|0|||
129474862|NCT00792298|466030046|FG007|Washout|Withdrawal by Subject|0|||
129474863|NCT00792298|466030039|FG000|Treatment Period 2|Lack of Efficacy|0|||
129474864|NCT00792298|466030040|FG001|Treatment Period 2|Lack of Efficacy|0|||
129474865|NCT00792298|466030041|FG002|Treatment Period 2|Lack of Efficacy|0|||
129474866|NCT00792298|466030042|FG003|Treatment Period 2|Lack of Efficacy|0|||
129474867|NCT00792298|466030043|FG004|Treatment Period 2|Lack of Efficacy|1|||
129474868|NCT00792298|466030044|FG005|Treatment Period 2|Lack of Efficacy|0|||
129474869|NCT00792298|466030045|FG006|Treatment Period 2|Lack of Efficacy|0|||
129474870|NCT00792298|466030046|FG007|Treatment Period 2|Lack of Efficacy|0|||
129474871|NCT00792298|466030039|FG000|Treatment Period 2|Physician Decision|0|||
129474872|NCT00792298|466030040|FG001|Treatment Period 2|Physician Decision|0|||
129474873|NCT00792298|466030041|FG002|Treatment Period 2|Physician Decision|0|||
129474874|NCT00792298|466030042|FG003|Treatment Period 2|Physician Decision|0|||
129474875|NCT00792298|466030043|FG004|Treatment Period 2|Physician Decision|0|||
129474876|NCT00792298|466030044|FG005|Treatment Period 2|Physician Decision|0|||
129474877|NCT00792298|466030045|FG006|Treatment Period 2|Physician Decision|1|||
129474878|NCT00792298|466030046|FG007|Treatment Period 2|Physician Decision|0|||
129474879|NCT00792298|466030039|FG000|Treatment Period 2|Pregnancy|0|||
129474880|NCT00792298|466030040|FG001|Treatment Period 2|Pregnancy|0|||
129474881|NCT00792298|466030041|FG002|Treatment Period 2|Pregnancy|1|||
129474882|NCT00792298|466030042|FG003|Treatment Period 2|Pregnancy|0|||
129474883|NCT00792298|466030043|FG004|Treatment Period 2|Pregnancy|0|||
129474884|NCT00792298|466030044|FG005|Treatment Period 2|Pregnancy|0|||
129474885|NCT00792298|466030045|FG006|Treatment Period 2|Pregnancy|0|||
129474886|NCT00792298|466030046|FG007|Treatment Period 2|Pregnancy|0|||
129474887|NCT00792298|466030039|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129474888|NCT00792298|466030040|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129474889|NCT00792298|466030041|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129474890|NCT00792298|466030042|FG003|Treatment Period 2|Withdrawal by Subject|2|||
129474891|NCT00792298|466030043|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129474892|NCT00792298|466030044|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129474893|NCT00792298|466030045|FG006|Treatment Period 2|Withdrawal by Subject|0|||
129474894|NCT00792298|466030046|FG007|Treatment Period 2|Withdrawal by Subject|2|||
129474895|NCT04258579|466030052|FG000|Overall Study|Withdrawal by Subject|7|||
129474896|NCT04258579|466030052|FG000|Overall Study|Lost to Follow-up|3|||
129474897|NCT04258579|466030052|FG000|Overall Study|Protocol Violation|2|||
129474898|NCT04258579|466030052|FG000|Overall Study|Adverse Event|1|||
129474899|NCT01950819|466030058|FG000|Overall Study|Graft Loss|35|||
129474900|NCT01950819|466030059|FG001|Overall Study|Graft Loss|30|||
129474901|NCT01950819|466030058|FG000|Overall Study|Death|29|||
129474902|NCT01950819|466030059|FG001|Overall Study|Death|34|||
129474903|NCT01950819|466030058|FG000|Overall Study|Subject / Gardian decision|54|||
129474904|NCT01950819|466030059|FG001|Overall Study|Subject / Gardian decision|51|||
129474905|NCT01950819|466030058|FG000|Overall Study|technical problems|2|||
129474906|NCT01950819|466030059|FG001|Overall Study|technical problems|0|||
129474907|NCT01950819|466030058|FG000|Overall Study|Pregnancy|0|||
129474908|NCT01950819|466030059|FG001|Overall Study|Pregnancy|2|||
129474909|NCT01950819|466030058|FG000|Overall Study|Lost to Follow-up|9|||
129474910|NCT01950819|466030059|FG001|Overall Study|Lost to Follow-up|17|||
129474911|NCT02928952|466030060|FG000|Overall Study|Lost to Follow-up|5|||
129474912|NCT02928952|466030061|FG001|Overall Study|Lost to Follow-up|5|||
129474913|NCT02928952|466030060|FG000|Overall Study|Withdrawal by Subject|5|||
129474914|NCT02928952|466030061|FG001|Overall Study|Withdrawal by Subject|1|||
129474915|NCT02928952|466030060|FG000|Overall Study|Physician Decision|0|||
129474916|NCT02928952|466030061|FG001|Overall Study|Physician Decision|1|||
129474917|NCT01850615|466030062|FG000|Overall Study|Protocol Violation|4|||
129474918|NCT01850615|466030063|FG001|Overall Study|Protocol Violation|1|||
129474919|NCT01850615|466030062|FG000|Overall Study|Adverse Event|2|||
129474920|NCT01850615|466030063|FG001|Overall Study|Adverse Event|1|||
129474921|NCT01850615|466030062|FG000|Overall Study|Withdrawal by Subject|3|||
129474922|NCT01850615|466030063|FG001|Overall Study|Withdrawal by Subject|1|||
129474923|NCT01850615|466030062|FG000|Overall Study|Lost to Follow-up|0|||
129474924|NCT01850615|466030063|FG001|Overall Study|Lost to Follow-up|1|||
129474925|NCT01850615|466030062|FG000|Overall Study|Unclassified|0|||
129474926|NCT01850615|466030063|FG001|Overall Study|Unclassified|1|||
129474927|NCT00712348|466030067|FG000|Overall Study|Withdrawal by Subject|1|||
129474928|NCT01929135|466030072|FG000|Overall Study|Lost to Follow-up|1|||
129474929|NCT01929135|466030073|FG001|Overall Study|Lost to Follow-up|1|||
129474930|NCT02425098|466030074|FG000|Overall Study|Lost to Follow-up|7|||
129474931|NCT02425098|466030075|FG001|Overall Study|Lost to Follow-up|7|||
129474932|NCT02425098|466030074|FG000|Overall Study|Withdrawal by Subject|4|||
129474933|NCT02425098|466030075|FG001|Overall Study|Withdrawal by Subject|8|||
129474934|NCT02425098|466030074|FG000|Overall Study|Pregnancy|2|||
129474935|NCT02425098|466030075|FG001|Overall Study|Pregnancy|0|||
129474936|NCT02425098|466030074|FG000|Overall Study|Reason not Specified|0|||
129474937|NCT02425098|466030075|FG001|Overall Study|Reason not Specified|1|||
129474938|NCT02078219|466030076|FG000|Overall Study|Other|2|||
129474939|NCT02078219|466030077|FG001|Overall Study|Other|2|||
129474940|NCT02078219|466030078|FG002|Overall Study|Other|3|||
129474941|NCT02078219|466030079|FG003|Overall Study|Other|0|||
129474942|NCT02078219|466030080|FG004|Overall Study|Other|1|||
129474943|NCT02078219|466030076|FG000|Overall Study|Withdrawal by Subject|0|||
129474944|NCT02078219|466030077|FG001|Overall Study|Withdrawal by Subject|1|||
129474945|NCT02078219|466030078|FG002|Overall Study|Withdrawal by Subject|0|||
129474946|NCT02078219|466030079|FG003|Overall Study|Withdrawal by Subject|1|||
129474947|NCT02078219|466030080|FG004|Overall Study|Withdrawal by Subject|1|||
129474948|NCT02078219|466030076|FG000|Overall Study|Protocol Violation|0|||
129474949|NCT02078219|466030077|FG001|Overall Study|Protocol Violation|0|||
129474950|NCT02078219|466030078|FG002|Overall Study|Protocol Violation|0|||
129474951|NCT02078219|466030079|FG003|Overall Study|Protocol Violation|1|||
129474952|NCT02078219|466030080|FG004|Overall Study|Protocol Violation|0|||
129474953|NCT02078219|466030076|FG000|Overall Study|Death|0|||
129474954|NCT02078219|466030077|FG001|Overall Study|Death|0|||
129474955|NCT02078219|466030078|FG002|Overall Study|Death|0|||
129474956|NCT02078219|466030079|FG003|Overall Study|Death|1|||
129474957|NCT02078219|466030080|FG004|Overall Study|Death|0|||
129474958|NCT02078219|466030076|FG000|Overall Study|Adverse Event|1|||
129474959|NCT02078219|466030077|FG001|Overall Study|Adverse Event|1|||
129474960|NCT02078219|466030078|FG002|Overall Study|Adverse Event|3|||
129474961|NCT02078219|466030079|FG003|Overall Study|Adverse Event|1|||
129474962|NCT02078219|466030080|FG004|Overall Study|Adverse Event|0|||
129474963|NCT03136107|466030087|FG000|Overall Study|Other (Not specified)|1|||
129474964|NCT03283085|466030088|FG000|Overall Study|Adverse Event|18|||
129474965|NCT03283085|466030089|FG001|Overall Study|Adverse Event|3|||
129474966|NCT03283085|466030090|FG002|Overall Study|Adverse Event|13|||
129474967|NCT03283085|466030091|FG003|Overall Study|Adverse Event|0|||
129474968|NCT03283085|466030092|FG004|Overall Study|Adverse Event|0|||
129474969|NCT03283085|466030093|FG005|Overall Study|Adverse Event|5|||
129474970|NCT03283085|466030088|FG000|Overall Study|Death|0|||
129474971|NCT03283085|466030089|FG001|Overall Study|Death|0|||
129474972|NCT03283085|466030090|FG002|Overall Study|Death|3|||
129474973|NCT03283085|466030091|FG003|Overall Study|Death|1|||
129474974|NCT03283085|466030092|FG004|Overall Study|Death|0|||
129474975|NCT03283085|466030093|FG005|Overall Study|Death|0|||
129474976|NCT03283085|466030088|FG000|Overall Study|Withdrawal by Subject|42|||
129474977|NCT03283085|466030089|FG001|Overall Study|Withdrawal by Subject|21|||
129474978|NCT03283085|466030090|FG002|Overall Study|Withdrawal by Subject|66|||
129474979|NCT03283085|466030091|FG003|Overall Study|Withdrawal by Subject|3|||
129474980|NCT03283085|466030092|FG004|Overall Study|Withdrawal by Subject|3|||
129474981|NCT03283085|466030093|FG005|Overall Study|Withdrawal by Subject|5|||
129474982|NCT03283085|466030088|FG000|Overall Study|Physician Decision|14|||
129474983|NCT03283085|466030089|FG001|Overall Study|Physician Decision|8|||
129474984|NCT03283085|466030090|FG002|Overall Study|Physician Decision|19|||
129474985|NCT03283085|466030091|FG003|Overall Study|Physician Decision|0|||
129474986|NCT03283085|466030092|FG004|Overall Study|Physician Decision|0|||
129474987|NCT03283085|466030093|FG005|Overall Study|Physician Decision|2|||
129474988|NCT03283085|466030088|FG000|Overall Study|Site Terminated by Sponsor|1|||
129474989|NCT03283085|466030089|FG001|Overall Study|Site Terminated by Sponsor|0|||
129474990|NCT03283085|466030090|FG002|Overall Study|Site Terminated by Sponsor|3|||
129474991|NCT03283085|466030091|FG003|Overall Study|Site Terminated by Sponsor|0|||
129474992|NCT03283085|466030092|FG004|Overall Study|Site Terminated by Sponsor|0|||
129474993|NCT03283085|466030093|FG005|Overall Study|Site Terminated by Sponsor|0|||
129474994|NCT03283085|466030088|FG000|Overall Study|Lost to Follow-up|2|||
129474995|NCT03283085|466030089|FG001|Overall Study|Lost to Follow-up|0|||
129474996|NCT03283085|466030090|FG002|Overall Study|Lost to Follow-up|2|||
129474997|NCT03283085|466030091|FG003|Overall Study|Lost to Follow-up|0|||
129474998|NCT03283085|466030092|FG004|Overall Study|Lost to Follow-up|0|||
129474999|NCT03283085|466030093|FG005|Overall Study|Lost to Follow-up|1|||
129475000|NCT03283085|466030088|FG000|Overall Study|Pregnancy|0|||
129475001|NCT03283085|466030089|FG001|Overall Study|Pregnancy|0|||
129475002|NCT03283085|466030090|FG002|Overall Study|Pregnancy|1|||
129475003|NCT03283085|466030091|FG003|Overall Study|Pregnancy|0|||
129475004|NCT03283085|466030092|FG004|Overall Study|Pregnancy|0|||
129475005|NCT03283085|466030093|FG005|Overall Study|Pregnancy|0|||
129475006|NCT03283085|466030088|FG000|Overall Study|Lack of Efficacy|12|||
129475007|NCT03283085|466030089|FG001|Overall Study|Lack of Efficacy|6|||
129475008|NCT03283085|466030090|FG002|Overall Study|Lack of Efficacy|24|||
129475009|NCT03283085|466030091|FG003|Overall Study|Lack of Efficacy|1|||
129475010|NCT03283085|466030092|FG004|Overall Study|Lack of Efficacy|1|||
129475011|NCT03283085|466030093|FG005|Overall Study|Lack of Efficacy|0|||
129475012|NCT03283085|466030088|FG000|Overall Study|Reason not Specified|0|||
129475013|NCT03283085|466030089|FG001|Overall Study|Reason not Specified|4|||
129475014|NCT03283085|466030090|FG002|Overall Study|Reason not Specified|8|||
129475015|NCT03283085|466030091|FG003|Overall Study|Reason not Specified|0|||
129475016|NCT03283085|466030092|FG004|Overall Study|Reason not Specified|0|||
129475017|NCT03283085|466030093|FG005|Overall Study|Reason not Specified|1|||
129475018|NCT02292771|466030097|FG000|Overall Study|Withdrawal by Subject|2|||
129475019|NCT02292771|466030098|FG001|Overall Study|Withdrawal by Subject|1|||
129475020|NCT02292771|466030097|FG000|Overall Study|Lost to Follow-up|2|||
129475021|NCT02292771|466030098|FG001|Overall Study|Lost to Follow-up|1|||
129475022|NCT04025632|466031775|FG000|Overall Study|Adverse Event|1|||
129475023|NCT04025632|466031776|FG001|Overall Study|Adverse Event|1|||
129475024|NCT04025632|466031775|FG000|Overall Study|Withdrawal by Subject|1|||
129475025|NCT04025632|466031776|FG001|Overall Study|Withdrawal by Subject|1|||
129475026|NCT04025632|466031775|FG000|Overall Study|Study Terminated by Sponsor|10|||
129475027|NCT04025632|466031776|FG001|Overall Study|Study Terminated by Sponsor|9|||
129475028|NCT04025632|466031775|FG000|Overall Study|Physician Decision|3|||
129475029|NCT04025632|466031776|FG001|Overall Study|Physician Decision|1|||
129475030|NCT00127127|466031777|FG000|Overall Study|Adverse Event|0|||
129475031|NCT00127127|466031778|FG001|Overall Study|Adverse Event|2|||
129475032|NCT00127127|466031779|FG002|Overall Study|Adverse Event|0|||
129475033|NCT00127127|466031780|FG003|Overall Study|Adverse Event|1|||
129475034|NCT00127127|466031777|FG000|Overall Study|Lack of Efficacy|1|||
129475035|NCT00127127|466031778|FG001|Overall Study|Lack of Efficacy|3|||
129475036|NCT00127127|466031779|FG002|Overall Study|Lack of Efficacy|0|||
129475037|NCT00127127|466031780|FG003|Overall Study|Lack of Efficacy|2|||
129475038|NCT01524991|466031781|FG000|Overall Study|Adverse Event|12|||
129475039|NCT01524991|466031781|FG000|Overall Study|Death|1|||
129475040|NCT01524991|466031781|FG000|Overall Study|Disease ProgressionDu|17|||
129475041|NCT01524991|466031781|FG000|Overall Study|Other complicating disease|1|||
129475042|NCT01524991|466031781|FG000|Overall Study|Withdrawal by Subject|2|||
129475043|NCT01524991|466031781|FG000|Overall Study|Symptomatic Deterioration|1|||
129475044|NCT01805180|466031782|FG000|Lead-in Donor Phase|screen failure|1|||
129475045|NCT01805180|466031783|FG001|Lead-in Donor Phase|screen failure|0|||
129475046|NCT01805180|466031784|FG002|Lead-in Donor Phase|screen failure|0|||
129475047|NCT00398112|466031805|FG000|Overall Study|Adverse Event|4|||
129475048|NCT00398112|466031805|FG000|Overall Study|Disease progression|9|||
129475049|NCT00398112|466031805|FG000|Overall Study|Alternative treatment|1|||
129475050|NCT00398112|466031805|FG000|Overall Study|Withdrawal by Subject|3|||
129475051|NCT00398112|466031805|FG000|Overall Study|Death|1|||
129475052|NCT05148884|466031806|FG000|Overall Study|Withdrawal by Subject|3|||
129475053|NCT05148884|466031807|FG001|Overall Study|Withdrawal by Subject|0|||
129475054|NCT05148884|466031806|FG000|Overall Study|Deep brain stimulation operation|0|||
129475055|NCT05148884|466031807|FG001|Overall Study|Deep brain stimulation operation|1|||
129475056|NCT00365989|466031808|FG000|Overall Study|Withdrawal by Subject|1|||
129475057|NCT00365989|466031808|FG000|Overall Study|Non-compliance|1|||
129475058|NCT00851903|466031810|FG000|Overall Study|Withdrawal by Subject|2|||
129475059|NCT02318095|466031811|FG000|Overall Study|Adverse Event|1|||
129475060|NCT00686127|466031812|FG000|Overall Study|Withdrawal by Subject|14|||
129475061|NCT00686127|466031813|FG001|Overall Study|Withdrawal by Subject|6|||
129475062|NCT02300129|466031814|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
129475063|NCT02300129|466031815|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
129475064|NCT02300129|466031816|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
129475065|NCT02300129|466031817|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
129475066|NCT02300129|466031814|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
129475067|NCT02300129|466031815|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
129475068|NCT02300129|466031816|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
129475069|NCT02300129|466031817|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
129475070|NCT02300129|466031814|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
129475071|NCT02300129|466031815|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
129475072|NCT02300129|466031816|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
129475073|NCT02300129|466031817|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
129475074|NCT00522392|466031820|FG000|Overall Study|Disease progression|0|||
129475075|NCT00522392|466031821|FG001|Overall Study|Disease progression|3|||
129475076|NCT00522392|466031820|FG000|Overall Study|Adverse Event|7|||
129475077|NCT00522392|466031821|FG001|Overall Study|Adverse Event|7|||
129475078|NCT00522392|466031820|FG000|Overall Study|Withdrawal by Subject|1|||
129475079|NCT00522392|466031821|FG001|Overall Study|Withdrawal by Subject|1|||
129475080|NCT00522392|466031820|FG000|Overall Study|Physician Decision|0|||
129475081|NCT00522392|466031821|FG001|Overall Study|Physician Decision|1|||
129475082|NCT00522392|466031820|FG000|Overall Study|Non-compliance|0|||
129475083|NCT00522392|466031821|FG001|Overall Study|Non-compliance|1|||
129475084|NCT05211336|466031824|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
129475085|NCT05211336|466031825|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
129475086|NCT05211336|466031824|FG000|Overall Study|Progressive disease|0|||
129475087|NCT05211336|466031825|FG001|Overall Study|Progressive disease|4|||
129475088|NCT05211336|466031824|FG000|Overall Study|Death due to myocardial infarction|0|||
129475089|NCT05211336|466031825|FG001|Overall Study|Death due to myocardial infarction|1|||
129475090|NCT05211336|466031824|FG000|Overall Study|Death due to unknown cause|0|||
129475091|NCT05211336|466031825|FG001|Overall Study|Death due to unknown cause|1|||
129475092|NCT05211336|466031824|FG000|Overall Study|Worsening kidney function and quality of response|0|||
129475093|NCT05211336|466031825|FG001|Overall Study|Worsening kidney function and quality of response|1|||
129475094|NCT00332709|466031826|FG000|Overall Study|Adverse Event|11|||
129475095|NCT00332709|466031827|FG001|Overall Study|Adverse Event|14|||
129475096|NCT00332709|466031826|FG000|Overall Study|Withdrawal by Subject|2|||
129475097|NCT00332709|466031827|FG001|Overall Study|Withdrawal by Subject|3|||
129475098|NCT00332709|466031826|FG000|Overall Study|Lost to Follow-up|2|||
129475099|NCT00332709|466031827|FG001|Overall Study|Lost to Follow-up|0|||
129475100|NCT00332709|466031826|FG000|Overall Study|Administrative Problems|0|||
129475101|NCT00332709|466031827|FG001|Overall Study|Administrative Problems|3|||
129475102|NCT00332709|466031826|FG000|Overall Study|Abnormal test procedure result|1|||
129475103|NCT00332709|466031827|FG001|Overall Study|Abnormal test procedure result|0|||
129475104|NCT03575104|466031828|FG000|Overall Study|Adverse Event|4|||
129475105|NCT03575104|466031829|FG001|Overall Study|Adverse Event|3|||
129475106|NCT03575104|466031830|FG002|Overall Study|Adverse Event|4|||
129475107|NCT03575104|466031828|FG000|Overall Study|Withdrawal by Subject|13|||
129475108|NCT03575104|466031829|FG001|Overall Study|Withdrawal by Subject|16|||
129475109|NCT03575104|466031830|FG002|Overall Study|Withdrawal by Subject|11|||
129475110|NCT03575104|466031828|FG000|Overall Study|Other reasons|6|||
129475111|NCT03575104|466031829|FG001|Overall Study|Other reasons|8|||
129475112|NCT03575104|466031830|FG002|Overall Study|Other reasons|6|||
129475113|NCT03575104|466031828|FG000|Overall Study|Lost to Follow-up|1|||
129475114|NCT03575104|466031829|FG001|Overall Study|Lost to Follow-up|2|||
129475115|NCT03575104|466031830|FG002|Overall Study|Lost to Follow-up|1|||
129475116|NCT01409928|466031832|FG000|Overall Study|Physician Decision|12|||
129475117|NCT00408005|466031835|FG000|Induction|Adverse Event|19|||
129475118|NCT00408005|466031836|FG001|Induction|Adverse Event|3|||
129475119|NCT00408005|466031837|FG002|Induction|Adverse Event|0|||
129475120|NCT00408005|466031838|FG003|Induction|Adverse Event|0|||
129475121|NCT00408005|466031839|FG004|Induction|Adverse Event|0|||
129475122|NCT00408005|466031840|FG005|Induction|Adverse Event|0|||
129475123|NCT00408005|466031841|FG006|Induction|Adverse Event|0|||
129475124|NCT00408005|466031842|FG007|Induction|Adverse Event|0|||
129475125|NCT00408005|466031835|FG000|Induction|Death|6|||
129475126|NCT00408005|466031836|FG001|Induction|Death|0|||
129475127|NCT00408005|466031837|FG002|Induction|Death|0|||
129475128|NCT00408005|466031838|FG003|Induction|Death|0|||
129475129|NCT00408005|466031839|FG004|Induction|Death|0|||
129475130|NCT00408005|466031840|FG005|Induction|Death|0|||
129475131|NCT00408005|466031841|FG006|Induction|Death|0|||
129475132|NCT00408005|466031842|FG007|Induction|Death|0|||
129475133|NCT00408005|466031835|FG000|Induction|Physician Decision|83|||
129475134|NCT00408005|466031836|FG001|Induction|Physician Decision|9|||
129475135|NCT00408005|466031837|FG002|Induction|Physician Decision|0|||
129475136|NCT00408005|466031838|FG003|Induction|Physician Decision|0|||
129475137|NCT00408005|466031839|FG004|Induction|Physician Decision|0|||
129475138|NCT00408005|466031840|FG005|Induction|Physician Decision|0|||
129475139|NCT00408005|466031841|FG006|Induction|Physician Decision|0|||
129475140|NCT00408005|466031842|FG007|Induction|Physician Decision|0|||
129475141|NCT00408005|466031835|FG000|Induction|Withdrawal by Subject|2|||
129475142|NCT00408005|466031836|FG001|Induction|Withdrawal by Subject|4|||
129475143|NCT00408005|466031837|FG002|Induction|Withdrawal by Subject|0|||
129475144|NCT00408005|466031838|FG003|Induction|Withdrawal by Subject|0|||
129475145|NCT00408005|466031839|FG004|Induction|Withdrawal by Subject|0|||
129475146|NCT00408005|466031840|FG005|Induction|Withdrawal by Subject|0|||
129475147|NCT00408005|466031841|FG006|Induction|Withdrawal by Subject|0|||
129475148|NCT00408005|466031842|FG007|Induction|Withdrawal by Subject|0|||
129475149|NCT00408005|466031835|FG000|Induction|Ineligible|33|||
129475150|NCT00408005|466031836|FG001|Induction|Ineligible|14|||
129475151|NCT00408005|466031837|FG002|Induction|Ineligible|0|||
129475152|NCT00408005|466031838|FG003|Induction|Ineligible|0|||
129475153|NCT00408005|466031839|FG004|Induction|Ineligible|0|||
129475154|NCT00408005|466031840|FG005|Induction|Ineligible|0|||
129475155|NCT00408005|466031841|FG006|Induction|Ineligible|0|||
129475156|NCT00408005|466031842|FG007|Induction|Ineligible|0|||
129475157|NCT00408005|466031835|FG000|Induction|Refusal of Further Protocol Therapy|225|||
129475158|NCT00408005|466031836|FG001|Induction|Refusal of Further Protocol Therapy|44|||
129475159|NCT00408005|466031837|FG002|Induction|Refusal of Further Protocol Therapy|0|||
129475160|NCT00408005|466031838|FG003|Induction|Refusal of Further Protocol Therapy|0|||
129475161|NCT00408005|466031839|FG004|Induction|Refusal of Further Protocol Therapy|0|||
129475162|NCT00408005|466031840|FG005|Induction|Refusal of Further Protocol Therapy|0|||
129475163|NCT00408005|466031841|FG006|Induction|Refusal of Further Protocol Therapy|0|||
129475164|NCT00408005|466031842|FG007|Induction|Refusal of Further Protocol Therapy|0|||
129475165|NCT00408005|466031835|FG000|Induction|Entered another COG therapeutic protocol|4|||
129475166|NCT00408005|466031836|FG001|Induction|Entered another COG therapeutic protocol|0|||
129475167|NCT00408005|466031837|FG002|Induction|Entered another COG therapeutic protocol|0|||
129475168|NCT00408005|466031838|FG003|Induction|Entered another COG therapeutic protocol|0|||
129475169|NCT00408005|466031839|FG004|Induction|Entered another COG therapeutic protocol|0|||
129475170|NCT00408005|466031840|FG005|Induction|Entered another COG therapeutic protocol|0|||
129475171|NCT00408005|466031841|FG006|Induction|Entered another COG therapeutic protocol|0|||
129475172|NCT00408005|466031842|FG007|Induction|Entered another COG therapeutic protocol|0|||
129475173|NCT00408005|466031835|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
129475174|NCT00408005|466031836|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
129475175|NCT00408005|466031837|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
129976219|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
129475176|NCT00408005|466031838|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
129475177|NCT00408005|466031839|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
129475178|NCT00408005|466031840|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
129475179|NCT00408005|466031841|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
129475180|NCT00408005|466031842|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
129475181|NCT00408005|466031835|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
129475182|NCT00408005|466031836|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
129475183|NCT00408005|466031837|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
129475184|NCT00408005|466031838|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
129475185|NCT00408005|466031839|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
129475186|NCT00408005|466031840|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
129475187|NCT00408005|466031841|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
129475188|NCT00408005|466031842|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
129475189|NCT00408005|466031835|FG000|Induction|Progressive Disease|0|||
129475190|NCT00408005|466031836|FG001|Induction|Progressive Disease|1|||
129475191|NCT00408005|466031837|FG002|Induction|Progressive Disease|0|||
129475192|NCT00408005|466031838|FG003|Induction|Progressive Disease|0|||
129475193|NCT00408005|466031839|FG004|Induction|Progressive Disease|0|||
129475194|NCT00408005|466031840|FG005|Induction|Progressive Disease|0|||
129475195|NCT00408005|466031841|FG006|Induction|Progressive Disease|0|||
129475196|NCT00408005|466031842|FG007|Induction|Progressive Disease|0|||
129475197|NCT00408005|466031835|FG000|Induction|Inevaluable|18|||
129475198|NCT00408005|466031836|FG001|Induction|Inevaluable|14|||
129475199|NCT00408005|466031837|FG002|Induction|Inevaluable|0|||
129475200|NCT00408005|466031838|FG003|Induction|Inevaluable|0|||
129475201|NCT00408005|466031839|FG004|Induction|Inevaluable|0|||
129475202|NCT00408005|466031840|FG005|Induction|Inevaluable|0|||
129475203|NCT00408005|466031841|FG006|Induction|Inevaluable|0|||
129475204|NCT00408005|466031842|FG007|Induction|Inevaluable|0|||
129475205|NCT00408005|466031835|FG000|Induction|Failed to Complete Randomization|3|||
129475206|NCT00408005|466031836|FG001|Induction|Failed to Complete Randomization|2|||
129475207|NCT00408005|466031837|FG002|Induction|Failed to Complete Randomization|0|||
129475208|NCT00408005|466031838|FG003|Induction|Failed to Complete Randomization|0|||
129475209|NCT00408005|466031839|FG004|Induction|Failed to Complete Randomization|0|||
129475210|NCT00408005|466031840|FG005|Induction|Failed to Complete Randomization|0|||
129475211|NCT00408005|466031841|FG006|Induction|Failed to Complete Randomization|0|||
129475212|NCT00408005|466031842|FG007|Induction|Failed to Complete Randomization|0|||
129475213|NCT00408005|466031835|FG000|Induction|Protocol Deviation|3|||
129475214|NCT00408005|466031836|FG001|Induction|Protocol Deviation|1|||
129475215|NCT00408005|466031837|FG002|Induction|Protocol Deviation|0|||
129475216|NCT00408005|466031838|FG003|Induction|Protocol Deviation|0|||
129475217|NCT00408005|466031839|FG004|Induction|Protocol Deviation|0|||
129475218|NCT00408005|466031840|FG005|Induction|Protocol Deviation|0|||
129475219|NCT00408005|466031841|FG006|Induction|Protocol Deviation|0|||
129475220|NCT00408005|466031842|FG007|Induction|Protocol Deviation|0|||
129475221|NCT00408005|466031835|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
129475222|NCT00408005|466031836|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475223|NCT00408005|466031837|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475224|NCT00408005|466031838|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475225|NCT00408005|466031839|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475226|NCT00408005|466031840|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475227|NCT00408005|466031841|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475228|NCT00408005|466031842|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
129475229|NCT00408005|466031835|FG000|Induction|Recurrent leukemia|1|||
129475230|NCT00408005|466031836|FG001|Induction|Recurrent leukemia|0|||
129475231|NCT00408005|466031837|FG002|Induction|Recurrent leukemia|0|||
129475232|NCT00408005|466031838|FG003|Induction|Recurrent leukemia|0|||
129475233|NCT00408005|466031839|FG004|Induction|Recurrent leukemia|0|||
129475234|NCT00408005|466031840|FG005|Induction|Recurrent leukemia|0|||
129475235|NCT00408005|466031841|FG006|Induction|Recurrent leukemia|0|||
129475236|NCT00408005|466031842|FG007|Induction|Recurrent leukemia|0|||
129475237|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129475238|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129475239|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
129475240|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
129475241|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
129475242|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
129475243|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
129475244|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
129475245|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
129976220|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976221|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
129976222|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976223|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976224|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976225|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129475246|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
129475247|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
129475248|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
129475249|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
129475250|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
129475251|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
129475252|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
129475253|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
129475254|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
129475255|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
129475256|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
129475257|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
129475258|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
129475259|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
129475260|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
129475261|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
129475262|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
129475263|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
129475264|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
129475265|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
129475266|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
129475267|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
129475268|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
129475269|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
129475270|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
129475271|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
129475272|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
129475273|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
129475274|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
129475275|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
129475276|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
129475277|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
129475278|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
129475279|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
129475280|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
129475281|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
129475282|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
129475283|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
129475284|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
129475285|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475286|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475287|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475288|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475289|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
129475290|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475291|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475292|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
129475293|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
129475294|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
129475295|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
129475296|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
129475297|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
129475298|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
129475299|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
129475300|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
129475301|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
129475302|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
129475303|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
129475304|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
129475305|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
129475306|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
129475307|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
129475308|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
129475309|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475310|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475311|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475312|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475313|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475314|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
129976226|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976227|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129475315|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475316|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
129475317|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
129475318|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
129475319|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
129475320|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
129475321|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
129475322|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
129475323|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
129475324|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
129475325|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
129475326|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
129475327|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
129475328|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
129475329|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
129475330|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
129475331|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
129475332|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
129475333|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
129475334|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
129475335|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
129475336|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
129475337|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
129475338|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
129475339|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
129475340|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
129475341|NCT00408005|466031835|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
129475342|NCT00408005|466031836|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
129475343|NCT00408005|466031837|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
129475344|NCT00408005|466031838|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
129475345|NCT00408005|466031839|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
129475346|NCT00408005|466031840|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
129475347|NCT00408005|466031841|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
129475348|NCT00408005|466031842|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
129475349|NCT04067518|466031843|FG000|Overall Study|Adverse Event|1|||
129475350|NCT04067518|466031844|FG001|Overall Study|Adverse Event|3|||
129475351|NCT04067518|466031843|FG000|Overall Study|Screen failures|0|||
129475352|NCT04067518|466031844|FG001|Overall Study|Screen failures|1|||
129475353|NCT04067518|466031843|FG000|Overall Study|Enrolled but not treated|0|||
129475354|NCT04067518|466031844|FG001|Overall Study|Enrolled but not treated|1|||
129475355|NCT00862251|466031845|FG000|Overall Study|Adverse Event|8|||
129976228|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
129976229|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
129976230|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
129976231|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
129976232|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
129976233|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
129976234|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
129976235|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
129976236|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
129976237|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
129976238|NCT00477490|467875773|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976239|NCT00477490|467875774|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
129976240|NCT00477490|467875775|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
129976241|NCT00477490|467875776|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129475356|NCT00862251|466031846|FG001|Overall Study|Adverse Event|3|||
129475357|NCT00862251|466031847|FG002|Overall Study|Adverse Event|1|||
129475358|NCT00862251|466031845|FG000|Overall Study|Lost to Follow-up|0|||
129475359|NCT00862251|466031846|FG001|Overall Study|Lost to Follow-up|0|||
129475360|NCT00862251|466031847|FG002|Overall Study|Lost to Follow-up|1|||
129475361|NCT00862251|466031845|FG000|Overall Study|Protocol Violation|2|||
129475362|NCT00862251|466031846|FG001|Overall Study|Protocol Violation|0|||
129475363|NCT00862251|466031847|FG002|Overall Study|Protocol Violation|1|||
129475364|NCT00862251|466031845|FG000|Overall Study|Withdrawal by Subject|9|||
129475365|NCT00862251|466031846|FG001|Overall Study|Withdrawal by Subject|2|||
129475366|NCT00862251|466031847|FG002|Overall Study|Withdrawal by Subject|6|||
129475367|NCT00675025|466031848|FG000|Overall Study|Study Terminated by Sponsor|38|||
129475368|NCT00675025|466031849|FG001|Overall Study|Study Terminated by Sponsor|42|||
129475369|NCT00675025|466031848|FG000|Overall Study|Adverse Event|6|||
129475370|NCT00675025|466031849|FG001|Overall Study|Adverse Event|11|||
129475371|NCT00675025|466031848|FG000|Overall Study|Lost to Follow-up|6|||
129475372|NCT00675025|466031849|FG001|Overall Study|Lost to Follow-up|4|||
129475373|NCT00675025|466031848|FG000|Overall Study|Withdrawal by Subject|4|||
129475374|NCT00675025|466031849|FG001|Overall Study|Withdrawal by Subject|6|||
129475375|NCT02054702|466031853|FG000|Overall Study|Lost to Follow-up|3|||
129475376|NCT02054702|466031854|FG001|Overall Study|Lost to Follow-up|5|||
129475377|NCT02054702|466031853|FG000|Overall Study|Adverse Event|3|||
129475378|NCT02054702|466031854|FG001|Overall Study|Adverse Event|1|||
129475379|NCT02054702|466031853|FG000|Overall Study|Met Withdrawal Criteria|4|||
129475380|NCT02054702|466031854|FG001|Overall Study|Met Withdrawal Criteria|1|||
129475381|NCT02054702|466031853|FG000|Overall Study|Physician Decision|0|||
129475382|NCT02054702|466031854|FG001|Overall Study|Physician Decision|1|||
129475383|NCT02054702|466031853|FG000|Overall Study|Withdrawal by Subject|14|||
129475384|NCT02054702|466031854|FG001|Overall Study|Withdrawal by Subject|4|||
129475385|NCT02347631|466031857|FG000|First Intervention (2 Months)|Adverse Event|1|||
129475386|NCT02347631|466031858|FG001|First Intervention (2 Months)|Adverse Event|1|||
129475387|NCT02347631|466031857|FG000|First Intervention (2 Months)|Pregnancy|1|||
129475388|NCT02347631|466031858|FG001|First Intervention (2 Months)|Pregnancy|0|||
129475389|NCT02347631|466031857|FG000|First Intervention (2 Months)|Moved out of area|0|||
129475390|NCT02347631|466031858|FG001|First Intervention (2 Months)|Moved out of area|2|||
129475391|NCT02347631|466031857|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
129475392|NCT02347631|466031858|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
129475393|NCT02347631|466031857|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
129475394|NCT02347631|466031858|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
129475395|NCT02347631|466031857|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
129475396|NCT02347631|466031858|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
129475397|NCT02347631|466031857|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
129475398|NCT02347631|466031858|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
129475399|NCT02347631|466031857|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
129475400|NCT02347631|466031858|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
129475401|NCT00934102|466031860|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
129475402|NCT00934102|466031861|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
129475403|NCT00934102|466031862|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
129475404|NCT02318784|466031863|FG000|Overall Study|Adverse Event|13|||
129475405|NCT02318784|466031863|FG000|Overall Study|Death|2|||
129475406|NCT02318784|466031863|FG000|Overall Study|Progressive Disease|37|||
129475407|NCT02318784|466031863|FG000|Overall Study|Withdrawal by Subject|10|||
129475408|NCT02304926|466031864|FG000|Overall Study|Lost to Follow-up|2|||
129475409|NCT02304926|466031865|FG001|Overall Study|Lost to Follow-up|1|||
129475410|NCT04007159|466031867|FG000|Induction Phase|(missed study visits)|16|||
129475411|NCT04007159|466031867|FG000|Induction Phase|Withdrawal by Subject|4|||
129475412|NCT04007159|466031867|FG000|Induction Phase|Adverse Event|2|||
129475413|NCT04007159|466031867|FG000|Challenge Phase|missed study visits|3|||
129475414|NCT02388295|466031869|FG000|Dose Escalation Week 1|Adverse Event|1|||
129475415|NCT02388295|466031870|FG001|Dose Escalation Week 1|Adverse Event|2|||
129475416|NCT02388295|466031871|FG002|Dose Escalation Week 1|Adverse Event|1|||
129475417|NCT02388295|466031869|FG000|Dose Escalation Week 1|Determined not eligible|1|||
129475418|NCT02388295|466031870|FG001|Dose Escalation Week 1|Determined not eligible|1|||
129475419|NCT02388295|466031871|FG002|Dose Escalation Week 1|Determined not eligible|1|||
129475420|NCT02388295|466031869|FG000|Dose Escalation Week 2|Protocol Violation|0|||
129475421|NCT02388295|466031870|FG001|Dose Escalation Week 2|Protocol Violation|1|||
129475422|NCT02388295|466031871|FG002|Dose Escalation Week 2|Protocol Violation|0|||
129475423|NCT02388295|466031869|FG000|Dose Escalation Week 2|Determined not eligible|1|||
129475424|NCT02388295|466031870|FG001|Dose Escalation Week 2|Determined not eligible|1|||
129475425|NCT02388295|466031871|FG002|Dose Escalation Week 2|Determined not eligible|1|||
129976242|NCT00477490|467875777|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
129976243|NCT00477490|467875778|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976244|NCT00477490|467875779|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129475426|NCT02388295|466031869|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
129475427|NCT02388295|466031870|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
129475428|NCT02388295|466031871|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
129475429|NCT02076165|466031872|FG000|Overall Study|Lost to Follow-up|7|||
129475430|NCT02076165|466031873|FG001|Overall Study|Lost to Follow-up|5|||
129475431|NCT02076165|466031872|FG000|Overall Study|Refused follow-up assessment|1|||
129475432|NCT02076165|466031873|FG001|Overall Study|Refused follow-up assessment|1|||
129475433|NCT03157531|466031874|FG000|Overall Study|Death|2|||
129475434|NCT03157531|466031874|FG000|Overall Study|Lost to Follow-up|4|||
129475435|NCT00331006|466031875|FG000|Screening Phase|Withdrawal by Subject|1|||
129475436|NCT00331006|466031875|FG000|Screening Phase|enrollment halted|1|||
129475437|NCT00331006|466031875|FG000|Screening Phase|Lost to Follow-up|1|||
129475438|NCT00331006|466031875|FG000|Screening Phase|Ineligible for treatment phase|4|||
129475439|NCT00331006|466031875|FG000|Treatment Phase|Withdrawal by Subject|1|||
129475440|NCT00331006|466031875|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
129475441|NCT00331006|466031875|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
129475442|NCT03417440|466031885|FG000|Overall Study|Lost to Follow-up|0|||
129475443|NCT03417440|466031886|FG001|Overall Study|Lost to Follow-up|1|||
129475444|NCT03417440|466031887|FG002|Overall Study|Lost to Follow-up|0|||
129475445|NCT03417440|466031888|FG003|Overall Study|Lost to Follow-up|0|||
129475446|NCT03417440|466031889|FG004|Overall Study|Lost to Follow-up|1|||
129475447|NCT03417440|466031890|FG005|Overall Study|Lost to Follow-up|0|||
129475448|NCT03417440|466031891|FG006|Overall Study|Lost to Follow-up|0|||
129475449|NCT03417440|466031892|FG007|Overall Study|Lost to Follow-up|0|||
129475450|NCT03417440|466031885|FG000|Overall Study|Withdrawal by Subject|2|||
129475451|NCT03417440|466031886|FG001|Overall Study|Withdrawal by Subject|0|||
129475452|NCT03417440|466031887|FG002|Overall Study|Withdrawal by Subject|2|||
129475453|NCT03417440|466031888|FG003|Overall Study|Withdrawal by Subject|1|||
129475454|NCT03417440|466031889|FG004|Overall Study|Withdrawal by Subject|1|||
129475455|NCT03417440|466031890|FG005|Overall Study|Withdrawal by Subject|0|||
129475456|NCT03417440|466031891|FG006|Overall Study|Withdrawal by Subject|0|||
129475457|NCT03417440|466031892|FG007|Overall Study|Withdrawal by Subject|1|||
129475458|NCT03304522|466031893|FG000|Overall Study|Adverse Event|0|||
129475459|NCT03304522|466031894|FG001|Overall Study|Adverse Event|4|||
129475460|NCT03304522|466031893|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
129475461|NCT03304522|466031894|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
129475462|NCT03304522|466031893|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
129475463|NCT03304522|466031894|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
129475464|NCT03304522|466031893|FG000|Overall Study|Other|0|||
129475465|NCT03304522|466031894|FG001|Overall Study|Other|1|||
129475466|NCT00238264|466031897|FG000|Overall Study|Death|7|||
129475467|NCT00238264|466031897|FG000|Overall Study|Lost to Follow-up|18|||
129475468|NCT00238264|466031897|FG000|Overall Study|Withdrawal by Subject|4|||
129475469|NCT00238264|466031897|FG000|Overall Study|Ineligible|7|||
129475470|NCT02706938|466031898|FG000|First Period, 6 Weeks|Adverse Event|8|||
129475471|NCT02706938|466031899|FG001|First Period, 6 Weeks|Adverse Event|0|||
129475472|NCT02706938|466031898|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
129475473|NCT02706938|466031899|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
129475474|NCT02706938|466031898|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
129475475|NCT02706938|466031899|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
129475476|NCT02706938|466031898|FG000|Second Period, 6 Weeks|Adverse Event|0|||
129475477|NCT02706938|466031899|FG001|Second Period, 6 Weeks|Adverse Event|7|||
129475478|NCT02706938|466031898|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
129475479|NCT02706938|466031899|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
129475480|NCT01838044|466031900|FG000|Overall Study|Adverse Event|4|||
129475481|NCT01838044|466031901|FG001|Overall Study|Adverse Event|6|||
129475482|NCT01838044|466031900|FG000|Overall Study|Protocol Violation|3|||
129475483|NCT01838044|466031901|FG001|Overall Study|Protocol Violation|3|||
129475484|NCT01838044|466031900|FG000|Overall Study|Withdrawal by Subject|0|||
129475485|NCT01838044|466031901|FG001|Overall Study|Withdrawal by Subject|2|||
129475486|NCT01838044|466031900|FG000|Overall Study|Insufficient clinical response|1|||
129475487|NCT01838044|466031901|FG001|Overall Study|Insufficient clinical response|2|||
129475488|NCT01838044|466031900|FG000|Overall Study|Medication error without associated AE|0|||
129475489|NCT01838044|466031901|FG001|Overall Study|Medication error without associated AE|1|||
129475490|NCT01838044|466031900|FG000|Overall Study|Lost to Follow-up|0|||
129475491|NCT01838044|466031901|FG001|Overall Study|Lost to Follow-up|2|||
129475492|NCT00860470|466031905|FG000|Overall Study|Death|6|||
129475493|NCT00860470|466031906|FG001|Overall Study|Death|10|||
129475494|NCT00860470|466031905|FG000|Overall Study|Moved away|8|||
129475495|NCT00860470|466031906|FG001|Overall Study|Moved away|10|||
129475496|NCT00860470|466031905|FG000|Overall Study|Lost to Follow-up|34|||
129475497|NCT00860470|466031906|FG001|Overall Study|Lost to Follow-up|39|||
129475498|NCT00723957|466031908|FG000|Overall Study|Adverse event unrelated to study drug|1|||
129475499|NCT00723957|466031909|FG001|Overall Study|Adverse event unrelated to study drug|4|||
129475500|NCT00723957|466031908|FG000|Overall Study|Death|3|||
129475501|NCT00723957|466031909|FG001|Overall Study|Death|4|||
129475502|NCT00723957|466031908|FG000|Overall Study|Disease progression|27|||
129475503|NCT00723957|466031909|FG001|Overall Study|Disease progression|25|||
129475504|NCT00723957|466031908|FG000|Overall Study|Maximum clinical benefit|4|||
129475505|NCT00723957|466031909|FG001|Overall Study|Maximum clinical benefit|5|||
129475506|NCT00723957|466031908|FG000|Overall Study|Investigator decision|1|||
129475507|NCT00723957|466031909|FG001|Overall Study|Investigator decision|1|||
129475508|NCT00723957|466031908|FG000|Overall Study|Study drug toxicity|4|||
129475509|NCT00723957|466031909|FG001|Overall Study|Study drug toxicity|6|||
129475510|NCT00723957|466031908|FG000|Overall Study|Withdrawal by Subject|7|||
129475511|NCT00723957|466031909|FG001|Overall Study|Withdrawal by Subject|5|||
129475512|NCT00723957|466031908|FG000|Overall Study|Reason not analyzed|1|||
129475513|NCT00723957|466031909|FG001|Overall Study|Reason not analyzed|0|||
129475514|NCT00723957|466031908|FG000|Overall Study|Never received treatment|3|||
129475515|NCT00723957|466031909|FG001|Overall Study|Never received treatment|3|||
129475516|NCT00706628|466031911|FG000|Overall Study|Other Adverse Event|16|||
129475517|NCT00706628|466031912|FG001|Overall Study|Other Adverse Event|5|||
129475518|NCT00706628|466031913|FG002|Overall Study|Other Adverse Event|5|||
129475519|NCT00706628|466031914|FG003|Overall Study|Other Adverse Event|2|||
129475520|NCT00706628|466031911|FG000|Overall Study|Non compliant with protocol|0|||
129475521|NCT00706628|466031912|FG001|Overall Study|Non compliant with protocol|1|||
129475522|NCT00706628|466031913|FG002|Overall Study|Non compliant with protocol|0|||
129475523|NCT00706628|466031914|FG003|Overall Study|Non compliant with protocol|0|||
129475524|NCT00706628|466031911|FG000|Overall Study|Consent withdrawn|6|||
129475525|NCT00706628|466031912|FG001|Overall Study|Consent withdrawn|1|||
129475526|NCT00706628|466031913|FG002|Overall Study|Consent withdrawn|3|||
129475527|NCT00706628|466031914|FG003|Overall Study|Consent withdrawn|0|||
129475528|NCT00706628|466031911|FG000|Overall Study|Progressive disease|20|||
129475529|NCT00706628|466031912|FG001|Overall Study|Progressive disease|13|||
129475530|NCT00706628|466031913|FG002|Overall Study|Progressive disease|8|||
129475531|NCT00706628|466031914|FG003|Overall Study|Progressive disease|1|||
129475532|NCT00706628|466031911|FG000|Overall Study|Other than those stated above|4|||
129475533|NCT00706628|466031912|FG001|Overall Study|Other than those stated above|0|||
129475534|NCT00706628|466031913|FG002|Overall Study|Other than those stated above|0|||
129475535|NCT00706628|466031914|FG003|Overall Study|Other than those stated above|0|||
129475536|NCT00706628|466031911|FG000|Overall Study|Not treated|1|||
129475537|NCT00706628|466031912|FG001|Overall Study|Not treated|1|||
129475538|NCT00706628|466031913|FG002|Overall Study|Not treated|0|||
129475539|NCT00706628|466031914|FG003|Overall Study|Not treated|0|||
129475540|NCT02266433|466031919|FG000|Overall Study|Lost to Follow-up|54|||
129475541|NCT02266433|466031920|FG001|Overall Study|Lost to Follow-up|46|||
129475542|NCT02266433|466031919|FG000|Overall Study|Withdrawal by Subject|5|||
129475543|NCT02266433|466031920|FG001|Overall Study|Withdrawal by Subject|7|||
129475544|NCT01285349|466031921|FG000|Overall Study|Lost to Follow-up|27|||
129475545|NCT01285349|466031922|FG001|Overall Study|Lost to Follow-up|20|||
129475546|NCT01285349|466031923|FG002|Overall Study|Lost to Follow-up|27|||
129475547|NCT01194440|466031928|FG000|Baseline (First Dose)|Reason not specified|4|||
129475548|NCT01194440|466031928|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
129475549|NCT01194440|466031928|FG000|Baseline (First Dose)|Change in therapy|1|||
129475550|NCT01194440|466031928|FG000|Baseline (First Dose)|Adverse Event|1|||
129475551|NCT01194440|466031928|FG000|6-months (2nd Dose)|Change in therapy|4|||
129475552|NCT02292212|466031929|FG000|ViE Phase|Withdrawal by Subject|1|||
129475553|NCT02292212|466031929|FG000|ViE Phase|Protocol Violation|2|||
129475554|NCT00927563|466031932|FG000|Overall Study|Lost to Follow-up|1|||
129475555|NCT00927563|466031932|FG000|Overall Study|Withdrawal by Subject|1|||
129475556|NCT01468987|466031933|FG000|Overall Study|Adverse Event|12|||
129475557|NCT01468987|466031934|FG001|Overall Study|Adverse Event|9|||
129475558|NCT01468987|466031933|FG000|Overall Study|Death|4|||
129475559|NCT01468987|466031934|FG001|Overall Study|Death|1|||
129475560|NCT01468987|466031933|FG000|Overall Study|Lost to Follow-up|10|||
129475561|NCT01468987|466031934|FG001|Overall Study|Lost to Follow-up|5|||
129475562|NCT01468987|466031933|FG000|Overall Study|Protocol Violation|8|||
129475563|NCT01468987|466031934|FG001|Overall Study|Protocol Violation|2|||
129475564|NCT01468987|466031933|FG000|Overall Study|Withdrawal by Subject|28|||
129475565|NCT01468987|466031934|FG001|Overall Study|Withdrawal by Subject|28|||
129475566|NCT01468987|466031933|FG000|Overall Study|Physician Decision|8|||
129475567|NCT01468987|466031934|FG001|Overall Study|Physician Decision|15|||
129475568|NCT01468987|466031933|FG000|Overall Study|Sponsor Decision|1|||
129475569|NCT01468987|466031934|FG001|Overall Study|Sponsor Decision|0|||
129475570|NCT01245673|466031936|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
129475571|NCT02040142|466031939|FG000|Overall Study|Lost to Follow-up|5|||
129475572|NCT02040142|466031939|FG000|Overall Study|Death|17|||
129976245|NCT00477490|467875780|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976246|NCT00477490|467875781|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
129976247|NCT00669877|467875782|FG000|Overall Study|Disease Progression/Death|4|||
129976248|NCT01427725|467875785|FG000|Overall Study|Lost to Follow-up|17|||
129475573|NCT02040142|466031939|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
129475574|NCT01565980|466031941|FG000|Overall Study|Death|1|||
129475575|NCT01565980|466031942|FG001|Overall Study|Death|0|||
129475576|NCT01565980|466031941|FG000|Overall Study|Lost to Follow-up|1|||
129475577|NCT01565980|466031942|FG001|Overall Study|Lost to Follow-up|0|||
129475578|NCT01565980|466031941|FG000|Overall Study|health complications|1|||
129475579|NCT01565980|466031942|FG001|Overall Study|health complications|1|||
129475580|NCT01565980|466031941|FG000|Overall Study|stopped medical treatment|1|||
129475581|NCT01565980|466031942|FG001|Overall Study|stopped medical treatment|0|||
129475582|NCT01565980|466031941|FG000|Overall Study|Withdrawal by Subject|0|||
129475583|NCT01565980|466031942|FG001|Overall Study|Withdrawal by Subject|3|||
129475584|NCT01955707|466031951|FG000|Overall Study|Adverse Event|1|||
129475585|NCT01955707|466031952|FG001|Overall Study|Adverse Event|2|||
129976249|NCT01427725|467875785|FG000|Overall Study|Protocol Violation|1|||
129475586|NCT01955707|466031951|FG000|Overall Study|Lost to Follow-up|2|||
129475587|NCT01955707|466031952|FG001|Overall Study|Lost to Follow-up|1|||
129475588|NCT01955707|466031951|FG000|Overall Study|Withdrawal by Subject|0|||
129475589|NCT01955707|466031952|FG001|Overall Study|Withdrawal by Subject|3|||
129475590|NCT01955707|466031951|FG000|Overall Study|Death|13|||
129475591|NCT01955707|466031952|FG001|Overall Study|Death|14|||
129475592|NCT01955707|466031951|FG000|Overall Study|Other|4|||
129475593|NCT01955707|466031952|FG001|Overall Study|Other|2|||
129475594|NCT03219164|466034052|FG000|Overall Study|Study Terminated by Sponsor|16|||
129475595|NCT03219164|466034053|FG001|Overall Study|Study Terminated by Sponsor|12|||
129475596|NCT03219164|466034052|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
129475597|NCT03219164|466034053|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
129475598|NCT03219164|466034052|FG000|Overall Study|Lost to Follow-up|1|||
129475599|NCT03219164|466034053|FG001|Overall Study|Lost to Follow-up|1|||
129475600|NCT03219164|466034052|FG000|Overall Study|Adverse Event|1|||
129475601|NCT03219164|466034053|FG001|Overall Study|Adverse Event|0|||
129475602|NCT03219164|466034052|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129475603|NCT03219164|466034053|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129475604|NCT03219164|466034052|FG000|Overall Study|Protocol Violation|0|||
129475605|NCT03219164|466034053|FG001|Overall Study|Protocol Violation|1|||
129475606|NCT03219164|466034052|FG000|Overall Study|Withdrew Assent|1|||
129475607|NCT03219164|466034053|FG001|Overall Study|Withdrew Assent|0|||
129475608|NCT00434967|466034059|FG000|Overall Study|Adverse Event|2|||
129475609|NCT00434967|466034060|FG001|Overall Study|Adverse Event|4|||
129475610|NCT00434967|466034061|FG002|Overall Study|Adverse Event|3|||
129475611|NCT00434967|466034062|FG003|Overall Study|Adverse Event|3|||
129475612|NCT00434967|466034059|FG000|Overall Study|Lost to Follow-up|0|||
129475613|NCT00434967|466034060|FG001|Overall Study|Lost to Follow-up|0|||
129475614|NCT00434967|466034061|FG002|Overall Study|Lost to Follow-up|1|||
129475615|NCT00434967|466034062|FG003|Overall Study|Lost to Follow-up|0|||
129475616|NCT00434967|466034059|FG000|Overall Study|Withdrawal by Subject|2|||
129475617|NCT00434967|466034060|FG001|Overall Study|Withdrawal by Subject|2|||
129475618|NCT00434967|466034061|FG002|Overall Study|Withdrawal by Subject|4|||
129475619|NCT00434967|466034062|FG003|Overall Study|Withdrawal by Subject|6|||
129475620|NCT00434967|466034059|FG000|Overall Study|Randomized in error|0|||
129475621|NCT00434967|466034060|FG001|Overall Study|Randomized in error|0|||
129475622|NCT00434967|466034061|FG002|Overall Study|Randomized in error|0|||
129475623|NCT00434967|466034062|FG003|Overall Study|Randomized in error|1|||
129475624|NCT00434967|466034059|FG000|Overall Study|Protocol Violation|0|||
129475625|NCT00434967|466034060|FG001|Overall Study|Protocol Violation|1|||
129475626|NCT00434967|466034061|FG002|Overall Study|Protocol Violation|0|||
129475627|NCT00434967|466034062|FG003|Overall Study|Protocol Violation|1|||
129475628|NCT00434967|466034059|FG000|Overall Study|Physician Decision|1|||
129475629|NCT00434967|466034060|FG001|Overall Study|Physician Decision|1|||
129475630|NCT00434967|466034061|FG002|Overall Study|Physician Decision|1|||
129475631|NCT00434967|466034062|FG003|Overall Study|Physician Decision|0|||
129475632|NCT00434967|466034059|FG000|Overall Study|Patient Disposition Challenges|2|||
129475633|NCT00434967|466034060|FG001|Overall Study|Patient Disposition Challenges|0|||
129475634|NCT00434967|466034061|FG002|Overall Study|Patient Disposition Challenges|0|||
129475635|NCT00434967|466034062|FG003|Overall Study|Patient Disposition Challenges|3|||
129475636|NCT03155997|466034064|FG000|Overall Study|Withdrawal by Subject|119|||
129475637|NCT03155997|466034065|FG001|Overall Study|Withdrawal by Subject|134|||
129475638|NCT03155997|466034064|FG000|Overall Study|Lost to Follow-up|12|||
129475639|NCT03155997|466034065|FG001|Overall Study|Lost to Follow-up|13|||
129475640|NCT03155997|466034064|FG000|Overall Study|Missing disposition data|0|||
129475641|NCT03155997|466034065|FG001|Overall Study|Missing disposition data|1|||
129475642|NCT03155997|466034064|FG000|Overall Study|On study treatment|2027|||
129475643|NCT03155997|466034065|FG001|Overall Study|On study treatment|2074|||
129475644|NCT01848145|466034066|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
129475645|NCT01848145|466034066|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
129475646|NCT01848145|466034066|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
129475647|NCT01848145|466034066|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
129475648|NCT01848145|466034066|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
129475649|NCT01848145|466034066|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
129475650|NCT01848145|466034066|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
129475651|NCT00501228|466034067|FG000|Overall Study|Withdrawal by Subject|1|||
129475652|NCT03804684|466034068|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
129475653|NCT03804684|466034069|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
129475654|NCT01670994|466034074|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
129475655|NCT01670994|466034075|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
129475656|NCT01670994|466034074|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
129475657|NCT01670994|466034075|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
129475658|NCT01670994|466034074|FG000|Overall Study|Patient experienced DLT|0|||
129475659|NCT01670994|466034075|FG001|Overall Study|Patient experienced DLT|1|||
129475660|NCT02013544|466034076|FG000|Overall Study|Adverse Event|5|||
129475661|NCT02013544|466034077|FG001|Overall Study|Adverse Event|5|||
129475662|NCT02013544|466034076|FG000|Overall Study|Lost to Follow-up|2|||
129475663|NCT02013544|466034077|FG001|Overall Study|Lost to Follow-up|3|||
129475664|NCT02013544|466034076|FG000|Overall Study|Withdrawal by Subject|2|||
129475665|NCT02013544|466034077|FG001|Overall Study|Withdrawal by Subject|8|||
129475666|NCT02013544|466034076|FG000|Overall Study|Physician Decision|0|||
129475667|NCT02013544|466034077|FG001|Overall Study|Physician Decision|1|||
129475668|NCT02013544|466034076|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
129475669|NCT02013544|466034077|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
129475670|NCT01295125|466034078|FG000|Overall Study|Study stopped prematurely|9|||
129475671|NCT00885365|466034081|FG000|4 Weeks ON Treatment|Adverse Event|2|||
129475672|NCT00885365|466034082|FG001|4 Weeks ON Treatment|Adverse Event|4|||
129475673|NCT00885365|466034081|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
129475674|NCT00885365|466034082|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
129475675|NCT00885365|466034081|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
129475676|NCT00885365|466034082|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
129475677|NCT01824979|466034083|FG000|Overall Study|Withdrawal by Subject|5|||
129475678|NCT01824979|466034084|FG001|Overall Study|Withdrawal by Subject|0|||
129475679|NCT01824979|466034083|FG000|Overall Study|Physician Decision|2|||
129475680|NCT01824979|466034084|FG001|Overall Study|Physician Decision|0|||
129475681|NCT01824979|466034083|FG000|Overall Study|Protocol Violation|6|||
129475682|NCT01824979|466034084|FG001|Overall Study|Protocol Violation|13|||
129475683|NCT00888238|466034086|FG000|Washout Period After Period 2|Adverse Event|0|||
129475684|NCT00888238|466034087|FG001|Washout Period After Period 2|Adverse Event|0|||
129475685|NCT00888238|466034088|FG002|Washout Period After Period 2|Adverse Event|1|||
129475686|NCT03371355|466034097|FG000|Overall Study|Investigator judgment|0|||
129475687|NCT03371355|466034098|FG001|Overall Study|Investigator judgment|0|||
129475688|NCT03371355|466034099|FG002|Overall Study|Investigator judgment|1|||
129475689|NCT03371355|466034100|FG003|Overall Study|Investigator judgment|1|||
129475690|NCT03371355|466034097|FG000|Overall Study|Voluntary withdrawal|1|||
129475691|NCT03371355|466034098|FG001|Overall Study|Voluntary withdrawal|0|||
129475692|NCT03371355|466034099|FG002|Overall Study|Voluntary withdrawal|1|||
129475693|NCT03371355|466034100|FG003|Overall Study|Voluntary withdrawal|2|||
129475694|NCT03371355|466034097|FG000|Overall Study|Adverse Event|0|||
129475695|NCT03371355|466034098|FG001|Overall Study|Adverse Event|1|||
129475696|NCT03371355|466034099|FG002|Overall Study|Adverse Event|2|||
129475697|NCT03371355|466034100|FG003|Overall Study|Adverse Event|3|||
129475698|NCT03371355|466034097|FG000|Overall Study|Reason not Specified|0|||
129475699|NCT03371355|466034098|FG001|Overall Study|Reason not Specified|1|||
129475700|NCT03371355|466034099|FG002|Overall Study|Reason not Specified|0|||
129475701|NCT03371355|466034100|FG003|Overall Study|Reason not Specified|1|||
129475702|NCT01662648|466034101|FG000|Overall Study|Death|1|||
129475703|NCT01662648|466034102|FG001|Overall Study|Death|3|||
129475704|NCT01662648|466034101|FG000|Overall Study|Adverse Event|40|||
129475705|NCT01662648|466034102|FG001|Overall Study|Adverse Event|37|||
129475706|NCT01662648|466034101|FG000|Overall Study|Lack of Efficacy|17|||
129475707|NCT01662648|466034102|FG001|Overall Study|Lack of Efficacy|16|||
129475708|NCT01662648|466034101|FG000|Overall Study|Participant ineligible to continue trial|1|||
129475709|NCT01662648|466034102|FG001|Overall Study|Participant ineligible to continue trial|1|||
129475710|NCT01662648|466034101|FG000|Overall Study|Lost to Follow-up|24|||
129475711|NCT01662648|466034102|FG001|Overall Study|Lost to Follow-up|36|||
129475712|NCT01662648|466034101|FG000|Overall Study|Withdrawal by Subject|36|||
129475713|NCT01662648|466034102|FG001|Overall Study|Withdrawal by Subject|53|||
129475714|NCT01662648|466034101|FG000|Overall Study|Participant non-compliant|16|||
129475715|NCT01662648|466034102|FG001|Overall Study|Participant non-compliant|20|||
129475716|NCT01662648|466034101|FG000|Overall Study|Other|8|||
129475717|NCT01662648|466034102|FG001|Overall Study|Other|11|||
129475718|NCT01662648|466034101|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
129976250|NCT01427725|467875785|FG000|Overall Study|Drug not administered|1|||
129976251|NCT01427725|467875785|FG000|Overall Study|Failure to visit|7|||
129976252|NCT01427725|467875785|FG000|Overall Study|Adverse Event|46|||
129976253|NCT01427725|467875785|FG000|Overall Study|Failure to visit after administration|40|||
129976254|NCT01427725|467875785|FG000|Overall Study|Patient's rejection|27|||
129475719|NCT01662648|466034102|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
129475720|NCT01662648|466034101|FG000|Overall Study|LOE and other reason unspecified|1|||
129976255|NCT01427725|467875785|FG000|Overall Study|Transfer to a different hospital|17|||
129475721|NCT01662648|466034102|FG001|Overall Study|LOE and other reason unspecified|0|||
129475722|NCT01662648|466034101|FG000|Overall Study|LOE and Participant non-compliant|0|||
129475723|NCT01662648|466034102|FG001|Overall Study|LOE and Participant non-compliant|1|||
129475724|NCT03751111|466034104|FG000|Overall Study|Lack of Efficacy|9|||
129475725|NCT03751111|466034105|FG001|Overall Study|Lack of Efficacy|30|||
129475726|NCT03751111|466034104|FG000|Overall Study|Adverse Event|3|||
129475727|NCT03751111|466034105|FG001|Overall Study|Adverse Event|2|||
129475728|NCT01264939|466034106|FG000|Overall Study|Adverse Event|1|||
129475729|NCT01264939|466034107|FG001|Overall Study|Adverse Event|3|||
129475730|NCT01264939|466034106|FG000|Overall Study|Lost to Follow-up|0|||
129475731|NCT01264939|466034107|FG001|Overall Study|Lost to Follow-up|3|||
129475732|NCT01264939|466034106|FG000|Overall Study|Physician Decision|1|||
129475733|NCT01264939|466034107|FG001|Overall Study|Physician Decision|1|||
129475734|NCT01264939|466034106|FG000|Overall Study|Patient/Guardian Decision|8|||
129475735|NCT01264939|466034107|FG001|Overall Study|Patient/Guardian Decision|10|||
129475736|NCT01264939|466034106|FG000|Overall Study|Disease Progression|8|||
129475737|NCT01264939|466034107|FG001|Overall Study|Disease Progression|11|||
129475738|NCT01145560|466034112|FG000|Overall Study|Withdrawal by Subject|2|||
129976256|NCT01427725|467875785|FG000|Overall Study|Lack of Efficacy|8|||
129976257|NCT01427725|467875785|FG000|Overall Study|Death|7|||
129475739|NCT01145560|466034113|FG001|Overall Study|Withdrawal by Subject|1|||
129475740|NCT01145560|466034114|FG002|Overall Study|Withdrawal by Subject|0|||
129475741|NCT01145560|466034112|FG000|Overall Study|Lost to Follow-up|1|||
129475742|NCT01145560|466034113|FG001|Overall Study|Lost to Follow-up|1|||
129475743|NCT01145560|466034114|FG002|Overall Study|Lost to Follow-up|1|||
129475744|NCT01145560|466034112|FG000|Overall Study|No study drug by 24h after organ failure|1|||
129475745|NCT01145560|466034113|FG001|Overall Study|No study drug by 24h after organ failure|0|||
129475746|NCT01145560|466034114|FG002|Overall Study|No study drug by 24h after organ failure|0|||
129475747|NCT01145560|466034112|FG000|Overall Study|Accidental unblinding of study treatment|0|||
129475748|NCT01145560|466034113|FG001|Overall Study|Accidental unblinding of study treatment|1|||
129475749|NCT01145560|466034114|FG002|Overall Study|Accidental unblinding of study treatment|0|||
129475750|NCT01145560|466034112|FG000|Overall Study|False insurance information|0|||
129475751|NCT01145560|466034113|FG001|Overall Study|False insurance information|1|||
129475752|NCT01145560|466034114|FG002|Overall Study|False insurance information|0|||
129475753|NCT01145560|466034112|FG000|Overall Study|Withdrawal of therapy|0|||
129475754|NCT01145560|466034113|FG001|Overall Study|Withdrawal of therapy|0|||
129475755|NCT01145560|466034114|FG002|Overall Study|Withdrawal of therapy|1|||
129475756|NCT02452762|466034116|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
129475757|NCT02452762|466034117|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
129475758|NCT02452762|466034116|FG000|Overall Study|Withdrawal by Subject|1|||
129475759|NCT02452762|466034117|FG001|Overall Study|Withdrawal by Subject|0|||
129475760|NCT00584870|466034118|FG000|Overall Study|Adverse Event|4|||
129475761|NCT00584870|466034119|FG001|Overall Study|Adverse Event|3|||
129475762|NCT00584870|466034120|FG002|Overall Study|Adverse Event|2|||
129475763|NCT00584870|466034118|FG000|Overall Study|Lost to Follow-up|4|||
129475764|NCT00584870|466034119|FG001|Overall Study|Lost to Follow-up|1|||
129475765|NCT00584870|466034120|FG002|Overall Study|Lost to Follow-up|1|||
129475766|NCT00584870|466034118|FG000|Overall Study|Lack of Efficacy|7|||
129475767|NCT00584870|466034119|FG001|Overall Study|Lack of Efficacy|14|||
129475768|NCT00584870|466034120|FG002|Overall Study|Lack of Efficacy|8|||
129475769|NCT00584870|466034118|FG000|Overall Study|Withdrawal by Subject|10|||
129475770|NCT00584870|466034119|FG001|Overall Study|Withdrawal by Subject|5|||
129475771|NCT00584870|466034120|FG002|Overall Study|Withdrawal by Subject|3|||
129475772|NCT00584870|466034118|FG000|Overall Study|Protocol Violation|1|||
129475773|NCT00584870|466034119|FG001|Overall Study|Protocol Violation|1|||
129475774|NCT00584870|466034120|FG002|Overall Study|Protocol Violation|2|||
129475775|NCT00584870|466034118|FG000|Overall Study|Did not met entrance criteria|1|||
129475776|NCT00584870|466034119|FG001|Overall Study|Did not met entrance criteria|0|||
129475777|NCT00584870|466034120|FG002|Overall Study|Did not met entrance criteria|0|||
129475778|NCT00584870|466034118|FG000|Overall Study|Other|2|||
129475779|NCT00584870|466034119|FG001|Overall Study|Other|0|||
129475780|NCT00584870|466034120|FG002|Overall Study|Other|0|||
129475781|NCT00584870|466034118|FG000|Overall Study|Randomized but not treated|0|||
129475782|NCT00584870|466034119|FG001|Overall Study|Randomized but not treated|1|||
129475783|NCT00584870|466034120|FG002|Overall Study|Randomized but not treated|2|||
129475784|NCT02675075|466034121|FG000|Overall Study|Lost to Follow-up|3|||
129475785|NCT02675075|466034122|FG001|Overall Study|Lost to Follow-up|0|||
129475786|NCT00675597|466034123|FG000|Overall Study|Withdrawal by Subject|3|||
129475787|NCT00631137|466034124|FG000|Overall Study|Withdrawal by Subject|1|||
129475788|NCT00631137|466034125|FG001|Overall Study|Withdrawal by Subject|0|||
129475789|NCT03682120|466034126|FG000|Overall Study|Lost to Follow-up|11|||
129475790|NCT03682120|466034127|FG001|Overall Study|Lost to Follow-up|4|||
129475791|NCT03682120|466034128|FG002|Overall Study|Lost to Follow-up|5|||
129475792|NCT03682120|466034129|FG003|Overall Study|Lost to Follow-up|2|||
129475793|NCT03682120|466034126|FG000|Overall Study|Physician Decision|1|||
129475794|NCT03682120|466034127|FG001|Overall Study|Physician Decision|0|||
129475795|NCT03682120|466034128|FG002|Overall Study|Physician Decision|0|||
129475796|NCT03682120|466034129|FG003|Overall Study|Physician Decision|0|||
129475797|NCT03682120|466034126|FG000|Overall Study|Withdrawal by Subject|1|||
129475798|NCT03682120|466034127|FG001|Overall Study|Withdrawal by Subject|2|||
129475799|NCT03682120|466034128|FG002|Overall Study|Withdrawal by Subject|3|||
129475800|NCT03682120|466034129|FG003|Overall Study|Withdrawal by Subject|0|||
129475801|NCT03682120|466034126|FG000|Overall Study|Death|0|||
129475802|NCT03682120|466034127|FG001|Overall Study|Death|1|||
129475803|NCT03682120|466034128|FG002|Overall Study|Death|0|||
129475804|NCT03682120|466034129|FG003|Overall Study|Death|0|||
129475805|NCT03682120|466034126|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
129475806|NCT03682120|466034127|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
129475807|NCT03682120|466034128|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
129475808|NCT03682120|466034129|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
129475809|NCT03308188|466034130|FG000|Overall Study|Withdrawal by Subject|0|||
129475810|NCT03308188|466034131|FG001|Overall Study|Withdrawal by Subject|3|||
129475811|NCT03308188|466034130|FG000|Overall Study|Death|0|||
129475812|NCT03308188|466034131|FG001|Overall Study|Death|1|||
129475813|NCT01791855|466034132|FG000|Overall Study|Adverse Event|0|||
129475814|NCT01791855|466034133|FG001|Overall Study|Adverse Event|0|||
129475815|NCT01791855|466034134|FG002|Overall Study|Adverse Event|0|||
129475816|NCT01791855|466034135|FG003|Overall Study|Adverse Event|1|||
129475817|NCT01791855|466034132|FG000|Overall Study|Randomized, not treated|0|||
129475818|NCT01791855|466034133|FG001|Overall Study|Randomized, not treated|1|||
129475819|NCT01791855|466034134|FG002|Overall Study|Randomized, not treated|0|||
129475820|NCT01791855|466034135|FG003|Overall Study|Randomized, not treated|0|||
129475821|NCT00772447|466034136|FG000|Overall Study|Withdrawal by Subject|9|||
129475822|NCT00772447|466034137|FG001|Overall Study|Withdrawal by Subject|5|||
129475823|NCT00772447|466034136|FG000|Overall Study|Physician Decision|4|||
129475824|NCT00772447|466034137|FG001|Overall Study|Physician Decision|8|||
129475825|NCT00772447|466034136|FG000|Overall Study|Lost to Follow-up|2|||
129475826|NCT00772447|466034137|FG001|Overall Study|Lost to Follow-up|4|||
129475827|NCT00772447|466034136|FG000|Overall Study|incorrect enrolment|3|||
129475828|NCT00772447|466034137|FG001|Overall Study|incorrect enrolment|4|||
129475829|NCT00772447|466034136|FG000|Overall Study|Protocol Violation|0|||
129475830|NCT00772447|466034137|FG001|Overall Study|Protocol Violation|1|||
129475831|NCT00772447|466034136|FG000|Overall Study|all others|2|||
129475832|NCT00772447|466034137|FG001|Overall Study|all others|2|||
129475833|NCT01957137|466034141|FG000|Randomized Portion|Adverse Event|1|||
129475834|NCT01957137|466034141|FG000|Randomized Portion|Withdrawal by Subject|1|||
129475835|NCT03529409|466034142|FG000|Randomized|Lost to Follow-up|0|||
129475836|NCT03529409|466034143|FG001|Randomized|Lost to Follow-up|0|||
129475837|NCT03529409|466034144|FG002|Randomized|Lost to Follow-up|4|||
129475838|NCT03529409|466034142|FG000|Randomized|Excluded|0|||
129475839|NCT03529409|466034143|FG001|Randomized|Excluded|0|||
129475840|NCT03529409|466034144|FG002|Randomized|Excluded|1|||
129475841|NCT03529409|466034142|FG000|Post-treatment Assessment|Death|1|||
129475842|NCT03529409|466034143|FG001|Post-treatment Assessment|Death|0|||
129475843|NCT03529409|466034144|FG002|Post-treatment Assessment|Death|0|||
129475844|NCT03529409|466034142|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
129475845|NCT03529409|466034143|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
129475846|NCT03529409|466034144|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
129475847|NCT03529409|466034142|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
129475848|NCT03529409|466034143|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
129475849|NCT03529409|466034144|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
129475850|NCT03529409|466034142|FG000|Follow-up Assessment|Death|1|||
129475851|NCT03529409|466034143|FG001|Follow-up Assessment|Death|0|||
129475852|NCT03529409|466034144|FG002|Follow-up Assessment|Death|0|||
129475853|NCT03529409|466034142|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
129475854|NCT03529409|466034143|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
129475855|NCT03529409|466034144|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
129475856|NCT01497262|466034147|FG000|Overall Study|Abnormal Lab Values|4|||
129475857|NCT01497262|466034147|FG000|Overall Study|Abnormal Test Procedure Result|1|||
129475858|NCT01497262|466034147|FG000|Overall Study|Physician Decision|1|||
129475859|NCT01497262|466034147|FG000|Overall Study|Withdrawal by Subject|2|||
129475860|NCT01497262|466034147|FG000|Overall Study|Adverse Event|2|||
129475861|NCT01497262|466034147|FG000|Overall Study|Protocol Violation|1|||
129475862|NCT02497001|466034148|FG000|Overall Study|Lost to Follow-up|10|||
129976258|NCT01427725|467875785|FG000|Overall Study|Symptom improvement|6|||
129475863|NCT02497001|466034149|FG001|Overall Study|Lost to Follow-up|2|||
129475864|NCT02497001|466034150|FG002|Overall Study|Lost to Follow-up|0|||
129475865|NCT02497001|466034151|FG003|Overall Study|Lost to Follow-up|2|||
129475866|NCT02497001|466034148|FG000|Overall Study|Adverse Event|28|||
129475867|NCT02497001|466034149|FG001|Overall Study|Adverse Event|30|||
129475868|NCT02497001|466034150|FG002|Overall Study|Adverse Event|11|||
129475869|NCT02497001|466034151|FG003|Overall Study|Adverse Event|11|||
129475870|NCT02497001|466034148|FG000|Overall Study|Withdrawal by Subject|14|||
129475871|NCT02497001|466034149|FG001|Overall Study|Withdrawal by Subject|37|||
129475872|NCT02497001|466034150|FG002|Overall Study|Withdrawal by Subject|19|||
129475873|NCT02497001|466034151|FG003|Overall Study|Withdrawal by Subject|15|||
129475874|NCT02497001|466034148|FG000|Overall Study|Physician Decision|5|||
129475875|NCT02497001|466034149|FG001|Overall Study|Physician Decision|11|||
129475876|NCT02497001|466034150|FG002|Overall Study|Physician Decision|5|||
129475877|NCT02497001|466034151|FG003|Overall Study|Physician Decision|1|||
129475878|NCT02497001|466034148|FG000|Overall Study|subjects that were not treated|1|||
129475879|NCT02497001|466034149|FG001|Overall Study|subjects that were not treated|2|||
129475880|NCT02497001|466034150|FG002|Overall Study|subjects that were not treated|2|||
129475881|NCT02497001|466034151|FG003|Overall Study|subjects that were not treated|1|||
129475882|NCT02497001|466034148|FG000|Overall Study|Major Protocol Deviation|3|||
129475883|NCT02497001|466034149|FG001|Overall Study|Major Protocol Deviation|4|||
129475884|NCT02497001|466034150|FG002|Overall Study|Major Protocol Deviation|4|||
129475885|NCT02497001|466034151|FG003|Overall Study|Major Protocol Deviation|4|||
129475886|NCT02497001|466034148|FG000|Overall Study|Lack of Efficacy|10|||
129475887|NCT02497001|466034149|FG001|Overall Study|Lack of Efficacy|16|||
129475888|NCT02497001|466034150|FG002|Overall Study|Lack of Efficacy|6|||
129475889|NCT02497001|466034151|FG003|Overall Study|Lack of Efficacy|6|||
129475890|NCT02497001|466034148|FG000|Overall Study|Protocol Violation|3|||
129475891|NCT02497001|466034149|FG001|Overall Study|Protocol Violation|1|||
129475892|NCT02497001|466034150|FG002|Overall Study|Protocol Violation|3|||
129475893|NCT02497001|466034151|FG003|Overall Study|Protocol Violation|1|||
129475894|NCT03898063|466034152|FG000|Overall Study|Withdrawal by Subject|10|||
129475895|NCT03898063|466034153|FG001|Overall Study|Withdrawal by Subject|8|||
129475896|NCT00054132|466034154|FG000|Overall Study|Not Treated|1|||
129475897|NCT02949830|466034155|FG000|Overall Study|Adverse Event|1|||
129475898|NCT02949830|466034155|FG000|Overall Study|Withdrawal by Subject|1|||
129475899|NCT01290887|466034156|FG000|Overall Study|Adverse Event|6|||
129475900|NCT01290887|466034157|FG001|Overall Study|Adverse Event|11|||
129475901|NCT01290887|466034156|FG000|Overall Study|Lack of Efficacy|4|||
129475902|NCT01290887|466034157|FG001|Overall Study|Lack of Efficacy|5|||
129475903|NCT01290887|466034156|FG000|Overall Study|Withdrawal by Subject|26|||
129475904|NCT01290887|466034157|FG001|Overall Study|Withdrawal by Subject|32|||
129475905|NCT01290887|466034156|FG000|Overall Study|Protocol Violation|2|||
129475906|NCT01290887|466034157|FG001|Overall Study|Protocol Violation|1|||
129475907|NCT01290887|466034156|FG000|Overall Study|Lost to Follow-up|4|||
129475908|NCT01290887|466034157|FG001|Overall Study|Lost to Follow-up|4|||
129475909|NCT01290887|466034156|FG000|Overall Study|Non-compliance to study procedures|0|||
129475910|NCT01290887|466034157|FG001|Overall Study|Non-compliance to study procedures|1|||
129475911|NCT01290887|466034156|FG000|Overall Study|Non-compliance to study medications|1|||
129475912|NCT01290887|466034157|FG001|Overall Study|Non-compliance to study medications|0|||
129475913|NCT01290887|466034156|FG000|Overall Study|Sponsor closure of study|420|||
129475914|NCT01290887|466034157|FG001|Overall Study|Sponsor closure of study|476|||
129475915|NCT01290887|466034156|FG000|Overall Study|Other|3|||
129475916|NCT01290887|466034157|FG001|Overall Study|Other|6|||
129475917|NCT01795547|466034158|FG000|Overall Study|Adverse Event|16|||
129475918|NCT01795547|466034159|FG001|Overall Study|Adverse Event|27|||
129475919|NCT01795547|466034158|FG000|Overall Study|Lack of Efficacy|8|||
129475920|NCT01795547|466034159|FG001|Overall Study|Lack of Efficacy|3|||
129475921|NCT01795547|466034158|FG000|Overall Study|Protocol Violation|6|||
129475922|NCT01795547|466034159|FG001|Overall Study|Protocol Violation|4|||
129475923|NCT01795547|466034158|FG000|Overall Study|Lost to Follow-up|2|||
129475924|NCT01795547|466034159|FG001|Overall Study|Lost to Follow-up|5|||
129475925|NCT01795547|466034158|FG000|Overall Study|Withdrawal of consent|7|||
129475926|NCT01795547|466034159|FG001|Overall Study|Withdrawal of consent|12|||
129475927|NCT01795547|466034158|FG000|Overall Study|Not Treated|4|||
129475928|NCT01795547|466034159|FG001|Overall Study|Not Treated|10|||
129475929|NCT01795547|466034158|FG000|Overall Study|Non-compliance with IMP|1|||
129475930|NCT01795547|466034159|FG001|Overall Study|Non-compliance with IMP|1|||
129475931|NCT01795547|466034158|FG000|Overall Study|Others|4|||
129475932|NCT01795547|466034159|FG001|Overall Study|Others|1|||
129475933|NCT01795547|466034158|FG000|Overall Study|Not stated|0|||
129475934|NCT01795547|466034159|FG001|Overall Study|Not stated|1|||
129475935|NCT03437447|466034160|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129475936|NCT03437447|466034161|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129475937|NCT03437447|466034162|FG002|Treatment Period 1|Withdrawal by Subject|1|||
129475938|NCT00484315|466034163|FG000|12-Month Clinical Follow-up|Death|6|||
129475939|NCT00484315|466034164|FG001|12-Month Clinical Follow-up|Death|2|||
129475940|NCT00484315|466034163|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
129475941|NCT00484315|466034164|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
129475942|NCT00484315|466034163|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
129475943|NCT00484315|466034164|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
129475944|NCT00484315|466034163|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
129475945|NCT00484315|466034164|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
129475946|NCT00484315|466034163|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
129475947|NCT00484315|466034164|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
129475948|NCT00484315|466034163|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
129475949|NCT00484315|466034164|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
129475950|NCT00484315|466034163|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
129475951|NCT00484315|466034164|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
129475952|NCT00943683|466034165|FG000|Overall Study|Adverse Event|3|||
129475953|NCT00943683|466034166|FG001|Overall Study|Adverse Event|3|||
129475954|NCT00943683|466034165|FG000|Overall Study|Lost to Follow-up|1|||
129475955|NCT00943683|466034166|FG001|Overall Study|Lost to Follow-up|1|||
129475956|NCT00943683|466034165|FG000|Overall Study|Protocol Violation|1|||
129475957|NCT00943683|466034166|FG001|Overall Study|Protocol Violation|2|||
129475958|NCT00943683|466034165|FG000|Overall Study|Withdrawal by Subject|1|||
129475959|NCT00943683|466034166|FG001|Overall Study|Withdrawal by Subject|0|||
129475960|NCT00943683|466034165|FG000|Overall Study|Patient Moved|1|||
129475961|NCT00943683|466034166|FG001|Overall Study|Patient Moved|0|||
129475962|NCT01551745|466034167|FG000|Overall Study|Withdrawal by Subject|1|||
129475963|NCT01551745|466034167|FG000|Overall Study|Disease Progression|2|||
129475964|NCT02764541|466034168|FG000|Overall Study|Withdrawal by Subject|0|||
129475965|NCT02764541|466034169|FG001|Overall Study|Withdrawal by Subject|0|||
129475966|NCT02764541|466034170|FG002|Overall Study|Withdrawal by Subject|0|||
129475967|NCT02764541|466034171|FG003|Overall Study|Withdrawal by Subject|0|||
129475968|NCT02764541|466034172|FG004|Overall Study|Withdrawal by Subject|1|||
129475969|NCT02764541|466034173|FG005|Overall Study|Withdrawal by Subject|1|||
129475970|NCT02764541|466034174|FG006|Overall Study|Withdrawal by Subject|0|||
129475971|NCT02764541|466034175|FG007|Overall Study|Withdrawal by Subject|1|||
129475972|NCT02764541|466034168|FG000|Overall Study|Adverse Event|1|||
129475973|NCT02764541|466034169|FG001|Overall Study|Adverse Event|0|||
129475974|NCT02764541|466034170|FG002|Overall Study|Adverse Event|0|||
129475975|NCT02764541|466034171|FG003|Overall Study|Adverse Event|0|||
129475976|NCT02764541|466034172|FG004|Overall Study|Adverse Event|0|||
129475977|NCT02764541|466034173|FG005|Overall Study|Adverse Event|0|||
129475978|NCT02764541|466034174|FG006|Overall Study|Adverse Event|1|||
129475979|NCT02764541|466034175|FG007|Overall Study|Adverse Event|0|||
129475980|NCT02764541|466034168|FG000|Overall Study|Metastasis|1|||
129475981|NCT02764541|466034169|FG001|Overall Study|Metastasis|0|||
129475982|NCT02764541|466034170|FG002|Overall Study|Metastasis|0|||
129475983|NCT02764541|466034171|FG003|Overall Study|Metastasis|0|||
129475984|NCT02764541|466034172|FG004|Overall Study|Metastasis|0|||
129475985|NCT02764541|466034173|FG005|Overall Study|Metastasis|0|||
129475986|NCT02764541|466034174|FG006|Overall Study|Metastasis|0|||
129475987|NCT02764541|466034175|FG007|Overall Study|Metastasis|0|||
129475988|NCT02764541|466034168|FG000|Overall Study|Disease progression|1|||
129475989|NCT02764541|466034169|FG001|Overall Study|Disease progression|1|||
129475990|NCT02764541|466034170|FG002|Overall Study|Disease progression|0|||
129475991|NCT02764541|466034171|FG003|Overall Study|Disease progression|0|||
129475992|NCT02764541|466034172|FG004|Overall Study|Disease progression|0|||
129475993|NCT02764541|466034173|FG005|Overall Study|Disease progression|0|||
129475994|NCT02764541|466034174|FG006|Overall Study|Disease progression|0|||
129475995|NCT02764541|466034175|FG007|Overall Study|Disease progression|1|||
129475996|NCT02764541|466034168|FG000|Overall Study|Protocol Violation|0|||
129475997|NCT02764541|466034169|FG001|Overall Study|Protocol Violation|0|||
129475998|NCT02764541|466034170|FG002|Overall Study|Protocol Violation|0|||
129475999|NCT02764541|466034171|FG003|Overall Study|Protocol Violation|1|||
129476000|NCT02764541|466034172|FG004|Overall Study|Protocol Violation|0|||
129476001|NCT02764541|466034173|FG005|Overall Study|Protocol Violation|1|||
129476002|NCT02764541|466034174|FG006|Overall Study|Protocol Violation|0|||
129476003|NCT02764541|466034175|FG007|Overall Study|Protocol Violation|0|||
129476004|NCT02764541|466034168|FG000|Overall Study|Physician Decision|0|||
129476005|NCT02764541|466034169|FG001|Overall Study|Physician Decision|0|||
129476006|NCT02764541|466034170|FG002|Overall Study|Physician Decision|0|||
129476007|NCT02764541|466034171|FG003|Overall Study|Physician Decision|1|||
129476008|NCT02764541|466034172|FG004|Overall Study|Physician Decision|0|||
129476009|NCT02764541|466034173|FG005|Overall Study|Physician Decision|0|||
129476010|NCT02764541|466034174|FG006|Overall Study|Physician Decision|0|||
129476011|NCT02764541|466034175|FG007|Overall Study|Physician Decision|1|||
129476012|NCT02764541|466034168|FG000|Overall Study|Three Cycles completed before surgery|0|||
129476013|NCT02764541|466034169|FG001|Overall Study|Three Cycles completed before surgery|0|||
129476014|NCT02764541|466034170|FG002|Overall Study|Three Cycles completed before surgery|0|||
129476015|NCT02764541|466034171|FG003|Overall Study|Three Cycles completed before surgery|1|||
129476016|NCT02764541|466034172|FG004|Overall Study|Three Cycles completed before surgery|0|||
129976259|NCT01427725|467875785|FG000|Overall Study|AE and Patient's rejection|5|||
129976260|NCT01427725|467875785|FG000|Overall Study|Physician Decision|5|||
129476017|NCT02764541|466034173|FG005|Overall Study|Three Cycles completed before surgery|0|||
129976261|NCT01427725|467875785|FG000|Overall Study|Exacerbation of underlying disease|5|||
129976262|NCT01427725|467875785|FG000|Overall Study|Oral feeding difficulty|5|||
129476018|NCT02764541|466034174|FG006|Overall Study|Three Cycles completed before surgery|0|||
129476019|NCT02764541|466034175|FG007|Overall Study|Three Cycles completed before surgery|0|||
129476020|NCT02764541|466034168|FG000|Overall Study|Patient Compliance|0|||
129476021|NCT02764541|466034169|FG001|Overall Study|Patient Compliance|0|||
129476022|NCT02764541|466034170|FG002|Overall Study|Patient Compliance|1|||
129476023|NCT02764541|466034171|FG003|Overall Study|Patient Compliance|0|||
129476024|NCT02764541|466034172|FG004|Overall Study|Patient Compliance|0|||
129476025|NCT02764541|466034173|FG005|Overall Study|Patient Compliance|0|||
129476026|NCT02764541|466034174|FG006|Overall Study|Patient Compliance|0|||
129476027|NCT02764541|466034175|FG007|Overall Study|Patient Compliance|0|||
129476028|NCT02764541|466034168|FG000|Overall Study|Death|0|||
129976263|NCT01427725|467875785|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
129476029|NCT02764541|466034169|FG001|Overall Study|Death|0|||
129476030|NCT02764541|466034170|FG002|Overall Study|Death|0|||
129476031|NCT02764541|466034171|FG003|Overall Study|Death|0|||
129476032|NCT02764541|466034172|FG004|Overall Study|Death|0|||
129476033|NCT02764541|466034173|FG005|Overall Study|Death|0|||
129476034|NCT02764541|466034174|FG006|Overall Study|Death|1|||
129476035|NCT02764541|466034175|FG007|Overall Study|Death|0|||
129476036|NCT02764541|466034168|FG000|Overall Study|Insurance reasons|0|||
129476037|NCT02764541|466034169|FG001|Overall Study|Insurance reasons|0|||
129476038|NCT02764541|466034170|FG002|Overall Study|Insurance reasons|0|||
129476039|NCT02764541|466034171|FG003|Overall Study|Insurance reasons|0|||
129476040|NCT02764541|466034172|FG004|Overall Study|Insurance reasons|0|||
129476041|NCT02764541|466034173|FG005|Overall Study|Insurance reasons|0|||
129476042|NCT02764541|466034174|FG006|Overall Study|Insurance reasons|1|||
129476043|NCT02764541|466034175|FG007|Overall Study|Insurance reasons|0|||
129476044|NCT00749190|466034180|FG000|Overall Study|Adverse Event|0|||
129476045|NCT00749190|466034181|FG001|Overall Study|Adverse Event|2|||
129476046|NCT00749190|466034182|FG002|Overall Study|Adverse Event|0|||
129476047|NCT00749190|466034183|FG003|Overall Study|Adverse Event|4|||
129476048|NCT00749190|466034184|FG004|Overall Study|Adverse Event|0|||
129476049|NCT00749190|466034185|FG005|Overall Study|Adverse Event|3|||
129476050|NCT00749190|466034186|FG006|Overall Study|Adverse Event|0|||
129476051|NCT00749190|466034180|FG000|Overall Study|Lack of Efficacy|3|||
129476052|NCT00749190|466034181|FG001|Overall Study|Lack of Efficacy|1|||
129476053|NCT00749190|466034182|FG002|Overall Study|Lack of Efficacy|1|||
129476054|NCT00749190|466034183|FG003|Overall Study|Lack of Efficacy|0|||
129476055|NCT00749190|466034184|FG004|Overall Study|Lack of Efficacy|0|||
129476056|NCT00749190|466034185|FG005|Overall Study|Lack of Efficacy|1|||
129476057|NCT00749190|466034186|FG006|Overall Study|Lack of Efficacy|0|||
129476058|NCT00749190|466034180|FG000|Overall Study|Withdrawal by Subject|2|||
129476059|NCT00749190|466034181|FG001|Overall Study|Withdrawal by Subject|1|||
129476060|NCT00749190|466034182|FG002|Overall Study|Withdrawal by Subject|0|||
129476061|NCT00749190|466034183|FG003|Overall Study|Withdrawal by Subject|0|||
129476062|NCT00749190|466034184|FG004|Overall Study|Withdrawal by Subject|0|||
129476063|NCT00749190|466034185|FG005|Overall Study|Withdrawal by Subject|1|||
129476064|NCT00749190|466034186|FG006|Overall Study|Withdrawal by Subject|0|||
129476065|NCT00749190|466034180|FG000|Overall Study|Protocol Violation|0|||
129476066|NCT00749190|466034181|FG001|Overall Study|Protocol Violation|1|||
129476067|NCT00749190|466034182|FG002|Overall Study|Protocol Violation|0|||
129476068|NCT00749190|466034183|FG003|Overall Study|Protocol Violation|0|||
129476069|NCT00749190|466034184|FG004|Overall Study|Protocol Violation|0|||
129476070|NCT00749190|466034185|FG005|Overall Study|Protocol Violation|0|||
129476071|NCT00749190|466034186|FG006|Overall Study|Protocol Violation|1|||
129476072|NCT00749190|466034180|FG000|Overall Study|Other reason not defined above|0|||
129476073|NCT00749190|466034181|FG001|Overall Study|Other reason not defined above|0|||
129476074|NCT00749190|466034182|FG002|Overall Study|Other reason not defined above|0|||
129476075|NCT00749190|466034183|FG003|Overall Study|Other reason not defined above|1|||
129476076|NCT00749190|466034184|FG004|Overall Study|Other reason not defined above|0|||
129476077|NCT00749190|466034185|FG005|Overall Study|Other reason not defined above|0|||
129476078|NCT00749190|466034186|FG006|Overall Study|Other reason not defined above|0|||
129476079|NCT00355121|466034187|FG000|Overall Study|Did not receive study vaccine|1|||
129476080|NCT00355121|466034188|FG001|Overall Study|Did not receive study vaccine|0|||
129476081|NCT00355121|466034189|FG002|Overall Study|Did not receive study vaccine|1|||
129476082|NCT00355121|466034187|FG000|Overall Study|Adverse Event|0|||
129476083|NCT00355121|466034188|FG001|Overall Study|Adverse Event|1|||
129476084|NCT00355121|466034189|FG002|Overall Study|Adverse Event|0|||
129476085|NCT00355121|466034187|FG000|Overall Study|Protocol Violation|7|||
129476086|NCT00355121|466034188|FG001|Overall Study|Protocol Violation|9|||
129476087|NCT00355121|466034189|FG002|Overall Study|Protocol Violation|1|||
129476088|NCT00355121|466034187|FG000|Overall Study|Lost to Follow-up|4|||
129476089|NCT00355121|466034188|FG001|Overall Study|Lost to Follow-up|7|||
129476090|NCT00355121|466034189|FG002|Overall Study|Lost to Follow-up|1|||
129476091|NCT00355121|466034187|FG000|Overall Study|Withdrawal by Subject|9|||
129476092|NCT00355121|466034188|FG001|Overall Study|Withdrawal by Subject|10|||
129476093|NCT00355121|466034189|FG002|Overall Study|Withdrawal by Subject|2|||
129476094|NCT00355121|466034187|FG000|Overall Study|Serious adverse events|0|||
129476095|NCT00355121|466034188|FG001|Overall Study|Serious adverse events|2|||
129476096|NCT00355121|466034189|FG002|Overall Study|Serious adverse events|0|||
129476097|NCT04752384|466034197|FG000|Overall Study|Withdrawal by Subject|1|||
129476098|NCT04752384|466034197|FG000|Overall Study|Death|1|||
129476099|NCT02330419|466034199|FG000|Overall Study|Lost to Follow-up|3|||
129476100|NCT02330419|466034200|FG001|Overall Study|Lost to Follow-up|7|||
129476101|NCT01813890|466034203|FG000|Overall Study|Adverse Event|0|||
129476102|NCT01813890|466034204|FG001|Overall Study|Adverse Event|3|||
129476103|NCT01813890|466034205|FG002|Overall Study|Adverse Event|4|||
129476104|NCT01813890|466034203|FG000|Overall Study|Lack of Efficacy|9|||
129476105|NCT01813890|466034204|FG001|Overall Study|Lack of Efficacy|1|||
129476106|NCT01813890|466034205|FG002|Overall Study|Lack of Efficacy|2|||
129476107|NCT04439123|466034206|FG000|Overall Study|Adverse Event|11|||
129476108|NCT04439123|466034206|FG000|Overall Study|Death|1|||
129476109|NCT04439123|466034206|FG000|Overall Study|Disease progression|19|||
129476110|NCT04439123|466034206|FG000|Overall Study|Withdrawal by Subject|2|||
129476111|NCT04439123|466034206|FG000|Overall Study|Still on treatment|2|||
129476112|NCT03952559|466034207|FG000|Double Blind Treatment Period|Adverse Event|0|||
129476113|NCT03952559|466034208|FG001|Double Blind Treatment Period|Adverse Event|2|||
129476114|NCT03952559|466034209|FG002|Double Blind Treatment Period|Adverse Event|1|||
129476115|NCT03952559|466034210|FG003|Double Blind Treatment Period|Adverse Event|0|||
129476116|NCT03952559|466034211|FG004|Double Blind Treatment Period|Adverse Event|1|||
129476117|NCT03952559|466034207|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
129476118|NCT03952559|466034208|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
129476119|NCT03952559|466034209|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
129476120|NCT03952559|466034210|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
129476121|NCT03952559|466034211|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
129476122|NCT03952559|466034207|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
129476123|NCT03952559|466034208|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
129476124|NCT03952559|466034209|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
129476125|NCT03952559|466034210|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
129476126|NCT03952559|466034211|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
129476127|NCT03952559|466034207|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
129476128|NCT03952559|466034208|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
129476129|NCT03952559|466034209|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
129476130|NCT03952559|466034210|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
129476131|NCT03952559|466034211|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
129476132|NCT01870739|466034214|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
129476133|NCT01870739|466034215|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
129476134|NCT01870739|466034214|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
129476135|NCT01870739|466034215|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
129476136|NCT01870739|466034214|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
129476137|NCT01870739|466034215|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
129476138|NCT01870739|466034214|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
129476139|NCT01870739|466034215|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
129476140|NCT01870739|466034214|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
129476141|NCT01870739|466034215|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
129476142|NCT01870739|466034214|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
129476143|NCT01870739|466034215|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
129476144|NCT01870739|466034214|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
129476145|NCT01870739|466034215|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
129476146|NCT01986062|466034216|FG000|Overall Study|Lost to Follow-up|1|||
129476147|NCT01986062|466034217|FG001|Overall Study|Lost to Follow-up|0|||
129476148|NCT01986062|466034216|FG000|Overall Study|Withdrawal by Subject|0|||
129476149|NCT01986062|466034217|FG001|Overall Study|Withdrawal by Subject|1|||
129476150|NCT03538743|466034218|FG000|Overall Study|Adverse Event|0|||
129476151|NCT03538743|466034219|FG001|Overall Study|Adverse Event|0|||
129476152|NCT03538743|466034220|FG002|Overall Study|Adverse Event|1|||
129476153|NCT03538743|466034221|FG003|Overall Study|Adverse Event|1|||
129476154|NCT03538743|466034222|FG004|Overall Study|Adverse Event|0|||
129476155|NCT03538743|466034223|FG005|Overall Study|Adverse Event|0|||
129476156|NCT03538743|466034224|FG006|Overall Study|Adverse Event|0|||
129476157|NCT03538743|466034225|FG007|Overall Study|Adverse Event|0|||
129476158|NCT03538743|466034226|FG008|Overall Study|Adverse Event|0|||
129476159|NCT03538743|466034218|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
129476160|NCT03538743|466034219|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
129476161|NCT03538743|466034220|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
129476162|NCT03538743|466034221|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
129476163|NCT03538743|466034222|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
129476164|NCT03538743|466034223|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
129476165|NCT03538743|466034224|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
129476166|NCT03538743|466034225|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
129476167|NCT03538743|466034226|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
129476168|NCT03538743|466034218|FG000|Overall Study|Withdrawal by Subject|0|||
129476169|NCT03538743|466034219|FG001|Overall Study|Withdrawal by Subject|0|||
129476170|NCT03538743|466034220|FG002|Overall Study|Withdrawal by Subject|0|||
129476171|NCT03538743|466034221|FG003|Overall Study|Withdrawal by Subject|1|||
129476172|NCT03538743|466034222|FG004|Overall Study|Withdrawal by Subject|0|||
129476173|NCT03538743|466034223|FG005|Overall Study|Withdrawal by Subject|0|||
129476174|NCT03538743|466034224|FG006|Overall Study|Withdrawal by Subject|0|||
129476175|NCT03538743|466034225|FG007|Overall Study|Withdrawal by Subject|0|||
129476176|NCT03538743|466034226|FG008|Overall Study|Withdrawal by Subject|0|||
129476177|NCT04640766|466034227|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
129476178|NCT00630331|466034228|FG000|Overall Study|Death|2|||
129476179|NCT00630331|466034229|FG001|Overall Study|Death|1|||
129476180|NCT00630331|466034230|FG002|Overall Study|Death|1|||
129476181|NCT00630331|466034228|FG000|Overall Study|Adverse Event|1|||
129476182|NCT00630331|466034229|FG001|Overall Study|Adverse Event|0|||
129476183|NCT00630331|466034230|FG002|Overall Study|Adverse Event|0|||
129476184|NCT00630331|466034228|FG000|Overall Study|Withdrawal by Subject|12|||
129476185|NCT00630331|466034229|FG001|Overall Study|Withdrawal by Subject|7|||
129476186|NCT00630331|466034230|FG002|Overall Study|Withdrawal by Subject|5|||
129476187|NCT00630331|466034228|FG000|Overall Study|Lost to Follow-up|175|||
129476188|NCT00630331|466034229|FG001|Overall Study|Lost to Follow-up|143|||
129476189|NCT00630331|466034230|FG002|Overall Study|Lost to Follow-up|170|||
129476190|NCT00630331|466034228|FG000|Overall Study|Inappropriate enrollment|3|||
129476191|NCT00630331|466034229|FG001|Overall Study|Inappropriate enrollment|6|||
129476192|NCT00630331|466034230|FG002|Overall Study|Inappropriate enrollment|3|||
129476193|NCT00630331|466034228|FG000|Overall Study|Unable to classify|9|||
129476194|NCT00630331|466034229|FG001|Overall Study|Unable to classify|4|||
129476195|NCT00630331|466034230|FG002|Overall Study|Unable to classify|3|||
129476196|NCT00630331|466034228|FG000|Overall Study|Protocol Violation|4|||
129476197|NCT00630331|466034229|FG001|Overall Study|Protocol Violation|5|||
129476198|NCT00630331|466034230|FG002|Overall Study|Protocol Violation|6|||
129476199|NCT01827384|466034232|FG000|Overall Study|Switched to alternative treatment|0|||
129476200|NCT01827384|466034233|FG001|Overall Study|Switched to alternative treatment|0|||
129476201|NCT01827384|466034234|FG002|Overall Study|Switched to alternative treatment|0|||
129476202|NCT01827384|466034235|FG003|Overall Study|Switched to alternative treatment|0|||
129476203|NCT01827384|466034236|FG004|Overall Study|Switched to alternative treatment|0|||
129476204|NCT01827384|466034237|FG005|Overall Study|Switched to alternative treatment|0|||
129476205|NCT01827384|466034238|FG006|Overall Study|Switched to alternative treatment|0|||
129476206|NCT01827384|466034239|FG007|Overall Study|Switched to alternative treatment|0|||
129476207|NCT01827384|466034240|FG008|Overall Study|Switched to alternative treatment|0|||
129476208|NCT01827384|466034241|FG009|Overall Study|Switched to alternative treatment|0|||
129476209|NCT01827384|466034242|FG010|Overall Study|Switched to alternative treatment|0|||
129476210|NCT01827384|466034243|FG011|Overall Study|Switched to alternative treatment|0|||
129476211|NCT01827384|466034244|FG012|Overall Study|Switched to alternative treatment|0|||
129476212|NCT01827384|466034245|FG013|Overall Study|Switched to alternative treatment|2|||
129476213|NCT01827384|466034232|FG000|Overall Study|Disease progression before treatment|0|||
129476214|NCT01827384|466034233|FG001|Overall Study|Disease progression before treatment|0|||
129476215|NCT01827384|466034234|FG002|Overall Study|Disease progression before treatment|0|||
129476216|NCT01827384|466034235|FG003|Overall Study|Disease progression before treatment|0|||
129476217|NCT01827384|466034236|FG004|Overall Study|Disease progression before treatment|0|||
129476218|NCT01827384|466034237|FG005|Overall Study|Disease progression before treatment|0|||
129476219|NCT01827384|466034238|FG006|Overall Study|Disease progression before treatment|0|||
129476220|NCT01827384|466034239|FG007|Overall Study|Disease progression before treatment|0|||
129476221|NCT01827384|466034240|FG008|Overall Study|Disease progression before treatment|0|||
129476222|NCT01827384|466034241|FG009|Overall Study|Disease progression before treatment|0|||
129476223|NCT01827384|466034242|FG010|Overall Study|Disease progression before treatment|0|||
129476224|NCT01827384|466034243|FG011|Overall Study|Disease progression before treatment|0|||
129476225|NCT01827384|466034244|FG012|Overall Study|Disease progression before treatment|0|||
129476226|NCT01827384|466034245|FG013|Overall Study|Disease progression before treatment|4|||
129476227|NCT01827384|466034232|FG000|Overall Study|Ineligible|0|||
129476228|NCT01827384|466034233|FG001|Overall Study|Ineligible|0|||
129476229|NCT01827384|466034234|FG002|Overall Study|Ineligible|0|||
129476230|NCT01827384|466034235|FG003|Overall Study|Ineligible|0|||
129476231|NCT01827384|466034236|FG004|Overall Study|Ineligible|0|||
129476232|NCT01827384|466034237|FG005|Overall Study|Ineligible|0|||
129476233|NCT01827384|466034238|FG006|Overall Study|Ineligible|0|||
129476234|NCT01827384|466034239|FG007|Overall Study|Ineligible|0|||
129476235|NCT01827384|466034240|FG008|Overall Study|Ineligible|0|||
129476236|NCT01827384|466034241|FG009|Overall Study|Ineligible|0|||
129476237|NCT01827384|466034242|FG010|Overall Study|Ineligible|0|||
129976264|NCT01427725|467875785|FG000|Overall Study|Forgetting prescription|1|||
129976265|NCT01427725|467875785|FG000|Overall Study|Other|2|||
129976266|NCT01277887|467875787|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
129476238|NCT01827384|466034243|FG011|Overall Study|Ineligible|0|||
129476239|NCT01827384|466034244|FG012|Overall Study|Ineligible|0|||
129476240|NCT01827384|466034245|FG013|Overall Study|Ineligible|19|||
129476241|NCT01827384|466034232|FG000|Overall Study|Participant died before treatment|0|||
129476242|NCT01827384|466034233|FG001|Overall Study|Participant died before treatment|0|||
129476243|NCT01827384|466034234|FG002|Overall Study|Participant died before treatment|0|||
129476244|NCT01827384|466034235|FG003|Overall Study|Participant died before treatment|0|||
129476245|NCT01827384|466034236|FG004|Overall Study|Participant died before treatment|0|||
129476246|NCT01827384|466034237|FG005|Overall Study|Participant died before treatment|0|||
129476247|NCT01827384|466034238|FG006|Overall Study|Participant died before treatment|0|||
129976267|NCT01277887|467875788|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
129976268|NCT01277887|467875787|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
129476248|NCT01827384|466034239|FG007|Overall Study|Participant died before treatment|0|||
129476249|NCT01827384|466034240|FG008|Overall Study|Participant died before treatment|0|||
129476250|NCT01827384|466034241|FG009|Overall Study|Participant died before treatment|0|||
129476251|NCT01827384|466034242|FG010|Overall Study|Participant died before treatment|0|||
129476252|NCT01827384|466034243|FG011|Overall Study|Participant died before treatment|0|||
129476253|NCT01827384|466034244|FG012|Overall Study|Participant died before treatment|0|||
129476254|NCT01827384|466034245|FG013|Overall Study|Participant died before treatment|5|||
129476255|NCT01827384|466034232|FG000|Overall Study|Insufficient tumor cells|0|||
129476256|NCT01827384|466034233|FG001|Overall Study|Insufficient tumor cells|0|||
129476257|NCT01827384|466034234|FG002|Overall Study|Insufficient tumor cells|0|||
129476258|NCT01827384|466034235|FG003|Overall Study|Insufficient tumor cells|0|||
129476259|NCT01827384|466034236|FG004|Overall Study|Insufficient tumor cells|0|||
129476260|NCT01827384|466034237|FG005|Overall Study|Insufficient tumor cells|0|||
129476261|NCT01827384|466034238|FG006|Overall Study|Insufficient tumor cells|0|||
129476262|NCT01827384|466034239|FG007|Overall Study|Insufficient tumor cells|0|||
129476263|NCT01827384|466034240|FG008|Overall Study|Insufficient tumor cells|0|||
129476264|NCT01827384|466034241|FG009|Overall Study|Insufficient tumor cells|0|||
129476265|NCT01827384|466034242|FG010|Overall Study|Insufficient tumor cells|0|||
129476266|NCT01827384|466034243|FG011|Overall Study|Insufficient tumor cells|0|||
129976269|NCT01277887|467875788|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
129976270|NCT01277887|467875787|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
129976271|NCT01277887|467875788|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
129976272|NCT00415051|467875789|FG000|Overall Study|Protocol Violation|1|||
129976273|NCT01754753|467875794|FG000|Overall Study|Study close|43|||
129976274|NCT01754753|467875795|FG001|Overall Study|Study close|44|||
129976275|NCT01754753|467875794|FG000|Overall Study|Lost to Follow-up|9|||
129976276|NCT01754753|467875795|FG001|Overall Study|Lost to Follow-up|5|||
129976277|NCT00856245|467875797|FG000|Overall Study|Was not transplanted|5|||
129976278|NCT01250509|467875798|FG000|Overall Study|Lost to Follow-up|5|||
129976279|NCT01250509|467875799|FG001|Overall Study|Lost to Follow-up|2|||
129976280|NCT00203268|467875803|FG000|Early Treatment|only treated one headache|2|||
129976281|NCT00203268|467875803|FG000|Early Treatment|Lost to Follow-up|1|||
129976282|NCT00203268|467875803|FG000|Early Treatment|Withdrawal by Subject|1|||
129976283|NCT01371708|467875806|FG000|Overall Study|Insufficient clinical response|3|||
129976284|NCT01371708|467875807|FG001|Overall Study|Insufficient clinical response|2|||
129976285|NCT01371708|467875808|FG002|Overall Study|Insufficient clinical response|0|||
129976286|NCT01371708|467875806|FG000|Overall Study|Lost to Follow-up|5|||
129976287|NCT01371708|467875807|FG001|Overall Study|Lost to Follow-up|9|||
129976288|NCT01371708|467875808|FG002|Overall Study|Lost to Follow-up|7|||
129976289|NCT01371708|467875806|FG000|Overall Study|Protocol Violation|2|||
129976290|NCT01371708|467875807|FG001|Overall Study|Protocol Violation|1|||
129976291|NCT01371708|467875808|FG002|Overall Study|Protocol Violation|2|||
129976292|NCT01371708|467875806|FG000|Overall Study|No longer willing to participate|7|||
129976293|NCT01371708|467875807|FG001|Overall Study|No longer willing to participate|7|||
129976294|NCT01371708|467875808|FG002|Overall Study|No longer willing to participate|13|||
129976295|NCT01371708|467875806|FG000|Overall Study|Medication error/not related to AE|0|||
129976296|NCT01371708|467875807|FG001|Overall Study|Medication error/not related to AE|1|||
129976297|NCT01371708|467875808|FG002|Overall Study|Medication error/not related to AE|0|||
129976298|NCT01371708|467875806|FG000|Overall Study|Other|3|||
129976299|NCT01371708|467875807|FG001|Overall Study|Other|2|||
129976300|NCT01371708|467875808|FG002|Overall Study|Other|4|||
129976301|NCT01371708|467875806|FG000|Overall Study|Adverse Event|5|||
129976302|NCT01371708|467875807|FG001|Overall Study|Adverse Event|8|||
129976303|NCT01371708|467875808|FG002|Overall Study|Adverse Event|12|||
129976304|NCT01371708|467875806|FG000|Overall Study|Started but did not receive treatment|1|||
129976305|NCT01371708|467875807|FG001|Overall Study|Started but did not receive treatment|0|||
129976306|NCT01371708|467875808|FG002|Overall Study|Started but did not receive treatment|1|||
129976307|NCT02819024|467875810|FG000|Overall Study|Withdrawal by Subject|1|||
129976308|NCT00792948|467875811|FG000|Overall Study|Adverse Event|6|||
129476267|NCT01827384|466034244|FG012|Overall Study|Insufficient tumor cells|0|||
129476268|NCT01827384|466034245|FG013|Overall Study|Insufficient tumor cells|13|||
129476269|NCT01827384|466034232|FG000|Overall Study|No actionable mutation|0|||
129476270|NCT01827384|466034233|FG001|Overall Study|No actionable mutation|0|||
129476271|NCT01827384|466034234|FG002|Overall Study|No actionable mutation|0|||
129476272|NCT01827384|466034235|FG003|Overall Study|No actionable mutation|0|||
129476273|NCT01827384|466034236|FG004|Overall Study|No actionable mutation|0|||
129476274|NCT01827384|466034237|FG005|Overall Study|No actionable mutation|0|||
129476275|NCT01827384|466034238|FG006|Overall Study|No actionable mutation|0|||
129476276|NCT01827384|466034239|FG007|Overall Study|No actionable mutation|0|||
129476277|NCT01827384|466034240|FG008|Overall Study|No actionable mutation|0|||
129476278|NCT01827384|466034241|FG009|Overall Study|No actionable mutation|0|||
129976309|NCT00792948|467875811|FG000|Overall Study|Death|4|||
129976310|NCT00792948|467875811|FG000|Overall Study|Withdrawal by Subject|3|||
129976311|NCT00792948|467875811|FG000|Overall Study|Ineligible|2|||
129976312|NCT00792948|467875811|FG000|Overall Study|Insurance denial - not treated|1|||
129476279|NCT01827384|466034242|FG010|Overall Study|No actionable mutation|0|||
129476280|NCT01827384|466034243|FG011|Overall Study|No actionable mutation|0|||
129476281|NCT01827384|466034244|FG012|Overall Study|No actionable mutation|0|||
129476282|NCT01827384|466034245|FG013|Overall Study|No actionable mutation|73|||
129476283|NCT01827384|466034232|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
129476284|NCT01827384|466034233|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
129476285|NCT01827384|466034234|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
129476286|NCT01827384|466034235|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
129476287|NCT01827384|466034236|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
129476288|NCT01827384|466034237|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
129476289|NCT01827384|466034238|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
129476290|NCT01827384|466034239|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
129476291|NCT01827384|466034240|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
129476292|NCT01827384|466034241|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
129476293|NCT01827384|466034242|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
129476294|NCT01827384|466034243|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
129476295|NCT01827384|466034244|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
129476296|NCT01827384|466034245|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
129476297|NCT01817790|466034250|FG000|Overall Study|Adverse Event|0|||
129476298|NCT01817790|466034251|FG001|Overall Study|Adverse Event|2|||
129476299|NCT01817790|466034250|FG000|Overall Study|Lost to Follow-up|0|||
129476300|NCT01817790|466034251|FG001|Overall Study|Lost to Follow-up|1|||
129476301|NCT01817790|466034250|FG000|Overall Study|Protocol Violation|2|||
129476302|NCT01817790|466034251|FG001|Overall Study|Protocol Violation|1|||
129476303|NCT01817790|466034250|FG000|Overall Study|Withdrawal by Subject|1|||
129476304|NCT01817790|466034251|FG001|Overall Study|Withdrawal by Subject|3|||
129476305|NCT01817790|466034250|FG000|Overall Study|Other: Could not attend appointment|1|||
129476306|NCT01817790|466034251|FG001|Overall Study|Other: Could not attend appointment|1|||
129476307|NCT01671345|466034252|FG000|Overall Study|Lost to Follow-up|10|||
129476308|NCT01671345|466034253|FG001|Overall Study|Lost to Follow-up|6|||
129476309|NCT01671345|466034252|FG000|Overall Study|visit with non-participating physician|3|||
129476310|NCT01671345|466034253|FG001|Overall Study|visit with non-participating physician|3|||
129476311|NCT04280081|466034256|FG000|Overall Study|Adverse Event|4|||
129476312|NCT04280081|466034256|FG000|Overall Study|Death|2|||
129476313|NCT04280081|466034256|FG000|Overall Study|Progressive Disease|6|||
129476314|NCT01468311|466034257|FG000|Overall Study|mobilization failure|1|||
129476315|NCT01468311|466034257|FG000|Overall Study|Withdrawal by Subject|1|||
129476316|NCT02689492|466036429|FG000|Overall Study|Lost to Follow-up|61|||
129476317|NCT02689492|466036429|FG000|Overall Study|Withdrawal by Subject|11|||
129476318|NCT02689492|466036429|FG000|Overall Study|Death|9|||
129476319|NCT02689492|466036429|FG000|Overall Study|Physician Decision|2|||
129476320|NCT02689492|466036429|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
129476321|NCT02689492|466036429|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
129476322|NCT02689492|466036429|FG000|Overall Study|Other than listed|1|||
129476323|NCT02029976|466036430|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
129476324|NCT02029976|466036431|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
129476325|NCT02029976|466036430|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
129476326|NCT02029976|466036431|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
129476327|NCT02029976|466036430|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
129476328|NCT02029976|466036431|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
129476329|NCT02029976|466036430|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
129476330|NCT02029976|466036431|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
129476331|NCT01750918|466036432|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
129476332|NCT01750918|466036433|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
129476333|NCT01750918|466036434|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
129476334|NCT01750918|466036435|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
129476335|NCT01750918|466036436|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
129476336|NCT01750918|466036437|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
129476337|NCT01750918|466036438|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
129976313|NCT00792948|467875811|FG000|Overall Study|Physician Decision|11|||
129976314|NCT00792948|467875811|FG000|Overall Study|Protocol Violation|1|||
129976315|NCT03832595|467875819|FG000|Overall Study|Death|142|||
129476338|NCT01750918|466036439|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
129476339|NCT01750918|466036432|FG000|Overall Study|Lost to Follow-up|0|||
129476340|NCT01750918|466036433|FG001|Overall Study|Lost to Follow-up|0|||
129476341|NCT01750918|466036434|FG002|Overall Study|Lost to Follow-up|2|||
129476342|NCT01750918|466036435|FG003|Overall Study|Lost to Follow-up|2|||
129476343|NCT01750918|466036436|FG004|Overall Study|Lost to Follow-up|0|||
129476344|NCT01750918|466036437|FG005|Overall Study|Lost to Follow-up|0|||
129476345|NCT01750918|466036438|FG006|Overall Study|Lost to Follow-up|0|||
129976316|NCT03832595|467875820|FG001|Overall Study|Death|130|||
129476346|NCT01750918|466036439|FG007|Overall Study|Lost to Follow-up|1|||
129476347|NCT01750918|466036432|FG000|Overall Study|Withdrawal by Subject|0|||
129476348|NCT01750918|466036433|FG001|Overall Study|Withdrawal by Subject|0|||
129476349|NCT01750918|466036434|FG002|Overall Study|Withdrawal by Subject|1|||
129476350|NCT01750918|466036435|FG003|Overall Study|Withdrawal by Subject|2|||
129476351|NCT01750918|466036436|FG004|Overall Study|Withdrawal by Subject|1|||
129476352|NCT01750918|466036437|FG005|Overall Study|Withdrawal by Subject|1|||
129476353|NCT01750918|466036438|FG006|Overall Study|Withdrawal by Subject|2|||
129476354|NCT01750918|466036439|FG007|Overall Study|Withdrawal by Subject|2|||
129476355|NCT02338843|466036445|FG000|Overall Study|Adverse Event|2|||
129476356|NCT02338843|466036446|FG001|Overall Study|Adverse Event|1|||
129476357|NCT02338843|466036445|FG000|Overall Study|Death|40|||
129476358|NCT02338843|466036446|FG001|Overall Study|Death|53|||
129476359|NCT02338843|466036445|FG000|Overall Study|Physician Decision|1|||
129476360|NCT02338843|466036446|FG001|Overall Study|Physician Decision|0|||
129476361|NCT02338843|466036445|FG000|Overall Study|Withdrawal by Subject|0|||
129476362|NCT02338843|466036446|FG001|Overall Study|Withdrawal by Subject|2|||
129476363|NCT02338843|466036445|FG000|Overall Study|Subject Recovered|0|||
129476364|NCT02338843|466036446|FG001|Overall Study|Subject Recovered|2|||
129476365|NCT02338843|466036445|FG000|Overall Study|Discontinued prior to randomizat|1|||
129476366|NCT02338843|466036446|FG001|Overall Study|Discontinued prior to randomizat|0|||
129476367|NCT00023322|466036447|FG000|Overall Study|Lost to Follow-up|1|||
129476368|NCT01793792|466036450|FG000|Overall Study|Death|5|||
129476369|NCT01793792|466036450|FG000|Overall Study|Lost to Follow-up|5|||
129476370|NCT01793792|466036450|FG000|Overall Study|Withdrawal by Subject|1|||
129476371|NCT01793792|466036450|FG000|Overall Study|Device Not Implanted|1|||
129476372|NCT02185521|466036453|FG000|Overall Study|Withdrawal by Subject|1|||
129476373|NCT02185521|466036453|FG000|Overall Study|Protocol Violation|1|||
129476374|NCT01341457|466036454|FG000|Overall Study|Adverse Event|2|||
129476375|NCT01341457|466036455|FG001|Overall Study|Adverse Event|0|||
129476376|NCT03124459|466036460|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
129476377|NCT03124459|466036461|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
129476378|NCT03124459|466036462|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
129476379|NCT03124459|466036463|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
129476380|NCT03124459|466036464|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
129476381|NCT03124459|466036465|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
129476382|NCT03124459|466036460|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
129476383|NCT03124459|466036461|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
129476384|NCT03124459|466036462|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
129476385|NCT03124459|466036463|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
129476386|NCT03124459|466036464|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
129476387|NCT03124459|466036465|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
129476388|NCT03124459|466036460|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
129476389|NCT03124459|466036461|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
129476390|NCT03124459|466036462|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
129476391|NCT03124459|466036463|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
129476392|NCT03124459|466036464|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
129476393|NCT03124459|466036465|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
129476394|NCT03124459|466036460|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
129476395|NCT03124459|466036461|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
129476396|NCT03124459|466036462|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
129476397|NCT03124459|466036463|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
129476398|NCT03124459|466036464|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
129476399|NCT03124459|466036465|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
129476400|NCT03124459|466036460|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
129476401|NCT03124459|466036461|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
129476402|NCT03124459|466036462|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
129476403|NCT03124459|466036463|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
129476404|NCT03124459|466036464|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
129976317|NCT03832595|467875819|FG000|Overall Study|Medical management without dialysis|37|||
129976318|NCT03832595|467875820|FG001|Overall Study|Medical management without dialysis|1|||
129976319|NCT02397447|467875821|FG000|Overall Study|Lost to Follow-up|2|||
129476405|NCT03124459|466036465|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
129476406|NCT03124459|466036460|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
129476407|NCT03124459|466036461|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
129476408|NCT03124459|466036462|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
129476409|NCT03124459|466036463|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
129476410|NCT03124459|466036464|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
129976320|NCT02397447|467875822|FG001|Overall Study|Lost to Follow-up|2|||
129976321|NCT04942366|467877728|FG000|Overall Study|Withdrawal by Subject|5|||
129976322|NCT04942366|467877729|FG001|Overall Study|Withdrawal by Subject|5|||
129976323|NCT04996004|467877730|FG000|Phase I|Death|1|||
129476411|NCT03124459|466036465|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
129476412|NCT00496366|466036466|FG000|Overall Study|Death|1|||
129476413|NCT01717638|466036471|FG000|Overall Study|Lost to Follow-up|0|||
129476414|NCT01717638|466036472|FG001|Overall Study|Lost to Follow-up|0|||
129476415|NCT01717638|466036473|FG002|Overall Study|Lost to Follow-up|0|||
129476416|NCT01717638|466036474|FG003|Overall Study|Lost to Follow-up|0|||
129476417|NCT01717638|466036475|FG004|Overall Study|Lost to Follow-up|0|||
129476418|NCT01717638|466036476|FG005|Overall Study|Lost to Follow-up|1|||
129476419|NCT01717638|466036477|FG006|Overall Study|Lost to Follow-up|0|||
129476420|NCT01717638|466036478|FG007|Overall Study|Lost to Follow-up|0|||
129476421|NCT01717638|466036479|FG008|Overall Study|Lost to Follow-up|0|||
129476422|NCT01717638|466036480|FG009|Overall Study|Lost to Follow-up|0|||
129476423|NCT01717638|466036481|FG010|Overall Study|Lost to Follow-up|0|||
129476424|NCT01717638|466036482|FG011|Overall Study|Lost to Follow-up|0|||
129476425|NCT01717638|466036483|FG012|Overall Study|Lost to Follow-up|0|||
129476426|NCT01717638|466036471|FG000|Overall Study|Father in hospital|0|||
129476427|NCT01717638|466036472|FG001|Overall Study|Father in hospital|0|||
129476428|NCT01717638|466036473|FG002|Overall Study|Father in hospital|0|||
129476429|NCT01717638|466036474|FG003|Overall Study|Father in hospital|0|||
129476430|NCT01717638|466036475|FG004|Overall Study|Father in hospital|0|||
129476431|NCT01717638|466036476|FG005|Overall Study|Father in hospital|0|||
129476432|NCT01717638|466036477|FG006|Overall Study|Father in hospital|0|||
129476433|NCT01717638|466036478|FG007|Overall Study|Father in hospital|0|||
129476434|NCT01717638|466036479|FG008|Overall Study|Father in hospital|0|||
129476435|NCT01717638|466036480|FG009|Overall Study|Father in hospital|0|||
129476436|NCT01717638|466036481|FG010|Overall Study|Father in hospital|0|||
129476437|NCT01717638|466036482|FG011|Overall Study|Father in hospital|0|||
129476438|NCT01717638|466036483|FG012|Overall Study|Father in hospital|1|||
129476439|NCT01717638|466036471|FG000|Overall Study|Withdrawal by Subject|0|||
129476440|NCT01717638|466036472|FG001|Overall Study|Withdrawal by Subject|1|||
129476441|NCT01717638|466036473|FG002|Overall Study|Withdrawal by Subject|1|||
129476442|NCT01717638|466036474|FG003|Overall Study|Withdrawal by Subject|0|||
129476443|NCT01717638|466036475|FG004|Overall Study|Withdrawal by Subject|1|||
129476444|NCT01717638|466036476|FG005|Overall Study|Withdrawal by Subject|0|||
129476445|NCT01717638|466036477|FG006|Overall Study|Withdrawal by Subject|2|||
129476446|NCT01717638|466036478|FG007|Overall Study|Withdrawal by Subject|1|||
129476447|NCT01717638|466036479|FG008|Overall Study|Withdrawal by Subject|2|||
129476448|NCT01717638|466036480|FG009|Overall Study|Withdrawal by Subject|1|||
129476449|NCT01717638|466036481|FG010|Overall Study|Withdrawal by Subject|0|||
129476450|NCT01717638|466036482|FG011|Overall Study|Withdrawal by Subject|0|||
129476451|NCT01717638|466036483|FG012|Overall Study|Withdrawal by Subject|18|||
129476452|NCT01756274|466036484|FG000|Overall Study|Protocol Violation|2|||
129476453|NCT01756274|466036484|FG000|Overall Study|Laboratory error|1|||
129476454|NCT01147926|466036485|FG000|Overall Study|Subject Withdrew Consent|9|||
129476455|NCT01147926|466036486|FG001|Overall Study|Subject Withdrew Consent|10|||
129476456|NCT01147926|466036485|FG000|Overall Study|Adverse Event|7|||
129476457|NCT01147926|466036486|FG001|Overall Study|Adverse Event|6|||
129476458|NCT01147926|466036485|FG000|Overall Study|Subject Non-Compliant|5|||
129476459|NCT01147926|466036486|FG001|Overall Study|Subject Non-Compliant|4|||
129476460|NCT01147926|466036485|FG000|Overall Study|Principal investigator left hospital|1|||
129476461|NCT01147926|466036486|FG001|Overall Study|Principal investigator left hospital|3|||
129476462|NCT01147926|466036485|FG000|Overall Study|Selection criteria not met|3|||
129476463|NCT01147926|466036486|FG001|Overall Study|Selection criteria not met|1|||
129476464|NCT01147926|466036485|FG000|Overall Study|Lost to Follow-up|0|||
129476465|NCT01147926|466036486|FG001|Overall Study|Lost to Follow-up|2|||
129476466|NCT01147926|466036485|FG000|Overall Study|Sponsor's Decision|0|||
129476467|NCT01147926|466036486|FG001|Overall Study|Sponsor's Decision|1|||
129476468|NCT01147926|466036485|FG000|Overall Study|Lack of Efficacy|1|||
129476469|NCT01147926|466036486|FG001|Overall Study|Lack of Efficacy|0|||
129476470|NCT01147926|466036485|FG000|Overall Study|Too busy, no time for study|1|||
129476471|NCT01147926|466036486|FG001|Overall Study|Too busy, no time for study|0|||
129476472|NCT01147926|466036485|FG000|Overall Study|Went on holiday|0|||
129476473|NCT01147926|466036486|FG001|Overall Study|Went on holiday|1|||
129476474|NCT01147926|466036485|FG000|Overall Study|Colonoscopy result|0|||
129476475|NCT01147926|466036486|FG001|Overall Study|Colonoscopy result|1|||
129476476|NCT00486603|466036487|FG000|Overall Study|Withdrawal by Subject|1|||
129476477|NCT00486603|466036488|FG001|Overall Study|Withdrawal by Subject|0|||
129476478|NCT00486603|466036489|FG002|Overall Study|Withdrawal by Subject|0|||
129476479|NCT00486603|466036490|FG003|Overall Study|Withdrawal by Subject|0|||
129476480|NCT00486603|466036491|FG004|Overall Study|Withdrawal by Subject|0|||
129476481|NCT00486603|466036487|FG000|Overall Study|Physician Decision|0|||
129476482|NCT00486603|466036488|FG001|Overall Study|Physician Decision|1|||
129476483|NCT00486603|466036489|FG002|Overall Study|Physician Decision|0|||
129476484|NCT00486603|466036490|FG003|Overall Study|Physician Decision|0|||
129476485|NCT00486603|466036491|FG004|Overall Study|Physician Decision|0|||
129476486|NCT03514914|466036493|FG000|Overall Study|Death|3|||
129476487|NCT03514914|466036494|FG001|Overall Study|Death|3|||
129476488|NCT03514914|466036493|FG000|Overall Study|Lost to Follow-up|117|||
129476489|NCT03514914|466036494|FG001|Overall Study|Lost to Follow-up|89|||
129476490|NCT02978222|466036498|FG000|Overall Study|Withdrawal by Subject|2|||
129476491|NCT02978222|466036499|FG001|Overall Study|Withdrawal by Subject|2|||
129476492|NCT02978222|466036498|FG000|Overall Study|Physician Decision|2|||
129476493|NCT02978222|466036499|FG001|Overall Study|Physician Decision|0|||
129476494|NCT02978222|466036498|FG000|Overall Study|Adverse Event|0|||
129476495|NCT02978222|466036499|FG001|Overall Study|Adverse Event|1|||
129476496|NCT02978222|466036498|FG000|Overall Study|Death|1|||
129476497|NCT02978222|466036499|FG001|Overall Study|Death|0|||
129476498|NCT02978222|466036498|FG000|Overall Study|Disease Progression|32|||
129476499|NCT02978222|466036499|FG001|Overall Study|Disease Progression|32|||
129476500|NCT02978222|466036498|FG000|Overall Study|Early Study Termination|24|||
129476501|NCT02978222|466036499|FG001|Overall Study|Early Study Termination|21|||
129476502|NCT01686568|466036500|FG000|Main Study|Withdrawal by Subject|1|||
129476503|NCT01686568|466036501|FG001|Main Study|Withdrawal by Subject|3|||
129476504|NCT01686568|466036500|FG000|Main Study|Noncompliance with protocol|0|||
129476505|NCT01686568|466036501|FG001|Main Study|Noncompliance with protocol|1|||
129476506|NCT01686568|466036500|FG000|Main Study|Liver enzymes above range of exclusion|1|||
129476507|NCT01686568|466036501|FG001|Main Study|Liver enzymes above range of exclusion|0|||
129476508|NCT01686568|466036500|FG000|Sub-Study|Not consented for sub-study|2|||
129476509|NCT01686568|466036501|FG001|Sub-Study|Not consented for sub-study|2|||
129476510|NCT03838484|466036504|FG000|Overall Study|Lost to Follow-up|0|||
129476511|NCT03838484|466036505|FG001|Overall Study|Lost to Follow-up|1|||
129476512|NCT03838484|466036506|FG002|Overall Study|Lost to Follow-up|0|||
129476513|NCT03838484|466036507|FG003|Overall Study|Lost to Follow-up|0|||
129476514|NCT00813995|466036508|FG000|Overall Study|Clinical adverse event|9|||
129476515|NCT00813995|466036509|FG001|Overall Study|Clinical adverse event|3|||
129476516|NCT00813995|466036508|FG000|Overall Study|Laboratory adverse event|0|||
129476517|NCT00813995|466036509|FG001|Overall Study|Laboratory adverse event|2|||
129476518|NCT00813995|466036508|FG000|Overall Study|Lack of Efficacy|1|||
129476519|NCT00813995|466036509|FG001|Overall Study|Lack of Efficacy|0|||
129476520|NCT00813995|466036508|FG000|Overall Study|Lost to Follow-up|4|||
129476521|NCT00813995|466036509|FG001|Overall Study|Lost to Follow-up|2|||
129476522|NCT00813995|466036508|FG000|Overall Study|Other reason|2|||
129476523|NCT00813995|466036509|FG001|Overall Study|Other reason|2|||
129476524|NCT00813995|466036508|FG000|Overall Study|Protocol Violation|3|||
129476525|NCT00813995|466036509|FG001|Overall Study|Protocol Violation|2|||
129476526|NCT00813995|466036508|FG000|Overall Study|Subject moved|4|||
129476527|NCT00813995|466036509|FG001|Overall Study|Subject moved|0|||
129476528|NCT00813995|466036508|FG000|Overall Study|Withdrawal by Subject|0|||
129476529|NCT00813995|466036509|FG001|Overall Study|Withdrawal by Subject|5|||
129476530|NCT02507349|466036510|FG000|Overall Study|Death|12|||
129476531|NCT02507349|466036511|FG001|Overall Study|Death|16|||
129476532|NCT02507349|466036510|FG000|Overall Study|Withdrawal by Subject|1|||
129476533|NCT02507349|466036511|FG001|Overall Study|Withdrawal by Subject|1|||
129476534|NCT02507349|466036510|FG000|Overall Study|Lost to Follow-up|174|||
129476535|NCT02507349|466036511|FG001|Overall Study|Lost to Follow-up|144|||
129476536|NCT01614964|466036512|FG000|Overall Study|Withdrawal by Subject|2|||
129476537|NCT01614964|466036513|FG001|Overall Study|Withdrawal by Subject|0|||
129476538|NCT01614964|466036512|FG000|Overall Study|Lost to Follow-up|3|||
129476539|NCT01614964|466036513|FG001|Overall Study|Lost to Follow-up|0|||
129476540|NCT02700984|466036522|FG000|Overall Study|Death|2|||
129476541|NCT02700984|466036523|FG001|Overall Study|Death|1|||
129476542|NCT02700984|466036522|FG000|Overall Study|Lost to Follow-up|2|||
129476543|NCT02700984|466036523|FG001|Overall Study|Lost to Follow-up|1|||
129476544|NCT02700984|466036522|FG000|Overall Study|Physician Decision|0|||
129476545|NCT02700984|466036523|FG001|Overall Study|Physician Decision|1|||
129476546|NCT02700984|466036522|FG000|Overall Study|Withdrawal by Subject|8|||
129476547|NCT02700984|466036523|FG001|Overall Study|Withdrawal by Subject|9|||
129476548|NCT02700984|466036522|FG000|Overall Study|Reason not specified|3|||
129476549|NCT02700984|466036523|FG001|Overall Study|Reason not specified|2|||
129476550|NCT00473876|466036524|FG000|Overall Study|Lost to Follow-up|3|||
129476551|NCT00473876|466036525|FG001|Overall Study|Lost to Follow-up|1|||
129476552|NCT01032629|466036527|FG000|Overall Study|Closed Site|21|||
129476553|NCT01032629|466036528|FG001|Overall Study|Closed Site|18|||
129476554|NCT01032629|466036529|FG002|Overall Study|Closed Site|16|||
129476555|NCT01032629|466036527|FG000|Overall Study|Withdrawal by Subject|50|||
129476556|NCT01032629|466036528|FG001|Overall Study|Withdrawal by Subject|36|||
129476557|NCT01032629|466036529|FG002|Overall Study|Withdrawal by Subject|35|||
129476558|NCT01032629|466036527|FG000|Overall Study|Lost to Follow-up|74|||
129476559|NCT01032629|466036528|FG001|Overall Study|Lost to Follow-up|47|||
129476560|NCT01032629|466036529|FG002|Overall Study|Lost to Follow-up|37|||
129476561|NCT00348140|466036530|FG000|Overall Study|Adverse Event|46|||
129476562|NCT00348140|466036531|FG001|Overall Study|Adverse Event|49|||
129476563|NCT00348140|466036532|FG002|Overall Study|Adverse Event|78|||
129476564|NCT00348140|466036530|FG000|Overall Study|Lost to Follow-up|4|||
129476565|NCT00348140|466036531|FG001|Overall Study|Lost to Follow-up|4|||
129476566|NCT00348140|466036532|FG002|Overall Study|Lost to Follow-up|4|||
129476567|NCT00348140|466036530|FG000|Overall Study|Protocol Violation|12|||
129476568|NCT00348140|466036531|FG001|Overall Study|Protocol Violation|13|||
129476569|NCT00348140|466036532|FG002|Overall Study|Protocol Violation|14|||
129476570|NCT00348140|466036530|FG000|Overall Study|Withdrawal by Subject|32|||
129476571|NCT00348140|466036531|FG001|Overall Study|Withdrawal by Subject|40|||
129476572|NCT00348140|466036532|FG002|Overall Study|Withdrawal by Subject|40|||
129476573|NCT00348140|466036530|FG000|Overall Study|Non-compliance|8|||
129476574|NCT00348140|466036531|FG001|Overall Study|Non-compliance|13|||
129476575|NCT00348140|466036532|FG002|Overall Study|Non-compliance|5|||
129476576|NCT00348140|466036530|FG000|Overall Study|Participant at risk due to study drug|2|||
129476577|NCT00348140|466036531|FG001|Overall Study|Participant at risk due to study drug|0|||
129476578|NCT00348140|466036532|FG002|Overall Study|Participant at risk due to study drug|0|||
129476579|NCT00348140|466036530|FG000|Overall Study|Conditional medication increased dose|1|||
129476580|NCT00348140|466036531|FG001|Overall Study|Conditional medication increased dose|0|||
129476581|NCT00348140|466036532|FG002|Overall Study|Conditional medication increased dose|0|||
129476582|NCT00348140|466036530|FG000|Overall Study|Caregiver related|4|||
129476583|NCT00348140|466036531|FG001|Overall Study|Caregiver related|7|||
129476584|NCT00348140|466036532|FG002|Overall Study|Caregiver related|3|||
129476585|NCT00348140|466036530|FG000|Overall Study|Participant hospitalised|3|||
129476586|NCT00348140|466036531|FG001|Overall Study|Participant hospitalised|0|||
129476587|NCT00348140|466036532|FG002|Overall Study|Participant hospitalised|0|||
129476588|NCT00348140|466036530|FG000|Overall Study|Efficacy related|1|||
129476589|NCT00348140|466036531|FG001|Overall Study|Efficacy related|1|||
129476590|NCT00348140|466036532|FG002|Overall Study|Efficacy related|0|||
129476591|NCT00348140|466036530|FG000|Overall Study|Administration related|3|||
129476592|NCT00348140|466036531|FG001|Overall Study|Administration related|1|||
129476593|NCT00348140|466036532|FG002|Overall Study|Administration related|1|||
129476594|NCT00348140|466036530|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
129476595|NCT00348140|466036531|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
129476596|NCT00348140|466036532|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
129476597|NCT00348140|466036530|FG000|Overall Study|Participant unwell|1|||
129476598|NCT00348140|466036531|FG001|Overall Study|Participant unwell|0|||
129476599|NCT00348140|466036532|FG002|Overall Study|Participant unwell|0|||
129476600|NCT00348140|466036530|FG000|Overall Study|Screen failure|1|||
129476601|NCT00348140|466036531|FG001|Overall Study|Screen failure|0|||
129476602|NCT00348140|466036532|FG002|Overall Study|Screen failure|0|||
129476603|NCT00348140|466036530|FG000|Overall Study|Investigator decided to discontinue|4|||
129476604|NCT00348140|466036531|FG001|Overall Study|Investigator decided to discontinue|1|||
129476605|NCT00348140|466036532|FG002|Overall Study|Investigator decided to discontinue|4|||
129476606|NCT00348140|466036530|FG000|Overall Study|Decided to discontinue on their own|1|||
129476607|NCT00348140|466036531|FG001|Overall Study|Decided to discontinue on their own|4|||
129476608|NCT00348140|466036532|FG002|Overall Study|Decided to discontinue on their own|1|||
129476609|NCT00348140|466036530|FG000|Overall Study|Use of prohibited drug|1|||
129476610|NCT00348140|466036531|FG001|Overall Study|Use of prohibited drug|0|||
129476611|NCT00348140|466036532|FG002|Overall Study|Use of prohibited drug|2|||
129476612|NCT00348140|466036530|FG000|Overall Study|Disease progression|1|||
129476613|NCT00348140|466036531|FG001|Overall Study|Disease progression|2|||
129476614|NCT00348140|466036532|FG002|Overall Study|Disease progression|5|||
129476615|NCT00348140|466036530|FG000|Overall Study|Increased risk of cardiac infarction|0|||
129476616|NCT00348140|466036531|FG001|Overall Study|Increased risk of cardiac infarction|1|||
129476617|NCT00348140|466036532|FG002|Overall Study|Increased risk of cardiac infarction|0|||
129476618|NCT00348140|466036530|FG000|Overall Study|Serious adverse event|0|||
129476619|NCT00348140|466036531|FG001|Overall Study|Serious adverse event|1|||
129476620|NCT00348140|466036532|FG002|Overall Study|Serious adverse event|0|||
129476621|NCT00348140|466036530|FG000|Overall Study|Abnormal ECG|0|||
129476622|NCT00348140|466036531|FG001|Overall Study|Abnormal ECG|1|||
129476623|NCT00348140|466036532|FG002|Overall Study|Abnormal ECG|3|||
129476624|NCT00348140|466036530|FG000|Overall Study|Participant died|0|||
129476625|NCT00348140|466036531|FG001|Overall Study|Participant died|1|||
129476626|NCT00348140|466036532|FG002|Overall Study|Participant died|0|||
129476627|NCT00348140|466036530|FG000|Overall Study|Exclusion criteria met|0|||
129476628|NCT00348140|466036531|FG001|Overall Study|Exclusion criteria met|0|||
129476629|NCT00348140|466036532|FG002|Overall Study|Exclusion criteria met|1|||
129476630|NCT00348140|466036530|FG000|Overall Study|Memory declined|0|||
129476631|NCT00348140|466036531|FG001|Overall Study|Memory declined|0|||
129476632|NCT00348140|466036532|FG002|Overall Study|Memory declined|1|||
129476633|NCT02868892|466036535|FG000|Overall Study|Investigator left site and no follow-up|6|||
129476634|NCT00619957|466036539|FG000|Month 24 Double-Blind|Adverse Event|9|||
129476635|NCT00619957|466036540|FG001|Month 24 Double-Blind|Adverse Event|7|||
129476636|NCT00619957|466036539|FG000|Month 24 Double-Blind|Protocol Violation|1|||
129476637|NCT00619957|466036540|FG001|Month 24 Double-Blind|Protocol Violation|0|||
129476638|NCT00619957|466036539|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
129476639|NCT00619957|466036540|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
129476640|NCT00619957|466036539|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
129476641|NCT00619957|466036540|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
129476642|NCT00619957|466036539|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
129476643|NCT00619957|466036540|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
129476644|NCT00619957|466036539|FG000|Month 48 Open-Label|Adverse Event|4|||
129476645|NCT00619957|466036540|FG001|Month 48 Open-Label|Adverse Event|4|||
129476646|NCT00619957|466036539|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
129476647|NCT00619957|466036540|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
129476648|NCT00619957|466036539|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
129476649|NCT00619957|466036540|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
129476650|NCT00868790|466036542|FG000|Period 1|Adverse Event|1|||
129476651|NCT00868790|466036543|FG001|Period 1|Adverse Event|0|||
129476652|NCT00868790|466036544|FG002|Period 1|Adverse Event|0|||
129476653|NCT00868790|466036545|FG003|Period 1|Adverse Event|0|||
129476654|NCT00868790|466036546|FG004|Period 1|Adverse Event|0|||
129476655|NCT00868790|466036547|FG005|Period 1|Adverse Event|0|||
129476656|NCT00868790|466036548|FG006|Period 1|Adverse Event|0|||
129476657|NCT00868790|466036549|FG007|Period 1|Adverse Event|3|||
129476658|NCT00868790|466036550|FG008|Period 1|Adverse Event|1|||
129476659|NCT00868790|466036551|FG009|Period 1|Adverse Event|0|||
129476660|NCT00868790|466036552|FG010|Period 1|Adverse Event|0|||
129476661|NCT00868790|466036553|FG011|Period 1|Adverse Event|0|||
129476662|NCT00868790|466036554|FG012|Period 1|Adverse Event|0|||
129476663|NCT00868790|466036555|FG013|Period 1|Adverse Event|1|||
129476664|NCT00868790|466036542|FG000|Period 1|Protocol Violation|1|||
129476665|NCT00868790|466036543|FG001|Period 1|Protocol Violation|0|||
129476666|NCT00868790|466036544|FG002|Period 1|Protocol Violation|0|||
129476667|NCT00868790|466036545|FG003|Period 1|Protocol Violation|0|||
129476668|NCT00868790|466036546|FG004|Period 1|Protocol Violation|0|||
129476669|NCT00868790|466036547|FG005|Period 1|Protocol Violation|0|||
129476670|NCT00868790|466036548|FG006|Period 1|Protocol Violation|0|||
129476671|NCT00868790|466036549|FG007|Period 1|Protocol Violation|0|||
129476672|NCT00868790|466036550|FG008|Period 1|Protocol Violation|0|||
129476673|NCT00868790|466036551|FG009|Period 1|Protocol Violation|0|||
129476674|NCT00868790|466036552|FG010|Period 1|Protocol Violation|0|||
129476675|NCT00868790|466036553|FG011|Period 1|Protocol Violation|0|||
129476676|NCT00868790|466036554|FG012|Period 1|Protocol Violation|0|||
129476677|NCT00868790|466036555|FG013|Period 1|Protocol Violation|0|||
129476678|NCT00868790|466036542|FG000|Period 1|Withdrawal by Subject|0|||
129476679|NCT00868790|466036543|FG001|Period 1|Withdrawal by Subject|1|||
129476680|NCT00868790|466036544|FG002|Period 1|Withdrawal by Subject|0|||
129476681|NCT00868790|466036545|FG003|Period 1|Withdrawal by Subject|0|||
129476682|NCT00868790|466036546|FG004|Period 1|Withdrawal by Subject|0|||
129476683|NCT00868790|466036547|FG005|Period 1|Withdrawal by Subject|0|||
129476684|NCT00868790|466036548|FG006|Period 1|Withdrawal by Subject|0|||
129476685|NCT00868790|466036549|FG007|Period 1|Withdrawal by Subject|0|||
129476686|NCT00868790|466036550|FG008|Period 1|Withdrawal by Subject|0|||
129476687|NCT00868790|466036551|FG009|Period 1|Withdrawal by Subject|0|||
129476688|NCT00868790|466036552|FG010|Period 1|Withdrawal by Subject|0|||
129476689|NCT00868790|466036553|FG011|Period 1|Withdrawal by Subject|0|||
129476690|NCT00868790|466036554|FG012|Period 1|Withdrawal by Subject|0|||
129476691|NCT00868790|466036555|FG013|Period 1|Withdrawal by Subject|1|||
129476692|NCT00868790|466036542|FG000|Period 1|Abnormal Triglycerides|0|||
129476693|NCT00868790|466036543|FG001|Period 1|Abnormal Triglycerides|0|||
129476694|NCT00868790|466036544|FG002|Period 1|Abnormal Triglycerides|0|||
129476695|NCT00868790|466036545|FG003|Period 1|Abnormal Triglycerides|0|||
129476696|NCT00868790|466036546|FG004|Period 1|Abnormal Triglycerides|1|||
129476697|NCT00868790|466036547|FG005|Period 1|Abnormal Triglycerides|0|||
129476698|NCT00868790|466036548|FG006|Period 1|Abnormal Triglycerides|0|||
129476699|NCT00868790|466036549|FG007|Period 1|Abnormal Triglycerides|0|||
129476700|NCT00868790|466036550|FG008|Period 1|Abnormal Triglycerides|0|||
129476701|NCT00868790|466036551|FG009|Period 1|Abnormal Triglycerides|0|||
129476702|NCT00868790|466036552|FG010|Period 1|Abnormal Triglycerides|0|||
129476703|NCT00868790|466036553|FG011|Period 1|Abnormal Triglycerides|0|||
129476704|NCT00868790|466036554|FG012|Period 1|Abnormal Triglycerides|0|||
129476705|NCT00868790|466036555|FG013|Period 1|Abnormal Triglycerides|0|||
129476706|NCT00868790|466036542|FG000|Period 1|Lost to Follow-up|0|||
129476707|NCT00868790|466036543|FG001|Period 1|Lost to Follow-up|0|||
129476708|NCT00868790|466036544|FG002|Period 1|Lost to Follow-up|0|||
129476709|NCT00868790|466036545|FG003|Period 1|Lost to Follow-up|0|||
129476710|NCT00868790|466036546|FG004|Period 1|Lost to Follow-up|0|||
129476711|NCT00868790|466036547|FG005|Period 1|Lost to Follow-up|1|||
129476712|NCT00868790|466036548|FG006|Period 1|Lost to Follow-up|0|||
129476713|NCT00868790|466036549|FG007|Period 1|Lost to Follow-up|0|||
129476714|NCT00868790|466036550|FG008|Period 1|Lost to Follow-up|0|||
129476715|NCT00868790|466036551|FG009|Period 1|Lost to Follow-up|0|||
129476716|NCT00868790|466036552|FG010|Period 1|Lost to Follow-up|0|||
129476717|NCT00868790|466036553|FG011|Period 1|Lost to Follow-up|0|||
129476718|NCT00868790|466036554|FG012|Period 1|Lost to Follow-up|0|||
129476719|NCT00868790|466036555|FG013|Period 1|Lost to Follow-up|0|||
129476720|NCT00868790|466036542|FG000|Period 2|Adverse Event|0|||
129476721|NCT00868790|466036543|FG001|Period 2|Adverse Event|0|||
129476722|NCT00868790|466036544|FG002|Period 2|Adverse Event|0|||
129476723|NCT00868790|466036545|FG003|Period 2|Adverse Event|0|||
129476724|NCT00868790|466036546|FG004|Period 2|Adverse Event|0|||
129476725|NCT00868790|466036547|FG005|Period 2|Adverse Event|0|||
129476726|NCT00868790|466036548|FG006|Period 2|Adverse Event|0|||
129476727|NCT00868790|466036549|FG007|Period 2|Adverse Event|0|||
129476728|NCT00868790|466036550|FG008|Period 2|Adverse Event|1|||
129476729|NCT00868790|466036551|FG009|Period 2|Adverse Event|0|||
129476730|NCT00868790|466036552|FG010|Period 2|Adverse Event|0|||
129476731|NCT00868790|466036553|FG011|Period 2|Adverse Event|0|||
129476732|NCT00868790|466036554|FG012|Period 2|Adverse Event|0|||
129476733|NCT00868790|466036555|FG013|Period 2|Adverse Event|0|||
129476734|NCT00868790|466036542|FG000|Period 2|Lost to Follow-up|0|||
129476735|NCT00868790|466036543|FG001|Period 2|Lost to Follow-up|1|||
129476736|NCT00868790|466036544|FG002|Period 2|Lost to Follow-up|0|||
129476737|NCT00868790|466036545|FG003|Period 2|Lost to Follow-up|0|||
129476738|NCT00868790|466036546|FG004|Period 2|Lost to Follow-up|0|||
129476739|NCT00868790|466036547|FG005|Period 2|Lost to Follow-up|1|||
129976324|NCT04996004|467877731|FG001|Phase I|Death|2|||
129976325|NCT04996004|467877732|FG002|Phase I|Death|1|||
129976326|NCT04996004|467877733|FG003|Phase I|Death|0|||
129976327|NCT04996004|467877734|FG004|Phase I|Death|0|||
129976328|NCT04996004|467877735|FG005|Phase I|Death|0|||
129976329|NCT04996004|467877730|FG000|Phase I|Study terminated by sponsor|2|||
129976330|NCT04996004|467877731|FG001|Phase I|Study terminated by sponsor|1|||
129976331|NCT04996004|467877732|FG002|Phase I|Study terminated by sponsor|2|||
129976332|NCT04996004|467877733|FG003|Phase I|Study terminated by sponsor|0|||
129976333|NCT04996004|467877734|FG004|Phase I|Study terminated by sponsor|0|||
129976334|NCT04996004|467877735|FG005|Phase I|Study terminated by sponsor|0|||
129976335|NCT04996004|467877730|FG000|Phase II|Study terminated by sponsor|0|||
129976336|NCT04996004|467877731|FG001|Phase II|Study terminated by sponsor|0|||
129976337|NCT04996004|467877732|FG002|Phase II|Study terminated by sponsor|0|||
129976338|NCT04996004|467877733|FG003|Phase II|Study terminated by sponsor|20|||
129976339|NCT04996004|467877734|FG004|Phase II|Study terminated by sponsor|10|||
129976340|NCT04996004|467877735|FG005|Phase II|Study terminated by sponsor|10|||
129976341|NCT04996004|467877730|FG000|Phase II|Withdrawal by Subject|0|||
129976342|NCT04996004|467877731|FG001|Phase II|Withdrawal by Subject|0|||
129976343|NCT04996004|467877732|FG002|Phase II|Withdrawal by Subject|0|||
129976344|NCT04996004|467877733|FG003|Phase II|Withdrawal by Subject|0|||
129976345|NCT04996004|467877734|FG004|Phase II|Withdrawal by Subject|1|||
129976346|NCT04996004|467877735|FG005|Phase II|Withdrawal by Subject|2|||
129976347|NCT04996004|467877730|FG000|Phase II|Death|0|||
129976348|NCT04996004|467877731|FG001|Phase II|Death|0|||
129976349|NCT04996004|467877732|FG002|Phase II|Death|0|||
129976350|NCT04996004|467877733|FG003|Phase II|Death|12|||
129976351|NCT04996004|467877734|FG004|Phase II|Death|2|||
129976352|NCT04996004|467877735|FG005|Phase II|Death|9|||
129976353|NCT04996004|467877730|FG000|Phase II|Other|0|||
129976354|NCT04996004|467877731|FG001|Phase II|Other|0|||
129976355|NCT04996004|467877732|FG002|Phase II|Other|0|||
129976356|NCT04996004|467877733|FG003|Phase II|Other|0|||
129976357|NCT04996004|467877734|FG004|Phase II|Other|0|||
129976358|NCT04996004|467877735|FG005|Phase II|Other|1|||
129976359|NCT01736189|467877736|FG000|Overall Study|Violation of registration criteria|41|||
129976360|NCT01736189|467877736|FG000|Overall Study|Protocol Violation|4|||
129976361|NCT01736189|467877736|FG000|Overall Study|Criteria and protocol violations|1|||
129976362|NCT03809039|467877737|FG000|Part 1|Withdrawal by Subject|1|||
129976363|NCT03809039|467877738|FG001|Part 1|Withdrawal by Subject|0|||
129976364|NCT03809039|467877739|FG002|Part 1|Withdrawal by Subject|0|||
129976365|NCT03809039|467877740|FG003|Part 1|Withdrawal by Subject|1|||
129976366|NCT03809039|467877741|FG004|Part 1|Withdrawal by Subject|0|||
129976367|NCT03809039|467877742|FG005|Part 1|Withdrawal by Subject|0|||
129976368|NCT03809039|467877743|FG006|Part 1|Withdrawal by Subject|0|||
129976369|NCT03809039|467877744|FG007|Part 1|Withdrawal by Subject|0|||
129976370|NCT03809039|467877745|FG008|Part 1|Withdrawal by Subject|0|||
129976371|NCT03809039|467877737|FG000|Part 3|Withdrawn by study termination|0|||
129976372|NCT03809039|467877738|FG001|Part 3|Withdrawn by study termination|0|||
129976373|NCT03809039|467877739|FG002|Part 3|Withdrawn by study termination|0|||
129976374|NCT03809039|467877740|FG003|Part 3|Withdrawn by study termination|0|||
129976375|NCT03809039|467877741|FG004|Part 3|Withdrawn by study termination|0|||
129976376|NCT03809039|467877742|FG005|Part 3|Withdrawn by study termination|0|||
129476740|NCT00868790|466036548|FG006|Period 2|Lost to Follow-up|0|||
129476741|NCT00868790|466036549|FG007|Period 2|Lost to Follow-up|0|||
129976377|NCT03809039|467877743|FG006|Part 3|Withdrawn by study termination|0|||
129976378|NCT03809039|467877744|FG007|Part 3|Withdrawn by study termination|2|||
129976379|NCT03809039|467877745|FG008|Part 3|Withdrawn by study termination|6|||
129976380|NCT01250925|467877748|FG000|Overall Study|Lost to Follow-up|1|||
129976381|NCT01250925|467877749|FG001|Overall Study|Lost to Follow-up|1|||
129976382|NCT01250925|467877750|FG002|Overall Study|Lost to Follow-up|0|||
129976383|NCT01250925|467877748|FG000|Overall Study|Withdrawal by Subject|2|||
129976384|NCT01250925|467877749|FG001|Overall Study|Withdrawal by Subject|0|||
129476742|NCT00868790|466036550|FG008|Period 2|Lost to Follow-up|0|||
129476743|NCT00868790|466036551|FG009|Period 2|Lost to Follow-up|0|||
129976385|NCT01250925|467877750|FG002|Overall Study|Withdrawal by Subject|0|||
129476744|NCT00868790|466036552|FG010|Period 2|Lost to Follow-up|0|||
129976386|NCT01250925|467877748|FG000|Overall Study|Protocol Violation|2|||
129976387|NCT01250925|467877749|FG001|Overall Study|Protocol Violation|0|||
129976388|NCT01250925|467877750|FG002|Overall Study|Protocol Violation|0|||
129976389|NCT01250925|467877748|FG000|Overall Study|Physician Decision|0|||
129976390|NCT01250925|467877749|FG001|Overall Study|Physician Decision|2|||
129976391|NCT01250925|467877750|FG002|Overall Study|Physician Decision|1|||
129976392|NCT01250925|467877748|FG000|Overall Study|Adverse Event|0|||
129976393|NCT01250925|467877749|FG001|Overall Study|Adverse Event|0|||
129976394|NCT01250925|467877750|FG002|Overall Study|Adverse Event|1|||
129976395|NCT04421950|467877751|FG000|Overall Study|Dropped or lost to follow up|4|||
129976396|NCT04421950|467877752|FG001|Overall Study|Dropped or lost to follow up|2|||
129976397|NCT01252355|467877753|FG000|Overall Study|Adverse Event|9|||
129976398|NCT01252355|467877754|FG001|Overall Study|Adverse Event|17|||
129976399|NCT01252355|467877755|FG002|Overall Study|Adverse Event|22|||
129976400|NCT01252355|467877753|FG000|Overall Study|Lack of Efficacy|6|||
129976401|NCT01252355|467877754|FG001|Overall Study|Lack of Efficacy|4|||
129976402|NCT01252355|467877755|FG002|Overall Study|Lack of Efficacy|2|||
129976403|NCT01252355|467877753|FG000|Overall Study|Lost to Follow-up|0|||
129476745|NCT00868790|466036553|FG011|Period 2|Lost to Follow-up|0|||
129476746|NCT00868790|466036554|FG012|Period 2|Lost to Follow-up|0|||
129476747|NCT00868790|466036555|FG013|Period 2|Lost to Follow-up|0|||
129476748|NCT00868790|466036542|FG000|Period 2|Withdrawal by Subject|0|||
129476749|NCT00868790|466036543|FG001|Period 2|Withdrawal by Subject|0|||
129476750|NCT00868790|466036544|FG002|Period 2|Withdrawal by Subject|0|||
129476751|NCT00868790|466036545|FG003|Period 2|Withdrawal by Subject|0|||
129476752|NCT00868790|466036546|FG004|Period 2|Withdrawal by Subject|0|||
129476753|NCT00868790|466036547|FG005|Period 2|Withdrawal by Subject|0|||
129476754|NCT00868790|466036548|FG006|Period 2|Withdrawal by Subject|0|||
129476755|NCT00868790|466036549|FG007|Period 2|Withdrawal by Subject|0|||
129476756|NCT00868790|466036550|FG008|Period 2|Withdrawal by Subject|1|||
129476757|NCT00868790|466036551|FG009|Period 2|Withdrawal by Subject|0|||
129476758|NCT00868790|466036552|FG010|Period 2|Withdrawal by Subject|0|||
129476759|NCT00868790|466036553|FG011|Period 2|Withdrawal by Subject|0|||
129476760|NCT00868790|466036554|FG012|Period 2|Withdrawal by Subject|0|||
129476761|NCT00868790|466036555|FG013|Period 2|Withdrawal by Subject|1|||
129476762|NCT00868790|466036542|FG000|Period 3|Adverse Event|0|||
129476763|NCT00868790|466036543|FG001|Period 3|Adverse Event|0|||
129476764|NCT00868790|466036544|FG002|Period 3|Adverse Event|0|||
129476765|NCT00868790|466036545|FG003|Period 3|Adverse Event|0|||
129476766|NCT00868790|466036546|FG004|Period 3|Adverse Event|0|||
129476767|NCT00868790|466036547|FG005|Period 3|Adverse Event|0|||
129476768|NCT00868790|466036548|FG006|Period 3|Adverse Event|0|||
129476769|NCT00868790|466036549|FG007|Period 3|Adverse Event|0|||
129476770|NCT00868790|466036550|FG008|Period 3|Adverse Event|0|||
129476771|NCT00868790|466036551|FG009|Period 3|Adverse Event|1|||
129476772|NCT00868790|466036552|FG010|Period 3|Adverse Event|0|||
129476773|NCT00868790|466036553|FG011|Period 3|Adverse Event|0|||
129476774|NCT00868790|466036554|FG012|Period 3|Adverse Event|0|||
129476775|NCT00868790|466036555|FG013|Period 3|Adverse Event|0|||
129476776|NCT00868790|466036542|FG000|Period 3|Protocol Violation|0|||
129476777|NCT00868790|466036543|FG001|Period 3|Protocol Violation|0|||
129476778|NCT00868790|466036544|FG002|Period 3|Protocol Violation|0|||
129476779|NCT00868790|466036545|FG003|Period 3|Protocol Violation|0|||
129476780|NCT00868790|466036546|FG004|Period 3|Protocol Violation|0|||
129476781|NCT00868790|466036547|FG005|Period 3|Protocol Violation|0|||
129476782|NCT00868790|466036548|FG006|Period 3|Protocol Violation|0|||
129476783|NCT00868790|466036549|FG007|Period 3|Protocol Violation|0|||
129476784|NCT00868790|466036550|FG008|Period 3|Protocol Violation|0|||
129476785|NCT00868790|466036551|FG009|Period 3|Protocol Violation|0|||
129476786|NCT00868790|466036552|FG010|Period 3|Protocol Violation|1|||
129976404|NCT01252355|467877754|FG001|Overall Study|Lost to Follow-up|0|||
129976405|NCT01252355|467877755|FG002|Overall Study|Lost to Follow-up|1|||
129976406|NCT01252355|467877753|FG000|Overall Study|Poor Compliance to Protocol|1|||
129976407|NCT01252355|467877754|FG001|Overall Study|Poor Compliance to Protocol|1|||
129976408|NCT01252355|467877755|FG002|Overall Study|Poor Compliance to Protocol|1|||
129976409|NCT01252355|467877753|FG000|Overall Study|Progressive Disease|2|||
129476787|NCT00868790|466036553|FG011|Period 3|Protocol Violation|0|||
129476788|NCT00868790|466036554|FG012|Period 3|Protocol Violation|0|||
129476789|NCT00868790|466036555|FG013|Period 3|Protocol Violation|0|||
129476790|NCT00868790|466036542|FG000|Period 3|Study Terminated by Sponsor|0|||
129476791|NCT00868790|466036543|FG001|Period 3|Study Terminated by Sponsor|0|||
129476792|NCT00868790|466036544|FG002|Period 3|Study Terminated by Sponsor|0|||
129976410|NCT01252355|467877754|FG001|Overall Study|Progressive Disease|0|||
129976411|NCT01252355|467877755|FG002|Overall Study|Progressive Disease|0|||
129976412|NCT01252355|467877753|FG000|Overall Study|Sponsor Early Termination of Study|149|||
129976413|NCT01252355|467877754|FG001|Overall Study|Sponsor Early Termination of Study|149|||
129976414|NCT01252355|467877755|FG002|Overall Study|Sponsor Early Termination of Study|146|||
129476793|NCT00868790|466036545|FG003|Period 3|Study Terminated by Sponsor|1|||
129476794|NCT00868790|466036546|FG004|Period 3|Study Terminated by Sponsor|0|||
129476795|NCT00868790|466036547|FG005|Period 3|Study Terminated by Sponsor|0|||
129476796|NCT00868790|466036548|FG006|Period 3|Study Terminated by Sponsor|0|||
129476797|NCT00868790|466036549|FG007|Period 3|Study Terminated by Sponsor|0|||
129476798|NCT00868790|466036550|FG008|Period 3|Study Terminated by Sponsor|0|||
129476799|NCT00868790|466036551|FG009|Period 3|Study Terminated by Sponsor|0|||
129476800|NCT00868790|466036552|FG010|Period 3|Study Terminated by Sponsor|0|||
129476801|NCT00868790|466036553|FG011|Period 3|Study Terminated by Sponsor|0|||
129476802|NCT00868790|466036554|FG012|Period 3|Study Terminated by Sponsor|0|||
129476803|NCT00868790|466036555|FG013|Period 3|Study Terminated by Sponsor|0|||
129476804|NCT00868790|466036542|FG000|Period 4|Adverse Event|0|||
129476805|NCT00868790|466036543|FG001|Period 4|Adverse Event|0|||
129476806|NCT00868790|466036544|FG002|Period 4|Adverse Event|0|||
129476807|NCT00868790|466036545|FG003|Period 4|Adverse Event|0|||
129476808|NCT00868790|466036546|FG004|Period 4|Adverse Event|0|||
129476809|NCT00868790|466036547|FG005|Period 4|Adverse Event|0|||
129476810|NCT00868790|466036548|FG006|Period 4|Adverse Event|0|||
129476811|NCT00868790|466036549|FG007|Period 4|Adverse Event|1|||
129476812|NCT00868790|466036550|FG008|Period 4|Adverse Event|0|||
129476813|NCT00868790|466036551|FG009|Period 4|Adverse Event|0|||
129476814|NCT00868790|466036552|FG010|Period 4|Adverse Event|1|||
129476815|NCT00868790|466036553|FG011|Period 4|Adverse Event|0|||
129476816|NCT00868790|466036554|FG012|Period 4|Adverse Event|1|||
129476817|NCT00868790|466036555|FG013|Period 4|Adverse Event|0|||
129476818|NCT00868790|466036542|FG000|Period 4|Lost to Follow-up|0|||
129476819|NCT00868790|466036543|FG001|Period 4|Lost to Follow-up|0|||
129476820|NCT00868790|466036544|FG002|Period 4|Lost to Follow-up|0|||
129476821|NCT00868790|466036545|FG003|Period 4|Lost to Follow-up|0|||
129476822|NCT00868790|466036546|FG004|Period 4|Lost to Follow-up|0|||
129476823|NCT00868790|466036547|FG005|Period 4|Lost to Follow-up|0|||
129476824|NCT00868790|466036548|FG006|Period 4|Lost to Follow-up|0|||
129476825|NCT00868790|466036549|FG007|Period 4|Lost to Follow-up|1|||
129476826|NCT00868790|466036550|FG008|Period 4|Lost to Follow-up|0|||
129476827|NCT00868790|466036551|FG009|Period 4|Lost to Follow-up|0|||
129476828|NCT00868790|466036552|FG010|Period 4|Lost to Follow-up|0|||
129476829|NCT00868790|466036553|FG011|Period 4|Lost to Follow-up|0|||
129476830|NCT00868790|466036554|FG012|Period 4|Lost to Follow-up|0|||
129476831|NCT00868790|466036555|FG013|Period 4|Lost to Follow-up|0|||
129476832|NCT00868790|466036542|FG000|Period 4|Study Terminated by Sponsor|2|||
129476833|NCT00868790|466036543|FG001|Period 4|Study Terminated by Sponsor|0|||
129476834|NCT00868790|466036544|FG002|Period 4|Study Terminated by Sponsor|0|||
129476835|NCT00868790|466036545|FG003|Period 4|Study Terminated by Sponsor|0|||
129476836|NCT00868790|466036546|FG004|Period 4|Study Terminated by Sponsor|0|||
129476837|NCT00868790|466036547|FG005|Period 4|Study Terminated by Sponsor|0|||
129476838|NCT00868790|466036548|FG006|Period 4|Study Terminated by Sponsor|0|||
129476839|NCT00868790|466036549|FG007|Period 4|Study Terminated by Sponsor|1|||
129476840|NCT00868790|466036550|FG008|Period 4|Study Terminated by Sponsor|2|||
129476841|NCT00868790|466036551|FG009|Period 4|Study Terminated by Sponsor|0|||
129476842|NCT00868790|466036552|FG010|Period 4|Study Terminated by Sponsor|2|||
129476843|NCT00868790|466036553|FG011|Period 4|Study Terminated by Sponsor|1|||
129476844|NCT00868790|466036554|FG012|Period 4|Study Terminated by Sponsor|0|||
129476845|NCT00868790|466036555|FG013|Period 4|Study Terminated by Sponsor|1|||
129476846|NCT00868790|466036542|FG000|Period 4|Abnormal ALT/AST|0|||
129476847|NCT00868790|466036543|FG001|Period 4|Abnormal ALT/AST|0|||
129476848|NCT00868790|466036544|FG002|Period 4|Abnormal ALT/AST|1|||
129476849|NCT00868790|466036545|FG003|Period 4|Abnormal ALT/AST|0|||
129476850|NCT00868790|466036546|FG004|Period 4|Abnormal ALT/AST|0|||
129476851|NCT00868790|466036547|FG005|Period 4|Abnormal ALT/AST|0|||
129476852|NCT00868790|466036548|FG006|Period 4|Abnormal ALT/AST|0|||
129476853|NCT00868790|466036549|FG007|Period 4|Abnormal ALT/AST|0|||
129476854|NCT00868790|466036550|FG008|Period 4|Abnormal ALT/AST|0|||
129476855|NCT00868790|466036551|FG009|Period 4|Abnormal ALT/AST|0|||
129476856|NCT00868790|466036552|FG010|Period 4|Abnormal ALT/AST|0|||
129476857|NCT00868790|466036553|FG011|Period 4|Abnormal ALT/AST|0|||
129476858|NCT00868790|466036554|FG012|Period 4|Abnormal ALT/AST|0|||
129476859|NCT00868790|466036555|FG013|Period 4|Abnormal ALT/AST|0|||
129476860|NCT00868790|466036542|FG000|Post-study|Withdrawal by Subject|0|||
129476861|NCT00868790|466036543|FG001|Post-study|Withdrawal by Subject|0|||
129476862|NCT00868790|466036544|FG002|Post-study|Withdrawal by Subject|0|||
129476863|NCT00868790|466036545|FG003|Post-study|Withdrawal by Subject|0|||
129476864|NCT00868790|466036546|FG004|Post-study|Withdrawal by Subject|1|||
129476865|NCT00868790|466036547|FG005|Post-study|Withdrawal by Subject|0|||
129476866|NCT00868790|466036548|FG006|Post-study|Withdrawal by Subject|0|||
129476867|NCT00868790|466036549|FG007|Post-study|Withdrawal by Subject|0|||
129476868|NCT00868790|466036550|FG008|Post-study|Withdrawal by Subject|0|||
129476869|NCT00868790|466036551|FG009|Post-study|Withdrawal by Subject|0|||
129476870|NCT00868790|466036552|FG010|Post-study|Withdrawal by Subject|0|||
129476871|NCT00868790|466036553|FG011|Post-study|Withdrawal by Subject|0|||
129476872|NCT00868790|466036554|FG012|Post-study|Withdrawal by Subject|0|||
129476873|NCT00868790|466036555|FG013|Post-study|Withdrawal by Subject|0|||
129476874|NCT00868790|466036542|FG000|Post-study|Excluded Medication|0|||
129476875|NCT00868790|466036543|FG001|Post-study|Excluded Medication|0|||
129476876|NCT00868790|466036544|FG002|Post-study|Excluded Medication|0|||
129476877|NCT00868790|466036545|FG003|Post-study|Excluded Medication|0|||
129476878|NCT00868790|466036546|FG004|Post-study|Excluded Medication|0|||
129476879|NCT00868790|466036547|FG005|Post-study|Excluded Medication|0|||
129476880|NCT00868790|466036548|FG006|Post-study|Excluded Medication|0|||
129476881|NCT00868790|466036549|FG007|Post-study|Excluded Medication|2|||
129476882|NCT00868790|466036550|FG008|Post-study|Excluded Medication|0|||
129476883|NCT00868790|466036551|FG009|Post-study|Excluded Medication|1|||
129476884|NCT00868790|466036552|FG010|Post-study|Excluded Medication|0|||
129476885|NCT00868790|466036553|FG011|Post-study|Excluded Medication|0|||
129476886|NCT00868790|466036554|FG012|Post-study|Excluded Medication|0|||
129476887|NCT00868790|466036555|FG013|Post-study|Excluded Medication|0|||
129476888|NCT03377634|466036559|FG000|Study Period|Adverse Event|1|||
129476889|NCT03377634|466036560|FG001|Study Period|Adverse Event|0|||
129476890|NCT03377634|466036559|FG000|Study Period|Withdrawal by Subject|1|||
129476891|NCT03377634|466036560|FG001|Study Period|Withdrawal by Subject|0|||
129476892|NCT00977470|466036561|FG000|Overall Study|Lack of Efficacy|32|||
129476893|NCT00977470|466036562|FG001|Overall Study|Lack of Efficacy|30|||
129476894|NCT00977470|466036561|FG000|Overall Study|Physician Decision|2|||
129476895|NCT00977470|466036562|FG001|Overall Study|Physician Decision|0|||
129476896|NCT00977470|466036561|FG000|Overall Study|Adverse Event|1|||
129476897|NCT00977470|466036562|FG001|Overall Study|Adverse Event|2|||
129476898|NCT00977470|466036561|FG000|Overall Study|Protocol Violation|1|||
129476899|NCT00977470|466036562|FG001|Overall Study|Protocol Violation|0|||
129476900|NCT00977470|466036561|FG000|Overall Study|Withdrawal by Subject|0|||
129476901|NCT00977470|466036562|FG001|Overall Study|Withdrawal by Subject|2|||
129476902|NCT00977470|466036561|FG000|Overall Study|Death|0|||
129476903|NCT00977470|466036562|FG001|Overall Study|Death|2|||
129476904|NCT00977470|466036561|FG000|Overall Study|clinical decline|0|||
129476905|NCT00977470|466036562|FG001|Overall Study|clinical decline|1|||
129476906|NCT00977470|466036561|FG000|Overall Study|prolonged recovery post-surgery|0|||
129476907|NCT00977470|466036562|FG001|Overall Study|prolonged recovery post-surgery|1|||
129476908|NCT00977470|466036561|FG000|Overall Study|Still on-study|2|||
129476909|NCT00977470|466036562|FG001|Overall Study|Still on-study|0|||
129476910|NCT00737529|466036566|FG000|Overall Study|Disease Progression|95|||
129476911|NCT00737529|466036566|FG000|Overall Study|Adverse Event|24|||
129476912|NCT00737529|466036566|FG000|Overall Study|Withdrawal by Subject|5|||
129476913|NCT00737529|466036566|FG000|Overall Study|Death|4|||
129476914|NCT00737529|466036566|FG000|Overall Study|Protocol Violation|1|||
129476915|NCT00737529|466036566|FG000|Overall Study|Other|4|||
129476916|NCT01173653|466036573|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
129476917|NCT01173653|466036574|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
129476918|NCT01818297|466036575|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
129476919|NCT01818297|466036576|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
129476920|NCT01818297|466036575|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
129476921|NCT01818297|466036576|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
129476922|NCT01818297|466036575|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
129476923|NCT01818297|466036576|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
129476924|NCT01651780|466036584|FG000|Overall Study|Physician decision: No 30-day visit|2|||
129476925|NCT01651780|466036585|FG001|Overall Study|Physician decision: No 30-day visit|1|||
129476926|NCT01651780|466036584|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
129476927|NCT01651780|466036585|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
129476928|NCT01651780|466036584|FG000|Overall Study|Withdrawal by Subject|2|||
129476929|NCT01651780|466036585|FG001|Overall Study|Withdrawal by Subject|0|||
129476930|NCT01651780|466036584|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
129476931|NCT01651780|466036585|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
129476932|NCT01651780|466036584|FG000|Overall Study|Lost to Follow-up|1|||
129476933|NCT01651780|466036585|FG001|Overall Study|Lost to Follow-up|2|||
129476934|NCT01651780|466036584|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
129476935|NCT01651780|466036585|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
129476936|NCT01628926|466036586|FG000|Overall Study|Adverse Event|13|||
129476937|NCT01628926|466036587|FG001|Overall Study|Adverse Event|11|||
129476938|NCT01628926|466036588|FG002|Overall Study|Adverse Event|9|||
129476939|NCT01628926|466036586|FG000|Overall Study|Lack of Efficacy|2|||
129476940|NCT01628926|466036587|FG001|Overall Study|Lack of Efficacy|1|||
129476941|NCT01628926|466036588|FG002|Overall Study|Lack of Efficacy|5|||
129476942|NCT01628926|466036586|FG000|Overall Study|Withdrawal by Subject|6|||
129476943|NCT01628926|466036587|FG001|Overall Study|Withdrawal by Subject|4|||
129476944|NCT01628926|466036588|FG002|Overall Study|Withdrawal by Subject|2|||
129476945|NCT01628926|466036586|FG000|Overall Study|Protocol Violation|0|||
129476946|NCT01628926|466036587|FG001|Overall Study|Protocol Violation|1|||
129476947|NCT01628926|466036588|FG002|Overall Study|Protocol Violation|0|||
129476948|NCT01628926|466036586|FG000|Overall Study|Discontinuation criteria|3|||
129476949|NCT01628926|466036587|FG001|Overall Study|Discontinuation criteria|4|||
129476950|NCT01628926|466036588|FG002|Overall Study|Discontinuation criteria|0|||
129476951|NCT01628926|466036586|FG000|Overall Study|Physician Decision|2|||
129476952|NCT01628926|466036587|FG001|Overall Study|Physician Decision|2|||
129476953|NCT01628926|466036588|FG002|Overall Study|Physician Decision|1|||
129476954|NCT03029832|466036589|FG000|Overall Study|Safety Follow-Up Completed|2|||
129476955|NCT03029832|466036590|FG001|Overall Study|Safety Follow-Up Completed|0|||
129476956|NCT03029832|466036589|FG000|Overall Study|Death due to Disease Progression|1|||
129476957|NCT03029832|466036590|FG001|Overall Study|Death due to Disease Progression|0|||
129476958|NCT03029832|466036589|FG000|Overall Study|Study Terminated By Sponsor|1|||
129476959|NCT03029832|466036590|FG001|Overall Study|Study Terminated By Sponsor|1|||
129476960|NCT01412229|466036591|FG000|Overall Study|Physician Decision|1|||
129476961|NCT00151892|466036598|FG000|Overall Study|Lack of Efficacy|50|||
129476962|NCT00151892|466036599|FG001|Overall Study|Lack of Efficacy|57|||
129476963|NCT00151892|466036598|FG000|Overall Study|Patient request|10|||
129476964|NCT00151892|466036599|FG001|Overall Study|Patient request|7|||
129476965|NCT00151892|466036598|FG000|Overall Study|Lost to Follow-up|5|||
129476966|NCT00151892|466036599|FG001|Overall Study|Lost to Follow-up|10|||
129476967|NCT00151892|466036598|FG000|Overall Study|Adverse Event|6|||
129476968|NCT00151892|466036599|FG001|Overall Study|Adverse Event|3|||
129476969|NCT00151892|466036598|FG000|Overall Study|Protocol Violation|3|||
129476970|NCT00151892|466036599|FG001|Overall Study|Protocol Violation|3|||
129476971|NCT00151892|466036598|FG000|Overall Study|Non-compliance|0|||
129476972|NCT00151892|466036599|FG001|Overall Study|Non-compliance|1|||
129476973|NCT00151892|466036598|FG000|Overall Study|Pregnancy|0|||
129476974|NCT00151892|466036599|FG001|Overall Study|Pregnancy|1|||
129476975|NCT00151892|466036598|FG000|Overall Study|Did not return for a visit|1|||
129476976|NCT00151892|466036599|FG001|Overall Study|Did not return for a visit|0|||
129476977|NCT00151892|466036598|FG000|Overall Study|Used prohibited corticosteroids|1|||
129476978|NCT00151892|466036599|FG001|Overall Study|Used prohibited corticosteroids|0|||
129476979|NCT00151892|466036598|FG000|Overall Study|Lack of study medication at center|0|||
129476980|NCT00151892|466036599|FG001|Overall Study|Lack of study medication at center|1|||
129476981|NCT02901431|466036600|FG000|PK Part|Adverse Event|0|||
129476982|NCT02901431|466036601|FG001|PK Part|Adverse Event|1|||
129476983|NCT02901431|466036602|FG002|PK Part|Adverse Event|0|||
129476984|NCT02901431|466036603|FG003|PK Part|Adverse Event|0|||
129476985|NCT02901431|466036604|FG004|PK Part|Adverse Event|0|||
129476986|NCT02901431|466036605|FG005|PK Part|Adverse Event|0|||
129476987|NCT02901431|466036606|FG006|PK Part|Adverse Event|0|||
129476988|NCT02901431|466036607|FG007|PK Part|Adverse Event|0|||
129476989|NCT02901431|466036608|FG008|PK Part|Adverse Event|0|||
129476990|NCT02901431|466036609|FG009|PK Part|Adverse Event|0|||
129476991|NCT02901431|466036610|FG010|PK Part|Adverse Event|0|||
129476992|NCT02901431|466036611|FG011|PK Part|Adverse Event|0|||
129476993|NCT02901431|466036612|FG012|PK Part|Adverse Event|0|||
129476994|NCT02901431|466036600|FG000|PK Part|Lost to Follow-up|0|||
129476995|NCT02901431|466036601|FG001|PK Part|Lost to Follow-up|0|||
129476996|NCT02901431|466036602|FG002|PK Part|Lost to Follow-up|1|||
129476997|NCT02901431|466036603|FG003|PK Part|Lost to Follow-up|0|||
129476998|NCT02901431|466036604|FG004|PK Part|Lost to Follow-up|0|||
129476999|NCT02901431|466036605|FG005|PK Part|Lost to Follow-up|0|||
129477000|NCT02901431|466036606|FG006|PK Part|Lost to Follow-up|0|||
129477001|NCT02901431|466036607|FG007|PK Part|Lost to Follow-up|0|||
129477002|NCT02901431|466036608|FG008|PK Part|Lost to Follow-up|0|||
129477003|NCT02901431|466036609|FG009|PK Part|Lost to Follow-up|0|||
129477004|NCT02901431|466036610|FG010|PK Part|Lost to Follow-up|0|||
129477005|NCT02901431|466036611|FG011|PK Part|Lost to Follow-up|0|||
129477006|NCT02901431|466036612|FG012|PK Part|Lost to Follow-up|0|||
129477007|NCT02901431|466036600|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
129477008|NCT02901431|466036601|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477009|NCT02901431|466036602|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477010|NCT02901431|466036603|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477011|NCT02901431|466036604|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477012|NCT02901431|466036605|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477013|NCT02901431|466036606|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477014|NCT02901431|466036607|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477015|NCT02901431|466036608|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477016|NCT02901431|466036609|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477017|NCT02901431|466036610|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477018|NCT02901431|466036611|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477019|NCT02901431|466036612|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
129477020|NCT02901431|466036600|FG000|PK Part|Pending dose confirmation|0|||
129477021|NCT02901431|466036601|FG001|PK Part|Pending dose confirmation|1|||
129477022|NCT02901431|466036602|FG002|PK Part|Pending dose confirmation|0|||
129976415|NCT01252355|467877753|FG000|Overall Study|Randomized but not Treated|2|||
129976416|NCT01252355|467877754|FG001|Overall Study|Randomized but not Treated|0|||
129477023|NCT02901431|466036603|FG003|PK Part|Pending dose confirmation|0|||
129477024|NCT02901431|466036604|FG004|PK Part|Pending dose confirmation|0|||
129477025|NCT02901431|466036605|FG005|PK Part|Pending dose confirmation|0|||
129477026|NCT02901431|466036606|FG006|PK Part|Pending dose confirmation|0|||
129477027|NCT02901431|466036607|FG007|PK Part|Pending dose confirmation|0|||
129477028|NCT02901431|466036608|FG008|PK Part|Pending dose confirmation|0|||
129477029|NCT02901431|466036609|FG009|PK Part|Pending dose confirmation|0|||
129477030|NCT02901431|466036610|FG010|PK Part|Pending dose confirmation|0|||
129477031|NCT02901431|466036611|FG011|PK Part|Pending dose confirmation|0|||
129477032|NCT02901431|466036612|FG012|PK Part|Pending dose confirmation|0|||
129477033|NCT02901431|466036600|FG000|PK Part|8 weeks of treatment ran out|2|||
129477034|NCT02901431|466036601|FG001|PK Part|8 weeks of treatment ran out|0|||
129477035|NCT02901431|466036602|FG002|PK Part|8 weeks of treatment ran out|0|||
129477036|NCT02901431|466036603|FG003|PK Part|8 weeks of treatment ran out|0|||
129477037|NCT02901431|466036604|FG004|PK Part|8 weeks of treatment ran out|0|||
129477038|NCT02901431|466036605|FG005|PK Part|8 weeks of treatment ran out|0|||
129477039|NCT02901431|466036606|FG006|PK Part|8 weeks of treatment ran out|0|||
129477040|NCT02901431|466036607|FG007|PK Part|8 weeks of treatment ran out|0|||
129477041|NCT02901431|466036608|FG008|PK Part|8 weeks of treatment ran out|0|||
129477042|NCT02901431|466036609|FG009|PK Part|8 weeks of treatment ran out|0|||
129477043|NCT02901431|466036610|FG010|PK Part|8 weeks of treatment ran out|0|||
129477044|NCT02901431|466036611|FG011|PK Part|8 weeks of treatment ran out|0|||
129477045|NCT02901431|466036612|FG012|PK Part|8 weeks of treatment ran out|0|||
129477046|NCT02901431|466036600|FG000|PK Part|Stopped treatment after 8 weeks|1|||
129477047|NCT02901431|466036601|FG001|PK Part|Stopped treatment after 8 weeks|0|||
129477048|NCT02901431|466036602|FG002|PK Part|Stopped treatment after 8 weeks|1|||
129477049|NCT02901431|466036603|FG003|PK Part|Stopped treatment after 8 weeks|0|||
129477050|NCT02901431|466036604|FG004|PK Part|Stopped treatment after 8 weeks|0|||
129477051|NCT02901431|466036605|FG005|PK Part|Stopped treatment after 8 weeks|0|||
129477052|NCT02901431|466036606|FG006|PK Part|Stopped treatment after 8 weeks|0|||
129477053|NCT02901431|466036607|FG007|PK Part|Stopped treatment after 8 weeks|0|||
129477054|NCT02901431|466036608|FG008|PK Part|Stopped treatment after 8 weeks|0|||
129477055|NCT02901431|466036609|FG009|PK Part|Stopped treatment after 8 weeks|0|||
129477056|NCT02901431|466036610|FG010|PK Part|Stopped treatment after 8 weeks|0|||
129477057|NCT02901431|466036611|FG011|PK Part|Stopped treatment after 8 weeks|0|||
129477058|NCT02901431|466036612|FG012|PK Part|Stopped treatment after 8 weeks|0|||
129477059|NCT02901431|466036600|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
129477060|NCT02901431|466036601|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477061|NCT02901431|466036602|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
129477062|NCT02901431|466036603|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477063|NCT02901431|466036604|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477064|NCT02901431|466036605|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477065|NCT02901431|466036606|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477066|NCT02901431|466036607|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477067|NCT02901431|466036608|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477068|NCT02901431|466036609|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477069|NCT02901431|466036610|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477070|NCT02901431|466036611|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477071|NCT02901431|466036612|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
129477072|NCT02901431|466036600|FG000|PK Part|Discontinued per Sponsor|0|||
129477073|NCT02901431|466036601|FG001|PK Part|Discontinued per Sponsor|3|||
129477074|NCT02901431|466036602|FG002|PK Part|Discontinued per Sponsor|0|||
129477075|NCT02901431|466036603|FG003|PK Part|Discontinued per Sponsor|0|||
129477076|NCT02901431|466036604|FG004|PK Part|Discontinued per Sponsor|0|||
129477077|NCT02901431|466036605|FG005|PK Part|Discontinued per Sponsor|0|||
129477078|NCT02901431|466036606|FG006|PK Part|Discontinued per Sponsor|0|||
129477079|NCT02901431|466036607|FG007|PK Part|Discontinued per Sponsor|0|||
129477080|NCT02901431|466036608|FG008|PK Part|Discontinued per Sponsor|0|||
129477081|NCT02901431|466036609|FG009|PK Part|Discontinued per Sponsor|0|||
129477082|NCT02901431|466036610|FG010|PK Part|Discontinued per Sponsor|0|||
129477083|NCT02901431|466036611|FG011|PK Part|Discontinued per Sponsor|0|||
129477084|NCT02901431|466036612|FG012|PK Part|Discontinued per Sponsor|0|||
129477085|NCT02901431|466036600|FG000|PK Part|Withdrawal by Subject|1|||
129477086|NCT02901431|466036601|FG001|PK Part|Withdrawal by Subject|1|||
129477087|NCT02901431|466036602|FG002|PK Part|Withdrawal by Subject|3|||
129477088|NCT02901431|466036603|FG003|PK Part|Withdrawal by Subject|0|||
129477089|NCT02901431|466036604|FG004|PK Part|Withdrawal by Subject|0|||
129477090|NCT02901431|466036605|FG005|PK Part|Withdrawal by Subject|0|||
129477091|NCT02901431|466036606|FG006|PK Part|Withdrawal by Subject|0|||
129477092|NCT02901431|466036607|FG007|PK Part|Withdrawal by Subject|0|||
129477093|NCT02901431|466036608|FG008|PK Part|Withdrawal by Subject|0|||
129477094|NCT02901431|466036609|FG009|PK Part|Withdrawal by Subject|0|||
129477095|NCT02901431|466036610|FG010|PK Part|Withdrawal by Subject|0|||
129477096|NCT02901431|466036611|FG011|PK Part|Withdrawal by Subject|0|||
129477097|NCT02901431|466036612|FG012|PK Part|Withdrawal by Subject|0|||
129477098|NCT02901431|466036600|FG000|Main Treatment Part|Adverse Event|0|||
129477099|NCT02901431|466036601|FG001|Main Treatment Part|Adverse Event|0|||
129477100|NCT02901431|466036602|FG002|Main Treatment Part|Adverse Event|0|||
129477101|NCT02901431|466036603|FG003|Main Treatment Part|Adverse Event|3|||
129477102|NCT02901431|466036604|FG004|Main Treatment Part|Adverse Event|3|||
129477103|NCT02901431|466036605|FG005|Main Treatment Part|Adverse Event|4|||
129477104|NCT02901431|466036606|FG006|Main Treatment Part|Adverse Event|1|||
129477105|NCT02901431|466036607|FG007|Main Treatment Part|Adverse Event|0|||
129477106|NCT02901431|466036608|FG008|Main Treatment Part|Adverse Event|0|||
129477107|NCT02901431|466036609|FG009|Main Treatment Part|Adverse Event|0|||
129477108|NCT02901431|466036610|FG010|Main Treatment Part|Adverse Event|0|||
129477109|NCT02901431|466036611|FG011|Main Treatment Part|Adverse Event|0|||
129477110|NCT02901431|466036612|FG012|Main Treatment Part|Adverse Event|0|||
129477111|NCT02901431|466036600|FG000|Main Treatment Part|Lack of Efficacy|0|||
129477112|NCT02901431|466036601|FG001|Main Treatment Part|Lack of Efficacy|0|||
129477113|NCT02901431|466036602|FG002|Main Treatment Part|Lack of Efficacy|0|||
129477114|NCT02901431|466036603|FG003|Main Treatment Part|Lack of Efficacy|1|||
129477115|NCT02901431|466036604|FG004|Main Treatment Part|Lack of Efficacy|0|||
129477116|NCT02901431|466036605|FG005|Main Treatment Part|Lack of Efficacy|0|||
129477117|NCT02901431|466036606|FG006|Main Treatment Part|Lack of Efficacy|0|||
129477118|NCT02901431|466036607|FG007|Main Treatment Part|Lack of Efficacy|0|||
129477119|NCT02901431|466036608|FG008|Main Treatment Part|Lack of Efficacy|0|||
129477120|NCT02901431|466036609|FG009|Main Treatment Part|Lack of Efficacy|0|||
129477121|NCT02901431|466036610|FG010|Main Treatment Part|Lack of Efficacy|0|||
129477122|NCT02901431|466036611|FG011|Main Treatment Part|Lack of Efficacy|0|||
129477123|NCT02901431|466036612|FG012|Main Treatment Part|Lack of Efficacy|0|||
129477124|NCT02901431|466036600|FG000|Main Treatment Part|Lost to Follow-up|0|||
129477125|NCT02901431|466036601|FG001|Main Treatment Part|Lost to Follow-up|0|||
129477126|NCT02901431|466036602|FG002|Main Treatment Part|Lost to Follow-up|0|||
129477127|NCT02901431|466036603|FG003|Main Treatment Part|Lost to Follow-up|3|||
129477128|NCT02901431|466036604|FG004|Main Treatment Part|Lost to Follow-up|1|||
129477129|NCT02901431|466036605|FG005|Main Treatment Part|Lost to Follow-up|2|||
129477130|NCT02901431|466036606|FG006|Main Treatment Part|Lost to Follow-up|3|||
129477131|NCT02901431|466036607|FG007|Main Treatment Part|Lost to Follow-up|0|||
129477132|NCT02901431|466036608|FG008|Main Treatment Part|Lost to Follow-up|0|||
129477133|NCT02901431|466036609|FG009|Main Treatment Part|Lost to Follow-up|0|||
129477134|NCT02901431|466036610|FG010|Main Treatment Part|Lost to Follow-up|0|||
129477135|NCT02901431|466036611|FG011|Main Treatment Part|Lost to Follow-up|0|||
129477136|NCT02901431|466036612|FG012|Main Treatment Part|Lost to Follow-up|0|||
129477137|NCT02901431|466036600|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
129477138|NCT02901431|466036601|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
129477139|NCT02901431|466036602|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
129477140|NCT02901431|466036603|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
129477141|NCT02901431|466036604|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
129477142|NCT02901431|466036605|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
129477143|NCT02901431|466036606|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
129477144|NCT02901431|466036607|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
129477145|NCT02901431|466036608|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
129477146|NCT02901431|466036609|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
129477147|NCT02901431|466036610|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
129477148|NCT02901431|466036611|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
129477149|NCT02901431|466036612|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
129477150|NCT02901431|466036600|FG000|Main Treatment Part|Physician Decision|0|||
129477151|NCT02901431|466036601|FG001|Main Treatment Part|Physician Decision|0|||
129477152|NCT02901431|466036602|FG002|Main Treatment Part|Physician Decision|0|||
129477153|NCT02901431|466036603|FG003|Main Treatment Part|Physician Decision|1|||
129477154|NCT02901431|466036604|FG004|Main Treatment Part|Physician Decision|0|||
129477155|NCT02901431|466036605|FG005|Main Treatment Part|Physician Decision|0|||
129477156|NCT02901431|466036606|FG006|Main Treatment Part|Physician Decision|1|||
129477157|NCT02901431|466036607|FG007|Main Treatment Part|Physician Decision|0|||
129477158|NCT02901431|466036608|FG008|Main Treatment Part|Physician Decision|0|||
129477159|NCT02901431|466036609|FG009|Main Treatment Part|Physician Decision|0|||
129477160|NCT02901431|466036610|FG010|Main Treatment Part|Physician Decision|0|||
129477161|NCT02901431|466036611|FG011|Main Treatment Part|Physician Decision|0|||
129477162|NCT02901431|466036612|FG012|Main Treatment Part|Physician Decision|0|||
129477163|NCT02901431|466036600|FG000|Main Treatment Part|Withdrawal by Subject|0|||
129477164|NCT02901431|466036601|FG001|Main Treatment Part|Withdrawal by Subject|0|||
129477165|NCT02901431|466036602|FG002|Main Treatment Part|Withdrawal by Subject|0|||
129477166|NCT02901431|466036603|FG003|Main Treatment Part|Withdrawal by Subject|18|||
129477167|NCT02901431|466036604|FG004|Main Treatment Part|Withdrawal by Subject|3|||
129477168|NCT02901431|466036605|FG005|Main Treatment Part|Withdrawal by Subject|5|||
129477169|NCT02901431|466036606|FG006|Main Treatment Part|Withdrawal by Subject|6|||
129477170|NCT02901431|466036607|FG007|Main Treatment Part|Withdrawal by Subject|0|||
129477171|NCT02901431|466036608|FG008|Main Treatment Part|Withdrawal by Subject|0|||
129477172|NCT02901431|466036609|FG009|Main Treatment Part|Withdrawal by Subject|0|||
129477173|NCT02901431|466036610|FG010|Main Treatment Part|Withdrawal by Subject|0|||
129477174|NCT02901431|466036611|FG011|Main Treatment Part|Withdrawal by Subject|0|||
129477175|NCT02901431|466036612|FG012|Main Treatment Part|Withdrawal by Subject|0|||
129477176|NCT02901431|466036600|FG000|Open Label Part|Adverse Event|0|||
129477177|NCT02901431|466036601|FG001|Open Label Part|Adverse Event|0|||
129477178|NCT02901431|466036602|FG002|Open Label Part|Adverse Event|0|||
129477179|NCT02901431|466036603|FG003|Open Label Part|Adverse Event|0|||
129477180|NCT02901431|466036604|FG004|Open Label Part|Adverse Event|0|||
129477181|NCT02901431|466036605|FG005|Open Label Part|Adverse Event|0|||
129477182|NCT02901431|466036606|FG006|Open Label Part|Adverse Event|0|||
129477183|NCT02901431|466036607|FG007|Open Label Part|Adverse Event|0|||
129477184|NCT02901431|466036608|FG008|Open Label Part|Adverse Event|4|||
129477185|NCT02901431|466036609|FG009|Open Label Part|Adverse Event|4|||
129477186|NCT02901431|466036610|FG010|Open Label Part|Adverse Event|0|||
129477187|NCT02901431|466036611|FG011|Open Label Part|Adverse Event|4|||
129477188|NCT02901431|466036612|FG012|Open Label Part|Adverse Event|1|||
129477189|NCT02901431|466036600|FG000|Open Label Part|Lost to Follow-up|0|||
129477190|NCT02901431|466036601|FG001|Open Label Part|Lost to Follow-up|0|||
129477191|NCT02901431|466036602|FG002|Open Label Part|Lost to Follow-up|0|||
129477192|NCT02901431|466036603|FG003|Open Label Part|Lost to Follow-up|0|||
129477193|NCT02901431|466036604|FG004|Open Label Part|Lost to Follow-up|0|||
129477194|NCT02901431|466036605|FG005|Open Label Part|Lost to Follow-up|0|||
129477195|NCT02901431|466036606|FG006|Open Label Part|Lost to Follow-up|0|||
129477196|NCT02901431|466036607|FG007|Open Label Part|Lost to Follow-up|0|||
129477197|NCT02901431|466036608|FG008|Open Label Part|Lost to Follow-up|2|||
129477198|NCT02901431|466036609|FG009|Open Label Part|Lost to Follow-up|2|||
129477199|NCT02901431|466036610|FG010|Open Label Part|Lost to Follow-up|1|||
129477200|NCT02901431|466036611|FG011|Open Label Part|Lost to Follow-up|1|||
129477201|NCT02901431|466036612|FG012|Open Label Part|Lost to Follow-up|1|||
129477202|NCT02901431|466036600|FG000|Open Label Part|Physician Decision|0|||
129477203|NCT02901431|466036601|FG001|Open Label Part|Physician Decision|0|||
129477204|NCT02901431|466036602|FG002|Open Label Part|Physician Decision|0|||
129477205|NCT02901431|466036603|FG003|Open Label Part|Physician Decision|0|||
129477206|NCT02901431|466036604|FG004|Open Label Part|Physician Decision|0|||
129477207|NCT02901431|466036605|FG005|Open Label Part|Physician Decision|0|||
129477208|NCT02901431|466036606|FG006|Open Label Part|Physician Decision|0|||
129477209|NCT02901431|466036607|FG007|Open Label Part|Physician Decision|0|||
129477210|NCT02901431|466036608|FG008|Open Label Part|Physician Decision|1|||
129477211|NCT02901431|466036609|FG009|Open Label Part|Physician Decision|1|||
129477212|NCT02901431|466036610|FG010|Open Label Part|Physician Decision|0|||
129477213|NCT02901431|466036611|FG011|Open Label Part|Physician Decision|0|||
129477214|NCT02901431|466036612|FG012|Open Label Part|Physician Decision|0|||
129477215|NCT02901431|466036600|FG000|Open Label Part|Study Terminated By Sponsor|0|||
129477216|NCT02901431|466036601|FG001|Open Label Part|Study Terminated By Sponsor|0|||
129477217|NCT02901431|466036602|FG002|Open Label Part|Study Terminated By Sponsor|0|||
129477218|NCT02901431|466036603|FG003|Open Label Part|Study Terminated By Sponsor|0|||
129477219|NCT02901431|466036604|FG004|Open Label Part|Study Terminated By Sponsor|0|||
129477220|NCT02901431|466036605|FG005|Open Label Part|Study Terminated By Sponsor|0|||
129477221|NCT02901431|466036606|FG006|Open Label Part|Study Terminated By Sponsor|0|||
129477222|NCT02901431|466036607|FG007|Open Label Part|Study Terminated By Sponsor|0|||
129477223|NCT02901431|466036608|FG008|Open Label Part|Study Terminated By Sponsor|35|||
129477224|NCT02901431|466036609|FG009|Open Label Part|Study Terminated By Sponsor|12|||
129477225|NCT02901431|466036610|FG010|Open Label Part|Study Terminated By Sponsor|21|||
129477226|NCT02901431|466036611|FG011|Open Label Part|Study Terminated By Sponsor|31|||
129477227|NCT02901431|466036612|FG012|Open Label Part|Study Terminated By Sponsor|0|||
129477228|NCT02901431|466036600|FG000|Open Label Part|Withdrawal by Subject|0|||
129477229|NCT02901431|466036601|FG001|Open Label Part|Withdrawal by Subject|0|||
129477230|NCT02901431|466036602|FG002|Open Label Part|Withdrawal by Subject|0|||
129477231|NCT02901431|466036603|FG003|Open Label Part|Withdrawal by Subject|0|||
129477232|NCT02901431|466036604|FG004|Open Label Part|Withdrawal by Subject|0|||
129477233|NCT02901431|466036605|FG005|Open Label Part|Withdrawal by Subject|0|||
129477234|NCT02901431|466036606|FG006|Open Label Part|Withdrawal by Subject|0|||
129477235|NCT02901431|466036607|FG007|Open Label Part|Withdrawal by Subject|0|||
129477236|NCT02901431|466036608|FG008|Open Label Part|Withdrawal by Subject|6|||
129477237|NCT02901431|466036609|FG009|Open Label Part|Withdrawal by Subject|5|||
129477238|NCT02901431|466036610|FG010|Open Label Part|Withdrawal by Subject|7|||
129477239|NCT02901431|466036611|FG011|Open Label Part|Withdrawal by Subject|3|||
129477240|NCT02901431|466036612|FG012|Open Label Part|Withdrawal by Subject|1|||
129477241|NCT01889602|466036613|FG000|First Intervention|Adverse Event|1|||
129477242|NCT01889602|466036614|FG001|First Intervention|Adverse Event|1|||
129477243|NCT01889602|466036615|FG002|First Intervention|Adverse Event|1|||
129477244|NCT01889602|466036613|FG000|First Intervention|Protocol Violation|0|||
129477245|NCT01889602|466036614|FG001|First Intervention|Protocol Violation|1|||
129477246|NCT01889602|466036615|FG002|First Intervention|Protocol Violation|1|||
129477247|NCT01889602|466036613|FG000|First Intervention|Study ending|0|||
129477248|NCT01889602|466036614|FG001|First Intervention|Study ending|1|||
129477249|NCT01889602|466036615|FG002|First Intervention|Study ending|0|||
129477250|NCT01889602|466036613|FG000|Second Intervention|Adverse Event|0|||
129477251|NCT01889602|466036614|FG001|Second Intervention|Adverse Event|0|||
129477252|NCT01889602|466036615|FG002|Second Intervention|Adverse Event|1|||
129477253|NCT01889602|466036613|FG000|Second Intervention|Study ending|1|||
129477254|NCT01889602|466036614|FG001|Second Intervention|Study ending|0|||
129477255|NCT01889602|466036615|FG002|Second Intervention|Study ending|0|||
129477256|NCT01889602|466036613|FG000|Second Intervention|Withdrawal by Subject|0|||
129477257|NCT01889602|466036614|FG001|Second Intervention|Withdrawal by Subject|0|||
129477258|NCT01889602|466036615|FG002|Second Intervention|Withdrawal by Subject|1|||
129477259|NCT01889602|466036613|FG000|Third Intervention|Protocol Violation|1|||
129477260|NCT01889602|466036614|FG001|Third Intervention|Protocol Violation|0|||
129477261|NCT01889602|466036615|FG002|Third Intervention|Protocol Violation|0|||
129477262|NCT01889602|466036613|FG000|Third Intervention|Withdrawal by Subject|2|||
129477263|NCT01889602|466036614|FG001|Third Intervention|Withdrawal by Subject|2|||
129477264|NCT01889602|466036615|FG002|Third Intervention|Withdrawal by Subject|0|||
129477265|NCT00404092|466036616|FG000|Overall Study|Death|1|||
129477266|NCT00404092|466036617|FG001|Overall Study|Death|0|||
129477267|NCT00404092|466036618|FG002|Overall Study|Death|0|||
129477268|NCT00404092|466036619|FG003|Overall Study|Death|0|||
129477269|NCT00404092|466036616|FG000|Overall Study|Adverse Event|0|||
129477270|NCT00404092|466036617|FG001|Overall Study|Adverse Event|0|||
129477271|NCT00404092|466036618|FG002|Overall Study|Adverse Event|1|||
129477272|NCT00404092|466036619|FG003|Overall Study|Adverse Event|0|||
129477273|NCT04223609|466036624|FG000|Overall Study|Adverse Event|0|||
129477274|NCT04223609|466036625|FG001|Overall Study|Adverse Event|1|||
129477275|NCT04223609|466036624|FG000|Overall Study|Missed last visit|0|||
129477276|NCT04223609|466036625|FG001|Overall Study|Missed last visit|1|||
129477277|NCT03440944|466036628|FG000|Overall Study|Physician Decision|1|||
129477278|NCT03440944|466036629|FG001|Overall Study|Physician Decision|0|||
129477279|NCT03440944|466036628|FG000|Overall Study|No Acceptable Vasculature|0|||
129477280|NCT03440944|466036629|FG001|Overall Study|No Acceptable Vasculature|1|||
129477281|NCT03636906|466036636|FG000|Overall Study|Adverse Event|0|||
129477282|NCT03636906|466036637|FG001|Overall Study|Adverse Event|0|||
129477283|NCT03636906|466036638|FG002|Overall Study|Adverse Event|1|||
129477284|NCT03636906|466036636|FG000|Overall Study|Lost to Follow-up|1|||
129477285|NCT03636906|466036637|FG001|Overall Study|Lost to Follow-up|0|||
129477286|NCT03636906|466036638|FG002|Overall Study|Lost to Follow-up|0|||
129477287|NCT03636906|466036636|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
129477288|NCT03636906|466036637|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
129477289|NCT03636906|466036638|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
129477290|NCT03636906|466036636|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
129477291|NCT03636906|466036637|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
129477292|NCT03636906|466036638|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
129477293|NCT03636906|466036636|FG000|Overall Study|Other|0|||
129477294|NCT03636906|466036637|FG001|Overall Study|Other|0|||
129477295|NCT03636906|466036638|FG002|Overall Study|Other|1|||
129477296|NCT02732951|466038047|FG000|Overall Study|Other than listed|1|||
129477297|NCT02732951|466038048|FG001|Overall Study|Other than listed|0|||
129477298|NCT02732951|466038047|FG000|Overall Study|Lost to Follow-up|0|||
129477299|NCT02732951|466038048|FG001|Overall Study|Lost to Follow-up|1|||
129477300|NCT02732951|466038047|FG000|Overall Study|Adverse Event|4|||
129477301|NCT02732951|466038048|FG001|Overall Study|Adverse Event|4|||
129477302|NCT02732951|466038047|FG000|Overall Study|Protocol Violation|0|||
129477303|NCT02732951|466038048|FG001|Overall Study|Protocol Violation|1|||
129976417|NCT01252355|467877755|FG002|Overall Study|Randomized but not Treated|0|||
129976418|NCT01252355|467877753|FG000|Overall Study|Other Than Above|8|||
129976419|NCT01252355|467877754|FG001|Overall Study|Other Than Above|7|||
129477304|NCT04840667|466038049|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
129477305|NCT03658889|466038063|FG000|Overall Study|Protocol Violation|2|||
129477306|NCT03658889|466038064|FG001|Overall Study|Protocol Violation|0|||
129477307|NCT00224016|466038071|FG000|Titration Period|Withdrawal by Subject|0|||
129477308|NCT00224016|466038072|FG001|Titration Period|Withdrawal by Subject|1|||
129477309|NCT00224016|466038071|FG000|Titration Period|Lost to Follow-up|1|||
129477310|NCT00224016|466038072|FG001|Titration Period|Lost to Follow-up|0|||
129477311|NCT00224016|466038071|FG000|Maintenance Period|Withdrawal by Subject|2|||
129477312|NCT00224016|466038072|FG001|Maintenance Period|Withdrawal by Subject|0|||
129477313|NCT00224016|466038071|FG000|Maintenance Period|Lost to Follow-up|0|||
129477314|NCT00224016|466038072|FG001|Maintenance Period|Lost to Follow-up|1|||
129477315|NCT00206726|466038073|FG000|Overall Study|Delayed recovery of blood counts|1|||
129477316|NCT00206726|466038073|FG000|Overall Study|Progressive disease or relapsed disease|18|||
129477317|NCT00206726|466038073|FG000|Overall Study|Placed on new protocol|1|||
129477318|NCT00206726|466038073|FG000|Overall Study|Bone marrow transplant|1|||
129477319|NCT00206726|466038073|FG000|Overall Study|Adverse Event|17|||
129477320|NCT00206726|466038073|FG000|Overall Study|Death|4|||
129477321|NCT00206726|466038073|FG000|Overall Study|Protocol Violation|1|||
129477322|NCT00206726|466038073|FG000|Overall Study|Withdrawal by Subject|8|||
129477323|NCT01903876|466038074|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
129477324|NCT01903876|466038075|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
129477325|NCT01903876|466038074|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
129477326|NCT01903876|466038075|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
129477327|NCT04317690|466038078|FG000|Overall Study|did not have complete information for primary outcome|0|||
129477328|NCT04317690|466038079|FG001|Overall Study|did not have complete information for primary outcome|4|||
129477329|NCT04317690|466038080|FG002|Overall Study|did not have complete information for primary outcome|0|||
129477330|NCT04317690|466038081|FG003|Overall Study|did not have complete information for primary outcome|2|||
129477331|NCT04317690|466038082|FG004|Overall Study|did not have complete information for primary outcome|0|||
129477332|NCT02612909|466038083|FG000|Phase 2|Withdrawal by Subject|2|||
129477333|NCT02612909|466038084|FG001|Phase 2|Withdrawal by Subject|5|||
129477334|NCT02612909|466038085|FG002|Phase 2|Withdrawal by Subject|0|||
129477335|NCT02612909|466038086|FG003|Phase 2|Withdrawal by Subject|0|||
129477336|NCT02612909|466038087|FG004|Phase 2|Withdrawal by Subject|0|||
129477337|NCT02612909|466038083|FG000|Phase 2|Pregnancy|0|||
129477338|NCT02612909|466038084|FG001|Phase 2|Pregnancy|0|||
129477339|NCT02612909|466038085|FG002|Phase 2|Pregnancy|1|||
129477340|NCT02612909|466038086|FG003|Phase 2|Pregnancy|0|||
129477341|NCT02612909|466038087|FG004|Phase 2|Pregnancy|0|||
129477342|NCT02612909|466038083|FG000|Phase 3|Withdrawal by Subject|0|||
129477343|NCT02612909|466038084|FG001|Phase 3|Withdrawal by Subject|0|||
129477344|NCT02612909|466038085|FG002|Phase 3|Withdrawal by Subject|0|||
129477345|NCT02612909|466038086|FG003|Phase 3|Withdrawal by Subject|1|||
129477346|NCT02612909|466038087|FG004|Phase 3|Withdrawal by Subject|0|||
129477347|NCT01719757|466038089|FG000|Overall Study|Adverse Event|38|||
129477348|NCT01719757|466038089|FG000|Overall Study|Withdrawal by Subject|15|||
129477349|NCT01719757|466038089|FG000|Overall Study|Lost to Follow-up|20|||
129477350|NCT01719757|466038089|FG000|Overall Study|Protocol Violation|1|||
129477351|NCT01719757|466038089|FG000|Overall Study|well controlled pain|27|||
129477352|NCT02626338|466038090|FG000|Overall Study|Lack of Efficacy|3|||
129477353|NCT02626338|466038091|FG001|Overall Study|Lack of Efficacy|2|||
129477354|NCT02626338|466038092|FG002|Overall Study|Lack of Efficacy|0|||
129477355|NCT01901224|466038098|FG000|Overall Study|study was not funded and terminated|2|||
129477356|NCT00450580|466038099|FG000|Overall Study|Adverse Event|5|||
129477357|NCT00450580|466038100|FG001|Overall Study|Adverse Event|7|||
129477358|NCT00450580|466038099|FG000|Overall Study|Lost to Follow-up|4|||
129477359|NCT00450580|466038100|FG001|Overall Study|Lost to Follow-up|5|||
129477360|NCT00450580|466038099|FG000|Overall Study|Withdrawal by Subject|2|||
129477361|NCT00450580|466038100|FG001|Overall Study|Withdrawal by Subject|2|||
129477362|NCT00450580|466038099|FG000|Overall Study|Protocol Violation|1|||
129477363|NCT00450580|466038100|FG001|Overall Study|Protocol Violation|1|||
129477364|NCT00450580|466038099|FG000|Overall Study|Protocol-defined virologic failure|1|||
129477365|NCT00450580|466038100|FG001|Overall Study|Protocol-defined virologic failure|0|||
129477366|NCT00450580|466038099|FG000|Overall Study|Could not comply with scheduled visits|1|||
129477367|NCT00450580|466038100|FG001|Overall Study|Could not comply with scheduled visits|0|||
129477368|NCT00450580|466038099|FG000|Overall Study|Patient went to Brazil|1|||
129477369|NCT00450580|466038100|FG001|Overall Study|Patient went to Brazil|0|||
129477370|NCT00450580|466038099|FG000|Overall Study|Patient could not swallow Norvir|1|||
129477371|NCT00450580|466038100|FG001|Overall Study|Patient could not swallow Norvir|0|||
129477372|NCT00450580|466038099|FG000|Overall Study|Withdrawal due to pregnancy|0|||
129477373|NCT00450580|466038100|FG001|Overall Study|Withdrawal due to pregnancy|1|||
129477374|NCT03902080|466038102|FG000|Overall Study|Adverse Event|17|||
129477375|NCT03902080|466038103|FG001|Overall Study|Adverse Event|15|||
129477376|NCT03902080|466038102|FG000|Overall Study|Withdrawal by Subject|28|||
129477377|NCT03902080|466038103|FG001|Overall Study|Withdrawal by Subject|35|||
129477378|NCT03902080|466038102|FG000|Overall Study|Lost to Follow-up|6|||
129477379|NCT03902080|466038103|FG001|Overall Study|Lost to Follow-up|7|||
129477380|NCT03902080|466038102|FG000|Overall Study|Other|3|||
129477381|NCT03902080|466038103|FG001|Overall Study|Other|5|||
129477382|NCT03902080|466038102|FG000|Overall Study|Non compliance|4|||
129477383|NCT03902080|466038103|FG001|Overall Study|Non compliance|3|||
129477384|NCT03902080|466038102|FG000|Overall Study|Physician Decision|5|||
129477385|NCT03902080|466038103|FG001|Overall Study|Physician Decision|1|||
129477386|NCT03902080|466038102|FG000|Overall Study|Protocol Violation|3|||
129477387|NCT03902080|466038103|FG001|Overall Study|Protocol Violation|3|||
129477388|NCT03902080|466038102|FG000|Overall Study|Lack of Efficacy|1|||
129477389|NCT03902080|466038103|FG001|Overall Study|Lack of Efficacy|3|||
129477390|NCT03902080|466038102|FG000|Overall Study|Withdrawn prior to dosing|0|||
129477391|NCT03902080|466038103|FG001|Overall Study|Withdrawn prior to dosing|1|||
129477392|NCT01919307|466038108|FG000|Overall Study|Withdrawal by Subject|9|||
129477393|NCT01701258|466038114|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
129477394|NCT01701258|466038115|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
129477395|NCT01701258|466038116|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
129477396|NCT01701258|466038117|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
129477397|NCT01701258|466038118|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
129477398|NCT01701258|466038119|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
129477399|NCT01701258|466038120|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
129477400|NCT01701258|466038121|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
129477401|NCT01701258|466038122|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
129477402|NCT01701258|466038123|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
129477403|NCT01701258|466038124|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
129477404|NCT01701258|466038125|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
129477405|NCT01701258|466038126|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
129477406|NCT01701258|466038114|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
129477407|NCT01701258|466038115|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
129477408|NCT01701258|466038116|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
129477409|NCT01701258|466038117|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
129477410|NCT01701258|466038118|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
129477411|NCT01701258|466038119|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
129477412|NCT01701258|466038120|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
129477413|NCT01701258|466038121|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
129477414|NCT01701258|466038122|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
129477415|NCT01701258|466038123|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
129477416|NCT01701258|466038124|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
129477417|NCT01701258|466038125|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
129477418|NCT01701258|466038126|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
129976420|NCT01252355|467877755|FG002|Overall Study|Other Than Above|7|||
129976421|NCT00335140|467877758|FG000|Overall Study|Ineligible|1|||
129976422|NCT01725126|467877759|FG000|Overall Study|Protocol Violation|0|||
129976423|NCT01725126|467877760|FG001|Overall Study|Protocol Violation|1|||
129976424|NCT01725126|467877761|FG002|Overall Study|Protocol Violation|0|||
129976425|NCT01725126|467877762|FG003|Overall Study|Protocol Violation|0|||
129976426|NCT01725126|467877763|FG004|Overall Study|Protocol Violation|0|||
129976427|NCT01725126|467877764|FG005|Overall Study|Protocol Violation|0|||
129976428|NCT01725126|467877759|FG000|Overall Study|Withdrawal by Subject|0|||
129976429|NCT01725126|467877760|FG001|Overall Study|Withdrawal by Subject|0|||
129976430|NCT01725126|467877761|FG002|Overall Study|Withdrawal by Subject|0|||
129976431|NCT01725126|467877762|FG003|Overall Study|Withdrawal by Subject|1|||
129976432|NCT01725126|467877763|FG004|Overall Study|Withdrawal by Subject|0|||
129976433|NCT01725126|467877764|FG005|Overall Study|Withdrawal by Subject|0|||
129976434|NCT00895895|467877768|FG000|Period 1|Adverse Event|7|||
129976435|NCT00895895|467877769|FG001|Period 1|Adverse Event|6|||
129477419|NCT01701258|466038114|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
129477420|NCT01701258|466038115|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
129477421|NCT01701258|466038116|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
129477422|NCT01701258|466038117|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
129477423|NCT01701258|466038118|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
129477424|NCT01701258|466038119|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
129477425|NCT01701258|466038120|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
129477426|NCT01701258|466038121|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
129477427|NCT01701258|466038122|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
129477428|NCT01701258|466038123|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
129477429|NCT01701258|466038124|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
129477430|NCT01701258|466038125|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
129477431|NCT01701258|466038126|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
129477432|NCT01701258|466038114|FG000|Assessment and Scheduling|Investigator Terminated|2|||
129477433|NCT01701258|466038115|FG001|Assessment and Scheduling|Investigator Terminated|0|||
129477434|NCT01701258|466038116|FG002|Assessment and Scheduling|Investigator Terminated|0|||
129477435|NCT01701258|466038117|FG003|Assessment and Scheduling|Investigator Terminated|0|||
129477436|NCT01701258|466038118|FG004|Assessment and Scheduling|Investigator Terminated|0|||
129477437|NCT01701258|466038119|FG005|Assessment and Scheduling|Investigator Terminated|0|||
129477438|NCT01701258|466038120|FG006|Assessment and Scheduling|Investigator Terminated|0|||
129477439|NCT01701258|466038121|FG007|Assessment and Scheduling|Investigator Terminated|0|||
129477440|NCT01701258|466038122|FG008|Assessment and Scheduling|Investigator Terminated|0|||
129477441|NCT01701258|466038123|FG009|Assessment and Scheduling|Investigator Terminated|0|||
129477442|NCT01701258|466038124|FG010|Assessment and Scheduling|Investigator Terminated|0|||
129477443|NCT01701258|466038125|FG011|Assessment and Scheduling|Investigator Terminated|0|||
129477444|NCT01701258|466038126|FG012|Assessment and Scheduling|Investigator Terminated|0|||
129477445|NCT02429856|466038129|FG000|Overall Study|Death|12|||
129477446|NCT02429856|466038130|FG001|Overall Study|Death|13|||
129477447|NCT02429856|466038129|FG000|Overall Study|Lost to Follow-up|6|||
129477448|NCT02429856|466038130|FG001|Overall Study|Lost to Follow-up|5|||
129477449|NCT02429856|466038129|FG000|Overall Study|Withdrawal by Subject|1|||
129477450|NCT02429856|466038130|FG001|Overall Study|Withdrawal by Subject|1|||
129477451|NCT00891735|466038138|FG000|Overall Study|Adverse Event|2|||
129477452|NCT00891735|466038139|FG001|Overall Study|Adverse Event|0|||
129477453|NCT00891735|466038140|FG002|Overall Study|Adverse Event|2|||
129477454|NCT00891735|466038141|FG003|Overall Study|Adverse Event|0|||
129477455|NCT00891735|466038138|FG000|Overall Study|Death|8|||
129477456|NCT00891735|466038139|FG001|Overall Study|Death|5|||
129477457|NCT00891735|466038140|FG002|Overall Study|Death|4|||
129477458|NCT00891735|466038141|FG003|Overall Study|Death|5|||
129477459|NCT00891735|466038138|FG000|Overall Study|Lost to Follow-up|2|||
129477460|NCT00891735|466038139|FG001|Overall Study|Lost to Follow-up|2|||
129477461|NCT00891735|466038140|FG002|Overall Study|Lost to Follow-up|2|||
129477462|NCT00891735|466038141|FG003|Overall Study|Lost to Follow-up|2|||
129477463|NCT00891735|466038138|FG000|Overall Study|Physician's decision to withdraw patient|1|||
129976436|NCT00895895|467877770|FG002|Period 1|Adverse Event|4|||
129976437|NCT00895895|467877771|FG003|Period 1|Adverse Event|6|||
129976438|NCT00895895|467877772|FG004|Period 1|Adverse Event|7|||
129976439|NCT00895895|467877768|FG000|Period 1|Death|0|||
129976440|NCT00895895|467877769|FG001|Period 1|Death|0|||
129976441|NCT00895895|467877770|FG002|Period 1|Death|0|||
129477464|NCT00891735|466038139|FG001|Overall Study|Physician's decision to withdraw patient|0|||
129477465|NCT00891735|466038140|FG002|Overall Study|Physician's decision to withdraw patient|0|||
129477466|NCT00891735|466038141|FG003|Overall Study|Physician's decision to withdraw patient|0|||
129477467|NCT00891735|466038138|FG000|Overall Study|Patient's decision to withdraw|4|||
129477468|NCT00891735|466038139|FG001|Overall Study|Patient's decision to withdraw|9|||
129477469|NCT00891735|466038140|FG002|Overall Study|Patient's decision to withdraw|4|||
129477470|NCT00891735|466038141|FG003|Overall Study|Patient's decision to withdraw|8|||
129477471|NCT01355289|466038144|FG000|Core Study|Adverse Event, Non-Fatal|1|||
129477472|NCT01355289|466038145|FG001|Core Study|Adverse Event, Non-Fatal|0|||
129477473|NCT01355289|466038146|FG002|Core Study|Adverse Event, Non-Fatal|0|||
129477474|NCT01355289|466038147|FG003|Core Study|Adverse Event, Non-Fatal|0|||
129477475|NCT01355289|466038148|FG004|Core Study|Adverse Event, Non-Fatal|0|||
129477476|NCT01355289|466038144|FG000|Core Study|Inadequate Therapeutic Effect|0|||
129477477|NCT01355289|466038145|FG001|Core Study|Inadequate Therapeutic Effect|0|||
129477478|NCT01355289|466038146|FG002|Core Study|Inadequate Therapeutic Effect|0|||
129477479|NCT01355289|466038147|FG003|Core Study|Inadequate Therapeutic Effect|1|||
129477480|NCT01355289|466038148|FG004|Core Study|Inadequate Therapeutic Effect|0|||
129477481|NCT01355289|466038144|FG000|Core Study|Other|0|||
129477482|NCT01355289|466038145|FG001|Core Study|Other|0|||
129477483|NCT01355289|466038146|FG002|Core Study|Other|0|||
129477484|NCT01355289|466038147|FG003|Core Study|Other|1|||
129477485|NCT01355289|466038148|FG004|Core Study|Other|0|||
129477486|NCT01355289|466038144|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
129477487|NCT01355289|466038145|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
129477488|NCT01355289|466038146|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
129477489|NCT01355289|466038147|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
129477490|NCT01355289|466038148|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
129477491|NCT01355289|466038144|FG000|Open Label Extension|Lost to Follow-up|0|||
129477492|NCT01355289|466038145|FG001|Open Label Extension|Lost to Follow-up|0|||
129477493|NCT01355289|466038146|FG002|Open Label Extension|Lost to Follow-up|0|||
129477494|NCT01355289|466038147|FG003|Open Label Extension|Lost to Follow-up|0|||
129477495|NCT01355289|466038148|FG004|Open Label Extension|Lost to Follow-up|1|||
129477496|NCT01355289|466038144|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
129477497|NCT01355289|466038145|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
129477498|NCT01355289|466038146|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
129477499|NCT01355289|466038147|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
129477500|NCT01355289|466038148|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
129477501|NCT01355289|466038144|FG000|Open Label Extension|Other|0|||
129477502|NCT01355289|466038145|FG001|Open Label Extension|Other|0|||
129477503|NCT01355289|466038146|FG002|Open Label Extension|Other|0|||
129477504|NCT01355289|466038147|FG003|Open Label Extension|Other|0|||
129477505|NCT01355289|466038148|FG004|Open Label Extension|Other|3|||
129477506|NCT04336163|466038151|FG000|Overall Study|Lost to Follow-up|55|||
129477507|NCT04336163|466038152|FG001|Overall Study|Lost to Follow-up|0|||
129477508|NCT01085682|466038153|FG000|Overall Study|Withdrawal by Subject|25|||
129477509|NCT01085682|466038154|FG001|Overall Study|Withdrawal by Subject|25|||
129477510|NCT01451645|466038155|FG000|Overall Study|Protocol Violation|1|||
129477511|NCT01451645|466038156|FG001|Overall Study|Protocol Violation|0|||
129976442|NCT00895895|467877771|FG003|Period 1|Death|0|||
129976443|NCT00895895|467877772|FG004|Period 1|Death|1|||
129976444|NCT00895895|467877768|FG000|Period 1|discontinued by sponsor|2|||
129976445|NCT00895895|467877769|FG001|Period 1|discontinued by sponsor|1|||
129976446|NCT00895895|467877770|FG002|Period 1|discontinued by sponsor|2|||
129976447|NCT00895895|467877771|FG003|Period 1|discontinued by sponsor|1|||
129976448|NCT00895895|467877772|FG004|Period 1|discontinued by sponsor|1|||
129976449|NCT00895895|467877768|FG000|Period 1|failed to return|0|||
129976450|NCT00895895|467877769|FG001|Period 1|failed to return|0|||
129976451|NCT00895895|467877770|FG002|Period 1|failed to return|1|||
129976452|NCT00895895|467877771|FG003|Period 1|failed to return|0|||
129976453|NCT00895895|467877772|FG004|Period 1|failed to return|1|||
129976454|NCT00895895|467877768|FG000|Period 1|investigator request|0|||
129976455|NCT00895895|467877769|FG001|Period 1|investigator request|1|||
129976456|NCT00895895|467877770|FG002|Period 1|investigator request|0|||
129477512|NCT01451645|466038155|FG000|Overall Study|Adverse Event|0|||
129976457|NCT00895895|467877771|FG003|Period 1|investigator request|0|||
129477513|NCT01451645|466038156|FG001|Overall Study|Adverse Event|3|||
129477514|NCT01451645|466038155|FG000|Overall Study|Withdrawal by Subject|4|||
129477515|NCT01451645|466038156|FG001|Overall Study|Withdrawal by Subject|2|||
129477516|NCT01451645|466038155|FG000|Overall Study|Lost to Follow-up|4|||
129477517|NCT01451645|466038156|FG001|Overall Study|Lost to Follow-up|3|||
129976458|NCT00895895|467877772|FG004|Period 1|investigator request|0|||
129976459|NCT00895895|467877768|FG000|Period 1|Lost to Follow-up|2|||
129976460|NCT00895895|467877769|FG001|Period 1|Lost to Follow-up|1|||
129976461|NCT00895895|467877770|FG002|Period 1|Lost to Follow-up|3|||
129976462|NCT00895895|467877771|FG003|Period 1|Lost to Follow-up|2|||
129976463|NCT00895895|467877772|FG004|Period 1|Lost to Follow-up|3|||
129477518|NCT03040024|466038159|FG000|Overall Study|Adverse Event|0|||
129976464|NCT00895895|467877768|FG000|Period 1|Other|1|||
129477519|NCT03040024|466038160|FG001|Overall Study|Adverse Event|1|||
129477520|NCT03040024|466038161|FG002|Overall Study|Adverse Event|0|||
129477521|NCT03040024|466038159|FG000|Overall Study|Death|0|||
129477522|NCT03040024|466038160|FG001|Overall Study|Death|1|||
129477523|NCT03040024|466038161|FG002|Overall Study|Death|0|||
129477524|NCT03040024|466038159|FG000|Overall Study|Physician Decision|0|||
129477525|NCT03040024|466038160|FG001|Overall Study|Physician Decision|0|||
129477526|NCT03040024|466038161|FG002|Overall Study|Physician Decision|1|||
129477527|NCT01526148|466038163|FG000|Overall Study|Adverse Event|6|||
129477528|NCT01526148|466038164|FG001|Overall Study|Adverse Event|5|||
129477529|NCT01526148|466038163|FG000|Overall Study|Lost to Follow-up|3|||
129477530|NCT01526148|466038164|FG001|Overall Study|Lost to Follow-up|6|||
129477531|NCT01526148|466038163|FG000|Overall Study|Withdrawal by Subject|2|||
129477532|NCT01526148|466038164|FG001|Overall Study|Withdrawal by Subject|0|||
129477533|NCT01526148|466038163|FG000|Overall Study|Unstable Medical Condition|1|||
129477534|NCT01526148|466038164|FG001|Overall Study|Unstable Medical Condition|0|||
129477535|NCT01526148|466038163|FG000|Overall Study|Unable to discontinue concomitant med|1|||
129477536|NCT01526148|466038164|FG001|Overall Study|Unable to discontinue concomitant med|0|||
129477537|NCT01526148|466038163|FG000|Overall Study|Moved out of state|1|||
129477538|NCT01526148|466038164|FG001|Overall Study|Moved out of state|0|||
129477539|NCT01526148|466038163|FG000|Overall Study|Incarcerated|0|||
129477540|NCT01526148|466038164|FG001|Overall Study|Incarcerated|2|||
129477541|NCT01275222|466038165|FG000|Phase l by Treatment|Adverse Event|1|||
129477542|NCT01275222|466038166|FG001|Phase l by Treatment|Adverse Event|4|||
129477543|NCT01275222|466038167|FG002|Phase l by Treatment|Adverse Event|2|||
129477544|NCT01275222|466038168|FG003|Phase l by Treatment|Adverse Event|3|||
129477545|NCT01275222|466038169|FG004|Phase l by Treatment|Adverse Event|0|||
129477546|NCT01275222|466038170|FG005|Phase l by Treatment|Adverse Event|0|||
129477547|NCT01275222|466038165|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
129477548|NCT01275222|466038166|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
129477549|NCT01275222|466038167|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
129477550|NCT01275222|466038168|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
129477551|NCT01275222|466038169|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
129477552|NCT01275222|466038170|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
129477553|NCT01275222|466038165|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
129477554|NCT01275222|466038166|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
129477555|NCT01275222|466038167|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
129477556|NCT01275222|466038168|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
129477557|NCT01275222|466038169|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
129477558|NCT01275222|466038170|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
129477559|NCT01275222|466038165|FG000|Phase l by Treatment|Disease progression|12|||
129477560|NCT01275222|466038166|FG001|Phase l by Treatment|Disease progression|8|||
129477561|NCT01275222|466038167|FG002|Phase l by Treatment|Disease progression|2|||
129477562|NCT01275222|466038168|FG003|Phase l by Treatment|Disease progression|5|||
129477563|NCT01275222|466038169|FG004|Phase l by Treatment|Disease progression|0|||
129477564|NCT01275222|466038170|FG005|Phase l by Treatment|Disease progression|0|||
129477565|NCT01275222|466038165|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
129477566|NCT01275222|466038166|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
129477567|NCT01275222|466038167|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
129477568|NCT01275222|466038168|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
129477569|NCT01275222|466038169|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
129477570|NCT01275222|466038170|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
129477571|NCT01275222|466038165|FG000|Phase l by Treatment|Death|0|||
129477572|NCT01275222|466038166|FG001|Phase l by Treatment|Death|1|||
129976465|NCT00895895|467877769|FG001|Period 1|Other|2|||
129976466|NCT00895895|467877770|FG002|Period 1|Other|1|||
129976467|NCT00895895|467877771|FG003|Period 1|Other|1|||
129976468|NCT00895895|467877772|FG004|Period 1|Other|1|||
129976469|NCT00895895|467877768|FG000|Period 1|Protocol Violation|0|||
129976470|NCT00895895|467877769|FG001|Period 1|Protocol Violation|1|||
129976471|NCT00895895|467877770|FG002|Period 1|Protocol Violation|0|||
129976472|NCT00895895|467877771|FG003|Period 1|Protocol Violation|0|||
129976473|NCT00895895|467877772|FG004|Period 1|Protocol Violation|0|||
129976474|NCT00895895|467877768|FG000|Period 1|Withdrawal by Subject|6|||
129976475|NCT00895895|467877769|FG001|Period 1|Withdrawal by Subject|6|||
129976476|NCT00895895|467877770|FG002|Period 1|Withdrawal by Subject|8|||
129976477|NCT00895895|467877771|FG003|Period 1|Withdrawal by Subject|2|||
129477573|NCT01275222|466038167|FG002|Phase l by Treatment|Death|0|||
129477574|NCT01275222|466038168|FG003|Phase l by Treatment|Death|1|||
129477575|NCT01275222|466038169|FG004|Phase l by Treatment|Death|0|||
129477576|NCT01275222|466038170|FG005|Phase l by Treatment|Death|0|||
129477577|NCT01275222|466038165|FG000|Phase ll by Stratum|Adverse Event|0|||
129976478|NCT00895895|467877772|FG004|Period 1|Withdrawal by Subject|4|||
129976479|NCT00895895|467877768|FG000|Period 1|unsatisfactory response-efficacy|2|||
129976480|NCT00895895|467877769|FG001|Period 1|unsatisfactory response-efficacy|0|||
129976481|NCT00895895|467877770|FG002|Period 1|unsatisfactory response-efficacy|0|||
129976482|NCT00895895|467877771|FG003|Period 1|unsatisfactory response-efficacy|0|||
129976483|NCT00895895|467877772|FG004|Period 1|unsatisfactory response-efficacy|0|||
129976484|NCT00895895|467877768|FG000|Period 1|randomized and not treated|1|||
129976485|NCT00895895|467877769|FG001|Period 1|randomized and not treated|3|||
129976486|NCT00895895|467877770|FG002|Period 1|randomized and not treated|1|||
129976487|NCT00895895|467877771|FG003|Period 1|randomized and not treated|1|||
129976488|NCT00895895|467877772|FG004|Period 1|randomized and not treated|2|||
129976489|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
129976490|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
129976491|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
129976492|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
129976493|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
129976494|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Other|0|||
129477578|NCT01275222|466038166|FG001|Phase ll by Stratum|Adverse Event|0|||
129477579|NCT01275222|466038167|FG002|Phase ll by Stratum|Adverse Event|0|||
129477580|NCT01275222|466038168|FG003|Phase ll by Stratum|Adverse Event|0|||
129477581|NCT01275222|466038169|FG004|Phase ll by Stratum|Adverse Event|2|||
129477582|NCT01275222|466038170|FG005|Phase ll by Stratum|Adverse Event|10|||
129477583|NCT01275222|466038165|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
129477584|NCT01275222|466038166|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
129477585|NCT01275222|466038167|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
129477586|NCT01275222|466038168|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
129477587|NCT01275222|466038169|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
129477588|NCT01275222|466038170|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
129477589|NCT01275222|466038165|FG000|Phase ll by Stratum|Disease progression|0|||
129477590|NCT01275222|466038166|FG001|Phase ll by Stratum|Disease progression|0|||
129477591|NCT01275222|466038167|FG002|Phase ll by Stratum|Disease progression|0|||
129477592|NCT01275222|466038168|FG003|Phase ll by Stratum|Disease progression|0|||
129477593|NCT01275222|466038169|FG004|Phase ll by Stratum|Disease progression|23|||
129477594|NCT01275222|466038170|FG005|Phase ll by Stratum|Disease progression|31|||
129477595|NCT01275222|466038165|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
129477596|NCT01275222|466038166|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
129477597|NCT01275222|466038167|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
129477598|NCT01275222|466038168|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
129477599|NCT01275222|466038169|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
129477600|NCT01275222|466038170|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
129477601|NCT01275222|466038165|FG000|Phase ll by Stratum|Death|0|||
129477602|NCT01275222|466038166|FG001|Phase ll by Stratum|Death|0|||
129477603|NCT01275222|466038167|FG002|Phase ll by Stratum|Death|0|||
129477604|NCT01275222|466038168|FG003|Phase ll by Stratum|Death|0|||
129477605|NCT01275222|466038169|FG004|Phase ll by Stratum|Death|1|||
129477606|NCT01275222|466038170|FG005|Phase ll by Stratum|Death|1|||
129477607|NCT00591734|466038171|FG000|Overall Study|Lack of Efficacy|35|||
129477608|NCT00591734|466038171|FG000|Overall Study|Adverse Event|5|||
129477609|NCT00591734|466038171|FG000|Overall Study|Physician Decision|5|||
129477610|NCT00591734|466038171|FG000|Overall Study|Intercurrent Illness|8|||
129477611|NCT04672083|466038172|FG000|Overall Study|Lost to Follow-up|1|||
129477612|NCT04672083|466038173|FG001|Overall Study|Lost to Follow-up|0|||
129477613|NCT04672083|466038174|FG002|Overall Study|Lost to Follow-up|0|||
129477614|NCT04672083|466038175|FG003|Overall Study|Lost to Follow-up|0|||
129477615|NCT04672083|466038176|FG004|Overall Study|Lost to Follow-up|0|||
129477616|NCT01661790|466038177|FG000|Overall Study|Lost to Follow-up|0|||
129477617|NCT01661790|466038178|FG001|Overall Study|Lost to Follow-up|2|||
129477618|NCT02048904|466038179|FG000|Overall Study|Withdrawal by Subject|7|||
129477619|NCT02048904|466038179|FG000|Overall Study|Physician Decision|70|||
129477620|NCT00784758|466038180|FG000|Overall Study|Withdrawal by Subject|3|||
129477621|NCT00784758|466038181|FG001|Overall Study|Withdrawal by Subject|0|||
129477622|NCT00784758|466038180|FG000|Overall Study|Adverse Event|1|||
129477623|NCT00784758|466038181|FG001|Overall Study|Adverse Event|0|||
129477624|NCT00891202|466038182|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
129477625|NCT00891202|466038183|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
129477626|NCT00891202|466038184|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
129477627|NCT00891202|466038185|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
129477628|NCT00891202|466038182|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
129477629|NCT00891202|466038183|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
129477630|NCT00891202|466038184|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
129477631|NCT00891202|466038185|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
129477632|NCT00891202|466038182|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
129477633|NCT00891202|466038183|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
129477634|NCT00891202|466038184|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
129477635|NCT00891202|466038185|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
129477636|NCT00891202|466038182|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
129477637|NCT00891202|466038183|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
129477638|NCT00891202|466038184|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
129976495|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Other|0|||
129976496|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Other|1|||
129477639|NCT00891202|466038185|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
129477640|NCT01291017|466038188|FG000|Overall Study|Lost to Follow-up|2|||
129477641|NCT01291017|466038188|FG000|Overall Study|Withdrawal by Subject|3|||
129477642|NCT04980391|466038189|FG000|Overall Study|Death|0|||
129477643|NCT04980391|466038190|FG001|Overall Study|Death|0|||
129477644|NCT04980391|466038191|FG002|Overall Study|Death|1|||
129477645|NCT04980391|466038192|FG003|Overall Study|Death|1|||
129477646|NCT04980391|466038189|FG000|Overall Study|Lost to Follow-up|3|||
129477647|NCT04980391|466038190|FG001|Overall Study|Lost to Follow-up|3|||
129477648|NCT04980391|466038191|FG002|Overall Study|Lost to Follow-up|2|||
129477649|NCT04980391|466038192|FG003|Overall Study|Lost to Follow-up|3|||
129477650|NCT04980391|466038189|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
129477651|NCT04980391|466038190|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
129477652|NCT04980391|466038191|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
129477653|NCT04980391|466038192|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
129477654|NCT04980391|466038189|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129477655|NCT04980391|466038190|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129477656|NCT04980391|466038191|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
129477657|NCT04980391|466038192|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129477658|NCT04980391|466038189|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
129477659|NCT04980391|466038190|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
129477660|NCT04980391|466038191|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
129477661|NCT04980391|466038192|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
129477662|NCT03690869|466038193|FG000|Overall Study|Adverse Event|0|||
129477663|NCT03690869|466038194|FG001|Overall Study|Adverse Event|0|||
129477664|NCT03690869|466038195|FG002|Overall Study|Adverse Event|0|||
129477665|NCT03690869|466038196|FG003|Overall Study|Adverse Event|1|||
129477666|NCT03690869|466038197|FG004|Overall Study|Adverse Event|0|||
129477667|NCT03690869|466038198|FG005|Overall Study|Adverse Event|0|||
129477668|NCT03690869|466038199|FG006|Overall Study|Adverse Event|0|||
129477669|NCT03690869|466038200|FG007|Overall Study|Adverse Event|1|||
129477670|NCT03690869|466038201|FG008|Overall Study|Adverse Event|0|||
129477671|NCT03690869|466038202|FG009|Overall Study|Adverse Event|1|||
129477672|NCT03690869|466038193|FG000|Overall Study|Death|1|||
129477673|NCT03690869|466038194|FG001|Overall Study|Death|1|||
129477674|NCT03690869|466038195|FG002|Overall Study|Death|1|||
129477675|NCT03690869|466038196|FG003|Overall Study|Death|4|||
129477676|NCT03690869|466038197|FG004|Overall Study|Death|2|||
129477677|NCT03690869|466038198|FG005|Overall Study|Death|5|||
129477678|NCT03690869|466038199|FG006|Overall Study|Death|3|||
129477679|NCT03690869|466038200|FG007|Overall Study|Death|2|||
129477680|NCT03690869|466038201|FG008|Overall Study|Death|0|||
129477681|NCT03690869|466038202|FG009|Overall Study|Death|3|||
129477682|NCT03690869|466038193|FG000|Overall Study|Lost to Follow-up|0|||
129477683|NCT03690869|466038194|FG001|Overall Study|Lost to Follow-up|0|||
129477684|NCT03690869|466038195|FG002|Overall Study|Lost to Follow-up|1|||
129477685|NCT03690869|466038196|FG003|Overall Study|Lost to Follow-up|0|||
129477686|NCT03690869|466038197|FG004|Overall Study|Lost to Follow-up|0|||
129477687|NCT03690869|466038198|FG005|Overall Study|Lost to Follow-up|0|||
129477688|NCT03690869|466038199|FG006|Overall Study|Lost to Follow-up|0|||
129477689|NCT03690869|466038200|FG007|Overall Study|Lost to Follow-up|0|||
129477690|NCT03690869|466038201|FG008|Overall Study|Lost to Follow-up|0|||
129477691|NCT03690869|466038202|FG009|Overall Study|Lost to Follow-up|0|||
129477692|NCT03690869|466038193|FG000|Overall Study|Other Treatment|1|||
129477693|NCT03690869|466038194|FG001|Overall Study|Other Treatment|1|||
129477694|NCT03690869|466038195|FG002|Overall Study|Other Treatment|1|||
129477695|NCT03690869|466038196|FG003|Overall Study|Other Treatment|2|||
129477696|NCT03690869|466038197|FG004|Overall Study|Other Treatment|3|||
129477697|NCT03690869|466038198|FG005|Overall Study|Other Treatment|1|||
129477698|NCT03690869|466038199|FG006|Overall Study|Other Treatment|2|||
129477699|NCT03690869|466038200|FG007|Overall Study|Other Treatment|7|||
129976497|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Other|0|||
129976498|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Other|0|||
129477700|NCT03690869|466038201|FG008|Overall Study|Other Treatment|0|||
129477701|NCT03690869|466038202|FG009|Overall Study|Other Treatment|3|||
129477702|NCT03690869|466038193|FG000|Overall Study|Physician Decision|0|||
129477703|NCT03690869|466038194|FG001|Overall Study|Physician Decision|1|||
129477704|NCT03690869|466038195|FG002|Overall Study|Physician Decision|0|||
129477705|NCT03690869|466038196|FG003|Overall Study|Physician Decision|0|||
129477706|NCT03690869|466038197|FG004|Overall Study|Physician Decision|0|||
129477707|NCT03690869|466038198|FG005|Overall Study|Physician Decision|0|||
129477708|NCT03690869|466038199|FG006|Overall Study|Physician Decision|0|||
129477709|NCT03690869|466038200|FG007|Overall Study|Physician Decision|0|||
129477710|NCT03690869|466038201|FG008|Overall Study|Physician Decision|0|||
129477711|NCT03690869|466038202|FG009|Overall Study|Physician Decision|0|||
129976499|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
129477712|NCT03690869|466038193|FG000|Overall Study|Progressive Disease|1|||
129477713|NCT03690869|466038194|FG001|Overall Study|Progressive Disease|2|||
129477714|NCT03690869|466038195|FG002|Overall Study|Progressive Disease|0|||
129477715|NCT03690869|466038196|FG003|Overall Study|Progressive Disease|1|||
129477716|NCT03690869|466038197|FG004|Overall Study|Progressive Disease|0|||
129477717|NCT03690869|466038198|FG005|Overall Study|Progressive Disease|0|||
129477718|NCT03690869|466038199|FG006|Overall Study|Progressive Disease|0|||
129477719|NCT03690869|466038200|FG007|Overall Study|Progressive Disease|0|||
129477720|NCT03690869|466038201|FG008|Overall Study|Progressive Disease|1|||
129477721|NCT03690869|466038202|FG009|Overall Study|Progressive Disease|1|||
129477722|NCT03690869|466038193|FG000|Overall Study|Subject Decision|0|||
129477723|NCT03690869|466038194|FG001|Overall Study|Subject Decision|0|||
129477724|NCT03690869|466038195|FG002|Overall Study|Subject Decision|0|||
129477725|NCT03690869|466038196|FG003|Overall Study|Subject Decision|1|||
129477726|NCT03690869|466038197|FG004|Overall Study|Subject Decision|0|||
129477727|NCT03690869|466038198|FG005|Overall Study|Subject Decision|0|||
129477728|NCT03690869|466038199|FG006|Overall Study|Subject Decision|0|||
129477729|NCT03690869|466038200|FG007|Overall Study|Subject Decision|1|||
129477730|NCT03690869|466038201|FG008|Overall Study|Subject Decision|0|||
129477731|NCT03690869|466038202|FG009|Overall Study|Subject Decision|0|||
129477732|NCT05047523|466040442|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
129477733|NCT05047523|466040443|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
129477734|NCT05047523|466040444|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
129477735|NCT05047523|466040445|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
129477736|NCT05047523|466040446|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
129477737|NCT05047523|466040447|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
129477738|NCT05047523|466040442|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129477739|NCT05047523|466040443|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
129477740|NCT05047523|466040444|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129477741|NCT05047523|466040445|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129477742|NCT05047523|466040446|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129477743|NCT05047523|466040447|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
129477744|NCT05047523|466040442|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
129477745|NCT05047523|466040443|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
129477746|NCT05047523|466040444|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
129477747|NCT05047523|466040445|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
129477748|NCT05047523|466040446|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
129477749|NCT05047523|466040447|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
129477750|NCT05047523|466040442|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
129477751|NCT05047523|466040443|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129477752|NCT05047523|466040444|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129477753|NCT05047523|466040445|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129477754|NCT05047523|466040446|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129477755|NCT05047523|466040447|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
129477756|NCT05047523|466040442|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
129477757|NCT05047523|466040443|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
129477758|NCT05047523|466040444|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
129477759|NCT05047523|466040445|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
129477760|NCT05047523|466040446|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
129477761|NCT05047523|466040447|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
129477762|NCT05047523|466040442|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
129477763|NCT05047523|466040443|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
129477764|NCT05047523|466040444|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
129477765|NCT05047523|466040445|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
129477766|NCT05047523|466040446|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
129477767|NCT05047523|466040447|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
129477768|NCT01609933|466040448|FG000|Overall Study|Adverse Event|1|||
129477769|NCT01609933|466040448|FG000|Overall Study|Withdrawal by Subject|3|||
129477770|NCT01252966|466040449|FG000|Overall Study|Lost to Follow-up|16|||
129477771|NCT01252966|466040450|FG001|Overall Study|Lost to Follow-up|10|||
129477772|NCT01252966|466040449|FG000|Overall Study|Withdrawal by Subject|7|||
129477773|NCT01252966|466040450|FG001|Overall Study|Withdrawal by Subject|3|||
129477774|NCT00393718|466040458|FG000|Overall Study|Adverse Event|20|||
129477775|NCT00393718|466040459|FG001|Overall Study|Adverse Event|8|||
129477776|NCT00393718|466040458|FG000|Overall Study|Protocol Violation|1|||
129477777|NCT00393718|466040459|FG001|Overall Study|Protocol Violation|2|||
129477778|NCT00393718|466040458|FG000|Overall Study|Lack of Efficacy|10|||
129477779|NCT00393718|466040459|FG001|Overall Study|Lack of Efficacy|9|||
129477780|NCT00393718|466040458|FG000|Overall Study|Hypoglycaemia|3|||
129477781|NCT00393718|466040459|FG001|Overall Study|Hypoglycaemia|2|||
129477782|NCT00393718|466040458|FG000|Overall Study|Subject decision|5|||
129477783|NCT00393718|466040459|FG001|Overall Study|Subject decision|0|||
129477784|NCT00393718|466040458|FG000|Overall Study|Withdrawal of consent|2|||
129477785|NCT00393718|466040459|FG001|Overall Study|Withdrawal of consent|1|||
129477786|NCT00393718|466040458|FG000|Overall Study|Missed measurement|1|||
129477787|NCT00393718|466040459|FG001|Overall Study|Missed measurement|0|||
129477788|NCT00393718|466040458|FG000|Overall Study|Move|1|||
129477789|NCT00393718|466040459|FG001|Overall Study|Move|0|||
129477790|NCT04938648|466040460|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
129477791|NCT04938648|466040461|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
129477792|NCT04938648|466040460|FG000|Overall Study|Patient too ill|0|||
129477793|NCT04938648|466040461|FG001|Overall Study|Patient too ill|1|||
129477794|NCT04938648|466040460|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
129477795|NCT04938648|466040461|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
129976500|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
129976501|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
129976502|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
129976503|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
129976504|NCT00895895|467877768|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129976505|NCT00895895|467877769|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129976506|NCT00895895|467877770|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129477796|NCT04938648|466040460|FG000|Overall Study|Patient did not have memory problems|1|||
129477797|NCT04938648|466040461|FG001|Overall Study|Patient did not have memory problems|1|||
129477798|NCT04938648|466040460|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
129477799|NCT04938648|466040461|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
129477800|NCT04938648|466040460|FG000|Overall Study|Care partner could not be reached|0|||
129477801|NCT04938648|466040461|FG001|Overall Study|Care partner could not be reached|1|||
129477802|NCT04938648|466040460|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
129477803|NCT04938648|466040461|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
129477804|NCT04938648|466040460|FG000|Overall Study|Withdrawal by Subject|2|||
129477805|NCT04938648|466040461|FG001|Overall Study|Withdrawal by Subject|1|||
129477806|NCT03293654|466040462|FG000|Overall Study|Lost to Follow-up|0|||
129477807|NCT03293654|466040463|FG001|Overall Study|Lost to Follow-up|1|||
129477808|NCT03293654|466040464|FG002|Overall Study|Lost to Follow-up|0|||
129477809|NCT00391976|466040465|FG000|Overall Study|Adverse Event|0|||
129477810|NCT00391976|466040466|FG001|Overall Study|Adverse Event|0|||
129477811|NCT00391976|466040467|FG002|Overall Study|Adverse Event|1|||
129477812|NCT00391976|466040465|FG000|Overall Study|Withdrawal of consent|0|||
129477813|NCT00391976|466040466|FG001|Overall Study|Withdrawal of consent|1|||
129477814|NCT00391976|466040467|FG002|Overall Study|Withdrawal of consent|1|||
129477815|NCT00391976|466040465|FG000|Overall Study|Lost to Follow-up|1|||
129477816|NCT00391976|466040466|FG001|Overall Study|Lost to Follow-up|2|||
129477817|NCT00391976|466040467|FG002|Overall Study|Lost to Follow-up|0|||
129477818|NCT00391976|466040465|FG000|Overall Study|Inappropriate enrollment|1|||
129477819|NCT00391976|466040466|FG001|Overall Study|Inappropriate enrollment|1|||
129477820|NCT00391976|466040467|FG002|Overall Study|Inappropriate enrollment|0|||
129477821|NCT00391976|466040465|FG000|Overall Study|Protocol deviation/violation|4|||
129477822|NCT00391976|466040466|FG001|Overall Study|Protocol deviation/violation|2|||
129477823|NCT00391976|466040467|FG002|Overall Study|Protocol deviation/violation|1|||
129477824|NCT00391976|466040465|FG000|Overall Study|Recurrence/no eradication of infection|21|||
129477825|NCT00391976|466040466|FG001|Overall Study|Recurrence/no eradication of infection|19|||
129477826|NCT00391976|466040467|FG002|Overall Study|Recurrence/no eradication of infection|0|||
129477827|NCT00391976|466040465|FG000|Overall Study|Unable to classify|0|||
129477828|NCT00391976|466040466|FG001|Overall Study|Unable to classify|0|||
129477829|NCT00391976|466040467|FG002|Overall Study|Unable to classify|1|||
129477830|NCT00391976|466040465|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
129477831|NCT00391976|466040466|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
129477832|NCT00391976|466040467|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
129477833|NCT03093402|466040468|FG000|Overall Study|Lost to Follow-up|1|||
129477834|NCT03093402|466040469|FG001|Overall Study|Lost to Follow-up|0|||
129477835|NCT03093402|466040470|FG002|Overall Study|Lost to Follow-up|0|||
129477836|NCT03093402|466040471|FG003|Overall Study|Lost to Follow-up|0|||
129477837|NCT03093402|466040468|FG000|Overall Study|Withdrawal by Subject|3|||
129477838|NCT03093402|466040469|FG001|Overall Study|Withdrawal by Subject|3|||
129477839|NCT03093402|466040470|FG002|Overall Study|Withdrawal by Subject|0|||
129976507|NCT00895895|467877771|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
129976508|NCT00895895|467877772|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
129976509|NCT00895895|467877768|FG000|Period 2|Adverse Event|3|||
129477840|NCT03093402|466040471|FG003|Overall Study|Withdrawal by Subject|1|||
129477841|NCT03093402|466040468|FG000|Overall Study|Withdrew prior to dosing|2|||
129477842|NCT03093402|466040469|FG001|Overall Study|Withdrew prior to dosing|1|||
129477843|NCT03093402|466040470|FG002|Overall Study|Withdrew prior to dosing|2|||
129477844|NCT03093402|466040471|FG003|Overall Study|Withdrew prior to dosing|3|||
129477845|NCT03093402|466040468|FG000|Overall Study|Ineligible for study|1|||
129477846|NCT03093402|466040469|FG001|Overall Study|Ineligible for study|0|||
129477847|NCT03093402|466040470|FG002|Overall Study|Ineligible for study|0|||
129976510|NCT00895895|467877769|FG001|Period 2|Adverse Event|3|||
129477848|NCT03093402|466040471|FG003|Overall Study|Ineligible for study|0|||
129477849|NCT03093402|466040468|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
129477850|NCT03093402|466040469|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
129477851|NCT03093402|466040470|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
129477852|NCT03093402|466040471|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
129477853|NCT02886702|466040472|FG000|Overall Study|Other|4|||
129477854|NCT02886702|466040473|FG001|Overall Study|Other|3|||
129477855|NCT02886702|466040474|FG002|Overall Study|Other|9|||
129477856|NCT02886702|466040472|FG000|Overall Study|Withdrawal by Subject|24|||
129477857|NCT02886702|466040473|FG001|Overall Study|Withdrawal by Subject|18|||
129477858|NCT02886702|466040474|FG002|Overall Study|Withdrawal by Subject|22|||
129477859|NCT02886702|466040472|FG000|Overall Study|Significant Worsening of Condition|0|||
129477860|NCT02886702|466040473|FG001|Overall Study|Significant Worsening of Condition|1|||
129477861|NCT02886702|466040474|FG002|Overall Study|Significant Worsening of Condition|0|||
129477862|NCT02886702|466040472|FG000|Overall Study|Protocol Violation|2|||
129477863|NCT02886702|466040473|FG001|Overall Study|Protocol Violation|2|||
129477864|NCT02886702|466040474|FG002|Overall Study|Protocol Violation|1|||
129477865|NCT02886702|466040472|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129477866|NCT02886702|466040473|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129477867|NCT02886702|466040474|FG002|Overall Study|Non-Compliance With Study Drug|4|||
129477868|NCT02886702|466040472|FG000|Overall Study|Lost to Follow-up|11|||
129477869|NCT02886702|466040473|FG001|Overall Study|Lost to Follow-up|13|||
129477870|NCT02886702|466040474|FG002|Overall Study|Lost to Follow-up|8|||
129477871|NCT02886702|466040472|FG000|Overall Study|Lack of Efficacy|3|||
129477872|NCT02886702|466040473|FG001|Overall Study|Lack of Efficacy|4|||
129477873|NCT02886702|466040474|FG002|Overall Study|Lack of Efficacy|5|||
129477874|NCT02886702|466040472|FG000|Overall Study|Adverse Event|4|||
129477875|NCT02886702|466040473|FG001|Overall Study|Adverse Event|9|||
129477876|NCT02886702|466040474|FG002|Overall Study|Adverse Event|3|||
129477877|NCT02886702|466040472|FG000|Overall Study|Administrative Reasons|0|||
129477878|NCT02886702|466040473|FG001|Overall Study|Administrative Reasons|0|||
129477879|NCT02886702|466040474|FG002|Overall Study|Administrative Reasons|1|||
129477880|NCT00763009|466040475|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
129477881|NCT00158184|466040484|FG000|Overall Study|personal issues|3|||
129477882|NCT00158184|466040485|FG001|Overall Study|personal issues|1|||
129477883|NCT00158184|466040484|FG000|Overall Study|failed for follow unit/study rules|2|||
129477884|NCT00158184|466040485|FG001|Overall Study|failed for follow unit/study rules|0|||
129477885|NCT00158184|466040484|FG000|Overall Study|Adverse Event|1|||
129477886|NCT00158184|466040485|FG001|Overall Study|Adverse Event|1|||
129477887|NCT05340504|466040486|FG000|Overall Study|Withdrawal by Subject|1|||
129477888|NCT05340504|466040487|FG001|Overall Study|Withdrawal by Subject|0|||
129477889|NCT02393209|466040490|FG000|Overall Study|Study Terminated by Sponsor|1|||
129477890|NCT02393209|466040491|FG001|Overall Study|Study Terminated by Sponsor|1|||
129477891|NCT02393209|466040492|FG002|Overall Study|Study Terminated by Sponsor|0|||
129477892|NCT02393209|466040493|FG003|Overall Study|Study Terminated by Sponsor|0|||
129477893|NCT02393209|466040490|FG000|Overall Study|Withdrawal by Patient|1|||
129477894|NCT02393209|466040491|FG001|Overall Study|Withdrawal by Patient|0|||
129477895|NCT02393209|466040492|FG002|Overall Study|Withdrawal by Patient|0|||
129477896|NCT02393209|466040493|FG003|Overall Study|Withdrawal by Patient|0|||
129477897|NCT02393209|466040490|FG000|Overall Study|Death|2|||
129477898|NCT02393209|466040491|FG001|Overall Study|Death|2|||
129477899|NCT02393209|466040492|FG002|Overall Study|Death|0|||
129477900|NCT02393209|466040493|FG003|Overall Study|Death|0|||
129477901|NCT02393209|466040490|FG000|Overall Study|Death due to Disease Progression|2|||
129477902|NCT02393209|466040491|FG001|Overall Study|Death due to Disease Progression|2|||
129477903|NCT02393209|466040492|FG002|Overall Study|Death due to Disease Progression|0|||
129477904|NCT02393209|466040493|FG003|Overall Study|Death due to Disease Progression|0|||
129477905|NCT02393209|466040490|FG000|Overall Study|Death from Legionella Infection|0|||
129477906|NCT02393209|466040491|FG001|Overall Study|Death from Legionella Infection|1|||
129477907|NCT02393209|466040492|FG002|Overall Study|Death from Legionella Infection|0|||
129477908|NCT02393209|466040493|FG003|Overall Study|Death from Legionella Infection|0|||
129477909|NCT02393209|466040490|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
129477910|NCT02393209|466040491|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
129477911|NCT02393209|466040492|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
129477912|NCT02393209|466040493|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
129477913|NCT02393209|466040490|FG000|Overall Study|Lost to Follow-up|0|||
129477914|NCT02393209|466040491|FG001|Overall Study|Lost to Follow-up|1|||
129477915|NCT02393209|466040492|FG002|Overall Study|Lost to Follow-up|0|||
129477916|NCT02393209|466040493|FG003|Overall Study|Lost to Follow-up|0|||
129477917|NCT03545282|466040494|FG000|Overall Study|Lost to Follow-up|15|||
129477918|NCT03545282|466040495|FG001|Overall Study|Lost to Follow-up|10|||
129477919|NCT03545282|466040494|FG000|Overall Study|Withdrawal by Subject|2|||
129477920|NCT03545282|466040495|FG001|Overall Study|Withdrawal by Subject|2|||
129477921|NCT00755079|466040496|FG000|Overall Study|Lost to Follow-up|1|||
129477922|NCT00755079|466040497|FG001|Overall Study|Lost to Follow-up|3|||
129477923|NCT00755079|466040496|FG000|Overall Study|Adverse Event|0|||
129477924|NCT00755079|466040497|FG001|Overall Study|Adverse Event|1|||
129477925|NCT00755079|466040496|FG000|Overall Study|Withdrawal by Subject|0|||
129477926|NCT00755079|466040497|FG001|Overall Study|Withdrawal by Subject|2|||
129477927|NCT02582671|466040498|FG000|Overall Study|Failure to return|1|||
129477928|NCT02582671|466040498|FG000|Overall Study|Other, not specified|1|||
129477929|NCT01287104|466040499|FG000|Overall Study|Patient developed progressive disease|1|||
129477930|NCT01287104|466040500|FG001|Overall Study|Patient developed progressive disease|1|||
129477931|NCT01287104|466040501|FG002|Overall Study|Patient developed progressive disease|3|||
129477932|NCT01287104|466040502|FG003|Overall Study|Patient developed progressive disease|2|||
129477933|NCT01287104|466040499|FG000|Overall Study|Donor anaphylaxis|0|||
129477934|NCT01287104|466040500|FG001|Overall Study|Donor anaphylaxis|1|||
129477935|NCT01287104|466040501|FG002|Overall Study|Donor anaphylaxis|0|||
129477936|NCT01287104|466040502|FG003|Overall Study|Donor anaphylaxis|1|||
129477937|NCT01287104|466040499|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
129477938|NCT01287104|466040500|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
129477939|NCT01287104|466040501|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
129477940|NCT01287104|466040502|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
129477941|NCT01287104|466040499|FG000|Overall Study|Low donor chimerism|0|||
129477942|NCT01287104|466040500|FG001|Overall Study|Low donor chimerism|1|||
129477943|NCT01287104|466040501|FG002|Overall Study|Low donor chimerism|0|||
129477944|NCT01287104|466040502|FG003|Overall Study|Low donor chimerism|0|||
129477945|NCT01287104|466040499|FG000|Overall Study|NK cells did not meet release criteria|0|||
129477946|NCT01287104|466040500|FG001|Overall Study|NK cells did not meet release criteria|1|||
129477947|NCT01287104|466040501|FG002|Overall Study|NK cells did not meet release criteria|0|||
129477948|NCT01287104|466040502|FG003|Overall Study|NK cells did not meet release criteria|0|||
129477949|NCT03068715|466040507|FG000|Overall Study|No longer met inclusion criteria|1|||
129477950|NCT03068715|466040508|FG001|Overall Study|No longer met inclusion criteria|0|||
129477951|NCT01276288|466040509|FG000|Overall Study|Adverse Event|1|||
129477952|NCT01276288|466040510|FG001|Overall Study|Adverse Event|1|||
129477953|NCT01276288|466040511|FG002|Overall Study|Adverse Event|0|||
129477954|NCT01276288|466040512|FG003|Overall Study|Adverse Event|0|||
129477955|NCT01276288|466040509|FG000|Overall Study|not treated|1|||
129477956|NCT01276288|466040510|FG001|Overall Study|not treated|0|||
129477957|NCT01276288|466040511|FG002|Overall Study|not treated|0|||
129477958|NCT01276288|466040512|FG003|Overall Study|not treated|0|||
129477959|NCT03168867|466040513|FG000|Overall Study|Withdrawal by Subject|1|||
129477960|NCT03168867|466040514|FG001|Overall Study|Withdrawal by Subject|5|||
129477961|NCT00481065|466040520|FG000|Overall Study|Adverse event or death|1|||
129477962|NCT00481065|466040521|FG001|Overall Study|Adverse event or death|1|||
129477963|NCT00481065|466040522|FG002|Overall Study|Adverse event or death|3|||
129477964|NCT00481065|466040523|FG003|Overall Study|Adverse event or death|0|||
129477965|NCT00481065|466040524|FG004|Overall Study|Adverse event or death|2|||
129477966|NCT00481065|466040525|FG005|Overall Study|Adverse event or death|0|||
129477967|NCT00481065|466040526|FG006|Overall Study|Adverse event or death|1|||
129477968|NCT00481065|466040527|FG007|Overall Study|Adverse event or death|1|||
129477969|NCT00481065|466040520|FG000|Overall Study|Withdrawal by Subject|11|||
129477970|NCT00481065|466040521|FG001|Overall Study|Withdrawal by Subject|12|||
129477971|NCT00481065|466040522|FG002|Overall Study|Withdrawal by Subject|7|||
129477972|NCT00481065|466040523|FG003|Overall Study|Withdrawal by Subject|11|||
129477973|NCT00481065|466040524|FG004|Overall Study|Withdrawal by Subject|13|||
129477974|NCT00481065|466040525|FG005|Overall Study|Withdrawal by Subject|12|||
129477975|NCT00481065|466040526|FG006|Overall Study|Withdrawal by Subject|9|||
129477976|NCT00481065|466040527|FG007|Overall Study|Withdrawal by Subject|10|||
129477977|NCT00481065|466040520|FG000|Overall Study|Lost to Follow-up|4|||
129477978|NCT00481065|466040521|FG001|Overall Study|Lost to Follow-up|2|||
129477979|NCT00481065|466040522|FG002|Overall Study|Lost to Follow-up|4|||
129477980|NCT00481065|466040523|FG003|Overall Study|Lost to Follow-up|3|||
129477981|NCT00481065|466040524|FG004|Overall Study|Lost to Follow-up|3|||
129477982|NCT00481065|466040525|FG005|Overall Study|Lost to Follow-up|3|||
129477983|NCT00481065|466040526|FG006|Overall Study|Lost to Follow-up|2|||
129477984|NCT00481065|466040527|FG007|Overall Study|Lost to Follow-up|5|||
129976511|NCT00895895|467877770|FG002|Period 2|Adverse Event|5|||
129976512|NCT00895895|467877771|FG003|Period 2|Adverse Event|2|||
129976513|NCT00895895|467877772|FG004|Period 2|Adverse Event|5|||
129976514|NCT00895895|467877768|FG000|Period 2|Death|0|||
129477985|NCT00481065|466040520|FG000|Overall Study|Inappropriate enrollment|4|||
129477986|NCT00481065|466040521|FG001|Overall Study|Inappropriate enrollment|0|||
129477987|NCT00481065|466040522|FG002|Overall Study|Inappropriate enrollment|2|||
129477988|NCT00481065|466040523|FG003|Overall Study|Inappropriate enrollment|0|||
129477989|NCT00481065|466040524|FG004|Overall Study|Inappropriate enrollment|2|||
129477990|NCT00481065|466040525|FG005|Overall Study|Inappropriate enrollment|1|||
129477991|NCT00481065|466040526|FG006|Overall Study|Inappropriate enrollment|0|||
129477992|NCT00481065|466040527|FG007|Overall Study|Inappropriate enrollment|1|||
129477993|NCT00481065|466040520|FG000|Overall Study|Administrative reason|0|||
129477994|NCT00481065|466040521|FG001|Overall Study|Administrative reason|0|||
129976515|NCT00895895|467877769|FG001|Period 2|Death|0|||
129976516|NCT00895895|467877770|FG002|Period 2|Death|1|||
129477995|NCT00481065|466040522|FG002|Overall Study|Administrative reason|0|||
129477996|NCT00481065|466040523|FG003|Overall Study|Administrative reason|0|||
129477997|NCT00481065|466040524|FG004|Overall Study|Administrative reason|0|||
129477998|NCT00481065|466040525|FG005|Overall Study|Administrative reason|2|||
129477999|NCT00481065|466040526|FG006|Overall Study|Administrative reason|1|||
129478000|NCT00481065|466040527|FG007|Overall Study|Administrative reason|0|||
129478001|NCT00481065|466040520|FG000|Overall Study|Protocol Violation|2|||
129478002|NCT00481065|466040521|FG001|Overall Study|Protocol Violation|1|||
129976517|NCT00895895|467877771|FG003|Period 2|Death|0|||
129976518|NCT00895895|467877772|FG004|Period 2|Death|0|||
129976519|NCT00895895|467877768|FG000|Period 2|discontinued by sponsor|44|||
129976520|NCT00895895|467877769|FG001|Period 2|discontinued by sponsor|44|||
129478003|NCT00481065|466040522|FG002|Overall Study|Protocol Violation|1|||
129478004|NCT00481065|466040523|FG003|Overall Study|Protocol Violation|1|||
129478005|NCT00481065|466040524|FG004|Overall Study|Protocol Violation|2|||
129478006|NCT00481065|466040525|FG005|Overall Study|Protocol Violation|6|||
129478007|NCT00481065|466040526|FG006|Overall Study|Protocol Violation|3|||
129478008|NCT00481065|466040527|FG007|Overall Study|Protocol Violation|2|||
129478009|NCT00481065|466040520|FG000|Overall Study|Unable to classify|0|||
129478010|NCT00481065|466040521|FG001|Overall Study|Unable to classify|1|||
129478011|NCT00481065|466040522|FG002|Overall Study|Unable to classify|2|||
129478012|NCT00481065|466040523|FG003|Overall Study|Unable to classify|0|||
129478013|NCT00481065|466040524|FG004|Overall Study|Unable to classify|1|||
129478014|NCT00481065|466040525|FG005|Overall Study|Unable to classify|0|||
129478015|NCT00481065|466040526|FG006|Overall Study|Unable to classify|0|||
129478016|NCT00481065|466040527|FG007|Overall Study|Unable to classify|0|||
129478017|NCT01709331|466040530|FG000|Overall Study|Adverse Event|1|||
129478018|NCT03896295|466040533|FG000|Overall Study|Adverse Event|0|||
129478019|NCT03896295|466040534|FG001|Overall Study|Adverse Event|1|||
129478020|NCT03896295|466040533|FG000|Overall Study|COVID-19|7|||
129478021|NCT03896295|466040534|FG001|Overall Study|COVID-19|29|||
129478022|NCT00700804|466040535|FG000|Overall Study|Withdrawal by Subject|1|||
129478023|NCT00700804|466040536|FG001|Overall Study|Withdrawal by Subject|2|||
129478024|NCT00700804|466040535|FG000|Overall Study|Protocol Violation|1|||
129478025|NCT00700804|466040536|FG001|Overall Study|Protocol Violation|1|||
129478026|NCT00700804|466040535|FG000|Overall Study|Loose Stools|1|||
129478027|NCT00700804|466040536|FG001|Overall Study|Loose Stools|1|||
129478028|NCT02500537|466040537|FG000|Overall Study|Death|2|||
129478029|NCT02500537|466040538|FG001|Overall Study|Death|0|||
129478030|NCT02500537|466040537|FG000|Overall Study|Lost to Follow-up|0|||
129478031|NCT02500537|466040538|FG001|Overall Study|Lost to Follow-up|1|||
129478032|NCT02500537|466040537|FG000|Overall Study|Withdrawal by Subject|1|||
129478033|NCT02500537|466040538|FG001|Overall Study|Withdrawal by Subject|0|||
129478034|NCT02875223|466040543|FG000|Overall Study|Other reasons|0|||
129478035|NCT02875223|466040544|FG001|Overall Study|Other reasons|0|||
129478036|NCT02875223|466040545|FG002|Overall Study|Other reasons|1|||
129478037|NCT02875223|466040546|FG003|Overall Study|Other reasons|0|||
129478038|NCT02875223|466040547|FG004|Overall Study|Other reasons|1|||
129478039|NCT02875223|466040548|FG005|Overall Study|Other reasons|2|||
129478040|NCT02875223|466040549|FG006|Overall Study|Other reasons|0|||
129478041|NCT02875223|466040550|FG007|Overall Study|Other reasons|2|||
129478042|NCT02875223|466040551|FG008|Overall Study|Other reasons|0|||
129478043|NCT02875223|466040552|FG009|Overall Study|Other reasons|0|||
129478044|NCT02875223|466040553|FG010|Overall Study|Other reasons|0|||
129478045|NCT02875223|466040554|FG011|Overall Study|Other reasons|0|||
129478046|NCT02875223|466040555|FG012|Overall Study|Other reasons|0|||
129478047|NCT02875223|466040543|FG000|Overall Study|Withdrawal by Subject|0|||
129478048|NCT02875223|466040544|FG001|Overall Study|Withdrawal by Subject|0|||
129478049|NCT02875223|466040545|FG002|Overall Study|Withdrawal by Subject|0|||
129478050|NCT02875223|466040546|FG003|Overall Study|Withdrawal by Subject|0|||
129478051|NCT02875223|466040547|FG004|Overall Study|Withdrawal by Subject|1|||
129478052|NCT02875223|466040548|FG005|Overall Study|Withdrawal by Subject|1|||
129478053|NCT02875223|466040549|FG006|Overall Study|Withdrawal by Subject|0|||
129478054|NCT02875223|466040550|FG007|Overall Study|Withdrawal by Subject|0|||
129478055|NCT02875223|466040551|FG008|Overall Study|Withdrawal by Subject|1|||
129478056|NCT02875223|466040552|FG009|Overall Study|Withdrawal by Subject|0|||
129478057|NCT02875223|466040553|FG010|Overall Study|Withdrawal by Subject|0|||
129478058|NCT02875223|466040554|FG011|Overall Study|Withdrawal by Subject|0|||
129976521|NCT00895895|467877770|FG002|Period 2|discontinued by sponsor|38|||
129976522|NCT00895895|467877771|FG003|Period 2|discontinued by sponsor|46|||
129478059|NCT02875223|466040555|FG012|Overall Study|Withdrawal by Subject|0|||
129478060|NCT02875223|466040543|FG000|Overall Study|Progressive disease|0|||
129478061|NCT02875223|466040544|FG001|Overall Study|Progressive disease|0|||
129478062|NCT02875223|466040545|FG002|Overall Study|Progressive disease|1|||
129478063|NCT02875223|466040546|FG003|Overall Study|Progressive disease|0|||
129478064|NCT02875223|466040547|FG004|Overall Study|Progressive disease|0|||
129478065|NCT02875223|466040548|FG005|Overall Study|Progressive disease|0|||
129478066|NCT02875223|466040549|FG006|Overall Study|Progressive disease|0|||
129478067|NCT02875223|466040550|FG007|Overall Study|Progressive disease|0|||
129976523|NCT00895895|467877772|FG004|Period 2|discontinued by sponsor|37|||
129478068|NCT02875223|466040551|FG008|Overall Study|Progressive disease|0|||
129478069|NCT02875223|466040552|FG009|Overall Study|Progressive disease|12|||
129478070|NCT02875223|466040553|FG010|Overall Study|Progressive disease|2|||
129478071|NCT02875223|466040554|FG011|Overall Study|Progressive disease|3|||
129478072|NCT02875223|466040555|FG012|Overall Study|Progressive disease|6|||
129478073|NCT02875223|466040543|FG000|Overall Study|Death|4|||
129478074|NCT02875223|466040544|FG001|Overall Study|Death|4|||
129478075|NCT02875223|466040545|FG002|Overall Study|Death|3|||
129478076|NCT02875223|466040546|FG003|Overall Study|Death|4|||
129478077|NCT02875223|466040547|FG004|Overall Study|Death|2|||
129478078|NCT02875223|466040548|FG005|Overall Study|Death|3|||
129478079|NCT02875223|466040549|FG006|Overall Study|Death|5|||
129478080|NCT02875223|466040550|FG007|Overall Study|Death|7|||
129478081|NCT02875223|466040551|FG008|Overall Study|Death|3|||
129478082|NCT02875223|466040552|FG009|Overall Study|Death|2|||
129478083|NCT02875223|466040553|FG010|Overall Study|Death|0|||
129478084|NCT02875223|466040554|FG011|Overall Study|Death|0|||
129478085|NCT02875223|466040555|FG012|Overall Study|Death|0|||
129478086|NCT02875223|466040543|FG000|Overall Study|Lost to Follow-up|0|||
129478087|NCT02875223|466040544|FG001|Overall Study|Lost to Follow-up|1|||
129478088|NCT02875223|466040545|FG002|Overall Study|Lost to Follow-up|1|||
129478089|NCT02875223|466040546|FG003|Overall Study|Lost to Follow-up|0|||
129478090|NCT02875223|466040547|FG004|Overall Study|Lost to Follow-up|1|||
129478091|NCT02875223|466040548|FG005|Overall Study|Lost to Follow-up|0|||
129478092|NCT02875223|466040549|FG006|Overall Study|Lost to Follow-up|1|||
129478093|NCT02875223|466040550|FG007|Overall Study|Lost to Follow-up|1|||
129478094|NCT02875223|466040551|FG008|Overall Study|Lost to Follow-up|0|||
129478095|NCT02875223|466040552|FG009|Overall Study|Lost to Follow-up|0|||
129478096|NCT02875223|466040553|FG010|Overall Study|Lost to Follow-up|0|||
129478097|NCT02875223|466040554|FG011|Overall Study|Lost to Follow-up|0|||
129478098|NCT02875223|466040555|FG012|Overall Study|Lost to Follow-up|0|||
129478099|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
129478100|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
129478101|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
129478102|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
129478103|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
129478104|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
129478105|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
129478106|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
129478107|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
129478108|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
129478109|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
129478110|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
129478111|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
129478112|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
129478113|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
129478114|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
129478115|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
129478116|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
129478117|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
129478118|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
129478119|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
129478120|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
129478121|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
129478122|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
129478123|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
129478124|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
129478125|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
129478126|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
129478127|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
129478128|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
129478129|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
129478130|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
129478131|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
129478132|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
129478133|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
129976524|NCT00895895|467877768|FG000|Period 2|failed to return|2|||
129976525|NCT00895895|467877769|FG001|Period 2|failed to return|0|||
129976526|NCT00895895|467877770|FG002|Period 2|failed to return|0|||
129976527|NCT00895895|467877771|FG003|Period 2|failed to return|0|||
129478134|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
129478135|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
129478136|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
129976528|NCT00895895|467877772|FG004|Period 2|failed to return|0|||
129478137|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
129478138|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
129478139|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
129478140|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
129478141|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
129478142|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
129478143|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
129478144|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
129478145|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
129478146|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
129478147|NCT01707992|466040558|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
129478148|NCT01707992|466040559|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
129478149|NCT01707992|466040560|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
129478150|NCT01707992|466040561|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
129478151|NCT01707992|466040562|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
129478152|NCT01707992|466040563|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
129478153|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
129478154|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
129478155|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
129478156|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
129478157|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
129478158|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
129478159|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
129478160|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
129478161|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
129478162|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
129478163|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
129478164|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
129478165|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
129478166|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
129478167|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
129478168|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
129478169|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
129478170|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
129478171|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
129478172|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
129478173|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
129478174|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
129478175|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
129478176|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
129478177|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
129478178|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
129478179|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
129478180|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
129478181|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
129478182|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
129478183|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Death|0|||
129478184|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Death|0|||
129478185|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Death|0|||
129478186|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Death|2|||
129478187|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Death|0|||
129478188|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Death|0|||
129478189|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
129976529|NCT00895895|467877768|FG000|Period 2|investigator request|2|||
129976530|NCT00895895|467877769|FG001|Period 2|investigator request|0|||
129976531|NCT00895895|467877770|FG002|Period 2|investigator request|0|||
129976532|NCT00895895|467877771|FG003|Period 2|investigator request|0|||
129976533|NCT00895895|467877772|FG004|Period 2|investigator request|0|||
129976534|NCT00895895|467877768|FG000|Period 2|Lost to Follow-up|1|||
129976535|NCT00895895|467877769|FG001|Period 2|Lost to Follow-up|2|||
129976536|NCT00895895|467877770|FG002|Period 2|Lost to Follow-up|1|||
129976537|NCT00895895|467877771|FG003|Period 2|Lost to Follow-up|1|||
129976538|NCT00895895|467877772|FG004|Period 2|Lost to Follow-up|0|||
129976539|NCT00895895|467877768|FG000|Period 2|Other|1|||
129976540|NCT00895895|467877769|FG001|Period 2|Other|1|||
129976541|NCT00895895|467877770|FG002|Period 2|Other|3|||
129976542|NCT00895895|467877771|FG003|Period 2|Other|1|||
129976543|NCT00895895|467877772|FG004|Period 2|Other|1|||
129976544|NCT00895895|467877768|FG000|Period 2|Protocol Violation|1|||
129976545|NCT00895895|467877769|FG001|Period 2|Protocol Violation|0|||
129478190|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
129478191|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
129478192|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
129478193|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
129478194|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
129478195|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
129478196|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
129478197|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
129478198|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
129478199|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
129478200|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
129478201|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
129478202|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
129478203|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
129478204|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
129478205|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
129478206|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
129478207|NCT01707992|466040558|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
129478208|NCT01707992|466040559|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
129478209|NCT01707992|466040560|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
129478210|NCT01707992|466040561|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
129478211|NCT01707992|466040562|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
129478212|NCT01707992|466040563|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
129478213|NCT02654002|466040567|FG000|Overall Study|Adverse Event|0|||
129478214|NCT02654002|466040568|FG001|Overall Study|Adverse Event|0|||
129478215|NCT02654002|466040569|FG002|Overall Study|Adverse Event|0|||
129478216|NCT02654002|466040570|FG003|Overall Study|Adverse Event|0|||
129478217|NCT02654002|466040571|FG004|Overall Study|Adverse Event|0|||
129478218|NCT02654002|466040572|FG005|Overall Study|Adverse Event|0|||
129478219|NCT02654002|466040573|FG006|Overall Study|Adverse Event|1|||
129478220|NCT02654002|466040574|FG007|Overall Study|Adverse Event|0|||
129478221|NCT02654002|466040575|FG008|Overall Study|Adverse Event|0|||
129478222|NCT02654002|466040567|FG000|Overall Study|Withdrew Consent|0|||
129478223|NCT02654002|466040568|FG001|Overall Study|Withdrew Consent|0|||
129478224|NCT02654002|466040569|FG002|Overall Study|Withdrew Consent|0|||
129478225|NCT02654002|466040570|FG003|Overall Study|Withdrew Consent|0|||
129478226|NCT02654002|466040571|FG004|Overall Study|Withdrew Consent|0|||
129478227|NCT02654002|466040572|FG005|Overall Study|Withdrew Consent|1|||
129478228|NCT02654002|466040573|FG006|Overall Study|Withdrew Consent|0|||
129478229|NCT02654002|466040574|FG007|Overall Study|Withdrew Consent|1|||
129478230|NCT02654002|466040575|FG008|Overall Study|Withdrew Consent|0|||
129478231|NCT01523873|466040576|FG000|Overall Study|Protocol Violation|422|||
129478232|NCT03313050|466040578|FG000|Stage 2: 12 Months|Adverse Event|0|||
129478233|NCT03313050|466040579|FG001|Stage 2: 12 Months|Adverse Event|0|||
129478234|NCT03313050|466040580|FG002|Stage 2: 12 Months|Adverse Event|0|||
129478235|NCT03313050|466040581|FG003|Stage 2: 12 Months|Adverse Event|1|||
129478236|NCT03313050|466040578|FG000|Stage 2: 12 Months|Death|0|||
129478237|NCT03313050|466040579|FG001|Stage 2: 12 Months|Death|0|||
129478238|NCT03313050|466040580|FG002|Stage 2: 12 Months|Death|3|||
129478239|NCT03313050|466040581|FG003|Stage 2: 12 Months|Death|0|||
129478240|NCT03313050|466040578|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
129478241|NCT03313050|466040579|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
129478242|NCT03313050|466040580|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
129478243|NCT03313050|466040581|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
129478244|NCT03313050|466040578|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
129478245|NCT03313050|466040579|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
129478246|NCT03313050|466040580|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
129478247|NCT03313050|466040581|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
129478248|NCT03313050|466040578|FG000|Stage 2: 12 Months|Protocol deviation|0|||
129478249|NCT03313050|466040579|FG001|Stage 2: 12 Months|Protocol deviation|0|||
129478250|NCT03313050|466040580|FG002|Stage 2: 12 Months|Protocol deviation|7|||
129478251|NCT03313050|466040581|FG003|Stage 2: 12 Months|Protocol deviation|7|||
129478252|NCT03313050|466040578|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
129478253|NCT03313050|466040579|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
129478254|NCT03313050|466040580|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
129478255|NCT03313050|466040581|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
129478256|NCT03313050|466040578|FG000|Stage 2: 12 Months|Other|0|||
129478257|NCT03313050|466040579|FG001|Stage 2: 12 Months|Other|0|||
129478258|NCT03313050|466040580|FG002|Stage 2: 12 Months|Other|0|||
129478259|NCT03313050|466040581|FG003|Stage 2: 12 Months|Other|1|||
129478260|NCT04211337|466040582|FG000|Overall Study|On Treatment|175|||
129478261|NCT04211337|466040583|FG001|Overall Study|On Treatment|40|||
129976546|NCT00895895|467877770|FG002|Period 2|Protocol Violation|1|||
129478262|NCT04211337|466040582|FG000|Overall Study|Withdrawal by Subject|0|||
129478263|NCT04211337|466040583|FG001|Overall Study|Withdrawal by Subject|2|||
129478264|NCT02847598|466040594|FG000|Overall Study|Adverse Event|0|||
129478265|NCT02847598|466040595|FG001|Overall Study|Adverse Event|0|||
129478266|NCT02847598|466040596|FG002|Overall Study|Adverse Event|0|||
129478267|NCT02847598|466040597|FG003|Overall Study|Adverse Event|0|||
129478268|NCT02847598|466040598|FG004|Overall Study|Adverse Event|0|||
129478269|NCT02847598|466040599|FG005|Overall Study|Adverse Event|0|||
129478270|NCT02847598|466040600|FG006|Overall Study|Adverse Event|0|||
129478271|NCT02847598|466040601|FG007|Overall Study|Adverse Event|1|||
129478272|NCT02847598|466040594|FG000|Overall Study|Consent withdrawn|2|||
129478273|NCT02847598|466040595|FG001|Overall Study|Consent withdrawn|0|||
129478274|NCT02847598|466040596|FG002|Overall Study|Consent withdrawn|0|||
129478275|NCT02847598|466040597|FG003|Overall Study|Consent withdrawn|4|||
129478276|NCT02847598|466040598|FG004|Overall Study|Consent withdrawn|3|||
129478277|NCT02847598|466040599|FG005|Overall Study|Consent withdrawn|2|||
129478278|NCT02847598|466040600|FG006|Overall Study|Consent withdrawn|1|||
129478279|NCT02847598|466040601|FG007|Overall Study|Consent withdrawn|3|||
129478280|NCT02847598|466040594|FG000|Overall Study|Death|3|||
129478281|NCT02847598|466040595|FG001|Overall Study|Death|0|||
129478282|NCT02847598|466040596|FG002|Overall Study|Death|0|||
129478283|NCT02847598|466040597|FG003|Overall Study|Death|0|||
129478284|NCT02847598|466040598|FG004|Overall Study|Death|0|||
129478285|NCT02847598|466040599|FG005|Overall Study|Death|0|||
129478286|NCT02847598|466040600|FG006|Overall Study|Death|0|||
129478287|NCT02847598|466040601|FG007|Overall Study|Death|0|||
129478288|NCT02847598|466040594|FG000|Overall Study|Lost to Follow-up|0|||
129478289|NCT02847598|466040595|FG001|Overall Study|Lost to Follow-up|0|||
129478290|NCT02847598|466040596|FG002|Overall Study|Lost to Follow-up|0|||
129478291|NCT02847598|466040597|FG003|Overall Study|Lost to Follow-up|0|||
129478292|NCT02847598|466040598|FG004|Overall Study|Lost to Follow-up|0|||
129478293|NCT02847598|466040599|FG005|Overall Study|Lost to Follow-up|1|||
129478294|NCT02847598|466040600|FG006|Overall Study|Lost to Follow-up|1|||
129478295|NCT02847598|466040601|FG007|Overall Study|Lost to Follow-up|0|||
129478296|NCT02848833|466040602|FG000|Overall Study|subject who are duplicated|1|||
129478297|NCT02848833|466040602|FG000|Overall Study|have not taken the study drug|11|||
129478298|NCT02848833|466040602|FG000|Overall Study|follow-up failure|6|||
129478299|NCT02848833|466040602|FG000|Overall Study|Protocol Violation|119|||
129478300|NCT04167345|466040603|FG000|Overall Study|Other|1|||
129478301|NCT04167345|466040604|FG001|Overall Study|Other|1|||
129478302|NCT04167345|466040605|FG002|Overall Study|Other|0|||
129478303|NCT04167345|466040606|FG003|Overall Study|Other|0|||
129478304|NCT04167345|466040607|FG004|Overall Study|Other|0|||
129478305|NCT06119191|466040610|FG000|Overall Study|Adverse Event|0|||
129478306|NCT06119191|466040611|FG001|Overall Study|Adverse Event|1|||
129478307|NCT06119191|466040610|FG000|Overall Study|Protocol Violation|1|||
129478308|NCT06119191|466040611|FG001|Overall Study|Protocol Violation|0|||
129478309|NCT03896581|466042844|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
129478310|NCT03896581|466042845|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
129478311|NCT03896581|466042844|FG000|Overall Study|Withdrawal by Subject|4|||
129478312|NCT03896581|466042845|FG001|Overall Study|Withdrawal by Subject|1|||
129478313|NCT03896581|466042844|FG000|Overall Study|Lost to Follow-up|1|||
129478314|NCT03896581|466042845|FG001|Overall Study|Lost to Follow-up|0|||
129478315|NCT03896581|466042844|FG000|Overall Study|Lack of Efficacy|2|||
129478316|NCT03896581|466042845|FG001|Overall Study|Lack of Efficacy|1|||
129478317|NCT03896581|466042844|FG000|Overall Study|Adverse event, non-fatal|0|||
129478318|NCT03896581|466042845|FG001|Overall Study|Adverse event, non-fatal|2|||
129478319|NCT00960076|466042857|FG000|Overall Study|Adverse Event|1|||
129478320|NCT00960076|466042858|FG001|Overall Study|Adverse Event|7|||
129478321|NCT00960076|466042857|FG000|Overall Study|No longer met study criteria|1|||
129478322|NCT00960076|466042858|FG001|Overall Study|No longer met study criteria|5|||
129478323|NCT00960076|466042857|FG000|Overall Study|Withdrawal by Subject|1|||
129478324|NCT00960076|466042858|FG001|Overall Study|Withdrawal by Subject|2|||
129478325|NCT00960076|466042857|FG000|Overall Study|Lost to Follow-up|3|||
129478326|NCT00960076|466042858|FG001|Overall Study|Lost to Follow-up|3|||
129478327|NCT00960076|466042857|FG000|Overall Study|Severe non-compliance to protocol|1|||
129478328|NCT00960076|466042858|FG001|Overall Study|Severe non-compliance to protocol|2|||
129478329|NCT00960076|466042857|FG000|Overall Study|Hyperglycemia|1|||
129478330|NCT00960076|466042858|FG001|Overall Study|Hyperglycemia|5|||
129478331|NCT00960076|466042857|FG000|Overall Study|Did not attend the termination visit|0|||
129478332|NCT00960076|466042858|FG001|Overall Study|Did not attend the termination visit|1|||
129478333|NCT00500266|466042859|FG000|Overall Study|Death|3|||
129478334|NCT00500266|466042859|FG000|Overall Study|Lost to Follow-up|3|||
129478335|NCT00500266|466042859|FG000|Overall Study|Withdrawal by Subject|3|||
129478336|NCT00500266|466042859|FG000|Overall Study|Assigned, not treated|4|||
129478337|NCT01431287|466042860|FG000|Overall Study|not treated|0|||
129478338|NCT01431287|466042861|FG001|Overall Study|not treated|0|||
129478339|NCT01431287|466042862|FG002|Overall Study|not treated|1|||
129478340|NCT01431287|466042863|FG003|Overall Study|not treated|0|||
129478341|NCT01431287|466042864|FG004|Overall Study|not treated|0|||
129478342|NCT01431287|466042860|FG000|Overall Study|Adverse Event|59|||
129478343|NCT01431287|466042861|FG001|Overall Study|Adverse Event|57|||
129478344|NCT01431287|466042862|FG002|Overall Study|Adverse Event|53|||
129478345|NCT01431287|466042863|FG003|Overall Study|Adverse Event|33|||
129478346|NCT01431287|466042864|FG004|Overall Study|Adverse Event|41|||
129478347|NCT01431287|466042860|FG000|Overall Study|Non compliant with protocol|6|||
129478348|NCT01431287|466042861|FG001|Overall Study|Non compliant with protocol|6|||
129478349|NCT01431287|466042862|FG002|Overall Study|Non compliant with protocol|5|||
129478350|NCT01431287|466042863|FG003|Overall Study|Non compliant with protocol|6|||
129478351|NCT01431287|466042864|FG004|Overall Study|Non compliant with protocol|5|||
129478352|NCT01431287|466042860|FG000|Overall Study|Lost to Follow-up|0|||
129478353|NCT01431287|466042861|FG001|Overall Study|Lost to Follow-up|3|||
129478354|NCT01431287|466042862|FG002|Overall Study|Lost to Follow-up|2|||
129478355|NCT01431287|466042863|FG003|Overall Study|Lost to Follow-up|3|||
129478356|NCT01431287|466042864|FG004|Overall Study|Lost to Follow-up|1|||
129478357|NCT01431287|466042860|FG000|Overall Study|Consent withdrawn not due to AE|29|||
129478358|NCT01431287|466042861|FG001|Overall Study|Consent withdrawn not due to AE|30|||
129478359|NCT01431287|466042862|FG002|Overall Study|Consent withdrawn not due to AE|34|||
129478360|NCT01431287|466042863|FG003|Overall Study|Consent withdrawn not due to AE|19|||
129478361|NCT01431287|466042864|FG004|Overall Study|Consent withdrawn not due to AE|29|||
129478362|NCT01431287|466042860|FG000|Overall Study|not stated above|4|||
129478363|NCT01431287|466042861|FG001|Overall Study|not stated above|2|||
129478364|NCT01431287|466042862|FG002|Overall Study|not stated above|2|||
129478365|NCT01431287|466042863|FG003|Overall Study|not stated above|2|||
129478366|NCT01431287|466042864|FG004|Overall Study|not stated above|1|||
129478367|NCT02224664|466042865|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
129478368|NCT02224664|466042866|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
129478369|NCT02224664|466042867|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
129478370|NCT02224664|466042868|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
129478371|NCT02224664|466042869|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
129478372|NCT02224664|466042865|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
129478373|NCT02224664|466042866|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
129478374|NCT02224664|466042867|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
129478375|NCT02224664|466042868|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
129478376|NCT02224664|466042869|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
129478377|NCT02224664|466042865|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
129478378|NCT02224664|466042866|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
129478379|NCT02224664|466042867|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
129478380|NCT02224664|466042868|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
129478381|NCT02224664|466042869|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
129478382|NCT03263806|466042872|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
129478383|NCT03263806|466042873|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
129478384|NCT03263806|466042872|FG000|Overall Study|Withdrawal by Subject|0|||
129478385|NCT03263806|466042873|FG001|Overall Study|Withdrawal by Subject|1|||
129478386|NCT03263806|466042872|FG000|Overall Study|Study Termination|5|||
129478387|NCT03263806|466042873|FG001|Overall Study|Study Termination|6|||
129478388|NCT01412879|466042876|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
129478389|NCT01412879|466042877|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
129478390|NCT01412879|466042878|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
129478391|NCT01412879|466042876|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
129478392|NCT01412879|466042877|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
129976547|NCT00895895|467877771|FG003|Period 2|Protocol Violation|1|||
129976548|NCT00895895|467877772|FG004|Period 2|Protocol Violation|1|||
129478393|NCT01412879|466042878|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
129478394|NCT01412879|466042876|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
129478395|NCT01412879|466042877|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
129478396|NCT01412879|466042878|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
129478397|NCT01412879|466042876|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
129478398|NCT01412879|466042877|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
129478399|NCT01412879|466042878|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
129478400|NCT01412879|466042876|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
129478401|NCT01412879|466042877|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
129478402|NCT01412879|466042878|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
129478403|NCT02109029|466042879|FG000|Part B|Adverse Event|0|||
129478404|NCT02109029|466042880|FG001|Part B|Adverse Event|0|||
129478405|NCT02109029|466042881|FG002|Part B|Adverse Event|0|||
129478406|NCT02109029|466042882|FG003|Part B|Adverse Event|0|||
129478407|NCT02109029|466042883|FG004|Part B|Adverse Event|1|||
129478408|NCT02109029|466042884|FG005|Part B|Adverse Event|1|||
129478409|NCT01445171|466042891|FG000|Overall Study|Lost to Follow-up|11|||
129976549|NCT00895895|467877768|FG000|Period 2|Withdrawal by Subject|0|||
129976550|NCT00895895|467877769|FG001|Period 2|Withdrawal by Subject|2|||
129478410|NCT01445171|466042891|FG000|Overall Study|Withdrawal by Subject|16|||
129478411|NCT01445171|466042891|FG000|Overall Study|Death|51|||
129478412|NCT01445171|466042891|FG000|Overall Study|Subjects declined to return for followup|9|||
129478413|NCT01445171|466042891|FG000|Overall Study|Consented but did not receive device|8|||
129478414|NCT03195894|466042892|FG000|Overall Study|"An example is Started other treatment."|4|||
129478415|NCT03195894|466042893|FG001|Overall Study|"An example is Started other treatment."|5|||
129478416|NCT03195894|466042892|FG000|Overall Study|Withdrawal by Subject|15|||
129478417|NCT03195894|466042893|FG001|Overall Study|Withdrawal by Subject|4|||
129478418|NCT03195894|466042892|FG000|Overall Study|Lost to Follow-up|14|||
129478419|NCT03195894|466042893|FG001|Overall Study|Lost to Follow-up|19|||
129478420|NCT00162773|466042897|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
129478421|NCT00110305|466042898|FG000|Overall Study|Adverse Event|46|||
129478422|NCT00110305|466042899|FG001|Overall Study|Adverse Event|13|||
129478423|NCT00110305|466042898|FG000|Overall Study|Sponsors Decision|1|||
129478424|NCT00110305|466042899|FG001|Overall Study|Sponsors Decision|0|||
129478425|NCT00110305|466042898|FG000|Overall Study|Subject Non-Compliant|9|||
129478426|NCT00110305|466042899|FG001|Overall Study|Subject Non-Compliant|2|||
129478427|NCT00110305|466042898|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
129478428|NCT00110305|466042899|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
129478429|NCT00110305|466042898|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
129478430|NCT00110305|466042899|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
129478431|NCT00110305|466042898|FG000|Overall Study|Protocol Violation|0|||
129478432|NCT00110305|466042899|FG001|Overall Study|Protocol Violation|1|||
129478433|NCT00110305|466042898|FG000|Overall Study|Withdrawal by Subject|7|||
129478434|NCT00110305|466042899|FG001|Overall Study|Withdrawal by Subject|7|||
129478435|NCT00110305|466042898|FG000|Overall Study|Lost to Follow-up|20|||
129478436|NCT00110305|466042899|FG001|Overall Study|Lost to Follow-up|3|||
129478437|NCT00110305|466042898|FG000|Overall Study|Other|8|||
129478438|NCT00110305|466042899|FG001|Overall Study|Other|2|||
129478439|NCT01887912|466042902|FG000|Overall Study|Serious adverse event|400|||
129478440|NCT01887912|466042903|FG001|Overall Study|Serious adverse event|198|||
129478441|NCT01887912|466042902|FG000|Overall Study|Other Adverse Event|34|||
129478442|NCT01887912|466042903|FG001|Overall Study|Other Adverse Event|15|||
129478443|NCT01887912|466042902|FG000|Overall Study|Protocol Violation|67|||
129478444|NCT01887912|466042903|FG001|Overall Study|Protocol Violation|37|||
129478445|NCT01887912|466042902|FG000|Overall Study|Lost to Follow-up|163|||
129478446|NCT01887912|466042903|FG001|Overall Study|Lost to Follow-up|74|||
129478447|NCT01887912|466042902|FG000|Overall Study|Withdrawal by Subject|606|||
129478448|NCT01887912|466042903|FG001|Overall Study|Withdrawal by Subject|349|||
129478449|NCT01887912|466042902|FG000|Overall Study|Other|122|||
129478450|NCT01887912|466042903|FG001|Overall Study|Other|58|||
129478451|NCT01154101|466042906|FG000|Overall Study|Adverse Event|0|||
129478452|NCT01154101|466042907|FG001|Overall Study|Adverse Event|2|||
129478453|NCT01154101|466042908|FG002|Overall Study|Adverse Event|1|||
129478454|NCT01154101|466042909|FG003|Overall Study|Adverse Event|1|||
129478455|NCT01154101|466042910|FG004|Overall Study|Adverse Event|0|||
129478456|NCT01154101|466042906|FG000|Overall Study|Lost to Follow-up|0|||
129478457|NCT01154101|466042907|FG001|Overall Study|Lost to Follow-up|1|||
129478458|NCT01154101|466042908|FG002|Overall Study|Lost to Follow-up|0|||
129478459|NCT01154101|466042909|FG003|Overall Study|Lost to Follow-up|1|||
129478460|NCT01154101|466042910|FG004|Overall Study|Lost to Follow-up|0|||
129478461|NCT01154101|466042906|FG000|Overall Study|Withdrawal by Subject|0|||
129478462|NCT01154101|466042907|FG001|Overall Study|Withdrawal by Subject|1|||
129478463|NCT01154101|466042908|FG002|Overall Study|Withdrawal by Subject|2|||
129478464|NCT01154101|466042909|FG003|Overall Study|Withdrawal by Subject|0|||
129478465|NCT01154101|466042910|FG004|Overall Study|Withdrawal by Subject|1|||
129478466|NCT04125680|466042912|FG000|Overall Study|Lost to Follow-up|15|||
129478467|NCT01562028|466042913|FG000|Overall Study|Withdrawal by Subject|1|||
129478468|NCT01562028|466042914|FG001|Overall Study|Withdrawal by Subject|1|||
129976551|NCT00895895|467877770|FG002|Period 2|Withdrawal by Subject|0|||
129976552|NCT00895895|467877771|FG003|Period 2|Withdrawal by Subject|3|||
129976553|NCT00895895|467877772|FG004|Period 2|Withdrawal by Subject|5|||
129478469|NCT01562028|466042913|FG000|Overall Study|Lost to Follow-up|2|||
129478470|NCT01562028|466042914|FG001|Overall Study|Lost to Follow-up|1|||
129478471|NCT02360098|466042915|FG000|Overall Study|Physician Decision|7|||
129478472|NCT03619213|466042916|FG000|Overall Study|Lost to Follow-up|2|||
129478473|NCT03619213|466042917|FG001|Overall Study|Lost to Follow-up|1|||
129478474|NCT03619213|466042916|FG000|Overall Study|Withdrawal by Subject|8|||
129478475|NCT03619213|466042917|FG001|Overall Study|Withdrawal by Subject|10|||
129976554|NCT00895895|467877768|FG000|Period 2|unsatisfactory response-efficacy|2|||
129478476|NCT02542267|466042918|FG000|Overall Study|Withdrawal by Subject|10|||
129478477|NCT02542267|466042918|FG000|Overall Study|Physician Decision|6|||
129478478|NCT02542267|466042918|FG000|Overall Study|Lost to Follow-up|4|||
129478479|NCT02542267|466042918|FG000|Overall Study|Death|13|||
129478480|NCT02542267|466042918|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
129478481|NCT02542267|466042918|FG000|Overall Study|Other|9|||
129478482|NCT01974323|466042921|FG000|Overall Study|Other Reasons|25|||
129478483|NCT01974323|466042922|FG001|Overall Study|Other Reasons|28|||
129478484|NCT01974323|466042921|FG000|Overall Study|Protocol Violation|2|||
129478485|NCT01974323|466042922|FG001|Overall Study|Protocol Violation|2|||
129478486|NCT01974323|466042921|FG000|Overall Study|Personal Reasons|15|||
129478487|NCT01974323|466042922|FG001|Overall Study|Personal Reasons|19|||
129478488|NCT01974323|466042921|FG000|Overall Study|Lost to Follow-up|45|||
129478489|NCT01974323|466042922|FG001|Overall Study|Lost to Follow-up|40|||
129478490|NCT01974323|466042921|FG000|Overall Study|Pregnancy|2|||
129478491|NCT01974323|466042922|FG001|Overall Study|Pregnancy|1|||
129478492|NCT01974323|466042921|FG000|Overall Study|Lack of Efficacy|1|||
129478493|NCT01974323|466042922|FG001|Overall Study|Lack of Efficacy|1|||
129478494|NCT01974323|466042921|FG000|Overall Study|Adverse Event|2|||
129478495|NCT01974323|466042922|FG001|Overall Study|Adverse Event|2|||
129478496|NCT00331760|466042923|FG000|Overall Study|Ineligible / no protocol treatment|15|||
129478497|NCT00331760|466042924|FG001|Overall Study|Ineligible / no protocol treatment|8|||
129478498|NCT00461175|466042925|FG000|Overall Study|Protocol Violation|522|||
129478499|NCT00461175|466042926|FG001|Overall Study|Protocol Violation|365|||
129478500|NCT00619229|466042927|FG000|Overall Study|Withdrawal by Subject|1|||
129478501|NCT00619229|466042928|FG001|Overall Study|Withdrawal by Subject|1|||
129478502|NCT00619229|466042927|FG000|Overall Study|Lost to Follow-up|1|||
129478503|NCT00619229|466042928|FG001|Overall Study|Lost to Follow-up|0|||
129478504|NCT00619229|466042927|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
129478505|NCT00619229|466042928|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
129478506|NCT00619229|466042927|FG000|Overall Study|Investigator planned Cataract Operation|1|||
129478507|NCT00619229|466042928|FG001|Overall Study|Investigator planned Cataract Operation|0|||
129478508|NCT02786901|466042929|FG000|Overall Study|Adverse Event|1|||
129478509|NCT02786901|466042930|FG001|Overall Study|Adverse Event|1|||
129478510|NCT02786901|466042931|FG002|Overall Study|Adverse Event|2|||
129478511|NCT02786901|466042929|FG000|Overall Study|Physician Decision|1|||
129478512|NCT02786901|466042930|FG001|Overall Study|Physician Decision|0|||
129478513|NCT02786901|466042931|FG002|Overall Study|Physician Decision|0|||
129478514|NCT02786901|466042929|FG000|Overall Study|Rescue Therapy Use|71|||
129478515|NCT02786901|466042930|FG001|Overall Study|Rescue Therapy Use|49|||
129478516|NCT02786901|466042931|FG002|Overall Study|Rescue Therapy Use|33|||
129478517|NCT02786901|466042929|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
129478518|NCT02786901|466042930|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
129478519|NCT02786901|466042931|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
129478520|NCT02786901|466042929|FG000|Overall Study|Disallowed medication|1|||
129478521|NCT02786901|466042930|FG001|Overall Study|Disallowed medication|1|||
129478522|NCT02786901|466042931|FG002|Overall Study|Disallowed medication|0|||
129478523|NCT02786901|466042929|FG000|Overall Study|Randomized in error|2|||
129478524|NCT02786901|466042930|FG001|Overall Study|Randomized in error|0|||
129478525|NCT02786901|466042931|FG002|Overall Study|Randomized in error|1|||
129478526|NCT01075178|466042932|FG000|Subject Matching|eligible but not matched|130|||
129478527|NCT01075178|466042933|FG001|Subject Matching|eligible but not matched|403|||
129478528|NCT01075178|466042932|FG000|Subject Chart Review|died before chart review period|0|||
129478529|NCT01075178|466042933|FG001|Subject Chart Review|died before chart review period|2|||
129478530|NCT01075178|466042932|FG000|Subject Chart Review|no data collected due to site closure|3|||
129478531|NCT01075178|466042933|FG001|Subject Chart Review|no data collected due to site closure|4|||
129478532|NCT01075178|466042932|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
129478533|NCT01075178|466042933|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
129478534|NCT03367871|466042934|FG000|Overall Study|Lost to Follow-up|1|||
129478535|NCT02983604|466042935|FG000|Overall Study|Enrolled but not Treated|0|||
129478536|NCT02983604|466042936|FG001|Overall Study|Enrolled but not Treated|0|||
129478537|NCT02983604|466042937|FG002|Overall Study|Enrolled but not Treated|1|||
129478538|NCT02983604|466042938|FG003|Overall Study|Enrolled but not Treated|0|||
129478539|NCT01111604|466042939|FG000|Overall Study|Lost to Follow-up|0|||
129478540|NCT01111604|466042940|FG001|Overall Study|Lost to Follow-up|0|||
129478541|NCT01111604|466042941|FG002|Overall Study|Lost to Follow-up|1|||
129478542|NCT01111604|466042939|FG000|Overall Study|Withdrew Consent|3|||
129478543|NCT01111604|466042940|FG001|Overall Study|Withdrew Consent|0|||
129478544|NCT01111604|466042941|FG002|Overall Study|Withdrew Consent|2|||
129478545|NCT01111604|466042939|FG000|Overall Study|Withdrawal by Subject|2|||
129478546|NCT01111604|466042940|FG001|Overall Study|Withdrawal by Subject|0|||
129478547|NCT01111604|466042941|FG002|Overall Study|Withdrawal by Subject|0|||
129478548|NCT01111604|466042939|FG000|Overall Study|Death|1|||
129478549|NCT01111604|466042940|FG001|Overall Study|Death|0|||
129478550|NCT01111604|466042941|FG002|Overall Study|Death|0|||
129976555|NCT00895895|467877769|FG001|Period 2|unsatisfactory response-efficacy|1|||
129478551|NCT01111604|466042939|FG000|Overall Study|Met Exclusion Criteria|2|||
129478552|NCT01111604|466042940|FG001|Overall Study|Met Exclusion Criteria|0|||
129478553|NCT01111604|466042941|FG002|Overall Study|Met Exclusion Criteria|0|||
129478554|NCT00316264|466042943|FG000|Overall Study|Lost to Follow-up|0|||
129478555|NCT00316264|466042944|FG001|Overall Study|Lost to Follow-up|1|||
129478556|NCT00316264|466042945|FG002|Overall Study|Lost to Follow-up|0|||
129478557|NCT00316264|466042943|FG000|Overall Study|Withdrawal of Consent|3|||
129478558|NCT00316264|466042944|FG001|Overall Study|Withdrawal of Consent|5|||
129478559|NCT00316264|466042945|FG002|Overall Study|Withdrawal of Consent|6|||
129478560|NCT00316264|466042943|FG000|Overall Study|Death|2|||
129478561|NCT00316264|466042944|FG001|Overall Study|Death|0|||
129478562|NCT00316264|466042945|FG002|Overall Study|Death|0|||
129478563|NCT00316264|466042943|FG000|Overall Study|Other|1|||
129478564|NCT00316264|466042944|FG001|Overall Study|Other|1|||
129478565|NCT00316264|466042945|FG002|Overall Study|Other|0|||
129478566|NCT00607048|466042946|FG000|Overall Study|Adverse Event|0|||
129478567|NCT00607048|466042947|FG001|Overall Study|Adverse Event|1|||
129478568|NCT00607048|466042948|FG002|Overall Study|Adverse Event|0|||
129478569|NCT00607048|466042949|FG003|Overall Study|Adverse Event|0|||
129478570|NCT00607048|466042950|FG004|Overall Study|Adverse Event|4|||
129478571|NCT00607048|466042951|FG005|Overall Study|Adverse Event|0|||
129478572|NCT00607048|466042946|FG000|Overall Study|Global deterioration of health|1|||
129478573|NCT00607048|466042947|FG001|Overall Study|Global deterioration of health|0|||
129478574|NCT00607048|466042948|FG002|Overall Study|Global deterioration of health|0|||
129478575|NCT00607048|466042949|FG003|Overall Study|Global deterioration of health|0|||
129478576|NCT00607048|466042950|FG004|Overall Study|Global deterioration of health|0|||
129478577|NCT00607048|466042951|FG005|Overall Study|Global deterioration of health|0|||
129478578|NCT00607048|466042946|FG000|Overall Study|Objective disease progression - relapse|1|||
129478579|NCT00607048|466042947|FG001|Overall Study|Objective disease progression - relapse|2|||
129478580|NCT00607048|466042948|FG002|Overall Study|Objective disease progression - relapse|4|||
129478581|NCT00607048|466042949|FG003|Overall Study|Objective disease progression - relapse|2|||
129478582|NCT00607048|466042950|FG004|Overall Study|Objective disease progression - relapse|2|||
129478583|NCT00607048|466042951|FG005|Overall Study|Objective disease progression - relapse|2|||
129478584|NCT00607048|466042946|FG000|Overall Study|Withdrawal by Subject|0|||
129478585|NCT00607048|466042947|FG001|Overall Study|Withdrawal by Subject|0|||
129478586|NCT00607048|466042948|FG002|Overall Study|Withdrawal by Subject|0|||
129478587|NCT00607048|466042949|FG003|Overall Study|Withdrawal by Subject|1|||
129478588|NCT00607048|466042950|FG004|Overall Study|Withdrawal by Subject|0|||
129478589|NCT00607048|466042951|FG005|Overall Study|Withdrawal by Subject|2|||
129478590|NCT00607048|466042946|FG000|Overall Study|Other|1|||
129478591|NCT00607048|466042947|FG001|Overall Study|Other|1|||
129478592|NCT00607048|466042948|FG002|Overall Study|Other|0|||
129478593|NCT00607048|466042949|FG003|Overall Study|Other|0|||
129478594|NCT00607048|466042950|FG004|Overall Study|Other|0|||
129478595|NCT00607048|466042951|FG005|Overall Study|Other|1|||
129478596|NCT00355264|466042952|FG000|Extension (Variable Duration)|Adverse Event|1|||
129478597|NCT00355264|466042952|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
129478598|NCT01157117|466042953|FG000|Overall Study|Dosing Symptoms|0|||
129478599|NCT01157117|466042954|FG001|Overall Study|Dosing Symptoms|4|||
129478600|NCT01157117|466042955|FG002|Overall Study|Dosing Symptoms|0|||
129478601|NCT01157117|466042953|FG000|Overall Study|Withdrawal by Subject|4|||
129478602|NCT01157117|466042954|FG001|Overall Study|Withdrawal by Subject|1|||
129478603|NCT01157117|466042955|FG002|Overall Study|Withdrawal by Subject|1|||
129478604|NCT01157117|466042953|FG000|Overall Study|Lack of Efficacy|1|||
129478605|NCT01157117|466042954|FG001|Overall Study|Lack of Efficacy|1|||
129478606|NCT01157117|466042955|FG002|Overall Study|Lack of Efficacy|0|||
129478607|NCT01157117|466042953|FG000|Overall Study|Lost to Follow-up|0|||
129478608|NCT01157117|466042954|FG001|Overall Study|Lost to Follow-up|0|||
129478609|NCT01157117|466042955|FG002|Overall Study|Lost to Follow-up|1|||
129478610|NCT01157117|466042953|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
129478611|NCT01157117|466042954|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
129478612|NCT01157117|466042955|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
129478613|NCT00826514|466042956|FG000|Overall Study|Adverse Event|1|||
129478614|NCT00826514|466042957|FG001|Overall Study|Adverse Event|1|||
129478615|NCT00826514|466042956|FG000|Overall Study|Lack of Efficacy|0|||
129478616|NCT00826514|466042957|FG001|Overall Study|Lack of Efficacy|1|||
129478617|NCT00826514|466042956|FG000|Overall Study|Withdrawal by Subject|2|||
129478618|NCT00826514|466042957|FG001|Overall Study|Withdrawal by Subject|3|||
129478619|NCT03663166|466042960|FG000|Overall Study|Withdrawal by Subject|1|||
129478620|NCT03926143|466042962|FG000|Overall Study|Physician Decision|3|||
129478621|NCT03926143|466042962|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
129478622|NCT03926143|466042962|FG000|Overall Study|Adverse Event|2|||
129478623|NCT03926143|466042962|FG000|Overall Study|Progressive disease|3|||
129478624|NCT02207907|466042967|FG000|Overall Study|Lost to Follow-up|3|||
129478625|NCT02207907|466042968|FG001|Overall Study|Lost to Follow-up|1|||
129478626|NCT02207907|466042967|FG000|Overall Study|Withdrawal by Subject|5|||
129478627|NCT02207907|466042968|FG001|Overall Study|Withdrawal by Subject|6|||
129478628|NCT02207907|466042967|FG000|Overall Study|Did not meet study criteria|3|||
129478629|NCT02207907|466042968|FG001|Overall Study|Did not meet study criteria|0|||
129478630|NCT02207907|466042967|FG000|Overall Study|Pregnancy|0|||
129478631|NCT02207907|466042968|FG001|Overall Study|Pregnancy|1|||
129478632|NCT02620020|466042969|FG000|Overall Study|Adverse Event|8|||
129478633|NCT02620020|466042970|FG001|Overall Study|Adverse Event|4|||
129478634|NCT02620020|466042971|FG002|Overall Study|Adverse Event|3|||
129478635|NCT02620020|466042972|FG003|Overall Study|Adverse Event|5|||
129478636|NCT02620020|466042969|FG000|Overall Study|Lost to Follow-up|4|||
129478637|NCT02620020|466042970|FG001|Overall Study|Lost to Follow-up|8|||
129478638|NCT02620020|466042971|FG002|Overall Study|Lost to Follow-up|1|||
129478639|NCT02620020|466042972|FG003|Overall Study|Lost to Follow-up|4|||
129478640|NCT02620020|466042969|FG000|Overall Study|Physician Decision|7|||
129478641|NCT02620020|466042970|FG001|Overall Study|Physician Decision|4|||
129478642|NCT02620020|466042971|FG002|Overall Study|Physician Decision|3|||
129478643|NCT02620020|466042972|FG003|Overall Study|Physician Decision|4|||
129478644|NCT02620020|466042969|FG000|Overall Study|Protocol Violation|5|||
129478645|NCT02620020|466042970|FG001|Overall Study|Protocol Violation|2|||
129478646|NCT02620020|466042971|FG002|Overall Study|Protocol Violation|1|||
129478647|NCT02620020|466042972|FG003|Overall Study|Protocol Violation|1|||
129478648|NCT02620020|466042969|FG000|Overall Study|Withdrawal by Subject|20|||
129478649|NCT02620020|466042970|FG001|Overall Study|Withdrawal by Subject|16|||
129478650|NCT02620020|466042971|FG002|Overall Study|Withdrawal by Subject|17|||
129478651|NCT02620020|466042972|FG003|Overall Study|Withdrawal by Subject|12|||
129478652|NCT02620020|466042969|FG000|Overall Study|Death|0|||
129478653|NCT02620020|466042970|FG001|Overall Study|Death|1|||
129478654|NCT02620020|466042971|FG002|Overall Study|Death|0|||
129478655|NCT02620020|466042972|FG003|Overall Study|Death|0|||
129478656|NCT04348851|466042973|FG000|Post-Test 1|Withdrawal by Subject|0|||
129478657|NCT04348851|466042974|FG001|Post-Test 1|Withdrawal by Subject|1|||
129478658|NCT04348851|466042975|FG002|Post-Test 1|Withdrawal by Subject|0|||
129478659|NCT04348851|466042976|FG003|Post-Test 1|Withdrawal by Subject|0|||
129478660|NCT04348851|466042973|FG000|Post-Test 1|Lost to Follow-up|0|||
129478661|NCT04348851|466042974|FG001|Post-Test 1|Lost to Follow-up|1|||
129478662|NCT04348851|466042975|FG002|Post-Test 1|Lost to Follow-up|0|||
129478663|NCT04348851|466042976|FG003|Post-Test 1|Lost to Follow-up|0|||
129478664|NCT04348851|466042973|FG000|Post-Test 2|Stroke survivor death|0|||
129478665|NCT04348851|466042974|FG001|Post-Test 2|Stroke survivor death|1|||
129478666|NCT04348851|466042975|FG002|Post-Test 2|Stroke survivor death|0|||
129478667|NCT04348851|466042976|FG003|Post-Test 2|Stroke survivor death|1|||
129478668|NCT02965378|466042977|FG000|Overall Study|Progression|16|||
129478669|NCT02965378|466042978|FG001|Overall Study|Progression|4|||
129478670|NCT02965378|466042977|FG000|Overall Study|Adverse Event|5|||
129478671|NCT02965378|466042978|FG001|Overall Study|Adverse Event|2|||
129478672|NCT02965378|466042977|FG000|Overall Study|Death|2|||
129478673|NCT02965378|466042978|FG001|Overall Study|Death|0|||
129478674|NCT02965378|466042977|FG000|Overall Study|Refusal|2|||
129478675|NCT02965378|466042978|FG001|Overall Study|Refusal|1|||
129478676|NCT02965378|466042977|FG000|Overall Study|Not protocol specified|0|||
129478677|NCT02965378|466042978|FG001|Overall Study|Not protocol specified|2|||
129478678|NCT00629083|466042979|FG000|Overall Study|Adverse Event|0|||
129478679|NCT00629083|466042980|FG001|Overall Study|Adverse Event|2|||
129478680|NCT00629083|466042979|FG000|Overall Study|Lack of Efficacy|3|||
129478681|NCT00629083|466042980|FG001|Overall Study|Lack of Efficacy|1|||
129478682|NCT00629083|466042979|FG000|Overall Study|Withdrawal by Subject|10|||
129478683|NCT00629083|466042980|FG001|Overall Study|Withdrawal by Subject|2|||
129478684|NCT00629083|466042979|FG000|Overall Study|Lost to Follow-up|12|||
129478685|NCT00629083|466042980|FG001|Overall Study|Lost to Follow-up|8|||
129478686|NCT00629083|466042979|FG000|Overall Study|Moved out of country/state|2|||
129478687|NCT00629083|466042980|FG001|Overall Study|Moved out of country/state|1|||
129478688|NCT00629083|466042979|FG000|Overall Study|Refused to return for 12 month visit|1|||
129478689|NCT00629083|466042980|FG001|Overall Study|Refused to return for 12 month visit|0|||
129478690|NCT02909153|466042981|FG000|Overall Study|Withdrawal by Subject|0|||
129478691|NCT02909153|466042982|FG001|Overall Study|Withdrawal by Subject|1|||
129478692|NCT02909153|466042983|FG002|Overall Study|Withdrawal by Subject|0|||
129478693|NCT02909153|466042984|FG003|Overall Study|Withdrawal by Subject|0|||
129478694|NCT02909153|466042985|FG004|Overall Study|Withdrawal by Subject|0|||
129478695|NCT01147809|466042986|FG000|Phase I (168 Days)|Adverse Event|0|||
129478696|NCT01147809|466042987|FG001|Phase I (168 Days)|Adverse Event|0|||
129478697|NCT01147809|466042988|FG002|Phase I (168 Days)|Adverse Event|0|||
129976556|NCT00895895|467877770|FG002|Period 2|unsatisfactory response-efficacy|0|||
129478698|NCT01147809|466042989|FG003|Phase I (168 Days)|Adverse Event|1|||
129478699|NCT01147809|466042990|FG004|Phase I (168 Days)|Adverse Event|0|||
129478700|NCT01147809|466042991|FG005|Phase I (168 Days)|Adverse Event|0|||
129478701|NCT01147809|466042986|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
129478702|NCT01147809|466042987|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
129478703|NCT01147809|466042988|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
129478704|NCT01147809|466042989|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
129478705|NCT01147809|466042990|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
129478706|NCT01147809|466042991|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
129478707|NCT01147809|466042986|FG000|Phase I (168 Days)|Physician Decision|0|||
129478708|NCT01147809|466042987|FG001|Phase I (168 Days)|Physician Decision|1|||
129478709|NCT01147809|466042988|FG002|Phase I (168 Days)|Physician Decision|2|||
129478710|NCT01147809|466042989|FG003|Phase I (168 Days)|Physician Decision|0|||
129478711|NCT01147809|466042990|FG004|Phase I (168 Days)|Physician Decision|0|||
129478712|NCT01147809|466042991|FG005|Phase I (168 Days)|Physician Decision|0|||
129478713|NCT01147809|466042986|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
129478714|NCT01147809|466042987|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
129478715|NCT01147809|466042988|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
129478716|NCT01147809|466042989|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
129478717|NCT01147809|466042990|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
129478718|NCT01147809|466042991|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
129478719|NCT01147809|466042986|FG000|Phase II (168 Days)|Adverse Event|0|||
129478720|NCT01147809|466042987|FG001|Phase II (168 Days)|Adverse Event|0|||
129478721|NCT01147809|466042988|FG002|Phase II (168 Days)|Adverse Event|0|||
129478722|NCT01147809|466042989|FG003|Phase II (168 Days)|Adverse Event|0|||
129478723|NCT01147809|466042990|FG004|Phase II (168 Days)|Adverse Event|3|||
129478724|NCT01147809|466042991|FG005|Phase II (168 Days)|Adverse Event|6|||
129478725|NCT01147809|466042986|FG000|Phase II (168 Days)|Protocol Violation|0|||
129478726|NCT01147809|466042987|FG001|Phase II (168 Days)|Protocol Violation|0|||
129478727|NCT01147809|466042988|FG002|Phase II (168 Days)|Protocol Violation|0|||
129478728|NCT01147809|466042989|FG003|Phase II (168 Days)|Protocol Violation|0|||
129478729|NCT01147809|466042990|FG004|Phase II (168 Days)|Protocol Violation|0|||
129478730|NCT01147809|466042991|FG005|Phase II (168 Days)|Protocol Violation|1|||
129478731|NCT01147809|466042986|FG000|Phase II (168 Days)|Physician Decision|0|||
129478732|NCT01147809|466042987|FG001|Phase II (168 Days)|Physician Decision|0|||
129478733|NCT01147809|466042988|FG002|Phase II (168 Days)|Physician Decision|0|||
129478734|NCT01147809|466042989|FG003|Phase II (168 Days)|Physician Decision|0|||
129478735|NCT01147809|466042990|FG004|Phase II (168 Days)|Physician Decision|5|||
129478736|NCT01147809|466042991|FG005|Phase II (168 Days)|Physician Decision|11|||
129478737|NCT01147809|466042986|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
129478738|NCT01147809|466042987|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
129478739|NCT01147809|466042988|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
129478740|NCT01147809|466042989|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
129478741|NCT01147809|466042990|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
129478742|NCT01147809|466042991|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
129478743|NCT01147809|466042986|FG000|Phase II (168 Days)|Ongoing|0|||
129478744|NCT01147809|466042987|FG001|Phase II (168 Days)|Ongoing|0|||
129478745|NCT01147809|466042988|FG002|Phase II (168 Days)|Ongoing|0|||
129478746|NCT01147809|466042989|FG003|Phase II (168 Days)|Ongoing|0|||
129478747|NCT01147809|466042990|FG004|Phase II (168 Days)|Ongoing|1|||
129478748|NCT01147809|466042991|FG005|Phase II (168 Days)|Ongoing|0|||
129478749|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
129478750|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
129478751|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
129478752|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129478753|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129478754|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129478755|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129478756|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129478757|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
129478758|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
129478759|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
129478760|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
129478761|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129478762|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129478763|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129478764|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129478765|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129478766|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
129478767|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
129478768|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
129478769|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
129478770|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129478771|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129478772|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129478773|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129478774|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129478775|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
129478776|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478777|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478778|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
129478779|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478780|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478781|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478782|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129976557|NCT00895895|467877771|FG003|Period 2|unsatisfactory response-efficacy|0|||
129478783|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478784|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
129478785|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
129478786|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
129478787|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
129478788|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129478789|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129478790|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129478791|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129478792|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129478793|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
129478794|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
129478795|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478796|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478797|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129976558|NCT00895895|467877772|FG004|Period 2|unsatisfactory response-efficacy|0|||
129976559|NCT00820170|467877775|FG000|Overall Study|Adverse Event|0|||
129976560|NCT00820170|467877776|FG001|Overall Study|Adverse Event|0|||
129976561|NCT00820170|467877777|FG002|Overall Study|Adverse Event|0|||
129976562|NCT00820170|467877778|FG003|Overall Study|Adverse Event|0|||
129976563|NCT00820170|467877779|FG004|Overall Study|Adverse Event|2|||
129976564|NCT00820170|467877775|FG000|Overall Study|Progressive Disease|0|||
129976565|NCT00820170|467877776|FG001|Overall Study|Progressive Disease|0|||
129976566|NCT00820170|467877777|FG002|Overall Study|Progressive Disease|0|||
129976567|NCT00820170|467877778|FG003|Overall Study|Progressive Disease|0|||
129976568|NCT00820170|467877779|FG004|Overall Study|Progressive Disease|2|||
129976569|NCT03538938|467877780|FG000|Overall Study|Death|0|||
129976570|NCT03538938|467877781|FG001|Overall Study|Death|0|||
129976571|NCT03538938|467877782|FG002|Overall Study|Death|2|||
129976572|NCT03538938|467877783|FG003|Overall Study|Death|0|||
129976573|NCT03538938|467877784|FG004|Overall Study|Death|0|||
129478798|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478799|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478800|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478801|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478802|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
129478803|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
129478804|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
129478805|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478806|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478807|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478808|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478809|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478810|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478811|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
129478812|NCT01307423|466042992|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478813|NCT01307423|466042993|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
129478814|NCT01307423|466042994|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
129478815|NCT01307423|466042995|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478816|NCT01307423|466042996|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478817|NCT01307423|466042997|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478818|NCT01307423|466042998|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478819|NCT01307423|466042999|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478820|NCT01307423|466043000|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
129478821|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
129478822|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
129478823|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
129478824|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
129478825|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
129478826|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
129478827|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
129478828|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
129478829|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
129478830|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
129478831|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
129478832|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
129478833|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
129976574|NCT03538938|467877785|FG005|Overall Study|Death|1|||
129976575|NCT03538938|467877786|FG006|Overall Study|Death|0|||
129478834|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
129478835|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
129478836|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
129478837|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
129478838|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
129478839|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478840|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478841|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478842|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478843|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478844|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
129478845|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478846|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478847|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
129478848|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
129478849|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
129478850|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
129478851|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
129478852|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
129478853|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
129478854|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
129478855|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
129478856|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
129478857|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478858|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478859|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478860|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
129478861|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478862|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478863|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478864|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478865|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
129478866|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
129478867|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
129478868|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
129478869|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
129478870|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
129478871|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
129478872|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
129478873|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
129478874|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
129478875|NCT01307423|466042992|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478876|NCT01307423|466042993|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478877|NCT01307423|466042994|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478878|NCT01307423|466042995|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478879|NCT01307423|466042996|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478880|NCT01307423|466042997|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
129478881|NCT01307423|466042998|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478882|NCT01307423|466042999|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478883|NCT01307423|466043000|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
129478884|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129478885|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
129478886|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
129478887|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129478888|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129478889|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129478890|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
129478891|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
129478892|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
129478893|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129478894|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
129478895|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
129478896|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129478897|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129478898|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129478899|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
129976576|NCT03538938|467877787|FG007|Overall Study|Death|1|||
129478900|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
129478901|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
129478902|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478903|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478904|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
129478905|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478906|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478907|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478908|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478909|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478910|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
129478911|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129478912|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
129478913|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
129478914|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129478915|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129478916|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129478917|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
129478918|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
129478919|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
129478920|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129976577|NCT03538938|467877788|FG008|Overall Study|Death|1|||
129976578|NCT03538938|467877789|FG009|Overall Study|Death|1|||
129976579|NCT03538938|467877790|FG010|Overall Study|Death|0|||
129976580|NCT03538938|467877791|FG011|Overall Study|Death|0|||
129478921|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129478922|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129478923|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129478924|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129478925|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129478926|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
129478927|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129478928|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
129478929|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129478930|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
129478931|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
129478932|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129478933|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129478934|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129478935|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
129478936|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
129478937|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
129478938|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129478939|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
129478940|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
129478941|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129478942|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129478943|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129478944|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
129478945|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
129478946|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
129478947|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478948|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
129478949|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
129478950|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478951|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478952|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478953|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478954|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478955|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
129478956|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129478957|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
129478958|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
129478959|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129478960|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129478961|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129976581|NCT03538938|467877792|FG012|Overall Study|Death|1|||
129976582|NCT03538938|467877793|FG013|Overall Study|Death|1|||
129478962|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
129478963|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
129478964|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
129478965|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129478966|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
129478967|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
129478968|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129478969|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129478970|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129478971|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
129478972|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
129478973|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
129478974|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478975|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129478976|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478977|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478978|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478979|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478980|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478981|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
129478982|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
129478983|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478984|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
129478985|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478986|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478987|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478988|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478989|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478990|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478991|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
129478992|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129478993|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
129478994|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129478995|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129478996|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129478997|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129478998|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129478999|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
129479000|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
129479001|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129479002|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
129479003|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
129479004|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129479005|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129479006|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129479007|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
129479008|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
129479009|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
129479010|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479011|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479012|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
129479013|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479014|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479015|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479016|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479017|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479018|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
129479019|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129479020|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129479021|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129479022|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129976583|NCT03538938|467877794|FG014|Overall Study|Death|0|||
129976584|NCT03538938|467877795|FG015|Overall Study|Death|1|||
129479023|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129479024|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129479025|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129479026|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
129479027|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
129976585|NCT03538938|467877780|FG000|Overall Study|Withdrawal by Subject|4|||
129976586|NCT03538938|467877781|FG001|Overall Study|Withdrawal by Subject|6|||
129479028|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129479029|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
129479030|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
129479031|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129479032|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129479033|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129479034|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129479035|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
129479036|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
129479037|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479038|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
129479039|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
129479040|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479041|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479042|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479043|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479044|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479045|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
129479046|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129479047|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
129479048|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
129479049|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129479050|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129479051|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129479052|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129479053|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
129479054|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
129479055|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479056|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
129479057|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479058|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479059|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479060|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479061|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479062|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479063|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
129479064|NCT01307423|466042992|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129479065|NCT01307423|466042993|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129479066|NCT01307423|466042994|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
129479067|NCT01307423|466042995|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129479068|NCT01307423|466042996|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129479069|NCT01307423|466042997|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129479070|NCT01307423|466042998|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
129479071|NCT01307423|466042999|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
129479072|NCT01307423|466043000|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
129479073|NCT00190775|466043001|FG000|Overall Study|Adverse Event|57|||
129479074|NCT00190775|466043002|FG001|Overall Study|Adverse Event|22|||
129479075|NCT00190775|466043001|FG000|Overall Study|Satisfactory Response|1|||
129479076|NCT00190775|466043002|FG001|Overall Study|Satisfactory Response|0|||
129479077|NCT00190775|466043001|FG000|Overall Study|Lack of Efficacy|28|||
129479078|NCT00190775|466043002|FG001|Overall Study|Lack of Efficacy|32|||
129479079|NCT00190775|466043001|FG000|Overall Study|Lost to Follow-up|31|||
129479080|NCT00190775|466043002|FG001|Overall Study|Lost to Follow-up|23|||
129479081|NCT00190775|466043001|FG000|Overall Study|Participant Moved|0|||
129479082|NCT00190775|466043002|FG001|Overall Study|Participant Moved|1|||
129479083|NCT00190775|466043001|FG000|Overall Study|Withdrawal by Subject|24|||
129479084|NCT00190775|466043002|FG001|Overall Study|Withdrawal by Subject|13|||
129479085|NCT00190775|466043001|FG000|Overall Study|Sponsor Decision|1|||
129479086|NCT00190775|466043002|FG001|Overall Study|Sponsor Decision|0|||
129479087|NCT00190775|466043001|FG000|Overall Study|Physician Decision|3|||
129479088|NCT00190775|466043002|FG001|Overall Study|Physician Decision|0|||
129479089|NCT00190775|466043001|FG000|Overall Study|Noncompliance|3|||
129479090|NCT00190775|466043002|FG001|Overall Study|Noncompliance|5|||
129479091|NCT00190775|466043001|FG000|Overall Study|Protocol Violation|0|||
129479092|NCT00190775|466043002|FG001|Overall Study|Protocol Violation|1|||
129479093|NCT00190775|466043001|FG000|Overall Study|Exclusion Criteria Met|1|||
129479094|NCT00190775|466043002|FG001|Overall Study|Exclusion Criteria Met|3|||
129479095|NCT00519077|466043003|FG000|Overall Study|Death|6|||
129479096|NCT00519077|466043003|FG000|Overall Study|Other|2|||
129479097|NCT01967225|466043004|FG000|Overall Study|Adverse Event|3|||
129479098|NCT01967225|466043005|FG001|Overall Study|Adverse Event|1|||
129479099|NCT01967225|466043004|FG000|Overall Study|Withdrawal by Subject|2|||
129976587|NCT03538938|467877782|FG002|Overall Study|Withdrawal by Subject|5|||
129479100|NCT01967225|466043005|FG001|Overall Study|Withdrawal by Subject|1|||
129479101|NCT01967225|466043004|FG000|Overall Study|Lack of Efficacy|1|||
129479102|NCT01967225|466043005|FG001|Overall Study|Lack of Efficacy|1|||
129479103|NCT01967225|466043004|FG000|Overall Study|Switching to other therapy|2|||
129479104|NCT01967225|466043005|FG001|Overall Study|Switching to other therapy|0|||
129479105|NCT01967225|466043004|FG000|Overall Study|Protocol driven decision point|1|||
129479106|NCT01967225|466043005|FG001|Overall Study|Protocol driven decision point|0|||
129479107|NCT01967225|466043004|FG000|Overall Study|Logistical difficulties|1|||
129479108|NCT01967225|466043005|FG001|Overall Study|Logistical difficulties|0|||
129479109|NCT01967225|466043004|FG000|Overall Study|Protocol Violation|2|||
129479110|NCT01967225|466043005|FG001|Overall Study|Protocol Violation|0|||
129479111|NCT01511445|466043006|FG000|Overall Study|Lost to Follow-up|3|||
129479112|NCT01511445|466043007|FG001|Overall Study|Lost to Follow-up|1|||
129479113|NCT01511445|466043006|FG000|Overall Study|Protocol Violation|1|||
129479114|NCT01511445|466043007|FG001|Overall Study|Protocol Violation|3|||
129479115|NCT01511445|466043006|FG000|Overall Study|Protocol Violation|1|||
129479116|NCT01511445|466043007|FG001|Overall Study|Protocol Violation|0|||
129479117|NCT04696861|466043008|FG000|Overall Study|Death|1|||
129479118|NCT04696861|466043009|FG001|Overall Study|Death|0|||
129479119|NCT04696861|466043008|FG000|Overall Study|Lost to Follow-up|3|||
129479120|NCT04696861|466043009|FG001|Overall Study|Lost to Follow-up|0|||
129479121|NCT01926626|466043010|FG000|Overall Study|Withdrawal by Subject|15|||
129479122|NCT01926626|466043010|FG000|Overall Study|Lost to Follow-up|7|||
129479123|NCT02382133|466043011|FG000|Overall Study|Death|22|||
129479124|NCT02382133|466043011|FG000|Overall Study|transfer out of ICU|4|||
129479125|NCT02382133|466043011|FG000|Overall Study|Physician Decision|2|||
129479126|NCT02382133|466043011|FG000|Overall Study|arterial catheter loss|4|||
129479127|NCT02382133|466043011|FG000|Overall Study|pressure injury both sites|1|||
129479128|NCT00655928|466043012|FG000|Overall Study|Withdrawal by Subject|2|||
129479129|NCT00655928|466043013|FG001|Overall Study|Withdrawal by Subject|1|||
129479130|NCT00655928|466043012|FG000|Overall Study|Physician Decision|1|||
129479131|NCT00655928|466043013|FG001|Overall Study|Physician Decision|1|||
129479132|NCT04906707|466043014|FG000|Overall Study|Withdrawal by Subject|2|||
129479133|NCT04906707|466043015|FG001|Overall Study|Withdrawal by Subject|0|||
129479134|NCT04906707|466043014|FG000|Overall Study|Withdrawal due to PI decision|1|||
129479135|NCT04906707|466043015|FG001|Overall Study|Withdrawal due to PI decision|0|||
129479136|NCT04906707|466043014|FG000|Overall Study|Lost to Follow-up|0|||
129479137|NCT04906707|466043015|FG001|Overall Study|Lost to Follow-up|1|||
129479138|NCT01976806|466043016|FG000|Overall Study|Lost to Follow-up|1|||
129479139|NCT01976806|466043017|FG001|Overall Study|Lost to Follow-up|4|||
129479140|NCT01976806|466043016|FG000|Overall Study|Adverse Event|1|||
129479141|NCT01976806|466043017|FG001|Overall Study|Adverse Event|1|||
129479142|NCT01976806|466043016|FG000|Overall Study|Withdrawal by Subject|1|||
129479143|NCT01976806|466043017|FG001|Overall Study|Withdrawal by Subject|1|||
129479144|NCT00998738|466043022|FG000|Overall Study|Uknown|1|||
129479145|NCT03946449|466043023|FG000|Treatment Extension II|Rolled over to another study|0|||
129479146|NCT03946449|466043024|FG001|Treatment Extension II|Rolled over to another study|0|||
129479147|NCT03946449|466043025|FG002|Treatment Extension II|Rolled over to another study|2|||
129479148|NCT03946449|466043023|FG000|Treatment Extension II|Withdrawal by Subject|0|||
129479149|NCT03946449|466043024|FG001|Treatment Extension II|Withdrawal by Subject|0|||
129479150|NCT03946449|466043025|FG002|Treatment Extension II|Withdrawal by Subject|1|||
129479151|NCT02251743|466045263|FG000|Overall Study|Withdrawal by Subject|1|||
129479152|NCT02251743|466045264|FG001|Overall Study|Withdrawal by Subject|1|||
129479153|NCT00215150|466045265|FG000|Open Label Phase|Lost to Follow-up|7|||
129479154|NCT00215150|466045265|FG000|Open Label Phase|Withdrawal by Subject|1|||
129479155|NCT00215150|466045265|FG000|Open Label Phase|Did not complete a post base visit|13|||
129479156|NCT00215150|466045265|FG000|Open Label Phase|Did not meet randomization criteria|9|||
129479157|NCT00215150|466045265|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
129479158|NCT00215150|466045265|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
129479159|NCT00215150|466045265|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
129479160|NCT01028352|466045270|FG000|Overall Study|Ineligible due to baseline average pain|5|||
129479161|NCT01028352|466045270|FG000|Overall Study|Withdrawal by Subject|1|||
129479162|NCT00260208|466045271|FG000|Overall Study|Subject withdrew consent|11|||
129479163|NCT00260208|466045272|FG001|Overall Study|Subject withdrew consent|7|||
129479164|NCT00260208|466045271|FG000|Overall Study|Lost to Follow-up|6|||
129479165|NCT00260208|466045272|FG001|Overall Study|Lost to Follow-up|1|||
129479166|NCT00260208|466045271|FG000|Overall Study|Death|12|||
129479167|NCT00260208|466045272|FG001|Overall Study|Death|10|||
129479168|NCT00260208|466045271|FG000|Overall Study|Missing|18|||
129479169|NCT00260208|466045272|FG001|Overall Study|Missing|16|||
129479170|NCT02091440|466045273|FG000|Overall Study|Death|2|||
129479171|NCT00768222|466045274|FG000|Overall Study|Lost to Follow-up|1|||
129479172|NCT00768222|466045275|FG001|Overall Study|Lost to Follow-up|1|||
129479173|NCT00768222|466045274|FG000|Overall Study|Withdrawal by Subject|3|||
129479174|NCT00768222|466045275|FG001|Overall Study|Withdrawal by Subject|1|||
129479175|NCT00768222|466045274|FG000|Overall Study|Protocol Violation|0|||
129479176|NCT00768222|466045275|FG001|Overall Study|Protocol Violation|2|||
129479177|NCT00278629|466045282|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
129479178|NCT03323749|466045283|FG000|Double-blind Period|Lost to Follow-up|4|||
129479179|NCT03323749|466045284|FG001|Double-blind Period|Lost to Follow-up|5|||
129479180|NCT03323749|466045283|FG000|Double-blind Period|Adverse Event|3|||
129479181|NCT03323749|466045284|FG001|Double-blind Period|Adverse Event|1|||
129479182|NCT03323749|466045283|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
129479183|NCT03323749|466045284|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
129479184|NCT03323749|466045283|FG000|Open-Label Period|Adverse Event|3|||
129479185|NCT03323749|466045284|FG001|Open-Label Period|Adverse Event|10|||
129479186|NCT03323749|466045283|FG000|Open-Label Period|Withdrawal by Subject|7|||
129479187|NCT03323749|466045284|FG001|Open-Label Period|Withdrawal by Subject|5|||
129479188|NCT02468193|466045286|FG000|Overall Study|Adverse Event|4|||
129479189|NCT02468193|466045286|FG000|Overall Study|Subject/ Guardian decision|2|||
129479190|NCT00826748|466045287|FG000|Overall Study|Withdrawal by Subject|0|||
129479191|NCT00826748|466045288|FG001|Overall Study|Withdrawal by Subject|0|||
129479192|NCT00826748|466045289|FG002|Overall Study|Withdrawal by Subject|2|||
129479193|NCT00826748|466045287|FG000|Overall Study|Physician Decision|0|||
129479194|NCT00826748|466045288|FG001|Overall Study|Physician Decision|0|||
129479195|NCT00826748|466045289|FG002|Overall Study|Physician Decision|1|||
129479196|NCT00826748|466045287|FG000|Overall Study|Samples Did Not pass QC|0|||
129479197|NCT00826748|466045288|FG001|Overall Study|Samples Did Not pass QC|0|||
129479198|NCT00826748|466045289|FG002|Overall Study|Samples Did Not pass QC|1|||
129479199|NCT03312218|466045292|FG000|Overall Study|Never signed in to access the app|54|||
129479200|NCT03312218|466045293|FG001|Overall Study|Never signed in to access the app|58|||
129479201|NCT05067127|466045294|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
129479202|NCT05067127|466045295|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
129479203|NCT05067127|466045296|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
129479204|NCT05067127|466045297|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
129479205|NCT05067127|466045294|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
129479206|NCT05067127|466045295|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
129479207|NCT05067127|466045296|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
129976588|NCT03538938|467877783|FG003|Overall Study|Withdrawal by Subject|3|||
129976589|NCT03538938|467877784|FG004|Overall Study|Withdrawal by Subject|0|||
129976590|NCT03538938|467877785|FG005|Overall Study|Withdrawal by Subject|0|||
129976591|NCT03538938|467877786|FG006|Overall Study|Withdrawal by Subject|3|||
129479208|NCT05067127|466045297|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
129479209|NCT05067127|466045294|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
129479210|NCT05067127|466045295|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
129479211|NCT05067127|466045296|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
129479212|NCT05067127|466045297|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
129479213|NCT05067127|466045294|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
129976592|NCT03538938|467877787|FG007|Overall Study|Withdrawal by Subject|1|||
129976593|NCT03538938|467877788|FG008|Overall Study|Withdrawal by Subject|5|||
129976594|NCT03538938|467877789|FG009|Overall Study|Withdrawal by Subject|1|||
129976595|NCT03538938|467877790|FG010|Overall Study|Withdrawal by Subject|2|||
129976596|NCT03538938|467877791|FG011|Overall Study|Withdrawal by Subject|1|||
129976597|NCT03538938|467877792|FG012|Overall Study|Withdrawal by Subject|3|||
129479214|NCT05067127|466045295|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
129479215|NCT05067127|466045296|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
129479216|NCT05067127|466045297|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
129479217|NCT05067127|466045294|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
129479218|NCT05067127|466045295|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
129479219|NCT05067127|466045296|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
129479220|NCT05067127|466045297|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
129479221|NCT05067127|466045294|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
129479222|NCT05067127|466045295|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
129479223|NCT05067127|466045296|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
129479224|NCT05067127|466045297|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
129479225|NCT05067127|466045294|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
129479226|NCT05067127|466045295|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
129479227|NCT05067127|466045296|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
129479228|NCT05067127|466045297|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
129976598|NCT03538938|467877793|FG013|Overall Study|Withdrawal by Subject|0|||
129976599|NCT03538938|467877794|FG014|Overall Study|Withdrawal by Subject|2|||
129976600|NCT03538938|467877795|FG015|Overall Study|Withdrawal by Subject|4|||
129479229|NCT04462536|466045298|FG000|Overall Study|Withdrawal by Subject|3|||
129479230|NCT04462536|466045299|FG001|Overall Study|Withdrawal by Subject|9|||
129479231|NCT04462536|466045298|FG000|Overall Study|Lost to Follow-up|2|||
129976601|NCT03538938|467877780|FG000|Overall Study|Incarcerated|0|||
129479232|NCT04462536|466045299|FG001|Overall Study|Lost to Follow-up|4|||
129479233|NCT06161012|466045307|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
129479234|NCT06161012|466045308|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
129479235|NCT02601950|466045309|FG000|Overall Study|Participant enrolled in rollover study|0|||
129479236|NCT02601950|466045310|FG001|Overall Study|Participant enrolled in rollover study|0|||
129479237|NCT02601950|466045311|FG002|Overall Study|Participant enrolled in rollover study|1|||
129479238|NCT02601950|466045312|FG003|Overall Study|Participant enrolled in rollover study|0|||
129479239|NCT02601950|466045313|FG004|Overall Study|Participant enrolled in rollover study|1|||
129479240|NCT02601950|466045314|FG005|Overall Study|Participant enrolled in rollover study|1|||
129479241|NCT02601950|466045315|FG006|Overall Study|Participant enrolled in rollover study|1|||
129479242|NCT02601950|466045316|FG007|Overall Study|Participant enrolled in rollover study|0|||
129479243|NCT02601950|466045309|FG000|Overall Study|Disease progression - radiological|21|||
129479244|NCT02601950|466045310|FG001|Overall Study|Disease progression - radiological|26|||
129479245|NCT02601950|466045311|FG002|Overall Study|Disease progression - radiological|22|||
129479246|NCT02601950|466045312|FG003|Overall Study|Disease progression - radiological|11|||
129479247|NCT02601950|466045313|FG004|Overall Study|Disease progression - radiological|46|||
129479248|NCT02601950|466045314|FG005|Overall Study|Disease progression - radiological|52|||
129479249|NCT02601950|466045315|FG006|Overall Study|Disease progression - radiological|7|||
129479250|NCT02601950|466045316|FG007|Overall Study|Disease progression - radiological|5|||
129479251|NCT02601950|466045309|FG000|Overall Study|Disease progression - clinical|3|||
129479252|NCT02601950|466045310|FG001|Overall Study|Disease progression - clinical|5|||
129479253|NCT02601950|466045311|FG002|Overall Study|Disease progression - clinical|4|||
129479254|NCT02601950|466045312|FG003|Overall Study|Disease progression - clinical|2|||
129479255|NCT02601950|466045313|FG004|Overall Study|Disease progression - clinical|6|||
129479256|NCT02601950|466045314|FG005|Overall Study|Disease progression - clinical|6|||
129479257|NCT02601950|466045315|FG006|Overall Study|Disease progression - clinical|5|||
129479258|NCT02601950|466045316|FG007|Overall Study|Disease progression - clinical|1|||
129479259|NCT02601950|466045309|FG000|Overall Study|Death|6|||
129479260|NCT02601950|466045310|FG001|Overall Study|Death|0|||
129479261|NCT02601950|466045311|FG002|Overall Study|Death|3|||
129479262|NCT02601950|466045312|FG003|Overall Study|Death|1|||
129479263|NCT02601950|466045313|FG004|Overall Study|Death|4|||
129479264|NCT02601950|466045314|FG005|Overall Study|Death|1|||
129479265|NCT02601950|466045315|FG006|Overall Study|Death|0|||
129479266|NCT02601950|466045316|FG007|Overall Study|Death|0|||
129479267|NCT02601950|466045309|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479268|NCT02601950|466045310|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479269|NCT02601950|466045311|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479270|NCT02601950|466045312|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479271|NCT02601950|466045313|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479272|NCT02601950|466045314|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
129479273|NCT02601950|466045315|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479274|NCT02601950|466045316|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
129479275|NCT02601950|466045309|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
129479276|NCT02601950|466045310|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
129479277|NCT02601950|466045311|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
129479278|NCT02601950|466045312|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
129479279|NCT02601950|466045313|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
129479280|NCT02601950|466045314|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
129479281|NCT02601950|466045315|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
129479282|NCT02601950|466045316|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
129479283|NCT02601950|466045309|FG000|Overall Study|Non-compliance|0|||
129479284|NCT02601950|466045310|FG001|Overall Study|Non-compliance|1|||
129479285|NCT02601950|466045311|FG002|Overall Study|Non-compliance|0|||
129479286|NCT02601950|466045312|FG003|Overall Study|Non-compliance|0|||
129479287|NCT02601950|466045313|FG004|Overall Study|Non-compliance|0|||
129479288|NCT02601950|466045314|FG005|Overall Study|Non-compliance|1|||
129479289|NCT02601950|466045315|FG006|Overall Study|Non-compliance|1|||
129479290|NCT02601950|466045316|FG007|Overall Study|Non-compliance|0|||
129479291|NCT02601950|466045309|FG000|Overall Study|Participant refused further study treatment|0|||
129479292|NCT02601950|466045310|FG001|Overall Study|Participant refused further study treatment|1|||
129479293|NCT02601950|466045311|FG002|Overall Study|Participant refused further study treatment|1|||
129479294|NCT02601950|466045312|FG003|Overall Study|Participant refused further study treatment|0|||
129479295|NCT02601950|466045313|FG004|Overall Study|Participant refused further study treatment|2|||
129479296|NCT02601950|466045314|FG005|Overall Study|Participant refused further study treatment|2|||
129479297|NCT02601950|466045315|FG006|Overall Study|Participant refused further study treatment|2|||
129479298|NCT02601950|466045316|FG007|Overall Study|Participant refused further study treatment|1|||
129479299|NCT02601950|466045309|FG000|Overall Study|Investigator discretion|1|||
129479300|NCT02601950|466045310|FG001|Overall Study|Investigator discretion|0|||
129479301|NCT02601950|466045311|FG002|Overall Study|Investigator discretion|1|||
129479302|NCT02601950|466045312|FG003|Overall Study|Investigator discretion|0|||
129479303|NCT02601950|466045313|FG004|Overall Study|Investigator discretion|1|||
129479304|NCT02601950|466045314|FG005|Overall Study|Investigator discretion|1|||
129479305|NCT02601950|466045315|FG006|Overall Study|Investigator discretion|1|||
129479306|NCT02601950|466045316|FG007|Overall Study|Investigator discretion|0|||
129479307|NCT02601950|466045309|FG000|Overall Study|Other|0|||
129479308|NCT02601950|466045310|FG001|Overall Study|Other|0|||
129479309|NCT02601950|466045311|FG002|Overall Study|Other|0|||
129479310|NCT02601950|466045312|FG003|Overall Study|Other|0|||
129479311|NCT02601950|466045313|FG004|Overall Study|Other|2|||
129479312|NCT02601950|466045314|FG005|Overall Study|Other|2|||
129479313|NCT02601950|466045315|FG006|Overall Study|Other|1|||
129479314|NCT02601950|466045316|FG007|Overall Study|Other|0|||
129479315|NCT05817045|466045317|FG000|Overall Study|Protocol Violation|0|||
129479316|NCT05817045|466045318|FG001|Overall Study|Protocol Violation|3|||
129479317|NCT05817045|466045317|FG000|Overall Study|Withdrawal by Subject|10|||
129479318|NCT05817045|466045318|FG001|Overall Study|Withdrawal by Subject|7|||
129479319|NCT05817045|466045317|FG000|Overall Study|Physician Decision|3|||
129479320|NCT05817045|466045318|FG001|Overall Study|Physician Decision|0|||
129479321|NCT05817045|466045317|FG000|Overall Study|Lost to Follow-up|0|||
129479322|NCT05817045|466045318|FG001|Overall Study|Lost to Follow-up|1|||
129479323|NCT05817045|466045317|FG000|Overall Study|Device Deficiency|1|||
129479324|NCT05817045|466045318|FG001|Overall Study|Device Deficiency|0|||
129479325|NCT05817045|466045317|FG000|Overall Study|System Error|1|||
129479326|NCT05817045|466045318|FG001|Overall Study|System Error|0|||
129479327|NCT05113940|466045325|FG000|Part A (18 Days)|Adverse Event|0|||
129479328|NCT05113940|466045326|FG001|Part A (18 Days)|Adverse Event|0|||
129479329|NCT05113940|466045327|FG002|Part A (18 Days)|Adverse Event|1|||
129479330|NCT05113940|466045328|FG003|Part A (18 Days)|Adverse Event|1|||
129479331|NCT05113940|466045329|FG004|Part A (18 Days)|Adverse Event|1|||
129479332|NCT05113940|466045330|FG005|Part A (18 Days)|Adverse Event|0|||
129479333|NCT05113940|466045331|FG006|Part A (18 Days)|Adverse Event|0|||
129479334|NCT05113940|466045332|FG007|Part A (18 Days)|Adverse Event|0|||
129479335|NCT05113940|466045333|FG008|Part A (18 Days)|Adverse Event|0|||
129479336|NCT05113940|466045334|FG009|Part A (18 Days)|Adverse Event|0|||
129479337|NCT05113940|466045335|FG010|Part A (18 Days)|Adverse Event|0|||
129479338|NCT05113940|466045336|FG011|Part A (18 Days)|Adverse Event|2|||
129479339|NCT05113940|466045337|FG012|Part A (18 Days)|Adverse Event|0|||
129479340|NCT05113940|466045338|FG013|Part A (18 Days)|Adverse Event|0|||
129479341|NCT05113940|466045339|FG014|Part A (18 Days)|Adverse Event|0|||
129479342|NCT05113940|466045325|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479343|NCT05113940|466045326|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479344|NCT05113940|466045327|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479345|NCT05113940|466045328|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479346|NCT05113940|466045329|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479347|NCT05113940|466045330|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479348|NCT05113940|466045331|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479349|NCT05113940|466045332|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479350|NCT05113940|466045333|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479351|NCT05113940|466045334|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479352|NCT05113940|466045335|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479353|NCT05113940|466045336|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479354|NCT05113940|466045337|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479355|NCT05113940|466045338|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
129479356|NCT05113940|466045339|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
129479357|NCT02688647|466045342|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
129479358|NCT02688647|466045343|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
129479359|NCT02688647|466045342|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
129479360|NCT02688647|466045343|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
129479361|NCT02688647|466045342|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
129479362|NCT02688647|466045343|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
129479363|NCT02688647|466045342|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
129479364|NCT02688647|466045343|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
129479365|NCT02688647|466045342|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
129479366|NCT02688647|466045343|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
129479367|NCT02688647|466045342|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
129479368|NCT02688647|466045343|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
129479369|NCT02688647|466045342|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
129479370|NCT02688647|466045343|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
129479371|NCT00382967|466045344|FG000|Overall Study|Protocol Violation|1|||
129479372|NCT00382967|466045345|FG001|Overall Study|Protocol Violation|1|||
129479373|NCT03049449|466045349|FG000|Overall Study|Did not receive treatment.|0|||
129479374|NCT03049449|466045350|FG001|Overall Study|Did not receive treatment.|0|||
129479375|NCT03049449|466045351|FG002|Overall Study|Did not receive treatment.|0|||
129479376|NCT03049449|466045352|FG003|Overall Study|Did not receive treatment.|0|||
129479377|NCT03049449|466045353|FG004|Overall Study|Did not receive treatment.|0|||
129479378|NCT03049449|466045354|FG005|Overall Study|Did not receive treatment.|0|||
129479379|NCT03049449|466045355|FG006|Overall Study|Did not receive treatment.|0|||
129479380|NCT03049449|466045356|FG007|Overall Study|Did not receive treatment.|0|||
129479381|NCT03049449|466045357|FG008|Overall Study|Did not receive treatment.|1|||
129479382|NCT03049449|466045358|FG009|Overall Study|Did not receive treatment.|0|||
129479383|NCT03049449|466045349|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
129479384|NCT03049449|466045350|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
129479385|NCT03049449|466045351|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
129479386|NCT03049449|466045352|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
129479387|NCT03049449|466045353|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
129479388|NCT03049449|466045354|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
129479389|NCT03049449|466045355|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
129479390|NCT03049449|466045356|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
129479391|NCT03049449|466045357|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
129479392|NCT03049449|466045358|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
129479393|NCT03049449|466045349|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479394|NCT03049449|466045350|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479395|NCT03049449|466045351|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479396|NCT03049449|466045352|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479397|NCT03049449|466045353|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479398|NCT03049449|466045354|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479399|NCT03049449|466045355|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479400|NCT03049449|466045356|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
129479401|NCT03049449|466045357|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
129479402|NCT03049449|466045358|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
129479403|NCT00442598|466045359|FG000|Overall Study|Adverse Event|1|||
129479404|NCT00442598|466045360|FG001|Overall Study|Adverse Event|0|||
129479405|NCT00442598|466045361|FG002|Overall Study|Adverse Event|0|||
129479406|NCT00442598|466045359|FG000|Overall Study|Tumor progression|3|||
129479407|NCT00442598|466045360|FG001|Overall Study|Tumor progression|4|||
129479408|NCT00442598|466045361|FG002|Overall Study|Tumor progression|0|||
129479409|NCT00442598|466045359|FG000|Overall Study|Clinical deterioration|1|||
129479410|NCT00442598|466045360|FG001|Overall Study|Clinical deterioration|2|||
129479411|NCT00442598|466045361|FG002|Overall Study|Clinical deterioration|0|||
129479412|NCT00442598|466045359|FG000|Overall Study|CA125 progression|0|||
129479413|NCT00442598|466045360|FG001|Overall Study|CA125 progression|1|||
129479414|NCT00442598|466045361|FG002|Overall Study|CA125 progression|0|||
129479415|NCT00442598|466045359|FG000|Overall Study|Reduced creatinine clearance|1|||
129479416|NCT00442598|466045360|FG001|Overall Study|Reduced creatinine clearance|0|||
129479417|NCT00442598|466045361|FG002|Overall Study|Reduced creatinine clearance|0|||
129479418|NCT00442598|466045359|FG000|Overall Study|Death|0|||
129479419|NCT00442598|466045360|FG001|Overall Study|Death|1|||
129479420|NCT00442598|466045361|FG002|Overall Study|Death|0|||
129479421|NCT01147497|466045362|FG000|Overall Study|failed insertion|2|||
129479422|NCT01147497|466045363|FG001|Overall Study|failed insertion|0|||
129479423|NCT01262898|466045366|FG000|Overall Study|Protocol Violation|1|||
129479424|NCT01262898|466045367|FG001|Overall Study|Protocol Violation|1|||
129479425|NCT01262898|466045368|FG002|Overall Study|Protocol Violation|0|||
129479426|NCT01262898|466045369|FG003|Overall Study|Protocol Violation|0|||
129479427|NCT01262898|466045366|FG000|Overall Study|Lost to Follow-up|1|||
129479428|NCT01262898|466045367|FG001|Overall Study|Lost to Follow-up|0|||
129479429|NCT01262898|466045368|FG002|Overall Study|Lost to Follow-up|0|||
129479430|NCT01262898|466045369|FG003|Overall Study|Lost to Follow-up|0|||
129479431|NCT01262898|466045366|FG000|Overall Study|Withdrawal by Subject|1|||
129479432|NCT01262898|466045367|FG001|Overall Study|Withdrawal by Subject|1|||
129479433|NCT01262898|466045368|FG002|Overall Study|Withdrawal by Subject|0|||
129479434|NCT01262898|466045369|FG003|Overall Study|Withdrawal by Subject|0|||
129479435|NCT02731742|466045370|FG000|Overall Study|Death|1|||
129479436|NCT02731742|466045371|FG001|Overall Study|Death|2|||
129479437|NCT02731742|466045372|FG002|Overall Study|Death|5|||
129479438|NCT02731742|466045373|FG003|Overall Study|Death|0|||
129479439|NCT02731742|466045370|FG000|Overall Study|Physician Decision|0|||
129479440|NCT02731742|466045371|FG001|Overall Study|Physician Decision|0|||
129479441|NCT02731742|466045372|FG002|Overall Study|Physician Decision|0|||
129479442|NCT02731742|466045373|FG003|Overall Study|Physician Decision|1|||
129479443|NCT02731742|466045370|FG000|Overall Study|Study Terminated by Sponsor|2|||
129479444|NCT02731742|466045371|FG001|Overall Study|Study Terminated by Sponsor|1|||
129479445|NCT02731742|466045372|FG002|Overall Study|Study Terminated by Sponsor|1|||
129479446|NCT02731742|466045373|FG003|Overall Study|Study Terminated by Sponsor|1|||
129479447|NCT04026568|466045376|FG000|Overall Study|study terminated|0|||
129479448|NCT04026568|466045377|FG001|Overall Study|study terminated|1|||
129479449|NCT02197377|466045378|FG000|Overall Study|Insertion Failure|0|||
129479450|NCT02197377|466045379|FG001|Overall Study|Insertion Failure|3|||
129479451|NCT00502840|466045380|FG000|Overall Study|Adverse Event|5|||
129479452|NCT00502840|466045380|FG000|Overall Study|Additional or changed therapy|48|||
129479453|NCT00502840|466045380|FG000|Overall Study|Lack of Efficacy|11|||
129479454|NCT00502840|466045380|FG000|Overall Study|Protocol Violation|4|||
129479455|NCT00502840|466045380|FG000|Overall Study|Withdrawal by Subject|5|||
129479456|NCT00502840|466045380|FG000|Overall Study|Lost to Follow-up|6|||
129479457|NCT00502840|466045380|FG000|Overall Study|Administrative problems|1|||
129479458|NCT00502840|466045380|FG000|Overall Study|Other|20|||
129479459|NCT03093155|466045382|FG000|Overall Study|Not Eligible|1|||
129479460|NCT03093155|466045383|FG001|Overall Study|Not Eligible|0|||
129479461|NCT03093155|466045382|FG000|Overall Study|Withdrawal by Subject|0|||
129479462|NCT03093155|466045383|FG001|Overall Study|Withdrawal by Subject|1|||
129479463|NCT01700829|466045384|FG000|Overall Study|Withdrawal by Subject|1|||
129479464|NCT01700829|466045385|FG001|Overall Study|Withdrawal by Subject|1|||
129479465|NCT02561156|466045386|FG000|Part 2|Adverse Event|0|||
129479466|NCT02561156|466045387|FG001|Part 2|Adverse Event|0|||
129479467|NCT02561156|466045388|FG002|Part 2|Adverse Event|0|||
129479468|NCT02561156|466045389|FG003|Part 2|Adverse Event|0|||
129479469|NCT02561156|466045390|FG004|Part 2|Adverse Event|0|||
129479470|NCT02561156|466045391|FG005|Part 2|Adverse Event|0|||
129479471|NCT02561156|466045392|FG006|Part 2|Adverse Event|0|||
129479472|NCT02561156|466045393|FG007|Part 2|Adverse Event|0|||
129479473|NCT02561156|466045394|FG008|Part 2|Adverse Event|0|||
129479474|NCT02561156|466045395|FG009|Part 2|Adverse Event|0|||
129479475|NCT02561156|466045396|FG010|Part 2|Adverse Event|0|||
129479476|NCT02561156|466045397|FG011|Part 2|Adverse Event|1|||
129479477|NCT02561156|466045398|FG012|Part 2|Adverse Event|0|||
129479478|NCT02209506|466045404|FG000|Overall Study|Withdrawal by Subject|0|||
129479479|NCT02209506|466045405|FG001|Overall Study|Withdrawal by Subject|0|||
129479480|NCT02209506|466045406|FG002|Overall Study|Withdrawal by Subject|0|||
129479481|NCT02209506|466045407|FG003|Overall Study|Withdrawal by Subject|0|||
129479482|NCT02209506|466045408|FG004|Overall Study|Withdrawal by Subject|1|||
129479483|NCT00098787|466045409|FG000|Overall Study|Never started treatment|3|||
129479484|NCT00098787|466045410|FG001|Overall Study|Never started treatment|2|||
129479485|NCT00098787|466045411|FG002|Overall Study|Never started treatment|1|||
129479486|NCT00098787|466045409|FG000|Overall Study|Ineligible|9|||
129479487|NCT00098787|466045410|FG001|Overall Study|Ineligible|7|||
129479488|NCT00098787|466045411|FG002|Overall Study|Ineligible|3|||
129479489|NCT00098787|466045409|FG000|Overall Study|Disease progression|28|||
129479490|NCT00098787|466045410|FG001|Overall Study|Disease progression|17|||
129479491|NCT00098787|466045411|FG002|Overall Study|Disease progression|23|||
129479492|NCT00098787|466045409|FG000|Overall Study|Adverse Event|8|||
129479493|NCT00098787|466045410|FG001|Overall Study|Adverse Event|17|||
129479494|NCT00098787|466045411|FG002|Overall Study|Adverse Event|8|||
129479495|NCT00098787|466045409|FG000|Overall Study|Death|6|||
129479496|NCT00098787|466045410|FG001|Overall Study|Death|1|||
129479497|NCT00098787|466045411|FG002|Overall Study|Death|0|||
129479498|NCT00098787|466045409|FG000|Overall Study|Withdrawal by Subject|4|||
129479499|NCT00098787|466045410|FG001|Overall Study|Withdrawal by Subject|12|||
129479500|NCT00098787|466045411|FG002|Overall Study|Withdrawal by Subject|6|||
129479501|NCT00098787|466045409|FG000|Overall Study|Alternative therapy|8|||
129479502|NCT00098787|466045410|FG001|Overall Study|Alternative therapy|13|||
129479503|NCT00098787|466045411|FG002|Overall Study|Alternative therapy|13|||
129479504|NCT00098787|466045409|FG000|Overall Study|Other|7|||
129479505|NCT00098787|466045410|FG001|Overall Study|Other|6|||
129479506|NCT00098787|466045411|FG002|Overall Study|Other|9|||
129479507|NCT02537678|466045414|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
129479508|NCT02537678|466045415|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
129479509|NCT02537678|466045414|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
129479510|NCT02537678|466045415|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
129479511|NCT02537678|466045414|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
129479512|NCT02537678|466045415|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
129479513|NCT02537678|466045414|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
129479514|NCT02537678|466045415|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
129479515|NCT02537678|466045414|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
129479516|NCT02537678|466045415|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
129479517|NCT02537678|466045414|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
129479518|NCT02537678|466045415|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
129479519|NCT02537678|466045414|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
129479520|NCT02537678|466045415|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
129479521|NCT01360996|466045416|FG000|Overall Study|Withdrawal by Subject|4|||
129479522|NCT01360996|466045417|FG001|Overall Study|Withdrawal by Subject|3|||
129479523|NCT01360996|466045418|FG002|Overall Study|Withdrawal by Subject|2|||
129479524|NCT01360996|466045416|FG000|Overall Study|Noncompliant|2|||
129479525|NCT01360996|466045417|FG001|Overall Study|Noncompliant|0|||
129479526|NCT01360996|466045418|FG002|Overall Study|Noncompliant|0|||
129479527|NCT04964258|466045420|FG000|Overall Study|Lost to Follow-up|1|||
129479528|NCT04964258|466045421|FG001|Overall Study|Lost to Follow-up|0|||
129479529|NCT04964258|466045422|FG002|Overall Study|Lost to Follow-up|0|||
129479530|NCT04964258|466045423|FG003|Overall Study|Lost to Follow-up|0|||
129479531|NCT04964258|466045424|FG004|Overall Study|Lost to Follow-up|0|||
129479532|NCT04964258|466045425|FG005|Overall Study|Lost to Follow-up|1|||
129479533|NCT04964258|466045426|FG006|Overall Study|Lost to Follow-up|0|||
129479534|NCT04964258|466045427|FG007|Overall Study|Lost to Follow-up|0|||
129479535|NCT04964258|466045428|FG008|Overall Study|Lost to Follow-up|0|||
129479536|NCT04964258|466045429|FG009|Overall Study|Lost to Follow-up|0|||
129479537|NCT04964258|466045430|FG010|Overall Study|Lost to Follow-up|0|||
129479538|NCT01499290|466045433|FG000|Overall Study|Withdrawal by Subject|22|||
129479539|NCT01499290|466045434|FG001|Overall Study|Withdrawal by Subject|15|||
129479540|NCT01499290|466045433|FG000|Overall Study|Not specified in study report|11|||
129479541|NCT01499290|466045434|FG001|Overall Study|Not specified in study report|5|||
129479542|NCT01499290|466045433|FG000|Overall Study|Condition improved/subject recovered|1|||
129479543|NCT01499290|466045434|FG001|Overall Study|Condition improved/subject recovered|0|||
129479544|NCT01499290|466045433|FG000|Overall Study|Lack of Efficacy|7|||
129479545|NCT01499290|466045434|FG001|Overall Study|Lack of Efficacy|8|||
129479546|NCT01499290|466045433|FG000|Overall Study|Adverse Event|14|||
129479547|NCT01499290|466045434|FG001|Overall Study|Adverse Event|7|||
129479548|NCT04052139|466045435|FG000|Overall Study|Lost to Follow-up|2|||
129479549|NCT04052139|466045436|FG001|Overall Study|Lost to Follow-up|0|||
129479550|NCT04052139|466045437|FG002|Overall Study|Lost to Follow-up|0|||
129479551|NCT04052139|466045435|FG000|Overall Study|Withdrawal by Subject|1|||
129479552|NCT04052139|466045436|FG001|Overall Study|Withdrawal by Subject|0|||
129479553|NCT04052139|466045437|FG002|Overall Study|Withdrawal by Subject|0|||
129479554|NCT03406962|466045438|FG000|Overall Study|Death|2|||
129479555|NCT03406962|466045438|FG000|Overall Study|Adverse Event|1|||
129479556|NCT00327444|466045439|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
129479557|NCT00327444|466045440|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
129479558|NCT00327444|466045439|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
129479559|NCT00327444|466045440|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
129479560|NCT00327444|466045439|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
129479561|NCT00327444|466045440|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
129479562|NCT00327444|466045439|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
129479563|NCT00327444|466045440|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
129479564|NCT00327444|466045439|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
129479565|NCT00327444|466045440|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
129479566|NCT00327444|466045439|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
129479567|NCT00327444|466045440|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
129479568|NCT00327444|466045439|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
129479569|NCT00327444|466045440|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
129479570|NCT00327444|466045439|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
129479571|NCT00327444|466045440|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
129479572|NCT04439344|466045441|FG000|Overall Study|Never started threapy|3|||
129479573|NCT04439344|466045441|FG000|Overall Study|Ineligible|3|||
129479574|NCT04439344|466045441|FG000|Overall Study|Adverse Event|13|||
129479575|NCT04439344|466045441|FG000|Overall Study|Death|2|||
129479576|NCT04439344|466045441|FG000|Overall Study|Disease progression|29|||
129479577|NCT04439344|466045441|FG000|Overall Study|Withdrawal by Subject|2|||
129479578|NCT04439344|466045441|FG000|Overall Study|Alternative therapy|1|||
129479579|NCT00552110|466045442|FG000|Overall Study|Serious or Life-Threatening AE|0|||
129479580|NCT00552110|466045443|FG001|Overall Study|Serious or Life-Threatening AE|0|||
129479581|NCT00552110|466045444|FG002|Overall Study|Serious or Life-Threatening AE|1|||
129479582|NCT00552110|466045445|FG003|Overall Study|Serious or Life-Threatening AE|0|||
129479583|NCT00552110|466045446|FG004|Overall Study|Serious or Life-Threatening AE|0|||
129479584|NCT00552110|466045442|FG000|Overall Study|Lack of Efficacy|1|||
129479585|NCT00552110|466045443|FG001|Overall Study|Lack of Efficacy|0|||
129479586|NCT00552110|466045444|FG002|Overall Study|Lack of Efficacy|0|||
129479587|NCT00552110|466045445|FG003|Overall Study|Lack of Efficacy|1|||
129479588|NCT00552110|466045446|FG004|Overall Study|Lack of Efficacy|4|||
129479589|NCT00552110|466045442|FG000|Overall Study|Withdrawal by Subject|0|||
129479590|NCT00552110|466045443|FG001|Overall Study|Withdrawal by Subject|2|||
129479591|NCT00552110|466045444|FG002|Overall Study|Withdrawal by Subject|0|||
129479592|NCT00552110|466045445|FG003|Overall Study|Withdrawal by Subject|3|||
129479593|NCT00552110|466045446|FG004|Overall Study|Withdrawal by Subject|2|||
129479594|NCT00552110|466045442|FG000|Overall Study|Lost to Follow-up|0|||
129479595|NCT00552110|466045443|FG001|Overall Study|Lost to Follow-up|0|||
129479596|NCT00552110|466045444|FG002|Overall Study|Lost to Follow-up|0|||
129479597|NCT00552110|466045445|FG003|Overall Study|Lost to Follow-up|1|||
129479598|NCT00552110|466045446|FG004|Overall Study|Lost to Follow-up|1|||
129479599|NCT00552110|466045442|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
129479600|NCT00552110|466045443|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
129479601|NCT00552110|466045444|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
129479602|NCT00552110|466045445|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
129479603|NCT00552110|466045446|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
129479604|NCT00552110|466045442|FG000|Overall Study|Withdrawn per Sponsor|0|||
129479605|NCT00552110|466045443|FG001|Overall Study|Withdrawn per Sponsor|1|||
129479606|NCT00552110|466045444|FG002|Overall Study|Withdrawn per Sponsor|0|||
129479607|NCT00552110|466045445|FG003|Overall Study|Withdrawn per Sponsor|0|||
129479608|NCT00552110|466045446|FG004|Overall Study|Withdrawn per Sponsor|1|||
129479609|NCT00552110|466045442|FG000|Overall Study|Use of Prohibited Medication|1|||
129479610|NCT00552110|466045443|FG001|Overall Study|Use of Prohibited Medication|1|||
129479611|NCT00552110|466045444|FG002|Overall Study|Use of Prohibited Medication|0|||
129479612|NCT00552110|466045445|FG003|Overall Study|Use of Prohibited Medication|0|||
129479613|NCT00552110|466045446|FG004|Overall Study|Use of Prohibited Medication|0|||
129479614|NCT00552110|466045442|FG000|Overall Study|Delay of Study due to Relabeling|0|||
129479615|NCT00552110|466045443|FG001|Overall Study|Delay of Study due to Relabeling|0|||
129479616|NCT00552110|466045444|FG002|Overall Study|Delay of Study due to Relabeling|0|||
129479617|NCT00552110|466045445|FG003|Overall Study|Delay of Study due to Relabeling|1|||
129479618|NCT00552110|466045446|FG004|Overall Study|Delay of Study due to Relabeling|0|||
129479619|NCT00552110|466045442|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
129479620|NCT00552110|466045443|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
129479621|NCT00552110|466045444|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
129479622|NCT00552110|466045445|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
129479623|NCT00552110|466045446|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
129479624|NCT00552110|466045442|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
129479625|NCT00552110|466045443|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
129479626|NCT00552110|466045444|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
129479627|NCT00552110|466045445|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
129479628|NCT00552110|466045446|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
129479629|NCT01672957|466045447|FG000|Overall Study|Protocol Violation|48|||
129479630|NCT01672957|466045447|FG000|Overall Study|Death|2|||
129479631|NCT01672957|466045447|FG000|Overall Study|ICF Signed After Transplantation|5|||
129479632|NCT02272790|466045450|FG000|Overall Study|Physician Decision|0|||
129479633|NCT02272790|466045451|FG001|Overall Study|Physician Decision|1|||
129479634|NCT02272790|466045452|FG002|Overall Study|Physician Decision|0|||
129479635|NCT02272790|466045453|FG003|Overall Study|Physician Decision|0|||
129479636|NCT02272790|466045454|FG004|Overall Study|Physician Decision|0|||
129479637|NCT02272790|466045455|FG005|Overall Study|Physician Decision|0|||
129479638|NCT00490542|466045460|FG000|Overall Study|Lost to Follow-up|3|||
129479639|NCT00490542|466045461|FG001|Overall Study|Lost to Follow-up|0|||
129479640|NCT00490542|466045460|FG000|Overall Study|Adverse Event|3|||
129479641|NCT00490542|466045461|FG001|Overall Study|Adverse Event|3|||
129479642|NCT00490542|466045460|FG000|Overall Study|Lack of Efficacy|1|||
129479643|NCT00490542|466045461|FG001|Overall Study|Lack of Efficacy|1|||
129479644|NCT01053429|466045462|FG000|Overall Study|Adverse Event|64|||
129479645|NCT01053429|466045462|FG000|Overall Study|Other|309|||
129479646|NCT04375761|466047622|FG000|Overall Study|Death|1|||
129479647|NCT04375761|466047623|FG001|Overall Study|Death|2|||
129479648|NCT04375761|466047622|FG000|Overall Study|Lost to Follow-up|203|||
129479649|NCT04375761|466047623|FG001|Overall Study|Lost to Follow-up|380|||
129479650|NCT04375761|466047622|FG000|Overall Study|Withdrawal by Subject|47|||
129479651|NCT04375761|466047623|FG001|Overall Study|Withdrawal by Subject|98|||
129479652|NCT04375761|466047622|FG000|Overall Study|Noncompliance with study procedure|121|||
129479653|NCT04375761|466047623|FG001|Overall Study|Noncompliance with study procedure|251|||
129479654|NCT04375761|466047622|FG000|Overall Study|Reimbursement not enough|1|||
129479655|NCT04375761|466047623|FG001|Overall Study|Reimbursement not enough|2|||
129479656|NCT04375761|466047622|FG000|Overall Study|Unforeseen family circumstances|1|||
129479657|NCT04375761|466047623|FG001|Overall Study|Unforeseen family circumstances|3|||
129479658|NCT04375761|466047622|FG000|Overall Study|Test too painful|1|||
129479659|NCT04375761|466047623|FG001|Overall Study|Test too painful|1|||
129479660|NCT04375761|466047622|FG000|Overall Study|Moved|0|||
129479661|NCT04375761|466047623|FG001|Overall Study|Moved|2|||
129479662|NCT04375761|466047622|FG000|Overall Study|Nonresponsive|0|||
129479663|NCT04375761|466047623|FG001|Overall Study|Nonresponsive|5|||
129479664|NCT03797001|466047624|FG000|Overall Study|Withdrawn due to COVID19|4|||
129479665|NCT03797001|466047625|FG001|Overall Study|Withdrawn due to COVID19|0|||
129479666|NCT03797001|466047624|FG000|Overall Study|Withdrawal by Subject|7|||
129479667|NCT03797001|466047625|FG001|Overall Study|Withdrawal by Subject|6|||
129479668|NCT03797001|466047624|FG000|Overall Study|Adverse Event|0|||
129479669|NCT03797001|466047625|FG001|Overall Study|Adverse Event|1|||
129479670|NCT05630846|466047628|FG000|Overall Study|Death|1|||
129976602|NCT03538938|467877781|FG001|Overall Study|Incarcerated|0|||
129976603|NCT03538938|467877782|FG002|Overall Study|Incarcerated|0|||
129479671|NCT05630846|466047629|FG001|Overall Study|Death|0|||
129479672|NCT05630846|466047630|FG002|Overall Study|Death|0|||
129479673|NCT05630846|466047631|FG003|Overall Study|Death|0|||
129479674|NCT05630846|466047628|FG000|Overall Study|Withdrawal by Subject|3|||
129479675|NCT05630846|466047629|FG001|Overall Study|Withdrawal by Subject|3|||
129479676|NCT05630846|466047630|FG002|Overall Study|Withdrawal by Subject|4|||
129479677|NCT05630846|466047631|FG003|Overall Study|Withdrawal by Subject|1|||
129479678|NCT05630846|466047628|FG000|Overall Study|Lost to Follow-up|6|||
129479679|NCT05630846|466047629|FG001|Overall Study|Lost to Follow-up|5|||
129479680|NCT05630846|466047630|FG002|Overall Study|Lost to Follow-up|2|||
129479681|NCT05630846|466047631|FG003|Overall Study|Lost to Follow-up|5|||
129479682|NCT05630846|466047628|FG000|Overall Study|Other|1|||
129479683|NCT05630846|466047629|FG001|Overall Study|Other|0|||
129479684|NCT05630846|466047630|FG002|Overall Study|Other|0|||
129479685|NCT05630846|466047631|FG003|Overall Study|Other|0|||
129479686|NCT05556616|466047632|FG000|Overall Study|Withdrawal by Subject|1|||
129479687|NCT05556616|466047633|FG001|Overall Study|Withdrawal by Subject|0|||
129479688|NCT05556616|466047634|FG002|Overall Study|Withdrawal by Subject|0|||
129479689|NCT05556616|466047635|FG003|Overall Study|Withdrawal by Subject|0|||
129479690|NCT05556616|466047636|FG004|Overall Study|Withdrawal by Subject|0|||
129479691|NCT05556616|466047637|FG005|Overall Study|Withdrawal by Subject|0|||
129479692|NCT05556616|466047638|FG006|Overall Study|Withdrawal by Subject|0|||
129479693|NCT05556616|466047632|FG000|Overall Study|Death|0|||
129479694|NCT05556616|466047633|FG001|Overall Study|Death|0|||
129479695|NCT05556616|466047634|FG002|Overall Study|Death|2|||
129479696|NCT05556616|466047635|FG003|Overall Study|Death|1|||
129479697|NCT05556616|466047636|FG004|Overall Study|Death|0|||
129479698|NCT05556616|466047637|FG005|Overall Study|Death|0|||
129479699|NCT05556616|466047638|FG006|Overall Study|Death|0|||
129479700|NCT05556616|466047632|FG000|Overall Study|Study Terminated by Sponsor|0|||
129479701|NCT05556616|466047633|FG001|Overall Study|Study Terminated by Sponsor|3|||
129479702|NCT05556616|466047634|FG002|Overall Study|Study Terminated by Sponsor|0|||
129479703|NCT05556616|466047635|FG003|Overall Study|Study Terminated by Sponsor|0|||
129479704|NCT05556616|466047636|FG004|Overall Study|Study Terminated by Sponsor|0|||
129479705|NCT05556616|466047637|FG005|Overall Study|Study Terminated by Sponsor|0|||
129479706|NCT05556616|466047638|FG006|Overall Study|Study Terminated by Sponsor|0|||
129479707|NCT00075881|466047641|FG000|Overall Study|Lack of Efficacy|18|||
129479708|NCT00075881|466047641|FG000|Overall Study|Adverse Event|7|||
129479709|NCT00075881|466047641|FG000|Overall Study|Death|1|||
129479710|NCT00075881|466047641|FG000|Overall Study|Withdrawal by Subject|2|||
129479711|NCT00075881|466047641|FG000|Overall Study|Protocol Violation|4|||
129479712|NCT00075881|466047641|FG000|Overall Study|other complicating disease|3|||
129479713|NCT00075881|466047641|FG000|Overall Study|other|4|||
129479714|NCT00075881|466047641|FG000|Overall Study|missing data|2|||
129479715|NCT00075881|466047641|FG000|Overall Study|Ineligible|1|||
129479716|NCT00075881|466047641|FG000|Overall Study|never start protocol therapy|1|||
129479717|NCT02031679|466047642|FG000|Overall Study|Protocol Violation|0|||
129479718|NCT02031679|466047643|FG001|Overall Study|Protocol Violation|1|||
129479719|NCT02031679|466047642|FG000|Overall Study|Lack of Efficacy|0|||
129479720|NCT02031679|466047643|FG001|Overall Study|Lack of Efficacy|1|||
129479721|NCT03019549|466047644|FG000|Washout|DId not meet genotype criteria|11|||
129479722|NCT03019549|466047644|FG000|Period 2|Adverse Event|2|||
129479723|NCT03019549|466047644|FG000|Period 2|Physician Decision|2|||
129479724|NCT03019549|466047644|FG000|Period 2|Withdrawal by Subject|1|||
129479725|NCT04030195|466047645|FG000|Overall Study|Withdrawal by Subject|2|||
129479726|NCT04030195|466047646|FG001|Overall Study|Withdrawal by Subject|0|||
129479727|NCT04030195|466047647|FG002|Overall Study|Withdrawal by Subject|0|||
129479728|NCT03263091|466047649|FG000|OL Component|Withdrawal by Subject|1|||
129479729|NCT03263091|466047650|FG001|OL Component|Withdrawal by Subject|1|||
129479730|NCT03263091|466047651|FG002|OL Component|Withdrawal by Subject|0|||
129479731|NCT03263091|466047652|FG003|OL Component|Withdrawal by Subject|0|||
129479732|NCT03263091|466047653|FG004|OL Component|Withdrawal by Subject|0|||
129479733|NCT03263091|466047654|FG005|OL Component|Withdrawal by Subject|0|||
129479734|NCT03263091|466047649|FG000|OL Component|Physician Decision|0|||
129479735|NCT03263091|466047650|FG001|OL Component|Physician Decision|1|||
129479736|NCT03263091|466047651|FG002|OL Component|Physician Decision|2|||
129479737|NCT03263091|466047652|FG003|OL Component|Physician Decision|0|||
129479738|NCT03263091|466047653|FG004|OL Component|Physician Decision|0|||
129479739|NCT03263091|466047654|FG005|OL Component|Physician Decision|0|||
129479740|NCT03263091|466047649|FG000|OL Component|Death|1|||
129479741|NCT03263091|466047650|FG001|OL Component|Death|0|||
129479742|NCT03263091|466047651|FG002|OL Component|Death|0|||
129479743|NCT03263091|466047652|FG003|OL Component|Death|0|||
129479744|NCT03263091|466047653|FG004|OL Component|Death|0|||
129479745|NCT03263091|466047654|FG005|OL Component|Death|0|||
129479746|NCT03263091|466047649|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
129479747|NCT03263091|466047650|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
129479748|NCT03263091|466047651|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
129479749|NCT03263091|466047652|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
129479750|NCT03263091|466047653|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
129479751|NCT03263091|466047654|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
129479752|NCT03263091|466047649|FG000|OL High-EPO Component|Physician Decision|0|||
129479753|NCT03263091|466047650|FG001|OL High-EPO Component|Physician Decision|0|||
129479754|NCT03263091|466047651|FG002|OL High-EPO Component|Physician Decision|0|||
129479755|NCT03263091|466047652|FG003|OL High-EPO Component|Physician Decision|1|||
129479756|NCT03263091|466047653|FG004|OL High-EPO Component|Physician Decision|0|||
129479757|NCT03263091|466047654|FG005|OL High-EPO Component|Physician Decision|0|||
129479758|NCT03263091|466047649|FG000|OL High-EPO Component|Death|0|||
129479759|NCT03263091|466047650|FG001|OL High-EPO Component|Death|0|||
129479760|NCT03263091|466047651|FG002|OL High-EPO Component|Death|0|||
129479761|NCT03263091|466047652|FG003|OL High-EPO Component|Death|3|||
129479762|NCT03263091|466047653|FG004|OL High-EPO Component|Death|0|||
129479763|NCT03263091|466047654|FG005|OL High-EPO Component|Death|0|||
129479764|NCT03263091|466047649|FG000|DB Component|Withdrawal by Subject|0|||
129479765|NCT03263091|466047650|FG001|DB Component|Withdrawal by Subject|0|||
129479766|NCT03263091|466047651|FG002|DB Component|Withdrawal by Subject|0|||
129479767|NCT03263091|466047652|FG003|DB Component|Withdrawal by Subject|0|||
129479768|NCT03263091|466047653|FG004|DB Component|Withdrawal by Subject|22|||
129479769|NCT03263091|466047654|FG005|DB Component|Withdrawal by Subject|8|||
129479770|NCT03263091|466047649|FG000|DB Component|Physician Decision|0|||
129479771|NCT03263091|466047650|FG001|DB Component|Physician Decision|0|||
129479772|NCT03263091|466047651|FG002|DB Component|Physician Decision|0|||
129479773|NCT03263091|466047652|FG003|DB Component|Physician Decision|0|||
129479774|NCT03263091|466047653|FG004|DB Component|Physician Decision|3|||
129479775|NCT03263091|466047654|FG005|DB Component|Physician Decision|1|||
129479776|NCT03263091|466047649|FG000|DB Component|Adverse Event|0|||
129479777|NCT03263091|466047650|FG001|DB Component|Adverse Event|0|||
129479778|NCT03263091|466047651|FG002|DB Component|Adverse Event|0|||
129479779|NCT03263091|466047652|FG003|DB Component|Adverse Event|0|||
129479780|NCT03263091|466047653|FG004|DB Component|Adverse Event|2|||
129479781|NCT03263091|466047654|FG005|DB Component|Adverse Event|1|||
129479782|NCT03263091|466047649|FG000|DB Component|Lost to Follow-up|0|||
129479783|NCT03263091|466047650|FG001|DB Component|Lost to Follow-up|0|||
129479784|NCT03263091|466047651|FG002|DB Component|Lost to Follow-up|0|||
129479785|NCT03263091|466047652|FG003|DB Component|Lost to Follow-up|0|||
129479786|NCT03263091|466047653|FG004|DB Component|Lost to Follow-up|2|||
129479787|NCT03263091|466047654|FG005|DB Component|Lost to Follow-up|1|||
129479788|NCT03263091|466047649|FG000|DB Component|Death|0|||
129479789|NCT03263091|466047650|FG001|DB Component|Death|0|||
129479790|NCT03263091|466047651|FG002|DB Component|Death|0|||
129479791|NCT03263091|466047652|FG003|DB Component|Death|0|||
129479792|NCT03263091|466047653|FG004|DB Component|Death|7|||
129479793|NCT03263091|466047654|FG005|DB Component|Death|4|||
129479794|NCT03263091|466047649|FG000|DB Component|Other than specified|0|||
129479795|NCT03263091|466047650|FG001|DB Component|Other than specified|0|||
129479796|NCT03263091|466047651|FG002|DB Component|Other than specified|0|||
129479797|NCT03263091|466047652|FG003|DB Component|Other than specified|0|||
129479798|NCT03263091|466047653|FG004|DB Component|Other than specified|8|||
129479799|NCT03263091|466047654|FG005|DB Component|Other than specified|6|||
129479800|NCT00742781|466047655|FG000|Overall Study|Withdrawal by Subject|3|||
129479801|NCT03539432|466047662|FG000|Overall Study|Lost to Follow-up|0|||
129479802|NCT03539432|466047663|FG001|Overall Study|Lost to Follow-up|1|||
129479803|NCT02443402|466047666|FG000|Overall Study|Withdrawal by Subject|3|||
129479804|NCT02443402|466047667|FG001|Overall Study|Withdrawal by Subject|1|||
129479805|NCT02443402|466047666|FG000|Overall Study|Screen Failure|1|||
129479806|NCT02443402|466047667|FG001|Overall Study|Screen Failure|2|||
129479807|NCT00824564|466047675|FG000|Overall Study|Lost to Follow-up|5|||
129479808|NCT00824564|466047676|FG001|Overall Study|Lost to Follow-up|7|||
129479809|NCT00824564|466047675|FG000|Overall Study|Withdrawal by Subject|1|||
129479810|NCT00824564|466047676|FG001|Overall Study|Withdrawal by Subject|1|||
129479811|NCT00824564|466047675|FG000|Overall Study|Other|1|||
129479812|NCT00824564|466047676|FG001|Overall Study|Other|2|||
129479813|NCT00824564|466047675|FG000|Overall Study|Randomized, but not treated|1|||
129479814|NCT00824564|466047676|FG001|Overall Study|Randomized, but not treated|0|||
129479815|NCT01552057|466047685|FG000|Overall Study|Adverse Event|14|||
129479816|NCT01552057|466047686|FG001|Overall Study|Adverse Event|15|||
129479817|NCT01552057|466047685|FG000|Overall Study|Lack of Efficacy|8|||
129479818|NCT01552057|466047686|FG001|Overall Study|Lack of Efficacy|23|||
129479819|NCT01552057|466047685|FG000|Overall Study|Withdrawal by Subject|5|||
129479820|NCT01552057|466047686|FG001|Overall Study|Withdrawal by Subject|8|||
129479821|NCT01552057|466047685|FG000|Overall Study|Entry Criteria Not Met|2|||
129479822|NCT01552057|466047686|FG001|Overall Study|Entry Criteria Not Met|2|||
129479823|NCT01552057|466047685|FG000|Overall Study|Physician Decision|1|||
129479824|NCT01552057|466047686|FG001|Overall Study|Physician Decision|0|||
129479825|NCT00476086|466047687|FG000|Overall Study|Alternative therapy|1|||
129479826|NCT00476086|466047687|FG000|Overall Study|Progressive Disease|4|||
129479827|NCT02900092|466047688|FG000|Overall Study|Adverse Event|1|||
129479828|NCT05127486|466047690|FG000|Overall Study|Adverse Event|2|||
129479829|NCT05127486|466047691|FG001|Overall Study|Adverse Event|4|||
129479830|NCT05127486|466047690|FG000|Overall Study|Lack of Efficacy|1|||
129479831|NCT05127486|466047691|FG001|Overall Study|Lack of Efficacy|0|||
129479832|NCT05127486|466047690|FG000|Overall Study|Pregnancy|0|||
129479833|NCT05127486|466047691|FG001|Overall Study|Pregnancy|1|||
129479834|NCT05127486|466047690|FG000|Overall Study|Physician Decision|4|||
129479835|NCT05127486|466047691|FG001|Overall Study|Physician Decision|1|||
129479836|NCT05127486|466047690|FG000|Overall Study|Withdrawal by Subject|14|||
129479837|NCT05127486|466047691|FG001|Overall Study|Withdrawal by Subject|13|||
129479838|NCT05127486|466047690|FG000|Overall Study|Lost to Follow-up|5|||
129479839|NCT05127486|466047691|FG001|Overall Study|Lost to Follow-up|8|||
129479840|NCT01287754|466047692|FG000|Overall Study|Death|2|||
129479841|NCT01287754|466047693|FG001|Overall Study|Death|12|||
129479842|NCT01287754|466047692|FG000|Overall Study|Lost to Follow-up|1|||
129479843|NCT01287754|466047693|FG001|Overall Study|Lost to Follow-up|6|||
129479844|NCT01287754|466047692|FG000|Overall Study|Protocol Violation|0|||
129479845|NCT01287754|466047693|FG001|Overall Study|Protocol Violation|3|||
129479846|NCT04439266|466047704|FG000|Overall Study|Ineligible|1|||
129479847|NCT04439266|466047704|FG000|Overall Study|Adverse Event|1|||
129479848|NCT04439266|466047704|FG000|Overall Study|Death|1|||
129479849|NCT04439266|466047704|FG000|Overall Study|Disease progression|1|||
129479850|NCT04439266|466047704|FG000|Overall Study|Still on treatment|1|||
129479851|NCT04971226|466047705|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
129479852|NCT04971226|466047706|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
129479853|NCT04971226|466047707|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
129479854|NCT04971226|466047708|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
129479855|NCT04971226|466047705|FG000|Overall Study|Adverse Event|6|||
129479856|NCT04971226|466047706|FG001|Overall Study|Adverse Event|5|||
129479857|NCT04971226|466047707|FG002|Overall Study|Adverse Event|11|||
129479858|NCT04971226|466047708|FG003|Overall Study|Adverse Event|10|||
129479859|NCT04971226|466047705|FG000|Overall Study|Progressive disease|2|||
129479860|NCT04971226|466047706|FG001|Overall Study|Progressive disease|0|||
129479861|NCT04971226|466047707|FG002|Overall Study|Progressive disease|3|||
129479862|NCT04971226|466047708|FG003|Overall Study|Progressive disease|1|||
129479863|NCT04971226|466047705|FG000|Overall Study|Protocol Deviation|1|||
129479864|NCT04971226|466047706|FG001|Overall Study|Protocol Deviation|0|||
129479865|NCT04971226|466047707|FG002|Overall Study|Protocol Deviation|1|||
129479866|NCT04971226|466047708|FG003|Overall Study|Protocol Deviation|1|||
129479867|NCT04971226|466047705|FG000|Overall Study|Subject Decision|0|||
129479868|NCT04971226|466047706|FG001|Overall Study|Subject Decision|1|||
129479869|NCT04971226|466047707|FG002|Overall Study|Subject Decision|1|||
129479870|NCT04971226|466047708|FG003|Overall Study|Subject Decision|1|||
129479871|NCT04971226|466047705|FG000|Overall Study|Pregnancy|0|||
129479872|NCT04971226|466047706|FG001|Overall Study|Pregnancy|0|||
129479873|NCT04971226|466047707|FG002|Overall Study|Pregnancy|0|||
129479874|NCT04971226|466047708|FG003|Overall Study|Pregnancy|1|||
129479875|NCT04971226|466047705|FG000|Overall Study|Participants not treated|1|||
129479876|NCT04971226|466047706|FG001|Overall Study|Participants not treated|0|||
129479877|NCT04971226|466047707|FG002|Overall Study|Participants not treated|2|||
129479878|NCT04971226|466047708|FG003|Overall Study|Participants not treated|1|||
129479879|NCT00001337|466047710|FG000|Overall Study|Switched to alternate treatment|2|||
129479880|NCT00001337|466047711|FG001|Overall Study|Switched to alternate treatment|2|||
129479881|NCT00001337|466047712|FG002|Overall Study|Switched to alternate treatment|0|||
129479882|NCT00001337|466047710|FG000|Overall Study|Refused further treatment|2|||
129479883|NCT00001337|466047711|FG001|Overall Study|Refused further treatment|1|||
129479884|NCT00001337|466047712|FG002|Overall Study|Refused further treatment|0|||
129479885|NCT00001337|466047710|FG000|Overall Study|Began other Tx|1|||
129479886|NCT00001337|466047711|FG001|Overall Study|Began other Tx|0|||
129479887|NCT00001337|466047712|FG002|Overall Study|Began other Tx|0|||
129479888|NCT00001337|466047710|FG000|Overall Study|Physician Decision|3|||
129479889|NCT00001337|466047711|FG001|Overall Study|Physician Decision|1|||
129479890|NCT00001337|466047712|FG002|Overall Study|Physician Decision|0|||
129479891|NCT00001337|466047710|FG000|Overall Study|Doesn't have NHL|0|||
129479892|NCT00001337|466047711|FG001|Overall Study|Doesn't have NHL|1|||
129479893|NCT00001337|466047712|FG002|Overall Study|Doesn't have NHL|0|||
129479894|NCT00001337|466047710|FG000|Overall Study|Non protocol tx needed|3|||
129479895|NCT00001337|466047711|FG001|Overall Study|Non protocol tx needed|1|||
129479896|NCT00001337|466047712|FG002|Overall Study|Non protocol tx needed|0|||
129976604|NCT03538938|467877783|FG003|Overall Study|Incarcerated|0|||
129976605|NCT03538938|467877784|FG004|Overall Study|Incarcerated|0|||
129479897|NCT00001337|466047710|FG000|Overall Study|Protocol change|1|||
129479898|NCT00001337|466047711|FG001|Overall Study|Protocol change|0|||
129479899|NCT00001337|466047712|FG002|Overall Study|Protocol change|0|||
129479900|NCT00001337|466047710|FG000|Overall Study|2nd primary disease|0|||
129479901|NCT00001337|466047711|FG001|Overall Study|2nd primary disease|0|||
129479902|NCT00001337|466047712|FG002|Overall Study|2nd primary disease|1|||
129479903|NCT00001337|466047710|FG000|Overall Study|Death during follow up period|9|||
129479904|NCT00001337|466047711|FG001|Overall Study|Death during follow up period|4|||
129479905|NCT00001337|466047712|FG002|Overall Study|Death during follow up period|0|||
129479906|NCT00001337|466047710|FG000|Overall Study|Death on study|19|||
129479907|NCT00001337|466047711|FG001|Overall Study|Death on study|9|||
129479908|NCT00001337|466047712|FG002|Overall Study|Death on study|0|||
129479909|NCT00001337|466047710|FG000|Overall Study|Disease progression during follow-up period|3|||
129479910|NCT00001337|466047711|FG001|Overall Study|Disease progression during follow-up period|1|||
129479911|NCT00001337|466047712|FG002|Overall Study|Disease progression during follow-up period|0|||
129479912|NCT00001337|466047710|FG000|Overall Study|Disease progression on study|33|||
129479913|NCT00001337|466047711|FG001|Overall Study|Disease progression on study|41|||
129479914|NCT00001337|466047712|FG002|Overall Study|Disease progression on study|0|||
129479915|NCT00001337|466047710|FG000|Overall Study|Lost to further follow-up|10|||
129479916|NCT00001337|466047711|FG001|Overall Study|Lost to further follow-up|6|||
129479917|NCT00001337|466047712|FG002|Overall Study|Lost to further follow-up|0|||
129479918|NCT00001337|466047710|FG000|Overall Study|2nd malignancy|1|||
129479919|NCT00001337|466047711|FG001|Overall Study|2nd malignancy|0|||
129479920|NCT00001337|466047712|FG002|Overall Study|2nd malignancy|0|||
129479921|NCT00001337|466047710|FG000|Overall Study|Treatment for second lymphoma|0|||
129479922|NCT00001337|466047711|FG001|Overall Study|Treatment for second lymphoma|1|||
129479923|NCT00001337|466047712|FG002|Overall Study|Treatment for second lymphoma|0|||
129479924|NCT00001337|466047710|FG000|Overall Study|Transfer to transplant|0|||
129479925|NCT00001337|466047711|FG001|Overall Study|Transfer to transplant|1|||
129479926|NCT00001337|466047712|FG002|Overall Study|Transfer to transplant|0|||
129479927|NCT04889209|466047719|FG000|All Cohorts Except 15E|Adverse Event|0|||
129479928|NCT04889209|466047720|FG001|All Cohorts Except 15E|Adverse Event|0|||
129479929|NCT04889209|466047721|FG002|All Cohorts Except 15E|Adverse Event|0|||
129479930|NCT04889209|466047722|FG003|All Cohorts Except 15E|Adverse Event|0|||
129479931|NCT04889209|466047723|FG004|All Cohorts Except 15E|Adverse Event|0|||
129479932|NCT04889209|466047724|FG005|All Cohorts Except 15E|Adverse Event|0|||
129479933|NCT04889209|466047725|FG006|All Cohorts Except 15E|Adverse Event|1|||
129479934|NCT04889209|466047726|FG007|All Cohorts Except 15E|Adverse Event|0|||
129479935|NCT04889209|466047727|FG008|All Cohorts Except 15E|Adverse Event|0|||
129479936|NCT04889209|466047728|FG009|All Cohorts Except 15E|Adverse Event|0|||
129479937|NCT04889209|466047729|FG010|All Cohorts Except 15E|Adverse Event|0|||
129479938|NCT04889209|466047730|FG011|All Cohorts Except 15E|Adverse Event|0|||
129479939|NCT04889209|466047731|FG012|All Cohorts Except 15E|Adverse Event|0|||
129479940|NCT04889209|466047732|FG013|All Cohorts Except 15E|Adverse Event|0|||
129479941|NCT04889209|466047733|FG014|All Cohorts Except 15E|Adverse Event|0|||
129479942|NCT04889209|466047734|FG015|All Cohorts Except 15E|Adverse Event|0|||
129479943|NCT04889209|466047735|FG016|All Cohorts Except 15E|Adverse Event|0|||
129479944|NCT04889209|466047736|FG017|All Cohorts Except 15E|Adverse Event|0|||
129479945|NCT04889209|466047719|FG000|All Cohorts Except 15E|Death|0|||
129479946|NCT04889209|466047720|FG001|All Cohorts Except 15E|Death|1|||
129479947|NCT04889209|466047721|FG002|All Cohorts Except 15E|Death|0|||
129479948|NCT04889209|466047722|FG003|All Cohorts Except 15E|Death|0|||
129479949|NCT04889209|466047723|FG004|All Cohorts Except 15E|Death|0|||
129479950|NCT04889209|466047724|FG005|All Cohorts Except 15E|Death|0|||
129479951|NCT04889209|466047725|FG006|All Cohorts Except 15E|Death|0|||
129479952|NCT04889209|466047726|FG007|All Cohorts Except 15E|Death|0|||
129976606|NCT03538938|467877785|FG005|Overall Study|Incarcerated|0|||
129976607|NCT03538938|467877786|FG006|Overall Study|Incarcerated|0|||
129976608|NCT03538938|467877787|FG007|Overall Study|Incarcerated|0|||
129976609|NCT03538938|467877788|FG008|Overall Study|Incarcerated|0|||
129976610|NCT03538938|467877789|FG009|Overall Study|Incarcerated|0|||
129976611|NCT03538938|467877790|FG010|Overall Study|Incarcerated|0|||
129976612|NCT03538938|467877791|FG011|Overall Study|Incarcerated|1|||
129976613|NCT03538938|467877792|FG012|Overall Study|Incarcerated|0|||
129976614|NCT03538938|467877793|FG013|Overall Study|Incarcerated|0|||
129976615|NCT03538938|467877794|FG014|Overall Study|Incarcerated|0|||
129976616|NCT03538938|467877795|FG015|Overall Study|Incarcerated|0|||
129976617|NCT03995316|467877796|FG000|Overall Study|Lost to Follow-up|10|||
129976618|NCT03995316|467877797|FG001|Overall Study|Lost to Follow-up|3|||
129976619|NCT01361594|467877798|FG000|Overall Study|Withdrawal by Subject|1|||
129976620|NCT01361594|467877799|FG001|Overall Study|Withdrawal by Subject|2|||
129479953|NCT04889209|466047727|FG008|All Cohorts Except 15E|Death|0|||
129976621|NCT00780559|467877801|FG000|Overall Study|Lost to Follow-up|2|||
129976622|NCT00780559|467877802|FG001|Overall Study|Lost to Follow-up|7|||
129976623|NCT00780559|467877801|FG000|Overall Study|Death|1|||
129479954|NCT04889209|466047728|FG009|All Cohorts Except 15E|Death|0|||
129479955|NCT04889209|466047729|FG010|All Cohorts Except 15E|Death|0|||
129479956|NCT04889209|466047730|FG011|All Cohorts Except 15E|Death|0|||
129976624|NCT00780559|467877802|FG001|Overall Study|Death|0|||
129479957|NCT04889209|466047731|FG012|All Cohorts Except 15E|Death|0|||
129479958|NCT04889209|466047732|FG013|All Cohorts Except 15E|Death|0|||
129479959|NCT04889209|466047733|FG014|All Cohorts Except 15E|Death|0|||
129479960|NCT04889209|466047734|FG015|All Cohorts Except 15E|Death|0|||
129479961|NCT04889209|466047735|FG016|All Cohorts Except 15E|Death|0|||
129479962|NCT04889209|466047736|FG017|All Cohorts Except 15E|Death|0|||
129479963|NCT04889209|466047719|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
129479964|NCT04889209|466047720|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
129976625|NCT00839956|467877810|FG000|Overall Study|Adverse Event|2|||
129976626|NCT00839956|467877810|FG000|Overall Study|Lack of Efficacy|6|||
129976627|NCT00839956|467877810|FG000|Overall Study|Physician Decision|1|||
129976628|NCT00839956|467877810|FG000|Overall Study|Withdrawal by Subject|3|||
129976629|NCT02807883|467877811|FG000|Overall Study|Withdrawal by Subject|2|||
129976630|NCT01399918|467877815|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
129976631|NCT03197766|467877820|FG000|Overall Study|Withdrawal by Subject|2|||
129976632|NCT03197766|467877821|FG001|Overall Study|Withdrawal by Subject|0|||
129976633|NCT00972322|467877823|FG000|Overall Study|Adverse Event|2|||
129976634|NCT00972322|467877824|FG001|Overall Study|Adverse Event|1|||
129976635|NCT00972322|467877823|FG000|Overall Study|Positive drug screen|0|||
129976636|NCT00972322|467877824|FG001|Overall Study|Positive drug screen|1|||
129976637|NCT00972322|467877823|FG000|Overall Study|Lost to Follow-up|0|||
129976638|NCT00972322|467877824|FG001|Overall Study|Lost to Follow-up|1|||
129479965|NCT04889209|466047721|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
129479966|NCT04889209|466047722|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
129479967|NCT04889209|466047723|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
129479968|NCT04889209|466047724|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
129479969|NCT04889209|466047725|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
129479970|NCT04889209|466047726|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
129479971|NCT04889209|466047727|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
129479972|NCT04889209|466047728|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
129479973|NCT04889209|466047729|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
129479974|NCT04889209|466047730|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
129479975|NCT04889209|466047731|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
129479976|NCT04889209|466047732|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
129479977|NCT04889209|466047733|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
129479978|NCT04889209|466047734|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
129479979|NCT04889209|466047735|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
129479980|NCT04889209|466047736|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
129479981|NCT04889209|466047719|FG000|All Cohorts Except 15E|Physician Decision|0|||
129479982|NCT04889209|466047720|FG001|All Cohorts Except 15E|Physician Decision|0|||
129479983|NCT04889209|466047721|FG002|All Cohorts Except 15E|Physician Decision|0|||
129479984|NCT04889209|466047722|FG003|All Cohorts Except 15E|Physician Decision|0|||
129479985|NCT04889209|466047723|FG004|All Cohorts Except 15E|Physician Decision|1|||
129479986|NCT04889209|466047724|FG005|All Cohorts Except 15E|Physician Decision|0|||
129479987|NCT04889209|466047725|FG006|All Cohorts Except 15E|Physician Decision|0|||
129479988|NCT04889209|466047726|FG007|All Cohorts Except 15E|Physician Decision|1|||
129479989|NCT04889209|466047727|FG008|All Cohorts Except 15E|Physician Decision|0|||
129479990|NCT04889209|466047728|FG009|All Cohorts Except 15E|Physician Decision|1|||
129479991|NCT04889209|466047729|FG010|All Cohorts Except 15E|Physician Decision|0|||
129479992|NCT04889209|466047730|FG011|All Cohorts Except 15E|Physician Decision|1|||
129479993|NCT04889209|466047731|FG012|All Cohorts Except 15E|Physician Decision|1|||
129479994|NCT04889209|466047732|FG013|All Cohorts Except 15E|Physician Decision|0|||
129479995|NCT04889209|466047733|FG014|All Cohorts Except 15E|Physician Decision|0|||
129479996|NCT04889209|466047734|FG015|All Cohorts Except 15E|Physician Decision|0|||
129479997|NCT04889209|466047735|FG016|All Cohorts Except 15E|Physician Decision|0|||
129479998|NCT04889209|466047736|FG017|All Cohorts Except 15E|Physician Decision|0|||
129479999|NCT04889209|466047719|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
129480000|NCT04889209|466047720|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
129480001|NCT04889209|466047721|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
129480002|NCT04889209|466047722|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
129480003|NCT04889209|466047723|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
129480004|NCT04889209|466047724|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480005|NCT04889209|466047725|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480006|NCT04889209|466047726|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
129480007|NCT04889209|466047727|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480008|NCT04889209|466047728|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480009|NCT04889209|466047729|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480010|NCT04889209|466047730|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480011|NCT04889209|466047731|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480012|NCT04889209|466047732|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
129480013|NCT04889209|466047733|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
129480014|NCT04889209|466047734|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
129976639|NCT00972322|467877823|FG000|Overall Study|Consistently high glucose values|1|||
129976640|NCT00972322|467877824|FG001|Overall Study|Consistently high glucose values|0|||
129480015|NCT04889209|466047735|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
129480016|NCT04889209|466047736|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
129976641|NCT00277095|467877827|FG000|Overall Study|Death|2|||
129976642|NCT00277095|467877827|FG000|Overall Study|Explanted|7|||
129976643|NCT00277095|467877827|FG000|Overall Study|Lost to Follow-up|2|||
129976644|NCT00277095|467877827|FG000|Overall Study|Missed Follow-up|9|||
129976645|NCT00277095|467877827|FG000|Overall Study|Physician Decision|1|||
129480017|NCT04889209|466047719|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
129480018|NCT04889209|466047720|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
129480019|NCT04889209|466047721|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480020|NCT04889209|466047722|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480021|NCT04889209|466047723|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480022|NCT04889209|466047724|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
129480023|NCT04889209|466047725|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480024|NCT04889209|466047726|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
129480025|NCT04889209|466047727|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480026|NCT04889209|466047728|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
129480027|NCT04889209|466047729|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480028|NCT04889209|466047730|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480029|NCT04889209|466047731|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480030|NCT04889209|466047732|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480031|NCT04889209|466047733|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480032|NCT04889209|466047734|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480033|NCT04889209|466047735|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
129480034|NCT04889209|466047736|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
129480035|NCT04889209|466047719|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480036|NCT04889209|466047720|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480037|NCT04889209|466047721|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480038|NCT04889209|466047722|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
129480039|NCT04889209|466047723|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480040|NCT04889209|466047724|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480041|NCT04889209|466047725|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480042|NCT04889209|466047726|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480043|NCT04889209|466047727|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480044|NCT04889209|466047728|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480045|NCT04889209|466047729|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480046|NCT04889209|466047730|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480047|NCT04889209|466047731|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480048|NCT04889209|466047732|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480049|NCT04889209|466047733|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480050|NCT04889209|466047734|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480051|NCT04889209|466047735|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480052|NCT04889209|466047736|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
129480053|NCT04889209|466047719|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480054|NCT04889209|466047720|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480055|NCT04889209|466047721|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480056|NCT04889209|466047722|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480057|NCT04889209|466047723|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480058|NCT04889209|466047724|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480059|NCT04889209|466047725|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480060|NCT04889209|466047726|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480061|NCT04889209|466047727|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480062|NCT04889209|466047728|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480063|NCT04889209|466047729|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480064|NCT04889209|466047730|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480065|NCT04889209|466047731|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480066|NCT04889209|466047732|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480067|NCT04889209|466047733|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480068|NCT04889209|466047734|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480069|NCT04889209|466047735|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
129480070|NCT04889209|466047736|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
129480071|NCT04889209|466047719|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480072|NCT04889209|466047720|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480073|NCT04889209|466047721|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480074|NCT04889209|466047722|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129976646|NCT05140915|467877829|FG000|Overall Study|Lost to Follow-up|2|||
129480075|NCT04889209|466047723|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480076|NCT04889209|466047724|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480077|NCT04889209|466047725|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480078|NCT04889209|466047726|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480079|NCT04889209|466047727|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480080|NCT04889209|466047728|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480081|NCT04889209|466047729|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480082|NCT04889209|466047730|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480083|NCT04889209|466047731|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480084|NCT04889209|466047732|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480085|NCT04889209|466047733|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480086|NCT04889209|466047734|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480087|NCT04889209|466047735|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
129480088|NCT04889209|466047736|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
129480089|NCT04889209|466047719|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480090|NCT04889209|466047720|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480091|NCT04889209|466047721|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480092|NCT04889209|466047722|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480093|NCT04889209|466047723|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480094|NCT04889209|466047724|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480095|NCT04889209|466047725|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480096|NCT04889209|466047726|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480097|NCT04889209|466047727|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480098|NCT04889209|466047728|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480099|NCT04889209|466047729|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480100|NCT04889209|466047730|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480101|NCT04889209|466047731|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480102|NCT04889209|466047732|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480103|NCT04889209|466047733|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480104|NCT04889209|466047734|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480105|NCT04889209|466047735|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
129480106|NCT04889209|466047736|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
129480107|NCT04889209|466047719|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480108|NCT04889209|466047720|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480109|NCT04889209|466047721|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480110|NCT04889209|466047722|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480111|NCT04889209|466047723|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480112|NCT04889209|466047724|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480113|NCT04889209|466047725|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480114|NCT04889209|466047726|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480115|NCT04889209|466047727|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480116|NCT04889209|466047728|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480117|NCT04889209|466047729|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480118|NCT04889209|466047730|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480119|NCT04889209|466047731|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480120|NCT04889209|466047732|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480121|NCT04889209|466047733|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
129480122|NCT04889209|466047734|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480123|NCT04889209|466047735|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480124|NCT04889209|466047736|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
129480125|NCT01725165|466047737|FG000|Overall Study|Death|11|||
129480126|NCT01725165|466047738|FG001|Overall Study|Death|18|||
129480127|NCT00474240|466047744|FG000|Overall Study|Withdrawal by Subject|1|||
129480128|NCT00474240|466047745|FG001|Overall Study|Withdrawal by Subject|1|||
129480129|NCT00474240|466047746|FG002|Overall Study|Withdrawal by Subject|0|||
129480130|NCT00474240|466047747|FG003|Overall Study|Withdrawal by Subject|2|||
129480131|NCT00474240|466047748|FG004|Overall Study|Withdrawal by Subject|3|||
129480132|NCT00474240|466047749|FG005|Overall Study|Withdrawal by Subject|1|||
129480133|NCT00474240|466047744|FG000|Overall Study|Adverse Event|0|||
129480134|NCT00474240|466047745|FG001|Overall Study|Adverse Event|0|||
129480135|NCT00474240|466047746|FG002|Overall Study|Adverse Event|9|||
129480136|NCT00474240|466047747|FG003|Overall Study|Adverse Event|14|||
129480137|NCT00474240|466047748|FG004|Overall Study|Adverse Event|5|||
129480138|NCT00474240|466047749|FG005|Overall Study|Adverse Event|16|||
129480139|NCT00474240|466047744|FG000|Overall Study|Removed due to lab value|0|||
129480140|NCT00474240|466047745|FG001|Overall Study|Removed due to lab value|0|||
129480141|NCT00474240|466047746|FG002|Overall Study|Removed due to lab value|0|||
129480142|NCT00474240|466047747|FG003|Overall Study|Removed due to lab value|0|||
129480143|NCT00474240|466047748|FG004|Overall Study|Removed due to lab value|0|||
129480144|NCT00474240|466047749|FG005|Overall Study|Removed due to lab value|1|||
129480145|NCT01071070|466047753|FG000|Overall Study|Adverse Event|0|||
129480146|NCT01071070|466047754|FG001|Overall Study|Adverse Event|3|||
129480147|NCT01071070|466047753|FG000|Overall Study|Withdrawal by Subject|1|||
129480148|NCT01071070|466047754|FG001|Overall Study|Withdrawal by Subject|0|||
129480149|NCT01071070|466047753|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
129480150|NCT01071070|466047754|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
129480151|NCT01071070|466047753|FG000|Overall Study|Hypercalcemia|1|||
129480152|NCT01071070|466047754|FG001|Overall Study|Hypercalcemia|0|||
129480153|NCT02203149|466047755|FG000|Part 1|Adverse Event|0|||
129480154|NCT02203149|466047756|FG001|Part 1|Adverse Event|1|||
129480155|NCT02203149|466047757|FG002|Part 1|Adverse Event|0|||
129480156|NCT02203149|466047758|FG003|Part 1|Adverse Event|0|||
129480157|NCT02203149|466047759|FG004|Part 1|Adverse Event|0|||
129480158|NCT02203149|466047755|FG000|Part 2|Death|0|||
129480159|NCT02203149|466047756|FG001|Part 2|Death|0|||
129480160|NCT02203149|466047757|FG002|Part 2|Death|1|||
129480161|NCT02203149|466047758|FG003|Part 2|Death|1|||
129480162|NCT02203149|466047759|FG004|Part 2|Death|0|||
129480163|NCT02203149|466047755|FG000|Part 2|Withdrawal by Subject|0|||
129480164|NCT02203149|466047756|FG001|Part 2|Withdrawal by Subject|0|||
129480165|NCT02203149|466047757|FG002|Part 2|Withdrawal by Subject|0|||
129480166|NCT02203149|466047758|FG003|Part 2|Withdrawal by Subject|1|||
129480167|NCT02203149|466047759|FG004|Part 2|Withdrawal by Subject|0|||
129480168|NCT02203149|466047755|FG000|Part 2|Adverse Event|0|||
129480169|NCT02203149|466047756|FG001|Part 2|Adverse Event|0|||
129480170|NCT02203149|466047757|FG002|Part 2|Adverse Event|0|||
129480171|NCT02203149|466047758|FG003|Part 2|Adverse Event|1|||
129480172|NCT02203149|466047759|FG004|Part 2|Adverse Event|1|||
129480173|NCT01454076|466047760|FG000|Overall Study|Other|2|||
129480174|NCT01454076|466047761|FG001|Overall Study|Other|0|||
129480175|NCT01454076|466047762|FG002|Overall Study|Other|0|||
129480176|NCT01454076|466047763|FG003|Overall Study|Other|1|||
129480177|NCT01454076|466047764|FG004|Overall Study|Other|2|||
129480178|NCT01454076|466047760|FG000|Overall Study|Withdrawal by Subject|3|||
129480179|NCT01454076|466047761|FG001|Overall Study|Withdrawal by Subject|4|||
129480180|NCT01454076|466047762|FG002|Overall Study|Withdrawal by Subject|2|||
129480181|NCT01454076|466047763|FG003|Overall Study|Withdrawal by Subject|1|||
129480182|NCT01454076|466047764|FG004|Overall Study|Withdrawal by Subject|2|||
129480183|NCT01454076|466047760|FG000|Overall Study|Adverse Event|8|||
129480184|NCT01454076|466047761|FG001|Overall Study|Adverse Event|2|||
129480185|NCT01454076|466047762|FG002|Overall Study|Adverse Event|7|||
129480186|NCT01454076|466047763|FG003|Overall Study|Adverse Event|0|||
129480187|NCT01454076|466047764|FG004|Overall Study|Adverse Event|2|||
129480188|NCT01478958|466047765|FG000|Overall Study|Withdrawal by Subject|1|||
129480189|NCT01478958|466047766|FG001|Overall Study|Withdrawal by Subject|1|||
129480190|NCT01478958|466047767|FG002|Overall Study|Withdrawal by Subject|1|||
129480191|NCT01478958|466047765|FG000|Overall Study|Weight loss|1|||
129480192|NCT01478958|466047766|FG001|Overall Study|Weight loss|0|||
129480193|NCT01478958|466047767|FG002|Overall Study|Weight loss|0|||
129480194|NCT01478958|466047765|FG000|Overall Study|Re-located|0|||
129480195|NCT01478958|466047766|FG001|Overall Study|Re-located|1|||
129480196|NCT01478958|466047767|FG002|Overall Study|Re-located|0|||
129480197|NCT01478958|466047765|FG000|Overall Study|Unable to comply|0|||
129480198|NCT01478958|466047766|FG001|Overall Study|Unable to comply|0|||
129480199|NCT01478958|466047767|FG002|Overall Study|Unable to comply|2|||
129480200|NCT01193686|466047768|FG000|Overall Study|Withdrawal by Subject|4|||
129480201|NCT01193686|466047769|FG001|Overall Study|Withdrawal by Subject|1|||
129480202|NCT01193686|466047768|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
129480203|NCT01193686|466047769|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
129976647|NCT05140915|467877830|FG001|Overall Study|Lost to Follow-up|1|||
129976648|NCT04520659|467877831|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
129976649|NCT04520659|467877832|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
129976650|NCT04520659|467877833|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
129976651|NCT04520659|467877834|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
129976652|NCT04879849|467877839|FG000|Overall Study|Lost to Follow-up|0|||
129480204|NCT03401749|466047770|FG000|Overall Study|Lost to Follow-up|20|||
129480205|NCT03401749|466047771|FG001|Overall Study|Lost to Follow-up|16|||
129480206|NCT03401749|466047772|FG002|Overall Study|Lost to Follow-up|26|||
129480207|NCT03075839|466047773|FG000|Overall Study|Lost to Follow-up|4|||
129480208|NCT03853694|466047774|FG000|Overall Study|Protocol Violation|3|||
129480209|NCT03853694|466047775|FG001|Overall Study|Protocol Violation|5|||
129480210|NCT03853694|466047776|FG002|Overall Study|Protocol Violation|3|||
129480211|NCT03853694|466047774|FG000|Overall Study|Delivered early|0|||
129480212|NCT03853694|466047775|FG001|Overall Study|Delivered early|1|||
129480213|NCT03853694|466047776|FG002|Overall Study|Delivered early|0|||
129480214|NCT03853694|466047774|FG000|Overall Study|not suitable to proceed|0|||
129480215|NCT03853694|466047775|FG001|Overall Study|not suitable to proceed|1|||
129976653|NCT04879849|467877840|FG001|Overall Study|Lost to Follow-up|0|||
129976654|NCT04879849|467877841|FG002|Overall Study|Lost to Follow-up|0|||
129976655|NCT04879849|467877842|FG003|Overall Study|Lost to Follow-up|1|||
129976656|NCT04879849|467877843|FG004|Overall Study|Lost to Follow-up|0|||
129480216|NCT03853694|466047776|FG002|Overall Study|not suitable to proceed|0|||
129480217|NCT03853694|466047774|FG000|Overall Study|difficult surgery|0|||
129480218|NCT03853694|466047775|FG001|Overall Study|difficult surgery|0|||
129480219|NCT03853694|466047776|FG002|Overall Study|difficult surgery|1|||
129480220|NCT03853694|466047774|FG000|Overall Study|Lost to Follow-up|0|||
129480221|NCT03853694|466047775|FG001|Overall Study|Lost to Follow-up|1|||
129480222|NCT03853694|466047776|FG002|Overall Study|Lost to Follow-up|0|||
129480223|NCT03853694|466047774|FG000|Overall Study|Withdrawal by Subject|0|||
129480224|NCT03853694|466047775|FG001|Overall Study|Withdrawal by Subject|1|||
129480225|NCT03853694|466047776|FG002|Overall Study|Withdrawal by Subject|0|||
129480226|NCT05089708|466047777|FG000|Overall Study|Lost to Follow-up|9|||
129480227|NCT05089708|466047778|FG001|Overall Study|Lost to Follow-up|7|||
129480228|NCT05089708|466047777|FG000|Overall Study|Withdrawal by Subject|3|||
129480229|NCT05089708|466047778|FG001|Overall Study|Withdrawal by Subject|1|||
129480230|NCT05089708|466047777|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
129480231|NCT05089708|466047778|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
129480232|NCT05089708|466047777|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
129480233|NCT05089708|466047778|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
129480234|NCT02305563|466047780|FG000|Treatment Period|Disease progression|0|||
129480235|NCT02305563|466047781|FG001|Treatment Period|Disease progression|0|||
129480236|NCT02305563|466047782|FG002|Treatment Period|Disease progression|15|||
129480237|NCT02305563|466047783|FG003|Treatment Period|Disease progression|6|||
129480238|NCT02305563|466047784|FG004|Treatment Period|Disease progression|6|||
129480239|NCT02305563|466047780|FG000|Treatment Period|Study drug toxicity|0|||
129480240|NCT02305563|466047781|FG001|Treatment Period|Study drug toxicity|0|||
129480241|NCT02305563|466047782|FG002|Treatment Period|Study drug toxicity|0|||
129480242|NCT02305563|466047783|FG003|Treatment Period|Study drug toxicity|1|||
129480243|NCT02305563|466047784|FG004|Treatment Period|Study drug toxicity|2|||
129480244|NCT02305563|466047780|FG000|Treatment Period|Death|0|||
129480245|NCT02305563|466047781|FG001|Treatment Period|Death|0|||
129480246|NCT02305563|466047782|FG002|Treatment Period|Death|1|||
129480247|NCT02305563|466047783|FG003|Treatment Period|Death|2|||
129480248|NCT02305563|466047784|FG004|Treatment Period|Death|1|||
129480249|NCT02305563|466047780|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
129480250|NCT02305563|466047781|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
129480251|NCT02305563|466047782|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
129480252|NCT02305563|466047783|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
129480253|NCT02305563|466047784|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
129480254|NCT02305563|466047780|FG000|Treatment Period|Participant request to stop therapy|0|||
129480255|NCT02305563|466047781|FG001|Treatment Period|Participant request to stop therapy|2|||
129480256|NCT02305563|466047782|FG002|Treatment Period|Participant request to stop therapy|0|||
129480257|NCT02305563|466047783|FG003|Treatment Period|Participant request to stop therapy|1|||
129480258|NCT02305563|466047784|FG004|Treatment Period|Participant request to stop therapy|0|||
129480259|NCT02305563|466047780|FG000|Treatment Period|Participant withdrew consent|0|||
129480260|NCT02305563|466047781|FG001|Treatment Period|Participant withdrew consent|0|||
129480261|NCT02305563|466047782|FG002|Treatment Period|Participant withdrew consent|1|||
129480262|NCT02305563|466047783|FG003|Treatment Period|Participant withdrew consent|1|||
129480263|NCT02305563|466047784|FG004|Treatment Period|Participant withdrew consent|1|||
129480264|NCT02305563|466047780|FG000|Treatment Period|Maximum clinical benefit|0|||
129480265|NCT02305563|466047781|FG001|Treatment Period|Maximum clinical benefit|0|||
129480266|NCT02305563|466047782|FG002|Treatment Period|Maximum clinical benefit|0|||
129480267|NCT02305563|466047783|FG003|Treatment Period|Maximum clinical benefit|0|||
129480268|NCT02305563|466047784|FG004|Treatment Period|Maximum clinical benefit|1|||
129480269|NCT02305563|466047780|FG000|Treatment Period|Poor/non-compliance|0|||
129480270|NCT02305563|466047781|FG001|Treatment Period|Poor/non-compliance|0|||
129480271|NCT02305563|466047782|FG002|Treatment Period|Poor/non-compliance|0|||
129480272|NCT02305563|466047783|FG003|Treatment Period|Poor/non-compliance|0|||
129480273|NCT02305563|466047784|FG004|Treatment Period|Poor/non-compliance|1|||
129480274|NCT02305563|466047780|FG000|Treatment Period|Administrative reason by Sponsor|0|||
129480275|NCT02305563|466047781|FG001|Treatment Period|Administrative reason by Sponsor|0|||
129480276|NCT02305563|466047782|FG002|Treatment Period|Administrative reason by Sponsor|0|||
129480277|NCT02305563|466047783|FG003|Treatment Period|Administrative reason by Sponsor|0|||
129480278|NCT02305563|466047784|FG004|Treatment Period|Administrative reason by Sponsor|1|||
129480279|NCT02305563|466047780|FG000|Treatment Period|other reason|2|||
129480280|NCT02305563|466047781|FG001|Treatment Period|other reason|0|||
129480281|NCT02305563|466047782|FG002|Treatment Period|other reason|2|||
129480282|NCT02305563|466047783|FG003|Treatment Period|other reason|2|||
129480283|NCT02305563|466047784|FG004|Treatment Period|other reason|1|||
129976657|NCT04879849|467877844|FG005|Overall Study|Lost to Follow-up|0|||
129976658|NCT04879849|467877845|FG006|Overall Study|Lost to Follow-up|0|||
129976659|NCT04879849|467877846|FG007|Overall Study|Lost to Follow-up|0|||
129480284|NCT02305563|466047780|FG000|Treatment Period|Randomized but not treated|0|||
129480285|NCT02305563|466047781|FG001|Treatment Period|Randomized but not treated|0|||
129480286|NCT02305563|466047782|FG002|Treatment Period|Randomized but not treated|0|||
129480287|NCT02305563|466047783|FG003|Treatment Period|Randomized but not treated|0|||
129480288|NCT02305563|466047784|FG004|Treatment Period|Randomized but not treated|2|||
129480289|NCT02305563|466047780|FG000|Treatment Period|added ULO, then disease progression|0|||
129480290|NCT02305563|466047781|FG001|Treatment Period|added ULO, then disease progression|0|||
129480291|NCT02305563|466047782|FG002|Treatment Period|added ULO, then disease progression|0|||
129480292|NCT02305563|466047783|FG003|Treatment Period|added ULO, then disease progression|0|||
129480293|NCT02305563|466047784|FG004|Treatment Period|added ULO, then disease progression|4|||
129480294|NCT02305563|466047780|FG000|Treatment Period|added ULO; then other reason|0|||
129480295|NCT02305563|466047781|FG001|Treatment Period|added ULO; then other reason|0|||
129480296|NCT02305563|466047782|FG002|Treatment Period|added ULO; then other reason|0|||
129480297|NCT02305563|466047783|FG003|Treatment Period|added ULO; then other reason|0|||
129480298|NCT02305563|466047784|FG004|Treatment Period|added ULO; then other reason|1|||
129480299|NCT02305563|466047780|FG000|Treatment Period|added ULO, then request to stop|0|||
129480300|NCT02305563|466047781|FG001|Treatment Period|added ULO, then request to stop|0|||
129480301|NCT02305563|466047782|FG002|Treatment Period|added ULO, then request to stop|0|||
129480302|NCT02305563|466047783|FG003|Treatment Period|added ULO, then request to stop|0|||
129480303|NCT02305563|466047784|FG004|Treatment Period|added ULO, then request to stop|1|||
129480304|NCT02305563|466047780|FG000|Follow-up Period|Death|0|||
129480305|NCT02305563|466047781|FG001|Follow-up Period|Death|0|||
129480306|NCT02305563|466047782|FG002|Follow-up Period|Death|5|||
129480307|NCT02305563|466047783|FG003|Follow-up Period|Death|4|||
129480308|NCT02305563|466047784|FG004|Follow-up Period|Death|7|||
129480309|NCT02305563|466047780|FG000|Follow-up Period|Participant withdrew consent|0|||
129480310|NCT02305563|466047781|FG001|Follow-up Period|Participant withdrew consent|0|||
129480311|NCT02305563|466047782|FG002|Follow-up Period|Participant withdrew consent|2|||
129480312|NCT02305563|466047783|FG003|Follow-up Period|Participant withdrew consent|1|||
129480313|NCT02305563|466047784|FG004|Follow-up Period|Participant withdrew consent|0|||
129480314|NCT02305563|466047780|FG000|Follow-up Period|other reason|0|||
129480315|NCT02305563|466047781|FG001|Follow-up Period|other reason|0|||
129480316|NCT02305563|466047782|FG002|Follow-up Period|other reason|0|||
129480317|NCT02305563|466047783|FG003|Follow-up Period|other reason|0|||
129480318|NCT02305563|466047784|FG004|Follow-up Period|other reason|1|||
129480319|NCT02305563|466047780|FG000|Follow-up Period|Followup no longer required per protocol|3|||
129480320|NCT02305563|466047781|FG001|Follow-up Period|Followup no longer required per protocol|3|||
129480321|NCT02305563|466047782|FG002|Follow-up Period|Followup no longer required per protocol|4|||
129480322|NCT02305563|466047783|FG003|Follow-up Period|Followup no longer required per protocol|1|||
129480323|NCT02305563|466047784|FG004|Follow-up Period|Followup no longer required per protocol|4|||
129480324|NCT02700451|466047785|FG000|Overall Study|Protocol Violation|2|||
129480325|NCT02700451|466047786|FG001|Overall Study|Protocol Violation|2|||
129480326|NCT02700451|466047787|FG002|Overall Study|Protocol Violation|3|||
129480327|NCT02700451|466047785|FG000|Overall Study|Discontinued intervention|14|||
129480328|NCT02700451|466047786|FG001|Overall Study|Discontinued intervention|15|||
129480329|NCT02700451|466047787|FG002|Overall Study|Discontinued intervention|14|||
129480330|NCT04373460|466047788|FG000|Overall Study|Did not receive tranfusion|18|||
129480331|NCT04373460|466047789|FG001|Overall Study|Did not receive tranfusion|26|||
129480332|NCT00454207|466047790|FG000|Overall Study|Adverse Event|3|||
129480333|NCT00454207|466047791|FG001|Overall Study|Adverse Event|1|||
129480334|NCT00454207|466047790|FG000|Overall Study|Lack of Efficacy|1|||
129480335|NCT00454207|466047791|FG001|Overall Study|Lack of Efficacy|0|||
129480336|NCT00454207|466047790|FG000|Overall Study|Protocol Violation|0|||
129480337|NCT00454207|466047791|FG001|Overall Study|Protocol Violation|1|||
129480338|NCT00642642|466047793|FG000|Treatment & Follow Up|Adverse Event|2|||
129480339|NCT00642642|466047793|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
129480340|NCT00642642|466047793|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
129480341|NCT02337387|466047796|FG000|Overall Study|Adverse Event|0|||
129480342|NCT02337387|466047797|FG001|Overall Study|Adverse Event|1|||
129480343|NCT02337387|466047798|FG002|Overall Study|Adverse Event|0|||
129480344|NCT02337387|466047799|FG003|Overall Study|Adverse Event|0|||
129480345|NCT02337387|466047796|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
129480346|NCT02337387|466047797|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
129480347|NCT02337387|466047798|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
129480348|NCT02337387|466047799|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
129480349|NCT00332202|466047800|FG000|Overall Study|Adverse Event|72|||
129480350|NCT00332202|466047801|FG001|Overall Study|Adverse Event|28|||
129480351|NCT00332202|466047800|FG000|Overall Study|Lost to Follow-up|2|||
129480352|NCT00332202|466047801|FG001|Overall Study|Lost to Follow-up|1|||
129480353|NCT00332202|466047800|FG000|Overall Study|Physician Decision|6|||
129480354|NCT00332202|466047801|FG001|Overall Study|Physician Decision|8|||
129480355|NCT00332202|466047800|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
129480356|NCT00332202|466047801|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
129480357|NCT00332202|466047800|FG000|Overall Study|Protocol Violation|7|||
129480358|NCT00332202|466047801|FG001|Overall Study|Protocol Violation|2|||
129480359|NCT00332202|466047800|FG000|Overall Study|Sponsor Decision|1|||
129480360|NCT00332202|466047801|FG001|Overall Study|Sponsor Decision|2|||
129480361|NCT00332202|466047800|FG000|Overall Study|Withdrawal by Subject|36|||
129480362|NCT00332202|466047801|FG001|Overall Study|Withdrawal by Subject|17|||
129480363|NCT00332202|466047800|FG000|Overall Study|Progressive Disease|106|||
129480364|NCT00332202|466047801|FG001|Overall Study|Progressive Disease|60|||
129976660|NCT04879849|467877839|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
129976661|NCT04879849|467877840|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
129976662|NCT04879849|467877841|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
129976663|NCT04879849|467877842|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
129976664|NCT04879849|467877843|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
129976665|NCT04879849|467877844|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
129976666|NCT04879849|467877845|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
129976667|NCT04879849|467877846|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
129976668|NCT04879849|467877839|FG000|Overall Study|Withdrawal by Subject|0|||
129976669|NCT04879849|467877840|FG001|Overall Study|Withdrawal by Subject|0|||
129976670|NCT04879849|467877841|FG002|Overall Study|Withdrawal by Subject|0|||
129976671|NCT04879849|467877842|FG003|Overall Study|Withdrawal by Subject|0|||
129976672|NCT04879849|467877843|FG004|Overall Study|Withdrawal by Subject|2|||
129976673|NCT04879849|467877844|FG005|Overall Study|Withdrawal by Subject|0|||
129976674|NCT04879849|467877845|FG006|Overall Study|Withdrawal by Subject|1|||
129976675|NCT04879849|467877846|FG007|Overall Study|Withdrawal by Subject|0|||
129976676|NCT04879849|467877839|FG000|Overall Study|Progressive Disease|0|||
129976677|NCT04879849|467877840|FG001|Overall Study|Progressive Disease|0|||
129480365|NCT00332202|466047800|FG000|Overall Study|Death|5|||
129480366|NCT00332202|466047801|FG001|Overall Study|Death|2|||
129480367|NCT05202808|466047802|FG000|Overall Study|Lost to Follow-up|3|||
129480368|NCT05202808|466047803|FG001|Overall Study|Lost to Follow-up|1|||
129480369|NCT02495948|466047804|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
129480370|NCT02495948|466047805|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
129480371|NCT02495948|466047804|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
129480372|NCT02495948|466047805|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
129480373|NCT00818259|466047806|FG000|Part I|Withdrawal by Subject|1|||
129480374|NCT00818259|466047807|FG001|Part I|Withdrawal by Subject|0|||
129480375|NCT00818259|466047808|FG002|Part I|Withdrawal by Subject|0|||
129480376|NCT00818259|466047809|FG003|Part I|Withdrawal by Subject|0|||
129480377|NCT00818259|466047810|FG004|Part I|Withdrawal by Subject|0|||
129480378|NCT00818259|466047811|FG005|Part I|Withdrawal by Subject|0|||
129480379|NCT00818259|466047812|FG006|Part I|Withdrawal by Subject|0|||
129480380|NCT00818259|466047813|FG007|Part I|Withdrawal by Subject|0|||
129480381|NCT00818259|466047814|FG008|Part I|Withdrawal by Subject|0|||
129480382|NCT00818259|466047806|FG000|Part II|Physician Decision|0|||
129480383|NCT00818259|466047807|FG001|Part II|Physician Decision|0|||
129480384|NCT00818259|466047808|FG002|Part II|Physician Decision|1|||
129480385|NCT00818259|466047809|FG003|Part II|Physician Decision|0|||
129480386|NCT00818259|466047810|FG004|Part II|Physician Decision|0|||
129480387|NCT00818259|466047811|FG005|Part II|Physician Decision|0|||
129480388|NCT00818259|466047812|FG006|Part II|Physician Decision|0|||
129480389|NCT00818259|466047813|FG007|Part II|Physician Decision|0|||
129480390|NCT00818259|466047814|FG008|Part II|Physician Decision|0|||
129480391|NCT00818259|466047806|FG000|Part II|Lack of Efficacy|0|||
129480392|NCT00818259|466047807|FG001|Part II|Lack of Efficacy|0|||
129480393|NCT00818259|466047808|FG002|Part II|Lack of Efficacy|0|||
129480394|NCT00818259|466047809|FG003|Part II|Lack of Efficacy|1|||
129480395|NCT00818259|466047810|FG004|Part II|Lack of Efficacy|0|||
129480396|NCT00818259|466047811|FG005|Part II|Lack of Efficacy|0|||
129480397|NCT00818259|466047812|FG006|Part II|Lack of Efficacy|0|||
129480398|NCT00818259|466047813|FG007|Part II|Lack of Efficacy|0|||
129480399|NCT00818259|466047814|FG008|Part II|Lack of Efficacy|0|||
129480400|NCT00818259|466047806|FG000|Part II|Not Treated|0|||
129480401|NCT00818259|466047807|FG001|Part II|Not Treated|0|||
129480402|NCT00818259|466047808|FG002|Part II|Not Treated|0|||
129480403|NCT00818259|466047809|FG003|Part II|Not Treated|1|||
129480404|NCT00818259|466047810|FG004|Part II|Not Treated|0|||
129480405|NCT00818259|466047811|FG005|Part II|Not Treated|0|||
129480406|NCT00818259|466047812|FG006|Part II|Not Treated|0|||
129480407|NCT00818259|466047813|FG007|Part II|Not Treated|0|||
129480408|NCT00818259|466047814|FG008|Part II|Not Treated|0|||
129480409|NCT00818259|466047806|FG000|Part IV|Physician Decision|0|||
129480410|NCT00818259|466047807|FG001|Part IV|Physician Decision|0|||
129480411|NCT00818259|466047808|FG002|Part IV|Physician Decision|0|||
129480412|NCT00818259|466047809|FG003|Part IV|Physician Decision|0|||
129480413|NCT00818259|466047810|FG004|Part IV|Physician Decision|0|||
129480414|NCT00818259|466047811|FG005|Part IV|Physician Decision|1|||
129480415|NCT00818259|466047812|FG006|Part IV|Physician Decision|0|||
129480416|NCT00818259|466047813|FG007|Part IV|Physician Decision|0|||
129480417|NCT00818259|466047814|FG008|Part IV|Physician Decision|0|||
129480418|NCT00818259|466047806|FG000|Part V|Adverse Event|0|||
129480419|NCT00818259|466047807|FG001|Part V|Adverse Event|0|||
129480420|NCT00818259|466047808|FG002|Part V|Adverse Event|0|||
129480421|NCT00818259|466047809|FG003|Part V|Adverse Event|0|||
129480422|NCT00818259|466047810|FG004|Part V|Adverse Event|0|||
129480423|NCT00818259|466047811|FG005|Part V|Adverse Event|0|||
129480424|NCT00818259|466047812|FG006|Part V|Adverse Event|0|||
129480425|NCT00818259|466047813|FG007|Part V|Adverse Event|1|||
129480426|NCT00818259|466047814|FG008|Part V|Adverse Event|0|||
129480427|NCT01237951|466047818|FG000|Overall Study|Death|1|||
129480428|NCT00752986|466047821|FG000|Overall Study|Withdrawal by Subject|2|||
129480429|NCT00752986|466047822|FG001|Overall Study|Withdrawal by Subject|1|||
129480430|NCT00752986|466047823|FG002|Overall Study|Withdrawal by Subject|2|||
129480431|NCT00752986|466047821|FG000|Overall Study|Protocol Violation|3|||
129480432|NCT00752986|466047822|FG001|Overall Study|Protocol Violation|0|||
129480433|NCT00752986|466047823|FG002|Overall Study|Protocol Violation|0|||
129480434|NCT00924703|466047826|FG000|Overall Study|Withdrawal by Subject|11|||
129480435|NCT00924703|466047826|FG000|Overall Study|Physician Decision|5|||
129480436|NCT00924703|466047826|FG000|Overall Study|Lost to Follow-up|3|||
129480437|NCT00924703|466047826|FG000|Overall Study|Adverse Event|2|||
129480438|NCT00924703|466047826|FG000|Overall Study|Withdrawal by Sponsor|1|||
129480439|NCT00666562|466047827|FG000|Overall Study|Withdrawal by Subject|0|||
129480440|NCT00666562|466047828|FG001|Overall Study|Withdrawal by Subject|1|||
129480441|NCT00666562|466047829|FG002|Overall Study|Withdrawal by Subject|0|||
129480442|NCT00666562|466047827|FG000|Overall Study|Concomitant Medication|0|||
129480443|NCT00666562|466047828|FG001|Overall Study|Concomitant Medication|1|||
129480444|NCT00666562|466047829|FG002|Overall Study|Concomitant Medication|0|||
129480445|NCT01587989|466047831|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
129480446|NCT01587989|466047832|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
129480447|NCT01587989|466047833|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
129480448|NCT01587989|466047831|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
129480449|NCT01587989|466047832|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
129480450|NCT01587989|466047833|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
129480451|NCT01587989|466047831|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
129480452|NCT01587989|466047832|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
129480453|NCT01587989|466047833|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
129480454|NCT01587989|466047831|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
129480455|NCT01587989|466047832|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
129480456|NCT01587989|466047833|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
129480457|NCT01587989|466047831|FG000|Randomized Study Treatment|Screening failure|0|||
129480458|NCT01587989|466047832|FG001|Randomized Study Treatment|Screening failure|1|||
129480459|NCT01587989|466047833|FG002|Randomized Study Treatment|Screening failure|0|||
129480460|NCT01587989|466047831|FG000|Randomized Study Treatment|Physician Decision|0|||
129480461|NCT01587989|466047832|FG001|Randomized Study Treatment|Physician Decision|0|||
129480462|NCT01587989|466047833|FG002|Randomized Study Treatment|Physician Decision|1|||
129480463|NCT00275561|466047836|FG000|Overall Study|Withdrawal by Subject|0|||
129480464|NCT00275561|466047837|FG001|Overall Study|Withdrawal by Subject|1|||
129480465|NCT00275561|466047836|FG000|Overall Study|Travel|1|||
129480466|NCT00275561|466047837|FG001|Overall Study|Travel|1|||
129480467|NCT00275561|466047836|FG000|Overall Study|Scheduling|1|||
129480468|NCT00275561|466047837|FG001|Overall Study|Scheduling|2|||
129480469|NCT00275561|466047836|FG000|Overall Study|Family Issues|0|||
129480470|NCT00275561|466047837|FG001|Overall Study|Family Issues|2|||
129480471|NCT00684177|466047840|FG000|Overall Study|Adverse Event|4|||
129480472|NCT00684177|466047841|FG001|Overall Study|Adverse Event|3|||
129480473|NCT00684177|466047840|FG000|Overall Study|Lack of Efficacy|10|||
129480474|NCT00684177|466047841|FG001|Overall Study|Lack of Efficacy|15|||
129480475|NCT00684177|466047840|FG000|Overall Study|Protocol Violation|1|||
129480476|NCT00684177|466047841|FG001|Overall Study|Protocol Violation|0|||
129480477|NCT00684177|466047840|FG000|Overall Study|Lost to Follow-up|2|||
129480478|NCT00684177|466047841|FG001|Overall Study|Lost to Follow-up|1|||
129480479|NCT00684177|466047840|FG000|Overall Study|Physician Decision|2|||
129480480|NCT00684177|466047841|FG001|Overall Study|Physician Decision|0|||
129480481|NCT00684177|466047840|FG000|Overall Study|Withdrawal by Subject|1|||
129976678|NCT04879849|467877841|FG002|Overall Study|Progressive Disease|1|||
129480482|NCT00684177|466047841|FG001|Overall Study|Withdrawal by Subject|2|||
129480483|NCT00684177|466047840|FG000|Overall Study|Other|1|||
129976679|NCT04879849|467877842|FG003|Overall Study|Progressive Disease|0|||
129976680|NCT04879849|467877843|FG004|Overall Study|Progressive Disease|0|||
129480484|NCT00684177|466047841|FG001|Overall Study|Other|2|||
129480485|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
129480486|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
129480487|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
129480488|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
129480489|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
129480490|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
129976681|NCT04879849|467877844|FG005|Overall Study|Progressive Disease|0|||
129480491|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
129480492|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
129480493|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
129480494|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
129480495|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
129480496|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
129480497|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
129480498|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
129480499|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
129480500|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
129480501|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
129480502|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
129480503|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
129480504|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
129480505|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
129480506|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
129480507|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
129480508|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
129480509|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
129480510|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
129480511|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
129480512|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
129480513|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
129480514|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
129480515|NCT02660580|466049590|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
129480516|NCT02660580|466049591|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
129480517|NCT02660580|466049592|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
129480518|NCT02660580|466049593|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
129480519|NCT02660580|466049594|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
129480520|NCT02660580|466049590|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
129480521|NCT02660580|466049591|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
129480522|NCT02660580|466049592|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
129480523|NCT02660580|466049593|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
129480524|NCT02660580|466049594|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
129480525|NCT02660580|466049590|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
129480526|NCT02660580|466049591|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
129480527|NCT02660580|466049592|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
129480528|NCT02660580|466049593|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
129480529|NCT02660580|466049594|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
129480530|NCT02660580|466049590|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
129480531|NCT02660580|466049591|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
129480532|NCT02660580|466049592|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
129480533|NCT02660580|466049593|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
129480534|NCT02660580|466049594|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
129480535|NCT02660580|466049590|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
129480536|NCT02660580|466049591|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
129480537|NCT02660580|466049592|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
129480538|NCT02660580|466049593|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
129480539|NCT02660580|466049594|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
129480540|NCT02660580|466049590|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
129480541|NCT02660580|466049591|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
129480542|NCT02660580|466049592|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
129480543|NCT02660580|466049593|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
129480544|NCT02660580|466049594|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
129480545|NCT02660580|466049590|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
129480546|NCT02660580|466049591|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
129480547|NCT02660580|466049592|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
129480548|NCT02660580|466049593|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
129480549|NCT02660580|466049594|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
129976682|NCT04879849|467877845|FG006|Overall Study|Progressive Disease|0|||
129480550|NCT00377962|466049595|FG000|Core Study: 0-12 Months|Adverse Event|18|||
129480551|NCT00377962|466049596|FG001|Core Study: 0-12 Months|Adverse Event|2|||
129976683|NCT04879849|467877846|FG007|Overall Study|Progressive Disease|0|||
129976684|NCT04879849|467877839|FG000|Overall Study|Death|0|||
129976685|NCT04879849|467877840|FG001|Overall Study|Death|0|||
129480552|NCT00377962|466049595|FG000|Core Study: 0-12 Months|Death|3|||
129480553|NCT00377962|466049596|FG001|Core Study: 0-12 Months|Death|0|||
129480554|NCT00377962|466049595|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
129480555|NCT00377962|466049596|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
129480556|NCT00377962|466049595|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
129480557|NCT00377962|466049596|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
129480558|NCT00377962|466049595|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
129480559|NCT00377962|466049596|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
129480560|NCT00377962|466049595|FG000|Extension Study: 12-24 Months|Death|1|||
129480561|NCT00377962|466049596|FG001|Extension Study: 12-24 Months|Death|1|||
129480562|NCT00377962|466049595|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
129480563|NCT00377962|466049596|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
129480564|NCT00377962|466049595|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
129480565|NCT00377962|466049596|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
129480566|NCT00377962|466049595|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
129480567|NCT00377962|466049596|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
129480568|NCT03095703|466049602|FG000|Overall Study|Withdrawal by Subject|1|||
129480569|NCT02665689|466049603|FG000|Overall Study|Adverse Event|1|||
129480570|NCT02665689|466049604|FG001|Overall Study|Adverse Event|0|||
129480571|NCT02665689|466049603|FG000|Overall Study|Trial termination|1|||
129480572|NCT02665689|466049604|FG001|Overall Study|Trial termination|1|||
129480573|NCT02665689|466049603|FG000|Overall Study|Lost to Follow-up|0|||
129480574|NCT02665689|466049604|FG001|Overall Study|Lost to Follow-up|1|||
129480575|NCT00486902|466049605|FG000|Overall Study|Withdrawal by Subject|1|||
129480576|NCT00486902|466049606|FG001|Overall Study|Withdrawal by Subject|2|||
129480577|NCT00486902|466049605|FG000|Overall Study|decision for postpartum tubal ligation|3|||
129480578|NCT00486902|466049606|FG001|Overall Study|decision for postpartum tubal ligation|1|||
129480579|NCT00486902|466049605|FG000|Overall Study|spinal anesthetic protocal violation|1|||
129480580|NCT00486902|466049606|FG001|Overall Study|spinal anesthetic protocal violation|1|||
129480581|NCT00486902|466049605|FG000|Overall Study|Did not meet inclusion criteria|1|||
129480582|NCT00486902|466049606|FG001|Overall Study|Did not meet inclusion criteria|0|||
129480583|NCT00486902|466049605|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
129480584|NCT00486902|466049606|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
129480585|NCT04178590|466049607|FG000|Overall Study|Pregnancy|1|||
129480586|NCT04178590|466049607|FG000|Overall Study|Lost to Follow-up|1|||
129480587|NCT01389245|466049608|FG000|Overall Study|Protocol Violation|10|||
129480588|NCT01389245|466049608|FG000|Overall Study|Lost to Follow-up|3|||
129480589|NCT01389245|466049608|FG000|Overall Study|Withdrawal by Subject|2|||
129480590|NCT02292849|466049609|FG000|Overall Study|Lost to Follow-up|0|||
129480591|NCT02292849|466049610|FG001|Overall Study|Lost to Follow-up|2|||
129480592|NCT02292849|466049611|FG002|Overall Study|Lost to Follow-up|2|||
129480593|NCT02292849|466049609|FG000|Overall Study|Physician Decision|4|||
129480594|NCT02292849|466049610|FG001|Overall Study|Physician Decision|0|||
129480595|NCT02292849|466049611|FG002|Overall Study|Physician Decision|0|||
129480596|NCT00886938|466049612|FG000|Overall Study|Adverse Event|1|||
129480597|NCT00886938|466049612|FG000|Overall Study|Withdrawal by Subject|1|||
129480598|NCT00364793|466049613|FG000|Overall Study|Adverse Event|2|||
129480599|NCT00364793|466049614|FG001|Overall Study|Adverse Event|0|||
129480600|NCT00364793|466049615|FG002|Overall Study|Adverse Event|0|||
129480601|NCT00364793|466049616|FG003|Overall Study|Adverse Event|0|||
129480602|NCT00364793|466049613|FG000|Overall Study|Death|1|||
129480603|NCT00364793|466049614|FG001|Overall Study|Death|0|||
129480604|NCT00364793|466049615|FG002|Overall Study|Death|1|||
129480605|NCT00364793|466049616|FG003|Overall Study|Death|0|||
129480606|NCT00364793|466049613|FG000|Overall Study|Lack of Efficacy|3|||
129480607|NCT00364793|466049614|FG001|Overall Study|Lack of Efficacy|3|||
129480608|NCT00364793|466049615|FG002|Overall Study|Lack of Efficacy|1|||
129480609|NCT00364793|466049616|FG003|Overall Study|Lack of Efficacy|1|||
129480610|NCT00364793|466049613|FG000|Overall Study|Lost to Follow-up|1|||
129480611|NCT00364793|466049614|FG001|Overall Study|Lost to Follow-up|0|||
129480612|NCT00364793|466049615|FG002|Overall Study|Lost to Follow-up|2|||
129480613|NCT00364793|466049616|FG003|Overall Study|Lost to Follow-up|0|||
129480614|NCT00364793|466049613|FG000|Overall Study|Poor or non-compliance|1|||
129480615|NCT00364793|466049614|FG001|Overall Study|Poor or non-compliance|1|||
129480616|NCT00364793|466049615|FG002|Overall Study|Poor or non-compliance|0|||
129480617|NCT00364793|466049616|FG003|Overall Study|Poor or non-compliance|1|||
129480618|NCT00364793|466049613|FG000|Overall Study|No longer meets criteria|0|||
129480619|NCT00364793|466049614|FG001|Overall Study|No longer meets criteria|0|||
129480620|NCT00364793|466049615|FG002|Overall Study|No longer meets criteria|0|||
129480621|NCT00364793|466049616|FG003|Overall Study|No longer meets criteria|1|||
129480622|NCT00364793|466049613|FG000|Overall Study|Withdrawal by Subject|0|||
129480623|NCT00364793|466049614|FG001|Overall Study|Withdrawal by Subject|1|||
129480624|NCT00364793|466049615|FG002|Overall Study|Withdrawal by Subject|0|||
129480625|NCT00364793|466049616|FG003|Overall Study|Withdrawal by Subject|0|||
129480626|NCT00363415|466049619|FG000|Overall Study|Progressive Disease|196|||
129480627|NCT00363415|466049620|FG001|Overall Study|Progressive Disease|107|||
129480628|NCT00363415|466049619|FG000|Overall Study|Sponsor Decision|67|||
129480629|NCT00363415|466049620|FG001|Overall Study|Sponsor Decision|31|||
129480630|NCT00363415|466049619|FG000|Overall Study|Death|32|||
129480631|NCT00363415|466049620|FG001|Overall Study|Death|29|||
129480632|NCT00363415|466049619|FG000|Overall Study|Adverse Event|24|||
129480633|NCT00363415|466049620|FG001|Overall Study|Adverse Event|15|||
129480634|NCT00363415|466049619|FG000|Overall Study|Physician Decision|18|||
129480635|NCT00363415|466049620|FG001|Overall Study|Physician Decision|35|||
129480636|NCT00363415|466049619|FG000|Overall Study|Entry Criteria Not Met|11|||
129480637|NCT00363415|466049620|FG001|Overall Study|Entry Criteria Not Met|10|||
129480638|NCT00363415|466049619|FG000|Overall Study|Withdrawal by Subject|9|||
129480639|NCT00363415|466049620|FG001|Overall Study|Withdrawal by Subject|15|||
129480640|NCT00363415|466049619|FG000|Overall Study|Lost to Follow-up|3|||
129480641|NCT00363415|466049620|FG001|Overall Study|Lost to Follow-up|3|||
129480642|NCT00363415|466049619|FG000|Overall Study|Protocol Violation|1|||
129480643|NCT00363415|466049620|FG001|Overall Study|Protocol Violation|4|||
129480644|NCT05027802|466049623|FG000|Overall Study|Adverse Event|2|||
129480645|NCT05027802|466049623|FG000|Overall Study|Withdrawal by Subject|18|||
129480646|NCT05027802|466049623|FG000|Overall Study|Death|2|||
129480647|NCT05027802|466049623|FG000|Overall Study|Other|1|||
129480648|NCT02725788|466049624|FG000|Overall Study|Lost to Follow-up|1|||
129480649|NCT02725788|466049625|FG001|Overall Study|Lost to Follow-up|1|||
129480650|NCT02725788|466049624|FG000|Overall Study|Protocol Violation|0|||
129480651|NCT02725788|466049625|FG001|Overall Study|Protocol Violation|1|||
129480652|NCT05590377|466049626|FG000|Overall Study|Death|1|||
129480653|NCT05590377|466049627|FG001|Overall Study|Death|1|||
129480654|NCT05590377|466049628|FG002|Overall Study|Death|2|||
129480655|NCT05590377|466049629|FG003|Overall Study|Death|0|||
129480656|NCT05590377|466049630|FG004|Overall Study|Death|0|||
129480657|NCT05590377|466049626|FG000|Overall Study|Study Terminated by Sponsor|1|||
129480658|NCT05590377|466049627|FG001|Overall Study|Study Terminated by Sponsor|5|||
129480659|NCT05590377|466049628|FG002|Overall Study|Study Terminated by Sponsor|4|||
129480660|NCT05590377|466049629|FG003|Overall Study|Study Terminated by Sponsor|0|||
129480661|NCT05590377|466049630|FG004|Overall Study|Study Terminated by Sponsor|0|||
129480662|NCT05590377|466049626|FG000|Overall Study|Withdrawal by Subject|1|||
129480663|NCT05590377|466049627|FG001|Overall Study|Withdrawal by Subject|0|||
129480664|NCT05590377|466049628|FG002|Overall Study|Withdrawal by Subject|0|||
129480665|NCT05590377|466049629|FG003|Overall Study|Withdrawal by Subject|0|||
129480666|NCT05590377|466049630|FG004|Overall Study|Withdrawal by Subject|0|||
129480667|NCT00828464|466049631|FG000|Overall Study|Withdrawal by Subject|1|||
129480668|NCT00809133|466049632|FG000|Overall Study|Progressive disease|2|||
129480669|NCT00809133|466049633|FG001|Overall Study|Progressive disease|5|||
129480670|NCT00809133|466049634|FG002|Overall Study|Progressive disease|5|||
129480671|NCT00809133|466049635|FG003|Overall Study|Progressive disease|3|||
129480672|NCT00809133|466049636|FG004|Overall Study|Progressive disease|4|||
129480673|NCT00809133|466049637|FG005|Overall Study|Progressive disease|1|||
129480674|NCT00809133|466049638|FG006|Overall Study|Progressive disease|3|||
129480675|NCT00809133|466049639|FG007|Overall Study|Progressive disease|3|||
129480676|NCT00809133|466049640|FG008|Overall Study|Progressive disease|3|||
129480677|NCT00809133|466049641|FG009|Overall Study|Progressive disease|9|||
129480678|NCT00809133|466049642|FG010|Overall Study|Progressive disease|5|||
129480679|NCT00809133|466049643|FG011|Overall Study|Progressive disease|7|||
129480680|NCT00809133|466049644|FG012|Overall Study|Progressive disease|5|||
129480681|NCT00809133|466049645|FG013|Overall Study|Progressive disease|4|||
129480682|NCT00809133|466049632|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480683|NCT00809133|466049633|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129976686|NCT04879849|467877841|FG002|Overall Study|Death|1|||
129976687|NCT04879849|467877842|FG003|Overall Study|Death|1|||
129976688|NCT04879849|467877843|FG004|Overall Study|Death|1|||
129976689|NCT04879849|467877844|FG005|Overall Study|Death|2|||
129976690|NCT04879849|467877845|FG006|Overall Study|Death|1|||
129976691|NCT04879849|467877846|FG007|Overall Study|Death|2|||
129480684|NCT00809133|466049634|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480685|NCT00809133|466049635|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480686|NCT00809133|466049636|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480687|NCT00809133|466049637|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129480688|NCT00809133|466049638|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129480689|NCT00809133|466049639|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
129480690|NCT00809133|466049640|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480691|NCT00809133|466049641|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480692|NCT00809133|466049642|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480693|NCT00809133|466049643|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480694|NCT00809133|466049644|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
129480695|NCT00809133|466049645|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
129480696|NCT00809133|466049632|FG000|Overall Study|Other adverse event|1|||
129480697|NCT00809133|466049633|FG001|Overall Study|Other adverse event|1|||
129480698|NCT00809133|466049634|FG002|Overall Study|Other adverse event|1|||
129976692|NCT04879849|467877839|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
129480699|NCT00809133|466049635|FG003|Overall Study|Other adverse event|0|||
129480700|NCT00809133|466049636|FG004|Overall Study|Other adverse event|0|||
129480701|NCT00809133|466049637|FG005|Overall Study|Other adverse event|3|||
129480702|NCT00809133|466049638|FG006|Overall Study|Other adverse event|2|||
129480703|NCT00809133|466049639|FG007|Overall Study|Other adverse event|4|||
129480704|NCT00809133|466049640|FG008|Overall Study|Other adverse event|0|||
129480705|NCT00809133|466049641|FG009|Overall Study|Other adverse event|0|||
129480706|NCT00809133|466049642|FG010|Overall Study|Other adverse event|1|||
129480707|NCT00809133|466049643|FG011|Overall Study|Other adverse event|1|||
129480708|NCT00809133|466049644|FG012|Overall Study|Other adverse event|0|||
129480709|NCT00809133|466049645|FG013|Overall Study|Other adverse event|1|||
129480710|NCT00809133|466049632|FG000|Overall Study|Lost to Follow-up|0|||
129480711|NCT00809133|466049633|FG001|Overall Study|Lost to Follow-up|0|||
129480712|NCT00809133|466049634|FG002|Overall Study|Lost to Follow-up|0|||
129480713|NCT00809133|466049635|FG003|Overall Study|Lost to Follow-up|0|||
129480714|NCT00809133|466049636|FG004|Overall Study|Lost to Follow-up|0|||
129480715|NCT00809133|466049637|FG005|Overall Study|Lost to Follow-up|1|||
129480716|NCT00809133|466049638|FG006|Overall Study|Lost to Follow-up|0|||
129480717|NCT00809133|466049639|FG007|Overall Study|Lost to Follow-up|0|||
129480718|NCT00809133|466049640|FG008|Overall Study|Lost to Follow-up|0|||
129480719|NCT00809133|466049641|FG009|Overall Study|Lost to Follow-up|0|||
129480720|NCT00809133|466049642|FG010|Overall Study|Lost to Follow-up|0|||
129480721|NCT00809133|466049643|FG011|Overall Study|Lost to Follow-up|0|||
129480722|NCT00809133|466049644|FG012|Overall Study|Lost to Follow-up|0|||
129480723|NCT00809133|466049645|FG013|Overall Study|Lost to Follow-up|0|||
129480724|NCT00809133|466049632|FG000|Overall Study|Consent withdrawn|0|||
129480725|NCT00809133|466049633|FG001|Overall Study|Consent withdrawn|0|||
129480726|NCT00809133|466049634|FG002|Overall Study|Consent withdrawn|0|||
129480727|NCT00809133|466049635|FG003|Overall Study|Consent withdrawn|0|||
129480728|NCT00809133|466049636|FG004|Overall Study|Consent withdrawn|1|||
129480729|NCT00809133|466049637|FG005|Overall Study|Consent withdrawn|0|||
129480730|NCT00809133|466049638|FG006|Overall Study|Consent withdrawn|0|||
129480731|NCT00809133|466049639|FG007|Overall Study|Consent withdrawn|0|||
129480732|NCT00809133|466049640|FG008|Overall Study|Consent withdrawn|0|||
129480733|NCT00809133|466049641|FG009|Overall Study|Consent withdrawn|0|||
129480734|NCT00809133|466049642|FG010|Overall Study|Consent withdrawn|0|||
129480735|NCT00809133|466049643|FG011|Overall Study|Consent withdrawn|0|||
129480736|NCT00809133|466049644|FG012|Overall Study|Consent withdrawn|0|||
129480737|NCT00809133|466049645|FG013|Overall Study|Consent withdrawn|0|||
129480738|NCT00809133|466049632|FG000|Overall Study|Other not mentioned above|0|||
129480739|NCT00809133|466049633|FG001|Overall Study|Other not mentioned above|1|||
129480740|NCT00809133|466049634|FG002|Overall Study|Other not mentioned above|0|||
129480741|NCT00809133|466049635|FG003|Overall Study|Other not mentioned above|0|||
129480742|NCT00809133|466049636|FG004|Overall Study|Other not mentioned above|0|||
129480743|NCT00809133|466049637|FG005|Overall Study|Other not mentioned above|1|||
129480744|NCT00809133|466049638|FG006|Overall Study|Other not mentioned above|0|||
129480745|NCT00809133|466049639|FG007|Overall Study|Other not mentioned above|0|||
129480746|NCT00809133|466049640|FG008|Overall Study|Other not mentioned above|0|||
129480747|NCT00809133|466049641|FG009|Overall Study|Other not mentioned above|0|||
129480748|NCT00809133|466049642|FG010|Overall Study|Other not mentioned above|0|||
129480749|NCT00809133|466049643|FG011|Overall Study|Other not mentioned above|0|||
129480750|NCT00809133|466049644|FG012|Overall Study|Other not mentioned above|0|||
129480751|NCT00809133|466049645|FG013|Overall Study|Other not mentioned above|0|||
129480752|NCT00833092|466049646|FG000|Overall Study|Withdrawal by Subject|2|||
129480753|NCT00833092|466049647|FG001|Overall Study|Withdrawal by Subject|3|||
129480754|NCT00833092|466049646|FG000|Overall Study|Protocol Violation|2|||
129480755|NCT00833092|466049647|FG001|Overall Study|Protocol Violation|1|||
129480756|NCT00833092|466049646|FG000|Overall Study|Diarrhea|0|||
129480757|NCT00833092|466049647|FG001|Overall Study|Diarrhea|2|||
129480758|NCT00833092|466049646|FG000|Overall Study|constipation|0|||
129976693|NCT04879849|467877840|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
129976694|NCT04879849|467877841|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
129976695|NCT04879849|467877842|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
129976696|NCT04879849|467877843|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
129480759|NCT00833092|466049647|FG001|Overall Study|constipation|1|||
129480760|NCT00699192|466049648|FG000|Overall Study|Missing|1|||
129480761|NCT00699192|466049649|FG001|Overall Study|Missing|1|||
129480762|NCT00699192|466049650|FG002|Overall Study|Missing|1|||
129480763|NCT00699192|466049648|FG000|Overall Study|Adverse Event|9|||
129480764|NCT00699192|466049649|FG001|Overall Study|Adverse Event|4|||
129480765|NCT00699192|466049650|FG002|Overall Study|Adverse Event|3|||
129480766|NCT00699192|466049648|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129480767|NCT00699192|466049649|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129480768|NCT00699192|466049650|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129480769|NCT00699192|466049648|FG000|Overall Study|Lack of Efficacy|0|||
129480770|NCT00699192|466049649|FG001|Overall Study|Lack of Efficacy|0|||
129480771|NCT00699192|466049650|FG002|Overall Study|Lack of Efficacy|1|||
129480772|NCT00699192|466049648|FG000|Overall Study|Withdrawal by Subject|3|||
129480773|NCT00699192|466049649|FG001|Overall Study|Withdrawal by Subject|2|||
129480774|NCT00699192|466049650|FG002|Overall Study|Withdrawal by Subject|4|||
129480775|NCT00699192|466049648|FG000|Overall Study|Administrative problems|1|||
129480776|NCT00699192|466049649|FG001|Overall Study|Administrative problems|3|||
129480777|NCT00699192|466049650|FG002|Overall Study|Administrative problems|1|||
129480778|NCT00699192|466049648|FG000|Overall Study|Protocol Violation|2|||
129976697|NCT04879849|467877844|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
129976698|NCT04879849|467877845|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
129976699|NCT04879849|467877846|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
129976700|NCT04879849|467877839|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976701|NCT04879849|467877840|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129480779|NCT00699192|466049649|FG001|Overall Study|Protocol Violation|2|||
129480780|NCT00699192|466049650|FG002|Overall Study|Protocol Violation|0|||
129480781|NCT01773473|466049651|FG000|Overall Study|Adverse Event|3|||
129480782|NCT01773473|466049652|FG001|Overall Study|Adverse Event|2|||
129480783|NCT01773473|466049651|FG000|Overall Study|Protocol Violation|0|||
129480784|NCT01773473|466049652|FG001|Overall Study|Protocol Violation|4|||
129480785|NCT01773473|466049651|FG000|Overall Study|Physician Decision|3|||
129480786|NCT01773473|466049652|FG001|Overall Study|Physician Decision|5|||
129480787|NCT01773473|466049651|FG000|Overall Study|Sponsor Decision|2|||
129480788|NCT01773473|466049652|FG001|Overall Study|Sponsor Decision|0|||
129480789|NCT01773473|466049651|FG000|Overall Study|Lack of Efficacy|0|||
129480790|NCT01773473|466049652|FG001|Overall Study|Lack of Efficacy|1|||
129480791|NCT01773473|466049651|FG000|Overall Study|Non-Compliance with study drug|1|||
129480792|NCT01773473|466049652|FG001|Overall Study|Non-Compliance with study drug|4|||
129480793|NCT01773473|466049651|FG000|Overall Study|Withdrawal by Subject|5|||
129480794|NCT01773473|466049652|FG001|Overall Study|Withdrawal by Subject|3|||
129480795|NCT01773473|466049651|FG000|Overall Study|Lost to Follow-up|2|||
129480796|NCT01773473|466049652|FG001|Overall Study|Lost to Follow-up|0|||
129480797|NCT01025635|466049662|FG000|Overall Study|Withdrawal by Subject|6|||
129480798|NCT01025635|466049663|FG001|Overall Study|Withdrawal by Subject|7|||
129480799|NCT01025635|466049662|FG000|Overall Study|Protocol Violation|4|||
129480800|NCT01025635|466049663|FG001|Overall Study|Protocol Violation|2|||
129480801|NCT01025635|466049662|FG000|Overall Study|Lack of Efficacy|0|||
129480802|NCT01025635|466049663|FG001|Overall Study|Lack of Efficacy|1|||
129480803|NCT01025635|466049662|FG000|Overall Study|Lost to Follow-up|9|||
129480804|NCT01025635|466049663|FG001|Overall Study|Lost to Follow-up|13|||
129480805|NCT01025635|466049662|FG000|Overall Study|Reason not known|4|||
129480806|NCT01025635|466049663|FG001|Overall Study|Reason not known|2|||
129480807|NCT00727402|466049664|FG000|Overall Study|Physician Decision|116|||
129480808|NCT00929240|466049665|FG000|Initial Treatment Phase|Adverse Event|31|||
129480809|NCT00929240|466049666|FG001|Initial Treatment Phase|Adverse Event|0|||
129480810|NCT00929240|466049667|FG002|Initial Treatment Phase|Adverse Event|0|||
129480811|NCT00929240|466049665|FG000|Initial Treatment Phase|Disease progression|41|||
129480812|NCT00929240|466049666|FG001|Initial Treatment Phase|Disease progression|0|||
129480813|NCT00929240|466049667|FG002|Initial Treatment Phase|Disease progression|0|||
129480814|NCT00929240|466049665|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
129480815|NCT00929240|466049666|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
129480816|NCT00929240|466049667|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
129480817|NCT00929240|466049665|FG000|Initial Treatment Phase|Protocol Violation|5|||
129480818|NCT00929240|466049666|FG001|Initial Treatment Phase|Protocol Violation|0|||
129480819|NCT00929240|466049667|FG002|Initial Treatment Phase|Protocol Violation|0|||
129480820|NCT00929240|466049665|FG000|Initial Treatment Phase|Death|2|||
129480821|NCT00929240|466049666|FG001|Initial Treatment Phase|Death|0|||
129480822|NCT00929240|466049667|FG002|Initial Treatment Phase|Death|0|||
129480823|NCT00929240|466049665|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
129480824|NCT00929240|466049666|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
129480825|NCT00929240|466049667|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
129480826|NCT00929240|466049665|FG000|Initial Treatment Phase|Physician Decision|4|||
129480827|NCT00929240|466049666|FG001|Initial Treatment Phase|Physician Decision|0|||
129480828|NCT00929240|466049667|FG002|Initial Treatment Phase|Physician Decision|0|||
129480829|NCT00929240|466049665|FG000|Maintenance Phase|Disease progression|0|||
129480830|NCT00929240|466049666|FG001|Maintenance Phase|Disease progression|73|||
129480831|NCT00929240|466049667|FG002|Maintenance Phase|Disease progression|60|||
129480832|NCT00929240|466049665|FG000|Maintenance Phase|Adverse Event|0|||
129480833|NCT00929240|466049666|FG001|Maintenance Phase|Adverse Event|9|||
129480834|NCT00929240|466049667|FG002|Maintenance Phase|Adverse Event|12|||
129480835|NCT00929240|466049665|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129480836|NCT00929240|466049666|FG001|Maintenance Phase|Withdrawal by Subject|2|||
129480837|NCT00929240|466049667|FG002|Maintenance Phase|Withdrawal by Subject|6|||
129480838|NCT00929240|466049665|FG000|Maintenance Phase|Protocol Violation|0|||
129480839|NCT00929240|466049666|FG001|Maintenance Phase|Protocol Violation|1|||
129480840|NCT00929240|466049667|FG002|Maintenance Phase|Protocol Violation|0|||
129480841|NCT00929240|466049665|FG000|Maintenance Phase|Health authority/Study termination|0|||
129480842|NCT00929240|466049666|FG001|Maintenance Phase|Health authority/Study termination|1|||
129480843|NCT00929240|466049667|FG002|Maintenance Phase|Health authority/Study termination|2|||
129480844|NCT00929240|466049665|FG000|Maintenance Phase|Physician Decision|0|||
129480845|NCT00929240|466049666|FG001|Maintenance Phase|Physician Decision|2|||
129480846|NCT00929240|466049667|FG002|Maintenance Phase|Physician Decision|1|||
129480847|NCT00929240|466049665|FG000|Maintenance Phase|Change of treatment|0|||
129480848|NCT00929240|466049666|FG001|Maintenance Phase|Change of treatment|4|||
129480849|NCT00929240|466049667|FG002|Maintenance Phase|Change of treatment|0|||
129480850|NCT00929240|466049665|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
129480851|NCT00929240|466049666|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
129480852|NCT00929240|466049667|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
129480853|NCT00929240|466049665|FG000|Maintenance Phase|Participant not treated|0|||
129480854|NCT00929240|466049666|FG001|Maintenance Phase|Participant not treated|2|||
129480855|NCT00929240|466049667|FG002|Maintenance Phase|Participant not treated|0|||
129480856|NCT05292755|466049668|FG000|Overall Study|Lost to Follow-up|5|||
129480857|NCT05292755|466049669|FG001|Overall Study|Lost to Follow-up|9|||
129480858|NCT00432809|466049670|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
129480859|NCT00432809|466049671|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
129480860|NCT00432809|466049672|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
129480861|NCT00432809|466049670|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
129480862|NCT00432809|466049671|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
129480863|NCT00432809|466049672|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
129480864|NCT04433117|466049673|FG000|Overall Study|Withdrawal by Subject|1|||
129480865|NCT04433117|466049674|FG001|Overall Study|Withdrawal by Subject|0|||
129480866|NCT01051739|466049675|FG000|Overall Study|Death|3|||
129480867|NCT01051739|466049676|FG001|Overall Study|Death|3|||
129480868|NCT01051739|466049675|FG000|Overall Study|Withdrawal by Subject|25|||
129480869|NCT01051739|466049676|FG001|Overall Study|Withdrawal by Subject|10|||
129480870|NCT00707577|466049677|FG000|Overall Study|Withdrawal by Subject|3|||
129480871|NCT00707577|466049678|FG001|Overall Study|Withdrawal by Subject|2|||
129480872|NCT00707577|466049677|FG000|Overall Study|Lost to Follow-up|34|||
129480873|NCT00707577|466049678|FG001|Overall Study|Lost to Follow-up|25|||
129480874|NCT00707577|466049677|FG000|Overall Study|Left employment|13|||
129480875|NCT00707577|466049678|FG001|Overall Study|Left employment|10|||
129480876|NCT00707577|466049677|FG000|Overall Study|Pregnancy|4|||
129480877|NCT00707577|466049678|FG001|Overall Study|Pregnancy|1|||
129480878|NCT02499952|466049679|FG000|Overall Study|Lost to Follow-up|1|||
129480879|NCT02499952|466049679|FG000|Overall Study|Death|9|||
129480880|NCT02209766|466049680|FG000|Overall Study|Withdrawal by Subject|0|||
129480881|NCT02209766|466049681|FG001|Overall Study|Withdrawal by Subject|0|||
129480882|NCT02209766|466049682|FG002|Overall Study|Withdrawal by Subject|0|||
129480883|NCT02209766|466049683|FG003|Overall Study|Withdrawal by Subject|1|||
129480884|NCT02209766|466049684|FG004|Overall Study|Withdrawal by Subject|0|||
129480885|NCT00805207|466049685|FG000|Overall Study|Protocol Violation|0|||
129480886|NCT00805207|466049686|FG001|Overall Study|Protocol Violation|0|||
129480887|NCT00805207|466049687|FG002|Overall Study|Protocol Violation|1|||
129480888|NCT00805207|466049688|FG003|Overall Study|Protocol Violation|0|||
129480889|NCT00805207|466049689|FG004|Overall Study|Protocol Violation|0|||
129480890|NCT00805207|466049690|FG005|Overall Study|Protocol Violation|0|||
129480891|NCT00805207|466049691|FG006|Overall Study|Protocol Violation|0|||
129480892|NCT00805207|466049692|FG007|Overall Study|Protocol Violation|0|||
129480893|NCT00805207|466049693|FG008|Overall Study|Protocol Violation|0|||
129480894|NCT00805207|466049685|FG000|Overall Study|Physician Decision|0|||
129480895|NCT00805207|466049686|FG001|Overall Study|Physician Decision|1|||
129480896|NCT00805207|466049687|FG002|Overall Study|Physician Decision|0|||
129480897|NCT00805207|466049688|FG003|Overall Study|Physician Decision|0|||
129480898|NCT00805207|466049689|FG004|Overall Study|Physician Decision|0|||
129480899|NCT00805207|466049690|FG005|Overall Study|Physician Decision|1|||
129480900|NCT00805207|466049691|FG006|Overall Study|Physician Decision|0|||
129480901|NCT00805207|466049692|FG007|Overall Study|Physician Decision|0|||
129979964|NCT04372121|467889512|FG002|Overall Study|Withdrawal by Subject|0|||
129480902|NCT00805207|466049693|FG008|Overall Study|Physician Decision|0|||
129480903|NCT00805207|466049685|FG000|Overall Study|Withdrawal by Subject|0|||
129480904|NCT00805207|466049686|FG001|Overall Study|Withdrawal by Subject|1|||
129480905|NCT00805207|466049687|FG002|Overall Study|Withdrawal by Subject|0|||
129480906|NCT00805207|466049688|FG003|Overall Study|Withdrawal by Subject|0|||
129480907|NCT00805207|466049689|FG004|Overall Study|Withdrawal by Subject|1|||
129480908|NCT00805207|466049690|FG005|Overall Study|Withdrawal by Subject|2|||
129480909|NCT00805207|466049691|FG006|Overall Study|Withdrawal by Subject|0|||
129480910|NCT00805207|466049692|FG007|Overall Study|Withdrawal by Subject|0|||
129480911|NCT00805207|466049693|FG008|Overall Study|Withdrawal by Subject|0|||
129480912|NCT00064701|466049694|FG000|One Year Post-transplant|Did not receive study drug|7|||
129480913|NCT00064701|466049695|FG001|One Year Post-transplant|Did not receive study drug|12|||
129480914|NCT00064701|466049696|FG002|One Year Post-transplant|Did not receive study drug|11|||
129480915|NCT00064701|466049694|FG000|One Year Post-transplant|Adverse Event|23|||
129480916|NCT00064701|466049695|FG001|One Year Post-transplant|Adverse Event|19|||
129480917|NCT00064701|466049696|FG002|One Year Post-transplant|Adverse Event|37|||
129480918|NCT00064701|466049694|FG000|One Year Post-transplant|Rejection|0|||
129480919|NCT00064701|466049695|FG001|One Year Post-transplant|Rejection|1|||
129480920|NCT00064701|466049696|FG002|One Year Post-transplant|Rejection|16|||
129480921|NCT00064701|466049694|FG000|One Year Post-transplant|Non-compliance|4|||
129480922|NCT00064701|466049695|FG001|One Year Post-transplant|Non-compliance|2|||
129480923|NCT00064701|466049696|FG002|One Year Post-transplant|Non-compliance|5|||
129480924|NCT00064701|466049694|FG000|One Year Post-transplant|Graft Failure|3|||
129480925|NCT00064701|466049695|FG001|One Year Post-transplant|Graft Failure|2|||
129480926|NCT00064701|466049696|FG002|One Year Post-transplant|Graft Failure|1|||
129480927|NCT00064701|466049694|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
129480928|NCT00064701|466049695|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
129480929|NCT00064701|466049696|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
129480930|NCT00064701|466049694|FG000|One Year Post-transplant|Lost to Follow-up|1|||
129480931|NCT00064701|466049695|FG001|One Year Post-transplant|Lost to Follow-up|0|||
129480932|NCT00064701|466049696|FG002|One Year Post-transplant|Lost to Follow-up|0|||
129480933|NCT00064701|466049694|FG000|One Year Post-transplant|Converted to rapamycin|1|||
129480934|NCT00064701|466049695|FG001|One Year Post-transplant|Converted to rapamycin|0|||
129480935|NCT00064701|466049696|FG002|One Year Post-transplant|Converted to rapamycin|0|||
129480936|NCT00064701|466049694|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
129480937|NCT00064701|466049695|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
129480938|NCT00064701|466049696|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
129480939|NCT00064701|466049694|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
129480940|NCT00064701|466049695|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
129480941|NCT00064701|466049696|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
129480942|NCT00064701|466049694|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
129480943|NCT00064701|466049695|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
129480944|NCT00064701|466049696|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
129480945|NCT00064701|466049694|FG000|One Year Post-transplant|Poor absorption|0|||
129480946|NCT00064701|466049695|FG001|One Year Post-transplant|Poor absorption|1|||
129480947|NCT00064701|466049696|FG002|One Year Post-transplant|Poor absorption|0|||
129480948|NCT00064701|466049694|FG000|One Year Post-transplant|Pancreas transplant|0|||
129480949|NCT00064701|466049695|FG001|One Year Post-transplant|Pancreas transplant|0|||
129480950|NCT00064701|466049696|FG002|One Year Post-transplant|Pancreas transplant|1|||
129480951|NCT00064701|466049694|FG000|Clinical Continuation Phase|Adverse Event|12|||
129480952|NCT00064701|466049695|FG001|Clinical Continuation Phase|Adverse Event|21|||
129480953|NCT00064701|466049696|FG002|Clinical Continuation Phase|Adverse Event|14|||
129480954|NCT00064701|466049694|FG000|Clinical Continuation Phase|Non-compliance|8|||
129480955|NCT00064701|466049695|FG001|Clinical Continuation Phase|Non-compliance|6|||
129480956|NCT00064701|466049696|FG002|Clinical Continuation Phase|Non-compliance|7|||
129480957|NCT00064701|466049694|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
129480958|NCT00064701|466049695|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
129480959|NCT00064701|466049696|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
129480960|NCT00064701|466049694|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
129480961|NCT00064701|466049695|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
129480962|NCT00064701|466049696|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
129480963|NCT00064701|466049694|FG000|Clinical Continuation Phase|Graft Failure|5|||
129480964|NCT00064701|466049695|FG001|Clinical Continuation Phase|Graft Failure|5|||
129480965|NCT00064701|466049696|FG002|Clinical Continuation Phase|Graft Failure|2|||
129480966|NCT00064701|466049694|FG000|Clinical Continuation Phase|Rejection|1|||
129480967|NCT00064701|466049695|FG001|Clinical Continuation Phase|Rejection|2|||
129480968|NCT00064701|466049696|FG002|Clinical Continuation Phase|Rejection|2|||
129480969|NCT00064701|466049694|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
129480970|NCT00064701|466049695|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
129480971|NCT00064701|466049696|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
129480972|NCT00064701|466049694|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
129480973|NCT00064701|466049695|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
129480974|NCT00064701|466049696|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
129480975|NCT00064701|466049694|FG000|Clinical Continuation Phase|Physician Decision|1|||
129480976|NCT00064701|466049695|FG001|Clinical Continuation Phase|Physician Decision|3|||
129480977|NCT00064701|466049696|FG002|Clinical Continuation Phase|Physician Decision|0|||
129480978|NCT00064701|466049694|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
129480979|NCT00064701|466049695|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
129480980|NCT00064701|466049696|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
129480981|NCT00064701|466049694|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
129480982|NCT00064701|466049695|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
129480983|NCT00064701|466049696|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
129480984|NCT00064701|466049694|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
129480985|NCT00064701|466049695|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
129480986|NCT00064701|466049696|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
129480987|NCT00064701|466049694|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
129480988|NCT00064701|466049695|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
129480989|NCT00064701|466049696|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
129480990|NCT00064701|466049694|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
129480991|NCT00064701|466049695|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
129480992|NCT00064701|466049696|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
129480993|NCT00064701|466049694|FG000|Clinical Continuation Phase|Patient opted out|0|||
129480994|NCT00064701|466049695|FG001|Clinical Continuation Phase|Patient opted out|0|||
129480995|NCT00064701|466049696|FG002|Clinical Continuation Phase|Patient opted out|1|||
129480996|NCT01491945|466049698|FG000|Overall Study|Death|30|||
129480997|NCT01491945|466049698|FG000|Overall Study|Withdrwan/LTF|16|||
129480998|NCT01491945|466049698|FG000|Overall Study|Conversion|4|||
129480999|NCT01491945|466049698|FG000|Overall Study|Missed Visit|1|||
129481000|NCT05681715|466049699|FG000|Training Period (6-weeks)|Adverse Event|3|||
129481001|NCT05681715|466049700|FG001|Training Period (6-weeks)|Adverse Event|0|||
129481002|NCT05681715|466049701|FG002|Training Period (6-weeks)|Adverse Event|0|||
129481003|NCT05681715|466049699|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
129481004|NCT05681715|466049700|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
129481005|NCT05681715|466049701|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
129481006|NCT05681715|466049699|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
129481007|NCT05681715|466049700|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
129481008|NCT05681715|466049701|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
129481009|NCT05681715|466049699|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
129481010|NCT05681715|466049700|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
129481011|NCT05681715|466049701|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
129481012|NCT05681715|466049699|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
129481013|NCT05681715|466049700|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
129481014|NCT05681715|466049701|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
129481015|NCT05681715|466049699|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
129481016|NCT05681715|466049700|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
129481017|NCT05681715|466049701|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
129481018|NCT05681715|466049699|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
129481019|NCT05681715|466049700|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
129481020|NCT05681715|466049701|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
129481021|NCT05681715|466049699|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
129481022|NCT05681715|466049700|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
129481023|NCT05681715|466049701|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
129481024|NCT03770403|466049702|FG000|Overall Study|Adverse Event|8|||
129481025|NCT03770403|466049702|FG000|Overall Study|Death|5|||
129481026|NCT03770403|466049702|FG000|Overall Study|Physician Decision|1|||
129481027|NCT03770403|466049702|FG000|Overall Study|Sponsor decision|1|||
129481028|NCT03770403|466049702|FG000|Overall Study|Study terminated by Sponsor|1|||
129481029|NCT03770403|466049702|FG000|Overall Study|Withdrawal by Subject|13|||
129481030|NCT03770403|466049702|FG000|Overall Study|Other|88|||
129481031|NCT02115308|466049717|FG000|Overall Study|Safety Screening|2|||
129481032|NCT02115308|466049718|FG001|Overall Study|Safety Screening|2|||
129481033|NCT04325503|466049719|FG000|Overall Study|Withdrawal by Subject|1|||
129481034|NCT04325503|466049719|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
129481035|NCT01856114|466049720|FG000|Overall Study|Withdrawal by Subject|1|||
129481036|NCT01856114|466049721|FG001|Overall Study|Withdrawal by Subject|0|||
129481037|NCT01856114|466049720|FG000|Overall Study|Adverse Event|1|||
129481038|NCT01856114|466049721|FG001|Overall Study|Adverse Event|0|||
129481039|NCT00981526|466049722|FG000|Overall Study|Withdrawal by Subject|0|||
129481040|NCT00981526|466049723|FG001|Overall Study|Withdrawal by Subject|2|||
129481041|NCT00981526|466049722|FG000|Overall Study|Physician Decision|4|||
129481042|NCT00981526|466049723|FG001|Overall Study|Physician Decision|4|||
129481043|NCT01564784|466049724|FG000|Overall Study|Other|1|||
129481044|NCT01564784|466049725|FG001|Overall Study|Other|0|||
129481045|NCT01564784|466049724|FG000|Overall Study|Subject refused further follow-up|1|||
129481046|NCT01564784|466049725|FG001|Overall Study|Subject refused further follow-up|6|||
129481047|NCT01564784|466049724|FG000|Overall Study|Lost to Follow-up|1|||
129481048|NCT01564784|466049725|FG001|Overall Study|Lost to Follow-up|1|||
129481049|NCT01564784|466049724|FG000|Overall Study|Death|131|||
129481050|NCT01564784|466049725|FG001|Overall Study|Death|126|||
129481051|NCT03871491|466049726|FG000|Overall Study|Withdrawal by Subject|14|||
129481052|NCT03871491|466049727|FG001|Overall Study|Withdrawal by Subject|14|||
129481053|NCT03871491|466049728|FG002|Overall Study|Withdrawal by Subject|14|||
129481054|NCT03871491|466049729|FG003|Overall Study|Withdrawal by Subject|14|||
129481055|NCT03871491|466049726|FG000|Overall Study|Physician Decision|0|||
129481056|NCT03871491|466049727|FG001|Overall Study|Physician Decision|0|||
129481057|NCT03871491|466049728|FG002|Overall Study|Physician Decision|1|||
129481058|NCT03871491|466049729|FG003|Overall Study|Physician Decision|1|||
129481059|NCT03871491|466049726|FG000|Overall Study|Lost to Follow-up|50|||
129481060|NCT03871491|466049727|FG001|Overall Study|Lost to Follow-up|15|||
129481061|NCT03871491|466049728|FG002|Overall Study|Lost to Follow-up|36|||
129481062|NCT03871491|466049729|FG003|Overall Study|Lost to Follow-up|11|||
129481063|NCT04439331|466049730|FG000|Overall Study|Never Start Protocol Therapy|2|||
129481064|NCT04439331|466049730|FG000|Overall Study|Ineligible|2|||
129481065|NCT04439331|466049730|FG000|Overall Study|Mutation Status Not Confirmed|1|||
129481066|NCT04439331|466049730|FG000|Overall Study|Adverse Event|1|||
129481067|NCT04439331|466049730|FG000|Overall Study|Death|1|||
129481068|NCT04439331|466049730|FG000|Overall Study|Disease Progression|20|||
129481069|NCT04439331|466049730|FG000|Overall Study|Withdrawal by Subject|6|||
129481070|NCT04439331|466049730|FG000|Overall Study|Physician Decision|1|||
129481071|NCT04439331|466049730|FG000|Overall Study|Other Complicating Disease|1|||
129481072|NCT02747004|466049732|FG000|Overall Study|Withdrawal by Subject|8|||
129481073|NCT02747004|466049733|FG001|Overall Study|Withdrawal by Subject|5|||
129481074|NCT02747004|466049734|FG002|Overall Study|Withdrawal by Subject|4|||
129481075|NCT02747004|466049732|FG000|Overall Study|Lost to Follow-up|1|||
129481076|NCT02747004|466049733|FG001|Overall Study|Lost to Follow-up|2|||
129481077|NCT02747004|466049734|FG002|Overall Study|Lost to Follow-up|2|||
129481078|NCT02747004|466049732|FG000|Overall Study|on study treatment/follow-up|48|||
129481079|NCT02747004|466049733|FG001|Overall Study|on study treatment/follow-up|42|||
129481080|NCT02747004|466049734|FG002|Overall Study|on study treatment/follow-up|41|||
129481081|NCT06218251|466049735|FG000|Overall Study|Lost to Follow-up|4|||
129481082|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
129481083|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
129481084|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
129481085|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
129481086|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
129481087|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
129481088|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
129481089|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
129481090|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
129481091|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
129481092|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
129481093|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129481094|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129481095|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129481096|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
129481097|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
129481098|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
129481099|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
129481100|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
129481101|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
129481102|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Death|0|||
129481103|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Death|1|||
129481104|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Death|0|||
129481105|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Death|0|||
129481106|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Death|0|||
129481107|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
129481108|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
129481109|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
129481110|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
129481111|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
129481112|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
129481113|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
129976702|NCT04879849|467877841|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976703|NCT04879849|467877842|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976704|NCT04879849|467877843|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129481114|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
129481115|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
129481116|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
129481117|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
129481118|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
129481119|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
129481120|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
129481121|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
129481122|NCT05087030|466049736|FG000|Main Period (Week 0 to Week 52)|Other|1|||
129481123|NCT05087030|466049737|FG001|Main Period (Week 0 to Week 52)|Other|2|||
129481124|NCT05087030|466049738|FG002|Main Period (Week 0 to Week 52)|Other|0|||
129481125|NCT05087030|466049739|FG003|Main Period (Week 0 to Week 52)|Other|0|||
129481126|NCT05087030|466049740|FG004|Main Period (Week 0 to Week 52)|Other|0|||
129481127|NCT05087030|466049736|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129481128|NCT05087030|466049737|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129481129|NCT05087030|466049738|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129481130|NCT05087030|466049739|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
129481131|NCT05087030|466049740|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
129481132|NCT01444300|466049741|FG000|Overall Study|Adverse Event|4|||
129481133|NCT01444300|466049742|FG001|Overall Study|Adverse Event|0|||
129481134|NCT01769105|466049747|FG000|First Intervention|Protocol Violation|2|||
129481135|NCT01769105|466049748|FG001|First Intervention|Protocol Violation|2|||
129481136|NCT01769105|466049747|FG000|Cross-over|Lost to Follow-up|5|||
129481137|NCT01769105|466049748|FG001|Cross-over|Lost to Follow-up|0|||
129481138|NCT01024244|466052137|FG000|Overall Study|Adverse Event|1|||
129481139|NCT01024244|466052138|FG001|Overall Study|Adverse Event|2|||
129481140|NCT01024244|466052139|FG002|Overall Study|Adverse Event|0|||
129481141|NCT01024244|466052140|FG003|Overall Study|Adverse Event|1|||
129481142|NCT01024244|466052141|FG004|Overall Study|Adverse Event|2|||
129481143|NCT01024244|466052137|FG000|Overall Study|Entry Criteria Not Met|0|||
129481144|NCT01024244|466052138|FG001|Overall Study|Entry Criteria Not Met|1|||
129481145|NCT01024244|466052139|FG002|Overall Study|Entry Criteria Not Met|0|||
129481146|NCT01024244|466052140|FG003|Overall Study|Entry Criteria Not Met|0|||
129481147|NCT01024244|466052141|FG004|Overall Study|Entry Criteria Not Met|0|||
129481148|NCT01024244|466052137|FG000|Overall Study|Lack of Efficacy|1|||
129481149|NCT01024244|466052138|FG001|Overall Study|Lack of Efficacy|0|||
129481150|NCT01024244|466052139|FG002|Overall Study|Lack of Efficacy|0|||
129481151|NCT01024244|466052140|FG003|Overall Study|Lack of Efficacy|0|||
129481152|NCT01024244|466052141|FG004|Overall Study|Lack of Efficacy|0|||
129481153|NCT01024244|466052137|FG000|Overall Study|Protocol Violation|1|||
129481154|NCT01024244|466052138|FG001|Overall Study|Protocol Violation|0|||
129481155|NCT01024244|466052139|FG002|Overall Study|Protocol Violation|0|||
129481156|NCT01024244|466052140|FG003|Overall Study|Protocol Violation|0|||
129481157|NCT01024244|466052141|FG004|Overall Study|Protocol Violation|2|||
129481158|NCT01024244|466052137|FG000|Overall Study|Sponsor Decision|14|||
129481159|NCT01024244|466052138|FG001|Overall Study|Sponsor Decision|7|||
129481160|NCT01024244|466052139|FG002|Overall Study|Sponsor Decision|14|||
129481161|NCT01024244|466052140|FG003|Overall Study|Sponsor Decision|12|||
129481162|NCT01024244|466052141|FG004|Overall Study|Sponsor Decision|10|||
129481163|NCT01024244|466052137|FG000|Overall Study|Withdrawal by Subject|0|||
129481164|NCT01024244|466052138|FG001|Overall Study|Withdrawal by Subject|1|||
129481165|NCT01024244|466052139|FG002|Overall Study|Withdrawal by Subject|0|||
129481166|NCT01024244|466052140|FG003|Overall Study|Withdrawal by Subject|0|||
129481167|NCT01024244|466052141|FG004|Overall Study|Withdrawal by Subject|0|||
129481168|NCT01381094|466052142|FG000|Overall Study|Adverse Event|1|||
129481169|NCT01381094|466052143|FG001|Overall Study|Adverse Event|2|||
129481170|NCT01381094|466052144|FG002|Overall Study|Adverse Event|0|||
129481171|NCT01381094|466052145|FG003|Overall Study|Adverse Event|1|||
129481172|NCT01381094|466052146|FG004|Overall Study|Adverse Event|0|||
129481173|NCT01381094|466052142|FG000|Overall Study|Lost to Follow-up|0|||
129481174|NCT01381094|466052143|FG001|Overall Study|Lost to Follow-up|0|||
129481175|NCT01381094|466052144|FG002|Overall Study|Lost to Follow-up|0|||
129481176|NCT01381094|466052145|FG003|Overall Study|Lost to Follow-up|0|||
129481177|NCT01381094|466052146|FG004|Overall Study|Lost to Follow-up|1|||
129481178|NCT01381094|466052142|FG000|Overall Study|Withdrawal of informed consent|0|||
129481179|NCT01381094|466052143|FG001|Overall Study|Withdrawal of informed consent|1|||
129481180|NCT01381094|466052144|FG002|Overall Study|Withdrawal of informed consent|0|||
129481181|NCT01381094|466052145|FG003|Overall Study|Withdrawal of informed consent|0|||
129481182|NCT01381094|466052146|FG004|Overall Study|Withdrawal of informed consent|0|||
129481183|NCT01381094|466052142|FG000|Overall Study|Participant given Aranesp injection|1|||
129481184|NCT01381094|466052143|FG001|Overall Study|Participant given Aranesp injection|0|||
129481185|NCT01381094|466052144|FG002|Overall Study|Participant given Aranesp injection|0|||
129481186|NCT01381094|466052145|FG003|Overall Study|Participant given Aranesp injection|0|||
129481187|NCT01381094|466052146|FG004|Overall Study|Participant given Aranesp injection|0|||
129481188|NCT01934504|466052149|FG000|Overall Study|Protocol Deviation|0|||
129481189|NCT01934504|466052150|FG001|Overall Study|Protocol Deviation|0|||
129481190|NCT01934504|466052151|FG002|Overall Study|Protocol Deviation|0|||
129481191|NCT01934504|466052152|FG003|Overall Study|Protocol Deviation|2|||
129481192|NCT01934504|466052149|FG000|Overall Study|Study Terminated by Sponsor|1|||
129481193|NCT01934504|466052150|FG001|Overall Study|Study Terminated by Sponsor|0|||
129481194|NCT01934504|466052151|FG002|Overall Study|Study Terminated by Sponsor|5|||
129481195|NCT01934504|466052152|FG003|Overall Study|Study Terminated by Sponsor|5|||
129481196|NCT00541307|466052155|FG000|Overall Study|Death|5|||
129481197|NCT00541307|466052155|FG000|Overall Study|Physician Decision|3|||
129481198|NCT00541307|466052155|FG000|Overall Study|Withdrawal by Subject|6|||
129481199|NCT00541307|466052155|FG000|Overall Study|Lost to Follow-up|4|||
129481200|NCT00541307|466052155|FG000|Overall Study|Subject returned early (outside window)|1|||
129481201|NCT00541307|466052155|FG000|Overall Study|Surgical Bypass|5|||
129481202|NCT03615222|466052156|FG000|Overall Study|Ineligible|26|||
129481203|NCT03615222|466052156|FG000|Overall Study|Withdrawal by Subject|7|||
129481204|NCT03615222|466052156|FG000|Overall Study|Death|1|||
129481205|NCT00733902|466052157|FG000|Overall Study|Death|0|||
129481206|NCT00733902|466052158|FG001|Overall Study|Death|0|||
129481207|NCT00733902|466052159|FG002|Overall Study|Death|0|||
129481208|NCT00733902|466052160|FG003|Overall Study|Death|1|||
129481209|NCT00733902|466052157|FG000|Overall Study|Adverse Event|3|||
129481210|NCT00733902|466052158|FG001|Overall Study|Adverse Event|4|||
129481211|NCT00733902|466052159|FG002|Overall Study|Adverse Event|7|||
129481212|NCT00733902|466052160|FG003|Overall Study|Adverse Event|11|||
129481213|NCT00733902|466052157|FG000|Overall Study|Lack of Efficacy|56|||
129481214|NCT00733902|466052158|FG001|Overall Study|Lack of Efficacy|21|||
129481215|NCT00733902|466052159|FG002|Overall Study|Lack of Efficacy|34|||
129481216|NCT00733902|466052160|FG003|Overall Study|Lack of Efficacy|23|||
129481217|NCT00733902|466052157|FG000|Overall Study|Protocol Violation|4|||
129481218|NCT00733902|466052158|FG001|Overall Study|Protocol Violation|6|||
129481219|NCT00733902|466052159|FG002|Overall Study|Protocol Violation|3|||
129481220|NCT00733902|466052160|FG003|Overall Study|Protocol Violation|3|||
129481221|NCT00733902|466052157|FG000|Overall Study|Withdrawal by Subject|10|||
129481222|NCT00733902|466052158|FG001|Overall Study|Withdrawal by Subject|5|||
129481223|NCT00733902|466052159|FG002|Overall Study|Withdrawal by Subject|4|||
129481224|NCT00733902|466052160|FG003|Overall Study|Withdrawal by Subject|16|||
129481225|NCT00733902|466052157|FG000|Overall Study|Entered extension study|89|||
129481226|NCT00733902|466052158|FG001|Overall Study|Entered extension study|124|||
129481227|NCT00733902|466052159|FG002|Overall Study|Entered extension study|111|||
129481228|NCT00733902|466052160|FG003|Overall Study|Entered extension study|109|||
129481229|NCT00733902|466052157|FG000|Overall Study|Randomized but not treated|2|||
129481230|NCT00733902|466052158|FG001|Overall Study|Randomized but not treated|2|||
129481231|NCT00733902|466052159|FG002|Overall Study|Randomized but not treated|2|||
129481232|NCT00733902|466052160|FG003|Overall Study|Randomized but not treated|1|||
129481233|NCT00775021|466052161|FG000|First Intervention|Lost to Follow-up|1|||
129481234|NCT00775021|466052162|FG001|First Intervention|Lost to Follow-up|0|||
129481235|NCT00775021|466052161|FG000|Second Intervention|Adverse Event|0|||
129481236|NCT00775021|466052162|FG001|Second Intervention|Adverse Event|1|||
129481237|NCT00870688|466052163|FG000|Overall Study|Lost to Follow-up|2|||
129481238|NCT00870688|466052163|FG000|Overall Study|Death, Unrelated|1|||
129976705|NCT04879849|467877844|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976706|NCT04879849|467877845|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
129976707|NCT04879849|467877846|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
129976708|NCT04879849|467877839|FG000|Overall Study|Reason Not Specified|1|||
129976709|NCT04879849|467877840|FG001|Overall Study|Reason Not Specified|0|||
129976710|NCT04879849|467877841|FG002|Overall Study|Reason Not Specified|0|||
129976711|NCT04879849|467877842|FG003|Overall Study|Reason Not Specified|0|||
129976712|NCT04879849|467877843|FG004|Overall Study|Reason Not Specified|0|||
129976713|NCT04879849|467877844|FG005|Overall Study|Reason Not Specified|0|||
129976714|NCT04879849|467877845|FG006|Overall Study|Reason Not Specified|0|||
129976715|NCT04879849|467877846|FG007|Overall Study|Reason Not Specified|0|||
129976716|NCT03361865|467877847|FG000|Overall Study|Death|17|||
129976717|NCT03361865|467877848|FG001|Overall Study|Death|18|||
129976718|NCT03361865|467877847|FG000|Overall Study|Physician Decision|1|||
129976719|NCT03361865|467877848|FG001|Overall Study|Physician Decision|9|||
129976720|NCT03361865|467877847|FG000|Overall Study|Withdrawal by Subject|1|||
129976721|NCT03361865|467877848|FG001|Overall Study|Withdrawal by Subject|0|||
129976722|NCT03852719|467877849|FG000|Overall Study|Withdrawal of consent|8|||
129481239|NCT00870688|466052163|FG000|Overall Study|Granules in the Stools|1|||
129481240|NCT03872180|466052172|FG000|Overall Study|Adverse Event|4|||
129481241|NCT03872180|466052172|FG000|Overall Study|Lack of Efficacy|2|||
129481242|NCT01506141|466052173|FG000|Overall Study|Adverse Event|0|||
129481243|NCT01506141|466052174|FG001|Overall Study|Adverse Event|2|||
129481244|NCT01506141|466052173|FG000|Overall Study|Participation Terminated by Investigator|1|||
129481245|NCT01506141|466052174|FG001|Overall Study|Participation Terminated by Investigator|1|||
129481246|NCT01506141|466052173|FG000|Overall Study|Site Terminated by Sponsor|2|||
129481247|NCT01506141|466052174|FG001|Overall Study|Site Terminated by Sponsor|0|||
129481248|NCT01506141|466052173|FG000|Overall Study|Reason Not Specified|4|||
129481249|NCT01506141|466052174|FG001|Overall Study|Reason Not Specified|2|||
129976723|NCT03852719|467877850|FG001|Overall Study|Withdrawal of consent|8|||
129481250|NCT04607408|466052175|FG000|Overall Study|Lost to Follow-up|0|||
129976724|NCT03852719|467877851|FG002|Overall Study|Withdrawal of consent|9|||
129976725|NCT03852719|467877849|FG000|Overall Study|Physician Decision|5|||
129976726|NCT03852719|467877850|FG001|Overall Study|Physician Decision|4|||
129976727|NCT03852719|467877851|FG002|Overall Study|Physician Decision|1|||
129976728|NCT03852719|467877849|FG000|Overall Study|Pregnancy|2|||
129976729|NCT03852719|467877850|FG001|Overall Study|Pregnancy|1|||
129976730|NCT03852719|467877851|FG002|Overall Study|Pregnancy|0|||
129976731|NCT03852719|467877849|FG000|Overall Study|Death|1|||
129976732|NCT03852719|467877850|FG001|Overall Study|Death|0|||
129976733|NCT03852719|467877851|FG002|Overall Study|Death|0|||
129976734|NCT03852719|467877849|FG000|Overall Study|Reason not Specified|3|||
129976735|NCT03852719|467877850|FG001|Overall Study|Reason not Specified|3|||
129976736|NCT03852719|467877851|FG002|Overall Study|Reason not Specified|5|||
129976737|NCT03852719|467877849|FG000|Overall Study|Adverse Event|2|||
129976738|NCT03852719|467877850|FG001|Overall Study|Adverse Event|1|||
129976739|NCT03852719|467877851|FG002|Overall Study|Adverse Event|4|||
129976740|NCT03852719|467877849|FG000|Overall Study|Progressive disease|1|||
129976741|NCT03852719|467877850|FG001|Overall Study|Progressive disease|4|||
129976742|NCT03852719|467877851|FG002|Overall Study|Progressive disease|1|||
129976743|NCT03852719|467877849|FG000|Overall Study|Lost to Follow-up|1|||
129976744|NCT03852719|467877850|FG001|Overall Study|Lost to Follow-up|0|||
129976745|NCT03852719|467877851|FG002|Overall Study|Lost to Follow-up|0|||
129976746|NCT05543187|467877854|FG000|Overall Study|Ongoing|3|||
129976747|NCT05543187|467877855|FG001|Overall Study|Ongoing|2|||
129976748|NCT03810235|467877856|FG000|Overall Study|Withdrawal by Subject|2|||
129976749|NCT03810235|467877857|FG001|Overall Study|Withdrawal by Subject|0|||
129976750|NCT04777864|467877858|FG000|Overall Study|Lost to Follow-up|8|||
129976751|NCT04777864|467877859|FG001|Overall Study|Lost to Follow-up|19|||
129976752|NCT01647542|467877860|FG000|Overall Study|Major Protocol Deviation|1|||
129976753|NCT01647542|467877861|FG001|Overall Study|Major Protocol Deviation|0|||
129976754|NCT01647542|467877862|FG002|Overall Study|Major Protocol Deviation|0|||
129976755|NCT01647542|467877860|FG000|Overall Study|Adverse Event|4|||
129976756|NCT01647542|467877861|FG001|Overall Study|Adverse Event|5|||
129976757|NCT01647542|467877862|FG002|Overall Study|Adverse Event|4|||
129976758|NCT01647542|467877860|FG000|Overall Study|Lost to Follow-up|0|||
129976759|NCT01647542|467877861|FG001|Overall Study|Lost to Follow-up|2|||
129976760|NCT01647542|467877862|FG002|Overall Study|Lost to Follow-up|2|||
129976761|NCT01647542|467877860|FG000|Overall Study|Withdrawal by Subject|6|||
129976762|NCT01647542|467877861|FG001|Overall Study|Withdrawal by Subject|4|||
129976763|NCT01647542|467877862|FG002|Overall Study|Withdrawal by Subject|0|||
129976764|NCT01647542|467877860|FG000|Overall Study|Study Termination|64|||
129976765|NCT01647542|467877861|FG001|Overall Study|Study Termination|61|||
129976766|NCT01647542|467877862|FG002|Overall Study|Study Termination|65|||
129976767|NCT01647542|467877860|FG000|Overall Study|Lack of Efficacy|1|||
129976768|NCT01647542|467877861|FG001|Overall Study|Lack of Efficacy|1|||
129976769|NCT01647542|467877862|FG002|Overall Study|Lack of Efficacy|0|||
129976770|NCT01647542|467877860|FG000|Overall Study|Death|0|||
129976771|NCT01647542|467877861|FG001|Overall Study|Death|0|||
129976772|NCT01647542|467877862|FG002|Overall Study|Death|1|||
129976773|NCT03086655|467877863|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
129976774|NCT03086655|467877864|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
129976775|NCT03086655|467877863|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
129976776|NCT03086655|467877864|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
129976777|NCT03086655|467877863|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
129976778|NCT03086655|467877864|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
129976779|NCT03086655|467877863|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
129976780|NCT03086655|467877864|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
129976781|NCT03086655|467877863|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
129976782|NCT03086655|467877864|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
129481251|NCT04607408|466052176|FG001|Overall Study|Lost to Follow-up|0|||
129481252|NCT04607408|466052177|FG002|Overall Study|Lost to Follow-up|0|||
129481253|NCT04607408|466052178|FG003|Overall Study|Lost to Follow-up|1|||
129481254|NCT04607408|466052179|FG004|Overall Study|Lost to Follow-up|0|||
129976783|NCT03086655|467877863|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
129976784|NCT03086655|467877864|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
129976785|NCT03086655|467877863|FG000|12 Month Follow-up = Final Assessment|Death|0|||
129976786|NCT03086655|467877864|FG001|12 Month Follow-up = Final Assessment|Death|1|||
129976787|NCT05576662|467877865|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
129976788|NCT05576662|467877866|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
129976789|NCT05576662|467877865|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
129481255|NCT04607408|466052175|FG000|Overall Study|Withdrawal by Subject|0|||
129481256|NCT04607408|466052176|FG001|Overall Study|Withdrawal by Subject|1|||
129976790|NCT05576662|467877866|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
129976791|NCT05576662|467877865|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
129976792|NCT05576662|467877866|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
129976793|NCT05576662|467877865|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
129976794|NCT05576662|467877866|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
129976795|NCT03008005|467877867|FG000|Overall Study|Physician Decision|1|||
129976796|NCT03008005|467877868|FG001|Overall Study|Physician Decision|0|||
129976797|NCT03008005|467877869|FG002|Overall Study|Physician Decision|0|||
129976798|NCT03008005|467877867|FG000|Overall Study|Withdrawal by Subject|1|||
129976799|NCT03008005|467877868|FG001|Overall Study|Withdrawal by Subject|0|||
129976800|NCT03008005|467877869|FG002|Overall Study|Withdrawal by Subject|0|||
129976801|NCT03008005|467877867|FG000|Overall Study|Ineligible|0|||
129976802|NCT03008005|467877868|FG001|Overall Study|Ineligible|1|||
129976803|NCT03008005|467877869|FG002|Overall Study|Ineligible|0|||
129976804|NCT01040169|467877885|FG000|Overall Study|Lost to Follow-up|3|||
129976805|NCT01040169|467877886|FG001|Overall Study|Lost to Follow-up|8|||
129976806|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Adverse Event|4|||
129976807|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Adverse Event|0|||
129976808|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Adverse Event|0|||
129976809|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
129976810|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
129976811|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
129976812|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Death|1|||
129976813|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Death|0|||
129976814|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Death|0|||
129976815|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Physician Decision|1|||
129976816|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Physician Decision|0|||
129976817|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Physician Decision|0|||
129976818|NCT00350727|467877887|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
129976819|NCT00350727|467877888|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
129976820|NCT00350727|467877889|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
129976821|NCT00350727|467877887|FG000|Phase II|Disease Progression|0|||
129976822|NCT00350727|467877888|FG001|Phase II|Disease Progression|15|||
129976823|NCT00350727|467877889|FG002|Phase II|Disease Progression|16|||
129976824|NCT00350727|467877887|FG000|Phase II|Clinical Deterioration|0|||
129976825|NCT00350727|467877888|FG001|Phase II|Clinical Deterioration|1|||
129976826|NCT00350727|467877889|FG002|Phase II|Clinical Deterioration|0|||
129976827|NCT00350727|467877887|FG000|Phase II|Withdrawal by Subject|0|||
129976828|NCT00350727|467877888|FG001|Phase II|Withdrawal by Subject|2|||
129976829|NCT00350727|467877889|FG002|Phase II|Withdrawal by Subject|1|||
129976830|NCT00350727|467877887|FG000|Phase II|Adverse Event|0|||
129976831|NCT00350727|467877888|FG001|Phase II|Adverse Event|1|||
129976832|NCT00350727|467877889|FG002|Phase II|Adverse Event|1|||
129976833|NCT00350727|467877887|FG000|Phase II|Death|0|||
129976834|NCT00350727|467877888|FG001|Phase II|Death|0|||
129976835|NCT00350727|467877889|FG002|Phase II|Death|2|||
129976836|NCT00350727|467877887|FG000|Phase II|Sponsor Terminated Study|0|||
129976837|NCT00350727|467877888|FG001|Phase II|Sponsor Terminated Study|0|||
129976838|NCT00350727|467877889|FG002|Phase II|Sponsor Terminated Study|1|||
129976839|NCT00350727|467877887|FG000|Phase II|Enrolled in Rollover Study|0|||
129976840|NCT00350727|467877888|FG001|Phase II|Enrolled in Rollover Study|0|||
129976841|NCT00350727|467877889|FG002|Phase II|Enrolled in Rollover Study|1|||
129976842|NCT03633799|467877894|FG000|Overall Study|Adverse Event|349|||
129976843|NCT03633799|467877894|FG000|Overall Study|Withdrawal by Subject|288|||
129976844|NCT03633799|467877894|FG000|Overall Study|Lost to Follow-up|97|||
129976845|NCT03633799|467877894|FG000|Overall Study|Physician Decision|9|||
129976846|NCT03633799|467877894|FG000|Overall Study|Protocol Violation|4|||
129976847|NCT03633799|467877894|FG000|Overall Study|Pregnancy|20|||
129976848|NCT03633799|467877894|FG000|Overall Study|other|39|||
129976849|NCT03633799|467877894|FG000|Overall Study|ongoing within third year of study|106|||
129976850|NCT03633799|467877894|FG000|Overall Study|unsuccessful study drug placement|19|||
129976851|NCT03551691|467877895|FG000|Overall Study|Withdrawal by Subject|3|||
129976852|NCT03551691|467877896|FG001|Overall Study|Withdrawal by Subject|3|||
129976853|NCT03520712|467877897|FG000|Overall Study|Early termination of the study by Sponsor|2|||
129976854|NCT05855967|467877898|FG000|Overall Study|Withdrawal by Subject|7|||
129976855|NCT05855967|467877899|FG001|Overall Study|Withdrawal by Subject|5|||
129976856|NCT05855967|467877898|FG000|Overall Study|Lost to Follow-up|2|||
129976857|NCT05855967|467877899|FG001|Overall Study|Lost to Follow-up|1|||
129976858|NCT02446821|467877900|FG000|Overall Study|Adverse Event|28|||
129976859|NCT02446821|467877900|FG000|Overall Study|Withdrawal by Subject|6|||
129976860|NCT02446821|467877900|FG000|Overall Study|Lost to Follow-up|22|||
129976861|NCT02446821|467877900|FG000|Overall Study|other|9|||
129976862|NCT02446821|467877900|FG000|Overall Study|insertion failure|3|||
129976863|NCT04427280|467879465|FG000|Overall Study|Withdrawal by Subject|0|||
129976864|NCT04427280|467879466|FG001|Overall Study|Withdrawal by Subject|2|||
129976865|NCT02942277|467879474|FG000|Year 1|Withdrawal by Subject|0|||
129976866|NCT02942277|467879475|FG001|Year 1|Withdrawal by Subject|0|||
129976867|NCT02942277|467879476|FG002|Year 1|Withdrawal by Subject|0|||
129976868|NCT02942277|467879477|FG003|Year 1|Withdrawal by Subject|0|||
129976869|NCT02942277|467879478|FG004|Year 1|Withdrawal by Subject|1|||
129976870|NCT02942277|467879479|FG005|Year 1|Withdrawal by Subject|3|||
129976871|NCT02942277|467879480|FG006|Year 1|Withdrawal by Subject|0|||
129976872|NCT02942277|467879481|FG007|Year 1|Withdrawal by Subject|1|||
129976873|NCT02942277|467879482|FG008|Year 1|Withdrawal by Subject|0|||
129976874|NCT02942277|467879483|FG009|Year 1|Withdrawal by Subject|0|||
129976875|NCT02942277|467879484|FG010|Year 1|Withdrawal by Subject|3|||
129976876|NCT02942277|467879474|FG000|Year 1|Travel|0|||
129976877|NCT02942277|467879475|FG001|Year 1|Travel|1|||
129976878|NCT02942277|467879476|FG002|Year 1|Travel|0|||
129976879|NCT02942277|467879477|FG003|Year 1|Travel|0|||
129976880|NCT02942277|467879478|FG004|Year 1|Travel|4|||
129976881|NCT02942277|467879479|FG005|Year 1|Travel|5|||
129976882|NCT02942277|467879480|FG006|Year 1|Travel|0|||
129976883|NCT02942277|467879481|FG007|Year 1|Travel|0|||
129976884|NCT02942277|467879482|FG008|Year 1|Travel|0|||
129976885|NCT02942277|467879483|FG009|Year 1|Travel|0|||
129976886|NCT02942277|467879484|FG010|Year 1|Travel|8|||
129976887|NCT02942277|467879474|FG000|Year 1|Joined Army|0|||
129976888|NCT02942277|467879475|FG001|Year 1|Joined Army|1|||
129976889|NCT02942277|467879476|FG002|Year 1|Joined Army|0|||
129976890|NCT02942277|467879477|FG003|Year 1|Joined Army|0|||
129976891|NCT02942277|467879478|FG004|Year 1|Joined Army|0|||
129976892|NCT02942277|467879479|FG005|Year 1|Joined Army|0|||
129976893|NCT02942277|467879480|FG006|Year 1|Joined Army|0|||
129976894|NCT02942277|467879481|FG007|Year 1|Joined Army|0|||
129976895|NCT02942277|467879482|FG008|Year 1|Joined Army|0|||
129976896|NCT02942277|467879483|FG009|Year 1|Joined Army|0|||
129976897|NCT02942277|467879484|FG010|Year 1|Joined Army|0|||
129976898|NCT02942277|467879474|FG000|Year 1|Subject met withdrawal criteria|0|||
129976899|NCT02942277|467879475|FG001|Year 1|Subject met withdrawal criteria|0|||
129976900|NCT02942277|467879476|FG002|Year 1|Subject met withdrawal criteria|0|||
129976901|NCT02942277|467879477|FG003|Year 1|Subject met withdrawal criteria|1|||
129976902|NCT02942277|467879478|FG004|Year 1|Subject met withdrawal criteria|0|||
129976903|NCT02942277|467879479|FG005|Year 1|Subject met withdrawal criteria|0|||
129976904|NCT02942277|467879480|FG006|Year 1|Subject met withdrawal criteria|0|||
129976905|NCT02942277|467879481|FG007|Year 1|Subject met withdrawal criteria|0|||
129976906|NCT02942277|467879482|FG008|Year 1|Subject met withdrawal criteria|0|||
129976907|NCT02942277|467879483|FG009|Year 1|Subject met withdrawal criteria|0|||
129976908|NCT02942277|467879484|FG010|Year 1|Subject met withdrawal criteria|0|||
129976909|NCT02942277|467879474|FG000|Year 1|Lost to Follow-up|0|||
129976910|NCT02942277|467879475|FG001|Year 1|Lost to Follow-up|0|||
129976911|NCT02942277|467879476|FG002|Year 1|Lost to Follow-up|0|||
129976912|NCT02942277|467879477|FG003|Year 1|Lost to Follow-up|0|||
129976913|NCT02942277|467879478|FG004|Year 1|Lost to Follow-up|1|||
129976914|NCT02942277|467879479|FG005|Year 1|Lost to Follow-up|0|||
129976915|NCT02942277|467879480|FG006|Year 1|Lost to Follow-up|0|||
129976916|NCT02942277|467879481|FG007|Year 1|Lost to Follow-up|0|||
129976917|NCT02942277|467879482|FG008|Year 1|Lost to Follow-up|0|||
129976918|NCT02942277|467879483|FG009|Year 1|Lost to Follow-up|0|||
129976919|NCT02942277|467879484|FG010|Year 1|Lost to Follow-up|2|||
129976920|NCT02942277|467879474|FG000|Year 1|Protocol Violation|0|||
129976921|NCT02942277|467879475|FG001|Year 1|Protocol Violation|0|||
129976922|NCT02942277|467879476|FG002|Year 1|Protocol Violation|0|||
129976923|NCT02942277|467879477|FG003|Year 1|Protocol Violation|0|||
129976924|NCT02942277|467879478|FG004|Year 1|Protocol Violation|1|||
129976925|NCT02942277|467879479|FG005|Year 1|Protocol Violation|1|||
129976926|NCT02942277|467879480|FG006|Year 1|Protocol Violation|0|||
129976927|NCT02942277|467879481|FG007|Year 1|Protocol Violation|0|||
129976928|NCT02942277|467879482|FG008|Year 1|Protocol Violation|0|||
129976929|NCT02942277|467879483|FG009|Year 1|Protocol Violation|0|||
129976930|NCT02942277|467879484|FG010|Year 1|Protocol Violation|2|||
129976931|NCT02942277|467879474|FG000|Year 1|Pregnancy|0|||
129976932|NCT02942277|467879475|FG001|Year 1|Pregnancy|0|||
129976933|NCT02942277|467879476|FG002|Year 1|Pregnancy|0|||
129976934|NCT02942277|467879477|FG003|Year 1|Pregnancy|0|||
129976935|NCT02942277|467879478|FG004|Year 1|Pregnancy|0|||
129976936|NCT02942277|467879479|FG005|Year 1|Pregnancy|1|||
129976937|NCT02942277|467879480|FG006|Year 1|Pregnancy|0|||
129976938|NCT02942277|467879481|FG007|Year 1|Pregnancy|0|||
129976939|NCT02942277|467879482|FG008|Year 1|Pregnancy|0|||
129976940|NCT02942277|467879483|FG009|Year 1|Pregnancy|0|||
129976941|NCT02942277|467879484|FG010|Year 1|Pregnancy|0|||
129976942|NCT02942277|467879474|FG000|Year 2|Lost to Follow-up|0|||
129976943|NCT02942277|467879475|FG001|Year 2|Lost to Follow-up|0|||
129976944|NCT02942277|467879476|FG002|Year 2|Lost to Follow-up|0|||
129976945|NCT02942277|467879477|FG003|Year 2|Lost to Follow-up|0|||
129976946|NCT02942277|467879478|FG004|Year 2|Lost to Follow-up|2|||
129976947|NCT02942277|467879479|FG005|Year 2|Lost to Follow-up|1|||
129976948|NCT02942277|467879480|FG006|Year 2|Lost to Follow-up|0|||
129976949|NCT02942277|467879481|FG007|Year 2|Lost to Follow-up|0|||
129976950|NCT02942277|467879482|FG008|Year 2|Lost to Follow-up|0|||
129976951|NCT02942277|467879483|FG009|Year 2|Lost to Follow-up|0|||
129976952|NCT02942277|467879484|FG010|Year 2|Lost to Follow-up|0|||
129976953|NCT02942277|467879474|FG000|Year 2|Did not rescreen|0|||
129976954|NCT02942277|467879475|FG001|Year 2|Did not rescreen|0|||
129976955|NCT02942277|467879476|FG002|Year 2|Did not rescreen|1|||
129976956|NCT02942277|467879477|FG003|Year 2|Did not rescreen|1|||
129976957|NCT02942277|467879478|FG004|Year 2|Did not rescreen|9|||
129976958|NCT02942277|467879479|FG005|Year 2|Did not rescreen|6|||
129976959|NCT02942277|467879480|FG006|Year 2|Did not rescreen|0|||
129976960|NCT02942277|467879481|FG007|Year 2|Did not rescreen|1|||
129976961|NCT02942277|467879482|FG008|Year 2|Did not rescreen|0|||
129976962|NCT02942277|467879483|FG009|Year 2|Did not rescreen|0|||
129976963|NCT02942277|467879484|FG010|Year 2|Did not rescreen|21|||
129976964|NCT02942277|467879474|FG000|Year 2|Met withdrawal criteria|0|||
129976965|NCT02942277|467879475|FG001|Year 2|Met withdrawal criteria|0|||
129976966|NCT02942277|467879476|FG002|Year 2|Met withdrawal criteria|0|||
129976967|NCT02942277|467879477|FG003|Year 2|Met withdrawal criteria|0|||
129976968|NCT02942277|467879478|FG004|Year 2|Met withdrawal criteria|1|||
129976969|NCT02942277|467879479|FG005|Year 2|Met withdrawal criteria|2|||
129976970|NCT02942277|467879480|FG006|Year 2|Met withdrawal criteria|0|||
129976971|NCT02942277|467879481|FG007|Year 2|Met withdrawal criteria|0|||
129976972|NCT02942277|467879482|FG008|Year 2|Met withdrawal criteria|0|||
129976973|NCT02942277|467879483|FG009|Year 2|Met withdrawal criteria|0|||
129976974|NCT02942277|467879484|FG010|Year 2|Met withdrawal criteria|1|||
129976975|NCT02942277|467879474|FG000|Year 2|Travel|0|||
129976976|NCT02942277|467879475|FG001|Year 2|Travel|1|||
129976977|NCT02942277|467879476|FG002|Year 2|Travel|0|||
129976978|NCT02942277|467879477|FG003|Year 2|Travel|0|||
129976979|NCT02942277|467879478|FG004|Year 2|Travel|0|||
129976980|NCT02942277|467879479|FG005|Year 2|Travel|1|||
129976981|NCT02942277|467879480|FG006|Year 2|Travel|0|||
129976982|NCT02942277|467879481|FG007|Year 2|Travel|0|||
129976983|NCT02942277|467879482|FG008|Year 2|Travel|0|||
129976984|NCT02942277|467879483|FG009|Year 2|Travel|1|||
129976985|NCT02942277|467879484|FG010|Year 2|Travel|3|||
129976986|NCT02942277|467879474|FG000|Year 2|Non-compliant|0|||
129976987|NCT02942277|467879475|FG001|Year 2|Non-compliant|0|||
129976988|NCT02942277|467879476|FG002|Year 2|Non-compliant|0|||
129976989|NCT02942277|467879477|FG003|Year 2|Non-compliant|0|||
129976990|NCT02942277|467879478|FG004|Year 2|Non-compliant|1|||
129976991|NCT02942277|467879479|FG005|Year 2|Non-compliant|1|||
129976992|NCT02942277|467879480|FG006|Year 2|Non-compliant|0|||
129976993|NCT02942277|467879481|FG007|Year 2|Non-compliant|0|||
129976994|NCT02942277|467879482|FG008|Year 2|Non-compliant|0|||
129976995|NCT02942277|467879483|FG009|Year 2|Non-compliant|0|||
129976996|NCT02942277|467879484|FG010|Year 2|Non-compliant|0|||
129976997|NCT02942277|467879474|FG000|Year 2|Withdrawal by Subject|0|||
129976998|NCT02942277|467879475|FG001|Year 2|Withdrawal by Subject|0|||
129976999|NCT02942277|467879476|FG002|Year 2|Withdrawal by Subject|0|||
129977000|NCT02942277|467879477|FG003|Year 2|Withdrawal by Subject|0|||
129977001|NCT02942277|467879478|FG004|Year 2|Withdrawal by Subject|0|||
129977002|NCT02942277|467879479|FG005|Year 2|Withdrawal by Subject|0|||
129977003|NCT02942277|467879480|FG006|Year 2|Withdrawal by Subject|1|||
129977004|NCT02942277|467879481|FG007|Year 2|Withdrawal by Subject|0|||
129977005|NCT02942277|467879482|FG008|Year 2|Withdrawal by Subject|0|||
129977006|NCT02942277|467879483|FG009|Year 2|Withdrawal by Subject|0|||
129977007|NCT02942277|467879484|FG010|Year 2|Withdrawal by Subject|0|||
129977008|NCT05577715|467879485|FG000|Overall Study|Withdrawal by Subject|1|||
129977009|NCT05577715|467879485|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
129977010|NCT05577715|467879485|FG000|Overall Study|Lost to Follow-up|1|||
129977011|NCT05577715|467879485|FG000|Overall Study|Death|6|||
129977012|NCT05282121|467879489|FG000|Overall Study|Adverse Event|1|||
129977013|NCT05282121|467879490|FG001|Overall Study|Adverse Event|1|||
129977014|NCT05282121|467879491|FG002|Overall Study|Adverse Event|4|||
129977015|NCT05282121|467879492|FG003|Overall Study|Adverse Event|1|||
129977016|NCT05282121|467879489|FG000|Overall Study|Study Terminated by Sponsor|1|||
129977017|NCT05282121|467879490|FG001|Overall Study|Study Terminated by Sponsor|2|||
129977018|NCT05282121|467879491|FG002|Overall Study|Study Terminated by Sponsor|2|||
129977019|NCT05282121|467879492|FG003|Overall Study|Study Terminated by Sponsor|2|||
129977020|NCT05282121|467879489|FG000|Overall Study|Other than listed|0|||
129977021|NCT05282121|467879490|FG001|Overall Study|Other than listed|0|||
129977022|NCT05282121|467879491|FG002|Overall Study|Other than listed|1|||
129977023|NCT05282121|467879492|FG003|Overall Study|Other than listed|0|||
129977024|NCT05282121|467879489|FG000|Overall Study|No reason available|0|||
129977025|NCT05282121|467879490|FG001|Overall Study|No reason available|0|||
129977026|NCT05282121|467879491|FG002|Overall Study|No reason available|1|||
129977027|NCT05282121|467879492|FG003|Overall Study|No reason available|0|||
129977028|NCT00608868|467879495|FG000|Overall Study|Withdrawal by Subject|7|||
129977029|NCT00608868|467879495|FG000|Overall Study|Protocol Violation|3|||
129977030|NCT00608868|467879495|FG000|Overall Study|Lost to Follow-up|2|||
129977031|NCT00608868|467879495|FG000|Overall Study|Adverse Event|1|||
129977032|NCT00608868|467879495|FG000|Overall Study|Physician Decision|2|||
129977033|NCT04546425|467879496|FG000|Overall Study|Protocol Violation|1|||
129977034|NCT04546425|467879497|FG001|Overall Study|Protocol Violation|1|||
129977035|NCT04546425|467879498|FG002|Overall Study|Protocol Violation|0|||
129977036|NCT04546425|467879499|FG003|Overall Study|Protocol Violation|0|||
129977037|NCT04546425|467879496|FG000|Overall Study|Adverse Event|3|||
129977038|NCT04546425|467879497|FG001|Overall Study|Adverse Event|0|||
129977039|NCT04546425|467879498|FG002|Overall Study|Adverse Event|0|||
129977040|NCT04546425|467879499|FG003|Overall Study|Adverse Event|0|||
129977041|NCT04546425|467879496|FG000|Overall Study|Lost to Follow-up|5|||
129977042|NCT04546425|467879497|FG001|Overall Study|Lost to Follow-up|4|||
129977043|NCT04546425|467879498|FG002|Overall Study|Lost to Follow-up|0|||
129977044|NCT04546425|467879499|FG003|Overall Study|Lost to Follow-up|0|||
129977045|NCT04546425|467879496|FG000|Overall Study|No Longer met eligibility criteria|3|||
129977046|NCT04546425|467879497|FG001|Overall Study|No Longer met eligibility criteria|3|||
129977047|NCT04546425|467879498|FG002|Overall Study|No Longer met eligibility criteria|1|||
129977048|NCT04546425|467879499|FG003|Overall Study|No Longer met eligibility criteria|1|||
129977049|NCT04546425|467879496|FG000|Overall Study|Withdrawal by parent/guardian|6|||
129977050|NCT04546425|467879497|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129977051|NCT04546425|467879498|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129977052|NCT04546425|467879499|FG003|Overall Study|Withdrawal by parent/guardian|1|||
129977053|NCT00677534|467879500|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
129977054|NCT00677534|467879500|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
129977055|NCT00677534|467879500|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
129977056|NCT00863681|467879507|FG000|Overall Study|Other|2|||
129977057|NCT00863681|467879508|FG001|Overall Study|Other|0|||
129977058|NCT00863681|467879509|FG002|Overall Study|Other|0|||
129977059|NCT00863681|467879507|FG000|Overall Study|Missing|1|||
129977060|NCT00863681|467879508|FG001|Overall Study|Missing|0|||
129977061|NCT00863681|467879509|FG002|Overall Study|Missing|0|||
129977062|NCT00863681|467879507|FG000|Overall Study|Death|40|||
129977063|NCT00863681|467879508|FG001|Overall Study|Death|23|||
129977064|NCT00863681|467879509|FG002|Overall Study|Death|6|||
129977065|NCT00863681|467879507|FG000|Overall Study|Withdrawal by Subject|12|||
129977066|NCT00863681|467879508|FG001|Overall Study|Withdrawal by Subject|5|||
129977067|NCT00863681|467879509|FG002|Overall Study|Withdrawal by Subject|2|||
129977068|NCT00863681|467879507|FG000|Overall Study|Protocol Violation|2|||
129977069|NCT00863681|467879508|FG001|Overall Study|Protocol Violation|0|||
129977070|NCT00863681|467879509|FG002|Overall Study|Protocol Violation|0|||
129977071|NCT00863681|467879507|FG000|Overall Study|Lost to Follow-up|3|||
129977072|NCT00863681|467879508|FG001|Overall Study|Lost to Follow-up|0|||
129977073|NCT00863681|467879509|FG002|Overall Study|Lost to Follow-up|3|||
129977074|NCT00863681|467879507|FG000|Overall Study|Adverse Event|28|||
129977075|NCT00863681|467879508|FG001|Overall Study|Adverse Event|10|||
129977076|NCT00863681|467879509|FG002|Overall Study|Adverse Event|6|||
129977077|NCT00863681|467879507|FG000|Overall Study|Lack of Efficacy|2|||
129977078|NCT00863681|467879508|FG001|Overall Study|Lack of Efficacy|2|||
129977079|NCT00863681|467879509|FG002|Overall Study|Lack of Efficacy|1|||
129977080|NCT00863681|467879507|FG000|Overall Study|Non-compliance with study drug|1|||
129977081|NCT00863681|467879508|FG001|Overall Study|Non-compliance with study drug|3|||
129977082|NCT00863681|467879509|FG002|Overall Study|Non-compliance with study drug|0|||
129977083|NCT03031496|467879510|FG000|Period 1|Adverse Event|2|||
129977084|NCT03031496|467879511|FG001|Period 1|Adverse Event|0|||
129977085|NCT03031496|467879510|FG000|Period 1|Withdrawal by Subject|0|||
129977086|NCT03031496|467879511|FG001|Period 1|Withdrawal by Subject|2|||
129977087|NCT02979249|467879513|FG000|Overall Study|Lost to Follow-up|2|||
129977088|NCT02979249|467879513|FG000|Overall Study|Withdrawal by Subject|4|||
129977089|NCT01125046|467879514|FG000|First 6 Months of Treatment|Death|1|||
129977090|NCT01125046|467879514|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
129977091|NCT01125046|467879514|FG000|First 6 Months of Treatment|Non-compliance|1|||
129977092|NCT01125046|467879514|FG000|First 6 Months of Treatment|Surgery|1|||
129977093|NCT01125046|467879514|FG000|First 6 Months of Treatment|Progressive Disease|7|||
129977094|NCT01125046|467879514|FG000|First 6 Months of Treatment|Adverse Event|2|||
129977095|NCT01125046|467879514|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
129977096|NCT01125046|467879514|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
129977097|NCT01125046|467879514|FG000|Follow-up/Data Cut Off Point|Death|29|||
129977098|NCT01125046|467879514|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
129977099|NCT01685229|467879516|FG000|Overall Study|Subjects missing Study Exit form|3|||
129977100|NCT01685229|467879517|FG001|Overall Study|Subjects missing Study Exit form|1|||
129977101|NCT01685229|467879516|FG000|Overall Study|Lost to Follow-up|16|||
129977102|NCT01685229|467879517|FG001|Overall Study|Lost to Follow-up|10|||
129977103|NCT01685229|467879516|FG000|Overall Study|Withdrawal by Subject|6|||
129977104|NCT01685229|467879517|FG001|Overall Study|Withdrawal by Subject|5|||
129977105|NCT01685229|467879516|FG000|Overall Study|Death|1|||
129977106|NCT01685229|467879517|FG001|Overall Study|Death|0|||
129977107|NCT01399697|467879518|FG000|Overall Study|Adverse Event|13|||
129977108|NCT01399697|467879519|FG001|Overall Study|Adverse Event|3|||
129977109|NCT01399697|467879520|FG002|Overall Study|Adverse Event|1|||
129977110|NCT01399697|467879518|FG000|Overall Study|Lost to Follow-up|2|||
129977111|NCT01399697|467879519|FG001|Overall Study|Lost to Follow-up|0|||
129977112|NCT01399697|467879520|FG002|Overall Study|Lost to Follow-up|0|||
129977113|NCT01399697|467879518|FG000|Overall Study|Withdrawal by Subject|8|||
129977114|NCT01399697|467879519|FG001|Overall Study|Withdrawal by Subject|0|||
129977115|NCT01399697|467879520|FG002|Overall Study|Withdrawal by Subject|0|||
129977116|NCT01399697|467879518|FG000|Overall Study|Investigator Decisión|1|||
129977117|NCT01399697|467879519|FG001|Overall Study|Investigator Decisión|0|||
129977118|NCT01399697|467879520|FG002|Overall Study|Investigator Decisión|2|||
129977119|NCT01399697|467879518|FG000|Overall Study|Lack of Efficacy|9|||
129977120|NCT01399697|467879519|FG001|Overall Study|Lack of Efficacy|0|||
129977121|NCT01399697|467879520|FG002|Overall Study|Lack of Efficacy|1|||
129977122|NCT01399697|467879518|FG000|Overall Study|Protocol Violation|2|||
129977123|NCT01399697|467879519|FG001|Overall Study|Protocol Violation|0|||
129977124|NCT01399697|467879520|FG002|Overall Study|Protocol Violation|0|||
129977125|NCT01399697|467879518|FG000|Overall Study|Non-Compliant|1|||
129977126|NCT01399697|467879519|FG001|Overall Study|Non-Compliant|0|||
129977127|NCT01399697|467879520|FG002|Overall Study|Non-Compliant|0|||
129977128|NCT01399697|467879518|FG000|Overall Study|Inclusion Error|2|||
129977129|NCT01399697|467879519|FG001|Overall Study|Inclusion Error|0|||
129977130|NCT01399697|467879520|FG002|Overall Study|Inclusion Error|0|||
129977131|NCT01399697|467879518|FG000|Overall Study|Positive result for hepatitis B|1|||
129977132|NCT01399697|467879519|FG001|Overall Study|Positive result for hepatitis B|0|||
129977133|NCT01399697|467879520|FG002|Overall Study|Positive result for hepatitis B|0|||
129977134|NCT01399697|467879518|FG000|Overall Study|Clinical RA remission|1|||
129977135|NCT01399697|467879519|FG001|Overall Study|Clinical RA remission|0|||
129977136|NCT01399697|467879520|FG002|Overall Study|Clinical RA remission|0|||
129977137|NCT01399697|467879518|FG000|Overall Study|Sponsor Decision|1|||
129977138|NCT01399697|467879519|FG001|Overall Study|Sponsor Decision|0|||
129977139|NCT01399697|467879520|FG002|Overall Study|Sponsor Decision|0|||
129977140|NCT02766777|467879525|FG000|Overall Study|Adverse Event|12|||
129977141|NCT02766777|467879525|FG000|Overall Study|Lost to Follow-up|16|||
129977142|NCT02766777|467879525|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129977143|NCT02766777|467879525|FG000|Overall Study|Protocol Violation|1|||
129977144|NCT02766777|467879525|FG000|Overall Study|Withdrawal by Subject|4|||
129977145|NCT00967005|467879528|FG000|Overall Study|Lost to Follow-up|7|||
129977146|NCT00967005|467879529|FG001|Overall Study|Lost to Follow-up|10|||
129977147|NCT03019640|467879530|FG000|Overall Study|Screen Failures|4|||
129977148|NCT03019640|467879530|FG000|Overall Study|Adverse Event|3|||
129977149|NCT03019640|467879530|FG000|Overall Study|Participant Relapsed|1|||
129977150|NCT01162863|467879531|FG000|Overall Study|Lack of Efficacy|1|||
129977151|NCT01162863|467879532|FG001|Overall Study|Lack of Efficacy|0|||
129977152|NCT01162863|467879533|FG002|Overall Study|Lack of Efficacy|0|||
129977153|NCT01162863|467879531|FG000|Overall Study|Adverse Event|0|||
129977154|NCT01162863|467879532|FG001|Overall Study|Adverse Event|1|||
129977155|NCT01162863|467879533|FG002|Overall Study|Adverse Event|0|||
129977156|NCT00588692|467879534|FG000|Overall Study|Withdrawal by Subject|4|||
129977157|NCT00588692|467879535|FG001|Overall Study|Withdrawal by Subject|2|||
129977158|NCT00588692|467879534|FG000|Overall Study|Hip Surgery|0|||
129977159|NCT00588692|467879535|FG001|Overall Study|Hip Surgery|1|||
129977160|NCT00588692|467879534|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
129977161|NCT00588692|467879535|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
129977162|NCT00588692|467879534|FG000|Overall Study|Cancer|1|||
129977163|NCT00588692|467879535|FG001|Overall Study|Cancer|0|||
129977164|NCT00588692|467879534|FG000|Overall Study|Death|1|||
129977165|NCT00588692|467879535|FG001|Overall Study|Death|0|||
129977166|NCT03552523|467879536|FG000|Overall Study|Withdrawal by Subject|1|||
129977167|NCT03552523|467879537|FG001|Overall Study|Withdrawal by Subject|1|||
129977168|NCT04462289|467879538|FG000|Overall Study|Lost to Follow-up|4|||
129977169|NCT04462289|467879539|FG001|Overall Study|Lost to Follow-up|5|||
129977170|NCT04462289|467879538|FG000|Overall Study|Death|0|||
129977171|NCT04462289|467879539|FG001|Overall Study|Death|3|||
129977172|NCT04462289|467879538|FG000|Overall Study|Withdrawal by Subject|1|||
129977173|NCT04462289|467879539|FG001|Overall Study|Withdrawal by Subject|3|||
129481257|NCT04607408|466052177|FG002|Overall Study|Withdrawal by Subject|0|||
129481258|NCT04607408|466052178|FG003|Overall Study|Withdrawal by Subject|1|||
129481259|NCT04607408|466052179|FG004|Overall Study|Withdrawal by Subject|0|||
129481260|NCT02599402|466052184|FG000|Overall Study|Disease progression|153|||
129977174|NCT03686423|467879540|FG000|Overall Study|Withdrawal by Subject|9|||
129977175|NCT03686423|467879540|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
129481261|NCT02599402|466052184|FG000|Overall Study|Study drug toxicity|201|||
129481262|NCT02599402|466052184|FG000|Overall Study|Death|26|||
129481263|NCT02599402|466052184|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
129977176|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
129977177|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
129977178|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
129977179|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
129481264|NCT02599402|466052184|FG000|Overall Study|Participant request to discontinue study treatment|13|||
129481265|NCT02599402|466052184|FG000|Overall Study|Participant withdrew consent|5|||
129481266|NCT02599402|466052184|FG000|Overall Study|Lost to Follow-up|1|||
129977180|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
129977181|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
129977182|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
129977183|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
129977184|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
129977185|NCT01077518|467879541|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
129481267|NCT02599402|466052184|FG000|Overall Study|Maximum Clinical Benefit|7|||
129481268|NCT02599402|466052184|FG000|Overall Study|Poor/non-compliance|1|||
129977186|NCT01077518|467879542|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
129977187|NCT01077518|467879543|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
129977188|NCT01077518|467879541|FG000|Optional Ofa Phase|Physician Decision|0|||
129977189|NCT01077518|467879542|FG001|Optional Ofa Phase|Physician Decision|0|||
129977190|NCT01077518|467879543|FG002|Optional Ofa Phase|Physician Decision|1|||
129977191|NCT01077518|467879541|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
129977192|NCT01077518|467879542|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
129977193|NCT01077518|467879543|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
129977194|NCT01077518|467879541|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
129977195|NCT01077518|467879542|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
129977196|NCT01077518|467879543|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
129977197|NCT02387970|467879544|FG000|Overall Study|Did not complete 1-year follow up|1|||
129977198|NCT02387970|467879545|FG001|Overall Study|Did not complete 1-year follow up|2|||
129977199|NCT01436253|467879550|FG000|Overall Study|Lost to Follow-up|182|||
129977200|NCT01436253|467879550|FG000|Overall Study|Not meeting all eligibility criteria|117|||
129977201|NCT01495598|467879552|FG000|Overall Study|Death during follow up period|2|||
129977202|NCT01495598|467879552|FG000|Overall Study|Death on study|1|||
129977203|NCT01495598|467879552|FG000|Overall Study|Lost to Follow-up|3|||
129977204|NCT01495598|467879552|FG000|Overall Study|Physician Decision|8|||
129977205|NCT02671500|467879555|FG000|Overall Study|Lack of Efficacy|12|||
129977206|NCT02671500|467879555|FG000|Overall Study|Lost to Follow-up|2|||
129977207|NCT05511038|467879557|FG000|Overall|Withdrawal by Subject|5|||
129977208|NCT05511038|467879558|FG001|Overall|Withdrawal by Subject|3|||
129977209|NCT05511038|467879557|FG000|Overall|Screen Failure|20|||
129977210|NCT05511038|467879558|FG001|Overall|Screen Failure|1|||
129977211|NCT05511038|467879557|FG000|Overall|Physician Decision|3|||
129977212|NCT05511038|467879558|FG001|Overall|Physician Decision|0|||
129977213|NCT05511038|467879557|FG000|Overall|Lost to Follow-up|3|||
129977214|NCT05511038|467879558|FG001|Overall|Lost to Follow-up|0|||
129977215|NCT05511038|467879557|FG000|Overall|Death|1|||
129977216|NCT05511038|467879558|FG001|Overall|Death|0|||
129977217|NCT05511038|467879557|FG000|Screening|Withdrawal by Subject|1|||
129977218|NCT05511038|467879558|FG001|Screening|Withdrawal by Subject|0|||
129977219|NCT05511038|467879557|FG000|Screening|Lost to Follow Up (1 participant)|1|||
129977220|NCT05511038|467879558|FG001|Screening|Lost to Follow Up (1 participant)|0|||
129977221|NCT05511038|467879557|FG000|Screening|Screen Failure|3|||
129977222|NCT05511038|467879558|FG001|Screening|Screen Failure|0|||
129977223|NCT05511038|467879557|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
129977224|NCT05511038|467879558|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
129977225|NCT05511038|467879557|FG000|Treatment|Withdrawal by Subject|5|||
129977226|NCT05511038|467879558|FG001|Treatment|Withdrawal by Subject|3|||
129977227|NCT05511038|467879557|FG000|Treatment|Physician Decision|4|||
129977228|NCT05511038|467879558|FG001|Treatment|Physician Decision|0|||
129977229|NCT05511038|467879557|FG000|Treatment|Lost to Follow-up|2|||
129977230|NCT05511038|467879558|FG001|Treatment|Lost to Follow-up|0|||
129977231|NCT05511038|467879557|FG000|Treatment|Death|1|||
129977232|NCT05511038|467879558|FG001|Treatment|Death|0|||
129977233|NCT05511038|467879557|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
129977234|NCT05511038|467879558|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
129977235|NCT05511038|467879557|FG000|Treatment|Refuse by subject|1|||
129977236|NCT05511038|467879558|FG001|Treatment|Refuse by subject|0|||
129977237|NCT05511038|467879557|FG000|Treatment|Subject did not go to the site for visit|1|||
129977238|NCT05511038|467879558|FG001|Treatment|Subject did not go to the site for visit|0|||
129977239|NCT04485611|467879559|FG000|Prehabilitation|Physician Decision|1|||
129977240|NCT05292586|467879562|FG000|Overall Study|Withdrawal by Subject|3|||
129977241|NCT05292586|467879563|FG001|Overall Study|Withdrawal by Subject|10|||
129977242|NCT05292586|467879562|FG000|Overall Study|Randomization error|3|||
129977243|NCT05292586|467879563|FG001|Overall Study|Randomization error|7|||
129977244|NCT05292586|467879562|FG000|Overall Study|Adverse Event|3|||
129977245|NCT05292586|467879563|FG001|Overall Study|Adverse Event|0|||
129977246|NCT05292586|467879562|FG000|Overall Study|Lost to Follow-up|0|||
129977247|NCT05292586|467879563|FG001|Overall Study|Lost to Follow-up|1|||
129977248|NCT05292586|467879562|FG000|Overall Study|Patient refused treatment|1|||
129977249|NCT05292586|467879563|FG001|Overall Study|Patient refused treatment|0|||
129977250|NCT05292586|467879562|FG000|Overall Study|Patient could not travel to the study site|1|||
129977251|NCT05292586|467879563|FG001|Overall Study|Patient could not travel to the study site|0|||
129977252|NCT05292586|467879562|FG000|Overall Study|Technical issues with the masterscope|0|||
129977253|NCT05292586|467879563|FG001|Overall Study|Technical issues with the masterscope|3|||
129977254|NCT05292586|467879562|FG000|Overall Study|Patient moved to a different state|0|||
129977255|NCT05292586|467879563|FG001|Overall Study|Patient moved to a different state|1|||
129977256|NCT03682185|467879566|FG000|Overall Study|Lost to Follow-up|4|||
129977257|NCT03682185|467879567|FG001|Overall Study|Lost to Follow-up|7|||
129977258|NCT03682185|467879568|FG002|Overall Study|Lost to Follow-up|4|||
129977259|NCT03682185|467879569|FG003|Overall Study|Lost to Follow-up|7|||
129977260|NCT03682185|467879570|FG004|Overall Study|Lost to Follow-up|1|||
129977261|NCT03682185|467879566|FG000|Overall Study|Withdrawal by Subject|7|||
129977262|NCT03682185|467879567|FG001|Overall Study|Withdrawal by Subject|3|||
129977263|NCT03682185|467879568|FG002|Overall Study|Withdrawal by Subject|7|||
129977264|NCT03682185|467879569|FG003|Overall Study|Withdrawal by Subject|3|||
129977265|NCT03682185|467879570|FG004|Overall Study|Withdrawal by Subject|0|||
129977266|NCT04908631|467879571|FG000|Overall Study|Lost to Follow-up|1|||
129977267|NCT04908631|467879571|FG000|Overall Study|Physician Decision|1|||
129977268|NCT04908631|467879571|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
129977269|NCT02284009|467879572|FG000|Overall Study|Adverse Event|3|||
129977270|NCT02284009|467879573|FG001|Overall Study|Adverse Event|0|||
129977271|NCT02284009|467879572|FG000|Overall Study|Lost to Follow-up|1|||
129977272|NCT02284009|467879573|FG001|Overall Study|Lost to Follow-up|3|||
129977273|NCT02284009|467879572|FG000|Overall Study|Physician Decision|0|||
129977274|NCT02284009|467879573|FG001|Overall Study|Physician Decision|2|||
129977275|NCT02284009|467879572|FG000|Overall Study|Withdrawal by Subject|2|||
129977276|NCT02284009|467879573|FG001|Overall Study|Withdrawal by Subject|5|||
129977277|NCT04047862|467879586|FG000|Overall Study|Death|0|||
129977278|NCT04047862|467879587|FG001|Overall Study|Death|0|||
129481269|NCT02599402|466052184|FG000|Overall Study|Pregnancy|1|||
129481270|NCT02599402|466052184|FG000|Overall Study|Participant no longer met study criteria|7|||
129481271|NCT02599402|466052184|FG000|Overall Study|Other Reasons|95|||
129481272|NCT04919564|466052187|FG000|Overall Study|Lost to Follow-up|1|||
129481273|NCT04919564|466052188|FG001|Overall Study|Lost to Follow-up|0|||
129481274|NCT04919564|466052187|FG000|Overall Study|Physician Decision|1|||
129481275|NCT04919564|466052188|FG001|Overall Study|Physician Decision|1|||
129977279|NCT04047862|467879588|FG002|Overall Study|Death|4|||
129977280|NCT04047862|467879589|FG003|Overall Study|Death|7|||
129977281|NCT04047862|467879590|FG004|Overall Study|Death|2|||
129977282|NCT04047862|467879591|FG005|Overall Study|Death|4|||
129977283|NCT04047862|467879592|FG006|Overall Study|Death|3|||
129977284|NCT04047862|467879593|FG007|Overall Study|Death|24|||
129977285|NCT04047862|467879594|FG008|Overall Study|Death|24|||
129977286|NCT04047862|467879595|FG009|Overall Study|Death|22|||
129977287|NCT04047862|467879596|FG010|Overall Study|Death|35|||
129977288|NCT04047862|467879597|FG011|Overall Study|Death|18|||
129977289|NCT04047862|467879598|FG012|Overall Study|Death|14|||
129977290|NCT04047862|467879599|FG013|Overall Study|Death|6|||
129977291|NCT04047862|467879600|FG014|Overall Study|Death|19|||
129977292|NCT04047862|467879601|FG015|Overall Study|Death|42|||
129977293|NCT04047862|467879602|FG016|Overall Study|Death|9|||
129977294|NCT04047862|467879603|FG017|Overall Study|Death|8|||
129977295|NCT04047862|467879604|FG018|Overall Study|Death|10|||
129977296|NCT04047862|467879586|FG000|Overall Study|Withdrawal by Subject|0|||
129977297|NCT04047862|467879587|FG001|Overall Study|Withdrawal by Subject|0|||
129977298|NCT04047862|467879588|FG002|Overall Study|Withdrawal by Subject|0|||
129977299|NCT04047862|467879589|FG003|Overall Study|Withdrawal by Subject|5|||
129977300|NCT04047862|467879590|FG004|Overall Study|Withdrawal by Subject|2|||
129977301|NCT04047862|467879591|FG005|Overall Study|Withdrawal by Subject|0|||
129977302|NCT04047862|467879592|FG006|Overall Study|Withdrawal by Subject|1|||
129977303|NCT04047862|467879593|FG007|Overall Study|Withdrawal by Subject|0|||
129977304|NCT04047862|467879594|FG008|Overall Study|Withdrawal by Subject|4|||
129977305|NCT04047862|467879595|FG009|Overall Study|Withdrawal by Subject|4|||
129977306|NCT04047862|467879596|FG010|Overall Study|Withdrawal by Subject|4|||
129977307|NCT04047862|467879597|FG011|Overall Study|Withdrawal by Subject|2|||
129977308|NCT04047862|467879598|FG012|Overall Study|Withdrawal by Subject|3|||
129977309|NCT04047862|467879599|FG013|Overall Study|Withdrawal by Subject|0|||
129977310|NCT04047862|467879600|FG014|Overall Study|Withdrawal by Subject|9|||
129977311|NCT04047862|467879601|FG015|Overall Study|Withdrawal by Subject|5|||
129977312|NCT04047862|467879602|FG016|Overall Study|Withdrawal by Subject|1|||
129977313|NCT04047862|467879603|FG017|Overall Study|Withdrawal by Subject|3|||
129977314|NCT04047862|467879604|FG018|Overall Study|Withdrawal by Subject|1|||
129977315|NCT04047862|467879586|FG000|Overall Study|Lost to Follow-up|0|||
129481276|NCT01241786|466052189|FG000|Overall Study|Lack of Efficacy|5|||
129977316|NCT04047862|467879587|FG001|Overall Study|Lost to Follow-up|0|||
129977317|NCT04047862|467879588|FG002|Overall Study|Lost to Follow-up|1|||
129977318|NCT04047862|467879589|FG003|Overall Study|Lost to Follow-up|0|||
129977319|NCT04047862|467879590|FG004|Overall Study|Lost to Follow-up|0|||
129977320|NCT04047862|467879591|FG005|Overall Study|Lost to Follow-up|0|||
129977321|NCT04047862|467879592|FG006|Overall Study|Lost to Follow-up|0|||
129977322|NCT04047862|467879593|FG007|Overall Study|Lost to Follow-up|1|||
129977323|NCT04047862|467879594|FG008|Overall Study|Lost to Follow-up|0|||
129481277|NCT01440101|466052191|FG000|Overall Study|Adverse Event|2|||
129481278|NCT01440101|466052192|FG001|Overall Study|Adverse Event|0|||
129977324|NCT04047862|467879595|FG009|Overall Study|Lost to Follow-up|1|||
129977325|NCT04047862|467879596|FG010|Overall Study|Lost to Follow-up|0|||
129977326|NCT04047862|467879597|FG011|Overall Study|Lost to Follow-up|3|||
129481279|NCT01440101|466052193|FG002|Overall Study|Adverse Event|0|||
129481280|NCT01440101|466052191|FG000|Overall Study|Withdrawal by Subject|0|||
129977327|NCT04047862|467879598|FG012|Overall Study|Lost to Follow-up|0|||
129977328|NCT04047862|467879599|FG013|Overall Study|Lost to Follow-up|0|||
129977329|NCT04047862|467879600|FG014|Overall Study|Lost to Follow-up|2|||
129977330|NCT04047862|467879601|FG015|Overall Study|Lost to Follow-up|2|||
129977331|NCT04047862|467879602|FG016|Overall Study|Lost to Follow-up|1|||
129977332|NCT04047862|467879603|FG017|Overall Study|Lost to Follow-up|0|||
129977333|NCT04047862|467879604|FG018|Overall Study|Lost to Follow-up|0|||
129977334|NCT04047862|467879586|FG000|Overall Study|Physician Decision|0|||
129977335|NCT04047862|467879587|FG001|Overall Study|Physician Decision|0|||
129977336|NCT04047862|467879588|FG002|Overall Study|Physician Decision|0|||
129977337|NCT04047862|467879589|FG003|Overall Study|Physician Decision|1|||
129977338|NCT04047862|467879590|FG004|Overall Study|Physician Decision|0|||
129977339|NCT04047862|467879591|FG005|Overall Study|Physician Decision|0|||
129977340|NCT04047862|467879592|FG006|Overall Study|Physician Decision|0|||
129977341|NCT04047862|467879593|FG007|Overall Study|Physician Decision|0|||
129977342|NCT04047862|467879594|FG008|Overall Study|Physician Decision|0|||
129977343|NCT04047862|467879595|FG009|Overall Study|Physician Decision|0|||
129977344|NCT04047862|467879596|FG010|Overall Study|Physician Decision|0|||
129977345|NCT04047862|467879597|FG011|Overall Study|Physician Decision|0|||
129977346|NCT04047862|467879598|FG012|Overall Study|Physician Decision|0|||
129977347|NCT04047862|467879599|FG013|Overall Study|Physician Decision|0|||
129977348|NCT04047862|467879600|FG014|Overall Study|Physician Decision|1|||
129977349|NCT04047862|467879601|FG015|Overall Study|Physician Decision|0|||
129977350|NCT04047862|467879602|FG016|Overall Study|Physician Decision|1|||
129977351|NCT04047862|467879603|FG017|Overall Study|Physician Decision|0|||
129977352|NCT04047862|467879604|FG018|Overall Study|Physician Decision|0|||
129977353|NCT04047862|467879586|FG000|Overall Study|Completed all Assessments|1|||
129977354|NCT04047862|467879587|FG001|Overall Study|Completed all Assessments|3|||
129977355|NCT04047862|467879588|FG002|Overall Study|Completed all Assessments|1|||
129977356|NCT04047862|467879589|FG003|Overall Study|Completed all Assessments|3|||
129977357|NCT04047862|467879590|FG004|Overall Study|Completed all Assessments|2|||
129977358|NCT04047862|467879591|FG005|Overall Study|Completed all Assessments|5|||
129977359|NCT04047862|467879592|FG006|Overall Study|Completed all Assessments|7|||
129977360|NCT04047862|467879593|FG007|Overall Study|Completed all Assessments|0|||
129977361|NCT04047862|467879594|FG008|Overall Study|Completed all Assessments|0|||
129977362|NCT04047862|467879595|FG009|Overall Study|Completed all Assessments|0|||
129977363|NCT04047862|467879596|FG010|Overall Study|Completed all Assessments|0|||
129977364|NCT04047862|467879597|FG011|Overall Study|Completed all Assessments|0|||
129977365|NCT04047862|467879598|FG012|Overall Study|Completed all Assessments|0|||
129977366|NCT04047862|467879599|FG013|Overall Study|Completed all Assessments|0|||
129977367|NCT04047862|467879600|FG014|Overall Study|Completed all Assessments|0|||
129977368|NCT04047862|467879601|FG015|Overall Study|Completed all Assessments|0|||
129977369|NCT04047862|467879602|FG016|Overall Study|Completed all Assessments|0|||
129977370|NCT04047862|467879603|FG017|Overall Study|Completed all Assessments|0|||
129977371|NCT04047862|467879604|FG018|Overall Study|Completed all Assessments|0|||
129977372|NCT04047862|467879586|FG000|Overall Study|Sponsor Decision|0|||
129977373|NCT04047862|467879587|FG001|Overall Study|Sponsor Decision|0|||
129977374|NCT04047862|467879588|FG002|Overall Study|Sponsor Decision|0|||
129977375|NCT04047862|467879589|FG003|Overall Study|Sponsor Decision|0|||
129977376|NCT04047862|467879590|FG004|Overall Study|Sponsor Decision|0|||
129977377|NCT04047862|467879591|FG005|Overall Study|Sponsor Decision|0|||
129977378|NCT04047862|467879592|FG006|Overall Study|Sponsor Decision|0|||
129977379|NCT04047862|467879593|FG007|Overall Study|Sponsor Decision|13|||
129481281|NCT01440101|466052192|FG001|Overall Study|Withdrawal by Subject|3|||
129481282|NCT01440101|466052193|FG002|Overall Study|Withdrawal by Subject|1|||
129481283|NCT01440101|466052191|FG000|Overall Study|Other|0|||
129481284|NCT01440101|466052192|FG001|Overall Study|Other|1|||
129481285|NCT01440101|466052193|FG002|Overall Study|Other|0|||
129481286|NCT00636818|466052197|FG000|Overall Study|Adverse Event|1|||
129481287|NCT00636818|466052197|FG000|Overall Study|Lost to Follow-up|2|||
129481288|NCT00636818|466052197|FG000|Overall Study|Entry Criteria Exclusion|3|||
129977380|NCT04047862|467879594|FG008|Overall Study|Sponsor Decision|10|||
129977381|NCT04047862|467879595|FG009|Overall Study|Sponsor Decision|18|||
129977382|NCT04047862|467879596|FG010|Overall Study|Sponsor Decision|3|||
129977383|NCT04047862|467879597|FG011|Overall Study|Sponsor Decision|3|||
129977384|NCT04047862|467879598|FG012|Overall Study|Sponsor Decision|4|||
129977385|NCT04047862|467879599|FG013|Overall Study|Sponsor Decision|0|||
129977386|NCT04047862|467879600|FG014|Overall Study|Sponsor Decision|7|||
129977387|NCT04047862|467879601|FG015|Overall Study|Sponsor Decision|8|||
129977388|NCT04047862|467879602|FG016|Overall Study|Sponsor Decision|9|||
129977389|NCT04047862|467879603|FG017|Overall Study|Sponsor Decision|7|||
129977390|NCT04047862|467879604|FG018|Overall Study|Sponsor Decision|8|||
129977391|NCT04047862|467879586|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129481289|NCT00636818|466052197|FG000|Overall Study|Protocol Violation|1|||
129977392|NCT04047862|467879587|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129481290|NCT00636818|466052197|FG000|Overall Study|Withdrawal by Subject|4|||
129481291|NCT00074958|466052198|FG000|Overall Study|Adverse Event|1|||
129481292|NCT01658514|466052213|FG000|Overall Study|Protocol Violation|1|||
129977393|NCT04047862|467879588|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977394|NCT04047862|467879589|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977395|NCT04047862|467879590|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977396|NCT04047862|467879591|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977397|NCT04047862|467879592|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977398|NCT04047862|467879593|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
129977399|NCT04047862|467879594|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
129977400|NCT04047862|467879595|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977401|NCT04047862|467879596|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
129977402|NCT04047862|467879597|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977403|NCT04047862|467879598|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977404|NCT04047862|467879599|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
129977405|NCT04047862|467879600|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
129977406|NCT04047862|467879601|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
129977407|NCT04047862|467879602|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
129977408|NCT04047862|467879603|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
129977409|NCT04047862|467879604|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
129977410|NCT04047862|467879586|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977411|NCT04047862|467879587|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977412|NCT04047862|467879588|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977413|NCT04047862|467879589|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977414|NCT04047862|467879590|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977415|NCT04047862|467879591|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977416|NCT04047862|467879592|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977417|NCT04047862|467879593|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977418|NCT04047862|467879594|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977419|NCT04047862|467879595|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977420|NCT04047862|467879596|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977421|NCT04047862|467879597|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977422|NCT04047862|467879598|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977423|NCT04047862|467879599|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977424|NCT04047862|467879600|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977425|NCT04047862|467879601|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
129977426|NCT04047862|467879602|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129481293|NCT01658514|466052214|FG001|Overall Study|Protocol Violation|0|||
129481294|NCT01658514|466052215|FG002|Overall Study|Protocol Violation|2|||
129481295|NCT02344576|466052219|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
129481296|NCT02344576|466052220|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
129481297|NCT02344576|466052221|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
129481298|NCT02344576|466052222|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
129481299|NCT02344576|466052219|FG000|1-Month Follow-Up|Death|13|||
129481300|NCT02344576|466052220|FG001|1-Month Follow-Up|Death|8|||
129481301|NCT02344576|466052221|FG002|1-Month Follow-Up|Death|0|||
129481302|NCT02344576|466052222|FG003|1-Month Follow-Up|Death|0|||
129977427|NCT04047862|467879603|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
129977428|NCT04047862|467879604|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
129977429|NCT04047862|467879586|FG000|Overall Study|Other|0|||
129977430|NCT04047862|467879587|FG001|Overall Study|Other|0|||
129977431|NCT04047862|467879588|FG002|Overall Study|Other|0|||
129977432|NCT04047862|467879589|FG003|Overall Study|Other|0|||
129977433|NCT04047862|467879590|FG004|Overall Study|Other|0|||
129977434|NCT04047862|467879591|FG005|Overall Study|Other|0|||
129977435|NCT04047862|467879592|FG006|Overall Study|Other|0|||
129977436|NCT04047862|467879593|FG007|Overall Study|Other|0|||
129977437|NCT04047862|467879594|FG008|Overall Study|Other|0|||
129977438|NCT04047862|467879595|FG009|Overall Study|Other|0|||
129977439|NCT04047862|467879596|FG010|Overall Study|Other|0|||
129977440|NCT04047862|467879597|FG011|Overall Study|Other|0|||
129977441|NCT04047862|467879598|FG012|Overall Study|Other|0|||
129977442|NCT04047862|467879599|FG013|Overall Study|Other|0|||
129977443|NCT04047862|467879600|FG014|Overall Study|Other|2|||
129977444|NCT04047862|467879601|FG015|Overall Study|Other|1|||
129977445|NCT04047862|467879602|FG016|Overall Study|Other|1|||
129977446|NCT04047862|467879603|FG017|Overall Study|Other|1|||
129977447|NCT04047862|467879604|FG018|Overall Study|Other|0|||
129481303|NCT02344576|466052219|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
129977448|NCT01876082|467881048|FG000|Overall Study|Withdrawal by Subject|0|||
129977449|NCT01876082|467881049|FG001|Overall Study|Withdrawal by Subject|2|||
129977450|NCT01876082|467881048|FG000|Overall Study|Protocol Violation|1|||
129977451|NCT01876082|467881049|FG001|Overall Study|Protocol Violation|0|||
129977452|NCT01876082|467881048|FG000|Overall Study|Adverse Event|1|||
129481304|NCT02344576|466052220|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
129481305|NCT02344576|466052221|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
129481306|NCT02344576|466052222|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
129977453|NCT01876082|467881049|FG001|Overall Study|Adverse Event|1|||
129977454|NCT01876082|467881048|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
129977455|NCT01876082|467881049|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
129977456|NCT00626197|467881055|FG000|Overall Study|Did not cooperate|2|||
129977457|NCT00626197|467881056|FG001|Overall Study|Did not cooperate|6|||
129977458|NCT00626197|467881057|FG002|Overall Study|Did not cooperate|1|||
129977459|NCT00626197|467881055|FG000|Overall Study|Failure to return|6|||
129481307|NCT02344576|466052219|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
129481308|NCT02344576|466052220|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
129481309|NCT02344576|466052221|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
129481310|NCT02344576|466052222|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
129481311|NCT02344576|466052219|FG000|6-Month Follow-Up|Death|14|||
129481312|NCT02344576|466052220|FG001|6-Month Follow-Up|Death|14|||
129481313|NCT02344576|466052221|FG002|6-Month Follow-Up|Death|0|||
129481314|NCT02344576|466052222|FG003|6-Month Follow-Up|Death|0|||
129481315|NCT02344576|466052219|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
129481316|NCT02344576|466052220|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
129481317|NCT02344576|466052221|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
129481318|NCT02344576|466052222|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
129481319|NCT02344576|466052219|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
129481320|NCT02344576|466052220|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
129481321|NCT02344576|466052221|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
129481322|NCT02344576|466052222|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
129481323|NCT03832387|466052237|FG000|Overall Study|Protocol Violation|2|||
129481324|NCT03832387|466052238|FG001|Overall Study|Protocol Violation|6|||
129481325|NCT03832387|466052237|FG000|Overall Study|EXCLUSION CRITERIA|3|||
129481326|NCT03832387|466052238|FG001|Overall Study|EXCLUSION CRITERIA|1|||
129481327|NCT00144170|466052239|FG000|Overall Study|Adverse Event|84|||
129481328|NCT00144170|466052240|FG001|Overall Study|Adverse Event|41|||
129977460|NCT00626197|467881056|FG001|Overall Study|Failure to return|5|||
129977461|NCT00626197|467881057|FG002|Overall Study|Failure to return|6|||
129977462|NCT00626197|467881055|FG000|Overall Study|Adverse event, serious fatal|3|||
129977463|NCT00626197|467881056|FG001|Overall Study|Adverse event, serious fatal|6|||
129977464|NCT00626197|467881057|FG002|Overall Study|Adverse event, serious fatal|6|||
129977465|NCT00626197|467881055|FG000|Overall Study|Adverse Event|1|||
129977466|NCT00626197|467881056|FG001|Overall Study|Adverse Event|1|||
129977467|NCT00626197|467881057|FG002|Overall Study|Adverse Event|2|||
129977468|NCT00626197|467881055|FG000|Overall Study|Withdrawal by Subject|17|||
129977469|NCT00626197|467881056|FG001|Overall Study|Withdrawal by Subject|17|||
129977470|NCT00626197|467881057|FG002|Overall Study|Withdrawal by Subject|7|||
129977471|NCT00626197|467881055|FG000|Overall Study|Administrative reasons|15|||
129977472|NCT00626197|467881056|FG001|Overall Study|Administrative reasons|19|||
129977473|NCT00626197|467881057|FG002|Overall Study|Administrative reasons|55|||
129977474|NCT04833127|467881058|FG000|Overall Study|Lost to Follow-up|1|||
129977475|NCT04833127|467881059|FG001|Overall Study|Lost to Follow-up|1|||
129977476|NCT00461981|467881065|FG000|Overall Study|Lost to Follow-up|9|||
129977477|NCT00461981|467881066|FG001|Overall Study|Lost to Follow-up|6|||
129977478|NCT00461981|467881065|FG000|Overall Study|Withdrawal by Subject|2|||
129977479|NCT00461981|467881066|FG001|Overall Study|Withdrawal by Subject|3|||
129977480|NCT03301155|467881070|FG000|Overall Study|Сompliance with exclusion criteria|8|||
129977481|NCT03301155|467881071|FG001|Overall Study|Сompliance with exclusion criteria|7|||
129977482|NCT00731133|467881072|FG000|Overall Study|Withdrawal by Subject|10|||
129977483|NCT03510455|467881073|FG000|Overall Study|Physician Decision|1|||
129977484|NCT00384189|467881074|FG000|Overall Study|Reason Not Specified|50|||
129977485|NCT00384189|467881075|FG001|Overall Study|Reason Not Specified|57|||
129977486|NCT00384189|467881076|FG002|Overall Study|Reason Not Specified|58|||
129977487|NCT00384189|467881077|FG003|Overall Study|Reason Not Specified|40|||
129977488|NCT04958642|467881078|FG000|Overall Study|Transferred to OLEX program|3|||
129977489|NCT04958642|467881079|FG001|Overall Study|Transferred to OLEX program|0|||
129977490|NCT04958642|467881080|FG002|Overall Study|Transferred to OLEX program|5|||
129977491|NCT04958642|467881078|FG000|Overall Study|Death|0|||
129481329|NCT00144170|466052239|FG000|Overall Study|Protocol Violation|23|||
129481330|NCT00144170|466052240|FG001|Overall Study|Protocol Violation|16|||
129481331|NCT00144170|466052239|FG000|Overall Study|Lost to Follow-up|5|||
129977492|NCT04958642|467881079|FG001|Overall Study|Death|0|||
129977493|NCT04958642|467881080|FG002|Overall Study|Death|1|||
129977494|NCT04958642|467881078|FG000|Overall Study|Withdrawal by Subject|4|||
129481332|NCT00144170|466052240|FG001|Overall Study|Lost to Follow-up|10|||
129481333|NCT00144170|466052239|FG000|Overall Study|Withdrawal by Subject|29|||
129481334|NCT00144170|466052240|FG001|Overall Study|Withdrawal by Subject|13|||
129481335|NCT00144170|466052239|FG000|Overall Study|Other reason not defined above|211|||
129977495|NCT04958642|467881079|FG001|Overall Study|Withdrawal by Subject|9|||
129977496|NCT04958642|467881080|FG002|Overall Study|Withdrawal by Subject|13|||
129977497|NCT04958642|467881078|FG000|Overall Study|Investigator's Decision|0|||
129481336|NCT00144170|466052240|FG001|Overall Study|Other reason not defined above|316|||
129481337|NCT00702143|466052241|FG000|Overall Study|Lost to Follow-up|0|||
129977498|NCT04958642|467881079|FG001|Overall Study|Investigator's Decision|0|||
129977499|NCT04958642|467881080|FG002|Overall Study|Investigator's Decision|1|||
129977500|NCT04958642|467881078|FG000|Overall Study|Adverse Event|1|||
129977501|NCT04958642|467881079|FG001|Overall Study|Adverse Event|0|||
129977502|NCT04958642|467881080|FG002|Overall Study|Adverse Event|1|||
129977503|NCT04958642|467881078|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
129977504|NCT04958642|467881079|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
129977505|NCT04958642|467881080|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
129977506|NCT04958642|467881078|FG000|Overall Study|Lost to Follow-up|1|||
129977507|NCT04958642|467881079|FG001|Overall Study|Lost to Follow-up|0|||
129977508|NCT04958642|467881080|FG002|Overall Study|Lost to Follow-up|0|||
129977509|NCT04958642|467881078|FG000|Overall Study|Transferred to EAP following study termination|0|||
129977510|NCT04958642|467881079|FG001|Overall Study|Transferred to EAP following study termination|0|||
129977511|NCT04958642|467881080|FG002|Overall Study|Transferred to EAP following study termination|1|||
129977512|NCT04958642|467881078|FG000|Overall Study|Transferred to Expanded Access Program|1|||
129977513|NCT04958642|467881079|FG001|Overall Study|Transferred to Expanded Access Program|0|||
129977514|NCT04958642|467881080|FG002|Overall Study|Transferred to Expanded Access Program|0|||
129977515|NCT02476175|467881084|FG000|Overall Study|Adverse Event|2|||
129977516|NCT03868787|467881089|FG000|Overall Study|Withdrawal by Subject|2|||
129977517|NCT03868787|467881090|FG001|Overall Study|Withdrawal by Subject|1|||
129977518|NCT04313608|467881103|FG000|Overall Study|Death|12|||
129977519|NCT04313608|467881104|FG001|Overall Study|Death|3|||
129977520|NCT02964325|467881105|FG000|Overall Study|Lost to Follow-up|3|||
129977521|NCT02964325|467881106|FG001|Overall Study|Lost to Follow-up|3|||
129977522|NCT02964325|467881105|FG000|Overall Study|Physician Decision|5|||
129977523|NCT02964325|467881106|FG001|Overall Study|Physician Decision|4|||
129977524|NCT02964325|467881105|FG000|Overall Study|Death|1|||
129977525|NCT02964325|467881106|FG001|Overall Study|Death|3|||
129977526|NCT02964325|467881105|FG000|Overall Study|Withdrawal by Subject|2|||
129977527|NCT02964325|467881106|FG001|Overall Study|Withdrawal by Subject|1|||
129977528|NCT02964325|467881105|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
129977529|NCT02964325|467881106|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
129977530|NCT02510040|467881107|FG000|Overall Study|Deemed no longer eligible|18|||
129977531|NCT02510040|467881108|FG001|Overall Study|Deemed no longer eligible|3|||
129977532|NCT02510040|467881109|FG002|Overall Study|Deemed no longer eligible|1|||
129977533|NCT01371825|467881117|FG000|Overall Study|Death|4|||
129977534|NCT00534495|467881123|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
129977535|NCT00534495|467881124|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
129977536|NCT00534495|467881125|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
129977537|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
129977538|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
129977539|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
129977540|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
129977541|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
129977542|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
129977543|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
129977544|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
129977545|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
129977546|NCT00534495|467881123|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
129977547|NCT00534495|467881124|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
129977548|NCT00534495|467881125|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
129977549|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
129977550|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
129977551|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
129977552|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
129977553|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
129977554|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
129977555|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
129977556|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
129977557|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
129977558|NCT00534495|467881123|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
129977559|NCT00534495|467881124|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
129977560|NCT00534495|467881125|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
129977561|NCT02440425|467881126|FG000|Overall Study|Death likely due to disease progression|1|||
129977562|NCT02440425|467881126|FG000|Overall Study|Withdrawal by Subject|2|||
129977563|NCT02440425|467881126|FG000|Overall Study|Adverse Event|1|||
129481338|NCT00702143|466052242|FG001|Overall Study|Lost to Follow-up|0|||
129977564|NCT02440425|467881126|FG000|Overall Study|Adverse Event/Ineligible|1|||
129977565|NCT01068665|467881127|FG000|Overall Study|Adverse Event|5|||
129977566|NCT01068665|467881128|FG001|Overall Study|Adverse Event|4|||
129977567|NCT01068665|467881127|FG000|Overall Study|Lack of Efficacy|0|||
129977568|NCT01068665|467881128|FG001|Overall Study|Lack of Efficacy|2|||
129977569|NCT01068665|467881127|FG000|Overall Study|Protocol Violation|5|||
129977570|NCT01068665|467881128|FG001|Overall Study|Protocol Violation|2|||
129977571|NCT01068665|467881127|FG000|Overall Study|Withdrawal Criteria|3|||
129977572|NCT01068665|467881128|FG001|Overall Study|Withdrawal Criteria|9|||
129977573|NCT01068665|467881127|FG000|Overall Study|Other|17|||
129977574|NCT01068665|467881128|FG001|Overall Study|Other|12|||
129977575|NCT02807272|467881129|FG000|Overall Study|Death|9|||
129977576|NCT02807272|467881130|FG001|Overall Study|Death|5|||
129977577|NCT02807272|467881131|FG002|Overall Study|Death|2|||
129977578|NCT02807272|467881132|FG003|Overall Study|Death|0|||
129977579|NCT02807272|467881133|FG004|Overall Study|Death|1|||
129977580|NCT02807272|467881129|FG000|Overall Study|Lost to Follow-up|1|||
129977581|NCT02807272|467881130|FG001|Overall Study|Lost to Follow-up|0|||
129977582|NCT02807272|467881131|FG002|Overall Study|Lost to Follow-up|0|||
129977583|NCT02807272|467881132|FG003|Overall Study|Lost to Follow-up|0|||
129481339|NCT00702143|466052243|FG002|Overall Study|Lost to Follow-up|1|||
129481340|NCT04826900|466052244|FG000|Overall Study|Family factor|1|||
129481341|NCT04826900|466052245|FG001|Overall Study|Family factor|1|||
129481342|NCT03372941|466052246|FG000|Overall Study|Lost to Follow-up|2|||
129481343|NCT03372941|466052247|FG001|Overall Study|Lost to Follow-up|4|||
129481344|NCT00741819|466052248|FG000|Overall Study|Adverse Event|3|||
129977584|NCT02807272|467881133|FG004|Overall Study|Lost to Follow-up|0|||
129977585|NCT02807272|467881129|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
129481345|NCT00741819|466052248|FG000|Overall Study|Withdrawal by Subject|3|||
129481346|NCT00741819|466052248|FG000|Overall Study|Death|1|||
129481347|NCT00741819|466052248|FG000|Overall Study|Disease progression|1|||
129481348|NCT01126580|466052249|FG000|Overall Study|Adverse Event|14|||
129481349|NCT01126580|466052250|FG001|Overall Study|Adverse Event|8|||
129481350|NCT01126580|466052251|FG002|Overall Study|Adverse Event|12|||
129481351|NCT01126580|466052249|FG000|Overall Study|Withdrawal by Subject|11|||
129481352|NCT01126580|466052250|FG001|Overall Study|Withdrawal by Subject|19|||
129481353|NCT01126580|466052251|FG002|Overall Study|Withdrawal by Subject|14|||
129481354|NCT01126580|466052249|FG000|Overall Study|Sponsor Decision|5|||
129481355|NCT01126580|466052250|FG001|Overall Study|Sponsor Decision|4|||
129481356|NCT01126580|466052251|FG002|Overall Study|Sponsor Decision|7|||
129481357|NCT01126580|466052249|FG000|Overall Study|Physician Decision|1|||
129481358|NCT01126580|466052250|FG001|Overall Study|Physician Decision|1|||
129481359|NCT01126580|466052251|FG002|Overall Study|Physician Decision|2|||
129481360|NCT01126580|466052249|FG000|Overall Study|Entry Criteria Not Met|1|||
129481361|NCT01126580|466052250|FG001|Overall Study|Entry Criteria Not Met|1|||
129481362|NCT01126580|466052251|FG002|Overall Study|Entry Criteria Not Met|2|||
129481363|NCT01126580|466052249|FG000|Overall Study|Lack of Efficacy|2|||
129481364|NCT01126580|466052250|FG001|Overall Study|Lack of Efficacy|3|||
129481365|NCT01126580|466052251|FG002|Overall Study|Lack of Efficacy|4|||
129481366|NCT01126580|466052249|FG000|Overall Study|Protocol Violation|0|||
129481367|NCT01126580|466052250|FG001|Overall Study|Protocol Violation|1|||
129481368|NCT01126580|466052251|FG002|Overall Study|Protocol Violation|2|||
129481369|NCT01126580|466052249|FG000|Overall Study|Lost to Follow-up|15|||
129481370|NCT01126580|466052250|FG001|Overall Study|Lost to Follow-up|13|||
129481371|NCT01126580|466052251|FG002|Overall Study|Lost to Follow-up|9|||
129481372|NCT01126580|466052249|FG000|Overall Study|Treatment Non-compliance|0|||
129977586|NCT02807272|467881130|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
129977587|NCT02807272|467881131|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
129977588|NCT02807272|467881132|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
129977589|NCT02807272|467881133|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
129977590|NCT02807272|467881129|FG000|Overall Study|Protocol-defined Disease Progression|0|||
129977591|NCT02807272|467881130|FG001|Overall Study|Protocol-defined Disease Progression|1|||
129977592|NCT02807272|467881131|FG002|Overall Study|Protocol-defined Disease Progression|0|||
129977593|NCT02807272|467881132|FG003|Overall Study|Protocol-defined Disease Progression|0|||
129977594|NCT02807272|467881133|FG004|Overall Study|Protocol-defined Disease Progression|1|||
129481373|NCT01126580|466052250|FG001|Overall Study|Treatment Non-compliance|2|||
129481374|NCT01126580|466052251|FG002|Overall Study|Treatment Non-compliance|3|||
129481375|NCT00609622|466052252|FG000|Overall Study|Adverse Event|14|||
129481376|NCT00609622|466052253|FG001|Overall Study|Adverse Event|10|||
129481377|NCT00609622|466052252|FG000|Overall Study|Withdrawal by Subject|4|||
129481378|NCT00609622|466052253|FG001|Overall Study|Withdrawal by Subject|20|||
129481379|NCT00609622|466052252|FG000|Overall Study|Death|1|||
129481380|NCT00609622|466052253|FG001|Overall Study|Death|4|||
129977595|NCT02807272|467881129|FG000|Overall Study|Study Terminated by Sponsor|1|||
129977596|NCT02807272|467881130|FG001|Overall Study|Study Terminated by Sponsor|0|||
129977597|NCT02807272|467881131|FG002|Overall Study|Study Terminated by Sponsor|0|||
129977598|NCT02807272|467881132|FG003|Overall Study|Study Terminated by Sponsor|1|||
129977599|NCT02807272|467881133|FG004|Overall Study|Study Terminated by Sponsor|0|||
129977600|NCT02807272|467881129|FG000|Overall Study|Other|1|||
129481381|NCT00609622|466052252|FG000|Overall Study|Protocol Violation|1|||
129977601|NCT02807272|467881130|FG001|Overall Study|Other|0|||
129977602|NCT02807272|467881131|FG002|Overall Study|Other|0|||
129977603|NCT02807272|467881132|FG003|Overall Study|Other|0|||
129977604|NCT02807272|467881133|FG004|Overall Study|Other|1|||
129977605|NCT01038427|467881134|FG000|Overall Study|Lost to follow up|1|||
129977606|NCT01038427|467881135|FG001|Overall Study|Lost to follow up|1|||
129977607|NCT01038427|467881136|FG002|Overall Study|Lost to follow up|0|||
129977608|NCT01038427|467881134|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
129977609|NCT01038427|467881135|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
129977610|NCT01038427|467881136|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
129977611|NCT01038427|467881134|FG000|Overall Study|Withdrew consent|0|||
129977612|NCT01038427|467881135|FG001|Overall Study|Withdrew consent|0|||
129977613|NCT01038427|467881136|FG002|Overall Study|Withdrew consent|1|||
129977614|NCT01038427|467881134|FG000|Overall Study|Adverse Event|2|||
129977615|NCT01038427|467881135|FG001|Overall Study|Adverse Event|2|||
129977616|NCT01038427|467881136|FG002|Overall Study|Adverse Event|1|||
129977617|NCT01038427|467881134|FG000|Overall Study|Enrolled in error|0|||
129977618|NCT01038427|467881135|FG001|Overall Study|Enrolled in error|1|||
129977619|NCT01038427|467881136|FG002|Overall Study|Enrolled in error|1|||
129977620|NCT01038427|467881134|FG000|Overall Study|Other|0|||
129977621|NCT01038427|467881135|FG001|Overall Study|Other|2|||
129977622|NCT01038427|467881136|FG002|Overall Study|Other|0|||
129977623|NCT04230122|467881137|FG000|Overall Study|Lost to Follow-up|1|||
129977624|NCT04230122|467881138|FG001|Overall Study|Lost to Follow-up|0|||
129977625|NCT00604708|467881139|FG000|Overall Study|Withdrawal by Subject|9|||
129977626|NCT00604708|467881140|FG001|Overall Study|Withdrawal by Subject|10|||
129977627|NCT00604708|467881139|FG000|Overall Study|Protocol Violation|2|||
129977628|NCT00604708|467881140|FG001|Overall Study|Protocol Violation|8|||
129977629|NCT00604708|467881139|FG000|Overall Study|Lost to Follow-up|5|||
129977630|NCT00604708|467881140|FG001|Overall Study|Lost to Follow-up|5|||
129977631|NCT00604708|467881139|FG000|Overall Study|administrative reasons|9|||
129977632|NCT00604708|467881140|FG001|Overall Study|administrative reasons|11|||
129977633|NCT00604708|467881139|FG000|Overall Study|Adverse Event|6|||
129977634|NCT00604708|467881140|FG001|Overall Study|Adverse Event|6|||
129977635|NCT02202785|467881141|FG000|Overall Study|Study Terminated by Sponsor|1|||
129977636|NCT02202785|467881142|FG001|Overall Study|Study Terminated by Sponsor|6|||
129977637|NCT02202785|467881143|FG002|Overall Study|Study Terminated by Sponsor|4|||
129977638|NCT02202785|467881141|FG000|Overall Study|Withdrawal by Subject|0|||
129977639|NCT02202785|467881142|FG001|Overall Study|Withdrawal by Subject|1|||
129977640|NCT02202785|467881143|FG002|Overall Study|Withdrawal by Subject|0|||
129977641|NCT02202785|467881141|FG000|Overall Study|Lost to Follow-up|0|||
129977642|NCT02202785|467881142|FG001|Overall Study|Lost to Follow-up|1|||
129977643|NCT02202785|467881143|FG002|Overall Study|Lost to Follow-up|0|||
129977644|NCT02202785|467881141|FG000|Overall Study|Reason not Specified|10|||
129977645|NCT02202785|467881142|FG001|Overall Study|Reason not Specified|7|||
129977646|NCT02202785|467881143|FG002|Overall Study|Reason not Specified|13|||
129977647|NCT01137578|467881144|FG000|Overall Study|Participant requested to Discontinue|3|||
129977648|NCT01137578|467881145|FG001|Overall Study|Participant requested to Discontinue|0|||
129977649|NCT01137578|467881146|FG002|Overall Study|Participant requested to Discontinue|0|||
129977650|NCT01137578|467881144|FG000|Overall Study|Withdrawal by Subject|1|||
129977651|NCT01137578|467881145|FG001|Overall Study|Withdrawal by Subject|0|||
129977652|NCT01137578|467881146|FG002|Overall Study|Withdrawal by Subject|0|||
129977653|NCT01137578|467881144|FG000|Overall Study|Other|12|||
129977654|NCT01137578|467881145|FG001|Overall Study|Other|2|||
129977655|NCT01137578|467881146|FG002|Overall Study|Other|6|||
129977656|NCT04145700|467881147|FG000|Overall Study|Withdrawal by Subject|8|||
129977657|NCT04145700|467881148|FG001|Overall Study|Withdrawal by Subject|3|||
129977658|NCT00818779|467881149|FG000|Overall Study|Protocol Violation|1|||
129977659|NCT00818779|467881150|FG001|Overall Study|Protocol Violation|0|||
129977660|NCT00818779|467881149|FG000|Overall Study|Lost to Follow-up|1|||
129481382|NCT00609622|466052253|FG001|Overall Study|Protocol Violation|1|||
129481383|NCT00609622|466052252|FG000|Overall Study|Objective progression or relapse|47|||
129481384|NCT00609622|466052253|FG001|Overall Study|Objective progression or relapse|41|||
129481385|NCT00609622|466052252|FG000|Overall Study|Study terminated by sponsor|16|||
129481386|NCT00609622|466052253|FG001|Overall Study|Study terminated by sponsor|3|||
129481387|NCT00609622|466052252|FG000|Overall Study|Other|7|||
129481388|NCT00609622|466052253|FG001|Overall Study|Other|14|||
129481389|NCT00609622|466052252|FG000|Overall Study|Global deterioration of health status|6|||
129977661|NCT00818779|467881150|FG001|Overall Study|Lost to Follow-up|0|||
129481390|NCT00609622|466052253|FG001|Overall Study|Global deterioration of health status|2|||
129977662|NCT00818779|467881149|FG000|Overall Study|Adverse Event|4|||
129977663|NCT00818779|467881150|FG001|Overall Study|Adverse Event|1|||
129977664|NCT04978493|467881151|FG000|Overall Study|No reason available|0|||
129977665|NCT04978493|467881152|FG001|Overall Study|No reason available|1|||
129977666|NCT04978493|467881151|FG000|Overall Study|Adverse Event|1|||
129977667|NCT04978493|467881152|FG001|Overall Study|Adverse Event|0|||
129977668|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital status: missing)|1|||
129977669|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital status: missing)|2|||
129977670|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital status: missing)|2|||
129977671|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital status: missing)|1|||
129977672|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
129977673|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
129977674|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
129977675|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
129977676|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
129977677|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
129977678|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
129977679|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
129977680|NCT01327846|467881155|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
129977681|NCT01327846|467881156|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
129977682|NCT01327846|467881157|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
129977683|NCT01327846|467881158|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
129977684|NCT01327846|467881155|FG000|Core Phase|Lost to Follow-up|3|||
129977685|NCT01327846|467881156|FG001|Core Phase|Lost to Follow-up|3|||
129977686|NCT01327846|467881157|FG002|Core Phase|Lost to Follow-up|4|||
129977687|NCT01327846|467881158|FG003|Core Phase|Lost to Follow-up|5|||
129977688|NCT01327846|467881155|FG000|Extension Phase|Study terminated by sponsor|1073|||
129977689|NCT01327846|467881156|FG001|Extension Phase|Study terminated by sponsor|1124|||
129977690|NCT01327846|467881157|FG002|Extension Phase|Study terminated by sponsor|1067|||
129977691|NCT01327846|467881158|FG003|Extension Phase|Study terminated by sponsor|1660|||
129977692|NCT01327846|467881155|FG000|Extension Phase|Withdrawal by Subject|20|||
129977693|NCT01327846|467881156|FG001|Extension Phase|Withdrawal by Subject|13|||
129977694|NCT01327846|467881157|FG002|Extension Phase|Withdrawal by Subject|19|||
129977695|NCT01327846|467881158|FG003|Extension Phase|Withdrawal by Subject|37|||
129977696|NCT01327846|467881155|FG000|Extension Phase|Lost to Follow-up|4|||
129977697|NCT01327846|467881156|FG001|Extension Phase|Lost to Follow-up|3|||
129977698|NCT01327846|467881157|FG002|Extension Phase|Lost to Follow-up|4|||
129977699|NCT01327846|467881158|FG003|Extension Phase|Lost to Follow-up|7|||
129977700|NCT01327846|467881155|FG000|Extension Phase|Technical Problems|2|||
129977701|NCT01327846|467881156|FG001|Extension Phase|Technical Problems|4|||
129977702|NCT01327846|467881157|FG002|Extension Phase|Technical Problems|2|||
129481391|NCT00686543|466052254|FG000|Overall Study|Adverse Event|9|||
129481392|NCT00686543|466052255|FG001|Overall Study|Adverse Event|1|||
129481393|NCT00686543|466052256|FG002|Overall Study|Adverse Event|3|||
129481394|NCT00686543|466052257|FG003|Overall Study|Adverse Event|2|||
129481395|NCT00686543|466052254|FG000|Overall Study|Withdrawal by Subject|2|||
129481396|NCT00686543|466052255|FG001|Overall Study|Withdrawal by Subject|0|||
129481397|NCT00686543|466052256|FG002|Overall Study|Withdrawal by Subject|0|||
129481398|NCT00686543|466052257|FG003|Overall Study|Withdrawal by Subject|0|||
129481399|NCT00686543|466052254|FG000|Overall Study|Protocol Violation|3|||
129481400|NCT00686543|466052255|FG001|Overall Study|Protocol Violation|0|||
129977703|NCT01327846|467881158|FG003|Extension Phase|Technical Problems|2|||
129977704|NCT04343976|467881159|FG000|Overall Study|Withdrawal by Subject|0|||
129977705|NCT04343976|467881160|FG001|Overall Study|Withdrawal by Subject|1|||
129977706|NCT00594880|467881161|FG000|Overall Study|Withdrawal by Subject|1|||
129977707|NCT00594880|467881162|FG001|Overall Study|Withdrawal by Subject|1|||
129977708|NCT00594880|467881161|FG000|Overall Study|Lost to Follow-up|1|||
129977709|NCT00594880|467881162|FG001|Overall Study|Lost to Follow-up|0|||
129977710|NCT00694109|467881163|FG000|Overall Study|Physician Decision|3|||
129977711|NCT00694109|467881163|FG000|Overall Study|Adverse Event|74|||
129977712|NCT00694109|467881163|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
129977713|NCT00694109|467881163|FG000|Overall Study|Lack of Efficacy|2|||
129977714|NCT00694109|467881163|FG000|Overall Study|Withdrawal by Subject|13|||
129977715|NCT00694109|467881163|FG000|Overall Study|Pregnancy|1|||
129977716|NCT00694109|467881163|FG000|Overall Study|Enrolled but not treated|1|||
129977717|NCT00694109|467881163|FG000|Overall Study|Other|2|||
129977718|NCT00694109|467881163|FG000|Overall Study|Consented but no additional treatment|3|||
129977719|NCT01254747|467881164|FG000|Overall Study|Unacceptable subjective vision|0|||
129977720|NCT01254747|467881165|FG001|Overall Study|Unacceptable subjective vision|0|||
129977721|NCT01254747|467881166|FG002|Overall Study|Unacceptable subjective vision|0|||
129977722|NCT01254747|467881167|FG003|Overall Study|Unacceptable subjective vision|2|||
129977723|NCT01254747|467881164|FG000|Overall Study|Difficult removal handling|0|||
129481401|NCT00686543|466052256|FG002|Overall Study|Protocol Violation|2|||
129481402|NCT00686543|466052257|FG003|Overall Study|Protocol Violation|1|||
129481403|NCT02370121|466052258|FG000|Overall Study|Lost to Follow-up|1|||
129977724|NCT01254747|467881165|FG001|Overall Study|Difficult removal handling|0|||
129977725|NCT01254747|467881166|FG002|Overall Study|Difficult removal handling|1|||
129977726|NCT01254747|467881167|FG003|Overall Study|Difficult removal handling|0|||
129977727|NCT01254747|467881164|FG000|Overall Study|Symptoms and problems|0|||
129977728|NCT01254747|467881165|FG001|Overall Study|Symptoms and problems|2|||
129977729|NCT01254747|467881166|FG002|Overall Study|Symptoms and problems|1|||
129977730|NCT01254747|467881167|FG003|Overall Study|Symptoms and problems|0|||
129977731|NCT01254747|467881164|FG000|Overall Study|Lost to Follow-up|0|||
129481404|NCT02370121|466052259|FG001|Overall Study|Lost to Follow-up|1|||
129481405|NCT04429022|466052260|FG000|Overall Study|Protocol Violation|18|||
129977732|NCT01254747|467881165|FG001|Overall Study|Lost to Follow-up|0|||
129977733|NCT01254747|467881166|FG002|Overall Study|Lost to Follow-up|1|||
129977734|NCT01254747|467881167|FG003|Overall Study|Lost to Follow-up|0|||
129977735|NCT01254747|467881164|FG000|Overall Study|Biomicroscopy|0|||
129977736|NCT01254747|467881165|FG001|Overall Study|Biomicroscopy|0|||
129977737|NCT01254747|467881166|FG002|Overall Study|Biomicroscopy|1|||
129977738|NCT01254747|467881167|FG003|Overall Study|Biomicroscopy|0|||
129977739|NCT01254747|467881164|FG000|Overall Study|Discomfort|0|||
129977740|NCT01254747|467881165|FG001|Overall Study|Discomfort|4|||
129977741|NCT01254747|467881166|FG002|Overall Study|Discomfort|0|||
129977742|NCT01254747|467881167|FG003|Overall Study|Discomfort|0|||
129977743|NCT00846807|467881168|FG000|Overall Study|Adverse Event|270|||
129977744|NCT00846807|467881168|FG000|Overall Study|Lost to Follow-up|94|||
129977745|NCT00846807|467881168|FG000|Overall Study|Withdrawal by Subject|56|||
129977746|NCT00846807|467881168|FG000|Overall Study|Non compliant with European label|7|||
129977747|NCT00846807|467881168|FG000|Overall Study|Switch to other anticoagulants|89|||
129977748|NCT00846807|467881168|FG000|Overall Study|No prescription after hospital discharge|56|||
129977749|NCT00846807|467881168|FG000|Overall Study|Other|60|||
129977750|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
129977751|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
129977752|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
129977753|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
129977754|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
129977755|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
129977756|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
129977757|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
129977758|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
129977759|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
129977760|NCT00245960|467881169|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
129977761|NCT00245960|467881170|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
129977762|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
129977763|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
129977764|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
129977765|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
129977766|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
129977767|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
129977768|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
129977769|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
129977770|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
129977771|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
129977772|NCT00245960|467881169|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
129977773|NCT00245960|467881170|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
129977774|NCT00737698|467881171|FG000|Overall Study|Withdrawal by Subject|6|||
129977775|NCT00737698|467881172|FG001|Overall Study|Withdrawal by Subject|5|||
129977776|NCT00737698|467881173|FG002|Overall Study|Withdrawal by Subject|3|||
129977777|NCT00737698|467881171|FG000|Overall Study|Death|0|||
129977778|NCT00737698|467881172|FG001|Overall Study|Death|0|||
129977779|NCT00737698|467881173|FG002|Overall Study|Death|1|||
129977780|NCT01067846|467881174|FG000|Overall Study|Lost to Follow-up|17|||
129977781|NCT01067846|467881175|FG001|Overall Study|Lost to Follow-up|19|||
129977782|NCT01067846|467881174|FG000|Overall Study|Withdrawal by Subject|1|||
129977783|NCT01067846|467881175|FG001|Overall Study|Withdrawal by Subject|0|||
129977784|NCT01067846|467881174|FG000|Overall Study|participation in other tx study|1|||
129977785|NCT01067846|467881175|FG001|Overall Study|participation in other tx study|0|||
129977786|NCT02817906|467881176|FG000|Overall Study|Adverse Event|3|||
129977787|NCT02817906|467881177|FG001|Overall Study|Adverse Event|0|||
129977788|NCT02817906|467881176|FG000|Overall Study|Lack of Efficacy|1|||
129977789|NCT02817906|467881177|FG001|Overall Study|Lack of Efficacy|0|||
129977790|NCT02817906|467881176|FG000|Overall Study|Protocol Violation|1|||
129977791|NCT02817906|467881177|FG001|Overall Study|Protocol Violation|1|||
129977792|NCT02817906|467881176|FG000|Overall Study|Study Terminated by Sponsor|2|||
129481406|NCT04429022|466052261|FG001|Overall Study|Protocol Violation|1|||
129481407|NCT00963807|466052262|FG000|Overall Study|Physician Decision|2|||
129481408|NCT00963807|466052262|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
129977793|NCT02817906|467881177|FG001|Overall Study|Study Terminated by Sponsor|2|||
129977794|NCT02817906|467881176|FG000|Overall Study|Withdrawal by Subject|7|||
129977795|NCT02817906|467881177|FG001|Overall Study|Withdrawal by Subject|0|||
129481409|NCT00963807|466052262|FG000|Overall Study|Disease progression|15|||
129481410|NCT00045032|466052271|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
129977796|NCT02817906|467881176|FG000|Overall Study|Other|2|||
129977797|NCT02817906|467881177|FG001|Overall Study|Other|2|||
129977798|NCT04608773|467881179|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
129977799|NCT04608773|467881180|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
129977800|NCT04608773|467881179|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
129977801|NCT04608773|467881180|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
129977802|NCT04608773|467881179|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
129977803|NCT04608773|467881180|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
129977804|NCT04608773|467881179|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
129977805|NCT04608773|467881180|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
129977806|NCT04608773|467881179|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
129977807|NCT04608773|467881180|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
129977808|NCT02833077|467881181|FG000|Overall Study|Adverse Event|1|||
129977809|NCT02833077|467881182|FG001|Overall Study|Adverse Event|2|||
129977810|NCT02833077|467881181|FG000|Overall Study|Lost to Follow-up|10|||
129977811|NCT02833077|467881182|FG001|Overall Study|Lost to Follow-up|1|||
129977812|NCT02833077|467881181|FG000|Overall Study|Personal Reasons|6|||
129977813|NCT02833077|467881182|FG001|Overall Study|Personal Reasons|4|||
129977814|NCT02833077|467881181|FG000|Overall Study|Protocol Deviation|0|||
129977815|NCT02833077|467881182|FG001|Overall Study|Protocol Deviation|1|||
129977816|NCT00316017|467881183|FG000|Overall Study|Protocol Violation|11|||
129977817|NCT00316017|467881184|FG001|Overall Study|Protocol Violation|13|||
129977818|NCT00316017|467881185|FG002|Overall Study|Protocol Violation|19|||
129977819|NCT04531982|467881186|FG000|Overall Study|Withdrawal by Subject|10|||
129977820|NCT04531982|467881187|FG001|Overall Study|Withdrawal by Subject|11|||
129977821|NCT04531982|467881186|FG000|Overall Study|Adverse Event|6|||
129977822|NCT04531982|467881187|FG001|Overall Study|Adverse Event|14|||
129977823|NCT04531982|467881186|FG000|Overall Study|Protocol Violation|6|||
129977824|NCT04531982|467881187|FG001|Overall Study|Protocol Violation|9|||
129977825|NCT04531982|467881186|FG000|Overall Study|Non-compliance with study drug|3|||
129977826|NCT04531982|467881187|FG001|Overall Study|Non-compliance with study drug|2|||
129977827|NCT04531982|467881186|FG000|Overall Study|Use of prohibited medication|2|||
129977828|NCT04531982|467881187|FG001|Overall Study|Use of prohibited medication|0|||
129977829|NCT04531982|467881186|FG000|Overall Study|Lost to Follow-up|0|||
129977830|NCT04531982|467881187|FG001|Overall Study|Lost to Follow-up|1|||
129977831|NCT04531982|467881186|FG000|Overall Study|Geopolitical conflict|2|||
129977832|NCT04531982|467881187|FG001|Overall Study|Geopolitical conflict|0|||
129977833|NCT04531982|467881186|FG000|Overall Study|Lack of Efficacy|3|||
129977834|NCT04531982|467881187|FG001|Overall Study|Lack of Efficacy|1|||
129977835|NCT03841526|467881189|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
129977836|NCT03841526|467881190|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977837|NCT03841526|467881191|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977838|NCT03841526|467881192|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
129977839|NCT03841526|467881193|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977840|NCT03841526|467881194|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
129977841|NCT03841526|467881189|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
129977842|NCT03841526|467881190|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
129977843|NCT03841526|467881191|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
129481411|NCT00045032|466052272|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
129481412|NCT00045032|466052273|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
129481413|NCT00045032|466052271|FG000|Overall Study|Death|22|||
129481414|NCT00045032|466052272|FG001|Overall Study|Death|24|||
129481415|NCT00045032|466052273|FG002|Overall Study|Death|17|||
129481416|NCT00045032|466052271|FG000|Overall Study|Insufficient Therapeutic Response|542|||
129481417|NCT00045032|466052272|FG001|Overall Study|Insufficient Therapeutic Response|437|||
129481418|NCT00045032|466052273|FG002|Overall Study|Insufficient Therapeutic Response|445|||
129481419|NCT00045032|466052271|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
129481420|NCT00045032|466052272|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
129481421|NCT00045032|466052273|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
129481422|NCT00045032|466052271|FG000|Overall Study|Other Protocol Violation|2|||
129481423|NCT00045032|466052272|FG001|Overall Study|Other Protocol Violation|0|||
129481424|NCT00045032|466052273|FG002|Overall Study|Other Protocol Violation|1|||
129481425|NCT00045032|466052271|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
129977844|NCT03841526|467881192|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
129977845|NCT03841526|467881193|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
129481426|NCT00045032|466052272|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
129481427|NCT00045032|466052273|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
129481428|NCT00045032|466052271|FG000|Overall Study|Failure to Return|57|||
129481429|NCT00045032|466052272|FG001|Overall Study|Failure to Return|62|||
129977846|NCT03841526|467881194|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
129977847|NCT03841526|467881189|FG000|Outpatient Phase Treatment|Physician Decision|0|||
129977848|NCT03841526|467881190|FG001|Outpatient Phase Treatment|Physician Decision|1|||
129977849|NCT03841526|467881191|FG002|Outpatient Phase Treatment|Physician Decision|0|||
129977850|NCT03841526|467881192|FG003|Outpatient Phase Treatment|Physician Decision|0|||
129977851|NCT03841526|467881193|FG004|Outpatient Phase Treatment|Physician Decision|0|||
129977852|NCT03841526|467881194|FG005|Outpatient Phase Treatment|Physician Decision|0|||
129977853|NCT03841526|467881189|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129977854|NCT03841526|467881190|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129977855|NCT03841526|467881191|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
129977856|NCT03841526|467881192|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129481430|NCT00045032|466052273|FG002|Overall Study|Failure to Return|61|||
129481431|NCT00045032|466052271|FG000|Overall Study|Other|93|||
129481432|NCT00045032|466052272|FG001|Overall Study|Other|84|||
129481433|NCT00045032|466052273|FG002|Overall Study|Other|105|||
129481434|NCT02582658|466052274|FG000|Overall Study|Failure to Return|10|||
129481435|NCT02582658|466052274|FG000|Overall Study|Insufficient Virological Response|2|||
129481436|NCT02582658|466052274|FG000|Overall Study|Withdrawn Consent|1|||
129481437|NCT02582658|466052274|FG000|Overall Study|Death|1|||
129481438|NCT02582658|466052274|FG000|Overall Study|Not further specified|11|||
129481439|NCT02581995|466052282|FG000|Overall Study|Unspecified other|3|||
129481440|NCT02581995|466052282|FG000|Overall Study|Adverse Event|6|||
129481441|NCT02581995|466052282|FG000|Overall Study|Lost to Follow-up|5|||
129481442|NCT02581995|466052282|FG000|Overall Study|Withdrawal by participant|12|||
129481443|NCT02581995|466052282|FG000|Overall Study|Physician Decision|1|||
129481444|NCT02581995|466052282|FG000|Overall Study|Death|4|||
129481445|NCT00473694|466054137|FG000|Overall Study|Adverse Event|0|||
129481446|NCT00473694|466054138|FG001|Overall Study|Adverse Event|1|||
129481447|NCT00473694|466054139|FG002|Overall Study|Adverse Event|0|||
129481448|NCT00473694|466054140|FG003|Overall Study|Adverse Event|0|||
129481449|NCT00473694|466054137|FG000|Overall Study|Participants did not receive treatment|11|||
129481450|NCT00473694|466054138|FG001|Overall Study|Participants did not receive treatment|3|||
129481451|NCT00473694|466054139|FG002|Overall Study|Participants did not receive treatment|5|||
129481452|NCT00473694|466054140|FG003|Overall Study|Participants did not receive treatment|6|||
129481453|NCT00473694|466054137|FG000|Overall Study|Lost to Follow-up|0|||
129481454|NCT00473694|466054138|FG001|Overall Study|Lost to Follow-up|0|||
129481455|NCT00473694|466054139|FG002|Overall Study|Lost to Follow-up|0|||
129481456|NCT00473694|466054140|FG003|Overall Study|Lost to Follow-up|1|||
129481457|NCT00506389|466054148|FG000|In-treatment Period|Other|3|||
129481458|NCT00506389|466054149|FG001|In-treatment Period|Other|3|||
129481459|NCT00506389|466054150|FG002|In-treatment Period|Other|4|||
129977857|NCT03841526|467881193|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
129977858|NCT03841526|467881194|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
129977859|NCT03829501|467882561|FG000|Overall Study|Withdrawal of Consent|2|||
129977860|NCT03829501|467882562|FG001|Overall Study|Withdrawal of Consent|0|||
129977861|NCT03829501|467882563|FG002|Overall Study|Withdrawal of Consent|3|||
129977862|NCT03829501|467882564|FG003|Overall Study|Withdrawal of Consent|0|||
129977863|NCT03829501|467882565|FG004|Overall Study|Withdrawal of Consent|1|||
129977864|NCT03829501|467882566|FG005|Overall Study|Withdrawal of Consent|1|||
129977865|NCT03829501|467882567|FG006|Overall Study|Withdrawal of Consent|0|||
129977866|NCT03829501|467882568|FG007|Overall Study|Withdrawal of Consent|10|||
129977867|NCT03829501|467882569|FG008|Overall Study|Withdrawal of Consent|10|||
129977868|NCT03829501|467882570|FG009|Overall Study|Withdrawal of Consent|3|||
129977869|NCT03829501|467882571|FG010|Overall Study|Withdrawal of Consent|4|||
129977870|NCT03829501|467882572|FG011|Overall Study|Withdrawal of Consent|4|||
129977871|NCT03829501|467882573|FG012|Overall Study|Withdrawal of Consent|4|||
129977872|NCT03829501|467882574|FG013|Overall Study|Withdrawal of Consent|0|||
129977873|NCT03829501|467882575|FG014|Overall Study|Withdrawal of Consent|3|||
129977874|NCT03829501|467882576|FG015|Overall Study|Withdrawal of Consent|0|||
129977875|NCT03829501|467882577|FG016|Overall Study|Withdrawal of Consent|1|||
129977876|NCT03829501|467882578|FG017|Overall Study|Withdrawal of Consent|1|||
129977877|NCT03829501|467882579|FG018|Overall Study|Withdrawal of Consent|0|||
129977878|NCT03829501|467882580|FG019|Overall Study|Withdrawal of Consent|0|||
129977879|NCT03829501|467882581|FG020|Overall Study|Withdrawal of Consent|3|||
129977880|NCT03829501|467882582|FG021|Overall Study|Withdrawal of Consent|0|||
129977881|NCT03829501|467882583|FG022|Overall Study|Withdrawal of Consent|1|||
129977882|NCT03829501|467882561|FG000|Overall Study|PD|0|||
129977883|NCT03829501|467882562|FG001|Overall Study|PD|0|||
129977884|NCT03829501|467882563|FG002|Overall Study|PD|0|||
129977885|NCT03829501|467882564|FG003|Overall Study|PD|2|||
129977886|NCT03829501|467882565|FG004|Overall Study|PD|0|||
129977887|NCT03829501|467882566|FG005|Overall Study|PD|0|||
129977888|NCT03829501|467882567|FG006|Overall Study|PD|0|||
129481460|NCT00506389|466054148|FG000|In-treatment Period|Lost to Follow-up|0|||
129481461|NCT00506389|466054149|FG001|In-treatment Period|Lost to Follow-up|0|||
129481462|NCT00506389|466054150|FG002|In-treatment Period|Lost to Follow-up|1|||
129481463|NCT00506389|466054148|FG000|In-treatment Period|Lack of compliance|1|||
129977889|NCT03829501|467882568|FG007|Overall Study|PD|0|||
129977890|NCT03829501|467882569|FG008|Overall Study|PD|0|||
129977891|NCT03829501|467882570|FG009|Overall Study|PD|0|||
129977892|NCT03829501|467882571|FG010|Overall Study|PD|0|||
129977893|NCT03829501|467882572|FG011|Overall Study|PD|0|||
129977894|NCT03829501|467882573|FG012|Overall Study|PD|0|||
129977895|NCT03829501|467882574|FG013|Overall Study|PD|0|||
129481464|NCT00506389|466054149|FG001|In-treatment Period|Lack of compliance|0|||
129481465|NCT00506389|466054150|FG002|In-treatment Period|Lack of compliance|0|||
129977896|NCT03829501|467882575|FG014|Overall Study|PD|0|||
129481466|NCT00506389|466054148|FG000|In-treatment Period|Reasons not related to trial|4|||
129481467|NCT00506389|466054149|FG001|In-treatment Period|Reasons not related to trial|1|||
129481468|NCT00506389|466054150|FG002|In-treatment Period|Reasons not related to trial|0|||
129977897|NCT03829501|467882576|FG015|Overall Study|PD|1|||
129977898|NCT03829501|467882577|FG016|Overall Study|PD|0|||
129977899|NCT03829501|467882578|FG017|Overall Study|PD|0|||
129977900|NCT03829501|467882579|FG018|Overall Study|PD|0|||
129977901|NCT03829501|467882580|FG019|Overall Study|PD|0|||
129977902|NCT03829501|467882581|FG020|Overall Study|PD|1|||
129977903|NCT03829501|467882582|FG021|Overall Study|PD|0|||
129977904|NCT03829501|467882583|FG022|Overall Study|PD|0|||
129977905|NCT03829501|467882561|FG000|Overall Study|Study Terminated by Sponsor|0|||
129977906|NCT03829501|467882562|FG001|Overall Study|Study Terminated by Sponsor|0|||
129977907|NCT03829501|467882563|FG002|Overall Study|Study Terminated by Sponsor|0|||
129977908|NCT03829501|467882564|FG003|Overall Study|Study Terminated by Sponsor|0|||
129977909|NCT03829501|467882565|FG004|Overall Study|Study Terminated by Sponsor|0|||
129977910|NCT03829501|467882566|FG005|Overall Study|Study Terminated by Sponsor|0|||
129977911|NCT03829501|467882567|FG006|Overall Study|Study Terminated by Sponsor|0|||
129977912|NCT03829501|467882568|FG007|Overall Study|Study Terminated by Sponsor|3|||
129977913|NCT03829501|467882569|FG008|Overall Study|Study Terminated by Sponsor|1|||
129977914|NCT03829501|467882570|FG009|Overall Study|Study Terminated by Sponsor|0|||
129977915|NCT03829501|467882571|FG010|Overall Study|Study Terminated by Sponsor|0|||
129977916|NCT03829501|467882572|FG011|Overall Study|Study Terminated by Sponsor|0|||
129977917|NCT03829501|467882573|FG012|Overall Study|Study Terminated by Sponsor|0|||
129977918|NCT03829501|467882574|FG013|Overall Study|Study Terminated by Sponsor|0|||
129977919|NCT03829501|467882575|FG014|Overall Study|Study Terminated by Sponsor|3|||
129977920|NCT03829501|467882576|FG015|Overall Study|Study Terminated by Sponsor|2|||
129977921|NCT03829501|467882577|FG016|Overall Study|Study Terminated by Sponsor|2|||
129977922|NCT03829501|467882578|FG017|Overall Study|Study Terminated by Sponsor|0|||
129977923|NCT03829501|467882579|FG018|Overall Study|Study Terminated by Sponsor|0|||
129977924|NCT03829501|467882580|FG019|Overall Study|Study Terminated by Sponsor|0|||
129977925|NCT03829501|467882581|FG020|Overall Study|Study Terminated by Sponsor|1|||
129977926|NCT03829501|467882582|FG021|Overall Study|Study Terminated by Sponsor|0|||
129977927|NCT03829501|467882583|FG022|Overall Study|Study Terminated by Sponsor|3|||
129977928|NCT03829501|467882561|FG000|Overall Study|Lost to Follow Up|0|||
129977929|NCT03829501|467882562|FG001|Overall Study|Lost to Follow Up|0|||
129977930|NCT03829501|467882563|FG002|Overall Study|Lost to Follow Up|0|||
129977931|NCT03829501|467882564|FG003|Overall Study|Lost to Follow Up|0|||
129977932|NCT03829501|467882565|FG004|Overall Study|Lost to Follow Up|1|||
129977933|NCT03829501|467882566|FG005|Overall Study|Lost to Follow Up|0|||
129977934|NCT03829501|467882567|FG006|Overall Study|Lost to Follow Up|0|||
129977935|NCT03829501|467882568|FG007|Overall Study|Lost to Follow Up|2|||
129977936|NCT03829501|467882569|FG008|Overall Study|Lost to Follow Up|2|||
129977937|NCT03829501|467882570|FG009|Overall Study|Lost to Follow Up|0|||
129977938|NCT03829501|467882571|FG010|Overall Study|Lost to Follow Up|2|||
129977939|NCT03829501|467882572|FG011|Overall Study|Lost to Follow Up|1|||
129977940|NCT03829501|467882573|FG012|Overall Study|Lost to Follow Up|0|||
129977941|NCT03829501|467882574|FG013|Overall Study|Lost to Follow Up|1|||
129977942|NCT03829501|467882575|FG014|Overall Study|Lost to Follow Up|1|||
129977943|NCT03829501|467882576|FG015|Overall Study|Lost to Follow Up|0|||
129977944|NCT03829501|467882577|FG016|Overall Study|Lost to Follow Up|0|||
129977945|NCT03829501|467882578|FG017|Overall Study|Lost to Follow Up|0|||
129977946|NCT03829501|467882579|FG018|Overall Study|Lost to Follow Up|0|||
129977947|NCT03829501|467882580|FG019|Overall Study|Lost to Follow Up|0|||
129977948|NCT03829501|467882581|FG020|Overall Study|Lost to Follow Up|0|||
129977949|NCT03829501|467882582|FG021|Overall Study|Lost to Follow Up|0|||
129977950|NCT03829501|467882583|FG022|Overall Study|Lost to Follow Up|1|||
129977951|NCT03829501|467882561|FG000|Overall Study|Death|2|||
129977952|NCT03829501|467882562|FG001|Overall Study|Death|4|||
129977953|NCT03829501|467882563|FG002|Overall Study|Death|5|||
129977954|NCT03829501|467882564|FG003|Overall Study|Death|6|||
129977955|NCT03829501|467882565|FG004|Overall Study|Death|5|||
129977956|NCT03829501|467882566|FG005|Overall Study|Death|4|||
129977957|NCT03829501|467882567|FG006|Overall Study|Death|5|||
129977958|NCT03829501|467882568|FG007|Overall Study|Death|24|||
129481469|NCT00506389|466054148|FG000|In-treatment Period|Withdrawal by Subject|3|||
129481470|NCT00506389|466054149|FG001|In-treatment Period|Withdrawal by Subject|3|||
129977959|NCT03829501|467882569|FG008|Overall Study|Death|22|||
129977960|NCT03829501|467882570|FG009|Overall Study|Death|6|||
129977961|NCT03829501|467882571|FG010|Overall Study|Death|3|||
129977962|NCT03829501|467882572|FG011|Overall Study|Death|10|||
129977963|NCT03829501|467882573|FG012|Overall Study|Death|10|||
129977964|NCT03829501|467882574|FG013|Overall Study|Death|5|||
129977965|NCT03829501|467882575|FG014|Overall Study|Death|7|||
129481471|NCT00506389|466054150|FG002|In-treatment Period|Withdrawal by Subject|4|||
129977966|NCT03829501|467882576|FG015|Overall Study|Death|2|||
129977967|NCT03829501|467882577|FG016|Overall Study|Death|2|||
129977968|NCT03829501|467882578|FG017|Overall Study|Death|1|||
129977969|NCT03829501|467882579|FG018|Overall Study|Death|1|||
129977970|NCT03829501|467882580|FG019|Overall Study|Death|1|||
129977971|NCT03829501|467882581|FG020|Overall Study|Death|1|||
129977972|NCT03829501|467882582|FG021|Overall Study|Death|2|||
129977973|NCT03829501|467882583|FG022|Overall Study|Death|3|||
129977974|NCT03829501|467882561|FG000|Overall Study|Miscellaneous|0|||
129977975|NCT03829501|467882562|FG001|Overall Study|Miscellaneous|0|||
129977976|NCT03829501|467882563|FG002|Overall Study|Miscellaneous|1|||
129977977|NCT03829501|467882564|FG003|Overall Study|Miscellaneous|0|||
129977978|NCT03829501|467882565|FG004|Overall Study|Miscellaneous|0|||
129977979|NCT03829501|467882566|FG005|Overall Study|Miscellaneous|0|||
129977980|NCT03829501|467882567|FG006|Overall Study|Miscellaneous|0|||
129977981|NCT03829501|467882568|FG007|Overall Study|Miscellaneous|1|||
129977982|NCT03829501|467882569|FG008|Overall Study|Miscellaneous|0|||
129977983|NCT03829501|467882570|FG009|Overall Study|Miscellaneous|0|||
129977984|NCT03829501|467882571|FG010|Overall Study|Miscellaneous|0|||
129977985|NCT03829501|467882572|FG011|Overall Study|Miscellaneous|0|||
129977986|NCT03829501|467882573|FG012|Overall Study|Miscellaneous|0|||
129977987|NCT03829501|467882574|FG013|Overall Study|Miscellaneous|0|||
129977988|NCT03829501|467882575|FG014|Overall Study|Miscellaneous|0|||
129977989|NCT03829501|467882576|FG015|Overall Study|Miscellaneous|0|||
129977990|NCT03829501|467882577|FG016|Overall Study|Miscellaneous|0|||
129977991|NCT03829501|467882578|FG017|Overall Study|Miscellaneous|0|||
129977992|NCT03829501|467882579|FG018|Overall Study|Miscellaneous|0|||
129977993|NCT03829501|467882580|FG019|Overall Study|Miscellaneous|0|||
129977994|NCT03829501|467882581|FG020|Overall Study|Miscellaneous|0|||
129977995|NCT03829501|467882582|FG021|Overall Study|Miscellaneous|0|||
129977996|NCT03829501|467882583|FG022|Overall Study|Miscellaneous|1|||
129977997|NCT01123070|467882584|FG000|Part B Double Blind Period|Protocol Violation|0|||
129977998|NCT01123070|467882585|FG001|Part B Double Blind Period|Protocol Violation|0|||
129977999|NCT01123070|467882586|FG002|Part B Double Blind Period|Protocol Violation|0|||
129978000|NCT01123070|467882587|FG003|Part B Double Blind Period|Protocol Violation|1|||
129978001|NCT01123070|467882584|FG000|Part B Double Blind Period|Adverse Event|0|||
129978002|NCT01123070|467882585|FG001|Part B Double Blind Period|Adverse Event|0|||
129978003|NCT01123070|467882586|FG002|Part B Double Blind Period|Adverse Event|2|||
129978004|NCT01123070|467882587|FG003|Part B Double Blind Period|Adverse Event|0|||
129978005|NCT01123070|467882584|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
129978006|NCT01123070|467882585|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
129978007|NCT01123070|467882586|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
129978008|NCT01123070|467882587|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
129978009|NCT03284229|467882588|FG000|Overall Study|Lost to Follow-up|3|||
129978010|NCT04165031|467882589|FG000|Overall Study|Adverse Event|1|||
129978011|NCT04165031|467882590|FG001|Overall Study|Adverse Event|1|||
129978012|NCT04165031|467882591|FG002|Overall Study|Adverse Event|0|||
129978013|NCT04165031|467882592|FG003|Overall Study|Adverse Event|0|||
129978014|NCT04165031|467882593|FG004|Overall Study|Adverse Event|0|||
129978015|NCT04165031|467882594|FG005|Overall Study|Adverse Event|0|||
129978016|NCT04165031|467882589|FG000|Overall Study|Withdrawal by Subject|0|||
129978017|NCT04165031|467882590|FG001|Overall Study|Withdrawal by Subject|0|||
129978018|NCT04165031|467882591|FG002|Overall Study|Withdrawal by Subject|1|||
129978019|NCT04165031|467882592|FG003|Overall Study|Withdrawal by Subject|0|||
129978020|NCT04165031|467882593|FG004|Overall Study|Withdrawal by Subject|0|||
129978021|NCT04165031|467882594|FG005|Overall Study|Withdrawal by Subject|0|||
129978022|NCT01332630|467882595|FG000|Overall Study|Withdrawal by Subject|3|||
129978023|NCT03140280|467882596|FG000|Overall Study|Physician Decision|5|||
129978024|NCT00663702|467882605|FG000|Overall Study|Adverse Event|8|||
129978025|NCT00663702|467882606|FG001|Overall Study|Adverse Event|4|||
129978026|NCT00663702|467882605|FG000|Overall Study|Withdrawal by Subject|3|||
129978027|NCT00663702|467882606|FG001|Overall Study|Withdrawal by Subject|1|||
129978028|NCT00663702|467882605|FG000|Overall Study|Pregnancy|0|||
129978029|NCT00663702|467882606|FG001|Overall Study|Pregnancy|1|||
129978030|NCT00663702|467882605|FG000|Overall Study|Lost to Follow-up|3|||
129978031|NCT00663702|467882606|FG001|Overall Study|Lost to Follow-up|0|||
129978032|NCT00663702|467882605|FG000|Overall Study|Death|1|||
129978033|NCT00663702|467882606|FG001|Overall Study|Death|1|||
129978034|NCT00663702|467882605|FG000|Overall Study|Lack of Efficacy|3|||
129978035|NCT00663702|467882606|FG001|Overall Study|Lack of Efficacy|3|||
129978036|NCT01977677|467882609|FG000|Overall Study|Unrelated Adverse Event|0|||
129978037|NCT01977677|467882610|FG001|Overall Study|Unrelated Adverse Event|0|||
129978038|NCT01977677|467882611|FG002|Overall Study|Unrelated Adverse Event|1|||
129978039|NCT01498887|467882612|FG000|Overall Study|Administrative problems|1|||
129978040|NCT01498887|467882613|FG001|Overall Study|Administrative problems|0|||
129978041|NCT01498887|467882612|FG000|Overall Study|Lost to Follow-up|1|||
129978042|NCT01498887|467882613|FG001|Overall Study|Lost to Follow-up|1|||
129978043|NCT01498887|467882612|FG000|Overall Study|Withdrawal by Subject|1|||
129978044|NCT01498887|467882613|FG001|Overall Study|Withdrawal by Subject|0|||
129978045|NCT01498887|467882612|FG000|Overall Study|Protocol Violation|1|||
129978046|NCT01498887|467882613|FG001|Overall Study|Protocol Violation|3|||
129978047|NCT01498887|467882612|FG000|Overall Study|Lack of Efficacy|5|||
129481472|NCT00506389|466054148|FG000|In-treatment Period|Lack of Efficacy|0|||
129978048|NCT01498887|467882613|FG001|Overall Study|Lack of Efficacy|3|||
129978049|NCT01498887|467882612|FG000|Overall Study|Abnormal result from test procedure|1|||
129978050|NCT01498887|467882613|FG001|Overall Study|Abnormal result from test procedure|1|||
129978051|NCT01498887|467882612|FG000|Overall Study|Abnormal laboratory value|2|||
129978052|NCT01498887|467882613|FG001|Overall Study|Abnormal laboratory value|2|||
129978053|NCT01498887|467882612|FG000|Overall Study|Adverse Event|4|||
129978054|NCT01498887|467882613|FG001|Overall Study|Adverse Event|1|||
129978055|NCT00667225|467882616|FG000|Overall Study|Subject had no more lesions to treat.|1|||
129978056|NCT00667225|467882617|FG001|Overall Study|Subject had no more lesions to treat.|0|||
129978057|NCT00667225|467882616|FG000|Overall Study|Lost to Follow-up|0|||
129978058|NCT00667225|467882617|FG001|Overall Study|Lost to Follow-up|1|||
129978059|NCT02993406|467882618|FG000|Overall Study|Withdrawal by Subject|170|||
129978060|NCT02993406|467882619|FG001|Overall Study|Withdrawal by Subject|196|||
129978061|NCT02993406|467882618|FG000|Overall Study|Physician Decision|3|||
129978062|NCT02993406|467882619|FG001|Overall Study|Physician Decision|5|||
129978063|NCT02993406|467882618|FG000|Overall Study|Lost to Follow-up|12|||
129978064|NCT02993406|467882619|FG001|Overall Study|Lost to Follow-up|13|||
129978065|NCT02993406|467882618|FG000|Overall Study|Unclassifiable Response|105|||
129978066|NCT02993406|467882619|FG001|Overall Study|Unclassifiable Response|139|||
129978067|NCT02993406|467882618|FG000|Overall Study|Administrative decision|1|||
129978068|NCT02993406|467882619|FG001|Overall Study|Administrative decision|0|||
129978069|NCT02993406|467882618|FG000|Overall Study|Sponsor decision|4|||
129978070|NCT02993406|467882619|FG001|Overall Study|Sponsor decision|5|||
129978071|NCT02248818|467882620|FG000|Screening|Protocol Violation|0|||
129978072|NCT02248818|467882621|FG001|Screening|Protocol Violation|0|||
129978073|NCT02248818|467882622|FG002|Screening|Protocol Violation|0|||
129978074|NCT02248818|467882623|FG003|Screening|Protocol Violation|0|||
129978075|NCT02248818|467882624|FG004|Screening|Protocol Violation|0|||
129978076|NCT02248818|467882625|FG005|Screening|Protocol Violation|0|||
129978077|NCT02248818|467882626|FG006|Screening|Protocol Violation|0|||
129978078|NCT02248818|467882627|FG007|Screening|Protocol Violation|0|||
129978079|NCT02248818|467882628|FG008|Screening|Protocol Violation|7|||
129978080|NCT02248818|467882620|FG000|Screening|Study fully enrolled|0|||
129978081|NCT02248818|467882621|FG001|Screening|Study fully enrolled|0|||
129978082|NCT02248818|467882622|FG002|Screening|Study fully enrolled|0|||
129978083|NCT02248818|467882623|FG003|Screening|Study fully enrolled|0|||
129978084|NCT02248818|467882624|FG004|Screening|Study fully enrolled|0|||
129978085|NCT02248818|467882625|FG005|Screening|Study fully enrolled|0|||
129978086|NCT02248818|467882626|FG006|Screening|Study fully enrolled|0|||
129978087|NCT02248818|467882627|FG007|Screening|Study fully enrolled|0|||
129978088|NCT02248818|467882628|FG008|Screening|Study fully enrolled|14|||
129978089|NCT02248818|467882620|FG000|Screening|Physician Decision|0|||
129978090|NCT02248818|467882621|FG001|Screening|Physician Decision|0|||
129978091|NCT02248818|467882622|FG002|Screening|Physician Decision|0|||
129978092|NCT02248818|467882623|FG003|Screening|Physician Decision|0|||
129978093|NCT02248818|467882624|FG004|Screening|Physician Decision|0|||
129978094|NCT02248818|467882625|FG005|Screening|Physician Decision|0|||
129978095|NCT02248818|467882626|FG006|Screening|Physician Decision|0|||
129978096|NCT02248818|467882627|FG007|Screening|Physician Decision|0|||
129978097|NCT02248818|467882628|FG008|Screening|Physician Decision|73|||
129978098|NCT02248818|467882620|FG000|Screening|Withdrawal by Subject|0|||
129978099|NCT02248818|467882621|FG001|Screening|Withdrawal by Subject|0|||
129978100|NCT02248818|467882622|FG002|Screening|Withdrawal by Subject|0|||
129978101|NCT02248818|467882623|FG003|Screening|Withdrawal by Subject|0|||
129978102|NCT02248818|467882624|FG004|Screening|Withdrawal by Subject|0|||
129978103|NCT02248818|467882625|FG005|Screening|Withdrawal by Subject|0|||
129978104|NCT02248818|467882626|FG006|Screening|Withdrawal by Subject|0|||
129978105|NCT02248818|467882627|FG007|Screening|Withdrawal by Subject|0|||
129978106|NCT02248818|467882628|FG008|Screening|Withdrawal by Subject|6|||
129978107|NCT02248818|467882620|FG000|Screening|Lost to Follow-up|0|||
129978108|NCT02248818|467882621|FG001|Screening|Lost to Follow-up|0|||
129978109|NCT02248818|467882622|FG002|Screening|Lost to Follow-up|0|||
129978110|NCT02248818|467882623|FG003|Screening|Lost to Follow-up|0|||
129978111|NCT02248818|467882624|FG004|Screening|Lost to Follow-up|0|||
129978112|NCT02248818|467882625|FG005|Screening|Lost to Follow-up|0|||
129978113|NCT02248818|467882626|FG006|Screening|Lost to Follow-up|0|||
129978114|NCT02248818|467882627|FG007|Screening|Lost to Follow-up|0|||
129978115|NCT02248818|467882628|FG008|Screening|Lost to Follow-up|7|||
129978116|NCT02248818|467882620|FG000|Randomised Study|Administrative - randomization error|0|||
129978117|NCT02248818|467882621|FG001|Randomised Study|Administrative - randomization error|0|||
129978118|NCT02248818|467882622|FG002|Randomised Study|Administrative - randomization error|0|||
129978119|NCT02248818|467882623|FG003|Randomised Study|Administrative - randomization error|0|||
129978120|NCT02248818|467882624|FG004|Randomised Study|Administrative - randomization error|0|||
129978121|NCT02248818|467882625|FG005|Randomised Study|Administrative - randomization error|8|||
129978122|NCT02248818|467882626|FG006|Randomised Study|Administrative - randomization error|0|||
129978123|NCT02248818|467882627|FG007|Randomised Study|Administrative - randomization error|0|||
129978124|NCT02248818|467882628|FG008|Randomised Study|Administrative - randomization error|0|||
129978125|NCT05262517|467882629|FG000|Overall Study|Randomized but not treated|5|||
129978126|NCT05262517|467882630|FG001|Overall Study|Randomized but not treated|11|||
129978127|NCT04325282|467882631|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
129978128|NCT04325282|467882632|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
129978129|NCT04325282|467882631|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
129978130|NCT04325282|467882632|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
129978131|NCT02643303|467882634|FG000|Overall Study|Progressive Disease|4|||
129978132|NCT02643303|467882635|FG001|Overall Study|Progressive Disease|4|||
129978133|NCT02643303|467882636|FG002|Overall Study|Progressive Disease|1|||
129978134|NCT02643303|467882637|FG003|Overall Study|Progressive Disease|12|||
129978135|NCT02643303|467882638|FG004|Overall Study|Progressive Disease|6|||
129978136|NCT02643303|467882639|FG005|Overall Study|Progressive Disease|4|||
129978137|NCT02643303|467882640|FG006|Overall Study|Progressive Disease|8|||
129978138|NCT02643303|467882641|FG007|Overall Study|Progressive Disease|2|||
129978139|NCT02643303|467882642|FG008|Overall Study|Progressive Disease|6|||
129978140|NCT02643303|467882634|FG000|Overall Study|Adverse Event|0|||
129978141|NCT02643303|467882635|FG001|Overall Study|Adverse Event|1|||
129978142|NCT02643303|467882636|FG002|Overall Study|Adverse Event|0|||
129978143|NCT02643303|467882637|FG003|Overall Study|Adverse Event|0|||
129978144|NCT02643303|467882638|FG004|Overall Study|Adverse Event|1|||
129978145|NCT02643303|467882639|FG005|Overall Study|Adverse Event|0|||
129978146|NCT02643303|467882640|FG006|Overall Study|Adverse Event|0|||
129978147|NCT02643303|467882641|FG007|Overall Study|Adverse Event|0|||
129978148|NCT02643303|467882642|FG008|Overall Study|Adverse Event|0|||
129978149|NCT02643303|467882634|FG000|Overall Study|Withdrawal by Subject|0|||
129978150|NCT02643303|467882635|FG001|Overall Study|Withdrawal by Subject|0|||
129978151|NCT02643303|467882636|FG002|Overall Study|Withdrawal by Subject|0|||
129978152|NCT02643303|467882637|FG003|Overall Study|Withdrawal by Subject|1|||
129978153|NCT02643303|467882638|FG004|Overall Study|Withdrawal by Subject|0|||
129978154|NCT02643303|467882639|FG005|Overall Study|Withdrawal by Subject|0|||
129978155|NCT02643303|467882640|FG006|Overall Study|Withdrawal by Subject|1|||
129978156|NCT02643303|467882641|FG007|Overall Study|Withdrawal by Subject|1|||
129978157|NCT02643303|467882642|FG008|Overall Study|Withdrawal by Subject|1|||
129978158|NCT04552899|467882645|FG000|Overall Study|Adverse Event|4|||
129978159|NCT04552899|467882646|FG001|Overall Study|Adverse Event|3|||
129978160|NCT04552899|467882645|FG000|Overall Study|Death|4|||
129978161|NCT04552899|467882646|FG001|Overall Study|Death|4|||
129978162|NCT04552899|467882645|FG000|Overall Study|Lost to Follow-up|8|||
129978163|NCT04552899|467882646|FG001|Overall Study|Lost to Follow-up|13|||
129978164|NCT04552899|467882645|FG000|Overall Study|Lung Transplant|4|||
129978165|NCT04552899|467882646|FG001|Overall Study|Lung Transplant|3|||
129978166|NCT04552899|467882645|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
129978167|NCT04552899|467882646|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
129978168|NCT04552899|467882645|FG000|Overall Study|Physician Decision|3|||
129978169|NCT04552899|467882646|FG001|Overall Study|Physician Decision|4|||
129978170|NCT04552899|467882645|FG000|Overall Study|Study Terminated By Sponsor|237|||
129978171|NCT04552899|467882646|FG001|Overall Study|Study Terminated By Sponsor|239|||
129978172|NCT04552899|467882645|FG000|Overall Study|Withdrawal by Subject|15|||
129978173|NCT04552899|467882646|FG001|Overall Study|Withdrawal by Subject|17|||
129978174|NCT01499303|467882647|FG000|Overall Study|Ongoing|2|||
129978175|NCT01499303|467882648|FG001|Overall Study|Ongoing|1|||
129978176|NCT01499303|467882647|FG000|Overall Study|Withdrawal by Subject|0|||
129978177|NCT01499303|467882648|FG001|Overall Study|Withdrawal by Subject|1|||
129978178|NCT01499303|467882647|FG000|Overall Study|Adverse Event|1|||
129978179|NCT01499303|467882648|FG001|Overall Study|Adverse Event|4|||
129978180|NCT01499303|467882647|FG000|Overall Study|Other|0|||
129978181|NCT01499303|467882648|FG001|Overall Study|Other|1|||
129978182|NCT04308590|467882655|FG000|Overall Study|Adverse Event|12|||
129978183|NCT04308590|467882656|FG001|Overall Study|Adverse Event|2|||
129978184|NCT04308590|467882655|FG000|Overall Study|Withdrawal by Subject|10|||
129978185|NCT04308590|467882656|FG001|Overall Study|Withdrawal by Subject|4|||
129978186|NCT04308590|467882655|FG000|Overall Study|Death|1|||
129978187|NCT04308590|467882656|FG001|Overall Study|Death|0|||
129978188|NCT04308590|467882655|FG000|Overall Study|Lost to Follow-up|1|||
129978189|NCT04308590|467882656|FG001|Overall Study|Lost to Follow-up|1|||
129978190|NCT04308590|467882655|FG000|Overall Study|Physician Decision|1|||
129978191|NCT04308590|467882656|FG001|Overall Study|Physician Decision|0|||
129978192|NCT04308590|467882655|FG000|Overall Study|Subject does not want to continue with Pi|0|||
129978193|NCT04308590|467882656|FG001|Overall Study|Subject does not want to continue with Pi|1|||
129978194|NCT03853551|467882657|FG000|Overall Study|Death|2|||
129978195|NCT03853551|467882657|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
129978196|NCT01401153|467882658|FG000|First Test Day|Learning disabilities; illness|1|||
129978197|NCT01401153|467882659|FG001|First Test Day|Learning disabilities; illness|10|||
129978198|NCT01401153|467882658|FG000|Second Test Day|illness|0|||
129978199|NCT01401153|467882659|FG001|Second Test Day|illness|5|||
129978200|NCT00214019|467882660|FG000|Overall Study|Lost to Follow-up|11|||
129978201|NCT00214019|467882660|FG000|Overall Study|Withdrawal by Subject|2|||
129978202|NCT00214019|467882660|FG000|Overall Study|Screen Failed prior to randomization|17|||
129978203|NCT03635099|467882663|FG000|Period 1|Adverse Event|1|||
129978204|NCT03635099|467882664|FG001|Period 1|Adverse Event|0|||
129978205|NCT03635099|467882665|FG002|Period 1|Adverse Event|0|||
129978206|NCT03635099|467882666|FG003|Period 1|Adverse Event|1|||
129978207|NCT03635099|467882667|FG004|Period 1|Adverse Event|0|||
129978208|NCT03635099|467882668|FG005|Period 1|Adverse Event|0|||
129978209|NCT03635099|467882669|FG006|Period 1|Adverse Event|0|||
129978210|NCT03635099|467882670|FG007|Period 1|Adverse Event|0|||
129978211|NCT03635099|467882663|FG000|Period 1|Protocol Violation|0|||
129978212|NCT03635099|467882664|FG001|Period 1|Protocol Violation|0|||
129978213|NCT03635099|467882665|FG002|Period 1|Protocol Violation|1|||
129978214|NCT03635099|467882666|FG003|Period 1|Protocol Violation|0|||
129978215|NCT03635099|467882667|FG004|Period 1|Protocol Violation|0|||
129978216|NCT03635099|467882668|FG005|Period 1|Protocol Violation|0|||
129978217|NCT03635099|467882669|FG006|Period 1|Protocol Violation|0|||
129978218|NCT03635099|467882670|FG007|Period 1|Protocol Violation|0|||
129978219|NCT03635099|467882663|FG000|Period 1|Lost to Follow-up|0|||
129978220|NCT03635099|467882664|FG001|Period 1|Lost to Follow-up|0|||
129978221|NCT03635099|467882665|FG002|Period 1|Lost to Follow-up|1|||
129978222|NCT03635099|467882666|FG003|Period 1|Lost to Follow-up|2|||
129978223|NCT03635099|467882667|FG004|Period 1|Lost to Follow-up|1|||
129978224|NCT03635099|467882668|FG005|Period 1|Lost to Follow-up|0|||
129978225|NCT03635099|467882669|FG006|Period 1|Lost to Follow-up|1|||
129978226|NCT03635099|467882670|FG007|Period 1|Lost to Follow-up|2|||
129978227|NCT03635099|467882663|FG000|Period 1|Withdrawal by Subject|3|||
129978228|NCT03635099|467882664|FG001|Period 1|Withdrawal by Subject|3|||
129978229|NCT03635099|467882665|FG002|Period 1|Withdrawal by Subject|5|||
129978230|NCT03635099|467882666|FG003|Period 1|Withdrawal by Subject|2|||
129978231|NCT03635099|467882667|FG004|Period 1|Withdrawal by Subject|2|||
129978232|NCT03635099|467882668|FG005|Period 1|Withdrawal by Subject|0|||
129978233|NCT03635099|467882669|FG006|Period 1|Withdrawal by Subject|3|||
129978234|NCT03635099|467882670|FG007|Period 1|Withdrawal by Subject|0|||
129978235|NCT03635099|467882663|FG000|Period 1|History of suicidal ideation|0|||
129978236|NCT03635099|467882664|FG001|Period 1|History of suicidal ideation|0|||
129978237|NCT03635099|467882665|FG002|Period 1|History of suicidal ideation|1|||
129978238|NCT03635099|467882666|FG003|Period 1|History of suicidal ideation|0|||
129978239|NCT03635099|467882667|FG004|Period 1|History of suicidal ideation|0|||
129978240|NCT03635099|467882668|FG005|Period 1|History of suicidal ideation|0|||
129978241|NCT03635099|467882669|FG006|Period 1|History of suicidal ideation|0|||
129978242|NCT03635099|467882670|FG007|Period 1|History of suicidal ideation|0|||
129978243|NCT03635099|467882663|FG000|Period 1|pursue other treatment options|0|||
129978244|NCT03635099|467882664|FG001|Period 1|pursue other treatment options|0|||
129978245|NCT03635099|467882665|FG002|Period 1|pursue other treatment options|0|||
129978246|NCT03635099|467882666|FG003|Period 1|pursue other treatment options|0|||
129978247|NCT03635099|467882667|FG004|Period 1|pursue other treatment options|0|||
129978248|NCT03635099|467882668|FG005|Period 1|pursue other treatment options|1|||
129978249|NCT03635099|467882669|FG006|Period 1|pursue other treatment options|0|||
129978250|NCT03635099|467882670|FG007|Period 1|pursue other treatment options|0|||
129978251|NCT03635099|467882663|FG000|Not Eligible for Period 2|Pregnancy|0|||
129978252|NCT03635099|467882664|FG001|Not Eligible for Period 2|Pregnancy|0|||
129978253|NCT03635099|467882665|FG002|Not Eligible for Period 2|Pregnancy|0|||
129978254|NCT03635099|467882666|FG003|Not Eligible for Period 2|Pregnancy|1|||
129978255|NCT03635099|467882667|FG004|Not Eligible for Period 2|Pregnancy|0|||
129978256|NCT03635099|467882668|FG005|Not Eligible for Period 2|Pregnancy|0|||
129978257|NCT03635099|467882669|FG006|Not Eligible for Period 2|Pregnancy|0|||
129978258|NCT03635099|467882670|FG007|Not Eligible for Period 2|Pregnancy|0|||
129978259|NCT03635099|467882663|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
129978260|NCT03635099|467882664|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978261|NCT03635099|467882665|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978262|NCT03635099|467882666|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978263|NCT03635099|467882667|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978264|NCT03635099|467882668|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978265|NCT03635099|467882669|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978266|NCT03635099|467882670|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
129978267|NCT03635099|467882663|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978268|NCT03635099|467882664|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978269|NCT03635099|467882665|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978270|NCT03635099|467882666|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978271|NCT03635099|467882667|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
129978272|NCT03635099|467882668|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
129978273|NCT03635099|467882669|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
129978274|NCT03635099|467882670|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
129978275|NCT03635099|467882663|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
129978276|NCT03635099|467882664|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
129978277|NCT03635099|467882665|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
129978278|NCT03635099|467882666|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
129978279|NCT03635099|467882667|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978280|NCT03635099|467882668|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978281|NCT03635099|467882669|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978282|NCT03635099|467882670|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
129978283|NCT03635099|467882663|FG000|Period 2|Adverse Event|0|||
129978284|NCT03635099|467882664|FG001|Period 2|Adverse Event|0|||
129978285|NCT03635099|467882665|FG002|Period 2|Adverse Event|1|||
129978286|NCT03635099|467882666|FG003|Period 2|Adverse Event|0|||
129978287|NCT03635099|467882667|FG004|Period 2|Adverse Event|1|||
129978288|NCT03635099|467882668|FG005|Period 2|Adverse Event|0|||
129978289|NCT03635099|467882669|FG006|Period 2|Adverse Event|0|||
129978290|NCT03635099|467882670|FG007|Period 2|Adverse Event|0|||
129978291|NCT03635099|467882663|FG000|Period 2|Lost to Follow-up|0|||
129978292|NCT03635099|467882664|FG001|Period 2|Lost to Follow-up|0|||
129978293|NCT03635099|467882665|FG002|Period 2|Lost to Follow-up|1|||
129978294|NCT03635099|467882666|FG003|Period 2|Lost to Follow-up|0|||
129978295|NCT03635099|467882667|FG004|Period 2|Lost to Follow-up|4|||
129978296|NCT03635099|467882668|FG005|Period 2|Lost to Follow-up|0|||
129978297|NCT03635099|467882669|FG006|Period 2|Lost to Follow-up|0|||
129978298|NCT03635099|467882670|FG007|Period 2|Lost to Follow-up|0|||
129978299|NCT03635099|467882663|FG000|Period 2|Withdrawal by Subject|0|||
129978300|NCT03635099|467882664|FG001|Period 2|Withdrawal by Subject|0|||
129978301|NCT03635099|467882665|FG002|Period 2|Withdrawal by Subject|7|||
129978302|NCT03635099|467882666|FG003|Period 2|Withdrawal by Subject|4|||
129978303|NCT03635099|467882667|FG004|Period 2|Withdrawal by Subject|7|||
129978304|NCT03635099|467882668|FG005|Period 2|Withdrawal by Subject|0|||
129978305|NCT03635099|467882669|FG006|Period 2|Withdrawal by Subject|0|||
129978306|NCT03635099|467882670|FG007|Period 2|Withdrawal by Subject|0|||
129978307|NCT04191616|467882673|FG000|Pre-assignment Period|Did not receive study treatment|2|||
129978308|NCT04191616|467882673|FG000|Treatment Period|Death|37|||
129978309|NCT04191616|467882673|FG000|Treatment Period|Sponsor decision|11|||
129978310|NCT04191616|467882673|FG000|Treatment Period|Withdrawal by Subject|4|||
129978311|NCT02180243|467882674|FG000|Overall Study|Withdrawal by Subject|12|||
129978312|NCT02180243|467882675|FG001|Overall Study|Withdrawal by Subject|12|||
129978313|NCT02180243|467882674|FG000|Overall Study|Lost to Follow-up|12|||
129978314|NCT02180243|467882675|FG001|Overall Study|Lost to Follow-up|2|||
129978315|NCT01840410|467882678|FG000|Overall Study|Physician Decision|1|||
129978316|NCT01840410|467882679|FG001|Overall Study|Physician Decision|2|||
129978317|NCT01840410|467882678|FG000|Overall Study|Pregnancy|1|||
129978318|NCT01840410|467882679|FG001|Overall Study|Pregnancy|0|||
129978319|NCT01840410|467882678|FG000|Overall Study|Protocol deviation|1|||
129978320|NCT01840410|467882679|FG001|Overall Study|Protocol deviation|0|||
129978321|NCT01840410|467882678|FG000|Overall Study|Lost to Follow-up|1|||
129978322|NCT01840410|467882679|FG001|Overall Study|Lost to Follow-up|0|||
129978323|NCT01840410|467882678|FG000|Overall Study|Withdrawal by Subject|2|||
129978324|NCT01840410|467882679|FG001|Overall Study|Withdrawal by Subject|1|||
129978325|NCT01840410|467882678|FG000|Overall Study|Adverse Event|1|||
129978326|NCT01840410|467882679|FG001|Overall Study|Adverse Event|1|||
129978327|NCT01217437|467882680|FG000|Overall Study|Adverse Event|0|||
129978328|NCT01217437|467882681|FG001|Overall Study|Adverse Event|8|||
129978329|NCT01217437|467882680|FG000|Overall Study|Death|5|||
129978330|NCT01217437|467882681|FG001|Overall Study|Death|0|||
129978331|NCT01217437|467882680|FG000|Overall Study|Lack of Efficacy|29|||
129978332|NCT01217437|467882681|FG001|Overall Study|Lack of Efficacy|25|||
129978333|NCT01217437|467882680|FG000|Overall Study|Physician Decision|8|||
129978334|NCT01217437|467882681|FG001|Overall Study|Physician Decision|5|||
129978335|NCT01217437|467882680|FG000|Overall Study|Withdrawal by Subject|0|||
129978336|NCT01217437|467882681|FG001|Overall Study|Withdrawal by Subject|2|||
129978337|NCT01217437|467882680|FG000|Overall Study|Ineligible|1|||
129978338|NCT01217437|467882681|FG001|Overall Study|Ineligible|1|||
129978339|NCT06748729|467882683|FG000|Overall Study|Withdrawal by Subject|1|||
129978340|NCT01283152|467883689|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
129978341|NCT01283152|467883690|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
129978342|NCT01283152|467883689|FG000|Overall Study|Refused HESA|1|||
129978343|NCT01283152|467883690|FG001|Overall Study|Refused HESA|0|||
129978344|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
129978345|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
129978346|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
129978347|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
129978348|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
129978349|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
129978350|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
129481473|NCT00506389|466054149|FG001|In-treatment Period|Lack of Efficacy|2|||
129978351|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
129978352|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
129978353|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
129978354|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
129978355|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
129978356|NCT04939701|467883699|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
129978357|NCT04939701|467883700|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
129978358|NCT04939701|467883701|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
129978359|NCT04939701|467883699|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
129978360|NCT04939701|467883700|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
129978361|NCT04939701|467883701|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
129481474|NCT00506389|466054150|FG002|In-treatment Period|Lack of Efficacy|0|||
129481475|NCT00506389|466054148|FG000|In-treatment Period|Adverse Event|11|||
129481476|NCT00506389|466054149|FG001|In-treatment Period|Adverse Event|5|||
129481477|NCT00506389|466054150|FG002|In-treatment Period|Adverse Event|2|||
129481478|NCT00506389|466054148|FG000|In-treatment Period|Randomized but not treated|4|||
129481479|NCT00506389|466054149|FG001|In-treatment Period|Randomized but not treated|1|||
129481480|NCT00506389|466054150|FG002|In-treatment Period|Randomized but not treated|1|||
129481481|NCT05224258|466054151|FG000|Overall Study|Withdrawal by Subject|1|||
129481482|NCT05224258|466054152|FG001|Overall Study|Withdrawal by Subject|1|||
129481483|NCT05224258|466054151|FG000|Overall Study|Physician Decision|1|||
129481484|NCT05224258|466054152|FG001|Overall Study|Physician Decision|1|||
129481485|NCT05224258|466054151|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129481486|NCT05224258|466054152|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129481487|NCT05224258|466054151|FG000|Overall Study|Study Product No Longer in Use|1|||
129481488|NCT05224258|466054152|FG001|Overall Study|Study Product No Longer in Use|0|||
129481489|NCT05224258|466054151|FG000|Overall Study|Adverse Event|0|||
129481490|NCT05224258|466054152|FG001|Overall Study|Adverse Event|1|||
129481491|NCT05224258|466054151|FG000|Overall Study|Protocol Deviation|0|||
129481492|NCT05224258|466054152|FG001|Overall Study|Protocol Deviation|1|||
129481493|NCT03895203|466054157|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
129481494|NCT03895203|466054158|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
129481495|NCT03895203|466054159|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
129481496|NCT03895203|466054160|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
129481497|NCT03895203|466054161|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
129481498|NCT03895203|466054162|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
129481499|NCT03895203|466054157|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
129481500|NCT03895203|466054158|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
129481501|NCT03895203|466054159|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
129481502|NCT03895203|466054160|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
129481503|NCT03895203|466054161|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
129481504|NCT03895203|466054162|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
129481505|NCT03895203|466054157|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
129481506|NCT03895203|466054158|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
129481507|NCT03895203|466054159|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
129481508|NCT03895203|466054160|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
129481509|NCT03895203|466054161|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
129481510|NCT03895203|466054162|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
129481511|NCT03895203|466054157|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
129481512|NCT03895203|466054158|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
129481513|NCT03895203|466054159|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
129481514|NCT03895203|466054160|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
129481515|NCT03895203|466054161|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
129481516|NCT03895203|466054162|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
129481517|NCT03895203|466054157|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
129481518|NCT03895203|466054158|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
129481519|NCT03895203|466054159|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
129481520|NCT03895203|466054160|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
129481521|NCT03895203|466054161|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
129481522|NCT03895203|466054162|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
129481523|NCT03895203|466054157|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
129481524|NCT03895203|466054158|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
129481525|NCT03895203|466054159|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
129481526|NCT03895203|466054160|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
129481527|NCT03895203|466054161|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
129481528|NCT03895203|466054162|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
129481529|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
129481530|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
129481531|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
129481532|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
129481533|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
129481534|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
129481535|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
129978362|NCT04939701|467883699|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
129481536|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
129481537|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
129481538|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
129481539|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
129481540|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
129481541|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
129481542|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
129481543|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
129481544|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
129481545|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
129481546|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
129481547|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
129481548|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
129481549|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
129481550|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
129481551|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
129481552|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
129481553|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
129481554|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
129481555|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
129481556|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
129481557|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
129481558|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
129481559|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
129481560|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
129481561|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
129481562|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
129481563|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
129481564|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
129481565|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
129481566|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
129481567|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
129481568|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
129481569|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
129481570|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
129481571|NCT03895203|466054157|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
129481572|NCT03895203|466054158|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
129481573|NCT03895203|466054159|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
129481574|NCT03895203|466054160|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
129481575|NCT03895203|466054161|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
129481576|NCT03895203|466054162|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
129481577|NCT00996840|466054163|FG000|Overall Study|Adverse Event|0|||
129481578|NCT00996840|466054164|FG001|Overall Study|Adverse Event|1|||
129481579|NCT00996840|466054165|FG002|Overall Study|Adverse Event|0|||
129481580|NCT00996840|466054166|FG003|Overall Study|Adverse Event|0|||
129481581|NCT00996840|466054167|FG004|Overall Study|Adverse Event|0|||
129481582|NCT00996840|466054163|FG000|Overall Study|Physician Decision|0|||
129481583|NCT00996840|466054164|FG001|Overall Study|Physician Decision|0|||
129481584|NCT00996840|466054165|FG002|Overall Study|Physician Decision|1|||
129481585|NCT00996840|466054166|FG003|Overall Study|Physician Decision|1|||
129481586|NCT00996840|466054167|FG004|Overall Study|Physician Decision|2|||
129481587|NCT00996840|466054163|FG000|Overall Study|Withdrawal by Subject|1|||
129481588|NCT00996840|466054164|FG001|Overall Study|Withdrawal by Subject|1|||
129481589|NCT00996840|466054165|FG002|Overall Study|Withdrawal by Subject|0|||
129481590|NCT00996840|466054166|FG003|Overall Study|Withdrawal by Subject|0|||
129481591|NCT00996840|466054167|FG004|Overall Study|Withdrawal by Subject|0|||
129481592|NCT04645797|466054168|FG000|Overall Study|Disease Progression|3|||
129481593|NCT04645797|466054169|FG001|Overall Study|Disease Progression|3|||
129481594|NCT04645797|466054170|FG002|Overall Study|Disease Progression|1|||
129481595|NCT04645797|466054171|FG003|Overall Study|Disease Progression|0|||
129481596|NCT04645797|466054172|FG004|Overall Study|Disease Progression|0|||
129481597|NCT04645797|466054173|FG005|Overall Study|Disease Progression|0|||
129978363|NCT04939701|467883700|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
129481598|NCT04645797|466054174|FG006|Overall Study|Disease Progression|0|||
129481599|NCT04645797|466054168|FG000|Overall Study|Death|3|||
129481600|NCT04645797|466054169|FG001|Overall Study|Death|1|||
129481601|NCT04645797|466054170|FG002|Overall Study|Death|0|||
129481602|NCT04645797|466054171|FG003|Overall Study|Death|0|||
129481603|NCT04645797|466054172|FG004|Overall Study|Death|0|||
129481604|NCT04645797|466054173|FG005|Overall Study|Death|0|||
129481605|NCT04645797|466054174|FG006|Overall Study|Death|0|||
129481606|NCT01485614|466054176|FG000|Randomization|Not Treated|1|||
129481607|NCT01485614|466054177|FG001|Randomization|Not Treated|0|||
129481608|NCT01485614|466054178|FG002|Randomization|Not Treated|0|||
129481609|NCT01485614|466054179|FG003|Randomization|Not Treated|0|||
129481610|NCT01485614|466054176|FG000|Weeks 0-20|Lost to Follow-up|2|||
129481611|NCT01485614|466054177|FG001|Weeks 0-20|Lost to Follow-up|0|||
129481612|NCT01485614|466054178|FG002|Weeks 0-20|Lost to Follow-up|0|||
129481613|NCT01485614|466054179|FG003|Weeks 0-20|Lost to Follow-up|0|||
129481614|NCT01485614|466054176|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
129481615|NCT01485614|466054177|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
129481616|NCT01485614|466054178|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
129481617|NCT01485614|466054179|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
129481618|NCT01485614|466054176|FG000|Weeks 0-20|Withdrawal by Subject|3|||
129481619|NCT01485614|466054177|FG001|Weeks 0-20|Withdrawal by Subject|2|||
129481620|NCT01485614|466054178|FG002|Weeks 0-20|Withdrawal by Subject|1|||
129481621|NCT01485614|466054179|FG003|Weeks 0-20|Withdrawal by Subject|0|||
129481622|NCT01485614|466054176|FG000|Weeks 20-54|Lost to Follow-up|4|||
129481623|NCT01485614|466054177|FG001|Weeks 20-54|Lost to Follow-up|3|||
129481624|NCT01485614|466054178|FG002|Weeks 20-54|Lost to Follow-up|1|||
129481625|NCT01485614|466054179|FG003|Weeks 20-54|Lost to Follow-up|0|||
129481626|NCT01485614|466054176|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
129481627|NCT01485614|466054177|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
129481628|NCT01485614|466054178|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
129481629|NCT01485614|466054179|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
129481630|NCT01485614|466054176|FG000|Weeks 20-54|Withdrawal by Subject|5|||
129481631|NCT01485614|466054177|FG001|Weeks 20-54|Withdrawal by Subject|3|||
129481632|NCT01485614|466054178|FG002|Weeks 20-54|Withdrawal by Subject|0|||
129481633|NCT01485614|466054179|FG003|Weeks 20-54|Withdrawal by Subject|0|||
129481634|NCT02210780|466054180|FG000|Overall Study|Adverse Event|0|||
129481635|NCT02210780|466054181|FG001|Overall Study|Adverse Event|5|||
129481636|NCT02210780|466054180|FG000|Overall Study|Lost to Follow-up|2|||
129481637|NCT02210780|466054181|FG001|Overall Study|Lost to Follow-up|1|||
129481638|NCT02210780|466054180|FG000|Overall Study|Withdrawal by Subject|1|||
129481639|NCT02210780|466054181|FG001|Overall Study|Withdrawal by Subject|1|||
129481640|NCT02210780|466054180|FG000|Overall Study|Physician Decision|1|||
129481641|NCT02210780|466054181|FG001|Overall Study|Physician Decision|0|||
129481642|NCT02210780|466054180|FG000|Overall Study|Protocol Violation|1|||
129481643|NCT02210780|466054181|FG001|Overall Study|Protocol Violation|0|||
129481644|NCT02210780|466054180|FG000|Overall Study|Other than specified above|0|||
129481645|NCT02210780|466054181|FG001|Overall Study|Other than specified above|1|||
129481646|NCT00049127|466054182|FG000|Overall Study|Withdrawal by Subject|0|||
129481647|NCT00049127|466054183|FG001|Overall Study|Withdrawal by Subject|0|||
129481648|NCT00049127|466054184|FG002|Overall Study|Withdrawal by Subject|1|||
129481649|NCT00049127|466054185|FG003|Overall Study|Withdrawal by Subject|0|||
129481650|NCT00049127|466054186|FG004|Overall Study|Withdrawal by Subject|0|||
129481651|NCT02582515|466054187|FG000|Overall Study|Withdrawal by Subject|0|||
129481652|NCT02582515|466054188|FG001|Overall Study|Withdrawal by Subject|1|||
129481653|NCT04927312|466054189|FG000|Overall Study|Adverse Event|1|||
129481654|NCT04927312|466054189|FG000|Overall Study|Death|1|||
129481655|NCT04927312|466054189|FG000|Overall Study|Withdrawal by Subject|1|||
129481656|NCT04927312|466054189|FG000|Overall Study|Other|1|||
129481657|NCT01122927|466054195|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
129481658|NCT01122927|466054196|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
129481659|NCT01122927|466054195|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
129481660|NCT01122927|466054196|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
129481661|NCT01122927|466054195|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
129481662|NCT01122927|466054196|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
129978364|NCT04939701|467883701|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
129978365|NCT02383940|467883702|FG000|Overall Study|Adverse Event|1|||
129978366|NCT02383940|467883703|FG001|Overall Study|Adverse Event|0|||
129978367|NCT02383940|467883702|FG000|Overall Study|Lost to Follow-up|2|||
129481663|NCT01122927|466054195|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
129481664|NCT01122927|466054196|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
129978368|NCT02383940|467883703|FG001|Overall Study|Lost to Follow-up|2|||
129481665|NCT01122927|466054195|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
129481666|NCT01122927|466054196|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
129481667|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
129481668|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
129481669|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
129481670|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
129481671|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
129481672|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
129481673|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
129481674|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
129481675|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
129481676|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
129481677|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
129481678|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
129481679|NCT01122927|466054195|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
129481680|NCT01122927|466054196|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
129481681|NCT00684814|466054197|FG000|Washout Period of 7 Days|Adverse Event|1|||
129481682|NCT00684814|466054198|FG001|Washout Period of 7 Days|Adverse Event|2|||
129481683|NCT00684814|466054197|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
129481684|NCT00684814|466054198|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
129481685|NCT00684814|466054197|FG000|Second Intervention|Adverse Event|1|||
129481686|NCT00684814|466054198|FG001|Second Intervention|Adverse Event|0|||
129481687|NCT01676961|466054201|FG000|Overall Study|Death|3|||
129481688|NCT01676961|466054201|FG000|Overall Study|Lost to Follow-up|1|||
129481689|NCT01676961|466054201|FG000|Overall Study|Withdrawal by Subject|1|||
129481690|NCT00117312|466054202|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
129481691|NCT00117312|466054203|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
129481692|NCT00117312|466054204|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
129481693|NCT00117312|466054205|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
129481694|NCT00117312|466054202|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
129481695|NCT00117312|466054203|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
129481696|NCT00117312|466054204|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
129481697|NCT00117312|466054205|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
129481698|NCT00117312|466054202|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
129481699|NCT00117312|466054203|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
129481700|NCT00117312|466054204|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
129481701|NCT00117312|466054205|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
129481702|NCT00117312|466054202|FG000|Overall Study|Other|0|||
129481703|NCT00117312|466054203|FG001|Overall Study|Other|1|||
129481704|NCT00117312|466054204|FG002|Overall Study|Other|3|||
129481705|NCT00117312|466054205|FG003|Overall Study|Other|1|||
129481706|NCT00117312|466054202|FG000|Overall Study|Patient choice|0|||
129481707|NCT00117312|466054203|FG001|Overall Study|Patient choice|0|||
129481708|NCT00117312|466054204|FG002|Overall Study|Patient choice|2|||
129481709|NCT00117312|466054205|FG003|Overall Study|Patient choice|1|||
129481710|NCT00117312|466054202|FG000|Overall Study|Adverse Event|0|||
129481711|NCT00117312|466054203|FG001|Overall Study|Adverse Event|2|||
129481712|NCT00117312|466054204|FG002|Overall Study|Adverse Event|0|||
129481713|NCT00117312|466054205|FG003|Overall Study|Adverse Event|0|||
129481714|NCT00117312|466054202|FG000|Overall Study|Protocol Violation|0|||
129481715|NCT00117312|466054203|FG001|Overall Study|Protocol Violation|1|||
129481716|NCT00117312|466054204|FG002|Overall Study|Protocol Violation|3|||
129481717|NCT00117312|466054205|FG003|Overall Study|Protocol Violation|0|||
129481718|NCT00117312|466054202|FG000|Overall Study|PSA decrease <=50%|0|||
129481719|NCT00117312|466054203|FG001|Overall Study|PSA decrease <=50%|2|||
129481720|NCT00117312|466054204|FG002|Overall Study|PSA decrease <=50%|2|||
129481721|NCT00117312|466054205|FG003|Overall Study|PSA decrease <=50%|4|||
129481722|NCT00117312|466054202|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
129481723|NCT00117312|466054203|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
129481724|NCT00117312|466054204|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
129481725|NCT00117312|466054205|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
129481726|NCT00117312|466054202|FG000|Overall Study|Hepatic abnormality|0|||
129481727|NCT00117312|466054203|FG001|Overall Study|Hepatic abnormality|1|||
129481728|NCT00117312|466054204|FG002|Overall Study|Hepatic abnormality|0|||
129481729|NCT00117312|466054205|FG003|Overall Study|Hepatic abnormality|1|||
129481730|NCT00117312|466054202|FG000|Overall Study|Withdrawal by Subject|0|||
129481731|NCT00117312|466054203|FG001|Overall Study|Withdrawal by Subject|2|||
129481732|NCT00117312|466054204|FG002|Overall Study|Withdrawal by Subject|0|||
129481733|NCT00117312|466054205|FG003|Overall Study|Withdrawal by Subject|0|||
129481734|NCT00195650|466054206|FG000|Overall Study|Adverse Event|194|||
129481735|NCT00195650|466054206|FG000|Overall Study|Lack of Efficacy|99|||
129481736|NCT00195650|466054206|FG000|Overall Study|Withdrawal by Subject|67|||
129481737|NCT00195650|466054206|FG000|Overall Study|Lost to Follow-up|44|||
129481738|NCT00195650|466054206|FG000|Overall Study|Death|23|||
129481739|NCT00195650|466054206|FG000|Overall Study|Protocol Violation|15|||
129481740|NCT00195650|466054206|FG000|Overall Study|Administrative reasons|83|||
129481741|NCT02371629|466054208|FG000|Overall Study|Patient decision|14|||
129481742|NCT02371629|466054209|FG001|Overall Study|Patient decision|10|||
129481743|NCT02371629|466054208|FG000|Overall Study|Adverse Event|8|||
129481744|NCT02371629|466054209|FG001|Overall Study|Adverse Event|8|||
129481745|NCT02371629|466054208|FG000|Overall Study|Physician Decision|2|||
129481746|NCT02371629|466054209|FG001|Overall Study|Physician Decision|3|||
129481747|NCT02371629|466054208|FG000|Overall Study|Death|1|||
129481748|NCT02371629|466054209|FG001|Overall Study|Death|1|||
129481749|NCT02371629|466054208|FG000|Overall Study|Noncompliance with study treatment|1|||
129481750|NCT02371629|466054209|FG001|Overall Study|Noncompliance with study treatment|0|||
129481751|NCT02371629|466054208|FG000|Overall Study|Lack of Efficacy|0|||
129481752|NCT02371629|466054209|FG001|Overall Study|Lack of Efficacy|2|||
129481753|NCT02371629|466054208|FG000|Overall Study|Protocol deviation|0|||
129481754|NCT02371629|466054209|FG001|Overall Study|Protocol deviation|1|||
129481755|NCT00201851|466054210|FG000|Overall Study|Lost to Follow-up|2|||
129481756|NCT00201851|466054211|FG001|Overall Study|Lost to Follow-up|1|||
129481757|NCT00201851|466054212|FG002|Overall Study|Lost to Follow-up|0|||
129481758|NCT00201851|466054210|FG000|Overall Study|Ineligible post enrollment|6|||
129481759|NCT00201851|466054211|FG001|Overall Study|Ineligible post enrollment|1|||
129481760|NCT00201851|466054212|FG002|Overall Study|Ineligible post enrollment|1|||
129481761|NCT02469246|466054213|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
129481762|NCT02469246|466054214|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
129481763|NCT02469246|466054213|FG000|Double-Blind Phase|Adverse Event|12|||
129481764|NCT02469246|466054214|FG001|Double-Blind Phase|Adverse Event|9|||
129481765|NCT02469246|466054213|FG000|Double-Blind Phase|Death|2|||
129481766|NCT02469246|466054214|FG001|Double-Blind Phase|Death|0|||
129481767|NCT02469246|466054213|FG000|Double-Blind Phase|Lack of Efficacy|2|||
129481768|NCT02469246|466054214|FG001|Double-Blind Phase|Lack of Efficacy|1|||
129481769|NCT02469246|466054213|FG000|Double-Blind Phase|Investigator's Discretion|8|||
129481770|NCT02469246|466054214|FG001|Double-Blind Phase|Investigator's Discretion|8|||
129481771|NCT02469246|466054213|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
129481772|NCT02469246|466054214|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
129481773|NCT02469246|466054213|FG000|Double-Blind Phase|Protocol Violation|1|||
129481774|NCT02469246|466054214|FG001|Double-Blind Phase|Protocol Violation|1|||
129481775|NCT02469246|466054213|FG000|Double-Blind Phase|Withdrew Consent|25|||
129481776|NCT02469246|466054214|FG001|Double-Blind Phase|Withdrew Consent|25|||
129481777|NCT02469246|466054213|FG000|Double-Blind Phase|Lost to Follow-up|9|||
129481778|NCT02469246|466054214|FG001|Double-Blind Phase|Lost to Follow-up|5|||
129481779|NCT00749203|466054218|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
129481780|NCT00749203|466054219|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
129481781|NCT00749203|466054218|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
129481782|NCT00749203|466054219|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
129481783|NCT00749203|466054218|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
129481784|NCT00749203|466054219|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
129481785|NCT00749203|466054218|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
129481786|NCT00749203|466054219|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
129481787|NCT00749203|466054218|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
129481788|NCT00749203|466054219|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
129481789|NCT00749203|466054218|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
129481790|NCT00749203|466054219|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
129481791|NCT02853760|466054220|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
129481792|NCT02853760|466054221|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
129481793|NCT02853760|466054222|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
129481794|NCT02853760|466054223|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
129481795|NCT02853760|466054224|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
129481796|NCT02853760|466054225|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
129481797|NCT01642212|466054226|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
129481798|NCT01642212|466054227|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
129481799|NCT01642212|466054228|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
129481800|NCT01642212|466054229|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
129481801|NCT01642212|466054230|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
129481802|NCT01642212|466054226|FG000|Double-blind Treatment|Other|0|||
129481803|NCT01642212|466054227|FG001|Double-blind Treatment|Other|2|||
129481804|NCT01642212|466054228|FG002|Double-blind Treatment|Other|1|||
129481805|NCT01642212|466054229|FG003|Double-blind Treatment|Other|0|||
129481806|NCT01642212|466054230|FG004|Double-blind Treatment|Other|0|||
129481807|NCT01642212|466054226|FG000|Double-blind Treatment|Non-compliance|0|||
129481808|NCT01642212|466054227|FG001|Double-blind Treatment|Non-compliance|1|||
129481809|NCT01642212|466054228|FG002|Double-blind Treatment|Non-compliance|0|||
129481810|NCT01642212|466054229|FG003|Double-blind Treatment|Non-compliance|0|||
129481811|NCT01642212|466054230|FG004|Double-blind Treatment|Non-compliance|0|||
129481812|NCT01642212|466054226|FG000|Double-blind Treatment|Adverse Event|0|||
129481813|NCT01642212|466054227|FG001|Double-blind Treatment|Adverse Event|0|||
129481814|NCT01642212|466054228|FG002|Double-blind Treatment|Adverse Event|1|||
129481815|NCT01642212|466054229|FG003|Double-blind Treatment|Adverse Event|0|||
129481816|NCT01642212|466054230|FG004|Double-blind Treatment|Adverse Event|0|||
129481817|NCT01642212|466054226|FG000|Open-label Extension|Adverse Event|0|||
129481818|NCT01642212|466054227|FG001|Open-label Extension|Adverse Event|0|||
129481819|NCT01642212|466054228|FG002|Open-label Extension|Adverse Event|0|||
129481820|NCT01642212|466054229|FG003|Open-label Extension|Adverse Event|3|||
129481821|NCT01642212|466054230|FG004|Open-label Extension|Adverse Event|0|||
129481822|NCT01642212|466054226|FG000|Open-label Extension|Sponsor Decision|0|||
129481823|NCT01642212|466054227|FG001|Open-label Extension|Sponsor Decision|0|||
129481824|NCT01642212|466054228|FG002|Open-label Extension|Sponsor Decision|0|||
129481825|NCT01642212|466054229|FG003|Open-label Extension|Sponsor Decision|7|||
129481826|NCT01642212|466054230|FG004|Open-label Extension|Sponsor Decision|4|||
129481827|NCT01642212|466054226|FG000|Open-label Extension|Consent Withdrawn|0|||
129481828|NCT01642212|466054227|FG001|Open-label Extension|Consent Withdrawn|0|||
129481829|NCT01642212|466054228|FG002|Open-label Extension|Consent Withdrawn|0|||
129481830|NCT01642212|466054229|FG003|Open-label Extension|Consent Withdrawn|0|||
129481831|NCT01642212|466054230|FG004|Open-label Extension|Consent Withdrawn|2|||
129481832|NCT01642212|466054226|FG000|Open-label Extension|Lost to Follow-up|0|||
129481833|NCT01642212|466054227|FG001|Open-label Extension|Lost to Follow-up|0|||
129481834|NCT01642212|466054228|FG002|Open-label Extension|Lost to Follow-up|0|||
129481835|NCT01642212|466054229|FG003|Open-label Extension|Lost to Follow-up|0|||
129481836|NCT01642212|466054230|FG004|Open-label Extension|Lost to Follow-up|1|||
129481837|NCT01642212|466054226|FG000|Open-label Extension|Other|0|||
129481838|NCT01642212|466054227|FG001|Open-label Extension|Other|0|||
129481839|NCT01642212|466054228|FG002|Open-label Extension|Other|0|||
129481840|NCT01642212|466054229|FG003|Open-label Extension|Other|0|||
129481841|NCT01642212|466054230|FG004|Open-label Extension|Other|1|||
129481842|NCT01243268|466054231|FG000|Overall Study|Lost to Follow-up|4|||
129481843|NCT01243268|466054231|FG000|Overall Study|Protocol Violation|51|||
129481844|NCT01243268|466054231|FG000|Overall Study|Deviation with contract date|7|||
129481845|NCT01243268|466054231|FG000|Overall Study|Duplicate subject|2|||
129481846|NCT00957853|466054232|FG000|Overall Study|Withdrawal by Subject|1|||
129481847|NCT00957853|466054233|FG001|Overall Study|Withdrawal by Subject|0|||
129481848|NCT00957853|466054234|FG002|Overall Study|Withdrawal by Subject|0|||
129481849|NCT00004980|466054235|FG000|Overall Study|Withdrawal by Subject|1|||
129481850|NCT00004980|466054236|FG001|Overall Study|Withdrawal by Subject|0|||
129481851|NCT00004980|466054235|FG000|Overall Study|memory difficulties|1|||
129481852|NCT00004980|466054236|FG001|Overall Study|memory difficulties|1|||
129481853|NCT00004980|466054235|FG000|Overall Study|Physician Decision|0|||
129481854|NCT00004980|466054236|FG001|Overall Study|Physician Decision|1|||
129481855|NCT03577990|466054237|FG000|Overall Study|Lost to Follow-up|4|||
129481856|NCT03577990|466054238|FG001|Overall Study|Lost to Follow-up|6|||
129481857|NCT03577990|466054237|FG000|Overall Study|Withdrawal by Subject|4|||
129481858|NCT03577990|466054238|FG001|Overall Study|Withdrawal by Subject|7|||
129481859|NCT04996797|466054243|FG000|Overall Study|Adverse Event|0|||
129481860|NCT04996797|466054244|FG001|Overall Study|Adverse Event|2|||
129481861|NCT04996797|466054245|FG002|Overall Study|Adverse Event|0|||
129481862|NCT04996797|466054246|FG003|Overall Study|Adverse Event|1|||
129481863|NCT04996797|466054243|FG000|Overall Study|Lack of Efficacy|0|||
129481864|NCT04996797|466054244|FG001|Overall Study|Lack of Efficacy|2|||
129481865|NCT04996797|466054245|FG002|Overall Study|Lack of Efficacy|0|||
129481866|NCT04996797|466054246|FG003|Overall Study|Lack of Efficacy|0|||
129481867|NCT04996797|466054243|FG000|Overall Study|Prohibited Medication|0|||
129481868|NCT04996797|466054244|FG001|Overall Study|Prohibited Medication|1|||
129481869|NCT04996797|466054245|FG002|Overall Study|Prohibited Medication|0|||
129481870|NCT04996797|466054246|FG003|Overall Study|Prohibited Medication|0|||
129481871|NCT04996797|466054243|FG000|Overall Study|Ongoing|68|||
129481872|NCT04996797|466054244|FG001|Overall Study|Ongoing|60|||
129481873|NCT04996797|466054245|FG002|Overall Study|Ongoing|22|||
129481874|NCT04996797|466054246|FG003|Overall Study|Ongoing|20|||
129481875|NCT04996797|466054243|FG000|Overall Study|Withdrawal by Subject|0|||
129481876|NCT04996797|466054244|FG001|Overall Study|Withdrawal by Subject|2|||
129481877|NCT04996797|466054245|FG002|Overall Study|Withdrawal by Subject|0|||
129481878|NCT04996797|466054246|FG003|Overall Study|Withdrawal by Subject|0|||
129481879|NCT02793544|466054247|FG000|Overall Study|Death|10|||
129481880|NCT02793544|466054248|FG001|Overall Study|Death|8|||
129481881|NCT02793544|466054247|FG000|Overall Study|Lost to Follow-up|2|||
129481882|NCT02793544|466054248|FG001|Overall Study|Lost to Follow-up|0|||
129481883|NCT02793544|466054247|FG000|Overall Study|Withdrawal by Subject|1|||
129481884|NCT02793544|466054248|FG001|Overall Study|Withdrawal by Subject|0|||
129481885|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
129481886|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
129481887|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
129481888|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
129481889|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
129481890|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
129481891|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
129481892|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
129481893|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
129481894|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
129481895|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
129481896|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
129481897|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
129481898|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
129481899|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
129481900|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
129481901|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
129481902|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
129481903|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
129481904|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
129481905|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
129481906|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
129481907|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
129481908|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
129481909|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
129481910|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
129481911|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
129481912|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
129481913|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
129481914|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
129481915|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
129481916|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
129481917|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
129481918|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
129481919|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
129481920|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
129481921|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
129481922|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
129481923|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
129481924|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
129481925|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
129481926|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
129481927|NCT00100048|466054251|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
129481928|NCT00100048|466054252|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
129481929|NCT00100048|466054253|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
129481930|NCT00100048|466054254|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
129481931|NCT00100048|466054255|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
129481932|NCT00100048|466054256|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
129481933|NCT01624142|466054257|FG000|Overall Study|Withdrawal by Subject|14|||
129481934|NCT01624142|466054258|FG001|Overall Study|Withdrawal by Subject|4|||
129481935|NCT01624142|466054257|FG000|Overall Study|Death|3|||
129481936|NCT01624142|466054258|FG001|Overall Study|Death|6|||
129481937|NCT01624142|466054257|FG000|Overall Study|Study Closure|12|||
129481938|NCT01624142|466054258|FG001|Overall Study|Study Closure|6|||
129481939|NCT01624142|466054257|FG000|Overall Study|Lost to Follow-up|2|||
129481940|NCT01624142|466054258|FG001|Overall Study|Lost to Follow-up|0|||
129481941|NCT01624142|466054257|FG000|Overall Study|Other|1|||
129481942|NCT01624142|466054258|FG001|Overall Study|Other|0|||
129481943|NCT01708057|466054264|FG000|Overall Study|Withdrawal due to study termination.|1|||
129481944|NCT01708057|466054265|FG001|Overall Study|Withdrawal due to study termination.|1|||
129481945|NCT01708057|466054266|FG002|Overall Study|Withdrawal due to study termination.|1|||
129481946|NCT04194944|466054269|FG000|Overall Study|Lost to Follow-up|3|||
129481947|NCT04194944|466054270|FG001|Overall Study|Lost to Follow-up|0|||
129481948|NCT04194944|466054269|FG000|Overall Study|Withdrawal by Subject|2|||
129481949|NCT04194944|466054270|FG001|Overall Study|Withdrawal by Subject|2|||
129481950|NCT04194944|466054269|FG000|Overall Study|On Treatment|93|||
129481951|NCT04194944|466054270|FG001|Overall Study|On Treatment|30|||
129481952|NCT03277196|466054277|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
129481953|NCT03277196|466054277|FG000|Overall Study|Lost to Follow-up|3|||
129481954|NCT03277196|466054277|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
129481955|NCT03277196|466054277|FG000|Overall Study|Other|2|||
129481956|NCT01821963|466056064|FG000|Overall Study|Adverse Event|1|||
129481957|NCT00783289|466056065|FG000|Overall Study|Protocol Violation|0|||
129481958|NCT00783289|466056066|FG001|Overall Study|Protocol Violation|1|||
129481959|NCT00783289|466056067|FG002|Overall Study|Protocol Violation|0|||
129481960|NCT00783289|466056068|FG003|Overall Study|Protocol Violation|0|||
129481961|NCT01896232|466056069|FG000|Overall Study|Death|6|||
129481962|NCT01896232|466056070|FG001|Overall Study|Death|10|||
129481963|NCT01896232|466056069|FG000|Overall Study|Withdrawal by Subject|32|||
129481964|NCT01896232|466056070|FG001|Overall Study|Withdrawal by Subject|31|||
129481965|NCT01896232|466056069|FG000|Overall Study|Sponsor Decision|2|||
129481966|NCT01896232|466056070|FG001|Overall Study|Sponsor Decision|0|||
129481967|NCT01896232|466056069|FG000|Overall Study|Lost to Follow-up|9|||
129481968|NCT01896232|466056070|FG001|Overall Study|Lost to Follow-up|12|||
129481969|NCT01324830|466056077|FG000|Overall Study|Progressive Disease|3|||
129481970|NCT01324830|466056078|FG001|Overall Study|Progressive Disease|2|||
129481971|NCT01324830|466056079|FG002|Overall Study|Progressive Disease|3|||
129481972|NCT01324830|466056080|FG003|Overall Study|Progressive Disease|3|||
129481973|NCT01324830|466056081|FG004|Overall Study|Progressive Disease|6|||
129481974|NCT01324830|466056082|FG005|Overall Study|Progressive Disease|6|||
129481975|NCT01324830|466056083|FG006|Overall Study|Progressive Disease|3|||
129481976|NCT01324830|466056084|FG007|Overall Study|Progressive Disease|3|||
129481977|NCT01324830|466056085|FG008|Overall Study|Progressive Disease|3|||
129481978|NCT01324830|466056086|FG009|Overall Study|Progressive Disease|6|||
129481979|NCT01324830|466056087|FG010|Overall Study|Progressive Disease|2|||
129481980|NCT01324830|466056088|FG011|Overall Study|Progressive Disease|1|||
129481981|NCT01324830|466056089|FG012|Overall Study|Progressive Disease|1|||
129481982|NCT01324830|466056090|FG013|Overall Study|Progressive Disease|1|||
129481983|NCT01324830|466056091|FG014|Overall Study|Progressive Disease|1|||
129481984|NCT01324830|466056092|FG015|Overall Study|Progressive Disease|3|||
129481985|NCT01324830|466056093|FG016|Overall Study|Progressive Disease|2|||
129481986|NCT01324830|466056094|FG017|Overall Study|Progressive Disease|3|||
129481987|NCT01324830|466056095|FG018|Overall Study|Progressive Disease|4|||
129481988|NCT01324830|466056077|FG000|Overall Study|Dose limiting toxicity|0|||
129481989|NCT01324830|466056078|FG001|Overall Study|Dose limiting toxicity|0|||
129481990|NCT01324830|466056079|FG002|Overall Study|Dose limiting toxicity|0|||
129481991|NCT01324830|466056080|FG003|Overall Study|Dose limiting toxicity|0|||
129481992|NCT01324830|466056081|FG004|Overall Study|Dose limiting toxicity|1|||
129481993|NCT01324830|466056082|FG005|Overall Study|Dose limiting toxicity|0|||
129481994|NCT01324830|466056083|FG006|Overall Study|Dose limiting toxicity|0|||
129481995|NCT01324830|466056084|FG007|Overall Study|Dose limiting toxicity|0|||
129481996|NCT01324830|466056085|FG008|Overall Study|Dose limiting toxicity|0|||
129481997|NCT01324830|466056086|FG009|Overall Study|Dose limiting toxicity|0|||
129481998|NCT01324830|466056087|FG010|Overall Study|Dose limiting toxicity|0|||
129481999|NCT01324830|466056088|FG011|Overall Study|Dose limiting toxicity|0|||
129482000|NCT01324830|466056089|FG012|Overall Study|Dose limiting toxicity|0|||
129482001|NCT01324830|466056090|FG013|Overall Study|Dose limiting toxicity|0|||
129482002|NCT01324830|466056091|FG014|Overall Study|Dose limiting toxicity|0|||
129482003|NCT01324830|466056092|FG015|Overall Study|Dose limiting toxicity|0|||
129482004|NCT01324830|466056093|FG016|Overall Study|Dose limiting toxicity|1|||
129482005|NCT01324830|466056094|FG017|Overall Study|Dose limiting toxicity|1|||
129482006|NCT01324830|466056095|FG018|Overall Study|Dose limiting toxicity|1|||
129482007|NCT01324830|466056077|FG000|Overall Study|Reason not mentioned above|0|||
129482008|NCT01324830|466056078|FG001|Overall Study|Reason not mentioned above|0|||
129482009|NCT01324830|466056079|FG002|Overall Study|Reason not mentioned above|0|||
129482010|NCT01324830|466056080|FG003|Overall Study|Reason not mentioned above|0|||
129482011|NCT01324830|466056081|FG004|Overall Study|Reason not mentioned above|0|||
129482012|NCT01324830|466056082|FG005|Overall Study|Reason not mentioned above|0|||
129482013|NCT01324830|466056083|FG006|Overall Study|Reason not mentioned above|0|||
129482014|NCT01324830|466056084|FG007|Overall Study|Reason not mentioned above|0|||
129482015|NCT01324830|466056085|FG008|Overall Study|Reason not mentioned above|0|||
129482016|NCT01324830|466056086|FG009|Overall Study|Reason not mentioned above|0|||
129482017|NCT01324830|466056087|FG010|Overall Study|Reason not mentioned above|0|||
129482018|NCT01324830|466056088|FG011|Overall Study|Reason not mentioned above|0|||
129482019|NCT01324830|466056089|FG012|Overall Study|Reason not mentioned above|0|||
129482020|NCT01324830|466056090|FG013|Overall Study|Reason not mentioned above|0|||
129482021|NCT01324830|466056091|FG014|Overall Study|Reason not mentioned above|0|||
129482022|NCT01324830|466056092|FG015|Overall Study|Reason not mentioned above|0|||
129482023|NCT01324830|466056093|FG016|Overall Study|Reason not mentioned above|0|||
129482024|NCT01324830|466056094|FG017|Overall Study|Reason not mentioned above|1|||
129482025|NCT01324830|466056095|FG018|Overall Study|Reason not mentioned above|0|||
129482026|NCT01324830|466056077|FG000|Overall Study|Adverse Event, serious fatal|0|||
129482027|NCT01324830|466056078|FG001|Overall Study|Adverse Event, serious fatal|1|||
129482028|NCT01324830|466056079|FG002|Overall Study|Adverse Event, serious fatal|0|||
129482029|NCT01324830|466056080|FG003|Overall Study|Adverse Event, serious fatal|0|||
129482030|NCT01324830|466056081|FG004|Overall Study|Adverse Event, serious fatal|0|||
129482031|NCT01324830|466056082|FG005|Overall Study|Adverse Event, serious fatal|0|||
129482032|NCT01324830|466056083|FG006|Overall Study|Adverse Event, serious fatal|0|||
129482033|NCT01324830|466056084|FG007|Overall Study|Adverse Event, serious fatal|0|||
129482034|NCT01324830|466056085|FG008|Overall Study|Adverse Event, serious fatal|0|||
129482035|NCT01324830|466056086|FG009|Overall Study|Adverse Event, serious fatal|0|||
129482036|NCT01324830|466056087|FG010|Overall Study|Adverse Event, serious fatal|0|||
129482037|NCT01324830|466056088|FG011|Overall Study|Adverse Event, serious fatal|0|||
129482038|NCT01324830|466056089|FG012|Overall Study|Adverse Event, serious fatal|0|||
129482039|NCT01324830|466056090|FG013|Overall Study|Adverse Event, serious fatal|0|||
129482040|NCT01324830|466056091|FG014|Overall Study|Adverse Event, serious fatal|0|||
129482041|NCT01324830|466056092|FG015|Overall Study|Adverse Event, serious fatal|0|||
129482042|NCT01324830|466056093|FG016|Overall Study|Adverse Event, serious fatal|0|||
129482043|NCT01324830|466056094|FG017|Overall Study|Adverse Event, serious fatal|0|||
129482044|NCT01324830|466056095|FG018|Overall Study|Adverse Event, serious fatal|0|||
129482045|NCT01324830|466056077|FG000|Overall Study|Adverse Event, non-fatal|0|||
129482046|NCT01324830|466056078|FG001|Overall Study|Adverse Event, non-fatal|0|||
129482047|NCT01324830|466056079|FG002|Overall Study|Adverse Event, non-fatal|0|||
129482048|NCT01324830|466056080|FG003|Overall Study|Adverse Event, non-fatal|0|||
129482049|NCT01324830|466056081|FG004|Overall Study|Adverse Event, non-fatal|0|||
129482050|NCT01324830|466056082|FG005|Overall Study|Adverse Event, non-fatal|0|||
129482051|NCT01324830|466056083|FG006|Overall Study|Adverse Event, non-fatal|0|||
129482052|NCT01324830|466056084|FG007|Overall Study|Adverse Event, non-fatal|0|||
129482053|NCT01324830|466056085|FG008|Overall Study|Adverse Event, non-fatal|2|||
129482054|NCT01324830|466056086|FG009|Overall Study|Adverse Event, non-fatal|0|||
129482055|NCT01324830|466056087|FG010|Overall Study|Adverse Event, non-fatal|1|||
129482056|NCT01324830|466056088|FG011|Overall Study|Adverse Event, non-fatal|0|||
129482057|NCT01324830|466056089|FG012|Overall Study|Adverse Event, non-fatal|0|||
129482058|NCT01324830|466056090|FG013|Overall Study|Adverse Event, non-fatal|0|||
129482059|NCT01324830|466056091|FG014|Overall Study|Adverse Event, non-fatal|0|||
129482060|NCT01324830|466056092|FG015|Overall Study|Adverse Event, non-fatal|0|||
129482061|NCT01324830|466056093|FG016|Overall Study|Adverse Event, non-fatal|0|||
129482062|NCT01324830|466056094|FG017|Overall Study|Adverse Event, non-fatal|1|||
129482063|NCT01324830|466056095|FG018|Overall Study|Adverse Event, non-fatal|0|||
129482064|NCT01324830|466056077|FG000|Overall Study|Withdrawal by Subject|0|||
129482065|NCT01324830|466056078|FG001|Overall Study|Withdrawal by Subject|0|||
129482066|NCT01324830|466056079|FG002|Overall Study|Withdrawal by Subject|0|||
129482067|NCT01324830|466056080|FG003|Overall Study|Withdrawal by Subject|0|||
129482068|NCT01324830|466056081|FG004|Overall Study|Withdrawal by Subject|0|||
129482069|NCT01324830|466056082|FG005|Overall Study|Withdrawal by Subject|1|||
129482070|NCT01324830|466056083|FG006|Overall Study|Withdrawal by Subject|0|||
129482071|NCT01324830|466056084|FG007|Overall Study|Withdrawal by Subject|0|||
129482072|NCT01324830|466056085|FG008|Overall Study|Withdrawal by Subject|0|||
129482073|NCT01324830|466056086|FG009|Overall Study|Withdrawal by Subject|0|||
129482074|NCT01324830|466056087|FG010|Overall Study|Withdrawal by Subject|1|||
129482075|NCT01324830|466056088|FG011|Overall Study|Withdrawal by Subject|0|||
129482076|NCT01324830|466056089|FG012|Overall Study|Withdrawal by Subject|0|||
129482077|NCT01324830|466056090|FG013|Overall Study|Withdrawal by Subject|0|||
129482078|NCT01324830|466056091|FG014|Overall Study|Withdrawal by Subject|0|||
129482079|NCT01324830|466056092|FG015|Overall Study|Withdrawal by Subject|0|||
129482080|NCT01324830|466056093|FG016|Overall Study|Withdrawal by Subject|0|||
129482081|NCT01324830|466056094|FG017|Overall Study|Withdrawal by Subject|0|||
129482082|NCT01324830|466056095|FG018|Overall Study|Withdrawal by Subject|1|||
129482083|NCT00942409|466056096|FG000|Overall Study|Lack of Efficacy|1|||
129482084|NCT00942409|466056096|FG000|Overall Study|study drug unavailable|2|||
129482085|NCT01503021|466056101|FG000|Overall Study|Adverse Event|7|||
129482086|NCT01503021|466056102|FG001|Overall Study|Adverse Event|6|||
129482087|NCT01503021|466056101|FG000|Overall Study|Death|0|||
129482088|NCT01503021|466056102|FG001|Overall Study|Death|2|||
129482089|NCT01503021|466056101|FG000|Overall Study|Lost to Follow-up|2|||
129482090|NCT01503021|466056102|FG001|Overall Study|Lost to Follow-up|0|||
129482091|NCT01503021|466056101|FG000|Overall Study|Physician Decision|3|||
129482092|NCT01503021|466056102|FG001|Overall Study|Physician Decision|0|||
129482093|NCT01503021|466056101|FG000|Overall Study|Protocol Violation|1|||
129482094|NCT01503021|466056102|FG001|Overall Study|Protocol Violation|3|||
129482095|NCT01503021|466056101|FG000|Overall Study|Withdrawal by Subject|9|||
129482096|NCT01503021|466056102|FG001|Overall Study|Withdrawal by Subject|8|||
129482097|NCT01503021|466056101|FG000|Overall Study|Moved, received transplant, etc.|5|||
129482098|NCT01503021|466056102|FG001|Overall Study|Moved, received transplant, etc.|7|||
129482099|NCT00817414|466056103|FG000|Overall Study|Adverse Event|1|||
129482100|NCT00817414|466056104|FG001|Overall Study|Adverse Event|1|||
129482101|NCT00817414|466056105|FG002|Overall Study|Adverse Event|1|||
129482102|NCT00817414|466056106|FG003|Overall Study|Adverse Event|0|||
129482103|NCT00817414|466056107|FG004|Overall Study|Adverse Event|0|||
129482104|NCT00817414|466056103|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
129482105|NCT00817414|466056104|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
129482106|NCT00817414|466056105|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
129482107|NCT00817414|466056106|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
129482108|NCT00817414|466056107|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
129482109|NCT00817414|466056103|FG000|Overall Study|Withdrawal by Subject|1|||
129482110|NCT00817414|466056104|FG001|Overall Study|Withdrawal by Subject|1|||
129482111|NCT00817414|466056105|FG002|Overall Study|Withdrawal by Subject|0|||
129482112|NCT00817414|466056106|FG003|Overall Study|Withdrawal by Subject|0|||
129482113|NCT00817414|466056107|FG004|Overall Study|Withdrawal by Subject|0|||
129482114|NCT00817414|466056103|FG000|Overall Study|Lost to Follow-up|0|||
129482115|NCT00817414|466056104|FG001|Overall Study|Lost to Follow-up|0|||
129482116|NCT00817414|466056105|FG002|Overall Study|Lost to Follow-up|1|||
129482117|NCT00817414|466056106|FG003|Overall Study|Lost to Follow-up|1|||
129482118|NCT00817414|466056107|FG004|Overall Study|Lost to Follow-up|1|||
129482119|NCT00817414|466056103|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
129482120|NCT00817414|466056104|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
129978369|NCT02383940|467883702|FG000|Overall Study|Physician Decision|2|||
129978370|NCT02383940|467883703|FG001|Overall Study|Physician Decision|0|||
129978371|NCT02383940|467883702|FG000|Overall Study|Withdrawal by Subject|1|||
129978372|NCT02383940|467883703|FG001|Overall Study|Withdrawal by Subject|1|||
129978373|NCT02383940|467883702|FG000|Overall Study|Randomized but not treated|2|||
129978374|NCT02383940|467883703|FG001|Overall Study|Randomized but not treated|0|||
129978375|NCT02383940|467883702|FG000|Overall Study|Other than specified above|1|||
129978376|NCT02383940|467883703|FG001|Overall Study|Other than specified above|0|||
129978377|NCT02672852|467883705|FG000|Part A1|Disease Worsening|1|||
129978378|NCT02672852|467883706|FG001|Part A1|Disease Worsening|0|||
129978379|NCT02672852|467883707|FG002|Part A1|Disease Worsening|0|||
129978380|NCT02672852|467883708|FG003|Part A1|Disease Worsening|0|||
129978381|NCT02672852|467883709|FG004|Part A1|Disease Worsening|0|||
129978382|NCT02672852|467883710|FG005|Part A1|Disease Worsening|0|||
129978383|NCT02672852|467883711|FG006|Part A1|Disease Worsening|0|||
129978384|NCT02672852|467883705|FG000|Part A1|Adverse Event|0|||
129978385|NCT02672852|467883706|FG001|Part A1|Adverse Event|1|||
129978386|NCT02672852|467883707|FG002|Part A1|Adverse Event|0|||
129978387|NCT02672852|467883708|FG003|Part A1|Adverse Event|0|||
129978388|NCT02672852|467883709|FG004|Part A1|Adverse Event|0|||
129978389|NCT02672852|467883710|FG005|Part A1|Adverse Event|0|||
129978390|NCT02672852|467883711|FG006|Part A1|Adverse Event|0|||
129978391|NCT02672852|467883705|FG000|Part A1|Lost to Follow-up|1|||
129978392|NCT02672852|467883706|FG001|Part A1|Lost to Follow-up|2|||
129978393|NCT02672852|467883707|FG002|Part A1|Lost to Follow-up|0|||
129978394|NCT02672852|467883708|FG003|Part A1|Lost to Follow-up|0|||
129978395|NCT02672852|467883709|FG004|Part A1|Lost to Follow-up|0|||
129978396|NCT02672852|467883710|FG005|Part A1|Lost to Follow-up|0|||
129978397|NCT02672852|467883711|FG006|Part A1|Lost to Follow-up|0|||
129978398|NCT02672852|467883705|FG000|Part A1|Withdrawal by Subject|1|||
129978399|NCT02672852|467883706|FG001|Part A1|Withdrawal by Subject|1|||
129978400|NCT02672852|467883707|FG002|Part A1|Withdrawal by Subject|0|||
129978401|NCT02672852|467883708|FG003|Part A1|Withdrawal by Subject|0|||
129978402|NCT02672852|467883709|FG004|Part A1|Withdrawal by Subject|0|||
129978403|NCT02672852|467883710|FG005|Part A1|Withdrawal by Subject|0|||
129978404|NCT02672852|467883711|FG006|Part A1|Withdrawal by Subject|0|||
129978405|NCT02672852|467883705|FG000|Part A2|Disease worsening|0|||
129978406|NCT02672852|467883706|FG001|Part A2|Disease worsening|0|||
129978407|NCT02672852|467883707|FG002|Part A2|Disease worsening|1|||
129482121|NCT00817414|466056105|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
129482122|NCT00817414|466056106|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
129482123|NCT00817414|466056107|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
129482124|NCT00817414|466056103|FG000|Overall Study|Protocol Violation|0|||
129482125|NCT00817414|466056104|FG001|Overall Study|Protocol Violation|0|||
129482126|NCT00817414|466056105|FG002|Overall Study|Protocol Violation|0|||
129482127|NCT00817414|466056106|FG003|Overall Study|Protocol Violation|0|||
129482128|NCT00817414|466056107|FG004|Overall Study|Protocol Violation|1|||
129482129|NCT00097539|466056108|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
129482130|NCT00097539|466056109|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
129482131|NCT00097539|466056110|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
129482132|NCT00097539|466056111|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
129482133|NCT00097539|466056112|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
129482134|NCT00097539|466056113|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
129482135|NCT00097539|466056114|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
129482136|NCT00097539|466056108|FG000|Overall Study|Withdrawal by Subject|925|||
129482137|NCT00097539|466056109|FG001|Overall Study|Withdrawal by Subject|323|||
129482138|NCT00097539|466056110|FG002|Overall Study|Withdrawal by Subject|346|||
129482139|NCT00097539|466056111|FG003|Overall Study|Withdrawal by Subject|217|||
129482140|NCT00097539|466056112|FG004|Overall Study|Withdrawal by Subject|68|||
129482141|NCT00097539|466056113|FG005|Overall Study|Withdrawal by Subject|229|||
129482142|NCT00097539|466056114|FG006|Overall Study|Withdrawal by Subject|3|||
129482143|NCT00097539|466056108|FG000|Overall Study|Participant Non-compliant|2140|||
129482144|NCT00097539|466056109|FG001|Overall Study|Participant Non-compliant|567|||
129978408|NCT02672852|467883708|FG003|Part A2|Disease worsening|0|||
129482145|NCT00097539|466056110|FG002|Overall Study|Participant Non-compliant|1067|||
129482146|NCT00097539|466056111|FG003|Overall Study|Participant Non-compliant|353|||
129978409|NCT02672852|467883709|FG004|Part A2|Disease worsening|0|||
129978410|NCT02672852|467883710|FG005|Part A2|Disease worsening|0|||
129978411|NCT02672852|467883711|FG006|Part A2|Disease worsening|0|||
129978412|NCT02672852|467883705|FG000|Part A2|Adverse Event|0|||
129978413|NCT02672852|467883706|FG001|Part A2|Adverse Event|0|||
129978414|NCT02672852|467883707|FG002|Part A2|Adverse Event|3|||
129978415|NCT02672852|467883708|FG003|Part A2|Adverse Event|0|||
129978416|NCT02672852|467883709|FG004|Part A2|Adverse Event|0|||
129978417|NCT02672852|467883710|FG005|Part A2|Adverse Event|0|||
129978418|NCT02672852|467883711|FG006|Part A2|Adverse Event|0|||
129978419|NCT02672852|467883705|FG000|Part A2|Lost to Follow-up|0|||
129978420|NCT02672852|467883706|FG001|Part A2|Lost to Follow-up|0|||
129978421|NCT02672852|467883707|FG002|Part A2|Lost to Follow-up|2|||
129978422|NCT02672852|467883708|FG003|Part A2|Lost to Follow-up|0|||
129978423|NCT02672852|467883709|FG004|Part A2|Lost to Follow-up|0|||
129978424|NCT02672852|467883710|FG005|Part A2|Lost to Follow-up|0|||
129978425|NCT02672852|467883711|FG006|Part A2|Lost to Follow-up|0|||
129978426|NCT02672852|467883705|FG000|Part A2|Withdrawal by Subject|0|||
129978427|NCT02672852|467883706|FG001|Part A2|Withdrawal by Subject|0|||
129978428|NCT02672852|467883707|FG002|Part A2|Withdrawal by Subject|1|||
129978429|NCT02672852|467883708|FG003|Part A2|Withdrawal by Subject|0|||
129978430|NCT02672852|467883709|FG004|Part A2|Withdrawal by Subject|0|||
129978431|NCT02672852|467883710|FG005|Part A2|Withdrawal by Subject|0|||
129978432|NCT02672852|467883711|FG006|Part A2|Withdrawal by Subject|0|||
129978433|NCT02672852|467883705|FG000|Part A2|Other|0|||
129978434|NCT02672852|467883706|FG001|Part A2|Other|0|||
129978435|NCT02672852|467883707|FG002|Part A2|Other|3|||
129978436|NCT02672852|467883708|FG003|Part A2|Other|0|||
129978437|NCT02672852|467883709|FG004|Part A2|Other|0|||
129978438|NCT02672852|467883710|FG005|Part A2|Other|0|||
129978439|NCT02672852|467883711|FG006|Part A2|Other|0|||
129978440|NCT02672852|467883705|FG000|Part A2|Not entered in Part B|0|||
129978441|NCT02672852|467883706|FG001|Part A2|Not entered in Part B|0|||
129978442|NCT02672852|467883707|FG002|Part A2|Not entered in Part B|0|||
129978443|NCT02672852|467883708|FG003|Part A2|Not entered in Part B|4|||
129978444|NCT02672852|467883709|FG004|Part A2|Not entered in Part B|0|||
129978445|NCT02672852|467883710|FG005|Part A2|Not entered in Part B|0|||
129978446|NCT02672852|467883711|FG006|Part A2|Not entered in Part B|0|||
129978447|NCT02672852|467883705|FG000|Part B|Disease worsening|0|||
129978448|NCT02672852|467883706|FG001|Part B|Disease worsening|0|||
129978449|NCT02672852|467883707|FG002|Part B|Disease worsening|0|||
129978450|NCT02672852|467883708|FG003|Part B|Disease worsening|0|||
129978451|NCT02672852|467883709|FG004|Part B|Disease worsening|1|||
129978452|NCT02672852|467883710|FG005|Part B|Disease worsening|0|||
129978453|NCT02672852|467883711|FG006|Part B|Disease worsening|1|||
129978454|NCT02672852|467883705|FG000|Part B|Worsening pre-existing condition|0|||
129978455|NCT02672852|467883706|FG001|Part B|Worsening pre-existing condition|0|||
129978456|NCT02672852|467883707|FG002|Part B|Worsening pre-existing condition|0|||
129978457|NCT02672852|467883708|FG003|Part B|Worsening pre-existing condition|0|||
129978458|NCT02672852|467883709|FG004|Part B|Worsening pre-existing condition|0|||
129978459|NCT02672852|467883710|FG005|Part B|Worsening pre-existing condition|1|||
129978460|NCT02672852|467883711|FG006|Part B|Worsening pre-existing condition|0|||
129978461|NCT02672852|467883705|FG000|Part B|Other adverse event|0|||
129978462|NCT02672852|467883706|FG001|Part B|Other adverse event|0|||
129978463|NCT02672852|467883707|FG002|Part B|Other adverse event|0|||
129978464|NCT02672852|467883708|FG003|Part B|Other adverse event|0|||
129978465|NCT02672852|467883709|FG004|Part B|Other adverse event|3|||
129978466|NCT02672852|467883710|FG005|Part B|Other adverse event|5|||
129978467|NCT02672852|467883711|FG006|Part B|Other adverse event|1|||
129978468|NCT02672852|467883705|FG000|Part B|Lost to Follow-up|0|||
129978469|NCT02672852|467883706|FG001|Part B|Lost to Follow-up|0|||
129978470|NCT02672852|467883707|FG002|Part B|Lost to Follow-up|0|||
129978471|NCT02672852|467883708|FG003|Part B|Lost to Follow-up|0|||
129978472|NCT02672852|467883709|FG004|Part B|Lost to Follow-up|3|||
129978473|NCT02672852|467883710|FG005|Part B|Lost to Follow-up|4|||
129978474|NCT02672852|467883711|FG006|Part B|Lost to Follow-up|1|||
129978475|NCT02672852|467883705|FG000|Part B|Withdrawal by Subject|0|||
129978476|NCT02672852|467883706|FG001|Part B|Withdrawal by Subject|0|||
129978477|NCT02672852|467883707|FG002|Part B|Withdrawal by Subject|0|||
129978478|NCT02672852|467883708|FG003|Part B|Withdrawal by Subject|0|||
129978479|NCT02672852|467883709|FG004|Part B|Withdrawal by Subject|5|||
129978480|NCT02672852|467883710|FG005|Part B|Withdrawal by Subject|0|||
129978481|NCT02672852|467883711|FG006|Part B|Withdrawal by Subject|7|||
129978482|NCT02672852|467883705|FG000|Part B|Other|0|||
129978483|NCT02672852|467883706|FG001|Part B|Other|0|||
129978484|NCT02672852|467883707|FG002|Part B|Other|0|||
129978485|NCT02672852|467883708|FG003|Part B|Other|0|||
129978486|NCT02672852|467883709|FG004|Part B|Other|4|||
129978487|NCT02672852|467883710|FG005|Part B|Other|1|||
129978488|NCT02672852|467883711|FG006|Part B|Other|2|||
129978489|NCT00702962|467883712|FG000|Overall Study|Progressive disease|0|||
129978490|NCT00702962|467883713|FG001|Overall Study|Progressive disease|1|||
129978491|NCT00702962|467883712|FG000|Overall Study|Hospitalized for other health disorder|1|||
129978492|NCT00702962|467883713|FG001|Overall Study|Hospitalized for other health disorder|0|||
129978493|NCT02175641|467883714|FG000|Overall Study|Death|3|||
129978494|NCT02175641|467883715|FG001|Overall Study|Death|4|||
129978495|NCT02175641|467883714|FG000|Overall Study|Lost to Follow-up|4|||
129978496|NCT02175641|467883715|FG001|Overall Study|Lost to Follow-up|4|||
129978497|NCT02175641|467883714|FG000|Overall Study|Withdrawal by Subject|7|||
129978498|NCT02175641|467883715|FG001|Overall Study|Withdrawal by Subject|4|||
129978499|NCT02175641|467883714|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
129978500|NCT02175641|467883715|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
129978501|NCT02175641|467883714|FG000|Overall Study|Developed Contraindicated Condition|8|||
129978502|NCT02175641|467883715|FG001|Overall Study|Developed Contraindicated Condition|0|||
129978503|NCT01923467|467883717|FG000|Overall Study|Lost to Follow-up|62|||
129978504|NCT01923467|467883717|FG000|Overall Study|Subject non-interest|479|||
129978505|NCT01876901|467883718|FG000|Overall Study|Protocol Violation|10|||
129978506|NCT01876901|467883719|FG001|Overall Study|Protocol Violation|2|||
129978507|NCT01876901|467883718|FG000|Overall Study|No or other surgical intervention|7|||
129482147|NCT00097539|466056112|FG004|Overall Study|Participant Non-compliant|136|||
129482148|NCT00097539|466056113|FG005|Overall Study|Participant Non-compliant|543|||
129482149|NCT00097539|466056114|FG006|Overall Study|Participant Non-compliant|18|||
129482150|NCT00097539|466056108|FG000|Overall Study|Lack of Efficacy|249|||
129482151|NCT00097539|466056109|FG001|Overall Study|Lack of Efficacy|122|||
129482152|NCT00097539|466056110|FG002|Overall Study|Lack of Efficacy|202|||
129482153|NCT00097539|466056111|FG003|Overall Study|Lack of Efficacy|105|||
129482154|NCT00097539|466056112|FG004|Overall Study|Lack of Efficacy|45|||
129482155|NCT00097539|466056113|FG005|Overall Study|Lack of Efficacy|228|||
129482156|NCT00097539|466056114|FG006|Overall Study|Lack of Efficacy|5|||
129482157|NCT00097539|466056108|FG000|Overall Study|Adverse Event|78|||
129482158|NCT00097539|466056109|FG001|Overall Study|Adverse Event|133|||
129482159|NCT00097539|466056110|FG002|Overall Study|Adverse Event|37|||
129482160|NCT00097539|466056111|FG003|Overall Study|Adverse Event|27|||
129482161|NCT00097539|466056112|FG004|Overall Study|Adverse Event|30|||
129482162|NCT00097539|466056113|FG005|Overall Study|Adverse Event|59|||
129482163|NCT00097539|466056114|FG006|Overall Study|Adverse Event|1|||
129482164|NCT00097539|466056108|FG000|Overall Study|Death|2|||
129482165|NCT00097539|466056109|FG001|Overall Study|Death|7|||
129482166|NCT00097539|466056110|FG002|Overall Study|Death|0|||
129482167|NCT00097539|466056111|FG003|Overall Study|Death|0|||
129482168|NCT00097539|466056112|FG004|Overall Study|Death|1|||
129482169|NCT00097539|466056113|FG005|Overall Study|Death|3|||
129482170|NCT00097539|466056114|FG006|Overall Study|Death|0|||
129482171|NCT00097539|466056108|FG000|Overall Study|Reasons Other Than Above|3602|||
129482172|NCT00097539|466056109|FG001|Overall Study|Reasons Other Than Above|1382|||
129482173|NCT00097539|466056110|FG002|Overall Study|Reasons Other Than Above|1757|||
129482174|NCT00097539|466056111|FG003|Overall Study|Reasons Other Than Above|692|||
129482175|NCT00097539|466056112|FG004|Overall Study|Reasons Other Than Above|361|||
129482176|NCT00097539|466056113|FG005|Overall Study|Reasons Other Than Above|1244|||
129482177|NCT00097539|466056114|FG006|Overall Study|Reasons Other Than Above|34|||
129482178|NCT00097539|466056108|FG000|Overall Study|Reason not Specified|111|||
129482179|NCT00097539|466056109|FG001|Overall Study|Reason not Specified|49|||
129482180|NCT00097539|466056110|FG002|Overall Study|Reason not Specified|53|||
129482181|NCT00097539|466056111|FG003|Overall Study|Reason not Specified|21|||
129482182|NCT00097539|466056112|FG004|Overall Study|Reason not Specified|11|||
129482183|NCT00097539|466056113|FG005|Overall Study|Reason not Specified|40|||
129482184|NCT00097539|466056114|FG006|Overall Study|Reason not Specified|2|||
129482185|NCT03812510|466056121|FG000|Overall Study|Lost to Follow-up|39|||
129482186|NCT03812510|466056121|FG000|Overall Study|Withdrawal by Subject|42|||
129482187|NCT03812510|466056121|FG000|Overall Study|Physician Decision|2|||
129482188|NCT03812510|466056121|FG000|Overall Study|Study Terminated by Sponsor|9|||
129482189|NCT03812510|466056121|FG000|Overall Study|Did Not Start Study Medication|55|||
129482190|NCT03812510|466056121|FG000|Overall Study|Adverse Event|5|||
129482191|NCT00768560|466056122|FG000|Intervention Set 1|Adverse Event|0|||
129482192|NCT00768560|466056123|FG001|Intervention Set 1|Adverse Event|1|||
129482193|NCT00768560|466056124|FG002|Intervention Set 1|Adverse Event|0|||
129978508|NCT01876901|467883719|FG001|Overall Study|No or other surgical intervention|5|||
129482194|NCT00768560|466056125|FG003|Intervention Set 1|Adverse Event|0|||
129482195|NCT00768560|466056126|FG004|Intervention Set 1|Adverse Event|0|||
129482196|NCT00768560|466056127|FG005|Intervention Set 1|Adverse Event|0|||
129978509|NCT01598662|467883720|FG000|Overall Study|Lost to Follow-up|10|||
129978510|NCT01598662|467883721|FG001|Overall Study|Lost to Follow-up|17|||
129978511|NCT01598662|467883720|FG000|Overall Study|Physician Decision|1|||
129482197|NCT01128387|466056128|FG000|Overall Study|Physician Decision|0|||
129482198|NCT01128387|466056129|FG001|Overall Study|Physician Decision|1|||
129482199|NCT02635204|466056130|FG000|Overall Study|Adverse Event|1|||
129978512|NCT01598662|467883721|FG001|Overall Study|Physician Decision|2|||
129482200|NCT02635204|466056131|FG001|Overall Study|Adverse Event|0|||
129482201|NCT02635204|466056130|FG000|Overall Study|Lost to Follow-up|1|||
129482202|NCT02635204|466056131|FG001|Overall Study|Lost to Follow-up|1|||
129482203|NCT01535235|466056133|FG000|Overall Study|Adverse Event|1|||
129482204|NCT01535235|466056134|FG001|Overall Study|Adverse Event|0|||
129482205|NCT00858832|466056135|FG000|Overall Study|became ineligible: delivered vaginally|1|||
129482206|NCT00858832|466056136|FG001|Overall Study|became ineligible: delivered vaginally|0|||
129482207|NCT00858832|466056135|FG000|Overall Study|Adverse Event|0|||
129482208|NCT00858832|466056136|FG001|Overall Study|Adverse Event|1|||
129482209|NCT00389207|466056137|FG000|Overall Study|Adverse Event|26|||
129482210|NCT00389207|466056138|FG001|Overall Study|Adverse Event|32|||
129482211|NCT00389207|466056139|FG002|Overall Study|Adverse Event|10|||
129482212|NCT00389207|466056137|FG000|Overall Study|Protocol Violation|3|||
129482213|NCT00389207|466056138|FG001|Overall Study|Protocol Violation|1|||
129482214|NCT00389207|466056139|FG002|Overall Study|Protocol Violation|4|||
129482215|NCT00389207|466056137|FG000|Overall Study|Lost to Follow-up|12|||
129482216|NCT00389207|466056138|FG001|Overall Study|Lost to Follow-up|9|||
129482217|NCT00389207|466056139|FG002|Overall Study|Lost to Follow-up|7|||
129482218|NCT00389207|466056137|FG000|Overall Study|Withdrawal by Subject|5|||
129482219|NCT00389207|466056138|FG001|Overall Study|Withdrawal by Subject|7|||
129482220|NCT00389207|466056139|FG002|Overall Study|Withdrawal by Subject|11|||
129482221|NCT00389207|466056137|FG000|Overall Study|Other|17|||
129482222|NCT00389207|466056138|FG001|Overall Study|Other|23|||
129482223|NCT00389207|466056139|FG002|Overall Study|Other|9|||
129482224|NCT03293680|466056144|FG000|Overall Study|Death|1|||
129482225|NCT03293680|466056144|FG000|Overall Study|Did not meet inclusion criteria|8|||
129482226|NCT02690701|466056147|FG000|Treatment Period 1|Adverse Event|2|||
129482227|NCT02690701|466056148|FG001|Treatment Period 1|Adverse Event|2|||
129482228|NCT02690701|466056147|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129482229|NCT02690701|466056148|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129482230|NCT02690701|466056147|FG000|Treatment Period 2|Adverse Event|2|||
129482231|NCT02690701|466056148|FG001|Treatment Period 2|Adverse Event|0|||
129482232|NCT02690701|466056147|FG000|Treatment Period 2|Lack of Efficacy|1|||
129482233|NCT02690701|466056148|FG001|Treatment Period 2|Lack of Efficacy|0|||
129482234|NCT02690701|466056147|FG000|Treatment Period 2|Lost to Follow-up|0|||
129482235|NCT02690701|466056148|FG001|Treatment Period 2|Lost to Follow-up|2|||
129482236|NCT02690701|466056147|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129482237|NCT02690701|466056148|FG001|Treatment Period 2|Withdrawal by Subject|2|||
129482238|NCT02690701|466056147|FG000|Treatment Period 2|Protocol Violation|0|||
129482239|NCT02690701|466056148|FG001|Treatment Period 2|Protocol Violation|1|||
129482240|NCT01309737|466056149|FG000|Week 0 to 16|Death|1|||
129482241|NCT01309737|466056150|FG001|Week 0 to 16|Death|0|||
129482242|NCT01309737|466056151|FG002|Week 0 to 16|Death|1|||
129482243|NCT01309737|466056152|FG003|Week 0 to 16|Death|0|||
129482244|NCT01309737|466056153|FG004|Week 0 to 16|Death|0|||
129482245|NCT01309737|466056149|FG000|Week 0 to 16|Adverse Event|11|||
129482246|NCT01309737|466056150|FG001|Week 0 to 16|Adverse Event|10|||
129482247|NCT01309737|466056151|FG002|Week 0 to 16|Adverse Event|5|||
129482248|NCT01309737|466056152|FG003|Week 0 to 16|Adverse Event|0|||
129482249|NCT01309737|466056153|FG004|Week 0 to 16|Adverse Event|0|||
129482250|NCT01309737|466056149|FG000|Week 0 to 16|Lack of Efficacy|15|||
129482251|NCT01309737|466056150|FG001|Week 0 to 16|Lack of Efficacy|2|||
129482252|NCT01309737|466056151|FG002|Week 0 to 16|Lack of Efficacy|24|||
129482253|NCT01309737|466056152|FG003|Week 0 to 16|Lack of Efficacy|0|||
129482254|NCT01309737|466056153|FG004|Week 0 to 16|Lack of Efficacy|0|||
129482255|NCT01309737|466056149|FG000|Week 0 to 16|Lost to Follow-up|7|||
129482256|NCT01309737|466056150|FG001|Week 0 to 16|Lost to Follow-up|8|||
129482257|NCT01309737|466056151|FG002|Week 0 to 16|Lost to Follow-up|3|||
129482258|NCT01309737|466056152|FG003|Week 0 to 16|Lost to Follow-up|0|||
129482259|NCT01309737|466056153|FG004|Week 0 to 16|Lost to Follow-up|0|||
129482260|NCT01309737|466056149|FG000|Week 0 to 16|Withdrawal by Subject|7|||
129482261|NCT01309737|466056150|FG001|Week 0 to 16|Withdrawal by Subject|6|||
129482262|NCT01309737|466056151|FG002|Week 0 to 16|Withdrawal by Subject|7|||
129482263|NCT01309737|466056152|FG003|Week 0 to 16|Withdrawal by Subject|0|||
129482264|NCT01309737|466056153|FG004|Week 0 to 16|Withdrawal by Subject|0|||
129482265|NCT01309737|466056149|FG000|Week 0 to 16|Other|10|||
129482266|NCT01309737|466056150|FG001|Week 0 to 16|Other|14|||
129482267|NCT01309737|466056151|FG002|Week 0 to 16|Other|4|||
129482268|NCT01309737|466056152|FG003|Week 0 to 16|Other|0|||
129482269|NCT01309737|466056153|FG004|Week 0 to 16|Other|0|||
129482270|NCT01309737|466056149|FG000|Week 0 to 16|Randomized, but not treated|1|||
129482271|NCT01309737|466056150|FG001|Week 0 to 16|Randomized, but not treated|0|||
129482272|NCT01309737|466056151|FG002|Week 0 to 16|Randomized, but not treated|0|||
129482273|NCT01309737|466056152|FG003|Week 0 to 16|Randomized, but not treated|0|||
129482274|NCT01309737|466056153|FG004|Week 0 to 16|Randomized, but not treated|0|||
129482275|NCT01309737|466056149|FG000|Week 16 to 52|Death|0|||
129482276|NCT01309737|466056150|FG001|Week 16 to 52|Death|0|||
129482277|NCT01309737|466056151|FG002|Week 16 to 52|Death|0|||
129482278|NCT01309737|466056152|FG003|Week 16 to 52|Death|0|||
129482279|NCT01309737|466056153|FG004|Week 16 to 52|Death|1|||
129482280|NCT01309737|466056149|FG000|Week 16 to 52|Adverse Event|7|||
129482281|NCT01309737|466056150|FG001|Week 16 to 52|Adverse Event|7|||
129482282|NCT01309737|466056151|FG002|Week 16 to 52|Adverse Event|0|||
129482283|NCT01309737|466056152|FG003|Week 16 to 52|Adverse Event|6|||
129482284|NCT01309737|466056153|FG004|Week 16 to 52|Adverse Event|5|||
129482285|NCT01309737|466056149|FG000|Week 16 to 52|Lack of Efficacy|107|||
129482286|NCT01309737|466056150|FG001|Week 16 to 52|Lack of Efficacy|76|||
129482287|NCT01309737|466056151|FG002|Week 16 to 52|Lack of Efficacy|0|||
129482288|NCT01309737|466056152|FG003|Week 16 to 52|Lack of Efficacy|25|||
129482289|NCT01309737|466056153|FG004|Week 16 to 52|Lack of Efficacy|21|||
129482290|NCT01309737|466056149|FG000|Week 16 to 52|Lost to Follow-up|4|||
129482291|NCT01309737|466056150|FG001|Week 16 to 52|Lost to Follow-up|2|||
129482292|NCT01309737|466056151|FG002|Week 16 to 52|Lost to Follow-up|0|||
129482293|NCT01309737|466056152|FG003|Week 16 to 52|Lost to Follow-up|1|||
129482294|NCT01309737|466056153|FG004|Week 16 to 52|Lost to Follow-up|4|||
129482295|NCT01309737|466056149|FG000|Week 16 to 52|Withdrawal by Subject|5|||
129482296|NCT01309737|466056150|FG001|Week 16 to 52|Withdrawal by Subject|6|||
129482297|NCT01309737|466056151|FG002|Week 16 to 52|Withdrawal by Subject|0|||
129482298|NCT01309737|466056152|FG003|Week 16 to 52|Withdrawal by Subject|0|||
129482299|NCT01309737|466056153|FG004|Week 16 to 52|Withdrawal by Subject|2|||
129482300|NCT01309737|466056149|FG000|Week 16 to 52|Other|10|||
129482301|NCT01309737|466056150|FG001|Week 16 to 52|Other|12|||
129482302|NCT01309737|466056151|FG002|Week 16 to 52|Other|0|||
129482303|NCT01309737|466056152|FG003|Week 16 to 52|Other|2|||
129482304|NCT01309737|466056153|FG004|Week 16 to 52|Other|0|||
129482305|NCT01442181|466056154|FG000|Overall Study|patient refused surgery|1|||
129482306|NCT01442181|466056155|FG001|Overall Study|patient refused surgery|0|||
129482307|NCT01442181|466056154|FG000|Overall Study|no insurance for surgery|1|||
129482308|NCT01442181|466056155|FG001|Overall Study|no insurance for surgery|0|||
129482309|NCT01442181|466056154|FG000|Overall Study|low ejection factor|0|||
129482310|NCT01442181|466056155|FG001|Overall Study|low ejection factor|1|||
129482311|NCT01442181|466056154|FG000|Overall Study|Lost to Follow-up|1|||
129482312|NCT01442181|466056155|FG001|Overall Study|Lost to Follow-up|1|||
129482313|NCT01442181|466056154|FG000|Overall Study|patient in an additional study|1|||
129482314|NCT01442181|466056155|FG001|Overall Study|patient in an additional study|0|||
129482315|NCT01442181|466056154|FG000|Overall Study|atrial fibrillation not noted|0|||
129482316|NCT01442181|466056155|FG001|Overall Study|atrial fibrillation not noted|1|||
129482317|NCT00709202|466056156|FG000|Overall Study|Withdrawal by Subject|6|||
129482318|NCT00709202|466056157|FG001|Overall Study|Withdrawal by Subject|6|||
129482319|NCT01822561|466056159|FG000|Overall Study|Withdrawal by Subject|2|||
129482320|NCT02597062|466056160|FG000|Overall Study|Ineligible|1|||
129482321|NCT00947349|466056161|FG000|Triple Treatment Combination Period|Adverse Event|0|||
129482322|NCT00947349|466056162|FG001|Triple Treatment Combination Period|Adverse Event|1|||
129482323|NCT00947349|466056163|FG002|Triple Treatment Combination Period|Adverse Event|0|||
129482324|NCT00947349|466056164|FG003|Triple Treatment Combination Period|Adverse Event|0|||
129482325|NCT00947349|466056161|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
129482326|NCT00947349|466056162|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
129482327|NCT00947349|466056163|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
129482328|NCT00947349|466056164|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
129482329|NCT00947349|466056161|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
129482330|NCT00947349|466056162|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
129482331|NCT00947349|466056163|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
129482332|NCT00947349|466056164|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
129482333|NCT00947349|466056161|FG000|Overall Study Standard of Care|Other|0|||
129482334|NCT00947349|466056162|FG001|Overall Study Standard of Care|Other|0|||
129482335|NCT00947349|466056163|FG002|Overall Study Standard of Care|Other|0|||
129482336|NCT00947349|466056164|FG003|Overall Study Standard of Care|Other|1|||
129482337|NCT00538681|466056165|FG000|Overall Study|Progressive Disease|7|||
129482338|NCT00538681|466056166|FG001|Overall Study|Progressive Disease|0|||
129482339|NCT00538681|466056167|FG002|Overall Study|Progressive Disease|1|||
129482340|NCT00538681|466056168|FG003|Overall Study|Progressive Disease|0|||
129482341|NCT00538681|466056165|FG000|Overall Study|Sponsor Decision|1|||
129482342|NCT00538681|466056166|FG001|Overall Study|Sponsor Decision|3|||
129482343|NCT00538681|466056167|FG002|Overall Study|Sponsor Decision|8|||
129482344|NCT00538681|466056168|FG003|Overall Study|Sponsor Decision|9|||
129482345|NCT00538681|466056165|FG000|Overall Study|Adverse Event|1|||
129482346|NCT00538681|466056166|FG001|Overall Study|Adverse Event|1|||
129482347|NCT00538681|466056167|FG002|Overall Study|Adverse Event|1|||
129482348|NCT00538681|466056168|FG003|Overall Study|Adverse Event|0|||
129482349|NCT00538681|466056165|FG000|Overall Study|Death|0|||
129482350|NCT00538681|466056166|FG001|Overall Study|Death|0|||
129482351|NCT00538681|466056167|FG002|Overall Study|Death|1|||
129482352|NCT00538681|466056168|FG003|Overall Study|Death|1|||
129482353|NCT00538681|466056165|FG000|Overall Study|Investigator Decision|0|||
129482354|NCT00538681|466056166|FG001|Overall Study|Investigator Decision|0|||
129482355|NCT00538681|466056167|FG002|Overall Study|Investigator Decision|0|||
129482356|NCT00538681|466056168|FG003|Overall Study|Investigator Decision|1|||
129482357|NCT02970929|466056169|FG000|Overall Study|Adverse Event|18|||
129482358|NCT02970929|466056169|FG000|Overall Study|Lack of Efficacy|8|||
129482359|NCT02970929|466056169|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
129482360|NCT02970929|466056169|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
129482361|NCT02970929|466056169|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
129482362|NCT02970929|466056169|FG000|Overall Study|LOST TO FOLLOWUP|6|||
129482363|NCT02970929|466056169|FG000|Overall Study|MOVED OUT OF STATE|1|||
129482364|NCT02970929|466056169|FG000|Overall Study|Withdrawal by Subject|16|||
129482365|NCT05369806|466056172|FG000|Overall Study|Lost to Follow-up|1|||
129482366|NCT00140855|466056173|FG000|Overall Study|Progressive disease|2|||
129482367|NCT03929250|466056181|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
129482368|NCT03929250|466056182|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
129482369|NCT05262764|466056187|FG000|Overall Study|Case report form not collected|9|||
129482370|NCT05262764|466056187|FG000|Overall Study|No patient visits after entry|23|||
129482371|NCT05262764|466056187|FG000|Overall Study|Registration rule not followed|2|||
129482372|NCT05262764|466056187|FG000|Overall Study|Patient of non-chronic heart failure|1|||
129482373|NCT01392183|466056188|FG000|First Drug Administration|Adverse Event|3|||
129482374|NCT01392183|466056189|FG001|First Drug Administration|Adverse Event|2|||
129482375|NCT01392183|466056188|FG000|First Drug Administration|Death|1|||
129482376|NCT01392183|466056189|FG001|First Drug Administration|Death|0|||
129482377|NCT01392183|466056188|FG000|First Drug Administration|Withdrawal by Subject|10|||
129482378|NCT01392183|466056189|FG001|First Drug Administration|Withdrawal by Subject|17|||
129482379|NCT04321343|466056190|FG000|Overall Study|Adverse Event|0|||
129482380|NCT04321343|466056191|FG001|Overall Study|Adverse Event|0|||
129482381|NCT04321343|466056192|FG002|Overall Study|Adverse Event|1|||
129482382|NCT04321343|466056193|FG003|Overall Study|Adverse Event|0|||
129482383|NCT04321343|466056190|FG000|Overall Study|Death|0|||
129482384|NCT04321343|466056191|FG001|Overall Study|Death|0|||
129482385|NCT04321343|466056192|FG002|Overall Study|Death|0|||
129482386|NCT04321343|466056193|FG003|Overall Study|Death|1|||
129482387|NCT04321343|466056190|FG000|Overall Study|Pregnancy|1|||
129482388|NCT04321343|466056191|FG001|Overall Study|Pregnancy|0|||
129482389|NCT04321343|466056192|FG002|Overall Study|Pregnancy|0|||
129482390|NCT04321343|466056193|FG003|Overall Study|Pregnancy|0|||
129482391|NCT04321343|466056190|FG000|Overall Study|Protocol Violation|1|||
129482392|NCT04321343|466056191|FG001|Overall Study|Protocol Violation|1|||
129482393|NCT04321343|466056192|FG002|Overall Study|Protocol Violation|1|||
129482394|NCT04321343|466056193|FG003|Overall Study|Protocol Violation|1|||
129482395|NCT04321343|466056190|FG000|Overall Study|Withdrawal by Subject|0|||
129482396|NCT04321343|466056191|FG001|Overall Study|Withdrawal by Subject|6|||
129482397|NCT04321343|466056192|FG002|Overall Study|Withdrawal by Subject|0|||
129482398|NCT04321343|466056193|FG003|Overall Study|Withdrawal by Subject|2|||
129482399|NCT04321343|466056190|FG000|Overall Study|Lost to Follow-up|2|||
129482400|NCT04321343|466056191|FG001|Overall Study|Lost to Follow-up|2|||
129482401|NCT04321343|466056192|FG002|Overall Study|Lost to Follow-up|1|||
129482402|NCT04321343|466056193|FG003|Overall Study|Lost to Follow-up|3|||
129482403|NCT03430310|466056194|FG000|Overall Study|Protocol Violation|2|||
129482404|NCT03430310|466056195|FG001|Overall Study|Protocol Violation|0|||
129482405|NCT03430310|466056194|FG000|Overall Study|Withdrawal by Subject|3|||
129482406|NCT03430310|466056195|FG001|Overall Study|Withdrawal by Subject|2|||
129482407|NCT03430310|466056194|FG000|Overall Study|COVID shutdown March 2020|0|||
129482408|NCT03430310|466056195|FG001|Overall Study|COVID shutdown March 2020|1|||
129482409|NCT03476239|466056197|FG000|Overall Study|Withdrawal by Subject|10|||
129482410|NCT03476239|466056197|FG000|Overall Study|Death|80|||
129482411|NCT03476239|466056197|FG000|Overall Study|Lost to Follow-up|8|||
129482412|NCT01446809|466056201|FG000|Overall Study|Adverse Event|0|||
129482413|NCT01446809|466056202|FG001|Overall Study|Adverse Event|0|||
129482414|NCT01446809|466056203|FG002|Overall Study|Adverse Event|1|||
129482415|NCT01446809|466056201|FG000|Overall Study|Failure to complete study procedures|0|||
129482416|NCT01446809|466056202|FG001|Overall Study|Failure to complete study procedures|0|||
129482417|NCT01446809|466056203|FG002|Overall Study|Failure to complete study procedures|1|||
129482418|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
129482419|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
129482420|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
129482421|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
129482422|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
129482423|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
129482424|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
129482425|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
129482426|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
129482427|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
129482428|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
129482429|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
129482430|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
129482431|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
129482432|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
129482433|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
129482434|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
129482435|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
129482436|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
129482437|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
129482438|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
129482439|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
129482440|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
129482441|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
129482442|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
129482443|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
129482444|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
129482445|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
129482446|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
129482447|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
129482448|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
129482449|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
129482450|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
129482451|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
129482452|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
129482453|NCT00785577|466056204|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
129482454|NCT00785577|466056205|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
129482455|NCT00785577|466056206|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
129482456|NCT00785577|466056207|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
129482457|NCT00785577|466056208|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
129482458|NCT00785577|466056204|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
129482459|NCT00785577|466056205|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
129482460|NCT00785577|466056206|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
129482461|NCT00785577|466056207|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
129482462|NCT00785577|466056208|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
129482463|NCT00785577|466056204|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
129482464|NCT00785577|466056205|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
129482465|NCT00785577|466056206|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
129482466|NCT00785577|466056207|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
129482467|NCT00785577|466056208|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
129482468|NCT01097044|466056209|FG000|Overall Study|Withdrawal by Subject|4|||
129482469|NCT01097044|466056210|FG001|Overall Study|Withdrawal by Subject|4|||
129482470|NCT01097044|466056209|FG000|Overall Study|Lost to Follow-up|1|||
129482471|NCT01097044|466056210|FG001|Overall Study|Lost to Follow-up|0|||
129482472|NCT01097044|466056209|FG000|Overall Study|Withdrawal by Sponsor|0|||
129482473|NCT01097044|466056210|FG001|Overall Study|Withdrawal by Sponsor|1|||
129482474|NCT01331161|466056211|FG000|Overall Study|Physician Decision|1|||
129482475|NCT01331161|466056212|FG001|Overall Study|Physician Decision|0|||
129482476|NCT01331161|466056211|FG000|Overall Study|Lost to Follow-up|0|||
129482477|NCT01331161|466056212|FG001|Overall Study|Lost to Follow-up|1|||
129482478|NCT01331161|466056211|FG000|Overall Study|Pregnancy|0|||
129482479|NCT01331161|466056212|FG001|Overall Study|Pregnancy|1|||
129482480|NCT01682044|466056213|FG000|Overall Study|Death|1|||
129482481|NCT01682044|466056213|FG000|Overall Study|Progression|3|||
129482482|NCT01826214|466057681|FG000|Overall Study|Adverse Event|7|||
129482483|NCT01826214|466057682|FG001|Overall Study|Adverse Event|6|||
129482484|NCT01826214|466057681|FG000|Overall Study|Death|3|||
129482485|NCT01826214|466057682|FG001|Overall Study|Death|1|||
129482486|NCT01826214|466057681|FG000|Overall Study|Lost to Follow-up|1|||
129482487|NCT01826214|466057682|FG001|Overall Study|Lost to Follow-up|0|||
129482488|NCT01826214|466057681|FG000|Overall Study|Physician Decision|0|||
129482489|NCT01826214|466057682|FG001|Overall Study|Physician Decision|2|||
129482490|NCT01826214|466057681|FG000|Overall Study|Progressive disease|22|||
129482491|NCT01826214|466057682|FG001|Overall Study|Progressive disease|21|||
129482492|NCT01826214|466057681|FG000|Overall Study|Study terminated by Sponsor|0|||
129482493|NCT01826214|466057682|FG001|Overall Study|Study terminated by Sponsor|1|||
129482494|NCT01826214|466057681|FG000|Overall Study|Subject/guardian decision|2|||
129482495|NCT01826214|466057682|FG001|Overall Study|Subject/guardian decision|3|||
129482496|NCT01056107|466057685|FG000|Overall Study|Withdrawal by Subject|0|||
129482497|NCT01056107|466057686|FG001|Overall Study|Withdrawal by Subject|1|||
129482498|NCT01056107|466057687|FG002|Overall Study|Withdrawal by Subject|3|||
129482499|NCT01056107|466057688|FG003|Overall Study|Withdrawal by Subject|0|||
129482500|NCT02017444|466057689|FG000|Overall Study|Physician Decision|1|||
129482501|NCT02017444|466057690|FG001|Overall Study|Physician Decision|0|||
129482502|NCT02017444|466057689|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
129482503|NCT02017444|466057690|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
129482504|NCT01614457|466057691|FG000|Overall Study|Non-Compliance|1|||
129482505|NCT01614457|466057692|FG001|Overall Study|Non-Compliance|0|||
129482506|NCT01614457|466057691|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
129482507|NCT01614457|466057692|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
129482508|NCT00374556|466057695|FG000|Overall Study|Lost to Follow-up|1|||
129482509|NCT00374556|466057696|FG001|Overall Study|Lost to Follow-up|0|||
129482510|NCT00374556|466057695|FG000|Overall Study|Removed at baseline due to medical cond|0|||
129482511|NCT00374556|466057696|FG001|Overall Study|Removed at baseline due to medical cond|1|||
129482512|NCT03874234|466057702|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482513|NCT03874234|466057703|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482514|NCT03874234|466057704|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482515|NCT03874234|466057705|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
129482516|NCT03874234|466057706|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482517|NCT03874234|466057707|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482518|NCT03874234|466057708|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482519|NCT03874234|466057709|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482520|NCT03874234|466057710|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482521|NCT03874234|466057711|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482522|NCT03874234|466057712|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482523|NCT03874234|466057713|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482524|NCT03874234|466057714|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
129482525|NCT03874234|466057702|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
129482526|NCT03874234|466057703|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482527|NCT03874234|466057704|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482528|NCT03874234|466057705|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482529|NCT03874234|466057706|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482530|NCT03874234|466057707|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482531|NCT03874234|466057708|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482532|NCT03874234|466057709|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482533|NCT03874234|466057710|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482534|NCT03874234|466057711|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482535|NCT03874234|466057712|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482536|NCT03874234|466057713|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482537|NCT03874234|466057714|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
129482538|NCT03874234|466057702|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482539|NCT03874234|466057703|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482540|NCT03874234|466057704|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482541|NCT03874234|466057705|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
129482542|NCT03874234|466057706|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482543|NCT03874234|466057707|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482544|NCT03874234|466057708|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482545|NCT03874234|466057709|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482546|NCT03874234|466057710|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482547|NCT03874234|466057711|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482548|NCT03874234|466057712|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482549|NCT03874234|466057713|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482550|NCT03874234|466057714|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
129482551|NCT03874234|466057702|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482552|NCT03874234|466057703|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482553|NCT03874234|466057704|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482554|NCT03874234|466057705|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482555|NCT03874234|466057706|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
129482556|NCT03874234|466057707|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482557|NCT03874234|466057708|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482558|NCT03874234|466057709|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482559|NCT03874234|466057710|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482560|NCT03874234|466057711|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482561|NCT03874234|466057712|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482562|NCT03874234|466057713|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482563|NCT03874234|466057714|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
129482564|NCT03874234|466057702|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482565|NCT03874234|466057703|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482566|NCT03874234|466057704|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482567|NCT03874234|466057705|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482568|NCT03874234|466057706|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482569|NCT03874234|466057707|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482570|NCT03874234|466057708|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482571|NCT03874234|466057709|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
129482572|NCT03874234|466057710|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482573|NCT03874234|466057711|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482574|NCT03874234|466057712|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482575|NCT03874234|466057713|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482576|NCT03874234|466057714|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
129482577|NCT03874234|466057702|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482578|NCT03874234|466057703|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482579|NCT03874234|466057704|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482580|NCT03874234|466057705|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482581|NCT03874234|466057706|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
129482582|NCT03874234|466057707|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
129482583|NCT03874234|466057708|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482584|NCT03874234|466057709|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482585|NCT03874234|466057710|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482586|NCT03874234|466057711|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482587|NCT03874234|466057712|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482588|NCT03874234|466057713|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482589|NCT03874234|466057714|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
129482590|NCT03874234|466057702|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482591|NCT03874234|466057703|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482592|NCT03874234|466057704|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482593|NCT03874234|466057705|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482594|NCT03874234|466057706|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482595|NCT03874234|466057707|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482596|NCT03874234|466057708|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
129482597|NCT03874234|466057709|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482598|NCT03874234|466057710|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482599|NCT03874234|466057711|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482600|NCT03874234|466057712|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482601|NCT03874234|466057713|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482602|NCT03874234|466057714|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
129482603|NCT03874234|466057702|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482604|NCT03874234|466057703|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482605|NCT03874234|466057704|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482606|NCT03874234|466057705|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482607|NCT03874234|466057706|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
129482608|NCT03874234|466057707|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482609|NCT03874234|466057708|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482610|NCT03874234|466057709|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482611|NCT03874234|466057710|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482612|NCT03874234|466057711|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482613|NCT03874234|466057712|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482614|NCT03874234|466057713|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482615|NCT03874234|466057714|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
129482616|NCT00686205|466057716|FG000|Overall Study|Protocol Violation|127|||
129482617|NCT00686205|466057717|FG001|Overall Study|Protocol Violation|0|||
129482618|NCT00686205|466057716|FG000|Overall Study|Withdrawal by Subject|2|||
129482619|NCT00686205|466057717|FG001|Overall Study|Withdrawal by Subject|0|||
129482620|NCT00686205|466057716|FG000|Overall Study|Specimen handling procedure altered|5878|||
129482621|NCT00686205|466057717|FG001|Overall Study|Specimen handling procedure altered|0|||
129482622|NCT00686205|466057716|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
129482623|NCT00686205|466057717|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
129482624|NCT00265941|466057718|FG000|Overall Study|Protocol Violation|22|||
129482625|NCT00265941|466057719|FG001|Overall Study|Protocol Violation|25|||
129482626|NCT00265941|466057718|FG000|Overall Study|Lost to Follow-up|1|||
129482627|NCT00265941|466057719|FG001|Overall Study|Lost to Follow-up|1|||
129482628|NCT03816995|466057722|FG000|Overall Study|Withdrawal by Subject|3|||
129482629|NCT03816995|466057723|FG001|Overall Study|Withdrawal by Subject|1|||
129482630|NCT03816995|466057722|FG000|Overall Study|Cancelled Surgery|8|||
129482631|NCT03816995|466057723|FG001|Overall Study|Cancelled Surgery|12|||
129482632|NCT03816995|466057722|FG000|Overall Study|No wound protector used|11|||
129978513|NCT01598662|467883720|FG000|Overall Study|IUD expelled before month 6|0|||
129978514|NCT01598662|467883721|FG001|Overall Study|IUD expelled before month 6|2|||
129978515|NCT00643617|467883722|FG000|Overall Study|Death|6|||
129978516|NCT00643617|467883723|FG001|Overall Study|Death|9|||
129978517|NCT00643617|467883722|FG000|Overall Study|Lost to Follow-up|42|||
129978518|NCT00643617|467883723|FG001|Overall Study|Lost to Follow-up|51|||
129978519|NCT02683785|467883726|FG000|Overall Study|Withdrawal by Subject|1|||
129978520|NCT02683785|467883727|FG001|Overall Study|Withdrawal by Subject|1|||
129978521|NCT02683785|467883726|FG000|Overall Study|Lost to Follow-up|0|||
129978522|NCT02683785|467883727|FG001|Overall Study|Lost to Follow-up|1|||
129978523|NCT02683785|467883726|FG000|Overall Study|Adverse Event|0|||
129482633|NCT03816995|466057723|FG001|Overall Study|No wound protector used|17|||
129978524|NCT02683785|467883727|FG001|Overall Study|Adverse Event|2|||
129978525|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
129978526|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
129482634|NCT03816995|466057722|FG000|Overall Study|Protocol Violation|2|||
129482635|NCT03816995|466057723|FG001|Overall Study|Protocol Violation|3|||
129482636|NCT03976401|466057725|FG000|Overall Study|Adverse Event|2|||
129482637|NCT03976401|466057726|FG001|Overall Study|Adverse Event|0|||
129482638|NCT03976401|466057727|FG002|Overall Study|Adverse Event|4|||
129482639|NCT03976401|466057728|FG003|Overall Study|Adverse Event|1|||
129482640|NCT03976401|466057729|FG004|Overall Study|Adverse Event|1|||
129482641|NCT03976401|466057730|FG005|Overall Study|Adverse Event|0|||
129482642|NCT03976401|466057725|FG000|Overall Study|Withdrawal by Subject|0|||
129482643|NCT03976401|466057726|FG001|Overall Study|Withdrawal by Subject|1|||
129482644|NCT03976401|466057727|FG002|Overall Study|Withdrawal by Subject|0|||
129482645|NCT03976401|466057728|FG003|Overall Study|Withdrawal by Subject|0|||
129482646|NCT03976401|466057729|FG004|Overall Study|Withdrawal by Subject|0|||
129482647|NCT03976401|466057730|FG005|Overall Study|Withdrawal by Subject|1|||
129482648|NCT03976401|466057725|FG000|Overall Study|Physician Decision|0|||
129482649|NCT03976401|466057726|FG001|Overall Study|Physician Decision|0|||
129482650|NCT03976401|466057727|FG002|Overall Study|Physician Decision|1|||
129482651|NCT03976401|466057728|FG003|Overall Study|Physician Decision|0|||
129482652|NCT03976401|466057729|FG004|Overall Study|Physician Decision|0|||
129482653|NCT03976401|466057730|FG005|Overall Study|Physician Decision|0|||
129482654|NCT03976401|466057725|FG000|Overall Study|Lost to Follow-up|1|||
129482655|NCT03976401|466057726|FG001|Overall Study|Lost to Follow-up|2|||
129482656|NCT03976401|466057727|FG002|Overall Study|Lost to Follow-up|0|||
129482657|NCT03976401|466057728|FG003|Overall Study|Lost to Follow-up|0|||
129482658|NCT03976401|466057729|FG004|Overall Study|Lost to Follow-up|0|||
129482659|NCT03976401|466057730|FG005|Overall Study|Lost to Follow-up|0|||
129482660|NCT03976401|466057725|FG000|Overall Study|Protocol Violation|0|||
129482661|NCT03976401|466057726|FG001|Overall Study|Protocol Violation|1|||
129482662|NCT03976401|466057727|FG002|Overall Study|Protocol Violation|0|||
129482663|NCT03976401|466057728|FG003|Overall Study|Protocol Violation|0|||
129482664|NCT03976401|466057729|FG004|Overall Study|Protocol Violation|0|||
129482665|NCT03976401|466057730|FG005|Overall Study|Protocol Violation|0|||
129482666|NCT03976401|466057725|FG000|Overall Study|Withdrew Consent|0|||
129482667|NCT03976401|466057726|FG001|Overall Study|Withdrew Consent|0|||
129482668|NCT03976401|466057727|FG002|Overall Study|Withdrew Consent|0|||
129482669|NCT03976401|466057728|FG003|Overall Study|Withdrew Consent|1|||
129482670|NCT03976401|466057729|FG004|Overall Study|Withdrew Consent|0|||
129482671|NCT03976401|466057730|FG005|Overall Study|Withdrew Consent|0|||
129482672|NCT03941548|466057737|FG000|Overall Study|Adverse Event|0|||
129482673|NCT03941548|466057738|FG001|Overall Study|Adverse Event|1|||
129482674|NCT03941548|466057737|FG000|Overall Study|Lost to Follow-up|0|||
129482675|NCT03941548|466057738|FG001|Overall Study|Lost to Follow-up|1|||
129482676|NCT03941548|466057737|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
129482677|NCT03941548|466057738|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
129482678|NCT01242111|466057741|FG000|Overall Study|Adverse Event|1|||
129482679|NCT01242111|466057741|FG000|Overall Study|Withdrawal by Subject|1|||
129482680|NCT01242111|466057741|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
129482681|NCT02015819|466057742|FG000|Overall Study|Rickham catheter was misaligned|0|||
129482682|NCT02015819|466057743|FG001|Overall Study|Rickham catheter was misaligned|0|||
129482683|NCT02015819|466057744|FG002|Overall Study|Rickham catheter was misaligned|0|||
129482684|NCT02015819|466057745|FG003|Overall Study|Rickham catheter was misaligned|1|||
129482685|NCT02945657|466057746|FG000|Overall Study|Adverse Event|1|||
129482686|NCT02945657|466057746|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
129482687|NCT01486264|466057748|FG000|Overall Study|Death|1|||
129482688|NCT01486264|466057749|FG001|Overall Study|Death|1|||
129482689|NCT01486264|466057748|FG000|Overall Study|Adverse Event|3|||
129482690|NCT01486264|466057749|FG001|Overall Study|Adverse Event|3|||
129482691|NCT01486264|466057748|FG000|Overall Study|Lack of Efficacy|6|||
129482692|NCT01486264|466057749|FG001|Overall Study|Lack of Efficacy|10|||
129482693|NCT01486264|466057748|FG000|Overall Study|Withdrawal by Subject|7|||
129482694|NCT01486264|466057749|FG001|Overall Study|Withdrawal by Subject|18|||
129978527|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
129978528|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
129978529|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
129482695|NCT01486264|466057748|FG000|Overall Study|Physician Decision|1|||
129482696|NCT01486264|466057749|FG001|Overall Study|Physician Decision|1|||
129482697|NCT01486264|466057748|FG000|Overall Study|Protocol Violation|3|||
129482698|NCT01486264|466057749|FG001|Overall Study|Protocol Violation|0|||
129482699|NCT01486264|466057748|FG000|Overall Study|Lost to Follow-up|3|||
129482700|NCT01486264|466057749|FG001|Overall Study|Lost to Follow-up|2|||
129482701|NCT01486264|466057748|FG000|Overall Study|Other|5|||
129482702|NCT01486264|466057749|FG001|Overall Study|Other|11|||
129482703|NCT01486264|466057748|FG000|Overall Study|Not treated|0|||
129482704|NCT01486264|466057749|FG001|Overall Study|Not treated|1|||
129482705|NCT00813748|466057750|FG000|Skin Test Substudy|Physician Decision|0|||
129482706|NCT00813748|466057751|FG001|Skin Test Substudy|Physician Decision|1|||
129482707|NCT00283387|466057752|FG000|First Intervention|Subject non-compliant|1|||
129482708|NCT00283387|466057753|FG001|First Intervention|Subject non-compliant|1|||
129482709|NCT00283387|466057752|FG000|First Intervention|Withdrawal by Subject|0|||
129482710|NCT00283387|466057753|FG001|First Intervention|Withdrawal by Subject|1|||
129482711|NCT03584009|466057758|FG000|Overall Study|Death|25|||
129482712|NCT03584009|466057759|FG001|Overall Study|Death|18|||
129482713|NCT03584009|466057758|FG000|Overall Study|Lost to Follow-up|0|||
129482714|NCT03584009|466057759|FG001|Overall Study|Lost to Follow-up|1|||
129482715|NCT03584009|466057758|FG000|Overall Study|Physician Decision|1|||
129482716|NCT03584009|466057759|FG001|Overall Study|Physician Decision|1|||
129482717|NCT03584009|466057758|FG000|Overall Study|Study Terminated by Sponsor|22|||
129482718|NCT03584009|466057759|FG001|Overall Study|Study Terminated by Sponsor|30|||
129482719|NCT03584009|466057758|FG000|Overall Study|Withdrawal by Subject|3|||
129482720|NCT03584009|466057759|FG001|Overall Study|Withdrawal by Subject|2|||
129482721|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
129482722|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
129482723|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
129482724|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
129482725|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
129482726|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
129482727|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
129482728|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
129482729|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
129482730|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
129482731|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
129482732|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
129482733|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
129482734|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
129482735|NCT00446030|466057760|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
129482736|NCT00446030|466057761|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
129482737|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
129482738|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
129482739|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
129482740|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
129482741|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
129482742|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
129482743|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
129482744|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
129482745|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
129482746|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
129482747|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
129482748|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
129482749|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
129482750|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
129482751|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
129482752|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
129482753|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
129482754|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
129482755|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
129482756|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
129482757|NCT00446030|466057760|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
129482758|NCT00446030|466057761|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
129482759|NCT02886715|466057762|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129482760|NCT02886715|466057763|FG001|Overall Study|Non-Compliance With Study Drug|2|||
129482761|NCT02886715|466057764|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129482762|NCT02886715|466057762|FG000|Overall Study|Adverse Event|4|||
129482763|NCT02886715|466057763|FG001|Overall Study|Adverse Event|2|||
129482764|NCT02886715|466057764|FG002|Overall Study|Adverse Event|0|||
129482765|NCT02886715|466057762|FG000|Overall Study|Lack of Efficacy|0|||
129482766|NCT02886715|466057763|FG001|Overall Study|Lack of Efficacy|2|||
129482767|NCT02886715|466057764|FG002|Overall Study|Lack of Efficacy|1|||
129482768|NCT02886715|466057762|FG000|Overall Study|Lost to Follow-up|29|||
129482769|NCT02886715|466057763|FG001|Overall Study|Lost to Follow-up|26|||
129482770|NCT02886715|466057764|FG002|Overall Study|Lost to Follow-up|10|||
129482771|NCT02886715|466057762|FG000|Overall Study|Pregnancy|1|||
129482772|NCT02886715|466057763|FG001|Overall Study|Pregnancy|1|||
129482773|NCT02886715|466057764|FG002|Overall Study|Pregnancy|1|||
129482774|NCT02886715|466057762|FG000|Overall Study|Protocol Violation|3|||
129482775|NCT02886715|466057763|FG001|Overall Study|Protocol Violation|2|||
129482776|NCT02886715|466057764|FG002|Overall Study|Protocol Violation|1|||
129482777|NCT02886715|466057762|FG000|Overall Study|Withdrawal by Subject|20|||
129482778|NCT02886715|466057763|FG001|Overall Study|Withdrawal by Subject|18|||
129482779|NCT02886715|466057764|FG002|Overall Study|Withdrawal by Subject|5|||
129482780|NCT02886715|466057762|FG000|Overall Study|missing|7|||
129482781|NCT02886715|466057763|FG001|Overall Study|missing|2|||
129482782|NCT02886715|466057764|FG002|Overall Study|missing|2|||
129482783|NCT00222105|466057765|FG000|Overall Study|Removed due to wrong diagnosis|1|||
129482784|NCT00222105|466057765|FG000|Overall Study|Withdrawal by Subject|1|||
129482785|NCT00222105|466057765|FG000|Overall Study|Adverse Event|8|||
129482786|NCT00222105|466057765|FG000|Overall Study|Treatment delays|2|||
129482787|NCT00222105|466057765|FG000|Overall Study|Death|2|||
129482788|NCT00503399|466057766|FG000|Overall Study|Death|2|||
129482789|NCT00503399|466057767|FG001|Overall Study|Death|1|||
129482790|NCT00503399|466057766|FG000|Overall Study|Protocol Violation|1|||
129482791|NCT00503399|466057767|FG001|Overall Study|Protocol Violation|0|||
129482792|NCT00503399|466057766|FG000|Overall Study|Withdrawal by Subject|4|||
129482793|NCT00503399|466057767|FG001|Overall Study|Withdrawal by Subject|2|||
129482794|NCT00503399|466057766|FG000|Overall Study|Adverse Event|0|||
129482795|NCT00503399|466057767|FG001|Overall Study|Adverse Event|3|||
129482796|NCT00503399|466057766|FG000|Overall Study|Lost to Follow-up|0|||
129482797|NCT00503399|466057767|FG001|Overall Study|Lost to Follow-up|2|||
129482798|NCT01120626|466057770|FG000|Overall Study|Withdrawal by Subject|1|||
129482799|NCT01120626|466057771|FG001|Overall Study|Withdrawal by Subject|0|||
129482800|NCT01073943|466057785|FG000|Overall Study|Withdrawal by Subject|8|||
129482801|NCT01073943|466057786|FG001|Overall Study|Withdrawal by Subject|2|||
129482802|NCT01073943|466057785|FG000|Overall Study|Protocol Violation|2|||
129482803|NCT01073943|466057786|FG001|Overall Study|Protocol Violation|1|||
129482804|NCT01073943|466057785|FG000|Overall Study|Adverse Event|1|||
129482805|NCT01073943|466057786|FG001|Overall Study|Adverse Event|1|||
129482806|NCT01073943|466057785|FG000|Overall Study|Lost to Follow-up|0|||
129482807|NCT01073943|466057786|FG001|Overall Study|Lost to Follow-up|2|||
129482808|NCT01073943|466057785|FG000|Overall Study|Power outage; colonoscopy not done|1|||
129482809|NCT01073943|466057786|FG001|Overall Study|Power outage; colonoscopy not done|0|||
129482810|NCT01073943|466057785|FG000|Overall Study|Subject forgot|0|||
129482811|NCT01073943|466057786|FG001|Overall Study|Subject forgot|1|||
129482812|NCT01073943|466057785|FG000|Overall Study|Unable to return for follow-up|0|||
129482813|NCT01073943|466057786|FG001|Overall Study|Unable to return for follow-up|1|||
129482814|NCT01073943|466057785|FG000|Overall Study|Could not tolerate prep|1|||
129482815|NCT01073943|466057786|FG001|Overall Study|Could not tolerate prep|0|||
129482816|NCT01794780|466057789|FG000|Overall Study|Adverse Event|0|||
129482817|NCT01794780|466057790|FG001|Overall Study|Adverse Event|1|||
129482818|NCT01794780|466057791|FG002|Overall Study|Adverse Event|2|||
129482819|NCT01794780|466057792|FG003|Overall Study|Adverse Event|0|||
129482820|NCT01794780|466057793|FG004|Overall Study|Adverse Event|0|||
129482821|NCT01794780|466057794|FG005|Overall Study|Adverse Event|0|||
129482822|NCT01794780|466057795|FG006|Overall Study|Adverse Event|0|||
129482823|NCT01794780|466057796|FG007|Overall Study|Adverse Event|0|||
129482824|NCT01794780|466057789|FG000|Overall Study|Death|0|||
129482825|NCT01794780|466057790|FG001|Overall Study|Death|2|||
129482826|NCT01794780|466057791|FG002|Overall Study|Death|14|||
129482827|NCT01794780|466057792|FG003|Overall Study|Death|1|||
129482828|NCT01794780|466057793|FG004|Overall Study|Death|0|||
129482829|NCT01794780|466057794|FG005|Overall Study|Death|9|||
129482830|NCT01794780|466057795|FG006|Overall Study|Death|4|||
129482831|NCT01794780|466057796|FG007|Overall Study|Death|0|||
129482832|NCT01794780|466057789|FG000|Overall Study|Lost to Follow-up|10|||
129482833|NCT01794780|466057790|FG001|Overall Study|Lost to Follow-up|64|||
129482834|NCT01794780|466057791|FG002|Overall Study|Lost to Follow-up|165|||
129482835|NCT01794780|466057792|FG003|Overall Study|Lost to Follow-up|53|||
129482836|NCT01794780|466057793|FG004|Overall Study|Lost to Follow-up|2|||
129978530|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
129978531|NCT02233803|467883730|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
129978532|NCT02233803|467883731|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
129978533|NCT02233803|467883730|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
129978534|NCT02233803|467883731|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
129978535|NCT02233803|467883730|FG000|Washout Period (4-Wks)|Physician Decision|1|||
129978536|NCT02233803|467883731|FG001|Washout Period (4-Wks)|Physician Decision|0|||
129978537|NCT02233803|467883730|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
129978538|NCT02233803|467883731|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
129482837|NCT01794780|466057794|FG005|Overall Study|Lost to Follow-up|99|||
129482838|NCT01794780|466057795|FG006|Overall Study|Lost to Follow-up|30|||
129482839|NCT01794780|466057796|FG007|Overall Study|Lost to Follow-up|5|||
129482840|NCT01794780|466057789|FG000|Overall Study|Withdrew informed consent|7|||
129482841|NCT01794780|466057790|FG001|Overall Study|Withdrew informed consent|17|||
129482842|NCT01794780|466057791|FG002|Overall Study|Withdrew informed consent|36|||
129978539|NCT02233803|467883730|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
129482843|NCT01794780|466057792|FG003|Overall Study|Withdrew informed consent|9|||
129482844|NCT01794780|466057793|FG004|Overall Study|Withdrew informed consent|0|||
129482845|NCT01794780|466057794|FG005|Overall Study|Withdrew informed consent|48|||
129482846|NCT01794780|466057795|FG006|Overall Study|Withdrew informed consent|4|||
129482847|NCT01794780|466057796|FG007|Overall Study|Withdrew informed consent|3|||
129482848|NCT01794780|466057789|FG000|Overall Study|Other|0|||
129482849|NCT01794780|466057790|FG001|Overall Study|Other|12|||
129482850|NCT01794780|466057791|FG002|Overall Study|Other|25|||
129978540|NCT02233803|467883731|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
129978541|NCT02233803|467883730|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
129978542|NCT02233803|467883731|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
129482851|NCT01794780|466057792|FG003|Overall Study|Other|20|||
129482852|NCT01794780|466057793|FG004|Overall Study|Other|1|||
129482853|NCT01794780|466057794|FG005|Overall Study|Other|24|||
129482854|NCT01794780|466057795|FG006|Overall Study|Other|4|||
129482855|NCT01794780|466057796|FG007|Overall Study|Other|1|||
129482856|NCT03527043|466057798|FG000|Overall Study|Withdrawal by Subject|1|||
129482857|NCT03527043|466057799|FG001|Overall Study|Withdrawal by Subject|0|||
129482858|NCT02120417|466057800|FG000|Overall Study|Death|5|||
129482859|NCT02120417|466057801|FG001|Overall Study|Death|1|||
129482860|NCT02120417|466057800|FG000|Overall Study|Adverse Event|3|||
129482861|NCT02120417|466057801|FG001|Overall Study|Adverse Event|9|||
129482862|NCT02120417|466057800|FG000|Overall Study|Participant decision|4|||
129482863|NCT02120417|466057801|FG001|Overall Study|Participant decision|4|||
129482864|NCT02120417|466057800|FG000|Overall Study|Disease progression|41|||
129482865|NCT02120417|466057801|FG001|Overall Study|Disease progression|45|||
129482866|NCT02120417|466057800|FG000|Overall Study|Noncompliance with study treatment|0|||
129482867|NCT02120417|466057801|FG001|Overall Study|Noncompliance with study treatment|2|||
129482868|NCT02120417|466057800|FG000|Overall Study|Physician Decision|2|||
129482869|NCT02120417|466057801|FG001|Overall Study|Physician Decision|3|||
129482870|NCT02120417|466057800|FG000|Overall Study|Other unspecified|5|||
129482871|NCT02120417|466057801|FG001|Overall Study|Other unspecified|4|||
129482872|NCT02286102|466057802|FG000|Overall Study|Screen Failure|1|||
129482873|NCT02286102|466057803|FG001|Overall Study|Screen Failure|1|||
129482874|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
129482875|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
129482876|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
129482877|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
129482878|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
129482879|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
129482880|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Personal issues|2|||
129482881|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Personal issues|0|||
129482882|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Personal issues|0|||
129482883|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Too busy|7|||
129482884|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Too busy|1|||
129482885|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Too busy|0|||
129482886|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Pain|2|||
129482887|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Pain|0|||
129482888|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Pain|0|||
129482889|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Moved|1|||
129482890|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Moved|0|||
129482891|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Moved|0|||
129482892|NCT00594399|466057804|FG000|Initial 3 Month Counseling|Family illness|1|||
129482893|NCT00594399|466057805|FG001|Initial 3 Month Counseling|Family illness|0|||
129482894|NCT00594399|466057806|FG002|Initial 3 Month Counseling|Family illness|0|||
129482895|NCT00594399|466057804|FG000|Rerandomization Arm 1 Only|Death|2|||
129482896|NCT00594399|466057805|FG001|Rerandomization Arm 1 Only|Death|1|||
129482897|NCT00594399|466057806|FG002|Rerandomization Arm 1 Only|Death|0|||
129482898|NCT00594399|466057804|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
129482899|NCT00594399|466057805|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
129482900|NCT00594399|466057806|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
129482901|NCT03830281|466057807|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
129482902|NCT03830281|466057808|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
129482903|NCT03830281|466057807|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
129482904|NCT03830281|466057808|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
129482905|NCT03830281|466057807|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
129482906|NCT03830281|466057808|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
129482907|NCT03830281|466057807|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
129482908|NCT03830281|466057808|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
129978543|NCT00468143|467883732|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
129978544|NCT00468143|467883733|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
129482909|NCT03830281|466057807|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
129482910|NCT03830281|466057808|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
129482911|NCT03830281|466057807|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
129978545|NCT00468143|467883732|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
129482912|NCT03830281|466057808|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
129482913|NCT03830281|466057807|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
129482914|NCT03830281|466057808|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
129482915|NCT03830281|466057807|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
129482916|NCT03830281|466057808|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
129482917|NCT03830281|466057807|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
129482918|NCT03830281|466057808|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
129978546|NCT00468143|467883733|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
129482919|NCT01985321|466057810|FG000|Overall Study|Protocol Violation|4|||
129482920|NCT01985321|466057811|FG001|Overall Study|Protocol Violation|3|||
129482921|NCT01985321|466057810|FG000|Overall Study|Withdrawal by Subject|1|||
129482922|NCT01985321|466057811|FG001|Overall Study|Withdrawal by Subject|0|||
129482923|NCT01985321|466057810|FG000|Overall Study|Lost to Follow-up|5|||
129482924|NCT01985321|466057811|FG001|Overall Study|Lost to Follow-up|2|||
129482925|NCT01985321|466057810|FG000|Overall Study|Subject treated wrong type of sore|1|||
129482926|NCT01985321|466057811|FG001|Overall Study|Subject treated wrong type of sore|0|||
129482927|NCT02201940|466057812|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
129482928|NCT02201940|466057813|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
129482929|NCT02201940|466057812|FG000|Overall Study|Lack of Efficacy|2|||
129482930|NCT02201940|466057813|FG001|Overall Study|Lack of Efficacy|113|||
129482931|NCT02201940|466057812|FG000|Overall Study|Lost to Follow-up|5|||
129482932|NCT02201940|466057813|FG001|Overall Study|Lost to Follow-up|0|||
129482933|NCT02201940|466057812|FG000|Overall Study|Withdrew Consent|2|||
129482934|NCT02201940|466057813|FG001|Overall Study|Withdrew Consent|1|||
129482935|NCT02201940|466057812|FG000|Overall Study|Investigator's Discretion|1|||
129482936|NCT02201940|466057813|FG001|Overall Study|Investigator's Discretion|1|||
129482937|NCT02201940|466057812|FG000|Overall Study|Death|1|||
129482938|NCT02201940|466057813|FG001|Overall Study|Death|0|||
129482939|NCT02201940|466057812|FG000|Overall Study|Adverse Event|0|||
129482940|NCT02201940|466057813|FG001|Overall Study|Adverse Event|1|||
129482941|NCT03192904|466057814|FG000|Overall Study|Physician Decision|3|||
129482942|NCT03192904|466057815|FG001|Overall Study|Physician Decision|1|||
129482943|NCT03192904|466057814|FG000|Overall Study|Lost to Follow-up|0|||
129482944|NCT03192904|466057815|FG001|Overall Study|Lost to Follow-up|1|||
129482945|NCT00424398|466057816|FG000|Overall Study|Withdrawal by Subject|2|||
129482946|NCT00424398|466057817|FG001|Overall Study|Withdrawal by Subject|1|||
129482947|NCT00424398|466057818|FG002|Overall Study|Withdrawal by Subject|0|||
129482948|NCT00424398|466057816|FG000|Overall Study|Subject met exclusion criteria|1|||
129482949|NCT00424398|466057817|FG001|Overall Study|Subject met exclusion criteria|0|||
129482950|NCT00424398|466057818|FG002|Overall Study|Subject met exclusion criteria|0|||
129482951|NCT01023789|466057819|FG000|3 - Year Visit|Death|29|||
129482952|NCT01023789|466057819|FG000|3 - Year Visit|Withdrawal of consent|1|||
129482953|NCT01023789|466057819|FG000|3 - Year Visit|Lost to Follow-up|13|||
129482954|NCT03934684|466057821|FG000|Overall Study|Participants continuing in study|11|||
129482955|NCT03934684|466057822|FG001|Overall Study|Participants continuing in study|4|||
129482956|NCT03934684|466057821|FG000|Overall Study|Discontinuation of carfilzomib|20|||
129482957|NCT03934684|466057822|FG001|Overall Study|Discontinuation of carfilzomib|30|||
129482958|NCT03934684|466057821|FG000|Overall Study|Death|2|||
129482959|NCT03934684|466057822|FG001|Overall Study|Death|2|||
129482960|NCT03934684|466057821|FG000|Overall Study|Lost to Follow-up|2|||
129482961|NCT03934684|466057822|FG001|Overall Study|Lost to Follow-up|5|||
129482962|NCT03934684|466057821|FG000|Overall Study|Withdrawal by Subject|7|||
129482963|NCT03934684|466057822|FG001|Overall Study|Withdrawal by Subject|8|||
129482964|NCT05662332|466057823|FG000|Overall Study|Death|3|||
129482965|NCT05662332|466057824|FG001|Overall Study|Death|3|||
129978547|NCT01559129|467883736|FG000|Treatment Phase|Adverse Event|0|||
129978548|NCT01559129|467883737|FG001|Treatment Phase|Adverse Event|2|||
129978549|NCT01559129|467883736|FG000|Treatment Phase|Progressive Disease|1|||
129978550|NCT01559129|467883737|FG001|Treatment Phase|Progressive Disease|1|||
129978551|NCT01559129|467883736|FG000|Treatment Phase|Lack of Efficacy|0|||
129978552|NCT01559129|467883737|FG001|Treatment Phase|Lack of Efficacy|1|||
129978553|NCT01559129|467883736|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
129978554|NCT01559129|467883737|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
129978555|NCT01559129|467883736|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
129978556|NCT01559129|467883737|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
129482966|NCT05662332|466057823|FG000|Overall Study|Lost to Follow-up|3|||
129482967|NCT05662332|466057824|FG001|Overall Study|Lost to Follow-up|8|||
129482968|NCT05662332|466057823|FG000|Overall Study|Physician Decision|1|||
129482969|NCT05662332|466057824|FG001|Overall Study|Physician Decision|2|||
129482970|NCT05662332|466057823|FG000|Overall Study|Protocol Deviation|2|||
129978557|NCT01559129|467883736|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
129978558|NCT01559129|467883737|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
129978559|NCT01559129|467883736|FG000|Open-label Extension Period|Adverse Event|1|||
129482971|NCT05662332|466057824|FG001|Overall Study|Protocol Deviation|1|||
129482972|NCT05662332|466057823|FG000|Overall Study|Withdrawal by Subject|14|||
129482973|NCT05662332|466057824|FG001|Overall Study|Withdrawal by Subject|14|||
129482974|NCT05662332|466057823|FG000|Overall Study|Assigned Treatment by Mistake|5|||
129482975|NCT05662332|466057824|FG001|Overall Study|Assigned Treatment by Mistake|7|||
129482976|NCT05662332|466057823|FG000|Overall Study|Non-compliance with study drug|4|||
129482977|NCT05662332|466057824|FG001|Overall Study|Non-compliance with study drug|1|||
129482978|NCT05662332|466057823|FG000|Overall Study|Due to Bariatric surgery|1|||
129482979|NCT05662332|466057824|FG001|Overall Study|Due to Bariatric surgery|0|||
129482980|NCT05662332|466057823|FG000|Overall Study|Subject Moving out of State|0|||
129482981|NCT05662332|466057824|FG001|Overall Study|Subject Moving out of State|1|||
129482982|NCT05662332|466057823|FG000|Overall Study|Subject Missed the Schedule|1|||
129482983|NCT05662332|466057824|FG001|Overall Study|Subject Missed the Schedule|0|||
129482984|NCT05662332|466057823|FG000|Overall Study|The Patient Moved to Another City|1|||
129482985|NCT05662332|466057824|FG001|Overall Study|The Patient Moved to Another City|0|||
129482986|NCT00256295|466057825|FG000|Overall Study|Withdrawal by Subject|3|||
129482987|NCT00256295|466057825|FG000|Overall Study|Death|1|||
129482988|NCT01697345|466057828|FG000|Overall Study|Withdrawal by Subject|1|||
129482989|NCT02770807|466057831|FG000|Overall Study|Adverse Event|3|||
129482990|NCT02770807|466057832|FG001|Overall Study|Adverse Event|3|||
129482991|NCT02770807|466057833|FG002|Overall Study|Adverse Event|1|||
129482992|NCT02770807|466057831|FG000|Overall Study|Withdrawal by Subject|7|||
129482993|NCT02770807|466057832|FG001|Overall Study|Withdrawal by Subject|3|||
129482994|NCT02770807|466057833|FG002|Overall Study|Withdrawal by Subject|4|||
129482995|NCT02770807|466057831|FG000|Overall Study|Other|0|||
129482996|NCT02770807|466057832|FG001|Overall Study|Other|1|||
129482997|NCT02770807|466057833|FG002|Overall Study|Other|0|||
129482998|NCT02770807|466057831|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
129482999|NCT02770807|466057832|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
129483000|NCT02770807|466057833|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
129483001|NCT02770807|466057831|FG000|Overall Study|Physician Decision|0|||
129483002|NCT02770807|466057832|FG001|Overall Study|Physician Decision|0|||
129483003|NCT02770807|466057833|FG002|Overall Study|Physician Decision|1|||
129483004|NCT00942162|466059271|FG000|Overall Study|Death|45|||
129483005|NCT00942162|466059272|FG001|Overall Study|Death|35|||
129483006|NCT00942162|466059273|FG002|Overall Study|Death|0|||
129483007|NCT00942162|466059271|FG000|Overall Study|Withdrawal by Subject|7|||
129483008|NCT00942162|466059272|FG001|Overall Study|Withdrawal by Subject|2|||
129483009|NCT00942162|466059273|FG002|Overall Study|Withdrawal by Subject|0|||
129483010|NCT00942162|466059271|FG000|Overall Study|Lost to Follow-up|4|||
129483011|NCT00942162|466059272|FG001|Overall Study|Lost to Follow-up|0|||
129483012|NCT00942162|466059273|FG002|Overall Study|Lost to Follow-up|0|||
129483013|NCT00942162|466059271|FG000|Overall Study|Other|14|||
129483014|NCT00942162|466059272|FG001|Overall Study|Other|13|||
129483015|NCT00942162|466059273|FG002|Overall Study|Other|2|||
129483016|NCT02799381|466059282|FG000|Overall Study|Withdrew consent|3|||
129483017|NCT02799381|466059283|FG001|Overall Study|Withdrew consent|2|||
129483018|NCT02799381|466059282|FG000|Overall Study|Adverse Event|0|||
129483019|NCT02799381|466059283|FG001|Overall Study|Adverse Event|1|||
129483020|NCT02799381|466059282|FG000|Overall Study|Participant did not take any study drug|1|||
129483021|NCT02799381|466059283|FG001|Overall Study|Participant did not take any study drug|0|||
129483022|NCT03952130|466059284|FG000|Overall Study|Adverse Event|0|||
129483023|NCT03952130|466059285|FG001|Overall Study|Adverse Event|1|||
129483024|NCT03952130|466059284|FG000|Overall Study|Lost to Follow-up|1|||
129483025|NCT03952130|466059285|FG001|Overall Study|Lost to Follow-up|0|||
129483026|NCT03952130|466059284|FG000|Overall Study|Withdrawal by Subject|1|||
129483027|NCT03952130|466059285|FG001|Overall Study|Withdrawal by Subject|5|||
129483028|NCT01713348|466059286|FG000|Overall Study|Withdrawal by Subject|3|||
129483029|NCT01713348|466059287|FG001|Overall Study|Withdrawal by Subject|2|||
129483030|NCT01713348|466059288|FG002|Overall Study|Withdrawal by Subject|2|||
129483031|NCT01713348|466059289|FG003|Overall Study|Withdrawal by Subject|0|||
129483032|NCT01713348|466059286|FG000|Overall Study|Lost to Follow-up|1|||
129483033|NCT01713348|466059287|FG001|Overall Study|Lost to Follow-up|0|||
129483034|NCT01713348|466059288|FG002|Overall Study|Lost to Follow-up|0|||
129483035|NCT01713348|466059289|FG003|Overall Study|Lost to Follow-up|0|||
129483036|NCT05882890|466059292|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
129483037|NCT01584024|466059295|FG000|Overall Study|Lost to Follow-up|10|||
129483038|NCT01584024|466059295|FG000|Overall Study|Withdrawal by Subject|3|||
129483039|NCT00613314|466059296|FG000|Overall Study|Adverse Event|5|||
129483040|NCT00613314|466059296|FG000|Overall Study|Protocol Violation|14|||
129483041|NCT00613314|466059296|FG000|Overall Study|Lost to Follow-up|46|||
129483042|NCT00613314|466059296|FG000|Overall Study|Other reason not defined above|90|||
129483043|NCT01217606|466059297|FG000|Initial Treatment Phase|Other Reasons|0|||
129483044|NCT01217606|466059298|FG001|Initial Treatment Phase|Other Reasons|2|||
129978560|NCT01559129|467883737|FG001|Open-label Extension Period|Adverse Event|0|||
129483045|NCT01217606|466059297|FG000|Initial Treatment Phase|Protocol Violation|3|||
129483046|NCT01217606|466059298|FG001|Initial Treatment Phase|Protocol Violation|2|||
129483047|NCT01217606|466059297|FG000|Initial Treatment Phase|Personal Reasons|0|||
129483048|NCT01217606|466059298|FG001|Initial Treatment Phase|Personal Reasons|2|||
129483049|NCT01217606|466059297|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
129483050|NCT01217606|466059298|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
129483051|NCT01217606|466059297|FG000|Initial Treatment Phase|Adverse Event|10|||
129483052|NCT01217606|466059298|FG001|Initial Treatment Phase|Adverse Event|6|||
129483053|NCT01217606|466059297|FG000|9-Month Masked Extension|Adverse Event|3|||
129483054|NCT01217606|466059298|FG001|9-Month Masked Extension|Adverse Event|6|||
129483055|NCT01217606|466059297|FG000|9-Month Masked Extension|Other Reasons|4|||
129483056|NCT01217606|466059298|FG001|9-Month Masked Extension|Other Reasons|4|||
129483057|NCT01217606|466059297|FG000|9-Month Masked Extension|Personal Reasons|2|||
129483058|NCT01217606|466059298|FG001|9-Month Masked Extension|Personal Reasons|1|||
129483059|NCT01217606|466059297|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
129483060|NCT01217606|466059298|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
129483061|NCT01217606|466059297|FG000|9-Month Masked Extension|Pregnancy|1|||
129483062|NCT01217606|466059298|FG001|9-Month Masked Extension|Pregnancy|0|||
129483063|NCT01217606|466059297|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
129483064|NCT01217606|466059298|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
129483065|NCT03090191|466059305|FG000|Overall Study|Adverse Event|90|||
129483066|NCT03090191|466059306|FG001|Overall Study|Adverse Event|72|||
129483067|NCT03090191|466059305|FG000|Overall Study|Death|365|||
129483068|NCT03090191|466059306|FG001|Overall Study|Death|358|||
129483069|NCT03090191|466059305|FG000|Overall Study|Lost to Follow-up|382|||
129483070|NCT03090191|466059306|FG001|Overall Study|Lost to Follow-up|394|||
129483071|NCT03090191|466059305|FG000|Overall Study|Physician Decision|77|||
129483072|NCT03090191|466059306|FG001|Overall Study|Physician Decision|66|||
129483073|NCT03090191|466059305|FG000|Overall Study|Protocol Violation|43|||
129483074|NCT03090191|466059306|FG001|Overall Study|Protocol Violation|52|||
129483075|NCT03090191|466059305|FG000|Overall Study|Withdrawal by Subject|2160|||
129483076|NCT03090191|466059306|FG001|Overall Study|Withdrawal by Subject|2133|||
129483077|NCT03090191|466059305|FG000|Overall Study|Site terminated|7|||
129483078|NCT03090191|466059306|FG001|Overall Study|Site terminated|8|||
129483079|NCT03090191|466059305|FG000|Overall Study|Other|66|||
129483080|NCT03090191|466059306|FG001|Overall Study|Other|60|||
129483081|NCT03090191|466059305|FG000|Overall Study|Withdrawn before any study vaccination|43|||
129483082|NCT03090191|466059306|FG001|Overall Study|Withdrawn before any study vaccination|52|||
129483083|NCT04723537|466059308|FG000|Overall Study|Withdrawal by Subject|3|||
129483084|NCT04723537|466059309|FG001|Overall Study|Withdrawal by Subject|0|||
129483085|NCT04723537|466059310|FG002|Overall Study|Withdrawal by Subject|0|||
129483086|NCT04723537|466059308|FG000|Overall Study|Physician Decision|0|||
129483087|NCT04723537|466059309|FG001|Overall Study|Physician Decision|0|||
129483088|NCT04723537|466059310|FG002|Overall Study|Physician Decision|1|||
129483089|NCT04723537|466059308|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
129483090|NCT04723537|466059309|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
129483091|NCT04723537|466059310|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
129483092|NCT02432807|466059311|FG000|Overall Study|Adverse Event|0|||
129483093|NCT02432807|466059312|FG001|Overall Study|Adverse Event|2|||
129483094|NCT02432807|466059311|FG000|Overall Study|Lost to Follow-up|1|||
129483095|NCT02432807|466059312|FG001|Overall Study|Lost to Follow-up|0|||
129483096|NCT02432807|466059311|FG000|Overall Study|Withdrawal by Subject|1|||
129483097|NCT02432807|466059312|FG001|Overall Study|Withdrawal by Subject|1|||
129483098|NCT02432807|466059311|FG000|Overall Study|Other|1|||
129483099|NCT02432807|466059312|FG001|Overall Study|Other|1|||
129483100|NCT04419506|466059313|FG000|Overall Study|Adverse Event|0|||
129483101|NCT04419506|466059314|FG001|Overall Study|Adverse Event|10|||
129483102|NCT04419506|466059315|FG002|Overall Study|Adverse Event|0|||
129483103|NCT04419506|466059316|FG003|Overall Study|Adverse Event|3|||
129483104|NCT04419506|466059313|FG000|Overall Study|Withdrawal by Subject|0|||
129483105|NCT04419506|466059314|FG001|Overall Study|Withdrawal by Subject|0|||
129483106|NCT04419506|466059315|FG002|Overall Study|Withdrawal by Subject|0|||
129483107|NCT04419506|466059316|FG003|Overall Study|Withdrawal by Subject|1|||
129483108|NCT04419506|466059313|FG000|Overall Study|poor-compliance|0|||
129483109|NCT04419506|466059314|FG001|Overall Study|poor-compliance|0|||
129483110|NCT04419506|466059315|FG002|Overall Study|poor-compliance|0|||
129483111|NCT04419506|466059316|FG003|Overall Study|poor-compliance|1|||
129483112|NCT01845025|466059317|FG000|Overall Study|Adverse Event|6|||
129483113|NCT01845025|466059318|FG001|Overall Study|Adverse Event|3|||
129483114|NCT01845025|466059317|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129483115|NCT01845025|466059318|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129483116|NCT01845025|466059317|FG000|Overall Study|Withdrawal by Subject|48|||
129483117|NCT01845025|466059318|FG001|Overall Study|Withdrawal by Subject|44|||
129483118|NCT01845025|466059317|FG000|Overall Study|Lost to Follow-up|13|||
129483119|NCT01845025|466059318|FG001|Overall Study|Lost to Follow-up|13|||
129483120|NCT01845025|466059317|FG000|Overall Study|Administrative problems|8|||
129483121|NCT01845025|466059318|FG001|Overall Study|Administrative problems|8|||
129483122|NCT01845025|466059317|FG000|Overall Study|Death|2|||
129483123|NCT01845025|466059318|FG001|Overall Study|Death|0|||
129483124|NCT01845025|466059317|FG000|Overall Study|Protocol deviation|3|||
129483125|NCT01845025|466059318|FG001|Overall Study|Protocol deviation|6|||
129483126|NCT01845025|466059317|FG000|Overall Study|Missing|1|||
129483127|NCT01845025|466059318|FG001|Overall Study|Missing|1|||
129483128|NCT02966314|466059320|FG000|Overall Study|Lost to Follow-up|1|||
129483129|NCT02966314|466059321|FG001|Overall Study|Lost to Follow-up|0|||
129483130|NCT01021007|466059324|FG000|Overall Study|Lost to Follow-up|1|||
129483131|NCT01021007|466059325|FG001|Overall Study|Lost to Follow-up|1|||
129483132|NCT01021007|466059324|FG000|Overall Study|Adverse Event|1|||
129483133|NCT01021007|466059325|FG001|Overall Study|Adverse Event|3|||
129483134|NCT00728416|466059336|FG000|Overall Study|Adverse Event|1|||
129483135|NCT00728416|466059337|FG001|Overall Study|Adverse Event|1|||
129483136|NCT00728416|466059336|FG000|Overall Study|Treatment Failure|0|||
129483137|NCT00728416|466059337|FG001|Overall Study|Treatment Failure|1|||
129483138|NCT00728416|466059336|FG000|Overall Study|Withdrawal by Subject|1|||
129483139|NCT00728416|466059337|FG001|Overall Study|Withdrawal by Subject|0|||
129483140|NCT00356915|466059342|FG000|Overall Study|Non compliance|1|||
129483141|NCT00356915|466059343|FG001|Overall Study|Non compliance|2|||
129483142|NCT00356915|466059344|FG002|Overall Study|Non compliance|1|||
129483143|NCT00356915|466059342|FG000|Overall Study|Protocol Violation|2|||
129483144|NCT00356915|466059343|FG001|Overall Study|Protocol Violation|3|||
129483145|NCT00356915|466059344|FG002|Overall Study|Protocol Violation|2|||
129483146|NCT00356915|466059342|FG000|Overall Study|Withdrawal by Subject|14|||
129483147|NCT00356915|466059343|FG001|Overall Study|Withdrawal by Subject|14|||
129483148|NCT00356915|466059344|FG002|Overall Study|Withdrawal by Subject|10|||
129483149|NCT00356915|466059342|FG000|Overall Study|Lack of Efficacy|0|||
129483150|NCT00356915|466059343|FG001|Overall Study|Lack of Efficacy|0|||
129483151|NCT00356915|466059344|FG002|Overall Study|Lack of Efficacy|3|||
129483152|NCT00356915|466059342|FG000|Overall Study|Lost to Follow-up|27|||
129483153|NCT00356915|466059343|FG001|Overall Study|Lost to Follow-up|34|||
129483154|NCT00356915|466059344|FG002|Overall Study|Lost to Follow-up|14|||
129483155|NCT00356915|466059342|FG000|Overall Study|Administrative Decision|0|||
129483156|NCT00356915|466059343|FG001|Overall Study|Administrative Decision|0|||
129483157|NCT00356915|466059344|FG002|Overall Study|Administrative Decision|1|||
129483158|NCT00356915|466059342|FG000|Overall Study|Physician Decision|0|||
129483159|NCT00356915|466059343|FG001|Overall Study|Physician Decision|2|||
129483160|NCT00356915|466059344|FG002|Overall Study|Physician Decision|0|||
129483161|NCT00356915|466059342|FG000|Overall Study|Adverse Event|21|||
129483162|NCT00356915|466059343|FG001|Overall Study|Adverse Event|31|||
129483163|NCT00356915|466059344|FG002|Overall Study|Adverse Event|8|||
129483164|NCT00356915|466059342|FG000|Overall Study|Miscellaneous reasons|11|||
129483165|NCT00356915|466059343|FG001|Overall Study|Miscellaneous reasons|8|||
129483166|NCT00356915|466059344|FG002|Overall Study|Miscellaneous reasons|3|||
129483167|NCT00509106|466059345|FG000|Overall Study|Adverse Event|3|||
129483168|NCT00509106|466059346|FG001|Overall Study|Adverse Event|2|||
129483169|NCT00509106|466059345|FG000|Overall Study|Noncompliance|0|||
129483170|NCT00509106|466059346|FG001|Overall Study|Noncompliance|1|||
129483171|NCT00509106|466059345|FG000|Overall Study|At the request of sponsor/investigator|1|||
129483172|NCT00509106|466059346|FG001|Overall Study|At the request of sponsor/investigator|2|||
129483173|NCT00509106|466059345|FG000|Overall Study|Withdrew consent|4|||
129483174|NCT00509106|466059346|FG001|Overall Study|Withdrew consent|8|||
129483175|NCT00509106|466059345|FG000|Overall Study|Lost to Follow-up|16|||
129483176|NCT00509106|466059346|FG001|Overall Study|Lost to Follow-up|10|||
129483177|NCT00509106|466059345|FG000|Overall Study|Other|1|||
129483178|NCT00509106|466059346|FG001|Overall Study|Other|0|||
129483179|NCT00509106|466059345|FG000|Overall Study|Death|6|||
129483180|NCT00509106|466059346|FG001|Overall Study|Death|6|||
129483181|NCT00824421|466059353|FG000|Overall Study|Adverse Event|6|||
129483182|NCT00824421|466059354|FG001|Overall Study|Adverse Event|6|||
129483183|NCT00824421|466059355|FG002|Overall Study|Adverse Event|6|||
129483184|NCT00824421|466059353|FG000|Overall Study|Death|0|||
129483185|NCT00824421|466059354|FG001|Overall Study|Death|1|||
129483186|NCT00824421|466059355|FG002|Overall Study|Death|0|||
129483187|NCT00824421|466059353|FG000|Overall Study|Lack of Efficacy|5|||
129483188|NCT00824421|466059354|FG001|Overall Study|Lack of Efficacy|7|||
129483189|NCT00824421|466059355|FG002|Overall Study|Lack of Efficacy|4|||
129483190|NCT00824421|466059353|FG000|Overall Study|Lost to Follow-up|2|||
129483191|NCT00824421|466059354|FG001|Overall Study|Lost to Follow-up|3|||
129483192|NCT00824421|466059355|FG002|Overall Study|Lost to Follow-up|0|||
129483193|NCT00824421|466059353|FG000|Overall Study|Pregnancy|1|||
129483194|NCT00824421|466059354|FG001|Overall Study|Pregnancy|0|||
129483195|NCT00824421|466059355|FG002|Overall Study|Pregnancy|1|||
129483196|NCT00824421|466059353|FG000|Overall Study|Withdrawal by Subject|2|||
129483197|NCT00824421|466059354|FG001|Overall Study|Withdrawal by Subject|3|||
129483198|NCT00824421|466059355|FG002|Overall Study|Withdrawal by Subject|3|||
129978561|NCT01559129|467883736|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
129483199|NCT00824421|466059353|FG000|Overall Study|Randomized but not Treated|1|||
129483200|NCT00824421|466059354|FG001|Overall Study|Randomized but not Treated|1|||
129483201|NCT00824421|466059355|FG002|Overall Study|Randomized but not Treated|0|||
129483202|NCT00824421|466059353|FG000|Overall Study|Other|0|||
129483203|NCT00824421|466059354|FG001|Overall Study|Other|1|||
129483204|NCT00824421|466059355|FG002|Overall Study|Other|0|||
129483205|NCT00659438|466059357|FG000|Overall Study|Withdrawal by Subject|2|||
129483206|NCT00659438|466059358|FG001|Overall Study|Withdrawal by Subject|2|||
129483207|NCT00659438|466059357|FG000|Overall Study|Death|11|||
129483208|NCT00659438|466059358|FG001|Overall Study|Death|6|||
129483209|NCT00659438|466059357|FG000|Overall Study|Lost to Follow-up|1|||
129483210|NCT00659438|466059358|FG001|Overall Study|Lost to Follow-up|0|||
129483211|NCT03953118|466059359|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
129483212|NCT03953118|466059360|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
129483213|NCT02034123|466059365|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483214|NCT02034123|466059366|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483215|NCT02034123|466059367|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483216|NCT02034123|466059368|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483217|NCT02034123|466059369|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
129483218|NCT02034123|466059370|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483219|NCT02034123|466059371|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483220|NCT02034123|466059372|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
129483221|NCT02034123|466059373|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
129483222|NCT02034123|466059374|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483223|NCT02034123|466059375|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483224|NCT02034123|466059376|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483225|NCT02034123|466059377|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483226|NCT02034123|466059378|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483227|NCT02034123|466059379|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483228|NCT02034123|466059380|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483229|NCT02034123|466059381|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483230|NCT02034123|466059382|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
129483231|NCT02034123|466059365|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483232|NCT02034123|466059366|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483233|NCT02034123|466059367|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483234|NCT02034123|466059368|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
129483235|NCT02034123|466059369|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483236|NCT02034123|466059370|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483237|NCT02034123|466059371|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483238|NCT02034123|466059372|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483239|NCT02034123|466059373|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483240|NCT02034123|466059374|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483241|NCT02034123|466059375|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483242|NCT02034123|466059376|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483243|NCT02034123|466059377|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483244|NCT02034123|466059378|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483245|NCT02034123|466059379|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483246|NCT02034123|466059380|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483247|NCT02034123|466059381|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483248|NCT02034123|466059382|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
129483249|NCT02034123|466059365|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483250|NCT02034123|466059366|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483251|NCT02034123|466059367|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483252|NCT02034123|466059368|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483253|NCT02034123|466059369|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483254|NCT02034123|466059370|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483255|NCT02034123|466059371|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483256|NCT02034123|466059372|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483257|NCT02034123|466059373|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
129483258|NCT02034123|466059374|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483259|NCT02034123|466059375|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483260|NCT02034123|466059376|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483261|NCT02034123|466059377|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483262|NCT02034123|466059378|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483263|NCT02034123|466059379|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483264|NCT02034123|466059380|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483265|NCT02034123|466059381|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483266|NCT02034123|466059382|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
129483267|NCT02034123|466059365|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483268|NCT02034123|466059366|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483269|NCT02034123|466059367|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483270|NCT02034123|466059368|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
129483271|NCT02034123|466059369|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
129483272|NCT02034123|466059370|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483273|NCT02034123|466059371|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483274|NCT02034123|466059372|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483275|NCT02034123|466059373|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483276|NCT02034123|466059374|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483277|NCT02034123|466059375|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483278|NCT02034123|466059376|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483279|NCT02034123|466059377|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483280|NCT02034123|466059378|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483281|NCT02034123|466059379|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483282|NCT02034123|466059380|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483283|NCT02034123|466059381|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483284|NCT02034123|466059382|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
129483285|NCT03133767|466059384|FG000|Overall Study|Lost to Follow-up|38|||
129483286|NCT03133767|466059385|FG001|Overall Study|Lost to Follow-up|24|||
129483287|NCT03133767|466059384|FG000|Overall Study|Protocol Violation|0|||
129483288|NCT03133767|466059385|FG001|Overall Study|Protocol Violation|1|||
129483289|NCT02240706|466059388|FG000|Overall Study|Lack of Efficacy|2|||
129483290|NCT02240706|466059389|FG001|Overall Study|Lack of Efficacy|2|||
129483291|NCT02240706|466059390|FG002|Overall Study|Lack of Efficacy|2|||
129483292|NCT02240706|466059391|FG003|Overall Study|Lack of Efficacy|2|||
129483293|NCT02240706|466059392|FG004|Overall Study|Lack of Efficacy|5|||
129483294|NCT02240706|466059393|FG005|Overall Study|Lack of Efficacy|0|||
129483295|NCT02240706|466059394|FG006|Overall Study|Lack of Efficacy|0|||
129483296|NCT02240706|466059388|FG000|Overall Study|Adverse Event|1|||
129483297|NCT02240706|466059389|FG001|Overall Study|Adverse Event|0|||
129483298|NCT02240706|466059390|FG002|Overall Study|Adverse Event|1|||
129483299|NCT02240706|466059391|FG003|Overall Study|Adverse Event|0|||
129483300|NCT02240706|466059392|FG004|Overall Study|Adverse Event|2|||
129483301|NCT02240706|466059393|FG005|Overall Study|Adverse Event|0|||
129483302|NCT02240706|466059394|FG006|Overall Study|Adverse Event|0|||
129483303|NCT02240706|466059388|FG000|Overall Study|Progressive disease|0|||
129483304|NCT02240706|466059389|FG001|Overall Study|Progressive disease|0|||
129483305|NCT02240706|466059390|FG002|Overall Study|Progressive disease|0|||
129483306|NCT02240706|466059391|FG003|Overall Study|Progressive disease|0|||
129483307|NCT02240706|466059392|FG004|Overall Study|Progressive disease|1|||
129483308|NCT02240706|466059393|FG005|Overall Study|Progressive disease|0|||
129483309|NCT02240706|466059394|FG006|Overall Study|Progressive disease|0|||
129483310|NCT02240706|466059388|FG000|Overall Study|Dose limiting toxicity|0|||
129483311|NCT02240706|466059389|FG001|Overall Study|Dose limiting toxicity|0|||
129483312|NCT02240706|466059390|FG002|Overall Study|Dose limiting toxicity|0|||
129483313|NCT02240706|466059391|FG003|Overall Study|Dose limiting toxicity|0|||
129483314|NCT02240706|466059392|FG004|Overall Study|Dose limiting toxicity|1|||
129483315|NCT02240706|466059393|FG005|Overall Study|Dose limiting toxicity|0|||
129483316|NCT02240706|466059394|FG006|Overall Study|Dose limiting toxicity|0|||
129483317|NCT02240706|466059388|FG000|Overall Study|Refused to continue taking medication|0|||
129483318|NCT02240706|466059389|FG001|Overall Study|Refused to continue taking medication|1|||
129483319|NCT02240706|466059390|FG002|Overall Study|Refused to continue taking medication|3|||
129483320|NCT02240706|466059391|FG003|Overall Study|Refused to continue taking medication|1|||
129483321|NCT02240706|466059392|FG004|Overall Study|Refused to continue taking medication|2|||
129483322|NCT02240706|466059393|FG005|Overall Study|Refused to continue taking medication|0|||
129483323|NCT02240706|466059394|FG006|Overall Study|Refused to continue taking medication|0|||
129483324|NCT02240706|466059388|FG000|Overall Study|Insurance billing concerns|0|||
129483325|NCT02240706|466059389|FG001|Overall Study|Insurance billing concerns|0|||
129483326|NCT02240706|466059390|FG002|Overall Study|Insurance billing concerns|0|||
129483327|NCT02240706|466059391|FG003|Overall Study|Insurance billing concerns|1|||
129483328|NCT02240706|466059392|FG004|Overall Study|Insurance billing concerns|0|||
129483329|NCT02240706|466059393|FG005|Overall Study|Insurance billing concerns|0|||
129483330|NCT02240706|466059394|FG006|Overall Study|Insurance billing concerns|0|||
129483331|NCT03301857|466059395|FG000|Overall Study|Death|0|||
129483332|NCT03301857|466059396|FG001|Overall Study|Death|2|||
129483333|NCT03301857|466059395|FG000|Overall Study|Lost to Follow-up|4|||
129483334|NCT03301857|466059396|FG001|Overall Study|Lost to Follow-up|2|||
129483335|NCT03301857|466059395|FG000|Overall Study|Decision by Sponsor|6|||
129483336|NCT03301857|466059396|FG001|Overall Study|Decision by Sponsor|0|||
129483337|NCT03301857|466059395|FG000|Overall Study|Withdrawal by Subject|12|||
129978562|NCT01559129|467883737|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
129978563|NCT00368927|467883738|FG000|Overall Study|Lost to Follow-up|2|||
129483338|NCT03301857|466059396|FG001|Overall Study|Withdrawal by Subject|4|||
129483339|NCT00855439|466059397|FG000|Overall Study|Withdrawal by Subject|2|||
129483340|NCT00855439|466059398|FG001|Overall Study|Withdrawal by Subject|0|||
129483341|NCT00855439|466059397|FG000|Overall Study|Pregnancy|1|||
129483342|NCT00855439|466059398|FG001|Overall Study|Pregnancy|0|||
129483343|NCT00613626|466059404|FG000|Overall Study|Ineligible|0|||
129483344|NCT00613626|466059405|FG001|Overall Study|Ineligible|1|||
129483345|NCT00613626|466059406|FG002|Overall Study|Ineligible|0|||
129483346|NCT01299025|466059407|FG000|Overall Study|Withdrawal by Subject|2|||
129483347|NCT01299025|466059408|FG001|Overall Study|Withdrawal by Subject|1|||
129483348|NCT01299025|466059407|FG000|Overall Study|Lost to Follow-up|1|||
129483349|NCT01299025|466059408|FG001|Overall Study|Lost to Follow-up|0|||
129483350|NCT04091217|466059409|FG000|Overall Study|Lost to Follow-up|2|||
129483351|NCT04885257|466059410|FG000|Overall Study|Withdrawal by Subject|1|||
129483352|NCT04885257|466059411|FG001|Overall Study|Withdrawal by Subject|0|||
129483353|NCT01731002|466059421|FG000|Overall Study|Adverse Event|0|||
129483354|NCT01731002|466059422|FG001|Overall Study|Adverse Event|2|||
129483355|NCT01731002|466059423|FG002|Overall Study|Adverse Event|2|||
129483356|NCT01731002|466059421|FG000|Overall Study|Non-Compliant|0|||
129483357|NCT01731002|466059422|FG001|Overall Study|Non-Compliant|1|||
129483358|NCT01731002|466059423|FG002|Overall Study|Non-Compliant|0|||
129483359|NCT01731002|466059421|FG000|Overall Study|Lost to Follow-up|1|||
129483360|NCT01731002|466059422|FG001|Overall Study|Lost to Follow-up|0|||
129483361|NCT01731002|466059423|FG002|Overall Study|Lost to Follow-up|0|||
129483362|NCT01731002|466059421|FG000|Overall Study|Test Agent Discontinuation|0|||
129483363|NCT01731002|466059422|FG001|Overall Study|Test Agent Discontinuation|1|||
129483364|NCT01731002|466059423|FG002|Overall Study|Test Agent Discontinuation|0|||
129483365|NCT01731002|466059421|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
129483366|NCT01731002|466059422|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
129483367|NCT01731002|466059423|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
129483368|NCT01731002|466059421|FG000|Overall Study|Elevated IOP|1|||
129483369|NCT01731002|466059422|FG001|Overall Study|Elevated IOP|0|||
129483370|NCT01731002|466059423|FG002|Overall Study|Elevated IOP|0|||
129483371|NCT01731002|466059421|FG000|Overall Study|Inappropriate use of study medications|0|||
129483372|NCT01731002|466059422|FG001|Overall Study|Inappropriate use of study medications|0|||
129483373|NCT01731002|466059423|FG002|Overall Study|Inappropriate use of study medications|1|||
129483374|NCT03542682|466059424|FG000|Overall Study|COVID-19 Protocol|0|||
129483375|NCT03542682|466059425|FG001|Overall Study|COVID-19 Protocol|1|||
129483376|NCT01659151|466059429|FG000|Overall Study|Inadequate TIL growth|1|||
129483377|NCT03972488|466059430|FG000|Overall Study|Progressive disease|42|||
129483378|NCT03972488|466059431|FG001|Overall Study|Progressive disease|44|||
129483379|NCT03972488|466059430|FG000|Overall Study|Physician Decision|13|||
129483380|NCT03972488|466059431|FG001|Overall Study|Physician Decision|7|||
129483381|NCT03972488|466059430|FG000|Overall Study|Adverse Event|8|||
129483382|NCT03972488|466059431|FG001|Overall Study|Adverse Event|1|||
129483383|NCT03972488|466059430|FG000|Overall Study|Death|4|||
129483384|NCT03972488|466059431|FG001|Overall Study|Death|4|||
129483385|NCT03972488|466059430|FG000|Overall Study|Withdrawal by Subject|3|||
129483386|NCT03972488|466059431|FG001|Overall Study|Withdrawal by Subject|4|||
129483387|NCT03972488|466059430|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
129483388|NCT03972488|466059431|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
129483389|NCT04865731|466059432|FG000|Overall Study|Physician Decision|2|||
129483390|NCT04865731|466059433|FG001|Overall Study|Physician Decision|1|||
129483391|NCT04865731|466059432|FG000|Overall Study|Adverse Event|1|||
129483392|NCT04865731|466059433|FG001|Overall Study|Adverse Event|0|||
129483393|NCT04865731|466059432|FG000|Overall Study|Withdrawal by Subject|0|||
129483394|NCT04865731|466059433|FG001|Overall Study|Withdrawal by Subject|1|||
129483395|NCT01672892|466060707|FG000|Overall Study|Protocol Violation|7|||
129483396|NCT01672892|466060708|FG001|Overall Study|Protocol Violation|3|||
129483397|NCT00886821|466060720|FG000|Stage 2|Adverse Event|0|||
129483398|NCT00886821|466060721|FG001|Stage 2|Adverse Event|0|||
129483399|NCT00886821|466060722|FG002|Stage 2|Adverse Event|0|||
129483400|NCT00886821|466060723|FG003|Stage 2|Adverse Event|0|||
129483401|NCT00886821|466060724|FG004|Stage 2|Adverse Event|0|||
129483402|NCT00886821|466060725|FG005|Stage 2|Adverse Event|0|||
129483403|NCT00886821|466060726|FG006|Stage 2|Adverse Event|0|||
129483404|NCT00886821|466060727|FG007|Stage 2|Adverse Event|0|||
129483405|NCT00886821|466060728|FG008|Stage 2|Adverse Event|0|||
129483406|NCT00886821|466060729|FG009|Stage 2|Adverse Event|0|||
129483407|NCT00886821|466060730|FG010|Stage 2|Adverse Event|0|||
129483408|NCT00886821|466060731|FG011|Stage 2|Adverse Event|1|||
129483409|NCT00886821|466060732|FG012|Stage 2|Adverse Event|3|||
129483410|NCT00886821|466060733|FG013|Stage 2|Adverse Event|0|||
129483411|NCT00886821|466060720|FG000|Stage 2|Lost to Follow-up|0|||
129483412|NCT00886821|466060721|FG001|Stage 2|Lost to Follow-up|0|||
129483413|NCT00886821|466060722|FG002|Stage 2|Lost to Follow-up|0|||
129483414|NCT00886821|466060723|FG003|Stage 2|Lost to Follow-up|0|||
129483415|NCT00886821|466060724|FG004|Stage 2|Lost to Follow-up|0|||
129483416|NCT00886821|466060725|FG005|Stage 2|Lost to Follow-up|0|||
129483417|NCT00886821|466060726|FG006|Stage 2|Lost to Follow-up|0|||
129483418|NCT00886821|466060727|FG007|Stage 2|Lost to Follow-up|0|||
129483419|NCT00886821|466060728|FG008|Stage 2|Lost to Follow-up|0|||
129483420|NCT00886821|466060729|FG009|Stage 2|Lost to Follow-up|0|||
129483421|NCT00886821|466060730|FG010|Stage 2|Lost to Follow-up|0|||
129483422|NCT00886821|466060731|FG011|Stage 2|Lost to Follow-up|0|||
129483423|NCT00886821|466060732|FG012|Stage 2|Lost to Follow-up|2|||
129483424|NCT00886821|466060733|FG013|Stage 2|Lost to Follow-up|1|||
129483425|NCT00914628|466060734|FG000|Overall Study|Death|35|||
129483426|NCT00914628|466060735|FG001|Overall Study|Death|17|||
129483427|NCT00914628|466060734|FG000|Overall Study|Medical decision|4|||
129483428|NCT00914628|466060735|FG001|Overall Study|Medical decision|0|||
129483429|NCT00914628|466060734|FG000|Overall Study|Protocol Violation|1|||
129483430|NCT00914628|466060735|FG001|Overall Study|Protocol Violation|0|||
129483431|NCT00914628|466060734|FG000|Overall Study|Lack of Efficacy|1|||
129483432|NCT00914628|466060735|FG001|Overall Study|Lack of Efficacy|0|||
129483433|NCT00914628|466060734|FG000|Overall Study|non-randomized|1|||
129483434|NCT00914628|466060735|FG001|Overall Study|non-randomized|0|||
129483435|NCT00914628|466060734|FG000|Overall Study|Relapse|1|||
129483436|NCT00914628|466060735|FG001|Overall Study|Relapse|2|||
129483437|NCT00914628|466060734|FG000|Overall Study|Study terminated by Sponsor|14|||
129483438|NCT00914628|466060735|FG001|Overall Study|Study terminated by Sponsor|8|||
129483439|NCT00914628|466060734|FG000|Overall Study|Patients who did not receive a single dose|7|||
129483440|NCT00914628|466060735|FG001|Overall Study|Patients who did not receive a single dose|1|||
129483441|NCT03311126|466060736|FG000|Induction|Death|1|||
129483442|NCT03311126|466060736|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
129483443|NCT02579603|466060737|FG000|Overall Study|Not treated|1|||
129483444|NCT02579603|466060738|FG001|Overall Study|Not treated|0|||
129483445|NCT02579603|466060737|FG000|Overall Study|Adverse Event|2|||
129483446|NCT02579603|466060738|FG001|Overall Study|Adverse Event|2|||
129483447|NCT02579603|466060737|FG000|Overall Study|Other than stated|1|||
129483448|NCT02579603|466060738|FG001|Overall Study|Other than stated|0|||
129483449|NCT00469079|466060739|FG000|Overall Study|Lack of Efficacy|3|||
129483450|NCT00469079|466060740|FG001|Overall Study|Lack of Efficacy|8|||
129483451|NCT00469079|466060741|FG002|Overall Study|Lack of Efficacy|5|||
129483452|NCT00469079|466060739|FG000|Overall Study|Adverse Event|1|||
129483453|NCT00469079|466060740|FG001|Overall Study|Adverse Event|3|||
129483454|NCT00469079|466060741|FG002|Overall Study|Adverse Event|2|||
129483455|NCT00469079|466060739|FG000|Overall Study|Lost to Follow-up|4|||
129483456|NCT00469079|466060740|FG001|Overall Study|Lost to Follow-up|8|||
129483457|NCT00469079|466060741|FG002|Overall Study|Lost to Follow-up|10|||
129483458|NCT00469079|466060739|FG000|Overall Study|Withdrawal by Subject|1|||
129483459|NCT00469079|466060740|FG001|Overall Study|Withdrawal by Subject|2|||
129483460|NCT00469079|466060741|FG002|Overall Study|Withdrawal by Subject|2|||
129483461|NCT00469079|466060739|FG000|Overall Study|Ineligible|0|||
129483462|NCT00469079|466060740|FG001|Overall Study|Ineligible|1|||
129483463|NCT00469079|466060741|FG002|Overall Study|Ineligible|0|||
129483464|NCT01006356|466060742|FG000|Overall Study|Adverse Event|6|||
129483465|NCT01006356|466060742|FG000|Overall Study|Physician Decision|1|||
129483466|NCT01006356|466060742|FG000|Overall Study|Paticipants did not cooperate|6|||
129483467|NCT01006356|466060742|FG000|Overall Study|Withdrawal by Subject|1|||
129483468|NCT01006356|466060742|FG000|Overall Study|Choice by participants|2|||
129483469|NCT01006356|466060742|FG000|Overall Study|Protocol Violation|3|||
129483470|NCT01006356|466060742|FG000|Overall Study|Other|23|||
129483471|NCT01756157|466060747|FG000|First Intervention Period|Withdrawal by Subject|1|||
129483472|NCT01756157|466060748|FG001|First Intervention Period|Withdrawal by Subject|0|||
129483473|NCT01756157|466060747|FG000|First Intervention Period|Lost to Follow-up|0|||
129483474|NCT01756157|466060748|FG001|First Intervention Period|Lost to Follow-up|2|||
129483475|NCT03368859|466060749|FG000|Overall Study|Withdrew Consent|5|||
129483476|NCT03368859|466060750|FG001|Overall Study|Withdrew Consent|4|||
129483477|NCT03368859|466060749|FG000|Overall Study|Death|12|||
129483478|NCT03368859|466060750|FG001|Overall Study|Death|6|||
129483479|NCT03368859|466060749|FG000|Overall Study|Study terminated by Sponsor|18|||
129483480|NCT03368859|466060750|FG001|Overall Study|Study terminated by Sponsor|23|||
129483481|NCT03368859|466060749|FG000|Overall Study|Other|1|||
129483482|NCT03368859|466060750|FG001|Overall Study|Other|1|||
129483483|NCT02424539|466060755|FG000|Overall Study|Adverse Event|0|||
129483484|NCT02424539|466060756|FG001|Overall Study|Adverse Event|0|||
129483485|NCT02424539|466060757|FG002|Overall Study|Adverse Event|1|||
129483486|NCT02424539|466060755|FG000|Overall Study|Physician Decision|0|||
129483487|NCT02424539|466060756|FG001|Overall Study|Physician Decision|0|||
129483488|NCT02424539|466060757|FG002|Overall Study|Physician Decision|1|||
129483489|NCT02424539|466060755|FG000|Overall Study|Withdrawal by Subject|3|||
129483490|NCT02424539|466060756|FG001|Overall Study|Withdrawal by Subject|1|||
129483491|NCT02424539|466060757|FG002|Overall Study|Withdrawal by Subject|0|||
129483492|NCT02424539|466060755|FG000|Overall Study|Other: Reached stopping criteria|11|||
129483493|NCT02424539|466060756|FG001|Overall Study|Other: Reached stopping criteria|7|||
129483494|NCT02424539|466060757|FG002|Overall Study|Other: Reached stopping criteria|6|||
129483495|NCT04893265|466060758|FG000|Overall Study|Withdrawal by Subject|2|||
129483496|NCT04893265|466060759|FG001|Overall Study|Withdrawal by Subject|5|||
129483497|NCT04893265|466060758|FG000|Overall Study|Lost to Follow-up|0|||
129483498|NCT04893265|466060759|FG001|Overall Study|Lost to Follow-up|4|||
129483499|NCT00573131|466060760|FG000|Overall Study|Withdrawal by Subject|10|||
129483500|NCT00573131|466060761|FG001|Overall Study|Withdrawal by Subject|8|||
129483501|NCT00893789|466060762|FG000|Overall Study|Withdrawal by Subject|3|||
129483502|NCT00893789|466060763|FG001|Overall Study|Withdrawal by Subject|1|||
129483503|NCT00893789|466060764|FG002|Overall Study|Withdrawal by Subject|3|||
129483504|NCT00893789|466060765|FG003|Overall Study|Withdrawal by Subject|1|||
129483505|NCT00893789|466060762|FG000|Overall Study|Noncompliance With Study Drug|1|||
129483506|NCT00893789|466060763|FG001|Overall Study|Noncompliance With Study Drug|0|||
129483507|NCT00893789|466060764|FG002|Overall Study|Noncompliance With Study Drug|1|||
129483508|NCT00893789|466060765|FG003|Overall Study|Noncompliance With Study Drug|2|||
129483509|NCT00893789|466060762|FG000|Overall Study|Noncompliance With Study Procedures|1|||
129483510|NCT00893789|466060763|FG001|Overall Study|Noncompliance With Study Procedures|0|||
129483511|NCT00893789|466060764|FG002|Overall Study|Noncompliance With Study Procedures|0|||
129483512|NCT00893789|466060765|FG003|Overall Study|Noncompliance With Study Procedures|0|||
129483513|NCT00893789|466060762|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
129483514|NCT00893789|466060763|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
129483515|NCT00893789|466060764|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
129483516|NCT00893789|466060765|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
129483517|NCT00893789|466060762|FG000|Overall Study|Adverse Event|0|||
129483518|NCT00893789|466060763|FG001|Overall Study|Adverse Event|2|||
129483519|NCT00893789|466060764|FG002|Overall Study|Adverse Event|1|||
129483520|NCT00893789|466060765|FG003|Overall Study|Adverse Event|5|||
129483521|NCT00893789|466060762|FG000|Overall Study|Protocol Violation|0|||
129483522|NCT00893789|466060763|FG001|Overall Study|Protocol Violation|1|||
129483523|NCT00893789|466060764|FG002|Overall Study|Protocol Violation|1|||
129483524|NCT00893789|466060765|FG003|Overall Study|Protocol Violation|4|||
129483525|NCT00893789|466060762|FG000|Overall Study|Lost to Follow-up|0|||
129483526|NCT00893789|466060763|FG001|Overall Study|Lost to Follow-up|0|||
129483527|NCT00893789|466060764|FG002|Overall Study|Lost to Follow-up|0|||
129483528|NCT00893789|466060765|FG003|Overall Study|Lost to Follow-up|1|||
129483529|NCT02024464|466060766|FG000|Overall Study|Discontinued|5|||
129483530|NCT02024464|466060767|FG001|Overall Study|Discontinued|4|||
129483531|NCT02024464|466060766|FG000|Overall Study|Missed Visits|1|||
129483532|NCT02024464|466060767|FG001|Overall Study|Missed Visits|0|||
129483533|NCT02024464|466060766|FG000|Overall Study|Lost to Follow-up|4|||
129483534|NCT02024464|466060767|FG001|Overall Study|Lost to Follow-up|7|||
129483535|NCT01973283|466060770|FG000|Overall Study|Lost to Follow-up|4|||
129483536|NCT00087438|466060772|FG000|Overall Study|Ineligible / No protocol treatment|4|||
129483537|NCT00466505|466060773|FG000|Overall Study|disease progression|13|||
129483538|NCT00466505|466060773|FG000|Overall Study|Adverse Event|4|||
129483539|NCT00811252|466060774|FG000|Overall Study|Adverse Event|6|||
129483540|NCT00811252|466060775|FG001|Overall Study|Adverse Event|10|||
129483541|NCT00811252|466060776|FG002|Overall Study|Adverse Event|15|||
129483542|NCT00811252|466060774|FG000|Overall Study|Lack of Efficacy|7|||
129483543|NCT00811252|466060775|FG001|Overall Study|Lack of Efficacy|2|||
129483544|NCT00811252|466060776|FG002|Overall Study|Lack of Efficacy|0|||
129483545|NCT00811252|466060774|FG000|Overall Study|Protocol Violation|3|||
129483546|NCT00811252|466060775|FG001|Overall Study|Protocol Violation|3|||
129483547|NCT00811252|466060776|FG002|Overall Study|Protocol Violation|2|||
129483548|NCT00811252|466060774|FG000|Overall Study|Withdrawal of Consent|1|||
129483549|NCT00811252|466060775|FG001|Overall Study|Withdrawal of Consent|2|||
129483550|NCT00811252|466060776|FG002|Overall Study|Withdrawal of Consent|2|||
129483551|NCT00811252|466060774|FG000|Overall Study|Lost to Follow-up|0|||
129483552|NCT00811252|466060775|FG001|Overall Study|Lost to Follow-up|0|||
129483553|NCT00811252|466060776|FG002|Overall Study|Lost to Follow-up|2|||
129483554|NCT00811252|466060774|FG000|Overall Study|Administrative or Other Reasons|0|||
129483555|NCT00811252|466060775|FG001|Overall Study|Administrative or Other Reasons|3|||
129483556|NCT00811252|466060776|FG002|Overall Study|Administrative or Other Reasons|2|||
129483557|NCT01931865|466060777|FG000|Overall Study|Lost to Follow-up|2|||
129483558|NCT01931865|466060777|FG000|Overall Study|Withdrawal by Subject|2|||
129483559|NCT00488631|466060783|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
129483560|NCT00488631|466060784|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
129483561|NCT00488631|466060785|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
129483562|NCT00488631|466060786|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
129483563|NCT00488631|466060787|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
129483564|NCT00488631|466060788|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
129483565|NCT00488631|466060789|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
129483566|NCT00488631|466060790|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
129483567|NCT00488631|466060791|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
129483568|NCT00488631|466060792|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
129483569|NCT00488631|466060783|FG000|Double Blind Period (Week 0-54)|Death|0|||
129483570|NCT00488631|466060784|FG001|Double Blind Period (Week 0-54)|Death|0|||
129483571|NCT00488631|466060785|FG002|Double Blind Period (Week 0-54)|Death|0|||
129483572|NCT00488631|466060786|FG003|Double Blind Period (Week 0-54)|Death|0|||
129483573|NCT00488631|466060787|FG004|Double Blind Period (Week 0-54)|Death|0|||
129483574|NCT00488631|466060788|FG005|Double Blind Period (Week 0-54)|Death|1|||
129483575|NCT00488631|466060789|FG006|Double Blind Period (Week 0-54)|Death|0|||
129483576|NCT00488631|466060790|FG007|Double Blind Period (Week 0-54)|Death|0|||
129483577|NCT00488631|466060791|FG008|Double Blind Period (Week 0-54)|Death|0|||
129483578|NCT00488631|466060792|FG009|Double Blind Period (Week 0-54)|Death|0|||
129483579|NCT00488631|466060783|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
129483580|NCT00488631|466060784|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
129483581|NCT00488631|466060785|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
129483582|NCT00488631|466060786|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
129483583|NCT00488631|466060787|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
129483584|NCT00488631|466060788|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
129483585|NCT00488631|466060789|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
129483586|NCT00488631|466060790|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
129483587|NCT00488631|466060791|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
129483588|NCT00488631|466060792|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
129483589|NCT00488631|466060783|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
129483590|NCT00488631|466060784|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
129483591|NCT00488631|466060785|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
129483592|NCT00488631|466060786|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
129483593|NCT00488631|466060787|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
129483594|NCT00488631|466060788|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
129483595|NCT00488631|466060789|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
129483596|NCT00488631|466060790|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
129483597|NCT00488631|466060791|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
129483598|NCT00488631|466060792|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
129483599|NCT00488631|466060783|FG000|Double Blind Period (Week 0-54)|Other|6|||
129483600|NCT00488631|466060784|FG001|Double Blind Period (Week 0-54)|Other|12|||
129483601|NCT00488631|466060785|FG002|Double Blind Period (Week 0-54)|Other|10|||
129483602|NCT00488631|466060786|FG003|Double Blind Period (Week 0-54)|Other|11|||
129483603|NCT00488631|466060787|FG004|Double Blind Period (Week 0-54)|Other|14|||
129483604|NCT00488631|466060788|FG005|Double Blind Period (Week 0-54)|Other|34|||
129483605|NCT00488631|466060789|FG006|Double Blind Period (Week 0-54)|Other|0|||
129483606|NCT00488631|466060790|FG007|Double Blind Period (Week 0-54)|Other|0|||
129483607|NCT00488631|466060791|FG008|Double Blind Period (Week 0-54)|Other|0|||
129483608|NCT00488631|466060792|FG009|Double Blind Period (Week 0-54)|Other|0|||
129483609|NCT00488631|466060783|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483610|NCT00488631|466060784|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483611|NCT00488631|466060785|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483612|NCT00488631|466060786|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483613|NCT00488631|466060787|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483614|NCT00488631|466060788|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483615|NCT00488631|466060789|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
129483616|NCT00488631|466060790|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
129483617|NCT00488631|466060791|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
129483618|NCT00488631|466060792|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
129483619|NCT00488631|466060783|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
129483620|NCT00488631|466060784|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
129483621|NCT00488631|466060785|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
129483622|NCT00488631|466060786|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
129483623|NCT00488631|466060787|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
129483624|NCT00488631|466060788|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
129483625|NCT00488631|466060789|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
129483626|NCT00488631|466060790|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
129483627|NCT00488631|466060791|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
129483628|NCT00488631|466060792|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
129483629|NCT00488631|466060783|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
129483630|NCT00488631|466060784|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
129483631|NCT00488631|466060785|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
129483632|NCT00488631|466060786|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
129483633|NCT00488631|466060787|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
129483634|NCT00488631|466060788|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
129483635|NCT00488631|466060789|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
129483636|NCT00488631|466060790|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
129483637|NCT00488631|466060791|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
129483638|NCT00488631|466060792|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
129483639|NCT00488631|466060783|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483640|NCT00488631|466060784|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483641|NCT00488631|466060785|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483642|NCT00488631|466060786|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483643|NCT00488631|466060787|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483644|NCT00488631|466060788|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483645|NCT00488631|466060789|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
129483646|NCT00488631|466060790|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483647|NCT00488631|466060791|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
129483648|NCT00488631|466060792|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
129483649|NCT00488631|466060783|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483650|NCT00488631|466060784|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483651|NCT00488631|466060785|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483652|NCT00488631|466060786|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483653|NCT00488631|466060787|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483654|NCT00488631|466060788|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483655|NCT00488631|466060789|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
129483656|NCT00488631|466060790|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
129483657|NCT00488631|466060791|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
129483658|NCT00488631|466060792|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
129483659|NCT00927485|466060793|FG000|Overall Study|Adverse Event|4|||
129483660|NCT00927485|466060794|FG001|Overall Study|Adverse Event|2|||
129483661|NCT00927485|466060793|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
129483662|NCT00927485|466060794|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
129483663|NCT03486314|466060795|FG000|Part A|Adverse Event|1|||
129483664|NCT03486314|466060796|FG001|Part A|Adverse Event|0|||
129483665|NCT03486314|466060797|FG002|Part A|Adverse Event|0|||
129483666|NCT03486314|466060795|FG000|Part A|Symptomatic Deterioration|2|||
129483667|NCT03486314|466060796|FG001|Part A|Symptomatic Deterioration|0|||
129483668|NCT03486314|466060797|FG002|Part A|Symptomatic Deterioration|0|||
129483669|NCT00246259|466060799|FG000|Overall Study|Other|3|||
129483670|NCT00246259|466060800|FG001|Overall Study|Other|3|||
129483671|NCT00246259|466060799|FG000|Overall Study|Not stable by Week 18|2|||
129483672|NCT00246259|466060800|FG001|Overall Study|Not stable by Week 18|1|||
129483673|NCT00246259|466060799|FG000|Overall Study|Participant non-compliant|4|||
129483674|NCT00246259|466060800|FG001|Overall Study|Participant non-compliant|9|||
129483675|NCT00246259|466060799|FG000|Overall Study|Lack of Efficacy|2|||
129483676|NCT00246259|466060800|FG001|Overall Study|Lack of Efficacy|2|||
129483677|NCT00246259|466060799|FG000|Overall Study|Investigator withdrew participant|2|||
129483678|NCT00246259|466060800|FG001|Overall Study|Investigator withdrew participant|0|||
129483679|NCT00246259|466060799|FG000|Overall Study|Adverse Event|5|||
129483680|NCT00246259|466060800|FG001|Overall Study|Adverse Event|0|||
129483681|NCT00246259|466060799|FG000|Overall Study|Lost to Follow-up|3|||
129483682|NCT00246259|466060800|FG001|Overall Study|Lost to Follow-up|4|||
129483683|NCT00246259|466060799|FG000|Overall Study|Withdrawal by Subject|5|||
129483684|NCT00246259|466060800|FG001|Overall Study|Withdrawal by Subject|1|||
129483685|NCT00246259|466060799|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
129483686|NCT00246259|466060800|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
129483687|NCT02333227|466060806|FG000|Overall Study|Lost to Follow-up|137|||
129483688|NCT02333227|466060807|FG001|Overall Study|Lost to Follow-up|106|||
129483689|NCT02333227|466060806|FG000|Overall Study|Pregnancy Interrupted|42|||
129483690|NCT02333227|466060807|FG001|Overall Study|Pregnancy Interrupted|89|||
129483691|NCT02333227|466060806|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
129483692|NCT02333227|466060807|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
129483693|NCT00816036|466060810|FG000|Overall Study|Death|47|||
129483694|NCT00816036|466060811|FG001|Overall Study|Death|28|||
129483695|NCT00816036|466060810|FG000|Overall Study|Lost to Follow-up|75|||
129483696|NCT00816036|466060811|FG001|Overall Study|Lost to Follow-up|57|||
129483697|NCT00816036|466060810|FG000|Overall Study|Withdrawal by Subject|54|||
129483698|NCT00816036|466060811|FG001|Overall Study|Withdrawal by Subject|23|||
129483699|NCT01624194|466060812|FG000|Overall Study|Lost to Follow-up|1|||
129483700|NCT01624194|466060813|FG001|Overall Study|Lost to Follow-up|0|||
129483701|NCT01624194|466060812|FG000|Overall Study|Withdrawal by Subject|1|||
129483702|NCT01624194|466060813|FG001|Overall Study|Withdrawal by Subject|0|||
129483703|NCT03212261|466060814|FG000|Overall Study|Became ineligible d/t tech|2|||
129483704|NCT03212261|466060814|FG000|Overall Study|Tech Trouble- No first study visit|1|||
129483705|NCT03212261|466060814|FG000|Overall Study|Lost to Follow-up|7|||
129483706|NCT03212261|466060814|FG000|Overall Study|Family Emergency|1|||
129483707|NCT03212261|466060814|FG000|Overall Study|Too busy/ No time|5|||
129483708|NCT01076179|466060815|FG000|Overall Study|Withdrawal by Subject|1|||
129483709|NCT05480514|466060816|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
129483710|NCT05480514|466060817|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
129483711|NCT05480514|466060816|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
129483712|NCT05480514|466060817|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
129483713|NCT05480514|466060816|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
129483714|NCT05480514|466060817|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
129483715|NCT05480514|466060816|FG000|Period 1|Covid-19 Related|1|||
129483716|NCT05480514|466060817|FG001|Period 1|Covid-19 Related|0|||
129483717|NCT05480514|466060816|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
129483718|NCT05480514|466060817|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
129483719|NCT00457639|466060818|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
129483720|NCT00457639|466060819|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
129483721|NCT00457639|466060818|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
129483722|NCT00457639|466060819|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
129483723|NCT00457639|466060818|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
129483724|NCT00457639|466060819|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
129483725|NCT00628355|466060822|FG000|Overall Study|Withdrawal by Subject|1|||
129483726|NCT00628355|466060823|FG001|Overall Study|Withdrawal by Subject|1|||
129483727|NCT01901328|466060826|FG000|Overall Study|Lost to Follow-up|1|||
129483728|NCT01901328|466060827|FG001|Overall Study|Lost to Follow-up|0|||
129483729|NCT01901328|466060826|FG000|Overall Study|Physician Decision|0|||
129483730|NCT01901328|466060827|FG001|Overall Study|Physician Decision|1|||
129483731|NCT01901328|466060826|FG000|Overall Study|Protocol Violation|1|||
129483732|NCT01901328|466060827|FG001|Overall Study|Protocol Violation|1|||
129483733|NCT01901328|466060826|FG000|Overall Study|Study Terminated by Sponsor|19|||
129483734|NCT01901328|466060827|FG001|Overall Study|Study Terminated by Sponsor|16|||
129483735|NCT01901328|466060826|FG000|Overall Study|Withdrawal by Subject|1|||
129483736|NCT01901328|466060827|FG001|Overall Study|Withdrawal by Subject|2|||
129483737|NCT01901328|466060826|FG000|Overall Study|Lack of Efficacy|0|||
129483738|NCT01901328|466060827|FG001|Overall Study|Lack of Efficacy|1|||
129483739|NCT03232073|466060828|FG000|Overall Study|Death|1|||
129483740|NCT03232073|466060829|FG001|Overall Study|Death|0|||
129483741|NCT03232073|466060828|FG000|Overall Study|Adverse Event|7|||
129483742|NCT03232073|466060829|FG001|Overall Study|Adverse Event|12|||
129483743|NCT03232073|466060828|FG000|Overall Study|Lost to Follow-up|6|||
129483744|NCT03232073|466060829|FG001|Overall Study|Lost to Follow-up|6|||
129483745|NCT03232073|466060828|FG000|Overall Study|Lack of Efficacy|10|||
129483746|NCT03232073|466060829|FG001|Overall Study|Lack of Efficacy|8|||
129483747|NCT03232073|466060828|FG000|Overall Study|Physician Decision|9|||
129483748|NCT03232073|466060829|FG001|Overall Study|Physician Decision|2|||
129483749|NCT03232073|466060828|FG000|Overall Study|Withdrawal by Subject|54|||
129483750|NCT03232073|466060829|FG001|Overall Study|Withdrawal by Subject|39|||
129483751|NCT00853632|466062378|FG000|Overall Study|Death|88|||
129483752|NCT00853632|466062378|FG000|Overall Study|Withdrawal by Subject|45|||
129483753|NCT00853632|466062378|FG000|Overall Study|Lost to Follow-up|30|||
129483754|NCT00853632|466062378|FG000|Overall Study|Reoperation/Explant|17|||
129483755|NCT00853632|466062378|FG000|Overall Study|Exit with other reason|22|||
129483756|NCT02698410|466062379|FG000|Overall Study|Adverse Event|2|||
129483757|NCT02698410|466062379|FG000|Overall Study|Withdrawal by Subject|1|||
129483758|NCT02698410|466062379|FG000|Overall Study|Other|1|||
129483759|NCT04331899|466062387|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
129483760|NCT04331899|466062388|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
129483761|NCT00719810|466062391|FG000|Overall Study|Adverse Event|0|||
129483762|NCT00719810|466062392|FG001|Overall Study|Adverse Event|2|||
129483763|NCT00719810|466062393|FG002|Overall Study|Adverse Event|3|||
129483764|NCT00719810|466062391|FG000|Overall Study|Lost to Follow-up|2|||
129483765|NCT00719810|466062392|FG001|Overall Study|Lost to Follow-up|0|||
129483766|NCT00719810|466062393|FG002|Overall Study|Lost to Follow-up|3|||
129483767|NCT00719810|466062391|FG000|Overall Study|Physician Decision|0|||
129483768|NCT00719810|466062392|FG001|Overall Study|Physician Decision|1|||
129483769|NCT00719810|466062393|FG002|Overall Study|Physician Decision|0|||
129483770|NCT00719810|466062391|FG000|Overall Study|Withdrawal by Subject|1|||
129483771|NCT00719810|466062392|FG001|Overall Study|Withdrawal by Subject|1|||
129483772|NCT00719810|466062393|FG002|Overall Study|Withdrawal by Subject|2|||
129483773|NCT05408858|466062398|FG000|Overall Study|no longer met eligibility criteria|1|||
129483774|NCT02037919|466062402|FG000|Overall Study|Lost to Follow-up|30|||
129483775|NCT02037919|466062403|FG001|Overall Study|Lost to Follow-up|45|||
129483776|NCT03717922|466062411|FG000|Overall Study|Lost to Follow-up|2|||
129483777|NCT03717922|466062412|FG001|Overall Study|Lost to Follow-up|2|||
129483778|NCT01929083|466062422|FG000|Intervention 1|Lost to Follow-up|2|||
129483779|NCT01929083|466062423|FG001|Intervention 1|Lost to Follow-up|0|||
129483780|NCT01929083|466062422|FG000|Intervention 1|Nonadherent to study medications|1|||
129483781|NCT01929083|466062423|FG001|Intervention 1|Nonadherent to study medications|0|||
129483782|NCT01929083|466062422|FG000|Intervention 2|Adverse Event|0|||
129483783|NCT01929083|466062423|FG001|Intervention 2|Adverse Event|1|||
129483784|NCT02586805|466062426|FG000|Overall Study|Withdrawal by Subject|3|||
129483785|NCT02586805|466062427|FG001|Overall Study|Withdrawal by Subject|1|||
129483786|NCT02586805|466062428|FG002|Overall Study|Withdrawal by Subject|1|||
129483787|NCT02586805|466062429|FG003|Overall Study|Withdrawal by Subject|2|||
129483788|NCT02586805|466062426|FG000|Overall Study|Adverse Event|2|||
129483789|NCT02586805|466062427|FG001|Overall Study|Adverse Event|0|||
129483790|NCT02586805|466062428|FG002|Overall Study|Adverse Event|1|||
129483791|NCT02586805|466062429|FG003|Overall Study|Adverse Event|0|||
129483792|NCT02586805|466062426|FG000|Overall Study|Lost to Follow-up|0|||
129483793|NCT02586805|466062427|FG001|Overall Study|Lost to Follow-up|0|||
129483794|NCT02586805|466062428|FG002|Overall Study|Lost to Follow-up|1|||
129483795|NCT02586805|466062429|FG003|Overall Study|Lost to Follow-up|0|||
129483796|NCT02586805|466062426|FG000|Overall Study|Physician Decision|1|||
129483797|NCT02586805|466062427|FG001|Overall Study|Physician Decision|0|||
129483798|NCT02586805|466062428|FG002|Overall Study|Physician Decision|0|||
129483799|NCT02586805|466062429|FG003|Overall Study|Physician Decision|0|||
129483800|NCT01829048|466062430|FG000|Overall Study|Withdrawal by Subject|0|||
129483801|NCT01829048|466062431|FG001|Overall Study|Withdrawal by Subject|0|||
129483802|NCT01829048|466062432|FG002|Overall Study|Withdrawal by Subject|0|||
129483803|NCT01829048|466062433|FG003|Overall Study|Withdrawal by Subject|2|||
129483804|NCT01829048|466062434|FG004|Overall Study|Withdrawal by Subject|0|||
129483805|NCT02317510|466062435|FG000|Overall Study|Adverse Event|0|||
129483806|NCT02317510|466062436|FG001|Overall Study|Adverse Event|1|||
129483807|NCT00500071|466062437|FG000|Screening and Washout Phase|Protocol Violation|1|||
129483808|NCT00500071|466062437|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
129483809|NCT00500071|466062437|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
129483810|NCT00500071|466062437|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
129483811|NCT00500071|466062437|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
129483812|NCT00500071|466062437|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
129483813|NCT00500071|466062437|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
129483814|NCT00472303|466062438|FG000|Titration Phase|Adverse Event|22|||
129483815|NCT00472303|466062439|FG001|Titration Phase|Adverse Event|12|||
129483816|NCT00472303|466062440|FG002|Titration Phase|Adverse Event|0|||
129483817|NCT00472303|466062438|FG000|Titration Phase|Death|4|||
129483818|NCT00472303|466062439|FG001|Titration Phase|Death|2|||
129483819|NCT00472303|466062440|FG002|Titration Phase|Death|0|||
129483820|NCT00472303|466062438|FG000|Titration Phase|Lack of Efficacy|10|||
129483821|NCT00472303|466062439|FG001|Titration Phase|Lack of Efficacy|0|||
129483822|NCT00472303|466062440|FG002|Titration Phase|Lack of Efficacy|0|||
129483823|NCT00472303|466062438|FG000|Titration Phase|Withdrawal by Subject|16|||
129483824|NCT00472303|466062439|FG001|Titration Phase|Withdrawal by Subject|13|||
129483825|NCT00472303|466062440|FG002|Titration Phase|Withdrawal by Subject|0|||
129483826|NCT00472303|466062438|FG000|Titration Phase|Trial Medication non-compliant|4|||
129483827|NCT00472303|466062439|FG001|Titration Phase|Trial Medication non-compliant|1|||
129483828|NCT00472303|466062440|FG002|Titration Phase|Trial Medication non-compliant|0|||
129483829|NCT00472303|466062438|FG000|Titration Phase|Other|3|||
129483830|NCT00472303|466062439|FG001|Titration Phase|Other|1|||
129483831|NCT00472303|466062440|FG002|Titration Phase|Other|0|||
129483832|NCT00472303|466062438|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
129483833|NCT00472303|466062439|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
129483834|NCT00472303|466062440|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
129483835|NCT00472303|466062438|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
129483836|NCT00472303|466062439|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
129483837|NCT00472303|466062440|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
129483838|NCT00472303|466062438|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
129483839|NCT00472303|466062439|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
129483840|NCT00472303|466062440|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
129483841|NCT00472303|466062438|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
129483842|NCT00472303|466062439|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
129483843|NCT00472303|466062440|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
129483844|NCT00472303|466062438|FG000|Discontinuations After Titration Phase|Other|5|||
129483845|NCT00472303|466062439|FG001|Discontinuations After Titration Phase|Other|0|||
129483846|NCT00472303|466062440|FG002|Discontinuations After Titration Phase|Other|0|||
129483847|NCT00472303|466062438|FG000|Maintenance Phase|Adverse Event|5|||
129483848|NCT00472303|466062439|FG001|Maintenance Phase|Adverse Event|6|||
129483849|NCT00472303|466062440|FG002|Maintenance Phase|Adverse Event|6|||
129483850|NCT00472303|466062438|FG000|Maintenance Phase|Death|3|||
129483851|NCT00472303|466062439|FG001|Maintenance Phase|Death|0|||
129483852|NCT00472303|466062440|FG002|Maintenance Phase|Death|2|||
129483853|NCT00472303|466062438|FG000|Maintenance Phase|Lack of Efficacy|2|||
129483854|NCT00472303|466062439|FG001|Maintenance Phase|Lack of Efficacy|2|||
129483855|NCT00472303|466062440|FG002|Maintenance Phase|Lack of Efficacy|4|||
129483856|NCT00472303|466062438|FG000|Maintenance Phase|Withdrawal by Subject|6|||
129483857|NCT00472303|466062439|FG001|Maintenance Phase|Withdrawal by Subject|7|||
129483858|NCT00472303|466062440|FG002|Maintenance Phase|Withdrawal by Subject|3|||
129483859|NCT00472303|466062438|FG000|Maintenance Phase|Trial medication non-compliant|0|||
129483860|NCT00472303|466062439|FG001|Maintenance Phase|Trial medication non-compliant|0|||
129483861|NCT00472303|466062440|FG002|Maintenance Phase|Trial medication non-compliant|1|||
129483862|NCT00472303|466062438|FG000|Maintenance Phase|Resolution of pain|0|||
129483863|NCT00472303|466062439|FG001|Maintenance Phase|Resolution of pain|0|||
129483864|NCT00472303|466062440|FG002|Maintenance Phase|Resolution of pain|1|||
129483865|NCT00472303|466062438|FG000|Maintenance Phase|Other|1|||
129483866|NCT00472303|466062439|FG001|Maintenance Phase|Other|1|||
129483867|NCT00472303|466062440|FG002|Maintenance Phase|Other|0|||
129483868|NCT03596164|466062450|FG000|Overall Study|Adverse Event|0|||
129483869|NCT03596164|466062451|FG001|Overall Study|Adverse Event|1|||
129483870|NCT03596164|466062450|FG000|Overall Study|Death|1|||
129483871|NCT03596164|466062451|FG001|Overall Study|Death|0|||
129483872|NCT01244737|466062459|FG000|Overall Study|Physician Decision|2|||
129483873|NCT01244737|466062460|FG001|Overall Study|Physician Decision|18|||
129483874|NCT01244737|466062461|FG002|Overall Study|Physician Decision|5|||
129483875|NCT01244737|466062459|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
129483876|NCT01244737|466062460|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
129483877|NCT01244737|466062461|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
129483878|NCT01244737|466062459|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
129483879|NCT01244737|466062460|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
129483880|NCT01244737|466062461|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
129483881|NCT01244737|466062459|FG000|Overall Study|MIB immunopathology results not available|3|||
129483882|NCT01244737|466062460|FG001|Overall Study|MIB immunopathology results not available|2|||
129483883|NCT01244737|466062461|FG002|Overall Study|MIB immunopathology results not available|0|||
129483884|NCT01244737|466062459|FG000|Overall Study|PET data failure|0|||
129483885|NCT01244737|466062460|FG001|Overall Study|PET data failure|1|||
129483886|NCT01244737|466062461|FG002|Overall Study|PET data failure|0|||
129483887|NCT01244737|466062459|FG000|Overall Study|Withdrawal by Subject|0|||
129483888|NCT01244737|466062460|FG001|Overall Study|Withdrawal by Subject|0|||
129483889|NCT01244737|466062461|FG002|Overall Study|Withdrawal by Subject|1|||
129483890|NCT01873950|466062463|FG000|Period 5|Withdrawal by Subject|0|||
129483891|NCT01873950|466062464|FG001|Period 5|Withdrawal by Subject|0|||
129483892|NCT01873950|466062465|FG002|Period 5|Withdrawal by Subject|0|||
129483893|NCT01873950|466062466|FG003|Period 5|Withdrawal by Subject|1|||
129483894|NCT01873950|466062467|FG004|Period 5|Withdrawal by Subject|0|||
129483895|NCT00730236|466062468|FG000|Overall Study|Adverse Event|4|||
129483896|NCT00730236|466062468|FG000|Overall Study|Withdrawal by Subject|1|||
129483897|NCT00730236|466062468|FG000|Overall Study|Non-compliance|1|||
129483898|NCT01772134|466062473|FG000|Overall Study|Adverse Event|6|||
129483899|NCT01772134|466062474|FG001|Overall Study|Adverse Event|5|||
129483900|NCT01772134|466062475|FG002|Overall Study|Adverse Event|10|||
129483901|NCT01772134|466062473|FG000|Overall Study|Withdrew Consent|3|||
129483902|NCT01772134|466062474|FG001|Overall Study|Withdrew Consent|1|||
129483903|NCT01772134|466062475|FG002|Overall Study|Withdrew Consent|5|||
129483904|NCT01772134|466062473|FG000|Overall Study|Lost to Follow-up|2|||
129483905|NCT01772134|466062474|FG001|Overall Study|Lost to Follow-up|0|||
129483906|NCT01772134|466062475|FG002|Overall Study|Lost to Follow-up|0|||
129483907|NCT01772134|466062473|FG000|Overall Study|Protocol Deviation|4|||
129483908|NCT01772134|466062474|FG001|Overall Study|Protocol Deviation|3|||
129483909|NCT01772134|466062475|FG002|Overall Study|Protocol Deviation|3|||
129483910|NCT01772134|466062473|FG000|Overall Study|Lack of Efficacy|11|||
129483911|NCT01772134|466062474|FG001|Overall Study|Lack of Efficacy|5|||
129483912|NCT01772134|466062475|FG002|Overall Study|Lack of Efficacy|3|||
129483913|NCT01772134|466062473|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
129483914|NCT01772134|466062474|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
129483915|NCT01772134|466062475|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
129483916|NCT01772134|466062473|FG000|Overall Study|Randomized Study Medication Not Received|2|||
129483917|NCT01772134|466062474|FG001|Overall Study|Randomized Study Medication Not Received|0|||
129483918|NCT01772134|466062475|FG002|Overall Study|Randomized Study Medication Not Received|1|||
129483919|NCT02604264|466062482|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
129483920|NCT02604264|466062483|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
129483921|NCT04003610|466062484|FG000|Overall Study|Lost to Follow-up|0|||
129483922|NCT04003610|466062485|FG001|Overall Study|Lost to Follow-up|1|||
129483923|NCT04003610|466062486|FG002|Overall Study|Lost to Follow-up|0|||
129483924|NCT04003610|466062484|FG000|Overall Study|Death|0|||
129483925|NCT04003610|466062485|FG001|Overall Study|Death|0|||
129483926|NCT04003610|466062486|FG002|Overall Study|Death|3|||
129483927|NCT04003610|466062484|FG000|Overall Study|Study Terminated by Sponsor|0|||
129483928|NCT04003610|466062485|FG001|Overall Study|Study Terminated by Sponsor|0|||
129483929|NCT04003610|466062486|FG002|Overall Study|Study Terminated by Sponsor|3|||
129483930|NCT05502289|466062491|FG000|Period 1|Out Of Window|1|||
129483931|NCT05502289|466062492|FG001|Period 1|Out Of Window|0|||
129483932|NCT01254344|466062493|FG000|Overall Study|Adverse Event|2|||
129483933|NCT01254344|466062494|FG001|Overall Study|Adverse Event|5|||
129483934|NCT01254344|466062493|FG000|Overall Study|Physician Decision|7|||
129483935|NCT01254344|466062494|FG001|Overall Study|Physician Decision|4|||
129483936|NCT01254344|466062493|FG000|Overall Study|Protocol Violation|1|||
129483937|NCT01254344|466062494|FG001|Overall Study|Protocol Violation|4|||
129483938|NCT01254344|466062493|FG000|Overall Study|Withdrawal by Subject|3|||
129483939|NCT01254344|466062494|FG001|Overall Study|Withdrawal by Subject|6|||
129483940|NCT03022461|466062495|FG000|Overall Study|Death|3|||
129483941|NCT03459040|466062496|FG000|Overall Study|Death|8|||
129483942|NCT03459040|466062496|FG000|Overall Study|Withdrawal by Subject|1|||
129483943|NCT00986349|466062499|FG000|Overall Study|Unsuccessful implant procedure|3|||
129483944|NCT00986349|466062499|FG000|Overall Study|Adverse Event|2|||
129483945|NCT00986349|466062499|FG000|Overall Study|Physician Decision|1|||
129483946|NCT00986349|466062499|FG000|Overall Study|device migration|1|||
129483947|NCT02299934|466062500|FG000|Overall Study|Termination of study|13|||
129483948|NCT01273818|466062501|FG000|Overall Study|Physician Decision|13|||
129483949|NCT01273818|466062502|FG001|Overall Study|Physician Decision|2|||
129483950|NCT01273818|466062503|FG002|Overall Study|Physician Decision|9|||
129483951|NCT03815175|466062504|FG000|Overall Study|Subject Lost to Follow-up|6|||
129483952|NCT03815175|466062504|FG000|Overall Study|Subject Withdrew Consent|48|||
129483953|NCT03815175|466062504|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
129483954|NCT03815175|466062504|FG000|Overall Study|Death|86|||
129483955|NCT03815175|466062504|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
129483956|NCT03815175|466062504|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
129483957|NCT03815175|466062504|FG000|Overall Study|Other Status Change Reason|1|||
129483958|NCT03815175|466062504|FG000|Overall Study|Missed Visit|12|||
129483959|NCT03822468|466062505|FG000|Treatment Period|Progressive disease|98|||
129483960|NCT03822468|466062506|FG001|Treatment Period|Progressive disease|94|||
129483961|NCT03822468|466062505|FG000|Treatment Period|Adverse Event|21|||
129483962|NCT03822468|466062506|FG001|Treatment Period|Adverse Event|24|||
129483963|NCT03822468|466062505|FG000|Treatment Period|Withdrawal by Subject|9|||
129483964|NCT03822468|466062506|FG001|Treatment Period|Withdrawal by Subject|5|||
129483965|NCT03822468|466062505|FG000|Treatment Period|Physician Decision|9|||
129483966|NCT03822468|466062506|FG001|Treatment Period|Physician Decision|7|||
129483967|NCT03822468|466062505|FG000|Treatment Period|Protocol Violation|2|||
129483968|NCT03822468|466062506|FG001|Treatment Period|Protocol Violation|1|||
129483969|NCT03822468|466062505|FG000|Treatment Period|Death|2|||
129483970|NCT03822468|466062506|FG001|Treatment Period|Death|3|||
129483971|NCT03822468|466062505|FG000|Treatment Period|Lost to Follow-up|1|||
129483972|NCT03822468|466062506|FG001|Treatment Period|Lost to Follow-up|1|||
129483973|NCT03822468|466062505|FG000|Treatment Period|Sponsor decision|46|||
129483974|NCT03822468|466062506|FG001|Treatment Period|Sponsor decision|53|||
129483975|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
129483976|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
129483977|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
129483978|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
129483979|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Death|1|||
129483980|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Death|0|||
129483981|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
129483982|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
129483983|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
129483984|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
129483985|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
129483986|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
129483987|NCT03822468|466062505|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
129483988|NCT03822468|466062506|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
129483989|NCT02117687|466062507|FG000|Overall Study|Lost to Follow-up|0|||
129483990|NCT02117687|466062508|FG001|Overall Study|Lost to Follow-up|1|||
129483991|NCT02117687|466062507|FG000|Overall Study|Adverse Event|0|||
129483992|NCT02117687|466062508|FG001|Overall Study|Adverse Event|2|||
129483993|NCT02117687|466062507|FG000|Overall Study|Other Reasons|1|||
129483994|NCT02117687|466062508|FG001|Overall Study|Other Reasons|1|||
129483995|NCT04909463|466064515|FG000|Overall Study|Withdrawal by Subject|0|||
129483996|NCT04909463|466064516|FG001|Overall Study|Withdrawal by Subject|1|||
129483997|NCT04909463|466064517|FG002|Overall Study|Withdrawal by Subject|0|||
129483998|NCT04909463|466064518|FG003|Overall Study|Withdrawal by Subject|0|||
129483999|NCT04909463|466064515|FG000|Overall Study|Lost to Follow-up|2|||
129484000|NCT04909463|466064516|FG001|Overall Study|Lost to Follow-up|1|||
129484001|NCT04909463|466064517|FG002|Overall Study|Lost to Follow-up|1|||
129484002|NCT04909463|466064518|FG003|Overall Study|Lost to Follow-up|0|||
129484003|NCT01416181|466064521|FG000|Part 1|Other|10|||
129484004|NCT01416181|466064522|FG001|Part 1|Other|24|||
129484005|NCT01416181|466064521|FG000|Part 1|Death|0|||
129484006|NCT01416181|466064522|FG001|Part 1|Death|1|||
129484007|NCT01416181|466064521|FG000|Part 1|Investigator Decision|7|||
129484008|NCT01416181|466064522|FG001|Part 1|Investigator Decision|6|||
129484009|NCT01416181|466064521|FG000|Part 1|Withdrawal by Subject|74|||
129484010|NCT01416181|466064522|FG001|Part 1|Withdrawal by Subject|48|||
129484011|NCT01416181|466064521|FG000|Part 1|Lack of Efficacy|16|||
129484012|NCT01416181|466064522|FG001|Part 1|Lack of Efficacy|8|||
129484013|NCT01416181|466064521|FG000|Part 1|Lost to Follow-up|1|||
129484014|NCT01416181|466064522|FG001|Part 1|Lost to Follow-up|1|||
129484015|NCT01416181|466064521|FG000|Part 1|Adverse Event|15|||
129484016|NCT01416181|466064522|FG001|Part 1|Adverse Event|18|||
129484017|NCT01416181|466064521|FG000|Part 1|Ongoing in Follow-Up|14|||
129484018|NCT01416181|466064522|FG001|Part 1|Ongoing in Follow-Up|8|||
129484019|NCT01416181|466064521|FG000|Part 2|Adverse Event|11|||
129484020|NCT01416181|466064522|FG001|Part 2|Adverse Event|4|||
129484021|NCT01416181|466064521|FG000|Part 2|Other|234|||
129484022|NCT01416181|466064522|FG001|Part 2|Other|267|||
129484023|NCT01416181|466064521|FG000|Part 2|Investigator Decision|6|||
129484024|NCT01416181|466064522|FG001|Part 2|Investigator Decision|7|||
129484025|NCT01416181|466064521|FG000|Part 2|Withdrawal by Subject|14|||
129484026|NCT01416181|466064522|FG001|Part 2|Withdrawal by Subject|5|||
129484027|NCT01416181|466064521|FG000|Part 2|Lack of Efficacy|4|||
129484028|NCT01416181|466064522|FG001|Part 2|Lack of Efficacy|1|||
129484029|NCT01416181|466064521|FG000|Part 2|Lost to Follow-up|2|||
129484030|NCT01416181|466064522|FG001|Part 2|Lost to Follow-up|2|||
129484031|NCT02981472|466064523|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
129484032|NCT02981472|466064524|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
129484033|NCT02981472|466064523|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
129484034|NCT02981472|466064524|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
129484035|NCT02981472|466064523|FG000|Treatment Period|Adverse Event|6|||
129484036|NCT02981472|466064524|FG001|Treatment Period|Adverse Event|1|||
129484037|NCT02981472|466064523|FG000|Treatment Period|Participant withdrew consent|1|||
129484038|NCT02981472|466064524|FG001|Treatment Period|Participant withdrew consent|0|||
129484039|NCT02981472|466064523|FG000|Treatment Period|Lost to Follow-up|0|||
129484040|NCT02981472|466064524|FG001|Treatment Period|Lost to Follow-up|1|||
129484041|NCT00621023|466064527|FG000|Overall Study|Death|5|||
129484042|NCT00621023|466064527|FG000|Overall Study|Follow up discontinued|1|||
129484043|NCT04430348|466064538|FG000|Overall Study|Death|3|||
129484044|NCT04430348|466064539|FG001|Overall Study|Death|2|||
129484045|NCT04430348|466064540|FG002|Overall Study|Death|2|||
129484046|NCT04430348|466064541|FG003|Overall Study|Death|2|||
129484047|NCT04430348|466064542|FG004|Overall Study|Death|2|||
129484048|NCT04430348|466064543|FG005|Overall Study|Death|3|||
129484049|NCT04430348|466064538|FG000|Overall Study|Lost to Follow-up|0|||
129484050|NCT04430348|466064539|FG001|Overall Study|Lost to Follow-up|0|||
129484051|NCT04430348|466064540|FG002|Overall Study|Lost to Follow-up|0|||
129484052|NCT04430348|466064541|FG003|Overall Study|Lost to Follow-up|1|||
129484053|NCT04430348|466064542|FG004|Overall Study|Lost to Follow-up|0|||
129484054|NCT04430348|466064543|FG005|Overall Study|Lost to Follow-up|0|||
129484055|NCT04430348|466064538|FG000|Overall Study|Adverse Event|0|||
129484056|NCT04430348|466064539|FG001|Overall Study|Adverse Event|0|||
129484057|NCT04430348|466064540|FG002|Overall Study|Adverse Event|0|||
129484058|NCT04430348|466064541|FG003|Overall Study|Adverse Event|0|||
129484059|NCT04430348|466064542|FG004|Overall Study|Adverse Event|0|||
129484060|NCT04430348|466064543|FG005|Overall Study|Adverse Event|1|||
129484061|NCT04430348|466064538|FG000|Overall Study|Withdrawal by Subject|0|||
129484062|NCT04430348|466064539|FG001|Overall Study|Withdrawal by Subject|1|||
129484063|NCT04430348|466064540|FG002|Overall Study|Withdrawal by Subject|0|||
129484064|NCT04430348|466064541|FG003|Overall Study|Withdrawal by Subject|0|||
129484065|NCT04430348|466064542|FG004|Overall Study|Withdrawal by Subject|0|||
129484066|NCT04430348|466064543|FG005|Overall Study|Withdrawal by Subject|1|||
129484067|NCT04430348|466064538|FG000|Overall Study|Study Terminated by Sponsor|0|||
129484068|NCT04430348|466064539|FG001|Overall Study|Study Terminated by Sponsor|0|||
129484069|NCT04430348|466064540|FG002|Overall Study|Study Terminated by Sponsor|2|||
129484070|NCT04430348|466064541|FG003|Overall Study|Study Terminated by Sponsor|0|||
129484071|NCT04430348|466064542|FG004|Overall Study|Study Terminated by Sponsor|1|||
129484072|NCT04430348|466064543|FG005|Overall Study|Study Terminated by Sponsor|1|||
129484073|NCT02559505|466064544|FG000|Overall Study|Lost to Follow-up|23|||
129484074|NCT02559505|466064545|FG001|Overall Study|Lost to Follow-up|20|||
129484075|NCT02559505|466064544|FG000|Overall Study|Withdrawal by Subject|4|||
129484076|NCT02559505|466064545|FG001|Overall Study|Withdrawal by Subject|2|||
129484077|NCT00698516|466064546|FG000|Overall Study|Study Termination|2|||
129484078|NCT00698516|466064546|FG000|Overall Study|Withdrawal by Subject|3|||
129484079|NCT00756002|466064557|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
129484080|NCT00756002|466064558|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
129484081|NCT00756002|466064557|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129484082|NCT00756002|466064558|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129484083|NCT00756002|466064557|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
129484084|NCT00756002|466064558|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
129484085|NCT00756002|466064557|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
129484086|NCT00756002|466064558|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
129484087|NCT00756002|466064557|FG000|Double-Blind Treatment Period|Other|2|||
129484088|NCT00756002|466064558|FG001|Double-Blind Treatment Period|Other|2|||
129484089|NCT01697215|466064564|FG000|Overall Study|Physician Decision|5|||
129484090|NCT01697215|466064564|FG000|Overall Study|Malfunction|9|||
129484091|NCT01697215|466064564|FG000|Overall Study|CXR not available|9|||
129484092|NCT00900796|466064567|FG000|Phase 1|Lacked sufficient information|4|||
129484093|NCT00900796|466064567|FG000|Phase 1|Missing information at Week 16|7|||
129484094|NCT00900796|466064567|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
129484095|NCT00900796|466064567|FG000|Phase 2|Lost to Follow-up|5|||
129484096|NCT01859403|466064570|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
129484097|NCT01859403|466064571|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
129484098|NCT01859403|466064570|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
129484099|NCT01859403|466064571|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
129484100|NCT01859403|466064570|FG000|Primary Endpoint Measure|Physician Decision|0|||
129978564|NCT00368927|467883739|FG001|Overall Study|Lost to Follow-up|0|||
129484101|NCT01859403|466064571|FG001|Primary Endpoint Measure|Physician Decision|1|||
129484102|NCT01859403|466064570|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
129484103|NCT01859403|466064571|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
129484104|NCT00504257|466064573|FG000|Overall Study|Withdrawal by Subject|2|||
129484105|NCT00504257|466064573|FG000|Overall Study|ineligible histology|2|||
129484106|NCT02750410|466064574|FG000|Double-Blind Treatment Period|Adverse Event|2|||
129484107|NCT02750410|466064575|FG001|Double-Blind Treatment Period|Adverse Event|2|||
129484108|NCT02750410|466064574|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129484109|NCT02750410|466064575|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129484110|NCT02750410|466064574|FG000|Open-Label Extension Period|Adverse Event|5|||
129484111|NCT02750410|466064575|FG001|Open-Label Extension Period|Adverse Event|3|||
129484112|NCT02750410|466064574|FG000|Open-Label Extension Period|Protocol Violation|0|||
129484113|NCT02750410|466064575|FG001|Open-Label Extension Period|Protocol Violation|1|||
129484114|NCT02750410|466064574|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
129484115|NCT02750410|466064575|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
129484116|NCT02504541|466064576|FG000|Overall Study|Adverse Event|4|||
129484117|NCT02504541|466064576|FG000|Overall Study|Withdrawal by Subject|4|||
129484118|NCT02504541|466064576|FG000|Overall Study|Lost to Follow-up|1|||
129484119|NCT02504541|466064576|FG000|Overall Study|Met Stopping Criteria|1|||
129484120|NCT02504541|466064576|FG000|Overall Study|Protocol Violation|2|||
129484121|NCT02504541|466064576|FG000|Overall Study|Termination by Sponsor|1|||
129484122|NCT02504541|466064576|FG000|Overall Study|Other|2|||
129484123|NCT02504541|466064576|FG000|Overall Study|Multiple|5|||
129484124|NCT01531725|466064580|FG000|Overall Study|Protocol Violation|5|||
129484125|NCT03182738|466064581|FG000|Overall Study|Lost to Follow-up|9|||
129484126|NCT03182738|466064582|FG001|Overall Study|Lost to Follow-up|3|||
129484127|NCT03182738|466064581|FG000|Overall Study|Pregnancy|0|||
129484128|NCT03182738|466064582|FG001|Overall Study|Pregnancy|1|||
129484129|NCT03182738|466064581|FG000|Overall Study|Withdrawal by Subject|0|||
129484130|NCT03182738|466064582|FG001|Overall Study|Withdrawal by Subject|1|||
129484131|NCT04112914|466064584|FG000|Overall Study|Lost to Follow-up|13|||
129484132|NCT04112914|466064585|FG001|Overall Study|Lost to Follow-up|9|||
129484133|NCT04112914|466064584|FG000|Overall Study|Withdrawal by Subject|1|||
129484134|NCT04112914|466064585|FG001|Overall Study|Withdrawal by Subject|0|||
129484135|NCT03427073|466064586|FG000|Overall Study|Disease Progression|1|||
129484136|NCT03427073|466064587|FG001|Overall Study|Disease Progression|1|||
129484137|NCT03427073|466064588|FG002|Overall Study|Disease Progression|1|||
129484138|NCT03427073|466064589|FG003|Overall Study|Disease Progression|3|||
129484139|NCT03427073|466064590|FG004|Overall Study|Disease Progression|3|||
129484140|NCT03427073|466064591|FG005|Overall Study|Disease Progression|4|||
129484141|NCT03427073|466064592|FG006|Overall Study|Disease Progression|2|||
129484142|NCT03427073|466064593|FG007|Overall Study|Disease Progression|3|||
129484143|NCT03427073|466064586|FG000|Overall Study|Physician Decision|0|||
129484144|NCT03427073|466064587|FG001|Overall Study|Physician Decision|0|||
129484145|NCT03427073|466064588|FG002|Overall Study|Physician Decision|0|||
129484146|NCT03427073|466064589|FG003|Overall Study|Physician Decision|0|||
129484147|NCT03427073|466064590|FG004|Overall Study|Physician Decision|0|||
129484148|NCT03427073|466064591|FG005|Overall Study|Physician Decision|0|||
129484149|NCT03427073|466064592|FG006|Overall Study|Physician Decision|1|||
129484150|NCT03427073|466064593|FG007|Overall Study|Physician Decision|1|||
129484151|NCT01486238|466064597|FG000|Overall Study|Death|0|||
129484152|NCT01486238|466064598|FG001|Overall Study|Death|2|||
129484153|NCT01486238|466064597|FG000|Overall Study|Withdrawal by Subject|2|||
129484154|NCT01486238|466064598|FG001|Overall Study|Withdrawal by Subject|1|||
129484155|NCT01486238|466064597|FG000|Overall Study|Lost to Follow-up|0|||
129484156|NCT01486238|466064598|FG001|Overall Study|Lost to Follow-up|3|||
129484157|NCT02835495|466064600|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
129484158|NCT02835495|466064601|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
129484159|NCT02835495|466064600|FG000|Overall Study|Declined in-person follow-up visit|4|||
129484160|NCT02835495|466064601|FG001|Overall Study|Declined in-person follow-up visit|2|||
129484161|NCT02318602|466064602|FG000|Overall Study|Adverse Event|0|||
129484162|NCT02318602|466064603|FG001|Overall Study|Adverse Event|1|||
129484163|NCT02318602|466064604|FG002|Overall Study|Adverse Event|1|||
129484164|NCT02318602|466064602|FG000|Overall Study|Withdrawal by Subject|0|||
129484165|NCT02318602|466064603|FG001|Overall Study|Withdrawal by Subject|3|||
129484166|NCT02318602|466064604|FG002|Overall Study|Withdrawal by Subject|0|||
129484167|NCT02318602|466064602|FG000|Overall Study|Death|1|||
129484168|NCT02318602|466064603|FG001|Overall Study|Death|0|||
129484169|NCT02318602|466064604|FG002|Overall Study|Death|0|||
129484170|NCT02318602|466064602|FG000|Overall Study|Guardian decision to withdraw|0|||
129484171|NCT02318602|466064603|FG001|Overall Study|Guardian decision to withdraw|0|||
129484172|NCT02318602|466064604|FG002|Overall Study|Guardian decision to withdraw|1|||
129484173|NCT00693706|466064605|FG000|Overall Study|Protocol Violation|0|||
129484174|NCT00693706|466064606|FG001|Overall Study|Protocol Violation|1|||
129484175|NCT05421754|466064607|FG000|Overall Study|Technical issue with sensor|1|||
129484176|NCT02580058|466064608|FG000|Overall Study|Adverse Event|16|||
129484177|NCT02580058|466064609|FG001|Overall Study|Adverse Event|30|||
129484178|NCT02580058|466064610|FG002|Overall Study|Adverse Event|20|||
129484179|NCT02580058|466064608|FG000|Overall Study|Death|4|||
129484180|NCT02580058|466064609|FG001|Overall Study|Death|4|||
129484181|NCT02580058|466064610|FG002|Overall Study|Death|5|||
129484182|NCT02580058|466064608|FG000|Overall Study|Physician Decision|1|||
129484183|NCT02580058|466064609|FG001|Overall Study|Physician Decision|3|||
129484184|NCT02580058|466064610|FG002|Overall Study|Physician Decision|11|||
129484185|NCT02580058|466064608|FG000|Overall Study|Other|5|||
129484186|NCT02580058|466064609|FG001|Overall Study|Other|1|||
129484187|NCT02580058|466064610|FG002|Overall Study|Other|3|||
129484188|NCT02580058|466064608|FG000|Overall Study|Withdrawal by Subject|4|||
129484189|NCT02580058|466064609|FG001|Overall Study|Withdrawal by Subject|7|||
129484190|NCT02580058|466064610|FG002|Overall Study|Withdrawal by Subject|31|||
129484191|NCT02580058|466064608|FG000|Overall Study|Global Deterioration of Health Status|19|||
129484192|NCT02580058|466064609|FG001|Overall Study|Global Deterioration of Health Status|18|||
129484193|NCT02580058|466064610|FG002|Overall Study|Global Deterioration of Health Status|24|||
129484194|NCT02580058|466064608|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
129484195|NCT02580058|466064609|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129484196|NCT02580058|466064610|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
129484197|NCT02580058|466064608|FG000|Overall Study|Progressive Disease|137|||
129484198|NCT02580058|466064609|FG001|Overall Study|Progressive Disease|125|||
129484199|NCT02580058|466064610|FG002|Overall Study|Progressive Disease|94|||
129484200|NCT02580058|466064608|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129484201|NCT02580058|466064609|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129484202|NCT02580058|466064610|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129484203|NCT01193335|466064611|FG000|After Infant Series|Lost to Follow-up|1|||
129484204|NCT01193335|466064612|FG001|After Infant Series|Lost to Follow-up|2|||
129484205|NCT01193335|466064611|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
129484206|NCT01193335|466064612|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
129484207|NCT01193335|466064611|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
129484208|NCT01193335|466064612|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
129484209|NCT01193335|466064611|FG000|1-Year Follow-up|Lost to Follow-up|4|||
129484210|NCT01193335|466064612|FG001|1-Year Follow-up|Lost to Follow-up|0|||
129484211|NCT01193335|466064611|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
129484212|NCT01193335|466064612|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
129484213|NCT01193335|466064611|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
129484214|NCT01193335|466064612|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
129484215|NCT01733329|466064614|FG000|Overall Study|Protocol Violation|1|||
129484216|NCT01733329|466064615|FG001|Overall Study|Protocol Violation|1|||
129484217|NCT01733329|466064614|FG000|Overall Study|Uterine artery injury|1|||
129484218|NCT01733329|466064615|FG001|Overall Study|Uterine artery injury|0|||
129484219|NCT00542828|466064616|FG000|Overall Study|Physician Decision|1|||
129484220|NCT00542828|466064616|FG000|Overall Study|Need for Prohibited Treatment|3|||
129484221|NCT00542828|466064616|FG000|Overall Study|Study Prematurely Discontinued|7|||
129484222|NCT00542828|466064616|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
129484223|NCT03228186|466064617|FG000|Overall Study|Patient never started treatment|1|||
129484224|NCT04246047|466064618|FG000|Overall Study|Death|50|||
129484225|NCT04246047|466064619|FG001|Overall Study|Death|77|||
129484226|NCT04246047|466064618|FG000|Overall Study|Lost to Follow-up|1|||
129484227|NCT04246047|466064619|FG001|Overall Study|Lost to Follow-up|3|||
129484228|NCT04246047|466064618|FG000|Overall Study|Physician Decision|4|||
129484229|NCT04246047|466064619|FG001|Overall Study|Physician Decision|10|||
129484230|NCT04246047|466064618|FG000|Overall Study|Withdrawal by Subject|19|||
129484231|NCT04246047|466064619|FG001|Overall Study|Withdrawal by Subject|26|||
129484232|NCT04246047|466064618|FG000|Overall Study|Ongoing|169|||
129484233|NCT04246047|466064619|FG001|Overall Study|Ongoing|135|||
129484234|NCT05139030|466064623|FG000|Overall Study|Withdrawal by Subject|1|||
129484235|NCT05139030|466064624|FG001|Overall Study|Withdrawal by Subject|3|||
129484236|NCT05139030|466064623|FG000|Overall Study|Adverse Event|0|||
129484237|NCT05139030|466064624|FG001|Overall Study|Adverse Event|1|||
129484238|NCT05139030|466064623|FG000|Overall Study|Failure to meet continuation criteria|0|||
129484239|NCT05139030|466064624|FG001|Overall Study|Failure to meet continuation criteria|1|||
129484240|NCT02502864|466064632|FG000|Overall Study|Withdrawal by Subject|1|||
129484241|NCT03772327|466064633|FG000|Overall Study|Lost to Follow-up|3|||
129484242|NCT03772327|466064634|FG001|Overall Study|Lost to Follow-up|4|||
129484243|NCT03772327|466064633|FG000|Overall Study|Withdrawal by Subject|2|||
129484244|NCT03772327|466064634|FG001|Overall Study|Withdrawal by Subject|3|||
129484245|NCT04233424|466064642|FG000|Overall Study|Death|15|||
129484246|NCT04233424|466064643|FG001|Overall Study|Death|16|||
129484247|NCT04233424|466064642|FG000|Overall Study|Withdrawal by Subject|2|||
129484248|NCT04233424|466064643|FG001|Overall Study|Withdrawal by Subject|8|||
129484249|NCT04233424|466064642|FG000|Overall Study|Physician Decision|1|||
129484250|NCT04233424|466064643|FG001|Overall Study|Physician Decision|3|||
129484251|NCT04233424|466064642|FG000|Overall Study|Protocol Violation|3|||
129484252|NCT04233424|466064643|FG001|Overall Study|Protocol Violation|1|||
129484253|NCT04233424|466064642|FG000|Overall Study|Lost to Follow-up|1|||
129484254|NCT04233424|466064643|FG001|Overall Study|Lost to Follow-up|3|||
129484255|NCT04233424|466064642|FG000|Overall Study|subject refuse to visit site|2|||
129484256|NCT04233424|466064643|FG001|Overall Study|subject refuse to visit site|0|||
129484257|NCT03517436|466064644|FG000|Overall Study|Death|3|||
129484258|NCT03517436|466064644|FG000|Overall Study|Withdrawal by Subject|4|||
129484259|NCT03517436|466064644|FG000|Overall Study|Did not receive study valve.|1|||
129484260|NCT02698189|466064645|FG000|Overall Study|Physician Decision|3|||
129484261|NCT02698189|466064646|FG001|Overall Study|Physician Decision|0|||
129484262|NCT02698189|466064645|FG000|Overall Study|Progressive disease|0|||
129484263|NCT02698189|466064646|FG001|Overall Study|Progressive disease|5|||
129484264|NCT02698189|466064645|FG000|Overall Study|Study terminated by sponsor|0|||
129484265|NCT02698189|466064646|FG001|Overall Study|Study terminated by sponsor|1|||
129484266|NCT01982630|466064649|FG000|Overall Study|Adverse Event|2|||
129484267|NCT01982630|466064650|FG001|Overall Study|Adverse Event|0|||
129484268|NCT01982630|466064651|FG002|Overall Study|Adverse Event|1|||
129484269|NCT01982630|466064652|FG003|Overall Study|Adverse Event|0|||
129484270|NCT01982630|466064653|FG004|Overall Study|Adverse Event|1|||
129484271|NCT01982630|466064654|FG005|Overall Study|Adverse Event|2|||
129484272|NCT01982630|466064655|FG006|Overall Study|Adverse Event|1|||
129484273|NCT01982630|466064656|FG007|Overall Study|Adverse Event|0|||
129484274|NCT01982630|466064649|FG000|Overall Study|Physician Decision|1|||
129484275|NCT01982630|466064650|FG001|Overall Study|Physician Decision|0|||
129484276|NCT01982630|466064651|FG002|Overall Study|Physician Decision|2|||
129484277|NCT01982630|466064652|FG003|Overall Study|Physician Decision|1|||
129484278|NCT01982630|466064653|FG004|Overall Study|Physician Decision|2|||
129484279|NCT01982630|466064654|FG005|Overall Study|Physician Decision|0|||
129484280|NCT01982630|466064655|FG006|Overall Study|Physician Decision|0|||
129484281|NCT01982630|466064656|FG007|Overall Study|Physician Decision|0|||
129484282|NCT01982630|466064649|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484283|NCT01982630|466064650|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484284|NCT01982630|466064651|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
129484285|NCT01982630|466064652|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484286|NCT01982630|466064653|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484287|NCT01982630|466064654|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484288|NCT01982630|466064655|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484289|NCT01982630|466064656|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
129484290|NCT01982630|466064649|FG000|Overall Study|Withdrawal by Subject|0|||
129484291|NCT01982630|466064650|FG001|Overall Study|Withdrawal by Subject|0|||
129484292|NCT01982630|466064651|FG002|Overall Study|Withdrawal by Subject|0|||
129484293|NCT01982630|466064652|FG003|Overall Study|Withdrawal by Subject|0|||
129484294|NCT01982630|466064653|FG004|Overall Study|Withdrawal by Subject|0|||
129484295|NCT01982630|466064654|FG005|Overall Study|Withdrawal by Subject|1|||
129484296|NCT01982630|466064655|FG006|Overall Study|Withdrawal by Subject|0|||
129484297|NCT01982630|466064656|FG007|Overall Study|Withdrawal by Subject|0|||
129484298|NCT00561353|466064657|FG000|Overall Study|Subject reached a virologic endpoint|2|||
129484299|NCT00561353|466064658|FG001|Overall Study|Subject reached a virologic endpoint|1|||
129484300|NCT00561353|466064659|FG002|Overall Study|Subject reached a virologic endpoint|1|||
129484301|NCT00561353|466064660|FG003|Overall Study|Subject reached a virologic endpoint|4|||
129484302|NCT00561353|466064661|FG004|Overall Study|Subject reached a virologic endpoint|1|||
129484303|NCT00561353|466064662|FG005|Overall Study|Subject reached a virologic endpoint|3|||
129484304|NCT00561353|466064663|FG006|Overall Study|Subject reached a virologic endpoint|4|||
129484305|NCT00561353|466064664|FG007|Overall Study|Subject reached a virologic endpoint|4|||
129484306|NCT00561353|466064665|FG008|Overall Study|Subject reached a virologic endpoint|5|||
129484307|NCT00561353|466064666|FG009|Overall Study|Subject reached a virologic endpoint|0|||
129484308|NCT00561353|466064657|FG000|Overall Study|Subject ineligible to continue the trial|0|||
129484309|NCT00561353|466064658|FG001|Overall Study|Subject ineligible to continue the trial|0|||
129484310|NCT00561353|466064659|FG002|Overall Study|Subject ineligible to continue the trial|0|||
129484311|NCT00561353|466064660|FG003|Overall Study|Subject ineligible to continue the trial|0|||
129484312|NCT00561353|466064661|FG004|Overall Study|Subject ineligible to continue the trial|0|||
129484313|NCT00561353|466064662|FG005|Overall Study|Subject ineligible to continue the trial|1|||
129484314|NCT00561353|466064663|FG006|Overall Study|Subject ineligible to continue the trial|1|||
129484315|NCT00561353|466064664|FG007|Overall Study|Subject ineligible to continue the trial|0|||
129484316|NCT00561353|466064665|FG008|Overall Study|Subject ineligible to continue the trial|2|||
129484317|NCT00561353|466064666|FG009|Overall Study|Subject ineligible to continue the trial|1|||
129484318|NCT00561353|466064657|FG000|Overall Study|Other|1|||
129484319|NCT00561353|466064658|FG001|Overall Study|Other|0|||
129484320|NCT00561353|466064659|FG002|Overall Study|Other|1|||
129484321|NCT00561353|466064660|FG003|Overall Study|Other|0|||
129484322|NCT00561353|466064661|FG004|Overall Study|Other|0|||
129484323|NCT00561353|466064662|FG005|Overall Study|Other|2|||
129484324|NCT00561353|466064663|FG006|Overall Study|Other|0|||
129484325|NCT00561353|466064664|FG007|Overall Study|Other|0|||
129484326|NCT00561353|466064665|FG008|Overall Study|Other|0|||
129484327|NCT00561353|466064666|FG009|Overall Study|Other|0|||
129484328|NCT00561353|466064657|FG000|Overall Study|Adverse Event|0|||
129484329|NCT00561353|466064658|FG001|Overall Study|Adverse Event|0|||
129484330|NCT00561353|466064659|FG002|Overall Study|Adverse Event|0|||
129484331|NCT00561353|466064660|FG003|Overall Study|Adverse Event|2|||
129978565|NCT00368927|467883738|FG000|Overall Study|Adverse Event|1|||
129978566|NCT00368927|467883739|FG001|Overall Study|Adverse Event|1|||
129978567|NCT00368927|467883738|FG000|Overall Study|Withdrawal by Subject|1|||
129978568|NCT00368927|467883739|FG001|Overall Study|Withdrawal by Subject|2|||
129978569|NCT00368927|467883738|FG000|Overall Study|Physician Decision|1|||
129978570|NCT00368927|467883739|FG001|Overall Study|Physician Decision|0|||
129978571|NCT03525392|467883740|FG000|Overall Study|Adverse Event|1|||
129978572|NCT03525392|467883741|FG001|Overall Study|Adverse Event|0|||
129978573|NCT03525392|467883742|FG002|Overall Study|Adverse Event|2|||
129978574|NCT03525392|467883743|FG003|Overall Study|Adverse Event|0|||
129978575|NCT03525392|467883744|FG004|Overall Study|Adverse Event|0|||
129978576|NCT03525392|467883740|FG000|Overall Study|Progressive disease|0|||
129978577|NCT03525392|467883741|FG001|Overall Study|Progressive disease|1|||
129978578|NCT03525392|467883742|FG002|Overall Study|Progressive disease|1|||
129978579|NCT03525392|467883743|FG003|Overall Study|Progressive disease|3|||
129978580|NCT03525392|467883744|FG004|Overall Study|Progressive disease|1|||
129978581|NCT04187326|467883747|FG000|Overall Study|Lost to Follow-up|2|||
129978582|NCT04187326|467883748|FG001|Overall Study|Lost to Follow-up|1|||
129978583|NCT04187326|467883747|FG000|Overall Study|Computer error- task was only partially completed.|0|||
129978584|NCT04187326|467883748|FG001|Overall Study|Computer error- task was only partially completed.|1|||
129484332|NCT00561353|466064661|FG004|Overall Study|Adverse Event|0|||
129484333|NCT00561353|466064662|FG005|Overall Study|Adverse Event|0|||
129484334|NCT00561353|466064663|FG006|Overall Study|Adverse Event|1|||
129484335|NCT00561353|466064664|FG007|Overall Study|Adverse Event|0|||
129484336|NCT00561353|466064665|FG008|Overall Study|Adverse Event|0|||
129484337|NCT00561353|466064666|FG009|Overall Study|Adverse Event|1|||
129484338|NCT00561353|466064657|FG000|Overall Study|Lost to Follow-up|2|||
129484339|NCT00561353|466064658|FG001|Overall Study|Lost to Follow-up|0|||
129484340|NCT00561353|466064659|FG002|Overall Study|Lost to Follow-up|1|||
129484341|NCT00561353|466064660|FG003|Overall Study|Lost to Follow-up|0|||
129484342|NCT00561353|466064661|FG004|Overall Study|Lost to Follow-up|0|||
129484343|NCT00561353|466064662|FG005|Overall Study|Lost to Follow-up|0|||
129484344|NCT00561353|466064663|FG006|Overall Study|Lost to Follow-up|0|||
129484345|NCT00561353|466064664|FG007|Overall Study|Lost to Follow-up|0|||
129484346|NCT00561353|466064665|FG008|Overall Study|Lost to Follow-up|0|||
129484347|NCT00561353|466064666|FG009|Overall Study|Lost to Follow-up|0|||
129484348|NCT00561353|466064657|FG000|Overall Study|Withdrawal by Subject|0|||
129484349|NCT00561353|466064658|FG001|Overall Study|Withdrawal by Subject|2|||
129484350|NCT00561353|466064659|FG002|Overall Study|Withdrawal by Subject|0|||
129484351|NCT00561353|466064660|FG003|Overall Study|Withdrawal by Subject|0|||
129484352|NCT00561353|466064661|FG004|Overall Study|Withdrawal by Subject|0|||
129484353|NCT00561353|466064662|FG005|Overall Study|Withdrawal by Subject|0|||
129484354|NCT00561353|466064663|FG006|Overall Study|Withdrawal by Subject|0|||
129484355|NCT00561353|466064664|FG007|Overall Study|Withdrawal by Subject|0|||
129484356|NCT00561353|466064665|FG008|Overall Study|Withdrawal by Subject|0|||
129484357|NCT00561353|466064666|FG009|Overall Study|Withdrawal by Subject|0|||
129484358|NCT00820040|466064667|FG000|Overall Study|Death|1|||
129484359|NCT00820040|466064667|FG000|Overall Study|Sponsor terminated study|1|||
129484360|NCT00820040|466064667|FG000|Overall Study|Screen failure|1|||
129484361|NCT02493751|466064670|FG000|Overall Study|Withdrawal by Subject|2|||
129484362|NCT02493751|466064671|FG001|Overall Study|Withdrawal by Subject|8|||
129484363|NCT02493751|466064670|FG000|Overall Study|Death|6|||
129484364|NCT02493751|466064671|FG001|Overall Study|Death|13|||
129484365|NCT02493751|466064670|FG000|Overall Study|Lost to Follow-up|2|||
129484366|NCT02493751|466064671|FG001|Overall Study|Lost to Follow-up|3|||
129484367|NCT02493751|466064670|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
129484368|NCT02493751|466064671|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
129484369|NCT03248128|466064672|FG000|Overall Study|Lost to Follow-up|1|||
129484370|NCT03248128|466064673|FG001|Overall Study|Lost to Follow-up|0|||
129484371|NCT03248128|466064672|FG000|Overall Study|Withdrawal by Subject|16|||
129484372|NCT03248128|466064673|FG001|Overall Study|Withdrawal by Subject|14|||
129484373|NCT03248128|466064672|FG000|Overall Study|Site Closed|4|||
129484374|NCT03248128|466064673|FG001|Overall Study|Site Closed|3|||
129484375|NCT03248128|466064672|FG000|Overall Study|Randomized, but did not receive treatment|1|||
129484376|NCT03248128|466064673|FG001|Overall Study|Randomized, but did not receive treatment|3|||
129484377|NCT01914679|466064674|FG000|Overall Study|Lack of Efficacy|1|||
129484378|NCT01914679|466064674|FG000|Overall Study|Sponsor terminated study|4|||
129484379|NCT02722044|466064675|FG000|Overall Study|Adverse Event|2|||
129484380|NCT02722044|466064675|FG000|Overall Study|Physician Decision|1|||
129484381|NCT02722044|466064675|FG000|Overall Study|Withdrawal by Subject|1|||
129978585|NCT05235269|467883755|FG000|Overall Study|Adverse Event|1|||
129978586|NCT05235269|467883755|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
129978587|NCT05235269|467883755|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
129484382|NCT02722044|466064675|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
129484383|NCT00002850|466064676|FG000|Overall Study|Death|4|||
129484384|NCT00002850|466064677|FG001|Overall Study|Death|1|||
129484385|NCT00002850|466064678|FG002|Overall Study|Death|3|||
129484386|NCT00002850|466064676|FG000|Overall Study|Protocol Violation|1|||
129484387|NCT00002850|466064677|FG001|Overall Study|Protocol Violation|0|||
129484388|NCT00002850|466064678|FG002|Overall Study|Protocol Violation|1|||
129978588|NCT00798434|467883756|FG000|Double-Blind|Adverse Event|22|||
129978589|NCT00798434|467883757|FG001|Double-Blind|Adverse Event|46|||
129978590|NCT00798434|467883756|FG000|Double-Blind|Death|0|||
129978591|NCT00798434|467883757|FG001|Double-Blind|Death|1|||
129978592|NCT00798434|467883756|FG000|Double-Blind|Lost to Follow-up|1|||
129978593|NCT00798434|467883757|FG001|Double-Blind|Lost to Follow-up|0|||
129978594|NCT00798434|467883756|FG000|Double-Blind|Lack of Efficacy|8|||
129978595|NCT00798434|467883757|FG001|Double-Blind|Lack of Efficacy|12|||
129978596|NCT00798434|467883756|FG000|Double-Blind|Withdrawal by Subject|17|||
129978597|NCT00798434|467883757|FG001|Double-Blind|Withdrawal by Subject|14|||
129978598|NCT00798434|467883756|FG000|Double-Blind|Protocol Violation|1|||
129978599|NCT00798434|467883757|FG001|Double-Blind|Protocol Violation|4|||
129978600|NCT00798434|467883756|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
129978601|NCT00798434|467883757|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
129978602|NCT00798434|467883756|FG000|Double-Blind|Other|1|||
129978603|NCT00798434|467883757|FG001|Double-Blind|Other|0|||
129978604|NCT00798434|467883756|FG000|Double-Blind|Not Treated|3|||
129978605|NCT00798434|467883757|FG001|Double-Blind|Not Treated|6|||
129978606|NCT00798434|467883756|FG000|Open-Label|Adverse Event|33|||
129978607|NCT00798434|467883757|FG001|Open-Label|Adverse Event|11|||
129978608|NCT00798434|467883756|FG000|Open-Label|Lack of Efficacy|5|||
129978609|NCT00798434|467883757|FG001|Open-Label|Lack of Efficacy|11|||
129978610|NCT00798434|467883756|FG000|Open-Label|Withdrawal by Subject|2|||
129978611|NCT00798434|467883757|FG001|Open-Label|Withdrawal by Subject|7|||
129978612|NCT00798434|467883756|FG000|Open-Label|Protocol Violation|1|||
129978613|NCT00798434|467883757|FG001|Open-Label|Protocol Violation|0|||
129978614|NCT00798434|467883756|FG000|Open-Label|Other|1|||
129978615|NCT00798434|467883757|FG001|Open-Label|Other|2|||
129484389|NCT00002850|466064676|FG000|Overall Study|Withdrawal by Subject|0|||
129484390|NCT00002850|466064677|FG001|Overall Study|Withdrawal by Subject|1|||
129484391|NCT00002850|466064678|FG002|Overall Study|Withdrawal by Subject|0|||
129484392|NCT01084252|466066392|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484393|NCT01084252|466066393|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484394|NCT01084252|466066394|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484395|NCT01084252|466066395|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484396|NCT01084252|466066396|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484397|NCT01084252|466066397|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484398|NCT01084252|466066398|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484399|NCT01084252|466066399|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484400|NCT01084252|466066400|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484401|NCT01084252|466066401|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484402|NCT01084252|466066402|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484403|NCT01084252|466066403|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484404|NCT01084252|466066404|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
129484405|NCT01084252|466066405|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
129484406|NCT03528681|466066406|FG000|Open-Label Phase|Physician Decision|2|||
129484407|NCT03528681|466066407|FG001|Open-Label Phase|Physician Decision|0|||
129484408|NCT03528681|466066408|FG002|Open-Label Phase|Physician Decision|0|||
129484409|NCT03528681|466066409|FG003|Open-Label Phase|Physician Decision|0|||
129484410|NCT03528681|466066406|FG000|Open-Label Phase|Withdrawal by Subject|8|||
129484411|NCT03528681|466066407|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129484412|NCT03528681|466066408|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129484413|NCT03528681|466066409|FG003|Open-Label Phase|Withdrawal by Subject|0|||
129484414|NCT03528681|466066406|FG000|Open-Label Phase|(Not collected)|4|||
129484415|NCT03528681|466066407|FG001|Open-Label Phase|(Not collected)|0|||
129484416|NCT03528681|466066408|FG002|Open-Label Phase|(Not collected)|0|||
129484417|NCT03528681|466066409|FG003|Open-Label Phase|(Not collected)|0|||
129484418|NCT03528681|466066406|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
129484419|NCT03528681|466066407|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
129484420|NCT03528681|466066408|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
129484421|NCT03528681|466066409|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
129484422|NCT03528681|466066406|FG000|Randomized Treatment Phase|Physician Decision|0|||
129484423|NCT03528681|466066407|FG001|Randomized Treatment Phase|Physician Decision|5|||
129484424|NCT03528681|466066408|FG002|Randomized Treatment Phase|Physician Decision|1|||
129978616|NCT00798434|467883756|FG000|Open-Label|Not Treated|0|||
129978617|NCT00798434|467883757|FG001|Open-Label|Not Treated|1|||
129978618|NCT03898167|467883758|FG000|Overall Study|Terminated phone call early|7|||
129978619|NCT03898167|467883759|FG001|Overall Study|Terminated phone call early|0|||
129978620|NCT03898167|467883760|FG002|Overall Study|Terminated phone call early|0|||
129484425|NCT03528681|466066409|FG003|Randomized Treatment Phase|Physician Decision|2|||
129484426|NCT03528681|466066406|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
129484427|NCT03528681|466066407|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
129484428|NCT03528681|466066408|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
129484429|NCT03528681|466066409|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
129484430|NCT03528681|466066406|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
129484431|NCT03528681|466066407|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
129484432|NCT03528681|466066408|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
129484433|NCT03528681|466066409|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
129484434|NCT03528681|466066406|FG000|Randomized Treatment Phase|(Not collected)|0|||
129484435|NCT03528681|466066407|FG001|Randomized Treatment Phase|(Not collected)|4|||
129484436|NCT03528681|466066408|FG002|Randomized Treatment Phase|(Not collected)|6|||
129484437|NCT03528681|466066409|FG003|Randomized Treatment Phase|(Not collected)|5|||
129484438|NCT00955110|466066410|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
129484439|NCT00955110|466066410|FG000|Treatment Phase|Adverse Event|2|||
129484440|NCT00955110|466066410|FG000|Treatment Phase|Administrative reasons|2|||
129484441|NCT00955110|466066410|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
129484442|NCT00955110|466066410|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
129484443|NCT03715465|466066418|FG000|Overall Study|Withdrawal by Subject|1|||
129484444|NCT03715465|466066419|FG001|Overall Study|Withdrawal by Subject|2|||
129484445|NCT02158533|466066427|FG000|Stage 1|Adverse Event|6|||
129484446|NCT02158533|466066428|FG001|Stage 1|Adverse Event|4|||
129484447|NCT02158533|466066429|FG002|Stage 1|Adverse Event|7|||
129484448|NCT02158533|466066430|FG003|Stage 1|Adverse Event|0|||
129484449|NCT02158533|466066431|FG004|Stage 1|Adverse Event|0|||
129484450|NCT02158533|466066432|FG005|Stage 1|Adverse Event|0|||
129484451|NCT02158533|466066427|FG000|Stage 1|Withdrawal by Subject|3|||
129484452|NCT02158533|466066428|FG001|Stage 1|Withdrawal by Subject|2|||
129484453|NCT02158533|466066429|FG002|Stage 1|Withdrawal by Subject|1|||
129484454|NCT02158533|466066430|FG003|Stage 1|Withdrawal by Subject|0|||
129484455|NCT02158533|466066431|FG004|Stage 1|Withdrawal by Subject|0|||
129484456|NCT02158533|466066432|FG005|Stage 1|Withdrawal by Subject|0|||
129484457|NCT02158533|466066427|FG000|Stage 1|Lack of Efficacy|1|||
129484458|NCT02158533|466066428|FG001|Stage 1|Lack of Efficacy|0|||
129484459|NCT02158533|466066429|FG002|Stage 1|Lack of Efficacy|0|||
129484460|NCT02158533|466066430|FG003|Stage 1|Lack of Efficacy|0|||
129484461|NCT02158533|466066431|FG004|Stage 1|Lack of Efficacy|0|||
129484462|NCT02158533|466066432|FG005|Stage 1|Lack of Efficacy|0|||
129484463|NCT02158533|466066427|FG000|Stage 1|Lost to Follow-up|3|||
129484464|NCT02158533|466066428|FG001|Stage 1|Lost to Follow-up|1|||
129484465|NCT02158533|466066429|FG002|Stage 1|Lost to Follow-up|0|||
129484466|NCT02158533|466066430|FG003|Stage 1|Lost to Follow-up|0|||
129484467|NCT02158533|466066431|FG004|Stage 1|Lost to Follow-up|0|||
129484468|NCT02158533|466066432|FG005|Stage 1|Lost to Follow-up|0|||
129484469|NCT02158533|466066427|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
129484470|NCT02158533|466066428|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
129484471|NCT02158533|466066429|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
129484472|NCT02158533|466066430|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
129484473|NCT02158533|466066431|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
129484474|NCT02158533|466066432|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
129484475|NCT02158533|466066427|FG000|Stage 1|Non-compliance with study visits|1|||
129484476|NCT02158533|466066428|FG001|Stage 1|Non-compliance with study visits|0|||
129484477|NCT02158533|466066429|FG002|Stage 1|Non-compliance with study visits|0|||
129484478|NCT02158533|466066430|FG003|Stage 1|Non-compliance with study visits|0|||
129484479|NCT02158533|466066431|FG004|Stage 1|Non-compliance with study visits|0|||
129484480|NCT02158533|466066432|FG005|Stage 1|Non-compliance with study visits|0|||
129484481|NCT02158533|466066427|FG000|Stage 2|Adverse Event|0|||
129484482|NCT02158533|466066428|FG001|Stage 2|Adverse Event|0|||
129484483|NCT02158533|466066429|FG002|Stage 2|Adverse Event|0|||
129484484|NCT02158533|466066430|FG003|Stage 2|Adverse Event|0|||
129484485|NCT02158533|466066431|FG004|Stage 2|Adverse Event|0|||
129484486|NCT02158533|466066432|FG005|Stage 2|Adverse Event|1|||
129484487|NCT02158533|466066427|FG000|Stage 2|Lack of Efficacy|0|||
129484488|NCT02158533|466066428|FG001|Stage 2|Lack of Efficacy|0|||
129484489|NCT02158533|466066429|FG002|Stage 2|Lack of Efficacy|0|||
129484490|NCT02158533|466066430|FG003|Stage 2|Lack of Efficacy|0|||
129484491|NCT02158533|466066431|FG004|Stage 2|Lack of Efficacy|1|||
129484492|NCT02158533|466066432|FG005|Stage 2|Lack of Efficacy|0|||
129484493|NCT02158533|466066427|FG000|Stage 2|Lost to Follow-up|0|||
129484494|NCT02158533|466066428|FG001|Stage 2|Lost to Follow-up|0|||
129484495|NCT02158533|466066429|FG002|Stage 2|Lost to Follow-up|0|||
129484496|NCT02158533|466066430|FG003|Stage 2|Lost to Follow-up|1|||
129484497|NCT02158533|466066431|FG004|Stage 2|Lost to Follow-up|1|||
129484498|NCT02158533|466066432|FG005|Stage 2|Lost to Follow-up|2|||
129484499|NCT02158533|466066427|FG000|Stage 2|Withdrawal by Subject|0|||
129484500|NCT02158533|466066428|FG001|Stage 2|Withdrawal by Subject|0|||
129484501|NCT02158533|466066429|FG002|Stage 2|Withdrawal by Subject|0|||
129484502|NCT02158533|466066430|FG003|Stage 2|Withdrawal by Subject|0|||
129484503|NCT02158533|466066431|FG004|Stage 2|Withdrawal by Subject|1|||
129484504|NCT02158533|466066432|FG005|Stage 2|Withdrawal by Subject|2|||
129484505|NCT02158533|466066427|FG000|Stage 2|Physician Decision|0|||
129484506|NCT02158533|466066428|FG001|Stage 2|Physician Decision|0|||
129484507|NCT02158533|466066429|FG002|Stage 2|Physician Decision|0|||
129484508|NCT02158533|466066430|FG003|Stage 2|Physician Decision|0|||
129484509|NCT02158533|466066431|FG004|Stage 2|Physician Decision|1|||
129484510|NCT02158533|466066432|FG005|Stage 2|Physician Decision|0|||
129484511|NCT02158533|466066427|FG000|Stage 2|Pregnancy|0|||
129484512|NCT02158533|466066428|FG001|Stage 2|Pregnancy|0|||
129978621|NCT03898167|467883758|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
129978622|NCT03898167|467883759|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
129978623|NCT03898167|467883760|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
129978624|NCT05177354|467883761|FG000|Implant to 30-day Visit|Physician Decision|1|||
129978625|NCT05177354|467883761|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
129978626|NCT05177354|467883761|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
129978627|NCT05177354|467883761|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
129978628|NCT03548220|467883763|FG000|Overall Study|Lost to Follow-up|1|||
129978629|NCT03548220|467883764|FG001|Overall Study|Lost to Follow-up|0|||
129978630|NCT03548220|467883765|FG002|Overall Study|Lost to Follow-up|0|||
129978631|NCT03548220|467883766|FG003|Overall Study|Lost to Follow-up|0|||
129978632|NCT02906007|467883767|FG000|Overall Study|Physician Decision|0|||
129978633|NCT02906007|467883768|FG001|Overall Study|Physician Decision|0|||
129978634|NCT02906007|467883769|FG002|Overall Study|Physician Decision|1|||
129978635|NCT02906007|467883767|FG000|Overall Study|Died|1|||
129978636|NCT02906007|467883768|FG001|Overall Study|Died|0|||
129978637|NCT02906007|467883769|FG002|Overall Study|Died|0|||
129978638|NCT01946529|467883770|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
129978639|NCT01946529|467883771|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
129978640|NCT01946529|467883772|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
129978641|NCT01946529|467883770|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
129978642|NCT01946529|467883771|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
129978643|NCT01946529|467883772|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
129978644|NCT06655558|467883773|FG000|Overall Study|Protocol Violation|1|||
129978645|NCT03570892|467883774|FG000|Overall Study|Death|51|||
129978646|NCT03570892|467883775|FG001|Overall Study|Death|45|||
129978647|NCT03570892|467883774|FG000|Overall Study|Subject decision|5|||
129978648|NCT03570892|467883775|FG001|Overall Study|Subject decision|3|||
129978649|NCT03570892|467883774|FG000|Overall Study|Protocol Violation|1|||
129978650|NCT03570892|467883775|FG001|Overall Study|Protocol Violation|4|||
129978651|NCT03570892|467883774|FG000|Overall Study|Physician Decision|0|||
129978652|NCT03570892|467883775|FG001|Overall Study|Physician Decision|2|||
129978653|NCT01099215|467885148|FG000|Overall Study|Withdrawal by Subject|1|||
129978654|NCT01099215|467885149|FG001|Overall Study|Withdrawal by Subject|0|||
129978655|NCT01099215|467885148|FG000|Overall Study|Adverse Event|0|||
129978656|NCT01099215|467885149|FG001|Overall Study|Adverse Event|1|||
129978657|NCT00747227|467885151|FG000|Overall Study|Death|3|||
129978658|NCT00747227|467885152|FG001|Overall Study|Death|1|||
129978659|NCT00747227|467885151|FG000|Overall Study|Withdrawal by Subject|1|||
129978660|NCT00747227|467885152|FG001|Overall Study|Withdrawal by Subject|0|||
129978661|NCT00747227|467885151|FG000|Overall Study|Lost to Follow-up|1|||
129978662|NCT00747227|467885152|FG001|Overall Study|Lost to Follow-up|2|||
129978663|NCT00747227|467885151|FG000|Overall Study|Illness|1|||
129978664|NCT00747227|467885152|FG001|Overall Study|Illness|1|||
129978665|NCT03554629|467885153|FG000|Overall Study|Inadequate data|6|||
129978666|NCT01901432|467885154|FG000|Overall Study|Adverse Event|0|||
129978667|NCT01901432|467885155|FG001|Overall Study|Adverse Event|1|||
129978668|NCT01901432|467885156|FG002|Overall Study|Adverse Event|1|||
129978669|NCT01901432|467885157|FG003|Overall Study|Adverse Event|0|||
129978670|NCT01901432|467885158|FG004|Overall Study|Adverse Event|1|||
129978671|NCT01901432|467885154|FG000|Overall Study|Withdrawal by Subject|0|||
129978672|NCT01901432|467885155|FG001|Overall Study|Withdrawal by Subject|0|||
129978673|NCT01901432|467885156|FG002|Overall Study|Withdrawal by Subject|1|||
129484513|NCT02158533|466066429|FG002|Stage 2|Pregnancy|0|||
129484514|NCT02158533|466066430|FG003|Stage 2|Pregnancy|1|||
129978674|NCT01901432|467885157|FG003|Overall Study|Withdrawal by Subject|0|||
129978675|NCT01901432|467885158|FG004|Overall Study|Withdrawal by Subject|5|||
129978676|NCT01901432|467885154|FG000|Overall Study|Physician Decision|0|||
129978677|NCT01901432|467885155|FG001|Overall Study|Physician Decision|0|||
129978678|NCT01901432|467885156|FG002|Overall Study|Physician Decision|0|||
129978679|NCT01901432|467885157|FG003|Overall Study|Physician Decision|0|||
129978680|NCT01901432|467885158|FG004|Overall Study|Physician Decision|2|||
129978681|NCT01901432|467885154|FG000|Overall Study|Patient decision to stop study drug|0|||
129978682|NCT01901432|467885155|FG001|Overall Study|Patient decision to stop study drug|0|||
129484515|NCT02158533|466066431|FG004|Stage 2|Pregnancy|0|||
129484516|NCT02158533|466066432|FG005|Stage 2|Pregnancy|0|||
129484517|NCT02158533|466066427|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
129484518|NCT02158533|466066428|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
129978683|NCT01901432|467885156|FG002|Overall Study|Patient decision to stop study drug|0|||
129978684|NCT01901432|467885157|FG003|Overall Study|Patient decision to stop study drug|0|||
129978685|NCT01901432|467885158|FG004|Overall Study|Patient decision to stop study drug|1|||
129978686|NCT00379288|467885159|FG000|Overall Study|Adverse Event|5|||
129978687|NCT00379288|467885160|FG001|Overall Study|Adverse Event|6|||
129978688|NCT00379288|467885161|FG002|Overall Study|Adverse Event|2|||
129978689|NCT00379288|467885162|FG003|Overall Study|Adverse Event|0|||
129978690|NCT00379288|467885159|FG000|Overall Study|Treatment Failure|0|||
129978691|NCT00379288|467885160|FG001|Overall Study|Treatment Failure|1|||
129978692|NCT00379288|467885161|FG002|Overall Study|Treatment Failure|0|||
129978693|NCT00379288|467885162|FG003|Overall Study|Treatment Failure|1|||
129978694|NCT00379288|467885159|FG000|Overall Study|Lost to Follow-up|3|||
129978695|NCT00379288|467885160|FG001|Overall Study|Lost to Follow-up|3|||
129978696|NCT00379288|467885161|FG002|Overall Study|Lost to Follow-up|2|||
129978697|NCT00379288|467885162|FG003|Overall Study|Lost to Follow-up|0|||
129978698|NCT00379288|467885159|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
129978699|NCT00379288|467885160|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
129978700|NCT00379288|467885161|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
129978701|NCT00379288|467885162|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
129978702|NCT00379288|467885159|FG000|Overall Study|Subject withdrew-related to study drug|1|||
129978703|NCT00379288|467885160|FG001|Overall Study|Subject withdrew-related to study drug|0|||
129978704|NCT00379288|467885161|FG002|Overall Study|Subject withdrew-related to study drug|0|||
129978705|NCT00379288|467885162|FG003|Overall Study|Subject withdrew-related to study drug|1|||
129978706|NCT00379288|467885159|FG000|Overall Study|Noncompliance with protocol|8|||
129978707|NCT00379288|467885160|FG001|Overall Study|Noncompliance with protocol|6|||
129484519|NCT02158533|466066429|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
129484520|NCT02158533|466066430|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
129484521|NCT02158533|466066431|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
129484522|NCT02158533|466066432|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
129484523|NCT02158533|466066427|FG000|Stage 2|Non-adherence with study visits|0|||
129484524|NCT02158533|466066428|FG001|Stage 2|Non-adherence with study visits|0|||
129484525|NCT02158533|466066429|FG002|Stage 2|Non-adherence with study visits|0|||
129484526|NCT02158533|466066430|FG003|Stage 2|Non-adherence with study visits|0|||
129484527|NCT02158533|466066431|FG004|Stage 2|Non-adherence with study visits|0|||
129484528|NCT02158533|466066432|FG005|Stage 2|Non-adherence with study visits|1|||
129484529|NCT00917384|466066433|FG000|Overall Study|Lost to Follow-up|4|||
129484530|NCT00917384|466066434|FG001|Overall Study|Lost to Follow-up|2|||
129484531|NCT00917384|466066433|FG000|Overall Study|Withdrawal by Subject|10|||
129484532|NCT00917384|466066434|FG001|Overall Study|Withdrawal by Subject|2|||
129484533|NCT01126619|466066440|FG000|Overall Study|Not eligible for the study|2|||
129484534|NCT01126619|466066440|FG000|Overall Study|Investigator decision|4|||
129484535|NCT01126619|466066440|FG000|Overall Study|Serious adverse event|1|||
129484536|NCT01126619|466066440|FG000|Overall Study|Withdrawal by Subject|9|||
129484537|NCT01126619|466066440|FG000|Overall Study|Non-compliance|1|||
129484538|NCT03351244|466066441|FG000|Overall Study|Adverse Event|7|||
129484539|NCT03351244|466066442|FG001|Overall Study|Adverse Event|11|||
129484540|NCT03351244|466066443|FG002|Overall Study|Adverse Event|12|||
129484541|NCT03351244|466066441|FG000|Overall Study|Investigator's decision|0|||
129484542|NCT03351244|466066442|FG001|Overall Study|Investigator's decision|0|||
129484543|NCT03351244|466066443|FG002|Overall Study|Investigator's decision|2|||
129484544|NCT03351244|466066441|FG000|Overall Study|System error|0|||
129484545|NCT03351244|466066442|FG001|Overall Study|System error|0|||
129484546|NCT03351244|466066443|FG002|Overall Study|System error|2|||
129484547|NCT03351244|466066441|FG000|Overall Study|COVID-19 restrictions|3|||
129484548|NCT03351244|466066442|FG001|Overall Study|COVID-19 restrictions|0|||
129484549|NCT03351244|466066443|FG002|Overall Study|COVID-19 restrictions|1|||
129484550|NCT03351244|466066441|FG000|Overall Study|Non-compliance|2|||
129484551|NCT03351244|466066442|FG001|Overall Study|Non-compliance|5|||
129484552|NCT03351244|466066443|FG002|Overall Study|Non-compliance|0|||
129484553|NCT03351244|466066441|FG000|Overall Study|Withdrawal by Subject|11|||
129484554|NCT03351244|466066442|FG001|Overall Study|Withdrawal by Subject|16|||
129484555|NCT03351244|466066443|FG002|Overall Study|Withdrawal by Subject|13|||
129484556|NCT03351244|466066441|FG000|Overall Study|Lost to Follow-up|2|||
129484557|NCT03351244|466066442|FG001|Overall Study|Lost to Follow-up|6|||
129978708|NCT00379288|467885161|FG002|Overall Study|Noncompliance with protocol|2|||
129978709|NCT00379288|467885162|FG003|Overall Study|Noncompliance with protocol|1|||
129978710|NCT00379288|467885159|FG000|Overall Study|Did not meet protocol eligibility|0|||
129978711|NCT00379288|467885160|FG001|Overall Study|Did not meet protocol eligibility|1|||
129978712|NCT00379288|467885161|FG002|Overall Study|Did not meet protocol eligibility|0|||
129484558|NCT03351244|466066443|FG002|Overall Study|Lost to Follow-up|4|||
129484559|NCT03351244|466066441|FG000|Overall Study|Protocol Violation|2|||
129484560|NCT03351244|466066442|FG001|Overall Study|Protocol Violation|2|||
129484561|NCT03351244|466066443|FG002|Overall Study|Protocol Violation|0|||
129484562|NCT04899271|466066444|FG000|Overall Study|Lost to Follow-up|1|||
129484563|NCT04899271|466066445|FG001|Overall Study|Lost to Follow-up|0|||
129978713|NCT00379288|467885162|FG003|Overall Study|Did not meet protocol eligibility|2|||
129978714|NCT00379288|467885159|FG000|Overall Study|Administrative|2|||
129978715|NCT00379288|467885160|FG001|Overall Study|Administrative|2|||
129978716|NCT00379288|467885161|FG002|Overall Study|Administrative|0|||
129978717|NCT00379288|467885162|FG003|Overall Study|Administrative|1|||
129978718|NCT00515671|467885173|FG000|Overall Study|Lost to Follow-up|13|||
129978719|NCT00515671|467885174|FG001|Overall Study|Lost to Follow-up|10|||
129978720|NCT00515671|467885173|FG000|Overall Study|Withdrawal by Subject|3|||
129978721|NCT00515671|467885174|FG001|Overall Study|Withdrawal by Subject|5|||
129978722|NCT00515671|467885173|FG000|Overall Study|incarcerated|1|||
129978723|NCT00515671|467885174|FG001|Overall Study|incarcerated|2|||
129978724|NCT00288639|467885177|FG000|Overall Study|Adverse Event|5|||
129978725|NCT00288639|467885177|FG000|Overall Study|Lack of Efficacy|4|||
129978726|NCT00288639|467885177|FG000|Overall Study|Withdrawal by Subject|2|||
129978727|NCT00288639|467885177|FG000|Overall Study|Other|1|||
129978728|NCT01014208|467885186|FG000|Overall Study|Lost to Follow-up|2|||
129978729|NCT01014208|467885187|FG001|Overall Study|Lost to Follow-up|5|||
129978730|NCT01014208|467885186|FG000|Overall Study|Participant Withdrew Consent|12|||
129978731|NCT01014208|467885187|FG001|Overall Study|Participant Withdrew Consent|12|||
129978732|NCT01014208|467885186|FG000|Overall Study|Did Not Receive Study Drug|2|||
129978733|NCT01014208|467885187|FG001|Overall Study|Did Not Receive Study Drug|0|||
129978734|NCT01014208|467885186|FG000|Overall Study|Study Closed/terminated|78|||
129978735|NCT01014208|467885187|FG001|Overall Study|Study Closed/terminated|83|||
129978736|NCT05602727|467885194|FG000|Overall Study|Physician Decision|0|||
129978737|NCT05602727|467885195|FG001|Overall Study|Physician Decision|1|||
129978738|NCT05602727|467885196|FG002|Overall Study|Physician Decision|0|||
129978739|NCT05602727|467885194|FG000|Overall Study|Randomized by mistake without study medication|1|||
129978740|NCT05602727|467885195|FG001|Overall Study|Randomized by mistake without study medication|0|||
129978741|NCT05602727|467885196|FG002|Overall Study|Randomized by mistake without study medication|0|||
129978742|NCT05602727|467885194|FG000|Overall Study|Study termination by Sponsor|18|||
129978743|NCT05602727|467885195|FG001|Overall Study|Study termination by Sponsor|15|||
129978744|NCT05602727|467885196|FG002|Overall Study|Study termination by Sponsor|19|||
129978745|NCT05602727|467885194|FG000|Overall Study|Withdrawal by Subject|2|||
129978746|NCT05602727|467885195|FG001|Overall Study|Withdrawal by Subject|1|||
129978747|NCT05602727|467885196|FG002|Overall Study|Withdrawal by Subject|1|||
129978748|NCT05602727|467885194|FG000|Overall Study|Various reasons|1|||
129978749|NCT05602727|467885195|FG001|Overall Study|Various reasons|6|||
129978750|NCT05602727|467885196|FG002|Overall Study|Various reasons|1|||
129978751|NCT04020185|467885197|FG000|Overall Study|Death|0|||
129978752|NCT04020185|467885198|FG001|Overall Study|Death|0|||
129978753|NCT04020185|467885199|FG002|Overall Study|Death|1|||
129978754|NCT04020185|467885200|FG003|Overall Study|Death|2|||
129978755|NCT04020185|467885201|FG004|Overall Study|Death|1|||
129978756|NCT04020185|467885202|FG005|Overall Study|Death|0|||
129978757|NCT04020185|467885203|FG006|Overall Study|Death|1|||
129978758|NCT04020185|467885204|FG007|Overall Study|Death|0|||
129978759|NCT04020185|467885197|FG000|Overall Study|Consent withdrawn|1|||
129978760|NCT04020185|467885198|FG001|Overall Study|Consent withdrawn|0|||
129978761|NCT04020185|467885199|FG002|Overall Study|Consent withdrawn|0|||
129978762|NCT04020185|467885200|FG003|Overall Study|Consent withdrawn|0|||
129978763|NCT04020185|467885201|FG004|Overall Study|Consent withdrawn|2|||
129978764|NCT04020185|467885202|FG005|Overall Study|Consent withdrawn|0|||
129978765|NCT04020185|467885203|FG006|Overall Study|Consent withdrawn|1|||
129978766|NCT04020185|467885204|FG007|Overall Study|Consent withdrawn|1|||
129978767|NCT04020185|467885197|FG000|Overall Study|Patient in hospice|0|||
129978768|NCT04020185|467885198|FG001|Overall Study|Patient in hospice|1|||
129978769|NCT04020185|467885199|FG002|Overall Study|Patient in hospice|0|||
129978770|NCT04020185|467885200|FG003|Overall Study|Patient in hospice|0|||
129978771|NCT04020185|467885201|FG004|Overall Study|Patient in hospice|0|||
129978772|NCT04020185|467885202|FG005|Overall Study|Patient in hospice|0|||
129978773|NCT04020185|467885203|FG006|Overall Study|Patient in hospice|0|||
129484564|NCT04899271|466066444|FG000|Overall Study|Subject request/consent withdrawal|2|||
129484565|NCT04899271|466066445|FG001|Overall Study|Subject request/consent withdrawal|0|||
129484566|NCT01121406|466066454|FG000|Overall Study|Progressive disease RECIST|44|||
129484567|NCT01121406|466066455|FG001|Overall Study|Progressive disease RECIST|28|||
129978774|NCT04020185|467885204|FG007|Overall Study|Patient in hospice|0|||
129978775|NCT04020185|467885197|FG000|Overall Study|Continuing on expanded access|0|||
129978776|NCT04020185|467885198|FG001|Overall Study|Continuing on expanded access|0|||
129978777|NCT04020185|467885199|FG002|Overall Study|Continuing on expanded access|0|||
129978778|NCT04020185|467885200|FG003|Overall Study|Continuing on expanded access|0|||
129978779|NCT04020185|467885201|FG004|Overall Study|Continuing on expanded access|0|||
129978780|NCT04020185|467885202|FG005|Overall Study|Continuing on expanded access|0|||
129978781|NCT04020185|467885203|FG006|Overall Study|Continuing on expanded access|1|||
129978782|NCT04020185|467885204|FG007|Overall Study|Continuing on expanded access|1|||
129978783|NCT00527787|467885206|FG000|Overall Study|Adverse Event|14|||
129484568|NCT01121406|466066454|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
129978784|NCT00527787|467885207|FG001|Overall Study|Adverse Event|24|||
129978785|NCT00527787|467885206|FG000|Overall Study|Withdrawal by Subject|13|||
129484569|NCT01121406|466066455|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
129484570|NCT01121406|466066454|FG000|Overall Study|Other AE|3|||
129484571|NCT01121406|466066455|FG001|Overall Study|Other AE|10|||
129484572|NCT01121406|466066454|FG000|Overall Study|Non-compliant with protocol|0|||
129484573|NCT01121406|466066455|FG001|Overall Study|Non-compliant with protocol|2|||
129484574|NCT01121406|466066454|FG000|Overall Study|Lost to Follow-up|0|||
129484575|NCT01121406|466066455|FG001|Overall Study|Lost to Follow-up|1|||
129484576|NCT01121406|466066454|FG000|Overall Study|Refused continuation of study med.|1|||
129484577|NCT01121406|466066455|FG001|Overall Study|Refused continuation of study med.|2|||
129484578|NCT01121406|466066454|FG000|Overall Study|Reason other than specified above|2|||
129484579|NCT01121406|466066455|FG001|Overall Study|Reason other than specified above|6|||
129484580|NCT01121406|466066454|FG000|Overall Study|Not treated|1|||
129484581|NCT01121406|466066455|FG001|Overall Study|Not treated|0|||
129484582|NCT00892437|466066456|FG000|Randomized Phase|Randomized but not treated|6|||
129484583|NCT00892437|466066457|FG001|Randomized Phase|Randomized but not treated|0|||
129978786|NCT00527787|467885207|FG001|Overall Study|Withdrawal by Subject|25|||
129978787|NCT00527787|467885206|FG000|Overall Study|Lost to Follow-up|5|||
129978788|NCT00527787|467885207|FG001|Overall Study|Lost to Follow-up|2|||
129978789|NCT00527787|467885206|FG000|Overall Study|Duodenal Ulcer|1|||
129978790|NCT00527787|467885207|FG001|Overall Study|Duodenal Ulcer|10|||
129484584|NCT00892437|466066456|FG000|Randomized Phase|Adverse Event|2|||
129484585|NCT00892437|466066457|FG001|Randomized Phase|Adverse Event|2|||
129484586|NCT00892437|466066456|FG000|Randomized Phase|Lost to Follow-up|1|||
129484587|NCT00892437|466066457|FG001|Randomized Phase|Lost to Follow-up|3|||
129484588|NCT00892437|466066456|FG000|Randomized Phase|Investigator's Discretion|1|||
129484589|NCT00892437|466066457|FG001|Randomized Phase|Investigator's Discretion|0|||
129484590|NCT00892437|466066456|FG000|Randomized Phase|Withdrew Consent|1|||
129484591|NCT00892437|466066457|FG001|Randomized Phase|Withdrew Consent|0|||
129978791|NCT00527787|467885206|FG000|Overall Study|misc|5|||
129978792|NCT00527787|467885207|FG001|Overall Study|misc|2|||
129484592|NCT00892437|466066456|FG000|Open-Label Extension Phase|Adverse Event|4|||
129484593|NCT00892437|466066457|FG001|Open-Label Extension Phase|Adverse Event|2|||
129484594|NCT00892437|466066456|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
129484595|NCT00892437|466066457|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
129484596|NCT00892437|466066456|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
129484597|NCT00892437|466066457|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
129484598|NCT00892437|466066456|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
129484599|NCT00892437|466066457|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
129484600|NCT00892437|466066456|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
129484601|NCT00892437|466066457|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
129484602|NCT03185130|466066459|FG000|Overall Study|Withdrawal by Subject|0|||
129484603|NCT03185130|466066460|FG001|Overall Study|Withdrawal by Subject|2|||
129484604|NCT01925703|466066461|FG000|Overall Study|Physician Decision|1|||
129484605|NCT01925703|466066461|FG000|Overall Study|Lost to Follow-up|2|||
129484606|NCT01925703|466066461|FG000|Overall Study|Discharge prior to full iron repletion|1|||
129484607|NCT01238120|466066464|FG000|Overall Study|Withdrawal by Subject|4|||
129484608|NCT01238120|466066465|FG001|Overall Study|Withdrawal by Subject|1|||
129484609|NCT01238120|466066466|FG002|Overall Study|Withdrawal by Subject|2|||
129484610|NCT01238120|466066467|FG003|Overall Study|Withdrawal by Subject|5|||
129484611|NCT01238120|466066464|FG000|Overall Study|Lost to Follow-up|2|||
129484612|NCT01238120|466066465|FG001|Overall Study|Lost to Follow-up|0|||
129484613|NCT01238120|466066466|FG002|Overall Study|Lost to Follow-up|1|||
129484614|NCT01238120|466066467|FG003|Overall Study|Lost to Follow-up|1|||
129484615|NCT01238120|466066464|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
129484616|NCT01238120|466066465|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
129978793|NCT03433677|467885208|FG000|Period 1|Protocol Violation|1|||
129978794|NCT03433677|467885209|FG001|Period 1|Protocol Violation|0|||
129978795|NCT03433677|467885208|FG000|Period 2|Withdrawal by Subject|1|||
129978796|NCT03433677|467885209|FG001|Period 2|Withdrawal by Subject|1|||
129978797|NCT03330405|467885210|FG000|Overall Study|Other|1|||
129978798|NCT03330405|467885211|FG001|Overall Study|Other|3|||
129978799|NCT03330405|467885212|FG002|Overall Study|Other|1|||
129484617|NCT01238120|466066466|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
129484618|NCT01238120|466066467|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
129484619|NCT02498652|466066470|FG000|Overall Study|Protocol Violation|0|||
129978800|NCT03330405|467885213|FG003|Overall Study|Other|0|||
129978801|NCT03330405|467885214|FG004|Overall Study|Other|2|||
129484620|NCT02498652|466066471|FG001|Overall Study|Protocol Violation|1|||
129484621|NCT02500550|466066478|FG000|Overall Study|Death|7|||
129484622|NCT02388776|466066480|FG000|Overall Study|Death|1|||
129484623|NCT02388776|466066480|FG000|Overall Study|Lost to Follow-up|1|||
129484624|NCT03826914|466066481|FG000|Overall Study|Withdrawal by Subject|1|||
129484625|NCT03826914|466066482|FG001|Overall Study|Withdrawal by Subject|1|||
129484626|NCT04334148|466066485|FG000|Overall Study|positive nasal swab at baseline|0|||
129978802|NCT03330405|467885215|FG005|Overall Study|Other|0|||
129978803|NCT03330405|467885216|FG006|Overall Study|Other|1|||
129978804|NCT03330405|467885217|FG007|Overall Study|Other|0|||
129978805|NCT03330405|467885218|FG008|Overall Study|Other|0|||
129978806|NCT03330405|467885219|FG009|Overall Study|Other|0|||
129978807|NCT03330405|467885220|FG010|Overall Study|Other|0|||
129978808|NCT03330405|467885210|FG000|Overall Study|Progressive disease|8|||
129978809|NCT03330405|467885211|FG001|Overall Study|Progressive disease|27|||
129978810|NCT03330405|467885212|FG002|Overall Study|Progressive disease|4|||
129978811|NCT03330405|467885213|FG003|Overall Study|Progressive disease|18|||
129978812|NCT03330405|467885214|FG004|Overall Study|Progressive disease|16|||
129978813|NCT03330405|467885215|FG005|Overall Study|Progressive disease|14|||
129978814|NCT03330405|467885216|FG006|Overall Study|Progressive disease|7|||
129978815|NCT03330405|467885217|FG007|Overall Study|Progressive disease|29|||
129978816|NCT03330405|467885218|FG008|Overall Study|Progressive disease|9|||
129978817|NCT03330405|467885219|FG009|Overall Study|Progressive disease|11|||
129978818|NCT03330405|467885220|FG010|Overall Study|Progressive disease|5|||
129978819|NCT03330405|467885210|FG000|Overall Study|Withdrawal by Subject|1|||
129978820|NCT03330405|467885211|FG001|Overall Study|Withdrawal by Subject|4|||
129978821|NCT03330405|467885212|FG002|Overall Study|Withdrawal by Subject|0|||
129978822|NCT03330405|467885213|FG003|Overall Study|Withdrawal by Subject|1|||
129978823|NCT03330405|467885214|FG004|Overall Study|Withdrawal by Subject|1|||
129978824|NCT03330405|467885215|FG005|Overall Study|Withdrawal by Subject|1|||
129978825|NCT03330405|467885216|FG006|Overall Study|Withdrawal by Subject|0|||
129978826|NCT03330405|467885217|FG007|Overall Study|Withdrawal by Subject|2|||
129978827|NCT03330405|467885218|FG008|Overall Study|Withdrawal by Subject|2|||
129978828|NCT03330405|467885219|FG009|Overall Study|Withdrawal by Subject|1|||
129978829|NCT03330405|467885220|FG010|Overall Study|Withdrawal by Subject|1|||
129978830|NCT03330405|467885210|FG000|Overall Study|Global deterioration of health status|2|||
129978831|NCT03330405|467885211|FG001|Overall Study|Global deterioration of health status|3|||
129978832|NCT03330405|467885212|FG002|Overall Study|Global deterioration of health status|0|||
129484627|NCT04334148|466066486|FG001|Overall Study|positive nasal swab at baseline|1|||
129978833|NCT03330405|467885213|FG003|Overall Study|Global deterioration of health status|2|||
129978834|NCT03330405|467885214|FG004|Overall Study|Global deterioration of health status|3|||
129978835|NCT03330405|467885215|FG005|Overall Study|Global deterioration of health status|3|||
129978836|NCT03330405|467885216|FG006|Overall Study|Global deterioration of health status|0|||
129978837|NCT03330405|467885217|FG007|Overall Study|Global deterioration of health status|2|||
129978838|NCT03330405|467885218|FG008|Overall Study|Global deterioration of health status|8|||
129978839|NCT03330405|467885219|FG009|Overall Study|Global deterioration of health status|4|||
129978840|NCT03330405|467885220|FG010|Overall Study|Global deterioration of health status|1|||
129484628|NCT00922935|466066487|FG000|Overall Study|Protocol Violation|0|||
129484629|NCT00922935|466066488|FG001|Overall Study|Protocol Violation|3|||
129484630|NCT00922935|466066489|FG002|Overall Study|Protocol Violation|0|||
129484631|NCT00922935|466066487|FG000|Overall Study|Physician Decision|1|||
129484632|NCT00922935|466066488|FG001|Overall Study|Physician Decision|1|||
129484633|NCT00922935|466066489|FG002|Overall Study|Physician Decision|0|||
129484634|NCT00922935|466066487|FG000|Overall Study|Lost to Follow-up|0|||
129484635|NCT00922935|466066488|FG001|Overall Study|Lost to Follow-up|1|||
129484636|NCT00922935|466066489|FG002|Overall Study|Lost to Follow-up|0|||
129978841|NCT03330405|467885210|FG000|Overall Study|Adverse Event|0|||
129978842|NCT03330405|467885211|FG001|Overall Study|Adverse Event|1|||
129978843|NCT03330405|467885212|FG002|Overall Study|Adverse Event|0|||
129978844|NCT03330405|467885213|FG003|Overall Study|Adverse Event|1|||
129978845|NCT03330405|467885214|FG004|Overall Study|Adverse Event|1|||
129978846|NCT03330405|467885215|FG005|Overall Study|Adverse Event|1|||
129978847|NCT03330405|467885216|FG006|Overall Study|Adverse Event|3|||
129978848|NCT03330405|467885217|FG007|Overall Study|Adverse Event|4|||
129484637|NCT01499576|466066492|FG000|Overall Study|Physician Decision|12|||
129978849|NCT03330405|467885218|FG008|Overall Study|Adverse Event|2|||
129978850|NCT03330405|467885219|FG009|Overall Study|Adverse Event|2|||
129978851|NCT03330405|467885220|FG010|Overall Study|Adverse Event|2|||
129978852|NCT03330405|467885210|FG000|Overall Study|Death|0|||
129978853|NCT03330405|467885211|FG001|Overall Study|Death|4|||
129484638|NCT01499576|466066492|FG000|Overall Study|Withdrawal by Subject|9|||
129978854|NCT03330405|467885212|FG002|Overall Study|Death|0|||
129978855|NCT03330405|467885213|FG003|Overall Study|Death|0|||
129978856|NCT03330405|467885214|FG004|Overall Study|Death|0|||
129978857|NCT03330405|467885215|FG005|Overall Study|Death|1|||
129978858|NCT03330405|467885216|FG006|Overall Study|Death|0|||
129978859|NCT03330405|467885217|FG007|Overall Study|Death|2|||
129978860|NCT03330405|467885218|FG008|Overall Study|Death|0|||
129978861|NCT03330405|467885219|FG009|Overall Study|Death|0|||
129978862|NCT03330405|467885220|FG010|Overall Study|Death|0|||
129978863|NCT03330405|467885210|FG000|Overall Study|Physician Decision|0|||
129978864|NCT03330405|467885211|FG001|Overall Study|Physician Decision|0|||
129484639|NCT04283461|466066493|FG000|Overall Study|Enrolled in separate trial|0|||
129978865|NCT03330405|467885212|FG002|Overall Study|Physician Decision|0|||
129978866|NCT03330405|467885213|FG003|Overall Study|Physician Decision|0|||
129978867|NCT03330405|467885214|FG004|Overall Study|Physician Decision|0|||
129978868|NCT03330405|467885215|FG005|Overall Study|Physician Decision|0|||
129978869|NCT03330405|467885216|FG006|Overall Study|Physician Decision|0|||
129978870|NCT03330405|467885217|FG007|Overall Study|Physician Decision|1|||
129978871|NCT03330405|467885218|FG008|Overall Study|Physician Decision|0|||
129978872|NCT03330405|467885219|FG009|Overall Study|Physician Decision|0|||
129978873|NCT03330405|467885220|FG010|Overall Study|Physician Decision|0|||
129978874|NCT03889704|467885221|FG000|Overall Study|Study terminated due to pandemic|1|||
129978875|NCT02060370|467885222|FG000|Overall Study|Physician Decision|1|||
129978876|NCT00356408|467885223|FG000|Overall Study|Adverse Event|9|||
129978877|NCT00356408|467885223|FG000|Overall Study|Lack of Efficacy|36|||
129978878|NCT00356408|467885223|FG000|Overall Study|Lost to Follow-up|2|||
129978879|NCT00356408|467885223|FG000|Overall Study|Withdrawal by Subject|6|||
129978880|NCT00356408|467885223|FG000|Overall Study|Other: Principal investigator discretion|3|||
129978881|NCT00356408|467885223|FG000|Overall Study|Other: Sponsor request|1|||
129978882|NCT00356408|467885223|FG000|Overall Study|Other: Azathioprine stopped|1|||
129978883|NCT00356408|467885223|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
129978884|NCT00356408|467885223|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
129978885|NCT05487586|467885224|FG000|Overall Study|Death|22|||
129978886|NCT05487586|467885224|FG000|Overall Study|Physician Decision|1|||
129978887|NCT05487586|467885224|FG000|Overall Study|Transfer to another hospital|4|||
129978888|NCT05487586|467885224|FG000|Overall Study|Other|1|||
129978889|NCT01493427|467885225|FG000|Overall Study|Adverse Event|10|||
129978890|NCT01493427|467885225|FG000|Overall Study|Personal Reasons|4|||
129978891|NCT01493427|467885225|FG000|Overall Study|Lost to Follow-up|2|||
129978892|NCT01493427|467885225|FG000|Overall Study|Inability to Follow Instructions|2|||
129978893|NCT01493427|467885225|FG000|Overall Study|Other|2|||
129978894|NCT00565773|467885226|FG000|Overall Study|Withdrawal by Subject|1|||
129978895|NCT00565773|467885226|FG000|Overall Study|Physician Decision|1|||
129978896|NCT04798781|467885227|FG000|Overall Study|Withdrawal by Subject|1|||
129978897|NCT03921723|467885230|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
129978898|NCT03921723|467885230|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
129978899|NCT03015129|467885231|FG000|Overall Study|Death|2|||
129978900|NCT03015129|467885232|FG001|Overall Study|Death|2|||
129978901|NCT03015129|467885231|FG000|Overall Study|Lost to Follow-up|0|||
129978902|NCT03015129|467885232|FG001|Overall Study|Lost to Follow-up|1|||
129978903|NCT03015129|467885231|FG000|Overall Study|Progression of disease|38|||
129978904|NCT03015129|467885232|FG001|Overall Study|Progression of disease|33|||
129484640|NCT04283461|466066494|FG001|Overall Study|Enrolled in separate trial|0|||
129484641|NCT04283461|466066495|FG002|Overall Study|Enrolled in separate trial|8|||
129484642|NCT04283461|466066496|FG003|Overall Study|Enrolled in separate trial|13|||
129484643|NCT04283461|466066497|FG004|Overall Study|Enrolled in separate trial|12|||
129484644|NCT04283461|466066498|FG005|Overall Study|Enrolled in separate trial|0|||
129978905|NCT03015129|467885231|FG000|Overall Study|Adverse Event|0|||
129978906|NCT03015129|467885232|FG001|Overall Study|Adverse Event|4|||
129978907|NCT02242097|467885233|FG000|Ibrutinib Treatment|Adverse Event|16|||
129978908|NCT02242097|467885233|FG000|Ibrutinib Treatment|Physician Decision|1|||
129978909|NCT02242097|467885233|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
129978910|NCT02242097|467885233|FG000|Ibrutinib Treatment|Death|1|||
129978911|NCT02242097|467885233|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
129978912|NCT02242097|467885233|FG000|Post Therapy Follow Up|Death|3|||
129978913|NCT02242097|467885233|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
129978914|NCT02574845|467885236|FG000|Overall Study|Consent withdrawn further participation|0|||
129978915|NCT02574845|467885237|FG001|Overall Study|Consent withdrawn further participation|0|||
129978916|NCT02574845|467885238|FG002|Overall Study|Consent withdrawn further participation|0|||
129978917|NCT02574845|467885239|FG003|Overall Study|Consent withdrawn further participation|0|||
129978918|NCT02574845|467885240|FG004|Overall Study|Consent withdrawn further participation|1|||
129978919|NCT02574845|467885241|FG005|Overall Study|Consent withdrawn further participation|0|||
129978920|NCT02574845|467885236|FG000|Overall Study|Adverse Event|0|||
129978921|NCT02574845|467885237|FG001|Overall Study|Adverse Event|1|||
129978922|NCT02574845|467885238|FG002|Overall Study|Adverse Event|0|||
129978923|NCT02574845|467885239|FG003|Overall Study|Adverse Event|0|||
129978924|NCT02574845|467885240|FG004|Overall Study|Adverse Event|0|||
129978925|NCT02574845|467885241|FG005|Overall Study|Adverse Event|1|||
129978926|NCT03435692|467885243|FG000|Overall Study|Lack of Efficacy|2|||
129978927|NCT03435692|467885244|FG001|Overall Study|Lack of Efficacy|2|||
129978928|NCT03435692|467885245|FG002|Overall Study|Lack of Efficacy|0|||
129978929|NCT00821587|467885250|FG000|Overall Study|Physician Decision|0|||
129978930|NCT00821587|467885251|FG001|Overall Study|Physician Decision|1|||
129978931|NCT02781090|467885254|FG000|3-Month Follow-Up|Missed Visit|20|||
129978932|NCT02781090|467885255|FG001|3-Month Follow-Up|Missed Visit|20|||
129978933|NCT02781090|467885254|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
129978934|NCT02781090|467885255|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
129978935|NCT02781090|467885254|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
129978936|NCT02781090|467885255|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
129978937|NCT02781090|467885254|FG000|3-Month Follow-Up|Death|1|||
129978938|NCT02781090|467885255|FG001|3-Month Follow-Up|Death|0|||
129978939|NCT02781090|467885254|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
129978940|NCT02781090|467885255|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
129978941|NCT02781090|467885254|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
129978942|NCT02781090|467885255|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
129978943|NCT02781090|467885254|FG000|6-Month Follow-Up|Death|0|||
129978944|NCT02781090|467885255|FG001|6-Month Follow-Up|Death|1|||
129978945|NCT01145898|467885256|FG000|3-year Treatment|medication change by treating physician|3|||
129978946|NCT01145898|467885257|FG001|3-year Treatment|medication change by treating physician|16|||
129484645|NCT04283461|466066499|FG006|Overall Study|Enrolled in separate trial|0|||
129484646|NCT04283461|466066500|FG007|Overall Study|Enrolled in separate trial|8|||
129484647|NCT04283461|466066501|FG008|Overall Study|Enrolled in separate trial|0|||
129484648|NCT04283461|466066502|FG009|Overall Study|Enrolled in separate trial|0|||
129484649|NCT04283461|466066503|FG010|Overall Study|Enrolled in separate trial|0|||
129484650|NCT04283461|466066504|FG011|Overall Study|Enrolled in separate trial|7|||
129484651|NCT04283461|466066505|FG012|Overall Study|Enrolled in separate trial|0|||
129484652|NCT04375878|466066510|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
129484653|NCT04375878|466066511|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
129484654|NCT04375878|466066512|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
129484655|NCT04375878|466066513|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
129484656|NCT04375878|466066514|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
129484657|NCT04375878|466066515|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
129484658|NCT04375878|466066510|FG000|Crossover First and Second Interventions|Adverse Event|0|||
129484659|NCT04375878|466066511|FG001|Crossover First and Second Interventions|Adverse Event|0|||
129484660|NCT04375878|466066512|FG002|Crossover First and Second Interventions|Adverse Event|1|||
129978947|NCT01712061|467885258|FG000|Overall Study|Adverse Event|4|||
129978948|NCT01712061|467885259|FG001|Overall Study|Adverse Event|9|||
129978949|NCT01712061|467885260|FG002|Overall Study|Adverse Event|5|||
129978950|NCT01712061|467885258|FG000|Overall Study|Death|0|||
129978951|NCT01712061|467885259|FG001|Overall Study|Death|0|||
129978952|NCT01712061|467885260|FG002|Overall Study|Death|1|||
129978953|NCT01712061|467885258|FG000|Overall Study|Lost to Follow-up|1|||
129978954|NCT01712061|467885259|FG001|Overall Study|Lost to Follow-up|0|||
129978955|NCT01712061|467885260|FG002|Overall Study|Lost to Follow-up|1|||
129978956|NCT01712061|467885258|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
129978957|NCT01712061|467885259|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
129484661|NCT04375878|466066513|FG003|Crossover First and Second Interventions|Adverse Event|0|||
129484662|NCT04375878|466066514|FG004|Crossover First and Second Interventions|Adverse Event|0|||
129978958|NCT01712061|467885260|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
129978959|NCT01712061|467885258|FG000|Overall Study|Medication Error Without Associated AE|0|||
129978960|NCT01712061|467885259|FG001|Overall Study|Medication Error Without Associated AE|1|||
129978961|NCT01712061|467885260|FG002|Overall Study|Medication Error Without Associated AE|0|||
129978962|NCT01712061|467885258|FG000|Overall Study|Withdrawal by Subject|1|||
129978963|NCT01712061|467885259|FG001|Overall Study|Withdrawal by Subject|7|||
129978964|NCT01712061|467885260|FG002|Overall Study|Withdrawal by Subject|1|||
129978965|NCT01712061|467885258|FG000|Overall Study|Other|0|||
129978966|NCT01712061|467885259|FG001|Overall Study|Other|3|||
129978967|NCT01712061|467885260|FG002|Overall Study|Other|0|||
129978968|NCT00879775|467885261|FG000|Overall Study|Lost to Follow-up|2|||
129978969|NCT00879775|467885262|FG001|Overall Study|Lost to Follow-up|1|||
129978970|NCT01195623|467885263|FG000|Overall Study|Lost to Follow-up|35|||
129978971|NCT01195623|467885264|FG001|Overall Study|Lost to Follow-up|37|||
129978972|NCT01677767|467885268|FG000|Overall Study|Adverse Event|1|||
129978973|NCT01677767|467885268|FG000|Overall Study|Death|4|||
129978974|NCT01677767|467885268|FG000|Overall Study|Protocol Violation|4|||
129978975|NCT01677767|467885268|FG000|Overall Study|Withdrawal by Subject|10|||
129978976|NCT01677767|467885268|FG000|Overall Study|Non-compliance by the participants|3|||
129978977|NCT00842244|467885269|FG000|Overall Study|Death|3|||
129978978|NCT00842244|467885269|FG000|Overall Study|Withdrawal by Subject|1|||
129978979|NCT00842244|467885269|FG000|Overall Study|Other|17|||
129978980|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
129978981|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
129978982|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
129978983|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
129978984|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
129978985|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
129978986|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
129978987|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
129978988|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
129978989|NCT03846453|467885274|FG000|Placebo Run-in (14 Days)|Other|2|||
129978990|NCT03846453|467885275|FG001|Placebo Run-in (14 Days)|Other|0|||
129978991|NCT03846453|467885276|FG002|Placebo Run-in (14 Days)|Other|0|||
129978992|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
129978993|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
129978994|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
129978995|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
129978996|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
129978997|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
129978998|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
129978999|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
129979000|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
129979001|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
129979002|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
129979003|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
129979004|NCT03846453|467885274|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
129979005|NCT03846453|467885275|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
129979006|NCT03846453|467885276|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
129979007|NCT00757627|467885277|FG000|Overall Study|Adverse Event|15|||
129979008|NCT00757627|467885277|FG000|Overall Study|Lack of Efficacy|10|||
129979009|NCT00757627|467885277|FG000|Overall Study|Lost to Follow-up|28|||
129979010|NCT00757627|467885277|FG000|Overall Study|Withdrawal by Subject|27|||
129979011|NCT00757627|467885277|FG000|Overall Study|Other|1|||
129979012|NCT00635661|467885278|FG000|Overall Study|Withdrawal by Subject|4|||
129979013|NCT01606670|467885281|FG000|Overall Study|Adverse Event|6|||
129979014|NCT01606670|467885281|FG000|Overall Study|Lack of Efficacy|2|||
129979015|NCT01606670|467885281|FG000|Overall Study|Lost to Follow-up|3|||
129979016|NCT01606670|467885281|FG000|Overall Study|Withdrawal by Subject|3|||
129979017|NCT01606670|467885281|FG000|Overall Study|Other Reason|2|||
129979018|NCT03578887|467885295|FG000|Overall Study|Withdrawal by Subject|7|||
129979019|NCT03578887|467885296|FG001|Overall Study|Withdrawal by Subject|2|||
129979020|NCT03578887|467885297|FG002|Overall Study|Withdrawal by Subject|1|||
129979021|NCT03578887|467885295|FG000|Overall Study|Lost to Follow-up|13|||
129979022|NCT03578887|467885296|FG001|Overall Study|Lost to Follow-up|1|||
129979023|NCT03578887|467885297|FG002|Overall Study|Lost to Follow-up|4|||
129484663|NCT04375878|466066515|FG005|Crossover First and Second Interventions|Adverse Event|0|||
129979024|NCT03578887|467885295|FG000|Overall Study|Physician Decision|0|||
129979025|NCT03578887|467885296|FG001|Overall Study|Physician Decision|1|||
129979026|NCT03578887|467885297|FG002|Overall Study|Physician Decision|1|||
129979027|NCT05718466|467887373|FG000|Overall Study|Withdrawal by Subject|1|||
129979028|NCT05718466|467887374|FG001|Overall Study|Withdrawal by Subject|2|||
129979029|NCT05718466|467887373|FG000|Overall Study|Death|0|||
129979030|NCT05718466|467887374|FG001|Overall Study|Death|1|||
129979031|NCT00387426|467887376|FG000|Overall Study|Lack of Response|7|||
129979032|NCT00387426|467887376|FG000|Overall Study|Toxicities|4|||
129979033|NCT00387426|467887376|FG000|Overall Study|Disease Progression|3|||
129979034|NCT01253135|467887383|FG000|Original Protocol|Protocol Amendment|15|||
129979035|NCT01253135|467887383|FG000|Amended Protocol|Non-compliance|1|||
129979036|NCT00918879|467887390|FG000|Overall Study|Withdrawal by Subject|4|||
129979037|NCT00918879|467887391|FG001|Overall Study|Withdrawal by Subject|4|||
129979038|NCT00918879|467887390|FG000|Overall Study|Lost to Follow-up|1|||
129979039|NCT00918879|467887391|FG001|Overall Study|Lost to Follow-up|1|||
129979040|NCT00918879|467887390|FG000|Overall Study|Severe non-compliance to protocol|1|||
129979041|NCT00918879|467887391|FG001|Overall Study|Severe non-compliance to protocol|1|||
129979042|NCT00833261|467887392|FG000|Overall Study|Withdrawal by Subject|4|||
129979043|NCT00357110|467887393|FG000|Overall Study|Early study termination|5|||
129979044|NCT00357110|467887394|FG001|Overall Study|Early study termination|5|||
129979045|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Physician Decision|2|||
129979046|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Physician Decision|0|||
129979047|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Physician Decision|0|||
129979048|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Adverse Event|33|||
129979049|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Adverse Event|0|||
129979050|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Adverse Event|0|||
129979051|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
129979052|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129979053|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
129979054|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
129979055|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
129979056|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
129979057|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
129979058|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129979059|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
129979060|NCT01008553|467887395|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
129979061|NCT01008553|467887396|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
129979062|NCT01008553|467887397|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
129979063|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
129979064|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
129979065|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
129979066|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
129979067|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
129979068|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
129979069|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
129979070|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
129979071|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
129979072|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
129979073|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
129979074|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
129979075|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
129979076|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
129979077|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
129979078|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
129979079|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
129979080|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
129979081|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129979082|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
129979083|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
129979084|NCT01008553|467887395|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
129979085|NCT01008553|467887396|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
129979086|NCT01008553|467887397|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
129979087|NCT01008410|467887399|FG000|Overall Study|Adverse Event|13|||
129979088|NCT01008410|467887400|FG001|Overall Study|Adverse Event|7|||
129979089|NCT01008410|467887399|FG000|Overall Study|Withdrawal by Subject|6|||
129979090|NCT01008410|467887400|FG001|Overall Study|Withdrawal by Subject|2|||
129979091|NCT01008410|467887399|FG000|Overall Study|Lost to Follow-up|1|||
129979092|NCT01008410|467887400|FG001|Overall Study|Lost to Follow-up|0|||
129979093|NCT01008410|467887399|FG000|Overall Study|Noncompliance|1|||
129979094|NCT01008410|467887400|FG001|Overall Study|Noncompliance|0|||
129979095|NCT01008410|467887399|FG000|Overall Study|Low Cortisol|2|||
129979096|NCT01008410|467887400|FG001|Overall Study|Low Cortisol|0|||
129979097|NCT01008410|467887399|FG000|Overall Study|Lack of Efficacy|2|||
129979098|NCT01008410|467887400|FG001|Overall Study|Lack of Efficacy|6|||
129979099|NCT01008410|467887399|FG000|Overall Study|Met Exclusion Criterion|0|||
129484664|NCT04375878|466066510|FG000|Extension Phase|Withdrawal by Subject|0|||
129979100|NCT01008410|467887400|FG001|Overall Study|Met Exclusion Criterion|1|||
129979101|NCT03056300|467887403|FG000|Overall Study|Surgical reason per study protocol|3|||
129979102|NCT03563157|467887404|FG000|Overall Study|Progressive Disease|2|||
129979103|NCT02187159|467887407|FG000|Overall Study|Protocol Violation|4|||
129484665|NCT04375878|466066511|FG001|Extension Phase|Withdrawal by Subject|0|||
129484666|NCT04375878|466066512|FG002|Extension Phase|Withdrawal by Subject|0|||
129484667|NCT04375878|466066513|FG003|Extension Phase|Withdrawal by Subject|0|||
129484668|NCT04375878|466066514|FG004|Extension Phase|Withdrawal by Subject|1|||
129484669|NCT04375878|466066515|FG005|Extension Phase|Withdrawal by Subject|0|||
129484670|NCT00195351|466066516|FG000|Overall Study|Lost to Follow-up|9|||
129484671|NCT00195351|466066517|FG001|Overall Study|Lost to Follow-up|9|||
129484672|NCT00195351|466066516|FG000|Overall Study|Withdrawal by Subject|6|||
129484673|NCT00195351|466066517|FG001|Overall Study|Withdrawal by Subject|3|||
129484674|NCT00195351|466066516|FG000|Overall Study|Protocol Deviation|3|||
129484675|NCT00195351|466066517|FG001|Overall Study|Protocol Deviation|2|||
129484676|NCT00195351|466066516|FG000|Overall Study|Death|3|||
129484677|NCT00195351|466066517|FG001|Overall Study|Death|1|||
129484678|NCT00195351|466066516|FG000|Overall Study|Lack of Efficacy|0|||
129484679|NCT00195351|466066517|FG001|Overall Study|Lack of Efficacy|1|||
129484680|NCT01259466|466066520|FG000|Overall Study|Withdrawal by Subject|1|||
129484681|NCT01259466|466066521|FG001|Overall Study|Withdrawal by Subject|9|||
129484682|NCT01824602|466066522|FG000|Overall Study|Withdrawal by Subject|0|||
129484683|NCT01824602|466066523|FG001|Overall Study|Withdrawal by Subject|0|||
129484684|NCT01824602|466066524|FG002|Overall Study|Withdrawal by Subject|1|||
129484685|NCT01824602|466066525|FG003|Overall Study|Withdrawal by Subject|2|||
129484686|NCT01824602|466066522|FG000|Overall Study|Patient non-compliance|0|||
129484687|NCT01824602|466066523|FG001|Overall Study|Patient non-compliance|0|||
129484688|NCT01824602|466066524|FG002|Overall Study|Patient non-compliance|1|||
129484689|NCT01824602|466066525|FG003|Overall Study|Patient non-compliance|0|||
129484690|NCT01824602|466066522|FG000|Overall Study|Adverse Event|1|||
129484691|NCT01824602|466066523|FG001|Overall Study|Adverse Event|0|||
129484692|NCT01824602|466066524|FG002|Overall Study|Adverse Event|2|||
129484693|NCT01824602|466066525|FG003|Overall Study|Adverse Event|2|||
129484694|NCT01824602|466066522|FG000|Overall Study|Treatment failure|0|||
129484695|NCT01824602|466066523|FG001|Overall Study|Treatment failure|0|||
129484696|NCT01824602|466066524|FG002|Overall Study|Treatment failure|0|||
129484697|NCT01824602|466066525|FG003|Overall Study|Treatment failure|1|||
129484698|NCT02485717|466066528|FG000|Overall Study|Lost to Follow-up|6|||
129484699|NCT02485717|466066529|FG001|Overall Study|Lost to Follow-up|0|||
129484700|NCT02485717|466066530|FG002|Overall Study|Lost to Follow-up|0|||
129484701|NCT02485717|466066528|FG000|Overall Study|Withdrawal by Subject|0|||
129484702|NCT02485717|466066529|FG001|Overall Study|Withdrawal by Subject|0|||
129484703|NCT02485717|466066530|FG002|Overall Study|Withdrawal by Subject|1|||
129484704|NCT02485717|466066528|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
129484705|NCT02485717|466066529|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
129484706|NCT02485717|466066530|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
129484707|NCT02485717|466066528|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
129979104|NCT02187159|467887408|FG001|Overall Study|Protocol Violation|6|||
129979105|NCT02187159|467887409|FG002|Overall Study|Protocol Violation|3|||
129979106|NCT02187159|467887410|FG003|Overall Study|Protocol Violation|4|||
129979107|NCT02187159|467887407|FG000|Overall Study|Lack of Efficacy|10|||
129979108|NCT02187159|467887408|FG001|Overall Study|Lack of Efficacy|5|||
129979109|NCT02187159|467887409|FG002|Overall Study|Lack of Efficacy|4|||
129979110|NCT02187159|467887410|FG003|Overall Study|Lack of Efficacy|7|||
129979111|NCT02187159|467887407|FG000|Overall Study|Adverse Event|28|||
129979112|NCT02187159|467887408|FG001|Overall Study|Adverse Event|33|||
129979113|NCT02187159|467887409|FG002|Overall Study|Adverse Event|42|||
129979114|NCT02187159|467887410|FG003|Overall Study|Adverse Event|50|||
129979115|NCT02187159|467887407|FG000|Overall Study|Withdrawal by Subject|24|||
129979116|NCT02187159|467887408|FG001|Overall Study|Withdrawal by Subject|28|||
129979117|NCT02187159|467887409|FG002|Overall Study|Withdrawal by Subject|25|||
129979118|NCT02187159|467887410|FG003|Overall Study|Withdrawal by Subject|26|||
129979119|NCT02187159|467887407|FG000|Overall Study|Other|3|||
129979120|NCT02187159|467887408|FG001|Overall Study|Other|7|||
129979121|NCT02187159|467887409|FG002|Overall Study|Other|3|||
129979122|NCT02187159|467887410|FG003|Overall Study|Other|9|||
129484708|NCT02485717|466066529|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
129484709|NCT02485717|466066530|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
129484710|NCT05300087|466066533|FG000|Overall Study|Withdrawal by Subject|0|||
129484711|NCT05300087|466066534|FG001|Overall Study|Withdrawal by Subject|1|||
129484712|NCT01877655|466066546|FG000|Overall Study|Death|57|||
129484713|NCT01877655|466066547|FG001|Overall Study|Death|52|||
129484714|NCT01877655|466066546|FG000|Overall Study|Withdrawal by Subject|18|||
129484715|NCT01877655|466066547|FG001|Overall Study|Withdrawal by Subject|26|||
129484716|NCT01877655|466066546|FG000|Overall Study|Physician Decision|11|||
129484717|NCT01877655|466066547|FG001|Overall Study|Physician Decision|10|||
129979123|NCT00567567|467887411|FG000|Overall Study|Adverse Event|0|||
129979124|NCT00567567|467887412|FG001|Overall Study|Adverse Event|2|||
129979125|NCT00567567|467887413|FG002|Overall Study|Adverse Event|5|||
129979126|NCT00567567|467887411|FG000|Overall Study|Death|8|||
129979127|NCT00567567|467887412|FG001|Overall Study|Death|1|||
129979128|NCT00567567|467887413|FG002|Overall Study|Death|5|||
129979129|NCT00567567|467887411|FG000|Overall Study|Lack of Efficacy|16|||
129979130|NCT00567567|467887412|FG001|Overall Study|Lack of Efficacy|17|||
129979131|NCT00567567|467887413|FG002|Overall Study|Lack of Efficacy|48|||
129979132|NCT00567567|467887411|FG000|Overall Study|Lost to Follow-up|0|||
129979133|NCT00567567|467887412|FG001|Overall Study|Lost to Follow-up|0|||
129979134|NCT00567567|467887413|FG002|Overall Study|Lost to Follow-up|1|||
129484718|NCT01877655|466066546|FG000|Overall Study|Miscellaneous|4|||
129484719|NCT01877655|466066547|FG001|Overall Study|Miscellaneous|4|||
129979135|NCT00567567|467887411|FG000|Overall Study|Physician Decision|16|||
129979136|NCT00567567|467887412|FG001|Overall Study|Physician Decision|18|||
129979137|NCT00567567|467887413|FG002|Overall Study|Physician Decision|84|||
129979138|NCT00567567|467887411|FG000|Overall Study|Withdrawal by Subject|0|||
129979139|NCT00567567|467887412|FG001|Overall Study|Withdrawal by Subject|0|||
129979140|NCT00567567|467887413|FG002|Overall Study|Withdrawal by Subject|2|||
129979141|NCT00567567|467887411|FG000|Overall Study|Ineligible|4|||
129979142|NCT00567567|467887412|FG001|Overall Study|Ineligible|0|||
129979143|NCT00567567|467887413|FG002|Overall Study|Ineligible|9|||
129979144|NCT00567567|467887411|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
129979145|NCT00567567|467887412|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
129979146|NCT00567567|467887413|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
129979147|NCT00567567|467887411|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
129979148|NCT00567567|467887412|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
129979149|NCT00567567|467887413|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
129979150|NCT00567567|467887411|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
129979151|NCT00567567|467887412|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
129979152|NCT00567567|467887413|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
129979153|NCT03482466|467887414|FG000|Overall Study|Protocol Violation|2|||
129979154|NCT04335591|467887415|FG000|Overall Study|Adverse Event|5|||
129979155|NCT04335591|467887416|FG001|Overall Study|Adverse Event|2|||
129979156|NCT04335591|467887417|FG002|Overall Study|Adverse Event|3|||
129979157|NCT04335591|467887418|FG003|Overall Study|Adverse Event|2|||
129979158|NCT04335591|467887415|FG000|Overall Study|Protocol Violation|1|||
129979159|NCT04335591|467887416|FG001|Overall Study|Protocol Violation|0|||
129979160|NCT04335591|467887417|FG002|Overall Study|Protocol Violation|0|||
129979161|NCT04335591|467887418|FG003|Overall Study|Protocol Violation|0|||
129979162|NCT04335591|467887415|FG000|Overall Study|Withdrawal by Subject|8|||
129979163|NCT04335591|467887416|FG001|Overall Study|Withdrawal by Subject|4|||
129979164|NCT04335591|467887417|FG002|Overall Study|Withdrawal by Subject|4|||
129979165|NCT04335591|467887418|FG003|Overall Study|Withdrawal by Subject|5|||
129979166|NCT04335591|467887415|FG000|Overall Study|Subject planning pregnancy|0|||
129979167|NCT04335591|467887416|FG001|Overall Study|Subject planning pregnancy|1|||
129979168|NCT04335591|467887417|FG002|Overall Study|Subject planning pregnancy|0|||
129979169|NCT04335591|467887418|FG003|Overall Study|Subject planning pregnancy|0|||
129979170|NCT04335591|467887415|FG000|Overall Study|Ukrainian Russian war conflict|4|||
129979171|NCT04335591|467887416|FG001|Overall Study|Ukrainian Russian war conflict|5|||
129979172|NCT04335591|467887417|FG002|Overall Study|Ukrainian Russian war conflict|2|||
129979173|NCT04335591|467887418|FG003|Overall Study|Ukrainian Russian war conflict|0|||
129979174|NCT03268603|467887419|FG000|Overall Study|Withdrawal by Subject|6|||
129979175|NCT03268603|467887419|FG000|Overall Study|Physician Decision|1|||
129979176|NCT03268603|467887419|FG000|Overall Study|Withdrawn due to disease progression|2|||
129979177|NCT05775991|467887421|FG000|Overall Study|Withdrawal by Subject|0|||
129979178|NCT05775991|467887422|FG001|Overall Study|Withdrawal by Subject|0|||
129484720|NCT01877655|466066546|FG000|Overall Study|Randomized but Never Received Drug|8|||
129484721|NCT01877655|466066547|FG001|Overall Study|Randomized but Never Received Drug|5|||
129484722|NCT02332915|466066548|FG000|Overall Study|Moved out of region|3|||
129484723|NCT02332915|466066549|FG001|Overall Study|Moved out of region|0|||
129979179|NCT05775991|467887423|FG002|Overall Study|Withdrawal by Subject|2|||
129979180|NCT01461811|467887424|FG000|Overall Study|Adverse Event|2|||
129979181|NCT01461811|467887425|FG001|Overall Study|Adverse Event|1|||
129979182|NCT01461811|467887424|FG000|Overall Study|Subject decision unrelated to an AE|1|||
129979183|NCT01461811|467887425|FG001|Overall Study|Subject decision unrelated to an AE|1|||
129979184|NCT01461811|467887424|FG000|Overall Study|Noncompliance|1|||
129979185|NCT01461811|467887425|FG001|Overall Study|Noncompliance|1|||
129979186|NCT01075958|467887426|FG000|Overall Study|Blood sample could not be obtained|44|||
129979187|NCT03733314|467887427|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
129979188|NCT03733314|467887428|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
129979189|NCT03733314|467887427|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
129979190|NCT03733314|467887428|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
129979191|NCT03733314|467887427|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
129979192|NCT03733314|467887428|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
129979193|NCT03733314|467887427|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
129979194|NCT03733314|467887428|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
129484724|NCT02332915|466066548|FG000|Overall Study|Unrelated illness|1|||
129484725|NCT02332915|466066549|FG001|Overall Study|Unrelated illness|1|||
129979195|NCT03733314|467887427|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
129979196|NCT03733314|467887428|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
129979197|NCT03733314|467887427|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
129979198|NCT03733314|467887428|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
129979199|NCT01240915|467887429|FG000|Overall Study|Adverse Event|0|||
129979200|NCT01240915|467887430|FG001|Overall Study|Adverse Event|0|||
129979201|NCT01240915|467887431|FG002|Overall Study|Adverse Event|0|||
129979202|NCT01240915|467887432|FG003|Overall Study|Adverse Event|1|||
129979203|NCT01240915|467887433|FG004|Overall Study|Adverse Event|0|||
129979204|NCT01240915|467887434|FG005|Overall Study|Adverse Event|2|||
129979205|NCT01240915|467887435|FG006|Overall Study|Adverse Event|0|||
129979206|NCT01240915|467887436|FG007|Overall Study|Adverse Event|0|||
129979207|NCT01240915|467887437|FG008|Overall Study|Adverse Event|1|||
129979208|NCT01240915|467887429|FG000|Overall Study|Lost to Follow-up|0|||
129979209|NCT01240915|467887430|FG001|Overall Study|Lost to Follow-up|0|||
129979210|NCT01240915|467887431|FG002|Overall Study|Lost to Follow-up|0|||
129979211|NCT01240915|467887432|FG003|Overall Study|Lost to Follow-up|0|||
129484726|NCT02332915|466066548|FG000|Overall Study|Travel distance prohibitive|0|||
129484727|NCT02332915|466066549|FG001|Overall Study|Travel distance prohibitive|1|||
129484728|NCT02332915|466066548|FG000|Overall Study|did not meet inclusion criteria|2|||
129484729|NCT02332915|466066549|FG001|Overall Study|did not meet inclusion criteria|4|||
129484730|NCT05847881|466066553|FG000|Overall Study|Principal Investigator Decision|8|||
129484731|NCT05847881|466066553|FG000|Overall Study|Withdrawal by Subject|2|||
129484732|NCT04513158|466066556|FG000|Overall Study|Screen Failure|1|||
129488476|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
129488477|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
129488478|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
129979212|NCT01240915|467887433|FG004|Overall Study|Lost to Follow-up|1|||
129979213|NCT01240915|467887434|FG005|Overall Study|Lost to Follow-up|1|||
129979214|NCT01240915|467887435|FG006|Overall Study|Lost to Follow-up|0|||
129979215|NCT01240915|467887436|FG007|Overall Study|Lost to Follow-up|1|||
129979216|NCT01240915|467887437|FG008|Overall Study|Lost to Follow-up|1|||
129979217|NCT01240915|467887429|FG000|Overall Study|Withdrawal by Subject|2|||
129979218|NCT01240915|467887430|FG001|Overall Study|Withdrawal by Subject|1|||
129979219|NCT01240915|467887431|FG002|Overall Study|Withdrawal by Subject|0|||
129488479|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
129488480|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
129488481|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
129488482|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
129488483|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
129488484|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
129488485|NCT00092547|466080719|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
129488486|NCT00092547|466080720|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
129488487|NCT00092547|466080721|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
129488488|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
129488489|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
129488490|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
129488491|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
129488492|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
129488493|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
129488494|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
129488495|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
129488496|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
129488497|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
129488498|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
129488499|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
129979220|NCT01240915|467887432|FG003|Overall Study|Withdrawal by Subject|2|||
129979221|NCT01240915|467887433|FG004|Overall Study|Withdrawal by Subject|0|||
129979222|NCT01240915|467887434|FG005|Overall Study|Withdrawal by Subject|4|||
129979223|NCT01240915|467887435|FG006|Overall Study|Withdrawal by Subject|2|||
129979224|NCT01240915|467887436|FG007|Overall Study|Withdrawal by Subject|3|||
129979225|NCT01240915|467887437|FG008|Overall Study|Withdrawal by Subject|3|||
129488500|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
129488501|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
129488502|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
129488503|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
129488504|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
129979226|NCT01240915|467887429|FG000|Overall Study|Other|0|||
129979227|NCT01240915|467887430|FG001|Overall Study|Other|0|||
129979228|NCT01240915|467887431|FG002|Overall Study|Other|0|||
129979229|NCT01240915|467887432|FG003|Overall Study|Other|0|||
129484733|NCT04493619|466067714|FG000|Overall Study|Death|4|||
129484734|NCT04493619|466067715|FG001|Overall Study|Death|3|||
129484735|NCT04493619|466067716|FG002|Overall Study|Death|3|||
129484736|NCT04493619|466067717|FG003|Overall Study|Death|4|||
129484737|NCT04493619|466067714|FG000|Overall Study|Study discontinued early|10|||
129484738|NCT04493619|466067715|FG001|Overall Study|Study discontinued early|0|||
129484739|NCT04493619|466067716|FG002|Overall Study|Study discontinued early|4|||
129484740|NCT04493619|466067717|FG003|Overall Study|Study discontinued early|8|||
129484741|NCT04493619|466067714|FG000|Overall Study|Lost to Follow-up|0|||
129484742|NCT04493619|466067715|FG001|Overall Study|Lost to Follow-up|0|||
129484743|NCT04493619|466067716|FG002|Overall Study|Lost to Follow-up|0|||
129484744|NCT04493619|466067717|FG003|Overall Study|Lost to Follow-up|1|||
129979230|NCT01240915|467887433|FG004|Overall Study|Other|2|||
129979231|NCT01240915|467887434|FG005|Overall Study|Other|0|||
129979232|NCT01240915|467887435|FG006|Overall Study|Other|0|||
129979233|NCT01240915|467887436|FG007|Overall Study|Other|0|||
129979234|NCT01240915|467887437|FG008|Overall Study|Other|0|||
129979235|NCT01240915|467887429|FG000|Overall Study|Insufficient Clinical Response|0|||
129979236|NCT01240915|467887430|FG001|Overall Study|Insufficient Clinical Response|0|||
129979237|NCT01240915|467887431|FG002|Overall Study|Insufficient Clinical Response|0|||
129979238|NCT01240915|467887432|FG003|Overall Study|Insufficient Clinical Response|0|||
129484745|NCT02128490|466067720|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129484746|NCT02128490|466067721|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129484747|NCT02128490|466067722|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
129484748|NCT02128490|466067723|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
129484749|NCT02128490|466067724|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
129484750|NCT02128490|466067720|FG000|Overall Study|Major Protocol Deviation|1|||
129484751|NCT02128490|466067721|FG001|Overall Study|Major Protocol Deviation|2|||
129484752|NCT02128490|466067722|FG002|Overall Study|Major Protocol Deviation|0|||
129484753|NCT02128490|466067723|FG003|Overall Study|Major Protocol Deviation|2|||
129484754|NCT02128490|466067724|FG004|Overall Study|Major Protocol Deviation|2|||
129484755|NCT02128490|466067720|FG000|Overall Study|Lost to Follow-up|0|||
129484756|NCT02128490|466067721|FG001|Overall Study|Lost to Follow-up|0|||
129484757|NCT02128490|466067722|FG002|Overall Study|Lost to Follow-up|1|||
129484758|NCT02128490|466067723|FG003|Overall Study|Lost to Follow-up|1|||
129979239|NCT01240915|467887433|FG004|Overall Study|Insufficient Clinical Response|1|||
129979240|NCT01240915|467887434|FG005|Overall Study|Insufficient Clinical Response|3|||
129979241|NCT01240915|467887435|FG006|Overall Study|Insufficient Clinical Response|6|||
129979242|NCT01240915|467887436|FG007|Overall Study|Insufficient Clinical Response|0|||
129979243|NCT01240915|467887437|FG008|Overall Study|Insufficient Clinical Response|3|||
129979244|NCT04514510|467887438|FG000|Overall Study|Lost to Follow-up|0|||
129979245|NCT04514510|467887439|FG001|Overall Study|Lost to Follow-up|1|||
129979246|NCT04514510|467887438|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
129979247|NCT04514510|467887439|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
129979248|NCT00406692|467887440|FG000|Overall Study|Withdrawal by Subject|4|||
129979249|NCT00406692|467887440|FG000|Overall Study|Physician Decision|1|||
129979250|NCT00406692|467887440|FG000|Overall Study|Adverse Event|1|||
129979251|NCT00406692|467887440|FG000|Overall Study|Lack of Efficacy|1|||
129979252|NCT02636725|467887443|FG000|Overall Study|Adverse Event|1|||
129979253|NCT05330676|467887444|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
129979254|NCT05330676|467887445|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
129979255|NCT03284203|467887446|FG000|Overall Study|Lost to Follow-up|3|||
129979256|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
129979257|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
129979258|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
129979259|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
129979260|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
129979261|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
129979262|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
129979263|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979264|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
129979265|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979266|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979267|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979268|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979269|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
129979270|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
129979271|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
129484759|NCT02128490|466067724|FG004|Overall Study|Lost to Follow-up|1|||
129484760|NCT02128490|466067720|FG000|Overall Study|Voluntary Withdrawal|3|||
129484761|NCT02128490|466067721|FG001|Overall Study|Voluntary Withdrawal|3|||
129484762|NCT02128490|466067722|FG002|Overall Study|Voluntary Withdrawal|1|||
129484763|NCT02128490|466067723|FG003|Overall Study|Voluntary Withdrawal|1|||
129484764|NCT02128490|466067724|FG004|Overall Study|Voluntary Withdrawal|2|||
129979272|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
129979273|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979274|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979275|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979276|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
129979277|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979278|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979279|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
129979280|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979281|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979282|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979283|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
129979284|NCT02229851|467887447|FG000|Main Phase (Double-blind Phase)|Death|1|||
129979285|NCT02229851|467887448|FG001|Main Phase (Double-blind Phase)|Death|1|||
129979286|NCT02229851|467887449|FG002|Main Phase (Double-blind Phase)|Death|0|||
129979287|NCT02229851|467887450|FG003|Main Phase (Double-blind Phase)|Death|0|||
129979288|NCT02229851|467887451|FG004|Main Phase (Double-blind Phase)|Death|0|||
129979289|NCT02229851|467887452|FG005|Main Phase (Double-blind Phase)|Death|0|||
129979290|NCT02229851|467887453|FG006|Main Phase (Double-blind Phase)|Death|0|||
129979291|NCT02229851|467887447|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979292|NCT02229851|467887448|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979293|NCT02229851|467887449|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979294|NCT02229851|467887450|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
129979295|NCT02229851|467887451|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
129979296|NCT02229851|467887452|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
129979297|NCT02229851|467887453|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
129979298|NCT02229851|467887447|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
129979299|NCT02229851|467887448|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
129979300|NCT02229851|467887449|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
129979301|NCT02229851|467887450|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
129979302|NCT02229851|467887451|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
129979303|NCT02229851|467887452|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
129979304|NCT02229851|467887453|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
129979305|NCT02229851|467887447|FG000|Extension Phase (Open-label Phase)|Death|0|||
129979306|NCT02229851|467887448|FG001|Extension Phase (Open-label Phase)|Death|0|||
129979307|NCT02229851|467887449|FG002|Extension Phase (Open-label Phase)|Death|0|||
129979308|NCT02229851|467887450|FG003|Extension Phase (Open-label Phase)|Death|1|||
129979309|NCT02229851|467887451|FG004|Extension Phase (Open-label Phase)|Death|0|||
129979310|NCT02229851|467887452|FG005|Extension Phase (Open-label Phase)|Death|1|||
129979311|NCT02229851|467887453|FG006|Extension Phase (Open-label Phase)|Death|1|||
129979312|NCT01111240|467887454|FG000|Overall Study|Adverse Event|190|||
129979313|NCT01111240|467887454|FG000|Overall Study|Lack of Efficacy|545|||
129979314|NCT01111240|467887454|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
129979315|NCT01111240|467887454|FG000|Overall Study|Other|312|||
129979316|NCT02206061|467887455|FG000|Overall Study|Withdrawal by Subject|4|||
129979317|NCT02206061|467887456|FG001|Overall Study|Withdrawal by Subject|7|||
129979318|NCT02206061|467887457|FG002|Overall Study|Withdrawal by Subject|1|||
129979319|NCT02206061|467887455|FG000|Overall Study|Lost to Follow-up|14|||
129979320|NCT02206061|467887456|FG001|Overall Study|Lost to Follow-up|7|||
129979321|NCT02206061|467887457|FG002|Overall Study|Lost to Follow-up|20|||
129979322|NCT01607476|467887458|FG000|Overall Study|Withdrawal by Subject|1|||
129979323|NCT01607476|467887459|FG001|Overall Study|Withdrawal by Subject|0|||
129979324|NCT01607476|467887460|FG002|Overall Study|Withdrawal by Subject|1|||
129979325|NCT01607476|467887458|FG000|Overall Study|Lost to Follow-up|0|||
129979326|NCT01607476|467887459|FG001|Overall Study|Lost to Follow-up|0|||
129979327|NCT01607476|467887460|FG002|Overall Study|Lost to Follow-up|2|||
129979328|NCT04958200|467887467|FG000|Overall Study|Withdrawal by Subject|0|||
129979329|NCT04958200|467887468|FG001|Overall Study|Withdrawal by Subject|2|||
129979330|NCT04958200|467887467|FG000|Overall Study|Lost to Follow-up|3|||
129979331|NCT04958200|467887468|FG001|Overall Study|Lost to Follow-up|2|||
129979332|NCT04531098|467887469|FG000|Stage I|Adverse Event|0|||
129979333|NCT04531098|467887470|FG001|Stage I|Adverse Event|0|||
129979334|NCT04531098|467887471|FG002|Stage I|Adverse Event|3|||
129979335|NCT04531098|467887469|FG000|Stage I|Protocol Violation|0|||
129979336|NCT04531098|467887470|FG001|Stage I|Protocol Violation|0|||
129979337|NCT04531098|467887471|FG002|Stage I|Protocol Violation|5|||
129979338|NCT04531098|467887469|FG000|Stage I|Withdrawal by Subject|0|||
129979339|NCT04531098|467887470|FG001|Stage I|Withdrawal by Subject|5|||
129979340|NCT04531098|467887471|FG002|Stage I|Withdrawal by Subject|10|||
129979341|NCT04531098|467887469|FG000|Stage II|Adverse Event|1|||
129979342|NCT04531098|467887470|FG001|Stage II|Adverse Event|2|||
129979343|NCT04531098|467887471|FG002|Stage II|Adverse Event|0|||
129979344|NCT04531098|467887469|FG000|Stage II|Protocol Violation|1|||
129979345|NCT04531098|467887470|FG001|Stage II|Protocol Violation|2|||
129979346|NCT04531098|467887471|FG002|Stage II|Protocol Violation|0|||
129484765|NCT02128490|466067720|FG000|Overall Study|Lack of Efficacy|0|||
129484766|NCT02128490|466067721|FG001|Overall Study|Lack of Efficacy|1|||
129484767|NCT02128490|466067722|FG002|Overall Study|Lack of Efficacy|0|||
129484768|NCT02128490|466067723|FG003|Overall Study|Lack of Efficacy|0|||
129484769|NCT02128490|466067724|FG004|Overall Study|Lack of Efficacy|0|||
129484770|NCT02128490|466067720|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
129979347|NCT04531098|467887469|FG000|Stage II|Withdrawal by Subject|3|||
129979348|NCT04531098|467887470|FG001|Stage II|Withdrawal by Subject|1|||
129979349|NCT04531098|467887471|FG002|Stage II|Withdrawal by Subject|0|||
129979350|NCT04531098|467887469|FG000|Stage II|Moved from study area|8|||
129979351|NCT04531098|467887470|FG001|Stage II|Moved from study area|5|||
129979352|NCT04531098|467887471|FG002|Stage II|Moved from study area|0|||
129979353|NCT02628028|467887472|FG000|Dosing Period|Withdrawal by Subject|0|||
129979354|NCT02628028|467887473|FG001|Dosing Period|Withdrawal by Subject|0|||
129484771|NCT02128490|466067721|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
129484772|NCT02128490|466067722|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
129484773|NCT02128490|466067723|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
129484774|NCT02128490|466067724|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
129484775|NCT02128490|466067720|FG000|Overall Study|Other Miscellaneous Reasons|0|||
129484776|NCT02128490|466067721|FG001|Overall Study|Other Miscellaneous Reasons|0|||
129979355|NCT02628028|467887474|FG002|Dosing Period|Withdrawal by Subject|1|||
129979356|NCT02628028|467887475|FG003|Dosing Period|Withdrawal by Subject|0|||
129979357|NCT02628028|467887476|FG004|Dosing Period|Withdrawal by Subject|2|||
129979358|NCT02628028|467887477|FG005|Dosing Period|Withdrawal by Subject|4|||
129979359|NCT02628028|467887478|FG006|Dosing Period|Withdrawal by Subject|1|||
129979360|NCT02628028|467887479|FG007|Dosing Period|Withdrawal by Subject|1|||
129979361|NCT02628028|467887472|FG000|Dosing Period|Adverse Event|0|||
129979362|NCT02628028|467887473|FG001|Dosing Period|Adverse Event|0|||
129979363|NCT02628028|467887474|FG002|Dosing Period|Adverse Event|0|||
129979364|NCT02628028|467887475|FG003|Dosing Period|Adverse Event|0|||
129979365|NCT02628028|467887476|FG004|Dosing Period|Adverse Event|2|||
129979366|NCT02628028|467887477|FG005|Dosing Period|Adverse Event|1|||
129979367|NCT02628028|467887478|FG006|Dosing Period|Adverse Event|3|||
129979368|NCT02628028|467887479|FG007|Dosing Period|Adverse Event|2|||
129979369|NCT02628028|467887472|FG000|Dosing Period|Death|0|||
129979370|NCT02628028|467887473|FG001|Dosing Period|Death|0|||
129979371|NCT02628028|467887474|FG002|Dosing Period|Death|0|||
129484777|NCT02128490|466067722|FG002|Overall Study|Other Miscellaneous Reasons|2|||
129484778|NCT02128490|466067723|FG003|Overall Study|Other Miscellaneous Reasons|1|||
129484779|NCT02128490|466067724|FG004|Overall Study|Other Miscellaneous Reasons|1|||
129484780|NCT02243176|466067725|FG000|Overall Study|Other reason|1|||
129484781|NCT02243176|466067726|FG001|Overall Study|Other reason|2|||
129484782|NCT02243176|466067725|FG000|Overall Study|protocol specified withdrawal critera|1|||
129484783|NCT02243176|466067726|FG001|Overall Study|protocol specified withdrawal critera|3|||
129484784|NCT02243176|466067725|FG000|Overall Study|Protocol Violation|2|||
129484785|NCT02243176|466067726|FG001|Overall Study|Protocol Violation|1|||
129484786|NCT02243176|466067725|FG000|Overall Study|Withdrawal by Subject|8|||
129484787|NCT02243176|466067726|FG001|Overall Study|Withdrawal by Subject|7|||
129979372|NCT02628028|467887475|FG003|Dosing Period|Death|0|||
129979373|NCT02628028|467887476|FG004|Dosing Period|Death|0|||
129979374|NCT02628028|467887477|FG005|Dosing Period|Death|0|||
129979375|NCT02628028|467887478|FG006|Dosing Period|Death|0|||
129979376|NCT02628028|467887479|FG007|Dosing Period|Death|1|||
129979377|NCT02628028|467887472|FG000|Dosing Period|Lack of Efficacy|0|||
129979378|NCT02628028|467887473|FG001|Dosing Period|Lack of Efficacy|0|||
129484788|NCT02243176|466067725|FG000|Overall Study|Adverse Event|2|||
129484789|NCT02243176|466067726|FG001|Overall Study|Adverse Event|2|||
129484790|NCT02342171|466067730|FG000|Overall Study|Death|4|||
129484791|NCT02342171|466067731|FG001|Overall Study|Death|87|||
129484792|NCT02342171|466067730|FG000|Overall Study|Received favipiravir|10|||
129484793|NCT02342171|466067731|FG001|Overall Study|Received favipiravir|0|||
129979379|NCT02628028|467887474|FG002|Dosing Period|Lack of Efficacy|0|||
129979380|NCT02628028|467887475|FG003|Dosing Period|Lack of Efficacy|0|||
129979381|NCT02628028|467887476|FG004|Dosing Period|Lack of Efficacy|3|||
129979382|NCT02628028|467887477|FG005|Dosing Period|Lack of Efficacy|0|||
129979383|NCT02628028|467887478|FG006|Dosing Period|Lack of Efficacy|1|||
129979384|NCT02628028|467887479|FG007|Dosing Period|Lack of Efficacy|0|||
129979385|NCT02628028|467887472|FG000|Dosing Period|Study Terminated by Sponsor|0|||
129484794|NCT02342171|466067730|FG000|Overall Study|Missing cycle treshold value|1|||
129979386|NCT02628028|467887473|FG001|Dosing Period|Study Terminated by Sponsor|0|||
129979387|NCT02628028|467887474|FG002|Dosing Period|Study Terminated by Sponsor|0|||
129979388|NCT02628028|467887475|FG003|Dosing Period|Study Terminated by Sponsor|0|||
129979389|NCT02628028|467887476|FG004|Dosing Period|Study Terminated by Sponsor|7|||
129979390|NCT02628028|467887477|FG005|Dosing Period|Study Terminated by Sponsor|6|||
129979391|NCT02628028|467887478|FG006|Dosing Period|Study Terminated by Sponsor|7|||
129979392|NCT02628028|467887479|FG007|Dosing Period|Study Terminated by Sponsor|7|||
129979393|NCT02628028|467887472|FG000|Dosing Period|Physician Decision|0|||
129979394|NCT02628028|467887473|FG001|Dosing Period|Physician Decision|0|||
129979395|NCT02628028|467887474|FG002|Dosing Period|Physician Decision|0|||
129979396|NCT02628028|467887475|FG003|Dosing Period|Physician Decision|0|||
129979397|NCT02628028|467887476|FG004|Dosing Period|Physician Decision|0|||
129979398|NCT02628028|467887477|FG005|Dosing Period|Physician Decision|1|||
129979399|NCT02628028|467887478|FG006|Dosing Period|Physician Decision|0|||
129979400|NCT02628028|467887479|FG007|Dosing Period|Physician Decision|0|||
129979401|NCT02628028|467887472|FG000|Dosing Period|Site Terminated by Sponsor|0|||
129979402|NCT02628028|467887473|FG001|Dosing Period|Site Terminated by Sponsor|0|||
129979403|NCT02628028|467887474|FG002|Dosing Period|Site Terminated by Sponsor|0|||
129979404|NCT02628028|467887475|FG003|Dosing Period|Site Terminated by Sponsor|0|||
129979405|NCT02628028|467887476|FG004|Dosing Period|Site Terminated by Sponsor|0|||
129979406|NCT02628028|467887477|FG005|Dosing Period|Site Terminated by Sponsor|1|||
129979407|NCT02628028|467887478|FG006|Dosing Period|Site Terminated by Sponsor|1|||
129979408|NCT02628028|467887479|FG007|Dosing Period|Site Terminated by Sponsor|0|||
129979409|NCT02628028|467887472|FG000|Dosing Period|Lost to Follow-up|0|||
129979410|NCT02628028|467887473|FG001|Dosing Period|Lost to Follow-up|0|||
129979411|NCT02628028|467887474|FG002|Dosing Period|Lost to Follow-up|0|||
129979412|NCT02628028|467887475|FG003|Dosing Period|Lost to Follow-up|0|||
129979413|NCT02628028|467887476|FG004|Dosing Period|Lost to Follow-up|0|||
129979414|NCT02628028|467887477|FG005|Dosing Period|Lost to Follow-up|0|||
129979415|NCT02628028|467887478|FG006|Dosing Period|Lost to Follow-up|1|||
129979416|NCT02628028|467887479|FG007|Dosing Period|Lost to Follow-up|0|||
129979417|NCT02628028|467887472|FG000|Dosing Period|Other|0|||
129979418|NCT02628028|467887473|FG001|Dosing Period|Other|0|||
129979419|NCT02628028|467887474|FG002|Dosing Period|Other|0|||
129979420|NCT02628028|467887475|FG003|Dosing Period|Other|0|||
129979421|NCT02628028|467887476|FG004|Dosing Period|Other|2|||
129979422|NCT02628028|467887477|FG005|Dosing Period|Other|1|||
129979423|NCT02628028|467887478|FG006|Dosing Period|Other|2|||
129979424|NCT02628028|467887479|FG007|Dosing Period|Other|4|||
129979425|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
129979426|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
129979427|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
129979428|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
129979429|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
129979430|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
129979431|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
129979432|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
129979433|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979434|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979435|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979436|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979437|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979438|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
129979439|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
129979440|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
129979441|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979442|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979443|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979444|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979445|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
129979446|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
129979447|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
129979448|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
129979449|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979450|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979451|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979452|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979453|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
129979454|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
129979455|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
129979456|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
129979457|NCT02628028|467887472|FG000|Long-term Extension (LTE) Period|Other|0|||
129979458|NCT02628028|467887473|FG001|Long-term Extension (LTE) Period|Other|0|||
129979459|NCT02628028|467887474|FG002|Long-term Extension (LTE) Period|Other|0|||
129979460|NCT02628028|467887475|FG003|Long-term Extension (LTE) Period|Other|0|||
129979461|NCT02628028|467887476|FG004|Long-term Extension (LTE) Period|Other|0|||
129979462|NCT02628028|467887477|FG005|Long-term Extension (LTE) Period|Other|3|||
129979463|NCT02628028|467887478|FG006|Long-term Extension (LTE) Period|Other|4|||
129979464|NCT02628028|467887479|FG007|Long-term Extension (LTE) Period|Other|3|||
129979465|NCT02145468|467887480|FG000|Overall Study|Withdrawal by Subject|5|||
129979466|NCT02145468|467887481|FG001|Overall Study|Withdrawal by Subject|8|||
129979467|NCT04157400|467887482|FG000|Overall Study|Withdrawal by Subject|1|||
129979468|NCT04157400|467887482|FG000|Overall Study|Lost to Follow-up|3|||
129979469|NCT00623805|467887483|FG000|Overall Study|Adverse Event|9|||
129979470|NCT00623805|467887484|FG001|Overall Study|Adverse Event|6|||
129979471|NCT00623805|467887483|FG000|Overall Study|Death|2|||
129979472|NCT00623805|467887484|FG001|Overall Study|Death|0|||
129979473|NCT00623805|467887483|FG000|Overall Study|Lack of Efficacy|3|||
129979474|NCT00623805|467887484|FG001|Overall Study|Lack of Efficacy|7|||
129979475|NCT00623805|467887483|FG000|Overall Study|Lost to Follow-up|2|||
129979476|NCT00623805|467887484|FG001|Overall Study|Lost to Follow-up|2|||
129979477|NCT00623805|467887483|FG000|Overall Study|Protocol Violation|1|||
129979478|NCT00623805|467887484|FG001|Overall Study|Protocol Violation|1|||
129979479|NCT00623805|467887483|FG000|Overall Study|Reason not Specified|3|||
129979480|NCT00623805|467887484|FG001|Overall Study|Reason not Specified|6|||
129979481|NCT04655027|467887500|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
129979482|NCT04655027|467887501|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
129979483|NCT03519997|467887504|FG000|Overall Study|Adverse Event|4|||
129979484|NCT03519997|467887504|FG000|Overall Study|Withdrawal by Subject|2|||
129979485|NCT03519997|467887504|FG000|Overall Study|Protocol Violation|1|||
129979486|NCT05543707|467887505|FG000|Overall Study|Study drug non-compliance/|5|||
129979487|NCT05543707|467887506|FG001|Overall Study|Study drug non-compliance/|0|||
129979488|NCT05543707|467887505|FG000|Overall Study|Withdrawal by Subject|1|||
129979489|NCT05543707|467887506|FG001|Overall Study|Withdrawal by Subject|1|||
129979490|NCT05543707|467887505|FG000|Overall Study|Adverse Event|1|||
129979491|NCT05543707|467887506|FG001|Overall Study|Adverse Event|0|||
129979492|NCT05543707|467887505|FG000|Overall Study|concurrent illness|0|||
129979493|NCT05543707|467887506|FG001|Overall Study|concurrent illness|1|||
129979494|NCT05543707|467887505|FG000|Overall Study|Pregnancy|1|||
129979495|NCT05543707|467887506|FG001|Overall Study|Pregnancy|1|||
129979496|NCT00186888|467887507|FG000|Overall Study|Toxicity|0|||
129979497|NCT00186888|467887508|FG001|Overall Study|Toxicity|1|||
129979498|NCT00186888|467887509|FG002|Overall Study|Toxicity|0|||
129979499|NCT00186888|467887507|FG000|Overall Study|Relapse or progression of disease|4|||
129979500|NCT00186888|467887508|FG001|Overall Study|Relapse or progression of disease|2|||
129979501|NCT00186888|467887509|FG002|Overall Study|Relapse or progression of disease|0|||
129979502|NCT02336451|467887510|FG000|Overall Study|Adverse Event|1|||
129979503|NCT02336451|467887511|FG001|Overall Study|Adverse Event|2|||
129979504|NCT02336451|467887512|FG002|Overall Study|Adverse Event|0|||
129979505|NCT02336451|467887513|FG003|Overall Study|Adverse Event|6|||
129979506|NCT02336451|467887514|FG004|Overall Study|Adverse Event|4|||
129979507|NCT02336451|467887510|FG000|Overall Study|Death|6|||
129979508|NCT02336451|467887511|FG001|Overall Study|Death|2|||
129979509|NCT02336451|467887512|FG002|Overall Study|Death|3|||
129979510|NCT02336451|467887513|FG003|Overall Study|Death|6|||
129979511|NCT02336451|467887514|FG004|Overall Study|Death|6|||
129979512|NCT02336451|467887510|FG000|Overall Study|Physician Decision|9|||
129979513|NCT02336451|467887511|FG001|Overall Study|Physician Decision|6|||
129979514|NCT02336451|467887512|FG002|Overall Study|Physician Decision|7|||
129979515|NCT02336451|467887513|FG003|Overall Study|Physician Decision|16|||
129979516|NCT02336451|467887514|FG004|Overall Study|Physician Decision|3|||
129979517|NCT02336451|467887510|FG000|Overall Study|Progressive disease|23|||
129979518|NCT02336451|467887511|FG001|Overall Study|Progressive disease|26|||
129979519|NCT02336451|467887512|FG002|Overall Study|Progressive disease|2|||
129979520|NCT02336451|467887513|FG003|Overall Study|Progressive disease|14|||
129979521|NCT02336451|467887514|FG004|Overall Study|Progressive disease|4|||
129979522|NCT02336451|467887510|FG000|Overall Study|Protocol Violation|1|||
129979523|NCT02336451|467887511|FG001|Overall Study|Protocol Violation|0|||
129979524|NCT02336451|467887512|FG002|Overall Study|Protocol Violation|0|||
129979525|NCT02336451|467887513|FG003|Overall Study|Protocol Violation|0|||
129979526|NCT02336451|467887514|FG004|Overall Study|Protocol Violation|0|||
129979527|NCT02336451|467887510|FG000|Overall Study|Patient/guardian decision|2|||
129979528|NCT02336451|467887511|FG001|Overall Study|Patient/guardian decision|4|||
129979529|NCT02336451|467887512|FG002|Overall Study|Patient/guardian decision|0|||
129979530|NCT02336451|467887513|FG003|Overall Study|Patient/guardian decision|2|||
129979531|NCT02336451|467887514|FG004|Overall Study|Patient/guardian decision|1|||
129979532|NCT02344290|467887522|FG000|Overall Study|Withdrawal by Subject|315|||
129979533|NCT02344290|467887523|FG001|Overall Study|Withdrawal by Subject|324|||
129484795|NCT02342171|466067731|FG001|Overall Study|Missing cycle treshold value|0|||
129484796|NCT02342171|466067730|FG000|Overall Study|Unknown outcome|0|||
129484797|NCT02342171|466067731|FG001|Overall Study|Unknown outcome|1|||
129484798|NCT02342171|466067730|FG000|Overall Study|Missing age data|0|||
129484799|NCT02342171|466067731|FG001|Overall Study|Missing age data|1|||
129484800|NCT03518840|466067734|FG000|Overall Study|Lost to Follow-up|6|||
129484801|NCT03704051|466067735|FG000|Overall Study|Withdrawal by Subject|4|||
129484802|NCT03704051|466067736|FG001|Overall Study|Withdrawal by Subject|0|||
129484803|NCT01335971|466067739|FG000|Overall Study|Withdrawal by Subject|1|||
129484804|NCT01335971|466067740|FG001|Overall Study|Withdrawal by Subject|0|||
129484805|NCT01335971|466067741|FG002|Overall Study|Withdrawal by Subject|0|||
129484806|NCT01335971|466067739|FG000|Overall Study|Did not complete bronchoscopy|1|||
129484807|NCT01335971|466067740|FG001|Overall Study|Did not complete bronchoscopy|1|||
129484808|NCT01335971|466067741|FG002|Overall Study|Did not complete bronchoscopy|1|||
129484809|NCT00384956|466067742|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
129484810|NCT00149214|466067746|FG000|Overall Study|Adverse Event|12|||
129484811|NCT00149214|466067747|FG001|Overall Study|Adverse Event|9|||
129484812|NCT00149214|466067746|FG000|Overall Study|Withdrawal by Subject|4|||
129484813|NCT00149214|466067747|FG001|Overall Study|Withdrawal by Subject|1|||
129484814|NCT00149214|466067746|FG000|Overall Study|Physician Decision|3|||
129484815|NCT00149214|466067747|FG001|Overall Study|Physician Decision|3|||
129484816|NCT00149214|466067746|FG000|Overall Study|Sponsor Decision|0|||
129484817|NCT00149214|466067747|FG001|Overall Study|Sponsor Decision|1|||
129484818|NCT00149214|466067746|FG000|Overall Study|Progressive Disease|7|||
129484819|NCT00149214|466067747|FG001|Overall Study|Progressive Disease|3|||
129484820|NCT00174941|466067750|FG000|Overall Study|Adverse Event|1|||
129484821|NCT00174941|466067751|FG001|Overall Study|Adverse Event|10|||
129484822|NCT00174941|466067752|FG002|Overall Study|Adverse Event|2|||
129484823|NCT00174941|466067753|FG003|Overall Study|Adverse Event|13|||
129484824|NCT00174941|466067750|FG000|Overall Study|Protocol Violation|0|||
129484825|NCT00174941|466067751|FG001|Overall Study|Protocol Violation|1|||
129484826|NCT00174941|466067752|FG002|Overall Study|Protocol Violation|0|||
129484827|NCT00174941|466067753|FG003|Overall Study|Protocol Violation|1|||
129484828|NCT00174941|466067750|FG000|Overall Study|Lost to Follow-up|0|||
129484829|NCT00174941|466067751|FG001|Overall Study|Lost to Follow-up|3|||
129484830|NCT00174941|466067752|FG002|Overall Study|Lost to Follow-up|2|||
129484831|NCT00174941|466067753|FG003|Overall Study|Lost to Follow-up|5|||
129484832|NCT00174941|466067750|FG000|Overall Study|Personal Reason(s)|0|||
129484833|NCT00174941|466067751|FG001|Overall Study|Personal Reason(s)|14|||
129484834|NCT00174941|466067752|FG002|Overall Study|Personal Reason(s)|8|||
129484835|NCT00174941|466067753|FG003|Overall Study|Personal Reason(s)|22|||
129484836|NCT00174941|466067750|FG000|Overall Study|Gout Flare|0|||
129484837|NCT00174941|466067751|FG001|Overall Study|Gout Flare|4|||
129484838|NCT00174941|466067752|FG002|Overall Study|Gout Flare|4|||
129484839|NCT00174941|466067753|FG003|Overall Study|Gout Flare|8|||
129979534|NCT02344290|467887522|FG000|Overall Study|Lost to Follow-up|258|||
129484840|NCT00174941|466067750|FG000|Overall Study|Reason Not Specified|1|||
129484841|NCT00174941|466067751|FG001|Overall Study|Reason Not Specified|6|||
129979535|NCT02344290|467887523|FG001|Overall Study|Lost to Follow-up|249|||
129979536|NCT02344290|467887522|FG000|Overall Study|Unable to get to clinic|69|||
129979537|NCT02344290|467887523|FG001|Overall Study|Unable to get to clinic|60|||
129979538|NCT02344290|467887522|FG000|Overall Study|Physician Decision|25|||
129979539|NCT02344290|467887523|FG001|Overall Study|Physician Decision|25|||
129484842|NCT00174941|466067752|FG002|Overall Study|Reason Not Specified|2|||
129484843|NCT00174941|466067753|FG003|Overall Study|Reason Not Specified|9|||
129484844|NCT03126227|466067754|FG000|Overall Study|Adverse Event|43|||
129484845|NCT03126227|466067755|FG001|Overall Study|Adverse Event|4|||
129484846|NCT03126227|466067754|FG000|Overall Study|Death|0|||
129484847|NCT03126227|466067755|FG001|Overall Study|Death|1|||
129484848|NCT03126227|466067754|FG000|Overall Study|Lost to Follow-up|0|||
129484849|NCT03126227|466067755|FG001|Overall Study|Lost to Follow-up|1|||
129484850|NCT03126227|466067754|FG000|Overall Study|Physician Decision|2|||
129484851|NCT03126227|466067755|FG001|Overall Study|Physician Decision|0|||
129484852|NCT03126227|466067754|FG000|Overall Study|Protocol Violation|1|||
129484853|NCT03126227|466067755|FG001|Overall Study|Protocol Violation|0|||
129484854|NCT03126227|466067754|FG000|Overall Study|Withdrawal by Subject|19|||
129484855|NCT03126227|466067755|FG001|Overall Study|Withdrawal by Subject|3|||
129979540|NCT02344290|467887522|FG000|Overall Study|Site Closure|15|||
129979541|NCT02344290|467887523|FG001|Overall Study|Site Closure|19|||
129979542|NCT02344290|467887522|FG000|Overall Study|Other|5|||
129484856|NCT03126227|466067754|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
129484857|NCT03126227|466067755|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
129484858|NCT03126227|466067754|FG000|Overall Study|Lack of dosing compliance|2|||
129484859|NCT03126227|466067755|FG001|Overall Study|Lack of dosing compliance|0|||
129484860|NCT03126227|466067754|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
129484861|NCT03126227|466067755|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
129484862|NCT03126227|466067754|FG000|Overall Study|Scheduling conflict|1|||
129484863|NCT03126227|466067755|FG001|Overall Study|Scheduling conflict|0|||
129484864|NCT03230097|466067758|FG000|Overall Study|Adverse Event|2|||
129484865|NCT03230097|466067759|FG001|Overall Study|Adverse Event|1|||
129484866|NCT03230097|466067758|FG000|Overall Study|non-compliance|0|||
129484867|NCT03230097|466067759|FG001|Overall Study|non-compliance|1|||
129484868|NCT03230097|466067758|FG000|Overall Study|Lost to Follow-up|2|||
129484869|NCT03230097|466067759|FG001|Overall Study|Lost to Follow-up|4|||
129484870|NCT03230097|466067758|FG000|Overall Study|Withdrawal by Subject|7|||
129484871|NCT03230097|466067759|FG001|Overall Study|Withdrawal by Subject|3|||
129484872|NCT03230097|466067758|FG000|Overall Study|Trial termination|4|||
129484873|NCT03230097|466067759|FG001|Overall Study|Trial termination|5|||
129484874|NCT03230097|466067758|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
129484875|NCT03230097|466067759|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
129484876|NCT03230097|466067758|FG000|Overall Study|outcome event|0|||
129484877|NCT03230097|466067759|FG001|Overall Study|outcome event|1|||
129484878|NCT03215277|466067761|FG000|Overall Study|Adverse Event|2|||
129484879|NCT03215277|466067762|FG001|Overall Study|Adverse Event|3|||
129484880|NCT03215277|466067761|FG000|Overall Study|Death|1|||
129484881|NCT03215277|466067762|FG001|Overall Study|Death|0|||
129484882|NCT03215277|466067761|FG000|Overall Study|Lost to Follow-up|0|||
129484883|NCT03215277|466067762|FG001|Overall Study|Lost to Follow-up|1|||
129484884|NCT03215277|466067761|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
129484885|NCT03215277|466067762|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
129484886|NCT03794986|466067763|FG000|Overall Study|0 Sessions Attended|34|||
129484887|NCT03794986|466067764|FG001|Overall Study|0 Sessions Attended|37|||
129484888|NCT03794986|466067763|FG000|Overall Study|Withdrawal by Subject|4|||
129484889|NCT03794986|466067764|FG001|Overall Study|Withdrawal by Subject|6|||
129484890|NCT03794986|466067763|FG000|Overall Study|Protocol Violation|1|||
129484891|NCT03794986|466067764|FG001|Overall Study|Protocol Violation|0|||
129484892|NCT00465569|466067767|FG000|Overall Study|persistent eczema during dose escalation|1|||
129484893|NCT00465569|466067768|FG001|Overall Study|persistent eczema during dose escalation|0|||
129484894|NCT00095303|466067769|FG000|Main Study|Lost to Follow-up|91|||
129484895|NCT00095303|466067770|FG001|Main Study|Lost to Follow-up|87|||
129484896|NCT00095303|466067769|FG000|Follow Up Study|Lost to Follow-up|59|||
129484897|NCT00095303|466067770|FG001|Follow Up Study|Lost to Follow-up|58|||
129484898|NCT01364467|466067771|FG000|Overall Study|Lost to Follow-up|1|||
129484899|NCT01364467|466067772|FG001|Overall Study|Lost to Follow-up|2|||
129484900|NCT01634243|466067773|FG000|Overall Study|Adverse Event|5|||
129484901|NCT01634243|466067774|FG001|Overall Study|Adverse Event|5|||
129484902|NCT01634243|466067773|FG000|Overall Study|Lack of Efficacy|1|||
129484903|NCT01634243|466067774|FG001|Overall Study|Lack of Efficacy|0|||
129484904|NCT00971321|466067783|FG000|Up to Month 7|Withdrawal by Subject|1|||
129484905|NCT00971321|466067784|FG001|Up to Month 7|Withdrawal by Subject|0|||
129484906|NCT00971321|466067783|FG000|Up to Month 7|Migrated/moved from study area|3|||
129484907|NCT00971321|466067784|FG001|Up to Month 7|Migrated/moved from study area|2|||
129484908|NCT00971321|466067783|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
129484909|NCT00971321|466067784|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
129484910|NCT00971321|466067783|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
129484911|NCT00971321|466067784|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
129484912|NCT00971321|466067783|FG000|Up to Month 11-12|Lost to Follow-up|1|||
129484913|NCT00971321|466067784|FG001|Up to Month 11-12|Lost to Follow-up|0|||
129484914|NCT00519623|466067787|FG000|Overall Study|Adverse Event|1|||
129484915|NCT02296840|466067791|FG000|Overall Study|Adverse Event|1|||
129484916|NCT02296840|466067792|FG001|Overall Study|Adverse Event|1|||
129484917|NCT02296840|466067791|FG000|Overall Study|Protocol Violation|2|||
129484918|NCT02296840|466067792|FG001|Overall Study|Protocol Violation|1|||
129484919|NCT02296840|466067791|FG000|Overall Study|Lost to Follow-up|6|||
129484920|NCT02296840|466067792|FG001|Overall Study|Lost to Follow-up|17|||
129484921|NCT00104871|466067795|FG000|Overall Study|Not evaluable|1|||
129484922|NCT00761215|466067796|FG000|Overall Study|Randomized but didn't receive drug|1|||
129484923|NCT00761215|466067797|FG001|Overall Study|Randomized but didn't receive drug|1|||
129484924|NCT00761215|466067798|FG002|Overall Study|Randomized but didn't receive drug|2|||
129484925|NCT00761215|466067796|FG000|Overall Study|Lost to Follow-up|6|||
129484926|NCT00761215|466067797|FG001|Overall Study|Lost to Follow-up|3|||
129484927|NCT00761215|466067798|FG002|Overall Study|Lost to Follow-up|6|||
129484928|NCT00761215|466067796|FG000|Overall Study|Withdrawal by Subject|1|||
129484929|NCT00761215|466067797|FG001|Overall Study|Withdrawal by Subject|0|||
129484930|NCT00761215|466067798|FG002|Overall Study|Withdrawal by Subject|0|||
129484931|NCT00761215|466067796|FG000|Overall Study|Bacteremia|1|||
129484932|NCT00761215|466067797|FG001|Overall Study|Bacteremia|0|||
129484933|NCT00761215|466067798|FG002|Overall Study|Bacteremia|0|||
129484934|NCT01476787|466067809|FG000|Treatment|Progression|64|||
129484935|NCT01476787|466067810|FG001|Treatment|Progression|71|||
129484936|NCT01476787|466067809|FG000|Treatment|Toxicity|44|||
129484937|NCT01476787|466067810|FG001|Treatment|Toxicity|16|||
129484938|NCT01476787|466067809|FG000|Treatment|Death|0|||
129484939|NCT01476787|466067810|FG001|Treatment|Death|1|||
129484940|NCT01476787|466067809|FG000|Treatment|Withdrawal by Subject|3|||
129484941|NCT01476787|466067810|FG001|Treatment|Withdrawal by Subject|14|||
129484942|NCT01476787|466067809|FG000|Treatment|Major protocol violation|1|||
129484943|NCT01476787|466067810|FG001|Treatment|Major protocol violation|6|||
129484944|NCT01476787|466067809|FG000|Treatment|Other reasons|10|||
129484945|NCT01476787|466067810|FG001|Treatment|Other reasons|22|||
129484946|NCT01476787|466067809|FG000|Treatment|Concurrent illness|12|||
129484947|NCT01476787|466067810|FG001|Treatment|Concurrent illness|9|||
129484948|NCT01476787|466067809|FG000|Treatment|Insufficient response|15|||
129484949|NCT01476787|466067810|FG001|Treatment|Insufficient response|3|||
129484950|NCT01476787|466067809|FG000|Treatment|Voluntary treatment discontinuation|8|||
129484951|NCT01476787|466067810|FG001|Treatment|Voluntary treatment discontinuation|4|||
129484952|NCT01450137|466067811|FG000|Up to Week 12|Adverse Event|2|||
129484953|NCT01450137|466067812|FG001|Up to Week 12|Adverse Event|1|||
129484954|NCT01450137|466067811|FG000|Up to Week 12|Withdrawal by Subject|0|||
129484955|NCT01450137|466067812|FG001|Up to Week 12|Withdrawal by Subject|2|||
129484956|NCT01450137|466067811|FG000|Week 12 to Study End|Death|0|||
129484957|NCT01450137|466067812|FG001|Week 12 to Study End|Death|1|||
129484958|NCT01450137|466067811|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
129484959|NCT01450137|466067812|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
129484960|NCT01687673|466067820|FG000|Overall Study|Physician Decision|1|||
129484961|NCT02234622|466067821|FG000|Overall Study|Withdrawal by Subject|16|||
129484962|NCT02234622|466067822|FG001|Overall Study|Withdrawal by Subject|22|||
129484963|NCT02234622|466067821|FG000|Overall Study|Lost to Follow-up|27|||
129484964|NCT02234622|466067822|FG001|Overall Study|Lost to Follow-up|14|||
129484965|NCT00618956|466067823|FG000|Overall Study|Adverse Event|10|||
129484966|NCT00618956|466067824|FG001|Overall Study|Adverse Event|34|||
129484967|NCT00618956|466067823|FG000|Overall Study|Lack of Efficacy|2|||
129484968|NCT00618956|466067824|FG001|Overall Study|Lack of Efficacy|1|||
129484969|NCT00618956|466067823|FG000|Overall Study|Withdrawal by Subject|5|||
129484970|NCT00618956|466067824|FG001|Overall Study|Withdrawal by Subject|7|||
129484971|NCT00618956|466067823|FG000|Overall Study|Lost to Follow-up|4|||
129484972|NCT00618956|466067824|FG001|Overall Study|Lost to Follow-up|5|||
129484973|NCT00618956|466067823|FG000|Overall Study|Protocol Violation|2|||
129484974|NCT00618956|466067824|FG001|Overall Study|Protocol Violation|2|||
129484975|NCT00618956|466067823|FG000|Overall Study|did not meet criteria, non-compliance|2|||
129484976|NCT00618956|466067824|FG001|Overall Study|did not meet criteria, non-compliance|1|||
129484977|NCT02006576|466067825|FG000|Overall Study|Withdrawal by Subject|4|||
129484978|NCT02006576|466067826|FG001|Overall Study|Withdrawal by Subject|6|||
129484979|NCT02006576|466067827|FG002|Overall Study|Withdrawal by Subject|2|||
129484980|NCT02006576|466067825|FG000|Overall Study|Death|0|||
129484981|NCT02006576|466067826|FG001|Overall Study|Death|0|||
129484982|NCT02006576|466067827|FG002|Overall Study|Death|1|||
129484983|NCT02006576|466067825|FG000|Overall Study|Lost to Follow-up|1|||
129484984|NCT02006576|466067826|FG001|Overall Study|Lost to Follow-up|0|||
129484985|NCT02006576|466067827|FG002|Overall Study|Lost to Follow-up|1|||
129484986|NCT02006576|466067825|FG000|Overall Study|Screen Failure, too sick, other|13|||
129484987|NCT02006576|466067826|FG001|Overall Study|Screen Failure, too sick, other|1|||
129484988|NCT02006576|466067827|FG002|Overall Study|Screen Failure, too sick, other|13|||
129484989|NCT03478683|466067828|FG000|Overall Study|Adverse Event|5|||
129484990|NCT03478683|466067829|FG001|Overall Study|Adverse Event|3|||
129484991|NCT03478683|466067828|FG000|Overall Study|Lost to Follow-up|0|||
129484992|NCT03478683|466067829|FG001|Overall Study|Lost to Follow-up|5|||
129484993|NCT03478683|466067828|FG000|Overall Study|Physician Decision|1|||
129484994|NCT03478683|466067829|FG001|Overall Study|Physician Decision|3|||
129484995|NCT03478683|466067828|FG000|Overall Study|Withdrawal by Subject|7|||
129484996|NCT03478683|466067829|FG001|Overall Study|Withdrawal by Subject|7|||
129484997|NCT04090164|466067832|FG000|Overall Study|incomplete data on file|245|||
129484998|NCT04090164|466067833|FG001|Overall Study|incomplete data on file|0|||
129484999|NCT01650805|466067834|FG000|Overall Study|Withdrawal by Subject|1|||
129485000|NCT01650805|466067835|FG001|Overall Study|Withdrawal by Subject|0|||
129485001|NCT02452359|466067836|FG000|Overall Study|Adverse Event|1|||
129485002|NCT02452359|466067836|FG000|Overall Study|Lost to Follow-up|15|||
129485003|NCT02452359|466067836|FG000|Overall Study|Pregnancy|1|||
129485004|NCT02452359|466067836|FG000|Overall Study|Withdrawal by Subject|4|||
129485005|NCT01887210|466067837|FG000|Overall Study|Withdrawal by Subject|1|||
129485006|NCT01887210|466067838|FG001|Overall Study|Withdrawal by Subject|3|||
129485007|NCT01887210|466067837|FG000|Overall Study|Lost to Follow-up|0|||
129485008|NCT01887210|466067838|FG001|Overall Study|Lost to Follow-up|1|||
129485009|NCT03497689|466067847|FG000|Overall Study|Adverse Event|2|||
129485010|NCT03497689|466067847|FG000|Overall Study|Death|1|||
129485011|NCT03497689|466067847|FG000|Overall Study|Physician Decision|1|||
129485012|NCT03497689|466067847|FG000|Overall Study|Withdrawal by Subject|1|||
129485013|NCT03497689|466067847|FG000|Overall Study|Protocol Violation|2|||
129485014|NCT03191786|466067848|FG000|Overall Study|Death|236|||
129485015|NCT03191786|466067849|FG001|Overall Study|Death|127|||
129485016|NCT03191786|466067848|FG000|Overall Study|Lost to Follow-up|9|||
129485017|NCT03191786|466067849|FG001|Overall Study|Lost to Follow-up|3|||
129485018|NCT03191786|466067848|FG000|Overall Study|Physician Decision|1|||
129485019|NCT03191786|466067849|FG001|Overall Study|Physician Decision|0|||
129485020|NCT03191786|466067848|FG000|Overall Study|Moved to Post Trial Access Program|30|||
129485021|NCT03191786|466067849|FG001|Overall Study|Moved to Post Trial Access Program|5|||
129485022|NCT03191786|466067848|FG000|Overall Study|Withdrawal by Subject|26|||
129485023|NCT03191786|466067849|FG001|Overall Study|Withdrawal by Subject|16|||
129485024|NCT03439345|466070067|FG000|Overall Study|Lost to Follow-up|0|||
129485025|NCT03439345|466070068|FG001|Overall Study|Lost to Follow-up|1|||
129485026|NCT03439345|466070067|FG000|Overall Study|Consent withdrawn|0|||
129485027|NCT03439345|466070068|FG001|Overall Study|Consent withdrawn|1|||
129485028|NCT05635838|466070071|FG000|16-Week DBVC Period|Adverse Event|2|||
129485029|NCT05635838|466070072|FG001|16-Week DBVC Period|Adverse Event|0|||
129485030|NCT05635838|466070073|FG002|16-Week DBVC Period|Adverse Event|0|||
129485031|NCT05635838|466070074|FG003|16-Week DBVC Period|Adverse Event|0|||
129485032|NCT05635838|466070071|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
129485033|NCT05635838|466070072|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
129485034|NCT05635838|466070073|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
129485035|NCT05635838|466070074|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
129485036|NCT05635838|466070071|FG000|16-Week DBVC Period|Physician Decision|0|||
129485037|NCT05635838|466070072|FG001|16-Week DBVC Period|Physician Decision|1|||
129485038|NCT05635838|466070073|FG002|16-Week DBVC Period|Physician Decision|0|||
129485039|NCT05635838|466070074|FG003|16-Week DBVC Period|Physician Decision|0|||
129485040|NCT05635838|466070071|FG000|16-Week DBVC Period|Protocol Violation|1|||
129485041|NCT05635838|466070072|FG001|16-Week DBVC Period|Protocol Violation|0|||
129485042|NCT05635838|466070073|FG002|16-Week DBVC Period|Protocol Violation|0|||
129485043|NCT05635838|466070074|FG003|16-Week DBVC Period|Protocol Violation|0|||
129485044|NCT05635838|466070071|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
129485045|NCT05635838|466070072|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
129485046|NCT05635838|466070073|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
129485047|NCT05635838|466070074|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
129485048|NCT05635838|466070071|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
129485049|NCT05635838|466070072|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
129485050|NCT05635838|466070073|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
129485051|NCT05635838|466070074|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
129485052|NCT05635838|466070071|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
129485053|NCT05635838|466070072|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
129485054|NCT05635838|466070073|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
129485055|NCT05635838|466070074|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
129485056|NCT05635838|466070071|FG000|16-Week OLE Period|Adverse Event|0|||
129485057|NCT05635838|466070072|FG001|16-Week OLE Period|Adverse Event|0|||
129485058|NCT05635838|466070073|FG002|16-Week OLE Period|Adverse Event|0|||
129485059|NCT05635838|466070074|FG003|16-Week OLE Period|Adverse Event|2|||
129485060|NCT05635838|466070071|FG000|16-Week OLE Period|Lost to Follow-up|0|||
129485061|NCT05635838|466070072|FG001|16-Week OLE Period|Lost to Follow-up|0|||
129485062|NCT05635838|466070073|FG002|16-Week OLE Period|Lost to Follow-up|1|||
129485063|NCT05635838|466070074|FG003|16-Week OLE Period|Lost to Follow-up|3|||
129485064|NCT05635838|466070071|FG000|16-Week OLE Period|Physician Decision|0|||
129485065|NCT05635838|466070072|FG001|16-Week OLE Period|Physician Decision|0|||
129485066|NCT05635838|466070073|FG002|16-Week OLE Period|Physician Decision|0|||
129485067|NCT05635838|466070074|FG003|16-Week OLE Period|Physician Decision|1|||
129485068|NCT05635838|466070071|FG000|16-Week OLE Period|Protocol Violation|0|||
129485069|NCT05635838|466070072|FG001|16-Week OLE Period|Protocol Violation|0|||
129485070|NCT05635838|466070073|FG002|16-Week OLE Period|Protocol Violation|1|||
129485071|NCT05635838|466070074|FG003|16-Week OLE Period|Protocol Violation|1|||
129485072|NCT05635838|466070071|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
129485073|NCT05635838|466070072|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
129485074|NCT05635838|466070073|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
129485075|NCT05635838|466070074|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
129485076|NCT05635838|466070071|FG000|16-Week OLE Period|Pregnancy|0|||
129485077|NCT05635838|466070072|FG001|16-Week OLE Period|Pregnancy|0|||
129485078|NCT05635838|466070073|FG002|16-Week OLE Period|Pregnancy|1|||
129485079|NCT05635838|466070074|FG003|16-Week OLE Period|Pregnancy|0|||
129485080|NCT05165394|466070077|FG000|Overall Study|Withdrawal by Subject|5|||
129485081|NCT05165394|466070078|FG001|Overall Study|Withdrawal by Subject|1|||
129485082|NCT05165394|466070077|FG000|Overall Study|Lost to Follow-up|1|||
129485083|NCT05165394|466070078|FG001|Overall Study|Lost to Follow-up|2|||
129485084|NCT05165394|466070077|FG000|Overall Study|Other Than Specified|0|||
129485085|NCT05165394|466070078|FG001|Overall Study|Other Than Specified|1|||
129485086|NCT00875420|466070081|FG000|Overall Study|Adverse Event|0|||
129485087|NCT00875420|466070082|FG001|Overall Study|Adverse Event|1|||
129485088|NCT00875420|466070083|FG002|Overall Study|Adverse Event|1|||
129485089|NCT00875420|466070084|FG003|Overall Study|Adverse Event|0|||
129485090|NCT00875420|466070085|FG004|Overall Study|Adverse Event|0|||
129485091|NCT00875420|466070081|FG000|Overall Study|Inability to complete study procedures|1|||
129485092|NCT00875420|466070082|FG001|Overall Study|Inability to complete study procedures|0|||
129485093|NCT00875420|466070083|FG002|Overall Study|Inability to complete study procedures|1|||
129485094|NCT00875420|466070084|FG003|Overall Study|Inability to complete study procedures|1|||
129485095|NCT00875420|466070085|FG004|Overall Study|Inability to complete study procedures|1|||
129485096|NCT00875420|466070081|FG000|Overall Study|Lost to Follow-up|1|||
129485097|NCT00875420|466070082|FG001|Overall Study|Lost to Follow-up|0|||
129485098|NCT00875420|466070083|FG002|Overall Study|Lost to Follow-up|0|||
129485099|NCT00875420|466070084|FG003|Overall Study|Lost to Follow-up|0|||
129485100|NCT00875420|466070085|FG004|Overall Study|Lost to Follow-up|0|||
129485101|NCT00875420|466070081|FG000|Overall Study|Personal reason|0|||
129485102|NCT00875420|466070082|FG001|Overall Study|Personal reason|0|||
129485103|NCT00875420|466070083|FG002|Overall Study|Personal reason|0|||
129485104|NCT00875420|466070084|FG003|Overall Study|Personal reason|0|||
129485105|NCT00875420|466070085|FG004|Overall Study|Personal reason|1|||
129485106|NCT00875420|466070081|FG000|Overall Study|Prohibited medication|0|||
129485107|NCT00875420|466070082|FG001|Overall Study|Prohibited medication|0|||
129485108|NCT00875420|466070083|FG002|Overall Study|Prohibited medication|0|||
129485109|NCT00875420|466070084|FG003|Overall Study|Prohibited medication|1|||
129485110|NCT00875420|466070085|FG004|Overall Study|Prohibited medication|0|||
129485111|NCT00875420|466070081|FG000|Overall Study|Sponsor decision|0|||
129485112|NCT00875420|466070082|FG001|Overall Study|Sponsor decision|1|||
129485113|NCT00875420|466070083|FG002|Overall Study|Sponsor decision|0|||
129485114|NCT00875420|466070084|FG003|Overall Study|Sponsor decision|0|||
129485115|NCT00875420|466070085|FG004|Overall Study|Sponsor decision|0|||
129485116|NCT00875420|466070081|FG000|Overall Study|Withdrawal by Subject|0|||
129485117|NCT00875420|466070082|FG001|Overall Study|Withdrawal by Subject|0|||
129485118|NCT00875420|466070083|FG002|Overall Study|Withdrawal by Subject|1|||
129485119|NCT00875420|466070084|FG003|Overall Study|Withdrawal by Subject|0|||
129485120|NCT00875420|466070085|FG004|Overall Study|Withdrawal by Subject|0|||
129485121|NCT00001259|466070086|FG000|Study 2|Adverse Event|0|||
129485122|NCT00001259|466070087|FG001|Study 2|Adverse Event|0|||
129485123|NCT00001259|466070088|FG002|Study 2|Adverse Event|0|||
129485124|NCT00001259|466070089|FG003|Study 2|Adverse Event|0|||
129485125|NCT00001259|466070090|FG004|Study 2|Adverse Event|2|||
129485126|NCT00001259|466070091|FG005|Study 2|Adverse Event|0|||
129485127|NCT00001259|466070092|FG006|Study 2|Adverse Event|0|||
129485128|NCT03705494|466070093|FG000|Overall Study|Lost to Follow-up|2|||
129485129|NCT03705494|466070094|FG001|Overall Study|Lost to Follow-up|1|||
129485130|NCT03705494|466070093|FG000|Overall Study|Withdrawal by Subject|5|||
129485131|NCT03705494|466070094|FG001|Overall Study|Withdrawal by Subject|2|||
129485132|NCT02629393|466070100|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
129485133|NCT02629393|466070100|FG000|Overall Study|Physician Decision|1|||
129485134|NCT02517515|466070102|FG000|Overall Study|Adverse Event|0|||
129485135|NCT02517515|466070103|FG001|Overall Study|Adverse Event|1|||
129485136|NCT02517515|466070102|FG000|Overall Study|Withdrew Consent|0|||
129485137|NCT02517515|466070103|FG001|Overall Study|Withdrew Consent|1|||
129485138|NCT02517515|466070102|FG000|Overall Study|Lost to Follow-up|1|||
129485139|NCT02517515|466070103|FG001|Overall Study|Lost to Follow-up|0|||
129485140|NCT02517515|466070102|FG000|Overall Study|Other|1|||
129485141|NCT02517515|466070103|FG001|Overall Study|Other|0|||
129485142|NCT03716726|466070106|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
129485143|NCT03716726|466070107|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
129485144|NCT03716726|466070106|FG000|12 Months Followup|Lost to Follow-up|10|||
129485145|NCT03716726|466070107|FG001|12 Months Followup|Lost to Follow-up|17|||
129485146|NCT02786537|466070110|FG000|As Randomized|Adverse Event|0|||
129485147|NCT02786537|466070111|FG001|As Randomized|Adverse Event|11|||
129485148|NCT02786537|466070112|FG002|As Randomized|Adverse Event|0|||
129485149|NCT02786537|466070113|FG003|As Randomized|Adverse Event|4|||
129485150|NCT02786537|466070114|FG004|As Randomized|Adverse Event|6|||
129485151|NCT02786537|466070115|FG005|As Randomized|Adverse Event|2|||
129485152|NCT02786537|466070110|FG000|As Randomized|Lack of Efficacy|0|||
129485153|NCT02786537|466070111|FG001|As Randomized|Lack of Efficacy|0|||
129485154|NCT02786537|466070112|FG002|As Randomized|Lack of Efficacy|0|||
129485155|NCT02786537|466070113|FG003|As Randomized|Lack of Efficacy|1|||
129485156|NCT02786537|466070114|FG004|As Randomized|Lack of Efficacy|0|||
129485157|NCT02786537|466070115|FG005|As Randomized|Lack of Efficacy|0|||
129485158|NCT02786537|466070110|FG000|As Randomized|Withdrawal by Subject|1|||
129485159|NCT02786537|466070111|FG001|As Randomized|Withdrawal by Subject|2|||
129485160|NCT02786537|466070112|FG002|As Randomized|Withdrawal by Subject|0|||
129485161|NCT02786537|466070113|FG003|As Randomized|Withdrawal by Subject|1|||
129485162|NCT02786537|466070114|FG004|As Randomized|Withdrawal by Subject|1|||
129485163|NCT02786537|466070115|FG005|As Randomized|Withdrawal by Subject|0|||
129485164|NCT02786537|466070110|FG000|As Randomized|Death|0|||
129485165|NCT02786537|466070111|FG001|As Randomized|Death|2|||
129485166|NCT02786537|466070112|FG002|As Randomized|Death|0|||
129485167|NCT02786537|466070113|FG003|As Randomized|Death|3|||
129485168|NCT02786537|466070114|FG004|As Randomized|Death|1|||
129485169|NCT02786537|466070115|FG005|As Randomized|Death|0|||
129485170|NCT02786537|466070110|FG000|As Randomized|Non-compliance with study drug|1|||
129485171|NCT02786537|466070111|FG001|As Randomized|Non-compliance with study drug|11|||
129485172|NCT02786537|466070112|FG002|As Randomized|Non-compliance with study drug|0|||
129485173|NCT02786537|466070113|FG003|As Randomized|Non-compliance with study drug|1|||
129485174|NCT02786537|466070114|FG004|As Randomized|Non-compliance with study drug|0|||
129485175|NCT02786537|466070115|FG005|As Randomized|Non-compliance with study drug|1|||
129485176|NCT02786537|466070110|FG000|As Randomized|Lost to treatment follow-up|4|||
129485177|NCT02786537|466070111|FG001|As Randomized|Lost to treatment follow-up|32|||
129485178|NCT02786537|466070112|FG002|As Randomized|Lost to treatment follow-up|0|||
129485179|NCT02786537|466070113|FG003|As Randomized|Lost to treatment follow-up|24|||
129485180|NCT02786537|466070114|FG004|As Randomized|Lost to treatment follow-up|4|||
129485181|NCT02786537|466070115|FG005|As Randomized|Lost to treatment follow-up|4|||
129485182|NCT02786537|466070110|FG000|As Randomized|Incarceration|0|||
129485183|NCT02786537|466070111|FG001|As Randomized|Incarceration|1|||
129485184|NCT02786537|466070112|FG002|As Randomized|Incarceration|0|||
129485185|NCT02786537|466070113|FG003|As Randomized|Incarceration|0|||
129485186|NCT02786537|466070114|FG004|As Randomized|Incarceration|0|||
129485187|NCT02786537|466070115|FG005|As Randomized|Incarceration|0|||
129485188|NCT02786537|466070110|FG000|As Randomized|Opiate Dependency Relapse|0|||
129485189|NCT02786537|466070111|FG001|As Randomized|Opiate Dependency Relapse|1|||
129485190|NCT02786537|466070112|FG002|As Randomized|Opiate Dependency Relapse|0|||
129485191|NCT02786537|466070113|FG003|As Randomized|Opiate Dependency Relapse|0|||
129485192|NCT02786537|466070114|FG004|As Randomized|Opiate Dependency Relapse|0|||
129485193|NCT02786537|466070115|FG005|As Randomized|Opiate Dependency Relapse|0|||
129485194|NCT02786537|466070110|FG000|As Randomized|HCV drugs stolen from pt|0|||
129485195|NCT02786537|466070111|FG001|As Randomized|HCV drugs stolen from pt|1|||
129485196|NCT02786537|466070112|FG002|As Randomized|HCV drugs stolen from pt|0|||
129485197|NCT02786537|466070113|FG003|As Randomized|HCV drugs stolen from pt|0|||
129485198|NCT02786537|466070114|FG004|As Randomized|HCV drugs stolen from pt|0|||
129485199|NCT02786537|466070115|FG005|As Randomized|HCV drugs stolen from pt|0|||
129485200|NCT02786537|466070110|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
129485201|NCT02786537|466070111|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
129485202|NCT02786537|466070112|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
129485203|NCT02786537|466070113|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
129485204|NCT02786537|466070114|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
129485205|NCT02786537|466070115|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
129485206|NCT02786537|466070110|FG000|As Randomized|Subject lost insurance|0|||
129485207|NCT02786537|466070111|FG001|As Randomized|Subject lost insurance|0|||
129485208|NCT02786537|466070112|FG002|As Randomized|Subject lost insurance|0|||
129485209|NCT02786537|466070113|FG003|As Randomized|Subject lost insurance|1|||
129485210|NCT02786537|466070114|FG004|As Randomized|Subject lost insurance|0|||
129485211|NCT02786537|466070115|FG005|As Randomized|Subject lost insurance|0|||
129485212|NCT02786537|466070110|FG000|As Treated|Adverse Event|0|||
129485213|NCT02786537|466070111|FG001|As Treated|Adverse Event|11|||
129485214|NCT02786537|466070112|FG002|As Treated|Adverse Event|0|||
129485215|NCT02786537|466070113|FG003|As Treated|Adverse Event|4|||
129485216|NCT02786537|466070114|FG004|As Treated|Adverse Event|6|||
129485217|NCT02786537|466070115|FG005|As Treated|Adverse Event|2|||
129485218|NCT02786537|466070110|FG000|As Treated|Death|0|||
129485219|NCT02786537|466070111|FG001|As Treated|Death|2|||
129485220|NCT02786537|466070112|FG002|As Treated|Death|0|||
129485221|NCT02786537|466070113|FG003|As Treated|Death|3|||
129485222|NCT02786537|466070114|FG004|As Treated|Death|1|||
129485223|NCT02786537|466070115|FG005|As Treated|Death|0|||
129485224|NCT02786537|466070110|FG000|As Treated|Lack of Efficacy|0|||
129485225|NCT02786537|466070111|FG001|As Treated|Lack of Efficacy|0|||
129485226|NCT02786537|466070112|FG002|As Treated|Lack of Efficacy|0|||
129485227|NCT02786537|466070113|FG003|As Treated|Lack of Efficacy|1|||
129485228|NCT02786537|466070114|FG004|As Treated|Lack of Efficacy|0|||
129485229|NCT02786537|466070115|FG005|As Treated|Lack of Efficacy|0|||
129485230|NCT02786537|466070110|FG000|As Treated|Lost to Follow-up|4|||
129485231|NCT02786537|466070111|FG001|As Treated|Lost to Follow-up|32|||
129485232|NCT02786537|466070112|FG002|As Treated|Lost to Follow-up|0|||
129485233|NCT02786537|466070113|FG003|As Treated|Lost to Follow-up|25|||
129485234|NCT02786537|466070114|FG004|As Treated|Lost to Follow-up|4|||
129485235|NCT02786537|466070115|FG005|As Treated|Lost to Follow-up|4|||
129485236|NCT02786537|466070110|FG000|As Treated|Non-compliance with study drug|1|||
129485237|NCT02786537|466070111|FG001|As Treated|Non-compliance with study drug|11|||
129485238|NCT02786537|466070112|FG002|As Treated|Non-compliance with study drug|0|||
129485239|NCT02786537|466070113|FG003|As Treated|Non-compliance with study drug|1|||
129485240|NCT02786537|466070114|FG004|As Treated|Non-compliance with study drug|0|||
129485241|NCT02786537|466070115|FG005|As Treated|Non-compliance with study drug|1|||
129485242|NCT02786537|466070110|FG000|As Treated|Lost insurance|0|||
129485243|NCT02786537|466070111|FG001|As Treated|Lost insurance|0|||
129485244|NCT02786537|466070112|FG002|As Treated|Lost insurance|0|||
129485245|NCT02786537|466070113|FG003|As Treated|Lost insurance|1|||
129485246|NCT02786537|466070114|FG004|As Treated|Lost insurance|0|||
129485247|NCT02786537|466070115|FG005|As Treated|Lost insurance|0|||
129485248|NCT02786537|466070110|FG000|As Treated|Withdrawal by Subject|1|||
129485249|NCT02786537|466070111|FG001|As Treated|Withdrawal by Subject|2|||
129485250|NCT02786537|466070112|FG002|As Treated|Withdrawal by Subject|0|||
129485251|NCT02786537|466070113|FG003|As Treated|Withdrawal by Subject|0|||
129485252|NCT02786537|466070114|FG004|As Treated|Withdrawal by Subject|1|||
129485253|NCT02786537|466070115|FG005|As Treated|Withdrawal by Subject|0|||
129485254|NCT02786537|466070110|FG000|As Treated|Incarceration|0|||
129485255|NCT02786537|466070111|FG001|As Treated|Incarceration|1|||
129485256|NCT02786537|466070112|FG002|As Treated|Incarceration|0|||
129485257|NCT02786537|466070113|FG003|As Treated|Incarceration|0|||
129485258|NCT02786537|466070114|FG004|As Treated|Incarceration|0|||
129485259|NCT02786537|466070115|FG005|As Treated|Incarceration|0|||
129485260|NCT02786537|466070110|FG000|As Treated|Opiate dependency relapse|0|||
129485261|NCT02786537|466070111|FG001|As Treated|Opiate dependency relapse|1|||
129485262|NCT02786537|466070112|FG002|As Treated|Opiate dependency relapse|0|||
129485263|NCT02786537|466070113|FG003|As Treated|Opiate dependency relapse|0|||
129485264|NCT02786537|466070114|FG004|As Treated|Opiate dependency relapse|0|||
129485265|NCT02786537|466070115|FG005|As Treated|Opiate dependency relapse|0|||
129485266|NCT02786537|466070110|FG000|As Treated|Drugs stolen from patient|0|||
129485267|NCT02786537|466070111|FG001|As Treated|Drugs stolen from patient|1|||
129485268|NCT02786537|466070112|FG002|As Treated|Drugs stolen from patient|0|||
129485269|NCT02786537|466070113|FG003|As Treated|Drugs stolen from patient|0|||
129485270|NCT02786537|466070114|FG004|As Treated|Drugs stolen from patient|0|||
129485271|NCT02786537|466070115|FG005|As Treated|Drugs stolen from patient|0|||
129485272|NCT02786537|466070110|FG000|As Treated|Advised to stop tx after loss of meds|0|||
129485273|NCT02786537|466070111|FG001|As Treated|Advised to stop tx after loss of meds|1|||
129485274|NCT02786537|466070112|FG002|As Treated|Advised to stop tx after loss of meds|0|||
129485275|NCT02786537|466070113|FG003|As Treated|Advised to stop tx after loss of meds|0|||
129485276|NCT02786537|466070114|FG004|As Treated|Advised to stop tx after loss of meds|0|||
129485277|NCT02786537|466070115|FG005|As Treated|Advised to stop tx after loss of meds|0|||
129485278|NCT01981187|466070116|FG000|Overall Study|Participant/guardian decision|2|||
129485279|NCT01981187|466070116|FG000|Overall Study|Physician Decision|1|||
129485280|NCT01981187|466070116|FG000|Overall Study|Disease progression|2|||
129485281|NCT01981187|466070116|FG000|Overall Study|Adverse Event|7|||
129485282|NCT02638012|466070117|FG000|Overall Study|Lost to Follow-up|1|||
129485283|NCT00443560|466070121|FG000|Overall Study|No intrathecal dose|58|||
129485284|NCT00443560|466070122|FG001|Overall Study|No intrathecal dose|26|||
129485285|NCT00443560|466070121|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
129485286|NCT00443560|466070122|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
129485287|NCT01943539|466070123|FG000|Overall Study|Non-compliance with at-home intervention|4|||
129485288|NCT01943539|466070124|FG001|Overall Study|Non-compliance with at-home intervention|0|||
129485289|NCT03199911|466070125|FG000|Overall Study|Lost to Follow-up|5|||
129485290|NCT03199911|466070126|FG001|Overall Study|Lost to Follow-up|5|||
129485291|NCT03199911|466070125|FG000|Overall Study|Did not proceed with surgery|2|||
129485292|NCT03199911|466070126|FG001|Overall Study|Did not proceed with surgery|1|||
129485293|NCT01009463|466070127|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
129485294|NCT01009463|466070128|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129485295|NCT01009463|466070129|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129485296|NCT01009463|466070130|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129485297|NCT01009463|466070131|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
129485298|NCT01009463|466070127|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
129485299|NCT01009463|466070128|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
129485300|NCT01009463|466070129|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
129485301|NCT01009463|466070130|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
129485302|NCT01009463|466070131|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
129485303|NCT01009463|466070127|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
129485304|NCT01009463|466070128|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129485305|NCT01009463|466070129|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129485306|NCT01009463|466070130|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129485307|NCT01009463|466070131|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
129485308|NCT01009463|466070127|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
129485309|NCT01009463|466070128|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
129485310|NCT01009463|466070129|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
129485311|NCT01009463|466070130|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
129485312|NCT01009463|466070131|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
129485313|NCT01009463|466070127|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
129485314|NCT01009463|466070128|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129485315|NCT01009463|466070129|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129485316|NCT01009463|466070130|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129485317|NCT01009463|466070131|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
129485318|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
129485319|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
129485320|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
129485321|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
129485322|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
129485323|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129485324|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
129485325|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
129485326|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
129485327|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
129485328|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
129485329|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
129485330|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
129485331|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
129485332|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
129485333|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
129485334|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
129485335|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
129485336|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
129485337|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
129485338|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129485339|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
129485340|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
129485341|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
129485342|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
129485343|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129485344|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
129485345|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129485346|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
129485347|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
129485348|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129485349|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
129485350|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
129485351|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
129485352|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
129485353|NCT01009463|466070127|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
129485354|NCT01009463|466070128|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
129485355|NCT01009463|466070129|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
129485356|NCT01009463|466070130|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
129485357|NCT01009463|466070131|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
129485358|NCT02413255|466070132|FG000|Overall Study|Voluntary Withdrawal|0|||
129485359|NCT02413255|466070133|FG001|Overall Study|Voluntary Withdrawal|0|||
129485360|NCT02413255|466070134|FG002|Overall Study|Voluntary Withdrawal|0|||
129485361|NCT02413255|466070135|FG003|Overall Study|Voluntary Withdrawal|0|||
129485362|NCT02413255|466070136|FG004|Overall Study|Voluntary Withdrawal|0|||
129485363|NCT02413255|466070137|FG005|Overall Study|Voluntary Withdrawal|0|||
129485364|NCT02413255|466070138|FG006|Overall Study|Voluntary Withdrawal|0|||
129485365|NCT02413255|466070139|FG007|Overall Study|Voluntary Withdrawal|0|||
129485366|NCT02413255|466070140|FG008|Overall Study|Voluntary Withdrawal|0|||
129485367|NCT02413255|466070141|FG009|Overall Study|Voluntary Withdrawal|0|||
129485368|NCT02413255|466070142|FG010|Overall Study|Voluntary Withdrawal|0|||
129485369|NCT02413255|466070143|FG011|Overall Study|Voluntary Withdrawal|0|||
129485370|NCT02413255|466070144|FG012|Overall Study|Voluntary Withdrawal|0|||
129485371|NCT02413255|466070145|FG013|Overall Study|Voluntary Withdrawal|0|||
129485372|NCT02413255|466070146|FG014|Overall Study|Voluntary Withdrawal|1|||
129485373|NCT02413255|466070147|FG015|Overall Study|Voluntary Withdrawal|0|||
129485374|NCT02413255|466070148|FG016|Overall Study|Voluntary Withdrawal|0|||
129485375|NCT02333331|466070149|FG000|Overall Study|Adverse Event|1|||
129485376|NCT02333331|466070150|FG001|Overall Study|Adverse Event|0|||
129485377|NCT02333331|466070151|FG002|Overall Study|Adverse Event|4|||
129485378|NCT02333331|466070152|FG003|Overall Study|Adverse Event|1|||
129485379|NCT02333331|466070149|FG000|Overall Study|Death|0|||
129485380|NCT02333331|466070150|FG001|Overall Study|Death|0|||
129485381|NCT02333331|466070151|FG002|Overall Study|Death|2|||
129485382|NCT02333331|466070152|FG003|Overall Study|Death|0|||
129485383|NCT02333331|466070149|FG000|Overall Study|Lost to Follow-up|0|||
129485384|NCT02333331|466070150|FG001|Overall Study|Lost to Follow-up|0|||
129485385|NCT02333331|466070151|FG002|Overall Study|Lost to Follow-up|1|||
129485386|NCT02333331|466070152|FG003|Overall Study|Lost to Follow-up|0|||
129485387|NCT02333331|466070149|FG000|Overall Study|Physician Decision|0|||
129485388|NCT02333331|466070150|FG001|Overall Study|Physician Decision|1|||
129485389|NCT02333331|466070151|FG002|Overall Study|Physician Decision|0|||
129485390|NCT02333331|466070152|FG003|Overall Study|Physician Decision|0|||
129485391|NCT02333331|466070149|FG000|Overall Study|Protocol Deviation|0|||
129485392|NCT02333331|466070150|FG001|Overall Study|Protocol Deviation|3|||
129485393|NCT02333331|466070151|FG002|Overall Study|Protocol Deviation|2|||
129485394|NCT02333331|466070152|FG003|Overall Study|Protocol Deviation|1|||
129485395|NCT02333331|466070149|FG000|Overall Study|Patient/Guardian Decision|1|||
129485396|NCT02333331|466070150|FG001|Overall Study|Patient/Guardian Decision|2|||
129485397|NCT02333331|466070151|FG002|Overall Study|Patient/Guardian Decision|9|||
129485398|NCT02333331|466070152|FG003|Overall Study|Patient/Guardian Decision|1|||
129485399|NCT01494038|466070153|FG000|Overall Study|Protocol Violation|1|||
129485400|NCT01494038|466070154|FG001|Overall Study|Protocol Violation|1|||
129485401|NCT01494038|466070153|FG000|Overall Study|Lost to Follow-up|18|||
129485402|NCT01494038|466070154|FG001|Overall Study|Lost to Follow-up|20|||
129485403|NCT01494038|466070153|FG000|Overall Study|Withdrawal by Subject|44|||
129485404|NCT01494038|466070154|FG001|Overall Study|Withdrawal by Subject|34|||
129485405|NCT01494038|466070153|FG000|Overall Study|Not able to get to clinic|21|||
129485406|NCT01494038|466070154|FG001|Overall Study|Not able to get to clinic|15|||
129485407|NCT01494038|466070153|FG000|Overall Study|Not willing to adhere to reqs|2|||
129485408|NCT01494038|466070154|FG001|Overall Study|Not willing to adhere to reqs|9|||
129485409|NCT01494038|466070153|FG000|Overall Study|Death|2|||
129485410|NCT01494038|466070154|FG001|Overall Study|Death|4|||
129485411|NCT05309668|466070156|FG000|Overall Study|Ongoing at data cut-off|14|||
129485412|NCT05309668|466070157|FG001|Overall Study|Ongoing at data cut-off|17|||
129485413|NCT05309668|466070158|FG002|Overall Study|Ongoing at data cut-off|4|||
129485414|NCT02401256|466070161|FG000|Overall Study|Adverse Event|5|||
129485415|NCT02401256|466070161|FG000|Overall Study|Withdrawal by Subject|12|||
129485416|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
129485417|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
129485418|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
129485419|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
129485420|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
129485421|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
129485422|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
129485423|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
129485424|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
129485425|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
129485426|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
129485427|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
129485428|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
129485429|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
129485430|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
129485431|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
129485432|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
129485433|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
129485434|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Death|0|||
129485435|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Death|1|||
129485436|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Death|0|||
129485437|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
129485438|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
129485439|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
129485440|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
129485441|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
129485442|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
129485443|NCT00430781|466070162|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
129485444|NCT00430781|466070163|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
129485445|NCT00430781|466070164|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
129485446|NCT00430781|466070162|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
129485447|NCT00430781|466070163|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
129485448|NCT00430781|466070164|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
129485449|NCT00430781|466070162|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
129485450|NCT00430781|466070163|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
129485451|NCT00430781|466070164|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
129485452|NCT00430781|466070162|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
129485453|NCT00430781|466070163|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
129485454|NCT00430781|466070164|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
129485455|NCT00430781|466070162|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
129485456|NCT00430781|466070163|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
129485457|NCT00430781|466070164|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
129485458|NCT00430781|466070162|FG000|Final Analysis; 31 July 2008|Other|0|||
129485459|NCT00430781|466070163|FG001|Final Analysis; 31 July 2008|Other|1|||
129485460|NCT00430781|466070164|FG002|Final Analysis; 31 July 2008|Other|0|||
129485461|NCT00430781|466070162|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
129485462|NCT00430781|466070163|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
129485463|NCT00430781|466070164|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
129485464|NCT00430781|466070162|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
129485465|NCT00430781|466070163|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
129485466|NCT00430781|466070164|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
129485467|NCT00430781|466070162|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
129485468|NCT00430781|466070163|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
129485469|NCT00430781|466070164|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
129485470|NCT00430781|466070162|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
129485471|NCT00430781|466070163|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
129485472|NCT00430781|466070164|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
129485473|NCT00430781|466070162|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
129485474|NCT00430781|466070163|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
129485475|NCT00430781|466070164|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
129485476|NCT00430781|466070162|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
129485477|NCT00430781|466070163|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
129485478|NCT00430781|466070164|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
129485479|NCT00430781|466070162|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
129485480|NCT00430781|466070163|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
129485481|NCT00430781|466070164|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
129485482|NCT04329949|466070168|FG000|Overall Study|Death|36|||
129485483|NCT04329949|466070168|FG000|Overall Study|Withdrawal by Subject|4|||
129485484|NCT04329949|466070168|FG000|Overall Study|Termination of study by sponsor|3|||
129485485|NCT00345605|466070171|FG000|Arm 1|Adverse Event|0|||
129485486|NCT00345605|466070172|FG001|Arm 1|Adverse Event|1|||
129485487|NCT00345605|466070171|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
129485488|NCT00345605|466070172|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
129485489|NCT01059812|466070173|FG000|Overall Study|Adverse Event|9|||
129485490|NCT01059812|466070174|FG001|Overall Study|Adverse Event|5|||
129485491|NCT01059812|466070173|FG000|Overall Study|Lack of Efficacy|2|||
129485492|NCT01059812|466070174|FG001|Overall Study|Lack of Efficacy|2|||
129485493|NCT01059812|466070173|FG000|Overall Study|Protocol Violation|3|||
129485494|NCT01059812|466070174|FG001|Overall Study|Protocol Violation|1|||
129485495|NCT01059812|466070173|FG000|Overall Study|Withdrawal Criteria|9|||
129485496|NCT01059812|466070174|FG001|Overall Study|Withdrawal Criteria|4|||
129485497|NCT01059812|466070173|FG000|Overall Study|Unclassified|14|||
129485498|NCT01059812|466070174|FG001|Overall Study|Unclassified|4|||
129485499|NCT03180736|466070175|FG000|Overall Study|Adverse Event|3|||
129485500|NCT03180736|466070176|FG001|Overall Study|Adverse Event|4|||
129485501|NCT03180736|466070175|FG000|Overall Study|Death|10|||
129485502|NCT03180736|466070176|FG001|Overall Study|Death|7|||
129485503|NCT03180736|466070175|FG000|Overall Study|Withdrawal by Subject|5|||
129485504|NCT03180736|466070176|FG001|Overall Study|Withdrawal by Subject|12|||
129485505|NCT03180736|466070175|FG000|Overall Study|Lost to Follow-up|1|||
129485506|NCT03180736|466070176|FG001|Overall Study|Lost to Follow-up|0|||
129485507|NCT03180736|466070175|FG000|Overall Study|Lack of Efficacy|66|||
129485508|NCT03180736|466070176|FG001|Overall Study|Lack of Efficacy|87|||
129485509|NCT03180736|466070175|FG000|Overall Study|Physician Decision|4|||
129485510|NCT03180736|466070176|FG001|Overall Study|Physician Decision|7|||
129485511|NCT03180736|466070175|FG000|Overall Study|randomized but not treated|2|||
129485512|NCT03180736|466070176|FG001|Overall Study|randomized but not treated|3|||
129485513|NCT01451515|466070179|FG000|Overall Study|Death|0|||
129485514|NCT01451515|466070180|FG001|Overall Study|Death|1|||
129485515|NCT01451515|466070181|FG002|Overall Study|Death|0|||
129485516|NCT01451515|466070179|FG000|Overall Study|Withdrawal by Subject|0|||
129485517|NCT01451515|466070180|FG001|Overall Study|Withdrawal by Subject|1|||
129485518|NCT01451515|466070181|FG002|Overall Study|Withdrawal by Subject|0|||
129485519|NCT01451515|466070179|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
129485520|NCT01451515|466070180|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
129485521|NCT01451515|466070181|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
129485522|NCT01451515|466070179|FG000|Overall Study|Relapse (except CNS)|1|||
129485523|NCT01451515|466070180|FG001|Overall Study|Relapse (except CNS)|1|||
129485524|NCT01451515|466070181|FG002|Overall Study|Relapse (except CNS)|0|||
129485525|NCT01458340|466070184|FG000|Overall Study|Adverse Event|5|||
129485526|NCT01458340|466070185|FG001|Overall Study|Adverse Event|4|||
129485527|NCT01458340|466070186|FG002|Overall Study|Adverse Event|2|||
129485528|NCT01458340|466070184|FG000|Overall Study|Lost to Follow-up|3|||
129485529|NCT01458340|466070185|FG001|Overall Study|Lost to Follow-up|3|||
129485530|NCT01458340|466070186|FG002|Overall Study|Lost to Follow-up|10|||
129485531|NCT01458340|466070184|FG000|Overall Study|Miscellaneous|0|||
129485532|NCT01458340|466070185|FG001|Overall Study|Miscellaneous|1|||
129485533|NCT01458340|466070186|FG002|Overall Study|Miscellaneous|0|||
129485534|NCT01458340|466070184|FG000|Overall Study|Physician Decision|1|||
129485535|NCT01458340|466070185|FG001|Overall Study|Physician Decision|1|||
129485536|NCT01458340|466070186|FG002|Overall Study|Physician Decision|2|||
129485537|NCT01458340|466070184|FG000|Overall Study|Protocol Violation|6|||
129485538|NCT01458340|466070185|FG001|Overall Study|Protocol Violation|6|||
129485539|NCT01458340|466070186|FG002|Overall Study|Protocol Violation|5|||
129485540|NCT01458340|466070184|FG000|Overall Study|Withdrawal by Subject|12|||
129485541|NCT01458340|466070185|FG001|Overall Study|Withdrawal by Subject|6|||
129485542|NCT01458340|466070186|FG002|Overall Study|Withdrawal by Subject|4|||
129485543|NCT00091793|466070187|FG000|Overall Study|Adverse Event|1|||
129485544|NCT00091793|466070188|FG001|Overall Study|Adverse Event|2|||
129485545|NCT00091793|466070187|FG000|Overall Study|Withdrawal by Subject|10|||
129485546|NCT00091793|466070188|FG001|Overall Study|Withdrawal by Subject|15|||
129485547|NCT00091793|466070187|FG000|Overall Study|Ineligibility determined|2|||
129485548|NCT00091793|466070188|FG001|Overall Study|Ineligibility determined|0|||
129485549|NCT00091793|466070187|FG000|Overall Study|Lost to Follow-up|7|||
129485550|NCT00091793|466070188|FG001|Overall Study|Lost to Follow-up|5|||
129485551|NCT00091793|466070187|FG000|Overall Study|Noncompliance|2|||
129485552|NCT00091793|466070188|FG001|Overall Study|Noncompliance|0|||
129485553|NCT00091793|466070187|FG000|Overall Study|Other|2|||
129485554|NCT00091793|466070188|FG001|Overall Study|Other|0|||
129485555|NCT05309083|466070189|FG000|Overall Study|Withdrawal by Subject|2|||
129485556|NCT01165229|466070190|FG000|Overall Study|Serious Adverse Event|456|||
129485557|NCT01165229|466070191|FG001|Overall Study|Serious Adverse Event|487|||
129485558|NCT01165229|466070190|FG000|Overall Study|Non-Serious Adverse Event|47|||
129485559|NCT01165229|466070191|FG001|Overall Study|Non-Serious Adverse Event|15|||
129485560|NCT01165229|466070190|FG000|Overall Study|Protocol Violation|6|||
129485561|NCT01165229|466070191|FG001|Overall Study|Protocol Violation|8|||
129485562|NCT01165229|466070190|FG000|Overall Study|Withdrawal by Subject|387|||
129485563|NCT01165229|466070191|FG001|Overall Study|Withdrawal by Subject|396|||
129485564|NCT01165229|466070190|FG000|Overall Study|Migrated/moved from study area|51|||
129485565|NCT01165229|466070191|FG001|Overall Study|Migrated/moved from study area|46|||
129485566|NCT01165229|466070190|FG000|Overall Study|Lost to Follow-up|123|||
129485567|NCT01165229|466070191|FG001|Overall Study|Lost to Follow-up|133|||
129485568|NCT01165229|466070190|FG000|Overall Study|Suspected HZ Episode|2|||
129485569|NCT01165229|466070191|FG001|Overall Study|Suspected HZ Episode|2|||
129485570|NCT01165229|466070190|FG000|Overall Study|No reason from the subject|108|||
129485571|NCT01165229|466070191|FG001|Overall Study|No reason from the subject|102|||
129485572|NCT01165229|466070190|FG000|Overall Study|Unknown completion status|0|||
129485573|NCT01165229|466070191|FG001|Overall Study|Unknown completion status|1|||
129485574|NCT00881205|466070195|FG000|Overall Study|Adverse Event|8|||
129485575|NCT00881205|466070196|FG001|Overall Study|Adverse Event|3|||
129485576|NCT00881205|466070195|FG000|Overall Study|Withdrawal by Subject|1|||
129485577|NCT00881205|466070196|FG001|Overall Study|Withdrawal by Subject|2|||
129485578|NCT00881205|466070195|FG000|Overall Study|Lost to Follow-up|0|||
129485579|NCT00881205|466070196|FG001|Overall Study|Lost to Follow-up|1|||
129485580|NCT00881205|466070195|FG000|Overall Study|Administrative problems|1|||
129485581|NCT00881205|466070196|FG001|Overall Study|Administrative problems|1|||
129485582|NCT00881205|466070195|FG000|Overall Study|Condition no longer requires drug|1|||
129485583|NCT00881205|466070196|FG001|Overall Study|Condition no longer requires drug|0|||
129485584|NCT04786210|466070197|FG000|Overall Study|Lost to Follow-up|2|||
129485585|NCT04786210|466070197|FG000|Overall Study|Withdrawal by Subject|4|||
129485586|NCT00849212|466070198|FG000|Overall Study|Lack of Efficacy|1|||
129485587|NCT00849212|466070198|FG000|Overall Study|Withdrawal by Subject|3|||
129485588|NCT00849212|466070198|FG000|Overall Study|Adverse Event|2|||
129485589|NCT00849212|466070198|FG000|Overall Study|Miscellaneous|1|||
129485590|NCT00845429|466070206|FG000|Overall Study|Protocol Violation|5|||
129485591|NCT00845429|466070207|FG001|Overall Study|Protocol Violation|4|||
129485592|NCT00845429|466070208|FG002|Overall Study|Protocol Violation|7|||
129485593|NCT00845429|466070206|FG000|Overall Study|Lost to Follow-up|7|||
129485594|NCT00845429|466070207|FG001|Overall Study|Lost to Follow-up|9|||
129485595|NCT00845429|466070208|FG002|Overall Study|Lost to Follow-up|10|||
129485596|NCT00845429|466070206|FG000|Overall Study|Withdrawal by Subject|2|||
129979543|NCT02344290|467887523|FG001|Overall Study|Other|3|||
129485597|NCT00845429|466070207|FG001|Overall Study|Withdrawal by Subject|2|||
129485598|NCT00845429|466070208|FG002|Overall Study|Withdrawal by Subject|2|||
129485599|NCT00845429|466070206|FG000|Overall Study|Serious adverse event|0|||
129485600|NCT00845429|466070207|FG001|Overall Study|Serious adverse event|0|||
129485601|NCT00845429|466070208|FG002|Overall Study|Serious adverse event|1|||
129485602|NCT00587223|466070212|FG000|Overall Study|Adverse Event|1|||
129485603|NCT02111369|466070213|FG000|Overall Study|Lost to Follow-up|2|||
129485604|NCT02111369|466070213|FG000|Overall Study|Withdrawal by Subject|1|||
129485605|NCT03240081|466070217|FG000|Overall Study|Withdrawal by Subject|0|||
129485606|NCT03240081|466070218|FG001|Overall Study|Withdrawal by Subject|2|||
129485607|NCT03240081|466070217|FG000|Overall Study|Lost to Follow-up|0|||
129485608|NCT03240081|466070218|FG001|Overall Study|Lost to Follow-up|1|||
129485609|NCT00883753|466070219|FG000|Overall Study|Adverse Event|37|||
129485610|NCT00883753|466070219|FG000|Overall Study|Death|2|||
129485611|NCT00883753|466070219|FG000|Overall Study|Insufficient therapeutic response|16|||
129485612|NCT00883753|466070219|FG000|Overall Study|Lost to Follow-up|4|||
129485613|NCT00883753|466070219|FG000|Overall Study|Violation of selection criteria at entry|7|||
129485614|NCT00883753|466070219|FG000|Overall Study|Protocol Violation|2|||
129485615|NCT00883753|466070219|FG000|Overall Study|Refused treatment|4|||
129485616|NCT00883753|466070219|FG000|Overall Study|Withdrew consent|10|||
129485617|NCT00883753|466070219|FG000|Overall Study|Investigator's decision|17|||
129485618|NCT00883753|466070219|FG000|Overall Study|Administrative/Other|8|||
129485619|NCT01480180|466070220|FG000|Main Phase|Withdrawal criteria|12|||
129485620|NCT01480180|466070221|FG001|Main Phase|Withdrawal criteria|1|||
129485621|NCT01480180|466070222|FG002|Main Phase|Withdrawal criteria|0|||
129485622|NCT01480180|466070223|FG003|Main Phase|Withdrawal criteria|0|||
129485623|NCT01480180|466070224|FG004|Main Phase|Withdrawal criteria|0|||
129485624|NCT01480180|466070225|FG005|Main Phase|Withdrawal criteria|0|||
129485625|NCT01480180|466070220|FG000|Main Phase|Lack of Efficacy|1|||
129485626|NCT01480180|466070221|FG001|Main Phase|Lack of Efficacy|0|||
129485627|NCT01480180|466070222|FG002|Main Phase|Lack of Efficacy|0|||
129485628|NCT01480180|466070223|FG003|Main Phase|Lack of Efficacy|0|||
129485629|NCT01480180|466070224|FG004|Main Phase|Lack of Efficacy|0|||
129485630|NCT01480180|466070225|FG005|Main Phase|Lack of Efficacy|0|||
129485631|NCT01480180|466070220|FG000|Main Phase|Non-compliance|3|||
129485632|NCT01480180|466070221|FG001|Main Phase|Non-compliance|0|||
129485633|NCT01480180|466070222|FG002|Main Phase|Non-compliance|0|||
129485634|NCT01480180|466070223|FG003|Main Phase|Non-compliance|0|||
129485635|NCT01480180|466070224|FG004|Main Phase|Non-compliance|0|||
129485636|NCT01480180|466070225|FG005|Main Phase|Non-compliance|0|||
129485637|NCT01480180|466070220|FG000|Main Phase|Unclassified|3|||
129485638|NCT01480180|466070221|FG001|Main Phase|Unclassified|0|||
129485639|NCT01480180|466070222|FG002|Main Phase|Unclassified|0|||
129485640|NCT01480180|466070223|FG003|Main Phase|Unclassified|0|||
129485641|NCT01480180|466070224|FG004|Main Phase|Unclassified|0|||
129485642|NCT01480180|466070225|FG005|Main Phase|Unclassified|0|||
129485643|NCT01480180|466070220|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
129485644|NCT01480180|466070221|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
129485645|NCT01480180|466070222|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
129485646|NCT01480180|466070223|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
129485647|NCT01480180|466070224|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
129485648|NCT01480180|466070225|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
129485649|NCT01480180|466070220|FG000|Extension Phase, Part 1|Unclassified|0|||
129485650|NCT01480180|466070221|FG001|Extension Phase, Part 1|Unclassified|0|||
129485651|NCT01480180|466070222|FG002|Extension Phase, Part 1|Unclassified|1|||
129485652|NCT01480180|466070223|FG003|Extension Phase, Part 1|Unclassified|0|||
129485653|NCT01480180|466070224|FG004|Extension Phase, Part 1|Unclassified|0|||
129485654|NCT01480180|466070225|FG005|Extension Phase, Part 1|Unclassified|0|||
129485655|NCT01480180|466070220|FG000|Extension Phase, Part 1|Adverse Event|0|||
129485656|NCT01480180|466070221|FG001|Extension Phase, Part 1|Adverse Event|0|||
129485657|NCT01480180|466070222|FG002|Extension Phase, Part 1|Adverse Event|4|||
129485658|NCT01480180|466070223|FG003|Extension Phase, Part 1|Adverse Event|1|||
129485659|NCT01480180|466070224|FG004|Extension Phase, Part 1|Adverse Event|0|||
129485660|NCT01480180|466070225|FG005|Extension Phase, Part 1|Adverse Event|0|||
129485661|NCT01480180|466070220|FG000|Extension Phase, Part 1|Change of treatment|0|||
129485662|NCT01480180|466070221|FG001|Extension Phase, Part 1|Change of treatment|0|||
129485663|NCT01480180|466070222|FG002|Extension Phase, Part 1|Change of treatment|0|||
129485664|NCT01480180|466070223|FG003|Extension Phase, Part 1|Change of treatment|9|||
129485665|NCT01480180|466070224|FG004|Extension Phase, Part 1|Change of treatment|0|||
129485666|NCT01480180|466070225|FG005|Extension Phase, Part 1|Change of treatment|0|||
129485667|NCT01480180|466070220|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
129485668|NCT01480180|466070221|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
129485669|NCT01480180|466070222|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
129485670|NCT01480180|466070223|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
129485671|NCT01480180|466070224|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
129485672|NCT01480180|466070225|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
129485673|NCT01480180|466070220|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
129485674|NCT01480180|466070221|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
129485675|NCT01480180|466070222|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
129485676|NCT01480180|466070223|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
129485677|NCT01480180|466070224|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
129485678|NCT01480180|466070225|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
129485679|NCT01480180|466070220|FG000|Extension Phase, Part 2|Unclassified|0|||
129485680|NCT01480180|466070221|FG001|Extension Phase, Part 2|Unclassified|0|||
129485681|NCT01480180|466070222|FG002|Extension Phase, Part 2|Unclassified|3|||
129485682|NCT01480180|466070223|FG003|Extension Phase, Part 2|Unclassified|1|||
129485683|NCT01480180|466070224|FG004|Extension Phase, Part 2|Unclassified|1|||
129485684|NCT01480180|466070225|FG005|Extension Phase, Part 2|Unclassified|0|||
129485685|NCT01926886|466070230|FG000|Overall Study|Administrative/other|1|||
129485686|NCT01926886|466070231|FG001|Overall Study|Administrative/other|0|||
129485687|NCT01926886|466070230|FG000|Overall Study|Adverse event/intercurrent illness|4|||
129485688|NCT01926886|466070231|FG001|Overall Study|Adverse event/intercurrent illness|0|||
129485689|NCT01926886|466070230|FG000|Overall Study|Disease progression/recurrence|4|||
129485690|NCT01926886|466070231|FG001|Overall Study|Disease progression/recurrence|0|||
129485691|NCT01926886|466070230|FG000|Overall Study|Withdrawal by Subject|15|||
129485692|NCT01926886|466070231|FG001|Overall Study|Withdrawal by Subject|0|||
129485693|NCT01926886|466070230|FG000|Overall Study|Failure to return|3|||
129485694|NCT01926886|466070231|FG001|Overall Study|Failure to return|0|||
129485695|NCT01926886|466070230|FG000|Overall Study|Recurrence of disease|1|||
129485696|NCT01926886|466070231|FG001|Overall Study|Recurrence of disease|0|||
129485697|NCT01926886|466070230|FG000|Overall Study|Progression of disease|2|||
129485698|NCT01926886|466070231|FG001|Overall Study|Progression of disease|0|||
129485699|NCT01926886|466070230|FG000|Overall Study|Death|1|||
129485700|NCT01926886|466070231|FG001|Overall Study|Death|0|||
129485701|NCT01926886|466070230|FG000|Overall Study|Did not cooperate|1|||
129485702|NCT01926886|466070231|FG001|Overall Study|Did not cooperate|0|||
129485703|NCT01450540|466070232|FG000|Overall Study|Withdrawal by Subject|19|||
129485704|NCT01450540|466070233|FG001|Overall Study|Withdrawal by Subject|13|||
129485705|NCT01450540|466070232|FG000|Overall Study|protocol deviation|3|||
129485706|NCT01450540|466070233|FG001|Overall Study|protocol deviation|23|||
129485707|NCT01662999|466070242|FG000|Period 3|Withdrawal by Subject|0|||
129485708|NCT01662999|466070243|FG001|Period 3|Withdrawal by Subject|1|||
129485709|NCT01662999|466070244|FG002|Period 3|Withdrawal by Subject|0|||
129485710|NCT01662999|466070245|FG003|Period 3|Withdrawal by Subject|0|||
129485711|NCT01662999|466070246|FG004|Period 3|Withdrawal by Subject|0|||
129485712|NCT01662999|466070247|FG005|Period 3|Withdrawal by Subject|0|||
129485713|NCT02932267|466070248|FG000|Overall Study|Withdrawal by Subject|3|||
129485714|NCT02932267|466070248|FG000|Overall Study|Lost to Follow-up|4|||
129485715|NCT02932267|466070248|FG000|Overall Study|Pregnancy|1|||
129485716|NCT01919411|466070249|FG000|Overall Study|Lost to Follow-up|2|||
129485717|NCT01919411|466070250|FG001|Overall Study|Lost to Follow-up|4|||
129485718|NCT01919411|466070249|FG000|Overall Study|Physician Decision|1|||
129485719|NCT01919411|466070250|FG001|Overall Study|Physician Decision|0|||
129485720|NCT01919411|466070249|FG000|Overall Study|Protocol Violation|2|||
129485721|NCT01919411|466070250|FG001|Overall Study|Protocol Violation|1|||
129485722|NCT00524303|466070251|FG000|Overall Study|Lost to Follow-up|6|||
129485723|NCT00524303|466070252|FG001|Overall Study|Lost to Follow-up|0|||
129485724|NCT00524303|466070253|FG002|Overall Study|Lost to Follow-up|3|||
129485725|NCT00524303|466070251|FG000|Overall Study|Protocol Violation|0|||
129485726|NCT00524303|466070252|FG001|Overall Study|Protocol Violation|1|||
129485727|NCT00524303|466070253|FG002|Overall Study|Protocol Violation|1|||
129485728|NCT00524303|466070251|FG000|Overall Study|Withdrawal by Subject|3|||
129485729|NCT00524303|466070252|FG001|Overall Study|Withdrawal by Subject|0|||
129485730|NCT00524303|466070253|FG002|Overall Study|Withdrawal by Subject|4|||
129485731|NCT00524303|466070251|FG000|Overall Study|Death|0|||
129485732|NCT00524303|466070252|FG001|Overall Study|Death|2|||
129485733|NCT00524303|466070253|FG002|Overall Study|Death|3|||
129485734|NCT00524303|466070251|FG000|Overall Study|Adverse Event|1|||
129485735|NCT00524303|466070252|FG001|Overall Study|Adverse Event|2|||
129485736|NCT00524303|466070253|FG002|Overall Study|Adverse Event|3|||
129485737|NCT00524303|466070251|FG000|Overall Study|Did not Complete Study Dosing|1|||
129485738|NCT00524303|466070252|FG001|Overall Study|Did not Complete Study Dosing|0|||
129485739|NCT00524303|466070253|FG002|Overall Study|Did not Complete Study Dosing|0|||
129485740|NCT00524303|466070251|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
129485741|NCT00524303|466070252|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
129485742|NCT00524303|466070253|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
129485743|NCT00524303|466070251|FG000|Overall Study|Disease Progression|0|||
129485744|NCT00524303|466070252|FG001|Overall Study|Disease Progression|4|||
129485745|NCT00524303|466070253|FG002|Overall Study|Disease Progression|1|||
129485746|NCT00524303|466070251|FG000|Overall Study|Disease Recurrence|0|||
129485747|NCT00524303|466070252|FG001|Overall Study|Disease Recurrence|1|||
129485748|NCT00524303|466070253|FG002|Overall Study|Disease Recurrence|0|||
129485749|NCT00524303|466070251|FG000|Overall Study|Sponsor Request|0|||
129485750|NCT00524303|466070252|FG001|Overall Study|Sponsor Request|0|||
129485751|NCT00524303|466070253|FG002|Overall Study|Sponsor Request|1|||
129485752|NCT00524303|466070251|FG000|Overall Study|Physician Decision|0|||
129485753|NCT00524303|466070252|FG001|Overall Study|Physician Decision|0|||
129485754|NCT00524303|466070253|FG002|Overall Study|Physician Decision|1|||
129485755|NCT00524303|466070251|FG000|Overall Study|Completed 5 years|0|||
129485756|NCT00524303|466070252|FG001|Overall Study|Completed 5 years|0|||
129485757|NCT00524303|466070253|FG002|Overall Study|Completed 5 years|1|||
129485758|NCT03750838|466070254|FG000|Overall Study|Lost to Follow-up|10|||
129485759|NCT03750838|466070255|FG001|Overall Study|Lost to Follow-up|6|||
129485760|NCT00630032|466070257|FG000|Overall Study|Death|55|||
129485761|NCT00630032|466070258|FG001|Overall Study|Death|49|||
129485762|NCT00630032|466070257|FG000|Overall Study|Withdrawal by Subject|3|||
129485763|NCT00630032|466070258|FG001|Overall Study|Withdrawal by Subject|2|||
129485764|NCT00630032|466070257|FG000|Overall Study|Lost to Follow-up|18|||
129485765|NCT00630032|466070258|FG001|Overall Study|Lost to Follow-up|31|||
129485766|NCT00630032|466070257|FG000|Overall Study|Protocol Violation|1|||
129485767|NCT00630032|466070258|FG001|Overall Study|Protocol Violation|0|||
129485768|NCT00630032|466070257|FG000|Overall Study|Patient has moved|1|||
129485769|NCT00630032|466070258|FG001|Overall Study|Patient has moved|1|||
129485770|NCT00630032|466070257|FG000|Overall Study|Disease progression|1|||
129485771|NCT00630032|466070258|FG001|Overall Study|Disease progression|1|||
129485772|NCT00630032|466070257|FG000|Overall Study|End of monitoring in US centers|11|||
129485773|NCT00630032|466070258|FG001|Overall Study|End of monitoring in US centers|11|||
129485774|NCT02413398|466071757|FG000|Overall Study|Lost to Follow-up|2|||
129485775|NCT02413398|466071758|FG001|Overall Study|Lost to Follow-up|4|||
129485776|NCT02413398|466071757|FG000|Overall Study|Withdrawal by Subject|1|||
129485777|NCT02413398|466071758|FG001|Overall Study|Withdrawal by Subject|1|||
129485778|NCT02413398|466071757|FG000|Overall Study|Other Eligibility criteria|1|||
129485779|NCT02413398|466071758|FG001|Overall Study|Other Eligibility criteria|2|||
129485780|NCT02874794|466071759|FG000|Overall Study|Physician Decision|3|||
129485781|NCT02874794|466071760|FG001|Overall Study|Physician Decision|2|||
129485782|NCT02874794|466071759|FG000|Overall Study|Withdrawal by Subject|2|||
129485783|NCT02874794|466071760|FG001|Overall Study|Withdrawal by Subject|8|||
129485784|NCT02874794|466071759|FG000|Overall Study|Death|2|||
129485785|NCT02874794|466071760|FG001|Overall Study|Death|1|||
129485786|NCT00537940|466071761|FG000|Overall Study|Adverse Event|20|||
129485787|NCT00537940|466071762|FG001|Overall Study|Adverse Event|19|||
129485788|NCT00537940|466071761|FG000|Overall Study|Lack of Efficacy|8|||
129485789|NCT00537940|466071762|FG001|Overall Study|Lack of Efficacy|16|||
129485790|NCT00537940|466071761|FG000|Overall Study|Lost to Follow-up|23|||
129485791|NCT00537940|466071762|FG001|Overall Study|Lost to Follow-up|29|||
129485792|NCT00537940|466071761|FG000|Overall Study|Withdrawal by Subject|113|||
129485793|NCT00537940|466071762|FG001|Overall Study|Withdrawal by Subject|95|||
129485794|NCT00537940|466071761|FG000|Overall Study|Protocol Violation|6|||
129485795|NCT00537940|466071762|FG001|Overall Study|Protocol Violation|4|||
129485796|NCT00537940|466071761|FG000|Overall Study|Pregnancy|1|||
129485797|NCT00537940|466071762|FG001|Overall Study|Pregnancy|1|||
129485798|NCT00537940|466071761|FG000|Overall Study|Study terminated by sponsor|2|||
129485799|NCT00537940|466071762|FG001|Overall Study|Study terminated by sponsor|3|||
129485800|NCT00537940|466071761|FG000|Overall Study|Other|10|||
129485801|NCT00537940|466071762|FG001|Overall Study|Other|12|||
129485802|NCT01389128|466071765|FG000|Overall Study|Fetal distress|1|||
129485803|NCT01389128|466071766|FG001|Overall Study|Fetal distress|0|||
129485804|NCT01389128|466071765|FG000|Overall Study|Cervix dilation stop|1|||
129485805|NCT01389128|466071766|FG001|Overall Study|Cervix dilation stop|2|||
129485806|NCT01389128|466071765|FG000|Overall Study|Rapid labor evolution|3|||
129485807|NCT01389128|466071766|FG001|Overall Study|Rapid labor evolution|2|||
129485808|NCT01389128|466071765|FG000|Overall Study|Intolerance to procedure|0|||
129485809|NCT01389128|466071766|FG001|Overall Study|Intolerance to procedure|2|||
129485810|NCT03056287|466071767|FG000|Overall Study|Withdrawal by Subject|0|||
129485811|NCT03056287|466071768|FG001|Overall Study|Withdrawal by Subject|1|||
129485812|NCT03056287|466071769|FG002|Overall Study|Withdrawal by Subject|0|||
129485813|NCT03056287|466071770|FG003|Overall Study|Withdrawal by Subject|0|||
129485814|NCT03056287|466071767|FG000|Overall Study|move out of area|0|||
129485815|NCT03056287|466071768|FG001|Overall Study|move out of area|0|||
129485816|NCT03056287|466071769|FG002|Overall Study|move out of area|1|||
129485817|NCT03056287|466071770|FG003|Overall Study|move out of area|1|||
129485818|NCT00947154|466071774|FG000|Overall Study|Lost to Follow-up|1|||
129485819|NCT02286960|466071784|FG000|Overall Study|Lost to Follow-up|3|||
129485820|NCT02286960|466071785|FG001|Overall Study|Lost to Follow-up|3|||
129485821|NCT00440401|466071786|FG000|Overall Study|Adverse Event|2|||
129485822|NCT00440401|466071787|FG001|Overall Study|Adverse Event|1|||
129485823|NCT00440401|466071786|FG000|Overall Study|Other|2|||
129485824|NCT00440401|466071787|FG001|Overall Study|Other|5|||
129485825|NCT00550238|466071789|FG000|Overall Study|Adverse Event|88|||
129485826|NCT00550238|466071789|FG000|Overall Study|Death|34|||
129485827|NCT00550238|466071789|FG000|Overall Study|Disease progression|46|||
129485828|NCT00550238|466071789|FG000|Overall Study|Withdrawal by Subject|167|||
129485829|NCT00550238|466071789|FG000|Overall Study|Physician Decision|31|||
129485830|NCT00550238|466071789|FG000|Overall Study|Patient noncompliance|25|||
129485831|NCT00550238|466071789|FG000|Overall Study|Lost to Follow-up|13|||
129485832|NCT00550238|466071789|FG000|Overall Study|Sponsor decision|55|||
129485833|NCT00779038|466071790|FG000|Overall Study|Study Prematurely Terminated|13|||
129485834|NCT00537745|466071791|FG000|Overall Study|Did not meet eligibility criteria|2|||
129485835|NCT00537745|466071791|FG000|Overall Study|Withdrawal by Subject|2|||
129485836|NCT00537745|466071791|FG000|Overall Study|Subject unable to provide Interlock info|1|||
129485837|NCT05370157|466071792|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
129485838|NCT05370157|466071793|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
129485839|NCT05370157|466071792|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
129485840|NCT05370157|466071793|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
129485841|NCT03700892|466071794|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
129485842|NCT03700892|466071795|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
129979544|NCT04998812|467887524|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
129979545|NCT04998812|467887525|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
129979546|NCT04998812|467887524|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
129979547|NCT04998812|467887525|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
129979548|NCT04998812|467887524|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
129979549|NCT04998812|467887525|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
129979550|NCT04998812|467887524|FG000|Vaccination Period|Ongoing in study|23|||
129979551|NCT04998812|467887525|FG001|Vaccination Period|Ongoing in study|23|||
129979552|NCT04893460|467887528|FG000|Overall Study|Lost to Follow-up|18|||
129979553|NCT03248882|467889386|FG000|Overall Study|Adverse Event|3|||
129979554|NCT03248882|467889387|FG001|Overall Study|Adverse Event|3|||
129979555|NCT03248882|467889388|FG002|Overall Study|Adverse Event|2|||
129979556|NCT03248882|467889389|FG003|Overall Study|Adverse Event|6|||
129979557|NCT03248882|467889390|FG004|Overall Study|Adverse Event|9|||
129979558|NCT03248882|467889386|FG000|Overall Study|Lost to Follow-up|0|||
129979559|NCT03248882|467889387|FG001|Overall Study|Lost to Follow-up|0|||
129979560|NCT03248882|467889388|FG002|Overall Study|Lost to Follow-up|0|||
129979561|NCT03248882|467889389|FG003|Overall Study|Lost to Follow-up|0|||
129979562|NCT03248882|467889390|FG004|Overall Study|Lost to Follow-up|1|||
129979563|NCT03248882|467889386|FG000|Overall Study|Protocol Violation|2|||
129979564|NCT03248882|467889387|FG001|Overall Study|Protocol Violation|0|||
129979565|NCT03248882|467889388|FG002|Overall Study|Protocol Violation|2|||
129485843|NCT03700892|466071796|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
129485844|NCT00258154|466071806|FG000|Overall Study|Adverse Event|1|||
129485845|NCT00258154|466071807|FG001|Overall Study|Adverse Event|0|||
129485846|NCT00258154|466071806|FG000|Overall Study|Lost to Follow-up|0|||
129485847|NCT00258154|466071807|FG001|Overall Study|Lost to Follow-up|1|||
129485848|NCT00258154|466071806|FG000|Overall Study|Protocol Violation|2|||
129485849|NCT00258154|466071807|FG001|Overall Study|Protocol Violation|1|||
129485850|NCT00258154|466071806|FG000|Overall Study|Withdrawal by Subject|3|||
129485851|NCT00258154|466071807|FG001|Overall Study|Withdrawal by Subject|4|||
129485852|NCT00258154|466071806|FG000|Overall Study|Patient Moved|3|||
129485853|NCT00258154|466071807|FG001|Overall Study|Patient Moved|1|||
129485854|NCT01856673|466071808|FG000|Overall Study|Withdrawal by Subject|44|||
129485855|NCT01856673|466071809|FG001|Overall Study|Withdrawal by Subject|50|||
129485856|NCT01856673|466071810|FG002|Overall Study|Withdrawal by Subject|33|||
129485857|NCT01856673|466071808|FG000|Overall Study|Lost to Follow-up|31|||
129485858|NCT01856673|466071809|FG001|Overall Study|Lost to Follow-up|34|||
129485859|NCT01856673|466071810|FG002|Overall Study|Lost to Follow-up|0|||
129485860|NCT01856673|466071808|FG000|Overall Study|Unknown reasons|9|||
129485861|NCT01856673|466071809|FG001|Overall Study|Unknown reasons|0|||
129485862|NCT01856673|466071810|FG002|Overall Study|Unknown reasons|0|||
129485863|NCT01856673|466071808|FG000|Overall Study|Psychologist decision|1|||
129485864|NCT01856673|466071809|FG001|Overall Study|Psychologist decision|0|||
129485865|NCT01856673|466071810|FG002|Overall Study|Psychologist decision|0|||
129485866|NCT01856673|466071808|FG000|Overall Study|Paperwork errors|8|||
129485867|NCT01856673|466071809|FG001|Overall Study|Paperwork errors|0|||
129485868|NCT01856673|466071810|FG002|Overall Study|Paperwork errors|0|||
129485869|NCT01856673|466071808|FG000|Overall Study|Death|1|||
129485870|NCT01856673|466071809|FG001|Overall Study|Death|1|||
129485871|NCT01856673|466071810|FG002|Overall Study|Death|0|||
129485872|NCT01856673|466071808|FG000|Overall Study|Protocol Violation|1|||
129485873|NCT01856673|466071809|FG001|Overall Study|Protocol Violation|0|||
129485874|NCT01856673|466071810|FG002|Overall Study|Protocol Violation|1|||
129485875|NCT00184054|466071811|FG000|Overall Study|Adverse Event|1|||
129485876|NCT00667277|466071814|FG000|Overall Study|Withdrawal by Subject|2|||
129485877|NCT05121103|466071815|FG000|Overall Study|Progressive disease|2|||
129485878|NCT05121103|466071816|FG001|Overall Study|Progressive disease|1|||
129485879|NCT05121103|466071817|FG002|Overall Study|Progressive disease|6|||
129485880|NCT05121103|466071815|FG000|Overall Study|Physician Decision|2|||
129485881|NCT05121103|466071816|FG001|Overall Study|Physician Decision|1|||
129485882|NCT05121103|466071817|FG002|Overall Study|Physician Decision|0|||
129485883|NCT05121103|466071815|FG000|Overall Study|Withdrawal by Subject|0|||
129485884|NCT05121103|466071816|FG001|Overall Study|Withdrawal by Subject|1|||
129485885|NCT05121103|466071817|FG002|Overall Study|Withdrawal by Subject|0|||
129485886|NCT03138564|466071818|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
129485887|NCT03138564|466071819|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
129485888|NCT03138564|466071818|FG000|Overall Study|Lost to Follow-up|16|||
129485889|NCT03138564|466071819|FG001|Overall Study|Lost to Follow-up|2|||
129485890|NCT03138564|466071818|FG000|Overall Study|Withdrawal by Subject|48|||
129485891|NCT03138564|466071819|FG001|Overall Study|Withdrawal by Subject|4|||
129485892|NCT03138564|466071818|FG000|Overall Study|No longer met eligibility criteria|2|||
129485893|NCT03138564|466071819|FG001|Overall Study|No longer met eligibility criteria|0|||
129485894|NCT03138564|466071818|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
129485895|NCT03138564|466071819|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
129485896|NCT03138564|466071818|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
129485897|NCT03138564|466071819|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
129485898|NCT03138564|466071818|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
129485899|NCT03138564|466071819|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
129485900|NCT03138564|466071818|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
129485901|NCT03138564|466071819|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
129485902|NCT00814710|466071820|FG000|Overall Study|Adverse Event|1|||
129485903|NCT00814710|466071821|FG001|Overall Study|Adverse Event|0|||
129485904|NCT00814710|466071820|FG000|Overall Study|Lost to Follow-up|7|||
129485905|NCT00814710|466071821|FG001|Overall Study|Lost to Follow-up|3|||
129485906|NCT05593432|466071823|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
129485907|NCT05593432|466071824|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
129485908|NCT05593432|466071825|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
129485909|NCT05593432|466071826|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
129485910|NCT05593432|466071823|FG000|16-Week OLE Period|Lack of Efficacy|0|||
129485911|NCT05593432|466071824|FG001|16-Week OLE Period|Lack of Efficacy|0|||
129485912|NCT05593432|466071825|FG002|16-Week OLE Period|Lack of Efficacy|0|||
129485913|NCT05593432|466071826|FG003|16-Week OLE Period|Lack of Efficacy|1|||
129485914|NCT05593432|466071823|FG000|16-Week OLE Period|Lost to Follow-up|0|||
129485915|NCT05593432|466071824|FG001|16-Week OLE Period|Lost to Follow-up|0|||
129485916|NCT05593432|466071825|FG002|16-Week OLE Period|Lost to Follow-up|1|||
129485917|NCT05593432|466071826|FG003|16-Week OLE Period|Lost to Follow-up|2|||
129485918|NCT05593432|466071823|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
129485919|NCT05593432|466071824|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
129485920|NCT05593432|466071825|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
129485921|NCT05593432|466071826|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
129485922|NCT03885284|466071827|FG000|Overall Study|Disease Progression|1|||
129485923|NCT03885284|466071828|FG001|Overall Study|Disease Progression|3|||
129485924|NCT03885284|466071827|FG000|Overall Study|Physician Decision|0|||
129485925|NCT03885284|466071828|FG001|Overall Study|Physician Decision|1|||
129485926|NCT01591330|466071831|FG000|Period 1|Adverse Event|1|||
129485927|NCT01591330|466071832|FG001|Period 1|Adverse Event|0|||
129485928|NCT01591330|466071833|FG002|Period 1|Adverse Event|0|||
129485929|NCT01591330|466071834|FG003|Period 1|Adverse Event|0|||
129485930|NCT01591330|466071831|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
129485931|NCT01591330|466071832|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
129485932|NCT01591330|466071833|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
129485933|NCT01591330|466071834|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
129485934|NCT01591330|466071831|FG000|Period 2|Adverse Event|1|||
129485935|NCT01591330|466071832|FG001|Period 2|Adverse Event|0|||
129485936|NCT01591330|466071833|FG002|Period 2|Adverse Event|0|||
129485937|NCT01591330|466071834|FG003|Period 2|Adverse Event|0|||
129485938|NCT02609399|466071838|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
129485939|NCT02609399|466071839|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
129485940|NCT02609399|466071838|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
129485941|NCT02609399|466071839|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
129485942|NCT02609399|466071838|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
129485943|NCT02609399|466071839|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
129485944|NCT04800315|466071840|FG000|Randomization|Did not receive study treatment|1|||
129485945|NCT04800315|466071841|FG001|Randomization|Did not receive study treatment|0|||
129485946|NCT04800315|466071842|FG002|Randomization|Did not receive study treatment|0|||
129485947|NCT04800315|466071843|FG003|Randomization|Did not receive study treatment|0|||
129485948|NCT04800315|466071840|FG000|Treatment Period|Adverse Event|4|||
129485949|NCT04800315|466071841|FG001|Treatment Period|Adverse Event|2|||
129485950|NCT04800315|466071842|FG002|Treatment Period|Adverse Event|1|||
129485951|NCT04800315|466071843|FG003|Treatment Period|Adverse Event|2|||
129485952|NCT04800315|466071840|FG000|Treatment Period|Lack of Efficacy|1|||
129485953|NCT04800315|466071841|FG001|Treatment Period|Lack of Efficacy|0|||
129485954|NCT04800315|466071842|FG002|Treatment Period|Lack of Efficacy|0|||
129485955|NCT04800315|466071843|FG003|Treatment Period|Lack of Efficacy|3|||
129485956|NCT04800315|466071840|FG000|Treatment Period|Lost to Follow-up|0|||
129485957|NCT04800315|466071841|FG001|Treatment Period|Lost to Follow-up|1|||
129485958|NCT04800315|466071842|FG002|Treatment Period|Lost to Follow-up|2|||
129485959|NCT04800315|466071843|FG003|Treatment Period|Lost to Follow-up|2|||
129485960|NCT04800315|466071840|FG000|Treatment Period|Withdrawal by participant|0|||
129485961|NCT04800315|466071841|FG001|Treatment Period|Withdrawal by participant|0|||
129485962|NCT04800315|466071842|FG002|Treatment Period|Withdrawal by participant|0|||
129485963|NCT04800315|466071843|FG003|Treatment Period|Withdrawal by participant|4|||
129485964|NCT04800315|466071840|FG000|Treatment Period|Other Reasons|0|||
129485965|NCT04800315|466071841|FG001|Treatment Period|Other Reasons|2|||
129485966|NCT04800315|466071842|FG002|Treatment Period|Other Reasons|0|||
129485967|NCT04800315|466071843|FG003|Treatment Period|Other Reasons|1|||
129485968|NCT00753922|466071844|FG000|Overall Study|Lost to Follow-up|155|||
129485969|NCT00753922|466071845|FG001|Overall Study|Lost to Follow-up|24|||
129485970|NCT00753922|466071846|FG002|Overall Study|Lost to Follow-up|28|||
129485971|NCT00753922|466071847|FG003|Overall Study|Lost to Follow-up|5|||
129485972|NCT00753922|466071844|FG000|Overall Study|Withdrawal by Subject|9|||
129485973|NCT00753922|466071845|FG001|Overall Study|Withdrawal by Subject|11|||
129485974|NCT00753922|466071846|FG002|Overall Study|Withdrawal by Subject|4|||
129485975|NCT00753922|466071847|FG003|Overall Study|Withdrawal by Subject|2|||
129485976|NCT00753922|466071844|FG000|Overall Study|Patient Non-compliance|55|||
129485977|NCT00753922|466071845|FG001|Overall Study|Patient Non-compliance|22|||
129485978|NCT00753922|466071846|FG002|Overall Study|Patient Non-compliance|14|||
129485979|NCT00753922|466071847|FG003|Overall Study|Patient Non-compliance|11|||
129485980|NCT00753922|466071844|FG000|Overall Study|Patients Not Completing Visit|11|||
129485981|NCT00753922|466071845|FG001|Overall Study|Patients Not Completing Visit|0|||
129485982|NCT00753922|466071846|FG002|Overall Study|Patients Not Completing Visit|1|||
129485983|NCT00753922|466071847|FG003|Overall Study|Patients Not Completing Visit|0|||
129485984|NCT00753922|466071844|FG000|Overall Study|Death|2|||
129485985|NCT00753922|466071845|FG001|Overall Study|Death|23|||
129485986|NCT00753922|466071846|FG002|Overall Study|Death|2|||
129485987|NCT00753922|466071847|FG003|Overall Study|Death|1|||
129485988|NCT00753922|466071844|FG000|Overall Study|Discontinuation Due to Explantation|14|||
129485989|NCT00753922|466071845|FG001|Overall Study|Discontinuation Due to Explantation|14|||
129485990|NCT00753922|466071846|FG002|Overall Study|Discontinuation Due to Explantation|14|||
129485991|NCT00753922|466071847|FG003|Overall Study|Discontinuation Due to Explantation|4|||
129485992|NCT02453841|466071852|FG000|Overall Study|Protocol Violation|1|||
129485993|NCT02453841|466071852|FG000|Overall Study|Unable to obtain blood samples|2|||
129485994|NCT02190591|466071853|FG000|Overall Study|Withdrawal by Subject|1|||
129485995|NCT02190591|466071854|FG001|Overall Study|Withdrawal by Subject|8|||
129485996|NCT02190591|466071853|FG000|Overall Study|Protocol Violation|1|||
129485997|NCT02190591|466071854|FG001|Overall Study|Protocol Violation|0|||
129485998|NCT02190591|466071853|FG000|Overall Study|did not use peanut ball as instructed|0|||
129485999|NCT02190591|466071854|FG001|Overall Study|did not use peanut ball as instructed|2|||
129486000|NCT02190591|466071853|FG000|Overall Study|face presentation so she was ineligible|0|||
129486001|NCT02190591|466071854|FG001|Overall Study|face presentation so she was ineligible|1|||
129486002|NCT03851510|466071855|FG000|Overall Study|Screen Fail|1|||
129486003|NCT03851510|466071855|FG000|Overall Study|Adverse Event|1|||
129486004|NCT03851510|466071855|FG000|Overall Study|Withdrawal by Subject|1|||
129486005|NCT03598777|466071856|FG000|Overall Study|Study Terminated by Sponsor|3|||
129486006|NCT03598777|466071857|FG001|Overall Study|Study Terminated by Sponsor|0|||
129486007|NCT03598777|466071858|FG002|Overall Study|Study Terminated by Sponsor|0|||
129486008|NCT03598777|466071859|FG003|Overall Study|Study Terminated by Sponsor|0|||
129486009|NCT03598777|466071860|FG004|Overall Study|Study Terminated by Sponsor|15|||
129486010|NCT03598777|466071856|FG000|Overall Study|Withdrawal by Subject|1|||
129486011|NCT03598777|466071857|FG001|Overall Study|Withdrawal by Subject|1|||
129486012|NCT03598777|466071858|FG002|Overall Study|Withdrawal by Subject|0|||
129486013|NCT03598777|466071859|FG003|Overall Study|Withdrawal by Subject|0|||
129486014|NCT03598777|466071860|FG004|Overall Study|Withdrawal by Subject|0|||
129486015|NCT03598777|466071856|FG000|Overall Study|Adverse Event|1|||
129486016|NCT03598777|466071857|FG001|Overall Study|Adverse Event|0|||
129486017|NCT03598777|466071858|FG002|Overall Study|Adverse Event|0|||
129486018|NCT03598777|466071859|FG003|Overall Study|Adverse Event|0|||
129486019|NCT03598777|466071860|FG004|Overall Study|Adverse Event|0|||
129486020|NCT03598777|466071856|FG000|Overall Study|Lost to Follow-up|1|||
129486021|NCT03598777|466071857|FG001|Overall Study|Lost to Follow-up|0|||
129486022|NCT03598777|466071858|FG002|Overall Study|Lost to Follow-up|0|||
129486023|NCT03598777|466071859|FG003|Overall Study|Lost to Follow-up|0|||
129486024|NCT03598777|466071860|FG004|Overall Study|Lost to Follow-up|0|||
129486025|NCT01151137|466071861|FG000|Overall Study|Death|15|||
129486026|NCT01151137|466071862|FG001|Overall Study|Death|27|||
129486027|NCT01151137|466071861|FG000|Overall Study|Lost to Follow-up|1|||
129486028|NCT01151137|466071862|FG001|Overall Study|Lost to Follow-up|1|||
129486029|NCT00072189|466071863|FG000|Overall Study|Withdrawal by Subject|1|||
129486030|NCT00144300|466071864|FG000|Overall Study|Adverse Event|18|||
129486031|NCT00144300|466071865|FG001|Overall Study|Adverse Event|16|||
129486032|NCT00144300|466071864|FG000|Overall Study|Protocol Violation|1|||
129486033|NCT00144300|466071865|FG001|Overall Study|Protocol Violation|3|||
129486034|NCT00144300|466071864|FG000|Overall Study|Lost to Follow-up|3|||
129486035|NCT00144300|466071865|FG001|Overall Study|Lost to Follow-up|0|||
129486036|NCT00144300|466071864|FG000|Overall Study|Withdrawal by Subject|6|||
129486037|NCT00144300|466071865|FG001|Overall Study|Withdrawal by Subject|6|||
129486038|NCT00144300|466071864|FG000|Overall Study|Other reason (not specified)|1|||
129486039|NCT00144300|466071865|FG001|Overall Study|Other reason (not specified)|3|||
129486040|NCT02426086|466071869|FG000|Overall Study|Death|33|||
129486041|NCT02426086|466071870|FG001|Overall Study|Death|36|||
129486042|NCT02426086|466071869|FG000|Overall Study|Lost to Follow-up|2|||
129486043|NCT02426086|466071870|FG001|Overall Study|Lost to Follow-up|0|||
129486044|NCT02426086|466071869|FG000|Overall Study|Study Terminated by Sponsor|5|||
129486045|NCT02426086|466071870|FG001|Overall Study|Study Terminated by Sponsor|14|||
129486046|NCT02426086|466071869|FG000|Overall Study|Withdrawal by Subject|8|||
129486047|NCT02426086|466071870|FG001|Overall Study|Withdrawal by Subject|9|||
129486048|NCT00840463|466071874|FG000|Overall Study|Adverse Event|1|||
129486049|NCT00840463|466071875|FG001|Overall Study|Adverse Event|0|||
129486050|NCT02515669|466071878|FG000|228 Week Open-Label Phase|Other|0|||
129486051|NCT02515669|466071879|FG001|228 Week Open-Label Phase|Other|0|||
129486052|NCT02515669|466071880|FG002|228 Week Open-Label Phase|Other|1|||
129486053|NCT02515669|466071881|FG003|228 Week Open-Label Phase|Other|4|||
129486054|NCT02515669|466071878|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
129486055|NCT02515669|466071879|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
129486056|NCT02515669|466071880|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
129486057|NCT02515669|466071881|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
129486058|NCT02515669|466071878|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
129486059|NCT02515669|466071879|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
129486060|NCT02515669|466071880|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
129486061|NCT02515669|466071881|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
129486062|NCT02515669|466071878|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
129486063|NCT02515669|466071879|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
129486064|NCT02515669|466071880|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
129486065|NCT02515669|466071881|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
129486066|NCT02515669|466071878|FG000|228 Week Open-Label Phase|Missing|0|||
129486067|NCT02515669|466071879|FG001|228 Week Open-Label Phase|Missing|2|||
129486068|NCT02515669|466071880|FG002|228 Week Open-Label Phase|Missing|2|||
129486069|NCT02515669|466071881|FG003|228 Week Open-Label Phase|Missing|2|||
129486070|NCT01739595|466071882|FG000|Overall Study|Adverse Event|3|||
129486071|NCT01739595|466071883|FG001|Overall Study|Adverse Event|0|||
129486072|NCT01739595|466071884|FG002|Overall Study|Adverse Event|0|||
129486073|NCT01739595|466071882|FG000|Overall Study|Lost to Follow-up|2|||
129486074|NCT01739595|466071883|FG001|Overall Study|Lost to Follow-up|0|||
129486075|NCT01739595|466071884|FG002|Overall Study|Lost to Follow-up|0|||
129486076|NCT01739595|466071882|FG000|Overall Study|Withdrawal by Subject|2|||
129486077|NCT01739595|466071883|FG001|Overall Study|Withdrawal by Subject|1|||
129486078|NCT01739595|466071884|FG002|Overall Study|Withdrawal by Subject|2|||
129486079|NCT01739595|466071882|FG000|Overall Study|Eligibility issue|3|||
129486080|NCT01739595|466071883|FG001|Overall Study|Eligibility issue|0|||
129486081|NCT01739595|466071884|FG002|Overall Study|Eligibility issue|0|||
129486082|NCT01739595|466071882|FG000|Overall Study|Protocol Violation|1|||
129486083|NCT01739595|466071883|FG001|Overall Study|Protocol Violation|0|||
129486084|NCT01739595|466071884|FG002|Overall Study|Protocol Violation|0|||
129486085|NCT01739595|466071882|FG000|Overall Study|Lab assessment|1|||
129486086|NCT01739595|466071883|FG001|Overall Study|Lab assessment|0|||
129486087|NCT01739595|466071884|FG002|Overall Study|Lab assessment|0|||
129486088|NCT01739595|466071882|FG000|Overall Study|Drug discrepancy|1|||
129486089|NCT01739595|466071883|FG001|Overall Study|Drug discrepancy|0|||
129486090|NCT01739595|466071884|FG002|Overall Study|Drug discrepancy|0|||
129486091|NCT01287117|466071887|FG000|Overall Study|Adverse Event|2|||
129486092|NCT01287117|466071888|FG001|Overall Study|Adverse Event|1|||
129486093|NCT01287117|466071889|FG002|Overall Study|Adverse Event|1|||
129486094|NCT01287117|466071890|FG003|Overall Study|Adverse Event|1|||
129486095|NCT01287117|466071887|FG000|Overall Study|Lost to Follow-up|1|||
129486096|NCT01287117|466071888|FG001|Overall Study|Lost to Follow-up|1|||
129486097|NCT01287117|466071889|FG002|Overall Study|Lost to Follow-up|0|||
129486098|NCT01287117|466071890|FG003|Overall Study|Lost to Follow-up|0|||
129486099|NCT01287117|466071887|FG000|Overall Study|Physician Decision|0|||
129486100|NCT01287117|466071888|FG001|Overall Study|Physician Decision|1|||
129486101|NCT01287117|466071889|FG002|Overall Study|Physician Decision|1|||
129486102|NCT01287117|466071890|FG003|Overall Study|Physician Decision|1|||
129486103|NCT01287117|466071887|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
129486104|NCT01287117|466071888|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
129486105|NCT01287117|466071889|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
129486106|NCT01287117|466071890|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
129486107|NCT01287117|466071887|FG000|Overall Study|Disease Progression|10|||
129486108|NCT01287117|466071888|FG001|Overall Study|Disease Progression|5|||
129486109|NCT01287117|466071889|FG002|Overall Study|Disease Progression|6|||
129486110|NCT01287117|466071890|FG003|Overall Study|Disease Progression|5|||
129486111|NCT01676116|466071891|FG000|Overall Study|Withdrawal criteria|2|||
129486112|NCT01676116|466071892|FG001|Overall Study|Withdrawal criteria|14|||
129486113|NCT01676116|466071891|FG000|Overall Study|Adverse Event|1|||
129486114|NCT01676116|466071892|FG001|Overall Study|Adverse Event|2|||
129486115|NCT01676116|466071891|FG000|Overall Study|Unclassified|4|||
129486116|NCT01676116|466071892|FG001|Overall Study|Unclassified|10|||
129486117|NCT01676116|466071891|FG000|Overall Study|Protocol Violation|9|||
129486118|NCT01676116|466071892|FG001|Overall Study|Protocol Violation|3|||
129486119|NCT01769404|466071895|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
129486120|NCT01769404|466071896|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
129486121|NCT01769404|466071895|FG000|Treatment Period 1|Withdrawal by Subject|3|||
129486122|NCT01769404|466071896|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129486123|NCT01769404|466071895|FG000|Treatment Period 1|Sponsor decision|1|||
129486124|NCT01769404|466071896|FG001|Treatment Period 1|Sponsor decision|0|||
129486125|NCT01769404|466071895|FG000|Treatment Period 2|Sponsor decision|7|||
129486126|NCT01769404|466071896|FG001|Treatment Period 2|Sponsor decision|0|||
129486127|NCT00538733|466071897|FG000|Overall Study|Adverse Event|8|||
129486128|NCT00538733|466071897|FG000|Overall Study|Death|1|||
129486129|NCT00538733|466071897|FG000|Overall Study|declined to participate|2|||
129486130|NCT00538733|466071897|FG000|Overall Study|still on therapy|1|||
129486131|NCT00095121|466071900|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
129486132|NCT00095121|466071901|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
129486133|NCT00095121|466071900|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
129486134|NCT00095121|466071901|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
129486135|NCT01266148|466073664|FG000|Overall Study|Adverse Event|2|||
129486136|NCT01266148|466073665|FG001|Overall Study|Adverse Event|0|||
129486137|NCT01266148|466073664|FG000|Overall Study|Ongoing rejection|1|||
129486138|NCT01266148|466073665|FG001|Overall Study|Ongoing rejection|0|||
129486139|NCT01266148|466073664|FG000|Overall Study|2 2R rejections|1|||
129486140|NCT01266148|466073665|FG001|Overall Study|2 2R rejections|0|||
129486141|NCT01266148|466073664|FG000|Overall Study|Death|2|||
129486142|NCT01266148|466073665|FG001|Overall Study|Death|3|||
129486143|NCT01266148|466073664|FG000|Overall Study|missing mGFR value + AE|1|||
129486144|NCT01266148|466073665|FG001|Overall Study|missing mGFR value + AE|0|||
129486145|NCT01853228|466073666|FG000|Phase 1|Lack of Efficacy|8|||
129486146|NCT01853228|466073667|FG001|Phase 1|Lack of Efficacy|0|||
129486147|NCT01853228|466073666|FG000|Phase 1|Other|1|||
129486148|NCT01853228|466073667|FG001|Phase 1|Other|0|||
129486149|NCT01853228|466073666|FG000|Phase 2|Physician Decision|0|||
129486150|NCT01853228|466073667|FG001|Phase 2|Physician Decision|1|||
129486151|NCT01853228|466073666|FG000|Phase 2|Proceed To Transplant|0|||
129486152|NCT01853228|466073667|FG001|Phase 2|Proceed To Transplant|3|||
129486153|NCT01853228|466073666|FG000|Phase 2|Lack of Efficacy|0|||
129486154|NCT01853228|466073667|FG001|Phase 2|Lack of Efficacy|4|||
129486155|NCT03167619|466073668|FG000|Overall Study|Death|11|||
129486156|NCT03167619|466073669|FG001|Overall Study|Death|8|||
129486157|NCT03167619|466073668|FG000|Overall Study|Withdrawal by Subject|1|||
129486158|NCT03167619|466073669|FG001|Overall Study|Withdrawal by Subject|2|||
129486159|NCT03167619|466073668|FG000|Overall Study|Physician Decision|0|||
129486160|NCT03167619|466073669|FG001|Overall Study|Physician Decision|1|||
129486161|NCT01348919|466073671|FG000|Overall Study|Adverse Event|3|||
129486162|NCT01348919|466073672|FG001|Overall Study|Adverse Event|1|||
129486163|NCT01348919|466073673|FG002|Overall Study|Adverse Event|0|||
129486164|NCT01348919|466073671|FG000|Overall Study|Withdrawal by Subject|0|||
129486165|NCT01348919|466073672|FG001|Overall Study|Withdrawal by Subject|1|||
129486166|NCT01348919|466073673|FG002|Overall Study|Withdrawal by Subject|0|||
129486167|NCT01348919|466073671|FG000|Overall Study|Disease progression|0|||
129486168|NCT01348919|466073672|FG001|Overall Study|Disease progression|1|||
129486169|NCT01348919|466073673|FG002|Overall Study|Disease progression|1|||
129486170|NCT02089737|466073674|FG000|Overall Study|Survey form not completed|5|||
129486171|NCT02089737|466073674|FG000|Overall Study|Not treated|1|||
129486172|NCT02082184|466073676|FG000|Overall Study|Adverse Event|1|||
129486173|NCT02082184|466073677|FG001|Overall Study|Adverse Event|0|||
129486174|NCT02082184|466073676|FG000|Overall Study|Medical diagnosis|1|||
129486175|NCT02082184|466073677|FG001|Overall Study|Medical diagnosis|2|||
129486176|NCT02082184|466073676|FG000|Overall Study|Device associated symptoms|5|||
129486177|NCT02082184|466073677|FG001|Overall Study|Device associated symptoms|0|||
129486178|NCT02082184|466073676|FG000|Overall Study|Withdrawal by Subject|3|||
129486179|NCT02082184|466073677|FG001|Overall Study|Withdrawal by Subject|2|||
129486180|NCT02082184|466073676|FG000|Overall Study|Protocol Violation|0|||
129486181|NCT02082184|466073677|FG001|Overall Study|Protocol Violation|6|||
129486182|NCT02082184|466073676|FG000|Overall Study|Lost to Follow-up|0|||
129486183|NCT02082184|466073677|FG001|Overall Study|Lost to Follow-up|2|||
129486184|NCT02082184|466073676|FG000|Overall Study|Subject non-compliance|0|||
129486185|NCT02082184|466073677|FG001|Overall Study|Subject non-compliance|1|||
129486186|NCT01362322|466073682|FG000|Overall Study|Withdrawal by Subject|3|||
129486187|NCT01362322|466073683|FG001|Overall Study|Withdrawal by Subject|1|||
129486188|NCT01362322|466073682|FG000|Overall Study|Lost to Follow-up|2|||
129486189|NCT01362322|466073683|FG001|Overall Study|Lost to Follow-up|6|||
129486190|NCT01062399|466073691|FG000|Overall Study|Protocol Violation|0|||
129486191|NCT01062399|466073692|FG001|Overall Study|Protocol Violation|1|||
129486192|NCT01062399|466073693|FG002|Overall Study|Protocol Violation|0|||
129486193|NCT01062399|466073694|FG003|Overall Study|Protocol Violation|6|||
129486194|NCT01062399|466073695|FG004|Overall Study|Protocol Violation|4|||
129486195|NCT00634543|466073697|FG000|Overall Study|Other|1|||
129486196|NCT00634543|466073698|FG001|Overall Study|Other|2|||
129486197|NCT00634543|466073697|FG000|Overall Study|Protocol Violation|3|||
129486198|NCT00634543|466073698|FG001|Overall Study|Protocol Violation|3|||
129486199|NCT00634543|466073697|FG000|Overall Study|Adverse Event|11|||
129486200|NCT00634543|466073698|FG001|Overall Study|Adverse Event|11|||
129486201|NCT00634543|466073697|FG000|Overall Study|Withdrawal by Subject|4|||
129486202|NCT00634543|466073698|FG001|Overall Study|Withdrawal by Subject|4|||
129486203|NCT00634543|466073697|FG000|Overall Study|Lost to Follow-up|0|||
129486204|NCT00634543|466073698|FG001|Overall Study|Lost to Follow-up|1|||
129486205|NCT02465034|466073701|FG000|Overall Study|Withdrawal by Subject|1|||
129486206|NCT02465034|466073702|FG001|Overall Study|Withdrawal by Subject|1|||
129486207|NCT02465034|466073701|FG000|Overall Study|Screen fail|2|||
129486208|NCT02465034|466073702|FG001|Overall Study|Screen fail|0|||
129486209|NCT02465034|466073701|FG000|Overall Study|Could not be scheduled for study visit|0|||
129486210|NCT02465034|466073702|FG001|Overall Study|Could not be scheduled for study visit|5|||
129486211|NCT02397655|466073703|FG000|Overall Study|data not completed|1301|||
129486212|NCT01736683|466073704|FG000|Overall Study|Disease Relapse|0|||
129486213|NCT01736683|466073705|FG001|Overall Study|Disease Relapse|0|||
129486214|NCT01736683|466073706|FG002|Overall Study|Disease Relapse|2|||
129486215|NCT01736683|466073707|FG003|Overall Study|Disease Relapse|1|||
129486216|NCT01736683|466073708|FG004|Overall Study|Disease Relapse|0|||
129486217|NCT01736683|466073704|FG000|Overall Study|Adverse Event|0|||
129486218|NCT01736683|466073705|FG001|Overall Study|Adverse Event|2|||
129486219|NCT01736683|466073706|FG002|Overall Study|Adverse Event|2|||
129486220|NCT01736683|466073707|FG003|Overall Study|Adverse Event|3|||
129486221|NCT01736683|466073708|FG004|Overall Study|Adverse Event|2|||
129486222|NCT01736683|466073704|FG000|Overall Study|Withdrawal by Subject|0|||
129486223|NCT01736683|466073705|FG001|Overall Study|Withdrawal by Subject|0|||
129486224|NCT01736683|466073706|FG002|Overall Study|Withdrawal by Subject|3|||
129486225|NCT01736683|466073707|FG003|Overall Study|Withdrawal by Subject|1|||
129486226|NCT01736683|466073708|FG004|Overall Study|Withdrawal by Subject|1|||
129486227|NCT01736683|466073704|FG000|Overall Study|Lack of Therapeutic Effect|7|||
129486228|NCT01736683|466073705|FG001|Overall Study|Lack of Therapeutic Effect|4|||
129486229|NCT01736683|466073706|FG002|Overall Study|Lack of Therapeutic Effect|13|||
129486230|NCT01736683|466073707|FG003|Overall Study|Lack of Therapeutic Effect|20|||
129486231|NCT01736683|466073708|FG004|Overall Study|Lack of Therapeutic Effect|1|||
129486232|NCT01736683|466073704|FG000|Overall Study|Progressive Disease|0|||
129486233|NCT01736683|466073705|FG001|Overall Study|Progressive Disease|0|||
129486234|NCT01736683|466073706|FG002|Overall Study|Progressive Disease|0|||
129486235|NCT01736683|466073707|FG003|Overall Study|Progressive Disease|1|||
129486236|NCT01736683|466073708|FG004|Overall Study|Progressive Disease|0|||
129486237|NCT01736683|466073704|FG000|Overall Study|Other|0|||
129486238|NCT01736683|466073705|FG001|Overall Study|Other|0|||
129486239|NCT01736683|466073706|FG002|Overall Study|Other|1|||
129486240|NCT01736683|466073707|FG003|Overall Study|Other|9|||
129486241|NCT01736683|466073708|FG004|Overall Study|Other|1|||
129486242|NCT01588197|466073709|FG000|Overall Study|Lack of Efficacy|0|||
129486243|NCT01588197|466073710|FG001|Overall Study|Lack of Efficacy|1|||
129486244|NCT01588197|466073709|FG000|Overall Study|No MRI|1|||
129486245|NCT01588197|466073710|FG001|Overall Study|No MRI|0|||
129486246|NCT00474253|466073715|FG000|Overall Study|Withdrew consent|2|||
129486247|NCT00474253|466073716|FG001|Overall Study|Withdrew consent|0|||
129486248|NCT00474253|466073715|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
129486249|NCT00474253|466073716|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
129486250|NCT00474253|466073715|FG000|Overall Study|Lost to Follow-up|1|||
129486251|NCT00474253|466073716|FG001|Overall Study|Lost to Follow-up|0|||
129486252|NCT00474253|466073715|FG000|Overall Study|Discharged prior to study completion|0|||
129486253|NCT00474253|466073716|FG001|Overall Study|Discharged prior to study completion|1|||
129486254|NCT01570491|466073721|FG000|Overall Study|Lost to Follow-up|3|||
129486255|NCT01570491|466073722|FG001|Overall Study|Lost to Follow-up|1|||
129486256|NCT01570491|466073721|FG000|Overall Study|treatment: not given or discontinued|2|||
129486257|NCT01570491|466073722|FG001|Overall Study|treatment: not given or discontinued|0|||
129486258|NCT03047213|466073723|FG000|Overall Study|Withdrawal by Subject|2|||
129486259|NCT03047213|466073724|FG001|Overall Study|Withdrawal by Subject|0|||
129486260|NCT03047213|466073723|FG000|Overall Study|Adverse Event|2|||
129486261|NCT03047213|466073724|FG001|Overall Study|Adverse Event|0|||
129486262|NCT00482001|466073725|FG000|Overall Study|Protocol Violation|1|||
129486263|NCT00482001|466073726|FG001|Overall Study|Protocol Violation|1|||
129486264|NCT00847613|466073733|FG000|Overall Study|Ongoing at cut-off date|250|||
129486265|NCT00847613|466073734|FG001|Overall Study|Ongoing at cut-off date|265|||
129486266|NCT00847613|466073735|FG002|Overall Study|Ongoing at cut-off date|64|||
129486267|NCT00847613|466073736|FG003|Overall Study|Ongoing at cut-off date|64|||
129486268|NCT00847613|466073733|FG000|Overall Study|Death|1|||
129486269|NCT00847613|466073734|FG001|Overall Study|Death|1|||
129486270|NCT00847613|466073735|FG002|Overall Study|Death|0|||
129486271|NCT00847613|466073736|FG003|Overall Study|Death|0|||
129486272|NCT00847613|466073733|FG000|Overall Study|Adverse Event|36|||
129486273|NCT00847613|466073734|FG001|Overall Study|Adverse Event|26|||
129486274|NCT00847613|466073735|FG002|Overall Study|Adverse Event|5|||
129486275|NCT00847613|466073736|FG003|Overall Study|Adverse Event|6|||
129486276|NCT00847613|466073733|FG000|Overall Study|Lack of Efficacy|7|||
129486277|NCT00847613|466073734|FG001|Overall Study|Lack of Efficacy|3|||
129486278|NCT00847613|466073735|FG002|Overall Study|Lack of Efficacy|3|||
129486279|NCT00847613|466073736|FG003|Overall Study|Lack of Efficacy|1|||
129486280|NCT00847613|466073733|FG000|Overall Study|Study terminated by Sponsor|1|||
129486281|NCT00847613|466073734|FG001|Overall Study|Study terminated by Sponsor|0|||
129486282|NCT00847613|466073735|FG002|Overall Study|Study terminated by Sponsor|2|||
129486283|NCT00847613|466073736|FG003|Overall Study|Study terminated by Sponsor|1|||
129486284|NCT00847613|466073733|FG000|Overall Study|Lost to Follow-up|5|||
129486285|NCT00847613|466073734|FG001|Overall Study|Lost to Follow-up|0|||
129486286|NCT00847613|466073735|FG002|Overall Study|Lost to Follow-up|0|||
129486287|NCT00847613|466073736|FG003|Overall Study|Lost to Follow-up|3|||
129486288|NCT00847613|466073733|FG000|Overall Study|Protocol Violation|6|||
129486289|NCT00847613|466073734|FG001|Overall Study|Protocol Violation|6|||
129486290|NCT00847613|466073735|FG002|Overall Study|Protocol Violation|3|||
129486291|NCT00847613|466073736|FG003|Overall Study|Protocol Violation|1|||
129486292|NCT00847613|466073733|FG000|Overall Study|Pregnancy|1|||
129486293|NCT00847613|466073734|FG001|Overall Study|Pregnancy|1|||
129486294|NCT00847613|466073735|FG002|Overall Study|Pregnancy|0|||
129486295|NCT00847613|466073736|FG003|Overall Study|Pregnancy|0|||
129486296|NCT00847613|466073733|FG000|Overall Study|Site closure|1|||
129486297|NCT00847613|466073734|FG001|Overall Study|Site closure|0|||
129486298|NCT00847613|466073735|FG002|Overall Study|Site closure|0|||
129486299|NCT00847613|466073736|FG003|Overall Study|Site closure|1|||
129486300|NCT00847613|466073733|FG000|Overall Study|Withdrawal by Subject|8|||
129486301|NCT00847613|466073734|FG001|Overall Study|Withdrawal by Subject|11|||
129486302|NCT00847613|466073735|FG002|Overall Study|Withdrawal by Subject|2|||
129486303|NCT00847613|466073736|FG003|Overall Study|Withdrawal by Subject|2|||
129486304|NCT00847613|466073733|FG000|Overall Study|Participant moved|4|||
129486305|NCT00847613|466073734|FG001|Overall Study|Participant moved|1|||
129486306|NCT00847613|466073735|FG002|Overall Study|Participant moved|0|||
129486307|NCT00847613|466073736|FG003|Overall Study|Participant moved|0|||
129486308|NCT00847613|466073733|FG000|Overall Study|Sponsor request|0|||
129486309|NCT00847613|466073734|FG001|Overall Study|Sponsor request|1|||
129486310|NCT00847613|466073735|FG002|Overall Study|Sponsor request|0|||
129486311|NCT00847613|466073736|FG003|Overall Study|Sponsor request|0|||
129486312|NCT00847613|466073733|FG000|Overall Study|Randomized, but not treated|0|||
129486313|NCT00847613|466073734|FG001|Overall Study|Randomized, but not treated|3|||
129486314|NCT00847613|466073735|FG002|Overall Study|Randomized, but not treated|0|||
129486315|NCT00847613|466073736|FG003|Overall Study|Randomized, but not treated|0|||
129486316|NCT00847613|466073733|FG000|Overall Study|Other|1|||
129486317|NCT00847613|466073734|FG001|Overall Study|Other|1|||
129486318|NCT00847613|466073735|FG002|Overall Study|Other|2|||
129486319|NCT00847613|466073736|FG003|Overall Study|Other|0|||
129486320|NCT00754390|466073737|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
129486321|NCT00754390|466073737|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
129486322|NCT00754390|466073737|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
129486323|NCT00754390|466073737|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
129486324|NCT01009294|466073738|FG000|Overall Study|Study discontinued by Sponsor|6|||
129486325|NCT04332419|466073739|FG000|Overall Study|Withdrawal by Subject|1|||
129486326|NCT04222725|466073742|FG000|Overall Study|Adverse Event|0|||
129486327|NCT04222725|466073743|FG001|Overall Study|Adverse Event|1|||
129486328|NCT04222725|466073744|FG002|Overall Study|Adverse Event|0|||
129486329|NCT04222725|466073745|FG003|Overall Study|Adverse Event|0|||
129486330|NCT04925570|466073746|FG000|Overall Study|Protocol Violation|24|||
129486331|NCT04925570|466073747|FG001|Overall Study|Protocol Violation|30|||
129486332|NCT04925570|466073746|FG000|Overall Study|Withdrawal by Subject|0|||
129486333|NCT04925570|466073747|FG001|Overall Study|Withdrawal by Subject|2|||
129486334|NCT00658333|466073748|FG000|Overall Study|Adverse Event|2|||
129486335|NCT00658333|466073749|FG001|Overall Study|Adverse Event|1|||
129486336|NCT00828451|466073752|FG000|Overall Study|Death|2|||
129486337|NCT00828451|466073752|FG000|Overall Study|Lack of intravenous line|7|||
129486338|NCT00828451|466073752|FG000|Overall Study|Withdrawal by Subject|1|||
129486339|NCT00828451|466073752|FG000|Overall Study|Deterioration in clinical status|1|||
129486340|NCT00519532|466073753|FG000|Overall Study|Adverse Event|11|||
129486341|NCT00519532|466073753|FG000|Overall Study|Withdrawal by Subject|5|||
129486342|NCT00519532|466073753|FG000|Overall Study|Lost to Follow-up|2|||
129486343|NCT00624338|466073756|FG000|Overall Study|Adverse Event|14|||
129486344|NCT00624338|466073757|FG001|Overall Study|Adverse Event|14|||
129486345|NCT00624338|466073758|FG002|Overall Study|Adverse Event|18|||
129486346|NCT00624338|466073756|FG000|Overall Study|Lost to Follow-up|1|||
129486347|NCT00624338|466073757|FG001|Overall Study|Lost to Follow-up|0|||
129486348|NCT00624338|466073758|FG002|Overall Study|Lost to Follow-up|0|||
129486349|NCT00624338|466073756|FG000|Overall Study|Lack of Efficacy|11|||
129486350|NCT00624338|466073757|FG001|Overall Study|Lack of Efficacy|3|||
129486351|NCT00624338|466073758|FG002|Overall Study|Lack of Efficacy|14|||
129486352|NCT00624338|466073756|FG000|Overall Study|Protocol Violation|3|||
129486353|NCT00624338|466073757|FG001|Overall Study|Protocol Violation|3|||
129486354|NCT00624338|466073758|FG002|Overall Study|Protocol Violation|2|||
129486355|NCT00624338|466073756|FG000|Overall Study|Death|0|||
129486356|NCT00624338|466073757|FG001|Overall Study|Death|2|||
129486357|NCT00624338|466073758|FG002|Overall Study|Death|0|||
129486358|NCT00624338|466073756|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
129486359|NCT00624338|466073757|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
129486360|NCT00624338|466073758|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
129486361|NCT00624338|466073756|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
129486362|NCT00624338|466073757|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
129486363|NCT00624338|466073758|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
129486364|NCT00624338|466073756|FG000|Overall Study|Other|15|||
129486365|NCT00624338|466073757|FG001|Overall Study|Other|5|||
129486366|NCT00624338|466073758|FG002|Overall Study|Other|9|||
129486367|NCT00624338|466073756|FG000|Overall Study|Randomized but not treated|2|||
129486368|NCT00624338|466073757|FG001|Overall Study|Randomized but not treated|1|||
129486369|NCT00624338|466073758|FG002|Overall Study|Randomized but not treated|3|||
129486370|NCT01548638|466073759|FG000|Overall Study|Protocol Violation|3|||
129486371|NCT01548638|466073759|FG000|Overall Study|Withdrawal by Subject|1|||
129486372|NCT01933672|466073763|FG000|Metformin Run-in Period|Adverse Event|1|||
129486373|NCT01933672|466073764|FG001|Metformin Run-in Period|Adverse Event|0|||
129486374|NCT01933672|466073765|FG002|Metformin Run-in Period|Adverse Event|0|||
129486375|NCT01933672|466073766|FG003|Metformin Run-in Period|Adverse Event|0|||
129486376|NCT01933672|466073767|FG004|Metformin Run-in Period|Adverse Event|0|||
129486377|NCT01933672|466073768|FG005|Metformin Run-in Period|Adverse Event|0|||
129486378|NCT01933672|466073769|FG006|Metformin Run-in Period|Adverse Event|0|||
129486379|NCT01933672|466073763|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
129486380|NCT01933672|466073764|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
129486381|NCT01933672|466073765|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
129486382|NCT01933672|466073766|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
129486383|NCT01933672|466073767|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
129486384|NCT01933672|466073768|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
129486385|NCT01933672|466073769|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
129486386|NCT01933672|466073763|FG000|Metformin Run-in Period|Other|5|||
129486387|NCT01933672|466073764|FG001|Metformin Run-in Period|Other|0|||
129486388|NCT01933672|466073765|FG002|Metformin Run-in Period|Other|0|||
129486389|NCT01933672|466073766|FG003|Metformin Run-in Period|Other|0|||
129486390|NCT01933672|466073767|FG004|Metformin Run-in Period|Other|0|||
129486391|NCT01933672|466073768|FG005|Metformin Run-in Period|Other|0|||
129486392|NCT01933672|466073769|FG006|Metformin Run-in Period|Other|0|||
129486393|NCT01933672|466073763|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486394|NCT01933672|466073764|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486395|NCT01933672|466073765|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486396|NCT01933672|466073766|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486397|NCT01933672|466073767|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
129486398|NCT01933672|466073768|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486399|NCT01933672|466073769|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129979566|NCT03248882|467889389|FG003|Overall Study|Protocol Violation|0|||
129979567|NCT03248882|467889390|FG004|Overall Study|Protocol Violation|1|||
129486400|NCT01933672|466073763|FG000|First Intervention Period (12-16 Days)|Other|0|||
129486401|NCT01933672|466073764|FG001|First Intervention Period (12-16 Days)|Other|0|||
129486402|NCT01933672|466073765|FG002|First Intervention Period (12-16 Days)|Other|1|||
129486403|NCT01933672|466073766|FG003|First Intervention Period (12-16 Days)|Other|0|||
129486404|NCT01933672|466073767|FG004|First Intervention Period (12-16 Days)|Other|0|||
129486405|NCT01933672|466073768|FG005|First Intervention Period (12-16 Days)|Other|1|||
129486406|NCT01933672|466073769|FG006|First Intervention Period (12-16 Days)|Other|0|||
129486407|NCT01933672|466073763|FG000|Second Intervention Period (12-16 Days)|Other|0|||
129486408|NCT01933672|466073764|FG001|Second Intervention Period (12-16 Days)|Other|1|||
129486409|NCT01933672|466073765|FG002|Second Intervention Period (12-16 Days)|Other|1|||
129486410|NCT01933672|466073766|FG003|Second Intervention Period (12-16 Days)|Other|0|||
129486411|NCT01933672|466073767|FG004|Second Intervention Period (12-16 Days)|Other|0|||
129486412|NCT01933672|466073768|FG005|Second Intervention Period (12-16 Days)|Other|0|||
129486413|NCT01933672|466073769|FG006|Second Intervention Period (12-16 Days)|Other|0|||
129486414|NCT01933672|466073763|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486415|NCT01933672|466073764|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486416|NCT01933672|466073765|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486417|NCT01933672|466073766|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
129486418|NCT01933672|466073767|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486419|NCT01933672|466073768|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486420|NCT01933672|466073769|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
129486421|NCT01933672|466073763|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129486422|NCT01933672|466073764|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
129486423|NCT01933672|466073765|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129486424|NCT01933672|466073766|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129486425|NCT01933672|466073767|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129486426|NCT01933672|466073768|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129486427|NCT01933672|466073769|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
129486428|NCT00778999|466073779|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
129486429|NCT00778999|466073780|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
129486430|NCT00778999|466073779|FG000|Overall Study|Did not receive recFSH|14|||
129486431|NCT00778999|466073780|FG001|Overall Study|Did not receive recFSH|20|||
129486432|NCT02032524|466073781|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
129486433|NCT02032524|466073782|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
129486434|NCT02032524|466073783|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
129486435|NCT02032524|466073784|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
129486436|NCT02032524|466073785|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
129486437|NCT02032524|466073786|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
129486438|NCT02032524|466073781|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
129486439|NCT02032524|466073782|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
129486440|NCT02032524|466073783|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
129486441|NCT02032524|466073784|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
129486442|NCT02032524|466073785|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
129486443|NCT02032524|466073786|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
129486444|NCT02032524|466073781|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
129486445|NCT02032524|466073782|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
129486446|NCT02032524|466073783|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
129486447|NCT02032524|466073784|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
129486448|NCT02032524|466073785|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
129486449|NCT02032524|466073786|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
129486450|NCT02032524|466073781|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
129486451|NCT02032524|466073782|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
129486452|NCT02032524|466073783|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
129486453|NCT02032524|466073784|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
129486454|NCT02032524|466073785|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
129486455|NCT02032524|466073786|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
129486456|NCT02032524|466073781|FG000|Period 2: LTS13769 Study|Other|0|||
129486457|NCT02032524|466073782|FG001|Period 2: LTS13769 Study|Other|0|||
129486458|NCT02032524|466073783|FG002|Period 2: LTS13769 Study|Other|0|||
129486459|NCT02032524|466073784|FG003|Period 2: LTS13769 Study|Other|0|||
129486460|NCT02032524|466073785|FG004|Period 2: LTS13769 Study|Other|0|||
129486461|NCT02032524|466073786|FG005|Period 2: LTS13769 Study|Other|1|||
129486462|NCT02975349|466073787|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129486463|NCT02975349|466073788|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129486464|NCT02975349|466073789|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129486465|NCT02975349|466073790|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
129486466|NCT02975349|466073791|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
129486467|NCT02975349|466073792|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129486468|NCT02975349|466073793|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129486469|NCT02975349|466073787|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129486470|NCT02975349|466073788|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129486471|NCT02975349|466073789|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129486472|NCT02975349|466073790|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129486473|NCT02975349|466073791|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129486474|NCT02975349|466073792|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129486475|NCT02975349|466073793|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129486476|NCT02975349|466073787|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
129486477|NCT02975349|466073788|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
129486478|NCT02975349|466073789|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
129486479|NCT02975349|466073790|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
129486480|NCT02975349|466073791|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
129486481|NCT02975349|466073792|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
129486482|NCT02975349|466073793|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
129486483|NCT02975349|466073787|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
129486484|NCT02975349|466073788|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
129486485|NCT02975349|466073789|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
129486486|NCT02975349|466073790|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
129486487|NCT02975349|466073791|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
129486488|NCT02975349|466073792|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
129486489|NCT02975349|466073793|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
129486490|NCT02975349|466073787|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
129486491|NCT02975349|466073788|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
129486492|NCT02975349|466073789|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
129486493|NCT02975349|466073790|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
129486494|NCT02975349|466073791|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
129486495|NCT02975349|466073792|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
129486496|NCT02975349|466073793|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
129486497|NCT02975349|466073787|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129486498|NCT02975349|466073788|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129486499|NCT02975349|466073789|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129486500|NCT02975349|466073790|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
129486501|NCT02975349|466073791|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129486502|NCT02975349|466073792|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129486503|NCT02975349|466073793|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
129486504|NCT02975349|466073787|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129486505|NCT02975349|466073788|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
129486506|NCT02975349|466073789|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129486507|NCT02975349|466073790|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129486508|NCT02975349|466073791|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129486509|NCT02975349|466073792|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129486510|NCT02975349|466073793|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
129486511|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
129486512|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
129486513|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
129486514|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
129486515|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
129486516|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
129486517|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
129486518|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
129486519|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
129486520|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
129486521|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
129486522|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
129486523|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
129486524|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
129486525|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
129486526|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
129486527|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
129486528|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
129486529|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
129486530|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
129486531|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
129486532|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
129486533|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
129486534|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
129486535|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
129486536|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
129486537|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
129486538|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
129486539|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
129486540|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
129486541|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
129486542|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
129486543|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
129486544|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
129486545|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
129486546|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
129486547|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
129486548|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
129486549|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
129486550|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
129486551|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
129486552|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
129486553|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
129486554|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
129486555|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
129486556|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
129486557|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
129486558|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
129486559|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
129486560|NCT02975349|466073787|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
129486561|NCT02975349|466073788|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
129486562|NCT02975349|466073789|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
129486563|NCT02975349|466073790|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
129486564|NCT02975349|466073791|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
129486565|NCT02975349|466073792|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
129486566|NCT02975349|466073793|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
129486567|NCT03567187|466073796|FG000|Overall Study|Lost to Follow-up|18|||
129486568|NCT02032875|466073799|FG000|Treatment Period|Adverse Event|1|||
129486569|NCT02032875|466073800|FG001|Treatment Period|Adverse Event|0|||
129486570|NCT02032875|466073799|FG000|Treatment Period|Liver transplant, No extension needed|0|||
129486571|NCT02032875|466073800|FG001|Treatment Period|Liver transplant, No extension needed|1|||
129486572|NCT02032875|466073799|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
129486573|NCT02032875|466073800|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
129486574|NCT02032875|466073799|FG000|Follow-up Period|Death|0|||
129486575|NCT02032875|466073800|FG001|Follow-up Period|Death|1|||
129486576|NCT02032875|466073799|FG000|Follow-up Period|Virologic Relapse|3|||
129486577|NCT02032875|466073800|FG001|Follow-up Period|Virologic Relapse|10|||
129486578|NCT04358458|466073801|FG000|Overall Study|Death|1|||
129486579|NCT04358458|466073802|FG001|Overall Study|Death|1|||
129486580|NCT04358458|466073803|FG002|Overall Study|Death|3|||
129486581|NCT04358458|466073804|FG003|Overall Study|Death|8|||
129486582|NCT04358458|466073805|FG004|Overall Study|Death|1|||
129486583|NCT04358458|466073806|FG005|Overall Study|Death|6|||
129486584|NCT04358458|466073807|FG006|Overall Study|Death|2|||
129486585|NCT04358458|466073808|FG007|Overall Study|Death|3|||
129486586|NCT04358458|466073801|FG000|Overall Study|Lost to Follow-up|0|||
129486587|NCT04358458|466073802|FG001|Overall Study|Lost to Follow-up|0|||
129486588|NCT04358458|466073803|FG002|Overall Study|Lost to Follow-up|0|||
129486589|NCT04358458|466073804|FG003|Overall Study|Lost to Follow-up|0|||
129486590|NCT04358458|466073805|FG004|Overall Study|Lost to Follow-up|0|||
129486591|NCT04358458|466073806|FG005|Overall Study|Lost to Follow-up|0|||
129486592|NCT04358458|466073807|FG006|Overall Study|Lost to Follow-up|0|||
129486593|NCT04358458|466073808|FG007|Overall Study|Lost to Follow-up|1|||
129486594|NCT04358458|466073801|FG000|Overall Study|Site is closing study participation|0|||
129486595|NCT04358458|466073802|FG001|Overall Study|Site is closing study participation|0|||
129486596|NCT04358458|466073803|FG002|Overall Study|Site is closing study participation|0|||
129486597|NCT04358458|466073804|FG003|Overall Study|Site is closing study participation|1|||
129486598|NCT04358458|466073805|FG004|Overall Study|Site is closing study participation|0|||
129486599|NCT04358458|466073806|FG005|Overall Study|Site is closing study participation|0|||
129486600|NCT04358458|466073807|FG006|Overall Study|Site is closing study participation|0|||
129486601|NCT04358458|466073808|FG007|Overall Study|Site is closing study participation|0|||
129979568|NCT03248882|467889386|FG000|Overall Study|Withdrawal by Subject|2|||
129486602|NCT04358458|466073801|FG000|Overall Study|Sponsor request|2|||
129486603|NCT04358458|466073802|FG001|Overall Study|Sponsor request|3|||
129486604|NCT04358458|466073803|FG002|Overall Study|Sponsor request|3|||
129486605|NCT04358458|466073804|FG003|Overall Study|Sponsor request|0|||
129486606|NCT04358458|466073805|FG004|Overall Study|Sponsor request|2|||
129486607|NCT04358458|466073806|FG005|Overall Study|Sponsor request|3|||
129486608|NCT04358458|466073807|FG006|Overall Study|Sponsor request|1|||
129486609|NCT04358458|466073808|FG007|Overall Study|Sponsor request|1|||
129486610|NCT04358458|466073801|FG000|Overall Study|Withdrawal by Subject|0|||
129979569|NCT03248882|467889387|FG001|Overall Study|Withdrawal by Subject|2|||
129486611|NCT04358458|466073802|FG001|Overall Study|Withdrawal by Subject|0|||
129486612|NCT04358458|466073803|FG002|Overall Study|Withdrawal by Subject|1|||
129486613|NCT04358458|466073804|FG003|Overall Study|Withdrawal by Subject|1|||
129486614|NCT04358458|466073805|FG004|Overall Study|Withdrawal by Subject|0|||
129486615|NCT04358458|466073806|FG005|Overall Study|Withdrawal by Subject|1|||
129486616|NCT04358458|466073807|FG006|Overall Study|Withdrawal by Subject|0|||
129486617|NCT04358458|466073808|FG007|Overall Study|Withdrawal by Subject|1|||
129486618|NCT00151411|466075124|FG000|Overall Study|Lost to Follow-up|15|||
129486619|NCT00151411|466075125|FG001|Overall Study|Lost to Follow-up|19|||
129486620|NCT00151411|466075124|FG000|Overall Study|Withdrawal by Subject|12|||
129486621|NCT00151411|466075125|FG001|Overall Study|Withdrawal by Subject|20|||
129486622|NCT00151411|466075124|FG000|Overall Study|Adverse Event|6|||
129486623|NCT00151411|466075125|FG001|Overall Study|Adverse Event|0|||
129486624|NCT00151411|466075124|FG000|Overall Study|Pregnancy|0|||
129486625|NCT00151411|466075125|FG001|Overall Study|Pregnancy|4|||
129486626|NCT01712438|466075126|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
129486627|NCT01712438|466075126|FG000|Overall Study|Ongoing ITI treatment|6|||
129486628|NCT01712438|466075126|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
129486629|NCT01712438|466075126|FG000|Overall Study|Prematurely Discontinued|25|||
129486630|NCT04426630|466075127|FG000|Overall Study|Death|4|||
129486631|NCT04426630|466075127|FG000|Overall Study|Lost to Follow-up|2|||
129486632|NCT01157169|466075130|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
129486633|NCT01157169|466075131|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
129486634|NCT01157169|466075130|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
129486635|NCT01157169|466075131|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
129486636|NCT01123889|466075132|FG000|Overall Study|Lost to Follow-up|3|||
129486637|NCT01123889|466075133|FG001|Overall Study|Lost to Follow-up|1|||
129486638|NCT03846947|466075138|FG000|Overall Study|technical issues with imaging sequence|2|||
129486639|NCT05299892|466075149|FG000|Overall Study|Withdrawal by Subject|2|||
129486640|NCT03334214|466075151|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
129486641|NCT03334214|466075152|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
129486642|NCT03334214|466075151|FG000|Overall Study|Withdrawal by Subject|0|||
129486643|NCT03334214|466075152|FG001|Overall Study|Withdrawal by Subject|1|||
129486644|NCT03334214|466075151|FG000|Overall Study|Other|1|||
129486645|NCT03334214|466075152|FG001|Overall Study|Other|0|||
129486646|NCT01260181|466075155|FG000|Overall Study|Decision of Investigator|1|||
129486647|NCT01844076|466075158|FG000|Overall Study|Adverse Event|1|||
129486648|NCT01844076|466075159|FG001|Overall Study|Adverse Event|0|||
129486649|NCT01844076|466075160|FG002|Overall Study|Adverse Event|0|||
129486650|NCT01844076|466075161|FG003|Overall Study|Adverse Event|0|||
129486651|NCT01844076|466075158|FG000|Overall Study|Withdrawal by Subject|1|||
129486652|NCT01844076|466075159|FG001|Overall Study|Withdrawal by Subject|0|||
129486653|NCT01844076|466075160|FG002|Overall Study|Withdrawal by Subject|0|||
129486654|NCT01844076|466075161|FG003|Overall Study|Withdrawal by Subject|0|||
129486655|NCT01937312|466075163|FG000|Overall Study|Adverse Event|10|||
129486656|NCT01937312|466075164|FG001|Overall Study|Adverse Event|1|||
129486657|NCT01937312|466075163|FG000|Overall Study|Lack of Efficacy|0|||
129486658|NCT01937312|466075164|FG001|Overall Study|Lack of Efficacy|1|||
129486659|NCT01937312|466075163|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
129486660|NCT01937312|466075164|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
129486661|NCT01025336|466075167|FG000|Overall Study|Protocol Violation|0|||
129486662|NCT01025336|466075168|FG001|Overall Study|Protocol Violation|0|||
129486663|NCT01025336|466075169|FG002|Overall Study|Protocol Violation|0|||
129486664|NCT01025336|466075170|FG003|Overall Study|Protocol Violation|2|||
129486665|NCT01025336|466075171|FG004|Overall Study|Protocol Violation|0|||
129486666|NCT03133481|466075172|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
129486667|NCT03133481|466075173|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
129486668|NCT00637728|466075180|FG000|Double-blind Phase|Adverse Event|1|||
129486669|NCT00637728|466075181|FG001|Double-blind Phase|Adverse Event|0|||
129486670|NCT00637728|466075182|FG002|Double-blind Phase|Adverse Event|0|||
129486671|NCT00637728|466075180|FG000|Double-blind Phase|Non-compliance|2|||
129486672|NCT00637728|466075181|FG001|Double-blind Phase|Non-compliance|0|||
129486673|NCT00637728|466075182|FG002|Double-blind Phase|Non-compliance|0|||
129486674|NCT00637728|466075180|FG000|Double-blind Phase|Study Discontinued|1|||
129486675|NCT00637728|466075181|FG001|Double-blind Phase|Study Discontinued|1|||
129486676|NCT00637728|466075182|FG002|Double-blind Phase|Study Discontinued|0|||
129486677|NCT00593112|466075185|FG000|Overall Study|Scan Anxiety|3|||
129486678|NCT00593112|466075186|FG001|Overall Study|Scan Anxiety|0|||
129486679|NCT00593112|466075185|FG000|Overall Study|Abnormal Scan|1|||
129486680|NCT00593112|466075186|FG001|Overall Study|Abnormal Scan|0|||
129486681|NCT00593112|466075185|FG000|Overall Study|Unreadable Scan|1|||
129486682|NCT00593112|466075186|FG001|Overall Study|Unreadable Scan|0|||
129486683|NCT00593112|466075185|FG000|Overall Study|Withdrawal by Subject|5|||
129486684|NCT00593112|466075186|FG001|Overall Study|Withdrawal by Subject|0|||
129486685|NCT02723630|466075187|FG000|Intervention Period 1|Adverse Event|1|||
129486686|NCT02723630|466075188|FG001|Intervention Period 1|Adverse Event|0|||
129486687|NCT02723630|466075189|FG002|Intervention Period 1|Adverse Event|0|||
129486688|NCT02723630|466075190|FG003|Intervention Period 1|Adverse Event|0|||
129486689|NCT02723630|466075191|FG004|Intervention Period 1|Adverse Event|0|||
129486690|NCT02723630|466075192|FG005|Intervention Period 1|Adverse Event|0|||
129486691|NCT02723630|466075187|FG000|Intervention Period 3|consumption of restricted item|0|||
129486692|NCT02723630|466075188|FG001|Intervention Period 3|consumption of restricted item|1|||
129486693|NCT02723630|466075189|FG002|Intervention Period 3|consumption of restricted item|0|||
129486694|NCT02723630|466075190|FG003|Intervention Period 3|consumption of restricted item|0|||
129486695|NCT02723630|466075191|FG004|Intervention Period 3|consumption of restricted item|0|||
129486696|NCT02723630|466075192|FG005|Intervention Period 3|consumption of restricted item|0|||
129486697|NCT01184989|466075193|FG000|Overall Study|Adverse Event|11|||
129486698|NCT01184989|466075193|FG000|Overall Study|Withdrawal by Subject|1|||
129486699|NCT04407507|466075194|FG000|Overall Study|Withdrawal by Subject|0|||
129486700|NCT04407507|466075195|FG001|Overall Study|Withdrawal by Subject|1|||
129486701|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Adverse Event|12|||
129486702|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Adverse Event|3|||
129486703|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Adverse Event|4|||
129486704|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Adverse Event|2|||
129486705|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
129486706|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
129486707|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
129486708|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
129486709|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
129486710|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
129486711|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
129486712|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
129486713|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
129486714|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
129486715|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
129486716|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
129486717|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
129486718|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
129486719|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
129486720|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
129486721|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
129486722|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
129486723|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
129486724|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
129486725|NCT02436239|466075198|FG000|Open-Lable Treatment Period|Other Reason|1|||
129486726|NCT02436239|466075199|FG001|Open-Lable Treatment Period|Other Reason|1|||
129486727|NCT02436239|466075200|FG002|Open-Lable Treatment Period|Other Reason|0|||
129486728|NCT02436239|466075201|FG003|Open-Lable Treatment Period|Other Reason|0|||
129486729|NCT02436239|466075198|FG000|Down-Taper Period|Withdrawal by Subject|4|||
129486730|NCT02436239|466075199|FG001|Down-Taper Period|Withdrawal by Subject|4|||
129486731|NCT02436239|466075200|FG002|Down-Taper Period|Withdrawal by Subject|1|||
129486732|NCT02436239|466075201|FG003|Down-Taper Period|Withdrawal by Subject|2|||
129486733|NCT03443024|466075205|FG000|Overall Study|Adverse Event|2|||
129486734|NCT03443024|466075206|FG001|Overall Study|Adverse Event|4|||
129486735|NCT03443024|466075207|FG002|Overall Study|Adverse Event|3|||
129486736|NCT03443024|466075208|FG003|Overall Study|Adverse Event|1|||
129486737|NCT03443024|466075205|FG000|Overall Study|Lost to Follow-up|9|||
129486738|NCT03443024|466075206|FG001|Overall Study|Lost to Follow-up|9|||
129486739|NCT03443024|466075207|FG002|Overall Study|Lost to Follow-up|7|||
129486740|NCT03443024|466075208|FG003|Overall Study|Lost to Follow-up|5|||
129486741|NCT03443024|466075205|FG000|Overall Study|Withdrawal by Subject|8|||
129486742|NCT03443024|466075206|FG001|Overall Study|Withdrawal by Subject|15|||
129486743|NCT03443024|466075207|FG002|Overall Study|Withdrawal by Subject|9|||
129486744|NCT03443024|466075208|FG003|Overall Study|Withdrawal by Subject|23|||
129486745|NCT03443024|466075205|FG000|Overall Study|Physician Decision|1|||
129486746|NCT03443024|466075206|FG001|Overall Study|Physician Decision|2|||
129486747|NCT03443024|466075207|FG002|Overall Study|Physician Decision|0|||
129486748|NCT03443024|466075208|FG003|Overall Study|Physician Decision|1|||
129486749|NCT03443024|466075205|FG000|Overall Study|Sponsor Decision|1|||
129486750|NCT03443024|466075206|FG001|Overall Study|Sponsor Decision|1|||
129486751|NCT03443024|466075207|FG002|Overall Study|Sponsor Decision|0|||
129486752|NCT03443024|466075208|FG003|Overall Study|Sponsor Decision|0|||
129486753|NCT03443024|466075205|FG000|Overall Study|Protocol Deviation|0|||
129486754|NCT03443024|466075206|FG001|Overall Study|Protocol Deviation|0|||
129486755|NCT03443024|466075207|FG002|Overall Study|Protocol Deviation|0|||
129486756|NCT03443024|466075208|FG003|Overall Study|Protocol Deviation|2|||
129486757|NCT05897853|466075210|FG000|Overall Study|Lost to Follow-up|2|||
129486758|NCT05897853|466075211|FG001|Overall Study|Lost to Follow-up|0|||
129486759|NCT05897853|466075210|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
129486760|NCT05897853|466075211|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
129486761|NCT02782715|466075216|FG000|Overall Study|Withdrawal by Subject|1|||
129486762|NCT04458857|466075217|FG000|Overall Study|Adverse Event|0|||
129486763|NCT04458857|466075218|FG001|Overall Study|Adverse Event|1|||
129486764|NCT04458857|466075219|FG002|Overall Study|Adverse Event|0|||
129486765|NCT04458857|466075217|FG000|Overall Study|Withdrawal by Subject|2|||
129486766|NCT04458857|466075218|FG001|Overall Study|Withdrawal by Subject|0|||
129486767|NCT04458857|466075219|FG002|Overall Study|Withdrawal by Subject|0|||
129486768|NCT04458857|466075217|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129486769|NCT04458857|466075218|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129486770|NCT04458857|466075219|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129486771|NCT04458857|466075217|FG000|Overall Study|Non-compliance with study drug|0|||
129486772|NCT04458857|466075218|FG001|Overall Study|Non-compliance with study drug|1|||
129486773|NCT04458857|466075219|FG002|Overall Study|Non-compliance with study drug|0|||
129486774|NCT04458857|466075217|FG000|Overall Study|Lost to Follow-up|4|||
129486775|NCT04458857|466075218|FG001|Overall Study|Lost to Follow-up|1|||
129486776|NCT04458857|466075219|FG002|Overall Study|Lost to Follow-up|0|||
129486777|NCT02986373|466075220|FG000|Overall Study|Adverse Event|4|||
129486778|NCT02986373|466075220|FG000|Overall Study|Lost to Follow-up|1|||
129486779|NCT02986373|466075220|FG000|Overall Study|Withdrawal by Subject|10|||
129486780|NCT02986373|466075220|FG000|Overall Study|Other|24|||
129486781|NCT03368404|466075228|FG000|Overall Study|Adverse Event|2|||
129486782|NCT03368404|466075229|FG001|Overall Study|Adverse Event|1|||
129486783|NCT03368404|466075228|FG000|Overall Study|Withdrawal by Subject|1|||
129486784|NCT03368404|466075229|FG001|Overall Study|Withdrawal by Subject|1|||
129486785|NCT00995371|466075230|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
129486786|NCT00995371|466075231|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
129486787|NCT02983292|466075232|FG000|Overall Study|Participant unwell & cannot travel|2|||
129486788|NCT02983292|466075232|FG000|Overall Study|Lost to Follow-up|3|||
129486789|NCT02983292|466075232|FG000|Overall Study|Participant withdrew consent|2|||
129486790|NCT02983292|466075232|FG000|Overall Study|Revision|7|||
129486791|NCT02983292|466075232|FG000|Overall Study|Death|1|||
129486792|NCT02983292|466075232|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
129486793|NCT02983292|466075232|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
129486794|NCT02983292|466075232|FG000|Overall Study|Participant relocation|1|||
129486795|NCT04725682|466075233|FG000|Overall Study|Withdrawal by Subject|7|||
129486796|NCT04725682|466075234|FG001|Overall Study|Withdrawal by Subject|5|||
129486797|NCT04725682|466075233|FG000|Overall Study|Failed to comply with the requirements|2|||
129486798|NCT04725682|466075234|FG001|Overall Study|Failed to comply with the requirements|1|||
129486799|NCT04725682|466075233|FG000|Overall Study|Adverse Event|1|||
129486800|NCT04725682|466075234|FG001|Overall Study|Adverse Event|1|||
129486801|NCT04725682|466075233|FG000|Overall Study|Death|0|||
129486802|NCT04725682|466075234|FG001|Overall Study|Death|1|||
129486803|NCT01607892|466075236|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
129486804|NCT01607892|466075237|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
129486805|NCT01607892|466075238|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
129486806|NCT01607892|466075239|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
129486807|NCT01607892|466075240|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
129486808|NCT01607892|466075236|FG000|Overall Study|Death|4|||
129486809|NCT01607892|466075237|FG001|Overall Study|Death|2|||
129486810|NCT01607892|466075238|FG002|Overall Study|Death|8|||
129486811|NCT01607892|466075239|FG003|Overall Study|Death|10|||
129486812|NCT01607892|466075240|FG004|Overall Study|Death|3|||
129486813|NCT01607892|466075236|FG000|Overall Study|Investigator discretion|2|||
129486814|NCT01607892|466075237|FG001|Overall Study|Investigator discretion|4|||
129486815|NCT01607892|466075238|FG002|Overall Study|Investigator discretion|4|||
129486816|NCT01607892|466075239|FG003|Overall Study|Investigator discretion|8|||
129486817|NCT01607892|466075240|FG004|Overall Study|Investigator discretion|0|||
129486818|NCT01607892|466075236|FG000|Overall Study|Other treatments became available|1|||
129486819|NCT01607892|466075237|FG001|Overall Study|Other treatments became available|1|||
129486820|NCT01607892|466075238|FG002|Overall Study|Other treatments became available|0|||
129486821|NCT01607892|466075239|FG003|Overall Study|Other treatments became available|0|||
129486822|NCT01607892|466075240|FG004|Overall Study|Other treatments became available|2|||
129486823|NCT01607892|466075236|FG000|Overall Study|Intercurrent illness|1|||
129486824|NCT01607892|466075237|FG001|Overall Study|Intercurrent illness|0|||
129979570|NCT03248882|467889388|FG002|Overall Study|Withdrawal by Subject|3|||
129979571|NCT03248882|467889389|FG003|Overall Study|Withdrawal by Subject|4|||
129979572|NCT03248882|467889390|FG004|Overall Study|Withdrawal by Subject|2|||
129486825|NCT01607892|466075238|FG002|Overall Study|Intercurrent illness|0|||
129486826|NCT01607892|466075239|FG003|Overall Study|Intercurrent illness|3|||
129486827|NCT01607892|466075240|FG004|Overall Study|Intercurrent illness|0|||
129486828|NCT01607892|466075236|FG000|Overall Study|Non-Compliance with study procedures|0|||
129486829|NCT01607892|466075237|FG001|Overall Study|Non-Compliance with study procedures|0|||
129486830|NCT01607892|466075238|FG002|Overall Study|Non-Compliance with study procedures|1|||
129979573|NCT01156376|467889393|FG000|Overall Study|Adverse Event|1|||
129486831|NCT01607892|466075239|FG003|Overall Study|Non-Compliance with study procedures|0|||
129486832|NCT01607892|466075240|FG004|Overall Study|Non-Compliance with study procedures|0|||
129486833|NCT01607892|466075236|FG000|Overall Study|Consent withdrawn by participant|9|||
129486834|NCT01607892|466075237|FG001|Overall Study|Consent withdrawn by participant|4|||
129486835|NCT01607892|466075238|FG002|Overall Study|Consent withdrawn by participant|24|||
129486836|NCT01607892|466075239|FG003|Overall Study|Consent withdrawn by participant|14|||
129486837|NCT01607892|466075240|FG004|Overall Study|Consent withdrawn by participant|4|||
129486838|NCT01607892|466075236|FG000|Overall Study|Disease progression|38|||
129486839|NCT01607892|466075237|FG001|Overall Study|Disease progression|13|||
129486840|NCT01607892|466075238|FG002|Overall Study|Disease progression|37|||
129486841|NCT01607892|466075239|FG003|Overall Study|Disease progression|57|||
129486842|NCT01607892|466075240|FG004|Overall Study|Disease progression|9|||
129486843|NCT01607892|466075236|FG000|Overall Study|Incidence or severity of Adverse events|3|||
129486844|NCT01607892|466075237|FG001|Overall Study|Incidence or severity of Adverse events|3|||
129486845|NCT01607892|466075238|FG002|Overall Study|Incidence or severity of Adverse events|7|||
129486846|NCT01607892|466075239|FG003|Overall Study|Incidence or severity of Adverse events|2|||
129486847|NCT01607892|466075240|FG004|Overall Study|Incidence or severity of Adverse events|6|||
129486848|NCT03414359|466075241|FG000|Overall Study|Lack of Efficacy|1|||
129486849|NCT03414359|466075242|FG001|Overall Study|Lack of Efficacy|1|||
129486850|NCT03414359|466075241|FG000|Overall Study|Protocol Violation|0|||
129486851|NCT03414359|466075242|FG001|Overall Study|Protocol Violation|1|||
129486852|NCT02273973|466075245|FG000|Overall Study|Adverse Event|4|||
129486853|NCT02273973|466075246|FG001|Overall Study|Adverse Event|0|||
129486854|NCT02273973|466075245|FG000|Overall Study|Withdrawal by Subject|2|||
129486855|NCT02273973|466075246|FG001|Overall Study|Withdrawal by Subject|3|||
129486856|NCT02273973|466075245|FG000|Overall Study|Death|1|||
129486857|NCT02273973|466075246|FG001|Overall Study|Death|0|||
129486858|NCT02273973|466075245|FG000|Overall Study|Non-compliance|1|||
129486859|NCT02273973|466075246|FG001|Overall Study|Non-compliance|0|||
129486860|NCT02273973|466075245|FG000|Overall Study|Protocol Violation|1|||
129486861|NCT02273973|466075246|FG001|Overall Study|Protocol Violation|0|||
129486862|NCT02273973|466075245|FG000|Overall Study|Progression of disease|0|||
129486863|NCT02273973|466075246|FG001|Overall Study|Progression of disease|2|||
129486864|NCT02273973|466075245|FG000|Overall Study|Lost to Follow-up|0|||
129486865|NCT02273973|466075246|FG001|Overall Study|Lost to Follow-up|1|||
129486866|NCT02273973|466075245|FG000|Overall Study|Physician Decision|0|||
129486867|NCT02273973|466075246|FG001|Overall Study|Physician Decision|1|||
129486868|NCT02273973|466075245|FG000|Overall Study|Reason not specified|0|||
129486869|NCT02273973|466075246|FG001|Overall Study|Reason not specified|1|||
129486870|NCT03022422|466075248|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
129486871|NCT03022422|466075249|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
129486872|NCT03022422|466075250|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
129486873|NCT03022422|466075251|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
129486874|NCT03022422|466075252|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
129486875|NCT03022422|466075253|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
129486876|NCT00957372|466075254|FG000|PART I|Lost to Follow-up|0|||
129486877|NCT00957372|466075255|FG001|PART I|Lost to Follow-up|0|||
129486878|NCT00957372|466075256|FG002|PART I|Lost to Follow-up|1|||
129486879|NCT00957372|466075257|FG003|PART I|Lost to Follow-up|0|||
129486880|NCT00957372|466075254|FG000|PART II|Withdrawal by Subject|0|||
129486881|NCT00957372|466075255|FG001|PART II|Withdrawal by Subject|0|||
129486882|NCT00957372|466075256|FG002|PART II|Withdrawal by Subject|0|||
129486883|NCT00957372|466075257|FG003|PART II|Withdrawal by Subject|8|||
129486884|NCT00957372|466075254|FG000|PART II|Physician Decision|0|||
129486885|NCT00957372|466075255|FG001|PART II|Physician Decision|0|||
129486886|NCT00957372|466075256|FG002|PART II|Physician Decision|0|||
129486887|NCT00957372|466075257|FG003|PART II|Physician Decision|1|||
129486888|NCT00957372|466075254|FG000|PART II|Pregnancy|0|||
129486889|NCT00957372|466075255|FG001|PART II|Pregnancy|0|||
129486890|NCT00957372|466075256|FG002|PART II|Pregnancy|0|||
129486891|NCT00957372|466075257|FG003|PART II|Pregnancy|1|||
129486892|NCT00957372|466075254|FG000|PART II|Not Know|0|||
129486893|NCT00957372|466075255|FG001|PART II|Not Know|0|||
129486894|NCT00957372|466075256|FG002|PART II|Not Know|0|||
129486895|NCT00957372|466075257|FG003|PART II|Not Know|20|||
129486896|NCT00957372|466075254|FG000|PART II|Adverse Event|0|||
129486897|NCT00957372|466075255|FG001|PART II|Adverse Event|0|||
129486898|NCT00957372|466075256|FG002|PART II|Adverse Event|0|||
129486899|NCT00957372|466075257|FG003|PART II|Adverse Event|10|||
129486900|NCT00957372|466075254|FG000|PART II|Patient non-compliance|0|||
129486901|NCT00957372|466075255|FG001|PART II|Patient non-compliance|0|||
129486902|NCT00957372|466075256|FG002|PART II|Patient non-compliance|0|||
129486903|NCT00957372|466075257|FG003|PART II|Patient non-compliance|4|||
129486904|NCT01282814|466075258|FG000|First Intervention|Emesis During Dosing Interval|0|||
129486905|NCT01282814|466075259|FG001|First Intervention|Emesis During Dosing Interval|3|||
129486906|NCT01282814|466075258|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
129486907|NCT01282814|466075259|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
129486908|NCT02403206|466075260|FG000|Overall Study|Lost to Follow-up|4|||
129979574|NCT01156376|467889394|FG001|Overall Study|Adverse Event|0|||
129979575|NCT01156376|467889395|FG002|Overall Study|Adverse Event|1|||
129486909|NCT02403206|466075261|FG001|Overall Study|Lost to Follow-up|3|||
129486910|NCT02403206|466075260|FG000|Overall Study|Physician Decision|2|||
129486911|NCT02403206|466075261|FG001|Overall Study|Physician Decision|0|||
129486912|NCT02403206|466075260|FG000|Overall Study|Withdrawal by Subject|3|||
129486913|NCT02403206|466075261|FG001|Overall Study|Withdrawal by Subject|3|||
129486914|NCT02403206|466075260|FG000|Overall Study|Reason not given|2|||
129486915|NCT02403206|466075261|FG001|Overall Study|Reason not given|4|||
129486916|NCT01444391|466075262|FG000|Overall Study|Death|1|||
129486917|NCT02704429|466075263|FG000|Part A: 24 Weeks|Adverse Event|3|||
129486918|NCT02704429|466075264|FG001|Part A: 24 Weeks|Adverse Event|0|||
129486919|NCT02704429|466075263|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
129486920|NCT02704429|466075264|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
129486921|NCT02209597|466075267|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
129486922|NCT02209597|466075267|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
129486923|NCT02209597|466075267|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
129486924|NCT02209597|466075267|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
129486925|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Adverse Event|37|||
129486926|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Adverse Event|0|||
129486927|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Adverse Event|0|||
129486928|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Adverse Event|0|||
129486929|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Death|2|||
129486930|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Death|0|||
129486931|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Death|0|||
129486932|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Death|0|||
129486933|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
129486934|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
129486935|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
129486936|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
129486937|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
129486938|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
129486939|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
129486940|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
129486941|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
129486942|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
129486943|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
129486944|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
129486945|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
129486946|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
129486947|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
129486948|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
129486949|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Physician Decision|4|||
129486950|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Physician Decision|0|||
129486951|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Physician Decision|0|||
129486952|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Physician Decision|0|||
129486953|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Pregnancy|1|||
129486954|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Pregnancy|0|||
129486955|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Pregnancy|0|||
129486956|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Pregnancy|0|||
129486957|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
129486958|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
129486959|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
129486960|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
129486961|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
129486962|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
129486963|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
129486964|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
129486965|NCT01855789|466075269|FG000|1) Baseline up to Week 24|Other|4|||
129486966|NCT01855789|466075270|FG001|1) Baseline up to Week 24|Other|0|||
129486967|NCT01855789|466075271|FG002|1) Baseline up to Week 24|Other|0|||
129486968|NCT01855789|466075272|FG003|1) Baseline up to Week 24|Other|0|||
129486969|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
129486970|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
129486971|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
129486972|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
129486973|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
129486974|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
129486975|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
129486976|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
129486977|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
129486978|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
129486979|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
129486980|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
129486981|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
129486982|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
129486983|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
129486984|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
129486985|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
129486986|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
129486987|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
129486988|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
129486989|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
129486990|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
129486991|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
129486992|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
129486993|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
129486994|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
129486995|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
129486996|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
129486997|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
129486998|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
129486999|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
129487000|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
129487001|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
129487002|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
129487003|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
129487004|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
129487005|NCT01855789|466075269|FG000|2) Week 24 up to End of Study|Other|0|||
129487006|NCT01855789|466075270|FG001|2) Week 24 up to End of Study|Other|0|||
129487007|NCT01855789|466075271|FG002|2) Week 24 up to End of Study|Other|0|||
129487008|NCT01855789|466075272|FG003|2) Week 24 up to End of Study|Other|1|||
129487009|NCT03067311|466075273|FG000|Overall Study|Lost to Follow-up|1|||
129487010|NCT03067311|466075274|FG001|Overall Study|Lost to Follow-up|1|||
129487011|NCT03067311|466075273|FG000|Overall Study|Moved away|1|||
129487012|NCT03067311|466075274|FG001|Overall Study|Moved away|1|||
129487013|NCT00907738|466075275|FG000|Overall Study|Adverse Event|2|||
129487014|NCT00907738|466075276|FG001|Overall Study|Adverse Event|0|||
129487015|NCT00907738|466075277|FG002|Overall Study|Adverse Event|1|||
129487016|NCT00907738|466075278|FG003|Overall Study|Adverse Event|0|||
129487017|NCT00907738|466075279|FG004|Overall Study|Adverse Event|0|||
129487018|NCT00907738|466075275|FG000|Overall Study|not specified or withdrew consent|3|||
129487019|NCT00907738|466075276|FG001|Overall Study|not specified or withdrew consent|0|||
129487020|NCT00907738|466075277|FG002|Overall Study|not specified or withdrew consent|0|||
129487021|NCT00907738|466075278|FG003|Overall Study|not specified or withdrew consent|0|||
129487022|NCT00907738|466075279|FG004|Overall Study|not specified or withdrew consent|0|||
129487023|NCT00907738|466075275|FG000|Overall Study|Disease progression|8|||
129487024|NCT00907738|466075276|FG001|Overall Study|Disease progression|1|||
129979576|NCT01156376|467889393|FG000|Overall Study|Withdrawal by Subject|0|||
129487025|NCT00907738|466075277|FG002|Overall Study|Disease progression|6|||
129487026|NCT00907738|466075278|FG003|Overall Study|Disease progression|4|||
129487027|NCT00907738|466075279|FG004|Overall Study|Disease progression|2|||
129487028|NCT02031146|466076783|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
129487029|NCT02031146|466076784|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
129487030|NCT02031146|466076785|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
129487031|NCT02031146|466076786|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
129487032|NCT02031146|466076787|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
129487033|NCT02031146|466076788|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
129487034|NCT02031146|466076789|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
129487035|NCT03937986|466076800|FG000|Overall Study|COVID-19 Pandemic|1|||
129487036|NCT02114203|466076805|FG000|Overall Study|Adverse Event|0|||
129487037|NCT02114203|466076806|FG001|Overall Study|Adverse Event|1|||
129487038|NCT02114203|466076807|FG002|Overall Study|Adverse Event|0|||
129487039|NCT02114203|466076805|FG000|Overall Study|Withdrawal by Subject|0|||
129487040|NCT02114203|466076806|FG001|Overall Study|Withdrawal by Subject|1|||
129487041|NCT02114203|466076807|FG002|Overall Study|Withdrawal by Subject|0|||
129487042|NCT01518699|466076808|FG000|Period 2|Protocol Violation|1|||
129487043|NCT01518699|466076809|FG001|Period 2|Protocol Violation|1|||
129487044|NCT01518699|466076810|FG002|Period 2|Protocol Violation|0|||
129487045|NCT01518699|466076811|FG003|Period 2|Protocol Violation|0|||
129487046|NCT01518699|466076812|FG004|Period 2|Protocol Violation|0|||
129487047|NCT01518699|466076813|FG005|Period 2|Protocol Violation|0|||
129487048|NCT01518699|466076808|FG000|Period 2|Lost to Follow-up|0|||
129487049|NCT01518699|466076809|FG001|Period 2|Lost to Follow-up|1|||
129487050|NCT01518699|466076810|FG002|Period 2|Lost to Follow-up|0|||
129487051|NCT01518699|466076811|FG003|Period 2|Lost to Follow-up|0|||
129487052|NCT01518699|466076812|FG004|Period 2|Lost to Follow-up|0|||
129487053|NCT01518699|466076813|FG005|Period 2|Lost to Follow-up|0|||
129487054|NCT01518699|466076808|FG000|Period 2|Adverse Event|1|||
129487055|NCT01518699|466076809|FG001|Period 2|Adverse Event|0|||
129487056|NCT01518699|466076810|FG002|Period 2|Adverse Event|0|||
129487057|NCT01518699|466076811|FG003|Period 2|Adverse Event|0|||
129487058|NCT01518699|466076812|FG004|Period 2|Adverse Event|0|||
129487059|NCT01518699|466076813|FG005|Period 2|Adverse Event|0|||
129487060|NCT02839746|466076815|FG000|Overall Study|Not met selection criteria|12|||
129487061|NCT00744055|466076816|FG000|Overall Study|Withdrawal by Subject|6|||
129487062|NCT00744055|466076817|FG001|Overall Study|Withdrawal by Subject|9|||
129487063|NCT00744055|466076816|FG000|Overall Study|Lack of Efficacy|0|||
129487064|NCT00744055|466076817|FG001|Overall Study|Lack of Efficacy|1|||
129487065|NCT00744055|466076816|FG000|Overall Study|Physician Decision|0|||
129487066|NCT00744055|466076817|FG001|Overall Study|Physician Decision|2|||
129487067|NCT00744055|466076816|FG000|Overall Study|Protocol Violation|1|||
129487068|NCT00744055|466076817|FG001|Overall Study|Protocol Violation|1|||
129487069|NCT00744055|466076816|FG000|Overall Study|Lost to Follow-up|0|||
129487070|NCT00744055|466076817|FG001|Overall Study|Lost to Follow-up|1|||
129487071|NCT02767570|466076818|FG000|Overall Study|Lost to Follow-up|3|||
129487072|NCT02767570|466076819|FG001|Overall Study|Lost to Follow-up|0|||
129487073|NCT02767570|466076818|FG000|Overall Study|COVID shutdown|2|||
129487074|NCT02767570|466076819|FG001|Overall Study|COVID shutdown|5|||
129487075|NCT02767570|466076818|FG000|Overall Study|Increased pain|2|||
129487076|NCT02767570|466076819|FG001|Overall Study|Increased pain|0|||
129487077|NCT02767570|466076818|FG000|Overall Study|Withdrawal by Subject|1|||
129487078|NCT02767570|466076819|FG001|Overall Study|Withdrawal by Subject|3|||
129487079|NCT02767570|466076818|FG000|Overall Study|Unrelated medical issue|1|||
129487080|NCT02767570|466076819|FG001|Overall Study|Unrelated medical issue|1|||
129487081|NCT02767570|466076818|FG000|Overall Study|Received intra-articular injection|0|||
129487082|NCT02767570|466076819|FG001|Overall Study|Received intra-articular injection|1|||
129487083|NCT01330381|466076820|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
129487084|NCT01330381|466076821|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
129487085|NCT01330381|466076822|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
129487086|NCT01330381|466076820|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
129487087|NCT01330381|466076821|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
129487088|NCT01330381|466076822|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
129487089|NCT01330381|466076820|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
129487090|NCT01330381|466076821|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
129487091|NCT01330381|466076822|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
129979577|NCT01156376|467889394|FG001|Overall Study|Withdrawal by Subject|0|||
129979578|NCT01156376|467889395|FG002|Overall Study|Withdrawal by Subject|3|||
129487092|NCT01330381|466076820|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
129979579|NCT04488770|467889396|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979580|NCT04488770|467889397|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979581|NCT04488770|467889398|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979582|NCT04488770|467889399|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
129979583|NCT04488770|467889400|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129487093|NCT01330381|466076821|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
129979584|NCT04488770|467889401|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979585|NCT04488770|467889402|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129487094|NCT01330381|466076822|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
129487095|NCT01330381|466076820|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
129487096|NCT01330381|466076821|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
129487097|NCT01330381|466076822|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
129487098|NCT01330381|466076820|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
129487099|NCT01330381|466076821|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
129487100|NCT01330381|466076822|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
129487101|NCT01330381|466076820|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
129487102|NCT01330381|466076821|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
129487103|NCT01330381|466076822|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
129487104|NCT01330381|466076820|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
129487105|NCT01330381|466076821|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
129487106|NCT01330381|466076822|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
129487107|NCT01330381|466076820|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
129487108|NCT01330381|466076821|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
129487109|NCT01330381|466076822|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
129487110|NCT01330381|466076820|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
129487111|NCT01330381|466076821|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
129487112|NCT01330381|466076822|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
129487113|NCT04328623|466076825|FG000|Overall Study|Protocol Violation|0|||
129487114|NCT04328623|466076826|FG001|Overall Study|Protocol Violation|1|||
129487115|NCT00849693|466076827|FG000|Acute Treatment Phase|Adverse Event|12|||
129487116|NCT00849693|466076828|FG001|Acute Treatment Phase|Adverse Event|7|||
129487117|NCT00849693|466076829|FG002|Acute Treatment Phase|Adverse Event|6|||
129487118|NCT00849693|466076830|FG003|Acute Treatment Phase|Adverse Event|4|||
129487119|NCT00849693|466076827|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
129487120|NCT00849693|466076828|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
129487121|NCT00849693|466076829|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
129487122|NCT00849693|466076830|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
129487123|NCT00849693|466076827|FG000|Acute Treatment Phase|Protocol Violation|1|||
129487124|NCT00849693|466076828|FG001|Acute Treatment Phase|Protocol Violation|5|||
129487125|NCT00849693|466076829|FG002|Acute Treatment Phase|Protocol Violation|2|||
129487126|NCT00849693|466076830|FG003|Acute Treatment Phase|Protocol Violation|6|||
129487127|NCT00849693|466076827|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
129487128|NCT00849693|466076828|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
129487129|NCT00849693|466076829|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
129487130|NCT00849693|466076830|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
129487131|NCT00849693|466076827|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
129487132|NCT00849693|466076828|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
129487133|NCT00849693|466076829|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
129487134|NCT00849693|466076830|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
129487135|NCT00849693|466076827|FG000|Acute Treatment Phase|Physician Decision|2|||
129487136|NCT00849693|466076828|FG001|Acute Treatment Phase|Physician Decision|1|||
129487137|NCT00849693|466076829|FG002|Acute Treatment Phase|Physician Decision|2|||
129487138|NCT00849693|466076830|FG003|Acute Treatment Phase|Physician Decision|1|||
129487139|NCT00849693|466076827|FG000|Acute Treatment Phase|Sponsor decision|0|||
129487140|NCT00849693|466076828|FG001|Acute Treatment Phase|Sponsor decision|0|||
129487141|NCT00849693|466076829|FG002|Acute Treatment Phase|Sponsor decision|1|||
129487142|NCT00849693|466076830|FG003|Acute Treatment Phase|Sponsor decision|0|||
129487143|NCT00849693|466076827|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
129487144|NCT00849693|466076828|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
129487145|NCT00849693|466076829|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
129487146|NCT00849693|466076830|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
129487147|NCT00849693|466076827|FG000|Extension Phase|Adverse Event|4|||
129487148|NCT00849693|466076828|FG001|Extension Phase|Adverse Event|6|||
129487149|NCT00849693|466076829|FG002|Extension Phase|Adverse Event|3|||
129487150|NCT00849693|466076830|FG003|Extension Phase|Adverse Event|7|||
129487151|NCT00849693|466076827|FG000|Extension Phase|Lost to Follow-up|7|||
129487152|NCT00849693|466076828|FG001|Extension Phase|Lost to Follow-up|5|||
129487153|NCT00849693|466076829|FG002|Extension Phase|Lost to Follow-up|6|||
129487154|NCT00849693|466076830|FG003|Extension Phase|Lost to Follow-up|6|||
129487155|NCT00849693|466076827|FG000|Extension Phase|Protocol Violation|0|||
129487156|NCT00849693|466076828|FG001|Extension Phase|Protocol Violation|3|||
129487157|NCT00849693|466076829|FG002|Extension Phase|Protocol Violation|2|||
129487158|NCT00849693|466076830|FG003|Extension Phase|Protocol Violation|3|||
129487159|NCT00849693|466076827|FG000|Extension Phase|Withdrawal by Subject|6|||
129487160|NCT00849693|466076828|FG001|Extension Phase|Withdrawal by Subject|9|||
129487161|NCT00849693|466076829|FG002|Extension Phase|Withdrawal by Subject|10|||
129487162|NCT00849693|466076830|FG003|Extension Phase|Withdrawal by Subject|15|||
129487163|NCT00849693|466076827|FG000|Extension Phase|Parent or caregiver decision|9|||
129487164|NCT00849693|466076828|FG001|Extension Phase|Parent or caregiver decision|4|||
129487165|NCT00849693|466076829|FG002|Extension Phase|Parent or caregiver decision|10|||
129487166|NCT00849693|466076830|FG003|Extension Phase|Parent or caregiver decision|5|||
129487167|NCT00849693|466076827|FG000|Extension Phase|Physician Decision|1|||
129487168|NCT00849693|466076828|FG001|Extension Phase|Physician Decision|1|||
129487169|NCT00849693|466076829|FG002|Extension Phase|Physician Decision|2|||
129487170|NCT00849693|466076830|FG003|Extension Phase|Physician Decision|0|||
129487171|NCT00849693|466076827|FG000|Extension Phase|Sponsor decision|1|||
129487172|NCT00849693|466076828|FG001|Extension Phase|Sponsor decision|0|||
129487173|NCT00849693|466076829|FG002|Extension Phase|Sponsor decision|0|||
129487174|NCT00849693|466076830|FG003|Extension Phase|Sponsor decision|1|||
129487175|NCT00849693|466076827|FG000|Extension Phase|Lack of Efficacy|2|||
129487176|NCT00849693|466076828|FG001|Extension Phase|Lack of Efficacy|2|||
129487177|NCT00849693|466076829|FG002|Extension Phase|Lack of Efficacy|2|||
129487178|NCT00849693|466076830|FG003|Extension Phase|Lack of Efficacy|1|||
129487179|NCT00685178|466076831|FG000|Overall Study|Adverse Event|1|||
129487180|NCT00685178|466076832|FG001|Overall Study|Adverse Event|5|||
129487181|NCT00685178|466076833|FG002|Overall Study|Adverse Event|2|||
129487182|NCT00685178|466076834|FG003|Overall Study|Adverse Event|4|||
129487183|NCT00685178|466076831|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
129487184|NCT00685178|466076832|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
129487185|NCT00685178|466076833|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
129487186|NCT00685178|466076834|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
129487187|NCT00685178|466076831|FG000|Overall Study|voluntary study discharge|4|||
129487188|NCT00685178|466076832|FG001|Overall Study|voluntary study discharge|5|||
129487189|NCT00685178|466076833|FG002|Overall Study|voluntary study discharge|1|||
129487190|NCT00685178|466076834|FG003|Overall Study|voluntary study discharge|1|||
129487191|NCT00685178|466076831|FG000|Overall Study|incarcerated|1|||
129487192|NCT00685178|466076832|FG001|Overall Study|incarcerated|3|||
129487193|NCT00685178|466076833|FG002|Overall Study|incarcerated|7|||
129487194|NCT00685178|466076834|FG003|Overall Study|incarcerated|0|||
129487195|NCT00685178|466076831|FG000|Overall Study|administrative (disciplinary) discharge|0|||
129487196|NCT00685178|466076832|FG001|Overall Study|administrative (disciplinary) discharge|1|||
129487197|NCT00685178|466076833|FG002|Overall Study|administrative (disciplinary) discharge|0|||
129487198|NCT00685178|466076834|FG003|Overall Study|administrative (disciplinary) discharge|2|||
129487199|NCT00685178|466076831|FG000|Overall Study|Pregnancy|0|||
129487200|NCT00685178|466076832|FG001|Overall Study|Pregnancy|0|||
129487201|NCT00685178|466076833|FG002|Overall Study|Pregnancy|0|||
129487202|NCT00685178|466076834|FG003|Overall Study|Pregnancy|1|||
129487203|NCT00077623|466076835|FG000|Overall Study|Adverse Event|1|||
129487204|NCT00077623|466076836|FG001|Overall Study|Adverse Event|0|||
129487205|NCT00077623|466076837|FG002|Overall Study|Adverse Event|1|||
129487206|NCT00077623|466076835|FG000|Overall Study|Withdrawal by Subject|2|||
129487207|NCT00077623|466076836|FG001|Overall Study|Withdrawal by Subject|10|||
129487208|NCT00077623|466076837|FG002|Overall Study|Withdrawal by Subject|1|||
129487209|NCT00077623|466076835|FG000|Overall Study|Other-Non safety reason|18|||
129487210|NCT00077623|466076836|FG001|Overall Study|Other-Non safety reason|15|||
129487211|NCT00077623|466076837|FG002|Overall Study|Other-Non safety reason|19|||
129487212|NCT00077623|466076835|FG000|Overall Study|Insufficient therapeutic response|2|||
129487213|NCT00077623|466076836|FG001|Overall Study|Insufficient therapeutic response|0|||
129487214|NCT00077623|466076837|FG002|Overall Study|Insufficient therapeutic response|0|||
129487215|NCT00077623|466076835|FG000|Overall Study|Death|12|||
129487216|NCT00077623|466076836|FG001|Overall Study|Death|18|||
129487217|NCT00077623|466076837|FG002|Overall Study|Death|11|||
129487218|NCT00077623|466076835|FG000|Overall Study|Failure to return|1|||
129487219|NCT00077623|466076836|FG001|Overall Study|Failure to return|0|||
129487220|NCT00077623|466076837|FG002|Overall Study|Failure to return|0|||
129487221|NCT02138110|466076840|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
129487222|NCT02138110|466076840|FG000|Overall Scaffold Implantation|Death|3|||
129487223|NCT00882713|466076842|FG000|Overall Study|Adverse Event|2|||
129487224|NCT00882713|466076842|FG000|Overall Study|Death|3|||
129487225|NCT00882713|466076842|FG000|Overall Study|Administrative reasons|4|||
129487226|NCT00882713|466076842|FG000|Overall Study|refused treatment/withdrew consent|4|||
129487227|NCT00882713|466076842|FG000|Overall Study|Blood transfusion|2|||
129487228|NCT00882713|466076842|FG000|Overall Study|Insufficient therapeutic response|3|||
129487229|NCT00882713|466076842|FG000|Overall Study|Failure to return|2|||
129487230|NCT00882713|466076842|FG000|Overall Study|Other - Reasons|2|||
129487231|NCT01408537|466076845|FG000|Overall Study|Withdrawal by Subject|2|||
129487232|NCT01408537|466076845|FG000|Overall Study|Protocol Violation|3|||
129487233|NCT01408537|466076845|FG000|Overall Study|Lost to Follow-up|3|||
129487234|NCT02760602|466076848|FG000|Overall Study|Withdrawal by Subject|1|||
129487235|NCT02760602|466076849|FG001|Overall Study|Withdrawal by Subject|0|||
129487236|NCT02760602|466076848|FG000|Overall Study|Terminated by sponsor|12|||
129487237|NCT02760602|466076849|FG001|Overall Study|Terminated by sponsor|13|||
129487238|NCT02046564|466076858|FG000|Overall Study|Adverse Event|6|||
129487239|NCT02046564|466076859|FG001|Overall Study|Adverse Event|3|||
129487240|NCT02046564|466076858|FG000|Overall Study|Physician Decision|0|||
129487241|NCT02046564|466076859|FG001|Overall Study|Physician Decision|1|||
129487242|NCT02046564|466076858|FG000|Overall Study|Protocol Violation|3|||
129487243|NCT02046564|466076859|FG001|Overall Study|Protocol Violation|1|||
129487244|NCT02046564|466076858|FG000|Overall Study|Withdrawal by Subject|4|||
129487245|NCT02046564|466076859|FG001|Overall Study|Withdrawal by Subject|10|||
129487246|NCT02046564|466076858|FG000|Overall Study|Subject met withdrawal criteria|2|||
129487247|NCT02046564|466076859|FG001|Overall Study|Subject met withdrawal criteria|5|||
129487248|NCT00984659|466076860|FG000|2-week Run-in Period|Adverse Event|8|||
129487249|NCT00984659|466076861|FG001|2-week Run-in Period|Adverse Event|0|||
129487250|NCT00984659|466076862|FG002|2-week Run-in Period|Adverse Event|0|||
129487251|NCT00984659|466076863|FG003|2-week Run-in Period|Adverse Event|0|||
129487252|NCT00984659|466076860|FG000|2-week Run-in Period|Protocol Violation|5|||
129487253|NCT00984659|466076861|FG001|2-week Run-in Period|Protocol Violation|0|||
129487254|NCT00984659|466076862|FG002|2-week Run-in Period|Protocol Violation|0|||
129487255|NCT00984659|466076863|FG003|2-week Run-in Period|Protocol Violation|0|||
129487256|NCT00984659|466076860|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
129487257|NCT00984659|466076861|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
129487258|NCT00984659|466076862|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
129487259|NCT00984659|466076863|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
129487260|NCT00984659|466076860|FG000|2-week Run-in Period|Lost to Follow-up|3|||
129487261|NCT00984659|466076861|FG001|2-week Run-in Period|Lost to Follow-up|0|||
129487262|NCT00984659|466076862|FG002|2-week Run-in Period|Lost to Follow-up|0|||
129487263|NCT00984659|466076863|FG003|2-week Run-in Period|Lost to Follow-up|0|||
129487264|NCT00984659|466076860|FG000|2-week Run-in Period|Physician Decision|10|||
129487265|NCT00984659|466076861|FG001|2-week Run-in Period|Physician Decision|0|||
129487266|NCT00984659|466076862|FG002|2-week Run-in Period|Physician Decision|0|||
129487267|NCT00984659|466076863|FG003|2-week Run-in Period|Physician Decision|0|||
129487268|NCT00984659|466076860|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
129487269|NCT00984659|466076861|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
129487270|NCT00984659|466076862|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
129487271|NCT00984659|466076863|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
129487272|NCT00984659|466076860|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
129487273|NCT00984659|466076861|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129487274|NCT00984659|466076862|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129487275|NCT00984659|466076863|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
129487276|NCT00984659|466076860|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
129487277|NCT00984659|466076861|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
129487278|NCT00984659|466076862|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
129487279|NCT00984659|466076863|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
129487280|NCT00984659|466076860|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
129487281|NCT00984659|466076861|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
129487282|NCT00984659|466076862|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
129487283|NCT00984659|466076863|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
129487284|NCT00984659|466076860|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
129487285|NCT00984659|466076861|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
129487286|NCT00984659|466076862|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
129487287|NCT00984659|466076863|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
129487288|NCT00984659|466076860|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
129487289|NCT00984659|466076861|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
129487290|NCT00984659|466076862|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
129487291|NCT00984659|466076863|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
129487292|NCT00984659|466076860|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
129487293|NCT00984659|466076861|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
129487294|NCT00984659|466076862|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
129487295|NCT00984659|466076863|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
129487296|NCT00635102|466076866|FG000|Overall Study|Withdrawal by Subject|7|||
129487297|NCT00635102|466076867|FG001|Overall Study|Withdrawal by Subject|8|||
129487298|NCT01938625|466076868|FG000|Overall Study|Withdrawal by Subject|0|||
129487299|NCT01938625|466076869|FG001|Overall Study|Withdrawal by Subject|1|||
129487300|NCT01938625|466076868|FG000|Overall Study|Adverse Event|0|||
129487301|NCT01938625|466076869|FG001|Overall Study|Adverse Event|1|||
129487302|NCT02088034|466076870|FG000|Overall Study|Lost to Follow-up|1|||
129487303|NCT02088034|466076871|FG001|Overall Study|Lost to Follow-up|1|||
129487304|NCT02088034|466076872|FG002|Overall Study|Lost to Follow-up|0|||
129487305|NCT02088034|466076870|FG000|Overall Study|Pregnancy|2|||
129487306|NCT02088034|466076871|FG001|Overall Study|Pregnancy|1|||
129487307|NCT02088034|466076872|FG002|Overall Study|Pregnancy|2|||
129487308|NCT00308620|466076873|FG000|Overall Study|Death|1|||
129979586|NCT04488770|467889403|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129487309|NCT00308620|466076874|FG001|Overall Study|Death|1|||
129487310|NCT00308620|466076875|FG002|Overall Study|Death|0|||
129487311|NCT00308620|466076873|FG000|Overall Study|Lost to Follow-up|0|||
129487312|NCT00308620|466076874|FG001|Overall Study|Lost to Follow-up|0|||
129487313|NCT00308620|466076875|FG002|Overall Study|Lost to Follow-up|1|||
129487314|NCT03043365|466076879|FG000|Weeks 0 to Week 8|Adverse Event|1|||
129487315|NCT03043365|466076880|FG001|Weeks 0 to Week 8|Adverse Event|3|||
129487316|NCT03043365|466076879|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
129487317|NCT03043365|466076880|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
129487318|NCT03043365|466076879|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
129979587|NCT04488770|467889404|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129487319|NCT03043365|466076880|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
129487320|NCT02873221|466076881|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
129487321|NCT02873221|466076882|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
129487322|NCT02873221|466076883|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
129487323|NCT02873221|466076881|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
129487324|NCT02873221|466076882|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
129487325|NCT02873221|466076883|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
129487326|NCT02873221|466076881|FG000|Treatment Period|Protocol Violation|2|||
129487327|NCT02873221|466076882|FG001|Treatment Period|Protocol Violation|5|||
129487328|NCT02873221|466076883|FG002|Treatment Period|Protocol Violation|8|||
129487329|NCT02873221|466076881|FG000|Treatment Period|Pregnancy|4|||
129487330|NCT02873221|466076882|FG001|Treatment Period|Pregnancy|6|||
129487331|NCT02873221|466076883|FG002|Treatment Period|Pregnancy|3|||
129487332|NCT02873221|466076881|FG000|Treatment Period|Lack of Qualifying Event|0|||
129487333|NCT02873221|466076882|FG001|Treatment Period|Lack of Qualifying Event|3|||
129487334|NCT02873221|466076883|FG002|Treatment Period|Lack of Qualifying Event|1|||
129487335|NCT02873221|466076881|FG000|Treatment Period|Withdrawal of Consent|52|||
129487336|NCT02873221|466076882|FG001|Treatment Period|Withdrawal of Consent|51|||
129487337|NCT02873221|466076883|FG002|Treatment Period|Withdrawal of Consent|41|||
129487338|NCT02873221|466076881|FG000|Treatment Period|Lack of Efficacy|0|||
129487339|NCT02873221|466076882|FG001|Treatment Period|Lack of Efficacy|17|||
129487340|NCT02873221|466076883|FG002|Treatment Period|Lack of Efficacy|12|||
129487341|NCT02873221|466076881|FG000|Treatment Period|Adverse Event|4|||
129487342|NCT02873221|466076882|FG001|Treatment Period|Adverse Event|9|||
129487343|NCT02873221|466076883|FG002|Treatment Period|Adverse Event|11|||
129487344|NCT02873221|466076881|FG000|Treatment Period|Lost to Follow-up|26|||
129487345|NCT02873221|466076882|FG001|Treatment Period|Lost to Follow-up|30|||
129487346|NCT02873221|466076883|FG002|Treatment Period|Lost to Follow-up|26|||
129487347|NCT02873221|466076881|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
129487348|NCT02873221|466076882|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
129487349|NCT02873221|466076883|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
129487350|NCT02873221|466076881|FG000|Safety Follow-up Period|Protocol Violation|0|||
129487351|NCT02873221|466076882|FG001|Safety Follow-up Period|Protocol Violation|0|||
129487352|NCT02873221|466076883|FG002|Safety Follow-up Period|Protocol Violation|1|||
129487353|NCT02873221|466076881|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
129487354|NCT02873221|466076882|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
129487355|NCT02873221|466076883|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
129487356|NCT02873221|466076881|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
129487357|NCT02873221|466076882|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
129487358|NCT02873221|466076883|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
129487359|NCT01325493|466076886|FG000|Overall Study|Protocol Violation|0|||
129487360|NCT01325493|466076887|FG001|Overall Study|Protocol Violation|1|||
129487361|NCT01325493|466076886|FG000|Overall Study|loss of neuromonitoring signals|0|||
129487362|NCT01325493|466076887|FG001|Overall Study|loss of neuromonitoring signals|2|||
129487363|NCT01325493|466076886|FG000|Overall Study|Allergy|1|||
129487364|NCT01325493|466076887|FG001|Overall Study|Allergy|0|||
129487365|NCT05372315|466076890|FG000|Overall Study|Withdrawal by Subject|1|||
129487366|NCT05372315|466076891|FG001|Overall Study|Withdrawal by Subject|0|||
129487367|NCT01508676|466076894|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
129487368|NCT01508676|466076895|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
129487369|NCT01508676|466076894|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
129487370|NCT01508676|466076895|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
129487371|NCT01508676|466076894|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
129487372|NCT01508676|466076895|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
129487373|NCT01508676|466076894|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
129487374|NCT01508676|466076895|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
129487375|NCT01508676|466076894|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
129487376|NCT01508676|466076895|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
129487377|NCT02532543|466076896|FG000|Overall Study|Lost to Follow-up|0|||
129487378|NCT02532543|466076897|FG001|Overall Study|Lost to Follow-up|0|||
129487379|NCT02532543|466076898|FG002|Overall Study|Lost to Follow-up|1|||
129487380|NCT02532543|466076899|FG003|Overall Study|Lost to Follow-up|0|||
129487381|NCT00650585|466076900|FG000|Overall Study|Lost to Follow-up|505|||
129487382|NCT00650585|466076901|FG001|Overall Study|Lost to Follow-up|482|||
129487383|NCT00650585|466076900|FG000|Overall Study|No parental consent|935|||
129979588|NCT04488770|467889405|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129487384|NCT00650585|466076901|FG001|Overall Study|No parental consent|866|||
129487385|NCT00650585|466076900|FG000|Overall Study|Excluded/ruled ineligible|357|||
129487386|NCT00650585|466076901|FG001|Overall Study|Excluded/ruled ineligible|129|||
129487387|NCT00923091|466076904|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
129487388|NCT00923091|466076905|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
129487389|NCT00923091|466076906|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
129487390|NCT00923091|466076907|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
129487391|NCT00923091|466076908|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
129487392|NCT00923091|466076909|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
129487393|NCT00923091|466076910|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
129487394|NCT00923091|466076911|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
129487395|NCT00923091|466076912|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
129487396|NCT00923091|466076913|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
129487397|NCT00923091|466076914|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
129487398|NCT00923091|466076915|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
129487399|NCT00923091|466076916|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
129487400|NCT00923091|466076904|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
129487401|NCT00923091|466076905|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
129487402|NCT00923091|466076906|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
129487403|NCT00923091|466076907|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
129487404|NCT00923091|466076908|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
129487405|NCT00923091|466076909|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
129487406|NCT00923091|466076910|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
129487407|NCT00923091|466076911|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
129487408|NCT00923091|466076912|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129487409|NCT00923091|466076913|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129487410|NCT00923091|466076914|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129487411|NCT00923091|466076915|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129487412|NCT00923091|466076916|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
129487413|NCT00923091|466076904|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
129487414|NCT00923091|466076905|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
129487415|NCT00923091|466076906|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
129487416|NCT00923091|466076907|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
129487417|NCT00923091|466076908|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
129487418|NCT00923091|466076909|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
129487419|NCT00923091|466076910|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
129487420|NCT00923091|466076911|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
129487421|NCT00923091|466076912|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129487422|NCT00923091|466076913|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129487423|NCT00923091|466076914|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129487424|NCT00923091|466076915|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129487425|NCT00923091|466076916|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
129487426|NCT00923091|466076904|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487427|NCT00923091|466076905|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487428|NCT00923091|466076906|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487429|NCT00923091|466076907|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487430|NCT00923091|466076908|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487431|NCT00923091|466076909|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
129487432|NCT00923091|466076910|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487433|NCT00923091|466076911|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487434|NCT00923091|466076912|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487435|NCT00923091|466076913|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487436|NCT00923091|466076914|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487437|NCT00923091|466076915|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487438|NCT00923091|466076916|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
129487439|NCT00923091|466076904|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487440|NCT00923091|466076905|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
129487441|NCT00923091|466076906|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487442|NCT00923091|466076907|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
129487443|NCT00923091|466076908|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487444|NCT00923091|466076909|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
129487445|NCT00923091|466076910|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487446|NCT00923091|466076911|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487447|NCT00923091|466076912|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487448|NCT00923091|466076913|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487449|NCT00923091|466076914|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487450|NCT00923091|466076915|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487451|NCT00923091|466076916|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
129487452|NCT00923091|466076904|FG000|Period III (Single-Blind)|Adverse Event|5|||
129979589|NCT04488770|467889406|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979590|NCT04488770|467889407|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979591|NCT04488770|467889408|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
129979592|NCT04488770|467889396|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
129979593|NCT04488770|467889397|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129487453|NCT00923091|466076905|FG001|Period III (Single-Blind)|Adverse Event|0|||
129487454|NCT00923091|466076906|FG002|Period III (Single-Blind)|Adverse Event|0|||
129487455|NCT00923091|466076907|FG003|Period III (Single-Blind)|Adverse Event|0|||
129487456|NCT00923091|466076908|FG004|Period III (Single-Blind)|Adverse Event|0|||
129487457|NCT00923091|466076909|FG005|Period III (Single-Blind)|Adverse Event|0|||
129487458|NCT00923091|466076910|FG006|Period III (Single-Blind)|Adverse Event|0|||
129487459|NCT00923091|466076911|FG007|Period III (Single-Blind)|Adverse Event|0|||
129487460|NCT00923091|466076912|FG008|Period III (Single-Blind)|Adverse Event|0|||
129487461|NCT00923091|466076913|FG009|Period III (Single-Blind)|Adverse Event|0|||
129487462|NCT00923091|466076914|FG010|Period III (Single-Blind)|Adverse Event|0|||
129487463|NCT00923091|466076915|FG011|Period III (Single-Blind)|Adverse Event|0|||
129487464|NCT00923091|466076916|FG012|Period III (Single-Blind)|Adverse Event|0|||
129487465|NCT00923091|466076904|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
129487466|NCT00923091|466076905|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487467|NCT00923091|466076906|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487468|NCT00923091|466076907|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487469|NCT00923091|466076908|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487470|NCT00923091|466076909|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487471|NCT00923091|466076910|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487472|NCT00923091|466076911|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487473|NCT00923091|466076912|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487474|NCT00923091|466076913|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487475|NCT00923091|466076914|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487476|NCT00923091|466076915|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487477|NCT00923091|466076916|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
129487478|NCT00923091|466076904|FG000|Period III (Single-Blind)|Protocol Violation|3|||
129487479|NCT00923091|466076905|FG001|Period III (Single-Blind)|Protocol Violation|0|||
129487480|NCT00923091|466076906|FG002|Period III (Single-Blind)|Protocol Violation|0|||
129487481|NCT00923091|466076907|FG003|Period III (Single-Blind)|Protocol Violation|0|||
129487482|NCT00923091|466076908|FG004|Period III (Single-Blind)|Protocol Violation|0|||
129487483|NCT00923091|466076909|FG005|Period III (Single-Blind)|Protocol Violation|0|||
129487484|NCT00923091|466076910|FG006|Period III (Single-Blind)|Protocol Violation|0|||
129487485|NCT00923091|466076911|FG007|Period III (Single-Blind)|Protocol Violation|0|||
129487486|NCT00923091|466076912|FG008|Period III (Single-Blind)|Protocol Violation|0|||
129487487|NCT00923091|466076913|FG009|Period III (Single-Blind)|Protocol Violation|0|||
129487488|NCT00923091|466076914|FG010|Period III (Single-Blind)|Protocol Violation|0|||
129487489|NCT00923091|466076915|FG011|Period III (Single-Blind)|Protocol Violation|0|||
129487490|NCT00923091|466076916|FG012|Period III (Single-Blind)|Protocol Violation|0|||
129487491|NCT00923091|466076904|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
129487492|NCT00923091|466076905|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
129487493|NCT00923091|466076906|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
129487494|NCT00923091|466076907|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
129487495|NCT00923091|466076908|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
129487496|NCT00923091|466076909|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
129487497|NCT00923091|466076910|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
129487498|NCT00923091|466076911|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
129487499|NCT00923091|466076912|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
129487500|NCT00923091|466076913|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
129487501|NCT00923091|466076914|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
129487502|NCT00923091|466076915|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
129487503|NCT00923091|466076916|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
129487504|NCT00923091|466076904|FG000|Period IV (Double-Blind)|Adverse Event|2|||
129487505|NCT00923091|466076905|FG001|Period IV (Double-Blind)|Adverse Event|0|||
129487506|NCT00923091|466076906|FG002|Period IV (Double-Blind)|Adverse Event|0|||
129487507|NCT00923091|466076907|FG003|Period IV (Double-Blind)|Adverse Event|0|||
129487508|NCT00923091|466076908|FG004|Period IV (Double-Blind)|Adverse Event|0|||
129487509|NCT00923091|466076909|FG005|Period IV (Double-Blind)|Adverse Event|0|||
129487510|NCT00923091|466076910|FG006|Period IV (Double-Blind)|Adverse Event|0|||
129487511|NCT00923091|466076911|FG007|Period IV (Double-Blind)|Adverse Event|0|||
129487512|NCT00923091|466076912|FG008|Period IV (Double-Blind)|Adverse Event|0|||
129487513|NCT00923091|466076913|FG009|Period IV (Double-Blind)|Adverse Event|0|||
129487514|NCT00923091|466076914|FG010|Period IV (Double-Blind)|Adverse Event|0|||
129487515|NCT00923091|466076915|FG011|Period IV (Double-Blind)|Adverse Event|0|||
129487516|NCT00923091|466076916|FG012|Period IV (Double-Blind)|Adverse Event|0|||
129487517|NCT00923091|466076904|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487518|NCT00923091|466076905|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
129487519|NCT00923091|466076906|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487520|NCT00923091|466076907|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487521|NCT00923091|466076908|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487522|NCT00923091|466076909|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487523|NCT00923091|466076910|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487524|NCT00923091|466076911|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487525|NCT00923091|466076912|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487526|NCT00923091|466076913|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487527|NCT00923091|466076914|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487528|NCT00923091|466076915|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487529|NCT00923091|466076916|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
129487530|NCT00923091|466076904|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
129487531|NCT00923091|466076905|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
129487532|NCT00923091|466076906|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
129487533|NCT00923091|466076907|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
129487534|NCT00923091|466076908|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
129487535|NCT00923091|466076909|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
129487536|NCT00923091|466076910|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
129487537|NCT00923091|466076911|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
129487538|NCT00923091|466076912|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
129487539|NCT00923091|466076913|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
129487540|NCT00923091|466076914|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
129487541|NCT00923091|466076915|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
129487542|NCT00923091|466076916|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
129487543|NCT00923091|466076904|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487544|NCT00923091|466076905|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487545|NCT00923091|466076906|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487546|NCT00923091|466076907|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487547|NCT00923091|466076908|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487548|NCT00923091|466076909|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487549|NCT00923091|466076910|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487550|NCT00923091|466076911|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487551|NCT00923091|466076912|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
129487552|NCT00923091|466076913|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487553|NCT00923091|466076914|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487554|NCT00923091|466076915|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
129487555|NCT00923091|466076916|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
129487556|NCT00923091|466076904|FG000|Period V (Double -Blind)|Protocol Violation|0|||
129487557|NCT00923091|466076905|FG001|Period V (Double -Blind)|Protocol Violation|0|||
129487558|NCT00923091|466076906|FG002|Period V (Double -Blind)|Protocol Violation|0|||
129487559|NCT00923091|466076907|FG003|Period V (Double -Blind)|Protocol Violation|0|||
129487560|NCT00923091|466076908|FG004|Period V (Double -Blind)|Protocol Violation|0|||
129487561|NCT00923091|466076909|FG005|Period V (Double -Blind)|Protocol Violation|0|||
129487562|NCT00923091|466076910|FG006|Period V (Double -Blind)|Protocol Violation|0|||
129487563|NCT00923091|466076911|FG007|Period V (Double -Blind)|Protocol Violation|0|||
129487564|NCT00923091|466076912|FG008|Period V (Double -Blind)|Protocol Violation|0|||
129487565|NCT00923091|466076913|FG009|Period V (Double -Blind)|Protocol Violation|0|||
129487566|NCT00923091|466076914|FG010|Period V (Double -Blind)|Protocol Violation|0|||
129487567|NCT00923091|466076915|FG011|Period V (Double -Blind)|Protocol Violation|0|||
129487568|NCT00923091|466076916|FG012|Period V (Double -Blind)|Protocol Violation|1|||
129487569|NCT00923091|466076904|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
129487570|NCT00923091|466076905|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
129487571|NCT00923091|466076906|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
129487572|NCT00923091|466076907|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
129487573|NCT00923091|466076908|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
129487574|NCT00923091|466076909|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
129487575|NCT00923091|466076910|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
129487576|NCT00923091|466076911|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
129487577|NCT00923091|466076912|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
129487578|NCT00923091|466076913|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
129487579|NCT00923091|466076914|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
129487580|NCT00923091|466076915|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
129487581|NCT00923091|466076916|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
129487582|NCT00923091|466076904|FG000|Period VI (Open-Label)|Adverse Event|17|||
129487583|NCT00923091|466076905|FG001|Period VI (Open-Label)|Adverse Event|0|||
129487584|NCT00923091|466076906|FG002|Period VI (Open-Label)|Adverse Event|4|||
129487585|NCT00923091|466076907|FG003|Period VI (Open-Label)|Adverse Event|1|||
129487586|NCT00923091|466076908|FG004|Period VI (Open-Label)|Adverse Event|1|||
129487587|NCT00923091|466076909|FG005|Period VI (Open-Label)|Adverse Event|0|||
129487588|NCT00923091|466076910|FG006|Period VI (Open-Label)|Adverse Event|0|||
129487589|NCT00923091|466076911|FG007|Period VI (Open-Label)|Adverse Event|0|||
129487590|NCT00923091|466076912|FG008|Period VI (Open-Label)|Adverse Event|0|||
129487591|NCT00923091|466076913|FG009|Period VI (Open-Label)|Adverse Event|0|||
129487592|NCT00923091|466076914|FG010|Period VI (Open-Label)|Adverse Event|0|||
129487593|NCT00923091|466076915|FG011|Period VI (Open-Label)|Adverse Event|0|||
129487594|NCT00923091|466076916|FG012|Period VI (Open-Label)|Adverse Event|0|||
129487595|NCT00923091|466076904|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
129487596|NCT00923091|466076905|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
129487597|NCT00923091|466076906|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
129487598|NCT00923091|466076907|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487599|NCT00923091|466076908|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
129487600|NCT00923091|466076909|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487601|NCT00923091|466076910|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487602|NCT00923091|466076911|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487603|NCT00923091|466076912|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487604|NCT00923091|466076913|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487605|NCT00923091|466076914|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487606|NCT00923091|466076915|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487607|NCT00923091|466076916|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
129487608|NCT00923091|466076904|FG000|Period VI (Open-Label)|Protocol Violation|6|||
129487609|NCT00923091|466076905|FG001|Period VI (Open-Label)|Protocol Violation|1|||
129487610|NCT00923091|466076906|FG002|Period VI (Open-Label)|Protocol Violation|3|||
129487611|NCT00923091|466076907|FG003|Period VI (Open-Label)|Protocol Violation|1|||
129487612|NCT00923091|466076908|FG004|Period VI (Open-Label)|Protocol Violation|4|||
129487613|NCT00923091|466076909|FG005|Period VI (Open-Label)|Protocol Violation|0|||
129487614|NCT00923091|466076910|FG006|Period VI (Open-Label)|Protocol Violation|0|||
129487615|NCT00923091|466076911|FG007|Period VI (Open-Label)|Protocol Violation|0|||
129487616|NCT00923091|466076912|FG008|Period VI (Open-Label)|Protocol Violation|0|||
129487617|NCT00923091|466076913|FG009|Period VI (Open-Label)|Protocol Violation|0|||
129487618|NCT00923091|466076914|FG010|Period VI (Open-Label)|Protocol Violation|0|||
129487619|NCT00923091|466076915|FG011|Period VI (Open-Label)|Protocol Violation|0|||
129487620|NCT00923091|466076916|FG012|Period VI (Open-Label)|Protocol Violation|0|||
129487621|NCT00923091|466076904|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
129487622|NCT00923091|466076905|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
129487623|NCT00923091|466076906|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
129487624|NCT00923091|466076907|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
129487625|NCT00923091|466076908|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
129487626|NCT00923091|466076909|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
129487627|NCT00923091|466076910|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
129487628|NCT00923091|466076911|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
129487629|NCT00923091|466076912|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
129487630|NCT00923091|466076913|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
129487631|NCT00923091|466076914|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
129487632|NCT00923091|466076915|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
129487633|NCT00923091|466076916|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
129487634|NCT00923091|466076904|FG000|Period VI (Open-Label)|Other Reason|0|||
129487635|NCT00923091|466076905|FG001|Period VI (Open-Label)|Other Reason|0|||
129487636|NCT00923091|466076906|FG002|Period VI (Open-Label)|Other Reason|0|||
129487637|NCT00923091|466076907|FG003|Period VI (Open-Label)|Other Reason|1|||
129487638|NCT00923091|466076908|FG004|Period VI (Open-Label)|Other Reason|1|||
129487639|NCT00923091|466076909|FG005|Period VI (Open-Label)|Other Reason|0|||
129487640|NCT00923091|466076910|FG006|Period VI (Open-Label)|Other Reason|0|||
129487641|NCT00923091|466076911|FG007|Period VI (Open-Label)|Other Reason|0|||
129487642|NCT00923091|466076912|FG008|Period VI (Open-Label)|Other Reason|0|||
129487643|NCT00923091|466076913|FG009|Period VI (Open-Label)|Other Reason|0|||
129487644|NCT00923091|466076914|FG010|Period VI (Open-Label)|Other Reason|0|||
129487645|NCT00923091|466076915|FG011|Period VI (Open-Label)|Other Reason|0|||
129487646|NCT00923091|466076916|FG012|Period VI (Open-Label)|Other Reason|0|||
129487647|NCT00467649|466076917|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
129487648|NCT00467649|466076918|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
129487649|NCT00467649|466076919|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
129487650|NCT00467649|466076920|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
129487651|NCT00467649|466076921|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
129487652|NCT00467649|466076922|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
129487653|NCT00467649|466076917|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
129487654|NCT00467649|466076918|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
129487655|NCT00467649|466076919|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
129487656|NCT00467649|466076920|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
129487657|NCT00467649|466076921|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
129487658|NCT00467649|466076922|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
129487659|NCT00467649|466076917|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
129487660|NCT00467649|466076918|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
129487661|NCT00467649|466076919|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
129487662|NCT00467649|466076920|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
129487663|NCT00467649|466076921|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
129487664|NCT00467649|466076922|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
129487665|NCT00467649|466076917|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
129487666|NCT00467649|466076918|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
129487667|NCT00467649|466076919|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
129487668|NCT00467649|466076920|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
129487669|NCT00467649|466076921|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
129487670|NCT00467649|466076922|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
129487671|NCT00467649|466076917|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
129487672|NCT00467649|466076918|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
129487673|NCT00467649|466076919|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
129487674|NCT00467649|466076920|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
129487675|NCT00467649|466076921|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
129487676|NCT00467649|466076922|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
129487677|NCT00467649|466076917|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
129487678|NCT00467649|466076918|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
129487679|NCT00467649|466076919|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
129487680|NCT00467649|466076920|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
129487681|NCT00467649|466076921|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
129487682|NCT00467649|466076922|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
129487683|NCT00467649|466076917|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
129487684|NCT00467649|466076918|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
129487685|NCT00467649|466076919|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
129487686|NCT00467649|466076920|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
129487687|NCT00467649|466076921|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
129487688|NCT00467649|466076922|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
129487689|NCT03633331|466076925|FG000|Overall Study|Withdrawal by Subject|1|||
129487690|NCT03233048|466076926|FG000|Overall Study|Withdrawal by Subject|1|||
129487691|NCT00964795|466076933|FG000|Overall Study|Withdrawal by Subject|79|||
129487692|NCT00964795|466076933|FG000|Overall Study|Adverse Event|12|||
129487693|NCT00964795|466076933|FG000|Overall Study|Death|14|||
129487694|NCT00964795|466076933|FG000|Overall Study|Lost to Follow-up|7|||
129487695|NCT00964795|466076933|FG000|Overall Study|Termination of Study by Sponsor|169|||
129487696|NCT00964795|466076933|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
129487697|NCT00964795|466076933|FG000|Overall Study|Other|23|||
129487698|NCT00586690|466076938|FG000|Overall Study|Death|2|||
129487699|NCT00586690|466076939|FG001|Overall Study|Death|0|||
129487700|NCT00586690|466076938|FG000|Overall Study|Disease Progression|10|||
129487701|NCT00586690|466076939|FG001|Overall Study|Disease Progression|0|||
129979594|NCT04488770|467889398|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979595|NCT04488770|467889399|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129487702|NCT00586690|466076938|FG000|Overall Study|Adverse Event|1|||
129487703|NCT00586690|466076939|FG001|Overall Study|Adverse Event|0|||
129487704|NCT00586690|466076938|FG000|Overall Study|Lack of Efficacy|2|||
129487705|NCT00586690|466076939|FG001|Overall Study|Lack of Efficacy|0|||
129487706|NCT00586690|466076938|FG000|Overall Study|Lab can't accommodate|1|||
129487707|NCT00586690|466076939|FG001|Overall Study|Lab can't accommodate|0|||
129487708|NCT00857246|466076940|FG000|Induction Regimen|Adverse Event|1|||
129487709|NCT00857246|466076940|FG000|Induction Regimen|disease-related complications|1|||
129487710|NCT00857246|466076940|FG000|Induction Regimen|Withdrawal by Subject|1|||
129487711|NCT00857246|466076940|FG000|Surgery (Curative)|disease progression|6|||
129487712|NCT00857246|466076940|FG000|ChemoRT|Withdrawal by Subject|1|||
129487713|NCT00857246|466076940|FG000|ChemoRT|Adverse Event|2|||
129487714|NCT02104180|466076953|FG000|Overall Study|Protocol Violation|1|||
129487715|NCT02104180|466076954|FG001|Overall Study|Protocol Violation|0|||
129487716|NCT01524289|466076955|FG000|Overall Study|Lost to Follow-up|0|||
129487717|NCT01524289|466076956|FG001|Overall Study|Lost to Follow-up|1|||
129487718|NCT01524289|466076955|FG000|Overall Study|Physician Decision|1|||
129487719|NCT01524289|466076956|FG001|Overall Study|Physician Decision|0|||
129487720|NCT01524289|466076955|FG000|Overall Study|Protocol Violation|5|||
129487721|NCT01524289|466076956|FG001|Overall Study|Protocol Violation|1|||
129487722|NCT01524289|466076955|FG000|Overall Study|Withdrawal by Subject|11|||
129487723|NCT01524289|466076956|FG001|Overall Study|Withdrawal by Subject|7|||
129487724|NCT01524289|466076955|FG000|Overall Study|Adverse Event|12|||
129487725|NCT01524289|466076956|FG001|Overall Study|Adverse Event|5|||
129487726|NCT01524289|466076955|FG000|Overall Study|Did not take study medication|1|||
129487727|NCT01524289|466076956|FG001|Overall Study|Did not take study medication|0|||
129487728|NCT01089725|466076957|FG000|Overall Study|Adverse Event|1|||
129487729|NCT01089725|466076958|FG001|Overall Study|Adverse Event|1|||
129487730|NCT01089725|466076959|FG002|Overall Study|Adverse Event|0|||
129487731|NCT01089725|466076960|FG003|Overall Study|Adverse Event|0|||
129487732|NCT01089725|466076961|FG004|Overall Study|Adverse Event|2|||
129487733|NCT01089725|466076957|FG000|Overall Study|Lack of Efficacy|4|||
129487734|NCT01089725|466076958|FG001|Overall Study|Lack of Efficacy|3|||
129487735|NCT01089725|466076959|FG002|Overall Study|Lack of Efficacy|1|||
129487736|NCT01089725|466076960|FG003|Overall Study|Lack of Efficacy|0|||
129487737|NCT01089725|466076961|FG004|Overall Study|Lack of Efficacy|4|||
129487738|NCT01089725|466076957|FG000|Overall Study|Lost to Follow-up|2|||
129487739|NCT01089725|466076958|FG001|Overall Study|Lost to Follow-up|2|||
129487740|NCT01089725|466076959|FG002|Overall Study|Lost to Follow-up|0|||
129487741|NCT01089725|466076960|FG003|Overall Study|Lost to Follow-up|3|||
129487742|NCT01089725|466076961|FG004|Overall Study|Lost to Follow-up|0|||
129487743|NCT01089725|466076957|FG000|Overall Study|Protocol Violation|0|||
129487744|NCT01089725|466076958|FG001|Overall Study|Protocol Violation|0|||
129487745|NCT01089725|466076959|FG002|Overall Study|Protocol Violation|1|||
129487746|NCT01089725|466076960|FG003|Overall Study|Protocol Violation|1|||
129487747|NCT01089725|466076961|FG004|Overall Study|Protocol Violation|0|||
129487748|NCT01089725|466076957|FG000|Overall Study|Withdrawal by Subject|5|||
129487749|NCT01089725|466076958|FG001|Overall Study|Withdrawal by Subject|5|||
129487750|NCT01089725|466076959|FG002|Overall Study|Withdrawal by Subject|4|||
129487751|NCT01089725|466076960|FG003|Overall Study|Withdrawal by Subject|5|||
129487752|NCT01089725|466076961|FG004|Overall Study|Withdrawal by Subject|4|||
129487753|NCT01089725|466076957|FG000|Overall Study|Study Terminated by Sponsor|51|||
129487754|NCT01089725|466076958|FG001|Overall Study|Study Terminated by Sponsor|56|||
129487755|NCT01089725|466076959|FG002|Overall Study|Study Terminated by Sponsor|53|||
129487756|NCT01089725|466076960|FG003|Overall Study|Study Terminated by Sponsor|68|||
129487757|NCT01089725|466076961|FG004|Overall Study|Study Terminated by Sponsor|68|||
129487758|NCT01089725|466076957|FG000|Overall Study|Randomized, but not treated|0|||
129487759|NCT01089725|466076958|FG001|Overall Study|Randomized, but not treated|1|||
129487760|NCT01089725|466076959|FG002|Overall Study|Randomized, but not treated|2|||
129487761|NCT01089725|466076960|FG003|Overall Study|Randomized, but not treated|1|||
129487762|NCT01089725|466076961|FG004|Overall Study|Randomized, but not treated|2|||
129487763|NCT01089725|466076957|FG000|Overall Study|Other|3|||
129487764|NCT01089725|466076958|FG001|Overall Study|Other|0|||
129487765|NCT01089725|466076959|FG002|Overall Study|Other|0|||
129487766|NCT01089725|466076960|FG003|Overall Study|Other|1|||
129487767|NCT01089725|466076961|FG004|Overall Study|Other|0|||
129487768|NCT01582282|466078740|FG000|Overall Study|Adverse Event|1|||
129487769|NCT01582282|466078741|FG001|Overall Study|Adverse Event|1|||
129487770|NCT01582282|466078742|FG002|Overall Study|Adverse Event|0|||
129487771|NCT01582282|466078740|FG000|Overall Study|Lost to Follow-up|1|||
129487772|NCT01582282|466078741|FG001|Overall Study|Lost to Follow-up|0|||
129487773|NCT01582282|466078742|FG002|Overall Study|Lost to Follow-up|0|||
129487774|NCT01582282|466078740|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
129487775|NCT01582282|466078741|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
129487776|NCT01582282|466078742|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
129487777|NCT01486316|466078743|FG000|Overall Study|Device explanted with/without re-implant|3|||
129487778|NCT01486316|466078744|FG001|Overall Study|Device explanted with/without re-implant|2|||
129487779|NCT01486316|466078745|FG002|Overall Study|Device explanted with/without re-implant|0|||
129979596|NCT04488770|467889400|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979597|NCT04488770|467889401|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129487780|NCT01486316|466078746|FG003|Overall Study|Device explanted with/without re-implant|2|||
129487781|NCT01486316|466078743|FG000|Overall Study|Not meeting eligibility criteria|0|||
129487782|NCT01486316|466078744|FG001|Overall Study|Not meeting eligibility criteria|0|||
129487783|NCT01486316|466078745|FG002|Overall Study|Not meeting eligibility criteria|1|||
129487784|NCT01486316|466078746|FG003|Overall Study|Not meeting eligibility criteria|0|||
129487785|NCT01486316|466078743|FG000|Overall Study|Withdrawal by Subject|1|||
129487786|NCT01486316|466078744|FG001|Overall Study|Withdrawal by Subject|0|||
129487787|NCT01486316|466078745|FG002|Overall Study|Withdrawal by Subject|3|||
129487788|NCT01486316|466078746|FG003|Overall Study|Withdrawal by Subject|0|||
129487789|NCT01486316|466078743|FG000|Overall Study|Physician Decision|0|||
129487790|NCT01486316|466078744|FG001|Overall Study|Physician Decision|0|||
129487791|NCT01486316|466078745|FG002|Overall Study|Physician Decision|1|||
129487792|NCT01486316|466078746|FG003|Overall Study|Physician Decision|0|||
129487793|NCT01486316|466078743|FG000|Overall Study|Death|0|||
129487794|NCT01486316|466078744|FG001|Overall Study|Death|1|||
129979598|NCT04488770|467889402|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129487795|NCT01486316|466078745|FG002|Overall Study|Death|0|||
129487796|NCT01486316|466078746|FG003|Overall Study|Death|0|||
129487797|NCT02495077|466078755|FG000|Overall Study|Adverse Event|0|||
129487798|NCT02495077|466078756|FG001|Overall Study|Adverse Event|1|||
129487799|NCT02495077|466078757|FG002|Overall Study|Adverse Event|1|||
129487800|NCT02495077|466078758|FG003|Overall Study|Adverse Event|0|||
129487801|NCT02495077|466078755|FG000|Overall Study|Death|3|||
129487802|NCT02495077|466078756|FG001|Overall Study|Death|5|||
129487803|NCT02495077|466078757|FG002|Overall Study|Death|0|||
129487804|NCT02495077|466078758|FG003|Overall Study|Death|0|||
129487805|NCT02495077|466078755|FG000|Overall Study|Lost to Follow-up|6|||
129487806|NCT02495077|466078756|FG001|Overall Study|Lost to Follow-up|4|||
129487807|NCT02495077|466078757|FG002|Overall Study|Lost to Follow-up|0|||
129487808|NCT02495077|466078758|FG003|Overall Study|Lost to Follow-up|0|||
129487809|NCT02495077|466078755|FG000|Overall Study|Physician Decision|2|||
129487810|NCT02495077|466078756|FG001|Overall Study|Physician Decision|1|||
129487811|NCT02495077|466078757|FG002|Overall Study|Physician Decision|4|||
129487812|NCT02495077|466078758|FG003|Overall Study|Physician Decision|0|||
129487813|NCT02495077|466078755|FG000|Overall Study|Protocol Violation|0|||
129487814|NCT02495077|466078756|FG001|Overall Study|Protocol Violation|1|||
129487815|NCT02495077|466078757|FG002|Overall Study|Protocol Violation|0|||
129487816|NCT02495077|466078758|FG003|Overall Study|Protocol Violation|0|||
129487817|NCT02495077|466078755|FG000|Overall Study|Screen Failure|0|||
129487818|NCT02495077|466078756|FG001|Overall Study|Screen Failure|0|||
129487819|NCT02495077|466078757|FG002|Overall Study|Screen Failure|0|||
129487820|NCT02495077|466078758|FG003|Overall Study|Screen Failure|48|||
129487821|NCT02495077|466078755|FG000|Overall Study|Withdrawal by Subject|7|||
129487822|NCT02495077|466078756|FG001|Overall Study|Withdrawal by Subject|7|||
129487823|NCT02495077|466078757|FG002|Overall Study|Withdrawal by Subject|7|||
129487824|NCT02495077|466078758|FG003|Overall Study|Withdrawal by Subject|0|||
129487825|NCT02495077|466078755|FG000|Overall Study|Covid-19 research restrictions|1|||
129487826|NCT02495077|466078756|FG001|Overall Study|Covid-19 research restrictions|0|||
129487827|NCT02495077|466078757|FG002|Overall Study|Covid-19 research restrictions|0|||
129487828|NCT02495077|466078758|FG003|Overall Study|Covid-19 research restrictions|0|||
129487829|NCT02495077|466078755|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
129487830|NCT02495077|466078756|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
129487831|NCT02495077|466078757|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
129487832|NCT02495077|466078758|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
129487833|NCT02495077|466078755|FG000|Overall Study|Incarcerated|0|||
129487834|NCT02495077|466078756|FG001|Overall Study|Incarcerated|1|||
129487835|NCT02495077|466078757|FG002|Overall Study|Incarcerated|0|||
129487836|NCT02495077|466078758|FG003|Overall Study|Incarcerated|0|||
129487837|NCT02495077|466078755|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
129487838|NCT02495077|466078756|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
129487839|NCT02495077|466078757|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
129487840|NCT02495077|466078758|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
129487841|NCT02495077|466078755|FG000|Overall Study|Timing of transplant and randomization|0|||
129487842|NCT02495077|466078756|FG001|Overall Study|Timing of transplant and randomization|0|||
129487843|NCT02495077|466078757|FG002|Overall Study|Timing of transplant and randomization|5|||
129487844|NCT02495077|466078758|FG003|Overall Study|Timing of transplant and randomization|0|||
129487845|NCT02742649|466078759|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
129487846|NCT02742649|466078760|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
129487847|NCT02742649|466078761|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
129487848|NCT02742649|466078762|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
129487849|NCT02742649|466078763|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
129487850|NCT02742649|466078759|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129487851|NCT02742649|466078760|FG001|Double-Blind Treatment Period|Adverse Event|1|||
129487852|NCT02742649|466078761|FG002|Double-Blind Treatment Period|Adverse Event|0|||
129487853|NCT02742649|466078762|FG003|Double-Blind Treatment Period|Adverse Event|0|||
129487854|NCT02742649|466078763|FG004|Double-Blind Treatment Period|Adverse Event|0|||
129487855|NCT02742649|466078759|FG000|Open-Label Period|Lost to Follow-up|0|||
129487856|NCT02742649|466078760|FG001|Open-Label Period|Lost to Follow-up|0|||
129487857|NCT02742649|466078761|FG002|Open-Label Period|Lost to Follow-up|0|||
129487858|NCT02742649|466078762|FG003|Open-Label Period|Lost to Follow-up|0|||
129487859|NCT02742649|466078763|FG004|Open-Label Period|Lost to Follow-up|1|||
129487860|NCT00417612|466078775|FG000|Overall Study|Errant diagnosis|0|||
129487861|NCT00417612|466078776|FG001|Overall Study|Errant diagnosis|1|||
129487862|NCT00417612|466078775|FG000|Overall Study|Adverse Event|2|||
129487863|NCT00417612|466078776|FG001|Overall Study|Adverse Event|0|||
129487864|NCT00417612|466078775|FG000|Overall Study|Protocol Violation|0|||
129487865|NCT00417612|466078776|FG001|Overall Study|Protocol Violation|2|||
129487866|NCT00417612|466078775|FG000|Overall Study|Lost to Follow-up|1|||
129487867|NCT00417612|466078776|FG001|Overall Study|Lost to Follow-up|0|||
129487868|NCT00224107|466078779|FG000|Overall Study|Adverse Event|20|||
129487869|NCT00224107|466078780|FG001|Overall Study|Adverse Event|6|||
129487870|NCT00224107|466078779|FG000|Overall Study|Protocol Violation|2|||
129487871|NCT00224107|466078780|FG001|Overall Study|Protocol Violation|3|||
129487872|NCT00224107|466078779|FG000|Overall Study|Withdrawal by Subject|1|||
129487873|NCT00224107|466078780|FG001|Overall Study|Withdrawal by Subject|4|||
129487874|NCT00224107|466078779|FG000|Overall Study|Lack of Efficacy|2|||
129487875|NCT00224107|466078780|FG001|Overall Study|Lack of Efficacy|0|||
129487876|NCT00224107|466078779|FG000|Overall Study|Lost to Follow-up|4|||
129487877|NCT00224107|466078780|FG001|Overall Study|Lost to Follow-up|0|||
129487878|NCT00224107|466078779|FG000|Overall Study|Physician Decision|1|||
129487879|NCT00224107|466078780|FG001|Overall Study|Physician Decision|0|||
129487880|NCT00224107|466078779|FG000|Overall Study|Other|1|||
129487881|NCT00224107|466078780|FG001|Overall Study|Other|1|||
129487882|NCT04220866|466078781|FG000|Overall Study|Death|4|||
129487883|NCT04220866|466078782|FG001|Overall Study|Death|5|||
129487884|NCT04220866|466078781|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
129487885|NCT04220866|466078782|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
129487886|NCT04220866|466078781|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
129487887|NCT04220866|466078782|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
129487888|NCT04220866|466078781|FG000|Overall Study|Withdrawal by Subject|0|||
129487889|NCT04220866|466078782|FG001|Overall Study|Withdrawal by Subject|1|||
129487890|NCT03515538|466078783|FG000|Overall Study|Lack of Efficacy|2|||
129487891|NCT03515538|466078784|FG001|Overall Study|Lack of Efficacy|0|||
129487892|NCT03515538|466078785|FG002|Overall Study|Lack of Efficacy|2|||
129487893|NCT03515538|466078786|FG003|Overall Study|Lack of Efficacy|0|||
129487894|NCT03515538|466078783|FG000|Overall Study|Death|0|||
129487895|NCT03515538|466078784|FG001|Overall Study|Death|0|||
129487896|NCT03515538|466078785|FG002|Overall Study|Death|1|||
129487897|NCT03515538|466078786|FG003|Overall Study|Death|0|||
129487898|NCT03515538|466078783|FG000|Overall Study|Protocol Violation|0|||
129487899|NCT03515538|466078784|FG001|Overall Study|Protocol Violation|0|||
129487900|NCT03515538|466078785|FG002|Overall Study|Protocol Violation|0|||
129487901|NCT03515538|466078786|FG003|Overall Study|Protocol Violation|1|||
129487902|NCT03515538|466078783|FG000|Overall Study|Screen failure (baseline dropout)|0|||
129487903|NCT03515538|466078784|FG001|Overall Study|Screen failure (baseline dropout)|1|||
129487904|NCT03515538|466078785|FG002|Overall Study|Screen failure (baseline dropout)|0|||
129487905|NCT03515538|466078786|FG003|Overall Study|Screen failure (baseline dropout)|0|||
129487906|NCT03515538|466078783|FG000|Overall Study|Withdrawal by Subject|2|||
129487907|NCT03515538|466078784|FG001|Overall Study|Withdrawal by Subject|2|||
129487908|NCT03515538|466078785|FG002|Overall Study|Withdrawal by Subject|1|||
129487909|NCT03515538|466078786|FG003|Overall Study|Withdrawal by Subject|3|||
129487910|NCT03515538|466078783|FG000|Overall Study|Physician Decision|1|||
129487911|NCT03515538|466078784|FG001|Overall Study|Physician Decision|0|||
129487912|NCT03515538|466078785|FG002|Overall Study|Physician Decision|0|||
129487913|NCT03515538|466078786|FG003|Overall Study|Physician Decision|1|||
129487914|NCT00546351|466078789|FG000|Overall Study|Adverse Event|76|||
129487915|NCT00546351|466078789|FG000|Overall Study|Lack of Efficacy|15|||
129487916|NCT00546351|466078789|FG000|Overall Study|Withdrawal by Subject|109|||
129487917|NCT00546351|466078789|FG000|Overall Study|Lost to Follow-up|9|||
129487918|NCT00546351|466078789|FG000|Overall Study|Protocol Deviation|1|||
129487919|NCT00546351|466078789|FG000|Overall Study|Unsatisfactory compliance|9|||
129487920|NCT00546351|466078789|FG000|Overall Study|Other reasons for premature termination|17|||
129487921|NCT03952650|466078790|FG000|Overall Study|TRAVEL|0|||
129487922|NCT03952650|466078791|FG001|Overall Study|TRAVEL|4|||
129487923|NCT03952650|466078792|FG002|Overall Study|TRAVEL|0|||
129487924|NCT03952650|466078793|FG003|Overall Study|TRAVEL|4|||
129487925|NCT03952650|466078794|FG004|Overall Study|TRAVEL|0|||
129487926|NCT03952650|466078795|FG005|Overall Study|TRAVEL|3|||
129487927|NCT03952650|466078796|FG006|Overall Study|TRAVEL|2|||
129487928|NCT03952650|466078790|FG000|Overall Study|Withdrawal by Subject|0|||
129487929|NCT03952650|466078791|FG001|Overall Study|Withdrawal by Subject|2|||
129487930|NCT03952650|466078792|FG002|Overall Study|Withdrawal by Subject|0|||
129487931|NCT03952650|466078793|FG003|Overall Study|Withdrawal by Subject|3|||
129487932|NCT03952650|466078794|FG004|Overall Study|Withdrawal by Subject|0|||
129487933|NCT03952650|466078795|FG005|Overall Study|Withdrawal by Subject|1|||
129487934|NCT03952650|466078796|FG006|Overall Study|Withdrawal by Subject|1|||
129487935|NCT03952650|466078790|FG000|Overall Study|Lost to Follow-up|0|||
129487936|NCT03952650|466078791|FG001|Overall Study|Lost to Follow-up|1|||
129487937|NCT03952650|466078792|FG002|Overall Study|Lost to Follow-up|0|||
129487938|NCT03952650|466078793|FG003|Overall Study|Lost to Follow-up|0|||
129487939|NCT03952650|466078794|FG004|Overall Study|Lost to Follow-up|0|||
129487940|NCT03952650|466078795|FG005|Overall Study|Lost to Follow-up|1|||
129487941|NCT03952650|466078796|FG006|Overall Study|Lost to Follow-up|1|||
129487942|NCT03952650|466078790|FG000|Overall Study|Received wrong vaccine and travelled|0|||
129487943|NCT03952650|466078791|FG001|Overall Study|Received wrong vaccine and travelled|0|||
129487944|NCT03952650|466078792|FG002|Overall Study|Received wrong vaccine and travelled|0|||
129487945|NCT03952650|466078793|FG003|Overall Study|Received wrong vaccine and travelled|0|||
129487946|NCT03952650|466078794|FG004|Overall Study|Received wrong vaccine and travelled|0|||
129487947|NCT03952650|466078795|FG005|Overall Study|Received wrong vaccine and travelled|1|||
129487948|NCT03952650|466078796|FG006|Overall Study|Received wrong vaccine and travelled|0|||
129487949|NCT03952650|466078790|FG000|Overall Study|Unable to make study visit|0|||
129487950|NCT03952650|466078791|FG001|Overall Study|Unable to make study visit|0|||
129487951|NCT03952650|466078792|FG002|Overall Study|Unable to make study visit|0|||
129487952|NCT03952650|466078793|FG003|Overall Study|Unable to make study visit|0|||
129487953|NCT03952650|466078794|FG004|Overall Study|Unable to make study visit|0|||
129487954|NCT03952650|466078795|FG005|Overall Study|Unable to make study visit|1|||
129487955|NCT03952650|466078796|FG006|Overall Study|Unable to make study visit|0|||
129487956|NCT02424149|466078797|FG000|Overall Study|surgery cancelled|2|||
129487957|NCT02424149|466078798|FG001|Overall Study|surgery cancelled|0|||
129487958|NCT02424149|466078797|FG000|Overall Study|Withdrawal by Subject|0|||
129487959|NCT02424149|466078798|FG001|Overall Study|Withdrawal by Subject|1|||
129487960|NCT00592683|466078799|FG000|Overall Study|Found ineligible|0|||
129487961|NCT00592683|466078800|FG001|Overall Study|Found ineligible|1|||
129487962|NCT00592683|466078799|FG000|Overall Study|Withdrawal by Subject|1|||
129487963|NCT00592683|466078800|FG001|Overall Study|Withdrawal by Subject|0|||
129487964|NCT00592683|466078799|FG000|Overall Study|Adverse Event|0|||
129487965|NCT00592683|466078800|FG001|Overall Study|Adverse Event|2|||
129487966|NCT00592683|466078799|FG000|Overall Study|Protocol Violation|1|||
129487967|NCT00592683|466078800|FG001|Overall Study|Protocol Violation|0|||
129487968|NCT00592683|466078799|FG000|Overall Study|Study drug expired|1|||
129487969|NCT00592683|466078800|FG001|Overall Study|Study drug expired|0|||
129487970|NCT00592683|466078799|FG000|Overall Study|Other|1|||
129487971|NCT00592683|466078800|FG001|Overall Study|Other|0|||
129487972|NCT00592683|466078799|FG000|Overall Study|Lost to Follow-up|0|||
129487973|NCT00592683|466078800|FG001|Overall Study|Lost to Follow-up|1|||
129487974|NCT01357239|466078803|FG000|Stratum: All Patients|Adverse Event|0|||
129487975|NCT01357239|466078804|FG001|Stratum: All Patients|Adverse Event|0|||
129487976|NCT01357239|466078805|FG002|Stratum: All Patients|Adverse Event|1|||
129487977|NCT01357239|466078806|FG003|Stratum: All Patients|Adverse Event|1|||
129487978|NCT01357239|466078803|FG000|Stratum: All Patients|Subject withdrew consent|0|||
129487979|NCT01357239|466078804|FG001|Stratum: All Patients|Subject withdrew consent|0|||
129487980|NCT01357239|466078805|FG002|Stratum: All Patients|Subject withdrew consent|1|||
129487981|NCT01357239|466078806|FG003|Stratum: All Patients|Subject withdrew consent|1|||
129487982|NCT01357239|466078803|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
129487983|NCT01357239|466078804|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
129487984|NCT01357239|466078805|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
129487985|NCT01357239|466078806|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
129487986|NCT01357239|466078803|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
129487987|NCT01357239|466078804|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
129487988|NCT01357239|466078805|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
129487989|NCT01357239|466078806|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
129487990|NCT01357239|466078803|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
129487991|NCT01357239|466078804|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
129487992|NCT01357239|466078805|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
129487993|NCT01357239|466078806|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
129487994|NCT00545818|466078813|FG000|Overall Study|Protocol Violation|1|||
129487995|NCT00545818|466078814|FG001|Overall Study|Protocol Violation|0|||
129487996|NCT00545818|466078813|FG000|Overall Study|Adverse Event|1|||
129487997|NCT00545818|466078814|FG001|Overall Study|Adverse Event|1|||
129487998|NCT00545818|466078813|FG000|Overall Study|Lost to Follow-up|1|||
129487999|NCT00545818|466078814|FG001|Overall Study|Lost to Follow-up|6|||
129488000|NCT00609609|466078815|FG000|Overall Study|Withdrawal by Subject|2|||
129488001|NCT00609609|466078816|FG001|Overall Study|Withdrawal by Subject|0|||
129488002|NCT00609609|466078815|FG000|Overall Study|Progression|4|||
129488003|NCT00609609|466078816|FG001|Overall Study|Progression|2|||
129488004|NCT01050062|466078817|FG000|Overall Study|Adverse Event|75|||
129488005|NCT01050062|466078818|FG001|Overall Study|Adverse Event|22|||
129488006|NCT01050062|466078817|FG000|Overall Study|Lost to Follow-up|83|||
129488007|NCT01050062|466078818|FG001|Overall Study|Lost to Follow-up|35|||
129488008|NCT01050062|466078817|FG000|Overall Study|Lack of Efficacy|22|||
129488009|NCT01050062|466078818|FG001|Overall Study|Lack of Efficacy|35|||
129488010|NCT01050062|466078817|FG000|Overall Study|Physician Decision|74|||
129488011|NCT01050062|466078818|FG001|Overall Study|Physician Decision|9|||
129488012|NCT01050062|466078817|FG000|Overall Study|Others|17|||
129488013|NCT01050062|466078818|FG001|Overall Study|Others|11|||
129488014|NCT00670111|466078821|FG000|Enrollment to One Month|Testing Failure|0|||
129488015|NCT00670111|466078822|FG001|Enrollment to One Month|Testing Failure|0|||
129488016|NCT00670111|466078823|FG002|Enrollment to One Month|Testing Failure|13|||
129488017|NCT00670111|466078821|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
129488018|NCT00670111|466078822|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
129488019|NCT00670111|466078823|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
129488020|NCT00670111|466078821|FG000|Enrollment to One Month|Physician Decision|1|||
129488021|NCT00670111|466078822|FG001|Enrollment to One Month|Physician Decision|0|||
129488022|NCT00670111|466078823|FG002|Enrollment to One Month|Physician Decision|0|||
129488023|NCT03988751|466078824|FG000|Overall Study|Withdrawal by Subject|1|||
129488024|NCT03988751|466078825|FG001|Overall Study|Withdrawal by Subject|0|||
129488025|NCT03988751|466078824|FG000|Overall Study|Protocol Violation|0|||
129488026|NCT03988751|466078825|FG001|Overall Study|Protocol Violation|1|||
129488027|NCT00844883|466078828|FG000|Overall Study|Bridged to liver transplant|3|||
129488028|NCT00844883|466078828|FG000|Overall Study|Bridged to resection|1|||
129488029|NCT02623361|466078829|FG000|Overall Study|Protocol Violation|0|||
129488030|NCT02623361|466078830|FG001|Overall Study|Protocol Violation|1|||
129488031|NCT02623361|466078829|FG000|Overall Study|Withdrawal by Subject|0|||
129488032|NCT02623361|466078830|FG001|Overall Study|Withdrawal by Subject|1|||
129488033|NCT03894540|466078831|FG000|Overall Study|Adverse Event|0|||
129488034|NCT03894540|466078832|FG001|Overall Study|Adverse Event|0|||
129488035|NCT03894540|466078833|FG002|Overall Study|Adverse Event|0|||
129488036|NCT03894540|466078834|FG003|Overall Study|Adverse Event|0|||
129488037|NCT03894540|466078835|FG004|Overall Study|Adverse Event|1|||
129488038|NCT03894540|466078836|FG005|Overall Study|Adverse Event|0|||
129488039|NCT03894540|466078831|FG000|Overall Study|Withdrawal by Subject|0|||
129488040|NCT03894540|466078832|FG001|Overall Study|Withdrawal by Subject|0|||
129488041|NCT03894540|466078833|FG002|Overall Study|Withdrawal by Subject|0|||
129488042|NCT03894540|466078834|FG003|Overall Study|Withdrawal by Subject|0|||
129488043|NCT03894540|466078835|FG004|Overall Study|Withdrawal by Subject|1|||
129488044|NCT03894540|466078836|FG005|Overall Study|Withdrawal by Subject|0|||
129488045|NCT03894540|466078831|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
129488046|NCT03894540|466078832|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
129488047|NCT03894540|466078833|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
129488048|NCT03894540|466078834|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
129488049|NCT03894540|466078835|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
129488050|NCT03894540|466078836|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
129488051|NCT03894540|466078831|FG000|Overall Study|Progressive Disease Clinical|1|||
129488052|NCT03894540|466078832|FG001|Overall Study|Progressive Disease Clinical|1|||
129488053|NCT03894540|466078833|FG002|Overall Study|Progressive Disease Clinical|0|||
129488054|NCT03894540|466078834|FG003|Overall Study|Progressive Disease Clinical|1|||
129488055|NCT03894540|466078835|FG004|Overall Study|Progressive Disease Clinical|5|||
129488056|NCT03894540|466078836|FG005|Overall Study|Progressive Disease Clinical|1|||
129488057|NCT03894540|466078831|FG000|Overall Study|Study termination by sponsor|0|||
129488058|NCT03894540|466078832|FG001|Overall Study|Study termination by sponsor|0|||
129488059|NCT03894540|466078833|FG002|Overall Study|Study termination by sponsor|0|||
129488060|NCT03894540|466078834|FG003|Overall Study|Study termination by sponsor|0|||
129488061|NCT03894540|466078835|FG004|Overall Study|Study termination by sponsor|2|||
129488062|NCT03894540|466078836|FG005|Overall Study|Study termination by sponsor|0|||
129488063|NCT03000452|466078839|FG000|Treatment Period|Death|1|||
129488064|NCT03000452|466078839|FG000|Treatment Period|Progressive Disease (PD)|14|||
129488065|NCT03000452|466078839|FG000|Treatment Period|Physician Decision|1|||
129488066|NCT03000452|466078839|FG000|Treatment Period|Miscellaneous|2|||
129488067|NCT03000452|466078839|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
129488068|NCT03000452|466078839|FG000|Follow-Up Period|Death|3|||
129488069|NCT03000452|466078839|FG000|Follow-Up Period|Withdrawal by Subject|3|||
129488070|NCT00537823|466078842|FG000|Overall Study|Adverse Event|2|||
129488071|NCT00537823|466078843|FG001|Overall Study|Adverse Event|0|||
129488072|NCT03065530|466078844|FG000|Overall Study|Lack of Efficacy|1|||
129488073|NCT03065530|466078845|FG001|Overall Study|Lack of Efficacy|1|||
129488074|NCT03065530|466078846|FG002|Overall Study|Lack of Efficacy|0|||
129488075|NCT03065530|466078847|FG003|Overall Study|Lack of Efficacy|1|||
129488076|NCT03065530|466078844|FG000|Overall Study|Protocol Violation|1|||
129488077|NCT03065530|466078845|FG001|Overall Study|Protocol Violation|0|||
129488078|NCT03065530|466078846|FG002|Overall Study|Protocol Violation|1|||
129488079|NCT03065530|466078847|FG003|Overall Study|Protocol Violation|1|||
129488080|NCT03455543|466078848|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
129488081|NCT03455543|466078849|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
129488082|NCT03455543|466078850|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
129488083|NCT03455543|466078848|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
129488084|NCT03455543|466078849|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
129488085|NCT03455543|466078850|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
129488086|NCT03455543|466078848|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
129488087|NCT03455543|466078849|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
129488088|NCT03455543|466078850|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
129488089|NCT03455543|466078848|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
129488090|NCT03455543|466078849|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
129488091|NCT03455543|466078850|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
129488092|NCT03455543|466078848|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
129488093|NCT03455543|466078849|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
129488094|NCT03455543|466078850|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
129488095|NCT03455543|466078848|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
129488096|NCT03455543|466078849|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
129488097|NCT03455543|466078850|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
129488098|NCT03455543|466078848|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
129488099|NCT03455543|466078849|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
129488100|NCT03455543|466078850|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
129488101|NCT03455543|466078848|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
129488102|NCT03455543|466078849|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
129488103|NCT03455543|466078850|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
129488104|NCT03455543|466078848|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
129488105|NCT03455543|466078849|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
129488106|NCT03455543|466078850|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
129488107|NCT00852930|466078851|FG000|Overall Study|Withdrawal by Subject|1|||
129488108|NCT00852930|466078852|FG001|Overall Study|Withdrawal by Subject|1|||
129488109|NCT00852930|466078853|FG002|Overall Study|Withdrawal by Subject|1|||
129488110|NCT00852930|466078851|FG000|Overall Study|Physician Decision|0|||
129488111|NCT00852930|466078852|FG001|Overall Study|Physician Decision|0|||
129488112|NCT00852930|466078853|FG002|Overall Study|Physician Decision|1|||
129488113|NCT00479466|466078854|FG000|Overall Study|Adverse Event|5|||
129488114|NCT00479466|466078855|FG001|Overall Study|Adverse Event|1|||
129488115|NCT00479466|466078856|FG002|Overall Study|Adverse Event|0|||
129488116|NCT00479466|466078857|FG003|Overall Study|Adverse Event|1|||
129488117|NCT00479466|466078858|FG004|Overall Study|Adverse Event|2|||
129488118|NCT00479466|466078859|FG005|Overall Study|Adverse Event|0|||
129488119|NCT00479466|466078854|FG000|Overall Study|Hyperglycemia|0|||
129488120|NCT00479466|466078855|FG001|Overall Study|Hyperglycemia|0|||
129488121|NCT00479466|466078856|FG002|Overall Study|Hyperglycemia|0|||
129488122|NCT00479466|466078857|FG003|Overall Study|Hyperglycemia|0|||
129488123|NCT00479466|466078858|FG004|Overall Study|Hyperglycemia|0|||
129488124|NCT00479466|466078859|FG005|Overall Study|Hyperglycemia|1|||
129488125|NCT00479466|466078854|FG000|Overall Study|Lack of Efficacy|2|||
129488126|NCT00479466|466078855|FG001|Overall Study|Lack of Efficacy|0|||
129488127|NCT00479466|466078856|FG002|Overall Study|Lack of Efficacy|1|||
129488128|NCT00479466|466078857|FG003|Overall Study|Lack of Efficacy|0|||
129488129|NCT00479466|466078858|FG004|Overall Study|Lack of Efficacy|0|||
129488130|NCT00479466|466078859|FG005|Overall Study|Lack of Efficacy|0|||
129488131|NCT00479466|466078854|FG000|Overall Study|Lost to Follow-up|0|||
129488132|NCT00479466|466078855|FG001|Overall Study|Lost to Follow-up|1|||
129488133|NCT00479466|466078856|FG002|Overall Study|Lost to Follow-up|1|||
129488134|NCT00479466|466078857|FG003|Overall Study|Lost to Follow-up|0|||
129488135|NCT00479466|466078858|FG004|Overall Study|Lost to Follow-up|2|||
129488136|NCT00479466|466078859|FG005|Overall Study|Lost to Follow-up|2|||
129488137|NCT00479466|466078854|FG000|Overall Study|Physician Decision|2|||
129488138|NCT00479466|466078855|FG001|Overall Study|Physician Decision|1|||
129488139|NCT00479466|466078856|FG002|Overall Study|Physician Decision|1|||
129488140|NCT00479466|466078857|FG003|Overall Study|Physician Decision|0|||
129488141|NCT00479466|466078858|FG004|Overall Study|Physician Decision|0|||
129488142|NCT00479466|466078859|FG005|Overall Study|Physician Decision|0|||
129488143|NCT00479466|466078854|FG000|Overall Study|Pregnancy|0|||
129488144|NCT00479466|466078855|FG001|Overall Study|Pregnancy|0|||
129488145|NCT00479466|466078856|FG002|Overall Study|Pregnancy|0|||
129488146|NCT00479466|466078857|FG003|Overall Study|Pregnancy|0|||
129488147|NCT00479466|466078858|FG004|Overall Study|Pregnancy|1|||
129488148|NCT00479466|466078859|FG005|Overall Study|Pregnancy|0|||
129488149|NCT00479466|466078854|FG000|Overall Study|Protocol Violation|1|||
129488150|NCT00479466|466078855|FG001|Overall Study|Protocol Violation|0|||
129488151|NCT00479466|466078856|FG002|Overall Study|Protocol Violation|0|||
129488152|NCT00479466|466078857|FG003|Overall Study|Protocol Violation|0|||
129488153|NCT00479466|466078858|FG004|Overall Study|Protocol Violation|0|||
129488154|NCT00479466|466078859|FG005|Overall Study|Protocol Violation|0|||
129488155|NCT00479466|466078854|FG000|Overall Study|Withdrawal by Subject|3|||
129488156|NCT00479466|466078855|FG001|Overall Study|Withdrawal by Subject|5|||
129488157|NCT00479466|466078856|FG002|Overall Study|Withdrawal by Subject|0|||
129488158|NCT00479466|466078857|FG003|Overall Study|Withdrawal by Subject|2|||
129488159|NCT00479466|466078858|FG004|Overall Study|Withdrawal by Subject|3|||
129488160|NCT00479466|466078859|FG005|Overall Study|Withdrawal by Subject|1|||
129488161|NCT02614794|466078866|FG000|Overall Study|Death|258|||
129488162|NCT02614794|466078867|FG001|Overall Study|Death|151|||
129488163|NCT02614794|466078866|FG000|Overall Study|Study closure by Sponsor|119|||
129488164|NCT02614794|466078867|FG001|Overall Study|Study closure by Sponsor|45|||
129488165|NCT02614794|466078866|FG000|Overall Study|Withdrawal by Subject|24|||
129488166|NCT02614794|466078867|FG001|Overall Study|Withdrawal by Subject|5|||
129488167|NCT02614794|466078866|FG000|Overall Study|Lost to Follow-up|7|||
129488168|NCT02614794|466078867|FG001|Overall Study|Lost to Follow-up|0|||
129488169|NCT02614794|466078866|FG000|Overall Study|Physician Decision|1|||
129488170|NCT02614794|466078867|FG001|Overall Study|Physician Decision|1|||
129488171|NCT02614794|466078866|FG000|Overall Study|Hospital closure|1|||
129488172|NCT02614794|466078867|FG001|Overall Study|Hospital closure|0|||
129488173|NCT01396525|466078878|FG000|Overall Study|Withdrawal by Subject|8|||
129488174|NCT01396525|466078878|FG000|Overall Study|Death|14|||
129488175|NCT01396525|466078878|FG000|Overall Study|Lost to Follow-up|4|||
129488176|NCT03114969|466078879|FG000|Overall Study|Lost to Follow-up|0|||
129488177|NCT03114969|466078880|FG001|Overall Study|Lost to Follow-up|0|||
129488178|NCT03114969|466078881|FG002|Overall Study|Lost to Follow-up|3|||
129488179|NCT03114969|466078882|FG003|Overall Study|Lost to Follow-up|2|||
129488180|NCT03114969|466078883|FG004|Overall Study|Lost to Follow-up|0|||
129488181|NCT03114969|466078884|FG005|Overall Study|Lost to Follow-up|0|||
129488182|NCT03114969|466078885|FG006|Overall Study|Lost to Follow-up|0|||
129488183|NCT03114969|466078886|FG007|Overall Study|Lost to Follow-up|0|||
129488184|NCT03114969|466078887|FG008|Overall Study|Lost to Follow-up|0|||
129488185|NCT03114969|466078879|FG000|Overall Study|Adverse Event|0|||
129488186|NCT03114969|466078880|FG001|Overall Study|Adverse Event|0|||
129488187|NCT03114969|466078881|FG002|Overall Study|Adverse Event|1|||
129488188|NCT03114969|466078882|FG003|Overall Study|Adverse Event|0|||
129488189|NCT03114969|466078883|FG004|Overall Study|Adverse Event|0|||
129488190|NCT03114969|466078884|FG005|Overall Study|Adverse Event|1|||
129488191|NCT03114969|466078885|FG006|Overall Study|Adverse Event|1|||
129488192|NCT03114969|466078886|FG007|Overall Study|Adverse Event|0|||
129488193|NCT03114969|466078887|FG008|Overall Study|Adverse Event|2|||
129488194|NCT00949650|466078888|FG000|Overall Study|Progressive disease|188|||
129488195|NCT00949650|466078889|FG001|Overall Study|Progressive disease|19|||
129488196|NCT00949650|466078888|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
129488197|NCT00949650|466078889|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
129488198|NCT00949650|466078888|FG000|Overall Study|Other Adverse Event (AE)|28|||
129488199|NCT00949650|466078889|FG001|Overall Study|Other Adverse Event (AE)|17|||
129488200|NCT00949650|466078888|FG000|Overall Study|Protocol Violation|1|||
129488201|NCT00949650|466078889|FG001|Overall Study|Protocol Violation|4|||
129488202|NCT00949650|466078888|FG000|Overall Study|Refusal to continue medication|7|||
129488203|NCT00949650|466078889|FG001|Overall Study|Refusal to continue medication|11|||
129488204|NCT00949650|466078888|FG000|Overall Study|Not treated|1|||
129488205|NCT00949650|466078889|FG001|Overall Study|Not treated|4|||
129488206|NCT00949650|466078888|FG000|Overall Study|Other not specified above|5|||
129488207|NCT00949650|466078889|FG001|Overall Study|Other not specified above|0|||
129488208|NCT02168946|466078890|FG000|Overall Study|Adverse Event|8|||
129488209|NCT02168946|466078891|FG001|Overall Study|Adverse Event|5|||
129488210|NCT02168946|466078890|FG000|Overall Study|Lost to Follow-up|3|||
129488211|NCT02168946|466078891|FG001|Overall Study|Lost to Follow-up|0|||
129488212|NCT02168946|466078890|FG000|Overall Study|Subject unable to come back for visits|1|||
129488213|NCT02168946|466078891|FG001|Overall Study|Subject unable to come back for visits|0|||
129488214|NCT00450866|466078897|FG000|Overall Study|Adverse Event|0|||
129488215|NCT00450866|466078898|FG001|Overall Study|Adverse Event|1|||
129488216|NCT00450866|466078897|FG000|Overall Study|Withdrawal by Subject|5|||
129488217|NCT00450866|466078898|FG001|Overall Study|Withdrawal by Subject|2|||
129488218|NCT00450866|466078897|FG000|Overall Study|Death|1|||
129488219|NCT00450866|466078898|FG001|Overall Study|Death|0|||
129488220|NCT00450866|466078897|FG000|Overall Study|Physician Decision|1|||
129488221|NCT00450866|466078898|FG001|Overall Study|Physician Decision|0|||
129488222|NCT01743027|466078899|FG000|Overall Study|Adverse Event|2|||
129488223|NCT01743027|466078900|FG001|Overall Study|Adverse Event|0|||
129488224|NCT01743027|466078901|FG002|Overall Study|Adverse Event|0|||
129488225|NCT01743027|466078902|FG003|Overall Study|Adverse Event|0|||
129488226|NCT01743027|466078899|FG000|Overall Study|Lost to Follow-up|0|||
129488227|NCT01743027|466078900|FG001|Overall Study|Lost to Follow-up|0|||
129488228|NCT01743027|466078901|FG002|Overall Study|Lost to Follow-up|2|||
129488229|NCT01743027|466078902|FG003|Overall Study|Lost to Follow-up|0|||
129488230|NCT01743027|466078899|FG000|Overall Study|Progressive Disease|1|||
129488231|NCT01743027|466078900|FG001|Overall Study|Progressive Disease|4|||
129488232|NCT01743027|466078901|FG002|Overall Study|Progressive Disease|3|||
129488233|NCT01743027|466078902|FG003|Overall Study|Progressive Disease|0|||
129488234|NCT01743027|466078899|FG000|Overall Study|Protocol Violation|1|||
129488235|NCT01743027|466078900|FG001|Overall Study|Protocol Violation|1|||
129488236|NCT01743027|466078901|FG002|Overall Study|Protocol Violation|1|||
129488237|NCT01743027|466078902|FG003|Overall Study|Protocol Violation|0|||
129488238|NCT01743027|466078899|FG000|Overall Study|Withdrawal by Subject|1|||
129488239|NCT01743027|466078900|FG001|Overall Study|Withdrawal by Subject|0|||
129488240|NCT01743027|466078901|FG002|Overall Study|Withdrawal by Subject|3|||
129488241|NCT01743027|466078902|FG003|Overall Study|Withdrawal by Subject|1|||
129488242|NCT00553787|466078905|FG000|Overall Study|Adverse Event|34|||
129488243|NCT00553787|466078906|FG001|Overall Study|Adverse Event|21|||
129488244|NCT00553787|466078907|FG002|Overall Study|Adverse Event|67|||
129488245|NCT00553787|466078905|FG000|Overall Study|Lost to Follow-up|132|||
129488246|NCT00553787|466078906|FG001|Overall Study|Lost to Follow-up|44|||
129488247|NCT00553787|466078907|FG002|Overall Study|Lost to Follow-up|78|||
129488248|NCT00553787|466078905|FG000|Overall Study|Withdrawal by Subject|151|||
129488249|NCT00553787|466078906|FG001|Overall Study|Withdrawal by Subject|40|||
129488250|NCT00553787|466078907|FG002|Overall Study|Withdrawal by Subject|83|||
129488251|NCT00553787|466078905|FG000|Overall Study|Lack of Efficacy|31|||
129488252|NCT00553787|466078906|FG001|Overall Study|Lack of Efficacy|1|||
129488253|NCT00553787|466078907|FG002|Overall Study|Lack of Efficacy|3|||
129488254|NCT00553787|466078905|FG000|Overall Study|Pregnancy|0|||
129488255|NCT00553787|466078906|FG001|Overall Study|Pregnancy|1|||
129488256|NCT00553787|466078907|FG002|Overall Study|Pregnancy|2|||
129488257|NCT00553787|466078905|FG000|Overall Study|non compliance|4|||
129488258|NCT00553787|466078906|FG001|Overall Study|non compliance|0|||
129488259|NCT00553787|466078907|FG002|Overall Study|non compliance|11|||
129488260|NCT00553787|466078905|FG000|Overall Study|Requirement for restricted medication|8|||
129488261|NCT00553787|466078906|FG001|Overall Study|Requirement for restricted medication|7|||
129488262|NCT00553787|466078907|FG002|Overall Study|Requirement for restricted medication|5|||
129488263|NCT00553787|466078905|FG000|Overall Study|Other|18|||
129488264|NCT00553787|466078906|FG001|Overall Study|Other|10|||
129488265|NCT00553787|466078907|FG002|Overall Study|Other|13|||
129488266|NCT02111811|466078908|FG000|Treatment Phase|Lost to Follow-up|22|||
129488267|NCT02111811|466078909|FG001|Treatment Phase|Lost to Follow-up|18|||
129488268|NCT02111811|466078908|FG000|Treatment Phase|Death|2|||
129488269|NCT02111811|466078909|FG001|Treatment Phase|Death|0|||
129488270|NCT02111811|466078908|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
129488271|NCT02111811|466078909|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
129488272|NCT02111811|466078908|FG000|Follow up Period (Aim 2)|Death|2|||
129488273|NCT02111811|466078909|FG001|Follow up Period (Aim 2)|Death|0|||
129488274|NCT00069121|466078914|FG000|Overall Study|Death|286|||
129488275|NCT00069121|466078915|FG001|Overall Study|Death|242|||
129488276|NCT00069121|466078914|FG000|Overall Study|Withdrawal by Subject|18|||
129488277|NCT00069121|466078915|FG001|Overall Study|Withdrawal by Subject|20|||
129488278|NCT00069121|466078914|FG000|Overall Study|Lost to Follow-up|63|||
129488279|NCT00069121|466078915|FG001|Overall Study|Lost to Follow-up|63|||
129488280|NCT00231478|466078918|FG000|Overall Study|Protocol Violation|3|||
129488281|NCT00231478|466078919|FG001|Overall Study|Protocol Violation|2|||
129488282|NCT00231478|466078918|FG000|Overall Study|Refused Treatment|1|||
129488283|NCT00231478|466078919|FG001|Overall Study|Refused Treatment|1|||
129488284|NCT00231478|466078918|FG000|Overall Study|Withdrawal by Subject|1|||
129488285|NCT00231478|466078919|FG001|Overall Study|Withdrawal by Subject|0|||
129488286|NCT00231478|466078918|FG000|Overall Study|Adverse Event|0|||
129488287|NCT00231478|466078919|FG001|Overall Study|Adverse Event|1|||
129488288|NCT00231478|466078918|FG000|Overall Study|Administrative|3|||
129488289|NCT00231478|466078919|FG001|Overall Study|Administrative|2|||
129488290|NCT00393458|466078924|FG000|Overall Study|Adverse Event|35|||
129488291|NCT00393458|466078925|FG001|Overall Study|Adverse Event|24|||
129488292|NCT00393458|466078926|FG002|Overall Study|Adverse Event|40|||
129488293|NCT00393458|466078927|FG003|Overall Study|Adverse Event|35|||
129488294|NCT00393458|466078924|FG000|Overall Study|Subject withdrew consent|27|||
129488295|NCT00393458|466078925|FG001|Overall Study|Subject withdrew consent|40|||
129488296|NCT00393458|466078926|FG002|Overall Study|Subject withdrew consent|33|||
129488297|NCT00393458|466078927|FG003|Overall Study|Subject withdrew consent|50|||
129488298|NCT00393458|466078924|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
129488299|NCT00393458|466078925|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
129488300|NCT00393458|466078926|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
129488301|NCT00393458|466078927|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
129488302|NCT00393458|466078924|FG000|Overall Study|Protocol deviation|11|||
129488303|NCT00393458|466078925|FG001|Overall Study|Protocol deviation|11|||
129488304|NCT00393458|466078926|FG002|Overall Study|Protocol deviation|11|||
129488305|NCT00393458|466078927|FG003|Overall Study|Protocol deviation|10|||
129488306|NCT00393458|466078924|FG000|Overall Study|Administrative problems|7|||
129488307|NCT00393458|466078925|FG001|Overall Study|Administrative problems|8|||
129488308|NCT00393458|466078926|FG002|Overall Study|Administrative problems|5|||
129488309|NCT00393458|466078927|FG003|Overall Study|Administrative problems|2|||
129488310|NCT00393458|466078924|FG000|Overall Study|Lost to Follow-up|5|||
129488311|NCT00393458|466078925|FG001|Overall Study|Lost to Follow-up|6|||
129488312|NCT00393458|466078926|FG002|Overall Study|Lost to Follow-up|5|||
129488313|NCT00393458|466078927|FG003|Overall Study|Lost to Follow-up|3|||
129488314|NCT00393458|466078924|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129488315|NCT00393458|466078925|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129488316|NCT00393458|466078926|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129488317|NCT00393458|466078927|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129488318|NCT00393458|466078924|FG000|Overall Study|Death|1|||
129488319|NCT00393458|466078925|FG001|Overall Study|Death|1|||
129488320|NCT00393458|466078926|FG002|Overall Study|Death|5|||
129488321|NCT00393458|466078927|FG003|Overall Study|Death|5|||
129488322|NCT00393458|466078924|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129488323|NCT00393458|466078925|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129488324|NCT00393458|466078926|FG002|Overall Study|Abnormal test procedure result(s)|1|||
129488325|NCT00393458|466078927|FG003|Overall Study|Abnormal test procedure result(s)|2|||
129488326|NCT00393458|466078924|FG000|Overall Study|Subject no longer requires study drug|0|||
129488327|NCT00393458|466078925|FG001|Overall Study|Subject no longer requires study drug|1|||
129488328|NCT00393458|466078926|FG002|Overall Study|Subject no longer requires study drug|0|||
129488329|NCT00393458|466078927|FG003|Overall Study|Subject no longer requires study drug|0|||
129488330|NCT00104104|466078932|FG000|Overall Study|Adverse Event|8|||
129488331|NCT00104104|466078933|FG001|Overall Study|Adverse Event|8|||
129488332|NCT00104104|466078932|FG000|Overall Study|Abnormal laboratory value(s)|20|||
129488333|NCT00104104|466078933|FG001|Overall Study|Abnormal laboratory value(s)|14|||
129488334|NCT00104104|466078932|FG000|Overall Study|Lack of Efficacy|0|||
129488335|NCT00104104|466078933|FG001|Overall Study|Lack of Efficacy|3|||
129488336|NCT00104104|466078932|FG000|Overall Study|Condition no longer requires study drug|7|||
129488337|NCT00104104|466078933|FG001|Overall Study|Condition no longer requires study drug|4|||
129979599|NCT04488770|467889403|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129488338|NCT00104104|466078932|FG000|Overall Study|Protocol Violation|5|||
129488339|NCT00104104|466078933|FG001|Overall Study|Protocol Violation|2|||
129488340|NCT00104104|466078932|FG000|Overall Study|Withdrawal by Subject|11|||
129488341|NCT00104104|466078933|FG001|Overall Study|Withdrawal by Subject|15|||
129488342|NCT00104104|466078932|FG000|Overall Study|Lost to Follow-up|3|||
129488343|NCT00104104|466078933|FG001|Overall Study|Lost to Follow-up|7|||
129488344|NCT00104104|466078932|FG000|Overall Study|Administrative problems|12|||
129488345|NCT00104104|466078933|FG001|Overall Study|Administrative problems|13|||
129488346|NCT00104104|466078932|FG000|Overall Study|Death|9|||
129488347|NCT00104104|466078933|FG001|Overall Study|Death|6|||
129488348|NCT01821677|466078936|FG000|Overall Study|Adverse Event|4|||
129488349|NCT01821677|466078937|FG001|Overall Study|Adverse Event|6|||
129488350|NCT01821677|466078938|FG002|Overall Study|Adverse Event|5|||
129488351|NCT01821677|466078936|FG000|Overall Study|Physician Decision|1|||
129488352|NCT01821677|466078937|FG001|Overall Study|Physician Decision|4|||
129488353|NCT01821677|466078938|FG002|Overall Study|Physician Decision|1|||
129488354|NCT01821677|466078936|FG000|Overall Study|Non-compliance|0|||
129488355|NCT01821677|466078937|FG001|Overall Study|Non-compliance|1|||
129488356|NCT01821677|466078938|FG002|Overall Study|Non-compliance|2|||
129979600|NCT04488770|467889404|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979601|NCT04488770|467889405|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129488357|NCT01821677|466078936|FG000|Overall Study|Lost to Follow-up|2|||
129488358|NCT01821677|466078937|FG001|Overall Study|Lost to Follow-up|1|||
129488359|NCT01821677|466078938|FG002|Overall Study|Lost to Follow-up|3|||
129488360|NCT01821677|466078936|FG000|Overall Study|Protocol Violation|0|||
129488361|NCT01821677|466078937|FG001|Overall Study|Protocol Violation|0|||
129488362|NCT01821677|466078938|FG002|Overall Study|Protocol Violation|2|||
129488363|NCT01821677|466078936|FG000|Overall Study|Withdrawal by Subject|7|||
129488364|NCT01821677|466078937|FG001|Overall Study|Withdrawal by Subject|3|||
129488365|NCT01821677|466078938|FG002|Overall Study|Withdrawal by Subject|2|||
129488366|NCT01821677|466078936|FG000|Overall Study|Other|9|||
129488367|NCT01821677|466078937|FG001|Overall Study|Other|0|||
129488368|NCT01821677|466078938|FG002|Overall Study|Other|0|||
129488369|NCT00035815|466078940|FG000|Overall Study|Withdrawal by Subject|17|||
129488370|NCT00035815|466078941|FG001|Overall Study|Withdrawal by Subject|11|||
129488371|NCT01894516|466080693|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
129488372|NCT01894516|466080694|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
129488373|NCT01894516|466080695|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
129488374|NCT01894516|466080696|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
129488375|NCT01894516|466080693|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
129488376|NCT01894516|466080694|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129488377|NCT01894516|466080695|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129488378|NCT01894516|466080696|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
129488379|NCT01894516|466080693|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
129488380|NCT01894516|466080694|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
129488381|NCT01894516|466080695|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
129488382|NCT01894516|466080696|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
129488383|NCT01894516|466080693|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
129488384|NCT01894516|466080694|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
129488385|NCT01894516|466080695|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
129488386|NCT01894516|466080696|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
129488387|NCT01894516|466080693|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
129488388|NCT01894516|466080694|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
129488389|NCT01894516|466080695|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
129488390|NCT01894516|466080696|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
129488391|NCT01894516|466080693|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
129488392|NCT01894516|466080694|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
129488393|NCT01894516|466080695|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
129488394|NCT01894516|466080696|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
129488395|NCT01894516|466080693|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
129488396|NCT01894516|466080694|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
129488397|NCT01894516|466080695|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
129488398|NCT01894516|466080696|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
129488399|NCT01894516|466080693|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129488400|NCT01894516|466080694|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129488401|NCT01894516|466080695|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
129488402|NCT01894516|466080696|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
129488403|NCT03191396|466080698|FG000|Overall Study|Lost to Follow-up|0|||
129488404|NCT03191396|466080699|FG001|Overall Study|Lost to Follow-up|3|||
129488405|NCT03191396|466080698|FG000|Overall Study|Withdrawal by Subject|3|||
129488406|NCT03191396|466080699|FG001|Overall Study|Withdrawal by Subject|2|||
129488407|NCT03635190|466080700|FG000|Overall Study|Lost to Follow-up|4|||
129488408|NCT03635190|466080700|FG000|Overall Study|Death|3|||
129488409|NCT03635190|466080700|FG000|Overall Study|Withdrawal by Subject|1|||
129488410|NCT03635190|466080700|FG000|Overall Study|Patient moved and did not return for follow up|1|||
129488411|NCT03692910|466080701|FG000|Overall Study|Lost to Follow-up|4|||
129488412|NCT03692910|466080702|FG001|Overall Study|Lost to Follow-up|0|||
129488413|NCT03692910|466080703|FG002|Overall Study|Lost to Follow-up|0|||
129488414|NCT03692910|466080701|FG000|Overall Study|Withdrawal by Subject|2|||
129488415|NCT03692910|466080702|FG001|Overall Study|Withdrawal by Subject|0|||
129488416|NCT03692910|466080703|FG002|Overall Study|Withdrawal by Subject|0|||
129488417|NCT01981122|466080706|FG000|Overall Study|Withdrawal by Subject|0|||
129488418|NCT01981122|466080707|FG001|Overall Study|Withdrawal by Subject|2|||
129488419|NCT01981122|466080706|FG000|Overall Study|Protocol Violation|0|||
129488420|NCT01981122|466080707|FG001|Overall Study|Protocol Violation|1|||
129488421|NCT01981122|466080706|FG000|Overall Study|Lost to Follow-up|0|||
129488422|NCT01981122|466080707|FG001|Overall Study|Lost to Follow-up|1|||
129488423|NCT01981122|466080706|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
129488424|NCT01981122|466080707|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
129488425|NCT01981122|466080706|FG000|Overall Study|Death|14|||
129488426|NCT01981122|466080707|FG001|Overall Study|Death|15|||
129488427|NCT03060577|466080708|FG000|Overall Study|Withdrawal by Subject|25|||
129488428|NCT03060577|466080709|FG001|Overall Study|Withdrawal by Subject|5|||
129488429|NCT03060577|466080708|FG000|Overall Study|Physician Decision|4|||
129979602|NCT04488770|467889406|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979603|NCT04488770|467889407|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979604|NCT04488770|467889408|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
129979605|NCT04488770|467889396|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979606|NCT04488770|467889397|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979607|NCT04488770|467889398|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979608|NCT04488770|467889399|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979609|NCT04488770|467889400|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979610|NCT04488770|467889401|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
129979611|NCT04488770|467889402|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
129979612|NCT04488770|467889403|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979613|NCT04488770|467889404|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979614|NCT04488770|467889405|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979615|NCT04488770|467889406|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979616|NCT04488770|467889407|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979617|NCT04488770|467889408|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
129979618|NCT04488770|467889396|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979619|NCT04488770|467889397|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979620|NCT04488770|467889398|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979621|NCT04488770|467889399|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979622|NCT04488770|467889400|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
129979623|NCT04488770|467889401|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979624|NCT04488770|467889402|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979625|NCT04488770|467889403|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979626|NCT04488770|467889404|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979627|NCT04488770|467889405|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979628|NCT04488770|467889406|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979629|NCT04488770|467889407|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979630|NCT04488770|467889408|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
129979631|NCT01867333|467889409|FG000|Overall Study|Withdrawal by Subject|1|||
129979632|NCT01867333|467889410|FG001|Overall Study|Withdrawal by Subject|0|||
129979633|NCT01867333|467889409|FG000|Overall Study|Adverse Event|1|||
129979634|NCT01867333|467889410|FG001|Overall Study|Adverse Event|0|||
129979635|NCT01867333|467889409|FG000|Overall Study|Participant choice|1|||
129979636|NCT01867333|467889410|FG001|Overall Study|Participant choice|2|||
129979637|NCT01867333|467889409|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
129979638|NCT01867333|467889410|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
129979639|NCT01867333|467889409|FG000|Overall Study|Death|0|||
129979640|NCT01867333|467889410|FG001|Overall Study|Death|1|||
129979641|NCT01867333|467889409|FG000|Overall Study|Physician Decision|3|||
129979642|NCT01867333|467889410|FG001|Overall Study|Physician Decision|2|||
129979643|NCT01867333|467889409|FG000|Overall Study|Switched to alternative treatment|1|||
129979644|NCT01867333|467889410|FG001|Overall Study|Switched to alternative treatment|0|||
129979645|NCT03361605|467889413|FG000|Overall Study|Analyzable data not available|3|||
129979646|NCT00403767|467889417|FG000|Overall Study|Adverse Event|993|||
129979647|NCT00403767|467889418|FG001|Overall Study|Adverse Event|919|||
129979648|NCT00403767|467889417|FG000|Overall Study|Non-compliant with study medication|134|||
129979649|NCT00403767|467889418|FG001|Overall Study|Non-compliant with study medication|164|||
129979650|NCT00403767|467889417|FG000|Overall Study|Consent withdrawn|671|||
129979651|NCT00403767|467889418|FG001|Overall Study|Consent withdrawn|673|||
129488430|NCT03060577|466080709|FG001|Overall Study|Physician Decision|3|||
129488431|NCT03060577|466080708|FG000|Overall Study|Lost to Follow-up|3|||
129488432|NCT03060577|466080709|FG001|Overall Study|Lost to Follow-up|0|||
129488433|NCT03060577|466080708|FG000|Overall Study|Death|7|||
129488434|NCT03060577|466080709|FG001|Overall Study|Death|1|||
129488435|NCT03060577|466080708|FG000|Overall Study|Adverse Event|9|||
129488436|NCT03060577|466080709|FG001|Overall Study|Adverse Event|1|||
129488437|NCT03060577|466080708|FG000|Overall Study|Inclusion/Exclusion|1|||
129488438|NCT03060577|466080709|FG001|Overall Study|Inclusion/Exclusion|0|||
129488439|NCT03060577|466080708|FG000|Overall Study|Other|8|||
129488440|NCT03060577|466080709|FG001|Overall Study|Other|2|||
129488441|NCT03216265|466080713|FG000|Overall Study|Adverse Event|2|||
129488442|NCT03216265|466080714|FG001|Overall Study|Adverse Event|0|||
129488443|NCT03216265|466080715|FG002|Overall Study|Adverse Event|2|||
129488444|NCT03216265|466080713|FG000|Overall Study|Lost to Follow-up|0|||
129488445|NCT03216265|466080714|FG001|Overall Study|Lost to Follow-up|1|||
129488446|NCT03216265|466080715|FG002|Overall Study|Lost to Follow-up|0|||
129488447|NCT03216265|466080713|FG000|Overall Study|Withdrawal by Subject|0|||
129488448|NCT03216265|466080714|FG001|Overall Study|Withdrawal by Subject|0|||
129488449|NCT03216265|466080715|FG002|Overall Study|Withdrawal by Subject|1|||
129488450|NCT01277289|466080717|FG000|Overall Study|fragile vein|1|||
129488451|NCT01277289|466080718|FG001|Overall Study|fragile vein|0|||
129488452|NCT01277289|466080717|FG000|Overall Study|Physician Decision|1|||
129488453|NCT01277289|466080718|FG001|Overall Study|Physician Decision|0|||
129488505|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
129488506|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
129488507|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
129488508|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
129488509|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
129488510|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
129488511|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
129488512|NCT00092547|466080719|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
129488513|NCT00092547|466080720|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
129488514|NCT00092547|466080721|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
129488515|NCT00092547|466080719|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
129979965|NCT04372121|467889513|FG003|Overall Study|Withdrawal by Subject|0|||
129979966|NCT04372121|467889510|FG000|Overall Study|Study termination|6|||
129979967|NCT04372121|467889511|FG001|Overall Study|Study termination|5|||
129979968|NCT04372121|467889512|FG002|Overall Study|Study termination|1|||
129979969|NCT04372121|467889513|FG003|Overall Study|Study termination|1|||
129979970|NCT04372121|467889510|FG000|Overall Study|Hysterectomy planned|1|||
129979971|NCT04372121|467889511|FG001|Overall Study|Hysterectomy planned|0|||
129979972|NCT04372121|467889512|FG002|Overall Study|Hysterectomy planned|0|||
129979973|NCT04372121|467889513|FG003|Overall Study|Hysterectomy planned|0|||
129979974|NCT03826030|467889514|FG000|Overall Study|Withdrawal by Subject|2|||
129979975|NCT03826030|467889515|FG001|Overall Study|Withdrawal by Subject|0|||
129979976|NCT03826030|467889516|FG002|Overall Study|Withdrawal by Subject|1|||
129979977|NCT03826030|467889514|FG000|Overall Study|Lost to Follow-up|1|||
129979978|NCT03826030|467889515|FG001|Overall Study|Lost to Follow-up|1|||
129979979|NCT03826030|467889516|FG002|Overall Study|Lost to Follow-up|1|||
129979980|NCT03826030|467889514|FG000|Overall Study|Too busy to return for visits|1|||
129979981|NCT03826030|467889515|FG001|Overall Study|Too busy to return for visits|0|||
129979982|NCT03826030|467889516|FG002|Overall Study|Too busy to return for visits|0|||
129979983|NCT03820947|467889521|FG000|Overall Study|Physician Decision|0|||
129979984|NCT03820947|467889522|FG001|Overall Study|Physician Decision|1|||
129979985|NCT03820947|467889523|FG002|Overall Study|Physician Decision|1|||
129979986|NCT03820947|467889524|FG003|Overall Study|Physician Decision|0|||
129979987|NCT03820947|467889525|FG004|Overall Study|Physician Decision|3|||
129979988|NCT03820947|467889521|FG000|Overall Study|Withdrawal by Subject|6|||
129979989|NCT03820947|467889522|FG001|Overall Study|Withdrawal by Subject|10|||
129979990|NCT03820947|467889523|FG002|Overall Study|Withdrawal by Subject|3|||
129979991|NCT03820947|467889524|FG003|Overall Study|Withdrawal by Subject|8|||
129979992|NCT03820947|467889525|FG004|Overall Study|Withdrawal by Subject|5|||
129979993|NCT03820947|467889521|FG000|Overall Study|Procedure Not Attempted|0|||
129979994|NCT03820947|467889522|FG001|Overall Study|Procedure Not Attempted|2|||
129979995|NCT03820947|467889523|FG002|Overall Study|Procedure Not Attempted|1|||
129979996|NCT03820947|467889524|FG003|Overall Study|Procedure Not Attempted|0|||
129979997|NCT03820947|467889525|FG004|Overall Study|Procedure Not Attempted|0|||
129979998|NCT03820947|467889521|FG000|Overall Study|Other Exit|1|||
129979999|NCT03820947|467889522|FG001|Overall Study|Other Exit|3|||
129980000|NCT03820947|467889523|FG002|Overall Study|Other Exit|3|||
129980001|NCT03820947|467889524|FG003|Overall Study|Other Exit|3|||
129980002|NCT03820947|467889525|FG004|Overall Study|Other Exit|0|||
129980003|NCT03820947|467889521|FG000|Overall Study|Follow-up Not Done|10|||
129980004|NCT03820947|467889522|FG001|Overall Study|Follow-up Not Done|13|||
129980005|NCT03820947|467889523|FG002|Overall Study|Follow-up Not Done|2|||
129980006|NCT03820947|467889524|FG003|Overall Study|Follow-up Not Done|3|||
129980007|NCT03820947|467889525|FG004|Overall Study|Follow-up Not Done|12|||
129980008|NCT03820947|467889521|FG000|Overall Study|Death|0|||
129980009|NCT03820947|467889522|FG001|Overall Study|Death|0|||
129980010|NCT03820947|467889523|FG002|Overall Study|Death|0|||
129980011|NCT03820947|467889524|FG003|Overall Study|Death|0|||
129980012|NCT03820947|467889525|FG004|Overall Study|Death|9|||
129980013|NCT03820947|467889521|FG000|Overall Study|Lost to Follow-up|4|||
129980014|NCT03820947|467889522|FG001|Overall Study|Lost to Follow-up|6|||
129980015|NCT03820947|467889523|FG002|Overall Study|Lost to Follow-up|0|||
129980016|NCT03820947|467889524|FG003|Overall Study|Lost to Follow-up|0|||
129980017|NCT03820947|467889525|FG004|Overall Study|Lost to Follow-up|9|||
129980018|NCT04500769|467891501|FG000|Overall Study|Withdrawal by Subject|5|||
129980019|NCT01967147|467891502|FG000|Overall Study|Adverse Event|5|||
129980020|NCT01967147|467891503|FG001|Overall Study|Adverse Event|2|||
129980021|NCT01967147|467891502|FG000|Overall Study|Lack of Efficacy|1|||
129980022|NCT01967147|467891503|FG001|Overall Study|Lack of Efficacy|4|||
129980023|NCT01967147|467891502|FG000|Overall Study|Lost to Follow-up|1|||
129980024|NCT01967147|467891503|FG001|Overall Study|Lost to Follow-up|2|||
129980025|NCT01967147|467891502|FG000|Overall Study|Withdrawal by Subject|2|||
129980026|NCT01967147|467891503|FG001|Overall Study|Withdrawal by Subject|4|||
129980027|NCT01967147|467891502|FG000|Overall Study|Non-compliance with Study Drug|0|||
129980028|NCT01967147|467891503|FG001|Overall Study|Non-compliance with Study Drug|3|||
129980029|NCT01967147|467891502|FG000|Overall Study|Other|4|||
129980030|NCT01967147|467891503|FG001|Overall Study|Other|5|||
129980031|NCT02218606|467891504|FG000|Overall Study|Adverse Event|1|||
129980032|NCT02218606|467891505|FG001|Overall Study|Adverse Event|1|||
129980033|NCT02218606|467891504|FG000|Overall Study|Death|15|||
129980034|NCT02218606|467891505|FG001|Overall Study|Death|28|||
129980035|NCT02218606|467891504|FG000|Overall Study|Physician Decision|0|||
129980036|NCT02218606|467891505|FG001|Overall Study|Physician Decision|1|||
129980037|NCT02218606|467891504|FG000|Overall Study|Withdrawal by Subject|4|||
129980038|NCT02218606|467891505|FG001|Overall Study|Withdrawal by Subject|0|||
129980039|NCT02218606|467891504|FG000|Overall Study|Noncompliance|1|||
129980040|NCT02218606|467891505|FG001|Overall Study|Noncompliance|0|||
129980041|NCT02218606|467891504|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
129980042|NCT02218606|467891505|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
129980043|NCT02218606|467891504|FG000|Overall Study|Other|2|||
129980044|NCT02218606|467891505|FG001|Overall Study|Other|1|||
129980045|NCT02218606|467891504|FG000|Overall Study|Never started treatment|0|||
129980046|NCT02218606|467891505|FG001|Overall Study|Never started treatment|1|||
129980047|NCT03203473|467891506|FG000|Induction Phase|Never started primary treatment|2|||
129980048|NCT03203473|467891507|FG001|Induction Phase|Never started primary treatment|0|||
129980049|NCT03203473|467891508|FG002|Induction Phase|Never started primary treatment|0|||
129980050|NCT03203473|467891506|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
129980051|NCT03203473|467891507|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
129980052|NCT03203473|467891508|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
129980053|NCT03203473|467891506|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
129980054|NCT03203473|467891507|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
129980055|NCT03203473|467891508|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
129980056|NCT03203473|467891506|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
129980057|NCT03203473|467891507|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
129980058|NCT03203473|467891508|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
129980059|NCT03203473|467891506|FG000|Arm Allocation Phase|started salvage therapy|0|||
129980060|NCT03203473|467891507|FG001|Arm Allocation Phase|started salvage therapy|5|||
129980061|NCT03203473|467891508|FG002|Arm Allocation Phase|started salvage therapy|0|||
129980062|NCT03203473|467891506|FG000|Arm Allocation Phase|Disease progression|0|||
129980063|NCT03203473|467891507|FG001|Arm Allocation Phase|Disease progression|0|||
129980064|NCT03203473|467891508|FG002|Arm Allocation Phase|Disease progression|37|||
129980065|NCT03203473|467891506|FG000|Arm Allocation Phase|Adverse Event|0|||
129980066|NCT03203473|467891507|FG001|Arm Allocation Phase|Adverse Event|0|||
129980067|NCT03203473|467891508|FG002|Arm Allocation Phase|Adverse Event|11|||
129980068|NCT03203473|467891506|FG000|Arm Allocation Phase|Physician Decision|0|||
129980069|NCT03203473|467891507|FG001|Arm Allocation Phase|Physician Decision|0|||
129980070|NCT03203473|467891508|FG002|Arm Allocation Phase|Physician Decision|3|||
129980071|NCT03203473|467891506|FG000|Arm Allocation Phase|Death|0|||
129980072|NCT03203473|467891507|FG001|Arm Allocation Phase|Death|0|||
129980073|NCT03203473|467891508|FG002|Arm Allocation Phase|Death|1|||
129980074|NCT03203473|467891506|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
129980075|NCT03203473|467891507|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
129980076|NCT03203473|467891508|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
129980077|NCT03203473|467891506|FG000|Arm Allocation Phase|Intercurrent illness|0|||
129980078|NCT03203473|467891507|FG001|Arm Allocation Phase|Intercurrent illness|0|||
129980079|NCT03203473|467891508|FG002|Arm Allocation Phase|Intercurrent illness|1|||
129980080|NCT03203473|467891506|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
129980081|NCT03203473|467891507|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
129980082|NCT03203473|467891508|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
129980083|NCT00890695|467891509|FG000|Overall Study|Protocol Violation|1|||
129980084|NCT00890695|467891510|FG001|Overall Study|Protocol Violation|0|||
129980085|NCT01732822|467891515|FG000|Overall Study|Withdrawal by Subject|123|||
129980086|NCT01732822|467891516|FG001|Overall Study|Withdrawal by Subject|113|||
129980087|NCT02314780|467891517|FG000|Overall Study|organizational reasons|0|||
129980088|NCT02314780|467891518|FG001|Overall Study|organizational reasons|2|||
129980089|NCT02314780|467891519|FG002|Overall Study|organizational reasons|0|||
129980090|NCT02314780|467891517|FG000|Overall Study|Adverse Event|0|||
129980091|NCT02314780|467891518|FG001|Overall Study|Adverse Event|1|||
129980092|NCT02314780|467891519|FG002|Overall Study|Adverse Event|0|||
129980093|NCT00215137|467891523|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
129980094|NCT00215137|467891524|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
129980095|NCT00215137|467891525|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
129980096|NCT00215137|467891523|FG000|Randomization Period|Lost to Follow-up|0|||
129980097|NCT00215137|467891524|FG001|Randomization Period|Lost to Follow-up|1|||
129980098|NCT00215137|467891525|FG002|Randomization Period|Lost to Follow-up|0|||
129980099|NCT00215137|467891523|FG000|Randomization Period|Withdrawal by Subject|0|||
129980100|NCT00215137|467891524|FG001|Randomization Period|Withdrawal by Subject|1|||
129980101|NCT00215137|467891525|FG002|Randomization Period|Withdrawal by Subject|0|||
129980102|NCT03002220|467891527|FG000|Overall Study|Lack of Efficacy|2|||
129980103|NCT03002220|467891527|FG000|Overall Study|Withdrawal by Subject|3|||
129980104|NCT03002220|467891527|FG000|Overall Study|Adverse Event|2|||
129980105|NCT03002220|467891527|FG000|Overall Study|Disease progression|13|||
129980106|NCT03002220|467891527|FG000|Overall Study|Physician Decision|1|||
129980107|NCT01183260|467891530|FG000|Overall Study|Intraop screen failure|2|||
129980108|NCT01183260|467891531|FG001|Overall Study|Intraop screen failure|0|||
129980109|NCT01183260|467891530|FG000|Overall Study|Withdrawal by Subject|1|||
129980110|NCT01183260|467891531|FG001|Overall Study|Withdrawal by Subject|1|||
129980111|NCT01183260|467891530|FG000|Overall Study|Revised within 30 days|0|||
129980112|NCT01183260|467891531|FG001|Overall Study|Revised within 30 days|1|||
129980113|NCT01183260|467891530|FG000|Overall Study|Death|1|||
129980114|NCT01183260|467891531|FG001|Overall Study|Death|0|||
129980115|NCT01255631|467891532|FG000|Overall Study|poor enrollment, no data analyzed|9|||
129980116|NCT01255631|467891533|FG001|Overall Study|poor enrollment, no data analyzed|6|||
129980117|NCT00568178|467891543|FG000|Double Blind Base Study|Adverse Event|0|||
129980118|NCT00568178|467891544|FG001|Double Blind Base Study|Adverse Event|2|||
129980119|NCT00568178|467891545|FG002|Double Blind Base Study|Adverse Event|1|||
129980120|NCT00568178|467891546|FG003|Double Blind Base Study|Adverse Event|2|||
129980121|NCT00568178|467891547|FG004|Double Blind Base Study|Adverse Event|0|||
129980122|NCT00568178|467891548|FG005|Double Blind Base Study|Adverse Event|0|||
129980123|NCT00568178|467891543|FG000|Double Blind Base Study|Lost to Follow-up|1|||
129980124|NCT00568178|467891544|FG001|Double Blind Base Study|Lost to Follow-up|0|||
129980125|NCT00568178|467891545|FG002|Double Blind Base Study|Lost to Follow-up|0|||
129980126|NCT00568178|467891546|FG003|Double Blind Base Study|Lost to Follow-up|1|||
129980127|NCT00568178|467891547|FG004|Double Blind Base Study|Lost to Follow-up|0|||
129980128|NCT00568178|467891548|FG005|Double Blind Base Study|Lost to Follow-up|0|||
129980129|NCT00568178|467891543|FG000|Double Blind Base Study|Physician Decision|1|||
129980130|NCT00568178|467891544|FG001|Double Blind Base Study|Physician Decision|1|||
129980131|NCT00568178|467891545|FG002|Double Blind Base Study|Physician Decision|0|||
129980132|NCT00568178|467891546|FG003|Double Blind Base Study|Physician Decision|1|||
129980133|NCT00568178|467891547|FG004|Double Blind Base Study|Physician Decision|0|||
129980134|NCT00568178|467891548|FG005|Double Blind Base Study|Physician Decision|0|||
129980135|NCT00568178|467891543|FG000|Double Blind Base Study|Protocol Violation|3|||
129980136|NCT00568178|467891544|FG001|Double Blind Base Study|Protocol Violation|2|||
129980137|NCT00568178|467891545|FG002|Double Blind Base Study|Protocol Violation|0|||
129980138|NCT00568178|467891546|FG003|Double Blind Base Study|Protocol Violation|0|||
129980139|NCT00568178|467891547|FG004|Double Blind Base Study|Protocol Violation|0|||
129980140|NCT00568178|467891548|FG005|Double Blind Base Study|Protocol Violation|0|||
129980141|NCT00568178|467891543|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
129980142|NCT00568178|467891544|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
129980143|NCT00568178|467891545|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
129980144|NCT00568178|467891546|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
129980145|NCT00568178|467891547|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
129980146|NCT00568178|467891548|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
129980147|NCT00568178|467891543|FG000|Double Blind Base Study|Progressive Disease|0|||
129980148|NCT00568178|467891544|FG001|Double Blind Base Study|Progressive Disease|0|||
129980149|NCT00568178|467891545|FG002|Double Blind Base Study|Progressive Disease|0|||
129980150|NCT00568178|467891546|FG003|Double Blind Base Study|Progressive Disease|1|||
129980151|NCT00568178|467891547|FG004|Double Blind Base Study|Progressive Disease|0|||
129980152|NCT00568178|467891548|FG005|Double Blind Base Study|Progressive Disease|0|||
129980153|NCT00568178|467891543|FG000|Open Label Extension|Adverse Event|0|||
129980154|NCT00568178|467891544|FG001|Open Label Extension|Adverse Event|0|||
129980155|NCT00568178|467891545|FG002|Open Label Extension|Adverse Event|0|||
129980156|NCT00568178|467891546|FG003|Open Label Extension|Adverse Event|0|||
129980157|NCT00568178|467891547|FG004|Open Label Extension|Adverse Event|11|||
129980158|NCT00568178|467891548|FG005|Open Label Extension|Adverse Event|8|||
129980159|NCT00568178|467891543|FG000|Open Label Extension|Protocol Violation|0|||
129980160|NCT00568178|467891544|FG001|Open Label Extension|Protocol Violation|0|||
129980161|NCT00568178|467891545|FG002|Open Label Extension|Protocol Violation|0|||
129980162|NCT00568178|467891546|FG003|Open Label Extension|Protocol Violation|0|||
129980163|NCT00568178|467891547|FG004|Open Label Extension|Protocol Violation|1|||
129980164|NCT00568178|467891548|FG005|Open Label Extension|Protocol Violation|0|||
129980165|NCT00568178|467891543|FG000|Open Label Extension|Lost to Follow-up|0|||
129980166|NCT00568178|467891544|FG001|Open Label Extension|Lost to Follow-up|0|||
129980167|NCT00568178|467891545|FG002|Open Label Extension|Lost to Follow-up|0|||
129980168|NCT00568178|467891546|FG003|Open Label Extension|Lost to Follow-up|0|||
129980169|NCT00568178|467891547|FG004|Open Label Extension|Lost to Follow-up|6|||
129980170|NCT00568178|467891548|FG005|Open Label Extension|Lost to Follow-up|11|||
129980171|NCT00568178|467891543|FG000|Open Label Extension|Physician Decision|0|||
129980172|NCT00568178|467891544|FG001|Open Label Extension|Physician Decision|0|||
129980173|NCT00568178|467891545|FG002|Open Label Extension|Physician Decision|0|||
129980174|NCT00568178|467891546|FG003|Open Label Extension|Physician Decision|0|||
129980175|NCT00568178|467891547|FG004|Open Label Extension|Physician Decision|9|||
129980176|NCT00568178|467891548|FG005|Open Label Extension|Physician Decision|8|||
129980177|NCT00568178|467891543|FG000|Open Label Extension|Pregnancy|0|||
129980178|NCT00568178|467891544|FG001|Open Label Extension|Pregnancy|0|||
129980179|NCT00568178|467891545|FG002|Open Label Extension|Pregnancy|0|||
129980180|NCT00568178|467891546|FG003|Open Label Extension|Pregnancy|0|||
129980181|NCT00568178|467891547|FG004|Open Label Extension|Pregnancy|0|||
129980182|NCT00568178|467891548|FG005|Open Label Extension|Pregnancy|1|||
129980183|NCT00568178|467891543|FG000|Open Label Extension|Progressive Disease|0|||
129980184|NCT00568178|467891544|FG001|Open Label Extension|Progressive Disease|0|||
129980185|NCT00568178|467891545|FG002|Open Label Extension|Progressive Disease|0|||
129980186|NCT00568178|467891546|FG003|Open Label Extension|Progressive Disease|0|||
129980187|NCT00568178|467891547|FG004|Open Label Extension|Progressive Disease|3|||
129980188|NCT00568178|467891548|FG005|Open Label Extension|Progressive Disease|1|||
129980189|NCT00568178|467891543|FG000|Open Label Extension|Termination of Trial|0|||
129980190|NCT00568178|467891544|FG001|Open Label Extension|Termination of Trial|0|||
129980191|NCT00568178|467891545|FG002|Open Label Extension|Termination of Trial|0|||
129980192|NCT00568178|467891546|FG003|Open Label Extension|Termination of Trial|0|||
129980193|NCT00568178|467891547|FG004|Open Label Extension|Termination of Trial|45|||
129980194|NCT00568178|467891548|FG005|Open Label Extension|Termination of Trial|47|||
129980195|NCT00568178|467891543|FG000|Open Label Extension|Withdrawal by Subject|0|||
129980196|NCT00568178|467891544|FG001|Open Label Extension|Withdrawal by Subject|0|||
129980197|NCT00568178|467891545|FG002|Open Label Extension|Withdrawal by Subject|0|||
129980198|NCT00568178|467891546|FG003|Open Label Extension|Withdrawal by Subject|0|||
129980199|NCT00568178|467891547|FG004|Open Label Extension|Withdrawal by Subject|4|||
129980200|NCT00568178|467891548|FG005|Open Label Extension|Withdrawal by Subject|4|||
129980201|NCT01531673|467891549|FG000|Overall Study|Non-Compliance|0|||
129980202|NCT01531673|467891550|FG001|Overall Study|Non-Compliance|0|||
129980203|NCT01531673|467891551|FG002|Overall Study|Non-Compliance|0|||
129980204|NCT01531673|467891552|FG003|Overall Study|Non-Compliance|0|||
129980205|NCT01531673|467891553|FG004|Overall Study|Non-Compliance|0|||
129980206|NCT01531673|467891554|FG005|Overall Study|Non-Compliance|1|||
129980207|NCT01531673|467891555|FG006|Overall Study|Non-Compliance|0|||
129980208|NCT01531673|467891556|FG007|Overall Study|Non-Compliance|0|||
129980209|NCT01531673|467891557|FG008|Overall Study|Non-Compliance|0|||
129980210|NCT01531673|467891558|FG009|Overall Study|Non-Compliance|0|||
129980211|NCT01531673|467891559|FG010|Overall Study|Non-Compliance|0|||
129980212|NCT01531673|467891560|FG011|Overall Study|Non-Compliance|0|||
129980213|NCT01531673|467891561|FG012|Overall Study|Non-Compliance|0|||
129980214|NCT01531673|467891549|FG000|Overall Study|Adverse Event|0|||
129980215|NCT01531673|467891550|FG001|Overall Study|Adverse Event|1|||
129980216|NCT01531673|467891551|FG002|Overall Study|Adverse Event|0|||
129980217|NCT01531673|467891552|FG003|Overall Study|Adverse Event|0|||
129980218|NCT01531673|467891553|FG004|Overall Study|Adverse Event|0|||
129980219|NCT01531673|467891554|FG005|Overall Study|Adverse Event|0|||
129980220|NCT01531673|467891555|FG006|Overall Study|Adverse Event|0|||
129980221|NCT01531673|467891556|FG007|Overall Study|Adverse Event|0|||
129980222|NCT01531673|467891557|FG008|Overall Study|Adverse Event|0|||
129488516|NCT00092547|466080720|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
129488517|NCT00092547|466080721|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
129488518|NCT00092547|466080719|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
129488519|NCT00092547|466080720|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
129488520|NCT00092547|466080721|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
129488521|NCT00092547|466080719|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
129488522|NCT00092547|466080720|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
129488523|NCT00092547|466080721|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
129488524|NCT00092547|466080719|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
129488525|NCT00092547|466080720|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
129488526|NCT00092547|466080721|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
129488527|NCT01539837|466080722|FG000|Overall Study|reduce neutrophil level|0|||
129488528|NCT01539837|466080723|FG001|Overall Study|reduce neutrophil level|1|||
129488529|NCT01539837|466080724|FG002|Overall Study|reduce neutrophil level|1|||
129488530|NCT01539837|466080722|FG000|Overall Study|bad compliance|0|||
129980223|NCT01531673|467891558|FG009|Overall Study|Adverse Event|0|||
129980224|NCT01531673|467891559|FG010|Overall Study|Adverse Event|0|||
129980225|NCT01531673|467891560|FG011|Overall Study|Adverse Event|0|||
129980226|NCT01531673|467891561|FG012|Overall Study|Adverse Event|0|||
129980227|NCT01531673|467891549|FG000|Overall Study|Lost to Follow-up|0|||
129980228|NCT01531673|467891550|FG001|Overall Study|Lost to Follow-up|0|||
129980229|NCT01531673|467891551|FG002|Overall Study|Lost to Follow-up|0|||
129980230|NCT01531673|467891552|FG003|Overall Study|Lost to Follow-up|0|||
129980231|NCT01531673|467891553|FG004|Overall Study|Lost to Follow-up|1|||
129980232|NCT01531673|467891554|FG005|Overall Study|Lost to Follow-up|0|||
129980233|NCT01531673|467891555|FG006|Overall Study|Lost to Follow-up|0|||
129980234|NCT01531673|467891556|FG007|Overall Study|Lost to Follow-up|0|||
129980235|NCT01531673|467891557|FG008|Overall Study|Lost to Follow-up|0|||
129980236|NCT01531673|467891558|FG009|Overall Study|Lost to Follow-up|0|||
129980237|NCT01531673|467891559|FG010|Overall Study|Lost to Follow-up|0|||
129980238|NCT01531673|467891560|FG011|Overall Study|Lost to Follow-up|0|||
129980239|NCT01531673|467891561|FG012|Overall Study|Lost to Follow-up|0|||
129980240|NCT01531673|467891549|FG000|Overall Study|Other|0|||
129980241|NCT01531673|467891550|FG001|Overall Study|Other|0|||
129980242|NCT01531673|467891551|FG002|Overall Study|Other|0|||
129980243|NCT01531673|467891552|FG003|Overall Study|Other|1|||
129980244|NCT01531673|467891553|FG004|Overall Study|Other|0|||
129980245|NCT01531673|467891554|FG005|Overall Study|Other|0|||
129980246|NCT01531673|467891555|FG006|Overall Study|Other|0|||
129980247|NCT01531673|467891556|FG007|Overall Study|Other|0|||
129980248|NCT01531673|467891557|FG008|Overall Study|Other|0|||
129980249|NCT01531673|467891558|FG009|Overall Study|Other|1|||
129980250|NCT01531673|467891559|FG010|Overall Study|Other|0|||
129980251|NCT01531673|467891560|FG011|Overall Study|Other|0|||
129980252|NCT01531673|467891561|FG012|Overall Study|Other|0|||
129980253|NCT02815579|467891562|FG000|Overall Study|Non-payment of loan down-payment|16|||
129980254|NCT02815579|467891563|FG001|Overall Study|Non-payment of loan down-payment|0|||
129980255|NCT02815579|467891562|FG000|Overall Study|Withdrawal by Subject|7|||
129980256|NCT02815579|467891563|FG001|Overall Study|Withdrawal by Subject|1|||
129980257|NCT02815579|467891562|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
129980258|NCT02815579|467891563|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
129980259|NCT02815579|467891562|FG000|Overall Study|Lost to Follow-up|7|||
129980260|NCT02815579|467891563|FG001|Overall Study|Lost to Follow-up|4|||
129980261|NCT02815579|467891562|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
129980262|NCT02815579|467891563|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
129980263|NCT02815579|467891562|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
129980264|NCT02815579|467891563|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
129980265|NCT02815579|467891562|FG000|Overall Study|Death|5|||
129980266|NCT02815579|467891563|FG001|Overall Study|Death|4|||
129980267|NCT02815579|467891562|FG000|Overall Study|Imprisoned|0|||
129980268|NCT02815579|467891563|FG001|Overall Study|Imprisoned|2|||
129980269|NCT02815579|467891562|FG000|Overall Study|Did not meet enrollment criteria|0|||
129980270|NCT02815579|467891563|FG001|Overall Study|Did not meet enrollment criteria|1|||
129980271|NCT00264303|467891564|FG000|Overall Study|Adverse Event|4|||
129980272|NCT00264303|467891565|FG001|Overall Study|Adverse Event|3|||
129980273|NCT00264303|467891564|FG000|Overall Study|Lack of Efficacy|10|||
129980274|NCT00264303|467891565|FG001|Overall Study|Lack of Efficacy|13|||
129980275|NCT00264303|467891564|FG000|Overall Study|Lost to Follow-up|3|||
129980276|NCT00264303|467891565|FG001|Overall Study|Lost to Follow-up|3|||
129980277|NCT00264303|467891564|FG000|Overall Study|Withdrawal by Subject|2|||
129980278|NCT00264303|467891565|FG001|Overall Study|Withdrawal by Subject|3|||
129980279|NCT00264303|467891564|FG000|Overall Study|Various reasons listed in study report|6|||
129980280|NCT00264303|467891565|FG001|Overall Study|Various reasons listed in study report|7|||
129980281|NCT02389452|467891566|FG000|Overall Study|Lost to Follow-up|13|||
129980282|NCT02389452|467891566|FG000|Overall Study|Adverse Event|1|||
129980283|NCT02389452|467891566|FG000|Overall Study|Withdrawal by Subject|5|||
129980284|NCT02389452|467891566|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
129980285|NCT02311673|467891567|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
129980286|NCT02311673|467891568|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
129980287|NCT02311673|467891569|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
129980288|NCT02311673|467891570|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
129980289|NCT00414908|467891581|FG000|Overall Study|Protocol Violation|1|||
129980290|NCT00414908|467891582|FG001|Overall Study|Protocol Violation|1|||
129980291|NCT01076153|467891583|FG000|Overall Study|Symptoms improved/resolved|10|||
129980292|NCT01076153|467891583|FG000|Overall Study|Adverse Event|1|||
129980293|NCT00818168|467891584|FG000|Overall Study|Lack of Efficacy|18|||
129980294|NCT00818168|467891584|FG000|Overall Study|Pregnancy|2|||
129980295|NCT00818168|467891584|FG000|Overall Study|Withdrawal by Subject|16|||
129980296|NCT00818168|467891584|FG000|Overall Study|Lost to Follow-up|7|||
129980297|NCT00818168|467891584|FG000|Overall Study|Adverse Event|19|||
129980298|NCT00818168|467891584|FG000|Overall Study|Reason for Non-completion Not reported|6|||
129980299|NCT00818168|467891584|FG000|Overall Study|Participant Moved|2|||
129980300|NCT02040259|467891587|FG000|Overall Study|Death|280|||
129980301|NCT02040259|467891587|FG000|Overall Study|Lost to Follow-up|76|||
129980302|NCT02040259|467891587|FG000|Overall Study|Assessment not completed|3|||
129980303|NCT02040259|467891587|FG000|Overall Study|Withdrawal by Subject|4|||
129980304|NCT04476251|467891588|FG000|Overall Study|Not treated|1|||
129980305|NCT00316602|467891599|FG000|Overall Study|Withdrawal by Subject|3|||
129980306|NCT00316602|467891600|FG001|Overall Study|Withdrawal by Subject|2|||
129980307|NCT00316602|467891599|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
129980308|NCT00316602|467891600|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
129980309|NCT00316602|467891599|FG000|Overall Study|Adverse Event|1|||
129980310|NCT00316602|467891600|FG001|Overall Study|Adverse Event|0|||
129980311|NCT00316602|467891599|FG000|Overall Study|Other|3|||
129980312|NCT00316602|467891600|FG001|Overall Study|Other|6|||
129980313|NCT01142232|467891601|FG000|Overall Study|Adverse Event|1|||
129980314|NCT01142232|467891602|FG001|Overall Study|Adverse Event|2|||
129980315|NCT01142232|467891603|FG002|Overall Study|Adverse Event|1|||
129980316|NCT01142232|467891604|FG003|Overall Study|Adverse Event|0|||
129980317|NCT01142232|467891605|FG004|Overall Study|Adverse Event|4|||
129980318|NCT01142232|467891601|FG000|Overall Study|Death|0|||
129980319|NCT01142232|467891602|FG001|Overall Study|Death|0|||
129980320|NCT01142232|467891603|FG002|Overall Study|Death|0|||
129980321|NCT01142232|467891604|FG003|Overall Study|Death|0|||
129980322|NCT01142232|467891605|FG004|Overall Study|Death|1|||
129980323|NCT01142232|467891601|FG000|Overall Study|Disease Progression|2|||
129980324|NCT01142232|467891602|FG001|Overall Study|Disease Progression|0|||
129980325|NCT01142232|467891603|FG002|Overall Study|Disease Progression|1|||
129980326|NCT01142232|467891604|FG003|Overall Study|Disease Progression|2|||
129980327|NCT01142232|467891605|FG004|Overall Study|Disease Progression|12|||
129980328|NCT01142232|467891601|FG000|Overall Study|Withdrawal by Subject|0|||
129980329|NCT01142232|467891602|FG001|Overall Study|Withdrawal by Subject|0|||
129980330|NCT01142232|467891603|FG002|Overall Study|Withdrawal by Subject|0|||
129980331|NCT01142232|467891604|FG003|Overall Study|Withdrawal by Subject|1|||
129980332|NCT01142232|467891605|FG004|Overall Study|Withdrawal by Subject|3|||
129980333|NCT01142232|467891601|FG000|Overall Study|Physician Decision|0|||
129980334|NCT01142232|467891602|FG001|Overall Study|Physician Decision|1|||
129980335|NCT01142232|467891603|FG002|Overall Study|Physician Decision|0|||
129980336|NCT01142232|467891604|FG003|Overall Study|Physician Decision|2|||
129980337|NCT01142232|467891605|FG004|Overall Study|Physician Decision|10|||
129980338|NCT01142232|467891601|FG000|Overall Study|Alternative Therapy|0|||
129980339|NCT01142232|467891602|FG001|Overall Study|Alternative Therapy|1|||
129980340|NCT01142232|467891603|FG002|Overall Study|Alternative Therapy|1|||
129980341|NCT01142232|467891604|FG003|Overall Study|Alternative Therapy|0|||
129980342|NCT01142232|467891605|FG004|Overall Study|Alternative Therapy|1|||
129980343|NCT01142232|467891601|FG000|Overall Study|Off Trt for other complicating disease|0|||
129980344|NCT01142232|467891602|FG001|Overall Study|Off Trt for other complicating disease|0|||
129980345|NCT01142232|467891603|FG002|Overall Study|Off Trt for other complicating disease|0|||
129980346|NCT01142232|467891604|FG003|Overall Study|Off Trt for other complicating disease|0|||
129980347|NCT01142232|467891605|FG004|Overall Study|Off Trt for other complicating disease|1|||
129980348|NCT01142232|467891601|FG000|Overall Study|Noncompliance|0|||
129980349|NCT01142232|467891602|FG001|Overall Study|Noncompliance|0|||
129980350|NCT01142232|467891603|FG002|Overall Study|Noncompliance|0|||
129980351|NCT01142232|467891604|FG003|Overall Study|Noncompliance|0|||
129980352|NCT01142232|467891605|FG004|Overall Study|Noncompliance|2|||
129980353|NCT00626990|467891608|FG000|Overall Study|Lack of Efficacy|6|||
129980354|NCT00626990|467891609|FG001|Overall Study|Lack of Efficacy|7|||
129980355|NCT00626990|467891610|FG002|Overall Study|Lack of Efficacy|49|||
129980356|NCT00626990|467891611|FG003|Overall Study|Lack of Efficacy|40|||
129980357|NCT00626990|467891608|FG000|Overall Study|Adverse Event|1|||
129980358|NCT00626990|467891609|FG001|Overall Study|Adverse Event|7|||
129980359|NCT00626990|467891610|FG002|Overall Study|Adverse Event|14|||
129980360|NCT00626990|467891611|FG003|Overall Study|Adverse Event|28|||
129980361|NCT00626990|467891608|FG000|Overall Study|Death|0|||
129980362|NCT00626990|467891609|FG001|Overall Study|Death|1|||
129980363|NCT00626990|467891610|FG002|Overall Study|Death|0|||
129980364|NCT00626990|467891611|FG003|Overall Study|Death|0|||
129980365|NCT00626990|467891608|FG000|Overall Study|Withdrawal by Subject|3|||
129980366|NCT00626990|467891609|FG001|Overall Study|Withdrawal by Subject|1|||
129980367|NCT00626990|467891610|FG002|Overall Study|Withdrawal by Subject|5|||
129980368|NCT00626990|467891611|FG003|Overall Study|Withdrawal by Subject|11|||
129980369|NCT00626990|467891608|FG000|Overall Study|Protocol Violation|0|||
129980370|NCT00626990|467891609|FG001|Overall Study|Protocol Violation|1|||
129980371|NCT00626990|467891610|FG002|Overall Study|Protocol Violation|1|||
129980372|NCT00626990|467891611|FG003|Overall Study|Protocol Violation|0|||
129980373|NCT00626990|467891608|FG000|Overall Study|Various different reasons/missing|4|||
129980374|NCT00626990|467891609|FG001|Overall Study|Various different reasons/missing|8|||
129980375|NCT00626990|467891610|FG002|Overall Study|Various different reasons/missing|8|||
129980376|NCT00626990|467891611|FG003|Overall Study|Various different reasons/missing|16|||
129980377|NCT04138576|467891616|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
129980378|NCT00297427|467891617|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
129980379|NCT00297427|467891618|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
129980380|NCT00297427|467891617|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
129980381|NCT00297427|467891618|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
129980382|NCT00297427|467891617|FG000|Phase 1: Initial Intervention|Death|0|||
129980383|NCT00297427|467891618|FG001|Phase 1: Initial Intervention|Death|1|||
129980384|NCT00297427|467891617|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
129980385|NCT00297427|467891618|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
129980386|NCT00297427|467891617|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
129980387|NCT00297427|467891618|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
129980388|NCT00297427|467891617|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
129980389|NCT00297427|467891618|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
129980390|NCT00297427|467891617|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
129980391|NCT00297427|467891618|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
129488531|NCT01539837|466080723|FG001|Overall Study|bad compliance|0|||
129488532|NCT01539837|466080724|FG002|Overall Study|bad compliance|1|||
129488533|NCT01978912|466080726|FG000|Overall Study|Adverse Event|0|||
129488534|NCT01978912|466080727|FG001|Overall Study|Adverse Event|1|||
129488535|NCT01978912|466080728|FG002|Overall Study|Adverse Event|0|||
129488536|NCT01978912|466080729|FG003|Overall Study|Adverse Event|0|||
129488537|NCT01978912|466080726|FG000|Overall Study|Lost to Follow-up|1|||
129488538|NCT01978912|466080727|FG001|Overall Study|Lost to Follow-up|1|||
129488539|NCT01978912|466080728|FG002|Overall Study|Lost to Follow-up|0|||
129488540|NCT01978912|466080729|FG003|Overall Study|Lost to Follow-up|1|||
129488541|NCT01978912|466080726|FG000|Overall Study|Withdrawal by Subject|1|||
129488542|NCT01978912|466080727|FG001|Overall Study|Withdrawal by Subject|0|||
129488543|NCT01978912|466080728|FG002|Overall Study|Withdrawal by Subject|2|||
129488544|NCT01978912|466080729|FG003|Overall Study|Withdrawal by Subject|2|||
129488545|NCT01978912|466080726|FG000|Overall Study|Lumbar Surgery|1|||
129488546|NCT01978912|466080727|FG001|Overall Study|Lumbar Surgery|0|||
129488547|NCT01978912|466080728|FG002|Overall Study|Lumbar Surgery|1|||
129488548|NCT01978912|466080729|FG003|Overall Study|Lumbar Surgery|0|||
129488549|NCT01978912|466080726|FG000|Overall Study|Intradiscal Steroid Injection|0|||
129488550|NCT01978912|466080727|FG001|Overall Study|Intradiscal Steroid Injection|1|||
129488551|NCT01978912|466080728|FG002|Overall Study|Intradiscal Steroid Injection|0|||
129488552|NCT01978912|466080729|FG003|Overall Study|Intradiscal Steroid Injection|0|||
129488553|NCT00401973|466080730|FG000|Overall Study|Adverse Event|2|||
129488554|NCT00401973|466080731|FG001|Overall Study|Adverse Event|8|||
129488555|NCT00401973|466080732|FG002|Overall Study|Adverse Event|4|||
129488556|NCT00401973|466080730|FG000|Overall Study|Clinical Relapse|0|||
129488557|NCT00401973|466080731|FG001|Overall Study|Clinical Relapse|1|||
129488558|NCT00401973|466080732|FG002|Overall Study|Clinical Relapse|1|||
129488559|NCT00401973|466080730|FG000|Overall Study|Lack of Efficacy|0|||
129488560|NCT00401973|466080731|FG001|Overall Study|Lack of Efficacy|0|||
129488561|NCT00401973|466080732|FG002|Overall Study|Lack of Efficacy|3|||
129488562|NCT00401973|466080730|FG000|Overall Study|Lost to Follow-up|2|||
129488563|NCT00401973|466080731|FG001|Overall Study|Lost to Follow-up|2|||
129488564|NCT00401973|466080732|FG002|Overall Study|Lost to Follow-up|2|||
129488565|NCT00401973|466080730|FG000|Overall Study|Physician Decision|2|||
129980392|NCT00297427|467891617|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
129980393|NCT00297427|467891618|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
129980394|NCT02787044|467891621|FG000|Overall Study|Lost to Follow-up|15|||
129980395|NCT02787044|467891622|FG001|Overall Study|Lost to Follow-up|19|||
129488566|NCT00401973|466080731|FG001|Overall Study|Physician Decision|0|||
129488567|NCT00401973|466080732|FG002|Overall Study|Physician Decision|1|||
129488568|NCT00401973|466080730|FG000|Overall Study|Protocol Violation|1|||
129488569|NCT00401973|466080731|FG001|Overall Study|Protocol Violation|2|||
129488570|NCT00401973|466080732|FG002|Overall Study|Protocol Violation|3|||
129488571|NCT00401973|466080730|FG000|Overall Study|Sponsor Decision|0|||
129488572|NCT00401973|466080731|FG001|Overall Study|Sponsor Decision|1|||
129488573|NCT00401973|466080732|FG002|Overall Study|Sponsor Decision|0|||
129980396|NCT02591953|467891624|FG000|Overall Study|Lost to Follow-up|6|||
129980397|NCT02591953|467891625|FG001|Overall Study|Lost to Follow-up|6|||
129980398|NCT01517295|467891628|FG000|Overall Study|Physician Decision|1|||
129980399|NCT01517295|467891629|FG001|Overall Study|Physician Decision|0|||
129488574|NCT00401973|466080730|FG000|Overall Study|Withdrawal by Subject|4|||
129488575|NCT00401973|466080731|FG001|Overall Study|Withdrawal by Subject|12|||
129488576|NCT00401973|466080732|FG002|Overall Study|Withdrawal by Subject|9|||
129488577|NCT05523362|466080733|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
129488578|NCT05523362|466080733|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
129488579|NCT05523362|466080733|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
129488580|NCT05523362|466080733|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
129980400|NCT02182947|467891630|FG000|Overall Study|Withdrawal by Subject|7|||
129980401|NCT02182947|467891630|FG000|Overall Study|Lost to Follow-up|3|||
129980402|NCT02182947|467891630|FG000|Overall Study|Failed screening activities|8|||
129980403|NCT01656200|467891631|FG000|Overall Study|Withdrawal by Subject|1|||
129980404|NCT04155047|467891637|FG000|Overall Study|Adverse Event|1|||
129980405|NCT04155047|467891638|FG001|Overall Study|Adverse Event|0|||
129980406|NCT04155047|467891637|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
129980407|NCT04155047|467891638|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
129980408|NCT03174431|467891642|FG000|Overall Study|Withdrawal by Subject|14|||
129980409|NCT03174431|467891643|FG001|Overall Study|Withdrawal by Subject|11|||
129980410|NCT03174431|467891642|FG000|Overall Study|alternative treatment|2|||
129980411|NCT03174431|467891643|FG001|Overall Study|alternative treatment|0|||
129980412|NCT03174431|467891642|FG000|Overall Study|Lost to Follow-up|1|||
129980413|NCT03174431|467891643|FG001|Overall Study|Lost to Follow-up|5|||
129980414|NCT02075073|467891644|FG000|Overall Study|Withdrawal by Subject|0|||
129980415|NCT02075073|467891645|FG001|Overall Study|Withdrawal by Subject|1|||
129980416|NCT02075073|467891646|FG002|Overall Study|Withdrawal by Subject|0|||
129980417|NCT02797080|467891652|FG000|Overall Study|Lost to Follow-up|1|||
129980418|NCT02797080|467891652|FG000|Overall Study|Withdrawal by Subject|1|||
129980419|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Adverse Event|1|||
129980420|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Adverse Event|1|||
129980421|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Adverse Event|2|||
129980422|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Adverse Event|5|||
129980423|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Adverse Event|0|||
129980424|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
129980425|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
129980426|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
129980427|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
129980428|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
129980429|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
129980430|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
129980431|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
129980432|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
129980433|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
129980434|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980435|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980436|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980437|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
129980438|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
129980439|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
129980440|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
129980441|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
129980442|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
129980443|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
129980444|NCT00951015|467891655|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
129980445|NCT00951015|467891656|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
129980446|NCT00951015|467891657|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
129980447|NCT00951015|467891658|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
129980448|NCT00951015|467891659|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
129980449|NCT00951015|467891655|FG000|Open-label Phase|Adverse Event|0|||
129980450|NCT00951015|467891656|FG001|Open-label Phase|Adverse Event|0|||
129980451|NCT00951015|467891657|FG002|Open-label Phase|Adverse Event|0|||
129980452|NCT00951015|467891658|FG003|Open-label Phase|Adverse Event|0|||
129980453|NCT00951015|467891659|FG004|Open-label Phase|Adverse Event|3|||
129980454|NCT00951015|467891655|FG000|Open-label Phase|Lack of Efficacy|0|||
129980455|NCT00951015|467891656|FG001|Open-label Phase|Lack of Efficacy|0|||
129980456|NCT00951015|467891657|FG002|Open-label Phase|Lack of Efficacy|0|||
129980457|NCT00951015|467891658|FG003|Open-label Phase|Lack of Efficacy|0|||
129980458|NCT00951015|467891659|FG004|Open-label Phase|Lack of Efficacy|1|||
129980459|NCT00951015|467891655|FG000|Open-label Phase|Protocol Violation|0|||
129980460|NCT00951015|467891656|FG001|Open-label Phase|Protocol Violation|0|||
129980461|NCT00951015|467891657|FG002|Open-label Phase|Protocol Violation|0|||
129980462|NCT00951015|467891658|FG003|Open-label Phase|Protocol Violation|0|||
129980463|NCT00951015|467891659|FG004|Open-label Phase|Protocol Violation|12|||
129980464|NCT00951015|467891655|FG000|Open-label Phase|Lost to Follow-up|0|||
129980465|NCT00951015|467891656|FG001|Open-label Phase|Lost to Follow-up|0|||
129980466|NCT00951015|467891657|FG002|Open-label Phase|Lost to Follow-up|0|||
129980467|NCT00951015|467891658|FG003|Open-label Phase|Lost to Follow-up|0|||
129980468|NCT00951015|467891659|FG004|Open-label Phase|Lost to Follow-up|12|||
129980469|NCT00951015|467891655|FG000|Open-label Phase|Withdrawal by Subject|0|||
129980470|NCT00951015|467891656|FG001|Open-label Phase|Withdrawal by Subject|0|||
129980471|NCT00951015|467891657|FG002|Open-label Phase|Withdrawal by Subject|0|||
129980472|NCT00951015|467891658|FG003|Open-label Phase|Withdrawal by Subject|0|||
129980473|NCT00951015|467891659|FG004|Open-label Phase|Withdrawal by Subject|14|||
129488581|NCT04075604|466080734|FG000|Overall Study|Adverse Event|0|||
129488582|NCT04075604|466080735|FG001|Overall Study|Adverse Event|0|||
129488583|NCT04075604|466080736|FG002|Overall Study|Adverse Event|3|||
129488584|NCT04075604|466080734|FG000|Overall Study|Participant request to discontinue study treatment|0|||
129488585|NCT04075604|466080735|FG001|Overall Study|Participant request to discontinue study treatment|0|||
129488586|NCT04075604|466080736|FG002|Overall Study|Participant request to discontinue study treatment|1|||
129488587|NCT04075604|466080734|FG000|Overall Study|Participant withdrew consent|0|||
129488588|NCT04075604|466080735|FG001|Overall Study|Participant withdrew consent|0|||
129980474|NCT00951015|467891655|FG000|Open-label Phase|Physician Decision|0|||
129980475|NCT00951015|467891656|FG001|Open-label Phase|Physician Decision|0|||
129980476|NCT00951015|467891657|FG002|Open-label Phase|Physician Decision|0|||
129980477|NCT00951015|467891658|FG003|Open-label Phase|Physician Decision|0|||
129980478|NCT00951015|467891659|FG004|Open-label Phase|Physician Decision|8|||
129980479|NCT01208103|467891661|FG000|Overall Study|Adverse Event|1|||
129980480|NCT01208103|467891661|FG000|Overall Study|Withdrawal by Subject|1|||
129980481|NCT03819634|467891662|FG000|Overall Study|Physician Decision|2|||
129980482|NCT00299494|467891663|FG000|Overall Study|Withdrawal by Subject|0|||
129980483|NCT00299494|467891664|FG001|Overall Study|Withdrawal by Subject|0|||
129980484|NCT00299494|467891665|FG002|Overall Study|Withdrawal by Subject|0|||
129980485|NCT00299494|467891666|FG003|Overall Study|Withdrawal by Subject|3|||
129980486|NCT00299494|467891667|FG004|Overall Study|Withdrawal by Subject|1|||
129980487|NCT00299494|467891668|FG005|Overall Study|Withdrawal by Subject|4|||
129980488|NCT00299494|467891663|FG000|Overall Study|Physician Decision|0|||
129980489|NCT00299494|467891664|FG001|Overall Study|Physician Decision|0|||
129980490|NCT00299494|467891665|FG002|Overall Study|Physician Decision|0|||
129980491|NCT00299494|467891666|FG003|Overall Study|Physician Decision|0|||
129980492|NCT00299494|467891667|FG004|Overall Study|Physician Decision|1|||
129980493|NCT00299494|467891668|FG005|Overall Study|Physician Decision|0|||
129980494|NCT00299494|467891663|FG000|Overall Study|Death|3|||
129980495|NCT00299494|467891664|FG001|Overall Study|Death|1|||
129980496|NCT00299494|467891665|FG002|Overall Study|Death|4|||
129980497|NCT00299494|467891666|FG003|Overall Study|Death|6|||
129980498|NCT00299494|467891667|FG004|Overall Study|Death|18|||
129980499|NCT00299494|467891668|FG005|Overall Study|Death|19|||
129980500|NCT00299494|467891663|FG000|Overall Study|Lost to Follow-up|0|||
129980501|NCT00299494|467891664|FG001|Overall Study|Lost to Follow-up|0|||
129980502|NCT00299494|467891665|FG002|Overall Study|Lost to Follow-up|0|||
129980503|NCT00299494|467891666|FG003|Overall Study|Lost to Follow-up|0|||
129980504|NCT00299494|467891667|FG004|Overall Study|Lost to Follow-up|3|||
129980505|NCT00299494|467891668|FG005|Overall Study|Lost to Follow-up|1|||
129980506|NCT00299494|467891663|FG000|Overall Study|Other - Unspecified|0|||
129980507|NCT00299494|467891664|FG001|Overall Study|Other - Unspecified|0|||
129980508|NCT00299494|467891665|FG002|Overall Study|Other - Unspecified|0|||
129980509|NCT00299494|467891666|FG003|Overall Study|Other - Unspecified|0|||
129980510|NCT00299494|467891667|FG004|Overall Study|Other - Unspecified|3|||
129980511|NCT00299494|467891668|FG005|Overall Study|Other - Unspecified|1|||
129980512|NCT00299494|467891663|FG000|Overall Study|Other - site closure|0|||
129980513|NCT00299494|467891664|FG001|Overall Study|Other - site closure|0|||
129980514|NCT00299494|467891665|FG002|Overall Study|Other - site closure|0|||
129980515|NCT00299494|467891666|FG003|Overall Study|Other - site closure|1|||
129980516|NCT00299494|467891667|FG004|Overall Study|Other - site closure|1|||
129980517|NCT00299494|467891668|FG005|Overall Study|Other - site closure|1|||
129980518|NCT01417104|467891669|FG000|Overall Study|Withdrawal by Subject|5|||
129980519|NCT01417104|467891670|FG001|Overall Study|Withdrawal by Subject|1|||
129980520|NCT01417104|467891669|FG000|Overall Study|Failure to make contact|0|||
129980521|NCT01417104|467891670|FG001|Overall Study|Failure to make contact|1|||
129980522|NCT01417104|467891669|FG000|Overall Study|Adverse Event|1|||
129980523|NCT01417104|467891670|FG001|Overall Study|Adverse Event|0|||
129980524|NCT03101462|467891671|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
129980525|NCT03101462|467891672|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
129980526|NCT02003222|467891678|FG000|Induction|Never started treatment|0|||
129980527|NCT02003222|467891679|FG001|Induction|Never started treatment|0|||
129980528|NCT02003222|467891680|FG002|Induction|Never started treatment|0|||
129980529|NCT02003222|467891681|FG003|Induction|Never started treatment|0|||
129980530|NCT02003222|467891682|FG004|Induction|Never started treatment|8|||
129980531|NCT02003222|467891678|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980532|NCT02003222|467891679|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980533|NCT02003222|467891680|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980534|NCT02003222|467891681|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
129980535|NCT02003222|467891682|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
129980536|NCT02003222|467891678|FG000|Induction|Adverse Event|0|||
129980537|NCT02003222|467891679|FG001|Induction|Adverse Event|0|||
129980538|NCT02003222|467891680|FG002|Induction|Adverse Event|0|||
129980539|NCT02003222|467891681|FG003|Induction|Adverse Event|0|||
129980540|NCT02003222|467891682|FG004|Induction|Adverse Event|13|||
129980541|NCT02003222|467891678|FG000|Induction|Alternative therapy|0|||
129488589|NCT04075604|466080736|FG002|Overall Study|Participant withdrew consent|1|||
129488590|NCT04075604|466080734|FG000|Overall Study|Other reasons|1|||
129488591|NCT04075604|466080735|FG001|Overall Study|Other reasons|0|||
129488592|NCT04075604|466080736|FG002|Overall Study|Other reasons|0|||
129488593|NCT04075604|466080734|FG000|Overall Study|Disease progression|0|||
129488594|NCT04075604|466080735|FG001|Overall Study|Disease progression|1|||
129488595|NCT04075604|466080736|FG002|Overall Study|Disease progression|0|||
129488596|NCT04075604|466080734|FG000|Overall Study|Study drug toxicity|0|||
129488597|NCT04075604|466080735|FG001|Overall Study|Study drug toxicity|5|||
129488598|NCT04075604|466080736|FG002|Overall Study|Study drug toxicity|1|||
129488599|NCT01650779|466080739|FG000|Overall Study|Withdrawal by Subject|1|||
129488600|NCT03666143|466080740|FG000|Overall Study|Death|158|||
129488601|NCT03666143|466080740|FG000|Overall Study|Sponsor Decision|31|||
129488602|NCT03666143|466080740|FG000|Overall Study|Withdrawal by Subject|11|||
129488603|NCT03666143|466080740|FG000|Overall Study|Lost to Follow-up|5|||
129488604|NCT03666143|466080740|FG000|Overall Study|Physician Decision|1|||
129488605|NCT03666143|466080740|FG000|Overall Study|Rolled into extension study|9|||
129488606|NCT03666143|466080740|FG000|Overall Study|Progressive Disease|1|||
129488607|NCT01183858|466080743|FG000|Overall Study|Death not related to Progressive Disease|5|||
129488608|NCT01183858|466080744|FG001|Overall Study|Death not related to Progressive Disease|6|||
129488609|NCT01183858|466080743|FG000|Overall Study|Adverse Event|14|||
129488610|NCT01183858|466080744|FG001|Overall Study|Adverse Event|11|||
129488611|NCT01183858|466080743|FG000|Overall Study|Investigator's Decision|0|||
129488612|NCT01183858|466080744|FG001|Overall Study|Investigator's Decision|3|||
129488613|NCT01183858|466080743|FG000|Overall Study|Insufficient Therapeutic Response|2|||
129488614|NCT01183858|466080744|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129488615|NCT01183858|466080743|FG000|Overall Study|Refused Treatment|1|||
129488616|NCT01183858|466080744|FG001|Overall Study|Refused Treatment|4|||
129488617|NCT01183858|466080743|FG000|Overall Study|Withdrew Consent|4|||
129488618|NCT01183858|466080744|FG001|Overall Study|Withdrew Consent|4|||
129488619|NCT01183858|466080743|FG000|Overall Study|Discontinued Smoking|3|||
129488620|NCT01183858|466080744|FG001|Overall Study|Discontinued Smoking|1|||
129488621|NCT01183858|466080743|FG000|Overall Study|Protocol Violation|1|||
129488622|NCT01183858|466080744|FG001|Overall Study|Protocol Violation|0|||
129488623|NCT01183858|466080743|FG000|Overall Study|Administrative/Other|6|||
129488624|NCT01183858|466080744|FG001|Overall Study|Administrative/Other|6|||
129488625|NCT01183858|466080743|FG000|Overall Study|Progressive Disease|112|||
129488626|NCT01183858|466080744|FG001|Overall Study|Progressive Disease|115|||
129488627|NCT01183858|466080743|FG000|Overall Study|Death related to Progressive Disease|4|||
129488628|NCT01183858|466080744|FG001|Overall Study|Death related to Progressive Disease|5|||
129488629|NCT01183858|466080743|FG000|Overall Study|Lost to Follow-up|1|||
129488630|NCT01183858|466080744|FG001|Overall Study|Lost to Follow-up|1|||
129488631|NCT02747043|466080747|FG000|Overall Study|Other|1|||
129488632|NCT02747043|466080748|FG001|Overall Study|Other|1|||
129488633|NCT02747043|466080747|FG000|Overall Study|Adverse Event|3|||
129488634|NCT02747043|466080748|FG001|Overall Study|Adverse Event|1|||
129488635|NCT02747043|466080747|FG000|Overall Study|Withdrawal by Subject|1|||
129488636|NCT02747043|466080748|FG001|Overall Study|Withdrawal by Subject|1|||
129488637|NCT02747043|466080747|FG000|Overall Study|Physician Decision|1|||
129488638|NCT02747043|466080748|FG001|Overall Study|Physician Decision|1|||
129488639|NCT02747043|466080747|FG000|Overall Study|Protocol Violation|0|||
129488640|NCT02747043|466080748|FG001|Overall Study|Protocol Violation|1|||
129488641|NCT02747043|466080747|FG000|Overall Study|Disease progression|4|||
129488642|NCT02747043|466080748|FG001|Overall Study|Disease progression|0|||
129488643|NCT01295905|466080755|FG000|Overall Study|Did not meet inclusion criteria|1|||
129488644|NCT01295905|466080756|FG001|Overall Study|Did not meet inclusion criteria|0|||
129488645|NCT01295905|466080755|FG000|Overall Study|Met exclusion criteria|1|||
129488646|NCT01295905|466080756|FG001|Overall Study|Met exclusion criteria|0|||
129488647|NCT03842709|466080758|FG000|Overall Study|Withdrawal by Subject|3|||
129488648|NCT03842709|466080759|FG001|Overall Study|Withdrawal by Subject|3|||
129488649|NCT03842709|466080758|FG000|Overall Study|Lost to Follow-up|1|||
129488650|NCT03842709|466080759|FG001|Overall Study|Lost to Follow-up|0|||
129488651|NCT00641147|466080760|FG000|Completed 4 Months.|Physician Decision|1|||
129488652|NCT00641147|466080761|FG001|Completed 4 Months.|Physician Decision|0|||
129488653|NCT00641147|466080760|FG000|Completed 4 Months.|Adverse Event|1|||
129488654|NCT00641147|466080761|FG001|Completed 4 Months.|Adverse Event|0|||
129488655|NCT00641147|466080760|FG000|Completed 8 Months.|Physician Decision|2|||
129488656|NCT00641147|466080761|FG001|Completed 8 Months.|Physician Decision|1|||
129488657|NCT00641147|466080760|FG000|Completed 8 Months.|non compliance|1|||
129488658|NCT00641147|466080761|FG001|Completed 8 Months.|non compliance|0|||
129488659|NCT00641147|466080760|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
129488660|NCT00641147|466080761|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
129488661|NCT00641147|466080760|FG000|Completed 12 Months.|Physician Decision|1|||
129488662|NCT00641147|466080761|FG001|Completed 12 Months.|Physician Decision|1|||
129488663|NCT00641147|466080760|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
129488664|NCT00641147|466080761|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
129488665|NCT00641147|466080760|FG000|Completed 16 Months.|Physician Decision|1|||
129488666|NCT00641147|466080761|FG001|Completed 16 Months.|Physician Decision|0|||
129488667|NCT00641147|466080760|FG000|Completed 16 Months.|Lost to Follow-up|1|||
129488668|NCT00641147|466080761|FG001|Completed 16 Months.|Lost to Follow-up|0|||
129488669|NCT00791128|466080762|FG000|Overall Study|Adverse Event|4|||
129488670|NCT00791128|466080762|FG000|Overall Study|Device migration|2|||
129488671|NCT00791128|466080762|FG000|Overall Study|non-compliance by subject|2|||
129488672|NCT00791128|466080762|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
129488673|NCT01629667|466080763|FG000|Overall Study|Lost to Follow-up|0|||
129488674|NCT01629667|466080764|FG001|Overall Study|Lost to Follow-up|1|||
129488675|NCT01629667|466080765|FG002|Overall Study|Lost to Follow-up|1|||
129488676|NCT01629667|466080763|FG000|Overall Study|Withdrawal by Subject|31|||
129488677|NCT01629667|466080764|FG001|Overall Study|Withdrawal by Subject|20|||
129488678|NCT01629667|466080765|FG002|Overall Study|Withdrawal by Subject|28|||
129488679|NCT01629667|466080763|FG000|Overall Study|Death|1|||
129488680|NCT01629667|466080764|FG001|Overall Study|Death|5|||
129488681|NCT01629667|466080765|FG002|Overall Study|Death|3|||
129488682|NCT01629667|466080763|FG000|Overall Study|Randomized, not treated|2|||
129488683|NCT01629667|466080764|FG001|Overall Study|Randomized, not treated|1|||
129488684|NCT01629667|466080765|FG002|Overall Study|Randomized, not treated|0|||
129488685|NCT01629667|466080763|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
129488686|NCT01629667|466080764|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
129488687|NCT01629667|466080765|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
129488688|NCT01629667|466080763|FG000|Overall Study|Requiring lung transplant|2|||
129488689|NCT01629667|466080764|FG001|Overall Study|Requiring lung transplant|1|||
129488690|NCT01629667|466080765|FG002|Overall Study|Requiring lung transplant|3|||
129488691|NCT01629667|466080763|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
129488692|NCT01629667|466080764|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
129488693|NCT01629667|466080765|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
129488694|NCT01629667|466080763|FG000|Overall Study|Started other medicine|1|||
129488695|NCT01629667|466080764|FG001|Overall Study|Started other medicine|0|||
129488696|NCT01629667|466080765|FG002|Overall Study|Started other medicine|1|||
129488697|NCT01629667|466080763|FG000|Overall Study|Site error in safety follow-up|0|||
129488698|NCT01629667|466080764|FG001|Overall Study|Site error in safety follow-up|0|||
129488699|NCT01629667|466080765|FG002|Overall Study|Site error in safety follow-up|1|||
129488700|NCT01629667|466080763|FG000|Overall Study|Enrolled in another clinical study|0|||
129488701|NCT01629667|466080764|FG001|Overall Study|Enrolled in another clinical study|1|||
129488702|NCT01629667|466080765|FG002|Overall Study|Enrolled in another clinical study|0|||
129488703|NCT01629667|466080763|FG000|Overall Study|Code break|1|||
129488704|NCT01629667|466080764|FG001|Overall Study|Code break|0|||
129488705|NCT01629667|466080765|FG002|Overall Study|Code break|0|||
129488706|NCT02441803|466080768|FG000|Overall Study|Physician Decision|0|||
129488707|NCT02441803|466080769|FG001|Overall Study|Physician Decision|2|||
129488708|NCT02441803|466080770|FG002|Overall Study|Physician Decision|2|||
129488709|NCT01512368|466080776|FG000|Overall Study|Protocol Violation|3|||
129488710|NCT00328198|466080777|FG000|Treatment|Adverse Event|21|||
129488711|NCT00328198|466080777|FG000|Treatment|Death|1|||
129488712|NCT00328198|466080777|FG000|Treatment|Physician Decision|5|||
129488713|NCT00328198|466080777|FG000|Treatment|Withdrawal by Subject|5|||
129488714|NCT00328198|466080777|FG000|Treatment|Evidence of disease progression|2|||
129488715|NCT00328198|466080777|FG000|Treatment|Non-compliance|1|||
129488716|NCT00328198|466080777|FG000|Treatment|Confirmed complete response, MRD -|3|||
129488717|NCT00328198|466080777|FG000|Follow-up|Lost to Follow-up|4|||
129488718|NCT00328198|466080777|FG000|Follow-up|Death|31|||
129488719|NCT02717546|466080779|FG000|Overall Study|Lost to Follow-up|12|||
129488720|NCT03396471|466080785|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
129488721|NCT03396471|466080785|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
129488722|NCT03396471|466080785|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
129488723|NCT03396471|466080785|FG000|Study Treatment - Up to 22 Months|Death|2|||
129488724|NCT03396471|466080785|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
129488725|NCT03396471|466080785|FG000|Follow up - Up to 2 Years|Death|9|||
129488726|NCT03396471|466080785|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
129488727|NCT03396471|466080785|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
129488728|NCT03396471|466080785|FG000|Follow up - Up to 2 Years|study terminated|1|||
129488729|NCT03396471|466080785|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
129488730|NCT03396471|466080785|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
129488731|NCT03237845|466080786|FG000|Overall Study|Adverse Event|0|||
129488732|NCT03237845|466080787|FG001|Overall Study|Adverse Event|1|||
129488733|NCT03237845|466080786|FG000|Overall Study|Lost to Follow-up|13|||
129488734|NCT03237845|466080787|FG001|Overall Study|Lost to Follow-up|10|||
129488735|NCT03237845|466080786|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
129488736|NCT03237845|466080787|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
129488737|NCT03237845|466080786|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
129488738|NCT03237845|466080787|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
129488739|NCT03237845|466080786|FG000|Overall Study|Physician Decision|1|||
129488740|NCT03237845|466080787|FG001|Overall Study|Physician Decision|2|||
129488741|NCT03237845|466080786|FG000|Overall Study|Pregnancy|1|||
129488742|NCT03237845|466080787|FG001|Overall Study|Pregnancy|0|||
129488743|NCT03237845|466080786|FG000|Overall Study|Protocol Deviation|0|||
129488744|NCT03237845|466080787|FG001|Overall Study|Protocol Deviation|1|||
129488745|NCT03237845|466080786|FG000|Overall Study|Technical Problems|8|||
129488746|NCT03237845|466080787|FG001|Overall Study|Technical Problems|1|||
129488747|NCT03237845|466080786|FG000|Overall Study|Withdrawal by Subject|3|||
129488748|NCT03237845|466080787|FG001|Overall Study|Withdrawal by Subject|3|||
129488749|NCT03237845|466080786|FG000|Overall Study|Other Reasons|4|||
129488750|NCT03237845|466080787|FG001|Overall Study|Other Reasons|0|||
129488751|NCT01645280|466080790|FG000|Overall Study|Death|0|||
129488752|NCT01645280|466080791|FG001|Overall Study|Death|1|||
129488753|NCT01645280|466080792|FG002|Overall Study|Death|0|||
129488754|NCT01645280|466080793|FG003|Overall Study|Death|0|||
129488755|NCT01645280|466080794|FG004|Overall Study|Death|0|||
129488756|NCT01645280|466080790|FG000|Overall Study|Withdrawal by Subject|4|||
129488757|NCT01645280|466080791|FG001|Overall Study|Withdrawal by Subject|0|||
129488758|NCT01645280|466080792|FG002|Overall Study|Withdrawal by Subject|2|||
129488759|NCT01645280|466080793|FG003|Overall Study|Withdrawal by Subject|4|||
129488760|NCT01645280|466080794|FG004|Overall Study|Withdrawal by Subject|5|||
129488761|NCT01645280|466080790|FG000|Overall Study|Lost to Follow-up|0|||
129488762|NCT01645280|466080791|FG001|Overall Study|Lost to Follow-up|0|||
129488763|NCT01645280|466080792|FG002|Overall Study|Lost to Follow-up|0|||
129488764|NCT01645280|466080793|FG003|Overall Study|Lost to Follow-up|2|||
129488765|NCT01645280|466080794|FG004|Overall Study|Lost to Follow-up|1|||
129488766|NCT01645280|466080790|FG000|Overall Study|Other|1|||
129488767|NCT01645280|466080791|FG001|Overall Study|Other|1|||
129488768|NCT01645280|466080792|FG002|Overall Study|Other|2|||
129488769|NCT01645280|466080793|FG003|Overall Study|Other|0|||
129488770|NCT01645280|466080794|FG004|Overall Study|Other|0|||
129488771|NCT01645280|466080790|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
129488772|NCT01645280|466080791|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
129488773|NCT01645280|466080792|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
129488774|NCT01645280|466080793|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
129488775|NCT01645280|466080794|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
129488776|NCT00234104|466080799|FG000|Overall Study|Adverse Event|4|||
129488777|NCT00234104|466080800|FG001|Overall Study|Adverse Event|0|||
129488778|NCT00234104|466080801|FG002|Overall Study|Adverse Event|3|||
129488779|NCT00234104|466080802|FG003|Overall Study|Adverse Event|5|||
129488780|NCT00234104|466080799|FG000|Overall Study|Protocol Violation|0|||
129488781|NCT00234104|466080800|FG001|Overall Study|Protocol Violation|0|||
129488782|NCT00234104|466080801|FG002|Overall Study|Protocol Violation|0|||
129488783|NCT00234104|466080802|FG003|Overall Study|Protocol Violation|1|||
129488784|NCT00234104|466080799|FG000|Overall Study|Physician Decision|0|||
129488785|NCT00234104|466080800|FG001|Overall Study|Physician Decision|1|||
129488786|NCT00234104|466080801|FG002|Overall Study|Physician Decision|2|||
129488787|NCT00234104|466080802|FG003|Overall Study|Physician Decision|2|||
129488788|NCT02052960|466080803|FG000|Overall Study|Adverse Event|19|||
129488789|NCT02052960|466080804|FG001|Overall Study|Adverse Event|17|||
129488790|NCT02052960|466080803|FG000|Overall Study|Protocol Violation|4|||
129488791|NCT02052960|466080804|FG001|Overall Study|Protocol Violation|3|||
129488792|NCT02052960|466080803|FG000|Overall Study|Withdrawal by Subject|6|||
129488793|NCT02052960|466080804|FG001|Overall Study|Withdrawal by Subject|11|||
129488794|NCT02052960|466080803|FG000|Overall Study|Other|25|||
129488795|NCT02052960|466080804|FG001|Overall Study|Other|15|||
129488796|NCT02460822|466080805|FG000|Overall Study|Withdrawal by Subject|1|||
129488797|NCT01633060|466080806|FG000|Randomization Phase|Protocol deviation|1|||
129488798|NCT01633060|466080807|FG001|Randomization Phase|Protocol deviation|2|||
129488799|NCT01633060|466080806|FG000|Randomization Phase|Technical problem|0|||
129488800|NCT01633060|466080807|FG001|Randomization Phase|Technical problem|1|||
129488801|NCT01633060|466080806|FG000|Treatment Phase|Adverse Event|24|||
129488802|NCT01633060|466080807|FG001|Treatment Phase|Adverse Event|3|||
129488803|NCT01633060|466080806|FG000|Treatment Phase|Lost to Follow-up|1|||
129488804|NCT01633060|466080807|FG001|Treatment Phase|Lost to Follow-up|0|||
129488805|NCT01633060|466080806|FG000|Treatment Phase|Physician Decision|16|||
129488806|NCT01633060|466080807|FG001|Treatment Phase|Physician Decision|7|||
129488807|NCT01633060|466080806|FG000|Treatment Phase|Progressive Disease|210|||
129488808|NCT01633060|466080807|FG001|Treatment Phase|Progressive Disease|120|||
129488809|NCT01633060|466080806|FG000|Treatment Phase|Protocol Deviation|1|||
129488810|NCT01633060|466080807|FG001|Treatment Phase|Protocol Deviation|0|||
129488811|NCT01633060|466080806|FG000|Treatment Phase|Study Terminated by sponsor|7|||
129488812|NCT01633060|466080807|FG001|Treatment Phase|Study Terminated by sponsor|3|||
129488813|NCT01633060|466080806|FG000|Treatment Phase|Subject/guardian decision|25|||
129488814|NCT01633060|466080807|FG001|Treatment Phase|Subject/guardian decision|4|||
129488815|NCT01633060|466080806|FG000|Treatment Phase|Death|4|||
129488816|NCT01633060|466080807|FG001|Treatment Phase|Death|3|||
129488817|NCT01633060|466080806|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
129488818|NCT01633060|466080807|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
129488819|NCT01633060|466080806|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
129488820|NCT01633060|466080807|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
129488821|NCT01633060|466080806|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
129488822|NCT01633060|466080807|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
129488823|NCT01633060|466080806|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
129488824|NCT01633060|466080807|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
129488825|NCT01633060|466080806|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
129488826|NCT01633060|466080807|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
129488827|NCT01633060|466080806|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
129488828|NCT01633060|466080807|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
129488829|NCT04601272|466080814|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
129488830|NCT04601272|466080815|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
129488831|NCT04601272|466080816|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
129488832|NCT00414440|466080817|FG000|Core Period|Withdrawal by Subject|70|||
129488833|NCT00414440|466080818|FG001|Core Period|Withdrawal by Subject|32|||
129488834|NCT00414440|466080817|FG000|Extension Period|Lost to Follow-up|44|||
129488835|NCT00414440|466080818|FG001|Extension Period|Lost to Follow-up|52|||
129488836|NCT00414440|466080817|FG000|Extension Period|Did not consent to continue follow up|61|||
129488837|NCT00414440|466080818|FG001|Extension Period|Did not consent to continue follow up|54|||
129488838|NCT00414440|466080817|FG000|Extension Period|Other|1|||
129488839|NCT00414440|466080818|FG001|Extension Period|Other|1|||
129488840|NCT00414440|466080817|FG000|Extension Period|Administrative|16|||
129488841|NCT00414440|466080818|FG001|Extension Period|Administrative|16|||
129488842|NCT00414440|466080817|FG000|Extension Period|Death|1|||
129488843|NCT00414440|466080818|FG001|Extension Period|Death|2|||
129488844|NCT00414440|466080817|FG000|Extension Period|Withdrawal by Subject|9|||
129488845|NCT00414440|466080818|FG001|Extension Period|Withdrawal by Subject|7|||
129488846|NCT00414440|466080817|FG000|Extension Period|Not included in follow up period|18|||
129488847|NCT00414440|466080818|FG001|Extension Period|Not included in follow up period|8|||
129488848|NCT02498821|466080819|FG000|Overall Study|Screen failure|3|||
129488849|NCT02498821|466080820|FG001|Overall Study|Screen failure|5|||
129488850|NCT02285010|466080821|FG000|Overall Study|not abdominal hysterectomy|2|||
129488851|NCT02285010|466080822|FG001|Overall Study|not abdominal hysterectomy|0|||
129488852|NCT02285010|466080821|FG000|Overall Study|Not spinal anesthesia|3|||
129488853|NCT02285010|466080822|FG001|Overall Study|Not spinal anesthesia|1|||
129488854|NCT05258058|466080838|FG000|Overall Study|Withdrawal by Subject|2|||
129488855|NCT04579393|466080843|FG000|Overall Study|Withdrawal by Subject|2|||
129488856|NCT04579393|466080844|FG001|Overall Study|Withdrawal by Subject|2|||
129488857|NCT04579393|466080843|FG000|Overall Study|Death|1|||
129488858|NCT04579393|466080844|FG001|Overall Study|Death|3|||
129488859|NCT02725177|466080854|FG000|Overall Study|Physician Decision|4|||
129488860|NCT02725177|466080854|FG000|Overall Study|Adverse Event|1|||
129488861|NCT00793585|466080855|FG000|Overall Study|Adverse Event|1|||
129488862|NCT00793585|466080856|FG001|Overall Study|Adverse Event|1|||
129488863|NCT00793585|466080855|FG000|Overall Study|Protocol Violation|1|||
129488864|NCT00793585|466080856|FG001|Overall Study|Protocol Violation|2|||
129488865|NCT02699515|466082673|FG000|Overall Study|Death|3|||
129488866|NCT02699515|466082674|FG001|Overall Study|Death|3|||
129488867|NCT02699515|466082675|FG002|Overall Study|Death|3|||
129488868|NCT02699515|466082676|FG003|Overall Study|Death|23|||
129488869|NCT02699515|466082677|FG004|Overall Study|Death|22|||
129488870|NCT02699515|466082678|FG005|Overall Study|Death|23|||
129488871|NCT02699515|466082679|FG006|Overall Study|Death|3|||
129488872|NCT02699515|466082680|FG007|Overall Study|Death|5|||
129488873|NCT02699515|466082673|FG000|Overall Study|Withdrawal by Subject|0|||
129488874|NCT02699515|466082674|FG001|Overall Study|Withdrawal by Subject|0|||
129488875|NCT02699515|466082675|FG002|Overall Study|Withdrawal by Subject|3|||
129488876|NCT02699515|466082676|FG003|Overall Study|Withdrawal by Subject|1|||
129488877|NCT02699515|466082677|FG004|Overall Study|Withdrawal by Subject|5|||
129488878|NCT02699515|466082678|FG005|Overall Study|Withdrawal by Subject|3|||
129488879|NCT02699515|466082679|FG006|Overall Study|Withdrawal by Subject|0|||
129488880|NCT02699515|466082680|FG007|Overall Study|Withdrawal by Subject|1|||
129488881|NCT02699515|466082673|FG000|Overall Study|Other|1|||
129488882|NCT02699515|466082674|FG001|Overall Study|Other|0|||
129488883|NCT02699515|466082675|FG002|Overall Study|Other|1|||
129488884|NCT02699515|466082676|FG003|Overall Study|Other|6|||
129488885|NCT02699515|466082677|FG004|Overall Study|Other|4|||
129488886|NCT02699515|466082678|FG005|Overall Study|Other|3|||
129488887|NCT02699515|466082679|FG006|Overall Study|Other|0|||
129980542|NCT02003222|467891679|FG001|Induction|Alternative therapy|0|||
129980543|NCT02003222|467891680|FG002|Induction|Alternative therapy|0|||
129980544|NCT02003222|467891681|FG003|Induction|Alternative therapy|0|||
129488888|NCT02699515|466082680|FG007|Overall Study|Other|0|||
129488889|NCT00375934|466082681|FG000|Overall Study|Adverse Event|1|||
129488890|NCT00375934|466082682|FG001|Overall Study|Adverse Event|1|||
129488891|NCT00375934|466082681|FG000|Overall Study|Withdrawal by Subject|2|||
129488892|NCT00375934|466082682|FG001|Overall Study|Withdrawal by Subject|2|||
129488893|NCT00375934|466082681|FG000|Overall Study|Lack of Efficacy|0|||
129488894|NCT00375934|466082682|FG001|Overall Study|Lack of Efficacy|2|||
129488895|NCT00375934|466082681|FG000|Overall Study|Physician Decision|0|||
129488896|NCT00375934|466082682|FG001|Overall Study|Physician Decision|1|||
129488897|NCT01300286|466082683|FG000|Overall Study|did not get dosed|1|||
129488898|NCT01334125|466082695|FG000|Overall Study|Lost to Follow-up|3|||
129488899|NCT01334125|466082696|FG001|Overall Study|Lost to Follow-up|3|||
129488900|NCT02584634|466082701|FG000|Overall Study|Adverse Event|3|||
129488901|NCT02584634|466082702|FG001|Overall Study|Adverse Event|5|||
129488902|NCT02584634|466082701|FG000|Overall Study|Death|0|||
129488903|NCT02584634|466082702|FG001|Overall Study|Death|1|||
129488904|NCT02584634|466082701|FG000|Overall Study|Lost to Follow-up|0|||
129488905|NCT02584634|466082702|FG001|Overall Study|Lost to Follow-up|1|||
129488906|NCT02584634|466082701|FG000|Overall Study|Physician Decision|1|||
129488907|NCT02584634|466082702|FG001|Overall Study|Physician Decision|2|||
129488908|NCT02584634|466082701|FG000|Overall Study|Progressive disease|7|||
129488909|NCT02584634|466082702|FG001|Overall Study|Progressive disease|15|||
129488910|NCT02584634|466082701|FG000|Overall Study|Withdrawal by Subject|1|||
129488911|NCT02584634|466082702|FG001|Overall Study|Withdrawal by Subject|1|||
129488912|NCT02584634|466082701|FG000|Overall Study|Other|0|||
129488913|NCT02584634|466082702|FG001|Overall Study|Other|6|||
129488914|NCT00283712|466082703|FG000|Overall Study|Death|0|||
129488915|NCT00283712|466082704|FG001|Overall Study|Death|1|||
129488916|NCT04329923|466082706|FG000|Overall Study|Withdrawal by Subject|1|||
129488917|NCT04329923|466082707|FG001|Overall Study|Withdrawal by Subject|4|||
129488918|NCT04329923|466082708|FG002|Overall Study|Withdrawal by Subject|1|||
129488919|NCT04329923|466082709|FG003|Overall Study|Withdrawal by Subject|1|||
129488920|NCT04329923|466082710|FG004|Overall Study|Withdrawal by Subject|1|||
129488921|NCT04329923|466082711|FG005|Overall Study|Withdrawal by Subject|1|||
129488922|NCT04329923|466082706|FG000|Overall Study|early termination of study|0|||
129488923|NCT04329923|466082707|FG001|Overall Study|early termination of study|0|||
129488924|NCT04329923|466082708|FG002|Overall Study|early termination of study|0|||
129488925|NCT04329923|466082709|FG003|Overall Study|early termination of study|0|||
129488926|NCT04329923|466082710|FG004|Overall Study|early termination of study|1|||
129488927|NCT04329923|466082711|FG005|Overall Study|early termination of study|2|||
129488928|NCT04329923|466082706|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
129488929|NCT04329923|466082707|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
129488930|NCT04329923|466082708|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
129488931|NCT04329923|466082709|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
129488932|NCT04329923|466082710|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
129488933|NCT04329923|466082711|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
129488934|NCT01272180|466082712|FG000|Overall Study|Adverse Event|0|||
129488935|NCT01272180|466082713|FG001|Overall Study|Adverse Event|0|||
129488936|NCT01272180|466082714|FG002|Overall Study|Adverse Event|1|||
129488937|NCT01272180|466082715|FG003|Overall Study|Adverse Event|0|||
129488938|NCT01272180|466082712|FG000|Overall Study|Withdrawal by Subject|2|||
129980545|NCT02003222|467891682|FG004|Induction|Alternative therapy|12|||
129980546|NCT02003222|467891678|FG000|Induction|Disease progression|0|||
129980547|NCT02003222|467891679|FG001|Induction|Disease progression|0|||
129980548|NCT02003222|467891680|FG002|Induction|Disease progression|0|||
129980549|NCT02003222|467891681|FG003|Induction|Disease progression|0|||
129980550|NCT02003222|467891682|FG004|Induction|Disease progression|22|||
129980551|NCT02003222|467891678|FG000|Induction|Death|0|||
129980552|NCT02003222|467891679|FG001|Induction|Death|0|||
129980553|NCT02003222|467891680|FG002|Induction|Death|0|||
129980554|NCT02003222|467891681|FG003|Induction|Death|0|||
129980555|NCT02003222|467891682|FG004|Induction|Death|3|||
129980556|NCT02003222|467891678|FG000|Induction|Withdrawal by Subject|0|||
129980557|NCT02003222|467891679|FG001|Induction|Withdrawal by Subject|0|||
129980558|NCT02003222|467891680|FG002|Induction|Withdrawal by Subject|0|||
129980559|NCT02003222|467891681|FG003|Induction|Withdrawal by Subject|0|||
129980560|NCT02003222|467891682|FG004|Induction|Withdrawal by Subject|8|||
129980561|NCT02003222|467891678|FG000|Induction|Other reasons|0|||
129980562|NCT02003222|467891679|FG001|Induction|Other reasons|0|||
129980563|NCT02003222|467891680|FG002|Induction|Other reasons|0|||
129980564|NCT02003222|467891681|FG003|Induction|Other reasons|0|||
129980565|NCT02003222|467891682|FG004|Induction|Other reasons|22|||
129980566|NCT02003222|467891678|FG000|Intensification|Never started treatment|0|||
129980567|NCT02003222|467891679|FG001|Intensification|Never started treatment|0|||
129980568|NCT02003222|467891680|FG002|Intensification|Never started treatment|0|||
129980569|NCT02003222|467891681|FG003|Intensification|Never started treatment|0|||
129980570|NCT02003222|467891682|FG004|Intensification|Never started treatment|2|||
129980571|NCT02003222|467891678|FG000|Intensification|Adverse Event|0|||
129980572|NCT02003222|467891679|FG001|Intensification|Adverse Event|0|||
129980573|NCT02003222|467891680|FG002|Intensification|Adverse Event|0|||
129980574|NCT02003222|467891681|FG003|Intensification|Adverse Event|0|||
129980575|NCT02003222|467891682|FG004|Intensification|Adverse Event|6|||
129980576|NCT02003222|467891678|FG000|Intensification|Alternative therapy|0|||
129488939|NCT01272180|466082713|FG001|Overall Study|Withdrawal by Subject|6|||
129488940|NCT01272180|466082714|FG002|Overall Study|Withdrawal by Subject|3|||
129488941|NCT01272180|466082715|FG003|Overall Study|Withdrawal by Subject|2|||
129488942|NCT01272180|466082712|FG000|Overall Study|Lost to Follow-up|15|||
129488943|NCT01272180|466082713|FG001|Overall Study|Lost to Follow-up|14|||
129488944|NCT01272180|466082714|FG002|Overall Study|Lost to Follow-up|8|||
129488945|NCT01272180|466082715|FG003|Overall Study|Lost to Follow-up|10|||
129488946|NCT01272180|466082712|FG000|Overall Study|Inappropriate enrollment|0|||
129488947|NCT01272180|466082713|FG001|Overall Study|Inappropriate enrollment|0|||
129488948|NCT01272180|466082714|FG002|Overall Study|Inappropriate enrollment|1|||
129488949|NCT01272180|466082715|FG003|Overall Study|Inappropriate enrollment|1|||
129488950|NCT01272180|466082712|FG000|Overall Study|Protocol Violation|0|||
129488951|NCT01272180|466082713|FG001|Overall Study|Protocol Violation|1|||
129488952|NCT01272180|466082714|FG002|Overall Study|Protocol Violation|0|||
129488953|NCT01272180|466082715|FG003|Overall Study|Protocol Violation|1|||
129488954|NCT00098345|466082716|FG000|Overall Study|Adverse Event|7|||
129488955|NCT00098345|466082716|FG000|Overall Study|Withdrawal by Subject|2|||
129488956|NCT00098345|466082716|FG000|Overall Study|progression|4|||
129488957|NCT03707977|466082719|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
129488958|NCT03707977|466082720|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
129488959|NCT03707977|466082721|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
129488960|NCT03707977|466082719|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
129488961|NCT03707977|466082720|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
129488962|NCT03707977|466082721|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
129488963|NCT02564120|466082722|FG000|Overall Study|Did not return release forms|160|||
129488964|NCT02564120|466082722|FG000|Overall Study|Death|58|||
129488965|NCT02564120|466082722|FG000|Overall Study|Withdrawal by Subject|204|||
129488966|NCT02564120|466082722|FG000|Overall Study|Other medical condition|24|||
129488967|NCT01966731|466082725|FG000|Overall Study|Death|2|||
129488968|NCT01966731|466082725|FG000|Overall Study|Lost to Follow-up|1|||
129488969|NCT01966731|466082725|FG000|Overall Study|Physician Decision|2|||
129488970|NCT01966731|466082725|FG000|Overall Study|Follow up is not complete|600|||
129488971|NCT01966731|466082725|FG000|Overall Study|Screening Failure|29|||
129488972|NCT01966731|466082725|FG000|Overall Study|Found to be ineligible|1|||
129488973|NCT01380093|466082727|FG000|Naloxone Challenge Phase|Screen failures|21|||
129488974|NCT01380093|466082728|FG001|Naloxone Challenge Phase|Screen failures|0|||
129488975|NCT01380093|466082729|FG002|Naloxone Challenge Phase|Screen failures|0|||
129488976|NCT01380093|466082730|FG003|Naloxone Challenge Phase|Screen failures|0|||
129488977|NCT01380093|466082731|FG004|Naloxone Challenge Phase|Screen failures|0|||
129488978|NCT01380093|466082732|FG005|Naloxone Challenge Phase|Screen failures|0|||
129488979|NCT01380093|466082733|FG006|Naloxone Challenge Phase|Screen failures|0|||
129488980|NCT01380093|466082734|FG007|Naloxone Challenge Phase|Screen failures|0|||
129488981|NCT01380093|466082735|FG008|Naloxone Challenge Phase|Screen failures|0|||
129488982|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488983|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
129488984|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488985|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488986|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488987|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488988|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488989|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488990|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
129488991|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129488992|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
129488993|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
129488994|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129488995|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129488996|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129488997|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129488998|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129488999|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
129489000|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489001|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
129489002|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489003|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489004|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489005|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489006|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489007|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489008|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
129489009|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489010|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
129489011|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
129489012|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489013|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489014|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489015|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489016|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489017|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
129489018|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489019|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
129489020|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
129489021|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489022|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489023|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489024|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489025|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489026|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
129489027|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489028|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489029|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
129489030|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489031|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489032|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489033|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489034|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489035|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
129489036|NCT01380093|466082727|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489037|NCT01380093|466082728|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489038|NCT01380093|466082729|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
129489039|NCT01380093|466082730|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489040|NCT01380093|466082731|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489041|NCT01380093|466082732|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489042|NCT01380093|466082733|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489043|NCT01380093|466082734|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489044|NCT01380093|466082735|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
129489045|NCT01380093|466082727|FG000|Treatment Phase: Second Intervention|Other|0|||
129489046|NCT01380093|466082728|FG001|Treatment Phase: Second Intervention|Other|0|||
129489047|NCT01380093|466082729|FG002|Treatment Phase: Second Intervention|Other|0|||
129489048|NCT01380093|466082730|FG003|Treatment Phase: Second Intervention|Other|1|||
129489049|NCT01380093|466082731|FG004|Treatment Phase: Second Intervention|Other|0|||
129489050|NCT01380093|466082732|FG005|Treatment Phase: Second Intervention|Other|0|||
129489051|NCT01380093|466082733|FG006|Treatment Phase: Second Intervention|Other|0|||
129489052|NCT01380093|466082734|FG007|Treatment Phase: Second Intervention|Other|0|||
129489053|NCT01380093|466082735|FG008|Treatment Phase: Second Intervention|Other|0|||
129489054|NCT01380093|466082727|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
129489055|NCT01380093|466082728|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
129489056|NCT01380093|466082729|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
129489057|NCT01380093|466082730|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
129489058|NCT01380093|466082731|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
129489059|NCT01380093|466082732|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
129489060|NCT01380093|466082733|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
129489061|NCT01380093|466082734|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
129489062|NCT01380093|466082735|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
129489063|NCT01380093|466082727|FG000|Treatment Phase: Third Intervention|Other|0|||
129489064|NCT01380093|466082728|FG001|Treatment Phase: Third Intervention|Other|0|||
129489065|NCT01380093|466082729|FG002|Treatment Phase: Third Intervention|Other|0|||
129489066|NCT01380093|466082730|FG003|Treatment Phase: Third Intervention|Other|0|||
129489067|NCT01380093|466082731|FG004|Treatment Phase: Third Intervention|Other|0|||
129489068|NCT01380093|466082732|FG005|Treatment Phase: Third Intervention|Other|0|||
129489069|NCT01380093|466082733|FG006|Treatment Phase: Third Intervention|Other|0|||
129489070|NCT01380093|466082734|FG007|Treatment Phase: Third Intervention|Other|0|||
129489071|NCT01380093|466082735|FG008|Treatment Phase: Third Intervention|Other|1|||
129980577|NCT02003222|467891679|FG001|Intensification|Alternative therapy|0|||
129980578|NCT02003222|467891680|FG002|Intensification|Alternative therapy|0|||
129980579|NCT02003222|467891681|FG003|Intensification|Alternative therapy|0|||
129980580|NCT02003222|467891682|FG004|Intensification|Alternative therapy|8|||
129980581|NCT02003222|467891678|FG000|Intensification|Disease progression|0|||
129489072|NCT04734873|466082736|FG000|Overall Study|Lost to Follow-up|1|||
129489073|NCT04734873|466082737|FG001|Overall Study|Lost to Follow-up|3|||
129489074|NCT04734873|466082738|FG002|Overall Study|Lost to Follow-up|2|||
129489075|NCT04734873|466082736|FG000|Overall Study|Randomized but not dosed|1|||
129489076|NCT04734873|466082737|FG001|Overall Study|Randomized but not dosed|0|||
129489077|NCT04734873|466082738|FG002|Overall Study|Randomized but not dosed|1|||
129489078|NCT00201201|466082739|FG000|Overall Study|Death|0|||
129489079|NCT00201201|466082740|FG001|Overall Study|Death|2|||
129489080|NCT00201201|466082739|FG000|Overall Study|Withdrawal by Subject|5|||
129489081|NCT00201201|466082740|FG001|Overall Study|Withdrawal by Subject|5|||
129489082|NCT01342640|466082742|FG000|Overall Study|Adverse Event|3|||
129489083|NCT01342640|466082742|FG000|Overall Study|Protocol Violation|16|||
129489084|NCT01342640|466082742|FG000|Overall Study|Lost to Follow-up|21|||
129489085|NCT01342640|466082742|FG000|Overall Study|Other|1|||
129489086|NCT02640612|466082744|FG000|Overall Study|Adverse Event|6|||
129489087|NCT02640612|466082745|FG001|Overall Study|Adverse Event|7|||
129489088|NCT02640612|466082746|FG002|Overall Study|Adverse Event|2|||
129489089|NCT02640612|466082744|FG000|Overall Study|Death|1|||
129489090|NCT02640612|466082745|FG001|Overall Study|Death|0|||
129489091|NCT02640612|466082746|FG002|Overall Study|Death|0|||
129489092|NCT02640612|466082744|FG000|Overall Study|Withdrawal by Subject|10|||
129489093|NCT02640612|466082745|FG001|Overall Study|Withdrawal by Subject|3|||
129489094|NCT02640612|466082746|FG002|Overall Study|Withdrawal by Subject|3|||
129489095|NCT02640612|466082744|FG000|Overall Study|Lost to Follow-up|4|||
129489096|NCT02640612|466082745|FG001|Overall Study|Lost to Follow-up|1|||
129489097|NCT02640612|466082746|FG002|Overall Study|Lost to Follow-up|1|||
129489098|NCT02640612|466082744|FG000|Overall Study|Protocol Violation|0|||
129489099|NCT02640612|466082745|FG001|Overall Study|Protocol Violation|2|||
129489100|NCT02640612|466082746|FG002|Overall Study|Protocol Violation|0|||
129489101|NCT02640612|466082744|FG000|Overall Study|Lack of Efficacy|1|||
129489102|NCT02640612|466082745|FG001|Overall Study|Lack of Efficacy|1|||
129489103|NCT02640612|466082746|FG002|Overall Study|Lack of Efficacy|0|||
129489104|NCT01319929|466082747|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
129489105|NCT01319929|466082748|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
129489106|NCT01319929|466082747|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
129489107|NCT01319929|466082748|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
129489108|NCT01319929|466082747|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
129489109|NCT01319929|466082748|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
129489110|NCT01319929|466082747|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
129489111|NCT01319929|466082748|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
129489112|NCT01319929|466082747|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
129489113|NCT01319929|466082748|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
129489114|NCT01221233|466082749|FG000|Overall Study|Withdrawal by Subject|3|||
129489115|NCT01221233|466082750|FG001|Overall Study|Withdrawal by Subject|1|||
129489116|NCT03865407|466082752|FG000|Overall Study|Adverse Event|1|||
129489117|NCT03865407|466082753|FG001|Overall Study|Adverse Event|0|||
129489118|NCT03865407|466082752|FG000|Overall Study|Withdrawal by Subject|1|||
129489119|NCT03865407|466082753|FG001|Overall Study|Withdrawal by Subject|0|||
129489120|NCT03865407|466082752|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
129489121|NCT03865407|466082753|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
129489122|NCT02117050|466082754|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
129489123|NCT00546819|466082757|FG000|Overall Study|Adverse Event|2|||
129489124|NCT00546819|466082758|FG001|Overall Study|Adverse Event|3|||
129489125|NCT00546819|466082757|FG000|Overall Study|Lost to Follow-up|2|||
129489126|NCT00546819|466082758|FG001|Overall Study|Lost to Follow-up|1|||
129489127|NCT00546819|466082757|FG000|Overall Study|Withdrawal by Subject|4|||
129489128|NCT00546819|466082758|FG001|Overall Study|Withdrawal by Subject|2|||
129489129|NCT03849560|466082760|FG000|Overall Study|Withdrawal by Subject|1|||
129489130|NCT03849560|466082761|FG001|Overall Study|Withdrawal by Subject|0|||
129489131|NCT03849560|466082762|FG002|Overall Study|Withdrawal by Subject|0|||
129489132|NCT04045613|466082763|FG000|Overall Study|Adverse Event|2|||
129489133|NCT04045613|466082764|FG001|Overall Study|Adverse Event|2|||
129489134|NCT04045613|466082765|FG002|Overall Study|Adverse Event|1|||
129489135|NCT04045613|466082766|FG003|Overall Study|Adverse Event|1|||
129489136|NCT04045613|466082767|FG004|Overall Study|Adverse Event|0|||
129489137|NCT04045613|466082768|FG005|Overall Study|Adverse Event|0|||
129980582|NCT02003222|467891679|FG001|Intensification|Disease progression|0|||
129980583|NCT02003222|467891680|FG002|Intensification|Disease progression|0|||
129489138|NCT04045613|466082769|FG006|Overall Study|Adverse Event|1|||
129489139|NCT04045613|466082763|FG000|Overall Study|Withdrawal by Subject|0|||
129980584|NCT02003222|467891681|FG003|Intensification|Disease progression|0|||
129489140|NCT04045613|466082764|FG001|Overall Study|Withdrawal by Subject|5|||
129489141|NCT04045613|466082765|FG002|Overall Study|Withdrawal by Subject|0|||
129489142|NCT04045613|466082766|FG003|Overall Study|Withdrawal by Subject|0|||
129489143|NCT04045613|466082767|FG004|Overall Study|Withdrawal by Subject|0|||
129489144|NCT04045613|466082768|FG005|Overall Study|Withdrawal by Subject|1|||
129489145|NCT04045613|466082769|FG006|Overall Study|Withdrawal by Subject|0|||
129489146|NCT04045613|466082763|FG000|Overall Study|Physician Decision|2|||
129489147|NCT04045613|466082764|FG001|Overall Study|Physician Decision|0|||
129489148|NCT04045613|466082765|FG002|Overall Study|Physician Decision|0|||
129489149|NCT04045613|466082766|FG003|Overall Study|Physician Decision|0|||
129489150|NCT04045613|466082767|FG004|Overall Study|Physician Decision|1|||
129489151|NCT04045613|466082768|FG005|Overall Study|Physician Decision|0|||
129489152|NCT04045613|466082769|FG006|Overall Study|Physician Decision|0|||
129489153|NCT04045613|466082763|FG000|Overall Study|Death|3|||
129489154|NCT04045613|466082764|FG001|Overall Study|Death|0|||
129489155|NCT04045613|466082765|FG002|Overall Study|Death|0|||
129489156|NCT04045613|466082766|FG003|Overall Study|Death|0|||
129489157|NCT04045613|466082767|FG004|Overall Study|Death|0|||
129489158|NCT04045613|466082768|FG005|Overall Study|Death|0|||
129489159|NCT04045613|466082769|FG006|Overall Study|Death|1|||
129489160|NCT04045613|466082763|FG000|Overall Study|Other reasons|0|||
129489161|NCT04045613|466082764|FG001|Overall Study|Other reasons|1|||
129489162|NCT04045613|466082765|FG002|Overall Study|Other reasons|0|||
129489163|NCT04045613|466082766|FG003|Overall Study|Other reasons|0|||
129489164|NCT04045613|466082767|FG004|Overall Study|Other reasons|0|||
129489165|NCT04045613|466082768|FG005|Overall Study|Other reasons|0|||
129489166|NCT04045613|466082769|FG006|Overall Study|Other reasons|1|||
129489167|NCT04045613|466082763|FG000|Overall Study|Progressive disease: Clinical progression|1|||
129489168|NCT04045613|466082764|FG001|Overall Study|Progressive disease: Clinical progression|0|||
129489169|NCT04045613|466082765|FG002|Overall Study|Progressive disease: Clinical progression|3|||
129489170|NCT04045613|466082766|FG003|Overall Study|Progressive disease: Clinical progression|1|||
129489171|NCT04045613|466082767|FG004|Overall Study|Progressive disease: Clinical progression|1|||
129489172|NCT04045613|466082768|FG005|Overall Study|Progressive disease: Clinical progression|3|||
129489173|NCT04045613|466082769|FG006|Overall Study|Progressive disease: Clinical progression|3|||
129980585|NCT02003222|467891682|FG004|Intensification|Disease progression|18|||
129980586|NCT02003222|467891678|FG000|Intensification|Withdrawal by Subject|0|||
129489174|NCT04045613|466082763|FG000|Overall Study|Progressive disease: Radiological progression|24|||
129489175|NCT04045613|466082764|FG001|Overall Study|Progressive disease: Radiological progression|6|||
129489176|NCT04045613|466082765|FG002|Overall Study|Progressive disease: Radiological progression|8|||
129489177|NCT04045613|466082766|FG003|Overall Study|Progressive disease: Radiological progression|0|||
129489178|NCT04045613|466082767|FG004|Overall Study|Progressive disease: Radiological progression|6|||
129489179|NCT04045613|466082768|FG005|Overall Study|Progressive disease: Radiological progression|6|||
129489180|NCT04045613|466082769|FG006|Overall Study|Progressive disease: Radiological progression|11|||
129489181|NCT00491530|466082772|FG000|Overall Study|Adverse Event|6|||
129980587|NCT02003222|467891679|FG001|Intensification|Withdrawal by Subject|0|||
129980588|NCT02003222|467891680|FG002|Intensification|Withdrawal by Subject|0|||
129980589|NCT02003222|467891681|FG003|Intensification|Withdrawal by Subject|0|||
129980590|NCT02003222|467891682|FG004|Intensification|Withdrawal by Subject|5|||
129980591|NCT02003222|467891678|FG000|Intensification|Other reasons|0|||
129980592|NCT02003222|467891679|FG001|Intensification|Other reasons|0|||
129980593|NCT02003222|467891680|FG002|Intensification|Other reasons|0|||
129980594|NCT02003222|467891681|FG003|Intensification|Other reasons|0|||
129980595|NCT02003222|467891682|FG004|Intensification|Other reasons|8|||
129980596|NCT01365481|467891683|FG000|Overall Study|Adverse Event|6|||
129980597|NCT01365481|467891684|FG001|Overall Study|Adverse Event|9|||
129980598|NCT01365481|467891685|FG002|Overall Study|Adverse Event|0|||
129980599|NCT01365481|467891686|FG003|Overall Study|Adverse Event|2|||
129980600|NCT01365481|467891683|FG000|Overall Study|Withdrawal by Subject|0|||
129980601|NCT01365481|467891684|FG001|Overall Study|Withdrawal by Subject|2|||
129980602|NCT01365481|467891685|FG002|Overall Study|Withdrawal by Subject|1|||
129980603|NCT01365481|467891686|FG003|Overall Study|Withdrawal by Subject|1|||
129980604|NCT01365481|467891683|FG000|Overall Study|Lost to Follow-up|1|||
129980605|NCT01365481|467891684|FG001|Overall Study|Lost to Follow-up|1|||
129489182|NCT00491530|466082773|FG001|Overall Study|Adverse Event|1|||
129489183|NCT00491530|466082774|FG002|Overall Study|Adverse Event|2|||
129489184|NCT00491530|466082772|FG000|Overall Study|Withdrawal by Subject|3|||
129489185|NCT00491530|466082773|FG001|Overall Study|Withdrawal by Subject|0|||
129489186|NCT00491530|466082774|FG002|Overall Study|Withdrawal by Subject|0|||
129489187|NCT00491530|466082772|FG000|Overall Study|Lost to Follow-up|3|||
129980606|NCT01365481|467891685|FG002|Overall Study|Lost to Follow-up|2|||
129489188|NCT00491530|466082773|FG001|Overall Study|Lost to Follow-up|2|||
129489189|NCT00491530|466082774|FG002|Overall Study|Lost to Follow-up|2|||
129489190|NCT00491530|466082772|FG000|Overall Study|Lack of Efficacy|0|||
129980607|NCT01365481|467891686|FG003|Overall Study|Lost to Follow-up|3|||
129489191|NCT00491530|466082773|FG001|Overall Study|Lack of Efficacy|1|||
129489192|NCT00491530|466082774|FG002|Overall Study|Lack of Efficacy|0|||
129489193|NCT00491530|466082772|FG000|Overall Study|Investigator Discretion|0|||
129489194|NCT00491530|466082773|FG001|Overall Study|Investigator Discretion|1|||
129489195|NCT00491530|466082774|FG002|Overall Study|Investigator Discretion|0|||
129489196|NCT00491530|466082772|FG000|Overall Study|Patient Request|0|||
129980608|NCT01365481|467891683|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129489197|NCT00491530|466082773|FG001|Overall Study|Patient Request|1|||
129489198|NCT00491530|466082774|FG002|Overall Study|Patient Request|0|||
129489199|NCT00491530|466082772|FG000|Overall Study|Use of Prohibited Medication|0|||
129489200|NCT00491530|466082773|FG001|Overall Study|Use of Prohibited Medication|0|||
129489201|NCT00491530|466082774|FG002|Overall Study|Use of Prohibited Medication|1|||
129489202|NCT02859415|466082775|FG000|Overall Study|Physician Decision|1|||
129489203|NCT02859415|466082776|FG001|Overall Study|Physician Decision|0|||
129489204|NCT02859415|466082775|FG000|Overall Study|Off treatment due to cardiac event|0|||
129489205|NCT02859415|466082776|FG001|Overall Study|Off treatment due to cardiac event|1|||
129489206|NCT01174784|466082777|FG000|Overall Study|Screen fails|4|||
129489207|NCT01716169|466082780|FG000|Overall Study|Adverse Event|1|||
129489208|NCT01716169|466082780|FG000|Overall Study|Lost to Follow-up|1|||
129489209|NCT01716169|466082780|FG000|Overall Study|Withdrawal by Subject|1|||
129489210|NCT01716169|466082780|FG000|Overall Study|inconsistent dressing application|1|||
129489211|NCT01478347|466082785|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
129489212|NCT01478347|466082785|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
129489213|NCT01478347|466082785|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
129489214|NCT00196937|466082786|FG000|Overall Study|Serious Adverse Event|1|||
129489215|NCT00196937|466082787|FG001|Overall Study|Serious Adverse Event|0|||
129489216|NCT00196937|466082788|FG002|Overall Study|Serious Adverse Event|0|||
129489217|NCT00196937|466082786|FG000|Overall Study|Non-serious adverse event|1|||
129489218|NCT00196937|466082787|FG001|Overall Study|Non-serious adverse event|1|||
129489219|NCT00196937|466082788|FG002|Overall Study|Non-serious adverse event|1|||
129489220|NCT00196937|466082786|FG000|Overall Study|Withdrawal by Subject|0|||
129489221|NCT00196937|466082787|FG001|Overall Study|Withdrawal by Subject|0|||
129489222|NCT00196937|466082788|FG002|Overall Study|Withdrawal by Subject|2|||
129489223|NCT00196937|466082786|FG000|Overall Study|Lost to Follow-up|4|||
129489224|NCT00196937|466082787|FG001|Overall Study|Lost to Follow-up|3|||
129489225|NCT00196937|466082788|FG002|Overall Study|Lost to Follow-up|3|||
129489226|NCT00196937|466082786|FG000|Overall Study|Other|3|||
129489227|NCT00196937|466082787|FG001|Overall Study|Other|1|||
129489228|NCT00196937|466082788|FG002|Overall Study|Other|1|||
129489229|NCT02973815|466082791|FG000|Post Intervention|Death|1|||
129489230|NCT02973815|466082792|FG001|Post Intervention|Death|0|||
129489231|NCT02973815|466082791|FG000|Post Intervention|Lost to Follow-up|7|||
129489232|NCT02973815|466082792|FG001|Post Intervention|Lost to Follow-up|24|||
129489233|NCT02973815|466082791|FG000|Follow-up|Lost to Follow-up|2|||
129489234|NCT02973815|466082792|FG001|Follow-up|Lost to Follow-up|0|||
129489235|NCT01787591|466082798|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
129489236|NCT01787591|466082799|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
129489237|NCT01787591|466082800|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
129489238|NCT01787591|466082801|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
129489239|NCT02489630|466082802|FG000|Overall Study|Oversedation|1|||
129489240|NCT02489630|466082803|FG001|Overall Study|Oversedation|1|||
129489241|NCT02489630|466082802|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
129489242|NCT02489630|466082803|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
129489243|NCT01326962|466082804|FG000|Overall Study|Adverse Event|1|||
129489244|NCT01326962|466082804|FG000|Overall Study|Withdrawal by Subject|1|||
129489245|NCT01326962|466082804|FG000|Overall Study|Lost to Follow-up|3|||
129489246|NCT01326962|466082804|FG000|Overall Study|Other|2|||
129489247|NCT01056523|466082805|FG000|Overall Study|Death|1|||
129489248|NCT01056523|466082806|FG001|Overall Study|Death|0|||
129489249|NCT01056523|466082807|FG002|Overall Study|Death|2|||
129489250|NCT01056523|466082808|FG003|Overall Study|Death|3|||
129489251|NCT01056523|466082809|FG004|Overall Study|Death|0|||
129489252|NCT01056523|466082810|FG005|Overall Study|Death|0|||
129489253|NCT01056523|466082811|FG006|Overall Study|Death|1|||
129489254|NCT03429556|466082814|FG000|Overall Study|Lost to Follow-up|0|||
129489255|NCT03429556|466082815|FG001|Overall Study|Lost to Follow-up|1|||
129489256|NCT03429556|466082816|FG002|Overall Study|Lost to Follow-up|0|||
129489257|NCT03429556|466082817|FG003|Overall Study|Lost to Follow-up|0|||
129489258|NCT00377299|466082818|FG000|Overall Study|Lost to Follow-up|14|||
129489259|NCT00377299|466082819|FG001|Overall Study|Lost to Follow-up|19|||
129489260|NCT00377299|466082818|FG000|Overall Study|Adverse Event|0|||
129489261|NCT00377299|466082819|FG001|Overall Study|Adverse Event|1|||
129980609|NCT01365481|467891684|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129489262|NCT00377299|466082818|FG000|Overall Study|Withdrawal by Subject|5|||
129489263|NCT00377299|466082819|FG001|Overall Study|Withdrawal by Subject|4|||
129489264|NCT01863758|466082824|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
129489265|NCT01863758|466082824|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
129489266|NCT02369510|466082825|FG000|Overall Study|Spilled Medication|1|||
129489267|NCT02369510|466082826|FG001|Overall Study|Spilled Medication|2|||
129489268|NCT02369510|466082827|FG002|Overall Study|Spilled Medication|1|||
129489269|NCT02369510|466082825|FG000|Overall Study|Epidural Activation|1|||
129489270|NCT02369510|466082826|FG001|Overall Study|Epidural Activation|1|||
129489271|NCT02369510|466082827|FG002|Overall Study|Epidural Activation|5|||
129489272|NCT04952389|466082828|FG000|Overall Study|Withdrawal by Subject|8|||
129489273|NCT04952389|466082829|FG001|Overall Study|Withdrawal by Subject|4|||
129489274|NCT02050048|466082830|FG000|Overall Study|Lost to Follow-up|0|||
129489275|NCT02050048|466082831|FG001|Overall Study|Lost to Follow-up|1|||
129489276|NCT02050048|466082830|FG000|Overall Study|Death|1|||
129489277|NCT02050048|466082831|FG001|Overall Study|Death|0|||
129489278|NCT02050048|466082830|FG000|Overall Study|Ineligible after ERCP|4|||
129489279|NCT02050048|466082831|FG001|Overall Study|Ineligible after ERCP|1|||
129489280|NCT04285723|466082835|FG000|Overall Study|Subject decision|1|||
129489281|NCT04285723|466082836|FG001|Overall Study|Subject decision|2|||
129489282|NCT04285723|466082835|FG000|Overall Study|Physician Decision|1|||
129489283|NCT04285723|466082836|FG001|Overall Study|Physician Decision|0|||
129489284|NCT04285723|466082835|FG000|Overall Study|No efficiency|1|||
129489285|NCT04285723|466082836|FG001|Overall Study|No efficiency|0|||
129489286|NCT01507246|466082837|FG000|Overall Study|Required different surgical procedures|2|||
129489287|NCT01507246|466082838|FG001|Overall Study|Required different surgical procedures|1|||
129489288|NCT02903511|466082842|FG000|Overall Study|Withdrawal by Subject|1|||
129489289|NCT02903511|466082843|FG001|Overall Study|Withdrawal by Subject|0|||
129489290|NCT02903511|466082842|FG000|Overall Study|Lost to Follow-up|3|||
129489291|NCT02903511|466082843|FG001|Overall Study|Lost to Follow-up|2|||
129489292|NCT00969618|466082844|FG000|Overall Study|Adverse Event|29|||
129489293|NCT00969618|466082844|FG000|Overall Study|Entry Criteria Not Met|3|||
129489294|NCT00969618|466082844|FG000|Overall Study|Lack of Efficacy|2|||
129489295|NCT00969618|466082844|FG000|Overall Study|Lost to Follow-up|7|||
129489296|NCT00969618|466082844|FG000|Overall Study|Physician Decision|1|||
129489297|NCT00969618|466082844|FG000|Overall Study|Protocol Violation|9|||
129489298|NCT00969618|466082844|FG000|Overall Study|Withdrawal by Subject|27|||
129489299|NCT05363293|466082849|FG000|Overall Study|Withdrawal by Subject|1|||
129489300|NCT05363293|466082850|FG001|Overall Study|Withdrawal by Subject|0|||
129489301|NCT05363293|466082851|FG002|Overall Study|Withdrawal by Subject|0|||
129489302|NCT05363293|466082852|FG003|Overall Study|Withdrawal by Subject|0|||
129489303|NCT05363293|466082853|FG004|Overall Study|Withdrawal by Subject|0|||
129489304|NCT05363293|466082854|FG005|Overall Study|Withdrawal by Subject|0|||
129489305|NCT05363293|466082855|FG006|Overall Study|Withdrawal by Subject|0|||
129489306|NCT05363293|466082856|FG007|Overall Study|Withdrawal by Subject|0|||
129489307|NCT05363293|466082857|FG008|Overall Study|Withdrawal by Subject|0|||
129489308|NCT05363293|466082858|FG009|Overall Study|Withdrawal by Subject|0|||
129489309|NCT02400346|466085073|FG000|Overall Study|Adverse Event|24|||
129489310|NCT02400346|466085073|FG000|Overall Study|Lack of Efficacy|9|||
129489311|NCT02400346|466085073|FG000|Overall Study|Non-compliance with IMP|1|||
129489312|NCT02400346|466085073|FG000|Overall Study|Withdrawal by Subject|7|||
129489313|NCT02400346|466085073|FG000|Overall Study|Administrative or other reason(s)|2|||
129489314|NCT02400346|466085073|FG000|Overall Study|Lost to Follow-up|1|||
129489315|NCT00486226|466085074|FG000|Overall Study|Death|3|||
129489316|NCT00486226|466085074|FG000|Overall Study|Adverse Event|1|||
129489317|NCT00486226|466085074|FG000|Overall Study|Withdrawal by Subject|1|||
129489318|NCT00486226|466085074|FG000|Overall Study|Lost to Follow-up|8|||
129489319|NCT01259492|466085075|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
129489320|NCT01259492|466085076|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
129489321|NCT01259492|466085077|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
129489322|NCT01259492|466085078|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
129489323|NCT01259492|466085075|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
129489324|NCT01259492|466085076|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
129489325|NCT01259492|466085077|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
129489326|NCT01259492|466085078|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
129489327|NCT01259492|466085075|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
129489328|NCT01259492|466085076|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
129489329|NCT01259492|466085077|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
129489330|NCT01259492|466085078|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
129980610|NCT01365481|467891685|FG002|Overall Study|Abnormal laboratory value(s)|0|||
129980611|NCT01365481|467891686|FG003|Overall Study|Abnormal laboratory value(s)|0|||
129980612|NCT01365481|467891683|FG000|Overall Study|Administrative problems|0|||
129980613|NCT01365481|467891684|FG001|Overall Study|Administrative problems|1|||
129489331|NCT01259492|466085075|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
129489332|NCT01259492|466085076|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
129489333|NCT01259492|466085077|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
129489334|NCT01259492|466085078|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
129489335|NCT01259492|466085075|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
129489336|NCT01259492|466085076|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
129489337|NCT01259492|466085077|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
129489338|NCT01259492|466085078|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
129489339|NCT01259492|466085075|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
129489340|NCT01259492|466085076|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
129489341|NCT01259492|466085077|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
129489342|NCT01259492|466085078|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
129489343|NCT01259492|466085075|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
129489344|NCT01259492|466085076|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
129489345|NCT01259492|466085077|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
129489346|NCT01259492|466085078|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
129489347|NCT01259492|466085075|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
129489348|NCT01259492|466085076|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
129489349|NCT01259492|466085077|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
129489350|NCT01259492|466085078|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
129489351|NCT01259492|466085075|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
129489352|NCT01259492|466085076|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
129489353|NCT01259492|466085077|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
129489354|NCT01259492|466085078|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
129489355|NCT01259492|466085075|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
129489356|NCT01259492|466085076|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
129489357|NCT01259492|466085077|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
129489358|NCT01259492|466085078|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
129489359|NCT01259492|466085075|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
129489360|NCT01259492|466085076|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
129489361|NCT01259492|466085077|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
129489362|NCT01259492|466085078|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
129489363|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
129489364|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
129489365|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
129489366|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
129489367|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
129489368|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
129489369|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
129489370|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
129489371|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
129489372|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
129489373|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
129489374|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
129489375|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
129489376|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
129489377|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
129489378|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
129489379|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
129489380|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
129489381|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
129489382|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
129489383|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
129489384|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
129489385|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
129489386|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
129489387|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
129489388|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
129489389|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
129489390|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
129489391|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
129489392|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
129489393|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
129489394|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
129489395|NCT01259492|466085075|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
129489396|NCT01259492|466085076|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
129489397|NCT01259492|466085077|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
129489398|NCT01259492|466085078|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
129489399|NCT00663858|466085081|FG000|Overall Study|Adverse Event|9|||
129489400|NCT00663858|466085082|FG001|Overall Study|Adverse Event|1|||
129489401|NCT00663858|466085083|FG002|Overall Study|Adverse Event|6|||
129489402|NCT00663858|466085081|FG000|Overall Study|Lack of Efficacy|5|||
129489403|NCT00663858|466085082|FG001|Overall Study|Lack of Efficacy|1|||
129489404|NCT00663858|466085083|FG002|Overall Study|Lack of Efficacy|3|||
129489405|NCT00663858|466085081|FG000|Overall Study|Withdrawal by Subject|7|||
129489406|NCT00663858|466085082|FG001|Overall Study|Withdrawal by Subject|3|||
129489407|NCT00663858|466085083|FG002|Overall Study|Withdrawal by Subject|3|||
129489408|NCT00663858|466085081|FG000|Overall Study|Protocol Violation|5|||
129489409|NCT00663858|466085082|FG001|Overall Study|Protocol Violation|3|||
129489410|NCT00663858|466085083|FG002|Overall Study|Protocol Violation|4|||
129489411|NCT00663858|466085081|FG000|Overall Study|Other|8|||
129489412|NCT00663858|466085082|FG001|Overall Study|Other|2|||
129489413|NCT00663858|466085083|FG002|Overall Study|Other|4|||
129489414|NCT01166659|466085090|FG000|Overall Study|Subject Decision|8|||
129489415|NCT01166659|466085090|FG000|Overall Study|Investigator Decision|2|||
129489416|NCT01166659|466085090|FG000|Overall Study|Death|1|||
129489417|NCT01166659|466085090|FG000|Overall Study|Lost to Follow-up|1|||
129489418|NCT01166659|466085090|FG000|Overall Study|Study Closed at Site|1|||
129489419|NCT01371838|466085099|FG000|Overall Study|Withdrawal by Subject|27|||
129489420|NCT01371838|466085100|FG001|Overall Study|Withdrawal by Subject|33|||
129489421|NCT01371838|466085099|FG000|Overall Study|Lost to Follow-up|10|||
129489422|NCT01371838|466085100|FG001|Overall Study|Lost to Follow-up|20|||
129489423|NCT01371838|466085099|FG000|Overall Study|Death|3|||
129489424|NCT01371838|466085100|FG001|Overall Study|Death|4|||
129489425|NCT01371838|466085099|FG000|Overall Study|Protocol Violation|3|||
129489426|NCT01371838|466085100|FG001|Overall Study|Protocol Violation|0|||
129489427|NCT01371838|466085099|FG000|Overall Study|Investigator Decision|3|||
129489428|NCT01371838|466085100|FG001|Overall Study|Investigator Decision|8|||
129489429|NCT01371838|466085099|FG000|Overall Study|Last follow-up visit not conducted|2|||
129489430|NCT01371838|466085100|FG001|Overall Study|Last follow-up visit not conducted|0|||
129489431|NCT01371838|466085099|FG000|Overall Study|Lack of therapeutic response|0|||
129489432|NCT01371838|466085100|FG001|Overall Study|Lack of therapeutic response|1|||
129489433|NCT01371838|466085099|FG000|Overall Study|Surgery|1|||
129489434|NCT01371838|466085100|FG001|Overall Study|Surgery|0|||
129489435|NCT00641043|466085101|FG000|Overall Study|Adverse Event|6|||
129489436|NCT00641043|466085102|FG001|Overall Study|Adverse Event|4|||
129489437|NCT00641043|466085101|FG000|Overall Study|Protocol Violation|2|||
129489438|NCT00641043|466085102|FG001|Overall Study|Protocol Violation|3|||
129489439|NCT00641043|466085101|FG000|Overall Study|Lost to Follow-up|3|||
129489440|NCT00641043|466085102|FG001|Overall Study|Lost to Follow-up|2|||
129489441|NCT00641043|466085101|FG000|Overall Study|Withdrawal by Subject|4|||
129489442|NCT00641043|466085102|FG001|Overall Study|Withdrawal by Subject|4|||
129489443|NCT00641043|466085101|FG000|Overall Study|Other incl. lack of efficacy|4|||
129489444|NCT00641043|466085102|FG001|Overall Study|Other incl. lack of efficacy|2|||
129489445|NCT04275310|466085103|FG000|Overall Study|Non-randomized due to running out of funding|4|||
129489446|NCT04275310|466085104|FG001|Overall Study|Non-randomized due to running out of funding|0|||
129489447|NCT04101422|466085107|FG000|Overall Study|Ineligible|1|||
129489448|NCT04101422|466085108|FG001|Overall Study|Ineligible|0|||
129489449|NCT04101422|466085109|FG002|Overall Study|Ineligible|9|||
129489450|NCT04101422|466085110|FG003|Overall Study|Ineligible|0|||
129489451|NCT04101422|466085107|FG000|Overall Study|Withdrawal by Subject|0|||
129489452|NCT04101422|466085108|FG001|Overall Study|Withdrawal by Subject|0|||
129489453|NCT04101422|466085109|FG002|Overall Study|Withdrawal by Subject|1|||
129489454|NCT04101422|466085110|FG003|Overall Study|Withdrawal by Subject|0|||
129489455|NCT04101422|466085107|FG000|Overall Study|Not attending to the stimuli|0|||
129489456|NCT04101422|466085108|FG001|Overall Study|Not attending to the stimuli|0|||
129489457|NCT04101422|466085109|FG002|Overall Study|Not attending to the stimuli|4|||
129489458|NCT04101422|466085110|FG003|Overall Study|Not attending to the stimuli|0|||
129489459|NCT04101422|466085107|FG000|Overall Study|Did not download app|0|||
129489460|NCT04101422|466085108|FG001|Overall Study|Did not download app|0|||
129489461|NCT04101422|466085109|FG002|Overall Study|Did not download app|0|||
129489462|NCT04101422|466085110|FG003|Overall Study|Did not download app|17|||
129489463|NCT04101422|466085107|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
129489464|NCT04101422|466085108|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
129489465|NCT04101422|466085109|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
129489466|NCT04101422|466085110|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
129489467|NCT01720667|466085111|FG000|Overall Study|Adverse Event|1|||
129489468|NCT01720667|466085112|FG001|Overall Study|Adverse Event|1|||
129489469|NCT01720667|466085111|FG000|Overall Study|Withdrawal by Subject|3|||
129489470|NCT01720667|466085112|FG001|Overall Study|Withdrawal by Subject|0|||
129489471|NCT03472534|466085113|FG000|Overall Study|Withdrawal by Subject|9|||
129489472|NCT03472534|466085113|FG000|Overall Study|Adverse Event|2|||
129980614|NCT01365481|467891685|FG002|Overall Study|Administrative problems|0|||
129489473|NCT00718861|466085119|FG000|Overall Study|Withdrawal by Subject|15|||
129489474|NCT00718861|466085120|FG001|Overall Study|Withdrawal by Subject|10|||
129489475|NCT00718861|466085119|FG000|Overall Study|Adverse Event|2|||
129489476|NCT00718861|466085120|FG001|Overall Study|Adverse Event|1|||
129489477|NCT00718861|466085119|FG000|Overall Study|Lost to Follow-up|2|||
129489478|NCT00718861|466085120|FG001|Overall Study|Lost to Follow-up|1|||
129489479|NCT00718861|466085119|FG000|Overall Study|Administrative Problems|1|||
129489480|NCT00718861|466085120|FG001|Overall Study|Administrative Problems|1|||
129489481|NCT00718861|466085119|FG000|Overall Study|Death|1|||
129489482|NCT00718861|466085120|FG001|Overall Study|Death|5|||
129489483|NCT01749735|466085122|FG000|Overall Study|Withdrawal by Subject|1|||
129489484|NCT01749735|466085123|FG001|Overall Study|Withdrawal by Subject|0|||
129489485|NCT00611455|466085126|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
129489486|NCT00611455|466085127|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
129489487|NCT00611455|466085128|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
129489488|NCT00611455|466085126|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
129489489|NCT00611455|466085127|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129489490|NCT00611455|466085128|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
129489491|NCT00611455|466085126|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
129489492|NCT00611455|466085127|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
129489493|NCT00611455|466085128|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
129489494|NCT00611455|466085126|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
129489495|NCT00611455|466085127|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
129489496|NCT00611455|466085128|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129489497|NCT00611455|466085126|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
129489498|NCT00611455|466085127|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
129489499|NCT00611455|466085128|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
129489500|NCT00611455|466085126|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
129489501|NCT00611455|466085127|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
129489502|NCT00611455|466085128|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
129489503|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
129489504|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
129489505|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
129489506|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
129489507|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
129489508|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
129489509|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
129489510|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
129489511|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
129489512|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
129489513|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
129489514|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
129489515|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
129489516|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
129489517|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
129489518|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
129489519|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
129489520|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
129489521|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
129489522|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
129489523|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
129489524|NCT00611455|466085126|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
129489525|NCT00611455|466085127|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
129489526|NCT00611455|466085128|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
129489527|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
129489528|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
129489529|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
129489530|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
129489531|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
129489532|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
129489533|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
129489534|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
129489535|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
129489536|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
129489537|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
129489538|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
129489539|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
129489540|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
129489541|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
129489542|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
129489543|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
129489544|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
129489545|NCT00611455|466085126|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
129489546|NCT00611455|466085127|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
129489547|NCT00611455|466085128|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
129489548|NCT04983901|466085129|FG000|Overall Study|Death|1|||
129489549|NCT04983901|466085130|FG001|Overall Study|Death|4|||
129489550|NCT04983901|466085129|FG000|Overall Study|Lost to Follow-up|3|||
129489551|NCT04983901|466085130|FG001|Overall Study|Lost to Follow-up|0|||
129489552|NCT04983901|466085129|FG000|Overall Study|Protocol Violation|1|||
129489553|NCT04983901|466085130|FG001|Overall Study|Protocol Violation|0|||
129489554|NCT04983901|466085129|FG000|Overall Study|Withdrawal by Subject|1|||
129489555|NCT04983901|466085130|FG001|Overall Study|Withdrawal by Subject|2|||
129489556|NCT03671369|466085135|FG000|Overall Study|Other|1|||
129489557|NCT03671369|466085135|FG000|Overall Study|Withdrawal by Subject|289|||
129489558|NCT03671369|466085135|FG000|Overall Study|Not willing to be vaccinated|1|||
129489559|NCT04382651|466085136|FG000|Overall Study|Death|26|||
129489560|NCT04382651|466085137|FG001|Overall Study|Death|23|||
129489561|NCT04382651|466085136|FG000|Overall Study|Lost to Follow-up|3|||
129489562|NCT04382651|466085137|FG001|Overall Study|Lost to Follow-up|4|||
129489563|NCT04382651|466085136|FG000|Overall Study|Withdrawal by Subject|2|||
129489564|NCT04382651|466085137|FG001|Overall Study|Withdrawal by Subject|0|||
129489565|NCT04382651|466085136|FG000|Overall Study|Physician Decision|0|||
129489566|NCT04382651|466085137|FG001|Overall Study|Physician Decision|1|||
129489567|NCT02732912|466085138|FG000|Overall Study|Discharged before night|2|||
129489568|NCT02732912|466085139|FG001|Overall Study|Discharged before night|6|||
129489569|NCT02732912|466085138|FG000|Overall Study|Incomplete completion of questionnaire|2|||
129489570|NCT02732912|466085139|FG001|Overall Study|Incomplete completion of questionnaire|3|||
129489571|NCT02732912|466085138|FG000|Overall Study|No outcome; discharged or refused|6|||
129489572|NCT02732912|466085139|FG001|Overall Study|No outcome; discharged or refused|9|||
129489573|NCT01507545|466085140|FG000|Overall Study|Withdrawal by Subject|6|||
129489574|NCT01507545|466085141|FG001|Overall Study|Withdrawal by Subject|2|||
129489575|NCT01507545|466085140|FG000|Overall Study|Lost to Follow-up|1|||
129489576|NCT01507545|466085141|FG001|Overall Study|Lost to Follow-up|0|||
129489577|NCT01507545|466085140|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
129489578|NCT01507545|466085141|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
129489579|NCT01507545|466085140|FG000|Overall Study|Progressive disease|60|||
129489580|NCT01507545|466085141|FG001|Overall Study|Progressive disease|27|||
129489581|NCT01507545|466085140|FG000|Overall Study|Other|6|||
129489582|NCT01507545|466085141|FG001|Overall Study|Other|4|||
129489583|NCT01873742|466085142|FG000|Overall Study|Lost to Follow-up|68|||
129489584|NCT01873742|466085143|FG001|Overall Study|Lost to Follow-up|76|||
129489585|NCT00790296|466085145|FG000|Overall Study|Did not meet study eligibility criteria|1|||
129489586|NCT00790296|466085146|FG001|Overall Study|Did not meet study eligibility criteria|1|||
129489587|NCT00790296|466085145|FG000|Overall Study|Adverse Event|0|||
129489588|NCT00790296|466085146|FG001|Overall Study|Adverse Event|1|||
129489589|NCT01671488|466085147|FG000|Overall Study|Withdrawal by Subject|1|||
129489590|NCT02612077|466085148|FG000|Overall Study|Adverse Event|3|||
129489591|NCT02612077|466085148|FG000|Overall Study|Withdrawal by Subject|9|||
129489592|NCT02612077|466085148|FG000|Overall Study|Protocol Violation|28|||
129489593|NCT02612077|466085148|FG000|Overall Study|Lost to Follow-up|20|||
129489594|NCT02612077|466085148|FG000|Overall Study|Death|377|||
129489595|NCT02612077|466085148|FG000|Overall Study|Moved or Changed Medical Team|23|||
129489596|NCT02612077|466085148|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
129489597|NCT02612077|466085148|FG000|Overall Study|Disease Progression|3|||
129489598|NCT02612077|466085148|FG000|Overall Study|Unknown reason|2|||
129489599|NCT01022853|466085149|FG000|Overall Study|Progressive disease|2|||
129489600|NCT01022853|466085150|FG001|Overall Study|Progressive disease|3|||
129489601|NCT01022853|466085151|FG002|Overall Study|Progressive disease|11|||
129489602|NCT01022853|466085152|FG003|Overall Study|Progressive disease|7|||
129489603|NCT01022853|466085153|FG004|Overall Study|Progressive disease|1|||
129489604|NCT01022853|466085149|FG000|Overall Study|Dose-limiting toxicity|0|||
129489605|NCT01022853|466085150|FG001|Overall Study|Dose-limiting toxicity|0|||
129489606|NCT01022853|466085151|FG002|Overall Study|Dose-limiting toxicity|0|||
129489607|NCT01022853|466085152|FG003|Overall Study|Dose-limiting toxicity|0|||
129980615|NCT01365481|467891686|FG003|Overall Study|Administrative problems|0|||
129980616|NCT01365481|467891683|FG000|Overall Study|Protocol deviation|0|||
129489608|NCT01022853|466085153|FG004|Overall Study|Dose-limiting toxicity|1|||
129489609|NCT01022853|466085149|FG000|Overall Study|Withdrawal by Subject|0|||
129489610|NCT01022853|466085150|FG001|Overall Study|Withdrawal by Subject|1|||
129489611|NCT01022853|466085151|FG002|Overall Study|Withdrawal by Subject|1|||
129489612|NCT01022853|466085152|FG003|Overall Study|Withdrawal by Subject|1|||
129489613|NCT01022853|466085153|FG004|Overall Study|Withdrawal by Subject|0|||
129489614|NCT01022853|466085149|FG000|Overall Study|Other not stated above|1|||
129489615|NCT01022853|466085150|FG001|Overall Study|Other not stated above|0|||
129489616|NCT01022853|466085151|FG002|Overall Study|Other not stated above|1|||
129489617|NCT01022853|466085152|FG003|Overall Study|Other not stated above|0|||
129489618|NCT01022853|466085153|FG004|Overall Study|Other not stated above|0|||
129489619|NCT01753518|466085154|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
129489620|NCT01753518|466085155|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
129489621|NCT01753518|466085154|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
129489622|NCT01753518|466085155|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
129489623|NCT01753518|466085154|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
129489624|NCT01753518|466085155|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
129489625|NCT01753518|466085154|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
129489626|NCT01753518|466085155|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
129489627|NCT01971476|466085156|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
129489628|NCT01971476|466085157|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
129489629|NCT01971476|466085158|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
129489630|NCT01971476|466085156|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
129489631|NCT01971476|466085157|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
129489632|NCT01971476|466085158|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
129489633|NCT01971476|466085156|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
129489634|NCT01971476|466085157|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
129489635|NCT01971476|466085158|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
129489636|NCT02075255|466085159|FG000|Overall Study|Study specific withdrawal criteria|0|||
129489637|NCT02075255|466085160|FG001|Overall Study|Study specific withdrawal criteria|1|||
129489638|NCT02075255|466085161|FG002|Overall Study|Study specific withdrawal criteria|1|||
129489639|NCT02075255|466085159|FG000|Overall Study|Withdrawal by Subject|4|||
129489640|NCT02075255|466085160|FG001|Overall Study|Withdrawal by Subject|1|||
129489641|NCT02075255|466085161|FG002|Overall Study|Withdrawal by Subject|0|||
129489642|NCT02075255|466085159|FG000|Overall Study|Lost to Follow-up|0|||
129489643|NCT02075255|466085160|FG001|Overall Study|Lost to Follow-up|0|||
129489644|NCT02075255|466085161|FG002|Overall Study|Lost to Follow-up|1|||
129489645|NCT02075255|466085159|FG000|Overall Study|Adverse Event|0|||
129489646|NCT02075255|466085160|FG001|Overall Study|Adverse Event|0|||
129489647|NCT02075255|466085161|FG002|Overall Study|Adverse Event|1|||
129489648|NCT02075255|466085159|FG000|Overall Study|Death|0|||
129489649|NCT02075255|466085160|FG001|Overall Study|Death|2|||
129489650|NCT02075255|466085161|FG002|Overall Study|Death|0|||
129489651|NCT01088412|466085162|FG000|Overall Study|Adverse Event|38|||
129489652|NCT01088412|466085163|FG001|Overall Study|Adverse Event|0|||
129489653|NCT01088412|466085164|FG002|Overall Study|Adverse Event|0|||
129489654|NCT01088412|466085162|FG000|Overall Study|Death|42|||
129489655|NCT01088412|466085163|FG001|Overall Study|Death|6|||
129489656|NCT01088412|466085164|FG002|Overall Study|Death|0|||
129489657|NCT01088412|466085162|FG000|Overall Study|Other Reason per Case Report Form|2089|||
129489658|NCT01088412|466085163|FG001|Overall Study|Other Reason per Case Report Form|103|||
129489659|NCT01088412|466085164|FG002|Overall Study|Other Reason per Case Report Form|9|||
129489660|NCT01088412|466085162|FG000|Overall Study|Withdrawal by Subject|1761|||
129489661|NCT01088412|466085163|FG001|Overall Study|Withdrawal by Subject|25|||
129489662|NCT01088412|466085164|FG002|Overall Study|Withdrawal by Subject|1|||
129489663|NCT01088412|466085162|FG000|Overall Study|Received Another GH Product|79|||
129489664|NCT01088412|466085163|FG001|Overall Study|Received Another GH Product|0|||
129489665|NCT01088412|466085164|FG002|Overall Study|Received Another GH Product|0|||
129489666|NCT01088412|466085162|FG000|Overall Study|Participant Moved|601|||
129489667|NCT01088412|466085163|FG001|Overall Study|Participant Moved|21|||
129489668|NCT01088412|466085164|FG002|Overall Study|Participant Moved|2|||
129489669|NCT01088412|466085162|FG000|Overall Study|Physician Decision|1041|||
129489670|NCT01088412|466085163|FG001|Overall Study|Physician Decision|8|||
129489671|NCT01088412|466085164|FG002|Overall Study|Physician Decision|4|||
129489672|NCT01088412|466085162|FG000|Overall Study|Sponsor Decision|4467|||
129489673|NCT01088412|466085163|FG001|Overall Study|Sponsor Decision|79|||
129489674|NCT01088412|466085164|FG002|Overall Study|Sponsor Decision|23|||
129489675|NCT01088412|466085162|FG000|Overall Study|Third Party Required to Change Brand|487|||
129489676|NCT01088412|466085163|FG001|Overall Study|Third Party Required to Change Brand|0|||
129489677|NCT01088412|466085164|FG002|Overall Study|Third Party Required to Change Brand|0|||
129489678|NCT01088412|466085162|FG000|Overall Study|Lost to Follow-up|3052|||
129489679|NCT01088412|466085163|FG001|Overall Study|Lost to Follow-up|130|||
129489680|NCT01088412|466085164|FG002|Overall Study|Lost to Follow-up|11|||
129489681|NCT01088412|466085162|FG000|Overall Study|Study Summary Not Completed|4360|||
129489682|NCT01088412|466085163|FG001|Overall Study|Study Summary Not Completed|64|||
129489683|NCT01088412|466085164|FG002|Overall Study|Study Summary Not Completed|22|||
129489684|NCT01208181|466085166|FG000|Part 1|Withdrawal by Subject|11|||
129489685|NCT01208181|466085167|FG001|Part 1|Withdrawal by Subject|10|||
129489686|NCT01208181|466085168|FG002|Part 1|Withdrawal by Subject|0|||
129489687|NCT01208181|466085169|FG003|Part 1|Withdrawal by Subject|0|||
129489688|NCT01208181|466085170|FG004|Part 1|Withdrawal by Subject|0|||
129489689|NCT01208181|466085166|FG000|Part 1|Technical problem|5|||
129489690|NCT01208181|466085167|FG001|Part 1|Technical problem|0|||
129489691|NCT01208181|466085168|FG002|Part 1|Technical problem|0|||
129489692|NCT01208181|466085169|FG003|Part 1|Technical problem|0|||
129489693|NCT01208181|466085170|FG004|Part 1|Technical problem|0|||
129489694|NCT01208181|466085166|FG000|Part 1|Protocol Violation|10|||
129489695|NCT01208181|466085167|FG001|Part 1|Protocol Violation|5|||
129489696|NCT01208181|466085168|FG002|Part 1|Protocol Violation|0|||
129489697|NCT01208181|466085169|FG003|Part 1|Protocol Violation|0|||
129489698|NCT01208181|466085170|FG004|Part 1|Protocol Violation|0|||
129489699|NCT01208181|466085166|FG000|Part 1|Physician Decision|4|||
129489700|NCT01208181|466085167|FG001|Part 1|Physician Decision|0|||
129489701|NCT01208181|466085168|FG002|Part 1|Physician Decision|0|||
129489702|NCT01208181|466085169|FG003|Part 1|Physician Decision|0|||
129489703|NCT01208181|466085170|FG004|Part 1|Physician Decision|0|||
129489704|NCT01208181|466085166|FG000|Part 1|Non-compliance with study drug|1|||
129489705|NCT01208181|466085167|FG001|Part 1|Non-compliance with study drug|1|||
129489706|NCT01208181|466085168|FG002|Part 1|Non-compliance with study drug|0|||
129489707|NCT01208181|466085169|FG003|Part 1|Non-compliance with study drug|0|||
129489708|NCT01208181|466085170|FG004|Part 1|Non-compliance with study drug|0|||
129489709|NCT01208181|466085166|FG000|Part 1|Lost to Follow-up|5|||
129489710|NCT01208181|466085167|FG001|Part 1|Lost to Follow-up|3|||
129489711|NCT01208181|466085168|FG002|Part 1|Lost to Follow-up|0|||
129489712|NCT01208181|466085169|FG003|Part 1|Lost to Follow-up|0|||
129489713|NCT01208181|466085170|FG004|Part 1|Lost to Follow-up|1|||
129489714|NCT01208181|466085166|FG000|Part 1|Lack of Efficacy|37|||
129489715|NCT01208181|466085167|FG001|Part 1|Lack of Efficacy|12|||
129489716|NCT01208181|466085168|FG002|Part 1|Lack of Efficacy|0|||
129489717|NCT01208181|466085169|FG003|Part 1|Lack of Efficacy|0|||
129489718|NCT01208181|466085170|FG004|Part 1|Lack of Efficacy|17|||
129489719|NCT01208181|466085166|FG000|Part 1|Adverse Event|26|||
129489720|NCT01208181|466085167|FG001|Part 1|Adverse Event|24|||
129489721|NCT01208181|466085168|FG002|Part 1|Adverse Event|0|||
129489722|NCT01208181|466085169|FG003|Part 1|Adverse Event|0|||
129489723|NCT01208181|466085170|FG004|Part 1|Adverse Event|4|||
129489724|NCT01208181|466085166|FG000|Part 2|Adverse Event|0|||
129489725|NCT01208181|466085167|FG001|Part 2|Adverse Event|0|||
129489726|NCT01208181|466085168|FG002|Part 2|Adverse Event|6|||
129489727|NCT01208181|466085169|FG003|Part 2|Adverse Event|7|||
129489728|NCT01208181|466085170|FG004|Part 2|Adverse Event|0|||
129489729|NCT01208181|466085166|FG000|Part 2|Withdrawal by Subject|0|||
129489730|NCT01208181|466085167|FG001|Part 2|Withdrawal by Subject|0|||
129489731|NCT01208181|466085168|FG002|Part 2|Withdrawal by Subject|1|||
129489732|NCT01208181|466085169|FG003|Part 2|Withdrawal by Subject|1|||
129489733|NCT01208181|466085170|FG004|Part 2|Withdrawal by Subject|0|||
129489734|NCT01208181|466085166|FG000|Part 2|Protocol Violation|0|||
129489735|NCT01208181|466085167|FG001|Part 2|Protocol Violation|0|||
129489736|NCT01208181|466085168|FG002|Part 2|Protocol Violation|1|||
129489737|NCT01208181|466085169|FG003|Part 2|Protocol Violation|0|||
129489738|NCT01208181|466085170|FG004|Part 2|Protocol Violation|0|||
129489739|NCT01208181|466085166|FG000|Part 2|Physician Decision|0|||
129489740|NCT01208181|466085167|FG001|Part 2|Physician Decision|0|||
129489741|NCT01208181|466085168|FG002|Part 2|Physician Decision|1|||
129489742|NCT01208181|466085169|FG003|Part 2|Physician Decision|2|||
129489743|NCT01208181|466085170|FG004|Part 2|Physician Decision|0|||
129489744|NCT01208181|466085166|FG000|Part 2|Non-compliance with study drug|0|||
129489745|NCT01208181|466085167|FG001|Part 2|Non-compliance with study drug|0|||
129489746|NCT01208181|466085168|FG002|Part 2|Non-compliance with study drug|1|||
129489747|NCT01208181|466085169|FG003|Part 2|Non-compliance with study drug|1|||
129489748|NCT01208181|466085170|FG004|Part 2|Non-compliance with study drug|0|||
129489749|NCT01208181|466085166|FG000|Part 2|Lost to Follow-up|0|||
129489750|NCT01208181|466085167|FG001|Part 2|Lost to Follow-up|0|||
129489751|NCT01208181|466085168|FG002|Part 2|Lost to Follow-up|1|||
129489752|NCT01208181|466085169|FG003|Part 2|Lost to Follow-up|2|||
129489753|NCT01208181|466085170|FG004|Part 2|Lost to Follow-up|0|||
129489754|NCT01208181|466085166|FG000|Part 2|Lack of Efficacy|0|||
129489755|NCT01208181|466085167|FG001|Part 2|Lack of Efficacy|0|||
129489756|NCT01208181|466085168|FG002|Part 2|Lack of Efficacy|5|||
129489757|NCT01208181|466085169|FG003|Part 2|Lack of Efficacy|7|||
129489758|NCT01208181|466085170|FG004|Part 2|Lack of Efficacy|0|||
129489759|NCT00942708|466085171|FG000|Overall Study|Withdrawal by Subject|1|||
129489760|NCT01426386|466085176|FG000|Overall Study|Adverse Event|0|||
129489761|NCT01426386|466085177|FG001|Overall Study|Adverse Event|1|||
129489762|NCT01426386|466085178|FG002|Overall Study|Adverse Event|0|||
129489763|NCT01426386|466085179|FG003|Overall Study|Adverse Event|0|||
129489764|NCT01426386|466085180|FG004|Overall Study|Adverse Event|0|||
129489765|NCT01426386|466085181|FG005|Overall Study|Adverse Event|0|||
129489766|NCT01426386|466085176|FG000|Overall Study|Did not attend scheduled visit|1|||
129489767|NCT01426386|466085177|FG001|Overall Study|Did not attend scheduled visit|4|||
129489768|NCT01426386|466085178|FG002|Overall Study|Did not attend scheduled visit|0|||
129980617|NCT01365481|467891684|FG001|Overall Study|Protocol deviation|1|||
129489769|NCT01426386|466085179|FG003|Overall Study|Did not attend scheduled visit|0|||
129489770|NCT01426386|466085180|FG004|Overall Study|Did not attend scheduled visit|2|||
129489771|NCT01426386|466085181|FG005|Overall Study|Did not attend scheduled visit|1|||
129489772|NCT01426386|466085176|FG000|Overall Study|Poor response|2|||
129980618|NCT01365481|467891685|FG002|Overall Study|Protocol deviation|0|||
129489773|NCT01426386|466085177|FG001|Overall Study|Poor response|1|||
129489774|NCT01426386|466085178|FG002|Overall Study|Poor response|2|||
129489775|NCT01426386|466085179|FG003|Overall Study|Poor response|0|||
129489776|NCT01426386|466085180|FG004|Overall Study|Poor response|1|||
129489777|NCT01426386|466085181|FG005|Overall Study|Poor response|0|||
129489778|NCT01426386|466085176|FG000|Overall Study|Personal reasons|0|||
129489779|NCT01426386|466085177|FG001|Overall Study|Personal reasons|0|||
129489780|NCT01426386|466085178|FG002|Overall Study|Personal reasons|0|||
129489781|NCT01426386|466085179|FG003|Overall Study|Personal reasons|0|||
129489782|NCT01426386|466085180|FG004|Overall Study|Personal reasons|1|||
129489783|NCT01426386|466085181|FG005|Overall Study|Personal reasons|0|||
129489784|NCT01457339|466085182|FG000|Period 3 (100 mg)|Adverse Event|0|||
129489785|NCT01457339|466085183|FG001|Period 3 (100 mg)|Adverse Event|1|||
129489786|NCT01457339|466085182|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
129489787|NCT01457339|466085183|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
129489788|NCT01457339|466085182|FG000|Period 6 (250 mg)|Family Emergency|1|||
129489789|NCT01457339|466085183|FG001|Period 6 (250 mg)|Family Emergency|0|||
129489790|NCT01457339|466085182|FG000|Period 6 (250 mg)|Personal appointment|0|||
129489791|NCT01457339|466085183|FG001|Period 6 (250 mg)|Personal appointment|1|||
129489792|NCT01096667|466085184|FG000|Overall Study|Lost to Follow-up|1|||
129489793|NCT01096667|466085185|FG001|Overall Study|Lost to Follow-up|1|||
129489794|NCT01096667|466085186|FG002|Overall Study|Lost to Follow-up|1|||
129489795|NCT01096667|466085187|FG003|Overall Study|Lost to Follow-up|0|||
129489796|NCT01096667|466085188|FG004|Overall Study|Lost to Follow-up|0|||
129489797|NCT01096667|466085184|FG000|Overall Study|Withdrawal by Subject|1|||
129489798|NCT01096667|466085185|FG001|Overall Study|Withdrawal by Subject|0|||
129489799|NCT01096667|466085186|FG002|Overall Study|Withdrawal by Subject|0|||
129489800|NCT01096667|466085187|FG003|Overall Study|Withdrawal by Subject|1|||
129489801|NCT01096667|466085188|FG004|Overall Study|Withdrawal by Subject|0|||
129489802|NCT01096667|466085184|FG000|Overall Study|Reason not available|0|||
129489803|NCT01096667|466085185|FG001|Overall Study|Reason not available|1|||
129489804|NCT01096667|466085186|FG002|Overall Study|Reason not available|1|||
129489805|NCT01096667|466085187|FG003|Overall Study|Reason not available|1|||
129489806|NCT01096667|466085188|FG004|Overall Study|Reason not available|0|||
129489807|NCT01096667|466085184|FG000|Overall Study|Protocol Violation|0|||
129489808|NCT01096667|466085185|FG001|Overall Study|Protocol Violation|0|||
129489809|NCT01096667|466085186|FG002|Overall Study|Protocol Violation|0|||
129489810|NCT01096667|466085187|FG003|Overall Study|Protocol Violation|1|||
129489811|NCT01096667|466085188|FG004|Overall Study|Protocol Violation|0|||
129489812|NCT01096667|466085184|FG000|Overall Study|Not treated|1|||
129489813|NCT01096667|466085185|FG001|Overall Study|Not treated|0|||
129489814|NCT01096667|466085186|FG002|Overall Study|Not treated|0|||
129489815|NCT01096667|466085187|FG003|Overall Study|Not treated|0|||
129489816|NCT01096667|466085188|FG004|Overall Study|Not treated|0|||
129489817|NCT01751646|466085189|FG000|Overall Study|Lost to Follow-up|5|||
129489818|NCT01751646|466085190|FG001|Overall Study|Lost to Follow-up|1|||
129489819|NCT01751646|466085189|FG000|Overall Study|Withdrawal by Subject|0|||
129489820|NCT01751646|466085190|FG001|Overall Study|Withdrawal by Subject|4|||
129489821|NCT01751646|466085189|FG000|Overall Study|Starting hormone therapy|1|||
129489822|NCT01751646|466085190|FG001|Overall Study|Starting hormone therapy|0|||
129489823|NCT01751646|466085189|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
129489824|NCT01751646|466085190|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
129489825|NCT01751646|466085189|FG000|Overall Study|Inadvertent enrollment|1|||
129489826|NCT01751646|466085190|FG001|Overall Study|Inadvertent enrollment|1|||
129489827|NCT01751646|466085189|FG000|Overall Study|Moved out of the area|1|||
129489828|NCT01751646|466085190|FG001|Overall Study|Moved out of the area|5|||
129489829|NCT01751646|466085189|FG000|Overall Study|Inability to attend required visits|0|||
129489830|NCT01751646|466085190|FG001|Overall Study|Inability to attend required visits|1|||
129489831|NCT01751646|466085189|FG000|Overall Study|Off study due to multiple obligations|0|||
129489832|NCT01751646|466085190|FG001|Overall Study|Off study due to multiple obligations|1|||
129489833|NCT01751646|466085189|FG000|Overall Study|Fails to comply with study requirements|0|||
129489834|NCT01751646|466085190|FG001|Overall Study|Fails to comply with study requirements|1|||
129489835|NCT01751646|466085189|FG000|Overall Study|Childcare issues|1|||
129489836|NCT01751646|466085190|FG001|Overall Study|Childcare issues|1|||
129489837|NCT02335450|466085191|FG000|Overall Study|Pregnancy|1|||
129489838|NCT02613572|466085192|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
129489839|NCT02613572|466085193|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
129489840|NCT02613572|466085194|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
129489841|NCT02613572|466085192|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
129489842|NCT02613572|466085193|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
129489843|NCT02613572|466085194|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
129489844|NCT04542291|466085195|FG000|Overall Study|Adverse Event|1|||
129489845|NCT04542291|466085195|FG000|Overall Study|Physician Decision|2|||
129489846|NCT00853905|466085196|FG000|Overall Study|Lost to Follow-up|1|||
129489847|NCT00853905|466085197|FG001|Overall Study|Lost to Follow-up|3|||
129489848|NCT00853905|466085196|FG000|Overall Study|Withdrawal by Subject|0|||
129489849|NCT00853905|466085197|FG001|Overall Study|Withdrawal by Subject|1|||
129489850|NCT00853905|466085196|FG000|Overall Study|never had surgery|1|||
129489851|NCT00853905|466085197|FG001|Overall Study|never had surgery|0|||
129489852|NCT00970294|466085200|FG000|Overall Study|Physician Decision|4|||
129489853|NCT00970294|466085200|FG000|Overall Study|Withdrawal by Subject|1|||
129489854|NCT00847561|466085201|FG000|Overall Study|Withdrawal by Subject|4|||
129489855|NCT00847561|466085202|FG001|Overall Study|Withdrawal by Subject|3|||
129980619|NCT01365481|467891686|FG003|Overall Study|Protocol deviation|1|||
129489856|NCT00847561|466085201|FG000|Overall Study|Unable to schedule|9|||
129489857|NCT00847561|466085202|FG001|Overall Study|Unable to schedule|1|||
129489858|NCT01333189|466085203|FG000|Overall Study|Time constraints|1|||
129980620|NCT01365481|467891683|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129489859|NCT01333189|466085204|FG001|Overall Study|Time constraints|0|||
129489860|NCT01333189|466085203|FG000|Overall Study|Adverse Event|1|||
129489861|NCT01333189|466085204|FG001|Overall Study|Adverse Event|0|||
129489862|NCT01333189|466085203|FG000|Overall Study|Transportation difficulties|0|||
129489863|NCT01333189|466085204|FG001|Overall Study|Transportation difficulties|1|||
129489864|NCT01333189|466085203|FG000|Overall Study|Moved from region|0|||
129489865|NCT01333189|466085204|FG001|Overall Study|Moved from region|1|||
129489866|NCT00465738|466085206|FG000|Overall Study|Lost to Follow-up|2|||
129489867|NCT00465738|466085207|FG001|Overall Study|Lost to Follow-up|0|||
129489868|NCT00465738|466085206|FG000|Overall Study|Adverse Event|0|||
129489869|NCT00465738|466085207|FG001|Overall Study|Adverse Event|1|||
129489870|NCT00465738|466085206|FG000|Overall Study|Withdrawal by Subject|2|||
129489871|NCT00465738|466085207|FG001|Overall Study|Withdrawal by Subject|0|||
129489872|NCT00465738|466085206|FG000|Overall Study|Other|2|||
129489873|NCT00465738|466085207|FG001|Overall Study|Other|5|||
129489874|NCT04799782|466085210|FG000|Washout|Physician Decision|2|||
129489875|NCT04799782|466085211|FG001|Washout|Physician Decision|0|||
129489876|NCT04799782|466085210|FG000|Washout|Withdrawal by Subject|0|||
129489877|NCT04799782|466085211|FG001|Washout|Withdrawal by Subject|2|||
129489878|NCT04799782|466085210|FG000|Washout|Lost to Follow-up|0|||
129489879|NCT04799782|466085211|FG001|Washout|Lost to Follow-up|1|||
129489880|NCT01318902|466085222|FG000|Overall Study|Symptomatic Deterioration|0|||
129489881|NCT01318902|466085223|FG001|Overall Study|Symptomatic Deterioration|1|||
129489882|NCT01318902|466085224|FG002|Overall Study|Symptomatic Deterioration|1|||
129489883|NCT01318902|466085225|FG003|Overall Study|Symptomatic Deterioration|2|||
129489884|NCT01318902|466085222|FG000|Overall Study|Withdrawal by Patient|0|||
129489885|NCT01318902|466085223|FG001|Overall Study|Withdrawal by Patient|1|||
129489886|NCT01318902|466085224|FG002|Overall Study|Withdrawal by Patient|0|||
129489887|NCT01318902|466085225|FG003|Overall Study|Withdrawal by Patient|3|||
129489888|NCT01318902|466085222|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
129489889|NCT01318902|466085223|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
129489890|NCT01318902|466085224|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
129489891|NCT01318902|466085225|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
129489892|NCT01318902|466085222|FG000|Overall Study|Adverse Event|0|||
129489893|NCT01318902|466085223|FG001|Overall Study|Adverse Event|1|||
129489894|NCT01318902|466085224|FG002|Overall Study|Adverse Event|0|||
129489895|NCT01318902|466085225|FG003|Overall Study|Adverse Event|0|||
129489896|NCT01318902|466085222|FG000|Overall Study|Terminated by Sponsor|0|||
129489897|NCT01318902|466085223|FG001|Overall Study|Terminated by Sponsor|0|||
129489898|NCT01318902|466085224|FG002|Overall Study|Terminated by Sponsor|1|||
129489899|NCT01318902|466085225|FG003|Overall Study|Terminated by Sponsor|0|||
129489900|NCT05243550|466086518|FG000|Overall Study|Ongoing in the Study|171|||
129489901|NCT05243550|466086518|FG000|Overall Study|Withdrawal by Subject|10|||
129489902|NCT05243550|466086518|FG000|Overall Study|Lost to Follow-up|7|||
129489903|NCT05243550|466086518|FG000|Overall Study|Adverse Event|3|||
129489904|NCT05243550|466086518|FG000|Overall Study|Noncompliance|1|||
129489905|NCT05243550|466086518|FG000|Overall Study|Physician Decision|1|||
129489906|NCT05243550|466086518|FG000|Overall Study|Other Reason|4|||
129489907|NCT02452970|466086527|FG000|Overall Study|Adverse Event|1|||
129489908|NCT00893113|466086528|FG000|Overall Study|Lost to Follow-up|4|||
129489909|NCT00893113|466086529|FG001|Overall Study|Lost to Follow-up|8|||
129489910|NCT00893113|466086528|FG000|Overall Study|Early Termination|1|||
129489911|NCT00893113|466086529|FG001|Overall Study|Early Termination|1|||
129489912|NCT00893113|466086528|FG000|Overall Study|Withdrew Consent|8|||
129489913|NCT00893113|466086529|FG001|Overall Study|Withdrew Consent|7|||
129489914|NCT00128206|466086538|FG000|Overall Study|Lost to Follow-up|137|||
129489915|NCT00128206|466086539|FG001|Overall Study|Lost to Follow-up|118|||
129489916|NCT00128206|466086538|FG000|Overall Study|Adverse Event|0|||
129489917|NCT00128206|466086539|FG001|Overall Study|Adverse Event|2|||
129489918|NCT03270085|466086540|FG000|Overall Study|Withdrawal by Subject|1|||
129489919|NCT03270085|466086541|FG001|Overall Study|Withdrawal by Subject|0|||
129489920|NCT01269125|466086542|FG000|Overall Study|Adverse Event|3|||
129489921|NCT01269125|466086543|FG001|Overall Study|Adverse Event|5|||
129489922|NCT01269125|466086544|FG002|Overall Study|Adverse Event|0|||
129489923|NCT01269125|466086542|FG000|Overall Study|Lost to Follow-up|4|||
129489924|NCT01269125|466086543|FG001|Overall Study|Lost to Follow-up|0|||
129489925|NCT01269125|466086544|FG002|Overall Study|Lost to Follow-up|0|||
129489926|NCT01040832|466086546|FG000|Overall Study|Adverse Event|4|||
129489927|NCT01040832|466086547|FG001|Overall Study|Adverse Event|5|||
129489928|NCT01040832|466086546|FG000|Overall Study|Death|4|||
129489929|NCT01040832|466086547|FG001|Overall Study|Death|6|||
129489930|NCT01040832|466086546|FG000|Overall Study|Withdrawal by Subject|2|||
129489931|NCT01040832|466086547|FG001|Overall Study|Withdrawal by Subject|3|||
129489932|NCT01040832|466086546|FG000|Overall Study|Progressive disease|32|||
129489933|NCT01040832|466086547|FG001|Overall Study|Progressive disease|17|||
129489934|NCT01040832|466086546|FG000|Overall Study|Symptomatic deterioration|2|||
129489935|NCT01040832|466086547|FG001|Overall Study|Symptomatic deterioration|5|||
129489936|NCT01040832|466086546|FG000|Overall Study|Other|2|||
129489937|NCT01040832|466086547|FG001|Overall Study|Other|1|||
129489938|NCT01283581|466086549|FG000|Overall Study|Lost to Follow-up|8|||
129489939|NCT01283581|466086550|FG001|Overall Study|Lost to Follow-up|6|||
129489940|NCT01283581|466086551|FG002|Overall Study|Lost to Follow-up|8|||
129489941|NCT01283581|466086549|FG000|Overall Study|Withdrawal by Subject|2|||
129489942|NCT01283581|466086550|FG001|Overall Study|Withdrawal by Subject|5|||
129489943|NCT01283581|466086551|FG002|Overall Study|Withdrawal by Subject|2|||
129489944|NCT01283581|466086549|FG000|Overall Study|Adverse Event|1|||
129489945|NCT01283581|466086550|FG001|Overall Study|Adverse Event|1|||
129489946|NCT01283581|466086551|FG002|Overall Study|Adverse Event|4|||
129489947|NCT01283581|466086549|FG000|Overall Study|Physician Decision|0|||
129489948|NCT01283581|466086550|FG001|Overall Study|Physician Decision|1|||
129489949|NCT01283581|466086551|FG002|Overall Study|Physician Decision|2|||
129489950|NCT01283581|466086549|FG000|Overall Study|Protocol Violation|0|||
129489951|NCT01283581|466086550|FG001|Overall Study|Protocol Violation|1|||
129489952|NCT01283581|466086551|FG002|Overall Study|Protocol Violation|2|||
129489953|NCT01283581|466086549|FG000|Overall Study|Noncompliance|1|||
129489954|NCT01283581|466086550|FG001|Overall Study|Noncompliance|0|||
129489955|NCT01283581|466086551|FG002|Overall Study|Noncompliance|0|||
129489956|NCT01283581|466086549|FG000|Overall Study|Investigator unblinded|0|||
129489957|NCT01283581|466086550|FG001|Overall Study|Investigator unblinded|0|||
129489958|NCT01283581|466086551|FG002|Overall Study|Investigator unblinded|1|||
129489959|NCT01283581|466086549|FG000|Overall Study|"Early termination"|0|||
129489960|NCT01283581|466086550|FG001|Overall Study|"Early termination"|0|||
129489961|NCT01283581|466086551|FG002|Overall Study|"Early termination"|1|||
129489962|NCT01058369|466086557|FG000|Overall Study|Adverse Event|1|||
129489963|NCT01058369|466086557|FG000|Overall Study|Early termination study|1|||
129489964|NCT02940886|466086558|FG000|Overall Study|Adverse Event|7|||
129489965|NCT02940886|466086559|FG001|Overall Study|Adverse Event|3|||
129489966|NCT02940886|466086558|FG000|Overall Study|Protocol Violation|0|||
129489967|NCT02940886|466086559|FG001|Overall Study|Protocol Violation|2|||
129489968|NCT02940886|466086558|FG000|Overall Study|Withdrawal by Subject|28|||
129489969|NCT02940886|466086559|FG001|Overall Study|Withdrawal by Subject|20|||
129489970|NCT02940886|466086558|FG000|Overall Study|Death|1|||
129489971|NCT02940886|466086559|FG001|Overall Study|Death|0|||
129489972|NCT02940886|466086558|FG000|Overall Study|Lack of Efficacy|1|||
129489973|NCT02940886|466086559|FG001|Overall Study|Lack of Efficacy|0|||
129489974|NCT02940886|466086558|FG000|Overall Study|Lost to Follow-up|49|||
129489975|NCT02940886|466086559|FG001|Overall Study|Lost to Follow-up|21|||
129489976|NCT02940886|466086558|FG000|Overall Study|Physician Decision|9|||
129489977|NCT02940886|466086559|FG001|Overall Study|Physician Decision|4|||
129489978|NCT02940886|466086558|FG000|Overall Study|Sponsor decision|0|||
129489979|NCT02940886|466086559|FG001|Overall Study|Sponsor decision|1|||
129489980|NCT02940886|466086558|FG000|Overall Study|No treatment|7|||
129489981|NCT02940886|466086559|FG001|Overall Study|No treatment|2|||
129489982|NCT02940886|466086558|FG000|Overall Study|Enrolment error|0|||
129489983|NCT02940886|466086559|FG001|Overall Study|Enrolment error|1|||
129489984|NCT01306058|466086561|FG000|Overall Study|Death|1|||
129489985|NCT01306058|466086561|FG000|Overall Study|Enrolled but did not get treatment|1|||
129489986|NCT01666444|466086562|FG000|Overall Study|Did not initiate treatment|2|||
129489987|NCT01666444|466086563|FG001|Overall Study|Did not initiate treatment|1|||
129489988|NCT00592358|466086566|FG000|Overall Study|Withdrawal by Subject|2|||
129489989|NCT00592358|466086566|FG000|Overall Study|Adverse Event|1|||
129489990|NCT00592358|466086566|FG000|Overall Study|Lack of Efficacy|2|||
129489991|NCT00592358|466086566|FG000|Overall Study|Inability to swallow pills|1|||
129489992|NCT00084682|466086567|FG000|Overall Study|Withdrawal by Subject|1|||
129489993|NCT02241512|466086575|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
129489994|NCT02241512|466086576|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
129489995|NCT00474630|466086579|FG000|Overall Study|Adverse Event|98|||
129489996|NCT00474630|466086580|FG001|Overall Study|Adverse Event|26|||
129489997|NCT00474630|466086579|FG000|Overall Study|Lost to Follow-up|22|||
129489998|NCT00474630|466086580|FG001|Overall Study|Lost to Follow-up|15|||
129489999|NCT00474630|466086579|FG000|Overall Study|Withdrawal by Subject|21|||
129490000|NCT00474630|466086580|FG001|Overall Study|Withdrawal by Subject|15|||
129490001|NCT00474630|466086579|FG000|Overall Study|Protocol Violation|3|||
129490002|NCT00474630|466086580|FG001|Overall Study|Protocol Violation|4|||
129490003|NCT00474630|466086579|FG000|Overall Study|Lack of Efficacy|5|||
129490004|NCT00474630|466086580|FG001|Overall Study|Lack of Efficacy|6|||
129490005|NCT00474630|466086579|FG000|Overall Study|Drug noncompliance, other|11|||
129490006|NCT00474630|466086580|FG001|Overall Study|Drug noncompliance, other|4|||
129490007|NCT03088605|466086581|FG000|Overall Study|Withdrawal by Subject|1|||
129490008|NCT03088605|466086582|FG001|Overall Study|Withdrawal by Subject|0|||
129490009|NCT02225223|466086583|FG000|Overall Study|Death|10|||
129490010|NCT02225223|466086584|FG001|Overall Study|Death|1|||
129490011|NCT02225223|466086583|FG000|Overall Study|Lost to Follow-up|5|||
129490012|NCT02225223|466086584|FG001|Overall Study|Lost to Follow-up|0|||
129490013|NCT02225223|466086583|FG000|Overall Study|Other|1|||
129490014|NCT02225223|466086584|FG001|Overall Study|Other|2|||
129490015|NCT02225223|466086583|FG000|Overall Study|Physician Decision|1|||
129490016|NCT02225223|466086584|FG001|Overall Study|Physician Decision|0|||
129490017|NCT02225223|466086583|FG000|Overall Study|Withdrawal by Subject|2|||
129490018|NCT02225223|466086584|FG001|Overall Study|Withdrawal by Subject|2|||
129490019|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
129490020|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
129490021|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
129490022|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
129490023|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
129490024|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
129490025|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
129490026|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
129490027|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
129490028|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
129490029|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
129490030|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
129490031|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
129490032|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
129490033|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
129490034|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
129490035|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
129490036|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
129490037|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
129490038|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
129490039|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
129490040|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
129490041|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
129490042|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
129490043|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
129490044|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
129490045|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
129490046|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
129490047|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
129490048|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
129490049|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
129490050|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
129490051|NCT00958568|466086586|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
129490052|NCT00958568|466086587|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
129490053|NCT00958568|466086588|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
129490054|NCT00958568|466086589|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
129490055|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
129490056|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
129490057|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
129490058|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
129490059|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
129490060|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
129490061|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
129490062|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
129490063|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
129490064|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
129490065|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
129980621|NCT01365481|467891684|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129980622|NCT01365481|467891685|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
129980623|NCT01365481|467891686|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
129980624|NCT01641159|467891689|FG000|Overall Study|Lost to Follow-up|2|||
129980625|NCT01641159|467891690|FG001|Overall Study|Lost to Follow-up|1|||
129980626|NCT01641159|467891689|FG000|Overall Study|Withdrawal by Subject|0|||
129980627|NCT01641159|467891690|FG001|Overall Study|Withdrawal by Subject|1|||
129980628|NCT00831129|467891694|FG000|Overall Study|Adverse Event|0|||
129980629|NCT00831129|467891695|FG001|Overall Study|Adverse Event|1|||
129980630|NCT00831129|467891694|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
129980631|NCT00831129|467891695|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
129980632|NCT01214642|467891696|FG000|Overall Study|Progressive Disease|3|||
129980633|NCT01214642|467891697|FG001|Overall Study|Progressive Disease|2|||
129490066|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
129490067|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
129490068|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
129490069|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
129538479|NCT05664672|466262108|FG001|Overall Study|Adverse Event|0|||
129980634|NCT01214642|467891698|FG002|Overall Study|Progressive Disease|3|||
129490070|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
129490071|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
129490072|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
129490073|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
129490074|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
129490075|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
129490076|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
129490077|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
129490078|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
129490079|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
129490080|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
129490081|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
129490082|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
129490083|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
129490084|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
129490085|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
129490086|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
129490087|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
129490088|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
129490089|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
129490090|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
129490091|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
129490092|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
129490093|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
129490094|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
129490095|NCT00958568|466086586|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
129490096|NCT00958568|466086587|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
129490097|NCT00958568|466086588|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
129490098|NCT00958568|466086589|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
129490099|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
129490100|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
129490101|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
129490102|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
129490103|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
129490104|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
129490105|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
129490106|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
129490107|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
129490108|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
129490109|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
129490110|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
129490111|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
129490112|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
129490113|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
129490114|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
129490115|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
129490116|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
129490117|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
129490118|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
129490119|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
129490120|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
129490121|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
129490122|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
129490123|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
129490124|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
129490125|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
129490126|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
129490127|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
129490128|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
129490129|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
129490130|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
129490131|NCT00958568|466086586|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
129490132|NCT00958568|466086587|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
129490133|NCT00958568|466086588|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
129490134|NCT00958568|466086589|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
129490135|NCT01936649|466086600|FG000|Overall Study|Withdrawal by Subject|4|||
129490136|NCT01936649|466086600|FG000|Overall Study|Physician Decision|2|||
129490137|NCT01936649|466086600|FG000|Overall Study|Protocol Violation|2|||
129490138|NCT01936649|466086600|FG000|Overall Study|Other than specified above|5|||
129490139|NCT04655586|466086607|FG000|Overall Study|Physician Decision|1|||
129490140|NCT04655586|466086608|FG001|Overall Study|Physician Decision|3|||
129490141|NCT04655586|466086609|FG002|Overall Study|Physician Decision|4|||
129490142|NCT04655586|466086607|FG000|Overall Study|Withdrawal by Subject|1|||
129490143|NCT04655586|466086608|FG001|Overall Study|Withdrawal by Subject|3|||
129490144|NCT04655586|466086609|FG002|Overall Study|Withdrawal by Subject|1|||
129490145|NCT02927171|466086616|FG000|Overall Study|Lost to Follow-up|0|||
129490146|NCT02927171|466086617|FG001|Overall Study|Lost to Follow-up|1|||
129490147|NCT00552305|466086623|FG000|Overall Study|Adverse Event|43|||
129490148|NCT00552305|466086623|FG000|Overall Study|Lack of Efficacy|120|||
129490149|NCT00552305|466086623|FG000|Overall Study|Lost to Follow-up|4|||
129490150|NCT00552305|466086623|FG000|Overall Study|Protocol Violation|3|||
129490151|NCT00552305|466086623|FG000|Overall Study|Withdrawal by Subject|44|||
129490152|NCT00552305|466086623|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
129490153|NCT00552305|466086623|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
129490154|NCT00552305|466086623|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
129490155|NCT00552305|466086623|FG000|Overall Study|Unsatisfactory compliance|11|||
129490156|NCT00552305|466086623|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
129490157|NCT00552305|466086623|FG000|Overall Study|AE/Other: prohibited drug required|1|||
129490158|NCT00552305|466086623|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
129490159|NCT00552305|466086623|FG000|Overall Study|Other: Site closed|4|||
129490160|NCT00552305|466086623|FG000|Overall Study|Other: Personal problems|1|||
129490161|NCT00552305|466086623|FG000|Overall Study|Other: Unable to attend visits|1|||
129490162|NCT00552305|466086623|FG000|Overall Study|Other: Subject underwent surgery|4|||
129490163|NCT00552305|466086623|FG000|Overall Study|Other: Subject became pregnant|1|||
129490164|NCT00552305|466086623|FG000|Overall Study|Other: Health problems, not drug related|1|||
129490165|NCT00552305|466086623|FG000|Overall Study|Other: Subject moved from area|2|||
129490166|NCT00552305|466086623|FG000|Overall Study|Other: Subject incarcerated|1|||
129490167|NCT00552305|466086623|FG000|Overall Study|Other: Subject went to rehab|1|||
129490168|NCT03503773|466086624|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
129490169|NCT03503773|466086625|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
129490170|NCT03503773|466086624|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
129490171|NCT03503773|466086625|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
129490172|NCT03503773|466086624|FG000|Overall Study|Not completing the primary ABPM|3|||
129490173|NCT03503773|466086625|FG001|Overall Study|Not completing the primary ABPM|1|||
129490174|NCT03503773|466086624|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
129490175|NCT03503773|466086625|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129490176|NCT02675517|466086628|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
129490177|NCT02675517|466086628|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
129490178|NCT00425438|466086629|FG000|Overall Study|Termination by Sponsor|25|||
129490179|NCT00425438|466086630|FG001|Overall Study|Termination by Sponsor|27|||
129490180|NCT02619253|466086631|FG000|Overall Study|Adverse Event|0|||
129490181|NCT02619253|466086632|FG001|Overall Study|Adverse Event|0|||
129490182|NCT02619253|466086633|FG002|Overall Study|Adverse Event|1|||
129490183|NCT02619253|466086634|FG003|Overall Study|Adverse Event|1|||
129490184|NCT02619253|466086635|FG004|Overall Study|Adverse Event|3|||
129490185|NCT02619253|466086631|FG000|Overall Study|Alternative Therapy|0|||
129490186|NCT02619253|466086632|FG001|Overall Study|Alternative Therapy|0|||
129490187|NCT02619253|466086633|FG002|Overall Study|Alternative Therapy|1|||
129490188|NCT02619253|466086634|FG003|Overall Study|Alternative Therapy|0|||
129490189|NCT02619253|466086635|FG004|Overall Study|Alternative Therapy|0|||
129490190|NCT02619253|466086631|FG000|Overall Study|Death|0|||
129490191|NCT02619253|466086632|FG001|Overall Study|Death|0|||
129490192|NCT02619253|466086633|FG002|Overall Study|Death|0|||
129490193|NCT02619253|466086634|FG003|Overall Study|Death|1|||
129490194|NCT02619253|466086635|FG004|Overall Study|Death|0|||
129490195|NCT02619253|466086631|FG000|Overall Study|Disease Progression|4|||
129490196|NCT02619253|466086632|FG001|Overall Study|Disease Progression|2|||
129490197|NCT02619253|466086633|FG002|Overall Study|Disease Progression|8|||
129490198|NCT02619253|466086634|FG003|Overall Study|Disease Progression|9|||
129490199|NCT02619253|466086635|FG004|Overall Study|Disease Progression|10|||
129490200|NCT02619253|466086631|FG000|Overall Study|Needed a disqualifying therapy|0|||
129490201|NCT02619253|466086632|FG001|Overall Study|Needed a disqualifying therapy|0|||
129490202|NCT02619253|466086633|FG002|Overall Study|Needed a disqualifying therapy|1|||
129490203|NCT02619253|466086634|FG003|Overall Study|Needed a disqualifying therapy|0|||
129490204|NCT02619253|466086635|FG004|Overall Study|Needed a disqualifying therapy|0|||
129490205|NCT02619253|466086631|FG000|Overall Study|Transferred to hospice|0|||
129490206|NCT02619253|466086632|FG001|Overall Study|Transferred to hospice|0|||
129490207|NCT02619253|466086633|FG002|Overall Study|Transferred to hospice|1|||
129490208|NCT02619253|466086634|FG003|Overall Study|Transferred to hospice|0|||
129490209|NCT02619253|466086635|FG004|Overall Study|Transferred to hospice|0|||
129490210|NCT02619253|466086631|FG000|Overall Study|Physician Decision|0|||
129490211|NCT02619253|466086632|FG001|Overall Study|Physician Decision|1|||
129490212|NCT02619253|466086633|FG002|Overall Study|Physician Decision|2|||
129490213|NCT02619253|466086634|FG003|Overall Study|Physician Decision|3|||
129490214|NCT02619253|466086635|FG004|Overall Study|Physician Decision|0|||
129490215|NCT02619253|466086631|FG000|Overall Study|Withdrawal by Subject|0|||
129490216|NCT02619253|466086632|FG001|Overall Study|Withdrawal by Subject|1|||
129490217|NCT02619253|466086633|FG002|Overall Study|Withdrawal by Subject|0|||
129490218|NCT02619253|466086634|FG003|Overall Study|Withdrawal by Subject|0|||
129490219|NCT02619253|466086635|FG004|Overall Study|Withdrawal by Subject|2|||
129490220|NCT00514449|466086636|FG000|Overall Study|Withdrawal by Subject|1|||
129490221|NCT00514449|466086637|FG001|Overall Study|Withdrawal by Subject|2|||
129490222|NCT00514449|466086636|FG000|Overall Study|Protocol Violation|1|||
129490223|NCT00514449|466086637|FG001|Overall Study|Protocol Violation|2|||
129490224|NCT00514449|466086636|FG000|Overall Study|Lost to Follow-up|1|||
129490225|NCT00514449|466086637|FG001|Overall Study|Lost to Follow-up|0|||
129490226|NCT00301067|466086641|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
129490227|NCT00301067|466086642|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
129490228|NCT00301067|466086643|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
129490229|NCT00301067|466086644|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
129490230|NCT00301067|466086641|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
129490231|NCT00301067|466086642|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
129490232|NCT00301067|466086643|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
129490233|NCT00301067|466086644|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
129490234|NCT00301067|466086641|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
129490235|NCT00301067|466086642|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
129490236|NCT00301067|466086643|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
129490237|NCT00301067|466086644|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
129490238|NCT00301067|466086641|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
129490239|NCT00301067|466086642|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
129490240|NCT00301067|466086643|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
129490241|NCT00301067|466086644|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
129490242|NCT00301067|466086641|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
129490243|NCT00301067|466086642|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
129490244|NCT00301067|466086643|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
129490245|NCT00301067|466086644|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
129490246|NCT00301067|466086641|FG000|Follow up Until Death|Alive at last data cut point|1|||
129490247|NCT00301067|466086642|FG001|Follow up Until Death|Alive at last data cut point|0|||
129490248|NCT00301067|466086643|FG002|Follow up Until Death|Alive at last data cut point|0|||
129490249|NCT00301067|466086644|FG003|Follow up Until Death|Alive at last data cut point|1|||
129490250|NCT00149825|466086645|FG000|Overall Study|Intolerance to medication side effects|1|||
129490251|NCT00149825|466086646|FG001|Overall Study|Intolerance to medication side effects|2|||
129490252|NCT00149825|466086645|FG000|Overall Study|Time commitments|2|||
129490253|NCT00149825|466086646|FG001|Overall Study|Time commitments|1|||
129490254|NCT00149825|466086645|FG000|Overall Study|Not liking insomnia therapy|1|||
129490255|NCT00149825|466086646|FG001|Overall Study|Not liking insomnia therapy|0|||
129490256|NCT00149825|466086645|FG000|Overall Study|Other|1|||
129490257|NCT00149825|466086646|FG001|Overall Study|Other|0|||
129490258|NCT01359982|466086647|FG000|Overall Study|Adverse Event|2|||
129490259|NCT01359982|466086648|FG001|Overall Study|Adverse Event|0|||
129490260|NCT01359982|466086649|FG002|Overall Study|Adverse Event|0|||
129490261|NCT01359982|466086650|FG003|Overall Study|Adverse Event|1|||
129490262|NCT01359982|466086651|FG004|Overall Study|Adverse Event|0|||
129490263|NCT01359982|466086652|FG005|Overall Study|Adverse Event|0|||
129490264|NCT01359982|466086647|FG000|Overall Study|Death|1|||
129490265|NCT01359982|466086648|FG001|Overall Study|Death|0|||
129490266|NCT01359982|466086649|FG002|Overall Study|Death|0|||
129490267|NCT01359982|466086650|FG003|Overall Study|Death|0|||
129490268|NCT01359982|466086651|FG004|Overall Study|Death|0|||
129490269|NCT01359982|466086652|FG005|Overall Study|Death|0|||
129490270|NCT03694522|466086654|FG000|Overall Study|Withdrawal by Subject|8|||
129490271|NCT03694522|466086655|FG001|Overall Study|Withdrawal by Subject|10|||
129490272|NCT03694522|466086654|FG000|Overall Study|Physician Decision|53|||
129490273|NCT03694522|466086655|FG001|Overall Study|Physician Decision|54|||
129490274|NCT03694522|466086654|FG000|Overall Study|Other|1|||
129490275|NCT03694522|466086655|FG001|Overall Study|Other|1|||
129490276|NCT03694522|466086654|FG000|Overall Study|Lost to Follow-up|0|||
129490277|NCT03694522|466086655|FG001|Overall Study|Lost to Follow-up|1|||
129490278|NCT01164501|466086656|FG000|Overall Study|Not treated|2|||
129490279|NCT01164501|466086657|FG001|Overall Study|Not treated|0|||
129490280|NCT01164501|466086658|FG002|Overall Study|Not treated|1|||
129490281|NCT01164501|466086656|FG000|Overall Study|Adverse Event|18|||
129490282|NCT01164501|466086657|FG001|Overall Study|Adverse Event|4|||
129490283|NCT01164501|466086658|FG002|Overall Study|Adverse Event|21|||
129490284|NCT01164501|466086656|FG000|Overall Study|Lack of Efficacy|0|||
129490285|NCT01164501|466086657|FG001|Overall Study|Lack of Efficacy|0|||
129490286|NCT01164501|466086658|FG002|Overall Study|Lack of Efficacy|1|||
129490287|NCT01164501|466086656|FG000|Overall Study|Non compliant with protocol|1|||
129490288|NCT01164501|466086657|FG001|Overall Study|Non compliant with protocol|1|||
129490289|NCT01164501|466086658|FG002|Overall Study|Non compliant with protocol|4|||
129490290|NCT01164501|466086656|FG000|Overall Study|Lost to Follow-up|3|||
129490291|NCT01164501|466086657|FG001|Overall Study|Lost to Follow-up|0|||
129490292|NCT01164501|466086658|FG002|Overall Study|Lost to Follow-up|3|||
129490293|NCT01164501|466086656|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
129490294|NCT01164501|466086657|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
129490295|NCT01164501|466086658|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
129490296|NCT01164501|466086656|FG000|Overall Study|Other reason not defined above|9|||
129490297|NCT01164501|466086657|FG001|Overall Study|Other reason not defined above|1|||
129490298|NCT01164501|466086658|FG002|Overall Study|Other reason not defined above|4|||
129490299|NCT00306891|466086659|FG000|Part A|Withdrawal by Subject|1|||
129490300|NCT00306891|466086660|FG001|Part A|Withdrawal by Subject|1|||
129490301|NCT00306891|466086661|FG002|Part A|Withdrawal by Subject|0|||
129490302|NCT00306891|466086662|FG003|Part A|Withdrawal by Subject|0|||
129490303|NCT00306891|466086659|FG000|Part A|Condition under investigation worsened|2|||
129490304|NCT00306891|466086660|FG001|Part A|Condition under investigation worsened|2|||
129490305|NCT00306891|466086661|FG002|Part A|Condition under investigation worsened|0|||
129490306|NCT00306891|466086662|FG003|Part A|Condition under investigation worsened|0|||
129490307|NCT00306891|466086659|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
129490308|NCT00306891|466086660|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
129490309|NCT00306891|466086661|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
129490310|NCT00306891|466086662|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
129490311|NCT00306891|466086659|FG000|Part A|Partial bowel obstruction|1|||
129490312|NCT00306891|466086660|FG001|Part A|Partial bowel obstruction|0|||
129490313|NCT00306891|466086661|FG002|Part A|Partial bowel obstruction|0|||
129490314|NCT00306891|466086662|FG003|Part A|Partial bowel obstruction|0|||
129490315|NCT00306891|466086659|FG000|Part A|Reaccumul. of ascites following drainage|0|||
129490316|NCT00306891|466086660|FG001|Part A|Reaccumul. of ascites following drainage|1|||
129490317|NCT00306891|466086661|FG002|Part A|Reaccumul. of ascites following drainage|0|||
129490318|NCT00306891|466086662|FG003|Part A|Reaccumul. of ascites following drainage|0|||
129490319|NCT00306891|466086659|FG000|Part A|Suspicion of second malignancy|0|||
129490320|NCT00306891|466086660|FG001|Part A|Suspicion of second malignancy|1|||
129490321|NCT00306891|466086661|FG002|Part A|Suspicion of second malignancy|0|||
129490322|NCT00306891|466086662|FG003|Part A|Suspicion of second malignancy|0|||
129490323|NCT00306891|466086659|FG000|Part A|QTC interval outwith elig. criteria|1|||
129490324|NCT00306891|466086660|FG001|Part A|QTC interval outwith elig. criteria|0|||
129490325|NCT00306891|466086661|FG002|Part A|QTC interval outwith elig. criteria|0|||
129490326|NCT00306891|466086662|FG003|Part A|QTC interval outwith elig. criteria|0|||
129490327|NCT00306891|466086659|FG000|Part B|Death|0|||
129490328|NCT00306891|466086660|FG001|Part B|Death|0|||
129490329|NCT00306891|466086661|FG002|Part B|Death|1|||
129490330|NCT00306891|466086662|FG003|Part B|Death|2|||
129490331|NCT00306891|466086659|FG000|Part B|Adverse Event|0|||
129490332|NCT00306891|466086660|FG001|Part B|Adverse Event|0|||
129490333|NCT00306891|466086661|FG002|Part B|Adverse Event|5|||
129490334|NCT00306891|466086662|FG003|Part B|Adverse Event|5|||
129490335|NCT00306891|466086659|FG000|Part B|Withdrawal by Subject|0|||
129490336|NCT00306891|466086660|FG001|Part B|Withdrawal by Subject|0|||
129490337|NCT00306891|466086661|FG002|Part B|Withdrawal by Subject|3|||
129980635|NCT01214642|467891699|FG003|Overall Study|Progressive Disease|5|||
129980636|NCT01214642|467891700|FG004|Overall Study|Progressive Disease|5|||
129980637|NCT01214642|467891701|FG005|Overall Study|Progressive Disease|3|||
129980638|NCT01214642|467891702|FG006|Overall Study|Progressive Disease|5|||
129980639|NCT01214642|467891703|FG007|Overall Study|Progressive Disease|3|||
129980640|NCT01214642|467891704|FG008|Overall Study|Progressive Disease|10|||
129490338|NCT00306891|466086662|FG003|Part B|Withdrawal by Subject|1|||
129490339|NCT00306891|466086659|FG000|Part B|Condition under investigation worsened|0|||
129490340|NCT00306891|466086660|FG001|Part B|Condition under investigation worsened|0|||
129490341|NCT00306891|466086661|FG002|Part B|Condition under investigation worsened|2|||
129490342|NCT00306891|466086662|FG003|Part B|Condition under investigation worsened|8|||
129490343|NCT00306891|466086659|FG000|Part B|Development of study specific disc crit.|0|||
129490344|NCT00306891|466086660|FG001|Part B|Development of study specific disc crit.|0|||
129490345|NCT00306891|466086661|FG002|Part B|Development of study specific disc crit.|0|||
129490346|NCT00306891|466086662|FG003|Part B|Development of study specific disc crit.|1|||
129490347|NCT00673673|466086663|FG000|Overall Study|Progressive disease|27|||
129490348|NCT00673673|466086663|FG000|Overall Study|Adverse Event|4|||
129490349|NCT00673673|466086663|FG000|Overall Study|Withdrawal by Subject|3|||
129490350|NCT00673673|466086663|FG000|Overall Study|Investigators' discretion|2|||
129490351|NCT04538950|466086664|FG000|Overall Study|Pulmonary Issues|2|||
129490352|NCT04538950|466086664|FG000|Overall Study|illness|2|||
129490353|NCT02792777|466086665|FG000|Overall Study|Withdrawal by Subject|2|||
129490354|NCT02792777|466086666|FG001|Overall Study|Withdrawal by Subject|0|||
129490355|NCT02792777|466086665|FG000|Overall Study|Recording malfunction|2|||
129490356|NCT02792777|466086666|FG001|Overall Study|Recording malfunction|0|||
129490357|NCT02792777|466086665|FG000|Overall Study|Later determined to be ineligible|2|||
129490358|NCT02792777|466086666|FG001|Overall Study|Later determined to be ineligible|0|||
129490359|NCT02792777|466086665|FG000|Overall Study|Participant interviewed twice|1|||
129490360|NCT02792777|466086666|FG001|Overall Study|Participant interviewed twice|0|||
129490361|NCT02606877|466086667|FG000|Overall Study|Adverse Event|3|||
129490362|NCT02606877|466086668|FG001|Overall Study|Adverse Event|0|||
129490363|NCT02606877|466086667|FG000|Overall Study|Non-compliance with protocol|0|||
129490364|NCT02606877|466086668|FG001|Overall Study|Non-compliance with protocol|1|||
129490365|NCT02606877|466086667|FG000|Overall Study|Other than listed above|1|||
129490366|NCT02606877|466086668|FG001|Overall Study|Other than listed above|0|||
129490367|NCT00515463|466086675|FG000|Overall Study|Physician Decision|4|||
129490368|NCT00515463|466086676|FG001|Overall Study|Physician Decision|2|||
129490369|NCT00515463|466086675|FG000|Overall Study|Adverse Event|1|||
129490370|NCT00515463|466086676|FG001|Overall Study|Adverse Event|2|||
129490371|NCT00515463|466086675|FG000|Overall Study|Withdrawal by Subject|3|||
129490372|NCT00515463|466086676|FG001|Overall Study|Withdrawal by Subject|4|||
129490373|NCT00515463|466086675|FG000|Overall Study|Lost to Follow-up|6|||
129490374|NCT00515463|466086676|FG001|Overall Study|Lost to Follow-up|5|||
129490375|NCT00515463|466086675|FG000|Overall Study|Other|0|||
129490376|NCT00515463|466086676|FG001|Overall Study|Other|1|||
129490377|NCT03238248|466088047|FG000|Overall Study|Death|5|||
129490378|NCT03238248|466088047|FG000|Overall Study|Withdrawal by Subject|7|||
129490379|NCT03238248|466088047|FG000|Overall Study|Participant proceeding to transplant|10|||
129490380|NCT03238248|466088047|FG000|Overall Study|Lack of Efficacy|4|||
129490381|NCT03238248|466088047|FG000|Overall Study|Physician Decision|3|||
129490382|NCT03238248|466088047|FG000|Overall Study|Transitioning to another study|1|||
129490383|NCT03238248|466088047|FG000|Overall Study|No longer benefiting|1|||
129490384|NCT03238248|466088047|FG000|Overall Study|Other complicating disease|1|||
129490385|NCT03238248|466088047|FG000|Overall Study|Adverse Event|5|||
129490386|NCT03238248|466088047|FG000|Overall Study|Disease progression|26|||
129490387|NCT03238248|466088047|FG000|Overall Study|N/A participant is still on treatment|1|||
129490388|NCT03238248|466088047|FG000|Overall Study|Decline in condition|1|||
129490389|NCT03238248|466088047|FG000|Overall Study|Alternative therapy|2|||
129490390|NCT01013883|466088049|FG000|Overall Study|Lost to Follow-up|2|||
129490391|NCT01013883|466088050|FG001|Overall Study|Lost to Follow-up|2|||
129490392|NCT03268746|466088055|FG000|Overall Study|Withdrawal by Subject|1|||
129490393|NCT00891657|466088058|FG000|Overall Study|Withdrawal by Subject|1|||
129490394|NCT00891657|466088059|FG001|Overall Study|Withdrawal by Subject|1|||
129490395|NCT04530825|466088060|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
129490396|NCT04530825|466088061|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
129490397|NCT04530825|466088062|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
129490398|NCT04530825|466088063|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
129490399|NCT04530825|466088060|FG000|Overall Study|Did not complete follow-up|3|||
129490400|NCT04530825|466088061|FG001|Overall Study|Did not complete follow-up|0|||
129490401|NCT04530825|466088062|FG002|Overall Study|Did not complete follow-up|0|||
129490402|NCT04530825|466088063|FG003|Overall Study|Did not complete follow-up|0|||
129490403|NCT00850499|466088064|FG000|Overall Study|Adverse Event|3|||
129490404|NCT00850499|466088065|FG001|Overall Study|Adverse Event|1|||
129490405|NCT00850499|466088064|FG000|Overall Study|Lack of Efficacy|0|||
129490406|NCT00850499|466088065|FG001|Overall Study|Lack of Efficacy|1|||
129490407|NCT04498910|466088066|FG000|Overall Study|Lost to Follow-up|0|||
129490408|NCT04498910|466088067|FG001|Overall Study|Lost to Follow-up|1|||
129490409|NCT04498910|466088066|FG000|Overall Study|Withdrawal by Subject|2|||
129490410|NCT04498910|466088067|FG001|Overall Study|Withdrawal by Subject|1|||
129490411|NCT04498910|466088066|FG000|Overall Study|Adverse Event|1|||
129490412|NCT04498910|466088067|FG001|Overall Study|Adverse Event|0|||
129490413|NCT01849848|466088068|FG000|Overall Study|Physician Decision|1|||
129490414|NCT01849848|466088068|FG000|Overall Study|Progression of the primary disease|3|||
129490415|NCT00909090|466088069|FG000|Overall Study|Lost to Follow-up|17|||
129490416|NCT00909090|466088070|FG001|Overall Study|Lost to Follow-up|17|||
129490417|NCT02926573|466088072|FG000|Overall Study|Nausea|1|||
129490418|NCT02926573|466088073|FG001|Overall Study|Nausea|0|||
129490419|NCT02926573|466088072|FG000|Overall Study|Remain intubated|2|||
129490420|NCT02926573|466088073|FG001|Overall Study|Remain intubated|2|||
129490421|NCT02926573|466088072|FG000|Overall Study|Change in surgery plan|3|||
129490422|NCT02926573|466088073|FG001|Overall Study|Change in surgery plan|1|||
129490423|NCT02926573|466088072|FG000|Overall Study|Change to outpatient status|5|||
129490424|NCT02926573|466088073|FG001|Overall Study|Change to outpatient status|1|||
129490425|NCT02926573|466088072|FG000|Overall Study|Withdrawal by Subject|0|||
129490426|NCT02926573|466088073|FG001|Overall Study|Withdrawal by Subject|2|||
129490427|NCT02926573|466088072|FG000|Overall Study|Return to operating room|0|||
129490428|NCT02926573|466088073|FG001|Overall Study|Return to operating room|2|||
129490429|NCT02926573|466088072|FG000|Overall Study|Delirium|0|||
129490430|NCT02926573|466088073|FG001|Overall Study|Delirium|1|||
129490431|NCT00858702|466088076|FG000|Overall Study|Lack of Efficacy|1|||
129490432|NCT00858702|466088077|FG001|Overall Study|Lack of Efficacy|0|||
129490433|NCT00858702|466088076|FG000|Overall Study|Protocol Violation|1|||
129490434|NCT00858702|466088077|FG001|Overall Study|Protocol Violation|1|||
129490435|NCT00858702|466088076|FG000|Overall Study|Other|2|||
129490436|NCT00858702|466088077|FG001|Overall Study|Other|1|||
129490437|NCT00858702|466088076|FG000|Overall Study|Withdrawal by Subject|1|||
129490438|NCT00858702|466088077|FG001|Overall Study|Withdrawal by Subject|0|||
129490439|NCT01839188|466088078|FG000|Overall Study|Withdrawal by Subject|1|||
129490440|NCT01214434|466088087|FG000|Overall Study|Withdrawal by Subject|1|||
129490441|NCT01214434|466088088|FG001|Overall Study|Withdrawal by Subject|0|||
129490442|NCT01214434|466088087|FG000|Overall Study|Lost to Follow-up|2|||
129490443|NCT01214434|466088088|FG001|Overall Study|Lost to Follow-up|2|||
129490444|NCT01214434|466088087|FG000|Overall Study|Site error|1|||
129490445|NCT01214434|466088088|FG001|Overall Study|Site error|0|||
129490446|NCT00138151|466088089|FG000|Overall Study|Withdrawal by Subject|3|||
129490447|NCT00138151|466088089|FG000|Overall Study|Physician Decision|1|||
129490448|NCT02902809|466088093|FG000|Overall Study|Discontinuation of asthma program|28|||
129490449|NCT00532259|466088094|FG000|Overall Study|Withdrawal by Subject|2|||
129490450|NCT00532259|466088094|FG000|Overall Study|Adverse Event|1|||
129490451|NCT00532259|466088094|FG000|Overall Study|Death|1|||
129490452|NCT00532259|466088094|FG000|Overall Study|Lack of Efficacy|21|||
129490453|NCT00532259|466088094|FG000|Overall Study|Lost to Follow-up|3|||
129490454|NCT00532259|466088094|FG000|Overall Study|Physician Decision|3|||
129490455|NCT00532259|466088094|FG000|Overall Study|Protocol Violation|1|||
129490456|NCT00793104|466088095|FG000|Overall Study|Lost to Follow-up|1|||
129490457|NCT01302769|466088096|FG000|Overall Study|Lost to Follow-up|1|||
129490458|NCT01302769|466088097|FG001|Overall Study|Lost to Follow-up|1|||
129490459|NCT03494725|466088098|FG000|Overall Study|Withdrawal by Subject|0|||
129490460|NCT03494725|466088099|FG001|Overall Study|Withdrawal by Subject|2|||
129490461|NCT03494725|466088098|FG000|Overall Study|Antibiotic use|1|||
129490462|NCT03494725|466088099|FG001|Overall Study|Antibiotic use|0|||
129490463|NCT04983940|466088100|FG000|Overall Study|Lost to Follow-up|14|||
129490464|NCT04983940|466088100|FG000|Overall Study|Lack of Efficacy|2|||
129490465|NCT02760407|466088103|FG000|Overall Study|Death|2|||
129490466|NCT02760407|466088104|FG001|Overall Study|Death|3|||
129490467|NCT02760407|466088105|FG002|Overall Study|Death|1|||
129490468|NCT02760407|466088106|FG003|Overall Study|Death|1|||
129490469|NCT02760407|466088103|FG000|Overall Study|Lost to Follow-up|1|||
129490470|NCT02760407|466088104|FG001|Overall Study|Lost to Follow-up|7|||
129490471|NCT02760407|466088105|FG002|Overall Study|Lost to Follow-up|4|||
129490472|NCT02760407|466088106|FG003|Overall Study|Lost to Follow-up|6|||
129490473|NCT02760407|466088103|FG000|Overall Study|Withdrawal by Subject|25|||
129490474|NCT02760407|466088104|FG001|Overall Study|Withdrawal by Subject|31|||
129490475|NCT02760407|466088105|FG002|Overall Study|Withdrawal by Subject|37|||
129490476|NCT02760407|466088106|FG003|Overall Study|Withdrawal by Subject|25|||
129490477|NCT02760407|466088103|FG000|Overall Study|Violation of Eligibility criteria|0|||
129490478|NCT02760407|466088104|FG001|Overall Study|Violation of Eligibility criteria|0|||
129490479|NCT02760407|466088105|FG002|Overall Study|Violation of Eligibility criteria|1|||
129490480|NCT02760407|466088106|FG003|Overall Study|Violation of Eligibility criteria|1|||
129490481|NCT02760407|466088103|FG000|Overall Study|Personal reasons|0|||
129490482|NCT02760407|466088104|FG001|Overall Study|Personal reasons|0|||
129490483|NCT02760407|466088105|FG002|Overall Study|Personal reasons|0|||
129490484|NCT02760407|466088106|FG003|Overall Study|Personal reasons|1|||
129490485|NCT02760407|466088103|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
129490486|NCT02760407|466088104|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
129490487|NCT02760407|466088105|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
129490488|NCT02760407|466088106|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
129490489|NCT02760407|466088103|FG000|Overall Study|Use of prohibited Medication|0|||
129490490|NCT02760407|466088104|FG001|Overall Study|Use of prohibited Medication|0|||
129490491|NCT02760407|466088105|FG002|Overall Study|Use of prohibited Medication|1|||
129490492|NCT02760407|466088106|FG003|Overall Study|Use of prohibited Medication|0|||
129490493|NCT02760407|466088103|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
129490494|NCT02760407|466088104|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
129490495|NCT02760407|466088105|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
129490496|NCT02760407|466088106|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
129490497|NCT02760407|466088103|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
129490498|NCT02760407|466088104|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
129490499|NCT02760407|466088105|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
129490500|NCT02760407|466088106|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
129490501|NCT02760407|466088103|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
129490502|NCT02760407|466088104|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
129490503|NCT02760407|466088105|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
129490504|NCT02760407|466088106|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
129490505|NCT02760407|466088103|FG000|Overall Study|Inadequately Enrolled|0|||
129490506|NCT02760407|466088104|FG001|Overall Study|Inadequately Enrolled|0|||
129490507|NCT02760407|466088105|FG002|Overall Study|Inadequately Enrolled|0|||
129490508|NCT02760407|466088106|FG003|Overall Study|Inadequately Enrolled|1|||
129490509|NCT02760407|466088103|FG000|Overall Study|Withdrawal By PI's Decision|0|||
129490510|NCT02760407|466088104|FG001|Overall Study|Withdrawal By PI's Decision|1|||
129490511|NCT02760407|466088105|FG002|Overall Study|Withdrawal By PI's Decision|0|||
129490512|NCT02760407|466088106|FG003|Overall Study|Withdrawal By PI's Decision|0|||
129490513|NCT02760407|466088103|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
129490514|NCT02760407|466088104|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
129490515|NCT02760407|466088105|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
129490516|NCT02760407|466088106|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
129490517|NCT02760407|466088103|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
129490518|NCT02760407|466088104|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
129490519|NCT02760407|466088105|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
129490520|NCT02760407|466088106|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
129490521|NCT02760407|466088103|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
129490522|NCT02760407|466088104|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
129490523|NCT02760407|466088105|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
129490524|NCT02760407|466088106|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
129490525|NCT02760407|466088103|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
129490526|NCT02760407|466088104|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
129490527|NCT02760407|466088105|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
129490528|NCT02760407|466088106|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
129490529|NCT02760407|466088103|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
129490530|NCT02760407|466088104|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
129490531|NCT02760407|466088105|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
129490532|NCT02760407|466088106|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
129490533|NCT02760407|466088103|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
129490534|NCT02760407|466088104|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
129490535|NCT02760407|466088105|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
129490536|NCT02760407|466088106|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
129490537|NCT02760407|466088103|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
129490538|NCT02760407|466088104|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
129490539|NCT02760407|466088105|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
129490540|NCT02760407|466088106|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
129490541|NCT02760407|466088103|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
129490542|NCT02760407|466088104|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
129490543|NCT02760407|466088105|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
129490544|NCT02760407|466088106|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
129490545|NCT02760407|466088103|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
129490546|NCT02760407|466088104|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
129490547|NCT02760407|466088105|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
129490548|NCT02760407|466088106|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
129490549|NCT01748760|466088107|FG000|Overall Study|Withdrawal by Subject|1|||
129490550|NCT01748760|466088108|FG001|Overall Study|Withdrawal by Subject|1|||
129490551|NCT01748760|466088107|FG000|Overall Study|Lost to Follow-up|5|||
129490552|NCT01748760|466088108|FG001|Overall Study|Lost to Follow-up|1|||
129490553|NCT03245814|466088109|FG000|Overall Study|Lost to Follow-up|5|||
129490554|NCT03245814|466088110|FG001|Overall Study|Lost to Follow-up|8|||
129490555|NCT03245814|466088109|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
129490556|NCT03245814|466088110|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
129490557|NCT02263365|466088111|FG000|Overall Study|Physician Decision|22|||
129490558|NCT02263365|466088112|FG001|Overall Study|Physician Decision|18|||
129490559|NCT00206518|466088113|FG000|Overall Study|Lack of Efficacy|6|||
129490560|NCT00206518|466088114|FG001|Overall Study|Lack of Efficacy|4|||
129490561|NCT00206518|466088113|FG000|Overall Study|Adverse Event|2|||
129490562|NCT00206518|466088114|FG001|Overall Study|Adverse Event|1|||
129490563|NCT00206518|466088113|FG000|Overall Study|Physician Decision|1|||
129490564|NCT00206518|466088114|FG001|Overall Study|Physician Decision|0|||
129490565|NCT00206518|466088113|FG000|Overall Study|Protocol Violation|1|||
129490566|NCT00206518|466088114|FG001|Overall Study|Protocol Violation|1|||
129490567|NCT00394914|466088117|FG000|Treatment Period|Adverse Event|0|||
129490568|NCT00394914|466088118|FG001|Treatment Period|Adverse Event|3|||
129490569|NCT00394914|466088119|FG002|Treatment Period|Adverse Event|1|||
129490570|NCT00394914|466088117|FG000|Treatment Period|Lost to Follow-up|0|||
129490571|NCT00394914|466088118|FG001|Treatment Period|Lost to Follow-up|1|||
129490572|NCT00394914|466088119|FG002|Treatment Period|Lost to Follow-up|0|||
129490573|NCT00394914|466088117|FG000|Treatment Period|Withdrawal by Subject|0|||
129490574|NCT00394914|466088118|FG001|Treatment Period|Withdrawal by Subject|2|||
129490575|NCT00394914|466088119|FG002|Treatment Period|Withdrawal by Subject|2|||
129490576|NCT00394914|466088117|FG000|Treatment Period|Noncompliance with protocol|0|||
129490577|NCT00394914|466088118|FG001|Treatment Period|Noncompliance with protocol|3|||
129490578|NCT00394914|466088119|FG002|Treatment Period|Noncompliance with protocol|2|||
129490579|NCT00394914|466088117|FG000|Treatment Period|Did not meet protocol eligibility|0|||
129490580|NCT00394914|466088118|FG001|Treatment Period|Did not meet protocol eligibility|1|||
129490581|NCT00394914|466088119|FG002|Treatment Period|Did not meet protocol eligibility|1|||
129490582|NCT00872898|466088122|FG000|Part Two - Double Blind|Adverse Event|4|||
129490583|NCT00872898|466088123|FG001|Part Two - Double Blind|Adverse Event|3|||
129490584|NCT00872898|466088122|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
129490585|NCT00872898|466088123|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
129490586|NCT00872898|466088122|FG000|Part Two - Double Blind|Protocol Violation|1|||
129490587|NCT00872898|466088123|FG001|Part Two - Double Blind|Protocol Violation|0|||
129490588|NCT00872898|466088122|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
129490589|NCT00872898|466088123|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
129490590|NCT00872898|466088122|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
129490591|NCT00872898|466088123|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
129490592|NCT00872898|466088122|FG000|Part Two - Double Blind|Other reasons|2|||
129490593|NCT00872898|466088123|FG001|Part Two - Double Blind|Other reasons|0|||
129490594|NCT01004146|466088124|FG000|Overall Study|Withdrawal by Subject|4|||
129490595|NCT01004146|466088125|FG001|Overall Study|Withdrawal by Subject|5|||
129490596|NCT01001494|466088126|FG000|Overall Study|Adverse Event|8|||
129490597|NCT01001494|466088127|FG001|Overall Study|Adverse Event|4|||
129490598|NCT01001494|466088128|FG002|Overall Study|Adverse Event|6|||
129490599|NCT01001494|466088126|FG000|Overall Study|Protocol Violation|0|||
129490600|NCT01001494|466088127|FG001|Overall Study|Protocol Violation|1|||
129490601|NCT01001494|466088128|FG002|Overall Study|Protocol Violation|1|||
129490602|NCT01001494|466088126|FG000|Overall Study|Lost to Follow-up|2|||
129490603|NCT01001494|466088127|FG001|Overall Study|Lost to Follow-up|0|||
129490604|NCT01001494|466088128|FG002|Overall Study|Lost to Follow-up|1|||
129490605|NCT01001494|466088126|FG000|Overall Study|Withdrawal by Subject|9|||
129490606|NCT01001494|466088127|FG001|Overall Study|Withdrawal by Subject|7|||
129490607|NCT01001494|466088128|FG002|Overall Study|Withdrawal by Subject|17|||
129490608|NCT01001494|466088126|FG000|Overall Study|COPD exacerbation|3|||
129490609|NCT01001494|466088127|FG001|Overall Study|COPD exacerbation|4|||
129980641|NCT01214642|467891705|FG009|Overall Study|Progressive Disease|2|||
129980642|NCT01214642|467891706|FG010|Overall Study|Progressive Disease|1|||
129980643|NCT01214642|467891707|FG011|Overall Study|Progressive Disease|4|||
129980644|NCT01214642|467891696|FG000|Overall Study|Adverse Event|0|||
129980645|NCT01214642|467891697|FG001|Overall Study|Adverse Event|1|||
129980646|NCT01214642|467891698|FG002|Overall Study|Adverse Event|0|||
129980647|NCT01214642|467891699|FG003|Overall Study|Adverse Event|0|||
129980648|NCT01214642|467891700|FG004|Overall Study|Adverse Event|0|||
129980649|NCT01214642|467891701|FG005|Overall Study|Adverse Event|0|||
129980650|NCT01214642|467891702|FG006|Overall Study|Adverse Event|1|||
129980651|NCT01214642|467891703|FG007|Overall Study|Adverse Event|0|||
129980652|NCT01214642|467891704|FG008|Overall Study|Adverse Event|0|||
129980653|NCT01214642|467891705|FG009|Overall Study|Adverse Event|1|||
129980654|NCT01214642|467891706|FG010|Overall Study|Adverse Event|1|||
129980655|NCT01214642|467891707|FG011|Overall Study|Adverse Event|0|||
129980656|NCT01214642|467891696|FG000|Overall Study|Death|0|||
129980657|NCT01214642|467891697|FG001|Overall Study|Death|0|||
129980658|NCT01214642|467891698|FG002|Overall Study|Death|1|||
129980659|NCT01214642|467891699|FG003|Overall Study|Death|0|||
129490610|NCT01001494|466088128|FG002|Overall Study|COPD exacerbation|5|||
129490611|NCT01001494|466088126|FG000|Overall Study|Lack of Efficacy|2|||
129490612|NCT01001494|466088127|FG001|Overall Study|Lack of Efficacy|0|||
129490613|NCT01001494|466088128|FG002|Overall Study|Lack of Efficacy|8|||
129980660|NCT01214642|467891700|FG004|Overall Study|Death|0|||
129980661|NCT01214642|467891701|FG005|Overall Study|Death|0|||
129490614|NCT01001494|466088126|FG000|Overall Study|Other|0|||
129490615|NCT01001494|466088127|FG001|Overall Study|Other|1|||
129980662|NCT01214642|467891702|FG006|Overall Study|Death|0|||
129980663|NCT01214642|467891703|FG007|Overall Study|Death|0|||
129490616|NCT01001494|466088128|FG002|Overall Study|Other|3|||
129980664|NCT01214642|467891704|FG008|Overall Study|Death|0|||
129980665|NCT01214642|467891705|FG009|Overall Study|Death|0|||
129490617|NCT02179398|466088129|FG000|Overall Study|Lack of obligatory data|3|||
129490618|NCT02179398|466088130|FG001|Overall Study|Lack of obligatory data|3|||
129490619|NCT02179398|466088129|FG000|Overall Study|Lost to Follow-up|0|||
129490620|NCT02179398|466088130|FG001|Overall Study|Lost to Follow-up|1|||
129490621|NCT00408681|466088137|FG000|Overall Study|Lack of Efficacy|2|||
129490622|NCT00408681|466088137|FG000|Overall Study|Adverse Event|7|||
129490623|NCT00447421|466088140|FG000|Overall Study|Lack of Efficacy|1|||
129490624|NCT00447421|466088140|FG000|Overall Study|Adverse Event|3|||
129490625|NCT00447421|466088140|FG000|Overall Study|Sponsor Decision|2|||
129490626|NCT02124798|466088142|FG000|Overall Study|Adverse Event|3|||
129490627|NCT02124798|466088142|FG000|Overall Study|Lost to Follow-up|1|||
129490628|NCT01707147|466088145|FG000|Overall Study|Administered Trajenta prior to contract|5|||
129490629|NCT01707147|466088145|FG000|Overall Study|Patients who have not taken Trajenta|1|||
129490630|NCT01707147|466088145|FG000|Overall Study|Follow-up failure|17|||
129490631|NCT01707147|466088145|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
129490632|NCT02053246|466088146|FG000|Overall Study|Withdrawal by Subject|3|||
129490633|NCT02053246|466088146|FG000|Overall Study|Physician Decision|1|||
129490634|NCT00815308|466088147|FG000|Overall Study|Adverse Event|4|||
129490635|NCT00815308|466088147|FG000|Overall Study|Withdrawal by Subject|0|||
129490636|NCT00815308|466088147|FG000|Overall Study|Protocol Violation|6|||
129490637|NCT00638846|466088151|FG000|Overall Study|Adverse Event|0|||
129490638|NCT00638846|466088152|FG001|Overall Study|Adverse Event|1|||
129490639|NCT00638846|466088151|FG000|Overall Study|Lost to Follow-up|3|||
129490640|NCT00638846|466088152|FG001|Overall Study|Lost to Follow-up|2|||
129490641|NCT00638846|466088151|FG000|Overall Study|lens issue|1|||
129490642|NCT00638846|466088152|FG001|Overall Study|lens issue|3|||
129490643|NCT01171521|466088155|FG000|Overall Study|Lost to Follow-up|5|||
129490644|NCT01171521|466088155|FG000|Overall Study|screen failure|1|||
129490645|NCT00734929|466088160|FG000|Overall Study|Lost to Follow-up|1|||
129490646|NCT00734929|466088161|FG001|Overall Study|Lost to Follow-up|2|||
129490647|NCT00734929|466088160|FG000|Overall Study|No intervention/ screen fail|5|||
129490648|NCT00734929|466088161|FG001|Overall Study|No intervention/ screen fail|3|||
129490649|NCT01696877|466088167|FG000|Overall Study|Adverse Event|0|||
129490650|NCT01696877|466088168|FG001|Overall Study|Adverse Event|1|||
129490651|NCT02961764|466088169|FG000|Overall Study|Protocol Violation|0|||
129490652|NCT02961764|466088170|FG001|Overall Study|Protocol Violation|1|||
129490653|NCT02961764|466088169|FG000|Overall Study|Death|2|||
129490654|NCT02961764|466088170|FG001|Overall Study|Death|0|||
129490655|NCT02961764|466088169|FG000|Overall Study|Lost to Follow-up|35|||
129490656|NCT02961764|466088170|FG001|Overall Study|Lost to Follow-up|24|||
129490657|NCT02961764|466088169|FG000|Overall Study|Withdrawal by Subject|2|||
129490658|NCT02961764|466088170|FG001|Overall Study|Withdrawal by Subject|0|||
129490659|NCT01422304|466088171|FG000|Overall Study|Adverse Event|0|||
129490660|NCT01422304|466088172|FG001|Overall Study|Adverse Event|1|||
129490661|NCT01422304|466088171|FG000|Overall Study|Lost to Follow-up|14|||
129490662|NCT01422304|466088172|FG001|Overall Study|Lost to Follow-up|20|||
129490663|NCT01422304|466088171|FG000|Overall Study|Never Entered Follow-up|2|||
129490664|NCT01422304|466088172|FG001|Overall Study|Never Entered Follow-up|1|||
129490665|NCT01422304|466088171|FG000|Overall Study|Protocol Violation|1|||
129490666|NCT01422304|466088172|FG001|Overall Study|Protocol Violation|0|||
129490667|NCT01422304|466088171|FG000|Overall Study|Withdrawal by Subject|4|||
129490668|NCT01422304|466088172|FG001|Overall Study|Withdrawal by Subject|2|||
129490669|NCT01422304|466088171|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
129490670|NCT01422304|466088172|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
129490671|NCT01422304|466088171|FG000|Overall Study|Not Treated|3|||
129490672|NCT01422304|466088172|FG001|Overall Study|Not Treated|11|||
129490673|NCT00469014|466088173|FG000|Initial Phase Randomization|Disease Progression|0|||
129490674|NCT00469014|466088174|FG001|Initial Phase Randomization|Disease Progression|1|||
129490675|NCT00469014|466088175|FG002|Initial Phase Randomization|Disease Progression|1|||
129490676|NCT00469014|466088176|FG003|Initial Phase Randomization|Disease Progression|0|||
129490677|NCT00469014|466088173|FG000|Initial Phase Randomization|No Response|1|||
129490678|NCT00469014|466088174|FG001|Initial Phase Randomization|No Response|0|||
129490679|NCT00469014|466088175|FG002|Initial Phase Randomization|No Response|0|||
129490680|NCT00469014|466088176|FG003|Initial Phase Randomization|No Response|1|||
129490681|NCT00469014|466088173|FG000|Adaptive Randomization|Not Evaluable|1|||
129490682|NCT00469014|466088174|FG001|Adaptive Randomization|Not Evaluable|0|||
129490683|NCT00469014|466088175|FG002|Adaptive Randomization|Not Evaluable|0|||
129490684|NCT00469014|466088176|FG003|Adaptive Randomization|Not Evaluable|1|||
129490685|NCT00469014|466088173|FG000|Adaptive Randomization|No Response|0|||
129490686|NCT00469014|466088174|FG001|Adaptive Randomization|No Response|1|||
129490687|NCT00469014|466088175|FG002|Adaptive Randomization|No Response|0|||
129490688|NCT00469014|466088176|FG003|Adaptive Randomization|No Response|0|||
129490689|NCT00469014|466088173|FG000|Adaptive Randomization|Death|0|||
129490690|NCT00469014|466088174|FG001|Adaptive Randomization|Death|0|||
129490691|NCT00469014|466088175|FG002|Adaptive Randomization|Death|1|||
129490692|NCT00469014|466088176|FG003|Adaptive Randomization|Death|0|||
129490693|NCT02190435|466088178|FG000|Overall Study|First 12 patients were lead-ins|12|||
129490694|NCT02190435|466088179|FG001|Overall Study|First 12 patients were lead-ins|0|||
129490695|NCT02190435|466088178|FG000|Overall Study|3 consented screen fails|3|||
129490696|NCT02190435|466088179|FG001|Overall Study|3 consented screen fails|0|||
129490697|NCT02269319|466088180|FG000|Overall Study|Lost to Follow-up|4|||
129490698|NCT02269319|466088181|FG001|Overall Study|Lost to Follow-up|3|||
129490699|NCT02269319|466088180|FG000|Overall Study|Adverse Event|0|||
129490700|NCT02269319|466088181|FG001|Overall Study|Adverse Event|1|||
129490701|NCT02269319|466088180|FG000|Overall Study|Instructions not followed|1|||
129490702|NCT02269319|466088181|FG001|Overall Study|Instructions not followed|0|||
129490703|NCT01589094|466088182|FG000|Overall Study|Did not receive treatment|2|||
129490704|NCT03575468|466088183|FG000|Overall Study|Withdrawal by Subject|3|||
129490705|NCT03575468|466088184|FG001|Overall Study|Withdrawal by Subject|0|||
129490706|NCT03575468|466088183|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
129490707|NCT03575468|466088184|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
129490708|NCT03575468|466088183|FG000|Overall Study|Lost to Follow-up|13|||
129490709|NCT03575468|466088184|FG001|Overall Study|Lost to Follow-up|17|||
129490710|NCT05270694|466089472|FG000|Overall Study|Death|1|||
129490711|NCT05270694|466089472|FG000|Overall Study|Medical issues impacted ability to participate|2|||
129490712|NCT05270694|466089472|FG000|Overall Study|Lost to Follow-up|3|||
129490713|NCT05270694|466089472|FG000|Overall Study|Withdrawal by Subject|3|||
129490714|NCT01991977|466089473|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
129490715|NCT01991977|466089473|FG000|Overall Study|Withdrew after start of treatment|5|||
129490716|NCT02531035|466089480|FG000|Overall Study|Death|0|||
129490717|NCT02531035|466089481|FG001|Overall Study|Death|1|||
129490718|NCT02531035|466089480|FG000|Overall Study|Protocol Violation|1|||
129490719|NCT02531035|466089481|FG001|Overall Study|Protocol Violation|1|||
129490720|NCT02531035|466089480|FG000|Overall Study|Noncompliance with study drug|8|||
129490721|NCT02531035|466089481|FG001|Overall Study|Noncompliance with study drug|3|||
129490722|NCT02531035|466089480|FG000|Overall Study|Physician Decision|1|||
129490723|NCT02531035|466089481|FG001|Overall Study|Physician Decision|0|||
129490724|NCT02531035|466089480|FG000|Overall Study|Adverse Event|16|||
129490725|NCT02531035|466089481|FG001|Overall Study|Adverse Event|45|||
129490726|NCT02531035|466089480|FG000|Overall Study|Other|3|||
129490727|NCT02531035|466089481|FG001|Overall Study|Other|2|||
129490728|NCT02531035|466089480|FG000|Overall Study|Withdrawal by Subject|42|||
129490729|NCT02531035|466089481|FG001|Overall Study|Withdrawal by Subject|32|||
129490730|NCT02531035|466089480|FG000|Overall Study|Lost to Follow-up|8|||
129490731|NCT02531035|466089481|FG001|Overall Study|Lost to Follow-up|10|||
129490732|NCT02531035|466089480|FG000|Overall Study|Randomized, not treated|2|||
129490733|NCT02531035|466089481|FG001|Overall Study|Randomized, not treated|1|||
129490734|NCT03032068|466089491|FG000|Overall Study|Adverse Event|1|||
129490735|NCT01597622|466089492|FG000|Overall Study|Adverse Event|7|||
129490736|NCT01597622|466089492|FG000|Overall Study|Lack of Efficacy|3|||
129490737|NCT01597622|466089492|FG000|Overall Study|Protocol Violation|1|||
129490738|NCT01597622|466089492|FG000|Overall Study|Lost to Follow-up|1|||
129490739|NCT01597622|466089492|FG000|Overall Study|Investigator Discretion|5|||
129490740|NCT01597622|466089492|FG000|Overall Study|Withdrawal by Subject|20|||
129490741|NCT01597622|466089492|FG000|Overall Study|Death|1|||
129490742|NCT03918642|466089494|FG000|Overall Study|Lost to Follow-up|12|||
129490743|NCT03918642|466089495|FG001|Overall Study|Lost to Follow-up|10|||
129490744|NCT03825042|466089496|FG000|Overall Study|Adverse Event|1|||
129490745|NCT03825042|466089497|FG001|Overall Study|Adverse Event|0|||
129490746|NCT03825042|466089496|FG000|Overall Study|Withdrawal by Subject|1|||
129490747|NCT03825042|466089497|FG001|Overall Study|Withdrawal by Subject|0|||
129490748|NCT00500149|466089505|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
129490749|NCT00500149|466089506|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
129490750|NCT00500149|466089505|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
129490751|NCT00500149|466089506|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
129980666|NCT01214642|467891706|FG010|Overall Study|Death|1|||
129980667|NCT01214642|467891707|FG011|Overall Study|Death|0|||
129980668|NCT01214642|467891696|FG000|Overall Study|Withdrawal by Subject|0|||
129490752|NCT00500149|466089505|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
129490753|NCT00500149|466089506|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
129490754|NCT00500149|466089505|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
129980669|NCT01214642|467891697|FG001|Overall Study|Withdrawal by Subject|0|||
129980670|NCT01214642|467891698|FG002|Overall Study|Withdrawal by Subject|1|||
129980671|NCT01214642|467891699|FG003|Overall Study|Withdrawal by Subject|0|||
129490755|NCT00500149|466089506|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
129490756|NCT00500149|466089505|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
129490757|NCT00500149|466089506|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
129490758|NCT00500149|466089505|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
129490759|NCT00500149|466089506|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
129490760|NCT00500149|466089505|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
129490761|NCT00500149|466089506|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
129490762|NCT00521339|466089507|FG000|Treatment Phase|Adverse Event|2|||
129490763|NCT00521339|466089508|FG001|Treatment Phase|Adverse Event|0|||
129490764|NCT00521339|466089509|FG002|Treatment Phase|Adverse Event|0|||
129490765|NCT00521339|466089507|FG000|Treatment Phase|Intolerability to study drug|2|||
129490766|NCT00521339|466089508|FG001|Treatment Phase|Intolerability to study drug|0|||
129490767|NCT00521339|466089509|FG002|Treatment Phase|Intolerability to study drug|0|||
129490768|NCT00521339|466089507|FG000|Treatment Phase|Lack of Efficacy|3|||
129490769|NCT00521339|466089508|FG001|Treatment Phase|Lack of Efficacy|0|||
129490770|NCT00521339|466089509|FG002|Treatment Phase|Lack of Efficacy|0|||
129490771|NCT00521339|466089507|FG000|Treatment Phase|Withdrawal by Subject|3|||
129490772|NCT00521339|466089508|FG001|Treatment Phase|Withdrawal by Subject|0|||
129490773|NCT00521339|466089509|FG002|Treatment Phase|Withdrawal by Subject|0|||
129490774|NCT00521339|466089507|FG000|Treatment Phase|Lost to Follow-up|1|||
129490775|NCT00521339|466089508|FG001|Treatment Phase|Lost to Follow-up|0|||
129490776|NCT00521339|466089509|FG002|Treatment Phase|Lost to Follow-up|0|||
129490777|NCT00521339|466089507|FG000|Treatment Phase|Protocol Violation|1|||
129490778|NCT00521339|466089508|FG001|Treatment Phase|Protocol Violation|0|||
129490779|NCT00521339|466089509|FG002|Treatment Phase|Protocol Violation|0|||
129490780|NCT00521339|466089507|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
129490781|NCT00521339|466089508|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
129490782|NCT00521339|466089509|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
129490783|NCT00521339|466089507|FG000|Treatment Extension Phase|Death|0|||
129490784|NCT00521339|466089508|FG001|Treatment Extension Phase|Death|0|||
129490785|NCT00521339|466089509|FG002|Treatment Extension Phase|Death|1|||
129490786|NCT00089843|466089510|FG000|Overall Study|Withdrawal by Subject|1|||
129490787|NCT00089843|466089511|FG001|Overall Study|Withdrawal by Subject|4|||
129490788|NCT00089843|466089512|FG002|Overall Study|Withdrawal by Subject|5|||
129490789|NCT00089843|466089513|FG003|Overall Study|Withdrawal by Subject|6|||
129490790|NCT00089843|466089510|FG000|Overall Study|Physician Decision|1|||
129490791|NCT00089843|466089511|FG001|Overall Study|Physician Decision|0|||
129490792|NCT00089843|466089512|FG002|Overall Study|Physician Decision|0|||
129490793|NCT00089843|466089513|FG003|Overall Study|Physician Decision|1|||
129490794|NCT03042611|466089514|FG000|Core Phase|Withdrawal by Subject|13|||
129490795|NCT03042611|466089515|FG001|Core Phase|Withdrawal by Subject|4|||
129490796|NCT03042611|466089516|FG002|Core Phase|Withdrawal by Subject|0|||
129490797|NCT03042611|466089517|FG003|Core Phase|Withdrawal by Subject|0|||
129490798|NCT03042611|466089514|FG000|Core Phase|Death|232|||
129490799|NCT03042611|466089515|FG001|Core Phase|Death|110|||
129490800|NCT03042611|466089516|FG002|Core Phase|Death|0|||
129490801|NCT03042611|466089517|FG003|Core Phase|Death|0|||
129490802|NCT03042611|466089514|FG000|Core Phase|Lost to Follow-up|4|||
129490803|NCT03042611|466089515|FG001|Core Phase|Lost to Follow-up|7|||
129490804|NCT03042611|466089516|FG002|Core Phase|Lost to Follow-up|0|||
129490805|NCT03042611|466089517|FG003|Core Phase|Lost to Follow-up|0|||
129490806|NCT03042611|466089514|FG000|Core Phase|Physician Decision|7|||
129490807|NCT03042611|466089515|FG001|Core Phase|Physician Decision|2|||
129490808|NCT03042611|466089516|FG002|Core Phase|Physician Decision|0|||
129490809|NCT03042611|466089517|FG003|Core Phase|Physician Decision|0|||
129490810|NCT03042611|466089514|FG000|Core Phase|Study Closed|0|||
129490811|NCT03042611|466089515|FG001|Core Phase|Study Closed|1|||
129490812|NCT03042611|466089516|FG002|Core Phase|Study Closed|0|||
129490813|NCT03042611|466089517|FG003|Core Phase|Study Closed|0|||
129490814|NCT03042611|466089514|FG000|Extension Phase|Death|0|||
129490815|NCT03042611|466089515|FG001|Extension Phase|Death|0|||
129490816|NCT03042611|466089516|FG002|Extension Phase|Death|34|||
129490817|NCT03042611|466089517|FG003|Extension Phase|Death|16|||
129490818|NCT03042611|466089514|FG000|Extension Phase|Lost to Follow-up|0|||
129490819|NCT03042611|466089515|FG001|Extension Phase|Lost to Follow-up|0|||
129490820|NCT03042611|466089516|FG002|Extension Phase|Lost to Follow-up|1|||
129490821|NCT03042611|466089517|FG003|Extension Phase|Lost to Follow-up|1|||
129490822|NCT03042611|466089514|FG000|Extension Phase|Study Closed|0|||
129490823|NCT03042611|466089515|FG001|Extension Phase|Study Closed|0|||
129490824|NCT03042611|466089516|FG002|Extension Phase|Study Closed|17|||
129490825|NCT03042611|466089517|FG003|Extension Phase|Study Closed|11|||
129490826|NCT03567291|466089522|FG000|Period I|Adverse Event|14|||
129980672|NCT01214642|467891700|FG004|Overall Study|Withdrawal by Subject|0|||
129980673|NCT01214642|467891701|FG005|Overall Study|Withdrawal by Subject|0|||
129490827|NCT03567291|466089523|FG001|Period I|Adverse Event|0|||
129490828|NCT03567291|466089524|FG002|Period I|Adverse Event|0|||
129490829|NCT03567291|466089525|FG003|Period I|Adverse Event|0|||
129490830|NCT03567291|466089522|FG000|Period I|Protocol Violation|1|||
129490831|NCT03567291|466089523|FG001|Period I|Protocol Violation|0|||
129490832|NCT03567291|466089524|FG002|Period I|Protocol Violation|0|||
129490833|NCT03567291|466089525|FG003|Period I|Protocol Violation|0|||
129490834|NCT03567291|466089522|FG000|Period I|Withdrawal by Subject|23|||
129490835|NCT03567291|466089523|FG001|Period I|Withdrawal by Subject|0|||
129490836|NCT03567291|466089524|FG002|Period I|Withdrawal by Subject|0|||
129490837|NCT03567291|466089525|FG003|Period I|Withdrawal by Subject|0|||
129490838|NCT03567291|466089522|FG000|Period I|Lost to Follow-up|2|||
129490839|NCT03567291|466089523|FG001|Period I|Lost to Follow-up|0|||
129490840|NCT03567291|466089524|FG002|Period I|Lost to Follow-up|0|||
129490841|NCT03567291|466089525|FG003|Period I|Lost to Follow-up|0|||
129490842|NCT03567291|466089522|FG000|Period I|Terminated by sponsor|44|||
129490843|NCT03567291|466089523|FG001|Period I|Terminated by sponsor|0|||
129490844|NCT03567291|466089524|FG002|Period I|Terminated by sponsor|0|||
129490845|NCT03567291|466089525|FG003|Period I|Terminated by sponsor|0|||
129490846|NCT03567291|466089522|FG000|Period I|Missing or unknown|7|||
129490847|NCT03567291|466089523|FG001|Period I|Missing or unknown|0|||
129490848|NCT03567291|466089524|FG002|Period I|Missing or unknown|0|||
129490849|NCT03567291|466089525|FG003|Period I|Missing or unknown|0|||
129490850|NCT03567291|466089522|FG000|Period II|Adverse Event|0|||
129490851|NCT03567291|466089523|FG001|Period II|Adverse Event|1|||
129490852|NCT03567291|466089524|FG002|Period II|Adverse Event|0|||
129490853|NCT03567291|466089525|FG003|Period II|Adverse Event|0|||
129490854|NCT03567291|466089522|FG000|Period II|Missing or unknown|0|||
129490855|NCT03567291|466089523|FG001|Period II|Missing or unknown|2|||
129490856|NCT03567291|466089524|FG002|Period II|Missing or unknown|1|||
129490857|NCT03567291|466089525|FG003|Period II|Missing or unknown|0|||
129490858|NCT03567291|466089522|FG000|Period III|Adverse Event|0|||
129490859|NCT03567291|466089523|FG001|Period III|Adverse Event|0|||
129490860|NCT03567291|466089524|FG002|Period III|Adverse Event|0|||
129490861|NCT03567291|466089525|FG003|Period III|Adverse Event|4|||
129490862|NCT03567291|466089522|FG000|Period III|Withdrawal by Subject|0|||
129490863|NCT03567291|466089523|FG001|Period III|Withdrawal by Subject|0|||
129490864|NCT03567291|466089524|FG002|Period III|Withdrawal by Subject|0|||
129490865|NCT03567291|466089525|FG003|Period III|Withdrawal by Subject|4|||
129490866|NCT03567291|466089522|FG000|Period III|Lost to Follow-up|0|||
129490867|NCT03567291|466089523|FG001|Period III|Lost to Follow-up|0|||
129490868|NCT03567291|466089524|FG002|Period III|Lost to Follow-up|0|||
129490869|NCT03567291|466089525|FG003|Period III|Lost to Follow-up|1|||
129490870|NCT03567291|466089522|FG000|Period III|Terminated by sponsor|0|||
129490871|NCT03567291|466089523|FG001|Period III|Terminated by sponsor|0|||
129490872|NCT03567291|466089524|FG002|Period III|Terminated by sponsor|0|||
129490873|NCT03567291|466089525|FG003|Period III|Terminated by sponsor|68|||
129490874|NCT03567291|466089522|FG000|Period III|Missing or unknown|0|||
129490875|NCT03567291|466089523|FG001|Period III|Missing or unknown|0|||
129490876|NCT03567291|466089524|FG002|Period III|Missing or unknown|0|||
129490877|NCT03567291|466089525|FG003|Period III|Missing or unknown|8|||
129490878|NCT01103349|466089526|FG000|Overall Study|Adverse Event|8|||
129490879|NCT01103349|466089527|FG001|Overall Study|Adverse Event|5|||
129490880|NCT01103349|466089528|FG002|Overall Study|Adverse Event|3|||
129490881|NCT01103349|466089526|FG000|Overall Study|Consent withdrawn|1|||
129490882|NCT01103349|466089527|FG001|Overall Study|Consent withdrawn|0|||
129490883|NCT01103349|466089528|FG002|Overall Study|Consent withdrawn|0|||
129490884|NCT01103349|466089526|FG000|Overall Study|Incorrectly included in the trial|1|||
129490885|NCT01103349|466089527|FG001|Overall Study|Incorrectly included in the trial|0|||
129490886|NCT01103349|466089528|FG002|Overall Study|Incorrectly included in the trial|0|||
129490887|NCT01103349|466089526|FG000|Overall Study|Withdrawal by Subject|1|||
129490888|NCT01103349|466089527|FG001|Overall Study|Withdrawal by Subject|1|||
129490889|NCT01103349|466089528|FG002|Overall Study|Withdrawal by Subject|0|||
129490890|NCT01103349|466089526|FG000|Overall Study|did not want to take trial medication|0|||
129490891|NCT01103349|466089527|FG001|Overall Study|did not want to take trial medication|1|||
129490892|NCT01103349|466089528|FG002|Overall Study|did not want to take trial medication|0|||
129490893|NCT01103349|466089526|FG000|Overall Study|forgot to take medication|0|||
129490894|NCT01103349|466089527|FG001|Overall Study|forgot to take medication|0|||
129490895|NCT01103349|466089528|FG002|Overall Study|forgot to take medication|1|||
129490896|NCT00090285|466089529|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
129490897|NCT00090285|466089530|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
129490898|NCT00090285|466089531|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129490899|NCT00090285|466089532|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129490900|NCT00090285|466089533|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129490901|NCT00090285|466089534|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
129490902|NCT00090285|466089529|FG000|Base Study Vaccination Period|Adverse Event|2|||
129490903|NCT00090285|466089530|FG001|Base Study Vaccination Period|Adverse Event|4|||
129490904|NCT00090285|466089531|FG002|Base Study Vaccination Period|Adverse Event|0|||
129490905|NCT00090285|466089532|FG003|Base Study Vaccination Period|Adverse Event|0|||
129490906|NCT00090285|466089533|FG004|Base Study Vaccination Period|Adverse Event|0|||
129490907|NCT00090285|466089534|FG005|Base Study Vaccination Period|Adverse Event|0|||
129490908|NCT00090285|466089529|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
129490909|NCT00090285|466089530|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
129490910|NCT00090285|466089531|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
129490911|NCT00090285|466089532|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
129490912|NCT00090285|466089533|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
129490913|NCT00090285|466089534|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
129490914|NCT00090285|466089529|FG000|Base Study Vaccination Period|Protocol Violation|2|||
129490915|NCT00090285|466089530|FG001|Base Study Vaccination Period|Protocol Violation|3|||
129490916|NCT00090285|466089531|FG002|Base Study Vaccination Period|Protocol Violation|0|||
129490917|NCT00090285|466089532|FG003|Base Study Vaccination Period|Protocol Violation|0|||
129490918|NCT00090285|466089533|FG004|Base Study Vaccination Period|Protocol Violation|0|||
129490919|NCT00090285|466089534|FG005|Base Study Vaccination Period|Protocol Violation|0|||
129490920|NCT00090285|466089529|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
129490921|NCT00090285|466089530|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
129490922|NCT00090285|466089531|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
129490923|NCT00090285|466089532|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
129490924|NCT00090285|466089533|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
129490925|NCT00090285|466089534|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
129490926|NCT00090285|466089529|FG000|Base Study Vaccination Period|Uncooperative|2|||
129490927|NCT00090285|466089530|FG001|Base Study Vaccination Period|Uncooperative|2|||
129490928|NCT00090285|466089531|FG002|Base Study Vaccination Period|Uncooperative|0|||
129490929|NCT00090285|466089532|FG003|Base Study Vaccination Period|Uncooperative|0|||
129490930|NCT00090285|466089533|FG004|Base Study Vaccination Period|Uncooperative|0|||
129490931|NCT00090285|466089534|FG005|Base Study Vaccination Period|Uncooperative|0|||
129490932|NCT00090285|466089529|FG000|Base Study Vaccination Period|Moved|20|||
129490933|NCT00090285|466089530|FG001|Base Study Vaccination Period|Moved|21|||
129490934|NCT00090285|466089531|FG002|Base Study Vaccination Period|Moved|0|||
129490935|NCT00090285|466089532|FG003|Base Study Vaccination Period|Moved|0|||
129490936|NCT00090285|466089533|FG004|Base Study Vaccination Period|Moved|0|||
129490937|NCT00090285|466089534|FG005|Base Study Vaccination Period|Moved|0|||
129490938|NCT00090285|466089529|FG000|Base Study Vaccination Period|Site Terminated|1|||
129490939|NCT00090285|466089530|FG001|Base Study Vaccination Period|Site Terminated|0|||
129490940|NCT00090285|466089531|FG002|Base Study Vaccination Period|Site Terminated|0|||
129490941|NCT00090285|466089532|FG003|Base Study Vaccination Period|Site Terminated|0|||
129490942|NCT00090285|466089533|FG004|Base Study Vaccination Period|Site Terminated|0|||
129490943|NCT00090285|466089534|FG005|Base Study Vaccination Period|Site Terminated|0|||
129490944|NCT00090285|466089529|FG000|Base Study Vaccination Period|Other|2|||
129490945|NCT00090285|466089530|FG001|Base Study Vaccination Period|Other|2|||
129490946|NCT00090285|466089531|FG002|Base Study Vaccination Period|Other|0|||
129490947|NCT00090285|466089532|FG003|Base Study Vaccination Period|Other|0|||
129490948|NCT00090285|466089533|FG004|Base Study Vaccination Period|Other|0|||
129490949|NCT00090285|466089534|FG005|Base Study Vaccination Period|Other|0|||
129490950|NCT00090285|466089529|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
129490951|NCT00090285|466089530|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
129490952|NCT00090285|466089531|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
129490953|NCT00090285|466089532|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
129490954|NCT00090285|466089533|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
129490955|NCT00090285|466089534|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
129490956|NCT00090285|466089529|FG000|Base Study Vaccination Period|HIV positive|1|||
129490957|NCT00090285|466089530|FG001|Base Study Vaccination Period|HIV positive|1|||
129490958|NCT00090285|466089531|FG002|Base Study Vaccination Period|HIV positive|0|||
129490959|NCT00090285|466089532|FG003|Base Study Vaccination Period|HIV positive|0|||
129490960|NCT00090285|466089533|FG004|Base Study Vaccination Period|HIV positive|0|||
129490961|NCT00090285|466089534|FG005|Base Study Vaccination Period|HIV positive|0|||
129490962|NCT00090285|466089529|FG000|Base Study Follow-up Period|Adverse Event|3|||
129490963|NCT00090285|466089530|FG001|Base Study Follow-up Period|Adverse Event|10|||
129490964|NCT00090285|466089531|FG002|Base Study Follow-up Period|Adverse Event|0|||
129490965|NCT00090285|466089532|FG003|Base Study Follow-up Period|Adverse Event|0|||
129490966|NCT00090285|466089533|FG004|Base Study Follow-up Period|Adverse Event|0|||
129490967|NCT00090285|466089534|FG005|Base Study Follow-up Period|Adverse Event|0|||
129490968|NCT00090285|466089529|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
129490969|NCT00090285|466089530|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
129490970|NCT00090285|466089531|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
129490971|NCT00090285|466089532|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
129490972|NCT00090285|466089533|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
129490973|NCT00090285|466089534|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
129490974|NCT00090285|466089529|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
129490975|NCT00090285|466089530|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
129490976|NCT00090285|466089531|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
129490977|NCT00090285|466089532|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
129490978|NCT00090285|466089533|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
129490979|NCT00090285|466089534|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
129490980|NCT00090285|466089529|FG000|Base Study Follow-up Period|Moved|41|||
129490981|NCT00090285|466089530|FG001|Base Study Follow-up Period|Moved|36|||
129490982|NCT00090285|466089531|FG002|Base Study Follow-up Period|Moved|0|||
129490983|NCT00090285|466089532|FG003|Base Study Follow-up Period|Moved|0|||
129490984|NCT00090285|466089533|FG004|Base Study Follow-up Period|Moved|0|||
129490985|NCT00090285|466089534|FG005|Base Study Follow-up Period|Moved|0|||
129490986|NCT00090285|466089529|FG000|Base Study Follow-up Period|Other|2|||
129980674|NCT01214642|467891702|FG006|Overall Study|Withdrawal by Subject|0|||
129980675|NCT01214642|467891703|FG007|Overall Study|Withdrawal by Subject|0|||
129490987|NCT00090285|466089530|FG001|Base Study Follow-up Period|Other|0|||
129490988|NCT00090285|466089531|FG002|Base Study Follow-up Period|Other|0|||
129490989|NCT00090285|466089532|FG003|Base Study Follow-up Period|Other|0|||
129490990|NCT00090285|466089533|FG004|Base Study Follow-up Period|Other|0|||
129490991|NCT00090285|466089534|FG005|Base Study Follow-up Period|Other|0|||
129490992|NCT00090285|466089529|FG000|Base Study Follow-up Period|Protocol Violation|1|||
129490993|NCT00090285|466089530|FG001|Base Study Follow-up Period|Protocol Violation|0|||
129490994|NCT00090285|466089531|FG002|Base Study Follow-up Period|Protocol Violation|0|||
129490995|NCT00090285|466089532|FG003|Base Study Follow-up Period|Protocol Violation|0|||
129490996|NCT00090285|466089533|FG004|Base Study Follow-up Period|Protocol Violation|0|||
129490997|NCT00090285|466089534|FG005|Base Study Follow-up Period|Protocol Violation|0|||
129490998|NCT00090285|466089529|FG000|Base Study Follow-up Period|Uncooperative|3|||
129490999|NCT00090285|466089530|FG001|Base Study Follow-up Period|Uncooperative|4|||
129491000|NCT00090285|466089531|FG002|Base Study Follow-up Period|Uncooperative|0|||
129491001|NCT00090285|466089532|FG003|Base Study Follow-up Period|Uncooperative|0|||
129491002|NCT00090285|466089533|FG004|Base Study Follow-up Period|Uncooperative|0|||
129491003|NCT00090285|466089534|FG005|Base Study Follow-up Period|Uncooperative|0|||
129491004|NCT00090285|466089529|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
129491005|NCT00090285|466089530|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
129491006|NCT00090285|466089531|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
129491007|NCT00090285|466089532|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
129491008|NCT00090285|466089533|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
129491009|NCT00090285|466089534|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
129491010|NCT00090285|466089529|FG000|Extension 1|Adverse Event|0|||
129491011|NCT00090285|466089530|FG001|Extension 1|Adverse Event|0|||
129491012|NCT00090285|466089531|FG002|Extension 1|Adverse Event|2|||
129491013|NCT00090285|466089532|FG003|Extension 1|Adverse Event|0|||
129491014|NCT00090285|466089533|FG004|Extension 1|Adverse Event|0|||
129491015|NCT00090285|466089534|FG005|Extension 1|Adverse Event|0|||
129491016|NCT00090285|466089529|FG000|Extension 1|Lost to Follow-up|0|||
129491017|NCT00090285|466089530|FG001|Extension 1|Lost to Follow-up|0|||
129491018|NCT00090285|466089531|FG002|Extension 1|Lost to Follow-up|35|||
129491019|NCT00090285|466089532|FG003|Extension 1|Lost to Follow-up|0|||
129491020|NCT00090285|466089533|FG004|Extension 1|Lost to Follow-up|0|||
129491021|NCT00090285|466089534|FG005|Extension 1|Lost to Follow-up|0|||
129491022|NCT00090285|466089529|FG000|Extension 1|Withdrawal by Subject|0|||
129491023|NCT00090285|466089530|FG001|Extension 1|Withdrawal by Subject|0|||
129491024|NCT00090285|466089531|FG002|Extension 1|Withdrawal by Subject|13|||
129491025|NCT00090285|466089532|FG003|Extension 1|Withdrawal by Subject|1|||
129491026|NCT00090285|466089533|FG004|Extension 1|Withdrawal by Subject|0|||
129491027|NCT00090285|466089534|FG005|Extension 1|Withdrawal by Subject|0|||
129491028|NCT00090285|466089529|FG000|Extension 1|Other|0|||
129491029|NCT00090285|466089530|FG001|Extension 1|Other|0|||
129491030|NCT00090285|466089531|FG002|Extension 1|Other|4|||
129491031|NCT00090285|466089532|FG003|Extension 1|Other|0|||
129491032|NCT00090285|466089533|FG004|Extension 1|Other|0|||
129491033|NCT00090285|466089534|FG005|Extension 1|Other|0|||
129491034|NCT00090285|466089529|FG000|Extension 1|Moved|0|||
129491035|NCT00090285|466089530|FG001|Extension 1|Moved|0|||
129491036|NCT00090285|466089531|FG002|Extension 1|Moved|3|||
129491037|NCT00090285|466089532|FG003|Extension 1|Moved|0|||
129491038|NCT00090285|466089533|FG004|Extension 1|Moved|0|||
129491039|NCT00090285|466089534|FG005|Extension 1|Moved|0|||
129491040|NCT00090285|466089529|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
129491041|NCT00090285|466089530|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
129491042|NCT00090285|466089531|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
129491043|NCT00090285|466089532|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
129491044|NCT00090285|466089533|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
129491045|NCT00090285|466089534|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
129491046|NCT00090285|466089529|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129491047|NCT00090285|466089530|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129491048|NCT00090285|466089531|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129491049|NCT00090285|466089532|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
129491050|NCT00090285|466089533|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
129491051|NCT00090285|466089534|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
129491052|NCT00090285|466089529|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129491053|NCT00090285|466089530|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129491054|NCT00090285|466089531|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129491055|NCT00090285|466089532|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
129491056|NCT00090285|466089533|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
129491057|NCT00090285|466089534|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
129491058|NCT00090285|466089529|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
129491059|NCT00090285|466089530|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
129491060|NCT00090285|466089531|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
129491061|NCT00090285|466089532|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
129491062|NCT00090285|466089533|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
129491063|NCT00090285|466089534|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
129491064|NCT00907478|466089535|FG000|Overall Study|Ineligibility determined|0|||
129491065|NCT00907478|466089536|FG001|Overall Study|Ineligibility determined|0|||
129491066|NCT00907478|466089537|FG002|Overall Study|Ineligibility determined|1|||
129491067|NCT00907478|466089535|FG000|Overall Study|Noncompliance|0|||
129491068|NCT00907478|466089536|FG001|Overall Study|Noncompliance|0|||
129491069|NCT00907478|466089537|FG002|Overall Study|Noncompliance|1|||
129491070|NCT00907478|466089535|FG000|Overall Study|Adverse Event|3|||
129491071|NCT00907478|466089536|FG001|Overall Study|Adverse Event|1|||
129491072|NCT00907478|466089537|FG002|Overall Study|Adverse Event|2|||
129491073|NCT00907478|466089535|FG000|Overall Study|Withdrawal by Subject|8|||
129491074|NCT00907478|466089536|FG001|Overall Study|Withdrawal by Subject|9|||
129491075|NCT00907478|466089537|FG002|Overall Study|Withdrawal by Subject|6|||
129491076|NCT00907478|466089535|FG000|Overall Study|Requirement for alternative therapy|1|||
129491077|NCT00907478|466089536|FG001|Overall Study|Requirement for alternative therapy|2|||
129491078|NCT00907478|466089537|FG002|Overall Study|Requirement for alternative therapy|3|||
129491079|NCT00907478|466089535|FG000|Overall Study|Physician Decision|2|||
129491080|NCT00907478|466089536|FG001|Overall Study|Physician Decision|0|||
129491081|NCT00907478|466089537|FG002|Overall Study|Physician Decision|3|||
129491082|NCT00907478|466089535|FG000|Overall Study|Death|4|||
129491083|NCT00907478|466089536|FG001|Overall Study|Death|2|||
129491084|NCT00907478|466089537|FG002|Overall Study|Death|1|||
129491085|NCT00907478|466089535|FG000|Overall Study|Protocol-specified criteria|5|||
129491086|NCT00907478|466089536|FG001|Overall Study|Protocol-specified criteria|2|||
129491087|NCT00907478|466089537|FG002|Overall Study|Protocol-specified criteria|3|||
129491088|NCT00907478|466089535|FG000|Overall Study|Pregnancy|0|||
129491089|NCT00907478|466089536|FG001|Overall Study|Pregnancy|1|||
129491090|NCT00907478|466089537|FG002|Overall Study|Pregnancy|1|||
129491091|NCT00907478|466089535|FG000|Overall Study|Lost to Follow-up|1|||
129491092|NCT00907478|466089536|FG001|Overall Study|Lost to Follow-up|0|||
129491093|NCT00907478|466089537|FG002|Overall Study|Lost to Follow-up|0|||
129491094|NCT00907478|466089535|FG000|Overall Study|Other|3|||
129491095|NCT00907478|466089536|FG001|Overall Study|Other|0|||
129491096|NCT00907478|466089537|FG002|Overall Study|Other|1|||
129491097|NCT02639182|466089538|FG000|Overall Study|Disease Progression|50|||
129491098|NCT02639182|466089539|FG001|Overall Study|Disease Progression|49|||
129491099|NCT02639182|466089538|FG000|Overall Study|Adverse Event|7|||
129491100|NCT02639182|466089539|FG001|Overall Study|Adverse Event|5|||
129491101|NCT02639182|466089538|FG000|Overall Study|Physician Decision|3|||
129491102|NCT02639182|466089539|FG001|Overall Study|Physician Decision|3|||
129491103|NCT02639182|466089538|FG000|Overall Study|Withdrew Consent|5|||
129491104|NCT02639182|466089539|FG001|Overall Study|Withdrew Consent|4|||
129491105|NCT02639182|466089538|FG000|Overall Study|Lost to Follow-up|0|||
129491106|NCT02639182|466089539|FG001|Overall Study|Lost to Follow-up|1|||
129491107|NCT02639182|466089538|FG000|Overall Study|Study Closure|1|||
129491108|NCT02639182|466089539|FG001|Overall Study|Study Closure|2|||
129491109|NCT02639182|466089538|FG000|Overall Study|Sponsor Ended Study|0|||
129491110|NCT02639182|466089539|FG001|Overall Study|Sponsor Ended Study|1|||
129491111|NCT02639182|466089538|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
129491112|NCT02639182|466089539|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
129491113|NCT03069690|466089540|FG000|Pregnancy Intervention|Pregnancy loss|9|||
129491114|NCT03069690|466089541|FG001|Pregnancy Intervention|Pregnancy loss|4|||
129491115|NCT03069690|466089542|FG002|Pregnancy Intervention|Pregnancy loss|0|||
129491116|NCT03069690|466089543|FG003|Pregnancy Intervention|Pregnancy loss|0|||
129491117|NCT03069690|466089544|FG004|Pregnancy Intervention|Pregnancy loss|0|||
129491118|NCT03069690|466089545|FG005|Pregnancy Intervention|Pregnancy loss|0|||
129491119|NCT03069690|466089540|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
129491120|NCT03069690|466089541|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
129491121|NCT03069690|466089542|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
129491122|NCT03069690|466089543|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
129491123|NCT03069690|466089544|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
129491124|NCT03069690|466089545|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
129491125|NCT03069690|466089540|FG000|Postpartum Intervention|Lost to Follow-up|0|||
129491126|NCT03069690|466089541|FG001|Postpartum Intervention|Lost to Follow-up|0|||
129491127|NCT03069690|466089542|FG002|Postpartum Intervention|Lost to Follow-up|5|||
129491128|NCT03069690|466089543|FG003|Postpartum Intervention|Lost to Follow-up|5|||
129491129|NCT03069690|466089544|FG004|Postpartum Intervention|Lost to Follow-up|2|||
129491130|NCT03069690|466089545|FG005|Postpartum Intervention|Lost to Follow-up|4|||
129491131|NCT01372878|466089546|FG000|Overall Study|Withdrawal by Subject|63|||
129491132|NCT01372878|466089546|FG000|Overall Study|Protocol Violation|17|||
129491133|NCT01372878|466089546|FG000|Overall Study|incomplete study procedure|104|||
129491134|NCT04504032|466089547|FG000|Overall Study|Adverse Event|1|||
129491135|NCT04504032|466089548|FG001|Overall Study|Adverse Event|2|||
129491136|NCT04504032|466089547|FG000|Overall Study|Lost to Follow-up|6|||
129491137|NCT04504032|466089548|FG001|Overall Study|Lost to Follow-up|9|||
129491138|NCT04504032|466089547|FG000|Overall Study|Protocol Violation|2|||
129491139|NCT04504032|466089548|FG001|Overall Study|Protocol Violation|0|||
129491140|NCT04504032|466089547|FG000|Overall Study|Study terminated by sponsor|1|||
129491141|NCT04504032|466089548|FG001|Overall Study|Study terminated by sponsor|2|||
129491142|NCT04504032|466089547|FG000|Overall Study|Withdrawal by Subject|9|||
129491143|NCT04504032|466089548|FG001|Overall Study|Withdrawal by Subject|11|||
129491144|NCT04504032|466089547|FG000|Overall Study|Disease progression prior to dosing|15|||
129491145|NCT04504032|466089548|FG001|Overall Study|Disease progression prior to dosing|3|||
129491146|NCT04504032|466089547|FG000|Overall Study|Drug supply issues|1|||
129491147|NCT04504032|466089548|FG001|Overall Study|Drug supply issues|1|||
129491148|NCT04504032|466089547|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
129491149|NCT04504032|466089548|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
129491150|NCT02416908|466089551|FG000|Dose Escalation Phase|Adverse Event|0|||
129491151|NCT02416908|466089552|FG001|Dose Escalation Phase|Adverse Event|0|||
129491152|NCT02416908|466089553|FG002|Dose Escalation Phase|Adverse Event|3|||
129491153|NCT02416908|466089554|FG003|Dose Escalation Phase|Adverse Event|0|||
129491154|NCT02416908|466089551|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129491155|NCT02416908|466089552|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129491156|NCT02416908|466089553|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
129491157|NCT02416908|466089554|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129491158|NCT00940342|466089557|FG000|Overall Study|Adverse Event|0|||
129491159|NCT00940342|466089558|FG001|Overall Study|Adverse Event|2|||
129491160|NCT00940342|466089559|FG002|Overall Study|Adverse Event|1|||
129491161|NCT03792750|466089561|FG000|Overall Study|Death|3|||
129491162|NCT00700752|466089566|FG000|First Intervention|Withdrawal by Subject|0|||
129491163|NCT00700752|466089567|FG001|First Intervention|Withdrawal by Subject|2|||
129491164|NCT01645930|466089568|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
129491165|NCT01645930|466089568|FG000|Overall Study|Progressive Disease|12|||
129491166|NCT01645930|466089568|FG000|Overall Study|Adverse Event|4|||
129491167|NCT01645930|466089568|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
129491168|NCT01645930|466089568|FG000|Overall Study|Withdrawal by Participant|2|||
129491169|NCT01645930|466089568|FG000|Overall Study|Reason not Defined|1|||
129491170|NCT02522377|466089569|FG000|Overall Study|Withdrawal by Subject|1|||
129491171|NCT02522377|466089570|FG001|Overall Study|Withdrawal by Subject|0|||
129491172|NCT02522377|466089569|FG000|Overall Study|Remission Achieved|3|||
129491173|NCT02522377|466089570|FG001|Overall Study|Remission Achieved|0|||
129491174|NCT01158950|466089574|FG000|1st Intervention (1 Day)|Physician Decision|1|||
129491175|NCT01158950|466089575|FG001|1st Intervention (1 Day)|Physician Decision|2|||
129491176|NCT00945191|466089576|FG000|Overall Study|Did not achieve a complete response|18|||
129491177|NCT00945191|466089576|FG000|Overall Study|Participant relocated to another state|1|||
129491178|NCT00945191|466089576|FG000|Overall Study|Disease progression|3|||
129491179|NCT00945191|466089576|FG000|Overall Study|Serious adverse event or adverse event|1|||
129491180|NCT00945191|466089576|FG000|Overall Study|Investigator's discretion|1|||
129491181|NCT00312377|466089582|FG000|Overall Study|Death|403|||
129491182|NCT00312377|466089583|FG001|Overall Study|Death|418|||
129491183|NCT00312377|466089582|FG000|Overall Study|Withdrawal by Subject|23|||
129491184|NCT00312377|466089583|FG001|Overall Study|Withdrawal by Subject|30|||
129491185|NCT00312377|466089582|FG000|Overall Study|Lost to Follow-up|9|||
129491186|NCT00312377|466089583|FG001|Overall Study|Lost to Follow-up|12|||
129491187|NCT00312377|466089582|FG000|Overall Study|Non-compliance|0|||
129491188|NCT00312377|466089583|FG001|Overall Study|Non-compliance|2|||
129491189|NCT00312377|466089582|FG000|Overall Study|Randomised but never received treatment|6|||
129491190|NCT00312377|466089583|FG001|Overall Study|Randomised but never received treatment|6|||
129491191|NCT00312377|466089582|FG000|Overall Study|Discontinue treatment survival follow up|202|||
129491192|NCT00312377|466089583|FG001|Overall Study|Discontinue treatment survival follow up|200|||
129491193|NCT00312377|466089582|FG000|Overall Study|Site ended participation in study|1|||
129491194|NCT00312377|466089583|FG001|Overall Study|Site ended participation in study|0|||
129491195|NCT02519231|466089598|FG000|Overall Study|Lost to Follow-up|2|||
129491196|NCT02519231|466089599|FG001|Overall Study|Lost to Follow-up|5|||
129491197|NCT02519231|466089598|FG000|Overall Study|Withdrawal by Subject|0|||
129491198|NCT02519231|466089599|FG001|Overall Study|Withdrawal by Subject|1|||
129491199|NCT02795156|466089601|FG000|Overall Study|Progressive Disease|22|||
129491200|NCT02795156|466089602|FG001|Overall Study|Progressive Disease|7|||
129491201|NCT02795156|466089603|FG002|Overall Study|Progressive Disease|34|||
129491202|NCT02795156|466089604|FG003|Overall Study|Progressive Disease|7|||
129491203|NCT02795156|466089601|FG000|Overall Study|Adverse Event|13|||
129491204|NCT02795156|466089602|FG001|Overall Study|Adverse Event|2|||
129980676|NCT01214642|467891704|FG008|Overall Study|Withdrawal by Subject|3|||
129491205|NCT02795156|466089603|FG002|Overall Study|Adverse Event|3|||
129491206|NCT02795156|466089604|FG003|Overall Study|Adverse Event|2|||
129491207|NCT02795156|466089601|FG000|Overall Study|Death|1|||
129491208|NCT02795156|466089602|FG001|Overall Study|Death|1|||
129491209|NCT02795156|466089603|FG002|Overall Study|Death|1|||
129491210|NCT02795156|466089604|FG003|Overall Study|Death|0|||
129491211|NCT02795156|466089601|FG000|Overall Study|Physician Decision|1|||
129491212|NCT02795156|466089602|FG001|Overall Study|Physician Decision|0|||
129980677|NCT01214642|467891705|FG009|Overall Study|Withdrawal by Subject|1|||
129491213|NCT02795156|466089603|FG002|Overall Study|Physician Decision|1|||
129491214|NCT02795156|466089604|FG003|Overall Study|Physician Decision|0|||
129491215|NCT02795156|466089601|FG000|Overall Study|Withdrawal by Subject|2|||
129491216|NCT02795156|466089602|FG001|Overall Study|Withdrawal by Subject|0|||
129980678|NCT01214642|467891706|FG010|Overall Study|Withdrawal by Subject|1|||
129491217|NCT02795156|466089603|FG002|Overall Study|Withdrawal by Subject|3|||
129491218|NCT02795156|466089604|FG003|Overall Study|Withdrawal by Subject|0|||
129491219|NCT02707757|466089605|FG000|Overall Study|Protocol Violation|3|||
129491220|NCT02707757|466089606|FG001|Overall Study|Protocol Violation|2|||
129491221|NCT02707757|466089605|FG000|Overall Study|Withdrawal by Subject|2|||
129980679|NCT01214642|467891707|FG011|Overall Study|Withdrawal by Subject|0|||
129980680|NCT01214642|467891696|FG000|Overall Study|Physician Decision|0|||
129491222|NCT02707757|466089606|FG001|Overall Study|Withdrawal by Subject|0|||
129491223|NCT02707757|466089605|FG000|Overall Study|Death|0|||
129491224|NCT02707757|466089606|FG001|Overall Study|Death|1|||
129491225|NCT02707757|466089605|FG000|Overall Study|Adverse Event|6|||
129491226|NCT02707757|466089606|FG001|Overall Study|Adverse Event|4|||
129980681|NCT01214642|467891697|FG001|Overall Study|Physician Decision|0|||
129980682|NCT01214642|467891698|FG002|Overall Study|Physician Decision|1|||
129980683|NCT01214642|467891699|FG003|Overall Study|Physician Decision|1|||
129980684|NCT01214642|467891700|FG004|Overall Study|Physician Decision|1|||
129980685|NCT01214642|467891701|FG005|Overall Study|Physician Decision|0|||
129491227|NCT02707757|466089605|FG000|Overall Study|Renal transplant/elective operation|1|||
129491228|NCT02707757|466089606|FG001|Overall Study|Renal transplant/elective operation|5|||
129491229|NCT00652093|466089607|FG000|Overall Study|Withdrawal by Subject|0|||
129491230|NCT00652093|466089608|FG001|Overall Study|Withdrawal by Subject|0|||
129491231|NCT00652093|466089609|FG002|Overall Study|Withdrawal by Subject|1|||
129491232|NCT00652093|466089610|FG003|Overall Study|Withdrawal by Subject|0|||
129491233|NCT00652093|466089611|FG004|Overall Study|Withdrawal by Subject|1|||
129491234|NCT00652093|466089612|FG005|Overall Study|Withdrawal by Subject|0|||
129491235|NCT00652093|466089607|FG000|Overall Study|Physician Decision|0|||
129491236|NCT00652093|466089608|FG001|Overall Study|Physician Decision|0|||
129491237|NCT00652093|466089609|FG002|Overall Study|Physician Decision|0|||
129491238|NCT00652093|466089610|FG003|Overall Study|Physician Decision|0|||
129491239|NCT00652093|466089611|FG004|Overall Study|Physician Decision|1|||
129491240|NCT00652093|466089612|FG005|Overall Study|Physician Decision|0|||
129491241|NCT03176966|466089613|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
129491242|NCT03176966|466089614|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
129491243|NCT03176966|466089613|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
129491244|NCT03176966|466089614|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
129491245|NCT03176966|466089613|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
129491246|NCT03176966|466089614|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
129491247|NCT03176966|466089613|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
129491248|NCT03176966|466089614|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
129491249|NCT03176966|466089613|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
129491250|NCT03176966|466089614|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
129491251|NCT03176966|466089613|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
129491252|NCT03176966|466089614|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
129491253|NCT03176966|466089613|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
129491254|NCT03176966|466089614|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
129491255|NCT02955186|466089615|FG000|Overall Study|Withdrawal by Subject|6|||
129491256|NCT02955186|466089616|FG001|Overall Study|Withdrawal by Subject|2|||
129491257|NCT02955186|466089615|FG000|Overall Study|Protocol Violation|1|||
129491258|NCT02955186|466089616|FG001|Overall Study|Protocol Violation|0|||
129491259|NCT00866294|466089617|FG000|Overall Study|Adverse Event|12|||
129491260|NCT00866294|466089618|FG001|Overall Study|Adverse Event|13|||
129491261|NCT00866294|466089619|FG002|Overall Study|Adverse Event|9|||
129491262|NCT00866294|466089617|FG000|Overall Study|Lack of Efficacy|7|||
129491263|NCT00866294|466089618|FG001|Overall Study|Lack of Efficacy|1|||
129491264|NCT00866294|466089619|FG002|Overall Study|Lack of Efficacy|0|||
129491265|NCT00866294|466089617|FG000|Overall Study|Protocol Violation|2|||
129491266|NCT00866294|466089618|FG001|Overall Study|Protocol Violation|0|||
129491267|NCT00866294|466089619|FG002|Overall Study|Protocol Violation|0|||
129491268|NCT00866294|466089617|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
129980686|NCT01214642|467891702|FG006|Overall Study|Physician Decision|0|||
129980687|NCT01214642|467891703|FG007|Overall Study|Physician Decision|0|||
129491269|NCT00866294|466089618|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129491270|NCT00866294|466089619|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
129491271|NCT00866294|466089617|FG000|Overall Study|Lost to Follow-up|1|||
129491272|NCT00866294|466089618|FG001|Overall Study|Lost to Follow-up|3|||
129491273|NCT00866294|466089619|FG002|Overall Study|Lost to Follow-up|0|||
129491274|NCT00866294|466089617|FG000|Overall Study|Physician Decision|6|||
129491275|NCT00866294|466089618|FG001|Overall Study|Physician Decision|2|||
129491276|NCT00866294|466089619|FG002|Overall Study|Physician Decision|1|||
129491277|NCT00916721|466089620|FG000|Overall Study|Lost to Follow-up|0|||
129491278|NCT00916721|466089621|FG001|Overall Study|Lost to Follow-up|1|||
129491279|NCT00916721|466089620|FG000|Overall Study|Adverse Event|6|||
129491280|NCT00916721|466089621|FG001|Overall Study|Adverse Event|3|||
129491281|NCT00916721|466089620|FG000|Overall Study|Withdrawal by Subject|2|||
129538480|NCT05664672|466262109|FG002|Overall Study|Adverse Event|0|||
129980688|NCT01214642|467891704|FG008|Overall Study|Physician Decision|0|||
129491282|NCT00916721|466089621|FG001|Overall Study|Withdrawal by Subject|2|||
129491283|NCT00916721|466089620|FG000|Overall Study|Protocol Violation|2|||
129491284|NCT00916721|466089621|FG001|Overall Study|Protocol Violation|4|||
129491285|NCT01903434|466089625|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
129491286|NCT01903434|466089626|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
129491287|NCT01903434|466089625|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
129491288|NCT01903434|466089626|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
129491289|NCT01469052|466089629|FG000|Overall Study|Adverse Event|2|||
129491290|NCT01469052|466089630|FG001|Overall Study|Adverse Event|3|||
129491291|NCT01469052|466089631|FG002|Overall Study|Adverse Event|0|||
129491292|NCT01469052|466089632|FG003|Overall Study|Adverse Event|2|||
129491293|NCT01469052|466089633|FG004|Overall Study|Adverse Event|0|||
129491294|NCT01469052|466089634|FG005|Overall Study|Adverse Event|1|||
129491295|NCT01469052|466089629|FG000|Overall Study|Progressive disease|3|||
129491296|NCT01469052|466089630|FG001|Overall Study|Progressive disease|0|||
129491297|NCT01469052|466089631|FG002|Overall Study|Progressive disease|5|||
129491298|NCT01469052|466089632|FG003|Overall Study|Progressive disease|3|||
129491299|NCT01469052|466089633|FG004|Overall Study|Progressive disease|7|||
129491300|NCT01469052|466089634|FG005|Overall Study|Progressive disease|2|||
129491301|NCT01469052|466089629|FG000|Overall Study|Lack of Efficacy|0|||
129491302|NCT01469052|466089630|FG001|Overall Study|Lack of Efficacy|0|||
129491303|NCT01469052|466089631|FG002|Overall Study|Lack of Efficacy|0|||
129491304|NCT01469052|466089632|FG003|Overall Study|Lack of Efficacy|0|||
129491305|NCT01469052|466089633|FG004|Overall Study|Lack of Efficacy|0|||
129491306|NCT01469052|466089634|FG005|Overall Study|Lack of Efficacy|2|||
129491307|NCT01469052|466089629|FG000|Overall Study|Moved to rollover protocol|1|||
129491308|NCT01469052|466089630|FG001|Overall Study|Moved to rollover protocol|0|||
129491309|NCT01469052|466089631|FG002|Overall Study|Moved to rollover protocol|1|||
129491310|NCT01469052|466089632|FG003|Overall Study|Moved to rollover protocol|0|||
129491311|NCT01469052|466089633|FG004|Overall Study|Moved to rollover protocol|0|||
129491312|NCT01469052|466089634|FG005|Overall Study|Moved to rollover protocol|1|||
129491313|NCT01469052|466089629|FG000|Overall Study|Other|0|||
129491314|NCT01469052|466089630|FG001|Overall Study|Other|1|||
129491315|NCT01469052|466089631|FG002|Overall Study|Other|0|||
129491316|NCT01469052|466089632|FG003|Overall Study|Other|0|||
129491317|NCT01469052|466089633|FG004|Overall Study|Other|1|||
129491318|NCT01469052|466089634|FG005|Overall Study|Other|0|||
129491319|NCT01519427|466089638|FG000|Overall Study|disease progression|2|||
129491320|NCT03894904|466089639|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
129491321|NCT03894904|466089640|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
129491322|NCT03894904|466089639|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
129491323|NCT03894904|466089640|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
129491324|NCT01781026|466089641|FG000|Overall Study|Lack of Efficacy|2|||
129491325|NCT05094154|466090946|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
129491326|NCT05094154|466090947|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
129491327|NCT05094154|466090946|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
129491328|NCT05094154|466090947|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
129491329|NCT01240811|466090950|FG000|Overall Study|Physician Decision|0|||
129491330|NCT01240811|466090951|FG001|Overall Study|Physician Decision|1|||
129491331|NCT01240811|466090952|FG002|Overall Study|Physician Decision|0|||
129491332|NCT01240811|466090950|FG000|Overall Study|Withdrawal by Subject|0|||
129491333|NCT01240811|466090951|FG001|Overall Study|Withdrawal by Subject|0|||
129491334|NCT01240811|466090952|FG002|Overall Study|Withdrawal by Subject|1|||
129491335|NCT01543490|466090956|FG000|Overall Study|Adverse Event|4|||
129491336|NCT01543490|466090957|FG001|Overall Study|Adverse Event|0|||
129491337|NCT01543490|466090956|FG000|Overall Study|Physician Decision|1|||
129491338|NCT01543490|466090957|FG001|Overall Study|Physician Decision|0|||
129491339|NCT01543490|466090956|FG000|Overall Study|Lack of Efficacy|3|||
129491340|NCT01543490|466090957|FG001|Overall Study|Lack of Efficacy|3|||
129491341|NCT01543490|466090956|FG000|Overall Study|Lost to Follow-up|5|||
129491342|NCT01543490|466090957|FG001|Overall Study|Lost to Follow-up|0|||
129491343|NCT01543490|466090956|FG000|Overall Study|Withdrawal by Subject|2|||
129491344|NCT01543490|466090957|FG001|Overall Study|Withdrawal by Subject|0|||
129491345|NCT01543490|466090956|FG000|Overall Study|Other-Various Administrative Reasons|1|||
129491346|NCT01543490|466090957|FG001|Overall Study|Other-Various Administrative Reasons|2|||
129491347|NCT04168645|466090959|FG000|Overall Study|Lost to Follow-up|23|||
129491348|NCT04168645|466090960|FG001|Overall Study|Lost to Follow-up|28|||
129491349|NCT04168645|466090961|FG002|Overall Study|Lost to Follow-up|15|||
129491350|NCT04168645|466090962|FG003|Overall Study|Lost to Follow-up|12|||
129491351|NCT04168645|466090959|FG000|Overall Study|Death|1|||
129491352|NCT04168645|466090960|FG001|Overall Study|Death|1|||
129491353|NCT04168645|466090961|FG002|Overall Study|Death|0|||
129491354|NCT04168645|466090962|FG003|Overall Study|Death|0|||
129491355|NCT04168645|466090959|FG000|Overall Study|Withdrawal by Subject|5|||
129491356|NCT04168645|466090960|FG001|Overall Study|Withdrawal by Subject|2|||
129491357|NCT04168645|466090961|FG002|Overall Study|Withdrawal by Subject|2|||
129491358|NCT04168645|466090962|FG003|Overall Study|Withdrawal by Subject|2|||
129491359|NCT04168645|466090959|FG000|Overall Study|Administrative Withdrawal|3|||
129491360|NCT04168645|466090960|FG001|Overall Study|Administrative Withdrawal|1|||
129491361|NCT04168645|466090961|FG002|Overall Study|Administrative Withdrawal|1|||
129491362|NCT04168645|466090962|FG003|Overall Study|Administrative Withdrawal|3|||
129491363|NCT03132805|466090965|FG000|Overall Study|Lost to Follow-up|142|||
129491364|NCT03132805|466090966|FG001|Overall Study|Lost to Follow-up|141|||
129491365|NCT03132805|466090967|FG002|Overall Study|Lost to Follow-up|113|||
129491366|NCT01158534|466090969|FG000|Overall Study|Withdrawal by Subject|1|||
129491367|NCT01158534|466090969|FG000|Overall Study|Death|1|||
129491368|NCT01158534|466090969|FG000|Overall Study|Other|1|||
129491369|NCT01988012|466090970|FG000|Overall Study|Adverse Event|5|||
129491370|NCT01988012|466090970|FG000|Overall Study|Insufficient Therapeutic Response|3|||
129491371|NCT01988012|466090970|FG000|Overall Study|Patient Withdrawal of Consent|4|||
129491372|NCT01988012|466090970|FG000|Overall Study|Lost to Follow-up|1|||
129491373|NCT01988012|466090970|FG000|Overall Study|Physician Decision|1|||
129491374|NCT01988012|466090970|FG000|Overall Study|Protocol Violation|1|||
129491375|NCT03314519|466090971|FG000|Overall Study|Protocol Violation|3|||
129491376|NCT03314519|466090972|FG001|Overall Study|Protocol Violation|2|||
129491377|NCT00950690|466090973|FG000|Overall Study|Death|4|||
129491378|NCT00950690|466090973|FG000|Overall Study|Adverse Event|15|||
129491379|NCT00950690|466090973|FG000|Overall Study|Lack of Efficacy|22|||
129491380|NCT00950690|466090973|FG000|Overall Study|Lost to Follow-up|40|||
129491381|NCT00950690|466090973|FG000|Overall Study|Other|163|||
129491382|NCT01713036|466090974|FG000|Overall Study|Death|1|||
129491383|NCT00553059|466090977|FG000|Overall Study|Deemed ineligible|1|||
129491384|NCT00553059|466090978|FG001|Overall Study|Deemed ineligible|1|||
129491385|NCT00553059|466090977|FG000|Overall Study|Drug supply not available|0|||
129491386|NCT00553059|466090978|FG001|Overall Study|Drug supply not available|1|||
129491387|NCT00117338|466090979|FG000|Overall Study|Adverse Event|0|||
129491388|NCT00117338|466090980|FG001|Overall Study|Adverse Event|1|||
129491389|NCT00117338|466090979|FG000|Overall Study|Protocol Violation|3|||
129491390|NCT00117338|466090980|FG001|Overall Study|Protocol Violation|2|||
129491391|NCT00117338|466090979|FG000|Overall Study|Withdrawal by Subject|1|||
129491392|NCT00117338|466090980|FG001|Overall Study|Withdrawal by Subject|0|||
129491393|NCT00117338|466090979|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
129491394|NCT00117338|466090980|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
129491395|NCT00117338|466090979|FG000|Overall Study|Lack of Efficacy|0|||
129491396|NCT00117338|466090980|FG001|Overall Study|Lack of Efficacy|1|||
129491397|NCT02240628|466090983|FG000|Overall Study|Physician Decision|6|||
129491398|NCT02240628|466090984|FG001|Overall Study|Physician Decision|5|||
129491399|NCT02385123|466090985|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
129491400|NCT01070303|466090989|FG000|Overall Study|Adverse Event|39|||
129491401|NCT01070303|466090989|FG000|Overall Study|Withdrawal by Subject|20|||
129491402|NCT01070303|466090989|FG000|Overall Study|Lost to Follow-up|9|||
129491403|NCT01070303|466090989|FG000|Overall Study|Protocol Violation|0|||
129491404|NCT01070303|466090989|FG000|Overall Study|Lack of Efficacy|2|||
129491405|NCT01070303|466090989|FG000|Overall Study|Administrative Reason|1|||
129491406|NCT01070303|466090989|FG000|Overall Study|Other|18|||
129491407|NCT02345434|466090990|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
129491408|NCT02345434|466090991|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
129491409|NCT00859898|466090993|FG000|Overall Study|Lack of Efficacy|0|||
129491410|NCT00859898|466090994|FG001|Overall Study|Lack of Efficacy|1|||
129491411|NCT00859898|466090995|FG002|Overall Study|Lack of Efficacy|1|||
129491412|NCT00859898|466090993|FG000|Overall Study|Adverse Event|4|||
129491413|NCT00859898|466090994|FG001|Overall Study|Adverse Event|9|||
129980689|NCT01214642|467891705|FG009|Overall Study|Physician Decision|0|||
129491414|NCT00859898|466090995|FG002|Overall Study|Adverse Event|8|||
129491415|NCT00859898|466090993|FG000|Overall Study|Withdrawal by Subject|11|||
129491416|NCT00859898|466090994|FG001|Overall Study|Withdrawal by Subject|8|||
129491417|NCT00859898|466090995|FG002|Overall Study|Withdrawal by Subject|11|||
129491418|NCT00859898|466090993|FG000|Overall Study|Death|0|||
129491419|NCT00859898|466090994|FG001|Overall Study|Death|0|||
129491420|NCT00859898|466090995|FG002|Overall Study|Death|1|||
129491421|NCT00859898|466090993|FG000|Overall Study|Lost to Follow-up|10|||
129491422|NCT00859898|466090994|FG001|Overall Study|Lost to Follow-up|11|||
129980690|NCT01214642|467891706|FG010|Overall Study|Physician Decision|0|||
129491423|NCT00859898|466090995|FG002|Overall Study|Lost to Follow-up|5|||
129491424|NCT00859898|466090993|FG000|Overall Study|poor/non-compliance|2|||
129491425|NCT00859898|466090994|FG001|Overall Study|poor/non-compliance|0|||
129491426|NCT00859898|466090995|FG002|Overall Study|poor/non-compliance|0|||
129980691|NCT01214642|467891707|FG011|Overall Study|Physician Decision|2|||
129491427|NCT00859898|466090993|FG000|Overall Study|No longer meets criteria|0|||
129491428|NCT00859898|466090994|FG001|Overall Study|No longer meets criteria|1|||
129491429|NCT00859898|466090995|FG002|Overall Study|No longer meets criteria|0|||
129491430|NCT00859898|466090993|FG000|Overall Study|non-specified|1|||
129491431|NCT00859898|466090994|FG001|Overall Study|non-specified|1|||
129491432|NCT00859898|466090995|FG002|Overall Study|non-specified|1|||
129491433|NCT01302041|466090996|FG000|Overall Study|Death|5|||
129491434|NCT01302041|466090996|FG000|Overall Study|Withdrawal by Subject|4|||
129491435|NCT01302041|466090996|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
129491436|NCT01302041|466090996|FG000|Overall Study|Other-Miscellaneous Reason|2|||
129491437|NCT00771030|466090999|FG000|Overall Study|Adverse Event|0|||
129491438|NCT00771030|466091000|FG001|Overall Study|Adverse Event|1|||
129491439|NCT00771030|466091001|FG002|Overall Study|Adverse Event|0|||
129491440|NCT00771030|466091002|FG003|Overall Study|Adverse Event|0|||
129491441|NCT00771030|466091003|FG004|Overall Study|Adverse Event|0|||
129491442|NCT00771030|466091004|FG005|Overall Study|Adverse Event|0|||
129491443|NCT00771030|466091005|FG006|Overall Study|Adverse Event|0|||
129491444|NCT01327339|466091015|FG000|Overall Study|Protocol Violation|8|||
129491445|NCT01097330|466091018|FG000|Overall Study|Study terminated early|7|||
129491446|NCT01097330|466091019|FG001|Overall Study|Study terminated early|5|||
129491447|NCT00510692|466091021|FG000|Overall Study|Adverse Event|1|||
129491448|NCT00510692|466091022|FG001|Overall Study|Adverse Event|3|||
129491449|NCT00510692|466091021|FG000|Overall Study|Withdrawal by Subject|1|||
129491450|NCT00510692|466091022|FG001|Overall Study|Withdrawal by Subject|0|||
129491451|NCT01845077|466091023|FG000|Washout Period|Lost to Follow-up|0|||
129491452|NCT01845077|466091024|FG001|Washout Period|Lost to Follow-up|1|||
129491453|NCT01845077|466091025|FG002|Washout Period|Lost to Follow-up|0|||
129491454|NCT01845077|466091026|FG003|Washout Period|Lost to Follow-up|1|||
129491455|NCT01845077|466091027|FG004|Washout Period|Lost to Follow-up|0|||
129491456|NCT01845077|466091028|FG005|Washout Period|Lost to Follow-up|1|||
129491457|NCT01845077|466091023|FG000|Washout Period|Adverse Event|1|||
129491458|NCT01845077|466091024|FG001|Washout Period|Adverse Event|0|||
129491459|NCT01845077|466091025|FG002|Washout Period|Adverse Event|0|||
129491460|NCT01845077|466091026|FG003|Washout Period|Adverse Event|0|||
129491461|NCT01845077|466091027|FG004|Washout Period|Adverse Event|0|||
129491462|NCT01845077|466091028|FG005|Washout Period|Adverse Event|0|||
129491463|NCT01845077|466091023|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
129491464|NCT01845077|466091024|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
129491465|NCT01845077|466091025|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
129491466|NCT01845077|466091026|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
129491467|NCT01845077|466091027|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
129491468|NCT01845077|466091028|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
129491469|NCT01845077|466091023|FG000|Washout Period|Protocol Violation|0|||
129491470|NCT01845077|466091024|FG001|Washout Period|Protocol Violation|0|||
129491471|NCT01845077|466091025|FG002|Washout Period|Protocol Violation|0|||
129491472|NCT01845077|466091026|FG003|Washout Period|Protocol Violation|1|||
129491473|NCT01845077|466091027|FG004|Washout Period|Protocol Violation|1|||
129491474|NCT01845077|466091028|FG005|Washout Period|Protocol Violation|0|||
129491475|NCT01797432|466091029|FG000|Overall Study|Lost to Follow-up|1|||
129491476|NCT01797432|466091029|FG000|Overall Study|Adverse Event|1|||
129491477|NCT01797432|466091029|FG000|Overall Study|Withdrawal by Subject|1|||
129491478|NCT01797432|466091029|FG000|Overall Study|lived too far from study site|1|||
129491479|NCT01137435|466091030|FG000|Overall Study|Lost to Follow-up|24|||
129491480|NCT01137435|466091030|FG000|Overall Study|Off label usage|4|||
129491481|NCT00501852|466091036|FG000|Overall Study|Adverse Event|3|||
129491482|NCT00501852|466091036|FG000|Overall Study|Withdrawal by Subject|2|||
129491483|NCT01416610|466091039|FG000|Overall Study|Adverse Event|4|||
129491484|NCT01416610|466091039|FG000|Overall Study|Adverse Event -Patient decision|3|||
129491485|NCT01416610|466091039|FG000|Overall Study|Lack of Efficacy|4|||
129491486|NCT01416610|466091039|FG000|Overall Study|No reason given|5|||
129491487|NCT01416610|466091039|FG000|Overall Study|Withdrawal by Subject|13|||
129491488|NCT01416610|466091039|FG000|Overall Study|Lost to Follow-up|7|||
129491489|NCT01416610|466091039|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
129491490|NCT01927562|466091041|FG000|Overall Study|Lost to Follow-up|30|||
129491491|NCT01927562|466091041|FG000|Overall Study|Withdrawal by Subject|3|||
129491492|NCT01927562|466091041|FG000|Overall Study|Physician Decision|5|||
129491493|NCT00642616|466091042|FG000|Overall Study|Adverse Event|2|||
129491494|NCT00642616|466091043|FG001|Overall Study|Adverse Event|0|||
129491495|NCT00642616|466091044|FG002|Overall Study|Adverse Event|1|||
129491496|NCT00642616|466091045|FG003|Overall Study|Adverse Event|0|||
129491497|NCT00642616|466091042|FG000|Overall Study|Study Terminated by Sponsor|7|||
129491498|NCT00642616|466091043|FG001|Overall Study|Study Terminated by Sponsor|6|||
129491499|NCT00642616|466091044|FG002|Overall Study|Study Terminated by Sponsor|4|||
129491500|NCT00642616|466091045|FG003|Overall Study|Study Terminated by Sponsor|5|||
129491501|NCT00642616|466091042|FG000|Overall Study|Withdrawal by Subject|0|||
129491502|NCT00642616|466091043|FG001|Overall Study|Withdrawal by Subject|1|||
129491503|NCT00642616|466091044|FG002|Overall Study|Withdrawal by Subject|1|||
129491504|NCT00642616|466091045|FG003|Overall Study|Withdrawal by Subject|1|||
129491505|NCT00642616|466091042|FG000|Overall Study|Protocol Violation|0|||
129491506|NCT00642616|466091043|FG001|Overall Study|Protocol Violation|0|||
129491507|NCT00642616|466091044|FG002|Overall Study|Protocol Violation|2|||
129491508|NCT00642616|466091045|FG003|Overall Study|Protocol Violation|0|||
129491509|NCT00642616|466091042|FG000|Overall Study|Physician Decision|0|||
129491510|NCT00642616|466091043|FG001|Overall Study|Physician Decision|0|||
129491511|NCT00642616|466091044|FG002|Overall Study|Physician Decision|1|||
129491512|NCT00642616|466091045|FG003|Overall Study|Physician Decision|1|||
129491513|NCT00492921|466091046|FG000|Overall Study|Death|1|||
129491514|NCT00492921|466091047|FG001|Overall Study|Death|0|||
129491515|NCT00492921|466091048|FG002|Overall Study|Death|1|||
129491516|NCT00399802|466091049|FG000|Overall Study|Adverse Event|0|||
129491517|NCT00399802|466091050|FG001|Overall Study|Adverse Event|2|||
129491518|NCT00399802|466091049|FG000|Overall Study|Participant discontinued by mistake|0|||
129491519|NCT00399802|466091050|FG001|Overall Study|Participant discontinued by mistake|1|||
129491520|NCT00542815|466091051|FG000|Overall Study|Adverse Event|19|||
129491521|NCT00542815|466091052|FG001|Overall Study|Adverse Event|6|||
129491522|NCT00542815|466091053|FG002|Overall Study|Adverse Event|9|||
129491523|NCT00542815|466091051|FG000|Overall Study|Death|10|||
129491524|NCT00542815|466091052|FG001|Overall Study|Death|7|||
129491525|NCT00542815|466091053|FG002|Overall Study|Death|3|||
129491526|NCT00542815|466091051|FG000|Overall Study|Lack of Efficacy|9|||
129491527|NCT00542815|466091052|FG001|Overall Study|Lack of Efficacy|2|||
129491528|NCT00542815|466091053|FG002|Overall Study|Lack of Efficacy|0|||
129491529|NCT00542815|466091051|FG000|Overall Study|Physician Decision|2|||
129491530|NCT00542815|466091052|FG001|Overall Study|Physician Decision|1|||
129491531|NCT00542815|466091053|FG002|Overall Study|Physician Decision|0|||
129491532|NCT00542815|466091051|FG000|Overall Study|Protocol Violation|1|||
129491533|NCT00542815|466091052|FG001|Overall Study|Protocol Violation|1|||
129491534|NCT00542815|466091053|FG002|Overall Study|Protocol Violation|2|||
129491535|NCT00542815|466091051|FG000|Overall Study|Withdrawal by Subject|41|||
129491536|NCT00542815|466091052|FG001|Overall Study|Withdrawal by Subject|5|||
129491537|NCT00542815|466091053|FG002|Overall Study|Withdrawal by Subject|8|||
129491538|NCT00542815|466091051|FG000|Overall Study|Other reasons|24|||
129491539|NCT00542815|466091052|FG001|Overall Study|Other reasons|10|||
129491540|NCT00542815|466091053|FG002|Overall Study|Other reasons|10|||
129491541|NCT01632878|466091054|FG000|Screening|Physician Decision|268|||
129491542|NCT01632878|466091054|FG000|Treatment|Lost to Follow-up|41|||
129491543|NCT01632878|466091054|FG000|Treatment|Withdrawal by Subject|36|||
129491544|NCT01632878|466091054|FG000|Treatment|Physician Decision|34|||
129491545|NCT01632878|466091054|FG000|Treatment|missing information|4|||
129491546|NCT01632878|466091054|FG000|Treatment|no information on study completion|43|||
129491547|NCT00081289|466091055|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
129491548|NCT00081289|466091056|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
129491549|NCT00081289|466091055|FG000|Overall Study|Ineligible / no protocol treatment|3|||
129491550|NCT00081289|466091056|FG001|Overall Study|Ineligible / no protocol treatment|4|||
129491551|NCT01558089|466091057|FG000|Overall Study|Adverse Event|1|||
129491552|NCT01558089|466091057|FG000|Overall Study|Lack of Efficacy|1|||
129491553|NCT01558089|466091057|FG000|Overall Study|Lost to Follow-up|5|||
129491554|NCT01558089|466091057|FG000|Overall Study|Withdrawal by Subject|6|||
129491555|NCT02749370|466091058|FG000|Overall Study|Withdrawal by Subject|11|||
129491556|NCT02749370|466091058|FG000|Overall Study|Lost to Follow-up|3|||
129491557|NCT03242759|466091059|FG000|Overall Study|Adverse Event|5|||
129491558|NCT03242759|466091060|FG001|Overall Study|Adverse Event|1|||
129491559|NCT03242759|466091059|FG000|Overall Study|Withdrawal by Subject|4|||
129491560|NCT03242759|466091060|FG001|Overall Study|Withdrawal by Subject|3|||
129491561|NCT03242759|466091059|FG000|Overall Study|Lost to Follow-up|3|||
129491562|NCT03242759|466091060|FG001|Overall Study|Lost to Follow-up|1|||
129491563|NCT03242759|466091059|FG000|Overall Study|Administrative problems|1|||
129491564|NCT03242759|466091060|FG001|Overall Study|Administrative problems|1|||
129491565|NCT03242759|466091059|FG000|Overall Study|Death|22|||
129491566|NCT03242759|466091060|FG001|Overall Study|Death|0|||
129491567|NCT03242759|466091059|FG000|Overall Study|Change visit schedule|0|||
129491568|NCT03242759|466091060|FG001|Overall Study|Change visit schedule|1|||
129491569|NCT00336492|466091063|FG000|Overall Study|Adverse Event|4|||
129491570|NCT00336492|466091064|FG001|Overall Study|Adverse Event|3|||
129491571|NCT00336492|466091065|FG002|Overall Study|Adverse Event|6|||
129491572|NCT00336492|466091063|FG000|Overall Study|Lack of Efficacy|6|||
129491573|NCT00336492|466091064|FG001|Overall Study|Lack of Efficacy|1|||
129491574|NCT00336492|466091065|FG002|Overall Study|Lack of Efficacy|4|||
129491575|NCT00336492|466091063|FG000|Overall Study|Other|5|||
129491576|NCT00336492|466091064|FG001|Overall Study|Other|0|||
129491577|NCT00336492|466091065|FG002|Overall Study|Other|1|||
129491578|NCT00227877|466091066|FG000|Pre-visit Assessment|Technical difficulties|7|||
129491579|NCT00227877|466091067|FG001|Pre-visit Assessment|Technical difficulties|3|||
129491580|NCT00227877|466091068|FG002|Pre-visit Assessment|Technical difficulties|0|||
129491581|NCT00227877|466091069|FG003|Pre-visit Assessment|Technical difficulties|0|||
129491582|NCT00227877|466091066|FG000|Post-visit Checklist|Lost to Follow-up|24|||
129491583|NCT00227877|466091067|FG001|Post-visit Checklist|Lost to Follow-up|13|||
129491584|NCT00227877|466091068|FG002|Post-visit Checklist|Lost to Follow-up|1|||
129491585|NCT00227877|466091069|FG003|Post-visit Checklist|Lost to Follow-up|0|||
129491586|NCT00227877|466091066|FG000|3-months Follow-up|Completed late|135|||
129491587|NCT00227877|466091067|FG001|3-months Follow-up|Completed late|128|||
129491588|NCT00227877|466091068|FG002|3-months Follow-up|Completed late|34|||
129491589|NCT00227877|466091069|FG003|3-months Follow-up|Completed late|8|||
129491590|NCT00227877|466091066|FG000|3-months Follow-up|Lost to Follow-up|178|||
129491591|NCT00227877|466091067|FG001|3-months Follow-up|Lost to Follow-up|139|||
129491592|NCT00227877|466091068|FG002|3-months Follow-up|Lost to Follow-up|18|||
129491593|NCT00227877|466091069|FG003|3-months Follow-up|Lost to Follow-up|13|||
129491594|NCT00227877|466091066|FG000|12-months Follow-up|Completed late|78|||
129491595|NCT00227877|466091067|FG001|12-months Follow-up|Completed late|74|||
129491596|NCT00227877|466091068|FG002|12-months Follow-up|Completed late|1|||
129491597|NCT00227877|466091069|FG003|12-months Follow-up|Completed late|0|||
129491598|NCT00227877|466091066|FG000|12-months Follow-up|Lost to Follow-up|232|||
129491599|NCT00227877|466091067|FG001|12-months Follow-up|Lost to Follow-up|189|||
129491600|NCT00227877|466091068|FG002|12-months Follow-up|Lost to Follow-up|30|||
129491601|NCT00227877|466091069|FG003|12-months Follow-up|Lost to Follow-up|26|||
129491602|NCT02522481|466091074|FG000|Overall Study|discontinued|1|||
129491603|NCT02522481|466091074|FG000|Overall Study|Not dosed|2|||
129491604|NCT00404768|466091077|FG000|Part A and B|Withdrawn due to labor progression|1|||
129491605|NCT00404768|466091078|FG001|Part A and B|Withdrawn due to labor progression|0|||
129491606|NCT00404768|466091079|FG002|Part A and B|Withdrawn due to labor progression|0|||
129491607|NCT00404768|466091080|FG003|Part A and B|Withdrawn due to labor progression|0|||
129491608|NCT00404768|466091077|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
129491609|NCT00404768|466091078|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
129491610|NCT00404768|466091079|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
129491611|NCT00404768|466091080|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
129491612|NCT00404768|466091077|FG000|Part C|Adverse Event|0|||
129491613|NCT00404768|466091078|FG001|Part C|Adverse Event|0|||
129491614|NCT00404768|466091079|FG002|Part C|Adverse Event|0|||
129491615|NCT00404768|466091080|FG003|Part C|Adverse Event|3|||
129491616|NCT00404768|466091077|FG000|Part C|Lost to Follow-up|0|||
129491617|NCT00404768|466091078|FG001|Part C|Lost to Follow-up|0|||
129491618|NCT00404768|466091079|FG002|Part C|Lost to Follow-up|3|||
129491619|NCT00404768|466091080|FG003|Part C|Lost to Follow-up|1|||
129491620|NCT00404768|466091077|FG000|Part C|Withdrawal by Subject|0|||
129491621|NCT00404768|466091078|FG001|Part C|Withdrawal by Subject|0|||
129491622|NCT00404768|466091079|FG002|Part C|Withdrawal by Subject|2|||
129491623|NCT00404768|466091080|FG003|Part C|Withdrawal by Subject|1|||
129491624|NCT00404768|466091077|FG000|Part C|Early withdrawal from study medication|0|||
129491625|NCT00404768|466091078|FG001|Part C|Early withdrawal from study medication|0|||
129491626|NCT00404768|466091079|FG002|Part C|Early withdrawal from study medication|1|||
129491627|NCT00404768|466091080|FG003|Part C|Early withdrawal from study medication|0|||
129491628|NCT00404768|466091077|FG000|Part C|Participant did not respond to therapy|0|||
129491629|NCT00404768|466091078|FG001|Part C|Participant did not respond to therapy|0|||
129491630|NCT00404768|466091079|FG002|Part C|Participant did not respond to therapy|1|||
129491631|NCT00404768|466091080|FG003|Part C|Participant did not respond to therapy|1|||
129491632|NCT00404768|466091077|FG000|Part C|Physician withdrew the study medication|0|||
129491633|NCT00404768|466091078|FG001|Part C|Physician withdrew the study medication|0|||
129491634|NCT00404768|466091079|FG002|Part C|Physician withdrew the study medication|1|||
129491635|NCT00404768|466091080|FG003|Part C|Physician withdrew the study medication|0|||
129491636|NCT00404768|466091077|FG000|Part C|Participant delivered baby|0|||
129491637|NCT00404768|466091078|FG001|Part C|Participant delivered baby|0|||
129491638|NCT00404768|466091079|FG002|Part C|Participant delivered baby|0|||
129491639|NCT00404768|466091080|FG003|Part C|Participant delivered baby|1|||
129491640|NCT00404768|466091077|FG000|Part C|Unsatisfactory uterine response to IP|0|||
129491641|NCT00404768|466091078|FG001|Part C|Unsatisfactory uterine response to IP|0|||
129491642|NCT00404768|466091079|FG002|Part C|Unsatisfactory uterine response to IP|0|||
129491643|NCT00404768|466091080|FG003|Part C|Unsatisfactory uterine response to IP|1|||
129491644|NCT00404768|466091077|FG000|Part C|Active labor|0|||
129491645|NCT00404768|466091078|FG001|Part C|Active labor|0|||
129491646|NCT00404768|466091079|FG002|Part C|Active labor|0|||
129491647|NCT00404768|466091080|FG003|Part C|Active labor|1|||
129491648|NCT00404768|466091077|FG000|Part C|Lack of Efficacy|0|||
129491649|NCT00404768|466091078|FG001|Part C|Lack of Efficacy|0|||
129491650|NCT00404768|466091079|FG002|Part C|Lack of Efficacy|0|||
129491651|NCT00404768|466091080|FG003|Part C|Lack of Efficacy|2|||
129491652|NCT00404768|466091077|FG000|Part C|Treatment failure|0|||
129491653|NCT00404768|466091078|FG001|Part C|Treatment failure|0|||
129491654|NCT00404768|466091079|FG002|Part C|Treatment failure|0|||
129491655|NCT00404768|466091080|FG003|Part C|Treatment failure|1|||
129491656|NCT00404768|466091077|FG000|Part C|Investigator discretion|0|||
129491657|NCT00404768|466091078|FG001|Part C|Investigator discretion|0|||
129491658|NCT00404768|466091079|FG002|Part C|Investigator discretion|0|||
129491659|NCT00404768|466091080|FG003|Part C|Investigator discretion|1|||
129491660|NCT00404768|466091077|FG000|Part C|Researcher suspended study medication|0|||
129491661|NCT00404768|466091078|FG001|Part C|Researcher suspended study medication|0|||
129491662|NCT00404768|466091079|FG002|Part C|Researcher suspended study medication|0|||
129491663|NCT00404768|466091080|FG003|Part C|Researcher suspended study medication|1|||
129491664|NCT03123939|466091081|FG000|Overall Study|Lack of Efficacy|6|||
129491665|NCT03123939|466091081|FG000|Overall Study|Death|5|||
129491666|NCT03123939|466091081|FG000|Overall Study|Physician Decision|2|||
129491667|NCT03123939|466091081|FG000|Overall Study|Subject/guardian decision|2|||
129491668|NCT03123939|466091081|FG000|Overall Study|Lost to Follow-up|1|||
129491669|NCT03123939|466091081|FG000|Overall Study|New therapy for study indication|1|||
129491670|NCT03123939|466091081|FG000|Overall Study|Protocol deviation|1|||
129491671|NCT03123939|466091081|FG000|Overall Study|Progressive disease|18|||
129491672|NCT03123939|466091081|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
129491673|NCT03123939|466091081|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
129491674|NCT04773041|466091082|FG000|Overall Study|Unable to data match|1|||
129491675|NCT04773041|466091083|FG001|Overall Study|Unable to data match|0|||
129491676|NCT04773041|466091084|FG002|Overall Study|Unable to data match|0|||
129491677|NCT01118143|466091085|FG000|Overall Study|Withdrawal by Subject|2|||
129491678|NCT01118143|466091086|FG001|Overall Study|Withdrawal by Subject|5|||
129491679|NCT02112448|466091087|FG000|Overall Study|lab values precluding use of ketorolac|2|||
129491680|NCT02112448|466091088|FG001|Overall Study|lab values precluding use of ketorolac|2|||
129491681|NCT02112448|466091087|FG000|Overall Study|Protocol Violation|1|||
129491682|NCT02112448|466091088|FG001|Overall Study|Protocol Violation|2|||
129491683|NCT02112448|466091087|FG000|Overall Study|Physician Decision|4|||
129491684|NCT02112448|466091088|FG001|Overall Study|Physician Decision|6|||
129491685|NCT02112448|466091087|FG000|Overall Study|required heparin so could not use ketoro|1|||
129491686|NCT02112448|466091088|FG001|Overall Study|required heparin so could not use ketoro|0|||
129491687|NCT01937130|466092674|FG000|Overall Study|Withdrawal by Subject|0|||
129491688|NCT01937130|466092675|FG001|Overall Study|Withdrawal by Subject|0|||
129491689|NCT01937130|466092676|FG002|Overall Study|Withdrawal by Subject|0|||
129491690|NCT01937130|466092677|FG003|Overall Study|Withdrawal by Subject|1|||
129491691|NCT01937130|466092674|FG000|Overall Study|Adverse Event|0|||
129491692|NCT01937130|466092675|FG001|Overall Study|Adverse Event|1|||
129491693|NCT01937130|466092676|FG002|Overall Study|Adverse Event|0|||
129491694|NCT01937130|466092677|FG003|Overall Study|Adverse Event|1|||
129491695|NCT01937130|466092674|FG000|Overall Study|Death|1|||
129491696|NCT01937130|466092675|FG001|Overall Study|Death|1|||
129491697|NCT01937130|466092676|FG002|Overall Study|Death|1|||
129491698|NCT01937130|466092677|FG003|Overall Study|Death|0|||
129491699|NCT01937130|466092674|FG000|Overall Study|Lost to Follow-up|2|||
129491700|NCT01937130|466092675|FG001|Overall Study|Lost to Follow-up|0|||
129491701|NCT01937130|466092676|FG002|Overall Study|Lost to Follow-up|2|||
129491702|NCT01937130|466092677|FG003|Overall Study|Lost to Follow-up|0|||
129491703|NCT01937130|466092674|FG000|Overall Study|Physician Decision|0|||
129491704|NCT01937130|466092675|FG001|Overall Study|Physician Decision|1|||
129491705|NCT01937130|466092676|FG002|Overall Study|Physician Decision|0|||
129491706|NCT01937130|466092677|FG003|Overall Study|Physician Decision|0|||
129491707|NCT01937130|466092674|FG000|Overall Study|Patients unable to swallow|0|||
129491708|NCT01937130|466092675|FG001|Overall Study|Patients unable to swallow|1|||
129491709|NCT01937130|466092676|FG002|Overall Study|Patients unable to swallow|0|||
129491710|NCT01937130|466092677|FG003|Overall Study|Patients unable to swallow|0|||
129491711|NCT01937130|466092674|FG000|Overall Study|Patient lost to FU due to death|2|||
129491712|NCT01937130|466092675|FG001|Overall Study|Patient lost to FU due to death|0|||
129491713|NCT01937130|466092676|FG002|Overall Study|Patient lost to FU due to death|0|||
129491714|NCT01937130|466092677|FG003|Overall Study|Patient lost to FU due to death|0|||
129491715|NCT02100657|466092678|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
129491716|NCT02100657|466092679|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
129491717|NCT02100657|466092680|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
129491718|NCT02100657|466092678|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
129491719|NCT02100657|466092679|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
129491720|NCT02100657|466092680|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
129491721|NCT02100657|466092678|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
129491722|NCT02100657|466092679|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
129491723|NCT02100657|466092680|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
129491724|NCT02100657|466092678|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
129491725|NCT02100657|466092679|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
129491726|NCT02100657|466092680|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
129491727|NCT02100657|466092678|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
129491728|NCT02100657|466092679|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
129491729|NCT02100657|466092680|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
129491730|NCT02100657|466092678|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
129491731|NCT02100657|466092679|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
129491732|NCT02100657|466092680|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
129491733|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
129491734|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
129491735|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
129491736|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Death|0|||
129491737|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Death|0|||
129491738|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Death|1|||
129491739|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
129491740|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
129491741|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
129491742|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
129491743|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
129491744|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
129491745|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
129491746|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
129491747|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
129491748|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
129491749|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
129491750|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
129491751|NCT02100657|466092678|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
129491752|NCT02100657|466092679|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
129491753|NCT02100657|466092680|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
129491754|NCT02115815|466092682|FG000|Overall Study|Withdrawal by Subject|2|||
129491755|NCT02115815|466092683|FG001|Overall Study|Withdrawal by Subject|0|||
129491756|NCT02115815|466092684|FG002|Overall Study|Withdrawal by Subject|0|||
129491757|NCT02115815|466092685|FG003|Overall Study|Withdrawal by Subject|0|||
129491758|NCT02115815|466092686|FG004|Overall Study|Withdrawal by Subject|0|||
129491759|NCT02115815|466092687|FG005|Overall Study|Withdrawal by Subject|0|||
129491760|NCT02115815|466092688|FG006|Overall Study|Withdrawal by Subject|0|||
129491761|NCT02115815|466092682|FG000|Overall Study|Not enough drug to dose participant|0|||
129491762|NCT02115815|466092683|FG001|Overall Study|Not enough drug to dose participant|0|||
129491763|NCT02115815|466092684|FG002|Overall Study|Not enough drug to dose participant|0|||
129491764|NCT02115815|466092685|FG003|Overall Study|Not enough drug to dose participant|0|||
129491765|NCT02115815|466092686|FG004|Overall Study|Not enough drug to dose participant|0|||
129491766|NCT02115815|466092687|FG005|Overall Study|Not enough drug to dose participant|1|||
129491767|NCT02115815|466092688|FG006|Overall Study|Not enough drug to dose participant|0|||
129491768|NCT02115815|466092682|FG000|Overall Study|Missed appointment, randomized in error|0|||
129491769|NCT02115815|466092683|FG001|Overall Study|Missed appointment, randomized in error|0|||
129491770|NCT02115815|466092684|FG002|Overall Study|Missed appointment, randomized in error|0|||
129491771|NCT02115815|466092685|FG003|Overall Study|Missed appointment, randomized in error|0|||
129491772|NCT02115815|466092686|FG004|Overall Study|Missed appointment, randomized in error|0|||
129491773|NCT02115815|466092687|FG005|Overall Study|Missed appointment, randomized in error|1|||
129491774|NCT02115815|466092688|FG006|Overall Study|Missed appointment, randomized in error|0|||
129491775|NCT01228071|466092689|FG000|Overall Study|Protocol Violation|1|||
129491776|NCT01228071|466092689|FG000|Overall Study|Withdrawal by Subject|1|||
129491777|NCT04003155|466092690|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
129491778|NCT04003155|466092691|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
129491779|NCT04003155|466092692|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
129491780|NCT04003155|466092693|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
129491781|NCT04003155|466092694|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
129491782|NCT04003155|466092690|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
129491783|NCT04003155|466092691|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
129491784|NCT04003155|466092692|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
129491785|NCT04003155|466092693|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
129491786|NCT04003155|466092694|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
129491787|NCT04003155|466092690|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
129491788|NCT04003155|466092691|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
129491789|NCT04003155|466092692|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
129491790|NCT04003155|466092693|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
129491791|NCT04003155|466092694|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
129491792|NCT04003155|466092690|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
129491793|NCT04003155|466092691|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
129491794|NCT04003155|466092692|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
129491795|NCT04003155|466092693|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
129491796|NCT04003155|466092694|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
129491797|NCT04003155|466092690|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
129491798|NCT04003155|466092691|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
129491799|NCT04003155|466092692|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
129491800|NCT04003155|466092693|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
129491801|NCT04003155|466092694|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
129491802|NCT04003155|466092690|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
129491803|NCT04003155|466092691|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
129491804|NCT04003155|466092692|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
129491805|NCT04003155|466092693|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
129491806|NCT04003155|466092694|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
129491807|NCT04003155|466092690|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
129491808|NCT04003155|466092691|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
129491809|NCT04003155|466092692|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
129491810|NCT04003155|466092693|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
129491811|NCT04003155|466092694|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
129491812|NCT04003155|466092690|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
129491813|NCT04003155|466092691|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
129491814|NCT04003155|466092692|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
129491815|NCT04003155|466092693|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
129491816|NCT04003155|466092694|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
129491817|NCT04003155|466092690|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
129491818|NCT04003155|466092691|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
129491819|NCT04003155|466092692|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
129491820|NCT04003155|466092693|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
129491821|NCT04003155|466092694|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
129491822|NCT01912872|466092695|FG000|Overall Study|Lost to Follow-up|2|||
129491823|NCT01912872|466092696|FG001|Overall Study|Lost to Follow-up|3|||
129491824|NCT01912872|466092697|FG002|Overall Study|Lost to Follow-up|5|||
129491825|NCT01912872|466092698|FG003|Overall Study|Lost to Follow-up|5|||
129491826|NCT01912872|466092695|FG000|Overall Study|Other unspecified|3|||
129491827|NCT01912872|466092696|FG001|Overall Study|Other unspecified|1|||
129491828|NCT01912872|466092697|FG002|Overall Study|Other unspecified|3|||
129491829|NCT01912872|466092698|FG003|Overall Study|Other unspecified|0|||
129491830|NCT01912872|466092695|FG000|Overall Study|Informed consent withdrawn|0|||
129491831|NCT01912872|466092696|FG001|Overall Study|Informed consent withdrawn|0|||
129491832|NCT01912872|466092697|FG002|Overall Study|Informed consent withdrawn|1|||
129491833|NCT01912872|466092698|FG003|Overall Study|Informed consent withdrawn|1|||
129491834|NCT01912872|466092695|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
129491835|NCT01912872|466092696|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
129491836|NCT01912872|466092697|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
129491837|NCT01912872|466092698|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
129491838|NCT01912872|466092695|FG000|Overall Study|Protocol Violation|0|||
129491839|NCT01912872|466092696|FG001|Overall Study|Protocol Violation|0|||
129491840|NCT01912872|466092697|FG002|Overall Study|Protocol Violation|1|||
129491841|NCT01912872|466092698|FG003|Overall Study|Protocol Violation|0|||
129491842|NCT01912872|466092695|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129491843|NCT01912872|466092696|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129491844|NCT01912872|466092697|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129491845|NCT01912872|466092698|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
129491846|NCT01912872|466092695|FG000|Overall Study|Withdrawal of study medication|0|||
129491847|NCT01912872|466092696|FG001|Overall Study|Withdrawal of study medication|0|||
129491848|NCT01912872|466092697|FG002|Overall Study|Withdrawal of study medication|0|||
129491849|NCT01912872|466092698|FG003|Overall Study|Withdrawal of study medication|2|||
129491850|NCT01912872|466092695|FG000|Overall Study|Missing|0|||
129491851|NCT01912872|466092696|FG001|Overall Study|Missing|0|||
129491852|NCT01912872|466092697|FG002|Overall Study|Missing|0|||
129491853|NCT01912872|466092698|FG003|Overall Study|Missing|1|||
129491854|NCT02778867|466092699|FG000|Phase 1|Withdrawal by Subject|2|||
129491855|NCT02778867|466092700|FG001|Phase 1|Withdrawal by Subject|3|||
129491856|NCT02778867|466092701|FG002|Phase 1|Withdrawal by Subject|0|||
129491857|NCT02778867|466092702|FG003|Phase 1|Withdrawal by Subject|0|||
129491858|NCT02778867|466092699|FG000|Phase 2|Withdrawal by Subject|0|||
129491859|NCT02778867|466092700|FG001|Phase 2|Withdrawal by Subject|0|||
129491860|NCT02778867|466092701|FG002|Phase 2|Withdrawal by Subject|1|||
129491861|NCT02778867|466092702|FG003|Phase 2|Withdrawal by Subject|0|||
129491862|NCT02778867|466092699|FG000|Phase 2|Physician Decision|0|||
129491863|NCT02778867|466092700|FG001|Phase 2|Physician Decision|0|||
129491864|NCT02778867|466092701|FG002|Phase 2|Physician Decision|0|||
129491865|NCT02778867|466092702|FG003|Phase 2|Physician Decision|1|||
129491866|NCT02778867|466092699|FG000|Phase 2|Adverse Event|0|||
129980692|NCT03345576|467891708|FG000|Overall Study|Withdrawal by Subject|2|||
129980693|NCT03345576|467891709|FG001|Overall Study|Withdrawal by Subject|2|||
129491867|NCT02778867|466092700|FG001|Phase 2|Adverse Event|0|||
129491868|NCT02778867|466092701|FG002|Phase 2|Adverse Event|0|||
129491869|NCT02778867|466092702|FG003|Phase 2|Adverse Event|1|||
129491870|NCT02546856|466092708|FG000|4 Months Evaluation|Death|2|||
129491871|NCT02546856|466092709|FG001|4 Months Evaluation|Death|3|||
129491872|NCT02546856|466092708|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
129491873|NCT02546856|466092709|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
129491874|NCT02546856|466092708|FG000|4 Months Evaluation|Lost to Follow-up|3|||
129491875|NCT02546856|466092709|FG001|4 Months Evaluation|Lost to Follow-up|3|||
129491876|NCT02546856|466092708|FG000|4 Months Evaluation|Physician Decision|3|||
129491877|NCT02546856|466092709|FG001|4 Months Evaluation|Physician Decision|0|||
129491878|NCT02546856|466092708|FG000|4 Months Evaluation|Working or living abroad|5|||
129491879|NCT02546856|466092709|FG001|4 Months Evaluation|Working or living abroad|1|||
129491880|NCT02546856|466092708|FG000|4 Months Evaluation|reasons not due to titration|4|||
129491881|NCT02546856|466092709|FG001|4 Months Evaluation|reasons not due to titration|1|||
129491882|NCT02546856|466092708|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
129491883|NCT02546856|466092709|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
129491884|NCT02546856|466092708|FG000|6 Months Evaluation|Death|1|||
129491885|NCT02546856|466092709|FG001|6 Months Evaluation|Death|1|||
129491886|NCT02546856|466092708|FG000|6 Months Evaluation|Lost to Follow-up|1|||
129491887|NCT02546856|466092709|FG001|6 Months Evaluation|Lost to Follow-up|1|||
129491888|NCT02546856|466092708|FG000|6 Months Evaluation|Working or living abroad|6|||
129491889|NCT02546856|466092709|FG001|6 Months Evaluation|Working or living abroad|4|||
129491890|NCT02546856|466092708|FG000|6 Months Evaluation|reasons not due to titration|0|||
129491891|NCT02546856|466092709|FG001|6 Months Evaluation|reasons not due to titration|1|||
129491892|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
129491893|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
129491894|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
129491895|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129491896|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129491897|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129491898|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129491899|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
129491900|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
129491901|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
129491902|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
129491903|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129491904|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129491905|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129491906|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129491907|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
129491908|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
129491909|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
129491910|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
129491911|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129491912|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129491913|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129491914|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129491915|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
129491916|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
129491917|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
129491918|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129491919|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129491920|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129491921|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129491922|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129491923|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
129491924|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
129491925|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
129491926|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
129491927|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129491928|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129491929|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129491930|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129491931|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
129491932|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
129491933|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
129491934|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
129491935|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
129491936|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
129491937|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
129491938|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
129491939|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
129491940|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
129491941|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
129491942|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129980694|NCT03345576|467891708|FG000|Overall Study|Adverse Event|1|||
129980695|NCT03345576|467891709|FG001|Overall Study|Adverse Event|0|||
129980696|NCT00730275|467893303|FG000|Overall Study|Withdrawal by Subject|0|||
129980697|NCT00730275|467893304|FG001|Overall Study|Withdrawal by Subject|0|||
129980698|NCT00730275|467893305|FG002|Overall Study|Withdrawal by Subject|0|||
129980699|NCT00730275|467893306|FG003|Overall Study|Withdrawal by Subject|1|||
129491943|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129491944|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129491945|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129491946|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129491947|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
129491948|NCT01097616|466092711|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491949|NCT01097616|466092712|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491950|NCT01097616|466092713|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
129491951|NCT01097616|466092714|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491952|NCT01097616|466092715|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491953|NCT01097616|466092716|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491954|NCT01097616|466092717|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491955|NCT01097616|466092718|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
129491956|NCT01097616|466092711|FG000|Optional DB EXT Phase|Adverse Event|0|||
129491957|NCT01097616|466092712|FG001|Optional DB EXT Phase|Adverse Event|7|||
129491958|NCT01097616|466092713|FG002|Optional DB EXT Phase|Adverse Event|2|||
129491959|NCT01097616|466092714|FG003|Optional DB EXT Phase|Adverse Event|0|||
129491960|NCT01097616|466092715|FG004|Optional DB EXT Phase|Adverse Event|0|||
129491961|NCT01097616|466092716|FG005|Optional DB EXT Phase|Adverse Event|0|||
129491962|NCT01097616|466092717|FG006|Optional DB EXT Phase|Adverse Event|0|||
129491963|NCT01097616|466092718|FG007|Optional DB EXT Phase|Adverse Event|0|||
129491964|NCT01097616|466092711|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
129491965|NCT01097616|466092712|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
129491966|NCT01097616|466092713|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
129491967|NCT01097616|466092714|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
129491968|NCT01097616|466092715|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
129491969|NCT01097616|466092716|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
129491970|NCT01097616|466092717|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
129491971|NCT01097616|466092718|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
129491972|NCT01097616|466092711|FG000|Optional DB EXT Phase|Protocol Violation|0|||
129491973|NCT01097616|466092712|FG001|Optional DB EXT Phase|Protocol Violation|2|||
129491974|NCT01097616|466092713|FG002|Optional DB EXT Phase|Protocol Violation|3|||
129491975|NCT01097616|466092714|FG003|Optional DB EXT Phase|Protocol Violation|0|||
129491976|NCT01097616|466092715|FG004|Optional DB EXT Phase|Protocol Violation|0|||
129491977|NCT01097616|466092716|FG005|Optional DB EXT Phase|Protocol Violation|0|||
129491978|NCT01097616|466092717|FG006|Optional DB EXT Phase|Protocol Violation|0|||
129491979|NCT01097616|466092718|FG007|Optional DB EXT Phase|Protocol Violation|0|||
129491980|NCT01097616|466092711|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
129491981|NCT01097616|466092712|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
129491982|NCT01097616|466092713|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
129491983|NCT01097616|466092714|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
129491984|NCT01097616|466092715|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
129491985|NCT01097616|466092716|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
129491986|NCT01097616|466092717|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
129491987|NCT01097616|466092718|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
129491988|NCT01097616|466092711|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
129491989|NCT01097616|466092712|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
129491990|NCT01097616|466092713|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
129491991|NCT01097616|466092714|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
129491992|NCT01097616|466092715|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
129491993|NCT01097616|466092716|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
129491994|NCT01097616|466092717|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
129491995|NCT01097616|466092718|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
129491996|NCT01097616|466092711|FG000|Optional DB EXT Phase|Physician Decision|1|||
129491997|NCT01097616|466092712|FG001|Optional DB EXT Phase|Physician Decision|0|||
129491998|NCT01097616|466092713|FG002|Optional DB EXT Phase|Physician Decision|0|||
129491999|NCT01097616|466092714|FG003|Optional DB EXT Phase|Physician Decision|0|||
129492000|NCT01097616|466092715|FG004|Optional DB EXT Phase|Physician Decision|0|||
129492001|NCT01097616|466092716|FG005|Optional DB EXT Phase|Physician Decision|0|||
129492002|NCT01097616|466092717|FG006|Optional DB EXT Phase|Physician Decision|0|||
129492003|NCT01097616|466092718|FG007|Optional DB EXT Phase|Physician Decision|0|||
129492004|NCT01097616|466092711|FG000|DB RO Phase|Adverse Event|0|||
129492005|NCT01097616|466092712|FG001|DB RO Phase|Adverse Event|0|||
129492006|NCT01097616|466092713|FG002|DB RO Phase|Adverse Event|0|||
129492007|NCT01097616|466092714|FG003|DB RO Phase|Adverse Event|0|||
129980700|NCT00939822|467893311|FG000|Overall Study|Lost to Follow-up|1|||
129492008|NCT01097616|466092715|FG004|DB RO Phase|Adverse Event|0|||
129980701|NCT00939822|467893312|FG001|Overall Study|Lost to Follow-up|0|||
129492009|NCT01097616|466092716|FG005|DB RO Phase|Adverse Event|0|||
129492010|NCT01097616|466092717|FG006|DB RO Phase|Adverse Event|1|||
129492011|NCT01097616|466092718|FG007|DB RO Phase|Adverse Event|0|||
129492012|NCT01097616|466092711|FG000|DB RO Phase|Withdrawal by Subject|0|||
129492013|NCT01097616|466092712|FG001|DB RO Phase|Withdrawal by Subject|0|||
129492014|NCT01097616|466092713|FG002|DB RO Phase|Withdrawal by Subject|0|||
129492015|NCT01097616|466092714|FG003|DB RO Phase|Withdrawal by Subject|0|||
129492016|NCT01097616|466092715|FG004|DB RO Phase|Withdrawal by Subject|0|||
129492017|NCT01097616|466092716|FG005|DB RO Phase|Withdrawal by Subject|1|||
129492018|NCT01097616|466092717|FG006|DB RO Phase|Withdrawal by Subject|0|||
129492019|NCT01097616|466092718|FG007|DB RO Phase|Withdrawal by Subject|0|||
129492020|NCT01097616|466092711|FG000|DB RO Phase|Lost to Follow-up|0|||
129492021|NCT01097616|466092712|FG001|DB RO Phase|Lost to Follow-up|0|||
129492022|NCT01097616|466092713|FG002|DB RO Phase|Lost to Follow-up|0|||
129492023|NCT01097616|466092714|FG003|DB RO Phase|Lost to Follow-up|1|||
129492024|NCT01097616|466092715|FG004|DB RO Phase|Lost to Follow-up|1|||
129492025|NCT01097616|466092716|FG005|DB RO Phase|Lost to Follow-up|0|||
129492026|NCT01097616|466092717|FG006|DB RO Phase|Lost to Follow-up|0|||
129492027|NCT01097616|466092718|FG007|DB RO Phase|Lost to Follow-up|1|||
129492028|NCT01097616|466092711|FG000|DB RO Phase|Not Treated in RO|0|||
129492029|NCT01097616|466092712|FG001|DB RO Phase|Not Treated in RO|0|||
129492030|NCT01097616|466092713|FG002|DB RO Phase|Not Treated in RO|0|||
129492031|NCT01097616|466092714|FG003|DB RO Phase|Not Treated in RO|0|||
129492032|NCT01097616|466092715|FG004|DB RO Phase|Not Treated in RO|0|||
129492033|NCT01097616|466092716|FG005|DB RO Phase|Not Treated in RO|1|||
129492034|NCT01097616|466092717|FG006|DB RO Phase|Not Treated in RO|0|||
129492035|NCT01097616|466092718|FG007|DB RO Phase|Not Treated in RO|0|||
129492036|NCT00130208|466092719|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
129492037|NCT00130208|466092720|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
129492038|NCT00130208|466092719|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
129492039|NCT00130208|466092720|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
129492040|NCT00130208|466092719|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
129492041|NCT00130208|466092720|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
129492042|NCT00130208|466092719|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
129492043|NCT00130208|466092720|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
129492044|NCT00130208|466092719|FG000|Maintenance Period (26 Weeks)|Other|1|||
129492045|NCT00130208|466092720|FG001|Maintenance Period (26 Weeks)|Other|1|||
129492046|NCT00130208|466092719|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
129492047|NCT00130208|466092720|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
129492048|NCT00130208|466092719|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
129492049|NCT00130208|466092720|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
129492050|NCT00130208|466092719|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
129492051|NCT00130208|466092720|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
129492052|NCT00130208|466092719|FG000|Washout Period (8 Weeks)|Other|1|||
129492053|NCT00130208|466092720|FG001|Washout Period (8 Weeks)|Other|1|||
129492054|NCT00589472|466092722|FG000|Overall Study|Adverse Event|1|||
129492055|NCT01703819|466092725|FG000|Overall Study|Adverse Event|0|||
129492056|NCT01703819|466092726|FG001|Overall Study|Adverse Event|1|||
129492057|NCT01703819|466092725|FG000|Overall Study|Withdrawal by Subject|0|||
129492058|NCT01703819|466092726|FG001|Overall Study|Withdrawal by Subject|1|||
129492059|NCT02145156|466092727|FG000|Overall Study|No match to vaccination records|60|||
129492060|NCT02145156|466092728|FG001|Overall Study|No match to vaccination records|52|||
129492061|NCT02145156|466092729|FG002|Overall Study|No match to vaccination records|41|||
129492062|NCT00532883|466092730|FG000|Overall Study|Adverse Event|1|||
129492063|NCT00532883|466092731|FG001|Overall Study|Adverse Event|0|||
129492064|NCT00532883|466092732|FG002|Overall Study|Adverse Event|0|||
129492065|NCT00532883|466092733|FG003|Overall Study|Adverse Event|1|||
129492066|NCT00532883|466092730|FG000|Overall Study|Lost to Follow-up|1|||
129492067|NCT00532883|466092731|FG001|Overall Study|Lost to Follow-up|1|||
129492068|NCT00532883|466092732|FG002|Overall Study|Lost to Follow-up|1|||
129492069|NCT00532883|466092733|FG003|Overall Study|Lost to Follow-up|0|||
129492070|NCT00532883|466092730|FG000|Overall Study|Withdrawal by Subject|0|||
129492071|NCT00532883|466092731|FG001|Overall Study|Withdrawal by Subject|1|||
129492072|NCT00532883|466092732|FG002|Overall Study|Withdrawal by Subject|1|||
129492073|NCT00532883|466092733|FG003|Overall Study|Withdrawal by Subject|0|||
129492074|NCT00532883|466092730|FG000|Overall Study|Subject was Nonadherent|0|||
129492075|NCT00532883|466092731|FG001|Overall Study|Subject was Nonadherent|1|||
129492076|NCT00532883|466092732|FG002|Overall Study|Subject was Nonadherent|1|||
129492077|NCT00532883|466092733|FG003|Overall Study|Subject was Nonadherent|0|||
129492078|NCT00532883|466092730|FG000|Overall Study|Early Study Termination|4|||
129492079|NCT00532883|466092731|FG001|Overall Study|Early Study Termination|4|||
129492080|NCT00532883|466092732|FG002|Overall Study|Early Study Termination|1|||
129492081|NCT00532883|466092733|FG003|Overall Study|Early Study Termination|4|||
129492082|NCT01797783|466092734|FG000|Overall Study|Adverse Event|1|||
129492083|NCT01797783|466092735|FG001|Overall Study|Adverse Event|1|||
129492084|NCT01797783|466092734|FG000|Overall Study|Withdrawal by Subject|1|||
129492085|NCT01797783|466092735|FG001|Overall Study|Withdrawal by Subject|0|||
129492086|NCT05232097|466092738|FG000|Overall Study|Physician Decision|1|||
129492087|NCT01172288|466092739|FG000|Overall Study|Adverse Event|1|||
129492088|NCT01172288|466092740|FG001|Overall Study|Adverse Event|0|||
129980702|NCT00939822|467893311|FG000|Overall Study|withdrew from study due to busy schedule|1|||
129492089|NCT01172288|466092739|FG000|Overall Study|Protocol Violation|0|||
129492090|NCT01172288|466092740|FG001|Overall Study|Protocol Violation|1|||
129492091|NCT00871858|466092743|FG000|Overall Study|Protocol Violation|3|||
129492092|NCT00871858|466092744|FG001|Overall Study|Protocol Violation|4|||
129492093|NCT00871858|466092743|FG000|Overall Study|Adverse Event|1|||
129492094|NCT00871858|466092744|FG001|Overall Study|Adverse Event|1|||
129492095|NCT00871858|466092743|FG000|Overall Study|Withdrawal by Subject|1|||
129492096|NCT00871858|466092744|FG001|Overall Study|Withdrawal by Subject|1|||
129492097|NCT00871858|466092743|FG000|Overall Study|Lost to Follow-up|0|||
129492098|NCT00871858|466092744|FG001|Overall Study|Lost to Follow-up|1|||
129492099|NCT01188798|466092745|FG000|Overall Study|Death|0|||
129492100|NCT01188798|466092746|FG001|Overall Study|Death|1|||
129492101|NCT01188798|466092745|FG000|Overall Study|Required additional transplant|1|||
129492102|NCT01188798|466092746|FG001|Overall Study|Required additional transplant|1|||
129492103|NCT01188798|466092745|FG000|Overall Study|Protocol closure|1|||
129492104|NCT01188798|466092746|FG001|Overall Study|Protocol closure|1|||
129492105|NCT02795767|466092747|FG000|Overall Study|Received Commercial Emicizumab|1|||
129492106|NCT02795767|466092748|FG001|Overall Study|Received Commercial Emicizumab|0|||
129492107|NCT02795767|466092749|FG002|Overall Study|Received Commercial Emicizumab|0|||
129492108|NCT03662334|466092750|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
129492109|NCT03662334|466092751|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
129492110|NCT02853331|466092762|FG000|Overall Study|Death|59|||
129492111|NCT02853331|466092763|FG001|Overall Study|Death|95|||
129492112|NCT02853331|466092762|FG000|Overall Study|Withdrawal by Subject|5|||
129492113|NCT02853331|466092763|FG001|Overall Study|Withdrawal by Subject|9|||
129492114|NCT02853331|466092762|FG000|Overall Study|Ongoing in study|368|||
129492115|NCT02853331|466092763|FG001|Overall Study|Ongoing in study|325|||
129492116|NCT03290300|466092766|FG000|Overall Study|Lost to Follow-up|3|||
129492117|NCT02746679|466092770|FG000|Overall Study|Lost to Follow-up|4|||
129492118|NCT02746679|466092771|FG001|Overall Study|Lost to Follow-up|6|||
129492119|NCT00487279|466092772|FG000|Overall Study|Death|1|||
129492120|NCT00487279|466092773|FG001|Overall Study|Death|0|||
129492121|NCT00487279|466092772|FG000|Overall Study|Withdrawal by Subject|0|||
129492122|NCT00487279|466092773|FG001|Overall Study|Withdrawal by Subject|2|||
129492123|NCT01520922|466092774|FG000|Treatment Phase|Physician Decision|2|||
129492124|NCT01520922|466092775|FG001|Treatment Phase|Physician Decision|1|||
129492125|NCT01520922|466092774|FG000|Treatment Phase|Progression|0|||
129492126|NCT01520922|466092775|FG001|Treatment Phase|Progression|2|||
129492127|NCT01520922|466092774|FG000|Treatment Phase|Adverse Event|3|||
129492128|NCT01520922|466092775|FG001|Treatment Phase|Adverse Event|5|||
129492129|NCT01520922|466092774|FG000|Follow up|Lost to Follow-up|0|||
129492130|NCT01520922|466092775|FG001|Follow up|Lost to Follow-up|1|||
129492131|NCT01520922|466092774|FG000|Survival Follow-up|Withdrawal by Subject|1|||
129492132|NCT01520922|466092775|FG001|Survival Follow-up|Withdrawal by Subject|0|||
129492133|NCT01618656|466092777|FG000|Overall Study|Withdrawal by Subject|7|||
129492134|NCT01618656|466092778|FG001|Overall Study|Withdrawal by Subject|3|||
129492135|NCT01618656|466092777|FG000|Overall Study|Physician Decision|1|||
129492136|NCT01618656|466092778|FG001|Overall Study|Physician Decision|1|||
129492137|NCT04770155|466092783|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492138|NCT04770155|466092784|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492139|NCT04770155|466092785|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492140|NCT04770155|466092786|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492141|NCT04770155|466092787|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492142|NCT04770155|466092788|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492143|NCT04770155|466092789|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492144|NCT04770155|466092790|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
129492145|NCT00864227|466092794|FG000|Overall Study|Withdrawal by Subject|1|||
129492146|NCT00864227|466092794|FG000|Overall Study|Disease Relapse/Progression|3|||
129980703|NCT00939822|467893312|FG001|Overall Study|withdrew from study due to busy schedule|1|||
129980704|NCT00939822|467893311|FG000|Overall Study|Mental health issues|0|||
129980705|NCT00939822|467893312|FG001|Overall Study|Mental health issues|2|||
129492147|NCT03461289|466092797|FG000|Overall Study|Death|1|||
129492148|NCT00935220|466092807|FG000|Overall Study|Adverse Event|1|||
129492149|NCT00935220|466092807|FG000|Overall Study|Other reason (not specified)|1|||
129492150|NCT00798967|466092808|FG000|Overall Study|Adverse Event|2|||
129492151|NCT00798967|466092809|FG001|Overall Study|Adverse Event|3|||
129492152|NCT00798967|466092808|FG000|Overall Study|Withdrawal by Subject|0|||
129492153|NCT00798967|466092809|FG001|Overall Study|Withdrawal by Subject|1|||
129492154|NCT00798967|466092808|FG000|Overall Study|Physician Decision|1|||
129492155|NCT00798967|466092809|FG001|Overall Study|Physician Decision|0|||
129492156|NCT00798967|466092808|FG000|Overall Study|Randomized in error by site|1|||
129492157|NCT00798967|466092809|FG001|Overall Study|Randomized in error by site|0|||
129492158|NCT01415440|466092812|FG000|Overall Study|Lost to Follow-up|0|||
129980706|NCT03046121|467893315|FG000|Overall Study|Death|32|||
129492159|NCT01415440|466092813|FG001|Overall Study|Lost to Follow-up|1|||
129492160|NCT01415440|466092814|FG002|Overall Study|Lost to Follow-up|2|||
129492161|NCT01415440|466092812|FG000|Overall Study|Physician Decision|3|||
129492162|NCT01415440|466092813|FG001|Overall Study|Physician Decision|0|||
129492163|NCT01415440|466092814|FG002|Overall Study|Physician Decision|0|||
129492164|NCT01415440|466092812|FG000|Overall Study|Withdrawal by Subject|1|||
129492165|NCT01415440|466092813|FG001|Overall Study|Withdrawal by Subject|0|||
129492166|NCT01415440|466092814|FG002|Overall Study|Withdrawal by Subject|0|||
129492167|NCT00633139|466092815|FG000|Overall Study|Non compliance|0|||
129492168|NCT00633139|466092816|FG001|Overall Study|Non compliance|0|||
129492169|NCT00633139|466092817|FG002|Overall Study|Non compliance|1|||
129492170|NCT00633139|466092815|FG000|Overall Study|Withdrawal by Subject|0|||
129492171|NCT00633139|466092816|FG001|Overall Study|Withdrawal by Subject|1|||
129492172|NCT00633139|466092817|FG002|Overall Study|Withdrawal by Subject|0|||
129492173|NCT02160977|466092818|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
129492174|NCT02160977|466092819|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
129492175|NCT02160977|466092818|FG000|Three Months After Surgery|Lost to Follow-up|0|||
129492176|NCT02160977|466092819|FG001|Three Months After Surgery|Lost to Follow-up|2|||
129492177|NCT02160977|466092818|FG000|Six Months After Surgery|Lost to Follow-up|2|||
129492178|NCT02160977|466092819|FG001|Six Months After Surgery|Lost to Follow-up|1|||
129492179|NCT01522651|466092823|FG000|Overall Study|Adverse Event|3|||
129492180|NCT01522651|466092824|FG001|Overall Study|Adverse Event|4|||
129492181|NCT01522651|466092825|FG002|Overall Study|Adverse Event|4|||
129492182|NCT01522651|466092826|FG003|Overall Study|Adverse Event|5|||
129492183|NCT01522651|466092827|FG004|Overall Study|Adverse Event|4|||
129492184|NCT01522651|466092823|FG000|Overall Study|Cardioversion|1|||
129492185|NCT01522651|466092824|FG001|Overall Study|Cardioversion|0|||
129492186|NCT01522651|466092825|FG002|Overall Study|Cardioversion|0|||
129492187|NCT01522651|466092826|FG003|Overall Study|Cardioversion|0|||
129492188|NCT01522651|466092827|FG004|Overall Study|Cardioversion|0|||
129492189|NCT01522651|466092823|FG000|Overall Study|Device Malfunction|0|||
129492190|NCT01522651|466092824|FG001|Overall Study|Device Malfunction|1|||
129492191|NCT01522651|466092825|FG002|Overall Study|Device Malfunction|0|||
129492192|NCT01522651|466092826|FG003|Overall Study|Device Malfunction|0|||
129492193|NCT01522651|466092827|FG004|Overall Study|Device Malfunction|0|||
129492194|NCT01522651|466092823|FG000|Overall Study|Investigator's Discretion|0|||
129492195|NCT01522651|466092824|FG001|Overall Study|Investigator's Discretion|1|||
129492196|NCT01522651|466092825|FG002|Overall Study|Investigator's Discretion|0|||
129492197|NCT01522651|466092826|FG003|Overall Study|Investigator's Discretion|0|||
129492198|NCT01522651|466092827|FG004|Overall Study|Investigator's Discretion|0|||
129492199|NCT01522651|466092823|FG000|Overall Study|Protocol Violation|3|||
129492200|NCT01522651|466092824|FG001|Overall Study|Protocol Violation|0|||
129492201|NCT01522651|466092825|FG002|Overall Study|Protocol Violation|0|||
129492202|NCT01522651|466092826|FG003|Overall Study|Protocol Violation|0|||
129492203|NCT01522651|466092827|FG004|Overall Study|Protocol Violation|0|||
129492204|NCT01522651|466092823|FG000|Overall Study|Reason Not Specified|0|||
129492205|NCT01522651|466092824|FG001|Overall Study|Reason Not Specified|0|||
129492206|NCT01522651|466092825|FG002|Overall Study|Reason Not Specified|0|||
129492207|NCT01522651|466092826|FG003|Overall Study|Reason Not Specified|1|||
129492208|NCT01522651|466092827|FG004|Overall Study|Reason Not Specified|0|||
129492209|NCT01522651|466092823|FG000|Overall Study|Participant Non-Compliance|1|||
129492210|NCT01522651|466092824|FG001|Overall Study|Participant Non-Compliance|0|||
129492211|NCT01522651|466092825|FG002|Overall Study|Participant Non-Compliance|0|||
129492212|NCT01522651|466092826|FG003|Overall Study|Participant Non-Compliance|0|||
129492213|NCT01522651|466092827|FG004|Overall Study|Participant Non-Compliance|0|||
129492214|NCT01522651|466092823|FG000|Overall Study|Withdrew Consent|1|||
129492215|NCT01522651|466092824|FG001|Overall Study|Withdrew Consent|1|||
129492216|NCT01522651|466092825|FG002|Overall Study|Withdrew Consent|0|||
129492217|NCT01522651|466092826|FG003|Overall Study|Withdrew Consent|1|||
129492218|NCT01522651|466092827|FG004|Overall Study|Withdrew Consent|1|||
129492219|NCT01522651|466092823|FG000|Overall Study|Randomized but Never Treated|0|||
129492220|NCT01522651|466092824|FG001|Overall Study|Randomized but Never Treated|1|||
129492221|NCT01522651|466092825|FG002|Overall Study|Randomized but Never Treated|0|||
129492222|NCT01522651|466092826|FG003|Overall Study|Randomized but Never Treated|1|||
129492223|NCT01522651|466092827|FG004|Overall Study|Randomized but Never Treated|1|||
129492224|NCT02658656|466092828|FG000|Screening|Failed eligibility criteria|0|||
129492225|NCT02658656|466092829|FG001|Screening|Failed eligibility criteria|0|||
129492226|NCT02658656|466092830|FG002|Screening|Failed eligibility criteria|263|||
129492227|NCT02658656|466092828|FG000|Randomization|Withdrawal by Subject|8|||
129492228|NCT02658656|466092829|FG001|Randomization|Withdrawal by Subject|7|||
129492229|NCT02658656|466092830|FG002|Randomization|Withdrawal by Subject|0|||
129492230|NCT02658656|466092828|FG000|Randomization|Lost to Follow-up|1|||
129492231|NCT02658656|466092829|FG001|Randomization|Lost to Follow-up|3|||
129492232|NCT02658656|466092830|FG002|Randomization|Lost to Follow-up|0|||
129492233|NCT02658656|466092828|FG000|Randomization|Adverse Event|4|||
129492234|NCT02658656|466092829|FG001|Randomization|Adverse Event|0|||
129492235|NCT02658656|466092830|FG002|Randomization|Adverse Event|0|||
129980707|NCT03046121|467893316|FG001|Overall Study|Death|60|||
129980708|NCT03046121|467893315|FG000|Overall Study|Withdrawal by Subject|14|||
129980709|NCT03046121|467893316|FG001|Overall Study|Withdrawal by Subject|12|||
129980710|NCT00910039|467893317|FG000|Overall Study|Physician Decision|1|||
129980711|NCT03547739|467893324|FG000|Overall Study|Death|0|||
129980712|NCT03547739|467893325|FG001|Overall Study|Death|1|||
129980713|NCT03547739|467893326|FG002|Overall Study|Death|5|||
129980714|NCT03547739|467893324|FG000|Overall Study|Adverse Event|24|||
129980715|NCT03547739|467893325|FG001|Overall Study|Adverse Event|11|||
129980716|NCT03547739|467893326|FG002|Overall Study|Adverse Event|13|||
129980717|NCT03547739|467893324|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
129980718|NCT03547739|467893325|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
129980719|NCT03547739|467893326|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
129980720|NCT03547739|467893324|FG000|Overall Study|Lost to Follow-up|80|||
129980721|NCT03547739|467893325|FG001|Overall Study|Lost to Follow-up|84|||
129980722|NCT03547739|467893326|FG002|Overall Study|Lost to Follow-up|116|||
129980723|NCT04035499|467893329|FG000|Overall Study|Death|2|||
129980724|NCT04035499|467893329|FG000|Overall Study|Withdrawal by Subject|1|||
129980725|NCT00416195|467893330|FG000|Overall Study|Adverse Event|1|||
129980726|NCT00416195|467893331|FG001|Overall Study|Adverse Event|2|||
129980727|NCT00416195|467893330|FG000|Overall Study|Protocol Violation|1|||
129980728|NCT00416195|467893331|FG001|Overall Study|Protocol Violation|1|||
129980729|NCT00416195|467893330|FG000|Overall Study|Other|0|||
129980730|NCT00416195|467893331|FG001|Overall Study|Other|1|||
129980731|NCT01305408|467893337|FG000|Overall Study|Adverse Event|10|||
129980732|NCT01305408|467893338|FG001|Overall Study|Adverse Event|7|||
129980733|NCT01305408|467893337|FG000|Overall Study|Lack of Efficacy|3|||
129980734|NCT01305408|467893338|FG001|Overall Study|Lack of Efficacy|4|||
129980735|NCT01305408|467893337|FG000|Overall Study|Withdrawal by Subject|9|||
129980736|NCT01305408|467893338|FG001|Overall Study|Withdrawal by Subject|9|||
129980737|NCT01305408|467893337|FG000|Overall Study|Protocol Violation|4|||
129980738|NCT01305408|467893338|FG001|Overall Study|Protocol Violation|6|||
129980739|NCT01305408|467893337|FG000|Overall Study|Lost to Follow-up|5|||
129980740|NCT01305408|467893338|FG001|Overall Study|Lost to Follow-up|3|||
129980741|NCT01305408|467893337|FG000|Overall Study|Noncompliance with study medication|0|||
129980742|NCT01305408|467893338|FG001|Overall Study|Noncompliance with study medication|1|||
129980743|NCT01305408|467893337|FG000|Overall Study|Noncompliance with study procedures|0|||
129980744|NCT01305408|467893338|FG001|Overall Study|Noncompliance with study procedures|1|||
129980745|NCT01305408|467893337|FG000|Overall Study|Other|1|||
129980746|NCT01305408|467893338|FG001|Overall Study|Other|0|||
129980747|NCT02530970|467893339|FG000|Overall Study|Adverse Event|8|||
129980748|NCT02530970|467893339|FG000|Overall Study|Lost to Follow-up|88|||
129980749|NCT02530970|467893339|FG000|Overall Study|Physician Decision|5|||
129980750|NCT02530970|467893339|FG000|Overall Study|Withdrawal by Subject|14|||
129980751|NCT02530970|467893339|FG000|Overall Study|Death|6|||
129980752|NCT02530970|467893339|FG000|Overall Study|Hospitalization|1|||
129980753|NCT02530970|467893339|FG000|Overall Study|Insurance|2|||
129980754|NCT02530970|467893339|FG000|Overall Study|Explant|2|||
129980755|NCT02530970|467893339|FG000|Overall Study|Change in Provider|5|||
129980756|NCT02530970|467893339|FG000|Overall Study|Relocation|3|||
129980757|NCT02770612|467893341|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
129980758|NCT00958841|467893346|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129980759|NCT00958841|467893346|FG000|Overall Study|Abnormal test procedure result(s)|3|||
129980760|NCT00958841|467893346|FG000|Overall Study|Administrative problems|1|||
129980761|NCT00958841|467893346|FG000|Overall Study|Adverse Event|8|||
129980762|NCT00958841|467893346|FG000|Overall Study|New cancer therapy|5|||
129980763|NCT00958841|467893346|FG000|Overall Study|Withdrawal by Subject|1|||
129980764|NCT00958841|467893346|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
129980765|NCT00958841|467893346|FG000|Overall Study|Completed M6/did not enter extension|27|||
129980766|NCT00958841|467893346|FG000|Overall Study|Discontinued prior to M*|28|||
129980767|NCT03014011|467893354|FG000|First Intervention|Withdrawal by Subject|1|||
129980768|NCT03014011|467893355|FG001|First Intervention|Withdrawal by Subject|0|||
129980769|NCT03014011|467893354|FG000|Washout|Withdrawal by Subject|1|||
129980770|NCT03014011|467893355|FG001|Washout|Withdrawal by Subject|0|||
129980771|NCT02416453|467893357|FG000|Overall Study|Adverse Event|0|||
129980772|NCT02416453|467893358|FG001|Overall Study|Adverse Event|0|||
129980773|NCT02416453|467893359|FG002|Overall Study|Adverse Event|0|||
129980774|NCT02416453|467893360|FG003|Overall Study|Adverse Event|2|||
129980775|NCT02416453|467893361|FG004|Overall Study|Adverse Event|0|||
129980776|NCT02416453|467893362|FG005|Overall Study|Adverse Event|1|||
129980777|NCT02416453|467893363|FG006|Overall Study|Adverse Event|0|||
129980778|NCT02416453|467893364|FG007|Overall Study|Adverse Event|0|||
129980779|NCT02416453|467893365|FG008|Overall Study|Adverse Event|0|||
129980780|NCT02416453|467893366|FG009|Overall Study|Adverse Event|0|||
129980781|NCT02416453|467893367|FG010|Overall Study|Adverse Event|0|||
129980782|NCT02416453|467893357|FG000|Overall Study|Lost to Follow-up|1|||
129980783|NCT02416453|467893358|FG001|Overall Study|Lost to Follow-up|3|||
129980784|NCT02416453|467893359|FG002|Overall Study|Lost to Follow-up|0|||
129492236|NCT02658656|466092828|FG000|Randomization|Administrative Termination|3|||
129492237|NCT02658656|466092829|FG001|Randomization|Administrative Termination|1|||
129492238|NCT02658656|466092830|FG002|Randomization|Administrative Termination|0|||
129492239|NCT02658656|466092828|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
129492240|NCT02658656|466092829|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
129492241|NCT02658656|466092830|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
129492242|NCT02658656|466092828|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
129492243|NCT02658656|466092829|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
129492244|NCT02658656|466092830|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
129492245|NCT02658656|466092828|FG000|Randomization|Not eligible for Randomization|1|||
129492246|NCT02658656|466092829|FG001|Randomization|Not eligible for Randomization|0|||
129492247|NCT02658656|466092830|FG002|Randomization|Not eligible for Randomization|0|||
129492248|NCT02658656|466092828|FG000|Randomization|Protocol Violation|1|||
129492249|NCT02658656|466092829|FG001|Randomization|Protocol Violation|0|||
129492250|NCT02658656|466092830|FG002|Randomization|Protocol Violation|0|||
129492251|NCT02322892|466094137|FG000|Overall Study|Surgery cancelled|1|||
129492252|NCT02322892|466094138|FG001|Overall Study|Surgery cancelled|2|||
129492253|NCT02322892|466094137|FG000|Overall Study|Met exclusion criteria|0|||
129492254|NCT02322892|466094138|FG001|Overall Study|Met exclusion criteria|1|||
129492255|NCT02322892|466094137|FG000|Overall Study|Protocol Violation|1|||
129492256|NCT02322892|466094138|FG001|Overall Study|Protocol Violation|0|||
129492257|NCT02125331|466094141|FG000|Overall Study|Protocol Violation|1|||
129492258|NCT02125331|466094142|FG001|Overall Study|Protocol Violation|0|||
129492259|NCT02125331|466094141|FG000|Overall Study|technical problem|2|||
129492260|NCT02125331|466094142|FG001|Overall Study|technical problem|0|||
129492261|NCT02125331|466094141|FG000|Overall Study|screen failure|2|||
129492262|NCT02125331|466094142|FG001|Overall Study|screen failure|0|||
129492263|NCT03504774|466094143|FG000|Overall Study|Adverse Event|2|||
129492264|NCT03504774|466094144|FG001|Overall Study|Adverse Event|0|||
129492265|NCT03504774|466094143|FG000|Overall Study|Lost to Follow-up|0|||
129492266|NCT03504774|466094144|FG001|Overall Study|Lost to Follow-up|1|||
129492267|NCT03504774|466094143|FG000|Overall Study|Protocol Violation|11|||
129492268|NCT03504774|466094144|FG001|Overall Study|Protocol Violation|3|||
129492269|NCT03504774|466094143|FG000|Overall Study|failed wk 52 DBPCFC|1|||
129492270|NCT03504774|466094144|FG001|Overall Study|failed wk 52 DBPCFC|0|||
129492271|NCT00915005|466094150|FG000|Overall Study|Withdrawal by Subject|4|||
129492272|NCT00915005|466094151|FG001|Overall Study|Withdrawal by Subject|4|||
129492273|NCT00915005|466094150|FG000|Overall Study|Patient preferred protons therapy|6|||
129492274|NCT00915005|466094151|FG001|Overall Study|Patient preferred protons therapy|0|||
129492275|NCT00915005|466094150|FG000|Overall Study|Insurance denial|3|||
129492276|NCT00915005|466094151|FG001|Overall Study|Insurance denial|15|||
129492277|NCT03554005|466094154|FG000|Overall Study|Not in participant's best interest|0|||
129492278|NCT03554005|466094155|FG001|Overall Study|Not in participant's best interest|0|||
129492279|NCT03554005|466094156|FG002|Overall Study|Not in participant's best interest|0|||
129492280|NCT03554005|466094157|FG003|Overall Study|Not in participant's best interest|0|||
129492281|NCT03554005|466094158|FG004|Overall Study|Not in participant's best interest|0|||
129492282|NCT03554005|466094159|FG005|Overall Study|Not in participant's best interest|1|||
129492283|NCT03554005|466094154|FG000|Overall Study|Disease Progression|1|||
129492284|NCT03554005|466094155|FG001|Overall Study|Disease Progression|1|||
129492285|NCT03554005|466094156|FG002|Overall Study|Disease Progression|1|||
129492286|NCT03554005|466094157|FG003|Overall Study|Disease Progression|1|||
129492287|NCT03554005|466094158|FG004|Overall Study|Disease Progression|5|||
129492288|NCT03554005|466094159|FG005|Overall Study|Disease Progression|6|||
129492289|NCT03554005|466094154|FG000|Overall Study|Adverse Event|0|||
129492290|NCT03554005|466094155|FG001|Overall Study|Adverse Event|0|||
129492291|NCT03554005|466094156|FG002|Overall Study|Adverse Event|0|||
129492292|NCT03554005|466094157|FG003|Overall Study|Adverse Event|0|||
129492293|NCT03554005|466094158|FG004|Overall Study|Adverse Event|0|||
129492294|NCT03554005|466094159|FG005|Overall Study|Adverse Event|3|||
129492295|NCT03554005|466094154|FG000|Overall Study|Physician Decision|0|||
129492296|NCT03554005|466094155|FG001|Overall Study|Physician Decision|0|||
129492297|NCT03554005|466094156|FG002|Overall Study|Physician Decision|0|||
129492298|NCT03554005|466094157|FG003|Overall Study|Physician Decision|0|||
129492299|NCT03554005|466094158|FG004|Overall Study|Physician Decision|1|||
129492300|NCT03554005|466094159|FG005|Overall Study|Physician Decision|0|||
129492301|NCT03554005|466094154|FG000|Overall Study|Other|0|||
129492302|NCT03554005|466094155|FG001|Overall Study|Other|0|||
129492303|NCT03554005|466094156|FG002|Overall Study|Other|0|||
129492304|NCT03554005|466094157|FG003|Overall Study|Other|0|||
129492305|NCT03554005|466094158|FG004|Overall Study|Other|0|||
129492306|NCT03554005|466094159|FG005|Overall Study|Other|1|||
129492307|NCT00631488|466094160|FG000|Overall Study|Adverse Event|1|||
129492308|NCT00631488|466094161|FG001|Overall Study|Adverse Event|0|||
129492309|NCT00631488|466094162|FG002|Overall Study|Adverse Event|0|||
129492310|NCT00631488|466094160|FG000|Overall Study|Lost to Follow-up|2|||
129492311|NCT00631488|466094161|FG001|Overall Study|Lost to Follow-up|2|||
129492312|NCT00631488|466094162|FG002|Overall Study|Lost to Follow-up|0|||
129492313|NCT00631488|466094160|FG000|Overall Study|Physician Decision|1|||
129492314|NCT00631488|466094161|FG001|Overall Study|Physician Decision|0|||
129492315|NCT00631488|466094162|FG002|Overall Study|Physician Decision|1|||
129492316|NCT00631488|466094160|FG000|Overall Study|Protocol Violation|0|||
129492317|NCT00631488|466094161|FG001|Overall Study|Protocol Violation|0|||
129492318|NCT00631488|466094162|FG002|Overall Study|Protocol Violation|1|||
129492319|NCT03648476|466094163|FG000|Overall Study|Withdrawal by Subject|2|||
129492320|NCT03648476|466094164|FG001|Overall Study|Withdrawal by Subject|1|||
129492321|NCT02855411|466094166|FG000|Overall Study|Study terminated by sponsor|21|||
129492322|NCT02855411|466094166|FG000|Overall Study|Does not meet entrance criteria|14|||
129492323|NCT01996319|466094169|FG000|Overall Study|Protocol Violation|1|||
129492324|NCT01996319|466094170|FG001|Overall Study|Protocol Violation|0|||
129492325|NCT01996319|466094169|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
129492326|NCT01996319|466094170|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
129492327|NCT01996319|466094169|FG000|Overall Study|Adverse Event|2|||
129492328|NCT01996319|466094170|FG001|Overall Study|Adverse Event|2|||
129492329|NCT01671085|466094171|FG000|Overall Study|Withdrawal by Subject|1|||
129492330|NCT01671085|466094172|FG001|Overall Study|Withdrawal by Subject|0|||
129492331|NCT00637273|466094173|FG000|Overall Study|Adverse Event|11|||
129492332|NCT00637273|466094174|FG001|Overall Study|Adverse Event|5|||
129492333|NCT00637273|466094175|FG002|Overall Study|Adverse Event|7|||
129492334|NCT00637273|466094173|FG000|Overall Study|Lost to Follow-up|8|||
129492335|NCT00637273|466094174|FG001|Overall Study|Lost to Follow-up|9|||
129492336|NCT00637273|466094175|FG002|Overall Study|Lost to Follow-up|13|||
129492337|NCT00637273|466094173|FG000|Overall Study|Protocol Violation|2|||
129492338|NCT00637273|466094174|FG001|Overall Study|Protocol Violation|4|||
129492339|NCT00637273|466094175|FG002|Overall Study|Protocol Violation|1|||
129492340|NCT00637273|466094173|FG000|Overall Study|Withdrawal of Consent|18|||
129492341|NCT00637273|466094174|FG001|Overall Study|Withdrawal of Consent|6|||
129492342|NCT00637273|466094175|FG002|Overall Study|Withdrawal of Consent|18|||
129492343|NCT00637273|466094173|FG000|Overall Study|Investigator Decision|1|||
129492344|NCT00637273|466094174|FG001|Overall Study|Investigator Decision|3|||
129492345|NCT00637273|466094175|FG002|Overall Study|Investigator Decision|1|||
129492346|NCT00637273|466094173|FG000|Overall Study|Administrative|2|||
129492347|NCT00637273|466094174|FG001|Overall Study|Administrative|0|||
129492348|NCT00637273|466094175|FG002|Overall Study|Administrative|0|||
129492349|NCT00637273|466094173|FG000|Overall Study|Loss of Glucose Control|1|||
129492350|NCT00637273|466094174|FG001|Overall Study|Loss of Glucose Control|1|||
129492351|NCT00637273|466094175|FG002|Overall Study|Loss of Glucose Control|1|||
129492352|NCT00986258|466094176|FG000|Observation Period|Not eligible to be dosed|11|||
129492353|NCT00986258|466094176|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
129492354|NCT00986258|466094176|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
129492355|NCT00986258|466094176|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
129492356|NCT00986258|466094176|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
129492357|NCT00986258|466094176|FG000|Titration and Optimal Dose Period|Other|1|||
129492358|NCT00986258|466094176|FG000|Maintenance Period|Adverse Event|5|||
129492359|NCT00986258|466094176|FG000|Maintenance Period|Lack of Efficacy|2|||
129492360|NCT00986258|466094176|FG000|Maintenance Period|Withdrawal by Subject|2|||
129492361|NCT04230486|466094185|FG000|Overall Study|Screen Failure|1|||
129492362|NCT03215264|466094186|FG000|Dose Level 2|Adverse Event|0|||
129492363|NCT03215264|466094187|FG001|Dose Level 2|Adverse Event|1|||
129492364|NCT03215264|466094188|FG002|Dose Level 2|Adverse Event|0|||
129492365|NCT03215264|466094186|FG000|Dose Level 3|Withdrawal by Subject|0|||
129492366|NCT03215264|466094187|FG001|Dose Level 3|Withdrawal by Subject|0|||
129492367|NCT03215264|466094188|FG002|Dose Level 3|Withdrawal by Subject|1|||
129492368|NCT02234583|466094191|FG000|Overall Study|Adverse Event|172|||
129492369|NCT02234583|466094192|FG001|Overall Study|Adverse Event|156|||
129492370|NCT02234583|466094191|FG000|Overall Study|Withdrawal by Subject|109|||
129492371|NCT02234583|466094192|FG001|Overall Study|Withdrawal by Subject|157|||
129492372|NCT02234583|466094191|FG000|Overall Study|Lost to Follow-up|0|||
129492373|NCT02234583|466094192|FG001|Overall Study|Lost to Follow-up|1|||
129492374|NCT02234583|466094191|FG000|Overall Study|Lack of Efficacy|58|||
129492375|NCT02234583|466094192|FG001|Overall Study|Lack of Efficacy|103|||
129492376|NCT02234583|466094191|FG000|Overall Study|Protocol Violation|35|||
129492377|NCT02234583|466094192|FG001|Overall Study|Protocol Violation|42|||
129492378|NCT02234583|466094191|FG000|Overall Study|Other|39|||
129492379|NCT02234583|466094192|FG001|Overall Study|Other|97|||
129492380|NCT02805907|466094193|FG000|Overall Study|Lost to Follow-up|3|||
129492381|NCT02805907|466094194|FG001|Overall Study|Lost to Follow-up|3|||
129492382|NCT03408873|466094195|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
129492383|NCT03408873|466094195|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
129492384|NCT03408873|466094195|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
129492385|NCT03408873|466094195|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
129492386|NCT03408873|466094195|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
129492387|NCT03408873|466094195|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
129492388|NCT01264965|466094196|FG000|Overall Study|Withdrawal by Subject|10|||
129492389|NCT03799718|466094197|FG000|Overall Study|Adverse Event|2|||
129492390|NCT02202031|466094198|FG000|Overall Study|Lost to Follow-up|1|||
129492391|NCT02202031|466094199|FG001|Overall Study|Lost to Follow-up|0|||
129492392|NCT02202031|466094198|FG000|Overall Study|Too Busy|1|||
129492393|NCT02202031|466094199|FG001|Overall Study|Too Busy|3|||
129492394|NCT02202031|466094198|FG000|Overall Study|Illness/Medical Reason|0|||
129492395|NCT02202031|466094199|FG001|Overall Study|Illness/Medical Reason|2|||
129492396|NCT02202031|466094198|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
129492397|NCT02202031|466094199|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
129492398|NCT01651052|466094203|FG000|Overall Study|Death|21|||
129492399|NCT01651052|466094203|FG000|Overall Study|Explant|1|||
129492400|NCT01651052|466094203|FG000|Overall Study|Withdrawal by Subject|1|||
129492401|NCT01651052|466094203|FG000|Overall Study|Lost to Follow-up|3|||
129492402|NCT01024465|466094219|FG000|Overall Study|Adverse Event|2|||
129492403|NCT01024465|466094219|FG000|Overall Study|Physician Decision|1|||
129492404|NCT03078608|466094220|FG000|Overall Study|Death|1|||
129492405|NCT03078608|466094221|FG001|Overall Study|Death|2|||
129492406|NCT03078608|466094222|FG002|Overall Study|Death|0|||
129492407|NCT03078608|466094223|FG003|Overall Study|Death|0|||
129492408|NCT03078608|466094220|FG000|Overall Study|Withdrawal by Subject|8|||
129492409|NCT03078608|466094221|FG001|Overall Study|Withdrawal by Subject|1|||
129492410|NCT03078608|466094222|FG002|Overall Study|Withdrawal by Subject|0|||
129492411|NCT03078608|466094223|FG003|Overall Study|Withdrawal by Subject|0|||
129492412|NCT03078608|466094220|FG000|Overall Study|Lost to Follow-up|5|||
129492413|NCT03078608|466094221|FG001|Overall Study|Lost to Follow-up|8|||
129492414|NCT03078608|466094222|FG002|Overall Study|Lost to Follow-up|4|||
129492415|NCT03078608|466094223|FG003|Overall Study|Lost to Follow-up|1|||
129492416|NCT00723840|466094224|FG000|Overall Study|Lost to Follow-up|2|||
129492417|NCT00723840|466094224|FG000|Overall Study|Failure to return|18|||
129492418|NCT00723840|466094224|FG000|Overall Study|Withdrawal by Subject|55|||
129492419|NCT00723840|466094224|FG000|Overall Study|Serious Adverse Events|3|||
129492420|NCT00723840|466094224|FG000|Overall Study|Other Medical Event|2|||
129492421|NCT00723840|466094224|FG000|Overall Study|Unspecified reason|2|||
129492422|NCT01899144|466094229|FG000|Treatment Period 2|Other|1|||
129492423|NCT01899144|466094229|FG000|Treatment Period 3|Other|2|||
129492424|NCT01899144|466094229|FG000|Treatment Period 5|Other|1|||
129492425|NCT00751881|466094230|FG000|Core Treatment Period|Not treated|1|||
129492426|NCT00751881|466094231|FG001|Core Treatment Period|Not treated|1|||
129492427|NCT00751881|466094232|FG002|Core Treatment Period|Not treated|2|||
129492428|NCT00751881|466094230|FG000|Core Treatment Period|Adverse Event|26|||
129492429|NCT00751881|466094231|FG001|Core Treatment Period|Adverse Event|54|||
129492430|NCT00751881|466094232|FG002|Core Treatment Period|Adverse Event|58|||
129492431|NCT00751881|466094230|FG000|Core Treatment Period|Lack of Efficacy|37|||
129492432|NCT00751881|466094231|FG001|Core Treatment Period|Lack of Efficacy|30|||
129492433|NCT00751881|466094232|FG002|Core Treatment Period|Lack of Efficacy|20|||
129492434|NCT00751881|466094230|FG000|Core Treatment Period|Poor compliance to protocol|15|||
129492435|NCT00751881|466094231|FG001|Core Treatment Period|Poor compliance to protocol|3|||
129492436|NCT00751881|466094232|FG002|Core Treatment Period|Poor compliance to protocol|4|||
129492437|NCT00751881|466094230|FG000|Core Treatment Period|Lost to Follow-up|6|||
129492438|NCT00751881|466094231|FG001|Core Treatment Period|Lost to Follow-up|4|||
129492439|NCT00751881|466094232|FG002|Core Treatment Period|Lost to Follow-up|3|||
129492440|NCT00751881|466094230|FG000|Core Treatment Period|Other: protocol deviation|3|||
129492441|NCT00751881|466094231|FG001|Core Treatment Period|Other: protocol deviation|3|||
129492442|NCT00751881|466094232|FG002|Core Treatment Period|Other: protocol deviation|7|||
129492443|NCT00751881|466094230|FG000|Core Treatment Period|Other: wish to parent|5|||
129492444|NCT00751881|466094231|FG001|Core Treatment Period|Other: wish to parent|7|||
129980785|NCT02416453|467893360|FG003|Overall Study|Lost to Follow-up|8|||
129980786|NCT02416453|467893361|FG004|Overall Study|Lost to Follow-up|0|||
129980787|NCT02416453|467893362|FG005|Overall Study|Lost to Follow-up|5|||
129980788|NCT02416453|467893363|FG006|Overall Study|Lost to Follow-up|1|||
129980789|NCT02416453|467893364|FG007|Overall Study|Lost to Follow-up|3|||
129980790|NCT02416453|467893365|FG008|Overall Study|Lost to Follow-up|1|||
129980791|NCT02416453|467893366|FG009|Overall Study|Lost to Follow-up|0|||
129980792|NCT02416453|467893367|FG010|Overall Study|Lost to Follow-up|0|||
129492445|NCT00751881|466094232|FG002|Core Treatment Period|Other: wish to parent|4|||
129492446|NCT00751881|466094230|FG000|Core Treatment Period|Other: personal/family constraints|6|||
129492447|NCT00751881|466094231|FG001|Core Treatment Period|Other: personal/family constraints|7|||
129980793|NCT02416453|467893357|FG000|Overall Study|Physician Decision|0|||
129492448|NCT00751881|466094232|FG002|Core Treatment Period|Other: personal/family constraints|10|||
129492449|NCT00751881|466094230|FG000|Core Treatment Period|Other: MS treatment change|6|||
129492450|NCT00751881|466094231|FG001|Core Treatment Period|Other: MS treatment change|4|||
129492451|NCT00751881|466094232|FG002|Core Treatment Period|Other: MS treatment change|4|||
129492452|NCT00751881|466094230|FG000|Core Treatment Period|Other: tolerability complaints|2|||
129492453|NCT00751881|466094231|FG001|Core Treatment Period|Other: tolerability complaints|0|||
129980794|NCT02416453|467893358|FG001|Overall Study|Physician Decision|0|||
129492454|NCT00751881|466094232|FG002|Core Treatment Period|Other: tolerability complaints|0|||
129492455|NCT00751881|466094230|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
129980795|NCT02416453|467893359|FG002|Overall Study|Physician Decision|0|||
129492456|NCT00751881|466094231|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
129492457|NCT00751881|466094232|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
129492458|NCT00751881|466094230|FG000|Extension Study Period|Adverse Event|18|||
129492459|NCT00751881|466094231|FG001|Extension Study Period|Adverse Event|20|||
129492460|NCT00751881|466094232|FG002|Extension Study Period|Adverse Event|21|||
129492461|NCT00751881|466094230|FG000|Extension Study Period|Lack of Efficacy|14|||
129492462|NCT00751881|466094231|FG001|Extension Study Period|Lack of Efficacy|10|||
129492463|NCT00751881|466094232|FG002|Extension Study Period|Lack of Efficacy|20|||
129492464|NCT00751881|466094230|FG000|Extension Study Period|Lost to Follow-up|4|||
129492465|NCT00751881|466094231|FG001|Extension Study Period|Lost to Follow-up|9|||
129492466|NCT00751881|466094232|FG002|Extension Study Period|Lost to Follow-up|6|||
129492467|NCT00751881|466094230|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
129492468|NCT00751881|466094231|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
129492469|NCT00751881|466094232|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
129492470|NCT00751881|466094230|FG000|Extension Study Period|Other than specified above|26|||
129492471|NCT00751881|466094231|FG001|Extension Study Period|Other than specified above|30|||
129492472|NCT00751881|466094232|FG002|Extension Study Period|Other than specified above|18|||
129492473|NCT03321929|466094233|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
129492474|NCT01765764|466094234|FG000|Treatment Period|Adverse Event|1|||
129492475|NCT01765764|466094235|FG001|Treatment Period|Adverse Event|2|||
129492476|NCT01765764|466094236|FG002|Treatment Period|Adverse Event|1|||
129492477|NCT01765764|466094234|FG000|Treatment Period|Lost to Follow-up|0|||
129492478|NCT01765764|466094235|FG001|Treatment Period|Lost to Follow-up|3|||
129492479|NCT01765764|466094236|FG002|Treatment Period|Lost to Follow-up|2|||
129492480|NCT01765764|466094234|FG000|Treatment Period|Personal Reasons|1|||
129492481|NCT01765764|466094235|FG001|Treatment Period|Personal Reasons|2|||
129492482|NCT01765764|466094236|FG002|Treatment Period|Personal Reasons|1|||
129492483|NCT01765764|466094234|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
129492484|NCT01765764|466094235|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
129492485|NCT01765764|466094236|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
129492486|NCT00530712|466094242|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
129492487|NCT00530712|466094242|FG000|30 Day Follow-up Visit|Missed Visit|5|||
129492488|NCT00530712|466094242|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
129492489|NCT00530712|466094242|FG000|6 Month Follow-up Visit|Missed Visit|3|||
129492490|NCT00530712|466094242|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
129492491|NCT00530712|466094242|FG000|6 Month Follow-up Visit|Death|2|||
129492492|NCT00530712|466094242|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
129492493|NCT00530712|466094242|FG000|12 Month Follow-up Visit|Missed Visit|3|||
129492494|NCT00530712|466094242|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
129492495|NCT00530712|466094242|FG000|12 Month Follow-up Visit|Death|9|||
129492496|NCT03117049|466094250|FG000|Overall Study|Continued the follow-up period|109|||
129492497|NCT03117049|466094251|FG001|Overall Study|Continued the follow-up period|129|||
129492498|NCT03117049|466094250|FG000|Overall Study|Died|82|||
129492499|NCT03117049|466094251|FG001|Overall Study|Died|93|||
129492500|NCT03117049|466094250|FG000|Overall Study|Consent withdrawal|7|||
129492501|NCT03117049|466094251|FG001|Overall Study|Consent withdrawal|6|||
129492502|NCT03117049|466094250|FG000|Overall Study|Missing contact|3|||
129492503|NCT03117049|466094251|FG001|Overall Study|Missing contact|3|||
129492504|NCT00651118|466094252|FG000|Overall Study|Adverse Event|4|||
129492505|NCT00651118|466094253|FG001|Overall Study|Adverse Event|0|||
129492506|NCT00651118|466094254|FG002|Overall Study|Adverse Event|1|||
129492507|NCT00651118|466094255|FG003|Overall Study|Adverse Event|1|||
129492508|NCT00651118|466094252|FG000|Overall Study|Protocol Violation|2|||
129492509|NCT00651118|466094253|FG001|Overall Study|Protocol Violation|2|||
129492510|NCT00651118|466094254|FG002|Overall Study|Protocol Violation|6|||
129492511|NCT00651118|466094255|FG003|Overall Study|Protocol Violation|2|||
129492512|NCT00651118|466094252|FG000|Overall Study|Lost to Follow-up|2|||
129492513|NCT00651118|466094253|FG001|Overall Study|Lost to Follow-up|0|||
129492514|NCT00651118|466094254|FG002|Overall Study|Lost to Follow-up|1|||
129492515|NCT00651118|466094255|FG003|Overall Study|Lost to Follow-up|2|||
129492516|NCT00651118|466094252|FG000|Overall Study|administrative|1|||
129492517|NCT00651118|466094253|FG001|Overall Study|administrative|4|||
129980796|NCT02416453|467893360|FG003|Overall Study|Physician Decision|0|||
129492518|NCT00651118|466094254|FG002|Overall Study|administrative|2|||
129492519|NCT00651118|466094255|FG003|Overall Study|administrative|1|||
129492520|NCT00651118|466094252|FG000|Overall Study|Withdrawal by Subject|0|||
129492521|NCT00651118|466094253|FG001|Overall Study|Withdrawal by Subject|1|||
129492522|NCT00651118|466094254|FG002|Overall Study|Withdrawal by Subject|1|||
129492523|NCT00651118|466094255|FG003|Overall Study|Withdrawal by Subject|1|||
129492524|NCT00839098|466094256|FG000|Overall Study|Withdrawal by Subject|2|||
129492525|NCT00839098|466094257|FG001|Overall Study|Withdrawal by Subject|1|||
129492526|NCT00839098|466094258|FG002|Overall Study|Withdrawal by Subject|7|||
129492527|NCT00365976|466094261|FG000|Overall Study|Withdrawal by Subject|1|||
129492528|NCT00365976|466094262|FG001|Overall Study|Withdrawal by Subject|5|||
129492529|NCT01850563|466096104|FG000|Overall Study|Not eligible|3|||
129492530|NCT01850563|466096105|FG001|Overall Study|Not eligible|0|||
129492531|NCT04359823|466096106|FG000|Overall Study|Lost to Follow-up|0|||
129492532|NCT04359823|466096107|FG001|Overall Study|Lost to Follow-up|1|||
129492533|NCT04359823|466096106|FG000|Overall Study|Withdrawal by Subject|0|||
129492534|NCT04359823|466096107|FG001|Overall Study|Withdrawal by Subject|1|||
129492535|NCT00408421|466096113|FG000|Treatment Initial Randomization|Adverse Event|5|||
129492536|NCT00408421|466096114|FG001|Treatment Initial Randomization|Adverse Event|9|||
129492537|NCT00408421|466096115|FG002|Treatment Initial Randomization|Adverse Event|0|||
129492538|NCT00408421|466096113|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
129492539|NCT00408421|466096114|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
129492540|NCT00408421|466096115|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
129492541|NCT00408421|466096113|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
129492542|NCT00408421|466096114|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
129492543|NCT00408421|466096115|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
129492544|NCT00408421|466096113|FG000|Treatment Initial Randomization|Physician Decision|1|||
129492545|NCT00408421|466096114|FG001|Treatment Initial Randomization|Physician Decision|0|||
129492546|NCT00408421|466096115|FG002|Treatment Initial Randomization|Physician Decision|0|||
129492547|NCT00408421|466096113|FG000|Treatment Initial Randomization|Protocol Violation|0|||
129492548|NCT00408421|466096114|FG001|Treatment Initial Randomization|Protocol Violation|1|||
129492549|NCT00408421|466096115|FG002|Treatment Initial Randomization|Protocol Violation|0|||
129492550|NCT00408421|466096113|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
129492551|NCT00408421|466096114|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
129492552|NCT00408421|466096115|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
129492553|NCT00408421|466096113|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
129492554|NCT00408421|466096114|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
129492555|NCT00408421|466096115|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
129492556|NCT00408421|466096113|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
129492557|NCT00408421|466096114|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
129492558|NCT00408421|466096115|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
129492559|NCT00408421|466096113|FG000|Treatment Re-Randomization|Adverse Event|2|||
129492560|NCT00408421|466096114|FG001|Treatment Re-Randomization|Adverse Event|2|||
129492561|NCT00408421|466096115|FG002|Treatment Re-Randomization|Adverse Event|4|||
129492562|NCT00408421|466096113|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
129492563|NCT00408421|466096114|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
129492564|NCT00408421|466096115|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
129492565|NCT00408421|466096113|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
129492566|NCT00408421|466096114|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
129492567|NCT00408421|466096115|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
129492568|NCT00408421|466096113|FG000|Treatment Re-Randomization|Physician Decision|1|||
129492569|NCT00408421|466096114|FG001|Treatment Re-Randomization|Physician Decision|3|||
129492570|NCT00408421|466096115|FG002|Treatment Re-Randomization|Physician Decision|0|||
129492571|NCT00408421|466096113|FG000|Treatment Re-Randomization|Protocol Violation|1|||
129492572|NCT00408421|466096114|FG001|Treatment Re-Randomization|Protocol Violation|1|||
129492573|NCT00408421|466096115|FG002|Treatment Re-Randomization|Protocol Violation|0|||
129492574|NCT00408421|466096113|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
129492575|NCT00408421|466096114|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
129492576|NCT00408421|466096115|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
129492577|NCT03009539|466096118|FG000|Overall Study|Lost to Follow-up|132|||
129492578|NCT03009539|466096119|FG001|Overall Study|Lost to Follow-up|113|||
129492579|NCT03009539|466096120|FG002|Overall Study|Lost to Follow-up|132|||
129492580|NCT03009539|466096121|FG003|Overall Study|Lost to Follow-up|113|||
129492581|NCT03151148|466096122|FG000|Overall Study|Lost to Follow-up|1|||
129492582|NCT03151148|466096123|FG001|Overall Study|Lost to Follow-up|0|||
129492583|NCT03151148|466096122|FG000|Overall Study|Withdrawal by Subject|1|||
129492584|NCT03151148|466096123|FG001|Overall Study|Withdrawal by Subject|0|||
129492585|NCT00710034|466096124|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
129492586|NCT00710034|466096125|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
129492587|NCT00710034|466096124|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
129492588|NCT00710034|466096125|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
129492589|NCT00710034|466096124|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
129492590|NCT00710034|466096125|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
129492591|NCT00710034|466096124|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
129492592|NCT00710034|466096125|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
129492593|NCT00710034|466096124|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
129492594|NCT00710034|466096125|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
129492595|NCT00710034|466096124|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
129492596|NCT00710034|466096125|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
129492597|NCT00710034|466096124|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
129492598|NCT00710034|466096125|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
129492599|NCT00710034|466096124|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
129492600|NCT00710034|466096125|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
129538481|NCT05664672|466262110|FG003|Overall Study|Adverse Event|0|||
129492601|NCT00710034|466096124|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
129492602|NCT00710034|466096125|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
129492603|NCT00710034|466096124|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
129492604|NCT00710034|466096125|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
129492605|NCT00710034|466096124|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
129492606|NCT00710034|466096125|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
129492607|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
129492608|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
129492609|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
129492610|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
129492611|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Death|8|||
129492612|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Death|3|||
129492613|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
129492614|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
129492615|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
129492616|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
129492617|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
129492618|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
129492619|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
129492620|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
129492621|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
129492622|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
129492623|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
129492624|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
129492625|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
129492626|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
129492627|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
129492628|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
129492629|NCT00494871|466096126|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
129492630|NCT00494871|466096127|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
129492631|NCT00494871|466096126|FG000|Follow-up (FU) Period|Adverse Event|1|||
129492632|NCT00494871|466096127|FG001|Follow-up (FU) Period|Adverse Event|1|||
129492633|NCT00494871|466096126|FG000|Follow-up (FU) Period|Death|13|||
129492634|NCT00494871|466096127|FG001|Follow-up (FU) Period|Death|12|||
129492635|NCT00494871|466096126|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
129492636|NCT00494871|466096127|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
129492637|NCT00494871|466096126|FG000|Follow-up (FU) Period|Physician Decision|0|||
129492638|NCT00494871|466096127|FG001|Follow-up (FU) Period|Physician Decision|1|||
129492639|NCT00494871|466096126|FG000|Follow-up (FU) Period|Protocol Violation|1|||
129492640|NCT00494871|466096127|FG001|Follow-up (FU) Period|Protocol Violation|0|||
129492641|NCT00494871|466096126|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
129492642|NCT00494871|466096127|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
129492643|NCT00494871|466096126|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
129492644|NCT00494871|466096127|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
129492645|NCT04543955|466096128|FG000|Overall Study|Company cancelled study|1|||
129492646|NCT04543955|466096129|FG001|Overall Study|Company cancelled study|0|||
129492647|NCT02601001|466096132|FG000|Dosing Period 2|Adverse Event|0|||
129492648|NCT02601001|466096133|FG001|Dosing Period 2|Adverse Event|0|||
129492649|NCT02601001|466096134|FG002|Dosing Period 2|Adverse Event|0|||
129492650|NCT02601001|466096135|FG003|Dosing Period 2|Adverse Event|0|||
129492651|NCT02601001|466096136|FG004|Dosing Period 2|Adverse Event|0|||
129492652|NCT02601001|466096137|FG005|Dosing Period 2|Adverse Event|0|||
129492653|NCT02601001|466096138|FG006|Dosing Period 2|Adverse Event|1|||
129492654|NCT02433210|466096144|FG000|Overall Study|Physician Decision|1|||
129492655|NCT02433210|466096145|FG001|Overall Study|Physician Decision|0|||
129492656|NCT02433210|466096146|FG002|Overall Study|Physician Decision|0|||
129492657|NCT01614769|466096151|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
129492658|NCT01614769|466096152|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
129492659|NCT01614769|466096153|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
129980797|NCT02416453|467893361|FG004|Overall Study|Physician Decision|0|||
129492660|NCT01614769|466096154|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
129492661|NCT01614769|466096155|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
129492662|NCT01614769|466096156|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
129492663|NCT01614769|466096151|FG000|Period 1|Protocol Violation|0|||
129492664|NCT01614769|466096152|FG001|Period 1|Protocol Violation|0|||
129492665|NCT01614769|466096153|FG002|Period 1|Protocol Violation|0|||
129492666|NCT01614769|466096154|FG003|Period 1|Protocol Violation|1|||
129492667|NCT01614769|466096155|FG004|Period 1|Protocol Violation|0|||
129492668|NCT01614769|466096156|FG005|Period 1|Protocol Violation|0|||
129492669|NCT01614769|466096151|FG000|Period 1|Withdrawal by Subject|1|||
129980798|NCT02416453|467893362|FG005|Overall Study|Physician Decision|1|||
129980799|NCT02416453|467893363|FG006|Overall Study|Physician Decision|1|||
129492670|NCT01614769|466096152|FG001|Period 1|Withdrawal by Subject|0|||
129492671|NCT01614769|466096153|FG002|Period 1|Withdrawal by Subject|0|||
129492672|NCT01614769|466096154|FG003|Period 1|Withdrawal by Subject|0|||
129492673|NCT01614769|466096155|FG004|Period 1|Withdrawal by Subject|0|||
129492674|NCT01614769|466096156|FG005|Period 1|Withdrawal by Subject|0|||
129492675|NCT01614769|466096151|FG000|Period 3|Withdrawal by Subject|0|||
129492676|NCT01614769|466096152|FG001|Period 3|Withdrawal by Subject|0|||
129492677|NCT01614769|466096153|FG002|Period 3|Withdrawal by Subject|1|||
129492678|NCT01614769|466096154|FG003|Period 3|Withdrawal by Subject|0|||
129492679|NCT01614769|466096155|FG004|Period 3|Withdrawal by Subject|0|||
129492680|NCT01614769|466096156|FG005|Period 3|Withdrawal by Subject|0|||
129492681|NCT03123354|466096157|FG000|Overall Study|Physician Decision|6|||
129492682|NCT01958671|466096160|FG000|Overall Study|Adverse Event|1|||
129492683|NCT01958671|466096161|FG001|Overall Study|Adverse Event|1|||
129492684|NCT01958671|466096162|FG002|Overall Study|Adverse Event|5|||
129492685|NCT01958671|466096160|FG000|Overall Study|Death|1|||
129492686|NCT01958671|466096161|FG001|Overall Study|Death|0|||
129492687|NCT01958671|466096162|FG002|Overall Study|Death|0|||
129492688|NCT01958671|466096160|FG000|Overall Study|Excluded medication|0|||
129492689|NCT01958671|466096161|FG001|Overall Study|Excluded medication|0|||
129492690|NCT01958671|466096162|FG002|Overall Study|Excluded medication|1|||
129492691|NCT01958671|466096160|FG000|Overall Study|Hyperglycemia|0|||
129492692|NCT01958671|466096161|FG001|Overall Study|Hyperglycemia|0|||
129492693|NCT01958671|466096162|FG002|Overall Study|Hyperglycemia|2|||
129492694|NCT01958671|466096160|FG000|Overall Study|Lost to Follow-up|7|||
129492695|NCT01958671|466096161|FG001|Overall Study|Lost to Follow-up|11|||
129492696|NCT01958671|466096162|FG002|Overall Study|Lost to Follow-up|7|||
129492697|NCT01958671|466096160|FG000|Overall Study|Non-compliance with study drug|1|||
129492698|NCT01958671|466096161|FG001|Overall Study|Non-compliance with study drug|1|||
129492699|NCT01958671|466096162|FG002|Overall Study|Non-compliance with study drug|1|||
129492700|NCT01958671|466096160|FG000|Overall Study|Pregnancy|0|||
129492701|NCT01958671|466096161|FG001|Overall Study|Pregnancy|0|||
129492702|NCT01958671|466096162|FG002|Overall Study|Pregnancy|1|||
129492703|NCT01958671|466096160|FG000|Overall Study|Protocol Violation|0|||
129492704|NCT01958671|466096161|FG001|Overall Study|Protocol Violation|1|||
129492705|NCT01958671|466096162|FG002|Overall Study|Protocol Violation|0|||
129492706|NCT01958671|466096160|FG000|Overall Study|Study site terminated by sponsor|1|||
129492707|NCT01958671|466096161|FG001|Overall Study|Study site terminated by sponsor|0|||
129492708|NCT01958671|466096162|FG002|Overall Study|Study site terminated by sponsor|1|||
129492709|NCT01958671|466096160|FG000|Overall Study|Participant moved|0|||
129492710|NCT01958671|466096161|FG001|Overall Study|Participant moved|0|||
129492711|NCT01958671|466096162|FG002|Overall Study|Participant moved|1|||
129492712|NCT01958671|466096160|FG000|Overall Study|Withdrawal by Subject|8|||
129492713|NCT01958671|466096161|FG001|Overall Study|Withdrawal by Subject|10|||
129492714|NCT01958671|466096162|FG002|Overall Study|Withdrawal by Subject|13|||
129492715|NCT04760314|466096163|FG000|Induction Period|Withdrawal by Subject|0|||
129492716|NCT04760314|466096164|FG001|Induction Period|Withdrawal by Subject|1|||
129492717|NCT04760314|466096165|FG002|Induction Period|Withdrawal by Subject|1|||
129492718|NCT04760314|466096166|FG003|Induction Period|Withdrawal by Subject|0|||
129492719|NCT04760314|466096167|FG004|Induction Period|Withdrawal by Subject|0|||
129492720|NCT04760314|466096168|FG005|Induction Period|Withdrawal by Subject|0|||
129492721|NCT04760314|466096169|FG006|Induction Period|Withdrawal by Subject|0|||
129492722|NCT04760314|466096170|FG007|Induction Period|Withdrawal by Subject|0|||
129492723|NCT04760314|466096171|FG008|Induction Period|Withdrawal by Subject|0|||
129492724|NCT04760314|466096172|FG009|Induction Period|Withdrawal by Subject|0|||
129492725|NCT04760314|466096173|FG010|Induction Period|Withdrawal by Subject|0|||
129492726|NCT04760314|466096163|FG000|Induction Period|Adverse Event|0|||
129492727|NCT04760314|466096164|FG001|Induction Period|Adverse Event|0|||
129492728|NCT04760314|466096165|FG002|Induction Period|Adverse Event|2|||
129980800|NCT02416453|467893364|FG007|Overall Study|Physician Decision|1|||
129980801|NCT02416453|467893365|FG008|Overall Study|Physician Decision|0|||
129492729|NCT04760314|466096166|FG003|Induction Period|Adverse Event|0|||
129980802|NCT02416453|467893366|FG009|Overall Study|Physician Decision|0|||
129980803|NCT02416453|467893367|FG010|Overall Study|Physician Decision|0|||
129980804|NCT02416453|467893357|FG000|Overall Study|Withdrawal by Subject|2|||
129492730|NCT04760314|466096167|FG004|Induction Period|Adverse Event|0|||
129492731|NCT04760314|466096168|FG005|Induction Period|Adverse Event|0|||
129492732|NCT04760314|466096169|FG006|Induction Period|Adverse Event|0|||
129492733|NCT04760314|466096170|FG007|Induction Period|Adverse Event|0|||
129492734|NCT04760314|466096171|FG008|Induction Period|Adverse Event|0|||
129492735|NCT04760314|466096172|FG009|Induction Period|Adverse Event|0|||
129492736|NCT04760314|466096173|FG010|Induction Period|Adverse Event|0|||
129492737|NCT04760314|466096163|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492738|NCT04760314|466096164|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492739|NCT04760314|466096165|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492740|NCT04760314|466096166|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
129492741|NCT04760314|466096167|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
129492742|NCT04760314|466096168|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
129492743|NCT04760314|466096169|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
129492744|NCT04760314|466096170|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492745|NCT04760314|466096171|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492746|NCT04760314|466096172|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492747|NCT04760314|466096173|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
129492748|NCT04760314|466096163|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492749|NCT04760314|466096164|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492750|NCT04760314|466096165|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492751|NCT04760314|466096166|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
129492752|NCT04760314|466096167|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492753|NCT04760314|466096168|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
129492754|NCT04760314|466096169|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
129492755|NCT04760314|466096170|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492756|NCT04760314|466096171|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492757|NCT04760314|466096172|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492758|NCT04760314|466096173|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
129492759|NCT04760314|466096163|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492760|NCT04760314|466096164|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492761|NCT04760314|466096165|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492762|NCT04760314|466096166|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492763|NCT04760314|466096167|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
129492764|NCT04760314|466096168|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492765|NCT04760314|466096169|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492766|NCT04760314|466096170|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492767|NCT04760314|466096171|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492768|NCT04760314|466096172|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492769|NCT04760314|466096173|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
129492770|NCT04760314|466096163|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
129492771|NCT04760314|466096164|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
129492772|NCT04760314|466096165|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
129492773|NCT04760314|466096166|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
129492774|NCT04760314|466096167|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
129492775|NCT04760314|466096168|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
129492776|NCT04760314|466096169|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
129492777|NCT04760314|466096170|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
129492778|NCT04760314|466096171|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
129492779|NCT04760314|466096172|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
129492780|NCT04760314|466096173|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
129492781|NCT04760314|466096163|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492782|NCT04760314|466096164|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492783|NCT04760314|466096165|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492784|NCT04760314|466096166|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492785|NCT04760314|466096167|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492786|NCT04760314|466096168|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492787|NCT04760314|466096169|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492788|NCT04760314|466096170|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
129492789|NCT04760314|466096171|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
129492790|NCT04760314|466096172|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
129492791|NCT04760314|466096173|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
129492792|NCT04760314|466096163|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492793|NCT04760314|466096164|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492794|NCT04760314|466096165|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492795|NCT04760314|466096166|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492796|NCT04760314|466096167|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492797|NCT04760314|466096168|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492798|NCT04760314|466096169|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492799|NCT04760314|466096170|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
129980805|NCT02416453|467893358|FG001|Overall Study|Withdrawal by Subject|0|||
129980806|NCT02416453|467893359|FG002|Overall Study|Withdrawal by Subject|0|||
129980807|NCT02416453|467893360|FG003|Overall Study|Withdrawal by Subject|5|||
129492800|NCT04760314|466096171|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
129492801|NCT04760314|466096172|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
129492802|NCT04760314|466096173|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
129492803|NCT04760314|466096163|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129980808|NCT02416453|467893361|FG004|Overall Study|Withdrawal by Subject|1|||
129492804|NCT04760314|466096164|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492805|NCT04760314|466096165|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492806|NCT04760314|466096166|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492807|NCT04760314|466096167|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492808|NCT04760314|466096168|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492809|NCT04760314|466096169|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492810|NCT04760314|466096170|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
129492811|NCT04760314|466096171|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492812|NCT04760314|466096172|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492813|NCT04760314|466096173|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
129492814|NCT04760314|466096163|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492815|NCT04760314|466096164|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492816|NCT04760314|466096165|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492817|NCT04760314|466096166|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492818|NCT04760314|466096167|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492819|NCT04760314|466096168|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492820|NCT04760314|466096169|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492821|NCT04760314|466096170|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492822|NCT04760314|466096171|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
129492823|NCT04760314|466096172|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
129492824|NCT04760314|466096173|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
129492825|NCT00960440|466096175|FG000|Overall Study|Death|0|||
129492826|NCT00960440|466096176|FG001|Overall Study|Death|0|||
129492827|NCT00960440|466096177|FG002|Overall Study|Death|0|||
129492828|NCT00960440|466096178|FG003|Overall Study|Death|1|||
129492829|NCT00960440|466096175|FG000|Overall Study|Adverse Event|12|||
129492830|NCT00960440|466096176|FG001|Overall Study|Adverse Event|12|||
129492831|NCT00960440|466096177|FG002|Overall Study|Adverse Event|4|||
129492832|NCT00960440|466096178|FG003|Overall Study|Adverse Event|4|||
129492833|NCT00960440|466096175|FG000|Overall Study|Lack of Efficacy|2|||
129492834|NCT00960440|466096176|FG001|Overall Study|Lack of Efficacy|5|||
129492835|NCT00960440|466096177|FG002|Overall Study|Lack of Efficacy|3|||
129492836|NCT00960440|466096178|FG003|Overall Study|Lack of Efficacy|8|||
129492837|NCT00960440|466096175|FG000|Overall Study|Protocol Violation|2|||
129492838|NCT00960440|466096176|FG001|Overall Study|Protocol Violation|8|||
129492839|NCT00960440|466096177|FG002|Overall Study|Protocol Violation|3|||
129492840|NCT00960440|466096178|FG003|Overall Study|Protocol Violation|4|||
129492841|NCT00960440|466096175|FG000|Overall Study|Withdrawal by Subject|9|||
129492842|NCT00960440|466096176|FG001|Overall Study|Withdrawal by Subject|5|||
129492843|NCT00960440|466096177|FG002|Overall Study|Withdrawal by Subject|2|||
129492844|NCT00960440|466096178|FG003|Overall Study|Withdrawal by Subject|1|||
129492845|NCT00960440|466096175|FG000|Overall Study|Other|1|||
129492846|NCT00960440|466096176|FG001|Overall Study|Other|1|||
129492847|NCT00960440|466096177|FG002|Overall Study|Other|1|||
129492848|NCT00960440|466096178|FG003|Overall Study|Other|0|||
129492849|NCT02421120|466096179|FG000|Overall Study|Adverse Event|1|||
129492850|NCT02207530|466096180|FG000|Overall Study|Worsening condition under investigation|78|||
129492851|NCT02207530|466096180|FG000|Overall Study|Patient decision to stop study treatment|5|||
129492852|NCT02207530|466096180|FG000|Overall Study|Adverse Event|8|||
129492853|NCT02345161|466096181|FG000|Overall Study|Withdrawal by Subject|25|||
129492854|NCT02345161|466096182|FG001|Overall Study|Withdrawal by Subject|33|||
129492855|NCT02345161|466096181|FG000|Overall Study|Adverse Event|16|||
129492856|NCT02345161|466096182|FG001|Overall Study|Adverse Event|19|||
129492857|NCT02345161|466096181|FG000|Overall Study|Physician Decision|4|||
129492858|NCT02345161|466096182|FG001|Overall Study|Physician Decision|4|||
129492859|NCT02345161|466096181|FG000|Overall Study|Lost to Follow-up|0|||
129492860|NCT02345161|466096182|FG001|Overall Study|Lost to Follow-up|1|||
129492861|NCT00305006|466096189|FG000|Overall Study|Withdrawal by Subject|1|||
129492862|NCT00305006|466096190|FG001|Overall Study|Withdrawal by Subject|0|||
129492863|NCT00305006|466096189|FG000|Overall Study|Failure to complete pretest|0|||
129492864|NCT00305006|466096190|FG001|Overall Study|Failure to complete pretest|1|||
129492865|NCT02606045|466096194|FG000|Overall Study|Study closed before treament could begin|1|||
129492866|NCT02606045|466096195|FG001|Overall Study|Study closed before treament could begin|2|||
129492867|NCT00907881|466096196|FG000|Overall Study|Lost to Follow-up|59|||
129492868|NCT00907881|466096196|FG000|Overall Study|Noncompliance|5|||
129492869|NCT00907881|466096196|FG000|Overall Study|Withdrawal by Subject|5|||
129492870|NCT00907881|466096196|FG000|Overall Study|Protocol Violation|1|||
129492871|NCT00907881|466096196|FG000|Overall Study|Missing discontinuation information|15|||
129492872|NCT02616029|466096197|FG000|Overall Study|Adverse Event|1|||
129492873|NCT02616029|466096198|FG001|Overall Study|Adverse Event|0|||
129492874|NCT02616029|466096197|FG000|Overall Study|Death|0|||
129492875|NCT02616029|466096198|FG001|Overall Study|Death|1|||
129492876|NCT02616029|466096197|FG000|Overall Study|Protocol Violation|1|||
129492877|NCT02616029|466096198|FG001|Overall Study|Protocol Violation|0|||
129492878|NCT02616029|466096197|FG000|Overall Study|Withdrew Consent|1|||
129492879|NCT02616029|466096198|FG001|Overall Study|Withdrew Consent|0|||
129492880|NCT02616029|466096197|FG000|Overall Study|Enrolled and Never Treated|1|||
129492881|NCT02616029|466096198|FG001|Overall Study|Enrolled and Never Treated|1|||
129492882|NCT01740440|466096199|FG000|Overall Study|Lost to Follow-up|3|||
129492883|NCT04156646|466096205|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
129492884|NCT04156646|466096206|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
129492885|NCT02086565|466096210|FG000|Overall Study|Lost to Follow-up|9|||
129492886|NCT02086565|466096211|FG001|Overall Study|Lost to Follow-up|7|||
129492887|NCT02086565|466096210|FG000|Overall Study|Withdrawal by Subject|2|||
129492888|NCT02086565|466096211|FG001|Overall Study|Withdrawal by Subject|1|||
129492889|NCT02086565|466096210|FG000|Overall Study|Death|3|||
129492890|NCT02086565|466096211|FG001|Overall Study|Death|2|||
129492891|NCT02086565|466096210|FG000|Overall Study|withdrawn by research team|2|||
129492892|NCT02086565|466096211|FG001|Overall Study|withdrawn by research team|2|||
129492893|NCT02116972|466096212|FG000|Overall Study|Adverse Event|4|||
129492894|NCT02116972|466096213|FG001|Overall Study|Adverse Event|4|||
129492895|NCT02116972|466096214|FG002|Overall Study|Adverse Event|1|||
129492896|NCT02116972|466096212|FG000|Overall Study|Withdrawal by Subject|1|||
129492897|NCT02116972|466096213|FG001|Overall Study|Withdrawal by Subject|1|||
129492898|NCT02116972|466096214|FG002|Overall Study|Withdrawal by Subject|5|||
129492899|NCT02116972|466096212|FG000|Overall Study|Protocol Violation|1|||
129492900|NCT02116972|466096213|FG001|Overall Study|Protocol Violation|0|||
129492901|NCT02116972|466096214|FG002|Overall Study|Protocol Violation|1|||
129492902|NCT02116972|466096212|FG000|Overall Study|Lost to Follow-up|4|||
129492903|NCT02116972|466096213|FG001|Overall Study|Lost to Follow-up|3|||
129492904|NCT02116972|466096214|FG002|Overall Study|Lost to Follow-up|1|||
129492905|NCT02116972|466096212|FG000|Overall Study|Lack of Efficacy|6|||
129492906|NCT02116972|466096213|FG001|Overall Study|Lack of Efficacy|6|||
129492907|NCT02116972|466096214|FG002|Overall Study|Lack of Efficacy|5|||
129492908|NCT02116972|466096212|FG000|Overall Study|scheduling conflicts and relocation|3|||
129492909|NCT02116972|466096213|FG001|Overall Study|scheduling conflicts and relocation|3|||
129492910|NCT02116972|466096214|FG002|Overall Study|scheduling conflicts and relocation|6|||
129492911|NCT00784784|466096215|FG000|Overall Study|Withdrawal by Subject|2|||
129492912|NCT00784784|466096216|FG001|Overall Study|Withdrawal by Subject|2|||
129492913|NCT01400971|466096217|FG000|Overall Study|Death|82|||
129492914|NCT01400971|466096217|FG000|Overall Study|Lost to Follow-up|196|||
129492915|NCT01400971|466096217|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
129492916|NCT01400971|466096217|FG000|Overall Study|Physician Decision|57|||
129492917|NCT01400971|466096217|FG000|Overall Study|Withdrawal by Subject|158|||
129492918|NCT01400971|466096217|FG000|Overall Study|Other|422|||
129492919|NCT00863928|466096220|FG000|Overall Study|Protocol Violation|26|||
129492920|NCT00863928|466096221|FG001|Overall Study|Protocol Violation|0|||
129492921|NCT00863928|466096220|FG000|Overall Study|Withdrawal by Subject|3|||
129492922|NCT00863928|466096221|FG001|Overall Study|Withdrawal by Subject|0|||
129492923|NCT00863928|466096220|FG000|Overall Study|surgery cancellation|4|||
129980809|NCT02416453|467893362|FG005|Overall Study|Withdrawal by Subject|8|||
129980810|NCT02416453|467893363|FG006|Overall Study|Withdrawal by Subject|0|||
129980811|NCT02416453|467893364|FG007|Overall Study|Withdrawal by Subject|8|||
129980812|NCT02416453|467893365|FG008|Overall Study|Withdrawal by Subject|4|||
129980813|NCT02416453|467893366|FG009|Overall Study|Withdrawal by Subject|0|||
129980814|NCT02416453|467893367|FG010|Overall Study|Withdrawal by Subject|0|||
129980815|NCT02416453|467893357|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980816|NCT02416453|467893358|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980817|NCT02416453|467893359|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
129980818|NCT02416453|467893360|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980819|NCT02416453|467893361|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980820|NCT02416453|467893362|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980821|NCT02416453|467893363|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980822|NCT02416453|467893364|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980823|NCT02416453|467893365|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980824|NCT02416453|467893366|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980825|NCT02416453|467893367|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
129980826|NCT02416453|467893357|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980827|NCT02416453|467893358|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129492924|NCT00863928|466096221|FG001|Overall Study|surgery cancellation|0|||
129492925|NCT00863928|466096220|FG000|Overall Study|medication allergy|3|||
129492926|NCT00863928|466096221|FG001|Overall Study|medication allergy|0|||
129492927|NCT04172831|466096224|FG000|Overall Study|Adverse Event|21|||
129492928|NCT04172831|466096225|FG001|Overall Study|Adverse Event|9|||
129492929|NCT04172831|466096224|FG000|Overall Study|Lack of Efficacy|2|||
129492930|NCT04172831|466096225|FG001|Overall Study|Lack of Efficacy|8|||
129492931|NCT04172831|466096224|FG000|Overall Study|Physician Decision|0|||
129980828|NCT02416453|467893359|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129492932|NCT04172831|466096225|FG001|Overall Study|Physician Decision|1|||
129492933|NCT04172831|466096224|FG000|Overall Study|Withdrawal by Subject|12|||
129492934|NCT04172831|466096225|FG001|Overall Study|Withdrawal by Subject|11|||
129492935|NCT04172831|466096224|FG000|Overall Study|Lost to Follow-up|4|||
129492936|NCT04172831|466096225|FG001|Overall Study|Lost to Follow-up|9|||
129492937|NCT04172831|466096224|FG000|Overall Study|COVID-19 related crisis|3|||
129492938|NCT04172831|466096225|FG001|Overall Study|COVID-19 related crisis|3|||
129492939|NCT04172831|466096224|FG000|Overall Study|Subject non-compliance|1|||
129492940|NCT04172831|466096225|FG001|Overall Study|Subject non-compliance|1|||
129492941|NCT04172831|466096224|FG000|Overall Study|Family emergency|1|||
129492942|NCT04172831|466096225|FG001|Overall Study|Family emergency|0|||
129492943|NCT01041573|466096226|FG000|Overall Study|Withdrawal by Subject|2|||
129492944|NCT01041573|466096227|FG001|Overall Study|Withdrawal by Subject|5|||
129492945|NCT01041573|466096228|FG002|Overall Study|Withdrawal by Subject|2|||
129492946|NCT01041573|466096229|FG003|Overall Study|Withdrawal by Subject|0|||
129492947|NCT01041573|466096226|FG000|Overall Study|Death|1|||
129492948|NCT01041573|466096227|FG001|Overall Study|Death|0|||
129492949|NCT01041573|466096228|FG002|Overall Study|Death|0|||
129492950|NCT01041573|466096229|FG003|Overall Study|Death|0|||
129492951|NCT01041573|466096226|FG000|Overall Study|Lost to Follow-up|0|||
129492952|NCT01041573|466096227|FG001|Overall Study|Lost to Follow-up|1|||
129492953|NCT01041573|466096228|FG002|Overall Study|Lost to Follow-up|2|||
129492954|NCT01041573|466096229|FG003|Overall Study|Lost to Follow-up|1|||
129492955|NCT01041573|466096226|FG000|Overall Study|Adverse Event|0|||
129492956|NCT01041573|466096227|FG001|Overall Study|Adverse Event|2|||
129492957|NCT01041573|466096228|FG002|Overall Study|Adverse Event|0|||
129492958|NCT01041573|466096229|FG003|Overall Study|Adverse Event|0|||
129492959|NCT01041573|466096226|FG000|Overall Study|relocation|1|||
129492960|NCT01041573|466096227|FG001|Overall Study|relocation|4|||
129492961|NCT01041573|466096228|FG002|Overall Study|relocation|3|||
129492962|NCT01041573|466096229|FG003|Overall Study|relocation|1|||
129492963|NCT01041573|466096226|FG000|Overall Study|further blood extraction|0|||
129492964|NCT01041573|466096227|FG001|Overall Study|further blood extraction|1|||
129492965|NCT01041573|466096228|FG002|Overall Study|further blood extraction|0|||
129492966|NCT01041573|466096229|FG003|Overall Study|further blood extraction|0|||
129492967|NCT01041573|466096226|FG000|Overall Study|positive to anti-HCV|1|||
129492968|NCT01041573|466096227|FG001|Overall Study|positive to anti-HCV|0|||
129492969|NCT01041573|466096228|FG002|Overall Study|positive to anti-HCV|0|||
129492970|NCT01041573|466096229|FG003|Overall Study|positive to anti-HCV|0|||
129492971|NCT01276847|466096231|FG000|Overall Study|Withdrawal by Subject|1|||
129492972|NCT01276847|466096232|FG001|Overall Study|Withdrawal by Subject|0|||
129492973|NCT01276847|466096233|FG002|Overall Study|Withdrawal by Subject|0|||
129492974|NCT02119104|466096236|FG000|Overall Study|Protocol Violation|16|||
129492975|NCT02239094|466096238|FG000|Overall Study|Withdrawal by Subject|1|||
129492976|NCT02239094|466096238|FG000|Overall Study|Remitted before started|1|||
129492977|NCT03184701|466096239|FG000|Overall Study|Death|3|||
129492978|NCT03184701|466096239|FG000|Overall Study|Physician Decision|3|||
129492979|NCT03184701|466096239|FG000|Overall Study|Withdrawal by Subject|6|||
129492980|NCT03184701|466096239|FG000|Overall Study|Lost to Follow-up|5|||
129492981|NCT02399475|466096245|FG000|Overall Study|Physician Decision|1|||
129492982|NCT02399475|466096246|FG001|Overall Study|Physician Decision|0|||
129492983|NCT02260193|466096247|FG000|Overall Study|Lack of Efficacy|0|||
129492984|NCT02260193|466096248|FG001|Overall Study|Lack of Efficacy|1|||
129492985|NCT02260193|466096249|FG002|Overall Study|Lack of Efficacy|6|||
129492986|NCT02260193|466096247|FG000|Overall Study|Adverse Event|3|||
129492987|NCT02260193|466096248|FG001|Overall Study|Adverse Event|4|||
129492988|NCT02260193|466096249|FG002|Overall Study|Adverse Event|1|||
129492989|NCT02260193|466096247|FG000|Overall Study|Protocol Violation|0|||
129492990|NCT02260193|466096248|FG001|Overall Study|Protocol Violation|4|||
129492991|NCT02260193|466096249|FG002|Overall Study|Protocol Violation|0|||
129492992|NCT02260193|466096247|FG000|Overall Study|Withdrawal by Subject|3|||
129492993|NCT02260193|466096248|FG001|Overall Study|Withdrawal by Subject|0|||
129492994|NCT02260193|466096249|FG002|Overall Study|Withdrawal by Subject|2|||
129492995|NCT02260193|466096247|FG000|Overall Study|Kidney Transplantation|0|||
129492996|NCT02260193|466096248|FG001|Overall Study|Kidney Transplantation|0|||
129492997|NCT02260193|466096249|FG002|Overall Study|Kidney Transplantation|1|||
129492998|NCT01963117|466096257|FG000|Overall Study|Death|1|||
129492999|NCT01000064|466096258|FG000|Overall Study|Withdrawal by Subject|1|||
129493000|NCT01000064|466096259|FG001|Overall Study|Withdrawal by Subject|1|||
129493001|NCT01518192|466096260|FG000|Overall Study|Lost to Follow-up|29|||
129493002|NCT01518192|466096261|FG001|Overall Study|Lost to Follow-up|26|||
129493003|NCT01518192|466096262|FG002|Overall Study|Lost to Follow-up|35|||
129493004|NCT03090737|466096265|FG000|Overall Study|Other reasons|1|||
129493005|NCT03090737|466096265|FG000|Overall Study|Completed treatment as per protocol|17|||
129493006|NCT03090737|466096265|FG000|Overall Study|Maximum clinical benefit|2|||
129493007|NCT03090737|466096265|FG000|Overall Study|Adverse event unrelated to study drug|7|||
129493008|NCT03090737|466096265|FG000|Overall Study|Study drug toxicity|4|||
129493009|NCT03090737|466096265|FG000|Overall Study|Disease progression|98|||
129493010|NCT03141307|466096266|FG000|In-Hospital|Withdrawal by Subject|0|||
129493011|NCT03141307|466096267|FG001|In-Hospital|Withdrawal by Subject|2|||
129493012|NCT03141307|466096266|FG000|In-Hospital|Protocol Violation|4|||
129493013|NCT03141307|466096267|FG001|In-Hospital|Protocol Violation|0|||
129493014|NCT03141307|466096266|FG000|Follow-Up|Lost to Follow-up|97|||
129493015|NCT03141307|466096267|FG001|Follow-Up|Lost to Follow-up|54|||
129493016|NCT04430582|466096270|FG000|Overall Study|Found to meet exclusionary criteria|1|||
129493017|NCT04430582|466096271|FG001|Overall Study|Found to meet exclusionary criteria|0|||
129493018|NCT04430582|466096270|FG000|Overall Study|Withdrawal by Subject|0|||
129493019|NCT04430582|466096271|FG001|Overall Study|Withdrawal by Subject|1|||
129493020|NCT01505491|466097896|FG000|Overall Study|Other reason not listed|1|||
129493021|NCT01505491|466097897|FG001|Overall Study|Other reason not listed|0|||
129493022|NCT01505491|466097898|FG002|Overall Study|Other reason not listed|0|||
129493023|NCT01505491|466097896|FG000|Overall Study|Withdrawal by Subject|1|||
129980829|NCT02416453|467893360|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980830|NCT02416453|467893361|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980831|NCT02416453|467893362|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
129980832|NCT02416453|467893363|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980833|NCT02416453|467893364|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980834|NCT02416453|467893365|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980835|NCT02416453|467893366|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129980836|NCT02416453|467893367|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
129493024|NCT01505491|466097897|FG001|Overall Study|Withdrawal by Subject|1|||
129493025|NCT01505491|466097898|FG002|Overall Study|Withdrawal by Subject|4|||
129493026|NCT01505491|466097896|FG000|Overall Study|Lost to Follow-up|0|||
129493027|NCT01505491|466097897|FG001|Overall Study|Lost to Follow-up|0|||
129493028|NCT01505491|466097898|FG002|Overall Study|Lost to Follow-up|1|||
129493029|NCT00367640|466097907|FG000|Overall Study|Adverse Event|3|||
129493030|NCT00367640|466097908|FG001|Overall Study|Adverse Event|6|||
129493031|NCT00367640|466097909|FG002|Overall Study|Adverse Event|8|||
129493032|NCT00367640|466097910|FG003|Overall Study|Adverse Event|0|||
129493033|NCT00367640|466097907|FG000|Overall Study|Withdrawal by Subject|8|||
129493034|NCT00367640|466097908|FG001|Overall Study|Withdrawal by Subject|11|||
129493035|NCT00367640|466097909|FG002|Overall Study|Withdrawal by Subject|8|||
129980837|NCT01152814|467893369|FG000|Overall Study|Lost to Follow-up|2|||
129980838|NCT01877239|467893377|FG000|Overall Study|Adverse Event|4|||
129493036|NCT00367640|466097910|FG003|Overall Study|Withdrawal by Subject|6|||
129493037|NCT00367640|466097907|FG000|Overall Study|Any other reason not above-mentioned|7|||
129493038|NCT00367640|466097908|FG001|Overall Study|Any other reason not above-mentioned|5|||
129493039|NCT00367640|466097909|FG002|Overall Study|Any other reason not above-mentioned|3|||
129493040|NCT00367640|466097910|FG003|Overall Study|Any other reason not above-mentioned|4|||
129493041|NCT01063751|466097912|FG000|Overall Study|Censored from analyses|42|||
129493042|NCT01063751|466097912|FG000|Overall Study|Withdrawal by Subject|34|||
129493043|NCT01063751|466097912|FG000|Overall Study|Lost to Follow-up|30|||
129493044|NCT01063751|466097912|FG000|Overall Study|Death|13|||
129493045|NCT01063751|466097912|FG000|Overall Study|Sponsored Terminated Study|60|||
129493046|NCT01063751|466097912|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
129493047|NCT01063751|466097912|FG000|Overall Study|Investigator site closed|10|||
129493048|NCT01063751|466097912|FG000|Overall Study|Revision|6|||
129493049|NCT01063751|466097912|FG000|Overall Study|Physician Decision|4|||
129493050|NCT00406315|466097915|FG000|Overall Study|Death|1|||
129493051|NCT00406315|466097915|FG000|Overall Study|Adverse Event|39|||
129493052|NCT00406315|466097915|FG000|Overall Study|Laboratory Abnormality|4|||
129493053|NCT00406315|466097915|FG000|Overall Study|Lack of Efficacy|13|||
129493054|NCT00406315|466097915|FG000|Overall Study|Other|33|||
129493055|NCT00406315|466097915|FG000|Overall Study|Lost to Follow-up|21|||
129493056|NCT00406315|466097915|FG000|Overall Study|Withdrawal by Subject|30|||
129493057|NCT01312428|466097916|FG000|Overall Study|Study Termination|3|||
129493058|NCT01312428|466097917|FG001|Overall Study|Study Termination|4|||
129493059|NCT02214186|466097923|FG000|Overall Study|Lost to Follow-up|1|||
129493060|NCT02214186|466097924|FG001|Overall Study|Lost to Follow-up|1|||
129493061|NCT02214186|466097923|FG000|Overall Study|Protocol Violation|1|||
129493062|NCT02214186|466097924|FG001|Overall Study|Protocol Violation|1|||
129493063|NCT01525849|466097925|FG000|Overall Study|Lost to Follow-up|3|||
129493064|NCT01525849|466097926|FG001|Overall Study|Lost to Follow-up|2|||
129493065|NCT01525849|466097925|FG000|Overall Study|Withdrawal by Subject|1|||
129493066|NCT01525849|466097926|FG001|Overall Study|Withdrawal by Subject|9|||
129493067|NCT01525849|466097925|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
129493068|NCT01525849|466097926|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
129493069|NCT01525849|466097925|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
129980839|NCT01877239|467893377|FG000|Overall Study|Disease Remission|1|||
129493070|NCT01525849|466097926|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
129493071|NCT00339183|466097927|FG000|Overall Study|Adverse Event|5|||
129493072|NCT00339183|466097928|FG001|Overall Study|Adverse Event|3|||
129493073|NCT00339183|466097927|FG000|Overall Study|Withdrawal by Subject|16|||
129493074|NCT00339183|466097928|FG001|Overall Study|Withdrawal by Subject|19|||
129493075|NCT00339183|466097927|FG000|Overall Study|Physician Decision|2|||
129493076|NCT00339183|466097928|FG001|Overall Study|Physician Decision|4|||
129493077|NCT00339183|466097927|FG000|Overall Study|Lost to Follow-up|17|||
129493078|NCT00339183|466097928|FG001|Overall Study|Lost to Follow-up|17|||
129493079|NCT00339183|466097927|FG000|Overall Study|Protocol-specified criteria|12|||
129493080|NCT00339183|466097928|FG001|Overall Study|Protocol-specified criteria|8|||
129493081|NCT00339183|466097927|FG000|Overall Study|Missing reason|3|||
129493082|NCT00339183|466097928|FG001|Overall Study|Missing reason|1|||
129493083|NCT00339183|466097927|FG000|Overall Study|Other|46|||
129493084|NCT00339183|466097928|FG001|Overall Study|Other|40|||
129493085|NCT00339183|466097927|FG000|Overall Study|Ongoing|20|||
129493086|NCT00339183|466097928|FG001|Overall Study|Ongoing|13|||
129493087|NCT00793819|466097929|FG000|Overall Study|Adverse Event|8|||
129493088|NCT00793819|466097930|FG001|Overall Study|Adverse Event|4|||
129493089|NCT00793819|466097929|FG000|Overall Study|Lack of Efficacy|1|||
129493090|NCT00793819|466097930|FG001|Overall Study|Lack of Efficacy|1|||
129493091|NCT00793819|466097929|FG000|Overall Study|Withdrawal by Subject|4|||
129493092|NCT00793819|466097930|FG001|Overall Study|Withdrawal by Subject|3|||
129493093|NCT00793819|466097929|FG000|Overall Study|Lost to Follow-up|1|||
129493094|NCT00793819|466097930|FG001|Overall Study|Lost to Follow-up|1|||
129493095|NCT00446446|466097931|FG000|Overall Study|Death|10|||
129493096|NCT00446446|466097931|FG000|Overall Study|Withdrawal by Subject|6|||
129493097|NCT00446446|466097931|FG000|Overall Study|Other|4|||
129493098|NCT00446446|466097931|FG000|Overall Study|Disease Progession|2|||
129493099|NCT00446446|466097931|FG000|Overall Study|Adverse Event|1|||
129493100|NCT00446446|466097931|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
129493101|NCT00611130|466097934|FG000|Overall Study|Lost to Follow-up|25|||
129493102|NCT00611130|466097935|FG001|Overall Study|Lost to Follow-up|29|||
129493103|NCT00611130|466097934|FG000|Overall Study|Protocol noncompliance|7|||
129493104|NCT00611130|466097935|FG001|Overall Study|Protocol noncompliance|6|||
129493105|NCT00611130|466097934|FG000|Overall Study|Withdrawal by Subject|6|||
129493106|NCT00611130|466097935|FG001|Overall Study|Withdrawal by Subject|5|||
129493107|NCT00611130|466097934|FG000|Overall Study|Other|5|||
129493108|NCT00611130|466097935|FG001|Overall Study|Other|4|||
129493109|NCT00611130|466097934|FG000|Overall Study|Incarceration|3|||
129493110|NCT00611130|466097935|FG001|Overall Study|Incarceration|2|||
129493111|NCT00611130|466097934|FG000|Overall Study|Administrative|1|||
129493112|NCT00611130|466097935|FG001|Overall Study|Administrative|1|||
129493113|NCT00611130|466097934|FG000|Overall Study|Adverse Event|1|||
129493114|NCT00611130|466097935|FG001|Overall Study|Adverse Event|0|||
129493115|NCT00611130|466097934|FG000|Overall Study|Death|1|||
129493116|NCT00611130|466097935|FG001|Overall Study|Death|0|||
129493117|NCT03964415|466097937|FG000|Overall Study|Sponsor's decision|1563|||
129493118|NCT03964415|466097938|FG001|Overall Study|Sponsor's decision|1528|||
129493119|NCT03964415|466097937|FG000|Overall Study|Lost to Follow-up|139|||
129493120|NCT03964415|466097938|FG001|Overall Study|Lost to Follow-up|146|||
129493121|NCT03964415|466097937|FG000|Overall Study|Withdrawal by Subject|68|||
129493122|NCT03964415|466097938|FG001|Overall Study|Withdrawal by Subject|72|||
129493123|NCT03964415|466097937|FG000|Overall Study|Physician Decision|34|||
129493124|NCT03964415|466097938|FG001|Overall Study|Physician Decision|48|||
129493125|NCT03964415|466097937|FG000|Overall Study|Adverse Event|3|||
129493126|NCT03964415|466097938|FG001|Overall Study|Adverse Event|0|||
129493127|NCT03964415|466097937|FG000|Overall Study|Death|4|||
129493128|NCT03964415|466097938|FG001|Overall Study|Death|6|||
129493129|NCT03964415|466097937|FG000|Overall Study|Protocol Violation|1|||
129493130|NCT03964415|466097938|FG001|Overall Study|Protocol Violation|4|||
129493131|NCT03964415|466097937|FG000|Overall Study|Other|35|||
129493132|NCT03964415|466097938|FG001|Overall Study|Other|38|||
129493133|NCT03964415|466097937|FG000|Overall Study|Randomized but not treated|6|||
129493134|NCT03964415|466097938|FG001|Overall Study|Randomized but not treated|7|||
129493135|NCT01734993|466097939|FG000|Overall Study|Adverse Event|1|||
129493136|NCT01734993|466097939|FG000|Overall Study|Lack of Efficacy|1|||
129493137|NCT01455428|466097943|FG000|Overall Study|Protocol Violation|2|||
129493138|NCT01455428|466097944|FG001|Overall Study|Protocol Violation|1|||
129493139|NCT01455428|466097943|FG000|Overall Study|Adverse Event|6|||
129493140|NCT01455428|466097944|FG001|Overall Study|Adverse Event|2|||
129493141|NCT01455428|466097943|FG000|Overall Study|Lost to Follow-up|1|||
129493142|NCT01455428|466097944|FG001|Overall Study|Lost to Follow-up|1|||
129493143|NCT01455428|466097943|FG000|Overall Study|Withdrawal by Subject|2|||
129493144|NCT01455428|466097944|FG001|Overall Study|Withdrawal by Subject|5|||
129493145|NCT01455428|466097943|FG000|Overall Study|Did not meet entrance criteria|0|||
129493146|NCT01455428|466097944|FG001|Overall Study|Did not meet entrance criteria|2|||
129493147|NCT01455428|466097943|FG000|Overall Study|Insufficient clinical response|0|||
129493148|NCT01455428|466097944|FG001|Overall Study|Insufficient clinical response|2|||
129493149|NCT01455428|466097943|FG000|Overall Study|Did not receive treatment|1|||
129493150|NCT01455428|466097944|FG001|Overall Study|Did not receive treatment|1|||
129493151|NCT01455428|466097943|FG000|Overall Study|Other|2|||
129493152|NCT01455428|466097944|FG001|Overall Study|Other|4|||
129493153|NCT03303339|466097945|FG000|Overall Study|Death|2|||
129493154|NCT03303339|466097946|FG001|Overall Study|Death|2|||
129493155|NCT03303339|466097947|FG002|Overall Study|Death|2|||
129493156|NCT03303339|466097948|FG003|Overall Study|Death|1|||
129493157|NCT03303339|466097949|FG004|Overall Study|Death|4|||
129493158|NCT03303339|466097950|FG005|Overall Study|Death|2|||
129493159|NCT03303339|466097951|FG006|Overall Study|Death|2|||
129493160|NCT03303339|466097952|FG007|Overall Study|Death|2|||
129493161|NCT03303339|466097953|FG008|Overall Study|Death|3|||
129493162|NCT03303339|466097954|FG009|Overall Study|Death|3|||
129493163|NCT03303339|466097955|FG010|Overall Study|Death|4|||
129493164|NCT03303339|466097956|FG011|Overall Study|Death|24|||
129493165|NCT03303339|466097945|FG000|Overall Study|Study Terminated by Sponsor|0|||
129493166|NCT03303339|466097946|FG001|Overall Study|Study Terminated by Sponsor|0|||
129493167|NCT03303339|466097947|FG002|Overall Study|Study Terminated by Sponsor|0|||
129493168|NCT03303339|466097948|FG003|Overall Study|Study Terminated by Sponsor|0|||
129493169|NCT03303339|466097949|FG004|Overall Study|Study Terminated by Sponsor|0|||
129493170|NCT03303339|466097950|FG005|Overall Study|Study Terminated by Sponsor|0|||
129493171|NCT03303339|466097951|FG006|Overall Study|Study Terminated by Sponsor|0|||
129493172|NCT03303339|466097952|FG007|Overall Study|Study Terminated by Sponsor|0|||
129493173|NCT03303339|466097953|FG008|Overall Study|Study Terminated by Sponsor|1|||
129493174|NCT03303339|466097954|FG009|Overall Study|Study Terminated by Sponsor|0|||
129493175|NCT03303339|466097955|FG010|Overall Study|Study Terminated by Sponsor|1|||
129493176|NCT03303339|466097956|FG011|Overall Study|Study Terminated by Sponsor|1|||
129493177|NCT03303339|466097945|FG000|Overall Study|Withdrawal by Subject|1|||
129493178|NCT03303339|466097946|FG001|Overall Study|Withdrawal by Subject|0|||
129493179|NCT03303339|466097947|FG002|Overall Study|Withdrawal by Subject|0|||
129493180|NCT03303339|466097948|FG003|Overall Study|Withdrawal by Subject|0|||
129493181|NCT03303339|466097949|FG004|Overall Study|Withdrawal by Subject|0|||
129493182|NCT03303339|466097950|FG005|Overall Study|Withdrawal by Subject|1|||
129493183|NCT03303339|466097951|FG006|Overall Study|Withdrawal by Subject|1|||
129493184|NCT03303339|466097952|FG007|Overall Study|Withdrawal by Subject|0|||
129493185|NCT03303339|466097953|FG008|Overall Study|Withdrawal by Subject|0|||
129493186|NCT03303339|466097954|FG009|Overall Study|Withdrawal by Subject|0|||
129493187|NCT03303339|466097955|FG010|Overall Study|Withdrawal by Subject|0|||
129493188|NCT03303339|466097956|FG011|Overall Study|Withdrawal by Subject|2|||
129493189|NCT03303339|466097945|FG000|Overall Study|Physician Decision|0|||
129493190|NCT03303339|466097946|FG001|Overall Study|Physician Decision|0|||
129493191|NCT03303339|466097947|FG002|Overall Study|Physician Decision|0|||
129493192|NCT03303339|466097948|FG003|Overall Study|Physician Decision|0|||
129493193|NCT03303339|466097949|FG004|Overall Study|Physician Decision|1|||
129493194|NCT03303339|466097950|FG005|Overall Study|Physician Decision|0|||
129493195|NCT03303339|466097951|FG006|Overall Study|Physician Decision|0|||
129493196|NCT03303339|466097952|FG007|Overall Study|Physician Decision|0|||
129493197|NCT03303339|466097953|FG008|Overall Study|Physician Decision|0|||
129493198|NCT03303339|466097954|FG009|Overall Study|Physician Decision|0|||
129493199|NCT03303339|466097955|FG010|Overall Study|Physician Decision|0|||
129493200|NCT03303339|466097956|FG011|Overall Study|Physician Decision|0|||
129493201|NCT03303339|466097945|FG000|Overall Study|Safety/Non-compliance|0|||
129493202|NCT03303339|466097946|FG001|Overall Study|Safety/Non-compliance|0|||
129493203|NCT03303339|466097947|FG002|Overall Study|Safety/Non-compliance|0|||
129493204|NCT03303339|466097948|FG003|Overall Study|Safety/Non-compliance|0|||
129493205|NCT03303339|466097949|FG004|Overall Study|Safety/Non-compliance|0|||
129493206|NCT03303339|466097950|FG005|Overall Study|Safety/Non-compliance|0|||
129493207|NCT03303339|466097951|FG006|Overall Study|Safety/Non-compliance|0|||
129493208|NCT03303339|466097952|FG007|Overall Study|Safety/Non-compliance|0|||
129493209|NCT03303339|466097953|FG008|Overall Study|Safety/Non-compliance|0|||
129493210|NCT03303339|466097954|FG009|Overall Study|Safety/Non-compliance|0|||
129493211|NCT03303339|466097955|FG010|Overall Study|Safety/Non-compliance|0|||
129493212|NCT03303339|466097956|FG011|Overall Study|Safety/Non-compliance|1|||
129493213|NCT02062151|466097961|FG000|Overall Study|screen failure|1|||
129493214|NCT00751101|466097964|FG000|Overall Study|Withdrawal by Subject|1|||
129493215|NCT00751101|466097965|FG001|Overall Study|Withdrawal by Subject|0|||
129493216|NCT00751101|466097964|FG000|Overall Study|No HFS / Never Started Patch/|0|||
129493217|NCT00751101|466097965|FG001|Overall Study|No HFS / Never Started Patch/|4|||
129493218|NCT00751101|466097964|FG000|Overall Study|Never began capecitabine|1|||
129493219|NCT00751101|466097965|FG001|Overall Study|Never began capecitabine|0|||
129493220|NCT00751101|466097964|FG000|Overall Study|Physician Decision|0|||
129493221|NCT00751101|466097965|FG001|Overall Study|Physician Decision|1|||
129493222|NCT01905397|466097968|FG000|Overall Study|Death|0|||
129493223|NCT01905397|466097969|FG001|Overall Study|Death|1|||
129980840|NCT01877239|467893377|FG000|Overall Study|Withdrawal by Subject|4|||
129980841|NCT01877239|467893377|FG000|Overall Study|Other|2|||
129980842|NCT01877239|467893377|FG000|Overall Study|Lack of Efficacy|4|||
129493224|NCT01905397|466097968|FG000|Overall Study|Withdrawal by Subject|2|||
129493225|NCT01905397|466097969|FG001|Overall Study|Withdrawal by Subject|0|||
129493226|NCT01905397|466097968|FG000|Overall Study|Surgery canceled/aborted|9|||
129493227|NCT01905397|466097969|FG001|Overall Study|Surgery canceled/aborted|5|||
129493228|NCT01905397|466097968|FG000|Overall Study|Incision < 7 cm|2|||
129493229|NCT01905397|466097969|FG001|Overall Study|Incision < 7 cm|0|||
129493230|NCT01905397|466097968|FG000|Overall Study|Wrong treatment|1|||
129493231|NCT01905397|466097969|FG001|Overall Study|Wrong treatment|1|||
129493232|NCT01905397|466097968|FG000|Overall Study|Device not applied|3|||
129493233|NCT01905397|466097969|FG001|Overall Study|Device not applied|0|||
129493234|NCT01905397|466097968|FG000|Overall Study|Dressing not applied in operating room|1|||
129493235|NCT01905397|466097969|FG001|Overall Study|Dressing not applied in operating room|0|||
129538482|NCT05664672|466262111|FG004|Overall Study|Adverse Event|0|||
129493236|NCT01905397|466097968|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
129493237|NCT01905397|466097969|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
129493238|NCT01921270|466097973|FG000|Overall Study|Withdrawal by Subject|1|||
129493239|NCT00844428|466097974|FG000|Screening Period|Screen Failure|3|||
129493240|NCT00844428|466097974|FG000|Extension Treatment Period|Death|1|||
129493241|NCT00844428|466097974|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
129493242|NCT00789477|466097975|FG000|Overall Study|Withdrawal by Subject|2|||
129493243|NCT00789477|466097976|FG001|Overall Study|Withdrawal by Subject|1|||
129493244|NCT00789477|466097977|FG002|Overall Study|Withdrawal by Subject|3|||
129493245|NCT00789477|466097978|FG003|Overall Study|Withdrawal by Subject|2|||
129493246|NCT00789477|466097979|FG004|Overall Study|Withdrawal by Subject|3|||
129493247|NCT00789477|466097975|FG000|Overall Study|Protocol Violation|1|||
129493248|NCT00789477|466097976|FG001|Overall Study|Protocol Violation|0|||
129493249|NCT00789477|466097977|FG002|Overall Study|Protocol Violation|0|||
129493250|NCT00789477|466097978|FG003|Overall Study|Protocol Violation|1|||
129493251|NCT00789477|466097979|FG004|Overall Study|Protocol Violation|0|||
129493252|NCT00789477|466097975|FG000|Overall Study|Adverse Event|3|||
129493253|NCT00789477|466097976|FG001|Overall Study|Adverse Event|3|||
129493254|NCT00789477|466097977|FG002|Overall Study|Adverse Event|1|||
129493255|NCT00789477|466097978|FG003|Overall Study|Adverse Event|0|||
129493256|NCT00789477|466097979|FG004|Overall Study|Adverse Event|0|||
129493257|NCT00789477|466097975|FG000|Overall Study|Death|1|||
129493258|NCT00789477|466097976|FG001|Overall Study|Death|1|||
129493259|NCT00789477|466097977|FG002|Overall Study|Death|2|||
129493260|NCT00789477|466097978|FG003|Overall Study|Death|2|||
129493261|NCT00789477|466097979|FG004|Overall Study|Death|0|||
129493262|NCT00789477|466097975|FG000|Overall Study|Lost to Follow-up|0|||
129493263|NCT00789477|466097976|FG001|Overall Study|Lost to Follow-up|1|||
129493264|NCT00789477|466097977|FG002|Overall Study|Lost to Follow-up|4|||
129493265|NCT00789477|466097978|FG003|Overall Study|Lost to Follow-up|2|||
129493266|NCT00789477|466097979|FG004|Overall Study|Lost to Follow-up|4|||
129493267|NCT00789477|466097975|FG000|Overall Study|Lack of Efficacy|2|||
129493268|NCT00789477|466097976|FG001|Overall Study|Lack of Efficacy|0|||
129493269|NCT00789477|466097977|FG002|Overall Study|Lack of Efficacy|0|||
129493270|NCT00789477|466097978|FG003|Overall Study|Lack of Efficacy|0|||
129493271|NCT00789477|466097979|FG004|Overall Study|Lack of Efficacy|0|||
129493272|NCT00789477|466097975|FG000|Overall Study|Other|2|||
129493273|NCT00789477|466097976|FG001|Overall Study|Other|0|||
129493274|NCT00789477|466097977|FG002|Overall Study|Other|1|||
129493275|NCT00789477|466097978|FG003|Overall Study|Other|3|||
129493276|NCT00789477|466097979|FG004|Overall Study|Other|0|||
129493277|NCT00455858|466097980|FG000|Overall Study|Lost to Follow-up|2|||
129493278|NCT00455858|466097980|FG000|Overall Study|Protocol Violation|1|||
129493279|NCT00455858|466097980|FG000|Overall Study|Lack of Efficacy|1|||
129493280|NCT00455858|466097980|FG000|Overall Study|Well controlled FPG without insulin|1|||
129493281|NCT00455858|466097980|FG000|Overall Study|Withdrawal|1|||
129493282|NCT02092389|466097982|FG000|Overall Study|Adverse Event|1|||
129493283|NCT02092389|466097982|FG000|Overall Study|Other|5|||
129493284|NCT01242020|466097983|FG000|Overall Study|Withdrawal by Subject|2|||
129493285|NCT01242020|466097984|FG001|Overall Study|Withdrawal by Subject|0|||
129493286|NCT01242020|466097983|FG000|Overall Study|Failed screening|1|||
129493287|NCT01242020|466097984|FG001|Overall Study|Failed screening|0|||
129493288|NCT00772967|466097985|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
129493289|NCT00772967|466097986|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
129493290|NCT00772967|466097987|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
129493291|NCT00772967|466097988|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
129493292|NCT00772967|466097989|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
129493293|NCT00772967|466097990|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
129493294|NCT00772967|466097985|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
129493295|NCT00772967|466097986|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
129980843|NCT01877239|467893377|FG000|Overall Study|Data not available|35|||
129980844|NCT01669577|467893378|FG000|Overall Study|Death|22|||
129980845|NCT01669577|467893378|FG000|Overall Study|Lost to Follow-up|78|||
129980846|NCT01669577|467893378|FG000|Overall Study|Physician Decision|34|||
129980847|NCT00132873|467893384|FG000|Overall Study|Adverse Event|3|||
129980848|NCT00132873|467893384|FG000|Overall Study|Lost to Follow-up|1|||
129980849|NCT00132873|467893384|FG000|Overall Study|Lack of Efficacy|1|||
129980850|NCT00132873|467893384|FG000|Overall Study|Withdrawal by Subject|3|||
129980851|NCT00132873|467893384|FG000|Overall Study|Planned Pregnancy|1|||
129980852|NCT02045875|467893385|FG000|Overall Study|Lost to Follow-up|3|||
129980853|NCT02045875|467893386|FG001|Overall Study|Lost to Follow-up|0|||
129493296|NCT00772967|466097987|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
129493297|NCT00772967|466097988|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
129493298|NCT00772967|466097989|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
129493299|NCT00772967|466097990|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
129493300|NCT00772967|466097985|FG000|Crossover Treatment 3|Adverse Event|0|||
129493301|NCT00772967|466097986|FG001|Crossover Treatment 3|Adverse Event|0|||
129493302|NCT00772967|466097987|FG002|Crossover Treatment 3|Adverse Event|0|||
129493303|NCT00772967|466097988|FG003|Crossover Treatment 3|Adverse Event|0|||
129493304|NCT00772967|466097989|FG004|Crossover Treatment 3|Adverse Event|1|||
129493305|NCT00772967|466097990|FG005|Crossover Treatment 3|Adverse Event|0|||
129493306|NCT01595646|466097991|FG000|Overall Study|Withdrawal by Subject|1|||
129493307|NCT01595646|466097992|FG001|Overall Study|Withdrawal by Subject|0|||
129493308|NCT01595646|466097993|FG002|Overall Study|Withdrawal by Subject|0|||
129493309|NCT01161524|466097996|FG000|Core Study (23 Weeks)|Adverse Event|3|||
129493310|NCT01161524|466097997|FG001|Core Study (23 Weeks)|Adverse Event|0|||
129493311|NCT01161524|466097998|FG002|Core Study (23 Weeks)|Adverse Event|0|||
129493312|NCT01161524|466097996|FG000|Core Study (23 Weeks)|Other|1|||
129493313|NCT01161524|466097997|FG001|Core Study (23 Weeks)|Other|0|||
129493314|NCT01161524|466097998|FG002|Core Study (23 Weeks)|Other|0|||
129493315|NCT01161524|466097996|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
129493316|NCT01161524|466097997|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
129493317|NCT01161524|466097998|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
129493318|NCT01161524|466097996|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
129493319|NCT01161524|466097997|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
129493320|NCT01161524|466097998|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
129493321|NCT01161524|466097996|FG000|Core Study (23 Weeks)|Subject Choice|3|||
129493322|NCT01161524|466097997|FG001|Core Study (23 Weeks)|Subject Choice|2|||
129493323|NCT01161524|466097998|FG002|Core Study (23 Weeks)|Subject Choice|0|||
129493324|NCT01161524|466097996|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
129493325|NCT01161524|466097997|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
129493326|NCT01161524|466097998|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
129493327|NCT01161524|466097996|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
129493328|NCT01161524|466097997|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
129493329|NCT01161524|466097998|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
129493330|NCT01161524|466097996|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
129493331|NCT01161524|466097997|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
129493332|NCT01161524|466097998|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
129493333|NCT01161524|466097996|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
129493334|NCT01161524|466097997|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
129493335|NCT01161524|466097998|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
129493336|NCT01161524|466097996|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
129493337|NCT01161524|466097997|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
129493338|NCT01161524|466097998|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
129493339|NCT00231062|466098005|FG000|Overall Study|Physician Decision|6|||
129493340|NCT01052012|466098006|FG000|Overall Study|Not treated|2|||
129493341|NCT01052012|466098007|FG001|Overall Study|Not treated|5|||
129493342|NCT01052012|466098008|FG002|Overall Study|Not treated|0|||
129493343|NCT01052012|466098009|FG003|Overall Study|Not treated|0|||
129493344|NCT01052012|466098010|FG004|Overall Study|Not treated|11|||
129493345|NCT01052012|466098011|FG005|Overall Study|Not treated|8|||
129493346|NCT01052012|466098006|FG000|Overall Study|Adverse Event|1|||
129493347|NCT01052012|466098007|FG001|Overall Study|Adverse Event|0|||
129493348|NCT01052012|466098008|FG002|Overall Study|Adverse Event|0|||
129493349|NCT01052012|466098009|FG003|Overall Study|Adverse Event|1|||
129493350|NCT01052012|466098010|FG004|Overall Study|Adverse Event|0|||
129493351|NCT01052012|466098011|FG005|Overall Study|Adverse Event|0|||
129493352|NCT01052012|466098006|FG000|Overall Study|Lost to Follow-up|0|||
129493353|NCT01052012|466098007|FG001|Overall Study|Lost to Follow-up|0|||
129493354|NCT01052012|466098008|FG002|Overall Study|Lost to Follow-up|0|||
129493355|NCT01052012|466098009|FG003|Overall Study|Lost to Follow-up|0|||
129493356|NCT01052012|466098010|FG004|Overall Study|Lost to Follow-up|1|||
129493357|NCT01052012|466098011|FG005|Overall Study|Lost to Follow-up|0|||
129493358|NCT01052012|466098006|FG000|Overall Study|Withdrawal by Subject|1|||
129493359|NCT01052012|466098007|FG001|Overall Study|Withdrawal by Subject|1|||
129493360|NCT01052012|466098008|FG002|Overall Study|Withdrawal by Subject|0|||
129493361|NCT01052012|466098009|FG003|Overall Study|Withdrawal by Subject|0|||
129493362|NCT01052012|466098010|FG004|Overall Study|Withdrawal by Subject|3|||
129493363|NCT01052012|466098011|FG005|Overall Study|Withdrawal by Subject|1|||
129493364|NCT01052012|466098006|FG000|Overall Study|Physician Decision|0|||
129493365|NCT01052012|466098007|FG001|Overall Study|Physician Decision|0|||
129493366|NCT01052012|466098008|FG002|Overall Study|Physician Decision|0|||
129493367|NCT01052012|466098009|FG003|Overall Study|Physician Decision|0|||
129493368|NCT01052012|466098010|FG004|Overall Study|Physician Decision|0|||
129493369|NCT01052012|466098011|FG005|Overall Study|Physician Decision|1|||
129493370|NCT01052012|466098006|FG000|Overall Study|Other|0|||
129493371|NCT01052012|466098007|FG001|Overall Study|Other|0|||
129493372|NCT01052012|466098008|FG002|Overall Study|Other|0|||
129493373|NCT01052012|466098009|FG003|Overall Study|Other|0|||
129493374|NCT01052012|466098010|FG004|Overall Study|Other|1|||
129493375|NCT01052012|466098011|FG005|Overall Study|Other|0|||
129493376|NCT02698423|466098018|FG000|Overall Study|Lost to Follow-up|19|||
129493377|NCT02698423|466098019|FG001|Overall Study|Lost to Follow-up|24|||
129493378|NCT01651260|466098020|FG000|Overall Study|unable to apply product|3|||
129493379|NCT01952015|466098023|FG000|Induction|Protocol Violation|1|||
129493380|NCT01952015|466098023|FG000|Maintenance|Adverse Event|2|||
129493381|NCT01952015|466098023|FG000|Treatment Period 3|Physician Decision|9|||
129493382|NCT01597193|466098024|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
129493383|NCT01597193|466098025|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
129493384|NCT01597193|466098026|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
129493385|NCT01597193|466098027|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
129493386|NCT01597193|466098028|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
129493387|NCT01597193|466098029|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
129493388|NCT01597193|466098030|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
129493389|NCT01597193|466098024|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
129493390|NCT01597193|466098025|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
129493391|NCT01597193|466098026|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
129493392|NCT01597193|466098027|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
129493393|NCT01597193|466098028|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
129493394|NCT01597193|466098029|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
129493395|NCT01597193|466098030|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
129493396|NCT01597193|466098024|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
129493397|NCT01597193|466098025|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
129493398|NCT01597193|466098026|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
129493399|NCT01597193|466098027|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
129493400|NCT01597193|466098028|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
129493401|NCT01597193|466098029|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
129493402|NCT01597193|466098030|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
129493403|NCT01597193|466098024|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
129493404|NCT01597193|466098025|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
129493405|NCT01597193|466098026|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
129493406|NCT01597193|466098027|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
129493407|NCT01597193|466098028|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
129493408|NCT01597193|466098029|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
129493409|NCT01597193|466098030|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
129493410|NCT01597193|466098024|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
129493411|NCT01597193|466098025|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
129493412|NCT01597193|466098026|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
129493413|NCT01597193|466098027|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
129493414|NCT01597193|466098028|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
129493415|NCT01597193|466098029|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
129493416|NCT01597193|466098030|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
129493417|NCT02508701|466098031|FG000|Overall Study|Lost to Follow-up|9|||
129493418|NCT02508701|466098032|FG001|Overall Study|Lost to Follow-up|5|||
129493419|NCT02508701|466098033|FG002|Overall Study|Lost to Follow-up|5|||
129493420|NCT02508701|466098034|FG003|Overall Study|Lost to Follow-up|3|||
129493421|NCT01259297|466098035|FG000|Double Blind Randomized Period|Death|1|||
129493422|NCT01259297|466098036|FG001|Double Blind Randomized Period|Death|1|||
129493423|NCT01259297|466098037|FG002|Double Blind Randomized Period|Death|1|||
129493424|NCT01259297|466098038|FG003|Double Blind Randomized Period|Death|2|||
129493425|NCT01259297|466098039|FG004|Double Blind Randomized Period|Death|1|||
129493426|NCT01259297|466098040|FG005|Double Blind Randomized Period|Death|5|||
129493427|NCT01259297|466098041|FG006|Double Blind Randomized Period|Death|2|||
129493428|NCT01259297|466098042|FG007|Double Blind Randomized Period|Death|1|||
129493429|NCT01259297|466098035|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
129493430|NCT01259297|466098036|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
129493431|NCT01259297|466098037|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
129493432|NCT01259297|466098038|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
129493433|NCT01259297|466098039|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
129493434|NCT01259297|466098040|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
129493435|NCT01259297|466098041|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
129493436|NCT01259297|466098042|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
129493437|NCT01259297|466098035|FG000|Double Blind Randomized Period|Other reasons|0|||
129493438|NCT01259297|466098036|FG001|Double Blind Randomized Period|Other reasons|1|||
129493439|NCT01259297|466098037|FG002|Double Blind Randomized Period|Other reasons|0|||
129493440|NCT01259297|466098038|FG003|Double Blind Randomized Period|Other reasons|0|||
129493441|NCT01259297|466098039|FG004|Double Blind Randomized Period|Other reasons|1|||
129493442|NCT01259297|466098040|FG005|Double Blind Randomized Period|Other reasons|2|||
129493443|NCT01259297|466098041|FG006|Double Blind Randomized Period|Other reasons|3|||
129493444|NCT01259297|466098042|FG007|Double Blind Randomized Period|Other reasons|1|||
129493445|NCT00592501|466098043|FG000|Overall Study|Withdrawal by Subject|1|||
129493446|NCT00592501|466098043|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
129493447|NCT03880227|466098047|FG000|First Visit|Withdrawal by Subject|1|||
129493448|NCT03880227|466098048|FG001|First Visit|Withdrawal by Subject|0|||
129980854|NCT02045875|467893385|FG000|Overall Study|Withdrawal by Subject|4|||
129493449|NCT03880227|466098049|FG002|First Visit|Withdrawal by Subject|0|||
129493450|NCT03880227|466098050|FG003|First Visit|Withdrawal by Subject|0|||
129493451|NCT03880227|466098047|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
129493452|NCT03880227|466098048|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
129493453|NCT03880227|466098049|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
129493454|NCT03880227|466098050|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
129493455|NCT03880227|466098047|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
129493456|NCT03880227|466098048|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
129493457|NCT03880227|466098049|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
129493458|NCT03880227|466098050|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
129493459|NCT03880227|466098047|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
129493460|NCT03880227|466098048|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
129493461|NCT03880227|466098049|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
129493462|NCT03880227|466098050|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
129493463|NCT01345786|466098054|FG000|Overall Study|Adverse Event|0|||
129493464|NCT01345786|466098055|FG001|Overall Study|Adverse Event|1|||
129493465|NCT01345786|466098056|FG002|Overall Study|Adverse Event|3|||
129493466|NCT01345786|466098057|FG003|Overall Study|Adverse Event|1|||
129493467|NCT01345786|466098054|FG000|Overall Study|Subject withdrew consent|2|||
129493468|NCT01345786|466098055|FG001|Overall Study|Subject withdrew consent|2|||
129493469|NCT01345786|466098056|FG002|Overall Study|Subject withdrew consent|1|||
129493470|NCT01345786|466098057|FG003|Overall Study|Subject withdrew consent|0|||
129493471|NCT01345786|466098054|FG000|Overall Study|Noncompliance with protocol|1|||
129493472|NCT01345786|466098055|FG001|Overall Study|Noncompliance with protocol|0|||
129493473|NCT01345786|466098056|FG002|Overall Study|Noncompliance with protocol|1|||
129493474|NCT01345786|466098057|FG003|Overall Study|Noncompliance with protocol|0|||
129493475|NCT01345786|466098054|FG000|Overall Study|Administrative|3|||
129493476|NCT01345786|466098055|FG001|Overall Study|Administrative|5|||
129493477|NCT01345786|466098056|FG002|Overall Study|Administrative|0|||
129493478|NCT01345786|466098057|FG003|Overall Study|Administrative|0|||
129493479|NCT01345786|466098054|FG000|Overall Study|Lost to Follow-up|0|||
129493480|NCT01345786|466098055|FG001|Overall Study|Lost to Follow-up|0|||
129493481|NCT01345786|466098056|FG002|Overall Study|Lost to Follow-up|0|||
129493482|NCT01345786|466098057|FG003|Overall Study|Lost to Follow-up|2|||
129493483|NCT01070784|466098060|FG000|Overall Study|Withdrawal by Subject|6|||
129493484|NCT01070784|466098061|FG001|Overall Study|Withdrawal by Subject|9|||
129493485|NCT01070784|466098060|FG000|Overall Study|Adverse Event|14|||
129493486|NCT01070784|466098061|FG001|Overall Study|Adverse Event|9|||
129493487|NCT02815397|466098063|FG000|Overall Study|Physician Decision|2|||
129493488|NCT02518620|466098064|FG000|Overall Study|Adverse Event|23|||
129493489|NCT02518620|466098065|FG001|Overall Study|Adverse Event|11|||
129493490|NCT02518620|466098064|FG000|Overall Study|Lack of Efficacy|2|||
129493491|NCT02518620|466098065|FG001|Overall Study|Lack of Efficacy|0|||
129493492|NCT02518620|466098064|FG000|Overall Study|Non-Compliance with Study Drug|1|||
129493493|NCT02518620|466098065|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129493494|NCT02518620|466098064|FG000|Overall Study|Physician Decision|1|||
129493495|NCT02518620|466098065|FG001|Overall Study|Physician Decision|1|||
129493496|NCT02518620|466098064|FG000|Overall Study|Sponsor's Decision|0|||
129493497|NCT02518620|466098065|FG001|Overall Study|Sponsor's Decision|3|||
129493498|NCT02518620|466098064|FG000|Overall Study|Lost to Follow-up|1|||
129493499|NCT02518620|466098065|FG001|Overall Study|Lost to Follow-up|1|||
129493500|NCT02518620|466098064|FG000|Overall Study|Withdrawal by Subject|17|||
129493501|NCT02518620|466098065|FG001|Overall Study|Withdrawal by Subject|9|||
129493502|NCT02518620|466098064|FG000|Overall Study|Death|1|||
129493503|NCT02518620|466098065|FG001|Overall Study|Death|0|||
129493504|NCT02518620|466098064|FG000|Overall Study|Pregnancy Wish|3|||
129493505|NCT02518620|466098065|FG001|Overall Study|Pregnancy Wish|0|||
129493506|NCT02518620|466098064|FG000|Overall Study|Pregnancy|1|||
129493507|NCT02518620|466098065|FG001|Overall Study|Pregnancy|0|||
129493508|NCT02518620|466098064|FG000|Overall Study|Relocation|2|||
129493509|NCT02518620|466098065|FG001|Overall Study|Relocation|1|||
129493510|NCT00085540|466098066|FG000|Overall Study|Withdrawal by Subject|0|||
129493511|NCT00085540|466098067|FG001|Overall Study|Withdrawal by Subject|1|||
129493512|NCT00085540|466098066|FG000|Overall Study|Protocol Violation|0|||
129493513|NCT00085540|466098067|FG001|Overall Study|Protocol Violation|1|||
129493514|NCT01605396|466098068|FG000|Overall Study|Adverse Event|5|||
129493515|NCT01605396|466098069|FG001|Overall Study|Adverse Event|3|||
129493516|NCT01605396|466098068|FG000|Overall Study|Lost to Follow-up|1|||
129493517|NCT01605396|466098069|FG001|Overall Study|Lost to Follow-up|0|||
129493518|NCT01605396|466098068|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129493519|NCT01605396|466098069|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129493520|NCT01605396|466098068|FG000|Overall Study|Physician Decision|2|||
129493521|NCT01605396|466098069|FG001|Overall Study|Physician Decision|2|||
129493522|NCT01605396|466098068|FG000|Overall Study|Progressive Disease|23|||
129493523|NCT01605396|466098069|FG001|Overall Study|Progressive Disease|27|||
129493524|NCT01605396|466098068|FG000|Overall Study|Withdrawal by Subject|4|||
129493525|NCT01605396|466098069|FG001|Overall Study|Withdrawal by Subject|2|||
129493526|NCT01605396|466098068|FG000|Overall Study|Transfer Off Study|4|||
129493527|NCT01605396|466098069|FG001|Overall Study|Transfer Off Study|5|||
129493528|NCT03607682|466098072|FG000|Overall Study|Withdrawal by Subject|1|||
129493529|NCT03607682|466098072|FG000|Overall Study|Disease progression|1|||
129493530|NCT00376688|466098073|FG000|Overall Study|Adverse Event|3|||
129493531|NCT00376688|466098073|FG000|Overall Study|Death|1|||
129493532|NCT01770353|466098074|FG000|Overall Study|Progressive disease|2|||
129493533|NCT01770353|466098075|FG001|Overall Study|Progressive disease|1|||
129493534|NCT01770353|466098074|FG000|Overall Study|Adverse Event|0|||
129493535|NCT01770353|466098075|FG001|Overall Study|Adverse Event|1|||
129493536|NCT01770353|466098074|FG000|Overall Study|Protocol Violation|1|||
129493537|NCT01770353|466098075|FG001|Overall Study|Protocol Violation|0|||
129493538|NCT01770353|466098074|FG000|Overall Study|Physician Decision|0|||
129493539|NCT01770353|466098075|FG001|Overall Study|Physician Decision|3|||
129493540|NCT01770353|466098074|FG000|Overall Study|Clinical deterioration|3|||
129493541|NCT01770353|466098075|FG001|Overall Study|Clinical deterioration|6|||
129493542|NCT01770353|466098074|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
129493543|NCT01770353|466098075|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
129493544|NCT02574312|466098076|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
129493545|NCT02574312|466098077|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
129493546|NCT04267562|466099979|FG000|Assessed for Eligibility|Screen Failure|64|||
129493547|NCT04267562|466099979|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
129493548|NCT04267562|466099979|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
129493549|NCT04267562|466099979|FG000|Assessed for Eligibility|Site closure|6|||
129493550|NCT04267562|466099979|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
129493551|NCT04267562|466099979|FG000|Assessed for Eligibility|Physician Decision|1|||
129493552|NCT04267562|466099979|FG000|Month 24|Elective hysterectomy|1|||
129493553|NCT04267562|466099979|FG000|Month 24|Lost to Follow-up|1|||
129493554|NCT04267562|466099979|FG000|Month 36|Elective hysterectomy|2|||
129493555|NCT04267562|466099979|FG000|Month 36|Lost to Follow-up|3|||
129493556|NCT02078713|466099980|FG000|Overall Study|Lost to Follow-up|49|||
129493557|NCT02078713|466099981|FG001|Overall Study|Lost to Follow-up|55|||
129493558|NCT02078713|466099982|FG002|Overall Study|Lost to Follow-up|0|||
129493559|NCT02078713|466099983|FG003|Overall Study|Lost to Follow-up|0|||
129493560|NCT02078713|466099980|FG000|Overall Study|Pregnant at baseline|3|||
129493561|NCT02078713|466099981|FG001|Overall Study|Pregnant at baseline|5|||
129493562|NCT02078713|466099982|FG002|Overall Study|Pregnant at baseline|0|||
129493563|NCT02078713|466099983|FG003|Overall Study|Pregnant at baseline|0|||
129493564|NCT02078713|466099980|FG000|Overall Study|Enrolled twice|0|||
129493565|NCT02078713|466099981|FG001|Overall Study|Enrolled twice|1|||
129493566|NCT02078713|466099982|FG002|Overall Study|Enrolled twice|0|||
129493567|NCT02078713|466099983|FG003|Overall Study|Enrolled twice|0|||
129493568|NCT00696657|466099988|FG000|Overall Study|Protocol Violation|0|||
129493569|NCT00696657|466099989|FG001|Overall Study|Protocol Violation|0|||
129493570|NCT00696657|466099990|FG002|Overall Study|Protocol Violation|0|||
129493571|NCT00696657|466099991|FG003|Overall Study|Protocol Violation|0|||
129493572|NCT00696657|466099992|FG004|Overall Study|Protocol Violation|0|||
129493573|NCT00696657|466099993|FG005|Overall Study|Protocol Violation|1|||
129493574|NCT00696657|466099994|FG006|Overall Study|Protocol Violation|0|||
129493575|NCT00696657|466099995|FG007|Overall Study|Protocol Violation|0|||
129493576|NCT00696657|466099996|FG008|Overall Study|Protocol Violation|1|||
129493577|NCT00696657|466099988|FG000|Overall Study|Lack of Efficacy|0|||
129493578|NCT00696657|466099989|FG001|Overall Study|Lack of Efficacy|1|||
129493579|NCT00696657|466099990|FG002|Overall Study|Lack of Efficacy|0|||
129493580|NCT00696657|466099991|FG003|Overall Study|Lack of Efficacy|0|||
129493581|NCT00696657|466099992|FG004|Overall Study|Lack of Efficacy|0|||
129493582|NCT00696657|466099993|FG005|Overall Study|Lack of Efficacy|0|||
129493583|NCT00696657|466099994|FG006|Overall Study|Lack of Efficacy|0|||
129493584|NCT00696657|466099995|FG007|Overall Study|Lack of Efficacy|0|||
129493585|NCT00696657|466099996|FG008|Overall Study|Lack of Efficacy|0|||
129493586|NCT00696657|466099988|FG000|Overall Study|Withdrawal criteria|1|||
129493587|NCT00696657|466099989|FG001|Overall Study|Withdrawal criteria|3|||
129493588|NCT00696657|466099990|FG002|Overall Study|Withdrawal criteria|2|||
129493589|NCT00696657|466099991|FG003|Overall Study|Withdrawal criteria|2|||
129493590|NCT00696657|466099992|FG004|Overall Study|Withdrawal criteria|0|||
129493591|NCT00696657|466099993|FG005|Overall Study|Withdrawal criteria|0|||
129493592|NCT00696657|466099994|FG006|Overall Study|Withdrawal criteria|1|||
129493593|NCT00696657|466099995|FG007|Overall Study|Withdrawal criteria|1|||
129493594|NCT00696657|466099996|FG008|Overall Study|Withdrawal criteria|2|||
129493595|NCT00696657|466099988|FG000|Overall Study|Unclassified|0|||
129493596|NCT00696657|466099989|FG001|Overall Study|Unclassified|1|||
129493597|NCT00696657|466099990|FG002|Overall Study|Unclassified|3|||
129493598|NCT00696657|466099991|FG003|Overall Study|Unclassified|2|||
129493599|NCT00696657|466099992|FG004|Overall Study|Unclassified|4|||
129493600|NCT00696657|466099993|FG005|Overall Study|Unclassified|2|||
129493601|NCT00696657|466099994|FG006|Overall Study|Unclassified|0|||
129493602|NCT00696657|466099995|FG007|Overall Study|Unclassified|0|||
129493603|NCT00696657|466099996|FG008|Overall Study|Unclassified|1|||
129493604|NCT00696657|466099988|FG000|Overall Study|Adverse Event|0|||
129493605|NCT00696657|466099989|FG001|Overall Study|Adverse Event|0|||
129493606|NCT00696657|466099990|FG002|Overall Study|Adverse Event|3|||
129493607|NCT00696657|466099991|FG003|Overall Study|Adverse Event|7|||
129493608|NCT00696657|466099992|FG004|Overall Study|Adverse Event|6|||
129493609|NCT00696657|466099993|FG005|Overall Study|Adverse Event|9|||
129493610|NCT00696657|466099994|FG006|Overall Study|Adverse Event|14|||
129493611|NCT00696657|466099995|FG007|Overall Study|Adverse Event|2|||
129493612|NCT00696657|466099996|FG008|Overall Study|Adverse Event|5|||
129493613|NCT01790438|466099997|FG000|Overall Study|Adverse Event|3|||
129493614|NCT01790438|466099998|FG001|Overall Study|Adverse Event|2|||
129493615|NCT01790438|466099997|FG000|Overall Study|Death|4|||
129493616|NCT01790438|466099998|FG001|Overall Study|Death|0|||
129493617|NCT01790438|466099997|FG000|Overall Study|Lost to Follow-up|5|||
129493618|NCT01790438|466099998|FG001|Overall Study|Lost to Follow-up|2|||
129493619|NCT01790438|466099997|FG000|Overall Study|Withdrawal by Subject|13|||
129493620|NCT01790438|466099998|FG001|Overall Study|Withdrawal by Subject|2|||
129493621|NCT01790438|466099997|FG000|Overall Study|Physician Decision|3|||
129493622|NCT01790438|466099998|FG001|Overall Study|Physician Decision|1|||
129493623|NCT01790438|466099997|FG000|Overall Study|Sponsor Decision|0|||
129493624|NCT01790438|466099998|FG001|Overall Study|Sponsor Decision|3|||
129493625|NCT01790438|466099997|FG000|Overall Study|Protocol Required Discontinuation|7|||
129493626|NCT01790438|466099998|FG001|Overall Study|Protocol Required Discontinuation|1|||
129493627|NCT02090114|466100002|FG000|Overall Study|Withdrawal by Subject|3|||
129493628|NCT02090114|466100003|FG001|Overall Study|Withdrawal by Subject|6|||
129493629|NCT02090114|466100004|FG002|Overall Study|Withdrawal by Subject|2|||
129493630|NCT02090114|466100005|FG003|Overall Study|Withdrawal by Subject|1|||
129493631|NCT02090114|466100002|FG000|Overall Study|Physician Decision|5|||
129493632|NCT02090114|466100003|FG001|Overall Study|Physician Decision|0|||
129493633|NCT02090114|466100004|FG002|Overall Study|Physician Decision|1|||
129493634|NCT02090114|466100005|FG003|Overall Study|Physician Decision|1|||
129493635|NCT02090114|466100002|FG000|Overall Study|Adverse Event|1|||
129493636|NCT02090114|466100003|FG001|Overall Study|Adverse Event|2|||
129493637|NCT02090114|466100004|FG002|Overall Study|Adverse Event|2|||
129493638|NCT02090114|466100005|FG003|Overall Study|Adverse Event|0|||
129493639|NCT02090114|466100002|FG000|Overall Study|Progressive Disease|20|||
129493640|NCT02090114|466100003|FG001|Overall Study|Progressive Disease|21|||
129493641|NCT02090114|466100004|FG002|Overall Study|Progressive Disease|23|||
129493642|NCT02090114|466100005|FG003|Overall Study|Progressive Disease|6|||
129493643|NCT02090114|466100002|FG000|Overall Study|Death|1|||
129493644|NCT02090114|466100003|FG001|Overall Study|Death|0|||
129493645|NCT02090114|466100004|FG002|Overall Study|Death|1|||
129493646|NCT02090114|466100005|FG003|Overall Study|Death|0|||
129493647|NCT01989546|466100006|FG000|Overall Study|Clinical Progression|1|||
129493648|NCT01989546|466100006|FG000|Overall Study|Disease progression on study|8|||
129493649|NCT04439838|466100009|FG000|Overall Study|Withdrawal by Subject|0|||
129493650|NCT04439838|466100010|FG001|Overall Study|Withdrawal by Subject|0|||
129493651|NCT04439838|466100011|FG002|Overall Study|Withdrawal by Subject|0|||
129493652|NCT04439838|466100012|FG003|Overall Study|Withdrawal by Subject|0|||
129493653|NCT04439838|466100013|FG004|Overall Study|Withdrawal by Subject|0|||
129493654|NCT04439838|466100014|FG005|Overall Study|Withdrawal by Subject|0|||
129493655|NCT04439838|466100015|FG006|Overall Study|Withdrawal by Subject|0|||
129493656|NCT04439838|466100016|FG007|Overall Study|Withdrawal by Subject|0|||
129493657|NCT04439838|466100017|FG008|Overall Study|Withdrawal by Subject|1|||
129493658|NCT04494633|466100018|FG000|Overall Study|Lost to Follow-up|5|||
129493659|NCT04494633|466100019|FG001|Overall Study|Lost to Follow-up|3|||
129493660|NCT04494633|466100018|FG000|Overall Study|Protocol Violation|1|||
129493661|NCT04494633|466100019|FG001|Overall Study|Protocol Violation|1|||
129493662|NCT00414310|466100020|FG000|Overall Study|Not treated|1|||
129493663|NCT00414310|466100021|FG001|Overall Study|Not treated|0|||
129493664|NCT01254604|466100022|FG000|Overall Study|Lost to Follow-up|1|||
129493665|NCT01254604|466100023|FG001|Overall Study|Lost to Follow-up|1|||
129493666|NCT01254604|466100022|FG000|Overall Study|Protocol Violation|2|||
129493667|NCT01254604|466100023|FG001|Overall Study|Protocol Violation|2|||
129493668|NCT01254604|466100022|FG000|Overall Study|Withdrawal by Subject|2|||
129493669|NCT01254604|466100023|FG001|Overall Study|Withdrawal by Subject|4|||
129493670|NCT01254604|466100022|FG000|Overall Study|Adverse Event|3|||
129493671|NCT01254604|466100023|FG001|Overall Study|Adverse Event|2|||
129493672|NCT03074162|466100024|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
129493673|NCT03074162|466100025|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
129493674|NCT03074162|466100026|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
129493675|NCT03074162|466100027|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
129493676|NCT03074162|466100028|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
129493677|NCT03074162|466100029|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
129493678|NCT03074162|466100024|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
129493679|NCT03074162|466100025|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
129493680|NCT03074162|466100026|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
129493681|NCT03074162|466100027|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
129493682|NCT03074162|466100028|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
129493683|NCT03074162|466100029|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
129493684|NCT03074162|466100024|FG000|Period 3|Withdrawal by Subject|1|||
129493685|NCT03074162|466100025|FG001|Period 3|Withdrawal by Subject|0|||
129493686|NCT03074162|466100026|FG002|Period 3|Withdrawal by Subject|0|||
129493687|NCT03074162|466100027|FG003|Period 3|Withdrawal by Subject|0|||
129493688|NCT03074162|466100028|FG004|Period 3|Withdrawal by Subject|1|||
129493689|NCT03074162|466100029|FG005|Period 3|Withdrawal by Subject|0|||
129493690|NCT02948777|466100030|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
129493691|NCT02311478|466100031|FG000|Overall Study|Withdrawal by Subject|1|||
129493692|NCT02311478|466100031|FG000|Overall Study|Lost to Follow-up|5|||
129493693|NCT02311478|466100031|FG000|Overall Study|Failed IUD Insertion|1|||
129493694|NCT03242928|466100032|FG000|Overall Study|Adverse Event|2|||
129493695|NCT03242928|466100033|FG001|Overall Study|Adverse Event|1|||
129493696|NCT03242928|466100032|FG000|Overall Study|Lost to Follow-up|2|||
129493697|NCT03242928|466100033|FG001|Overall Study|Lost to Follow-up|0|||
129493698|NCT03242928|466100032|FG000|Overall Study|Physician Decision|0|||
129493699|NCT03242928|466100033|FG001|Overall Study|Physician Decision|1|||
129493700|NCT03242928|466100032|FG000|Overall Study|Withdrawal by Subject|5|||
129493701|NCT03242928|466100033|FG001|Overall Study|Withdrawal by Subject|3|||
129493702|NCT00390780|466100034|FG000|Overall Study|Not completed|10|||
129493703|NCT00390780|466100035|FG001|Overall Study|Not completed|4|||
129493704|NCT00390780|466100034|FG000|Overall Study|Protocol Violation|6|||
129493705|NCT00390780|466100035|FG001|Overall Study|Protocol Violation|4|||
129493706|NCT00390780|466100034|FG000|Overall Study|Lost to Follow-up|3|||
129493707|NCT00390780|466100035|FG001|Overall Study|Lost to Follow-up|6|||
129980855|NCT02045875|467893386|FG001|Overall Study|Withdrawal by Subject|3|||
129980856|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
129980857|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
129980858|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
129980859|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
129980860|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
129980861|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
129980862|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
129980863|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
129980864|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
129980865|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
129980866|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Adverse Event|0|||
129980867|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Adverse Event|0|||
129980868|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Adverse Event|3|||
129980869|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Adverse Event|2|||
129980870|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Adverse Event|13|||
129980871|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
129980872|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
129980873|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
129980874|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
129980875|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
129980876|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Patient's wish|0|||
129980877|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Patient's wish|0|||
129980878|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Patient's wish|19|||
129980879|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Patient's wish|9|||
129980880|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Patient's wish|20|||
129980881|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
129980882|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
129980883|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
129980884|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
129980885|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
129980886|NCT00444275|467893387|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
129980887|NCT00444275|467893388|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
129980888|NCT00444275|467893389|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
129980889|NCT00444275|467893390|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
129980890|NCT00444275|467893391|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
129980891|NCT00743431|467893395|FG000|Overall Study|Toxicity|6|||
129980892|NCT00743431|467893395|FG000|Overall Study|Tumor progression|56|||
129493708|NCT00390780|466100034|FG000|Overall Study|Adverse Event|2|||
129493709|NCT00390780|466100035|FG001|Overall Study|Adverse Event|3|||
129980893|NCT00743431|467893395|FG000|Overall Study|Withdrawal by Subject|13|||
129980894|NCT00743431|467893395|FG000|Overall Study|Death|9|||
129980895|NCT00743431|467893395|FG000|Overall Study|Reason for discontinuation not specified|29|||
129493710|NCT00390780|466100034|FG000|Overall Study|Death|1|||
129493711|NCT00390780|466100035|FG001|Overall Study|Death|3|||
129493712|NCT00390780|466100034|FG000|Overall Study|Withdrawal by Subject|1|||
129493713|NCT00390780|466100035|FG001|Overall Study|Withdrawal by Subject|2|||
129493714|NCT00390780|466100034|FG000|Overall Study|Inclusion criteria not satisfied|0|||
129493715|NCT00390780|466100035|FG001|Overall Study|Inclusion criteria not satisfied|2|||
129493716|NCT00390780|466100034|FG000|Overall Study|Lost to follow up and other reasons|0|||
129493717|NCT00390780|466100035|FG001|Overall Study|Lost to follow up and other reasons|1|||
129493718|NCT00390780|466100034|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
129493719|NCT00390780|466100035|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
129493720|NCT00390780|466100034|FG000|Overall Study|SAE, death|0|||
129493721|NCT00390780|466100035|FG001|Overall Study|SAE, death|1|||
129493722|NCT00109733|466100036|FG000|Overall Study|Protocol Violation|0|||
129493723|NCT00109733|466100037|FG001|Overall Study|Protocol Violation|1|||
129493724|NCT00109733|466100036|FG000|Overall Study|Stopped taking study drug|1|||
129493725|NCT00109733|466100037|FG001|Overall Study|Stopped taking study drug|1|||
129493726|NCT00109733|466100036|FG000|Overall Study|Non-compliant|0|||
129493727|NCT00109733|466100037|FG001|Overall Study|Non-compliant|1|||
129493728|NCT00109733|466100036|FG000|Overall Study|Could not commit time for study|1|||
129493729|NCT00109733|466100037|FG001|Overall Study|Could not commit time for study|1|||
129493730|NCT03332667|466100042|FG000|Overall Study|Adverse Event|0|||
129493731|NCT03332667|466100043|FG001|Overall Study|Adverse Event|0|||
129493732|NCT03332667|466100044|FG002|Overall Study|Adverse Event|2|||
129493733|NCT03332667|466100045|FG003|Overall Study|Adverse Event|1|||
129493734|NCT03332667|466100042|FG000|Overall Study|Withdrawal by Subject|2|||
129493735|NCT03332667|466100043|FG001|Overall Study|Withdrawal by Subject|1|||
129493736|NCT03332667|466100044|FG002|Overall Study|Withdrawal by Subject|5|||
129493737|NCT03332667|466100045|FG003|Overall Study|Withdrawal by Subject|1|||
129493738|NCT03332667|466100042|FG000|Overall Study|Disease Progression or Relapse|2|||
129493739|NCT03332667|466100043|FG001|Overall Study|Disease Progression or Relapse|1|||
129493740|NCT03332667|466100044|FG002|Overall Study|Disease Progression or Relapse|3|||
129493741|NCT03332667|466100045|FG003|Overall Study|Disease Progression or Relapse|0|||
129493742|NCT03332667|466100042|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
129493743|NCT03332667|466100043|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
129493744|NCT03332667|466100044|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
129493745|NCT03332667|466100045|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
129493746|NCT03332667|466100042|FG000|Overall Study|No Treatment Received|0|||
129493747|NCT03332667|466100043|FG001|Overall Study|No Treatment Received|0|||
129493748|NCT03332667|466100044|FG002|Overall Study|No Treatment Received|1|||
129493749|NCT03332667|466100045|FG003|Overall Study|No Treatment Received|0|||
129493750|NCT04964063|466100046|FG000|Overall Study|Adverse Event|4|||
129493751|NCT04964063|466100046|FG000|Overall Study|Lost to Follow-up|47|||
129493752|NCT04964063|466100046|FG000|Overall Study|Withdrawal by Subject|5|||
129493753|NCT04964063|466100046|FG000|Overall Study|Baseline Tasks Expired|41|||
129493754|NCT04964063|466100046|FG000|Overall Study|Participant withdrawn in error|1|||
129493755|NCT01035606|466100047|FG000|Overall Study|change in health, job demands,family|3|||
129493756|NCT01035606|466100048|FG001|Overall Study|change in health, job demands,family|3|||
129493757|NCT01035606|466100049|FG002|Overall Study|change in health, job demands,family|4|||
129493758|NCT03350750|466100050|FG000|Overall Study|Death|1|||
129493759|NCT03350750|466100051|FG001|Overall Study|Death|1|||
129493760|NCT02433288|466100052|FG000|Overall Study|Severe non-compliance to protocol|13|||
129493761|NCT02433288|466100053|FG001|Overall Study|Severe non-compliance to protocol|7|||
129493762|NCT02433288|466100052|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
129493763|NCT02433288|466100053|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
129493764|NCT02433288|466100052|FG000|Overall Study|Withdrawal by Subject|101|||
129493765|NCT02433288|466100053|FG001|Overall Study|Withdrawal by Subject|99|||
129493766|NCT02433288|466100052|FG000|Overall Study|Lost to Follow-up|2|||
129493767|NCT02433288|466100053|FG001|Overall Study|Lost to Follow-up|14|||
129493768|NCT02433288|466100052|FG000|Overall Study|Death|0|||
129493769|NCT02433288|466100053|FG001|Overall Study|Death|3|||
129493770|NCT01849250|466100054|FG000|Overall Study|Withdrawal by Subject|1|||
129493771|NCT01849250|466100055|FG001|Overall Study|Withdrawal by Subject|0|||
129493772|NCT01849250|466100054|FG000|Overall Study|Not Evaluable|5|||
129493773|NCT01849250|466100055|FG001|Overall Study|Not Evaluable|3|||
129493774|NCT01849250|466100054|FG000|Overall Study|Screen Failure|1|||
129493775|NCT01849250|466100055|FG001|Overall Study|Screen Failure|0|||
129493776|NCT00257192|466100058|FG000|Overall Study|Adverse Event|21|||
129493777|NCT00257192|466100059|FG001|Overall Study|Adverse Event|10|||
129493778|NCT00257192|466100058|FG000|Overall Study|Laboratory abnormality|1|||
129493779|NCT00257192|466100059|FG001|Overall Study|Laboratory abnormality|1|||
129493780|NCT00257192|466100058|FG000|Overall Study|Lost to Follow-up|3|||
129493781|NCT00257192|466100059|FG001|Overall Study|Lost to Follow-up|3|||
129493782|NCT00257192|466100058|FG000|Overall Study|Insufficient clinical response|18|||
129493783|NCT00257192|466100059|FG001|Overall Study|Insufficient clinical response|18|||
129493784|NCT00257192|466100058|FG000|Overall Study|Withdrawal by Subject|14|||
129493785|NCT00257192|466100059|FG001|Overall Study|Withdrawal by Subject|2|||
129493786|NCT00257192|466100058|FG000|Overall Study|Randomized but not treated|0|||
129493787|NCT00257192|466100059|FG001|Overall Study|Randomized but not treated|1|||
129493788|NCT00257192|466100058|FG000|Overall Study|Study terminated by sponsor|1|||
129493789|NCT00257192|466100059|FG001|Overall Study|Study terminated by sponsor|0|||
129493790|NCT00257192|466100058|FG000|Overall Study|Miscellaneous|0|||
129493791|NCT00257192|466100059|FG001|Overall Study|Miscellaneous|4|||
129493792|NCT00570739|466100060|FG000|Overall Study|Adverse Event|8|||
129493793|NCT00570739|466100061|FG001|Overall Study|Adverse Event|6|||
129493794|NCT00570739|466100062|FG002|Overall Study|Adverse Event|2|||
129493795|NCT00570739|466100063|FG003|Overall Study|Adverse Event|2|||
129493796|NCT00570739|466100060|FG000|Overall Study|Lost to Follow-up|4|||
129493797|NCT00570739|466100061|FG001|Overall Study|Lost to Follow-up|5|||
129493798|NCT00570739|466100062|FG002|Overall Study|Lost to Follow-up|4|||
129493799|NCT00570739|466100063|FG003|Overall Study|Lost to Follow-up|1|||
129493800|NCT00570739|466100060|FG000|Overall Study|Physician Decision|1|||
129493801|NCT00570739|466100061|FG001|Overall Study|Physician Decision|1|||
129493802|NCT00570739|466100062|FG002|Overall Study|Physician Decision|0|||
129493803|NCT00570739|466100063|FG003|Overall Study|Physician Decision|0|||
129493804|NCT00570739|466100060|FG000|Overall Study|Withdrawal by Subject|7|||
129493805|NCT00570739|466100061|FG001|Overall Study|Withdrawal by Subject|7|||
129493806|NCT00570739|466100062|FG002|Overall Study|Withdrawal by Subject|3|||
129493807|NCT00570739|466100063|FG003|Overall Study|Withdrawal by Subject|5|||
129493808|NCT00570739|466100060|FG000|Overall Study|Required restricted medication|0|||
129493809|NCT00570739|466100061|FG001|Overall Study|Required restricted medication|0|||
129493810|NCT00570739|466100062|FG002|Overall Study|Required restricted medication|1|||
129493811|NCT00570739|466100063|FG003|Overall Study|Required restricted medication|0|||
129493812|NCT00570739|466100060|FG000|Overall Study|Met discontinuation criteria|1|||
129493813|NCT00570739|466100061|FG001|Overall Study|Met discontinuation criteria|0|||
129493814|NCT00570739|466100062|FG002|Overall Study|Met discontinuation criteria|1|||
129493815|NCT00570739|466100063|FG003|Overall Study|Met discontinuation criteria|1|||
129493816|NCT00570739|466100060|FG000|Overall Study|Other|0|||
129493817|NCT00570739|466100061|FG001|Overall Study|Other|2|||
129493818|NCT00570739|466100062|FG002|Overall Study|Other|5|||
129493819|NCT00570739|466100063|FG003|Overall Study|Other|3|||
129493820|NCT01844700|466100068|FG000|Overall Study|Lack of Efficacy|1|||
129493821|NCT01844700|466100069|FG001|Overall Study|Lack of Efficacy|0|||
129493822|NCT01844700|466100068|FG000|Overall Study|refused medication switch|1|||
129493823|NCT01844700|466100069|FG001|Overall Study|refused medication switch|0|||
129493824|NCT01844700|466100068|FG000|Overall Study|Withdrawal by Subject|1|||
129493825|NCT01844700|466100069|FG001|Overall Study|Withdrawal by Subject|0|||
129493826|NCT01844700|466100068|FG000|Overall Study|stopped taking meds|0|||
129493827|NCT01844700|466100069|FG001|Overall Study|stopped taking meds|1|||
129493828|NCT02375698|466100070|FG000|Overall Study|Withdrawal by Subject|0|||
129493829|NCT02375698|466100071|FG001|Overall Study|Withdrawal by Subject|2|||
129493830|NCT02375698|466100070|FG000|Overall Study|Physician Decision|2|||
129493831|NCT02375698|466100071|FG001|Overall Study|Physician Decision|0|||
129493832|NCT02680847|466100072|FG000|Overall Study|Other|2|||
129493833|NCT02680847|466100073|FG001|Overall Study|Other|0|||
129493834|NCT02680847|466100074|FG002|Overall Study|Other|0|||
129493835|NCT02680847|466100072|FG000|Overall Study|No longer met eligibility criteria|2|||
129493836|NCT02680847|466100073|FG001|Overall Study|No longer met eligibility criteria|2|||
129493837|NCT02680847|466100074|FG002|Overall Study|No longer met eligibility criteria|0|||
129493838|NCT02680847|466100072|FG000|Overall Study|Unwilling to participate in study|1|||
129493839|NCT02680847|466100073|FG001|Overall Study|Unwilling to participate in study|1|||
129493840|NCT02680847|466100074|FG002|Overall Study|Unwilling to participate in study|0|||
129493841|NCT02680847|466100072|FG000|Overall Study|Lack of Efficacy|0|||
129493842|NCT02680847|466100073|FG001|Overall Study|Lack of Efficacy|0|||
129493843|NCT02680847|466100074|FG002|Overall Study|Lack of Efficacy|2|||
129493844|NCT02680847|466100072|FG000|Overall Study|Adverse Event|0|||
129493845|NCT02680847|466100073|FG001|Overall Study|Adverse Event|0|||
129493846|NCT02680847|466100074|FG002|Overall Study|Adverse Event|1|||
129493847|NCT00803244|466100077|FG000|Overall Study|Adverse Event|1|||
129493848|NCT00803244|466100078|FG001|Overall Study|Adverse Event|2|||
129493849|NCT00803244|466100077|FG000|Overall Study|Withdrawal by Subject|2|||
129493850|NCT00803244|466100078|FG001|Overall Study|Withdrawal by Subject|3|||
129493851|NCT00803244|466100077|FG000|Overall Study|Any other reason not above-mentioned|4|||
129493852|NCT00803244|466100078|FG001|Overall Study|Any other reason not above-mentioned|10|||
129493853|NCT00616239|466100079|FG000|Overall Study|Withdrawal by Subject|2|||
129493854|NCT02873715|466100080|FG000|Overall Study|Lost to Follow-up|84|||
129493855|NCT02873715|466100081|FG001|Overall Study|Lost to Follow-up|94|||
129493856|NCT02873715|466100080|FG000|Overall Study|Withdrawal by Subject|7|||
129493857|NCT02873715|466100081|FG001|Overall Study|Withdrawal by Subject|26|||
129493858|NCT02021812|466100085|FG000|Overall Study|Death|8|||
129493859|NCT02021812|466100085|FG000|Overall Study|Withdrawal by Subject|3|||
129493860|NCT02021812|466100085|FG000|Overall Study|Lost to Follow-up|2|||
129493861|NCT02021812|466100085|FG000|Overall Study|Refuse to return, COVD 19|2|||
129493862|NCT00564629|466100086|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
129493863|NCT00564629|466100087|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
129493864|NCT03241173|466100088|FG000|Overall Study|Death|3|||
129493865|NCT03241173|466100089|FG001|Overall Study|Death|2|||
129493866|NCT03241173|466100090|FG002|Overall Study|Death|4|||
129493867|NCT03241173|466100091|FG003|Overall Study|Death|4|||
129493868|NCT03241173|466100092|FG004|Overall Study|Death|2|||
129493869|NCT03241173|466100093|FG005|Overall Study|Death|2|||
129493870|NCT03241173|466100094|FG006|Overall Study|Death|3|||
129493871|NCT03241173|466100095|FG007|Overall Study|Death|1|||
129493872|NCT03241173|466100096|FG008|Overall Study|Death|0|||
129493873|NCT03241173|466100097|FG009|Overall Study|Death|5|||
129493874|NCT03241173|466100098|FG010|Overall Study|Death|4|||
129493875|NCT03241173|466100099|FG011|Overall Study|Death|3|||
129493876|NCT03241173|466100100|FG012|Overall Study|Death|0|||
129493877|NCT03241173|466100101|FG013|Overall Study|Death|0|||
129493878|NCT03241173|466100102|FG014|Overall Study|Death|0|||
129493879|NCT03241173|466100088|FG000|Overall Study|Withdrawal by Subject|0|||
129493880|NCT03241173|466100089|FG001|Overall Study|Withdrawal by Subject|0|||
129493881|NCT03241173|466100090|FG002|Overall Study|Withdrawal by Subject|1|||
129493882|NCT03241173|466100091|FG003|Overall Study|Withdrawal by Subject|0|||
129493883|NCT03241173|466100092|FG004|Overall Study|Withdrawal by Subject|0|||
129493884|NCT03241173|466100093|FG005|Overall Study|Withdrawal by Subject|1|||
129493885|NCT03241173|466100094|FG006|Overall Study|Withdrawal by Subject|0|||
129493886|NCT03241173|466100095|FG007|Overall Study|Withdrawal by Subject|0|||
129493887|NCT03241173|466100096|FG008|Overall Study|Withdrawal by Subject|0|||
129980896|NCT00743431|467893395|FG000|Overall Study|No documentation available|13|||
129980897|NCT03291288|467893396|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
129980898|NCT03291288|467893397|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
129980899|NCT03291288|467893396|FG000|Drug-drug Interaction Phase|Disease progression|1|||
129980900|NCT03291288|467893397|FG001|Drug-drug Interaction Phase|Disease progression|0|||
129980901|NCT03291288|467893396|FG000|Drug-drug Interaction Phase|Other|3|||
129980902|NCT03291288|467893397|FG001|Drug-drug Interaction Phase|Other|0|||
129980903|NCT03291288|467893396|FG000|Pexidartinib Only|Ongoing|0|||
129980904|NCT03291288|467893397|FG001|Pexidartinib Only|Ongoing|2|||
129980905|NCT04276415|467893398|FG000|Overall Study|Adverse Event|0|||
129980906|NCT04276415|467893399|FG001|Overall Study|Adverse Event|0|||
129980907|NCT04276415|467893400|FG002|Overall Study|Adverse Event|0|||
129980908|NCT04276415|467893401|FG003|Overall Study|Adverse Event|3|||
129980909|NCT04276415|467893402|FG004|Overall Study|Adverse Event|0|||
129980910|NCT04276415|467893403|FG005|Overall Study|Adverse Event|0|||
129980911|NCT04276415|467893398|FG000|Overall Study|Clinical progression|1|||
129980912|NCT04276415|467893399|FG001|Overall Study|Clinical progression|1|||
129980913|NCT04276415|467893400|FG002|Overall Study|Clinical progression|0|||
129980914|NCT04276415|467893401|FG003|Overall Study|Clinical progression|0|||
129980915|NCT04276415|467893402|FG004|Overall Study|Clinical progression|1|||
129980916|NCT04276415|467893403|FG005|Overall Study|Clinical progression|0|||
129980917|NCT04276415|467893398|FG000|Overall Study|Other|0|||
129980918|NCT04276415|467893399|FG001|Overall Study|Other|0|||
129980919|NCT04276415|467893400|FG002|Overall Study|Other|0|||
129980920|NCT04276415|467893401|FG003|Overall Study|Other|1|||
129980921|NCT04276415|467893402|FG004|Overall Study|Other|0|||
129980922|NCT04276415|467893403|FG005|Overall Study|Other|0|||
129980923|NCT04276415|467893398|FG000|Overall Study|Physician Decision|0|||
129980924|NCT04276415|467893399|FG001|Overall Study|Physician Decision|0|||
129980925|NCT04276415|467893400|FG002|Overall Study|Physician Decision|1|||
129980926|NCT04276415|467893401|FG003|Overall Study|Physician Decision|3|||
129980927|NCT04276415|467893402|FG004|Overall Study|Physician Decision|2|||
129980928|NCT04276415|467893403|FG005|Overall Study|Physician Decision|0|||
129980929|NCT04276415|467893398|FG000|Overall Study|Progressive disease|3|||
129980930|NCT04276415|467893399|FG001|Overall Study|Progressive disease|3|||
129980931|NCT04276415|467893400|FG002|Overall Study|Progressive disease|4|||
129980932|NCT04276415|467893401|FG003|Overall Study|Progressive disease|5|||
129980933|NCT04276415|467893402|FG004|Overall Study|Progressive disease|1|||
129980934|NCT04276415|467893403|FG005|Overall Study|Progressive disease|2|||
129493888|NCT03241173|466100097|FG009|Overall Study|Withdrawal by Subject|0|||
129980935|NCT04276415|467893398|FG000|Overall Study|Withdrawal by patient|0|||
129980936|NCT04276415|467893399|FG001|Overall Study|Withdrawal by patient|0|||
129980937|NCT04276415|467893400|FG002|Overall Study|Withdrawal by patient|0|||
129980938|NCT04276415|467893401|FG003|Overall Study|Withdrawal by patient|1|||
129980939|NCT04276415|467893402|FG004|Overall Study|Withdrawal by patient|2|||
129493889|NCT03241173|466100098|FG010|Overall Study|Withdrawal by Subject|0|||
129980940|NCT04276415|467893403|FG005|Overall Study|Withdrawal by patient|0|||
129980941|NCT03309813|467893404|FG000|Main Randomized Study|Withdrawal by Subject|1|||
129493890|NCT03241173|466100099|FG011|Overall Study|Withdrawal by Subject|0|||
129493891|NCT03241173|466100100|FG012|Overall Study|Withdrawal by Subject|0|||
129493892|NCT03241173|466100101|FG013|Overall Study|Withdrawal by Subject|0|||
129493893|NCT03241173|466100102|FG014|Overall Study|Withdrawal by Subject|0|||
129980942|NCT03309813|467893405|FG001|Main Randomized Study|Withdrawal by Subject|0|||
129980943|NCT01989169|467893408|FG000|Period 2|Adverse Event|0|||
129493894|NCT03241173|466100088|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
129493895|NCT03241173|466100089|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
129980944|NCT01989169|467893409|FG001|Period 2|Adverse Event|1|||
129493896|NCT03241173|466100090|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
129493897|NCT03241173|466100091|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
129493898|NCT03241173|466100092|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
129493899|NCT03241173|466100093|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
129493900|NCT03241173|466100094|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
129493901|NCT03241173|466100095|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
129493902|NCT03241173|466100096|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
129493903|NCT03241173|466100097|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
129493904|NCT03241173|466100098|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
129493905|NCT03241173|466100099|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
129493906|NCT03241173|466100100|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
129493907|NCT03241173|466100101|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
129493908|NCT03241173|466100102|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
129493909|NCT03241173|466100088|FG000|Overall Study|Lost to Follow-up|0|||
129493910|NCT03241173|466100089|FG001|Overall Study|Lost to Follow-up|0|||
129493911|NCT03241173|466100090|FG002|Overall Study|Lost to Follow-up|0|||
129493912|NCT03241173|466100091|FG003|Overall Study|Lost to Follow-up|0|||
129493913|NCT03241173|466100092|FG004|Overall Study|Lost to Follow-up|1|||
129493914|NCT03241173|466100093|FG005|Overall Study|Lost to Follow-up|0|||
129493915|NCT03241173|466100094|FG006|Overall Study|Lost to Follow-up|0|||
129493916|NCT03241173|466100095|FG007|Overall Study|Lost to Follow-up|0|||
129493917|NCT03241173|466100096|FG008|Overall Study|Lost to Follow-up|0|||
129493918|NCT03241173|466100097|FG009|Overall Study|Lost to Follow-up|1|||
129980945|NCT02406677|467893410|FG000|Overall Study|Death|16|||
129980946|NCT02406677|467893411|FG001|Overall Study|Death|8|||
129980947|NCT02406677|467893410|FG000|Overall Study|Discharged without P2Y12|1|||
129980948|NCT02406677|467893411|FG001|Overall Study|Discharged without P2Y12|3|||
129980949|NCT02406677|467893410|FG000|Overall Study|Discharged on prasugrel|283|||
129980950|NCT02406677|467893411|FG001|Overall Study|Discharged on prasugrel|587|||
129980951|NCT02406677|467893410|FG000|Overall Study|Withdrawal by Subject|1|||
129980952|NCT02406677|467893411|FG001|Overall Study|Withdrawal by Subject|0|||
129980953|NCT04531904|467893412|FG000|Overall Study|Lost to Follow-up|1|||
129980954|NCT04531904|467893412|FG000|Overall Study|Death|14|||
129980955|NCT00283244|467893413|FG000|Overall Study|Adverse Event|0|||
129980956|NCT00283244|467893414|FG001|Overall Study|Adverse Event|8|||
129980957|NCT00283244|467893415|FG002|Overall Study|Adverse Event|11|||
129980958|NCT00283244|467893413|FG000|Overall Study|Death|4|||
129980959|NCT00283244|467893414|FG001|Overall Study|Death|3|||
129980960|NCT00283244|467893415|FG002|Overall Study|Death|2|||
129980961|NCT00283244|467893413|FG000|Overall Study|Lack of Efficacy|8|||
129980962|NCT00283244|467893414|FG001|Overall Study|Lack of Efficacy|32|||
129980963|NCT00283244|467893415|FG002|Overall Study|Lack of Efficacy|26|||
129980964|NCT00283244|467893413|FG000|Overall Study|Withdrawal by Subject|1|||
129980965|NCT00283244|467893414|FG001|Overall Study|Withdrawal by Subject|2|||
129980966|NCT00283244|467893415|FG002|Overall Study|Withdrawal by Subject|2|||
129980967|NCT00283244|467893413|FG000|Overall Study|Physician Decision|0|||
129980968|NCT00283244|467893414|FG001|Overall Study|Physician Decision|0|||
129980969|NCT00283244|467893415|FG002|Overall Study|Physician Decision|1|||
129980970|NCT00283244|467893413|FG000|Overall Study|Medical illness (other complicating dz)|4|||
129980971|NCT00283244|467893414|FG001|Overall Study|Medical illness (other complicating dz)|3|||
129980972|NCT00283244|467893415|FG002|Overall Study|Medical illness (other complicating dz)|6|||
129980973|NCT00283244|467893413|FG000|Overall Study|Clinical deterioration|1|||
129980974|NCT00283244|467893414|FG001|Overall Study|Clinical deterioration|3|||
129980975|NCT00283244|467893415|FG002|Overall Study|Clinical deterioration|3|||
129980976|NCT00586612|467893416|FG000|Primary Phase|Protocol Violation|1|||
129980977|NCT00586612|467893417|FG001|Primary Phase|Protocol Violation|0|||
129980978|NCT00586612|467893416|FG000|Primary Phase|Lost to Follow-up|0|||
129980979|NCT00586612|467893417|FG001|Primary Phase|Lost to Follow-up|1|||
129980980|NCT00586612|467893416|FG000|Primary Phase|Withdrawal by Subject|0|||
129980981|NCT00586612|467893417|FG001|Primary Phase|Withdrawal by Subject|2|||
129980982|NCT00586612|467893416|FG000|Booster Phase|Lost to Follow-up|3|||
129980983|NCT00586612|467893417|FG001|Booster Phase|Lost to Follow-up|1|||
129980984|NCT01609062|467893418|FG000|Extension Phase|Terminated by Sponsor|14|||
129980985|NCT01609062|467893419|FG001|Extension Phase|Terminated by Sponsor|9|||
129980986|NCT01609062|467893418|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
129980987|NCT01609062|467893419|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
129980988|NCT01609062|467893418|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
129980989|NCT01609062|467893419|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
129980990|NCT02738853|467893420|FG000|Enrollment|Inclusion/Exclusion not met|21|||
129980991|NCT02738853|467893420|FG000|Enrollment|Withdrawal by Subject|3|||
129980992|NCT02738853|467893420|FG000|Enrollment|Subject treated with commercially available device|6|||
129980993|NCT02738853|467893420|FG000|Enrollment|Study Enrollment Closed|3|||
129493919|NCT03241173|466100098|FG010|Overall Study|Lost to Follow-up|0|||
129493920|NCT03241173|466100099|FG011|Overall Study|Lost to Follow-up|0|||
129980994|NCT02738853|467893420|FG000|Procedure|Death|1|||
129980995|NCT02738853|467893420|FG000|1 Month|Death|2|||
129980996|NCT02738853|467893420|FG000|6 Month|Death|4|||
129980997|NCT02738853|467893420|FG000|6 Month|Withdrawal by Subject|2|||
129493921|NCT03241173|466100100|FG012|Overall Study|Lost to Follow-up|0|||
129493922|NCT03241173|466100101|FG013|Overall Study|Lost to Follow-up|0|||
129493923|NCT03241173|466100102|FG014|Overall Study|Lost to Follow-up|0|||
129493924|NCT03634072|466100103|FG000|Overall Study|Early termination of overall study|1|||
129493925|NCT03634072|466100104|FG001|Overall Study|Early termination of overall study|0|||
129493926|NCT02144220|466100106|FG000|Overall Study|technology incompatibility|9|||
129493927|NCT02144220|466100106|FG000|Overall Study|Lack of Efficacy|4|||
129493928|NCT02144220|466100106|FG000|Overall Study|Physician Decision|3|||
129493929|NCT02144220|466100106|FG000|Overall Study|Withdrawal by Subject|2|||
129493930|NCT02144220|466100106|FG000|Overall Study|Protocol Violation|1|||
129493931|NCT03648996|466100107|FG000|Overall Study|Withdrawal by Subject|0|||
129493932|NCT03648996|466100108|FG001|Overall Study|Withdrawal by Subject|2|||
129493933|NCT03648996|466100109|FG002|Overall Study|Withdrawal by Subject|2|||
129493934|NCT03648996|466100107|FG000|Overall Study|Physician Decision|2|||
129493935|NCT03648996|466100108|FG001|Overall Study|Physician Decision|0|||
129493936|NCT03648996|466100109|FG002|Overall Study|Physician Decision|0|||
129493937|NCT00590681|466100110|FG000|Overall Study|Withdrawal by Subject|7|||
129493938|NCT00590681|466100110|FG000|Overall Study|Adverse Event|8|||
129493939|NCT00590681|466100110|FG000|Overall Study|Death|3|||
129493940|NCT00590681|466100110|FG000|Overall Study|Lost to Follow-up|1|||
129493941|NCT00590681|466100110|FG000|Overall Study|disease progression|1|||
129493942|NCT00053846|466100116|FG000|Overall Study|Changed mind|8|||
129493943|NCT00053846|466100117|FG001|Overall Study|Changed mind|13|||
129493944|NCT00053846|466100116|FG000|Overall Study|Became too ill|8|||
129493945|NCT00053846|466100117|FG001|Overall Study|Became too ill|7|||
129493946|NCT00053846|466100116|FG000|Overall Study|Expired|5|||
129493947|NCT00053846|466100117|FG001|Overall Study|Expired|0|||
129493948|NCT00053846|466100116|FG000|Overall Study|Became ineligible|3|||
129493949|NCT00053846|466100117|FG001|Overall Study|Became ineligible|1|||
129493950|NCT00053846|466100116|FG000|Overall Study|Did not return data|1|||
129493951|NCT00053846|466100117|FG001|Overall Study|Did not return data|2|||
129493952|NCT00053846|466100116|FG000|Overall Study|Quit due to side effects|1|||
129493953|NCT00053846|466100117|FG001|Overall Study|Quit due to side effects|3|||
129493954|NCT00053846|466100116|FG000|Overall Study|Pills too large|0|||
129493955|NCT00053846|466100117|FG001|Overall Study|Pills too large|1|||
129493956|NCT00064662|466100118|FG000|Overall Study|Death|1|||
129493957|NCT00064662|466100119|FG001|Overall Study|Death|1|||
129493958|NCT00064662|466100118|FG000|Overall Study|Lost to Follow-up|57|||
129493959|NCT00064662|466100119|FG001|Overall Study|Lost to Follow-up|44|||
129493960|NCT00064662|466100118|FG000|Overall Study|Withdrawal by Subject|14|||
129493961|NCT00064662|466100119|FG001|Overall Study|Withdrawal by Subject|14|||
129493962|NCT00064662|466100118|FG000|Overall Study|Administratively withdrawn|2|||
129493963|NCT00064662|466100119|FG001|Overall Study|Administratively withdrawn|2|||
129493964|NCT01929044|466100124|FG000|Overall Study|Adverse Event|1|||
129493965|NCT01929044|466100125|FG001|Overall Study|Adverse Event|0|||
129493966|NCT01929044|466100124|FG000|Overall Study|Protocol Violation|9|||
129493967|NCT01929044|466100125|FG001|Overall Study|Protocol Violation|14|||
129493968|NCT01929044|466100124|FG000|Overall Study|Not Treated|1|||
129493969|NCT01929044|466100125|FG001|Overall Study|Not Treated|3|||
129493970|NCT02807454|466100126|FG000|Overall Study|Adverse Event|1|||
129493971|NCT02807454|466100127|FG001|Overall Study|Adverse Event|0|||
129493972|NCT02807454|466100126|FG000|Overall Study|Withdrawal by Subject|0|||
129493973|NCT02807454|466100127|FG001|Overall Study|Withdrawal by Subject|1|||
129493974|NCT02807454|466100126|FG000|Overall Study|Progressive Disease|30|||
129493975|NCT02807454|466100127|FG001|Overall Study|Progressive Disease|3|||
129493976|NCT02807454|466100126|FG000|Overall Study|Other Reasons|1|||
129493977|NCT02807454|466100127|FG001|Overall Study|Other Reasons|1|||
129493978|NCT02582749|466100128|FG000|Overall Study|Study terminated by funder|5|||
129493979|NCT02582749|466100129|FG001|Overall Study|Study terminated by funder|10|||
129980998|NCT02738853|467893420|FG000|1 Year|Death|6|||
129980999|NCT02738853|467893420|FG000|1 Year|Withdrawal by Subject|1|||
129493980|NCT02582749|466100128|FG000|Overall Study|Withdrawal by Subject|0|||
129493981|NCT02582749|466100129|FG001|Overall Study|Withdrawal by Subject|1|||
129493982|NCT02566525|466100130|FG000|Overall Study|Protocol Violation|3|||
129493983|NCT02566525|466100131|FG001|Overall Study|Protocol Violation|5|||
129493984|NCT01663740|466100132|FG000|Overall Study|Lost to Follow-up|1|||
129493985|NCT01663740|466100133|FG001|Overall Study|Lost to Follow-up|4|||
129493986|NCT01663740|466100132|FG000|Overall Study|Other|9|||
129493987|NCT01663740|466100133|FG001|Overall Study|Other|2|||
129493988|NCT01663740|466100132|FG000|Overall Study|Inclusion/Exclusion not met|1|||
129493989|NCT01663740|466100133|FG001|Overall Study|Inclusion/Exclusion not met|0|||
129493990|NCT01663740|466100132|FG000|Overall Study|Death|0|||
129493991|NCT01663740|466100133|FG001|Overall Study|Death|1|||
129493992|NCT01663740|466100132|FG000|Overall Study|Withdrawal by Subject|2|||
129981000|NCT02738853|467893420|FG000|2 Year|Death|2|||
129493993|NCT01663740|466100133|FG001|Overall Study|Withdrawal by Subject|1|||
129493994|NCT01663740|466100132|FG000|Overall Study|No end of study status|3|||
129493995|NCT01663740|466100133|FG001|Overall Study|No end of study status|0|||
129493996|NCT00059215|466102203|FG000|Overall Study|Adverse Event|5|||
129493997|NCT00059215|466102204|FG001|Overall Study|Adverse Event|5|||
129493998|NCT00059215|466102205|FG002|Overall Study|Adverse Event|9|||
129493999|NCT00059215|466102206|FG003|Overall Study|Adverse Event|9|||
129494000|NCT00059215|466102203|FG000|Overall Study|Death|0|||
129494001|NCT00059215|466102204|FG001|Overall Study|Death|0|||
129494002|NCT00059215|466102205|FG002|Overall Study|Death|3|||
129494003|NCT00059215|466102206|FG003|Overall Study|Death|0|||
129494004|NCT00059215|466102203|FG000|Overall Study|Lost to Follow-up|1|||
129494005|NCT00059215|466102204|FG001|Overall Study|Lost to Follow-up|2|||
129494006|NCT00059215|466102205|FG002|Overall Study|Lost to Follow-up|0|||
129494007|NCT00059215|466102206|FG003|Overall Study|Lost to Follow-up|0|||
129494008|NCT00059215|466102203|FG000|Overall Study|Withdrawal by Subject|4|||
129494009|NCT00059215|466102204|FG001|Overall Study|Withdrawal by Subject|4|||
129494010|NCT00059215|466102205|FG002|Overall Study|Withdrawal by Subject|1|||
129494011|NCT00059215|466102206|FG003|Overall Study|Withdrawal by Subject|3|||
129494012|NCT00059215|466102203|FG000|Overall Study|Protocol Violation|1|||
129494013|NCT00059215|466102204|FG001|Overall Study|Protocol Violation|0|||
129494014|NCT00059215|466102205|FG002|Overall Study|Protocol Violation|1|||
129494015|NCT00059215|466102206|FG003|Overall Study|Protocol Violation|0|||
129494016|NCT00059215|466102203|FG000|Overall Study|Protocol entry criteria not met|1|||
129494017|NCT00059215|466102204|FG001|Overall Study|Protocol entry criteria not met|1|||
129494018|NCT00059215|466102205|FG002|Overall Study|Protocol entry criteria not met|0|||
129494019|NCT00059215|466102206|FG003|Overall Study|Protocol entry criteria not met|2|||
129494020|NCT00059215|466102203|FG000|Overall Study|Physician Decision|1|||
129494021|NCT00059215|466102204|FG001|Overall Study|Physician Decision|2|||
129494022|NCT00059215|466102205|FG002|Overall Study|Physician Decision|1|||
129494023|NCT00059215|466102206|FG003|Overall Study|Physician Decision|1|||
129494024|NCT01993329|466102207|FG000|Period 2|Adverse Event|0|||
129494025|NCT01993329|466102208|FG001|Period 2|Adverse Event|0|||
129494026|NCT01993329|466102209|FG002|Period 2|Adverse Event|0|||
129494027|NCT01993329|466102210|FG003|Period 2|Adverse Event|0|||
129494028|NCT01993329|466102211|FG004|Period 2|Adverse Event|0|||
129494029|NCT01993329|466102212|FG005|Period 2|Adverse Event|1|||
129494030|NCT01993329|466102207|FG000|Wash-out|Personal reasons|0|||
129494031|NCT01993329|466102208|FG001|Wash-out|Personal reasons|1|||
129494032|NCT01993329|466102209|FG002|Wash-out|Personal reasons|0|||
129494033|NCT01993329|466102210|FG003|Wash-out|Personal reasons|0|||
129494034|NCT01993329|466102211|FG004|Wash-out|Personal reasons|0|||
129494035|NCT01993329|466102212|FG005|Wash-out|Personal reasons|0|||
129494036|NCT03276936|466102213|FG000|Overall Study|Adverse Event|4|||
129494037|NCT03276936|466102214|FG001|Overall Study|Adverse Event|2|||
129494038|NCT03276936|466102213|FG000|Overall Study|Lost to Follow-up|16|||
129494039|NCT03276936|466102214|FG001|Overall Study|Lost to Follow-up|13|||
129494040|NCT03276936|466102213|FG000|Overall Study|Withdrawal by Subject|30|||
129494041|NCT03276936|466102214|FG001|Overall Study|Withdrawal by Subject|20|||
129494042|NCT03276936|466102213|FG000|Overall Study|Not mentioned|6|||
129494043|NCT03276936|466102214|FG001|Overall Study|Not mentioned|3|||
129494044|NCT03041116|466102215|FG000|Double-blind|Death|0|||
129494045|NCT03041116|466102216|FG001|Double-blind|Death|2|||
129494046|NCT03041116|466102215|FG000|Double-blind|Withdrawal by Subject|0|||
129494047|NCT03041116|466102216|FG001|Double-blind|Withdrawal by Subject|4|||
129494048|NCT03041116|466102215|FG000|Open-label|Death|1|||
129494049|NCT03041116|466102216|FG001|Open-label|Death|0|||
129494050|NCT03041116|466102215|FG000|Open-label|Termination of the study by Sponsor|39|||
129494051|NCT03041116|466102216|FG001|Open-label|Termination of the study by Sponsor|37|||
129494052|NCT03041116|466102215|FG000|Open-label|Withdrawal by Subject|1|||
129494053|NCT03041116|466102216|FG001|Open-label|Withdrawal by Subject|0|||
129494054|NCT00943319|466102217|FG000|Overall Study|Death|1|||
129494055|NCT02043301|466102218|FG000|Overall Study|Discontinued|0|||
129494056|NCT02043301|466102219|FG001|Overall Study|Discontinued|1|||
129494057|NCT02043301|466102220|FG002|Overall Study|Discontinued|0|||
129494058|NCT01781429|466102224|FG000|Overall Study|Death|0|||
129494059|NCT01781429|466102225|FG001|Overall Study|Death|0|||
129494060|NCT01781429|466102226|FG002|Overall Study|Death|0|||
129494061|NCT01781429|466102227|FG003|Overall Study|Death|0|||
129494062|NCT01781429|466102228|FG004|Overall Study|Death|0|||
129494063|NCT01781429|466102229|FG005|Overall Study|Death|0|||
129494064|NCT01781429|466102230|FG006|Overall Study|Death|0|||
129494065|NCT01781429|466102231|FG007|Overall Study|Death|0|||
129494066|NCT01781429|466102232|FG008|Overall Study|Death|0|||
129494067|NCT01781429|466102233|FG009|Overall Study|Death|1|||
129494068|NCT01781429|466102234|FG010|Overall Study|Death|0|||
129494069|NCT01781429|466102235|FG011|Overall Study|Death|0|||
129494070|NCT01781429|466102236|FG012|Overall Study|Death|1|||
129494071|NCT01781429|466102237|FG013|Overall Study|Death|0|||
129494072|NCT01781429|466102238|FG014|Overall Study|Death|1|||
129494073|NCT01781429|466102239|FG015|Overall Study|Death|0|||
129494074|NCT01781429|466102224|FG000|Overall Study|Withdrawal by Subject|0|||
129494075|NCT01781429|466102225|FG001|Overall Study|Withdrawal by Subject|0|||
129494076|NCT01781429|466102226|FG002|Overall Study|Withdrawal by Subject|0|||
129494077|NCT01781429|466102227|FG003|Overall Study|Withdrawal by Subject|0|||
129494078|NCT01781429|466102228|FG004|Overall Study|Withdrawal by Subject|0|||
129494079|NCT01781429|466102229|FG005|Overall Study|Withdrawal by Subject|0|||
129494080|NCT01781429|466102230|FG006|Overall Study|Withdrawal by Subject|0|||
129494081|NCT01781429|466102231|FG007|Overall Study|Withdrawal by Subject|0|||
129494082|NCT01781429|466102232|FG008|Overall Study|Withdrawal by Subject|1|||
129494083|NCT01781429|466102233|FG009|Overall Study|Withdrawal by Subject|3|||
129494084|NCT01781429|466102234|FG010|Overall Study|Withdrawal by Subject|1|||
129494085|NCT01781429|466102235|FG011|Overall Study|Withdrawal by Subject|1|||
129494086|NCT01781429|466102236|FG012|Overall Study|Withdrawal by Subject|5|||
129494087|NCT01781429|466102237|FG013|Overall Study|Withdrawal by Subject|2|||
129494088|NCT01781429|466102238|FG014|Overall Study|Withdrawal by Subject|3|||
129494089|NCT01781429|466102239|FG015|Overall Study|Withdrawal by Subject|0|||
129494090|NCT01781429|466102224|FG000|Overall Study|Disease Progression|1|||
129494091|NCT01781429|466102225|FG001|Overall Study|Disease Progression|0|||
129494092|NCT01781429|466102226|FG002|Overall Study|Disease Progression|1|||
129494093|NCT01781429|466102227|FG003|Overall Study|Disease Progression|1|||
129494094|NCT01781429|466102228|FG004|Overall Study|Disease Progression|1|||
129494095|NCT01781429|466102229|FG005|Overall Study|Disease Progression|4|||
129494096|NCT01781429|466102230|FG006|Overall Study|Disease Progression|7|||
129494097|NCT01781429|466102231|FG007|Overall Study|Disease Progression|4|||
129494098|NCT01781429|466102232|FG008|Overall Study|Disease Progression|6|||
129494099|NCT01781429|466102233|FG009|Overall Study|Disease Progression|15|||
129494100|NCT01781429|466102234|FG010|Overall Study|Disease Progression|15|||
129494101|NCT01781429|466102235|FG011|Overall Study|Disease Progression|15|||
129494102|NCT01781429|466102236|FG012|Overall Study|Disease Progression|15|||
129494103|NCT01781429|466102237|FG013|Overall Study|Disease Progression|4|||
129494104|NCT01781429|466102238|FG014|Overall Study|Disease Progression|11|||
129494105|NCT01781429|466102239|FG015|Overall Study|Disease Progression|0|||
129494106|NCT01781429|466102224|FG000|Overall Study|Unacceptable Toxicity|0|||
129494107|NCT01781429|466102225|FG001|Overall Study|Unacceptable Toxicity|0|||
129494108|NCT01781429|466102226|FG002|Overall Study|Unacceptable Toxicity|0|||
129494109|NCT01781429|466102227|FG003|Overall Study|Unacceptable Toxicity|0|||
129494110|NCT01781429|466102228|FG004|Overall Study|Unacceptable Toxicity|0|||
129494111|NCT01781429|466102229|FG005|Overall Study|Unacceptable Toxicity|0|||
129494112|NCT01781429|466102230|FG006|Overall Study|Unacceptable Toxicity|0|||
129494113|NCT01781429|466102231|FG007|Overall Study|Unacceptable Toxicity|0|||
129494114|NCT01781429|466102232|FG008|Overall Study|Unacceptable Toxicity|0|||
129494115|NCT01781429|466102233|FG009|Overall Study|Unacceptable Toxicity|0|||
129494116|NCT01781429|466102234|FG010|Overall Study|Unacceptable Toxicity|0|||
129494117|NCT01781429|466102235|FG011|Overall Study|Unacceptable Toxicity|2|||
129494118|NCT01781429|466102236|FG012|Overall Study|Unacceptable Toxicity|0|||
129494119|NCT01781429|466102237|FG013|Overall Study|Unacceptable Toxicity|0|||
129494120|NCT01781429|466102238|FG014|Overall Study|Unacceptable Toxicity|0|||
129494121|NCT01781429|466102239|FG015|Overall Study|Unacceptable Toxicity|0|||
129494122|NCT01781429|466102224|FG000|Overall Study|Patient Condition Changed|0|||
129494123|NCT01781429|466102225|FG001|Overall Study|Patient Condition Changed|0|||
129494124|NCT01781429|466102226|FG002|Overall Study|Patient Condition Changed|0|||
129494125|NCT01781429|466102227|FG003|Overall Study|Patient Condition Changed|0|||
129494126|NCT01781429|466102228|FG004|Overall Study|Patient Condition Changed|0|||
129494127|NCT01781429|466102229|FG005|Overall Study|Patient Condition Changed|0|||
129494128|NCT01781429|466102230|FG006|Overall Study|Patient Condition Changed|0|||
129494129|NCT01781429|466102231|FG007|Overall Study|Patient Condition Changed|0|||
129494130|NCT01781429|466102232|FG008|Overall Study|Patient Condition Changed|0|||
129494131|NCT01781429|466102233|FG009|Overall Study|Patient Condition Changed|4|||
129494132|NCT01781429|466102234|FG010|Overall Study|Patient Condition Changed|0|||
129494133|NCT01781429|466102235|FG011|Overall Study|Patient Condition Changed|1|||
129494134|NCT01781429|466102236|FG012|Overall Study|Patient Condition Changed|0|||
129494135|NCT01781429|466102237|FG013|Overall Study|Patient Condition Changed|1|||
129494136|NCT01781429|466102238|FG014|Overall Study|Patient Condition Changed|0|||
129494137|NCT01781429|466102239|FG015|Overall Study|Patient Condition Changed|0|||
129494138|NCT01781429|466102224|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
129494139|NCT01781429|466102225|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
129494140|NCT01781429|466102226|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
129494141|NCT01781429|466102227|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
129494142|NCT01781429|466102228|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
129494143|NCT01781429|466102229|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
129494144|NCT01781429|466102230|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
129494145|NCT01781429|466102231|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
129494146|NCT01781429|466102232|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
129494147|NCT01781429|466102233|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
129494148|NCT01781429|466102234|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
129494149|NCT01781429|466102235|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
129538483|NCT05664672|466262112|FG005|Overall Study|Adverse Event|1|||
129494150|NCT01781429|466102236|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
129494151|NCT01781429|466102237|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
129494152|NCT01781429|466102238|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
129494153|NCT01781429|466102239|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
129494154|NCT01781429|466102224|FG000|Overall Study|Enrolled, but not treated|0|||
129494155|NCT01781429|466102225|FG001|Overall Study|Enrolled, but not treated|0|||
129494156|NCT01781429|466102226|FG002|Overall Study|Enrolled, but not treated|0|||
129494157|NCT01781429|466102227|FG003|Overall Study|Enrolled, but not treated|0|||
129494158|NCT01781429|466102228|FG004|Overall Study|Enrolled, but not treated|0|||
129494159|NCT01781429|466102229|FG005|Overall Study|Enrolled, but not treated|0|||
129494160|NCT01781429|466102230|FG006|Overall Study|Enrolled, but not treated|0|||
129494161|NCT01781429|466102231|FG007|Overall Study|Enrolled, but not treated|0|||
129494162|NCT01781429|466102232|FG008|Overall Study|Enrolled, but not treated|0|||
129494163|NCT01781429|466102233|FG009|Overall Study|Enrolled, but not treated|0|||
129494164|NCT01781429|466102234|FG010|Overall Study|Enrolled, but not treated|1|||
129494165|NCT01781429|466102235|FG011|Overall Study|Enrolled, but not treated|0|||
129494166|NCT01781429|466102236|FG012|Overall Study|Enrolled, but not treated|0|||
129494167|NCT01781429|466102237|FG013|Overall Study|Enrolled, but not treated|0|||
129494168|NCT01781429|466102238|FG014|Overall Study|Enrolled, but not treated|0|||
129494169|NCT01781429|466102239|FG015|Overall Study|Enrolled, but not treated|0|||
129494170|NCT02678741|466102240|FG000|Overall Study|Death|4|||
129494171|NCT02678741|466102240|FG000|Overall Study|Withdrawal by Subject|1|||
129494172|NCT02678741|466102240|FG000|Overall Study|ineligible|3|||
129494173|NCT02678741|466102240|FG000|Overall Study|Not RECIST Measurable|2|||
129494174|NCT02678741|466102240|FG000|Overall Study|Lack of Efficacy|10|||
129494175|NCT00903032|466102241|FG000|Overall Study|Withdrawal by Subject|5|||
129494176|NCT00903032|466102242|FG001|Overall Study|Withdrawal by Subject|3|||
129494177|NCT00903032|466102241|FG000|Overall Study|Lost to Follow-up|2|||
129494178|NCT00903032|466102242|FG001|Overall Study|Lost to Follow-up|2|||
129494179|NCT00931892|466102256|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
129494180|NCT00931892|466102257|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
129494181|NCT01876732|466102258|FG000|Overall Study|MMA was not over 800mg/dL|75|||
129494182|NCT01675531|466102259|FG000|Overall Study|Adverse Event|9|||
129494183|NCT01675531|466102259|FG000|Overall Study|Withdrawal by Subject|7|||
129494184|NCT01675531|466102259|FG000|Overall Study|Lack of Efficacy|1|||
129494185|NCT01675531|466102259|FG000|Overall Study|Protocol Violation|8|||
129494186|NCT00623467|466102260|FG000|Overall Study|Lost to Follow-up|1|||
129494187|NCT00623467|466102260|FG000|Overall Study|Protocol Violation|4|||
129494188|NCT00623467|466102260|FG000|Overall Study|Withdrawal by Subject|2|||
129494189|NCT02795988|466102269|FG000|Phase 1b|Withdrawal by Subject|0|||
129494190|NCT02795988|466102270|FG001|Phase 1b|Withdrawal by Subject|1|||
129494191|NCT02795988|466102271|FG002|Phase 1b|Withdrawal by Subject|0|||
129494192|NCT02795988|466102272|FG003|Phase 1b|Withdrawal by Subject|0|||
129494193|NCT02795988|466102273|FG004|Phase 1b|Withdrawal by Subject|0|||
129494194|NCT02795988|466102274|FG005|Phase 1b|Withdrawal by Subject|0|||
129494195|NCT02795988|466102275|FG006|Phase 1b|Withdrawal by Subject|0|||
129494196|NCT02795988|466102269|FG000|Phase 1b|Death|1|||
129494197|NCT02795988|466102270|FG001|Phase 1b|Death|2|||
129494198|NCT02795988|466102271|FG002|Phase 1b|Death|1|||
129494199|NCT02795988|466102272|FG003|Phase 1b|Death|0|||
129494200|NCT02795988|466102273|FG004|Phase 1b|Death|0|||
129494201|NCT02795988|466102274|FG005|Phase 1b|Death|0|||
129494202|NCT02795988|466102275|FG006|Phase 1b|Death|0|||
129494203|NCT02795988|466102269|FG000|Phase 1b|Physician Decision|0|||
129494204|NCT02795988|466102270|FG001|Phase 1b|Physician Decision|0|||
129494205|NCT02795988|466102271|FG002|Phase 1b|Physician Decision|1|||
129494206|NCT02795988|466102272|FG003|Phase 1b|Physician Decision|0|||
129494207|NCT02795988|466102273|FG004|Phase 1b|Physician Decision|0|||
129494208|NCT02795988|466102274|FG005|Phase 1b|Physician Decision|0|||
129494209|NCT02795988|466102275|FG006|Phase 1b|Physician Decision|0|||
129494210|NCT02795988|466102269|FG000|Phase 1b|Progressive Disease|2|||
129494211|NCT02795988|466102270|FG001|Phase 1b|Progressive Disease|2|||
129494212|NCT02795988|466102271|FG002|Phase 1b|Progressive Disease|0|||
129494213|NCT02795988|466102272|FG003|Phase 1b|Progressive Disease|0|||
129494214|NCT02795988|466102273|FG004|Phase 1b|Progressive Disease|0|||
129494215|NCT02795988|466102274|FG005|Phase 1b|Progressive Disease|0|||
129494216|NCT02795988|466102275|FG006|Phase 1b|Progressive Disease|0|||
129494217|NCT02795988|466102269|FG000|Phase 2|Withdrawal by Subject|0|||
129494218|NCT02795988|466102270|FG001|Phase 2|Withdrawal by Subject|0|||
129494219|NCT02795988|466102271|FG002|Phase 2|Withdrawal by Subject|0|||
129494220|NCT02795988|466102272|FG003|Phase 2|Withdrawal by Subject|1|||
129494221|NCT02795988|466102273|FG004|Phase 2|Withdrawal by Subject|0|||
129494222|NCT02795988|466102274|FG005|Phase 2|Withdrawal by Subject|0|||
129494223|NCT02795988|466102275|FG006|Phase 2|Withdrawal by Subject|0|||
129494224|NCT02795988|466102269|FG000|Phase 2|Death|0|||
129494225|NCT02795988|466102270|FG001|Phase 2|Death|0|||
129494226|NCT02795988|466102271|FG002|Phase 2|Death|0|||
129494227|NCT02795988|466102272|FG003|Phase 2|Death|17|||
129494228|NCT02795988|466102273|FG004|Phase 2|Death|17|||
129494229|NCT02795988|466102274|FG005|Phase 2|Death|0|||
129494230|NCT02795988|466102275|FG006|Phase 2|Death|0|||
129494231|NCT02795988|466102269|FG000|Phase 2|Other|0|||
129494232|NCT02795988|466102270|FG001|Phase 2|Other|0|||
129494233|NCT02795988|466102271|FG002|Phase 2|Other|0|||
129494234|NCT02795988|466102272|FG003|Phase 2|Other|1|||
129494235|NCT02795988|466102273|FG004|Phase 2|Other|0|||
129494236|NCT02795988|466102274|FG005|Phase 2|Other|0|||
129494237|NCT02795988|466102275|FG006|Phase 2|Other|0|||
129494238|NCT02795988|466102269|FG000|Phase 2 Extension|Death|0|||
129494239|NCT02795988|466102270|FG001|Phase 2 Extension|Death|0|||
129494240|NCT02795988|466102271|FG002|Phase 2 Extension|Death|0|||
129494241|NCT02795988|466102272|FG003|Phase 2 Extension|Death|0|||
129494242|NCT02795988|466102273|FG004|Phase 2 Extension|Death|0|||
129494243|NCT02795988|466102274|FG005|Phase 2 Extension|Death|5|||
129494244|NCT02795988|466102275|FG006|Phase 2 Extension|Death|6|||
129494245|NCT02795988|466102269|FG000|Phase 2 Extension|Other reasons|0|||
129494246|NCT02795988|466102270|FG001|Phase 2 Extension|Other reasons|0|||
129494247|NCT02795988|466102271|FG002|Phase 2 Extension|Other reasons|0|||
129494248|NCT02795988|466102272|FG003|Phase 2 Extension|Other reasons|0|||
129494249|NCT02795988|466102273|FG004|Phase 2 Extension|Other reasons|0|||
129494250|NCT02795988|466102274|FG005|Phase 2 Extension|Other reasons|2|||
129494251|NCT02795988|466102275|FG006|Phase 2 Extension|Other reasons|1|||
129494252|NCT02834403|466102276|FG000|Overall Study|Physician Decision|2|||
129494253|NCT02834403|466102277|FG001|Overall Study|Physician Decision|1|||
129494254|NCT02834403|466102278|FG002|Overall Study|Physician Decision|2|||
129494255|NCT02834403|466102279|FG003|Overall Study|Physician Decision|1|||
129494256|NCT02834403|466102280|FG004|Overall Study|Physician Decision|1|||
129494257|NCT02834403|466102281|FG005|Overall Study|Physician Decision|2|||
129494258|NCT02834403|466102282|FG006|Overall Study|Physician Decision|12|||
129494259|NCT02834403|466102276|FG000|Overall Study|Adverse Event|0|||
129494260|NCT02834403|466102277|FG001|Overall Study|Adverse Event|0|||
129494261|NCT02834403|466102278|FG002|Overall Study|Adverse Event|0|||
129494262|NCT02834403|466102279|FG003|Overall Study|Adverse Event|0|||
129494263|NCT02834403|466102280|FG004|Overall Study|Adverse Event|1|||
129494264|NCT02834403|466102281|FG005|Overall Study|Adverse Event|1|||
129494265|NCT02834403|466102282|FG006|Overall Study|Adverse Event|3|||
129494266|NCT02834403|466102276|FG000|Overall Study|Withdrawal by Subject|0|||
129494267|NCT02834403|466102277|FG001|Overall Study|Withdrawal by Subject|1|||
129494268|NCT02834403|466102278|FG002|Overall Study|Withdrawal by Subject|0|||
129494269|NCT02834403|466102279|FG003|Overall Study|Withdrawal by Subject|0|||
129494270|NCT02834403|466102280|FG004|Overall Study|Withdrawal by Subject|1|||
129494271|NCT02834403|466102281|FG005|Overall Study|Withdrawal by Subject|0|||
129494272|NCT02834403|466102282|FG006|Overall Study|Withdrawal by Subject|0|||
129494273|NCT02834403|466102276|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
129494274|NCT02834403|466102277|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
129494275|NCT02834403|466102278|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
129494276|NCT02834403|466102279|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
129494277|NCT02834403|466102280|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
129494278|NCT02834403|466102281|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
129494279|NCT02834403|466102282|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
129494280|NCT02341014|466102283|FG000|Overall Study|Adverse Event|0|||
129494281|NCT02341014|466102284|FG001|Overall Study|Adverse Event|1|||
129494282|NCT02341014|466102285|FG002|Overall Study|Adverse Event|0|||
129494283|NCT02341014|466102286|FG003|Overall Study|Adverse Event|0|||
129494284|NCT02341014|466102287|FG004|Overall Study|Adverse Event|2|||
129494285|NCT04705597|466102288|FG000|Overall Study|Death|16|||
129494286|NCT04705597|466102289|FG001|Overall Study|Death|9|||
129494287|NCT04705597|466102288|FG000|Overall Study|Lost to Follow-up|1|||
129494288|NCT04705597|466102289|FG001|Overall Study|Lost to Follow-up|0|||
129494289|NCT04705597|466102288|FG000|Overall Study|Withdrawal by Subject|1|||
129494290|NCT04705597|466102289|FG001|Overall Study|Withdrawal by Subject|2|||
129494291|NCT00273858|466102301|FG000|Overall Study|Not completed 24 month observation time|334|||
129494292|NCT00273858|466102301|FG000|Overall Study|Lost to Follow-up|101|||
129494293|NCT00273858|466102301|FG000|Overall Study|Withdrawal by Subject|21|||
129494294|NCT00273858|466102301|FG000|Overall Study|Adverse Event|81|||
129494295|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
129494296|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
129494297|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
129494298|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
129494299|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
129494300|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
129494301|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
129494302|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
129494303|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
129494304|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
129494305|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
129494306|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
129494307|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
129494308|NCT02232516|466102302|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
129494309|NCT02232516|466102302|FG000|Survival Follow-up|Death|15|||
129494310|NCT02232516|466102302|FG000|Survival Follow-up|Withdrawal by Subject|3|||
129494311|NCT02232516|466102302|FG000|Survival Follow-up|Lost to Follow-up|1|||
129494312|NCT02232516|466102302|FG000|Survival Follow-up|Still in follow-up|5|||
129494313|NCT01070550|466102303|FG000|Overall Study|Adverse Event|43|||
129494314|NCT01070550|466102304|FG001|Overall Study|Adverse Event|1|||
129494315|NCT01070550|466102305|FG002|Overall Study|Adverse Event|3|||
129494316|NCT01070550|466102306|FG003|Overall Study|Adverse Event|0|||
129494317|NCT01070550|466102307|FG004|Overall Study|Adverse Event|0|||
129494318|NCT01070550|466102308|FG005|Overall Study|Adverse Event|0|||
129494319|NCT01070550|466102303|FG000|Overall Study|Death|20|||
129494320|NCT01070550|466102304|FG001|Overall Study|Death|4|||
129494321|NCT01070550|466102305|FG002|Overall Study|Death|3|||
129494322|NCT01070550|466102306|FG003|Overall Study|Death|0|||
129494323|NCT01070550|466102307|FG004|Overall Study|Death|0|||
129494324|NCT01070550|466102308|FG005|Overall Study|Death|0|||
129494325|NCT01070550|466102303|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
129494326|NCT01070550|466102304|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
129494327|NCT01070550|466102305|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
129494328|NCT01070550|466102306|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129494329|NCT01070550|466102307|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129494330|NCT01070550|466102308|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
129494331|NCT01070550|466102303|FG000|Overall Study|Early termination|3|||
129494332|NCT01070550|466102304|FG001|Overall Study|Early termination|0|||
129494333|NCT01070550|466102305|FG002|Overall Study|Early termination|0|||
129494334|NCT01070550|466102306|FG003|Overall Study|Early termination|0|||
129494335|NCT01070550|466102307|FG004|Overall Study|Early termination|0|||
129494336|NCT01070550|466102308|FG005|Overall Study|Early termination|0|||
129494337|NCT01070550|466102303|FG000|Overall Study|Failed to return|450|||
129494338|NCT01070550|466102304|FG001|Overall Study|Failed to return|33|||
129494339|NCT01070550|466102305|FG002|Overall Study|Failed to return|144|||
129494340|NCT01070550|466102306|FG003|Overall Study|Failed to return|40|||
129494341|NCT01070550|466102307|FG004|Overall Study|Failed to return|1|||
129494342|NCT01070550|466102308|FG005|Overall Study|Failed to return|2|||
129494343|NCT01070550|466102303|FG000|Overall Study|Incomplete treatment|2|||
129494344|NCT01070550|466102304|FG001|Overall Study|Incomplete treatment|0|||
129494345|NCT01070550|466102305|FG002|Overall Study|Incomplete treatment|0|||
129494346|NCT01070550|466102306|FG003|Overall Study|Incomplete treatment|0|||
129494347|NCT01070550|466102307|FG004|Overall Study|Incomplete treatment|0|||
129494348|NCT01070550|466102308|FG005|Overall Study|Incomplete treatment|0|||
129494349|NCT01070550|466102303|FG000|Overall Study|Lab test not done|22|||
129494350|NCT01070550|466102304|FG001|Overall Study|Lab test not done|3|||
129494351|NCT01070550|466102305|FG002|Overall Study|Lab test not done|4|||
129494352|NCT01070550|466102306|FG003|Overall Study|Lab test not done|1|||
129494353|NCT01070550|466102307|FG004|Overall Study|Lab test not done|0|||
129494354|NCT01070550|466102308|FG005|Overall Study|Lab test not done|1|||
129494355|NCT01070550|466102303|FG000|Overall Study|Lack of Efficacy|65|||
129494356|NCT01070550|466102304|FG001|Overall Study|Lack of Efficacy|1|||
129494357|NCT01070550|466102305|FG002|Overall Study|Lack of Efficacy|5|||
129494358|NCT01070550|466102306|FG003|Overall Study|Lack of Efficacy|5|||
129494359|NCT01070550|466102307|FG004|Overall Study|Lack of Efficacy|0|||
129494360|NCT01070550|466102308|FG005|Overall Study|Lack of Efficacy|1|||
129494361|NCT01070550|466102303|FG000|Overall Study|Miscellaneous|12|||
129494362|NCT01070550|466102304|FG001|Overall Study|Miscellaneous|2|||
129494363|NCT01070550|466102305|FG002|Overall Study|Miscellaneous|3|||
129981001|NCT02738853|467893420|FG000|2 Year|Lost to Follow-up|1|||
129981002|NCT02738853|467893420|FG000|3 Year|Death|2|||
129981003|NCT02738853|467893420|FG000|3 Year|Withdrawal by Subject|1|||
129981004|NCT02738853|467893420|FG000|4 Year|Death|9|||
129981005|NCT02738853|467893420|FG000|5 Year|Lost to Follow-up|4|||
129981006|NCT01803282|467893421|FG000|Overall Study|Progressive Disease|4|||
129981007|NCT01803282|467893422|FG001|Overall Study|Progressive Disease|3|||
129494364|NCT01070550|466102306|FG003|Overall Study|Miscellaneous|1|||
129494365|NCT01070550|466102307|FG004|Overall Study|Miscellaneous|0|||
129494366|NCT01070550|466102308|FG005|Overall Study|Miscellaneous|0|||
129494367|NCT01070550|466102303|FG000|Overall Study|New treatment started|3|||
129981008|NCT01803282|467893423|FG002|Overall Study|Progressive Disease|6|||
129981009|NCT01803282|467893424|FG003|Overall Study|Progressive Disease|22|||
129494368|NCT01070550|466102304|FG001|Overall Study|New treatment started|1|||
129494369|NCT01070550|466102305|FG002|Overall Study|New treatment started|0|||
129494370|NCT01070550|466102306|FG003|Overall Study|New treatment started|2|||
129494371|NCT01070550|466102307|FG004|Overall Study|New treatment started|0|||
129494372|NCT01070550|466102308|FG005|Overall Study|New treatment started|0|||
129494373|NCT01070550|466102303|FG000|Overall Study|Non-responders|493|||
129981010|NCT01803282|467893425|FG004|Overall Study|Progressive Disease|5|||
129494374|NCT01070550|466102304|FG001|Overall Study|Non-responders|4|||
129494375|NCT01070550|466102305|FG002|Overall Study|Non-responders|21|||
129494376|NCT01070550|466102306|FG003|Overall Study|Non-responders|20|||
129494377|NCT01070550|466102307|FG004|Overall Study|Non-responders|0|||
129494378|NCT01070550|466102308|FG005|Overall Study|Non-responders|2|||
129494379|NCT01070550|466102303|FG000|Overall Study|Not categorized|33|||
129494380|NCT01070550|466102304|FG001|Overall Study|Not categorized|2|||
129494381|NCT01070550|466102305|FG002|Overall Study|Not categorized|6|||
129494382|NCT01070550|466102306|FG003|Overall Study|Not categorized|1|||
129494383|NCT01070550|466102307|FG004|Overall Study|Not categorized|0|||
129494384|NCT01070550|466102308|FG005|Overall Study|Not categorized|1|||
129494385|NCT01070550|466102303|FG000|Overall Study|Protocol Violation|15|||
129494386|NCT01070550|466102304|FG001|Overall Study|Protocol Violation|1|||
129494387|NCT01070550|466102305|FG002|Overall Study|Protocol Violation|1|||
129494388|NCT01070550|466102306|FG003|Overall Study|Protocol Violation|1|||
129494389|NCT01070550|466102307|FG004|Overall Study|Protocol Violation|0|||
129494390|NCT01070550|466102308|FG005|Overall Study|Protocol Violation|0|||
129494391|NCT01070550|466102303|FG000|Overall Study|Relapse|44|||
129494392|NCT01070550|466102304|FG001|Overall Study|Relapse|5|||
129494393|NCT01070550|466102305|FG002|Overall Study|Relapse|14|||
129494394|NCT01070550|466102306|FG003|Overall Study|Relapse|4|||
129494395|NCT01070550|466102307|FG004|Overall Study|Relapse|0|||
129494396|NCT01070550|466102308|FG005|Overall Study|Relapse|0|||
129494397|NCT01070550|466102303|FG000|Overall Study|Result not available|3|||
129494398|NCT01070550|466102304|FG001|Overall Study|Result not available|1|||
129494399|NCT01070550|466102305|FG002|Overall Study|Result not available|3|||
129494400|NCT01070550|466102306|FG003|Overall Study|Result not available|0|||
129494401|NCT01070550|466102307|FG004|Overall Study|Result not available|0|||
129494402|NCT01070550|466102308|FG005|Overall Study|Result not available|0|||
129494403|NCT01070550|466102303|FG000|Overall Study|Screen failure|1|||
129494404|NCT01070550|466102304|FG001|Overall Study|Screen failure|0|||
129494405|NCT01070550|466102305|FG002|Overall Study|Screen failure|0|||
129494406|NCT01070550|466102306|FG003|Overall Study|Screen failure|0|||
129494407|NCT01070550|466102307|FG004|Overall Study|Screen failure|0|||
129494408|NCT01070550|466102308|FG005|Overall Study|Screen failure|0|||
129494409|NCT01070550|466102303|FG000|Overall Study|Sponsor decision|1|||
129494410|NCT01070550|466102304|FG001|Overall Study|Sponsor decision|0|||
129494411|NCT01070550|466102305|FG002|Overall Study|Sponsor decision|0|||
129494412|NCT01070550|466102306|FG003|Overall Study|Sponsor decision|0|||
129494413|NCT01070550|466102307|FG004|Overall Study|Sponsor decision|0|||
129494414|NCT01070550|466102308|FG005|Overall Study|Sponsor decision|0|||
129494415|NCT01070550|466102303|FG000|Overall Study|Treatment duration shortened|1|||
129494416|NCT01070550|466102304|FG001|Overall Study|Treatment duration shortened|0|||
129494417|NCT01070550|466102305|FG002|Overall Study|Treatment duration shortened|0|||
129494418|NCT01070550|466102306|FG003|Overall Study|Treatment duration shortened|0|||
129494419|NCT01070550|466102307|FG004|Overall Study|Treatment duration shortened|0|||
129494420|NCT01070550|466102308|FG005|Overall Study|Treatment duration shortened|0|||
129494421|NCT01070550|466102303|FG000|Overall Study|Treatment interrupted|7|||
129494422|NCT01070550|466102304|FG001|Overall Study|Treatment interrupted|0|||
129494423|NCT01070550|466102305|FG002|Overall Study|Treatment interrupted|1|||
129494424|NCT01070550|466102306|FG003|Overall Study|Treatment interrupted|1|||
129494425|NCT01070550|466102307|FG004|Overall Study|Treatment interrupted|0|||
129494426|NCT01070550|466102308|FG005|Overall Study|Treatment interrupted|0|||
129494427|NCT01070550|466102303|FG000|Overall Study|Treatment not started|14|||
129494428|NCT01070550|466102304|FG001|Overall Study|Treatment not started|2|||
129494429|NCT01070550|466102305|FG002|Overall Study|Treatment not started|4|||
129494430|NCT01070550|466102306|FG003|Overall Study|Treatment not started|0|||
129494431|NCT01070550|466102307|FG004|Overall Study|Treatment not started|0|||
129494432|NCT01070550|466102308|FG005|Overall Study|Treatment not started|0|||
129494433|NCT01070550|466102303|FG000|Overall Study|Treatment restarted|0|||
129494434|NCT01070550|466102304|FG001|Overall Study|Treatment restarted|1|||
129494435|NCT01070550|466102305|FG002|Overall Study|Treatment restarted|0|||
129494436|NCT01070550|466102306|FG003|Overall Study|Treatment restarted|0|||
129494437|NCT01070550|466102307|FG004|Overall Study|Treatment restarted|0|||
129494438|NCT01070550|466102308|FG005|Overall Study|Treatment restarted|0|||
129494439|NCT01070550|466102303|FG000|Overall Study|Treatment stopped|3|||
129494440|NCT01070550|466102304|FG001|Overall Study|Treatment stopped|0|||
129494441|NCT01070550|466102305|FG002|Overall Study|Treatment stopped|0|||
129494442|NCT01070550|466102306|FG003|Overall Study|Treatment stopped|0|||
129494443|NCT01070550|466102307|FG004|Overall Study|Treatment stopped|0|||
129494444|NCT01070550|466102308|FG005|Overall Study|Treatment stopped|0|||
129494445|NCT01070550|466102303|FG000|Overall Study|Treatment unavailable|1|||
129494446|NCT01070550|466102304|FG001|Overall Study|Treatment unavailable|0|||
129494447|NCT01070550|466102305|FG002|Overall Study|Treatment unavailable|0|||
129494448|NCT01070550|466102306|FG003|Overall Study|Treatment unavailable|0|||
129494449|NCT01070550|466102307|FG004|Overall Study|Treatment unavailable|0|||
129494450|NCT01070550|466102308|FG005|Overall Study|Treatment unavailable|0|||
129494451|NCT01070550|466102303|FG000|Overall Study|Treatment was stopped early|7|||
129494452|NCT01070550|466102304|FG001|Overall Study|Treatment was stopped early|0|||
129494453|NCT01070550|466102305|FG002|Overall Study|Treatment was stopped early|0|||
129538913|NCT01238861|466265108|FG001|Overall Study|Unplanned surgery|0|||
129494454|NCT01070550|466102306|FG003|Overall Study|Treatment was stopped early|0|||
129494455|NCT01070550|466102307|FG004|Overall Study|Treatment was stopped early|0|||
129494456|NCT01070550|466102308|FG005|Overall Study|Treatment was stopped early|0|||
129494457|NCT01070550|466102303|FG000|Overall Study|Other|5|||
129494458|NCT01070550|466102304|FG001|Overall Study|Other|0|||
129494459|NCT01070550|466102305|FG002|Overall Study|Other|0|||
129494460|NCT01070550|466102306|FG003|Overall Study|Other|1|||
129494461|NCT01070550|466102307|FG004|Overall Study|Other|0|||
129494462|NCT01070550|466102308|FG005|Overall Study|Other|0|||
129494463|NCT01070550|466102303|FG000|Overall Study|Withdrawal by Subject|35|||
129494464|NCT01070550|466102304|FG001|Overall Study|Withdrawal by Subject|0|||
129494465|NCT01070550|466102305|FG002|Overall Study|Withdrawal by Subject|3|||
129494466|NCT01070550|466102306|FG003|Overall Study|Withdrawal by Subject|0|||
129494467|NCT01070550|466102307|FG004|Overall Study|Withdrawal by Subject|0|||
129494468|NCT01070550|466102308|FG005|Overall Study|Withdrawal by Subject|0|||
129494469|NCT01585961|466102309|FG000|Overall Study|Death|6|||
129494470|NCT01585961|466102309|FG000|Overall Study|Physician Decision|1|||
129494471|NCT01585961|466102309|FG000|Overall Study|Decision to use non-study catheter|1|||
129494472|NCT01585961|466102309|FG000|Overall Study|Withdrawal by Subject|1|||
129494473|NCT01585961|466102309|FG000|Overall Study|Lost to Follow-up|23|||
129494474|NCT01585961|466102309|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
129494475|NCT01258348|466102310|FG000|Overall Study|Adverse Event|1|||
129494476|NCT01258348|466102311|FG001|Overall Study|Adverse Event|1|||
129494477|NCT01258348|466102312|FG002|Overall Study|Adverse Event|3|||
129494478|NCT01258348|466102313|FG003|Overall Study|Adverse Event|2|||
129494479|NCT01258348|466102314|FG004|Overall Study|Adverse Event|4|||
129494480|NCT01258348|466102310|FG000|Overall Study|Progressive Disease|0|||
129494481|NCT01258348|466102311|FG001|Overall Study|Progressive Disease|3|||
129494482|NCT01258348|466102312|FG002|Overall Study|Progressive Disease|0|||
129494483|NCT01258348|466102313|FG003|Overall Study|Progressive Disease|2|||
129494484|NCT01258348|466102314|FG004|Overall Study|Progressive Disease|2|||
129494485|NCT01258348|466102310|FG000|Overall Study|Physician Decision|0|||
129494486|NCT01258348|466102311|FG001|Overall Study|Physician Decision|0|||
129494487|NCT01258348|466102312|FG002|Overall Study|Physician Decision|0|||
129494488|NCT01258348|466102313|FG003|Overall Study|Physician Decision|2|||
129494489|NCT01258348|466102314|FG004|Overall Study|Physician Decision|0|||
129494490|NCT01258348|466102310|FG000|Overall Study|Withdrawal by Subject|0|||
129494491|NCT01258348|466102311|FG001|Overall Study|Withdrawal by Subject|1|||
129494492|NCT01258348|466102312|FG002|Overall Study|Withdrawal by Subject|0|||
129494493|NCT01258348|466102313|FG003|Overall Study|Withdrawal by Subject|0|||
129494494|NCT01258348|466102314|FG004|Overall Study|Withdrawal by Subject|0|||
129494495|NCT06094296|466102315|FG000|Overall Study|Progressive Disease|1|||
129494496|NCT06094296|466102316|FG001|Overall Study|Progressive Disease|0|||
129494497|NCT06094296|466102317|FG002|Overall Study|Progressive Disease|0|||
129494498|NCT06094296|466102318|FG003|Overall Study|Progressive Disease|0|||
129494499|NCT01809262|466102319|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494500|NCT01809262|466102320|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494501|NCT01809262|466102321|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494502|NCT01809262|466102322|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494503|NCT01809262|466102323|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
129494504|NCT01809262|466102324|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494505|NCT01809262|466102325|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494506|NCT01809262|466102326|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494507|NCT01809262|466102327|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494508|NCT01809262|466102328|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
129494509|NCT01809262|466102319|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494510|NCT01809262|466102320|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
129494511|NCT01809262|466102321|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494512|NCT01809262|466102322|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494513|NCT01809262|466102323|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494514|NCT01809262|466102324|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494515|NCT01809262|466102325|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494516|NCT01809262|466102326|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494517|NCT01809262|466102327|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494518|NCT01809262|466102328|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
129494519|NCT02064439|466102330|FG000|Overall Study|Adverse Event|51|||
129494520|NCT02064439|466102331|FG001|Overall Study|Adverse Event|47|||
129494521|NCT02064439|466102332|FG002|Overall Study|Adverse Event|46|||
129494522|NCT02064439|466102330|FG000|Overall Study|Death|0|||
129494523|NCT02064439|466102331|FG001|Overall Study|Death|2|||
129494524|NCT02064439|466102332|FG002|Overall Study|Death|3|||
129494525|NCT02064439|466102330|FG000|Overall Study|Withdrawal by Subject|29|||
129494526|NCT02064439|466102331|FG001|Overall Study|Withdrawal by Subject|18|||
129494527|NCT02064439|466102332|FG002|Overall Study|Withdrawal by Subject|26|||
129494528|NCT02064439|466102330|FG000|Overall Study|Protocol Violation|3|||
129494529|NCT02064439|466102331|FG001|Overall Study|Protocol Violation|5|||
129494530|NCT02064439|466102332|FG002|Overall Study|Protocol Violation|3|||
129494531|NCT02064439|466102330|FG000|Overall Study|Lost to Follow-up|1|||
129494532|NCT02064439|466102331|FG001|Overall Study|Lost to Follow-up|3|||
129494533|NCT02064439|466102332|FG002|Overall Study|Lost to Follow-up|4|||
129494534|NCT02064439|466102330|FG000|Overall Study|Non-compliance with study medication|21|||
129494535|NCT02064439|466102331|FG001|Overall Study|Non-compliance with study medication|19|||
129494536|NCT02064439|466102332|FG002|Overall Study|Non-compliance with study medication|23|||
129494537|NCT02064439|466102330|FG000|Overall Study|Physician Decision|0|||
129494538|NCT02064439|466102331|FG001|Overall Study|Physician Decision|1|||
129494539|NCT02064439|466102332|FG002|Overall Study|Physician Decision|1|||
129494540|NCT02064439|466102330|FG000|Overall Study|Logistical difficulties|6|||
129494541|NCT02064439|466102331|FG001|Overall Study|Logistical difficulties|5|||
129494542|NCT02064439|466102332|FG002|Overall Study|Logistical difficulties|2|||
129494543|NCT02064439|466102330|FG000|Overall Study|Efficacy outcome reached|18|||
129494544|NCT02064439|466102331|FG001|Overall Study|Efficacy outcome reached|16|||
129494545|NCT02064439|466102332|FG002|Overall Study|Efficacy outcome reached|57|||
129494546|NCT02064439|466102330|FG000|Overall Study|Safety outcome reached|12|||
129494547|NCT02064439|466102331|FG001|Overall Study|Safety outcome reached|20|||
129494548|NCT02064439|466102332|FG002|Overall Study|Safety outcome reached|10|||
129494549|NCT02064439|466102330|FG000|Overall Study|Other|2|||
129494550|NCT02064439|466102331|FG001|Overall Study|Other|2|||
129494551|NCT02064439|466102332|FG002|Overall Study|Other|7|||
129494552|NCT01120093|466102337|FG000|Treatment Period 1|Adverse Event|0|||
129494553|NCT01120093|466102338|FG001|Treatment Period 1|Adverse Event|0|||
129494554|NCT01120093|466102339|FG002|Treatment Period 1|Adverse Event|1|||
129494555|NCT01120093|466102340|FG003|Treatment Period 1|Adverse Event|0|||
129494556|NCT01120093|466102341|FG004|Treatment Period 1|Adverse Event|1|||
129494557|NCT01120093|466102337|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129494558|NCT01120093|466102338|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129494559|NCT01120093|466102339|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129494560|NCT01120093|466102340|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129494561|NCT01120093|466102341|FG004|Treatment Period 1|Withdrawal by Subject|0|||
129494562|NCT01120093|466102337|FG000|Treatment Period 2|Adverse Event|0|||
129494563|NCT01120093|466102338|FG001|Treatment Period 2|Adverse Event|0|||
129494564|NCT01120093|466102339|FG002|Treatment Period 2|Adverse Event|0|||
129494565|NCT01120093|466102340|FG003|Treatment Period 2|Adverse Event|1|||
129494566|NCT01120093|466102341|FG004|Treatment Period 2|Adverse Event|0|||
129494567|NCT01120093|466102337|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129494568|NCT01120093|466102338|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129494569|NCT01120093|466102339|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129494570|NCT01120093|466102340|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129494571|NCT01120093|466102341|FG004|Treatment Period 2|Withdrawal by Subject|1|||
129494572|NCT01120093|466102337|FG000|Treatment Period 3|Lack of Efficacy|0|||
129494573|NCT01120093|466102338|FG001|Treatment Period 3|Lack of Efficacy|0|||
129494574|NCT01120093|466102339|FG002|Treatment Period 3|Lack of Efficacy|0|||
129494575|NCT01120093|466102340|FG003|Treatment Period 3|Lack of Efficacy|1|||
129494576|NCT01120093|466102341|FG004|Treatment Period 3|Lack of Efficacy|0|||
129494577|NCT01120093|466102337|FG000|Treatment Period 3|Adverse Event|0|||
129494578|NCT01120093|466102338|FG001|Treatment Period 3|Adverse Event|0|||
129494579|NCT01120093|466102339|FG002|Treatment Period 3|Adverse Event|0|||
129494580|NCT01120093|466102340|FG003|Treatment Period 3|Adverse Event|0|||
129494581|NCT01120093|466102341|FG004|Treatment Period 3|Adverse Event|1|||
129494582|NCT01120093|466102337|FG000|Treatment Period 3|Withdrawal by Subject|0|||
129494583|NCT01120093|466102338|FG001|Treatment Period 3|Withdrawal by Subject|0|||
129494584|NCT01120093|466102339|FG002|Treatment Period 3|Withdrawal by Subject|1|||
129494585|NCT01120093|466102340|FG003|Treatment Period 3|Withdrawal by Subject|0|||
129494586|NCT01120093|466102341|FG004|Treatment Period 3|Withdrawal by Subject|0|||
129494587|NCT01120093|466102337|FG000|Treatment Period 4|Adverse Event|1|||
129494588|NCT01120093|466102338|FG001|Treatment Period 4|Adverse Event|0|||
129494589|NCT01120093|466102339|FG002|Treatment Period 4|Adverse Event|0|||
129494590|NCT01120093|466102340|FG003|Treatment Period 4|Adverse Event|0|||
129494591|NCT01120093|466102341|FG004|Treatment Period 4|Adverse Event|0|||
129494592|NCT01120093|466102337|FG000|Treatment Period 5|Adverse Event|0|||
129494593|NCT01120093|466102338|FG001|Treatment Period 5|Adverse Event|1|||
129494594|NCT01120093|466102339|FG002|Treatment Period 5|Adverse Event|0|||
129494595|NCT01120093|466102340|FG003|Treatment Period 5|Adverse Event|1|||
129494596|NCT01120093|466102341|FG004|Treatment Period 5|Adverse Event|0|||
129494597|NCT03649321|466102344|FG000|Overall Study|Withdrawal by Subject|1|||
129494598|NCT03649321|466102345|FG001|Overall Study|Withdrawal by Subject|0|||
129494599|NCT03649321|466102344|FG000|Overall Study|Death|1|||
129494600|NCT03649321|466102345|FG001|Overall Study|Death|0|||
129494601|NCT01702363|466102346|FG000|Overall Study|Adverse Event|14|||
129494602|NCT01702363|466102346|FG000|Overall Study|Lack of Efficacy|4|||
129494603|NCT01702363|466102346|FG000|Overall Study|Withdrawal by Subject|2|||
129494604|NCT02184143|466102353|FG000|Overall Study|Withdrawal by Subject|4|||
129494605|NCT02184143|466102354|FG001|Overall Study|Withdrawal by Subject|4|||
129494606|NCT02184143|466102353|FG000|Overall Study|Lost to Follow-up|5|||
129494607|NCT02184143|466102354|FG001|Overall Study|Lost to Follow-up|3|||
129494608|NCT02184143|466102353|FG000|Overall Study|Death|1|||
129494609|NCT02184143|466102354|FG001|Overall Study|Death|0|||
129494610|NCT00321984|466102355|FG000|Overall Study|Adverse Event|9|||
129494611|NCT00321984|466102356|FG001|Overall Study|Adverse Event|6|||
129494612|NCT00321984|466102357|FG002|Overall Study|Adverse Event|8|||
129494613|NCT00321984|466102355|FG000|Overall Study|Protocol Violation|0|||
129494614|NCT00321984|466102356|FG001|Overall Study|Protocol Violation|1|||
129494615|NCT00321984|466102357|FG002|Overall Study|Protocol Violation|1|||
129494616|NCT00321984|466102355|FG000|Overall Study|Lost to Follow-up|2|||
129494617|NCT00321984|466102356|FG001|Overall Study|Lost to Follow-up|4|||
129494618|NCT00321984|466102357|FG002|Overall Study|Lost to Follow-up|2|||
129494619|NCT00321984|466102355|FG000|Overall Study|Withdrawal by Subject|8|||
129494620|NCT00321984|466102356|FG001|Overall Study|Withdrawal by Subject|6|||
129494621|NCT00321984|466102357|FG002|Overall Study|Withdrawal by Subject|5|||
129494622|NCT00321984|466102355|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
129494623|NCT00321984|466102356|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
129494624|NCT00321984|466102357|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
129494625|NCT00321984|466102355|FG000|Overall Study|Lack of Efficacy|3|||
129494626|NCT00321984|466102356|FG001|Overall Study|Lack of Efficacy|1|||
129494627|NCT00321984|466102357|FG002|Overall Study|Lack of Efficacy|3|||
129494628|NCT00321984|466102355|FG000|Overall Study|Noncompliant|0|||
129494629|NCT00321984|466102356|FG001|Overall Study|Noncompliant|0|||
129494630|NCT00321984|466102357|FG002|Overall Study|Noncompliant|2|||
129494631|NCT00321984|466102355|FG000|Overall Study|Pregnancy|0|||
129494632|NCT00321984|466102356|FG001|Overall Study|Pregnancy|1|||
129494633|NCT00321984|466102357|FG002|Overall Study|Pregnancy|0|||
129494634|NCT00321984|466102355|FG000|Overall Study|Per Subject Request|1|||
129494635|NCT00321984|466102356|FG001|Overall Study|Per Subject Request|0|||
129494636|NCT00321984|466102357|FG002|Overall Study|Per Subject Request|0|||
129494637|NCT00321984|466102355|FG000|Overall Study|Per Investigator Request|1|||
129494638|NCT00321984|466102356|FG001|Overall Study|Per Investigator Request|0|||
129494639|NCT00321984|466102357|FG002|Overall Study|Per Investigator Request|0|||
129494640|NCT00321984|466102355|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
129494641|NCT00321984|466102356|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
129494642|NCT00321984|466102357|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
129494643|NCT02142894|466102358|FG000|Overall Study|Protocol Violation|8|||
129494644|NCT00443430|466102364|FG000|Overall Study|Lack of Efficacy|3|||
129494645|NCT00443430|466102365|FG001|Overall Study|Lack of Efficacy|3|||
129494646|NCT00443430|466102364|FG000|Overall Study|Adverse Event|1|||
129494647|NCT00443430|466102365|FG001|Overall Study|Adverse Event|1|||
129494648|NCT00504166|466102367|FG000|Overall Study|Adverse Event|1|||
129494649|NCT00504166|466102368|FG001|Overall Study|Adverse Event|4|||
129494650|NCT00504166|466102367|FG000|Overall Study|Withdrawal by Subject|3|||
129494651|NCT00504166|466102368|FG001|Overall Study|Withdrawal by Subject|6|||
129494652|NCT00504166|466102367|FG000|Overall Study|Physician Decision|1|||
129494653|NCT00504166|466102368|FG001|Overall Study|Physician Decision|1|||
129494654|NCT00504166|466102367|FG000|Overall Study|Lost to Follow-up|1|||
129494655|NCT00504166|466102368|FG001|Overall Study|Lost to Follow-up|3|||
129494656|NCT02229864|466102369|FG000|Overall Study|Death|2|||
129494657|NCT02229864|466102369|FG000|Overall Study|Lost to Follow-up|1|||
129494658|NCT02650284|466102374|FG000|Overall Study|Lost to Follow-up|3|||
129494659|NCT02650284|466102375|FG001|Overall Study|Lost to Follow-up|3|||
129494660|NCT02650284|466102374|FG000|Overall Study|Consent incorrectly taken|0|||
129494661|NCT02650284|466102375|FG001|Overall Study|Consent incorrectly taken|1|||
129494662|NCT01165203|466102378|FG000|Active Phase|Serious Adverse Event|1|||
129494663|NCT01165203|466102379|FG001|Active Phase|Serious Adverse Event|0|||
129494664|NCT01165203|466102378|FG000|Active Phase|Withdrawal by Subject|2|||
129494665|NCT01165203|466102379|FG001|Active Phase|Withdrawal by Subject|1|||
129494666|NCT01165203|466102378|FG000|Active Phase|Migrated/moved from study area|0|||
129494667|NCT01165203|466102379|FG001|Active Phase|Migrated/moved from study area|1|||
129494668|NCT01165203|466102378|FG000|Active Phase|Lost to Follow-up|2|||
129494669|NCT01165203|466102379|FG001|Active Phase|Lost to Follow-up|0|||
129494670|NCT01165203|466102378|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
129494671|NCT01165203|466102379|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
129494672|NCT01165203|466102378|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
129494673|NCT01165203|466102379|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
129494674|NCT01165203|466102378|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
129494675|NCT01165203|466102379|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
129494676|NCT01165203|466102378|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
129494677|NCT01165203|466102379|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
129494678|NCT01165203|466102378|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
129494679|NCT01165203|466102379|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
129494680|NCT01780389|466102384|FG000|Overall Study|Adverse Event|1|||
129494681|NCT01323673|466102388|FG000|Overall Study|Adverse Event|0|||
129494682|NCT01323673|466102389|FG001|Overall Study|Adverse Event|1|||
129494683|NCT01323673|466102388|FG000|Overall Study|Lost to Follow-up|0|||
129494684|NCT01323673|466102389|FG001|Overall Study|Lost to Follow-up|1|||
129494685|NCT01323673|466102388|FG000|Overall Study|Protocol Violation|1|||
129494686|NCT01323673|466102389|FG001|Overall Study|Protocol Violation|0|||
129494687|NCT01323673|466102388|FG000|Overall Study|Withdrawal by Subject|2|||
129494688|NCT01323673|466102389|FG001|Overall Study|Withdrawal by Subject|3|||
129494689|NCT04598165|466102390|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
129494690|NCT04598165|466102391|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
129494691|NCT04598165|466102390|FG000|Completed 6-week Follow-up|Death|2|||
129494692|NCT04598165|466102391|FG001|Completed 6-week Follow-up|Death|1|||
129494693|NCT04598165|466102390|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
129494694|NCT04598165|466102391|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
129494695|NCT04598165|466102390|FG000|Completed 6-week Follow-up|Ineligible|4|||
129494696|NCT04598165|466102391|FG001|Completed 6-week Follow-up|Ineligible|3|||
129494697|NCT04598165|466102390|FG000|Completed 6-week Follow-up|Partner refusal|0|||
129494698|NCT04598165|466102391|FG001|Completed 6-week Follow-up|Partner refusal|1|||
129494699|NCT04598165|466102390|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
129494700|NCT04598165|466102391|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
129494701|NCT02379923|466102392|FG000|Overall Study|Death|5|||
129494702|NCT00426751|466102393|FG000|Overall Study|Adverse Event|8|||
129494703|NCT00426751|466102394|FG001|Overall Study|Adverse Event|1|||
129494704|NCT00426751|466102393|FG000|Overall Study|Lost to Follow-up|7|||
129494705|NCT00426751|466102394|FG001|Overall Study|Lost to Follow-up|6|||
129494706|NCT00426751|466102393|FG000|Overall Study|Consent Withdrawn|0|||
129494707|NCT00426751|466102394|FG001|Overall Study|Consent Withdrawn|1|||
129494708|NCT00426751|466102393|FG000|Overall Study|Other Reasons|7|||
129494709|NCT00426751|466102394|FG001|Overall Study|Other Reasons|12|||
129494710|NCT01200511|466102395|FG000|Overall Study|Lost to Follow-up|3|||
129494711|NCT01200511|466102395|FG000|Overall Study|Withdrawal by Subject|1|||
129494712|NCT01200511|466102395|FG000|Overall Study|Adverse Event|1|||
129494713|NCT00337467|466102399|FG000|Overall Study|Adverse Event|3|||
129494714|NCT00337467|466102399|FG000|Overall Study|Subject Withdrew Consent|2|||
129494715|NCT00337467|466102399|FG000|Overall Study|Pregnancy|1|||
129494716|NCT00337467|466102399|FG000|Overall Study|Lost to Follow-up|2|||
129494717|NCT00337467|466102399|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
129494718|NCT04083222|466102400|FG000|Overall Study|Voluntary Withdrawal|0|||
129494719|NCT04083222|466102401|FG001|Overall Study|Voluntary Withdrawal|1|||
129494720|NCT04083222|466102400|FG000|Overall Study|Reason not Specified|0|||
129494721|NCT04083222|466102401|FG001|Overall Study|Reason not Specified|1|||
129494722|NCT03103750|466102402|FG000|Overall Study|Adverse Event|1|||
129494723|NCT03103750|466102403|FG001|Overall Study|Adverse Event|0|||
129494724|NCT03103750|466102402|FG000|Overall Study|Lost to Follow-up|1|||
129494725|NCT03103750|466102403|FG001|Overall Study|Lost to Follow-up|0|||
129494726|NCT03103750|466102402|FG000|Overall Study|PET Equipment Related|2|||
129494727|NCT03103750|466102403|FG001|Overall Study|PET Equipment Related|2|||
129494728|NCT04400318|466103577|FG000|Overall Study|Adverse Event|1|||
129494729|NCT04400318|466103578|FG001|Overall Study|Adverse Event|0|||
129494730|NCT04400318|466103577|FG000|Overall Study|Withdrawal by Subject|1|||
129494731|NCT04400318|466103578|FG001|Overall Study|Withdrawal by Subject|1|||
129494732|NCT04400318|466103577|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
129494733|NCT04400318|466103578|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
129494734|NCT01096446|466103579|FG000|Overall Study|Death|1|||
129494735|NCT01096446|466103580|FG001|Overall Study|Death|0|||
129494736|NCT01096446|466103579|FG000|Overall Study|Protocol Violation|2|||
129494737|NCT01096446|466103580|FG001|Overall Study|Protocol Violation|0|||
129494738|NCT00747617|466103581|FG000|Overall Study|Lost to Follow-up|3|||
129494739|NCT00747617|466103582|FG001|Overall Study|Lost to Follow-up|1|||
129494740|NCT02279524|466103583|FG000|Overall Study|Withdrawal by Subject|3|||
129494741|NCT02279524|466103584|FG001|Overall Study|Withdrawal by Subject|6|||
129494742|NCT02279524|466103585|FG002|Overall Study|Withdrawal by Subject|3|||
129494743|NCT02279524|466103583|FG000|Overall Study|Adverse Event|4|||
129494744|NCT02279524|466103584|FG001|Overall Study|Adverse Event|3|||
129494745|NCT02279524|466103585|FG002|Overall Study|Adverse Event|2|||
129494746|NCT02279524|466103583|FG000|Overall Study|Lost to Follow-up|1|||
129494747|NCT02279524|466103584|FG001|Overall Study|Lost to Follow-up|1|||
129494748|NCT02279524|466103585|FG002|Overall Study|Lost to Follow-up|0|||
129494749|NCT02279524|466103583|FG000|Overall Study|Disallowed medication|1|||
129494750|NCT02279524|466103584|FG001|Overall Study|Disallowed medication|1|||
129494751|NCT02279524|466103585|FG002|Overall Study|Disallowed medication|2|||
129494752|NCT02279524|466103583|FG000|Overall Study|Bariatric surgery|1|||
129494753|NCT02279524|466103584|FG001|Overall Study|Bariatric surgery|0|||
129494754|NCT02279524|466103585|FG002|Overall Study|Bariatric surgery|0|||
129494755|NCT01746732|466103586|FG000|Lead-In Period|Withdrawal by Subject|1|||
129494756|NCT01746732|466103587|FG001|Lead-In Period|Withdrawal by Subject|0|||
129494757|NCT01746732|466103588|FG002|Lead-In Period|Withdrawal by Subject|0|||
129494758|NCT01746732|466103586|FG000|Period 1|Physician Decision|0|||
129494759|NCT01746732|466103587|FG001|Period 1|Physician Decision|1|||
129494760|NCT01746732|466103588|FG002|Period 1|Physician Decision|0|||
129494761|NCT01746732|466103586|FG000|Period 2|Withdrawal by Subject|0|||
129494762|NCT01746732|466103587|FG001|Period 2|Withdrawal by Subject|0|||
129494763|NCT01746732|466103588|FG002|Period 2|Withdrawal by Subject|2|||
129494764|NCT01746732|466103586|FG000|Period 2|Adverse Event|0|||
129494765|NCT01746732|466103587|FG001|Period 2|Adverse Event|0|||
129494766|NCT01746732|466103588|FG002|Period 2|Adverse Event|1|||
129494767|NCT01746732|466103586|FG000|Period 2|Lost to Follow-up|0|||
129494768|NCT01746732|466103587|FG001|Period 2|Lost to Follow-up|0|||
129494769|NCT01746732|466103588|FG002|Period 2|Lost to Follow-up|1|||
129494770|NCT03509207|466103589|FG000|Overall Study|Death|2|||
129494771|NCT02817555|466103590|FG000|Overall Study|Death|1|||
129494772|NCT02817555|466103591|FG001|Overall Study|Death|3|||
129494773|NCT02817555|466103590|FG000|Overall Study|moved away|1|||
129494774|NCT02817555|466103591|FG001|Overall Study|moved away|0|||
129494775|NCT02817555|466103590|FG000|Overall Study|transplant|1|||
129494776|NCT02817555|466103591|FG001|Overall Study|transplant|1|||
129494777|NCT02817555|466103590|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
129494778|NCT02817555|466103591|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
129494779|NCT00137436|466103592|FG000|Overall Study|Adverse Event|13|||
129494780|NCT00137436|466103592|FG000|Overall Study|Death|2|||
129494781|NCT00137436|466103592|FG000|Overall Study|Lack of Efficacy|17|||
129494782|NCT00137436|466103592|FG000|Overall Study|Withdrawal by Subject|6|||
129494783|NCT00137436|466103592|FG000|Overall Study|Other|5|||
129494784|NCT00912015|466103596|FG000|Overall Study|Lack of Efficacy|1|||
129494785|NCT00912015|466103597|FG001|Overall Study|Lack of Efficacy|0|||
129494786|NCT00912015|466103598|FG002|Overall Study|Lack of Efficacy|0|||
129494787|NCT00912015|466103599|FG003|Overall Study|Lack of Efficacy|0|||
129494788|NCT00912015|466103596|FG000|Overall Study|Withdrawal by Subject|8|||
129494789|NCT00912015|466103597|FG001|Overall Study|Withdrawal by Subject|8|||
129494790|NCT00912015|466103598|FG002|Overall Study|Withdrawal by Subject|3|||
129494791|NCT00912015|466103599|FG003|Overall Study|Withdrawal by Subject|0|||
129494792|NCT00912015|466103596|FG000|Overall Study|Protocol Violation|1|||
129494793|NCT00912015|466103597|FG001|Overall Study|Protocol Violation|0|||
129494794|NCT00912015|466103598|FG002|Overall Study|Protocol Violation|0|||
129494795|NCT00912015|466103599|FG003|Overall Study|Protocol Violation|1|||
129494796|NCT00912015|466103596|FG000|Overall Study|Adverse Event|6|||
129494797|NCT00912015|466103597|FG001|Overall Study|Adverse Event|0|||
129494798|NCT00912015|466103598|FG002|Overall Study|Adverse Event|0|||
129494799|NCT00912015|466103599|FG003|Overall Study|Adverse Event|1|||
129494800|NCT01356602|466103600|FG000|Overall Study|Protocol Deviation|0|||
129494801|NCT01356602|466103601|FG001|Overall Study|Protocol Deviation|1|||
129494802|NCT01356602|466103602|FG002|Overall Study|Protocol Deviation|1|||
129494803|NCT01356602|466103600|FG000|Overall Study|Administrative Problems|1|||
129494804|NCT01356602|466103601|FG001|Overall Study|Administrative Problems|4|||
129494805|NCT01356602|466103602|FG002|Overall Study|Administrative Problems|5|||
129494806|NCT01356602|466103600|FG000|Overall Study|Lost to Follow-up|4|||
129494807|NCT01356602|466103601|FG001|Overall Study|Lost to Follow-up|5|||
129494808|NCT01356602|466103602|FG002|Overall Study|Lost to Follow-up|6|||
129494809|NCT01356602|466103600|FG000|Overall Study|Withdrawal by Subject|4|||
129494810|NCT01356602|466103601|FG001|Overall Study|Withdrawal by Subject|3|||
129494811|NCT01356602|466103602|FG002|Overall Study|Withdrawal by Subject|7|||
129494812|NCT01356602|466103600|FG000|Overall Study|Lack of Efficacy|0|||
129494813|NCT01356602|466103601|FG001|Overall Study|Lack of Efficacy|1|||
129494814|NCT01356602|466103602|FG002|Overall Study|Lack of Efficacy|4|||
129494815|NCT01356602|466103600|FG000|Overall Study|Adverse Event|0|||
129494816|NCT01356602|466103601|FG001|Overall Study|Adverse Event|1|||
129494817|NCT01356602|466103602|FG002|Overall Study|Adverse Event|1|||
129494818|NCT01115569|466103603|FG000|Conversion/Titration Phase|Adverse Event|59|||
129494819|NCT01115569|466103604|FG001|Conversion/Titration Phase|Adverse Event|0|||
129981011|NCT01803282|467893426|FG005|Overall Study|Progressive Disease|8|||
129981012|NCT01803282|467893427|FG006|Overall Study|Progressive Disease|23|||
129981013|NCT01803282|467893428|FG007|Overall Study|Progressive Disease|24|||
129981014|NCT01803282|467893429|FG008|Overall Study|Progressive Disease|3|||
129494820|NCT01115569|466103603|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
129494821|NCT01115569|466103604|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
129981015|NCT01803282|467893430|FG009|Overall Study|Progressive Disease|29|||
129494822|NCT01115569|466103603|FG000|Conversion/Titration Phase|Physician Decision|5|||
129494823|NCT01115569|466103604|FG001|Conversion/Titration Phase|Physician Decision|0|||
129494824|NCT01115569|466103603|FG000|Conversion/Titration Phase|Protocol Violation|68|||
129494825|NCT01115569|466103604|FG001|Conversion/Titration Phase|Protocol Violation|0|||
129494826|NCT01115569|466103603|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
129494827|NCT01115569|466103604|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
129494828|NCT01115569|466103603|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
129494829|NCT01115569|466103604|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
129494830|NCT01115569|466103603|FG000|Maintenance Phase|Adverse Event|0|||
129494831|NCT01115569|466103604|FG001|Maintenance Phase|Adverse Event|43|||
129494832|NCT01115569|466103603|FG000|Maintenance Phase|Lost to Follow-up|0|||
129981016|NCT01803282|467893431|FG010|Overall Study|Progressive Disease|6|||
129494833|NCT01115569|466103604|FG001|Maintenance Phase|Lost to Follow-up|8|||
129494834|NCT01115569|466103603|FG000|Maintenance Phase|Physician Decision|0|||
129494835|NCT01115569|466103604|FG001|Maintenance Phase|Physician Decision|3|||
129494836|NCT01115569|466103603|FG000|Maintenance Phase|Protocol Violation|0|||
129494837|NCT01115569|466103604|FG001|Maintenance Phase|Protocol Violation|9|||
129494838|NCT01115569|466103603|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129494839|NCT01115569|466103604|FG001|Maintenance Phase|Withdrawal by Subject|27|||
129494840|NCT01115569|466103603|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
129494841|NCT01115569|466103604|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
129494842|NCT01115569|466103603|FG000|Maintenance Phase|Administrative|0|||
129494843|NCT01115569|466103604|FG001|Maintenance Phase|Administrative|1|||
129494844|NCT02361762|466103605|FG000|Overall Study|Withdrawal by Subject|0|||
129494845|NCT02361762|466103606|FG001|Overall Study|Withdrawal by Subject|1|||
129494846|NCT02361762|466103605|FG000|Overall Study|Lost to Follow-up|0|||
129494847|NCT02361762|466103606|FG001|Overall Study|Lost to Follow-up|1|||
129494848|NCT01931462|466103607|FG000|Overall Study|Withdrawal by Subject|1|||
129494849|NCT02819310|466103608|FG000|Overall Study|Withdrawal by Subject|37|||
129494850|NCT02819310|466103608|FG000|Overall Study|Lost to Follow-up|16|||
129494851|NCT02819310|466103608|FG000|Overall Study|Adverse Event|13|||
129494852|NCT02819310|466103608|FG000|Overall Study|Lack of Efficacy|5|||
129494853|NCT02819310|466103608|FG000|Overall Study|Physician Decision|8|||
129494854|NCT02819310|466103608|FG000|Overall Study|Protocol Violation|30|||
129494855|NCT05070429|466103616|FG000|Overall Study|Death|0|||
129494856|NCT05070429|466103617|FG001|Overall Study|Death|4|||
129494857|NCT05070429|466103616|FG000|Overall Study|Withdrawal by Subject|2|||
129494858|NCT05070429|466103617|FG001|Overall Study|Withdrawal by Subject|1|||
129494859|NCT05070429|466103616|FG000|Overall Study|Other|15|||
129494860|NCT05070429|466103617|FG001|Overall Study|Other|5|||
129494861|NCT03097328|466103618|FG000|Overall Study|Still on Therapy|2|||
129494862|NCT03097328|466103618|FG000|Overall Study|Progressive Disease|29|||
129494863|NCT03097328|466103618|FG000|Overall Study|Adverse Event|4|||
129494864|NCT03097328|466103618|FG000|Overall Study|Withdrawal by Subject|1|||
129494865|NCT03097328|466103618|FG000|Overall Study|Physician Decision|1|||
129494866|NCT03097328|466103618|FG000|Overall Study|Patient Decision|1|||
129494867|NCT03097328|466103618|FG000|Overall Study|Ineligible for Study Drug|1|||
129494868|NCT01798134|466103619|FG000|Overall Study|Lost to Follow-up|1|||
129494869|NCT01798134|466103619|FG000|Overall Study|Withdrawal by Subject|3|||
129494870|NCT01798134|466103619|FG000|Overall Study|Death|2|||
129494871|NCT01798134|466103619|FG000|Overall Study|Adverse Event|3|||
129494872|NCT01798134|466103619|FG000|Overall Study|Physician Decision|3|||
129494873|NCT01798134|466103619|FG000|Overall Study|Liver transplant/surgery|4|||
129494874|NCT02023164|466103620|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
129494875|NCT02023164|466103621|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
129494876|NCT02653976|466103622|FG000|Overall Study|Withdrawal by Subject|5|||
129981017|NCT01803282|467893432|FG011|Overall Study|Progressive Disease|11|||
129981018|NCT01803282|467893421|FG000|Overall Study|Death|0|||
129981019|NCT01803282|467893422|FG001|Overall Study|Death|0|||
129981020|NCT01803282|467893423|FG002|Overall Study|Death|0|||
129981021|NCT01803282|467893424|FG003|Overall Study|Death|0|||
129981022|NCT01803282|467893425|FG004|Overall Study|Death|2|||
129981023|NCT01803282|467893426|FG005|Overall Study|Death|1|||
129981024|NCT01803282|467893427|FG006|Overall Study|Death|1|||
129981025|NCT01803282|467893428|FG007|Overall Study|Death|5|||
129981026|NCT01803282|467893429|FG008|Overall Study|Death|1|||
129981027|NCT01803282|467893430|FG009|Overall Study|Death|1|||
129981028|NCT01803282|467893431|FG010|Overall Study|Death|0|||
129981029|NCT01803282|467893432|FG011|Overall Study|Death|0|||
129981030|NCT01803282|467893421|FG000|Overall Study|Withdrew Consent|0|||
129981031|NCT01803282|467893422|FG001|Overall Study|Withdrew Consent|0|||
129981032|NCT01803282|467893423|FG002|Overall Study|Withdrew Consent|0|||
129981033|NCT01803282|467893424|FG003|Overall Study|Withdrew Consent|6|||
129981034|NCT01803282|467893425|FG004|Overall Study|Withdrew Consent|1|||
129981035|NCT01803282|467893426|FG005|Overall Study|Withdrew Consent|0|||
129981036|NCT01803282|467893427|FG006|Overall Study|Withdrew Consent|8|||
129981037|NCT01803282|467893428|FG007|Overall Study|Withdrew Consent|3|||
129981038|NCT01803282|467893429|FG008|Overall Study|Withdrew Consent|1|||
129494877|NCT02653976|466103622|FG000|Overall Study|Death|4|||
129494878|NCT00883558|466103623|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
129494879|NCT00883558|466103624|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
129494880|NCT00883558|466103625|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
129494881|NCT00883558|466103623|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
129494882|NCT00883558|466103624|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
129494883|NCT00883558|466103625|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
129494884|NCT00883558|466103623|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
129494885|NCT00883558|466103624|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
129494886|NCT00883558|466103625|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
129494887|NCT00883558|466103623|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
129981039|NCT01803282|467893430|FG009|Overall Study|Withdrew Consent|5|||
129981040|NCT01803282|467893431|FG010|Overall Study|Withdrew Consent|0|||
129981041|NCT01803282|467893432|FG011|Overall Study|Withdrew Consent|1|||
129494888|NCT00883558|466103624|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
129494889|NCT00883558|466103625|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
129494890|NCT00883558|466103623|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
129494891|NCT00883558|466103624|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
129494892|NCT00883558|466103625|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
129494893|NCT02436577|466103626|FG000|Overall Study|Protocol Deviation|0|||
129494894|NCT02436577|466103627|FG001|Overall Study|Protocol Deviation|1|||
129494895|NCT02436577|466103628|FG002|Overall Study|Protocol Deviation|0|||
129494896|NCT02436577|466103629|FG003|Overall Study|Protocol Deviation|0|||
129494897|NCT02436577|466103630|FG004|Overall Study|Protocol Deviation|0|||
129494898|NCT02436577|466103631|FG005|Overall Study|Protocol Deviation|0|||
129494899|NCT03703375|466103632|FG000|Randomization Period|Withdrawal by Subject|0|||
129494900|NCT03703375|466103633|FG001|Randomization Period|Withdrawal by Subject|0|||
129494901|NCT03703375|466103634|FG002|Randomization Period|Withdrawal by Subject|0|||
129494902|NCT03703375|466103635|FG003|Randomization Period|Withdrawal by Subject|1|||
129494903|NCT03703375|466103632|FG000|Randomization Period|Completed safety run-in treatment|7|||
129494904|NCT03703375|466103633|FG001|Randomization Period|Completed safety run-in treatment|0|||
129494905|NCT03703375|466103634|FG002|Randomization Period|Completed safety run-in treatment|0|||
129494906|NCT03703375|466103635|FG003|Randomization Period|Completed safety run-in treatment|0|||
129494907|NCT03703375|466103632|FG000|Treatment Period|Other Reasons|0|||
129494908|NCT03703375|466103633|FG001|Treatment Period|Other Reasons|1|||
129494909|NCT03703375|466103634|FG002|Treatment Period|Other Reasons|0|||
129494910|NCT03703375|466103635|FG003|Treatment Period|Other Reasons|3|||
129494911|NCT03703375|466103632|FG000|Treatment Period|Consent Withdrawal|0|||
129494912|NCT03703375|466103633|FG001|Treatment Period|Consent Withdrawal|0|||
129494913|NCT03703375|466103634|FG002|Treatment Period|Consent Withdrawal|0|||
129494914|NCT03703375|466103635|FG003|Treatment Period|Consent Withdrawal|1|||
129494915|NCT03703375|466103632|FG000|Treatment Period|Death|1|||
129494916|NCT03703375|466103633|FG001|Treatment Period|Death|0|||
129494917|NCT03703375|466103634|FG002|Treatment Period|Death|1|||
129494918|NCT03703375|466103635|FG003|Treatment Period|Death|2|||
129494919|NCT03703375|466103632|FG000|Treatment Period|Toxicity of Study Treatment|2|||
129494920|NCT03703375|466103633|FG001|Treatment Period|Toxicity of Study Treatment|0|||
129494921|NCT03703375|466103634|FG002|Treatment Period|Toxicity of Study Treatment|4|||
129494922|NCT03703375|466103635|FG003|Treatment Period|Toxicity of Study Treatment|1|||
129494923|NCT03703375|466103632|FG000|Treatment Period|Progression|32|||
129494924|NCT03703375|466103633|FG001|Treatment Period|Progression|1|||
129494925|NCT03703375|466103634|FG002|Treatment Period|Progression|7|||
129494926|NCT03703375|466103635|FG003|Treatment Period|Progression|11|||
129494927|NCT03703375|466103632|FG000|Treatment Period|Completed treatment|7|||
129494928|NCT03703375|466103633|FG001|Treatment Period|Completed treatment|2|||
129494929|NCT03703375|466103634|FG002|Treatment Period|Completed treatment|0|||
129494930|NCT03703375|466103635|FG003|Treatment Period|Completed treatment|0|||
129494931|NCT00625365|466103637|FG000|Overall Study|Withdrawal by Subject|1|||
129494932|NCT00625365|466103637|FG000|Overall Study|No IV access|5|||
129494933|NCT00625365|466103637|FG000|Overall Study|VSD|1|||
129494934|NCT02531373|466103641|FG000|Overall Study|Lack of Efficacy|0|||
129494935|NCT02531373|466103642|FG001|Overall Study|Lack of Efficacy|0|||
129494936|NCT02531373|466103643|FG002|Overall Study|Lack of Efficacy|0|||
129494937|NCT02531373|466103644|FG003|Overall Study|Lack of Efficacy|0|||
129494938|NCT02531373|466103645|FG004|Overall Study|Lack of Efficacy|3|||
129494939|NCT02531373|466103646|FG005|Overall Study|Lack of Efficacy|2|||
129494940|NCT02531373|466103647|FG006|Overall Study|Lack of Efficacy|4|||
129494941|NCT02531373|466103648|FG007|Overall Study|Lack of Efficacy|8|||
129494942|NCT02531373|466103649|FG008|Overall Study|Lack of Efficacy|5|||
129494943|NCT02531373|466103641|FG000|Overall Study|Lost to Follow-up|0|||
129494944|NCT02531373|466103642|FG001|Overall Study|Lost to Follow-up|0|||
129494945|NCT02531373|466103643|FG002|Overall Study|Lost to Follow-up|0|||
129494946|NCT02531373|466103644|FG003|Overall Study|Lost to Follow-up|0|||
129494947|NCT02531373|466103645|FG004|Overall Study|Lost to Follow-up|0|||
129494948|NCT02531373|466103646|FG005|Overall Study|Lost to Follow-up|2|||
129494949|NCT02531373|466103647|FG006|Overall Study|Lost to Follow-up|2|||
129494950|NCT02531373|466103648|FG007|Overall Study|Lost to Follow-up|0|||
129494951|NCT02531373|466103649|FG008|Overall Study|Lost to Follow-up|0|||
129494952|NCT02531373|466103641|FG000|Overall Study|Physician Decision|0|||
129494953|NCT02531373|466103642|FG001|Overall Study|Physician Decision|0|||
129494954|NCT02531373|466103643|FG002|Overall Study|Physician Decision|0|||
129494955|NCT02531373|466103644|FG003|Overall Study|Physician Decision|0|||
129494956|NCT02531373|466103645|FG004|Overall Study|Physician Decision|2|||
129494957|NCT02531373|466103646|FG005|Overall Study|Physician Decision|1|||
129494958|NCT02531373|466103647|FG006|Overall Study|Physician Decision|0|||
129494959|NCT02531373|466103648|FG007|Overall Study|Physician Decision|0|||
129494960|NCT02531373|466103649|FG008|Overall Study|Physician Decision|0|||
129494961|NCT02531373|466103641|FG000|Overall Study|Protocol Violation|0|||
129494962|NCT02531373|466103642|FG001|Overall Study|Protocol Violation|0|||
129494963|NCT02531373|466103643|FG002|Overall Study|Protocol Violation|0|||
129494964|NCT02531373|466103644|FG003|Overall Study|Protocol Violation|0|||
129494965|NCT02531373|466103645|FG004|Overall Study|Protocol Violation|0|||
129494966|NCT02531373|466103646|FG005|Overall Study|Protocol Violation|1|||
129494967|NCT02531373|466103647|FG006|Overall Study|Protocol Violation|1|||
129494968|NCT02531373|466103648|FG007|Overall Study|Protocol Violation|0|||
129494969|NCT02531373|466103649|FG008|Overall Study|Protocol Violation|1|||
129494970|NCT02531373|466103641|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129494971|NCT02531373|466103642|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129494972|NCT02531373|466103643|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129494973|NCT02531373|466103644|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129494974|NCT02531373|466103645|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129494975|NCT02531373|466103646|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
129494976|NCT02531373|466103647|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
129494977|NCT02531373|466103648|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
129494978|NCT02531373|466103649|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
129494979|NCT02531373|466103641|FG000|Overall Study|Withdrawal by Subject|0|||
129494980|NCT02531373|466103642|FG001|Overall Study|Withdrawal by Subject|0|||
129494981|NCT02531373|466103643|FG002|Overall Study|Withdrawal by Subject|0|||
129494982|NCT02531373|466103644|FG003|Overall Study|Withdrawal by Subject|0|||
129494983|NCT02531373|466103645|FG004|Overall Study|Withdrawal by Subject|3|||
129494984|NCT02531373|466103646|FG005|Overall Study|Withdrawal by Subject|0|||
129494985|NCT02531373|466103647|FG006|Overall Study|Withdrawal by Subject|0|||
129494986|NCT02531373|466103648|FG007|Overall Study|Withdrawal by Subject|0|||
129494987|NCT02531373|466103649|FG008|Overall Study|Withdrawal by Subject|0|||
129494988|NCT00536731|466103650|FG000|Overall Study|Adverse Event|3|||
129494989|NCT00536731|466103651|FG001|Overall Study|Adverse Event|2|||
129494990|NCT00536731|466103652|FG002|Overall Study|Adverse Event|3|||
129494991|NCT00536731|466103650|FG000|Overall Study|Withdrawal by Subject|0|||
129494992|NCT00536731|466103651|FG001|Overall Study|Withdrawal by Subject|2|||
129494993|NCT00536731|466103652|FG002|Overall Study|Withdrawal by Subject|0|||
129494994|NCT00536731|466103650|FG000|Overall Study|Intake of prohibited conc. medication|0|||
129494995|NCT00536731|466103651|FG001|Overall Study|Intake of prohibited conc. medication|0|||
129494996|NCT00536731|466103652|FG002|Overall Study|Intake of prohibited conc. medication|1|||
129494997|NCT00536731|466103650|FG000|Overall Study|Safety reasons|0|||
129494998|NCT00536731|466103651|FG001|Overall Study|Safety reasons|0|||
129494999|NCT00536731|466103652|FG002|Overall Study|Safety reasons|1|||
129495000|NCT00536731|466103650|FG000|Overall Study|Other|1|||
129495001|NCT00536731|466103651|FG001|Overall Study|Other|1|||
129495002|NCT00536731|466103652|FG002|Overall Study|Other|0|||
129495003|NCT01234402|466103653|FG000|Overall Study|Lost to Follow-up|0|||
129495004|NCT01234402|466103654|FG001|Overall Study|Lost to Follow-up|1|||
129495005|NCT01234402|466103655|FG002|Overall Study|Lost to Follow-up|3|||
129495006|NCT01234402|466103653|FG000|Overall Study|Withdrawal by Subject|1|||
129495007|NCT01234402|466103654|FG001|Overall Study|Withdrawal by Subject|3|||
129495008|NCT01234402|466103655|FG002|Overall Study|Withdrawal by Subject|4|||
129495009|NCT01234402|466103653|FG000|Overall Study|Never treated: Death|0|||
129495010|NCT01234402|466103654|FG001|Overall Study|Never treated: Death|0|||
129495011|NCT01234402|466103655|FG002|Overall Study|Never treated: Death|1|||
129495012|NCT01234402|466103653|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
129495013|NCT01234402|466103654|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
129495014|NCT01234402|466103655|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
129495015|NCT01234402|466103653|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
129495016|NCT01234402|466103654|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
129495017|NCT01234402|466103655|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
129495018|NCT02389816|466103656|FG000|Overall Study|Randomized but Not Treated|1|||
129495019|NCT02389816|466103657|FG001|Overall Study|Randomized but Not Treated|0|||
129495020|NCT02389816|466103658|FG002|Overall Study|Randomized but Not Treated|0|||
129495021|NCT02389816|466103656|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
129495022|NCT02389816|466103657|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
129495023|NCT02389816|466103658|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
129495024|NCT02389816|466103656|FG000|Overall Study|Major Protocol Deviation|1|||
129495025|NCT02389816|466103657|FG001|Overall Study|Major Protocol Deviation|0|||
129495026|NCT02389816|466103658|FG002|Overall Study|Major Protocol Deviation|0|||
129495027|NCT02389816|466103656|FG000|Overall Study|Lost to Follow-up|1|||
129495028|NCT02389816|466103657|FG001|Overall Study|Lost to Follow-up|0|||
129495029|NCT02389816|466103658|FG002|Overall Study|Lost to Follow-up|0|||
129495030|NCT02389816|466103656|FG000|Overall Study|Withdrawal of Consent|6|||
129495031|NCT02389816|466103657|FG001|Overall Study|Withdrawal of Consent|4|||
129495032|NCT02389816|466103658|FG002|Overall Study|Withdrawal of Consent|4|||
129495033|NCT02389816|466103656|FG000|Overall Study|Lack of Efficacy|1|||
129495034|NCT02389816|466103657|FG001|Overall Study|Lack of Efficacy|0|||
129495035|NCT02389816|466103658|FG002|Overall Study|Lack of Efficacy|0|||
129495036|NCT02389816|466103656|FG000|Overall Study|Non Compliance with Study Drug|1|||
129495037|NCT02389816|466103657|FG001|Overall Study|Non Compliance with Study Drug|1|||
129495038|NCT02389816|466103658|FG002|Overall Study|Non Compliance with Study Drug|1|||
129495039|NCT02389816|466103656|FG000|Overall Study|Reason not Specified|0|||
129495040|NCT02389816|466103657|FG001|Overall Study|Reason not Specified|2|||
129495041|NCT02389816|466103658|FG002|Overall Study|Reason not Specified|0|||
129495042|NCT02417233|466103659|FG000|Overall Study|Death|4|||
129495043|NCT02417233|466103660|FG001|Overall Study|Death|10|||
129495044|NCT02417233|466103661|FG002|Overall Study|Death|14|||
129495045|NCT02417233|466103659|FG000|Overall Study|Lost to Follow-up|27|||
129495046|NCT02417233|466103660|FG001|Overall Study|Lost to Follow-up|39|||
129495047|NCT02417233|466103661|FG002|Overall Study|Lost to Follow-up|34|||
129495048|NCT02417233|466103659|FG000|Overall Study|Protocol Violation|2|||
129495049|NCT02417233|466103660|FG001|Overall Study|Protocol Violation|0|||
129981042|NCT01803282|467893421|FG000|Overall Study|Investigator's Discretion|0|||
129981043|NCT01803282|467893422|FG001|Overall Study|Investigator's Discretion|0|||
129981044|NCT01803282|467893423|FG002|Overall Study|Investigator's Discretion|0|||
129981045|NCT01803282|467893424|FG003|Overall Study|Investigator's Discretion|7|||
129981046|NCT01803282|467893425|FG004|Overall Study|Investigator's Discretion|2|||
129981047|NCT01803282|467893426|FG005|Overall Study|Investigator's Discretion|1|||
129981048|NCT01803282|467893427|FG006|Overall Study|Investigator's Discretion|7|||
129981049|NCT01803282|467893428|FG007|Overall Study|Investigator's Discretion|10|||
129981050|NCT01803282|467893429|FG008|Overall Study|Investigator's Discretion|6|||
129981051|NCT01803282|467893430|FG009|Overall Study|Investigator's Discretion|7|||
129981052|NCT01803282|467893431|FG010|Overall Study|Investigator's Discretion|1|||
129981053|NCT01803282|467893432|FG011|Overall Study|Investigator's Discretion|0|||
129981054|NCT01803282|467893421|FG000|Overall Study|Adverse Event|0|||
129981055|NCT01803282|467893422|FG001|Overall Study|Adverse Event|0|||
129981056|NCT01803282|467893423|FG002|Overall Study|Adverse Event|0|||
129981057|NCT01803282|467893424|FG003|Overall Study|Adverse Event|0|||
129981058|NCT01803282|467893425|FG004|Overall Study|Adverse Event|0|||
129981059|NCT01803282|467893426|FG005|Overall Study|Adverse Event|0|||
129981060|NCT01803282|467893427|FG006|Overall Study|Adverse Event|1|||
129981061|NCT01803282|467893428|FG007|Overall Study|Adverse Event|2|||
129981062|NCT01803282|467893429|FG008|Overall Study|Adverse Event|0|||
129981063|NCT01803282|467893430|FG009|Overall Study|Adverse Event|1|||
129981064|NCT01803282|467893431|FG010|Overall Study|Adverse Event|0|||
129981065|NCT01803282|467893432|FG011|Overall Study|Adverse Event|3|||
129981066|NCT01803282|467893421|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129981067|NCT01803282|467893422|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129981068|NCT01803282|467893423|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129981069|NCT01803282|467893424|FG003|Overall Study|Non-Compliance with Study Drug|1|||
129981070|NCT01803282|467893425|FG004|Overall Study|Non-Compliance with Study Drug|0|||
129981071|NCT01803282|467893426|FG005|Overall Study|Non-Compliance with Study Drug|0|||
129981072|NCT01803282|467893427|FG006|Overall Study|Non-Compliance with Study Drug|0|||
129981073|NCT01803282|467893428|FG007|Overall Study|Non-Compliance with Study Drug|0|||
129981074|NCT01803282|467893429|FG008|Overall Study|Non-Compliance with Study Drug|0|||
129981075|NCT01803282|467893430|FG009|Overall Study|Non-Compliance with Study Drug|0|||
129981076|NCT01803282|467893431|FG010|Overall Study|Non-Compliance with Study Drug|0|||
129981077|NCT01803282|467893432|FG011|Overall Study|Non-Compliance with Study Drug|0|||
129981078|NCT01803282|467893421|FG000|Overall Study|Unknown Reason|0|||
129981079|NCT01803282|467893422|FG001|Overall Study|Unknown Reason|0|||
129981080|NCT01803282|467893423|FG002|Overall Study|Unknown Reason|0|||
129981081|NCT01803282|467893424|FG003|Overall Study|Unknown Reason|0|||
129981082|NCT01803282|467893425|FG004|Overall Study|Unknown Reason|0|||
129981083|NCT01803282|467893426|FG005|Overall Study|Unknown Reason|0|||
129981084|NCT01803282|467893427|FG006|Overall Study|Unknown Reason|0|||
129981085|NCT01803282|467893428|FG007|Overall Study|Unknown Reason|1|||
129981086|NCT01803282|467893429|FG008|Overall Study|Unknown Reason|0|||
129981087|NCT01803282|467893430|FG009|Overall Study|Unknown Reason|0|||
129981088|NCT01803282|467893431|FG010|Overall Study|Unknown Reason|0|||
129981089|NCT01803282|467893432|FG011|Overall Study|Unknown Reason|0|||
129981090|NCT01803282|467893421|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
129981091|NCT01803282|467893422|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
129981092|NCT01803282|467893423|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
129981093|NCT01803282|467893424|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
129981094|NCT01803282|467893425|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
129981095|NCT01803282|467893426|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
129495050|NCT02417233|466103661|FG002|Overall Study|Protocol Violation|2|||
129495051|NCT02417233|466103659|FG000|Overall Study|Withdrawal by Subject|2|||
129981096|NCT01803282|467893427|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
129981097|NCT01803282|467893428|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
129981098|NCT01803282|467893429|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
129495052|NCT02417233|466103660|FG001|Overall Study|Withdrawal by Subject|1|||
129495053|NCT02417233|466103661|FG002|Overall Study|Withdrawal by Subject|8|||
129495054|NCT02417233|466103659|FG000|Overall Study|Relocation out of study area|1|||
129981099|NCT01803282|467893430|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
129981100|NCT01803282|467893431|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
129981101|NCT01803282|467893432|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
129495055|NCT02417233|466103660|FG001|Overall Study|Relocation out of study area|0|||
129495056|NCT02417233|466103661|FG002|Overall Study|Relocation out of study area|1|||
129495057|NCT02417233|466103659|FG000|Overall Study|Mentally unstable|0|||
129495058|NCT02417233|466103660|FG001|Overall Study|Mentally unstable|1|||
129495059|NCT02417233|466103661|FG002|Overall Study|Mentally unstable|0|||
129495060|NCT01594476|466103662|FG000|Overall Study|Protocol Violation|1|||
129495061|NCT01594476|466103663|FG001|Overall Study|Protocol Violation|3|||
129495062|NCT01469013|466103666|FG000|Part A (Treatment Period)|Adverse Event|1|||
129495063|NCT01469013|466103667|FG001|Part A (Treatment Period)|Adverse Event|0|||
129495064|NCT01469013|466103668|FG002|Part A (Treatment Period)|Adverse Event|0|||
129495065|NCT01469013|466103669|FG003|Part A (Treatment Period)|Adverse Event|0|||
129495066|NCT01469013|466103670|FG004|Part A (Treatment Period)|Adverse Event|1|||
129495067|NCT01469013|466103671|FG005|Part A (Treatment Period)|Adverse Event|0|||
129495068|NCT01469013|466103672|FG006|Part A (Treatment Period)|Adverse Event|0|||
129495069|NCT01469013|466103673|FG007|Part A (Treatment Period)|Adverse Event|0|||
129495070|NCT01469013|466103674|FG008|Part A (Treatment Period)|Adverse Event|0|||
129495071|NCT01469013|466103675|FG009|Part A (Treatment Period)|Adverse Event|0|||
129495072|NCT01469013|466103676|FG010|Part A (Treatment Period)|Adverse Event|0|||
129495073|NCT01469013|466103677|FG011|Part A (Treatment Period)|Adverse Event|0|||
129495074|NCT01469013|466103678|FG012|Part A (Treatment Period)|Adverse Event|0|||
129495075|NCT01469013|466103666|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495076|NCT01469013|466103667|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495077|NCT01469013|466103668|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
129495078|NCT01469013|466103669|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495079|NCT01469013|466103670|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495080|NCT01469013|466103671|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495081|NCT01469013|466103672|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495082|NCT01469013|466103673|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495083|NCT01469013|466103674|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495084|NCT01469013|466103675|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495085|NCT01469013|466103676|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495086|NCT01469013|466103677|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495087|NCT01469013|466103678|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
129495088|NCT01469013|466103666|FG000|Part B (Extension Period)|Adverse Event|0|||
129495089|NCT01469013|466103667|FG001|Part B (Extension Period)|Adverse Event|0|||
129495090|NCT01469013|466103668|FG002|Part B (Extension Period)|Adverse Event|0|||
129495091|NCT01469013|466103669|FG003|Part B (Extension Period)|Adverse Event|0|||
129495092|NCT01469013|466103670|FG004|Part B (Extension Period)|Adverse Event|0|||
129495093|NCT01469013|466103671|FG005|Part B (Extension Period)|Adverse Event|2|||
129495094|NCT01469013|466103672|FG006|Part B (Extension Period)|Adverse Event|5|||
129495095|NCT01469013|466103673|FG007|Part B (Extension Period)|Adverse Event|5|||
129495096|NCT01469013|466103674|FG008|Part B (Extension Period)|Adverse Event|3|||
129495097|NCT01469013|466103675|FG009|Part B (Extension Period)|Adverse Event|3|||
129495098|NCT01469013|466103676|FG010|Part B (Extension Period)|Adverse Event|1|||
129495099|NCT01469013|466103677|FG011|Part B (Extension Period)|Adverse Event|6|||
129495100|NCT01469013|466103678|FG012|Part B (Extension Period)|Adverse Event|3|||
129495101|NCT01469013|466103666|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
129495102|NCT01469013|466103667|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
129495103|NCT01469013|466103668|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
129495104|NCT01469013|466103669|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
129495105|NCT01469013|466103670|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
129495106|NCT01469013|466103671|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
129495107|NCT01469013|466103672|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
129495108|NCT01469013|466103673|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
129495109|NCT01469013|466103674|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
129495110|NCT01469013|466103675|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
129495111|NCT01469013|466103676|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
129495112|NCT01469013|466103677|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
129495113|NCT01469013|466103678|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
129495114|NCT00002663|466103679|FG000|Overall Study|Death|4|||
129981102|NCT01803282|467893421|FG000|Overall Study|Enrolled but Never Treated|0|||
129495115|NCT00002663|466103680|FG001|Overall Study|Death|1|||
129495116|NCT00002663|466103681|FG002|Overall Study|Death|1|||
129495117|NCT00002663|466103682|FG003|Overall Study|Death|0|||
129495118|NCT00002663|466103683|FG004|Overall Study|Death|0|||
129495119|NCT00002663|466103684|FG005|Overall Study|Death|13|||
129495120|NCT00002663|466103685|FG006|Overall Study|Death|0|||
129495121|NCT00002663|466103686|FG007|Overall Study|Death|1|||
129495122|NCT00002663|466103687|FG008|Overall Study|Death|1|||
129495123|NCT00002663|466103688|FG009|Overall Study|Death|1|||
129495124|NCT00002663|466103679|FG000|Overall Study|Lost to Follow-up|3|||
129495125|NCT00002663|466103680|FG001|Overall Study|Lost to Follow-up|0|||
129495126|NCT00002663|466103681|FG002|Overall Study|Lost to Follow-up|0|||
129495127|NCT00002663|466103682|FG003|Overall Study|Lost to Follow-up|1|||
129495128|NCT00002663|466103683|FG004|Overall Study|Lost to Follow-up|0|||
129495129|NCT00002663|466103684|FG005|Overall Study|Lost to Follow-up|1|||
129495130|NCT00002663|466103685|FG006|Overall Study|Lost to Follow-up|0|||
129495131|NCT00002663|466103686|FG007|Overall Study|Lost to Follow-up|0|||
129495132|NCT00002663|466103687|FG008|Overall Study|Lost to Follow-up|0|||
129495133|NCT00002663|466103688|FG009|Overall Study|Lost to Follow-up|0|||
129495134|NCT00002663|466103679|FG000|Overall Study|Other|0|||
129495135|NCT00002663|466103680|FG001|Overall Study|Other|1|||
129495136|NCT00002663|466103681|FG002|Overall Study|Other|0|||
129495137|NCT00002663|466103682|FG003|Overall Study|Other|0|||
129495138|NCT00002663|466103683|FG004|Overall Study|Other|0|||
129495139|NCT00002663|466103684|FG005|Overall Study|Other|1|||
129495140|NCT00002663|466103685|FG006|Overall Study|Other|1|||
129495141|NCT00002663|466103686|FG007|Overall Study|Other|0|||
129495142|NCT00002663|466103687|FG008|Overall Study|Other|0|||
129495143|NCT00002663|466103688|FG009|Overall Study|Other|0|||
129495144|NCT00002663|466103679|FG000|Overall Study|Physician Decision|0|||
129495145|NCT00002663|466103680|FG001|Overall Study|Physician Decision|0|||
129495146|NCT00002663|466103681|FG002|Overall Study|Physician Decision|0|||
129495147|NCT00002663|466103682|FG003|Overall Study|Physician Decision|0|||
129495148|NCT00002663|466103683|FG004|Overall Study|Physician Decision|1|||
129495149|NCT00002663|466103684|FG005|Overall Study|Physician Decision|0|||
129495150|NCT00002663|466103685|FG006|Overall Study|Physician Decision|0|||
129495151|NCT00002663|466103686|FG007|Overall Study|Physician Decision|0|||
129495152|NCT00002663|466103687|FG008|Overall Study|Physician Decision|1|||
129495153|NCT00002663|466103688|FG009|Overall Study|Physician Decision|1|||
129495154|NCT00002663|466103679|FG000|Overall Study|Adverse Event|0|||
129495155|NCT00002663|466103680|FG001|Overall Study|Adverse Event|0|||
129495156|NCT00002663|466103681|FG002|Overall Study|Adverse Event|0|||
129495157|NCT00002663|466103682|FG003|Overall Study|Adverse Event|1|||
129495158|NCT00002663|466103683|FG004|Overall Study|Adverse Event|0|||
129495159|NCT00002663|466103684|FG005|Overall Study|Adverse Event|0|||
129495160|NCT00002663|466103685|FG006|Overall Study|Adverse Event|0|||
129495161|NCT00002663|466103686|FG007|Overall Study|Adverse Event|1|||
129495162|NCT00002663|466103687|FG008|Overall Study|Adverse Event|0|||
129495163|NCT00002663|466103688|FG009|Overall Study|Adverse Event|0|||
129495164|NCT01603641|466103690|FG000|Overall Study|Did not Receive Treatment|3|||
129495165|NCT01603641|466103690|FG000|Overall Study|Adverse Event|1|||
129495166|NCT01603641|466103690|FG000|Overall Study|Lack of Efficacy|1|||
129495167|NCT01603641|466103690|FG000|Overall Study|Lost to Follow-up|6|||
129495168|NCT01603641|466103690|FG000|Overall Study|Personal Reasons|18|||
129495169|NCT01603641|466103690|FG000|Overall Study|Other Miscellaneous Reasons|6|||
129495170|NCT03161678|466103691|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
129495171|NCT03161678|466103692|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
129495172|NCT03161678|466103693|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129495173|NCT03161678|466103694|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
129495174|NCT03161678|466103695|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
129495175|NCT03161678|466103696|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
129495176|NCT03161678|466103691|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
129495177|NCT03161678|466103692|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
129495178|NCT03161678|466103693|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
129495179|NCT03161678|466103694|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
129495180|NCT03161678|466103695|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
129495181|NCT03161678|466103696|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
129495182|NCT03161678|466103691|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
129495183|NCT03161678|466103692|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
129495184|NCT03161678|466103693|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
129495185|NCT03161678|466103694|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
129495186|NCT03161678|466103695|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
129495187|NCT03161678|466103696|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
129495188|NCT03161678|466103691|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
129495189|NCT03161678|466103692|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
129495190|NCT03161678|466103693|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
129981103|NCT01803282|467893422|FG001|Overall Study|Enrolled but Never Treated|0|||
129981104|NCT01803282|467893423|FG002|Overall Study|Enrolled but Never Treated|0|||
129495191|NCT03161678|466103694|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
129495192|NCT03161678|466103695|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
129495193|NCT03161678|466103696|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
129495194|NCT00739297|466103697|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
129495195|NCT00739297|466103698|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
129495196|NCT00739297|466103699|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
129495197|NCT00739297|466103700|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
129495198|NCT00739297|466103701|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
129981105|NCT01803282|467893424|FG003|Overall Study|Enrolled but Never Treated|0|||
129495199|NCT00739297|466103702|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
129495200|NCT00739297|466103703|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
129495201|NCT00739297|466103697|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
129538914|NCT01238861|466265109|FG002|Overall Study|Unplanned surgery|0|||
129495202|NCT00739297|466103698|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
129495203|NCT00739297|466103699|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
129495204|NCT00739297|466103700|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
129495205|NCT00739297|466103701|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
129495206|NCT00739297|466103702|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
129495207|NCT00739297|466103703|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
129495208|NCT01757704|466103704|FG000|Overall Study|Protocol Violation|1|||
129495209|NCT01757704|466103705|FG001|Overall Study|Protocol Violation|3|||
129495210|NCT02890329|466103708|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
129495211|NCT02890329|466103709|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
129495212|NCT02890329|466103710|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
129495213|NCT02890329|466103711|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
129495214|NCT02890329|466103712|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
129495215|NCT02890329|466103713|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
129495216|NCT02890329|466103708|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
129495217|NCT02890329|466103709|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
129495218|NCT02890329|466103710|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
129495219|NCT02890329|466103711|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
129495220|NCT02890329|466103712|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
129495221|NCT02890329|466103713|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
129495222|NCT02890329|466103708|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
129495223|NCT02890329|466103709|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
129495224|NCT02890329|466103710|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
129495225|NCT02890329|466103711|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
129495226|NCT02890329|466103712|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
129495227|NCT02890329|466103713|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
129495228|NCT02890329|466103708|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
129495229|NCT02890329|466103709|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
129495230|NCT02890329|466103710|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
129495231|NCT02890329|466103711|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
129495232|NCT02890329|466103712|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
129495233|NCT02890329|466103713|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
129495234|NCT02749721|466103714|FG000|Screening|Withdrawal by Subject|1|||
129495235|NCT02749721|466103714|FG000|Screening|Lost to Follow-up|2|||
129495236|NCT02749721|466103714|FG000|Screening|Protocol Violation|3|||
129495237|NCT02749721|466103714|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
129495238|NCT02749721|466103714|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
129495239|NCT02137772|466103715|FG000|Overall Study|Adverse Event|6|||
129495240|NCT02137772|466103716|FG001|Overall Study|Adverse Event|3|||
129495241|NCT02137772|466103715|FG000|Overall Study|Death|71|||
129495242|NCT02137772|466103716|FG001|Overall Study|Death|44|||
129495243|NCT02137772|466103715|FG000|Overall Study|Lost to Follow-up|8|||
129495244|NCT02137772|466103716|FG001|Overall Study|Lost to Follow-up|4|||
129495245|NCT02137772|466103715|FG000|Overall Study|Physician Decision|15|||
129495246|NCT02137772|466103716|FG001|Overall Study|Physician Decision|5|||
129495247|NCT02137772|466103715|FG000|Overall Study|Withdrawal by Subject|28|||
129495248|NCT02137772|466103716|FG001|Overall Study|Withdrawal by Subject|17|||
129495249|NCT02137772|466103715|FG000|Overall Study|Non-compliance with study drug|1|||
129495250|NCT02137772|466103716|FG001|Overall Study|Non-compliance with study drug|0|||
129495251|NCT02137772|466103715|FG000|Overall Study|Not treated|3|||
129495252|NCT02137772|466103716|FG001|Overall Study|Not treated|2|||
129495253|NCT02084134|466103719|FG000|Overall Study|Protocol Violation|4|||
129495254|NCT02084134|466103720|FG001|Overall Study|Protocol Violation|2|||
129495255|NCT02084134|466103719|FG000|Overall Study|Death|0|||
129495256|NCT02084134|466103720|FG001|Overall Study|Death|1|||
129495257|NCT00374907|466103721|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
129495258|NCT00374907|466103722|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
129981106|NCT01803282|467893425|FG004|Overall Study|Enrolled but Never Treated|1|||
129981107|NCT01803282|467893426|FG005|Overall Study|Enrolled but Never Treated|0|||
129981108|NCT01803282|467893427|FG006|Overall Study|Enrolled but Never Treated|1|||
129981109|NCT01803282|467893428|FG007|Overall Study|Enrolled but Never Treated|1|||
129495259|NCT00374907|466103721|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
129495260|NCT00374907|466103722|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
129495261|NCT00374907|466103721|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
129495262|NCT00374907|466103722|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
129495263|NCT00374907|466103721|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
129538915|NCT01238861|466265110|FG003|Overall Study|Unplanned surgery|0|||
129495264|NCT00374907|466103722|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
129495265|NCT00374907|466103721|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
129495266|NCT00374907|466103722|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
129495267|NCT04229446|466103723|FG000|Overall Study|Death|12|||
129495268|NCT04229446|466103724|FG001|Overall Study|Death|10|||
129495269|NCT04229446|466103723|FG000|Overall Study|Lost to Follow-up|5|||
129495270|NCT04229446|466103724|FG001|Overall Study|Lost to Follow-up|8|||
129495271|NCT00705224|466103725|FG000|Overall Study|Adverse Event|1|||
129495272|NCT00705224|466103725|FG000|Overall Study|Lack of Efficacy|2|||
129495273|NCT00705224|466103725|FG000|Overall Study|Withdrawal by Subject|3|||
129495274|NCT00705224|466103725|FG000|Overall Study|Lost to Follow-up|5|||
129495275|NCT00968253|466103726|FG000|Overall Study|Death|0|||
129495276|NCT00968253|466103727|FG001|Overall Study|Death|0|||
129495277|NCT00968253|466103728|FG002|Overall Study|Death|2|||
129495278|NCT00968253|466103726|FG000|Overall Study|Withdrawal by Subject|0|||
129495279|NCT00968253|466103727|FG001|Overall Study|Withdrawal by Subject|0|||
129495280|NCT00968253|466103728|FG002|Overall Study|Withdrawal by Subject|1|||
129495281|NCT00968253|466103726|FG000|Overall Study|Disease Progression|0|||
129495282|NCT00968253|466103727|FG001|Overall Study|Disease Progression|3|||
129495283|NCT00968253|466103728|FG002|Overall Study|Disease Progression|3|||
129495284|NCT00968253|466103726|FG000|Overall Study|Adverse Event|0|||
129495285|NCT00968253|466103727|FG001|Overall Study|Adverse Event|0|||
129495286|NCT00968253|466103728|FG002|Overall Study|Adverse Event|1|||
129495287|NCT02429427|466103731|FG000|Overall Study|Adverse Event|220|||
129495288|NCT02429427|466103732|FG001|Overall Study|Adverse Event|92|||
129495289|NCT02429427|466103731|FG000|Overall Study|Protocol Violation|10|||
129495290|NCT02429427|466103732|FG001|Overall Study|Protocol Violation|6|||
129495291|NCT02429427|466103731|FG000|Overall Study|Lost to Follow-up|15|||
129495292|NCT02429427|466103732|FG001|Overall Study|Lost to Follow-up|6|||
129495293|NCT02429427|466103731|FG000|Overall Study|Withdrawal by Subject|64|||
129495294|NCT02429427|466103732|FG001|Overall Study|Withdrawal by Subject|34|||
129495295|NCT02429427|466103731|FG000|Overall Study|Other|62|||
129495296|NCT02429427|466103732|FG001|Overall Study|Other|41|||
129495297|NCT00719732|466103733|FG000|Overall Study|Lost to Follow-up|20|||
129495298|NCT00719732|466103733|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
129495299|NCT00719732|466103733|FG000|Overall Study|Illness not associated with device|1|||
129495300|NCT03625986|466105014|FG000|Randomization Period|Lost to Follow-up|7|||
129495301|NCT03625986|466105015|FG001|Randomization Period|Lost to Follow-up|12|||
129495302|NCT03625986|466105014|FG000|Randomization Period|Withdrawal by Subject|10|||
129495303|NCT03625986|466105015|FG001|Randomization Period|Withdrawal by Subject|6|||
129495304|NCT04920084|466105017|FG000|Overall Study|Adverse Event|1|||
129495305|NCT04920084|466105017|FG000|Overall Study|Lost to Follow-up|2|||
129495306|NCT04920084|466105017|FG000|Overall Study|Withdrawal by Subject|2|||
129495307|NCT00620321|466105018|FG000|Overall Study|Adverse Event|1|||
129495308|NCT00620321|466105019|FG001|Overall Study|Adverse Event|1|||
129495309|NCT00620321|466105018|FG000|Overall Study|Death|1|||
129495310|NCT00620321|466105019|FG001|Overall Study|Death|1|||
129495311|NCT00620321|466105018|FG000|Overall Study|Physician Decision|0|||
129495312|NCT00620321|466105019|FG001|Overall Study|Physician Decision|7|||
129495313|NCT00620321|466105018|FG000|Overall Study|Progressive Disease|5|||
129495314|NCT00620321|466105019|FG001|Overall Study|Progressive Disease|5|||
129495315|NCT00620321|466105018|FG000|Overall Study|Sponsor Decision|0|||
129495316|NCT00620321|466105019|FG001|Overall Study|Sponsor Decision|1|||
129495317|NCT00620321|466105018|FG000|Overall Study|Withdrawal by Subject|1|||
129495318|NCT00620321|466105019|FG001|Overall Study|Withdrawal by Subject|1|||
129495319|NCT04191967|466105020|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
129495320|NCT04191967|466105020|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
129495321|NCT01431144|466105021|FG000|Overall Study|Implant mobility and removal|2|||
129495322|NCT01431144|466105022|FG001|Overall Study|Implant mobility and removal|0|||
129495323|NCT02410902|466105030|FG000|Overall Study|Adverse Event|2|||
129495324|NCT02410902|466105031|FG001|Overall Study|Adverse Event|3|||
129495325|NCT02410902|466105030|FG000|Overall Study|Lost to Follow-up|4|||
129495326|NCT02410902|466105031|FG001|Overall Study|Lost to Follow-up|1|||
129495327|NCT02410902|466105030|FG000|Overall Study|Protocol Violation|1|||
129495328|NCT02410902|466105031|FG001|Overall Study|Protocol Violation|4|||
129495329|NCT02410902|466105030|FG000|Overall Study|Withdrawal by Subject|6|||
129495330|NCT02410902|466105031|FG001|Overall Study|Withdrawal by Subject|8|||
129495331|NCT02410902|466105030|FG000|Overall Study|Non-Compliance|8|||
129495332|NCT02410902|466105031|FG001|Overall Study|Non-Compliance|2|||
129495333|NCT00953043|466105032|FG000|Overall Study|Withdrawal by Subject|4|||
129495334|NCT00953043|466105033|FG001|Overall Study|Withdrawal by Subject|0|||
129495335|NCT00953043|466105032|FG000|Overall Study|Physician Decision|0|||
129495336|NCT00953043|466105033|FG001|Overall Study|Physician Decision|2|||
129495337|NCT01432262|466105034|FG000|Overall Study|Withdrawal by Subject|2|||
129495338|NCT01432262|466105035|FG001|Overall Study|Withdrawal by Subject|1|||
129495339|NCT00165646|466105036|FG000|Overall Study|Adverse Event|1|||
129495340|NCT00165646|466105037|FG001|Overall Study|Adverse Event|1|||
129495341|NCT00165646|466105038|FG002|Overall Study|Adverse Event|1|||
129495342|NCT00165646|466105036|FG000|Overall Study|Lack of Efficacy|1|||
129495343|NCT00165646|466105037|FG001|Overall Study|Lack of Efficacy|2|||
129495344|NCT00165646|466105038|FG002|Overall Study|Lack of Efficacy|0|||
129495345|NCT00165646|466105036|FG000|Overall Study|Withdrawal by Subject|0|||
129495346|NCT00165646|466105037|FG001|Overall Study|Withdrawal by Subject|2|||
129981110|NCT01803282|467893429|FG008|Overall Study|Enrolled but Never Treated|0|||
129981111|NCT01803282|467893430|FG009|Overall Study|Enrolled but Never Treated|1|||
129981112|NCT01803282|467893431|FG010|Overall Study|Enrolled but Never Treated|0|||
129981113|NCT01803282|467893432|FG011|Overall Study|Enrolled but Never Treated|0|||
129981114|NCT01743989|467893433|FG000|Treatment Phase|Unstable MR4.0|0|||
129981115|NCT01743989|467893434|FG001|Treatment Phase|Unstable MR4.0|6|||
129981116|NCT01743989|467893435|FG002|Treatment Phase|Unstable MR4.0|263|||
129981117|NCT01743989|467893433|FG000|Treatment Phase|Adverse Event|0|||
129981118|NCT01743989|467893434|FG001|Treatment Phase|Adverse Event|4|||
129981119|NCT01743989|467893435|FG002|Treatment Phase|Adverse Event|67|||
129981120|NCT01743989|467893433|FG000|Treatment Phase|Withdrawal by Subject|1|||
129981121|NCT01743989|467893434|FG001|Treatment Phase|Withdrawal by Subject|3|||
129981122|NCT01743989|467893435|FG002|Treatment Phase|Withdrawal by Subject|28|||
129981123|NCT01743989|467893433|FG000|Treatment Phase|Death|0|||
129981124|NCT01743989|467893434|FG001|Treatment Phase|Death|1|||
129981125|NCT01743989|467893435|FG002|Treatment Phase|Death|3|||
129981126|NCT01743989|467893433|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
129981127|NCT01743989|467893434|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
129981128|NCT01743989|467893435|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
129981129|NCT01743989|467893433|FG000|Treatment Phase|Protocol deviation|0|||
129981130|NCT01743989|467893434|FG001|Treatment Phase|Protocol deviation|0|||
129981131|NCT01743989|467893435|FG002|Treatment Phase|Protocol deviation|3|||
129981132|NCT01743989|467893433|FG000|Treatment Phase|Pregnancy|0|||
129981133|NCT01743989|467893434|FG001|Treatment Phase|Pregnancy|0|||
129981134|NCT01743989|467893435|FG002|Treatment Phase|Pregnancy|2|||
129981135|NCT01743989|467893433|FG000|Treatment Phase|Lost to Follow-up|0|||
129981136|NCT01743989|467893434|FG001|Treatment Phase|Lost to Follow-up|0|||
129981137|NCT01743989|467893435|FG002|Treatment Phase|Lost to Follow-up|2|||
129981138|NCT01743989|467893433|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
129981139|NCT01743989|467893434|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
129981140|NCT01743989|467893435|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
129981141|NCT01743989|467893433|FG000|Treatment Phase|Administrative problems|0|||
129981142|NCT01743989|467893434|FG001|Treatment Phase|Administrative problems|0|||
129981143|NCT01743989|467893435|FG002|Treatment Phase|Administrative problems|1|||
129981144|NCT01743989|467893433|FG000|Treatment Phase|New cancer (CML) therapy|0|||
129981145|NCT01743989|467893434|FG001|Treatment Phase|New cancer (CML) therapy|1|||
129981146|NCT01743989|467893435|FG002|Treatment Phase|New cancer (CML) therapy|0|||
129981147|NCT01743989|467893433|FG000|Treatment Phase|Physician Decision|0|||
129981148|NCT01743989|467893434|FG001|Treatment Phase|Physician Decision|0|||
129981149|NCT01743989|467893435|FG002|Treatment Phase|Physician Decision|3|||
129981150|NCT01743989|467893433|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
129981151|NCT01743989|467893434|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
129981152|NCT01743989|467893435|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
129981153|NCT01743989|467893433|FG000|Treatment Phase|Not randomized by mistake|0|||
129981154|NCT01743989|467893434|FG001|Treatment Phase|Not randomized by mistake|0|||
129981155|NCT01743989|467893435|FG002|Treatment Phase|Not randomized by mistake|1|||
129981156|NCT01743989|467893433|FG000|Treatment Phase|Included by mistake|0|||
129981157|NCT01743989|467893434|FG001|Treatment Phase|Included by mistake|0|||
129981158|NCT01743989|467893435|FG002|Treatment Phase|Included by mistake|1|||
129981159|NCT01743989|467893433|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
129495347|NCT00165646|466105038|FG002|Overall Study|Withdrawal by Subject|1|||
129495348|NCT00165646|466105036|FG000|Overall Study|Physician Decision|2|||
129495349|NCT00165646|466105037|FG001|Overall Study|Physician Decision|0|||
129495350|NCT00165646|466105038|FG002|Overall Study|Physician Decision|2|||
129495351|NCT00165646|466105036|FG000|Overall Study|Protocol Violation|1|||
129495352|NCT00165646|466105037|FG001|Overall Study|Protocol Violation|0|||
129495353|NCT00165646|466105038|FG002|Overall Study|Protocol Violation|0|||
129981160|NCT01743989|467893434|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
129981161|NCT01743989|467893435|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
129981162|NCT01743989|467893433|FG000|TFR Phase|Adverse Event|0|||
129981163|NCT01743989|467893434|FG001|TFR Phase|Adverse Event|1|||
129981164|NCT01743989|467893435|FG002|TFR Phase|Adverse Event|0|||
129981165|NCT01743989|467893433|FG000|TFR Phase|Lost to Follow-up|0|||
129981166|NCT01743989|467893434|FG001|TFR Phase|Lost to Follow-up|2|||
129981167|NCT01743989|467893435|FG002|TFR Phase|Lost to Follow-up|0|||
129981168|NCT01743989|467893433|FG000|TFR Phase|Physician Decision|0|||
129981169|NCT01743989|467893434|FG001|TFR Phase|Physician Decision|1|||
129981170|NCT01743989|467893435|FG002|TFR Phase|Physician Decision|0|||
129981171|NCT01743989|467893433|FG000|TFR Phase|Logistical problems|0|||
129495354|NCT04657016|466105039|FG000|Overall Study|Adverse Event|2|||
129495355|NCT04657016|466105040|FG001|Overall Study|Adverse Event|4|||
129981172|NCT01743989|467893434|FG001|TFR Phase|Logistical problems|2|||
129495356|NCT04657016|466105039|FG000|Overall Study|Death|1|||
129495357|NCT04657016|466105040|FG001|Overall Study|Death|1|||
129495358|NCT04657016|466105039|FG000|Overall Study|Lost to Follow-up|24|||
129495359|NCT04657016|466105040|FG001|Overall Study|Lost to Follow-up|12|||
129495360|NCT04657016|466105039|FG000|Overall Study|Physician Decision|1|||
129495361|NCT04657016|466105040|FG001|Overall Study|Physician Decision|2|||
129495362|NCT04657016|466105039|FG000|Overall Study|Pregnancy|2|||
129495363|NCT04657016|466105040|FG001|Overall Study|Pregnancy|2|||
129495364|NCT04657016|466105039|FG000|Overall Study|Protocol Deviation|1|||
129495365|NCT04657016|466105040|FG001|Overall Study|Protocol Deviation|0|||
129495366|NCT04657016|466105039|FG000|Overall Study|Withdrawal by Subject|28|||
129495367|NCT04657016|466105040|FG001|Overall Study|Withdrawal by Subject|14|||
129495368|NCT04657016|466105039|FG000|Overall Study|Other - as reported by the investigator|6|||
129495369|NCT04657016|466105040|FG001|Overall Study|Other - as reported by the investigator|0|||
129495370|NCT01104558|466105041|FG000|Overall Study|Protocol Violation|6|||
129495371|NCT01104558|466105041|FG000|Overall Study|Missing of primary efficacy assessment|10|||
129495372|NCT01104558|466105041|FG000|Overall Study|Missing of genetic analysis results|1|||
129495373|NCT01755195|466105042|FG000|Overall Study|Participant noncompliance|2|||
129495374|NCT01755195|466105042|FG000|Overall Study|Switched to alternative treatment|4|||
129495375|NCT01755195|466105042|FG000|Overall Study|Withdrawal by Subject|1|||
129495376|NCT01755195|466105042|FG000|Overall Study|Participant refused to start treatment|1|||
129495377|NCT01755195|466105042|FG000|Overall Study|Participant has been consented for another trial|1|||
129495378|NCT01755195|466105042|FG000|Overall Study|Refused further treatment|3|||
129981173|NCT01743989|467893435|FG002|TFR Phase|Logistical problems|0|||
129981174|NCT01743989|467893433|FG000|TFR Phase|Protocol deviation|0|||
129981175|NCT01743989|467893434|FG001|TFR Phase|Protocol deviation|1|||
129981176|NCT01743989|467893435|FG002|TFR Phase|Protocol deviation|0|||
129981177|NCT01743989|467893433|FG000|TFR Phase|Withdrawal by Subject|0|||
129981178|NCT01743989|467893434|FG001|TFR Phase|Withdrawal by Subject|2|||
129981179|NCT01743989|467893435|FG002|TFR Phase|Withdrawal by Subject|0|||
129981180|NCT01743989|467893433|FG000|Re-treatment Phase|Adverse Event|8|||
129981181|NCT01743989|467893434|FG001|Re-treatment Phase|Adverse Event|4|||
129981182|NCT01743989|467893435|FG002|Re-treatment Phase|Adverse Event|0|||
129981183|NCT01743989|467893433|FG000|Re-treatment Phase|Death|1|||
129981184|NCT01743989|467893434|FG001|Re-treatment Phase|Death|1|||
129981185|NCT01743989|467893435|FG002|Re-treatment Phase|Death|0|||
129981186|NCT01743989|467893433|FG000|Re-treatment Phase|Administrative problems|1|||
129981187|NCT01743989|467893434|FG001|Re-treatment Phase|Administrative problems|1|||
129981188|NCT01743989|467893435|FG002|Re-treatment Phase|Administrative problems|0|||
129981189|NCT01743989|467893433|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
129981190|NCT01743989|467893434|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
129981191|NCT01743989|467893435|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
129981192|NCT01743989|467893433|FG000|Re-treatment Phase|Unstable MR|1|||
129981193|NCT01743989|467893434|FG001|Re-treatment Phase|Unstable MR|0|||
129981194|NCT01743989|467893435|FG002|Re-treatment Phase|Unstable MR|0|||
129981195|NCT01743989|467893433|FG000|Re-treatment Phase|Physician Decision|0|||
129981196|NCT01743989|467893434|FG001|Re-treatment Phase|Physician Decision|1|||
129981197|NCT01743989|467893435|FG002|Re-treatment Phase|Physician Decision|0|||
129981198|NCT01743989|467893433|FG000|Re-treatment Phase|Lost to Follow-up|0|||
129981199|NCT01743989|467893434|FG001|Re-treatment Phase|Lost to Follow-up|1|||
129981200|NCT01743989|467893435|FG002|Re-treatment Phase|Lost to Follow-up|0|||
129981201|NCT02235311|467893440|FG000|Overall Study|Lost to Follow-up|0|||
129981202|NCT02235311|467893441|FG001|Overall Study|Lost to Follow-up|1|||
129981203|NCT02235311|467893440|FG000|Overall Study|Protocol Violation|0|||
129981204|NCT02235311|467893441|FG001|Overall Study|Protocol Violation|1|||
129495379|NCT01755195|466105042|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
129495380|NCT03470922|466105043|FG000|Overall Study|Death|107|||
129495381|NCT03470922|466105044|FG001|Overall Study|Death|118|||
129495382|NCT03470922|466105043|FG000|Overall Study|Lost to Follow-up|5|||
129495383|NCT03470922|466105044|FG001|Overall Study|Lost to Follow-up|5|||
129495384|NCT03470922|466105043|FG000|Overall Study|Participant Withdrew Consent|4|||
129495385|NCT03470922|466105044|FG001|Overall Study|Participant Withdrew Consent|9|||
129495386|NCT03470922|466105043|FG000|Overall Study|Other reasons|1|||
129495387|NCT03470922|466105044|FG001|Overall Study|Other reasons|0|||
129495388|NCT03470922|466105043|FG000|Overall Study|Not reported|1|||
129981205|NCT00658788|467893442|FG000|Overall Study|Adverse Event|11|||
129981206|NCT00658788|467893442|FG000|Overall Study|Withdrawal by Subject|13|||
129981207|NCT00658788|467893442|FG000|Overall Study|Lost to Follow-up|18|||
129981208|NCT00658788|467893442|FG000|Overall Study|Treatment Discontinuation|32|||
129495389|NCT03470922|466105044|FG001|Overall Study|Not reported|0|||
129981209|NCT00653523|467893443|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
129981210|NCT00653523|467893443|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
129981211|NCT00653523|467893443|FG000|Overall Study|Adverse Event|7|||
129495390|NCT02340819|466105045|FG000|Overall Study|Adverse Event|1|||
129495391|NCT02340819|466105045|FG000|Overall Study|Withdrawal by Subject|2|||
129495392|NCT02340819|466105045|FG000|Overall Study|Discontinued with other reason|1|||
129981212|NCT00653523|467893443|FG000|Overall Study|Withdrawal by Subject|6|||
129495393|NCT01793051|466105046|FG000|Overall Study|Withdrawal by Subject|6|||
129495394|NCT01793051|466105047|FG001|Overall Study|Withdrawal by Subject|4|||
129495395|NCT01793051|466105046|FG000|Overall Study|Adverse Event|0|||
129495396|NCT01793051|466105047|FG001|Overall Study|Adverse Event|2|||
129495397|NCT01793051|466105046|FG000|Overall Study|Too ill to continue|1|||
129495398|NCT01793051|466105047|FG001|Overall Study|Too ill to continue|0|||
129495399|NCT01793051|466105046|FG000|Overall Study|Switched chemo|1|||
129495400|NCT01793051|466105047|FG001|Overall Study|Switched chemo|1|||
129495401|NCT01793051|466105046|FG000|Overall Study|Lack of compliance|1|||
129495402|NCT01793051|466105047|FG001|Overall Study|Lack of compliance|0|||
129495403|NCT01793051|466105046|FG000|Overall Study|Requested to be removed from the study|1|||
129495404|NCT01793051|466105047|FG001|Overall Study|Requested to be removed from the study|1|||
129495405|NCT04467164|466105052|FG000|Washout (1 Week)|Lost to Follow-up|2|||
129495406|NCT04467164|466105053|FG001|Washout (1 Week)|Lost to Follow-up|0|||
129495407|NCT01675011|466105056|FG000|Overall Study|Trial terminated by Sponsor|3|||
129495408|NCT01675011|466105057|FG001|Overall Study|Trial terminated by Sponsor|1|||
129495409|NCT01703286|466105059|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
129495410|NCT01703286|466105060|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
129495411|NCT01703286|466105061|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
129495412|NCT01703286|466105062|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
129495413|NCT01703286|466105063|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
129495414|NCT01703286|466105064|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
129495415|NCT01703286|466105059|FG000|Period 2 Including Washout|Adverse Event|0|||
129495416|NCT01703286|466105060|FG001|Period 2 Including Washout|Adverse Event|0|||
129495417|NCT01703286|466105061|FG002|Period 2 Including Washout|Adverse Event|0|||
129495418|NCT01703286|466105062|FG003|Period 2 Including Washout|Adverse Event|1|||
129495419|NCT01703286|466105063|FG004|Period 2 Including Washout|Adverse Event|0|||
129495420|NCT01703286|466105064|FG005|Period 2 Including Washout|Adverse Event|0|||
129495421|NCT01984346|466105065|FG000|Overall Study|Physician Decision|4|||
129495422|NCT01984346|466105066|FG001|Overall Study|Physician Decision|2|||
129981213|NCT00653523|467893443|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
129981214|NCT00653523|467893443|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
129981215|NCT02425904|467893444|FG000|Overall Study|Lost to Follow-up|1|||
129981216|NCT02425904|467893445|FG001|Overall Study|Lost to Follow-up|0|||
129981217|NCT02425904|467893444|FG000|Overall Study|Withdrawal by Subject|2|||
129981218|NCT02425904|467893445|FG001|Overall Study|Withdrawal by Subject|0|||
129981219|NCT02425904|467893444|FG000|Overall Study|Death|0|||
129981220|NCT02425904|467893445|FG001|Overall Study|Death|3|||
129981221|NCT05384938|467893447|FG000|Overall Study|Withdrawal by Subject|8|||
129981222|NCT05384938|467893447|FG000|Overall Study|Lost to Follow-up|6|||
129981223|NCT05384938|467893447|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
129981224|NCT02626455|467893448|FG000|Overall Study|Other|1|||
129981225|NCT02626455|467893449|FG001|Overall Study|Other|1|||
129981226|NCT02626455|467893450|FG002|Overall Study|Other|0|||
129981227|NCT02626455|467893451|FG003|Overall Study|Other|0|||
129981228|NCT02626455|467893452|FG004|Overall Study|Other|0|||
129981229|NCT02626455|467893453|FG005|Overall Study|Other|17|||
129981230|NCT02626455|467893454|FG006|Overall Study|Other|23|||
129981231|NCT02626455|467893448|FG000|Overall Study|Withdrawal by Subject|1|||
129981232|NCT02626455|467893449|FG001|Overall Study|Withdrawal by Subject|0|||
129981233|NCT02626455|467893450|FG002|Overall Study|Withdrawal by Subject|0|||
129981234|NCT02626455|467893451|FG003|Overall Study|Withdrawal by Subject|0|||
129981235|NCT02626455|467893452|FG004|Overall Study|Withdrawal by Subject|0|||
129981236|NCT02626455|467893453|FG005|Overall Study|Withdrawal by Subject|10|||
129981237|NCT02626455|467893454|FG006|Overall Study|Withdrawal by Subject|6|||
129981238|NCT02626455|467893448|FG000|Overall Study|Physician Decision|0|||
129981239|NCT02626455|467893449|FG001|Overall Study|Physician Decision|2|||
129981240|NCT02626455|467893450|FG002|Overall Study|Physician Decision|2|||
129981241|NCT02626455|467893451|FG003|Overall Study|Physician Decision|2|||
129981242|NCT02626455|467893452|FG004|Overall Study|Physician Decision|1|||
129981243|NCT02626455|467893453|FG005|Overall Study|Physician Decision|10|||
129981244|NCT02626455|467893454|FG006|Overall Study|Physician Decision|3|||
129981245|NCT02626455|467893448|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129495423|NCT01984346|466105065|FG000|Overall Study|Withdrawal by Subject|2|||
129981246|NCT02626455|467893449|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129495424|NCT01984346|466105066|FG001|Overall Study|Withdrawal by Subject|2|||
129495425|NCT01984346|466105065|FG000|Overall Study|Enrollment Closed|8|||
129495426|NCT01984346|466105066|FG001|Overall Study|Enrollment Closed|1|||
129495427|NCT01984346|466105065|FG000|Overall Study|Insurance Coverage|1|||
129495428|NCT01984346|466105066|FG001|Overall Study|Insurance Coverage|0|||
129981247|NCT02626455|467893450|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129981248|NCT02626455|467893451|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129981249|NCT02626455|467893452|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129495429|NCT01984346|466105065|FG000|Overall Study|Intra-operative Exclusion|2|||
129495430|NCT01984346|466105066|FG001|Overall Study|Intra-operative Exclusion|0|||
129495431|NCT05058664|466105073|FG000|Overall Study|No follow-up data provided|4|||
129495432|NCT05058664|466105074|FG001|Overall Study|No follow-up data provided|0|||
129495433|NCT05058664|466105075|FG002|Overall Study|No follow-up data provided|2|||
129495434|NCT05058664|466105073|FG000|Overall Study|Withdrawal by Subject|0|||
129495435|NCT05058664|466105074|FG001|Overall Study|Withdrawal by Subject|0|||
129495436|NCT05058664|466105075|FG002|Overall Study|Withdrawal by Subject|1|||
129495437|NCT00972244|466105076|FG000|Overall Study|Incorrect Enrolment|1|||
129495438|NCT00972244|466105077|FG001|Overall Study|Incorrect Enrolment|0|||
129495439|NCT00972244|466105078|FG002|Overall Study|Incorrect Enrolment|0|||
129495440|NCT00972244|466105079|FG003|Overall Study|Incorrect Enrolment|0|||
129495441|NCT00972244|466105080|FG004|Overall Study|Incorrect Enrolment|0|||
129495442|NCT00972244|466105076|FG000|Overall Study|Adverse Event|0|||
129495443|NCT00972244|466105077|FG001|Overall Study|Adverse Event|1|||
129495444|NCT00972244|466105078|FG002|Overall Study|Adverse Event|1|||
129495445|NCT00972244|466105079|FG003|Overall Study|Adverse Event|0|||
129495446|NCT00972244|466105080|FG004|Overall Study|Adverse Event|0|||
129495447|NCT00972244|466105076|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
129495448|NCT00972244|466105077|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
129495449|NCT00972244|466105078|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
129495450|NCT00972244|466105079|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
129495451|NCT00972244|466105080|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
129495452|NCT00972244|466105076|FG000|Overall Study|Withdrawal by Subject|1|||
129495453|NCT00972244|466105077|FG001|Overall Study|Withdrawal by Subject|2|||
129495454|NCT00972244|466105078|FG002|Overall Study|Withdrawal by Subject|1|||
129495455|NCT00972244|466105079|FG003|Overall Study|Withdrawal by Subject|0|||
129495456|NCT00972244|466105080|FG004|Overall Study|Withdrawal by Subject|1|||
129495457|NCT00972244|466105076|FG000|Overall Study|Safety|0|||
129495458|NCT00972244|466105077|FG001|Overall Study|Safety|0|||
129495459|NCT00972244|466105078|FG002|Overall Study|Safety|0|||
129495460|NCT00972244|466105079|FG003|Overall Study|Safety|0|||
129495461|NCT00972244|466105080|FG004|Overall Study|Safety|1|||
129495462|NCT00972244|466105076|FG000|Overall Study|Death|1|||
129495463|NCT00972244|466105077|FG001|Overall Study|Death|0|||
129495464|NCT00972244|466105078|FG002|Overall Study|Death|0|||
129495465|NCT00972244|466105079|FG003|Overall Study|Death|0|||
129495466|NCT00972244|466105080|FG004|Overall Study|Death|0|||
129495467|NCT00972244|466105076|FG000|Overall Study|Various|0|||
129495468|NCT00972244|466105077|FG001|Overall Study|Various|0|||
129495469|NCT00972244|466105078|FG002|Overall Study|Various|0|||
129495470|NCT00972244|466105079|FG003|Overall Study|Various|0|||
129495471|NCT00972244|466105080|FG004|Overall Study|Various|2|||
129495472|NCT01597557|466105081|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
129495473|NCT01597557|466105082|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
129495474|NCT01293032|466105091|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
129495475|NCT01293032|466105092|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
129495476|NCT01293032|466105093|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
129495477|NCT01293032|466105094|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
129495478|NCT01293032|466105091|FG000|Treatment|Adverse Event|0|||
129495479|NCT01293032|466105092|FG001|Treatment|Adverse Event|0|||
129495480|NCT01293032|466105093|FG002|Treatment|Adverse Event|1|||
129495481|NCT01293032|466105094|FG003|Treatment|Adverse Event|1|||
129495482|NCT01293032|466105091|FG000|Treatment|Withdrawal by Subject|2|||
129495483|NCT01293032|466105092|FG001|Treatment|Withdrawal by Subject|4|||
129495484|NCT01293032|466105093|FG002|Treatment|Withdrawal by Subject|0|||
129495485|NCT01293032|466105094|FG003|Treatment|Withdrawal by Subject|0|||
129495486|NCT01293032|466105091|FG000|Treatment|Disease Progression, relapse|0|||
129495487|NCT01293032|466105092|FG001|Treatment|Disease Progression, relapse|1|||
129495488|NCT01293032|466105093|FG002|Treatment|Disease Progression, relapse|0|||
129495489|NCT01293032|466105094|FG003|Treatment|Disease Progression, relapse|0|||
129495490|NCT02985450|466105098|FG000|Overall Study|Lost to Follow-up|7|||
129495491|NCT00431847|466105099|FG000|Overall Study|completion of less than two study visits|6|||
129495492|NCT00431847|466105100|FG001|Overall Study|completion of less than two study visits|3|||
129495493|NCT00431847|466105101|FG002|Overall Study|completion of less than two study visits|4|||
129495494|NCT00431847|466105102|FG003|Overall Study|completion of less than two study visits|14|||
129981250|NCT02626455|467893453|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
129981251|NCT02626455|467893454|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
129981252|NCT02626455|467893448|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981253|NCT02626455|467893449|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981254|NCT02626455|467893450|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129495495|NCT00431847|466105103|FG004|Overall Study|completion of less than two study visits|0|||
129495496|NCT00431847|466105099|FG000|Overall Study|Protocol Violation|0|||
129495497|NCT00431847|466105100|FG001|Overall Study|Protocol Violation|0|||
129495498|NCT00431847|466105101|FG002|Overall Study|Protocol Violation|0|||
129495499|NCT00431847|466105102|FG003|Overall Study|Protocol Violation|0|||
129495500|NCT00431847|466105103|FG004|Overall Study|Protocol Violation|1|||
129495501|NCT01095250|466105112|FG000|Overall Study|administrative reasons|8|||
129495502|NCT01095250|466105113|FG001|Overall Study|administrative reasons|10|||
129495503|NCT01095250|466105114|FG002|Overall Study|administrative reasons|7|||
129495504|NCT01095250|466105115|FG003|Overall Study|administrative reasons|5|||
129495505|NCT01095250|466105112|FG000|Overall Study|Withdrawal by Subject|0|||
129495506|NCT01095250|466105113|FG001|Overall Study|Withdrawal by Subject|0|||
129495507|NCT01095250|466105114|FG002|Overall Study|Withdrawal by Subject|1|||
129495508|NCT01095250|466105115|FG003|Overall Study|Withdrawal by Subject|0|||
129495509|NCT03596177|466105116|FG000|Single Blind Period|Withdrawal by Subject|1|||
129495510|NCT03596177|466105117|FG001|Single Blind Period|Withdrawal by Subject|1|||
129495511|NCT03596177|466105116|FG000|Single Blind Period|Other|1|||
129495512|NCT03596177|466105117|FG001|Single Blind Period|Other|0|||
129495513|NCT03596177|466105116|FG000|Double Blind Period|Withdrawal by Subject|0|||
129495514|NCT03596177|466105117|FG001|Double Blind Period|Withdrawal by Subject|1|||
129495515|NCT03596177|466105116|FG000|Double Blind Period|Other|0|||
129495516|NCT03596177|466105117|FG001|Double Blind Period|Other|4|||
129495517|NCT03596177|466105116|FG000|Double Blind Period|Death during safety follow-up|0|||
129495518|NCT03596177|466105117|FG001|Double Blind Period|Death during safety follow-up|1|||
129495519|NCT03141086|466105120|FG000|Overall Study|Study Terminated By Sponsor|1|||
129495520|NCT03141086|466105121|FG001|Overall Study|Study Terminated By Sponsor|1|||
129495521|NCT03141086|466105120|FG000|Overall Study|Withdrawal by Subject|0|||
129495522|NCT03141086|466105121|FG001|Overall Study|Withdrawal by Subject|1|||
129495523|NCT03141086|466105120|FG000|Overall Study|Protocol Violation|0|||
129495524|NCT03141086|466105121|FG001|Overall Study|Protocol Violation|1|||
129495525|NCT03141086|466105120|FG000|Overall Study|Adverse Event|0|||
129495526|NCT03141086|466105121|FG001|Overall Study|Adverse Event|2|||
129495527|NCT02488759|466105123|FG000|Overall Study|Disease progression|73|||
129495528|NCT02488759|466105124|FG001|Overall Study|Disease progression|111|||
129495529|NCT02488759|466105125|FG002|Overall Study|Disease progression|62|||
129495530|NCT02488759|466105126|FG003|Overall Study|Disease progression|7|||
129495531|NCT02488759|466105127|FG004|Overall Study|Disease progression|4|||
129495532|NCT02488759|466105128|FG005|Overall Study|Disease progression|2|||
129495533|NCT02488759|466105123|FG000|Overall Study|Study drug toxicity|11|||
129495534|NCT02488759|466105124|FG001|Overall Study|Study drug toxicity|33|||
129495535|NCT02488759|466105125|FG002|Overall Study|Study drug toxicity|31|||
129495536|NCT02488759|466105126|FG003|Overall Study|Study drug toxicity|0|||
129495537|NCT02488759|466105127|FG004|Overall Study|Study drug toxicity|0|||
129495538|NCT02488759|466105128|FG005|Overall Study|Study drug toxicity|2|||
129495539|NCT02488759|466105123|FG000|Overall Study|Adverse event unrelated to study drug|9|||
129495540|NCT02488759|466105124|FG001|Overall Study|Adverse event unrelated to study drug|11|||
129495541|NCT02488759|466105125|FG002|Overall Study|Adverse event unrelated to study drug|7|||
129495542|NCT02488759|466105126|FG003|Overall Study|Adverse event unrelated to study drug|0|||
129495543|NCT02488759|466105127|FG004|Overall Study|Adverse event unrelated to study drug|1|||
129495544|NCT02488759|466105128|FG005|Overall Study|Adverse event unrelated to study drug|0|||
129495545|NCT02488759|466105123|FG000|Overall Study|Participant request to discontinue study treatment|6|||
129495546|NCT02488759|466105124|FG001|Overall Study|Participant request to discontinue study treatment|8|||
129495547|NCT02488759|466105125|FG002|Overall Study|Participant request to discontinue study treatment|4|||
129495548|NCT02488759|466105126|FG003|Overall Study|Participant request to discontinue study treatment|0|||
129495549|NCT02488759|466105127|FG004|Overall Study|Participant request to discontinue study treatment|0|||
129495550|NCT02488759|466105128|FG005|Overall Study|Participant request to discontinue study treatment|0|||
129495551|NCT02488759|466105123|FG000|Overall Study|Withdrawal by Subject|4|||
129495552|NCT02488759|466105124|FG001|Overall Study|Withdrawal by Subject|0|||
129495553|NCT02488759|466105125|FG002|Overall Study|Withdrawal by Subject|3|||
129495554|NCT02488759|466105126|FG003|Overall Study|Withdrawal by Subject|0|||
129495555|NCT02488759|466105127|FG004|Overall Study|Withdrawal by Subject|0|||
129495556|NCT02488759|466105128|FG005|Overall Study|Withdrawal by Subject|2|||
129495557|NCT02488759|466105123|FG000|Overall Study|Lost to Follow-up|0|||
129495558|NCT02488759|466105124|FG001|Overall Study|Lost to Follow-up|0|||
129495559|NCT02488759|466105125|FG002|Overall Study|Lost to Follow-up|2|||
129981255|NCT02626455|467893451|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981256|NCT02626455|467893452|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129981257|NCT02626455|467893453|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
129495560|NCT02488759|466105126|FG003|Overall Study|Lost to Follow-up|0|||
129495561|NCT02488759|466105127|FG004|Overall Study|Lost to Follow-up|0|||
129495562|NCT02488759|466105128|FG005|Overall Study|Lost to Follow-up|0|||
129495563|NCT02488759|466105123|FG000|Overall Study|Maximum clinical benefit|3|||
129981258|NCT02626455|467893454|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
129981259|NCT02626455|467893448|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129495564|NCT02488759|466105124|FG001|Overall Study|Maximum clinical benefit|0|||
129495565|NCT02488759|466105125|FG002|Overall Study|Maximum clinical benefit|1|||
129495566|NCT02488759|466105126|FG003|Overall Study|Maximum clinical benefit|0|||
129981260|NCT02626455|467893449|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129495567|NCT02488759|466105127|FG004|Overall Study|Maximum clinical benefit|0|||
129495568|NCT02488759|466105128|FG005|Overall Study|Maximum clinical benefit|0|||
129495569|NCT02488759|466105123|FG000|Overall Study|Other reasons|7|||
129495570|NCT02488759|466105124|FG001|Overall Study|Other reasons|32|||
129495571|NCT02488759|466105125|FG002|Overall Study|Other reasons|23|||
129495572|NCT02488759|466105126|FG003|Overall Study|Other reasons|1|||
129495573|NCT02488759|466105127|FG004|Overall Study|Other reasons|1|||
129495574|NCT02488759|466105128|FG005|Overall Study|Other reasons|1|||
129495575|NCT03860844|466105129|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
129495576|NCT03860844|466105130|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
129495577|NCT03860844|466105131|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
129495578|NCT03860844|466105129|FG000|Overall Study|Progressive disease|5|||
129495579|NCT03860844|466105130|FG001|Overall Study|Progressive disease|3|||
129495580|NCT03860844|466105131|FG002|Overall Study|Progressive disease|4|||
129495581|NCT03860844|466105129|FG000|Overall Study|Other, Not related to COVID-19|0|||
129495582|NCT03860844|466105130|FG001|Overall Study|Other, Not related to COVID-19|1|||
129495583|NCT03860844|466105131|FG002|Overall Study|Other, Not related to COVID-19|0|||
129495584|NCT01678807|466105132|FG000|Overall Study|Adverse Event|4|||
129495585|NCT01678807|466105133|FG001|Overall Study|Adverse Event|4|||
129495586|NCT01678807|466105134|FG002|Overall Study|Adverse Event|0|||
129495587|NCT01678807|466105132|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
129495588|NCT01678807|466105133|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
129495589|NCT01678807|466105134|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
129495590|NCT00370149|466105135|FG000|Overall Study|Physician Decision|16|||
129495591|NCT00370149|466105136|FG001|Overall Study|Physician Decision|16|||
129495592|NCT00370149|466105135|FG000|Overall Study|Protocol Violation|1|||
129495593|NCT00370149|466105136|FG001|Overall Study|Protocol Violation|0|||
129495594|NCT00370149|466105135|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
129495595|NCT00370149|466105136|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
129495596|NCT00370149|466105135|FG000|Overall Study|Pre-existing infection|0|||
129981261|NCT02626455|467893450|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981262|NCT02626455|467893451|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981263|NCT02626455|467893452|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
129981264|NCT02626455|467893453|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
129981265|NCT02626455|467893454|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
129981266|NCT02626455|467893448|FG000|Overall Study|Patient decision|0|||
129981267|NCT02626455|467893449|FG001|Overall Study|Patient decision|1|||
129981268|NCT02626455|467893450|FG002|Overall Study|Patient decision|0|||
129981269|NCT02626455|467893451|FG003|Overall Study|Patient decision|0|||
129981270|NCT02626455|467893452|FG004|Overall Study|Patient decision|1|||
129981271|NCT02626455|467893453|FG005|Overall Study|Patient decision|36|||
129981272|NCT02626455|467893454|FG006|Overall Study|Patient decision|22|||
129981273|NCT02626455|467893448|FG000|Overall Study|Protocol Violation|0|||
129981274|NCT02626455|467893449|FG001|Overall Study|Protocol Violation|0|||
129981275|NCT02626455|467893450|FG002|Overall Study|Protocol Violation|0|||
129981276|NCT02626455|467893451|FG003|Overall Study|Protocol Violation|0|||
129981277|NCT02626455|467893452|FG004|Overall Study|Protocol Violation|0|||
129981278|NCT02626455|467893453|FG005|Overall Study|Protocol Violation|0|||
129981279|NCT02626455|467893454|FG006|Overall Study|Protocol Violation|1|||
129981280|NCT02626455|467893448|FG000|Overall Study|Progressive disease - radiological progression|0|||
129981281|NCT02626455|467893449|FG001|Overall Study|Progressive disease - radiological progression|0|||
129981282|NCT02626455|467893450|FG002|Overall Study|Progressive disease - radiological progression|0|||
129981283|NCT02626455|467893451|FG003|Overall Study|Progressive disease - radiological progression|0|||
129981284|NCT02626455|467893452|FG004|Overall Study|Progressive disease - radiological progression|0|||
129981285|NCT02626455|467893453|FG005|Overall Study|Progressive disease - radiological progression|11|||
129981286|NCT02626455|467893454|FG006|Overall Study|Progressive disease - radiological progression|22|||
129981287|NCT02626455|467893448|FG000|Overall Study|Progressive disease - clinical progression|0|||
129981288|NCT02626455|467893449|FG001|Overall Study|Progressive disease - clinical progression|0|||
129981289|NCT02626455|467893450|FG002|Overall Study|Progressive disease - clinical progression|0|||
129981290|NCT02626455|467893451|FG003|Overall Study|Progressive disease - clinical progression|0|||
129981291|NCT02626455|467893452|FG004|Overall Study|Progressive disease - clinical progression|0|||
129981292|NCT02626455|467893453|FG005|Overall Study|Progressive disease - clinical progression|1|||
129981293|NCT02626455|467893454|FG006|Overall Study|Progressive disease - clinical progression|2|||
129981294|NCT02626455|467893448|FG000|Overall Study|Lost to Follow-up|0|||
129495597|NCT00370149|466105136|FG001|Overall Study|Pre-existing infection|1|||
129495598|NCT00370149|466105135|FG000|Overall Study|Antibiotic coated dressing placed|0|||
129495599|NCT00370149|466105136|FG001|Overall Study|Antibiotic coated dressing placed|1|||
129495600|NCT01043185|466106581|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
129495601|NCT01043185|466106582|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
129495602|NCT01043185|466106583|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
129981295|NCT02626455|467893449|FG001|Overall Study|Lost to Follow-up|0|||
129981296|NCT02626455|467893450|FG002|Overall Study|Lost to Follow-up|0|||
129981297|NCT02626455|467893451|FG003|Overall Study|Lost to Follow-up|0|||
129981298|NCT02626455|467893452|FG004|Overall Study|Lost to Follow-up|0|||
129495603|NCT01043185|466106584|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
129495604|NCT01043185|466106585|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
129495605|NCT01043185|466106586|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
129495606|NCT01043185|466106587|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
129495607|NCT01043185|466106588|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
129495608|NCT01043185|466106589|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
129495609|NCT01043185|466106590|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
129495610|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
129495611|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
129495612|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
129495613|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
129495614|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
129495615|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
129495616|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
129495617|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
129495618|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
129495619|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
129495620|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
129495621|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
129495622|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
129495623|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
129495624|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
129495625|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
129495626|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
129495627|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
129495628|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
129495629|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
129495630|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
129495631|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
129495632|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
129495633|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
129495634|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
129495635|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
129495636|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
129495637|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
129495638|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
129495639|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
129495640|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
129495641|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
129495642|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
129495643|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
129495644|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
129495645|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
129495646|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
129495647|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
129495648|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
129495649|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
129495650|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
129495651|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
129495652|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
129495653|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
129495654|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
129495655|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
129495656|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
129495657|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
129495658|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
129495659|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
129495660|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
129495661|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
129495662|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
129495663|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
129495664|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
129495665|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
129495666|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
129495667|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
129495668|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
129495669|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
129495670|NCT03395197|466106593|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
129495671|NCT03395197|466106594|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
129495672|NCT03395197|466106595|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
129495673|NCT03395197|466106596|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
129495674|NCT03395197|466106597|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
129495675|NCT03395197|466106598|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
129495676|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Death|0|||
129495677|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Death|0|||
129495678|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Death|0|||
129495679|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Death|0|||
129495680|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Death|1|||
129495681|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Death|4|||
129495682|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
129495683|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
129495684|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
129495685|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
129495686|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
129495687|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
129495688|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
129495689|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
129495690|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
129495691|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
129495692|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
129495693|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
129495694|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
129495695|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
129495696|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
129495697|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
129495698|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
129495699|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
129495700|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
129495701|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
129495702|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
129495703|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
129495704|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
129495705|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
129495706|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
129495707|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
129495708|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
129495709|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
129495710|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
129495711|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
129495712|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
129495713|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
129495714|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
129495715|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
129495716|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
129495717|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
129495718|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Other|0|||
129495719|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Other|0|||
129495720|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Other|0|||
129495721|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Other|0|||
129495722|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Other|3|||
129495723|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Other|3|||
129495724|NCT03395197|466106593|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
129495725|NCT03395197|466106594|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
129495726|NCT03395197|466106595|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
129495727|NCT03395197|466106596|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
129495728|NCT03395197|466106597|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
129495729|NCT03395197|466106598|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
129495730|NCT01605071|466106599|FG000|Overall Study|Withdrawal by Subject|3|||
129495731|NCT01605071|466106600|FG001|Overall Study|Withdrawal by Subject|2|||
129495732|NCT00392171|466106601|FG000|Overall Study|Did not meet inclusion criteria|4|||
129495733|NCT00392171|466106601|FG000|Overall Study|Disease progression|101|||
129495734|NCT00028002|466106605|FG000|Overall Study|Withdrawal by Subject|3|||
129495735|NCT00028002|466106605|FG000|Overall Study|Ineligible|8|||
129495736|NCT01881620|466106608|FG000|Overall Study|Protocol Violation|4|||
129495737|NCT01808118|466106611|FG000|Period 1|Adverse Event|15|||
129495738|NCT01808118|466106612|FG001|Period 1|Adverse Event|0|||
129495739|NCT01808118|466106613|FG002|Period 1|Adverse Event|0|||
129495740|NCT01808118|466106611|FG000|Period 1|Withdrew consent|24|||
129495741|NCT01808118|466106612|FG001|Period 1|Withdrew consent|0|||
129495742|NCT01808118|466106613|FG002|Period 1|Withdrew consent|0|||
129495743|NCT01808118|466106611|FG000|Period 1|Lost to Follow-up|9|||
129495744|NCT01808118|466106612|FG001|Period 1|Lost to Follow-up|0|||
129495745|NCT01808118|466106613|FG002|Period 1|Lost to Follow-up|0|||
129495746|NCT01808118|466106611|FG000|Period 1|Did not meet criteria for remission|303|||
129495747|NCT01808118|466106612|FG001|Period 1|Did not meet criteria for remission|0|||
129495748|NCT01808118|466106613|FG002|Period 1|Did not meet criteria for remission|0|||
129495749|NCT01808118|466106611|FG000|Period 1|Enrolled in error|7|||
129495750|NCT01808118|466106612|FG001|Period 1|Enrolled in error|0|||
129495751|NCT01808118|466106613|FG002|Period 1|Enrolled in error|0|||
129495752|NCT01808118|466106611|FG000|Period 1|Did not meet inclusion criteria|3|||
129495753|NCT01808118|466106612|FG001|Period 1|Did not meet inclusion criteria|0|||
129495754|NCT01808118|466106613|FG002|Period 1|Did not meet inclusion criteria|0|||
129495755|NCT01808118|466106611|FG000|Period 1|Non-conformance with inclusion criteria|3|||
129495756|NCT01808118|466106612|FG001|Period 1|Non-conformance with inclusion criteria|0|||
129495757|NCT01808118|466106613|FG002|Period 1|Non-conformance with inclusion criteria|0|||
129495758|NCT01808118|466106611|FG000|Period 1|Investigator decision: site closure|2|||
129495759|NCT01808118|466106612|FG001|Period 1|Investigator decision: site closure|0|||
129495760|NCT01808118|466106613|FG002|Period 1|Investigator decision: site closure|0|||
129495761|NCT01808118|466106611|FG000|Period 1|Non-compliance per sponsor|1|||
129495762|NCT01808118|466106612|FG001|Period 1|Non-compliance per sponsor|0|||
129495763|NCT01808118|466106613|FG002|Period 1|Non-compliance per sponsor|0|||
129495764|NCT01808118|466106611|FG000|Period 1|Lack of Efficacy|1|||
129495765|NCT01808118|466106612|FG001|Period 1|Lack of Efficacy|0|||
129495766|NCT01808118|466106613|FG002|Period 1|Lack of Efficacy|0|||
129495767|NCT01808118|466106611|FG000|Period 2|Adverse Event|0|||
129495768|NCT01808118|466106612|FG001|Period 2|Adverse Event|4|||
129495769|NCT01808118|466106613|FG002|Period 2|Adverse Event|0|||
129495770|NCT01808118|466106611|FG000|Period 2|Withdrew consent|0|||
129495771|NCT01808118|466106612|FG001|Period 2|Withdrew consent|7|||
129495772|NCT01808118|466106613|FG002|Period 2|Withdrew consent|6|||
129495773|NCT01808118|466106611|FG000|Period 2|Lost to Follow-up|0|||
129495774|NCT01808118|466106612|FG001|Period 2|Lost to Follow-up|0|||
129495775|NCT01808118|466106613|FG002|Period 2|Lost to Follow-up|2|||
129495776|NCT01808118|466106611|FG000|Period 2|Investigator no longer conducting trials|0|||
129495777|NCT01808118|466106612|FG001|Period 2|Investigator no longer conducting trials|1|||
129495778|NCT01808118|466106613|FG002|Period 2|Investigator no longer conducting trials|0|||
129495779|NCT01808118|466106611|FG000|Period 2|Switched to other therapy|0|||
129495780|NCT01808118|466106612|FG001|Period 2|Switched to other therapy|1|||
129495781|NCT01808118|466106613|FG002|Period 2|Switched to other therapy|0|||
129495782|NCT00615290|466106619|FG000|Overall Study|Adverse Event|2|||
129495783|NCT00615290|466106619|FG000|Overall Study|Lost to Follow-up|3|||
129495784|NCT00615290|466106619|FG000|Overall Study|Withdrawal by Subject|1|||
129495785|NCT00615290|466106619|FG000|Overall Study|Other|2|||
129495786|NCT01252134|466106620|FG000|Period 1, 8 Hours|Personal Reasons|0|||
129495787|NCT01252134|466106621|FG001|Period 1, 8 Hours|Personal Reasons|1|||
129495788|NCT01252134|466106622|FG002|Period 1, 8 Hours|Personal Reasons|1|||
129495789|NCT01252134|466106623|FG003|Period 1, 8 Hours|Personal Reasons|0|||
129981299|NCT02626455|467893453|FG005|Overall Study|Lost to Follow-up|1|||
129495790|NCT01252134|466106624|FG004|Period 1, 8 Hours|Personal Reasons|0|||
129495791|NCT01252134|466106625|FG005|Period 1, 8 Hours|Personal Reasons|0|||
129495792|NCT03650452|466106626|FG000|Overall Study|Physician Decision|1|||
129981300|NCT02626455|467893454|FG006|Overall Study|Lost to Follow-up|0|||
129981301|NCT02626455|467893448|FG000|Overall Study|AE not associated with clinical disease progression|1|||
129981302|NCT02626455|467893449|FG001|Overall Study|AE not associated with clinical disease progression|1|||
129981303|NCT02626455|467893450|FG002|Overall Study|AE not associated with clinical disease progression|0|||
129981304|NCT02626455|467893451|FG003|Overall Study|AE not associated with clinical disease progression|2|||
129495793|NCT03650452|466106627|FG001|Overall Study|Physician Decision|0|||
129495794|NCT03650452|466106626|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
129495795|NCT03650452|466106627|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
129495796|NCT03650452|466106626|FG000|Overall Study|Adverse Event|3|||
129495797|NCT03650452|466106627|FG001|Overall Study|Adverse Event|4|||
129495798|NCT03650452|466106626|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
129495799|NCT03650452|466106627|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
129495800|NCT02273050|466106628|FG000|Overall Study|Adverse Event|4|||
129495801|NCT02273050|466106629|FG001|Overall Study|Adverse Event|3|||
129495802|NCT02273050|466106630|FG002|Overall Study|Adverse Event|3|||
129495803|NCT02273050|466106628|FG000|Overall Study|Death|0|||
129495804|NCT02273050|466106629|FG001|Overall Study|Death|0|||
129495805|NCT02273050|466106630|FG002|Overall Study|Death|1|||
129495806|NCT02273050|466106628|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
129495807|NCT02273050|466106629|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
129495808|NCT02273050|466106630|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
129495809|NCT02273050|466106628|FG000|Overall Study|Lack of Efficacy|0|||
129495810|NCT02273050|466106629|FG001|Overall Study|Lack of Efficacy|1|||
129495811|NCT02273050|466106630|FG002|Overall Study|Lack of Efficacy|1|||
129495812|NCT02273050|466106628|FG000|Overall Study|Withdrawal by Subject|17|||
129495813|NCT02273050|466106629|FG001|Overall Study|Withdrawal by Subject|14|||
129495814|NCT02273050|466106630|FG002|Overall Study|Withdrawal by Subject|16|||
129495815|NCT02273050|466106628|FG000|Overall Study|Lost to Follow-up|0|||
129495816|NCT02273050|466106629|FG001|Overall Study|Lost to Follow-up|2|||
129495817|NCT02273050|466106630|FG002|Overall Study|Lost to Follow-up|3|||
129495818|NCT02273050|466106628|FG000|Overall Study|Protocol Violation|3|||
129495819|NCT02273050|466106629|FG001|Overall Study|Protocol Violation|1|||
129495820|NCT02273050|466106630|FG002|Overall Study|Protocol Violation|4|||
129495821|NCT01795898|466106632|FG000|Overall Study|Adverse Event|27|||
129495822|NCT01795898|466106632|FG000|Overall Study|Lost to Follow-up|20|||
129495823|NCT01795898|466106632|FG000|Overall Study|Withdrawal of consent|6|||
129495824|NCT01795898|466106632|FG000|Overall Study|Diagnosed with metastasis|1|||
129495825|NCT01795898|466106632|FG000|Overall Study|No pain|1|||
129495826|NCT01795898|466106632|FG000|Overall Study|Death|1|||
129495827|NCT01795898|466106632|FG000|Overall Study|Withdrew consent & had adverse events|3|||
129495828|NCT01795898|466106632|FG000|Overall Study|Physician Decision|1|||
129495829|NCT03539458|466106633|FG000|Overall Study|Death|1|||
129495830|NCT00718419|466106634|FG000|Overall Study|Adverse Event|2|||
129495831|NCT00718419|466106635|FG001|Overall Study|Adverse Event|1|||
129495832|NCT00718419|466106634|FG000|Overall Study|Physician Decision|1|||
129495833|NCT00718419|466106635|FG001|Overall Study|Physician Decision|6|||
129495834|NCT00718419|466106634|FG000|Overall Study|Sponsor decision|0|||
129495835|NCT00718419|466106635|FG001|Overall Study|Sponsor decision|1|||
129495836|NCT00718419|466106634|FG000|Overall Study|Withdrawal by Subject|0|||
129495837|NCT00718419|466106635|FG001|Overall Study|Withdrawal by Subject|5|||
129495838|NCT00718419|466106634|FG000|Overall Study|Progressive Disease|7|||
129495839|NCT00718419|466106635|FG001|Overall Study|Progressive Disease|25|||
129495840|NCT00718419|466106634|FG000|Overall Study|Death Due to Progressive Disease|2|||
129495841|NCT00718419|466106635|FG001|Overall Study|Death Due to Progressive Disease|0|||
129495842|NCT00718419|466106634|FG000|Overall Study|Death Due to Study Drug Related|0|||
129495843|NCT00718419|466106635|FG001|Overall Study|Death Due to Study Drug Related|1|||
129495844|NCT00718419|466106634|FG000|Overall Study|Death Due to Adverse Events|1|||
129495845|NCT00718419|466106635|FG001|Overall Study|Death Due to Adverse Events|0|||
129495846|NCT03952468|466106644|FG000|Overall Study|Death|0|||
129495847|NCT03952468|466106645|FG001|Overall Study|Death|1|||
129495848|NCT03952468|466106644|FG000|Overall Study|Adverse Event|0|||
129495849|NCT03952468|466106645|FG001|Overall Study|Adverse Event|1|||
129495850|NCT03952468|466106644|FG000|Overall Study|Physician Decision|1|||
129495851|NCT03952468|466106645|FG001|Overall Study|Physician Decision|0|||
129495852|NCT03952468|466106644|FG000|Overall Study|Lost to Follow-up|3|||
129495853|NCT03952468|466106645|FG001|Overall Study|Lost to Follow-up|4|||
129495854|NCT03952468|466106644|FG000|Overall Study|Withdrawal by Subject|2|||
129495855|NCT03952468|466106645|FG001|Overall Study|Withdrawal by Subject|1|||
129495856|NCT05761444|466106646|FG000|Overall Study|Protocol Violation|2|||
129495857|NCT05761444|466106647|FG001|Overall Study|Protocol Violation|1|||
129495858|NCT05761444|466106646|FG000|Overall Study|Adverse Event|2|||
129495859|NCT05761444|466106647|FG001|Overall Study|Adverse Event|2|||
129495860|NCT05761444|466106646|FG000|Overall Study|Withdrawal by Subject|3|||
129495861|NCT05761444|466106647|FG001|Overall Study|Withdrawal by Subject|2|||
129495862|NCT05761444|466106646|FG000|Overall Study|Other|1|||
129495863|NCT05761444|466106647|FG001|Overall Study|Other|0|||
129495864|NCT01106534|466106648|FG000|Overall Study|Withdrawal by Subject|18|||
129495865|NCT01106534|466106648|FG000|Overall Study|Lost to Follow-up|2|||
129495866|NCT01106534|466106648|FG000|Overall Study|Death|16|||
129495867|NCT01106534|466106648|FG000|Overall Study|Physician Decision|1|||
129495868|NCT05187013|466106652|FG000|Overall Study|Withdrawal by Subject|1|||
129495869|NCT05187013|466106653|FG001|Overall Study|Withdrawal by Subject|1|||
129495870|NCT05187013|466106654|FG002|Overall Study|Withdrawal by Subject|0|||
129495871|NCT05187013|466106652|FG000|Overall Study|Death|0|||
129495872|NCT05187013|466106653|FG001|Overall Study|Death|1|||
129495873|NCT05187013|466106654|FG002|Overall Study|Death|0|||
129495874|NCT05187013|466106652|FG000|Overall Study|Lost to Follow-up|20|||
129495875|NCT05187013|466106653|FG001|Overall Study|Lost to Follow-up|17|||
129495876|NCT05187013|466106654|FG002|Overall Study|Lost to Follow-up|0|||
129495877|NCT05187013|466106652|FG000|Overall Study|Ongoing Participants|3|||
129495878|NCT05187013|466106653|FG001|Overall Study|Ongoing Participants|5|||
129495879|NCT05187013|466106654|FG002|Overall Study|Ongoing Participants|0|||
129495880|NCT04488822|466106655|FG000|Overall Study|Adverse Event|8|||
129495881|NCT04488822|466106655|FG000|Overall Study|Withdrawal by Subject|1|||
129495882|NCT03838367|466106656|FG000|Overall Study|Early termination of study|3|||
129495883|NCT03838367|466106657|FG001|Overall Study|Early termination of study|4|||
129495884|NCT03838367|466106658|FG002|Overall Study|Early termination of study|3|||
129495885|NCT03838367|466106659|FG003|Overall Study|Early termination of study|0|||
129495886|NCT03406104|466106660|FG000|Overall Study|Lost to Follow-up|2|||
129495887|NCT03406104|466106660|FG000|Overall Study|Withdrawal by Subject|2|||
129495888|NCT03406104|466106660|FG000|Overall Study|due to Covid patient did not want to travel|1|||
129495889|NCT03406104|466106660|FG000|Overall Study|Death|2|||
129495890|NCT02499146|466106669|FG000|Overall Study|Lost to Follow-up|1|||
129495891|NCT02499146|466106669|FG000|Overall Study|Withdrawal by Subject|1|||
129495892|NCT02499146|466106669|FG000|Overall Study|Other|2|||
129495893|NCT02499146|466106669|FG000|Overall Study|Ongoing at date of cut-off|9|||
129495894|NCT02499146|466106669|FG000|Overall Study|Began other treatment/therapy|13|||
129495895|NCT05692154|466106670|FG000|Overall Study|Adverse Event|0|||
129495896|NCT05692154|466106671|FG001|Overall Study|Adverse Event|1|||
129495897|NCT01879618|466106672|FG000|Overall Study|Does not meet entrance criteria|1|||
129495898|NCT01879618|466106672|FG000|Overall Study|Withdrawal by Subject|1|||
129495899|NCT01879618|466106672|FG000|Overall Study|Surgery;changed schedule; not available|8|||
129495900|NCT01879618|466106672|FG000|Overall Study|Protocol Violation|6|||
129495901|NCT01879618|466106672|FG000|Overall Study|Adverse Event|5|||
129495902|NCT00938327|466106673|FG000|Overall Study|Adverse Event|2|||
129495903|NCT00938327|466106673|FG000|Overall Study|Protocol Violation|1|||
129495904|NCT00938327|466106673|FG000|Overall Study|Withdrawal by Subject|4|||
129495905|NCT00938327|466106673|FG000|Overall Study|Lost to Follow-up|37|||
129495906|NCT00938327|466106673|FG000|Overall Study|2nd dose received outside of the study|7|||
129495907|NCT00938327|466106673|FG000|Overall Study|Vaccine not received as out of stock|9|||
129495908|NCT02691247|466106674|FG000|Overall Study|Withdrawal by Subject|1|||
129495909|NCT02691247|466106675|FG001|Overall Study|Withdrawal by Subject|2|||
129495910|NCT02691247|466106676|FG002|Overall Study|Withdrawal by Subject|2|||
129495911|NCT02691247|466106674|FG000|Overall Study|Lost to Follow-up|2|||
129495912|NCT02691247|466106675|FG001|Overall Study|Lost to Follow-up|0|||
129495913|NCT02691247|466106676|FG002|Overall Study|Lost to Follow-up|1|||
129495914|NCT02552355|466106677|FG000|Overall Study|Adverse Event|0|||
129495915|NCT02552355|466106678|FG001|Overall Study|Adverse Event|2|||
129495916|NCT02552355|466106679|FG002|Overall Study|Adverse Event|2|||
129495917|NCT02552355|466106680|FG003|Overall Study|Adverse Event|0|||
129495918|NCT02552355|466106677|FG000|Overall Study|Withdrawal by Subject|0|||
129495919|NCT02552355|466106678|FG001|Overall Study|Withdrawal by Subject|0|||
129495920|NCT02552355|466106679|FG002|Overall Study|Withdrawal by Subject|0|||
129495921|NCT02552355|466106680|FG003|Overall Study|Withdrawal by Subject|1|||
129495922|NCT01519245|466106681|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
129495923|NCT01519245|466106682|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
129495924|NCT00933335|466106683|FG000|Overall Study|Lost to Follow-up|1|||
129495925|NCT00933335|466106684|FG001|Overall Study|Lost to Follow-up|3|||
129495926|NCT00933335|466106683|FG000|Overall Study|Withdrawal by Subject|0|||
129495927|NCT00933335|466106684|FG001|Overall Study|Withdrawal by Subject|1|||
129495928|NCT00933335|466106683|FG000|Overall Study|Progressive Disease|0|||
129495929|NCT00933335|466106684|FG001|Overall Study|Progressive Disease|11|||
129495930|NCT00933335|466106683|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
129495931|NCT00933335|466106684|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
129495932|NCT00933335|466106683|FG000|Overall Study|Co-morbid Illness|1|||
129495933|NCT00933335|466106684|FG001|Overall Study|Co-morbid Illness|0|||
129495934|NCT02275026|466106687|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
129495935|NCT02275026|466106687|FG000|Overall Study|Withdrawal by Subject|4|||
129495936|NCT02275026|466106687|FG000|Overall Study|Ineligible due to medical history|13|||
129981305|NCT02626455|467893452|FG004|Overall Study|AE not associated with clinical disease progression|1|||
129981306|NCT02626455|467893453|FG005|Overall Study|AE not associated with clinical disease progression|65|||
129981307|NCT02626455|467893454|FG006|Overall Study|AE not associated with clinical disease progression|21|||
129981308|NCT02626455|467893448|FG000|Overall Study|AE associated with clinical disease progression|0|||
129981309|NCT02626455|467893449|FG001|Overall Study|AE associated with clinical disease progression|0|||
129981310|NCT02626455|467893450|FG002|Overall Study|AE associated with clinical disease progression|0|||
129981311|NCT02626455|467893451|FG003|Overall Study|AE associated with clinical disease progression|0|||
129981312|NCT02626455|467893452|FG004|Overall Study|AE associated with clinical disease progression|0|||
129495937|NCT02275026|466106687|FG000|Overall Study|MRI malfunction precluded testing|1|||
129495938|NCT02275026|466106687|FG000|Overall Study|Ineligible after MRI findings|1|||
129495939|NCT02275026|466106687|FG000|Overall Study|Lost to Follow-up|2|||
129495940|NCT02275026|466106687|FG000|Overall Study|Scanner failure|1|||
129495941|NCT05468086|466106688|FG000|Overall Study|Withdrawal by Subject|3|||
129495942|NCT05468086|466106688|FG000|Overall Study|Subject was found ineligible after consent|1|||
129495943|NCT01108809|466106689|FG000|Overall Study|Adverse Event|3|||
129981313|NCT02626455|467893453|FG005|Overall Study|AE associated with clinical disease progression|1|||
129981314|NCT02626455|467893454|FG006|Overall Study|AE associated with clinical disease progression|2|||
129981315|NCT02626455|467893448|FG000|Overall Study|Study intervention never administered|0|||
129981316|NCT02626455|467893449|FG001|Overall Study|Study intervention never administered|0|||
129981317|NCT02626455|467893450|FG002|Overall Study|Study intervention never administered|0|||
129981318|NCT02626455|467893451|FG003|Overall Study|Study intervention never administered|0|||
129981319|NCT02626455|467893452|FG004|Overall Study|Study intervention never administered|0|||
129981320|NCT02626455|467893453|FG005|Overall Study|Study intervention never administered|1|||
129981321|NCT02626455|467893454|FG006|Overall Study|Study intervention never administered|3|||
129981322|NCT03843554|467894942|FG000|Overall Study|Physician Decision|0|||
129981323|NCT03843554|467894943|FG001|Overall Study|Physician Decision|2|||
129981324|NCT04396366|467894948|FG000|Overall Study|Adverse Event|1|||
129981325|NCT04396366|467894949|FG001|Overall Study|Adverse Event|0|||
129981326|NCT00166712|467894951|FG000|Overall Study|Death|0|||
129981327|NCT00166712|467894952|FG001|Overall Study|Death|1|||
129981328|NCT00166712|467894951|FG000|Overall Study|Adverse Event|1|||
129981329|NCT00166712|467894952|FG001|Overall Study|Adverse Event|0|||
129981330|NCT00166712|467894951|FG000|Overall Study|Withdrawal by Subject|1|||
129981331|NCT00166712|467894952|FG001|Overall Study|Withdrawal by Subject|2|||
129981332|NCT00166712|467894951|FG000|Overall Study|Physician Decision|0|||
129981333|NCT00166712|467894952|FG001|Overall Study|Physician Decision|2|||
129981334|NCT03986944|467894953|FG000|Overall Study|Adverse Event|1|||
129981335|NCT03986944|467894954|FG001|Overall Study|Adverse Event|2|||
129981336|NCT03986944|467894955|FG002|Overall Study|Adverse Event|3|||
129981337|NCT03986944|467894953|FG000|Overall Study|Protocol Violation|0|||
129981338|NCT03986944|467894954|FG001|Overall Study|Protocol Violation|1|||
129981339|NCT03986944|467894955|FG002|Overall Study|Protocol Violation|1|||
129981340|NCT03986944|467894953|FG000|Overall Study|Withdrawal by Subject|3|||
129981341|NCT03986944|467894954|FG001|Overall Study|Withdrawal by Subject|5|||
129981342|NCT03986944|467894955|FG002|Overall Study|Withdrawal by Subject|5|||
129981343|NCT03986944|467894953|FG000|Overall Study|Study termination|10|||
129981344|NCT03986944|467894954|FG001|Overall Study|Study termination|10|||
129981345|NCT03986944|467894955|FG002|Overall Study|Study termination|10|||
129981346|NCT03986944|467894953|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
129981347|NCT03986944|467894954|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
129981348|NCT03986944|467894955|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
129981349|NCT03986944|467894953|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
129981350|NCT03986944|467894954|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
129495944|NCT01108809|466106689|FG000|Overall Study|Lost to Follow-up|1|||
129495945|NCT00783705|466106691|FG000|Overall Study|Adverse Event|2|||
129495946|NCT00783705|466106692|FG001|Overall Study|Adverse Event|0|||
129495947|NCT00783705|466106691|FG000|Overall Study|Withdrawal by Subject|3|||
129495948|NCT00783705|466106692|FG001|Overall Study|Withdrawal by Subject|2|||
129495949|NCT00783705|466106691|FG000|Overall Study|Lost to Follow-up|1|||
129495950|NCT00783705|466106692|FG001|Overall Study|Lost to Follow-up|3|||
129495951|NCT01954121|466106693|FG000|Overall Study|Lack of Efficacy|94|||
129495952|NCT01954121|466106694|FG001|Overall Study|Lack of Efficacy|41|||
129495953|NCT01954121|466106693|FG000|Overall Study|Protocol Violation|0|||
129495954|NCT01954121|466106694|FG001|Overall Study|Protocol Violation|2|||
129495955|NCT01954121|466106693|FG000|Overall Study|Lost to Follow-up|5|||
129495956|NCT01954121|466106694|FG001|Overall Study|Lost to Follow-up|6|||
129495957|NCT01954121|466106693|FG000|Overall Study|Withdrawal by Subject|18|||
129495958|NCT01954121|466106694|FG001|Overall Study|Withdrawal by Subject|12|||
129495959|NCT01954121|466106693|FG000|Overall Study|Pregnancy|1|||
129495960|NCT01954121|466106694|FG001|Overall Study|Pregnancy|1|||
129495961|NCT01954121|466106693|FG000|Overall Study|AE, serious fatal|1|||
129495962|NCT01954121|466106694|FG001|Overall Study|AE, serious fatal|0|||
129495963|NCT01954121|466106693|FG000|Overall Study|AE, non-serious non-fatal|5|||
129495964|NCT01954121|466106694|FG001|Overall Study|AE, non-serious non-fatal|22|||
129495965|NCT01954121|466106693|FG000|Overall Study|SAE, non-fatal|1|||
129495966|NCT01954121|466106694|FG001|Overall Study|SAE, non-fatal|4|||
129495967|NCT01954121|466106693|FG000|Overall Study|Non-compliant with study procedures|1|||
129495968|NCT01954121|466106694|FG001|Overall Study|Non-compliant with study procedures|0|||
129495969|NCT01954121|466106693|FG000|Overall Study|Non-compliant patient|1|||
129495970|NCT01954121|466106694|FG001|Overall Study|Non-compliant patient|1|||
129495971|NCT01954121|466106693|FG000|Overall Study|Subject did not follow instructions|0|||
129495972|NCT01954121|466106694|FG001|Overall Study|Subject did not follow instructions|2|||
129495973|NCT02504892|466106700|FG000|Overall Study|Adverse event-pneumonitis|2|||
129495974|NCT00576693|466106701|FG000|Overall Study|Lost to Follow-up|7|||
129495975|NCT00576693|466106702|FG001|Overall Study|Lost to Follow-up|11|||
129495976|NCT00576693|466106701|FG000|Overall Study|Withdrawal by Subject|3|||
129495977|NCT00576693|466106702|FG001|Overall Study|Withdrawal by Subject|13|||
129495978|NCT01413178|466106703|FG000|Overall Study|Toxicity|1|||
129495979|NCT01413178|466106704|FG001|Overall Study|Toxicity|0|||
129495980|NCT01413178|466106703|FG000|Overall Study|Ineligible|0|||
129495981|NCT01413178|466106704|FG001|Overall Study|Ineligible|2|||
129495982|NCT03643432|466106705|FG000|Overall Study|Lost to Follow-up|1|||
129495983|NCT03643432|466106706|FG001|Overall Study|Lost to Follow-up|0|||
129495984|NCT00804193|466106707|FG000|Overall Study|Lack of baseline fungus|32|||
129495985|NCT00804193|466106708|FG001|Overall Study|Lack of baseline fungus|31|||
129495986|NCT00804193|466106709|FG002|Overall Study|Lack of baseline fungus|19|||
129495987|NCT00804193|466106707|FG000|Overall Study|Adverse Event|0|||
129495988|NCT00804193|466106708|FG001|Overall Study|Adverse Event|0|||
129495989|NCT00804193|466106709|FG002|Overall Study|Adverse Event|2|||
129495990|NCT00804193|466106707|FG000|Overall Study|Lack of Efficacy|1|||
129495991|NCT00804193|466106708|FG001|Overall Study|Lack of Efficacy|1|||
129495992|NCT00804193|466106709|FG002|Overall Study|Lack of Efficacy|3|||
129495993|NCT00804193|466106707|FG000|Overall Study|Protocol Violation|0|||
129495994|NCT00804193|466106708|FG001|Overall Study|Protocol Violation|8|||
129495995|NCT00804193|466106709|FG002|Overall Study|Protocol Violation|2|||
129495996|NCT00804193|466106707|FG000|Overall Study|Lost to Follow-up|3|||
129495997|NCT00804193|466106708|FG001|Overall Study|Lost to Follow-up|3|||
129495998|NCT00804193|466106709|FG002|Overall Study|Lost to Follow-up|4|||
129495999|NCT00804193|466106707|FG000|Overall Study|Withdrawal by Subject|3|||
129496000|NCT00804193|466106708|FG001|Overall Study|Withdrawal by Subject|1|||
129496001|NCT00804193|466106709|FG002|Overall Study|Withdrawal by Subject|2|||
129496002|NCT04072146|466106710|FG000|Overall Study|Adverse Event|0|||
129496003|NCT04072146|466106711|FG001|Overall Study|Adverse Event|1|||
129496004|NCT01617434|466106712|FG000|Overall Study|Adverse Event|12|||
129496005|NCT01617434|466106713|FG001|Overall Study|Adverse Event|3|||
129496006|NCT01617434|466106712|FG000|Overall Study|Protocol Violation|8|||
129496007|NCT01617434|466106713|FG001|Overall Study|Protocol Violation|7|||
129496008|NCT01617434|466106712|FG000|Overall Study|Withdrawal Criteria|12|||
129496009|NCT01617434|466106713|FG001|Overall Study|Withdrawal Criteria|37|||
129496010|NCT01617434|466106712|FG000|Overall Study|Unclassified|3|||
129496011|NCT01617434|466106713|FG001|Overall Study|Unclassified|4|||
129496012|NCT01987986|466106714|FG000|Overall Study|Lost to Follow-up|1|||
129496013|NCT01987986|466106715|FG001|Overall Study|Lost to Follow-up|0|||
129496014|NCT01987986|466106716|FG002|Overall Study|Lost to Follow-up|0|||
129496015|NCT01987986|466106717|FG003|Overall Study|Lost to Follow-up|0|||
129496016|NCT01987986|466106714|FG000|Overall Study|Adverse Event|1|||
129496017|NCT01987986|466106715|FG001|Overall Study|Adverse Event|0|||
129496018|NCT01987986|466106716|FG002|Overall Study|Adverse Event|2|||
129496019|NCT01987986|466106717|FG003|Overall Study|Adverse Event|0|||
129496020|NCT03283163|466106720|FG000|Overall Study|Lost to Follow-up|1|||
129496021|NCT03283163|466106720|FG000|Overall Study|other life commitments|6|||
129496022|NCT03283163|466106720|FG000|Overall Study|COVID-19 institution wide halting|1|||
129496023|NCT03283163|466106720|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
129496024|NCT03283163|466106720|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
129496025|NCT00237796|466106721|FG000|Overall Study|Baseline and one other ILSS required|10|||
129496026|NCT00237796|466106722|FG001|Overall Study|Baseline and one other ILSS required|5|||
129496027|NCT04238663|466106726|FG000|Overall Study|Lost to Follow-up|0|||
129496028|NCT04238663|466106727|FG001|Overall Study|Lost to Follow-up|1|||
129496029|NCT04238663|466106728|FG002|Overall Study|Lost to Follow-up|0|||
129496030|NCT01193348|466106729|FG000|Screening Period|Screen Failure|5|||
129496031|NCT01193348|466106729|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
129496032|NCT01193348|466106729|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
129496033|NCT01193348|466106729|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
129496034|NCT01193348|466106729|FG000|Extension Treatment Period|Physician Decision|1|||
129496035|NCT01193348|466106729|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
129496036|NCT04070378|466106730|FG000|Overall Study|Withdrawal by Subject|2|||
129496037|NCT04070378|466106730|FG000|Overall Study|Screen Failure|6|||
129496038|NCT04070378|466106730|FG000|Overall Study|Physician Decision|1|||
129496039|NCT04070378|466106730|FG000|Overall Study|Adverse Event|1|||
129496040|NCT03259334|466106731|FG000|Overall Study|Adverse Event|3|||
129496041|NCT03259334|466106732|FG001|Overall Study|Adverse Event|8|||
129496042|NCT03259334|466106733|FG002|Overall Study|Adverse Event|5|||
129496043|NCT03259334|466106731|FG000|Overall Study|Withdrawal by Subject|4|||
129496044|NCT03259334|466106732|FG001|Overall Study|Withdrawal by Subject|2|||
129496045|NCT03259334|466106733|FG002|Overall Study|Withdrawal by Subject|4|||
129496046|NCT03259334|466106731|FG000|Overall Study|Physician Decision|1|||
129496047|NCT03259334|466106732|FG001|Overall Study|Physician Decision|0|||
129496048|NCT03259334|466106733|FG002|Overall Study|Physician Decision|0|||
129496049|NCT03259334|466106731|FG000|Overall Study|Lost to Follow-up|0|||
129496050|NCT03259334|466106732|FG001|Overall Study|Lost to Follow-up|2|||
129496051|NCT03259334|466106733|FG002|Overall Study|Lost to Follow-up|1|||
129496052|NCT03259334|466106731|FG000|Overall Study|Protocol Deviation|0|||
129496053|NCT03259334|466106732|FG001|Overall Study|Protocol Deviation|3|||
129496054|NCT03259334|466106733|FG002|Overall Study|Protocol Deviation|2|||
129496055|NCT03259334|466106731|FG000|Overall Study|Lack of Efficacy|2|||
129496056|NCT03259334|466106732|FG001|Overall Study|Lack of Efficacy|0|||
129496057|NCT03259334|466106733|FG002|Overall Study|Lack of Efficacy|1|||
129496058|NCT03259334|466106731|FG000|Overall Study|Randomized but never treated|0|||
129496059|NCT03259334|466106732|FG001|Overall Study|Randomized but never treated|2|||
129496060|NCT03259334|466106733|FG002|Overall Study|Randomized but never treated|0|||
129496061|NCT00701727|466108146|FG000|First Treatment Period|Adverse Event|0|||
129496062|NCT00701727|466108147|FG001|First Treatment Period|Adverse Event|0|||
129496063|NCT00701727|466108146|FG000|First Treatment Period|Withdrawal by Subject|1|||
129496064|NCT00701727|466108147|FG001|First Treatment Period|Withdrawal by Subject|0|||
129496065|NCT00701727|466108146|FG000|First Treatment Period|sponsor decision|0|||
129496066|NCT00701727|466108147|FG001|First Treatment Period|sponsor decision|1|||
129496067|NCT00701727|466108146|FG000|First Treatment Period|Lost to Follow-up|0|||
129496068|NCT00701727|466108147|FG001|First Treatment Period|Lost to Follow-up|1|||
129496069|NCT00701727|466108146|FG000|Second Treatment Period|Withdrawal by Subject|2|||
129496070|NCT00701727|466108147|FG001|Second Treatment Period|Withdrawal by Subject|0|||
129496071|NCT05113953|466108150|FG000|Overall Study|Adverse Event|5|||
129496072|NCT05113953|466108151|FG001|Overall Study|Adverse Event|0|||
129496073|NCT05113953|466108152|FG002|Overall Study|Adverse Event|3|||
129496074|NCT05113953|466108150|FG000|Overall Study|Lost to Follow-up|3|||
129496075|NCT05113953|466108151|FG001|Overall Study|Lost to Follow-up|4|||
129496076|NCT05113953|466108152|FG002|Overall Study|Lost to Follow-up|2|||
129496077|NCT05113953|466108150|FG000|Overall Study|Non-compliance with Study Drug|1|||
129496078|NCT05113953|466108151|FG001|Overall Study|Non-compliance with Study Drug|0|||
129496079|NCT05113953|466108152|FG002|Overall Study|Non-compliance with Study Drug|0|||
129496080|NCT05113953|466108150|FG000|Overall Study|Withdrawal by Subject|2|||
129496081|NCT05113953|466108151|FG001|Overall Study|Withdrawal by Subject|6|||
129496082|NCT05113953|466108152|FG002|Overall Study|Withdrawal by Subject|4|||
129496083|NCT05113953|466108150|FG000|Overall Study|Reason not Specified|2|||
129496084|NCT05113953|466108151|FG001|Overall Study|Reason not Specified|0|||
129496085|NCT05113953|466108152|FG002|Overall Study|Reason not Specified|0|||
129496086|NCT00523341|466108153|FG000|Overall Study|Withdrawal by Subject|399|||
129496087|NCT00523341|466108154|FG001|Overall Study|Withdrawal by Subject|427|||
129496088|NCT00523341|466108153|FG000|Overall Study|Other|181|||
129496089|NCT00523341|466108154|FG001|Overall Study|Other|198|||
129496090|NCT00523341|466108153|FG000|Overall Study|Adverse Event|122|||
129496091|NCT00523341|466108154|FG001|Overall Study|Adverse Event|155|||
129496092|NCT00523341|466108153|FG000|Overall Study|Death|101|||
129496093|NCT00523341|466108154|FG001|Overall Study|Death|110|||
129496094|NCT00523341|466108153|FG000|Overall Study|Lost to Follow-up|73|||
129496095|NCT00523341|466108154|FG001|Overall Study|Lost to Follow-up|61|||
129496096|NCT00523341|466108153|FG000|Overall Study|Non-compliance|20|||
129496097|NCT00523341|466108154|FG001|Overall Study|Non-compliance|13|||
129496098|NCT00523341|466108153|FG000|Overall Study|Physician Decision|14|||
129496099|NCT00523341|466108154|FG001|Overall Study|Physician Decision|13|||
129496100|NCT00523341|466108153|FG000|Overall Study|Requirement for Alternative Therapy|4|||
129496101|NCT00523341|466108154|FG001|Overall Study|Requirement for Alternative Therapy|14|||
129496102|NCT00523341|466108153|FG000|Overall Study|Protocol Deviation|6|||
129496103|NCT00523341|466108154|FG001|Overall Study|Protocol Deviation|5|||
129496104|NCT00523341|466108153|FG000|Overall Study|Ineligibility Determined|3|||
129496105|NCT00523341|466108154|FG001|Overall Study|Ineligibility Determined|4|||
129496106|NCT00523341|466108153|FG000|Overall Study|Disease Progression|1|||
129496107|NCT00523341|466108154|FG001|Overall Study|Disease Progression|0|||
129496108|NCT05137041|466108155|FG000|Overall Study|Lost to Follow-up|1|||
129496109|NCT05137041|466108156|FG001|Overall Study|Lost to Follow-up|1|||
129496110|NCT05137041|466108155|FG000|Overall Study|Withdrawal by Subject|0|||
129981351|NCT03986944|467894955|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
129981352|NCT01015560|467894957|FG000|Overall Study|Adverse Event|1|||
129981353|NCT01015560|467894957|FG000|Overall Study|Not protocol specified|1|||
129981354|NCT01015560|467894957|FG000|Overall Study|Withdrawal by Subject|1|||
129981355|NCT00640133|467894958|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
129496111|NCT05137041|466108156|FG001|Overall Study|Withdrawal by Subject|2|||
129496112|NCT05137041|466108155|FG000|Overall Study|Reason not Specified|0|||
129496113|NCT05137041|466108156|FG001|Overall Study|Reason not Specified|1|||
129496114|NCT00502307|466108159|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
129496115|NCT00502307|466108160|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
129496116|NCT00502307|466108161|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
129496117|NCT00502307|466108159|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
129496118|NCT00502307|466108160|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
129496119|NCT00502307|466108161|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
129496120|NCT00502307|466108159|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
129496121|NCT00502307|466108160|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
129496122|NCT00502307|466108161|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
129496123|NCT00502307|466108159|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
129496124|NCT00502307|466108160|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
129496125|NCT00502307|466108161|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
129496126|NCT00502307|466108159|FG000|Maintenance Period|Progressive disease|80|||
129496127|NCT00502307|466108160|FG001|Maintenance Period|Progressive disease|0|||
129496128|NCT00502307|466108161|FG002|Maintenance Period|Progressive disease|0|||
129496129|NCT00502307|466108159|FG000|Maintenance Period|Discontinued due to other reasons|68|||
129496130|NCT00502307|466108160|FG001|Maintenance Period|Discontinued due to other reasons|0|||
129496131|NCT00502307|466108161|FG002|Maintenance Period|Discontinued due to other reasons|0|||
129496132|NCT04907539|466108162|FG000|Overall Study|Consent withdrawn|1|||
129496133|NCT04907539|466108163|FG001|Overall Study|Consent withdrawn|0|||
129496134|NCT04907539|466108162|FG000|Overall Study|Death|14|||
129496135|NCT04907539|466108163|FG001|Overall Study|Death|3|||
129496136|NCT00051558|466108165|FG000|Overall Study|Adverse Event|30|||
129496137|NCT00051558|466108166|FG001|Overall Study|Adverse Event|18|||
129496138|NCT00051558|466108165|FG000|Overall Study|Withdrawal by Subject|29|||
129496139|NCT00051558|466108166|FG001|Overall Study|Withdrawal by Subject|42|||
129496140|NCT00051558|466108165|FG000|Overall Study|Death|9|||
129496141|NCT00051558|466108166|FG001|Overall Study|Death|15|||
129496142|NCT00051558|466108165|FG000|Overall Study|Lost to Follow-up|4|||
129496143|NCT00051558|466108166|FG001|Overall Study|Lost to Follow-up|13|||
129496144|NCT00051558|466108165|FG000|Overall Study|Protocol Violation|3|||
129496145|NCT00051558|466108166|FG001|Overall Study|Protocol Violation|4|||
129496146|NCT00051558|466108165|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
129496147|NCT00051558|466108166|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
129496148|NCT00051558|466108165|FG000|Overall Study|Sponsor Decision|6|||
129496149|NCT00051558|466108166|FG001|Overall Study|Sponsor Decision|1|||
129496150|NCT00051558|466108165|FG000|Overall Study|Other|2|||
129496151|NCT00051558|466108166|FG001|Overall Study|Other|1|||
129496152|NCT00051558|466108165|FG000|Overall Study|Significant Lab Value|2|||
129496153|NCT00051558|466108166|FG001|Overall Study|Significant Lab Value|0|||
129496154|NCT00051558|466108165|FG000|Overall Study|Physician Decision|5|||
129496155|NCT00051558|466108166|FG001|Overall Study|Physician Decision|0|||
129496156|NCT02297438|466108169|FG000|Overall Study|Death|79|||
129496157|NCT02297438|466108170|FG001|Overall Study|Death|86|||
129496158|NCT02297438|466108169|FG000|Overall Study|Lost to Follow-up|9|||
129496159|NCT02297438|466108170|FG001|Overall Study|Lost to Follow-up|7|||
129496160|NCT02297438|466108169|FG000|Overall Study|Withdrawal by Subject|7|||
129496161|NCT02297438|466108170|FG001|Overall Study|Withdrawal by Subject|0|||
129496162|NCT02297438|466108169|FG000|Overall Study|Other|9|||
129496163|NCT02297438|466108170|FG001|Overall Study|Other|5|||
129496164|NCT02297438|466108169|FG000|Overall Study|Ongoing|65|||
129496165|NCT02297438|466108170|FG001|Overall Study|Ongoing|73|||
129496166|NCT02042404|466108171|FG000|Overall Study|Death|1|||
129496167|NCT02042404|466108172|FG001|Overall Study|Death|0|||
129496168|NCT02042404|466108171|FG000|Overall Study|Unrelated Adverse Event|3|||
129496169|NCT02042404|466108172|FG001|Overall Study|Unrelated Adverse Event|0|||
129496170|NCT02042404|466108171|FG000|Overall Study|Inability to meet time requirements|1|||
129496171|NCT02042404|466108172|FG001|Overall Study|Inability to meet time requirements|0|||
129496172|NCT00726323|466108173|FG000|Overall Study|Withdrawal by Subject|3|||
129496173|NCT00726323|466108174|FG001|Overall Study|Withdrawal by Subject|1|||
129496174|NCT00726323|466108173|FG000|Overall Study|Physician Decision|1|||
129496175|NCT00726323|466108174|FG001|Overall Study|Physician Decision|0|||
129496176|NCT00726323|466108173|FG000|Overall Study|Progressive disease|23|||
129496177|NCT00726323|466108174|FG001|Overall Study|Progressive disease|16|||
129496178|NCT00726323|466108173|FG000|Overall Study|Clinical progression|0|||
129496179|NCT00726323|466108174|FG001|Overall Study|Clinical progression|3|||
129496180|NCT00726323|466108173|FG000|Overall Study|Adverse Event|9|||
129496181|NCT00726323|466108174|FG001|Overall Study|Adverse Event|9|||
129496182|NCT00726323|466108173|FG000|Overall Study|Death|1|||
129496183|NCT00726323|466108174|FG001|Overall Study|Death|0|||
129981356|NCT00640133|467894959|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
129981357|NCT00640133|467894958|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
129981358|NCT00640133|467894959|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
129981359|NCT00640133|467894958|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
129496184|NCT00726323|466108173|FG000|Overall Study|Participant wished to discontinue|0|||
129496185|NCT00726323|466108174|FG001|Overall Study|Participant wished to discontinue|1|||
129496186|NCT00726323|466108173|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
129496187|NCT00726323|466108174|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
129981360|NCT00640133|467894959|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
129496188|NCT03521154|466108175|FG000|Overall Study|Ongoing study at data cut-off|111|||
129496189|NCT03521154|466108176|FG001|Overall Study|Ongoing study at data cut-off|52|||
129496190|NCT00972478|466108178|FG000|Overall Study|Adverse Event|3|||
129496191|NCT00972478|466108179|FG001|Overall Study|Adverse Event|16|||
129496192|NCT00972478|466108178|FG000|Overall Study|Withdrawal by Subject|1|||
129496193|NCT00972478|466108179|FG001|Overall Study|Withdrawal by Subject|8|||
129496194|NCT00972478|466108178|FG000|Overall Study|Progression/Relapse|0|||
129496195|NCT00972478|466108179|FG001|Overall Study|Progression/Relapse|2|||
129496196|NCT00972478|466108178|FG000|Overall Study|Death|0|||
129496197|NCT00972478|466108179|FG001|Overall Study|Death|2|||
129496198|NCT00972478|466108178|FG000|Overall Study|Not protocol specified|1|||
129496199|NCT00972478|466108179|FG001|Overall Study|Not protocol specified|1|||
129496200|NCT00972478|466108178|FG000|Overall Study|Ineligible|1|||
129496201|NCT00972478|466108179|FG001|Overall Study|Ineligible|7|||
129496202|NCT00972478|466108178|FG000|Overall Study|Not start protocol treatment|1|||
129496203|NCT00972478|466108179|FG001|Overall Study|Not start protocol treatment|2|||
129496204|NCT02561000|466108180|FG000|Overall Study|Withdrawal by Subject|2|||
129496205|NCT02561000|466108181|FG001|Overall Study|Withdrawal by Subject|3|||
129496206|NCT02561000|466108182|FG002|Overall Study|Withdrawal by Subject|0|||
129496207|NCT02561000|466108180|FG000|Overall Study|Adverse Event|0|||
129981361|NCT00128102|467894962|FG000|Overall Study|Site Discontinued|3|||
129981362|NCT00128102|467894963|FG001|Overall Study|Site Discontinued|6|||
129981363|NCT00128102|467894962|FG000|Overall Study|Other|0|||
129981364|NCT00128102|467894963|FG001|Overall Study|Other|1|||
129981365|NCT00128102|467894962|FG000|Overall Study|Progressive Disease|255|||
129981366|NCT00128102|467894963|FG001|Overall Study|Progressive Disease|285|||
129981367|NCT00128102|467894962|FG000|Overall Study|Adverse Event|34|||
129981368|NCT00128102|467894963|FG001|Overall Study|Adverse Event|11|||
129981369|NCT00128102|467894962|FG000|Overall Study|Death|12|||
129981370|NCT00128102|467894963|FG001|Overall Study|Death|13|||
129981371|NCT00128102|467894962|FG000|Overall Study|Physician Decision|3|||
129981372|NCT00128102|467894963|FG001|Overall Study|Physician Decision|3|||
129981373|NCT00128102|467894962|FG000|Overall Study|Withdrawal by Subject|19|||
129981374|NCT00128102|467894963|FG001|Overall Study|Withdrawal by Subject|11|||
129981375|NCT00128102|467894962|FG000|Overall Study|Protocol Violation|2|||
129981376|NCT00128102|467894963|FG001|Overall Study|Protocol Violation|2|||
129981377|NCT01202903|467894965|FG000|Overall Study|Administrative Probelms|1|||
129981378|NCT01202903|467894966|FG001|Overall Study|Administrative Probelms|4|||
129981379|NCT01202903|467894965|FG000|Overall Study|Protocol Violation|0|||
129981380|NCT01202903|467894966|FG001|Overall Study|Protocol Violation|1|||
129981381|NCT01202903|467894965|FG000|Overall Study|Death|1|||
129981382|NCT01202903|467894966|FG001|Overall Study|Death|0|||
129981383|NCT01202903|467894965|FG000|Overall Study|Lost to Follow-up|1|||
129981384|NCT01202903|467894966|FG001|Overall Study|Lost to Follow-up|1|||
129981385|NCT01202903|467894965|FG000|Overall Study|Lack of Efficacy|1|||
129981386|NCT01202903|467894966|FG001|Overall Study|Lack of Efficacy|3|||
129981387|NCT01202903|467894965|FG000|Overall Study|Adverse Event|3|||
129981388|NCT01202903|467894966|FG001|Overall Study|Adverse Event|3|||
129981389|NCT01202903|467894965|FG000|Overall Study|Withdrawal by Subject|4|||
129981390|NCT01202903|467894966|FG001|Overall Study|Withdrawal by Subject|4|||
129981391|NCT01302080|467894967|FG000|Overall Study|Withdrew Consent|92|||
129981392|NCT01302080|467894968|FG001|Overall Study|Withdrew Consent|39|||
129981393|NCT01302080|467894967|FG000|Overall Study|Patient/Family Moved|28|||
129981394|NCT01302080|467894968|FG001|Overall Study|Patient/Family Moved|3|||
129981395|NCT01302080|467894967|FG000|Overall Study|Lost to Follow-up|192|||
129981396|NCT01302080|467894968|FG001|Overall Study|Lost to Follow-up|93|||
129981397|NCT01302080|467894967|FG000|Overall Study|Death|1|||
129981398|NCT01302080|467894968|FG001|Overall Study|Death|0|||
129981399|NCT01302080|467894967|FG000|Overall Study|Other|52|||
129981400|NCT01302080|467894968|FG001|Overall Study|Other|8|||
129981401|NCT01302080|467894967|FG000|Overall Study|Reason Missing For Discontinuation|1|||
129981402|NCT01302080|467894968|FG001|Overall Study|Reason Missing For Discontinuation|0|||
129981403|NCT03339245|467894971|FG000|Overall Study|Adverse Event|1|||
129981404|NCT03339245|467894972|FG001|Overall Study|Adverse Event|1|||
129981405|NCT03339245|467894971|FG000|Overall Study|Withdrawal by Subject|1|||
129981406|NCT03339245|467894972|FG001|Overall Study|Withdrawal by Subject|0|||
129981407|NCT00837694|467894973|FG000|Overall Study|Lost to Follow-up|2|||
129981408|NCT00837694|467894974|FG001|Overall Study|Lost to Follow-up|0|||
129981409|NCT00837694|467894975|FG002|Overall Study|Lost to Follow-up|2|||
129981410|NCT00837694|467894976|FG003|Overall Study|Lost to Follow-up|1|||
129981411|NCT00837694|467894977|FG004|Overall Study|Lost to Follow-up|1|||
129981412|NCT00837694|467894978|FG005|Overall Study|Lost to Follow-up|1|||
129981413|NCT00306670|467894985|FG000|Overall Study|patients recruited; Genentech, the st|0|||
129496208|NCT02561000|466108181|FG001|Overall Study|Adverse Event|1|||
129981414|NCT00306670|467894986|FG001|Overall Study|patients recruited; Genentech, the st|2|||
129981415|NCT00503139|467894987|FG000|Overall Study|Case Report Forms were not collected|4|||
129981416|NCT00503139|467894987|FG000|Overall Study|Protocol Violation|4|||
129981417|NCT02735577|467894991|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
129981418|NCT02735577|467894991|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
129981419|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981420|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981421|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
129496209|NCT02561000|466108182|FG002|Overall Study|Adverse Event|0|||
129981422|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
129981423|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981424|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
129981425|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
129496210|NCT01522976|466108183|FG000|Overall Study|Ineligible|4|||
129496211|NCT01522976|466108184|FG001|Overall Study|Ineligible|0|||
129496212|NCT01522976|466108185|FG002|Overall Study|Ineligible|1|||
129496213|NCT01522976|466108183|FG000|Overall Study|Death|7|||
129496214|NCT01522976|466108184|FG001|Overall Study|Death|6|||
129496215|NCT01522976|466108185|FG002|Overall Study|Death|2|||
129496216|NCT01522976|466108183|FG000|Overall Study|Still on treatment|9|||
129496217|NCT01522976|466108184|FG001|Overall Study|Still on treatment|9|||
129496218|NCT01522976|466108185|FG002|Overall Study|Still on treatment|6|||
129496219|NCT01522976|466108183|FG000|Overall Study|Disease progression|28|||
129496220|NCT01522976|466108184|FG001|Overall Study|Disease progression|30|||
129496221|NCT01522976|466108185|FG002|Overall Study|Disease progression|25|||
129496222|NCT01522976|466108183|FG000|Overall Study|Adverse Event|17|||
129496223|NCT01522976|466108184|FG001|Overall Study|Adverse Event|7|||
129496224|NCT01522976|466108185|FG002|Overall Study|Adverse Event|18|||
129496225|NCT01522976|466108183|FG000|Overall Study|Refusal unrelated to adverse event|10|||
129496226|NCT01522976|466108184|FG001|Overall Study|Refusal unrelated to adverse event|13|||
129496227|NCT01522976|466108185|FG002|Overall Study|Refusal unrelated to adverse event|14|||
129496228|NCT01522976|466108183|FG000|Overall Study|Not protocol specified|22|||
129496229|NCT01522976|466108184|FG001|Overall Study|Not protocol specified|27|||
129496230|NCT01522976|466108185|FG002|Overall Study|Not protocol specified|27|||
129496231|NCT04075266|466108188|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
129496232|NCT04075266|466108189|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
129496233|NCT04075266|466108188|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
129496234|NCT04075266|466108189|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
129496235|NCT05132569|466108190|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
129496236|NCT05132569|466108191|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
129496237|NCT05132569|466108190|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
129496238|NCT05132569|466108191|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
129496239|NCT05132569|466108190|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
129496240|NCT05132569|466108191|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
129496241|NCT04102098|466108192|FG000|Main Study Period|Ongoing in study|302|||
129496242|NCT04102098|466108193|FG001|Main Study Period|Ongoing in study|291|||
129496243|NCT04102098|466108192|FG000|Main Study Period|Death|20|||
129496244|NCT04102098|466108193|FG001|Main Study Period|Death|27|||
129496245|NCT04102098|466108192|FG000|Main Study Period|Lost to Follow-up|1|||
129496246|NCT04102098|466108193|FG001|Main Study Period|Lost to Follow-up|1|||
129496247|NCT04102098|466108192|FG000|Main Study Period|Physician Decision|0|||
129496248|NCT04102098|466108193|FG001|Main Study Period|Physician Decision|1|||
129496249|NCT04102098|466108192|FG000|Main Study Period|Withdrawal by Subject|11|||
129496250|NCT04102098|466108193|FG001|Main Study Period|Withdrawal by Subject|14|||
129496251|NCT04102098|466108192|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
129496252|NCT04102098|466108193|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
129496253|NCT04102098|466108192|FG000|Crossover: AS Who Crossed Over|Death|11|||
129496254|NCT04102098|466108193|FG001|Crossover: AS Who Crossed Over|Death|0|||
129496255|NCT04102098|466108192|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
129496256|NCT04102098|466108193|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
129496257|NCT04742907|466108194|FG000|Overall Study|Adverse Event|1|||
129496258|NCT04742907|466108195|FG001|Overall Study|Adverse Event|0|||
129496259|NCT04742907|466108196|FG002|Overall Study|Adverse Event|1|||
129496260|NCT04742907|466108194|FG000|Overall Study|Lost to Follow-up|3|||
129496261|NCT04742907|466108195|FG001|Overall Study|Lost to Follow-up|3|||
129496262|NCT04742907|466108196|FG002|Overall Study|Lost to Follow-up|2|||
129496263|NCT04742907|466108194|FG000|Overall Study|Physician Decision|0|||
129496264|NCT04742907|466108195|FG001|Overall Study|Physician Decision|1|||
129496265|NCT04742907|466108196|FG002|Overall Study|Physician Decision|0|||
129496266|NCT04742907|466108194|FG000|Overall Study|Protocol Violation|1|||
129496267|NCT04742907|466108195|FG001|Overall Study|Protocol Violation|1|||
129496268|NCT04742907|466108196|FG002|Overall Study|Protocol Violation|1|||
129496269|NCT04742907|466108194|FG000|Overall Study|Withdrawal by Subject|5|||
129496270|NCT04742907|466108195|FG001|Overall Study|Withdrawal by Subject|6|||
129981426|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
129496271|NCT04742907|466108196|FG002|Overall Study|Withdrawal by Subject|4|||
129496272|NCT04742907|466108194|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
129496273|NCT04742907|466108195|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
129496274|NCT04742907|466108196|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
129496275|NCT04742907|466108194|FG000|Overall Study|Did Not Receive the Study Drug|2|||
129496276|NCT04742907|466108195|FG001|Overall Study|Did Not Receive the Study Drug|4|||
129496277|NCT04742907|466108196|FG002|Overall Study|Did Not Receive the Study Drug|4|||
129496278|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
129496279|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
129496280|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129496281|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129496282|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129496283|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129496284|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
129496285|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
129496286|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
129496287|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
129496288|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
129496289|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
129496290|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
129496291|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
129496292|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
129496293|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
129496294|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
129496295|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
129496296|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
129496297|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
129496298|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
129496299|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Other|0|||
129496300|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Other|1|||
129496301|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Other|0|||
129496302|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Other|0|||
129496303|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Other|0|||
129496304|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Other|0|||
129496305|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Other|0|||
129496306|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
129496307|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
129496308|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
129496309|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
129496310|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
129496311|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
129496312|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
129496313|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
129496314|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
129496315|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
129496316|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
129496317|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
129496318|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
129496319|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
129496320|NCT00365716|466108197|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
129496321|NCT00365716|466108198|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
129496322|NCT00365716|466108199|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
129496323|NCT00365716|466108200|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
129496324|NCT00365716|466108201|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
129496325|NCT00365716|466108202|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
129496326|NCT00365716|466108203|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
129496327|NCT00365716|466108197|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
129496328|NCT00365716|466108198|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
129496329|NCT00365716|466108199|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
129496330|NCT00365716|466108200|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
129496331|NCT00365716|466108201|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
129496332|NCT00365716|466108202|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
129496333|NCT00365716|466108203|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
129496334|NCT00365716|466108197|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
129496335|NCT00365716|466108198|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
129496336|NCT00365716|466108199|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
129496337|NCT00365716|466108200|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
129496338|NCT00365716|466108201|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
129496339|NCT00365716|466108202|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
129496340|NCT00365716|466108203|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
129496341|NCT00365716|466108197|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
129496342|NCT00365716|466108198|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
129496343|NCT00365716|466108199|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
129496344|NCT00365716|466108200|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
129496345|NCT00365716|466108201|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
129496346|NCT00365716|466108202|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
129496347|NCT00365716|466108203|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
129496348|NCT00365716|466108197|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
129496349|NCT00365716|466108198|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
129496350|NCT00365716|466108199|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
129496351|NCT00365716|466108200|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
129496352|NCT00365716|466108201|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
129496353|NCT00365716|466108202|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
129496354|NCT00365716|466108203|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
129496355|NCT00365716|466108197|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129496356|NCT00365716|466108198|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
129496357|NCT00365716|466108199|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
129496358|NCT00365716|466108200|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129496359|NCT00365716|466108201|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129496360|NCT00365716|466108202|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129496361|NCT00365716|466108203|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
129496362|NCT00365716|466108197|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
129496363|NCT00365716|466108198|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
129496364|NCT00365716|466108199|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
129496365|NCT00365716|466108200|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
129496366|NCT00365716|466108201|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
129496367|NCT00365716|466108202|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
129496368|NCT00365716|466108203|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
129496369|NCT00365716|466108197|FG000|Extension 1|Lost to Follow-up|0|||
129496370|NCT00365716|466108198|FG001|Extension 1|Lost to Follow-up|0|||
129496371|NCT00365716|466108199|FG002|Extension 1|Lost to Follow-up|0|||
129496372|NCT00365716|466108200|FG003|Extension 1|Lost to Follow-up|0|||
129496373|NCT00365716|466108201|FG004|Extension 1|Lost to Follow-up|0|||
129496374|NCT00365716|466108202|FG005|Extension 1|Lost to Follow-up|1|||
129496375|NCT00365716|466108203|FG006|Extension 1|Lost to Follow-up|0|||
129496376|NCT00365716|466108197|FG000|Extension 1|Other|0|||
129496377|NCT00365716|466108198|FG001|Extension 1|Other|0|||
129496378|NCT00365716|466108199|FG002|Extension 1|Other|0|||
129496379|NCT00365716|466108200|FG003|Extension 1|Other|0|||
129496380|NCT00365716|466108201|FG004|Extension 1|Other|0|||
129496381|NCT00365716|466108202|FG005|Extension 1|Other|9|||
129496382|NCT00365716|466108203|FG006|Extension 1|Other|0|||
129496383|NCT00365716|466108197|FG000|Extension 1|Moved|0|||
129496384|NCT00365716|466108198|FG001|Extension 1|Moved|0|||
129496385|NCT00365716|466108199|FG002|Extension 1|Moved|0|||
129496386|NCT00365716|466108200|FG003|Extension 1|Moved|0|||
129496387|NCT00365716|466108201|FG004|Extension 1|Moved|0|||
129496388|NCT00365716|466108202|FG005|Extension 1|Moved|4|||
129496389|NCT00365716|466108203|FG006|Extension 1|Moved|0|||
129496390|NCT00365716|466108197|FG000|Extension 1|Withdrawal by Subject|0|||
129496391|NCT00365716|466108198|FG001|Extension 1|Withdrawal by Subject|0|||
129496392|NCT00365716|466108199|FG002|Extension 1|Withdrawal by Subject|0|||
129496393|NCT00365716|466108200|FG003|Extension 1|Withdrawal by Subject|0|||
129496394|NCT00365716|466108201|FG004|Extension 1|Withdrawal by Subject|0|||
129496395|NCT00365716|466108202|FG005|Extension 1|Withdrawal by Subject|3|||
129496396|NCT00365716|466108203|FG006|Extension 1|Withdrawal by Subject|0|||
129496397|NCT00365716|466108197|FG000|Extension 1|Pregnancy|0|||
129496398|NCT00365716|466108198|FG001|Extension 1|Pregnancy|0|||
129496399|NCT00365716|466108199|FG002|Extension 1|Pregnancy|0|||
129496400|NCT00365716|466108200|FG003|Extension 1|Pregnancy|0|||
129496401|NCT00365716|466108201|FG004|Extension 1|Pregnancy|0|||
129496402|NCT00365716|466108202|FG005|Extension 1|Pregnancy|4|||
129496403|NCT00365716|466108203|FG006|Extension 1|Pregnancy|0|||
129496404|NCT00365716|466108197|FG000|Extension 1|Protocol Violation|0|||
129496405|NCT00365716|466108198|FG001|Extension 1|Protocol Violation|0|||
129496406|NCT00365716|466108199|FG002|Extension 1|Protocol Violation|0|||
129496407|NCT00365716|466108200|FG003|Extension 1|Protocol Violation|0|||
129496408|NCT00365716|466108201|FG004|Extension 1|Protocol Violation|0|||
129496409|NCT00365716|466108202|FG005|Extension 1|Protocol Violation|1|||
129496410|NCT00365716|466108203|FG006|Extension 1|Protocol Violation|0|||
129496411|NCT00365716|466108197|FG000|Extension 2|Lost to Follow-up|0|||
129496412|NCT00365716|466108198|FG001|Extension 2|Lost to Follow-up|0|||
129496413|NCT00365716|466108199|FG002|Extension 2|Lost to Follow-up|0|||
129496414|NCT00365716|466108200|FG003|Extension 2|Lost to Follow-up|0|||
129496415|NCT00365716|466108201|FG004|Extension 2|Lost to Follow-up|0|||
129496416|NCT00365716|466108202|FG005|Extension 2|Lost to Follow-up|0|||
129496417|NCT00365716|466108203|FG006|Extension 2|Lost to Follow-up|2|||
129496418|NCT00365716|466108197|FG000|Extension 2|Other|0|||
129496419|NCT00365716|466108198|FG001|Extension 2|Other|0|||
129496420|NCT00365716|466108199|FG002|Extension 2|Other|0|||
129496421|NCT00365716|466108200|FG003|Extension 2|Other|0|||
129496422|NCT00365716|466108201|FG004|Extension 2|Other|0|||
129496423|NCT00365716|466108202|FG005|Extension 2|Other|0|||
129496424|NCT00365716|466108203|FG006|Extension 2|Other|3|||
129496425|NCT00365716|466108197|FG000|Extension 2|Withdrawal by Subject|0|||
129496426|NCT00365716|466108198|FG001|Extension 2|Withdrawal by Subject|0|||
129496427|NCT00365716|466108199|FG002|Extension 2|Withdrawal by Subject|0|||
129496428|NCT00365716|466108200|FG003|Extension 2|Withdrawal by Subject|0|||
129496429|NCT00365716|466108201|FG004|Extension 2|Withdrawal by Subject|0|||
129496430|NCT00365716|466108202|FG005|Extension 2|Withdrawal by Subject|0|||
129496431|NCT00365716|466108203|FG006|Extension 2|Withdrawal by Subject|5|||
129496432|NCT02280291|466108204|FG000|Overall Study|Lost to Follow-up|2|||
129496433|NCT02280291|466108205|FG001|Overall Study|Lost to Follow-up|1|||
129496434|NCT02280291|466108206|FG002|Overall Study|Lost to Follow-up|3|||
129496435|NCT02280291|466108207|FG003|Overall Study|Lost to Follow-up|8|||
129496436|NCT02280291|466108204|FG000|Overall Study|Protocol Violation|1|||
129496437|NCT02280291|466108205|FG001|Overall Study|Protocol Violation|0|||
129496438|NCT02280291|466108206|FG002|Overall Study|Protocol Violation|0|||
129496439|NCT02280291|466108207|FG003|Overall Study|Protocol Violation|0|||
129496440|NCT02280291|466108204|FG000|Overall Study|Other|1|||
129496441|NCT02280291|466108205|FG001|Overall Study|Other|1|||
129496442|NCT02280291|466108206|FG002|Overall Study|Other|0|||
129496443|NCT02280291|466108207|FG003|Overall Study|Other|0|||
129496444|NCT06150573|466108208|FG000|Overall Study|Did not meet study criteria|1|||
129496445|NCT06150573|466108209|FG001|Overall Study|Did not meet study criteria|0|||
129496446|NCT06150573|466108208|FG000|Overall Study|Adverse Event|1|||
129496447|NCT06150573|466108209|FG001|Overall Study|Adverse Event|0|||
129496448|NCT06150573|466108208|FG000|Overall Study|Lost to Follow-up|0|||
129496449|NCT06150573|466108209|FG001|Overall Study|Lost to Follow-up|1|||
129496450|NCT06150573|466108208|FG000|Overall Study|Protocol Violation|0|||
129496451|NCT06150573|466108209|FG001|Overall Study|Protocol Violation|1|||
129496452|NCT06150573|466108208|FG000|Overall Study|Withdrawal by Subject|2|||
129496453|NCT06150573|466108209|FG001|Overall Study|Withdrawal by Subject|0|||
129496454|NCT00069095|466108210|FG000|Primary Treatment Phase|Ongoing|0|||
129496455|NCT00069095|466108211|FG001|Primary Treatment Phase|Ongoing|0|||
129496456|NCT00069095|466108212|FG002|Primary Treatment Phase|Ongoing|5|||
129496457|NCT00069095|466108213|FG003|Primary Treatment Phase|Ongoing|7|||
129496458|NCT00069095|466108214|FG004|Primary Treatment Phase|Ongoing|7|||
129496459|NCT00069095|466108215|FG005|Primary Treatment Phase|Ongoing|4|||
129496460|NCT00069095|466108210|FG000|Primary Treatment Phase|Admin/Other|29|||
129496461|NCT00069095|466108211|FG001|Primary Treatment Phase|Admin/Other|38|||
129496462|NCT00069095|466108212|FG002|Primary Treatment Phase|Admin/Other|31|||
129496463|NCT00069095|466108213|FG003|Primary Treatment Phase|Admin/Other|45|||
129496464|NCT00069095|466108214|FG004|Primary Treatment Phase|Admin/Other|48|||
129496465|NCT00069095|466108215|FG005|Primary Treatment Phase|Admin/Other|42|||
129496466|NCT00069095|466108210|FG000|Primary Treatment Phase|Adverse Event|99|||
129496467|NCT00069095|466108211|FG001|Primary Treatment Phase|Adverse Event|92|||
129496468|NCT00069095|466108212|FG002|Primary Treatment Phase|Adverse Event|71|||
129496469|NCT00069095|466108213|FG003|Primary Treatment Phase|Adverse Event|72|||
129496470|NCT00069095|466108214|FG004|Primary Treatment Phase|Adverse Event|109|||
129496471|NCT00069095|466108215|FG005|Primary Treatment Phase|Adverse Event|101|||
129496472|NCT00069095|466108210|FG000|Primary Treatment Phase|Death|14|||
129496473|NCT00069095|466108211|FG001|Primary Treatment Phase|Death|8|||
129496474|NCT00069095|466108212|FG002|Primary Treatment Phase|Death|2|||
129496475|NCT00069095|466108213|FG003|Primary Treatment Phase|Death|5|||
129496476|NCT00069095|466108214|FG004|Primary Treatment Phase|Death|8|||
129496477|NCT00069095|466108215|FG005|Primary Treatment Phase|Death|8|||
129496478|NCT00069095|466108210|FG000|Primary Treatment Phase|Failure to return|5|||
129496479|NCT00069095|466108211|FG001|Primary Treatment Phase|Failure to return|5|||
129496480|NCT00069095|466108212|FG002|Primary Treatment Phase|Failure to return|0|||
129496481|NCT00069095|466108213|FG003|Primary Treatment Phase|Failure to return|0|||
129496482|NCT00069095|466108214|FG004|Primary Treatment Phase|Failure to return|0|||
129496483|NCT00069095|466108215|FG005|Primary Treatment Phase|Failure to return|2|||
129496484|NCT00069095|466108210|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
129496485|NCT00069095|466108211|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
129496486|NCT00069095|466108212|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
129496487|NCT00069095|466108213|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
129981427|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
129496488|NCT00069095|466108214|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
129496489|NCT00069095|466108215|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
129496490|NCT00069095|466108210|FG000|Primary Treatment Phase|Refused treatment|15|||
129496491|NCT00069095|466108211|FG001|Primary Treatment Phase|Refused treatment|26|||
129496492|NCT00069095|466108212|FG002|Primary Treatment Phase|Refused treatment|17|||
129496493|NCT00069095|466108213|FG003|Primary Treatment Phase|Refused treatment|31|||
129496494|NCT00069095|466108214|FG004|Primary Treatment Phase|Refused treatment|24|||
129496495|NCT00069095|466108215|FG005|Primary Treatment Phase|Refused treatment|27|||
129981428|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
129981429|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
129496496|NCT00069095|466108210|FG000|Primary Treatment Phase|Withdrew|2|||
129496497|NCT00069095|466108211|FG001|Primary Treatment Phase|Withdrew|3|||
129496498|NCT00069095|466108212|FG002|Primary Treatment Phase|Withdrew|8|||
129496499|NCT00069095|466108213|FG003|Primary Treatment Phase|Withdrew|2|||
129496500|NCT00069095|466108214|FG004|Primary Treatment Phase|Withdrew|4|||
129496501|NCT00069095|466108215|FG005|Primary Treatment Phase|Withdrew|9|||
129496502|NCT00069095|466108210|FG000|Primary Treatment Phase|Other Violation|0|||
129496503|NCT00069095|466108211|FG001|Primary Treatment Phase|Other Violation|1|||
129496504|NCT00069095|466108212|FG002|Primary Treatment Phase|Other Violation|1|||
129496505|NCT00069095|466108213|FG003|Primary Treatment Phase|Other Violation|1|||
129496506|NCT00069095|466108214|FG004|Primary Treatment Phase|Other Violation|0|||
129496507|NCT00069095|466108215|FG005|Primary Treatment Phase|Other Violation|1|||
129496508|NCT00069095|466108210|FG000|Primary Treatment Phase|Violation criteria|0|||
129496509|NCT00069095|466108211|FG001|Primary Treatment Phase|Violation criteria|2|||
129496510|NCT00069095|466108212|FG002|Primary Treatment Phase|Violation criteria|4|||
129496511|NCT00069095|466108213|FG003|Primary Treatment Phase|Violation criteria|3|||
129496512|NCT00069095|466108214|FG004|Primary Treatment Phase|Violation criteria|1|||
129496513|NCT00069095|466108215|FG005|Primary Treatment Phase|Violation criteria|5|||
129496514|NCT00069095|466108210|FG000|Post-study Treatment Phase|Missing reason|1|||
129496515|NCT00069095|466108211|FG001|Post-study Treatment Phase|Missing reason|3|||
129496516|NCT00069095|466108212|FG002|Post-study Treatment Phase|Missing reason|12|||
129496517|NCT00069095|466108213|FG003|Post-study Treatment Phase|Missing reason|8|||
129496518|NCT00069095|466108214|FG004|Post-study Treatment Phase|Missing reason|18|||
129496519|NCT00069095|466108215|FG005|Post-study Treatment Phase|Missing reason|17|||
129496520|NCT00069095|466108210|FG000|Post-study Treatment Phase|Adverse Event|2|||
129496521|NCT00069095|466108211|FG001|Post-study Treatment Phase|Adverse Event|3|||
129496522|NCT00069095|466108212|FG002|Post-study Treatment Phase|Adverse Event|1|||
129496523|NCT00069095|466108213|FG003|Post-study Treatment Phase|Adverse Event|0|||
129496524|NCT00069095|466108214|FG004|Post-study Treatment Phase|Adverse Event|5|||
129496525|NCT00069095|466108215|FG005|Post-study Treatment Phase|Adverse Event|1|||
129496526|NCT00069095|466108210|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
129496527|NCT00069095|466108211|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
129496528|NCT00069095|466108212|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
129496529|NCT00069095|466108213|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
129496530|NCT00069095|466108214|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
129496531|NCT00069095|466108215|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
129496532|NCT00069095|466108210|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
129496533|NCT00069095|466108211|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
129496534|NCT00069095|466108212|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
129496535|NCT00069095|466108213|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
129496536|NCT00069095|466108214|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
129496537|NCT00069095|466108215|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
129496538|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
129496539|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
129496540|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
129496541|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
129496542|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
129496543|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
129496544|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant had complete response|1|||
129496545|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant had complete response|1|||
129496546|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant had complete response|0|||
129496547|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant had complete response|0|||
129496548|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant had complete response|0|||
129496549|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant had complete response|0|||
129496550|NCT00069095|466108210|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
129496551|NCT00069095|466108211|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
129496552|NCT00069095|466108212|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
129496553|NCT00069095|466108213|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
129496554|NCT00069095|466108214|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
129496555|NCT00069095|466108215|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
129496556|NCT00069095|466108210|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
129496557|NCT00069095|466108211|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
129496558|NCT00069095|466108212|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
129496559|NCT00069095|466108213|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
129496560|NCT00069095|466108214|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
129496561|NCT00069095|466108215|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
129496562|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
129496563|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
129496564|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
129496565|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
129496566|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
129496567|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
129496568|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
129496569|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
129496570|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
129496571|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
129496572|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
129496573|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
129496574|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
129496575|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
129496576|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
129496577|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
129496578|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
129496579|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
129496580|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
129496581|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
129496582|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
129496583|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
129496584|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
129496585|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
129496586|NCT00069095|466108210|FG000|Post-study Treatment Phase|Surgery|0|||
129496587|NCT00069095|466108211|FG001|Post-study Treatment Phase|Surgery|0|||
129496588|NCT00069095|466108212|FG002|Post-study Treatment Phase|Surgery|0|||
129496589|NCT00069095|466108213|FG003|Post-study Treatment Phase|Surgery|1|||
129496590|NCT00069095|466108214|FG004|Post-study Treatment Phase|Surgery|1|||
129496591|NCT00069095|466108215|FG005|Post-study Treatment Phase|Surgery|0|||
129496592|NCT00069095|466108210|FG000|Post-study Treatment Phase|Death|0|||
129496593|NCT00069095|466108211|FG001|Post-study Treatment Phase|Death|0|||
129496594|NCT00069095|466108212|FG002|Post-study Treatment Phase|Death|0|||
129496595|NCT00069095|466108213|FG003|Post-study Treatment Phase|Death|0|||
129496596|NCT00069095|466108214|FG004|Post-study Treatment Phase|Death|1|||
129496597|NCT00069095|466108215|FG005|Post-study Treatment Phase|Death|0|||
129496598|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
129496599|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
129496600|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
129496601|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
129496602|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
129496603|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
129496604|NCT00069095|466108210|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
129496605|NCT00069095|466108211|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
129496606|NCT00069095|466108212|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
129496607|NCT00069095|466108213|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
129496608|NCT00069095|466108214|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
129496609|NCT00069095|466108215|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
129496610|NCT00069095|466108210|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
129496611|NCT00069095|466108211|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
129496612|NCT00069095|466108212|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
129496613|NCT00069095|466108213|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
129496614|NCT00069095|466108214|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
129496615|NCT00069095|466108215|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
129496616|NCT00069095|466108210|FG000|Post-study Treatment Phase|Investigator decision|0|||
129496617|NCT00069095|466108211|FG001|Post-study Treatment Phase|Investigator decision|0|||
129496618|NCT00069095|466108212|FG002|Post-study Treatment Phase|Investigator decision|0|||
129496619|NCT00069095|466108213|FG003|Post-study Treatment Phase|Investigator decision|0|||
129496620|NCT00069095|466108214|FG004|Post-study Treatment Phase|Investigator decision|0|||
129496621|NCT00069095|466108215|FG005|Post-study Treatment Phase|Investigator decision|1|||
129496622|NCT00069095|466108210|FG000|Follow-up Phase|Death|174|||
129496623|NCT00069095|466108211|FG001|Follow-up Phase|Death|206|||
129496624|NCT00069095|466108212|FG002|Follow-up Phase|Death|120|||
129496625|NCT00069095|466108213|FG003|Follow-up Phase|Death|112|||
129496626|NCT00069095|466108214|FG004|Follow-up Phase|Death|92|||
129981430|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981431|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
129981432|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
129981433|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
129981434|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
129981435|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
129496627|NCT00069095|466108215|FG005|Follow-up Phase|Death|101|||
129496628|NCT03508622|466108216|FG000|Overall Study|Protocol Violation|1|||
129496629|NCT03508622|466108217|FG001|Overall Study|Protocol Violation|0|||
129496630|NCT03508622|466108216|FG000|Overall Study|Withdrawal by Subject|1|||
129496631|NCT03508622|466108217|FG001|Overall Study|Withdrawal by Subject|0|||
129981436|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
129496632|NCT03508622|466108216|FG000|Overall Study|Lost to Follow-up|16|||
129496633|NCT03508622|466108217|FG001|Overall Study|Lost to Follow-up|0|||
129496634|NCT03508622|466108216|FG000|Overall Study|Incomplete data|0|||
129496635|NCT03508622|466108217|FG001|Overall Study|Incomplete data|24|||
129496636|NCT00210158|466108219|FG000|Overall Study|Protocol Violation|0|||
129496637|NCT00210158|466108220|FG001|Overall Study|Protocol Violation|2|||
129496638|NCT04716933|466108221|FG000|Overall Study|Sponsor Decision|36|||
129496639|NCT04716933|466108222|FG001|Overall Study|Sponsor Decision|33|||
129496640|NCT04716933|466108221|FG000|Overall Study|Death|65|||
129496641|NCT04716933|466108222|FG001|Overall Study|Death|67|||
129496642|NCT03196505|466108225|FG000|Overall Study|Physician Decision|26|||
129496643|NCT03196505|466108226|FG001|Overall Study|Physician Decision|26|||
129496644|NCT01005719|466108227|FG000|Period 1|Adverse Event|0|||
129496645|NCT01005719|466108228|FG001|Period 1|Adverse Event|0|||
129496646|NCT01005719|466108229|FG002|Period 1|Adverse Event|0|||
129496647|NCT01005719|466108230|FG003|Period 1|Adverse Event|1|||
129496648|NCT01005719|466108231|FG004|Period 1|Adverse Event|0|||
129496649|NCT01005719|466108232|FG005|Period 1|Adverse Event|0|||
129496650|NCT01005719|466108227|FG000|Period 1|Delay in completing study procedures|0|||
129496651|NCT01005719|466108228|FG001|Period 1|Delay in completing study procedures|0|||
129496652|NCT01005719|466108229|FG002|Period 1|Delay in completing study procedures|0|||
129496653|NCT01005719|466108230|FG003|Period 1|Delay in completing study procedures|0|||
129496654|NCT01005719|466108231|FG004|Period 1|Delay in completing study procedures|0|||
129496655|NCT01005719|466108232|FG005|Period 1|Delay in completing study procedures|1|||
129496656|NCT01005719|466108227|FG000|Period 2|Adverse Event|0|||
129496657|NCT01005719|466108228|FG001|Period 2|Adverse Event|0|||
129496658|NCT01005719|466108229|FG002|Period 2|Adverse Event|0|||
129496659|NCT01005719|466108230|FG003|Period 2|Adverse Event|0|||
129496660|NCT01005719|466108231|FG004|Period 2|Adverse Event|1|||
129496661|NCT01005719|466108232|FG005|Period 2|Adverse Event|1|||
129496662|NCT00069576|466108233|FG000|Original Trial|Lost to Follow-up|25|||
129496663|NCT00069576|466108234|FG001|Original Trial|Lost to Follow-up|33|||
129496664|NCT00069576|466108233|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
129496665|NCT00069576|466108234|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
129496666|NCT04430738|466108235|FG000|Phase 1: Dose Escalation|Death|1|||
129496667|NCT04430738|466108236|FG001|Phase 1: Dose Escalation|Death|4|||
129496668|NCT04430738|466108237|FG002|Phase 1: Dose Escalation|Death|4|||
129496669|NCT04430738|466108238|FG003|Phase 1: Dose Escalation|Death|1|||
129496670|NCT04430738|466108239|FG004|Phase 1: Dose Escalation|Death|6|||
129496671|NCT04430738|466108240|FG005|Phase 1: Dose Escalation|Death|0|||
129496672|NCT04430738|466108235|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
129496673|NCT04430738|466108236|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
129496674|NCT04430738|466108237|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
129496675|NCT04430738|466108238|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
129496676|NCT04430738|466108239|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
129496677|NCT04430738|466108240|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
129496678|NCT04430738|466108235|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
129496679|NCT04430738|466108236|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
129496680|NCT04430738|466108237|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
129496681|NCT04430738|466108238|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
129496682|NCT04430738|466108239|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
129496683|NCT04430738|466108240|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
129496684|NCT04430738|466108235|FG000|Phase 1: Dose Escalation|Other|1|||
129496685|NCT04430738|466108236|FG001|Phase 1: Dose Escalation|Other|0|||
129496686|NCT04430738|466108237|FG002|Phase 1: Dose Escalation|Other|0|||
129496687|NCT04430738|466108238|FG003|Phase 1: Dose Escalation|Other|0|||
129496688|NCT04430738|466108239|FG004|Phase 1: Dose Escalation|Other|0|||
129496689|NCT04430738|466108240|FG005|Phase 1: Dose Escalation|Other|0|||
129496690|NCT04430738|466108235|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
129496691|NCT04430738|466108236|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
129496692|NCT04430738|466108237|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
129496693|NCT04430738|466108238|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
129496694|NCT04430738|466108239|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
129496695|NCT04430738|466108240|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
129496696|NCT04430738|466108235|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129496697|NCT04430738|466108236|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129496698|NCT04430738|466108237|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129496699|NCT04430738|466108238|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129496700|NCT04430738|466108239|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
129496701|NCT04430738|466108240|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
129496702|NCT05590793|466108241|FG000|Overall Study|Withdrawal by Subject|6|||
129496703|NCT05590793|466108241|FG000|Overall Study|Physician Decision|1|||
129496704|NCT03015610|466108242|FG000|Overall Study|Lost to Follow-up|1|||
129496705|NCT03015610|466108243|FG001|Overall Study|Lost to Follow-up|5|||
129496706|NCT05100199|466108244|FG000|Overall Study|Lost to Follow-up|5|||
129496707|NCT05100199|466108245|FG001|Overall Study|Lost to Follow-up|8|||
129496708|NCT05100199|466108246|FG002|Overall Study|Lost to Follow-up|3|||
129496709|NCT05100199|466108247|FG003|Overall Study|Lost to Follow-up|6|||
129496710|NCT05100199|466108244|FG000|Overall Study|Withdrawal by Subject|3|||
129496711|NCT05100199|466108245|FG001|Overall Study|Withdrawal by Subject|3|||
129496712|NCT05100199|466108246|FG002|Overall Study|Withdrawal by Subject|9|||
129496713|NCT05100199|466108247|FG003|Overall Study|Withdrawal by Subject|7|||
129496714|NCT05100199|466108244|FG000|Overall Study|Other|0|||
129496715|NCT05100199|466108245|FG001|Overall Study|Other|0|||
129496716|NCT05100199|466108246|FG002|Overall Study|Other|1|||
129496717|NCT05100199|466108247|FG003|Overall Study|Other|1|||
129496718|NCT00752609|466108248|FG000|Overall Study|Adverse Event|2|||
129496719|NCT00752609|466108249|FG001|Overall Study|Adverse Event|2|||
129496720|NCT00752609|466108248|FG000|Overall Study|Withdrawal by Subject|3|||
129496721|NCT00752609|466108249|FG001|Overall Study|Withdrawal by Subject|0|||
129496722|NCT00752609|466108248|FG000|Overall Study|Physician Decision|1|||
129496723|NCT00752609|466108249|FG001|Overall Study|Physician Decision|0|||
129496724|NCT00752609|466108248|FG000|Overall Study|Death|1|||
129496725|NCT00752609|466108249|FG001|Overall Study|Death|0|||
129496726|NCT00752609|466108248|FG000|Overall Study|Met exclusion criteria|1|||
129496727|NCT00752609|466108249|FG001|Overall Study|Met exclusion criteria|0|||
129496728|NCT00752609|466108248|FG000|Overall Study|Received Aranesp in error|1|||
129496729|NCT00752609|466108249|FG001|Overall Study|Received Aranesp in error|0|||
129496730|NCT05114590|466108250|FG000|Overall Study|Adverse Event|1|||
129496731|NCT05114590|466108250|FG000|Overall Study|Investigator decision|1|||
129496732|NCT05114590|466108250|FG000|Overall Study|Lost to Follow-up|5|||
129496733|NCT05114590|466108250|FG000|Overall Study|Withdrawal by Subject|5|||
129496734|NCT05114590|466108250|FG000|Overall Study|Other|2|||
129496735|NCT01379534|466108259|FG000|Treatment Phase|Withdrawal by Subject|2|||
129496736|NCT01379534|466108260|FG001|Treatment Phase|Withdrawal by Subject|2|||
129496737|NCT01379534|466108259|FG000|Treatment Phase|Progressive disease|13|||
129496738|NCT01379534|466108260|FG001|Treatment Phase|Progressive disease|22|||
129496739|NCT01379534|466108259|FG000|Treatment Phase|Adverse Event|7|||
129496740|NCT01379534|466108260|FG001|Treatment Phase|Adverse Event|7|||
129496741|NCT01379534|466108259|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
129496742|NCT01379534|466108260|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
129496743|NCT01379534|466108259|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
129496744|NCT01379534|466108260|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
129496745|NCT01379534|466108259|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
129496746|NCT01379534|466108260|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
129496747|NCT01379534|466108259|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
129496748|NCT01379534|466108260|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
129496749|NCT00001262|466108266|FG000|Overall Study|Death|10|||
129496750|NCT00001262|466108267|FG001|Overall Study|Death|11|||
129496751|NCT00001262|466108268|FG002|Overall Study|Death|0|||
129496752|NCT00001262|466108266|FG000|Overall Study|Withdrawal by Subject|0|||
129496753|NCT00001262|466108267|FG001|Overall Study|Withdrawal by Subject|3|||
129496754|NCT00001262|466108268|FG002|Overall Study|Withdrawal by Subject|0|||
129496755|NCT00878072|466108270|FG000|Overall Study|Withdrew consent|2|||
129496756|NCT03844633|466108274|FG000|1 Week FU|Lost to Follow-up|0|||
129496757|NCT03844633|466108275|FG001|1 Week FU|Lost to Follow-up|1|||
129496758|NCT03844633|466108276|FG002|1 Week FU|Lost to Follow-up|4|||
129496759|NCT03844633|466108274|FG000|12-month Follow-up|Lost to Follow-up|7|||
129496760|NCT03844633|466108275|FG001|12-month Follow-up|Lost to Follow-up|5|||
129496761|NCT03844633|466108276|FG002|12-month Follow-up|Lost to Follow-up|8|||
129496762|NCT02588248|466108281|FG000|Overall Study|Physician Decision|4|||
129496763|NCT02588248|466108282|FG001|Overall Study|Physician Decision|3|||
129496764|NCT05306873|466109745|FG000|Stage 2|Study stopped|1|||
129496765|NCT05306873|466109746|FG001|Stage 2|Study stopped|1|||
129496766|NCT05306873|466109747|FG002|Stage 2|Study stopped|0|||
129496767|NCT05306873|466109748|FG003|Stage 2|Study stopped|0|||
129496768|NCT05306873|466109745|FG000|Stage 2|Stage 2 Treatment Failure|2|||
129496769|NCT05306873|466109746|FG001|Stage 2|Stage 2 Treatment Failure|3|||
129496770|NCT05306873|466109747|FG002|Stage 2|Stage 2 Treatment Failure|0|||
129981437|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
129981438|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
129981439|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
129981440|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
129981441|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
129496771|NCT05306873|466109748|FG003|Stage 2|Stage 2 Treatment Failure|0|||
129496772|NCT05306873|466109745|FG000|Stage 2|Logistical issues due to participant moving|1|||
129496773|NCT05306873|466109746|FG001|Stage 2|Logistical issues due to participant moving|0|||
129496774|NCT05306873|466109747|FG002|Stage 2|Logistical issues due to participant moving|0|||
129496775|NCT05306873|466109748|FG003|Stage 2|Logistical issues due to participant moving|0|||
129981442|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
129496776|NCT05306873|466109745|FG000|Stage 3|Stage 3 Treatment Failure|0|||
129496777|NCT05306873|466109746|FG001|Stage 3|Stage 3 Treatment Failure|0|||
129496778|NCT05306873|466109747|FG002|Stage 3|Stage 3 Treatment Failure|0|||
129496779|NCT05306873|466109748|FG003|Stage 3|Stage 3 Treatment Failure|1|||
129496780|NCT05306873|466109745|FG000|Stage 3|Study Stopped|0|||
129496781|NCT05306873|466109746|FG001|Stage 3|Study Stopped|0|||
129496782|NCT05306873|466109747|FG002|Stage 3|Study Stopped|1|||
129496783|NCT05306873|466109748|FG003|Stage 3|Study Stopped|0|||
129496784|NCT02626819|466109749|FG000|Overall Study|Lost to Follow-up|3|||
129496785|NCT02626819|466109750|FG001|Overall Study|Lost to Follow-up|2|||
129496786|NCT02626819|466109749|FG000|Overall Study|Withdrawal by Subject|1|||
129496787|NCT02626819|466109750|FG001|Overall Study|Withdrawal by Subject|0|||
129496788|NCT02626819|466109749|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
129496789|NCT02626819|466109750|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
129496790|NCT01701583|466109754|FG000|Overall Study|Withdrawal by Subject|2|||
129496791|NCT01701583|466109755|FG001|Overall Study|Withdrawal by Subject|0|||
129496792|NCT01441440|466109756|FG000|Overall Study|Death|1|||
129496793|NCT01441440|466109757|FG001|Overall Study|Death|0|||
129496794|NCT01441440|466109758|FG002|Overall Study|Death|1|||
129496795|NCT01441440|466109756|FG000|Overall Study|Adverse Event|2|||
129496796|NCT01441440|466109757|FG001|Overall Study|Adverse Event|9|||
129496797|NCT01441440|466109758|FG002|Overall Study|Adverse Event|9|||
129496798|NCT01441440|466109756|FG000|Overall Study|Lost to Follow-up|0|||
129496799|NCT01441440|466109757|FG001|Overall Study|Lost to Follow-up|2|||
129496800|NCT01441440|466109758|FG002|Overall Study|Lost to Follow-up|1|||
129496801|NCT01441440|466109756|FG000|Overall Study|Withdrawal by Subject|11|||
129496802|NCT01441440|466109757|FG001|Overall Study|Withdrawal by Subject|9|||
129496803|NCT01441440|466109758|FG002|Overall Study|Withdrawal by Subject|9|||
129496804|NCT01441440|466109756|FG000|Overall Study|Pregnancy|1|||
129496805|NCT01441440|466109757|FG001|Overall Study|Pregnancy|0|||
129496806|NCT01441440|466109758|FG002|Overall Study|Pregnancy|0|||
129496807|NCT01441440|466109756|FG000|Overall Study|Lack of Efficacy|1|||
129496808|NCT01441440|466109757|FG001|Overall Study|Lack of Efficacy|0|||
129496809|NCT01441440|466109758|FG002|Overall Study|Lack of Efficacy|1|||
129496810|NCT01441440|466109756|FG000|Overall Study|Moving|0|||
129496811|NCT01441440|466109757|FG001|Overall Study|Moving|1|||
129496812|NCT01441440|466109758|FG002|Overall Study|Moving|1|||
129496813|NCT01441440|466109756|FG000|Overall Study|Work-related matter|0|||
129496814|NCT01441440|466109757|FG001|Overall Study|Work-related matter|1|||
129496815|NCT01441440|466109758|FG002|Overall Study|Work-related matter|0|||
129496816|NCT01441440|466109756|FG000|Overall Study|Difficllty in keeping the schedule|1|||
129496817|NCT01441440|466109757|FG001|Overall Study|Difficllty in keeping the schedule|1|||
129496818|NCT01441440|466109758|FG002|Overall Study|Difficllty in keeping the schedule|0|||
129496819|NCT02750813|466109759|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
129496820|NCT02750813|466109760|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
129496821|NCT02750813|466109759|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
129496822|NCT02750813|466109760|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
129496823|NCT02245568|466109761|FG000|Overall Study|Study terminated by Sponsor|346|||
129496824|NCT02245568|466109761|FG000|Overall Study|Adverse Event|144|||
129496825|NCT02245568|466109761|FG000|Overall Study|Lack of Efficacy|98|||
129496826|NCT02245568|466109761|FG000|Overall Study|Withdrawal by Caregiver|85|||
129496827|NCT02245568|466109761|FG000|Overall Study|Withdrawal by Subject|77|||
129496828|NCT02245568|466109761|FG000|Overall Study|Withdrawal by Legal Representative|31|||
129496829|NCT02245568|466109761|FG000|Overall Study|Missing (Site closure)|16|||
129496830|NCT02245568|466109761|FG000|Overall Study|Physician Decision|14|||
129496831|NCT02245568|466109761|FG000|Overall Study|Non-compliance with study drug|11|||
129496832|NCT02245568|466109761|FG000|Overall Study|Death|9|||
129496833|NCT02245568|466109761|FG000|Overall Study|Blue staining|6|||
129496834|NCT02245568|466109761|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
129496835|NCT02245568|466109761|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
129496836|NCT02245568|466109761|FG000|Overall Study|Lost to Follow-up|5|||
129496837|NCT00366548|466109762|FG000|Infant Series|Adverse Event|1|||
129496838|NCT00366548|466109763|FG001|Infant Series|Adverse Event|3|||
129496839|NCT00366548|466109762|FG000|Infant Series|Protocol Violation|0|||
129496840|NCT00366548|466109763|FG001|Infant Series|Protocol Violation|1|||
129981443|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
129496841|NCT00366548|466109762|FG000|Infant Series|Withdrawal by Subject|3|||
129496842|NCT00366548|466109763|FG001|Infant Series|Withdrawal by Subject|1|||
129496843|NCT00366548|466109762|FG000|After Infant Series|Withdrawal by Subject|3|||
129496844|NCT00366548|466109763|FG001|After Infant Series|Withdrawal by Subject|1|||
129496845|NCT00366548|466109762|FG000|After Infant Series|Adverse Event|2|||
129496846|NCT00366548|466109763|FG001|After Infant Series|Adverse Event|0|||
129496847|NCT00366548|466109762|FG000|After Infant Series|Lost to Follow-up|1|||
129496848|NCT00366548|466109763|FG001|After Infant Series|Lost to Follow-up|0|||
129496849|NCT02849990|466109764|FG000|Overall Study|Adverse Event|1|||
129496850|NCT02849990|466109764|FG000|Overall Study|Withdrawal by Subject|1|||
129496851|NCT01051986|466109766|FG000|Overall Study|Death|1|||
129496852|NCT01051986|466109767|FG001|Overall Study|Death|0|||
129496853|NCT01051986|466109766|FG000|Overall Study|Withdrawal by Subject|2|||
129496854|NCT01051986|466109767|FG001|Overall Study|Withdrawal by Subject|1|||
129496855|NCT01051986|466109766|FG000|Overall Study|Protocol Violation|2|||
129496856|NCT01051986|466109767|FG001|Overall Study|Protocol Violation|3|||
129496857|NCT01725152|466109769|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
129496858|NCT01725152|466109770|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
129496859|NCT01725152|466109769|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
129496860|NCT01725152|466109770|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
129496861|NCT01725152|466109769|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
129496862|NCT01725152|466109770|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
129496863|NCT01725152|466109769|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
129496864|NCT01725152|466109770|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
129496865|NCT02044159|466109771|FG000|Overall Study|Consent declined (deferred consent)|2|||
129496866|NCT02044159|466109772|FG001|Overall Study|Consent declined (deferred consent)|4|||
129496867|NCT02044159|466109771|FG000|Overall Study|No longer eligible, drug not given|1|||
129496868|NCT02044159|466109772|FG001|Overall Study|No longer eligible, drug not given|0|||
129496869|NCT02044159|466109771|FG000|Overall Study|Nurse declined to give study drug|1|||
129496870|NCT02044159|466109772|FG001|Overall Study|Nurse declined to give study drug|0|||
129496871|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
129496872|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129496873|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129496874|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129496875|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
129496876|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
129496877|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129496878|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129496879|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129496880|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
129496881|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
129496882|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129496883|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129496884|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129496885|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
129496886|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
129496887|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
129496888|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
129496889|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
129496890|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
129496891|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
129496892|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
129496893|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
129496894|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
129496895|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
129496896|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
129496897|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129496898|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129496899|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129496900|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
129496901|NCT01111539|466109773|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
129496902|NCT01111539|466109774|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
129496903|NCT01111539|466109775|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
129496904|NCT01111539|466109776|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
129496905|NCT01111539|466109777|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
129496906|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129496907|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129496908|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
129496909|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
129496910|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
129496911|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129496912|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129496913|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
129496914|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
129496915|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
129496916|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
129496917|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
129496918|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
129496919|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
129496920|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
129496921|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
129496922|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
129496923|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
129496924|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
129496925|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
129496926|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
129496927|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
129496928|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
129496929|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
129496930|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
129496931|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
129496932|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
129496933|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
129496934|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
129496935|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
129496936|NCT01111539|466109773|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129496937|NCT01111539|466109774|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129496938|NCT01111539|466109775|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129496939|NCT01111539|466109776|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
129496940|NCT01111539|466109777|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
129496941|NCT03628417|466109778|FG000|Overall Study|Death|1|||
129496942|NCT03628417|466109779|FG001|Overall Study|Death|1|||
129496943|NCT00372190|466109780|FG000|Overall Study|Lost to Follow-up|3|||
129496944|NCT00372190|466109781|FG001|Overall Study|Lost to Follow-up|1|||
129496945|NCT01623531|466109782|FG000|Overall Study|Death|1|||
129496946|NCT01623531|466109783|FG001|Overall Study|Death|0|||
129496947|NCT01623531|466109782|FG000|Overall Study|Protocol Violation|2|||
129496948|NCT01623531|466109783|FG001|Overall Study|Protocol Violation|1|||
129496949|NCT01623531|466109782|FG000|Overall Study|Missing data at primary outcome time poi|1|||
129496950|NCT01623531|466109783|FG001|Overall Study|Missing data at primary outcome time poi|1|||
129496951|NCT01429792|466109784|FG000|Overall Study|Other Reasons|67|||
129496952|NCT01429792|466109784|FG000|Overall Study|Unknown Disposition|94|||
129496953|NCT01429792|466109784|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
129496954|NCT01429792|466109784|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
129496955|NCT01429792|466109784|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
129496956|NCT01429792|466109784|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
129496957|NCT01429792|466109784|FG000|Overall Study|Withdrawal by Subject|70|||
129496958|NCT01429792|466109784|FG000|Overall Study|Lost to Follow-up|88|||
129496959|NCT01856595|466109790|FG000|Overall Study|Withdrawal by Subject|0|||
129496960|NCT01856595|466109791|FG001|Overall Study|Withdrawal by Subject|1|||
129496961|NCT01856595|466109792|FG002|Overall Study|Withdrawal by Subject|0|||
129496962|NCT01856595|466109793|FG003|Overall Study|Withdrawal by Subject|0|||
129496963|NCT01856595|466109794|FG004|Overall Study|Withdrawal by Subject|0|||
129496964|NCT01856595|466109795|FG005|Overall Study|Withdrawal by Subject|0|||
129496965|NCT01856595|466109796|FG006|Overall Study|Withdrawal by Subject|1|||
129496966|NCT01856595|466109797|FG007|Overall Study|Withdrawal by Subject|0|||
129496967|NCT01856595|466109798|FG008|Overall Study|Withdrawal by Subject|0|||
129496968|NCT04426825|466109800|FG000|Overall Study|Death|17|||
129496969|NCT04426825|466109800|FG000|Overall Study|Lost to Follow-up|1|||
129496970|NCT04426825|466109800|FG000|Overall Study|Study terminated by sponsor|5|||
129496971|NCT01554956|466109806|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
129496972|NCT01554956|466109807|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
129496973|NCT01554956|466109808|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
129496974|NCT01554956|466109806|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
129496975|NCT01554956|466109807|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
129496976|NCT01554956|466109808|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
129496977|NCT01554956|466109806|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
129496978|NCT01554956|466109807|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
129496979|NCT01554956|466109808|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
129496980|NCT00358917|466109823|FG000|Overall Study|Adverse Event|14|||
129496981|NCT00358917|466109824|FG001|Overall Study|Adverse Event|21|||
129496982|NCT00358917|466109823|FG000|Overall Study|Withdrawal by Subject|5|||
129496983|NCT00358917|466109824|FG001|Overall Study|Withdrawal by Subject|7|||
129496984|NCT00358917|466109823|FG000|Overall Study|Lost to Follow-up|20|||
129496985|NCT00358917|466109824|FG001|Overall Study|Lost to Follow-up|17|||
129496986|NCT00358917|466109823|FG000|Overall Study|Noncompliance|12|||
129981444|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129496987|NCT00358917|466109824|FG001|Overall Study|Noncompliance|11|||
129496988|NCT00358917|466109823|FG000|Overall Study|Death|2|||
129496989|NCT00358917|466109824|FG001|Overall Study|Death|3|||
129496990|NCT00358917|466109823|FG000|Overall Study|Virologic failure|11|||
129496991|NCT00358917|466109824|FG001|Overall Study|Virologic failure|8|||
129496992|NCT00358917|466109823|FG000|Overall Study|Unable to Continue Participation|2|||
129496993|NCT00358917|466109824|FG001|Overall Study|Unable to Continue Participation|2|||
129496994|NCT05372575|466109829|FG000|Overall Study|Protocol Violation|7|||
129496995|NCT05372575|466109830|FG001|Overall Study|Protocol Violation|16|||
129496996|NCT01096550|466109831|FG000|Overall Study|discontinued site|10|||
129496997|NCT01096550|466109832|FG001|Overall Study|discontinued site|11|||
129496998|NCT01096550|466109831|FG000|Overall Study|non-regular treatment track at clinic|1|||
129496999|NCT01096550|466109832|FG001|Overall Study|non-regular treatment track at clinic|1|||
129497000|NCT01096550|466109831|FG000|Overall Study|clinic readmission|1|||
129497001|NCT01096550|466109832|FG001|Overall Study|clinic readmission|1|||
129497002|NCT01096550|466109831|FG000|Overall Study|Withdrawal by Subject|0|||
129497003|NCT01096550|466109832|FG001|Overall Study|Withdrawal by Subject|1|||
129497004|NCT01096550|466109831|FG000|Overall Study|non-African American participant|13|||
129497005|NCT01096550|466109832|FG001|Overall Study|non-African American participant|6|||
129497006|NCT01096550|466109831|FG000|Overall Study|Lost to Follow-up|12|||
129497007|NCT01096550|466109832|FG001|Overall Study|Lost to Follow-up|9|||
129497008|NCT01544595|466109835|FG000|Status at Week 68|Adverse Event|3|||
129497009|NCT01544595|466109836|FG001|Status at Week 68|Adverse Event|2|||
129497010|NCT01544595|466109837|FG002|Status at Week 68|Adverse Event|1|||
129497011|NCT01544595|466109838|FG003|Status at Week 68|Adverse Event|0|||
129497012|NCT01544595|466109839|FG004|Status at Week 68|Adverse Event|0|||
129497013|NCT01544595|466109840|FG005|Status at Week 68|Adverse Event|0|||
129497014|NCT01544595|466109835|FG000|Status at Week 68|Lack of Efficacy|1|||
129497015|NCT01544595|466109836|FG001|Status at Week 68|Lack of Efficacy|0|||
129497016|NCT01544595|466109837|FG002|Status at Week 68|Lack of Efficacy|0|||
129497017|NCT01544595|466109838|FG003|Status at Week 68|Lack of Efficacy|0|||
129497018|NCT01544595|466109839|FG004|Status at Week 68|Lack of Efficacy|0|||
129497019|NCT01544595|466109840|FG005|Status at Week 68|Lack of Efficacy|0|||
129497020|NCT01544595|466109835|FG000|Status at Week 68|Lost to Follow-up|1|||
129497021|NCT01544595|466109836|FG001|Status at Week 68|Lost to Follow-up|1|||
129497022|NCT01544595|466109837|FG002|Status at Week 68|Lost to Follow-up|0|||
129497023|NCT01544595|466109838|FG003|Status at Week 68|Lost to Follow-up|0|||
129497024|NCT01544595|466109839|FG004|Status at Week 68|Lost to Follow-up|0|||
129497025|NCT01544595|466109840|FG005|Status at Week 68|Lost to Follow-up|0|||
129497026|NCT01544595|466109835|FG000|Status at Week 68|Non-compliance with study treatment|1|||
129497027|NCT01544595|466109836|FG001|Status at Week 68|Non-compliance with study treatment|0|||
129497028|NCT01544595|466109837|FG002|Status at Week 68|Non-compliance with study treatment|0|||
129497029|NCT01544595|466109838|FG003|Status at Week 68|Non-compliance with study treatment|1|||
129497030|NCT01544595|466109839|FG004|Status at Week 68|Non-compliance with study treatment|0|||
129497031|NCT01544595|466109840|FG005|Status at Week 68|Non-compliance with study treatment|0|||
129497032|NCT01544595|466109835|FG000|Status at Week 68|Protocol Violation|2|||
129497033|NCT01544595|466109836|FG001|Status at Week 68|Protocol Violation|0|||
129497034|NCT01544595|466109837|FG002|Status at Week 68|Protocol Violation|1|||
129497035|NCT01544595|466109838|FG003|Status at Week 68|Protocol Violation|1|||
129497036|NCT01544595|466109839|FG004|Status at Week 68|Protocol Violation|0|||
129497037|NCT01544595|466109840|FG005|Status at Week 68|Protocol Violation|0|||
129497038|NCT01544595|466109835|FG000|Status at Week 68|Technical problems|1|||
129497039|NCT01544595|466109836|FG001|Status at Week 68|Technical problems|0|||
129497040|NCT01544595|466109837|FG002|Status at Week 68|Technical problems|0|||
129497041|NCT01544595|466109838|FG003|Status at Week 68|Technical problems|1|||
129497042|NCT01544595|466109839|FG004|Status at Week 68|Technical problems|0|||
129497043|NCT01544595|466109840|FG005|Status at Week 68|Technical problems|0|||
129497044|NCT01544595|466109835|FG000|Status at Week 68|Withdrawal by Subject|0|||
129497045|NCT01544595|466109836|FG001|Status at Week 68|Withdrawal by Subject|1|||
129497046|NCT01544595|466109837|FG002|Status at Week 68|Withdrawal by Subject|1|||
129497047|NCT01544595|466109838|FG003|Status at Week 68|Withdrawal by Subject|2|||
129497048|NCT01544595|466109839|FG004|Status at Week 68|Withdrawal by Subject|0|||
129497049|NCT01544595|466109840|FG005|Status at Week 68|Withdrawal by Subject|0|||
129497050|NCT01544595|466109835|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
129497051|NCT01544595|466109836|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
129497052|NCT01544595|466109837|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
129497053|NCT01544595|466109838|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
129497054|NCT01544595|466109839|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
129497055|NCT01544595|466109840|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
129497056|NCT01544595|466109835|FG000|Status at Week 156|Withdrawal by Subject|9|||
129497057|NCT01544595|466109836|FG001|Status at Week 156|Withdrawal by Subject|10|||
129497058|NCT01544595|466109837|FG002|Status at Week 156|Withdrawal by Subject|4|||
129497059|NCT01544595|466109838|FG003|Status at Week 156|Withdrawal by Subject|9|||
129497060|NCT01544595|466109839|FG004|Status at Week 156|Withdrawal by Subject|20|||
129497061|NCT01544595|466109840|FG005|Status at Week 156|Withdrawal by Subject|6|||
129497062|NCT01544595|466109835|FG000|Status at Week 156|Adverse Event|9|||
129497063|NCT01544595|466109836|FG001|Status at Week 156|Adverse Event|11|||
129497064|NCT01544595|466109837|FG002|Status at Week 156|Adverse Event|1|||
129497065|NCT01544595|466109838|FG003|Status at Week 156|Adverse Event|3|||
129497066|NCT01544595|466109839|FG004|Status at Week 156|Adverse Event|4|||
129497067|NCT01544595|466109840|FG005|Status at Week 156|Adverse Event|2|||
129497068|NCT01544595|466109835|FG000|Status at Week 156|Lost to Follow-up|4|||
129497069|NCT01544595|466109836|FG001|Status at Week 156|Lost to Follow-up|4|||
129497070|NCT01544595|466109837|FG002|Status at Week 156|Lost to Follow-up|0|||
129497071|NCT01544595|466109838|FG003|Status at Week 156|Lost to Follow-up|1|||
129497072|NCT01544595|466109839|FG004|Status at Week 156|Lost to Follow-up|4|||
129497073|NCT01544595|466109840|FG005|Status at Week 156|Lost to Follow-up|1|||
129981445|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
129981446|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981447|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981448|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981449|NCT00833833|467894992|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
129497074|NCT01544595|466109835|FG000|Status at Week 156|Non-compliance with study treatement|0|||
129497075|NCT01544595|466109836|FG001|Status at Week 156|Non-compliance with study treatement|1|||
129497076|NCT01544595|466109837|FG002|Status at Week 156|Non-compliance with study treatement|0|||
129497077|NCT01544595|466109838|FG003|Status at Week 156|Non-compliance with study treatement|1|||
129497078|NCT01544595|466109839|FG004|Status at Week 156|Non-compliance with study treatement|0|||
129497079|NCT01544595|466109840|FG005|Status at Week 156|Non-compliance with study treatement|1|||
129497080|NCT01544595|466109835|FG000|Status at Week 156|Physician Decision|0|||
129497081|NCT01544595|466109836|FG001|Status at Week 156|Physician Decision|3|||
129497082|NCT01544595|466109837|FG002|Status at Week 156|Physician Decision|1|||
129497083|NCT01544595|466109838|FG003|Status at Week 156|Physician Decision|0|||
129497084|NCT01544595|466109839|FG004|Status at Week 156|Physician Decision|0|||
129497085|NCT01544595|466109840|FG005|Status at Week 156|Physician Decision|0|||
129497086|NCT01544595|466109835|FG000|Status at Week 156|Pregnancy|2|||
129497087|NCT01544595|466109836|FG001|Status at Week 156|Pregnancy|3|||
129497088|NCT01544595|466109837|FG002|Status at Week 156|Pregnancy|0|||
129497089|NCT01544595|466109838|FG003|Status at Week 156|Pregnancy|0|||
129497090|NCT01544595|466109839|FG004|Status at Week 156|Pregnancy|0|||
129497091|NCT01544595|466109840|FG005|Status at Week 156|Pregnancy|0|||
129497092|NCT01544595|466109835|FG000|Status at Week 156|Protocol Violation|3|||
129497093|NCT01544595|466109836|FG001|Status at Week 156|Protocol Violation|1|||
129497094|NCT01544595|466109837|FG002|Status at Week 156|Protocol Violation|2|||
129497095|NCT01544595|466109838|FG003|Status at Week 156|Protocol Violation|2|||
129497096|NCT01544595|466109839|FG004|Status at Week 156|Protocol Violation|0|||
129497097|NCT01544595|466109840|FG005|Status at Week 156|Protocol Violation|0|||
129497098|NCT01544595|466109835|FG000|Status at Week 156|Technical problems|3|||
129497099|NCT01544595|466109836|FG001|Status at Week 156|Technical problems|1|||
129497100|NCT01544595|466109837|FG002|Status at Week 156|Technical problems|0|||
129497101|NCT01544595|466109838|FG003|Status at Week 156|Technical problems|1|||
129497102|NCT01544595|466109839|FG004|Status at Week 156|Technical problems|0|||
129497103|NCT01544595|466109840|FG005|Status at Week 156|Technical problems|0|||
129497104|NCT01544595|466109835|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
129497105|NCT01544595|466109836|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
129497106|NCT01544595|466109837|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
129497107|NCT01544595|466109838|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
129497108|NCT01544595|466109839|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
129497109|NCT01544595|466109840|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
129497110|NCT01544595|466109835|FG000|Status at Week 156|Lack of Efficacy|1|||
129497111|NCT01544595|466109836|FG001|Status at Week 156|Lack of Efficacy|0|||
129497112|NCT01544595|466109837|FG002|Status at Week 156|Lack of Efficacy|1|||
129497113|NCT01544595|466109838|FG003|Status at Week 156|Lack of Efficacy|4|||
129497114|NCT01544595|466109839|FG004|Status at Week 156|Lack of Efficacy|10|||
129497115|NCT01544595|466109840|FG005|Status at Week 156|Lack of Efficacy|5|||
129497116|NCT04333433|466109845|FG000|Overall Study|Withdrawal by Subject|6|||
129497117|NCT04333433|466109846|FG001|Overall Study|Withdrawal by Subject|3|||
129497118|NCT04333433|466109845|FG000|Overall Study|Death|3|||
129497119|NCT04333433|466109846|FG001|Overall Study|Death|0|||
129497120|NCT04333433|466109845|FG000|Overall Study|Lost to Follow-up|6|||
129497121|NCT04333433|466109846|FG001|Overall Study|Lost to Follow-up|1|||
129497122|NCT04333433|466109845|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
129497123|NCT04333433|466109846|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
129497124|NCT00320385|466109847|FG000|Overall Study|Lost to Follow-up|7|||
129497125|NCT00320385|466109848|FG001|Overall Study|Lost to Follow-up|10|||
129497126|NCT00320385|466109847|FG000|Overall Study|Withdrawal by Subject|6|||
129497127|NCT00320385|466109848|FG001|Overall Study|Withdrawal by Subject|7|||
129497128|NCT00320385|466109847|FG000|Overall Study|Sponsor Terminated Study|2|||
129497129|NCT00320385|466109848|FG001|Overall Study|Sponsor Terminated Study|1|||
129497130|NCT00320385|466109847|FG000|Overall Study|Investigator Decision|0|||
129497131|NCT00320385|466109848|FG001|Overall Study|Investigator Decision|1|||
129497132|NCT00320385|466109847|FG000|Overall Study|Death|1|||
129497133|NCT00320385|466109848|FG001|Overall Study|Death|2|||
129497134|NCT00320385|466109847|FG000|Overall Study|Serious Adverse Event|1|||
129497135|NCT00320385|466109848|FG001|Overall Study|Serious Adverse Event|0|||
129497136|NCT00320385|466109847|FG000|Overall Study|Withdrew Consent|1|||
129497137|NCT00320385|466109848|FG001|Overall Study|Withdrew Consent|0|||
129497138|NCT00320385|466109847|FG000|Overall Study|Adverse Event|0|||
129497139|NCT00320385|466109848|FG001|Overall Study|Adverse Event|1|||
129497140|NCT03288779|466109854|FG000|Overall Study|Withdrawal by Subject|3|||
129497141|NCT01355068|466109855|FG000|First Intervention Period|Adverse Event|0|||
129497142|NCT01355068|466109856|FG001|First Intervention Period|Adverse Event|1|||
129497143|NCT01355068|466109855|FG000|First Intervention Period|Withdrawal by Subject|0|||
129497144|NCT01355068|466109856|FG001|First Intervention Period|Withdrawal by Subject|1|||
129497145|NCT00524745|466109857|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
129497146|NCT00524745|466109858|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
129497147|NCT00524745|466109859|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
129497148|NCT00524745|466109860|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
129497149|NCT00872170|466109861|FG000|Overall Study|Adverse Event|1|||
129497150|NCT00872170|466109862|FG001|Overall Study|Adverse Event|0|||
129497151|NCT00601523|466109863|FG000|Overall Study|Adverse Event|42|||
129497152|NCT00601523|466109864|FG001|Overall Study|Adverse Event|14|||
129497153|NCT00601523|466109863|FG000|Overall Study|Lack of Efficacy|3|||
129497154|NCT00601523|466109864|FG001|Overall Study|Lack of Efficacy|0|||
129497155|NCT00601523|466109863|FG000|Overall Study|Protocol Violation|5|||
129497156|NCT00601523|466109864|FG001|Overall Study|Protocol Violation|1|||
129497157|NCT00601523|466109863|FG000|Overall Study|Lost to Follow-up|0|||
129497158|NCT00601523|466109864|FG001|Overall Study|Lost to Follow-up|1|||
129497159|NCT00601523|466109863|FG000|Overall Study|Withdrawal by Subject|18|||
129497160|NCT00601523|466109864|FG001|Overall Study|Withdrawal by Subject|9|||
129497161|NCT00601523|466109863|FG000|Overall Study|Other|9|||
129497162|NCT00601523|466109864|FG001|Overall Study|Other|1|||
129497163|NCT01721408|466109865|FG000|Overall Study|Adverse Event|6|||
129497164|NCT01721408|466109866|FG001|Overall Study|Adverse Event|1|||
129497165|NCT01721408|466109865|FG000|Overall Study|Death|1|||
129497166|NCT01721408|466109866|FG001|Overall Study|Death|0|||
129497167|NCT01721408|466109865|FG000|Overall Study|Insufficient clinical response|15|||
129497168|NCT01721408|466109866|FG001|Overall Study|Insufficient clinical response|6|||
129497169|NCT01721408|466109865|FG000|Overall Study|No longer willing to participate study|9|||
129497170|NCT01721408|466109866|FG001|Overall Study|No longer willing to participate study|10|||
129497171|NCT01721408|466109865|FG000|Overall Study|Protocol Violation|0|||
129497172|NCT01721408|466109866|FG001|Overall Study|Protocol Violation|2|||
129497173|NCT01721408|466109865|FG000|Overall Study|Other|3|||
129497174|NCT01721408|466109866|FG001|Overall Study|Other|3|||
129497175|NCT01721408|466109865|FG000|Overall Study|Lost to Follow-up|1|||
129497176|NCT01721408|466109866|FG001|Overall Study|Lost to Follow-up|2|||
129497177|NCT01721408|466109865|FG000|Overall Study|Does not meet entrance criteria|1|||
129497178|NCT01721408|466109866|FG001|Overall Study|Does not meet entrance criteria|0|||
129497179|NCT03987620|466109869|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
129497180|NCT03987620|466109870|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
129497181|NCT03987620|466109869|FG000|Overall Study|Adverse Event|3|||
129497182|NCT03987620|466109870|FG001|Overall Study|Adverse Event|0|||
129497183|NCT03987620|466109869|FG000|Overall Study|Lost to Follow-up|1|||
129497184|NCT03987620|466109870|FG001|Overall Study|Lost to Follow-up|2|||
129497185|NCT03987620|466109869|FG000|Overall Study|Physician Decision|0|||
129497186|NCT03987620|466109870|FG001|Overall Study|Physician Decision|1|||
129497187|NCT03987620|466109869|FG000|Overall Study|Pregnancy|1|||
129497188|NCT03987620|466109870|FG001|Overall Study|Pregnancy|0|||
129497189|NCT03987620|466109869|FG000|Overall Study|Withdrawal by Subject|7|||
129497190|NCT03987620|466109870|FG001|Overall Study|Withdrawal by Subject|1|||
129497191|NCT03987620|466109869|FG000|Overall Study|Other|2|||
129981450|NCT00833833|467894993|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
129981451|NCT00833833|467894994|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
129497192|NCT03987620|466109870|FG001|Overall Study|Other|5|||
129981452|NCT00833833|467894995|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
129497193|NCT02149836|466109871|FG000|Overall Study|Withdrawal by Subject|1|||
129497194|NCT01204658|466109872|FG000|Primary Phase|Adverse Event|0|||
129497195|NCT01204658|466109873|FG001|Primary Phase|Adverse Event|0|||
129497196|NCT01204658|466109874|FG002|Primary Phase|Adverse Event|1|||
129497197|NCT01204658|466109875|FG003|Primary Phase|Adverse Event|0|||
129497198|NCT01064648|466109880|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
129497199|NCT01064648|466109881|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
129497200|NCT01064648|466109882|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
129497201|NCT01064648|466109883|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
129497202|NCT01064648|466109880|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
129497203|NCT01064648|466109881|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
129497204|NCT01064648|466109882|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
129497205|NCT01064648|466109883|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
129497206|NCT01064648|466109880|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
129497207|NCT01064648|466109881|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
129497208|NCT01064648|466109882|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
129497209|NCT01064648|466109883|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
129497210|NCT01064648|466109880|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
129497211|NCT01064648|466109881|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
129497212|NCT01064648|466109882|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
129497213|NCT01064648|466109883|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
129497214|NCT01064648|466109880|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
129497215|NCT01064648|466109881|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
129497216|NCT01064648|466109882|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
129497217|NCT01064648|466109883|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
129497218|NCT01064648|466109880|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
129497219|NCT01064648|466109881|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
129497220|NCT01064648|466109882|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
129497221|NCT01064648|466109883|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
129497222|NCT01064648|466109880|FG000|Phase II|Adverse Event|0|||
129497223|NCT01064648|466109881|FG001|Phase II|Adverse Event|0|||
129497224|NCT01064648|466109882|FG002|Phase II|Adverse Event|15|||
129497225|NCT01064648|466109883|FG003|Phase II|Adverse Event|8|||
129497226|NCT01064648|466109880|FG000|Phase II|Death|0|||
129497227|NCT01064648|466109881|FG001|Phase II|Death|0|||
129497228|NCT01064648|466109882|FG002|Phase II|Death|4|||
129497229|NCT01064648|466109883|FG003|Phase II|Death|5|||
129497230|NCT01064648|466109880|FG000|Phase II|Withdrawal by Subject|0|||
129497231|NCT01064648|466109881|FG001|Phase II|Withdrawal by Subject|0|||
129497232|NCT01064648|466109882|FG002|Phase II|Withdrawal by Subject|2|||
129497233|NCT01064648|466109883|FG003|Phase II|Withdrawal by Subject|5|||
129497234|NCT01064648|466109880|FG000|Phase II|Progression|0|||
129497235|NCT01064648|466109881|FG001|Phase II|Progression|0|||
129497236|NCT01064648|466109882|FG002|Phase II|Progression|21|||
129497237|NCT01064648|466109883|FG003|Phase II|Progression|27|||
129497238|NCT01064648|466109880|FG000|Phase II|Non-protocol specified|0|||
129497239|NCT01064648|466109881|FG001|Phase II|Non-protocol specified|0|||
129497240|NCT01064648|466109882|FG002|Phase II|Non-protocol specified|5|||
129497241|NCT01064648|466109883|FG003|Phase II|Non-protocol specified|3|||
129497242|NCT01064648|466109880|FG000|Phase II|Under Review|0|||
129497243|NCT01064648|466109881|FG001|Phase II|Under Review|0|||
129497244|NCT01064648|466109882|FG002|Phase II|Under Review|2|||
129497245|NCT01064648|466109883|FG003|Phase II|Under Review|0|||
129497246|NCT00977574|466109884|FG000|Overall Study|Never Treated|4|||
129497247|NCT00977574|466109885|FG001|Overall Study|Never Treated|2|||
129497248|NCT00977574|466109886|FG002|Overall Study|Never Treated|4|||
129497249|NCT05128162|466109887|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
129497250|NCT05128162|466109887|FG000|Overall Study|Physician Decision|1|||
129497251|NCT04491877|466112005|FG000|Overall Study|Protocol Deviation|1|||
129497252|NCT04491877|466112006|FG001|Overall Study|Protocol Deviation|0|||
129497253|NCT04491877|466112007|FG002|Overall Study|Protocol Deviation|2|||
129497254|NCT04491877|466112008|FG003|Overall Study|Protocol Deviation|0|||
129497255|NCT04491877|466112009|FG004|Overall Study|Protocol Deviation|0|||
129497256|NCT04491877|466112010|FG005|Overall Study|Protocol Deviation|0|||
129497257|NCT04491877|466112011|FG006|Overall Study|Protocol Deviation|1|||
129497258|NCT04491877|466112012|FG007|Overall Study|Protocol Deviation|1|||
129497259|NCT04491877|466112013|FG008|Overall Study|Protocol Deviation|0|||
129497260|NCT04491877|466112005|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
129497261|NCT04491877|466112006|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129497262|NCT04491877|466112007|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129497263|NCT04491877|466112008|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
129497264|NCT04491877|466112009|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129497265|NCT04491877|466112010|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
129497266|NCT04491877|466112011|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
129981453|NCT00833833|467894996|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
129497267|NCT04491877|466112012|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
129497268|NCT04491877|466112013|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
129497269|NCT04491877|466112005|FG000|Overall Study|Lost to Follow-up|0|||
129497270|NCT04491877|466112006|FG001|Overall Study|Lost to Follow-up|2|||
129497271|NCT04491877|466112007|FG002|Overall Study|Lost to Follow-up|0|||
129497272|NCT04491877|466112008|FG003|Overall Study|Lost to Follow-up|0|||
129497273|NCT04491877|466112009|FG004|Overall Study|Lost to Follow-up|0|||
129497274|NCT04491877|466112010|FG005|Overall Study|Lost to Follow-up|0|||
129497275|NCT04491877|466112011|FG006|Overall Study|Lost to Follow-up|2|||
129497276|NCT04491877|466112012|FG007|Overall Study|Lost to Follow-up|1|||
129981454|NCT00833833|467894997|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
129981455|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129497277|NCT04491877|466112013|FG008|Overall Study|Lost to Follow-up|1|||
129497278|NCT01286272|466112014|FG000|Overall Study|Ineligible after beginning treatment|1|||
129497279|NCT01286272|466112015|FG001|Overall Study|Ineligible after beginning treatment|3|||
129497280|NCT00074412|466112016|FG000|Overall Study|Death|30|||
129497281|NCT00074412|466112017|FG001|Overall Study|Death|26|||
129497282|NCT00074412|466112016|FG000|Overall Study|Lost to Follow-up|52|||
129497283|NCT00074412|466112017|FG001|Overall Study|Lost to Follow-up|58|||
129497284|NCT00418834|466112022|FG000|Overall Study|Adverse Event|16|||
129497285|NCT00418834|466112023|FG001|Overall Study|Adverse Event|9|||
129497286|NCT00418834|466112022|FG000|Overall Study|Lost to Follow-up|0|||
129497287|NCT00418834|466112023|FG001|Overall Study|Lost to Follow-up|1|||
129497288|NCT00418834|466112022|FG000|Overall Study|Protocol Violation|4|||
129497289|NCT00418834|466112023|FG001|Overall Study|Protocol Violation|3|||
129497290|NCT00418834|466112022|FG000|Overall Study|Withdrawal by Subject|3|||
129497291|NCT00418834|466112023|FG001|Overall Study|Withdrawal by Subject|7|||
129497292|NCT01953328|466112024|FG000|Overall Study|Withdrawal by Subject|0|||
129497293|NCT01953328|466112025|FG001|Overall Study|Withdrawal by Subject|0|||
129497294|NCT01953328|466112026|FG002|Overall Study|Withdrawal by Subject|0|||
129497295|NCT01953328|466112027|FG003|Overall Study|Withdrawal by Subject|0|||
129497296|NCT01953328|466112028|FG004|Overall Study|Withdrawal by Subject|1|||
129497297|NCT01953328|466112029|FG005|Overall Study|Withdrawal by Subject|0|||
129497298|NCT01953328|466112030|FG006|Overall Study|Withdrawal by Subject|0|||
129497299|NCT01953328|466112031|FG007|Overall Study|Withdrawal by Subject|0|||
129497300|NCT01953328|466112024|FG000|Overall Study|Lost to Follow-up|0|||
129497301|NCT01953328|466112025|FG001|Overall Study|Lost to Follow-up|0|||
129497302|NCT01953328|466112026|FG002|Overall Study|Lost to Follow-up|0|||
129497303|NCT01953328|466112027|FG003|Overall Study|Lost to Follow-up|0|||
129497304|NCT01953328|466112028|FG004|Overall Study|Lost to Follow-up|1|||
129497305|NCT01953328|466112029|FG005|Overall Study|Lost to Follow-up|0|||
129497306|NCT01953328|466112030|FG006|Overall Study|Lost to Follow-up|0|||
129497307|NCT01953328|466112031|FG007|Overall Study|Lost to Follow-up|0|||
129497308|NCT02364947|466112040|FG000|Overall Study|Withdrawal by Subject|10|||
129497309|NCT02364947|466112041|FG001|Overall Study|Withdrawal by Subject|8|||
129497310|NCT02364947|466112042|FG002|Overall Study|Withdrawal by Subject|9|||
129497311|NCT02364947|466112040|FG000|Overall Study|Adverse Event|45|||
129497312|NCT02364947|466112041|FG001|Overall Study|Adverse Event|33|||
129497313|NCT02364947|466112042|FG002|Overall Study|Adverse Event|11|||
129497314|NCT02364947|466112040|FG000|Overall Study|Protocol Violation|1|||
129497315|NCT02364947|466112041|FG001|Overall Study|Protocol Violation|1|||
129497316|NCT02364947|466112042|FG002|Overall Study|Protocol Violation|1|||
129497317|NCT02364947|466112040|FG000|Overall Study|Physician Decision|3|||
129497318|NCT02364947|466112041|FG001|Overall Study|Physician Decision|2|||
129497319|NCT02364947|466112042|FG002|Overall Study|Physician Decision|5|||
129497320|NCT02364947|466112040|FG000|Overall Study|Death|0|||
129497321|NCT02364947|466112041|FG001|Overall Study|Death|1|||
129497322|NCT02364947|466112042|FG002|Overall Study|Death|0|||
129497323|NCT00423085|466112043|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
129497324|NCT00423085|466112044|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
129497325|NCT00423085|466112045|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
129497326|NCT00423085|466112046|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
129497327|NCT00423085|466112043|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
129497328|NCT00423085|466112044|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
129497329|NCT00423085|466112045|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
129497330|NCT00423085|466112046|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129497331|NCT00423085|466112043|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
129497332|NCT00423085|466112044|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
129497333|NCT00423085|466112045|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
129497334|NCT00423085|466112046|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
129497335|NCT00423085|466112043|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
129497336|NCT00423085|466112044|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
129497337|NCT00423085|466112045|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
129497338|NCT00423085|466112046|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
129497339|NCT00423085|466112043|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
129497340|NCT00423085|466112044|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
129497341|NCT00423085|466112045|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
129497342|NCT00423085|466112046|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
129497343|NCT00423085|466112043|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
129497344|NCT00423085|466112044|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
129497345|NCT00423085|466112045|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
129497346|NCT00423085|466112046|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
129497347|NCT00423085|466112043|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
129497348|NCT00423085|466112044|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
129497349|NCT00423085|466112045|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
129497350|NCT00423085|466112046|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
129497351|NCT00423085|466112043|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
129497352|NCT00423085|466112044|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
129497353|NCT00423085|466112045|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
129497354|NCT00423085|466112046|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
129497355|NCT00423085|466112043|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
129497356|NCT00423085|466112044|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
129497357|NCT00423085|466112045|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
129497358|NCT00423085|466112046|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
129497359|NCT00423085|466112043|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
129497360|NCT00423085|466112044|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
129497361|NCT00423085|466112045|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
129497362|NCT00423085|466112046|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
129497363|NCT00423085|466112043|FG000|52-Week Open-Label Extension Phase|Death|0|||
129497364|NCT00423085|466112044|FG001|52-Week Open-Label Extension Phase|Death|0|||
129497365|NCT00423085|466112045|FG002|52-Week Open-Label Extension Phase|Death|0|||
129497366|NCT00423085|466112046|FG003|52-Week Open-Label Extension Phase|Death|2|||
129497367|NCT02163993|466112047|FG000|Treatment Period|Adverse Event|0|||
129497368|NCT02163993|466112048|FG001|Treatment Period|Adverse Event|1|||
129497369|NCT02163993|466112049|FG002|Treatment Period|Adverse Event|0|||
129497370|NCT02163993|466112050|FG003|Treatment Period|Adverse Event|0|||
129497371|NCT02163993|466112051|FG004|Treatment Period|Adverse Event|1|||
129497372|NCT02163993|466112047|FG000|Treatment Period|Lost to Follow-up|2|||
129497373|NCT02163993|466112048|FG001|Treatment Period|Lost to Follow-up|3|||
129497374|NCT02163993|466112049|FG002|Treatment Period|Lost to Follow-up|1|||
129497375|NCT02163993|466112050|FG003|Treatment Period|Lost to Follow-up|3|||
129497376|NCT02163993|466112051|FG004|Treatment Period|Lost to Follow-up|1|||
129497377|NCT02163993|466112047|FG000|Treatment Period|Physician Decision|1|||
129497378|NCT02163993|466112048|FG001|Treatment Period|Physician Decision|0|||
129497379|NCT02163993|466112049|FG002|Treatment Period|Physician Decision|0|||
129497380|NCT02163993|466112050|FG003|Treatment Period|Physician Decision|0|||
129497381|NCT02163993|466112051|FG004|Treatment Period|Physician Decision|0|||
129497382|NCT02163993|466112047|FG000|Treatment Period|Protocol Violation|2|||
129497383|NCT02163993|466112048|FG001|Treatment Period|Protocol Violation|1|||
129497384|NCT02163993|466112049|FG002|Treatment Period|Protocol Violation|0|||
129497385|NCT02163993|466112050|FG003|Treatment Period|Protocol Violation|1|||
129497386|NCT02163993|466112051|FG004|Treatment Period|Protocol Violation|2|||
129497387|NCT02163993|466112047|FG000|Treatment Period|Withdrawal by Subject|6|||
129497388|NCT02163993|466112048|FG001|Treatment Period|Withdrawal by Subject|4|||
129497389|NCT02163993|466112049|FG002|Treatment Period|Withdrawal by Subject|1|||
129497390|NCT02163993|466112050|FG003|Treatment Period|Withdrawal by Subject|4|||
129497391|NCT02163993|466112051|FG004|Treatment Period|Withdrawal by Subject|1|||
129497392|NCT02163993|466112047|FG000|Treatment Period|Not treated|1|||
129497393|NCT02163993|466112048|FG001|Treatment Period|Not treated|0|||
129497394|NCT02163993|466112049|FG002|Treatment Period|Not treated|0|||
129497395|NCT02163993|466112050|FG003|Treatment Period|Not treated|1|||
129497396|NCT02163993|466112051|FG004|Treatment Period|Not treated|2|||
129497397|NCT02163993|466112047|FG000|Post-treatment Period|Adverse Event|0|||
129497398|NCT02163993|466112048|FG001|Post-treatment Period|Adverse Event|0|||
129497399|NCT02163993|466112049|FG002|Post-treatment Period|Adverse Event|1|||
129497400|NCT02163993|466112050|FG003|Post-treatment Period|Adverse Event|0|||
129497401|NCT02163993|466112051|FG004|Post-treatment Period|Adverse Event|0|||
129497402|NCT02163993|466112047|FG000|Post-treatment Period|Lost to Follow-up|2|||
129497403|NCT02163993|466112048|FG001|Post-treatment Period|Lost to Follow-up|2|||
129497404|NCT02163993|466112049|FG002|Post-treatment Period|Lost to Follow-up|3|||
129497405|NCT02163993|466112050|FG003|Post-treatment Period|Lost to Follow-up|1|||
129497406|NCT02163993|466112051|FG004|Post-treatment Period|Lost to Follow-up|0|||
129497407|NCT02163993|466112047|FG000|Post-treatment Period|Protocol Violation|0|||
129497408|NCT02163993|466112048|FG001|Post-treatment Period|Protocol Violation|0|||
129497409|NCT02163993|466112049|FG002|Post-treatment Period|Protocol Violation|0|||
129981456|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129981457|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129981458|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
129981459|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
129497410|NCT02163993|466112050|FG003|Post-treatment Period|Protocol Violation|0|||
129497411|NCT02163993|466112051|FG004|Post-treatment Period|Protocol Violation|1|||
129497412|NCT02163993|466112047|FG000|Post-treatment Period|Withdrawal by Subject|2|||
129497413|NCT02163993|466112048|FG001|Post-treatment Period|Withdrawal by Subject|4|||
129497414|NCT02163993|466112049|FG002|Post-treatment Period|Withdrawal by Subject|0|||
129497415|NCT02163993|466112050|FG003|Post-treatment Period|Withdrawal by Subject|1|||
129497416|NCT02163993|466112051|FG004|Post-treatment Period|Withdrawal by Subject|2|||
129497417|NCT00853489|466112052|FG000|Overall Study|Lost to Follow-up|5|||
129497418|NCT00853489|466112053|FG001|Overall Study|Lost to Follow-up|2|||
129497419|NCT05525975|466112054|FG000|Overall Study|Surgery cancellation|4|||
129497420|NCT05525975|466112055|FG001|Overall Study|Surgery cancellation|5|||
129497421|NCT05525975|466112054|FG000|Overall Study|didn't fill prescription|1|||
129497422|NCT05525975|466112055|FG001|Overall Study|didn't fill prescription|0|||
129497423|NCT05525975|466112054|FG000|Overall Study|Withdrawal by Subject|0|||
129497424|NCT05525975|466112055|FG001|Overall Study|Withdrawal by Subject|3|||
129497425|NCT01998581|466112057|FG000|Overall Study|Refused repeat treatment|20|||
129497426|NCT01998581|466112058|FG001|Overall Study|Refused repeat treatment|4|||
129497427|NCT01998581|466112057|FG000|Overall Study|Protocol Violation|1|||
129497428|NCT01998581|466112058|FG001|Overall Study|Protocol Violation|0|||
129497429|NCT01998581|466112057|FG000|Overall Study|Withdrawal by Subject|8|||
129497430|NCT01998581|466112058|FG001|Overall Study|Withdrawal by Subject|1|||
129497431|NCT01998581|466112057|FG000|Overall Study|Lost to Follow-up|12|||
129497432|NCT01998581|466112058|FG001|Overall Study|Lost to Follow-up|4|||
129497433|NCT01998581|466112057|FG000|Overall Study|Adverse Event|1|||
129497434|NCT01998581|466112058|FG001|Overall Study|Adverse Event|1|||
129497435|NCT01998581|466112057|FG000|Overall Study|Other reasons|3|||
129497436|NCT01998581|466112058|FG001|Overall Study|Other reasons|2|||
129497437|NCT01998581|466112057|FG000|Overall Study|Randomized but withdrew before treatment|1|||
129497438|NCT01998581|466112058|FG001|Overall Study|Randomized but withdrew before treatment|0|||
129497439|NCT01251276|466112059|FG000|Overall Study|Protocol Violation|1|||
129497440|NCT01251276|466112060|FG001|Overall Study|Protocol Violation|0|||
129497441|NCT01251276|466112059|FG000|Overall Study|Lost to Follow-up|0|||
129497442|NCT01251276|466112060|FG001|Overall Study|Lost to Follow-up|1|||
129497443|NCT01345123|466112061|FG000|Overall Study|participants no longer with health plan|79|||
129497444|NCT01345123|466112062|FG001|Overall Study|participants no longer with health plan|85|||
129497445|NCT01345123|466112063|FG002|Overall Study|participants no longer with health plan|88|||
129497446|NCT02273752|466112064|FG000|Overall Study|Trial was terminated early|2|||
129497447|NCT02808312|466112065|FG000|Overall Study|Enrolled but Never Treated|0|||
129497448|NCT02808312|466112066|FG001|Overall Study|Enrolled but Never Treated|0|||
129497449|NCT02808312|466112067|FG002|Overall Study|Enrolled but Never Treated|1|||
129497450|NCT02808312|466112068|FG003|Overall Study|Enrolled but Never Treated|0|||
129497451|NCT02808312|466112069|FG004|Overall Study|Enrolled but Never Treated|0|||
129497452|NCT04184622|466112076|FG000|Primary Treatment Period|Adverse Event|6|||
129497453|NCT04184622|466112077|FG001|Primary Treatment Period|Adverse Event|4|||
129497454|NCT04184622|466112078|FG002|Primary Treatment Period|Adverse Event|8|||
129497455|NCT04184622|466112079|FG003|Primary Treatment Period|Adverse Event|6|||
129497456|NCT04184622|466112076|FG000|Primary Treatment Period|Death|4|||
129497457|NCT04184622|466112077|FG001|Primary Treatment Period|Death|4|||
129497458|NCT04184622|466112078|FG002|Primary Treatment Period|Death|2|||
129497459|NCT04184622|466112079|FG003|Primary Treatment Period|Death|1|||
129497460|NCT04184622|466112076|FG000|Primary Treatment Period|Lost to Follow-up|41|||
129497461|NCT04184622|466112077|FG001|Primary Treatment Period|Lost to Follow-up|17|||
129497462|NCT04184622|466112078|FG002|Primary Treatment Period|Lost to Follow-up|15|||
129497463|NCT04184622|466112079|FG003|Primary Treatment Period|Lost to Follow-up|13|||
129497464|NCT04184622|466112076|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
129497465|NCT04184622|466112077|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
129497466|NCT04184622|466112078|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
129497467|NCT04184622|466112079|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
129497468|NCT04184622|466112076|FG000|Primary Treatment Period|Physician Decision|0|||
129497469|NCT04184622|466112077|FG001|Primary Treatment Period|Physician Decision|0|||
129497470|NCT04184622|466112078|FG002|Primary Treatment Period|Physician Decision|3|||
129497471|NCT04184622|466112079|FG003|Primary Treatment Period|Physician Decision|1|||
129497472|NCT04184622|466112076|FG000|Primary Treatment Period|Pregnancy|4|||
129497473|NCT04184622|466112077|FG001|Primary Treatment Period|Pregnancy|3|||
129497474|NCT04184622|466112078|FG002|Primary Treatment Period|Pregnancy|4|||
129497475|NCT04184622|466112079|FG003|Primary Treatment Period|Pregnancy|1|||
129981460|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
129981461|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129981462|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129981463|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129981464|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
129497476|NCT04184622|466112076|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
129497477|NCT04184622|466112077|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
129497478|NCT04184622|466112078|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
129497479|NCT04184622|466112079|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
129497480|NCT04184622|466112076|FG000|Additional Treatment Period|Adverse Event|1|||
129497481|NCT04184622|466112077|FG001|Additional Treatment Period|Adverse Event|2|||
129497482|NCT04184622|466112078|FG002|Additional Treatment Period|Adverse Event|1|||
129497483|NCT04184622|466112079|FG003|Additional Treatment Period|Adverse Event|0|||
129497484|NCT04184622|466112076|FG000|Additional Treatment Period|Death|0|||
129497485|NCT04184622|466112077|FG001|Additional Treatment Period|Death|0|||
129497486|NCT04184622|466112078|FG002|Additional Treatment Period|Death|1|||
129981465|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
129497487|NCT04184622|466112079|FG003|Additional Treatment Period|Death|1|||
129497488|NCT04184622|466112076|FG000|Additional Treatment Period|Lost to Follow-up|6|||
129497489|NCT04184622|466112077|FG001|Additional Treatment Period|Lost to Follow-up|4|||
129497490|NCT04184622|466112078|FG002|Additional Treatment Period|Lost to Follow-up|8|||
129497491|NCT04184622|466112079|FG003|Additional Treatment Period|Lost to Follow-up|6|||
129497492|NCT04184622|466112076|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
129497493|NCT04184622|466112077|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
129497494|NCT04184622|466112078|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
129497495|NCT04184622|466112079|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
129497496|NCT04184622|466112076|FG000|Additional Treatment Period|Physician Decision|0|||
129497497|NCT04184622|466112077|FG001|Additional Treatment Period|Physician Decision|0|||
129497498|NCT04184622|466112078|FG002|Additional Treatment Period|Physician Decision|1|||
129497499|NCT04184622|466112079|FG003|Additional Treatment Period|Physician Decision|0|||
129497500|NCT04184622|466112076|FG000|Additional Treatment Period|Pregnancy|0|||
129497501|NCT04184622|466112077|FG001|Additional Treatment Period|Pregnancy|0|||
129497502|NCT04184622|466112078|FG002|Additional Treatment Period|Pregnancy|0|||
129497503|NCT04184622|466112079|FG003|Additional Treatment Period|Pregnancy|1|||
129497504|NCT04184622|466112076|FG000|Additional Treatment Period|Protocol deviation|0|||
129497505|NCT04184622|466112077|FG001|Additional Treatment Period|Protocol deviation|0|||
129497506|NCT04184622|466112078|FG002|Additional Treatment Period|Protocol deviation|1|||
129497507|NCT04184622|466112079|FG003|Additional Treatment Period|Protocol deviation|0|||
129497508|NCT04184622|466112076|FG000|Additional Treatment Period|Site closed|1|||
129497509|NCT04184622|466112077|FG001|Additional Treatment Period|Site closed|0|||
129497510|NCT04184622|466112078|FG002|Additional Treatment Period|Site closed|1|||
129497511|NCT04184622|466112079|FG003|Additional Treatment Period|Site closed|0|||
129497512|NCT04184622|466112076|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
129497513|NCT04184622|466112077|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
129497514|NCT04184622|466112078|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
129497515|NCT04184622|466112079|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
129497516|NCT04184622|466112076|FG000|Safety Follow-up Period|Adverse Event|6|||
129497517|NCT04184622|466112077|FG001|Safety Follow-up Period|Adverse Event|8|||
129497518|NCT04184622|466112078|FG002|Safety Follow-up Period|Adverse Event|9|||
129497519|NCT04184622|466112079|FG003|Safety Follow-up Period|Adverse Event|16|||
129497520|NCT04184622|466112076|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
129497521|NCT04184622|466112077|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
129497522|NCT04184622|466112078|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
129497523|NCT04184622|466112079|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
129497524|NCT04184622|466112076|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
129497525|NCT04184622|466112077|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
129497526|NCT04184622|466112078|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
129497527|NCT04184622|466112079|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
129497528|NCT04184622|466112076|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
129497529|NCT04184622|466112077|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
129497530|NCT04184622|466112078|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
129497531|NCT04184622|466112079|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
129497532|NCT04184622|466112076|FG000|Safety Follow-up Period|Physician Decision|1|||
129497533|NCT04184622|466112077|FG001|Safety Follow-up Period|Physician Decision|0|||
129497534|NCT04184622|466112078|FG002|Safety Follow-up Period|Physician Decision|0|||
129497535|NCT04184622|466112079|FG003|Safety Follow-up Period|Physician Decision|1|||
129497536|NCT04184622|466112076|FG000|Safety Follow-up Period|Pregnancy|1|||
129497537|NCT04184622|466112077|FG001|Safety Follow-up Period|Pregnancy|3|||
129497538|NCT04184622|466112078|FG002|Safety Follow-up Period|Pregnancy|0|||
129497539|NCT04184622|466112079|FG003|Safety Follow-up Period|Pregnancy|6|||
129497540|NCT04184622|466112076|FG000|Safety Follow-up Period|Protocol deviation|1|||
129497541|NCT04184622|466112077|FG001|Safety Follow-up Period|Protocol deviation|0|||
129497542|NCT04184622|466112078|FG002|Safety Follow-up Period|Protocol deviation|0|||
129497543|NCT04184622|466112079|FG003|Safety Follow-up Period|Protocol deviation|0|||
129981466|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
129981467|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
129981468|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
129497544|NCT04184622|466112076|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
129497545|NCT04184622|466112077|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
129497546|NCT04184622|466112078|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
129497547|NCT04184622|466112079|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
129497548|NCT01617681|466112080|FG000|Period 1 Double Blind|Adverse Event|2|||
129497549|NCT01617681|466112081|FG001|Period 1 Double Blind|Adverse Event|0|||
129497550|NCT01617681|466112082|FG002|Period 1 Double Blind|Adverse Event|0|||
129497551|NCT01617681|466112083|FG003|Period 1 Double Blind|Adverse Event|2|||
129497552|NCT01617681|466112084|FG004|Period 1 Double Blind|Adverse Event|0|||
129497553|NCT01617681|466112080|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
129981469|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
129497554|NCT01617681|466112081|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
129497555|NCT01617681|466112082|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
129497556|NCT01617681|466112083|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
129497557|NCT01617681|466112084|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
129497558|NCT01617681|466112080|FG000|Period 2 Open Label|Adverse Event|0|||
129497559|NCT01617681|466112081|FG001|Period 2 Open Label|Adverse Event|0|||
129497560|NCT01617681|466112082|FG002|Period 2 Open Label|Adverse Event|0|||
129497561|NCT01617681|466112083|FG003|Period 2 Open Label|Adverse Event|0|||
129497562|NCT01617681|466112084|FG004|Period 2 Open Label|Adverse Event|3|||
129497563|NCT01617681|466112080|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
129497564|NCT01617681|466112081|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
129497565|NCT01617681|466112082|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
129497566|NCT01617681|466112083|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
129497567|NCT01617681|466112084|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
129497568|NCT01763905|466112089|FG000|Overall Study|Withdrawal by Subject|1|||
129497569|NCT01763905|466112090|FG001|Overall Study|Withdrawal by Subject|1|||
129497570|NCT01763905|466112091|FG002|Overall Study|Withdrawal by Subject|0|||
129497571|NCT01763905|466112092|FG003|Overall Study|Withdrawal by Subject|1|||
129497572|NCT01763905|466112089|FG000|Overall Study|Decision by sponsor|5|||
129497573|NCT01763905|466112090|FG001|Overall Study|Decision by sponsor|0|||
129497574|NCT01763905|466112091|FG002|Overall Study|Decision by sponsor|8|||
129497575|NCT01763905|466112092|FG003|Overall Study|Decision by sponsor|0|||
129497576|NCT01763905|466112089|FG000|Overall Study|Lost to Follow-up|0|||
129497577|NCT01763905|466112090|FG001|Overall Study|Lost to Follow-up|0|||
129497578|NCT01763905|466112091|FG002|Overall Study|Lost to Follow-up|1|||
129497579|NCT01763905|466112092|FG003|Overall Study|Lost to Follow-up|0|||
129497580|NCT01028651|466112095|FG000|Overall Study|Death|2|||
129497581|NCT01028651|466112095|FG000|Overall Study|Adverse Event|1|||
129497582|NCT00913978|466112096|FG000|Overall Study|Surgeon choice|1|||
129497583|NCT00913978|466112097|FG001|Overall Study|Surgeon choice|3|||
129497584|NCT01327651|466112101|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
129497585|NCT01327651|466112102|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
129497586|NCT01327651|466112103|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
129497587|NCT01327651|466112104|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
129497588|NCT01327651|466112105|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
129497589|NCT01327651|466112106|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
129497590|NCT01327651|466112107|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
129497591|NCT01327651|466112108|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
129497592|NCT01327651|466112109|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
129497593|NCT01327651|466112101|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
129497594|NCT01327651|466112102|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497595|NCT01327651|466112103|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497596|NCT01327651|466112104|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497597|NCT01327651|466112105|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497598|NCT01327651|466112106|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497599|NCT01327651|466112107|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497600|NCT01327651|466112108|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497601|NCT01327651|466112109|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
129497602|NCT01327651|466112101|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
129497603|NCT01327651|466112102|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
129497604|NCT01327651|466112103|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
129497605|NCT01327651|466112104|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
129497606|NCT01327651|466112105|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
129497607|NCT01327651|466112106|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
129497608|NCT01327651|466112107|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
129497609|NCT01327651|466112108|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
129497610|NCT01327651|466112109|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
129497611|NCT01327651|466112101|FG000|Post Study Follow-up|Lost to Follow-up|0|||
129497612|NCT01327651|466112102|FG001|Post Study Follow-up|Lost to Follow-up|1|||
129981470|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
129981471|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
129981472|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
129981473|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981474|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129497613|NCT01327651|466112103|FG002|Post Study Follow-up|Lost to Follow-up|1|||
129497614|NCT01327651|466112104|FG003|Post Study Follow-up|Lost to Follow-up|0|||
129497615|NCT01327651|466112105|FG004|Post Study Follow-up|Lost to Follow-up|0|||
129497616|NCT01327651|466112106|FG005|Post Study Follow-up|Lost to Follow-up|0|||
129497617|NCT01327651|466112107|FG006|Post Study Follow-up|Lost to Follow-up|4|||
129497618|NCT01327651|466112108|FG007|Post Study Follow-up|Lost to Follow-up|1|||
129497619|NCT01327651|466112109|FG008|Post Study Follow-up|Lost to Follow-up|2|||
129497620|NCT03249792|466112114|FG000|Arms 1, 2, and 4|Death|1|||
129497621|NCT03249792|466112115|FG001|Arms 1, 2, and 4|Death|1|||
129497622|NCT03249792|466112116|FG002|Arms 1, 2, and 4|Death|0|||
129497623|NCT03249792|466112117|FG003|Arms 1, 2, and 4|Death|2|||
129497624|NCT03249792|466112118|FG004|Arms 1, 2, and 4|Death|3|||
129497625|NCT03249792|466112119|FG005|Arms 1, 2, and 4|Death|2|||
129497626|NCT03249792|466112120|FG006|Arms 1, 2, and 4|Death|2|||
129497627|NCT03249792|466112121|FG007|Arms 1, 2, and 4|Death|4|||
129497628|NCT03249792|466112122|FG008|Arms 1, 2, and 4|Death|2|||
129497629|NCT03249792|466112123|FG009|Arms 1, 2, and 4|Death|1|||
129497630|NCT03249792|466112124|FG010|Arms 1, 2, and 4|Death|7|||
129497631|NCT03249792|466112125|FG011|Arms 1, 2, and 4|Death|7|||
129497632|NCT03249792|466112126|FG012|Arms 1, 2, and 4|Death|12|||
129497633|NCT03249792|466112127|FG013|Arms 1, 2, and 4|Death|7|||
129497634|NCT03249792|466112128|FG014|Arms 1, 2, and 4|Death|0|||
129497635|NCT03249792|466112129|FG015|Arms 1, 2, and 4|Death|4|||
129497636|NCT03249792|466112130|FG016|Arms 1, 2, and 4|Death|4|||
129497637|NCT03249792|466112131|FG017|Arms 1, 2, and 4|Death|12|||
129497638|NCT03249792|466112132|FG018|Arms 1, 2, and 4|Death|6|||
129497639|NCT03249792|466112133|FG019|Arms 1, 2, and 4|Death|4|||
129497640|NCT03249792|466112134|FG020|Arms 1, 2, and 4|Death|2|||
129497641|NCT03249792|466112135|FG021|Arms 1, 2, and 4|Death|3|||
129497642|NCT03249792|466112136|FG022|Arms 1, 2, and 4|Death|1|||
129497643|NCT03249792|466112137|FG023|Arms 1, 2, and 4|Death|1|||
129497644|NCT03249792|466112138|FG024|Arms 1, 2, and 4|Death|4|||
129497645|NCT03249792|466112139|FG025|Arms 1, 2, and 4|Death|0|||
129497646|NCT03249792|466112140|FG026|Arms 1, 2, and 4|Death|0|||
129497647|NCT03249792|466112141|FG027|Arms 1, 2, and 4|Death|0|||
129497648|NCT03249792|466112142|FG028|Arms 1, 2, and 4|Death|0|||
129497649|NCT03249792|466112143|FG029|Arms 1, 2, and 4|Death|0|||
129497650|NCT03249792|466112144|FG030|Arms 1, 2, and 4|Death|0|||
129497651|NCT03249792|466112145|FG031|Arms 1, 2, and 4|Death|0|||
129497652|NCT03249792|466112146|FG032|Arms 1, 2, and 4|Death|0|||
129497653|NCT03249792|466112114|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497654|NCT03249792|466112115|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497655|NCT03249792|466112116|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
129497656|NCT03249792|466112117|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497657|NCT03249792|466112118|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497658|NCT03249792|466112119|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
129497659|NCT03249792|466112120|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
129497660|NCT03249792|466112121|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497661|NCT03249792|466112122|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
129497662|NCT03249792|466112123|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
129497663|NCT03249792|466112124|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
129497664|NCT03249792|466112125|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
129497665|NCT03249792|466112126|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
129497666|NCT03249792|466112127|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
129497667|NCT03249792|466112128|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497668|NCT03249792|466112129|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497669|NCT03249792|466112130|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
129497670|NCT03249792|466112131|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497671|NCT03249792|466112132|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
129497672|NCT03249792|466112133|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497673|NCT03249792|466112134|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497674|NCT03249792|466112135|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497675|NCT03249792|466112136|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
129497676|NCT03249792|466112137|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
129497677|NCT03249792|466112138|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497678|NCT03249792|466112139|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497679|NCT03249792|466112140|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497680|NCT03249792|466112141|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497681|NCT03249792|466112142|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497682|NCT03249792|466112143|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497683|NCT03249792|466112144|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497684|NCT03249792|466112145|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497685|NCT03249792|466112146|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
129497686|NCT03249792|466112114|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
129497687|NCT03249792|466112115|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
129497688|NCT03249792|466112116|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
129497689|NCT03249792|466112117|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
129497690|NCT03249792|466112118|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
129497691|NCT03249792|466112119|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
129497692|NCT03249792|466112120|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
129497693|NCT03249792|466112121|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
129497694|NCT03249792|466112122|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
129497695|NCT03249792|466112123|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
129497696|NCT03249792|466112124|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
129497697|NCT03249792|466112125|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
129497698|NCT03249792|466112126|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
129497699|NCT03249792|466112127|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
129497700|NCT03249792|466112128|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
129497701|NCT03249792|466112129|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
129497702|NCT03249792|466112130|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
129497703|NCT03249792|466112131|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
129497704|NCT03249792|466112132|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
129497705|NCT03249792|466112133|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
129497706|NCT03249792|466112134|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
129497707|NCT03249792|466112135|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
129497708|NCT03249792|466112136|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
129497709|NCT03249792|466112137|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
129497710|NCT03249792|466112138|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
129497711|NCT03249792|466112139|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
129497712|NCT03249792|466112140|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
129497713|NCT03249792|466112141|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
129497714|NCT03249792|466112142|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
129497715|NCT03249792|466112143|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
129497716|NCT03249792|466112144|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
129497717|NCT03249792|466112145|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
129497718|NCT03249792|466112146|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
129497719|NCT03249792|466112114|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497720|NCT03249792|466112115|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497721|NCT03249792|466112116|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497722|NCT03249792|466112117|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497723|NCT03249792|466112118|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497724|NCT03249792|466112119|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497725|NCT03249792|466112120|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497726|NCT03249792|466112121|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497727|NCT03249792|466112122|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
129497728|NCT03249792|466112123|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497729|NCT03249792|466112124|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497730|NCT03249792|466112125|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497731|NCT03249792|466112126|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497732|NCT03249792|466112127|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497733|NCT03249792|466112128|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497734|NCT03249792|466112129|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497735|NCT03249792|466112130|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
129497736|NCT03249792|466112131|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
129497737|NCT03249792|466112132|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497738|NCT03249792|466112133|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
129497739|NCT03249792|466112134|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497740|NCT03249792|466112135|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497741|NCT03249792|466112136|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497742|NCT03249792|466112137|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497743|NCT03249792|466112138|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497744|NCT03249792|466112139|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497745|NCT03249792|466112140|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497746|NCT03249792|466112141|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497747|NCT03249792|466112142|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497748|NCT03249792|466112143|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497749|NCT03249792|466112144|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497750|NCT03249792|466112145|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497751|NCT03249792|466112146|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
129497752|NCT03249792|466112114|FG000|Switch Over Period|Withdrawal by Subject|0|||
129497753|NCT03249792|466112115|FG001|Switch Over Period|Withdrawal by Subject|0|||
129497754|NCT03249792|466112116|FG002|Switch Over Period|Withdrawal by Subject|0|||
129497755|NCT03249792|466112117|FG003|Switch Over Period|Withdrawal by Subject|0|||
129497756|NCT03249792|466112118|FG004|Switch Over Period|Withdrawal by Subject|0|||
129497757|NCT03249792|466112119|FG005|Switch Over Period|Withdrawal by Subject|0|||
129497758|NCT03249792|466112120|FG006|Switch Over Period|Withdrawal by Subject|0|||
129497759|NCT03249792|466112121|FG007|Switch Over Period|Withdrawal by Subject|0|||
129497760|NCT03249792|466112122|FG008|Switch Over Period|Withdrawal by Subject|0|||
129497761|NCT03249792|466112123|FG009|Switch Over Period|Withdrawal by Subject|0|||
129497762|NCT03249792|466112124|FG010|Switch Over Period|Withdrawal by Subject|0|||
129497763|NCT03249792|466112125|FG011|Switch Over Period|Withdrawal by Subject|0|||
129497764|NCT03249792|466112126|FG012|Switch Over Period|Withdrawal by Subject|0|||
129497765|NCT03249792|466112127|FG013|Switch Over Period|Withdrawal by Subject|0|||
129497766|NCT03249792|466112128|FG014|Switch Over Period|Withdrawal by Subject|0|||
129497767|NCT03249792|466112129|FG015|Switch Over Period|Withdrawal by Subject|0|||
129497768|NCT03249792|466112130|FG016|Switch Over Period|Withdrawal by Subject|0|||
129497769|NCT03249792|466112131|FG017|Switch Over Period|Withdrawal by Subject|0|||
129497770|NCT03249792|466112132|FG018|Switch Over Period|Withdrawal by Subject|0|||
129497771|NCT03249792|466112133|FG019|Switch Over Period|Withdrawal by Subject|0|||
129497772|NCT03249792|466112134|FG020|Switch Over Period|Withdrawal by Subject|0|||
129497773|NCT03249792|466112135|FG021|Switch Over Period|Withdrawal by Subject|0|||
129497774|NCT03249792|466112136|FG022|Switch Over Period|Withdrawal by Subject|0|||
129497775|NCT03249792|466112137|FG023|Switch Over Period|Withdrawal by Subject|0|||
129497776|NCT03249792|466112138|FG024|Switch Over Period|Withdrawal by Subject|0|||
129497777|NCT03249792|466112139|FG025|Switch Over Period|Withdrawal by Subject|0|||
129497778|NCT03249792|466112140|FG026|Switch Over Period|Withdrawal by Subject|0|||
129497779|NCT03249792|466112141|FG027|Switch Over Period|Withdrawal by Subject|0|||
129497780|NCT03249792|466112142|FG028|Switch Over Period|Withdrawal by Subject|0|||
129497781|NCT03249792|466112143|FG029|Switch Over Period|Withdrawal by Subject|0|||
129497782|NCT03249792|466112144|FG030|Switch Over Period|Withdrawal by Subject|0|||
129497783|NCT03249792|466112145|FG031|Switch Over Period|Withdrawal by Subject|1|||
129497784|NCT03249792|466112146|FG032|Switch Over Period|Withdrawal by Subject|0|||
129497785|NCT03249792|466112114|FG000|Switch Over Period|Progressive Disease|0|||
129497786|NCT03249792|466112115|FG001|Switch Over Period|Progressive Disease|0|||
129497787|NCT03249792|466112116|FG002|Switch Over Period|Progressive Disease|0|||
129497788|NCT03249792|466112117|FG003|Switch Over Period|Progressive Disease|0|||
129497789|NCT03249792|466112118|FG004|Switch Over Period|Progressive Disease|0|||
129497790|NCT03249792|466112119|FG005|Switch Over Period|Progressive Disease|0|||
129497791|NCT03249792|466112120|FG006|Switch Over Period|Progressive Disease|0|||
129497792|NCT03249792|466112121|FG007|Switch Over Period|Progressive Disease|0|||
129497793|NCT03249792|466112122|FG008|Switch Over Period|Progressive Disease|0|||
129497794|NCT03249792|466112123|FG009|Switch Over Period|Progressive Disease|0|||
129497795|NCT03249792|466112124|FG010|Switch Over Period|Progressive Disease|0|||
129497796|NCT03249792|466112125|FG011|Switch Over Period|Progressive Disease|0|||
129497797|NCT03249792|466112126|FG012|Switch Over Period|Progressive Disease|0|||
129497798|NCT03249792|466112127|FG013|Switch Over Period|Progressive Disease|0|||
129497799|NCT03249792|466112128|FG014|Switch Over Period|Progressive Disease|0|||
129497800|NCT03249792|466112129|FG015|Switch Over Period|Progressive Disease|0|||
129497801|NCT03249792|466112130|FG016|Switch Over Period|Progressive Disease|0|||
129497802|NCT03249792|466112131|FG017|Switch Over Period|Progressive Disease|0|||
129497803|NCT03249792|466112132|FG018|Switch Over Period|Progressive Disease|0|||
129497804|NCT03249792|466112133|FG019|Switch Over Period|Progressive Disease|0|||
129497805|NCT03249792|466112134|FG020|Switch Over Period|Progressive Disease|0|||
129497806|NCT03249792|466112135|FG021|Switch Over Period|Progressive Disease|0|||
129497807|NCT03249792|466112136|FG022|Switch Over Period|Progressive Disease|0|||
129497808|NCT03249792|466112137|FG023|Switch Over Period|Progressive Disease|0|||
129497809|NCT03249792|466112138|FG024|Switch Over Period|Progressive Disease|0|||
129497810|NCT03249792|466112139|FG025|Switch Over Period|Progressive Disease|0|||
129497811|NCT03249792|466112140|FG026|Switch Over Period|Progressive Disease|1|||
129497812|NCT03249792|466112141|FG027|Switch Over Period|Progressive Disease|0|||
129497813|NCT03249792|466112142|FG028|Switch Over Period|Progressive Disease|1|||
129497814|NCT03249792|466112143|FG029|Switch Over Period|Progressive Disease|2|||
129497815|NCT03249792|466112144|FG030|Switch Over Period|Progressive Disease|1|||
129497816|NCT03249792|466112145|FG031|Switch Over Period|Progressive Disease|0|||
129497817|NCT03249792|466112146|FG032|Switch Over Period|Progressive Disease|1|||
129497818|NCT03249792|466112114|FG000|Switch Over Period|Adverse Event|0|||
129497819|NCT03249792|466112115|FG001|Switch Over Period|Adverse Event|0|||
129497820|NCT03249792|466112116|FG002|Switch Over Period|Adverse Event|0|||
129497821|NCT03249792|466112117|FG003|Switch Over Period|Adverse Event|0|||
129497822|NCT03249792|466112118|FG004|Switch Over Period|Adverse Event|0|||
129497823|NCT03249792|466112119|FG005|Switch Over Period|Adverse Event|0|||
129497824|NCT03249792|466112120|FG006|Switch Over Period|Adverse Event|0|||
129497825|NCT03249792|466112121|FG007|Switch Over Period|Adverse Event|0|||
129497826|NCT03249792|466112122|FG008|Switch Over Period|Adverse Event|0|||
129497827|NCT03249792|466112123|FG009|Switch Over Period|Adverse Event|0|||
129497828|NCT03249792|466112124|FG010|Switch Over Period|Adverse Event|0|||
129497829|NCT03249792|466112125|FG011|Switch Over Period|Adverse Event|0|||
129497830|NCT03249792|466112126|FG012|Switch Over Period|Adverse Event|0|||
129497831|NCT03249792|466112127|FG013|Switch Over Period|Adverse Event|0|||
129497832|NCT03249792|466112128|FG014|Switch Over Period|Adverse Event|0|||
129497833|NCT03249792|466112129|FG015|Switch Over Period|Adverse Event|0|||
129497834|NCT03249792|466112130|FG016|Switch Over Period|Adverse Event|0|||
129497835|NCT03249792|466112131|FG017|Switch Over Period|Adverse Event|0|||
129497836|NCT03249792|466112132|FG018|Switch Over Period|Adverse Event|0|||
129497837|NCT03249792|466112133|FG019|Switch Over Period|Adverse Event|0|||
129497838|NCT03249792|466112134|FG020|Switch Over Period|Adverse Event|0|||
129497839|NCT03249792|466112135|FG021|Switch Over Period|Adverse Event|0|||
129497840|NCT03249792|466112136|FG022|Switch Over Period|Adverse Event|0|||
129497841|NCT03249792|466112137|FG023|Switch Over Period|Adverse Event|0|||
129497842|NCT03249792|466112138|FG024|Switch Over Period|Adverse Event|0|||
129497843|NCT03249792|466112139|FG025|Switch Over Period|Adverse Event|1|||
129497844|NCT03249792|466112140|FG026|Switch Over Period|Adverse Event|0|||
129497845|NCT03249792|466112141|FG027|Switch Over Period|Adverse Event|1|||
129497846|NCT03249792|466112142|FG028|Switch Over Period|Adverse Event|0|||
129497847|NCT03249792|466112143|FG029|Switch Over Period|Adverse Event|0|||
129497848|NCT03249792|466112144|FG030|Switch Over Period|Adverse Event|0|||
129497849|NCT03249792|466112145|FG031|Switch Over Period|Adverse Event|0|||
129497850|NCT03249792|466112146|FG032|Switch Over Period|Adverse Event|0|||
129497851|NCT01201798|466112150|FG000|Overall Study|Adverse Event|2|||
129497852|NCT01201798|466112151|FG001|Overall Study|Adverse Event|0|||
129497853|NCT01201798|466112150|FG000|Overall Study|Lost to Follow-up|3|||
129497854|NCT01201798|466112151|FG001|Overall Study|Lost to Follow-up|5|||
129497855|NCT01201798|466112150|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
129497856|NCT01201798|466112151|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
129497857|NCT01201798|466112150|FG000|Overall Study|Noncompliance|1|||
129497858|NCT01201798|466112151|FG001|Overall Study|Noncompliance|0|||
129497859|NCT01201798|466112150|FG000|Overall Study|Protocol Violation|1|||
129497860|NCT01201798|466112151|FG001|Overall Study|Protocol Violation|1|||
129497861|NCT01201798|466112150|FG000|Overall Study|Treatment Failure|1|||
129497862|NCT01201798|466112151|FG001|Overall Study|Treatment Failure|8|||
129497863|NCT00525148|466112152|FG000|Overall Study|Other Adverse Event|3|||
129497864|NCT00525148|466112153|FG001|Overall Study|Other Adverse Event|5|||
129497865|NCT00525148|466112154|FG002|Overall Study|Other Adverse Event|1|||
129497866|NCT00525148|466112155|FG003|Overall Study|Other Adverse Event|8|||
129497867|NCT00525148|466112152|FG000|Overall Study|Progressive disease|18|||
129497868|NCT00525148|466112153|FG001|Overall Study|Progressive disease|30|||
129497869|NCT00525148|466112154|FG002|Overall Study|Progressive disease|6|||
129497870|NCT00525148|466112155|FG003|Overall Study|Progressive disease|49|||
129497871|NCT00525148|466112152|FG000|Overall Study|Refused continuation of study medication|0|||
129497872|NCT00525148|466112153|FG001|Overall Study|Refused continuation of study medication|2|||
129497873|NCT00525148|466112154|FG002|Overall Study|Refused continuation of study medication|0|||
129497874|NCT00525148|466112155|FG003|Overall Study|Refused continuation of study medication|1|||
129497875|NCT00525148|466112152|FG000|Overall Study|Other than stated|2|||
129497876|NCT00525148|466112153|FG001|Overall Study|Other than stated|1|||
129497877|NCT00525148|466112154|FG002|Overall Study|Other than stated|0|||
129497878|NCT00525148|466112155|FG003|Overall Study|Other than stated|3|||
129497879|NCT00114972|466112156|FG000|Overall Study|Withdrawal by Subject|40|||
129497880|NCT00114972|466112157|FG001|Overall Study|Withdrawal by Subject|7|||
129497881|NCT00114972|466112156|FG000|Overall Study|Lost to Follow-up|8|||
129497882|NCT00114972|466112157|FG001|Overall Study|Lost to Follow-up|5|||
129497883|NCT00830037|466112158|FG000|Overall Study|Withdrawal by Subject|2|||
129497884|NCT00830037|466112159|FG001|Overall Study|Withdrawal by Subject|3|||
129497885|NCT00830037|466112158|FG000|Overall Study|Lost to Follow-up|1|||
129497886|NCT00830037|466112159|FG001|Overall Study|Lost to Follow-up|2|||
129497887|NCT00830037|466112158|FG000|Overall Study|Active when terminated by DSMB|15|||
129497888|NCT00830037|466112159|FG001|Overall Study|Active when terminated by DSMB|14|||
129497889|NCT01425190|466112160|FG000|Overall Study|Full dose not consumed.|1|||
129497890|NCT01425190|466112161|FG001|Overall Study|Full dose not consumed.|0|||
129497891|NCT01425190|466112162|FG002|Overall Study|Full dose not consumed.|0|||
129497892|NCT02538666|466112166|FG000|Pre-Treatment|Disease progression|1|||
129497893|NCT02538666|466112167|FG001|Pre-Treatment|Disease progression|0|||
129497894|NCT02538666|466112168|FG002|Pre-Treatment|Disease progression|0|||
129497895|NCT02538666|466112166|FG000|Pre-Treatment|no longer meets study criteria|1|||
129497896|NCT02538666|466112167|FG001|Pre-Treatment|no longer meets study criteria|0|||
129497897|NCT02538666|466112168|FG002|Pre-Treatment|no longer meets study criteria|0|||
129497898|NCT02538666|466112166|FG000|Pre-Treatment|Withdrew Consent|0|||
129497899|NCT02538666|466112167|FG001|Pre-Treatment|Withdrew Consent|1|||
129497900|NCT02538666|466112168|FG002|Pre-Treatment|Withdrew Consent|1|||
129497901|NCT02538666|466112166|FG000|Treatment|Disease progression|270|||
129497902|NCT02538666|466112167|FG001|Treatment|Disease progression|227|||
129497903|NCT02538666|466112168|FG002|Treatment|Disease progression|165|||
129497904|NCT02538666|466112166|FG000|Treatment|Study drug toxicity|1|||
129497905|NCT02538666|466112167|FG001|Treatment|Study drug toxicity|29|||
129497906|NCT02538666|466112168|FG002|Treatment|Study drug toxicity|92|||
129497907|NCT02538666|466112166|FG000|Treatment|Death|0|||
129497908|NCT02538666|466112167|FG001|Treatment|Death|2|||
129497909|NCT02538666|466112168|FG002|Treatment|Death|3|||
129497910|NCT02538666|466112166|FG000|Treatment|Adverse event unrelated to study drug|8|||
129497911|NCT02538666|466112167|FG001|Treatment|Adverse event unrelated to study drug|10|||
129497912|NCT02538666|466112168|FG002|Treatment|Adverse event unrelated to study drug|15|||
129497913|NCT02538666|466112166|FG000|Treatment|Participant request to discontinue study treatment|3|||
129497914|NCT02538666|466112167|FG001|Treatment|Participant request to discontinue study treatment|6|||
129497915|NCT02538666|466112168|FG002|Treatment|Participant request to discontinue study treatment|11|||
129497916|NCT02538666|466112166|FG000|Treatment|Participant withdrew consent|2|||
129497917|NCT02538666|466112167|FG001|Treatment|Participant withdrew consent|5|||
129497918|NCT02538666|466112168|FG002|Treatment|Participant withdrew consent|3|||
129497919|NCT02538666|466112166|FG000|Treatment|Lost to Follow-up|0|||
129497920|NCT02538666|466112167|FG001|Treatment|Lost to Follow-up|1|||
129497921|NCT02538666|466112168|FG002|Treatment|Lost to Follow-up|1|||
129497922|NCT02538666|466112166|FG000|Treatment|Maximum clinical benefit|4|||
129497923|NCT02538666|466112167|FG001|Treatment|Maximum clinical benefit|3|||
129497924|NCT02538666|466112168|FG002|Treatment|Maximum clinical benefit|4|||
129497925|NCT02538666|466112166|FG000|Treatment|Poor/non-compliance|0|||
129497926|NCT02538666|466112167|FG001|Treatment|Poor/non-compliance|1|||
129497927|NCT02538666|466112168|FG002|Treatment|Poor/non-compliance|0|||
129497928|NCT02538666|466112166|FG000|Treatment|Participant no longer meets study criteria|0|||
129497929|NCT02538666|466112167|FG001|Treatment|Participant no longer meets study criteria|2|||
129497930|NCT02538666|466112168|FG002|Treatment|Participant no longer meets study criteria|0|||
129497931|NCT02538666|466112166|FG000|Treatment|Administrative reason by sponsor|0|||
129497932|NCT02538666|466112167|FG001|Treatment|Administrative reason by sponsor|0|||
129497933|NCT02538666|466112168|FG002|Treatment|Administrative reason by sponsor|1|||
129497934|NCT02538666|466112166|FG000|Treatment|Other reasons|8|||
129497935|NCT02538666|466112167|FG001|Treatment|Other reasons|15|||
129497936|NCT02538666|466112168|FG002|Treatment|Other reasons|5|||
129497937|NCT02538666|466112166|FG000|Treatment|Not reported|2|||
129497938|NCT02538666|466112167|FG001|Treatment|Not reported|2|||
129497939|NCT02538666|466112168|FG002|Treatment|Not reported|2|||
129497940|NCT04590937|466112169|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
129497941|NCT01555463|466112174|FG000|Treatment|Adverse Event|6|||
129497942|NCT01555463|466112175|FG001|Treatment|Adverse Event|12|||
129497943|NCT01555463|466112174|FG000|Treatment|Withdrawal by Subject|24|||
129497944|NCT01555463|466112175|FG001|Treatment|Withdrawal by Subject|36|||
129497945|NCT01555463|466112174|FG000|Treatment|Lost to Follow-up|28|||
129497946|NCT01555463|466112175|FG001|Treatment|Lost to Follow-up|23|||
129497947|NCT01555463|466112174|FG000|Treatment|Protocol Violation|4|||
129497948|NCT01555463|466112175|FG001|Treatment|Protocol Violation|5|||
129497949|NCT01555463|466112174|FG000|Treatment|Other reason|2|||
129497950|NCT01555463|466112175|FG001|Treatment|Other reason|3|||
129497951|NCT01555463|466112174|FG000|Follow up|Adverse Event|2|||
129497952|NCT01555463|466112175|FG001|Follow up|Adverse Event|5|||
129497953|NCT01555463|466112174|FG000|Follow up|Death|0|||
129497954|NCT01555463|466112175|FG001|Follow up|Death|1|||
129497955|NCT01555463|466112174|FG000|Follow up|Withdrawal by Subject|22|||
129497956|NCT01555463|466112175|FG001|Follow up|Withdrawal by Subject|22|||
129497957|NCT01555463|466112174|FG000|Follow up|Lost to Follow-up|9|||
129497958|NCT01555463|466112175|FG001|Follow up|Lost to Follow-up|10|||
129497959|NCT01555463|466112174|FG000|Follow up|Protocol Violation|2|||
129497960|NCT01555463|466112175|FG001|Follow up|Protocol Violation|4|||
129497961|NCT01555463|466112174|FG000|Follow up|Other reason|3|||
129497962|NCT01555463|466112175|FG001|Follow up|Other reason|3|||
129497963|NCT02026271|466112176|FG000|Overall Study|Adverse Event|2|||
129497964|NCT02026271|466112177|FG001|Overall Study|Adverse Event|3|||
129497965|NCT02026271|466112178|FG002|Overall Study|Adverse Event|2|||
129497966|NCT02026271|466112179|FG003|Overall Study|Adverse Event|3|||
129497967|NCT02026271|466112180|FG004|Overall Study|Adverse Event|0|||
129497968|NCT02026271|466112176|FG000|Overall Study|Withdrawal by Subject|0|||
129497969|NCT02026271|466112177|FG001|Overall Study|Withdrawal by Subject|0|||
129497970|NCT02026271|466112178|FG002|Overall Study|Withdrawal by Subject|0|||
129497971|NCT02026271|466112179|FG003|Overall Study|Withdrawal by Subject|0|||
129497972|NCT02026271|466112180|FG004|Overall Study|Withdrawal by Subject|1|||
129497973|NCT04370028|466112181|FG000|Overall Study|Withdrawal by Subject|695|||
129497974|NCT04370028|466112181|FG000|Overall Study|Protocol Violation|9|||
129497975|NCT04370028|466112181|FG000|Overall Study|Adverse Event|3|||
129497976|NCT04743635|466112182|FG000|Overall Study|Lost to Follow-up|2|||
129497977|NCT04743635|466112183|FG001|Overall Study|Lost to Follow-up|0|||
129497978|NCT03382899|466112184|FG000|Overall Study|Ineligibility Determined|0|||
129497979|NCT03382899|466112185|FG001|Overall Study|Ineligibility Determined|1|||
129497980|NCT03382899|466112184|FG000|Overall Study|Lost to Follow-up|0|||
129497981|NCT03382899|466112185|FG001|Overall Study|Lost to Follow-up|1|||
129497982|NCT03382899|466112184|FG000|Overall Study|Sponsor's decision|31|||
129497983|NCT03382899|466112185|FG001|Overall Study|Sponsor's decision|28|||
129497984|NCT03382899|466112184|FG000|Overall Study|Withdrawal by Subject|0|||
129497985|NCT03382899|466112185|FG001|Overall Study|Withdrawal by Subject|5|||
129497986|NCT00540449|466112186|FG000|Overall Study|Adverse Event|12|||
129497987|NCT00540449|466112187|FG001|Overall Study|Adverse Event|32|||
129497988|NCT00540449|466112186|FG000|Overall Study|Sponsor's Decision|1|||
129497989|NCT00540449|466112187|FG001|Overall Study|Sponsor's Decision|1|||
129497990|NCT00540449|466112186|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
129497991|NCT00540449|466112187|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
129497992|NCT00540449|466112186|FG000|Overall Study|Lost to Follow-up|19|||
129981475|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981476|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
129981477|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
129497993|NCT00540449|466112187|FG001|Overall Study|Lost to Follow-up|17|||
129497994|NCT00540449|466112186|FG000|Overall Study|Subject Non-Compliant|7|||
129497995|NCT00540449|466112187|FG001|Overall Study|Subject Non-Compliant|5|||
129497996|NCT00540449|466112186|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
129497997|NCT00540449|466112187|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
129497998|NCT00540449|466112186|FG000|Overall Study|Withdrawal by Subject|10|||
129497999|NCT00540449|466112187|FG001|Overall Study|Withdrawal by Subject|10|||
129498000|NCT00540449|466112186|FG000|Overall Study|Other|1|||
129498001|NCT00540449|466112187|FG001|Overall Study|Other|4|||
129498002|NCT02426658|466112188|FG000|Overall Study|Withdrawal by Subject|1|||
129498003|NCT02426658|466112188|FG000|Overall Study|Patient expired before treatment|2|||
129498004|NCT00524316|466112189|FG000|Overall Study|Withdrawal by Subject|2|||
129498005|NCT00524316|466112189|FG000|Overall Study|Adverse Event|7|||
129498006|NCT00524316|466112189|FG000|Overall Study|Disease Progression|7|||
129498007|NCT01199263|466112190|FG000|Overall Study|Ineligible|0|||
129498008|NCT01199263|466112191|FG001|Overall Study|Ineligible|2|||
129498009|NCT01199263|466112190|FG000|Overall Study|Never Treated|6|||
129498010|NCT01199263|466112191|FG001|Overall Study|Never Treated|0|||
129498011|NCT01402284|466112192|FG000|Overall Study|Withdrawal consent|2|||
129981478|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
129981479|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981480|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981481|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981482|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
129981483|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
129981484|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
129981485|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
129981486|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
129981487|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
129981488|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
129981489|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
129981490|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
129981491|NCT00833833|467894992|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981492|NCT00833833|467894993|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981493|NCT00833833|467894994|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981494|NCT00833833|467894995|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981495|NCT00833833|467894996|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
129981496|NCT00833833|467894997|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
129981497|NCT01994837|467894998|FG000|Overall Study|Progressive disease per protocol|23|||
129981498|NCT01994837|467894998|FG000|Overall Study|Adv event related to progressive disease|3|||
129981499|NCT01994837|467894998|FG000|Overall Study|Fatal progressive disease|2|||
129981500|NCT01994837|467894998|FG000|Overall Study|Adverse event not related to progression|1|||
129981501|NCT01994837|467894998|FG000|Overall Study|Chose palliative care|1|||
129981502|NCT01994837|467894998|FG000|Overall Study|Proceeded to transplant|1|||
129981503|NCT01994837|467894998|FG000|Overall Study|Removed from study due to no response|1|||
129981504|NCT01127893|467894999|FG000|Overall Study|Study Termination by the Sponsor|1|||
129981505|NCT00574873|467895000|FG000|Overall Study|Withdrawal by Subject|18|||
129981506|NCT00574873|467895001|FG001|Overall Study|Withdrawal by Subject|19|||
129981507|NCT00574873|467895000|FG000|Overall Study|Investigator request|18|||
129981508|NCT00574873|467895001|FG001|Overall Study|Investigator request|8|||
129981509|NCT00574873|467895000|FG000|Overall Study|Death|15|||
129981510|NCT00574873|467895001|FG001|Overall Study|Death|14|||
129981511|NCT00574873|467895000|FG000|Overall Study|Lost to Follow-up|14|||
129981512|NCT00574873|467895001|FG001|Overall Study|Lost to Follow-up|5|||
129981513|NCT00574873|467895000|FG000|Overall Study|Other|40|||
129981514|NCT00574873|467895001|FG001|Overall Study|Other|4|||
129981515|NCT00574873|467895000|FG000|Overall Study|Discontinuation of study by sponsor|5|||
129981516|NCT00574873|467895001|FG001|Overall Study|Discontinuation of study by sponsor|199|||
129981517|NCT00574873|467895000|FG000|Overall Study|Blank, site closed per local regulations|2|||
129981518|NCT00574873|467895001|FG001|Overall Study|Blank, site closed per local regulations|2|||
129981519|NCT00574873|467895000|FG000|Overall Study|Extension Study|126|||
129981520|NCT00574873|467895001|FG001|Overall Study|Extension Study|0|||
129981521|NCT03568318|467895007|FG000|Overall Study|Adverse Event|3|||
129981522|NCT03568318|467895008|FG001|Overall Study|Adverse Event|1|||
129981523|NCT03568318|467895009|FG002|Overall Study|Adverse Event|1|||
129981524|NCT03568318|467895010|FG003|Overall Study|Adverse Event|0|||
129981525|NCT03568318|467895011|FG004|Overall Study|Adverse Event|1|||
129981526|NCT03568318|467895012|FG005|Overall Study|Adverse Event|0|||
129981527|NCT03568318|467895007|FG000|Overall Study|Withdrawal by Subject|6|||
129981528|NCT03568318|467895008|FG001|Overall Study|Withdrawal by Subject|5|||
129981529|NCT03568318|467895009|FG002|Overall Study|Withdrawal by Subject|2|||
129498012|NCT01402284|466112192|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
129498013|NCT01402284|466112192|FG000|Overall Study|Physician Decision|1|||
129498014|NCT01402284|466112192|FG000|Overall Study|Disease progression on study|10|||
129498015|NCT02928406|466112193|FG000|Overall Study|Death|780|||
129498016|NCT02928406|466112193|FG000|Overall Study|Progressive disease|3|||
129498017|NCT02928406|466112193|FG000|Overall Study|Lost to Follow-up|49|||
129498018|NCT02928406|466112193|FG000|Overall Study|Non-compliance|2|||
129498019|NCT02928406|466112193|FG000|Overall Study|Withdrawal by Subject|40|||
129498020|NCT02928406|466112193|FG000|Overall Study|Study terminated by sponsor|57|||
129498021|NCT02928406|466112193|FG000|Overall Study|Physician Decision|1|||
129498022|NCT02928406|466112193|FG000|Overall Study|Various reasons|72|||
129498023|NCT05281523|466112198|FG000|Overall Study|Adverse Event|1|||
129981530|NCT03568318|467895010|FG003|Overall Study|Withdrawal by Subject|1|||
129981531|NCT03568318|467895011|FG004|Overall Study|Withdrawal by Subject|0|||
129981532|NCT03568318|467895012|FG005|Overall Study|Withdrawal by Subject|0|||
129981533|NCT03568318|467895007|FG000|Overall Study|Lost to Follow-up|3|||
129981534|NCT03568318|467895008|FG001|Overall Study|Lost to Follow-up|2|||
129981535|NCT03568318|467895009|FG002|Overall Study|Lost to Follow-up|2|||
129981536|NCT03568318|467895010|FG003|Overall Study|Lost to Follow-up|2|||
129498024|NCT05281523|466112199|FG001|Overall Study|Adverse Event|1|||
129498025|NCT05281523|466112198|FG000|Overall Study|Physician Decision|1|||
129498026|NCT05281523|466112199|FG001|Overall Study|Physician Decision|1|||
129498027|NCT05281523|466112198|FG000|Overall Study|Withdrawal by Subject|5|||
129498028|NCT05281523|466112199|FG001|Overall Study|Withdrawal by Subject|15|||
129498029|NCT05281523|466112198|FG000|Overall Study|GCP violations|3|||
129498030|NCT05281523|466112199|FG001|Overall Study|GCP violations|4|||
129498031|NCT05513391|466112200|FG000|Overall Study|Adverse Event|1|||
129498032|NCT05513391|466112201|FG001|Overall Study|Adverse Event|0|||
129498033|NCT05513391|466112200|FG000|Overall Study|Protocol Deviation|0|||
129498034|NCT05513391|466112201|FG001|Overall Study|Protocol Deviation|1|||
129498035|NCT05513391|466112200|FG000|Overall Study|Withdrawal by Subject|3|||
129498036|NCT05513391|466112201|FG001|Overall Study|Withdrawal by Subject|1|||
129498037|NCT05513391|466112200|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
129498038|NCT05513391|466112201|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
129498039|NCT05513391|466112200|FG000|Overall Study|Lost to Follow-up|0|||
129498040|NCT05513391|466112201|FG001|Overall Study|Lost to Follow-up|2|||
129498041|NCT04038255|466114213|FG000|Overall Study|Lost to Follow-up|0|||
129498042|NCT04038255|466114214|FG001|Overall Study|Lost to Follow-up|9|||
129498043|NCT04038255|466114215|FG002|Overall Study|Lost to Follow-up|5|||
129498044|NCT04038255|466114213|FG000|Overall Study|Withdrawal by Subject|0|||
129498045|NCT04038255|466114214|FG001|Overall Study|Withdrawal by Subject|0|||
129498046|NCT04038255|466114215|FG002|Overall Study|Withdrawal by Subject|1|||
129498047|NCT05183867|466114218|FG000|Overall Study|Withdrawal by Subject|3|||
129498048|NCT05183867|466114219|FG001|Overall Study|Withdrawal by Subject|2|||
129498049|NCT05183867|466114220|FG002|Overall Study|Withdrawal by Subject|0|||
129498050|NCT00492856|466114225|FG000|Induction|Adverse Event|2|||
129498051|NCT00492856|466114226|FG001|Induction|Adverse Event|0|||
129498052|NCT00492856|466114227|FG002|Induction|Adverse Event|0|||
129498053|NCT00492856|466114228|FG003|Induction|Adverse Event|0|||
129498054|NCT00492856|466114225|FG000|Induction|Withdrawal by Subject|1|||
129498055|NCT00492856|466114226|FG001|Induction|Withdrawal by Subject|0|||
129498056|NCT00492856|466114227|FG002|Induction|Withdrawal by Subject|0|||
129498057|NCT00492856|466114228|FG003|Induction|Withdrawal by Subject|0|||
129498058|NCT00492856|466114225|FG000|Induction|Death|3|||
129498059|NCT00492856|466114226|FG001|Induction|Death|0|||
129498060|NCT00492856|466114227|FG002|Induction|Death|0|||
129498061|NCT00492856|466114228|FG003|Induction|Death|0|||
129498062|NCT00492856|466114225|FG000|Consolidation|Adverse Event|6|||
129498063|NCT00492856|466114226|FG001|Consolidation|Adverse Event|0|||
129498064|NCT00492856|466114227|FG002|Consolidation|Adverse Event|0|||
129498065|NCT00492856|466114228|FG003|Consolidation|Adverse Event|0|||
129498066|NCT00492856|466114225|FG000|Consolidation|Not protocol specified|2|||
129498067|NCT00492856|466114226|FG001|Consolidation|Not protocol specified|0|||
129498068|NCT00492856|466114227|FG002|Consolidation|Not protocol specified|0|||
129498069|NCT00492856|466114228|FG003|Consolidation|Not protocol specified|0|||
129498070|NCT00492856|466114225|FG000|Consolidation|Lost to Follow-up|1|||
129498071|NCT00492856|466114226|FG001|Consolidation|Lost to Follow-up|0|||
129498072|NCT00492856|466114227|FG002|Consolidation|Lost to Follow-up|0|||
129498073|NCT00492856|466114228|FG003|Consolidation|Lost to Follow-up|0|||
129498074|NCT00492856|466114225|FG000|Post-consolidation|Adverse Event|0|||
129498075|NCT00492856|466114226|FG001|Post-consolidation|Adverse Event|4|||
129498076|NCT00492856|466114227|FG002|Post-consolidation|Adverse Event|0|||
129498077|NCT00492856|466114228|FG003|Post-consolidation|Adverse Event|1|||
129498078|NCT00492856|466114225|FG000|Post-consolidation|Withdrawal by Subject|0|||
129498079|NCT00492856|466114226|FG001|Post-consolidation|Withdrawal by Subject|4|||
129498080|NCT00492856|466114227|FG002|Post-consolidation|Withdrawal by Subject|0|||
129498081|NCT00492856|466114228|FG003|Post-consolidation|Withdrawal by Subject|0|||
129498082|NCT00492856|466114225|FG000|Post-consolidation|Death|0|||
129498083|NCT00492856|466114226|FG001|Post-consolidation|Death|1|||
129981537|NCT03568318|467895011|FG004|Overall Study|Lost to Follow-up|1|||
129498084|NCT00492856|466114227|FG002|Post-consolidation|Death|0|||
129498085|NCT00492856|466114228|FG003|Post-consolidation|Death|0|||
129498086|NCT00492856|466114225|FG000|Post-consolidation|Not protocol specified|0|||
129498087|NCT00492856|466114226|FG001|Post-consolidation|Not protocol specified|1|||
129498088|NCT00492856|466114227|FG002|Post-consolidation|Not protocol specified|0|||
129498089|NCT00492856|466114228|FG003|Post-consolidation|Not protocol specified|0|||
129498090|NCT00492856|466114225|FG000|Post-consolidation|Lost to Follow-up|0|||
129498091|NCT00492856|466114226|FG001|Post-consolidation|Lost to Follow-up|2|||
129498092|NCT00492856|466114227|FG002|Post-consolidation|Lost to Follow-up|0|||
129498093|NCT00492856|466114228|FG003|Post-consolidation|Lost to Follow-up|0|||
129498094|NCT00492856|466114225|FG000|Post-consolidation|Observation Arm|0|||
129498095|NCT00492856|466114226|FG001|Post-consolidation|Observation Arm|0|||
129498096|NCT00492856|466114227|FG002|Post-consolidation|Observation Arm|27|||
129981538|NCT03568318|467895012|FG005|Overall Study|Lost to Follow-up|0|||
129498097|NCT00492856|466114228|FG003|Post-consolidation|Observation Arm|0|||
129498098|NCT01520324|466114229|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
129498099|NCT03488472|466114230|FG000|Overall Study|disease progression additional mets|1|||
129498100|NCT00441441|466114234|FG000|Overall Study|Adverse Event|2|||
129498101|NCT00441441|466114235|FG001|Overall Study|Adverse Event|1|||
129498102|NCT00441441|466114234|FG000|Overall Study|Protocol Violation|4|||
129498103|NCT00441441|466114235|FG001|Overall Study|Protocol Violation|6|||
129498104|NCT00441441|466114234|FG000|Overall Study|Exacerbation of asthma|1|||
129498105|NCT00441441|466114235|FG001|Overall Study|Exacerbation of asthma|2|||
129498106|NCT00441441|466114234|FG000|Overall Study|Withdrawal by Subject|1|||
129498107|NCT00441441|466114235|FG001|Overall Study|Withdrawal by Subject|2|||
129498108|NCT00441441|466114234|FG000|Overall Study|Other|3|||
129498109|NCT00441441|466114235|FG001|Overall Study|Other|3|||
129498110|NCT00262080|466114236|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
129498111|NCT00262080|466114237|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129498112|NCT00262080|466114238|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
129498113|NCT00262080|466114236|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
129498114|NCT00262080|466114237|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
129498115|NCT00262080|466114238|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
129498116|NCT00262080|466114236|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
129498117|NCT00262080|466114237|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
129498118|NCT00262080|466114238|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
129498119|NCT00262080|466114236|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
129498120|NCT00262080|466114237|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
129498121|NCT00262080|466114238|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
129498122|NCT00262080|466114236|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
129498123|NCT00262080|466114237|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
129498124|NCT00262080|466114238|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
129498125|NCT00262080|466114236|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
129498126|NCT00262080|466114237|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
129498127|NCT00262080|466114238|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
129498128|NCT03100942|466114239|FG000|Randomized Treatment Period|Withdrew Consent|4|||
129498129|NCT03100942|466114240|FG001|Randomized Treatment Period|Withdrew Consent|5|||
129498130|NCT03100942|466114241|FG002|Randomized Treatment Period|Withdrew Consent|3|||
129498131|NCT03100942|466114242|FG003|Randomized Treatment Period|Withdrew Consent|3|||
129498132|NCT03100942|466114243|FG004|Randomized Treatment Period|Withdrew Consent|0|||
129498133|NCT03100942|466114244|FG005|Randomized Treatment Period|Withdrew Consent|0|||
129498134|NCT03100942|466114245|FG006|Randomized Treatment Period|Withdrew Consent|0|||
129498135|NCT03100942|466114239|FG000|Randomized Treatment Period|Adverse Event|5|||
129498136|NCT03100942|466114240|FG001|Randomized Treatment Period|Adverse Event|2|||
129498137|NCT03100942|466114241|FG002|Randomized Treatment Period|Adverse Event|1|||
129498138|NCT03100942|466114242|FG003|Randomized Treatment Period|Adverse Event|0|||
129498139|NCT03100942|466114243|FG004|Randomized Treatment Period|Adverse Event|0|||
129498140|NCT03100942|466114244|FG005|Randomized Treatment Period|Adverse Event|0|||
129498141|NCT03100942|466114245|FG006|Randomized Treatment Period|Adverse Event|0|||
129498142|NCT03100942|466114239|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
129498143|NCT03100942|466114240|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
129498144|NCT03100942|466114241|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
129498145|NCT03100942|466114242|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
129498146|NCT03100942|466114243|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
129498147|NCT03100942|466114244|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
129498148|NCT03100942|466114245|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
129498149|NCT03100942|466114239|FG000|Randomized Treatment Period|Protocol Violation|0|||
129498150|NCT03100942|466114240|FG001|Randomized Treatment Period|Protocol Violation|1|||
129498151|NCT03100942|466114241|FG002|Randomized Treatment Period|Protocol Violation|1|||
129498152|NCT03100942|466114242|FG003|Randomized Treatment Period|Protocol Violation|1|||
129498153|NCT03100942|466114243|FG004|Randomized Treatment Period|Protocol Violation|0|||
129498154|NCT03100942|466114244|FG005|Randomized Treatment Period|Protocol Violation|0|||
129498155|NCT03100942|466114245|FG006|Randomized Treatment Period|Protocol Violation|0|||
129498156|NCT03100942|466114239|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
129498157|NCT03100942|466114240|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
129498158|NCT03100942|466114241|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
129498159|NCT03100942|466114242|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
129498160|NCT03100942|466114243|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
129498161|NCT03100942|466114244|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
129498162|NCT03100942|466114245|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
129498163|NCT03100942|466114239|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
129498164|NCT03100942|466114240|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
129498165|NCT03100942|466114241|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
129498166|NCT03100942|466114242|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
129498167|NCT03100942|466114243|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
129498168|NCT03100942|466114244|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
129498169|NCT03100942|466114245|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
129498170|NCT03100942|466114239|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
129498171|NCT03100942|466114240|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
129498172|NCT03100942|466114241|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
129498173|NCT03100942|466114242|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
129498174|NCT03100942|466114243|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
129498175|NCT03100942|466114244|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
129498176|NCT03100942|466114245|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
129498177|NCT04009096|466114246|FG000|Overall Study|Withdrawal by Subject|0|||
129498178|NCT04009096|466114247|FG001|Overall Study|Withdrawal by Subject|7|||
129498179|NCT04009096|466114248|FG002|Overall Study|Withdrawal by Subject|0|||
129498180|NCT04009096|466114246|FG000|Overall Study|Physician Decision|0|||
129498181|NCT04009096|466114247|FG001|Overall Study|Physician Decision|1|||
129498182|NCT04009096|466114248|FG002|Overall Study|Physician Decision|0|||
129498183|NCT05151471|466114249|FG000|Overall Study|Adverse Event|21|||
129498184|NCT05151471|466114250|FG001|Overall Study|Adverse Event|16|||
129498185|NCT05151471|466114249|FG000|Overall Study|Death|1|||
129498186|NCT05151471|466114250|FG001|Overall Study|Death|0|||
129498187|NCT05151471|466114249|FG000|Overall Study|Lost to Follow-up|0|||
129498188|NCT05151471|466114250|FG001|Overall Study|Lost to Follow-up|1|||
129498189|NCT05151471|466114249|FG000|Overall Study|Withdrawal by Subject|7|||
129498190|NCT05151471|466114250|FG001|Overall Study|Withdrawal by Subject|9|||
129498191|NCT05151471|466114249|FG000|Overall Study|Study terminated by sponsor|49|||
129498192|NCT05151471|466114250|FG001|Overall Study|Study terminated by sponsor|47|||
129498193|NCT05151471|466114249|FG000|Overall Study|Other|2|||
129498194|NCT05151471|466114250|FG001|Overall Study|Other|1|||
129498195|NCT04263142|466114251|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
129498196|NCT04263142|466114252|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
129498197|NCT04263142|466114253|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
129498198|NCT04263142|466114254|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
129498199|NCT04263142|466114255|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
129498200|NCT04263142|466114251|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
129498201|NCT04263142|466114252|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
129498202|NCT04263142|466114253|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
129498203|NCT04263142|466114254|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
129498204|NCT04263142|466114255|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
129498205|NCT00769704|466114256|FG000|Overall Study|Lost to Follow-up|3|||
129498206|NCT00769704|466114257|FG001|Overall Study|Lost to Follow-up|2|||
129498207|NCT00769704|466114256|FG000|Overall Study|Death|95|||
129498208|NCT00769704|466114257|FG001|Overall Study|Death|190|||
129498209|NCT00769704|466114256|FG000|Overall Study|Withdrawal by Subject|12|||
129498210|NCT00769704|466114257|FG001|Overall Study|Withdrawal by Subject|5|||
129498211|NCT00769704|466114256|FG000|Overall Study|Other|1|||
129498212|NCT00769704|466114257|FG001|Overall Study|Other|2|||
129498213|NCT04346628|466114262|FG000|Overall Study|Lost to Follow-up|4|||
129498214|NCT04346628|466114263|FG001|Overall Study|Lost to Follow-up|4|||
129498215|NCT04346628|466114262|FG000|Overall Study|Withdrew (had personal reasons)|2|||
129498216|NCT04346628|466114263|FG001|Overall Study|Withdrew (had personal reasons)|5|||
129498217|NCT04346628|466114262|FG000|Overall Study|Withdrew (medication intolerant)|0|||
129498218|NCT04346628|466114263|FG001|Overall Study|Withdrew (medication intolerant)|3|||
129498219|NCT04346628|466114262|FG000|Overall Study|Withdrew (declined intervention)|0|||
129498220|NCT04346628|466114263|FG001|Overall Study|Withdrew (declined intervention)|1|||
129498221|NCT03456713|466114267|FG000|Overall Study|Lost to Follow-up|1|||
129498222|NCT03456713|466114268|FG001|Overall Study|Lost to Follow-up|0|||
129498223|NCT03456713|466114269|FG002|Overall Study|Lost to Follow-up|0|||
129498224|NCT03456713|466114270|FG003|Overall Study|Lost to Follow-up|0|||
129498225|NCT01263691|466114274|FG000|Overall Study|Lost to Follow-up|1|||
129498226|NCT01263691|466114275|FG001|Overall Study|Lost to Follow-up|0|||
129498227|NCT01263691|466114276|FG002|Overall Study|Lost to Follow-up|1|||
129498228|NCT01263691|466114277|FG003|Overall Study|Lost to Follow-up|1|||
129498229|NCT01263691|466114278|FG004|Overall Study|Lost to Follow-up|0|||
129498230|NCT01263691|466114279|FG005|Overall Study|Lost to Follow-up|0|||
129498231|NCT01263691|466114274|FG000|Overall Study|Withdrawal by Subject|1|||
129498232|NCT01263691|466114275|FG001|Overall Study|Withdrawal by Subject|0|||
129498233|NCT01263691|466114276|FG002|Overall Study|Withdrawal by Subject|0|||
129498234|NCT01263691|466114277|FG003|Overall Study|Withdrawal by Subject|0|||
129498235|NCT01263691|466114278|FG004|Overall Study|Withdrawal by Subject|0|||
129498236|NCT01263691|466114279|FG005|Overall Study|Withdrawal by Subject|0|||
129498237|NCT01263691|466114274|FG000|Overall Study|Adverse Event|1|||
129498238|NCT01263691|466114275|FG001|Overall Study|Adverse Event|0|||
129498239|NCT01263691|466114276|FG002|Overall Study|Adverse Event|0|||
129498240|NCT01263691|466114277|FG003|Overall Study|Adverse Event|0|||
129498241|NCT01263691|466114278|FG004|Overall Study|Adverse Event|0|||
129981539|NCT03568318|467895007|FG000|Overall Study|Other|3|||
129498242|NCT01263691|466114279|FG005|Overall Study|Adverse Event|0|||
129498243|NCT01428063|466114281|FG000|Overall Study|Lack of Efficacy|8|||
129498244|NCT01428063|466114282|FG001|Overall Study|Lack of Efficacy|4|||
129498245|NCT01428063|466114283|FG002|Overall Study|Lack of Efficacy|1|||
129981540|NCT03568318|467895008|FG001|Overall Study|Other|1|||
129498246|NCT01428063|466114281|FG000|Overall Study|Adverse Event|2|||
129498247|NCT01428063|466114282|FG001|Overall Study|Adverse Event|3|||
129498248|NCT01428063|466114283|FG002|Overall Study|Adverse Event|0|||
129498249|NCT01428063|466114281|FG000|Overall Study|Lost to Follow-up|0|||
129498250|NCT01428063|466114282|FG001|Overall Study|Lost to Follow-up|2|||
129498251|NCT01428063|466114283|FG002|Overall Study|Lost to Follow-up|0|||
129498252|NCT01428063|466114281|FG000|Overall Study|No longer meets study criteria|0|||
129498253|NCT01428063|466114282|FG001|Overall Study|No longer meets study criteria|1|||
129498254|NCT01428063|466114283|FG002|Overall Study|No longer meets study criteria|0|||
129498255|NCT02284906|466114284|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129498256|NCT02284906|466114285|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
129498257|NCT02284906|466114286|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129498258|NCT02284906|466114284|FG000|Overall Study|Major Protocol Deviation|0|||
129498259|NCT02284906|466114285|FG001|Overall Study|Major Protocol Deviation|1|||
129498260|NCT02284906|466114286|FG002|Overall Study|Major Protocol Deviation|0|||
129498261|NCT02284906|466114284|FG000|Overall Study|Voluntary Withdrawal|2|||
129498262|NCT02284906|466114285|FG001|Overall Study|Voluntary Withdrawal|4|||
129981541|NCT03568318|467895009|FG002|Overall Study|Other|3|||
129981542|NCT03568318|467895010|FG003|Overall Study|Other|0|||
129981543|NCT03568318|467895011|FG004|Overall Study|Other|0|||
129981544|NCT03568318|467895012|FG005|Overall Study|Other|0|||
129981545|NCT03568318|467895007|FG000|Overall Study|Ongoing at Time of Analysis|5|||
129981546|NCT03568318|467895008|FG001|Overall Study|Ongoing at Time of Analysis|3|||
129981547|NCT03568318|467895009|FG002|Overall Study|Ongoing at Time of Analysis|2|||
129981548|NCT03568318|467895010|FG003|Overall Study|Ongoing at Time of Analysis|1|||
129981549|NCT03568318|467895011|FG004|Overall Study|Ongoing at Time of Analysis|0|||
129981550|NCT03568318|467895012|FG005|Overall Study|Ongoing at Time of Analysis|0|||
129981551|NCT01638429|467895015|FG000|Overall Study|Withdrawal by Subject|1|||
129981552|NCT03207451|467895016|FG000|Overall Study|scheduling conflict|1|||
129981553|NCT03207451|467895017|FG001|Overall Study|scheduling conflict|0|||
129981554|NCT03207451|467895018|FG002|Overall Study|scheduling conflict|2|||
129981555|NCT03207451|467895019|FG003|Overall Study|scheduling conflict|2|||
129981556|NCT03207451|467895016|FG000|Overall Study|Adverse Event|0|||
129981557|NCT03207451|467895017|FG001|Overall Study|Adverse Event|0|||
129981558|NCT03207451|467895018|FG002|Overall Study|Adverse Event|0|||
129981559|NCT03207451|467895019|FG003|Overall Study|Adverse Event|1|||
129981560|NCT02040584|467895021|FG000|Overall Study|Adverse Event|13|||
129981561|NCT02040584|467895022|FG001|Overall Study|Adverse Event|6|||
129981562|NCT02040584|467895021|FG000|Overall Study|Protocol Violation|9|||
129981563|NCT02040584|467895022|FG001|Overall Study|Protocol Violation|11|||
129981564|NCT02040584|467895021|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
129981565|NCT02040584|467895022|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
129981566|NCT02040584|467895021|FG000|Overall Study|Death|6|||
129981567|NCT02040584|467895022|FG001|Overall Study|Death|3|||
129981568|NCT02040584|467895021|FG000|Overall Study|Transplant rejection/retransplant|0|||
129981569|NCT02040584|467895022|FG001|Overall Study|Transplant rejection/retransplant|1|||
129981570|NCT02040584|467895021|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
129981571|NCT02040584|467895022|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
129981572|NCT01802567|467895023|FG000|Overall Study|Withdrawal by Subject|2|||
129981573|NCT01802567|467895023|FG000|Overall Study|Physician Decision|1|||
129981574|NCT01802567|467895023|FG000|Overall Study|Lack of Efficacy|7|||
129981575|NCT01802567|467895023|FG000|Overall Study|Consented but did not start therapy|7|||
129981576|NCT01802567|467895023|FG000|Overall Study|Protocol Violation|1|||
129981577|NCT03167359|467895026|FG000|Overall Study|Physician Decision|1|||
129981578|NCT03167359|467895026|FG000|Overall Study|Lost to Follow-up|1|||
129981579|NCT03339583|467895027|FG000|First Intervention (14 Days)|Adverse Event|1|||
129981580|NCT03339583|467895028|FG001|First Intervention (14 Days)|Adverse Event|0|||
129981581|NCT03339583|467895027|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
129981582|NCT03339583|467895028|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
129981583|NCT03339583|467895027|FG000|Second Intervention (14 Days)|Adverse Event|0|||
129981584|NCT03339583|467895028|FG001|Second Intervention (14 Days)|Adverse Event|1|||
129498263|NCT02284906|466114286|FG002|Overall Study|Voluntary Withdrawal|5|||
129498264|NCT02284906|466114284|FG000|Overall Study|Study Termination|0|||
129498265|NCT02284906|466114285|FG001|Overall Study|Study Termination|11|||
129498266|NCT02284906|466114286|FG002|Overall Study|Study Termination|14|||
129498267|NCT02284906|466114284|FG000|Overall Study|Reason not Specified|1|||
129498268|NCT02284906|466114285|FG001|Overall Study|Reason not Specified|1|||
129981585|NCT03339583|467895027|FG000|Follow-up (14 Days)|Physician Decision|6|||
129981586|NCT03339583|467895028|FG001|Follow-up (14 Days)|Physician Decision|3|||
129981587|NCT01896557|467895029|FG000|Clopidogrel Alone|Adverse Event|1|||
129981588|NCT01896557|467895030|FG001|Clopidogrel Alone|Adverse Event|0|||
129981589|NCT01896557|467895029|FG000|Clopidogrel + GI Protector|low adherence|1|||
129981590|NCT01896557|467895030|FG001|Clopidogrel + GI Protector|low adherence|1|||
129981591|NCT01896557|467895029|FG000|Clopidogrel + GI Protector|Reading error|1|||
129981592|NCT01896557|467895030|FG001|Clopidogrel + GI Protector|Reading error|3|||
129981593|NCT00734591|467895031|FG000|Screening for Prospective Period|Site did not participate|1604|||
129498269|NCT02284906|466114286|FG002|Overall Study|Reason not Specified|0|||
129498270|NCT00850759|466114287|FG000|Overall Study|Lost to Follow-up|7|||
129498271|NCT00850759|466114288|FG001|Overall Study|Lost to Follow-up|5|||
129498272|NCT00850759|466114289|FG002|Overall Study|Lost to Follow-up|5|||
129498273|NCT00850759|466114290|FG003|Overall Study|Lost to Follow-up|3|||
129498274|NCT00532948|466114291|FG000|Overall Study|Protocol Violation|1|||
129498275|NCT00532948|466114292|FG001|Overall Study|Protocol Violation|0|||
129498276|NCT00532948|466114293|FG002|Overall Study|Protocol Violation|0|||
129498277|NCT00532948|466114291|FG000|Overall Study|Death|3|||
129498278|NCT00532948|466114292|FG001|Overall Study|Death|3|||
129498279|NCT00532948|466114293|FG002|Overall Study|Death|4|||
129498280|NCT00532948|466114291|FG000|Overall Study|Violation of selection criteria at entry|0|||
129498281|NCT00532948|466114292|FG001|Overall Study|Violation of selection criteria at entry|1|||
129498282|NCT00532948|466114293|FG002|Overall Study|Violation of selection criteria at entry|0|||
129498283|NCT00532948|466114291|FG000|Overall Study|Failure to return|0|||
129498284|NCT00532948|466114292|FG001|Overall Study|Failure to return|1|||
129498285|NCT00532948|466114293|FG002|Overall Study|Failure to return|0|||
129498286|NCT01753076|466114294|FG000|Overall Study|Adverse Event|17|||
129498287|NCT01753076|466114295|FG001|Overall Study|Adverse Event|18|||
129498288|NCT01753076|466114294|FG000|Overall Study|Lack of Efficacy|3|||
129498289|NCT01753076|466114295|FG001|Overall Study|Lack of Efficacy|1|||
129498290|NCT01753076|466114294|FG000|Overall Study|Lost to Follow-up|2|||
129498291|NCT01753076|466114295|FG001|Overall Study|Lost to Follow-up|1|||
129498292|NCT01753076|466114294|FG000|Overall Study|Physician Decision|4|||
129498293|NCT01753076|466114295|FG001|Overall Study|Physician Decision|2|||
129498294|NCT01753076|466114294|FG000|Overall Study|Withdrawal by Subject|14|||
129498295|NCT01753076|466114295|FG001|Overall Study|Withdrawal by Subject|24|||
129498296|NCT01753076|466114294|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
129498297|NCT01753076|466114295|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
129498298|NCT02575079|466114296|FG000|Overall Study|Death|3|||
129498299|NCT02575079|466114297|FG001|Overall Study|Death|0|||
129498300|NCT02575079|466114296|FG000|Overall Study|Withdrawal by Subject|3|||
129498301|NCT02575079|466114297|FG001|Overall Study|Withdrawal by Subject|0|||
129498302|NCT02918266|466114298|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
129498303|NCT02918266|466114299|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498304|NCT02918266|466114300|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498305|NCT02918266|466114301|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498306|NCT02918266|466114302|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498307|NCT02918266|466114303|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498308|NCT02918266|466114304|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
129498309|NCT02918266|466114305|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498310|NCT02918266|466114306|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
129498311|NCT02918266|466114307|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498312|NCT02918266|466114308|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
129498313|NCT01259856|466114315|FG000|Overall Study|Adverse Event|12|||
129498314|NCT01259856|466114316|FG001|Overall Study|Adverse Event|9|||
129498315|NCT01259856|466114315|FG000|Overall Study|Death|0|||
129498316|NCT01259856|466114316|FG001|Overall Study|Death|1|||
129498317|NCT01259856|466114315|FG000|Overall Study|Lack of Efficacy|3|||
129498318|NCT01259856|466114316|FG001|Overall Study|Lack of Efficacy|1|||
129498319|NCT01259856|466114315|FG000|Overall Study|Lost to Follow-up|1|||
129498320|NCT01259856|466114316|FG001|Overall Study|Lost to Follow-up|1|||
129498321|NCT01259856|466114315|FG000|Overall Study|Physician Decision|2|||
129498322|NCT01259856|466114316|FG001|Overall Study|Physician Decision|1|||
129498323|NCT01259856|466114315|FG000|Overall Study|Withdrawal by Subject|9|||
129498324|NCT01259856|466114316|FG001|Overall Study|Withdrawal by Subject|10|||
129498325|NCT01259856|466114315|FG000|Overall Study|Treatment never started|0|||
129498326|NCT01259856|466114316|FG001|Overall Study|Treatment never started|6|||
129498327|NCT01259856|466114315|FG000|Overall Study|Study closure by sponsor|40|||
129498328|NCT01259856|466114316|FG001|Overall Study|Study closure by sponsor|41|||
129498329|NCT01259856|466114315|FG000|Overall Study|Patient developed other disease|0|||
129498330|NCT01259856|466114316|FG001|Overall Study|Patient developed other disease|1|||
129498331|NCT01259856|466114315|FG000|Overall Study|Transfer to another study|0|||
129498332|NCT01259856|466114316|FG001|Overall Study|Transfer to another study|1|||
129498333|NCT01259856|466114315|FG000|Overall Study|Unknown/missing|2|||
129498334|NCT01259856|466114316|FG001|Overall Study|Unknown/missing|2|||
129498335|NCT00788775|466114317|FG000|Overall Study|Progressive Disease|8|||
129498336|NCT00788775|466114318|FG001|Overall Study|Progressive Disease|6|||
129498337|NCT00788775|466114317|FG000|Overall Study|Withdrawal by Subject|0|||
129498338|NCT00788775|466114318|FG001|Overall Study|Withdrawal by Subject|2|||
129498339|NCT00788775|466114317|FG000|Overall Study|Patient Non-Compliance|1|||
129498340|NCT00788775|466114318|FG001|Overall Study|Patient Non-Compliance|0|||
129498341|NCT00788775|466114317|FG000|Overall Study|Patient's measurable disease resected.|1|||
129498342|NCT00788775|466114318|FG001|Overall Study|Patient's measurable disease resected.|0|||
129498343|NCT00578864|466114319|FG000|Overall Study|Death|1|||
129498344|NCT00578864|466114320|FG001|Overall Study|Death|0|||
129498345|NCT01253044|466114325|FG000|Overall Study|Lost to Follow-up|38|||
129498346|NCT01253044|466114326|FG001|Overall Study|Lost to Follow-up|29|||
129498347|NCT01087528|466114327|FG000|Overall Study|Withdrawal by Subject|1|||
129498348|NCT01087528|466114327|FG000|Overall Study|Incomplete CE procedure|6|||
129498349|NCT00905307|466114332|FG000|Overall Study|Switched to Open Label Rescue|7|||
129498350|NCT00905307|466114333|FG001|Overall Study|Switched to Open Label Rescue|17|||
129498351|NCT00905307|466114334|FG002|Overall Study|Switched to Open Label Rescue|11|||
129498352|NCT00905307|466114335|FG003|Overall Study|Switched to Open Label Rescue|11|||
129498353|NCT00905307|466114336|FG004|Overall Study|Switched to Open Label Rescue|4|||
129498354|NCT00905307|466114337|FG005|Overall Study|Switched to Open Label Rescue|15|||
129498355|NCT00905307|466114332|FG000|Overall Study|Lost to Follow-up|0|||
129498356|NCT00905307|466114333|FG001|Overall Study|Lost to Follow-up|0|||
129498357|NCT00905307|466114334|FG002|Overall Study|Lost to Follow-up|0|||
129498358|NCT00905307|466114335|FG003|Overall Study|Lost to Follow-up|0|||
129498359|NCT00905307|466114336|FG004|Overall Study|Lost to Follow-up|1|||
129498360|NCT00905307|466114337|FG005|Overall Study|Lost to Follow-up|1|||
129498361|NCT00905307|466114332|FG000|Overall Study|Adverse Event|3|||
129498362|NCT00905307|466114333|FG001|Overall Study|Adverse Event|4|||
129498363|NCT00905307|466114334|FG002|Overall Study|Adverse Event|5|||
129498364|NCT00905307|466114335|FG003|Overall Study|Adverse Event|11|||
129498365|NCT00905307|466114336|FG004|Overall Study|Adverse Event|3|||
129498366|NCT00905307|466114337|FG005|Overall Study|Adverse Event|5|||
129498367|NCT00905307|466114332|FG000|Overall Study|Withdrawal by Subject|5|||
129498368|NCT00905307|466114333|FG001|Overall Study|Withdrawal by Subject|13|||
129498369|NCT00905307|466114334|FG002|Overall Study|Withdrawal by Subject|15|||
129498370|NCT00905307|466114335|FG003|Overall Study|Withdrawal by Subject|11|||
129498371|NCT00905307|466114336|FG004|Overall Study|Withdrawal by Subject|4|||
129498372|NCT00905307|466114337|FG005|Overall Study|Withdrawal by Subject|13|||
129498373|NCT00905307|466114332|FG000|Overall Study|Protocol Violation|1|||
129498374|NCT00905307|466114333|FG001|Overall Study|Protocol Violation|0|||
129498375|NCT00905307|466114334|FG002|Overall Study|Protocol Violation|1|||
129498376|NCT00905307|466114335|FG003|Overall Study|Protocol Violation|0|||
129981594|NCT00734591|467895032|FG001|Screening for Prospective Period|Site did not participate|1488|||
129981595|NCT00734591|467895031|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
129981596|NCT00734591|467895032|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
129981597|NCT00734591|467895031|FG000|Prospective Period|Withdrawal by Subject|11|||
129981598|NCT00734591|467895032|FG001|Prospective Period|Withdrawal by Subject|9|||
129981599|NCT00734591|467895031|FG000|Prospective Period|Lost to Follow-up|37|||
129981600|NCT00734591|467895032|FG001|Prospective Period|Lost to Follow-up|33|||
129981601|NCT00734591|467895031|FG000|Prospective Period|Study Terminated|1|||
129981602|NCT00734591|467895032|FG001|Prospective Period|Study Terminated|0|||
129981603|NCT00734591|467895031|FG000|Prospective Period|Other|2|||
129981604|NCT00734591|467895032|FG001|Prospective Period|Other|2|||
129981605|NCT02236988|467895033|FG000|Overall Study|Lost to Follow-up|0|||
129981606|NCT02236988|467895034|FG001|Overall Study|Lost to Follow-up|0|||
129981607|NCT02236988|467895035|FG002|Overall Study|Lost to Follow-up|0|||
129981608|NCT02236988|467895036|FG003|Overall Study|Lost to Follow-up|1|||
129981609|NCT02236988|467895033|FG000|Overall Study|Unable to Comply with Study Visits|0|||
129981610|NCT02236988|467895034|FG001|Overall Study|Unable to Comply with Study Visits|0|||
129981611|NCT02236988|467895035|FG002|Overall Study|Unable to Comply with Study Visits|0|||
129981612|NCT02236988|467895036|FG003|Overall Study|Unable to Comply with Study Visits|2|||
129981613|NCT04032613|467895037|FG000|Overall Study|Did not complete post-program assessment|5|||
129981614|NCT04032613|467895038|FG001|Overall Study|Did not complete post-program assessment|2|||
129981615|NCT01659853|467895039|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
129981616|NCT01659853|467895040|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
129981617|NCT01659853|467895039|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
129981618|NCT01659853|467895040|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
129981619|NCT03053518|467895043|FG000|Overall Study|Withdrawal by Subject|3|||
129981620|NCT03053518|467895043|FG000|Overall Study|Lost to Follow-up|2|||
129981621|NCT03053518|467895043|FG000|Overall Study|Ineligible|5|||
129498377|NCT00905307|466114336|FG004|Overall Study|Protocol Violation|0|||
129498378|NCT00905307|466114337|FG005|Overall Study|Protocol Violation|0|||
129498379|NCT00905307|466114332|FG000|Overall Study|Lack of Efficacy|6|||
129498380|NCT00905307|466114333|FG001|Overall Study|Lack of Efficacy|3|||
129498381|NCT00905307|466114334|FG002|Overall Study|Lack of Efficacy|5|||
129498382|NCT00905307|466114335|FG003|Overall Study|Lack of Efficacy|4|||
129498383|NCT00905307|466114336|FG004|Overall Study|Lack of Efficacy|4|||
129498384|NCT00905307|466114337|FG005|Overall Study|Lack of Efficacy|8|||
129498385|NCT04060667|466114338|FG000|Overall Study|Lost to Follow-up|75|||
129498386|NCT04060667|466114339|FG001|Overall Study|Lost to Follow-up|10|||
129498387|NCT02702193|466114340|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
129498388|NCT02702193|466114341|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
129498389|NCT02702193|466114340|FG000|4 Month Follow up|Withdrawal by Subject|1|||
129981622|NCT02071290|467895044|FG000|Overall Study|Death|1|||
129981623|NCT02071290|467895045|FG001|Overall Study|Death|0|||
129981624|NCT02071290|467895044|FG000|Overall Study|Withdrawal by Subject|0|||
129498390|NCT02702193|466114341|FG001|4 Month Follow up|Withdrawal by Subject|0|||
129498391|NCT02702193|466114340|FG000|4 Month Follow up|Lost to Follow-up|17|||
129498392|NCT02702193|466114341|FG001|4 Month Follow up|Lost to Follow-up|18|||
129498393|NCT02702193|466114340|FG000|8 Month Follow up|Withdrawal by Subject|1|||
129498394|NCT02702193|466114341|FG001|8 Month Follow up|Withdrawal by Subject|0|||
129498395|NCT02702193|466114340|FG000|8 Month Follow up|Lost to Follow-up|14|||
129498396|NCT02702193|466114341|FG001|8 Month Follow up|Lost to Follow-up|18|||
129498397|NCT02702193|466114340|FG000|12 Month Follow up|Withdrawal by Subject|1|||
129498398|NCT02702193|466114341|FG001|12 Month Follow up|Withdrawal by Subject|0|||
129498399|NCT02702193|466114340|FG000|12 Month Follow up|Lost to Follow-up|16|||
129498400|NCT02702193|466114341|FG001|12 Month Follow up|Lost to Follow-up|18|||
129498401|NCT01035255|466114346|FG000|Overall Study|Death|724|||
129498402|NCT01035255|466114347|FG001|Overall Study|Death|844|||
129498403|NCT01035255|466114346|FG000|Overall Study|Lost to Follow-up|2|||
129498404|NCT01035255|466114347|FG001|Overall Study|Lost to Follow-up|5|||
129498405|NCT01035255|466114346|FG000|Overall Study|patient's request|15|||
129498406|NCT01035255|466114347|FG001|Overall Study|patient's request|13|||
129498407|NCT00740779|466114348|FG000|Overall Study|Adverse Event|4|||
129498408|NCT00740779|466114349|FG001|Overall Study|Adverse Event|6|||
129498409|NCT00740779|466114350|FG002|Overall Study|Adverse Event|3|||
129498410|NCT00740779|466114348|FG000|Overall Study|Protocol Violation|1|||
129498411|NCT00740779|466114349|FG001|Overall Study|Protocol Violation|1|||
129498412|NCT00740779|466114350|FG002|Overall Study|Protocol Violation|1|||
129498413|NCT00740779|466114348|FG000|Overall Study|Lack of Efficacy|0|||
129498414|NCT00740779|466114349|FG001|Overall Study|Lack of Efficacy|0|||
129498415|NCT00740779|466114350|FG002|Overall Study|Lack of Efficacy|2|||
129498416|NCT00740779|466114348|FG000|Overall Study|Withdrawal by Subject|2|||
129498417|NCT00740779|466114349|FG001|Overall Study|Withdrawal by Subject|4|||
129498418|NCT00740779|466114350|FG002|Overall Study|Withdrawal by Subject|2|||
129498419|NCT00740779|466114348|FG000|Overall Study|Lost to Follow-up|2|||
129498420|NCT00740779|466114349|FG001|Overall Study|Lost to Follow-up|3|||
129498421|NCT00740779|466114350|FG002|Overall Study|Lost to Follow-up|5|||
129498422|NCT02399813|466114353|FG000|Overall Study|Progressive Disease-Radiographic|2|||
129498423|NCT02399813|466114353|FG000|Overall Study|Death|20|||
129498424|NCT02399813|466114353|FG000|Overall Study|Withdrawal by Subject|3|||
129498425|NCT02399813|466114353|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
129498426|NCT02399813|466114353|FG000|Overall Study|Lost to Follow-up|2|||
129498427|NCT02399813|466114353|FG000|Overall Study|Other than specified|5|||
129498428|NCT00988559|466114354|FG000|Overall Study|Withdrawal by Subject|1|||
129498429|NCT00988559|466114355|FG001|Overall Study|Withdrawal by Subject|1|||
129498430|NCT00988559|466114356|FG002|Overall Study|Withdrawal by Subject|0|||
129498431|NCT00988559|466114357|FG003|Overall Study|Withdrawal by Subject|1|||
129498432|NCT00988559|466114354|FG000|Overall Study|Pregnancy|0|||
129498433|NCT00988559|466114355|FG001|Overall Study|Pregnancy|1|||
129498434|NCT00988559|466114356|FG002|Overall Study|Pregnancy|1|||
129498435|NCT00988559|466114357|FG003|Overall Study|Pregnancy|0|||
129498436|NCT00988559|466114354|FG000|Overall Study|Lost to Follow-up|0|||
129498437|NCT00988559|466114355|FG001|Overall Study|Lost to Follow-up|0|||
129498438|NCT00988559|466114356|FG002|Overall Study|Lost to Follow-up|1|||
129498439|NCT00988559|466114357|FG003|Overall Study|Lost to Follow-up|0|||
129498440|NCT03007953|466114358|FG000|Overall Study|Withdrawal by Subject|5|||
129498441|NCT03007953|466114359|FG001|Overall Study|Withdrawal by Subject|2|||
129498442|NCT03007953|466114358|FG000|Overall Study|Death|5|||
129498443|NCT03007953|466114359|FG001|Overall Study|Death|7|||
129498444|NCT03007953|466114358|FG000|Overall Study|Lost to Follow-up|3|||
129498445|NCT03007953|466114359|FG001|Overall Study|Lost to Follow-up|2|||
129498446|NCT03007953|466114358|FG000|Overall Study|Enrolled in Hospice|3|||
129498447|NCT03007953|466114359|FG001|Overall Study|Enrolled in Hospice|2|||
129498448|NCT03196297|466114360|FG000|Main Period|Withdrawal by Subject|4|||
129498449|NCT03196297|466114360|FG000|Extension Period|Withdrawal by Subject|1|||
129981625|NCT02071290|467895045|FG001|Overall Study|Withdrawal by Subject|1|||
129981626|NCT02071290|467895044|FG000|Overall Study|Protocol Violation|3|||
129498450|NCT03196297|466114360|FG000|Extension Period|Lack of Efficacy|2|||
129498451|NCT03345836|466114361|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
129498452|NCT03345836|466114362|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
129498453|NCT03345836|466114363|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
129498454|NCT03345836|466114364|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
129498455|NCT03345836|466114365|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
129498456|NCT03345836|466114366|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
129498457|NCT03345836|466114361|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
129498458|NCT03345836|466114362|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
129498459|NCT03345836|466114363|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
129498460|NCT03345836|466114364|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
129498461|NCT03345836|466114365|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
129498462|NCT03345836|466114366|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
129498463|NCT03345836|466114361|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
129498464|NCT03345836|466114362|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
129498465|NCT03345836|466114363|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
129498466|NCT03345836|466114364|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
129498467|NCT03345836|466114365|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
129498468|NCT03345836|466114366|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
129498469|NCT03345836|466114361|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
129498470|NCT03345836|466114362|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
129498471|NCT03345836|466114363|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
129498472|NCT03345836|466114364|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
129498473|NCT03345836|466114365|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
129498474|NCT03345836|466114366|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
129498475|NCT03345836|466114361|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
129498476|NCT03345836|466114362|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
129498477|NCT03345836|466114363|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
129498478|NCT03345836|466114364|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
129498479|NCT03345836|466114365|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
129498480|NCT03345836|466114366|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
129498481|NCT03345836|466114361|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
129498482|NCT03345836|466114362|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
129498483|NCT03345836|466114363|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
129498484|NCT03345836|466114364|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
129498485|NCT03345836|466114365|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
129498486|NCT03345836|466114366|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
129498487|NCT03345836|466114361|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
129498488|NCT03345836|466114362|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
129498489|NCT03345836|466114363|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
129498490|NCT03345836|466114364|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
129498491|NCT03345836|466114365|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
129498492|NCT03345836|466114366|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
129498493|NCT03345836|466114361|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
129498494|NCT03345836|466114362|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
129498495|NCT03345836|466114363|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
129498496|NCT03345836|466114364|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
129498497|NCT03345836|466114365|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
129498498|NCT03345836|466114366|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
129498499|NCT03345836|466114361|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
129498500|NCT03345836|466114362|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
129498501|NCT03345836|466114363|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
129498502|NCT03345836|466114364|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
129498503|NCT03345836|466114365|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
129498504|NCT03345836|466114366|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
129498505|NCT03345836|466114361|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
129498506|NCT03345836|466114362|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
129498507|NCT03345836|466114363|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
129498508|NCT03345836|466114364|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
129498509|NCT03345836|466114365|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
129498510|NCT03345836|466114366|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
129498511|NCT03345836|466114361|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
129498512|NCT03345836|466114362|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
129498513|NCT03345836|466114363|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
129498514|NCT03345836|466114364|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
129498515|NCT03345836|466114365|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
129498516|NCT03345836|466114366|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
129498517|NCT00829166|466114369|FG000|Overall Study|Death|305|||
129498518|NCT00829166|466114370|FG001|Overall Study|Death|333|||
129498519|NCT00829166|466114369|FG000|Overall Study|Lost to Follow-up|5|||
129498520|NCT00829166|466114370|FG001|Overall Study|Lost to Follow-up|4|||
129498521|NCT00829166|466114369|FG000|Overall Study|Physician's Decision|4|||
129498522|NCT00829166|466114370|FG001|Overall Study|Physician's Decision|3|||
129498523|NCT00829166|466114369|FG000|Overall Study|Subject's Decision|41|||
129498524|NCT00829166|466114370|FG001|Overall Study|Subject's Decision|55|||
129498525|NCT00829166|466114369|FG000|Overall Study|Sponsor's Decision|137|||
129498526|NCT00829166|466114370|FG001|Overall Study|Sponsor's Decision|98|||
129498527|NCT00829166|466114369|FG000|Overall Study|Reason Not Specified|3|||
129498528|NCT00829166|466114370|FG001|Overall Study|Reason Not Specified|3|||
129498529|NCT01635933|466114371|FG000|Overall Study|Adverse Event|1|||
129498530|NCT01635933|466114372|FG001|Overall Study|Adverse Event|0|||
129498531|NCT01635933|466114371|FG000|Overall Study|Lost to Follow-up|0|||
129498532|NCT01635933|466114372|FG001|Overall Study|Lost to Follow-up|5|||
129498533|NCT01635933|466114371|FG000|Overall Study|Subject decision|1|||
129498534|NCT01635933|466114372|FG001|Overall Study|Subject decision|1|||
129498535|NCT01635933|466114371|FG000|Overall Study|Noncompliance|0|||
129498536|NCT01635933|466114372|FG001|Overall Study|Noncompliance|1|||
129498537|NCT01635933|466114371|FG000|Overall Study|No longer had transportation|0|||
129498538|NCT01635933|466114372|FG001|Overall Study|No longer had transportation|1|||
129498539|NCT03510663|466114373|FG000|Overall Study|Withdrawal by Subject|0|||
129498540|NCT03510663|466114374|FG001|Overall Study|Withdrawal by Subject|1|||
129498541|NCT03510663|466114375|FG002|Overall Study|Withdrawal by Subject|0|||
129498542|NCT03510663|466114376|FG003|Overall Study|Withdrawal by Subject|0|||
129498543|NCT03510663|466114377|FG004|Overall Study|Withdrawal by Subject|0|||
129498544|NCT03510663|466114378|FG005|Overall Study|Withdrawal by Subject|0|||
129498545|NCT03510663|466114379|FG006|Overall Study|Withdrawal by Subject|0|||
129498546|NCT03510663|466114380|FG007|Overall Study|Withdrawal by Subject|0|||
129498547|NCT02213198|466114383|FG000|Baseline|No show for intake|7|||
129498548|NCT02213198|466114384|FG001|Baseline|No show for intake|9|||
129498549|NCT02213198|466114383|FG000|Baseline|Withdrawal by Subject|34|||
129498550|NCT02213198|466114384|FG001|Baseline|Withdrawal by Subject|11|||
129498551|NCT02213198|466114383|FG000|Baseline|transferred out of clinic|7|||
129498552|NCT02213198|466114384|FG001|Baseline|transferred out of clinic|9|||
129498553|NCT02213198|466114383|FG000|Baseline|Lost to Follow-up|40|||
129498554|NCT02213198|466114384|FG001|Baseline|Lost to Follow-up|21|||
129498555|NCT02213198|466114383|FG000|Baseline|incarcerated,violent|0|||
129498556|NCT02213198|466114384|FG001|Baseline|incarcerated,violent|1|||
129498557|NCT02213198|466114383|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
129498558|NCT02213198|466114384|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
129498559|NCT02213198|466114383|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
129498560|NCT02213198|466114384|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
129498561|NCT02213198|466114383|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
129498562|NCT02213198|466114384|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
129498563|NCT02213198|466114383|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
129498564|NCT02213198|466114384|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
129498565|NCT02213198|466114383|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
129498566|NCT02213198|466114384|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
129498567|NCT02213198|466114383|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
129498568|NCT02213198|466114384|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
129498569|NCT00905021|466114385|FG000|Overall Study|Adverse Event|2|||
129498570|NCT04937816|466114386|FG000|Overall Study|Study drug stopped, reason missing|5|||
129498571|NCT04937816|466114387|FG001|Overall Study|Study drug stopped, reason missing|3|||
129498572|NCT04937816|466114388|FG002|Overall Study|Study drug stopped, reason missing|4|||
129498573|NCT04937816|466114389|FG003|Overall Study|Study drug stopped, reason missing|6|||
129498574|NCT04937816|466114390|FG004|Overall Study|Study drug stopped, reason missing|1|||
129498575|NCT04937816|466114391|FG005|Overall Study|Study drug stopped, reason missing|0|||
129498576|NCT04937816|466114392|FG006|Overall Study|Study drug stopped, reason missing|0|||
129498577|NCT04937816|466114386|FG000|Overall Study|Other than stated below|173|||
129498578|NCT04937816|466114387|FG001|Overall Study|Other than stated below|143|||
129498579|NCT04937816|466114388|FG002|Overall Study|Other than stated below|125|||
129498580|NCT04937816|466114389|FG003|Overall Study|Other than stated below|44|||
129498581|NCT04937816|466114390|FG004|Overall Study|Other than stated below|45|||
129498582|NCT04937816|466114391|FG005|Overall Study|Other than stated below|28|||
129498583|NCT04937816|466114392|FG006|Overall Study|Other than stated below|31|||
129498584|NCT04937816|466114386|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
129498585|NCT04937816|466114387|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
129498586|NCT04937816|466114388|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
129498587|NCT04937816|466114389|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
129498588|NCT04937816|466114390|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
129498589|NCT04937816|466114391|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
129498590|NCT04937816|466114392|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
129498591|NCT04937816|466114386|FG000|Overall Study|Lost to Follow-up|15|||
129498592|NCT04937816|466114387|FG001|Overall Study|Lost to Follow-up|9|||
129498593|NCT04937816|466114388|FG002|Overall Study|Lost to Follow-up|6|||
129498594|NCT04937816|466114389|FG003|Overall Study|Lost to Follow-up|6|||
129498595|NCT04937816|466114390|FG004|Overall Study|Lost to Follow-up|16|||
129498596|NCT04937816|466114391|FG005|Overall Study|Lost to Follow-up|11|||
129498597|NCT04937816|466114392|FG006|Overall Study|Lost to Follow-up|17|||
129498598|NCT04937816|466114386|FG000|Overall Study|Protocol Violation|15|||
129498599|NCT04937816|466114387|FG001|Overall Study|Protocol Violation|15|||
129498600|NCT04937816|466114388|FG002|Overall Study|Protocol Violation|12|||
129498601|NCT04937816|466114389|FG003|Overall Study|Protocol Violation|30|||
129498602|NCT04937816|466114390|FG004|Overall Study|Protocol Violation|24|||
129498603|NCT04937816|466114391|FG005|Overall Study|Protocol Violation|5|||
129498604|NCT04937816|466114392|FG006|Overall Study|Protocol Violation|5|||
129498605|NCT04937816|466114386|FG000|Overall Study|Adverse Event|303|||
129498606|NCT04937816|466114387|FG001|Overall Study|Adverse Event|267|||
129498607|NCT04937816|466114388|FG002|Overall Study|Adverse Event|273|||
129498608|NCT04937816|466114389|FG003|Overall Study|Adverse Event|553|||
129498609|NCT04937816|466114390|FG004|Overall Study|Adverse Event|575|||
129498610|NCT04937816|466114391|FG005|Overall Study|Adverse Event|343|||
129498611|NCT04937816|466114392|FG006|Overall Study|Adverse Event|337|||
129498612|NCT04937816|466114386|FG000|Overall Study|Not treated|4|||
129498613|NCT04937816|466114387|FG001|Overall Study|Not treated|2|||
129498614|NCT04937816|466114388|FG002|Overall Study|Not treated|2|||
129498615|NCT04937816|466114389|FG003|Overall Study|Not treated|2|||
129498616|NCT04937816|466114390|FG004|Overall Study|Not treated|1|||
129498617|NCT04937816|466114391|FG005|Overall Study|Not treated|4|||
129498618|NCT04937816|466114392|FG006|Overall Study|Not treated|0|||
129498619|NCT00309777|466114393|FG000|Overall Study|Adverse Event|13|||
129498620|NCT00309777|466114394|FG001|Overall Study|Adverse Event|2|||
129498621|NCT00309777|466114395|FG002|Overall Study|Adverse Event|8|||
129498622|NCT00309777|466114396|FG003|Overall Study|Adverse Event|1|||
129498623|NCT00309777|466114393|FG000|Overall Study|Protocol Violation|4|||
129498624|NCT00309777|466114394|FG001|Overall Study|Protocol Violation|1|||
129498625|NCT00309777|466114395|FG002|Overall Study|Protocol Violation|3|||
129498626|NCT00309777|466114396|FG003|Overall Study|Protocol Violation|1|||
129498627|NCT00309777|466114393|FG000|Overall Study|Withdrawal by Subject|6|||
129498628|NCT00309777|466114394|FG001|Overall Study|Withdrawal by Subject|5|||
129498629|NCT00309777|466114395|FG002|Overall Study|Withdrawal by Subject|7|||
129498630|NCT00309777|466114396|FG003|Overall Study|Withdrawal by Subject|2|||
129498631|NCT00309777|466114393|FG000|Overall Study|Lost to Follow-up|0|||
129498632|NCT00309777|466114394|FG001|Overall Study|Lost to Follow-up|0|||
129498633|NCT00309777|466114395|FG002|Overall Study|Lost to Follow-up|1|||
129498634|NCT00309777|466114396|FG003|Overall Study|Lost to Follow-up|0|||
129498635|NCT00309777|466114393|FG000|Overall Study|Death|0|||
129498636|NCT00309777|466114394|FG001|Overall Study|Death|1|||
129498637|NCT00309777|466114395|FG002|Overall Study|Death|0|||
129498638|NCT00309777|466114396|FG003|Overall Study|Death|0|||
129498639|NCT05513053|466114397|FG000|Overall Study|Lost to Follow-up|9|||
129498640|NCT05513053|466114398|FG001|Overall Study|Lost to Follow-up|11|||
129498641|NCT05513053|466114397|FG000|Overall Study|Withdrawal by parent/guardian|2|||
129498642|NCT05513053|466114398|FG001|Overall Study|Withdrawal by parent/guardian|0|||
129498643|NCT05513053|466114397|FG000|Overall Study|Withdrawal by Subject|2|||
129498644|NCT05513053|466114398|FG001|Overall Study|Withdrawal by Subject|9|||
129498645|NCT05513053|466114397|FG000|Overall Study|Protocol Violation|6|||
129498646|NCT05513053|466114398|FG001|Overall Study|Protocol Violation|3|||
129498647|NCT05513053|466114397|FG000|Overall Study|Adverse Event|0|||
129498648|NCT05513053|466114398|FG001|Overall Study|Adverse Event|2|||
129498649|NCT00450372|466115877|FG000|Overall Study|Physician Decision|1|||
129498650|NCT03484923|466115878|FG000|Overall Study|Adverse Event|3|||
129498651|NCT03484923|466115879|FG001|Overall Study|Adverse Event|3|||
129498652|NCT03484923|466115880|FG002|Overall Study|Adverse Event|5|||
129498653|NCT03484923|466115881|FG003|Overall Study|Adverse Event|11|||
129498654|NCT03484923|466115882|FG004|Overall Study|Adverse Event|1|||
129498655|NCT03484923|466115878|FG000|Overall Study|Death|2|||
129498656|NCT03484923|466115879|FG001|Overall Study|Death|2|||
129498657|NCT03484923|466115880|FG002|Overall Study|Death|3|||
129498658|NCT03484923|466115881|FG003|Overall Study|Death|0|||
129498659|NCT03484923|466115882|FG004|Overall Study|Death|1|||
129498660|NCT03484923|466115878|FG000|Overall Study|Physician Decision|6|||
129498661|NCT03484923|466115879|FG001|Overall Study|Physician Decision|7|||
129498662|NCT03484923|466115880|FG002|Overall Study|Physician Decision|6|||
129981627|NCT02071290|467895045|FG001|Overall Study|Protocol Violation|5|||
129981628|NCT02071290|467895044|FG000|Overall Study|Physician Decision|0|||
129981629|NCT02071290|467895045|FG001|Overall Study|Physician Decision|1|||
129981630|NCT05560243|467895047|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
129498663|NCT03484923|466115881|FG003|Overall Study|Physician Decision|3|||
129981631|NCT01072630|467895048|FG000|Overall Study|Adverse Event|11|||
129498664|NCT03484923|466115882|FG004|Overall Study|Physician Decision|2|||
129498665|NCT03484923|466115878|FG000|Overall Study|Progressive disease|33|||
129498666|NCT03484923|466115879|FG001|Overall Study|Progressive disease|28|||
129498667|NCT03484923|466115880|FG002|Overall Study|Progressive disease|26|||
129981632|NCT01072630|467895049|FG001|Overall Study|Adverse Event|19|||
129498668|NCT03484923|466115881|FG003|Overall Study|Progressive disease|30|||
129498669|NCT03484923|466115882|FG004|Overall Study|Progressive disease|16|||
129498670|NCT03484923|466115878|FG000|Overall Study|Subject Decision|1|||
129498671|NCT03484923|466115879|FG001|Overall Study|Subject Decision|3|||
129498672|NCT03484923|466115880|FG002|Overall Study|Subject Decision|3|||
129498673|NCT03484923|466115881|FG003|Overall Study|Subject Decision|0|||
129498674|NCT03484923|466115882|FG004|Overall Study|Subject Decision|1|||
129498675|NCT03165721|466115883|FG000|Overall Study|Refused further treatment|3|||
129538916|NCT01238861|466265111|FG004|Overall Study|Unplanned surgery|0|||
129498676|NCT03165721|466115884|FG001|Overall Study|Refused further treatment|0|||
129498677|NCT03165721|466115885|FG002|Overall Study|Refused further treatment|0|||
129498678|NCT03165721|466115883|FG000|Overall Study|Physician Decision|1|||
129498679|NCT03165721|466115884|FG001|Overall Study|Physician Decision|0|||
129498680|NCT03165721|466115885|FG002|Overall Study|Physician Decision|0|||
129498681|NCT01863849|466115886|FG000|Overall Study|Lost to Follow-up|1|||
129498682|NCT01863849|466115887|FG001|Overall Study|Lost to Follow-up|0|||
129498683|NCT01457118|466115888|FG000|Overall Study|Adverse Event|1|||
129498684|NCT01457118|466115889|FG001|Overall Study|Adverse Event|0|||
129498685|NCT01457118|466115890|FG002|Overall Study|Adverse Event|0|||
129498686|NCT01457118|466115891|FG003|Overall Study|Adverse Event|1|||
129498687|NCT01457118|466115888|FG000|Overall Study|Clinical Progression|0|||
129498688|NCT01457118|466115889|FG001|Overall Study|Clinical Progression|1|||
129498689|NCT01457118|466115890|FG002|Overall Study|Clinical Progression|0|||
129498690|NCT01457118|466115891|FG003|Overall Study|Clinical Progression|1|||
129498691|NCT01457118|466115888|FG000|Overall Study|Physician Decision|2|||
129498692|NCT01457118|466115889|FG001|Overall Study|Physician Decision|0|||
129498693|NCT01457118|466115890|FG002|Overall Study|Physician Decision|0|||
129498694|NCT01457118|466115891|FG003|Overall Study|Physician Decision|0|||
129498695|NCT01457118|466115888|FG000|Overall Study|Progressive Disease by RECIST|12|||
129498696|NCT01457118|466115889|FG001|Overall Study|Progressive Disease by RECIST|3|||
129498697|NCT01457118|466115890|FG002|Overall Study|Progressive Disease by RECIST|1|||
129498698|NCT01457118|466115891|FG003|Overall Study|Progressive Disease by RECIST|0|||
129498699|NCT01457118|466115888|FG000|Overall Study|Withdrawal by Subject|5|||
129498700|NCT01457118|466115889|FG001|Overall Study|Withdrawal by Subject|0|||
129498701|NCT01457118|466115890|FG002|Overall Study|Withdrawal by Subject|0|||
129498702|NCT01457118|466115891|FG003|Overall Study|Withdrawal by Subject|0|||
129498703|NCT01202227|466115896|FG000|Overall Study|Adverse Event|16|||
129498704|NCT01202227|466115896|FG000|Overall Study|Withdrawal by Subject|2|||
129498705|NCT01202227|466115896|FG000|Overall Study|Lack of Efficacy|1|||
129498706|NCT00643487|466115897|FG000|Overall Study|Technical difficulty|3|||
129498707|NCT04402008|466115898|FG000|Overall Study|Adverse Event|0|||
129498708|NCT04402008|466115899|FG001|Overall Study|Adverse Event|0|||
129498709|NCT04402008|466115900|FG002|Overall Study|Adverse Event|0|||
129498710|NCT04402008|466115901|FG003|Overall Study|Adverse Event|1|||
129498711|NCT04402008|466115902|FG004|Overall Study|Adverse Event|0|||
129498712|NCT04402008|466115903|FG005|Overall Study|Adverse Event|0|||
129498713|NCT04402008|466115904|FG006|Overall Study|Adverse Event|0|||
129498714|NCT04402008|466115898|FG000|Overall Study|Disease Progression|3|||
129498715|NCT04402008|466115899|FG001|Overall Study|Disease Progression|2|||
129498716|NCT04402008|466115900|FG002|Overall Study|Disease Progression|3|||
129498717|NCT04402008|466115901|FG003|Overall Study|Disease Progression|3|||
129498718|NCT04402008|466115902|FG004|Overall Study|Disease Progression|4|||
129498719|NCT04402008|466115903|FG005|Overall Study|Disease Progression|3|||
129498720|NCT04402008|466115904|FG006|Overall Study|Disease Progression|10|||
129498721|NCT04402008|466115898|FG000|Overall Study|Withdrawal by Subject|0|||
129498722|NCT04402008|466115899|FG001|Overall Study|Withdrawal by Subject|1|||
129498723|NCT04402008|466115900|FG002|Overall Study|Withdrawal by Subject|0|||
129498724|NCT04402008|466115901|FG003|Overall Study|Withdrawal by Subject|0|||
129498725|NCT04402008|466115902|FG004|Overall Study|Withdrawal by Subject|1|||
129498726|NCT04402008|466115903|FG005|Overall Study|Withdrawal by Subject|0|||
129498727|NCT04402008|466115904|FG006|Overall Study|Withdrawal by Subject|0|||
129498728|NCT04402008|466115898|FG000|Overall Study|Sponsor Decision|0|||
129498729|NCT04402008|466115899|FG001|Overall Study|Sponsor Decision|0|||
129498730|NCT04402008|466115900|FG002|Overall Study|Sponsor Decision|0|||
129498731|NCT04402008|466115901|FG003|Overall Study|Sponsor Decision|0|||
129498732|NCT04402008|466115902|FG004|Overall Study|Sponsor Decision|0|||
129498733|NCT04402008|466115903|FG005|Overall Study|Sponsor Decision|0|||
129498734|NCT04402008|466115904|FG006|Overall Study|Sponsor Decision|3|||
129498735|NCT04402008|466115898|FG000|Overall Study|Death|0|||
129498736|NCT04402008|466115899|FG001|Overall Study|Death|0|||
129498737|NCT04402008|466115900|FG002|Overall Study|Death|0|||
129498738|NCT04402008|466115901|FG003|Overall Study|Death|0|||
129498739|NCT04402008|466115902|FG004|Overall Study|Death|1|||
129498740|NCT04402008|466115903|FG005|Overall Study|Death|0|||
129498741|NCT04402008|466115904|FG006|Overall Study|Death|2|||
129498742|NCT04402008|466115898|FG000|Overall Study|Other|0|||
129498743|NCT04402008|466115899|FG001|Overall Study|Other|0|||
129498744|NCT04402008|466115900|FG002|Overall Study|Other|0|||
129498745|NCT04402008|466115901|FG003|Overall Study|Other|0|||
129498746|NCT04402008|466115902|FG004|Overall Study|Other|0|||
129498747|NCT04402008|466115903|FG005|Overall Study|Other|0|||
129981633|NCT01072630|467895050|FG002|Overall Study|Adverse Event|2|||
129498748|NCT04402008|466115904|FG006|Overall Study|Other|5|||
129498749|NCT01533935|466115905|FG000|Overall Study|Adverse Event|5|||
129498750|NCT01533935|466115906|FG001|Overall Study|Adverse Event|7|||
129498751|NCT01533935|466115907|FG002|Overall Study|Adverse Event|1|||
129498752|NCT01533935|466115908|FG003|Overall Study|Adverse Event|5|||
129498753|NCT01533935|466115909|FG004|Overall Study|Adverse Event|3|||
129498754|NCT01533935|466115905|FG000|Overall Study|Protocol Violation|0|||
129498755|NCT01533935|466115906|FG001|Overall Study|Protocol Violation|2|||
129498756|NCT01533935|466115907|FG002|Overall Study|Protocol Violation|0|||
129498757|NCT01533935|466115908|FG003|Overall Study|Protocol Violation|0|||
129498758|NCT01533935|466115909|FG004|Overall Study|Protocol Violation|0|||
129498759|NCT01533935|466115905|FG000|Overall Study|Lost to Follow-up|0|||
129498760|NCT01533935|466115906|FG001|Overall Study|Lost to Follow-up|0|||
129498761|NCT01533935|466115907|FG002|Overall Study|Lost to Follow-up|1|||
129498762|NCT01533935|466115908|FG003|Overall Study|Lost to Follow-up|0|||
129498763|NCT01533935|466115909|FG004|Overall Study|Lost to Follow-up|0|||
129498764|NCT01533935|466115905|FG000|Overall Study|Withdrawal by Subject|0|||
129498765|NCT01533935|466115906|FG001|Overall Study|Withdrawal by Subject|4|||
129498766|NCT01533935|466115907|FG002|Overall Study|Withdrawal by Subject|5|||
129498767|NCT01533935|466115908|FG003|Overall Study|Withdrawal by Subject|2|||
129498768|NCT01533935|466115909|FG004|Overall Study|Withdrawal by Subject|4|||
129498769|NCT01533935|466115905|FG000|Overall Study|Other reason not defined above|1|||
129498770|NCT01533935|466115906|FG001|Overall Study|Other reason not defined above|0|||
129498771|NCT01533935|466115907|FG002|Overall Study|Other reason not defined above|1|||
129498772|NCT01533935|466115908|FG003|Overall Study|Other reason not defined above|0|||
129498773|NCT01533935|466115909|FG004|Overall Study|Other reason not defined above|1|||
129498774|NCT00879814|466115910|FG000|Overall Study|Adverse Event|0|||
129498775|NCT00879814|466115911|FG001|Overall Study|Adverse Event|1|||
129498776|NCT00879814|466115912|FG002|Overall Study|Adverse Event|0|||
129498777|NCT00879814|466115913|FG003|Overall Study|Adverse Event|0|||
129498778|NCT00879814|466115910|FG000|Overall Study|Lost to Follow-up|1|||
129498779|NCT00879814|466115911|FG001|Overall Study|Lost to Follow-up|0|||
129498780|NCT00879814|466115912|FG002|Overall Study|Lost to Follow-up|0|||
129498781|NCT00879814|466115913|FG003|Overall Study|Lost to Follow-up|2|||
129498782|NCT00879814|466115910|FG000|Overall Study|Participant Failed to Return|0|||
129498783|NCT00879814|466115911|FG001|Overall Study|Participant Failed to Return|0|||
129498784|NCT00879814|466115912|FG002|Overall Study|Participant Failed to Return|0|||
129498785|NCT00879814|466115913|FG003|Overall Study|Participant Failed to Return|1|||
129498786|NCT00879814|466115910|FG000|Overall Study|Withdrawal by Subject|3|||
129498787|NCT00879814|466115911|FG001|Overall Study|Withdrawal by Subject|1|||
129498788|NCT00879814|466115912|FG002|Overall Study|Withdrawal by Subject|1|||
129498789|NCT00879814|466115913|FG003|Overall Study|Withdrawal by Subject|2|||
129498790|NCT00879814|466115910|FG000|Overall Study|Physician Decision|0|||
129498791|NCT00879814|466115911|FG001|Overall Study|Physician Decision|0|||
129498792|NCT00879814|466115912|FG002|Overall Study|Physician Decision|1|||
129498793|NCT00879814|466115913|FG003|Overall Study|Physician Decision|0|||
129498794|NCT00879814|466115910|FG000|Overall Study|Other|0|||
129498795|NCT00879814|466115911|FG001|Overall Study|Other|0|||
129498796|NCT00879814|466115912|FG002|Overall Study|Other|1|||
129498797|NCT00879814|466115913|FG003|Overall Study|Other|0|||
129498798|NCT00630812|466115926|FG000|Randomisation to First Dose|Adverse Event|1|||
129498799|NCT00630812|466115927|FG001|Randomisation to First Dose|Adverse Event|1|||
129498800|NCT00630812|466115926|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
129498801|NCT00630812|466115927|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
129498802|NCT00630812|466115926|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
129498803|NCT00630812|466115927|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
129498804|NCT00630812|466115926|FG000|Randomisation to First Dose|Protocol Violation|4|||
129498805|NCT00630812|466115927|FG001|Randomisation to First Dose|Protocol Violation|1|||
129498806|NCT00630812|466115926|FG000|Double Blind Treatment Period|Adverse Event|13|||
129498807|NCT00630812|466115927|FG001|Double Blind Treatment Period|Adverse Event|5|||
129498808|NCT00630812|466115926|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
129498809|NCT00630812|466115927|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
129498810|NCT00630812|466115926|FG000|Double Blind Treatment Period|Physician Decision|2|||
129981634|NCT01072630|467895048|FG000|Overall Study|Lack of Efficacy|10|||
129498811|NCT00630812|466115927|FG001|Double Blind Treatment Period|Physician Decision|1|||
129498812|NCT00630812|466115926|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129498813|NCT00630812|466115927|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129498814|NCT00630812|466115926|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
129498815|NCT00630812|466115927|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
129498816|NCT00630812|466115926|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
129498817|NCT00630812|466115927|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
129498818|NCT00630812|466115926|FG000|Double Blind Treatment Period|Non-compliance|0|||
129498819|NCT00630812|466115927|FG001|Double Blind Treatment Period|Non-compliance|1|||
129498820|NCT01219959|466115928|FG000|Overall Study|Adverse Event|6|||
129498821|NCT01219959|466115929|FG001|Overall Study|Adverse Event|14|||
129498822|NCT01219959|466115928|FG000|Overall Study|Physician Decision|0|||
129498823|NCT01219959|466115929|FG001|Overall Study|Physician Decision|4|||
129498824|NCT01219959|466115928|FG000|Overall Study|Withdrawal by Subject|0|||
129498825|NCT01219959|466115929|FG001|Overall Study|Withdrawal by Subject|2|||
129498826|NCT01219959|466115928|FG000|Overall Study|Renal Transplantation|0|||
129498827|NCT01219959|466115929|FG001|Overall Study|Renal Transplantation|3|||
129498828|NCT01219959|466115928|FG000|Overall Study|Other|1|||
129498829|NCT01219959|466115929|FG001|Overall Study|Other|0|||
129498830|NCT02935634|466115930|FG000|Randomization|Participant withdrew consent|0|||
129498831|NCT02935634|466115931|FG001|Randomization|Participant withdrew consent|1|||
129498832|NCT02935634|466115932|FG002|Randomization|Participant withdrew consent|0|||
129981635|NCT01072630|467895049|FG001|Overall Study|Lack of Efficacy|10|||
129981636|NCT01072630|467895050|FG002|Overall Study|Lack of Efficacy|1|||
129981637|NCT01072630|467895048|FG000|Overall Study|Withdrawal by Subject|8|||
129981638|NCT01072630|467895049|FG001|Overall Study|Withdrawal by Subject|7|||
129981639|NCT01072630|467895050|FG002|Overall Study|Withdrawal by Subject|2|||
129981640|NCT01072630|467895048|FG000|Overall Study|Protocol Violation|10|||
129981641|NCT01072630|467895049|FG001|Overall Study|Protocol Violation|8|||
129981642|NCT01072630|467895050|FG002|Overall Study|Protocol Violation|4|||
129981643|NCT01072630|467895048|FG000|Overall Study|Lost to Follow-up|11|||
129981644|NCT01072630|467895049|FG001|Overall Study|Lost to Follow-up|11|||
129981645|NCT01072630|467895050|FG002|Overall Study|Lost to Follow-up|1|||
129981646|NCT01072630|467895048|FG000|Overall Study|Noncompliance with study medication|1|||
129981647|NCT01072630|467895049|FG001|Overall Study|Noncompliance with study medication|1|||
129981648|NCT01072630|467895050|FG002|Overall Study|Noncompliance with study medication|1|||
129981649|NCT01072630|467895048|FG000|Overall Study|Noncompliance with study procedures|1|||
129981650|NCT01072630|467895049|FG001|Overall Study|Noncompliance with study procedures|2|||
129981651|NCT01072630|467895050|FG002|Overall Study|Noncompliance with study procedures|1|||
129981652|NCT01072630|467895048|FG000|Overall Study|Other|3|||
129981653|NCT01072630|467895049|FG001|Overall Study|Other|2|||
129981654|NCT01072630|467895050|FG002|Overall Study|Other|1|||
129981655|NCT01232738|467895051|FG000|Overall Study|Death|3|||
129981656|NCT01232738|467895051|FG000|Overall Study|Physician Decision|2|||
129981657|NCT01232738|467895051|FG000|Overall Study|Lost to Follow-up|1|||
129981658|NCT01232738|467895051|FG000|Overall Study|Withdrawal by Subject|2|||
129981659|NCT01232738|467895051|FG000|Overall Study|Adverse Event|5|||
129981660|NCT00338962|467895052|FG000|Overall Study|Lost to Follow-up|3|||
129981661|NCT00338962|467895053|FG001|Overall Study|Lost to Follow-up|3|||
129981662|NCT00338962|467895054|FG002|Overall Study|Lost to Follow-up|2|||
129981663|NCT00338962|467895055|FG003|Overall Study|Lost to Follow-up|3|||
129981664|NCT00338962|467895052|FG000|Overall Study|Withdrawal by Subject|1|||
129981665|NCT00338962|467895053|FG001|Overall Study|Withdrawal by Subject|0|||
129981666|NCT00338962|467895054|FG002|Overall Study|Withdrawal by Subject|0|||
129981667|NCT00338962|467895055|FG003|Overall Study|Withdrawal by Subject|0|||
129981668|NCT00338962|467895052|FG000|Overall Study|No Transportation|2|||
129981669|NCT00338962|467895053|FG001|Overall Study|No Transportation|0|||
129981670|NCT00338962|467895054|FG002|Overall Study|No Transportation|0|||
129981671|NCT00338962|467895055|FG003|Overall Study|No Transportation|0|||
129981672|NCT00338962|467895052|FG000|Overall Study|Time Constraint|2|||
129981673|NCT00338962|467895053|FG001|Overall Study|Time Constraint|0|||
129981674|NCT00338962|467895054|FG002|Overall Study|Time Constraint|0|||
129981675|NCT00338962|467895055|FG003|Overall Study|Time Constraint|0|||
129981676|NCT00338962|467895052|FG000|Overall Study|Moved|0|||
129981677|NCT00338962|467895053|FG001|Overall Study|Moved|1|||
129981678|NCT00338962|467895054|FG002|Overall Study|Moved|0|||
129981679|NCT00338962|467895055|FG003|Overall Study|Moved|0|||
129981680|NCT00338962|467895052|FG000|Overall Study|Adverse Event|0|||
129981681|NCT00338962|467895053|FG001|Overall Study|Adverse Event|0|||
129981682|NCT00338962|467895054|FG002|Overall Study|Adverse Event|2|||
129981683|NCT00338962|467895055|FG003|Overall Study|Adverse Event|0|||
129981684|NCT00338962|467895052|FG000|Overall Study|Poor Compliance|0|||
129981685|NCT00338962|467895053|FG001|Overall Study|Poor Compliance|0|||
129981686|NCT00338962|467895054|FG002|Overall Study|Poor Compliance|2|||
129981687|NCT00338962|467895055|FG003|Overall Study|Poor Compliance|0|||
129981688|NCT03214640|467895056|FG000|Overall Study|Protocol Violation|1|||
129981689|NCT03214640|467895057|FG001|Overall Study|Protocol Violation|2|||
129981690|NCT03214640|467895058|FG002|Overall Study|Protocol Violation|1|||
129981691|NCT03214640|467895059|FG003|Overall Study|Protocol Violation|4|||
129981692|NCT02731690|467896695|FG000|Overall Study|Adverse Event|1|||
129981693|NCT02731690|467896695|FG000|Overall Study|Withdrawal by Subject|3|||
129981694|NCT02731690|467896695|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
129498833|NCT02935634|466115933|FG003|Randomization|Participant withdrew consent|0|||
129981695|NCT01262677|467896696|FG000|Overall Study|Does not meet entrance criteria|0|||
129981696|NCT01262677|467896697|FG001|Overall Study|Does not meet entrance criteria|2|||
129498834|NCT02935634|466115934|FG004|Randomization|Participant withdrew consent|0|||
129981697|NCT01262677|467896698|FG002|Overall Study|Does not meet entrance criteria|0|||
129981698|NCT01262677|467896696|FG000|Overall Study|Insufficient clinical response|0|||
129981699|NCT01262677|467896697|FG001|Overall Study|Insufficient clinical response|0|||
129981700|NCT01262677|467896698|FG002|Overall Study|Insufficient clinical response|1|||
129981701|NCT01262677|467896696|FG000|Overall Study|Lost to Follow-up|1|||
129981702|NCT01262677|467896697|FG001|Overall Study|Lost to Follow-up|0|||
129981703|NCT01262677|467896698|FG002|Overall Study|Lost to Follow-up|2|||
129981704|NCT01262677|467896696|FG000|Overall Study|No longer willing to participate|3|||
129981705|NCT01262677|467896697|FG001|Overall Study|No longer willing to participate|3|||
129981706|NCT01262677|467896698|FG002|Overall Study|No longer willing to participate|2|||
129498835|NCT02935634|466115935|FG005|Randomization|Participant withdrew consent|0|||
129498836|NCT02935634|466115930|FG000|Randomization|Death|2|||
129498837|NCT02935634|466115931|FG001|Randomization|Death|1|||
129498838|NCT02935634|466115932|FG002|Randomization|Death|1|||
129498839|NCT02935634|466115933|FG003|Randomization|Death|0|||
129498840|NCT02935634|466115934|FG004|Randomization|Death|0|||
129498841|NCT02935634|466115935|FG005|Randomization|Death|0|||
129498842|NCT02935634|466115930|FG000|Randomization|Other reasons|0|||
129498843|NCT02935634|466115931|FG001|Randomization|Other reasons|2|||
129498844|NCT02935634|466115932|FG002|Randomization|Other reasons|2|||
129498845|NCT02935634|466115933|FG003|Randomization|Other reasons|0|||
129498846|NCT02935634|466115934|FG004|Randomization|Other reasons|0|||
129498847|NCT02935634|466115935|FG005|Randomization|Other reasons|0|||
129498848|NCT02935634|466115930|FG000|Treatment: Track 1|Disease progression|15|||
129498849|NCT02935634|466115931|FG001|Treatment: Track 1|Disease progression|17|||
129498850|NCT02935634|466115932|FG002|Treatment: Track 1|Disease progression|28|||
129498851|NCT02935634|466115933|FG003|Treatment: Track 1|Disease progression|4|||
129498852|NCT02935634|466115934|FG004|Treatment: Track 1|Disease progression|6|||
129498853|NCT02935634|466115935|FG005|Treatment: Track 1|Disease progression|2|||
129498854|NCT02935634|466115930|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
129498855|NCT02935634|466115931|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
129498856|NCT02935634|466115932|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
129498857|NCT02935634|466115933|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
129498858|NCT02935634|466115934|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
129498859|NCT02935634|466115935|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
129498860|NCT02935634|466115930|FG000|Treatment: Track 1|Lost to Follow-up|1|||
129498861|NCT02935634|466115931|FG001|Treatment: Track 1|Lost to Follow-up|0|||
129498862|NCT02935634|466115932|FG002|Treatment: Track 1|Lost to Follow-up|0|||
129498863|NCT02935634|466115933|FG003|Treatment: Track 1|Lost to Follow-up|0|||
129498864|NCT02935634|466115934|FG004|Treatment: Track 1|Lost to Follow-up|0|||
129498865|NCT02935634|466115935|FG005|Treatment: Track 1|Lost to Follow-up|0|||
129498866|NCT02935634|466115930|FG000|Treatment: Track 1|Study drug toxicity|2|||
129498867|NCT02935634|466115931|FG001|Treatment: Track 1|Study drug toxicity|1|||
129498868|NCT02935634|466115932|FG002|Treatment: Track 1|Study drug toxicity|3|||
129498869|NCT02935634|466115933|FG003|Treatment: Track 1|Study drug toxicity|0|||
129498870|NCT02935634|466115934|FG004|Treatment: Track 1|Study drug toxicity|0|||
129498871|NCT02935634|466115935|FG005|Treatment: Track 1|Study drug toxicity|1|||
129498872|NCT02935634|466115930|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
129498873|NCT02935634|466115931|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
129498874|NCT02935634|466115932|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
129498875|NCT02935634|466115933|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
129498876|NCT02935634|466115934|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
129498877|NCT02935634|466115935|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
129498878|NCT02935634|466115930|FG000|Treatment: Track 1|Participant withdrew consent|2|||
129498879|NCT02935634|466115931|FG001|Treatment: Track 1|Participant withdrew consent|0|||
129498880|NCT02935634|466115932|FG002|Treatment: Track 1|Participant withdrew consent|1|||
129498881|NCT02935634|466115933|FG003|Treatment: Track 1|Participant withdrew consent|0|||
129498882|NCT02935634|466115934|FG004|Treatment: Track 1|Participant withdrew consent|1|||
129498883|NCT02935634|466115935|FG005|Treatment: Track 1|Participant withdrew consent|0|||
129498884|NCT02935634|466115930|FG000|Treatment: Track 1|Other reasons|0|||
129498885|NCT02935634|466115931|FG001|Treatment: Track 1|Other reasons|0|||
129498886|NCT02935634|466115932|FG002|Treatment: Track 1|Other reasons|2|||
129498887|NCT02935634|466115933|FG003|Treatment: Track 1|Other reasons|0|||
129498888|NCT02935634|466115934|FG004|Treatment: Track 1|Other reasons|0|||
129498889|NCT02935634|466115935|FG005|Treatment: Track 1|Other reasons|0|||
129498890|NCT02935634|466115930|FG000|Treatment: Track 2|Disease progression|13|||
129498891|NCT02935634|466115931|FG001|Treatment: Track 2|Disease progression|26|||
129498892|NCT02935634|466115932|FG002|Treatment: Track 2|Disease progression|20|||
129498893|NCT02935634|466115933|FG003|Treatment: Track 2|Disease progression|5|||
129498894|NCT02935634|466115934|FG004|Treatment: Track 2|Disease progression|1|||
129498895|NCT02935634|466115935|FG005|Treatment: Track 2|Disease progression|4|||
129498896|NCT02935634|466115930|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
129498897|NCT02935634|466115931|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
129498898|NCT02935634|466115932|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
129498899|NCT02935634|466115933|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
129498900|NCT02935634|466115934|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
129981707|NCT01262677|467896696|FG000|Overall Study|Reason not provided|2|||
129981708|NCT01262677|467896697|FG001|Overall Study|Reason not provided|1|||
129498901|NCT02935634|466115935|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
129498902|NCT02935634|466115930|FG000|Treatment: Track 2|Study drug toxicity|7|||
129498903|NCT02935634|466115931|FG001|Treatment: Track 2|Study drug toxicity|3|||
129498904|NCT02935634|466115932|FG002|Treatment: Track 2|Study drug toxicity|0|||
129981709|NCT01262677|467896698|FG002|Overall Study|Reason not provided|3|||
129981710|NCT01262677|467896696|FG000|Overall Study|Protocol Violation|0|||
129498905|NCT02935634|466115933|FG003|Treatment: Track 2|Study drug toxicity|0|||
129498906|NCT02935634|466115934|FG004|Treatment: Track 2|Study drug toxicity|0|||
129498907|NCT02935634|466115935|FG005|Treatment: Track 2|Study drug toxicity|0|||
129498908|NCT02935634|466115930|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
129498909|NCT02935634|466115931|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
129498910|NCT02935634|466115932|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
129498911|NCT02935634|466115933|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
129498912|NCT02935634|466115934|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
129498913|NCT02935634|466115935|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
129498914|NCT02935634|466115930|FG000|Treatment: Track 2|Participant withdrew consent|0|||
129498915|NCT02935634|466115931|FG001|Treatment: Track 2|Participant withdrew consent|1|||
129498916|NCT02935634|466115932|FG002|Treatment: Track 2|Participant withdrew consent|1|||
129498917|NCT02935634|466115933|FG003|Treatment: Track 2|Participant withdrew consent|0|||
129498918|NCT02935634|466115934|FG004|Treatment: Track 2|Participant withdrew consent|1|||
129498919|NCT02935634|466115935|FG005|Treatment: Track 2|Participant withdrew consent|0|||
129498920|NCT03430245|466115936|FG000|Overall Study|Withdrawal by Subject|6|||
129498921|NCT03430245|466115936|FG000|Overall Study|Lost to Follow-up|1|||
129498922|NCT05628181|466115937|FG000|Overall Study|Death|2|||
129498923|NCT05628181|466115938|FG001|Overall Study|Death|4|||
129498924|NCT05628181|466115939|FG002|Overall Study|Death|0|||
129498925|NCT03656926|466115946|FG000|Overall Study|Adverse Event|5|||
129498926|NCT03656926|466115947|FG001|Overall Study|Adverse Event|4|||
129498927|NCT03656926|466115946|FG000|Overall Study|Withdrawal by Subject|7|||
129498928|NCT03656926|466115947|FG001|Overall Study|Withdrawal by Subject|2|||
129498929|NCT03656926|466115946|FG000|Overall Study|Screen fail after randomization|1|||
129498930|NCT03656926|466115947|FG001|Overall Study|Screen fail after randomization|0|||
129498931|NCT03656926|466115946|FG000|Overall Study|PI decision due to patient condition|1|||
129498932|NCT03656926|466115947|FG001|Overall Study|PI decision due to patient condition|0|||
129498933|NCT03656926|466115946|FG000|Overall Study|Patient unresponsiveness|1|||
129498934|NCT03656926|466115947|FG001|Overall Study|Patient unresponsiveness|0|||
129498935|NCT05610176|466115948|FG000|Overall Study|Death|6|||
129498936|NCT00316303|466115949|FG000|Overall Study|Lost to Follow-up|11|||
129498937|NCT00316303|466115950|FG001|Overall Study|Lost to Follow-up|16|||
129498938|NCT01864018|466115955|FG000|Overall Study|Ineligible|3|||
129498939|NCT01864018|466115956|FG001|Overall Study|Ineligible|1|||
129498940|NCT03609359|466115961|FG000|Overall Study|Progression of primary disease (PD)|25|||
129498941|NCT03609359|466115961|FG000|Overall Study|Patient's refusal|1|||
129498942|NCT03609359|466115961|FG000|Overall Study|Physician Decision|1|||
129498943|NCT03609359|466115961|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
129498944|NCT01912729|466115963|FG000|Overall Study|Withdrawal by Subject|0|||
129498945|NCT01912729|466115964|FG001|Overall Study|Withdrawal by Subject|1|||
129498946|NCT00195260|466115966|FG000|Part 1: Dose Escalation|Adverse Event|0|||
129498947|NCT00195260|466115967|FG001|Part 1: Dose Escalation|Adverse Event|1|||
129498948|NCT00195260|466115968|FG002|Part 1: Dose Escalation|Adverse Event|0|||
129498949|NCT00195260|466115969|FG003|Part 1: Dose Escalation|Adverse Event|1|||
129498950|NCT00195260|466115970|FG004|Part 1: Dose Escalation|Adverse Event|1|||
129498951|NCT00195260|466115971|FG005|Part 1: Dose Escalation|Adverse Event|0|||
129498952|NCT00195260|466115972|FG006|Part 1: Dose Escalation|Adverse Event|3|||
129498953|NCT00195260|466115973|FG007|Part 1: Dose Escalation|Adverse Event|0|||
129498954|NCT00195260|466115974|FG008|Part 1: Dose Escalation|Adverse Event|0|||
129498955|NCT00195260|466115975|FG009|Part 1: Dose Escalation|Adverse Event|0|||
129498956|NCT00195260|466115976|FG010|Part 1: Dose Escalation|Adverse Event|0|||
129498957|NCT00195260|466115966|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498958|NCT00195260|466115967|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498959|NCT00195260|466115968|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498960|NCT00195260|466115969|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498961|NCT00195260|466115970|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
129498962|NCT00195260|466115971|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498963|NCT00195260|466115972|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498964|NCT00195260|466115973|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
129498965|NCT00195260|466115974|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498966|NCT00195260|466115975|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498967|NCT00195260|466115976|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
129498968|NCT00195260|466115966|FG000|Part 1: Dose Escalation|Death|0|||
129498969|NCT00195260|466115967|FG001|Part 1: Dose Escalation|Death|0|||
129498970|NCT00195260|466115968|FG002|Part 1: Dose Escalation|Death|0|||
129498971|NCT00195260|466115969|FG003|Part 1: Dose Escalation|Death|0|||
129498972|NCT00195260|466115970|FG004|Part 1: Dose Escalation|Death|0|||
129498973|NCT00195260|466115971|FG005|Part 1: Dose Escalation|Death|0|||
129498974|NCT00195260|466115972|FG006|Part 1: Dose Escalation|Death|0|||
129498975|NCT00195260|466115973|FG007|Part 1: Dose Escalation|Death|1|||
129498976|NCT00195260|466115974|FG008|Part 1: Dose Escalation|Death|0|||
129498977|NCT00195260|466115975|FG009|Part 1: Dose Escalation|Death|0|||
129498978|NCT00195260|466115976|FG010|Part 1: Dose Escalation|Death|0|||
129498979|NCT00195260|466115966|FG000|Part 1: Dose Escalation|Disease Progression|3|||
129498980|NCT00195260|466115967|FG001|Part 1: Dose Escalation|Disease Progression|2|||
129498981|NCT00195260|466115968|FG002|Part 1: Dose Escalation|Disease Progression|5|||
129498982|NCT00195260|466115969|FG003|Part 1: Dose Escalation|Disease Progression|6|||
129498983|NCT00195260|466115970|FG004|Part 1: Dose Escalation|Disease Progression|4|||
129498984|NCT00195260|466115971|FG005|Part 1: Dose Escalation|Disease Progression|6|||
129498985|NCT00195260|466115972|FG006|Part 1: Dose Escalation|Disease Progression|7|||
129498986|NCT00195260|466115973|FG007|Part 1: Dose Escalation|Disease Progression|4|||
129498987|NCT00195260|466115974|FG008|Part 1: Dose Escalation|Disease Progression|0|||
129498988|NCT00195260|466115975|FG009|Part 1: Dose Escalation|Disease Progression|0|||
129498989|NCT00195260|466115976|FG010|Part 1: Dose Escalation|Disease Progression|0|||
129498990|NCT00195260|466115966|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
129498991|NCT00195260|466115967|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
129498992|NCT00195260|466115968|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
129498993|NCT00195260|466115969|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129498994|NCT00195260|466115970|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129498995|NCT00195260|466115971|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
129498996|NCT00195260|466115972|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129498997|NCT00195260|466115973|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129498998|NCT00195260|466115974|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129498999|NCT00195260|466115975|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129499000|NCT00195260|466115976|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
129499001|NCT00195260|466115966|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499002|NCT00195260|466115967|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499003|NCT00195260|466115968|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499004|NCT00195260|466115969|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499005|NCT00195260|466115970|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499006|NCT00195260|466115971|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499007|NCT00195260|466115972|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499008|NCT00195260|466115973|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
129499009|NCT00195260|466115974|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
129499010|NCT00195260|466115975|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
129499011|NCT00195260|466115976|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
129499012|NCT00195260|466115966|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499013|NCT00195260|466115967|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499014|NCT00195260|466115968|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499015|NCT00195260|466115969|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499016|NCT00195260|466115970|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499017|NCT00195260|466115971|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499018|NCT00195260|466115972|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499019|NCT00195260|466115973|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
129499020|NCT00195260|466115974|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
129499021|NCT00195260|466115975|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
129499022|NCT00195260|466115976|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
129499023|NCT00195260|466115966|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499024|NCT00195260|466115967|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499025|NCT00195260|466115968|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499026|NCT00195260|466115969|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499027|NCT00195260|466115970|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499028|NCT00195260|466115971|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499029|NCT00195260|466115972|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499030|NCT00195260|466115973|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
129499031|NCT00195260|466115974|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
129499032|NCT00195260|466115975|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
129499033|NCT00195260|466115976|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
129499034|NCT00195260|466115966|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499035|NCT00195260|466115967|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499036|NCT00195260|466115968|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499037|NCT00195260|466115969|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129981711|NCT01262677|467896697|FG001|Overall Study|Protocol Violation|1|||
129981712|NCT01262677|467896698|FG002|Overall Study|Protocol Violation|1|||
129981713|NCT01262677|467896696|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
129981714|NCT01262677|467896697|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
129981715|NCT01262677|467896698|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
129499038|NCT00195260|466115970|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499039|NCT00195260|466115971|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499040|NCT00195260|466115972|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499041|NCT00195260|466115973|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
129499042|NCT00195260|466115974|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
129499043|NCT00195260|466115975|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
129499044|NCT00195260|466115976|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
129499045|NCT01952834|466115977|FG000|Overall Study|Adverse Event|1|||
129499046|NCT04285346|466115978|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
129499047|NCT04285346|466115979|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
129499048|NCT04285346|466115978|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
129499049|NCT04285346|466115979|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
129499050|NCT04285346|466115978|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
129499051|NCT04285346|466115979|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
129499052|NCT00610935|466115980|FG000|Overall Study|Lost to Follow-up|0|||
129499053|NCT00610935|466115981|FG001|Overall Study|Lost to Follow-up|1|||
129499054|NCT00610935|466115980|FG000|Overall Study|Withdrawal by Subject|0|||
129499055|NCT00610935|466115981|FG001|Overall Study|Withdrawal by Subject|2|||
129499056|NCT00610935|466115980|FG000|Overall Study|Sponsor Discontinuation|1|||
129499057|NCT00610935|466115981|FG001|Overall Study|Sponsor Discontinuation|0|||
129499058|NCT00850460|466115982|FG000|Overall Study|Lost to Follow-up|4|||
129499059|NCT00850460|466115983|FG001|Overall Study|Lost to Follow-up|4|||
129499060|NCT02224846|466115984|FG000|Period 1 (Month 3)|Adverse Event|2|||
129499061|NCT02224846|466115985|FG001|Period 1 (Month 3)|Adverse Event|1|||
129499062|NCT02224846|466115984|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
129499063|NCT02224846|466115985|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
129499064|NCT02224846|466115984|FG000|Period 1 (Month 3)|Protocol Violation|4|||
129499065|NCT02224846|466115985|FG001|Period 1 (Month 3)|Protocol Violation|8|||
129499066|NCT02224846|466115984|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
129499067|NCT02224846|466115985|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
129499068|NCT02224846|466115984|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
129499069|NCT02224846|466115985|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
129499070|NCT02224846|466115984|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
129499071|NCT02224846|466115985|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
129499072|NCT02224846|466115984|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
129499073|NCT02224846|466115985|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
129499074|NCT02224846|466115984|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
129499075|NCT02224846|466115985|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
129499076|NCT02224846|466115984|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
129499077|NCT02224846|466115985|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
129499078|NCT02224846|466115984|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
129499079|NCT02224846|466115985|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
129499080|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
129499081|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
129499082|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
129499083|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
129499084|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
129499085|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
129499086|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
129499087|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
129499088|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
129499089|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
129499090|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
129499091|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
129499092|NCT02224846|466115984|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
129499093|NCT02224846|466115985|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
129499094|NCT03280550|466115986|FG000|Overall Study|Withdrawal by Subject|2|||
129499095|NCT03280550|466115987|FG001|Overall Study|Withdrawal by Subject|2|||
129499096|NCT03280550|466115986|FG000|Overall Study|Physician Decision|0|||
129499097|NCT03280550|466115987|FG001|Overall Study|Physician Decision|1|||
129499098|NCT02203838|466115990|FG000|Overall Study|Lack of Efficacy|7|||
129499099|NCT02203838|466115991|FG001|Overall Study|Lack of Efficacy|0|||
129499100|NCT02203838|466115992|FG002|Overall Study|Lack of Efficacy|1|||
129499101|NCT02203838|466115993|FG003|Overall Study|Lack of Efficacy|1|||
129499102|NCT02203838|466115990|FG000|Overall Study|Adverse Event|46|||
129499103|NCT02203838|466115991|FG001|Overall Study|Adverse Event|6|||
129499104|NCT02203838|466115992|FG002|Overall Study|Adverse Event|3|||
129499105|NCT02203838|466115993|FG003|Overall Study|Adverse Event|2|||
129499106|NCT02203838|466115990|FG000|Overall Study|Lost to Follow-up|39|||
129499107|NCT02203838|466115991|FG001|Overall Study|Lost to Follow-up|3|||
129499108|NCT02203838|466115992|FG002|Overall Study|Lost to Follow-up|2|||
129499109|NCT02203838|466115993|FG003|Overall Study|Lost to Follow-up|1|||
129499110|NCT02203838|466115990|FG000|Overall Study|Protocol Violation|7|||
129499111|NCT02203838|466115991|FG001|Overall Study|Protocol Violation|3|||
129499112|NCT02203838|466115992|FG002|Overall Study|Protocol Violation|0|||
129499113|NCT02203838|466115993|FG003|Overall Study|Protocol Violation|0|||
129981716|NCT00201643|467896704|FG000|Overall Study|Withdrawal by Subject|5|||
129499114|NCT02203838|466115990|FG000|Overall Study|Withdrawal by Subject|83|||
129499115|NCT02203838|466115991|FG001|Overall Study|Withdrawal by Subject|10|||
129499116|NCT02203838|466115992|FG002|Overall Study|Withdrawal by Subject|8|||
129499117|NCT02203838|466115993|FG003|Overall Study|Withdrawal by Subject|11|||
129499118|NCT02203838|466115990|FG000|Overall Study|Physician Decision|27|||
129499119|NCT02203838|466115991|FG001|Overall Study|Physician Decision|0|||
129499120|NCT02203838|466115992|FG002|Overall Study|Physician Decision|2|||
129499121|NCT02203838|466115993|FG003|Overall Study|Physician Decision|3|||
129499122|NCT02203838|466115990|FG000|Overall Study|Other|1|||
129499123|NCT02203838|466115991|FG001|Overall Study|Other|0|||
129499124|NCT02203838|466115992|FG002|Overall Study|Other|0|||
129499125|NCT02203838|466115993|FG003|Overall Study|Other|0|||
129499126|NCT01915849|466115998|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
129499127|NCT01915849|466115999|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
129499128|NCT01915849|466116000|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
129499129|NCT01915849|466116001|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
129499130|NCT01915849|466115998|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
129499131|NCT01915849|466115999|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129499132|NCT01915849|466116000|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129499133|NCT01915849|466116001|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
129499134|NCT02689219|466116004|FG000|Overall Study|Death|1|||
129499135|NCT02689219|466116005|FG001|Overall Study|Death|1|||
129499136|NCT02689219|466116004|FG000|Overall Study|Disease Progression|10|||
129499137|NCT02689219|466116005|FG001|Overall Study|Disease Progression|6|||
129499138|NCT01067508|466116006|FG000|Overall Study|Physician Decision|0|||
129499139|NCT01067508|466116007|FG001|Overall Study|Physician Decision|1|||
129499140|NCT01067508|466116006|FG000|Overall Study|Withdrawal by Subject|0|||
129499141|NCT01067508|466116007|FG001|Overall Study|Withdrawal by Subject|1|||
129499142|NCT00444626|466116008|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
129499143|NCT00444626|466116008|FG000|Initial Treatment Period|Adverse Event|1|||
129499144|NCT00444626|466116008|FG000|Initial Treatment Period|Lost to Follow-up|9|||
129499145|NCT00786838|466116009|FG000|Overall Study|Physician Decision|4|||
129499146|NCT00786838|466116009|FG000|Overall Study|Death|4|||
129499147|NCT00786838|466116009|FG000|Overall Study|Adverse Event|6|||
129499148|NCT00786838|466116009|FG000|Overall Study|Progressive disease|31|||
129499149|NCT00786838|466116009|FG000|Overall Study|Withdrawal by Subject|4|||
129499150|NCT00436215|466116010|FG000|Overall Study|Refused further treatment|3|||
129499151|NCT00436215|466116010|FG000|Overall Study|Small bowel obstruction|1|||
129499152|NCT03050359|466117455|FG000|Overall Study|Randomized But Not Treated|2|||
129499153|NCT03050359|466117456|FG001|Overall Study|Randomized But Not Treated|0|||
129499154|NCT03050359|466117455|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
129499155|NCT03050359|466117456|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
129499156|NCT03050359|466117455|FG000|Overall Study|Significant Protocol Deviation|2|||
129499157|NCT03050359|466117456|FG001|Overall Study|Significant Protocol Deviation|3|||
129499158|NCT03050359|466117455|FG000|Overall Study|Lost to Follow-up|2|||
129499159|NCT03050359|466117456|FG001|Overall Study|Lost to Follow-up|1|||
129499160|NCT03050359|466117455|FG000|Overall Study|Voluntary Withdrawal|4|||
129499161|NCT03050359|466117456|FG001|Overall Study|Voluntary Withdrawal|6|||
129499162|NCT03050359|466117455|FG000|Overall Study|Pregnancy|1|||
129499163|NCT03050359|466117456|FG001|Overall Study|Pregnancy|0|||
129499164|NCT03050359|466117455|FG000|Overall Study|Reason Not Specified|1|||
129499165|NCT03050359|466117456|FG001|Overall Study|Reason Not Specified|0|||
129499166|NCT02614287|466117457|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
129499167|NCT02614287|466117458|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
129499168|NCT02614287|466117457|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
129499169|NCT02614287|466117458|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
129499170|NCT02614287|466117457|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
129499171|NCT02614287|466117458|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
129499172|NCT02614287|466117457|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
129499173|NCT02614287|466117458|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
129499174|NCT02614287|466117457|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
129499175|NCT02614287|466117458|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
129499176|NCT02614287|466117457|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
129499177|NCT02614287|466117458|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
129499178|NCT02614287|466117457|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
129499179|NCT02614287|466117458|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
129499180|NCT02614287|466117457|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
129499181|NCT02614287|466117458|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
129499182|NCT03580382|466117462|FG000|Overall Study|Early Termination of Study|0|||
129499183|NCT03580382|466117463|FG001|Overall Study|Early Termination of Study|3|||
129499184|NCT05619172|466117464|FG000|Safety Cohort 1|Death|7|||
129499185|NCT05619172|466117465|FG001|Safety Cohort 1|Death|0|||
129499186|NCT05619172|466117464|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
129499187|NCT05619172|466117465|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
129499188|NCT05619172|466117464|FG000|Safety Cohort 2|Death|0|||
129499189|NCT05619172|466117465|FG001|Safety Cohort 2|Death|1|||
129499190|NCT05619172|466117464|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
129499191|NCT05619172|466117465|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
129499192|NCT03010423|466117466|FG000|Overall Study|Study termination|8|||
129499193|NCT00520676|466117467|FG000|Overall Study|Death|84|||
129499194|NCT00520676|466117468|FG001|Overall Study|Death|81|||
129499195|NCT00520676|466117467|FG000|Overall Study|Lost to Follow-up|6|||
129499196|NCT00520676|466117468|FG001|Overall Study|Lost to Follow-up|10|||
129499197|NCT00520676|466117467|FG000|Overall Study|Physician Decision|4|||
129499198|NCT00520676|466117468|FG001|Overall Study|Physician Decision|1|||
129499199|NCT00520676|466117467|FG000|Overall Study|Withdrawal by Subject|7|||
129499200|NCT00520676|466117468|FG001|Overall Study|Withdrawal by Subject|11|||
129499201|NCT01718509|466117473|FG000|Overall Study|Lost to Follow-up|18|||
129499202|NCT01718509|466117474|FG001|Overall Study|Lost to Follow-up|15|||
129499203|NCT01718509|466117473|FG000|Overall Study|Withdrawal by Subject|7|||
129499204|NCT01718509|466117474|FG001|Overall Study|Withdrawal by Subject|13|||
129499205|NCT01718509|466117473|FG000|Overall Study|Adverse Event|5|||
129499206|NCT01718509|466117474|FG001|Overall Study|Adverse Event|7|||
129499207|NCT01718509|466117473|FG000|Overall Study|Other|13|||
129499208|NCT01718509|466117474|FG001|Overall Study|Other|11|||
129499209|NCT01718509|466117473|FG000|Overall Study|Protocol Violation|4|||
129499210|NCT01718509|466117474|FG001|Overall Study|Protocol Violation|2|||
129499211|NCT01718509|466117473|FG000|Overall Study|Lack of Efficacy|1|||
129499212|NCT01718509|466117474|FG001|Overall Study|Lack of Efficacy|0|||
129499213|NCT00411788|466117480|FG000|Overall Study|Protocol Violation|1|||
129499214|NCT00411788|466117480|FG000|Overall Study|Adverse Event|1|||
129499215|NCT01728584|466117481|FG000|Overall Study|Adverse Event|1|||
129499216|NCT01728584|466117482|FG001|Overall Study|Adverse Event|0|||
129499217|NCT01728584|466117483|FG002|Overall Study|Adverse Event|0|||
129499218|NCT01728584|466117484|FG003|Overall Study|Adverse Event|0|||
129499219|NCT01728584|466117481|FG000|Overall Study|Physician Decision|4|||
129499220|NCT01728584|466117482|FG001|Overall Study|Physician Decision|0|||
129499221|NCT01728584|466117483|FG002|Overall Study|Physician Decision|1|||
129499222|NCT01728584|466117484|FG003|Overall Study|Physician Decision|0|||
129499223|NCT01728584|466117481|FG000|Overall Study|Withdrawal by Subject|1|||
129499224|NCT01728584|466117482|FG001|Overall Study|Withdrawal by Subject|0|||
129499225|NCT01728584|466117483|FG002|Overall Study|Withdrawal by Subject|0|||
129499226|NCT01728584|466117484|FG003|Overall Study|Withdrawal by Subject|0|||
129499227|NCT01728584|466117481|FG000|Overall Study|Screen failure|1|||
129499228|NCT01728584|466117482|FG001|Overall Study|Screen failure|0|||
129499229|NCT01728584|466117483|FG002|Overall Study|Screen failure|0|||
129499230|NCT01728584|466117484|FG003|Overall Study|Screen failure|0|||
129499231|NCT01728584|466117481|FG000|Overall Study|Other reason (not specified)|1|||
129499232|NCT01728584|466117482|FG001|Overall Study|Other reason (not specified)|0|||
129499233|NCT01728584|466117483|FG002|Overall Study|Other reason (not specified)|0|||
129499234|NCT01728584|466117484|FG003|Overall Study|Other reason (not specified)|1|||
129499235|NCT05906732|466117485|FG000|Overall Study|Withdrawal by Subject|1|||
129499236|NCT05906732|466117486|FG001|Overall Study|Withdrawal by Subject|0|||
129499237|NCT05906732|466117487|FG002|Overall Study|Withdrawal by Subject|0|||
129499238|NCT05906732|466117488|FG003|Overall Study|Withdrawal by Subject|0|||
129499239|NCT05906732|466117485|FG000|Overall Study|Physician Decision|2|||
129499240|NCT05906732|466117486|FG001|Overall Study|Physician Decision|4|||
129499241|NCT05906732|466117487|FG002|Overall Study|Physician Decision|0|||
129499242|NCT05906732|466117488|FG003|Overall Study|Physician Decision|0|||
129499243|NCT00506077|466117492|FG000|Treatment Period 1|Adverse Event|2|||
129499244|NCT00506077|466117493|FG001|Treatment Period 1|Adverse Event|1|||
129499245|NCT00506077|466117492|FG000|Treatment Period 1|Lost to Follow-up|0|||
129499246|NCT00506077|466117493|FG001|Treatment Period 1|Lost to Follow-up|2|||
129499247|NCT00506077|466117492|FG000|Treatment Period 1|Withdrawal by Subject|2|||
129981717|NCT00201643|467896705|FG001|Overall Study|Withdrawal by Subject|4|||
129981718|NCT03446781|467896714|FG000|Overall Study|Lost to Follow-up|11|||
129499248|NCT00506077|466117493|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129499249|NCT00506077|466117492|FG000|Treatment Period 2|Adverse Event|0|||
129981719|NCT03446781|467896715|FG001|Overall Study|Lost to Follow-up|5|||
129499250|NCT00506077|466117493|FG001|Treatment Period 2|Adverse Event|1|||
129499251|NCT00506077|466117492|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129499252|NCT00506077|466117493|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129499253|NCT01727713|466117496|FG000|Overall Study|Lost to Follow-up|5|||
129499254|NCT01727713|466117496|FG000|Overall Study|Adverse Event|10|||
129499255|NCT01727713|466117496|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
129499256|NCT01727713|466117496|FG000|Overall Study|Withdrawal by Subject|13|||
129499257|NCT01727713|466117496|FG000|Overall Study|Protocol Deviation|2|||
129499258|NCT00471536|466117501|FG000|Overall Study|Withdrawal by Subject|1|||
129499259|NCT02651194|466117502|FG000|Overall Study|Lost to Follow-up|3|||
129499260|NCT02651194|466117502|FG000|Overall Study|Other|2|||
129499261|NCT03885726|466117505|FG000|Overall Study|Staffing issues/lost interest|1|||
129499262|NCT03885726|466117505|FG000|Overall Study|Early discharge from hospital|3|||
129499263|NCT01217190|466117506|FG000|Second Dosing|Withdrawal by Subject|0|||
129499264|NCT01217190|466117507|FG001|Second Dosing|Withdrawal by Subject|2|||
129499265|NCT03116399|466117508|FG000|Overall Study|Death|8|||
129499266|NCT03116399|466117509|FG001|Overall Study|Death|3|||
129499267|NCT03116399|466117508|FG000|Overall Study|Lost to Follow-up|7|||
129499268|NCT03116399|466117509|FG001|Overall Study|Lost to Follow-up|11|||
129499269|NCT03116399|466117508|FG000|Overall Study|Investigator Decision|1|||
129499270|NCT03116399|466117509|FG001|Overall Study|Investigator Decision|1|||
129499271|NCT03116399|466117508|FG000|Overall Study|Withdrawal by Subject|24|||
129499272|NCT03116399|466117509|FG001|Overall Study|Withdrawal by Subject|9|||
129499273|NCT02868216|466117510|FG000|Overall Study|Death|0|||
129499274|NCT02868216|466117511|FG001|Overall Study|Death|1|||
129499275|NCT02868216|466117510|FG000|Overall Study|coronary artery bypass|1|||
129499276|NCT02868216|466117511|FG001|Overall Study|coronary artery bypass|0|||
129499277|NCT02868216|466117510|FG000|Overall Study|Withdrawal by Subject|7|||
129499278|NCT02868216|466117511|FG001|Overall Study|Withdrawal by Subject|5|||
129499279|NCT01975272|466117516|FG000|Overall Study|Excluded after protocol amendment|1|||
129499280|NCT01975272|466117517|FG001|Overall Study|Excluded after protocol amendment|1|||
129499281|NCT01975272|466117518|FG002|Overall Study|Excluded after protocol amendment|2|||
129499282|NCT00222729|466117521|FG000|Overall Study|Adverse Event|3|||
129499283|NCT00515008|466117522|FG000|Overall Study|Lost to Follow-up|1|||
129499284|NCT00515008|466117523|FG001|Overall Study|Lost to Follow-up|0|||
129499285|NCT00515008|466117522|FG000|Overall Study|Declined|0|||
129499286|NCT00515008|466117523|FG001|Overall Study|Declined|3|||
129499287|NCT00515008|466117522|FG000|Overall Study|Left the Boston Area|1|||
129499288|NCT00515008|466117523|FG001|Overall Study|Left the Boston Area|1|||
129499289|NCT00515008|466117522|FG000|Overall Study|Scheduling conflict|1|||
129499290|NCT00515008|466117523|FG001|Overall Study|Scheduling conflict|0|||
129499291|NCT05091060|466117524|FG000|Overall Study|Lost to Follow-up|1|||
129499292|NCT01798706|466117525|FG000|Overall Study|Adverse Event|15|||
129499293|NCT01798706|466117526|FG001|Overall Study|Adverse Event|10|||
129499294|NCT01798706|466117525|FG000|Overall Study|Lack of Efficacy|0|||
129499295|NCT01798706|466117526|FG001|Overall Study|Lack of Efficacy|2|||
129499296|NCT01798706|466117525|FG000|Overall Study|Poor compliance to protocol|1|||
129499297|NCT01798706|466117526|FG001|Overall Study|Poor compliance to protocol|0|||
129499298|NCT01798706|466117525|FG000|Overall Study|Other than specified above|5|||
129499299|NCT01798706|466117526|FG001|Overall Study|Other than specified above|9|||
129499300|NCT02775864|466117527|FG000|Overall Study|Data ended end of 2010|1764|||
129499301|NCT02775864|466117528|FG001|Overall Study|Data ended end of 2010|2880|||
129499302|NCT02775864|466117529|FG002|Overall Study|Data ended end of 2010|1140|||
129499303|NCT02775864|466117530|FG003|Overall Study|Data ended end of 2010|1194|||
129499304|NCT02775864|466117527|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
129499305|NCT02775864|466117528|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
129499306|NCT02775864|466117529|FG002|Overall Study|Medicaid eligibility discontinued|720|||
129499307|NCT02775864|466117530|FG003|Overall Study|Medicaid eligibility discontinued|890|||
129499308|NCT03238235|466117531|FG000|Overall Study|Adverse Event|2|||
129499309|NCT03238235|466117532|FG001|Overall Study|Adverse Event|0|||
129499310|NCT03238235|466117531|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
129499311|NCT03238235|466117532|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
129499312|NCT05896761|466117533|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
129499313|NCT05896761|466117534|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
129499314|NCT05896761|466117533|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
129499315|NCT05896761|466117534|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
129499316|NCT03552549|466117537|FG000|Overall Study|Disease progression|25|||
129499317|NCT03552549|466117538|FG001|Overall Study|Disease progression|17|||
129499318|NCT03552549|466117537|FG000|Overall Study|Adverse event in first 12 months|12|||
129499319|NCT03552549|466117538|FG001|Overall Study|Adverse event in first 12 months|8|||
129499320|NCT03552549|466117537|FG000|Overall Study|Withdrawal by Subject|7|||
129499321|NCT03552549|466117538|FG001|Overall Study|Withdrawal by Subject|7|||
129499322|NCT03552549|466117537|FG000|Overall Study|Unknown (no reason provided)|4|||
129499323|NCT03552549|466117538|FG001|Overall Study|Unknown (no reason provided)|2|||
129499324|NCT03552549|466117537|FG000|Overall Study|Not in participant's best interest|2|||
129499325|NCT03552549|466117538|FG001|Overall Study|Not in participant's best interest|1|||
129981720|NCT03446781|467896714|FG000|Overall Study|Withdrawal by Subject|9|||
129499326|NCT03552549|466117537|FG000|Overall Study|Did not complete study treatment|2|||
129499327|NCT03552549|466117538|FG001|Overall Study|Did not complete study treatment|3|||
129499328|NCT03552549|466117537|FG000|Overall Study|Did not meet eligibility criteria|1|||
129499329|NCT03552549|466117538|FG001|Overall Study|Did not meet eligibility criteria|0|||
129981721|NCT03446781|467896715|FG001|Overall Study|Withdrawal by Subject|7|||
129499330|NCT03552549|466117537|FG000|Overall Study|Administrative|0|||
129499331|NCT03552549|466117538|FG001|Overall Study|Administrative|14|||
129981722|NCT03446781|467896714|FG000|Overall Study|Adverse Event|8|||
129499332|NCT02739594|466117541|FG000|Overall Study|Undesired Event|3|||
129981723|NCT03446781|467896715|FG001|Overall Study|Adverse Event|2|||
129499333|NCT02739594|466117542|FG001|Overall Study|Undesired Event|4|||
129499334|NCT02739594|466117541|FG000|Overall Study|Violation of Eligibility Criteria|1|||
129499335|NCT02739594|466117542|FG001|Overall Study|Violation of Eligibility Criteria|2|||
129499336|NCT02739594|466117541|FG000|Overall Study|Protocol Violation|5|||
129499337|NCT02739594|466117542|FG001|Overall Study|Protocol Violation|6|||
129499338|NCT02739594|466117541|FG000|Overall Study|Death|4|||
129499339|NCT02739594|466117542|FG001|Overall Study|Death|2|||
129499340|NCT02739594|466117541|FG000|Overall Study|Renal Insufficiency|4|||
129499341|NCT02739594|466117542|FG001|Overall Study|Renal Insufficiency|6|||
129499342|NCT02739594|466117541|FG000|Overall Study|Administrative Reasons|1|||
129499343|NCT02739594|466117542|FG001|Overall Study|Administrative Reasons|3|||
129499344|NCT02739594|466117541|FG000|Overall Study|Withdrawal by Subject|1|||
129499345|NCT02739594|466117542|FG001|Overall Study|Withdrawal by Subject|1|||
129499346|NCT02739594|466117541|FG000|Overall Study|Lost to Follow-up|0|||
129499347|NCT02739594|466117542|FG001|Overall Study|Lost to Follow-up|1|||
129499348|NCT02739594|466117541|FG000|Overall Study|Elevated Serum Creatinine|0|||
129499349|NCT02739594|466117542|FG001|Overall Study|Elevated Serum Creatinine|1|||
129499350|NCT02739594|466117541|FG000|Overall Study|Other|6|||
129499351|NCT02739594|466117542|FG001|Overall Study|Other|2|||
129499352|NCT01465178|466117545|FG000|Overall Study|Withdrawal by Subject|1|||
129499353|NCT01465178|466117546|FG001|Overall Study|Withdrawal by Subject|0|||
129499354|NCT00527111|466117547|FG000|Overall Study|Adverse Event|14|||
129499355|NCT00527111|466117548|FG001|Overall Study|Adverse Event|13|||
129499356|NCT00527111|466117547|FG000|Overall Study|Death|0|||
129499357|NCT00527111|466117548|FG001|Overall Study|Death|1|||
129499358|NCT00527111|466117547|FG000|Overall Study|Investigator Request|2|||
129499359|NCT00527111|466117548|FG001|Overall Study|Investigator Request|1|||
129499360|NCT00527111|466117547|FG000|Overall Study|Patient Request|2|||
129499361|NCT00527111|466117548|FG001|Overall Study|Patient Request|5|||
129499362|NCT00527111|466117547|FG000|Overall Study|Other|2|||
129499363|NCT00527111|466117548|FG001|Overall Study|Other|2|||
129499364|NCT03827473|466117551|FG000|Overall Study|Withdrawal by Subject|1|||
129499365|NCT03827473|466117552|FG001|Overall Study|Withdrawal by Subject|0|||
129499366|NCT01477892|466117553|FG000|Overall Study|Withdrawal by Subject|0|||
129499367|NCT01477892|466117554|FG001|Overall Study|Withdrawal by Subject|2|||
129499368|NCT01921257|466117555|FG000|Overall Study|Adverse Event|1|||
129499369|NCT01921257|466117555|FG000|Overall Study|Protocol Violation|1|||
129499370|NCT01921257|466117555|FG000|Overall Study|Withdrawal by Subject|1|||
129499371|NCT05515601|466117559|FG000|Overall Study|Withdrawal by Subject|1|||
129499372|NCT05515601|466117560|FG001|Overall Study|Withdrawal by Subject|3|||
129499373|NCT05515601|466117561|FG002|Overall Study|Withdrawal by Subject|2|||
129499374|NCT05515601|466117562|FG003|Overall Study|Withdrawal by Subject|1|||
129499375|NCT05515601|466117563|FG004|Overall Study|Withdrawal by Subject|1|||
129499376|NCT05515601|466117564|FG005|Overall Study|Withdrawal by Subject|1|||
129499377|NCT05515601|466117559|FG000|Overall Study|Lost to Follow-up|0|||
129499378|NCT05515601|466117560|FG001|Overall Study|Lost to Follow-up|0|||
129499379|NCT05515601|466117561|FG002|Overall Study|Lost to Follow-up|0|||
129499380|NCT05515601|466117562|FG003|Overall Study|Lost to Follow-up|0|||
129499381|NCT05515601|466117563|FG004|Overall Study|Lost to Follow-up|1|||
129499382|NCT05515601|466117564|FG005|Overall Study|Lost to Follow-up|0|||
129499383|NCT00777491|466117565|FG000|Overall Study|Protocol Violation|0|||
129499384|NCT00777491|466117566|FG001|Overall Study|Protocol Violation|2|||
129499385|NCT00777491|466117565|FG000|Overall Study|Did not receive any protocol treatment|2|||
129499386|NCT00777491|466117566|FG001|Overall Study|Did not receive any protocol treatment|0|||
129499387|NCT00540436|466117569|FG000|First 12-Week Treatment Period|Adverse Event|1|||
129499388|NCT00540436|466117569|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
129499389|NCT00540436|466117569|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
129499390|NCT00540436|466117569|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
129499391|NCT03255291|466117570|FG000|Overall Study|Determined to be ineligible|10|||
129499392|NCT03255291|466117571|FG001|Overall Study|Determined to be ineligible|12|||
129499393|NCT03255291|466117572|FG002|Overall Study|Determined to be ineligible|6|||
129499394|NCT03255291|466117573|FG003|Overall Study|Determined to be ineligible|6|||
129499395|NCT03255291|466117574|FG004|Overall Study|Determined to be ineligible|5|||
129499396|NCT03255291|466117575|FG005|Overall Study|Determined to be ineligible|10|||
129499397|NCT03255291|466117570|FG000|Overall Study|Baseline data collection issues|3|||
129499398|NCT03255291|466117571|FG001|Overall Study|Baseline data collection issues|0|||
129499399|NCT03255291|466117572|FG002|Overall Study|Baseline data collection issues|0|||
129499400|NCT03255291|466117573|FG003|Overall Study|Baseline data collection issues|0|||
129499401|NCT03255291|466117574|FG004|Overall Study|Baseline data collection issues|2|||
129499402|NCT03255291|466117575|FG005|Overall Study|Baseline data collection issues|0|||
129499403|NCT01745393|466117576|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
129499404|NCT01745393|466117577|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
129499405|NCT01745393|466117576|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
129499406|NCT01745393|466117577|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
129499407|NCT01745393|466117576|FG000|12-month Follow-up|Lost to Follow-up|6|||
129499408|NCT01745393|466117577|FG001|12-month Follow-up|Lost to Follow-up|5|||
129499409|NCT00471445|466117579|FG000|Overall Study|Withdrawal by Subject|1|||
129499410|NCT00471445|466117580|FG001|Overall Study|Withdrawal by Subject|1|||
129499411|NCT00471445|466117579|FG000|Overall Study|Ineligible|1|||
129981724|NCT03446781|467896714|FG000|Overall Study|Protocol Violation|0|||
129981725|NCT03446781|467896715|FG001|Overall Study|Protocol Violation|3|||
129981726|NCT00996476|467896719|FG000|Overall Study|Withdrawal by Subject|1|||
129981727|NCT00996476|467896720|FG001|Overall Study|Withdrawal by Subject|2|||
129981728|NCT00996476|467896721|FG002|Overall Study|Withdrawal by Subject|1|||
129981729|NCT00996476|467896722|FG003|Overall Study|Withdrawal by Subject|0|||
129981730|NCT00996476|467896723|FG004|Overall Study|Withdrawal by Subject|1|||
129981731|NCT00996476|467896719|FG000|Overall Study|Adverse Event|0|||
129981732|NCT00996476|467896720|FG001|Overall Study|Adverse Event|1|||
129981733|NCT00996476|467896721|FG002|Overall Study|Adverse Event|0|||
129981734|NCT00996476|467896722|FG003|Overall Study|Adverse Event|0|||
129981735|NCT00996476|467896723|FG004|Overall Study|Adverse Event|1|||
129981736|NCT05540717|467896724|FG000|Overall Study|Lost to Follow-up|2|||
129981737|NCT05540717|467896725|FG001|Overall Study|Lost to Follow-up|5|||
129981738|NCT05540717|467896724|FG000|Overall Study|Withdrawal by Subject|6|||
129981739|NCT05540717|467896725|FG001|Overall Study|Withdrawal by Subject|6|||
129981740|NCT05540717|467896724|FG000|Overall Study|Sponsor request|1|||
129981741|NCT05540717|467896725|FG001|Overall Study|Sponsor request|0|||
129981742|NCT05540717|467896724|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
129981743|NCT05540717|467896725|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
129981744|NCT05540717|467896724|FG000|Overall Study|Other|0|||
129981745|NCT05540717|467896725|FG001|Overall Study|Other|1|||
129981746|NCT00473265|467896726|FG000|Overall Study|Unrelated adverse event|5|||
129981747|NCT00473265|467896726|FG000|Overall Study|Off treatment early|15|||
129981748|NCT01940939|467896731|FG000|Overall Study|Withdrawal by Subject|2|||
129981749|NCT01940939|467896732|FG001|Overall Study|Withdrawal by Subject|8|||
129981750|NCT01470001|467896733|FG000|Overall Study|Lost to Follow-up|1|||
129981751|NCT01470001|467896734|FG001|Overall Study|Lost to Follow-up|1|||
129981752|NCT01470001|467896733|FG000|Overall Study|Physician Decision|2|||
129981753|NCT01470001|467896734|FG001|Overall Study|Physician Decision|0|||
129981754|NCT01470001|467896733|FG000|Overall Study|Withdrawal by Subject|2|||
129981755|NCT01470001|467896734|FG001|Overall Study|Withdrawal by Subject|1|||
129981756|NCT01895101|467896735|FG000|Overall Study|OPCAB procedure|1|||
129981757|NCT01895101|467896736|FG001|Overall Study|OPCAB procedure|1|||
129981758|NCT01895101|467896737|FG002|Overall Study|OPCAB procedure|3|||
129981759|NCT01895101|467896735|FG000|Overall Study|Withdrawal by Subject|0|||
129981760|NCT01895101|467896736|FG001|Overall Study|Withdrawal by Subject|1|||
129981761|NCT01895101|467896737|FG002|Overall Study|Withdrawal by Subject|2|||
129981762|NCT01895101|467896735|FG000|Overall Study|another study, enrolled in other study|0|||
129981763|NCT01895101|467896736|FG001|Overall Study|another study, enrolled in other study|1|||
129981764|NCT01895101|467896737|FG002|Overall Study|another study, enrolled in other study|0|||
129981765|NCT01895101|467896735|FG000|Overall Study|Death|0|||
129981766|NCT01895101|467896736|FG001|Overall Study|Death|1|||
129981767|NCT01895101|467896737|FG002|Overall Study|Death|0|||
129981768|NCT01895101|467896735|FG000|Overall Study|coagulation disorder|0|||
129981769|NCT01895101|467896736|FG001|Overall Study|coagulation disorder|1|||
129981770|NCT01895101|467896737|FG002|Overall Study|coagulation disorder|0|||
129981771|NCT00370682|467896738|FG000|Overall Study|Moved from area|0|||
129981772|NCT00370682|467896739|FG001|Overall Study|Moved from area|2|||
129981773|NCT00370682|467896740|FG002|Overall Study|Moved from area|0|||
129981774|NCT00370682|467896738|FG000|Overall Study|Lost to Follow-up|0|||
129981775|NCT00370682|467896739|FG001|Overall Study|Lost to Follow-up|1|||
129981776|NCT00370682|467896740|FG002|Overall Study|Lost to Follow-up|1|||
129981777|NCT00127205|467896741|FG000|Overall Study|Adverse Event|228|||
129981778|NCT00127205|467896742|FG001|Overall Study|Adverse Event|387|||
129981779|NCT00127205|467896743|FG002|Overall Study|Adverse Event|273|||
129981780|NCT00127205|467896741|FG000|Overall Study|Death|8|||
129981781|NCT00127205|467896742|FG001|Overall Study|Death|6|||
129981782|NCT00127205|467896743|FG002|Overall Study|Death|5|||
129981783|NCT00127205|467896741|FG000|Overall Study|Withdrawal by Subject|318|||
129981784|NCT00127205|467896742|FG001|Overall Study|Withdrawal by Subject|310|||
129981785|NCT00127205|467896743|FG002|Overall Study|Withdrawal by Subject|172|||
129981786|NCT00127205|467896741|FG000|Overall Study|Other-non protocol specified|142|||
129981787|NCT00127205|467896742|FG001|Overall Study|Other-non protocol specified|129|||
129981788|NCT00127205|467896743|FG002|Overall Study|Other-non protocol specified|77|||
129981789|NCT00127205|467896741|FG000|Overall Study|Data not reported|6|||
129981790|NCT00127205|467896742|FG001|Overall Study|Data not reported|10|||
129981791|NCT00127205|467896743|FG002|Overall Study|Data not reported|1|||
129981792|NCT00127205|467896741|FG000|Overall Study|Progression|127|||
129981793|NCT00127205|467896742|FG001|Overall Study|Progression|131|||
129981794|NCT00127205|467896743|FG002|Overall Study|Progression|84|||
129981795|NCT01280357|467896748|FG000|Overall Study|Excluded no internal monitoring|14|||
129981796|NCT01280357|467896748|FG000|Overall Study|IInsufficient data/No data supplied|12|||
129981797|NCT01259089|467896749|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981798|NCT01259089|467896750|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981799|NCT01259089|467896751|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129499412|NCT00471445|466117580|FG001|Overall Study|Ineligible|0|||
129499413|NCT00471445|466117579|FG000|Overall Study|Protocol Violation|0|||
129499414|NCT00471445|466117580|FG001|Overall Study|Protocol Violation|1|||
129499415|NCT03591146|466117581|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
129499416|NCT03591146|466117582|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
129499417|NCT03591146|466117583|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
129499418|NCT03591146|466117584|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
129499419|NCT03591146|466117585|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
129499420|NCT03591146|466117581|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
129499421|NCT03591146|466117582|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
129499422|NCT03591146|466117583|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
129499423|NCT03591146|466117584|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
129499424|NCT03591146|466117585|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
129499425|NCT03591146|466117581|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
129499426|NCT03591146|466117582|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
129499427|NCT03591146|466117583|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
129981800|NCT01259089|467896752|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981801|NCT01259089|467896753|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
129981802|NCT01259089|467896754|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
129981803|NCT01259089|467896749|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
129981804|NCT01259089|467896750|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
129981805|NCT01259089|467896751|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
129981806|NCT01259089|467896752|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
129981807|NCT01259089|467896753|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
129981808|NCT01259089|467896754|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
129981809|NCT01259089|467896749|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981810|NCT01259089|467896750|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981811|NCT01259089|467896751|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981812|NCT01259089|467896752|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981813|NCT01259089|467896753|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
129981814|NCT01259089|467896754|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
129981815|NCT01259089|467896749|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981816|NCT01259089|467896750|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981817|NCT01259089|467896751|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981818|NCT01259089|467896752|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
129981819|NCT01259089|467896753|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
129981820|NCT01259089|467896754|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
129981821|NCT01259089|467896749|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
129981822|NCT01259089|467896750|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
129981823|NCT01259089|467896751|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
129981824|NCT01259089|467896752|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
129981825|NCT01259089|467896753|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
129981826|NCT01259089|467896754|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
129981827|NCT01259089|467896749|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
129981828|NCT01259089|467896750|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981829|NCT01259089|467896751|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981830|NCT01259089|467896752|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981831|NCT01259089|467896753|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981832|NCT01259089|467896754|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
129981833|NCT01259089|467896749|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981834|NCT01259089|467896750|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981835|NCT01259089|467896751|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981836|NCT01259089|467896752|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
129981837|NCT01259089|467896753|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
129981838|NCT01259089|467896754|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
129981839|NCT01259089|467896749|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981840|NCT01259089|467896750|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981841|NCT01259089|467896751|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981842|NCT01259089|467896752|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
129981843|NCT01259089|467896753|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
129981844|NCT01259089|467896754|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
129981845|NCT01259089|467896749|FG000|Survival Follow up for Two Years|Death|3|||
129981846|NCT01259089|467896750|FG001|Survival Follow up for Two Years|Death|2|||
129981847|NCT01259089|467896751|FG002|Survival Follow up for Two Years|Death|2|||
129981848|NCT01259089|467896752|FG003|Survival Follow up for Two Years|Death|3|||
129981849|NCT01259089|467896753|FG004|Survival Follow up for Two Years|Death|6|||
129981850|NCT01259089|467896754|FG005|Survival Follow up for Two Years|Death|13|||
129981851|NCT01259089|467896749|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
129499428|NCT03591146|466117584|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
129499429|NCT03591146|466117585|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
129499430|NCT03591146|466117581|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
129499431|NCT03591146|466117582|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
129499432|NCT03591146|466117583|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
129499433|NCT03591146|466117584|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
129499434|NCT03591146|466117585|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
129499435|NCT04737031|466117588|FG000|Overall Study|Patients who did not have a treatment visit|0|||
129499436|NCT04737031|466117589|FG001|Overall Study|Patients who did not have a treatment visit|31|||
129499437|NCT04737031|466117590|FG002|Overall Study|Patients who did not have a treatment visit|93|||
129499438|NCT04737031|466117591|FG003|Overall Study|Patients who did not have a treatment visit|227|||
129499439|NCT01511419|466117596|FG000|Dose 2|Physician Decision|1|||
129499440|NCT01511419|466117597|FG001|Dose 2|Physician Decision|0|||
129499441|NCT04594239|466117598|FG000|Overall Study|Withdrawal by Subject|3|||
129499442|NCT04594239|466117599|FG001|Overall Study|Withdrawal by Subject|4|||
129499443|NCT04594239|466117600|FG002|Overall Study|Withdrawal by Subject|2|||
129499444|NCT04594239|466117601|FG003|Overall Study|Withdrawal by Subject|4|||
129499445|NCT04594239|466117598|FG000|Overall Study|Lost to Follow-up|8|||
129499446|NCT04594239|466117599|FG001|Overall Study|Lost to Follow-up|5|||
129499447|NCT04594239|466117600|FG002|Overall Study|Lost to Follow-up|4|||
129499448|NCT04594239|466117601|FG003|Overall Study|Lost to Follow-up|6|||
129499449|NCT04594239|466117598|FG000|Overall Study|Subject relocated|0|||
129499450|NCT04594239|466117599|FG001|Overall Study|Subject relocated|0|||
129499451|NCT04594239|466117600|FG002|Overall Study|Subject relocated|0|||
129499452|NCT04594239|466117601|FG003|Overall Study|Subject relocated|1|||
129499453|NCT00091390|466117602|FG000|Overall Study|Protocol Violation|1|||
129499454|NCT00091390|466117602|FG000|Overall Study|No protocol treatment|3|||
129499455|NCT03229759|466117603|FG000|Overall Study|Screen Failure|30|||
129499456|NCT02326467|466119067|FG000|Overall Study|Withdrawal by Subject|1|||
129499457|NCT00434512|466119068|FG000|Overall Study|Migrated/moved from study area|0|||
129499458|NCT00434512|466119069|FG001|Overall Study|Migrated/moved from study area|0|||
129499459|NCT00434512|466119070|FG002|Overall Study|Migrated/moved from study area|0|||
129499460|NCT00434512|466119071|FG003|Overall Study|Migrated/moved from study area|1|||
129499461|NCT00434512|466119072|FG004|Overall Study|Migrated/moved from study area|1|||
129499462|NCT00434512|466119073|FG005|Overall Study|Migrated/moved from study area|1|||
129499463|NCT00434512|466119068|FG000|Overall Study|Other|0|||
129499464|NCT00434512|466119069|FG001|Overall Study|Other|1|||
129499465|NCT00434512|466119070|FG002|Overall Study|Other|0|||
129499466|NCT00434512|466119071|FG003|Overall Study|Other|0|||
129499467|NCT00434512|466119072|FG004|Overall Study|Other|0|||
129499468|NCT00434512|466119073|FG005|Overall Study|Other|0|||
129499469|NCT01575197|466119076|FG000|Overall Study|Migration out of study area|1|||
129499470|NCT01575197|466119077|FG001|Overall Study|Migration out of study area|5|||
129499471|NCT01575197|466119078|FG002|Overall Study|Migration out of study area|4|||
129499472|NCT01575197|466119076|FG000|Overall Study|SAE|0|||
129499473|NCT01575197|466119077|FG001|Overall Study|SAE|1|||
129499474|NCT01575197|466119078|FG002|Overall Study|SAE|0|||
129499475|NCT01575197|466119076|FG000|Overall Study|Lost to Follow-up|0|||
129499476|NCT01575197|466119077|FG001|Overall Study|Lost to Follow-up|1|||
129499477|NCT01575197|466119078|FG002|Overall Study|Lost to Follow-up|0|||
129499478|NCT01575197|466119076|FG000|Overall Study|Withdrawal by Subject|0|||
129499479|NCT01575197|466119077|FG001|Overall Study|Withdrawal by Subject|1|||
129499480|NCT01575197|466119078|FG002|Overall Study|Withdrawal by Subject|1|||
129499481|NCT01575197|466119076|FG000|Overall Study|Protocol Violation|2|||
129499482|NCT01575197|466119077|FG001|Overall Study|Protocol Violation|1|||
129499483|NCT01575197|466119078|FG002|Overall Study|Protocol Violation|1|||
129499484|NCT00111475|466119082|FG000|Overall Study|Lost to Follow-up|0|||
129499485|NCT00111475|466119083|FG001|Overall Study|Lost to Follow-up|0|||
129499486|NCT00111475|466119084|FG002|Overall Study|Lost to Follow-up|0|||
129499487|NCT00111475|466119085|FG003|Overall Study|Lost to Follow-up|0|||
129499488|NCT00111475|466119086|FG004|Overall Study|Lost to Follow-up|0|||
129499489|NCT00111475|466119087|FG005|Overall Study|Lost to Follow-up|1|||
129499490|NCT00111475|466119088|FG006|Overall Study|Lost to Follow-up|0|||
129499491|NCT00111475|466119089|FG007|Overall Study|Lost to Follow-up|0|||
129499492|NCT00111475|466119090|FG008|Overall Study|Lost to Follow-up|0|||
129499493|NCT00111475|466119091|FG009|Overall Study|Lost to Follow-up|0|||
129499494|NCT03303092|466119092|FG000|Overall Study|Adverse Event|1|||
129499495|NCT03303092|466119093|FG001|Overall Study|Adverse Event|0|||
129499496|NCT03303092|466119094|FG002|Overall Study|Adverse Event|1|||
129499497|NCT03303092|466119092|FG000|Overall Study|Protocol Violation|1|||
129499498|NCT03303092|466119093|FG001|Overall Study|Protocol Violation|5|||
129499499|NCT03303092|466119094|FG002|Overall Study|Protocol Violation|1|||
129499500|NCT03303092|466119092|FG000|Overall Study|Withdrawal by Subject|1|||
129499501|NCT03303092|466119093|FG001|Overall Study|Withdrawal by Subject|1|||
129499502|NCT03303092|466119094|FG002|Overall Study|Withdrawal by Subject|3|||
129499503|NCT00833248|466119100|FG000|Overall Study|Adverse Event|3|||
129499504|NCT00833248|466119101|FG001|Overall Study|Adverse Event|0|||
129499505|NCT00833248|466119100|FG000|Overall Study|Protocol Violation|1|||
129499506|NCT00833248|466119101|FG001|Overall Study|Protocol Violation|2|||
129499507|NCT00833248|466119100|FG000|Overall Study|Withdrawal by Subject|0|||
129499508|NCT00833248|466119101|FG001|Overall Study|Withdrawal by Subject|1|||
129499509|NCT02006667|466119102|FG000|Overall Study|Adverse Event|3|||
129499510|NCT02006667|466119102|FG000|Overall Study|Death|2|||
129499511|NCT02006667|466119102|FG000|Overall Study|Withdrawal by Subject|1|||
129499512|NCT02939937|466119103|FG000|Overall Study|Adverse Event|5|||
129499513|NCT02939937|466119104|FG001|Overall Study|Adverse Event|0|||
129499514|NCT02939937|466119103|FG000|Overall Study|Lost to Follow-up|1|||
129499515|NCT02939937|466119104|FG001|Overall Study|Lost to Follow-up|3|||
129499516|NCT04281030|466119113|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
129499517|NCT04281030|466119114|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
129499518|NCT04281030|466119113|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
129499519|NCT04281030|466119114|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
129499520|NCT01361009|466119115|FG000|Overall Study|Protocol Violation|116|||
129499521|NCT01826422|466119116|FG000|Overall Study|Withdrawal by Subject|1|||
129499522|NCT01826422|466119117|FG001|Overall Study|Withdrawal by Subject|3|||
129499523|NCT02179515|466119124|FG000|Overall Study|switched to alternative treatment|0|||
129499524|NCT02179515|466119125|FG001|Overall Study|switched to alternative treatment|1|||
129499525|NCT02179515|466119126|FG002|Overall Study|switched to alternative treatment|1|||
129499526|NCT02179515|466119124|FG000|Overall Study|Death|0|||
129499527|NCT02179515|466119125|FG001|Overall Study|Death|1|||
129499528|NCT02179515|466119126|FG002|Overall Study|Death|1|||
129499529|NCT02179515|466119124|FG000|Overall Study|refused further treatment|0|||
129499530|NCT02179515|466119125|FG001|Overall Study|refused further treatment|3|||
129499531|NCT02179515|466119126|FG002|Overall Study|refused further treatment|4|||
129499532|NCT02179515|466119124|FG000|Overall Study|Disease progression on study|2|||
129499533|NCT02179515|466119125|FG001|Overall Study|Disease progression on study|11|||
129499534|NCT02179515|466119126|FG002|Overall Study|Disease progression on study|8|||
129499535|NCT00115349|466119127|FG000|Overall Study|Study closed due to low enrollment.|11|||
129499536|NCT00115349|466119128|FG001|Overall Study|Study closed due to low enrollment.|9|||
129499537|NCT02116660|466119129|FG000|Overall Study|Deteriorating renal function|0|||
129499538|NCT02116660|466119130|FG001|Overall Study|Deteriorating renal function|1|||
129499539|NCT02116660|466119129|FG000|Overall Study|Adverse Event|1|||
129499540|NCT02116660|466119130|FG001|Overall Study|Adverse Event|1|||
129499541|NCT02116660|466119129|FG000|Overall Study|Withdrawal by Subject|0|||
129499542|NCT02116660|466119130|FG001|Overall Study|Withdrawal by Subject|2|||
129499543|NCT02116660|466119129|FG000|Overall Study|Organization reason|1|||
129499544|NCT02116660|466119130|FG001|Overall Study|Organization reason|0|||
129499545|NCT00390416|466119131|FG000|Overall Study|Withdrawal by Subject|1|||
129499546|NCT00390416|466119131|FG000|Overall Study|Not treated|3|||
129499547|NCT02496585|466119133|FG000|Overall Study|Death|3|||
129499548|NCT02496585|466119134|FG001|Overall Study|Death|0|||
129499549|NCT02496585|466119133|FG000|Overall Study|Lost to Follow-up|2|||
129499550|NCT02496585|466119134|FG001|Overall Study|Lost to Follow-up|0|||
129499551|NCT02496585|466119133|FG000|Overall Study|Withdrawal by Subject|1|||
129499552|NCT02496585|466119134|FG001|Overall Study|Withdrawal by Subject|2|||
129499553|NCT02496585|466119133|FG000|Overall Study|Progression of Malignancy|4|||
129499554|NCT02496585|466119134|FG001|Overall Study|Progression of Malignancy|1|||
129499555|NCT04891770|466119135|FG000|Overall Study|Withdrew consent|1|||
129499556|NCT04891770|466119136|FG001|Overall Study|Withdrew consent|3|||
129499557|NCT04891770|466119137|FG002|Overall Study|Withdrew consent|0|||
129499558|NCT04891770|466119135|FG000|Overall Study|Enrolled but never treated|0|||
129499559|NCT04891770|466119136|FG001|Overall Study|Enrolled but never treated|0|||
129499560|NCT04891770|466119137|FG002|Overall Study|Enrolled but never treated|1|||
129499561|NCT04891770|466119135|FG000|Overall Study|Investigator's discretion|0|||
129499562|NCT04891770|466119136|FG001|Overall Study|Investigator's discretion|1|||
129499563|NCT04891770|466119137|FG002|Overall Study|Investigator's discretion|0|||
129499564|NCT00496873|466119146|FG000|Overall Study|Ineligible|2|||
129499565|NCT00496873|466119146|FG000|Overall Study|Death|2|||
129499566|NCT00496873|466119146|FG000|Overall Study|Withdrawal by Subject|3|||
129499567|NCT01318083|466119149|FG000|Overall Study|Adverse Event|4|||
129499568|NCT01318083|466119150|FG001|Overall Study|Adverse Event|1|||
129499569|NCT01318083|466119151|FG002|Overall Study|Adverse Event|2|||
129499570|NCT01318083|466119149|FG000|Overall Study|Withdrawal by Subject|1|||
129499571|NCT01318083|466119150|FG001|Overall Study|Withdrawal by Subject|0|||
129499572|NCT01318083|466119151|FG002|Overall Study|Withdrawal by Subject|2|||
129499573|NCT01318083|466119149|FG000|Overall Study|Lack of Efficacy|0|||
129499574|NCT01318083|466119150|FG001|Overall Study|Lack of Efficacy|0|||
129499575|NCT01318083|466119151|FG002|Overall Study|Lack of Efficacy|1|||
129499576|NCT01318083|466119149|FG000|Overall Study|Treatment Complications|1|||
129499577|NCT01318083|466119150|FG001|Overall Study|Treatment Complications|0|||
129499578|NCT01318083|466119151|FG002|Overall Study|Treatment Complications|0|||
129499579|NCT01318083|466119149|FG000|Overall Study|Lack of Study Medication Compliance|0|||
129499580|NCT01318083|466119150|FG001|Overall Study|Lack of Study Medication Compliance|1|||
129499581|NCT01318083|466119151|FG002|Overall Study|Lack of Study Medication Compliance|0|||
129499582|NCT02028338|466119152|FG000|Overall Study|Withdrawal by Subject|3|||
129499583|NCT02028338|466119153|FG001|Overall Study|Withdrawal by Subject|1|||
129499584|NCT02028338|466119152|FG000|Overall Study|Unable to contact participant|1|||
129499585|NCT02028338|466119153|FG001|Overall Study|Unable to contact participant|0|||
129499586|NCT02761993|466119163|FG000|Overall Study|Adverse Event|0|||
129499587|NCT02761993|466119164|FG001|Overall Study|Adverse Event|2|||
129499588|NCT02761993|466119165|FG002|Overall Study|Adverse Event|0|||
129499589|NCT02761993|466119163|FG000|Overall Study|Lost to Follow-up|1|||
129499590|NCT02761993|466119164|FG001|Overall Study|Lost to Follow-up|3|||
129499591|NCT02761993|466119165|FG002|Overall Study|Lost to Follow-up|2|||
129499592|NCT02761993|466119163|FG000|Overall Study|Withdrawal by Subject|1|||
129499593|NCT02761993|466119164|FG001|Overall Study|Withdrawal by Subject|1|||
129499594|NCT02761993|466119165|FG002|Overall Study|Withdrawal by Subject|2|||
129499595|NCT01842620|466119166|FG000|Period 1|Withdrawal by Subject|1|||
129499596|NCT01842620|466119167|FG001|Period 1|Withdrawal by Subject|0|||
129499597|NCT00256867|466119168|FG000|Overall Study|Adverse Event|0|||
129499598|NCT00256867|466119169|FG001|Overall Study|Adverse Event|1|||
129499599|NCT00256867|466119170|FG002|Overall Study|Adverse Event|1|||
129499600|NCT00256867|466119171|FG003|Overall Study|Adverse Event|1|||
129499601|NCT00256867|466119172|FG004|Overall Study|Adverse Event|2|||
129499602|NCT00256867|466119173|FG005|Overall Study|Adverse Event|2|||
129499603|NCT00256867|466119174|FG006|Overall Study|Adverse Event|1|||
129499604|NCT00256867|466119175|FG007|Overall Study|Adverse Event|4|||
129499605|NCT00256867|466119168|FG000|Overall Study|Lost to Follow-up|2|||
129499606|NCT00256867|466119169|FG001|Overall Study|Lost to Follow-up|2|||
129499607|NCT00256867|466119170|FG002|Overall Study|Lost to Follow-up|2|||
129499608|NCT00256867|466119171|FG003|Overall Study|Lost to Follow-up|3|||
129499609|NCT00256867|466119172|FG004|Overall Study|Lost to Follow-up|2|||
129499610|NCT00256867|466119173|FG005|Overall Study|Lost to Follow-up|0|||
129499611|NCT00256867|466119174|FG006|Overall Study|Lost to Follow-up|1|||
129499612|NCT00256867|466119175|FG007|Overall Study|Lost to Follow-up|2|||
129499613|NCT00256867|466119168|FG000|Overall Study|Protocol Violation|0|||
129499614|NCT00256867|466119169|FG001|Overall Study|Protocol Violation|0|||
129499615|NCT00256867|466119170|FG002|Overall Study|Protocol Violation|0|||
129499616|NCT00256867|466119171|FG003|Overall Study|Protocol Violation|1|||
129499617|NCT00256867|466119172|FG004|Overall Study|Protocol Violation|0|||
129499618|NCT00256867|466119173|FG005|Overall Study|Protocol Violation|1|||
129499619|NCT00256867|466119174|FG006|Overall Study|Protocol Violation|0|||
129499620|NCT00256867|466119175|FG007|Overall Study|Protocol Violation|1|||
129499621|NCT00256867|466119168|FG000|Overall Study|Withdrawal by Subject|0|||
129499622|NCT00256867|466119169|FG001|Overall Study|Withdrawal by Subject|0|||
129499623|NCT00256867|466119170|FG002|Overall Study|Withdrawal by Subject|1|||
129499624|NCT00256867|466119171|FG003|Overall Study|Withdrawal by Subject|1|||
129499625|NCT00256867|466119172|FG004|Overall Study|Withdrawal by Subject|2|||
129499626|NCT00256867|466119173|FG005|Overall Study|Withdrawal by Subject|2|||
129499627|NCT00256867|466119174|FG006|Overall Study|Withdrawal by Subject|3|||
129499628|NCT00256867|466119175|FG007|Overall Study|Withdrawal by Subject|2|||
129499629|NCT00256867|466119168|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499630|NCT00256867|466119169|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
129499631|NCT00256867|466119170|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499632|NCT00256867|466119171|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499633|NCT00256867|466119172|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499634|NCT00256867|466119173|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499635|NCT00256867|466119174|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499636|NCT00256867|466119175|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
129499637|NCT00256867|466119168|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499638|NCT00256867|466119169|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499639|NCT00256867|466119170|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499640|NCT00256867|466119171|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499641|NCT00256867|466119172|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499642|NCT00256867|466119173|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499643|NCT00256867|466119174|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
129499644|NCT00256867|466119175|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
129499645|NCT00256867|466119168|FG000|Overall Study|Investigator's Decision|0|||
129499646|NCT00256867|466119169|FG001|Overall Study|Investigator's Decision|0|||
129499647|NCT00256867|466119170|FG002|Overall Study|Investigator's Decision|0|||
129499648|NCT00256867|466119171|FG003|Overall Study|Investigator's Decision|0|||
129499649|NCT00256867|466119172|FG004|Overall Study|Investigator's Decision|1|||
129499650|NCT00256867|466119173|FG005|Overall Study|Investigator's Decision|0|||
129499651|NCT00256867|466119174|FG006|Overall Study|Investigator's Decision|0|||
129499652|NCT00256867|466119175|FG007|Overall Study|Investigator's Decision|0|||
129499653|NCT00256867|466119168|FG000|Overall Study|Non-compliance with study medication|0|||
129499654|NCT00256867|466119169|FG001|Overall Study|Non-compliance with study medication|0|||
129499655|NCT00256867|466119170|FG002|Overall Study|Non-compliance with study medication|0|||
129499656|NCT00256867|466119171|FG003|Overall Study|Non-compliance with study medication|0|||
129499657|NCT00256867|466119172|FG004|Overall Study|Non-compliance with study medication|0|||
129499658|NCT00256867|466119173|FG005|Overall Study|Non-compliance with study medication|0|||
129499659|NCT00256867|466119174|FG006|Overall Study|Non-compliance with study medication|0|||
129499660|NCT00256867|466119175|FG007|Overall Study|Non-compliance with study medication|1|||
129499661|NCT00256867|466119168|FG000|Overall Study|Participant travelled Overseas|0|||
129499662|NCT00256867|466119169|FG001|Overall Study|Participant travelled Overseas|1|||
129499663|NCT00256867|466119170|FG002|Overall Study|Participant travelled Overseas|0|||
129499664|NCT00256867|466119171|FG003|Overall Study|Participant travelled Overseas|0|||
129499665|NCT00256867|466119172|FG004|Overall Study|Participant travelled Overseas|0|||
129499666|NCT00256867|466119173|FG005|Overall Study|Participant travelled Overseas|0|||
129499667|NCT00256867|466119174|FG006|Overall Study|Participant travelled Overseas|0|||
129499668|NCT00256867|466119175|FG007|Overall Study|Participant travelled Overseas|0|||
129499669|NCT00256867|466119168|FG000|Overall Study|Participant out of assessment window|0|||
129499670|NCT00256867|466119169|FG001|Overall Study|Participant out of assessment window|0|||
129499671|NCT00256867|466119170|FG002|Overall Study|Participant out of assessment window|1|||
129499672|NCT00256867|466119171|FG003|Overall Study|Participant out of assessment window|0|||
129499673|NCT00256867|466119172|FG004|Overall Study|Participant out of assessment window|0|||
129499674|NCT00256867|466119173|FG005|Overall Study|Participant out of assessment window|0|||
129499675|NCT00256867|466119174|FG006|Overall Study|Participant out of assessment window|0|||
129499676|NCT00256867|466119175|FG007|Overall Study|Participant out of assessment window|0|||
129499677|NCT00256867|466119168|FG000|Overall Study|Withdrawal by participant|0|||
129499678|NCT00256867|466119169|FG001|Overall Study|Withdrawal by participant|0|||
129499679|NCT00256867|466119170|FG002|Overall Study|Withdrawal by participant|0|||
129499680|NCT00256867|466119171|FG003|Overall Study|Withdrawal by participant|0|||
129499681|NCT00256867|466119172|FG004|Overall Study|Withdrawal by participant|0|||
129499682|NCT00256867|466119173|FG005|Overall Study|Withdrawal by participant|1|||
129499683|NCT00256867|466119174|FG006|Overall Study|Withdrawal by participant|0|||
129499684|NCT00256867|466119175|FG007|Overall Study|Withdrawal by participant|0|||
129499685|NCT02993224|466119176|FG000|Core Phase - Period 1|Adverse Event|4|||
129499686|NCT02993224|466119176|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
129499687|NCT02993224|466119176|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
129499688|NCT02993224|466119176|FG000|Core Phase- Period 2|Adverse Event|1|||
129499689|NCT02993224|466119176|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
129499690|NCT02993224|466119176|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
129499691|NCT02993224|466119176|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
129499692|NCT02993224|466119176|FG000|Extension Phase|Adverse Event|3|||
129499693|NCT02993224|466119176|FG000|Extension Phase|Withdrawal by Subject|3|||
129499694|NCT02993224|466119176|FG000|Extension Phase|Lost to Follow-up|2|||
129499695|NCT02993224|466119176|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
129499696|NCT01930799|466119178|FG000|Overall Study|Withdrawal by Subject|3|||
129499697|NCT01930799|466119178|FG000|Overall Study|Lost to Follow-up|5|||
129499698|NCT00952289|466119179|FG000|All Participants|Death|9|||
129499699|NCT00952289|466119180|FG001|All Participants|Death|9|||
129499700|NCT00952289|466119179|FG000|All Participants|Adverse Event|8|||
129499701|NCT00952289|466119180|FG001|All Participants|Adverse Event|8|||
129499702|NCT00952289|466119179|FG000|All Participants|Disease progression|3|||
129499703|NCT00952289|466119180|FG001|All Participants|Disease progression|12|||
129499704|NCT00952289|466119179|FG000|All Participants|Withdrawal by Subject|1|||
129499705|NCT00952289|466119180|FG001|All Participants|Withdrawal by Subject|10|||
129499706|NCT00952289|466119179|FG000|All Participants|Data lost during site relocation|0|||
129499707|NCT00952289|466119180|FG001|All Participants|Data lost during site relocation|1|||
129499708|NCT00952289|466119179|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
129499709|NCT00952289|466119180|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
129499710|NCT00952289|466119179|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
129499711|NCT00952289|466119180|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
129499712|NCT00952289|466119179|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
129499713|NCT00952289|466119180|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
129499714|NCT00952289|466119179|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
129499715|NCT00952289|466119180|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
129499716|NCT00952289|466119179|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
129499717|NCT00952289|466119180|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
129499718|NCT00875017|466119181|FG000|First Intervention|Withdrawal by Subject|1|||
129499719|NCT00875017|466119182|FG001|First Intervention|Withdrawal by Subject|0|||
129499720|NCT00875017|466119183|FG002|First Intervention|Withdrawal by Subject|1|||
129499721|NCT00875017|466119184|FG003|First Intervention|Withdrawal by Subject|0|||
129499722|NCT00875017|466119185|FG004|First Intervention|Withdrawal by Subject|0|||
129499723|NCT00875017|466119186|FG005|First Intervention|Withdrawal by Subject|0|||
129499724|NCT00875017|466119181|FG000|First Intervention|Adverse Event|0|||
129499725|NCT00875017|466119182|FG001|First Intervention|Adverse Event|0|||
129499726|NCT00875017|466119183|FG002|First Intervention|Adverse Event|0|||
129499727|NCT00875017|466119184|FG003|First Intervention|Adverse Event|1|||
129499728|NCT00875017|466119185|FG004|First Intervention|Adverse Event|0|||
129499729|NCT00875017|466119186|FG005|First Intervention|Adverse Event|0|||
129499730|NCT00875017|466119181|FG000|First Intervention|Problems collecting rectal effluent|1|||
129499731|NCT00875017|466119182|FG001|First Intervention|Problems collecting rectal effluent|0|||
129499732|NCT00875017|466119183|FG002|First Intervention|Problems collecting rectal effluent|0|||
129499733|NCT00875017|466119184|FG003|First Intervention|Problems collecting rectal effluent|0|||
129499734|NCT00875017|466119185|FG004|First Intervention|Problems collecting rectal effluent|0|||
129499735|NCT00875017|466119186|FG005|First Intervention|Problems collecting rectal effluent|0|||
129499736|NCT00875017|466119181|FG000|First Intervention|Intolerance to nasogastric tube|0|||
129499737|NCT00875017|466119182|FG001|First Intervention|Intolerance to nasogastric tube|0|||
129499738|NCT00875017|466119183|FG002|First Intervention|Intolerance to nasogastric tube|0|||
129499739|NCT00875017|466119184|FG003|First Intervention|Intolerance to nasogastric tube|0|||
129499740|NCT00875017|466119185|FG004|First Intervention|Intolerance to nasogastric tube|1|||
129499741|NCT00875017|466119186|FG005|First Intervention|Intolerance to nasogastric tube|0|||
129499742|NCT00875017|466119181|FG000|Washout|Problem collecting rectal effluent|0|||
129499743|NCT00875017|466119182|FG001|Washout|Problem collecting rectal effluent|0|||
129499744|NCT00875017|466119183|FG002|Washout|Problem collecting rectal effluent|1|||
129499745|NCT00875017|466119184|FG003|Washout|Problem collecting rectal effluent|0|||
129499746|NCT00875017|466119185|FG004|Washout|Problem collecting rectal effluent|0|||
129499747|NCT00875017|466119186|FG005|Washout|Problem collecting rectal effluent|0|||
129499748|NCT00875017|466119181|FG000|Second Intervention|Adverse Event|0|||
129499749|NCT00875017|466119182|FG001|Second Intervention|Adverse Event|0|||
129499750|NCT00875017|466119183|FG002|Second Intervention|Adverse Event|0|||
129499751|NCT00875017|466119184|FG003|Second Intervention|Adverse Event|1|||
129499752|NCT00875017|466119185|FG004|Second Intervention|Adverse Event|0|||
129499753|NCT00875017|466119186|FG005|Second Intervention|Adverse Event|0|||
129499754|NCT00875017|466119181|FG000|Washout|Problems collecting rectal effluent|0|||
129499755|NCT00875017|466119182|FG001|Washout|Problems collecting rectal effluent|1|||
129499756|NCT00875017|466119183|FG002|Washout|Problems collecting rectal effluent|0|||
129499757|NCT00875017|466119184|FG003|Washout|Problems collecting rectal effluent|0|||
129499758|NCT00875017|466119185|FG004|Washout|Problems collecting rectal effluent|0|||
129499759|NCT00875017|466119186|FG005|Washout|Problems collecting rectal effluent|0|||
129499760|NCT00875017|466119181|FG000|Third Intervention|Adverse Event|0|||
129499761|NCT00875017|466119182|FG001|Third Intervention|Adverse Event|1|||
129499762|NCT00875017|466119183|FG002|Third Intervention|Adverse Event|1|||
129499763|NCT00875017|466119184|FG003|Third Intervention|Adverse Event|0|||
129499764|NCT00875017|466119185|FG004|Third Intervention|Adverse Event|0|||
129499765|NCT00875017|466119186|FG005|Third Intervention|Adverse Event|0|||
129499766|NCT00875017|466119181|FG000|Washout|Withdrawal by Subject|0|||
129499767|NCT00875017|466119182|FG001|Washout|Withdrawal by Subject|0|||
129499768|NCT00875017|466119183|FG002|Washout|Withdrawal by Subject|0|||
129499769|NCT00875017|466119184|FG003|Washout|Withdrawal by Subject|0|||
129499770|NCT00875017|466119185|FG004|Washout|Withdrawal by Subject|1|||
129499771|NCT00875017|466119186|FG005|Washout|Withdrawal by Subject|0|||
129499772|NCT00875017|466119181|FG000|Fourth Intervention|Inability to comply with fasting|0|||
129499773|NCT00875017|466119182|FG001|Fourth Intervention|Inability to comply with fasting|0|||
129499774|NCT00875017|466119183|FG002|Fourth Intervention|Inability to comply with fasting|0|||
129499775|NCT00875017|466119184|FG003|Fourth Intervention|Inability to comply with fasting|0|||
129499776|NCT00875017|466119185|FG004|Fourth Intervention|Inability to comply with fasting|0|||
129499777|NCT00875017|466119186|FG005|Fourth Intervention|Inability to comply with fasting|1|||
129499778|NCT03342469|466119187|FG000|Overall Study|Withdrawal by Subject|0|||
129499779|NCT03342469|466119188|FG001|Overall Study|Withdrawal by Subject|1|||
129499780|NCT03342469|466119189|FG002|Overall Study|Withdrawal by Subject|0|||
129499781|NCT03342469|466119190|FG003|Overall Study|Withdrawal by Subject|0|||
129499782|NCT03136185|466119198|FG000|Overall Study|Adverse Event|0|||
129499783|NCT03136185|466119199|FG001|Overall Study|Adverse Event|1|||
129499784|NCT03136185|466119200|FG002|Overall Study|Adverse Event|3|||
129499785|NCT03136185|466119201|FG003|Overall Study|Adverse Event|1|||
129499786|NCT03136185|466119202|FG004|Overall Study|Adverse Event|2|||
129499787|NCT03136185|466119203|FG005|Overall Study|Adverse Event|2|||
129499788|NCT03136185|466119204|FG006|Overall Study|Adverse Event|5|||
129499789|NCT03136185|466119205|FG007|Overall Study|Adverse Event|1|||
129499790|NCT03136185|466119206|FG008|Overall Study|Adverse Event|1|||
129499791|NCT03136185|466119198|FG000|Overall Study|Death|0|||
129499792|NCT03136185|466119199|FG001|Overall Study|Death|0|||
129499793|NCT03136185|466119200|FG002|Overall Study|Death|0|||
129499794|NCT03136185|466119201|FG003|Overall Study|Death|1|||
129499795|NCT03136185|466119202|FG004|Overall Study|Death|1|||
129499796|NCT03136185|466119203|FG005|Overall Study|Death|0|||
129499797|NCT03136185|466119204|FG006|Overall Study|Death|1|||
129499798|NCT03136185|466119205|FG007|Overall Study|Death|0|||
129499799|NCT03136185|466119206|FG008|Overall Study|Death|0|||
129499800|NCT03136185|466119198|FG000|Overall Study|Physician Decision|3|||
129499801|NCT03136185|466119199|FG001|Overall Study|Physician Decision|1|||
129499802|NCT03136185|466119200|FG002|Overall Study|Physician Decision|1|||
129499803|NCT03136185|466119201|FG003|Overall Study|Physician Decision|2|||
129499804|NCT03136185|466119202|FG004|Overall Study|Physician Decision|1|||
129499805|NCT03136185|466119203|FG005|Overall Study|Physician Decision|2|||
129499806|NCT03136185|466119204|FG006|Overall Study|Physician Decision|1|||
129499807|NCT03136185|466119205|FG007|Overall Study|Physician Decision|0|||
129499808|NCT03136185|466119206|FG008|Overall Study|Physician Decision|1|||
129499809|NCT03136185|466119198|FG000|Overall Study|Protocol Defined Disease Progression|0|||
129499810|NCT03136185|466119199|FG001|Overall Study|Protocol Defined Disease Progression|0|||
129499811|NCT03136185|466119200|FG002|Overall Study|Protocol Defined Disease Progression|1|||
129499812|NCT03136185|466119201|FG003|Overall Study|Protocol Defined Disease Progression|0|||
129499813|NCT03136185|466119202|FG004|Overall Study|Protocol Defined Disease Progression|0|||
129499814|NCT03136185|466119203|FG005|Overall Study|Protocol Defined Disease Progression|1|||
129499815|NCT03136185|466119204|FG006|Overall Study|Protocol Defined Disease Progression|0|||
129499816|NCT03136185|466119205|FG007|Overall Study|Protocol Defined Disease Progression|1|||
129499817|NCT03136185|466119206|FG008|Overall Study|Protocol Defined Disease Progression|1|||
129499818|NCT03136185|466119198|FG000|Overall Study|Withdrawal by Subject|1|||
129499819|NCT03136185|466119199|FG001|Overall Study|Withdrawal by Subject|0|||
129499820|NCT03136185|466119200|FG002|Overall Study|Withdrawal by Subject|1|||
129499821|NCT03136185|466119201|FG003|Overall Study|Withdrawal by Subject|1|||
129499822|NCT03136185|466119202|FG004|Overall Study|Withdrawal by Subject|1|||
129499823|NCT03136185|466119203|FG005|Overall Study|Withdrawal by Subject|1|||
129499824|NCT03136185|466119204|FG006|Overall Study|Withdrawal by Subject|2|||
129499825|NCT03136185|466119205|FG007|Overall Study|Withdrawal by Subject|3|||
129499826|NCT03136185|466119206|FG008|Overall Study|Withdrawal by Subject|3|||
129499827|NCT03136185|466119198|FG000|Overall Study|Not Reported|4|||
129499828|NCT03136185|466119199|FG001|Overall Study|Not Reported|1|||
129499829|NCT03136185|466119200|FG002|Overall Study|Not Reported|0|||
129499830|NCT03136185|466119201|FG003|Overall Study|Not Reported|1|||
129499831|NCT03136185|466119202|FG004|Overall Study|Not Reported|0|||
129499832|NCT03136185|466119203|FG005|Overall Study|Not Reported|2|||
129499833|NCT03136185|466119204|FG006|Overall Study|Not Reported|1|||
129499834|NCT03136185|466119205|FG007|Overall Study|Not Reported|1|||
129499835|NCT03136185|466119206|FG008|Overall Study|Not Reported|0|||
129499836|NCT00364845|466119212|FG000|Overall Study|Adverse Event|1|||
129499837|NCT00364845|466119213|FG001|Overall Study|Adverse Event|0|||
129499838|NCT00364845|466119212|FG000|Overall Study|Withdrawal by Subject|2|||
129499839|NCT00364845|466119213|FG001|Overall Study|Withdrawal by Subject|1|||
129499840|NCT00364845|466119212|FG000|Overall Study|Physician Decision|8|||
129499841|NCT00364845|466119213|FG001|Overall Study|Physician Decision|8|||
129499842|NCT00364845|466119212|FG000|Overall Study|Lost to Follow-up|0|||
129499843|NCT00364845|466119213|FG001|Overall Study|Lost to Follow-up|1|||
129499844|NCT00364845|466119212|FG000|Overall Study|Death|0|||
129499845|NCT00364845|466119213|FG001|Overall Study|Death|1|||
129499846|NCT04160468|466119214|FG000|Overall Study|Lost to Follow-up|19|||
129499847|NCT04160468|466119215|FG001|Overall Study|Lost to Follow-up|4|||
129499848|NCT04160468|466119214|FG000|Overall Study|Randomized but not dosed|6|||
129499849|NCT04160468|466119215|FG001|Overall Study|Randomized but not dosed|0|||
129499850|NCT04160468|466119214|FG000|Overall Study|Withdrawal by Subject|4|||
129499851|NCT04160468|466119215|FG001|Overall Study|Withdrawal by Subject|1|||
129499852|NCT04160468|466119214|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
129499853|NCT04160468|466119215|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
129499854|NCT04160468|466119214|FG000|Overall Study|Participant incarcerated|1|||
129499855|NCT04160468|466119215|FG001|Overall Study|Participant incarcerated|0|||
129499856|NCT01187901|466119216|FG000|Overall Study|Protocol Violation|1|||
129499857|NCT01187901|466119217|FG001|Overall Study|Protocol Violation|0|||
129499858|NCT01187901|466119216|FG000|Overall Study|Lost to Follow-up|1|||
129499859|NCT01187901|466119217|FG001|Overall Study|Lost to Follow-up|2|||
129499860|NCT01187901|466119216|FG000|Overall Study|Unrelated Health Reasons|1|||
129499861|NCT01187901|466119217|FG001|Overall Study|Unrelated Health Reasons|2|||
129499862|NCT01187901|466119216|FG000|Overall Study|Suspected Allergic Reaction|1|||
129499863|NCT01187901|466119217|FG001|Overall Study|Suspected Allergic Reaction|1|||
129499864|NCT01187901|466119216|FG000|Overall Study|Adverse Event|3|||
129499865|NCT01187901|466119217|FG001|Overall Study|Adverse Event|0|||
129499866|NCT01187901|466119216|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
129499867|NCT01187901|466119217|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
129499868|NCT01187901|466119216|FG000|Overall Study|Pregnancy|0|||
129499869|NCT01187901|466119217|FG001|Overall Study|Pregnancy|2|||
129499870|NCT01912768|466119218|FG000|Overall Study|Adverse Event|2|||
129499871|NCT01912768|466119219|FG001|Overall Study|Adverse Event|0|||
129499872|NCT01912768|466119218|FG000|Overall Study|Lost to Follow-up|2|||
129499873|NCT01912768|466119219|FG001|Overall Study|Lost to Follow-up|1|||
129499874|NCT01912768|466119218|FG000|Overall Study|Withdrawal by Subject|5|||
129499875|NCT01912768|466119219|FG001|Overall Study|Withdrawal by Subject|3|||
129499876|NCT01912768|466119218|FG000|Overall Study|Randomized in error|1|||
129499877|NCT01912768|466119219|FG001|Overall Study|Randomized in error|0|||
129538917|NCT01238861|466265112|FG005|Overall Study|Unplanned surgery|0|||
129499878|NCT00488033|466119220|FG000|Overall Study|Withdrawal by Subject|1|||
129499879|NCT00488033|466119221|FG001|Overall Study|Withdrawal by Subject|0|||
129499880|NCT04715230|466119228|FG000|Overall Study|Withdrawal by Subject|1|||
129499881|NCT04715230|466119229|FG001|Overall Study|Withdrawal by Subject|0|||
129499882|NCT04715230|466119230|FG002|Overall Study|Withdrawal by Subject|0|||
129499883|NCT04715230|466119228|FG000|Overall Study|Lost to Follow-up|0|||
129499884|NCT04715230|466119229|FG001|Overall Study|Lost to Follow-up|5|||
129499885|NCT04715230|466119230|FG002|Overall Study|Lost to Follow-up|1|||
129499886|NCT03453151|466119231|FG000|Overall Study|Withdrawal by Subject|1|||
129499887|NCT03453151|466119231|FG000|Overall Study|Physician Decision|3|||
129499888|NCT00488618|466119236|FG000|Overall Study|Adverse Event|13|||
129499889|NCT00488618|466119237|FG001|Overall Study|Adverse Event|17|||
129499890|NCT00488618|466119236|FG000|Overall Study|Insufficient Therapeutic Response|18|||
129499891|NCT00488618|466119237|FG001|Overall Study|Insufficient Therapeutic Response|11|||
129499892|NCT00488618|466119236|FG000|Overall Study|Protocol Violation|0|||
129499893|NCT00488618|466119237|FG001|Overall Study|Protocol Violation|2|||
129499894|NCT00488618|466119236|FG000|Overall Study|Withdrawal of Consent|15|||
129499895|NCT00488618|466119237|FG001|Overall Study|Withdrawal of Consent|13|||
129499896|NCT00488618|466119236|FG000|Overall Study|Lost to Follow-up|1|||
129499897|NCT00488618|466119237|FG001|Overall Study|Lost to Follow-up|0|||
129499898|NCT03439748|466120383|FG000|Overall Study|Withdrawal by Subject|11|||
129499899|NCT03439748|466120384|FG001|Overall Study|Withdrawal by Subject|17|||
129499900|NCT05131451|466120385|FG000|Overall Study|Protocol Violation|1|||
129499901|NCT05131451|466120386|FG001|Overall Study|Protocol Violation|0|||
129499902|NCT00782418|466120393|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
129499903|NCT00782418|466120394|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129499904|NCT00782418|466120395|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129499905|NCT00782418|466120396|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129499906|NCT00782418|466120397|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129499907|NCT00782418|466120398|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129499908|NCT00782418|466120399|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
129499909|NCT00782418|466120393|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
129499910|NCT00782418|466120394|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
129499911|NCT00782418|466120395|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
129499912|NCT00782418|466120396|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
129499913|NCT00782418|466120397|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
129499914|NCT00782418|466120398|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
129499915|NCT00782418|466120399|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
129499916|NCT02324842|466120400|FG000|Overall Study|Lost to Follow-up|1|||
129499917|NCT02324842|466120401|FG001|Overall Study|Lost to Follow-up|1|||
129499918|NCT02324842|466120402|FG002|Overall Study|Lost to Follow-up|2|||
129499919|NCT02750800|466120403|FG000|Overall Study|Adverse Event|18|||
129499920|NCT02750800|466120403|FG000|Overall Study|Lost to Follow-up|12|||
129499921|NCT02750800|466120403|FG000|Overall Study|Investigator decision|53|||
129499922|NCT02750800|466120403|FG000|Overall Study|Patient request|12|||
129499923|NCT02750800|466120403|FG000|Overall Study|Other, not specified|3|||
129499924|NCT03298412|466120404|FG000|Run-in Period|Other, Not Specified|1|||
129499925|NCT03298412|466120404|FG000|Run-in Period|Disease Progression|1|||
129499926|NCT03298412|466120404|FG000|Run-in Period|Ineligibility Determined|1|||
129499927|NCT03298412|466120404|FG000|Run-in Period|Decision by Sponsor|6|||
129499928|NCT01894477|466120405|FG000|Overall Study|Protocol Violation|0|||
129499929|NCT01894477|466120406|FG001|Overall Study|Protocol Violation|1|||
129499930|NCT01894477|466120405|FG000|Overall Study|protocol changed due SC changed to cord|0|||
129499931|NCT01894477|466120406|FG001|Overall Study|protocol changed due SC changed to cord|1|||
129499932|NCT00995345|466120409|FG000|Overall Study|Withdrawal by Subject|4|||
129981852|NCT01259089|467896750|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981853|NCT01259089|467896751|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981854|NCT01259089|467896752|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981855|NCT01259089|467896753|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
129981856|NCT01259089|467896754|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
129981857|NCT01259089|467896749|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981858|NCT01259089|467896750|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981859|NCT01259089|467896751|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981860|NCT01259089|467896752|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129981861|NCT01259089|467896753|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
129499933|NCT00995345|466120410|FG001|Overall Study|Withdrawal by Subject|2|||
129499934|NCT00995345|466120411|FG002|Overall Study|Withdrawal by Subject|1|||
129499935|NCT00995345|466120412|FG003|Overall Study|Withdrawal by Subject|3|||
129499936|NCT00995345|466120413|FG004|Overall Study|Withdrawal by Subject|1|||
129499937|NCT00995345|466120409|FG000|Overall Study|Adverse Event|3|||
129499938|NCT00995345|466120410|FG001|Overall Study|Adverse Event|1|||
129499939|NCT00995345|466120411|FG002|Overall Study|Adverse Event|2|||
129499940|NCT00995345|466120412|FG003|Overall Study|Adverse Event|0|||
129499941|NCT00995345|466120413|FG004|Overall Study|Adverse Event|1|||
129499942|NCT00995345|466120409|FG000|Overall Study|Lost to Follow-up|2|||
129499943|NCT00995345|466120410|FG001|Overall Study|Lost to Follow-up|2|||
129499944|NCT00995345|466120411|FG002|Overall Study|Lost to Follow-up|2|||
129499945|NCT00995345|466120412|FG003|Overall Study|Lost to Follow-up|1|||
129499946|NCT00995345|466120413|FG004|Overall Study|Lost to Follow-up|0|||
129499947|NCT00995345|466120409|FG000|Overall Study|all other reasons combined|2|||
129499948|NCT00995345|466120410|FG001|Overall Study|all other reasons combined|2|||
129499949|NCT00995345|466120411|FG002|Overall Study|all other reasons combined|2|||
129499950|NCT00995345|466120412|FG003|Overall Study|all other reasons combined|1|||
129499951|NCT00995345|466120413|FG004|Overall Study|all other reasons combined|3|||
129499952|NCT01860534|466120414|FG000|ROP #1|Needed treatment for ROP|0|||
129499953|NCT01860534|466120415|FG001|ROP #1|Needed treatment for ROP|1|||
129499954|NCT01860534|466120414|FG000|ROP #2|discharged prior to ROP #2|1|||
129499955|NCT01860534|466120415|FG001|ROP #2|discharged prior to ROP #2|0|||
129499956|NCT05122650|466120421|FG000|Overall Study|Adverse Event|4|||
129499957|NCT05122650|466120422|FG001|Overall Study|Adverse Event|16|||
129499958|NCT05122650|466120423|FG002|Overall Study|Adverse Event|11|||
129499959|NCT05122650|466120424|FG003|Overall Study|Adverse Event|12|||
129499960|NCT05122650|466120421|FG000|Overall Study|Lack of Efficacy|0|||
129499961|NCT05122650|466120422|FG001|Overall Study|Lack of Efficacy|1|||
129499962|NCT05122650|466120423|FG002|Overall Study|Lack of Efficacy|1|||
129499963|NCT05122650|466120424|FG003|Overall Study|Lack of Efficacy|2|||
129499964|NCT05122650|466120421|FG000|Overall Study|Lost to Follow-up|1|||
129499965|NCT05122650|466120422|FG001|Overall Study|Lost to Follow-up|1|||
129499966|NCT05122650|466120423|FG002|Overall Study|Lost to Follow-up|3|||
129499967|NCT05122650|466120424|FG003|Overall Study|Lost to Follow-up|0|||
129499968|NCT05122650|466120421|FG000|Overall Study|Non-compliance with study intervention|0|||
129499969|NCT05122650|466120422|FG001|Overall Study|Non-compliance with study intervention|0|||
129499970|NCT05122650|466120423|FG002|Overall Study|Non-compliance with study intervention|0|||
129499971|NCT05122650|466120424|FG003|Overall Study|Non-compliance with study intervention|2|||
129499972|NCT05122650|466120421|FG000|Overall Study|Protocol Violation|0|||
129499973|NCT05122650|466120422|FG001|Overall Study|Protocol Violation|1|||
129499974|NCT05122650|466120423|FG002|Overall Study|Protocol Violation|0|||
129499975|NCT05122650|466120424|FG003|Overall Study|Protocol Violation|1|||
129499976|NCT05122650|466120421|FG000|Overall Study|Randomized by mistake|0|||
129499977|NCT05122650|466120422|FG001|Overall Study|Randomized by mistake|0|||
129499978|NCT05122650|466120423|FG002|Overall Study|Randomized by mistake|3|||
129499979|NCT05122650|466120424|FG003|Overall Study|Randomized by mistake|2|||
129499980|NCT05122650|466120421|FG000|Overall Study|Sponsor request|0|||
129499981|NCT05122650|466120422|FG001|Overall Study|Sponsor request|1|||
129499982|NCT05122650|466120423|FG002|Overall Study|Sponsor request|1|||
129499983|NCT05122650|466120424|FG003|Overall Study|Sponsor request|2|||
129499984|NCT05122650|466120421|FG000|Overall Study|Withdrawal by Subject|3|||
129499985|NCT05122650|466120422|FG001|Overall Study|Withdrawal by Subject|7|||
129499986|NCT05122650|466120423|FG002|Overall Study|Withdrawal by Subject|4|||
129499987|NCT05122650|466120424|FG003|Overall Study|Withdrawal by Subject|8|||
129499988|NCT05122650|466120421|FG000|Overall Study|Other|5|||
129499989|NCT05122650|466120422|FG001|Overall Study|Other|0|||
129499990|NCT05122650|466120423|FG002|Overall Study|Other|0|||
129499991|NCT05122650|466120424|FG003|Overall Study|Other|0|||
129499992|NCT01401010|466120425|FG000|Overall Study|Could not interpret assay results|1|||
129499993|NCT01401010|466120426|FG001|Overall Study|Could not interpret assay results|0|||
129499994|NCT04360187|466120437|FG000|Double-Blind Treatment|Adverse Event|9|||
129499995|NCT04360187|466120438|FG001|Double-Blind Treatment|Adverse Event|11|||
129499996|NCT04360187|466120437|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
129499997|NCT04360187|466120438|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
129499998|NCT04360187|466120437|FG000|Double-Blind Treatment|Physician Decision|1|||
129499999|NCT04360187|466120438|FG001|Double-Blind Treatment|Physician Decision|0|||
129500000|NCT04360187|466120437|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
129500001|NCT04360187|466120438|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
129500002|NCT04360187|466120437|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
129500003|NCT04360187|466120438|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
129500004|NCT04360187|466120437|FG000|Follow-Up|Lost to Follow-up|1|||
129500005|NCT04360187|466120438|FG001|Follow-Up|Lost to Follow-up|0|||
129500006|NCT01423617|466120446|FG000|Overall Study|Lost to Follow-up|0|||
129500007|NCT01423617|466120447|FG001|Overall Study|Lost to Follow-up|1|||
129500008|NCT01515306|466120448|FG000|Overall Study|Adverse Event|3|||
129500009|NCT01515306|466120449|FG001|Overall Study|Adverse Event|2|||
129500010|NCT01515306|466120448|FG000|Overall Study|Progressive Disease|19|||
129500011|NCT01515306|466120449|FG001|Overall Study|Progressive Disease|9|||
129500012|NCT01515306|466120448|FG000|Overall Study|Withdrawal by Subject|1|||
129500013|NCT01515306|466120449|FG001|Overall Study|Withdrawal by Subject|2|||
129500014|NCT01515306|466120448|FG000|Overall Study|Physician Decision|1|||
129500015|NCT01515306|466120449|FG001|Overall Study|Physician Decision|1|||
129500016|NCT00634244|466120453|FG000|Overall Study|Never started treatment|0|||
129500017|NCT00634244|466120454|FG001|Overall Study|Never started treatment|1|||
129500018|NCT00634244|466120455|FG002|Overall Study|Never started treatment|0|||
129500019|NCT00634244|466120453|FG000|Overall Study|Death|1|||
129500020|NCT00634244|466120454|FG001|Overall Study|Death|6|||
129500021|NCT00634244|466120455|FG002|Overall Study|Death|0|||
129500022|NCT00634244|466120453|FG000|Overall Study|Adverse Event|0|||
129500023|NCT00634244|466120454|FG001|Overall Study|Adverse Event|2|||
129500024|NCT00634244|466120455|FG002|Overall Study|Adverse Event|0|||
129500025|NCT00634244|466120453|FG000|Overall Study|Withdrawal by Subject|0|||
129500026|NCT00634244|466120454|FG001|Overall Study|Withdrawal by Subject|1|||
129500027|NCT00634244|466120455|FG002|Overall Study|Withdrawal by Subject|0|||
129500028|NCT00634244|466120453|FG000|Overall Study|Physician Decision|0|||
129500029|NCT00634244|466120454|FG001|Overall Study|Physician Decision|1|||
129500030|NCT00634244|466120455|FG002|Overall Study|Physician Decision|0|||
129500031|NCT00634244|466120453|FG000|Overall Study|Disease progression/relapse|0|||
129500032|NCT00634244|466120454|FG001|Overall Study|Disease progression/relapse|1|||
129500033|NCT00634244|466120455|FG002|Overall Study|Disease progression/relapse|0|||
129500034|NCT00634244|466120453|FG000|Overall Study|Other complicating disease|0|||
129500035|NCT00634244|466120454|FG001|Overall Study|Other complicating disease|1|||
129500036|NCT00634244|466120455|FG002|Overall Study|Other complicating disease|0|||
129500037|NCT02435277|466120458|FG000|Overall Study|Adverse Event|1|||
129500038|NCT02435277|466120459|FG001|Overall Study|Adverse Event|1|||
129500039|NCT02435277|466120460|FG002|Overall Study|Adverse Event|0|||
129500040|NCT02435277|466120461|FG003|Overall Study|Adverse Event|0|||
129500041|NCT02435277|466120458|FG000|Overall Study|Withdrawal by Subject|1|||
129500042|NCT02435277|466120459|FG001|Overall Study|Withdrawal by Subject|0|||
129500043|NCT02435277|466120460|FG002|Overall Study|Withdrawal by Subject|0|||
129500044|NCT02435277|466120461|FG003|Overall Study|Withdrawal by Subject|0|||
129500045|NCT01468909|466120465|FG000|Overall Study|Never Treated|2|||
129500046|NCT01468909|466120466|FG001|Overall Study|Never Treated|2|||
129500047|NCT02635737|466120473|FG000|Overall Study|Protocol Violation|1|||
129500048|NCT00937768|466120474|FG000|Overall Study|Refused Further Treatment|3|||
129500049|NCT00937768|466120475|FG001|Overall Study|Refused Further Treatment|2|||
129500050|NCT00937768|466120474|FG000|Overall Study|Disease Progression|1|||
129500051|NCT00937768|466120475|FG001|Overall Study|Disease Progression|1|||
129500052|NCT00937768|466120474|FG000|Overall Study|Alternate Treatment|0|||
129500053|NCT00937768|466120475|FG001|Overall Study|Alternate Treatment|1|||
129500054|NCT00937768|466120474|FG000|Overall Study|No Further Funding|4|||
129500055|NCT00937768|466120475|FG001|Overall Study|No Further Funding|4|||
129500056|NCT01687413|466120476|FG000|Overall Study|Withdrawal by Subject|0|||
129500057|NCT01687413|466120477|FG001|Overall Study|Withdrawal by Subject|2|||
129500058|NCT01687413|466120476|FG000|Overall Study|Not eligible|0|||
129500059|NCT01687413|466120477|FG001|Overall Study|Not eligible|2|||
129500060|NCT01687413|466120476|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
129500061|NCT01687413|466120477|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
129500062|NCT00992446|466120497|FG000|Overall Study|Disease Progression|1|||
129500063|NCT00992446|466120497|FG000|Overall Study|Withdrawal by Subject|2|||
129500064|NCT00992446|466120497|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
129500065|NCT03675737|466120500|FG000|Overall Study|Death|593|||
129500066|NCT03675737|466120501|FG001|Overall Study|Death|660|||
129500067|NCT03675737|466120500|FG000|Overall Study|Lost to Follow-up|1|||
129500068|NCT03675737|466120501|FG001|Overall Study|Lost to Follow-up|5|||
129500069|NCT03675737|466120500|FG000|Overall Study|Physician Decision|1|||
129500070|NCT03675737|466120501|FG001|Overall Study|Physician Decision|0|||
129500071|NCT03675737|466120500|FG000|Overall Study|Withdrawal by Subject|14|||
129500072|NCT03675737|466120501|FG001|Overall Study|Withdrawal by Subject|12|||
129500073|NCT03675737|466120500|FG000|Overall Study|Ongoing in Study|181|||
129500074|NCT03675737|466120501|FG001|Overall Study|Ongoing in Study|112|||
129500075|NCT02349789|466121896|FG000|Overall Study|Withdrawal by Subject|2|||
129500076|NCT00683475|466121897|FG000|Overall Study|Withdrawal by Subject|1|||
129500077|NCT00683475|466121898|FG001|Overall Study|Withdrawal by Subject|0|||
129500078|NCT00683475|466121897|FG000|Overall Study|Never Treated: Adverse Event|2|||
129500079|NCT00683475|466121898|FG001|Overall Study|Never Treated: Adverse Event|3|||
129500080|NCT00683475|466121897|FG000|Overall Study|Never Treated: Progressive Disease|1|||
129500081|NCT00683475|466121898|FG001|Overall Study|Never Treated: Progressive Disease|0|||
129500082|NCT02922634|466121899|FG000|Overall Study|Withdrawal by Subject|5|||
129500083|NCT02922634|466121899|FG000|Overall Study|Did not have their surgery|5|||
129500084|NCT02723604|466121900|FG000|Overall Study|ineligible|1|||
129500085|NCT02723604|466121900|FG000|Overall Study|never received treatment|1|||
129500086|NCT00352755|466121901|FG000|Overall Study|Physician Decision|1|||
129500087|NCT00352755|466121901|FG000|Overall Study|Adverse Event|1|||
129500088|NCT01694420|466121903|FG000|Overall Study|Lost to Follow-up|3|||
129500089|NCT03987919|466121904|FG000|Overall Study|Adverse Event|1|||
129500090|NCT03987919|466121905|FG001|Overall Study|Adverse Event|4|||
129500091|NCT03987919|466121906|FG002|Overall Study|Adverse Event|1|||
129500092|NCT03987919|466121907|FG003|Overall Study|Adverse Event|3|||
129500093|NCT03987919|466121904|FG000|Overall Study|Death|4|||
129500094|NCT03987919|466121905|FG001|Overall Study|Death|4|||
129500095|NCT03987919|466121906|FG002|Overall Study|Death|4|||
129500096|NCT03987919|466121907|FG003|Overall Study|Death|1|||
129500097|NCT03987919|466121904|FG000|Overall Study|Lost to Follow-up|5|||
129500098|NCT03987919|466121905|FG001|Overall Study|Lost to Follow-up|6|||
129500099|NCT03987919|466121906|FG002|Overall Study|Lost to Follow-up|8|||
129500100|NCT03987919|466121907|FG003|Overall Study|Lost to Follow-up|12|||
129500101|NCT03987919|466121904|FG000|Overall Study|Physician Decision|0|||
129500102|NCT03987919|466121905|FG001|Overall Study|Physician Decision|2|||
129500103|NCT03987919|466121906|FG002|Overall Study|Physician Decision|0|||
129500104|NCT03987919|466121907|FG003|Overall Study|Physician Decision|4|||
129500105|NCT03987919|466121904|FG000|Overall Study|Pregnancy|1|||
129500106|NCT03987919|466121905|FG001|Overall Study|Pregnancy|0|||
129500107|NCT03987919|466121906|FG002|Overall Study|Pregnancy|1|||
129500108|NCT03987919|466121907|FG003|Overall Study|Pregnancy|1|||
129500109|NCT03987919|466121904|FG000|Overall Study|Protocol Violation|0|||
129500110|NCT03987919|466121905|FG001|Overall Study|Protocol Violation|1|||
129500111|NCT03987919|466121906|FG002|Overall Study|Protocol Violation|0|||
129500112|NCT03987919|466121907|FG003|Overall Study|Protocol Violation|0|||
129500113|NCT03987919|466121904|FG000|Overall Study|Site terminated by Sponsor|0|||
129500114|NCT03987919|466121905|FG001|Overall Study|Site terminated by Sponsor|0|||
129500115|NCT03987919|466121906|FG002|Overall Study|Site terminated by Sponsor|0|||
129500116|NCT03987919|466121907|FG003|Overall Study|Site terminated by Sponsor|1|||
129500117|NCT03987919|466121904|FG000|Overall Study|Withdrawal by Subject|7|||
129500118|NCT03987919|466121905|FG001|Overall Study|Withdrawal by Subject|7|||
129500119|NCT03987919|466121906|FG002|Overall Study|Withdrawal by Subject|8|||
129500120|NCT03987919|466121907|FG003|Overall Study|Withdrawal by Subject|4|||
129500121|NCT03987919|466121904|FG000|Overall Study|Other - as reported by the investigator|1|||
129500122|NCT03987919|466121905|FG001|Overall Study|Other - as reported by the investigator|3|||
129500123|NCT03987919|466121906|FG002|Overall Study|Other - as reported by the investigator|2|||
129500124|NCT03987919|466121907|FG003|Overall Study|Other - as reported by the investigator|0|||
129500125|NCT01194804|466121908|FG000|Overall Study|Withdrawal by Subject|1|||
129500126|NCT03621943|466121909|FG000|First Randomized Intervention|Lost to Follow-up|51|||
129500127|NCT03621943|466121910|FG001|First Randomized Intervention|Lost to Follow-up|54|||
129500128|NCT03621943|466121909|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
129500129|NCT03621943|466121910|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
129500130|NCT03621943|466121909|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
129500131|NCT03621943|466121910|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
129500132|NCT03621943|466121909|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
129500133|NCT03621943|466121910|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
129500134|NCT00315705|466121911|FG000|Phase 1|Refused further treatment|1|||
129500135|NCT00315705|466121911|FG000|Phase 1|Failure to achieve response|8|||
129500136|NCT00315705|466121911|FG000|Phase 1|Disease relapse|4|||
129500137|NCT00315705|466121911|FG000|Phase 1|Scheduled for transplant|9|||
129500138|NCT00315705|466121911|FG000|Phase 1|Death|3|||
129500139|NCT00315705|466121911|FG000|Phase 2|Physician Decision|4|||
129500140|NCT00315705|466121911|FG000|Phase 2|Adverse Event|1|||
129500141|NCT00315705|466121911|FG000|Phase 2|Failure to achieve response|3|||
129500142|NCT00315705|466121911|FG000|Phase 2|Disease relapse|1|||
129500143|NCT00315705|466121911|FG000|Phase 2|Scheduled for transplant|8|||
129500144|NCT00315705|466121911|FG000|Phase 2|Other|1|||
129500145|NCT00315705|466121911|FG000|Phase 2|Death|7|||
129500146|NCT00748553|466121912|FG000|Overall Study|Adverse Event|0|||
129500147|NCT00748553|466121913|FG001|Overall Study|Adverse Event|1|||
129500148|NCT00748553|466121912|FG000|Overall Study|disease progression|2|||
129500149|NCT00748553|466121913|FG001|Overall Study|disease progression|0|||
129500150|NCT00748553|466121912|FG000|Overall Study|noncompliance|1|||
129500151|NCT00748553|466121913|FG001|Overall Study|noncompliance|0|||
129500152|NCT00948818|466121915|FG000|Overall Study|Adverse Event|10|||
129500153|NCT00948818|466121916|FG001|Overall Study|Adverse Event|32|||
129500154|NCT00948818|466121915|FG000|Overall Study|Protocol Violation|9|||
129500155|NCT00948818|466121916|FG001|Overall Study|Protocol Violation|10|||
129500156|NCT00948818|466121915|FG000|Overall Study|Withdrawal by Subject|25|||
129500157|NCT00948818|466121916|FG001|Overall Study|Withdrawal by Subject|25|||
129500158|NCT00948818|466121915|FG000|Overall Study|Lost to Follow-up|10|||
129500159|NCT00948818|466121916|FG001|Overall Study|Lost to Follow-up|17|||
129500160|NCT00948818|466121915|FG000|Overall Study|Lack of Efficacy|4|||
129500161|NCT00948818|466121916|FG001|Overall Study|Lack of Efficacy|5|||
129500162|NCT00948818|466121915|FG000|Overall Study|Other Reason|4|||
129500163|NCT00948818|466121916|FG001|Overall Study|Other Reason|5|||
129500164|NCT00745368|466121917|FG000|Overall Study|Unable to provide sample|3|||
129500165|NCT03446651|466121921|FG000|Overall Study|Lost to Follow-up|4|||
129500166|NCT03446651|466121922|FG001|Overall Study|Lost to Follow-up|0|||
129500167|NCT03446651|466121921|FG000|Overall Study|Open Label Participants|5|||
129500168|NCT03446651|466121922|FG001|Overall Study|Open Label Participants|0|||
129500169|NCT05631548|466121924|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
129500170|NCT05631548|466121925|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
129500171|NCT01592409|466121926|FG000|Overall Study|Withdrawal by Subject|0|||
129500172|NCT01592409|466121927|FG001|Overall Study|Withdrawal by Subject|1|||
129500173|NCT01409031|466121931|FG000|Overall Study|transferred to other hosp|1|||
129500174|NCT01409031|466121932|FG001|Overall Study|transferred to other hosp|0|||
129500175|NCT01934894|466121933|FG000|Overall Study|Adverse Event|1|||
129500176|NCT01934894|466121934|FG001|Overall Study|Adverse Event|2|||
129500177|NCT01934894|466121933|FG000|Overall Study|Death|2|||
129500178|NCT01934894|466121934|FG001|Overall Study|Death|0|||
129500179|NCT01934894|466121933|FG000|Overall Study|Withdrawal by Subject|0|||
129500180|NCT01934894|466121934|FG001|Overall Study|Withdrawal by Subject|1|||
129500181|NCT01934894|466121933|FG000|Overall Study|Progressive Disease|3|||
129500182|NCT01934894|466121934|FG001|Overall Study|Progressive Disease|2|||
129500183|NCT01100307|466121938|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
129500184|NCT01100307|466121939|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
129500185|NCT01100307|466121938|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
129500186|NCT01100307|466121939|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
129500187|NCT01100307|466121938|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
129500188|NCT01100307|466121939|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
129500189|NCT01100307|466121938|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
129500190|NCT01100307|466121939|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
129500191|NCT01100307|466121938|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
129500192|NCT01100307|466121939|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
129500193|NCT01100307|466121938|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
129500194|NCT01100307|466121939|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
129500195|NCT03135028|466121940|FG000|Overall Study|Death|6|||
129500196|NCT03135028|466121940|FG000|Overall Study|Study Terminated by Sponsor|2|||
129500197|NCT03135028|466121940|FG000|Overall Study|Withdrew Consent|1|||
129500198|NCT00748540|466121941|FG000|Overall Study|Physician Decision|1|||
129500199|NCT01814800|466121943|FG000|Overall Study|Adverse Event|2|||
129500200|NCT01814800|466121943|FG000|Overall Study|Pregnancy|1|||
129500201|NCT01814800|466121943|FG000|Overall Study|Sponsor decision|1|||
129500202|NCT01814800|466121943|FG000|Overall Study|Subject relocation|1|||
129500203|NCT04436822|466121944|FG000|Overall Study|Physician Decision|2|||
129500204|NCT04436822|466121945|FG001|Overall Study|Physician Decision|0|||
129500205|NCT04436822|466121944|FG000|Overall Study|Sponsor request|1|||
129500206|NCT04436822|466121945|FG001|Overall Study|Sponsor request|0|||
129500207|NCT04436822|466121944|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129500208|NCT04436822|466121945|FG001|Overall Study|Withdrawal by parent/guardian|3|||
129500209|NCT04436822|466121944|FG000|Overall Study|Unsuccessful procedure|0|||
129500210|NCT04436822|466121945|FG001|Overall Study|Unsuccessful procedure|1|||
129500211|NCT04436822|466121944|FG000|Overall Study|Withdrawal due to Covid-19|8|||
129500212|NCT04436822|466121945|FG001|Overall Study|Withdrawal due to Covid-19|1|||
129500213|NCT04436822|466121944|FG000|Overall Study|Withdrawal by Subject|1|||
129500214|NCT04436822|466121945|FG001|Overall Study|Withdrawal by Subject|0|||
129500215|NCT04436822|466121944|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
129500216|NCT04436822|466121945|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
129500217|NCT02371759|466121948|FG000|Overall Study|Protocol Violation|3|||
129500218|NCT02371759|466121949|FG001|Overall Study|Protocol Violation|1|||
129500219|NCT02371759|466121950|FG002|Overall Study|Protocol Violation|1|||
129500220|NCT02371759|466121951|FG003|Overall Study|Protocol Violation|0|||
129500221|NCT02371759|466121952|FG004|Overall Study|Protocol Violation|3|||
129500222|NCT02371759|466121953|FG005|Overall Study|Protocol Violation|1|||
129500223|NCT02371759|466121954|FG006|Overall Study|Protocol Violation|0|||
129500224|NCT02371759|466121955|FG007|Overall Study|Protocol Violation|3|||
129500225|NCT02371759|466121948|FG000|Overall Study|Withdrawal by Subject|0|||
129500226|NCT02371759|466121949|FG001|Overall Study|Withdrawal by Subject|0|||
129500227|NCT02371759|466121950|FG002|Overall Study|Withdrawal by Subject|0|||
129500228|NCT02371759|466121951|FG003|Overall Study|Withdrawal by Subject|0|||
129500229|NCT02371759|466121952|FG004|Overall Study|Withdrawal by Subject|0|||
129500230|NCT02371759|466121953|FG005|Overall Study|Withdrawal by Subject|0|||
129500231|NCT02371759|466121954|FG006|Overall Study|Withdrawal by Subject|0|||
129500232|NCT02371759|466121955|FG007|Overall Study|Withdrawal by Subject|1|||
129500233|NCT03375112|466121958|FG000|Overall Study|Withdrawal by Subject|3|||
129500234|NCT03375112|466121959|FG001|Overall Study|Withdrawal by Subject|0|||
129500235|NCT00243230|466121960|FG000|Double-Blind Period|Adverse Event|0|||
129500236|NCT00243230|466121961|FG001|Double-Blind Period|Adverse Event|2|||
129500237|NCT00243230|466121962|FG002|Double-Blind Period|Adverse Event|2|||
129500238|NCT00243230|466121963|FG003|Double-Blind Period|Adverse Event|0|||
129500239|NCT00243230|466121960|FG000|Double-Blind Period|Withdrawal by Subject|1|||
129500240|NCT00243230|466121961|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129500241|NCT00243230|466121962|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129500242|NCT00243230|466121963|FG003|Double-Blind Period|Withdrawal by Subject|0|||
129500243|NCT00243230|466121960|FG000|Double-Blind Period|Protocol Violation|0|||
129500244|NCT00243230|466121961|FG001|Double-Blind Period|Protocol Violation|0|||
129500245|NCT00243230|466121962|FG002|Double-Blind Period|Protocol Violation|1|||
129500246|NCT00243230|466121963|FG003|Double-Blind Period|Protocol Violation|0|||
129500247|NCT00243230|466121960|FG000|Double-Blind Period|Randomized but Not Treated|0|||
129500248|NCT00243230|466121961|FG001|Double-Blind Period|Randomized but Not Treated|0|||
129500249|NCT00243230|466121962|FG002|Double-Blind Period|Randomized but Not Treated|2|||
129500250|NCT00243230|466121963|FG003|Double-Blind Period|Randomized but Not Treated|0|||
129500251|NCT00243230|466121960|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
129500252|NCT00243230|466121961|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
129500253|NCT00243230|466121962|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
129500254|NCT00243230|466121963|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
129500255|NCT00243230|466121960|FG000|Open Label Period|Adverse Event|0|||
129500256|NCT00243230|466121961|FG001|Open Label Period|Adverse Event|0|||
129500257|NCT00243230|466121962|FG002|Open Label Period|Adverse Event|0|||
129500258|NCT00243230|466121963|FG003|Open Label Period|Adverse Event|2|||
129500259|NCT00243230|466121960|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
129500260|NCT00243230|466121961|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
129500261|NCT00243230|466121962|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
129500262|NCT00243230|466121963|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
129500263|NCT00243230|466121960|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
129500264|NCT00243230|466121961|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
129500265|NCT00243230|466121962|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
129500266|NCT00243230|466121963|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
129500267|NCT00243230|466121960|FG000|Open Label Period|Lost to Follow-up|0|||
129500268|NCT00243230|466121961|FG001|Open Label Period|Lost to Follow-up|0|||
129500269|NCT00243230|466121962|FG002|Open Label Period|Lost to Follow-up|0|||
129500270|NCT00243230|466121963|FG003|Open Label Period|Lost to Follow-up|2|||
129500271|NCT00243230|466121960|FG000|Open Label Period|Withdrawal by Subject|0|||
129500272|NCT00243230|466121961|FG001|Open Label Period|Withdrawal by Subject|0|||
129500273|NCT00243230|466121962|FG002|Open Label Period|Withdrawal by Subject|0|||
129500274|NCT00243230|466121963|FG003|Open Label Period|Withdrawal by Subject|2|||
129500275|NCT00243230|466121960|FG000|Open Label Period|Protocol Violation|0|||
129500276|NCT00243230|466121961|FG001|Open Label Period|Protocol Violation|0|||
129500277|NCT00243230|466121962|FG002|Open Label Period|Protocol Violation|0|||
129500278|NCT00243230|466121963|FG003|Open Label Period|Protocol Violation|2|||
129500279|NCT00243230|466121960|FG000|Open Label Period|Administrative Reason|0|||
129500280|NCT00243230|466121961|FG001|Open Label Period|Administrative Reason|0|||
129500281|NCT00243230|466121962|FG002|Open Label Period|Administrative Reason|0|||
129500282|NCT00243230|466121963|FG003|Open Label Period|Administrative Reason|63|||
129500283|NCT01689207|466121964|FG000|Overall Study|Adverse Event|0|||
129500284|NCT01689207|466121965|FG001|Overall Study|Adverse Event|1|||
129500285|NCT01689207|466121966|FG002|Overall Study|Adverse Event|0|||
129500286|NCT01689207|466121967|FG003|Overall Study|Adverse Event|0|||
129500287|NCT01689207|466121968|FG004|Overall Study|Adverse Event|2|||
129500288|NCT01689207|466121969|FG005|Overall Study|Adverse Event|1|||
129500289|NCT01689207|466121970|FG006|Overall Study|Adverse Event|0|||
129500290|NCT01689207|466121971|FG007|Overall Study|Adverse Event|0|||
129500291|NCT01689207|466121972|FG008|Overall Study|Adverse Event|1|||
129500292|NCT01689207|466121973|FG009|Overall Study|Adverse Event|0|||
129500293|NCT01689207|466121974|FG010|Overall Study|Adverse Event|0|||
129500294|NCT03855137|466121976|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
129500295|NCT03855137|466121977|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
129500296|NCT03855137|466121978|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
129500297|NCT03855137|466121976|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
129500298|NCT03855137|466121977|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
129500299|NCT03855137|466121978|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
129500300|NCT03855137|466121976|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
129500301|NCT03855137|466121977|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
129500302|NCT03855137|466121978|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
129500303|NCT03855137|466121976|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
129500304|NCT03855137|466121977|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
129500305|NCT03855137|466121978|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
129500306|NCT03855137|466121976|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
129500307|NCT03855137|466121977|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
129500308|NCT03855137|466121978|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
129500309|NCT03855137|466121976|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
129500310|NCT03855137|466121977|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
129500311|NCT03855137|466121978|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
129500312|NCT03855137|466121976|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
129500313|NCT03855137|466121977|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
129500314|NCT03855137|466121978|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
129539064|NCT02708524|466265144|FG000|Overall Study|Lens Discomfort|1|||
129500315|NCT03855137|466121976|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
129500316|NCT03855137|466121977|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
129500317|NCT03855137|466121978|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
129500318|NCT03855137|466121976|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
129500319|NCT03855137|466121977|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
129500320|NCT03855137|466121978|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
129500321|NCT03855137|466121976|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
129500322|NCT03855137|466121977|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
129500323|NCT03855137|466121978|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
129500324|NCT04369430|466121983|FG000|Overall Study|Adverse Event|2|||
129500325|NCT04369430|466121984|FG001|Overall Study|Adverse Event|3|||
129500326|NCT04369430|466121983|FG000|Overall Study|Death|1|||
129500327|NCT04369430|466121984|FG001|Overall Study|Death|0|||
129500328|NCT04369430|466121983|FG000|Overall Study|Withdrawal by Subject|4|||
129500329|NCT04369430|466121984|FG001|Overall Study|Withdrawal by Subject|3|||
129500330|NCT04369430|466121983|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
129500331|NCT04369430|466121984|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
129500332|NCT04369430|466121983|FG000|Overall Study|Lost to Follow-up|0|||
129500333|NCT04369430|466121984|FG001|Overall Study|Lost to Follow-up|1|||
129500334|NCT00008138|466121985|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
129500335|NCT00008138|466121985|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
129500336|NCT00008138|466121985|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
129500337|NCT00008138|466121985|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
129500338|NCT00008138|466121985|FG000|Interval Debulking|Withdrawal by Subject|2|||
129500339|NCT00008138|466121985|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
129500340|NCT00008138|466121985|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
129500341|NCT00008138|466121985|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
129500342|NCT02065622|466121986|FG000|Induction Study|Adverse Event|13|||
129500343|NCT02065622|466121987|FG001|Induction Study|Adverse Event|19|||
129500344|NCT02065622|466121988|FG002|Induction Study|Adverse Event|0|||
129500345|NCT02065622|466121989|FG003|Induction Study|Adverse Event|0|||
129500346|NCT02065622|466121990|FG004|Induction Study|Adverse Event|0|||
129500347|NCT02065622|466121986|FG000|Induction Study|Withdrawal by Subject|3|||
129500348|NCT02065622|466121987|FG001|Induction Study|Withdrawal by Subject|5|||
129500349|NCT02065622|466121988|FG002|Induction Study|Withdrawal by Subject|0|||
129500350|NCT02065622|466121989|FG003|Induction Study|Withdrawal by Subject|0|||
129500351|NCT02065622|466121990|FG004|Induction Study|Withdrawal by Subject|0|||
129500352|NCT02065622|466121986|FG000|Induction Study|Lost to Follow-up|1|||
129500353|NCT02065622|466121987|FG001|Induction Study|Lost to Follow-up|0|||
129500354|NCT02065622|466121988|FG002|Induction Study|Lost to Follow-up|0|||
129500355|NCT02065622|466121989|FG003|Induction Study|Lost to Follow-up|0|||
129500356|NCT02065622|466121990|FG004|Induction Study|Lost to Follow-up|0|||
129500357|NCT02065622|466121986|FG000|Induction Study|Lack of Efficacy|22|||
129500358|NCT02065622|466121987|FG001|Induction Study|Lack of Efficacy|27|||
129500359|NCT02065622|466121988|FG002|Induction Study|Lack of Efficacy|0|||
129500360|NCT02065622|466121989|FG003|Induction Study|Lack of Efficacy|0|||
129500361|NCT02065622|466121990|FG004|Induction Study|Lack of Efficacy|0|||
129500362|NCT02065622|466121986|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
129500363|NCT02065622|466121987|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
129500364|NCT02065622|466121988|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
129500365|NCT02065622|466121989|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
129500366|NCT02065622|466121990|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
129500367|NCT02065622|466121986|FG000|Induction Study|Subject Noncompliance|1|||
129500368|NCT02065622|466121987|FG001|Induction Study|Subject Noncompliance|1|||
129500369|NCT02065622|466121988|FG002|Induction Study|Subject Noncompliance|0|||
129500370|NCT02065622|466121989|FG003|Induction Study|Subject Noncompliance|0|||
129500371|NCT02065622|466121990|FG004|Induction Study|Subject Noncompliance|0|||
129500372|NCT02065622|466121986|FG000|Induction Study|Other, Not Specified|3|||
129500373|NCT02065622|466121987|FG001|Induction Study|Other, Not Specified|2|||
129500374|NCT02065622|466121988|FG002|Induction Study|Other, Not Specified|0|||
129500375|NCT02065622|466121989|FG003|Induction Study|Other, Not Specified|0|||
129981862|NCT01259089|467896754|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
129981863|NCT00886795|467896759|FG000|Overall Study|Lack of Efficacy|1|||
129500376|NCT02065622|466121990|FG004|Induction Study|Other, Not Specified|0|||
129500377|NCT02065622|466121986|FG000|Maintenance Study|Adverse Event|0|||
129500378|NCT02065622|466121987|FG001|Maintenance Study|Adverse Event|0|||
129500379|NCT02065622|466121988|FG002|Maintenance Study|Adverse Event|25|||
129500380|NCT02065622|466121989|FG003|Maintenance Study|Adverse Event|22|||
129500381|NCT02065622|466121990|FG004|Maintenance Study|Adverse Event|11|||
129500382|NCT02065622|466121986|FG000|Maintenance Study|Withdrawal by Subject|0|||
129500383|NCT02065622|466121987|FG001|Maintenance Study|Withdrawal by Subject|0|||
129500384|NCT02065622|466121988|FG002|Maintenance Study|Withdrawal by Subject|11|||
129500385|NCT02065622|466121989|FG003|Maintenance Study|Withdrawal by Subject|5|||
129500386|NCT02065622|466121990|FG004|Maintenance Study|Withdrawal by Subject|7|||
129500387|NCT02065622|466121986|FG000|Maintenance Study|Lost to Follow-up|0|||
129500388|NCT02065622|466121987|FG001|Maintenance Study|Lost to Follow-up|0|||
129500389|NCT02065622|466121988|FG002|Maintenance Study|Lost to Follow-up|4|||
129500390|NCT02065622|466121989|FG003|Maintenance Study|Lost to Follow-up|1|||
129500391|NCT02065622|466121990|FG004|Maintenance Study|Lost to Follow-up|1|||
129500392|NCT02065622|466121986|FG000|Maintenance Study|Lack of Efficacy|0|||
129500393|NCT02065622|466121987|FG001|Maintenance Study|Lack of Efficacy|0|||
129500394|NCT02065622|466121988|FG002|Maintenance Study|Lack of Efficacy|70|||
129500395|NCT02065622|466121989|FG003|Maintenance Study|Lack of Efficacy|55|||
129500396|NCT02065622|466121990|FG004|Maintenance Study|Lack of Efficacy|19|||
129500397|NCT02065622|466121986|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
129500398|NCT02065622|466121987|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
129500399|NCT02065622|466121988|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
129500400|NCT02065622|466121989|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
129500401|NCT02065622|466121990|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
129500402|NCT02065622|466121986|FG000|Maintenance Study|Subject Non-Compliance|0|||
129500403|NCT02065622|466121987|FG001|Maintenance Study|Subject Non-Compliance|0|||
129500404|NCT02065622|466121988|FG002|Maintenance Study|Subject Non-Compliance|1|||
129500405|NCT02065622|466121989|FG003|Maintenance Study|Subject Non-Compliance|3|||
129500406|NCT02065622|466121990|FG004|Maintenance Study|Subject Non-Compliance|2|||
129500407|NCT02065622|466121986|FG000|Maintenance Study|Other, Not Specified|0|||
129500408|NCT02065622|466121987|FG001|Maintenance Study|Other, Not Specified|0|||
129500409|NCT02065622|466121988|FG002|Maintenance Study|Other, Not Specified|6|||
129500410|NCT02065622|466121989|FG003|Maintenance Study|Other, Not Specified|14|||
129500411|NCT02065622|466121990|FG004|Maintenance Study|Other, Not Specified|2|||
129500412|NCT02065622|466121986|FG000|Maintenance Study|Unknown Reason|0|||
129500413|NCT02065622|466121987|FG001|Maintenance Study|Unknown Reason|0|||
129500414|NCT02065622|466121988|FG002|Maintenance Study|Unknown Reason|0|||
129500415|NCT02065622|466121989|FG003|Maintenance Study|Unknown Reason|1|||
129500416|NCT02065622|466121990|FG004|Maintenance Study|Unknown Reason|0|||
129500417|NCT01767194|466121993|FG000|Overall Study|Adverse Event|1|||
129500418|NCT01767194|466121994|FG001|Overall Study|Adverse Event|1|||
129500419|NCT01767194|466121993|FG000|Overall Study|Death|0|||
129500420|NCT01767194|466121994|FG001|Overall Study|Death|1|||
129500421|NCT01767194|466121993|FG000|Overall Study|Lack of Efficacy|12|||
129500422|NCT01767194|466121994|FG001|Overall Study|Lack of Efficacy|11|||
129500423|NCT01767194|466121993|FG000|Overall Study|Physician Decision|2|||
129500424|NCT01767194|466121994|FG001|Overall Study|Physician Decision|23|||
129500425|NCT01767194|466121993|FG000|Overall Study|Withdrawal by Subject|0|||
129500426|NCT01767194|466121994|FG001|Overall Study|Withdrawal by Subject|1|||
129500427|NCT01767194|466121993|FG000|Overall Study|Ineligible|1|||
129500428|NCT01767194|466121994|FG001|Overall Study|Ineligible|1|||
129500429|NCT01767194|466121993|FG000|Overall Study|Refusal by patient/parent|2|||
129500430|NCT01767194|466121994|FG001|Overall Study|Refusal by patient/parent|4|||
129500431|NCT01767194|466121993|FG000|Overall Study|Criteria not met on time for next cycle|0|||
129500432|NCT01767194|466121994|FG001|Overall Study|Criteria not met on time for next cycle|1|||
129500433|NCT04973228|466121995|FG000|Overall Study|Adverse Event|2|||
129500434|NCT04973228|466121996|FG001|Overall Study|Adverse Event|3|||
129500435|NCT04973228|466121995|FG000|Overall Study|Lack of Efficacy|1|||
129500436|NCT04973228|466121996|FG001|Overall Study|Lack of Efficacy|3|||
129500437|NCT04973228|466121995|FG000|Overall Study|Lost to Follow-up|12|||
129500438|NCT04973228|466121996|FG001|Overall Study|Lost to Follow-up|4|||
129500439|NCT04973228|466121995|FG000|Overall Study|Withdrawal by Subject|11|||
129500440|NCT04973228|466121996|FG001|Overall Study|Withdrawal by Subject|4|||
129500441|NCT04973228|466121995|FG000|Overall Study|Did not tolerate application|1|||
129500442|NCT04973228|466121996|FG001|Overall Study|Did not tolerate application|0|||
129500443|NCT04973228|466121995|FG000|Overall Study|Wanted to early terminate and use own product|0|||
129500444|NCT04973228|466121996|FG001|Overall Study|Wanted to early terminate and use own product|1|||
129500445|NCT04973228|466121995|FG000|Overall Study|Missed visits due to new work schedule|1|||
129500446|NCT04973228|466121996|FG001|Overall Study|Missed visits due to new work schedule|0|||
129500447|NCT02678780|466121999|FG000|Overall Study|Adverse Event|11|||
129500448|NCT02678780|466122000|FG001|Overall Study|Adverse Event|14|||
129500449|NCT02678780|466121999|FG000|Overall Study|Withdrawal by Subject|2|||
129500450|NCT02678780|466122000|FG001|Overall Study|Withdrawal by Subject|1|||
129500451|NCT02678780|466121999|FG000|Overall Study|Sponsor discontinuation|7|||
129500452|NCT02678780|466122000|FG001|Overall Study|Sponsor discontinuation|4|||
129500453|NCT02678780|466121999|FG000|Overall Study|Death|1|||
129500454|NCT02678780|466122000|FG001|Overall Study|Death|1|||
129981864|NCT02310100|467896760|FG000|Overall Study|Physician Decision|3|||
129500455|NCT02678780|466121999|FG000|Overall Study|Other|6|||
129500456|NCT02678780|466122000|FG001|Overall Study|Other|8|||
129500457|NCT00406640|466122001|FG000|Acute Phase|Adverse Event|18|||
129500458|NCT00406640|466122002|FG001|Acute Phase|Adverse Event|13|||
129500459|NCT00406640|466122001|FG000|Acute Phase|Failed to Return|5|||
129500460|NCT00406640|466122002|FG001|Acute Phase|Failed to Return|1|||
129500461|NCT00406640|466122001|FG000|Acute Phase|Physician Decision|0|||
129981865|NCT02310100|467896760|FG000|Overall Study|Withdrawal by Subject|10|||
129500462|NCT00406640|466122002|FG001|Acute Phase|Physician Decision|1|||
129500463|NCT00406640|466122001|FG000|Acute Phase|Lost to Follow-up|7|||
129500464|NCT00406640|466122002|FG001|Acute Phase|Lost to Follow-up|4|||
129500465|NCT00406640|466122001|FG000|Acute Phase|Protocol deviation|4|||
129500466|NCT00406640|466122002|FG001|Acute Phase|Protocol deviation|10|||
129500467|NCT00406640|466122001|FG000|Acute Phase|Protocol Violation|3|||
129500468|NCT00406640|466122002|FG001|Acute Phase|Protocol Violation|2|||
129500469|NCT00406640|466122001|FG000|Acute Phase|Withdrawal by Subject|11|||
129500470|NCT00406640|466122002|FG001|Acute Phase|Withdrawal by Subject|9|||
129500471|NCT00406640|466122001|FG000|Acute Phase|Lack of Efficacy|3|||
129500472|NCT00406640|466122002|FG001|Acute Phase|Lack of Efficacy|3|||
129500473|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
129500474|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
129500475|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Death|1|||
129500476|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Death|0|||
129500477|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
129500478|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
129500479|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
129500480|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
129500481|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
129500482|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
129500483|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|non-compliance|7|||
129500484|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|non-compliance|5|||
129500485|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
129500486|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
129500487|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
129500488|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
129500489|NCT00406640|466122001|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
129500490|NCT00406640|466122002|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
129500491|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
129500492|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
129500493|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
129500494|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
129500495|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
129500496|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
129500497|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
129500498|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
129500499|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
129500500|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
129500501|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
129500502|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
129500503|NCT00406640|466122001|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
129500504|NCT00406640|466122002|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
129500505|NCT01454401|466122005|FG000|Overall Study|Death|1|||
129500506|NCT01454401|466122005|FG000|Overall Study|hospitalised|1|||
129500507|NCT01454401|466122005|FG000|Overall Study|osteomyelitis|2|||
129500508|NCT01454401|466122005|FG000|Overall Study|non-adherence|1|||
129500509|NCT00755846|466123649|FG000|Overall Study|Adverse Event|0|||
129500510|NCT00755846|466123650|FG001|Overall Study|Adverse Event|0|||
129500511|NCT00755846|466123651|FG002|Overall Study|Adverse Event|0|||
129500512|NCT00755846|466123652|FG003|Overall Study|Adverse Event|1|||
129500513|NCT00755846|466123653|FG004|Overall Study|Adverse Event|3|||
129500514|NCT00755846|466123654|FG005|Overall Study|Adverse Event|2|||
129500515|NCT00755846|466123649|FG000|Overall Study|Protocol Violation|1|||
129500516|NCT00755846|466123650|FG001|Overall Study|Protocol Violation|1|||
129500517|NCT00755846|466123651|FG002|Overall Study|Protocol Violation|1|||
129500518|NCT00755846|466123652|FG003|Overall Study|Protocol Violation|1|||
129500519|NCT00755846|466123653|FG004|Overall Study|Protocol Violation|1|||
129500520|NCT00755846|466123654|FG005|Overall Study|Protocol Violation|1|||
129500521|NCT00755846|466123649|FG000|Overall Study|Lost to Follow-up|0|||
129500522|NCT00755846|466123650|FG001|Overall Study|Lost to Follow-up|2|||
129500523|NCT00755846|466123651|FG002|Overall Study|Lost to Follow-up|1|||
129500524|NCT00755846|466123652|FG003|Overall Study|Lost to Follow-up|0|||
129500525|NCT00755846|466123653|FG004|Overall Study|Lost to Follow-up|4|||
129500526|NCT00755846|466123654|FG005|Overall Study|Lost to Follow-up|2|||
129500527|NCT00755846|466123649|FG000|Overall Study|Withdrawal by Subject|2|||
129500528|NCT00755846|466123650|FG001|Overall Study|Withdrawal by Subject|3|||
129500529|NCT00755846|466123651|FG002|Overall Study|Withdrawal by Subject|5|||
129500530|NCT00755846|466123652|FG003|Overall Study|Withdrawal by Subject|2|||
129500531|NCT00755846|466123653|FG004|Overall Study|Withdrawal by Subject|0|||
129500532|NCT00755846|466123654|FG005|Overall Study|Withdrawal by Subject|1|||
129500533|NCT00755846|466123649|FG000|Overall Study|Hyperglycemic Rescue|21|||
129500534|NCT00755846|466123650|FG001|Overall Study|Hyperglycemic Rescue|7|||
129500535|NCT00755846|466123651|FG002|Overall Study|Hyperglycemic Rescue|5|||
129500536|NCT00755846|466123652|FG003|Overall Study|Hyperglycemic Rescue|8|||
129500537|NCT00755846|466123653|FG004|Overall Study|Hyperglycemic Rescue|8|||
129500538|NCT00755846|466123654|FG005|Overall Study|Hyperglycemic Rescue|7|||
129500539|NCT00755846|466123649|FG000|Overall Study|Physician Decision|1|||
129500540|NCT00755846|466123650|FG001|Overall Study|Physician Decision|3|||
129500541|NCT00755846|466123651|FG002|Overall Study|Physician Decision|0|||
129500542|NCT00755846|466123652|FG003|Overall Study|Physician Decision|1|||
129500543|NCT00755846|466123653|FG004|Overall Study|Physician Decision|0|||
129500544|NCT00755846|466123654|FG005|Overall Study|Physician Decision|1|||
129500545|NCT00755846|466123649|FG000|Overall Study|Administrative Error|0|||
129500546|NCT00755846|466123650|FG001|Overall Study|Administrative Error|1|||
129500547|NCT00755846|466123651|FG002|Overall Study|Administrative Error|0|||
129500548|NCT00755846|466123652|FG003|Overall Study|Administrative Error|0|||
129500549|NCT00755846|466123653|FG004|Overall Study|Administrative Error|0|||
129500550|NCT00755846|466123654|FG005|Overall Study|Administrative Error|0|||
129500551|NCT00755846|466123649|FG000|Overall Study|Participant Non-compliance|0|||
129500552|NCT00755846|466123650|FG001|Overall Study|Participant Non-compliance|0|||
129500553|NCT00755846|466123651|FG002|Overall Study|Participant Non-compliance|0|||
129500554|NCT00755846|466123652|FG003|Overall Study|Participant Non-compliance|0|||
129500555|NCT00755846|466123653|FG004|Overall Study|Participant Non-compliance|1|||
129500556|NCT00755846|466123654|FG005|Overall Study|Participant Non-compliance|0|||
129500557|NCT00311181|466123655|FG000|Overall Study|Final DFTs were not obtained|96|||
129500558|NCT02669862|466123656|FG000|Overall Study|Lost to Follow-up|0|||
129500559|NCT02669862|466123657|FG001|Overall Study|Lost to Follow-up|2|||
129500560|NCT02669862|466123658|FG002|Overall Study|Lost to Follow-up|1|||
129500561|NCT02669862|466123656|FG000|Overall Study|Withdrawal by Subject|2|||
129500562|NCT02669862|466123657|FG001|Overall Study|Withdrawal by Subject|2|||
129500563|NCT02669862|466123658|FG002|Overall Study|Withdrawal by Subject|3|||
129500564|NCT02669862|466123656|FG000|Overall Study|moved|0|||
129500565|NCT02669862|466123657|FG001|Overall Study|moved|1|||
129500566|NCT02669862|466123658|FG002|Overall Study|moved|0|||
129500567|NCT02669862|466123656|FG000|Overall Study|Protocol Violation|0|||
129500568|NCT02669862|466123657|FG001|Overall Study|Protocol Violation|0|||
129500569|NCT02669862|466123658|FG002|Overall Study|Protocol Violation|1|||
129500570|NCT02429258|466123661|FG000|Overall Study|Withdrawal by Subject|2|||
129500571|NCT02429258|466123662|FG001|Overall Study|Withdrawal by Subject|0|||
129500572|NCT02429258|466123661|FG000|Overall Study|Protocol Violation|0|||
129500573|NCT02429258|466123662|FG001|Overall Study|Protocol Violation|1|||
129500574|NCT02397694|466123663|FG000|Double-Blinded Phase|Adverse Event|1|||
129500575|NCT02397694|466123664|FG001|Double-Blinded Phase|Adverse Event|0|||
129500576|NCT02397694|466123663|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
129500577|NCT02397694|466123664|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
129500578|NCT02397694|466123663|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
129500579|NCT02397694|466123664|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
129500580|NCT02397694|466123663|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
129500581|NCT02397694|466123664|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
129500582|NCT02397694|466123663|FG000|Open Label Extension Phase|Protocol Violation|1|||
129500583|NCT02397694|466123664|FG001|Open Label Extension Phase|Protocol Violation|0|||
129500584|NCT02397694|466123663|FG000|Open Label Extension Phase|Withdrew Consent|3|||
129500585|NCT02397694|466123664|FG001|Open Label Extension Phase|Withdrew Consent|1|||
129500586|NCT02397694|466123663|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
129500587|NCT02397694|466123664|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
129500588|NCT00762372|466123668|FG000|Overall Study|Adverse Event|1|||
129500589|NCT00762372|466123669|FG001|Overall Study|Adverse Event|0|||
129500590|NCT00762372|466123670|FG002|Overall Study|Adverse Event|0|||
129981866|NCT02310100|467896760|FG000|Overall Study|Enrollment closure|1|||
129981867|NCT02310100|467896760|FG000|Overall Study|Unapproved ablation operator|1|||
129981868|NCT02310100|467896760|FG000|Overall Study|Visit compliance|1|||
129981869|NCT02310100|467896760|FG000|Overall Study|Lost to Follow-up|2|||
129981870|NCT00688870|467896763|FG000|Infant Series|Parent or legal guardian request|4|||
129981871|NCT00688870|467896764|FG001|Infant Series|Parent or legal guardian request|0|||
129981872|NCT01253018|467896775|FG000|Overall Study|Lost to Follow-up|1|||
129500591|NCT03364335|466123671|FG000|Overall Study|Adverse Event|3|||
129500592|NCT03364335|466123672|FG001|Overall Study|Adverse Event|4|||
129500593|NCT03364335|466123673|FG002|Overall Study|Adverse Event|1|||
129500594|NCT03364335|466123674|FG003|Overall Study|Adverse Event|2|||
129500595|NCT03364335|466123675|FG004|Overall Study|Adverse Event|0|||
129500596|NCT03364335|466123671|FG000|Overall Study|Lost to Follow-up|7|||
129500597|NCT03364335|466123672|FG001|Overall Study|Lost to Follow-up|7|||
129500598|NCT03364335|466123673|FG002|Overall Study|Lost to Follow-up|10|||
129500599|NCT03364335|466123674|FG003|Overall Study|Lost to Follow-up|11|||
129500600|NCT03364335|466123675|FG004|Overall Study|Lost to Follow-up|11|||
129500601|NCT00818207|466123676|FG000|Overall Study|Adverse Event|6|||
129500602|NCT00818207|466123677|FG001|Overall Study|Adverse Event|0|||
129500603|NCT00818207|466123676|FG000|Overall Study|Lost to Follow-up|160|||
129500604|NCT00818207|466123677|FG001|Overall Study|Lost to Follow-up|146|||
129500605|NCT00818207|466123676|FG000|Overall Study|Multiple reasons|11|||
129500606|NCT00818207|466123677|FG001|Overall Study|Multiple reasons|12|||
129500607|NCT00818207|466123676|FG000|Overall Study|Withdrawal by Subject|42|||
129500608|NCT00818207|466123677|FG001|Overall Study|Withdrawal by Subject|104|||
129500609|NCT00818207|466123676|FG000|Overall Study|Death|3|||
129500610|NCT00818207|466123677|FG001|Overall Study|Death|5|||
129500611|NCT02494778|466123678|FG000|Overall Study|Death|3|||
129500612|NCT02494778|466123678|FG000|Overall Study|Other|173|||
129500613|NCT02494778|466123678|FG000|Overall Study|Lack of Efficacy|4|||
129500614|NCT02494778|466123678|FG000|Overall Study|Adverse Event|18|||
129500615|NCT02494778|466123678|FG000|Overall Study|Withdrawal by Subject|20|||
129500616|NCT02494778|466123678|FG000|Overall Study|Lost to Follow-up|2|||
129500617|NCT02494778|466123678|FG000|Overall Study|Noncompliant with study drug admin.|1|||
129500618|NCT02616185|466123679|FG000|Overall Study|Death|0|||
129500619|NCT02616185|466123680|FG001|Overall Study|Death|0|||
129500620|NCT02616185|466123681|FG002|Overall Study|Death|0|||
129500621|NCT02616185|466123682|FG003|Overall Study|Death|1|||
129500622|NCT02616185|466123683|FG004|Overall Study|Death|2|||
129500623|NCT02616185|466123684|FG005|Overall Study|Death|0|||
129500624|NCT02616185|466123685|FG006|Overall Study|Death|0|||
129500625|NCT02616185|466123686|FG007|Overall Study|Death|2|||
129500626|NCT02616185|466123687|FG008|Overall Study|Death|1|||
129500627|NCT02616185|466123679|FG000|Overall Study|Study terminated by sponsor|0|||
129500628|NCT02616185|466123680|FG001|Overall Study|Study terminated by sponsor|0|||
129500629|NCT02616185|466123681|FG002|Overall Study|Study terminated by sponsor|1|||
129500630|NCT02616185|466123682|FG003|Overall Study|Study terminated by sponsor|0|||
129500631|NCT02616185|466123683|FG004|Overall Study|Study terminated by sponsor|0|||
129500632|NCT02616185|466123684|FG005|Overall Study|Study terminated by sponsor|0|||
129500633|NCT02616185|466123685|FG006|Overall Study|Study terminated by sponsor|5|||
129500634|NCT02616185|466123686|FG007|Overall Study|Study terminated by sponsor|2|||
129500635|NCT02616185|466123687|FG008|Overall Study|Study terminated by sponsor|0|||
129500636|NCT02616185|466123679|FG000|Overall Study|Participant refused further follow-up|1|||
129500637|NCT02616185|466123680|FG001|Overall Study|Participant refused further follow-up|1|||
129500638|NCT02616185|466123681|FG002|Overall Study|Participant refused further follow-up|2|||
129500639|NCT02616185|466123682|FG003|Overall Study|Participant refused further follow-up|3|||
129500640|NCT02616185|466123683|FG004|Overall Study|Participant refused further follow-up|4|||
129500641|NCT02616185|466123684|FG005|Overall Study|Participant refused further follow-up|0|||
129500642|NCT02616185|466123685|FG006|Overall Study|Participant refused further follow-up|3|||
129500643|NCT02616185|466123686|FG007|Overall Study|Participant refused further follow-up|4|||
129500644|NCT02616185|466123687|FG008|Overall Study|Participant refused further follow-up|3|||
129500645|NCT02616185|466123679|FG000|Overall Study|Not reported|0|||
129500646|NCT02616185|466123680|FG001|Overall Study|Not reported|0|||
129500647|NCT02616185|466123681|FG002|Overall Study|Not reported|0|||
129500648|NCT02616185|466123682|FG003|Overall Study|Not reported|1|||
129500649|NCT02616185|466123683|FG004|Overall Study|Not reported|3|||
129500650|NCT02616185|466123684|FG005|Overall Study|Not reported|1|||
129500651|NCT02616185|466123685|FG006|Overall Study|Not reported|0|||
129500652|NCT02616185|466123686|FG007|Overall Study|Not reported|5|||
129500653|NCT02616185|466123687|FG008|Overall Study|Not reported|2|||
129500654|NCT01303380|466123688|FG000|Overall Study|Lack of compliance to study procedures|1|||
129500655|NCT03725202|466123689|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
129500656|NCT03725202|466123690|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
129500657|NCT03725202|466123691|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
129500658|NCT03725202|466123692|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
129500659|NCT03725202|466123693|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
129981873|NCT01253018|467896776|FG001|Overall Study|Lost to Follow-up|1|||
129981874|NCT01253018|467896775|FG000|Overall Study|Robot Repair Issues|2|||
129981875|NCT01253018|467896776|FG001|Overall Study|Robot Repair Issues|0|||
129981876|NCT01253018|467896775|FG000|Overall Study|Withdrawal by Subject|1|||
129981877|NCT01253018|467896776|FG001|Overall Study|Withdrawal by Subject|1|||
129981878|NCT03449901|467896777|FG000|Overall Study|Progression|57|||
129981879|NCT03449901|467896778|FG001|Overall Study|Progression|12|||
129981880|NCT03449901|467896777|FG000|Overall Study|Adverse Event|3|||
129500660|NCT03725202|466123694|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
129500661|NCT03725202|466123695|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
129500662|NCT03725202|466123696|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
129500663|NCT03725202|466123689|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
129500664|NCT03725202|466123690|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
129500665|NCT03725202|466123691|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
129500666|NCT03725202|466123692|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
129500667|NCT03725202|466123693|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
129981881|NCT03449901|467896778|FG001|Overall Study|Adverse Event|0|||
129500668|NCT03725202|466123694|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
129500669|NCT03725202|466123695|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
129500670|NCT03725202|466123696|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
129981882|NCT03449901|467896777|FG000|Overall Study|Death|6|||
129500671|NCT03725202|466123689|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
129500672|NCT03725202|466123690|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500673|NCT03725202|466123691|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500674|NCT03725202|466123692|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500675|NCT03725202|466123693|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500676|NCT03725202|466123694|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500677|NCT03725202|466123695|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500678|NCT03725202|466123696|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
129500679|NCT03725202|466123689|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
129500680|NCT03725202|466123690|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500681|NCT03725202|466123691|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500682|NCT03725202|466123692|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500683|NCT03725202|466123693|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500684|NCT03725202|466123694|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500685|NCT03725202|466123695|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500686|NCT03725202|466123696|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
129500687|NCT03725202|466123689|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
129500688|NCT03725202|466123690|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
129500689|NCT03725202|466123691|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
129500690|NCT03725202|466123692|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
129500691|NCT03725202|466123693|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
129500692|NCT03725202|466123694|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
129500693|NCT03725202|466123695|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
129500694|NCT03725202|466123696|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
129500695|NCT03725202|466123689|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500696|NCT03725202|466123690|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500697|NCT03725202|466123691|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
129500698|NCT03725202|466123692|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500699|NCT03725202|466123693|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500700|NCT03725202|466123694|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500701|NCT03725202|466123695|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500702|NCT03725202|466123696|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
129500703|NCT03725202|466123689|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
129500704|NCT03725202|466123690|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
129500705|NCT03725202|466123691|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
129500706|NCT03725202|466123692|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
129500707|NCT03725202|466123693|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
129500708|NCT03725202|466123694|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
129500709|NCT03725202|466123695|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
129500710|NCT03725202|466123696|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
129500711|NCT03725202|466123689|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
129500712|NCT03725202|466123690|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
129500713|NCT03725202|466123691|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
129500714|NCT03725202|466123692|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
129500715|NCT03725202|466123693|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
129500716|NCT03725202|466123694|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
129500717|NCT03725202|466123695|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
129500718|NCT03725202|466123696|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
129500719|NCT03725202|466123689|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
129500720|NCT03725202|466123690|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
129500721|NCT03725202|466123691|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
129500722|NCT03725202|466123692|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
129500723|NCT03725202|466123693|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
129500724|NCT03725202|466123694|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
129500725|NCT03725202|466123695|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
129500726|NCT03725202|466123696|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
129500727|NCT03725202|466123689|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129500728|NCT03725202|466123690|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129500729|NCT03725202|466123691|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129981883|NCT03449901|467896778|FG001|Overall Study|Death|2|||
129981884|NCT03449901|467896777|FG000|Overall Study|Withdrawal by Subject|12|||
129500730|NCT03725202|466123692|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129500731|NCT03725202|466123693|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129500732|NCT03725202|466123694|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129500733|NCT03725202|466123695|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
129500734|NCT03725202|466123696|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
129500735|NCT03725202|466123689|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500736|NCT03725202|466123690|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500737|NCT03725202|466123691|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500738|NCT03725202|466123692|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500739|NCT03725202|466123693|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500740|NCT03725202|466123694|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
129500741|NCT03725202|466123695|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500742|NCT03725202|466123696|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
129500743|NCT03725202|466123689|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
129500744|NCT03725202|466123690|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
129500745|NCT03725202|466123691|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
129500746|NCT03725202|466123692|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
129500747|NCT03725202|466123693|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
129500748|NCT03725202|466123694|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
129500749|NCT03725202|466123695|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
129500750|NCT03725202|466123696|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
129500751|NCT01328249|466123699|FG000|Overall Study|Adverse Event|3|||
129500752|NCT01328249|466123700|FG001|Overall Study|Adverse Event|0|||
129500753|NCT01328249|466123699|FG000|Overall Study|Disease progression|1|||
129500754|NCT01328249|466123700|FG001|Overall Study|Disease progression|0|||
129500755|NCT01328249|466123699|FG000|Overall Study|Withdrawal by Subject|1|||
129500756|NCT01328249|466123700|FG001|Overall Study|Withdrawal by Subject|1|||
129500757|NCT01328249|466123699|FG000|Overall Study|Moved before end of treatment visit|1|||
129500758|NCT01328249|466123700|FG001|Overall Study|Moved before end of treatment visit|0|||
129500759|NCT01328249|466123699|FG000|Overall Study|Subject choice|1|||
129500760|NCT01328249|466123700|FG001|Overall Study|Subject choice|1|||
129500761|NCT01328249|466123699|FG000|Overall Study|Protocol Violation|0|||
129500762|NCT01328249|466123700|FG001|Overall Study|Protocol Violation|1|||
129500763|NCT01215734|466123701|FG000|Overall Study|Death|0|||
129500764|NCT01215734|466123702|FG001|Overall Study|Death|1|||
129500765|NCT01716533|466123703|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
129500766|NCT01716533|466123704|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
129500767|NCT01716533|466123705|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
129500768|NCT01716533|466123706|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
129500769|NCT01716533|466123703|FG000|Overall Study|Withdrawal by Subject|0|||
129500770|NCT01716533|466123704|FG001|Overall Study|Withdrawal by Subject|0|||
129500771|NCT01716533|466123705|FG002|Overall Study|Withdrawal by Subject|0|||
129500772|NCT01716533|466123706|FG003|Overall Study|Withdrawal by Subject|5|||
129500773|NCT01716533|466123703|FG000|Overall Study|Death|0|||
129500774|NCT01716533|466123704|FG001|Overall Study|Death|0|||
129500775|NCT01716533|466123705|FG002|Overall Study|Death|0|||
129500776|NCT01716533|466123706|FG003|Overall Study|Death|2|||
129500777|NCT01716533|466123703|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
129500778|NCT01716533|466123704|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
129500779|NCT01716533|466123705|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
129500780|NCT01716533|466123706|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
129500781|NCT02330549|466123707|FG000|Overall Study|Adverse Event|1|||
129500782|NCT02330549|466123708|FG001|Overall Study|Adverse Event|0|||
129500783|NCT02330549|466123707|FG000|Overall Study|Subject withdrew consent|2|||
129500784|NCT02330549|466123708|FG001|Overall Study|Subject withdrew consent|1|||
129500785|NCT02330549|466123707|FG000|Overall Study|Failure to meet randomization criteria|1|||
129500786|NCT02330549|466123708|FG001|Overall Study|Failure to meet randomization criteria|0|||
129500787|NCT00495495|466123714|FG000|Overall Study|Protocol Violation|99|||
129500788|NCT03331666|466123718|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
129500789|NCT03331666|466123719|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
129500790|NCT01026389|466123722|FG000|Overall Study|Withdrawal by Subject|1|||
129500791|NCT01026389|466123723|FG001|Overall Study|Withdrawal by Subject|3|||
129500792|NCT01026389|466123722|FG000|Overall Study|change of treatment, patient moved|4|||
129500793|NCT01026389|466123723|FG001|Overall Study|change of treatment, patient moved|2|||
129500794|NCT01995136|466123724|FG000|Overall Study|Change in residence|1|||
129500795|NCT04410198|466123725|FG000|Overall Study|Death|10|||
129500796|NCT04410198|466123725|FG000|Overall Study|Withdrawal by Subject|7|||
129500797|NCT04410198|466123725|FG000|Overall Study|Transferred/Relocation|4|||
129500798|NCT04410198|466123725|FG000|Overall Study|Kidney Transplant|9|||
129500799|NCT04410198|466123725|FG000|Overall Study|Adverse Event|4|||
129500800|NCT04410198|466123725|FG000|Overall Study|Physician Decision|2|||
129500801|NCT04410198|466123725|FG000|Overall Study|Other than specified|1|||
129500802|NCT01830543|466123728|FG000|Overall Study|Subject Decision|19|||
129500803|NCT01830543|466123729|FG001|Overall Study|Subject Decision|21|||
129500804|NCT01830543|466123730|FG002|Overall Study|Subject Decision|57|||
129500805|NCT01830543|466123728|FG000|Overall Study|Adverse Event|91|||
129500806|NCT01830543|466123729|FG001|Overall Study|Adverse Event|77|||
129500807|NCT01830543|466123730|FG002|Overall Study|Adverse Event|76|||
129500808|NCT01830543|466123728|FG000|Overall Study|Death|20|||
129500809|NCT01830543|466123729|FG001|Overall Study|Death|22|||
129500810|NCT01830543|466123730|FG002|Overall Study|Death|22|||
129500811|NCT01830543|466123728|FG000|Overall Study|Protocol Violation|3|||
129500812|NCT01830543|466123729|FG001|Overall Study|Protocol Violation|7|||
129500813|NCT01830543|466123730|FG002|Overall Study|Protocol Violation|7|||
129500814|NCT01830543|466123728|FG000|Overall Study|Physician Decision|11|||
129500815|NCT01830543|466123729|FG001|Overall Study|Physician Decision|5|||
129500816|NCT01830543|466123730|FG002|Overall Study|Physician Decision|12|||
129500817|NCT01830543|466123728|FG000|Overall Study|Withdrawal by consent|3|||
129500818|NCT01830543|466123729|FG001|Overall Study|Withdrawal by consent|3|||
129500819|NCT01830543|466123730|FG002|Overall Study|Withdrawal by consent|3|||
129500820|NCT01830543|466123728|FG000|Overall Study|Other|12|||
129500821|NCT01830543|466123729|FG001|Overall Study|Other|17|||
129500822|NCT01830543|466123730|FG002|Overall Study|Other|37|||
129500823|NCT03583372|466123733|FG000|Overall Study|Withdrawal by Subject|6|||
129500824|NCT03583372|466123734|FG001|Overall Study|Withdrawal by Subject|11|||
129500825|NCT03583372|466123735|FG002|Overall Study|Withdrawal by Subject|7|||
129500826|NCT03583372|466123736|FG003|Overall Study|Withdrawal by Subject|8|||
129500827|NCT03583372|466123733|FG000|Overall Study|Lost to Follow-up|4|||
129500828|NCT03583372|466123734|FG001|Overall Study|Lost to Follow-up|6|||
129500829|NCT03583372|466123735|FG002|Overall Study|Lost to Follow-up|3|||
129500830|NCT03583372|466123736|FG003|Overall Study|Lost to Follow-up|2|||
129500831|NCT03583372|466123733|FG000|Overall Study|Adverse Event|1|||
129500832|NCT03583372|466123734|FG001|Overall Study|Adverse Event|3|||
129500833|NCT03583372|466123735|FG002|Overall Study|Adverse Event|4|||
129500834|NCT03583372|466123736|FG003|Overall Study|Adverse Event|4|||
129500835|NCT03583372|466123733|FG000|Overall Study|Physician Decision|0|||
129500836|NCT03583372|466123734|FG001|Overall Study|Physician Decision|1|||
129500837|NCT03583372|466123735|FG002|Overall Study|Physician Decision|1|||
129500838|NCT03583372|466123736|FG003|Overall Study|Physician Decision|1|||
129500839|NCT03583372|466123733|FG000|Overall Study|Lack of Efficacy|0|||
129500840|NCT03583372|466123734|FG001|Overall Study|Lack of Efficacy|1|||
129500841|NCT03583372|466123735|FG002|Overall Study|Lack of Efficacy|0|||
129500842|NCT03583372|466123736|FG003|Overall Study|Lack of Efficacy|1|||
129500843|NCT03583372|466123733|FG000|Overall Study|Death|1|||
129500844|NCT03583372|466123734|FG001|Overall Study|Death|0|||
129500845|NCT03583372|466123735|FG002|Overall Study|Death|0|||
129500846|NCT03583372|466123736|FG003|Overall Study|Death|0|||
129500847|NCT03583372|466123733|FG000|Overall Study|Protocol Violation|0|||
129500848|NCT03583372|466123734|FG001|Overall Study|Protocol Violation|1|||
129500849|NCT03583372|466123735|FG002|Overall Study|Protocol Violation|0|||
129500850|NCT03583372|466123736|FG003|Overall Study|Protocol Violation|0|||
129500851|NCT03583372|466123733|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
129500852|NCT03583372|466123734|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
129500853|NCT03583372|466123735|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
129500854|NCT03583372|466123736|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
129500855|NCT03583372|466123733|FG000|Overall Study|Did Not Receive Study Drug|0|||
129500856|NCT03583372|466123734|FG001|Overall Study|Did Not Receive Study Drug|1|||
129500857|NCT03583372|466123735|FG002|Overall Study|Did Not Receive Study Drug|0|||
129500858|NCT03583372|466123736|FG003|Overall Study|Did Not Receive Study Drug|0|||
129500859|NCT03583372|466123733|FG000|Overall Study|Captured as Other in the Database|1|||
129500860|NCT03583372|466123734|FG001|Overall Study|Captured as Other in the Database|2|||
129500861|NCT03583372|466123735|FG002|Overall Study|Captured as Other in the Database|4|||
129500862|NCT03583372|466123736|FG003|Overall Study|Captured as Other in the Database|1|||
129500863|NCT01030458|466123747|FG000|Overall Study|Lost to Follow-up|9|||
129500864|NCT01030458|466123748|FG001|Overall Study|Lost to Follow-up|10|||
129500865|NCT01030458|466123747|FG000|Overall Study|Withdrawal by Subject|2|||
129500866|NCT01030458|466123748|FG001|Overall Study|Withdrawal by Subject|3|||
129500867|NCT01030458|466123747|FG000|Overall Study|Logistical reasons|9|||
129500868|NCT01030458|466123748|FG001|Overall Study|Logistical reasons|5|||
129500869|NCT01030458|466123747|FG000|Overall Study|Moved or changed job|6|||
129500870|NCT01030458|466123748|FG001|Overall Study|Moved or changed job|13|||
129500871|NCT01030458|466123747|FG000|Overall Study|Side effect of medication|1|||
129500872|NCT01030458|466123748|FG001|Overall Study|Side effect of medication|1|||
129500873|NCT02420223|466123749|FG000|Overall Study|Adverse Event|1|||
129500874|NCT02420223|466123750|FG001|Overall Study|Adverse Event|0|||
129500875|NCT02420223|466123749|FG000|Overall Study|Physician Decision|0|||
129500876|NCT02420223|466123750|FG001|Overall Study|Physician Decision|2|||
129500877|NCT05142332|466123757|FG000|Overall Study|Withdrawal by Subject|0|||
129500878|NCT05142332|466123758|FG001|Overall Study|Withdrawal by Subject|1|||
129500879|NCT05142332|466123759|FG002|Overall Study|Withdrawal by Subject|2|||
129500880|NCT05142332|466123760|FG003|Overall Study|Withdrawal by Subject|0|||
129500881|NCT05142332|466123761|FG004|Overall Study|Withdrawal by Subject|0|||
129500882|NCT05142332|466123762|FG005|Overall Study|Withdrawal by Subject|2|||
129500883|NCT05142332|466123763|FG006|Overall Study|Withdrawal by Subject|6|||
129500884|NCT05142332|466123757|FG000|Overall Study|Left ED|3|||
129500885|NCT05142332|466123758|FG001|Overall Study|Left ED|0|||
129500886|NCT05142332|466123759|FG002|Overall Study|Left ED|4|||
129500887|NCT05142332|466123760|FG003|Overall Study|Left ED|6|||
129500888|NCT05142332|466123761|FG004|Overall Study|Left ED|1|||
129500889|NCT05142332|466123762|FG005|Overall Study|Left ED|2|||
129500890|NCT05142332|466123763|FG006|Overall Study|Left ED|6|||
129500891|NCT05142332|466123757|FG000|Overall Study|Physician Decision|0|||
129500892|NCT05142332|466123758|FG001|Overall Study|Physician Decision|0|||
129500893|NCT05142332|466123759|FG002|Overall Study|Physician Decision|2|||
129500894|NCT05142332|466123760|FG003|Overall Study|Physician Decision|1|||
129500895|NCT05142332|466123761|FG004|Overall Study|Physician Decision|0|||
129500896|NCT05142332|466123762|FG005|Overall Study|Physician Decision|0|||
129500897|NCT05142332|466123763|FG006|Overall Study|Physician Decision|3|||
129500898|NCT05142332|466123757|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
129981885|NCT03449901|467896778|FG001|Overall Study|Withdrawal by Subject|1|||
129981886|NCT03449901|467896777|FG000|Overall Study|Physician Decision|1|||
129981887|NCT03449901|467896778|FG001|Overall Study|Physician Decision|0|||
129981888|NCT03449901|467896777|FG000|Overall Study|Patient elected for surgical intervention|1|||
129981889|NCT03449901|467896778|FG001|Overall Study|Patient elected for surgical intervention|0|||
129981890|NCT03449901|467896777|FG000|Overall Study|Patient off for other complicating disease|1|||
129981891|NCT03449901|467896778|FG001|Overall Study|Patient off for other complicating disease|0|||
129981892|NCT03466073|467896779|FG000|Overall Study|Death|1|||
129981893|NCT03466073|467896780|FG001|Overall Study|Death|0|||
129981894|NCT03466073|467896781|FG002|Overall Study|Death|0|||
129981895|NCT03466073|467896782|FG003|Overall Study|Death|0|||
129981896|NCT03466073|467896783|FG004|Overall Study|Death|0|||
129981897|NCT03466073|467896784|FG005|Overall Study|Death|1|||
129981898|NCT00744757|467896785|FG000|Overall Study|Objective disease progression|7|||
129981899|NCT00744757|467896785|FG000|Overall Study|Physician Decision|5|||
129981900|NCT00744757|467896785|FG000|Overall Study|Withdrawal by Subject|1|||
129981901|NCT00744757|467896785|FG000|Overall Study|Death|6|||
129981902|NCT00744757|467896785|FG000|Overall Study|Adverse Event|2|||
129981903|NCT03682302|467896786|FG000|Overall Study|Lost to Follow-up|1|||
129981904|NCT03682302|467896787|FG001|Overall Study|Lost to Follow-up|2|||
129981905|NCT03682302|467896788|FG002|Overall Study|Lost to Follow-up|0|||
129500899|NCT05142332|466123758|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
129500900|NCT05142332|466123759|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
129500901|NCT05142332|466123760|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
129500902|NCT05142332|466123761|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
129500903|NCT05142332|466123762|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
129500904|NCT05142332|466123763|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
129500905|NCT02052778|466123768|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
129500906|NCT02052778|466123769|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
129500907|NCT02052778|466123770|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
129500908|NCT02052778|466123771|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
129500909|NCT02052778|466123772|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
129500910|NCT02052778|466123773|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
129500911|NCT02052778|466123774|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500912|NCT02052778|466123775|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
129500913|NCT02052778|466123776|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
129500914|NCT02052778|466123777|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
129500915|NCT02052778|466123778|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
129500916|NCT02052778|466123779|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
129500917|NCT02052778|466123780|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
129500918|NCT02052778|466123781|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
129500919|NCT02052778|466123782|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500920|NCT02052778|466123783|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500921|NCT02052778|466123784|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500922|NCT02052778|466123785|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500923|NCT02052778|466123786|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500924|NCT02052778|466123787|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500925|NCT02052778|466123788|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500926|NCT02052778|466123789|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129500927|NCT02052778|466123790|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
129539065|NCT02708524|466265145|FG001|Overall Study|Lens Discomfort|0|||
129981906|NCT03682302|467896789|FG003|Overall Study|Lost to Follow-up|1|||
129981907|NCT03682302|467896786|FG000|Overall Study|Study drug was not administered|0|||
129981908|NCT03682302|467896787|FG001|Overall Study|Study drug was not administered|0|||
129981909|NCT03682302|467896788|FG002|Overall Study|Study drug was not administered|1|||
129500928|NCT02052778|466123768|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
129500929|NCT02052778|466123769|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
129500930|NCT02052778|466123770|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
129500931|NCT02052778|466123771|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
129500932|NCT02052778|466123772|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
129500933|NCT02052778|466123773|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
129500934|NCT02052778|466123774|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
129500935|NCT02052778|466123775|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
129500936|NCT02052778|466123776|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
129500937|NCT02052778|466123777|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500938|NCT02052778|466123778|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500939|NCT02052778|466123779|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
129500940|NCT02052778|466123780|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
129500941|NCT02052778|466123781|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
129500942|NCT02052778|466123782|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500943|NCT02052778|466123783|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500944|NCT02052778|466123784|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500945|NCT02052778|466123785|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500946|NCT02052778|466123786|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500947|NCT02052778|466123787|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500948|NCT02052778|466123788|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500949|NCT02052778|466123789|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500950|NCT02052778|466123790|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
129500951|NCT02052778|466123768|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500952|NCT02052778|466123769|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500953|NCT02052778|466123770|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500954|NCT02052778|466123771|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500955|NCT02052778|466123772|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500956|NCT02052778|466123773|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500957|NCT02052778|466123774|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500958|NCT02052778|466123775|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500959|NCT02052778|466123776|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500960|NCT02052778|466123777|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500961|NCT02052778|466123778|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500962|NCT02052778|466123779|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500963|NCT02052778|466123780|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500964|NCT02052778|466123781|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
129500965|NCT02052778|466123782|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500966|NCT02052778|466123783|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500967|NCT02052778|466123784|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500968|NCT02052778|466123785|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500969|NCT02052778|466123786|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500970|NCT02052778|466123787|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500971|NCT02052778|466123788|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500972|NCT02052778|466123789|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500973|NCT02052778|466123790|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
129500974|NCT02052778|466123768|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
129500975|NCT02052778|466123769|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
129500976|NCT02052778|466123770|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
129500977|NCT02052778|466123771|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
129500978|NCT02052778|466123772|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
129500979|NCT02052778|466123773|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
129500980|NCT02052778|466123774|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
129500981|NCT02052778|466123775|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
129981910|NCT03682302|467896789|FG003|Overall Study|Study drug was not administered|1|||
129981911|NCT01585155|467896790|FG000|Overall Study|Adverse Event|1|||
129981912|NCT01585155|467896790|FG000|Overall Study|Lack of Efficacy|2|||
129981913|NCT01585155|467896790|FG000|Overall Study|Worsening ulcerative colitis|2|||
129981914|NCT03772587|467896795|FG000|Overall Study|COVID-19|0|||
129981915|NCT03772587|467896796|FG001|Overall Study|COVID-19|0|||
129981916|NCT03772587|467896797|FG002|Overall Study|COVID-19|1|||
129981917|NCT03772587|467896798|FG003|Overall Study|COVID-19|1|||
129981918|NCT03772587|467896799|FG004|Overall Study|COVID-19|0|||
129981919|NCT03772587|467896795|FG000|Overall Study|Withdrawal by Subject|1|||
129981920|NCT03772587|467896796|FG001|Overall Study|Withdrawal by Subject|0|||
129500982|NCT02052778|466123776|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
129500983|NCT02052778|466123777|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
129500984|NCT02052778|466123778|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
129500985|NCT02052778|466123779|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
129500986|NCT02052778|466123780|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
129500987|NCT02052778|466123781|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
129500988|NCT02052778|466123782|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
129500989|NCT02052778|466123783|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
129500990|NCT02052778|466123784|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
129500991|NCT02052778|466123785|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
129500992|NCT02052778|466123786|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
129500993|NCT02052778|466123787|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
129500994|NCT02052778|466123788|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
129500995|NCT02052778|466123789|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
129500996|NCT02052778|466123790|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
129500997|NCT02052778|466123768|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129500998|NCT02052778|466123769|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129500999|NCT02052778|466123770|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501000|NCT02052778|466123771|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501001|NCT02052778|466123772|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501002|NCT02052778|466123773|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501003|NCT02052778|466123774|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501004|NCT02052778|466123775|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501005|NCT02052778|466123776|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
129501006|NCT02052778|466123777|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501007|NCT02052778|466123778|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501008|NCT02052778|466123779|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501009|NCT02052778|466123780|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501010|NCT02052778|466123781|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
129501011|NCT02052778|466123782|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501012|NCT02052778|466123783|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501013|NCT02052778|466123784|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501014|NCT02052778|466123785|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501015|NCT02052778|466123786|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501016|NCT02052778|466123787|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501017|NCT02052778|466123788|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501018|NCT02052778|466123789|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501019|NCT02052778|466123790|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
129501020|NCT02052778|466123768|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501021|NCT02052778|466123769|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501022|NCT02052778|466123770|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501023|NCT02052778|466123771|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501024|NCT02052778|466123772|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501025|NCT02052778|466123773|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
129501026|NCT02052778|466123774|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501027|NCT02052778|466123775|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501028|NCT02052778|466123776|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501029|NCT02052778|466123777|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501030|NCT02052778|466123778|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501031|NCT02052778|466123779|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501032|NCT02052778|466123780|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
129501033|NCT02052778|466123781|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501034|NCT02052778|466123782|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501035|NCT02052778|466123783|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501036|NCT02052778|466123784|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501037|NCT02052778|466123785|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501038|NCT02052778|466123786|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501039|NCT02052778|466123787|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501040|NCT02052778|466123788|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501041|NCT02052778|466123789|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501042|NCT02052778|466123790|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
129501043|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501044|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501045|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501046|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501047|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501048|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501049|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501050|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501051|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501052|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501053|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501054|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501055|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501056|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501057|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
129501058|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
129501059|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
129501060|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
129501061|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
129501062|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
129501063|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
129501064|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
129501065|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
129501066|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501067|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501068|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501069|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501070|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501071|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501072|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501073|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501074|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501075|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501076|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501077|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501078|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501079|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501080|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
129501081|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
129501082|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501083|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
129501084|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
129501085|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
129501086|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
129501087|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
129501088|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
129501089|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501090|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501091|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501092|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501093|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501094|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501095|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501096|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501097|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501098|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501099|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501100|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501101|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501102|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501103|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
129501104|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
129501105|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
129501106|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501107|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
129501108|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
129501109|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501110|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501111|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
129501112|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501113|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501114|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501115|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501116|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501117|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501118|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501119|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501120|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501121|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501122|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501123|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501124|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501125|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501126|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
129501127|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
129501128|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501129|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501130|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501131|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501132|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501133|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501134|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
129501135|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501136|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501137|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501138|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501139|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501140|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501141|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501142|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501143|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501144|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501145|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501146|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501147|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501148|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501149|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
129501150|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
129501151|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501152|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501153|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501154|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
129501155|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501156|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501157|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
129501158|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
129501159|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
129501160|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
129501161|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
129501162|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
129501163|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
129501164|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
129501165|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
129501166|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
129501167|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
129501168|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
129501169|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
129501170|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
129501171|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
129501172|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
129501173|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
129501174|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
129501175|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
129501176|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
129501177|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
129501178|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
129501179|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
129501180|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
129501181|NCT02052778|466123768|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501182|NCT02052778|466123769|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501183|NCT02052778|466123770|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501184|NCT02052778|466123771|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501185|NCT02052778|466123772|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501186|NCT02052778|466123773|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501187|NCT02052778|466123774|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501188|NCT02052778|466123775|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501189|NCT02052778|466123776|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501190|NCT02052778|466123777|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501191|NCT02052778|466123778|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501192|NCT02052778|466123779|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501193|NCT02052778|466123780|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501194|NCT02052778|466123781|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501195|NCT02052778|466123782|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
129501196|NCT02052778|466123783|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
129501197|NCT02052778|466123784|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
129501198|NCT02052778|466123785|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501199|NCT02052778|466123786|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
129501200|NCT02052778|466123787|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501201|NCT02052778|466123788|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501202|NCT02052778|466123789|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501203|NCT02052778|466123790|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
129501204|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501205|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501206|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501207|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501208|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501209|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501210|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501211|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501212|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501213|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501214|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501215|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501216|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501217|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501218|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501219|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501220|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501221|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501222|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501223|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501224|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501225|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
129501226|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
129501227|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129981921|NCT03772587|467896797|FG002|Overall Study|Withdrawal by Subject|0|||
129981922|NCT03772587|467896798|FG003|Overall Study|Withdrawal by Subject|0|||
129501228|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129981923|NCT03772587|467896799|FG004|Overall Study|Withdrawal by Subject|0|||
129501229|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501230|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501231|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501232|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501233|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501234|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501235|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501236|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501237|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501238|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501239|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501240|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501241|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501242|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501243|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501244|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501245|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501246|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501247|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501248|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
129501249|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
129501250|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501251|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501252|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501253|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501254|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501255|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501256|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501257|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501258|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501259|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501260|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501261|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501262|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501263|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501264|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501265|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501266|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501267|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501268|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501269|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501270|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501271|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
129501272|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
129501273|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501274|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501275|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501276|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501277|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501278|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501279|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501280|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501281|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501282|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501283|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501284|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501285|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501286|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501287|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501288|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501289|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501290|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501291|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501292|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501293|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129501294|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
129539066|NCT02708524|466265146|FG002|Overall Study|Lens Discomfort|1|||
129501295|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
129501296|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501297|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501298|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501299|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501300|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501301|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501302|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501303|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501304|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501305|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501306|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501307|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501308|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501309|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501310|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501311|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501312|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501313|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501314|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501315|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501316|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501317|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
129501318|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
129501319|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
129501320|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
129501321|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
129501322|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
129501323|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
129501324|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
129501325|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
129501326|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
129501327|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
129501328|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
129501329|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
129501330|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
129501331|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
129501332|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
129501333|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
129501334|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
129501335|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
129501336|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
129501337|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
129501338|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
129501339|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
129501340|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
129501341|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
129501342|NCT02052778|466123768|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501343|NCT02052778|466123769|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501344|NCT02052778|466123770|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501345|NCT02052778|466123771|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501346|NCT02052778|466123772|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501347|NCT02052778|466123773|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501348|NCT02052778|466123774|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501349|NCT02052778|466123775|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501350|NCT02052778|466123776|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501351|NCT02052778|466123777|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501352|NCT02052778|466123778|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501353|NCT02052778|466123779|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501354|NCT02052778|466123780|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501355|NCT02052778|466123781|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501356|NCT02052778|466123782|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501357|NCT02052778|466123783|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501358|NCT02052778|466123784|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501359|NCT02052778|466123785|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501360|NCT02052778|466123786|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501361|NCT02052778|466123787|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501362|NCT02052778|466123788|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501363|NCT02052778|466123789|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
129501364|NCT02052778|466123790|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
129501365|NCT01980706|466123795|FG000|Overall Study|Withdrawal by Subject|9|||
129501366|NCT01980706|466123796|FG001|Overall Study|Withdrawal by Subject|6|||
129501367|NCT01980706|466123797|FG002|Overall Study|Withdrawal by Subject|2|||
129501368|NCT01980706|466123795|FG000|Overall Study|Adverse Event|1|||
129501369|NCT01980706|466123796|FG001|Overall Study|Adverse Event|2|||
129501370|NCT01980706|466123797|FG002|Overall Study|Adverse Event|5|||
129501371|NCT01980706|466123795|FG000|Overall Study|Lost to Follow-up|3|||
129501372|NCT01980706|466123796|FG001|Overall Study|Lost to Follow-up|4|||
129501373|NCT01980706|466123797|FG002|Overall Study|Lost to Follow-up|3|||
129501374|NCT01980706|466123795|FG000|Overall Study|miscellaneous|4|||
129501375|NCT01980706|466123796|FG001|Overall Study|miscellaneous|5|||
129501376|NCT01980706|466123797|FG002|Overall Study|miscellaneous|3|||
129501377|NCT01094730|466123800|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
129501378|NCT01094730|466123801|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
129501379|NCT01094730|466123800|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
129501380|NCT01094730|466123801|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
129501381|NCT01094730|466123800|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
129501382|NCT01094730|466123801|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
129501383|NCT01094730|466123800|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
129501384|NCT01094730|466123801|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
129501385|NCT01094730|466123800|FG000|Period 2 (14 Days)|Protocol Violation|2|||
129501386|NCT01094730|466123801|FG001|Period 2 (14 Days)|Protocol Violation|0|||
129501387|NCT01094730|466123800|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
129501388|NCT01094730|466123801|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
129501389|NCT01094730|466123800|FG000|Period 2 (14 Days)|Adverse Event|0|||
129501390|NCT01094730|466123801|FG001|Period 2 (14 Days)|Adverse Event|1|||
129501391|NCT01094730|466123800|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
129501392|NCT01094730|466123801|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
129501393|NCT04171037|466123802|FG000|Overall Study|Lost to Follow-up|1|||
129501394|NCT04171037|466123803|FG001|Overall Study|Lost to Follow-up|0|||
129501395|NCT04171037|466123802|FG000|Overall Study|Physician Decision|3|||
129501396|NCT04171037|466123803|FG001|Overall Study|Physician Decision|3|||
129501397|NCT05118386|466123806|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
129501398|NCT05118386|466123807|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
129501399|NCT05118386|466123808|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
129501400|NCT05118386|466123809|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
129501401|NCT05118386|466123810|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
129501402|NCT05118386|466123811|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
129501403|NCT05118386|466123806|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
129501404|NCT05118386|466123807|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
129501405|NCT05118386|466123808|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
129501406|NCT05118386|466123809|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
129501407|NCT05118386|466123810|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
129501408|NCT05118386|466123811|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
129501409|NCT00303108|466123812|FG000|Overall Study|Adverse Event|5|||
129501410|NCT00303108|466123813|FG001|Overall Study|Adverse Event|6|||
129501411|NCT00303108|466123814|FG002|Overall Study|Adverse Event|7|||
129501412|NCT00303108|466123812|FG000|Overall Study|Patient Request|4|||
129501413|NCT00303108|466123813|FG001|Overall Study|Patient Request|2|||
129501414|NCT00303108|466123814|FG002|Overall Study|Patient Request|8|||
129501415|NCT00303108|466123812|FG000|Overall Study|Failed Entry|1|||
129501416|NCT00303108|466123813|FG001|Overall Study|Failed Entry|0|||
129501417|NCT00303108|466123814|FG002|Overall Study|Failed Entry|1|||
129501418|NCT00303108|466123812|FG000|Overall Study|ineligible|2|||
129501419|NCT00303108|466123813|FG001|Overall Study|ineligible|1|||
129501420|NCT00303108|466123814|FG002|Overall Study|ineligible|0|||
129501421|NCT00894413|466123817|FG000|Overall Study|Physician Decision|0|||
129501422|NCT00894413|466123818|FG001|Overall Study|Physician Decision|2|||
129501423|NCT00894413|466123817|FG000|Overall Study|Adverse Event|0|||
129501424|NCT00894413|466123818|FG001|Overall Study|Adverse Event|2|||
129501425|NCT00894413|466123817|FG000|Overall Study|Withdrawal by Subject|0|||
129501426|NCT00894413|466123818|FG001|Overall Study|Withdrawal by Subject|4|||
129501427|NCT03201198|466123819|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
129501428|NCT03201198|466123820|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
129501429|NCT03201198|466123819|FG000|Overall Study|Withdrawal by Subject|2|||
129501430|NCT03201198|466123820|FG001|Overall Study|Withdrawal by Subject|3|||
129501431|NCT02427477|466123823|FG000|Period 1|Adverse Event|1|||
129501432|NCT02427477|466123824|FG001|Period 1|Adverse Event|0|||
129501433|NCT03213626|466123825|FG000|Overall Study|Adverse Event|1|||
129501434|NCT03213626|466123825|FG000|Overall Study|Progressive Disease|6|||
129501435|NCT00786032|466125380|FG000|Overall Study|Death|4|||
129501436|NCT00786032|466125380|FG000|Overall Study|Withdrawal by Subject|14|||
129501437|NCT00786032|466125380|FG000|Overall Study|Did not complete in the timeframe|6|||
129501438|NCT02457182|466125381|FG000|Overall Study|Lost to Follow-up|1|||
129501439|NCT02457182|466125382|FG001|Overall Study|Lost to Follow-up|0|||
129501440|NCT02294318|466125385|FG000|Overall Study|Worsening of drinking|3|||
129501441|NCT02294318|466125386|FG001|Overall Study|Worsening of drinking|0|||
129501442|NCT02294318|466125385|FG000|Overall Study|Not exposed to intervention|0|||
129501443|NCT02294318|466125386|FG001|Overall Study|Not exposed to intervention|2|||
129501444|NCT02670915|466125387|FG000|Overall Study|Withdrawal by Subject|0|||
129501445|NCT02670915|466125388|FG001|Overall Study|Withdrawal by Subject|1|||
129501446|NCT02670915|466125389|FG002|Overall Study|Withdrawal by Subject|4|||
129501447|NCT02670915|466125387|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129501448|NCT02670915|466125388|FG001|Overall Study|Withdrawal by parent/guardian|4|||
129501449|NCT02670915|466125389|FG002|Overall Study|Withdrawal by parent/guardian|1|||
129501450|NCT02670915|466125387|FG000|Overall Study|Unclassified|0|||
129501451|NCT02670915|466125388|FG001|Overall Study|Unclassified|3|||
129501452|NCT02670915|466125389|FG002|Overall Study|Unclassified|0|||
129501453|NCT01346371|466125394|FG000|Overall Study|Lost to Follow-up|2|||
129501454|NCT01346371|466125395|FG001|Overall Study|Lost to Follow-up|0|||
129501455|NCT01670656|466125397|FG000|Overall Study|Non-compliance with study drug|0|||
129501456|NCT01670656|466125398|FG001|Overall Study|Non-compliance with study drug|0|||
129501457|NCT01670656|466125399|FG002|Overall Study|Non-compliance with study drug|3|||
129501458|NCT01670656|466125400|FG003|Overall Study|Non-compliance with study drug|0|||
129501459|NCT01670656|466125401|FG004|Overall Study|Non-compliance with study drug|1|||
129501460|NCT01670656|466125397|FG000|Overall Study|Pregnancy|0|||
129501461|NCT01670656|466125398|FG001|Overall Study|Pregnancy|0|||
129501462|NCT01670656|466125399|FG002|Overall Study|Pregnancy|0|||
129501463|NCT01670656|466125400|FG003|Overall Study|Pregnancy|0|||
129501464|NCT01670656|466125401|FG004|Overall Study|Pregnancy|1|||
129501465|NCT01670656|466125397|FG000|Overall Study|Withdrawal by Subject|1|||
129501466|NCT01670656|466125398|FG001|Overall Study|Withdrawal by Subject|1|||
129501467|NCT01670656|466125399|FG002|Overall Study|Withdrawal by Subject|0|||
129501468|NCT01670656|466125400|FG003|Overall Study|Withdrawal by Subject|0|||
129501469|NCT01670656|466125401|FG004|Overall Study|Withdrawal by Subject|0|||
129501470|NCT01670656|466125397|FG000|Overall Study|Non-compliance with protocol|0|||
129501471|NCT01670656|466125398|FG001|Overall Study|Non-compliance with protocol|3|||
129501472|NCT01670656|466125399|FG002|Overall Study|Non-compliance with protocol|1|||
129501473|NCT01670656|466125400|FG003|Overall Study|Non-compliance with protocol|1|||
129501474|NCT01670656|466125401|FG004|Overall Study|Non-compliance with protocol|2|||
129501475|NCT01670656|466125397|FG000|Overall Study|Adverse Event|2|||
129501476|NCT01670656|466125398|FG001|Overall Study|Adverse Event|2|||
129501477|NCT01670656|466125399|FG002|Overall Study|Adverse Event|2|||
129501478|NCT01670656|466125400|FG003|Overall Study|Adverse Event|3|||
129501479|NCT01670656|466125401|FG004|Overall Study|Adverse Event|3|||
129501480|NCT01670656|466125397|FG000|Overall Study|Subject withdrew consent|0|||
129501481|NCT01670656|466125398|FG001|Overall Study|Subject withdrew consent|1|||
129501482|NCT01670656|466125399|FG002|Overall Study|Subject withdrew consent|2|||
129501483|NCT01670656|466125400|FG003|Overall Study|Subject withdrew consent|1|||
129501484|NCT01670656|466125401|FG004|Overall Study|Subject withdrew consent|1|||
129501485|NCT01670656|466125397|FG000|Overall Study|Lost to Follow-up|0|||
129501486|NCT01670656|466125398|FG001|Overall Study|Lost to Follow-up|0|||
129501487|NCT01670656|466125399|FG002|Overall Study|Lost to Follow-up|0|||
129501488|NCT01670656|466125400|FG003|Overall Study|Lost to Follow-up|0|||
129501489|NCT01670656|466125401|FG004|Overall Study|Lost to Follow-up|3|||
129501490|NCT01670656|466125397|FG000|Overall Study|Subject moved|0|||
129501491|NCT01670656|466125398|FG001|Overall Study|Subject moved|0|||
129501492|NCT01670656|466125399|FG002|Overall Study|Subject moved|0|||
129501493|NCT01670656|466125400|FG003|Overall Study|Subject moved|1|||
129501494|NCT01670656|466125401|FG004|Overall Study|Subject moved|0|||
129501495|NCT00789958|466125402|FG000|Overall Study|Adverse Event|3|||
129501496|NCT00789958|466125402|FG000|Overall Study|Withdrawal by Subject|4|||
129501497|NCT00789958|466125402|FG000|Overall Study|Progression|3|||
129501498|NCT00789958|466125402|FG000|Overall Study|not protocol specified|1|||
129501499|NCT00789958|466125402|FG000|Overall Study|Not eligible/not analyzable|26|||
129981924|NCT05051462|467896801|FG000|Overall Study|Lost to Follow-up|1|||
129501500|NCT03137121|466125405|FG000|Overall Study|Withdrawal by Subject|0|||
129501501|NCT03137121|466125406|FG001|Overall Study|Withdrawal by Subject|1|||
129501502|NCT00836277|466125407|FG000|Overall Study|Not evaluable for response|6|||
129501503|NCT01354353|466125413|FG000|Overall Study|Adverse Event|1|||
129501504|NCT01354353|466125414|FG001|Overall Study|Adverse Event|0|||
129501505|NCT01354353|466125415|FG002|Overall Study|Adverse Event|0|||
129501506|NCT01354353|466125416|FG003|Overall Study|Adverse Event|4|||
129501507|NCT01354353|466125417|FG004|Overall Study|Adverse Event|0|||
129501508|NCT01354353|466125418|FG005|Overall Study|Adverse Event|5|||
129501509|NCT01354353|466125413|FG000|Overall Study|Entry Criteria Not Met|0|||
129501510|NCT01354353|466125414|FG001|Overall Study|Entry Criteria Not Met|0|||
129501511|NCT01354353|466125415|FG002|Overall Study|Entry Criteria Not Met|0|||
129981925|NCT05051462|467896802|FG001|Overall Study|Lost to Follow-up|8|||
129501512|NCT01354353|466125416|FG003|Overall Study|Entry Criteria Not Met|1|||
129501513|NCT01354353|466125417|FG004|Overall Study|Entry Criteria Not Met|1|||
129501514|NCT01354353|466125418|FG005|Overall Study|Entry Criteria Not Met|0|||
129501515|NCT01354353|466125413|FG000|Overall Study|Physician Decision|0|||
129501516|NCT01354353|466125414|FG001|Overall Study|Physician Decision|1|||
129501517|NCT01354353|466125415|FG002|Overall Study|Physician Decision|1|||
129501518|NCT01354353|466125416|FG003|Overall Study|Physician Decision|0|||
129501519|NCT01354353|466125417|FG004|Overall Study|Physician Decision|0|||
129501520|NCT01354353|466125418|FG005|Overall Study|Physician Decision|0|||
129501521|NCT01354353|466125413|FG000|Overall Study|Withdrawal by Subject|2|||
129501522|NCT01354353|466125414|FG001|Overall Study|Withdrawal by Subject|0|||
129501523|NCT01354353|466125415|FG002|Overall Study|Withdrawal by Subject|1|||
129501524|NCT01354353|466125416|FG003|Overall Study|Withdrawal by Subject|0|||
129501525|NCT01354353|466125417|FG004|Overall Study|Withdrawal by Subject|0|||
129501526|NCT01354353|466125418|FG005|Overall Study|Withdrawal by Subject|1|||
129501527|NCT04831515|466125421|FG000|First Intervention|Adverse Event|0|||
129501528|NCT04831515|466125422|FG001|First Intervention|Adverse Event|1|||
129501529|NCT01640925|466125425|FG000|Overall Study|Withdrawal by Subject|1|||
129501530|NCT01640925|466125426|FG001|Overall Study|Withdrawal by Subject|0|||
129501531|NCT01640925|466125425|FG000|Overall Study|Previously enrolled in this trial|13|||
129501532|NCT01640925|466125426|FG001|Overall Study|Previously enrolled in this trial|11|||
129501533|NCT01332019|466125437|FG000|Overall Study|Was Not Dosed|1|||
129501534|NCT01332019|466125438|FG001|Overall Study|Was Not Dosed|0|||
129501535|NCT01332019|466125437|FG000|Overall Study|Other|16|||
129501536|NCT01332019|466125438|FG001|Overall Study|Other|18|||
129501537|NCT01332019|466125437|FG000|Overall Study|Death|2|||
129501538|NCT01332019|466125438|FG001|Overall Study|Death|1|||
129501539|NCT01332019|466125437|FG000|Overall Study|Physician Decision|4|||
129501540|NCT01332019|466125438|FG001|Overall Study|Physician Decision|3|||
129501541|NCT01332019|466125437|FG000|Overall Study|Withdrawal by Subject|73|||
129501542|NCT01332019|466125438|FG001|Overall Study|Withdrawal by Subject|71|||
129501543|NCT01332019|466125437|FG000|Overall Study|Lost to Follow-up|4|||
129501544|NCT01332019|466125438|FG001|Overall Study|Lost to Follow-up|7|||
129501545|NCT01332019|466125437|FG000|Overall Study|Adverse Event|13|||
129501546|NCT01332019|466125438|FG001|Overall Study|Adverse Event|22|||
129501547|NCT00288860|466125443|FG000|Overall Study|Did not complete intake|4|||
129501548|NCT00288860|466125444|FG001|Overall Study|Did not complete intake|8|||
129501549|NCT00288860|466125443|FG000|Overall Study|Death|4|||
129501550|NCT00288860|466125444|FG001|Overall Study|Death|3|||
129501551|NCT00288860|466125443|FG000|Overall Study|Withdrawal by Subject|20|||
129501552|NCT00288860|466125444|FG001|Overall Study|Withdrawal by Subject|15|||
129501553|NCT00288860|466125443|FG000|Overall Study|Lost to Follow-up|74|||
129501554|NCT00288860|466125444|FG001|Overall Study|Lost to Follow-up|71|||
129501555|NCT01104584|466125446|FG000|Overall Study|Study drug never administered|21|||
129501556|NCT01104584|466125446|FG000|Overall Study|Study prematurely discontinued|2|||
129501557|NCT04017442|466125447|FG000|Overall Study|Withdrawal by Subject|0|||
129501558|NCT04017442|466125448|FG001|Overall Study|Withdrawal by Subject|3|||
129501559|NCT04017442|466125447|FG000|Overall Study|Lost to Follow-up|21|||
129501560|NCT04017442|466125448|FG001|Overall Study|Lost to Follow-up|19|||
129501561|NCT02586233|466125449|FG000|Overall Study|Randomized but did not receive treatment|0|||
129501562|NCT02586233|466125450|FG001|Overall Study|Randomized but did not receive treatment|1|||
129501563|NCT02586233|466125451|FG002|Overall Study|Randomized but did not receive treatment|0|||
129501564|NCT02586233|466125452|FG003|Overall Study|Randomized but did not receive treatment|0|||
129501565|NCT02586233|466125453|FG004|Overall Study|Randomized but did not receive treatment|0|||
129501566|NCT02586233|466125454|FG005|Overall Study|Randomized but did not receive treatment|2|||
129501567|NCT02586233|466125455|FG006|Overall Study|Randomized but did not receive treatment|2|||
129501568|NCT02586233|466125449|FG000|Overall Study|Death|0|||
129501569|NCT02586233|466125450|FG001|Overall Study|Death|1|||
129501570|NCT02586233|466125451|FG002|Overall Study|Death|0|||
129501571|NCT02586233|466125452|FG003|Overall Study|Death|0|||
129501572|NCT02586233|466125453|FG004|Overall Study|Death|2|||
129501573|NCT02586233|466125454|FG005|Overall Study|Death|0|||
129501574|NCT02586233|466125455|FG006|Overall Study|Death|0|||
129501575|NCT01757405|466125456|FG000|Overall Study|Lost to Follow-up|1|||
129501576|NCT01757405|466125457|FG001|Overall Study|Lost to Follow-up|1|||
129501577|NCT01757405|466125456|FG000|Overall Study|Withdrawal by Subject|0|||
129501578|NCT01757405|466125457|FG001|Overall Study|Withdrawal by Subject|1|||
129501579|NCT00082758|466125459|FG000|Overall Study|Adverse Event|0|||
129501580|NCT00082758|466125460|FG001|Overall Study|Adverse Event|2|||
129501581|NCT00082758|466125461|FG002|Overall Study|Adverse Event|0|||
129501582|NCT00082758|466125459|FG000|Overall Study|Lack of Efficacy|12|||
129501583|NCT00082758|466125460|FG001|Overall Study|Lack of Efficacy|13|||
129501584|NCT00082758|466125461|FG002|Overall Study|Lack of Efficacy|0|||
129501585|NCT00082758|466125459|FG000|Overall Study|Physician Decision|0|||
129501586|NCT00082758|466125460|FG001|Overall Study|Physician Decision|1|||
129501587|NCT00082758|466125461|FG002|Overall Study|Physician Decision|0|||
129501588|NCT00082758|466125459|FG000|Overall Study|Withdrawal by Subject|3|||
129501589|NCT00082758|466125460|FG001|Overall Study|Withdrawal by Subject|0|||
129501590|NCT00082758|466125461|FG002|Overall Study|Withdrawal by Subject|0|||
129501591|NCT00082758|466125459|FG000|Overall Study|Protocol Violation|0|||
129501592|NCT00082758|466125460|FG001|Overall Study|Protocol Violation|1|||
129501593|NCT00082758|466125461|FG002|Overall Study|Protocol Violation|0|||
129501594|NCT00238303|466125462|FG000|Overall Study|Withdrawal by Subject|11|||
129501595|NCT00238303|466125463|FG001|Overall Study|Withdrawal by Subject|1|||
129501596|NCT00238303|466125464|FG002|Overall Study|Withdrawal by Subject|2|||
129501597|NCT00238303|466125462|FG000|Overall Study|Death|1|||
129501598|NCT00238303|466125463|FG001|Overall Study|Death|0|||
129501599|NCT00238303|466125464|FG002|Overall Study|Death|1|||
129501600|NCT00238303|466125462|FG000|Overall Study|Other Medical Problems|2|||
129501601|NCT00238303|466125463|FG001|Overall Study|Other Medical Problems|0|||
129501602|NCT00238303|466125464|FG002|Overall Study|Other Medical Problems|2|||
129501603|NCT00238303|466125462|FG000|Overall Study|Poor tolerance of study treatment|1|||
129501604|NCT00238303|466125463|FG001|Overall Study|Poor tolerance of study treatment|0|||
129501605|NCT00238303|466125464|FG002|Overall Study|Poor tolerance of study treatment|1|||
129501606|NCT00238303|466125462|FG000|Overall Study|Adverse Event|0|||
129501607|NCT00238303|466125463|FG001|Overall Study|Adverse Event|1|||
129501608|NCT00238303|466125464|FG002|Overall Study|Adverse Event|3|||
129501609|NCT02561299|466125468|FG000|Overall Study|Death|2|||
129501610|NCT02561299|466125469|FG001|Overall Study|Death|4|||
129501611|NCT02561299|466125468|FG000|Overall Study|Lost to Follow-up|1|||
129501612|NCT02561299|466125469|FG001|Overall Study|Lost to Follow-up|0|||
129501613|NCT02561299|466125468|FG000|Overall Study|Withdrawal by Subject|2|||
129501614|NCT02561299|466125469|FG001|Overall Study|Withdrawal by Subject|2|||
129501615|NCT01248130|466125470|FG000|Overall Study|Protocol Violation|1|||
129501616|NCT01248130|466125471|FG001|Overall Study|Protocol Violation|0|||
129501617|NCT01248130|466125470|FG000|Overall Study|Ineligible|1|||
129501618|NCT01248130|466125471|FG001|Overall Study|Ineligible|0|||
129501619|NCT01358877|466125472|FG000|Overall Study|Death|80|||
129501620|NCT01358877|466125473|FG001|Overall Study|Death|89|||
129501621|NCT01358877|466125472|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
129501622|NCT01358877|466125473|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
129501623|NCT01358877|466125472|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
129501624|NCT01358877|466125473|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
129501625|NCT01358877|466125472|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
129501626|NCT01358877|466125473|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
129501627|NCT01358877|466125472|FG000|Overall Study|Other|142|||
129501628|NCT01358877|466125473|FG001|Overall Study|Other|129|||
129501629|NCT01911845|466125478|FG000|Overall Study|Adverse Event|2|||
129501630|NCT01911845|466125478|FG000|Overall Study|Lost to Follow-up|1|||
129501631|NCT01911845|466125478|FG000|Overall Study|Other (not specified)|3|||
129501632|NCT01994226|466125479|FG000|Overall Study|Protocol Violation|13|||
129501633|NCT01994226|466125480|FG001|Overall Study|Protocol Violation|10|||
129501634|NCT01994226|466125479|FG000|Overall Study|Early Cessation of treatment|6|||
129501635|NCT01994226|466125480|FG001|Overall Study|Early Cessation of treatment|11|||
129501636|NCT00501046|466125485|FG000|Overall Study|Adverse Event|21|||
129501637|NCT00501046|466125486|FG001|Overall Study|Adverse Event|25|||
129501638|NCT00501046|466125485|FG000|Overall Study|Death|23|||
129501639|NCT00501046|466125486|FG001|Overall Study|Death|30|||
129501640|NCT00501046|466125485|FG000|Overall Study|Lost to Follow-up|14|||
129501641|NCT00501046|466125486|FG001|Overall Study|Lost to Follow-up|13|||
129501642|NCT00501046|466125485|FG000|Overall Study|Physician Decision|7|||
129501643|NCT00501046|466125486|FG001|Overall Study|Physician Decision|2|||
129501644|NCT00501046|466125485|FG000|Overall Study|Pregnancy|0|||
129501645|NCT00501046|466125486|FG001|Overall Study|Pregnancy|3|||
129501646|NCT00501046|466125485|FG000|Overall Study|Protocol Violation|2|||
129501647|NCT00501046|466125486|FG001|Overall Study|Protocol Violation|1|||
129501648|NCT00501046|466125485|FG000|Overall Study|Withdrawal by Subject|84|||
129501649|NCT00501046|466125486|FG001|Overall Study|Withdrawal by Subject|83|||
129501650|NCT00501046|466125485|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
129501651|NCT00501046|466125486|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
129501652|NCT02345252|466125492|FG000|Double-Blind Phase|Adverse Event|2|||
129501653|NCT02345252|466125493|FG001|Double-Blind Phase|Adverse Event|3|||
129501654|NCT02345252|466125492|FG000|Double-Blind Phase|Death|1|||
129501655|NCT02345252|466125493|FG001|Double-Blind Phase|Death|2|||
129501656|NCT02345252|466125492|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129981926|NCT05051462|467896801|FG000|Overall Study|Withdrawal by Subject|1|||
129501657|NCT02345252|466125493|FG001|Double-Blind Phase|Lack of Efficacy|0|||
129981927|NCT05051462|467896802|FG001|Overall Study|Withdrawal by Subject|0|||
129501658|NCT02345252|466125492|FG000|Double-Blind Phase|Investigator's Discretion|4|||
129501659|NCT02345252|466125493|FG001|Double-Blind Phase|Investigator's Discretion|6|||
129501660|NCT02345252|466125492|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
129501661|NCT02345252|466125493|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
129501662|NCT02345252|466125492|FG000|Double-Blind Phase|Protocol Violation|2|||
129501663|NCT02345252|466125493|FG001|Double-Blind Phase|Protocol Violation|1|||
129501664|NCT02345252|466125492|FG000|Double-Blind Phase|Withdrew Consent|21|||
129981928|NCT05051462|467896801|FG000|Overall Study|Protocol Violation|0|||
129501665|NCT02345252|466125493|FG001|Double-Blind Phase|Withdrew Consent|23|||
129501666|NCT02345252|466125492|FG000|Double-Blind Phase|Lost to Follow-up|8|||
129501667|NCT02345252|466125493|FG001|Double-Blind Phase|Lost to Follow-up|10|||
129501668|NCT02345252|466125492|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
129501669|NCT02345252|466125493|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
129501670|NCT01842308|466125496|FG000|Overall Study|Withdrawal by Subject|0|||
129501671|NCT01842308|466125497|FG001|Overall Study|Withdrawal by Subject|0|||
129501672|NCT01842308|466125498|FG002|Overall Study|Withdrawal by Subject|0|||
129501673|NCT01842308|466125499|FG003|Overall Study|Withdrawal by Subject|0|||
129501674|NCT01842308|466125500|FG004|Overall Study|Withdrawal by Subject|1|||
129501675|NCT00779324|466125501|FG000|Overall Study|Lost to Follow-up|2|||
129501676|NCT00779324|466125502|FG001|Overall Study|Lost to Follow-up|1|||
129501677|NCT00779324|466125501|FG000|Overall Study|Withdrawal by Subject|4|||
129501678|NCT00779324|466125502|FG001|Overall Study|Withdrawal by Subject|2|||
129501679|NCT00779324|466125501|FG000|Overall Study|Missed visit|1|||
129501680|NCT00779324|466125502|FG001|Overall Study|Missed visit|1|||
129501681|NCT00617409|466125503|FG000|Overall Study|Withdrawal by Subject|4|||
129501682|NCT00617409|466125504|FG001|Overall Study|Withdrawal by Subject|1|||
129501683|NCT00617409|466125505|FG002|Overall Study|Withdrawal by Subject|2|||
129501684|NCT00617409|466125503|FG000|Overall Study|Adverse Event|0|||
129501685|NCT00617409|466125504|FG001|Overall Study|Adverse Event|2|||
129501686|NCT00617409|466125505|FG002|Overall Study|Adverse Event|3|||
129501687|NCT00617409|466125503|FG000|Overall Study|Disease Progression|8|||
129501688|NCT00617409|466125504|FG001|Overall Study|Disease Progression|8|||
129501689|NCT00617409|466125505|FG002|Overall Study|Disease Progression|18|||
129501690|NCT00617409|466125503|FG000|Overall Study|Death|3|||
129501691|NCT00617409|466125504|FG001|Overall Study|Death|5|||
129501692|NCT00617409|466125505|FG002|Overall Study|Death|4|||
129501693|NCT00617409|466125503|FG000|Overall Study|Alternative Therapy|1|||
129501694|NCT00617409|466125504|FG001|Overall Study|Alternative Therapy|2|||
129501695|NCT00617409|466125505|FG002|Overall Study|Alternative Therapy|0|||
129501696|NCT00987623|466125506|FG000|Overall Study|Lost to Follow-up|2|||
129501697|NCT00987623|466125507|FG001|Overall Study|Lost to Follow-up|1|||
129501698|NCT00987623|466125506|FG000|Overall Study|Time/job conflict|2|||
129501699|NCT00987623|466125507|FG001|Overall Study|Time/job conflict|0|||
129501700|NCT00987623|466125506|FG000|Overall Study|Discomfort|1|||
129501701|NCT00987623|466125507|FG001|Overall Study|Discomfort|0|||
129501702|NCT00987623|466125506|FG000|Overall Study|Biomicroscopy|0|||
129501703|NCT00987623|466125507|FG001|Overall Study|Biomicroscopy|1|||
129501704|NCT00987623|466125506|FG000|Overall Study|Influenza|0|||
129501705|NCT00987623|466125507|FG001|Overall Study|Influenza|1|||
129501706|NCT02509598|466125508|FG000|Overall Study|Withdrawal by Subject|1|||
129501707|NCT04056455|466125509|FG000|Overall Study|Adverse Event|1|||
129501708|NCT04056455|466125510|FG001|Overall Study|Adverse Event|0|||
129501709|NCT02196038|466125511|FG000|Overall Study|Death|16|||
129501710|NCT02196038|466125512|FG001|Overall Study|Death|21|||
129501711|NCT02196038|466125511|FG000|Overall Study|Withdrawal by Subject|0|||
129501712|NCT02196038|466125512|FG001|Overall Study|Withdrawal by Subject|1|||
129501713|NCT02196038|466125511|FG000|Overall Study|Lost to Follow-up|1|||
129501714|NCT02196038|466125512|FG001|Overall Study|Lost to Follow-up|0|||
129501715|NCT03521687|466125515|FG000|Overall Study|Adverse Event|4|||
129501716|NCT03521687|466125515|FG000|Overall Study|Physician Decision|1|||
129501717|NCT01151579|466125516|FG000|Overall Study|Physician Decision|3|||
129501718|NCT01151579|466125517|FG001|Overall Study|Physician Decision|1|||
129501719|NCT01151579|466125516|FG000|Overall Study|Withdrawal by Subject|3|||
129501720|NCT01151579|466125517|FG001|Overall Study|Withdrawal by Subject|2|||
129501721|NCT01151579|466125516|FG000|Overall Study|Not meet inclusion criteria|6|||
129501722|NCT01151579|466125517|FG001|Overall Study|Not meet inclusion criteria|4|||
129501723|NCT01276457|466125520|FG000|Core Study|Adverse Event|6|||
129501724|NCT01276457|466125521|FG001|Core Study|Adverse Event|3|||
129501725|NCT01276457|466125520|FG000|Core Study|Lost to Follow-up|1|||
129501726|NCT01276457|466125521|FG001|Core Study|Lost to Follow-up|2|||
129501727|NCT01276457|466125520|FG000|Core Study|Administrative problems|1|||
129501728|NCT01276457|466125521|FG001|Core Study|Administrative problems|1|||
129981929|NCT05051462|467896802|FG001|Overall Study|Protocol Violation|2|||
129501729|NCT01276457|466125520|FG000|Core Study|Death|2|||
129501730|NCT01276457|466125521|FG001|Core Study|Death|2|||
129501731|NCT01276457|466125520|FG000|Core Study|Lack of Efficacy|3|||
129501732|NCT01276457|466125521|FG001|Core Study|Lack of Efficacy|12|||
129501733|NCT01276457|466125520|FG000|Extension Study|Lost to Follow-up|3|||
129981930|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
129501734|NCT01276457|466125521|FG001|Extension Study|Lost to Follow-up|0|||
129501735|NCT01276457|466125520|FG000|Extension Study|Death|0|||
129501736|NCT01276457|466125521|FG001|Extension Study|Death|1|||
129501737|NCT01276457|466125520|FG000|Extension Study|Lack of Efficacy|3|||
129501738|NCT01276457|466125521|FG001|Extension Study|Lack of Efficacy|1|||
129501739|NCT02065869|466125527|FG000|Overall Study|Death|7|||
129501740|NCT02065869|466125527|FG000|Overall Study|Disease relapse|16|||
129501741|NCT02065869|466125527|FG000|Overall Study|Lost to Follow-up|4|||
129501742|NCT02065869|466125527|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
129981931|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
129501743|NCT02065869|466125527|FG000|Overall Study|Withdrawal by Subject|1|||
129501744|NCT03807739|466125528|FG000|Overall Study|Adverse Event|1|||
129501745|NCT03807739|466125529|FG001|Overall Study|Adverse Event|0|||
129501746|NCT03807739|466125530|FG002|Overall Study|Adverse Event|0|||
129501747|NCT03807739|466125531|FG003|Overall Study|Adverse Event|0|||
129501748|NCT03807739|466125528|FG000|Overall Study|Withdrawal by Subject|1|||
129501749|NCT03807739|466125529|FG001|Overall Study|Withdrawal by Subject|0|||
129501750|NCT03807739|466125530|FG002|Overall Study|Withdrawal by Subject|0|||
129501751|NCT03807739|466125531|FG003|Overall Study|Withdrawal by Subject|0|||
129501752|NCT00789191|466127675|FG000|Overall Study|Adverse Event|2|||
129501753|NCT00789191|466127676|FG001|Overall Study|Adverse Event|4|||
129501754|NCT00789191|466127675|FG000|Overall Study|Lack of Efficacy|0|||
129501755|NCT00789191|466127676|FG001|Overall Study|Lack of Efficacy|5|||
129501756|NCT00789191|466127675|FG000|Overall Study|Protocol Violation|5|||
129501757|NCT00789191|466127676|FG001|Overall Study|Protocol Violation|3|||
129501758|NCT00789191|466127675|FG000|Overall Study|Withdrawal Criteria|2|||
129501759|NCT00789191|466127676|FG001|Overall Study|Withdrawal Criteria|4|||
129501760|NCT00789191|466127675|FG000|Overall Study|Unclassified|5|||
129501761|NCT00789191|466127676|FG001|Overall Study|Unclassified|3|||
129501762|NCT03497429|466127677|FG000|Overall Study|Progressive disease|3|||
129501763|NCT03497429|466127678|FG001|Overall Study|Progressive disease|4|||
129501764|NCT03497429|466127677|FG000|Overall Study|Adverse Event|0|||
129501765|NCT03497429|466127678|FG001|Overall Study|Adverse Event|2|||
129501766|NCT01009983|466127679|FG000|Overall Study|necessary scans not completed|1|||
129501767|NCT00506948|466127680|FG000|Overall Study|Death|4|||
129501768|NCT00506948|466127680|FG000|Overall Study|Adverse Event|5|||
129501769|NCT00506948|466127680|FG000|Overall Study|Physician Decision|1|||
129501770|NCT02174861|466127681|FG000|Overall Study|Decision by sponsor|8|||
129501771|NCT02174861|466127681|FG000|Overall Study|Withdrawal by Subject|124|||
129501772|NCT02174861|466127681|FG000|Overall Study|Lost to Follow-up|26|||
129501773|NCT02702518|466127687|FG000|Overall Study|Lost to Follow-up|3|||
129501774|NCT02702518|466127688|FG001|Overall Study|Lost to Follow-up|4|||
129501775|NCT01000727|466127690|FG000|Overall Study|Lost to Follow-up|41|||
129501776|NCT01000727|466127691|FG001|Overall Study|Lost to Follow-up|43|||
129501777|NCT01000727|466127690|FG000|Overall Study|Withdrawal by Subject|111|||
129501778|NCT01000727|466127691|FG001|Overall Study|Withdrawal by Subject|109|||
129501779|NCT01000727|466127690|FG000|Overall Study|Study closed/terminated|23|||
129501780|NCT01000727|466127691|FG001|Overall Study|Study closed/terminated|24|||
129501781|NCT03544268|466127694|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
129501782|NCT03544268|466127695|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
129501783|NCT00568958|466127698|FG000|Allocation|Withdrawal by Subject|7|||
129501784|NCT00568958|466127699|FG001|Allocation|Withdrawal by Subject|3|||
129501785|NCT00568958|466127698|FG000|Allocation|Physician Decision|2|||
129501786|NCT00568958|466127699|FG001|Allocation|Physician Decision|0|||
129501787|NCT00568958|466127698|FG000|Follow-Up|Withdrawal by Subject|6|||
129501788|NCT00568958|466127699|FG001|Follow-Up|Withdrawal by Subject|6|||
129501789|NCT00568958|466127698|FG000|Follow-Up|Physician Decision|1|||
129501790|NCT00568958|466127699|FG001|Follow-Up|Physician Decision|1|||
129501791|NCT00568958|466127698|FG000|Follow-Up|Family Emergency|1|||
129501792|NCT00568958|466127699|FG001|Follow-Up|Family Emergency|0|||
129501793|NCT00568958|466127698|FG000|Follow-Up|Adverse Event|1|||
129501794|NCT00568958|466127699|FG001|Follow-Up|Adverse Event|0|||
129501795|NCT00377611|466127703|FG000|Overall Study|Adverse Event|2|||
129501796|NCT00377611|466127704|FG001|Overall Study|Adverse Event|9|||
129501797|NCT00377611|466127703|FG000|Overall Study|Protocol Violation|2|||
129501798|NCT00377611|466127704|FG001|Overall Study|Protocol Violation|0|||
129501799|NCT00377611|466127703|FG000|Overall Study|Withdrawal by Subject|0|||
129501800|NCT00377611|466127704|FG001|Overall Study|Withdrawal by Subject|5|||
129501801|NCT00377611|466127703|FG000|Overall Study|Lost to Follow-up|18|||
129501802|NCT00377611|466127704|FG001|Overall Study|Lost to Follow-up|16|||
129501803|NCT00377611|466127703|FG000|Overall Study|Other|0|||
129501804|NCT00377611|466127704|FG001|Overall Study|Other|3|||
129501805|NCT02156492|466127707|FG000|Period 1|No Reason Given|0|||
129501806|NCT02156492|466127708|FG001|Period 1|No Reason Given|1|||
129501807|NCT02156492|466127709|FG002|Period 1|No Reason Given|0|||
129501808|NCT02156492|466127707|FG000|Period 3|Adverse Event|0|||
129501809|NCT02156492|466127708|FG001|Period 3|Adverse Event|1|||
129501810|NCT02156492|466127709|FG002|Period 3|Adverse Event|0|||
129501811|NCT00871377|466127710|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129501812|NCT00871377|466127711|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129501813|NCT00871377|466127712|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
129501814|NCT00871377|466127713|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129501815|NCT00871377|466127714|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129501816|NCT00871377|466127715|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
129501817|NCT00871377|466127710|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129501818|NCT00871377|466127711|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129501819|NCT00871377|466127712|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129501820|NCT00871377|466127713|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129501821|NCT00871377|466127714|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
129501822|NCT00871377|466127715|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
129501823|NCT00871377|466127710|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
129501824|NCT00871377|466127711|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501825|NCT00871377|466127712|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501826|NCT00871377|466127713|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501827|NCT00871377|466127714|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501828|NCT00871377|466127715|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501829|NCT00871377|466127710|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501830|NCT00871377|466127711|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501831|NCT00871377|466127712|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501832|NCT00871377|466127713|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
129981932|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
129981933|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
129981934|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
129981935|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
129501833|NCT00871377|466127714|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
129501834|NCT00871377|466127715|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
129501835|NCT00871377|466127710|FG000|Third Intervention (10 Weeks)|Death|0|||
129501836|NCT00871377|466127711|FG001|Third Intervention (10 Weeks)|Death|0|||
129501837|NCT00871377|466127712|FG002|Third Intervention (10 Weeks)|Death|0|||
129501838|NCT00871377|466127713|FG003|Third Intervention (10 Weeks)|Death|1|||
129501839|NCT00871377|466127714|FG004|Third Intervention (10 Weeks)|Death|0|||
129501840|NCT00871377|466127715|FG005|Third Intervention (10 Weeks)|Death|0|||
129501841|NCT01395368|466127717|FG000|Overall Study|Physician Decision|14|||
129501842|NCT01395368|466127717|FG000|Overall Study|Withdrawal by Subject|2|||
129501843|NCT03072719|466127722|FG000|Overall Study|Adverse Event|1|||
129501844|NCT03072719|466127723|FG001|Overall Study|Adverse Event|1|||
129501845|NCT00882999|466127724|FG000|Overall Study|Adverse Event|0|||
129501846|NCT00882999|466127725|FG001|Overall Study|Adverse Event|0|||
129501847|NCT00882999|466127726|FG002|Overall Study|Adverse Event|0|||
129501848|NCT00882999|466127727|FG003|Overall Study|Adverse Event|0|||
129501849|NCT00882999|466127728|FG004|Overall Study|Adverse Event|1|||
129501850|NCT00882999|466127729|FG005|Overall Study|Adverse Event|0|||
129501851|NCT00882999|466127730|FG006|Overall Study|Adverse Event|0|||
129501852|NCT00882999|466127724|FG000|Overall Study|Death|0|||
129501853|NCT00882999|466127725|FG001|Overall Study|Death|1|||
129501854|NCT00882999|466127726|FG002|Overall Study|Death|0|||
129501855|NCT00882999|466127727|FG003|Overall Study|Death|0|||
129501856|NCT00882999|466127728|FG004|Overall Study|Death|0|||
129501857|NCT00882999|466127729|FG005|Overall Study|Death|0|||
129501858|NCT00882999|466127730|FG006|Overall Study|Death|0|||
129501859|NCT00882999|466127724|FG000|Overall Study|Withdrawal by Subject|7|||
129501860|NCT00882999|466127725|FG001|Overall Study|Withdrawal by Subject|6|||
129501861|NCT00882999|466127726|FG002|Overall Study|Withdrawal by Subject|3|||
129501862|NCT00882999|466127727|FG003|Overall Study|Withdrawal by Subject|3|||
129501863|NCT00882999|466127728|FG004|Overall Study|Withdrawal by Subject|6|||
129501864|NCT00882999|466127729|FG005|Overall Study|Withdrawal by Subject|5|||
129501865|NCT00882999|466127730|FG006|Overall Study|Withdrawal by Subject|5|||
129501866|NCT00882999|466127724|FG000|Overall Study|Lost to Follow-up|0|||
129501867|NCT00882999|466127725|FG001|Overall Study|Lost to Follow-up|1|||
129501868|NCT00882999|466127726|FG002|Overall Study|Lost to Follow-up|1|||
129501869|NCT00882999|466127727|FG003|Overall Study|Lost to Follow-up|2|||
129501870|NCT00882999|466127728|FG004|Overall Study|Lost to Follow-up|1|||
129501871|NCT00882999|466127729|FG005|Overall Study|Lost to Follow-up|1|||
129501872|NCT00882999|466127730|FG006|Overall Study|Lost to Follow-up|2|||
129501873|NCT00882999|466127724|FG000|Overall Study|Physician Decision|1|||
129501874|NCT00882999|466127725|FG001|Overall Study|Physician Decision|0|||
129501875|NCT00882999|466127726|FG002|Overall Study|Physician Decision|0|||
129501876|NCT00882999|466127727|FG003|Overall Study|Physician Decision|0|||
129501877|NCT00882999|466127728|FG004|Overall Study|Physician Decision|0|||
129501878|NCT00882999|466127729|FG005|Overall Study|Physician Decision|1|||
129501879|NCT00882999|466127730|FG006|Overall Study|Physician Decision|1|||
129501880|NCT04507867|466127739|FG000|Overall Study|Death|7|||
129501881|NCT04507867|466127740|FG001|Overall Study|Death|1|||
129501882|NCT01954251|466127742|FG000|Overall Study|Adverse Event|5|||
129501883|NCT01954251|466127743|FG001|Overall Study|Adverse Event|7|||
129501884|NCT01954251|466127742|FG000|Overall Study|Lost to Follow-up|6|||
129501885|NCT01954251|466127743|FG001|Overall Study|Lost to Follow-up|6|||
129501886|NCT01954251|466127742|FG000|Overall Study|Withdrawal by Subject|2|||
129501887|NCT01954251|466127743|FG001|Overall Study|Withdrawal by Subject|6|||
129501888|NCT02207556|466127744|FG000|Overall Study|Physician Decision|1|||
129501889|NCT02207556|466127745|FG001|Overall Study|Physician Decision|0|||
129501890|NCT02207556|466127744|FG000|Overall Study|Withdrawal by Subject|1|||
129501891|NCT02207556|466127745|FG001|Overall Study|Withdrawal by Subject|0|||
129501892|NCT02207556|466127744|FG000|Overall Study|Death|0|||
129501893|NCT02207556|466127745|FG001|Overall Study|Death|5|||
129501894|NCT03558555|466127746|FG000|Overall Study|Lost to Follow-up|2|||
129501895|NCT03558555|466127747|FG001|Overall Study|Lost to Follow-up|1|||
129501896|NCT01958125|466127748|FG000|Overall Study|Missing diary data|2|||
129501897|NCT01958125|466127749|FG001|Overall Study|Missing diary data|6|||
129501898|NCT01958125|466127748|FG000|Overall Study|No headache attacks|0|||
129501899|NCT01958125|466127749|FG001|Overall Study|No headache attacks|2|||
129501900|NCT00781599|466127757|FG000|Overall Study|Lost to Follow-up|7|||
129501901|NCT00781599|466127758|FG001|Overall Study|Lost to Follow-up|4|||
129501902|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
129501903|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
129501904|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
129501905|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
129501906|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
129501907|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
129501908|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
129501909|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
129501910|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
129501911|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
129501912|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
129501913|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
129501914|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
129501915|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
129501916|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
129501917|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
129501918|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
129501919|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
129501920|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
129501921|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
129501922|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
129501923|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129501924|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
129501925|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
129501926|NCT01106625|466127759|FG000|Core Period: Baseline to Week 26|Other|8|||
129501927|NCT01106625|466127760|FG001|Core Period: Baseline to Week 26|Other|7|||
129501928|NCT01106625|466127761|FG002|Core Period: Baseline to Week 26|Other|4|||
129501929|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
129501930|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
129501931|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
129501932|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
129501933|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
129501934|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
129501935|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
129501936|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
129501937|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
129501938|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129501939|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
129501940|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
129501941|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
129501942|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129501943|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
129501944|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
129501945|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
129501946|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
129501947|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
129501948|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
129501949|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
129501950|NCT01106625|466127759|FG000|Extension Period: Week 26 to Week 52|Other|5|||
129501951|NCT01106625|466127760|FG001|Extension Period: Week 26 to Week 52|Other|5|||
129501952|NCT01106625|466127761|FG002|Extension Period: Week 26 to Week 52|Other|4|||
129501953|NCT00668200|466127767|FG000|Overall Study|Withdrawal by Subject|2|||
129501954|NCT00668200|466127767|FG000|Overall Study|Lost to Follow-up|1|||
129501955|NCT01496430|466127768|FG000|Overall Study|Adverse Event|0|||
129501956|NCT01496430|466127769|FG001|Overall Study|Adverse Event|0|||
129501957|NCT01496430|466127770|FG002|Overall Study|Adverse Event|1|||
129501958|NCT01496430|466127768|FG000|Overall Study|Major Protocol Deviation|0|||
129501959|NCT01496430|466127769|FG001|Overall Study|Major Protocol Deviation|0|||
129501960|NCT01496430|466127770|FG002|Overall Study|Major Protocol Deviation|1|||
129501961|NCT01496430|466127768|FG000|Overall Study|Lost to Follow-up|2|||
129501962|NCT01496430|466127769|FG001|Overall Study|Lost to Follow-up|3|||
129501963|NCT01496430|466127770|FG002|Overall Study|Lost to Follow-up|1|||
129501964|NCT01496430|466127768|FG000|Overall Study|Voluntary Withdrawal|2|||
129501965|NCT01496430|466127769|FG001|Overall Study|Voluntary Withdrawal|1|||
129501966|NCT01496430|466127770|FG002|Overall Study|Voluntary Withdrawal|6|||
129501967|NCT01496430|466127768|FG000|Overall Study|Principal Investigator Discretion|0|||
129501968|NCT01496430|466127769|FG001|Overall Study|Principal Investigator Discretion|1|||
129501969|NCT01496430|466127770|FG002|Overall Study|Principal Investigator Discretion|1|||
129501970|NCT01496430|466127768|FG000|Overall Study|Other|2|||
129501971|NCT01496430|466127769|FG001|Overall Study|Other|0|||
129501972|NCT01496430|466127770|FG002|Overall Study|Other|0|||
129501973|NCT00997321|466127771|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
129501974|NCT00997321|466127772|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
129501975|NCT02512068|466127777|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
129501976|NCT02512068|466127778|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
129501977|NCT02512068|466127777|FG000|Overall Study|Major Protocol Deviation|1|||
129501978|NCT02512068|466127778|FG001|Overall Study|Major Protocol Deviation|0|||
129501979|NCT02512068|466127777|FG000|Overall Study|Voluntary Withdrawal|0|||
129501980|NCT02512068|466127778|FG001|Overall Study|Voluntary Withdrawal|1|||
129501981|NCT02512068|466127777|FG000|Overall Study|Lack of Efficacy|0|||
129501982|NCT02512068|466127778|FG001|Overall Study|Lack of Efficacy|1|||
129501983|NCT02512068|466127777|FG000|Overall Study|Reason Not Specified|3|||
129501984|NCT02512068|466127778|FG001|Overall Study|Reason Not Specified|5|||
129501985|NCT01098461|466127788|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
129501986|NCT01098461|466127789|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
129501987|NCT01098461|466127790|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
129501988|NCT01098461|466127791|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
129501989|NCT01098461|466127788|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
129501990|NCT01098461|466127789|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
129501991|NCT01098461|466127790|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
129501992|NCT01098461|466127791|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
129501993|NCT01098461|466127788|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
129501994|NCT01098461|466127789|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
129501995|NCT01098461|466127790|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
129501996|NCT01098461|466127791|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
129501997|NCT01098461|466127788|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
129501998|NCT01098461|466127789|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
129501999|NCT01098461|466127790|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
129502000|NCT01098461|466127791|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
129502001|NCT01098461|466127788|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
129502002|NCT01098461|466127789|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
129502003|NCT01098461|466127790|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
129502004|NCT01098461|466127791|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
129502005|NCT01098461|466127788|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
129502006|NCT01098461|466127789|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
129502007|NCT01098461|466127790|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
129502008|NCT01098461|466127791|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
129502009|NCT01098461|466127788|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
129502010|NCT01098461|466127789|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
129502011|NCT01098461|466127790|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
129502012|NCT01098461|466127791|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
129502013|NCT01153763|466127794|FG000|Overall Study|Study Closed|16|||
129502014|NCT01153763|466127794|FG000|Overall Study|Lost to Follow-up|1|||
129502015|NCT01153763|466127794|FG000|Overall Study|Physician Decision|2|||
129502016|NCT01153763|466127794|FG000|Overall Study|Withdrawal by Subject|2|||
129502017|NCT01474746|466127795|FG000|Overall Study|Lost to Follow-up|1|||
129502018|NCT01474746|466127796|FG001|Overall Study|Lost to Follow-up|1|||
129502019|NCT01474746|466127795|FG000|Overall Study|Withdrawal by Subject|2|||
129981936|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
129981937|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
129981938|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
129502020|NCT01474746|466127796|FG001|Overall Study|Withdrawal by Subject|1|||
129502021|NCT01766336|466127798|FG000|Overall Study|Adverse Event|11|||
129502022|NCT01766336|466127799|FG001|Overall Study|Adverse Event|8|||
129502023|NCT01766336|466127798|FG000|Overall Study|Death|4|||
129502024|NCT01766336|466127799|FG001|Overall Study|Death|3|||
129502025|NCT01766336|466127798|FG000|Overall Study|Lost to Follow-up|1|||
129502026|NCT01766336|466127799|FG001|Overall Study|Lost to Follow-up|3|||
129502027|NCT01766336|466127798|FG000|Overall Study|Physician Decision|4|||
129502028|NCT01766336|466127799|FG001|Overall Study|Physician Decision|2|||
129502029|NCT01766336|466127798|FG000|Overall Study|Protocol Violation|0|||
129502030|NCT01766336|466127799|FG001|Overall Study|Protocol Violation|1|||
129502031|NCT01766336|466127798|FG000|Overall Study|Sponsor Decision|52|||
129502032|NCT01766336|466127799|FG001|Overall Study|Sponsor Decision|43|||
129502033|NCT01766336|466127798|FG000|Overall Study|Withdrawal by Subject|18|||
129502034|NCT01766336|466127799|FG001|Overall Study|Withdrawal by Subject|15|||
129502035|NCT02605447|466127800|FG000|Overall Study|Death|66|||
129502036|NCT02605447|466127800|FG000|Overall Study|Physician Decision|1|||
129502037|NCT02605447|466127800|FG000|Overall Study|Lost to Follow-up|24|||
129502038|NCT02605447|466127800|FG000|Overall Study|Withdrawal by Subject|10|||
129502039|NCT02605447|466127800|FG000|Overall Study|Not disclosed|1|||
129502040|NCT04544709|466127804|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
129502041|NCT02045212|466127805|FG000|Overall Study|Adverse Event|0|||
129502042|NCT02045212|466127806|FG001|Overall Study|Adverse Event|1|||
129502043|NCT02045212|466127805|FG000|Overall Study|Withdrawal by Subject|1|||
129502044|NCT02045212|466127806|FG001|Overall Study|Withdrawal by Subject|0|||
129502045|NCT02045212|466127805|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
129502046|NCT02045212|466127806|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
129502047|NCT02402218|466127810|FG000|Overall Study|Did not pickup study medication|12|||
129502048|NCT02402218|466127811|FG001|Overall Study|Did not pickup study medication|9|||
129502049|NCT02402218|466127812|FG002|Overall Study|Did not pickup study medication|13|||
129502050|NCT02402218|466127810|FG000|Overall Study|Lack of Efficacy|0|||
129502051|NCT02402218|466127811|FG001|Overall Study|Lack of Efficacy|1|||
129502052|NCT02402218|466127812|FG002|Overall Study|Lack of Efficacy|1|||
129502053|NCT02402218|466127810|FG000|Overall Study|Death|1|||
129502054|NCT02402218|466127811|FG001|Overall Study|Death|0|||
129502055|NCT02402218|466127812|FG002|Overall Study|Death|0|||
129502056|NCT02402218|466127810|FG000|Overall Study|Reinfection|0|||
129502057|NCT02402218|466127811|FG001|Overall Study|Reinfection|0|||
129502058|NCT02402218|466127812|FG002|Overall Study|Reinfection|1|||
129502059|NCT02402218|466127810|FG000|Overall Study|Adverse Event|0|||
129502060|NCT02402218|466127811|FG001|Overall Study|Adverse Event|2|||
129502061|NCT02402218|466127812|FG002|Overall Study|Adverse Event|1|||
129502062|NCT02402218|466127810|FG000|Overall Study|Withdrawal by Subject|1|||
129502063|NCT02402218|466127811|FG001|Overall Study|Withdrawal by Subject|1|||
129502064|NCT02402218|466127812|FG002|Overall Study|Withdrawal by Subject|1|||
129502065|NCT00369668|466127814|FG000|Overall Study|Lack of Efficacy|4|||
129502066|NCT00369668|466127815|FG001|Overall Study|Lack of Efficacy|5|||
129502067|NCT00369668|466127816|FG002|Overall Study|Lack of Efficacy|7|||
129502068|NCT03126539|466127824|FG000|Overall Study|Lost to Follow-up|1|||
129502069|NCT03126539|466127825|FG001|Overall Study|Lost to Follow-up|1|||
129502070|NCT03126539|466127826|FG002|Overall Study|Lost to Follow-up|1|||
129502071|NCT03126539|466127827|FG003|Overall Study|Lost to Follow-up|0|||
129502072|NCT03126539|466127828|FG004|Overall Study|Lost to Follow-up|0|||
129502073|NCT03352414|466127829|FG000|Overall Study|Ineligible by operative criteria|12|||
129502074|NCT03352414|466127830|FG001|Overall Study|Ineligible by operative criteria|10|||
129502075|NCT02632110|466127831|FG000|Overall Study|Withdrawal by Subject|1|||
129502076|NCT02632110|466127832|FG001|Overall Study|Withdrawal by Subject|1|||
129502077|NCT02632110|466127833|FG002|Overall Study|Withdrawal by Subject|0|||
129502078|NCT02632110|466127834|FG003|Overall Study|Withdrawal by Subject|0|||
129502079|NCT02632110|466127835|FG004|Overall Study|Withdrawal by Subject|1|||
129502080|NCT02632110|466127836|FG005|Overall Study|Withdrawal by Subject|1|||
129502081|NCT02632110|466127837|FG006|Overall Study|Withdrawal by Subject|3|||
129502082|NCT02632110|466127838|FG007|Overall Study|Withdrawal by Subject|3|||
129502083|NCT02632110|466127839|FG008|Overall Study|Withdrawal by Subject|1|||
129502084|NCT02632110|466127840|FG009|Overall Study|Withdrawal by Subject|1|||
129502085|NCT00516269|466127843|FG000|Overall Study|Adverse Event|2|||
129502086|NCT00516269|466127844|FG001|Overall Study|Adverse Event|1|||
129502087|NCT00516269|466127843|FG000|Overall Study|Lost to Follow-up|0|||
129502088|NCT00516269|466127844|FG001|Overall Study|Lost to Follow-up|1|||
129502089|NCT00516269|466127843|FG000|Overall Study|Protocol Violation|0|||
129502090|NCT00516269|466127844|FG001|Overall Study|Protocol Violation|1|||
129502091|NCT00142519|466127845|FG000|Overall Study|Not Treated|7|||
129502092|NCT00142519|466127846|FG001|Overall Study|Not Treated|9|||
129502093|NCT00142519|466127845|FG000|Overall Study|Protocol Violation|1|||
129502094|NCT00142519|466127846|FG001|Overall Study|Protocol Violation|0|||
129502095|NCT00142519|466127845|FG000|Overall Study|Withdrawal by Subject|10|||
129502096|NCT00142519|466127846|FG001|Overall Study|Withdrawal by Subject|7|||
129502097|NCT02596711|466127847|FG000|Overall Study|Lost to Follow-up|1|||
129502098|NCT02596711|466127848|FG001|Overall Study|Lost to Follow-up|2|||
129502099|NCT02596711|466127849|FG002|Overall Study|Lost to Follow-up|3|||
129502100|NCT01005732|466127850|FG000|Overall Study|Lost to Follow-up|10|||
129502101|NCT01005732|466127850|FG000|Overall Study|Death|1|||
129502102|NCT01552928|466127851|FG000|Period 3|Adverse Event|0|||
129502103|NCT01552928|466127852|FG001|Period 3|Adverse Event|0|||
129502104|NCT01552928|466127853|FG002|Period 3|Adverse Event|1|||
129502105|NCT01552928|466127854|FG003|Period 3|Adverse Event|0|||
129502106|NCT04570657|466127856|FG000|Overall Study|Adverse Event|0|||
129502107|NCT04570657|466127857|FG001|Overall Study|Adverse Event|0|||
129502108|NCT04570657|466127858|FG002|Overall Study|Adverse Event|1|||
129502109|NCT04570657|466127856|FG000|Overall Study|Lost to Follow-up|0|||
129502110|NCT04570657|466127857|FG001|Overall Study|Lost to Follow-up|0|||
129502111|NCT04570657|466127858|FG002|Overall Study|Lost to Follow-up|1|||
129502112|NCT04570657|466127856|FG000|Overall Study|Physician Decision|0|||
129502113|NCT04570657|466127857|FG001|Overall Study|Physician Decision|1|||
129502114|NCT04570657|466127858|FG002|Overall Study|Physician Decision|0|||
129502115|NCT04570657|466127856|FG000|Overall Study|Withdrawal by Subject|1|||
129502116|NCT04570657|466127857|FG001|Overall Study|Withdrawal by Subject|2|||
129502117|NCT04570657|466127858|FG002|Overall Study|Withdrawal by Subject|2|||
129502118|NCT01079962|466127859|FG000|Overall Study|Adverse Event|2|||
129502119|NCT01079962|466127860|FG001|Overall Study|Adverse Event|2|||
129502120|NCT01079962|466127859|FG000|Overall Study|Withdrawal by Subject|5|||
129502121|NCT01079962|466127860|FG001|Overall Study|Withdrawal by Subject|7|||
129502122|NCT01079962|466127859|FG000|Overall Study|Protocol Violation|2|||
129502123|NCT01079962|466127860|FG001|Overall Study|Protocol Violation|2|||
129502124|NCT01079962|466127859|FG000|Overall Study|No blood pressure (BP) control|3|||
129502125|NCT01079962|466127860|FG001|Overall Study|No blood pressure (BP) control|0|||
129502126|NCT01079962|466127859|FG000|Overall Study|Inclusion/exclusion criteria|1|||
129502127|NCT01079962|466127860|FG001|Overall Study|Inclusion/exclusion criteria|3|||
129502128|NCT01079962|466127859|FG000|Overall Study|Participant not returning for next visit|1|||
129502129|NCT01079962|466127860|FG001|Overall Study|Participant not returning for next visit|0|||
129502130|NCT01079962|466127859|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
129502131|NCT01079962|466127860|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
129502132|NCT01331239|466127861|FG000|Part II: Core Study|Adverse Event|0|||
129502133|NCT01331239|466127862|FG001|Part II: Core Study|Adverse Event|3|||
129502134|NCT01331239|466127863|FG002|Part II: Core Study|Adverse Event|0|||
129502135|NCT01331239|466127861|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
129502136|NCT01331239|466127862|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
129502137|NCT01331239|466127863|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
129502138|NCT01331239|466127861|FG000|Part II: Core Study|Withdrawal by Subject|0|||
129502139|NCT01331239|466127862|FG001|Part II: Core Study|Withdrawal by Subject|2|||
129502140|NCT01331239|466127863|FG002|Part II: Core Study|Withdrawal by Subject|0|||
129502141|NCT01331239|466127861|FG000|Part II: Core Study|Administrative problems|0|||
129502142|NCT01331239|466127862|FG001|Part II: Core Study|Administrative problems|1|||
129502143|NCT01331239|466127863|FG002|Part II: Core Study|Administrative problems|0|||
129502144|NCT00946530|466127864|FG000|Overall Study|Withdrawal by Subject|0|||
129502145|NCT00946530|466127865|FG001|Overall Study|Withdrawal by Subject|3|||
129502146|NCT00946530|466127866|FG002|Overall Study|Withdrawal by Subject|0|||
129502147|NCT00946530|466127867|FG003|Overall Study|Withdrawal by Subject|3|||
129502148|NCT00946530|466127864|FG000|Overall Study|Physician Decision|1|||
129502149|NCT00946530|466127865|FG001|Overall Study|Physician Decision|1|||
129502150|NCT00946530|466127866|FG002|Overall Study|Physician Decision|1|||
129502151|NCT00946530|466127867|FG003|Overall Study|Physician Decision|1|||
129502152|NCT01008995|466127870|FG000|Controlled Period|Adverse Event|1|||
129502153|NCT01008995|466127871|FG001|Controlled Period|Adverse Event|2|||
129502154|NCT01008995|466127872|FG002|Controlled Period|Adverse Event|0|||
129502155|NCT01008995|466127873|FG003|Controlled Period|Adverse Event|0|||
129502156|NCT01008995|466127870|FG000|Controlled Period|Other|2|||
129502157|NCT01008995|466127871|FG001|Controlled Period|Other|1|||
129502158|NCT01008995|466127872|FG002|Controlled Period|Other|0|||
129502159|NCT01008995|466127873|FG003|Controlled Period|Other|0|||
129502160|NCT01008995|466127870|FG000|After Controlled Period|Adverse Event|0|||
129502161|NCT01008995|466127871|FG001|After Controlled Period|Adverse Event|0|||
129502162|NCT01008995|466127872|FG002|After Controlled Period|Adverse Event|1|||
129502163|NCT01008995|466127873|FG003|After Controlled Period|Adverse Event|1|||
129502164|NCT01008995|466127870|FG000|After Controlled Period|Other|0|||
129502165|NCT01008995|466127871|FG001|After Controlled Period|Other|0|||
129502166|NCT01008995|466127872|FG002|After Controlled Period|Other|1|||
129502167|NCT01008995|466127873|FG003|After Controlled Period|Other|0|||
129502168|NCT02625324|466129475|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
129502169|NCT02625324|466129475|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
129502170|NCT02625324|466129475|FG000|6-Month Follow-up Subject Accountability|Death|5|||
129502171|NCT02625324|466129475|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
129502172|NCT02625324|466129475|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
129502173|NCT02625324|466129475|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
129502174|NCT02625324|466129475|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
129502175|NCT02625324|466129475|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
129502176|NCT02625324|466129475|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
129502177|NCT02625324|466129475|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
129502178|NCT02625324|466129475|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
129502179|NCT02625324|466129475|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
129502180|NCT02625324|466129475|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
129502181|NCT02625324|466129475|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
129539067|NCT02708524|466265147|FG003|Overall Study|Lens Discomfort|0|||
129502182|NCT02625324|466129475|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
129502183|NCT02625324|466129475|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
129502184|NCT02625324|466129475|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
129502185|NCT01116687|466129480|FG000|Overall Study|Withdrawal by Subject|4|||
129502186|NCT00165841|466129483|FG000|Overall Study|Adverse Event|2|||
129502187|NCT00165841|466129484|FG001|Overall Study|Adverse Event|3|||
129502188|NCT00165841|466129483|FG000|Overall Study|Lack of Efficacy|6|||
129502189|NCT00165841|466129484|FG001|Overall Study|Lack of Efficacy|33|||
129502190|NCT00165841|466129483|FG000|Overall Study|Lost to Follow-up|4|||
129502191|NCT00165841|466129484|FG001|Overall Study|Lost to Follow-up|4|||
129502192|NCT00165841|466129483|FG000|Overall Study|Withdrawal by Subject|7|||
129502193|NCT00165841|466129484|FG001|Overall Study|Withdrawal by Subject|8|||
129502194|NCT00165841|466129483|FG000|Overall Study|Physician Decision|1|||
129502195|NCT00165841|466129484|FG001|Overall Study|Physician Decision|0|||
129502196|NCT00165841|466129483|FG000|Overall Study|Protocol Violation|6|||
129502197|NCT00165841|466129484|FG001|Overall Study|Protocol Violation|8|||
129502198|NCT00165841|466129483|FG000|Overall Study|Other|3|||
129502199|NCT00165841|466129484|FG001|Overall Study|Other|5|||
129502200|NCT00165841|466129483|FG000|Overall Study|Medication Noncompliance|1|||
129502201|NCT00165841|466129484|FG001|Overall Study|Medication Noncompliance|1|||
129502202|NCT00254293|466129485|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129502203|NCT00254293|466129486|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
129502204|NCT00254293|466129487|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129502205|NCT00254293|466129488|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
129502206|NCT00254293|466129489|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129502207|NCT00254293|466129490|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129502208|NCT00254293|466129491|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
129502209|NCT00254293|466129485|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129502210|NCT00254293|466129486|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129502211|NCT00254293|466129487|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
129502212|NCT00254293|466129488|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129502213|NCT00254293|466129489|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129502214|NCT00254293|466129490|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129502215|NCT00254293|466129491|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
129502216|NCT00254293|466129485|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129502217|NCT00254293|466129486|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129502218|NCT00254293|466129487|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
129502219|NCT00254293|466129488|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129502220|NCT00254293|466129489|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129502221|NCT00254293|466129490|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129502222|NCT00254293|466129491|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
129502223|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Death|0|||
129502224|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Death|0|||
129502225|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Death|1|||
129502226|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Death|0|||
129502227|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Death|0|||
129502228|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Death|0|||
129502229|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Death|0|||
129502230|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
129502231|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
129502232|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
129502233|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
129502234|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
129502235|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
129502236|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
129502237|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
129502238|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
129502239|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
129502240|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
129502241|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
129502242|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
129502243|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
129502244|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129502245|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129502246|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
129502247|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129502248|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129502249|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129981939|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
129502250|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
129502251|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129502252|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129502253|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
129502254|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129502255|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129502256|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129502257|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
129502258|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129502259|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129502260|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
129502261|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129502262|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129502263|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129502264|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
129502265|NCT00254293|466129485|FG000|LTE Open Label Variable SC Dosing|Other|0|||
129502266|NCT00254293|466129486|FG001|LTE Open Label Variable SC Dosing|Other|0|||
129502267|NCT00254293|466129487|FG002|LTE Open Label Variable SC Dosing|Other|2|||
129502268|NCT00254293|466129488|FG003|LTE Open Label Variable SC Dosing|Other|0|||
129502269|NCT00254293|466129489|FG004|LTE Open Label Variable SC Dosing|Other|0|||
129502270|NCT00254293|466129490|FG005|LTE Open Label Variable SC Dosing|Other|0|||
129502271|NCT00254293|466129491|FG006|LTE Open Label Variable SC Dosing|Other|0|||
129502272|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Death|0|||
129502273|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Death|0|||
129502274|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Death|0|||
129502275|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Death|0|||
129502276|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Death|0|||
129502277|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Death|0|||
129502278|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Death|3|||
129502279|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
129502280|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
129502281|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
129502282|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
129502283|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
129502284|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
129502285|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
129502286|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129502287|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129502288|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129502289|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129502290|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129502291|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
129502292|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
129502293|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
129502294|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
129502295|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
129502296|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
129502297|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
129502298|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
129502299|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
129502300|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
129502301|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
129502302|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
129502303|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
129502304|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
129502305|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
129502306|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
129502307|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129502308|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129502309|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129502310|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129502311|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129502312|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
129502313|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
129502314|NCT00254293|466129485|FG000|LTE Open Label Fixed Dosing|Other|0|||
129502315|NCT00254293|466129486|FG001|LTE Open Label Fixed Dosing|Other|0|||
129502316|NCT00254293|466129487|FG002|LTE Open Label Fixed Dosing|Other|0|||
129981940|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
129981941|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
129981942|NCT05260021|467896807|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
129981943|NCT05260021|467896808|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
129981944|NCT05260021|467896809|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
129981945|NCT03842358|467896810|FG000|Overall Study|Poor DOT probe contact with breast|2|||
129981946|NCT03842358|467896810|FG000|Overall Study|DOT system problem|1|||
129981947|NCT03842358|467896810|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
129981948|NCT03842358|467896810|FG000|Overall Study|No biopsy after physician review|4|||
129981949|NCT03842358|467896810|FG000|Overall Study|Patient withdrew|2|||
129981950|NCT01525238|467896811|FG000|Overall Study|Withdrawal by Subject|1|||
129981951|NCT01525238|467896812|FG001|Overall Study|Withdrawal by Subject|0|||
129981952|NCT01525238|467896813|FG002|Overall Study|Withdrawal by Subject|0|||
129981953|NCT04625413|467896814|FG000|Overall Study|Hospice|2|||
129981954|NCT04625413|467896814|FG000|Overall Study|Distress|1|||
129981955|NCT04625413|467896814|FG000|Overall Study|Not feeling well|1|||
129981956|NCT04679935|467896815|FG000|Overall Study|Death|0|||
129981957|NCT04679935|467896816|FG001|Overall Study|Death|1|||
129981958|NCT02993146|467896817|FG000|Overall Study|Withdrawal by Subject|0|||
129981959|NCT02993146|467896818|FG001|Overall Study|Withdrawal by Subject|0|||
129981960|NCT02993146|467896819|FG002|Overall Study|Withdrawal by Subject|1|||
129981961|NCT02993146|467896820|FG003|Overall Study|Withdrawal by Subject|1|||
129981962|NCT04362189|467896821|FG000|Overall Study|Lost to Follow-up|0|||
129981963|NCT04362189|467896822|FG001|Overall Study|Lost to Follow-up|1|||
129981964|NCT04362189|467896821|FG000|Overall Study|Withdrawal by Subject|1|||
129981965|NCT04362189|467896822|FG001|Overall Study|Withdrawal by Subject|0|||
129981966|NCT04362189|467896821|FG000|Overall Study|FDA Clinical Hold|7|||
129981967|NCT04362189|467896822|FG001|Overall Study|FDA Clinical Hold|2|||
129981968|NCT04362189|467896821|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
129981969|NCT04362189|467896822|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
129981970|NCT04362189|467896821|FG000|Overall Study|Adverse Event|0|||
129981971|NCT04362189|467896822|FG001|Overall Study|Adverse Event|2|||
129981972|NCT04362189|467896821|FG000|Overall Study|Death|4|||
129981973|NCT04362189|467896822|FG001|Overall Study|Death|1|||
129981974|NCT02111681|467896823|FG000|Overall Study|Death|5|||
129981975|NCT02111681|467896823|FG000|Overall Study|Lack of Efficacy|2|||
129981976|NCT02111681|467896823|FG000|Overall Study|Progression of disease|4|||
129981977|NCT01077271|467898740|FG000|Overall Study|Parental desire|8|||
129981978|NCT01077271|467898740|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
129981979|NCT01077271|467898740|FG000|Overall Study|Noncompliance|2|||
129981980|NCT01077271|467898740|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
129981981|NCT01077271|467898740|FG000|Overall Study|Changed doctors|2|||
129981982|NCT01077271|467898740|FG000|Overall Study|Parents thought too many injections|2|||
129981983|NCT01077271|467898740|FG000|Overall Study|End of RSV season nearly reached|1|||
129981984|NCT01077271|467898740|FG000|Overall Study|Mother unconvinced of the necessity|1|||
129981985|NCT03333876|467898741|FG000|Screening Period|Screen Failure|4|||
129981986|NCT03333876|467898741|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
129981987|NCT03333876|467898741|FG000|Mandibular Advancement|Adverse Event|2|||
129981988|NCT03333876|467898741|FG000|Mandibular Advancement|Product Damage|2|||
129981989|NCT00095498|467898742|FG000|Overall Study|Physician Decision|9|||
129981990|NCT00095498|467898743|FG001|Overall Study|Physician Decision|10|||
129981991|NCT00095498|467898744|FG002|Overall Study|Physician Decision|8|||
129981992|NCT00095498|467898742|FG000|Overall Study|Adverse Event|1|||
129981993|NCT00095498|467898743|FG001|Overall Study|Adverse Event|0|||
129981994|NCT00095498|467898744|FG002|Overall Study|Adverse Event|1|||
129981995|NCT00095498|467898742|FG000|Overall Study|Withdrawal by Subject|15|||
129502317|NCT00254293|466129488|FG003|LTE Open Label Fixed Dosing|Other|0|||
129502318|NCT00254293|466129489|FG004|LTE Open Label Fixed Dosing|Other|0|||
129502319|NCT00254293|466129490|FG005|LTE Open Label Fixed Dosing|Other|0|||
129981996|NCT00095498|467898743|FG001|Overall Study|Withdrawal by Subject|16|||
129981997|NCT00095498|467898744|FG002|Overall Study|Withdrawal by Subject|15|||
129981998|NCT00095498|467898742|FG000|Overall Study|Disease progression|0|||
129981999|NCT00095498|467898743|FG001|Overall Study|Disease progression|1|||
129982000|NCT00095498|467898744|FG002|Overall Study|Disease progression|1|||
129982001|NCT00095498|467898742|FG000|Overall Study|Ineligibility determined|3|||
129982002|NCT00095498|467898743|FG001|Overall Study|Ineligibility determined|0|||
129982003|NCT00095498|467898744|FG002|Overall Study|Ineligibility determined|2|||
129982004|NCT00095498|467898742|FG000|Overall Study|Lost to Follow-up|1|||
129982005|NCT00095498|467898743|FG001|Overall Study|Lost to Follow-up|1|||
129982006|NCT00095498|467898744|FG002|Overall Study|Lost to Follow-up|2|||
129982007|NCT00095498|467898742|FG000|Overall Study|Noncompliance|1|||
129982008|NCT00095498|467898743|FG001|Overall Study|Noncompliance|0|||
129982009|NCT00095498|467898744|FG002|Overall Study|Noncompliance|1|||
129982010|NCT00095498|467898742|FG000|Overall Study|Other|6|||
129982011|NCT00095498|467898743|FG001|Overall Study|Other|7|||
129982012|NCT00095498|467898744|FG002|Overall Study|Other|6|||
129982013|NCT00095498|467898742|FG000|Overall Study|Protocol Violation|0|||
129982014|NCT00095498|467898743|FG001|Overall Study|Protocol Violation|0|||
129982015|NCT00095498|467898744|FG002|Overall Study|Protocol Violation|1|||
129982016|NCT00095498|467898742|FG000|Overall Study|Requirement for alternative therapy|1|||
129982017|NCT00095498|467898743|FG001|Overall Study|Requirement for alternative therapy|0|||
129982018|NCT00095498|467898744|FG002|Overall Study|Requirement for alternative therapy|2|||
129982019|NCT05020327|467898745|FG000|Overall Study|Physician Decision|3|||
129982020|NCT05020327|467898746|FG001|Overall Study|Physician Decision|0|||
129982021|NCT05020327|467898747|FG002|Overall Study|Physician Decision|0|||
129982022|NCT05020327|467898745|FG000|Overall Study|Withdrawal by Subject|1|||
129982023|NCT05020327|467898746|FG001|Overall Study|Withdrawal by Subject|1|||
129982024|NCT05020327|467898747|FG002|Overall Study|Withdrawal by Subject|0|||
129982025|NCT05020327|467898745|FG000|Overall Study|personal/cultural, ineligible|12|||
129982026|NCT05020327|467898746|FG001|Overall Study|personal/cultural, ineligible|0|||
129982027|NCT05020327|467898747|FG002|Overall Study|personal/cultural, ineligible|0|||
129982028|NCT04684394|467898748|FG000|Overall Study|Death|1|||
129982029|NCT04684394|467898749|FG001|Overall Study|Death|2|||
129982030|NCT04684394|467898748|FG000|Overall Study|Lost to Follow-up|1|||
129982031|NCT04684394|467898749|FG001|Overall Study|Lost to Follow-up|0|||
129982032|NCT04684394|467898748|FG000|Overall Study|Withdrawal by Subject|2|||
129982033|NCT04684394|467898749|FG001|Overall Study|Withdrawal by Subject|0|||
129982034|NCT04684394|467898748|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
129982035|NCT04684394|467898749|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
129982036|NCT00591370|467898751|FG000|Overall Study|Not Treated|2|||
129982037|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
129982038|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
129982039|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
129982040|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
129982041|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
129982042|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
129982043|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
129982044|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982045|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982046|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982047|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982048|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
129982049|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Death|1|||
129982050|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Death|2|||
129982051|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Death|2|||
129982052|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Death|0|||
129502320|NCT00254293|466129491|FG006|LTE Open Label Fixed Dosing|Other|1|||
129502321|NCT03196193|466129498|FG000|Overall Study|Adverse Event|1|||
129502322|NCT03196193|466129499|FG001|Overall Study|Adverse Event|0|||
129502323|NCT03196193|466129498|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
129502324|NCT03196193|466129499|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
129502325|NCT02709083|466129500|FG000|Overall Study|Original PI left institution|7|||
129502326|NCT01697267|466129502|FG000|Overall Study|Death|3|||
129502327|NCT01697267|466129503|FG001|Overall Study|Death|1|||
129502328|NCT01697267|466129502|FG000|Overall Study|Withdrawal by Subject|5|||
129502329|NCT01697267|466129503|FG001|Overall Study|Withdrawal by Subject|5|||
129502330|NCT01697267|466129502|FG000|Overall Study|Adverse Event|2|||
129502331|NCT01697267|466129503|FG001|Overall Study|Adverse Event|1|||
129502332|NCT01697267|466129502|FG000|Overall Study|Lost to Follow-up|2|||
129502333|NCT01697267|466129503|FG001|Overall Study|Lost to Follow-up|4|||
129502334|NCT01697267|466129502|FG000|Overall Study|Physician Decision|2|||
129502335|NCT01697267|466129503|FG001|Overall Study|Physician Decision|4|||
129502336|NCT04031404|466129504|FG000|Baseline|Lost to Follow-up|0|||
129502337|NCT04031404|466129505|FG001|Baseline|Lost to Follow-up|1|||
129502338|NCT04031404|466129504|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
129502339|NCT04031404|466129505|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
129502340|NCT04031404|466129504|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
129502341|NCT04031404|466129505|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
129502342|NCT04031404|466129504|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
129502343|NCT04031404|466129505|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
129502344|NCT04031404|466129504|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
129982053|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Death|0|||
129982054|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Death|0|||
129502345|NCT04031404|466129505|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
129502346|NCT02796391|466129508|FG000|Overall Study|Lost to Follow-up|2|||
129502347|NCT02796391|466129509|FG001|Overall Study|Lost to Follow-up|2|||
129502348|NCT02796391|466129510|FG002|Overall Study|Lost to Follow-up|13|||
129502349|NCT02796391|466129511|FG003|Overall Study|Lost to Follow-up|8|||
129982055|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129982056|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
129982057|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
129982058|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129502350|NCT02796391|466129512|FG004|Overall Study|Lost to Follow-up|14|||
129502351|NCT02796391|466129513|FG005|Overall Study|Lost to Follow-up|13|||
129502352|NCT02796391|466129508|FG000|Overall Study|COVID|0|||
129502353|NCT02796391|466129509|FG001|Overall Study|COVID|0|||
129502354|NCT02796391|466129510|FG002|Overall Study|COVID|5|||
129502355|NCT02796391|466129511|FG003|Overall Study|COVID|5|||
129502356|NCT02796391|466129512|FG004|Overall Study|COVID|2|||
129502357|NCT02796391|466129513|FG005|Overall Study|COVID|4|||
129502358|NCT02796391|466129508|FG000|Overall Study|Participant did not like study cigarettes|0|||
129502359|NCT02796391|466129509|FG001|Overall Study|Participant did not like study cigarettes|0|||
129502360|NCT02796391|466129510|FG002|Overall Study|Participant did not like study cigarettes|3|||
129502361|NCT02796391|466129511|FG003|Overall Study|Participant did not like study cigarettes|0|||
129502362|NCT02796391|466129512|FG004|Overall Study|Participant did not like study cigarettes|0|||
129502363|NCT02796391|466129513|FG005|Overall Study|Participant did not like study cigarettes|0|||
129502364|NCT02796391|466129508|FG000|Overall Study|Withdrawal by Subject|1|||
129502365|NCT02796391|466129509|FG001|Overall Study|Withdrawal by Subject|1|||
129502366|NCT02796391|466129510|FG002|Overall Study|Withdrawal by Subject|4|||
129502367|NCT02796391|466129511|FG003|Overall Study|Withdrawal by Subject|3|||
129502368|NCT02796391|466129512|FG004|Overall Study|Withdrawal by Subject|4|||
129502369|NCT02796391|466129513|FG005|Overall Study|Withdrawal by Subject|3|||
129502370|NCT02796391|466129508|FG000|Overall Study|Adverse Event|0|||
129502371|NCT02796391|466129509|FG001|Overall Study|Adverse Event|0|||
129502372|NCT02796391|466129510|FG002|Overall Study|Adverse Event|0|||
129502373|NCT02796391|466129511|FG003|Overall Study|Adverse Event|1|||
129502374|NCT02796391|466129512|FG004|Overall Study|Adverse Event|0|||
129502375|NCT02796391|466129513|FG005|Overall Study|Adverse Event|0|||
129502376|NCT02796391|466129508|FG000|Overall Study|Protocol Violation|0|||
129502377|NCT02796391|466129509|FG001|Overall Study|Protocol Violation|0|||
129502378|NCT02796391|466129510|FG002|Overall Study|Protocol Violation|0|||
129502379|NCT02796391|466129511|FG003|Overall Study|Protocol Violation|1|||
129502380|NCT02796391|466129512|FG004|Overall Study|Protocol Violation|0|||
129502381|NCT02796391|466129513|FG005|Overall Study|Protocol Violation|0|||
129502382|NCT02681055|466129514|FG000|Weeks 5-12|Adverse Event|1|||
129502383|NCT02695524|466129515|FG000|Overall Study|Lost to Follow-up|3|||
129502384|NCT02695524|466129516|FG001|Overall Study|Lost to Follow-up|2|||
129502385|NCT02695524|466129515|FG000|Overall Study|Death|0|||
129502386|NCT02695524|466129516|FG001|Overall Study|Death|1|||
129502387|NCT00831441|466129519|FG000|Randomized|Death|82|||
129502388|NCT00831441|466129520|FG001|Randomized|Death|81|||
129502389|NCT00831441|466129519|FG000|Randomized|Adverse Event|248|||
129502390|NCT00831441|466129520|FG001|Randomized|Adverse Event|321|||
129502391|NCT00831441|466129519|FG000|Randomized|Emergency procedure|2|||
129502392|NCT00831441|466129520|FG001|Randomized|Emergency procedure|2|||
129502393|NCT00831441|466129519|FG000|Randomized|Elective procedure|26|||
129502394|NCT00831441|466129520|FG001|Randomized|Elective procedure|25|||
129502395|NCT00831441|466129519|FG000|Randomized|Physician Decision|26|||
129502396|NCT00831441|466129520|FG001|Randomized|Physician Decision|35|||
129502397|NCT00831441|466129519|FG000|Randomized|No longer met criteria|13|||
129502398|NCT00831441|466129520|FG001|Randomized|No longer met criteria|19|||
129502399|NCT00831441|466129519|FG000|Randomized|Withdrawal by Subject|178|||
129502400|NCT00831441|466129520|FG001|Randomized|Withdrawal by Subject|212|||
129502401|NCT00831441|466129519|FG000|Randomized|Lost to Follow-up|26|||
129502402|NCT00831441|466129520|FG001|Randomized|Lost to Follow-up|35|||
129502403|NCT00831441|466129519|FG000|Randomized|Administrative reason by sponsor|2780|||
129502404|NCT00831441|466129520|FG001|Randomized|Administrative reason by sponsor|2671|||
129502405|NCT00831441|466129519|FG000|Randomized|poor/non-compliance|30|||
129502406|NCT00831441|466129520|FG001|Randomized|poor/non-compliance|38|||
129502407|NCT00831441|466129519|FG000|Randomized|non-specified|276|||
129502408|NCT00831441|466129520|FG001|Randomized|non-specified|266|||
129502409|NCT00831441|466129519|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
129502410|NCT00831441|466129520|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
129502411|NCT00831441|466129519|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
129502412|NCT00831441|466129520|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
129502413|NCT00831441|466129519|FG000|Follow Up (30 Days)|Death|63|||
129502414|NCT00831441|466129520|FG001|Follow Up (30 Days)|Death|86|||
129502415|NCT00831441|466129519|FG000|Follow Up (30 Days)|non-specified|16|||
129502416|NCT00831441|466129520|FG001|Follow Up (30 Days)|non-specified|26|||
129502417|NCT00831441|466129519|FG000|Follow Up (30 Days)|missing end of study status|0|||
129502418|NCT00831441|466129520|FG001|Follow Up (30 Days)|missing end of study status|1|||
129502419|NCT05674344|466129521|FG000|Overall Study|Screen Fail|21|||
129502420|NCT05674344|466129521|FG000|Overall Study|Incomplete study procedures|3|||
129502421|NCT00111917|466129522|FG000|Overall Study|Withdrawal by Subject|1|||
129502422|NCT00111917|466129523|FG001|Overall Study|Withdrawal by Subject|1|||
129502423|NCT00798655|466129524|FG000|Overall Study|Did not receive at least one dose of pan|2|||
129502424|NCT00343291|466129525|FG000|Overall Study|Adverse Event|13|||
129982059|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129982060|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
129982061|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
129982062|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129982063|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129502425|NCT00343291|466129526|FG001|Overall Study|Adverse Event|13|||
129502426|NCT00343291|466129525|FG000|Overall Study|Death|3|||
129502427|NCT00343291|466129526|FG001|Overall Study|Death|2|||
129502428|NCT00343291|466129525|FG000|Overall Study|Progressive disease|33|||
129502429|NCT00343291|466129526|FG001|Overall Study|Progressive disease|34|||
129502430|NCT00343291|466129525|FG000|Overall Study|Withdrawal by Subject|0|||
129502431|NCT00343291|466129526|FG001|Overall Study|Withdrawal by Subject|2|||
129502432|NCT00343291|466129525|FG000|Overall Study|Other|8|||
129502433|NCT00343291|466129526|FG001|Overall Study|Other|5|||
129502434|NCT00960934|466129527|FG000|Overall Study|Adverse Event|2|||
129502435|NCT00960934|466129528|FG001|Overall Study|Adverse Event|3|||
129502436|NCT00960934|466129529|FG002|Overall Study|Adverse Event|3|||
129502437|NCT00960934|466129530|FG003|Overall Study|Adverse Event|2|||
129502438|NCT00960934|466129531|FG004|Overall Study|Adverse Event|4|||
129502439|NCT00960934|466129532|FG005|Overall Study|Adverse Event|3|||
129502440|NCT00960934|466129527|FG000|Overall Study|Lack of Efficacy|1|||
129502441|NCT00960934|466129528|FG001|Overall Study|Lack of Efficacy|0|||
129502442|NCT00960934|466129529|FG002|Overall Study|Lack of Efficacy|0|||
129502443|NCT00960934|466129530|FG003|Overall Study|Lack of Efficacy|0|||
129502444|NCT00960934|466129531|FG004|Overall Study|Lack of Efficacy|0|||
129502445|NCT00960934|466129532|FG005|Overall Study|Lack of Efficacy|0|||
129502446|NCT00960934|466129527|FG000|Overall Study|Lost to Follow-up|0|||
129502447|NCT00960934|466129528|FG001|Overall Study|Lost to Follow-up|1|||
129502448|NCT00960934|466129529|FG002|Overall Study|Lost to Follow-up|0|||
129502449|NCT00960934|466129530|FG003|Overall Study|Lost to Follow-up|0|||
129502450|NCT00960934|466129531|FG004|Overall Study|Lost to Follow-up|0|||
129502451|NCT00960934|466129532|FG005|Overall Study|Lost to Follow-up|0|||
129502452|NCT00960934|466129527|FG000|Overall Study|Other|2|||
129502453|NCT00960934|466129528|FG001|Overall Study|Other|1|||
129502454|NCT00960934|466129529|FG002|Overall Study|Other|5|||
129502455|NCT00960934|466129530|FG003|Overall Study|Other|4|||
129502456|NCT00960934|466129531|FG004|Overall Study|Other|2|||
129502457|NCT00960934|466129532|FG005|Overall Study|Other|2|||
129502458|NCT00960934|466129527|FG000|Overall Study|Physician Decision|0|||
129502459|NCT00960934|466129528|FG001|Overall Study|Physician Decision|1|||
129502460|NCT00960934|466129529|FG002|Overall Study|Physician Decision|0|||
129502461|NCT00960934|466129530|FG003|Overall Study|Physician Decision|0|||
129502462|NCT00960934|466129531|FG004|Overall Study|Physician Decision|0|||
129502463|NCT00960934|466129532|FG005|Overall Study|Physician Decision|0|||
129502464|NCT00960934|466129527|FG000|Overall Study|Progressive Disease|1|||
129502465|NCT00960934|466129528|FG001|Overall Study|Progressive Disease|1|||
129502466|NCT00960934|466129529|FG002|Overall Study|Progressive Disease|0|||
129502467|NCT00960934|466129530|FG003|Overall Study|Progressive Disease|0|||
129502468|NCT00960934|466129531|FG004|Overall Study|Progressive Disease|1|||
129502469|NCT00960934|466129532|FG005|Overall Study|Progressive Disease|1|||
129502470|NCT00960934|466129527|FG000|Overall Study|Protocol Violation|3|||
129502471|NCT00960934|466129528|FG001|Overall Study|Protocol Violation|4|||
129502472|NCT00960934|466129529|FG002|Overall Study|Protocol Violation|0|||
129502473|NCT00960934|466129530|FG003|Overall Study|Protocol Violation|3|||
129502474|NCT00960934|466129531|FG004|Overall Study|Protocol Violation|3|||
129502475|NCT00960934|466129532|FG005|Overall Study|Protocol Violation|2|||
129502476|NCT00960934|466129527|FG000|Overall Study|Withdrawal by Subject|5|||
129502477|NCT00960934|466129528|FG001|Overall Study|Withdrawal by Subject|6|||
129502478|NCT00960934|466129529|FG002|Overall Study|Withdrawal by Subject|4|||
129502479|NCT00960934|466129530|FG003|Overall Study|Withdrawal by Subject|5|||
129502480|NCT00960934|466129531|FG004|Overall Study|Withdrawal by Subject|5|||
129502481|NCT00960934|466129532|FG005|Overall Study|Withdrawal by Subject|7|||
129502482|NCT00960934|466129527|FG000|Overall Study|Study Terminated by Sponsor|50|||
129502483|NCT00960934|466129528|FG001|Overall Study|Study Terminated by Sponsor|46|||
129502484|NCT00960934|466129529|FG002|Overall Study|Study Terminated by Sponsor|52|||
129502485|NCT00960934|466129530|FG003|Overall Study|Study Terminated by Sponsor|50|||
129982064|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129982065|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129502486|NCT00960934|466129531|FG004|Overall Study|Study Terminated by Sponsor|49|||
129502487|NCT00960934|466129532|FG005|Overall Study|Study Terminated by Sponsor|49|||
129502488|NCT05254613|466129538|FG000|Overall Study|Lost to Follow-up|0|||
129502489|NCT05254613|466129539|FG001|Overall Study|Lost to Follow-up|0|||
129502490|NCT05254613|466129540|FG002|Overall Study|Lost to Follow-up|1|||
129502491|NCT00839423|466129543|FG000|Overall Study|Adverse Event|4|||
129502492|NCT00839423|466129544|FG001|Overall Study|Adverse Event|3|||
129502493|NCT00839423|466129545|FG002|Overall Study|Adverse Event|7|||
129502494|NCT00839423|466129546|FG003|Overall Study|Adverse Event|16|||
129502495|NCT00839423|466129543|FG000|Overall Study|Lack of Efficacy|6|||
129502496|NCT00839423|466129544|FG001|Overall Study|Lack of Efficacy|6|||
129502497|NCT00839423|466129545|FG002|Overall Study|Lack of Efficacy|3|||
129502498|NCT00839423|466129546|FG003|Overall Study|Lack of Efficacy|2|||
129502499|NCT00839423|466129543|FG000|Overall Study|Non-compliance|0|||
129502500|NCT00839423|466129544|FG001|Overall Study|Non-compliance|0|||
129502501|NCT00839423|466129545|FG002|Overall Study|Non-compliance|0|||
129502502|NCT00839423|466129546|FG003|Overall Study|Non-compliance|1|||
129502503|NCT00839423|466129543|FG000|Overall Study|Protocol Violation|0|||
129502504|NCT00839423|466129544|FG001|Overall Study|Protocol Violation|1|||
129502505|NCT00839423|466129545|FG002|Overall Study|Protocol Violation|2|||
129502506|NCT00839423|466129546|FG003|Overall Study|Protocol Violation|0|||
129502507|NCT00839423|466129543|FG000|Overall Study|Withdrawal of consent|4|||
129502508|NCT00839423|466129544|FG001|Overall Study|Withdrawal of consent|0|||
129502509|NCT00839423|466129545|FG002|Overall Study|Withdrawal of consent|4|||
129502510|NCT00839423|466129546|FG003|Overall Study|Withdrawal of consent|1|||
129502511|NCT00839423|466129543|FG000|Overall Study|Lost to Follow-up|1|||
129502512|NCT00839423|466129544|FG001|Overall Study|Lost to Follow-up|0|||
129502513|NCT00839423|466129545|FG002|Overall Study|Lost to Follow-up|1|||
129502514|NCT00839423|466129546|FG003|Overall Study|Lost to Follow-up|0|||
129502515|NCT00839423|466129543|FG000|Overall Study|Administrative or other reasons|3|||
129502516|NCT00839423|466129544|FG001|Overall Study|Administrative or other reasons|0|||
129502517|NCT00839423|466129545|FG002|Overall Study|Administrative or other reasons|1|||
129502518|NCT00839423|466129546|FG003|Overall Study|Administrative or other reasons|0|||
129502519|NCT04348656|466129547|FG000|Overall Study|Withdrawal by Subject|2|||
129502520|NCT04348656|466129548|FG001|Overall Study|Withdrawal by Subject|0|||
129502521|NCT04348656|466129547|FG000|Overall Study|Lost to Follow-up|11|||
129502522|NCT04348656|466129548|FG001|Overall Study|Lost to Follow-up|6|||
129502523|NCT02387372|466129549|FG000|Overall Study|Not Treated|1|||
129502524|NCT02387372|466129550|FG001|Overall Study|Not Treated|0|||
129502525|NCT00937560|466129551|FG000|Initial Treatment|Death|6|||
129502526|NCT00937560|466129551|FG000|Initial Treatment|Withdraw consent|3|||
129502527|NCT00937560|466129551|FG000|Initial Treatment|Adverse Event|1|||
129502528|NCT00937560|466129551|FG000|Initial Treatment|Lost to Follow-up|1|||
129502529|NCT00937560|466129551|FG000|Initial Treatment|No end of study page|10|||
129502530|NCT00937560|466129551|FG000|Maintenance Treatment|Death|12|||
129502531|NCT00937560|466129551|FG000|Maintenance Treatment|Withdraw consent|5|||
129502532|NCT00937560|466129551|FG000|Maintenance Treatment|According to protocol|1|||
129502533|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
129502534|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
129502535|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
129502536|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
129502537|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
129502538|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
129502539|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
129502540|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
129502541|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
129502542|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
129502543|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
129502544|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
129502545|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
129502546|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
129502547|NCT00848549|466129552|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
129502548|NCT00848549|466129553|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
129502549|NCT00848549|466129552|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
129502550|NCT00848549|466129553|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
129502551|NCT00848549|466129552|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
129502552|NCT00848549|466129553|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
129502553|NCT00848549|466129552|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
129502554|NCT00848549|466129553|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
129502555|NCT00848549|466129552|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
129502556|NCT00848549|466129553|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
129502557|NCT00848549|466129552|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
129502558|NCT00848549|466129553|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
129502559|NCT00848549|466129552|FG000|E2090-E044-314 (Extension Study)|Other|5|||
129502560|NCT00848549|466129553|FG001|E2090-E044-314 (Extension Study)|Other|6|||
129502561|NCT02106455|466129557|FG000|Overall Study|Case Report Form Uncollected|6|||
129502562|NCT02106455|466129557|FG000|Overall Study|Protocol Deviation|2|||
129502563|NCT01576016|466129558|FG000|Lead Safety|Death|132|||
129502564|NCT01576016|466129559|FG001|Lead Safety|Death|0|||
129502565|NCT01576016|466129558|FG000|Lead Safety|Withdrawal by Subject|81|||
129502566|NCT01576016|466129559|FG001|Lead Safety|Withdrawal by Subject|0|||
129502567|NCT01576016|466129558|FG000|Lead Safety|System Explanted without Replacement|24|||
129502568|NCT01576016|466129559|FG001|Lead Safety|System Explanted without Replacement|0|||
129502569|NCT01576016|466129558|FG000|Lead Safety|Physician Decision|14|||
129502570|NCT01576016|466129559|FG001|Lead Safety|Physician Decision|0|||
129502571|NCT01576016|466129558|FG000|Lead Safety|Lost to Follow-up|13|||
129502572|NCT01576016|466129559|FG001|Lead Safety|Lost to Follow-up|0|||
129502573|NCT01576016|466129558|FG000|Lead Safety|Unsuccessful implant|2|||
129502574|NCT01576016|466129559|FG001|Lead Safety|Unsuccessful implant|0|||
129502575|NCT01576016|466129558|FG000|Lead Safety|Sponsor request|1|||
129502576|NCT01576016|466129559|FG001|Lead Safety|Sponsor request|0|||
129502577|NCT01576016|466129558|FG000|Lead Safety|Device replaced with CRT-D|1|||
129502578|NCT01576016|466129559|FG001|Lead Safety|Device replaced with CRT-D|0|||
129502579|NCT01576016|466129558|FG000|Lead Safety|Patient on Palliative Care|1|||
129502580|NCT01576016|466129559|FG001|Lead Safety|Patient on Palliative Care|0|||
129502581|NCT01576016|466129558|FG000|Lead Safety|Patient noncompliance|1|||
129502582|NCT01576016|466129559|FG001|Lead Safety|Patient noncompliance|0|||
129502583|NCT01576016|466129558|FG000|Lead Safety|Too far from study site|1|||
129502584|NCT01576016|466129559|FG001|Lead Safety|Too far from study site|0|||
129502585|NCT01576016|466129558|FG000|Lead Safety|System deactivated|1|||
129502586|NCT01576016|466129559|FG001|Lead Safety|System deactivated|0|||
129502587|NCT01576016|466129558|FG000|Lead Safety|Patient no longer followed by study PI|1|||
129502588|NCT01576016|466129559|FG001|Lead Safety|Patient no longer followed by study PI|0|||
129502589|NCT01576016|466129558|FG000|MRI Safety|Withdrawal by Subject|0|||
129502590|NCT01576016|466129559|FG001|MRI Safety|Withdrawal by Subject|10|||
129502591|NCT01576016|466129558|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
129502592|NCT01576016|466129559|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
129502593|NCT01576016|466129558|FG000|MRI Safety|Has not yet completed MRI scan|0|||
129502594|NCT01576016|466129559|FG001|MRI Safety|Has not yet completed MRI scan|56|||
129502595|NCT01576016|466129558|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
129502596|NCT01576016|466129559|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
129502597|NCT02488551|466129562|FG000|Overall Study|Lost to Follow-up|4|||
129502598|NCT02488551|466129563|FG001|Overall Study|Lost to Follow-up|7|||
129502599|NCT02488551|466129564|FG002|Overall Study|Lost to Follow-up|0|||
129502600|NCT02488551|466129565|FG003|Overall Study|Lost to Follow-up|0|||
129502601|NCT02488551|466129562|FG000|Overall Study|Military Deployment|1|||
129502602|NCT02488551|466129563|FG001|Overall Study|Military Deployment|1|||
129502603|NCT02488551|466129564|FG002|Overall Study|Military Deployment|0|||
129502604|NCT02488551|466129565|FG003|Overall Study|Military Deployment|0|||
129502605|NCT03364608|466129568|FG000|Overall Study|Withdrawal by Subject|4|||
129502606|NCT03364608|466129568|FG000|Overall Study|Protocol Violation|2|||
129502607|NCT03364608|466129568|FG000|Overall Study|Lost to Follow-up|2|||
129502608|NCT00436566|466129575|FG000|Overall Study|Withdrawal by Subject|2|||
129502609|NCT00436566|466129575|FG000|Overall Study|Protocol Violation|1|||
129502610|NCT01188564|466129578|FG000|Double-blind Phase|randomized not treated|1|||
129502611|NCT01188564|466129579|FG001|Double-blind Phase|randomized not treated|0|||
129502612|NCT03888391|466129586|FG000|Overall Study|Lost to Follow-up|15|||
129502613|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
129502614|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502615|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502616|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502617|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502618|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502619|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502620|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502621|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129502622|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
129502623|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502624|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502625|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502626|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502627|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502628|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502629|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502630|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129502631|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
129502632|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502633|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502634|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502635|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502636|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502637|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502638|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502639|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129502640|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
129502641|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502642|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502643|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502644|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
129982066|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
129502645|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502646|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502647|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502648|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
129502649|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
129502650|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502651|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502652|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502653|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502654|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502655|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502656|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502657|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129502658|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
129502659|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502660|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502661|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502662|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502663|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502664|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502665|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502666|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129502667|NCT02175771|466129587|FG000|Run-In Period (Pre-assignment)|Other|8|||
129502668|NCT02175771|466129588|FG001|Run-In Period (Pre-assignment)|Other|0|||
129502669|NCT02175771|466129589|FG002|Run-In Period (Pre-assignment)|Other|0|||
129502670|NCT02175771|466129590|FG003|Run-In Period (Pre-assignment)|Other|0|||
129502671|NCT02175771|466129591|FG004|Run-In Period (Pre-assignment)|Other|0|||
129502672|NCT02175771|466129592|FG005|Run-In Period (Pre-assignment)|Other|0|||
129502673|NCT02175771|466129593|FG006|Run-In Period (Pre-assignment)|Other|0|||
129502674|NCT02175771|466129594|FG007|Run-In Period (Pre-assignment)|Other|0|||
129502675|NCT02175771|466129595|FG008|Run-In Period (Pre-assignment)|Other|0|||
129502676|NCT02175771|466129587|FG000|Treatment Period|Adverse Event|0|||
129502677|NCT02175771|466129588|FG001|Treatment Period|Adverse Event|2|||
129502678|NCT02175771|466129589|FG002|Treatment Period|Adverse Event|1|||
129502679|NCT02175771|466129590|FG003|Treatment Period|Adverse Event|1|||
129502680|NCT02175771|466129591|FG004|Treatment Period|Adverse Event|1|||
129502681|NCT02175771|466129592|FG005|Treatment Period|Adverse Event|3|||
129502682|NCT02175771|466129593|FG006|Treatment Period|Adverse Event|2|||
129502683|NCT02175771|466129594|FG007|Treatment Period|Adverse Event|0|||
129502684|NCT02175771|466129595|FG008|Treatment Period|Adverse Event|1|||
129502685|NCT02175771|466129587|FG000|Treatment Period|Withdrawal by Subject|0|||
129502686|NCT02175771|466129588|FG001|Treatment Period|Withdrawal by Subject|9|||
129502687|NCT02175771|466129589|FG002|Treatment Period|Withdrawal by Subject|3|||
129502688|NCT02175771|466129590|FG003|Treatment Period|Withdrawal by Subject|6|||
129502689|NCT02175771|466129591|FG004|Treatment Period|Withdrawal by Subject|2|||
129502690|NCT02175771|466129592|FG005|Treatment Period|Withdrawal by Subject|4|||
129502691|NCT02175771|466129593|FG006|Treatment Period|Withdrawal by Subject|2|||
129502692|NCT02175771|466129594|FG007|Treatment Period|Withdrawal by Subject|9|||
129502693|NCT02175771|466129595|FG008|Treatment Period|Withdrawal by Subject|2|||
129502694|NCT02175771|466129587|FG000|Treatment Period|Noncompliance|0|||
129502695|NCT02175771|466129588|FG001|Treatment Period|Noncompliance|1|||
129502696|NCT02175771|466129589|FG002|Treatment Period|Noncompliance|2|||
129502697|NCT02175771|466129590|FG003|Treatment Period|Noncompliance|0|||
129502698|NCT02175771|466129591|FG004|Treatment Period|Noncompliance|0|||
129502699|NCT02175771|466129592|FG005|Treatment Period|Noncompliance|0|||
129502700|NCT02175771|466129593|FG006|Treatment Period|Noncompliance|0|||
129502701|NCT02175771|466129594|FG007|Treatment Period|Noncompliance|0|||
129502702|NCT02175771|466129595|FG008|Treatment Period|Noncompliance|1|||
129502703|NCT02175771|466129587|FG000|Treatment Period|Protocol Violation|0|||
129502704|NCT02175771|466129588|FG001|Treatment Period|Protocol Violation|0|||
129502705|NCT02175771|466129589|FG002|Treatment Period|Protocol Violation|0|||
129502706|NCT02175771|466129590|FG003|Treatment Period|Protocol Violation|0|||
129502707|NCT02175771|466129591|FG004|Treatment Period|Protocol Violation|0|||
129502708|NCT02175771|466129592|FG005|Treatment Period|Protocol Violation|0|||
129502709|NCT02175771|466129593|FG006|Treatment Period|Protocol Violation|0|||
129502710|NCT02175771|466129594|FG007|Treatment Period|Protocol Violation|1|||
129502711|NCT02175771|466129595|FG008|Treatment Period|Protocol Violation|0|||
129502712|NCT02175771|466129587|FG000|Treatment Period|Disease progression|0|||
129502713|NCT02175771|466129588|FG001|Treatment Period|Disease progression|0|||
129502714|NCT02175771|466129589|FG002|Treatment Period|Disease progression|0|||
129502715|NCT02175771|466129590|FG003|Treatment Period|Disease progression|0|||
129502716|NCT02175771|466129591|FG004|Treatment Period|Disease progression|0|||
129502717|NCT02175771|466129592|FG005|Treatment Period|Disease progression|0|||
129502718|NCT02175771|466129593|FG006|Treatment Period|Disease progression|0|||
129502719|NCT02175771|466129594|FG007|Treatment Period|Disease progression|2|||
129502720|NCT02175771|466129595|FG008|Treatment Period|Disease progression|0|||
129502721|NCT02175771|466129587|FG000|Treatment Period|Lost to Follow-up|0|||
129502722|NCT02175771|466129588|FG001|Treatment Period|Lost to Follow-up|3|||
129502723|NCT02175771|466129589|FG002|Treatment Period|Lost to Follow-up|1|||
129502724|NCT02175771|466129590|FG003|Treatment Period|Lost to Follow-up|3|||
129502725|NCT02175771|466129591|FG004|Treatment Period|Lost to Follow-up|1|||
129502726|NCT02175771|466129592|FG005|Treatment Period|Lost to Follow-up|2|||
129502727|NCT02175771|466129593|FG006|Treatment Period|Lost to Follow-up|1|||
129502728|NCT02175771|466129594|FG007|Treatment Period|Lost to Follow-up|2|||
129502729|NCT02175771|466129595|FG008|Treatment Period|Lost to Follow-up|2|||
129502730|NCT02175771|466129587|FG000|Treatment Period|Lack of Efficacy|0|||
129502731|NCT02175771|466129588|FG001|Treatment Period|Lack of Efficacy|0|||
129502732|NCT02175771|466129589|FG002|Treatment Period|Lack of Efficacy|0|||
129502733|NCT02175771|466129590|FG003|Treatment Period|Lack of Efficacy|0|||
129502734|NCT02175771|466129591|FG004|Treatment Period|Lack of Efficacy|0|||
129502735|NCT02175771|466129592|FG005|Treatment Period|Lack of Efficacy|1|||
129502736|NCT02175771|466129593|FG006|Treatment Period|Lack of Efficacy|0|||
129502737|NCT02175771|466129594|FG007|Treatment Period|Lack of Efficacy|1|||
129502738|NCT02175771|466129595|FG008|Treatment Period|Lack of Efficacy|0|||
129502739|NCT02175771|466129587|FG000|Treatment Period|Other|0|||
129502740|NCT02175771|466129588|FG001|Treatment Period|Other|1|||
129502741|NCT02175771|466129589|FG002|Treatment Period|Other|0|||
129502742|NCT02175771|466129590|FG003|Treatment Period|Other|3|||
129502743|NCT02175771|466129591|FG004|Treatment Period|Other|1|||
129502744|NCT02175771|466129592|FG005|Treatment Period|Other|0|||
129502745|NCT02175771|466129593|FG006|Treatment Period|Other|0|||
129502746|NCT02175771|466129594|FG007|Treatment Period|Other|2|||
129502747|NCT02175771|466129595|FG008|Treatment Period|Other|0|||
129502748|NCT02232087|466129596|FG000|Overall Study|Withdrawal by Subject|2|||
129502749|NCT02232087|466129597|FG001|Overall Study|Withdrawal by Subject|0|||
129502750|NCT02232087|466129598|FG002|Overall Study|Withdrawal by Subject|0|||
129502751|NCT02232087|466129599|FG003|Overall Study|Withdrawal by Subject|0|||
129502752|NCT02232087|466129600|FG004|Overall Study|Withdrawal by Subject|0|||
129502753|NCT02232087|466129601|FG005|Overall Study|Withdrawal by Subject|1|||
129502754|NCT02232087|466129596|FG000|Overall Study|poor inhalation technique|0|||
129502755|NCT02232087|466129597|FG001|Overall Study|poor inhalation technique|1|||
129502756|NCT02232087|466129598|FG002|Overall Study|poor inhalation technique|0|||
129502757|NCT02232087|466129599|FG003|Overall Study|poor inhalation technique|0|||
129502758|NCT02232087|466129600|FG004|Overall Study|poor inhalation technique|0|||
129502759|NCT02232087|466129601|FG005|Overall Study|poor inhalation technique|2|||
129502760|NCT02232087|466129596|FG000|Overall Study|protocol stop criteria|0|||
129502761|NCT02232087|466129597|FG001|Overall Study|protocol stop criteria|1|||
129502762|NCT02232087|466129598|FG002|Overall Study|protocol stop criteria|0|||
129502763|NCT02232087|466129599|FG003|Overall Study|protocol stop criteria|1|||
129502764|NCT02232087|466129600|FG004|Overall Study|protocol stop criteria|0|||
129502765|NCT02232087|466129601|FG005|Overall Study|protocol stop criteria|0|||
129502766|NCT02232087|466129596|FG000|Overall Study|Adverse Event|0|||
129502767|NCT02232087|466129597|FG001|Overall Study|Adverse Event|0|||
129502768|NCT02232087|466129598|FG002|Overall Study|Adverse Event|0|||
129502769|NCT02232087|466129599|FG003|Overall Study|Adverse Event|0|||
129502770|NCT02232087|466129600|FG004|Overall Study|Adverse Event|1|||
129502771|NCT02232087|466129601|FG005|Overall Study|Adverse Event|0|||
129502772|NCT04069156|466129602|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
129502773|NCT04069156|466129603|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
129502774|NCT04069156|466129602|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
129502775|NCT04069156|466129603|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
129502776|NCT04069156|466129602|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
129502777|NCT04069156|466129603|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
129502778|NCT04069156|466129602|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
129982067|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
129502779|NCT04069156|466129603|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
129502780|NCT01088438|466129621|FG000|Overall Study|Withdrawal by Subject|11|||
129502781|NCT01088438|466129622|FG001|Overall Study|Withdrawal by Subject|6|||
129502782|NCT01088438|466129621|FG000|Overall Study|Lost to Follow-up|18|||
129502783|NCT01088438|466129622|FG001|Overall Study|Lost to Follow-up|30|||
129502784|NCT00511342|466129623|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
129502785|NCT00511342|466129624|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
129502786|NCT00511342|466129623|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
129502787|NCT00511342|466129624|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
129502788|NCT00511342|466129623|FG000|Overall Study|Pregnancy|0|||
129502789|NCT00511342|466129624|FG001|Overall Study|Pregnancy|1|||
129502790|NCT00511342|466129623|FG000|Overall Study|Pregnancy wish|0|||
129502791|NCT00511342|466129624|FG001|Overall Study|Pregnancy wish|1|||
129502792|NCT00511342|466129623|FG000|Overall Study|Lost to Follow-up|1|||
129502793|NCT00511342|466129624|FG001|Overall Study|Lost to Follow-up|5|||
129502794|NCT00511342|466129623|FG000|Overall Study|Other Reason|2|||
129502795|NCT00511342|466129624|FG001|Overall Study|Other Reason|2|||
129502796|NCT03628508|466129626|FG000|Overall Study|Lost to Follow-up|1|||
129502797|NCT01072539|466129628|FG000|Overall Study|Treated prior to the Site Initiation|1|||
129502798|NCT01072539|466129628|FG000|Overall Study|Protocol Violation|2|||
129502799|NCT00115804|466129629|FG000|Overall Study|Adverse Event|2|||
129502800|NCT01752842|466129630|FG000|Overall Study|Adverse Event|3|||
129502801|NCT01752842|466129631|FG001|Overall Study|Adverse Event|0|||
129502802|NCT01752842|466129630|FG000|Overall Study|Withdrawal by Subject|0|||
129502803|NCT01752842|466129631|FG001|Overall Study|Withdrawal by Subject|2|||
129502804|NCT01683071|466129632|FG000|Part 1|Lack of Efficacy|1|||
129502805|NCT01683071|466129633|FG001|Part 1|Lack of Efficacy|0|||
129502806|NCT01683071|466129634|FG002|Part 1|Lack of Efficacy|0|||
129502807|NCT01683071|466129635|FG003|Part 1|Lack of Efficacy|3|||
129502808|NCT01683071|466129636|FG004|Part 1|Lack of Efficacy|0|||
129502809|NCT01683071|466129637|FG005|Part 1|Lack of Efficacy|0|||
129502810|NCT01683071|466129632|FG000|Part 1|Withdrawal by Subject|1|||
129502811|NCT01683071|466129633|FG001|Part 1|Withdrawal by Subject|2|||
129502812|NCT01683071|466129634|FG002|Part 1|Withdrawal by Subject|2|||
129502813|NCT01683071|466129635|FG003|Part 1|Withdrawal by Subject|1|||
129502814|NCT01683071|466129636|FG004|Part 1|Withdrawal by Subject|0|||
129502815|NCT01683071|466129637|FG005|Part 1|Withdrawal by Subject|0|||
129502816|NCT01683071|466129632|FG000|Part 1|Surgery Cancelled|1|||
129502817|NCT01683071|466129633|FG001|Part 1|Surgery Cancelled|0|||
129502818|NCT01683071|466129634|FG002|Part 1|Surgery Cancelled|0|||
129502819|NCT01683071|466129635|FG003|Part 1|Surgery Cancelled|0|||
129502820|NCT01683071|466129636|FG004|Part 1|Surgery Cancelled|0|||
129502821|NCT01683071|466129637|FG005|Part 1|Surgery Cancelled|0|||
129502822|NCT01683071|466129632|FG000|Part 1|Did not receive study drug|1|||
129502823|NCT01683071|466129633|FG001|Part 1|Did not receive study drug|0|||
129502824|NCT01683071|466129634|FG002|Part 1|Did not receive study drug|0|||
129502825|NCT01683071|466129635|FG003|Part 1|Did not receive study drug|1|||
129502826|NCT01683071|466129636|FG004|Part 1|Did not receive study drug|0|||
129502827|NCT01683071|466129637|FG005|Part 1|Did not receive study drug|0|||
129502828|NCT01683071|466129632|FG000|Part 1|Early termination; met exclusion criteria|0|||
129502829|NCT01683071|466129633|FG001|Part 1|Early termination; met exclusion criteria|2|||
129502830|NCT01683071|466129634|FG002|Part 1|Early termination; met exclusion criteria|1|||
129502831|NCT01683071|466129635|FG003|Part 1|Early termination; met exclusion criteria|0|||
129502832|NCT01683071|466129636|FG004|Part 1|Early termination; met exclusion criteria|0|||
129502833|NCT01683071|466129637|FG005|Part 1|Early termination; met exclusion criteria|0|||
129502834|NCT01683071|466129632|FG000|Part 2|Lack of Efficacy|0|||
129502835|NCT01683071|466129633|FG001|Part 2|Lack of Efficacy|0|||
129502836|NCT01683071|466129634|FG002|Part 2|Lack of Efficacy|0|||
129502837|NCT01683071|466129635|FG003|Part 2|Lack of Efficacy|0|||
129502838|NCT01683071|466129636|FG004|Part 2|Lack of Efficacy|3|||
129502839|NCT01683071|466129637|FG005|Part 2|Lack of Efficacy|4|||
129502840|NCT01683071|466129632|FG000|Part 2|Lost to Follow-up|0|||
129502841|NCT01683071|466129633|FG001|Part 2|Lost to Follow-up|0|||
129502842|NCT01683071|466129634|FG002|Part 2|Lost to Follow-up|0|||
129502843|NCT01683071|466129635|FG003|Part 2|Lost to Follow-up|0|||
129502844|NCT01683071|466129636|FG004|Part 2|Lost to Follow-up|2|||
129502845|NCT01683071|466129637|FG005|Part 2|Lost to Follow-up|0|||
129502846|NCT01683071|466129632|FG000|Part 2|Withdrawal by Subject|0|||
129502847|NCT01683071|466129633|FG001|Part 2|Withdrawal by Subject|0|||
129502848|NCT01683071|466129634|FG002|Part 2|Withdrawal by Subject|0|||
129502849|NCT01683071|466129635|FG003|Part 2|Withdrawal by Subject|0|||
129502850|NCT01683071|466129636|FG004|Part 2|Withdrawal by Subject|3|||
129502851|NCT01683071|466129637|FG005|Part 2|Withdrawal by Subject|3|||
129502852|NCT01683071|466129632|FG000|Part 2|Surgery cancelled|0|||
129502853|NCT01683071|466129633|FG001|Part 2|Surgery cancelled|0|||
129502854|NCT01683071|466129634|FG002|Part 2|Surgery cancelled|0|||
129502855|NCT01683071|466129635|FG003|Part 2|Surgery cancelled|0|||
129502856|NCT01683071|466129636|FG004|Part 2|Surgery cancelled|4|||
129502857|NCT01683071|466129637|FG005|Part 2|Surgery cancelled|2|||
129502858|NCT01683071|466129632|FG000|Part 2|Did not receive study drug|0|||
129502859|NCT01683071|466129633|FG001|Part 2|Did not receive study drug|0|||
129502860|NCT01683071|466129634|FG002|Part 2|Did not receive study drug|0|||
129502861|NCT01683071|466129635|FG003|Part 2|Did not receive study drug|0|||
129502862|NCT01683071|466129636|FG004|Part 2|Did not receive study drug|2|||
129502863|NCT01683071|466129637|FG005|Part 2|Did not receive study drug|1|||
129502864|NCT01683071|466129632|FG000|Part 2|Met exclusion criterion|0|||
129502865|NCT01683071|466129633|FG001|Part 2|Met exclusion criterion|0|||
129502866|NCT01683071|466129634|FG002|Part 2|Met exclusion criterion|0|||
129502867|NCT01683071|466129635|FG003|Part 2|Met exclusion criterion|0|||
129502868|NCT01683071|466129636|FG004|Part 2|Met exclusion criterion|1|||
129502869|NCT01683071|466129637|FG005|Part 2|Met exclusion criterion|1|||
129502870|NCT01683071|466129632|FG000|Part 2|Protocol deviation|0|||
129502871|NCT01683071|466129633|FG001|Part 2|Protocol deviation|0|||
129502872|NCT01683071|466129634|FG002|Part 2|Protocol deviation|0|||
129502873|NCT01683071|466129635|FG003|Part 2|Protocol deviation|0|||
129502874|NCT01683071|466129636|FG004|Part 2|Protocol deviation|1|||
129502875|NCT01683071|466129637|FG005|Part 2|Protocol deviation|2|||
129502876|NCT01683071|466129632|FG000|Part 2|Withdrawal by investigator decision|0|||
129539068|NCT02708524|466265144|FG000|Overall Study|Lost to Follow-up|1|||
129502877|NCT01683071|466129633|FG001|Part 2|Withdrawal by investigator decision|0|||
129502878|NCT01683071|466129634|FG002|Part 2|Withdrawal by investigator decision|0|||
129502879|NCT01683071|466129635|FG003|Part 2|Withdrawal by investigator decision|0|||
129502880|NCT01683071|466129636|FG004|Part 2|Withdrawal by investigator decision|1|||
129502881|NCT01683071|466129637|FG005|Part 2|Withdrawal by investigator decision|2|||
129502882|NCT01968187|466129640|FG000|Overall Study|Adverse Event|0|||
129502883|NCT01968187|466129641|FG001|Overall Study|Adverse Event|1|||
129502884|NCT01968187|466129640|FG000|Overall Study|Randomized but not treated|1|||
129502885|NCT01968187|466129641|FG001|Overall Study|Randomized but not treated|0|||
129502886|NCT04095286|466129642|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502887|NCT04095286|466129643|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
129502888|NCT04095286|466129644|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502889|NCT04095286|466129645|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502890|NCT04095286|466129646|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502891|NCT04095286|466129647|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502892|NCT04095286|466129642|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
129502893|NCT04095286|466129643|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
129502894|NCT04095286|466129644|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
129502895|NCT04095286|466129645|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
129502896|NCT04095286|466129646|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
129502897|NCT04095286|466129647|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
129502898|NCT04095286|466129642|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
129502899|NCT04095286|466129643|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
129502900|NCT04095286|466129644|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
129502901|NCT04095286|466129645|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
129502902|NCT04095286|466129646|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
129502903|NCT04095286|466129647|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
129502904|NCT04095286|466129642|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502905|NCT04095286|466129643|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502906|NCT04095286|466129644|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
129502907|NCT04095286|466129645|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502908|NCT04095286|466129646|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502909|NCT04095286|466129647|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
129502910|NCT04095286|466129642|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
129502911|NCT04095286|466129643|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
129502912|NCT04095286|466129644|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
129502913|NCT04095286|466129645|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
129502914|NCT04095286|466129646|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
129502915|NCT04095286|466129647|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
129502916|NCT02020031|466131761|FG000|Overall Study|Physician Decision|1|||
129502917|NCT02020031|466131762|FG001|Overall Study|Physician Decision|1|||
129502918|NCT04092816|466131772|FG000|Overall Study|Lost to Follow-up|1|||
129502919|NCT04092816|466131773|FG001|Overall Study|Lost to Follow-up|2|||
129502920|NCT00424528|466131774|FG000|Overall Study|Adverse Event|2|||
129502921|NCT00424528|466131775|FG001|Overall Study|Adverse Event|1|||
129502922|NCT00424528|466131776|FG002|Overall Study|Adverse Event|2|||
129502923|NCT00424528|466131774|FG000|Overall Study|Protocol Violation|1|||
129502924|NCT00424528|466131775|FG001|Overall Study|Protocol Violation|1|||
129502925|NCT00424528|466131776|FG002|Overall Study|Protocol Violation|0|||
129502926|NCT00424528|466131774|FG000|Overall Study|Lost to Follow-up|0|||
129502927|NCT00424528|466131775|FG001|Overall Study|Lost to Follow-up|1|||
129502928|NCT00424528|466131776|FG002|Overall Study|Lost to Follow-up|0|||
129502929|NCT00424528|466131774|FG000|Overall Study|noncompliance with study requirements|2|||
129502930|NCT00424528|466131775|FG001|Overall Study|noncompliance with study requirements|1|||
129502931|NCT00424528|466131776|FG002|Overall Study|noncompliance with study requirements|2|||
129502932|NCT00967226|466131778|FG000|Overall Study|Adverse Event|0|||
129502933|NCT00967226|466131779|FG001|Overall Study|Adverse Event|5|||
129502934|NCT00967226|466131778|FG000|Overall Study|Protocol Violation|2|||
129502935|NCT00967226|466131779|FG001|Overall Study|Protocol Violation|0|||
129502936|NCT00967226|466131778|FG000|Overall Study|Physician Decision|0|||
129502937|NCT00967226|466131779|FG001|Overall Study|Physician Decision|1|||
129502938|NCT00296725|466131782|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
129502939|NCT00296725|466131782|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
129982068|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129982069|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129982070|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129502940|NCT00296725|466131782|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
129502941|NCT00333619|466131783|FG000|Overall Study|Death|12|||
129982071|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129502942|NCT00333619|466131784|FG001|Overall Study|Death|6|||
129502943|NCT00333619|466131783|FG000|Overall Study|Withdrawal by Subject|6|||
129502944|NCT00333619|466131784|FG001|Overall Study|Withdrawal by Subject|1|||
129502945|NCT00333619|466131783|FG000|Overall Study|Lost to Follow-up|3|||
129502946|NCT00333619|466131784|FG001|Overall Study|Lost to Follow-up|3|||
129502947|NCT01626352|466131785|FG000|Overall Study|Disease Progression|3|||
129502948|NCT01626352|466131785|FG000|Overall Study|Intercurrent Illness|2|||
129502949|NCT01626352|466131785|FG000|Overall Study|Death|2|||
129502950|NCT01626352|466131785|FG000|Overall Study|Withdrawal by Subject|1|||
129502951|NCT01626352|466131785|FG000|Overall Study|Non-Compliance|1|||
129502952|NCT01626352|466131785|FG000|Overall Study|Never Treated|1|||
129502953|NCT02338492|466131792|FG000|Overall Study|Death|32|||
129502954|NCT02338492|466131792|FG000|Overall Study|Adverse Event|3|||
129502955|NCT02338492|466131792|FG000|Overall Study|Lost to Follow-up|4|||
129502956|NCT02338492|466131792|FG000|Overall Study|Reason not captured above|6|||
129502957|NCT01071096|466131793|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
129502958|NCT01071096|466131794|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
129502959|NCT03421964|466131800|FG000|Overall Study|Lost to Follow-up|11|||
129502960|NCT03421964|466131801|FG001|Overall Study|Lost to Follow-up|21|||
129502961|NCT03421964|466131800|FG000|Overall Study|Withdrawal by Subject|9|||
129502962|NCT03421964|466131801|FG001|Overall Study|Withdrawal by Subject|3|||
129502963|NCT03421964|466131800|FG000|Overall Study|Incarcerated|1|||
129502964|NCT03421964|466131801|FG001|Overall Study|Incarcerated|0|||
129502965|NCT03421964|466131800|FG000|Overall Study|Inpt Treatment Facility|1|||
129502966|NCT03421964|466131801|FG001|Overall Study|Inpt Treatment Facility|1|||
129502967|NCT03421964|466131800|FG000|Overall Study|Virtual Platform Issues|1|||
129502968|NCT03421964|466131801|FG001|Overall Study|Virtual Platform Issues|1|||
129502969|NCT00229203|466131802|FG000|Overall Study|Progressive disease|18|||
129502970|NCT00229203|466131803|FG001|Overall Study|Progressive disease|9|||
129502971|NCT00229203|466131802|FG000|Overall Study|Toxicity|6|||
129502972|NCT00229203|466131803|FG001|Overall Study|Toxicity|1|||
129502973|NCT00229203|466131802|FG000|Overall Study|Death|4|||
129502974|NCT00229203|466131803|FG001|Overall Study|Death|2|||
129502975|NCT00229203|466131802|FG000|Overall Study|Other|3|||
129502976|NCT00229203|466131803|FG001|Overall Study|Other|3|||
129502977|NCT00229203|466131802|FG000|Overall Study|Withdrawal by Subject|1|||
129502978|NCT00229203|466131803|FG001|Overall Study|Withdrawal by Subject|4|||
129502979|NCT03607838|466131804|FG000|Overall Study|Lack of Efficacy|14|||
129502980|NCT03607838|466131805|FG001|Overall Study|Lack of Efficacy|20|||
129502981|NCT03607838|466131804|FG000|Overall Study|Withdrawal by Subject|13|||
129502982|NCT03607838|466131805|FG001|Overall Study|Withdrawal by Subject|8|||
129502983|NCT03607838|466131804|FG000|Overall Study|Lost to Follow-up|6|||
129502984|NCT03607838|466131805|FG001|Overall Study|Lost to Follow-up|11|||
129502985|NCT03607838|466131804|FG000|Overall Study|Adverse Event|2|||
129502986|NCT03607838|466131805|FG001|Overall Study|Adverse Event|2|||
129502987|NCT03607838|466131804|FG000|Overall Study|Physician Decision|2|||
129502988|NCT03607838|466131805|FG001|Overall Study|Physician Decision|0|||
129502989|NCT03607838|466131804|FG000|Overall Study|Failure to meet randomization criteria|1|||
129502990|NCT03607838|466131805|FG001|Overall Study|Failure to meet randomization criteria|2|||
129502991|NCT03607838|466131804|FG000|Overall Study|Pregnancy|1|||
129502992|NCT03607838|466131805|FG001|Overall Study|Pregnancy|0|||
129502993|NCT03607838|466131804|FG000|Overall Study|Protocol Violation|1|||
129502994|NCT03607838|466131805|FG001|Overall Study|Protocol Violation|0|||
129502995|NCT03607838|466131804|FG000|Overall Study|Due to work|1|||
129502996|NCT03607838|466131805|FG001|Overall Study|Due to work|0|||
129502997|NCT03607838|466131804|FG000|Overall Study|Litigation|0|||
129502998|NCT03607838|466131805|FG001|Overall Study|Litigation|1|||
129502999|NCT03607838|466131804|FG000|Overall Study|Temperature excursion for study drug|0|||
129503000|NCT03607838|466131805|FG001|Overall Study|Temperature excursion for study drug|1|||
129503001|NCT03607838|466131804|FG000|Overall Study|Change of mind|0|||
129503002|NCT03607838|466131805|FG001|Overall Study|Change of mind|1|||
129982072|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
129503003|NCT02546674|466131806|FG000|Overall Study|Adverse Event|19|||
129503004|NCT02546674|466131806|FG000|Overall Study|Death|1|||
129503005|NCT02546674|466131806|FG000|Overall Study|Lost to Follow-up|1|||
129503006|NCT02546674|466131806|FG000|Overall Study|Physician Decision|13|||
129503007|NCT02546674|466131806|FG000|Overall Study|Pregnancy|1|||
129503008|NCT02546674|466131806|FG000|Overall Study|Progressive Disease|2|||
129503009|NCT02546674|466131806|FG000|Overall Study|Protocol Deviation|2|||
129503010|NCT02546674|466131806|FG000|Overall Study|Subject/Guardian Decision|6|||
129503011|NCT02546674|466131806|FG000|Overall Study|Withdrawal of Informed Consent|3|||
129503012|NCT01163253|466131807|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
129503013|NCT01163253|466131808|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
129503014|NCT01163253|466131807|FG000|Overall Study|Study Terminated by Sponsor|978|||
129503015|NCT01163253|466131808|FG001|Overall Study|Study Terminated by Sponsor|349|||
129503016|NCT01163253|466131807|FG000|Overall Study|Protocol Violation|43|||
129503017|NCT01163253|466131808|FG001|Overall Study|Protocol Violation|12|||
129503018|NCT01163253|466131807|FG000|Overall Study|Withdrawal by Subject|199|||
129503019|NCT01163253|466131808|FG001|Overall Study|Withdrawal by Subject|50|||
129503020|NCT01163253|466131807|FG000|Overall Study|Medication Error|1|||
129503021|NCT01163253|466131808|FG001|Overall Study|Medication Error|0|||
129503022|NCT01163253|466131807|FG000|Overall Study|Lost to Follow-up|125|||
129503023|NCT01163253|466131808|FG001|Overall Study|Lost to Follow-up|23|||
129503024|NCT01163253|466131807|FG000|Overall Study|Insufficient Clinical Response|423|||
129503025|NCT01163253|466131808|FG001|Overall Study|Insufficient Clinical Response|29|||
129503026|NCT01163253|466131807|FG000|Overall Study|Adverse Event|300|||
129503027|NCT01163253|466131808|FG001|Overall Study|Adverse Event|78|||
129503028|NCT01163253|466131807|FG000|Overall Study|Death|17|||
129503029|NCT01163253|466131808|FG001|Overall Study|Death|5|||
129503030|NCT01163253|466131807|FG000|Overall Study|Ongoing|13|||
129503031|NCT01163253|466131808|FG001|Overall Study|Ongoing|4|||
129503032|NCT01163253|466131807|FG000|Overall Study|Other Unspecified|170|||
129503033|NCT01163253|466131808|FG001|Overall Study|Other Unspecified|34|||
129503034|NCT02492997|466131809|FG000|Overall Study|Withdrawal by Subject|1|||
129503035|NCT02492997|466131810|FG001|Overall Study|Withdrawal by Subject|0|||
129503036|NCT02492997|466131809|FG000|Overall Study|Gained Weight|1|||
129503037|NCT02492997|466131810|FG001|Overall Study|Gained Weight|0|||
129503038|NCT02492997|466131809|FG000|Overall Study|Lost to Follow-up|0|||
129503039|NCT02492997|466131810|FG001|Overall Study|Lost to Follow-up|1|||
129503040|NCT00423735|466131811|FG000|Overall Study|Ineligible / No protocol treatment|8|||
129503041|NCT00423735|466131812|FG001|Overall Study|Ineligible / No protocol treatment|6|||
129503042|NCT00423735|466131813|FG002|Overall Study|Ineligible / No protocol treatment|0|||
129503043|NCT02864940|466131814|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
129503044|NCT02864940|466131815|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
129503045|NCT00579501|466131820|FG000|Overall Study|Death|1|||
129503046|NCT00579501|466131820|FG000|Overall Study|End of neoadjuvant therapy|25|||
129503047|NCT00579501|466131820|FG000|Overall Study|toxicity|1|||
129503048|NCT00579501|466131820|FG000|Overall Study|Secondary lesion|1|||
129503049|NCT00579501|466131820|FG000|Overall Study|Radiation therapy before surgery|1|||
129503050|NCT03364673|466131821|FG000|Overall Study|Withdrawal by Subject|2|||
129503051|NCT03364673|466131821|FG000|Overall Study|Injury unrelated to study|3|||
129503052|NCT03025217|466131822|FG000|Overall Study|Pregnancy|1|||
129503053|NCT03025217|466131822|FG000|Overall Study|Lost to Follow-up|1|||
129503054|NCT03025217|466131822|FG000|Overall Study|Not eligible, poor English|2|||
129503055|NCT02208024|466131823|FG000|Overall Study|Withdrawal by Subject|1|||
129503056|NCT04096326|466131824|FG000|Overall Study|Withdrawal by Subject|0|||
129503057|NCT04096326|466131825|FG001|Overall Study|Withdrawal by Subject|0|||
129503058|NCT04096326|466131826|FG002|Overall Study|Withdrawal by Subject|0|||
129503059|NCT04096326|466131827|FG003|Overall Study|Withdrawal by Subject|0|||
129503060|NCT04096326|466131828|FG004|Overall Study|Withdrawal by Subject|0|||
129503061|NCT04096326|466131829|FG005|Overall Study|Withdrawal by Subject|0|||
129503062|NCT04096326|466131830|FG006|Overall Study|Withdrawal by Subject|1|||
129503063|NCT04096326|466131831|FG007|Overall Study|Withdrawal by Subject|0|||
129503064|NCT04096326|466131832|FG008|Overall Study|Withdrawal by Subject|0|||
129503065|NCT04096326|466131833|FG009|Overall Study|Withdrawal by Subject|0|||
129503066|NCT04096326|466131824|FG000|Overall Study|Lost to Follow-up|0|||
129503067|NCT04096326|466131825|FG001|Overall Study|Lost to Follow-up|1|||
129503068|NCT04096326|466131826|FG002|Overall Study|Lost to Follow-up|0|||
129503069|NCT04096326|466131827|FG003|Overall Study|Lost to Follow-up|0|||
129503070|NCT04096326|466131828|FG004|Overall Study|Lost to Follow-up|0|||
129503071|NCT04096326|466131829|FG005|Overall Study|Lost to Follow-up|0|||
129503072|NCT04096326|466131830|FG006|Overall Study|Lost to Follow-up|0|||
129503073|NCT04096326|466131831|FG007|Overall Study|Lost to Follow-up|0|||
129503074|NCT04096326|466131832|FG008|Overall Study|Lost to Follow-up|0|||
129503075|NCT04096326|466131833|FG009|Overall Study|Lost to Follow-up|0|||
129503076|NCT04096326|466131824|FG000|Overall Study|COVID-19-related reasons|0|||
129503077|NCT04096326|466131825|FG001|Overall Study|COVID-19-related reasons|0|||
129503078|NCT04096326|466131826|FG002|Overall Study|COVID-19-related reasons|0|||
129503079|NCT04096326|466131827|FG003|Overall Study|COVID-19-related reasons|0|||
129503080|NCT04096326|466131828|FG004|Overall Study|COVID-19-related reasons|1|||
129503081|NCT04096326|466131829|FG005|Overall Study|COVID-19-related reasons|5|||
129503082|NCT04096326|466131830|FG006|Overall Study|COVID-19-related reasons|0|||
129503083|NCT04096326|466131831|FG007|Overall Study|COVID-19-related reasons|0|||
129503084|NCT04096326|466131832|FG008|Overall Study|COVID-19-related reasons|0|||
129503085|NCT04096326|466131833|FG009|Overall Study|COVID-19-related reasons|0|||
129503086|NCT00194025|466131834|FG000|Overall Study|Adverse Event|1|||
129503087|NCT00194025|466131834|FG000|Overall Study|non-adherence with study medication|4|||
129503088|NCT04804033|466131838|FG000|Period 1: DBT Phase|Adverse Event|1|||
129503089|NCT04804033|466131839|FG001|Period 1: DBT Phase|Adverse Event|5|||
129503090|NCT04804033|466131840|FG002|Period 1: DBT Phase|Adverse Event|3|||
129503091|NCT04804033|466131841|FG003|Period 1: DBT Phase|Adverse Event|4|||
129503092|NCT04804033|466131838|FG000|Period 1: DBT Phase|Death|1|||
129503093|NCT04804033|466131839|FG001|Period 1: DBT Phase|Death|0|||
129503094|NCT04804033|466131840|FG002|Period 1: DBT Phase|Death|0|||
129503095|NCT04804033|466131841|FG003|Period 1: DBT Phase|Death|0|||
129503096|NCT04804033|466131838|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
129503097|NCT04804033|466131839|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
129503098|NCT04804033|466131840|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
129503099|NCT04804033|466131841|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
129503100|NCT04804033|466131838|FG000|Period 1: DBT Phase|Non-compliance|1|||
129503101|NCT04804033|466131839|FG001|Period 1: DBT Phase|Non-compliance|0|||
129503102|NCT04804033|466131840|FG002|Period 1: DBT Phase|Non-compliance|1|||
129503103|NCT04804033|466131841|FG003|Period 1: DBT Phase|Non-compliance|2|||
129503104|NCT04804033|466131838|FG000|Period 1: DBT Phase|Other|0|||
129503105|NCT04804033|466131839|FG001|Period 1: DBT Phase|Other|1|||
129503106|NCT04804033|466131840|FG002|Period 1: DBT Phase|Other|0|||
129503107|NCT04804033|466131841|FG003|Period 1: DBT Phase|Other|0|||
129503108|NCT04804033|466131838|FG000|Period 1: DBT Phase|Pregnancy|2|||
129503109|NCT04804033|466131839|FG001|Period 1: DBT Phase|Pregnancy|0|||
129503110|NCT04804033|466131840|FG002|Period 1: DBT Phase|Pregnancy|0|||
129503111|NCT04804033|466131841|FG003|Period 1: DBT Phase|Pregnancy|0|||
129503112|NCT04804033|466131838|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
129503113|NCT04804033|466131839|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
129503114|NCT04804033|466131840|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
129503115|NCT04804033|466131841|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
129503116|NCT04804033|466131838|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
129503117|NCT04804033|466131839|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
129503118|NCT04804033|466131840|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
129503119|NCT04804033|466131841|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
129503120|NCT04804033|466131838|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
129503121|NCT04804033|466131839|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
129503122|NCT04804033|466131840|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
129503123|NCT04804033|466131841|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
129503124|NCT04804033|466131838|FG000|Period 2: OLE Phase|Adverse Event|3|||
129503125|NCT04804033|466131839|FG001|Period 2: OLE Phase|Adverse Event|4|||
129503126|NCT04804033|466131840|FG002|Period 2: OLE Phase|Adverse Event|2|||
129503127|NCT04804033|466131841|FG003|Period 2: OLE Phase|Adverse Event|0|||
129503128|NCT04804033|466131838|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
129503129|NCT04804033|466131839|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
129503130|NCT04804033|466131840|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
129503131|NCT04804033|466131841|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
129503132|NCT04804033|466131838|FG000|Period 2: OLE Phase|Non-compliance|2|||
129503133|NCT04804033|466131839|FG001|Period 2: OLE Phase|Non-compliance|2|||
129503134|NCT04804033|466131840|FG002|Period 2: OLE Phase|Non-compliance|0|||
129503135|NCT04804033|466131841|FG003|Period 2: OLE Phase|Non-compliance|1|||
129503136|NCT04804033|466131838|FG000|Period 2: OLE Phase|Other|0|||
129503137|NCT04804033|466131839|FG001|Period 2: OLE Phase|Other|2|||
129503138|NCT04804033|466131840|FG002|Period 2: OLE Phase|Other|0|||
129503139|NCT04804033|466131841|FG003|Period 2: OLE Phase|Other|0|||
129503140|NCT04804033|466131838|FG000|Period 2: OLE Phase|Physician Decision|1|||
129503141|NCT04804033|466131839|FG001|Period 2: OLE Phase|Physician Decision|1|||
129503142|NCT04804033|466131840|FG002|Period 2: OLE Phase|Physician Decision|0|||
129503143|NCT04804033|466131841|FG003|Period 2: OLE Phase|Physician Decision|0|||
129503144|NCT04804033|466131838|FG000|Period 2: OLE Phase|Pregnancy|0|||
129503145|NCT04804033|466131839|FG001|Period 2: OLE Phase|Pregnancy|0|||
129503146|NCT04804033|466131840|FG002|Period 2: OLE Phase|Pregnancy|2|||
129503147|NCT04804033|466131841|FG003|Period 2: OLE Phase|Pregnancy|0|||
129503148|NCT04804033|466131838|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
129503149|NCT04804033|466131839|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
129503150|NCT04804033|466131840|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
129503151|NCT04804033|466131841|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
129503152|NCT04804033|466131838|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
129503153|NCT04804033|466131839|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
129503154|NCT04804033|466131840|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
129503155|NCT04804033|466131841|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
129503156|NCT04804033|466131838|FG000|Period 2: OLE Phase|Not reported|0|||
129503157|NCT04804033|466131839|FG001|Period 2: OLE Phase|Not reported|2|||
129503158|NCT04804033|466131840|FG002|Period 2: OLE Phase|Not reported|0|||
129503159|NCT04804033|466131841|FG003|Period 2: OLE Phase|Not reported|0|||
129503160|NCT04804033|466131838|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
129503161|NCT04804033|466131839|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
129503162|NCT04804033|466131840|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
129503163|NCT04804033|466131841|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
129503164|NCT04804033|466131838|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
129503165|NCT04804033|466131839|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
129503166|NCT04804033|466131840|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
129503167|NCT04804033|466131841|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
129503168|NCT04804033|466131838|FG000|Period 3: Follow-up Phase|Other|0|||
129503169|NCT04804033|466131839|FG001|Period 3: Follow-up Phase|Other|1|||
129503170|NCT04804033|466131840|FG002|Period 3: Follow-up Phase|Other|2|||
129503171|NCT04804033|466131841|FG003|Period 3: Follow-up Phase|Other|1|||
129503172|NCT04804033|466131838|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
129503173|NCT04804033|466131839|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
129503174|NCT04804033|466131840|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
129503175|NCT04804033|466131841|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
129503176|NCT04804033|466131838|FG000|Period 3: Follow-up Phase|Not reported|18|||
129503177|NCT04804033|466131839|FG001|Period 3: Follow-up Phase|Not reported|15|||
129503178|NCT04804033|466131840|FG002|Period 3: Follow-up Phase|Not reported|1|||
129503179|NCT04804033|466131841|FG003|Period 3: Follow-up Phase|Not reported|4|||
129503180|NCT00209170|466131842|FG000|Overall Study|Adverse Event|0|||
129503181|NCT00209170|466131843|FG001|Overall Study|Adverse Event|1|||
129503182|NCT00209170|466131842|FG000|Overall Study|Withdrawal by Subject|2|||
129503183|NCT00209170|466131843|FG001|Overall Study|Withdrawal by Subject|1|||
129503184|NCT00209170|466131842|FG000|Overall Study|Lack of Efficacy|0|||
129503185|NCT00209170|466131843|FG001|Overall Study|Lack of Efficacy|1|||
129503186|NCT00543569|466131844|FG000|Overall Study|Death|2|||
129503187|NCT00543569|466131845|FG001|Overall Study|Death|2|||
129503188|NCT00543569|466131846|FG002|Overall Study|Death|3|||
129503189|NCT00543569|466131847|FG003|Overall Study|Death|1|||
129503190|NCT00543569|466131844|FG000|Overall Study|Lost to Follow-up|0|||
129503191|NCT00543569|466131845|FG001|Overall Study|Lost to Follow-up|0|||
129503192|NCT00543569|466131846|FG002|Overall Study|Lost to Follow-up|1|||
129503193|NCT00543569|466131847|FG003|Overall Study|Lost to Follow-up|1|||
129503194|NCT00543569|466131844|FG000|Overall Study|Miscellaneous Reasons|7|||
129503195|NCT00543569|466131845|FG001|Overall Study|Miscellaneous Reasons|3|||
129503196|NCT00543569|466131846|FG002|Overall Study|Miscellaneous Reasons|11|||
129503197|NCT00543569|466131847|FG003|Overall Study|Miscellaneous Reasons|4|||
129503198|NCT00543569|466131844|FG000|Overall Study|Randomized but never received study drug|3|||
129503199|NCT00543569|466131845|FG001|Overall Study|Randomized but never received study drug|3|||
129503200|NCT00543569|466131846|FG002|Overall Study|Randomized but never received study drug|5|||
129503201|NCT00543569|466131847|FG003|Overall Study|Randomized but never received study drug|3|||
129503202|NCT03150095|466131848|FG000|Overall Study|Death|0|||
129503203|NCT03150095|466131849|FG001|Overall Study|Death|1|||
129503204|NCT03150095|466131848|FG000|Overall Study|Lost to Follow-up|1|||
129503205|NCT03150095|466131849|FG001|Overall Study|Lost to Follow-up|1|||
129503206|NCT03150095|466131848|FG000|Overall Study|Withdrawal by Subject|4|||
129503207|NCT03150095|466131849|FG001|Overall Study|Withdrawal by Subject|0|||
129503208|NCT03150095|466131848|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
129503209|NCT03150095|466131849|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
129503210|NCT02124707|466131850|FG000|Overall Study|Adverse Event|5|||
129503211|NCT02124707|466131850|FG000|Overall Study|Physician Decision|1|||
129503212|NCT02124707|466131850|FG000|Overall Study|Death|1|||
129503213|NCT00089479|466131859|FG000|Overall Study|Death|108|||
129503214|NCT00089479|466131860|FG001|Overall Study|Death|75|||
129503215|NCT00089479|466131859|FG000|Overall Study|Withdrawal by Subject|86|||
129503216|NCT00089479|466131860|FG001|Overall Study|Withdrawal by Subject|107|||
129503217|NCT00089479|466131859|FG000|Overall Study|Lost to Follow-up|137|||
129503218|NCT00089479|466131860|FG001|Overall Study|Lost to Follow-up|107|||
129503219|NCT01124448|466131863|FG000|Overall Study|Lost to Follow-up|0|||
129503220|NCT01124448|466131864|FG001|Overall Study|Lost to Follow-up|3|||
129503221|NCT01124448|466131863|FG000|Overall Study|Protocol Violation|2|||
129503222|NCT01124448|466131864|FG001|Overall Study|Protocol Violation|0|||
129503223|NCT03198754|466131866|FG000|Overall Study|Withdrawal by Subject|5|||
129503224|NCT03198754|466131867|FG001|Overall Study|Withdrawal by Subject|4|||
129503225|NCT03198754|466131866|FG000|Overall Study|Lost to Follow-up|4|||
129503226|NCT03198754|466131867|FG001|Overall Study|Lost to Follow-up|3|||
129503227|NCT03198754|466131866|FG000|Overall Study|Ineligible|2|||
129503228|NCT03198754|466131867|FG001|Overall Study|Ineligible|1|||
129503229|NCT01952730|466131870|FG000|Overall Study|FDA shut down core lab used by study|1|||
129503230|NCT00305253|466131875|FG000|Overall Study|Withdrawal by Subject|0|||
129503231|NCT00305253|466131876|FG001|Overall Study|Withdrawal by Subject|1|||
129503232|NCT05373706|466131880|FG000|Overall Study|Lost to Follow-up|2|||
129503233|NCT05373706|466131881|FG001|Overall Study|Lost to Follow-up|2|||
129503234|NCT01479374|466131886|FG000|Overall Study|Adverse Event|2|||
129503235|NCT01479374|466131887|FG001|Overall Study|Adverse Event|1|||
129503236|NCT01479374|466131888|FG002|Overall Study|Adverse Event|0|||
129503237|NCT01479374|466131886|FG000|Overall Study|Lost to Follow-up|1|||
129503238|NCT01479374|466131887|FG001|Overall Study|Lost to Follow-up|2|||
129503239|NCT01479374|466131888|FG002|Overall Study|Lost to Follow-up|0|||
129503240|NCT01479374|466131886|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
129503241|NCT01479374|466131887|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
129503242|NCT01479374|466131888|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
129503243|NCT01479374|466131886|FG000|Overall Study|Other|0|||
129503244|NCT01479374|466131887|FG001|Overall Study|Other|4|||
129503245|NCT01479374|466131888|FG002|Overall Study|Other|5|||
129503246|NCT01606761|466131889|FG000|Prior to Week 24|Lost to Follow-up|0|||
129503247|NCT01606761|466131890|FG001|Prior to Week 24|Lost to Follow-up|3|||
129503248|NCT01606761|466131891|FG002|Prior to Week 24|Lost to Follow-up|2|||
129503249|NCT01606761|466131892|FG003|Prior to Week 24|Lost to Follow-up|0|||
129503250|NCT01606761|466131893|FG004|Prior to Week 24|Lost to Follow-up|0|||
129503251|NCT01606761|466131889|FG000|Prior to Week 24|Withdrawal by Subject|12|||
129503252|NCT01606761|466131890|FG001|Prior to Week 24|Withdrawal by Subject|10|||
129503253|NCT01606761|466131891|FG002|Prior to Week 24|Withdrawal by Subject|9|||
129503254|NCT01606761|466131892|FG003|Prior to Week 24|Withdrawal by Subject|0|||
129503255|NCT01606761|466131893|FG004|Prior to Week 24|Withdrawal by Subject|0|||
129503256|NCT01606761|466131889|FG000|Prior to Week 24|Adverse Event|11|||
129503257|NCT01606761|466131890|FG001|Prior to Week 24|Adverse Event|18|||
129503258|NCT01606761|466131891|FG002|Prior to Week 24|Adverse Event|22|||
129503259|NCT01606761|466131892|FG003|Prior to Week 24|Adverse Event|0|||
129503260|NCT01606761|466131893|FG004|Prior to Week 24|Adverse Event|0|||
129503261|NCT01606761|466131889|FG000|Prior to Week 24|Lack of Efficacy|15|||
129503262|NCT01606761|466131890|FG001|Prior to Week 24|Lack of Efficacy|14|||
129503263|NCT01606761|466131891|FG002|Prior to Week 24|Lack of Efficacy|8|||
129503264|NCT01606761|466131892|FG003|Prior to Week 24|Lack of Efficacy|0|||
129503265|NCT01606761|466131893|FG004|Prior to Week 24|Lack of Efficacy|0|||
129503266|NCT01606761|466131889|FG000|Prior to Week 24|Physician Decision|0|||
129503267|NCT01606761|466131890|FG001|Prior to Week 24|Physician Decision|3|||
129503268|NCT01606761|466131891|FG002|Prior to Week 24|Physician Decision|1|||
129503269|NCT01606761|466131892|FG003|Prior to Week 24|Physician Decision|0|||
129503270|NCT01606761|466131893|FG004|Prior to Week 24|Physician Decision|0|||
129503271|NCT01606761|466131889|FG000|Prior to Week 24|Other|4|||
129503272|NCT01606761|466131890|FG001|Prior to Week 24|Other|7|||
129503273|NCT01606761|466131891|FG002|Prior to Week 24|Other|5|||
129503274|NCT01606761|466131892|FG003|Prior to Week 24|Other|0|||
129503275|NCT01606761|466131893|FG004|Prior to Week 24|Other|0|||
129503276|NCT01606761|466131889|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
129503277|NCT01606761|466131890|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
129503278|NCT01606761|466131891|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
129503279|NCT01606761|466131892|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
129503280|NCT01606761|466131893|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
129503281|NCT01606761|466131889|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
129503282|NCT01606761|466131890|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
129503283|NCT01606761|466131891|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
129503284|NCT01606761|466131892|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
129503285|NCT01606761|466131893|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
129503286|NCT01606761|466131889|FG000|Week 24 to Week 52|Adverse Event|0|||
129503287|NCT01606761|466131890|FG001|Week 24 to Week 52|Adverse Event|11|||
129503288|NCT01606761|466131891|FG002|Week 24 to Week 52|Adverse Event|14|||
129503289|NCT01606761|466131892|FG003|Week 24 to Week 52|Adverse Event|3|||
129503290|NCT01606761|466131893|FG004|Week 24 to Week 52|Adverse Event|15|||
129503291|NCT01606761|466131889|FG000|Week 24 to Week 52|Death|0|||
129503292|NCT01606761|466131890|FG001|Week 24 to Week 52|Death|0|||
129503293|NCT01606761|466131891|FG002|Week 24 to Week 52|Death|2|||
129503294|NCT01606761|466131892|FG003|Week 24 to Week 52|Death|1|||
129503295|NCT01606761|466131893|FG004|Week 24 to Week 52|Death|0|||
129503296|NCT01606761|466131889|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
129503297|NCT01606761|466131890|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
129503298|NCT01606761|466131891|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
129503299|NCT01606761|466131892|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
129503300|NCT01606761|466131893|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
129503301|NCT01606761|466131889|FG000|Week 24 to Week 52|Physician Decision|0|||
129503302|NCT01606761|466131890|FG001|Week 24 to Week 52|Physician Decision|1|||
129503303|NCT01606761|466131891|FG002|Week 24 to Week 52|Physician Decision|1|||
129503304|NCT01606761|466131892|FG003|Week 24 to Week 52|Physician Decision|0|||
129503305|NCT01606761|466131893|FG004|Week 24 to Week 52|Physician Decision|0|||
129503306|NCT01606761|466131889|FG000|Week 24 to Week 52|Other|0|||
129503307|NCT01606761|466131890|FG001|Week 24 to Week 52|Other|1|||
129503308|NCT01606761|466131891|FG002|Week 24 to Week 52|Other|5|||
129503309|NCT01606761|466131892|FG003|Week 24 to Week 52|Other|2|||
129503310|NCT01606761|466131893|FG004|Week 24 to Week 52|Other|2|||
129503311|NCT01606761|466131889|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
129503312|NCT01606761|466131890|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
129503313|NCT01606761|466131891|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
129503314|NCT01606761|466131892|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
129503315|NCT01606761|466131893|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
129503316|NCT01606761|466131889|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
129503317|NCT01606761|466131890|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
129503318|NCT01606761|466131891|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
129503319|NCT01606761|466131892|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
129503320|NCT01606761|466131893|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
129503321|NCT01606761|466131889|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
129503322|NCT01606761|466131890|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
129503323|NCT01606761|466131891|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
129503324|NCT01606761|466131892|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
129503325|NCT01606761|466131893|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
129503326|NCT01606761|466131889|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
129503327|NCT01606761|466131890|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
129503328|NCT01606761|466131891|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
129503329|NCT01606761|466131892|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
129503330|NCT01606761|466131893|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
129503331|NCT05086289|466131894|FG000|Overall Study|Adverse Event|4|||
129503332|NCT05086289|466131895|FG001|Overall Study|Adverse Event|2|||
129503333|NCT05086289|466131894|FG000|Overall Study|Lost to Follow-up|2|||
129503334|NCT05086289|466131895|FG001|Overall Study|Lost to Follow-up|0|||
129503335|NCT05086289|466131894|FG000|Overall Study|Non-compliance with study drug|2|||
129503336|NCT05086289|466131895|FG001|Overall Study|Non-compliance with study drug|1|||
129503337|NCT05086289|466131894|FG000|Overall Study|Physician Decision|2|||
129503338|NCT05086289|466131895|FG001|Overall Study|Physician Decision|0|||
129503339|NCT05086289|466131894|FG000|Overall Study|Withdrawal by Subject|5|||
129503340|NCT05086289|466131895|FG001|Overall Study|Withdrawal by Subject|2|||
129503341|NCT01996748|466131896|FG000|Overall Study|Personal reason|1|||
129503342|NCT01996748|466131897|FG001|Overall Study|Personal reason|0|||
129503343|NCT01996748|466131896|FG000|Overall Study|Physician Decision|2|||
129503344|NCT01996748|466131897|FG001|Overall Study|Physician Decision|0|||
129503345|NCT01996748|466131896|FG000|Overall Study|Adverse Event|1|||
129503346|NCT01996748|466131897|FG001|Overall Study|Adverse Event|4|||
129503347|NCT01996748|466131896|FG000|Overall Study|Withdrawal by Subject|0|||
129503348|NCT01996748|466131897|FG001|Overall Study|Withdrawal by Subject|1|||
129503349|NCT01996748|466131896|FG000|Overall Study|Lost to Follow-up|4|||
129503350|NCT01996748|466131897|FG001|Overall Study|Lost to Follow-up|1|||
129503351|NCT03599141|466131903|FG000|Overall Study|Lost to Follow-up|3|||
129503352|NCT03599141|466131904|FG001|Overall Study|Lost to Follow-up|1|||
129503353|NCT00807846|466131905|FG000|Overall Study|Adverse Event|5|||
129503354|NCT00807846|466131906|FG001|Overall Study|Adverse Event|0|||
129503355|NCT00807846|466131905|FG000|Overall Study|Lack of Efficacy|2|||
129503356|NCT00807846|466131906|FG001|Overall Study|Lack of Efficacy|0|||
129503357|NCT00807846|466131905|FG000|Overall Study|Protocol Violation|2|||
129503358|NCT00807846|466131906|FG001|Overall Study|Protocol Violation|1|||
129503359|NCT00807846|466131905|FG000|Overall Study|Withdrawal by Subject|2|||
129503360|NCT00807846|466131906|FG001|Overall Study|Withdrawal by Subject|1|||
129503361|NCT00807846|466131905|FG000|Overall Study|Other|1|||
129503362|NCT00807846|466131906|FG001|Overall Study|Other|2|||
129503363|NCT01081873|466131907|FG000|Overall Study|Death|86|||
129503364|NCT01081873|466131907|FG000|Overall Study|Withdrawal by Subject|10|||
129503365|NCT01081873|466131907|FG000|Overall Study|Lost to Follow-up|142|||
129503366|NCT01081873|466131907|FG000|Overall Study|Progression of prostate cancer|13|||
129503367|NCT01081873|466131907|FG000|Overall Study|Other|47|||
129503368|NCT03011840|466131909|FG000|Overall Study|Not received PIL in post PIL phase|0|||
129503369|NCT03011840|466131910|FG001|Overall Study|Not received PIL in post PIL phase|21|||
129503370|NCT01165021|466131911|FG000|Overall Study|Death|1|||
129503371|NCT02491073|466131912|FG000|Overall Study|screen failure|1|||
129503372|NCT02491073|466131913|FG001|Overall Study|screen failure|0|||
129503373|NCT03738566|466131914|FG000|Initial Study Phase|Withdrawal by Subject|1|||
129503374|NCT03738566|466131915|FG001|Initial Study Phase|Withdrawal by Subject|1|||
129503375|NCT03738566|466131916|FG002|Initial Study Phase|Withdrawal by Subject|2|||
129503376|NCT03738566|466131917|FG003|Initial Study Phase|Withdrawal by Subject|0|||
129503377|NCT03738566|466131914|FG000|Initial Study Phase|Death|0|||
129503378|NCT03738566|466131915|FG001|Initial Study Phase|Death|1|||
129503379|NCT03738566|466131916|FG002|Initial Study Phase|Death|0|||
129503380|NCT03738566|466131917|FG003|Initial Study Phase|Death|0|||
129503381|NCT03738566|466131914|FG000|Initial Study Phase|Treatment failure|5|||
129503382|NCT03738566|466131915|FG001|Initial Study Phase|Treatment failure|0|||
129503383|NCT03738566|466131916|FG002|Initial Study Phase|Treatment failure|0|||
129503384|NCT03738566|466131917|FG003|Initial Study Phase|Treatment failure|0|||
129503385|NCT03738566|466131914|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
129503386|NCT03738566|466131915|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
129503387|NCT03738566|466131916|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
129503388|NCT03738566|466131917|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
129503389|NCT01655823|466131918|FG000|Overall Study|Lost to Follow-up|0|||
129503390|NCT01655823|466131919|FG001|Overall Study|Lost to Follow-up|1|||
129503391|NCT01655823|466131920|FG002|Overall Study|Lost to Follow-up|0|||
129503392|NCT01655823|466131921|FG003|Overall Study|Lost to Follow-up|0|||
129503393|NCT01655823|466131922|FG004|Overall Study|Lost to Follow-up|1|||
129503394|NCT01655823|466131918|FG000|Overall Study|Withdrawal by Subject|0|||
129503395|NCT01655823|466131919|FG001|Overall Study|Withdrawal by Subject|1|||
129503396|NCT01655823|466131920|FG002|Overall Study|Withdrawal by Subject|0|||
129503397|NCT01655823|466131921|FG003|Overall Study|Withdrawal by Subject|1|||
129503398|NCT01655823|466131922|FG004|Overall Study|Withdrawal by Subject|0|||
129503399|NCT03095521|466131925|FG000|Overall Study|Withdrawal by Subject|0|||
129503400|NCT03095521|466131926|FG001|Overall Study|Withdrawal by Subject|1|||
129503401|NCT03095521|466131925|FG000|Overall Study|Lost to Follow-up|0|||
129503402|NCT03095521|466131926|FG001|Overall Study|Lost to Follow-up|1|||
129503403|NCT01810042|466131927|FG000|Overall Study|Lost to Follow-up|10|||
129503404|NCT02773238|466131929|FG000|Overall Study|Lack of Efficacy|4|||
129503405|NCT01877382|466131935|FG000|Dose Escalation|Progressive disease|2|||
129503406|NCT01877382|466131936|FG001|Dose Escalation|Progressive disease|0|||
129503407|NCT01877382|466131937|FG002|Dose Escalation|Progressive disease|1|||
129503408|NCT01877382|466131938|FG003|Dose Escalation|Progressive disease|6|||
129503409|NCT01877382|466131939|FG004|Dose Escalation|Progressive disease|1|||
129503410|NCT01877382|466131940|FG005|Dose Escalation|Progressive disease|0|||
129503411|NCT01877382|466131941|FG006|Dose Escalation|Progressive disease|3|||
129503412|NCT01877382|466131942|FG007|Dose Escalation|Progressive disease|10|||
129503413|NCT01877382|466131943|FG008|Dose Escalation|Progressive disease|4|||
129503414|NCT01877382|466131944|FG009|Dose Escalation|Progressive disease|2|||
129503415|NCT01877382|466131945|FG010|Dose Escalation|Progressive disease|3|||
129503416|NCT01877382|466131946|FG011|Dose Escalation|Progressive disease|3|||
129503417|NCT01877382|466131947|FG012|Dose Escalation|Progressive disease|13|||
129503418|NCT01877382|466131948|FG013|Dose Escalation|Progressive disease|1|||
129503419|NCT01877382|466131949|FG014|Dose Escalation|Progressive disease|0|||
129503420|NCT01877382|466131935|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
129503421|NCT01877382|466131936|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503422|NCT01877382|466131937|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503423|NCT01877382|466131938|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
129503424|NCT01877382|466131939|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503425|NCT01877382|466131940|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503426|NCT01877382|466131941|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
129503427|NCT01877382|466131942|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503428|NCT01877382|466131943|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503429|NCT01877382|466131944|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503430|NCT01877382|466131945|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503431|NCT01877382|466131946|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503432|NCT01877382|466131947|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503433|NCT01877382|466131948|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503434|NCT01877382|466131949|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503435|NCT01877382|466131935|FG000|Dose Escalation|Clinical progression|0|||
129503436|NCT01877382|466131936|FG001|Dose Escalation|Clinical progression|1|||
129503437|NCT01877382|466131937|FG002|Dose Escalation|Clinical progression|0|||
129503438|NCT01877382|466131938|FG003|Dose Escalation|Clinical progression|2|||
129503439|NCT01877382|466131939|FG004|Dose Escalation|Clinical progression|0|||
129503440|NCT01877382|466131940|FG005|Dose Escalation|Clinical progression|0|||
129503441|NCT01877382|466131941|FG006|Dose Escalation|Clinical progression|1|||
129503442|NCT01877382|466131942|FG007|Dose Escalation|Clinical progression|0|||
129503443|NCT01877382|466131943|FG008|Dose Escalation|Clinical progression|0|||
129503444|NCT01877382|466131944|FG009|Dose Escalation|Clinical progression|1|||
129503445|NCT01877382|466131945|FG010|Dose Escalation|Clinical progression|0|||
129503446|NCT01877382|466131946|FG011|Dose Escalation|Clinical progression|0|||
129503447|NCT01877382|466131947|FG012|Dose Escalation|Clinical progression|2|||
129503448|NCT01877382|466131948|FG013|Dose Escalation|Clinical progression|1|||
129503449|NCT01877382|466131949|FG014|Dose Escalation|Clinical progression|0|||
129503450|NCT01877382|466131935|FG000|Dose Escalation|Adverse Event|0|||
129503451|NCT01877382|466131936|FG001|Dose Escalation|Adverse Event|0|||
129503452|NCT01877382|466131937|FG002|Dose Escalation|Adverse Event|0|||
129503453|NCT01877382|466131938|FG003|Dose Escalation|Adverse Event|4|||
129503454|NCT01877382|466131939|FG004|Dose Escalation|Adverse Event|1|||
129503455|NCT01877382|466131940|FG005|Dose Escalation|Adverse Event|2|||
129503456|NCT01877382|466131941|FG006|Dose Escalation|Adverse Event|1|||
129503457|NCT01877382|466131942|FG007|Dose Escalation|Adverse Event|2|||
129503458|NCT01877382|466131943|FG008|Dose Escalation|Adverse Event|0|||
129503459|NCT01877382|466131944|FG009|Dose Escalation|Adverse Event|0|||
129503460|NCT01877382|466131945|FG010|Dose Escalation|Adverse Event|0|||
129503461|NCT01877382|466131946|FG011|Dose Escalation|Adverse Event|0|||
129503462|NCT01877382|466131947|FG012|Dose Escalation|Adverse Event|1|||
129503463|NCT01877382|466131948|FG013|Dose Escalation|Adverse Event|0|||
129503464|NCT01877382|466131949|FG014|Dose Escalation|Adverse Event|0|||
129503465|NCT01877382|466131935|FG000|Dose Escalation|Withdrawal by Subject|0|||
129503466|NCT01877382|466131936|FG001|Dose Escalation|Withdrawal by Subject|0|||
129503467|NCT01877382|466131937|FG002|Dose Escalation|Withdrawal by Subject|0|||
129503468|NCT01877382|466131938|FG003|Dose Escalation|Withdrawal by Subject|0|||
129503469|NCT01877382|466131939|FG004|Dose Escalation|Withdrawal by Subject|0|||
129503470|NCT01877382|466131940|FG005|Dose Escalation|Withdrawal by Subject|3|||
129503471|NCT01877382|466131941|FG006|Dose Escalation|Withdrawal by Subject|2|||
129503472|NCT01877382|466131942|FG007|Dose Escalation|Withdrawal by Subject|1|||
129503473|NCT01877382|466131943|FG008|Dose Escalation|Withdrawal by Subject|1|||
129503474|NCT01877382|466131944|FG009|Dose Escalation|Withdrawal by Subject|0|||
129503475|NCT01877382|466131945|FG010|Dose Escalation|Withdrawal by Subject|0|||
129503476|NCT01877382|466131946|FG011|Dose Escalation|Withdrawal by Subject|0|||
129503477|NCT01877382|466131947|FG012|Dose Escalation|Withdrawal by Subject|0|||
129503478|NCT01877382|466131948|FG013|Dose Escalation|Withdrawal by Subject|0|||
129503479|NCT01877382|466131949|FG014|Dose Escalation|Withdrawal by Subject|0|||
129503480|NCT01877382|466131935|FG000|Dose Escalation|Protocol Violation|0|||
129503481|NCT01877382|466131936|FG001|Dose Escalation|Protocol Violation|0|||
129503482|NCT01877382|466131937|FG002|Dose Escalation|Protocol Violation|0|||
129503483|NCT01877382|466131938|FG003|Dose Escalation|Protocol Violation|0|||
129503484|NCT01877382|466131939|FG004|Dose Escalation|Protocol Violation|0|||
129503485|NCT01877382|466131940|FG005|Dose Escalation|Protocol Violation|0|||
129503486|NCT01877382|466131941|FG006|Dose Escalation|Protocol Violation|1|||
129503487|NCT01877382|466131942|FG007|Dose Escalation|Protocol Violation|0|||
129503488|NCT01877382|466131943|FG008|Dose Escalation|Protocol Violation|0|||
129503489|NCT01877382|466131944|FG009|Dose Escalation|Protocol Violation|0|||
129503490|NCT01877382|466131945|FG010|Dose Escalation|Protocol Violation|0|||
129503491|NCT01877382|466131946|FG011|Dose Escalation|Protocol Violation|0|||
129503492|NCT01877382|466131947|FG012|Dose Escalation|Protocol Violation|0|||
129503493|NCT01877382|466131948|FG013|Dose Escalation|Protocol Violation|0|||
129503494|NCT01877382|466131949|FG014|Dose Escalation|Protocol Violation|0|||
129503495|NCT01877382|466131935|FG000|Dose Escalation|Study terminated by sponsor|0|||
129503496|NCT01877382|466131936|FG001|Dose Escalation|Study terminated by sponsor|0|||
129503497|NCT01877382|466131937|FG002|Dose Escalation|Study terminated by sponsor|0|||
129503498|NCT01877382|466131938|FG003|Dose Escalation|Study terminated by sponsor|0|||
129503499|NCT01877382|466131939|FG004|Dose Escalation|Study terminated by sponsor|0|||
129503500|NCT01877382|466131940|FG005|Dose Escalation|Study terminated by sponsor|0|||
129503501|NCT01877382|466131941|FG006|Dose Escalation|Study terminated by sponsor|0|||
129503502|NCT01877382|466131942|FG007|Dose Escalation|Study terminated by sponsor|1|||
129503503|NCT01877382|466131943|FG008|Dose Escalation|Study terminated by sponsor|1|||
129503504|NCT01877382|466131944|FG009|Dose Escalation|Study terminated by sponsor|0|||
129503505|NCT01877382|466131945|FG010|Dose Escalation|Study terminated by sponsor|0|||
129503506|NCT01877382|466131946|FG011|Dose Escalation|Study terminated by sponsor|0|||
129503507|NCT01877382|466131947|FG012|Dose Escalation|Study terminated by sponsor|3|||
129503508|NCT01877382|466131948|FG013|Dose Escalation|Study terminated by sponsor|0|||
129503509|NCT01877382|466131949|FG014|Dose Escalation|Study terminated by sponsor|0|||
129503510|NCT01877382|466131935|FG000|Dose Escalation|Death|0|||
129503511|NCT01877382|466131936|FG001|Dose Escalation|Death|0|||
129503512|NCT01877382|466131937|FG002|Dose Escalation|Death|0|||
129503513|NCT01877382|466131938|FG003|Dose Escalation|Death|0|||
129503514|NCT01877382|466131939|FG004|Dose Escalation|Death|0|||
129503515|NCT01877382|466131940|FG005|Dose Escalation|Death|0|||
129503516|NCT01877382|466131941|FG006|Dose Escalation|Death|0|||
129503517|NCT01877382|466131942|FG007|Dose Escalation|Death|1|||
129503518|NCT01877382|466131943|FG008|Dose Escalation|Death|0|||
129503519|NCT01877382|466131944|FG009|Dose Escalation|Death|0|||
129503520|NCT01877382|466131945|FG010|Dose Escalation|Death|0|||
129503521|NCT01877382|466131946|FG011|Dose Escalation|Death|0|||
129503522|NCT01877382|466131947|FG012|Dose Escalation|Death|1|||
129503523|NCT01877382|466131948|FG013|Dose Escalation|Death|1|||
129503524|NCT01877382|466131949|FG014|Dose Escalation|Death|0|||
129503525|NCT01877382|466131935|FG000|Dose Expansion|Progressive disease|0|||
129982073|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
129982074|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982075|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982076|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982077|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982078|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
129982079|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982080|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
129982081|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982082|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982083|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982084|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
129982085|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982086|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
129503526|NCT01877382|466131936|FG001|Dose Expansion|Progressive disease|0|||
129503527|NCT01877382|466131937|FG002|Dose Expansion|Progressive disease|0|||
129503528|NCT01877382|466131938|FG003|Dose Expansion|Progressive disease|0|||
129503529|NCT01877382|466131939|FG004|Dose Expansion|Progressive disease|0|||
129539069|NCT02708524|466265145|FG001|Overall Study|Lost to Follow-up|1|||
129982087|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
129982088|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982089|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982090|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
129982091|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982092|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982093|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
129982094|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982095|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982096|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
129982097|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Site closure|0|||
129982098|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Site closure|0|||
129982099|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Site closure|1|||
129982100|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Site closure|0|||
129982101|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Site closure|0|||
129982102|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Site closure|0|||
129982103|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
129982104|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
129982105|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
129982106|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
129982107|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
129982108|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
129982109|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
129982110|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982111|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982112|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982113|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982114|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
129982115|NCT03439254|467898752|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
129982116|NCT03439254|467898753|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
129982117|NCT03439254|467898754|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
129982118|NCT03439254|467898755|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
129982119|NCT03439254|467898756|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
129982120|NCT03439254|467898757|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
129982121|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
129982122|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
129982123|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
129982124|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
129982125|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
129982126|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
129982127|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982128|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982129|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982130|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
129982131|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
129982132|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
129982133|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982134|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982135|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982136|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982137|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
129982138|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
129982139|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982140|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982141|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982142|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982143|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
129982144|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
129982145|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982146|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982147|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982148|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982149|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
129982150|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
129982151|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982152|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982153|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982154|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982155|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
129982156|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
129982157|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982158|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982159|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982160|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
129982161|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982162|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
129982163|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129982164|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129982165|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129982166|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
129982167|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
129503530|NCT01877382|466131940|FG005|Dose Expansion|Progressive disease|0|||
129503531|NCT01877382|466131941|FG006|Dose Expansion|Progressive disease|0|||
129503532|NCT01877382|466131942|FG007|Dose Expansion|Progressive disease|0|||
129503533|NCT01877382|466131943|FG008|Dose Expansion|Progressive disease|0|||
129503534|NCT01877382|466131944|FG009|Dose Expansion|Progressive disease|0|||
129503535|NCT01877382|466131945|FG010|Dose Expansion|Progressive disease|0|||
129503536|NCT01877382|466131946|FG011|Dose Expansion|Progressive disease|0|||
129503537|NCT01877382|466131947|FG012|Dose Expansion|Progressive disease|0|||
129503538|NCT01877382|466131948|FG013|Dose Expansion|Progressive disease|0|||
129503539|NCT01877382|466131949|FG014|Dose Expansion|Progressive disease|11|||
129503540|NCT01877382|466131935|FG000|Dose Expansion|Clinical progression|0|||
129503541|NCT01877382|466131936|FG001|Dose Expansion|Clinical progression|0|||
129503542|NCT01877382|466131937|FG002|Dose Expansion|Clinical progression|0|||
129503543|NCT01877382|466131938|FG003|Dose Expansion|Clinical progression|0|||
129503544|NCT01877382|466131939|FG004|Dose Expansion|Clinical progression|0|||
129503545|NCT01877382|466131940|FG005|Dose Expansion|Clinical progression|0|||
129503546|NCT01877382|466131941|FG006|Dose Expansion|Clinical progression|0|||
129503547|NCT01877382|466131942|FG007|Dose Expansion|Clinical progression|0|||
129503548|NCT01877382|466131943|FG008|Dose Expansion|Clinical progression|0|||
129503549|NCT01877382|466131944|FG009|Dose Expansion|Clinical progression|0|||
129503550|NCT01877382|466131945|FG010|Dose Expansion|Clinical progression|0|||
129503551|NCT01877382|466131946|FG011|Dose Expansion|Clinical progression|0|||
129503552|NCT01877382|466131947|FG012|Dose Expansion|Clinical progression|0|||
129503553|NCT01877382|466131948|FG013|Dose Expansion|Clinical progression|0|||
129503554|NCT01877382|466131949|FG014|Dose Expansion|Clinical progression|6|||
129503555|NCT01877382|466131935|FG000|Dose Expansion|Adverse Event|0|||
129503556|NCT01877382|466131936|FG001|Dose Expansion|Adverse Event|0|||
129503557|NCT01877382|466131937|FG002|Dose Expansion|Adverse Event|0|||
129503558|NCT01877382|466131938|FG003|Dose Expansion|Adverse Event|0|||
129503559|NCT01877382|466131939|FG004|Dose Expansion|Adverse Event|0|||
129503560|NCT01877382|466131940|FG005|Dose Expansion|Adverse Event|0|||
129503561|NCT01877382|466131941|FG006|Dose Expansion|Adverse Event|0|||
129503562|NCT01877382|466131942|FG007|Dose Expansion|Adverse Event|0|||
129503563|NCT01877382|466131943|FG008|Dose Expansion|Adverse Event|0|||
129503564|NCT01877382|466131944|FG009|Dose Expansion|Adverse Event|0|||
129503565|NCT01877382|466131945|FG010|Dose Expansion|Adverse Event|0|||
129503566|NCT01877382|466131946|FG011|Dose Expansion|Adverse Event|0|||
129503567|NCT01877382|466131947|FG012|Dose Expansion|Adverse Event|0|||
129503568|NCT01877382|466131948|FG013|Dose Expansion|Adverse Event|0|||
129503569|NCT01877382|466131949|FG014|Dose Expansion|Adverse Event|1|||
129503570|NCT01877382|466131935|FG000|Dose Expansion|Death|0|||
129982168|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
129503571|NCT01877382|466131936|FG001|Dose Expansion|Death|0|||
129503572|NCT01877382|466131937|FG002|Dose Expansion|Death|0|||
129503573|NCT01877382|466131938|FG003|Dose Expansion|Death|0|||
129503574|NCT01877382|466131939|FG004|Dose Expansion|Death|0|||
129503575|NCT01877382|466131940|FG005|Dose Expansion|Death|0|||
129503576|NCT01877382|466131941|FG006|Dose Expansion|Death|0|||
129503577|NCT01877382|466131942|FG007|Dose Expansion|Death|0|||
129503578|NCT01877382|466131943|FG008|Dose Expansion|Death|0|||
129503579|NCT01877382|466131944|FG009|Dose Expansion|Death|0|||
129503580|NCT01877382|466131945|FG010|Dose Expansion|Death|0|||
129503581|NCT01877382|466131946|FG011|Dose Expansion|Death|0|||
129503582|NCT01877382|466131947|FG012|Dose Expansion|Death|0|||
129503583|NCT01877382|466131948|FG013|Dose Expansion|Death|0|||
129503584|NCT01877382|466131949|FG014|Dose Expansion|Death|1|||
129503585|NCT01877382|466131935|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503586|NCT01877382|466131936|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503587|NCT01877382|466131937|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503588|NCT01877382|466131938|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503589|NCT01877382|466131939|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503590|NCT01877382|466131940|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503591|NCT01877382|466131941|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503592|NCT01877382|466131942|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503593|NCT01877382|466131943|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503594|NCT01877382|466131944|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503595|NCT01877382|466131945|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503596|NCT01877382|466131946|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503597|NCT01877382|466131947|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503598|NCT01877382|466131948|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
129503599|NCT01877382|466131949|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
129503600|NCT02115113|466133524|FG000|Participants in Run-in Period|Death|0|||
129503601|NCT02115113|466133525|FG001|Participants in Run-in Period|Death|0|||
129503602|NCT02115113|466133526|FG002|Participants in Run-in Period|Death|1|||
129503603|NCT02115113|466133524|FG000|Participants in Run-in Period|Administrative problems|0|||
129503604|NCT02115113|466133525|FG001|Participants in Run-in Period|Administrative problems|0|||
129503605|NCT02115113|466133526|FG002|Participants in Run-in Period|Administrative problems|1|||
129503606|NCT02115113|466133524|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
129503607|NCT02115113|466133525|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
129503608|NCT02115113|466133526|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
129503609|NCT02115113|466133524|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
129503610|NCT02115113|466133525|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
129503611|NCT02115113|466133526|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
129503612|NCT02115113|466133524|FG000|Participants Randomized|Lost to Follow-up|1|||
129503613|NCT02115113|466133525|FG001|Participants Randomized|Lost to Follow-up|0|||
129503614|NCT02115113|466133526|FG002|Participants Randomized|Lost to Follow-up|0|||
129503615|NCT02115113|466133524|FG000|Participants Randomized|Death|1|||
129503616|NCT02115113|466133525|FG001|Participants Randomized|Death|0|||
129503617|NCT02115113|466133526|FG002|Participants Randomized|Death|0|||
129503618|NCT02395653|466133527|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
129503619|NCT02395653|466133527|FG000|Overall Study|Consent Withdrawn at Screening|1|||
129503620|NCT02395653|466133527|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
129503621|NCT02395653|466133527|FG000|Overall Study|Investigator Decision at Screening|1|||
129503622|NCT02395653|466133527|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
129503623|NCT02395653|466133527|FG000|Overall Study|Withdrawal by Subject|1|||
129503624|NCT02395653|466133527|FG000|Overall Study|Lost to Follow-up|1|||
129503625|NCT00605722|466133531|FG000|Overall Study|Adverse Event|6|||
129503626|NCT00605722|466133531|FG000|Overall Study|Insufficient therapeutic response|44|||
129503627|NCT00605722|466133531|FG000|Overall Study|Failure to return|1|||
129503628|NCT02622724|466133532|FG000|Overall Study|Death|51|||
129503629|NCT02622724|466133533|FG001|Overall Study|Death|53|||
129503630|NCT02622724|466133532|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
129503631|NCT02622724|466133533|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
129503632|NCT02622724|466133532|FG000|Overall Study|Early termination of study|38|||
129503633|NCT02622724|466133533|FG001|Overall Study|Early termination of study|43|||
129503634|NCT00487084|466133534|FG000|Overall Study|Did not receive intervention|4|||
129503635|NCT00487084|466133535|FG001|Overall Study|Did not receive intervention|3|||
129503636|NCT00487084|466133536|FG002|Overall Study|Did not receive intervention|5|||
129503637|NCT00356863|466133537|FG000|Overall Study|Death|16|||
129503638|NCT00356863|466133538|FG001|Overall Study|Death|32|||
129503639|NCT00356863|466133537|FG000|Overall Study|Lost to Follow-up|76|||
129503640|NCT00356863|466133538|FG001|Overall Study|Lost to Follow-up|43|||
129503641|NCT02690207|466133545|FG000|Overall Study|Lost to Follow-up|48|||
129503642|NCT02690207|466133545|FG000|Overall Study|Withdrawal by Subject|46|||
129503643|NCT02690207|466133545|FG000|Overall Study|Protocol Violation|2|||
129503644|NCT02690207|466133545|FG000|Overall Study|Serious adverse event|110|||
129982169|NCT03439254|467898752|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
129503645|NCT02690207|466133545|FG000|Overall Study|Non-serious Adverse Event|18|||
129503646|NCT02690207|466133545|FG000|Overall Study|Migrated/moved from study area|5|||
129503647|NCT02690207|466133545|FG000|Overall Study|Suspected HZ Episode|1|||
129503648|NCT02690207|466133545|FG000|Overall Study|Other reasons for withdrawal|23|||
129503649|NCT03712345|466133548|FG000|Overall Study|Failure to meet randomization criteria|0|||
129503650|NCT03712345|466133549|FG001|Overall Study|Failure to meet randomization criteria|0|||
129503651|NCT03712345|466133550|FG002|Overall Study|Failure to meet randomization criteria|1|||
129503652|NCT02585999|466133551|FG000|Overall Study|Lost to Follow-up|1|||
129503653|NCT02585999|466133551|FG000|Overall Study|Protocol Violation|1|||
129503654|NCT00485589|466133552|FG000|Overall Study|Death|2|||
129503655|NCT00485589|466133553|FG001|Overall Study|Death|2|||
129503656|NCT00485589|466133554|FG002|Overall Study|Death|0|||
129503657|NCT00485589|466133552|FG000|Overall Study|Failure to return|6|||
129503658|NCT00485589|466133553|FG001|Overall Study|Failure to return|5|||
129503659|NCT00485589|466133554|FG002|Overall Study|Failure to return|1|||
129503660|NCT00485589|466133552|FG000|Overall Study|Protocol Violation|1|||
129503661|NCT00485589|466133553|FG001|Overall Study|Protocol Violation|0|||
129503662|NCT00485589|466133554|FG002|Overall Study|Protocol Violation|0|||
129503663|NCT00485589|466133552|FG000|Overall Study|Violation of selection criteria at entry|0|||
129503664|NCT00485589|466133553|FG001|Overall Study|Violation of selection criteria at entry|3|||
129503665|NCT00485589|466133554|FG002|Overall Study|Violation of selection criteria at entry|1|||
129503666|NCT00485589|466133552|FG000|Overall Study|Administrative/Other|1|||
129503667|NCT00485589|466133553|FG001|Overall Study|Administrative/Other|2|||
129503668|NCT00485589|466133554|FG002|Overall Study|Administrative/Other|1|||
129503669|NCT00485589|466133552|FG000|Overall Study|Insufficient therapeutic response|10|||
129503670|NCT00485589|466133553|FG001|Overall Study|Insufficient therapeutic response|3|||
129503671|NCT00485589|466133554|FG002|Overall Study|Insufficient therapeutic response|1|||
129503672|NCT00485589|466133552|FG000|Overall Study|Refused treatment/did not cooperate|1|||
129503673|NCT00485589|466133553|FG001|Overall Study|Refused treatment/did not cooperate|0|||
129503674|NCT00485589|466133554|FG002|Overall Study|Refused treatment/did not cooperate|2|||
129503675|NCT00485589|466133552|FG000|Overall Study|Withdrawal by Subject|3|||
129503676|NCT00485589|466133553|FG001|Overall Study|Withdrawal by Subject|2|||
129503677|NCT00485589|466133554|FG002|Overall Study|Withdrawal by Subject|2|||
129503678|NCT00485589|466133552|FG000|Overall Study|Adverse Event|3|||
129503679|NCT00485589|466133553|FG001|Overall Study|Adverse Event|3|||
129503680|NCT00485589|466133554|FG002|Overall Study|Adverse Event|10|||
129503681|NCT01369849|466133555|FG000|Overall Study|Ineligible prior to treatment|0|||
129503682|NCT01369849|466133556|FG001|Overall Study|Ineligible prior to treatment|0|||
129503683|NCT01369849|466133557|FG002|Overall Study|Ineligible prior to treatment|1|||
129503684|NCT01369849|466133555|FG000|Overall Study|Ineligible after receiving treatment|0|||
129503685|NCT01369849|466133556|FG001|Overall Study|Ineligible after receiving treatment|1|||
129503686|NCT01369849|466133557|FG002|Overall Study|Ineligible after receiving treatment|0|||
129503687|NCT00756886|466133558|FG000|Overall Study|Lost to Follow-up|1|||
129503688|NCT00756886|466133559|FG001|Overall Study|Lost to Follow-up|0|||
129503689|NCT00756886|466133558|FG000|Overall Study|Adverse Event|0|||
129503690|NCT00756886|466133559|FG001|Overall Study|Adverse Event|3|||
129503691|NCT00756886|466133558|FG000|Overall Study|Lack of Efficacy|1|||
129503692|NCT00756886|466133559|FG001|Overall Study|Lack of Efficacy|0|||
129503693|NCT00756886|466133558|FG000|Overall Study|Ineligible|9|||
129503694|NCT00756886|466133559|FG001|Overall Study|Ineligible|4|||
129503695|NCT00174785|466133563|FG000|Overall Study|Adverse Event|293|||
129503696|NCT00174785|466133564|FG001|Overall Study|Adverse Event|191|||
129503697|NCT00174785|466133563|FG000|Overall Study|Protocol Violation|14|||
129503698|NCT00174785|466133564|FG001|Overall Study|Protocol Violation|14|||
129503699|NCT00174785|466133563|FG000|Overall Study|Withdrawal by Subject|173|||
129503700|NCT00174785|466133564|FG001|Overall Study|Withdrawal by Subject|175|||
129503701|NCT00174785|466133563|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
129503702|NCT00174785|466133564|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
129503703|NCT00174785|466133563|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
129503704|NCT00174785|466133564|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
129503705|NCT00174785|466133563|FG000|Overall Study|Other prohibited medication|5|||
129503706|NCT00174785|466133564|FG001|Overall Study|Other prohibited medication|3|||
129503707|NCT00174785|466133563|FG000|Overall Study|Family request|6|||
129503708|NCT00174785|466133564|FG001|Overall Study|Family request|8|||
129503709|NCT00174785|466133563|FG000|Overall Study|Not pre-specified/Not coded|56|||
129503710|NCT00174785|466133564|FG001|Overall Study|Not pre-specified/Not coded|70|||
129503711|NCT00120289|466133566|FG000|Overall Study|Death|96|||
129982170|NCT03439254|467898753|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
129982171|NCT03439254|467898754|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
129503712|NCT00120289|466133567|FG001|Overall Study|Death|82|||
129503713|NCT00120289|466133566|FG000|Overall Study|Lost to Follow-up|11|||
129503714|NCT00120289|466133567|FG001|Overall Study|Lost to Follow-up|14|||
129503715|NCT00120289|466133566|FG000|Overall Study|Withdrawal by Subject|14|||
129503716|NCT00120289|466133567|FG001|Overall Study|Withdrawal by Subject|13|||
129503717|NCT01944969|466133568|FG000|Overall Study|Adverse Event|1|||
129503718|NCT01944969|466133568|FG000|Overall Study|Lack of Efficacy|1|||
129503719|NCT01944969|466133568|FG000|Overall Study|Non-compliance with IMP|1|||
129503720|NCT01944969|466133568|FG000|Overall Study|Administrative or other reasons|23|||
129503721|NCT02938585|466133577|FG000|Overall Study|Withdrawal by parent or guardian|0|||
129503722|NCT02938585|466133578|FG001|Overall Study|Withdrawal by parent or guardian|1|||
129503723|NCT02938585|466133579|FG002|Overall Study|Withdrawal by parent or guardian|0|||
129982172|NCT03439254|467898755|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
129503724|NCT02938585|466133580|FG003|Overall Study|Withdrawal by parent or guardian|0|||
129503725|NCT02938585|466133577|FG000|Overall Study|Withdrawal by Subject|0|||
129503726|NCT02938585|466133578|FG001|Overall Study|Withdrawal by Subject|0|||
129503727|NCT02938585|466133579|FG002|Overall Study|Withdrawal by Subject|0|||
129503728|NCT02938585|466133580|FG003|Overall Study|Withdrawal by Subject|5|||
129503729|NCT02411201|466133581|FG000|Overall Study|Adverse Event|2|||
129503730|NCT02411201|466133581|FG000|Overall Study|Withdrawal by Subject|2|||
129503731|NCT02411201|466133581|FG000|Overall Study|Age group completed|2|||
129503732|NCT01260467|466133582|FG000|Overall Study|Withdrawal by Subject|2|||
129503733|NCT02504268|466133596|FG000|Overall Study|Adverse Event|18|||
129503734|NCT02504268|466133597|FG001|Overall Study|Adverse Event|8|||
129503735|NCT02504268|466133598|FG002|Overall Study|Adverse Event|14|||
129503736|NCT02504268|466133599|FG003|Overall Study|Adverse Event|0|||
129503737|NCT02504268|466133600|FG004|Overall Study|Adverse Event|0|||
129503738|NCT02504268|466133601|FG005|Overall Study|Adverse Event|0|||
129503739|NCT02504268|466133602|FG006|Overall Study|Adverse Event|0|||
129503740|NCT02504268|466133603|FG007|Overall Study|Adverse Event|0|||
129503741|NCT02504268|466133604|FG008|Overall Study|Adverse Event|0|||
129503742|NCT02504268|466133596|FG000|Overall Study|Withdrawal of Consent|11|||
129503743|NCT02504268|466133597|FG001|Overall Study|Withdrawal of Consent|10|||
129503744|NCT02504268|466133598|FG002|Overall Study|Withdrawal of Consent|3|||
129503745|NCT02504268|466133599|FG003|Overall Study|Withdrawal of Consent|0|||
129503746|NCT02504268|466133600|FG004|Overall Study|Withdrawal of Consent|0|||
129503747|NCT02504268|466133601|FG005|Overall Study|Withdrawal of Consent|0|||
129503748|NCT02504268|466133602|FG006|Overall Study|Withdrawal of Consent|0|||
129503749|NCT02504268|466133603|FG007|Overall Study|Withdrawal of Consent|0|||
129503750|NCT02504268|466133604|FG008|Overall Study|Withdrawal of Consent|0|||
129503751|NCT02504268|466133596|FG000|Overall Study|Pregnancy|2|||
129503752|NCT02504268|466133597|FG001|Overall Study|Pregnancy|0|||
129503753|NCT02504268|466133598|FG002|Overall Study|Pregnancy|0|||
129503754|NCT02504268|466133599|FG003|Overall Study|Pregnancy|0|||
129503755|NCT02504268|466133600|FG004|Overall Study|Pregnancy|0|||
129503756|NCT02504268|466133601|FG005|Overall Study|Pregnancy|0|||
129503757|NCT02504268|466133602|FG006|Overall Study|Pregnancy|0|||
129503758|NCT02504268|466133603|FG007|Overall Study|Pregnancy|0|||
129503759|NCT02504268|466133604|FG008|Overall Study|Pregnancy|0|||
129503760|NCT02504268|466133596|FG000|Overall Study|Lost to Follow-up|3|||
129503761|NCT02504268|466133597|FG001|Overall Study|Lost to Follow-up|6|||
129503762|NCT02504268|466133598|FG002|Overall Study|Lost to Follow-up|4|||
129503763|NCT02504268|466133599|FG003|Overall Study|Lost to Follow-up|0|||
129503764|NCT02504268|466133600|FG004|Overall Study|Lost to Follow-up|0|||
129503765|NCT02504268|466133601|FG005|Overall Study|Lost to Follow-up|0|||
129503766|NCT02504268|466133602|FG006|Overall Study|Lost to Follow-up|0|||
129503767|NCT02504268|466133603|FG007|Overall Study|Lost to Follow-up|0|||
129503768|NCT02504268|466133604|FG008|Overall Study|Lost to Follow-up|0|||
129503769|NCT02504268|466133596|FG000|Overall Study|Death|1|||
129503770|NCT02504268|466133597|FG001|Overall Study|Death|1|||
129503771|NCT02504268|466133598|FG002|Overall Study|Death|0|||
129503772|NCT02504268|466133599|FG003|Overall Study|Death|0|||
129503773|NCT02504268|466133600|FG004|Overall Study|Death|0|||
129503774|NCT02504268|466133601|FG005|Overall Study|Death|0|||
129503775|NCT02504268|466133602|FG006|Overall Study|Death|0|||
129503776|NCT02504268|466133603|FG007|Overall Study|Death|0|||
129503777|NCT02504268|466133604|FG008|Overall Study|Death|0|||
129503778|NCT02504268|466133596|FG000|Overall Study|Subject Request to Discontinue|11|||
129503779|NCT02504268|466133597|FG001|Overall Study|Subject Request to Discontinue|3|||
129503780|NCT02504268|466133598|FG002|Overall Study|Subject Request to Discontinue|6|||
129503781|NCT02504268|466133599|FG003|Overall Study|Subject Request to Discontinue|0|||
129503782|NCT02504268|466133600|FG004|Overall Study|Subject Request to Discontinue|0|||
129503783|NCT02504268|466133601|FG005|Overall Study|Subject Request to Discontinue|0|||
129503784|NCT02504268|466133602|FG006|Overall Study|Subject Request to Discontinue|0|||
129503785|NCT02504268|466133603|FG007|Overall Study|Subject Request to Discontinue|0|||
129503786|NCT02504268|466133604|FG008|Overall Study|Subject Request to Discontinue|0|||
129982173|NCT03439254|467898756|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
129503787|NCT02504268|466133596|FG000|Overall Study|No Longer Meets Study Criteria|2|||
129503788|NCT02504268|466133597|FG001|Overall Study|No Longer Meets Study Criteria|3|||
129503789|NCT02504268|466133598|FG002|Overall Study|No Longer Meets Study Criteria|0|||
129503790|NCT02504268|466133599|FG003|Overall Study|No Longer Meets Study Criteria|0|||
129503791|NCT02504268|466133600|FG004|Overall Study|No Longer Meets Study Criteria|0|||
129503792|NCT02504268|466133601|FG005|Overall Study|No Longer Meets Study Criteria|0|||
129503793|NCT02504268|466133602|FG006|Overall Study|No Longer Meets Study Criteria|0|||
129503794|NCT02504268|466133603|FG007|Overall Study|No Longer Meets Study Criteria|0|||
129982174|NCT03439254|467898757|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
129503795|NCT02504268|466133604|FG008|Overall Study|No Longer Meets Study Criteria|0|||
129503796|NCT02504268|466133596|FG000|Overall Study|Lack of Efficacy|11|||
129503797|NCT02504268|466133597|FG001|Overall Study|Lack of Efficacy|35|||
129503798|NCT02504268|466133598|FG002|Overall Study|Lack of Efficacy|9|||
129503799|NCT02504268|466133599|FG003|Overall Study|Lack of Efficacy|0|||
129503800|NCT02504268|466133600|FG004|Overall Study|Lack of Efficacy|0|||
129503801|NCT02504268|466133601|FG005|Overall Study|Lack of Efficacy|0|||
129503802|NCT02504268|466133602|FG006|Overall Study|Lack of Efficacy|0|||
129503803|NCT02504268|466133603|FG007|Overall Study|Lack of Efficacy|0|||
129503804|NCT02504268|466133604|FG008|Overall Study|Lack of Efficacy|0|||
129503805|NCT02504268|466133596|FG000|Overall Study|Poor/Non-Compliance|3|||
129503806|NCT02504268|466133597|FG001|Overall Study|Poor/Non-Compliance|2|||
129503807|NCT02504268|466133598|FG002|Overall Study|Poor/Non-Compliance|3|||
129503808|NCT02504268|466133599|FG003|Overall Study|Poor/Non-Compliance|0|||
129503809|NCT02504268|466133600|FG004|Overall Study|Poor/Non-Compliance|0|||
129503810|NCT02504268|466133601|FG005|Overall Study|Poor/Non-Compliance|0|||
129503811|NCT02504268|466133602|FG006|Overall Study|Poor/Non-Compliance|0|||
129503812|NCT02504268|466133603|FG007|Overall Study|Poor/Non-Compliance|0|||
129503813|NCT02504268|466133604|FG008|Overall Study|Poor/Non-Compliance|0|||
129503814|NCT02504268|466133596|FG000|Overall Study|Not Disclosed|1|||
129503815|NCT02504268|466133597|FG001|Overall Study|Not Disclosed|0|||
129503816|NCT02504268|466133598|FG002|Overall Study|Not Disclosed|2|||
129503817|NCT02504268|466133599|FG003|Overall Study|Not Disclosed|0|||
129503818|NCT02504268|466133600|FG004|Overall Study|Not Disclosed|0|||
129503819|NCT02504268|466133601|FG005|Overall Study|Not Disclosed|0|||
129503820|NCT02504268|466133602|FG006|Overall Study|Not Disclosed|0|||
129503821|NCT02504268|466133603|FG007|Overall Study|Not Disclosed|0|||
129503822|NCT02504268|466133604|FG008|Overall Study|Not Disclosed|0|||
129503823|NCT02130427|466133605|FG000|Overall Study|Imaging results not interpretable|30|||
129503824|NCT02108951|466133613|FG000|Overall Study|Lost to Follow-up|1|||
129503825|NCT02108951|466133613|FG000|Overall Study|Patient's/guardian's decision|1|||
129503826|NCT02108951|466133613|FG000|Overall Study|Study Terminated by Sponsor|14|||
129503827|NCT00718666|466133614|FG000|Booster Phase Year 5|No active participation request|0|||
129503828|NCT00718666|466133615|FG001|Booster Phase Year 5|No active participation request|0|||
129503829|NCT00718666|466133616|FG002|Booster Phase Year 5|No active participation request|1|||
129503830|NCT00718666|466133614|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
129503831|NCT00718666|466133615|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
129503832|NCT00718666|466133616|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
129503833|NCT00718666|466133614|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
129503834|NCT00718666|466133615|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
129503835|NCT00718666|466133616|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
129503836|NCT00718666|466133614|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
129503837|NCT00718666|466133615|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
129503838|NCT00718666|466133616|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
129503839|NCT00421343|466133619|FG000|Overall Study|Death|1|||
129503840|NCT00421343|466133619|FG000|Overall Study|Withdrawal by Subject|2|||
129503841|NCT00421343|466133619|FG000|Overall Study|Lost to Follow-up|3|||
129503842|NCT03471767|466133625|FG000|Overall Study|Withdrawal by Subject|3|||
129503843|NCT03471767|466133626|FG001|Overall Study|Withdrawal by Subject|1|||
129503844|NCT03471767|466133625|FG000|Overall Study|Adverse Event|1|||
129503845|NCT03471767|466133626|FG001|Overall Study|Adverse Event|0|||
129503846|NCT03471767|466133625|FG000|Overall Study|Lost to Follow-up|1|||
129503847|NCT03471767|466133626|FG001|Overall Study|Lost to Follow-up|0|||
129503848|NCT03471767|466133625|FG000|Overall Study|PI Withdrawal|1|||
129503849|NCT03471767|466133626|FG001|Overall Study|PI Withdrawal|3|||
129503850|NCT00678587|466133627|FG000|Overall Study|Adverse Event|3|||
129503851|NCT00678587|466133628|FG001|Overall Study|Adverse Event|3|||
129503852|NCT00678587|466133627|FG000|Overall Study|Lack of Efficacy|1|||
129503853|NCT00678587|466133628|FG001|Overall Study|Lack of Efficacy|0|||
129503854|NCT00678587|466133627|FG000|Overall Study|Protocol Violation|2|||
129503855|NCT00678587|466133628|FG001|Overall Study|Protocol Violation|1|||
129503856|NCT00678587|466133627|FG000|Overall Study|Study Closed/Terminated|1|||
129503857|NCT00678587|466133628|FG001|Overall Study|Study Closed/Terminated|0|||
129503858|NCT00678587|466133627|FG000|Overall Study|Lost to Follow-up|3|||
129503859|NCT00678587|466133628|FG001|Overall Study|Lost to Follow-up|5|||
129503860|NCT00678587|466133627|FG000|Overall Study|Investigator Discretion|2|||
129503861|NCT00678587|466133628|FG001|Overall Study|Investigator Discretion|6|||
129503862|NCT00678587|466133627|FG000|Overall Study|Withdrew Consent|8|||
129503863|NCT00678587|466133628|FG001|Overall Study|Withdrew Consent|3|||
129503864|NCT03806179|466133629|FG000|Overall Study|Progressive disease|0|||
129503865|NCT03806179|466133630|FG001|Overall Study|Progressive disease|2|||
129503866|NCT02237157|466133633|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
129503867|NCT02237157|466133634|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
129982175|NCT02075476|467898759|FG000|Overall Study|Death|2|||
129982176|NCT02075476|467898760|FG001|Overall Study|Death|2|||
129503868|NCT02237157|466133635|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
129503869|NCT02237157|466133636|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
129503870|NCT02237157|466133633|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
129503871|NCT02237157|466133634|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
129503872|NCT02237157|466133635|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
129503873|NCT02237157|466133636|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
129503874|NCT01419665|466133637|FG000|Combination Treatment|Adverse Event|7|||
129503875|NCT01419665|466133638|FG001|Combination Treatment|Adverse Event|10|||
129503876|NCT01419665|466133637|FG000|Combination Treatment|Physician Decision|5|||
129503877|NCT01419665|466133638|FG001|Combination Treatment|Physician Decision|8|||
129503878|NCT01419665|466133637|FG000|Combination Treatment|Protocol Violation|6|||
129503879|NCT01419665|466133638|FG001|Combination Treatment|Protocol Violation|2|||
129503880|NCT01419665|466133637|FG000|Combination Treatment|disease progression|10|||
129503881|NCT01419665|466133638|FG001|Combination Treatment|disease progression|9|||
129503882|NCT01419665|466133637|FG000|Combination Treatment|Death|5|||
129503883|NCT01419665|466133638|FG001|Combination Treatment|Death|7|||
129503884|NCT01419665|466133637|FG000|Combination Treatment|administrative problems|0|||
129503885|NCT01419665|466133638|FG001|Combination Treatment|administrative problems|1|||
129503886|NCT01419665|466133637|FG000|Combination Treatment|Withdrawal by Subject|5|||
129503887|NCT01419665|466133638|FG001|Combination Treatment|Withdrawal by Subject|4|||
129503888|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
129503889|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
129503890|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
129503891|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
129503892|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
129503893|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
129503894|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
129503895|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
129503896|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
129503897|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
129503898|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
129503899|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
129503900|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|Death|1|||
129503901|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|Death|2|||
129503902|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
129503903|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
129503904|NCT01419665|466133637|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
129503905|NCT01419665|466133638|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
129503906|NCT01419665|466133637|FG000|Open Label Phase|Death|1|||
129503907|NCT01419665|466133638|FG001|Open Label Phase|Death|0|||
129982177|NCT02075476|467898759|FG000|Overall Study|Lost to Follow-up|1|||
129982178|NCT02075476|467898760|FG001|Overall Study|Lost to Follow-up|3|||
129982179|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
129982180|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
129982181|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
129982182|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
129982183|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Death|1|||
129982184|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Death|0|||
129982185|NCT00095056|467898761|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
129982186|NCT00095056|467898762|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
129982187|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
129982188|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
129982189|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
129982190|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
129503908|NCT01419665|466133637|FG000|Open Label Phase|disease progression|0|||
129503909|NCT01419665|466133638|FG001|Open Label Phase|disease progression|1|||
129503910|NCT04799405|466133639|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
129503911|NCT02683525|466133640|FG000|Overall Study|Lost to Follow-up|1|||
129503912|NCT02683525|466133640|FG000|Overall Study|Physician Decision|1|||
129503913|NCT02683525|466133640|FG000|Overall Study|Disease Progression|6|||
129982191|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
129503914|NCT00926796|466133644|FG000|Overall Study|Did not receive randomized treatment|4|||
129503915|NCT00926796|466133645|FG001|Overall Study|Did not receive randomized treatment|7|||
129503916|NCT00926796|466133644|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
129503917|NCT00926796|466133645|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
129503918|NCT00926796|466133644|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
129503919|NCT00926796|466133645|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
129982192|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
129982193|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
129982194|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
129982195|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Death|3|||
129982196|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Death|1|||
129982197|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
129982198|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
129982199|NCT00095056|467898761|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
129982200|NCT00095056|467898762|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
129982201|NCT00923260|467898768|FG000|Overall Study|Lost to Follow-up|1|||
129503920|NCT00926796|466133644|FG000|Overall Study|Adverse Event|7|||
129503921|NCT00926796|466133645|FG001|Overall Study|Adverse Event|14|||
129503922|NCT00926796|466133644|FG000|Overall Study|Lost to Follow-up|22|||
129503923|NCT00926796|466133645|FG001|Overall Study|Lost to Follow-up|13|||
129503924|NCT00926796|466133644|FG000|Overall Study|Protocol Violation|15|||
129503925|NCT00926796|466133645|FG001|Overall Study|Protocol Violation|11|||
129503926|NCT00926796|466133644|FG000|Overall Study|Withdrawal by Subject|1|||
129503927|NCT00926796|466133645|FG001|Overall Study|Withdrawal by Subject|0|||
129503928|NCT01341652|466133646|FG000|Overall Study|Incorrect Random Assignment|0|||
129503929|NCT01341652|466133647|FG001|Overall Study|Incorrect Random Assignment|1|||
129503930|NCT01341652|466133646|FG000|Overall Study|ineligible; presence metastatic disease|0|||
129503931|NCT01341652|466133647|FG001|Overall Study|ineligible; presence metastatic disease|1|||
129503932|NCT02998554|466133657|FG000|Overall Study|Adverse Event|8|||
129503933|NCT02998554|466133658|FG001|Overall Study|Adverse Event|3|||
129503934|NCT02998554|466133657|FG000|Overall Study|Protocol deviation|1|||
129503935|NCT02998554|466133658|FG001|Overall Study|Protocol deviation|0|||
129503936|NCT02998554|466133657|FG000|Overall Study|Withdrawal by Subject|2|||
129503937|NCT02998554|466133658|FG001|Overall Study|Withdrawal by Subject|6|||
129503938|NCT02998554|466133657|FG000|Overall Study|Lost to Follow-up|0|||
129503939|NCT02998554|466133658|FG001|Overall Study|Lost to Follow-up|1|||
129503940|NCT02998554|466133657|FG000|Overall Study|Lack of Efficacy|0|||
129503941|NCT02998554|466133658|FG001|Overall Study|Lack of Efficacy|1|||
129503942|NCT03731364|466133660|FG000|Overall Study|Adverse Event|0|||
129503943|NCT03731364|466133661|FG001|Overall Study|Adverse Event|0|||
129503944|NCT03731364|466133662|FG002|Overall Study|Adverse Event|1|||
129503945|NCT03731364|466133663|FG003|Overall Study|Adverse Event|2|||
129503946|NCT03731364|466133664|FG004|Overall Study|Adverse Event|1|||
129503947|NCT01934192|466133665|FG000|Overall Study|Protocol Violation|0|||
129503948|NCT01934192|466133666|FG001|Overall Study|Protocol Violation|0|||
129503949|NCT01934192|466133667|FG002|Overall Study|Protocol Violation|0|||
129503950|NCT01934192|466133668|FG003|Overall Study|Protocol Violation|1|||
129503951|NCT01934192|466133665|FG000|Overall Study|Other: reached stopping criteria|6|||
129503952|NCT01934192|466133666|FG001|Overall Study|Other: reached stopping criteria|5|||
129503953|NCT01934192|466133667|FG002|Overall Study|Other: reached stopping criteria|1|||
129503954|NCT01934192|466133668|FG003|Overall Study|Other: reached stopping criteria|0|||
129503955|NCT01934192|466133665|FG000|Overall Study|Physician Decision|3|||
129503956|NCT01934192|466133666|FG001|Overall Study|Physician Decision|2|||
129503957|NCT01934192|466133667|FG002|Overall Study|Physician Decision|0|||
129503958|NCT01934192|466133668|FG003|Overall Study|Physician Decision|0|||
129503959|NCT01189435|466133669|FG000|Overall Study|Withdrawal by Subject|1|||
129503960|NCT01189435|466133669|FG000|Overall Study|Physician Decision|1|||
129503961|NCT02357849|466133672|FG000|Overall Study|Withdrawal by Subject|2|||
129503962|NCT02357849|466133673|FG001|Overall Study|Withdrawal by Subject|3|||
129503963|NCT01536119|466133674|FG000|Overall Study|Lost to Follow-up|17|||
129503964|NCT01536119|466133675|FG001|Overall Study|Lost to Follow-up|14|||
129503965|NCT00213980|466136080|FG000|Overall Study|Withdrawal by Subject|3|||
129503966|NCT00213980|466136081|FG001|Overall Study|Withdrawal by Subject|1|||
129503967|NCT00213980|466136080|FG000|Overall Study|Adverse Event|1|||
129503968|NCT00213980|466136081|FG001|Overall Study|Adverse Event|1|||
129503969|NCT00213980|466136080|FG000|Overall Study|Disease progression|0|||
129503970|NCT00213980|466136081|FG001|Overall Study|Disease progression|2|||
129503971|NCT00213980|466136080|FG000|Overall Study|Developed ovarian cancer|1|||
129503972|NCT00213980|466136081|FG001|Overall Study|Developed ovarian cancer|0|||
129503973|NCT00213980|466136080|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
129503974|NCT00213980|466136081|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
129503975|NCT00798694|466136082|FG000|Overall Study|Lost to Follow-up|1|||
129503976|NCT00798694|466136083|FG001|Overall Study|Lost to Follow-up|1|||
129503977|NCT00798694|466136082|FG000|Overall Study|Physician Decision|1|||
129503978|NCT00798694|466136083|FG001|Overall Study|Physician Decision|0|||
129503979|NCT01774344|466136085|FG000|Overall Study|Withdrawal by Subject|3|||
129503980|NCT01774344|466136086|FG001|Overall Study|Withdrawal by Subject|10|||
129982202|NCT00923260|467898769|FG001|Overall Study|Lost to Follow-up|1|||
129503981|NCT01774344|466136085|FG000|Overall Study|Protocol Violation|0|||
129503982|NCT01774344|466136086|FG001|Overall Study|Protocol Violation|1|||
129503983|NCT01774344|466136085|FG000|Overall Study|Lost to Follow-up|4|||
129503984|NCT01774344|466136086|FG001|Overall Study|Lost to Follow-up|10|||
129503985|NCT01774344|466136085|FG000|Overall Study|End of survival follow-up not available|2|||
129503986|NCT01774344|466136086|FG001|Overall Study|End of survival follow-up not available|2|||
129503987|NCT01774344|466136085|FG000|Overall Study|Data collection finished|4|||
129503988|NCT01774344|466136086|FG001|Overall Study|Data collection finished|14|||
129503989|NCT01774344|466136085|FG000|Overall Study|Other|0|||
129503990|NCT01774344|466136086|FG001|Overall Study|Other|1|||
129503991|NCT01774344|466136085|FG000|Overall Study|Did not enter Survival Follow up|49|||
129503992|NCT01774344|466136086|FG001|Overall Study|Did not enter Survival Follow up|83|||
129503993|NCT01397552|466136089|FG000|Overall Study|Adverse Event|1|||
129503994|NCT01397552|466136090|FG001|Overall Study|Adverse Event|0|||
129503995|NCT01397552|466136089|FG000|Overall Study|Withdrawal by Subject|2|||
129503996|NCT01397552|466136090|FG001|Overall Study|Withdrawal by Subject|1|||
129503997|NCT01089582|466136092|FG000|Overall Study|Death|2|||
129503998|NCT01089582|466136092|FG000|Overall Study|Adverse Event|15|||
129503999|NCT01089582|466136092|FG000|Overall Study|Lost to Follow-up|8|||
129504000|NCT01089582|466136092|FG000|Overall Study|Other|4|||
129504001|NCT01089582|466136092|FG000|Overall Study|Withdrawal by Subject|1|||
129504002|NCT02108600|466136093|FG000|Overall Study|Withdrawal by Subject|2|||
129504003|NCT02108600|466136094|FG001|Overall Study|Withdrawal by Subject|0|||
129504004|NCT02108600|466136093|FG000|Overall Study|Lost to Follow-up|1|||
129504005|NCT02108600|466136094|FG001|Overall Study|Lost to Follow-up|1|||
129504006|NCT00862849|466136095|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129504007|NCT00862849|466136096|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
129504008|NCT00862849|466136097|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129504009|NCT00862849|466136098|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129504010|NCT00862849|466136099|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129504011|NCT00862849|466136100|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
129504012|NCT00862849|466136095|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
129504013|NCT00862849|466136096|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
129504014|NCT00862849|466136097|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
129504015|NCT00862849|466136098|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
129504016|NCT00862849|466136099|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
129504017|NCT00862849|466136100|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
129504018|NCT04032171|466136108|FG000|Overall Study|Study Termination|1|||
129504019|NCT04032171|466136109|FG001|Overall Study|Study Termination|0|||
129504020|NCT00992784|466136110|FG000|Overall Study|Adverse Event|2|||
129504021|NCT00992784|466136111|FG001|Overall Study|Adverse Event|1|||
129504022|NCT00992784|466136112|FG002|Overall Study|Adverse Event|0|||
129504023|NCT00992784|466136110|FG000|Overall Study|Withdrawal by Subject|1|||
129504024|NCT00992784|466136111|FG001|Overall Study|Withdrawal by Subject|1|||
129504025|NCT00992784|466136112|FG002|Overall Study|Withdrawal by Subject|1|||
129504026|NCT01363713|466136113|FG000|Overall Study|Adverse Event|1|||
129504027|NCT01363713|466136113|FG000|Overall Study|Protocol Violation|3|||
129504028|NCT01363713|466136113|FG000|Overall Study|Withdrawal by Subject|2|||
129504029|NCT01658579|466136114|FG000|Treatment Period A|Other|0|||
129504030|NCT01658579|466136115|FG001|Treatment Period A|Other|0|||
129504031|NCT01658579|466136116|FG002|Treatment Period A|Other|1|||
129504032|NCT01658579|466136117|FG003|Treatment Period A|Other|1|||
129504033|NCT01658579|466136114|FG000|Treatment Period A|Adverse Event|1|||
129504034|NCT01658579|466136115|FG001|Treatment Period A|Adverse Event|0|||
129504035|NCT01658579|466136116|FG002|Treatment Period A|Adverse Event|0|||
129504036|NCT01658579|466136117|FG003|Treatment Period A|Adverse Event|0|||
129504037|NCT01658579|466136114|FG000|Treatment Period B|Other|0|||
129504038|NCT01658579|466136115|FG001|Treatment Period B|Other|0|||
129504039|NCT01658579|466136116|FG002|Treatment Period B|Other|0|||
129504040|NCT01658579|466136117|FG003|Treatment Period B|Other|1|||
129504041|NCT00608530|466136118|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
129504042|NCT00608530|466136119|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
129504043|NCT00608530|466136120|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
129504044|NCT00608530|466136121|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
129504045|NCT00608530|466136118|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
129504046|NCT00608530|466136119|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
129504047|NCT00608530|466136120|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
129504048|NCT00608530|466136121|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
129504049|NCT00608530|466136118|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
129504050|NCT00608530|466136119|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
129504051|NCT00608530|466136120|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
129504052|NCT00608530|466136121|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
129504053|NCT00608530|466136118|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
129504054|NCT00608530|466136119|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
129504055|NCT00608530|466136120|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
129504056|NCT00608530|466136121|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
129504057|NCT00608530|466136118|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
129504058|NCT00608530|466136119|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
129504059|NCT00608530|466136120|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
129504060|NCT00608530|466136121|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
129504061|NCT00608530|466136118|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
129504062|NCT00608530|466136119|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
129982203|NCT04410523|467898771|FG000|Overall Study|Study terminated by sponsor|1|||
129504063|NCT00608530|466136120|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
129504064|NCT00608530|466136121|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
129504065|NCT01357915|466136122|FG000|Overall Study|Lost to Follow-up|3|||
129504066|NCT01357915|466136123|FG001|Overall Study|Lost to Follow-up|0|||
129504067|NCT01514188|466136124|FG000|Overall Study|Adverse Event|3|||
129504068|NCT01514188|466136125|FG001|Overall Study|Adverse Event|5|||
129504069|NCT01514188|466136124|FG000|Overall Study|Withdrawal by Subject|2|||
129504070|NCT01514188|466136125|FG001|Overall Study|Withdrawal by Subject|4|||
129504071|NCT01514188|466136124|FG000|Overall Study|Protocol Violation|2|||
129504072|NCT01514188|466136125|FG001|Overall Study|Protocol Violation|4|||
129504073|NCT01514188|466136124|FG000|Overall Study|Physician Decision|0|||
129504074|NCT01514188|466136125|FG001|Overall Study|Physician Decision|2|||
129504075|NCT01514188|466136124|FG000|Overall Study|Disease Progression|13|||
129504076|NCT01514188|466136125|FG001|Overall Study|Disease Progression|14|||
129504077|NCT01514188|466136124|FG000|Overall Study|Death|1|||
129504078|NCT01514188|466136125|FG001|Overall Study|Death|3|||
129504079|NCT01514188|466136124|FG000|Overall Study|Other|2|||
129504080|NCT01514188|466136125|FG001|Overall Study|Other|1|||
129504081|NCT01019486|466136126|FG000|Overall Study|Withdrawal by Subject|1|||
129504082|NCT01019486|466136127|FG001|Overall Study|Withdrawal by Subject|1|||
129504083|NCT01019486|466136128|FG002|Overall Study|Withdrawal by Subject|1|||
129504084|NCT02932332|466136133|FG000|Overall Study|Withdrawal by Subject|1|||
129504085|NCT02932332|466136134|FG001|Overall Study|Withdrawal by Subject|1|||
129504086|NCT02932332|466136135|FG002|Overall Study|Withdrawal by Subject|0|||
129504087|NCT02932332|466136136|FG003|Overall Study|Withdrawal by Subject|1|||
129504088|NCT02932332|466136133|FG000|Overall Study|Chest pain|0|||
129504089|NCT02932332|466136134|FG001|Overall Study|Chest pain|0|||
129504090|NCT02932332|466136135|FG002|Overall Study|Chest pain|0|||
129504091|NCT02932332|466136136|FG003|Overall Study|Chest pain|1|||
129504092|NCT02932332|466136133|FG000|Overall Study|Not Dyspneic cough|1|||
129504093|NCT02932332|466136134|FG001|Overall Study|Not Dyspneic cough|2|||
129504094|NCT02932332|466136135|FG002|Overall Study|Not Dyspneic cough|1|||
129504095|NCT02932332|466136136|FG003|Overall Study|Not Dyspneic cough|0|||
129504096|NCT02841787|466136137|FG000|Overall Study|Lost to Follow-up|1|||
129504097|NCT02841787|466136138|FG001|Overall Study|Lost to Follow-up|0|||
129504098|NCT02841787|466136139|FG002|Overall Study|Lost to Follow-up|0|||
129504099|NCT02841787|466136137|FG000|Overall Study|Symptoms dropped below threshold|1|||
129504100|NCT02841787|466136138|FG001|Overall Study|Symptoms dropped below threshold|0|||
129504101|NCT02841787|466136139|FG002|Overall Study|Symptoms dropped below threshold|0|||
129504102|NCT02841787|466136137|FG000|Overall Study|Withdrawal by Subject|1|||
129504103|NCT02841787|466136138|FG001|Overall Study|Withdrawal by Subject|4|||
129504104|NCT02841787|466136139|FG002|Overall Study|Withdrawal by Subject|0|||
129504105|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
129504106|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
129504107|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Death|2|||
129504108|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Death|1|||
129504109|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
129504110|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
129504111|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
129504112|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
129504113|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
129504114|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
129504115|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
129504116|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
129504117|NCT03633227|466136140|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
129504118|NCT03633227|466136141|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
129504119|NCT03633227|466136140|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
129504120|NCT03633227|466136141|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
129504121|NCT03633227|466136140|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
129504122|NCT03633227|466136141|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
129504123|NCT03633227|466136140|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
129504124|NCT03633227|466136141|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
129504125|NCT03633227|466136140|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
129504126|NCT03633227|466136141|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
129504127|NCT03633227|466136140|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
129504128|NCT03633227|466136141|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
129504129|NCT03029650|466136146|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
129504130|NCT03029650|466136147|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
129504131|NCT03029650|466136146|FG000|Washout (1 Week)|Physician Decision|0|||
129504132|NCT03029650|466136147|FG001|Washout (1 Week)|Physician Decision|1|||
129504133|NCT01875367|466136148|FG000|Overall Study|Not complete at least 2 questionaries|4|||
129504134|NCT01875367|466136149|FG001|Overall Study|Not complete at least 2 questionaries|2|||
129504135|NCT01875367|466136148|FG000|Overall Study|Not receive study treatment|1|||
129504136|NCT01875367|466136149|FG001|Overall Study|Not receive study treatment|0|||
129504137|NCT04533815|466136152|FG000|Overall Study|Adverse Event|2|||
129504138|NCT04533815|466136152|FG000|Overall Study|Site withdrew|5|||
129504139|NCT02951988|466136155|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
129504140|NCT02951988|466136156|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
129504141|NCT02951988|466136157|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
129504142|NCT02951988|466136158|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
129504143|NCT02951988|466136155|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
129504144|NCT02951988|466136156|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
129504145|NCT02951988|466136157|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
129504146|NCT02951988|466136158|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
129504147|NCT02951988|466136155|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
129504148|NCT02951988|466136156|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
129504149|NCT02951988|466136157|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
129504150|NCT02951988|466136158|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
129504151|NCT02951988|466136155|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
129504152|NCT02951988|466136156|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
129504153|NCT02951988|466136157|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
129504154|NCT02951988|466136158|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
129504155|NCT02951988|466136155|FG000|Open-Label Treatment Period|Protocol Violation|22|||
129504156|NCT02951988|466136156|FG001|Open-Label Treatment Period|Protocol Violation|0|||
129504157|NCT02951988|466136157|FG002|Open-Label Treatment Period|Protocol Violation|0|||
129504158|NCT02951988|466136158|FG003|Open-Label Treatment Period|Protocol Violation|0|||
129504159|NCT02951988|466136155|FG000|Open-Label Treatment Period|Pregnancy|2|||
129504160|NCT02951988|466136156|FG001|Open-Label Treatment Period|Pregnancy|0|||
129504161|NCT02951988|466136157|FG002|Open-Label Treatment Period|Pregnancy|0|||
129504162|NCT02951988|466136158|FG003|Open-Label Treatment Period|Pregnancy|0|||
129504163|NCT02951988|466136155|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
129504164|NCT02951988|466136156|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
129504165|NCT02951988|466136157|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
129504166|NCT02951988|466136158|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
129504167|NCT02951988|466136155|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
129504168|NCT02951988|466136156|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
129504169|NCT02951988|466136157|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
129504170|NCT02951988|466136158|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
129504171|NCT02951988|466136155|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
129504172|NCT02951988|466136156|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
129504173|NCT02951988|466136157|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
129504174|NCT02951988|466136158|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
129504175|NCT02951988|466136155|FG000|Open-Label Treatment Period|Adverse Event|45|||
129504176|NCT02951988|466136156|FG001|Open-Label Treatment Period|Adverse Event|0|||
129504177|NCT02951988|466136157|FG002|Open-Label Treatment Period|Adverse Event|0|||
129504178|NCT02951988|466136158|FG003|Open-Label Treatment Period|Adverse Event|0|||
129504179|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
129504180|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
129504181|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
129504182|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
129504183|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
129504184|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
129504185|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
129504186|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
129504187|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
129504188|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
129504189|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
129504190|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
129504191|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
129504192|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
129504193|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
129504194|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
129504195|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Pregnancy|0|||
129504196|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Pregnancy|1|||
129504197|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Pregnancy|1|||
129504198|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Pregnancy|0|||
129504199|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129504200|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
129504201|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
129504202|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
129504203|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129504204|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
129504205|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
129504206|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
129504207|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Adverse Event|0|||
129504208|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Adverse Event|8|||
129504209|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Adverse Event|3|||
129504210|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Adverse Event|6|||
129504211|NCT02951988|466136155|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
129504212|NCT02951988|466136156|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
129504213|NCT02951988|466136157|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
129504214|NCT02951988|466136158|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
129504215|NCT00603980|466136160|FG000|Study Qualification|Protocol Violation|3|||
129504216|NCT00603980|466136160|FG000|Study Qualification|Inconsistent data reporting|13|||
129504217|NCT00603980|466136160|FG000|Main Study|14th subject completed trial|1|||
129504218|NCT01627067|466136161|FG000|Overall Study|Screen Failure|1|||
129504219|NCT00632463|466136162|FG000|Overall Study|Adverse Event|0|||
129504220|NCT00632463|466136163|FG001|Overall Study|Adverse Event|1|||
129504221|NCT00632463|466136164|FG002|Overall Study|Adverse Event|0|||
129504222|NCT00586924|466136165|FG000|Overall Study|Adverse event/serious adverse event|0|||
129504223|NCT00586924|466136166|FG001|Overall Study|Adverse event/serious adverse event|0|||
129504224|NCT00586924|466136167|FG002|Overall Study|Adverse event/serious adverse event|0|||
129504225|NCT00586924|466136168|FG003|Overall Study|Adverse event/serious adverse event|1|||
129504226|NCT00586924|466136169|FG004|Overall Study|Adverse event/serious adverse event|0|||
129504227|NCT00586924|466136170|FG005|Overall Study|Adverse event/serious adverse event|2|||
129504228|NCT00586924|466136165|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
129504229|NCT00586924|466136166|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
129504230|NCT00586924|466136167|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
129504231|NCT00586924|466136168|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
129504232|NCT00586924|466136169|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
129504233|NCT00586924|466136170|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
129504234|NCT00586924|466136165|FG000|Overall Study|Disease progression|0|||
129504235|NCT00586924|466136166|FG001|Overall Study|Disease progression|0|||
129504236|NCT00586924|466136167|FG002|Overall Study|Disease progression|0|||
129504237|NCT00586924|466136168|FG003|Overall Study|Disease progression|1|||
129504238|NCT00586924|466136169|FG004|Overall Study|Disease progression|1|||
129504239|NCT00586924|466136170|FG005|Overall Study|Disease progression|0|||
129504240|NCT00586924|466136165|FG000|Overall Study|Development of neutralizing antibodies|2|||
129504241|NCT00586924|466136166|FG001|Overall Study|Development of neutralizing antibodies|2|||
129504242|NCT00586924|466136167|FG002|Overall Study|Development of neutralizing antibodies|2|||
129504243|NCT00586924|466136168|FG003|Overall Study|Development of neutralizing antibodies|0|||
129504244|NCT00586924|466136169|FG004|Overall Study|Development of neutralizing antibodies|0|||
129504245|NCT00586924|466136170|FG005|Overall Study|Development of neutralizing antibodies|22|||
129504246|NCT00586924|466136165|FG000|Overall Study|Complete response|0|||
129504247|NCT00586924|466136166|FG001|Overall Study|Complete response|1|||
129504248|NCT00586924|466136167|FG002|Overall Study|Complete response|0|||
129504249|NCT00586924|466136168|FG003|Overall Study|Complete response|0|||
129504250|NCT00586924|466136169|FG004|Overall Study|Complete response|2|||
129504251|NCT00586924|466136170|FG005|Overall Study|Complete response|2|||
129504252|NCT00586924|466136165|FG000|Overall Study|Other|1|||
129504253|NCT00586924|466136166|FG001|Overall Study|Other|0|||
129504254|NCT00586924|466136167|FG002|Overall Study|Other|1|||
129504255|NCT00586924|466136168|FG003|Overall Study|Other|1|||
129504256|NCT00586924|466136169|FG004|Overall Study|Other|1|||
129504257|NCT00586924|466136170|FG005|Overall Study|Other|6|||
129504258|NCT04167306|466136171|FG000|Overall Study|Lost to Follow-up|2|||
129504259|NCT04167306|466136172|FG001|Overall Study|Lost to Follow-up|2|||
129504260|NCT04167306|466136173|FG002|Overall Study|Lost to Follow-up|5|||
129504261|NCT04167306|466136174|FG003|Overall Study|Lost to Follow-up|5|||
129504262|NCT04167306|466136171|FG000|Overall Study|Adverse Event|13|||
129504263|NCT04167306|466136172|FG001|Overall Study|Adverse Event|14|||
129504264|NCT04167306|466136173|FG002|Overall Study|Adverse Event|5|||
129504265|NCT04167306|466136174|FG003|Overall Study|Adverse Event|4|||
129504266|NCT04167306|466136171|FG000|Overall Study|Withdrawal by Subject|4|||
129504267|NCT04167306|466136172|FG001|Overall Study|Withdrawal by Subject|6|||
129504268|NCT04167306|466136173|FG002|Overall Study|Withdrawal by Subject|8|||
129504269|NCT04167306|466136174|FG003|Overall Study|Withdrawal by Subject|3|||
129504270|NCT04167306|466136171|FG000|Overall Study|covid|1|||
129504271|NCT04167306|466136172|FG001|Overall Study|covid|1|||
129504272|NCT04167306|466136173|FG002|Overall Study|covid|2|||
129504273|NCT04167306|466136174|FG003|Overall Study|covid|1|||
129504274|NCT04167306|466136171|FG000|Overall Study|concomitant medication|0|||
129504275|NCT04167306|466136172|FG001|Overall Study|concomitant medication|0|||
129504276|NCT04167306|466136173|FG002|Overall Study|concomitant medication|0|||
129504277|NCT04167306|466136174|FG003|Overall Study|concomitant medication|1|||
129504278|NCT04167306|466136171|FG000|Overall Study|Alcohol treatment|0|||
129504279|NCT04167306|466136172|FG001|Overall Study|Alcohol treatment|4|||
129504280|NCT04167306|466136173|FG002|Overall Study|Alcohol treatment|3|||
129504281|NCT04167306|466136174|FG003|Overall Study|Alcohol treatment|2|||
129504282|NCT04167306|466136171|FG000|Overall Study|non-compliance|0|||
129504283|NCT04167306|466136172|FG001|Overall Study|non-compliance|0|||
129504284|NCT04167306|466136173|FG002|Overall Study|non-compliance|1|||
129504285|NCT04167306|466136174|FG003|Overall Study|non-compliance|0|||
129504286|NCT04167306|466136171|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
129504287|NCT04167306|466136172|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
129504288|NCT04167306|466136173|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
129504289|NCT04167306|466136174|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
129504290|NCT04146467|466136178|FG000|Overall Study|Adverse Event|0|||
129504291|NCT04146467|466136179|FG001|Overall Study|Adverse Event|1|||
129504292|NCT04146467|466136178|FG000|Overall Study|Lost to Follow-up|0|||
129504293|NCT04146467|466136179|FG001|Overall Study|Lost to Follow-up|2|||
129504294|NCT01982773|466136188|FG000|Overall Study|Withdrawal by Subject|1|||
129504295|NCT01982773|466136189|FG001|Overall Study|Withdrawal by Subject|3|||
129504296|NCT01982773|466136188|FG000|Overall Study|Lost to Follow-up|7|||
129504297|NCT01982773|466136189|FG001|Overall Study|Lost to Follow-up|1|||
129504298|NCT01029886|466136190|FG000|Overall Study|Adverse Event|12|||
129504299|NCT01029886|466136191|FG001|Overall Study|Adverse Event|25|||
129504300|NCT01029886|466136190|FG000|Overall Study|Lost to Follow-up|1|||
129504301|NCT01029886|466136191|FG001|Overall Study|Lost to Follow-up|0|||
129504302|NCT01029886|466136190|FG000|Overall Study|Physician Decision|2|||
129504303|NCT01029886|466136191|FG001|Overall Study|Physician Decision|6|||
129504304|NCT01029886|466136190|FG000|Overall Study|Protocol Violation|17|||
129504305|NCT01029886|466136191|FG001|Overall Study|Protocol Violation|5|||
129504306|NCT01029886|466136190|FG000|Overall Study|Withdrawal by Subject|8|||
129504307|NCT01029886|466136191|FG001|Overall Study|Withdrawal by Subject|18|||
129504308|NCT01029886|466136190|FG000|Overall Study|Entry Criteria Not Met|13|||
129504309|NCT01029886|466136191|FG001|Overall Study|Entry Criteria Not Met|5|||
129504310|NCT01029886|466136190|FG000|Overall Study|Sponsor Decision|1|||
129504311|NCT01029886|466136191|FG001|Overall Study|Sponsor Decision|0|||
129504312|NCT01029886|466136190|FG000|Overall Study|Loss Glucose Control|7|||
129504313|NCT01029886|466136191|FG001|Overall Study|Loss Glucose Control|1|||
129504314|NCT03294681|466136192|FG000|Overall Study|Withdrawal by Subject|1|||
129504315|NCT01778127|466136193|FG000|Overall Study|Lost to Follow-up|5|||
129504316|NCT01778127|466136194|FG001|Overall Study|Lost to Follow-up|1|||
129504317|NCT01778127|466136195|FG002|Overall Study|Lost to Follow-up|2|||
129504318|NCT01778127|466136193|FG000|Overall Study|Withdrawal by Subject|3|||
129504319|NCT01778127|466136194|FG001|Overall Study|Withdrawal by Subject|1|||
129504320|NCT01778127|466136195|FG002|Overall Study|Withdrawal by Subject|4|||
129504321|NCT01348425|466136196|FG000|Overall Study|Imaging was not taken.|1|||
129504322|NCT01348425|466136197|FG001|Overall Study|Imaging was not taken.|1|||
129504323|NCT03722784|466136198|FG000|Overall Study|Withdrawal by Subject|1|||
129504324|NCT03722784|466136199|FG001|Overall Study|Withdrawal by Subject|0|||
129504325|NCT03722784|466136198|FG000|Overall Study|Physician Decision|1|||
129504326|NCT03722784|466136199|FG001|Overall Study|Physician Decision|1|||
129504327|NCT03722784|466136198|FG000|Overall Study|Protocol Violation|0|||
129504328|NCT03722784|466136199|FG001|Overall Study|Protocol Violation|1|||
129504329|NCT00751114|466136201|FG000|Overall Study|Adverse Event|2|||
129504330|NCT00751114|466136202|FG001|Overall Study|Adverse Event|4|||
129504331|NCT00751114|466136201|FG000|Overall Study|Protocol Violation|8|||
129504332|NCT00751114|466136202|FG001|Overall Study|Protocol Violation|9|||
129504333|NCT00751114|466136201|FG000|Overall Study|Withdrawal by Subject|9|||
129504334|NCT00751114|466136202|FG001|Overall Study|Withdrawal by Subject|4|||
129504335|NCT00751114|466136201|FG000|Overall Study|Lost to Follow-up|4|||
129504336|NCT00751114|466136202|FG001|Overall Study|Lost to Follow-up|7|||
129504337|NCT00751114|466136201|FG000|Overall Study|Lack of Efficacy|0|||
129504338|NCT00751114|466136202|FG001|Overall Study|Lack of Efficacy|7|||
129504339|NCT00751114|466136201|FG000|Overall Study|Not Treated|13|||
129504340|NCT00751114|466136202|FG001|Overall Study|Not Treated|1|||
129504341|NCT00751114|466136201|FG000|Overall Study|Out of country for 2 months|1|||
129504342|NCT00751114|466136202|FG001|Overall Study|Out of country for 2 months|0|||
129504343|NCT00751114|466136201|FG000|Overall Study|Move to another city|1|||
129504344|NCT00751114|466136202|FG001|Overall Study|Move to another city|0|||
129504345|NCT03259490|466136203|FG000|Period 1|Withdrawal by Subject|0|||
129504346|NCT03259490|466136204|FG001|Period 1|Withdrawal by Subject|1|||
129504347|NCT03259490|466136203|FG000|Period 2|Protocol Violation|1|||
129504348|NCT03259490|466136204|FG001|Period 2|Protocol Violation|0|||
129504349|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
129504350|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
129504351|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
129504352|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
129504353|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
129504354|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
129504355|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
129504356|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
129504357|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
129504358|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
129504359|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
129504360|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
129539070|NCT02708524|466265146|FG002|Overall Study|Lost to Follow-up|1|||
129504361|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
129504362|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
129504363|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
129504364|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
129504365|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
129504366|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
129504367|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
129504368|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
129504369|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
129504370|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
129504371|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
129504372|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
129504373|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
129504374|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
129504375|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
129504376|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
129504377|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
129504378|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
129504379|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129504380|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129504381|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129504382|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
129504383|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129504384|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
129504385|NCT01963208|466136205|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
129504386|NCT01963208|466136206|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
129504387|NCT01963208|466136207|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
129504388|NCT01963208|466136208|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
129504389|NCT01963208|466136209|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
129504390|NCT01963208|466136210|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
129504391|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129504392|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129504393|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129504394|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
129504395|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
129504396|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
129504397|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
129504398|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
129504399|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
129504400|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
129504401|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
129504402|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
129504403|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
129504404|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
129504405|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
129504406|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
129504407|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
129504408|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
129504409|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
129504410|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
129504411|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
129504412|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
129504413|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
129504414|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
129504415|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
129504416|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
129504417|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
129504418|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
129504419|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
129504420|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
129504421|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
129504422|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
129504423|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
129504424|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
129504425|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
129504426|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
129504427|NCT01963208|466136205|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
129504428|NCT01963208|466136206|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
129504429|NCT01963208|466136207|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
129504430|NCT01963208|466136208|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
129504431|NCT01963208|466136209|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
129504432|NCT01963208|466136210|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
129504433|NCT00448916|466136211|FG000|Overall Study|Adverse Event|2|||
129504434|NCT00448916|466136212|FG001|Overall Study|Adverse Event|2|||
129504435|NCT00448916|466136213|FG002|Overall Study|Adverse Event|3|||
129504436|NCT00448916|466136214|FG003|Overall Study|Adverse Event|2|||
129504437|NCT00448916|466136211|FG000|Overall Study|Lack of Efficacy|1|||
129504438|NCT00448916|466136212|FG001|Overall Study|Lack of Efficacy|0|||
129504439|NCT00448916|466136213|FG002|Overall Study|Lack of Efficacy|2|||
129504440|NCT00448916|466136214|FG003|Overall Study|Lack of Efficacy|1|||
129504441|NCT00448916|466136211|FG000|Overall Study|Withdrawal by Subject|3|||
129504442|NCT00448916|466136212|FG001|Overall Study|Withdrawal by Subject|3|||
129504443|NCT00448916|466136213|FG002|Overall Study|Withdrawal by Subject|1|||
129504444|NCT00448916|466136214|FG003|Overall Study|Withdrawal by Subject|1|||
129504445|NCT00448916|466136211|FG000|Overall Study|Other|1|||
129504446|NCT00448916|466136212|FG001|Overall Study|Other|0|||
129504447|NCT00448916|466136213|FG002|Overall Study|Other|0|||
129504448|NCT00448916|466136214|FG003|Overall Study|Other|0|||
129504449|NCT00448916|466136211|FG000|Overall Study|Lost to Follow-up|0|||
129504450|NCT00448916|466136212|FG001|Overall Study|Lost to Follow-up|1|||
129504451|NCT00448916|466136213|FG002|Overall Study|Lost to Follow-up|0|||
129504452|NCT00448916|466136214|FG003|Overall Study|Lost to Follow-up|1|||
129504453|NCT00448916|466136211|FG000|Overall Study|Protocol Violation|0|||
129504454|NCT00448916|466136212|FG001|Overall Study|Protocol Violation|0|||
129504455|NCT00448916|466136213|FG002|Overall Study|Protocol Violation|0|||
129504456|NCT00448916|466136214|FG003|Overall Study|Protocol Violation|1|||
129504457|NCT03521193|466136215|FG000|Overall Study|Withdrawal by Subject|8|||
129504458|NCT03521193|466136216|FG001|Overall Study|Withdrawal by Subject|0|||
129504459|NCT03521193|466136215|FG000|Overall Study|non compliant to ASA treatment|8|||
129504460|NCT03521193|466136216|FG001|Overall Study|non compliant to ASA treatment|0|||
129504461|NCT00012012|466136217|FG000|Overall Study|Protocol Violation|1|||
129504462|NCT00012012|466136218|FG001|Overall Study|Protocol Violation|1|||
129504463|NCT00012012|466136217|FG000|Overall Study|Withdrawal by Subject|0|||
129504464|NCT00012012|466136218|FG001|Overall Study|Withdrawal by Subject|2|||
129504465|NCT03707158|466136219|FG000|Midtreatment|Lost to Follow-up|16|||
129504466|NCT03707158|466136220|FG001|Midtreatment|Lost to Follow-up|7|||
129504467|NCT03707158|466136219|FG000|Midtreatment|Withdrawal by Subject|28|||
129504468|NCT03707158|466136220|FG001|Midtreatment|Withdrawal by Subject|19|||
129504469|NCT03707158|466136219|FG000|Posttreatment|Lost to Follow-up|0|||
129504470|NCT03707158|466136220|FG001|Posttreatment|Lost to Follow-up|5|||
129504471|NCT03707158|466136219|FG000|Follow-up|Lost to Follow-up|19|||
129504472|NCT03707158|466136220|FG001|Follow-up|Lost to Follow-up|18|||
129504473|NCT03707158|466136219|FG000|Follow-up|Withdrawal by Subject|13|||
129504474|NCT03707158|466136220|FG001|Follow-up|Withdrawal by Subject|6|||
129504475|NCT03260205|466136226|FG000|Overall Study|Adverse Event|2|||
129504476|NCT03260205|466136227|FG001|Overall Study|Adverse Event|0|||
129504477|NCT03260205|466136228|FG002|Overall Study|Adverse Event|2|||
129504478|NCT03260205|466136229|FG003|Overall Study|Adverse Event|2|||
129504479|NCT03260205|466136230|FG004|Overall Study|Adverse Event|4|||
129504480|NCT03260205|466136226|FG000|Overall Study|Lost to Follow-up|2|||
129504481|NCT03260205|466136227|FG001|Overall Study|Lost to Follow-up|2|||
129504482|NCT03260205|466136228|FG002|Overall Study|Lost to Follow-up|1|||
129504483|NCT03260205|466136229|FG003|Overall Study|Lost to Follow-up|1|||
129504484|NCT03260205|466136230|FG004|Overall Study|Lost to Follow-up|5|||
129504485|NCT03260205|466136226|FG000|Overall Study|Protocol Violation|0|||
129504486|NCT03260205|466136227|FG001|Overall Study|Protocol Violation|0|||
129504487|NCT03260205|466136228|FG002|Overall Study|Protocol Violation|2|||
129504488|NCT03260205|466136229|FG003|Overall Study|Protocol Violation|0|||
129504489|NCT03260205|466136230|FG004|Overall Study|Protocol Violation|1|||
129504490|NCT03260205|466136226|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
129504491|NCT03260205|466136227|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
129504492|NCT03260205|466136228|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
129504493|NCT03260205|466136229|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
129504494|NCT03260205|466136230|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
129504495|NCT03260205|466136226|FG000|Overall Study|Other: Unspecified|0|||
129504496|NCT03260205|466136227|FG001|Overall Study|Other: Unspecified|0|||
129504497|NCT03260205|466136228|FG002|Overall Study|Other: Unspecified|3|||
129504498|NCT03260205|466136229|FG003|Overall Study|Other: Unspecified|1|||
129504499|NCT03260205|466136230|FG004|Overall Study|Other: Unspecified|1|||
129504500|NCT03260205|466136226|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
129504501|NCT03260205|466136227|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
129504502|NCT03260205|466136228|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
129504503|NCT03260205|466136229|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
129504504|NCT03260205|466136230|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
129504505|NCT05301322|466136231|FG000|Overall Study|Adverse Event|7|||
129504506|NCT05301322|466136232|FG001|Overall Study|Adverse Event|3|||
129504507|NCT05301322|466136231|FG000|Overall Study|Death|0|||
129504508|NCT05301322|466136232|FG001|Overall Study|Death|1|||
129504509|NCT05301322|466136231|FG000|Overall Study|Lost to Follow-up|2|||
129504510|NCT05301322|466136232|FG001|Overall Study|Lost to Follow-up|1|||
129504511|NCT05301322|466136231|FG000|Overall Study|Protocol Violation|3|||
129504512|NCT05301322|466136232|FG001|Overall Study|Protocol Violation|1|||
129504513|NCT05301322|466136231|FG000|Overall Study|Withdrawal by Subject|3|||
129504514|NCT05301322|466136232|FG001|Overall Study|Withdrawal by Subject|0|||
129504515|NCT05301322|466136231|FG000|Overall Study|Other|4|||
129504516|NCT05301322|466136232|FG001|Overall Study|Other|0|||
129504517|NCT00808249|466136235|FG000|Overall Study|Adverse Event|4|||
129504518|NCT00808249|466136236|FG001|Overall Study|Adverse Event|7|||
129504519|NCT00808249|466136237|FG002|Overall Study|Adverse Event|10|||
129504520|NCT00808249|466136238|FG003|Overall Study|Adverse Event|6|||
129504521|NCT00808249|466136235|FG000|Overall Study|Lost to Follow-up|2|||
129504522|NCT00808249|466136236|FG001|Overall Study|Lost to Follow-up|3|||
129504523|NCT00808249|466136237|FG002|Overall Study|Lost to Follow-up|3|||
129504524|NCT00808249|466136238|FG003|Overall Study|Lost to Follow-up|5|||
129504525|NCT00808249|466136235|FG000|Overall Study|Withdrawal by Subject|4|||
129504526|NCT00808249|466136236|FG001|Overall Study|Withdrawal by Subject|0|||
129504527|NCT00808249|466136237|FG002|Overall Study|Withdrawal by Subject|2|||
129504528|NCT00808249|466136238|FG003|Overall Study|Withdrawal by Subject|4|||
129504529|NCT00808249|466136235|FG000|Overall Study|Protocol Violation|3|||
129504530|NCT00808249|466136236|FG001|Overall Study|Protocol Violation|3|||
129504531|NCT00808249|466136237|FG002|Overall Study|Protocol Violation|3|||
129504532|NCT00808249|466136238|FG003|Overall Study|Protocol Violation|0|||
129504533|NCT00808249|466136235|FG000|Overall Study|Lack of Efficacy|1|||
129504534|NCT00808249|466136236|FG001|Overall Study|Lack of Efficacy|1|||
129504535|NCT00808249|466136237|FG002|Overall Study|Lack of Efficacy|0|||
129504536|NCT00808249|466136238|FG003|Overall Study|Lack of Efficacy|0|||
129504537|NCT00808249|466136235|FG000|Overall Study|study specific discontinuation criteria|1|||
129504538|NCT00808249|466136236|FG001|Overall Study|study specific discontinuation criteria|0|||
129504539|NCT00808249|466136237|FG002|Overall Study|study specific discontinuation criteria|1|||
129504540|NCT00808249|466136238|FG003|Overall Study|study specific discontinuation criteria|0|||
129504541|NCT00808249|466136235|FG000|Overall Study|All other reasons|2|||
129504542|NCT00808249|466136236|FG001|Overall Study|All other reasons|1|||
129504543|NCT00808249|466136237|FG002|Overall Study|All other reasons|3|||
129504544|NCT00808249|466136238|FG003|Overall Study|All other reasons|1|||
129504545|NCT03829332|466136239|FG000|Overall Study|Death|225|||
129504546|NCT03829332|466136240|FG001|Overall Study|Death|230|||
129504547|NCT03829332|466136239|FG000|Overall Study|Lost to Follow-up|1|||
129504548|NCT03829332|466136240|FG001|Overall Study|Lost to Follow-up|3|||
129504549|NCT03829332|466136239|FG000|Overall Study|Physician Decision|1|||
129504550|NCT03829332|466136240|FG001|Overall Study|Physician Decision|0|||
129504551|NCT03829332|466136239|FG000|Overall Study|Sponsor Decision|71|||
129504552|NCT03829332|466136240|FG001|Overall Study|Sponsor Decision|72|||
129504553|NCT03829332|466136239|FG000|Overall Study|Withdrawal by Subject|11|||
129504554|NCT03829332|466136240|FG001|Overall Study|Withdrawal by Subject|9|||
129504555|NCT00430521|466136241|FG000|Overall Study|Adverse Event|0|||
129504556|NCT00430521|466136242|FG001|Overall Study|Adverse Event|0|||
129504557|NCT00430521|466136243|FG002|Overall Study|Adverse Event|0|||
129504558|NCT00430521|466136244|FG003|Overall Study|Adverse Event|0|||
129504559|NCT00430521|466136245|FG004|Overall Study|Adverse Event|0|||
129504560|NCT00430521|466136246|FG005|Overall Study|Adverse Event|2|||
129504561|NCT00430521|466136247|FG006|Overall Study|Adverse Event|1|||
129504562|NCT00430521|466136248|FG007|Overall Study|Adverse Event|0|||
129504563|NCT00430521|466136241|FG000|Overall Study|Lost to Follow-up|7|||
129504564|NCT00430521|466136242|FG001|Overall Study|Lost to Follow-up|8|||
129504565|NCT00430521|466136243|FG002|Overall Study|Lost to Follow-up|3|||
129504566|NCT00430521|466136244|FG003|Overall Study|Lost to Follow-up|5|||
129504567|NCT00430521|466136245|FG004|Overall Study|Lost to Follow-up|5|||
129504568|NCT00430521|466136246|FG005|Overall Study|Lost to Follow-up|2|||
129504569|NCT00430521|466136247|FG006|Overall Study|Lost to Follow-up|8|||
129504570|NCT00430521|466136248|FG007|Overall Study|Lost to Follow-up|10|||
129504571|NCT00430521|466136241|FG000|Overall Study|Pregnancy|0|||
129504572|NCT00430521|466136242|FG001|Overall Study|Pregnancy|0|||
129504573|NCT00430521|466136243|FG002|Overall Study|Pregnancy|0|||
129504574|NCT00430521|466136244|FG003|Overall Study|Pregnancy|0|||
129504575|NCT00430521|466136245|FG004|Overall Study|Pregnancy|0|||
129504576|NCT00430521|466136246|FG005|Overall Study|Pregnancy|0|||
129504577|NCT00430521|466136247|FG006|Overall Study|Pregnancy|1|||
129504578|NCT00430521|466136248|FG007|Overall Study|Pregnancy|0|||
129504579|NCT00430521|466136241|FG000|Overall Study|Vaccine Expired|0|||
129504580|NCT00430521|466136242|FG001|Overall Study|Vaccine Expired|0|||
129504581|NCT00430521|466136243|FG002|Overall Study|Vaccine Expired|0|||
129504582|NCT00430521|466136244|FG003|Overall Study|Vaccine Expired|0|||
129504583|NCT00430521|466136245|FG004|Overall Study|Vaccine Expired|0|||
129504584|NCT00430521|466136246|FG005|Overall Study|Vaccine Expired|1|||
129504585|NCT00430521|466136247|FG006|Overall Study|Vaccine Expired|0|||
129504586|NCT00430521|466136248|FG007|Overall Study|Vaccine Expired|0|||
129504587|NCT00430521|466136241|FG000|Overall Study|Protocol Violation|1|||
129504588|NCT00430521|466136242|FG001|Overall Study|Protocol Violation|0|||
129504589|NCT00430521|466136243|FG002|Overall Study|Protocol Violation|0|||
129504590|NCT00430521|466136244|FG003|Overall Study|Protocol Violation|0|||
129504591|NCT00430521|466136245|FG004|Overall Study|Protocol Violation|0|||
129504592|NCT00430521|466136246|FG005|Overall Study|Protocol Violation|0|||
129504593|NCT00430521|466136247|FG006|Overall Study|Protocol Violation|0|||
129504594|NCT00430521|466136248|FG007|Overall Study|Protocol Violation|0|||
129504595|NCT00430521|466136241|FG000|Overall Study|Withdrawal by Subject|3|||
129504596|NCT00430521|466136242|FG001|Overall Study|Withdrawal by Subject|1|||
129504597|NCT00430521|466136243|FG002|Overall Study|Withdrawal by Subject|0|||
129504598|NCT00430521|466136244|FG003|Overall Study|Withdrawal by Subject|3|||
129504599|NCT00430521|466136245|FG004|Overall Study|Withdrawal by Subject|0|||
129504600|NCT00430521|466136246|FG005|Overall Study|Withdrawal by Subject|0|||
129504601|NCT00430521|466136247|FG006|Overall Study|Withdrawal by Subject|0|||
129504602|NCT00430521|466136248|FG007|Overall Study|Withdrawal by Subject|2|||
129504603|NCT05108805|466136249|FG000|Overall Study|T-cell expansion was not successful.|5|||
129504604|NCT00280150|466138203|FG000|Overall Study|Adverse Event|0|||
129504605|NCT00280150|466138204|FG001|Overall Study|Adverse Event|1|||
129504606|NCT00280150|466138205|FG002|Overall Study|Adverse Event|2|||
129504607|NCT00280150|466138206|FG003|Overall Study|Adverse Event|3|||
129504608|NCT00280150|466138203|FG000|Overall Study|Lack of Efficacy|0|||
129504609|NCT00280150|466138204|FG001|Overall Study|Lack of Efficacy|0|||
129504610|NCT00280150|466138205|FG002|Overall Study|Lack of Efficacy|0|||
129504611|NCT00280150|466138206|FG003|Overall Study|Lack of Efficacy|3|||
129504612|NCT00280150|466138203|FG000|Overall Study|Physician Decision|0|||
129504613|NCT00280150|466138204|FG001|Overall Study|Physician Decision|0|||
129504614|NCT00280150|466138205|FG002|Overall Study|Physician Decision|0|||
129504615|NCT00280150|466138206|FG003|Overall Study|Physician Decision|1|||
129504616|NCT00280150|466138203|FG000|Overall Study|Protocol Violation|0|||
129504617|NCT00280150|466138204|FG001|Overall Study|Protocol Violation|0|||
129504618|NCT00280150|466138205|FG002|Overall Study|Protocol Violation|0|||
129504619|NCT00280150|466138206|FG003|Overall Study|Protocol Violation|1|||
129504620|NCT00280150|466138203|FG000|Overall Study|Withdrawal by Subject|0|||
129504621|NCT00280150|466138204|FG001|Overall Study|Withdrawal by Subject|0|||
129504622|NCT00280150|466138205|FG002|Overall Study|Withdrawal by Subject|0|||
129504623|NCT00280150|466138206|FG003|Overall Study|Withdrawal by Subject|1|||
129504624|NCT00280150|466138203|FG000|Overall Study|Did not get consolidation therapy|3|||
129504625|NCT00280150|466138204|FG001|Overall Study|Did not get consolidation therapy|0|||
129504626|NCT00280150|466138205|FG002|Overall Study|Did not get consolidation therapy|3|||
129504627|NCT00280150|466138206|FG003|Overall Study|Did not get consolidation therapy|0|||
129504628|NCT00280150|466138203|FG000|Overall Study|Declining Performance Status|0|||
129504629|NCT00280150|466138204|FG001|Overall Study|Declining Performance Status|0|||
129504630|NCT00280150|466138205|FG002|Overall Study|Declining Performance Status|0|||
129504631|NCT00280150|466138206|FG003|Overall Study|Declining Performance Status|1|||
129504632|NCT02871401|466138209|FG000|Overall Study|Adverse Event|1|||
129504633|NCT02871401|466138210|FG001|Overall Study|Adverse Event|0|||
129504634|NCT01120379|466138211|FG000|One Year Timepoint|Withdrawal by Subject|41|||
129504635|NCT01120379|466138211|FG000|One Year Timepoint|Lost to Follow-up|115|||
129504636|NCT01120379|466138211|FG000|One Year Timepoint|Death|108|||
129504637|NCT01120379|466138211|FG000|One Year Timepoint|Physician Decision|9|||
129504638|NCT01120379|466138211|FG000|One Year Timepoint|Any other reason for early termination|5|||
129504639|NCT01120379|466138211|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
129504640|NCT01120379|466138211|FG000|Two Year Timepoint|Lost to Follow-up|87|||
129504641|NCT01120379|466138211|FG000|Two Year Timepoint|Death|123|||
129504642|NCT01120379|466138211|FG000|Two Year Timepoint|Physician Decision|12|||
129504643|NCT01120379|466138211|FG000|Two Year Timepoint|Any other reason for early termination|4|||
129504644|NCT01120379|466138211|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
129504645|NCT01120379|466138211|FG000|Three Year Timepoint|Lost to Follow-up|43|||
129504646|NCT01120379|466138211|FG000|Three Year Timepoint|Death|120|||
129504647|NCT01120379|466138211|FG000|Three Year Timepoint|Physician Decision|9|||
129504648|NCT01120379|466138211|FG000|Three Year Timepoint|Any other reason for early termination|17|||
129504649|NCT01120379|466138211|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
129504650|NCT01120379|466138211|FG000|Four Year Timepoint|Lost to Follow-up|10|||
129504651|NCT01120379|466138211|FG000|Four Year Timepoint|Death|131|||
129504652|NCT01120379|466138211|FG000|Four Year Timepoint|Physician Decision|5|||
129504653|NCT01120379|466138211|FG000|Four Year Timepoint|Any other reason for early termination|217|||
129504654|NCT03162055|466138212|FG000|Overall Study|Adverse Event|6|||
129504655|NCT03162055|466138213|FG001|Overall Study|Adverse Event|5|||
129504656|NCT03162055|466138212|FG000|Overall Study|Death|3|||
129504657|NCT03162055|466138213|FG001|Overall Study|Death|3|||
129504658|NCT03162055|466138212|FG000|Overall Study|Lost to Follow-up|0|||
129504659|NCT03162055|466138213|FG001|Overall Study|Lost to Follow-up|1|||
129504660|NCT03162055|466138212|FG000|Overall Study|Study-specific withdrawal criteria|22|||
129504661|NCT03162055|466138213|FG001|Overall Study|Study-specific withdrawal criteria|14|||
129504662|NCT03162055|466138212|FG000|Overall Study|Withdrawal by Subject|17|||
129504663|NCT03162055|466138213|FG001|Overall Study|Withdrawal by Subject|2|||
129504664|NCT03162055|466138212|FG000|Overall Study|Did not receive treatment|2|||
129504665|NCT03162055|466138213|FG001|Overall Study|Did not receive treatment|0|||
129504666|NCT03162055|466138212|FG000|Overall Study|Incorrect randomization|4|||
129504667|NCT03162055|466138213|FG001|Overall Study|Incorrect randomization|3|||
129504668|NCT03162055|466138212|FG000|Overall Study|Other|8|||
129504669|NCT03162055|466138213|FG001|Overall Study|Other|15|||
129504670|NCT01993615|466138214|FG000|Overall Study|Death|1|||
129982204|NCT04410523|467898772|FG001|Overall Study|Study terminated by sponsor|3|||
129982205|NCT04410523|467898773|FG002|Overall Study|Study terminated by sponsor|2|||
129982206|NCT04410523|467898774|FG003|Overall Study|Study terminated by sponsor|6|||
129982207|NCT04410523|467898775|FG004|Overall Study|Study terminated by sponsor|3|||
129982208|NCT04410523|467898776|FG005|Overall Study|Study terminated by sponsor|4|||
129982209|NCT04410523|467898771|FG000|Overall Study|Adverse Event|1|||
129982210|NCT04410523|467898772|FG001|Overall Study|Adverse Event|0|||
129982211|NCT04410523|467898773|FG002|Overall Study|Adverse Event|0|||
129982212|NCT04410523|467898774|FG003|Overall Study|Adverse Event|0|||
129982213|NCT04410523|467898775|FG004|Overall Study|Adverse Event|0|||
129982214|NCT04410523|467898776|FG005|Overall Study|Adverse Event|2|||
129982215|NCT04410523|467898771|FG000|Overall Study|Lost to Follow-up|0|||
129982216|NCT04410523|467898772|FG001|Overall Study|Lost to Follow-up|1|||
129982217|NCT04410523|467898773|FG002|Overall Study|Lost to Follow-up|0|||
129982218|NCT04410523|467898774|FG003|Overall Study|Lost to Follow-up|0|||
129982219|NCT04410523|467898775|FG004|Overall Study|Lost to Follow-up|0|||
129982220|NCT04410523|467898776|FG005|Overall Study|Lost to Follow-up|0|||
129982221|NCT04410523|467898771|FG000|Overall Study|Physician Decision|0|||
129982222|NCT04410523|467898772|FG001|Overall Study|Physician Decision|1|||
129982223|NCT04410523|467898773|FG002|Overall Study|Physician Decision|0|||
129982224|NCT04410523|467898774|FG003|Overall Study|Physician Decision|0|||
129982225|NCT04410523|467898775|FG004|Overall Study|Physician Decision|0|||
129982226|NCT04410523|467898776|FG005|Overall Study|Physician Decision|0|||
129982227|NCT04410523|467898771|FG000|Overall Study|Pregnancy|0|||
129982228|NCT04410523|467898772|FG001|Overall Study|Pregnancy|0|||
129982229|NCT04410523|467898773|FG002|Overall Study|Pregnancy|0|||
129982230|NCT04410523|467898774|FG003|Overall Study|Pregnancy|0|||
129982231|NCT04410523|467898775|FG004|Overall Study|Pregnancy|0|||
129982232|NCT04410523|467898776|FG005|Overall Study|Pregnancy|1|||
129982233|NCT04410523|467898771|FG000|Overall Study|Protocol deviation|0|||
129982234|NCT04410523|467898772|FG001|Overall Study|Protocol deviation|0|||
129982235|NCT04410523|467898773|FG002|Overall Study|Protocol deviation|0|||
129982236|NCT04410523|467898774|FG003|Overall Study|Protocol deviation|0|||
129982237|NCT04410523|467898775|FG004|Overall Study|Protocol deviation|0|||
129982238|NCT04410523|467898776|FG005|Overall Study|Protocol deviation|2|||
129982239|NCT04410523|467898771|FG000|Overall Study|Subject decision|2|||
129982240|NCT04410523|467898772|FG001|Overall Study|Subject decision|0|||
129982241|NCT04410523|467898773|FG002|Overall Study|Subject decision|0|||
129982242|NCT04410523|467898774|FG003|Overall Study|Subject decision|1|||
129982243|NCT04410523|467898775|FG004|Overall Study|Subject decision|0|||
129982244|NCT04410523|467898776|FG005|Overall Study|Subject decision|1|||
129982245|NCT00490490|467898777|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
129982246|NCT00490490|467898777|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
129982247|NCT03651622|467898778|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
129982248|NCT03651622|467898779|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
129982249|NCT03651622|467898780|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
129982250|NCT03651622|467898778|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
129982251|NCT03651622|467898779|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
129982252|NCT03651622|467898780|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
129982253|NCT03651622|467898778|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
129982254|NCT03651622|467898779|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
129982255|NCT03651622|467898780|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
129982256|NCT03651622|467898778|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
129982257|NCT03651622|467898779|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
129982258|NCT03651622|467898780|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
129982259|NCT03651622|467898778|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
129982260|NCT03651622|467898779|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
129982261|NCT03651622|467898780|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
129982262|NCT01519089|467898781|FG000|Overall Study|Adverse Event|4|||
129982263|NCT01519089|467898782|FG001|Overall Study|Adverse Event|4|||
129982264|NCT01519089|467898781|FG000|Overall Study|Lack of Efficacy|0|||
129982265|NCT01519089|467898782|FG001|Overall Study|Lack of Efficacy|2|||
129982266|NCT01519089|467898781|FG000|Overall Study|Lost to Follow-up|1|||
129982267|NCT01519089|467898782|FG001|Overall Study|Lost to Follow-up|0|||
129982268|NCT01519089|467898781|FG000|Overall Study|Withdrawal by Subject|0|||
129504671|NCT01993615|466138215|FG001|Overall Study|Death|0|||
129504672|NCT00696436|466138221|FG000|Overall Study|Adverse Event|7|||
129504673|NCT00696436|466138222|FG001|Overall Study|Adverse Event|9|||
129504674|NCT00696436|466138223|FG002|Overall Study|Adverse Event|8|||
129982269|NCT01519089|467898782|FG001|Overall Study|Withdrawal by Subject|2|||
129504675|NCT00696436|466138224|FG003|Overall Study|Adverse Event|6|||
129504676|NCT00696436|466138225|FG004|Overall Study|Adverse Event|4|||
129504677|NCT00696436|466138221|FG000|Overall Study|Protocol Violation|3|||
129504678|NCT00696436|466138222|FG001|Overall Study|Protocol Violation|2|||
129504679|NCT00696436|466138223|FG002|Overall Study|Protocol Violation|2|||
129504680|NCT00696436|466138224|FG003|Overall Study|Protocol Violation|0|||
129504681|NCT00696436|466138225|FG004|Overall Study|Protocol Violation|1|||
129504682|NCT00696436|466138221|FG000|Overall Study|Lost to Follow-up|1|||
129504683|NCT00696436|466138222|FG001|Overall Study|Lost to Follow-up|6|||
129504684|NCT00696436|466138223|FG002|Overall Study|Lost to Follow-up|2|||
129504685|NCT00696436|466138224|FG003|Overall Study|Lost to Follow-up|4|||
129504686|NCT00696436|466138225|FG004|Overall Study|Lost to Follow-up|3|||
129504687|NCT00696436|466138221|FG000|Overall Study|Withdrawal by Subject|4|||
129504688|NCT00696436|466138222|FG001|Overall Study|Withdrawal by Subject|11|||
129504689|NCT00696436|466138223|FG002|Overall Study|Withdrawal by Subject|5|||
129504690|NCT00696436|466138224|FG003|Overall Study|Withdrawal by Subject|7|||
129504691|NCT00696436|466138225|FG004|Overall Study|Withdrawal by Subject|1|||
129504692|NCT00696436|466138221|FG000|Overall Study|Lack of Efficacy|3|||
129504693|NCT00696436|466138222|FG001|Overall Study|Lack of Efficacy|1|||
129504694|NCT00696436|466138223|FG002|Overall Study|Lack of Efficacy|5|||
129504695|NCT00696436|466138224|FG003|Overall Study|Lack of Efficacy|2|||
129504696|NCT00696436|466138225|FG004|Overall Study|Lack of Efficacy|4|||
129504697|NCT00696436|466138221|FG000|Overall Study|Participant Unavailability|2|||
129504698|NCT00696436|466138222|FG001|Overall Study|Participant Unavailability|0|||
129504699|NCT00696436|466138223|FG002|Overall Study|Participant Unavailability|2|||
129504700|NCT00696436|466138224|FG003|Overall Study|Participant Unavailability|1|||
129504701|NCT00696436|466138225|FG004|Overall Study|Participant Unavailability|0|||
129504702|NCT00696436|466138221|FG000|Overall Study|Administrative Error|2|||
129504703|NCT00696436|466138222|FG001|Overall Study|Administrative Error|0|||
129504704|NCT00696436|466138223|FG002|Overall Study|Administrative Error|2|||
129504705|NCT00696436|466138224|FG003|Overall Study|Administrative Error|0|||
129504706|NCT00696436|466138225|FG004|Overall Study|Administrative Error|0|||
129504707|NCT00696436|466138221|FG000|Overall Study|Participant Non-compliance|0|||
129504708|NCT00696436|466138222|FG001|Overall Study|Participant Non-compliance|0|||
129504709|NCT00696436|466138223|FG002|Overall Study|Participant Non-compliance|1|||
129504710|NCT00696436|466138224|FG003|Overall Study|Participant Non-compliance|2|||
129504711|NCT00696436|466138225|FG004|Overall Study|Participant Non-compliance|0|||
129504712|NCT00696436|466138221|FG000|Overall Study|Administrative Decision|1|||
129504713|NCT00696436|466138222|FG001|Overall Study|Administrative Decision|0|||
129504714|NCT00696436|466138223|FG002|Overall Study|Administrative Decision|0|||
129504715|NCT00696436|466138224|FG003|Overall Study|Administrative Decision|0|||
129504716|NCT00696436|466138225|FG004|Overall Study|Administrative Decision|0|||
129504717|NCT00696436|466138221|FG000|Overall Study|Missing|0|||
129504718|NCT00696436|466138222|FG001|Overall Study|Missing|1|||
129504719|NCT00696436|466138223|FG002|Overall Study|Missing|1|||
129504720|NCT00696436|466138224|FG003|Overall Study|Missing|0|||
129504721|NCT00696436|466138225|FG004|Overall Study|Missing|0|||
129504722|NCT02282982|466138226|FG000|Overall Study|Lost to Follow-up|15|||
129504723|NCT02282982|466138226|FG000|Overall Study|Withdrew consent|2|||
129504724|NCT02282982|466138226|FG000|Overall Study|Death|4|||
129504725|NCT02282982|466138226|FG000|Overall Study|Lack of product|156|||
129504726|NCT02282982|466138226|FG000|Overall Study|Palivizumab is ended|11|||
129504727|NCT02282982|466138226|FG000|Overall Study|Other, not specified|18|||
129504728|NCT00310388|466138228|FG000|Primary Reporting Phase|Adverse Event|101|||
129504729|NCT00310388|466138229|FG001|Primary Reporting Phase|Adverse Event|0|||
129504730|NCT00310388|466138228|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
129504731|NCT00310388|466138229|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
129504732|NCT00310388|466138228|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
129504733|NCT00310388|466138229|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
129504734|NCT00310388|466138228|FG000|Primary Reporting Phase|Protocol Violation|10|||
129504735|NCT00310388|466138229|FG001|Primary Reporting Phase|Protocol Violation|0|||
129504736|NCT00310388|466138228|FG000|Primary Reporting Phase|Pregnancy|3|||
129504737|NCT00310388|466138229|FG001|Primary Reporting Phase|Pregnancy|0|||
129504738|NCT00310388|466138228|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
129504739|NCT00310388|466138229|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
129504740|NCT00310388|466138228|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
129504741|NCT00310388|466138229|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
129504742|NCT00310388|466138228|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
129504743|NCT00310388|466138229|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
129504744|NCT00310388|466138228|FG000|Primary Reporting Phase|Physician Decision|2|||
129504745|NCT00310388|466138229|FG001|Primary Reporting Phase|Physician Decision|0|||
129982270|NCT01519089|467898781|FG000|Overall Study|Other|2|||
129504746|NCT00310388|466138228|FG000|Primary Reporting Phase|Request of the sponsor|19|||
129504747|NCT00310388|466138229|FG001|Primary Reporting Phase|Request of the sponsor|0|||
129504748|NCT00310388|466138228|FG000|Primary Reporting Phase|Failed to return|8|||
129504749|NCT00310388|466138229|FG001|Primary Reporting Phase|Failed to return|0|||
129504750|NCT00310388|466138228|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
129504751|NCT00310388|466138229|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
129504752|NCT00310388|466138228|FG000|Primary Reporting Phase|Participant request|2|||
129504753|NCT00310388|466138229|FG001|Primary Reporting Phase|Participant request|0|||
129504754|NCT00310388|466138228|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
129504755|NCT00310388|466138229|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
129504756|NCT00310388|466138228|FG000|Primary Reporting Phase|Discontinuation of study|1|||
129504757|NCT00310388|466138229|FG001|Primary Reporting Phase|Discontinuation of study|0|||
129504758|NCT00310388|466138228|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
129504759|NCT00310388|466138229|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
129504760|NCT00310388|466138228|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
129504761|NCT00310388|466138229|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
129504762|NCT00310388|466138228|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
129504763|NCT00310388|466138229|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
129504764|NCT00310388|466138228|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
129504765|NCT00310388|466138229|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
129504766|NCT00310388|466138228|FG000|Primary Reporting Phase|Participant passed away|1|||
129504767|NCT00310388|466138229|FG001|Primary Reporting Phase|Participant passed away|0|||
129504768|NCT00310388|466138228|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
129504769|NCT00310388|466138229|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
129504770|NCT00310388|466138228|FG000|Primary Reporting Phase|Missing|1|||
129504771|NCT00310388|466138229|FG001|Primary Reporting Phase|Missing|0|||
129504772|NCT00310388|466138228|FG000|Primary Reporting Phase|Other|1|||
129504773|NCT00310388|466138229|FG001|Primary Reporting Phase|Other|0|||
129504774|NCT00310388|466138228|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
129504775|NCT00310388|466138229|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
129504776|NCT00310388|466138228|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
129504777|NCT00310388|466138229|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
129504778|NCT00310388|466138228|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
129504779|NCT00310388|466138229|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
129504780|NCT00310388|466138228|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
129504781|NCT00310388|466138229|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
129504782|NCT02370498|466138231|FG000|Overall Study|Adverse Event|10|||
129504783|NCT02370498|466138232|FG001|Overall Study|Adverse Event|8|||
129504784|NCT02370498|466138231|FG000|Overall Study|Death|263|||
129504785|NCT02370498|466138232|FG001|Overall Study|Death|265|||
129504786|NCT02370498|466138231|FG000|Overall Study|Protocol Violation|1|||
129504787|NCT02370498|466138232|FG001|Overall Study|Protocol Violation|2|||
129504788|NCT02370498|466138231|FG000|Overall Study|Withdrawal by Subject|7|||
129504789|NCT02370498|466138232|FG001|Overall Study|Withdrawal by Subject|12|||
129504790|NCT02370498|466138231|FG000|Overall Study|Sponsor's decision|15|||
129504791|NCT02370498|466138232|FG001|Overall Study|Sponsor's decision|9|||
129504792|NCT00289185|466138237|FG000|Overall Study|Withdrawal by Subject|4|||
129504793|NCT00289185|466138238|FG001|Overall Study|Withdrawal by Subject|8|||
129504794|NCT00289185|466138237|FG000|Overall Study|Lost to Follow-up|23|||
129504795|NCT00289185|466138238|FG001|Overall Study|Lost to Follow-up|17|||
129504796|NCT00289185|466138237|FG000|Overall Study|Death|1|||
129504797|NCT00289185|466138238|FG001|Overall Study|Death|1|||
129504798|NCT02432040|466138241|FG000|Overall Study|Lack of Efficacy|3|||
129504799|NCT02432040|466138242|FG001|Overall Study|Lack of Efficacy|0|||
129504800|NCT02432040|466138241|FG000|Overall Study|Lost to Follow-up|4|||
129504801|NCT02432040|466138242|FG001|Overall Study|Lost to Follow-up|5|||
129504802|NCT02432040|466138241|FG000|Overall Study|Physician Decision|1|||
129504803|NCT02432040|466138242|FG001|Overall Study|Physician Decision|1|||
129504804|NCT05836818|466138243|FG000|Overall Study|Physician Decision|1|||
129504805|NCT05836818|466138244|FG001|Overall Study|Physician Decision|1|||
129504806|NCT05836818|466138245|FG002|Overall Study|Physician Decision|0|||
129504807|NCT05836818|466138243|FG000|Overall Study|Withdrawal by Subject|0|||
129504808|NCT05836818|466138244|FG001|Overall Study|Withdrawal by Subject|0|||
129504809|NCT05836818|466138245|FG002|Overall Study|Withdrawal by Subject|1|||
129504810|NCT05836818|466138243|FG000|Overall Study|Later found to be previously vaccinated|0|||
129504811|NCT05836818|466138244|FG001|Overall Study|Later found to be previously vaccinated|1|||
129504812|NCT05836818|466138245|FG002|Overall Study|Later found to be previously vaccinated|3|||
129504813|NCT05836818|466138243|FG000|Overall Study|Pregnancy|0|||
129504814|NCT05836818|466138244|FG001|Overall Study|Pregnancy|1|||
129504815|NCT05836818|466138245|FG002|Overall Study|Pregnancy|0|||
129504816|NCT05836818|466138243|FG000|Overall Study|Allergic to vaccines|0|||
129504817|NCT05836818|466138244|FG001|Overall Study|Allergic to vaccines|1|||
129504818|NCT05836818|466138245|FG002|Overall Study|Allergic to vaccines|0|||
129504819|NCT03977727|466138246|FG000|Second Treatment|Lost to Follow-up|0|||
129504820|NCT03977727|466138247|FG001|Second Treatment|Lost to Follow-up|3|||
129504821|NCT00621855|466138260|FG000|Overall Study|Adverse Event|32|||
129504822|NCT00621855|466138261|FG001|Overall Study|Adverse Event|31|||
129504823|NCT00621855|466138262|FG002|Overall Study|Adverse Event|48|||
129504824|NCT00621855|466138263|FG003|Overall Study|Adverse Event|34|||
129504825|NCT00621855|466138264|FG004|Overall Study|Adverse Event|31|||
129504826|NCT00621855|466138260|FG000|Overall Study|Lost to Follow-up|0|||
129504827|NCT00621855|466138261|FG001|Overall Study|Lost to Follow-up|1|||
129504828|NCT00621855|466138262|FG002|Overall Study|Lost to Follow-up|3|||
129504829|NCT00621855|466138263|FG003|Overall Study|Lost to Follow-up|4|||
129504830|NCT00621855|466138264|FG004|Overall Study|Lost to Follow-up|1|||
129504831|NCT00621855|466138260|FG000|Overall Study|Protocol Violation|16|||
129504832|NCT00621855|466138261|FG001|Overall Study|Protocol Violation|8|||
129504833|NCT00621855|466138262|FG002|Overall Study|Protocol Violation|6|||
129504834|NCT00621855|466138263|FG003|Overall Study|Protocol Violation|7|||
129504835|NCT00621855|466138264|FG004|Overall Study|Protocol Violation|8|||
129504836|NCT00621855|466138260|FG000|Overall Study|Withdrawal by Subject|16|||
129504837|NCT00621855|466138261|FG001|Overall Study|Withdrawal by Subject|11|||
129504838|NCT00621855|466138262|FG002|Overall Study|Withdrawal by Subject|13|||
129504839|NCT00621855|466138263|FG003|Overall Study|Withdrawal by Subject|13|||
129504840|NCT00621855|466138264|FG004|Overall Study|Withdrawal by Subject|9|||
129504841|NCT00621855|466138260|FG000|Overall Study|Other|9|||
129504842|NCT00621855|466138261|FG001|Overall Study|Other|7|||
129504843|NCT00621855|466138262|FG002|Overall Study|Other|6|||
129504844|NCT00621855|466138263|FG003|Overall Study|Other|5|||
129504845|NCT00621855|466138264|FG004|Overall Study|Other|4|||
129504846|NCT00621855|466138260|FG000|Overall Study|Patients did not receive study drug|3|||
129504847|NCT00621855|466138261|FG001|Overall Study|Patients did not receive study drug|3|||
129504848|NCT00621855|466138262|FG002|Overall Study|Patients did not receive study drug|5|||
129504849|NCT00621855|466138263|FG003|Overall Study|Patients did not receive study drug|4|||
129504850|NCT00621855|466138264|FG004|Overall Study|Patients did not receive study drug|2|||
129504851|NCT02953782|466138265|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
129504852|NCT02953782|466138266|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
129504853|NCT02953782|466138267|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
129504854|NCT02953782|466138268|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
129504855|NCT02953782|466138269|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
129504856|NCT02953782|466138270|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
129504857|NCT02953782|466138271|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
129504858|NCT02953782|466138272|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
129504859|NCT02953782|466138265|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
129504860|NCT02953782|466138266|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
129504861|NCT02953782|466138267|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
129504862|NCT02953782|466138268|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
129504863|NCT02953782|466138269|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
129504864|NCT02953782|466138270|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
129504865|NCT02953782|466138271|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
129504866|NCT02953782|466138272|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
129504867|NCT02953782|466138265|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
129504868|NCT02953782|466138266|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
129504869|NCT02953782|466138267|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
129504870|NCT02953782|466138268|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
129504871|NCT02953782|466138269|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
129504872|NCT02953782|466138270|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
129504873|NCT02953782|466138271|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
129504874|NCT02953782|466138272|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
129504875|NCT02953782|466138265|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129504876|NCT02953782|466138266|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129504877|NCT02953782|466138267|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
129504878|NCT02953782|466138268|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
129504879|NCT02953782|466138269|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129504880|NCT02953782|466138270|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129504881|NCT02953782|466138271|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129504882|NCT02953782|466138272|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
129504883|NCT02953782|466138265|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
129504884|NCT02953782|466138266|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
129504885|NCT02953782|466138267|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
129504886|NCT02953782|466138268|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
129504887|NCT02953782|466138269|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
129504888|NCT02953782|466138270|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
129504889|NCT02953782|466138271|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
129504890|NCT02953782|466138272|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
129504891|NCT02953782|466138265|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
129504892|NCT02953782|466138266|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
129504893|NCT02953782|466138267|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
129504894|NCT02953782|466138268|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
129504895|NCT02953782|466138269|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
129504896|NCT02953782|466138270|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
129504897|NCT02953782|466138271|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
129504898|NCT02953782|466138272|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
129504899|NCT02953782|466138265|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
129504900|NCT02953782|466138266|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
129504901|NCT02953782|466138267|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
129504902|NCT02953782|466138268|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
129504903|NCT02953782|466138269|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
129504904|NCT02953782|466138270|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
129504905|NCT02953782|466138271|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
129504906|NCT02953782|466138272|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
129504907|NCT02953782|466138265|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504908|NCT02953782|466138266|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504909|NCT02953782|466138267|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504910|NCT02953782|466138268|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504911|NCT02953782|466138269|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504912|NCT02953782|466138270|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504913|NCT02953782|466138271|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
129504914|NCT02953782|466138272|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
129504915|NCT01737840|466138273|FG000|Overall Study|Diagnosed with an other pathology|2|||
129504916|NCT01737840|466138274|FG001|Overall Study|Diagnosed with an other pathology|2|||
129504917|NCT03105700|466138277|FG000|Overall Study|screen fail|3|||
129504918|NCT03105700|466138277|FG000|Overall Study|Lost to Follow-up|4|||
129504919|NCT00403559|466138278|FG000|Overall Study|Adverse Event|0|||
129504920|NCT00403559|466138279|FG001|Overall Study|Adverse Event|1|||
129504921|NCT00403559|466138278|FG000|Overall Study|Lost to Follow-up|3|||
129504922|NCT00403559|466138279|FG001|Overall Study|Lost to Follow-up|3|||
129504923|NCT00403559|466138278|FG000|Overall Study|Withdrawal by Subject|1|||
129504924|NCT00403559|466138279|FG001|Overall Study|Withdrawal by Subject|0|||
129504925|NCT01253421|466138280|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
129504926|NCT01253421|466138281|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
129504927|NCT01253421|466138282|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
129504928|NCT01253421|466138283|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
129504929|NCT01253421|466138284|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
129504930|NCT01253421|466138280|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
129504931|NCT01253421|466138281|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
129504932|NCT01253421|466138282|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
129504933|NCT01253421|466138283|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
129504934|NCT01253421|466138284|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
129504935|NCT01253421|466138280|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
129504936|NCT01253421|466138281|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
129504937|NCT01253421|466138282|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
129504938|NCT01253421|466138283|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
129504939|NCT01253421|466138284|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
129504940|NCT01253421|466138280|FG000|Assessment and Scheduling|Physician Decision|1|||
129504941|NCT01253421|466138281|FG001|Assessment and Scheduling|Physician Decision|0|||
129504942|NCT01253421|466138282|FG002|Assessment and Scheduling|Physician Decision|0|||
129504943|NCT01253421|466138283|FG003|Assessment and Scheduling|Physician Decision|0|||
129504944|NCT01253421|466138284|FG004|Assessment and Scheduling|Physician Decision|0|||
129504945|NCT01253421|466138280|FG000|Drug+Scanning Visit|Physician Decision|0|||
129504946|NCT01253421|466138281|FG001|Drug+Scanning Visit|Physician Decision|0|||
129504947|NCT01253421|466138282|FG002|Drug+Scanning Visit|Physician Decision|0|||
129504948|NCT01253421|466138283|FG003|Drug+Scanning Visit|Physician Decision|0|||
129504949|NCT01253421|466138284|FG004|Drug+Scanning Visit|Physician Decision|1|||
129504950|NCT00929734|466138285|FG000|Overall Study|Lost to Follow-up|2|||
129504951|NCT00929734|466138286|FG001|Overall Study|Lost to Follow-up|1|||
129504952|NCT00929734|466138285|FG000|Overall Study|Withdrawal by Subject|0|||
129504953|NCT00929734|466138286|FG001|Overall Study|Withdrawal by Subject|2|||
129504954|NCT00980980|466138288|FG000|Overall Study|Withdrawal by Hospital|0|||
129504955|NCT00980980|466138289|FG001|Overall Study|Withdrawal by Hospital|1|||
129504956|NCT00980980|466138290|FG002|Overall Study|Withdrawal by Hospital|0|||
129504957|NCT00121992|466138291|FG000|Overall Study|Treatment not received|2|||
129504958|NCT00121992|466138292|FG001|Overall Study|Treatment not received|11|||
129504959|NCT01449682|466138293|FG000|Overall Study|Death|0|||
129982271|NCT01519089|467898782|FG001|Overall Study|Other|6|||
129982272|NCT01519089|467898781|FG000|Overall Study|Not received study drug|0|||
129504960|NCT01449682|466138294|FG001|Overall Study|Death|1|||
129504961|NCT01449682|466138293|FG000|Overall Study|Adverse Event|1|||
129504962|NCT01449682|466138294|FG001|Overall Study|Adverse Event|0|||
129504963|NCT04863014|466138295|FG000|Overall Study|Lost to Follow-up|3|||
129504964|NCT04863014|466138296|FG001|Overall Study|Lost to Follow-up|2|||
129504965|NCT04863014|466138295|FG000|Overall Study|Subject Decision|0|||
129504966|NCT04863014|466138296|FG001|Overall Study|Subject Decision|4|||
129504967|NCT04633473|466138297|FG000|Overall Study|Withdrawal by Subject|6|||
129504968|NCT01553916|466138298|FG000|Overall Study|Withdrawal by Subject|2|||
129504969|NCT01553916|466138298|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
129504970|NCT03089216|466138301|FG000|Overall Study|Adverse Event|0|||
129504971|NCT03089216|466138302|FG001|Overall Study|Adverse Event|0|||
129504972|NCT03089216|466138303|FG002|Overall Study|Adverse Event|0|||
129504973|NCT03089216|466138304|FG003|Overall Study|Adverse Event|1|||
129504974|NCT04348591|466138307|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
129504975|NCT04348591|466138308|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
129504976|NCT04348591|466138307|FG000|Imaging Session (120 Min)|Physician Decision|0|||
129504977|NCT04348591|466138308|FG001|Imaging Session (120 Min)|Physician Decision|1|||
129504978|NCT04348591|466138307|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
129504979|NCT04348591|466138308|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
129504980|NCT00417976|466138309|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
129504981|NCT00417976|466138309|FG000|Overall Study|Treatment -related toxicity|2|||
129504982|NCT02104804|466138314|FG000|Overall Study|Did not take study medication|0|||
129504983|NCT02104804|466138315|FG001|Overall Study|Did not take study medication|1|||
129504984|NCT02104804|466138314|FG000|Overall Study|Study specific discontinuation criteria|6|||
129504985|NCT02104804|466138315|FG001|Overall Study|Study specific discontinuation criteria|1|||
129504986|NCT02104804|466138314|FG000|Overall Study|Other listed|2|||
129504987|NCT02104804|466138315|FG001|Overall Study|Other listed|1|||
129504988|NCT02104804|466138314|FG000|Overall Study|Protocol Violation|0|||
129504989|NCT02104804|466138315|FG001|Overall Study|Protocol Violation|1|||
129504990|NCT02104804|466138314|FG000|Overall Study|Adverse Event|4|||
129504991|NCT02104804|466138315|FG001|Overall Study|Adverse Event|3|||
129504992|NCT02104804|466138314|FG000|Overall Study|Withdrawal by Subject|4|||
129504993|NCT02104804|466138315|FG001|Overall Study|Withdrawal by Subject|12|||
129504994|NCT02720016|466138316|FG000|Overall Study|Separation of couple|6|||
129504995|NCT02720016|466138317|FG001|Overall Study|Separation of couple|8|||
129504996|NCT02720016|466138318|FG002|Overall Study|Separation of couple|2|||
129504997|NCT02720016|466138316|FG000|Overall Study|Withdrawal by Subject|6|||
129504998|NCT02720016|466138317|FG001|Overall Study|Withdrawal by Subject|6|||
129504999|NCT02720016|466138318|FG002|Overall Study|Withdrawal by Subject|4|||
129505000|NCT02720016|466138316|FG000|Overall Study|Scheduling issues|2|||
129505001|NCT02720016|466138317|FG001|Overall Study|Scheduling issues|4|||
129505002|NCT02720016|466138318|FG002|Overall Study|Scheduling issues|7|||
129505003|NCT02720016|466138316|FG000|Overall Study|Childcare|2|||
129505004|NCT02720016|466138317|FG001|Overall Study|Childcare|0|||
129505005|NCT02720016|466138318|FG002|Overall Study|Childcare|2|||
129505006|NCT02720016|466138316|FG000|Overall Study|Withdrawal by PI|2|||
129505007|NCT02720016|466138317|FG001|Overall Study|Withdrawal by PI|2|||
129505008|NCT02720016|466138318|FG002|Overall Study|Withdrawal by PI|0|||
129505009|NCT02720016|466138316|FG000|Overall Study|Moved away|2|||
129505010|NCT02720016|466138317|FG001|Overall Study|Moved away|0|||
129505011|NCT02720016|466138318|FG002|Overall Study|Moved away|0|||
129505012|NCT02720016|466138316|FG000|Overall Study|Not Primary Health Concern|0|||
129505013|NCT02720016|466138317|FG001|Overall Study|Not Primary Health Concern|0|||
129505014|NCT02720016|466138318|FG002|Overall Study|Not Primary Health Concern|2|||
129505015|NCT02720016|466138316|FG000|Overall Study|Transportation issues|0|||
129505016|NCT02720016|466138317|FG001|Overall Study|Transportation issues|0|||
129505017|NCT02720016|466138318|FG002|Overall Study|Transportation issues|1|||
129505018|NCT02720016|466138316|FG000|Overall Study|Other|0|||
129505019|NCT02720016|466138317|FG001|Overall Study|Other|0|||
129505020|NCT02720016|466138318|FG002|Overall Study|Other|2|||
129505021|NCT01968954|466138325|FG000|Overall Study|Adverse Event|6|||
129505022|NCT01968954|466138326|FG001|Overall Study|Adverse Event|3|||
129505023|NCT01968954|466138325|FG000|Overall Study|Death|1|||
129505024|NCT01968954|466138326|FG001|Overall Study|Death|2|||
129505025|NCT01968954|466138325|FG000|Overall Study|Lost to Follow-up|6|||
129505026|NCT01968954|466138326|FG001|Overall Study|Lost to Follow-up|4|||
129505027|NCT01968954|466138325|FG000|Overall Study|Withdrawal by Subject|20|||
129505028|NCT01968954|466138326|FG001|Overall Study|Withdrawal by Subject|23|||
129505029|NCT01968954|466138325|FG000|Overall Study|Other|7|||
129505030|NCT01968954|466138326|FG001|Overall Study|Other|8|||
129505031|NCT01968954|466138325|FG000|Overall Study|Protocol Violation|0|||
129505032|NCT01968954|466138326|FG001|Overall Study|Protocol Violation|1|||
129505033|NCT01968954|466138325|FG000|Overall Study|Did not met inclusion criteria|0|||
129505034|NCT01968954|466138326|FG001|Overall Study|Did not met inclusion criteria|2|||
129505035|NCT05319080|466138327|FG000|Overall Study|Withdrawal by Subject|2|||
129505036|NCT05319080|466138327|FG000|Overall Study|Physician Decision|4|||
129505037|NCT04465396|466138330|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
129505038|NCT04465396|466138331|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
129505039|NCT04465396|466138332|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
129505040|NCT04465396|466138333|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
129505041|NCT02648724|466138336|FG000|Overall Study|Withdrawal by Subject|0|||
129505042|NCT02648724|466138337|FG001|Overall Study|Withdrawal by Subject|1|||
129505043|NCT02648724|466138338|FG002|Overall Study|Withdrawal by Subject|1|||
129505044|NCT02648724|466138339|FG003|Overall Study|Withdrawal by Subject|0|||
129505045|NCT02648724|466138340|FG004|Overall Study|Withdrawal by Subject|1|||
129505046|NCT02648724|466138341|FG005|Overall Study|Withdrawal by Subject|0|||
129505047|NCT02648724|466138342|FG006|Overall Study|Withdrawal by Subject|0|||
129505048|NCT02648724|466138336|FG000|Overall Study|Progressive disease|2|||
129505049|NCT02648724|466138337|FG001|Overall Study|Progressive disease|2|||
129505050|NCT02648724|466138338|FG002|Overall Study|Progressive disease|2|||
129505051|NCT02648724|466138339|FG003|Overall Study|Progressive disease|3|||
129505052|NCT02648724|466138340|FG004|Overall Study|Progressive disease|22|||
129505053|NCT02648724|466138341|FG005|Overall Study|Progressive disease|7|||
129505054|NCT02648724|466138342|FG006|Overall Study|Progressive disease|8|||
129505055|NCT02648724|466138336|FG000|Overall Study|Other reason (unknown)|1|||
129505056|NCT02648724|466138337|FG001|Overall Study|Other reason (unknown)|0|||
129505057|NCT02648724|466138338|FG002|Overall Study|Other reason (unknown)|0|||
129505058|NCT02648724|466138339|FG003|Overall Study|Other reason (unknown)|0|||
129505059|NCT02648724|466138340|FG004|Overall Study|Other reason (unknown)|0|||
129505060|NCT02648724|466138341|FG005|Overall Study|Other reason (unknown)|0|||
129505061|NCT02648724|466138342|FG006|Overall Study|Other reason (unknown)|0|||
129505062|NCT02648724|466138336|FG000|Overall Study|Protocol Violation|0|||
129505063|NCT02648724|466138337|FG001|Overall Study|Protocol Violation|0|||
129505064|NCT02648724|466138338|FG002|Overall Study|Protocol Violation|0|||
129505065|NCT02648724|466138339|FG003|Overall Study|Protocol Violation|0|||
129505066|NCT02648724|466138340|FG004|Overall Study|Protocol Violation|1|||
129505067|NCT02648724|466138341|FG005|Overall Study|Protocol Violation|0|||
129505068|NCT02648724|466138342|FG006|Overall Study|Protocol Violation|0|||
129505069|NCT02648724|466138336|FG000|Overall Study|Death|0|||
129505070|NCT02648724|466138337|FG001|Overall Study|Death|0|||
129505071|NCT02648724|466138338|FG002|Overall Study|Death|0|||
129505072|NCT02648724|466138339|FG003|Overall Study|Death|0|||
129505073|NCT02648724|466138340|FG004|Overall Study|Death|0|||
129505074|NCT02648724|466138341|FG005|Overall Study|Death|0|||
129505075|NCT02648724|466138342|FG006|Overall Study|Death|3|||
129505076|NCT02648724|466138336|FG000|Overall Study|Physician Decision|0|||
129505077|NCT02648724|466138337|FG001|Overall Study|Physician Decision|0|||
129505078|NCT02648724|466138338|FG002|Overall Study|Physician Decision|0|||
129505079|NCT02648724|466138339|FG003|Overall Study|Physician Decision|0|||
129505080|NCT02648724|466138340|FG004|Overall Study|Physician Decision|1|||
129505081|NCT02648724|466138341|FG005|Overall Study|Physician Decision|0|||
129505082|NCT02648724|466138342|FG006|Overall Study|Physician Decision|1|||
129505083|NCT02648724|466138336|FG000|Overall Study|Transferred to named patient program|0|||
129505084|NCT02648724|466138337|FG001|Overall Study|Transferred to named patient program|0|||
129505085|NCT02648724|466138338|FG002|Overall Study|Transferred to named patient program|0|||
129505086|NCT02648724|466138339|FG003|Overall Study|Transferred to named patient program|0|||
129505087|NCT02648724|466138340|FG004|Overall Study|Transferred to named patient program|0|||
129505088|NCT02648724|466138341|FG005|Overall Study|Transferred to named patient program|1|||
129505089|NCT02648724|466138342|FG006|Overall Study|Transferred to named patient program|0|||
129505090|NCT03076190|466138343|FG000|Overall Study|Lost to Follow-up|9|||
129505091|NCT03076190|466138344|FG001|Overall Study|Lost to Follow-up|34|||
129505092|NCT03076190|466138343|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
129505093|NCT03076190|466138344|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
129505094|NCT00434122|466138345|FG000|Overall Study|Non-compliance with protocol|0|||
129505095|NCT00434122|466138346|FG001|Overall Study|Non-compliance with protocol|1|||
129505096|NCT00434122|466138345|FG000|Overall Study|loss of subject contact|1|||
129505097|NCT00434122|466138346|FG001|Overall Study|loss of subject contact|1|||
129505098|NCT00434122|466138345|FG000|Overall Study|Personal reasons|1|||
129505099|NCT00434122|466138346|FG001|Overall Study|Personal reasons|1|||
129505100|NCT00434122|466138345|FG000|Overall Study|Large follicle size|2|||
129505101|NCT00434122|466138346|FG001|Overall Study|Large follicle size|2|||
129505102|NCT00434122|466138345|FG000|Overall Study|Low follicular response.|1|||
129982273|NCT01519089|467898782|FG001|Overall Study|Not received study drug|1|||
129505103|NCT00434122|466138346|FG001|Overall Study|Low follicular response.|2|||
129505104|NCT00434122|466138345|FG000|Overall Study|Travelling of subject.|1|||
129505105|NCT00434122|466138346|FG001|Overall Study|Travelling of subject.|0|||
129982274|NCT03582943|467898785|FG000|Allocated to Groups|Withdrawal by Subject|1|||
129505106|NCT04191577|466138349|FG000|Overall Study|Withdrawal by Subject|2|||
129505107|NCT04191577|466138350|FG001|Overall Study|Withdrawal by Subject|2|||
129505108|NCT04191577|466138351|FG002|Overall Study|Withdrawal by Subject|1|||
129505109|NCT04191577|466138349|FG000|Overall Study|Physician Decision|1|||
129505110|NCT04191577|466138350|FG001|Overall Study|Physician Decision|1|||
129505111|NCT04191577|466138351|FG002|Overall Study|Physician Decision|0|||
129505112|NCT04191577|466138349|FG000|Overall Study|Adverse Event|0|||
129505113|NCT04191577|466138350|FG001|Overall Study|Adverse Event|0|||
129505114|NCT04191577|466138351|FG002|Overall Study|Adverse Event|1|||
129505115|NCT04191577|466138349|FG000|Overall Study|Death|0|||
129505116|NCT04191577|466138350|FG001|Overall Study|Death|0|||
129505117|NCT04191577|466138351|FG002|Overall Study|Death|1|||
129505118|NCT01185249|466138352|FG000|Overall Study|Patients discharged or change in status|42|||
129505119|NCT00406783|466138355|FG000|Overall Study|Adverse Event|4|||
129505120|NCT00406783|466138356|FG001|Overall Study|Adverse Event|4|||
129505121|NCT00406783|466138355|FG000|Overall Study|Treatment Failure|2|||
129505122|NCT00406783|466138356|FG001|Overall Study|Treatment Failure|3|||
129505123|NCT00406783|466138355|FG000|Overall Study|Lost to Follow-up|3|||
129505124|NCT00406783|466138356|FG001|Overall Study|Lost to Follow-up|0|||
129505125|NCT00406783|466138355|FG000|Overall Study|Withdrawal by Subject|1|||
129505126|NCT00406783|466138356|FG001|Overall Study|Withdrawal by Subject|4|||
129505127|NCT00406783|466138355|FG000|Overall Study|Protocol Violation|4|||
129505128|NCT00406783|466138356|FG001|Overall Study|Protocol Violation|4|||
129505129|NCT01391819|466138357|FG000|Overall Study|Withdrawal by Subject|56|||
129505130|NCT01391819|466138357|FG000|Overall Study|Migrated/moved from study area|82|||
129505131|NCT01391819|466138357|FG000|Overall Study|Lost to Follow-up|252|||
129505132|NCT01391819|466138357|FG000|Overall Study|Death|3|||
129505133|NCT01391819|466138357|FG000|Overall Study|Other|9|||
129505134|NCT01208038|466138360|FG000|Overall Study|Withdrawal by Subject|1|||
129505135|NCT00479557|466138361|FG000|Overall Study|Death|0|||
129505136|NCT00479557|466138362|FG001|Overall Study|Death|0|||
129505137|NCT00479557|466138363|FG002|Overall Study|Death|0|||
129505138|NCT00479557|466138364|FG003|Overall Study|Death|0|||
129505139|NCT00479557|466138365|FG004|Overall Study|Death|0|||
129505140|NCT00479557|466138366|FG005|Overall Study|Death|1|||
129505141|NCT00479557|466138367|FG006|Overall Study|Death|0|||
129505142|NCT00479557|466138361|FG000|Overall Study|Lack of Efficacy|1|||
129505143|NCT00479557|466138362|FG001|Overall Study|Lack of Efficacy|0|||
129505144|NCT00479557|466138363|FG002|Overall Study|Lack of Efficacy|0|||
129505145|NCT00479557|466138364|FG003|Overall Study|Lack of Efficacy|0|||
129505146|NCT00479557|466138365|FG004|Overall Study|Lack of Efficacy|0|||
129505147|NCT00479557|466138366|FG005|Overall Study|Lack of Efficacy|0|||
129505148|NCT00479557|466138367|FG006|Overall Study|Lack of Efficacy|0|||
129505149|NCT00479557|466138361|FG000|Overall Study|Lost to Follow-up|0|||
129505150|NCT00479557|466138362|FG001|Overall Study|Lost to Follow-up|2|||
129505151|NCT00479557|466138363|FG002|Overall Study|Lost to Follow-up|0|||
129505152|NCT00479557|466138364|FG003|Overall Study|Lost to Follow-up|2|||
129505153|NCT00479557|466138365|FG004|Overall Study|Lost to Follow-up|0|||
129505154|NCT00479557|466138366|FG005|Overall Study|Lost to Follow-up|0|||
129505155|NCT00479557|466138367|FG006|Overall Study|Lost to Follow-up|0|||
129505156|NCT00479557|466138361|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129505157|NCT00479557|466138362|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129505158|NCT00479557|466138363|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
129505159|NCT00479557|466138364|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
129505160|NCT00479557|466138365|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129505161|NCT00479557|466138366|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
129505162|NCT00479557|466138367|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
129505163|NCT00479557|466138361|FG000|Overall Study|AE not related to Study Drug|1|||
129505164|NCT00479557|466138362|FG001|Overall Study|AE not related to Study Drug|3|||
129505165|NCT00479557|466138363|FG002|Overall Study|AE not related to Study Drug|0|||
129505166|NCT00479557|466138364|FG003|Overall Study|AE not related to Study Drug|0|||
129505167|NCT00479557|466138365|FG004|Overall Study|AE not related to Study Drug|2|||
129505168|NCT00479557|466138366|FG005|Overall Study|AE not related to Study Drug|2|||
129982275|NCT03582943|467898786|FG001|Allocated to Groups|Withdrawal by Subject|1|||
129982276|NCT03582943|467898785|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
129982277|NCT03582943|467898786|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
129982278|NCT03582943|467898785|FG000|Analyzed|Protocol Violation|4|||
129982279|NCT03582943|467898786|FG001|Analyzed|Protocol Violation|1|||
129982280|NCT05032872|467898789|FG000|Overall Study|Adverse Event|1|||
129982281|NCT05032872|467898790|FG001|Overall Study|Adverse Event|0|||
129982282|NCT05032872|467898789|FG000|Overall Study|Lost to Follow-up|2|||
129982283|NCT05032872|467898790|FG001|Overall Study|Lost to Follow-up|4|||
129982284|NCT05032872|467898789|FG000|Overall Study|Withdrawal by Subject|4|||
129982285|NCT05032872|467898790|FG001|Overall Study|Withdrawal by Subject|3|||
129982286|NCT05870228|467898791|FG000|Overall Study|Lost to Follow-up|2|||
129505169|NCT00479557|466138367|FG006|Overall Study|AE not related to Study Drug|1|||
129505170|NCT00479557|466138361|FG000|Overall Study|Caregiver Request|2|||
129505171|NCT00479557|466138362|FG001|Overall Study|Caregiver Request|2|||
129505172|NCT00479557|466138363|FG002|Overall Study|Caregiver Request|2|||
129505173|NCT00479557|466138364|FG003|Overall Study|Caregiver Request|0|||
129982287|NCT05870228|467898792|FG001|Overall Study|Lost to Follow-up|0|||
129505174|NCT00479557|466138365|FG004|Overall Study|Caregiver Request|1|||
129505175|NCT00479557|466138366|FG005|Overall Study|Caregiver Request|2|||
129505176|NCT00479557|466138367|FG006|Overall Study|Caregiver Request|0|||
129505177|NCT00479557|466138361|FG000|Overall Study|Investigator Request|0|||
129505178|NCT00479557|466138362|FG001|Overall Study|Investigator Request|0|||
129505179|NCT00479557|466138363|FG002|Overall Study|Investigator Request|1|||
129505180|NCT00479557|466138364|FG003|Overall Study|Investigator Request|0|||
129505181|NCT00479557|466138365|FG004|Overall Study|Investigator Request|0|||
129505182|NCT00479557|466138366|FG005|Overall Study|Investigator Request|0|||
129505183|NCT00479557|466138367|FG006|Overall Study|Investigator Request|0|||
129505184|NCT00479557|466138361|FG000|Overall Study|Subject Request|3|||
129505185|NCT00479557|466138362|FG001|Overall Study|Subject Request|0|||
129505186|NCT00479557|466138363|FG002|Overall Study|Subject Request|1|||
129505187|NCT00479557|466138364|FG003|Overall Study|Subject Request|1|||
129505188|NCT00479557|466138365|FG004|Overall Study|Subject Request|1|||
129505189|NCT00479557|466138366|FG005|Overall Study|Subject Request|4|||
129505190|NCT00479557|466138367|FG006|Overall Study|Subject Request|1|||
129505191|NCT00479557|466138361|FG000|Overall Study|Other|2|||
129505192|NCT00479557|466138362|FG001|Overall Study|Other|3|||
129505193|NCT00479557|466138363|FG002|Overall Study|Other|1|||
129505194|NCT00479557|466138364|FG003|Overall Study|Other|0|||
129505195|NCT00479557|466138365|FG004|Overall Study|Other|0|||
129505196|NCT00479557|466138366|FG005|Overall Study|Other|3|||
129505197|NCT00479557|466138367|FG006|Overall Study|Other|0|||
129505198|NCT04752189|466138368|FG000|Overall Study|Withdrawal by Subject|0|||
129505199|NCT04752189|466138369|FG001|Overall Study|Withdrawal by Subject|150|||
129505200|NCT04752189|466138368|FG000|Overall Study|Lost to Follow-up|261|||
129505201|NCT04752189|466138369|FG001|Overall Study|Lost to Follow-up|126|||
129505202|NCT03422133|466138370|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
129505203|NCT03422133|466138371|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
129505204|NCT03003403|466138372|FG000|Overall Study|Ineligible|8|||
129505205|NCT03003403|466138373|FG001|Overall Study|Ineligible|7|||
129505206|NCT03003403|466138372|FG000|Overall Study|Withdrawal by Subject|3|||
129505207|NCT03003403|466138373|FG001|Overall Study|Withdrawal by Subject|1|||
129505208|NCT02198651|466140128|FG000|Lead-in Period|Withdrew consent|13|||
129505209|NCT02198651|466140129|FG001|Lead-in Period|Withdrew consent|0|||
129505210|NCT02198651|466140130|FG002|Lead-in Period|Withdrew consent|0|||
129505211|NCT02198651|466140131|FG003|Lead-in Period|Withdrew consent|0|||
129505212|NCT02198651|466140132|FG004|Lead-in Period|Withdrew consent|0|||
129505213|NCT02198651|466140128|FG000|Lead-in Period|Adverse Event|2|||
129505214|NCT02198651|466140129|FG001|Lead-in Period|Adverse Event|0|||
129505215|NCT02198651|466140130|FG002|Lead-in Period|Adverse Event|0|||
129505216|NCT02198651|466140131|FG003|Lead-in Period|Adverse Event|0|||
129505217|NCT02198651|466140132|FG004|Lead-in Period|Adverse Event|0|||
129505218|NCT02198651|466140128|FG000|Lead-in Period|Other, not specified|22|||
129505219|NCT02198651|466140129|FG001|Lead-in Period|Other, not specified|0|||
129505220|NCT02198651|466140130|FG002|Lead-in Period|Other, not specified|0|||
129505221|NCT02198651|466140131|FG003|Lead-in Period|Other, not specified|0|||
129505222|NCT02198651|466140132|FG004|Lead-in Period|Other, not specified|0|||
129505223|NCT02198651|466140128|FG000|Double-blind Period|Withdrew consent|0|||
129505224|NCT02198651|466140129|FG001|Double-blind Period|Withdrew consent|4|||
129505225|NCT02198651|466140130|FG002|Double-blind Period|Withdrew consent|0|||
129505226|NCT02198651|466140131|FG003|Double-blind Period|Withdrew consent|0|||
129505227|NCT02198651|466140132|FG004|Double-blind Period|Withdrew consent|0|||
129505228|NCT02198651|466140128|FG000|Double-blind Period|Adverse Event|0|||
129505229|NCT02198651|466140129|FG001|Double-blind Period|Adverse Event|1|||
129505230|NCT02198651|466140130|FG002|Double-blind Period|Adverse Event|0|||
129505231|NCT02198651|466140131|FG003|Double-blind Period|Adverse Event|0|||
129505232|NCT02198651|466140132|FG004|Double-blind Period|Adverse Event|0|||
129505233|NCT02198651|466140128|FG000|Double-blind Period|Other, not specified|0|||
129505234|NCT02198651|466140129|FG001|Double-blind Period|Other, not specified|4|||
129505235|NCT02198651|466140130|FG002|Double-blind Period|Other, not specified|1|||
129505236|NCT02198651|466140131|FG003|Double-blind Period|Other, not specified|0|||
129505237|NCT02198651|466140132|FG004|Double-blind Period|Other, not specified|0|||
129505238|NCT02198651|466140128|FG000|Open-label Rescue Period|Withdrew consent|0|||
129505239|NCT02198651|466140129|FG001|Open-label Rescue Period|Withdrew consent|0|||
129505240|NCT02198651|466140130|FG002|Open-label Rescue Period|Withdrew consent|0|||
129505241|NCT02198651|466140131|FG003|Open-label Rescue Period|Withdrew consent|2|||
129505242|NCT02198651|466140132|FG004|Open-label Rescue Period|Withdrew consent|0|||
129505243|NCT02198651|466140128|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
129505244|NCT02198651|466140129|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
129505245|NCT02198651|466140130|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
129505246|NCT02198651|466140131|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
129505247|NCT02198651|466140132|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
129505248|NCT03073213|466140133|FG000|Multiple Dose Period|Protocol Violation|0|||
129505249|NCT03073213|466140134|FG001|Multiple Dose Period|Protocol Violation|0|||
129505250|NCT03073213|466140135|FG002|Multiple Dose Period|Protocol Violation|1|||
129505251|NCT01617655|466140140|FG000|Overall Study|Adverse Event|2|||
129505252|NCT01617655|466140141|FG001|Overall Study|Adverse Event|3|||
129982288|NCT05870228|467898791|FG000|Overall Study|Withdrawal by Subject|1|||
129505253|NCT01617655|466140140|FG000|Overall Study|Poor compliance to protocol|1|||
129505254|NCT01617655|466140141|FG001|Overall Study|Poor compliance to protocol|4|||
129505255|NCT01617655|466140140|FG000|Overall Study|Participants moved|0|||
129505256|NCT01617655|466140141|FG001|Overall Study|Participants moved|4|||
129505257|NCT01617655|466140140|FG000|Overall Study|Consent withdrawn by participant|1|||
129505258|NCT01617655|466140141|FG001|Overall Study|Consent withdrawn by participant|1|||
129505259|NCT01617655|466140140|FG000|Overall Study|Last visit outside protocol visit window|1|||
129505260|NCT01617655|466140141|FG001|Overall Study|Last visit outside protocol visit window|10|||
129505261|NCT01617655|466140140|FG000|Overall Study|Site closure|3|||
129505262|NCT01617655|466140141|FG001|Overall Study|Site closure|5|||
129505263|NCT01617655|466140140|FG000|Overall Study|Other than specified above|1|||
129505264|NCT01617655|466140141|FG001|Overall Study|Other than specified above|2|||
129505265|NCT01175213|466140142|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
129505266|NCT01175213|466140143|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
129505267|NCT01175213|466140142|FG000|IGSC, 10%/rHuPH20|Death|1|||
129505268|NCT01175213|466140143|FG001|IGSC, 10%/rHuPH20|Death|0|||
129505269|NCT01175213|466140142|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
129505270|NCT01175213|466140143|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
129505271|NCT01175213|466140142|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
129505272|NCT01175213|466140143|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
129505273|NCT01175213|466140142|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
129505274|NCT01175213|466140143|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
129505275|NCT01175213|466140142|FG000|Safety Follow-up|Adverse Event|1|||
129505276|NCT01175213|466140143|FG001|Safety Follow-up|Adverse Event|0|||
129505277|NCT01245764|466140147|FG000|Study Phase A|Other|3|||
129505278|NCT01245764|466140148|FG001|Study Phase A|Other|2|||
129505279|NCT01245764|466140149|FG002|Study Phase A|Other|3|||
129505280|NCT01245764|466140150|FG003|Study Phase A|Other|1|||
129505281|NCT01245764|466140147|FG000|Study Phase A|Protocol Violation|6|||
129505282|NCT01245764|466140148|FG001|Study Phase A|Protocol Violation|3|||
129505283|NCT01245764|466140149|FG002|Study Phase A|Protocol Violation|2|||
129505284|NCT01245764|466140150|FG003|Study Phase A|Protocol Violation|2|||
129505285|NCT01245764|466140147|FG000|Study Phase A|Lost to Follow-up|0|||
129505286|NCT01245764|466140148|FG001|Study Phase A|Lost to Follow-up|0|||
129505287|NCT01245764|466140149|FG002|Study Phase A|Lost to Follow-up|5|||
129505288|NCT01245764|466140150|FG003|Study Phase A|Lost to Follow-up|0|||
129505289|NCT00003476|466140151|FG000|Overall Study|Not evaluable|1|||
129505290|NCT00781963|466140154|FG000|Overall Study|Death|3|||
129505291|NCT00781963|466140155|FG001|Overall Study|Death|0|||
129505292|NCT00781963|466140154|FG000|Overall Study|Lost to Follow-up|2|||
129505293|NCT00781963|466140155|FG001|Overall Study|Lost to Follow-up|1|||
129505294|NCT00781963|466140154|FG000|Overall Study|Withdrawal by Subject|3|||
129505295|NCT00781963|466140155|FG001|Overall Study|Withdrawal by Subject|1|||
129505296|NCT00781963|466140154|FG000|Overall Study|Refused follow-up|9|||
129505297|NCT00781963|466140155|FG001|Overall Study|Refused follow-up|0|||
129505298|NCT03057951|466140159|FG000|Overall Study|Adverse Event|553|||
129505299|NCT03057951|466140160|FG001|Overall Study|Adverse Event|575|||
129505300|NCT03057951|466140159|FG000|Overall Study|Protocol Violation|30|||
129505301|NCT03057951|466140160|FG001|Overall Study|Protocol Violation|24|||
129505302|NCT03057951|466140159|FG000|Overall Study|Lost to Follow-up|6|||
129505303|NCT03057951|466140160|FG001|Overall Study|Lost to Follow-up|16|||
129505304|NCT03057951|466140159|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
129505305|NCT03057951|466140160|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
129505306|NCT03057951|466140159|FG000|Overall Study|Study drug stopped, reason missing|6|||
129505307|NCT03057951|466140160|FG001|Overall Study|Study drug stopped, reason missing|1|||
129505308|NCT03057951|466140159|FG000|Overall Study|Medical advice|6|||
129505309|NCT03057951|466140160|FG001|Overall Study|Medical advice|2|||
129505310|NCT03057951|466140159|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
129505311|NCT03057951|466140160|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
129505312|NCT03057951|466140159|FG000|Overall Study|Investigator decision|2|||
129505313|NCT03057951|466140160|FG001|Overall Study|Investigator decision|0|||
129505314|NCT03057951|466140159|FG000|Overall Study|Patient decision|5|||
129982289|NCT05870228|467898792|FG001|Overall Study|Withdrawal by Subject|0|||
129505315|NCT03057951|466140160|FG001|Overall Study|Patient decision|2|||
129505316|NCT03057951|466140159|FG000|Overall Study|Not attending study visits|3|||
129505317|NCT03057951|466140160|FG001|Overall Study|Not attending study visits|0|||
129505318|NCT03057951|466140159|FG000|Overall Study|Patient moved away|3|||
129982290|NCT00488475|467898793|FG000|Overall Study|Other|1754|||
129505319|NCT03057951|466140160|FG001|Overall Study|Patient moved away|4|||
129505320|NCT03057951|466140159|FG000|Overall Study|Other reason than stated above|23|||
129505321|NCT03057951|466140160|FG001|Overall Study|Other reason than stated above|29|||
129505322|NCT03057951|466140159|FG000|Overall Study|Not treated|2|||
129505323|NCT03057951|466140160|FG001|Overall Study|Not treated|1|||
129505324|NCT02064205|466140161|FG000|Overall Study|Withdrawal by Subject|1|||
129505325|NCT02062463|466140162|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
129505326|NCT02062463|466140163|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
129982291|NCT00798590|467898812|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
129505327|NCT02062463|466140164|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
129505328|NCT02062463|466140165|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
129505329|NCT02062463|466140162|FG000|Stage 2|Adverse Event|0|||
129505330|NCT02062463|466140163|FG001|Stage 2|Adverse Event|0|||
129505331|NCT02062463|466140164|FG002|Stage 2|Adverse Event|12|||
129505332|NCT02062463|466140165|FG003|Stage 2|Adverse Event|20|||
129505333|NCT02062463|466140162|FG000|Stage 2|Lack of Efficacy|0|||
129505334|NCT02062463|466140163|FG001|Stage 2|Lack of Efficacy|0|||
129505335|NCT02062463|466140164|FG002|Stage 2|Lack of Efficacy|3|||
129505336|NCT02062463|466140165|FG003|Stage 2|Lack of Efficacy|4|||
129505337|NCT02062463|466140162|FG000|Stage 2|Lost to Follow-up|0|||
129505338|NCT02062463|466140163|FG001|Stage 2|Lost to Follow-up|0|||
129505339|NCT02062463|466140164|FG002|Stage 2|Lost to Follow-up|20|||
129505340|NCT02062463|466140165|FG003|Stage 2|Lost to Follow-up|20|||
129505341|NCT02062463|466140162|FG000|Stage 2|Non-Compliance|0|||
129505342|NCT02062463|466140163|FG001|Stage 2|Non-Compliance|0|||
129505343|NCT02062463|466140164|FG002|Stage 2|Non-Compliance|0|||
129505344|NCT02062463|466140165|FG003|Stage 2|Non-Compliance|1|||
129505345|NCT02062463|466140162|FG000|Stage 2|Other than specified|0|||
129505346|NCT02062463|466140163|FG001|Stage 2|Other than specified|0|||
129505347|NCT02062463|466140164|FG002|Stage 2|Other than specified|3|||
129505348|NCT02062463|466140165|FG003|Stage 2|Other than specified|1|||
129505349|NCT02062463|466140162|FG000|Stage 2|Withdrawal by Subject|0|||
129505350|NCT02062463|466140163|FG001|Stage 2|Withdrawal by Subject|0|||
129505351|NCT02062463|466140164|FG002|Stage 2|Withdrawal by Subject|15|||
129505352|NCT02062463|466140165|FG003|Stage 2|Withdrawal by Subject|10|||
129505353|NCT04124692|466140166|FG000|Overall Study|Medical reason|0|||
129505354|NCT04124692|466140167|FG001|Overall Study|Medical reason|1|||
129505355|NCT04124692|466140166|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
129505356|NCT04124692|466140167|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
129505357|NCT04124692|466140166|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
129505358|NCT04124692|466140167|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
129505359|NCT04124692|466140166|FG000|Overall Study|Lost to Follow-up|2|||
129505360|NCT04124692|466140167|FG001|Overall Study|Lost to Follow-up|4|||
129505361|NCT04124692|466140166|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
129505362|NCT04124692|466140167|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
129505363|NCT02924688|466140168|FG000|Overall Study|Adverse Event|9|||
129505364|NCT02924688|466140169|FG001|Overall Study|Adverse Event|3|||
129505365|NCT02924688|466140170|FG002|Overall Study|Adverse Event|2|||
129505366|NCT02924688|466140171|FG003|Overall Study|Adverse Event|2|||
129505367|NCT02924688|466140172|FG004|Overall Study|Adverse Event|3|||
129505368|NCT02924688|466140173|FG005|Overall Study|Adverse Event|2|||
129505369|NCT02924688|466140168|FG000|Overall Study|Lack of Efficacy|2|||
129505370|NCT02924688|466140169|FG001|Overall Study|Lack of Efficacy|3|||
129505371|NCT02924688|466140170|FG002|Overall Study|Lack of Efficacy|4|||
129505372|NCT02924688|466140171|FG003|Overall Study|Lack of Efficacy|2|||
129505373|NCT02924688|466140172|FG004|Overall Study|Lack of Efficacy|1|||
129505374|NCT02924688|466140173|FG005|Overall Study|Lack of Efficacy|1|||
129505375|NCT02924688|466140168|FG000|Overall Study|Protocol Violation|3|||
129505376|NCT02924688|466140169|FG001|Overall Study|Protocol Violation|7|||
129505377|NCT02924688|466140170|FG002|Overall Study|Protocol Violation|5|||
129505378|NCT02924688|466140171|FG003|Overall Study|Protocol Violation|6|||
129505379|NCT02924688|466140172|FG004|Overall Study|Protocol Violation|2|||
129505380|NCT02924688|466140173|FG005|Overall Study|Protocol Violation|2|||
129505381|NCT02924688|466140168|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
129505382|NCT02924688|466140169|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
129505383|NCT02924688|466140170|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
129505384|NCT02924688|466140171|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
129505385|NCT02924688|466140172|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
129505386|NCT02924688|466140173|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
129505387|NCT02924688|466140168|FG000|Overall Study|Lost to Follow-up|2|||
129505388|NCT02924688|466140169|FG001|Overall Study|Lost to Follow-up|4|||
129505389|NCT02924688|466140170|FG002|Overall Study|Lost to Follow-up|2|||
129505390|NCT02924688|466140171|FG003|Overall Study|Lost to Follow-up|4|||
129505391|NCT02924688|466140172|FG004|Overall Study|Lost to Follow-up|2|||
129505392|NCT02924688|466140173|FG005|Overall Study|Lost to Follow-up|4|||
129505393|NCT02924688|466140168|FG000|Overall Study|Physician Decision|2|||
129505394|NCT02924688|466140169|FG001|Overall Study|Physician Decision|1|||
129505395|NCT02924688|466140170|FG002|Overall Study|Physician Decision|0|||
129505396|NCT02924688|466140171|FG003|Overall Study|Physician Decision|1|||
129505397|NCT02924688|466140172|FG004|Overall Study|Physician Decision|1|||
129505398|NCT02924688|466140173|FG005|Overall Study|Physician Decision|1|||
129505399|NCT02924688|466140168|FG000|Overall Study|Withdrawal by Subject|14|||
129505400|NCT02924688|466140169|FG001|Overall Study|Withdrawal by Subject|13|||
129505401|NCT02924688|466140170|FG002|Overall Study|Withdrawal by Subject|9|||
129505402|NCT02924688|466140171|FG003|Overall Study|Withdrawal by Subject|12|||
129505403|NCT02924688|466140172|FG004|Overall Study|Withdrawal by Subject|13|||
129982292|NCT00798590|467898813|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
129982293|NCT01769326|467898818|FG000|Overall Study|Lost to Follow-up|1|||
129505404|NCT02924688|466140173|FG005|Overall Study|Withdrawal by Subject|14|||
129505405|NCT01754922|466140174|FG000|Overall Study|Adverse Event|0|||
129505406|NCT01754922|466140175|FG001|Overall Study|Adverse Event|1|||
129505407|NCT00848250|466140176|FG000|Overall Study|surgery was completed without cardiopulm|0|||
129505408|NCT00848250|466140177|FG001|Overall Study|surgery was completed without cardiopulm|1|||
129505409|NCT03457103|466140188|FG000|Overall Study|illness/hospitalization|4|||
129505410|NCT03457103|466140189|FG001|Overall Study|illness/hospitalization|2|||
129505411|NCT03457103|466140188|FG000|Overall Study|Lost to Follow-up|2|||
129505412|NCT03457103|466140189|FG001|Overall Study|Lost to Follow-up|1|||
129505413|NCT03457103|466140188|FG000|Overall Study|Withdrawal by Subject|1|||
129505414|NCT03457103|466140189|FG001|Overall Study|Withdrawal by Subject|2|||
129505415|NCT03457103|466140188|FG000|Overall Study|financial/ insurance issues|1|||
129505416|NCT03457103|466140189|FG001|Overall Study|financial/ insurance issues|1|||
129505417|NCT00502320|466140190|FG000|Overall Study|Lost to Follow-up|1|||
129505418|NCT00502320|466140191|FG001|Overall Study|Lost to Follow-up|1|||
129505419|NCT00502320|466140190|FG000|Overall Study|Withdrew Consent|1|||
129505420|NCT00502320|466140191|FG001|Overall Study|Withdrew Consent|0|||
129505421|NCT00502320|466140190|FG000|Overall Study|No longer met criteria|1|||
129505422|NCT00502320|466140191|FG001|Overall Study|No longer met criteria|0|||
129505423|NCT00502320|466140190|FG000|Overall Study|Screen Failure|0|||
129505424|NCT00502320|466140191|FG001|Overall Study|Screen Failure|1|||
129505425|NCT00502320|466140190|FG000|Overall Study|Adverse Event|3|||
129505426|NCT00502320|466140191|FG001|Overall Study|Adverse Event|5|||
129505427|NCT03654755|466140197|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
129505428|NCT03654755|466140198|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
129505429|NCT03654755|466140199|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
129505430|NCT03654755|466140197|FG000|Overall Study|Withdrawal by Subject|2|||
129505431|NCT03654755|466140198|FG001|Overall Study|Withdrawal by Subject|4|||
129505432|NCT03654755|466140199|FG002|Overall Study|Withdrawal by Subject|8|||
129505433|NCT03654755|466140197|FG000|Overall Study|Lost to Follow-up|1|||
129505434|NCT03654755|466140198|FG001|Overall Study|Lost to Follow-up|3|||
129505435|NCT03654755|466140199|FG002|Overall Study|Lost to Follow-up|7|||
129505436|NCT03654755|466140197|FG000|Overall Study|Physician Decision|0|||
129505437|NCT03654755|466140198|FG001|Overall Study|Physician Decision|1|||
129505438|NCT03654755|466140199|FG002|Overall Study|Physician Decision|0|||
129505439|NCT03654755|466140197|FG000|Overall Study|Adverse Event|0|||
129505440|NCT03654755|466140198|FG001|Overall Study|Adverse Event|0|||
129505441|NCT03654755|466140199|FG002|Overall Study|Adverse Event|4|||
129505442|NCT03654755|466140197|FG000|Overall Study|Lack of Efficacy|0|||
129505443|NCT03654755|466140198|FG001|Overall Study|Lack of Efficacy|0|||
129505444|NCT03654755|466140199|FG002|Overall Study|Lack of Efficacy|1|||
129505445|NCT02394808|466140200|FG000|Period 1|Unsatisfactory lens fitting|0|||
129505446|NCT02394808|466140201|FG001|Period 1|Unsatisfactory lens fitting|1|||
129505447|NCT02394808|466140200|FG000|Period 2|Lost to Follow-up|1|||
129505448|NCT02394808|466140201|FG001|Period 2|Lost to Follow-up|0|||
129505449|NCT03943953|466140204|FG000|Trial of ITG 1|Lost to Follow-up|19|||
129505450|NCT03943953|466140205|FG001|Trial of ITG 1|Lost to Follow-up|1|||
129505451|NCT03943953|466140204|FG000|Trial of ITG 2|Lost to Follow-up|8|||
129505452|NCT03943953|466140205|FG001|Trial of ITG 2|Lost to Follow-up|0|||
129505453|NCT03943953|466140204|FG000|Trial of ITG 3|Lost to Follow-up|2|||
129505454|NCT03943953|466140205|FG001|Trial of ITG 3|Lost to Follow-up|0|||
129505455|NCT03943953|466140204|FG000|Trial of ITG 4|Lost to Follow-up|2|||
129505456|NCT03943953|466140205|FG001|Trial of ITG 4|Lost to Follow-up|0|||
129505457|NCT01199055|466140206|FG000|Overall Study|Death|0|||
129505458|NCT01199055|466140207|FG001|Overall Study|Death|1|||
129505459|NCT01199055|466140208|FG002|Overall Study|Death|0|||
129505460|NCT01199055|466140206|FG000|Overall Study|Physician Decision|0|||
129505461|NCT01199055|466140207|FG001|Overall Study|Physician Decision|1|||
129505462|NCT01199055|466140208|FG002|Overall Study|Physician Decision|1|||
129505463|NCT01199055|466140206|FG000|Overall Study|Progressive disease|2|||
129505464|NCT01199055|466140207|FG001|Overall Study|Progressive disease|1|||
129505465|NCT01199055|466140208|FG002|Overall Study|Progressive disease|2|||
129505466|NCT01199055|466140206|FG000|Overall Study|Withdrawal by Subject|0|||
129505467|NCT01199055|466140207|FG001|Overall Study|Withdrawal by Subject|0|||
129505468|NCT01199055|466140208|FG002|Overall Study|Withdrawal by Subject|1|||
129982294|NCT01769326|467898819|FG001|Overall Study|Lost to Follow-up|2|||
129505469|NCT04580394|466140209|FG000|First Intervention|Incorrectly Randomized|1|||
129505470|NCT04580394|466140209|FG000|First Intervention|Physician Decision|1|||
129505471|NCT04580394|466140209|FG000|First Intervention|Lost to Follow-up|1|||
129505472|NCT04580394|466140209|FG000|Washout (One Week)|Withdrawal by Subject|1|||
129505473|NCT04580394|466140209|FG000|Washout (One Week)|Adverse Event|1|||
129505474|NCT04580394|466140209|FG000|Washout (One Week)|Withdrawal by Subject|2|||
129505475|NCT04580394|466140209|FG000|Third Intervention|Adverse Event|1|||
129505476|NCT04580394|466140209|FG000|Third Intervention|Withdrawal by Subject|1|||
129505477|NCT04580394|466140209|FG000|Washout (One Week)|Withdrawal by Subject|2|||
129505478|NCT00642746|466140211|FG000|Overall Study|Patient unevaluable|1|||
129982295|NCT01769326|467898820|FG002|Overall Study|Lost to Follow-up|0|||
129982296|NCT01769326|467898821|FG003|Overall Study|Lost to Follow-up|0|||
129982297|NCT01769326|467898818|FG000|Overall Study|unrelated injry|1|||
129982298|NCT01769326|467898819|FG001|Overall Study|unrelated injry|1|||
129982299|NCT01769326|467898820|FG002|Overall Study|unrelated injry|0|||
129982300|NCT01769326|467898821|FG003|Overall Study|unrelated injry|0|||
129505479|NCT00642746|466140212|FG001|Overall Study|Patient unevaluable|0|||
129505480|NCT03337152|466140215|FG000|Overall Study|Physician Decision|1|||
129505481|NCT03337152|466140216|FG001|Overall Study|Physician Decision|0|||
129505482|NCT03337152|466140215|FG000|Overall Study|Lost to Follow-up|1|||
129505483|NCT03337152|466140216|FG001|Overall Study|Lost to Follow-up|3|||
129505484|NCT03337152|466140215|FG000|Overall Study|Adverse Event|3|||
129505485|NCT03337152|466140216|FG001|Overall Study|Adverse Event|1|||
129505486|NCT03337152|466140215|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
129505487|NCT03337152|466140216|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
129505488|NCT01069523|466140217|FG000|Overall Study|Withdrawal by Subject|4|||
129505489|NCT01069523|466140218|FG001|Overall Study|Withdrawal by Subject|7|||
129505490|NCT00488592|466140231|FG000|Overall Study|Withdrawal by Subject|1|||
129505491|NCT00488592|466140231|FG000|Overall Study|Disease progression|1|||
129505492|NCT00488592|466140231|FG000|Overall Study|Enrolled but not treated|1|||
129505493|NCT03670641|466140232|FG000|Overall Study|Lost to Follow-up|3|||
129505494|NCT00118482|466140233|FG000|Overall Study|Lost to Follow-up|7|||
129505495|NCT00118482|466140234|FG001|Overall Study|Lost to Follow-up|7|||
129505496|NCT00118482|466140233|FG000|Overall Study|Withdrawal by Subject|23|||
129505497|NCT00118482|466140234|FG001|Overall Study|Withdrawal by Subject|22|||
129505498|NCT03970395|466140235|FG000|Overall Study|Withdrawal by Subject|3|||
129505499|NCT03970395|466140236|FG001|Overall Study|Withdrawal by Subject|4|||
129505500|NCT03970395|466140235|FG000|Overall Study|Lost to Follow-up|4|||
129505501|NCT03970395|466140236|FG001|Overall Study|Lost to Follow-up|8|||
129505502|NCT00125190|466140238|FG000|Overall Study|Subject/Parent Decision|7|||
129505503|NCT00125190|466140238|FG000|Overall Study|Non-compliance|2|||
129505504|NCT00125190|466140238|FG000|Overall Study|Adverse Event|1|||
129505505|NCT00125190|466140238|FG000|Overall Study|Other|1|||
129505506|NCT00125190|466140238|FG000|Overall Study|Lost to Follow-up|4|||
129505507|NCT03666858|466140241|FG000|Cohort 1|Adverse Event|1|||
129505508|NCT03666858|466140242|FG001|Cohort 1|Adverse Event|0|||
129505509|NCT03666858|466140241|FG000|Cohort 2|Adverse Event|0|||
129505510|NCT03666858|466140242|FG001|Cohort 2|Adverse Event|1|||
129505511|NCT02921919|466140243|FG000|Overall Study|Other|5|||
129505512|NCT02921919|466140244|FG001|Overall Study|Other|6|||
129505513|NCT02921919|466140243|FG000|Overall Study|Lost to Follow-up|0|||
129505514|NCT02921919|466140244|FG001|Overall Study|Lost to Follow-up|1|||
129505515|NCT02921919|466140243|FG000|Overall Study|Withdrawal by Subject|5|||
129505516|NCT02921919|466140244|FG001|Overall Study|Withdrawal by Subject|1|||
129505517|NCT02921919|466140243|FG000|Overall Study|Disease Progression|47|||
129505518|NCT02921919|466140244|FG001|Overall Study|Disease Progression|38|||
129505519|NCT02921919|466140243|FG000|Overall Study|Physician Decision|3|||
129505520|NCT02921919|466140244|FG001|Overall Study|Physician Decision|2|||
129505521|NCT02921919|466140243|FG000|Overall Study|Adverse Event|6|||
129505522|NCT02921919|466140244|FG001|Overall Study|Adverse Event|4|||
129505523|NCT03282357|466140245|FG000|Overall Study|Lost to Follow-up|3|||
129505524|NCT03282357|466140245|FG000|Overall Study|Withdrawal by Subject|4|||
129505525|NCT03282357|466140245|FG000|Overall Study|Adverse Event|1|||
129505526|NCT03282357|466140245|FG000|Overall Study|Other|9|||
129505527|NCT01586156|466140246|FG000|Overall Study|Pregnancy|0|||
129505528|NCT01586156|466140247|FG001|Overall Study|Pregnancy|1|||
129505529|NCT01586156|466140248|FG002|Overall Study|Pregnancy|0|||
129505530|NCT00547378|466140249|FG000|Randomized Cohort|Withdrawal by Subject|7|||
129505531|NCT00547378|466140250|FG001|Randomized Cohort|Withdrawal by Subject|5|||
129505532|NCT00547378|466140251|FG002|Randomized Cohort|Withdrawal by Subject|0|||
129505533|NCT00547378|466140249|FG000|Randomized Cohort|Death|0|||
129505534|NCT00547378|466140250|FG001|Randomized Cohort|Death|1|||
129505535|NCT00547378|466140251|FG002|Randomized Cohort|Death|0|||
129505536|NCT00547378|466140249|FG000|Randomized Cohort|Lost to Follow-up|1|||
129505537|NCT00547378|466140250|FG001|Randomized Cohort|Lost to Follow-up|0|||
129505538|NCT00547378|466140251|FG002|Randomized Cohort|Lost to Follow-up|0|||
129505539|NCT00547378|466140249|FG000|Randomized Cohort|Adverse Event|1|||
129505540|NCT00547378|466140250|FG001|Randomized Cohort|Adverse Event|0|||
129505541|NCT00547378|466140251|FG002|Randomized Cohort|Adverse Event|0|||
129505542|NCT00547378|466140249|FG000|Randomized Cohort|Other reasons|2|||
129505543|NCT00547378|466140250|FG001|Randomized Cohort|Other reasons|0|||
129505544|NCT00547378|466140251|FG002|Randomized Cohort|Other reasons|0|||
129982301|NCT01769326|467898818|FG000|Overall Study|got a job|0|||
129505545|NCT00547378|466140249|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
129505546|NCT00547378|466140250|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
129505547|NCT00547378|466140251|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
129505548|NCT00547378|466140249|FG000|All Implanted Cohort|Adverse Event|4|||
129505549|NCT00547378|466140250|FG001|All Implanted Cohort|Adverse Event|10|||
129505550|NCT00547378|466140251|FG002|All Implanted Cohort|Adverse Event|17|||
129982302|NCT01769326|467898819|FG001|Overall Study|got a job|1|||
129505551|NCT00547378|466140249|FG000|All Implanted Cohort|Lost to Follow-up|0|||
129505552|NCT00547378|466140250|FG001|All Implanted Cohort|Lost to Follow-up|1|||
129505553|NCT00547378|466140251|FG002|All Implanted Cohort|Lost to Follow-up|14|||
129505554|NCT00547378|466140249|FG000|All Implanted Cohort|Death|3|||
129505555|NCT00547378|466140250|FG001|All Implanted Cohort|Death|1|||
129505556|NCT00547378|466140251|FG002|All Implanted Cohort|Death|4|||
129505557|NCT00547378|466140249|FG000|All Implanted Cohort|Physician Decision|0|||
129505558|NCT00547378|466140250|FG001|All Implanted Cohort|Physician Decision|2|||
129505559|NCT00547378|466140251|FG002|All Implanted Cohort|Physician Decision|6|||
129505560|NCT00547378|466140249|FG000|All Implanted Cohort|Site closure|2|||
129505561|NCT00547378|466140250|FG001|All Implanted Cohort|Site closure|0|||
129505562|NCT00547378|466140251|FG002|All Implanted Cohort|Site closure|1|||
129505563|NCT00547378|466140249|FG000|All Implanted Cohort|Other reasons|1|||
129505564|NCT00547378|466140250|FG001|All Implanted Cohort|Other reasons|0|||
129505565|NCT00547378|466140251|FG002|All Implanted Cohort|Other reasons|1|||
129505566|NCT02112994|466140252|FG000|Overall Study|Progressive Disease|0|||
129505567|NCT02112994|466140253|FG001|Overall Study|Progressive Disease|0|||
129505568|NCT02112994|466140254|FG002|Overall Study|Progressive Disease|1|||
129505569|NCT02112994|466140252|FG000|Overall Study|Pregnancy|0|||
129505570|NCT02112994|466140253|FG001|Overall Study|Pregnancy|1|||
129505571|NCT02112994|466140254|FG002|Overall Study|Pregnancy|1|||
129505572|NCT02112994|466140252|FG000|Overall Study|Liver Transplant|0|||
129505573|NCT02112994|466140253|FG001|Overall Study|Liver Transplant|1|||
129505574|NCT02112994|466140254|FG002|Overall Study|Liver Transplant|0|||
129505575|NCT02112994|466140252|FG000|Overall Study|Withdrawal by Subject|0|||
129505576|NCT02112994|466140253|FG001|Overall Study|Withdrawal by Subject|0|||
129505577|NCT02112994|466140254|FG002|Overall Study|Withdrawal by Subject|1|||
129505578|NCT04105244|466140256|FG000|Overall Study|Withdrawal by Subject|10|||
129505579|NCT04105244|466140257|FG001|Overall Study|Withdrawal by Subject|12|||
129505580|NCT04105244|466140256|FG000|Overall Study|Lost to Follow-up|20|||
129505581|NCT04105244|466140257|FG001|Overall Study|Lost to Follow-up|15|||
129505582|NCT04105244|466140256|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
129505583|NCT04105244|466140257|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
129505584|NCT04105244|466140256|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
129505585|NCT04105244|466140257|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
129505586|NCT00414960|466140258|FG000|Overall Study|Adverse Event|4|||
129505587|NCT00414960|466140259|FG001|Overall Study|Adverse Event|0|||
129505588|NCT00414960|466140258|FG000|Overall Study|Withdrawal by Subject|3|||
129505589|NCT00414960|466140259|FG001|Overall Study|Withdrawal by Subject|0|||
129505590|NCT00414960|466140258|FG000|Overall Study|Physician Decision|0|||
129505591|NCT00414960|466140259|FG001|Overall Study|Physician Decision|1|||
129505592|NCT02768194|466140260|FG000|Period 1|Adverse Event|0|||
129505593|NCT02768194|466140261|FG001|Period 1|Adverse Event|0|||
129505594|NCT02768194|466140262|FG002|Period 1|Adverse Event|0|||
129505595|NCT02768194|466140263|FG003|Period 1|Adverse Event|1|||
129505596|NCT02768194|466140264|FG004|Period 1|Adverse Event|0|||
129505597|NCT02768194|466140265|FG005|Period 1|Adverse Event|0|||
129505598|NCT02768194|466140260|FG000|Period 2|Other (Reason not specified)|1|||
129505599|NCT02768194|466140261|FG001|Period 2|Other (Reason not specified)|0|||
129505600|NCT02768194|466140262|FG002|Period 2|Other (Reason not specified)|0|||
129505601|NCT02768194|466140263|FG003|Period 2|Other (Reason not specified)|0|||
129505602|NCT02768194|466140264|FG004|Period 2|Other (Reason not specified)|0|||
129505603|NCT02768194|466140265|FG005|Period 2|Other (Reason not specified)|0|||
129505604|NCT02768194|466140260|FG000|Period 3|Other (Reason not specified)|0|||
129505605|NCT02768194|466140261|FG001|Period 3|Other (Reason not specified)|1|||
129505606|NCT02768194|466140262|FG002|Period 3|Other (Reason not specified)|0|||
129505607|NCT02768194|466140263|FG003|Period 3|Other (Reason not specified)|0|||
129505608|NCT02768194|466140264|FG004|Period 3|Other (Reason not specified)|0|||
129505609|NCT02768194|466140265|FG005|Period 3|Other (Reason not specified)|0|||
129505610|NCT00975195|466140266|FG000|Overall Study|Adverse Event|108|||
129505611|NCT00975195|466140267|FG001|Overall Study|Adverse Event|101|||
129505612|NCT00975195|466140266|FG000|Overall Study|Lack of Efficacy|6|||
129505613|NCT00975195|466140267|FG001|Overall Study|Lack of Efficacy|6|||
129505614|NCT00975195|466140266|FG000|Overall Study|Protocol Violation|27|||
129505615|NCT00975195|466140267|FG001|Overall Study|Protocol Violation|23|||
129505616|NCT00975195|466140266|FG000|Overall Study|Lost to Follow-up|9|||
129505617|NCT00975195|466140267|FG001|Overall Study|Lost to Follow-up|7|||
129505618|NCT00975195|466140266|FG000|Overall Study|Withdrawal by Subject|48|||
129505619|NCT00975195|466140267|FG001|Overall Study|Withdrawal by Subject|61|||
129505620|NCT00975195|466140266|FG000|Overall Study|Other reason not defined above|29|||
129505621|NCT00975195|466140267|FG001|Overall Study|Other reason not defined above|33|||
129505622|NCT00975195|466140266|FG000|Overall Study|Not treated|1|||
129505623|NCT00975195|466140267|FG001|Overall Study|Not treated|2|||
129505624|NCT01608724|466140268|FG000|Overall Study|Withdrawal by Subject|131|||
129505625|NCT01608724|466140268|FG000|Overall Study|Lost to Follow-up|41|||
129505626|NCT01608724|466140268|FG000|Overall Study|Study-specific discontinuation criteria|32|||
129505627|NCT01608724|466140268|FG000|Overall Study|Adverse Event|29|||
129505628|NCT01608724|466140268|FG000|Overall Study|Protocol Violation|6|||
129505629|NCT01608724|466140268|FG000|Overall Study|bood sugar too high, etc.|3|||
129505630|NCT01608724|466140268|FG000|Overall Study|Safety reasons|1|||
129505631|NCT00264849|466140273|FG000|Overall Study|Adverse Event|7|||
129505632|NCT00264849|466140274|FG001|Overall Study|Adverse Event|2|||
129505633|NCT00264849|466140273|FG000|Overall Study|Withdrawal by Subject|7|||
129505634|NCT00264849|466140274|FG001|Overall Study|Withdrawal by Subject|11|||
129505635|NCT00264849|466140273|FG000|Overall Study|Protocol Violation|5|||
129505636|NCT00264849|466140274|FG001|Overall Study|Protocol Violation|3|||
129505637|NCT00264849|466140273|FG000|Overall Study|Lack of Efficacy|1|||
129505638|NCT00264849|466140274|FG001|Overall Study|Lack of Efficacy|6|||
129505639|NCT00264849|466140273|FG000|Overall Study|Lost to Follow-up|0|||
129505640|NCT00264849|466140274|FG001|Overall Study|Lost to Follow-up|2|||
129505641|NCT00264849|466140273|FG000|Overall Study|Death|0|||
129505642|NCT00264849|466140274|FG001|Overall Study|Death|1|||
129505643|NCT00264849|466140273|FG000|Overall Study|Administrative Problems|2|||
129505644|NCT00264849|466140274|FG001|Overall Study|Administrative Problems|0|||
129505645|NCT00099359|466140277|FG000|Overall Study|Death|11|||
129505646|NCT00099359|466140278|FG001|Overall Study|Death|15|||
129505647|NCT00099359|466140279|FG002|Overall Study|Death|17|||
129505648|NCT00099359|466140277|FG000|Overall Study|Withdrawal by Subject|19|||
129505649|NCT00099359|466140278|FG001|Overall Study|Withdrawal by Subject|19|||
129505650|NCT00099359|466140279|FG002|Overall Study|Withdrawal by Subject|23|||
129505651|NCT00099359|466140277|FG000|Overall Study|Lost to Follow-up|15|||
129505652|NCT00099359|466140278|FG001|Overall Study|Lost to Follow-up|24|||
129505653|NCT00099359|466140279|FG002|Overall Study|Lost to Follow-up|24|||
129505654|NCT00099359|466140277|FG000|Overall Study|moved out of area|9|||
129505655|NCT00099359|466140278|FG001|Overall Study|moved out of area|7|||
129505656|NCT00099359|466140279|FG002|Overall Study|moved out of area|4|||
129505657|NCT01822691|466140280|FG000|Overall Study|Withdrawal by Subject|2|||
129505658|NCT02756650|466140281|FG000|Overall Study|Physician Decision|1|||
129505659|NCT02756650|466140281|FG000|Overall Study|Adverse Event|1|||
129505660|NCT04501679|466140286|FG000|Overall Study|Pregnancy|0|||
129505661|NCT04501679|466140287|FG001|Overall Study|Pregnancy|1|||
129505662|NCT04501679|466140286|FG000|Overall Study|Adverse Event|4|||
129505663|NCT04501679|466140287|FG001|Overall Study|Adverse Event|2|||
129505664|NCT04501679|466140286|FG000|Overall Study|Withdrawal by Subject|2|||
129505665|NCT04501679|466140287|FG001|Overall Study|Withdrawal by Subject|0|||
129505666|NCT04501679|466140286|FG000|Overall Study|Physician Decision|1|||
129505667|NCT04501679|466140287|FG001|Overall Study|Physician Decision|0|||
129505668|NCT04501679|466140286|FG000|Overall Study|Lost to Follow-up|2|||
129505669|NCT04501679|466140287|FG001|Overall Study|Lost to Follow-up|0|||
129505670|NCT02358369|466140293|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
129505671|NCT02358369|466140294|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
129505672|NCT02358369|466140295|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
129505673|NCT02358369|466140296|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
129505674|NCT02358369|466140297|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
129505675|NCT02358369|466140293|FG000|Treatment Period A/B|Adverse Event|0|||
129505676|NCT02358369|466140294|FG001|Treatment Period A/B|Adverse Event|0|||
129505677|NCT02358369|466140295|FG002|Treatment Period A/B|Adverse Event|1|||
129505678|NCT02358369|466140296|FG003|Treatment Period A/B|Adverse Event|2|||
129505679|NCT02358369|466140297|FG004|Treatment Period A/B|Adverse Event|0|||
129505680|NCT02358369|466140293|FG000|Treatment Period A/B|Death|0|||
129505681|NCT02358369|466140294|FG001|Treatment Period A/B|Death|0|||
129505682|NCT02358369|466140295|FG002|Treatment Period A/B|Death|1|||
129505683|NCT02358369|466140296|FG003|Treatment Period A/B|Death|0|||
129505684|NCT02358369|466140297|FG004|Treatment Period A/B|Death|0|||
129982303|NCT01769326|467898820|FG002|Overall Study|got a job|0|||
129505685|NCT02358369|466140293|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
129505686|NCT02358369|466140294|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
129505687|NCT02358369|466140295|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
129505688|NCT02358369|466140296|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
129505689|NCT02358369|466140297|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
129505690|NCT02358369|466140293|FG000|Treatment Period C|Adverse Event|0|||
129505691|NCT02358369|466140294|FG001|Treatment Period C|Adverse Event|0|||
129505692|NCT02358369|466140295|FG002|Treatment Period C|Adverse Event|0|||
129505693|NCT02358369|466140296|FG003|Treatment Period C|Adverse Event|0|||
129505694|NCT02358369|466140297|FG004|Treatment Period C|Adverse Event|7|||
129505695|NCT03655717|466140300|FG000|Overall Study|Withdrawal by Subject|4|||
129505696|NCT03655717|466140301|FG001|Overall Study|Withdrawal by Subject|8|||
129982304|NCT01769326|467898821|FG003|Overall Study|got a job|0|||
129982305|NCT01769326|467898818|FG000|Overall Study|Got sick and could not complete study|0|||
129982306|NCT01769326|467898819|FG001|Overall Study|Got sick and could not complete study|0|||
129982307|NCT01769326|467898820|FG002|Overall Study|Got sick and could not complete study|1|||
129982308|NCT01769326|467898821|FG003|Overall Study|Got sick and could not complete study|0|||
129982309|NCT01278173|467898822|FG000|Overall Study|Lack of Efficacy|13|||
129982310|NCT01278173|467898822|FG000|Overall Study|Adverse Event|8|||
129982311|NCT01278173|467898822|FG000|Overall Study|Administrative or other reason|4|||
129505697|NCT03655717|466140302|FG002|Overall Study|Withdrawal by Subject|1|||
129505698|NCT03655717|466140303|FG003|Overall Study|Withdrawal by Subject|0|||
129505699|NCT03655717|466140304|FG004|Overall Study|Withdrawal by Subject|0|||
129505700|NCT03655717|466140305|FG005|Overall Study|Withdrawal by Subject|1|||
129505701|NCT03655717|466140306|FG006|Overall Study|Withdrawal by Subject|3|||
129505702|NCT03655717|466140307|FG007|Overall Study|Withdrawal by Subject|1|||
129505703|NCT03655717|466140308|FG008|Overall Study|Withdrawal by Subject|2|||
129505704|NCT03655717|466140309|FG009|Overall Study|Withdrawal by Subject|0|||
129505705|NCT03655717|466140310|FG010|Overall Study|Withdrawal by Subject|0|||
129505706|NCT03655717|466140311|FG011|Overall Study|Withdrawal by Subject|1|||
129505707|NCT03655717|466140312|FG012|Overall Study|Withdrawal by Subject|0|||
129505708|NCT03655717|466140313|FG013|Overall Study|Withdrawal by Subject|3|||
129505709|NCT03655717|466140314|FG014|Overall Study|Withdrawal by Subject|0|||
129505710|NCT03655717|466140315|FG015|Overall Study|Withdrawal by Subject|1|||
129505711|NCT03655717|466140316|FG016|Overall Study|Withdrawal by Subject|0|||
129505712|NCT03655717|466140317|FG017|Overall Study|Withdrawal by Subject|0|||
129505713|NCT03655717|466140318|FG018|Overall Study|Withdrawal by Subject|1|||
129505714|NCT03655717|466140319|FG019|Overall Study|Withdrawal by Subject|0|||
129505715|NCT03655717|466140320|FG020|Overall Study|Withdrawal by Subject|0|||
129505716|NCT03655717|466140321|FG021|Overall Study|Withdrawal by Subject|1|||
129505717|NCT03655717|466140322|FG022|Overall Study|Withdrawal by Subject|2|||
129505718|NCT03655717|466140323|FG023|Overall Study|Withdrawal by Subject|1|||
129505719|NCT03655717|466140324|FG024|Overall Study|Withdrawal by Subject|1|||
129505720|NCT03655717|466140325|FG025|Overall Study|Withdrawal by Subject|0|||
129505721|NCT03655717|466140300|FG000|Overall Study|Physician Decision|3|||
129505722|NCT03655717|466140301|FG001|Overall Study|Physician Decision|3|||
129505723|NCT03655717|466140302|FG002|Overall Study|Physician Decision|0|||
129505724|NCT03655717|466140303|FG003|Overall Study|Physician Decision|0|||
129505725|NCT03655717|466140304|FG004|Overall Study|Physician Decision|0|||
129505726|NCT03655717|466140305|FG005|Overall Study|Physician Decision|0|||
129505727|NCT03655717|466140306|FG006|Overall Study|Physician Decision|0|||
129505728|NCT03655717|466140307|FG007|Overall Study|Physician Decision|0|||
129505729|NCT03655717|466140308|FG008|Overall Study|Physician Decision|0|||
129505730|NCT03655717|466140309|FG009|Overall Study|Physician Decision|1|||
129505731|NCT03655717|466140310|FG010|Overall Study|Physician Decision|0|||
129505732|NCT03655717|466140311|FG011|Overall Study|Physician Decision|0|||
129505733|NCT03655717|466140312|FG012|Overall Study|Physician Decision|0|||
129505734|NCT03655717|466140313|FG013|Overall Study|Physician Decision|0|||
129505735|NCT03655717|466140314|FG014|Overall Study|Physician Decision|0|||
129505736|NCT03655717|466140315|FG015|Overall Study|Physician Decision|0|||
129505737|NCT03655717|466140316|FG016|Overall Study|Physician Decision|0|||
129505738|NCT03655717|466140317|FG017|Overall Study|Physician Decision|0|||
129505739|NCT03655717|466140318|FG018|Overall Study|Physician Decision|0|||
129505740|NCT03655717|466140319|FG019|Overall Study|Physician Decision|1|||
129505741|NCT03655717|466140320|FG020|Overall Study|Physician Decision|0|||
129505742|NCT03655717|466140321|FG021|Overall Study|Physician Decision|0|||
129505743|NCT03655717|466140322|FG022|Overall Study|Physician Decision|0|||
129505744|NCT03655717|466140323|FG023|Overall Study|Physician Decision|1|||
129505745|NCT03655717|466140324|FG024|Overall Study|Physician Decision|0|||
129505746|NCT03655717|466140325|FG025|Overall Study|Physician Decision|0|||
129505747|NCT03655717|466140300|FG000|Overall Study|Lost to Follow-up|3|||
129505748|NCT03655717|466140301|FG001|Overall Study|Lost to Follow-up|1|||
129505749|NCT03655717|466140302|FG002|Overall Study|Lost to Follow-up|0|||
129505750|NCT03655717|466140303|FG003|Overall Study|Lost to Follow-up|1|||
129505751|NCT03655717|466140304|FG004|Overall Study|Lost to Follow-up|0|||
129505752|NCT03655717|466140305|FG005|Overall Study|Lost to Follow-up|1|||
129505753|NCT03655717|466140306|FG006|Overall Study|Lost to Follow-up|0|||
129505754|NCT03655717|466140307|FG007|Overall Study|Lost to Follow-up|0|||
129505755|NCT03655717|466140308|FG008|Overall Study|Lost to Follow-up|0|||
129505756|NCT03655717|466140309|FG009|Overall Study|Lost to Follow-up|0|||
129505757|NCT03655717|466140310|FG010|Overall Study|Lost to Follow-up|0|||
129505758|NCT03655717|466140311|FG011|Overall Study|Lost to Follow-up|1|||
129505759|NCT03655717|466140312|FG012|Overall Study|Lost to Follow-up|0|||
129505760|NCT03655717|466140313|FG013|Overall Study|Lost to Follow-up|0|||
129505761|NCT03655717|466140314|FG014|Overall Study|Lost to Follow-up|0|||
129505762|NCT03655717|466140315|FG015|Overall Study|Lost to Follow-up|0|||
129505763|NCT03655717|466140316|FG016|Overall Study|Lost to Follow-up|0|||
129505764|NCT03655717|466140317|FG017|Overall Study|Lost to Follow-up|0|||
129505765|NCT03655717|466140318|FG018|Overall Study|Lost to Follow-up|0|||
129505766|NCT03655717|466140319|FG019|Overall Study|Lost to Follow-up|0|||
129505767|NCT03655717|466140320|FG020|Overall Study|Lost to Follow-up|0|||
129505768|NCT03655717|466140321|FG021|Overall Study|Lost to Follow-up|0|||
129505769|NCT03655717|466140322|FG022|Overall Study|Lost to Follow-up|0|||
129505770|NCT03655717|466140323|FG023|Overall Study|Lost to Follow-up|0|||
129505771|NCT03655717|466140324|FG024|Overall Study|Lost to Follow-up|0|||
129505772|NCT03655717|466140325|FG025|Overall Study|Lost to Follow-up|0|||
129505773|NCT03225716|466141796|FG000|Overall Study|Withdrawal by Subject|2|||
129505774|NCT03225716|466141797|FG001|Overall Study|Withdrawal by Subject|2|||
129505775|NCT03225716|466141798|FG002|Overall Study|Withdrawal by Subject|0|||
129505776|NCT03225716|466141796|FG000|Overall Study|Lack of Efficacy|1|||
129505777|NCT03225716|466141797|FG001|Overall Study|Lack of Efficacy|0|||
129505778|NCT03225716|466141798|FG002|Overall Study|Lack of Efficacy|0|||
129505779|NCT03225716|466141796|FG000|Overall Study|Adverse Event|2|||
129505780|NCT03225716|466141797|FG001|Overall Study|Adverse Event|0|||
129505781|NCT03225716|466141798|FG002|Overall Study|Adverse Event|1|||
129505782|NCT03225716|466141796|FG000|Overall Study|Study early termination by Sponsor|0|||
129505783|NCT03225716|466141797|FG001|Overall Study|Study early termination by Sponsor|0|||
129505784|NCT03225716|466141798|FG002|Overall Study|Study early termination by Sponsor|2|||
129505785|NCT00571688|466141799|FG000|Overall Study|Lost to Follow-up|3|||
129505786|NCT00571688|466141800|FG001|Overall Study|Lost to Follow-up|6|||
129505787|NCT00571688|466141799|FG000|Overall Study|subject did not tolerate Consta|1|||
129505788|NCT00571688|466141800|FG001|Overall Study|subject did not tolerate Consta|0|||
129505789|NCT00571688|466141799|FG000|Overall Study|subject moved out of the area|1|||
129505790|NCT00571688|466141800|FG001|Overall Study|subject moved out of the area|0|||
129505791|NCT00190983|466141801|FG000|Overall Study|Inevaluable (never treated)|2|||
129505792|NCT01453998|466141802|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
129505793|NCT01453998|466141803|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
129505794|NCT01453998|466141804|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
129505795|NCT00077610|466141805|FG000|Overall Study|Adverse Event|9|||
129505796|NCT00077610|466141806|FG001|Overall Study|Adverse Event|7|||
129505797|NCT00077610|466141807|FG002|Overall Study|Adverse Event|1|||
129505798|NCT00077610|466141805|FG000|Overall Study|Lost to Follow-up|0|||
129505799|NCT00077610|466141806|FG001|Overall Study|Lost to Follow-up|1|||
129505800|NCT00077610|466141807|FG002|Overall Study|Lost to Follow-up|2|||
129505801|NCT00077610|466141805|FG000|Overall Study|Withdrawal by Subject|4|||
129505802|NCT00077610|466141806|FG001|Overall Study|Withdrawal by Subject|10|||
129505803|NCT00077610|466141807|FG002|Overall Study|Withdrawal by Subject|6|||
129505804|NCT00077610|466141805|FG000|Overall Study|Death|17|||
129505805|NCT00077610|466141806|FG001|Overall Study|Death|13|||
129505806|NCT00077610|466141807|FG002|Overall Study|Death|13|||
129505807|NCT00077610|466141805|FG000|Overall Study|Renal transplant|12|||
129505808|NCT00077610|466141806|FG001|Overall Study|Renal transplant|15|||
129505809|NCT00077610|466141807|FG002|Overall Study|Renal transplant|11|||
129505810|NCT00077610|466141805|FG000|Overall Study|Withdrew from dialysis care|5|||
129505811|NCT00077610|466141806|FG001|Overall Study|Withdrew from dialysis care|0|||
129505812|NCT00077610|466141807|FG002|Overall Study|Withdrew from dialysis care|3|||
129505813|NCT00077610|466141805|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129505814|NCT00077610|466141806|FG001|Overall Study|Insufficient Therapeutic Response|0|||
129505815|NCT00077610|466141807|FG002|Overall Study|Insufficient Therapeutic Response|0|||
129505816|NCT00077610|466141805|FG000|Overall Study|Multiple blood transfusions|0|||
129505817|NCT00077610|466141806|FG001|Overall Study|Multiple blood transfusions|0|||
129505818|NCT00077610|466141807|FG002|Overall Study|Multiple blood transfusions|1|||
129505819|NCT00077610|466141805|FG000|Overall Study|Principal Investigator's decision|1|||
129505820|NCT00077610|466141806|FG001|Overall Study|Principal Investigator's decision|0|||
129505821|NCT00077610|466141807|FG002|Overall Study|Principal Investigator's decision|1|||
129505822|NCT00077610|466141805|FG000|Overall Study|Worsening of health condition|1|||
129505823|NCT00077610|466141806|FG001|Overall Study|Worsening of health condition|1|||
129505824|NCT00077610|466141807|FG002|Overall Study|Worsening of health condition|0|||
129505825|NCT00077610|466141805|FG000|Overall Study|Given Epogen in hospital|1|||
129505826|NCT00077610|466141806|FG001|Overall Study|Given Epogen in hospital|0|||
129505827|NCT00077610|466141807|FG002|Overall Study|Given Epogen in hospital|0|||
129505828|NCT00077610|466141805|FG000|Overall Study|Transferred to other unit|0|||
129505829|NCT00077610|466141806|FG001|Overall Study|Transferred to other unit|0|||
129505830|NCT00077610|466141807|FG002|Overall Study|Transferred to other unit|1|||
129505831|NCT00077610|466141805|FG000|Overall Study|Transferred to nursing home|0|||
129505832|NCT00077610|466141806|FG001|Overall Study|Transferred to nursing home|0|||
129505833|NCT00077610|466141807|FG002|Overall Study|Transferred to nursing home|1|||
129505834|NCT00077610|466141805|FG000|Overall Study|Transfer to satellite unit|1|||
129505835|NCT00077610|466141806|FG001|Overall Study|Transfer to satellite unit|0|||
129505836|NCT00077610|466141807|FG002|Overall Study|Transfer to satellite unit|0|||
129505837|NCT00077610|466141805|FG000|Overall Study|Transfer to other center for surgery|1|||
129505838|NCT00077610|466141806|FG001|Overall Study|Transfer to other center for surgery|0|||
129505839|NCT00077610|466141807|FG002|Overall Study|Transfer to other center for surgery|0|||
129505840|NCT00077610|466141805|FG000|Overall Study|Change in dialysis modality|1|||
129505841|NCT00077610|466141806|FG001|Overall Study|Change in dialysis modality|0|||
129505842|NCT00077610|466141807|FG002|Overall Study|Change in dialysis modality|0|||
129505843|NCT00077610|466141805|FG000|Overall Study|Relocation|0|||
129505844|NCT00077610|466141806|FG001|Overall Study|Relocation|8|||
129505845|NCT00077610|466141807|FG002|Overall Study|Relocation|5|||
129505846|NCT00077610|466141805|FG000|Overall Study|Financial issues|0|||
129505847|NCT00077610|466141806|FG001|Overall Study|Financial issues|1|||
129505848|NCT00077610|466141807|FG002|Overall Study|Financial issues|0|||
129505849|NCT00077610|466141805|FG000|Overall Study|Sponsors decision to withdraw|0|||
129505850|NCT00077610|466141806|FG001|Overall Study|Sponsors decision to withdraw|0|||
129539071|NCT02708524|466265147|FG003|Overall Study|Lost to Follow-up|0|||
129505851|NCT00077610|466141807|FG002|Overall Study|Sponsors decision to withdraw|1|||
129505852|NCT00976950|466141808|FG000|Overall Study|Adverse Event|3|||
129505853|NCT00976950|466141808|FG000|Overall Study|Events with no relationship to Aptivus|3|||
129505854|NCT00304915|466141809|FG000|Overall Study|Lost to Follow-up|11|||
129505855|NCT00304915|466141810|FG001|Overall Study|Lost to Follow-up|11|||
129505856|NCT00304915|466141809|FG000|Overall Study|Death|4|||
129505857|NCT00304915|466141810|FG001|Overall Study|Death|5|||
129505858|NCT00304915|466141809|FG000|Overall Study|Withdrawal by Subject|3|||
129505859|NCT00304915|466141810|FG001|Overall Study|Withdrawal by Subject|0|||
129505860|NCT02662985|466141817|FG000|Treatment Period 1|Adverse Event|0|||
129505861|NCT02662985|466141818|FG001|Treatment Period 1|Adverse Event|2|||
129505862|NCT02662985|466141817|FG000|Treatment Period 1|Protocol Violation|0|||
129505863|NCT02662985|466141818|FG001|Treatment Period 1|Protocol Violation|1|||
129505864|NCT02662985|466141817|FG000|Treatment Period 1|Physician Decision|1|||
129505865|NCT02662985|466141818|FG001|Treatment Period 1|Physician Decision|0|||
129505866|NCT02662985|466141817|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129505867|NCT02662985|466141818|FG001|Treatment Period 1|Withdrawal by Subject|1|||
129505868|NCT02662985|466141817|FG000|Treatment Period 2|Lack of Efficacy|0|||
129505869|NCT02662985|466141818|FG001|Treatment Period 2|Lack of Efficacy|1|||
129505870|NCT02662985|466141817|FG000|Treatment Period 2|Lost to Follow-up|1|||
129505871|NCT02662985|466141818|FG001|Treatment Period 2|Lost to Follow-up|0|||
129505872|NCT02662985|466141817|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
129505873|NCT02662985|466141818|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
129505874|NCT02662985|466141817|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
129505875|NCT02662985|466141818|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
129505876|NCT02662985|466141817|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
129505877|NCT02662985|466141818|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
129505878|NCT02662985|466141817|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
129505879|NCT02662985|466141818|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
129505880|NCT02662985|466141817|FG000|Treatment Period 3 (Extension Period)|Death|0|||
129505881|NCT02662985|466141818|FG001|Treatment Period 3 (Extension Period)|Death|1|||
129505882|NCT03442829|466141819|FG000|Overall Study|Scheduling clash|3|||
129505883|NCT03442829|466141820|FG001|Overall Study|Scheduling clash|1|||
129505884|NCT03442829|466141819|FG000|Overall Study|Illness unrelated to study|1|||
129505885|NCT03442829|466141820|FG001|Overall Study|Illness unrelated to study|1|||
129505886|NCT01486784|466141821|FG000|Overall Study|Withdrawal by Subject|0|||
129505887|NCT01486784|466141822|FG001|Overall Study|Withdrawal by Subject|0|||
129505888|NCT01486784|466141823|FG002|Overall Study|Withdrawal by Subject|1|||
129505889|NCT01486784|466141824|FG003|Overall Study|Withdrawal by Subject|0|||
129505890|NCT01486784|466141825|FG004|Overall Study|Withdrawal by Subject|1|||
129505891|NCT01486784|466141826|FG005|Overall Study|Withdrawal by Subject|2|||
129505892|NCT01486784|466141821|FG000|Overall Study|Subject did not meet entry criteria|0|||
129505893|NCT01486784|466141822|FG001|Overall Study|Subject did not meet entry criteria|0|||
129505894|NCT01486784|466141823|FG002|Overall Study|Subject did not meet entry criteria|0|||
129505895|NCT01486784|466141824|FG003|Overall Study|Subject did not meet entry criteria|0|||
129505896|NCT01486784|466141825|FG004|Overall Study|Subject did not meet entry criteria|1|||
129505897|NCT01486784|466141826|FG005|Overall Study|Subject did not meet entry criteria|0|||
129505898|NCT01486784|466141821|FG000|Overall Study|Death|0|||
129505899|NCT01486784|466141822|FG001|Overall Study|Death|0|||
129505900|NCT01486784|466141823|FG002|Overall Study|Death|0|||
129505901|NCT01486784|466141824|FG003|Overall Study|Death|0|||
129505902|NCT01486784|466141825|FG004|Overall Study|Death|0|||
129505903|NCT01486784|466141826|FG005|Overall Study|Death|1|||
129505904|NCT01021852|466141829|FG000|Treatment Period 1|Adverse Event|3|||
129505905|NCT01021852|466141830|FG001|Treatment Period 1|Adverse Event|1|||
129505906|NCT01021852|466141831|FG002|Treatment Period 1|Adverse Event|1|||
129505907|NCT01021852|466141832|FG003|Treatment Period 1|Adverse Event|0|||
129505908|NCT01021852|466141833|FG004|Treatment Period 1|Adverse Event|2|||
129505909|NCT01021852|466141834|FG005|Treatment Period 1|Adverse Event|2|||
129505910|NCT01021852|466141835|FG006|Treatment Period 1|Adverse Event|0|||
129505911|NCT01021852|466141836|FG007|Treatment Period 1|Adverse Event|0|||
129505912|NCT01021852|466141829|FG000|Treatment Period 1|Pregnancy|0|||
129505913|NCT01021852|466141830|FG001|Treatment Period 1|Pregnancy|0|||
129505914|NCT01021852|466141831|FG002|Treatment Period 1|Pregnancy|1|||
129505915|NCT01021852|466141832|FG003|Treatment Period 1|Pregnancy|0|||
129505916|NCT01021852|466141833|FG004|Treatment Period 1|Pregnancy|0|||
129505917|NCT01021852|466141834|FG005|Treatment Period 1|Pregnancy|0|||
129505918|NCT01021852|466141835|FG006|Treatment Period 1|Pregnancy|0|||
129505919|NCT01021852|466141836|FG007|Treatment Period 1|Pregnancy|0|||
129982312|NCT01278173|467898822|FG000|Overall Study|Protocol Violation|1|||
129505920|NCT01021852|466141829|FG000|Treatment Period 1|Withdrawal by Subject|0|||
129505921|NCT01021852|466141830|FG001|Treatment Period 1|Withdrawal by Subject|0|||
129505922|NCT01021852|466141831|FG002|Treatment Period 1|Withdrawal by Subject|0|||
129505923|NCT01021852|466141832|FG003|Treatment Period 1|Withdrawal by Subject|0|||
129505924|NCT01021852|466141833|FG004|Treatment Period 1|Withdrawal by Subject|1|||
129505925|NCT01021852|466141834|FG005|Treatment Period 1|Withdrawal by Subject|0|||
129505926|NCT01021852|466141835|FG006|Treatment Period 1|Withdrawal by Subject|0|||
129505927|NCT01021852|466141836|FG007|Treatment Period 1|Withdrawal by Subject|1|||
129505928|NCT01021852|466141829|FG000|Treatment Period 1|Not Treated|0|||
129505929|NCT01021852|466141830|FG001|Treatment Period 1|Not Treated|0|||
129505930|NCT01021852|466141831|FG002|Treatment Period 1|Not Treated|0|||
129505931|NCT01021852|466141832|FG003|Treatment Period 1|Not Treated|2|||
129505932|NCT01021852|466141833|FG004|Treatment Period 1|Not Treated|0|||
129505933|NCT01021852|466141834|FG005|Treatment Period 1|Not Treated|0|||
129505934|NCT01021852|466141835|FG006|Treatment Period 1|Not Treated|0|||
129505935|NCT01021852|466141836|FG007|Treatment Period 1|Not Treated|0|||
129505936|NCT01021852|466141829|FG000|Washout Period-Placebo|Adverse Event|0|||
129505937|NCT01021852|466141830|FG001|Washout Period-Placebo|Adverse Event|0|||
129505938|NCT01021852|466141831|FG002|Washout Period-Placebo|Adverse Event|0|||
129505939|NCT01021852|466141832|FG003|Washout Period-Placebo|Adverse Event|1|||
129505940|NCT01021852|466141833|FG004|Washout Period-Placebo|Adverse Event|0|||
129505941|NCT01021852|466141834|FG005|Washout Period-Placebo|Adverse Event|1|||
129505942|NCT01021852|466141835|FG006|Washout Period-Placebo|Adverse Event|0|||
129505943|NCT01021852|466141836|FG007|Washout Period-Placebo|Adverse Event|0|||
129505944|NCT01021852|466141829|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
129505945|NCT01021852|466141830|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
129505946|NCT01021852|466141831|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
129505947|NCT01021852|466141832|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
129505948|NCT01021852|466141833|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
129505949|NCT01021852|466141834|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
129505950|NCT01021852|466141835|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
129505951|NCT01021852|466141836|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
129505952|NCT01021852|466141829|FG000|Washout Period-Placebo|Protocol Violation|0|||
129505953|NCT01021852|466141830|FG001|Washout Period-Placebo|Protocol Violation|0|||
129505954|NCT01021852|466141831|FG002|Washout Period-Placebo|Protocol Violation|0|||
129505955|NCT01021852|466141832|FG003|Washout Period-Placebo|Protocol Violation|0|||
129505956|NCT01021852|466141833|FG004|Washout Period-Placebo|Protocol Violation|0|||
129505957|NCT01021852|466141834|FG005|Washout Period-Placebo|Protocol Violation|0|||
129505958|NCT01021852|466141835|FG006|Washout Period-Placebo|Protocol Violation|1|||
129505959|NCT01021852|466141836|FG007|Washout Period-Placebo|Protocol Violation|0|||
129505960|NCT01021852|466141829|FG000|Washout Period-No Drug|Adverse Event|1|||
129505961|NCT01021852|466141830|FG001|Washout Period-No Drug|Adverse Event|0|||
129505962|NCT01021852|466141831|FG002|Washout Period-No Drug|Adverse Event|0|||
129505963|NCT01021852|466141832|FG003|Washout Period-No Drug|Adverse Event|0|||
129505964|NCT01021852|466141833|FG004|Washout Period-No Drug|Adverse Event|0|||
129505965|NCT01021852|466141834|FG005|Washout Period-No Drug|Adverse Event|1|||
129505966|NCT01021852|466141835|FG006|Washout Period-No Drug|Adverse Event|0|||
129505967|NCT01021852|466141836|FG007|Washout Period-No Drug|Adverse Event|0|||
129505968|NCT01021852|466141829|FG000|Treatment Period 2|Adverse Event|0|||
129505969|NCT01021852|466141830|FG001|Treatment Period 2|Adverse Event|1|||
129505970|NCT01021852|466141831|FG002|Treatment Period 2|Adverse Event|0|||
129505971|NCT01021852|466141832|FG003|Treatment Period 2|Adverse Event|0|||
129505972|NCT01021852|466141833|FG004|Treatment Period 2|Adverse Event|1|||
129505973|NCT01021852|466141834|FG005|Treatment Period 2|Adverse Event|0|||
129505974|NCT01021852|466141835|FG006|Treatment Period 2|Adverse Event|1|||
129505975|NCT01021852|466141836|FG007|Treatment Period 2|Adverse Event|0|||
129505976|NCT01021852|466141829|FG000|Treatment Period 2|Lack of Efficacy|0|||
129505977|NCT01021852|466141830|FG001|Treatment Period 2|Lack of Efficacy|0|||
129505978|NCT01021852|466141831|FG002|Treatment Period 2|Lack of Efficacy|0|||
129505979|NCT01021852|466141832|FG003|Treatment Period 2|Lack of Efficacy|0|||
129505980|NCT01021852|466141833|FG004|Treatment Period 2|Lack of Efficacy|0|||
129505981|NCT01021852|466141834|FG005|Treatment Period 2|Lack of Efficacy|1|||
129505982|NCT01021852|466141835|FG006|Treatment Period 2|Lack of Efficacy|0|||
129505983|NCT01021852|466141836|FG007|Treatment Period 2|Lack of Efficacy|0|||
129505984|NCT01021852|466141829|FG000|Treatment Period 2|Physician Decision|0|||
129505985|NCT01021852|466141830|FG001|Treatment Period 2|Physician Decision|0|||
129505986|NCT01021852|466141831|FG002|Treatment Period 2|Physician Decision|1|||
129505987|NCT01021852|466141832|FG003|Treatment Period 2|Physician Decision|0|||
129505988|NCT01021852|466141833|FG004|Treatment Period 2|Physician Decision|0|||
129505989|NCT01021852|466141834|FG005|Treatment Period 2|Physician Decision|0|||
129505990|NCT01021852|466141835|FG006|Treatment Period 2|Physician Decision|0|||
129505991|NCT01021852|466141836|FG007|Treatment Period 2|Physician Decision|0|||
129982313|NCT01278173|467898822|FG000|Overall Study|Withdrawal by Subject|1|||
129982314|NCT04662931|467898824|FG000|Overall Study|Withdrawal by Subject|17|||
129505992|NCT01021852|466141829|FG000|Treatment Period 2|Protocol Violation|0|||
129505993|NCT01021852|466141830|FG001|Treatment Period 2|Protocol Violation|0|||
129505994|NCT01021852|466141831|FG002|Treatment Period 2|Protocol Violation|0|||
129505995|NCT01021852|466141832|FG003|Treatment Period 2|Protocol Violation|0|||
129505996|NCT01021852|466141833|FG004|Treatment Period 2|Protocol Violation|1|||
129505997|NCT01021852|466141834|FG005|Treatment Period 2|Protocol Violation|0|||
129505998|NCT01021852|466141835|FG006|Treatment Period 2|Protocol Violation|1|||
129505999|NCT01021852|466141836|FG007|Treatment Period 2|Protocol Violation|0|||
129506000|NCT01021852|466141829|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129506001|NCT01021852|466141830|FG001|Treatment Period 2|Withdrawal by Subject|0|||
129506002|NCT01021852|466141831|FG002|Treatment Period 2|Withdrawal by Subject|0|||
129506003|NCT01021852|466141832|FG003|Treatment Period 2|Withdrawal by Subject|0|||
129506004|NCT01021852|466141833|FG004|Treatment Period 2|Withdrawal by Subject|0|||
129506005|NCT01021852|466141834|FG005|Treatment Period 2|Withdrawal by Subject|0|||
129506006|NCT01021852|466141835|FG006|Treatment Period 2|Withdrawal by Subject|1|||
129506007|NCT01021852|466141836|FG007|Treatment Period 2|Withdrawal by Subject|2|||
129506008|NCT02493426|466141837|FG000|Overall Study|Withdrawal by Subject|0|||
129506009|NCT02493426|466141838|FG001|Overall Study|Withdrawal by Subject|1|||
129506010|NCT03491553|466141839|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
129506011|NCT03491553|466141840|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
129506012|NCT03491553|466141841|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
129506013|NCT03491553|466141842|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
129506014|NCT03491553|466141843|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
129506015|NCT03491553|466141844|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
129506016|NCT03491553|466141839|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
129506017|NCT03491553|466141840|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
129506018|NCT03491553|466141841|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
129506019|NCT03491553|466141842|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
129506020|NCT03491553|466141843|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
129506021|NCT03491553|466141844|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
129506022|NCT01025817|466141846|FG000|Completed Study Medication|Adverse Event|66|||
129506023|NCT01025817|466141847|FG001|Completed Study Medication|Adverse Event|39|||
129506024|NCT01025817|466141846|FG000|Completed Study Medication|Protocol Deviation|9|||
129506025|NCT01025817|466141847|FG001|Completed Study Medication|Protocol Deviation|8|||
129506026|NCT01025817|466141846|FG000|Completed Study Medication|Withdrawal by Subject|8|||
129506027|NCT01025817|466141847|FG001|Completed Study Medication|Withdrawal by Subject|9|||
129506028|NCT01025817|466141846|FG000|Completed Study Medication|Administrative problems|7|||
129506029|NCT01025817|466141847|FG001|Completed Study Medication|Administrative problems|5|||
129506030|NCT01025817|466141846|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
129506031|NCT01025817|466141847|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
129506032|NCT01025817|466141846|FG000|Completed Study Medication|Abnormal test procedure|4|||
129506033|NCT01025817|466141847|FG001|Completed Study Medication|Abnormal test procedure|0|||
129506034|NCT01025817|466141846|FG000|Completed Study Medication|Graft loss|2|||
129506035|NCT01025817|466141847|FG001|Completed Study Medication|Graft loss|5|||
129506036|NCT01025817|466141846|FG000|Completed Study Medication|Death|2|||
129506037|NCT01025817|466141847|FG001|Completed Study Medication|Death|2|||
129506038|NCT01025817|466141846|FG000|Completed Study Medication|Abnormal lab values|0|||
129506039|NCT01025817|466141847|FG001|Completed Study Medication|Abnormal lab values|2|||
129982315|NCT04662931|467898824|FG000|Overall Study|Death|3|||
129982316|NCT04662931|467898824|FG000|Overall Study|Lost to Follow-up|3|||
129982317|NCT04662931|467898824|FG000|Overall Study|Guardian Decision|1|||
129982318|NCT00680992|467898828|FG000|Overall Study|Complete Resection (as per protocol)|25|||
129982319|NCT00680992|467898829|FG001|Overall Study|Complete Resection (as per protocol)|121|||
129982320|NCT00680992|467898830|FG002|Overall Study|Complete Resection (as per protocol)|0|||
129982321|NCT00680992|467898828|FG000|Overall Study|Administrative Decision|83|||
129982322|NCT00680992|467898829|FG001|Overall Study|Administrative Decision|42|||
129982323|NCT00680992|467898830|FG002|Overall Study|Administrative Decision|5|||
129982324|NCT00680992|467898828|FG000|Overall Study|End of Trial|32|||
129982325|NCT00680992|467898829|FG001|Overall Study|End of Trial|12|||
129982326|NCT00680992|467898830|FG002|Overall Study|End of Trial|3|||
129982327|NCT00680992|467898828|FG000|Overall Study|Withdrawal by Subject|33|||
129982328|NCT00680992|467898829|FG001|Overall Study|Withdrawal by Subject|11|||
129982329|NCT00680992|467898830|FG002|Overall Study|Withdrawal by Subject|1|||
129982330|NCT00680992|467898828|FG000|Overall Study|Adverse Event|21|||
129982331|NCT00680992|467898829|FG001|Overall Study|Adverse Event|19|||
129982332|NCT00680992|467898830|FG002|Overall Study|Adverse Event|1|||
129982333|NCT00680992|467898828|FG000|Overall Study|Other|19|||
129982334|NCT00680992|467898829|FG001|Overall Study|Other|14|||
129982335|NCT00680992|467898830|FG002|Overall Study|Other|1|||
129982336|NCT00680992|467898828|FG000|Overall Study|Disease Progression|21|||
129982337|NCT00680992|467898829|FG001|Overall Study|Disease Progression|9|||
129982338|NCT00680992|467898830|FG002|Overall Study|Disease Progression|0|||
129982339|NCT00680992|467898828|FG000|Overall Study|Lost to Follow-up|12|||
129982340|NCT00680992|467898829|FG001|Overall Study|Lost to Follow-up|14|||
129982341|NCT00680992|467898830|FG002|Overall Study|Lost to Follow-up|0|||
129982342|NCT00680992|467898828|FG000|Overall Study|Noncompliance|4|||
129982343|NCT00680992|467898829|FG001|Overall Study|Noncompliance|6|||
129982344|NCT00680992|467898830|FG002|Overall Study|Noncompliance|0|||
129982345|NCT00680992|467898828|FG000|Overall Study|Requirement for Alternative Therapy|8|||
129506040|NCT01025817|466141846|FG000|Completed Study Medication|Subject no longer required study drug|0|||
129982346|NCT00680992|467898829|FG001|Overall Study|Requirement for Alternative Therapy|2|||
129982347|NCT00680992|467898830|FG002|Overall Study|Requirement for Alternative Therapy|0|||
129506041|NCT01025817|466141847|FG001|Completed Study Medication|Subject no longer required study drug|1|||
129506042|NCT01025817|466141846|FG000|Completed Study Medication|Lost to Follow-up|0|||
129506043|NCT01025817|466141847|FG001|Completed Study Medication|Lost to Follow-up|1|||
129506044|NCT01025817|466141846|FG000|Completed Study|Withdrawal by Subject|8|||
129506045|NCT01025817|466141847|FG001|Completed Study|Withdrawal by Subject|16|||
129506046|NCT01025817|466141846|FG000|Completed Study|Death|6|||
129506047|NCT01025817|466141847|FG001|Completed Study|Death|5|||
129506048|NCT01025817|466141846|FG000|Completed Study|Missing|2|||
129506049|NCT01025817|466141847|FG001|Completed Study|Missing|0|||
129506050|NCT01025817|466141846|FG000|Completed Study|Lost to Follow-up|0|||
129506051|NCT01025817|466141847|FG001|Completed Study|Lost to Follow-up|1|||
129506052|NCT01551758|466141848|FG000|Overall Study|Adverse Event|29|||
129506053|NCT01551758|466141849|FG001|Overall Study|Adverse Event|43|||
129506054|NCT01551758|466141848|FG000|Overall Study|Lack of Efficacy|0|||
129506055|NCT01551758|466141849|FG001|Overall Study|Lack of Efficacy|1|||
129506056|NCT01551758|466141848|FG000|Overall Study|Protocol Violation|5|||
129506057|NCT01551758|466141849|FG001|Overall Study|Protocol Violation|6|||
129506058|NCT01551758|466141848|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
129506059|NCT01551758|466141849|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
129506060|NCT01551758|466141848|FG000|Overall Study|Lost to Follow-up|29|||
129506061|NCT01551758|466141849|FG001|Overall Study|Lost to Follow-up|25|||
129506062|NCT01551758|466141848|FG000|Overall Study|Physician Decision|9|||
129506063|NCT01551758|466141849|FG001|Overall Study|Physician Decision|3|||
129506064|NCT01551758|466141848|FG000|Overall Study|Withdrawal by Subject|14|||
129506065|NCT01551758|466141849|FG001|Overall Study|Withdrawal by Subject|17|||
129506066|NCT00101192|466141850|FG000|Overall Study|Ineligible|6|||
129506067|NCT00101192|466141850|FG000|Overall Study|Inevaluable|1|||
129506068|NCT01096849|466141853|FG000|Overall Study|Consent Withdrawn|1|||
129506069|NCT01096849|466141854|FG001|Overall Study|Consent Withdrawn|4|||
129506070|NCT01096849|466141855|FG002|Overall Study|Consent Withdrawn|2|||
129506071|NCT01096849|466141853|FG000|Overall Study|Lack of Efficacy|0|||
129506072|NCT01096849|466141854|FG001|Overall Study|Lack of Efficacy|2|||
129506073|NCT01096849|466141855|FG002|Overall Study|Lack of Efficacy|0|||
129506074|NCT01096849|466141853|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
129506075|NCT01096849|466141854|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
129506076|NCT01096849|466141855|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
129506077|NCT01096849|466141853|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
129506078|NCT01096849|466141854|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
129506079|NCT01096849|466141855|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
129506080|NCT01096849|466141853|FG000|Overall Study|Administrative Reasons|0|||
129506081|NCT01096849|466141854|FG001|Overall Study|Administrative Reasons|1|||
129506082|NCT01096849|466141855|FG002|Overall Study|Administrative Reasons|2|||
129506083|NCT01096849|466141853|FG000|Overall Study|Lost to Follow-up|1|||
129506084|NCT01096849|466141854|FG001|Overall Study|Lost to Follow-up|3|||
129506085|NCT01096849|466141855|FG002|Overall Study|Lost to Follow-up|1|||
129506086|NCT00242580|466141857|FG000|Overall Study|Adverse Event|3|||
129506087|NCT00242580|466141858|FG001|Overall Study|Adverse Event|0|||
129506088|NCT00242580|466141859|FG002|Overall Study|Adverse Event|2|||
129506089|NCT00242580|466141857|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129506090|NCT00242580|466141858|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
129506091|NCT00242580|466141859|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
129506092|NCT00242580|466141857|FG000|Overall Study|Protocol Violation|0|||
129506093|NCT00242580|466141858|FG001|Overall Study|Protocol Violation|0|||
129506094|NCT00242580|466141859|FG002|Overall Study|Protocol Violation|1|||
129506095|NCT00242580|466141857|FG000|Overall Study|Subject withdrew consent|2|||
129506096|NCT00242580|466141858|FG001|Overall Study|Subject withdrew consent|2|||
129506097|NCT00242580|466141859|FG002|Overall Study|Subject withdrew consent|5|||
129506098|NCT00242580|466141857|FG000|Overall Study|Lost to Follow-up|0|||
129506099|NCT00242580|466141858|FG001|Overall Study|Lost to Follow-up|3|||
129506100|NCT00242580|466141859|FG002|Overall Study|Lost to Follow-up|0|||
129506101|NCT00242580|466141857|FG000|Overall Study|Death|1|||
129506102|NCT00242580|466141858|FG001|Overall Study|Death|2|||
129506103|NCT00242580|466141859|FG002|Overall Study|Death|1|||
129506104|NCT01232894|466141860|FG000|Overall Study|Lost to Follow-up|0|||
129506105|NCT01232894|466141861|FG001|Overall Study|Lost to Follow-up|1|||
129506106|NCT01232894|466141860|FG000|Overall Study|Death|1|||
129506107|NCT01232894|466141861|FG001|Overall Study|Death|0|||
129506108|NCT01232894|466141860|FG000|Overall Study|Protocol Violation|1|||
129506109|NCT01232894|466141861|FG001|Overall Study|Protocol Violation|1|||
129506110|NCT01232894|466141860|FG000|Overall Study|Withdrawal by Subject|8|||
129506111|NCT01232894|466141861|FG001|Overall Study|Withdrawal by Subject|5|||
129506112|NCT01232894|466141860|FG000|Overall Study|Physician Decision|2|||
129506113|NCT01232894|466141861|FG001|Overall Study|Physician Decision|1|||
129506114|NCT02128763|466141864|FG000|Overall Study|Death|1|||
129506115|NCT02128763|466141865|FG001|Overall Study|Death|0|||
129506116|NCT02128763|466141864|FG000|Overall Study|Lost to Follow-up|19|||
129506117|NCT02128763|466141865|FG001|Overall Study|Lost to Follow-up|16|||
129506118|NCT00363246|466141866|FG000|Overall Study|Death|40|||
129539072|NCT02708524|466265144|FG000|Overall Study|Protocol Violation|0|||
129506119|NCT00363246|466141866|FG000|Overall Study|Withdrawal by Subject|19|||
129506120|NCT00363246|466141866|FG000|Overall Study|Lost to Follow-up|14|||
129506121|NCT00363246|466141866|FG000|Overall Study|Bad health|6|||
129506122|NCT00363246|466141866|FG000|Overall Study|Stopped using wheelchair|11|||
129506123|NCT00363246|466141866|FG000|Overall Study|Subject expressed security concerns|2|||
129506124|NCT00363246|466141866|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
129506125|NCT04387136|466141867|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
129506126|NCT04387136|466141868|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
129506127|NCT00717366|466141869|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
129506128|NCT00717366|466141870|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
129506129|NCT00717366|466141869|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
129506130|NCT00717366|466141870|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
129506131|NCT00717366|466141869|FG000|Core Study Period (20 Weeks)|Death|0|||
129506132|NCT00717366|466141870|FG001|Core Study Period (20 Weeks)|Death|1|||
129506133|NCT00717366|466141869|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
129506134|NCT00717366|466141870|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
129506135|NCT00717366|466141869|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
129506136|NCT00717366|466141870|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
129506137|NCT00717366|466141869|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
129506138|NCT00717366|466141870|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
129506139|NCT00717366|466141869|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
129506140|NCT00717366|466141870|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
129506141|NCT00910429|466141873|FG000|Overall Study|Death|18|||
129506142|NCT00910429|466141874|FG001|Overall Study|Death|12|||
129506143|NCT00910429|466141873|FG000|Overall Study|Withdrawal by Subject|3|||
129506144|NCT00910429|466141874|FG001|Overall Study|Withdrawal by Subject|2|||
129506145|NCT00910429|466141873|FG000|Overall Study|Protocol Violation|1|||
129506146|NCT00910429|466141874|FG001|Overall Study|Protocol Violation|0|||
129506147|NCT00910429|466141873|FG000|Overall Study|Lost to Follow-up|2|||
129506148|NCT00910429|466141874|FG001|Overall Study|Lost to Follow-up|1|||
129506149|NCT00910429|466141873|FG000|Overall Study|Adverse Event|10|||
129506150|NCT00910429|466141874|FG001|Overall Study|Adverse Event|5|||
129506151|NCT00910429|466141873|FG000|Overall Study|Drug non-compliance|1|||
129506152|NCT00910429|466141874|FG001|Overall Study|Drug non-compliance|0|||
129506153|NCT00910429|466141873|FG000|Overall Study|Lack of Efficacy|4|||
129506154|NCT00910429|466141874|FG001|Overall Study|Lack of Efficacy|1|||
129506155|NCT02121756|466141876|FG000|Overall Study|Adverse Event|3|||
129506156|NCT02121756|466141877|FG001|Overall Study|Adverse Event|0|||
129506157|NCT02121756|466141876|FG000|Overall Study|Protocol Violation|1|||
129506158|NCT02121756|466141877|FG001|Overall Study|Protocol Violation|1|||
129506159|NCT02121756|466141876|FG000|Overall Study|Physician Decision|2|||
129506160|NCT02121756|466141877|FG001|Overall Study|Physician Decision|1|||
129506161|NCT00255086|466141880|FG000|Overall Study|Adverse Event|1|||
129506162|NCT00255086|466141881|FG001|Overall Study|Adverse Event|1|||
129506163|NCT00255086|466141880|FG000|Overall Study|Protocol Violation|1|||
129506164|NCT00255086|466141881|FG001|Overall Study|Protocol Violation|1|||
129506165|NCT02365584|466141883|FG000|Overall Study|Adverse Event|2|||
129506166|NCT02365584|466141884|FG001|Overall Study|Adverse Event|2|||
129506167|NCT02365584|466141883|FG000|Overall Study|Withdrawal by Subject|1|||
129506168|NCT02365584|466141884|FG001|Overall Study|Withdrawal by Subject|0|||
129506169|NCT02365584|466141883|FG000|Overall Study|Disease Progression|9|||
129506170|NCT02365584|466141884|FG001|Overall Study|Disease Progression|12|||
129506171|NCT00349752|466141885|FG000|Overall Study|Adverse Event|8|||
129506172|NCT00349752|466141886|FG001|Overall Study|Adverse Event|12|||
129506173|NCT00349752|466141885|FG000|Overall Study|Lack of Efficacy|37|||
129506174|NCT00349752|466141886|FG001|Overall Study|Lack of Efficacy|42|||
129506175|NCT00349752|466141885|FG000|Overall Study|Lost to Follow-up|4|||
129506176|NCT00349752|466141886|FG001|Overall Study|Lost to Follow-up|2|||
129506177|NCT00349752|466141885|FG000|Overall Study|Personal reasons|6|||
129506178|NCT00349752|466141886|FG001|Overall Study|Personal reasons|5|||
129506179|NCT00349752|466141885|FG000|Overall Study|Other: Required exclusionary medication|0|||
129506180|NCT00349752|466141886|FG001|Overall Study|Other: Required exclusionary medication|1|||
129506181|NCT00349752|466141885|FG000|Overall Study|Other: Non compliance|0|||
129506182|NCT00349752|466141886|FG001|Overall Study|Other: Non compliance|1|||
129506183|NCT00349752|466141885|FG000|Overall Study|Other: Patient stopped steroids|0|||
129506184|NCT00349752|466141886|FG001|Overall Study|Other: Patient stopped steroids|1|||
129506185|NCT00349752|466141885|FG000|Overall Study|Other: Patient's steroid use|1|||
129506186|NCT00349752|466141886|FG001|Overall Study|Other: Patient's steroid use|0|||
129506187|NCT00349752|466141885|FG000|Overall Study|Other: Ineligible|1|||
129506188|NCT00349752|466141886|FG001|Overall Study|Other: Ineligible|0|||
129506189|NCT00349752|466141885|FG000|Overall Study|Other: Inadvertently unblinded|1|||
129506190|NCT00349752|466141886|FG001|Overall Study|Other: Inadvertently unblinded|0|||
129506191|NCT00349752|466141885|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
129506192|NCT00349752|466141886|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
129506193|NCT01973452|466141891|FG000|Overall Study|Lack of Efficacy|0|||
129506194|NCT01973452|466141892|FG001|Overall Study|Lack of Efficacy|1|||
129506195|NCT01973452|466141891|FG000|Overall Study|Lost to Follow-up|1|||
129506196|NCT01973452|466141892|FG001|Overall Study|Lost to Follow-up|0|||
129506197|NCT01973452|466141891|FG000|Overall Study|Withdrawal by Subject|10|||
129506198|NCT01973452|466141892|FG001|Overall Study|Withdrawal by Subject|9|||
129506199|NCT01973452|466141891|FG000|Overall Study|Ineligible|1|||
129506200|NCT01973452|466141892|FG001|Overall Study|Ineligible|1|||
129506201|NCT01973452|466141891|FG000|Overall Study|Surgery canceled by participant|5|||
129506202|NCT01973452|466141892|FG001|Overall Study|Surgery canceled by participant|3|||
129506203|NCT05294211|466141894|FG000|Overall Study|Withdrawal by Subject|3|||
129506204|NCT05294211|466141894|FG000|Overall Study|Physician Decision|2|||
129506205|NCT05294211|466141894|FG000|Overall Study|Progressed to active labor|1|||
129506206|NCT05294211|466141894|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
129506207|NCT05294211|466141894|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
129506208|NCT00064350|466141895|FG000|Induction Treatment|Disease Progression|5|||
129506209|NCT00064350|466141896|FG001|Induction Treatment|Disease Progression|1|||
129506210|NCT00064350|466141897|FG002|Induction Treatment|Disease Progression|110|||
129506211|NCT00064350|466141895|FG000|Induction Treatment|Adverse Event|0|||
129506212|NCT00064350|466141896|FG001|Induction Treatment|Adverse Event|2|||
129506213|NCT00064350|466141897|FG002|Induction Treatment|Adverse Event|49|||
129506214|NCT00064350|466141895|FG000|Induction Treatment|Death|0|||
129506215|NCT00064350|466141896|FG001|Induction Treatment|Death|0|||
129506216|NCT00064350|466141897|FG002|Induction Treatment|Death|9|||
129506217|NCT00064350|466141895|FG000|Induction Treatment|Withdrawal by Subject|0|||
129506218|NCT00064350|466141896|FG001|Induction Treatment|Withdrawal by Subject|0|||
129506219|NCT00064350|466141897|FG002|Induction Treatment|Withdrawal by Subject|21|||
129506220|NCT00064350|466141895|FG000|Induction Treatment|Ineligible or never started treatment|3|||
129506221|NCT00064350|466141896|FG001|Induction Treatment|Ineligible or never started treatment|6|||
129506222|NCT00064350|466141897|FG002|Induction Treatment|Ineligible or never started treatment|34|||
129506223|NCT00064350|466141895|FG000|Induction Treatment|Other|0|||
129506224|NCT00064350|466141896|FG001|Induction Treatment|Other|0|||
129506225|NCT00064350|466141897|FG002|Induction Treatment|Other|13|||
129506226|NCT00064350|466141895|FG000|Randomization|Adverse Event|8|||
129506227|NCT00064350|466141896|FG001|Randomization|Adverse Event|3|||
129506228|NCT00064350|466141897|FG002|Randomization|Adverse Event|0|||
129506229|NCT00064350|466141895|FG000|Randomization|Death|3|||
129506230|NCT00064350|466141896|FG001|Randomization|Death|0|||
129506231|NCT00064350|466141897|FG002|Randomization|Death|0|||
129506232|NCT00064350|466141895|FG000|Randomization|Withdrawal by Subject|1|||
129506233|NCT00064350|466141896|FG001|Randomization|Withdrawal by Subject|0|||
129506234|NCT00064350|466141897|FG002|Randomization|Withdrawal by Subject|0|||
129506235|NCT00064350|466141895|FG000|Randomization|Ineligible or never started treatment|9|||
129506236|NCT00064350|466141896|FG001|Randomization|Ineligible or never started treatment|15|||
129506237|NCT00064350|466141897|FG002|Randomization|Ineligible or never started treatment|0|||
129506238|NCT00064350|466141895|FG000|Randomization|Other|5|||
129506239|NCT00064350|466141896|FG001|Randomization|Other|0|||
129506240|NCT00064350|466141897|FG002|Randomization|Other|0|||
129506241|NCT00064350|466141895|FG000|Cross-Over|Adverse Event|0|||
129506242|NCT00064350|466141896|FG001|Cross-Over|Adverse Event|1|||
129506243|NCT00064350|466141897|FG002|Cross-Over|Adverse Event|0|||
129506244|NCT00064350|466141895|FG000|Cross-Over|Death|1|||
129506245|NCT00064350|466141896|FG001|Cross-Over|Death|3|||
129506246|NCT00064350|466141897|FG002|Cross-Over|Death|0|||
129506247|NCT00064350|466141895|FG000|Cross-Over|Withdrawal by Subject|2|||
129506248|NCT00064350|466141896|FG001|Cross-Over|Withdrawal by Subject|2|||
129506249|NCT00064350|466141897|FG002|Cross-Over|Withdrawal by Subject|0|||
129506250|NCT00064350|466141895|FG000|Cross-Over|Ineligible or never started treatment|3|||
129506251|NCT00064350|466141896|FG001|Cross-Over|Ineligible or never started treatment|6|||
129506252|NCT00064350|466141897|FG002|Cross-Over|Ineligible or never started treatment|0|||
129506253|NCT00064350|466141895|FG000|Cross-Over|Other|0|||
129506254|NCT00064350|466141896|FG001|Cross-Over|Other|2|||
129506255|NCT00064350|466141897|FG002|Cross-Over|Other|0|||
129506256|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
129506257|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
129506258|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
129506259|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
129506260|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
129506261|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
129506262|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
129506263|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
129506264|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
129506265|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
129506266|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
129506267|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
129506268|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
129506269|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
129506270|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
129506271|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
129506272|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Missing|3|||
129506273|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Missing|1|||
129506274|NCT00838916|466141898|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
129506275|NCT00838916|466141899|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
129506276|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
129506277|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
129506278|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
129506279|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
129506280|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
129506281|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
129506282|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
129506283|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
129506284|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
129506285|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
129506286|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
129506287|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
129506288|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
129506289|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
129506290|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
129506291|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
129506292|NCT00838916|466141898|FG000|Follow-up Period (8 Weeks)|Missing|3|||
129506293|NCT00838916|466141899|FG001|Follow-up Period (8 Weeks)|Missing|0|||
129506294|NCT01842607|466141900|FG000|Overall Study|Adverse Event|11|||
129506295|NCT01842607|466141900|FG000|Overall Study|Lack of Efficacy|19|||
129506296|NCT01842607|466141900|FG000|Overall Study|Protocol Violation|8|||
129506297|NCT01842607|466141900|FG000|Overall Study|Protocol defined stopping criteria|2|||
129506298|NCT01842607|466141900|FG000|Overall Study|Lost to Follow-up|3|||
129506299|NCT01842607|466141900|FG000|Overall Study|Physician Decision|9|||
129506300|NCT01842607|466141900|FG000|Overall Study|Withdrawal by Subject|14|||
129506301|NCT02034474|466141901|FG000|Overall Study|Adverse Event|3|||
129506302|NCT02034474|466141902|FG001|Overall Study|Adverse Event|2|||
129506303|NCT02034474|466141901|FG000|Overall Study|Withdrawal by Subject|1|||
129506304|NCT02034474|466141902|FG001|Overall Study|Withdrawal by Subject|2|||
129506305|NCT03600714|466141903|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
129506306|NCT00675103|466141904|FG000|Overall Study|Lack of Efficacy|2|||
129506307|NCT00675103|466141904|FG000|Overall Study|Adverse Event|1|||
129506308|NCT02164513|466141905|FG000|Overall Study|Adverse Event|162|||
129506309|NCT02164513|466141906|FG001|Overall Study|Adverse Event|180|||
129506310|NCT02164513|466141907|FG002|Overall Study|Adverse Event|111|||
129506311|NCT02164513|466141905|FG000|Overall Study|Other: Study Closed or terminated|5|||
129506312|NCT02164513|466141906|FG001|Overall Study|Other: Study Closed or terminated|2|||
129506313|NCT02164513|466141907|FG002|Overall Study|Other: Study Closed or terminated|4|||
129506314|NCT02164513|466141905|FG000|Overall Study|Lost to Follow-up|30|||
129506315|NCT02164513|466141906|FG001|Overall Study|Lost to Follow-up|36|||
129506316|NCT02164513|466141907|FG002|Overall Study|Lost to Follow-up|22|||
129506317|NCT02164513|466141905|FG000|Overall Study|Physician Decision|47|||
129506318|NCT02164513|466141906|FG001|Overall Study|Physician Decision|57|||
129506319|NCT02164513|466141907|FG002|Overall Study|Physician Decision|28|||
129506320|NCT02164513|466141905|FG000|Overall Study|Withdrawal by Subject|192|||
129506321|NCT02164513|466141906|FG001|Overall Study|Withdrawal by Subject|261|||
129506322|NCT02164513|466141907|FG002|Overall Study|Withdrawal by Subject|130|||
129506323|NCT02164513|466141905|FG000|Overall Study|Other: Reason not provided by site|1|||
129506324|NCT02164513|466141906|FG001|Overall Study|Other: Reason not provided by site|0|||
129506325|NCT02164513|466141907|FG002|Overall Study|Other: Reason not provided by site|0|||
129506326|NCT02509494|466141914|FG000|Overall Study|Lost to Follow-up|8|||
129506327|NCT02509494|466141915|FG001|Overall Study|Lost to Follow-up|47|||
129506328|NCT02509494|466141916|FG002|Overall Study|Lost to Follow-up|19|||
129506329|NCT02509494|466141917|FG003|Overall Study|Lost to Follow-up|6|||
129506330|NCT02509494|466141918|FG004|Overall Study|Lost to Follow-up|3|||
129506331|NCT02509494|466141919|FG005|Overall Study|Lost to Follow-up|3|||
129506332|NCT02509494|466141920|FG006|Overall Study|Lost to Follow-up|1|||
129506333|NCT02509494|466141921|FG007|Overall Study|Lost to Follow-up|3|||
129506334|NCT02509494|466141922|FG008|Overall Study|Lost to Follow-up|1|||
129506335|NCT02509494|466141914|FG000|Overall Study|Physician Decision|2|||
129506336|NCT02509494|466141915|FG001|Overall Study|Physician Decision|1|||
129506337|NCT02509494|466141916|FG002|Overall Study|Physician Decision|0|||
129506338|NCT02509494|466141917|FG003|Overall Study|Physician Decision|0|||
129506339|NCT02509494|466141918|FG004|Overall Study|Physician Decision|0|||
129506340|NCT02509494|466141919|FG005|Overall Study|Physician Decision|0|||
129506341|NCT02509494|466141920|FG006|Overall Study|Physician Decision|0|||
129506342|NCT02509494|466141921|FG007|Overall Study|Physician Decision|0|||
129506343|NCT02509494|466141922|FG008|Overall Study|Physician Decision|0|||
129506344|NCT02509494|466141914|FG000|Overall Study|Withdrawal by Subject|4|||
129506345|NCT02509494|466141915|FG001|Overall Study|Withdrawal by Subject|17|||
129506346|NCT02509494|466141916|FG002|Overall Study|Withdrawal by Subject|7|||
129506347|NCT02509494|466141917|FG003|Overall Study|Withdrawal by Subject|5|||
129506348|NCT02509494|466141918|FG004|Overall Study|Withdrawal by Subject|0|||
129506349|NCT02509494|466141919|FG005|Overall Study|Withdrawal by Subject|6|||
129506350|NCT02509494|466141920|FG006|Overall Study|Withdrawal by Subject|1|||
129506351|NCT02509494|466141921|FG007|Overall Study|Withdrawal by Subject|2|||
129506352|NCT02509494|466141922|FG008|Overall Study|Withdrawal by Subject|1|||
129506353|NCT02509494|466141914|FG000|Overall Study|Death|0|||
129506354|NCT02509494|466141915|FG001|Overall Study|Death|1|||
129506355|NCT02509494|466141916|FG002|Overall Study|Death|0|||
129506356|NCT02509494|466141917|FG003|Overall Study|Death|0|||
129506357|NCT02509494|466141918|FG004|Overall Study|Death|1|||
129506358|NCT02509494|466141919|FG005|Overall Study|Death|0|||
129506359|NCT02509494|466141920|FG006|Overall Study|Death|0|||
129506360|NCT02509494|466141921|FG007|Overall Study|Death|1|||
129506361|NCT02509494|466141922|FG008|Overall Study|Death|0|||
129506362|NCT02509494|466141914|FG000|Overall Study|Other|0|||
129506363|NCT02509494|466141915|FG001|Overall Study|Other|4|||
129506364|NCT02509494|466141916|FG002|Overall Study|Other|5|||
129506365|NCT02509494|466141917|FG003|Overall Study|Other|0|||
129506366|NCT02509494|466141918|FG004|Overall Study|Other|0|||
129506367|NCT02509494|466141919|FG005|Overall Study|Other|0|||
129506368|NCT02509494|466141920|FG006|Overall Study|Other|0|||
129506369|NCT02509494|466141921|FG007|Overall Study|Other|0|||
129506370|NCT02509494|466141922|FG008|Overall Study|Other|0|||
129506371|NCT02509494|466141914|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129506372|NCT02509494|466141915|FG001|Overall Study|Non-Compliance With Study Drug|11|||
129506373|NCT02509494|466141916|FG002|Overall Study|Non-Compliance With Study Drug|7|||
129506374|NCT02509494|466141917|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129506375|NCT02509494|466141918|FG004|Overall Study|Non-Compliance With Study Drug|1|||
129506376|NCT02509494|466141919|FG005|Overall Study|Non-Compliance With Study Drug|2|||
129506377|NCT02509494|466141920|FG006|Overall Study|Non-Compliance With Study Drug|1|||
129506378|NCT02509494|466141921|FG007|Overall Study|Non-Compliance With Study Drug|1|||
129506379|NCT02509494|466141922|FG008|Overall Study|Non-Compliance With Study Drug|0|||
129506380|NCT01511107|466141923|FG000|Overall Study|Ineligible|3|||
129506381|NCT01511107|466141924|FG001|Overall Study|Ineligible|2|||
129506382|NCT01511107|466141923|FG000|Overall Study|Lost to Follow-up|10|||
129506383|NCT01511107|466141924|FG001|Overall Study|Lost to Follow-up|19|||
129506384|NCT01511107|466141923|FG000|Overall Study|Withdrawal by Subject|9|||
129506385|NCT01511107|466141924|FG001|Overall Study|Withdrawal by Subject|20|||
129506386|NCT01179347|466143403|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
129506387|NCT01179347|466143404|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
129506388|NCT01179347|466143403|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
129506389|NCT01179347|466143404|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
129506390|NCT01179347|466143403|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
129506391|NCT01179347|466143404|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
129506392|NCT01179347|466143403|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
129506393|NCT01179347|466143404|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
129506394|NCT01179347|466143403|FG000|Double-blind Period (12 Weeks)|Other|2|||
129506395|NCT01179347|466143404|FG001|Double-blind Period (12 Weeks)|Other|4|||
129506396|NCT01179347|466143403|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
129506397|NCT01179347|466143404|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
129506398|NCT01179347|466143403|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
129506399|NCT01179347|466143404|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
129506400|NCT01179347|466143403|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
129506401|NCT01179347|466143404|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
129506402|NCT01179347|466143403|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
129506403|NCT01179347|466143404|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
129506404|NCT01179347|466143403|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
129506405|NCT01179347|466143404|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
129506406|NCT01179347|466143403|FG000|Open-label Period (12 Weeks)|Other|7|||
129506407|NCT01179347|466143404|FG001|Open-label Period (12 Weeks)|Other|4|||
129506408|NCT00369967|466143405|FG000|Overall Study|Lost to Follow-up|23|||
129506409|NCT00369967|466143406|FG001|Overall Study|Lost to Follow-up|12|||
129506410|NCT02586077|466143407|FG000|Overall Study|Withdrawal by Subject|1|||
129506411|NCT02586077|466143407|FG000|Overall Study|Physician Decision|4|||
129506412|NCT02586077|466143407|FG000|Overall Study|Lost to Follow-up|3|||
129506413|NCT00205699|466143414|FG000|Overall Study|Lost to Follow-up|1|||
129506414|NCT00205699|466143415|FG001|Overall Study|Lost to Follow-up|3|||
129506415|NCT00205699|466143416|FG002|Overall Study|Lost to Follow-up|5|||
129506416|NCT00205699|466143414|FG000|Overall Study|Adverse Event|1|||
129506417|NCT00205699|466143415|FG001|Overall Study|Adverse Event|0|||
129506418|NCT00205699|466143416|FG002|Overall Study|Adverse Event|0|||
129506419|NCT00205699|466143414|FG000|Overall Study|Withdrawal by Subject|1|||
129506420|NCT00205699|466143415|FG001|Overall Study|Withdrawal by Subject|2|||
129506421|NCT00205699|466143416|FG002|Overall Study|Withdrawal by Subject|1|||
129506422|NCT00205699|466143414|FG000|Overall Study|Lack of Efficacy|0|||
129506423|NCT00205699|466143415|FG001|Overall Study|Lack of Efficacy|1|||
129506424|NCT00205699|466143416|FG002|Overall Study|Lack of Efficacy|0|||
129506425|NCT01194869|466143419|FG000|Overall Study|Disease Progression|2|||
129506426|NCT01194869|466143419|FG000|Overall Study|Toxicity|2|||
129506427|NCT04321252|466143422|FG000|Overall Study|Withdrawal by Subject|0|||
129506428|NCT04321252|466143423|FG001|Overall Study|Withdrawal by Subject|0|||
129506429|NCT04321252|466143424|FG002|Overall Study|Withdrawal by Subject|0|||
129506430|NCT04321252|466143425|FG003|Overall Study|Withdrawal by Subject|0|||
129506431|NCT04321252|466143426|FG004|Overall Study|Withdrawal by Subject|0|||
129506432|NCT04321252|466143427|FG005|Overall Study|Withdrawal by Subject|1|||
129506433|NCT04321252|466143428|FG006|Overall Study|Withdrawal by Subject|0|||
129506434|NCT04321252|466143429|FG007|Overall Study|Withdrawal by Subject|0|||
129506435|NCT04321252|466143430|FG008|Overall Study|Withdrawal by Subject|0|||
129506436|NCT03004469|466143431|FG000|Overall Study|Adverse Event|6|||
129506437|NCT03004469|466143432|FG001|Overall Study|Adverse Event|4|||
129506438|NCT03004469|466143433|FG002|Overall Study|Adverse Event|6|||
129506439|NCT03004469|466143431|FG000|Overall Study|Lack of Efficacy|1|||
129506440|NCT03004469|466143432|FG001|Overall Study|Lack of Efficacy|0|||
129506441|NCT03004469|466143433|FG002|Overall Study|Lack of Efficacy|1|||
129506442|NCT03004469|466143431|FG000|Overall Study|Lost to Follow-up|23|||
129506443|NCT03004469|466143432|FG001|Overall Study|Lost to Follow-up|14|||
129506444|NCT03004469|466143433|FG002|Overall Study|Lost to Follow-up|6|||
129506445|NCT03004469|466143431|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129506446|NCT03004469|466143432|FG001|Overall Study|Non-Compliance with Study Drug|0|||
129506447|NCT03004469|466143433|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129506448|NCT03004469|466143431|FG000|Overall Study|Protocol Violation|0|||
129506449|NCT03004469|466143432|FG001|Overall Study|Protocol Violation|0|||
129506450|NCT03004469|466143433|FG002|Overall Study|Protocol Violation|1|||
129506451|NCT03004469|466143431|FG000|Overall Study|Withdrawal by Subject|29|||
129506452|NCT03004469|466143432|FG001|Overall Study|Withdrawal by Subject|27|||
129506453|NCT03004469|466143433|FG002|Overall Study|Withdrawal by Subject|10|||
129506454|NCT03004469|466143431|FG000|Overall Study|Other unspecified reason|0|||
129506455|NCT03004469|466143432|FG001|Overall Study|Other unspecified reason|4|||
129506456|NCT03004469|466143433|FG002|Overall Study|Other unspecified reason|1|||
129506457|NCT00259740|466143434|FG000|Overall Study|Physician Decision|1|||
129506458|NCT00259740|466143435|FG001|Overall Study|Physician Decision|1|||
129506459|NCT00259740|466143434|FG000|Overall Study|Adverse Event|0|||
129506460|NCT00259740|466143435|FG001|Overall Study|Adverse Event|2|||
129506461|NCT00259740|466143434|FG000|Overall Study|Withdrawal by Subject|2|||
129506462|NCT00259740|466143435|FG001|Overall Study|Withdrawal by Subject|6|||
129506463|NCT00259740|466143434|FG000|Overall Study|Death|1|||
129506464|NCT00259740|466143435|FG001|Overall Study|Death|1|||
129506465|NCT00259740|466143434|FG000|Overall Study|Disease progression|19|||
129506466|NCT00259740|466143435|FG001|Overall Study|Disease progression|36|||
129506467|NCT00259740|466143434|FG000|Overall Study|Ongoing|17|||
129506468|NCT00259740|466143435|FG001|Overall Study|Ongoing|3|||
129506469|NCT00259740|466143434|FG000|Overall Study|Other|3|||
129506470|NCT00259740|466143435|FG001|Overall Study|Other|0|||
129506471|NCT00259740|466143434|FG000|Overall Study|Requirement for alternative therapy|0|||
129506472|NCT00259740|466143435|FG001|Overall Study|Requirement for alternative therapy|4|||
129506473|NCT02287402|466143436|FG000|Treatment Period|Adverse Event|17|||
129506474|NCT02287402|466143436|FG000|Treatment Period|Voluntary Withdrawal|10|||
129506475|NCT02287402|466143436|FG000|Follow-up|Lost to Follow-up|1|||
129506476|NCT02287402|466143436|FG000|Follow-up|Voluntary Withdrawal|2|||
129506477|NCT01844830|466143437|FG000|Overall Study|Withdrawal by Subject|1|||
129506478|NCT01844830|466143438|FG001|Overall Study|Withdrawal by Subject|0|||
129506479|NCT04247815|466143439|FG000|Overall Study|Adverse Event|1|||
129506480|NCT04247815|466143440|FG001|Overall Study|Adverse Event|0|||
129506481|NCT04247815|466143439|FG000|Overall Study|Withdrawal by Subject|1|||
129506482|NCT04247815|466143440|FG001|Overall Study|Withdrawal by Subject|0|||
129506483|NCT04247815|466143439|FG000|Overall Study|Protocol Violation|0|||
129506484|NCT04247815|466143440|FG001|Overall Study|Protocol Violation|1|||
129506485|NCT03495453|466143448|FG000|Overall Study|Withdrawal by Subject|0|||
129506486|NCT03495453|466143449|FG001|Overall Study|Withdrawal by Subject|1|||
129506487|NCT03084718|466143452|FG000|Overall Study|Withdrawal by Subject|4|||
129506488|NCT03084718|466143453|FG001|Overall Study|Withdrawal by Subject|3|||
129506489|NCT03084718|466143454|FG002|Overall Study|Withdrawal by Subject|4|||
129506490|NCT03084718|466143455|FG003|Overall Study|Withdrawal by Subject|0|||
129982348|NCT00680992|467898828|FG000|Overall Study|Pregnancy|5|||
129982349|NCT00680992|467898829|FG001|Overall Study|Pregnancy|0|||
129982350|NCT00680992|467898830|FG002|Overall Study|Pregnancy|1|||
129982351|NCT00680992|467898828|FG000|Overall Study|Death|5|||
129982352|NCT00680992|467898829|FG001|Overall Study|Death|1|||
129982353|NCT00680992|467898830|FG002|Overall Study|Death|0|||
129982354|NCT00680992|467898828|FG000|Overall Study|Ineligibility Determined|0|||
129982355|NCT00680992|467898829|FG001|Overall Study|Ineligibility Determined|1|||
129982356|NCT00680992|467898830|FG002|Overall Study|Ineligibility Determined|0|||
129982357|NCT01397422|467898831|FG000|Overall Study|Adverse Event|0|||
129982358|NCT01397422|467898832|FG001|Overall Study|Adverse Event|3|||
129506491|NCT03084718|466143456|FG004|Overall Study|Withdrawal by Subject|0|||
129506492|NCT03084718|466143452|FG000|Overall Study|Physician Decision|1|||
129506493|NCT03084718|466143453|FG001|Overall Study|Physician Decision|0|||
129506494|NCT03084718|466143454|FG002|Overall Study|Physician Decision|0|||
129506495|NCT03084718|466143455|FG003|Overall Study|Physician Decision|0|||
129506496|NCT03084718|466143456|FG004|Overall Study|Physician Decision|0|||
129506497|NCT03084718|466143452|FG000|Overall Study|Adverse Event|3|||
129506498|NCT03084718|466143453|FG001|Overall Study|Adverse Event|5|||
129506499|NCT03084718|466143454|FG002|Overall Study|Adverse Event|5|||
129506500|NCT03084718|466143455|FG003|Overall Study|Adverse Event|8|||
129506501|NCT03084718|466143456|FG004|Overall Study|Adverse Event|2|||
129506502|NCT03084718|466143452|FG000|Overall Study|Lack of Efficacy|2|||
129506503|NCT03084718|466143453|FG001|Overall Study|Lack of Efficacy|0|||
129506504|NCT03084718|466143454|FG002|Overall Study|Lack of Efficacy|1|||
129506505|NCT03084718|466143455|FG003|Overall Study|Lack of Efficacy|4|||
129506506|NCT03084718|466143456|FG004|Overall Study|Lack of Efficacy|0|||
129506507|NCT03084718|466143452|FG000|Overall Study|Lost to Follow-up|0|||
129506508|NCT03084718|466143453|FG001|Overall Study|Lost to Follow-up|1|||
129506509|NCT03084718|466143454|FG002|Overall Study|Lost to Follow-up|0|||
129506510|NCT03084718|466143455|FG003|Overall Study|Lost to Follow-up|0|||
129506511|NCT03084718|466143456|FG004|Overall Study|Lost to Follow-up|2|||
129506512|NCT03084718|466143452|FG000|Overall Study|Protocol Violation|0|||
129506513|NCT03084718|466143453|FG001|Overall Study|Protocol Violation|0|||
129506514|NCT03084718|466143454|FG002|Overall Study|Protocol Violation|1|||
129506515|NCT03084718|466143455|FG003|Overall Study|Protocol Violation|0|||
129506516|NCT03084718|466143456|FG004|Overall Study|Protocol Violation|0|||
129506517|NCT03084718|466143452|FG000|Overall Study|Death|0|||
129506518|NCT03084718|466143453|FG001|Overall Study|Death|1|||
129506519|NCT03084718|466143454|FG002|Overall Study|Death|0|||
129506520|NCT03084718|466143455|FG003|Overall Study|Death|0|||
129506521|NCT03084718|466143456|FG004|Overall Study|Death|0|||
129506522|NCT03084718|466143452|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
129506523|NCT03084718|466143453|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
129506524|NCT03084718|466143454|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
129506525|NCT03084718|466143455|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
129506526|NCT03084718|466143456|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
129506527|NCT03341923|466143457|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
129506528|NCT03341923|466143458|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
129506529|NCT04929613|466143459|FG000|Overall Study|Withdrawal by Subject|12|||
129506530|NCT01742078|466143460|FG000|Overall Study|Withdrawal by Subject|0|||
129506531|NCT01742078|466143461|FG001|Overall Study|Withdrawal by Subject|0|||
129506532|NCT01742078|466143462|FG002|Overall Study|Withdrawal by Subject|0|||
129506533|NCT01742078|466143463|FG003|Overall Study|Withdrawal by Subject|1|||
129506534|NCT01742078|466143464|FG004|Overall Study|Withdrawal by Subject|0|||
129506535|NCT01742078|466143465|FG005|Overall Study|Withdrawal by Subject|0|||
129506536|NCT01742078|466143466|FG006|Overall Study|Withdrawal by Subject|0|||
129506537|NCT01742078|466143467|FG007|Overall Study|Withdrawal by Subject|0|||
129506538|NCT01742078|466143468|FG008|Overall Study|Withdrawal by Subject|0|||
129506539|NCT03247413|466143472|FG000|Overall Study|Lost to Follow-up|28|||
129506540|NCT02767856|466143473|FG000|Overall Study|Lost to Follow-up|9|||
129506541|NCT02767856|466143474|FG001|Overall Study|Lost to Follow-up|1|||
129506542|NCT02767856|466143473|FG000|Overall Study|Withdrawal by Subject|2|||
129506543|NCT02767856|466143474|FG001|Overall Study|Withdrawal by Subject|1|||
129506544|NCT00091026|466143477|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
129506545|NCT00091026|466143478|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
129506546|NCT00091026|466143477|FG000|Overall Study|Patient withdrew and never received trea|0|||
129506547|NCT00091026|466143478|FG001|Overall Study|Patient withdrew and never received trea|2|||
129506548|NCT00091026|466143477|FG000|Overall Study|Unknown-never received treatment|0|||
129506549|NCT00091026|466143478|FG001|Overall Study|Unknown-never received treatment|1|||
129506550|NCT00973921|466143482|FG000|Overall Study|IVUS results were not available|9|||
129506551|NCT04404010|466143486|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
129506552|NCT04404010|466143487|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
129506553|NCT02120157|466143488|FG000|Overall Study|Death|8|||
129506554|NCT00441103|466143493|FG000|Overall Study|Adverse Event|2|||
129506555|NCT00441103|466143494|FG001|Overall Study|Adverse Event|1|||
129506556|NCT00441103|466143493|FG000|Overall Study|Death|1|||
129506557|NCT00441103|466143494|FG001|Overall Study|Death|0|||
129506558|NCT00441103|466143493|FG000|Overall Study|Disease Progression|2|||
129506559|NCT00441103|466143494|FG001|Overall Study|Disease Progression|0|||
129506560|NCT00441103|466143493|FG000|Overall Study|Lost to Follow-up|1|||
129506561|NCT00441103|466143494|FG001|Overall Study|Lost to Follow-up|0|||
129506562|NCT00441103|466143493|FG000|Overall Study|Protocol Violation|1|||
129506563|NCT00441103|466143494|FG001|Overall Study|Protocol Violation|0|||
129506564|NCT00441103|466143493|FG000|Overall Study|Participant unable to use Rebiject II|1|||
129539073|NCT02708524|466265145|FG001|Overall Study|Protocol Violation|1|||
129506565|NCT00441103|466143494|FG001|Overall Study|Participant unable to use Rebiject II|0|||
129506566|NCT00441103|466143493|FG000|Overall Study|Participant refused MRI|1|||
129506567|NCT00441103|466143494|FG001|Overall Study|Participant refused MRI|0|||
129506568|NCT00441103|466143493|FG000|Overall Study|Inclusion criteria absent|1|||
129506569|NCT00441103|466143494|FG001|Overall Study|Inclusion criteria absent|0|||
129506570|NCT00441103|466143493|FG000|Overall Study|Non-compliant|0|||
129506571|NCT00441103|466143494|FG001|Overall Study|Non-compliant|1|||
129506572|NCT00441103|466143493|FG000|Overall Study|Participant decided to withdraw|1|||
129506573|NCT00441103|466143494|FG001|Overall Study|Participant decided to withdraw|0|||
129506574|NCT00441103|466143493|FG000|Overall Study|Participant's reason|0|||
129506575|NCT00441103|466143494|FG001|Overall Study|Participant's reason|1|||
129506576|NCT00441103|466143493|FG000|Overall Study|Participant decided to stop|0|||
129506577|NCT00441103|466143494|FG001|Overall Study|Participant decided to stop|1|||
129506578|NCT01354431|466143497|FG000|Pre-Treatment Period|Not reported|1|||
129506579|NCT01354431|466143498|FG001|Pre-Treatment Period|Not reported|0|||
129506580|NCT01354431|466143499|FG002|Pre-Treatment Period|Not reported|0|||
129506581|NCT01354431|466143497|FG000|Treatment Period|Disease Progression|50|||
129506582|NCT01354431|466143498|FG001|Treatment Period|Disease Progression|40|||
129506583|NCT01354431|466143499|FG002|Treatment Period|Disease Progression|44|||
129506584|NCT01354431|466143497|FG000|Treatment Period|Study Drug Toxicity|5|||
129506585|NCT01354431|466143498|FG001|Treatment Period|Study Drug Toxicity|8|||
129506586|NCT01354431|466143499|FG002|Treatment Period|Study Drug Toxicity|4|||
129506587|NCT01354431|466143497|FG000|Treatment Period|Death|0|||
129506588|NCT01354431|466143498|FG001|Treatment Period|Death|1|||
129506589|NCT01354431|466143499|FG002|Treatment Period|Death|0|||
129506590|NCT01354431|466143497|FG000|Treatment Period|AE unrelated to study drug|1|||
129506591|NCT01354431|466143498|FG001|Treatment Period|AE unrelated to study drug|2|||
129506592|NCT01354431|466143499|FG002|Treatment Period|AE unrelated to study drug|5|||
129506593|NCT01354431|466143497|FG000|Treatment Period|Participant request to discontinue|2|||
129506594|NCT01354431|466143498|FG001|Treatment Period|Participant request to discontinue|2|||
129506595|NCT01354431|466143499|FG002|Treatment Period|Participant request to discontinue|1|||
129506596|NCT01354431|466143497|FG000|Treatment Period|Participant withdrew consent|0|||
129506597|NCT01354431|466143498|FG001|Treatment Period|Participant withdrew consent|1|||
129506598|NCT01354431|466143499|FG002|Treatment Period|Participant withdrew consent|0|||
129506599|NCT01354431|466143497|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
129506600|NCT01354431|466143498|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
129506601|NCT01354431|466143499|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
129506602|NCT02802878|466143500|FG000|Overall Study|Withdrawal by Subject|3|||
129506603|NCT02802878|466143501|FG001|Overall Study|Withdrawal by Subject|3|||
129506604|NCT02802878|466143500|FG000|Overall Study|Protocol Violation|1|||
129506605|NCT02802878|466143501|FG001|Overall Study|Protocol Violation|0|||
129506606|NCT01599754|466143502|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
129506607|NCT01599754|466143503|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
129506608|NCT01599754|466143502|FG000|Overall Study|Participant noncompliance|4|||
129506609|NCT01599754|466143503|FG001|Overall Study|Participant noncompliance|4|||
129982359|NCT01397422|467898833|FG002|Overall Study|Adverse Event|3|||
129982360|NCT01397422|467898834|FG003|Overall Study|Adverse Event|8|||
129982361|NCT01397422|467898831|FG000|Overall Study|Withdrawal by Subject|1|||
129982362|NCT01397422|467898832|FG001|Overall Study|Withdrawal by Subject|0|||
129982363|NCT01397422|467898833|FG002|Overall Study|Withdrawal by Subject|0|||
129982364|NCT01397422|467898834|FG003|Overall Study|Withdrawal by Subject|0|||
129982365|NCT01397422|467898831|FG000|Overall Study|Increased bradykinesia related to PD|1|||
129982366|NCT01397422|467898832|FG001|Overall Study|Increased bradykinesia related to PD|0|||
129982367|NCT01397422|467898833|FG002|Overall Study|Increased bradykinesia related to PD|0|||
129982368|NCT01397422|467898834|FG003|Overall Study|Increased bradykinesia related to PD|0|||
129982369|NCT06665919|467898835|FG000|Overall Study|Withdrawal by Subject|4|||
129982370|NCT06665919|467898836|FG001|Overall Study|Withdrawal by Subject|4|||
129982371|NCT06665919|467898837|FG002|Overall Study|Withdrawal by Subject|4|||
129982372|NCT06665919|467898835|FG000|Overall Study|Non-compliance to Treatment|4|||
129982373|NCT06665919|467898836|FG001|Overall Study|Non-compliance to Treatment|1|||
129982374|NCT06665919|467898837|FG002|Overall Study|Non-compliance to Treatment|6|||
129982375|NCT06665919|467898835|FG000|Overall Study|Lost to Follow-up|3|||
129506610|NCT01599754|466143502|FG000|Overall Study|Lost to Follow-up|13|||
129506611|NCT01599754|466143503|FG001|Overall Study|Lost to Follow-up|6|||
129506612|NCT01599754|466143502|FG000|Overall Study|Death|31|||
129506613|NCT01599754|466143503|FG001|Overall Study|Death|33|||
129506614|NCT01599754|466143502|FG000|Overall Study|Adverse Event|3|||
129506615|NCT01599754|466143503|FG001|Overall Study|Adverse Event|2|||
129982376|NCT06665919|467898836|FG001|Overall Study|Lost to Follow-up|0|||
129982377|NCT06665919|467898837|FG002|Overall Study|Lost to Follow-up|2|||
129982378|NCT06665919|467898835|FG000|Overall Study|Physician Decision|4|||
129982379|NCT06665919|467898836|FG001|Overall Study|Physician Decision|0|||
129506616|NCT01599754|466143502|FG000|Overall Study|Investigator decision|1|||
129982380|NCT06665919|467898837|FG002|Overall Study|Physician Decision|1|||
129982381|NCT05148962|467898838|FG000|Overall Study|Withdrawal by Subject|1|||
129506617|NCT01599754|466143503|FG001|Overall Study|Investigator decision|3|||
129506618|NCT01599754|466143502|FG000|Overall Study|Withdrawal by Subject|24|||
129506619|NCT01599754|466143503|FG001|Overall Study|Withdrawal by Subject|25|||
129506620|NCT01599754|466143502|FG000|Overall Study|Study terminated by sponsor|282|||
129506621|NCT01599754|466143503|FG001|Overall Study|Study terminated by sponsor|285|||
129506622|NCT01029002|466143504|FG000|Overall Study|Lost to Follow-up|2|||
129506623|NCT01029002|466143505|FG001|Overall Study|Lost to Follow-up|4|||
129506624|NCT00702052|466143506|FG000|Overall Study|Adverse Event|23|||
129506625|NCT00702052|466143506|FG000|Overall Study|Disease Progression|30|||
129506626|NCT00702052|466143506|FG000|Overall Study|Withdrawal by Subject|5|||
129506627|NCT01577160|466143507|FG000|Overall Study|Adverse Event|9|||
129506628|NCT01577160|466143507|FG000|Overall Study|Lack of Efficacy|15|||
129506629|NCT01577160|466143507|FG000|Overall Study|Lost to Follow-up|40|||
129506630|NCT01577160|466143507|FG000|Overall Study|Withdrawal by Subject|18|||
129506631|NCT01577160|466143507|FG000|Overall Study|Subject Uncooperative|7|||
129506632|NCT01577160|466143507|FG000|Overall Study|Other|9|||
129506633|NCT02618928|466143508|FG000|Overall Study|Failure to Return|28|||
129506634|NCT02618928|466143508|FG000|Overall Study|Insufficient Virological Response|1|||
129506635|NCT02618928|466143508|FG000|Overall Study|Withdrawal by Subject|2|||
129506636|NCT02618928|466143508|FG000|Overall Study|Death|3|||
129506637|NCT02618928|466143508|FG000|Overall Study|Other|11|||
129506638|NCT02618928|466143508|FG000|Overall Study|Missing|6|||
129506639|NCT02618928|466143508|FG000|Overall Study|Treatment Never Started|7|||
129506640|NCT00916370|466143511|FG000|Overall Study|Death|3|||
129506641|NCT00916370|466143512|FG001|Overall Study|Death|1|||
129506642|NCT00916370|466143511|FG000|Overall Study|Withdrawal by Subject|2|||
129506643|NCT00916370|466143512|FG001|Overall Study|Withdrawal by Subject|0|||
129506644|NCT00916370|466143511|FG000|Overall Study|Physician Decision|0|||
129506645|NCT00916370|466143512|FG001|Overall Study|Physician Decision|1|||
129506646|NCT01317615|466143513|FG000|Overall Study|Disease progression|25|||
129982382|NCT05148962|467898839|FG001|Overall Study|Withdrawal by Subject|1|||
129982383|NCT05148962|467898840|FG002|Overall Study|Withdrawal by Subject|0|||
129982384|NCT05148962|467898841|FG003|Overall Study|Withdrawal by Subject|1|||
129982385|NCT05148962|467898842|FG004|Overall Study|Withdrawal by Subject|0|||
129982386|NCT05148962|467898838|FG000|Overall Study|Participant was early terminated per protocol|0|||
129982387|NCT05148962|467898839|FG001|Overall Study|Participant was early terminated per protocol|0|||
129982388|NCT05148962|467898840|FG002|Overall Study|Participant was early terminated per protocol|3|||
129982389|NCT05148962|467898841|FG003|Overall Study|Participant was early terminated per protocol|5|||
129982390|NCT05148962|467898842|FG004|Overall Study|Participant was early terminated per protocol|2|||
129982391|NCT05148962|467898838|FG000|Overall Study|Miscellaneous|0|||
129982392|NCT05148962|467898839|FG001|Overall Study|Miscellaneous|0|||
129982393|NCT05148962|467898840|FG002|Overall Study|Miscellaneous|0|||
129982394|NCT05148962|467898841|FG003|Overall Study|Miscellaneous|1|||
129982395|NCT05148962|467898842|FG004|Overall Study|Miscellaneous|0|||
129982396|NCT01200290|467898843|FG000|Treatment Period|Adverse Event|1|||
129982397|NCT01200290|467898843|FG000|Post-Treatment Follow-Up Period|Death|2|||
129982398|NCT01144377|467898844|FG000|52 Week Treatment Period|Adverse Event|0|||
129982399|NCT01144377|467898845|FG001|52 Week Treatment Period|Adverse Event|0|||
129982400|NCT01144377|467898846|FG002|52 Week Treatment Period|Adverse Event|3|||
129982401|NCT01144377|467898847|FG003|52 Week Treatment Period|Adverse Event|2|||
129982402|NCT01144377|467898848|FG004|52 Week Treatment Period|Adverse Event|1|||
129982403|NCT01144377|467898844|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
129982404|NCT01144377|467898845|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
129982405|NCT01144377|467898846|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
129982406|NCT01144377|467898847|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
129982407|NCT01144377|467898848|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
129982408|NCT01144377|467898844|FG000|52 Week Treatment Period|Protocol Violation|0|||
129982409|NCT01144377|467898845|FG001|52 Week Treatment Period|Protocol Violation|0|||
129982410|NCT01144377|467898846|FG002|52 Week Treatment Period|Protocol Violation|0|||
129982411|NCT01144377|467898847|FG003|52 Week Treatment Period|Protocol Violation|0|||
129982412|NCT01144377|467898848|FG004|52 Week Treatment Period|Protocol Violation|1|||
129982413|NCT01144377|467898844|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
129506647|NCT01317615|466143513|FG000|Overall Study|New cancer therapy|5|||
129506648|NCT01317615|466143513|FG000|Overall Study|Death|6|||
129506649|NCT01317615|466143513|FG000|Overall Study|Withdrawal by Subject|5|||
129506650|NCT01317615|466143513|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129982414|NCT01144377|467898845|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
129982415|NCT01144377|467898846|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
129982416|NCT01144377|467898847|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
129506651|NCT01317615|466143513|FG000|Overall Study|Adverse Event|7|||
129506652|NCT00438399|466143516|FG000|Overall Study|Lost to Follow-up|2|||
129506653|NCT00438399|466143517|FG001|Overall Study|Lost to Follow-up|2|||
129506654|NCT00438399|466143518|FG002|Overall Study|Lost to Follow-up|1|||
129506655|NCT00438399|466143519|FG003|Overall Study|Lost to Follow-up|1|||
129982417|NCT01144377|467898848|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
129982418|NCT01144377|467898844|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
129982419|NCT01144377|467898845|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
129982420|NCT01144377|467898846|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
129982421|NCT01144377|467898847|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
129982422|NCT01144377|467898848|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
129982423|NCT01144377|467898844|FG000|52 Week Treatment Period|Sponsor Decision|0|||
129982424|NCT01144377|467898845|FG001|52 Week Treatment Period|Sponsor Decision|0|||
129982425|NCT01144377|467898846|FG002|52 Week Treatment Period|Sponsor Decision|0|||
129982426|NCT01144377|467898847|FG003|52 Week Treatment Period|Sponsor Decision|0|||
129982427|NCT01144377|467898848|FG004|52 Week Treatment Period|Sponsor Decision|1|||
129982428|NCT01144377|467898844|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
129982429|NCT01144377|467898845|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
129982430|NCT01144377|467898846|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
129982431|NCT01144377|467898847|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
129982432|NCT01144377|467898848|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
129982433|NCT01144377|467898844|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982434|NCT01144377|467898845|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982435|NCT01144377|467898846|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982436|NCT01144377|467898847|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
129982437|NCT01144377|467898848|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
129982438|NCT01144377|467898844|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
129982439|NCT01144377|467898845|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982440|NCT01144377|467898846|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982441|NCT01144377|467898847|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982442|NCT01144377|467898848|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
129982443|NCT00151281|467898849|FG000|Overall Study|Not evaluable|3|||
129982444|NCT01133418|467898850|FG000|Overall Study|Lost to Follow-up|5|||
129982445|NCT01133418|467898851|FG001|Overall Study|Lost to Follow-up|6|||
129982446|NCT04150068|467898852|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
129982447|NCT04150068|467898853|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
129982448|NCT04150068|467898854|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
129982449|NCT04150068|467898852|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
129982450|NCT04150068|467898853|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
129982451|NCT04150068|467898854|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
129982452|NCT05316701|467898855|FG000|Overall Study|Adverse Event|0|||
129982453|NCT05316701|467898856|FG001|Overall Study|Adverse Event|1|||
129982454|NCT05316701|467898855|FG000|Overall Study|Death|3|||
129982455|NCT05316701|467898856|FG001|Overall Study|Death|9|||
129982456|NCT05316701|467898855|FG000|Overall Study|Lost to Follow-up|1|||
129982457|NCT05316701|467898856|FG001|Overall Study|Lost to Follow-up|0|||
129982458|NCT05316701|467898855|FG000|Overall Study|Physician Decision|1|||
129982459|NCT05316701|467898856|FG001|Overall Study|Physician Decision|4|||
129982460|NCT05316701|467898855|FG000|Overall Study|Withdrawal by Subject|3|||
129982461|NCT05316701|467898856|FG001|Overall Study|Withdrawal by Subject|5|||
129982462|NCT05316701|467898855|FG000|Overall Study|Progression/Relapse|14|||
129982463|NCT05316701|467898856|FG001|Overall Study|Progression/Relapse|9|||
129982464|NCT05316701|467898855|FG000|Overall Study|Received Standard of Care|1|||
129982465|NCT05316701|467898856|FG001|Overall Study|Received Standard of Care|0|||
129982466|NCT05316701|467898855|FG000|Overall Study|Ongoing|70|||
129982467|NCT05316701|467898856|FG001|Overall Study|Ongoing|64|||
129982468|NCT04696653|467898857|FG000|Overall Study|left organization|18|||
129982469|NCT04696653|467898857|FG000|Overall Study|Lost to Follow-up|3|||
129982470|NCT04349631|467898858|FG000|Overall Study|Lost to Follow-up|3|||
129982471|NCT04349631|467898858|FG000|Overall Study|Withdrawal by Subject|7|||
129982472|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
129982473|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
129982474|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
129982475|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
129982476|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
129982477|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
129982478|NCT01982448|467898859|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
129982479|NCT01982448|467898860|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
129982480|NCT00836745|467900578|FG000|Overall Study|Death|2|||
129982481|NCT00836745|467900578|FG000|Overall Study|Lost to Follow-up|10|||
129982482|NCT00836745|467900578|FG000|Overall Study|Adverse Event|3|||
129982483|NCT00836745|467900578|FG000|Overall Study|Objective progression or relapse|4|||
129982484|NCT00836745|467900578|FG000|Overall Study|Other|2|||
129982485|NCT02898077|467900580|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
129982486|NCT02898077|467900581|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
129982487|NCT02898077|467900580|FG000|Overall Study|Lost to Follow-up|4|||
129982488|NCT02898077|467900581|FG001|Overall Study|Lost to Follow-up|3|||
129982489|NCT02898077|467900580|FG000|Overall Study|Physician Decision|0|||
129982490|NCT02898077|467900581|FG001|Overall Study|Physician Decision|2|||
129982491|NCT02898077|467900580|FG000|Overall Study|Sponsor Decision|32|||
129982492|NCT02898077|467900581|FG001|Overall Study|Sponsor Decision|13|||
129982493|NCT02898077|467900580|FG000|Overall Study|Withdrawal by Subject|6|||
129982494|NCT02898077|467900581|FG001|Overall Study|Withdrawal by Subject|3|||
129982495|NCT02898077|467900580|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
129982496|NCT02898077|467900581|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
129982497|NCT02898077|467900580|FG000|Overall Study|Ended extension period|3|||
129982498|NCT02898077|467900581|FG001|Overall Study|Ended extension period|0|||
129982499|NCT00621777|467900582|FG000|Open Phase|Adverse Event|20|||
129982500|NCT00621777|467900583|FG001|Open Phase|Adverse Event|0|||
129982501|NCT00621777|467900582|FG000|Open Phase|Did not abstain during open phase|56|||
129982502|NCT00621777|467900583|FG001|Open Phase|Did not abstain during open phase|0|||
129982503|NCT00621777|467900582|FG000|Open Phase|Withdrawal by Subject|17|||
129982504|NCT00621777|467900583|FG001|Open Phase|Withdrawal by Subject|0|||
129982505|NCT00621777|467900582|FG000|Open Phase|administrative|13|||
129982506|NCT00621777|467900583|FG001|Open Phase|administrative|0|||
129982507|NCT00621777|467900582|FG000|Open Phase|Lost to Follow-up|10|||
129982508|NCT00621777|467900583|FG001|Open Phase|Lost to Follow-up|0|||
129982509|NCT00621777|467900582|FG000|Randomized Phase|Adverse Event|3|||
129982510|NCT00621777|467900583|FG001|Randomized Phase|Adverse Event|3|||
129982511|NCT00621777|467900582|FG000|Randomized Phase|Lost to Follow-up|3|||
129982512|NCT00621777|467900583|FG001|Randomized Phase|Lost to Follow-up|3|||
129982513|NCT00621777|467900582|FG000|Randomized Phase|Withdrawal by Subject|1|||
129982514|NCT00621777|467900583|FG001|Randomized Phase|Withdrawal by Subject|9|||
129982515|NCT00621777|467900582|FG000|Randomized Phase|administrative|0|||
129982516|NCT00621777|467900583|FG001|Randomized Phase|administrative|3|||
129982517|NCT00621777|467900582|FG000|Randomized Phase|Death|0|||
129982518|NCT00621777|467900583|FG001|Randomized Phase|Death|1|||
129982519|NCT01239043|467900584|FG000|Overall Study|Protocol Violation|2|||
129982520|NCT01239043|467900585|FG001|Overall Study|Protocol Violation|1|||
129982521|NCT02121301|467900588|FG000|Overall Study|Protocol Violation|1|||
129982522|NCT02121301|467900589|FG001|Overall Study|Protocol Violation|4|||
129982523|NCT02121301|467900590|FG002|Overall Study|Protocol Violation|1|||
129982524|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Death|0|||
129982525|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Death|0|||
129982526|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Death|1|||
129982527|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Death|0|||
129982528|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Death|0|||
129982529|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Death|0|||
129982530|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Death|0|||
129982531|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Death|0|||
129982532|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Death|0|||
129982533|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Death|0|||
129982534|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Death|0|||
129982535|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Death|0|||
129982536|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Death|0|||
129982537|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Death|0|||
129982538|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129506656|NCT00438399|466143520|FG004|Overall Study|Lost to Follow-up|1|||
129506657|NCT00438399|466143521|FG005|Overall Study|Lost to Follow-up|1|||
129506658|NCT00438399|466143516|FG000|Overall Study|Adverse Event|0|||
129506659|NCT00438399|466143517|FG001|Overall Study|Adverse Event|0|||
129506660|NCT00438399|466143518|FG002|Overall Study|Adverse Event|1|||
129506661|NCT00438399|466143519|FG003|Overall Study|Adverse Event|1|||
129506662|NCT00438399|466143520|FG004|Overall Study|Adverse Event|0|||
129506663|NCT00438399|466143521|FG005|Overall Study|Adverse Event|1|||
129982539|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982540|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
129982541|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982542|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982543|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982544|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982545|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129506664|NCT00438399|466143516|FG000|Overall Study|Withdrawal by Subject|5|||
129982546|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129506665|NCT00438399|466143517|FG001|Overall Study|Withdrawal by Subject|6|||
129506666|NCT00438399|466143518|FG002|Overall Study|Withdrawal by Subject|3|||
129506667|NCT00438399|466143519|FG003|Overall Study|Withdrawal by Subject|2|||
129506668|NCT00438399|466143520|FG004|Overall Study|Withdrawal by Subject|2|||
129506669|NCT00438399|466143521|FG005|Overall Study|Withdrawal by Subject|2|||
129506670|NCT00438399|466143516|FG000|Overall Study|Protocol Violation|0|||
129506671|NCT00438399|466143517|FG001|Overall Study|Protocol Violation|0|||
129982547|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982548|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129506672|NCT00438399|466143518|FG002|Overall Study|Protocol Violation|1|||
129506673|NCT00438399|466143519|FG003|Overall Study|Protocol Violation|0|||
129506674|NCT00438399|466143520|FG004|Overall Study|Protocol Violation|0|||
129506675|NCT00438399|466143521|FG005|Overall Study|Protocol Violation|1|||
129506676|NCT00438399|466143516|FG000|Overall Study|Subje stopped study|0|||
129506677|NCT00438399|466143517|FG001|Overall Study|Subje stopped study|0|||
129506678|NCT00438399|466143518|FG002|Overall Study|Subje stopped study|1|||
129506679|NCT00438399|466143519|FG003|Overall Study|Subje stopped study|0|||
129506680|NCT00438399|466143520|FG004|Overall Study|Subje stopped study|0|||
129506681|NCT00438399|466143521|FG005|Overall Study|Subje stopped study|0|||
129506682|NCT00438399|466143516|FG000|Overall Study|Pregnancy|0|||
129506683|NCT00438399|466143517|FG001|Overall Study|Pregnancy|0|||
129506684|NCT00438399|466143518|FG002|Overall Study|Pregnancy|0|||
129506685|NCT00438399|466143519|FG003|Overall Study|Pregnancy|0|||
129506686|NCT00438399|466143520|FG004|Overall Study|Pregnancy|0|||
129506687|NCT00438399|466143521|FG005|Overall Study|Pregnancy|1|||
129506688|NCT00438399|466143516|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
129506689|NCT00438399|466143517|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
129506690|NCT00438399|466143518|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
129506691|NCT00438399|466143519|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
129506692|NCT00438399|466143520|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
129506693|NCT00438399|466143521|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
129506694|NCT00632541|466143524|FG000|Overall Study|Adverse Event|7|||
129506695|NCT00393913|466143526|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
129506696|NCT00393913|466143526|FG000|Initial Assessment|Withdrawal by Subject|16|||
129506697|NCT00393913|466143526|FG000|CPAP|Withdrawal by Subject|3|||
129506698|NCT00393913|466143526|FG000|CPAP|Physician Decision|1|||
129506699|NCT00393913|466143526|FG000|CPAP|TEchnical problem with CPAP|3|||
129506700|NCT01927419|466143527|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
129506701|NCT01927419|466143528|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
129506702|NCT01927419|466143527|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
129506703|NCT01927419|466143528|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
129506704|NCT01927419|466143527|FG000|Treatment Period|Disease progression|17|||
129506705|NCT01927419|466143528|FG001|Treatment Period|Disease progression|20|||
129506706|NCT01927419|466143527|FG000|Treatment Period|Study drug toxicity|48|||
129506707|NCT01927419|466143528|FG001|Treatment Period|Study drug toxicity|10|||
129506708|NCT01927419|466143527|FG000|Treatment Period|Death|0|||
129506709|NCT01927419|466143528|FG001|Treatment Period|Death|1|||
129506710|NCT01927419|466143527|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
129506711|NCT01927419|466143528|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
129506712|NCT01927419|466143527|FG000|Treatment Period|Participant request to discontinue|12|||
129506713|NCT01927419|466143528|FG001|Treatment Period|Participant request to discontinue|4|||
129506714|NCT01927419|466143527|FG000|Treatment Period|Withdrawal by Subject|1|||
129506715|NCT01927419|466143528|FG001|Treatment Period|Withdrawal by Subject|1|||
129506716|NCT01927419|466143527|FG000|Treatment Period|Maximum Clinical Benefit|6|||
129506717|NCT01927419|466143528|FG001|Treatment Period|Maximum Clinical Benefit|2|||
129506718|NCT01927419|466143527|FG000|Treatment Period|Other reasons|3|||
129506719|NCT01927419|466143528|FG001|Treatment Period|Other reasons|4|||
129506720|NCT01927419|466143527|FG000|Treatment Period|Not Reported|1|||
129506721|NCT01927419|466143528|FG001|Treatment Period|Not Reported|1|||
129506722|NCT03488251|466143529|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
129506723|NCT03488251|466143530|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
129506724|NCT03488251|466143531|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
129506725|NCT03488251|466143532|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
129506726|NCT03488251|466143529|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
129506727|NCT03488251|466143530|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
129506728|NCT03488251|466143531|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
129506729|NCT03488251|466143532|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
129506730|NCT03488251|466143529|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
129506731|NCT03488251|466143530|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
129506732|NCT03488251|466143531|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
129506733|NCT03488251|466143532|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
129506734|NCT03488251|466143529|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
129506735|NCT03488251|466143530|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
129506736|NCT03488251|466143531|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
129506737|NCT03488251|466143532|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
129506738|NCT03488251|466143529|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
129506739|NCT03488251|466143530|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
129506740|NCT03488251|466143531|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
129506741|NCT03488251|466143532|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
129506742|NCT00592553|466143538|FG000|Overall Study|Protocol Noncompliance|1|||
129506743|NCT00592553|466143539|FG001|Overall Study|Protocol Noncompliance|0|||
129506744|NCT00592553|466143540|FG002|Overall Study|Protocol Noncompliance|0|||
129506745|NCT02379390|466143543|FG000|Overall Study|Adverse Event|1|||
129506746|NCT02379390|466143544|FG001|Overall Study|Adverse Event|1|||
129506747|NCT02379390|466143543|FG000|Overall Study|Investigator's decision|1|||
129506748|NCT02379390|466143544|FG001|Overall Study|Investigator's decision|0|||
129506749|NCT02379390|466143543|FG000|Overall Study|Study Termination|0|||
129506750|NCT02379390|466143544|FG001|Overall Study|Study Termination|1|||
129506751|NCT01244191|466143545|FG000|Overall Study|Progressive disease|295|||
129506752|NCT01244191|466143546|FG001|Overall Study|Progressive disease|350|||
129506753|NCT01244191|466143545|FG000|Overall Study|Clinical disease progression|54|||
129506754|NCT01244191|466143546|FG001|Overall Study|Clinical disease progression|36|||
129506755|NCT01244191|466143545|FG000|Overall Study|Adverse Event|65|||
129506756|NCT01244191|466143546|FG001|Overall Study|Adverse Event|48|||
129506757|NCT01244191|466143545|FG000|Overall Study|Death|22|||
129506758|NCT01244191|466143546|FG001|Overall Study|Death|29|||
129506759|NCT01244191|466143545|FG000|Overall Study|Lost to Follow-up|0|||
129506760|NCT01244191|466143546|FG001|Overall Study|Lost to Follow-up|2|||
129506761|NCT01244191|466143545|FG000|Overall Study|Protocol Violation|1|||
129506762|NCT01244191|466143546|FG001|Overall Study|Protocol Violation|2|||
129506763|NCT01244191|466143545|FG000|Overall Study|Withdrawal by Subject|31|||
129506764|NCT01244191|466143546|FG001|Overall Study|Withdrawal by Subject|23|||
129506765|NCT01244191|466143545|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
129506766|NCT01244191|466143546|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
129506767|NCT01830816|466145739|FG000|Overall Study|Progressive Disease|12|||
129506768|NCT01830816|466145740|FG001|Overall Study|Progressive Disease|7|||
129506769|NCT01830816|466145741|FG002|Overall Study|Progressive Disease|7|||
129506770|NCT01830816|466145739|FG000|Overall Study|Adverse Event|3|||
129506771|NCT01830816|466145740|FG001|Overall Study|Adverse Event|4|||
129506772|NCT01830816|466145741|FG002|Overall Study|Adverse Event|0|||
129506773|NCT01830816|466145739|FG000|Overall Study|Study Terminated by Sponsor|1|||
129506774|NCT01830816|466145740|FG001|Overall Study|Study Terminated by Sponsor|1|||
129506775|NCT01830816|466145741|FG002|Overall Study|Study Terminated by Sponsor|0|||
129506776|NCT01830816|466145739|FG000|Overall Study|Withdrawal by Subject|1|||
129506777|NCT01830816|466145740|FG001|Overall Study|Withdrawal by Subject|1|||
129506778|NCT01830816|466145741|FG002|Overall Study|Withdrawal by Subject|0|||
129506779|NCT01830816|466145739|FG000|Overall Study|Lost to Follow-up|0|||
129506780|NCT01830816|466145740|FG001|Overall Study|Lost to Follow-up|1|||
129506781|NCT01830816|466145741|FG002|Overall Study|Lost to Follow-up|0|||
129506782|NCT01830816|466145739|FG000|Overall Study|Symptomatic Deterioration|1|||
129506783|NCT01830816|466145740|FG001|Overall Study|Symptomatic Deterioration|0|||
129506784|NCT01830816|466145741|FG002|Overall Study|Symptomatic Deterioration|0|||
129506785|NCT01830816|466145739|FG000|Overall Study|Reason not Specified|2|||
129506786|NCT01830816|466145740|FG001|Overall Study|Reason not Specified|0|||
129506787|NCT01830816|466145741|FG002|Overall Study|Reason not Specified|0|||
129506788|NCT00363051|466145742|FG000|Overall Study|Adminstrative problems|1|||
129506789|NCT00363051|466145743|FG001|Overall Study|Adminstrative problems|1|||
129506790|NCT00363051|466145742|FG000|Overall Study|Adverse Event|21|||
129506791|NCT00363051|466145743|FG001|Overall Study|Adverse Event|12|||
129506792|NCT00363051|466145742|FG000|Overall Study|New Cancer Therapy|2|||
129506793|NCT00363051|466145743|FG001|Overall Study|New Cancer Therapy|1|||
129506794|NCT00363051|466145742|FG000|Overall Study|Withdrawal by Subject|11|||
129506795|NCT00363051|466145743|FG001|Overall Study|Withdrawal by Subject|3|||
129506796|NCT00363051|466145742|FG000|Overall Study|Lost to Follow-up|0|||
129506797|NCT00363051|466145743|FG001|Overall Study|Lost to Follow-up|1|||
129506798|NCT00363051|466145742|FG000|Overall Study|Protocol Violation|0|||
129506799|NCT00363051|466145743|FG001|Overall Study|Protocol Violation|2|||
129506800|NCT00363051|466145742|FG000|Overall Study|Death|3|||
129506801|NCT00363051|466145743|FG001|Overall Study|Death|2|||
129506802|NCT00830115|466145746|FG000|Overall Study|Adverse Event|2|||
129506803|NCT00830115|466145746|FG000|Overall Study|Improvement/recovery|1|||
129506804|NCT01207388|466145754|FG000|Overall Study|Death|67|||
129982549|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982550|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982551|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
129982552|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
129982553|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
129982554|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
129982555|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
129506805|NCT01207388|466145754|FG000|Overall Study|Withdrawal by Subject|1|||
129506806|NCT01885078|466145755|FG000|Treatment Period|Adverse Event|52|||
129506807|NCT01885078|466145756|FG001|Treatment Period|Adverse Event|136|||
129506808|NCT01885078|466145757|FG002|Treatment Period|Adverse Event|30|||
129506809|NCT01885078|466145758|FG003|Treatment Period|Adverse Event|73|||
129982556|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129506810|NCT01885078|466145759|FG004|Treatment Period|Adverse Event|17|||
129506811|NCT01885078|466145760|FG005|Treatment Period|Adverse Event|72|||
129506812|NCT01885078|466145761|FG006|Treatment Period|Adverse Event|24|||
129506813|NCT01885078|466145762|FG007|Treatment Period|Adverse Event|5|||
129506814|NCT01885078|466145763|FG008|Treatment Period|Adverse Event|0|||
129506815|NCT01885078|466145764|FG009|Treatment Period|Adverse Event|0|||
129506816|NCT01885078|466145755|FG000|Treatment Period|Death|13|||
129506817|NCT01885078|466145756|FG001|Treatment Period|Death|33|||
129506818|NCT01885078|466145757|FG002|Treatment Period|Death|5|||
129506819|NCT01885078|466145758|FG003|Treatment Period|Death|9|||
129506820|NCT01885078|466145759|FG004|Treatment Period|Death|2|||
129506821|NCT01885078|466145760|FG005|Treatment Period|Death|10|||
129506822|NCT01885078|466145761|FG006|Treatment Period|Death|3|||
129506823|NCT01885078|466145762|FG007|Treatment Period|Death|2|||
129506824|NCT01885078|466145763|FG008|Treatment Period|Death|0|||
129506825|NCT01885078|466145764|FG009|Treatment Period|Death|0|||
129506826|NCT01885078|466145755|FG000|Treatment Period|Lack of Efficacy|12|||
129506827|NCT01885078|466145756|FG001|Treatment Period|Lack of Efficacy|33|||
129506828|NCT01885078|466145757|FG002|Treatment Period|Lack of Efficacy|10|||
129506829|NCT01885078|466145758|FG003|Treatment Period|Lack of Efficacy|23|||
129506830|NCT01885078|466145759|FG004|Treatment Period|Lack of Efficacy|24|||
129506831|NCT01885078|466145760|FG005|Treatment Period|Lack of Efficacy|58|||
129506832|NCT01885078|466145761|FG006|Treatment Period|Lack of Efficacy|9|||
129506833|NCT01885078|466145762|FG007|Treatment Period|Lack of Efficacy|5|||
129982557|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982558|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982559|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982560|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982561|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982562|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982563|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982564|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982565|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
129982566|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
129982567|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982568|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
129982569|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
129982570|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982571|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982572|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982573|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982574|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982575|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982576|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982577|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982578|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982579|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
129982580|NCT02663518|467900594|FG000|Part 1: Phase 1a Escalation|Other|0|||
129982581|NCT02663518|467900595|FG001|Part 1: Phase 1a Escalation|Other|0|||
129982582|NCT02663518|467900596|FG002|Part 1: Phase 1a Escalation|Other|2|||
129982583|NCT02663518|467900597|FG003|Part 1: Phase 1a Escalation|Other|0|||
129982584|NCT02663518|467900598|FG004|Part 1: Phase 1a Escalation|Other|0|||
129982585|NCT02663518|467900599|FG005|Part 1: Phase 1a Escalation|Other|0|||
129982586|NCT02663518|467900600|FG006|Part 1: Phase 1a Escalation|Other|0|||
129982587|NCT02663518|467900601|FG007|Part 1: Phase 1a Escalation|Other|0|||
129982588|NCT02663518|467900602|FG008|Part 1: Phase 1a Escalation|Other|0|||
129982589|NCT02663518|467900603|FG009|Part 1: Phase 1a Escalation|Other|0|||
129982590|NCT02663518|467900604|FG010|Part 1: Phase 1a Escalation|Other|0|||
129982591|NCT02663518|467900605|FG011|Part 1: Phase 1a Escalation|Other|0|||
129982592|NCT02663518|467900606|FG012|Part 1: Phase 1a Escalation|Other|0|||
129982593|NCT02663518|467900607|FG013|Part 1: Phase 1a Escalation|Other|0|||
129982594|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982595|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982596|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982597|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982598|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
129982599|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982600|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
129982601|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
129982602|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982603|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982604|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982605|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982606|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
129982607|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
129506834|NCT01885078|466145763|FG008|Treatment Period|Lack of Efficacy|0|||
129506835|NCT01885078|466145764|FG009|Treatment Period|Lack of Efficacy|0|||
129506836|NCT01885078|466145755|FG000|Treatment Period|Lost to Follow-up|16|||
129506837|NCT01885078|466145756|FG001|Treatment Period|Lost to Follow-up|19|||
129506838|NCT01885078|466145757|FG002|Treatment Period|Lost to Follow-up|7|||
129506839|NCT01885078|466145758|FG003|Treatment Period|Lost to Follow-up|9|||
129506840|NCT01885078|466145759|FG004|Treatment Period|Lost to Follow-up|2|||
129506841|NCT01885078|466145760|FG005|Treatment Period|Lost to Follow-up|8|||
129506842|NCT01885078|466145761|FG006|Treatment Period|Lost to Follow-up|2|||
129506843|NCT01885078|466145762|FG007|Treatment Period|Lost to Follow-up|0|||
129506844|NCT01885078|466145763|FG008|Treatment Period|Lost to Follow-up|0|||
129506845|NCT01885078|466145764|FG009|Treatment Period|Lost to Follow-up|0|||
129506846|NCT01885078|466145755|FG000|Treatment Period|Physician Decision|19|||
129506847|NCT01885078|466145756|FG001|Treatment Period|Physician Decision|21|||
129506848|NCT01885078|466145757|FG002|Treatment Period|Physician Decision|5|||
129506849|NCT01885078|466145758|FG003|Treatment Period|Physician Decision|12|||
129506850|NCT01885078|466145759|FG004|Treatment Period|Physician Decision|9|||
129506851|NCT01885078|466145760|FG005|Treatment Period|Physician Decision|24|||
129506852|NCT01885078|466145761|FG006|Treatment Period|Physician Decision|4|||
129506853|NCT01885078|466145762|FG007|Treatment Period|Physician Decision|3|||
129506854|NCT01885078|466145763|FG008|Treatment Period|Physician Decision|0|||
129506855|NCT01885078|466145764|FG009|Treatment Period|Physician Decision|0|||
129506856|NCT01885078|466145755|FG000|Treatment Period|Protocol Violation|3|||
129506857|NCT01885078|466145756|FG001|Treatment Period|Protocol Violation|5|||
129506858|NCT01885078|466145757|FG002|Treatment Period|Protocol Violation|0|||
129506859|NCT01885078|466145758|FG003|Treatment Period|Protocol Violation|3|||
129506860|NCT01885078|466145759|FG004|Treatment Period|Protocol Violation|1|||
129506861|NCT01885078|466145760|FG005|Treatment Period|Protocol Violation|6|||
129506862|NCT01885078|466145761|FG006|Treatment Period|Protocol Violation|0|||
129506863|NCT01885078|466145762|FG007|Treatment Period|Protocol Violation|0|||
129506864|NCT01885078|466145763|FG008|Treatment Period|Protocol Violation|0|||
129506865|NCT01885078|466145764|FG009|Treatment Period|Protocol Violation|0|||
129506866|NCT01885078|466145755|FG000|Treatment Period|Sponsor Decision|245|||
129506867|NCT01885078|466145756|FG001|Treatment Period|Sponsor Decision|648|||
129506868|NCT01885078|466145757|FG002|Treatment Period|Sponsor Decision|49|||
129506869|NCT01885078|466145758|FG003|Treatment Period|Sponsor Decision|90|||
129506870|NCT01885078|466145759|FG004|Treatment Period|Sponsor Decision|20|||
129506871|NCT01885078|466145760|FG005|Treatment Period|Sponsor Decision|38|||
129506872|NCT01885078|466145761|FG006|Treatment Period|Sponsor Decision|162|||
129506873|NCT01885078|466145762|FG007|Treatment Period|Sponsor Decision|3|||
129506874|NCT01885078|466145763|FG008|Treatment Period|Sponsor Decision|0|||
129506875|NCT01885078|466145764|FG009|Treatment Period|Sponsor Decision|0|||
129506876|NCT01885078|466145755|FG000|Treatment Period|Withdrawal by Subject|72|||
129506877|NCT01885078|466145756|FG001|Treatment Period|Withdrawal by Subject|132|||
129506878|NCT01885078|466145757|FG002|Treatment Period|Withdrawal by Subject|25|||
129506879|NCT01885078|466145758|FG003|Treatment Period|Withdrawal by Subject|63|||
129506880|NCT01885078|466145759|FG004|Treatment Period|Withdrawal by Subject|15|||
129506881|NCT01885078|466145760|FG005|Treatment Period|Withdrawal by Subject|34|||
129506882|NCT01885078|466145761|FG006|Treatment Period|Withdrawal by Subject|17|||
129506883|NCT01885078|466145762|FG007|Treatment Period|Withdrawal by Subject|10|||
129506884|NCT01885078|466145763|FG008|Treatment Period|Withdrawal by Subject|0|||
129506885|NCT01885078|466145764|FG009|Treatment Period|Withdrawal by Subject|0|||
129506886|NCT01885078|466145755|FG000|Treatment Period|Other|0|||
129506887|NCT01885078|466145756|FG001|Treatment Period|Other|0|||
129982608|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982609|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982610|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982611|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982612|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
129982613|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982614|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
129982615|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
129982616|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982617|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982618|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982619|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982620|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982621|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
129982622|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982623|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982624|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129506888|NCT01885078|466145757|FG002|Treatment Period|Other|0|||
129506889|NCT01885078|466145758|FG003|Treatment Period|Other|1|||
129506890|NCT01885078|466145759|FG004|Treatment Period|Other|0|||
129506891|NCT01885078|466145760|FG005|Treatment Period|Other|0|||
129506892|NCT01885078|466145761|FG006|Treatment Period|Other|0|||
129506893|NCT01885078|466145762|FG007|Treatment Period|Other|0|||
129506894|NCT01885078|466145763|FG008|Treatment Period|Other|0|||
129506895|NCT01885078|466145764|FG009|Treatment Period|Other|0|||
129506896|NCT01885078|466145755|FG000|Step-down Period|Sponsor Decision|0|||
129506897|NCT01885078|466145756|FG001|Step-down Period|Sponsor Decision|0|||
129506898|NCT01885078|466145757|FG002|Step-down Period|Sponsor Decision|0|||
129506899|NCT01885078|466145758|FG003|Step-down Period|Sponsor Decision|0|||
129506900|NCT01885078|466145759|FG004|Step-down Period|Sponsor Decision|0|||
129506901|NCT01885078|466145760|FG005|Step-down Period|Sponsor Decision|0|||
129506902|NCT01885078|466145761|FG006|Step-down Period|Sponsor Decision|0|||
129506903|NCT01885078|466145762|FG007|Step-down Period|Sponsor Decision|0|||
129506904|NCT01885078|466145763|FG008|Step-down Period|Sponsor Decision|1|||
129506905|NCT01885078|466145764|FG009|Step-down Period|Sponsor Decision|1|||
129506906|NCT01885078|466145755|FG000|Step-down Period|Adverse Event|0|||
129506907|NCT01885078|466145756|FG001|Step-down Period|Adverse Event|0|||
129506908|NCT01885078|466145757|FG002|Step-down Period|Adverse Event|0|||
129506909|NCT01885078|466145758|FG003|Step-down Period|Adverse Event|0|||
129506910|NCT01885078|466145759|FG004|Step-down Period|Adverse Event|0|||
129506911|NCT01885078|466145760|FG005|Step-down Period|Adverse Event|0|||
129506912|NCT01885078|466145761|FG006|Step-down Period|Adverse Event|0|||
129506913|NCT01885078|466145762|FG007|Step-down Period|Adverse Event|0|||
129506914|NCT01885078|466145763|FG008|Step-down Period|Adverse Event|29|||
129506915|NCT01885078|466145764|FG009|Step-down Period|Adverse Event|38|||
129506916|NCT01885078|466145755|FG000|Step-down Period|Withdrawal by Subject|0|||
129506917|NCT01885078|466145756|FG001|Step-down Period|Withdrawal by Subject|0|||
129506918|NCT01885078|466145757|FG002|Step-down Period|Withdrawal by Subject|0|||
129506919|NCT01885078|466145758|FG003|Step-down Period|Withdrawal by Subject|0|||
129506920|NCT01885078|466145759|FG004|Step-down Period|Withdrawal by Subject|0|||
129506921|NCT01885078|466145760|FG005|Step-down Period|Withdrawal by Subject|0|||
129506922|NCT01885078|466145761|FG006|Step-down Period|Withdrawal by Subject|0|||
129506923|NCT01885078|466145762|FG007|Step-down Period|Withdrawal by Subject|0|||
129506924|NCT01885078|466145763|FG008|Step-down Period|Withdrawal by Subject|25|||
129506925|NCT01885078|466145764|FG009|Step-down Period|Withdrawal by Subject|15|||
129506926|NCT01885078|466145755|FG000|Step-down Period|Physician Decision|0|||
129506927|NCT01885078|466145756|FG001|Step-down Period|Physician Decision|0|||
129506928|NCT01885078|466145757|FG002|Step-down Period|Physician Decision|0|||
129506929|NCT01885078|466145758|FG003|Step-down Period|Physician Decision|0|||
129506930|NCT01885078|466145759|FG004|Step-down Period|Physician Decision|0|||
129506931|NCT01885078|466145760|FG005|Step-down Period|Physician Decision|0|||
129506932|NCT01885078|466145761|FG006|Step-down Period|Physician Decision|0|||
129506933|NCT01885078|466145762|FG007|Step-down Period|Physician Decision|0|||
129506934|NCT01885078|466145763|FG008|Step-down Period|Physician Decision|7|||
129506935|NCT01885078|466145764|FG009|Step-down Period|Physician Decision|2|||
129506936|NCT01885078|466145755|FG000|Step-down Period|Death|0|||
129506937|NCT01885078|466145756|FG001|Step-down Period|Death|0|||
129506938|NCT01885078|466145757|FG002|Step-down Period|Death|0|||
129506939|NCT01885078|466145758|FG003|Step-down Period|Death|0|||
129506940|NCT01885078|466145759|FG004|Step-down Period|Death|0|||
129506941|NCT01885078|466145760|FG005|Step-down Period|Death|0|||
129506942|NCT01885078|466145761|FG006|Step-down Period|Death|0|||
129506943|NCT01885078|466145762|FG007|Step-down Period|Death|0|||
129506944|NCT01885078|466145763|FG008|Step-down Period|Death|4|||
129506945|NCT01885078|466145764|FG009|Step-down Period|Death|3|||
129506946|NCT01885078|466145755|FG000|Step-down Period|Lost to Follow-up|0|||
129506947|NCT01885078|466145756|FG001|Step-down Period|Lost to Follow-up|0|||
129506948|NCT01885078|466145757|FG002|Step-down Period|Lost to Follow-up|0|||
129506949|NCT01885078|466145758|FG003|Step-down Period|Lost to Follow-up|0|||
129506950|NCT01885078|466145759|FG004|Step-down Period|Lost to Follow-up|0|||
129506951|NCT01885078|466145760|FG005|Step-down Period|Lost to Follow-up|0|||
129506952|NCT01885078|466145761|FG006|Step-down Period|Lost to Follow-up|0|||
129506953|NCT01885078|466145762|FG007|Step-down Period|Lost to Follow-up|0|||
129506954|NCT01885078|466145763|FG008|Step-down Period|Lost to Follow-up|1|||
129506955|NCT01885078|466145764|FG009|Step-down Period|Lost to Follow-up|1|||
129506956|NCT01885078|466145755|FG000|Step-down Period|Lack of Efficacy|0|||
129506957|NCT01885078|466145756|FG001|Step-down Period|Lack of Efficacy|0|||
129506958|NCT01885078|466145757|FG002|Step-down Period|Lack of Efficacy|0|||
129506959|NCT01885078|466145758|FG003|Step-down Period|Lack of Efficacy|0|||
129506960|NCT01885078|466145759|FG004|Step-down Period|Lack of Efficacy|0|||
129982625|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982626|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
129506961|NCT01885078|466145760|FG005|Step-down Period|Lack of Efficacy|0|||
129506962|NCT01885078|466145761|FG006|Step-down Period|Lack of Efficacy|0|||
129506963|NCT01885078|466145762|FG007|Step-down Period|Lack of Efficacy|0|||
129506964|NCT01885078|466145763|FG008|Step-down Period|Lack of Efficacy|1|||
129506965|NCT01885078|466145764|FG009|Step-down Period|Lack of Efficacy|0|||
129506966|NCT01885078|466145755|FG000|Step-down Period|Protocol Violation|0|||
129982627|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129506967|NCT01885078|466145756|FG001|Step-down Period|Protocol Violation|0|||
129506968|NCT01885078|466145757|FG002|Step-down Period|Protocol Violation|0|||
129982628|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129506969|NCT01885078|466145758|FG003|Step-down Period|Protocol Violation|0|||
129506970|NCT01885078|466145759|FG004|Step-down Period|Protocol Violation|0|||
129506971|NCT01885078|466145760|FG005|Step-down Period|Protocol Violation|0|||
129506972|NCT01885078|466145761|FG006|Step-down Period|Protocol Violation|0|||
129506973|NCT01885078|466145762|FG007|Step-down Period|Protocol Violation|0|||
129506974|NCT01885078|466145763|FG008|Step-down Period|Protocol Violation|1|||
129506975|NCT01885078|466145764|FG009|Step-down Period|Protocol Violation|1|||
129506976|NCT03115112|466145765|FG000|Overall Study|Adverse Event|5|||
129506977|NCT03115112|466145766|FG001|Overall Study|Adverse Event|1|||
129506978|NCT03115112|466145765|FG000|Overall Study|Withdrawal by Subject|4|||
129506979|NCT03115112|466145766|FG001|Overall Study|Withdrawal by Subject|2|||
129506980|NCT03115112|466145765|FG000|Overall Study|Lost to Follow-up|0|||
129506981|NCT03115112|466145766|FG001|Overall Study|Lost to Follow-up|1|||
129506982|NCT03115112|466145765|FG000|Overall Study|Death|1|||
129506983|NCT03115112|466145766|FG001|Overall Study|Death|0|||
129506984|NCT03115112|466145765|FG000|Overall Study|Pregnancy|1|||
129506985|NCT03115112|466145766|FG001|Overall Study|Pregnancy|0|||
129506986|NCT03115112|466145765|FG000|Overall Study|Site closure|1|||
129506987|NCT03115112|466145766|FG001|Overall Study|Site closure|1|||
129506988|NCT04019795|466145768|FG000|Overall Study|Withdrawal by Subject|1|||
129506989|NCT04019795|466145769|FG001|Overall Study|Withdrawal by Subject|2|||
129506990|NCT04019795|466145770|FG002|Overall Study|Withdrawal by Subject|2|||
129506991|NCT04019795|466145771|FG003|Overall Study|Withdrawal by Subject|1|||
129506992|NCT04019795|466145768|FG000|Overall Study|Lost to Follow-up|0|||
129506993|NCT04019795|466145769|FG001|Overall Study|Lost to Follow-up|1|||
129506994|NCT04019795|466145770|FG002|Overall Study|Lost to Follow-up|1|||
129506995|NCT04019795|466145771|FG003|Overall Study|Lost to Follow-up|2|||
129506996|NCT04019795|466145768|FG000|Overall Study|Treatment non-compliance|3|||
129506997|NCT04019795|466145769|FG001|Overall Study|Treatment non-compliance|1|||
129506998|NCT04019795|466145770|FG002|Overall Study|Treatment non-compliance|2|||
129506999|NCT04019795|466145771|FG003|Overall Study|Treatment non-compliance|0|||
129507000|NCT04019795|466145768|FG000|Overall Study|Physician Decision|0|||
129507001|NCT04019795|466145769|FG001|Overall Study|Physician Decision|0|||
129507002|NCT04019795|466145770|FG002|Overall Study|Physician Decision|1|||
129507003|NCT04019795|466145771|FG003|Overall Study|Physician Decision|0|||
129507004|NCT04019795|466145768|FG000|Overall Study|Adverse Event|1|||
129507005|NCT04019795|466145769|FG001|Overall Study|Adverse Event|0|||
129507006|NCT04019795|466145770|FG002|Overall Study|Adverse Event|0|||
129507007|NCT04019795|466145771|FG003|Overall Study|Adverse Event|0|||
129507008|NCT01107405|466145772|FG000|Overall Study|Adverse Event|1|||
129507009|NCT01107405|466145773|FG001|Overall Study|Adverse Event|1|||
129507010|NCT01107405|466145774|FG002|Overall Study|Adverse Event|0|||
129507011|NCT01107405|466145775|FG003|Overall Study|Adverse Event|0|||
129507012|NCT01107405|466145776|FG004|Overall Study|Adverse Event|2|||
129507013|NCT01107405|466145772|FG000|Overall Study|Withdrawal by Subject|1|||
129507014|NCT01107405|466145773|FG001|Overall Study|Withdrawal by Subject|0|||
129507015|NCT01107405|466145774|FG002|Overall Study|Withdrawal by Subject|1|||
129507016|NCT01107405|466145775|FG003|Overall Study|Withdrawal by Subject|2|||
129507017|NCT01107405|466145776|FG004|Overall Study|Withdrawal by Subject|1|||
129507018|NCT01107405|466145772|FG000|Overall Study|Protocol Violation|0|||
129507019|NCT01107405|466145773|FG001|Overall Study|Protocol Violation|0|||
129507020|NCT01107405|466145774|FG002|Overall Study|Protocol Violation|1|||
129507021|NCT01107405|466145775|FG003|Overall Study|Protocol Violation|1|||
129507022|NCT01107405|466145776|FG004|Overall Study|Protocol Violation|0|||
129507023|NCT01895452|466145780|FG000|Overall Study|Adverse Event|1|||
129507024|NCT01895452|466145781|FG001|Overall Study|Adverse Event|4|||
129507025|NCT01895452|466145780|FG000|Overall Study|Lost to Follow-up|1|||
129507026|NCT01895452|466145781|FG001|Overall Study|Lost to Follow-up|5|||
129507027|NCT01895452|466145780|FG000|Overall Study|Pregnancy|0|||
129507028|NCT01895452|466145781|FG001|Overall Study|Pregnancy|1|||
129507029|NCT01895452|466145780|FG000|Overall Study|Withdrawal by Subject|2|||
129507030|NCT01895452|466145781|FG001|Overall Study|Withdrawal by Subject|14|||
129507031|NCT01895452|466145780|FG000|Overall Study|Underlying disease|0|||
129507032|NCT01895452|466145781|FG001|Overall Study|Underlying disease|3|||
129507033|NCT01895452|466145780|FG000|Overall Study|Noncompliance with study drug|0|||
129507034|NCT01895452|466145781|FG001|Overall Study|Noncompliance with study drug|1|||
129507035|NCT01653158|466145782|FG000|Overall Study|Death|0|||
129507036|NCT01653158|466145783|FG001|Overall Study|Death|0|||
129507037|NCT01653158|466145784|FG002|Overall Study|Death|0|||
129507038|NCT01653158|466145785|FG003|Overall Study|Death|1|||
129507039|NCT01653158|466145786|FG004|Overall Study|Death|0|||
129507040|NCT01653158|466145787|FG005|Overall Study|Death|0|||
129507041|NCT01653158|466145788|FG006|Overall Study|Death|0|||
129507042|NCT01653158|466145789|FG007|Overall Study|Death|2|||
129507043|NCT01653158|466145782|FG000|Overall Study|Adverse Event|0|||
129507044|NCT01653158|466145783|FG001|Overall Study|Adverse Event|0|||
129507045|NCT01653158|466145784|FG002|Overall Study|Adverse Event|0|||
129507046|NCT01653158|466145785|FG003|Overall Study|Adverse Event|1|||
129507047|NCT01653158|466145786|FG004|Overall Study|Adverse Event|0|||
129507048|NCT01653158|466145787|FG005|Overall Study|Adverse Event|0|||
129507049|NCT01653158|466145788|FG006|Overall Study|Adverse Event|0|||
129507050|NCT01653158|466145789|FG007|Overall Study|Adverse Event|3|||
129507051|NCT01653158|466145782|FG000|Overall Study|Other|0|||
129507052|NCT01653158|466145783|FG001|Overall Study|Other|0|||
129507053|NCT01653158|466145784|FG002|Overall Study|Other|0|||
129507054|NCT01653158|466145785|FG003|Overall Study|Other|0|||
129507055|NCT01653158|466145786|FG004|Overall Study|Other|0|||
129507056|NCT01653158|466145787|FG005|Overall Study|Other|0|||
129507057|NCT01653158|466145788|FG006|Overall Study|Other|0|||
129507058|NCT01653158|466145789|FG007|Overall Study|Other|1|||
129507059|NCT01653158|466145782|FG000|Overall Study|Progressive disease|0|||
129507060|NCT01653158|466145783|FG001|Overall Study|Progressive disease|0|||
129507061|NCT01653158|466145784|FG002|Overall Study|Progressive disease|0|||
129507062|NCT01653158|466145785|FG003|Overall Study|Progressive disease|0|||
129507063|NCT01653158|466145786|FG004|Overall Study|Progressive disease|1|||
129507064|NCT01653158|466145787|FG005|Overall Study|Progressive disease|1|||
129507065|NCT01653158|466145788|FG006|Overall Study|Progressive disease|2|||
129507066|NCT01653158|466145789|FG007|Overall Study|Progressive disease|9|||
129507067|NCT01653158|466145782|FG000|Overall Study|Withdrawal by Subject|1|||
129507068|NCT01653158|466145783|FG001|Overall Study|Withdrawal by Subject|0|||
129507069|NCT01653158|466145784|FG002|Overall Study|Withdrawal by Subject|0|||
129507070|NCT01653158|466145785|FG003|Overall Study|Withdrawal by Subject|0|||
129507071|NCT01653158|466145786|FG004|Overall Study|Withdrawal by Subject|0|||
129507072|NCT01653158|466145787|FG005|Overall Study|Withdrawal by Subject|0|||
129507073|NCT01653158|466145788|FG006|Overall Study|Withdrawal by Subject|0|||
129507074|NCT01653158|466145789|FG007|Overall Study|Withdrawal by Subject|0|||
129507075|NCT00980343|466145790|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
129507076|NCT00980343|466145791|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
129507077|NCT01204697|466145796|FG000|Overall Study|Death|26|||
129507078|NCT01204697|466145797|FG001|Overall Study|Death|27|||
129507079|NCT01204697|466145796|FG000|Overall Study|Lost to Follow-up|3|||
129507080|NCT01204697|466145797|FG001|Overall Study|Lost to Follow-up|4|||
129507081|NCT01204697|466145796|FG000|Overall Study|Withdrawal by Subject|2|||
129507082|NCT01204697|466145797|FG001|Overall Study|Withdrawal by Subject|4|||
129507083|NCT01204697|466145796|FG000|Overall Study|Randomized, but not treated|0|||
129507084|NCT01204697|466145797|FG001|Overall Study|Randomized, but not treated|1|||
129507085|NCT01205451|466145798|FG000|Overall Study|Lost to Follow-up|1|||
129507086|NCT01205451|466145799|FG001|Overall Study|Lost to Follow-up|1|||
129507087|NCT01205451|466145798|FG000|Overall Study|Withdrawal by Subject|5|||
129507088|NCT01205451|466145799|FG001|Overall Study|Withdrawal by Subject|9|||
129507089|NCT01170702|466145800|FG000|Overall Study|Exclusion criteria met after consent|1|||
129507090|NCT01170702|466145801|FG001|Overall Study|Exclusion criteria met after consent|2|||
129507091|NCT01170702|466145802|FG002|Overall Study|Exclusion criteria met after consent|0|||
129507092|NCT01170702|466145803|FG003|Overall Study|Exclusion criteria met after consent|2|||
129507093|NCT01677507|466145804|FG000|Initial Assignment|Adverse Event|0|||
129507094|NCT01677507|466145805|FG001|Initial Assignment|Adverse Event|1|||
129507095|NCT01677507|466145804|FG000|Initial Assignment|Protocol Violation|0|||
129507096|NCT01677507|466145805|FG001|Initial Assignment|Protocol Violation|1|||
129507097|NCT01677507|466145804|FG000|Second Assigment|Withdrawal by Subject|2|||
129507098|NCT01677507|466145805|FG001|Second Assigment|Withdrawal by Subject|2|||
129507099|NCT01677507|466145804|FG000|Second Assigment|Adverse Event|1|||
129507100|NCT01677507|466145805|FG001|Second Assigment|Adverse Event|3|||
129507101|NCT01879319|466145813|FG000|Overall Study|Withdrawal by Subject|1|||
129507102|NCT01879319|466145814|FG001|Overall Study|Withdrawal by Subject|0|||
129507103|NCT01879319|466145813|FG000|Overall Study|Lost to Follow-up|1|||
129507104|NCT01879319|466145814|FG001|Overall Study|Lost to Follow-up|5|||
129507105|NCT03986190|466145815|FG000|Overall Study|Withdrawal by Subject|12|||
129507106|NCT03986190|466145816|FG001|Overall Study|Withdrawal by Subject|0|||
129507107|NCT04511819|466145817|FG000|Overall Study|Non-compliance with study drug|5|||
129507108|NCT04511819|466145818|FG001|Overall Study|Non-compliance with study drug|1|||
129507109|NCT04511819|466145817|FG000|Overall Study|Withdrawal by Subject|0|||
129507110|NCT04511819|466145818|FG001|Overall Study|Withdrawal by Subject|3|||
129507111|NCT04511819|466145817|FG000|Overall Study|Adverse Event|0|||
129507112|NCT04511819|466145818|FG001|Overall Study|Adverse Event|1|||
129507113|NCT04511819|466145817|FG000|Overall Study|Protocol deviation|1|||
129507114|NCT04511819|466145818|FG001|Overall Study|Protocol deviation|0|||
129507115|NCT00084929|466145819|FG000|Overall Study|ineligible - medical contraindication|1|||
129982629|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129507116|NCT00084929|466145819|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
129507117|NCT00084929|466145819|FG000|Overall Study|Ineligible - Medical history|6|||
129507118|NCT00084929|466145819|FG000|Overall Study|Withdrawal by Subject|10|||
129507119|NCT00084929|466145819|FG000|Overall Study|Missing/incomplete CTC exam|9|||
129507120|NCT00084929|466145819|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
129507121|NCT00424294|466145820|FG000|Overall Study|Adverse Event|4|||
129507122|NCT00424294|466145821|FG001|Overall Study|Adverse Event|10|||
129507123|NCT00424294|466145820|FG000|Overall Study|Lack of Efficacy|2|||
129507124|NCT00424294|466145821|FG001|Overall Study|Lack of Efficacy|1|||
129507125|NCT00424294|466145820|FG000|Overall Study|Withdrawal by Subject|1|||
129507126|NCT00424294|466145821|FG001|Overall Study|Withdrawal by Subject|2|||
129507127|NCT00424294|466145820|FG000|Overall Study|Other|0|||
129507128|NCT00424294|466145821|FG001|Overall Study|Other|2|||
129507129|NCT00424294|466145820|FG000|Overall Study|Randomized but not Treated|1|||
129507130|NCT00424294|466145821|FG001|Overall Study|Randomized but not Treated|0|||
129507131|NCT01464788|466145822|FG000|Overall Study|Lost to Follow-up|0|||
129507132|NCT01464788|466145823|FG001|Overall Study|Lost to Follow-up|1|||
129507133|NCT01464788|466145824|FG002|Overall Study|Lost to Follow-up|0|||
129507134|NCT01464788|466145822|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
129507135|NCT01464788|466145823|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
129507136|NCT01464788|466145824|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
129507137|NCT04397718|466145825|FG000|Overall Study|Death|7|||
129507138|NCT04397718|466145826|FG001|Overall Study|Death|11|||
129507139|NCT04397718|466145825|FG000|Overall Study|Lost to Follow-up|0|||
129507140|NCT04397718|466145826|FG001|Overall Study|Lost to Follow-up|4|||
129507141|NCT01797965|466145827|FG000|Overall Study|Adverse Event|104|||
129507142|NCT01797965|466145828|FG001|Overall Study|Adverse Event|129|||
129507143|NCT01797965|466145829|FG002|Overall Study|Adverse Event|4|||
129507144|NCT01797965|466145830|FG003|Overall Study|Adverse Event|21|||
129507145|NCT01797965|466145827|FG000|Overall Study|Lost to Follow-up|9|||
129507146|NCT01797965|466145828|FG001|Overall Study|Lost to Follow-up|8|||
129507147|NCT01797965|466145829|FG002|Overall Study|Lost to Follow-up|1|||
129507148|NCT01797965|466145830|FG003|Overall Study|Lost to Follow-up|2|||
129507149|NCT01797965|466145827|FG000|Overall Study|Consent withdrawn|130|||
129507150|NCT01797965|466145828|FG001|Overall Study|Consent withdrawn|117|||
129507151|NCT01797965|466145829|FG002|Overall Study|Consent withdrawn|3|||
129507152|NCT01797965|466145830|FG003|Overall Study|Consent withdrawn|35|||
129507153|NCT01797965|466145827|FG000|Overall Study|Investigator decision|21|||
129507154|NCT01797965|466145828|FG001|Overall Study|Investigator decision|15|||
129507155|NCT01797965|466145829|FG002|Overall Study|Investigator decision|0|||
129507156|NCT01797965|466145830|FG003|Overall Study|Investigator decision|0|||
129507157|NCT01797965|466145827|FG000|Overall Study|Death|2|||
129507158|NCT01797965|466145828|FG001|Overall Study|Death|4|||
129507159|NCT01797965|466145829|FG002|Overall Study|Death|0|||
129507160|NCT01797965|466145830|FG003|Overall Study|Death|0|||
129507161|NCT01797965|466145827|FG000|Overall Study|Disease progression, defined by protocol|3|||
129507162|NCT01797965|466145828|FG001|Overall Study|Disease progression, defined by protocol|1|||
129507163|NCT01797965|466145829|FG002|Overall Study|Disease progression, defined by protocol|0|||
129507164|NCT01797965|466145830|FG003|Overall Study|Disease progression, defined by protocol|0|||
129507165|NCT01797965|466145827|FG000|Overall Study|Reason Not Specified|280|||
129507166|NCT01797965|466145828|FG001|Overall Study|Reason Not Specified|295|||
129507167|NCT01797965|466145829|FG002|Overall Study|Reason Not Specified|0|||
129507168|NCT01797965|466145830|FG003|Overall Study|Reason Not Specified|15|||
129507169|NCT00589979|466145831|FG000|Run-In Period|Adverse Event|5|||
129507170|NCT00589979|466145832|FG001|Run-In Period|Adverse Event|0|||
129507171|NCT00589979|466145833|FG002|Run-In Period|Adverse Event|0|||
129507172|NCT00589979|466145831|FG000|Run-In Period|Protocol Violation|3|||
129507173|NCT00589979|466145832|FG001|Run-In Period|Protocol Violation|0|||
129507174|NCT00589979|466145833|FG002|Run-In Period|Protocol Violation|0|||
129507175|NCT00589979|466145831|FG000|Run-In Period|Did not qualify for randomization|54|||
129507176|NCT00589979|466145832|FG001|Run-In Period|Did not qualify for randomization|0|||
129507177|NCT00589979|466145833|FG002|Run-In Period|Did not qualify for randomization|0|||
129507178|NCT00589979|466145831|FG000|Run-In Period|Withdrawal by Subject|10|||
129507179|NCT00589979|466145832|FG001|Run-In Period|Withdrawal by Subject|0|||
129507180|NCT00589979|466145833|FG002|Run-In Period|Withdrawal by Subject|0|||
129507181|NCT00589979|466145831|FG000|Run-In Period|Informed Consent Withdrawn|4|||
129507182|NCT00589979|466145832|FG001|Run-In Period|Informed Consent Withdrawn|0|||
129507183|NCT00589979|466145833|FG002|Run-In Period|Informed Consent Withdrawn|0|||
129507184|NCT00589979|466145831|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
129507185|NCT00589979|466145832|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
129507186|NCT00589979|466145833|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
129507187|NCT00589979|466145831|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
129507188|NCT00589979|466145832|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
129507189|NCT00589979|466145833|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
129507190|NCT00589979|466145831|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
129507191|NCT00589979|466145832|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
129507192|NCT00589979|466145833|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
129507193|NCT00589979|466145831|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
129507194|NCT00589979|466145832|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
129507195|NCT00589979|466145833|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
129507196|NCT00589979|466145831|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
129507197|NCT00589979|466145832|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
129507198|NCT00589979|466145833|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
129507199|NCT00589979|466145831|FG000|Double-Blind Treatment Period 2|Other|0|||
129507200|NCT00589979|466145832|FG001|Double-Blind Treatment Period 2|Other|0|||
129507201|NCT00589979|466145833|FG002|Double-Blind Treatment Period 2|Other|1|||
129507202|NCT00589979|466145831|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
129507203|NCT00589979|466145832|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
129507204|NCT00589979|466145833|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
129507205|NCT00589979|466145831|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
129507206|NCT00589979|466145832|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
129507207|NCT00589979|466145833|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
129507208|NCT00712322|466145834|FG000|Overall Study|Protocol deviation|0|||
129507209|NCT00712322|466145835|FG001|Overall Study|Protocol deviation|1|||
129507210|NCT00712322|466145836|FG002|Overall Study|Protocol deviation|0|||
129507211|NCT02670330|466145838|FG000|Overall Study|Protocol Deviation|1|||
129507212|NCT02670330|466145839|FG001|Overall Study|Protocol Deviation|0|||
129507213|NCT02670330|466145838|FG000|Overall Study|Study Terminated By Sponsor|36|||
129507214|NCT02670330|466145839|FG001|Overall Study|Study Terminated By Sponsor|43|||
129507215|NCT02670330|466145838|FG000|Overall Study|Adverse Event|1|||
129507216|NCT02670330|466145839|FG001|Overall Study|Adverse Event|3|||
129507217|NCT02670330|466145838|FG000|Overall Study|Withdrawal by Subject|34|||
129507218|NCT02670330|466145839|FG001|Overall Study|Withdrawal by Subject|29|||
129507219|NCT02670330|466145838|FG000|Overall Study|Lost to Follow-up|3|||
129507220|NCT02670330|466145839|FG001|Overall Study|Lost to Follow-up|2|||
129507221|NCT00239837|466145840|FG000|Overall Study|Lost to Follow-up|3|||
129507222|NCT00239837|466145841|FG001|Overall Study|Lost to Follow-up|7|||
129507223|NCT01153893|466145842|FG000|Overall Study|Adverse Event|1|||
129507224|NCT01153893|466145843|FG001|Overall Study|Adverse Event|0|||
129507225|NCT01838590|466145844|FG000|Overall Study|Lack of Efficacy|12|||
129507226|NCT01838590|466145845|FG001|Overall Study|Lack of Efficacy|4|||
129507227|NCT01838590|466145844|FG000|Overall Study|Lost to Follow-up|0|||
129507228|NCT01838590|466145845|FG001|Overall Study|Lost to Follow-up|1|||
129507229|NCT00536978|466145846|FG000|Overall Study|Not eligible for Adback Infusion|22|||
129507230|NCT03550131|466145848|FG000|Overall Study|Lost to Follow-up|16|||
129507231|NCT03550131|466145849|FG001|Overall Study|Lost to Follow-up|24|||
129507232|NCT03550131|466145848|FG000|Overall Study|Withdrawal by Subject|36|||
129507233|NCT03550131|466145849|FG001|Overall Study|Withdrawal by Subject|28|||
129507234|NCT03550131|466145848|FG000|Overall Study|Illness of dyad member|10|||
129507235|NCT03550131|466145849|FG001|Overall Study|Illness of dyad member|2|||
129507236|NCT03550131|466145848|FG000|Overall Study|Death of person with dementia|4|||
129507237|NCT03550131|466145849|FG001|Overall Study|Death of person with dementia|8|||
129507238|NCT01318512|466145850|FG000|Maintenance Period (6 Months)|Death|2|||
129507239|NCT01318512|466145850|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
129507240|NCT01364233|466145852|FG000|Overall Study|Lost to Follow-up|1|||
129507241|NCT00878215|466145853|FG000|Overall Study|Determined to be ineligible|0|||
129507242|NCT00878215|466145854|FG001|Overall Study|Determined to be ineligible|10|||
129507243|NCT00878215|466145855|FG002|Overall Study|Determined to be ineligible|0|||
129507244|NCT00878215|466145856|FG003|Overall Study|Determined to be ineligible|0|||
129507245|NCT00819585|466145858|FG000|Core Study|Adverse Event|2|||
129507246|NCT00819585|466145859|FG001|Core Study|Adverse Event|1|||
129507247|NCT00819585|466145860|FG002|Core Study|Adverse Event|1|||
129507248|NCT00819585|466145861|FG003|Core Study|Adverse Event|4|||
129507249|NCT00819585|466145862|FG004|Core Study|Adverse Event|1|||
129507250|NCT00819585|466145863|FG005|Core Study|Adverse Event|0|||
129507251|NCT00819585|466145864|FG006|Core Study|Adverse Event|2|||
129507252|NCT00819585|466145865|FG007|Core Study|Adverse Event|0|||
129507253|NCT00819585|466145866|FG008|Core Study|Adverse Event|0|||
129507254|NCT00819585|466145867|FG009|Core Study|Adverse Event|0|||
129507255|NCT00819585|466145868|FG010|Core Study|Adverse Event|0|||
129507256|NCT00819585|466145858|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
129507257|NCT00819585|466145859|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
129507258|NCT00819585|466145860|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
129507259|NCT00819585|466145861|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
129507260|NCT00819585|466145862|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
129507261|NCT00819585|466145863|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
129507262|NCT00819585|466145864|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
129507263|NCT00819585|466145865|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
129507264|NCT00819585|466145866|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
129507265|NCT00819585|466145867|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
129507266|NCT00819585|466145868|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
129507267|NCT00819585|466145858|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507268|NCT00819585|466145859|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
129507269|NCT00819585|466145860|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507270|NCT00819585|466145861|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507271|NCT00819585|466145862|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507272|NCT00819585|466145863|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507273|NCT00819585|466145864|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
129507274|NCT00819585|466145865|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507275|NCT00819585|466145866|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507276|NCT00819585|466145867|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507277|NCT00819585|466145868|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
129507278|NCT00819585|466145858|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
129507279|NCT00819585|466145859|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
129507280|NCT00819585|466145860|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
129507281|NCT00819585|466145861|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
129507282|NCT00819585|466145862|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
129507283|NCT00819585|466145863|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
129507284|NCT00819585|466145864|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
129507285|NCT00819585|466145865|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
129507286|NCT00819585|466145866|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
129507287|NCT00819585|466145867|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
129507288|NCT00819585|466145868|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
129507289|NCT00819585|466145858|FG000|Core Study|Subject Withdrew Consent|0|||
129507290|NCT00819585|466145859|FG001|Core Study|Subject Withdrew Consent|3|||
129507291|NCT00819585|466145860|FG002|Core Study|Subject Withdrew Consent|2|||
129507292|NCT00819585|466145861|FG003|Core Study|Subject Withdrew Consent|1|||
129507293|NCT00819585|466145862|FG004|Core Study|Subject Withdrew Consent|0|||
129507294|NCT00819585|466145863|FG005|Core Study|Subject Withdrew Consent|0|||
129507295|NCT00819585|466145864|FG006|Core Study|Subject Withdrew Consent|3|||
129507296|NCT00819585|466145865|FG007|Core Study|Subject Withdrew Consent|0|||
129507297|NCT00819585|466145866|FG008|Core Study|Subject Withdrew Consent|0|||
129507298|NCT00819585|466145867|FG009|Core Study|Subject Withdrew Consent|0|||
129507299|NCT00819585|466145868|FG010|Core Study|Subject Withdrew Consent|0|||
129507300|NCT00819585|466145858|FG000|Core Study|Lost to Follow-up|2|||
129507301|NCT00819585|466145859|FG001|Core Study|Lost to Follow-up|1|||
129507302|NCT00819585|466145860|FG002|Core Study|Lost to Follow-up|2|||
129507303|NCT00819585|466145861|FG003|Core Study|Lost to Follow-up|0|||
129507304|NCT00819585|466145862|FG004|Core Study|Lost to Follow-up|1|||
129507305|NCT00819585|466145863|FG005|Core Study|Lost to Follow-up|1|||
129507306|NCT00819585|466145864|FG006|Core Study|Lost to Follow-up|1|||
129507307|NCT00819585|466145865|FG007|Core Study|Lost to Follow-up|0|||
129507308|NCT00819585|466145866|FG008|Core Study|Lost to Follow-up|0|||
129507309|NCT00819585|466145867|FG009|Core Study|Lost to Follow-up|0|||
129507310|NCT00819585|466145868|FG010|Core Study|Lost to Follow-up|0|||
129507311|NCT00819585|466145858|FG000|Core Study|Administrative Problems|0|||
129507312|NCT00819585|466145859|FG001|Core Study|Administrative Problems|0|||
129507313|NCT00819585|466145860|FG002|Core Study|Administrative Problems|0|||
129507314|NCT00819585|466145861|FG003|Core Study|Administrative Problems|0|||
129507315|NCT00819585|466145862|FG004|Core Study|Administrative Problems|0|||
129507316|NCT00819585|466145863|FG005|Core Study|Administrative Problems|0|||
129507317|NCT00819585|466145864|FG006|Core Study|Administrative Problems|2|||
129507318|NCT00819585|466145865|FG007|Core Study|Administrative Problems|0|||
129507319|NCT00819585|466145866|FG008|Core Study|Administrative Problems|0|||
129507320|NCT00819585|466145867|FG009|Core Study|Administrative Problems|0|||
129507321|NCT00819585|466145868|FG010|Core Study|Administrative Problems|0|||
129507322|NCT00819585|466145858|FG000|Core Study|Death|0|||
129507323|NCT00819585|466145859|FG001|Core Study|Death|0|||
129507324|NCT00819585|466145860|FG002|Core Study|Death|0|||
129507325|NCT00819585|466145861|FG003|Core Study|Death|0|||
129507326|NCT00819585|466145862|FG004|Core Study|Death|0|||
129507327|NCT00819585|466145863|FG005|Core Study|Death|0|||
129507328|NCT00819585|466145864|FG006|Core Study|Death|1|||
129507329|NCT00819585|466145865|FG007|Core Study|Death|0|||
129507330|NCT00819585|466145866|FG008|Core Study|Death|0|||
129507331|NCT00819585|466145867|FG009|Core Study|Death|0|||
129507332|NCT00819585|466145868|FG010|Core Study|Death|0|||
129507333|NCT00819585|466145858|FG000|Core Study|Protocol Violation|0|||
129507334|NCT00819585|466145859|FG001|Core Study|Protocol Violation|0|||
129507335|NCT00819585|466145860|FG002|Core Study|Protocol Violation|1|||
129507336|NCT00819585|466145861|FG003|Core Study|Protocol Violation|0|||
129507337|NCT00819585|466145862|FG004|Core Study|Protocol Violation|0|||
129507338|NCT00819585|466145863|FG005|Core Study|Protocol Violation|1|||
129982630|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129507339|NCT00819585|466145864|FG006|Core Study|Protocol Violation|3|||
129507340|NCT00819585|466145865|FG007|Core Study|Protocol Violation|0|||
129507341|NCT00819585|466145866|FG008|Core Study|Protocol Violation|0|||
129507342|NCT00819585|466145867|FG009|Core Study|Protocol Violation|0|||
129507343|NCT00819585|466145868|FG010|Core Study|Protocol Violation|0|||
129507344|NCT00819585|466145858|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
129507345|NCT00819585|466145859|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
129507346|NCT00819585|466145860|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
129507347|NCT00819585|466145861|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
129507348|NCT00819585|466145862|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
129507349|NCT00819585|466145863|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
129507350|NCT00819585|466145864|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
129507351|NCT00819585|466145865|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
129507352|NCT00819585|466145866|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
129507353|NCT00819585|466145867|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
129507354|NCT00819585|466145868|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
129507355|NCT00819585|466145858|FG000|Extension Study|Subject Withdrew Consent|0|||
129507356|NCT00819585|466145859|FG001|Extension Study|Subject Withdrew Consent|0|||
129507357|NCT00819585|466145860|FG002|Extension Study|Subject Withdrew Consent|0|||
129507358|NCT00819585|466145861|FG003|Extension Study|Subject Withdrew Consent|0|||
129507359|NCT00819585|466145862|FG004|Extension Study|Subject Withdrew Consent|0|||
129507360|NCT00819585|466145863|FG005|Extension Study|Subject Withdrew Consent|0|||
129507361|NCT00819585|466145864|FG006|Extension Study|Subject Withdrew Consent|0|||
129507362|NCT00819585|466145865|FG007|Extension Study|Subject Withdrew Consent|0|||
129507363|NCT00819585|466145866|FG008|Extension Study|Subject Withdrew Consent|3|||
129507364|NCT00819585|466145867|FG009|Extension Study|Subject Withdrew Consent|0|||
129507365|NCT00819585|466145868|FG010|Extension Study|Subject Withdrew Consent|1|||
129507366|NCT00819585|466145858|FG000|Extension Study|Lost to Follow-up|0|||
129507367|NCT00819585|466145859|FG001|Extension Study|Lost to Follow-up|0|||
129507368|NCT00819585|466145860|FG002|Extension Study|Lost to Follow-up|0|||
129507369|NCT00819585|466145861|FG003|Extension Study|Lost to Follow-up|0|||
129507370|NCT00819585|466145862|FG004|Extension Study|Lost to Follow-up|0|||
129507371|NCT00819585|466145863|FG005|Extension Study|Lost to Follow-up|0|||
129507372|NCT00819585|466145864|FG006|Extension Study|Lost to Follow-up|0|||
129507373|NCT00819585|466145865|FG007|Extension Study|Lost to Follow-up|0|||
129507374|NCT00819585|466145866|FG008|Extension Study|Lost to Follow-up|2|||
129507375|NCT00819585|466145867|FG009|Extension Study|Lost to Follow-up|1|||
129507376|NCT00819585|466145868|FG010|Extension Study|Lost to Follow-up|1|||
129507377|NCT00819585|466145858|FG000|Extension Study|Death|0|||
129507378|NCT00819585|466145859|FG001|Extension Study|Death|0|||
129507379|NCT00819585|466145860|FG002|Extension Study|Death|0|||
129507380|NCT00819585|466145861|FG003|Extension Study|Death|0|||
129507381|NCT00819585|466145862|FG004|Extension Study|Death|0|||
129507382|NCT00819585|466145863|FG005|Extension Study|Death|0|||
129507383|NCT00819585|466145864|FG006|Extension Study|Death|0|||
129507384|NCT00819585|466145865|FG007|Extension Study|Death|0|||
129507385|NCT00819585|466145866|FG008|Extension Study|Death|2|||
129507386|NCT00819585|466145867|FG009|Extension Study|Death|0|||
129507387|NCT00819585|466145868|FG010|Extension Study|Death|0|||
129507388|NCT03334396|466145869|FG000|Overall Study|Adverse Event|1|||
129507389|NCT03334396|466145870|FG001|Overall Study|Adverse Event|0|||
129507390|NCT03334396|466145871|FG002|Overall Study|Adverse Event|1|||
129507391|NCT03334396|466145872|FG003|Overall Study|Adverse Event|0|||
129507392|NCT03334396|466145873|FG004|Overall Study|Adverse Event|0|||
129507393|NCT03334396|466145874|FG005|Overall Study|Adverse Event|0|||
129507394|NCT03334396|466145875|FG006|Overall Study|Adverse Event|0|||
129507395|NCT03334396|466145876|FG007|Overall Study|Adverse Event|0|||
129507396|NCT03334396|466145869|FG000|Overall Study|Lack of Efficacy|10|||
129507397|NCT03334396|466145870|FG001|Overall Study|Lack of Efficacy|4|||
129507398|NCT03334396|466145871|FG002|Overall Study|Lack of Efficacy|1|||
129507399|NCT03334396|466145872|FG003|Overall Study|Lack of Efficacy|3|||
129507400|NCT03334396|466145873|FG004|Overall Study|Lack of Efficacy|1|||
129507401|NCT03334396|466145874|FG005|Overall Study|Lack of Efficacy|0|||
129507402|NCT03334396|466145875|FG006|Overall Study|Lack of Efficacy|0|||
129507403|NCT03334396|466145876|FG007|Overall Study|Lack of Efficacy|1|||
129507404|NCT03334396|466145869|FG000|Overall Study|Lost to Follow-up|0|||
129507405|NCT03334396|466145870|FG001|Overall Study|Lost to Follow-up|0|||
129507406|NCT03334396|466145871|FG002|Overall Study|Lost to Follow-up|1|||
129507407|NCT03334396|466145872|FG003|Overall Study|Lost to Follow-up|0|||
129507408|NCT03334396|466145873|FG004|Overall Study|Lost to Follow-up|0|||
129507409|NCT03334396|466145874|FG005|Overall Study|Lost to Follow-up|0|||
129507410|NCT03334396|466145875|FG006|Overall Study|Lost to Follow-up|1|||
129507411|NCT03334396|466145876|FG007|Overall Study|Lost to Follow-up|0|||
129507412|NCT03334396|466145869|FG000|Overall Study|Physician Decision|1|||
129507413|NCT03334396|466145870|FG001|Overall Study|Physician Decision|0|||
129507414|NCT03334396|466145871|FG002|Overall Study|Physician Decision|0|||
129507415|NCT03334396|466145872|FG003|Overall Study|Physician Decision|0|||
129982631|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129507416|NCT03334396|466145873|FG004|Overall Study|Physician Decision|0|||
129507417|NCT03334396|466145874|FG005|Overall Study|Physician Decision|0|||
129982632|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982633|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129507418|NCT03334396|466145875|FG006|Overall Study|Physician Decision|0|||
129507419|NCT03334396|466145876|FG007|Overall Study|Physician Decision|0|||
129507420|NCT03334396|466145869|FG000|Overall Study|Withdrawal by Subject|10|||
129507421|NCT03334396|466145870|FG001|Overall Study|Withdrawal by Subject|5|||
129507422|NCT03334396|466145871|FG002|Overall Study|Withdrawal by Subject|7|||
129507423|NCT03334396|466145872|FG003|Overall Study|Withdrawal by Subject|2|||
129507424|NCT03334396|466145873|FG004|Overall Study|Withdrawal by Subject|2|||
129507425|NCT03334396|466145874|FG005|Overall Study|Withdrawal by Subject|1|||
129507426|NCT03334396|466145875|FG006|Overall Study|Withdrawal by Subject|2|||
129507427|NCT03334396|466145876|FG007|Overall Study|Withdrawal by Subject|0|||
129507428|NCT03334396|466145869|FG000|Overall Study|Pregnancy|0|||
129507429|NCT03334396|466145870|FG001|Overall Study|Pregnancy|1|||
129507430|NCT03334396|466145871|FG002|Overall Study|Pregnancy|0|||
129507431|NCT03334396|466145872|FG003|Overall Study|Pregnancy|0|||
129507432|NCT03334396|466145873|FG004|Overall Study|Pregnancy|0|||
129507433|NCT03334396|466145874|FG005|Overall Study|Pregnancy|0|||
129507434|NCT03334396|466145875|FG006|Overall Study|Pregnancy|0|||
129507435|NCT03334396|466145876|FG007|Overall Study|Pregnancy|0|||
129507436|NCT03334396|466145869|FG000|Overall Study|Ineligible|0|||
129507437|NCT03334396|466145870|FG001|Overall Study|Ineligible|1|||
129507438|NCT03334396|466145871|FG002|Overall Study|Ineligible|0|||
129507439|NCT03334396|466145872|FG003|Overall Study|Ineligible|0|||
129507440|NCT03334396|466145873|FG004|Overall Study|Ineligible|0|||
129507441|NCT03334396|466145874|FG005|Overall Study|Ineligible|0|||
129507442|NCT03334396|466145875|FG006|Overall Study|Ineligible|0|||
129507443|NCT03334396|466145876|FG007|Overall Study|Ineligible|0|||
129507444|NCT03334396|466145869|FG000|Overall Study|Started New Job|1|||
129507445|NCT03334396|466145870|FG001|Overall Study|Started New Job|0|||
129507446|NCT03334396|466145871|FG002|Overall Study|Started New Job|0|||
129507447|NCT03334396|466145872|FG003|Overall Study|Started New Job|0|||
129507448|NCT03334396|466145873|FG004|Overall Study|Started New Job|0|||
129507449|NCT03334396|466145874|FG005|Overall Study|Started New Job|0|||
129507450|NCT03334396|466145875|FG006|Overall Study|Started New Job|0|||
129507451|NCT03334396|466145876|FG007|Overall Study|Started New Job|0|||
129507452|NCT02927873|466145879|FG000|Overall Study|Lost to Follow-up|0|||
129507453|NCT02927873|466145880|FG001|Overall Study|Lost to Follow-up|1|||
129507454|NCT02927873|466145881|FG002|Overall Study|Lost to Follow-up|0|||
129507455|NCT02927873|466145882|FG003|Overall Study|Lost to Follow-up|0|||
129507456|NCT02927873|466145883|FG004|Overall Study|Lost to Follow-up|0|||
129507457|NCT02927873|466145884|FG005|Overall Study|Lost to Follow-up|0|||
129507458|NCT02927873|466145879|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129507459|NCT02927873|466145880|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
129507460|NCT02927873|466145881|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129507461|NCT02927873|466145882|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129507462|NCT02927873|466145883|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129507463|NCT02927873|466145884|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
129507464|NCT02927873|466145879|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129507465|NCT02927873|466145880|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129507466|NCT02927873|466145881|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129507467|NCT02927873|466145882|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129507468|NCT02927873|466145883|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129507469|NCT02927873|466145884|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129507470|NCT02927873|466145879|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
129507471|NCT02927873|466145880|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
129507472|NCT02927873|466145881|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
129507473|NCT02927873|466145882|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
129507474|NCT02927873|466145883|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
129507475|NCT02927873|466145884|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
129507476|NCT02927873|466145879|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
129507477|NCT02927873|466145880|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
129507478|NCT02927873|466145881|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
129507479|NCT02927873|466145882|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
129507480|NCT02927873|466145883|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
129507481|NCT02927873|466145884|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
129507482|NCT02927873|466145879|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
129507483|NCT02927873|466145880|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
129507484|NCT02927873|466145881|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
129507485|NCT02927873|466145882|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
129507486|NCT02927873|466145883|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
129507487|NCT02927873|466145884|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
129507488|NCT02159469|466145885|FG000|Overall Study|Missing Completion status|1|||
129507489|NCT02159469|466145885|FG000|Overall Study|Adverse Event|5|||
129507490|NCT02159469|466145885|FG000|Overall Study|Non-compliance|2|||
129507491|NCT02159469|466145885|FG000|Overall Study|Withdrawal by Subject|9|||
129507492|NCT02159469|466145885|FG000|Overall Study|Lost to Follow-up|1|||
129507493|NCT02159469|466145885|FG000|Overall Study|Sponsor's request|2|||
129507494|NCT02159469|466145885|FG000|Overall Study|Met Stopping Criteria|3|||
129507495|NCT02159469|466145885|FG000|Overall Study|Other|1|||
129507496|NCT02159469|466145885|FG000|Overall Study|Multiple|29|||
129507497|NCT03629041|466145891|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
129507498|NCT03629041|466145892|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
129507499|NCT03629041|466145893|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
129507500|NCT03629041|466145894|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
129507501|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
129507502|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
129507503|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
129507504|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
129507505|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
129507506|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
129507507|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
129507508|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
129507509|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
129507510|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
129507511|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
129507512|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
129507513|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
129982634|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129507514|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
129507515|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
129507516|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
129507517|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
129507518|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
129507519|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
129507520|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
129507521|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
129507522|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
129507523|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
129507524|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
129507525|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
129507526|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
129507527|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
129507528|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
129507529|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
129507530|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
129507531|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
129507532|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
129507533|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
129507534|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
129507535|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
129507536|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
129507537|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
129507538|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
129507539|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
129507540|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
129507541|NCT00383721|466145896|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
129507542|NCT00383721|466145897|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
129507543|NCT00383721|466145898|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
129507544|NCT00383721|466145899|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
129507545|NCT00383721|466145900|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
129507546|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
129507547|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
129507548|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
129507549|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
129507550|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
129507551|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
129507552|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
129507553|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
129507554|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
129507555|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
129507556|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
129507557|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
129507558|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
129507559|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
129507560|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
129507561|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
129507562|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
129507563|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
129507564|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
129507565|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
129507566|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129507567|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129507568|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129507569|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
129507570|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
129507571|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
129507572|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129507573|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
129507574|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
129507575|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
129507576|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129507577|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129507578|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129507579|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
129507580|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
129507581|NCT00383721|466145896|FG000|26-Week Treatment Safety Extension|Administrative|1|||
129507582|NCT00383721|466145897|FG001|26-Week Treatment Safety Extension|Administrative|2|||
129507583|NCT00383721|466145898|FG002|26-Week Treatment Safety Extension|Administrative|3|||
129507584|NCT00383721|466145899|FG003|26-Week Treatment Safety Extension|Administrative|1|||
129507585|NCT00383721|466145900|FG004|26-Week Treatment Safety Extension|Administrative|0|||
129507586|NCT01146951|466147555|FG000|Overall Study|Adverse Event|4|||
129507587|NCT01146951|466147556|FG001|Overall Study|Adverse Event|1|||
129507588|NCT01747811|466147558|FG000|Overall Study|Lack of Efficacy|2|||
129507589|NCT01747811|466147559|FG001|Overall Study|Lack of Efficacy|4|||
129507590|NCT01337167|466147563|FG000|Infant Series|Adverse Event|1|||
129507591|NCT01337167|466147564|FG001|Infant Series|Adverse Event|1|||
129507592|NCT01337167|466147563|FG000|Infant Series|Death|1|||
129507593|NCT01337167|466147564|FG001|Infant Series|Death|1|||
129507594|NCT01337167|466147563|FG000|Infant Series|Lost to Follow-up|13|||
129507595|NCT01337167|466147564|FG001|Infant Series|Lost to Follow-up|7|||
129507596|NCT01337167|466147563|FG000|Infant Series|Non-compliance with study drug|2|||
129507597|NCT01337167|466147564|FG001|Infant Series|Non-compliance with study drug|1|||
129507598|NCT01337167|466147563|FG000|Infant Series|Physician Decision|3|||
129507599|NCT01337167|466147564|FG001|Infant Series|Physician Decision|1|||
129507600|NCT01337167|466147563|FG000|Infant Series|Protocol Violation|22|||
129507601|NCT01337167|466147564|FG001|Infant Series|Protocol Violation|9|||
129507602|NCT01337167|466147563|FG000|Infant Series|Withdrawal by Subject|15|||
129507603|NCT01337167|466147564|FG001|Infant Series|Withdrawal by Subject|4|||
129507604|NCT01337167|466147563|FG000|Infant Series|Randomized but not vaccinated|5|||
129507605|NCT01337167|466147564|FG001|Infant Series|Randomized but not vaccinated|3|||
129507606|NCT01337167|466147563|FG000|Interim Period|Lost to Follow-up|51|||
129507607|NCT01337167|466147564|FG001|Interim Period|Lost to Follow-up|23|||
129507608|NCT01337167|466147563|FG000|Interim Period|Non-compliance with study drug|1|||
129507609|NCT01337167|466147564|FG001|Interim Period|Non-compliance with study drug|0|||
129507610|NCT01337167|466147563|FG000|Interim Period|Physician Decision|6|||
129507611|NCT01337167|466147564|FG001|Interim Period|Physician Decision|3|||
129507612|NCT01337167|466147563|FG000|Interim Period|Protocol Violation|5|||
129507613|NCT01337167|466147564|FG001|Interim Period|Protocol Violation|3|||
129507614|NCT01337167|466147563|FG000|Interim Period|Withdrawal by Subject|18|||
129507615|NCT01337167|466147564|FG001|Interim Period|Withdrawal by Subject|10|||
129507616|NCT01337167|466147563|FG000|Interim Period|Other protocol criterion not met|0|||
129507617|NCT01337167|466147564|FG001|Interim Period|Other protocol criterion not met|1|||
129507618|NCT01337167|466147563|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
129507619|NCT01337167|466147564|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
129507620|NCT01337167|466147563|FG000|Toddler Vaccinations|Protocol Violation|0|||
129507621|NCT01337167|466147564|FG001|Toddler Vaccinations|Protocol Violation|1|||
129507622|NCT01337167|466147563|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
129507623|NCT01337167|466147564|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
129507624|NCT03833817|466147565|FG000|Overall Study|Withdrawal by Subject|3|||
129507625|NCT03833817|466147566|FG001|Overall Study|Withdrawal by Subject|3|||
129507626|NCT03833817|466147565|FG000|Overall Study|Lost to Follow-up|3|||
129507627|NCT03833817|466147566|FG001|Overall Study|Lost to Follow-up|3|||
129507628|NCT02126670|466147569|FG000|Overall Study|Withdrawal by Subject|1|||
129507629|NCT02126670|466147570|FG001|Overall Study|Withdrawal by Subject|0|||
129507630|NCT02126670|466147571|FG002|Overall Study|Withdrawal by Subject|0|||
129507631|NCT02126670|466147572|FG003|Overall Study|Withdrawal by Subject|1|||
129507632|NCT03363919|466147575|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
129507633|NCT03363919|466147576|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
129507634|NCT03363919|466147575|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
129539074|NCT02708524|466265146|FG002|Overall Study|Protocol Violation|0|||
129507635|NCT03363919|466147576|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
129507636|NCT01646398|466147577|FG000|Overall Study|Withdrawal by Subject|1|||
129507637|NCT01646398|466147578|FG001|Overall Study|Withdrawal by Subject|0|||
129507638|NCT00255034|466147579|FG000|Overall Study|Withdrawal by Subject|15|||
129507639|NCT00255034|466147580|FG001|Overall Study|Withdrawal by Subject|38|||
129507640|NCT00574119|466147582|FG000|Overall Study|Adverse Event|1|||
129507641|NCT00574119|466147582|FG000|Overall Study|Protocol Violation|1|||
129507642|NCT00574119|466147582|FG000|Overall Study|Withdrawal by Subject|1|||
129507643|NCT00574119|466147582|FG000|Overall Study|Physician Decision|1|||
129507644|NCT02667457|466147587|FG000|Overall Study|Withdrawal by Subject|1|||
129507645|NCT02667457|466147588|FG001|Overall Study|Withdrawal by Subject|0|||
129507646|NCT02667457|466147587|FG000|Overall Study|Other Reason|0|||
129507647|NCT02667457|466147588|FG001|Overall Study|Other Reason|2|||
129507648|NCT02475850|466147589|FG000|Overall Study|Death|155|||
129507649|NCT02475850|466147590|FG001|Overall Study|Death|141|||
129507650|NCT02475850|466147589|FG000|Overall Study|Lost to Follow-up|217|||
129982635|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
129982636|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982637|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982638|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982639|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982640|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
129982641|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
129982642|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
129982643|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
129982644|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982645|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982646|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982647|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982648|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982649|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
129982650|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982651|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982652|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982653|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982654|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
129982655|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982656|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
129982657|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982658|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982659|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982660|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982661|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982662|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982663|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
129982664|NCT02663518|467900594|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982665|NCT02663518|467900595|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982666|NCT02663518|467900596|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982667|NCT02663518|467900597|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982668|NCT02663518|467900598|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982669|NCT02663518|467900599|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982670|NCT02663518|467900600|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
129982671|NCT02663518|467900601|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982672|NCT02663518|467900602|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982673|NCT02663518|467900603|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982674|NCT02663518|467900604|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982675|NCT02663518|467900605|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982676|NCT02663518|467900606|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982677|NCT02663518|467900607|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
129982678|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
129982679|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
129982680|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
129982681|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
129982682|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
129982683|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
129982684|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
129507651|NCT02475850|466147590|FG001|Overall Study|Lost to Follow-up|188|||
129507652|NCT02475850|466147589|FG000|Overall Study|Withdrawal by Subject|221|||
129507653|NCT02475850|466147590|FG001|Overall Study|Withdrawal by Subject|155|||
129507654|NCT03297216|466147595|FG000|Overall Study|Death|0|||
129507655|NCT03297216|466147596|FG001|Overall Study|Death|1|||
129507656|NCT03297216|466147595|FG000|Overall Study|Miscarriage|0|||
129507657|NCT03297216|466147596|FG001|Overall Study|Miscarriage|2|||
129507658|NCT03297216|466147595|FG000|Overall Study|Lost to Follow-up|3|||
129507659|NCT03297216|466147596|FG001|Overall Study|Lost to Follow-up|2|||
129507660|NCT02700919|466147597|FG000|Overall Study|Physician Decision|1|||
129507661|NCT02700919|466147598|FG001|Overall Study|Physician Decision|0|||
129507662|NCT02700919|466147599|FG002|Overall Study|Physician Decision|0|||
129507663|NCT02700919|466147597|FG000|Overall Study|Protocol Violation|1|||
129507664|NCT02700919|466147598|FG001|Overall Study|Protocol Violation|0|||
129507665|NCT02700919|466147599|FG002|Overall Study|Protocol Violation|0|||
129507666|NCT02700919|466147597|FG000|Overall Study|Adverse Event|1|||
129507667|NCT02700919|466147598|FG001|Overall Study|Adverse Event|3|||
129507668|NCT02700919|466147599|FG002|Overall Study|Adverse Event|1|||
129507669|NCT02700919|466147597|FG000|Overall Study|Withdrawal by Subject|5|||
129507670|NCT02700919|466147598|FG001|Overall Study|Withdrawal by Subject|8|||
129507671|NCT02700919|466147599|FG002|Overall Study|Withdrawal by Subject|2|||
129507672|NCT02700919|466147597|FG000|Overall Study|Lost to Follow-up|2|||
129507673|NCT02700919|466147598|FG001|Overall Study|Lost to Follow-up|0|||
129507674|NCT02700919|466147599|FG002|Overall Study|Lost to Follow-up|0|||
129507675|NCT02700919|466147597|FG000|Overall Study|Other|2|||
129507676|NCT02700919|466147598|FG001|Overall Study|Other|1|||
129507677|NCT02700919|466147599|FG002|Overall Study|Other|1|||
129507678|NCT03434418|466147600|FG000|Overall Study|Disease Progression|11|||
129507679|NCT03434418|466147600|FG000|Overall Study|Adverse Event|2|||
129507680|NCT03434418|466147600|FG000|Overall Study|Physician Decision|1|||
129507681|NCT03434418|466147600|FG000|Overall Study|Decline in Performance Status (PS)|1|||
129507682|NCT00912340|466147604|FG000|Overall Study|Adverse Event|2|||
129507683|NCT00912340|466147605|FG001|Overall Study|Adverse Event|4|||
129507684|NCT00912340|466147606|FG002|Overall Study|Adverse Event|0|||
129507685|NCT00912340|466147604|FG000|Overall Study|Protocol revised to remove arm|0|||
129507686|NCT00912340|466147605|FG001|Overall Study|Protocol revised to remove arm|0|||
129507687|NCT00912340|466147606|FG002|Overall Study|Protocol revised to remove arm|4|||
129507688|NCT01517412|466147607|FG000|Overall Study|Adverse Event|10|||
129507689|NCT01517412|466147608|FG001|Overall Study|Adverse Event|11|||
129507690|NCT01517412|466147607|FG000|Overall Study|Lack of Efficacy|10|||
129507691|NCT01517412|466147608|FG001|Overall Study|Lack of Efficacy|5|||
129507692|NCT01517412|466147607|FG000|Overall Study|Poor compliance to protocol|8|||
129507693|NCT01517412|466147608|FG001|Overall Study|Poor compliance to protocol|3|||
129507694|NCT01517412|466147607|FG000|Overall Study|Other than specified above|8|||
129507695|NCT01517412|466147608|FG001|Overall Study|Other than specified above|5|||
129507696|NCT01253187|466147609|FG000|Period 2|Withdrawal by Subject|0|||
129507697|NCT01253187|466147610|FG001|Period 2|Withdrawal by Subject|0|||
129507698|NCT01253187|466147611|FG002|Period 2|Withdrawal by Subject|0|||
129507699|NCT01253187|466147612|FG003|Period 2|Withdrawal by Subject|0|||
129507700|NCT01253187|466147613|FG004|Period 2|Withdrawal by Subject|1|||
129507701|NCT01253187|466147614|FG005|Period 2|Withdrawal by Subject|0|||
129507702|NCT01253187|466147609|FG000|Period 3|Pregnancy|1|||
129507703|NCT01253187|466147610|FG001|Period 3|Pregnancy|0|||
129507704|NCT01253187|466147611|FG002|Period 3|Pregnancy|0|||
129507705|NCT01253187|466147612|FG003|Period 3|Pregnancy|0|||
129507706|NCT01253187|466147613|FG004|Period 3|Pregnancy|0|||
129507707|NCT01253187|466147614|FG005|Period 3|Pregnancy|0|||
129507708|NCT01253187|466147609|FG000|Period 3|difficulty with blood sampling|0|||
129507709|NCT01253187|466147610|FG001|Period 3|difficulty with blood sampling|1|||
129507710|NCT01253187|466147611|FG002|Period 3|difficulty with blood sampling|0|||
129507711|NCT01253187|466147612|FG003|Period 3|difficulty with blood sampling|0|||
129507712|NCT01253187|466147613|FG004|Period 3|difficulty with blood sampling|0|||
129507713|NCT01253187|466147614|FG005|Period 3|difficulty with blood sampling|0|||
129507714|NCT01253187|466147609|FG000|Period 3|non-compliance|0|||
129507715|NCT01253187|466147610|FG001|Period 3|non-compliance|0|||
129507716|NCT01253187|466147611|FG002|Period 3|non-compliance|0|||
129507717|NCT01253187|466147612|FG003|Period 3|non-compliance|0|||
129507718|NCT01253187|466147613|FG004|Period 3|non-compliance|1|||
129507719|NCT01253187|466147614|FG005|Period 3|non-compliance|0|||
129507720|NCT01956240|466147617|FG000|Overall Study|Lost to Follow-up|6|||
129507721|NCT01956240|466147618|FG001|Overall Study|Lost to Follow-up|20|||
129507722|NCT01956240|466147617|FG000|Overall Study|Adverse Event|17|||
129507723|NCT01956240|466147618|FG001|Overall Study|Adverse Event|4|||
129507724|NCT00600028|466147621|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
129507725|NCT00600028|466147622|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
129507726|NCT00600028|466147621|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
129507727|NCT00600028|466147622|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
129507728|NCT00600028|466147621|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
129507729|NCT00600028|466147622|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
129507730|NCT03172481|466147626|FG000|Double-blind|Withdrawal by Subject|1|||
129507731|NCT03172481|466147627|FG001|Double-blind|Withdrawal by Subject|0|||
129507732|NCT02168803|466147632|FG000|Overall Study|Lost to Follow-up|1|||
129507733|NCT02168803|466147633|FG001|Overall Study|Lost to Follow-up|0|||
129507734|NCT02168803|466147634|FG002|Overall Study|Lost to Follow-up|1|||
129507735|NCT02168803|466147632|FG000|Overall Study|Withdrawal by Subject|1|||
129507736|NCT02168803|466147633|FG001|Overall Study|Withdrawal by Subject|1|||
129982685|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
129982686|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
129982687|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
129982688|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
129982689|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
129982690|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
129982691|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
129982692|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982693|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982694|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982695|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982696|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982697|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982698|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982699|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982700|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982701|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982702|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982703|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982704|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
129982705|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
129982706|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982707|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982708|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982709|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982710|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982711|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982712|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982713|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982714|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982715|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982716|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982717|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
129982718|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982719|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
129982720|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982721|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982722|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982723|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982724|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982725|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982726|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982727|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982728|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982729|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
129982730|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
129982731|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
129982732|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
129982733|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
129982734|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
129982735|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
129982736|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
129982737|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
129982738|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
129982739|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
129982740|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
129982741|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
129982742|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
129982743|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
129982744|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
129982745|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
129982746|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
129982747|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
129507737|NCT02168803|466147634|FG002|Overall Study|Withdrawal by Subject|2|||
129507738|NCT02168803|466147632|FG000|Overall Study|Physician Decision|0|||
129507739|NCT02168803|466147633|FG001|Overall Study|Physician Decision|1|||
129507740|NCT02168803|466147634|FG002|Overall Study|Physician Decision|0|||
129507741|NCT02168803|466147632|FG000|Overall Study|Adverse Event|0|||
129507742|NCT02168803|466147633|FG001|Overall Study|Adverse Event|1|||
129507743|NCT02168803|466147634|FG002|Overall Study|Adverse Event|1|||
129507744|NCT02168803|466147632|FG000|Overall Study|Death|0|||
129507745|NCT02168803|466147633|FG001|Overall Study|Death|0|||
129507746|NCT02168803|466147634|FG002|Overall Study|Death|1|||
129507747|NCT02168803|466147632|FG000|Overall Study|Sponsor Decision|0|||
129507748|NCT02168803|466147633|FG001|Overall Study|Sponsor Decision|0|||
129507749|NCT02168803|466147634|FG002|Overall Study|Sponsor Decision|1|||
129507750|NCT01114373|466147639|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
129507751|NCT01114373|466147640|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
129507752|NCT01114373|466147639|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
129507753|NCT01114373|466147640|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
129507754|NCT01114373|466147639|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
129507755|NCT01114373|466147640|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
129507756|NCT01114373|466147639|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
129507757|NCT01114373|466147640|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
129507758|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
129507759|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
129507760|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
129507761|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
129507762|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
129507763|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
129507764|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
129507765|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
129507766|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
129507767|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
129507768|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
129507769|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
129507770|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
129507771|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
129507772|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
129507773|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129507774|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129507775|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
129507776|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
129507777|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
129507778|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
129507779|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
129507780|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
129507781|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
129507782|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
129507783|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
129507784|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
129507785|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
129507786|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
129507787|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
129507788|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
129507789|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129507790|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129507791|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129507792|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129507793|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
129507794|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
129507795|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
129507796|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
129507797|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
129507798|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
129507799|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
129982748|NCT02663518|467900594|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129507800|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
129507801|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
129507802|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
129507803|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
129507804|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
129507805|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
129507806|NCT03444870|466147643|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
129507807|NCT03444870|466147644|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
129507808|NCT03444870|466147645|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
129507809|NCT03444870|466147646|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
129507810|NCT03444870|466147647|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
129507811|NCT03444870|466147648|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
129507812|NCT03444870|466147643|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129507813|NCT03444870|466147644|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129507814|NCT03444870|466147645|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129507815|NCT03444870|466147646|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
129507816|NCT03444870|466147647|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
129507817|NCT03444870|466147648|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
129507818|NCT03444870|466147643|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
129507819|NCT03444870|466147644|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
129507820|NCT03444870|466147645|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
129507821|NCT03444870|466147646|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
129507822|NCT03444870|466147647|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
129507823|NCT03444870|466147648|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
129507824|NCT03444870|466147643|FG000|Open-Label Extension (OLE) Period|Death|0|||
129507825|NCT03444870|466147644|FG001|Open-Label Extension (OLE) Period|Death|0|||
129507826|NCT03444870|466147645|FG002|Open-Label Extension (OLE) Period|Death|0|||
129507827|NCT03444870|466147646|FG003|Open-Label Extension (OLE) Period|Death|0|||
129507828|NCT03444870|466147647|FG004|Open-Label Extension (OLE) Period|Death|1|||
129507829|NCT03444870|466147648|FG005|Open-Label Extension (OLE) Period|Death|0|||
129507830|NCT02310906|466147651|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
129507831|NCT02310906|466147652|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
129507832|NCT02310906|466147653|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
129507833|NCT02310906|466147654|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
129507834|NCT02310906|466147651|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
129507835|NCT02310906|466147652|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
129507836|NCT02310906|466147653|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
129507837|NCT02310906|466147654|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
129507838|NCT02310906|466147651|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
129507839|NCT02310906|466147652|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
129507840|NCT02310906|466147653|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
129507841|NCT02310906|466147654|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
129507842|NCT02310906|466147651|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
129507843|NCT02310906|466147652|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
129507844|NCT02310906|466147653|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
129507845|NCT02310906|466147654|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
129507846|NCT00098020|466147658|FG000|Overall Study|Adverse Event|2|||
129507847|NCT00098020|466147658|FG000|Overall Study|Lost to Follow-up|1|||
129507848|NCT00098020|466147658|FG000|Overall Study|elevated liver enzymes|1|||
129507849|NCT00098020|466147658|FG000|Overall Study|Low urine PCR|1|||
129507850|NCT00098020|466147658|FG000|Overall Study|Low epidermal growth factor receptor|1|||
129507851|NCT01840228|466147662|FG000|Overall Study|Lost to Follow-up|1|||
129507852|NCT01840228|466147663|FG001|Overall Study|Lost to Follow-up|1|||
129507853|NCT00712933|466147666|FG000|Overall Study|Adverse Event|69|||
129507854|NCT00712933|466147666|FG000|Overall Study|Lack of Efficacy|6|||
129507855|NCT00712933|466147666|FG000|Overall Study|Lost to Follow-up|22|||
129507856|NCT00712933|466147666|FG000|Overall Study|Non-compliance with study drug|13|||
129982749|NCT02663518|467900595|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982750|NCT02663518|467900596|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982751|NCT02663518|467900597|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982752|NCT02663518|467900598|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982753|NCT02663518|467900599|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982754|NCT02663518|467900600|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982755|NCT02663518|467900601|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982756|NCT02663518|467900602|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982757|NCT02663518|467900603|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129507857|NCT00712933|466147666|FG000|Overall Study|Other Pregnancy|37|||
129507858|NCT00712933|466147666|FG000|Overall Study|Sponsor decision|14|||
129507859|NCT00712933|466147666|FG000|Overall Study|Withdrew consent|4|||
129982758|NCT02663518|467900604|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129507860|NCT00712933|466147666|FG000|Overall Study|Hip replacement surgery|1|||
129507861|NCT00712933|466147666|FG000|Overall Study|Involved in Clinical research|3|||
129507862|NCT00712933|466147666|FG000|Overall Study|Participant hospitalized|1|||
129507863|NCT00712933|466147666|FG000|Overall Study|Participant travelled overseas|2|||
129507864|NCT00712933|466147666|FG000|Overall Study|Death of patient|1|||
129507865|NCT00712933|466147666|FG000|Overall Study|Other Physician decision|1|||
129507866|NCT00712933|466147666|FG000|Overall Study|Not committed to contraception|1|||
129507867|NCT00712933|466147666|FG000|Overall Study|Participant received medication|1|||
129507868|NCT00712933|466147666|FG000|Overall Study|Physician Decision|36|||
129507869|NCT00712933|466147666|FG000|Overall Study|Protocol Violation|4|||
129507870|NCT00712933|466147666|FG000|Overall Study|Withdrawal by Subject|151|||
129507871|NCT01295580|466147669|FG000|Overall Study|Protocol Violation|4|||
129507872|NCT01295580|466147670|FG001|Overall Study|Protocol Violation|2|||
129507873|NCT01295580|466147669|FG000|Overall Study|Withdrawal by Subject|1|||
129507874|NCT01295580|466147670|FG001|Overall Study|Withdrawal by Subject|4|||
129507875|NCT01295580|466147669|FG000|Overall Study|Adverse Event|2|||
129507876|NCT01295580|466147670|FG001|Overall Study|Adverse Event|1|||
129507877|NCT01295580|466147669|FG000|Overall Study|Lost to Follow-up|1|||
129507878|NCT01295580|466147670|FG001|Overall Study|Lost to Follow-up|0|||
129507879|NCT01295580|466147669|FG000|Overall Study|Lack of Efficacy|1|||
129507880|NCT01295580|466147670|FG001|Overall Study|Lack of Efficacy|0|||
129507881|NCT01295580|466147669|FG000|Overall Study|Other: inconvenience|1|||
129507882|NCT01295580|466147670|FG001|Overall Study|Other: inconvenience|0|||
129507883|NCT01295580|466147669|FG000|Overall Study|Other: family objection|0|||
129507884|NCT01295580|466147670|FG001|Overall Study|Other: family objection|1|||
129507885|NCT02022033|466147676|FG000|Overall Study|Physician Decision|1|||
129507886|NCT01360762|466147677|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
129507887|NCT01360762|466147677|FG000|Main Study Period (12-month Treatment)|Death|5|||
129507888|NCT01360762|466147677|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
129507889|NCT01360762|466147677|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
129507890|NCT01360762|466147677|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
129507891|NCT01360762|466147677|FG000|Whole Study Period|Lost to Follow-up|10|||
129507892|NCT01360762|466147677|FG000|Whole Study Period|Death|7|||
129507893|NCT01360762|466147677|FG000|Whole Study Period|Patient relapsed|18|||
129507894|NCT01360762|466147677|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
129507895|NCT01103778|466147678|FG000|Overall Study|Lost to Follow-up|1|||
129507896|NCT01103778|466147678|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
129507897|NCT01103778|466147678|FG000|Overall Study|Screen failure|1|||
129507898|NCT04724733|466147679|FG000|Overall Study|Lost to Follow-up|1|||
129507899|NCT04724733|466147680|FG001|Overall Study|Lost to Follow-up|1|||
129507900|NCT04724733|466147681|FG002|Overall Study|Lost to Follow-up|1|||
129507901|NCT00844649|466147682|FG000|Overall Study|Progressive Disease|196|||
129507902|NCT00844649|466147683|FG001|Overall Study|Progressive Disease|245|||
129507903|NCT00844649|466147682|FG000|Overall Study|Adverse Event|128|||
129507904|NCT00844649|466147683|FG001|Overall Study|Adverse Event|73|||
129507905|NCT00844649|466147682|FG000|Overall Study|Physician Decision|25|||
129507906|NCT00844649|466147683|FG001|Overall Study|Physician Decision|18|||
129507907|NCT00844649|466147682|FG000|Overall Study|Protocol Violation|10|||
129507908|NCT00844649|466147683|FG001|Overall Study|Protocol Violation|6|||
129507909|NCT00844649|466147682|FG000|Overall Study|Withdrawal by Subject|28|||
129507910|NCT00844649|466147683|FG001|Overall Study|Withdrawal by Subject|39|||
129507911|NCT00844649|466147682|FG000|Overall Study|Other|7|||
129507912|NCT00844649|466147683|FG001|Overall Study|Other|10|||
129507913|NCT00844649|466147682|FG000|Overall Study|Withdrew prior to starting treatment|11|||
129507914|NCT00844649|466147683|FG001|Overall Study|Withdrew prior to starting treatment|27|||
129507915|NCT00664209|466147684|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
129507916|NCT00664209|466147684|FG000|Study Treatment Period|Physician Decision|4|||
129507917|NCT00664209|466147684|FG000|Study Treatment Period|Withdrawal by Subject|2|||
129507918|NCT00065442|466147695|FG000|Overall Study|Lost to Follow-up|1|||
129507919|NCT00065442|466147696|FG001|Overall Study|Lost to Follow-up|1|||
129507920|NCT00065442|466147695|FG000|Overall Study|Death|121|||
129982759|NCT02663518|467900605|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982760|NCT02663518|467900606|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
129982761|NCT02663518|467900607|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
129982762|NCT03896152|467900613|FG000|Overall Study|Patient/guardian decision|1|||
129507921|NCT00065442|466147696|FG001|Overall Study|Death|210|||
129507922|NCT00065442|466147695|FG000|Overall Study|Withdrawal by Subject|3|||
129507923|NCT00065442|466147696|FG001|Overall Study|Withdrawal by Subject|9|||
129507924|NCT01594333|466147697|FG000|Overall Study|Death|96|||
129507925|NCT01594333|466147698|FG001|Overall Study|Death|83|||
129507926|NCT01594333|466147697|FG000|Overall Study|Lost to Follow-up|5|||
129507927|NCT01594333|466147698|FG001|Overall Study|Lost to Follow-up|5|||
129507928|NCT01594333|466147697|FG000|Overall Study|Withdrawal by Subject|60|||
129507929|NCT01594333|466147698|FG001|Overall Study|Withdrawal by Subject|63|||
129507930|NCT01397448|466147701|FG000|Overall Study|Adverse Event|4|||
129507931|NCT01397448|466147702|FG001|Overall Study|Adverse Event|4|||
129507932|NCT01397448|466147703|FG002|Overall Study|Adverse Event|6|||
129507933|NCT01397448|466147701|FG000|Overall Study|Withdrawal by Subject|4|||
129507934|NCT01397448|466147702|FG001|Overall Study|Withdrawal by Subject|4|||
129982763|NCT03896152|467900614|FG001|Overall Study|Patient/guardian decision|1|||
129507935|NCT01397448|466147703|FG002|Overall Study|Withdrawal by Subject|3|||
129507936|NCT01397448|466147701|FG000|Overall Study|Lack of Efficacy|2|||
129507937|NCT01397448|466147702|FG001|Overall Study|Lack of Efficacy|0|||
129507938|NCT01397448|466147703|FG002|Overall Study|Lack of Efficacy|5|||
129507939|NCT01397448|466147701|FG000|Overall Study|Other|8|||
129507940|NCT01397448|466147702|FG001|Overall Study|Other|7|||
129507941|NCT01397448|466147703|FG002|Overall Study|Other|4|||
129507942|NCT02180217|466147706|FG000|Overall Study|Adverse Event|3|||
129507943|NCT02180217|466147707|FG001|Overall Study|Adverse Event|2|||
129507944|NCT02180217|466147708|FG002|Overall Study|Adverse Event|22|||
129507945|NCT02180217|466147706|FG000|Overall Study|Death|1|||
129507946|NCT02180217|466147707|FG001|Overall Study|Death|1|||
129507947|NCT02180217|466147708|FG002|Overall Study|Death|0|||
129507948|NCT02180217|466147706|FG000|Overall Study|Withdrawal by Subject|1|||
129507949|NCT02180217|466147707|FG001|Overall Study|Withdrawal by Subject|1|||
129507950|NCT02180217|466147708|FG002|Overall Study|Withdrawal by Subject|4|||
129507951|NCT02180217|466147706|FG000|Overall Study|Subject/Guardian decision|5|||
129507952|NCT02180217|466147707|FG001|Overall Study|Subject/Guardian decision|3|||
129507953|NCT02180217|466147708|FG002|Overall Study|Subject/Guardian decision|6|||
129507954|NCT02180217|466147706|FG000|Overall Study|Physician Decision|1|||
129507955|NCT02180217|466147707|FG001|Overall Study|Physician Decision|1|||
129507956|NCT02180217|466147708|FG002|Overall Study|Physician Decision|6|||
129507957|NCT02180217|466147706|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129507958|NCT02180217|466147707|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129507959|NCT02180217|466147708|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
129507960|NCT00302718|466147713|FG000|Overall Study|Participant left the hospital|1|||
129507961|NCT00302718|466147714|FG001|Overall Study|Participant left the hospital|0|||
129507962|NCT00302718|466147715|FG002|Overall Study|Participant left the hospital|0|||
129507963|NCT00302718|466147716|FG003|Overall Study|Participant left the hospital|1|||
129507964|NCT00302718|466147713|FG000|Overall Study|Withdrawal by Subject|0|||
129507965|NCT00302718|466147714|FG001|Overall Study|Withdrawal by Subject|1|||
129507966|NCT00302718|466147715|FG002|Overall Study|Withdrawal by Subject|0|||
129507967|NCT00302718|466147716|FG003|Overall Study|Withdrawal by Subject|0|||
129507968|NCT00302718|466147713|FG000|Overall Study|Participant left primary care setting|0|||
129507969|NCT00302718|466147714|FG001|Overall Study|Participant left primary care setting|0|||
129507970|NCT00302718|466147715|FG002|Overall Study|Participant left primary care setting|2|||
129507971|NCT00302718|466147716|FG003|Overall Study|Participant left primary care setting|1|||
129507972|NCT00738374|466147717|FG000|Induction Treatment Phase|Adverse Event|14|||
129507973|NCT00738374|466147718|FG001|Induction Treatment Phase|Adverse Event|0|||
129507974|NCT00738374|466147719|FG002|Induction Treatment Phase|Adverse Event|0|||
129507975|NCT00738374|466147720|FG003|Induction Treatment Phase|Adverse Event|0|||
129507976|NCT00738374|466147717|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
129507977|NCT00738374|466147718|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
129507978|NCT00738374|466147719|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
129507979|NCT00738374|466147720|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
129507980|NCT00738374|466147717|FG000|Induction Treatment Phase|Physician Decision|2|||
129507981|NCT00738374|466147718|FG001|Induction Treatment Phase|Physician Decision|0|||
129507982|NCT00738374|466147719|FG002|Induction Treatment Phase|Physician Decision|0|||
129507983|NCT00738374|466147720|FG003|Induction Treatment Phase|Physician Decision|0|||
129507984|NCT00738374|466147717|FG000|Induction Treatment Phase|Protocol Violation|2|||
129507985|NCT00738374|466147718|FG001|Induction Treatment Phase|Protocol Violation|0|||
129507986|NCT00738374|466147719|FG002|Induction Treatment Phase|Protocol Violation|0|||
129507987|NCT00738374|466147720|FG003|Induction Treatment Phase|Protocol Violation|0|||
129507988|NCT00738374|466147717|FG000|Induction Treatment Phase|Non-compliance|1|||
129507989|NCT00738374|466147718|FG001|Induction Treatment Phase|Non-compliance|0|||
129507990|NCT00738374|466147719|FG002|Induction Treatment Phase|Non-compliance|0|||
129507991|NCT00738374|466147720|FG003|Induction Treatment Phase|Non-compliance|0|||
129507992|NCT00738374|466147717|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
129507993|NCT00738374|466147718|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
129982764|NCT03896152|467900613|FG000|Overall Study|Adverse Event|0|||
129507994|NCT00738374|466147719|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
129507995|NCT00738374|466147720|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
129507996|NCT00738374|466147717|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
129507997|NCT00738374|466147718|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
129507998|NCT00738374|466147719|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
129507999|NCT00738374|466147720|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
129508000|NCT00738374|466147717|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
129508001|NCT00738374|466147718|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
129508002|NCT00738374|466147719|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
129508003|NCT00738374|466147720|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
129982765|NCT03896152|467900614|FG001|Overall Study|Adverse Event|1|||
129508004|NCT00738374|466147717|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
129508005|NCT00738374|466147718|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
129508006|NCT00738374|466147719|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
129508007|NCT00738374|466147720|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
129508008|NCT00738374|466147717|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
129508009|NCT00738374|466147718|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
129508010|NCT00738374|466147719|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
129508011|NCT00738374|466147720|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
129508012|NCT00738374|466147717|FG000|Maintenance Treatment/Observation Phase|Other|0|||
129508013|NCT00738374|466147718|FG001|Maintenance Treatment/Observation Phase|Other|1|||
129508014|NCT00738374|466147719|FG002|Maintenance Treatment/Observation Phase|Other|0|||
129508015|NCT00738374|466147720|FG003|Maintenance Treatment/Observation Phase|Other|0|||
129508016|NCT01969799|466147721|FG000|Overall Study|Adverse Event|0|||
129508017|NCT01969799|466147722|FG001|Overall Study|Adverse Event|1|||
129508018|NCT01969799|466147721|FG000|Overall Study|Death|16|||
129508019|NCT01969799|466147722|FG001|Overall Study|Death|11|||
129508020|NCT01969799|466147721|FG000|Overall Study|Lost to Follow-up|0|||
129508021|NCT01969799|466147722|FG001|Overall Study|Lost to Follow-up|2|||
129508022|NCT01969799|466147721|FG000|Overall Study|Physician Decision|1|||
129508023|NCT01969799|466147722|FG001|Overall Study|Physician Decision|0|||
129508024|NCT00995670|466147723|FG000|Overall Study|Failed arterial cannulation|1|||
129508025|NCT00995670|466147724|FG001|Overall Study|Failed arterial cannulation|0|||
129508026|NCT00995670|466147725|FG002|Overall Study|Failed arterial cannulation|3|||
129508027|NCT03519516|466147727|FG000|Overall Study|Adverse Event|0|||
129508028|NCT03519516|466147728|FG001|Overall Study|Adverse Event|1|||
129508029|NCT01935336|466147729|FG000|Overall Study|Adverse Event|1|||
129508030|NCT01935336|466147730|FG001|Overall Study|Adverse Event|0|||
129508031|NCT01935336|466147731|FG002|Overall Study|Adverse Event|0|||
129508032|NCT01935336|466147732|FG003|Overall Study|Adverse Event|0|||
129508033|NCT01935336|466147729|FG000|Overall Study|Progressive disease|5|||
129508034|NCT01935336|466147730|FG001|Overall Study|Progressive disease|3|||
129508035|NCT01935336|466147731|FG002|Overall Study|Progressive disease|47|||
129508036|NCT01935336|466147732|FG003|Overall Study|Progressive disease|66|||
129508037|NCT01255306|466149282|FG000|Overall Study|Physician Decision|1|||
129508038|NCT01255306|466149283|FG001|Overall Study|Physician Decision|1|||
129508039|NCT01283997|466149284|FG000|Overall Study|Physician Decision|8|||
129508040|NCT01283997|466149285|FG001|Overall Study|Physician Decision|10|||
129508041|NCT01283997|466149284|FG000|Overall Study|Withdrawal by Subject|3|||
129508042|NCT01283997|466149285|FG001|Overall Study|Withdrawal by Subject|2|||
129508043|NCT01283997|466149284|FG000|Overall Study|Physically unable to continue|0|||
129508044|NCT01283997|466149285|FG001|Overall Study|Physically unable to continue|1|||
129508045|NCT01283997|466149284|FG000|Overall Study|Progressive disease|1|||
129508046|NCT01283997|466149285|FG001|Overall Study|Progressive disease|0|||
129508047|NCT01283997|466149284|FG000|Overall Study|Other|4|||
129508048|NCT01283997|466149285|FG001|Overall Study|Other|4|||
129508049|NCT02017899|466149286|FG000|Overall Study|Withdrawal by Subject|0|||
129508050|NCT02017899|466149287|FG001|Overall Study|Withdrawal by Subject|0|||
129508051|NCT02017899|466149288|FG002|Overall Study|Withdrawal by Subject|0|||
129508052|NCT02017899|466149289|FG003|Overall Study|Withdrawal by Subject|1|||
129508053|NCT02017899|466149290|FG004|Overall Study|Withdrawal by Subject|1|||
129508054|NCT02017899|466149291|FG005|Overall Study|Withdrawal by Subject|0|||
129508055|NCT01677624|466149295|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
129508056|NCT00804843|466149296|FG000|Overall Study|Protocol Violation|1|||
129508057|NCT00804843|466149297|FG001|Overall Study|Protocol Violation|0|||
129508058|NCT00804843|466149296|FG000|Overall Study|Adverse Event|8|||
129508059|NCT00804843|466149297|FG001|Overall Study|Adverse Event|5|||
129508060|NCT00804843|466149296|FG000|Overall Study|Withdrawal by Subject|1|||
129508061|NCT00804843|466149297|FG001|Overall Study|Withdrawal by Subject|2|||
129508062|NCT00884221|466149302|FG000|Overall Study|Withdrawal by Subject|0|||
129982766|NCT03896152|467900613|FG000|Overall Study|Physician Decision|1|||
129508063|NCT00884221|466149303|FG001|Overall Study|Withdrawal by Subject|3|||
129508064|NCT00884221|466149302|FG000|Overall Study|Adverse Event|6|||
129508065|NCT00884221|466149303|FG001|Overall Study|Adverse Event|3|||
129508066|NCT00884221|466149302|FG000|Overall Study|Protocol Violation|16|||
129508067|NCT00884221|466149303|FG001|Overall Study|Protocol Violation|13|||
129982767|NCT03896152|467900614|FG001|Overall Study|Physician Decision|0|||
129982768|NCT03896152|467900613|FG000|Overall Study|Technical problems|1|||
129508068|NCT00884221|466149302|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
129508069|NCT00884221|466149303|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
129508070|NCT01975246|466149308|FG000|Overall Study|Adverse Event|2|||
129508071|NCT01975246|466149309|FG001|Overall Study|Adverse Event|1|||
129508072|NCT01975246|466149308|FG000|Overall Study|Lack of Efficacy|1|||
129508073|NCT01975246|466149309|FG001|Overall Study|Lack of Efficacy|0|||
129508074|NCT01975246|466149308|FG000|Overall Study|Protocol Violation|1|||
129982769|NCT03896152|467900614|FG001|Overall Study|Technical problems|0|||
129982770|NCT00436852|467900615|FG000|Overall Study|Death|23|||
129508075|NCT01975246|466149309|FG001|Overall Study|Protocol Violation|0|||
129508076|NCT01975246|466149308|FG000|Overall Study|Other than stated|0|||
129508077|NCT01975246|466149309|FG001|Overall Study|Other than stated|1|||
129508078|NCT01263093|466149310|FG000|Washout|Physician Decision|1|||
129508079|NCT01263093|466149311|FG001|Washout|Physician Decision|0|||
129508080|NCT01263093|466149310|FG000|Period 2|Adverse Event|1|||
129508081|NCT01263093|466149311|FG001|Period 2|Adverse Event|0|||
129508082|NCT00424346|466149312|FG000|Core Study|Adverse Event|5|||
129508083|NCT00424346|466149313|FG001|Core Study|Adverse Event|3|||
129508084|NCT00424346|466149314|FG002|Core Study|Adverse Event|1|||
129508085|NCT00424346|466149315|FG003|Core Study|Adverse Event|1|||
129508086|NCT00424346|466149312|FG000|Core Study|Abnormal Laboratory Values|0|||
129508087|NCT00424346|466149313|FG001|Core Study|Abnormal Laboratory Values|1|||
129508088|NCT00424346|466149314|FG002|Core Study|Abnormal Laboratory Values|0|||
129508089|NCT00424346|466149315|FG003|Core Study|Abnormal Laboratory Values|0|||
129508090|NCT00424346|466149312|FG000|Core Study|Lack of Efficacy|1|||
129508091|NCT00424346|466149313|FG001|Core Study|Lack of Efficacy|3|||
129508092|NCT00424346|466149314|FG002|Core Study|Lack of Efficacy|0|||
129508093|NCT00424346|466149315|FG003|Core Study|Lack of Efficacy|4|||
129508094|NCT00424346|466149312|FG000|Core Study|Withdrawal by Subject|1|||
129508095|NCT00424346|466149313|FG001|Core Study|Withdrawal by Subject|0|||
129508096|NCT00424346|466149314|FG002|Core Study|Withdrawal by Subject|0|||
129508097|NCT00424346|466149315|FG003|Core Study|Withdrawal by Subject|2|||
129508098|NCT00424346|466149312|FG000|Core Study|Lost to Follow-up|1|||
129508099|NCT00424346|466149313|FG001|Core Study|Lost to Follow-up|1|||
129508100|NCT00424346|466149314|FG002|Core Study|Lost to Follow-up|0|||
129508101|NCT00424346|466149315|FG003|Core Study|Lost to Follow-up|0|||
129508102|NCT00424346|466149312|FG000|Core Study|Administrative Problems|1|||
129508103|NCT00424346|466149313|FG001|Core Study|Administrative Problems|0|||
129508104|NCT00424346|466149314|FG002|Core Study|Administrative Problems|1|||
129508105|NCT00424346|466149315|FG003|Core Study|Administrative Problems|0|||
129508106|NCT00424346|466149312|FG000|Core Study|Protocol Violation|0|||
129508107|NCT00424346|466149313|FG001|Core Study|Protocol Violation|0|||
129508108|NCT00424346|466149314|FG002|Core Study|Protocol Violation|2|||
129508109|NCT00424346|466149315|FG003|Core Study|Protocol Violation|0|||
129508110|NCT00424346|466149312|FG000|Extension Phase|Adverse Event|0|||
129508111|NCT00424346|466149313|FG001|Extension Phase|Adverse Event|9|||
129508112|NCT00424346|466149314|FG002|Extension Phase|Adverse Event|5|||
129508113|NCT00424346|466149315|FG003|Extension Phase|Adverse Event|4|||
129508114|NCT00424346|466149312|FG000|Extension Phase|Lack of Efficacy|0|||
129508115|NCT00424346|466149313|FG001|Extension Phase|Lack of Efficacy|16|||
129508116|NCT00424346|466149314|FG002|Extension Phase|Lack of Efficacy|14|||
129508117|NCT00424346|466149315|FG003|Extension Phase|Lack of Efficacy|11|||
129508118|NCT00424346|466149312|FG000|Extension Phase|Withdrawal by Subject|0|||
129508119|NCT00424346|466149313|FG001|Extension Phase|Withdrawal by Subject|5|||
129508120|NCT00424346|466149314|FG002|Extension Phase|Withdrawal by Subject|3|||
129508121|NCT00424346|466149315|FG003|Extension Phase|Withdrawal by Subject|4|||
129508122|NCT00424346|466149312|FG000|Extension Phase|Lost to Follow-up|0|||
129508123|NCT00424346|466149313|FG001|Extension Phase|Lost to Follow-up|2|||
129508124|NCT00424346|466149314|FG002|Extension Phase|Lost to Follow-up|0|||
129508125|NCT00424346|466149315|FG003|Extension Phase|Lost to Follow-up|0|||
129508126|NCT00424346|466149312|FG000|Extension Phase|Administrative Problems|0|||
129508127|NCT00424346|466149313|FG001|Extension Phase|Administrative Problems|69|||
129508128|NCT00424346|466149314|FG002|Extension Phase|Administrative Problems|32|||
129508129|NCT00424346|466149315|FG003|Extension Phase|Administrative Problems|35|||
129508130|NCT00424346|466149312|FG000|Extension Phase|Death|0|||
129508131|NCT00424346|466149313|FG001|Extension Phase|Death|0|||
129508132|NCT00424346|466149314|FG002|Extension Phase|Death|0|||
129982771|NCT00436852|467900616|FG001|Overall Study|Death|34|||
129982772|NCT00436852|467900615|FG000|Overall Study|Lack of Efficacy|9|||
129982773|NCT00436852|467900616|FG001|Overall Study|Lack of Efficacy|7|||
129982774|NCT00436852|467900615|FG000|Overall Study|Withdrawal by Subject|2|||
129982775|NCT00436852|467900616|FG001|Overall Study|Withdrawal by Subject|4|||
129982776|NCT00436852|467900615|FG000|Overall Study|Ineligible|1|||
129982777|NCT00436852|467900616|FG001|Overall Study|Ineligible|0|||
129982778|NCT00943852|467900617|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982779|NCT00943852|467900618|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982780|NCT00943852|467900619|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129508133|NCT00424346|466149315|FG003|Extension Phase|Death|1|||
129508134|NCT00424346|466149312|FG000|Extension Phase|Protocol Violation|0|||
129508135|NCT00424346|466149313|FG001|Extension Phase|Protocol Violation|1|||
129508136|NCT00424346|466149314|FG002|Extension Phase|Protocol Violation|1|||
129508137|NCT00424346|466149315|FG003|Extension Phase|Protocol Violation|0|||
129508138|NCT01827319|466149316|FG000|Overall Study|Lost to Follow-up|3|||
129508139|NCT00571519|466149317|FG000|Overall Study|Subject withdrew consent|0|||
129508140|NCT00571519|466149318|FG001|Overall Study|Subject withdrew consent|1|||
129508141|NCT00571519|466149319|FG002|Overall Study|Subject withdrew consent|0|||
129508142|NCT00571519|466149320|FG003|Overall Study|Subject withdrew consent|2|||
129508143|NCT00571519|466149321|FG004|Overall Study|Subject withdrew consent|1|||
129508144|NCT00571519|466149322|FG005|Overall Study|Subject withdrew consent|1|||
129508145|NCT00571519|466149323|FG006|Overall Study|Subject withdrew consent|2|||
129508146|NCT00571519|466149317|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
129508147|NCT00571519|466149318|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
129508148|NCT00571519|466149319|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
129508149|NCT00571519|466149320|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
129508150|NCT00571519|466149321|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
129508151|NCT00571519|466149322|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
129508152|NCT00571519|466149323|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
129508153|NCT00571519|466149317|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
129508154|NCT00571519|466149318|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
129508155|NCT00571519|466149319|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
129508156|NCT00571519|466149320|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
129508157|NCT00571519|466149321|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
129508158|NCT00571519|466149322|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
129508159|NCT00571519|466149323|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
129508160|NCT00571519|466149317|FG000|Overall Study|Termination of study by Sponsor|2|||
129508161|NCT00571519|466149318|FG001|Overall Study|Termination of study by Sponsor|7|||
129508162|NCT00571519|466149319|FG002|Overall Study|Termination of study by Sponsor|10|||
129508163|NCT00571519|466149320|FG003|Overall Study|Termination of study by Sponsor|24|||
129508164|NCT00571519|466149321|FG004|Overall Study|Termination of study by Sponsor|8|||
129508165|NCT00571519|466149322|FG005|Overall Study|Termination of study by Sponsor|9|||
129508166|NCT00571519|466149323|FG006|Overall Study|Termination of study by Sponsor|22|||
129508167|NCT00571519|466149317|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129508168|NCT00571519|466149318|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129508169|NCT00571519|466149319|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
129508170|NCT00571519|466149320|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129508171|NCT00571519|466149321|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129508172|NCT00571519|466149322|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129508173|NCT00571519|466149323|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
129508174|NCT03947255|466149326|FG000|Overall Study|Study Closure by Sponsor|2|||
129508175|NCT03947255|466149327|FG001|Overall Study|Study Closure by Sponsor|2|||
129508176|NCT03947255|466149326|FG000|Overall Study|Withdrawal by Subject|2|||
129508177|NCT03947255|466149327|FG001|Overall Study|Withdrawal by Subject|2|||
129508178|NCT03947255|466149326|FG000|Overall Study|Lost to Follow-up|2|||
129508179|NCT03947255|466149327|FG001|Overall Study|Lost to Follow-up|0|||
129508180|NCT03947255|466149326|FG000|Overall Study|Death|0|||
129508181|NCT03947255|466149327|FG001|Overall Study|Death|2|||
129508182|NCT02499575|466149328|FG000|Overall Study|Protocol Violation|0|||
129508183|NCT02499575|466149329|FG001|Overall Study|Protocol Violation|1|||
129508184|NCT02658968|466149330|FG000|Received Rituximab|Adverse Event|0|||
129508185|NCT02658968|466149331|FG001|Received Rituximab|Adverse Event|0|||
129508186|NCT02658968|466149332|FG002|Received Rituximab|Adverse Event|0|||
129508187|NCT02658968|466149333|FG003|Received Rituximab|Adverse Event|0|||
129508188|NCT02658968|466149334|FG004|Received Rituximab|Adverse Event|1|||
129508189|NCT02658968|466149330|FG000|Received Rituximab|Progressive disease|0|||
129508190|NCT02658968|466149331|FG001|Received Rituximab|Progressive disease|0|||
129508191|NCT02658968|466149332|FG002|Received Rituximab|Progressive disease|0|||
129508192|NCT02658968|466149333|FG003|Received Rituximab|Progressive disease|0|||
129508193|NCT02658968|466149334|FG004|Received Rituximab|Progressive disease|1|||
129508194|NCT02658968|466149330|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
129508195|NCT02658968|466149331|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
129508196|NCT02658968|466149332|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
129508197|NCT02658968|466149333|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
129508198|NCT02658968|466149334|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
129508199|NCT02658968|466149330|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
129508200|NCT02658968|466149331|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
129508201|NCT02658968|466149332|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
129508202|NCT02658968|466149333|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
129508203|NCT02658968|466149334|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
129508204|NCT02658968|466149330|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
129508205|NCT02658968|466149331|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
129508206|NCT02658968|466149332|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
129508207|NCT02658968|466149333|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
129508208|NCT02658968|466149334|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
129508209|NCT02658968|466149330|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
129508210|NCT02658968|466149331|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
129508211|NCT02658968|466149332|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
129508212|NCT02658968|466149333|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
129508213|NCT02658968|466149334|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
129508214|NCT02658968|466149330|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
129508215|NCT02658968|466149331|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
129508216|NCT02658968|466149332|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
129508217|NCT02658968|466149333|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
129508218|NCT02658968|466149334|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
129508219|NCT02716194|466149342|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
129508220|NCT02716194|466149343|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
129508221|NCT02716194|466149344|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
129508222|NCT01957709|466149350|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
129508223|NCT01061736|466149351|FG000|Overall Study|Dose regimen not selected|0|||
129508224|NCT01061736|466149352|FG001|Overall Study|Dose regimen not selected|0|||
129508225|NCT01061736|466149353|FG002|Overall Study|Dose regimen not selected|0|||
129508226|NCT01061736|466149354|FG003|Overall Study|Dose regimen not selected|0|||
129508227|NCT01061736|466149355|FG004|Overall Study|Dose regimen not selected|0|||
129508228|NCT01061736|466149356|FG005|Overall Study|Dose regimen not selected|0|||
129508229|NCT01061736|466149357|FG006|Overall Study|Dose regimen not selected|79|||
129508230|NCT01061736|466149358|FG007|Overall Study|Dose regimen not selected|0|||
129508231|NCT01061736|466149359|FG008|Overall Study|Dose regimen not selected|0|||
129508232|NCT01061736|466149360|FG009|Overall Study|Dose regimen not selected|0|||
129508233|NCT01061736|466149351|FG000|Overall Study|Adverse Event|13|||
129508234|NCT01061736|466149352|FG001|Overall Study|Adverse Event|1|||
129508235|NCT01061736|466149353|FG002|Overall Study|Adverse Event|3|||
129508236|NCT01061736|466149354|FG003|Overall Study|Adverse Event|2|||
129508237|NCT01061736|466149355|FG004|Overall Study|Adverse Event|4|||
129508238|NCT01061736|466149356|FG005|Overall Study|Adverse Event|1|||
129508239|NCT01061736|466149357|FG006|Overall Study|Adverse Event|4|||
129508240|NCT01061736|466149358|FG007|Overall Study|Adverse Event|63|||
129508241|NCT01061736|466149359|FG008|Overall Study|Adverse Event|67|||
129508242|NCT01061736|466149360|FG009|Overall Study|Adverse Event|34|||
129508243|NCT01061736|466149351|FG000|Overall Study|Lack of Efficacy|0|||
129508244|NCT01061736|466149352|FG001|Overall Study|Lack of Efficacy|2|||
129508245|NCT01061736|466149353|FG002|Overall Study|Lack of Efficacy|1|||
129508246|NCT01061736|466149354|FG003|Overall Study|Lack of Efficacy|1|||
129508247|NCT01061736|466149355|FG004|Overall Study|Lack of Efficacy|1|||
129508248|NCT01061736|466149356|FG005|Overall Study|Lack of Efficacy|2|||
129508249|NCT01061736|466149357|FG006|Overall Study|Lack of Efficacy|1|||
129508250|NCT01061736|466149358|FG007|Overall Study|Lack of Efficacy|9|||
129508251|NCT01061736|466149359|FG008|Overall Study|Lack of Efficacy|9|||
129508252|NCT01061736|466149360|FG009|Overall Study|Lack of Efficacy|10|||
129508253|NCT01061736|466149351|FG000|Overall Study|Poor compliance to protocol|0|||
129508254|NCT01061736|466149352|FG001|Overall Study|Poor compliance to protocol|0|||
129508255|NCT01061736|466149353|FG002|Overall Study|Poor compliance to protocol|0|||
129508256|NCT01061736|466149354|FG003|Overall Study|Poor compliance to protocol|0|||
129508257|NCT01061736|466149355|FG004|Overall Study|Poor compliance to protocol|0|||
129508258|NCT01061736|466149356|FG005|Overall Study|Poor compliance to protocol|0|||
129508259|NCT01061736|466149357|FG006|Overall Study|Poor compliance to protocol|0|||
129508260|NCT01061736|466149358|FG007|Overall Study|Poor compliance to protocol|2|||
129508261|NCT01061736|466149359|FG008|Overall Study|Poor compliance to protocol|5|||
129508262|NCT01061736|466149360|FG009|Overall Study|Poor compliance to protocol|9|||
129508263|NCT01061736|466149351|FG000|Overall Study|Not treated|0|||
129508264|NCT01061736|466149352|FG001|Overall Study|Not treated|0|||
129508265|NCT01061736|466149353|FG002|Overall Study|Not treated|0|||
129508266|NCT01061736|466149354|FG003|Overall Study|Not treated|0|||
129508267|NCT01061736|466149355|FG004|Overall Study|Not treated|1|||
129508268|NCT01061736|466149356|FG005|Overall Study|Not treated|0|||
129508269|NCT01061736|466149357|FG006|Overall Study|Not treated|0|||
129508270|NCT01061736|466149358|FG007|Overall Study|Not treated|2|||
129508271|NCT01061736|466149359|FG008|Overall Study|Not treated|1|||
129508272|NCT01061736|466149360|FG009|Overall Study|Not treated|0|||
129508273|NCT01061736|466149351|FG000|Overall Study|Other than specified above|0|||
129508274|NCT01061736|466149352|FG001|Overall Study|Other than specified above|1|||
129508275|NCT01061736|466149353|FG002|Overall Study|Other than specified above|2|||
129508276|NCT01061736|466149354|FG003|Overall Study|Other than specified above|0|||
129508277|NCT01061736|466149355|FG004|Overall Study|Other than specified above|1|||
129508278|NCT01061736|466149356|FG005|Overall Study|Other than specified above|0|||
129508279|NCT01061736|466149357|FG006|Overall Study|Other than specified above|0|||
129508280|NCT01061736|466149358|FG007|Overall Study|Other than specified above|18|||
129508281|NCT01061736|466149359|FG008|Overall Study|Other than specified above|15|||
129508282|NCT01061736|466149360|FG009|Overall Study|Other than specified above|21|||
129508283|NCT01610076|466149361|FG000|Overall Study|Technical issue with video|0|||
129508284|NCT01610076|466149362|FG001|Overall Study|Technical issue with video|1|||
129508285|NCT01610076|466149361|FG000|Overall Study|Lost to Follow-up|3|||
129508286|NCT01610076|466149362|FG001|Overall Study|Lost to Follow-up|4|||
129508287|NCT02680587|466149365|FG000|Overall Study|Withdrawal by Subject|1|||
129508288|NCT02680587|466149366|FG001|Overall Study|Withdrawal by Subject|0|||
129508289|NCT02899377|466149367|FG000|Overall Study|Adverse Event|1|||
129508290|NCT02899377|466149368|FG001|Overall Study|Adverse Event|0|||
129508291|NCT00469209|466149370|FG000|Overall Study|Adverse Event|1|||
129508292|NCT00469209|466149371|FG001|Overall Study|Adverse Event|0|||
129508293|NCT00469209|466149372|FG002|Overall Study|Adverse Event|1|||
129508294|NCT00418379|466149381|FG000|Year 1|Adverse Event|9|||
129508295|NCT00418379|466149382|FG001|Year 1|Adverse Event|15|||
129508296|NCT00418379|466149383|FG002|Year 1|Adverse Event|3|||
129508297|NCT00418379|466149381|FG000|Year 1|Withdrawal by Subject|7|||
129508298|NCT00418379|466149382|FG001|Year 1|Withdrawal by Subject|8|||
129508299|NCT00418379|466149383|FG002|Year 1|Withdrawal by Subject|5|||
129508300|NCT00418379|466149381|FG000|Year 1|Any other reason not above-mentioned|2|||
129508301|NCT00418379|466149382|FG001|Year 1|Any other reason not above-mentioned|5|||
129508302|NCT00418379|466149383|FG002|Year 1|Any other reason not above-mentioned|7|||
129508303|NCT00418379|466149381|FG000|Year 2|Adverse Event|5|||
129508304|NCT00418379|466149382|FG001|Year 2|Adverse Event|2|||
129508305|NCT00418379|466149383|FG002|Year 2|Adverse Event|1|||
129508306|NCT00418379|466149381|FG000|Year 2|Withdrawal by Subject|1|||
129508307|NCT00418379|466149382|FG001|Year 2|Withdrawal by Subject|1|||
129508308|NCT00418379|466149383|FG002|Year 2|Withdrawal by Subject|3|||
129508309|NCT00418379|466149381|FG000|Year 2|Any other reason not above-mentioned|2|||
129508310|NCT00418379|466149382|FG001|Year 2|Any other reason not above-mentioned|1|||
129508311|NCT00418379|466149383|FG002|Year 2|Any other reason not above-mentioned|6|||
129508312|NCT00418379|466149381|FG000|Year 3|Withdrawal by Subject|1|||
129508313|NCT00418379|466149382|FG001|Year 3|Withdrawal by Subject|1|||
129508314|NCT00418379|466149383|FG002|Year 3|Withdrawal by Subject|2|||
129508315|NCT00418379|466149381|FG000|Year 3|Any other reason not above-mentioned|2|||
129508316|NCT00418379|466149382|FG001|Year 3|Any other reason not above-mentioned|1|||
129508317|NCT00418379|466149383|FG002|Year 3|Any other reason not above-mentioned|1|||
129508318|NCT00418379|466149381|FG000|Year 4|Adverse Event|0|||
129508319|NCT00418379|466149382|FG001|Year 4|Adverse Event|1|||
129508320|NCT00418379|466149383|FG002|Year 4|Adverse Event|0|||
129508321|NCT00418379|466149381|FG000|Year 4|Withdrawal by Subject|2|||
129508322|NCT00418379|466149382|FG001|Year 4|Withdrawal by Subject|3|||
129508323|NCT00418379|466149383|FG002|Year 4|Withdrawal by Subject|2|||
129508324|NCT00418379|466149381|FG000|Year 4|Any other reason not above-mentioned|1|||
129508325|NCT00418379|466149382|FG001|Year 4|Any other reason not above-mentioned|1|||
129508326|NCT00418379|466149383|FG002|Year 4|Any other reason not above-mentioned|0|||
129508327|NCT00418379|466149381|FG000|Year 5|Adverse Event|0|||
129508328|NCT00418379|466149382|FG001|Year 5|Adverse Event|1|||
129508329|NCT00418379|466149383|FG002|Year 5|Adverse Event|0|||
129508330|NCT00418379|466149381|FG000|Year 5|Any other reason not above-mentioned|2|||
129508331|NCT00418379|466149382|FG001|Year 5|Any other reason not above-mentioned|4|||
129508332|NCT00418379|466149383|FG002|Year 5|Any other reason not above-mentioned|3|||
129508333|NCT00565058|466149384|FG000|Overall Study|Adverse Event|1|||
129508334|NCT00565058|466149385|FG001|Overall Study|Adverse Event|0|||
129508335|NCT00830804|466149388|FG000|Overall Study|Lost to Follow-up|4|||
129508336|NCT00830804|466149388|FG000|Overall Study|Death|1|||
129508337|NCT00830804|466149388|FG000|Overall Study|Unable to get to clinic|7|||
129508338|NCT00830804|466149388|FG000|Overall Study|Consent withdrawn|2|||
129508339|NCT00830804|466149388|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
129508340|NCT00510068|466149396|FG000|Double-blind Period|Disease progression|98|||
129508341|NCT00510068|466149397|FG001|Double-blind Period|Disease progression|169|||
129508342|NCT00510068|466149396|FG000|Double-blind Period|Final primary analysis|52|||
129508343|NCT00510068|466149397|FG001|Double-blind Period|Final primary analysis|18|||
129508344|NCT00510068|466149396|FG000|Double-blind Period|Adverse Event|37|||
129508345|NCT00510068|466149397|FG001|Double-blind Period|Adverse Event|7|||
129508346|NCT00510068|466149396|FG000|Double-blind Period|Withdrawal by Subject|8|||
129508347|NCT00510068|466149397|FG001|Double-blind Period|Withdrawal by Subject|6|||
129508348|NCT00510068|466149396|FG000|Double-blind Period|Death|4|||
129508349|NCT00510068|466149397|FG001|Double-blind Period|Death|3|||
129508350|NCT00510068|466149396|FG000|Double-blind Period|Abnormal test result (s)|1|||
129508351|NCT00510068|466149397|FG001|Double-blind Period|Abnormal test result (s)|0|||
129508352|NCT00510068|466149396|FG000|Double-blind Period|Lost to Follow-up|1|||
129508353|NCT00510068|466149397|FG001|Double-blind Period|Lost to Follow-up|0|||
129508354|NCT00510068|466149396|FG000|Double-blind Period|Protocol Violation|6|||
129508355|NCT00510068|466149397|FG001|Double-blind Period|Protocol Violation|0|||
129508356|NCT00510068|466149396|FG000|Open-label Period|Disease Progression|124|||
129508357|NCT00510068|466149397|FG001|Open-label Period|Disease Progression|0|||
129508358|NCT00510068|466149396|FG000|Open-label Period|Adverse Event|46|||
129508359|NCT00510068|466149397|FG001|Open-label Period|Adverse Event|0|||
129508360|NCT00510068|466149396|FG000|Open-label Period|Withdrawal by Subject|21|||
129508361|NCT00510068|466149397|FG001|Open-label Period|Withdrawal by Subject|0|||
129508362|NCT00510068|466149396|FG000|Open-label Period|Administrative problems|17|||
129508363|NCT00510068|466149397|FG001|Open-label Period|Administrative problems|0|||
129508364|NCT00510068|466149396|FG000|Open-label Period|Death|7|||
129508365|NCT00510068|466149397|FG001|Open-label Period|Death|0|||
129508366|NCT00510068|466149396|FG000|Open-label Period|New cancer therapy|7|||
129508367|NCT00510068|466149397|FG001|Open-label Period|New cancer therapy|0|||
129508368|NCT00510068|466149396|FG000|Open-label Period|Protocol Violation|2|||
129508369|NCT00510068|466149397|FG001|Open-label Period|Protocol Violation|0|||
129508370|NCT00510068|466149396|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
129508371|NCT00510068|466149397|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
129508372|NCT03691610|466149399|FG000|Overall Study|Adverse Event|0|||
129508373|NCT03691610|466149400|FG001|Overall Study|Adverse Event|1|||
129508374|NCT03691610|466149401|FG002|Overall Study|Adverse Event|0|||
129508375|NCT03691610|466149402|FG003|Overall Study|Adverse Event|0|||
129508376|NCT03691610|466149399|FG000|Overall Study|Protocol Deviation|15|||
129508377|NCT03691610|466149400|FG001|Overall Study|Protocol Deviation|8|||
129508378|NCT03691610|466149401|FG002|Overall Study|Protocol Deviation|1|||
129508379|NCT03691610|466149402|FG003|Overall Study|Protocol Deviation|2|||
129508380|NCT03691610|466149399|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
129508381|NCT03691610|466149400|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
129508382|NCT03691610|466149401|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
129508383|NCT03691610|466149402|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
129508384|NCT03691610|466149399|FG000|Overall Study|Lost to Follow-up|20|||
129508385|NCT03691610|466149400|FG001|Overall Study|Lost to Follow-up|11|||
129508386|NCT03691610|466149401|FG002|Overall Study|Lost to Follow-up|5|||
129508387|NCT03691610|466149402|FG003|Overall Study|Lost to Follow-up|2|||
129508388|NCT00622869|466149406|FG000|Overall Study|Subject Withdrew Consent|13|||
129508389|NCT00622869|466149407|FG001|Overall Study|Subject Withdrew Consent|17|||
129508390|NCT00622869|466149408|FG002|Overall Study|Subject Withdrew Consent|11|||
129508391|NCT00622869|466149406|FG000|Overall Study|Administrative Problems|11|||
129508392|NCT00622869|466149407|FG001|Overall Study|Administrative Problems|17|||
129508393|NCT00622869|466149408|FG002|Overall Study|Administrative Problems|13|||
129508394|NCT00622869|466149406|FG000|Overall Study|Death|12|||
129508395|NCT00622869|466149407|FG001|Overall Study|Death|15|||
129508396|NCT00622869|466149408|FG002|Overall Study|Death|10|||
129508397|NCT00622869|466149406|FG000|Overall Study|Lost to Follow-up|2|||
129508398|NCT00622869|466149407|FG001|Overall Study|Lost to Follow-up|4|||
129508399|NCT00622869|466149408|FG002|Overall Study|Lost to Follow-up|2|||
129508400|NCT00622869|466149406|FG000|Overall Study|Graft Loss|5|||
129508401|NCT00622869|466149407|FG001|Overall Study|Graft Loss|3|||
129508402|NCT00622869|466149408|FG002|Overall Study|Graft Loss|2|||
129508403|NCT00622869|466149406|FG000|Overall Study|Missing|0|||
129508404|NCT00622869|466149407|FG001|Overall Study|Missing|1|||
129508405|NCT00622869|466149408|FG002|Overall Study|Missing|1|||
129508406|NCT02475395|466149410|FG000|Overall Study|Protocol Violation|30|||
129508407|NCT02475395|466149411|FG001|Overall Study|Protocol Violation|3|||
129508408|NCT03730194|466149412|FG000|First Stage Treatment|Withdrawal by Subject|1|||
129508409|NCT03730194|466149413|FG001|First Stage Treatment|Withdrawal by Subject|1|||
129508410|NCT03730194|466149414|FG002|First Stage Treatment|Withdrawal by Subject|0|||
129508411|NCT03730194|466149415|FG003|First Stage Treatment|Withdrawal by Subject|0|||
129508412|NCT03730194|466149416|FG004|First Stage Treatment|Withdrawal by Subject|0|||
129508413|NCT03730194|466149417|FG005|First Stage Treatment|Withdrawal by Subject|0|||
129508414|NCT03730194|466149412|FG000|First Stage Treatment|Protocol Violation|3|||
129508415|NCT03730194|466149413|FG001|First Stage Treatment|Protocol Violation|3|||
129508416|NCT03730194|466149414|FG002|First Stage Treatment|Protocol Violation|0|||
129508417|NCT03730194|466149415|FG003|First Stage Treatment|Protocol Violation|0|||
129508418|NCT03730194|466149416|FG004|First Stage Treatment|Protocol Violation|0|||
129508419|NCT03730194|466149417|FG005|First Stage Treatment|Protocol Violation|0|||
129508420|NCT00115765|466149418|FG000|Overall Study|Withdrawal by Subject|22|||
129508421|NCT00115765|466149419|FG001|Overall Study|Withdrawal by Subject|53|||
129508422|NCT00115765|466149420|FG002|Overall Study|Withdrawal by Subject|76|||
129508423|NCT00115765|466149421|FG003|Overall Study|Withdrawal by Subject|15|||
129508424|NCT00115765|466149418|FG000|Overall Study|Physician Decision|4|||
129508425|NCT00115765|466149419|FG001|Overall Study|Physician Decision|15|||
129508426|NCT00115765|466149420|FG002|Overall Study|Physician Decision|18|||
129508427|NCT00115765|466149421|FG003|Overall Study|Physician Decision|13|||
129508428|NCT00115765|466149418|FG000|Overall Study|Lost to Follow-up|3|||
129508429|NCT00115765|466149419|FG001|Overall Study|Lost to Follow-up|20|||
129508430|NCT00115765|466149420|FG002|Overall Study|Lost to Follow-up|18|||
129508431|NCT00115765|466149421|FG003|Overall Study|Lost to Follow-up|1|||
129508432|NCT00115765|466149418|FG000|Overall Study|Other|6|||
129508433|NCT00115765|466149419|FG001|Overall Study|Other|12|||
129508434|NCT00115765|466149420|FG002|Overall Study|Other|9|||
129508435|NCT00115765|466149421|FG003|Overall Study|Other|2|||
129508436|NCT00567541|466149422|FG000|Overall Study|Adverse Event|0|||
129508437|NCT00567541|466149423|FG001|Overall Study|Adverse Event|1|||
129508438|NCT01890512|466149424|FG000|Overall Study|Physician Decision|1|||
129982781|NCT00943852|467900620|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
129508439|NCT01890512|466149424|FG000|Overall Study|Withdrawal by Subject|1|||
129508440|NCT01890512|466149424|FG000|Overall Study|Protocol Violation|1|||
129508441|NCT03337139|466149437|FG000|Phase I|Withdrawal by Subject|10|||
129508442|NCT03337139|466149438|FG001|Phase I|Withdrawal by Subject|0|||
129508443|NCT03288493|466149439|FG000|Overall Study|Withdrawal by Subject|4|||
129508444|NCT03288493|466149440|FG001|Overall Study|Withdrawal by Subject|0|||
129508445|NCT03288493|466149441|FG002|Overall Study|Withdrawal by Subject|0|||
129508446|NCT03288493|466149442|FG003|Overall Study|Withdrawal by Subject|0|||
129508447|NCT03288493|466149443|FG004|Overall Study|Withdrawal by Subject|0|||
129508448|NCT03288493|466149444|FG005|Overall Study|Withdrawal by Subject|2|||
129508449|NCT03288493|466149445|FG006|Overall Study|Withdrawal by Subject|0|||
129508450|NCT03288493|466149439|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
129508451|NCT03288493|466149440|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
129508452|NCT03288493|466149441|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
129508453|NCT03288493|466149442|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
129508454|NCT03288493|466149443|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
129508455|NCT03288493|466149444|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
129508456|NCT03288493|466149445|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
129508457|NCT03288493|466149439|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
129508458|NCT03288493|466149440|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
129508459|NCT03288493|466149441|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
129508460|NCT03288493|466149442|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
129508461|NCT03288493|466149443|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
129508462|NCT03288493|466149444|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
129508463|NCT03288493|466149445|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
129508464|NCT03288493|466149439|FG000|Overall Study|Death|2|||
129508465|NCT03288493|466149440|FG001|Overall Study|Death|0|||
129508466|NCT03288493|466149441|FG002|Overall Study|Death|0|||
129508467|NCT03288493|466149442|FG003|Overall Study|Death|0|||
129508468|NCT03288493|466149443|FG004|Overall Study|Death|0|||
129508469|NCT03288493|466149444|FG005|Overall Study|Death|0|||
129508470|NCT03288493|466149445|FG006|Overall Study|Death|0|||
129508471|NCT03288493|466149439|FG000|Overall Study|other reason not listed above|2|||
129508472|NCT03288493|466149440|FG001|Overall Study|other reason not listed above|0|||
129508473|NCT03288493|466149441|FG002|Overall Study|other reason not listed above|0|||
129508474|NCT03288493|466149442|FG003|Overall Study|other reason not listed above|0|||
129508475|NCT03288493|466149443|FG004|Overall Study|other reason not listed above|0|||
129508476|NCT03288493|466149444|FG005|Overall Study|other reason not listed above|0|||
129508477|NCT03288493|466149445|FG006|Overall Study|other reason not listed above|0|||
129508478|NCT03784027|466149446|FG000|Period 1|Withdrawal by Subject|0|||
129508479|NCT03784027|466149447|FG001|Period 1|Withdrawal by Subject|1|||
129508480|NCT00646113|466151745|FG000|Overall Study|Lost to Follow-up|5|||
129508481|NCT00646113|466151745|FG000|Overall Study|Adverse Event|3|||
129508482|NCT04095442|466151746|FG000|Overall Study|Lost to Follow-up|0|||
129508483|NCT04095442|466151747|FG001|Overall Study|Lost to Follow-up|1|||
129508484|NCT04095442|466151746|FG000|Overall Study|Screen failure|1|||
129508485|NCT04095442|466151747|FG001|Overall Study|Screen failure|0|||
129508486|NCT00562640|466151748|FG000|Overall Study|Death|0|||
129508487|NCT00562640|466151749|FG001|Overall Study|Death|1|||
129508488|NCT00562640|466151750|FG002|Overall Study|Death|1|||
129508489|NCT00562640|466151751|FG003|Overall Study|Death|0|||
129982782|NCT00943852|467900621|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982783|NCT00943852|467900622|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982784|NCT00943852|467900623|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982785|NCT00943852|467900624|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982786|NCT00943852|467900625|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982787|NCT00943852|467900626|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
129982788|NCT00943852|467900617|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982789|NCT00943852|467900618|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982790|NCT00943852|467900619|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129508490|NCT05263921|466151752|FG000|Overall Study|Other: family emergency.|0|||
129508491|NCT05263921|466151753|FG001|Overall Study|Other: family emergency.|0|||
129508492|NCT05263921|466151754|FG002|Overall Study|Other: family emergency.|1|||
129508493|NCT05263921|466151755|FG003|Overall Study|Other: family emergency.|0|||
129508494|NCT04656418|466151759|FG000|Overall Study|Withdrawal by Subject|1|||
129508495|NCT04656418|466151760|FG001|Overall Study|Withdrawal by Subject|3|||
129982791|NCT00943852|467900620|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982792|NCT00943852|467900621|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982793|NCT00943852|467900622|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
129982794|NCT00943852|467900623|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982795|NCT00943852|467900624|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982796|NCT00943852|467900625|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982797|NCT00943852|467900626|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
129982798|NCT00943852|467900617|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982799|NCT00943852|467900618|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982800|NCT00943852|467900619|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982801|NCT00943852|467900620|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982802|NCT00943852|467900621|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129508496|NCT03097614|466151763|FG000|Overall Study|Adverse Event|3|||
129508497|NCT00603733|466151765|FG000|Active Phase ITT|Adverse Event|8|||
129508498|NCT00603733|466151766|FG001|Active Phase ITT|Adverse Event|7|||
129508499|NCT00603733|466151765|FG000|Active Phase ITT|Withdrawal by Subject|0|||
129508500|NCT00603733|466151766|FG001|Active Phase ITT|Withdrawal by Subject|3|||
129508501|NCT00603733|466151765|FG000|Active Phase ITT|Lost to Follow-up|0|||
129508502|NCT00603733|466151766|FG001|Active Phase ITT|Lost to Follow-up|1|||
129508503|NCT00603733|466151765|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
129508504|NCT00603733|466151766|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
129508505|NCT00603733|466151765|FG000|Active Phase ITT|Lack of Efficacy|1|||
129508506|NCT00603733|466151766|FG001|Active Phase ITT|Lack of Efficacy|2|||
129508507|NCT00603733|466151765|FG000|Active Phase ITT|Subject moved, site closed|1|||
129508508|NCT00603733|466151766|FG001|Active Phase ITT|Subject moved, site closed|1|||
129508509|NCT00603733|466151765|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
129508510|NCT00603733|466151766|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
129508511|NCT00603733|466151765|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
129508512|NCT00603733|466151766|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
129508513|NCT00603733|466151765|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
129508514|NCT00603733|466151766|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
129508515|NCT00603733|466151765|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
129508516|NCT00603733|466151766|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
129508517|NCT00603733|466151765|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
129508518|NCT00603733|466151766|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
129508519|NCT00603733|466151765|FG000|Maintenance Phase ITT|Adverse Event|3|||
129508520|NCT00603733|466151766|FG001|Maintenance Phase ITT|Adverse Event|6|||
129508521|NCT00603733|466151765|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
129508522|NCT00603733|466151766|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
129508523|NCT00603733|466151765|FG000|Maintenance Phase ITT|Protocol Violation|1|||
129508524|NCT00603733|466151766|FG001|Maintenance Phase ITT|Protocol Violation|1|||
129508525|NCT00603733|466151765|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
129508526|NCT00603733|466151766|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
129508527|NCT00603733|466151765|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
129508528|NCT00603733|466151766|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
129508529|NCT00603733|466151765|FG000|Maintenance Phase ITT|Physician Decision|0|||
129508530|NCT00603733|466151766|FG001|Maintenance Phase ITT|Physician Decision|1|||
129508531|NCT00603733|466151765|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
129508532|NCT00603733|466151766|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
129508533|NCT01297309|466151772|FG000|Overall Study|Eligibility failure|2|||
129508534|NCT01297309|466151772|FG000|Overall Study|Screen failure|2|||
129508535|NCT01297309|466151772|FG000|Overall Study|Withdrawal by Subject|5|||
129508536|NCT01297309|466151772|FG000|Overall Study|Adverse Event|1|||
129508537|NCT01297309|466151772|FG000|Overall Study|Investigator Decision|2|||
129508538|NCT01297309|466151772|FG000|Overall Study|Death|1|||
129508539|NCT01297309|466151772|FG000|Overall Study|Participant not entering extensionperiod|1|||
129508540|NCT03039738|466151773|FG000|Overall Study|Incomplete data sets|54|||
129508541|NCT03039738|466151774|FG001|Overall Study|Incomplete data sets|0|||
129508542|NCT02254551|466151782|FG000|Dose Escalation|Physician Decision|1|||
129508543|NCT02254551|466151782|FG000|Dose Escalation|Dose-limiting toxicity|2|||
129508544|NCT03587584|466151788|FG000|Overall Study|SOC deviations|4|||
129508545|NCT03587584|466151789|FG001|Overall Study|SOC deviations|6|||
129508546|NCT03587584|466151788|FG000|Overall Study|Incomplete data|0|||
129508547|NCT03587584|466151789|FG001|Overall Study|Incomplete data|3|||
129508548|NCT00387348|466151790|FG000|Overall Study|Death|1|||
129508549|NCT00387348|466151791|FG001|Overall Study|Death|1|||
129508550|NCT00387348|466151792|FG002|Overall Study|Death|0|||
129508551|NCT00387348|466151790|FG000|Overall Study|Physician Decision|1|||
129508552|NCT00387348|466151791|FG001|Overall Study|Physician Decision|0|||
129508553|NCT00387348|466151792|FG002|Overall Study|Physician Decision|1|||
129508554|NCT00387348|466151790|FG000|Overall Study|Withdrawal by Subject|0|||
129508555|NCT00387348|466151791|FG001|Overall Study|Withdrawal by Subject|2|||
129508556|NCT00387348|466151792|FG002|Overall Study|Withdrawal by Subject|2|||
129508557|NCT00387348|466151790|FG000|Overall Study|Adverse Event|1|||
129508558|NCT00387348|466151791|FG001|Overall Study|Adverse Event|0|||
129508559|NCT00387348|466151792|FG002|Overall Study|Adverse Event|1|||
129508560|NCT00505752|466151793|FG000|Overall Study|Adverse Event|1|||
129508561|NCT00505752|466151794|FG001|Overall Study|Adverse Event|0|||
129508562|NCT00505752|466151795|FG002|Overall Study|Adverse Event|1|||
129508563|NCT00505752|466151796|FG003|Overall Study|Adverse Event|0|||
129508564|NCT00505752|466151793|FG000|Overall Study|Lost to Follow-up|1|||
129508565|NCT00505752|466151794|FG001|Overall Study|Lost to Follow-up|0|||
129508566|NCT00505752|466151795|FG002|Overall Study|Lost to Follow-up|0|||
129508567|NCT00505752|466151796|FG003|Overall Study|Lost to Follow-up|0|||
129508568|NCT00505752|466151793|FG000|Overall Study|Lack of ovarian response|1|||
129508569|NCT00505752|466151794|FG001|Overall Study|Lack of ovarian response|3|||
129508570|NCT00505752|466151795|FG002|Overall Study|Lack of ovarian response|0|||
129508571|NCT00505752|466151796|FG003|Overall Study|Lack of ovarian response|0|||
129508572|NCT00505752|466151793|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129508573|NCT00505752|466151794|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129508574|NCT00505752|466151795|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
129508575|NCT00505752|466151796|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
129508576|NCT00505752|466151793|FG000|Overall Study|No oocytes retrieved|0|||
129508577|NCT00505752|466151794|FG001|Overall Study|No oocytes retrieved|2|||
129508578|NCT00505752|466151795|FG002|Overall Study|No oocytes retrieved|0|||
129508579|NCT00505752|466151796|FG003|Overall Study|No oocytes retrieved|1|||
129508580|NCT00505752|466151793|FG000|Overall Study|No Fertilization|1|||
129508581|NCT00505752|466151794|FG001|Overall Study|No Fertilization|1|||
129508582|NCT00505752|466151795|FG002|Overall Study|No Fertilization|2|||
129508583|NCT00505752|466151796|FG003|Overall Study|No Fertilization|1|||
129508584|NCT00505752|466151793|FG000|Overall Study|All embryos/blastocysts discarded|0|||
129508585|NCT00505752|466151794|FG001|Overall Study|All embryos/blastocysts discarded|0|||
129508586|NCT00505752|466151795|FG002|Overall Study|All embryos/blastocysts discarded|1|||
129508587|NCT00505752|466151796|FG003|Overall Study|All embryos/blastocysts discarded|1|||
129508588|NCT00505752|466151793|FG000|Overall Study|Other|1|||
129508589|NCT00505752|466151794|FG001|Overall Study|Other|2|||
129508590|NCT00505752|466151795|FG002|Overall Study|Other|1|||
129508591|NCT00505752|466151796|FG003|Overall Study|Other|2|||
129508592|NCT01149343|466151797|FG000|Overall Study|Withdrawal by Subject|1|||
129508593|NCT01149343|466151798|FG001|Overall Study|Withdrawal by Subject|1|||
129508594|NCT01149343|466151799|FG002|Overall Study|Withdrawal by Subject|1|||
129508595|NCT01149343|466151800|FG003|Overall Study|Withdrawal by Subject|5|||
129508596|NCT01149343|466151797|FG000|Overall Study|Death|10|||
129508597|NCT01149343|466151798|FG001|Overall Study|Death|13|||
129508598|NCT01149343|466151799|FG002|Overall Study|Death|18|||
129508599|NCT01149343|466151800|FG003|Overall Study|Death|18|||
129508600|NCT01149343|466151797|FG000|Overall Study|Lost to Follow-up|1|||
129508601|NCT01149343|466151798|FG001|Overall Study|Lost to Follow-up|0|||
129508602|NCT01149343|466151799|FG002|Overall Study|Lost to Follow-up|0|||
129508603|NCT01149343|466151800|FG003|Overall Study|Lost to Follow-up|1|||
129508604|NCT01149343|466151797|FG000|Overall Study|Other|8|||
129508605|NCT01149343|466151798|FG001|Overall Study|Other|10|||
129508606|NCT01149343|466151799|FG002|Overall Study|Other|2|||
129508607|NCT01149343|466151800|FG003|Overall Study|Other|14|||
129508608|NCT01149343|466151797|FG000|Overall Study|Sponsor study termination|0|||
129508609|NCT01149343|466151798|FG001|Overall Study|Sponsor study termination|0|||
129508610|NCT01149343|466151799|FG002|Overall Study|Sponsor study termination|0|||
129508611|NCT01149343|466151800|FG003|Overall Study|Sponsor study termination|2|||
129508612|NCT01149343|466151797|FG000|Overall Study|Recurrence / Progressive disease|0|||
129508613|NCT01149343|466151798|FG001|Overall Study|Recurrence / Progressive disease|0|||
129508614|NCT01149343|466151799|FG002|Overall Study|Recurrence / Progressive disease|1|||
129508615|NCT01149343|466151800|FG003|Overall Study|Recurrence / Progressive disease|0|||
129508616|NCT01925612|466151801|FG000|Overall Study|Progressive Disease|1|||
129508617|NCT01925612|466151802|FG001|Overall Study|Progressive Disease|1|||
129508618|NCT01925612|466151803|FG002|Overall Study|Progressive Disease|1|||
129508619|NCT01925612|466151804|FG003|Overall Study|Progressive Disease|0|||
129508620|NCT01925612|466151805|FG004|Overall Study|Progressive Disease|0|||
129508621|NCT01925612|466151801|FG000|Overall Study|Adverse Event|3|||
129508622|NCT01925612|466151802|FG001|Overall Study|Adverse Event|3|||
129508623|NCT01925612|466151803|FG002|Overall Study|Adverse Event|0|||
129508624|NCT01925612|466151804|FG003|Overall Study|Adverse Event|1|||
129508625|NCT01925612|466151805|FG004|Overall Study|Adverse Event|2|||
129508626|NCT01093755|466151809|FG000|Overall Study|Withdrawal by Subject|3|||
129508627|NCT01093755|466151810|FG001|Overall Study|Withdrawal by Subject|4|||
129508628|NCT00085917|466151814|FG000|Overall Study|Adverse Event|4|||
129508629|NCT00085917|466151815|FG001|Overall Study|Adverse Event|3|||
129508630|NCT01429077|466151816|FG000|Overall Study|Lost to Follow-up|0|||
129508631|NCT01429077|466151817|FG001|Overall Study|Lost to Follow-up|3|||
129508632|NCT03067129|466151819|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
129508633|NCT03067129|466151820|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
129508634|NCT03067129|466151821|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
129508635|NCT03067129|466151822|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
129508636|NCT03067129|466151819|FG000|Overall Study|Withdrawal by Subject|0|||
129508637|NCT03067129|466151820|FG001|Overall Study|Withdrawal by Subject|0|||
129508638|NCT03067129|466151821|FG002|Overall Study|Withdrawal by Subject|1|||
129508639|NCT03067129|466151822|FG003|Overall Study|Withdrawal by Subject|2|||
129508640|NCT03067129|466151819|FG000|Overall Study|Lost to Follow-up|5|||
129508641|NCT03067129|466151820|FG001|Overall Study|Lost to Follow-up|5|||
129508642|NCT03067129|466151821|FG002|Overall Study|Lost to Follow-up|4|||
129508643|NCT03067129|466151822|FG003|Overall Study|Lost to Follow-up|3|||
129508644|NCT03372603|466151823|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
129508645|NCT03372603|466151824|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
129508646|NCT03372603|466151823|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
129508647|NCT03372603|466151824|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
129508648|NCT02806947|466151825|FG000|Overall Study|Withdrawal by Subject|5|||
129508649|NCT02806947|466151826|FG001|Overall Study|Withdrawal by Subject|1|||
129508650|NCT00865189|466151827|FG000|Overall Study|Other|1|||
129508651|NCT00865189|466151828|FG001|Overall Study|Other|2|||
129508652|NCT00865189|466151827|FG000|Overall Study|Death|4|||
129508653|NCT00865189|466151828|FG001|Overall Study|Death|11|||
129508654|NCT00865189|466151827|FG000|Overall Study|Lost to Follow-up|6|||
129508655|NCT00865189|466151828|FG001|Overall Study|Lost to Follow-up|6|||
129508656|NCT00865189|466151827|FG000|Overall Study|Withdrawal by Subject|1|||
129508657|NCT00865189|466151828|FG001|Overall Study|Withdrawal by Subject|0|||
129508658|NCT00843843|466151829|FG000|Overall Study|Physician Decision|1|||
129508659|NCT00843843|466151830|FG001|Overall Study|Physician Decision|1|||
129508660|NCT00843843|466151829|FG000|Overall Study|Protocol Violation|1|||
129508661|NCT00843843|466151830|FG001|Overall Study|Protocol Violation|1|||
129508662|NCT02029638|466151832|FG000|Overall Study|Death|0|||
129508663|NCT02029638|466151833|FG001|Overall Study|Death|0|||
129508664|NCT02029638|466151834|FG002|Overall Study|Death|1|||
129508665|NCT02029638|466151832|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
129508666|NCT02029638|466151833|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
129508667|NCT02029638|466151834|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
129508668|NCT01153841|466151835|FG000|Overall Study|Adverse Event|1|||
129508669|NCT01153841|466151836|FG001|Overall Study|Adverse Event|0|||
129508670|NCT01153841|466151835|FG000|Overall Study|Withdrawal by Subject|1|||
129508671|NCT01153841|466151836|FG001|Overall Study|Withdrawal by Subject|0|||
129508672|NCT01153841|466151835|FG000|Overall Study|Protocol Violation|2|||
129508673|NCT01153841|466151836|FG001|Overall Study|Protocol Violation|0|||
129508674|NCT01153841|466151835|FG000|Overall Study|Lost to Follow-up|2|||
129508675|NCT01153841|466151836|FG001|Overall Study|Lost to Follow-up|0|||
129508676|NCT03428997|466151837|FG000|Overall Study|Sponsor decision.|1|||
129508677|NCT03428997|466151837|FG000|Overall Study|Withdrawal by Subject|3|||
129508678|NCT03428997|466151837|FG000|Overall Study|Lost to Follow-up|4|||
129508679|NCT02563925|466151841|FG000|Overall Study|Withdrawal by Subject|2|||
129508680|NCT00400712|466151842|FG000|Overall Study|Death|1|||
129508681|NCT00400712|466151843|FG001|Overall Study|Death|0|||
129508682|NCT00400712|466151842|FG000|Overall Study|Withdrawal by Subject|11|||
129508683|NCT00400712|466151843|FG001|Overall Study|Withdrawal by Subject|12|||
129508684|NCT00400712|466151842|FG000|Overall Study|Physician Decision|5|||
129508685|NCT00400712|466151843|FG001|Overall Study|Physician Decision|4|||
129508686|NCT00645567|466151845|FG000|Overall Study|Adverse Event|1|||
129508687|NCT03814590|466151850|FG000|Overall Study|Adverse Event|0|||
129508688|NCT03814590|466151851|FG001|Overall Study|Adverse Event|0|||
129508689|NCT03814590|466151852|FG002|Overall Study|Adverse Event|0|||
129508690|NCT03814590|466151853|FG003|Overall Study|Adverse Event|0|||
129508691|NCT03814590|466151854|FG004|Overall Study|Adverse Event|0|||
129508692|NCT03814590|466151855|FG005|Overall Study|Adverse Event|1|||
129508693|NCT03814590|466151856|FG006|Overall Study|Adverse Event|1|||
129508694|NCT03814590|466151857|FG007|Overall Study|Adverse Event|1|||
129508695|NCT03814590|466151858|FG008|Overall Study|Adverse Event|0|||
129508696|NCT03814590|466151859|FG009|Overall Study|Adverse Event|0|||
129508697|NCT03814590|466151860|FG010|Overall Study|Adverse Event|1|||
129982803|NCT00943852|467900622|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129508698|NCT03814590|466151861|FG011|Overall Study|Adverse Event|0|||
129508699|NCT03814590|466151862|FG012|Overall Study|Adverse Event|3|||
129508700|NCT03814590|466151863|FG013|Overall Study|Adverse Event|0|||
129508701|NCT03814590|466151850|FG000|Overall Study|Lost to Follow-up|0|||
129508702|NCT03814590|466151851|FG001|Overall Study|Lost to Follow-up|2|||
129508703|NCT03814590|466151852|FG002|Overall Study|Lost to Follow-up|1|||
129508704|NCT03814590|466151853|FG003|Overall Study|Lost to Follow-up|0|||
129982804|NCT00943852|467900623|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
129508705|NCT03814590|466151854|FG004|Overall Study|Lost to Follow-up|1|||
129508706|NCT03814590|466151855|FG005|Overall Study|Lost to Follow-up|1|||
129508707|NCT03814590|466151856|FG006|Overall Study|Lost to Follow-up|1|||
129508708|NCT03814590|466151857|FG007|Overall Study|Lost to Follow-up|1|||
129508709|NCT03814590|466151858|FG008|Overall Study|Lost to Follow-up|0|||
129508710|NCT03814590|466151859|FG009|Overall Study|Lost to Follow-up|0|||
129508711|NCT03814590|466151860|FG010|Overall Study|Lost to Follow-up|1|||
129508712|NCT03814590|466151861|FG011|Overall Study|Lost to Follow-up|0|||
129508713|NCT03814590|466151862|FG012|Overall Study|Lost to Follow-up|0|||
129508714|NCT03814590|466151863|FG013|Overall Study|Lost to Follow-up|1|||
129508715|NCT03814590|466151850|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508716|NCT03814590|466151851|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508717|NCT03814590|466151852|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508718|NCT03814590|466151853|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508719|NCT03814590|466151854|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508720|NCT03814590|466151855|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508721|NCT03814590|466151856|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508722|NCT03814590|466151857|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508723|NCT03814590|466151858|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508724|NCT03814590|466151859|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
129508725|NCT03814590|466151860|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508726|NCT03814590|466151861|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508727|NCT03814590|466151862|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508728|NCT03814590|466151863|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
129508729|NCT03814590|466151850|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508730|NCT03814590|466151851|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508731|NCT03814590|466151852|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508732|NCT03814590|466151853|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508733|NCT03814590|466151854|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508734|NCT03814590|466151855|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
129508735|NCT03814590|466151856|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
129508736|NCT03814590|466151857|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
129508737|NCT03814590|466151858|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508738|NCT03814590|466151859|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
129508739|NCT03814590|466151860|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
129508740|NCT03814590|466151861|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
129508741|NCT03814590|466151862|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
129508742|NCT03814590|466151863|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
129508743|NCT03814590|466151850|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508744|NCT03814590|466151851|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508745|NCT03814590|466151852|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508746|NCT03814590|466151853|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508747|NCT03814590|466151854|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508748|NCT03814590|466151855|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508749|NCT03814590|466151856|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508750|NCT03814590|466151857|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129508751|NCT03814590|466151858|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508752|NCT03814590|466151859|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
129508753|NCT03814590|466151860|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508754|NCT03814590|466151861|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508755|NCT03814590|466151862|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508756|NCT03814590|466151863|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
129508757|NCT03814590|466151850|FG000|Overall Study|UNKNOWN REASON|0|||
129508758|NCT03814590|466151851|FG001|Overall Study|UNKNOWN REASON|0|||
129508759|NCT03814590|466151852|FG002|Overall Study|UNKNOWN REASON|0|||
129508760|NCT03814590|466151853|FG003|Overall Study|UNKNOWN REASON|0|||
129508761|NCT03814590|466151854|FG004|Overall Study|UNKNOWN REASON|0|||
129508762|NCT03814590|466151855|FG005|Overall Study|UNKNOWN REASON|0|||
129508763|NCT03814590|466151856|FG006|Overall Study|UNKNOWN REASON|0|||
129508764|NCT03814590|466151857|FG007|Overall Study|UNKNOWN REASON|1|||
129508765|NCT03814590|466151858|FG008|Overall Study|UNKNOWN REASON|0|||
129508766|NCT03814590|466151859|FG009|Overall Study|UNKNOWN REASON|0|||
129982805|NCT00943852|467900624|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982806|NCT00943852|467900625|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129982807|NCT00943852|467900626|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
129508767|NCT03814590|466151860|FG010|Overall Study|UNKNOWN REASON|0|||
129508768|NCT03814590|466151861|FG011|Overall Study|UNKNOWN REASON|0|||
129508769|NCT03814590|466151862|FG012|Overall Study|UNKNOWN REASON|0|||
129508770|NCT03814590|466151863|FG013|Overall Study|UNKNOWN REASON|0|||
129508771|NCT00964158|466151868|FG000|Overall Study|Lost to Follow-up|0|||
129508772|NCT00964158|466151869|FG001|Overall Study|Lost to Follow-up|1|||
129508773|NCT00964158|466151870|FG002|Overall Study|Lost to Follow-up|2|||
129508774|NCT00964158|466151868|FG000|Overall Study|Withdrawal by Subject|0|||
129508775|NCT00964158|466151869|FG001|Overall Study|Withdrawal by Subject|0|||
129508776|NCT00964158|466151870|FG002|Overall Study|Withdrawal by Subject|6|||
129508777|NCT01054976|466151879|FG000|Overall Study|Adverse Event|16|||
129508778|NCT01054976|466151879|FG000|Overall Study|Uncooperative participations to study|7|||
129508779|NCT01054976|466151879|FG000|Overall Study|Withdrawal by Subject|4|||
129508780|NCT01054976|466151879|FG000|Overall Study|Other|8|||
129508781|NCT01763866|466151880|FG000|Overall Study|Withdrawal by Subject|2|||
129508782|NCT01763866|466151881|FG001|Overall Study|Withdrawal by Subject|1|||
129508783|NCT01763866|466151882|FG002|Overall Study|Withdrawal by Subject|4|||
129508784|NCT01763866|466151883|FG003|Overall Study|Withdrawal by Subject|0|||
129508785|NCT01763866|466151884|FG004|Overall Study|Withdrawal by Subject|0|||
129508786|NCT01763866|466151885|FG005|Overall Study|Withdrawal by Subject|3|||
129508787|NCT01763866|466151886|FG006|Overall Study|Withdrawal by Subject|4|||
129508788|NCT01763866|466151887|FG007|Overall Study|Withdrawal by Subject|0|||
129508789|NCT01763866|466151888|FG008|Overall Study|Withdrawal by Subject|1|||
129508790|NCT01763866|466151889|FG009|Overall Study|Withdrawal by Subject|1|||
129508791|NCT01763866|466151890|FG010|Overall Study|Withdrawal by Subject|2|||
129508792|NCT01763866|466151891|FG011|Overall Study|Withdrawal by Subject|2|||
129508793|NCT01763866|466151892|FG012|Overall Study|Withdrawal by Subject|2|||
129508794|NCT01763866|466151893|FG013|Overall Study|Withdrawal by Subject|0|||
129508795|NCT01763866|466151894|FG014|Overall Study|Withdrawal by Subject|6|||
129508796|NCT01763866|466151895|FG015|Overall Study|Withdrawal by Subject|3|||
129508797|NCT01763866|466151896|FG016|Overall Study|Withdrawal by Subject|0|||
129508798|NCT01763866|466151897|FG017|Overall Study|Withdrawal by Subject|1|||
129508799|NCT01763866|466151898|FG018|Overall Study|Withdrawal by Subject|1|||
129508800|NCT01763866|466151899|FG019|Overall Study|Withdrawal by Subject|1|||
129508801|NCT01763866|466151900|FG020|Overall Study|Withdrawal by Subject|2|||
129508802|NCT01763866|466151901|FG021|Overall Study|Withdrawal by Subject|1|||
129508803|NCT01763866|466151902|FG022|Overall Study|Withdrawal by Subject|2|||
129508804|NCT01763866|466151903|FG023|Overall Study|Withdrawal by Subject|1|||
129508805|NCT01763866|466151880|FG000|Overall Study|Decision by sponsor|0|||
129508806|NCT01763866|466151881|FG001|Overall Study|Decision by sponsor|0|||
129508807|NCT01763866|466151882|FG002|Overall Study|Decision by sponsor|1|||
129508808|NCT01763866|466151883|FG003|Overall Study|Decision by sponsor|0|||
129508809|NCT01763866|466151884|FG004|Overall Study|Decision by sponsor|2|||
129508810|NCT01763866|466151885|FG005|Overall Study|Decision by sponsor|0|||
129508811|NCT01763866|466151886|FG006|Overall Study|Decision by sponsor|2|||
129508812|NCT01763866|466151887|FG007|Overall Study|Decision by sponsor|0|||
129508813|NCT01763866|466151888|FG008|Overall Study|Decision by sponsor|2|||
129508814|NCT01763866|466151889|FG009|Overall Study|Decision by sponsor|0|||
129508815|NCT01763866|466151890|FG010|Overall Study|Decision by sponsor|6|||
129508816|NCT01763866|466151891|FG011|Overall Study|Decision by sponsor|0|||
129508817|NCT01763866|466151892|FG012|Overall Study|Decision by sponsor|1|||
129508818|NCT01763866|466151893|FG013|Overall Study|Decision by sponsor|0|||
129508819|NCT01763866|466151894|FG014|Overall Study|Decision by sponsor|5|||
129508820|NCT01763866|466151895|FG015|Overall Study|Decision by sponsor|0|||
129508821|NCT01763866|466151896|FG016|Overall Study|Decision by sponsor|0|||
129508822|NCT01763866|466151897|FG017|Overall Study|Decision by sponsor|0|||
129508823|NCT01763866|466151898|FG018|Overall Study|Decision by sponsor|4|||
129508824|NCT01763866|466151899|FG019|Overall Study|Decision by sponsor|0|||
129508825|NCT01763866|466151900|FG020|Overall Study|Decision by sponsor|2|||
129508826|NCT01763866|466151901|FG021|Overall Study|Decision by sponsor|0|||
129508827|NCT01763866|466151902|FG022|Overall Study|Decision by sponsor|1|||
129508828|NCT01763866|466151903|FG023|Overall Study|Decision by sponsor|0|||
129508829|NCT01763866|466151880|FG000|Overall Study|Lost to Follow-up|0|||
129508830|NCT01763866|466151881|FG001|Overall Study|Lost to Follow-up|0|||
129508831|NCT01763866|466151882|FG002|Overall Study|Lost to Follow-up|0|||
129982808|NCT00943852|467900617|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982809|NCT00943852|467900618|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129508832|NCT01763866|466151883|FG003|Overall Study|Lost to Follow-up|0|||
129508833|NCT01763866|466151884|FG004|Overall Study|Lost to Follow-up|0|||
129508834|NCT01763866|466151885|FG005|Overall Study|Lost to Follow-up|0|||
129508835|NCT01763866|466151886|FG006|Overall Study|Lost to Follow-up|1|||
129508836|NCT01763866|466151887|FG007|Overall Study|Lost to Follow-up|0|||
129508837|NCT01763866|466151888|FG008|Overall Study|Lost to Follow-up|0|||
129508838|NCT01763866|466151889|FG009|Overall Study|Lost to Follow-up|0|||
129508839|NCT01763866|466151890|FG010|Overall Study|Lost to Follow-up|0|||
129508840|NCT01763866|466151891|FG011|Overall Study|Lost to Follow-up|0|||
129508841|NCT01763866|466151892|FG012|Overall Study|Lost to Follow-up|1|||
129508842|NCT01763866|466151893|FG013|Overall Study|Lost to Follow-up|0|||
129508843|NCT01763866|466151894|FG014|Overall Study|Lost to Follow-up|1|||
129508844|NCT01763866|466151895|FG015|Overall Study|Lost to Follow-up|0|||
129508845|NCT01763866|466151896|FG016|Overall Study|Lost to Follow-up|0|||
129508846|NCT01763866|466151897|FG017|Overall Study|Lost to Follow-up|0|||
129508847|NCT01763866|466151898|FG018|Overall Study|Lost to Follow-up|1|||
129508848|NCT01763866|466151899|FG019|Overall Study|Lost to Follow-up|1|||
129508849|NCT01763866|466151900|FG020|Overall Study|Lost to Follow-up|0|||
129508850|NCT01763866|466151901|FG021|Overall Study|Lost to Follow-up|0|||
129508851|NCT01763866|466151902|FG022|Overall Study|Lost to Follow-up|0|||
129508852|NCT01763866|466151903|FG023|Overall Study|Lost to Follow-up|1|||
129508853|NCT01763866|466151880|FG000|Overall Study|Death|0|||
129508854|NCT01763866|466151881|FG001|Overall Study|Death|0|||
129508855|NCT01763866|466151882|FG002|Overall Study|Death|0|||
129508856|NCT01763866|466151883|FG003|Overall Study|Death|0|||
129508857|NCT01763866|466151884|FG004|Overall Study|Death|0|||
129508858|NCT01763866|466151885|FG005|Overall Study|Death|0|||
129508859|NCT01763866|466151886|FG006|Overall Study|Death|0|||
129508860|NCT01763866|466151887|FG007|Overall Study|Death|0|||
129508861|NCT01763866|466151888|FG008|Overall Study|Death|0|||
129508862|NCT01763866|466151889|FG009|Overall Study|Death|0|||
129508863|NCT01763866|466151890|FG010|Overall Study|Death|0|||
129508864|NCT01763866|466151891|FG011|Overall Study|Death|0|||
129508865|NCT01763866|466151892|FG012|Overall Study|Death|0|||
129508866|NCT01763866|466151893|FG013|Overall Study|Death|0|||
129508867|NCT01763866|466151894|FG014|Overall Study|Death|0|||
129508868|NCT01763866|466151895|FG015|Overall Study|Death|0|||
129508869|NCT01763866|466151896|FG016|Overall Study|Death|1|||
129508870|NCT01763866|466151897|FG017|Overall Study|Death|0|||
129508871|NCT01763866|466151898|FG018|Overall Study|Death|0|||
129508872|NCT01763866|466151899|FG019|Overall Study|Death|0|||
129508873|NCT01763866|466151900|FG020|Overall Study|Death|0|||
129508874|NCT01763866|466151901|FG021|Overall Study|Death|0|||
129508875|NCT01763866|466151902|FG022|Overall Study|Death|0|||
129508876|NCT01763866|466151903|FG023|Overall Study|Death|0|||
129508877|NCT01669811|466151910|FG000|Overall Study|Investigator decision|0|||
129508878|NCT01669811|466151911|FG001|Overall Study|Investigator decision|1|||
129508879|NCT01669811|466151910|FG000|Overall Study|Withdrawal by Subject|1|||
129508880|NCT01669811|466151911|FG001|Overall Study|Withdrawal by Subject|2|||
129508881|NCT01669811|466151910|FG000|Overall Study|Adverse Event|2|||
129508882|NCT01669811|466151911|FG001|Overall Study|Adverse Event|6|||
129508883|NCT01669811|466151910|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129508884|NCT01669811|466151911|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
129508885|NCT03245723|466151912|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
129508886|NCT03245723|466151913|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
129508887|NCT03245723|466151912|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
129508888|NCT03245723|466151913|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
129508889|NCT03245723|466151912|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
129508890|NCT03245723|466151913|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
129508891|NCT03245723|466151912|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
129508892|NCT03245723|466151913|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
129508893|NCT00077376|466151914|FG000|Overall Study|Adverse Event|8|||
129508894|NCT00077376|466151914|FG000|Overall Study|Withdrawal by Subject|2|||
129508895|NCT00077376|466151914|FG000|Overall Study|Death|1|||
129508896|NCT00077376|466151914|FG000|Overall Study|Physician Decision|1|||
129508897|NCT00077376|466151914|FG000|Overall Study|Alternative therapy|5|||
129508898|NCT00077376|466151914|FG000|Overall Study|Complicating disease|1|||
129508899|NCT00077376|466151914|FG000|Overall Study|Still on treatment|1|||
129508900|NCT00077376|466151914|FG000|Overall Study|Symptomatic deterioration|1|||
129508901|NCT00077376|466151914|FG000|Overall Study|Surgery|1|||
129508902|NCT00077376|466151914|FG000|Overall Study|Insurance ran out|1|||
129508903|NCT02109744|466153759|FG000|Overall Study|Death|1|||
129508904|NCT02109744|466153760|FG001|Overall Study|Death|1|||
129508905|NCT02109744|466153759|FG000|Overall Study|no marrow exam|1|||
129508906|NCT02109744|466153760|FG001|Overall Study|no marrow exam|0|||
129508907|NCT03287245|466153761|FG000|Overall Study|Study terminated by sponsor|3|||
129508908|NCT03287245|466153762|FG001|Overall Study|Study terminated by sponsor|0|||
129508909|NCT03287245|466153763|FG002|Overall Study|Study terminated by sponsor|3|||
129508910|NCT03287245|466153764|FG003|Overall Study|Study terminated by sponsor|1|||
129508911|NCT03287245|466153761|FG000|Overall Study|Adverse Event|1|||
129508912|NCT03287245|466153762|FG001|Overall Study|Adverse Event|0|||
129508913|NCT03287245|466153763|FG002|Overall Study|Adverse Event|0|||
129508914|NCT03287245|466153764|FG003|Overall Study|Adverse Event|0|||
129508915|NCT03287245|466153761|FG000|Overall Study|Withdrawal by Subject|8|||
129508916|NCT03287245|466153762|FG001|Overall Study|Withdrawal by Subject|3|||
129508917|NCT03287245|466153763|FG002|Overall Study|Withdrawal by Subject|3|||
129508918|NCT03287245|466153764|FG003|Overall Study|Withdrawal by Subject|0|||
129508919|NCT03287245|466153761|FG000|Overall Study|Physician Decision|3|||
129508920|NCT03287245|466153762|FG001|Overall Study|Physician Decision|2|||
129508921|NCT03287245|466153763|FG002|Overall Study|Physician Decision|0|||
129508922|NCT03287245|466153764|FG003|Overall Study|Physician Decision|0|||
129508923|NCT02150213|466153765|FG000|Overall Study|Lost to Follow-up|1|||
129508924|NCT02150213|466153765|FG000|Overall Study|Withdrawal by Subject|1|||
129508925|NCT02678312|466153766|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
129508926|NCT02678312|466153767|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
129508927|NCT02678312|466153768|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
129508928|NCT02678312|466153769|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
129508929|NCT02678312|466153770|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
129508930|NCT02678312|466153766|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
129508931|NCT02678312|466153767|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
129508932|NCT02678312|466153768|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
129508933|NCT02678312|466153769|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
129508934|NCT02678312|466153770|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
129508935|NCT02678312|466153766|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
129508936|NCT02678312|466153767|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
129508937|NCT02678312|466153768|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
129508938|NCT02678312|466153769|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
129508939|NCT02678312|466153770|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
129508940|NCT02678312|466153766|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
129508941|NCT02678312|466153767|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
129508942|NCT02678312|466153768|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
129508943|NCT02678312|466153769|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
129508944|NCT02678312|466153770|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
129508945|NCT02678312|466153766|FG000|Part 2 Double Blind Epoch|Death|0|||
129508946|NCT02678312|466153767|FG001|Part 2 Double Blind Epoch|Death|0|||
129508947|NCT02678312|466153768|FG002|Part 2 Double Blind Epoch|Death|0|||
129508948|NCT02678312|466153769|FG003|Part 2 Double Blind Epoch|Death|8|||
129508949|NCT02678312|466153770|FG004|Part 2 Double Blind Epoch|Death|12|||
129508950|NCT02678312|466153766|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
129508951|NCT02678312|466153767|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
129508952|NCT02678312|466153768|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
129508953|NCT02678312|466153769|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
129508954|NCT02678312|466153770|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
129508955|NCT02678312|466153766|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
129508956|NCT02678312|466153767|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
129508957|NCT02678312|466153768|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
129508958|NCT02678312|466153769|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
129508959|NCT02678312|466153770|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
129508960|NCT02678312|466153766|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
129508961|NCT02678312|466153767|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
129508962|NCT02678312|466153768|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
129508963|NCT02678312|466153769|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
129508964|NCT02678312|466153770|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
129508965|NCT00971425|466153771|FG000|Overall Study|Adverse Event|1|||
129508966|NCT00971425|466153772|FG001|Overall Study|Adverse Event|1|||
129508967|NCT00971425|466153771|FG000|Overall Study|Withdrawal by Subject|0|||
129508968|NCT00971425|466153772|FG001|Overall Study|Withdrawal by Subject|1|||
129508969|NCT04624672|466153773|FG000|Overall Study|Early Study Closure|2|||
129508970|NCT04624672|466153774|FG001|Overall Study|Early Study Closure|1|||
129508971|NCT03472040|466153775|FG000|Overall Study|Physician Decision|0|||
129508972|NCT03472040|466153776|FG001|Overall Study|Physician Decision|3|||
129508973|NCT03472040|466153775|FG000|Overall Study|Withdrawal by Subject|10|||
129508974|NCT03472040|466153776|FG001|Overall Study|Withdrawal by Subject|23|||
129508975|NCT03472040|466153775|FG000|Overall Study|Perceived Lack of Efficacy|29|||
129508976|NCT03472040|466153776|FG001|Overall Study|Perceived Lack of Efficacy|30|||
129508977|NCT03472040|466153775|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
129508978|NCT03472040|466153776|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
129508979|NCT03472040|466153775|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
129508980|NCT03472040|466153776|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
129508981|NCT03472040|466153775|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
129508982|NCT03472040|466153776|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
129508983|NCT03472040|466153775|FG000|Overall Study|Subject Non-compliance|2|||
129508984|NCT03472040|466153776|FG001|Overall Study|Subject Non-compliance|5|||
129508985|NCT03472040|466153775|FG000|Overall Study|Discontinuation due to Rash|0|||
129508986|NCT03472040|466153776|FG001|Overall Study|Discontinuation due to Rash|1|||
129508987|NCT03472040|466153775|FG000|Overall Study|Subsequent Ineligibility|0|||
129508988|NCT03472040|466153776|FG001|Overall Study|Subsequent Ineligibility|2|||
129508989|NCT03472040|466153775|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
129508990|NCT03472040|466153776|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
129508991|NCT02769832|466153777|FG000|Overall Study|Death|30|||
129508992|NCT00225147|466153786|FG000|Open-label Phase|Lost to Follow-up|0|||
129508993|NCT00225147|466153787|FG001|Open-label Phase|Lost to Follow-up|0|||
129508994|NCT00225147|466153788|FG002|Open-label Phase|Lost to Follow-up|0|||
129508995|NCT00225147|466153789|FG003|Open-label Phase|Lost to Follow-up|4|||
129508996|NCT00225147|466153786|FG000|Open-label Phase|Withdrawal by Subject|0|||
129508997|NCT00225147|466153787|FG001|Open-label Phase|Withdrawal by Subject|0|||
129508998|NCT00225147|466153788|FG002|Open-label Phase|Withdrawal by Subject|0|||
129508999|NCT00225147|466153789|FG003|Open-label Phase|Withdrawal by Subject|6|||
129509000|NCT02685995|466153795|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
129509001|NCT02685995|466153796|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
129509002|NCT03625141|466153797|FG000|Overall Study|Adverse Event|0|||
129509003|NCT03625141|466153798|FG001|Overall Study|Adverse Event|2|||
129509004|NCT03625141|466153797|FG000|Overall Study|Study Terminated By Sponsor|1|||
129509005|NCT03625141|466153798|FG001|Overall Study|Study Terminated By Sponsor|13|||
129509006|NCT03625141|466153797|FG000|Overall Study|Withdrawal by Subject|3|||
129509007|NCT03625141|466153798|FG001|Overall Study|Withdrawal by Subject|0|||
129509008|NCT03625141|466153797|FG000|Overall Study|Withdrawal Of Consent|0|||
129509009|NCT03625141|466153798|FG001|Overall Study|Withdrawal Of Consent|1|||
129509010|NCT03625141|466153797|FG000|Overall Study|Death|11|||
129509011|NCT03625141|466153798|FG001|Overall Study|Death|47|||
129509012|NCT03625141|466153797|FG000|Overall Study|Progressive Disease|0|||
129509013|NCT03625141|466153798|FG001|Overall Study|Progressive Disease|2|||
129509014|NCT00868166|466153800|FG000|Overall Study|Death|58|||
129509015|NCT00868166|466153801|FG001|Overall Study|Death|65|||
129509016|NCT00868166|466153800|FG000|Overall Study|Withdrawal by Subject|33|||
129509017|NCT00868166|466153801|FG001|Overall Study|Withdrawal by Subject|25|||
129509018|NCT00868166|466153800|FG000|Overall Study|Protocol Violation|1|||
129509019|NCT00868166|466153801|FG001|Overall Study|Protocol Violation|0|||
129509020|NCT00868166|466153800|FG000|Overall Study|Lost to Follow-up|1|||
129509021|NCT00868166|466153801|FG001|Overall Study|Lost to Follow-up|3|||
129509022|NCT00868166|466153800|FG000|Overall Study|Adverse Event|9|||
129509023|NCT00868166|466153801|FG001|Overall Study|Adverse Event|10|||
129509024|NCT00868166|466153800|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
129509025|NCT00868166|466153801|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
129509026|NCT00868166|466153800|FG000|Overall Study|Non-compliance with IMP|1|||
129509027|NCT00868166|466153801|FG001|Overall Study|Non-compliance with IMP|1|||
129509028|NCT00433446|466153808|FG000|Overall Study|Adverse Event|4|||
129509029|NCT00433446|466153808|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
129509030|NCT00433446|466153808|FG000|Overall Study|Progression|44|||
129509031|NCT00433446|466153808|FG000|Overall Study|Other - Not Protocol specified|3|||
129509032|NCT00433446|466153808|FG000|Overall Study|Ineligible|9|||
129509033|NCT03819218|466153809|FG000|Overall Study|Protocol Violation|1|||
129509034|NCT01188538|466153810|FG000|Overall Study|Lost to Follow-up|0|||
129509035|NCT01188538|466153811|FG001|Overall Study|Lost to Follow-up|1|||
129509036|NCT01231607|466153815|FG000|Overall Study|Adverse Event|0|||
129509037|NCT01231607|466153816|FG001|Overall Study|Adverse Event|8|||
129509038|NCT01231607|466153817|FG002|Overall Study|Adverse Event|4|||
129509039|NCT01231607|466153818|FG003|Overall Study|Adverse Event|4|||
129509040|NCT01231607|466153819|FG004|Overall Study|Adverse Event|5|||
129509041|NCT01231607|466153815|FG000|Overall Study|Lost to Follow-up|13|||
129509042|NCT01231607|466153816|FG001|Overall Study|Lost to Follow-up|11|||
129509043|NCT01231607|466153817|FG002|Overall Study|Lost to Follow-up|10|||
129509044|NCT01231607|466153818|FG003|Overall Study|Lost to Follow-up|10|||
129509045|NCT01231607|466153819|FG004|Overall Study|Lost to Follow-up|4|||
129509046|NCT01231607|466153815|FG000|Overall Study|Physician Decision|4|||
129509047|NCT01231607|466153816|FG001|Overall Study|Physician Decision|4|||
129509048|NCT01231607|466153817|FG002|Overall Study|Physician Decision|3|||
129509049|NCT01231607|466153818|FG003|Overall Study|Physician Decision|5|||
129509050|NCT01231607|466153819|FG004|Overall Study|Physician Decision|4|||
129509051|NCT01231607|466153815|FG000|Overall Study|Protocol Violation|3|||
129509052|NCT01231607|466153816|FG001|Overall Study|Protocol Violation|2|||
129509053|NCT01231607|466153817|FG002|Overall Study|Protocol Violation|0|||
129509054|NCT01231607|466153818|FG003|Overall Study|Protocol Violation|2|||
129509055|NCT01231607|466153819|FG004|Overall Study|Protocol Violation|2|||
129509056|NCT01231607|466153815|FG000|Overall Study|Withdrawal by Subject|9|||
129509057|NCT01231607|466153816|FG001|Overall Study|Withdrawal by Subject|9|||
129509058|NCT01231607|466153817|FG002|Overall Study|Withdrawal by Subject|14|||
129509059|NCT01231607|466153818|FG003|Overall Study|Withdrawal by Subject|17|||
129982810|NCT00943852|467900619|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129509060|NCT01231607|466153819|FG004|Overall Study|Withdrawal by Subject|9|||
129509061|NCT02267278|466153820|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
129509062|NCT02267278|466153820|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
129509063|NCT02267278|466153820|FG000|Overall Study|Developed new cancer diagnoses|2|||
129509064|NCT02267278|466153820|FG000|Overall Study|prescribed prohibited medication|1|||
129509065|NCT00650091|466153821|FG000|Amended Study Design|Withdrawal by Subject|12|||
129509066|NCT00650091|466153822|FG001|Amended Study Design|Withdrawal by Subject|11|||
129509067|NCT00650091|466153823|FG002|Amended Study Design|Withdrawal by Subject|0|||
129509068|NCT00650091|466153821|FG000|Amended Study Design|Physician Decision|5|||
129509069|NCT00650091|466153822|FG001|Amended Study Design|Physician Decision|0|||
129509070|NCT00650091|466153823|FG002|Amended Study Design|Physician Decision|0|||
129509071|NCT00650091|466153821|FG000|Amended Study Design|Adverse Event|1|||
129509072|NCT00650091|466153822|FG001|Amended Study Design|Adverse Event|4|||
129509073|NCT00650091|466153823|FG002|Amended Study Design|Adverse Event|0|||
129509074|NCT00650091|466153821|FG000|Amended Study Design|Lung transplantation|4|||
129509075|NCT00650091|466153822|FG001|Amended Study Design|Lung transplantation|2|||
129509076|NCT00650091|466153823|FG002|Amended Study Design|Lung transplantation|0|||
129509077|NCT00650091|466153821|FG000|Amended Study Design|Other|1|||
129509078|NCT00650091|466153822|FG001|Amended Study Design|Other|3|||
129509079|NCT00650091|466153823|FG002|Amended Study Design|Other|0|||
129509080|NCT04116073|466153830|FG000|Overall Study|Withdrawal by Subject|2|||
129509081|NCT04116073|466153830|FG000|Overall Study|failed to maintained eligibility|1|||
129509082|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
129509083|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
129509084|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
129509085|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
129509086|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
129509087|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
129509088|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Death|1|||
129509089|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Death|3|||
129509090|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
129509091|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
129509092|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
129509093|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
129509094|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
129509095|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
129509096|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
129509097|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
129509098|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
129509099|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
129509100|NCT02553317|466153837|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
129509101|NCT02553317|466153838|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
129509102|NCT02940626|466153839|FG000|Overall Study|Death|40|||
129509103|NCT02940626|466153840|FG001|Overall Study|Death|32|||
129509104|NCT02940626|466153839|FG000|Overall Study|Lost to Follow-up|5|||
129509105|NCT02940626|466153840|FG001|Overall Study|Lost to Follow-up|2|||
129509106|NCT02940626|466153839|FG000|Overall Study|Withdrawal by Subject|1|||
129509107|NCT02940626|466153840|FG001|Overall Study|Withdrawal by Subject|0|||
129509108|NCT02940626|466153839|FG000|Overall Study|Transfer to Hospice Care|1|||
129509109|NCT02940626|466153840|FG001|Overall Study|Transfer to Hospice Care|0|||
129509110|NCT02940626|466153839|FG000|Overall Study|Prohibited Concomitant Medication|0|||
129509111|NCT02940626|466153840|FG001|Overall Study|Prohibited Concomitant Medication|1|||
129509112|NCT01996904|466153841|FG000|Overall Study|Lost to Follow-up|38|||
129509113|NCT01996904|466153842|FG001|Overall Study|Lost to Follow-up|27|||
129509114|NCT04664855|466153844|FG000|Overall Study|Withdrawal by Subject|0|||
129509115|NCT04664855|466153845|FG001|Overall Study|Withdrawal by Subject|2|||
129509116|NCT05127421|466153846|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
129509117|NCT05127421|466153847|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
129509118|NCT05127421|466153848|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
129509119|NCT05127421|466153849|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
129509120|NCT05127421|466153846|FG000|4-Week Double-Blind Period|Physician Decision|1|||
129509121|NCT05127421|466153847|FG001|4-Week Double-Blind Period|Physician Decision|0|||
129509122|NCT05127421|466153848|FG002|4-Week Double-Blind Period|Physician Decision|0|||
129509123|NCT05127421|466153849|FG003|4-Week Double-Blind Period|Physician Decision|0|||
129509124|NCT05127421|466153846|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
129509125|NCT05127421|466153847|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
129509126|NCT05127421|466153848|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
129509127|NCT05127421|466153849|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
129509128|NCT05127421|466153846|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
129509129|NCT05127421|466153847|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
129509130|NCT05127421|466153848|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
129509131|NCT05127421|466153849|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
129509132|NCT05127421|466153846|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
129509133|NCT05127421|466153847|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
129509134|NCT05127421|466153848|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
129509135|NCT05127421|466153849|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
129982811|NCT00943852|467900620|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129509136|NCT05127421|466153846|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
129509137|NCT05127421|466153847|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
129509138|NCT05127421|466153848|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
129509139|NCT05127421|466153849|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
129509140|NCT05127421|466153846|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
129509141|NCT05127421|466153847|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
129509142|NCT05127421|466153848|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
129509143|NCT05127421|466153849|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
129509144|NCT05127421|466153846|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
129509145|NCT05127421|466153847|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
129509146|NCT05127421|466153848|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
129509147|NCT05127421|466153849|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
129509148|NCT02219087|466153850|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
129509149|NCT02219087|466153851|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
129509150|NCT00574496|466153854|FG000|Overall Study|Withdrawal by Subject|1|||
129509151|NCT03454412|466153855|FG000|Baseline Assesment|Physician Decision|12|||
129509152|NCT01518244|466153856|FG000|Overall Study|Adverse Event|3|||
129509153|NCT03543358|466153857|FG000|Overall Study|Death|1|||
129509154|NCT03543358|466153858|FG001|Overall Study|Death|0|||
129509155|NCT03543358|466153857|FG000|Overall Study|Disease Progression|1|||
129509156|NCT03543358|466153858|FG001|Overall Study|Disease Progression|0|||
129509157|NCT03543358|466153857|FG000|Overall Study|Parent Study Closure|1|||
129509158|NCT03543358|466153858|FG001|Overall Study|Parent Study Closure|0|||
129509159|NCT01766817|466153859|FG000|Overall Study|Drug-related adverse event|1|||
129509160|NCT01766817|466153860|FG001|Overall Study|Drug-related adverse event|2|||
129509161|NCT01766817|466153861|FG002|Overall Study|Drug-related adverse event|1|||
129509162|NCT01766817|466153859|FG000|Overall Study|Drug-unrelated adverse event|3|||
129509163|NCT01766817|466153860|FG001|Overall Study|Drug-unrelated adverse event|3|||
129509164|NCT01766817|466153861|FG002|Overall Study|Drug-unrelated adverse event|3|||
129509165|NCT01766817|466153859|FG000|Overall Study|Death|1|||
129509166|NCT01766817|466153860|FG001|Overall Study|Death|1|||
129509167|NCT01766817|466153861|FG002|Overall Study|Death|0|||
129509168|NCT01766817|466153859|FG000|Overall Study|Unable to take study drug|0|||
129509169|NCT01766817|466153860|FG001|Overall Study|Unable to take study drug|1|||
129509170|NCT01766817|466153861|FG002|Overall Study|Unable to take study drug|0|||
129509171|NCT01766817|466153859|FG000|Overall Study|Withdrawal by Subject|2|||
129509172|NCT01766817|466153860|FG001|Overall Study|Withdrawal by Subject|0|||
129509173|NCT01766817|466153861|FG002|Overall Study|Withdrawal by Subject|3|||
129509174|NCT01766817|466153859|FG000|Overall Study|Subject non-compliance|0|||
129509175|NCT01766817|466153860|FG001|Overall Study|Subject non-compliance|1|||
129509176|NCT01766817|466153861|FG002|Overall Study|Subject non-compliance|2|||
129509177|NCT01766817|466153859|FG000|Overall Study|Physician Decision|3|||
129509178|NCT01766817|466153860|FG001|Overall Study|Physician Decision|3|||
129509179|NCT01766817|466153861|FG002|Overall Study|Physician Decision|4|||
129509180|NCT01766817|466153859|FG000|Overall Study|Other|1|||
129509181|NCT01766817|466153860|FG001|Overall Study|Other|0|||
129509182|NCT01766817|466153861|FG002|Overall Study|Other|0|||
129509183|NCT00178464|466153862|FG000|Overall Study|Withdrawal by Subject|1|||
129509184|NCT00178464|466153862|FG000|Overall Study|Physician Decision|1|||
129509185|NCT00870818|466153864|FG000|Overall Study|Lost to Follow-up|3|||
129509186|NCT00870818|466153865|FG001|Overall Study|Lost to Follow-up|2|||
129509187|NCT00870818|466153866|FG002|Overall Study|Lost to Follow-up|1|||
129509188|NCT00870818|466153867|FG003|Overall Study|Lost to Follow-up|0|||
129509189|NCT00870818|466153868|FG004|Overall Study|Lost to Follow-up|0|||
129509190|NCT00870818|466153864|FG000|Overall Study|Withdrawal by Subject|0|||
129509191|NCT00870818|466153865|FG001|Overall Study|Withdrawal by Subject|0|||
129509192|NCT00870818|466153866|FG002|Overall Study|Withdrawal by Subject|1|||
129509193|NCT00870818|466153867|FG003|Overall Study|Withdrawal by Subject|2|||
129509194|NCT00870818|466153868|FG004|Overall Study|Withdrawal by Subject|0|||
129509195|NCT00870818|466153864|FG000|Overall Study|Terminated by sponsor|29|||
129509196|NCT00870818|466153865|FG001|Overall Study|Terminated by sponsor|70|||
129509197|NCT00870818|466153866|FG002|Overall Study|Terminated by sponsor|36|||
129509198|NCT00870818|466153867|FG003|Overall Study|Terminated by sponsor|36|||
129509199|NCT00870818|466153868|FG004|Overall Study|Terminated by sponsor|38|||
129509200|NCT00870818|466153864|FG000|Overall Study|Other|0|||
129509201|NCT00870818|466153865|FG001|Overall Study|Other|1|||
129509202|NCT00870818|466153866|FG002|Overall Study|Other|0|||
129509203|NCT00870818|466153867|FG003|Overall Study|Other|0|||
129509204|NCT00870818|466153868|FG004|Overall Study|Other|0|||
129509205|NCT02227108|466153871|FG000|Overall Study|Did not receive treatment|2|||
129509206|NCT02227108|466153871|FG000|Overall Study|Other|3|||
129509207|NCT02227108|466153871|FG000|Overall Study|Progressive disease|17|||
129509208|NCT02227108|466153871|FG000|Overall Study|Initiation of alternative therapy|2|||
129509209|NCT02227108|466153871|FG000|Overall Study|Investigator discretion|1|||
129509210|NCT02227108|466153871|FG000|Overall Study|Adverse Event|6|||
129509211|NCT04900038|466153872|FG000|Overall Study|Adverse Event|1|||
129509212|NCT04900038|466153873|FG001|Overall Study|Adverse Event|0|||
129509213|NCT04900038|466153874|FG002|Overall Study|Adverse Event|1|||
129509214|NCT04900038|466153875|FG003|Overall Study|Adverse Event|1|||
129509215|NCT04900038|466153872|FG000|Overall Study|Withdrawal by Subject|0|||
129509216|NCT04900038|466153873|FG001|Overall Study|Withdrawal by Subject|1|||
129509217|NCT04900038|466153874|FG002|Overall Study|Withdrawal by Subject|0|||
129509218|NCT04900038|466153875|FG003|Overall Study|Withdrawal by Subject|0|||
129509219|NCT04900038|466153872|FG000|Overall Study|Study terminated by sponsor|18|||
129509220|NCT04900038|466153873|FG001|Overall Study|Study terminated by sponsor|15|||
129509221|NCT04900038|466153874|FG002|Overall Study|Study terminated by sponsor|17|||
129509222|NCT04900038|466153875|FG003|Overall Study|Study terminated by sponsor|14|||
129509223|NCT04900038|466153872|FG000|Overall Study|Protocol Deviation|1|||
129509224|NCT04900038|466153873|FG001|Overall Study|Protocol Deviation|1|||
129509225|NCT04900038|466153874|FG002|Overall Study|Protocol Deviation|0|||
129509226|NCT04900038|466153875|FG003|Overall Study|Protocol Deviation|0|||
129509227|NCT04900038|466153872|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
129509228|NCT04900038|466153873|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
129509229|NCT04900038|466153874|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
129509230|NCT04900038|466153875|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
129509231|NCT04900038|466153872|FG000|Overall Study|Lost to Follow-up|0|||
129509232|NCT04900038|466153873|FG001|Overall Study|Lost to Follow-up|0|||
129509233|NCT04900038|466153874|FG002|Overall Study|Lost to Follow-up|0|||
129509234|NCT04900038|466153875|FG003|Overall Study|Lost to Follow-up|1|||
129509235|NCT02486952|466153876|FG000|Overall Study|Not Started Induction Therapy|3|||
129509236|NCT02486952|466153876|FG000|Overall Study|Adverse Event|1|||
129509237|NCT02486952|466153876|FG000|Overall Study|Death|15|||
129509238|NCT02486952|466153876|FG000|Overall Study|Lack of Efficacy|3|||
129509239|NCT02486952|466153876|FG000|Overall Study|Lost to Follow-up|26|||
129509240|NCT02486952|466153876|FG000|Overall Study|Other|2|||
129509241|NCT01928485|466153878|FG000|Overall Study|Physician Decision|0|||
129509242|NCT01928485|466153879|FG001|Overall Study|Physician Decision|1|||
129509243|NCT04111107|466153880|FG000|Overall Study|Withdrawal by Subject|6|||
129509244|NCT04111107|466153880|FG000|Overall Study|Declining Health|5|||
129509245|NCT03956225|466153881|FG000|Overall Study|Lack of Efficacy|1|||
129509246|NCT03956225|466153882|FG001|Overall Study|Lack of Efficacy|1|||
129509247|NCT03956225|466153881|FG000|Overall Study|Lost to Follow-up|0|||
129509248|NCT03956225|466153882|FG001|Overall Study|Lost to Follow-up|1|||
129509249|NCT03956225|466153881|FG000|Overall Study|Withdrawal by Subject|2|||
129509250|NCT03956225|466153882|FG001|Overall Study|Withdrawal by Subject|1|||
129509251|NCT03956225|466153881|FG000|Overall Study|Other Reasons|2|||
129509252|NCT03956225|466153882|FG001|Overall Study|Other Reasons|1|||
129509253|NCT02260648|466153883|FG000|Overall Study|Adverse Event|3|||
129509254|NCT02260648|466153884|FG001|Overall Study|Adverse Event|0|||
129509255|NCT02260648|466153885|FG002|Overall Study|Adverse Event|1|||
129509256|NCT02260648|466153883|FG000|Overall Study|Withdrawal by Subject|1|||
129509257|NCT02260648|466153884|FG001|Overall Study|Withdrawal by Subject|1|||
129509258|NCT02260648|466153885|FG002|Overall Study|Withdrawal by Subject|0|||
129509259|NCT02260648|466153883|FG000|Overall Study|Protocol Violation|1|||
129509260|NCT02260648|466153884|FG001|Overall Study|Protocol Violation|0|||
129509261|NCT02260648|466153885|FG002|Overall Study|Protocol Violation|0|||
129509262|NCT02260648|466153883|FG000|Overall Study|Discontinue Due to Study Termination|13|||
129509263|NCT02260648|466153884|FG001|Overall Study|Discontinue Due to Study Termination|12|||
129509264|NCT02260648|466153885|FG002|Overall Study|Discontinue Due to Study Termination|7|||
129509265|NCT04093258|466153886|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
129509266|NCT04093258|466153887|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
129509267|NCT00594204|466153888|FG000|Overall Study|Adverse Event|15|||
129509268|NCT00594204|466153889|FG001|Overall Study|Adverse Event|3|||
129509269|NCT00594204|466153888|FG000|Overall Study|Lost to Follow-up|9|||
129509270|NCT00594204|466153889|FG001|Overall Study|Lost to Follow-up|5|||
129509271|NCT00594204|466153888|FG000|Overall Study|Withdrawal by Subject|23|||
129509272|NCT00594204|466153889|FG001|Overall Study|Withdrawal by Subject|29|||
129509273|NCT00594204|466153888|FG000|Overall Study|Other|4|||
129509274|NCT00594204|466153889|FG001|Overall Study|Other|3|||
129509275|NCT00594204|466153888|FG000|Overall Study|Lack of Efficacy|3|||
129509276|NCT00594204|466153889|FG001|Overall Study|Lack of Efficacy|4|||
129509277|NCT00594204|466153888|FG000|Overall Study|Randomized but not treated|4|||
129509278|NCT00594204|466153889|FG001|Overall Study|Randomized but not treated|1|||
129509279|NCT01529385|466153890|FG000|Overall Study|Lost to Follow-up|2|||
129509280|NCT01529385|466153891|FG001|Overall Study|Lost to Follow-up|1|||
129509281|NCT01401465|466153892|FG000|Treatment Period 1|Adverse Event|4|||
129509282|NCT01401465|466153893|FG001|Treatment Period 1|Adverse Event|1|||
129509283|NCT01401465|466153892|FG000|Treatment Period 1|Pregnancy|0|||
129509284|NCT01401465|466153893|FG001|Treatment Period 1|Pregnancy|1|||
129509285|NCT01401465|466153892|FG000|Treatment Period 1|Protocol Violation|5|||
129509286|NCT01401465|466153893|FG001|Treatment Period 1|Protocol Violation|0|||
129509287|NCT01401465|466153892|FG000|Treatment Period 1|Withdrawal by Subject|1|||
129509288|NCT01401465|466153893|FG001|Treatment Period 1|Withdrawal by Subject|4|||
129509289|NCT01401465|466153892|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
129539075|NCT02708524|466265147|FG003|Overall Study|Protocol Violation|0|||
129509290|NCT01401465|466153893|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
129509291|NCT01401465|466153892|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
129509292|NCT01401465|466153893|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
129509293|NCT01401465|466153892|FG000|Treatment Period 1|Scheduling Difficulties|1|||
129509294|NCT01401465|466153893|FG001|Treatment Period 1|Scheduling Difficulties|1|||
129509295|NCT01401465|466153892|FG000|Treatment Period 2|Lost to Follow-up|0|||
129509296|NCT01401465|466153893|FG001|Treatment Period 2|Lost to Follow-up|1|||
129509297|NCT01401465|466153892|FG000|Treatment Period 2|Withdrawal by Subject|0|||
129509298|NCT01401465|466153893|FG001|Treatment Period 2|Withdrawal by Subject|1|||
129509299|NCT00986427|466153894|FG000|Overall Study|Lost to Follow-up|2|||
129509300|NCT00986427|466153895|FG001|Overall Study|Lost to Follow-up|0|||
129509301|NCT00986427|466153894|FG000|Overall Study|Lack of Efficacy|1|||
129509302|NCT00986427|466153895|FG001|Overall Study|Lack of Efficacy|0|||
129509303|NCT00986427|466153894|FG000|Overall Study|Withdrawal by Subject|1|||
129509304|NCT00986427|466153895|FG001|Overall Study|Withdrawal by Subject|0|||
129509305|NCT01115738|466153896|FG000|Overall Study|Death|1|||
129509306|NCT01115738|466153897|FG001|Overall Study|Death|0|||
129509307|NCT01115738|466153898|FG002|Overall Study|Death|0|||
129509308|NCT01115738|466153896|FG000|Overall Study|Lost to Follow-up|0|||
129509309|NCT01115738|466153897|FG001|Overall Study|Lost to Follow-up|0|||
129509310|NCT01115738|466153898|FG002|Overall Study|Lost to Follow-up|1|||
129509311|NCT01115738|466153896|FG000|Overall Study|Physician Decision|18|||
129509312|NCT01115738|466153897|FG001|Overall Study|Physician Decision|15|||
129509313|NCT01115738|466153898|FG002|Overall Study|Physician Decision|17|||
129509314|NCT01115738|466153896|FG000|Overall Study|Withdrawal by Subject|6|||
129509315|NCT01115738|466153897|FG001|Overall Study|Withdrawal by Subject|6|||
129509316|NCT01115738|466153898|FG002|Overall Study|Withdrawal by Subject|9|||
129509317|NCT02721251|466153899|FG000|Overall Study|Withdrawal by Subject|8|||
129509318|NCT02721251|466153900|FG001|Overall Study|Withdrawal by Subject|7|||
129509319|NCT02721251|466153901|FG002|Overall Study|Withdrawal by Subject|9|||
129509320|NCT02721251|466153899|FG000|Overall Study|poor adherence|2|||
129509321|NCT02721251|466153900|FG001|Overall Study|poor adherence|2|||
129509322|NCT02721251|466153901|FG002|Overall Study|poor adherence|2|||
129509323|NCT01714817|466153902|FG000|Year 1 Period|Lack of Efficacy|11|||
129509324|NCT01714817|466153903|FG001|Year 1 Period|Lack of Efficacy|9|||
129509325|NCT01714817|466153902|FG000|Year 1 Period|Adverse Event|20|||
129509326|NCT01714817|466153903|FG001|Year 1 Period|Adverse Event|17|||
129509327|NCT01714817|466153902|FG000|Year 1 Period|Withdrawal by Subject|6|||
129509328|NCT01714817|466153903|FG001|Year 1 Period|Withdrawal by Subject|7|||
129509329|NCT01714817|466153902|FG000|Year 1 Period|Death|1|||
129509330|NCT01714817|466153903|FG001|Year 1 Period|Death|1|||
129509331|NCT01714817|466153902|FG000|Year 1 Period|Lost to Follow-up|0|||
129509332|NCT01714817|466153903|FG001|Year 1 Period|Lost to Follow-up|2|||
129509333|NCT01714817|466153902|FG000|Year 1 Period|Poor / non-compliance|0|||
129509334|NCT01714817|466153903|FG001|Year 1 Period|Poor / non-compliance|1|||
129509335|NCT01714817|466153902|FG000|Year 1 Period|Pregnancy|2|||
129509336|NCT01714817|466153903|FG001|Year 1 Period|Pregnancy|0|||
129509337|NCT01714817|466153902|FG000|Year 1 Period|Participant no longer meets criteria|6|||
129509338|NCT01714817|466153903|FG001|Year 1 Period|Participant no longer meets criteria|2|||
129509339|NCT01714817|466153902|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
129509340|NCT01714817|466153903|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
129509341|NCT01714817|466153902|FG000|Year 1 Period|Change in Concomitant Medication|0|||
129509342|NCT01714817|466153903|FG001|Year 1 Period|Change in Concomitant Medication|1|||
129509343|NCT01714817|466153902|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
129509344|NCT01714817|466153903|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
129509345|NCT01714817|466153902|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
129509346|NCT01714817|466153903|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
129509347|NCT01714817|466153902|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
129509348|NCT01714817|466153903|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
129509349|NCT01714817|466153902|FG000|Year 2 Period|Lack of Efficacy|4|||
129509350|NCT01714817|466153903|FG001|Year 2 Period|Lack of Efficacy|12|||
129509351|NCT01714817|466153902|FG000|Year 2 Period|Adverse Event|7|||
129509352|NCT01714817|466153903|FG001|Year 2 Period|Adverse Event|6|||
129509353|NCT01714817|466153902|FG000|Year 2 Period|Participant request to stop treatment|4|||
129509354|NCT01714817|466153903|FG001|Year 2 Period|Participant request to stop treatment|4|||
129509355|NCT01714817|466153902|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
129509356|NCT01714817|466153903|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
129509357|NCT01714817|466153902|FG000|Year 2 Period|Participant withdrew consent|1|||
129509358|NCT01714817|466153903|FG001|Year 2 Period|Participant withdrew consent|5|||
129509359|NCT01714817|466153902|FG000|Year 2 Period|Participant no longer meets criteria|1|||
129509360|NCT01714817|466153903|FG001|Year 2 Period|Participant no longer meets criteria|4|||
129509361|NCT01714817|466153902|FG000|Year 2 Period|Lost to Follow-up|2|||
129509362|NCT01714817|466153903|FG001|Year 2 Period|Lost to Follow-up|0|||
129509363|NCT01714817|466153902|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
129509364|NCT01714817|466153903|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
129509365|NCT01714817|466153902|FG000|Year 2 Period|Pregnancy|1|||
129509366|NCT01714817|466153903|FG001|Year 2 Period|Pregnancy|1|||
129509367|NCT01714817|466153902|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
129509368|NCT01714817|466153903|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
129509369|NCT01714817|466153902|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
129509370|NCT01714817|466153903|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
129509371|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
129509372|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
129509373|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
129509374|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
129509375|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
129509376|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
129509377|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
129509378|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
129509379|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
129509380|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
129509381|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
129509382|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
129509383|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
129509384|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
129509385|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
129509386|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
129509387|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
129509388|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
129509389|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
129509390|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
129509391|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
129509392|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
129509393|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
129509394|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
129509395|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
129509396|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
129509397|NCT01714817|466153902|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
129509398|NCT01714817|466153903|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
129509399|NCT02921763|466153904|FG000|Overall Study|Adverse Event|4|||
129509400|NCT02921763|466153904|FG000|Overall Study|Lost to Follow-up|4|||
129509401|NCT02921763|466153904|FG000|Overall Study|Lack of Efficacy|3|||
129509402|NCT02921763|466153904|FG000|Overall Study|Protocol Violation|2|||
129509403|NCT02921763|466153904|FG000|Overall Study|Withdrawal by Subject|2|||
129509404|NCT02921763|466153904|FG000|Overall Study|Physician Decision|1|||
129509405|NCT02921763|466153904|FG000|Overall Study|No data obtained|2|||
129509406|NCT01582971|466153905|FG000|Overall Study|Death|2|||
129509407|NCT01582971|466153906|FG001|Overall Study|Death|1|||
129509408|NCT01582971|466153905|FG000|Overall Study|Lost to Follow-up|18|||
129509409|NCT01582971|466153906|FG001|Overall Study|Lost to Follow-up|21|||
129509410|NCT01582971|466153905|FG000|Overall Study|Withdrawal by Subject|4|||
129509411|NCT01582971|466153906|FG001|Overall Study|Withdrawal by Subject|2|||
129509412|NCT01582971|466153905|FG000|Overall Study|Other|15|||
129509413|NCT01582971|466153906|FG001|Overall Study|Other|13|||
129509414|NCT02554253|466153914|FG000|Overall Study|ineligible after enrollment|1|||
129509415|NCT02554253|466153915|FG001|Overall Study|ineligible after enrollment|0|||
129509416|NCT02554253|466153914|FG000|Overall Study|converted to transcatheter procedure|0|||
129509417|NCT02554253|466153915|FG001|Overall Study|converted to transcatheter procedure|1|||
129509418|NCT02554253|466153914|FG000|Overall Study|received both drugs|0|||
129509419|NCT02554253|466153915|FG001|Overall Study|received both drugs|1|||
129509420|NCT01736254|466153918|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
129509421|NCT01736254|466153918|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
129509422|NCT02559206|466153919|FG000|Overall Study|Adverse Event|0|||
129509423|NCT02559206|466153920|FG001|Overall Study|Adverse Event|4|||
129509424|NCT02559206|466153921|FG002|Overall Study|Adverse Event|1|||
129509425|NCT02559206|466153922|FG003|Overall Study|Adverse Event|5|||
129509426|NCT02559206|466153923|FG004|Overall Study|Adverse Event|3|||
129509427|NCT02559206|466153924|FG005|Overall Study|Adverse Event|0|||
129509428|NCT02559206|466153925|FG006|Overall Study|Adverse Event|1|||
129509429|NCT02559206|466153926|FG007|Overall Study|Adverse Event|0|||
129509430|NCT02559206|466153919|FG000|Overall Study|Protocol Violation|1|||
129509431|NCT02559206|466153920|FG001|Overall Study|Protocol Violation|0|||
129509432|NCT02559206|466153921|FG002|Overall Study|Protocol Violation|1|||
129509433|NCT02559206|466153922|FG003|Overall Study|Protocol Violation|0|||
129509434|NCT02559206|466153923|FG004|Overall Study|Protocol Violation|0|||
129509435|NCT02559206|466153924|FG005|Overall Study|Protocol Violation|2|||
129509436|NCT02559206|466153925|FG006|Overall Study|Protocol Violation|0|||
129509437|NCT02559206|466153926|FG007|Overall Study|Protocol Violation|0|||
129509438|NCT02559206|466153919|FG000|Overall Study|Withdrawal by Subject|3|||
129509439|NCT02559206|466153920|FG001|Overall Study|Withdrawal by Subject|3|||
129509440|NCT02559206|466153921|FG002|Overall Study|Withdrawal by Subject|1|||
129509441|NCT02559206|466153922|FG003|Overall Study|Withdrawal by Subject|3|||
129509442|NCT02559206|466153923|FG004|Overall Study|Withdrawal by Subject|5|||
129509443|NCT02559206|466153924|FG005|Overall Study|Withdrawal by Subject|4|||
129509444|NCT02559206|466153925|FG006|Overall Study|Withdrawal by Subject|1|||
129509445|NCT02559206|466153926|FG007|Overall Study|Withdrawal by Subject|2|||
129509446|NCT02559206|466153919|FG000|Overall Study|Lost to Follow-up|3|||
129509447|NCT02559206|466153920|FG001|Overall Study|Lost to Follow-up|5|||
129509448|NCT02559206|466153921|FG002|Overall Study|Lost to Follow-up|3|||
129509449|NCT02559206|466153922|FG003|Overall Study|Lost to Follow-up|3|||
129509450|NCT02559206|466153923|FG004|Overall Study|Lost to Follow-up|2|||
129509451|NCT02559206|466153924|FG005|Overall Study|Lost to Follow-up|5|||
129509452|NCT02559206|466153925|FG006|Overall Study|Lost to Follow-up|1|||
129509453|NCT02559206|466153926|FG007|Overall Study|Lost to Follow-up|4|||
129509454|NCT02559206|466153919|FG000|Overall Study|Lack of Efficacy|1|||
129509455|NCT02559206|466153920|FG001|Overall Study|Lack of Efficacy|0|||
129509456|NCT02559206|466153921|FG002|Overall Study|Lack of Efficacy|3|||
129509457|NCT02559206|466153922|FG003|Overall Study|Lack of Efficacy|2|||
129509458|NCT02559206|466153923|FG004|Overall Study|Lack of Efficacy|2|||
129509459|NCT02559206|466153924|FG005|Overall Study|Lack of Efficacy|3|||
129509460|NCT02559206|466153925|FG006|Overall Study|Lack of Efficacy|3|||
129509461|NCT02559206|466153926|FG007|Overall Study|Lack of Efficacy|3|||
129509462|NCT02559206|466153919|FG000|Overall Study|Other Not Specified|0|||
129509463|NCT02559206|466153920|FG001|Overall Study|Other Not Specified|0|||
129509464|NCT02559206|466153921|FG002|Overall Study|Other Not Specified|0|||
129509465|NCT02559206|466153922|FG003|Overall Study|Other Not Specified|1|||
129509466|NCT02559206|466153923|FG004|Overall Study|Other Not Specified|0|||
129509467|NCT02559206|466153924|FG005|Overall Study|Other Not Specified|0|||
129509468|NCT02559206|466153925|FG006|Overall Study|Other Not Specified|0|||
129509469|NCT02559206|466153926|FG007|Overall Study|Other Not Specified|0|||
129509470|NCT01561560|466153927|FG000|First Two Weeks of Wear|Time/job conflict|0|||
129509471|NCT01561560|466153928|FG001|First Two Weeks of Wear|Time/job conflict|1|||
129509472|NCT01561560|466153927|FG000|First Two Weeks of Wear|Adverse Event|0|||
129509473|NCT01561560|466153928|FG001|First Two Weeks of Wear|Adverse Event|1|||
129509474|NCT01561560|466153927|FG000|Second Two Weeks of Wear|Adverse Event|0|||
129509475|NCT01561560|466153928|FG001|Second Two Weeks of Wear|Adverse Event|1|||
129509476|NCT01871896|466153931|FG000|Overall Study|Lost to Follow-up|1|||
129509477|NCT06025396|466155527|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
129509478|NCT06025396|466155528|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
129509479|NCT06025396|466155529|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
129509480|NCT06025396|466155530|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
129509481|NCT06025396|466155531|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
129509482|NCT06025396|466155527|FG000|Overall Study|Withdrawal by Subject|0|||
129509483|NCT06025396|466155528|FG001|Overall Study|Withdrawal by Subject|1|||
129509484|NCT06025396|466155529|FG002|Overall Study|Withdrawal by Subject|1|||
129509485|NCT06025396|466155530|FG003|Overall Study|Withdrawal by Subject|0|||
129509486|NCT06025396|466155531|FG004|Overall Study|Withdrawal by Subject|0|||
129509487|NCT01512108|466155532|FG000|Overall Study|Adverse Event|9|||
129509488|NCT01512108|466155533|FG001|Overall Study|Adverse Event|4|||
129509489|NCT01512108|466155532|FG000|Overall Study|Protocol Violation|1|||
129509490|NCT01512108|466155533|FG001|Overall Study|Protocol Violation|2|||
129509491|NCT01512108|466155532|FG000|Overall Study|Withdrawal Criteria|1|||
129509492|NCT01512108|466155533|FG001|Overall Study|Withdrawal Criteria|0|||
129509493|NCT01512108|466155532|FG000|Overall Study|Unclassified|11|||
129982812|NCT00943852|467900621|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982813|NCT00943852|467900622|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982814|NCT00943852|467900623|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982815|NCT00943852|467900624|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
129509494|NCT01512108|466155533|FG001|Overall Study|Unclassified|3|||
129509495|NCT06422377|466155539|FG000|Overall Study|Study Terminated by Sponsor|1|||
129509496|NCT02843178|466155541|FG000|Overall Study|Lost to Follow-up|8|||
129509497|NCT02843178|466155542|FG001|Overall Study|Lost to Follow-up|8|||
129509498|NCT02843178|466155543|FG002|Overall Study|Lost to Follow-up|6|||
129509499|NCT02843178|466155544|FG003|Overall Study|Lost to Follow-up|3|||
129509500|NCT02843178|466155541|FG000|Overall Study|Withdrawal by Subject|0|||
129509501|NCT02843178|466155542|FG001|Overall Study|Withdrawal by Subject|0|||
129509502|NCT02843178|466155543|FG002|Overall Study|Withdrawal by Subject|1|||
129509503|NCT02843178|466155544|FG003|Overall Study|Withdrawal by Subject|1|||
129509504|NCT02701192|466155547|FG000|Overall Study|Protocol Violation|2|||
129509505|NCT02701192|466155547|FG000|Overall Study|Lost to Follow-up|4|||
129509506|NCT00949910|466155548|FG000|Overall Study|Progressive Disease|3750|||
129509507|NCT00949910|466155548|FG000|Overall Study|Symptomatic Deterioration|1088|||
129509508|NCT00949910|466155548|FG000|Overall Study|Lost to Follow-up|100|||
129509509|NCT00949910|466155548|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
129509510|NCT00949910|466155548|FG000|Overall Study|Participant Refusal|390|||
129509511|NCT00949910|466155548|FG000|Overall Study|Death Due to Malignant Disease|456|||
129509512|NCT00949910|466155548|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
129509513|NCT00949910|466155548|FG000|Overall Study|Death Due to Adverse Event|115|||
129509514|NCT00949910|466155548|FG000|Overall Study|Death Due to Toxicity|3|||
129509515|NCT00949910|466155548|FG000|Overall Study|Death from Unknown Cause|5|||
129509516|NCT00949910|466155548|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
129509517|NCT00949910|466155548|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
129509518|NCT00949910|466155548|FG000|Overall Study|Switched to Commercial Treatment|4|||
129509519|NCT00949910|466155548|FG000|Overall Study|Violation of Eligibility|23|||
129509520|NCT00949910|466155548|FG000|Overall Study|Logistical Reasons|13|||
129509521|NCT00949910|466155548|FG000|Overall Study|Non-Compliance|10|||
129509522|NCT00949910|466155548|FG000|Overall Study|Prolonged Dosing Interruption|4|||
129509523|NCT00949910|466155548|FG000|Overall Study|Adverse Event|83|||
129509524|NCT00949910|466155548|FG000|Overall Study|Serious Adverse Event|6|||
129509525|NCT00949910|466155548|FG000|Overall Study|Physician/Participant Decision|7|||
129509526|NCT00949910|466155548|FG000|Overall Study|Other|4|||
129509527|NCT00949910|466155548|FG000|Overall Study|No Data|9|||
129509528|NCT02759562|466155551|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
129509529|NCT02759562|466155552|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
129509530|NCT02759562|466155551|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
129509531|NCT02759562|466155552|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
129509532|NCT02501902|466155557|FG000|Overall Study|Subject Refused Further Follow-up|0|||
129509533|NCT02501902|466155558|FG001|Overall Study|Subject Refused Further Follow-up|0|||
129509534|NCT02501902|466155559|FG002|Overall Study|Subject Refused Further Follow-up|0|||
129509535|NCT02501902|466155560|FG003|Overall Study|Subject Refused Further Follow-up|0|||
129509536|NCT02501902|466155561|FG004|Overall Study|Subject Refused Further Follow-up|0|||
129509537|NCT02501902|466155562|FG005|Overall Study|Subject Refused Further Follow-up|0|||
129509538|NCT02501902|466155563|FG006|Overall Study|Subject Refused Further Follow-up|0|||
129509539|NCT02501902|466155564|FG007|Overall Study|Subject Refused Further Follow-up|1|||
129509540|NCT02501902|466155557|FG000|Overall Study|Study Terminated by Sponsor|0|||
129509541|NCT02501902|466155558|FG001|Overall Study|Study Terminated by Sponsor|3|||
129509542|NCT02501902|466155559|FG002|Overall Study|Study Terminated by Sponsor|0|||
129509543|NCT02501902|466155560|FG003|Overall Study|Study Terminated by Sponsor|1|||
129509544|NCT02501902|466155561|FG004|Overall Study|Study Terminated by Sponsor|1|||
129509545|NCT02501902|466155562|FG005|Overall Study|Study Terminated by Sponsor|0|||
129509546|NCT02501902|466155563|FG006|Overall Study|Study Terminated by Sponsor|2|||
129509547|NCT02501902|466155564|FG007|Overall Study|Study Terminated by Sponsor|4|||
129509548|NCT02501902|466155557|FG000|Overall Study|Death|3|||
129509549|NCT02501902|466155558|FG001|Overall Study|Death|4|||
129509550|NCT02501902|466155559|FG002|Overall Study|Death|4|||
129509551|NCT02501902|466155560|FG003|Overall Study|Death|10|||
129509552|NCT02501902|466155561|FG004|Overall Study|Death|10|||
129509553|NCT02501902|466155562|FG005|Overall Study|Death|11|||
129509554|NCT02501902|466155563|FG006|Overall Study|Death|7|||
129509555|NCT02501902|466155564|FG007|Overall Study|Death|15|||
129509556|NCT02513771|466155565|FG000|Overall Study|Lost to Follow-up|1|||
129509557|NCT02513771|466155566|FG001|Overall Study|Lost to Follow-up|1|||
129509558|NCT02513771|466155565|FG000|Overall Study|Not being able to get to clinic|1|||
129509559|NCT02513771|466155566|FG001|Overall Study|Not being able to get to clinic|0|||
129509560|NCT01797445|466155569|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
129509561|NCT01797445|466155570|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
129509562|NCT01797445|466155569|FG000|Double-Blind Phase|Adverse Event|3|||
129509563|NCT01797445|466155570|FG001|Double-Blind Phase|Adverse Event|0|||
129509564|NCT01797445|466155569|FG000|Double-Blind Phase|Death|5|||
129509565|NCT01797445|466155570|FG001|Double-Blind Phase|Death|4|||
129509566|NCT01797445|466155569|FG000|Double-Blind Phase|Pregnancy|0|||
129509567|NCT01797445|466155570|FG001|Double-Blind Phase|Pregnancy|1|||
129509568|NCT01797445|466155569|FG000|Double-Blind Phase|Lack of Efficacy|1|||
129509569|NCT01797445|466155570|FG001|Double-Blind Phase|Lack of Efficacy|2|||
129509570|NCT01797445|466155569|FG000|Double-Blind Phase|Investigator's Discretion|15|||
129509571|NCT01797445|466155570|FG001|Double-Blind Phase|Investigator's Discretion|17|||
129509572|NCT01797445|466155569|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
129509573|NCT01797445|466155570|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
129509574|NCT01797445|466155569|FG000|Double-Blind Phase|Protocol Violation|0|||
129509575|NCT01797445|466155570|FG001|Double-Blind Phase|Protocol Violation|1|||
129509576|NCT01797445|466155569|FG000|Double-Blind Phase|Withdrew Consent|20|||
129509577|NCT01797445|466155570|FG001|Double-Blind Phase|Withdrew Consent|35|||
129509578|NCT01797445|466155569|FG000|Double-Blind Phase|Lost to Follow-up|34|||
129509579|NCT01797445|466155570|FG001|Double-Blind Phase|Lost to Follow-up|26|||
129509580|NCT01797445|466155569|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
129509581|NCT01797445|466155570|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
129509582|NCT01595438|466155573|FG000|Overall Study|Lost to Follow-up|20|||
129509583|NCT01595438|466155574|FG001|Overall Study|Lost to Follow-up|20|||
129509584|NCT01595438|466155573|FG000|Overall Study|Withdrawal by Subject|12|||
129509585|NCT01595438|466155574|FG001|Overall Study|Withdrawal by Subject|12|||
129509586|NCT01595438|466155573|FG000|Overall Study|Other Eligibility criteria|11|||
129509587|NCT01595438|466155574|FG001|Overall Study|Other Eligibility criteria|9|||
129509588|NCT01280266|466155581|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
129509589|NCT01280266|466155582|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
129509590|NCT01280266|466155581|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
129509591|NCT01280266|466155582|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
129509592|NCT01413542|466155587|FG000|Overall Study|Physician Decision|1|||
129509593|NCT01413542|466155588|FG001|Overall Study|Physician Decision|0|||
129509594|NCT01413542|466155589|FG002|Overall Study|Physician Decision|3|||
129509595|NCT01413542|466155590|FG003|Overall Study|Physician Decision|0|||
129509596|NCT01413542|466155587|FG000|Overall Study|Adverse Event|0|||
129509597|NCT01413542|466155588|FG001|Overall Study|Adverse Event|0|||
129509598|NCT01413542|466155589|FG002|Overall Study|Adverse Event|0|||
129509599|NCT01413542|466155590|FG003|Overall Study|Adverse Event|1|||
129509600|NCT02505542|466155591|FG000|Part A: Open-Label Period|Adverse Event|31|||
129509601|NCT02505542|466155592|FG001|Part A: Open-Label Period|Adverse Event|0|||
129509602|NCT02505542|466155593|FG002|Part A: Open-Label Period|Adverse Event|0|||
129509603|NCT02505542|466155594|FG003|Part A: Open-Label Period|Adverse Event|0|||
129509604|NCT02505542|466155591|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
129509605|NCT02505542|466155592|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
129509606|NCT02505542|466155593|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
129509607|NCT02505542|466155594|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
129509608|NCT02505542|466155591|FG000|Part A: Open-Label Period|Protocol Violation|1|||
129509609|NCT02505542|466155592|FG001|Part A: Open-Label Period|Protocol Violation|0|||
129509610|NCT02505542|466155593|FG002|Part A: Open-Label Period|Protocol Violation|0|||
129509611|NCT02505542|466155594|FG003|Part A: Open-Label Period|Protocol Violation|0|||
129509612|NCT02505542|466155591|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
129509613|NCT02505542|466155592|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
129509614|NCT02505542|466155593|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
129509615|NCT02505542|466155594|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
129509616|NCT02505542|466155591|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
129509617|NCT02505542|466155592|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
129509618|NCT02505542|466155593|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
129509619|NCT02505542|466155594|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
129509620|NCT02505542|466155591|FG000|Part A: Open-Label Period|New medical history available|1|||
129509621|NCT02505542|466155592|FG001|Part A: Open-Label Period|New medical history available|0|||
129509622|NCT02505542|466155593|FG002|Part A: Open-Label Period|New medical history available|0|||
129509623|NCT02505542|466155594|FG003|Part A: Open-Label Period|New medical history available|0|||
129509624|NCT02505542|466155591|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
129509625|NCT02505542|466155592|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
129509626|NCT02505542|466155593|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
129509627|NCT02505542|466155594|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
129509628|NCT02505542|466155591|FG000|Part A: Open-Label Period|Pregnancy|2|||
129509629|NCT02505542|466155592|FG001|Part A: Open-Label Period|Pregnancy|0|||
129509630|NCT02505542|466155593|FG002|Part A: Open-Label Period|Pregnancy|0|||
129509631|NCT02505542|466155594|FG003|Part A: Open-Label Period|Pregnancy|0|||
129509632|NCT02505542|466155591|FG000|Part A: Open-Label Period|Sponsor directive|1|||
129509633|NCT02505542|466155592|FG001|Part A: Open-Label Period|Sponsor directive|0|||
129509634|NCT02505542|466155593|FG002|Part A: Open-Label Period|Sponsor directive|0|||
129509635|NCT02505542|466155594|FG003|Part A: Open-Label Period|Sponsor directive|0|||
129509636|NCT02505542|466155591|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
129509637|NCT02505542|466155592|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
129509638|NCT02505542|466155593|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
129509639|NCT02505542|466155594|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
129509640|NCT02505542|466155591|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
129509641|NCT02505542|466155592|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
129509642|NCT02505542|466155593|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
129509643|NCT02505542|466155594|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
129509644|NCT02505542|466155591|FG000|Part A: Open-Label Period|Non-compliance|1|||
129509645|NCT02505542|466155592|FG001|Part A: Open-Label Period|Non-compliance|0|||
129509646|NCT02505542|466155593|FG002|Part A: Open-Label Period|Non-compliance|0|||
129509647|NCT02505542|466155594|FG003|Part A: Open-Label Period|Non-compliance|0|||
129509648|NCT02505542|466155591|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
129509649|NCT02505542|466155592|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
129509650|NCT02505542|466155593|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
129509651|NCT02505542|466155594|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
129509652|NCT02505542|466155591|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
129509653|NCT02505542|466155592|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
129509654|NCT02505542|466155593|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
129509655|NCT02505542|466155594|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
129509656|NCT02505542|466155591|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
129509657|NCT02505542|466155592|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
129509658|NCT02505542|466155593|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
129509659|NCT02505542|466155594|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
129509660|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Adverse Event|0|||
129509661|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Adverse Event|0|||
129509662|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Adverse Event|1|||
129509663|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Adverse Event|3|||
129509664|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
129509665|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
129509666|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
129509667|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
129509668|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
129509669|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
129509670|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
129509671|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
129509672|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
129509673|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
129509674|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
129509675|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
129509676|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
129509677|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
129509678|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
129509679|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
129509680|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
129509681|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
129509682|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
129509683|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
129509684|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
129509685|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
129509686|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
129509687|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
129509688|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Miscalculation|0|||
129509689|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Miscalculation|1|||
129509690|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Miscalculation|0|||
129509691|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Miscalculation|0|||
129509692|NCT02505542|466155591|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
129509693|NCT02505542|466155592|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
129509694|NCT02505542|466155593|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
129509695|NCT02505542|466155594|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
129509696|NCT02759861|466155597|FG000|Overall Study|Death|1|||
129509697|NCT01522443|466155598|FG000|Overall Study|No longer receiving clinical benefit|36|||
129509698|NCT01522443|466155599|FG001|Overall Study|No longer receiving clinical benefit|28|||
129509699|NCT01522443|466155598|FG000|Overall Study|Adverse Event|10|||
129509700|NCT01522443|466155599|FG001|Overall Study|Adverse Event|15|||
129509701|NCT01522443|466155598|FG000|Overall Study|Withdrawal by Subject|5|||
129982816|NCT00943852|467900625|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982817|NCT00943852|467900626|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
129982818|NCT00943852|467900617|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982819|NCT00943852|467900618|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982820|NCT00943852|467900619|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982821|NCT00943852|467900620|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982822|NCT00943852|467900621|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129509702|NCT01522443|466155599|FG001|Overall Study|Withdrawal by Subject|8|||
129509703|NCT01522443|466155598|FG000|Overall Study|No study treatment given|1|||
129509704|NCT01522443|466155599|FG001|Overall Study|No study treatment given|1|||
129509705|NCT01522443|466155598|FG000|Overall Study|Other|1|||
129509706|NCT01522443|466155599|FG001|Overall Study|Other|3|||
129509707|NCT05590767|466155602|FG000|Overall Study|Protocol Violation|1|||
129509708|NCT05590767|466155602|FG000|Overall Study|surgery canceled|1|||
129509709|NCT05590767|466155602|FG000|Overall Study|interscalene brachial block not performed|1|||
129509710|NCT01764256|466155603|FG000|Received All Vaccinations|Adverse Event|1|||
129509711|NCT01764256|466155604|FG001|Received All Vaccinations|Adverse Event|1|||
129509712|NCT01764256|466155605|FG002|Received All Vaccinations|Adverse Event|0|||
129509713|NCT01764256|466155606|FG003|Received All Vaccinations|Adverse Event|0|||
129509714|NCT01764256|466155603|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
129509715|NCT01764256|466155604|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
129509716|NCT01764256|466155605|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
129509717|NCT01764256|466155606|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
129509718|NCT01764256|466155603|FG000|Received All Vaccinations|Lost to Follow-up|1|||
129509719|NCT01764256|466155604|FG001|Received All Vaccinations|Lost to Follow-up|0|||
129509720|NCT01764256|466155605|FG002|Received All Vaccinations|Lost to Follow-up|0|||
129509721|NCT01764256|466155606|FG003|Received All Vaccinations|Lost to Follow-up|0|||
129509722|NCT01764256|466155603|FG000|Completed Study|Lost to Follow-up|0|||
129509723|NCT01764256|466155604|FG001|Completed Study|Lost to Follow-up|0|||
129509724|NCT01764256|466155605|FG002|Completed Study|Lost to Follow-up|0|||
129509725|NCT01764256|466155606|FG003|Completed Study|Lost to Follow-up|1|||
129509726|NCT00776555|466155616|FG000|Overall Study|Study terminated|3|||
129509727|NCT00776555|466155617|FG001|Overall Study|Study terminated|0|||
129509728|NCT03483116|466155620|FG000|Overall Study|Adverse Event|0|||
129509729|NCT03483116|466155621|FG001|Overall Study|Adverse Event|1|||
129509730|NCT03483116|466155622|FG002|Overall Study|Adverse Event|0|||
129509731|NCT03483116|466155623|FG003|Overall Study|Adverse Event|1|||
129509732|NCT03483116|466155620|FG000|Overall Study|Protocol Violation|1|||
129509733|NCT03483116|466155621|FG001|Overall Study|Protocol Violation|0|||
129509734|NCT03483116|466155622|FG002|Overall Study|Protocol Violation|0|||
129509735|NCT03483116|466155623|FG003|Overall Study|Protocol Violation|7|||
129509736|NCT03483116|466155620|FG000|Overall Study|Lost to Follow-up|9|||
129509737|NCT03483116|466155621|FG001|Overall Study|Lost to Follow-up|4|||
129509738|NCT03483116|466155622|FG002|Overall Study|Lost to Follow-up|9|||
129509739|NCT03483116|466155623|FG003|Overall Study|Lost to Follow-up|5|||
129509740|NCT03483116|466155620|FG000|Overall Study|Death|1|||
129509741|NCT03483116|466155621|FG001|Overall Study|Death|0|||
129509742|NCT03483116|466155622|FG002|Overall Study|Death|2|||
129509743|NCT03483116|466155623|FG003|Overall Study|Death|1|||
129509744|NCT03483116|466155620|FG000|Overall Study|Withdrawal by Subject|14|||
129509745|NCT03483116|466155621|FG001|Overall Study|Withdrawal by Subject|16|||
129509746|NCT03483116|466155622|FG002|Overall Study|Withdrawal by Subject|14|||
129509747|NCT03483116|466155623|FG003|Overall Study|Withdrawal by Subject|16|||
129509748|NCT03483116|466155620|FG000|Overall Study|Unknown other reason|3|||
129509749|NCT03483116|466155621|FG001|Overall Study|Unknown other reason|2|||
129509750|NCT03483116|466155622|FG002|Overall Study|Unknown other reason|1|||
129509751|NCT03483116|466155623|FG003|Overall Study|Unknown other reason|1|||
129509752|NCT01181102|466155624|FG000|Overall Study|Adverse Event|28|||
129509753|NCT01181102|466155625|FG001|Overall Study|Adverse Event|26|||
129509754|NCT01181102|466155624|FG000|Overall Study|Lack of Efficacy|3|||
129509755|NCT01181102|466155625|FG001|Overall Study|Lack of Efficacy|1|||
129509756|NCT01181102|466155624|FG000|Overall Study|Lost to Follow-up|2|||
129509757|NCT01181102|466155625|FG001|Overall Study|Lost to Follow-up|0|||
129509758|NCT01181102|466155624|FG000|Overall Study|Physician Decision|3|||
129509759|NCT01181102|466155625|FG001|Overall Study|Physician Decision|1|||
129509760|NCT01181102|466155624|FG000|Overall Study|Protocol Violation|5|||
129509761|NCT01181102|466155625|FG001|Overall Study|Protocol Violation|6|||
129509762|NCT01181102|466155624|FG000|Overall Study|Withdrawal by Subject|10|||
129509763|NCT01181102|466155625|FG001|Overall Study|Withdrawal by Subject|12|||
129509764|NCT04685499|466155631|FG000|Overall Study|Study Terminated Early|1|||
129509765|NCT03176277|466155632|FG000|Part A Dose Escalation Study|Adverse Event|1|||
129509766|NCT03176277|466155633|FG001|Part A Dose Escalation Study|Adverse Event|0|||
129509767|NCT03176277|466155634|FG002|Part A Dose Escalation Study|Adverse Event|1|||
129509768|NCT03176277|466155635|FG003|Part A Dose Escalation Study|Adverse Event|0|||
129509769|NCT03176277|466155632|FG000|Part A Dose Escalation Study|Physician Decision|1|||
129509770|NCT03176277|466155633|FG001|Part A Dose Escalation Study|Physician Decision|1|||
129509771|NCT03176277|466155634|FG002|Part A Dose Escalation Study|Physician Decision|2|||
129509772|NCT03176277|466155635|FG003|Part A Dose Escalation Study|Physician Decision|0|||
129509773|NCT03176277|466155632|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
129509774|NCT03176277|466155633|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
129509775|NCT03176277|466155634|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
129509776|NCT03176277|466155635|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
129509777|NCT03176277|466155632|FG000|Part A Dose Escalation Study|Progressive disease|3|||
129509778|NCT03176277|466155633|FG001|Part A Dose Escalation Study|Progressive disease|1|||
129509779|NCT03176277|466155634|FG002|Part A Dose Escalation Study|Progressive disease|3|||
129509780|NCT03176277|466155635|FG003|Part A Dose Escalation Study|Progressive disease|0|||
129509781|NCT00634114|466155636|FG000|Overall Study|Adverse Event|6|||
129509782|NCT00634114|466155637|FG001|Overall Study|Adverse Event|8|||
129509783|NCT00634114|466155638|FG002|Overall Study|Adverse Event|3|||
129509784|NCT00634114|466155636|FG000|Overall Study|Withdrawal by Subject|9|||
129509785|NCT00634114|466155637|FG001|Overall Study|Withdrawal by Subject|6|||
129509786|NCT00634114|466155638|FG002|Overall Study|Withdrawal by Subject|11|||
129509787|NCT00634114|466155636|FG000|Overall Study|Lost to Follow-up|0|||
129509788|NCT00634114|466155637|FG001|Overall Study|Lost to Follow-up|0|||
129509789|NCT00634114|466155638|FG002|Overall Study|Lost to Follow-up|1|||
129509790|NCT00634114|466155636|FG000|Overall Study|Protocol Violation|3|||
129509791|NCT00634114|466155637|FG001|Overall Study|Protocol Violation|3|||
129509792|NCT00634114|466155638|FG002|Overall Study|Protocol Violation|1|||
129509793|NCT00634114|466155636|FG000|Overall Study|Pregnancy|1|||
129509794|NCT00634114|466155637|FG001|Overall Study|Pregnancy|0|||
129509795|NCT00634114|466155638|FG002|Overall Study|Pregnancy|0|||
129509796|NCT00634114|466155636|FG000|Overall Study|Incorrect enrolment|0|||
129509797|NCT00634114|466155637|FG001|Overall Study|Incorrect enrolment|1|||
129509798|NCT00634114|466155638|FG002|Overall Study|Incorrect enrolment|0|||
129509799|NCT00634114|466155636|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
129509800|NCT00634114|466155637|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
129509801|NCT00634114|466155638|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
129509802|NCT00634114|466155636|FG000|Overall Study|Difficult to continue|3|||
129509803|NCT00634114|466155637|FG001|Overall Study|Difficult to continue|1|||
129509804|NCT00634114|466155638|FG002|Overall Study|Difficult to continue|1|||
129509805|NCT00634114|466155636|FG000|Overall Study|Other reason|1|||
129509806|NCT00634114|466155637|FG001|Overall Study|Other reason|1|||
129509807|NCT00634114|466155638|FG002|Overall Study|Other reason|1|||
129509808|NCT00585923|466155639|FG000|Overall Study|Physician decided not to continue|31|||
129509809|NCT00585923|466155640|FG001|Overall Study|Physician decided not to continue|33|||
129509810|NCT00618449|466155641|FG000|Overall Study|Lost to Follow-up|98|||
129509811|NCT00618449|466155642|FG001|Overall Study|Lost to Follow-up|110|||
129509812|NCT01441115|466155643|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
129509813|NCT04311177|466155648|FG000|Overall Study|Adverse Event|3|||
129509814|NCT04311177|466155649|FG001|Overall Study|Adverse Event|1|||
129509815|NCT04311177|466155648|FG000|Overall Study|Physician Decision|4|||
129509816|NCT04311177|466155649|FG001|Overall Study|Physician Decision|3|||
129509817|NCT04311177|466155648|FG000|Overall Study|Withdrawal by Subject|1|||
129509818|NCT04311177|466155649|FG001|Overall Study|Withdrawal by Subject|0|||
129509819|NCT01681576|466155654|FG000|Period 1|Adverse Event|1|||
129509820|NCT01681576|466155655|FG001|Period 1|Adverse Event|0|||
129509821|NCT01681576|466155654|FG000|Period 1|Protocol Deviation|1|||
129509822|NCT01681576|466155655|FG001|Period 1|Protocol Deviation|0|||
129509823|NCT01681576|466155654|FG000|Period 2|subject/guardian decision|3|||
129509824|NCT01681576|466155655|FG001|Period 2|subject/guardian decision|1|||
129509825|NCT01681576|466155654|FG000|Period 2|Non-compliance with study treatment|1|||
129509826|NCT01681576|466155655|FG001|Period 2|Non-compliance with study treatment|0|||
129509827|NCT04142216|466155657|FG000|Overall Study|Hospitalization|0|||
129509828|NCT04142216|466155658|FG001|Overall Study|Hospitalization|2|||
129509829|NCT04142216|466155657|FG000|Overall Study|Death|3|||
129509830|NCT04142216|466155658|FG001|Overall Study|Death|1|||
129509831|NCT04142216|466155657|FG000|Overall Study|Referral to another hemodialysis unit|3|||
129509832|NCT04142216|466155658|FG001|Overall Study|Referral to another hemodialysis unit|2|||
129509833|NCT04142216|466155657|FG000|Overall Study|Use of clove|0|||
129509834|NCT04142216|466155658|FG001|Overall Study|Use of clove|1|||
129509835|NCT02007954|466155659|FG000|Overall Study|Received liver transplant|3|||
129509836|NCT02007954|466155659|FG000|Overall Study|Switch in treatment modality|2|||
129509837|NCT02007954|466155659|FG000|Overall Study|Disease progression and unrelated AE|1|||
129509838|NCT02007954|466155659|FG000|Overall Study|Death|1|||
129509839|NCT01195363|466155662|FG000|Overall Study|Lost to Follow-up|7|||
129509840|NCT01195363|466155663|FG001|Overall Study|Lost to Follow-up|4|||
129509841|NCT01195363|466155662|FG000|Overall Study|Adverse Event|3|||
129509842|NCT01195363|466155663|FG001|Overall Study|Adverse Event|1|||
129509843|NCT01195363|466155662|FG000|Overall Study|Lack of Efficacy|0|||
129509844|NCT01195363|466155663|FG001|Overall Study|Lack of Efficacy|4|||
129509845|NCT01195363|466155662|FG000|Overall Study|incarceration|1|||
129509846|NCT01195363|466155663|FG001|Overall Study|incarceration|0|||
129509847|NCT00377429|466155665|FG000|Overall Study|Withdrawal by Subject|5|||
129982823|NCT00943852|467900622|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129509848|NCT00377429|466155665|FG000|Overall Study|Adverse Event|8|||
129509849|NCT00377429|466155665|FG000|Overall Study|Physician Decision|1|||
129509850|NCT00377429|466155665|FG000|Overall Study|Patient non-compliance|1|||
129509851|NCT05691829|466157313|FG000|Overall Study|Physician Decision|2|||
129509852|NCT05691829|466157313|FG000|Overall Study|Eligibility criteria not met|3|||
129509853|NCT00453180|466157318|FG000|Overall Study|Lost to Follow-up|2|||
129509854|NCT00453180|466157319|FG001|Overall Study|Lost to Follow-up|1|||
129509855|NCT00453180|466157318|FG000|Overall Study|Adverse Event|1|||
129509856|NCT00453180|466157319|FG001|Overall Study|Adverse Event|2|||
129509857|NCT02420795|466157326|FG000|Overall Study|Withdrawal by Subject|1|||
129509858|NCT02420795|466157327|FG001|Overall Study|Withdrawal by Subject|0|||
129509859|NCT02420795|466157328|FG002|Overall Study|Withdrawal by Subject|0|||
129509860|NCT02420795|466157326|FG000|Overall Study|Adverse Event|1|||
129509861|NCT02420795|466157327|FG001|Overall Study|Adverse Event|0|||
129509862|NCT02420795|466157328|FG002|Overall Study|Adverse Event|0|||
129509863|NCT02420795|466157326|FG000|Overall Study|Progressive disease|2|||
129509864|NCT02420795|466157327|FG001|Overall Study|Progressive disease|2|||
129509865|NCT02420795|466157328|FG002|Overall Study|Progressive disease|4|||
129509866|NCT02420795|466157326|FG000|Overall Study|Death|0|||
129509867|NCT02420795|466157327|FG001|Overall Study|Death|0|||
129509868|NCT02420795|466157328|FG002|Overall Study|Death|1|||
129509869|NCT01002742|466157331|FG000|Overall Study|Determined to be ineligible|0|||
129509870|NCT01002742|466157332|FG001|Overall Study|Determined to be ineligible|1|||
129509871|NCT02862548|466157344|FG000|Randomized Phase (Up to Week 48)|Death|0|||
129509872|NCT02862548|466157345|FG001|Randomized Phase (Up to Week 48)|Death|1|||
129509873|NCT02862548|466157344|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
129509874|NCT02862548|466157345|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
129509875|NCT02862548|466157344|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
129509876|NCT02862548|466157345|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
129509877|NCT02862548|466157344|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
129509878|NCT02862548|466157345|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
129509879|NCT00880763|466157346|FG000|Extension Period (Part 2)|Adverse Event|0|||
129509880|NCT00880763|466157347|FG001|Extension Period (Part 2)|Adverse Event|0|||
129509881|NCT00880763|466157348|FG002|Extension Period (Part 2)|Adverse Event|1|||
129509882|NCT00880763|466157349|FG003|Extension Period (Part 2)|Adverse Event|1|||
129509883|NCT00880763|466157346|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
129509884|NCT00880763|466157347|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
129509885|NCT00880763|466157348|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
129509886|NCT00880763|466157349|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
129509887|NCT00880763|466157346|FG000|Extension Period (Part 2)|Physician Decision|0|||
129509888|NCT00880763|466157347|FG001|Extension Period (Part 2)|Physician Decision|1|||
129509889|NCT00880763|466157348|FG002|Extension Period (Part 2)|Physician Decision|1|||
129509890|NCT00880763|466157349|FG003|Extension Period (Part 2)|Physician Decision|0|||
129509891|NCT00880763|466157346|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
129509892|NCT00880763|466157347|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
129509893|NCT00880763|466157348|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
129509894|NCT00880763|466157349|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
129509895|NCT00656084|466157350|FG000|Overall Study|Adverse Event|4|||
129509896|NCT00656084|466157350|FG000|Overall Study|Withdrawal by Subject|1|||
129509897|NCT00656084|466157350|FG000|Overall Study|Patient Request|1|||
129509898|NCT00656084|466157350|FG000|Overall Study|Investigator Request|1|||
129509899|NCT01293006|466157351|FG000|Period 2|Lost to Follow-up|1|||
129509900|NCT01293006|466157352|FG001|Period 2|Lost to Follow-up|0|||
129509901|NCT01293006|466157353|FG002|Period 2|Lost to Follow-up|0|||
129509902|NCT01293006|466157354|FG003|Period 2|Lost to Follow-up|0|||
129509903|NCT01494987|466157355|FG000|Overall Study|Adverse Event|6|||
129509904|NCT01494987|466157356|FG001|Overall Study|Adverse Event|5|||
129509905|NCT01494987|466157355|FG000|Overall Study|Hyperglycemia|6|||
129509906|NCT01494987|466157356|FG001|Overall Study|Hyperglycemia|4|||
129509907|NCT01494987|466157355|FG000|Overall Study|Investigator's Discretion|1|||
129509908|NCT01494987|466157356|FG001|Overall Study|Investigator's Discretion|2|||
129509909|NCT01494987|466157355|FG000|Overall Study|Lost to Follow-up|1|||
129509910|NCT01494987|466157356|FG001|Overall Study|Lost to Follow-up|1|||
129509911|NCT01494987|466157355|FG000|Overall Study|Protocol Violation|3|||
129509912|NCT01494987|466157356|FG001|Overall Study|Protocol Violation|3|||
129509913|NCT01494987|466157355|FG000|Overall Study|Subject Non-Compliance|9|||
129509914|NCT01494987|466157356|FG001|Overall Study|Subject Non-Compliance|10|||
129509915|NCT01494987|466157355|FG000|Overall Study|Subject Withdrew Consent|2|||
129509916|NCT01494987|466157356|FG001|Overall Study|Subject Withdrew Consent|3|||
129509917|NCT00436982|466157359|FG000|Overall Study|Withdrawal by Subject|3|||
129509918|NCT00436982|466157360|FG001|Overall Study|Withdrawal by Subject|1|||
129509919|NCT00436982|466157359|FG000|Overall Study|Did not receive allocated intervention|0|||
129509920|NCT00436982|466157360|FG001|Overall Study|Did not receive allocated intervention|1|||
129509921|NCT00436982|466157359|FG000|Overall Study|no RSA data|1|||
129509922|NCT00436982|466157360|FG001|Overall Study|no RSA data|2|||
129509923|NCT00953225|466157364|FG000|Overall Study|Withdrawal by Subject|2|||
129509924|NCT00953225|466157365|FG001|Overall Study|Withdrawal by Subject|0|||
129509925|NCT00640146|466157367|FG000|Overall Study|Adverse Event|2|||
129509926|NCT00640146|466157368|FG001|Overall Study|Adverse Event|0|||
129509927|NCT00640146|466157367|FG000|Overall Study|Lost to Follow-up|0|||
129509928|NCT00640146|466157368|FG001|Overall Study|Lost to Follow-up|1|||
129509929|NCT00640146|466157367|FG000|Overall Study|Lack of Efficacy|0|||
129509930|NCT00640146|466157368|FG001|Overall Study|Lack of Efficacy|1|||
129509931|NCT00640146|466157367|FG000|Overall Study|Withdrawal by Subject|1|||
129509932|NCT00640146|466157368|FG001|Overall Study|Withdrawal by Subject|1|||
129509933|NCT00640146|466157367|FG000|Overall Study|Randomized but not treated|1|||
129509934|NCT00640146|466157368|FG001|Overall Study|Randomized but not treated|3|||
129509935|NCT04058158|466157371|FG000|Period 1|Death|1|||
129509936|NCT04058158|466157372|FG001|Period 1|Death|0|||
129509937|NCT04058158|466157371|FG000|Period 1|Adverse Event|1|||
129509938|NCT04058158|466157372|FG001|Period 1|Adverse Event|1|||
129509939|NCT04058158|466157371|FG000|Period 1|Pregnancy|0|||
129509940|NCT04058158|466157372|FG001|Period 1|Pregnancy|1|||
129509941|NCT04847141|466157373|FG000|Overall Study|Adverse Event|1|||
129509942|NCT04847141|466157374|FG001|Overall Study|Adverse Event|0|||
129509943|NCT04847141|466157375|FG002|Overall Study|Adverse Event|1|||
129509944|NCT04847141|466157373|FG000|Overall Study|Withdrawal by Subject|2|||
129509945|NCT04847141|466157374|FG001|Overall Study|Withdrawal by Subject|4|||
129509946|NCT04847141|466157375|FG002|Overall Study|Withdrawal by Subject|3|||
129509947|NCT04847141|466157373|FG000|Overall Study|Lost to Follow-up|7|||
129509948|NCT04847141|466157374|FG001|Overall Study|Lost to Follow-up|5|||
129509949|NCT04847141|466157375|FG002|Overall Study|Lost to Follow-up|7|||
129509950|NCT04847141|466157373|FG000|Overall Study|Reason not Specified|0|||
129509951|NCT04847141|466157374|FG001|Overall Study|Reason not Specified|1|||
129509952|NCT04847141|466157375|FG002|Overall Study|Reason not Specified|0|||
129509953|NCT02215616|466157376|FG000|Overall Study|Sponsor requested to stop study drug|0|||
129509954|NCT02215616|466157377|FG001|Overall Study|Sponsor requested to stop study drug|0|||
129509955|NCT02215616|466157378|FG002|Overall Study|Sponsor requested to stop study drug|1|||
129509956|NCT02215616|466157379|FG003|Overall Study|Sponsor requested to stop study drug|4|||
129509957|NCT02215616|466157376|FG000|Overall Study|Death|1|||
129982824|NCT00943852|467900623|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
129982825|NCT00943852|467900624|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982826|NCT00943852|467900625|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982827|NCT00943852|467900626|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
129982828|NCT02141620|467900627|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
129982829|NCT02141620|467900628|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
129982830|NCT03377699|467900632|FG000|Overall Study|Withdrawal by Subject|2|||
129982831|NCT03377699|467900633|FG001|Overall Study|Withdrawal by Subject|9|||
129509958|NCT02215616|466157377|FG001|Overall Study|Death|0|||
129509959|NCT02215616|466157378|FG002|Overall Study|Death|0|||
129509960|NCT02215616|466157379|FG003|Overall Study|Death|0|||
129509961|NCT02215616|466157376|FG000|Overall Study|Adverse Event|7|||
129509962|NCT02215616|466157377|FG001|Overall Study|Adverse Event|4|||
129509963|NCT02215616|466157378|FG002|Overall Study|Adverse Event|9|||
129509964|NCT02215616|466157379|FG003|Overall Study|Adverse Event|2|||
129509965|NCT02215616|466157376|FG000|Overall Study|Withdrawal by Subject|1|||
129509966|NCT02215616|466157377|FG001|Overall Study|Withdrawal by Subject|8|||
129509967|NCT02215616|466157378|FG002|Overall Study|Withdrawal by Subject|2|||
129509968|NCT02215616|466157379|FG003|Overall Study|Withdrawal by Subject|5|||
129509969|NCT02215616|466157376|FG000|Overall Study|Non-compliance|0|||
129509970|NCT02215616|466157377|FG001|Overall Study|Non-compliance|2|||
129509971|NCT02215616|466157378|FG002|Overall Study|Non-compliance|1|||
129509972|NCT02215616|466157379|FG003|Overall Study|Non-compliance|0|||
129509973|NCT02215616|466157376|FG000|Overall Study|Protocol Violation|0|||
129509974|NCT02215616|466157377|FG001|Overall Study|Protocol Violation|2|||
129509975|NCT02215616|466157378|FG002|Overall Study|Protocol Violation|0|||
129509976|NCT02215616|466157379|FG003|Overall Study|Protocol Violation|0|||
129509977|NCT02215616|466157376|FG000|Overall Study|Lost to Follow-up|1|||
129509978|NCT02215616|466157377|FG001|Overall Study|Lost to Follow-up|1|||
129509979|NCT02215616|466157378|FG002|Overall Study|Lost to Follow-up|0|||
129509980|NCT02215616|466157379|FG003|Overall Study|Lost to Follow-up|1|||
129509981|NCT02215616|466157376|FG000|Overall Study|Other than specified|1|||
129509982|NCT02215616|466157377|FG001|Overall Study|Other than specified|0|||
129509983|NCT02215616|466157378|FG002|Overall Study|Other than specified|1|||
129509984|NCT02215616|466157379|FG003|Overall Study|Other than specified|1|||
129509985|NCT02293993|466157380|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
129509986|NCT02293993|466157381|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
129509987|NCT02293993|466157382|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
129509988|NCT02293993|466157383|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
129509989|NCT02293993|466157380|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
129509990|NCT02293993|466157381|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
129509991|NCT02293993|466157382|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
129509992|NCT02293993|466157383|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
129509993|NCT02293993|466157380|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
129509994|NCT02293993|466157381|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
129509995|NCT02293993|466157382|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
129982832|NCT03377699|467900632|FG000|Overall Study|Lost to Follow-up|1|||
129509996|NCT02293993|466157383|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
129509997|NCT02293993|466157380|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
129509998|NCT02293993|466157381|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
129509999|NCT02293993|466157382|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
129510000|NCT02293993|466157383|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
129539153|NCT00361504|466265168|FG000|Overall Study|Resolution of Pain|2|||
129982833|NCT03377699|467900633|FG001|Overall Study|Lost to Follow-up|1|||
129510001|NCT02293993|466157380|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
129510002|NCT02293993|466157381|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
129510003|NCT02293993|466157382|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
129510004|NCT02293993|466157383|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
129510005|NCT03583606|466157384|FG000|Overall Study|Lost to Follow-up|0|||
129510006|NCT03583606|466157385|FG001|Overall Study|Lost to Follow-up|1|||
129510007|NCT03583606|466157386|FG002|Overall Study|Lost to Follow-up|0|||
129510008|NCT03583606|466157384|FG000|Overall Study|Ineligible at baseline|1|||
129510009|NCT03583606|466157385|FG001|Overall Study|Ineligible at baseline|0|||
129510010|NCT03583606|466157386|FG002|Overall Study|Ineligible at baseline|0|||
129510011|NCT03728140|466157392|FG000|Overall Study|Abnormal embryo transfer operation|10|||
129510012|NCT03728140|466157393|FG001|Overall Study|Abnormal embryo transfer operation|7|||
129510013|NCT04295356|466157394|FG000|Overall Study|Physician Decision|1|||
129510014|NCT04295356|466157395|FG001|Overall Study|Physician Decision|0|||
129510015|NCT04295356|466157394|FG000|Overall Study|Lost to Follow-up|0|||
129510016|NCT04295356|466157395|FG001|Overall Study|Lost to Follow-up|3|||
129510017|NCT04295356|466157394|FG000|Overall Study|Protocol Violation|0|||
129510018|NCT04295356|466157395|FG001|Overall Study|Protocol Violation|1|||
129510019|NCT01106391|466157396|FG000|Overall Study|Death|12|||
129510020|NCT01106391|466157396|FG000|Overall Study|Withdrawal by Subject|7|||
129510021|NCT04268004|466157403|FG000|Overall Study|Excluded from analyses|0|||
129510022|NCT04268004|466157404|FG001|Overall Study|Excluded from analyses|1|||
129510023|NCT03783442|466157405|FG000|Overall Study|Death|252|||
129510024|NCT03783442|466157406|FG001|Overall Study|Death|268|||
129510025|NCT03783442|466157405|FG000|Overall Study|Withdrawal by Subject|19|||
129510026|NCT03783442|466157406|FG001|Overall Study|Withdrawal by Subject|21|||
129510027|NCT03783442|466157405|FG000|Overall Study|Lost to Follow-up|7|||
129510028|NCT03783442|466157406|FG001|Overall Study|Lost to Follow-up|6|||
129510029|NCT03783442|466157405|FG000|Overall Study|Sponsor Ended Study|48|||
129510030|NCT03783442|466157406|FG001|Overall Study|Sponsor Ended Study|28|||
129510031|NCT00881361|466157407|FG000|Overall Study|Terminated prior to surgery|27|||
129510032|NCT00881361|466157408|FG001|Overall Study|Terminated prior to surgery|7|||
129510033|NCT00881361|466157409|FG002|Overall Study|Terminated prior to surgery|0|||
129510034|NCT00881361|466157407|FG000|Overall Study|Ineligible|17|||
129510035|NCT00881361|466157408|FG001|Overall Study|Ineligible|2|||
129510036|NCT00881361|466157409|FG002|Overall Study|Ineligible|2|||
129510037|NCT01381718|466157410|FG000|Overall Study|Withdrawal by Subject|2|||
129510038|NCT01381718|466157411|FG001|Overall Study|Withdrawal by Subject|5|||
129510039|NCT01381718|466157410|FG000|Overall Study|Lost to Follow-up|3|||
129510040|NCT01381718|466157411|FG001|Overall Study|Lost to Follow-up|5|||
129510041|NCT01381718|466157410|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
129510042|NCT01381718|466157411|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
129510043|NCT00618995|466157414|FG000|Period 1|Adverse Event|0|||
129510044|NCT00618995|466157415|FG001|Period 1|Adverse Event|0|||
129510045|NCT00618995|466157416|FG002|Period 1|Adverse Event|1|||
129510046|NCT00618995|466157417|FG003|Period 1|Adverse Event|0|||
129510047|NCT00618995|466157414|FG000|Period 1|Protocol Violation|0|||
129510048|NCT00618995|466157415|FG001|Period 1|Protocol Violation|1|||
129510049|NCT00618995|466157416|FG002|Period 1|Protocol Violation|1|||
129510050|NCT00618995|466157417|FG003|Period 1|Protocol Violation|0|||
129510051|NCT00618995|466157414|FG000|Period 2|Protocol Violation|0|||
129510052|NCT00618995|466157415|FG001|Period 2|Protocol Violation|0|||
129510053|NCT00618995|466157416|FG002|Period 2|Protocol Violation|1|||
129510054|NCT00618995|466157417|FG003|Period 2|Protocol Violation|0|||
129510055|NCT00618995|466157414|FG000|Period 4|Adverse Event|1|||
129510056|NCT00618995|466157415|FG001|Period 4|Adverse Event|0|||
129510057|NCT00618995|466157416|FG002|Period 4|Adverse Event|0|||
129510058|NCT00618995|466157417|FG003|Period 4|Adverse Event|0|||
129510059|NCT02988219|466157418|FG000|Overall Study|Lack of Efficacy|1|||
129510060|NCT02988219|466157419|FG001|Overall Study|Lack of Efficacy|1|||
129510061|NCT02988219|466157418|FG000|Overall Study|Withdrawal by Subject|0|||
129510062|NCT02988219|466157419|FG001|Overall Study|Withdrawal by Subject|2|||
129510063|NCT01504971|466157420|FG000|Overall Study|Physician Decision|13|||
129510064|NCT00936117|466157421|FG000|Overall Study|Adverse Event|7|||
129510065|NCT00936117|466157421|FG000|Overall Study|Unable to continue oral medication|3|||
129510066|NCT00225212|466157428|FG000|Overall Study|Disease progression|2|||
129510067|NCT00225212|466157428|FG000|Overall Study|Death|1|||
129510068|NCT00225212|466157428|FG000|Overall Study|Adverse Event|2|||
129510069|NCT00225212|466157428|FG000|Overall Study|Intercurrent illness|1|||
129510070|NCT01309841|466157431|FG000|Overall Study|Other|0|||
129510071|NCT01309841|466157432|FG001|Overall Study|Other|1|||
129510072|NCT01309841|466157433|FG002|Overall Study|Other|1|||
129510073|NCT01309841|466157431|FG000|Overall Study|Lost to Follow-up|7|||
129510074|NCT01309841|466157432|FG001|Overall Study|Lost to Follow-up|6|||
129510075|NCT01309841|466157433|FG002|Overall Study|Lost to Follow-up|4|||
129510076|NCT01309841|466157431|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
129510077|NCT01309841|466157432|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
129510078|NCT01309841|466157433|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
129510079|NCT01309841|466157431|FG000|Overall Study|Lack of Efficacy|0|||
129510080|NCT01309841|466157432|FG001|Overall Study|Lack of Efficacy|0|||
129510081|NCT01309841|466157433|FG002|Overall Study|Lack of Efficacy|2|||
129510082|NCT01309841|466157431|FG000|Overall Study|Adverse Event|9|||
129510083|NCT01309841|466157432|FG001|Overall Study|Adverse Event|22|||
129510084|NCT01309841|466157433|FG002|Overall Study|Adverse Event|11|||
129510085|NCT01309841|466157431|FG000|Overall Study|Death|1|||
129510086|NCT01309841|466157432|FG001|Overall Study|Death|0|||
129510087|NCT01309841|466157433|FG002|Overall Study|Death|0|||
129510088|NCT01309841|466157431|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129510089|NCT01309841|466157432|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
129510090|NCT01309841|466157433|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
129510091|NCT01309841|466157431|FG000|Overall Study|Withdrawal by Subject|17|||
129510092|NCT01309841|466157432|FG001|Overall Study|Withdrawal by Subject|6|||
129510093|NCT01309841|466157433|FG002|Overall Study|Withdrawal by Subject|13|||
129510094|NCT01309841|466157431|FG000|Overall Study|Did Not Receive Treatment|2|||
129510095|NCT01309841|466157432|FG001|Overall Study|Did Not Receive Treatment|0|||
129510096|NCT01309841|466157433|FG002|Overall Study|Did Not Receive Treatment|1|||
129510097|NCT01309841|466157431|FG000|Overall Study|Severe non-compliance with protocol|0|||
129510098|NCT01309841|466157432|FG001|Overall Study|Severe non-compliance with protocol|5|||
129510099|NCT01309841|466157433|FG002|Overall Study|Severe non-compliance with protocol|2|||
129510100|NCT03699631|466157434|FG000|Overall Study|Adverse Event|3|||
129510101|NCT01324622|466157435|FG000|Overall Study|Lost to Follow-up|7|||
129510102|NCT01324622|466157436|FG001|Overall Study|Lost to Follow-up|7|||
129510103|NCT01324622|466157435|FG000|Overall Study|Death|1|||
129510104|NCT01324622|466157436|FG001|Overall Study|Death|0|||
129510105|NCT01324622|466157435|FG000|Overall Study|Lack of Efficacy|1|||
129510106|NCT01324622|466157436|FG001|Overall Study|Lack of Efficacy|0|||
129510107|NCT00138424|466157437|FG000|Overall Study|Physician Decision|0|||
129510108|NCT00138424|466157438|FG001|Overall Study|Physician Decision|1|||
129510109|NCT00138424|466157439|FG002|Overall Study|Physician Decision|0|||
129510110|NCT00138424|466157440|FG003|Overall Study|Physician Decision|0|||
129510111|NCT00413062|466157441|FG000|Overall Study|Adverse event/serious adverse event|289|||
129510112|NCT00413062|466157442|FG001|Overall Study|Adverse event/serious adverse event|56|||
129510113|NCT00413062|466157441|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
129510114|NCT00413062|466157442|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
129510115|NCT00413062|466157441|FG000|Overall Study|Withdrawal of informed consent|111|||
129510116|NCT00413062|466157442|FG001|Overall Study|Withdrawal of informed consent|36|||
129510117|NCT00413062|466157441|FG000|Overall Study|Pregnancy|15|||
129510118|NCT00413062|466157442|FG001|Overall Study|Pregnancy|5|||
129510119|NCT00413062|466157441|FG000|Overall Study|Pregnancy wish|17|||
129510120|NCT00413062|466157442|FG001|Overall Study|Pregnancy wish|6|||
129510121|NCT00413062|466157441|FG000|Overall Study|Lost to Follow-up|175|||
129510122|NCT00413062|466157442|FG001|Overall Study|Lost to Follow-up|73|||
129510123|NCT00413062|466157441|FG000|Overall Study|Other reason|70|||
129510124|NCT00413062|466157442|FG001|Overall Study|Other reason|34|||
129510125|NCT02176291|466157443|FG000|Overall Study|Death|1|||
129510126|NCT02176291|466157444|FG001|Overall Study|Death|0|||
129510127|NCT02176291|466157443|FG000|Overall Study|non compliance with protocol|2|||
129510128|NCT02176291|466157444|FG001|Overall Study|non compliance with protocol|0|||
129510129|NCT02176291|466157443|FG000|Overall Study|Withdrawal by Subject|2|||
129510130|NCT02176291|466157444|FG001|Overall Study|Withdrawal by Subject|0|||
129510131|NCT02815293|466157447|FG000|Overall Study|Study termination by sponsor|10|||
129510132|NCT02815293|466157448|FG001|Overall Study|Study termination by sponsor|7|||
129510133|NCT02815293|466157449|FG002|Overall Study|Study termination by sponsor|0|||
129510134|NCT02815293|466157447|FG000|Overall Study|Participants not randomized|0|||
129510135|NCT02815293|466157448|FG001|Overall Study|Participants not randomized|0|||
129510136|NCT02815293|466157449|FG002|Overall Study|Participants not randomized|18|||
129510137|NCT02815293|466157447|FG000|Overall Study|Adverse Event|0|||
129510138|NCT02815293|466157448|FG001|Overall Study|Adverse Event|1|||
129510139|NCT02815293|466157449|FG002|Overall Study|Adverse Event|0|||
129510140|NCT00006604|466157450|FG000|Overall Study|Met study objective - no further FU|1|||
129510141|NCT00006604|466157451|FG001|Overall Study|Met study objective - no further FU|0|||
129510142|NCT00006604|466157452|FG002|Overall Study|Met study objective - no further FU|0|||
129510143|NCT00006604|466157453|FG003|Overall Study|Met study objective - no further FU|0|||
129510144|NCT00006604|466157454|FG004|Overall Study|Met study objective - no further FU|0|||
129510145|NCT00006604|466157455|FG005|Overall Study|Met study objective - no further FU|0|||
129510146|NCT00006604|466157456|FG006|Overall Study|Met study objective - no further FU|0|||
129510147|NCT00006604|466157457|FG007|Overall Study|Met study objective - no further FU|0|||
129510148|NCT00006604|466157458|FG008|Overall Study|Met study objective - no further FU|0|||
129510149|NCT00006604|466157459|FG009|Overall Study|Met study objective - no further FU|0|||
129510150|NCT00006604|466157460|FG010|Overall Study|Met study objective - no further FU|0|||
129510151|NCT00006604|466157461|FG011|Overall Study|Met study objective - no further FU|0|||
129510152|NCT00006604|466157462|FG012|Overall Study|Met study objective - no further FU|0|||
129510153|NCT00006604|466157463|FG013|Overall Study|Met study objective - no further FU|0|||
129510154|NCT00006604|466157464|FG014|Overall Study|Met study objective - no further FU|1|||
129510155|NCT00006604|466157465|FG015|Overall Study|Met study objective - no further FU|1|||
129510156|NCT00006604|466157466|FG016|Overall Study|Met study objective - no further FU|0|||
129510157|NCT00006604|466157450|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
129510158|NCT00006604|466157451|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
129510159|NCT00006604|466157452|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
129510160|NCT00006604|466157453|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
129510161|NCT00006604|466157454|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
129510162|NCT00006604|466157455|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
129510163|NCT00006604|466157456|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
129510164|NCT00006604|466157457|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
129510165|NCT00006604|466157458|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
129510166|NCT00006604|466157459|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
129510167|NCT00006604|466157460|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
129510168|NCT00006604|466157461|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
129510169|NCT00006604|466157462|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
129510170|NCT00006604|466157463|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
129510171|NCT00006604|466157464|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
129510172|NCT00006604|466157465|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
129510173|NCT00006604|466157466|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
129510174|NCT00006604|466157450|FG000|Overall Study|Death|0|||
129510175|NCT00006604|466157451|FG001|Overall Study|Death|0|||
129510176|NCT00006604|466157452|FG002|Overall Study|Death|0|||
129510177|NCT00006604|466157453|FG003|Overall Study|Death|0|||
129510178|NCT00006604|466157454|FG004|Overall Study|Death|0|||
129510179|NCT00006604|466157455|FG005|Overall Study|Death|0|||
129510180|NCT00006604|466157456|FG006|Overall Study|Death|0|||
129510181|NCT00006604|466157457|FG007|Overall Study|Death|0|||
129510182|NCT00006604|466157458|FG008|Overall Study|Death|0|||
129510183|NCT00006604|466157459|FG009|Overall Study|Death|1|||
129510184|NCT00006604|466157460|FG010|Overall Study|Death|1|||
129510185|NCT00006604|466157461|FG011|Overall Study|Death|1|||
129510186|NCT00006604|466157462|FG012|Overall Study|Death|0|||
129510187|NCT00006604|466157463|FG013|Overall Study|Death|0|||
129510188|NCT00006604|466157464|FG014|Overall Study|Death|0|||
129510189|NCT00006604|466157465|FG015|Overall Study|Death|0|||
129510190|NCT00006604|466157466|FG016|Overall Study|Death|0|||
129510191|NCT00006604|466157450|FG000|Overall Study|Severe debilitation, unable to continue|0|||
129510192|NCT00006604|466157451|FG001|Overall Study|Severe debilitation, unable to continue|0|||
129510193|NCT00006604|466157452|FG002|Overall Study|Severe debilitation, unable to continue|0|||
129510194|NCT00006604|466157453|FG003|Overall Study|Severe debilitation, unable to continue|0|||
129510195|NCT00006604|466157454|FG004|Overall Study|Severe debilitation, unable to continue|0|||
129510196|NCT00006604|466157455|FG005|Overall Study|Severe debilitation, unable to continue|0|||
129510197|NCT00006604|466157456|FG006|Overall Study|Severe debilitation, unable to continue|3|||
129510198|NCT00006604|466157457|FG007|Overall Study|Severe debilitation, unable to continue|0|||
129510199|NCT00006604|466157458|FG008|Overall Study|Severe debilitation, unable to continue|0|||
129510200|NCT00006604|466157459|FG009|Overall Study|Severe debilitation, unable to continue|5|||
129510201|NCT00006604|466157460|FG010|Overall Study|Severe debilitation, unable to continue|0|||
129510202|NCT00006604|466157461|FG011|Overall Study|Severe debilitation, unable to continue|2|||
129510203|NCT00006604|466157462|FG012|Overall Study|Severe debilitation, unable to continue|1|||
129510204|NCT00006604|466157463|FG013|Overall Study|Severe debilitation, unable to continue|0|||
129510205|NCT00006604|466157464|FG014|Overall Study|Severe debilitation, unable to continue|2|||
129510206|NCT00006604|466157465|FG015|Overall Study|Severe debilitation, unable to continue|0|||
129510207|NCT00006604|466157466|FG016|Overall Study|Severe debilitation, unable to continue|0|||
129510208|NCT00006604|466157450|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
129510209|NCT00006604|466157451|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
129510210|NCT00006604|466157452|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
129510211|NCT00006604|466157453|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
129510212|NCT00006604|466157454|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
129510213|NCT00006604|466157455|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
129510214|NCT00006604|466157456|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
129510215|NCT00006604|466157457|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
129510216|NCT00006604|466157458|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
129510217|NCT00006604|466157459|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
129510218|NCT00006604|466157460|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
129510219|NCT00006604|466157461|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
129510220|NCT00006604|466157462|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
129510221|NCT00006604|466157463|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
129510222|NCT00006604|466157464|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
129510223|NCT00006604|466157465|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
129510224|NCT00006604|466157466|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
129510225|NCT00006604|466157450|FG000|Overall Study|Site closing|0|||
129510226|NCT00006604|466157451|FG001|Overall Study|Site closing|0|||
129510227|NCT00006604|466157452|FG002|Overall Study|Site closing|1|||
129510228|NCT00006604|466157453|FG003|Overall Study|Site closing|1|||
129510229|NCT00006604|466157454|FG004|Overall Study|Site closing|0|||
129510230|NCT00006604|466157455|FG005|Overall Study|Site closing|0|||
129510231|NCT00006604|466157456|FG006|Overall Study|Site closing|0|||
129510232|NCT00006604|466157457|FG007|Overall Study|Site closing|1|||
129510233|NCT00006604|466157458|FG008|Overall Study|Site closing|0|||
129510234|NCT00006604|466157459|FG009|Overall Study|Site closing|0|||
129510235|NCT00006604|466157460|FG010|Overall Study|Site closing|0|||
129510236|NCT00006604|466157461|FG011|Overall Study|Site closing|1|||
129510237|NCT00006604|466157462|FG012|Overall Study|Site closing|1|||
129510238|NCT00006604|466157463|FG013|Overall Study|Site closing|1|||
129510239|NCT00006604|466157464|FG014|Overall Study|Site closing|0|||
129510240|NCT00006604|466157465|FG015|Overall Study|Site closing|0|||
129510241|NCT00006604|466157466|FG016|Overall Study|Site closing|1|||
129510242|NCT00006604|466157450|FG000|Overall Study|Withdrawal by Subject|1|||
129510243|NCT00006604|466157451|FG001|Overall Study|Withdrawal by Subject|0|||
129510244|NCT00006604|466157452|FG002|Overall Study|Withdrawal by Subject|2|||
129510245|NCT00006604|466157453|FG003|Overall Study|Withdrawal by Subject|0|||
129510246|NCT00006604|466157454|FG004|Overall Study|Withdrawal by Subject|1|||
129510247|NCT00006604|466157455|FG005|Overall Study|Withdrawal by Subject|2|||
129510248|NCT00006604|466157456|FG006|Overall Study|Withdrawal by Subject|2|||
129510249|NCT00006604|466157457|FG007|Overall Study|Withdrawal by Subject|0|||
129510250|NCT00006604|466157458|FG008|Overall Study|Withdrawal by Subject|1|||
129510251|NCT00006604|466157459|FG009|Overall Study|Withdrawal by Subject|3|||
129510252|NCT00006604|466157460|FG010|Overall Study|Withdrawal by Subject|2|||
129510253|NCT00006604|466157461|FG011|Overall Study|Withdrawal by Subject|0|||
129510254|NCT00006604|466157462|FG012|Overall Study|Withdrawal by Subject|1|||
129510255|NCT00006604|466157463|FG013|Overall Study|Withdrawal by Subject|2|||
129510256|NCT00006604|466157464|FG014|Overall Study|Withdrawal by Subject|1|||
129510257|NCT00006604|466157465|FG015|Overall Study|Withdrawal by Subject|0|||
129510258|NCT00006604|466157466|FG016|Overall Study|Withdrawal by Subject|1|||
129510259|NCT00006604|466157450|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
129510260|NCT00006604|466157451|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
129510261|NCT00006604|466157452|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
129510262|NCT00006604|466157453|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
129510263|NCT00006604|466157454|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
129510264|NCT00006604|466157455|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
129510265|NCT00006604|466157456|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
129510266|NCT00006604|466157457|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
129510267|NCT00006604|466157458|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
129510268|NCT00006604|466157459|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
129510269|NCT00006604|466157460|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
129510270|NCT00006604|466157461|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
129510271|NCT00006604|466157462|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
129510272|NCT00006604|466157463|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
129510273|NCT00006604|466157464|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
129510274|NCT00006604|466157465|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
129510275|NCT00006604|466157466|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
129510276|NCT00006604|466157450|FG000|Overall Study|Lost to Follow-up|0|||
129510277|NCT00006604|466157451|FG001|Overall Study|Lost to Follow-up|0|||
129510278|NCT00006604|466157452|FG002|Overall Study|Lost to Follow-up|0|||
129510279|NCT00006604|466157453|FG003|Overall Study|Lost to Follow-up|0|||
129510280|NCT00006604|466157454|FG004|Overall Study|Lost to Follow-up|0|||
129510281|NCT00006604|466157455|FG005|Overall Study|Lost to Follow-up|0|||
129982834|NCT03377699|467900632|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
129982835|NCT03377699|467900633|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
129982836|NCT03377699|467900632|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
129982837|NCT03377699|467900633|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
129982838|NCT03377699|467900632|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
129982839|NCT03377699|467900633|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
129510282|NCT00006604|466157456|FG006|Overall Study|Lost to Follow-up|0|||
129510283|NCT00006604|466157457|FG007|Overall Study|Lost to Follow-up|1|||
129510284|NCT00006604|466157458|FG008|Overall Study|Lost to Follow-up|0|||
129510285|NCT00006604|466157459|FG009|Overall Study|Lost to Follow-up|2|||
129510286|NCT00006604|466157460|FG010|Overall Study|Lost to Follow-up|0|||
129510287|NCT00006604|466157461|FG011|Overall Study|Lost to Follow-up|0|||
129510288|NCT00006604|466157462|FG012|Overall Study|Lost to Follow-up|0|||
129510289|NCT00006604|466157463|FG013|Overall Study|Lost to Follow-up|0|||
129510290|NCT00006604|466157464|FG014|Overall Study|Lost to Follow-up|0|||
129510291|NCT00006604|466157465|FG015|Overall Study|Lost to Follow-up|1|||
129510292|NCT00006604|466157466|FG016|Overall Study|Lost to Follow-up|3|||
129510293|NCT00006604|466157450|FG000|Overall Study|Other Reason|0|||
129510294|NCT00006604|466157451|FG001|Overall Study|Other Reason|0|||
129510295|NCT00006604|466157452|FG002|Overall Study|Other Reason|0|||
129510296|NCT00006604|466157453|FG003|Overall Study|Other Reason|0|||
129510297|NCT00006604|466157454|FG004|Overall Study|Other Reason|0|||
129510298|NCT00006604|466157455|FG005|Overall Study|Other Reason|1|||
129510299|NCT00006604|466157456|FG006|Overall Study|Other Reason|0|||
129510300|NCT00006604|466157457|FG007|Overall Study|Other Reason|0|||
129510301|NCT00006604|466157458|FG008|Overall Study|Other Reason|0|||
129510302|NCT00006604|466157459|FG009|Overall Study|Other Reason|1|||
129510303|NCT00006604|466157460|FG010|Overall Study|Other Reason|0|||
129510304|NCT00006604|466157461|FG011|Overall Study|Other Reason|0|||
129510305|NCT00006604|466157462|FG012|Overall Study|Other Reason|0|||
129510306|NCT00006604|466157463|FG013|Overall Study|Other Reason|0|||
129510307|NCT00006604|466157464|FG014|Overall Study|Other Reason|0|||
129510308|NCT00006604|466157465|FG015|Overall Study|Other Reason|0|||
129510309|NCT00006604|466157466|FG016|Overall Study|Other Reason|0|||
129510310|NCT01056341|466157469|FG000|Overall Study|Treatment Intolerance|0|||
129510311|NCT01056341|466157470|FG001|Overall Study|Treatment Intolerance|2|||
129510312|NCT01056341|466157471|FG002|Overall Study|Treatment Intolerance|0|||
129510313|NCT01056341|466157472|FG003|Overall Study|Treatment Intolerance|2|||
129510314|NCT01056341|466157473|FG004|Overall Study|Treatment Intolerance|0|||
129510315|NCT01056341|466157469|FG000|Overall Study|Lack of Efficacy|32|||
129510316|NCT01056341|466157470|FG001|Overall Study|Lack of Efficacy|30|||
129510317|NCT01056341|466157471|FG002|Overall Study|Lack of Efficacy|7|||
129510318|NCT01056341|466157472|FG003|Overall Study|Lack of Efficacy|25|||
129510319|NCT01056341|466157473|FG004|Overall Study|Lack of Efficacy|9|||
129510320|NCT01056341|466157469|FG000|Overall Study|Other reasons|4|||
129510321|NCT01056341|466157470|FG001|Overall Study|Other reasons|4|||
129510322|NCT01056341|466157471|FG002|Overall Study|Other reasons|8|||
129510323|NCT01056341|466157472|FG003|Overall Study|Other reasons|9|||
129510324|NCT01056341|466157473|FG004|Overall Study|Other reasons|5|||
129510325|NCT01167582|466157474|FG000|Overall Study|Lost to Follow-up|0|||
129510326|NCT01167582|466157475|FG001|Overall Study|Lost to Follow-up|1|||
129510327|NCT01182337|466157478|FG000|Overall Study|Withdrawal by Subject|3|||
129510328|NCT01182337|466157479|FG001|Overall Study|Withdrawal by Subject|1|||
129510329|NCT01182337|466157478|FG000|Overall Study|Lost to Follow-up|0|||
129510330|NCT01182337|466157479|FG001|Overall Study|Lost to Follow-up|1|||
129510331|NCT03103906|466157480|FG000|Overall Study|Adverse Event|2|||
129510332|NCT03103906|466157481|FG001|Overall Study|Adverse Event|3|||
129510333|NCT03103906|466157480|FG000|Overall Study|Other|2|||
129510334|NCT03103906|466157481|FG001|Overall Study|Other|0|||
129510335|NCT03571256|466157482|FG000|Overall Study|Adverse Event|3|||
129510336|NCT03571256|466157483|FG001|Overall Study|Adverse Event|0|||
129510337|NCT03571256|466157484|FG002|Overall Study|Adverse Event|1|||
129510338|NCT03571256|466157482|FG000|Overall Study|Withdrawal by Subject|3|||
129510339|NCT03571256|466157483|FG001|Overall Study|Withdrawal by Subject|1|||
129510340|NCT03571256|466157484|FG002|Overall Study|Withdrawal by Subject|1|||
129510341|NCT03571256|466157482|FG000|Overall Study|Other than specified|0|||
129510342|NCT03571256|466157483|FG001|Overall Study|Other than specified|1|||
129510343|NCT03571256|466157484|FG002|Overall Study|Other than specified|1|||
129510344|NCT03571256|466157482|FG000|Overall Study|Protocol Violation|0|||
129510345|NCT03571256|466157483|FG001|Overall Study|Protocol Violation|1|||
129510346|NCT03571256|466157484|FG002|Overall Study|Protocol Violation|1|||
129510347|NCT00575094|466157487|FG000|Overall Study|Adverse Event|2|||
129510348|NCT00575094|466157487|FG000|Overall Study|Withdrawal by Subject|1|||
129510349|NCT00772382|466157488|FG000|Overall Study|Adverse Event|19|||
129510350|NCT00772382|466157488|FG000|Overall Study|Death|6|||
129510351|NCT00772382|466157488|FG000|Overall Study|Lack of Efficacy|4|||
129510352|NCT00772382|466157488|FG000|Overall Study|Physician Decision|5|||
129510353|NCT00772382|466157488|FG000|Overall Study|Protocol Violation|1|||
129510354|NCT00772382|466157488|FG000|Overall Study|Withdrawal by Subject|10|||
129510355|NCT00772382|466157488|FG000|Overall Study|Other Reasons|10|||
129510356|NCT00643604|466157494|FG000|Overall Study|Death|1|||
129510357|NCT02702011|466157495|FG000|Overall Study|Withdrawal by Subject|0|||
129510358|NCT02702011|466157496|FG001|Overall Study|Withdrawal by Subject|1|||
129510359|NCT02702011|466157497|FG002|Overall Study|Withdrawal by Subject|0|||
129510360|NCT02702011|466157498|FG003|Overall Study|Withdrawal by Subject|0|||
129510361|NCT00475540|466157499|FG000|36 Months|Lost to Follow-up|4|||
129510362|NCT00475540|466157500|FG001|36 Months|Lost to Follow-up|4|||
129510363|NCT00475540|466157499|FG000|36 Months|Death|1|||
129510364|NCT00475540|466157500|FG001|36 Months|Death|2|||
129510365|NCT00475540|466157499|FG000|36 Months|Censored due to reoperation|3|||
129510366|NCT00475540|466157500|FG001|36 Months|Censored due to reoperation|0|||
129510367|NCT03287869|466159262|FG000|Overall Study|Adverse Event|14|||
129510368|NCT03287869|466159263|FG001|Overall Study|Adverse Event|12|||
129510369|NCT03287869|466159262|FG000|Overall Study|Lack of Efficacy|1|||
129510370|NCT03287869|466159263|FG001|Overall Study|Lack of Efficacy|0|||
129510371|NCT03287869|466159262|FG000|Overall Study|Lost to Follow-up|13|||
129510372|NCT03287869|466159263|FG001|Overall Study|Lost to Follow-up|19|||
129510373|NCT03287869|466159262|FG000|Overall Study|Non-Compliance With Study Drug|5|||
129510374|NCT03287869|466159263|FG001|Overall Study|Non-Compliance With Study Drug|9|||
129510375|NCT03287869|466159262|FG000|Overall Study|Progressive Disease|1|||
129510376|NCT03287869|466159263|FG001|Overall Study|Progressive Disease|0|||
129510377|NCT03287869|466159262|FG000|Overall Study|Protocol Deviation|2|||
129510378|NCT03287869|466159263|FG001|Overall Study|Protocol Deviation|1|||
129510379|NCT03287869|466159262|FG000|Overall Study|Withdrawal by Subject|36|||
129510380|NCT03287869|466159263|FG001|Overall Study|Withdrawal by Subject|43|||
129510381|NCT03287869|466159262|FG000|Overall Study|Early Closure of the Site|0|||
129510382|NCT03287869|466159263|FG001|Overall Study|Early Closure of the Site|1|||
129510383|NCT03287869|466159262|FG000|Overall Study|Physician Decision|5|||
129510384|NCT03287869|466159263|FG001|Overall Study|Physician Decision|5|||
129510385|NCT03287869|466159262|FG000|Overall Study|Reason not Specified|6|||
129510386|NCT03287869|466159263|FG001|Overall Study|Reason not Specified|3|||
129510387|NCT03488238|466159264|FG000|Overall Study|Equipment malfunction|1|||
129510388|NCT03488238|466159264|FG000|Overall Study|Adverse Event|1|||
129510389|NCT02670928|466159265|FG000|Overall Study|Adverse Event|3|||
129510390|NCT02670928|466159266|FG001|Overall Study|Adverse Event|1|||
129510391|NCT02670928|466159265|FG000|Overall Study|Withdrawal by Subject|4|||
129510392|NCT02670928|466159266|FG001|Overall Study|Withdrawal by Subject|0|||
129510393|NCT02670928|466159265|FG000|Overall Study|Lost to Follow-up|1|||
129510394|NCT02670928|466159266|FG001|Overall Study|Lost to Follow-up|0|||
129510395|NCT02670928|466159265|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
129510396|NCT02670928|466159266|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
129510397|NCT02591238|466159267|FG000|Overall Study|Pregnancy|1|||
129510398|NCT02591238|466159268|FG001|Overall Study|Pregnancy|0|||
129510399|NCT02591238|466159269|FG002|Overall Study|Pregnancy|0|||
129510400|NCT02591238|466159270|FG003|Overall Study|Pregnancy|0|||
129510401|NCT02591238|466159267|FG000|Overall Study|Withdrawal by Subject|0|||
129510402|NCT02591238|466159268|FG001|Overall Study|Withdrawal by Subject|0|||
129510403|NCT02591238|466159269|FG002|Overall Study|Withdrawal by Subject|0|||
129510404|NCT02591238|466159270|FG003|Overall Study|Withdrawal by Subject|1|||
129510405|NCT02591238|466159267|FG000|Overall Study|influenza|0|||
129510406|NCT02591238|466159268|FG001|Overall Study|influenza|0|||
129510407|NCT02591238|466159269|FG002|Overall Study|influenza|0|||
129510408|NCT02591238|466159270|FG003|Overall Study|influenza|1|||
129510409|NCT02591238|466159267|FG000|Overall Study|personal circumstances|0|||
129510410|NCT02591238|466159268|FG001|Overall Study|personal circumstances|0|||
129510411|NCT02591238|466159269|FG002|Overall Study|personal circumstances|0|||
129510412|NCT02591238|466159270|FG003|Overall Study|personal circumstances|1|||
129510413|NCT02591238|466159267|FG000|Overall Study|personal circumstances|0|||
129510414|NCT02591238|466159268|FG001|Overall Study|personal circumstances|1|||
129510415|NCT02591238|466159269|FG002|Overall Study|personal circumstances|0|||
129510416|NCT02591238|466159270|FG003|Overall Study|personal circumstances|0|||
129510417|NCT01634113|466159271|FG000|Overall Study|Not treated|0|||
129510418|NCT01634113|466159272|FG001|Overall Study|Not treated|0|||
129510419|NCT01634113|466159273|FG002|Overall Study|Not treated|1|||
129510420|NCT00324740|466159274|FG000|Overall Study|Withdrawal by Subject|1|||
129510421|NCT00324740|466159275|FG001|Overall Study|Withdrawal by Subject|0|||
129510422|NCT00324740|466159276|FG002|Overall Study|Withdrawal by Subject|1|||
129510423|NCT00520299|466159279|FG000|Overall Study|Withdrawal by Subject|0|||
129510424|NCT00520299|466159280|FG001|Overall Study|Withdrawal by Subject|0|||
129510425|NCT00520299|466159281|FG002|Overall Study|Withdrawal by Subject|2|||
129510426|NCT00520299|466159279|FG000|Overall Study|Progressive disease|0|||
129510427|NCT00520299|466159280|FG001|Overall Study|Progressive disease|3|||
129510428|NCT00520299|466159281|FG002|Overall Study|Progressive disease|4|||
129510429|NCT01352845|466159283|FG000|Overall Study|Lost to Follow-up|313|||
129510430|NCT01352845|466159284|FG001|Overall Study|Lost to Follow-up|92|||
129510431|NCT01352845|466159283|FG000|Overall Study|No Longer Willing to Participate|205|||
129510432|NCT01352845|466159284|FG001|Overall Study|No Longer Willing to Participate|58|||
129510433|NCT01352845|466159283|FG000|Overall Study|Withdrawal by Subject|48|||
129510434|NCT01352845|466159284|FG001|Overall Study|Withdrawal by Subject|16|||
129510435|NCT01352845|466159283|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
129510436|NCT01352845|466159284|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
129510437|NCT01352845|466159283|FG000|Overall Study|Pregnancy|27|||
129510438|NCT01352845|466159284|FG001|Overall Study|Pregnancy|7|||
129510439|NCT01352845|466159283|FG000|Overall Study|Adverse Event|22|||
129510440|NCT01352845|466159284|FG001|Overall Study|Adverse Event|6|||
129510441|NCT01352845|466159283|FG000|Overall Study|Other|17|||
129510442|NCT01352845|466159284|FG001|Overall Study|Other|7|||
129510443|NCT01352845|466159283|FG000|Overall Study|Protocol Violation|12|||
129510444|NCT01352845|466159284|FG001|Overall Study|Protocol Violation|6|||
129510445|NCT01352845|466159283|FG000|Overall Study|Death|3|||
129510446|NCT01352845|466159284|FG001|Overall Study|Death|0|||
129510447|NCT01357980|466159289|FG000|Overall Study|Lack of Efficacy|0|||
129510448|NCT01357980|466159290|FG001|Overall Study|Lack of Efficacy|1|||
129510449|NCT01357980|466159291|FG002|Overall Study|Lack of Efficacy|0|||
129510450|NCT01357980|466159292|FG003|Overall Study|Lack of Efficacy|0|||
129510451|NCT01357980|466159289|FG000|Overall Study|Consent withdrawn|0|||
129510452|NCT01357980|466159290|FG001|Overall Study|Consent withdrawn|0|||
129510453|NCT01357980|466159291|FG002|Overall Study|Consent withdrawn|1|||
129510454|NCT01357980|466159292|FG003|Overall Study|Consent withdrawn|0|||
129510455|NCT02528253|466159293|FG000|Overall Study|Adverse Event|3|||
129510456|NCT02528253|466159294|FG001|Overall Study|Adverse Event|4|||
129510457|NCT02528253|466159295|FG002|Overall Study|Adverse Event|4|||
129510458|NCT02528253|466159296|FG003|Overall Study|Adverse Event|8|||
129510459|NCT02528253|466159297|FG004|Overall Study|Adverse Event|18|||
129510460|NCT02528253|466159293|FG000|Overall Study|Death|2|||
129510461|NCT02528253|466159294|FG001|Overall Study|Death|2|||
129510462|NCT02528253|466159295|FG002|Overall Study|Death|1|||
129510463|NCT02528253|466159296|FG003|Overall Study|Death|0|||
129510464|NCT02528253|466159297|FG004|Overall Study|Death|1|||
129510465|NCT02528253|466159293|FG000|Overall Study|Insufficient clinical response|7|||
129510466|NCT02528253|466159294|FG001|Overall Study|Insufficient clinical response|10|||
129510467|NCT02528253|466159295|FG002|Overall Study|Insufficient clinical response|13|||
129510468|NCT02528253|466159296|FG003|Overall Study|Insufficient clinical response|12|||
129510469|NCT02528253|466159297|FG004|Overall Study|Insufficient clinical response|16|||
129510470|NCT02528253|466159293|FG000|Overall Study|Lost to Follow-up|16|||
129510471|NCT02528253|466159294|FG001|Overall Study|Lost to Follow-up|9|||
129510472|NCT02528253|466159295|FG002|Overall Study|Lost to Follow-up|31|||
129510473|NCT02528253|466159296|FG003|Overall Study|Lost to Follow-up|16|||
129510474|NCT02528253|466159297|FG004|Overall Study|Lost to Follow-up|34|||
129510475|NCT02528253|466159293|FG000|Overall Study|Other|21|||
129510476|NCT02528253|466159294|FG001|Overall Study|Other|22|||
129510477|NCT02528253|466159295|FG002|Overall Study|Other|58|||
129510478|NCT02528253|466159296|FG003|Overall Study|Other|52|||
129510479|NCT02528253|466159297|FG004|Overall Study|Other|76|||
129510480|NCT02528253|466159293|FG000|Overall Study|Withdrawal by Subject|25|||
129510481|NCT02528253|466159294|FG001|Overall Study|Withdrawal by Subject|20|||
129510482|NCT02528253|466159295|FG002|Overall Study|Withdrawal by Subject|29|||
129510483|NCT02528253|466159296|FG003|Overall Study|Withdrawal by Subject|48|||
129510484|NCT02528253|466159297|FG004|Overall Study|Withdrawal by Subject|73|||
129510485|NCT02528253|466159293|FG000|Overall Study|Protocol Violation|1|||
129510486|NCT02528253|466159294|FG001|Overall Study|Protocol Violation|2|||
129510487|NCT02528253|466159295|FG002|Overall Study|Protocol Violation|4|||
129510488|NCT02528253|466159296|FG003|Overall Study|Protocol Violation|0|||
129510489|NCT02528253|466159297|FG004|Overall Study|Protocol Violation|4|||
129510490|NCT02528253|466159293|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
129510491|NCT02528253|466159294|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
129510492|NCT02528253|466159295|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
129510493|NCT02528253|466159296|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
129510494|NCT02528253|466159297|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
129510495|NCT04507776|466159298|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
129510496|NCT00094835|466159299|FG000|Overall Study|Physician Decision|1|||
129510497|NCT00094835|466159300|FG001|Overall Study|Physician Decision|0|||
129510498|NCT00094835|466159301|FG002|Overall Study|Physician Decision|0|||
129510499|NCT00094835|466159302|FG003|Overall Study|Physician Decision|0|||
129510500|NCT00094835|466159303|FG004|Overall Study|Physician Decision|0|||
129510501|NCT00094835|466159304|FG005|Overall Study|Physician Decision|1|||
129510502|NCT00094835|466159305|FG006|Overall Study|Physician Decision|0|||
129510503|NCT00094835|466159299|FG000|Overall Study|Withdrawal by Subject|0|||
129510504|NCT00094835|466159300|FG001|Overall Study|Withdrawal by Subject|0|||
129510505|NCT00094835|466159301|FG002|Overall Study|Withdrawal by Subject|0|||
129510506|NCT00094835|466159302|FG003|Overall Study|Withdrawal by Subject|0|||
129510507|NCT00094835|466159303|FG004|Overall Study|Withdrawal by Subject|0|||
129510508|NCT00094835|466159304|FG005|Overall Study|Withdrawal by Subject|0|||
129510509|NCT00094835|466159305|FG006|Overall Study|Withdrawal by Subject|1|||
129510510|NCT00094835|466159299|FG000|Overall Study|Lost to Follow-up|0|||
129510511|NCT00094835|466159300|FG001|Overall Study|Lost to Follow-up|0|||
129510512|NCT00094835|466159301|FG002|Overall Study|Lost to Follow-up|0|||
129510513|NCT00094835|466159302|FG003|Overall Study|Lost to Follow-up|0|||
129510514|NCT00094835|466159303|FG004|Overall Study|Lost to Follow-up|1|||
129510515|NCT00094835|466159304|FG005|Overall Study|Lost to Follow-up|0|||
129510516|NCT00094835|466159305|FG006|Overall Study|Lost to Follow-up|0|||
129510517|NCT00094835|466159299|FG000|Overall Study|Death|1|||
129510518|NCT00094835|466159300|FG001|Overall Study|Death|0|||
129510519|NCT00094835|466159301|FG002|Overall Study|Death|0|||
129510520|NCT00094835|466159302|FG003|Overall Study|Death|0|||
129510521|NCT00094835|466159303|FG004|Overall Study|Death|1|||
129510522|NCT00094835|466159304|FG005|Overall Study|Death|0|||
129510523|NCT00094835|466159305|FG006|Overall Study|Death|0|||
129510524|NCT00094835|466159299|FG000|Overall Study|Non-compliance|1|||
129510525|NCT00094835|466159300|FG001|Overall Study|Non-compliance|2|||
129510526|NCT00094835|466159301|FG002|Overall Study|Non-compliance|2|||
129510527|NCT00094835|466159302|FG003|Overall Study|Non-compliance|0|||
129510528|NCT00094835|466159303|FG004|Overall Study|Non-compliance|2|||
129510529|NCT00094835|466159304|FG005|Overall Study|Non-compliance|2|||
129510530|NCT00094835|466159305|FG006|Overall Study|Non-compliance|1|||
129510531|NCT00094835|466159299|FG000|Overall Study|Other|1|||
129510532|NCT00094835|466159300|FG001|Overall Study|Other|1|||
129510533|NCT00094835|466159301|FG002|Overall Study|Other|1|||
129510534|NCT00094835|466159302|FG003|Overall Study|Other|1|||
129510535|NCT00094835|466159303|FG004|Overall Study|Other|0|||
129510536|NCT00094835|466159304|FG005|Overall Study|Other|0|||
129510537|NCT00094835|466159305|FG006|Overall Study|Other|0|||
129510538|NCT03024255|466159308|FG000|Overall Study|Adverse Event|1|||
129510539|NCT03024255|466159309|FG001|Overall Study|Adverse Event|4|||
129510540|NCT03024255|466159310|FG002|Overall Study|Adverse Event|8|||
129510541|NCT03024255|466159311|FG003|Overall Study|Adverse Event|0|||
129510542|NCT03024255|466159308|FG000|Overall Study|Withdrawal by Subject|3|||
129510543|NCT03024255|466159309|FG001|Overall Study|Withdrawal by Subject|1|||
129510544|NCT03024255|466159310|FG002|Overall Study|Withdrawal by Subject|0|||
129510545|NCT03024255|466159311|FG003|Overall Study|Withdrawal by Subject|3|||
129510546|NCT03024255|466159308|FG000|Overall Study|Protocol Violation|0|||
129510547|NCT03024255|466159309|FG001|Overall Study|Protocol Violation|0|||
129510548|NCT03024255|466159310|FG002|Overall Study|Protocol Violation|2|||
129510549|NCT03024255|466159311|FG003|Overall Study|Protocol Violation|0|||
129510550|NCT03024255|466159308|FG000|Overall Study|Lost to Follow-up|1|||
129510551|NCT03024255|466159309|FG001|Overall Study|Lost to Follow-up|2|||
129510552|NCT03024255|466159310|FG002|Overall Study|Lost to Follow-up|1|||
129510553|NCT03024255|466159311|FG003|Overall Study|Lost to Follow-up|1|||
129510554|NCT03024255|466159308|FG000|Overall Study|Lack of Efficacy|1|||
129510555|NCT03024255|466159309|FG001|Overall Study|Lack of Efficacy|0|||
129510556|NCT03024255|466159310|FG002|Overall Study|Lack of Efficacy|0|||
129510557|NCT03024255|466159311|FG003|Overall Study|Lack of Efficacy|0|||
129510558|NCT03024255|466159308|FG000|Overall Study|Protocol Noncompliance|1|||
129510559|NCT03024255|466159309|FG001|Overall Study|Protocol Noncompliance|1|||
129510560|NCT03024255|466159310|FG002|Overall Study|Protocol Noncompliance|0|||
129510561|NCT03024255|466159311|FG003|Overall Study|Protocol Noncompliance|1|||
129510562|NCT00817206|466159312|FG000|Overall Study|Adverse Event|10|||
129510563|NCT00817206|466159313|FG001|Overall Study|Adverse Event|3|||
129510564|NCT00817206|466159312|FG000|Overall Study|Protocol Violation|0|||
129510565|NCT00817206|466159313|FG001|Overall Study|Protocol Violation|2|||
129510566|NCT00817206|466159312|FG000|Overall Study|Lost to Follow-up|0|||
129510567|NCT00817206|466159313|FG001|Overall Study|Lost to Follow-up|1|||
129510568|NCT00817206|466159312|FG000|Overall Study|Death|2|||
129510569|NCT00817206|466159313|FG001|Overall Study|Death|0|||
129510570|NCT00817206|466159312|FG000|Overall Study|Withdrawal by Subject|7|||
129510571|NCT00817206|466159313|FG001|Overall Study|Withdrawal by Subject|3|||
129510572|NCT00817206|466159312|FG000|Overall Study|Physician Decision|2|||
129510573|NCT00817206|466159313|FG001|Overall Study|Physician Decision|0|||
129510574|NCT00126581|466159314|FG000|Overall Study|Adverse Event|3|||
129510575|NCT00126581|466159315|FG001|Overall Study|Adverse Event|7|||
129510576|NCT00126581|466159314|FG000|Overall Study|Death|3|||
129510577|NCT00126581|466159315|FG001|Overall Study|Death|2|||
129510578|NCT00126581|466159314|FG000|Overall Study|Withdrawal by Subject|1|||
129510579|NCT00126581|466159315|FG001|Overall Study|Withdrawal by Subject|4|||
129510580|NCT00126581|466159314|FG000|Overall Study|Alternative therapy|3|||
129510581|NCT00126581|466159315|FG001|Overall Study|Alternative therapy|3|||
129510582|NCT00126581|466159314|FG000|Overall Study|Other illness/MD discretion|3|||
129510583|NCT00126581|466159315|FG001|Overall Study|Other illness/MD discretion|4|||
129510584|NCT00793182|466159316|FG000|Overall Study|Adverse Event|0|||
129510585|NCT00793182|466159317|FG001|Overall Study|Adverse Event|1|||
129510586|NCT02034552|466159318|FG000|Overall Study|Never treated|3|||
129510587|NCT02034552|466159319|FG001|Overall Study|Never treated|2|||
129510588|NCT02034552|466159320|FG002|Overall Study|Never treated|0|||
129510589|NCT02034552|466159318|FG000|Overall Study|Radiological progression|3|||
129510590|NCT02034552|466159319|FG001|Overall Study|Radiological progression|5|||
129510591|NCT02034552|466159320|FG002|Overall Study|Radiological progression|4|||
129510592|NCT02034552|466159318|FG000|Overall Study|AE not assoc. with disease progression|1|||
129510593|NCT02034552|466159319|FG001|Overall Study|AE not assoc. with disease progression|4|||
129510594|NCT02034552|466159320|FG002|Overall Study|AE not assoc. with disease progression|2|||
129510595|NCT02034552|466159318|FG000|Overall Study|AE associated with disease progression|0|||
129510596|NCT02034552|466159319|FG001|Overall Study|AE associated with disease progression|1|||
129510597|NCT02034552|466159320|FG002|Overall Study|AE associated with disease progression|0|||
129510598|NCT02034552|466159318|FG000|Overall Study|Withdrawal by Subject|2|||
129510599|NCT02034552|466159319|FG001|Overall Study|Withdrawal by Subject|1|||
129510600|NCT02034552|466159320|FG002|Overall Study|Withdrawal by Subject|1|||
129510601|NCT02034552|466159318|FG000|Overall Study|Non-compliance with study drug|0|||
129510602|NCT02034552|466159319|FG001|Overall Study|Non-compliance with study drug|0|||
129510603|NCT02034552|466159320|FG002|Overall Study|Non-compliance with study drug|1|||
129982840|NCT03377699|467900632|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
129510604|NCT02034552|466159318|FG000|Overall Study|Clinical progression|5|||
129510605|NCT02034552|466159319|FG001|Overall Study|Clinical progression|7|||
129510606|NCT02034552|466159320|FG002|Overall Study|Clinical progression|9|||
129510607|NCT02197897|466159321|FG000|Overall Study|not eligible|1|||
129510608|NCT02384395|466159322|FG000|Overall Study|Physician Decision|4|||
129510609|NCT02384395|466159322|FG000|Overall Study|Withdrawal by Subject|3|||
129510610|NCT02384395|466159322|FG000|Overall Study|Lost to Follow-up|3|||
129510611|NCT00291499|466159327|FG000|Overall Study|Adverse Event|3|||
129510612|NCT00291499|466159328|FG001|Overall Study|Adverse Event|8|||
129510613|NCT00291499|466159327|FG000|Overall Study|Change to other therapy|2|||
129510614|NCT00291499|466159328|FG001|Overall Study|Change to other therapy|1|||
129510615|NCT00291499|466159327|FG000|Overall Study|Intercurrent illness|1|||
129510616|NCT00291499|466159328|FG001|Overall Study|Intercurrent illness|0|||
129510617|NCT00291499|466159327|FG000|Overall Study|Protocol Violation|2|||
129510618|NCT00291499|466159328|FG001|Overall Study|Protocol Violation|2|||
129510619|NCT00291499|466159327|FG000|Overall Study|Other reasons|1|||
129510620|NCT00291499|466159328|FG001|Overall Study|Other reasons|4|||
129510621|NCT01532570|466159329|FG000|Overall Study|Lack of Efficacy|1|||
129510622|NCT01532570|466159330|FG001|Overall Study|Lack of Efficacy|0|||
129510623|NCT01532570|466159331|FG002|Overall Study|Lack of Efficacy|0|||
129510624|NCT01532570|466159332|FG003|Overall Study|Lack of Efficacy|0|||
129510625|NCT01532570|466159329|FG000|Overall Study|Withdrawal by Subject|0|||
129510626|NCT01532570|466159330|FG001|Overall Study|Withdrawal by Subject|1|||
129510627|NCT01532570|466159331|FG002|Overall Study|Withdrawal by Subject|0|||
129510628|NCT01532570|466159332|FG003|Overall Study|Withdrawal by Subject|0|||
129982841|NCT03377699|467900633|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
129982842|NCT00307684|467900634|FG000|Open Label Phase|Lack of Efficacy|0|||
129982843|NCT00307684|467900635|FG001|Open Label Phase|Lack of Efficacy|0|||
129982844|NCT00307684|467900636|FG002|Open Label Phase|Lack of Efficacy|3|||
129982845|NCT00307684|467900634|FG000|Open Label Phase|Adverse Event|0|||
129982846|NCT00307684|467900635|FG001|Open Label Phase|Adverse Event|0|||
129510629|NCT03939637|466159336|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
129510630|NCT03939637|466159337|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
129510631|NCT03939637|466159336|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
129510632|NCT03939637|466159337|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
129510633|NCT05224076|466159338|FG000|Overall Study|Lost to Follow-up|24|||
129510634|NCT04325906|466159339|FG000|Overall Study|Withdrawal by Subject|2|||
129510635|NCT04325906|466159340|FG001|Overall Study|Withdrawal by Subject|0|||
129510636|NCT01082367|466159341|FG000|Double-blind Period|Administrative problems|0|||
129510637|NCT01082367|466159342|FG001|Double-blind Period|Administrative problems|1|||
129510638|NCT01082367|466159341|FG000|Double-blind Period|Lack of Efficacy|5|||
129510639|NCT01082367|466159342|FG001|Double-blind Period|Lack of Efficacy|11|||
129510640|NCT01082367|466159341|FG000|Double-blind Period|Adverse Event|0|||
129510641|NCT01082367|466159342|FG001|Double-blind Period|Adverse Event|1|||
129510642|NCT01082367|466159341|FG000|Follow-up (F-U) Period|Administrative problems|1|||
129510643|NCT01082367|466159342|FG001|Follow-up (F-U) Period|Administrative problems|0|||
129510644|NCT01082367|466159341|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
129510645|NCT01082367|466159342|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
129510646|NCT01082367|466159341|FG000|Follow-up (F-U) Period|Adverse Event|0|||
129510647|NCT01082367|466159342|FG001|Follow-up (F-U) Period|Adverse Event|1|||
129510648|NCT04190186|466159343|FG000|Overall Study|ILR is no longer functioning|0|||
129510649|NCT04190186|466159344|FG001|Overall Study|ILR is no longer functioning|1|||
129510650|NCT04190186|466159343|FG000|Overall Study|Lost to Follow-up|0|||
129510651|NCT04190186|466159344|FG001|Overall Study|Lost to Follow-up|1|||
129510652|NCT04190186|466159343|FG000|Overall Study|Withdrawal by Subject|2|||
129510653|NCT04190186|466159344|FG001|Overall Study|Withdrawal by Subject|0|||
129510654|NCT04190186|466159343|FG000|Overall Study|Subject choice to explant|1|||
129510655|NCT04190186|466159344|FG001|Overall Study|Subject choice to explant|0|||
129510656|NCT04190186|466159343|FG000|Overall Study|Physician Decision|0|||
129510657|NCT04190186|466159344|FG001|Overall Study|Physician Decision|1|||
129510658|NCT04190186|466159343|FG000|Overall Study|Study was stopped|4|||
129510659|NCT04190186|466159344|FG001|Overall Study|Study was stopped|5|||
129510660|NCT02016898|466159345|FG000|Overall Study|Death|1|||
129510661|NCT02016898|466159346|FG001|Overall Study|Death|1|||
129510662|NCT02016898|466159345|FG000|Overall Study|Lost to Follow-up|4|||
129510663|NCT02016898|466159346|FG001|Overall Study|Lost to Follow-up|4|||
129510664|NCT03017846|466159347|FG000|Overall Study|Lost to Follow-up|3|||
129510665|NCT03017846|466159347|FG000|Overall Study|Adverse Event|2|||
129510666|NCT02677220|466159350|FG000|Overall Study|Adverse Event|1|||
129510667|NCT00965146|466159351|FG000|Overall Study|Death|7|||
129510668|NCT00965146|466159351|FG000|Overall Study|Lost to Follow-up|22|||
129510669|NCT00965146|466159351|FG000|Overall Study|Withdrawal by Subject|17|||
129510670|NCT00965146|466159351|FG000|Overall Study|Unable to return|1|||
129510671|NCT00965146|466159351|FG000|Overall Study|Unwilling to return|11|||
129510672|NCT00965146|466159351|FG000|Overall Study|Intercurrent illness|1|||
129510673|NCT00965146|466159351|FG000|Overall Study|Revision / Removal of Study Implant|6|||
129510674|NCT00965146|466159351|FG000|Overall Study|Overall Study Termination|145|||
129510675|NCT00830960|466159352|FG000|Overall Study|Death|5|||
129510676|NCT00830960|466159353|FG001|Overall Study|Death|4|||
129510677|NCT00830960|466159354|FG002|Overall Study|Death|3|||
129510678|NCT00830960|466159355|FG003|Overall Study|Death|2|||
129510679|NCT00830960|466159356|FG004|Overall Study|Death|6|||
129510680|NCT00830960|466159357|FG005|Overall Study|Death|1|||
129510681|NCT00830960|466159352|FG000|Overall Study|Lost to Follow-up|1|||
129510682|NCT00830960|466159353|FG001|Overall Study|Lost to Follow-up|1|||
129510683|NCT00830960|466159354|FG002|Overall Study|Lost to Follow-up|1|||
129510684|NCT00830960|466159355|FG003|Overall Study|Lost to Follow-up|0|||
129510685|NCT00830960|466159356|FG004|Overall Study|Lost to Follow-up|0|||
129510686|NCT00830960|466159357|FG005|Overall Study|Lost to Follow-up|1|||
129510687|NCT00830960|466159352|FG000|Overall Study|Withdrawal by Subject|19|||
129510688|NCT00830960|466159353|FG001|Overall Study|Withdrawal by Subject|19|||
129510689|NCT00830960|466159354|FG002|Overall Study|Withdrawal by Subject|18|||
129510690|NCT00830960|466159355|FG003|Overall Study|Withdrawal by Subject|23|||
129510691|NCT00830960|466159356|FG004|Overall Study|Withdrawal by Subject|16|||
129510692|NCT00830960|466159357|FG005|Overall Study|Withdrawal by Subject|21|||
129510693|NCT00830960|466159352|FG000|Overall Study|Sponsor Decision|1|||
129510694|NCT00830960|466159353|FG001|Overall Study|Sponsor Decision|2|||
129510695|NCT00830960|466159354|FG002|Overall Study|Sponsor Decision|3|||
129510696|NCT00830960|466159355|FG003|Overall Study|Sponsor Decision|4|||
129510697|NCT00830960|466159356|FG004|Overall Study|Sponsor Decision|5|||
129510698|NCT00830960|466159357|FG005|Overall Study|Sponsor Decision|7|||
129510699|NCT00830960|466159352|FG000|Overall Study|No study drug received|7|||
129510700|NCT00830960|466159353|FG001|Overall Study|No study drug received|2|||
129510701|NCT00830960|466159354|FG002|Overall Study|No study drug received|4|||
129510702|NCT00830960|466159355|FG003|Overall Study|No study drug received|3|||
129510703|NCT00830960|466159356|FG004|Overall Study|No study drug received|5|||
129510704|NCT00830960|466159357|FG005|Overall Study|No study drug received|7|||
129510705|NCT01086150|466159358|FG000|Overall Study|Withdrawal by Subject|0|||
129510706|NCT01086150|466159359|FG001|Overall Study|Withdrawal by Subject|4|||
129510707|NCT01086150|466159360|FG002|Overall Study|Withdrawal by Subject|1|||
129510708|NCT01086150|466159358|FG000|Overall Study|Lost to Follow-up|0|||
129510709|NCT01086150|466159359|FG001|Overall Study|Lost to Follow-up|1|||
129510710|NCT01086150|466159360|FG002|Overall Study|Lost to Follow-up|0|||
129510711|NCT01086150|466159358|FG000|Overall Study|Screen Failure|0|||
129510712|NCT01086150|466159359|FG001|Overall Study|Screen Failure|1|||
129510713|NCT01086150|466159360|FG002|Overall Study|Screen Failure|0|||
129510714|NCT00805545|466159361|FG000|Overall Study|Protocol Violation|3|||
129510715|NCT00805545|466159362|FG001|Overall Study|Protocol Violation|2|||
129510716|NCT00805545|466159361|FG000|Overall Study|Protocol Violation|3|||
129510717|NCT00805545|466159362|FG001|Overall Study|Protocol Violation|1|||
129510718|NCT03448224|466159363|FG000|Overall Study|Provided same answer to every question|1|||
129510719|NCT03448224|466159364|FG001|Overall Study|Provided same answer to every question|0|||
129510720|NCT01021813|466159365|FG000|DB Treatment Phase|Adverse Event|60|||
129510721|NCT01021813|466159366|FG001|DB Treatment Phase|Adverse Event|22|||
129510722|NCT01021813|466159367|FG002|DB Treatment Phase|Adverse Event|0|||
129510723|NCT01021813|466159368|FG003|DB Treatment Phase|Adverse Event|0|||
129510724|NCT01021813|466159369|FG004|DB Treatment Phase|Adverse Event|0|||
129510725|NCT01021813|466159365|FG000|DB Treatment Phase|Lack of Efficacy|44|||
129510726|NCT01021813|466159366|FG001|DB Treatment Phase|Lack of Efficacy|28|||
129510727|NCT01021813|466159367|FG002|DB Treatment Phase|Lack of Efficacy|0|||
129510728|NCT01021813|466159368|FG003|DB Treatment Phase|Lack of Efficacy|0|||
129510729|NCT01021813|466159369|FG004|DB Treatment Phase|Lack of Efficacy|0|||
129510730|NCT01021813|466159365|FG000|DB Treatment Phase|Lost to Follow-up|14|||
129510731|NCT01021813|466159366|FG001|DB Treatment Phase|Lost to Follow-up|12|||
129510732|NCT01021813|466159367|FG002|DB Treatment Phase|Lost to Follow-up|0|||
129510733|NCT01021813|466159368|FG003|DB Treatment Phase|Lost to Follow-up|0|||
129510734|NCT01021813|466159369|FG004|DB Treatment Phase|Lost to Follow-up|0|||
129510735|NCT01021813|466159365|FG000|DB Treatment Phase|Physician Decision|17|||
129510736|NCT01021813|466159366|FG001|DB Treatment Phase|Physician Decision|8|||
129510737|NCT01021813|466159367|FG002|DB Treatment Phase|Physician Decision|0|||
129510738|NCT01021813|466159368|FG003|DB Treatment Phase|Physician Decision|0|||
129510739|NCT01021813|466159369|FG004|DB Treatment Phase|Physician Decision|0|||
129510740|NCT01021813|466159365|FG000|DB Treatment Phase|Pregnancy|1|||
129510741|NCT01021813|466159366|FG001|DB Treatment Phase|Pregnancy|0|||
129510742|NCT01021813|466159367|FG002|DB Treatment Phase|Pregnancy|0|||
129510743|NCT01021813|466159368|FG003|DB Treatment Phase|Pregnancy|0|||
129510744|NCT01021813|466159369|FG004|DB Treatment Phase|Pregnancy|0|||
129510745|NCT01021813|466159365|FG000|DB Treatment Phase|Protocol Violation|4|||
129510746|NCT01021813|466159366|FG001|DB Treatment Phase|Protocol Violation|3|||
129510747|NCT01021813|466159367|FG002|DB Treatment Phase|Protocol Violation|0|||
129510748|NCT01021813|466159368|FG003|DB Treatment Phase|Protocol Violation|0|||
129510749|NCT01021813|466159369|FG004|DB Treatment Phase|Protocol Violation|0|||
129510750|NCT01021813|466159365|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
129510751|NCT01021813|466159366|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
129510752|NCT01021813|466159367|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
129510753|NCT01021813|466159368|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
129510754|NCT01021813|466159369|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
129510755|NCT01021813|466159365|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
129510756|NCT01021813|466159366|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
129510757|NCT01021813|466159367|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
129510758|NCT01021813|466159368|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
129510759|NCT01021813|466159369|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
129510760|NCT01021813|466159365|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
129510761|NCT01021813|466159366|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
129510762|NCT01021813|466159367|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
129510763|NCT01021813|466159368|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
129510764|NCT01021813|466159369|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
129510765|NCT01021813|466159365|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
129510766|NCT01021813|466159366|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
129510767|NCT01021813|466159367|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
129510768|NCT01021813|466159368|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
129510769|NCT01021813|466159369|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
129510770|NCT01021813|466159365|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
129510771|NCT01021813|466159366|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
129510772|NCT01021813|466159367|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
129510773|NCT01021813|466159368|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
129510774|NCT01021813|466159369|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
129510775|NCT01021813|466159365|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
129510776|NCT01021813|466159366|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
129510777|NCT01021813|466159367|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
129510778|NCT01021813|466159368|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
129510779|NCT01021813|466159369|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
129510780|NCT00862121|466159372|FG000|Overall Study|Adverse Event|1|||
129510781|NCT00862121|466159373|FG001|Overall Study|Adverse Event|2|||
129510782|NCT00862121|466159372|FG000|Overall Study|Lack of Efficacy|0|||
129510783|NCT00862121|466159373|FG001|Overall Study|Lack of Efficacy|3|||
129510784|NCT00862121|466159372|FG000|Overall Study|Protocol Violation|0|||
129510785|NCT00862121|466159373|FG001|Overall Study|Protocol Violation|1|||
129510786|NCT00862121|466159372|FG000|Overall Study|Exclusion criterion violation|0|||
129510787|NCT00862121|466159373|FG001|Overall Study|Exclusion criterion violation|1|||
129510788|NCT00862121|466159372|FG000|Overall Study|Incorrect randomisation|0|||
129510789|NCT00862121|466159373|FG001|Overall Study|Incorrect randomisation|1|||
129510790|NCT00171314|466159378|FG000|Overall Study|Adverse Event|44|||
129510791|NCT00171314|466159379|FG001|Overall Study|Adverse Event|41|||
129510792|NCT00171314|466159378|FG000|Overall Study|Lack of Efficacy|19|||
129510793|NCT00171314|466159379|FG001|Overall Study|Lack of Efficacy|14|||
129510794|NCT00171314|466159378|FG000|Overall Study|Withdrawal by Subject|9|||
129510795|NCT00171314|466159379|FG001|Overall Study|Withdrawal by Subject|6|||
129510796|NCT00171314|466159378|FG000|Overall Study|Abnormal Test Procedure Results|9|||
129510797|NCT00171314|466159379|FG001|Overall Study|Abnormal Test Procedure Results|3|||
129510798|NCT00171314|466159378|FG000|Overall Study|Protocol Violation|3|||
129510799|NCT00171314|466159379|FG001|Overall Study|Protocol Violation|7|||
129510800|NCT00171314|466159378|FG000|Overall Study|Administrative Problems|4|||
129510801|NCT00171314|466159379|FG001|Overall Study|Administrative Problems|3|||
129510802|NCT00171314|466159378|FG000|Overall Study|Lost to Follow-up|1|||
129510803|NCT00171314|466159379|FG001|Overall Study|Lost to Follow-up|3|||
129510804|NCT00171314|466159378|FG000|Overall Study|Death|2|||
129510805|NCT00171314|466159379|FG001|Overall Study|Death|1|||
129510806|NCT01033487|466159383|FG000|Fourth Intervention Period|Adverse Event|0|||
129510807|NCT01033487|466159384|FG001|Fourth Intervention Period|Adverse Event|0|||
129510808|NCT01033487|466159385|FG002|Fourth Intervention Period|Adverse Event|0|||
129510809|NCT01033487|466159386|FG003|Fourth Intervention Period|Adverse Event|0|||
129510810|NCT01033487|466159387|FG004|Fourth Intervention Period|Adverse Event|0|||
129510811|NCT01033487|466159388|FG005|Fourth Intervention Period|Adverse Event|0|||
129510812|NCT01033487|466159389|FG006|Fourth Intervention Period|Adverse Event|0|||
129510813|NCT01033487|466159390|FG007|Fourth Intervention Period|Adverse Event|0|||
129510814|NCT01033487|466159391|FG008|Fourth Intervention Period|Adverse Event|1|||
129510815|NCT01033487|466159392|FG009|Fourth Intervention Period|Adverse Event|0|||
129510816|NCT02939599|466159393|FG000|Overall Study|Adverse Event|1|||
129510817|NCT02939599|466159394|FG001|Overall Study|Adverse Event|0|||
129510818|NCT02939599|466159393|FG000|Overall Study|Study Terminated By Sponsor|2|||
129510819|NCT02939599|466159394|FG001|Overall Study|Study Terminated By Sponsor|2|||
129510820|NCT02148211|466159395|FG000|Overall Study|Lost to Follow-up|352|||
129510821|NCT02726113|466159396|FG000|Total Enrollment|Physician Decision|0|||
129510822|NCT02726113|466159397|FG001|Total Enrollment|Physician Decision|1|||
129510823|NCT02726113|466159396|FG000|Total Enrollment|Protocol Violation|1|||
129510824|NCT02726113|466159397|FG001|Total Enrollment|Protocol Violation|0|||
129510825|NCT02726113|466159396|FG000|Total Enrollment|Withdrawal by Subject|2|||
129510826|NCT02726113|466159397|FG001|Total Enrollment|Withdrawal by Subject|1|||
129510827|NCT02726113|466159396|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
129510828|NCT02726113|466159397|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
129510829|NCT02726113|466159396|FG000|Genomic Analysis|Protocol Violation|1|||
129510830|NCT02726113|466159397|FG001|Genomic Analysis|Protocol Violation|0|||
129510831|NCT02726113|466159396|FG000|Genomic Analysis|Withdrawal by Subject|2|||
129510832|NCT02726113|466159397|FG001|Genomic Analysis|Withdrawal by Subject|1|||
129510833|NCT02726113|466159396|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
129510834|NCT02726113|466159397|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
129510835|NCT03326869|466160885|FG000|Overall Study|Study data has been lost to natural disa|1|||
129510836|NCT03326869|466160886|FG001|Overall Study|Study data has been lost to natural disa|1|||
129510837|NCT00525785|466160888|FG000|Overall Study|Withdrawal by Subject|1|||
129510838|NCT00525785|466160888|FG000|Overall Study|Lack of Efficacy|1|||
129510839|NCT00525785|466160888|FG000|Overall Study|Physician Decision|1|||
129510840|NCT02455388|466160889|FG000|Overall Study|Protocol Violation|1|||
129510841|NCT02455388|466160890|FG001|Overall Study|Protocol Violation|0|||
129510842|NCT02455388|466160891|FG002|Overall Study|Protocol Violation|4|||
129510843|NCT02455388|466160889|FG000|Overall Study|Withdrawal by Subject|0|||
129510844|NCT02455388|466160890|FG001|Overall Study|Withdrawal by Subject|0|||
129510845|NCT02455388|466160891|FG002|Overall Study|Withdrawal by Subject|7|||
129510846|NCT01316939|466160892|FG000|Overall Study|Study closed/terminated|26|||
129510847|NCT01316939|466160893|FG001|Overall Study|Study closed/terminated|25|||
129510848|NCT01316939|466160894|FG002|Overall Study|Study closed/terminated|23|||
129510849|NCT01316939|466160892|FG000|Overall Study|Lack of Efficacy|24|||
129510850|NCT01316939|466160893|FG001|Overall Study|Lack of Efficacy|25|||
129510851|NCT01316939|466160894|FG002|Overall Study|Lack of Efficacy|25|||
129510852|NCT01316939|466160892|FG000|Overall Study|Adverse Event|9|||
129510853|NCT01316939|466160893|FG001|Overall Study|Adverse Event|12|||
129510854|NCT01316939|466160894|FG002|Overall Study|Adverse Event|11|||
129510855|NCT01316939|466160892|FG000|Overall Study|Withdrawal by Subject|1|||
129510856|NCT01316939|466160893|FG001|Overall Study|Withdrawal by Subject|3|||
129510857|NCT01316939|466160894|FG002|Overall Study|Withdrawal by Subject|6|||
129510858|NCT01316939|466160892|FG000|Overall Study|Physician Decision|2|||
129510859|NCT01316939|466160893|FG001|Overall Study|Physician Decision|2|||
129510860|NCT01316939|466160894|FG002|Overall Study|Physician Decision|1|||
129510861|NCT01316939|466160892|FG000|Overall Study|Lost to Follow-up|0|||
129510862|NCT01316939|466160893|FG001|Overall Study|Lost to Follow-up|0|||
129510863|NCT01316939|466160894|FG002|Overall Study|Lost to Follow-up|2|||
129510864|NCT01316939|466160892|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
129510865|NCT01316939|466160893|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
129510866|NCT01316939|466160894|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
129510867|NCT01316939|466160892|FG000|Overall Study|Protocol Violation|0|||
129510868|NCT01316939|466160893|FG001|Overall Study|Protocol Violation|1|||
129510869|NCT01316939|466160894|FG002|Overall Study|Protocol Violation|0|||
129510870|NCT03628599|466160896|FG000|Overall Study|Adverse Event|0|||
129510871|NCT03628599|466160897|FG001|Overall Study|Adverse Event|1|||
129510872|NCT01624506|466160898|FG000|Overall Study|Lost to Follow-up|29|||
129510873|NCT01624506|466160899|FG001|Overall Study|Lost to Follow-up|15|||
129510874|NCT01624506|466160898|FG000|Overall Study|Withdrawal by Subject|9|||
129510875|NCT01624506|466160899|FG001|Overall Study|Withdrawal by Subject|2|||
129510876|NCT01624506|466160898|FG000|Overall Study|Death|1|||
129510877|NCT01624506|466160899|FG001|Overall Study|Death|0|||
129510878|NCT01624506|466160898|FG000|Overall Study|LINX explants|23|||
129510879|NCT01624506|466160899|FG001|Overall Study|LINX explants|0|||
129510880|NCT01624506|466160898|FG000|Overall Study|Adverse Event|3|||
129510881|NCT01624506|466160899|FG001|Overall Study|Adverse Event|0|||
129510882|NCT00132314|466160905|FG000|Overall Study|Lost to Follow-up|70|||
129510883|NCT00132314|466160906|FG001|Overall Study|Lost to Follow-up|62|||
129510884|NCT00132314|466160905|FG000|Overall Study|Lacked SSN|1|||
129510885|NCT00132314|466160906|FG001|Overall Study|Lacked SSN|3|||
129510886|NCT00132314|466160905|FG000|Overall Study|Refused intervention at baseline|2|||
129510887|NCT00132314|466160906|FG001|Overall Study|Refused intervention at baseline|7|||
129510888|NCT02966353|466160909|FG000|Overall Study|Withdrawal by Subject|7|||
129510889|NCT02966353|466160909|FG000|Overall Study|Adverse Event|4|||
129510890|NCT02966353|466160909|FG000|Overall Study|Death|4|||
129510891|NCT02966353|466160909|FG000|Overall Study|Physician Decision|3|||
129510892|NCT02966353|466160909|FG000|Overall Study|Progressive disease|2|||
129510893|NCT02966353|466160909|FG000|Overall Study|Protocol deviation|2|||
129510894|NCT00093470|466160910|FG000|Overall Study|Disease progression|39|||
129510895|NCT00093470|466160911|FG001|Overall Study|Disease progression|0|||
129510896|NCT00093470|466160910|FG000|Overall Study|Adverse Event|15|||
129510897|NCT00093470|466160911|FG001|Overall Study|Adverse Event|0|||
129510898|NCT00093470|466160910|FG000|Overall Study|Death|2|||
129510899|NCT00093470|466160911|FG001|Overall Study|Death|0|||
129510900|NCT00093470|466160910|FG000|Overall Study|Withdrawal by Subject|8|||
129510901|NCT00093470|466160911|FG001|Overall Study|Withdrawal by Subject|0|||
129510902|NCT00093470|466160910|FG000|Overall Study|Alternative therapy|2|||
129510903|NCT00093470|466160911|FG001|Overall Study|Alternative therapy|0|||
129510904|NCT00093470|466160910|FG000|Overall Study|Other complicating disease|3|||
129510905|NCT00093470|466160911|FG001|Overall Study|Other complicating disease|0|||
129510906|NCT00093470|466160910|FG000|Overall Study|Physician Decision|2|||
129510907|NCT00093470|466160911|FG001|Overall Study|Physician Decision|0|||
129510908|NCT00093470|466160910|FG000|Overall Study|Never started treatment|1|||
129510909|NCT00093470|466160911|FG001|Overall Study|Never started treatment|0|||
129510910|NCT00093470|466160910|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
129510911|NCT00093470|466160911|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
129510912|NCT05905601|466160912|FG000|Overall Study|Lost to Follow-up|1|||
129510913|NCT05905601|466160913|FG001|Overall Study|Lost to Follow-up|3|||
129510914|NCT02514772|466160914|FG000|Overall Study|Adverse Event|1|||
129510915|NCT02514772|466160915|FG001|Overall Study|Adverse Event|0|||
129510916|NCT02514772|466160914|FG000|Overall Study|Death|0|||
129510917|NCT02514772|466160915|FG001|Overall Study|Death|1|||
129510918|NCT02514772|466160914|FG000|Overall Study|Withdrawal by Subject|2|||
129510919|NCT02514772|466160915|FG001|Overall Study|Withdrawal by Subject|1|||
129510920|NCT01415908|466160916|FG000|Overall Study|Withdrawal by Subject|1|||
129510921|NCT01415908|466160917|FG001|Overall Study|Withdrawal by Subject|0|||
129510922|NCT03250377|466160918|FG000|Overall Study|Adverse Event|2|||
129510923|NCT03250377|466160919|FG001|Overall Study|Adverse Event|4|||
129510924|NCT03250377|466160920|FG002|Overall Study|Adverse Event|0|||
129510925|NCT03250377|466160921|FG003|Overall Study|Adverse Event|4|||
129510926|NCT03250377|466160918|FG000|Overall Study|Lack of Efficacy|5|||
129510927|NCT03250377|466160919|FG001|Overall Study|Lack of Efficacy|14|||
129510928|NCT03250377|466160920|FG002|Overall Study|Lack of Efficacy|1|||
129510929|NCT03250377|466160921|FG003|Overall Study|Lack of Efficacy|3|||
129510930|NCT03250377|466160918|FG000|Overall Study|Protocol Violation|0|||
129510931|NCT03250377|466160919|FG001|Overall Study|Protocol Violation|2|||
129510932|NCT03250377|466160920|FG002|Overall Study|Protocol Violation|0|||
129510933|NCT03250377|466160921|FG003|Overall Study|Protocol Violation|1|||
129510934|NCT03250377|466160918|FG000|Overall Study|Lost to Follow-up|0|||
129510935|NCT03250377|466160919|FG001|Overall Study|Lost to Follow-up|1|||
129510936|NCT03250377|466160920|FG002|Overall Study|Lost to Follow-up|0|||
129510937|NCT03250377|466160921|FG003|Overall Study|Lost to Follow-up|0|||
129510938|NCT03250377|466160918|FG000|Overall Study|Withdrawal by Subject|7|||
129510939|NCT03250377|466160919|FG001|Overall Study|Withdrawal by Subject|7|||
129510940|NCT03250377|466160920|FG002|Overall Study|Withdrawal by Subject|0|||
129510941|NCT03250377|466160921|FG003|Overall Study|Withdrawal by Subject|4|||
129510942|NCT03250377|466160918|FG000|Overall Study|Investigator's Judgment|1|||
129510943|NCT03250377|466160919|FG001|Overall Study|Investigator's Judgment|0|||
129510944|NCT03250377|466160920|FG002|Overall Study|Investigator's Judgment|0|||
129510945|NCT03250377|466160921|FG003|Overall Study|Investigator's Judgment|0|||
129510946|NCT03250377|466160918|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
129982847|NCT00307684|467900636|FG002|Open Label Phase|Adverse Event|16|||
129982848|NCT00307684|467900634|FG000|Open Label Phase|Withdrawal by Subject|0|||
129982849|NCT00307684|467900635|FG001|Open Label Phase|Withdrawal by Subject|0|||
129982850|NCT00307684|467900636|FG002|Open Label Phase|Withdrawal by Subject|15|||
129982851|NCT00307684|467900634|FG000|Open Label Phase|Lost to Follow-up|0|||
129982852|NCT00307684|467900635|FG001|Open Label Phase|Lost to Follow-up|0|||
129982853|NCT00307684|467900636|FG002|Open Label Phase|Lost to Follow-up|11|||
129982854|NCT00307684|467900634|FG000|Open Label Phase|non compliance|0|||
129982855|NCT00307684|467900635|FG001|Open Label Phase|non compliance|0|||
129982856|NCT00307684|467900636|FG002|Open Label Phase|non compliance|5|||
129982857|NCT00307684|467900634|FG000|Open Label Phase|other|0|||
129982858|NCT00307684|467900635|FG001|Open Label Phase|other|0|||
129982859|NCT00307684|467900636|FG002|Open Label Phase|other|6|||
129982860|NCT00307684|467900634|FG000|Double Blind Phase|Lack of Efficacy|2|||
129982861|NCT00307684|467900635|FG001|Double Blind Phase|Lack of Efficacy|5|||
129982862|NCT00307684|467900636|FG002|Double Blind Phase|Lack of Efficacy|0|||
129982863|NCT02580305|467900637|FG000|Overall Study|Adverse Event|15|||
129982864|NCT02580305|467900638|FG001|Overall Study|Adverse Event|19|||
129982865|NCT02580305|467900639|FG002|Overall Study|Adverse Event|10|||
129982866|NCT02580305|467900637|FG000|Overall Study|Lack of Efficacy|5|||
129982867|NCT02580305|467900638|FG001|Overall Study|Lack of Efficacy|0|||
129982868|NCT02580305|467900639|FG002|Overall Study|Lack of Efficacy|2|||
129982869|NCT02580305|467900637|FG000|Overall Study|Protocol Violation|4|||
129982870|NCT02580305|467900638|FG001|Overall Study|Protocol Violation|9|||
129982871|NCT02580305|467900639|FG002|Overall Study|Protocol Violation|6|||
129982872|NCT02580305|467900637|FG000|Overall Study|Lost to Follow-up|4|||
129982873|NCT02580305|467900638|FG001|Overall Study|Lost to Follow-up|4|||
129510947|NCT03250377|466160919|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
129982874|NCT02580305|467900639|FG002|Overall Study|Lost to Follow-up|2|||
129982875|NCT02580305|467900637|FG000|Overall Study|Withdrawal by Subject|11|||
129982876|NCT02580305|467900638|FG001|Overall Study|Withdrawal by Subject|9|||
129982877|NCT02580305|467900639|FG002|Overall Study|Withdrawal by Subject|7|||
129982878|NCT02580305|467900637|FG000|Overall Study|Randomized in error and never treated|4|||
129982879|NCT02580305|467900638|FG001|Overall Study|Randomized in error and never treated|8|||
129982880|NCT02580305|467900639|FG002|Overall Study|Randomized in error and never treated|5|||
129510948|NCT03250377|466160920|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
129510949|NCT03250377|466160921|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
129510950|NCT03250377|466160918|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
129510951|NCT03250377|466160919|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
129510952|NCT03250377|466160920|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
129510953|NCT03250377|466160921|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
129510954|NCT03250377|466160918|FG000|Overall Study|Epilepsy Surgery|0|||
129510955|NCT03250377|466160919|FG001|Overall Study|Epilepsy Surgery|1|||
129510956|NCT03250377|466160920|FG002|Overall Study|Epilepsy Surgery|2|||
129510957|NCT03250377|466160921|FG003|Overall Study|Epilepsy Surgery|0|||
129510958|NCT03250377|466160918|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
129510959|NCT03250377|466160919|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
129510960|NCT03250377|466160920|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
129510961|NCT03250377|466160921|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
129510962|NCT03250377|466160918|FG000|Overall Study|Request From The Sponsor|0|||
129510963|NCT03250377|466160919|FG001|Overall Study|Request From The Sponsor|1|||
129510964|NCT03250377|466160920|FG002|Overall Study|Request From The Sponsor|0|||
129510965|NCT03250377|466160921|FG003|Overall Study|Request From The Sponsor|0|||
129510966|NCT03250377|466160918|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
129510967|NCT03250377|466160919|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
129510968|NCT03250377|466160920|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
129510969|NCT03250377|466160921|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
129510970|NCT03250377|466160918|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
129510971|NCT03250377|466160919|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
129510972|NCT03250377|466160920|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
129510973|NCT03250377|466160921|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
129510974|NCT03250377|466160918|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
129510975|NCT03250377|466160919|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
129510976|NCT03250377|466160920|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
129510977|NCT03250377|466160921|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
129510978|NCT03250377|466160918|FG000|Overall Study|Pregnancy Event|0|||
129510979|NCT03250377|466160919|FG001|Overall Study|Pregnancy Event|1|||
129510980|NCT03250377|466160920|FG002|Overall Study|Pregnancy Event|0|||
129510981|NCT03250377|466160921|FG003|Overall Study|Pregnancy Event|0|||
129510982|NCT03250377|466160918|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
129510983|NCT03250377|466160919|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
129510984|NCT03250377|466160920|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
129510985|NCT03250377|466160921|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
129510986|NCT03250377|466160918|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
129510987|NCT03250377|466160919|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
129510988|NCT03250377|466160920|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
129510989|NCT03250377|466160921|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
129510990|NCT03250377|466160918|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
129510991|NCT03250377|466160919|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
129510992|NCT03250377|466160920|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
129510993|NCT03250377|466160921|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
129510994|NCT03250377|466160918|FG000|Overall Study|Patient requested to change hospital|0|||
129510995|NCT03250377|466160919|FG001|Overall Study|Patient requested to change hospital|0|||
129510996|NCT03250377|466160920|FG002|Overall Study|Patient requested to change hospital|0|||
129510997|NCT03250377|466160921|FG003|Overall Study|Patient requested to change hospital|1|||
129510998|NCT03250377|466160918|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
129510999|NCT03250377|466160919|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
129511000|NCT03250377|466160920|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
129511001|NCT03250377|466160921|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
129511002|NCT01665768|466160928|FG000|Overall Study|Adverse Event|3|||
129511003|NCT01665768|466160928|FG000|Overall Study|Lack of Efficacy|19|||
129511004|NCT01665768|466160928|FG000|Overall Study|Withdrawal by Subject|1|||
129511005|NCT01329341|466160929|FG000|Overall Study|Withdrawal by Subject|44|||
129511006|NCT04603391|466160930|FG000|First Intervention (4 Days)|Adverse Event|1|||
129511007|NCT04603391|466160931|FG001|First Intervention (4 Days)|Adverse Event|0|||
129511008|NCT04603391|466160930|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
129511009|NCT04603391|466160931|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
129511010|NCT02151682|466160932|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
129511011|NCT02151682|466160933|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
129511012|NCT02151682|466160934|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
129511013|NCT02151682|466160935|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
129511014|NCT02151682|466160936|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
129511015|NCT02151682|466160937|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
129511016|NCT02151682|466160932|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
129511017|NCT02151682|466160933|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
129511018|NCT02151682|466160934|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
129511019|NCT02151682|466160935|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
129511020|NCT02151682|466160936|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
129511021|NCT02151682|466160937|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
129511022|NCT02151682|466160932|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
129511023|NCT02151682|466160933|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
129511024|NCT02151682|466160934|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
129511025|NCT02151682|466160935|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
129511026|NCT02151682|466160936|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
129511027|NCT02151682|466160937|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
129511028|NCT02151682|466160932|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
129511029|NCT02151682|466160933|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
129511030|NCT02151682|466160934|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
129511031|NCT02151682|466160935|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
129511032|NCT02151682|466160936|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
129511033|NCT02151682|466160937|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
129511034|NCT02151682|466160932|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
129511035|NCT02151682|466160933|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
129511036|NCT02151682|466160934|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
129511037|NCT02151682|466160935|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
129511038|NCT02151682|466160936|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
129511039|NCT02151682|466160937|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
129511040|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
129511041|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
129511042|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
129511043|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
129511044|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
129511045|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
129511046|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
129511047|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
129511048|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
129511049|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
129511050|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
129511051|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
129511052|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
129511053|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
129511054|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
129511055|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
129511056|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
129511057|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
129511058|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
129511059|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
129511060|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
129511061|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
129511062|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
129511063|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
129511064|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
129511065|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
129511066|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
129511067|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
129511068|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
129511069|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
129511070|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
129511071|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
129511072|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
129511073|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
129511074|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
129511075|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
129511076|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
129511077|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
129511078|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
129982881|NCT00224887|467900640|FG000|Overall Study|Pregnancy|6|||
129511079|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
129511080|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
129511081|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
129511082|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
129511083|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
129511084|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
129511085|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
129511086|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
129511087|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
129511088|NCT02151682|466160932|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
129511089|NCT02151682|466160933|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
129511090|NCT02151682|466160934|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
129511091|NCT02151682|466160935|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
129511092|NCT02151682|466160936|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
129511093|NCT02151682|466160937|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
129511094|NCT02151682|466160932|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
129511095|NCT02151682|466160933|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
129511096|NCT02151682|466160934|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
129511097|NCT02151682|466160935|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
129511098|NCT02151682|466160936|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
129511099|NCT02151682|466160937|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
129511100|NCT02151682|466160932|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
129511101|NCT02151682|466160933|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
129511102|NCT02151682|466160934|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
129511103|NCT02151682|466160935|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
129511104|NCT02151682|466160936|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
129511105|NCT02151682|466160937|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
129511106|NCT02151682|466160932|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
129511107|NCT02151682|466160933|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
129511108|NCT02151682|466160934|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
129511109|NCT02151682|466160935|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
129511110|NCT02151682|466160936|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
129511111|NCT02151682|466160937|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
129511112|NCT02151682|466160932|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
129511113|NCT02151682|466160933|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
129511114|NCT02151682|466160934|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
129511115|NCT02151682|466160935|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
129511116|NCT02151682|466160936|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
129511117|NCT02151682|466160937|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
129511118|NCT03260894|466160939|FG000|Overall Study|Death|6|||
129511119|NCT03260894|466160940|FG001|Overall Study|Death|8|||
129511120|NCT03260894|466160939|FG000|Overall Study|Withdrawal by Subject|4|||
129511121|NCT03260894|466160940|FG001|Overall Study|Withdrawal by Subject|11|||
129511122|NCT03260894|466160939|FG000|Overall Study|On-going at clinical cut off date|36|||
129511123|NCT03260894|466160940|FG001|Overall Study|On-going at clinical cut off date|31|||
129511124|NCT00992186|466160941|FG000|Overall Study|Withdrawal by Subject|2|||
129511125|NCT00992186|466160941|FG000|Overall Study|Protocol Violation|1|||
129511126|NCT00992186|466160941|FG000|Overall Study|Physician Decision|1|||
129511127|NCT00992186|466160941|FG000|Overall Study|Adverse Event|9|||
129511128|NCT00992186|466160941|FG000|Overall Study|Progressive Disease|30|||
129511129|NCT00992186|466160941|FG000|Overall Study|Refusal To Receive Study Agent|3|||
129511130|NCT00168064|466160942|FG000|Overall Study|Adverse Event|26|||
129511131|NCT00168064|466160943|FG001|Overall Study|Adverse Event|22|||
129511132|NCT00168064|466160942|FG000|Overall Study|Withdrawal by Subject|3|||
129511133|NCT00168064|466160943|FG001|Overall Study|Withdrawal by Subject|4|||
129511134|NCT00168064|466160942|FG000|Overall Study|Lack of Efficacy|4|||
129511135|NCT00168064|466160943|FG001|Overall Study|Lack of Efficacy|4|||
129511136|NCT00168064|466160942|FG000|Overall Study|Lost to Follow-up|4|||
129511137|NCT00168064|466160943|FG001|Overall Study|Lost to Follow-up|3|||
129511138|NCT00168064|466160942|FG000|Overall Study|Non-compliance|2|||
129511139|NCT00168064|466160943|FG001|Overall Study|Non-compliance|3|||
129511140|NCT00168064|466160942|FG000|Overall Study|Concurrent Illness|4|||
129511141|NCT00168064|466160943|FG001|Overall Study|Concurrent Illness|3|||
129511142|NCT00168064|466160942|FG000|Overall Study|Subject's Best interest|2|||
129511143|NCT00168064|466160943|FG001|Overall Study|Subject's Best interest|2|||
129511144|NCT00168064|466160942|FG000|Overall Study|Various|4|||
129511145|NCT00168064|466160943|FG001|Overall Study|Various|3|||
129511146|NCT00318565|466160944|FG000|Overall Study|Excluded per protocol|24|||
129511147|NCT01896856|466160945|FG000|Overall Study|Transportation issues / Non-compliance|0|||
129511148|NCT01896856|466160946|FG001|Overall Study|Transportation issues / Non-compliance|0|||
129511149|NCT01896856|466160947|FG002|Overall Study|Transportation issues / Non-compliance|1|||
129511150|NCT01896856|466160948|FG003|Overall Study|Transportation issues / Non-compliance|0|||
129511151|NCT01896856|466160949|FG004|Overall Study|Transportation issues / Non-compliance|0|||
129511152|NCT01896856|466160950|FG005|Overall Study|Transportation issues / Non-compliance|0|||
129511153|NCT00282867|466160951|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
129511154|NCT00282867|466160952|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
129511155|NCT00282867|466160953|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
129511156|NCT02855450|466160954|FG000|Overall Study|Adverse Event|1|||
129511157|NCT02855450|466160955|FG001|Overall Study|Adverse Event|0|||
129511158|NCT02855450|466160954|FG000|Overall Study|Lost to Follow-up|4|||
129511159|NCT02855450|466160955|FG001|Overall Study|Lost to Follow-up|0|||
129511160|NCT00426556|466160956|FG000|Phase I - Core Phase|Disease Progression|0|||
129511161|NCT00426556|466160957|FG001|Phase I - Core Phase|Disease Progression|6|||
129511162|NCT00426556|466160958|FG002|Phase I - Core Phase|Disease Progression|2|||
129511163|NCT00426556|466160959|FG003|Phase I - Core Phase|Disease Progression|0|||
129511164|NCT00426556|466160956|FG000|Phase I - Core Phase|Adverse Event|1|||
129511165|NCT00426556|466160957|FG001|Phase I - Core Phase|Adverse Event|3|||
129511166|NCT00426556|466160958|FG002|Phase I - Core Phase|Adverse Event|1|||
129511167|NCT00426556|466160959|FG003|Phase I - Core Phase|Adverse Event|0|||
129511168|NCT00426556|466160956|FG000|Phase I - Core Phase|Death|0|||
129511169|NCT00426556|466160957|FG001|Phase I - Core Phase|Death|1|||
129511170|NCT00426556|466160958|FG002|Phase I - Core Phase|Death|0|||
129511171|NCT00426556|466160959|FG003|Phase I - Core Phase|Death|0|||
129511172|NCT00426556|466160956|FG000|Phase I - Extension Phase|Adverse Event|0|||
129511173|NCT00426556|466160957|FG001|Phase I - Extension Phase|Adverse Event|1|||
129511174|NCT00426556|466160958|FG002|Phase I - Extension Phase|Adverse Event|1|||
129511175|NCT00426556|466160959|FG003|Phase I - Extension Phase|Adverse Event|0|||
129511176|NCT00426556|466160956|FG000|Phase I - Extension Phase|Disease Progression|5|||
129511177|NCT00426556|466160957|FG001|Phase I - Extension Phase|Disease Progression|5|||
129511178|NCT00426556|466160958|FG002|Phase I - Extension Phase|Disease Progression|6|||
129511179|NCT00426556|466160959|FG003|Phase I - Extension Phase|Disease Progression|0|||
129511180|NCT00426556|466160956|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
129511181|NCT00426556|466160957|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
129511182|NCT00426556|466160958|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
129511183|NCT00426556|466160959|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
129511184|NCT00426556|466160956|FG000|Phase II - Core Phase|Disease Progression|0|||
129511185|NCT00426556|466160957|FG001|Phase II - Core Phase|Disease Progression|0|||
129511186|NCT00426556|466160958|FG002|Phase II - Core Phase|Disease Progression|0|||
129511187|NCT00426556|466160959|FG003|Phase II - Core Phase|Disease Progression|16|||
129511188|NCT00426556|466160956|FG000|Phase II - Core Phase|Adverse Event|0|||
129511189|NCT00426556|466160957|FG001|Phase II - Core Phase|Adverse Event|0|||
129511190|NCT00426556|466160958|FG002|Phase II - Core Phase|Adverse Event|0|||
129511191|NCT00426556|466160959|FG003|Phase II - Core Phase|Adverse Event|8|||
129511192|NCT00426556|466160956|FG000|Phase II - Extension Phase|Disease Progression|0|||
129511193|NCT00426556|466160957|FG001|Phase II - Extension Phase|Disease Progression|0|||
129511194|NCT00426556|466160958|FG002|Phase II - Extension Phase|Disease Progression|0|||
129511195|NCT00426556|466160959|FG003|Phase II - Extension Phase|Disease Progression|21|||
129511196|NCT00426556|466160956|FG000|Phase II - Extension Phase|Adverse Event|0|||
129511197|NCT00426556|466160957|FG001|Phase II - Extension Phase|Adverse Event|0|||
129511198|NCT00426556|466160958|FG002|Phase II - Extension Phase|Adverse Event|0|||
129511199|NCT00426556|466160959|FG003|Phase II - Extension Phase|Adverse Event|2|||
129511200|NCT05159362|466160960|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
129511201|NCT05159362|466160961|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
129511202|NCT05159362|466160962|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
129511203|NCT01376245|466160963|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
129511204|NCT01376245|466160964|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
129511205|NCT01376245|466160965|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
129982882|NCT00224887|467900641|FG001|Overall Study|Pregnancy|6|||
129982883|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
129982884|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129982885|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129511206|NCT01376245|466160966|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
129511207|NCT01376245|466160967|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
129511208|NCT01376245|466160963|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
129511209|NCT01376245|466160964|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
129511210|NCT01376245|466160965|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
129511211|NCT01376245|466160966|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
129511212|NCT01376245|466160967|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
129511213|NCT01376245|466160963|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
129539154|NCT00361504|466265169|FG001|Overall Study|Resolution of Pain|0|||
129511214|NCT01376245|466160964|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
129511215|NCT01376245|466160965|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
129511216|NCT01376245|466160966|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
129511217|NCT01376245|466160967|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
129511218|NCT01376245|466160963|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
129511219|NCT01376245|466160964|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
129982886|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129982887|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
129982888|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
129982889|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982890|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982891|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982892|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
129982893|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
129982894|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982895|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982896|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982897|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
129982898|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
129982899|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982900|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982901|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982902|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
129982903|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
129982904|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982905|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982906|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982907|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
129982908|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
129982909|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982910|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982911|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982912|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
129982913|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
129982914|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982915|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982916|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982917|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
129982918|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
129982919|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982920|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982921|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982922|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
129982923|NCT00700427|467900644|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
129982924|NCT00700427|467900645|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982925|NCT00700427|467900646|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982926|NCT00700427|467900647|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982927|NCT00700427|467900648|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
129982928|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982929|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
129982930|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982931|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982932|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
129982933|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982934|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
129982935|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982936|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982937|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
129982938|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129982939|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
129982940|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129982941|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129982942|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
129511220|NCT01376245|466160965|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
129511221|NCT01376245|466160966|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
129511222|NCT01376245|466160967|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
129511223|NCT01376245|466160963|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
129511224|NCT01376245|466160964|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
129511225|NCT01376245|466160965|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
129511226|NCT01376245|466160966|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
129511227|NCT01376245|466160967|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
129511228|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
129511229|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
129511230|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
129511231|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
129511232|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
129511233|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
129511234|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
129511235|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
129511236|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
129511237|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
129511238|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129511239|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
129511240|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
129511241|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
129511242|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
129511243|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129511244|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
129511245|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
129511246|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
129511247|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
129511248|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129511249|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
129511250|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
129511251|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129511252|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
129511253|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
129511254|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
129511255|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
129511256|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
129511257|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
129511258|NCT01376245|466160963|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
129511259|NCT01376245|466160964|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
129511260|NCT01376245|466160965|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
129511261|NCT01376245|466160966|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
129511262|NCT01376245|466160967|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
129511263|NCT01335698|466160968|FG000|Treatment Stage 1|Lack of Efficacy|3|||
129511264|NCT01335698|466160969|FG001|Treatment Stage 1|Lack of Efficacy|1|||
129511265|NCT01335698|466160970|FG002|Treatment Stage 1|Lack of Efficacy|3|||
129511266|NCT01335698|466160971|FG003|Treatment Stage 1|Lack of Efficacy|3|||
129511267|NCT01335698|466160972|FG004|Treatment Stage 1|Lack of Efficacy|1|||
129511268|NCT01335698|466160968|FG000|Treatment Stage 1|Adverse Event|1|||
129511269|NCT01335698|466160969|FG001|Treatment Stage 1|Adverse Event|2|||
129511270|NCT01335698|466160970|FG002|Treatment Stage 1|Adverse Event|2|||
129511271|NCT01335698|466160971|FG003|Treatment Stage 1|Adverse Event|1|||
129511272|NCT01335698|466160972|FG004|Treatment Stage 1|Adverse Event|1|||
129511273|NCT01335698|466160968|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
129511274|NCT01335698|466160969|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
129511275|NCT01335698|466160970|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
129511276|NCT01335698|466160971|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
129511277|NCT01335698|466160972|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
129511278|NCT01335698|466160968|FG000|Treatment Stage 1|Lost to Follow-up|1|||
129511279|NCT01335698|466160969|FG001|Treatment Stage 1|Lost to Follow-up|1|||
129511280|NCT01335698|466160970|FG002|Treatment Stage 1|Lost to Follow-up|0|||
129511281|NCT01335698|466160971|FG003|Treatment Stage 1|Lost to Follow-up|0|||
129511282|NCT01335698|466160972|FG004|Treatment Stage 1|Lost to Follow-up|0|||
129511283|NCT01335698|466160968|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
129511284|NCT01335698|466160969|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
129511285|NCT01335698|466160970|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
129511286|NCT01335698|466160971|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
129511287|NCT01335698|466160972|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
129511288|NCT01335698|466160968|FG000|Treatment Stage 1|No longer meets study criteria|1|||
129511289|NCT01335698|466160969|FG001|Treatment Stage 1|No longer meets study criteria|1|||
129511290|NCT01335698|466160970|FG002|Treatment Stage 1|No longer meets study criteria|0|||
129511291|NCT01335698|466160971|FG003|Treatment Stage 1|No longer meets study criteria|1|||
129511292|NCT01335698|466160972|FG004|Treatment Stage 1|No longer meets study criteria|0|||
129511293|NCT01335698|466160968|FG000|Treatment Stage 1|Other|1|||
129511294|NCT01335698|466160969|FG001|Treatment Stage 1|Other|0|||
129511295|NCT01335698|466160970|FG002|Treatment Stage 1|Other|0|||
129511296|NCT01335698|466160971|FG003|Treatment Stage 1|Other|1|||
129511297|NCT01335698|466160972|FG004|Treatment Stage 1|Other|0|||
129511298|NCT01335698|466160968|FG000|Treatment Stage 2|Lack of Efficacy|2|||
129511299|NCT01335698|466160969|FG001|Treatment Stage 2|Lack of Efficacy|1|||
129511300|NCT01335698|466160970|FG002|Treatment Stage 2|Lack of Efficacy|3|||
129511301|NCT01335698|466160971|FG003|Treatment Stage 2|Lack of Efficacy|1|||
129511302|NCT01335698|466160972|FG004|Treatment Stage 2|Lack of Efficacy|0|||
129511303|NCT01335698|466160968|FG000|Treatment Stage 2|Adverse Event|2|||
129511304|NCT01335698|466160969|FG001|Treatment Stage 2|Adverse Event|0|||
129511305|NCT01335698|466160970|FG002|Treatment Stage 2|Adverse Event|0|||
129511306|NCT01335698|466160971|FG003|Treatment Stage 2|Adverse Event|3|||
129511307|NCT01335698|466160972|FG004|Treatment Stage 2|Adverse Event|0|||
129511308|NCT01335698|466160968|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
129511309|NCT01335698|466160969|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
129511310|NCT01335698|466160970|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
129511311|NCT01335698|466160971|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
129511312|NCT01335698|466160972|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
129511313|NCT01335698|466160968|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
129511314|NCT01335698|466160969|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
129511315|NCT01335698|466160970|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
129511316|NCT01335698|466160971|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
129511317|NCT01335698|466160972|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
129511318|NCT01335698|466160968|FG000|Treatment Stage 2|Lost to Follow-up|1|||
129511319|NCT01335698|466160969|FG001|Treatment Stage 2|Lost to Follow-up|0|||
129511320|NCT01335698|466160970|FG002|Treatment Stage 2|Lost to Follow-up|0|||
129511321|NCT01335698|466160971|FG003|Treatment Stage 2|Lost to Follow-up|0|||
129511322|NCT01335698|466160972|FG004|Treatment Stage 2|Lost to Follow-up|0|||
129511323|NCT01335698|466160968|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
129511324|NCT01335698|466160969|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
129511325|NCT01335698|466160970|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
129511326|NCT01335698|466160971|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
129511327|NCT01335698|466160972|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
129511328|NCT01335698|466160968|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
129511329|NCT01335698|466160969|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
129511330|NCT01335698|466160970|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
129511331|NCT01335698|466160971|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
129511332|NCT01335698|466160972|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
129511333|NCT01335698|466160968|FG000|Treatment Stage 2|Switched to another formulation|1|||
129511334|NCT01335698|466160969|FG001|Treatment Stage 2|Switched to another formulation|1|||
129511335|NCT01335698|466160970|FG002|Treatment Stage 2|Switched to another formulation|0|||
129511336|NCT01335698|466160971|FG003|Treatment Stage 2|Switched to another formulation|0|||
129511337|NCT01335698|466160972|FG004|Treatment Stage 2|Switched to another formulation|0|||
129511338|NCT01357889|466160973|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
129511339|NCT01357889|466160974|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
129511340|NCT01357889|466160973|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
129511341|NCT01357889|466160974|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
129511342|NCT01357889|466160973|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
129511343|NCT01357889|466160974|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
129511344|NCT01357889|466160973|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
129511345|NCT01357889|466160974|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
129511346|NCT01357889|466160973|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
129511347|NCT01357889|466160974|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
129511348|NCT01357889|466160973|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
129511349|NCT01357889|466160974|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
129511350|NCT01357889|466160973|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
129511351|NCT01357889|466160974|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
129511352|NCT01357889|466160973|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
129511353|NCT01357889|466160974|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
129511354|NCT01357889|466160973|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
129511355|NCT01357889|466160974|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
129511356|NCT01357889|466160973|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
129511357|NCT01357889|466160974|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
129511358|NCT01357889|466160973|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
129511359|NCT01357889|466160974|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
129511360|NCT01357889|466160973|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
129511361|NCT01357889|466160974|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
129511362|NCT01357889|466160973|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
129511363|NCT01357889|466160974|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
129511364|NCT03970824|466160975|FG000|Overall Study|Withdrawal by Subject|1|||
129511365|NCT03970824|466160976|FG001|Overall Study|Withdrawal by Subject|1|||
129511366|NCT03970824|466160977|FG002|Overall Study|Withdrawal by Subject|3|||
129511367|NCT03970824|466160975|FG000|Overall Study|Lost to Follow-up|0|||
129511368|NCT03970824|466160976|FG001|Overall Study|Lost to Follow-up|2|||
129511369|NCT03970824|466160977|FG002|Overall Study|Lost to Follow-up|1|||
129511370|NCT03970824|466160975|FG000|Overall Study|Adverse Event|1|||
129511371|NCT03970824|466160976|FG001|Overall Study|Adverse Event|0|||
129511372|NCT03970824|466160977|FG002|Overall Study|Adverse Event|0|||
129511373|NCT00105560|466160978|FG000|Overall Study|Lost to Follow-up|1|||
129511374|NCT01361919|466160987|FG000|Overall Study|technical issues|10|||
129511375|NCT01361919|466160988|FG001|Overall Study|technical issues|12|||
129511376|NCT01361919|466160989|FG002|Overall Study|technical issues|10|||
129511377|NCT01767519|466160993|FG000|Overall Study|Other Reasons|4|||
129511378|NCT01767519|466160994|FG001|Overall Study|Other Reasons|4|||
129511379|NCT01767519|466160995|FG002|Overall Study|Other Reasons|2|||
129511380|NCT01767519|466160993|FG000|Overall Study|Protocol Violation|0|||
129511381|NCT01767519|466160994|FG001|Overall Study|Protocol Violation|3|||
129511382|NCT01767519|466160995|FG002|Overall Study|Protocol Violation|0|||
129511383|NCT01767519|466160993|FG000|Overall Study|Personal Reasons|1|||
129511384|NCT01767519|466160994|FG001|Overall Study|Personal Reasons|0|||
129511385|NCT01767519|466160995|FG002|Overall Study|Personal Reasons|0|||
129511386|NCT01767519|466160993|FG000|Overall Study|Lost to Follow-up|3|||
129511387|NCT01767519|466160994|FG001|Overall Study|Lost to Follow-up|1|||
129511388|NCT01767519|466160995|FG002|Overall Study|Lost to Follow-up|2|||
129511389|NCT01767519|466160993|FG000|Overall Study|Lack of Efficacy|1|||
129511390|NCT01767519|466160994|FG001|Overall Study|Lack of Efficacy|0|||
129511391|NCT01767519|466160995|FG002|Overall Study|Lack of Efficacy|0|||
129511392|NCT01767519|466160993|FG000|Overall Study|Adverse Event|5|||
129511393|NCT01767519|466160994|FG001|Overall Study|Adverse Event|5|||
129511394|NCT01767519|466160995|FG002|Overall Study|Adverse Event|1|||
129511395|NCT00039741|466160996|FG000|Overall Study|Death|0|||
129511396|NCT00039741|466160997|FG001|Overall Study|Death|1|||
129511397|NCT00039741|466160998|FG002|Overall Study|Death|0|||
129511398|NCT00039741|466160999|FG003|Overall Study|Death|0|||
129511399|NCT00039741|466160996|FG000|Overall Study|Lost to Follow-up|3|||
129511400|NCT00039741|466160997|FG001|Overall Study|Lost to Follow-up|1|||
129511401|NCT00039741|466160998|FG002|Overall Study|Lost to Follow-up|5|||
129511402|NCT00039741|466160999|FG003|Overall Study|Lost to Follow-up|2|||
129511403|NCT00039741|466160996|FG000|Overall Study|Confounding medical condition|1|||
129511404|NCT00039741|466160997|FG001|Overall Study|Confounding medical condition|0|||
129511405|NCT00039741|466160998|FG002|Overall Study|Confounding medical condition|0|||
129511406|NCT00039741|466160999|FG003|Overall Study|Confounding medical condition|0|||
129511407|NCT00039741|466160996|FG000|Overall Study|Not able to get to clinic|5|||
129511408|NCT00039741|466160997|FG001|Overall Study|Not able to get to clinic|2|||
129511409|NCT00039741|466160998|FG002|Overall Study|Not able to get to clinic|0|||
129511410|NCT00039741|466160999|FG003|Overall Study|Not able to get to clinic|3|||
129511411|NCT00039741|466160996|FG000|Overall Study|Moved|3|||
129511412|NCT00039741|466160997|FG001|Overall Study|Moved|2|||
129511413|NCT00039741|466160998|FG002|Overall Study|Moved|3|||
129511414|NCT00039741|466160999|FG003|Overall Study|Moved|6|||
129511415|NCT00039741|466160996|FG000|Overall Study|Non-compliance with protocol|1|||
129511416|NCT00039741|466160997|FG001|Overall Study|Non-compliance with protocol|0|||
129511417|NCT00039741|466160998|FG002|Overall Study|Non-compliance with protocol|1|||
129511418|NCT00039741|466160999|FG003|Overall Study|Non-compliance with protocol|0|||
129511419|NCT00039741|466160996|FG000|Overall Study|Withdrew consent|0|||
129511420|NCT00039741|466160997|FG001|Overall Study|Withdrew consent|5|||
129511421|NCT00039741|466160998|FG002|Overall Study|Withdrew consent|0|||
129511422|NCT00039741|466160999|FG003|Overall Study|Withdrew consent|1|||
129511423|NCT00039741|466160996|FG000|Overall Study|Missed final visit|2|||
129511424|NCT00039741|466160997|FG001|Overall Study|Missed final visit|1|||
129511425|NCT00039741|466160998|FG002|Overall Study|Missed final visit|2|||
129511426|NCT00039741|466160999|FG003|Overall Study|Missed final visit|2|||
129511427|NCT00946881|466161000|FG000|First Treatment|Withdrawal by Subject|1|||
129511428|NCT00946881|466161000|FG000|First Treatment|Patient relocated to another state|1|||
129511429|NCT00946881|466161000|FG000|Retreatment|Withdrawal by Subject|1|||
129511430|NCT00293423|466161001|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
129511431|NCT00293423|466161002|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
129511432|NCT00293423|466161001|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
129511433|NCT00293423|466161002|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
129511434|NCT00293423|466161001|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
129511435|NCT00293423|466161002|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
129511436|NCT00293423|466161001|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
129511437|NCT00293423|466161002|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
129511438|NCT00293423|466161001|FG000|Surgical Resection|processing error during surgical resection|1|||
129511439|NCT00293423|466161002|FG001|Surgical Resection|processing error during surgical resection|0|||
129511440|NCT00293423|466161001|FG000|Surgical Resection|Withdrawal by Subject|4|||
129511441|NCT00293423|466161002|FG001|Surgical Resection|Withdrawal by Subject|0|||
129511442|NCT00293423|466161001|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
129511443|NCT00293423|466161002|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
129511444|NCT00507416|466161003|FG000|Overall Study|Adverse Event|58|||
129511445|NCT00507416|466161004|FG001|Overall Study|Adverse Event|67|||
129511446|NCT00507416|466161005|FG002|Overall Study|Adverse Event|65|||
129511447|NCT00507416|466161003|FG000|Overall Study|Protocol Violation|1|||
129511448|NCT00507416|466161004|FG001|Overall Study|Protocol Violation|2|||
129511449|NCT00507416|466161005|FG002|Overall Study|Protocol Violation|0|||
129511450|NCT00507416|466161003|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
129511451|NCT00507416|466161004|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
129511452|NCT00507416|466161005|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
129511453|NCT00507416|466161003|FG000|Overall Study|Progressive Disease|20|||
129511454|NCT00507416|466161004|FG001|Overall Study|Progressive Disease|10|||
129511455|NCT00507416|466161005|FG002|Overall Study|Progressive Disease|13|||
129511456|NCT00507416|466161003|FG000|Overall Study|Patient declined further treatment|18|||
129511457|NCT00507416|466161004|FG001|Overall Study|Patient declined further treatment|14|||
129511458|NCT00507416|466161005|FG002|Overall Study|Patient declined further treatment|11|||
129511459|NCT00507416|466161003|FG000|Overall Study|Other|11|||
129511460|NCT00507416|466161004|FG001|Overall Study|Other|16|||
129511461|NCT00507416|466161005|FG002|Overall Study|Other|13|||
129511462|NCT00507416|466161003|FG000|Overall Study|Did not Receive Study Treatment|3|||
129511463|NCT00507416|466161004|FG001|Overall Study|Did not Receive Study Treatment|9|||
129511464|NCT00507416|466161005|FG002|Overall Study|Did not Receive Study Treatment|4|||
129511465|NCT02157506|466161008|FG000|Overall Study|Adverse Event|0|||
129511466|NCT02157506|466161009|FG001|Overall Study|Adverse Event|1|||
129511467|NCT02157506|466161010|FG002|Overall Study|Adverse Event|0|||
129511468|NCT02157506|466161011|FG003|Overall Study|Adverse Event|0|||
129511469|NCT02157506|466161012|FG004|Overall Study|Adverse Event|0|||
129511470|NCT02157506|466161008|FG000|Overall Study|Lost to Follow-up|0|||
129511471|NCT02157506|466161009|FG001|Overall Study|Lost to Follow-up|0|||
129511472|NCT02157506|466161010|FG002|Overall Study|Lost to Follow-up|1|||
129511473|NCT02157506|466161011|FG003|Overall Study|Lost to Follow-up|0|||
129511474|NCT02157506|466161012|FG004|Overall Study|Lost to Follow-up|0|||
129511475|NCT03101514|466161013|FG000|Overall Study|Withdrawal by Subject|4|||
129511476|NCT03101514|466161013|FG000|Overall Study|Protocol Violation|2|||
129511477|NCT03101514|466161013|FG000|Overall Study|patient's information was incomplete|1|||
129511478|NCT00764478|466161014|FG000|Overall Study|Adverse Event|1|||
129511479|NCT00764478|466161015|FG001|Overall Study|Adverse Event|1|||
129511480|NCT00764478|466161016|FG002|Overall Study|Adverse Event|1|||
129511481|NCT00764478|466161014|FG000|Overall Study|Withdrawal by Subject|7|||
129511482|NCT00764478|466161015|FG001|Overall Study|Withdrawal by Subject|12|||
129511483|NCT00764478|466161016|FG002|Overall Study|Withdrawal by Subject|1|||
129511484|NCT00764478|466161014|FG000|Overall Study|Lost to Follow-up|7|||
129511485|NCT00764478|466161015|FG001|Overall Study|Lost to Follow-up|8|||
129511486|NCT00764478|466161016|FG002|Overall Study|Lost to Follow-up|5|||
129511487|NCT00764478|466161014|FG000|Overall Study|Protocol Violation|0|||
129511488|NCT00764478|466161015|FG001|Overall Study|Protocol Violation|1|||
129511489|NCT00764478|466161016|FG002|Overall Study|Protocol Violation|1|||
129511490|NCT02270684|466161017|FG000|Overall Study|Lost to Follow-up|0|||
129511491|NCT02270684|466161018|FG001|Overall Study|Lost to Follow-up|3|||
129511492|NCT02270684|466161017|FG000|Overall Study|Study terminated|1|||
129511493|NCT02270684|466161018|FG001|Overall Study|Study terminated|0|||
129511494|NCT03498287|466161028|FG000|Overall Study|Withdrawal by Subject|3|||
129511495|NCT03498287|466161029|FG001|Overall Study|Withdrawal by Subject|0|||
129511496|NCT03498287|466161028|FG000|Overall Study|Protocol Violation|0|||
129511497|NCT03498287|466161029|FG001|Overall Study|Protocol Violation|4|||
129511498|NCT03498287|466161028|FG000|Overall Study|Adverse Event|0|||
129511499|NCT03498287|466161029|FG001|Overall Study|Adverse Event|1|||
129511500|NCT01374217|466161030|FG000|Overall Study|Lack of Efficacy|13|||
129511501|NCT01740388|466161031|FG000|Overall Study|Withdrawal by Subject|1|||
129511502|NCT01740388|466161032|FG001|Overall Study|Withdrawal by Subject|2|||
129511503|NCT01740388|466161031|FG000|Overall Study|Lost to Follow-up|2|||
129511504|NCT01740388|466161032|FG001|Overall Study|Lost to Follow-up|0|||
129511505|NCT01740388|466161031|FG000|Overall Study|Physician Decision|2|||
129511506|NCT01740388|466161032|FG001|Overall Study|Physician Decision|6|||
129511507|NCT01740388|466161031|FG000|Overall Study|Subjects missing data, completed|41|||
129511508|NCT01740388|466161032|FG001|Overall Study|Subjects missing data, completed|36|||
129511509|NCT01117012|466161033|FG000|Overall Study|Adverse Event|0|||
129511510|NCT01117012|466161034|FG001|Overall Study|Adverse Event|1|||
129511511|NCT01117012|466161033|FG000|Overall Study|Death|1|||
129511512|NCT01117012|466161034|FG001|Overall Study|Death|1|||
129511513|NCT01117012|466161033|FG000|Overall Study|Withdrawal by Subject|3|||
129511514|NCT01117012|466161034|FG001|Overall Study|Withdrawal by Subject|0|||
129511515|NCT01117012|466161033|FG000|Overall Study|Undefined|4|||
129511516|NCT01117012|466161034|FG001|Overall Study|Undefined|3|||
129511517|NCT03695393|466161037|FG000|Overall Study|Death|3|||
129511518|NCT03695393|466161038|FG001|Overall Study|Death|1|||
129511519|NCT03695393|466161037|FG000|Overall Study|Lost to Follow-up|0|||
129511520|NCT03695393|466161038|FG001|Overall Study|Lost to Follow-up|1|||
129511521|NCT01641991|466161039|FG000|Overall Study|Physician Decision|0|||
129511522|NCT01641991|466161040|FG001|Overall Study|Physician Decision|1|||
129511523|NCT01641991|466161041|FG002|Overall Study|Physician Decision|7|||
129511524|NCT01641991|466161042|FG003|Overall Study|Physician Decision|5|||
129511525|NCT01641991|466161039|FG000|Overall Study|Withdrawal by Subject|4|||
129511526|NCT01641991|466161040|FG001|Overall Study|Withdrawal by Subject|2|||
129511527|NCT01641991|466161041|FG002|Overall Study|Withdrawal by Subject|1|||
129511528|NCT01641991|466161042|FG003|Overall Study|Withdrawal by Subject|5|||
129511529|NCT01641991|466161039|FG000|Overall Study|Adverse Event|2|||
129511530|NCT01641991|466161040|FG001|Overall Study|Adverse Event|1|||
129511531|NCT01641991|466161041|FG002|Overall Study|Adverse Event|2|||
129511532|NCT01641991|466161042|FG003|Overall Study|Adverse Event|1|||
129511533|NCT01641991|466161039|FG000|Overall Study|Lost to Follow-up|0|||
129511534|NCT01641991|466161040|FG001|Overall Study|Lost to Follow-up|2|||
129511535|NCT01641991|466161041|FG002|Overall Study|Lost to Follow-up|3|||
129511536|NCT01641991|466161042|FG003|Overall Study|Lost to Follow-up|1|||
129511537|NCT01641991|466161039|FG000|Overall Study|Protocol Violation|1|||
129511538|NCT01641991|466161040|FG001|Overall Study|Protocol Violation|1|||
129511539|NCT01641991|466161041|FG002|Overall Study|Protocol Violation|3|||
129511540|NCT01641991|466161042|FG003|Overall Study|Protocol Violation|0|||
129511541|NCT01641991|466161039|FG000|Overall Study|Pregnancy|0|||
129511542|NCT01641991|466161040|FG001|Overall Study|Pregnancy|0|||
129511543|NCT01641991|466161041|FG002|Overall Study|Pregnancy|1|||
129511544|NCT01641991|466161042|FG003|Overall Study|Pregnancy|0|||
129511545|NCT01641991|466161039|FG000|Overall Study|no longer eligible|2|||
129511546|NCT01641991|466161040|FG001|Overall Study|no longer eligible|1|||
129511547|NCT01641991|466161041|FG002|Overall Study|no longer eligible|0|||
129511548|NCT01641991|466161042|FG003|Overall Study|no longer eligible|4|||
129511549|NCT01578785|466161043|FG000|Overall Study|Withdrawal by Subject|0|||
129511550|NCT01578785|466161044|FG001|Overall Study|Withdrawal by Subject|1|||
129511551|NCT01578785|466161043|FG000|Overall Study|Study terminated by sponsor|59|||
129511552|NCT01578785|466161044|FG001|Overall Study|Study terminated by sponsor|118|||
129511553|NCT03371732|466161045|FG000|Overall Study|Withdrawal by Subject|9|||
129511554|NCT03371732|466161046|FG001|Overall Study|Withdrawal by Subject|3|||
129511555|NCT03371732|466161045|FG000|Overall Study|Refusal to continue|3|||
129511556|NCT03371732|466161046|FG001|Overall Study|Refusal to continue|4|||
129511557|NCT02581982|466161047|FG000|Overall Study|Lack of Efficacy|12|||
129511558|NCT02581982|466161047|FG000|Overall Study|Adverse Event|3|||
129511559|NCT02581982|466161047|FG000|Overall Study|Physician Decision|1|||
129511560|NCT00599027|466161048|FG000|Overall Study|Withdrawal by Subject|1|||
129511561|NCT00599027|466161049|FG001|Overall Study|Withdrawal by Subject|1|||
129511562|NCT00599027|466161048|FG000|Overall Study|Adverse Event|0|||
129511563|NCT00599027|466161049|FG001|Overall Study|Adverse Event|1|||
129511564|NCT00599027|466161048|FG000|Overall Study|Treatment Failure|0|||
129511565|NCT00599027|466161049|FG001|Overall Study|Treatment Failure|1|||
129511566|NCT03479216|466161051|FG000|Overall Study|Withdrawal by Subject|3|||
129511567|NCT03479216|466161052|FG001|Overall Study|Withdrawal by Subject|2|||
129511568|NCT03479216|466161051|FG000|Overall Study|Physician Decision|2|||
129511569|NCT03479216|466161052|FG001|Overall Study|Physician Decision|3|||
129511570|NCT01181778|466161055|FG000|Overall Study|Physician Decision|48|||
129511571|NCT02332798|466162856|FG000|Overall Study|Unwilling to Participate in Study|0|||
129511572|NCT02332798|466162857|FG001|Overall Study|Unwilling to Participate in Study|1|||
129511573|NCT02332798|466162858|FG002|Overall Study|Unwilling to Participate in Study|1|||
129511574|NCT02332798|466162856|FG000|Overall Study|Positive Urine Drug Test|0|||
129511575|NCT02332798|466162857|FG001|Overall Study|Positive Urine Drug Test|1|||
129511576|NCT02332798|466162858|FG002|Overall Study|Positive Urine Drug Test|0|||
129511577|NCT02332798|466162856|FG000|Overall Study|Abnormal Laboratory Findings|1|||
129511578|NCT02332798|466162857|FG001|Overall Study|Abnormal Laboratory Findings|0|||
129511579|NCT02332798|466162858|FG002|Overall Study|Abnormal Laboratory Findings|0|||
129511580|NCT03788967|466162859|FG000|Overall Study|Lost to Follow-up|14|||
129511581|NCT03788967|466162860|FG001|Overall Study|Lost to Follow-up|10|||
129511582|NCT03788967|466162859|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
129511583|NCT03788967|466162860|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
129511584|NCT03788967|466162859|FG000|Overall Study|Participant Withdrawal of Consent|13|||
129511585|NCT03788967|466162860|FG001|Overall Study|Participant Withdrawal of Consent|5|||
129511586|NCT03788967|466162859|FG000|Overall Study|Adverse Event|1|||
129511587|NCT03788967|466162860|FG001|Overall Study|Adverse Event|1|||
129511588|NCT03788967|466162859|FG000|Overall Study|COVID-19|1|||
129511589|NCT03788967|466162860|FG001|Overall Study|COVID-19|2|||
129511590|NCT03927911|466162861|FG000|Overall Study|problems with eDiary|0|||
129511591|NCT03927911|466162862|FG001|Overall Study|problems with eDiary|1|||
129511592|NCT03927911|466162863|FG002|Overall Study|problems with eDiary|0|||
129511593|NCT03927911|466162864|FG003|Overall Study|problems with eDiary|1|||
129511594|NCT03927911|466162865|FG004|Overall Study|problems with eDiary|0|||
129511595|NCT03927911|466162866|FG005|Overall Study|problems with eDiary|4|||
129511596|NCT03927911|466162861|FG000|Overall Study|Adverse Event|0|||
129511597|NCT03927911|466162862|FG001|Overall Study|Adverse Event|0|||
129511598|NCT03927911|466162863|FG002|Overall Study|Adverse Event|0|||
129511599|NCT03927911|466162864|FG003|Overall Study|Adverse Event|0|||
129511600|NCT03927911|466162865|FG004|Overall Study|Adverse Event|0|||
129511601|NCT03927911|466162866|FG005|Overall Study|Adverse Event|1|||
129511602|NCT03927911|466162861|FG000|Overall Study|not treated -study terminated by sponsor|0|||
129511603|NCT03927911|466162862|FG001|Overall Study|not treated -study terminated by sponsor|1|||
129511604|NCT03927911|466162863|FG002|Overall Study|not treated -study terminated by sponsor|0|||
129511605|NCT03927911|466162864|FG003|Overall Study|not treated -study terminated by sponsor|0|||
129511606|NCT03927911|466162865|FG004|Overall Study|not treated -study terminated by sponsor|0|||
129511607|NCT03927911|466162866|FG005|Overall Study|not treated -study terminated by sponsor|0|||
129511608|NCT03927911|466162861|FG000|Overall Study|Surgery cancelled|0|||
129511609|NCT03927911|466162862|FG001|Overall Study|Surgery cancelled|0|||
129511610|NCT03927911|466162863|FG002|Overall Study|Surgery cancelled|0|||
129511611|NCT03927911|466162864|FG003|Overall Study|Surgery cancelled|1|||
129511612|NCT03927911|466162865|FG004|Overall Study|Surgery cancelled|0|||
129511613|NCT03927911|466162866|FG005|Overall Study|Surgery cancelled|1|||
129511614|NCT03927911|466162861|FG000|Overall Study|Protocol Violation|0|||
129511615|NCT03927911|466162862|FG001|Overall Study|Protocol Violation|0|||
129511616|NCT03927911|466162863|FG002|Overall Study|Protocol Violation|0|||
129511617|NCT03927911|466162864|FG003|Overall Study|Protocol Violation|0|||
129511618|NCT03927911|466162865|FG004|Overall Study|Protocol Violation|0|||
129511619|NCT03927911|466162866|FG005|Overall Study|Protocol Violation|1|||
129511620|NCT04432376|466162867|FG000|Double-blind Treatment Period|Adverse Event|2|||
129511621|NCT04432376|466162868|FG001|Double-blind Treatment Period|Adverse Event|6|||
129511622|NCT04432376|466162869|FG002|Double-blind Treatment Period|Adverse Event|0|||
129511623|NCT04432376|466162867|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
129511624|NCT04432376|466162868|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
129511625|NCT04432376|466162869|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
129511626|NCT04432376|466162867|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129511627|NCT04432376|466162868|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129511628|NCT04432376|466162869|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129511629|NCT04432376|466162867|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129511630|NCT04432376|466162868|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129511631|NCT04432376|466162869|FG002|Double-blind Treatment Period|Protocol Violation|0|||
129511632|NCT04432376|466162867|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
129511633|NCT04432376|466162868|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
129511634|NCT04432376|466162869|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
129511635|NCT01824693|466162870|FG000|Overall Study|Death|0|||
129511636|NCT01824693|466162871|FG001|Overall Study|Death|1|||
129511637|NCT01824693|466162872|FG002|Overall Study|Death|0|||
129511638|NCT01824693|466162870|FG000|Overall Study|Physician Decision|1|||
129511639|NCT01824693|466162871|FG001|Overall Study|Physician Decision|1|||
129511640|NCT01824693|466162872|FG002|Overall Study|Physician Decision|1|||
129511641|NCT01824693|466162870|FG000|Overall Study|Withdrawal by Subject|0|||
129511642|NCT01824693|466162871|FG001|Overall Study|Withdrawal by Subject|0|||
129511643|NCT01824693|466162872|FG002|Overall Study|Withdrawal by Subject|1|||
129511644|NCT01824693|466162870|FG000|Overall Study|Progressive Disease|0|||
129511645|NCT01824693|466162871|FG001|Overall Study|Progressive Disease|5|||
129982943|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129511646|NCT01824693|466162872|FG002|Overall Study|Progressive Disease|0|||
129511647|NCT01824693|466162870|FG000|Overall Study|Ineligible|0|||
129511648|NCT01824693|466162871|FG001|Overall Study|Ineligible|0|||
129511649|NCT01824693|466162872|FG002|Overall Study|Ineligible|3|||
129511650|NCT01824693|466162870|FG000|Overall Study|No Transplant Planned|0|||
129511651|NCT01824693|466162871|FG001|Overall Study|No Transplant Planned|0|||
129511652|NCT01824693|466162872|FG002|Overall Study|No Transplant Planned|10|||
129511653|NCT00801892|466162873|FG000|Main Study Period|Withdrawal by Subject|0|||
129511654|NCT00801892|466162874|FG001|Main Study Period|Withdrawal by Subject|1|||
129511655|NCT00801892|466162873|FG000|Sham Crossover Period|Lost to Follow-up|0|||
129511656|NCT00801892|466162874|FG001|Sham Crossover Period|Lost to Follow-up|2|||
129511657|NCT01188096|466162888|FG000|Overall Study|progression of disease|4|||
129511658|NCT01188096|466162888|FG000|Overall Study|Withdrawal by Subject|2|||
129511659|NCT00851253|466162889|FG000|Overall Study|Disease Progression|1|||
129511660|NCT00851253|466162890|FG001|Overall Study|Disease Progression|0|||
129511661|NCT02062398|466162891|FG000|Overall Study|Implant removal|1|||
129511662|NCT01779648|466162892|FG000|Overall Study|Protocol Violation|1|||
129511663|NCT01779648|466162893|FG001|Overall Study|Protocol Violation|0|||
129511664|NCT00415519|466162894|FG000|Overall Study|Adverse Event|1|||
129511665|NCT00415519|466162895|FG001|Overall Study|Adverse Event|0|||
129511666|NCT00415519|466162894|FG000|Overall Study|Withdrawal by Subject|2|||
129511667|NCT00415519|466162895|FG001|Overall Study|Withdrawal by Subject|0|||
129511668|NCT00415519|466162894|FG000|Overall Study|Patient's convenience|1|||
129511669|NCT00415519|466162895|FG001|Overall Study|Patient's convenience|0|||
129511670|NCT03485222|466162902|FG000|Overall Study|Death|0|||
129511671|NCT03485222|466162903|FG001|Overall Study|Death|1|||
129511672|NCT03485222|466162902|FG000|Overall Study|Lost to Follow-up|2|||
129511673|NCT03485222|466162903|FG001|Overall Study|Lost to Follow-up|1|||
129511674|NCT03657810|466162904|FG000|Overall Study|Adverse Event|0|||
129511675|NCT03657810|466162905|FG001|Overall Study|Adverse Event|1|||
129511676|NCT03657810|466162906|FG002|Overall Study|Adverse Event|0|||
129511677|NCT03657810|466162904|FG000|Overall Study|Lack of Efficacy|4|||
129511678|NCT03657810|466162905|FG001|Overall Study|Lack of Efficacy|1|||
129511679|NCT03657810|466162906|FG002|Overall Study|Lack of Efficacy|3|||
129511680|NCT03657810|466162904|FG000|Overall Study|Protocol Violation|1|||
129511681|NCT03657810|466162905|FG001|Overall Study|Protocol Violation|0|||
129511682|NCT03657810|466162906|FG002|Overall Study|Protocol Violation|0|||
129511683|NCT03657810|466162904|FG000|Overall Study|Lost to Follow-up|0|||
129511684|NCT03657810|466162905|FG001|Overall Study|Lost to Follow-up|1|||
129511685|NCT03657810|466162906|FG002|Overall Study|Lost to Follow-up|0|||
129511686|NCT03657810|466162904|FG000|Overall Study|Not provided|0|||
129511687|NCT03657810|466162905|FG001|Overall Study|Not provided|1|||
129511688|NCT03657810|466162906|FG002|Overall Study|Not provided|0|||
129511689|NCT00688545|466162907|FG000|Overall Study|Lost to Follow-up|1|||
129511690|NCT00688545|466162908|FG001|Overall Study|Lost to Follow-up|4|||
129511691|NCT00688545|466162907|FG000|Overall Study|Insurance/cost of drug|0|||
129511692|NCT00688545|466162908|FG001|Overall Study|Insurance/cost of drug|1|||
129511693|NCT00688545|466162907|FG000|Overall Study|Withdrawal by Subject|2|||
129511694|NCT00688545|466162908|FG001|Overall Study|Withdrawal by Subject|3|||
129511695|NCT00688545|466162907|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
129511696|NCT00688545|466162908|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
129511697|NCT01705587|466162912|FG000|Overall Study|Withdrawal by Subject|0|||
129511698|NCT01705587|466162913|FG001|Overall Study|Withdrawal by Subject|1|||
129511699|NCT01373918|466162914|FG000|Overall Study|Physician Decision|0|||
129511700|NCT01373918|466162915|FG001|Overall Study|Physician Decision|1|||
129511701|NCT03004976|466162917|FG000|Overall Study|Lost to Follow-up|7|||
129511702|NCT03004976|466162918|FG001|Overall Study|Lost to Follow-up|5|||
129511703|NCT03004976|466162917|FG000|Overall Study|Physician Decision|1|||
129511704|NCT03004976|466162918|FG001|Overall Study|Physician Decision|0|||
129511705|NCT03004976|466162917|FG000|Overall Study|Withdrawal by Subject|1|||
129511706|NCT03004976|466162918|FG001|Overall Study|Withdrawal by Subject|0|||
129511707|NCT03004976|466162917|FG000|Overall Study|Death|4|||
129511708|NCT03004976|466162918|FG001|Overall Study|Death|1|||
129511709|NCT02137837|466162922|FG000|Overall Study|Adverse Event|0|||
129511710|NCT02137837|466162923|FG001|Overall Study|Adverse Event|2|||
129511711|NCT02137837|466162924|FG002|Overall Study|Adverse Event|1|||
129511712|NCT02137837|466162922|FG000|Overall Study|Refusal unrelated to adverse event|2|||
129511713|NCT02137837|466162923|FG001|Overall Study|Refusal unrelated to adverse event|2|||
129511714|NCT02137837|466162924|FG002|Overall Study|Refusal unrelated to adverse event|1|||
129511715|NCT02137837|466162922|FG000|Overall Study|Progression/relapse|9|||
129511716|NCT02137837|466162923|FG001|Overall Study|Progression/relapse|7|||
129511717|NCT02137837|466162924|FG002|Overall Study|Progression/relapse|7|||
129511718|NCT02137837|466162922|FG000|Overall Study|Not protocol specified|2|||
129511719|NCT02137837|466162923|FG001|Overall Study|Not protocol specified|1|||
129511720|NCT02137837|466162924|FG002|Overall Study|Not protocol specified|3|||
129511721|NCT02141217|466162925|FG000|Overall Study|Adverse Event|1|||
129511722|NCT02141217|466162926|FG001|Overall Study|Adverse Event|2|||
129511723|NCT02141217|466162925|FG000|Overall Study|Protocol Violation|1|||
129511724|NCT02141217|466162926|FG001|Overall Study|Protocol Violation|4|||
129511725|NCT02141217|466162925|FG000|Overall Study|Withdrawal by Subject|6|||
129511726|NCT02141217|466162926|FG001|Overall Study|Withdrawal by Subject|0|||
129511727|NCT02141217|466162925|FG000|Overall Study|Lost to Follow-up|1|||
129511728|NCT02141217|466162926|FG001|Overall Study|Lost to Follow-up|1|||
129511729|NCT02141217|466162925|FG000|Overall Study|Physician Decision|1|||
129511730|NCT02141217|466162926|FG001|Overall Study|Physician Decision|0|||
129511731|NCT02141217|466162925|FG000|Overall Study|Surgical Intervention|1|||
129511732|NCT02141217|466162926|FG001|Overall Study|Surgical Intervention|1|||
129511733|NCT00448760|466162931|FG000|Overall Study|Death|3|||
129511734|NCT01306032|466162937|FG000|First Intervention|Adverse Event|1|||
129511735|NCT01306032|466162938|FG001|First Intervention|Adverse Event|0|||
129511736|NCT01306032|466162939|FG002|First Intervention|Adverse Event|1|||
129511737|NCT01306032|466162940|FG003|First Intervention|Adverse Event|0|||
129511738|NCT01306032|466162941|FG004|First Intervention|Adverse Event|0|||
129511739|NCT01306032|466162942|FG005|First Intervention|Adverse Event|1|||
129511740|NCT01306032|466162937|FG000|First Intervention|Withdrawal by Subject|0|||
129511741|NCT01306032|466162938|FG001|First Intervention|Withdrawal by Subject|2|||
129511742|NCT01306032|466162939|FG002|First Intervention|Withdrawal by Subject|0|||
129511743|NCT01306032|466162940|FG003|First Intervention|Withdrawal by Subject|1|||
129511744|NCT01306032|466162941|FG004|First Intervention|Withdrawal by Subject|0|||
129511745|NCT01306032|466162942|FG005|First Intervention|Withdrawal by Subject|0|||
129511746|NCT01306032|466162937|FG000|First Intervention|Death|0|||
129511747|NCT01306032|466162938|FG001|First Intervention|Death|0|||
129511748|NCT01306032|466162939|FG002|First Intervention|Death|1|||
129511749|NCT01306032|466162940|FG003|First Intervention|Death|0|||
129511750|NCT01306032|466162941|FG004|First Intervention|Death|0|||
129511751|NCT01306032|466162942|FG005|First Intervention|Death|0|||
129511752|NCT01306032|466162937|FG000|First Intervention|Ineligible|0|||
129511753|NCT01306032|466162938|FG001|First Intervention|Ineligible|0|||
129511754|NCT01306032|466162939|FG002|First Intervention|Ineligible|0|||
129511755|NCT01306032|466162940|FG003|First Intervention|Ineligible|0|||
129511756|NCT01306032|466162941|FG004|First Intervention|Ineligible|0|||
129511757|NCT01306032|466162942|FG005|First Intervention|Ineligible|1|||
129511758|NCT01306032|466162937|FG000|First Intervention|Progressive disease|0|||
129511759|NCT01306032|466162938|FG001|First Intervention|Progressive disease|0|||
129511760|NCT01306032|466162939|FG002|First Intervention|Progressive disease|0|||
129511761|NCT01306032|466162940|FG003|First Intervention|Progressive disease|0|||
129511762|NCT01306032|466162941|FG004|First Intervention|Progressive disease|2|||
129511763|NCT01306032|466162942|FG005|First Intervention|Progressive disease|0|||
129511764|NCT01306032|466162937|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
129511765|NCT01306032|466162938|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
129511766|NCT01306032|466162939|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
129511767|NCT01306032|466162940|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
129511768|NCT01306032|466162941|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
129511769|NCT01306032|466162942|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
129511770|NCT01306032|466162937|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
129511771|NCT01306032|466162938|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
129511772|NCT01306032|466162939|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
129511773|NCT01306032|466162940|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
129511774|NCT01306032|466162941|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
129511775|NCT01306032|466162942|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
129511776|NCT01213264|466162943|FG000|Overall Study|Adverse Event|1|||
129511777|NCT01213264|466162944|FG001|Overall Study|Adverse Event|0|||
129511778|NCT01213264|466162945|FG002|Overall Study|Adverse Event|0|||
129511779|NCT01213264|466162943|FG000|Overall Study|Lost to Follow-up|1|||
129511780|NCT01213264|466162944|FG001|Overall Study|Lost to Follow-up|2|||
129511781|NCT01213264|466162945|FG002|Overall Study|Lost to Follow-up|6|||
129511782|NCT05507580|466162947|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
129511783|NCT05507580|466162948|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
129511784|NCT05507580|466162949|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
129511785|NCT05507580|466162950|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
129511786|NCT05507580|466162951|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
129511787|NCT05507580|466162952|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
129511788|NCT05507580|466162947|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
129511789|NCT05507580|466162948|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
129511790|NCT05507580|466162949|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129511791|NCT05507580|466162950|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129511792|NCT05507580|466162951|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129511793|NCT05507580|466162952|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
129511794|NCT05507580|466162947|FG000|Double-Blind Treatment Period|Other, not specified|5|||
129511795|NCT05507580|466162948|FG001|Double-Blind Treatment Period|Other, not specified|4|||
129511796|NCT05507580|466162949|FG002|Double-Blind Treatment Period|Other, not specified|0|||
129511797|NCT05507580|466162950|FG003|Double-Blind Treatment Period|Other, not specified|0|||
129511798|NCT05507580|466162951|FG004|Double-Blind Treatment Period|Other, not specified|0|||
129511799|NCT05507580|466162952|FG005|Double-Blind Treatment Period|Other, not specified|0|||
129511800|NCT05507580|466162947|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
129511801|NCT05507580|466162948|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
129511802|NCT05507580|466162949|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
129511803|NCT05507580|466162950|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
129511804|NCT05507580|466162951|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
129511805|NCT05507580|466162952|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
129511806|NCT05507580|466162947|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
129511807|NCT05507580|466162948|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
129511808|NCT05507580|466162949|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
129511809|NCT05507580|466162950|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
129511810|NCT05507580|466162951|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
129511811|NCT05507580|466162952|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
129511812|NCT05507580|466162947|FG000|Single-Blind Treatment Period|Other, not specified|0|||
129511813|NCT05507580|466162948|FG001|Single-Blind Treatment Period|Other, not specified|0|||
129511814|NCT05507580|466162949|FG002|Single-Blind Treatment Period|Other, not specified|2|||
129511815|NCT05507580|466162950|FG003|Single-Blind Treatment Period|Other, not specified|7|||
129511816|NCT05507580|466162951|FG004|Single-Blind Treatment Period|Other, not specified|3|||
129511817|NCT05507580|466162952|FG005|Single-Blind Treatment Period|Other, not specified|5|||
129511818|NCT03496662|466162953|FG000|Overall Study|Adverse Event|0|||
129511819|NCT03496662|466162954|FG001|Overall Study|Adverse Event|0|||
129511820|NCT03496662|466162955|FG002|Overall Study|Adverse Event|4|||
129511821|NCT03496662|466162953|FG000|Overall Study|Withdrawal by Subject|1|||
129511822|NCT03496662|466162954|FG001|Overall Study|Withdrawal by Subject|0|||
129511823|NCT03496662|466162955|FG002|Overall Study|Withdrawal by Subject|2|||
129511824|NCT03496662|466162953|FG000|Overall Study|Death|0|||
129511825|NCT03496662|466162954|FG001|Overall Study|Death|0|||
129511826|NCT03496662|466162955|FG002|Overall Study|Death|2|||
129511827|NCT03496662|466162953|FG000|Overall Study|Noncompliance|0|||
129511828|NCT03496662|466162954|FG001|Overall Study|Noncompliance|0|||
129511829|NCT03496662|466162955|FG002|Overall Study|Noncompliance|1|||
129511830|NCT02378883|466162956|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
129511831|NCT02378883|466162956|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
129511832|NCT02378883|466162956|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
129511833|NCT02378883|466162956|FG000|30 Day Follow-Up|Physician Decision|2|||
129511834|NCT02378883|466162956|FG000|30 Day Follow-Up|Missed Visit|2|||
129511835|NCT02378883|466162956|FG000|30 Day Follow-Up|Death|1|||
129511836|NCT02378883|466162956|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
129511837|NCT02378883|466162956|FG000|12 Months Follow-Up|Death|2|||
129511838|NCT03037307|466162957|FG000|Period 1|Did Not Meet Study Criteria|0|||
129511839|NCT03037307|466162958|FG001|Period 1|Did Not Meet Study Criteria|0|||
129511840|NCT03037307|466162959|FG002|Period 1|Did Not Meet Study Criteria|0|||
129511841|NCT03037307|466162960|FG003|Period 1|Did Not Meet Study Criteria|1|||
129511842|NCT03037307|466162961|FG004|Period 1|Did Not Meet Study Criteria|0|||
129511843|NCT03037307|466162962|FG005|Period 1|Did Not Meet Study Criteria|0|||
129511844|NCT00691093|466162963|FG000|Overall Study|Adverse Event|1|||
129511845|NCT00691093|466162963|FG000|Overall Study|Lost to Follow-up|1|||
129511846|NCT00691093|466162963|FG000|Overall Study|Lack of Efficacy|1|||
129511847|NCT00691093|466162963|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
129511848|NCT00416312|466162968|FG000|Overall Study|tumors not visible on imaging|2|||
129511849|NCT02727660|466162971|FG000|Overall Study|Lack of Efficacy|40|||
129511850|NCT02727660|466162972|FG001|Overall Study|Lack of Efficacy|40|||
129511851|NCT02727660|466162973|FG002|Overall Study|Lack of Efficacy|70|||
129511852|NCT02727660|466162971|FG000|Overall Study|Adverse Event|28|||
129511853|NCT02727660|466162972|FG001|Overall Study|Adverse Event|21|||
129511854|NCT02727660|466162973|FG002|Overall Study|Adverse Event|32|||
129511855|NCT02727660|466162971|FG000|Overall Study|Withdrawal by Subject|26|||
129511856|NCT02727660|466162972|FG001|Overall Study|Withdrawal by Subject|25|||
129511857|NCT02727660|466162973|FG002|Overall Study|Withdrawal by Subject|30|||
129511858|NCT02727660|466162971|FG000|Overall Study|Physician Decision|3|||
129511859|NCT02727660|466162972|FG001|Overall Study|Physician Decision|8|||
129511860|NCT02727660|466162973|FG002|Overall Study|Physician Decision|14|||
129511861|NCT02727660|466162971|FG000|Overall Study|Lost to Follow-up|5|||
129511862|NCT02727660|466162972|FG001|Overall Study|Lost to Follow-up|9|||
129511863|NCT02727660|466162973|FG002|Overall Study|Lost to Follow-up|8|||
129511864|NCT02727660|466162971|FG000|Overall Study|Protocol Violation|7|||
129511865|NCT02727660|466162972|FG001|Overall Study|Protocol Violation|5|||
129511866|NCT02727660|466162973|FG002|Overall Study|Protocol Violation|5|||
129511867|NCT02727660|466162971|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
129511868|NCT02727660|466162972|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
129511869|NCT02727660|466162973|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
129511870|NCT02727660|466162971|FG000|Overall Study|Administrative Reasons|2|||
129511871|NCT02727660|466162972|FG001|Overall Study|Administrative Reasons|3|||
129511872|NCT02727660|466162973|FG002|Overall Study|Administrative Reasons|4|||
129511873|NCT00050960|466162974|FG000|Overall Study|Progressive Disease|137|||
129511874|NCT00050960|466162975|FG001|Overall Study|Progressive Disease|93|||
129511875|NCT00050960|466162974|FG000|Overall Study|Stable Disease|19|||
129511876|NCT00050960|466162975|FG001|Overall Study|Stable Disease|48|||
129511877|NCT00050960|466162974|FG000|Overall Study|Partial Response|14|||
129511878|NCT00050960|466162975|FG001|Overall Study|Partial Response|19|||
129511879|NCT00050960|466162974|FG000|Overall Study|Complete Response|0|||
129511880|NCT00050960|466162975|FG001|Overall Study|Complete Response|2|||
129511881|NCT00050960|466162974|FG000|Overall Study|Adverse Event|62|||
129511882|NCT00050960|466162975|FG001|Overall Study|Adverse Event|61|||
129511883|NCT00050960|466162974|FG000|Overall Study|Lost to Follow-up|0|||
129511884|NCT00050960|466162975|FG001|Overall Study|Lost to Follow-up|1|||
129511885|NCT00050960|466162974|FG000|Overall Study|Withdrawal by Subject|23|||
129511886|NCT00050960|466162975|FG001|Overall Study|Withdrawal by Subject|18|||
129511887|NCT00050960|466162974|FG000|Overall Study|Administrative|31|||
129511888|NCT00050960|466162975|FG001|Overall Study|Administrative|46|||
129511889|NCT00050960|466162974|FG000|Overall Study|Non-compliance|3|||
129511890|NCT00050960|466162975|FG001|Overall Study|Non-compliance|1|||
129511891|NCT00050960|466162974|FG000|Overall Study|Death|13|||
129511892|NCT00050960|466162975|FG001|Overall Study|Death|15|||
129511893|NCT00305604|466162976|FG000|Overall Study|Adverse Event|6|||
129511894|NCT00305604|466162977|FG001|Overall Study|Adverse Event|3|||
129511895|NCT00305604|466162976|FG000|Overall Study|Lack of Efficacy|11|||
129511896|NCT00305604|466162977|FG001|Overall Study|Lack of Efficacy|18|||
129511897|NCT00305604|466162976|FG000|Overall Study|Lost to Follow-up|0|||
129511898|NCT00305604|466162977|FG001|Overall Study|Lost to Follow-up|4|||
129511899|NCT00305604|466162976|FG000|Overall Study|Protocol Violation|2|||
129511900|NCT00305604|466162977|FG001|Overall Study|Protocol Violation|1|||
129511901|NCT00305604|466162976|FG000|Overall Study|Withdrawal by Subject|12|||
129511902|NCT00305604|466162977|FG001|Overall Study|Withdrawal by Subject|21|||
129511903|NCT00305604|466162976|FG000|Overall Study|Patient moved|1|||
129511904|NCT00305604|466162977|FG001|Overall Study|Patient moved|0|||
129511905|NCT01248364|466162978|FG000|Overall Study|Adverse Event|0|||
129511906|NCT01248364|466162979|FG001|Overall Study|Adverse Event|1|||
129511907|NCT01248364|466162980|FG002|Overall Study|Adverse Event|0|||
129511908|NCT01248364|466162981|FG003|Overall Study|Adverse Event|0|||
129511909|NCT00764946|466162982|FG000|Overall Study|Lack of Efficacy|1|||
129511910|NCT00764946|466162983|FG001|Overall Study|Lack of Efficacy|0|||
129511911|NCT00764946|466162984|FG002|Overall Study|Lack of Efficacy|0|||
129511912|NCT00764946|466162982|FG000|Overall Study|Lost to Follow-up|3|||
129511913|NCT00764946|466162983|FG001|Overall Study|Lost to Follow-up|4|||
129511914|NCT00764946|466162984|FG002|Overall Study|Lost to Follow-up|0|||
129511915|NCT00764946|466162982|FG000|Overall Study|Physician Decision|2|||
129511916|NCT00764946|466162983|FG001|Overall Study|Physician Decision|4|||
129511917|NCT00764946|466162984|FG002|Overall Study|Physician Decision|0|||
129511918|NCT00764946|466162982|FG000|Overall Study|Adverse Event|3|||
129511919|NCT00764946|466162983|FG001|Overall Study|Adverse Event|2|||
129511920|NCT00764946|466162984|FG002|Overall Study|Adverse Event|1|||
129511921|NCT00764946|466162982|FG000|Overall Study|Withdrawal by Subject|3|||
129511922|NCT00764946|466162983|FG001|Overall Study|Withdrawal by Subject|6|||
129511923|NCT00764946|466162984|FG002|Overall Study|Withdrawal by Subject|2|||
129511924|NCT00764946|466162982|FG000|Overall Study|Never Treated|1|||
129511925|NCT00764946|466162983|FG001|Overall Study|Never Treated|1|||
129511926|NCT00764946|466162984|FG002|Overall Study|Never Treated|1|||
129511927|NCT02146248|466162985|FG000|Overall Study|Withdrawal by Subject|2|||
129511928|NCT02431468|466162987|FG000|Overall Study|Adverse Event|2|||
129511929|NCT02431468|466162988|FG001|Overall Study|Adverse Event|4|||
129511930|NCT02431468|466162989|FG002|Overall Study|Adverse Event|5|||
129511931|NCT02431468|466162987|FG000|Overall Study|Withdrawal by Subject|4|||
129511932|NCT02431468|466162988|FG001|Overall Study|Withdrawal by Subject|12|||
129511933|NCT02431468|466162989|FG002|Overall Study|Withdrawal by Subject|2|||
129511934|NCT02431468|466162987|FG000|Overall Study|noncompliance, investigator termination,|2|||
129511935|NCT02431468|466162988|FG001|Overall Study|noncompliance, investigator termination,|2|||
129511936|NCT02431468|466162989|FG002|Overall Study|noncompliance, investigator termination,|2|||
129511937|NCT03589885|466162990|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
129511938|NCT03589885|466162991|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
129511939|NCT03589885|466162992|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
129511940|NCT03589885|466162993|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
129511941|NCT03589885|466162994|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
129511942|NCT03589885|466162990|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
129511943|NCT03589885|466162991|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
129511944|NCT03589885|466162992|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
129511945|NCT03589885|466162993|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
129511946|NCT03589885|466162994|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
129511947|NCT03589885|466162990|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
129511948|NCT03589885|466162991|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
129511949|NCT03589885|466162992|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
129511950|NCT03589885|466162993|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
129511951|NCT03589885|466162994|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
129511952|NCT03589885|466162990|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
129511953|NCT03589885|466162991|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
129511954|NCT03589885|466162992|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
129511955|NCT03589885|466162993|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
129511956|NCT03589885|466162994|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
129511957|NCT03589885|466162990|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
129511958|NCT03589885|466162991|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
129511959|NCT03589885|466162992|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
129511960|NCT03589885|466162993|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
129511961|NCT03589885|466162994|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
129511962|NCT03589885|466162990|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
129511963|NCT03589885|466162991|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
129511964|NCT03589885|466162992|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
129511965|NCT03589885|466162993|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
129511966|NCT03589885|466162994|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
129511967|NCT03589885|466162990|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
129511968|NCT03589885|466162991|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
129511969|NCT03589885|466162992|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
129511970|NCT03589885|466162993|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
129511971|NCT03589885|466162994|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
129511972|NCT03589885|466162990|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
129511973|NCT03589885|466162991|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
129511974|NCT03589885|466162992|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
129511975|NCT03589885|466162993|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
129511976|NCT03589885|466162994|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
129511977|NCT00673894|466162998|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
129511978|NCT00673894|466162999|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
129511979|NCT00673894|466162998|FG000|First Intervention 4 Weeks|Adverse Event|1|||
129511980|NCT00673894|466162999|FG001|First Intervention 4 Weeks|Adverse Event|0|||
129511981|NCT00493974|466163000|FG000|Overall Study|Death|1|||
129511982|NCT00493974|466163001|FG001|Overall Study|Death|2|||
129511983|NCT00493974|466163000|FG000|Overall Study|Withdrawal by Subject|8|||
129511984|NCT00493974|466163001|FG001|Overall Study|Withdrawal by Subject|6|||
129511985|NCT00493974|466163000|FG000|Overall Study|Lost to Follow-up|4|||
129511986|NCT00493974|466163001|FG001|Overall Study|Lost to Follow-up|6|||
129511987|NCT02555657|466163002|FG000|Overall Study|Death|274|||
129511988|NCT02555657|466163003|FG001|Overall Study|Death|262|||
129511989|NCT02555657|466163002|FG000|Overall Study|Physician Decision|0|||
129511990|NCT02555657|466163003|FG001|Overall Study|Physician Decision|1|||
129511991|NCT02555657|466163002|FG000|Overall Study|Sponsor Decision|27|||
129511992|NCT02555657|466163003|FG001|Overall Study|Sponsor Decision|15|||
129511993|NCT02555657|466163002|FG000|Overall Study|Withdrawal by Subject|11|||
129511994|NCT02555657|466163003|FG001|Overall Study|Withdrawal by Subject|32|||
129511995|NCT02807363|466163004|FG000|Dosing Period|Adverse Event|0|||
129511996|NCT02807363|466163005|FG001|Dosing Period|Adverse Event|1|||
129511997|NCT02807363|466163006|FG002|Dosing Period|Adverse Event|0|||
129511998|NCT02807363|466163007|FG003|Dosing Period|Adverse Event|0|||
129511999|NCT02188719|466163008|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
129512000|NCT02188719|466163009|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
129512001|NCT02188719|466163010|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
129512002|NCT02188719|466163011|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
129512003|NCT00966693|466163012|FG000|Overall Study|Adverse Event|0|||
129512004|NCT00966693|466163013|FG001|Overall Study|Adverse Event|0|||
129512005|NCT00966693|466163014|FG002|Overall Study|Adverse Event|1|||
129512006|NCT00966693|466163015|FG003|Overall Study|Adverse Event|2|||
129982944|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
129982945|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129982946|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129982947|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
129982948|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982949|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
129982950|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982951|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982952|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
129982953|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982954|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
129982955|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982956|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982957|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
129982958|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982959|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
129982960|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982961|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982962|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
129982963|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982964|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
129982965|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982966|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982967|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
129982968|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
129982969|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
129982970|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
129512007|NCT00966693|466163012|FG000|Overall Study|Death|0|||
129512008|NCT00966693|466163013|FG001|Overall Study|Death|0|||
129512009|NCT00966693|466163014|FG002|Overall Study|Death|1|||
129512010|NCT00966693|466163015|FG003|Overall Study|Death|0|||
129512011|NCT00966693|466163012|FG000|Overall Study|Withdrawal by Subject|1|||
129512012|NCT00966693|466163013|FG001|Overall Study|Withdrawal by Subject|0|||
129512013|NCT00966693|466163014|FG002|Overall Study|Withdrawal by Subject|0|||
129512014|NCT00966693|466163015|FG003|Overall Study|Withdrawal by Subject|5|||
129512015|NCT00966693|466163012|FG000|Overall Study|Disease Progression|0|||
129512016|NCT00966693|466163013|FG001|Overall Study|Disease Progression|0|||
129512017|NCT00966693|466163014|FG002|Overall Study|Disease Progression|1|||
129512018|NCT00966693|466163015|FG003|Overall Study|Disease Progression|16|||
129512019|NCT01164865|466163016|FG000|Overall Study|Lost to Follow-up|2|||
129512020|NCT01164865|466163017|FG001|Overall Study|Lost to Follow-up|1|||
129512021|NCT00405821|466163020|FG000|Overall Study|Death|5|||
129512022|NCT00405821|466163021|FG001|Overall Study|Death|7|||
129512023|NCT00405821|466163020|FG000|Overall Study|Lost to Follow-up|7|||
129512024|NCT00405821|466163021|FG001|Overall Study|Lost to Follow-up|7|||
129512025|NCT00405821|466163020|FG000|Overall Study|Protocol Violation|1|||
129512026|NCT00405821|466163021|FG001|Overall Study|Protocol Violation|0|||
129512027|NCT00405821|466163020|FG000|Overall Study|initiated ART|9|||
129512028|NCT00405821|466163021|FG001|Overall Study|initiated ART|8|||
129512029|NCT01617187|466163036|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
129512030|NCT01617187|466163037|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
129512031|NCT01617187|466163038|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
129512032|NCT01617187|466163039|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
129512033|NCT01617187|466163036|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
129512034|NCT01617187|466163037|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
129512035|NCT01617187|466163038|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
129512036|NCT01617187|466163039|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
129512037|NCT01617187|466163036|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
129512038|NCT01617187|466163037|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
129512039|NCT01617187|466163038|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
129512040|NCT01617187|466163039|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
129512041|NCT01617187|466163036|FG000|Treatment Through Study Completion|Adverse Event|1|||
129512042|NCT01617187|466163037|FG001|Treatment Through Study Completion|Adverse Event|1|||
129512043|NCT01617187|466163038|FG002|Treatment Through Study Completion|Adverse Event|0|||
129512044|NCT01617187|466163039|FG003|Treatment Through Study Completion|Adverse Event|1|||
129512045|NCT01617187|466163036|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
129512046|NCT01617187|466163037|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
129512047|NCT01617187|466163038|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
129512048|NCT01617187|466163039|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
129512049|NCT01617187|466163036|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
129512050|NCT01617187|466163037|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
129512051|NCT01617187|466163038|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
129512052|NCT01617187|466163039|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
129512053|NCT01617187|466163036|FG000|Treatment Through Study Completion|Protocol Violation|1|||
129512054|NCT01617187|466163037|FG001|Treatment Through Study Completion|Protocol Violation|0|||
129512055|NCT01617187|466163038|FG002|Treatment Through Study Completion|Protocol Violation|0|||
129512056|NCT01617187|466163039|FG003|Treatment Through Study Completion|Protocol Violation|1|||
129512057|NCT01265420|466163040|FG000|Overall Study|Lost to Follow-up|1|||
129512058|NCT03862131|466163044|FG000|Overall Study|Lost to Follow-up|1|||
129512059|NCT03862131|466163045|FG001|Overall Study|Lost to Follow-up|0|||
129512060|NCT03862131|466163046|FG002|Overall Study|Lost to Follow-up|1|||
129512061|NCT03862131|466163044|FG000|Overall Study|Determined to be ineligible|0|||
129512062|NCT03862131|466163045|FG001|Overall Study|Determined to be ineligible|0|||
129512063|NCT03862131|466163046|FG002|Overall Study|Determined to be ineligible|5|||
129512064|NCT03862131|466163044|FG000|Overall Study|Death|4|||
129512065|NCT03862131|466163045|FG001|Overall Study|Death|4|||
129512066|NCT03862131|466163046|FG002|Overall Study|Death|0|||
129512067|NCT03862131|466163044|FG000|Overall Study|Withdrawal by Subject|5|||
129512068|NCT03862131|466163045|FG001|Overall Study|Withdrawal by Subject|3|||
129512069|NCT03862131|466163046|FG002|Overall Study|Withdrawal by Subject|0|||
129512070|NCT03862131|466163044|FG000|Overall Study|Physician Decision|0|||
129512071|NCT03862131|466163045|FG001|Overall Study|Physician Decision|1|||
129512072|NCT03862131|466163046|FG002|Overall Study|Physician Decision|0|||
129512073|NCT01770145|466164852|FG000|Baseline|Adverse Event|20|||
129512074|NCT01770145|466164852|FG000|Baseline|Withdrawal by Subject|1|||
129512075|NCT01770145|466164852|FG000|Baseline|Lost to Follow-up|1|||
129982971|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
129512076|NCT01770145|466164852|FG000|Baseline|Unable to define optimal dose|4|||
129512077|NCT01770145|466164852|FG000|Treatment|Adverse Event|3|||
129512078|NCT01770145|466164852|FG000|Treatment|Withdrawal by Subject|1|||
129512079|NCT00595868|466164853|FG000|Overall Study|Lost to Follow-up|45|||
129512080|NCT00595868|466164854|FG001|Overall Study|Lost to Follow-up|50|||
129512081|NCT05406440|466164855|FG000|Overall Study|Lost to Follow-up|0|||
129512082|NCT05406440|466164856|FG001|Overall Study|Lost to Follow-up|0|||
129512083|NCT05406440|466164857|FG002|Overall Study|Lost to Follow-up|0|||
129512084|NCT05406440|466164858|FG003|Overall Study|Lost to Follow-up|0|||
129512085|NCT05406440|466164859|FG004|Overall Study|Lost to Follow-up|2|||
129512086|NCT05406440|466164860|FG005|Overall Study|Lost to Follow-up|0|||
129512087|NCT05406440|466164861|FG006|Overall Study|Lost to Follow-up|0|||
129512088|NCT05406440|466164855|FG000|Overall Study|Physician Decision|0|||
129512089|NCT05406440|466164856|FG001|Overall Study|Physician Decision|0|||
129512090|NCT05406440|466164857|FG002|Overall Study|Physician Decision|0|||
129512091|NCT05406440|466164858|FG003|Overall Study|Physician Decision|0|||
129512092|NCT05406440|466164859|FG004|Overall Study|Physician Decision|1|||
129512093|NCT05406440|466164860|FG005|Overall Study|Physician Decision|0|||
129512094|NCT05406440|466164861|FG006|Overall Study|Physician Decision|0|||
129512095|NCT05406440|466164855|FG000|Overall Study|Withdrawal by Subject|0|||
129512096|NCT05406440|466164856|FG001|Overall Study|Withdrawal by Subject|0|||
129512097|NCT05406440|466164857|FG002|Overall Study|Withdrawal by Subject|0|||
129512098|NCT05406440|466164858|FG003|Overall Study|Withdrawal by Subject|0|||
129512099|NCT05406440|466164859|FG004|Overall Study|Withdrawal by Subject|0|||
129512100|NCT05406440|466164860|FG005|Overall Study|Withdrawal by Subject|2|||
129512101|NCT05406440|466164861|FG006|Overall Study|Withdrawal by Subject|0|||
129512102|NCT04268303|466164863|FG000|Overall Study|Lost to Follow-up|1|||
129512103|NCT04268303|466164864|FG001|Overall Study|Lost to Follow-up|1|||
129512104|NCT04268303|466164865|FG002|Overall Study|Lost to Follow-up|2|||
129512105|NCT04268303|466164863|FG000|Overall Study|Withdrawal by Subject|0|||
129512106|NCT04268303|466164864|FG001|Overall Study|Withdrawal by Subject|1|||
129512107|NCT04268303|466164865|FG002|Overall Study|Withdrawal by Subject|1|||
129512108|NCT04268303|466164863|FG000|Overall Study|Adverse Event|2|||
129512109|NCT04268303|466164864|FG001|Overall Study|Adverse Event|0|||
129512110|NCT04268303|466164865|FG002|Overall Study|Adverse Event|0|||
129512111|NCT05742841|466164869|FG000|Overall Study|Withdrawal by Subject|1|||
129512112|NCT05742841|466164869|FG000|Overall Study|Lost to Follow-up|1|||
129512113|NCT01711541|466164870|FG000|Overall Study|Cancel prior to treatment|0|||
129512114|NCT01711541|466164871|FG001|Overall Study|Cancel prior to treatment|0|||
129512115|NCT01711541|466164872|FG002|Overall Study|Cancel prior to treatment|0|||
129512116|NCT01711541|466164873|FG003|Overall Study|Cancel prior to treatment|1|||
129512117|NCT01711541|466164874|FG004|Overall Study|Cancel prior to treatment|0|||
129512118|NCT01711541|466164870|FG000|Overall Study|Ineligible|0|||
129512119|NCT01711541|466164871|FG001|Overall Study|Ineligible|1|||
129512120|NCT01711541|466164872|FG002|Overall Study|Ineligible|0|||
129512121|NCT01711541|466164873|FG003|Overall Study|Ineligible|0|||
129512122|NCT01711541|466164874|FG004|Overall Study|Ineligible|0|||
129512123|NCT00728936|466164875|FG000|Overall Study|Withdrawal by Subject|0|||
129512124|NCT00728936|466164876|FG001|Overall Study|Withdrawal by Subject|0|||
129512125|NCT00728936|466164877|FG002|Overall Study|Withdrawal by Subject|0|||
129512126|NCT00728936|466164878|FG003|Overall Study|Withdrawal by Subject|0|||
129512127|NCT00728936|466164879|FG004|Overall Study|Withdrawal by Subject|0|||
129512128|NCT00728936|466164880|FG005|Overall Study|Withdrawal by Subject|1|||
129512129|NCT00728936|466164881|FG006|Overall Study|Withdrawal by Subject|0|||
129512130|NCT01175590|466164889|FG000|Overall Study|Lost to Follow-up|1|||
129512131|NCT01175590|466164890|FG001|Overall Study|Lost to Follow-up|0|||
129512132|NCT01175590|466164889|FG000|Overall Study|Withdrawal by Subject|0|||
129512133|NCT01175590|466164890|FG001|Overall Study|Withdrawal by Subject|2|||
129512134|NCT01175590|466164889|FG000|Overall Study|Adverse Event|4|||
129512135|NCT01175590|466164890|FG001|Overall Study|Adverse Event|0|||
129512136|NCT01175590|466164889|FG000|Overall Study|Physician Decision|1|||
129512137|NCT01175590|466164890|FG001|Overall Study|Physician Decision|4|||
129512138|NCT01175590|466164889|FG000|Overall Study|Lack of Efficacy|1|||
129512139|NCT01175590|466164890|FG001|Overall Study|Lack of Efficacy|1|||
129512140|NCT01175590|466164889|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
129512141|NCT01175590|466164890|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
129512142|NCT01175590|466164889|FG000|Overall Study|Treated not as randomized|3|||
129512143|NCT01175590|466164890|FG001|Overall Study|Treated not as randomized|2|||
129512144|NCT01175590|466164889|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
129512145|NCT01175590|466164890|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
129512146|NCT01175590|466164889|FG000|Overall Study|Protocol Violation|0|||
129512147|NCT01175590|466164890|FG001|Overall Study|Protocol Violation|1|||
129512148|NCT00877006|466164898|FG000|Treatment Period|Death|2|||
129512149|NCT00877006|466164899|FG001|Treatment Period|Death|1|||
129512150|NCT00877006|466164898|FG000|Treatment Period|Adverse Event|10|||
129512151|NCT00877006|466164899|FG001|Treatment Period|Adverse Event|3|||
129512152|NCT00877006|466164898|FG000|Treatment Period|Withdrawal by Subject|2|||
129512153|NCT00877006|466164899|FG001|Treatment Period|Withdrawal by Subject|3|||
129512154|NCT00877006|466164898|FG000|Treatment Period|Protocol Violation|1|||
129512155|NCT00877006|466164899|FG001|Treatment Period|Protocol Violation|0|||
129512156|NCT00877006|466164898|FG000|Treatment Period|Lost to Follow-up|0|||
129512157|NCT00877006|466164899|FG001|Treatment Period|Lost to Follow-up|1|||
129512158|NCT00877006|466164898|FG000|Treatment Period|Disease Progression|1|||
129512159|NCT00877006|466164899|FG001|Treatment Period|Disease Progression|2|||
129512160|NCT00877006|466164898|FG000|Treatment Period|Started New Treatment Regimen|2|||
129512161|NCT00877006|466164899|FG001|Treatment Period|Started New Treatment Regimen|5|||
129512162|NCT00877006|466164898|FG000|Treatment Period|Other|4|||
129512163|NCT00877006|466164899|FG001|Treatment Period|Other|4|||
129512164|NCT00877006|466164898|FG000|Treatment Period|Randomized but Not Treated|3|||
129512165|NCT00877006|466164899|FG001|Treatment Period|Randomized but Not Treated|8|||
129512166|NCT00877006|466164898|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
129512167|NCT00877006|466164899|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
129512168|NCT00877006|466164898|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
129512169|NCT00877006|466164899|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
129512170|NCT00877006|466164898|FG000|Long-Term Follow-up Period|Death|26|||
129512171|NCT00877006|466164899|FG001|Long-Term Follow-up Period|Death|18|||
129512172|NCT00877006|466164898|FG000|Long-Term Follow-up Period|Other|7|||
129512173|NCT00877006|466164899|FG001|Long-Term Follow-up Period|Other|9|||
129512174|NCT04671342|466164900|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
129512175|NCT04671342|466164900|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
129512176|NCT04671342|466164900|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
129512177|NCT04671342|466164900|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
129512178|NCT04671342|466164900|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
129512179|NCT04671342|466164900|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
129512180|NCT03911869|466164901|FG000|Safety Lead-in Phase|Death|7|||
129512181|NCT03911869|466164902|FG001|Safety Lead-in Phase|Death|0|||
129512182|NCT03911869|466164903|FG002|Safety Lead-in Phase|Death|0|||
129512183|NCT03911869|466164901|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
129512184|NCT03911869|466164902|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
129512185|NCT03911869|466164903|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
129512186|NCT03911869|466164901|FG000|Safety Lead-in Phase|Other|1|||
129512187|NCT03911869|466164902|FG001|Safety Lead-in Phase|Other|0|||
129512188|NCT03911869|466164903|FG002|Safety Lead-in Phase|Other|0|||
129512189|NCT03911869|466164901|FG000|Phase 2|Death|0|||
129512190|NCT03911869|466164902|FG001|Phase 2|Death|3|||
129512191|NCT03911869|466164903|FG002|Phase 2|Death|0|||
129512192|NCT01878097|466164904|FG000|Baseline|Surveys not fully completed|2497|||
129512193|NCT01878097|466164905|FG001|Baseline|Surveys not fully completed|1800|||
129512194|NCT01878097|466164904|FG000|Implementation Year 1|Surveys not fully completed|3202|||
129512195|NCT01878097|466164905|FG001|Implementation Year 1|Surveys not fully completed|2549|||
129512196|NCT01878097|466164904|FG000|Implementation Year 2|Surveys not fully completed|3281|||
129512197|NCT01878097|466164905|FG001|Implementation Year 2|Surveys not fully completed|2841|||
129512198|NCT01878097|466164904|FG000|Implementation Year 3|Surveys not fully completed|3494|||
129512199|NCT01878097|466164905|FG001|Implementation Year 3|Surveys not fully completed|2980|||
129512200|NCT01878097|466164904|FG000|Implementation Year 4|Surveys not fully completed|3604|||
129512201|NCT01878097|466164905|FG001|Implementation Year 4|Surveys not fully completed|3007|||
129512202|NCT00367341|466164906|FG000|Overall Study|Physician Decision|1|||
129512203|NCT00367341|466164907|FG001|Overall Study|Physician Decision|0|||
129512204|NCT00367341|466164906|FG000|Overall Study|Protocol Violation|1|||
129512205|NCT00367341|466164907|FG001|Overall Study|Protocol Violation|0|||
129512206|NCT03325556|466164908|FG000|Open-label Period|Lack of Response in OL period|70|||
129512207|NCT03325556|466164909|FG001|Open-label Period|Lack of Response in OL period|0|||
129512208|NCT03325556|466164910|FG002|Open-label Period|Lack of Response in OL period|0|||
129512209|NCT03325556|466164908|FG000|Open-label Period|Adverse Event|27|||
129512210|NCT03325556|466164909|FG001|Open-label Period|Adverse Event|0|||
129512211|NCT03325556|466164910|FG002|Open-label Period|Adverse Event|0|||
129512212|NCT03325556|466164908|FG000|Open-label Period|Death|1|||
129512213|NCT03325556|466164909|FG001|Open-label Period|Death|0|||
129512214|NCT03325556|466164910|FG002|Open-label Period|Death|0|||
129512215|NCT03325556|466164908|FG000|Open-label Period|Lost to Follow-up|1|||
129512216|NCT03325556|466164909|FG001|Open-label Period|Lost to Follow-up|0|||
129512217|NCT03325556|466164910|FG002|Open-label Period|Lost to Follow-up|0|||
129512218|NCT03325556|466164908|FG000|Open-label Period|Non-compliance with study drug|5|||
129512219|NCT03325556|466164909|FG001|Open-label Period|Non-compliance with study drug|0|||
129512220|NCT03325556|466164910|FG002|Open-label Period|Non-compliance with study drug|0|||
129512221|NCT03325556|466164908|FG000|Open-label Period|Use of prohibited medication|1|||
129512222|NCT03325556|466164909|FG001|Open-label Period|Use of prohibited medication|0|||
129512223|NCT03325556|466164910|FG002|Open-label Period|Use of prohibited medication|0|||
129512224|NCT03325556|466164908|FG000|Open-label Period|Protocol Violation|4|||
129512225|NCT03325556|466164909|FG001|Open-label Period|Protocol Violation|0|||
129512226|NCT03325556|466164910|FG002|Open-label Period|Protocol Violation|0|||
129512227|NCT03325556|466164908|FG000|Open-label Period|Withdrawal by Subject|17|||
129512228|NCT03325556|466164909|FG001|Open-label Period|Withdrawal by Subject|0|||
129512229|NCT03325556|466164910|FG002|Open-label Period|Withdrawal by Subject|0|||
129512230|NCT03325556|466164908|FG000|Open-label Period|Not otherwise specified|8|||
129512231|NCT03325556|466164909|FG001|Open-label Period|Not otherwise specified|0|||
129982972|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
129512232|NCT03325556|466164910|FG002|Open-label Period|Not otherwise specified|0|||
129512233|NCT03325556|466164908|FG000|Open-label Period|Administrative discont. at study termination|41|||
129512234|NCT03325556|466164909|FG001|Open-label Period|Administrative discont. at study termination|0|||
129512235|NCT03325556|466164910|FG002|Open-label Period|Administrative discont. at study termination|0|||
129512236|NCT03325556|466164908|FG000|Double-blind Period|Relapse|0|||
129512237|NCT03325556|466164909|FG001|Double-blind Period|Relapse|15|||
129512238|NCT03325556|466164910|FG002|Double-blind Period|Relapse|34|||
129512239|NCT03325556|466164908|FG000|Double-blind Period|Adverse Event|0|||
129512240|NCT03325556|466164909|FG001|Double-blind Period|Adverse Event|3|||
129512241|NCT03325556|466164910|FG002|Double-blind Period|Adverse Event|1|||
129512242|NCT03325556|466164908|FG000|Double-blind Period|Noncompliance with study drug|0|||
129512243|NCT03325556|466164909|FG001|Double-blind Period|Noncompliance with study drug|0|||
129512244|NCT03325556|466164910|FG002|Double-blind Period|Noncompliance with study drug|1|||
129512245|NCT03325556|466164908|FG000|Double-blind Period|Use of prohibited medication|0|||
129512246|NCT03325556|466164909|FG001|Double-blind Period|Use of prohibited medication|1|||
129512247|NCT03325556|466164910|FG002|Double-blind Period|Use of prohibited medication|0|||
129512248|NCT03325556|466164908|FG000|Double-blind Period|Physician Decision|0|||
129512249|NCT03325556|466164909|FG001|Double-blind Period|Physician Decision|0|||
129512250|NCT03325556|466164910|FG002|Double-blind Period|Physician Decision|1|||
129512251|NCT03325556|466164908|FG000|Double-blind Period|Withdrawal by Subject|0|||
129512252|NCT03325556|466164909|FG001|Double-blind Period|Withdrawal by Subject|6|||
129512253|NCT03325556|466164910|FG002|Double-blind Period|Withdrawal by Subject|4|||
129512254|NCT03325556|466164908|FG000|Double-blind Period|Not otherwise specified|0|||
129512255|NCT03325556|466164909|FG001|Double-blind Period|Not otherwise specified|1|||
129512256|NCT03325556|466164910|FG002|Double-blind Period|Not otherwise specified|5|||
129512257|NCT03325556|466164908|FG000|Double-blind Period|Administrative discont. at study termination|0|||
129512258|NCT03325556|466164909|FG001|Double-blind Period|Administrative discont. at study termination|35|||
129512259|NCT03325556|466164910|FG002|Double-blind Period|Administrative discont. at study termination|31|||
129512260|NCT02119026|466164911|FG000|1st-line Treatment|Adverse Event|9|||
129512261|NCT02119026|466164912|FG001|1st-line Treatment|Adverse Event|14|||
129512262|NCT02119026|466164911|FG000|1st-line Treatment|Physician Decision|3|||
129512263|NCT02119026|466164912|FG001|1st-line Treatment|Physician Decision|8|||
129512264|NCT02119026|466164911|FG000|1st-line Treatment|Withdrawal by Subject|4|||
129512265|NCT02119026|466164912|FG001|1st-line Treatment|Withdrawal by Subject|10|||
129512266|NCT02119026|466164911|FG000|1st-line Treatment|Patient condition or compliance|6|||
129512267|NCT02119026|466164912|FG001|1st-line Treatment|Patient condition or compliance|4|||
129512268|NCT02119026|466164911|FG000|1st-line Treatment|Surgery of metastases|2|||
129512269|NCT02119026|466164912|FG001|1st-line Treatment|Surgery of metastases|1|||
129512270|NCT02119026|466164911|FG000|1st-line Treatment|Death|2|||
129512271|NCT02119026|466164912|FG001|1st-line Treatment|Death|1|||
129512272|NCT02119026|466164911|FG000|2nd-line Treatment|Lost to Follow-up|2|||
129512273|NCT02119026|466164912|FG001|2nd-line Treatment|Lost to Follow-up|0|||
129512274|NCT02119026|466164911|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
129512275|NCT02119026|466164912|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
129512276|NCT02119026|466164911|FG000|2nd-line Treatment|Adverse Event|4|||
129512277|NCT02119026|466164912|FG001|2nd-line Treatment|Adverse Event|1|||
129512278|NCT00340834|466164913|FG000|Core Phase of Study|Adverse Event|26|||
129512279|NCT00340834|466164914|FG001|Core Phase of Study|Adverse Event|9|||
129512280|NCT00340834|466164915|FG002|Core Phase of Study|Adverse Event|9|||
129512281|NCT00340834|466164916|FG003|Core Phase of Study|Adverse Event|0|||
129512282|NCT00340834|466164917|FG004|Core Phase of Study|Adverse Event|0|||
129512283|NCT00340834|466164913|FG000|Core Phase of Study|Withdrawal by Subject|11|||
129512284|NCT00340834|466164914|FG001|Core Phase of Study|Withdrawal by Subject|9|||
129512285|NCT00340834|466164915|FG002|Core Phase of Study|Withdrawal by Subject|16|||
129512286|NCT00340834|466164916|FG003|Core Phase of Study|Withdrawal by Subject|0|||
129512287|NCT00340834|466164917|FG004|Core Phase of Study|Withdrawal by Subject|0|||
129512288|NCT00340834|466164913|FG000|Core Phase of Study|Administrative Problems|6|||
129512289|NCT00340834|466164914|FG001|Core Phase of Study|Administrative Problems|2|||
129512290|NCT00340834|466164915|FG002|Core Phase of Study|Administrative Problems|7|||
129512291|NCT00340834|466164916|FG003|Core Phase of Study|Administrative Problems|0|||
129512292|NCT00340834|466164917|FG004|Core Phase of Study|Administrative Problems|0|||
129512293|NCT00340834|466164913|FG000|Core Phase of Study|Lack of Efficacy|3|||
129512294|NCT00340834|466164914|FG001|Core Phase of Study|Lack of Efficacy|3|||
129512295|NCT00340834|466164915|FG002|Core Phase of Study|Lack of Efficacy|7|||
129512296|NCT00340834|466164916|FG003|Core Phase of Study|Lack of Efficacy|0|||
129512297|NCT00340834|466164917|FG004|Core Phase of Study|Lack of Efficacy|0|||
129512298|NCT00340834|466164913|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
129512299|NCT00340834|466164914|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
129512300|NCT00340834|466164915|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
129512301|NCT00340834|466164916|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
129512302|NCT00340834|466164917|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
129512303|NCT00340834|466164913|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
129512304|NCT00340834|466164914|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
129512305|NCT00340834|466164915|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
129512306|NCT00340834|466164916|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
129512307|NCT00340834|466164917|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
129512308|NCT00340834|466164913|FG000|Core Phase of Study|Lost to Follow-up|1|||
129512309|NCT00340834|466164914|FG001|Core Phase of Study|Lost to Follow-up|1|||
129512310|NCT00340834|466164915|FG002|Core Phase of Study|Lost to Follow-up|4|||
129512311|NCT00340834|466164916|FG003|Core Phase of Study|Lost to Follow-up|0|||
129512312|NCT00340834|466164917|FG004|Core Phase of Study|Lost to Follow-up|0|||
129512313|NCT00340834|466164913|FG000|Core Phase of Study|Death|2|||
129512314|NCT00340834|466164914|FG001|Core Phase of Study|Death|0|||
129512315|NCT00340834|466164915|FG002|Core Phase of Study|Death|0|||
129512316|NCT00340834|466164916|FG003|Core Phase of Study|Death|0|||
129512317|NCT00340834|466164917|FG004|Core Phase of Study|Death|0|||
129512318|NCT00340834|466164913|FG000|Core Phase of Study|Protocol Violation|0|||
129512319|NCT00340834|466164914|FG001|Core Phase of Study|Protocol Violation|0|||
129512320|NCT00340834|466164915|FG002|Core Phase of Study|Protocol Violation|2|||
129512321|NCT00340834|466164916|FG003|Core Phase of Study|Protocol Violation|0|||
129512322|NCT00340834|466164917|FG004|Core Phase of Study|Protocol Violation|0|||
129512323|NCT00340834|466164913|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
129512324|NCT00340834|466164914|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
129512325|NCT00340834|466164915|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
129512326|NCT00340834|466164916|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
129512327|NCT00340834|466164917|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
129512328|NCT00340834|466164913|FG000|Extension Phase of Study|Subject withdrew consent|26|||
129512329|NCT00340834|466164914|FG001|Extension Phase of Study|Subject withdrew consent|31|||
129512330|NCT00340834|466164915|FG002|Extension Phase of Study|Subject withdrew consent|0|||
129512331|NCT00340834|466164916|FG003|Extension Phase of Study|Subject withdrew consent|12|||
129512332|NCT00340834|466164917|FG004|Extension Phase of Study|Subject withdrew consent|15|||
129512333|NCT00340834|466164913|FG000|Extension Phase of Study|Adverse Event|21|||
129512334|NCT00340834|466164914|FG001|Extension Phase of Study|Adverse Event|22|||
129512335|NCT00340834|466164915|FG002|Extension Phase of Study|Adverse Event|0|||
129512336|NCT00340834|466164916|FG003|Extension Phase of Study|Adverse Event|19|||
129512337|NCT00340834|466164917|FG004|Extension Phase of Study|Adverse Event|7|||
129512338|NCT00340834|466164913|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
129512339|NCT00340834|466164914|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
129512340|NCT00340834|466164915|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
129512341|NCT00340834|466164916|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
129512342|NCT00340834|466164917|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
129512343|NCT00340834|466164913|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
129512344|NCT00340834|466164914|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
129512345|NCT00340834|466164915|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
129512346|NCT00340834|466164916|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
129512347|NCT00340834|466164917|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
129512348|NCT00340834|466164913|FG000|Extension Phase of Study|Lost to Follow-up|1|||
129512349|NCT00340834|466164914|FG001|Extension Phase of Study|Lost to Follow-up|1|||
129512350|NCT00340834|466164915|FG002|Extension Phase of Study|Lost to Follow-up|0|||
129512351|NCT00340834|466164916|FG003|Extension Phase of Study|Lost to Follow-up|2|||
129512352|NCT00340834|466164917|FG004|Extension Phase of Study|Lost to Follow-up|3|||
129512353|NCT00340834|466164913|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
129512354|NCT00340834|466164914|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
129512355|NCT00340834|466164915|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
129512356|NCT00340834|466164916|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
129512357|NCT00340834|466164917|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
129512358|NCT00340834|466164913|FG000|Extension Phase of Study|Administrative problems|3|||
129512359|NCT00340834|466164914|FG001|Extension Phase of Study|Administrative problems|0|||
129512360|NCT00340834|466164915|FG002|Extension Phase of Study|Administrative problems|0|||
129512361|NCT00340834|466164916|FG003|Extension Phase of Study|Administrative problems|1|||
129512362|NCT00340834|466164917|FG004|Extension Phase of Study|Administrative problems|1|||
129512363|NCT00340834|466164913|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
129512364|NCT00340834|466164914|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
129512365|NCT00340834|466164915|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
129512366|NCT00340834|466164916|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
129512367|NCT00340834|466164917|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
129512368|NCT00340834|466164913|FG000|Extension Phase of Study|Protocol Violation|3|||
129512369|NCT00340834|466164914|FG001|Extension Phase of Study|Protocol Violation|0|||
129512370|NCT00340834|466164915|FG002|Extension Phase of Study|Protocol Violation|0|||
129512371|NCT00340834|466164916|FG003|Extension Phase of Study|Protocol Violation|0|||
129512372|NCT00340834|466164917|FG004|Extension Phase of Study|Protocol Violation|0|||
129512373|NCT00340834|466164913|FG000|Extension Phase of Study|Death|0|||
129512374|NCT00340834|466164914|FG001|Extension Phase of Study|Death|0|||
129512375|NCT00340834|466164915|FG002|Extension Phase of Study|Death|0|||
129512376|NCT00340834|466164916|FG003|Extension Phase of Study|Death|0|||
129512377|NCT00340834|466164917|FG004|Extension Phase of Study|Death|1|||
129512378|NCT02786836|466164920|FG000|Overall Study|Death|1|||
129512379|NCT02786836|466164920|FG000|Overall Study|Lack of Efficacy|2|||
129512380|NCT02786836|466164920|FG000|Overall Study|Protocol Violation|3|||
129512381|NCT02786836|466164920|FG000|Overall Study|Withdrawal by Subject|3|||
129512382|NCT02786836|466164920|FG000|Overall Study|Liver Transplantation|2|||
129512383|NCT02786836|466164920|FG000|Overall Study|Device or Pharmacy Issues|3|||
129512384|NCT01143714|466164922|FG000|Overall Study|Adverse Event|4|||
129512385|NCT01143714|466164923|FG001|Overall Study|Adverse Event|2|||
129512386|NCT01143714|466164922|FG000|Overall Study|Withdrawal by Subject|1|||
129512387|NCT01143714|466164923|FG001|Overall Study|Withdrawal by Subject|0|||
129512388|NCT01143714|466164922|FG000|Overall Study|Subject non-compliance|0|||
129512389|NCT01143714|466164923|FG001|Overall Study|Subject non-compliance|1|||
129512390|NCT01143714|466164922|FG000|Overall Study|wound closed = deemed healed|1|||
129512391|NCT01143714|466164923|FG001|Overall Study|wound closed = deemed healed|0|||
129512392|NCT01143714|466164922|FG000|Overall Study|wound size increased|1|||
129512393|NCT01143714|466164923|FG001|Overall Study|wound size increased|0|||
129512394|NCT01387074|466164924|FG000|Overall Study|Lost to Follow-up|7|||
129512395|NCT01387074|466164924|FG000|Overall Study|Lack of Efficacy|1|||
129512396|NCT03892707|466164931|FG000|Overall Study|Screen failure|6|||
129512397|NCT03892707|466164932|FG001|Overall Study|Screen failure|0|||
129512398|NCT03892707|466164931|FG000|Overall Study|Pain resolution|0|||
129512399|NCT03892707|466164932|FG001|Overall Study|Pain resolution|4|||
129512400|NCT03892707|466164931|FG000|Overall Study|Withdrawal by Subject|0|||
129512401|NCT03892707|466164932|FG001|Overall Study|Withdrawal by Subject|1|||
129512402|NCT03892707|466164931|FG000|Overall Study|Other (long business trip)|0|||
129512403|NCT03892707|466164932|FG001|Overall Study|Other (long business trip)|1|||
129512404|NCT01807949|466164933|FG000|Overall Study|Adverse Event|1|||
129512405|NCT01807949|466164934|FG001|Overall Study|Adverse Event|2|||
129512406|NCT01807949|466164935|FG002|Overall Study|Adverse Event|2|||
129512407|NCT01807949|466164933|FG000|Overall Study|Withdrawal by Subject|1|||
129512408|NCT01807949|466164934|FG001|Overall Study|Withdrawal by Subject|2|||
129512409|NCT01807949|466164935|FG002|Overall Study|Withdrawal by Subject|2|||
129512410|NCT01807949|466164933|FG000|Overall Study|Non-Compliance|0|||
129512411|NCT01807949|466164934|FG001|Overall Study|Non-Compliance|0|||
129512412|NCT01807949|466164935|FG002|Overall Study|Non-Compliance|1|||
129512413|NCT01807949|466164933|FG000|Overall Study|Undefined|0|||
129512414|NCT01807949|466164934|FG001|Overall Study|Undefined|1|||
129512415|NCT01807949|466164935|FG002|Overall Study|Undefined|2|||
129512416|NCT01807949|466164933|FG000|Overall Study|Randomized But Not Treated|0|||
129512417|NCT01807949|466164934|FG001|Overall Study|Randomized But Not Treated|2|||
129512418|NCT01807949|466164935|FG002|Overall Study|Randomized But Not Treated|2|||
129512419|NCT01181141|466164936|FG000|Overall Study|Adverse Event|2|||
129512420|NCT01181141|466164937|FG001|Overall Study|Adverse Event|1|||
129512421|NCT01181141|466164936|FG000|Overall Study|Lack of Efficacy|1|||
129512422|NCT01181141|466164937|FG001|Overall Study|Lack of Efficacy|0|||
129512423|NCT01181141|466164936|FG000|Overall Study|Lost to Follow-up|1|||
129512424|NCT01181141|466164937|FG001|Overall Study|Lost to Follow-up|1|||
129512425|NCT01181141|466164936|FG000|Overall Study|Physician Decision|2|||
129512426|NCT01181141|466164937|FG001|Overall Study|Physician Decision|0|||
129512427|NCT01181141|466164936|FG000|Overall Study|Protocol Violation|3|||
129512428|NCT01181141|466164937|FG001|Overall Study|Protocol Violation|1|||
129512429|NCT01181141|466164936|FG000|Overall Study|Withdrawal by Subject|3|||
129982973|NCT00700427|467900644|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129982974|NCT00700427|467900645|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
129982975|NCT00700427|467900646|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129982976|NCT00700427|467900647|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129512430|NCT01181141|466164937|FG001|Overall Study|Withdrawal by Subject|1|||
129512431|NCT00290589|466164938|FG000|Overall Study|Lost to Follow-up|2|||
129512432|NCT00290589|466164939|FG001|Overall Study|Lost to Follow-up|2|||
129512433|NCT00118911|466164940|FG000|Overall Study|Withdrawal by Subject|2|||
129512434|NCT00118911|466164941|FG001|Overall Study|Withdrawal by Subject|5|||
129512435|NCT05014542|466164942|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
129512436|NCT05014542|466164943|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
129512437|NCT05014542|466164942|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
129512438|NCT05014542|466164943|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
129512439|NCT05014542|466164942|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
129512440|NCT05014542|466164943|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
129512441|NCT05014542|466164942|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
129512442|NCT05014542|466164943|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
129512443|NCT00555568|466164944|FG000|Overall Study|Lost to Follow-up|26|||
129512444|NCT00555568|466164945|FG001|Overall Study|Lost to Follow-up|16|||
129512445|NCT00555568|466164946|FG002|Overall Study|Lost to Follow-up|16|||
129512446|NCT04702984|466164947|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
129512447|NCT06000501|466164950|FG000|Overall Study|Screen failure|3|||
129512448|NCT06000501|466164950|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
129512449|NCT06000501|466164950|FG000|Overall Study|Physician Decision|4|||
129512450|NCT06000501|466164950|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
129512451|NCT06000501|466164950|FG000|Overall Study|Scheduling issues|2|||
129512452|NCT01588353|466164951|FG000|Step2|Withdrawal by Subject|0|||
129512453|NCT01588353|466164952|FG001|Step2|Withdrawal by Subject|1|||
129512454|NCT01588353|466164953|FG002|Step2|Withdrawal by Subject|0|||
129512455|NCT01588353|466164951|FG000|Step3|Adverse Event|0|||
129512456|NCT01588353|466164952|FG001|Step3|Adverse Event|0|||
129512457|NCT01588353|466164953|FG002|Step3|Adverse Event|2|||
129512458|NCT00493467|466164954|FG000|Overall Study|Death|1|||
129512459|NCT05489081|466164956|FG000|Overall Study|student left classroom|0|||
129512460|NCT05489081|466164957|FG001|Overall Study|student left classroom|1|||
129512461|NCT05489081|466164956|FG000|Overall Study|teacher left school|0|||
129512462|NCT05489081|466164957|FG001|Overall Study|teacher left school|2|||
129512463|NCT00810810|466164958|FG000|Overall Study|Withdrawal by Subject|0|||
129512464|NCT00810810|466164959|FG001|Overall Study|Withdrawal by Subject|8|||
129512465|NCT00810810|466164960|FG002|Overall Study|Withdrawal by Subject|10|||
129512466|NCT00810810|466164961|FG003|Overall Study|Withdrawal by Subject|8|||
129512467|NCT00810810|466164958|FG000|Overall Study|Physician Decision|0|||
129512468|NCT00810810|466164959|FG001|Overall Study|Physician Decision|3|||
129512469|NCT00810810|466164960|FG002|Overall Study|Physician Decision|1|||
129512470|NCT00810810|466164961|FG003|Overall Study|Physician Decision|5|||
129512471|NCT01409993|466164962|FG000|Overall Study|Adverse Event|4|||
129512472|NCT01409993|466164963|FG001|Overall Study|Adverse Event|4|||
129512473|NCT01409993|466164964|FG002|Overall Study|Adverse Event|3|||
129512474|NCT01409993|466164965|FG003|Overall Study|Adverse Event|1|||
129512475|NCT01409993|466164962|FG000|Overall Study|Withdrawal by Subject|0|||
129512476|NCT01409993|466164963|FG001|Overall Study|Withdrawal by Subject|0|||
129512477|NCT01409993|466164964|FG002|Overall Study|Withdrawal by Subject|0|||
129512478|NCT01409993|466164965|FG003|Overall Study|Withdrawal by Subject|4|||
129512479|NCT01409993|466164962|FG000|Overall Study|Lost to Follow-up|0|||
129512480|NCT01409993|466164963|FG001|Overall Study|Lost to Follow-up|1|||
129512481|NCT01409993|466164964|FG002|Overall Study|Lost to Follow-up|0|||
129512482|NCT01409993|466164965|FG003|Overall Study|Lost to Follow-up|0|||
129512483|NCT01700985|466164966|FG000|Overall Study|Incarcerated|0|||
129512484|NCT01700985|466164967|FG001|Overall Study|Incarcerated|1|||
129512485|NCT05067452|466164968|FG000|Overall Study|Lost to Follow-up|0|||
129512486|NCT05067452|466164969|FG001|Overall Study|Lost to Follow-up|4|||
129512487|NCT03074149|466164970|FG000|Overall Study|Reason unknown|22|||
129512488|NCT03074149|466164971|FG001|Overall Study|Reason unknown|35|||
129512489|NCT03074149|466164970|FG000|Overall Study|Death|10|||
129512490|NCT03074149|466164971|FG001|Overall Study|Death|45|||
129512491|NCT00067470|466164974|FG000|Overall Study|Withdrawal by Subject|0|||
129512492|NCT00067470|466164975|FG001|Overall Study|Withdrawal by Subject|1|||
129512493|NCT00050622|466164976|FG000|Overall Study|Adverse Event|1|||
129512494|NCT01192204|466164977|FG000|Overall Study|could not keep recall appointments|1|||
129512495|NCT01192204|466164978|FG001|Overall Study|could not keep recall appointments|0|||
129512496|NCT01315847|466164979|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
129512497|NCT01315847|466164980|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
129512498|NCT01315847|466164979|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
129512499|NCT01315847|466164980|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
129512500|NCT02247401|466164981|FG000|Overall Study|Adverse Event|1|||
129512501|NCT02247401|466164982|FG001|Overall Study|Adverse Event|0|||
129512502|NCT02247401|466164983|FG002|Overall Study|Adverse Event|0|||
129512503|NCT02247401|466164981|FG000|Overall Study|Withdrawal by Subject|4|||
129512504|NCT02247401|466164982|FG001|Overall Study|Withdrawal by Subject|1|||
129512505|NCT02247401|466164983|FG002|Overall Study|Withdrawal by Subject|1|||
129512506|NCT02247401|466164981|FG000|Overall Study|Lost to Follow-up|1|||
129512507|NCT02247401|466164982|FG001|Overall Study|Lost to Follow-up|1|||
129512508|NCT02247401|466164983|FG002|Overall Study|Lost to Follow-up|1|||
129512509|NCT00192036|466164987|FG000|Overall Study|Protocol Violation|3|||
129512510|NCT00192036|466164987|FG000|Overall Study|Adverse Event|6|||
129512511|NCT00192036|466164987|FG000|Overall Study|Patient/Physician Perception|1|||
129512512|NCT00192036|466164987|FG000|Overall Study|Objective Tumor Progression|4|||
129512513|NCT00192036|466164987|FG000|Overall Study|Clinical Disease Progression|1|||
129512514|NCT00192036|466164987|FG000|Overall Study|Death|1|||
129512515|NCT00192036|466164987|FG000|Overall Study|Unknown or Not Specified|5|||
129512516|NCT05425719|466164990|FG000|Overall Study|Lost to Follow-up|4|||
129512517|NCT05425719|466164991|FG001|Overall Study|Lost to Follow-up|0|||
129512518|NCT05425719|466164990|FG000|Overall Study|Withdrew consent|1|||
129512519|NCT05425719|466164991|FG001|Overall Study|Withdrew consent|1|||
129512520|NCT04682353|466164992|FG000|Overall Study|Lost to Follow-up|0|||
129512521|NCT04682353|466164993|FG001|Overall Study|Lost to Follow-up|1|||
129512522|NCT04682353|466164994|FG002|Overall Study|Lost to Follow-up|0|||
129512523|NCT04682353|466164995|FG003|Overall Study|Lost to Follow-up|1|||
129512524|NCT04682353|466164992|FG000|Overall Study|Personal reasons|0|||
129512525|NCT04682353|466164993|FG001|Overall Study|Personal reasons|1|||
129512526|NCT04682353|466164994|FG002|Overall Study|Personal reasons|0|||
129512527|NCT04682353|466164995|FG003|Overall Study|Personal reasons|0|||
129512528|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
129512529|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
129512530|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
129512531|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
129512532|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
129512533|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
129512534|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
129512535|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
129512536|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
129512537|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
129512538|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
129512539|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
129512540|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
129512541|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
129512542|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
129512543|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
129512544|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
129512545|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
129512546|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
129512547|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
129512548|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
129512549|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
129512550|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
129512551|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
129512552|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
129512553|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
129512554|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
129512555|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
129512556|NCT00476996|466164997|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
129512557|NCT00476996|466164998|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
129512558|NCT00476996|466164999|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
129512559|NCT00476996|466165000|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
129512560|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
129512561|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
129512562|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
129512563|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
129512564|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
129512565|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
129512566|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
129512567|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
129512568|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Death|0|||
129512569|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Death|0|||
129512570|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Death|0|||
129512571|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Death|7|||
129512572|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
129512573|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
129512574|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
129512575|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
129512576|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
129512577|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
129512578|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
129512579|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
129512580|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
129512581|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
129512582|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
129512583|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
129512584|NCT00476996|466164997|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
129512585|NCT00476996|466164998|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
129512586|NCT00476996|466164999|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
129512587|NCT00476996|466165000|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
129512588|NCT01586806|466165003|FG000|Overall Study|Protocol Violation|0|||
129512589|NCT01586806|466165004|FG001|Overall Study|Protocol Violation|1|||
129512590|NCT01586806|466165005|FG002|Overall Study|Protocol Violation|0|||
129512591|NCT01586806|466165003|FG000|Overall Study|Withdrawal by Subject|1|||
129512592|NCT01586806|466165004|FG001|Overall Study|Withdrawal by Subject|0|||
129512593|NCT01586806|466165005|FG002|Overall Study|Withdrawal by Subject|0|||
129512594|NCT01586806|466165003|FG000|Overall Study|Lost to Follow-up|2|||
129512595|NCT01586806|466165004|FG001|Overall Study|Lost to Follow-up|3|||
129512596|NCT01586806|466165005|FG002|Overall Study|Lost to Follow-up|2|||
129512597|NCT01769469|466165006|FG000|Overall Study|Consent Withdrawn|5|||
129512598|NCT01769469|466165006|FG000|Overall Study|Moved Out Of Area|3|||
129512599|NCT01769469|466165006|FG000|Overall Study|Lost to Follow-up|17|||
129512600|NCT01769469|466165006|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
129512601|NCT01769469|466165006|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
129512602|NCT02394795|466165014|FG000|Overall Study|Adverse Event|92|||
129512603|NCT02394795|466165015|FG001|Overall Study|Adverse Event|70|||
129512604|NCT02394795|466165014|FG000|Overall Study|Lost to Follow-up|0|||
129512605|NCT02394795|466165015|FG001|Overall Study|Lost to Follow-up|1|||
129512606|NCT02394795|466165014|FG000|Overall Study|Withdrawal by Subject|17|||
129512607|NCT02394795|466165015|FG001|Overall Study|Withdrawal by Subject|26|||
129512608|NCT02394795|466165014|FG000|Overall Study|Lack of Efficacy|181|||
129512609|NCT02394795|466165015|FG001|Overall Study|Lack of Efficacy|211|||
129512610|NCT02394795|466165014|FG000|Overall Study|Death|4|||
129512611|NCT02394795|466165015|FG001|Overall Study|Death|5|||
129512612|NCT02394795|466165014|FG000|Overall Study|Physician Decision|109|||
129512613|NCT02394795|466165015|FG001|Overall Study|Physician Decision|93|||
129512614|NCT02031432|466165019|FG000|Overall Study|Protocol Violation|1|||
129512615|NCT02031432|466165019|FG000|Overall Study|Lack of Efficacy|5|||
129512616|NCT02031432|466165019|FG000|Overall Study|Cancer Progression|2|||
129512617|NCT02031432|466165019|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
129512618|NCT02031432|466165019|FG000|Overall Study|Adverse Event|8|||
129512619|NCT02031432|466165019|FG000|Overall Study|Withdrawal by Subject|5|||
129512620|NCT02031432|466165019|FG000|Overall Study|Lost to Follow-up|1|||
129512621|NCT02031432|466165019|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
129512622|NCT02031432|466165019|FG000|Overall Study|Death|10|||
129512623|NCT02293902|466165020|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
129512624|NCT02293902|466165021|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
129512625|NCT02293902|466165022|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
129512626|NCT02293902|466165023|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
129512627|NCT02293902|466165024|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
129512628|NCT02293902|466165020|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
129512629|NCT02293902|466165021|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
129512630|NCT02293902|466165022|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
129512631|NCT02293902|466165023|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
129512632|NCT02293902|466165024|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
129512633|NCT02293902|466165020|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
129512634|NCT02293902|466165021|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
129512635|NCT02293902|466165022|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
129512636|NCT02293902|466165023|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
129512637|NCT02293902|466165024|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
129512638|NCT02293902|466165020|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
129512639|NCT02293902|466165021|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
129512640|NCT02293902|466165022|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
129512641|NCT02293902|466165023|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
129512642|NCT02293902|466165024|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
129512643|NCT02293902|466165020|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
129512644|NCT02293902|466165021|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
129512645|NCT02293902|466165022|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
129512646|NCT02293902|466165023|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
129512647|NCT02293902|466165024|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
129538484|NCT05664672|466262107|FG000|Overall Study|Withdrawal by Subject|0|||
129538485|NCT05664672|466262108|FG001|Overall Study|Withdrawal by Subject|1|||
129538486|NCT05664672|466262109|FG002|Overall Study|Withdrawal by Subject|3|||
129538487|NCT05664672|466262110|FG003|Overall Study|Withdrawal by Subject|0|||
129538488|NCT05664672|466262111|FG004|Overall Study|Withdrawal by Subject|5|||
129538489|NCT05664672|466262112|FG005|Overall Study|Withdrawal by Subject|6|||
129538490|NCT05664672|466262107|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
129538491|NCT05664672|466262108|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
129538492|NCT05664672|466262109|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
129538493|NCT05664672|466262110|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
129538494|NCT05664672|466262111|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
129538495|NCT05664672|466262112|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
129538496|NCT05664672|466262107|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
129538497|NCT05664672|466262108|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
129538498|NCT05664672|466262109|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
129539300|NCT01397409|466265247|FG005|Stage 2|Adverse Event|3|||
129512648|NCT04021706|466167161|FG000|Overall Study|Adverse Event|2|||
129512649|NCT04021706|466167162|FG001|Overall Study|Adverse Event|0|||
129512650|NCT04021706|466167161|FG000|Overall Study|Withdrawal by Subject|1|||
129512651|NCT04021706|466167162|FG001|Overall Study|Withdrawal by Subject|2|||
129512652|NCT04021706|466167161|FG000|Overall Study|Physician Decision|1|||
129512653|NCT04021706|466167162|FG001|Overall Study|Physician Decision|0|||
129512654|NCT01412151|466167163|FG000|Week 0 - 306 - Treatment Period|Death|1|||
129512655|NCT01412151|466167163|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
129512656|NCT01412151|466167163|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
129512657|NCT01412151|466167163|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
129512658|NCT03127852|466167165|FG000|Overall Study|Withdrawal by Subject|4|||
129512659|NCT03127852|466167166|FG001|Overall Study|Withdrawal by Subject|1|||
129512660|NCT03127852|466167165|FG000|Overall Study|Death|1|||
129512661|NCT03127852|466167166|FG001|Overall Study|Death|1|||
129512662|NCT00859573|466167168|FG000|Overall Study|Withdrawal by Subject|4|||
129512663|NCT00859573|466167169|FG001|Overall Study|Withdrawal by Subject|1|||
129512664|NCT00859573|466167168|FG000|Overall Study|Physician Decision|1|||
129512665|NCT00859573|466167169|FG001|Overall Study|Physician Decision|1|||
129512666|NCT01432457|466167170|FG000|Overall Study|Adverse Event|7|||
129512667|NCT01432457|466167171|FG001|Overall Study|Adverse Event|10|||
129512668|NCT01432457|466167172|FG002|Overall Study|Adverse Event|16|||
129512669|NCT01432457|466167170|FG000|Overall Study|Lack of Efficacy|2|||
129512670|NCT01432457|466167171|FG001|Overall Study|Lack of Efficacy|1|||
129512671|NCT01432457|466167172|FG002|Overall Study|Lack of Efficacy|1|||
129512672|NCT01432457|466167170|FG000|Overall Study|Lost to Follow-up|11|||
129512673|NCT01432457|466167171|FG001|Overall Study|Lost to Follow-up|15|||
129512674|NCT01432457|466167172|FG002|Overall Study|Lost to Follow-up|20|||
129512675|NCT01432457|466167170|FG000|Overall Study|Protocol Violation|3|||
129512676|NCT01432457|466167171|FG001|Overall Study|Protocol Violation|2|||
129512677|NCT01432457|466167172|FG002|Overall Study|Protocol Violation|6|||
129512678|NCT01432457|466167170|FG000|Overall Study|Withdrawal by Subject|6|||
129512679|NCT01432457|466167171|FG001|Overall Study|Withdrawal by Subject|11|||
129512680|NCT01432457|466167172|FG002|Overall Study|Withdrawal by Subject|9|||
129512681|NCT01432457|466167170|FG000|Overall Study|Reasons not defined|2|||
129512682|NCT01432457|466167171|FG001|Overall Study|Reasons not defined|3|||
129512683|NCT01432457|466167172|FG002|Overall Study|Reasons not defined|4|||
129512684|NCT01432457|466167170|FG000|Overall Study|Did not take study drug|6|||
129512685|NCT01432457|466167171|FG001|Overall Study|Did not take study drug|6|||
129512686|NCT01432457|466167172|FG002|Overall Study|Did not take study drug|3|||
129512687|NCT02574481|466167173|FG000|Overall Study|Withdrawal by Subject|29|||
129512688|NCT02574481|466167174|FG001|Overall Study|Withdrawal by Subject|15|||
129512689|NCT02574481|466167175|FG002|Overall Study|Withdrawal by Subject|4|||
129512690|NCT02574481|466167176|FG003|Overall Study|Withdrawal by Subject|1|||
129512691|NCT02574481|466167173|FG000|Overall Study|Adverse Event|5|||
129512692|NCT02574481|466167174|FG001|Overall Study|Adverse Event|1|||
129512693|NCT02574481|466167175|FG002|Overall Study|Adverse Event|1|||
129512694|NCT02574481|466167176|FG003|Overall Study|Adverse Event|0|||
129512695|NCT02574481|466167173|FG000|Overall Study|Visit Missed|15|||
129512696|NCT02574481|466167174|FG001|Overall Study|Visit Missed|7|||
129512697|NCT02574481|466167175|FG002|Overall Study|Visit Missed|5|||
129512698|NCT02574481|466167176|FG003|Overall Study|Visit Missed|0|||
129512699|NCT02574481|466167173|FG000|Overall Study|Other|7|||
129512700|NCT02574481|466167174|FG001|Overall Study|Other|2|||
129512701|NCT02574481|466167175|FG002|Overall Study|Other|0|||
129512702|NCT02574481|466167176|FG003|Overall Study|Other|0|||
129512703|NCT02574481|466167173|FG000|Overall Study|Death|48|||
129512704|NCT02574481|466167174|FG001|Overall Study|Death|26|||
129512705|NCT02574481|466167175|FG002|Overall Study|Death|12|||
129512706|NCT02574481|466167176|FG003|Overall Study|Death|4|||
129512707|NCT02574481|466167173|FG000|Overall Study|Physician Decision|5|||
129512708|NCT02574481|466167174|FG001|Overall Study|Physician Decision|2|||
129512709|NCT02574481|466167175|FG002|Overall Study|Physician Decision|0|||
129512710|NCT02574481|466167176|FG003|Overall Study|Physician Decision|0|||
129512711|NCT02574481|466167173|FG000|Overall Study|Lost to Follow-up|5|||
129512712|NCT02574481|466167174|FG001|Overall Study|Lost to Follow-up|1|||
129512713|NCT02574481|466167175|FG002|Overall Study|Lost to Follow-up|3|||
129512714|NCT02574481|466167176|FG003|Overall Study|Lost to Follow-up|0|||
129512715|NCT04134728|466167177|FG000|Overall Study|Adverse Event|3|||
129512716|NCT04134728|466167178|FG001|Overall Study|Adverse Event|2|||
129512717|NCT04134728|466167179|FG002|Overall Study|Adverse Event|9|||
129512718|NCT04134728|466167180|FG003|Overall Study|Adverse Event|0|||
129512719|NCT04134728|466167181|FG004|Overall Study|Adverse Event|0|||
129512720|NCT04134728|466167182|FG005|Overall Study|Adverse Event|0|||
129512721|NCT04134728|466167177|FG000|Overall Study|Lack of Efficacy|3|||
129512722|NCT04134728|466167178|FG001|Overall Study|Lack of Efficacy|3|||
129512723|NCT04134728|466167179|FG002|Overall Study|Lack of Efficacy|1|||
129512724|NCT04134728|466167180|FG003|Overall Study|Lack of Efficacy|2|||
129512725|NCT04134728|466167181|FG004|Overall Study|Lack of Efficacy|0|||
129512726|NCT04134728|466167182|FG005|Overall Study|Lack of Efficacy|0|||
129512727|NCT04134728|466167177|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
129512728|NCT04134728|466167178|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129512729|NCT04134728|466167179|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
129512730|NCT04134728|466167180|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129512731|NCT04134728|466167181|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129512732|NCT04134728|466167182|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
129512733|NCT04134728|466167177|FG000|Overall Study|Protocol Deviation|0|||
129512734|NCT04134728|466167178|FG001|Overall Study|Protocol Deviation|0|||
129512735|NCT04134728|466167179|FG002|Overall Study|Protocol Deviation|1|||
129512736|NCT04134728|466167180|FG003|Overall Study|Protocol Deviation|0|||
129512737|NCT04134728|466167181|FG004|Overall Study|Protocol Deviation|0|||
129512738|NCT04134728|466167182|FG005|Overall Study|Protocol Deviation|0|||
129512739|NCT04134728|466167177|FG000|Overall Study|Informed Consent Withdrawn|3|||
129512740|NCT04134728|466167178|FG001|Overall Study|Informed Consent Withdrawn|6|||
129512741|NCT04134728|466167179|FG002|Overall Study|Informed Consent Withdrawn|8|||
129512742|NCT04134728|466167180|FG003|Overall Study|Informed Consent Withdrawn|1|||
129512743|NCT04134728|466167181|FG004|Overall Study|Informed Consent Withdrawn|1|||
129512744|NCT04134728|466167182|FG005|Overall Study|Informed Consent Withdrawn|0|||
129512745|NCT04134728|466167177|FG000|Overall Study|Physician Decision|2|||
129512746|NCT04134728|466167178|FG001|Overall Study|Physician Decision|0|||
129512747|NCT04134728|466167179|FG002|Overall Study|Physician Decision|0|||
129512748|NCT04134728|466167180|FG003|Overall Study|Physician Decision|0|||
129512749|NCT04134728|466167181|FG004|Overall Study|Physician Decision|0|||
129512750|NCT04134728|466167182|FG005|Overall Study|Physician Decision|0|||
129512751|NCT04134728|466167177|FG000|Overall Study|Lost to Follow-up|1|||
129512752|NCT04134728|466167178|FG001|Overall Study|Lost to Follow-up|2|||
129512753|NCT04134728|466167179|FG002|Overall Study|Lost to Follow-up|1|||
129512754|NCT04134728|466167180|FG003|Overall Study|Lost to Follow-up|0|||
129512755|NCT04134728|466167181|FG004|Overall Study|Lost to Follow-up|0|||
129512756|NCT04134728|466167182|FG005|Overall Study|Lost to Follow-up|1|||
129512757|NCT04134728|466167177|FG000|Overall Study|Investigator Site Closed|0|||
129512758|NCT04134728|466167178|FG001|Overall Study|Investigator Site Closed|1|||
129512759|NCT04134728|466167179|FG002|Overall Study|Investigator Site Closed|1|||
129512760|NCT04134728|466167180|FG003|Overall Study|Investigator Site Closed|0|||
129512761|NCT04134728|466167181|FG004|Overall Study|Investigator Site Closed|0|||
129512762|NCT04134728|466167182|FG005|Overall Study|Investigator Site Closed|0|||
129512763|NCT02905825|466167183|FG000|Overall Study|Protocol Violation|11|||
129512764|NCT02905825|466167183|FG000|Overall Study|Device Malfunction|1|||
129512765|NCT03351478|466167184|FG000|Overall Study|At the subject's own request|11|||
129512766|NCT03351478|466167185|FG001|Overall Study|At the subject's own request|12|||
129512767|NCT03351478|466167186|FG002|Overall Study|At the subject's own request|5|||
129512768|NCT03351478|466167184|FG000|Overall Study|Adverse Event|1|||
129512769|NCT03351478|466167185|FG001|Overall Study|Adverse Event|2|||
129512770|NCT03351478|466167186|FG002|Overall Study|Adverse Event|1|||
129512771|NCT03351478|466167184|FG000|Overall Study|Poor compliance to protocol|1|||
129512772|NCT03351478|466167185|FG001|Overall Study|Poor compliance to protocol|0|||
129512773|NCT03351478|466167186|FG002|Overall Study|Poor compliance to protocol|0|||
129512774|NCT03351478|466167184|FG000|Overall Study|Reason not Specified|1|||
129512775|NCT03351478|466167185|FG001|Overall Study|Reason not Specified|3|||
129512776|NCT03351478|466167186|FG002|Overall Study|Reason not Specified|0|||
129512777|NCT03351478|466167184|FG000|Overall Study|Lost to Follow-up|0|||
129512778|NCT03351478|466167185|FG001|Overall Study|Lost to Follow-up|0|||
129512779|NCT03351478|466167186|FG002|Overall Study|Lost to Follow-up|1|||
129512780|NCT00510484|466167188|FG000|Wash-out Period|Adverse Event|0|||
129512781|NCT00510484|466167189|FG001|Wash-out Period|Adverse Event|1|||
129512782|NCT00762268|466167192|FG000|Overall Study|Withdrawal by Subject|3|||
129512783|NCT00762268|466167193|FG001|Overall Study|Withdrawal by Subject|3|||
129512784|NCT02533401|466167194|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
129512785|NCT02533401|466167194|FG000|Overall Study|Death|5|||
129512786|NCT02533401|466167194|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
129512787|NCT02533401|466167194|FG000|Overall Study|Lost to Follow-up|1|||
129512788|NCT02533401|466167194|FG000|Overall Study|Violation of Selection Criteria|1|||
129512789|NCT01438307|466167200|FG000|Overall Study|Death|1|||
129512790|NCT01438307|466167201|FG001|Overall Study|Death|1|||
129512791|NCT00973622|466167203|FG000|Overall Study|did not attend MRI|14|||
129512792|NCT00973622|466167204|FG001|Overall Study|did not attend MRI|3|||
129512793|NCT00973622|466167203|FG000|Overall Study|did not pass MRI screen|6|||
129512794|NCT00973622|466167204|FG001|Overall Study|did not pass MRI screen|0|||
129512795|NCT00973622|466167203|FG000|Overall Study|did not complete rTMS sessions|11|||
129512796|NCT00973622|466167204|FG001|Overall Study|did not complete rTMS sessions|2|||
129512797|NCT03814005|466167208|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
129512798|NCT03814005|466167209|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
129512799|NCT03814005|466167210|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
129512800|NCT03814005|466167208|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
129512801|NCT03814005|466167209|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
129512802|NCT03814005|466167210|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
129512803|NCT03814005|466167208|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
129512804|NCT03814005|466167209|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
129512805|NCT03814005|466167210|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
129512806|NCT03814005|466167208|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
129512807|NCT03814005|466167209|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
129512808|NCT03814005|466167210|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
129512809|NCT03814005|466167208|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
129982977|NCT00700427|467900648|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
129982978|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
129982979|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
129982980|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
129982981|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
129982982|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
129982983|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
129982984|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
129982985|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
129982986|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
129982987|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
129982988|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
129982989|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
129982990|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
129982991|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
129982992|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
129982993|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
129982994|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
129982995|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
129982996|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
129982997|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
129982998|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
129982999|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
129983000|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
129983001|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
129983002|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
129983003|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983004|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983005|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983006|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
129983007|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
129983008|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983009|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983010|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983011|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
129983012|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
129983013|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
129983014|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
129983015|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
129983016|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
129983017|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
129983018|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983019|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983020|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
129983021|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983022|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
129983023|NCT00700427|467900644|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983024|NCT00700427|467900645|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983025|NCT00700427|467900646|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
129983026|NCT00700427|467900647|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983027|NCT00700427|467900648|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
129983028|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983029|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983030|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983031|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
129983032|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
129983033|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
129512810|NCT03814005|466167209|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
129512811|NCT03814005|466167210|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
129512812|NCT03814005|466167208|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
129512813|NCT03814005|466167209|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
129512814|NCT03814005|466167210|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
129512815|NCT03395223|466167211|FG000|Overall Study|Lost to Follow-up|3|||
129512816|NCT03395223|466167211|FG000|Overall Study|Other|1|||
129512817|NCT01855945|466167217|FG000|Overall Study|Adverse Event|0|||
129512818|NCT01855945|466167218|FG001|Overall Study|Adverse Event|0|||
129512819|NCT01855945|466167219|FG002|Overall Study|Adverse Event|0|||
129512820|NCT01855945|466167220|FG003|Overall Study|Adverse Event|0|||
129512821|NCT01855945|466167221|FG004|Overall Study|Adverse Event|0|||
129512822|NCT01855945|466167222|FG005|Overall Study|Adverse Event|0|||
129512823|NCT01855945|466167223|FG006|Overall Study|Adverse Event|1|||
129512824|NCT01855945|466167224|FG007|Overall Study|Adverse Event|0|||
129512825|NCT01855945|466167225|FG008|Overall Study|Adverse Event|0|||
129512826|NCT01855945|466167226|FG009|Overall Study|Adverse Event|0|||
129512827|NCT01855945|466167227|FG010|Overall Study|Adverse Event|0|||
129512828|NCT01855945|466167228|FG011|Overall Study|Adverse Event|0|||
129512829|NCT01855945|466167217|FG000|Overall Study|Death|0|||
129512830|NCT01855945|466167218|FG001|Overall Study|Death|0|||
129512831|NCT01855945|466167219|FG002|Overall Study|Death|0|||
129512832|NCT01855945|466167220|FG003|Overall Study|Death|0|||
129512833|NCT01855945|466167221|FG004|Overall Study|Death|0|||
129512834|NCT01855945|466167222|FG005|Overall Study|Death|0|||
129512835|NCT01855945|466167223|FG006|Overall Study|Death|2|||
129983034|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
129983035|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
129983036|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
129983037|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
129983038|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983039|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983040|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983041|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
129983042|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
129983043|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983044|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983045|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983046|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
129983047|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
129983048|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983049|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983050|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983051|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
129983052|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
129983053|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983054|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983055|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983056|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
129983057|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
129983058|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983059|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983060|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983061|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
129983062|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
129983063|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983064|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983065|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983066|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
129983067|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
129983068|NCT00700427|467900644|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983069|NCT00700427|467900645|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983070|NCT00700427|467900646|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983071|NCT00700427|467900647|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
129983072|NCT00700427|467900648|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
129983073|NCT00941070|467900650|FG000|Overall Study|Patient non-compliant|1|||
129983074|NCT04075994|467900651|FG000|Overall Study|Withdrawal by Subject|8|||
129983075|NCT04075994|467900652|FG001|Overall Study|Withdrawal by Subject|9|||
129512836|NCT01855945|466167224|FG007|Overall Study|Death|0|||
129512837|NCT01855945|466167225|FG008|Overall Study|Death|0|||
129512838|NCT01855945|466167226|FG009|Overall Study|Death|0|||
129512839|NCT01855945|466167227|FG010|Overall Study|Death|0|||
129512840|NCT01855945|466167228|FG011|Overall Study|Death|0|||
129512841|NCT01855945|466167217|FG000|Overall Study|Lost to Follow-up|11|||
129512842|NCT01855945|466167218|FG001|Overall Study|Lost to Follow-up|10|||
129512843|NCT01855945|466167219|FG002|Overall Study|Lost to Follow-up|7|||
129512844|NCT01855945|466167220|FG003|Overall Study|Lost to Follow-up|3|||
129512845|NCT01855945|466167221|FG004|Overall Study|Lost to Follow-up|0|||
129512846|NCT01855945|466167222|FG005|Overall Study|Lost to Follow-up|3|||
129983076|NCT04075994|467900651|FG000|Overall Study|Adverse Event|2|||
129983077|NCT04075994|467900652|FG001|Overall Study|Adverse Event|2|||
129983078|NCT04075994|467900651|FG000|Overall Study|Investigator withdrew|3|||
129983079|NCT04075994|467900652|FG001|Overall Study|Investigator withdrew|1|||
129983080|NCT01125514|467900662|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
129983081|NCT01125514|467900662|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
129983082|NCT01125514|467900662|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
129983083|NCT01125514|467900662|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
129983084|NCT01125514|467900662|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
129983085|NCT01125514|467900662|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
129983086|NCT00858364|467900665|FG000|Overall Study|Administrative Decision|3|||
129983087|NCT00858364|467900666|FG001|Overall Study|Administrative Decision|2|||
129983088|NCT00858364|467900665|FG000|Overall Study|Adverse Event|5|||
129983089|NCT00858364|467900666|FG001|Overall Study|Adverse Event|2|||
129983090|NCT00858364|467900665|FG000|Overall Study|Withdrawal by Subject|44|||
129983091|NCT00858364|467900666|FG001|Overall Study|Withdrawal by Subject|118|||
129983092|NCT00858364|467900665|FG000|Overall Study|Ineligibility Determined|1|||
129983093|NCT00858364|467900666|FG001|Overall Study|Ineligibility Determined|10|||
129983094|NCT00858364|467900665|FG000|Overall Study|Lost to Follow-up|24|||
129983095|NCT00858364|467900666|FG001|Overall Study|Lost to Follow-up|54|||
129983096|NCT00858364|467900665|FG000|Overall Study|Noncompliance|3|||
129983097|NCT00858364|467900666|FG001|Overall Study|Noncompliance|4|||
129983098|NCT00858364|467900665|FG000|Overall Study|Protocol Deviation|0|||
129983099|NCT00858364|467900666|FG001|Overall Study|Protocol Deviation|2|||
129983100|NCT00858364|467900665|FG000|Overall Study|Other|9|||
129983101|NCT00858364|467900666|FG001|Overall Study|Other|17|||
129983102|NCT00858364|467900665|FG000|Overall Study|Missing|1|||
129983103|NCT00858364|467900666|FG001|Overall Study|Missing|1|||
129983104|NCT00858364|467900665|FG000|Overall Study|Still on-study|114|||
129983105|NCT00858364|467900666|FG001|Overall Study|Still on-study|247|||
129983106|NCT02755818|467900667|FG000|Overall Study|Withdrawal by Subject|0|||
129983107|NCT02755818|467900668|FG001|Overall Study|Withdrawal by Subject|0|||
129983108|NCT02755818|467900669|FG002|Overall Study|Withdrawal by Subject|0|||
129983109|NCT02755818|467900670|FG003|Overall Study|Withdrawal by Subject|2|||
129983110|NCT02755818|467900667|FG000|Overall Study|withdrawal by PI|0|||
129983111|NCT02755818|467900668|FG001|Overall Study|withdrawal by PI|0|||
129983112|NCT02755818|467900669|FG002|Overall Study|withdrawal by PI|1|||
129983113|NCT02755818|467900670|FG003|Overall Study|withdrawal by PI|1|||
129983114|NCT01163292|467900676|FG000|Overall Study|Lack of Efficacy|9|||
129983115|NCT01163292|467900677|FG001|Overall Study|Lack of Efficacy|0|||
129983116|NCT01163292|467900676|FG000|Overall Study|Adverse Event|6|||
129983117|NCT01163292|467900677|FG001|Overall Study|Adverse Event|0|||
129983118|NCT01163292|467900676|FG000|Overall Study|Initiation of biological therapy|0|||
129983119|NCT01163292|467900677|FG001|Overall Study|Initiation of biological therapy|15|||
129983120|NCT01163292|467900676|FG000|Overall Study|Sufficient response to adalimumab|8|||
129983121|NCT01163292|467900677|FG001|Overall Study|Sufficient response to adalimumab|0|||
129983122|NCT01163292|467900676|FG000|Overall Study|Refusal to receive adalimumab|7|||
129983123|NCT01163292|467900677|FG001|Overall Study|Refusal to receive adalimumab|0|||
129983124|NCT01163292|467900676|FG000|Overall Study|Economic reasons|6|||
129983125|NCT01163292|467900677|FG001|Overall Study|Economic reasons|0|||
129983126|NCT01163292|467900676|FG000|Overall Study|No further visits|5|||
129983127|NCT01163292|467900677|FG001|Overall Study|No further visits|7|||
129983128|NCT02535091|467900678|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
129983129|NCT02535091|467900679|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
129983130|NCT02535091|467900680|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
129983131|NCT02535091|467900678|FG000|Overall Study|Withdrawal by Subject|14|||
129983132|NCT02535091|467900679|FG001|Overall Study|Withdrawal by Subject|5|||
129983133|NCT02535091|467900680|FG002|Overall Study|Withdrawal by Subject|121|||
129983134|NCT02535091|467900678|FG000|Overall Study|Adverse Event|9|||
129983135|NCT02535091|467900679|FG001|Overall Study|Adverse Event|4|||
129983136|NCT02535091|467900680|FG002|Overall Study|Adverse Event|170|||
129983137|NCT02535091|467900678|FG000|Overall Study|Other|4|||
129983138|NCT02535091|467900679|FG001|Overall Study|Other|3|||
129983139|NCT02535091|467900680|FG002|Overall Study|Other|81|||
129983140|NCT02535091|467900678|FG000|Overall Study|Lost to Follow-up|0|||
129983141|NCT02535091|467900679|FG001|Overall Study|Lost to Follow-up|1|||
129983142|NCT02535091|467900680|FG002|Overall Study|Lost to Follow-up|19|||
129983143|NCT02535091|467900678|FG000|Overall Study|Protocol Violation|0|||
129512847|NCT01855945|466167223|FG006|Overall Study|Lost to Follow-up|4|||
129983144|NCT02535091|467900679|FG001|Overall Study|Protocol Violation|1|||
129983145|NCT02535091|467900680|FG002|Overall Study|Protocol Violation|11|||
129512848|NCT01855945|466167224|FG007|Overall Study|Lost to Follow-up|7|||
129512849|NCT01855945|466167225|FG008|Overall Study|Lost to Follow-up|2|||
129512850|NCT01855945|466167226|FG009|Overall Study|Lost to Follow-up|0|||
129512851|NCT01855945|466167227|FG010|Overall Study|Lost to Follow-up|0|||
129512852|NCT01855945|466167228|FG011|Overall Study|Lost to Follow-up|2|||
129512853|NCT01855945|466167217|FG000|Overall Study|Other - Unclassified|1|||
129512854|NCT01855945|466167218|FG001|Overall Study|Other - Unclassified|1|||
129512855|NCT01855945|466167219|FG002|Overall Study|Other - Unclassified|1|||
129512856|NCT01855945|466167220|FG003|Overall Study|Other - Unclassified|0|||
129512857|NCT01855945|466167221|FG004|Overall Study|Other - Unclassified|0|||
129512858|NCT01855945|466167222|FG005|Overall Study|Other - Unclassified|0|||
129512859|NCT01855945|466167223|FG006|Overall Study|Other - Unclassified|2|||
129512860|NCT01855945|466167224|FG007|Overall Study|Other - Unclassified|1|||
129512861|NCT01855945|466167225|FG008|Overall Study|Other - Unclassified|0|||
129512862|NCT01855945|466167226|FG009|Overall Study|Other - Unclassified|0|||
129512863|NCT01855945|466167227|FG010|Overall Study|Other - Unclassified|1|||
129512864|NCT01855945|466167228|FG011|Overall Study|Other - Unclassified|0|||
129512865|NCT01855945|466167217|FG000|Overall Study|Withdrawal by Subject|4|||
129512866|NCT01855945|466167218|FG001|Overall Study|Withdrawal by Subject|0|||
129512867|NCT01855945|466167219|FG002|Overall Study|Withdrawal by Subject|4|||
129512868|NCT01855945|466167220|FG003|Overall Study|Withdrawal by Subject|1|||
129512869|NCT01855945|466167221|FG004|Overall Study|Withdrawal by Subject|1|||
129512870|NCT01855945|466167222|FG005|Overall Study|Withdrawal by Subject|0|||
129512871|NCT01855945|466167223|FG006|Overall Study|Withdrawal by Subject|1|||
129512872|NCT01855945|466167224|FG007|Overall Study|Withdrawal by Subject|0|||
129512873|NCT01855945|466167225|FG008|Overall Study|Withdrawal by Subject|0|||
129512874|NCT01855945|466167226|FG009|Overall Study|Withdrawal by Subject|2|||
129512875|NCT01855945|466167227|FG010|Overall Study|Withdrawal by Subject|4|||
129512876|NCT01855945|466167228|FG011|Overall Study|Withdrawal by Subject|1|||
129512877|NCT01148693|466167229|FG000|Overall Study|Attempts for cannulation were failed|13|||
129512878|NCT01148693|466167230|FG001|Overall Study|Attempts for cannulation were failed|10|||
129512879|NCT01135017|466167231|FG000|Overall Study|Adverse Event|3|||
129512880|NCT01135017|466167232|FG001|Overall Study|Adverse Event|8|||
129512881|NCT01135017|466167231|FG000|Overall Study|Other than above|3|||
129512882|NCT01135017|466167232|FG001|Overall Study|Other than above|4|||
129512883|NCT01074658|466167234|FG000|Overall Study|No implant attempted|19|||
129512884|NCT01342952|466167235|FG000|Overall Study|Adverse Event|0|||
129512885|NCT01342952|466167236|FG001|Overall Study|Adverse Event|5|||
129512886|NCT01342952|466167237|FG002|Overall Study|Adverse Event|1|||
129512887|NCT01342952|466167238|FG003|Overall Study|Adverse Event|0|||
129512888|NCT01342952|466167235|FG000|Overall Study|Lost to Follow-up|0|||
129512889|NCT01342952|466167236|FG001|Overall Study|Lost to Follow-up|2|||
129512890|NCT01342952|466167237|FG002|Overall Study|Lost to Follow-up|0|||
129512891|NCT01342952|466167238|FG003|Overall Study|Lost to Follow-up|0|||
129512892|NCT01342952|466167235|FG000|Overall Study|Withdrawal by Subject|1|||
129512893|NCT01342952|466167236|FG001|Overall Study|Withdrawal by Subject|1|||
129512894|NCT01342952|466167237|FG002|Overall Study|Withdrawal by Subject|0|||
129512895|NCT01342952|466167238|FG003|Overall Study|Withdrawal by Subject|0|||
129512896|NCT01342952|466167235|FG000|Overall Study|Physician Decision|3|||
129512897|NCT01342952|466167236|FG001|Overall Study|Physician Decision|3|||
129512898|NCT01342952|466167237|FG002|Overall Study|Physician Decision|1|||
129512899|NCT01342952|466167238|FG003|Overall Study|Physician Decision|0|||
129512900|NCT02156804|466167239|FG000|Overall Study|Withdrawal by Subject|1|||
129512901|NCT03228394|466167240|FG000|Overall Study|Lost to Follow-up|0|||
129512902|NCT03228394|466167241|FG001|Overall Study|Lost to Follow-up|0|||
129512903|NCT03228394|466167242|FG002|Overall Study|Lost to Follow-up|1|||
129512904|NCT03228394|466167243|FG003|Overall Study|Lost to Follow-up|1|||
129983146|NCT02535091|467900678|FG000|Overall Study|Pregnancy|0|||
129512905|NCT03228394|466167244|FG004|Overall Study|Lost to Follow-up|0|||
129512906|NCT03228394|466167245|FG005|Overall Study|Lost to Follow-up|0|||
129512907|NCT03228394|466167246|FG006|Overall Study|Lost to Follow-up|2|||
129512908|NCT03228394|466167247|FG007|Overall Study|Lost to Follow-up|0|||
129512909|NCT03228394|466167240|FG000|Overall Study|Withdrawal by Subject|0|||
129512910|NCT03228394|466167241|FG001|Overall Study|Withdrawal by Subject|0|||
129512911|NCT03228394|466167242|FG002|Overall Study|Withdrawal by Subject|1|||
129512912|NCT03228394|466167243|FG003|Overall Study|Withdrawal by Subject|0|||
129512913|NCT03228394|466167244|FG004|Overall Study|Withdrawal by Subject|0|||
129512914|NCT03228394|466167245|FG005|Overall Study|Withdrawal by Subject|0|||
129512915|NCT03228394|466167246|FG006|Overall Study|Withdrawal by Subject|1|||
129512916|NCT03228394|466167247|FG007|Overall Study|Withdrawal by Subject|3|||
129512917|NCT03228394|466167240|FG000|Overall Study|Protocol Violation|0|||
129512918|NCT03228394|466167241|FG001|Overall Study|Protocol Violation|0|||
129512919|NCT03228394|466167242|FG002|Overall Study|Protocol Violation|0|||
129512920|NCT03228394|466167243|FG003|Overall Study|Protocol Violation|1|||
129512921|NCT03228394|466167244|FG004|Overall Study|Protocol Violation|0|||
129512922|NCT03228394|466167245|FG005|Overall Study|Protocol Violation|0|||
129512923|NCT03228394|466167246|FG006|Overall Study|Protocol Violation|0|||
129983147|NCT02535091|467900679|FG001|Overall Study|Pregnancy|0|||
129512924|NCT03228394|466167247|FG007|Overall Study|Protocol Violation|0|||
129512925|NCT03228394|466167240|FG000|Overall Study|Physician Decision|0|||
129512926|NCT03228394|466167241|FG001|Overall Study|Physician Decision|0|||
129512927|NCT03228394|466167242|FG002|Overall Study|Physician Decision|0|||
129512928|NCT03228394|466167243|FG003|Overall Study|Physician Decision|0|||
129512929|NCT03228394|466167244|FG004|Overall Study|Physician Decision|0|||
129512930|NCT03228394|466167245|FG005|Overall Study|Physician Decision|0|||
129512931|NCT03228394|466167246|FG006|Overall Study|Physician Decision|1|||
129512932|NCT03228394|466167247|FG007|Overall Study|Physician Decision|0|||
129512933|NCT03228394|466167240|FG000|Overall Study|Noncompliance|0|||
129512934|NCT03228394|466167241|FG001|Overall Study|Noncompliance|0|||
129512935|NCT03228394|466167242|FG002|Overall Study|Noncompliance|0|||
129512936|NCT03228394|466167243|FG003|Overall Study|Noncompliance|0|||
129512937|NCT03228394|466167244|FG004|Overall Study|Noncompliance|0|||
129512938|NCT03228394|466167245|FG005|Overall Study|Noncompliance|0|||
129512939|NCT03228394|466167246|FG006|Overall Study|Noncompliance|1|||
129512940|NCT03228394|466167247|FG007|Overall Study|Noncompliance|0|||
129512941|NCT04581863|466167248|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
129512942|NCT04581863|466167249|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
129512943|NCT01803711|466167254|FG000|Overall Study|Adverse Event|1|||
129512944|NCT01803711|466167255|FG001|Overall Study|Adverse Event|1|||
129512945|NCT01170221|466167259|FG000|Overall Study|Lost to Follow-up|22|||
129512946|NCT01170221|466167260|FG001|Overall Study|Lost to Follow-up|21|||
129512947|NCT01170221|466167259|FG000|Overall Study|Withdrawal by Subject|9|||
129512948|NCT01170221|466167260|FG001|Overall Study|Withdrawal by Subject|7|||
129512949|NCT01170221|466167259|FG000|Overall Study|Subject completed only screening and LFU|1|||
129512950|NCT01170221|466167260|FG001|Overall Study|Subject completed only screening and LFU|0|||
129512951|NCT01170221|466167259|FG000|Overall Study|Randomized but not treated|1|||
129512952|NCT01170221|466167260|FG001|Overall Study|Randomized but not treated|0|||
129512953|NCT00432562|466167261|FG000|Overall Study|Death|3|||
129512954|NCT00432562|466167262|FG001|Overall Study|Death|0|||
129512955|NCT02693691|466167263|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
129512956|NCT02693691|466167263|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
129512957|NCT02693691|466167263|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
129512958|NCT02693691|466167263|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
129512959|NCT02693691|466167263|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
129512960|NCT02693691|466167263|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
129512961|NCT02693691|466167263|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
129512962|NCT01162304|466167266|FG000|Overall Study|Beck scale to high|11|||
129512963|NCT00862654|466167269|FG000|Overall Study|Lack of Efficacy|1|||
129512964|NCT00862654|466167270|FG001|Overall Study|Lack of Efficacy|0|||
129512965|NCT00862654|466167271|FG002|Overall Study|Lack of Efficacy|1|||
129512966|NCT00862654|466167272|FG003|Overall Study|Lack of Efficacy|0|||
129512967|NCT00862654|466167269|FG000|Overall Study|Lost to Follow-up|1|||
129512968|NCT00862654|466167270|FG001|Overall Study|Lost to Follow-up|2|||
129512969|NCT00862654|466167271|FG002|Overall Study|Lost to Follow-up|1|||
129512970|NCT00862654|466167272|FG003|Overall Study|Lost to Follow-up|3|||
129512971|NCT00862654|466167269|FG000|Overall Study|Adverse Event|0|||
129512972|NCT00862654|466167270|FG001|Overall Study|Adverse Event|1|||
129512973|NCT00862654|466167271|FG002|Overall Study|Adverse Event|1|||
129512974|NCT00862654|466167272|FG003|Overall Study|Adverse Event|0|||
129512975|NCT00862654|466167269|FG000|Overall Study|Pregnancy|1|||
129512976|NCT00862654|466167270|FG001|Overall Study|Pregnancy|1|||
129512977|NCT00862654|466167271|FG002|Overall Study|Pregnancy|0|||
129512978|NCT00862654|466167272|FG003|Overall Study|Pregnancy|0|||
129512979|NCT00862654|466167269|FG000|Overall Study|Withdrawal by Subject|2|||
129512980|NCT00862654|466167270|FG001|Overall Study|Withdrawal by Subject|2|||
129512981|NCT00862654|466167271|FG002|Overall Study|Withdrawal by Subject|2|||
129512982|NCT00862654|466167272|FG003|Overall Study|Withdrawal by Subject|3|||
129512983|NCT00862654|466167269|FG000|Overall Study|Subject mistake|0|||
129512984|NCT00862654|466167270|FG001|Overall Study|Subject mistake|1|||
129512985|NCT00862654|466167271|FG002|Overall Study|Subject mistake|0|||
129512986|NCT00862654|466167272|FG003|Overall Study|Subject mistake|0|||
129512987|NCT00862654|466167269|FG000|Overall Study|Familly constraint|0|||
129512988|NCT00862654|466167270|FG001|Overall Study|Familly constraint|1|||
129512989|NCT00862654|466167271|FG002|Overall Study|Familly constraint|0|||
129512990|NCT00862654|466167272|FG003|Overall Study|Familly constraint|0|||
129512991|NCT00862654|466167269|FG000|Overall Study|Never used study drugs|1|||
129512992|NCT00862654|466167270|FG001|Overall Study|Never used study drugs|0|||
129512993|NCT00862654|466167271|FG002|Overall Study|Never used study drugs|0|||
129512994|NCT00862654|466167272|FG003|Overall Study|Never used study drugs|0|||
129512995|NCT00862654|466167269|FG000|Overall Study|Included after end of inclusions|0|||
129512996|NCT00862654|466167270|FG001|Overall Study|Included after end of inclusions|0|||
129512997|NCT00862654|466167271|FG002|Overall Study|Included after end of inclusions|1|||
129512998|NCT00862654|466167272|FG003|Overall Study|Included after end of inclusions|0|||
129512999|NCT04377672|466167273|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
129983148|NCT02535091|467900680|FG002|Overall Study|Pregnancy|7|||
129983149|NCT03223662|467900681|FG000|Overall Study|Physician Decision|1|||
129983150|NCT03223662|467900681|FG000|Overall Study|Study closure|1|||
129983151|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
129983152|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
129983153|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
129983154|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
129983155|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
129983156|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
129983157|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
129983158|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
129983159|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
129983160|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
129983161|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
129983162|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
129983163|NCT02217475|467900682|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
129983164|NCT02217475|467900683|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
129983165|NCT02217475|467900684|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
129983166|NCT02217475|467900682|FG000|Discontinued After Period 1|Adverse Event|1|||
129983167|NCT02217475|467900683|FG001|Discontinued After Period 1|Adverse Event|2|||
129983168|NCT02217475|467900684|FG002|Discontinued After Period 1|Adverse Event|0|||
129983169|NCT02217475|467900682|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
129983170|NCT02217475|467900683|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
129983171|NCT02217475|467900684|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
129983172|NCT02217475|467900682|FG000|Discontinued After Period 1|Physician Decision|0|||
129983173|NCT02217475|467900683|FG001|Discontinued After Period 1|Physician Decision|0|||
129983174|NCT02217475|467900684|FG002|Discontinued After Period 1|Physician Decision|1|||
129983175|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
129983176|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
129983177|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
129983178|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
129983179|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
129983180|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
129983181|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
129983182|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
129983183|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
129983184|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
129983185|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
129983186|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
129983187|NCT02217475|467900682|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
129983188|NCT02217475|467900683|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
129983189|NCT02217475|467900684|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
129983190|NCT02643472|467900685|FG000|Overall Study|Death|2|||
129983191|NCT02643472|467900686|FG001|Overall Study|Death|5|||
129983192|NCT02643472|467900685|FG000|Overall Study|Withdrawal by Subject|3|||
129983193|NCT02643472|467900686|FG001|Overall Study|Withdrawal by Subject|2|||
129983194|NCT02643472|467900685|FG000|Overall Study|Protocol Violation|0|||
129983195|NCT02643472|467900686|FG001|Overall Study|Protocol Violation|1|||
129983196|NCT02643472|467900685|FG000|Overall Study|Lost to Follow-up|22|||
129983197|NCT02643472|467900686|FG001|Overall Study|Lost to Follow-up|26|||
129983198|NCT01215188|467900687|FG000|Overall Study|Lost to Follow-up|22|||
129983199|NCT01215188|467900688|FG001|Overall Study|Lost to Follow-up|22|||
129983200|NCT01215188|467900689|FG002|Overall Study|Lost to Follow-up|16|||
129983201|NCT01215188|467900687|FG000|Overall Study|Adverse Event|1|||
129983202|NCT01215188|467900688|FG001|Overall Study|Adverse Event|1|||
129983203|NCT01215188|467900689|FG002|Overall Study|Adverse Event|3|||
129983204|NCT01215188|467900687|FG000|Overall Study|Physician Decision|2|||
129983205|NCT01215188|467900688|FG001|Overall Study|Physician Decision|1|||
129983206|NCT01215188|467900689|FG002|Overall Study|Physician Decision|0|||
129983207|NCT01215188|467900687|FG000|Overall Study|Lack of Efficacy|0|||
129983208|NCT01215188|467900688|FG001|Overall Study|Lack of Efficacy|0|||
129983209|NCT01215188|467900689|FG002|Overall Study|Lack of Efficacy|1|||
129983210|NCT01215188|467900687|FG000|Overall Study|Protocol Violation|1|||
129983211|NCT01215188|467900688|FG001|Overall Study|Protocol Violation|1|||
129983212|NCT01215188|467900689|FG002|Overall Study|Protocol Violation|1|||
129983213|NCT01215188|467900687|FG000|Overall Study|Withdrawal by Subject|32|||
129983214|NCT01215188|467900688|FG001|Overall Study|Withdrawal by Subject|34|||
129983215|NCT01215188|467900689|FG002|Overall Study|Withdrawal by Subject|31|||
129983216|NCT01012414|467900690|FG000|Overall Study|Withdrawal by Subject|2|||
129983217|NCT01012414|467900690|FG000|Overall Study|Lost to Follow-up|1|||
129983218|NCT01012414|467900690|FG000|Overall Study|Trial was stopped before completed|7|||
129983219|NCT00506441|467900691|FG000|Period 1; Open-label Period|Adverse Event|21|||
129983220|NCT00506441|467900692|FG001|Period 1; Open-label Period|Adverse Event|0|||
129513000|NCT03954444|466167274|FG000|Overall Study|Withdrawal by Subject|5|||
129513001|NCT03954444|466167275|FG001|Overall Study|Withdrawal by Subject|5|||
129513002|NCT03954444|466167276|FG002|Overall Study|Withdrawal by Subject|5|||
129513003|NCT03954444|466167274|FG000|Overall Study|Adverse Event|1|||
129513004|NCT03954444|466167275|FG001|Overall Study|Adverse Event|3|||
129513005|NCT03954444|466167276|FG002|Overall Study|Adverse Event|2|||
129513006|NCT03954444|466167274|FG000|Overall Study|Protocol Violation|0|||
129513007|NCT03954444|466167275|FG001|Overall Study|Protocol Violation|3|||
129513008|NCT03954444|466167276|FG002|Overall Study|Protocol Violation|5|||
129513009|NCT03954444|466167274|FG000|Overall Study|Use of prohibited therapy|1|||
129513010|NCT03954444|466167275|FG001|Overall Study|Use of prohibited therapy|1|||
129513011|NCT03954444|466167276|FG002|Overall Study|Use of prohibited therapy|2|||
129513012|NCT03954444|466167274|FG000|Overall Study|Lost to Follow-up|1|||
129513013|NCT03954444|466167275|FG001|Overall Study|Lost to Follow-up|0|||
129513014|NCT03954444|466167276|FG002|Overall Study|Lost to Follow-up|1|||
129513015|NCT03954444|466167274|FG000|Overall Study|Non-compliant with study drug application|2|||
129513016|NCT03954444|466167275|FG001|Overall Study|Non-compliant with study drug application|2|||
129513017|NCT03954444|466167276|FG002|Overall Study|Non-compliant with study drug application|0|||
129513018|NCT03954444|466167274|FG000|Overall Study|Administrative reasons|0|||
129513019|NCT03954444|466167275|FG001|Overall Study|Administrative reasons|0|||
129513020|NCT03954444|466167276|FG002|Overall Study|Administrative reasons|1|||
129513021|NCT03954444|466167274|FG000|Overall Study|Miscellaneous|3|||
129513022|NCT03954444|466167275|FG001|Overall Study|Miscellaneous|2|||
129513023|NCT03954444|466167276|FG002|Overall Study|Miscellaneous|1|||
129513024|NCT02447458|466167277|FG000|Overall Study|Other|0|||
129513025|NCT02447458|466167278|FG001|Overall Study|Other|0|||
129513026|NCT02447458|466167279|FG002|Overall Study|Other|1|||
129513027|NCT02447458|466167280|FG003|Overall Study|Other|0|||
129513028|NCT02447458|466167281|FG004|Overall Study|Other|0|||
129513029|NCT02447458|466167282|FG005|Overall Study|Other|0|||
129513030|NCT02133742|466167283|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
129513031|NCT02133742|466167283|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
129513032|NCT02133742|466167283|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
129513033|NCT02133742|466167283|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
129513034|NCT02133742|466167283|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
129513035|NCT03505749|466167285|FG000|Overall Study|Lost to Follow-up|7|||
129513036|NCT03505749|466167286|FG001|Overall Study|Lost to Follow-up|11|||
129513037|NCT03505749|466167285|FG000|Overall Study|Withdrawal by Subject|6|||
129513038|NCT03505749|466167286|FG001|Overall Study|Withdrawal by Subject|0|||
129513039|NCT03505749|466167285|FG000|Overall Study|Discharged from treatment|3|||
129513040|NCT03505749|466167286|FG001|Overall Study|Discharged from treatment|6|||
129513041|NCT01688635|466167287|FG000|Washout 1|Withdrawal by Subject|1|||
129513042|NCT01688635|466167288|FG001|Washout 1|Withdrawal by Subject|0|||
129513043|NCT01688635|466167287|FG000|Washout 1|Adverse Event|0|||
129513044|NCT01688635|466167288|FG001|Washout 1|Adverse Event|1|||
129513045|NCT01688635|466167287|FG000|Washout 1|Physician Decision|0|||
129513046|NCT01688635|466167288|FG001|Washout 1|Physician Decision|1|||
129513047|NCT01688635|466167287|FG000|Washout 2|Physician Decision|1|||
129513048|NCT01688635|466167288|FG001|Washout 2|Physician Decision|0|||
129513049|NCT01688635|466167287|FG000|Washout 2|Withdrawal by Subject|1|||
129513050|NCT01688635|466167288|FG001|Washout 2|Withdrawal by Subject|0|||
129513051|NCT01688635|466167287|FG000|Washout 2|Sponsor Decision|1|||
129513052|NCT01688635|466167288|FG001|Washout 2|Sponsor Decision|2|||
129513053|NCT01688635|466167287|FG000|Washout 3|Withdrawal by Subject|1|||
129513054|NCT01688635|466167288|FG001|Washout 3|Withdrawal by Subject|0|||
129513055|NCT03549117|466167292|FG000|Overall Study|Withdrawal by Subject|1|||
129513056|NCT03549117|466167293|FG001|Overall Study|Withdrawal by Subject|0|||
129513057|NCT00888615|466167295|FG000|Overall Study|No treatment|2|||
129513058|NCT02091921|466167298|FG000|Overall Study|Adverse Event|3|||
129513059|NCT03307629|466167299|FG000|Overall Study|Withdrawal by Subject|0|||
129513060|NCT03307629|466167300|FG001|Overall Study|Withdrawal by Subject|0|||
129513061|NCT03307629|466167301|FG002|Overall Study|Withdrawal by Subject|0|||
129513062|NCT03307629|466167302|FG003|Overall Study|Withdrawal by Subject|2|||
129513063|NCT03307629|466167299|FG000|Overall Study|Disease Progression|0|||
129513064|NCT03307629|466167300|FG001|Overall Study|Disease Progression|0|||
129513065|NCT03307629|466167301|FG002|Overall Study|Disease Progression|0|||
129513066|NCT03307629|466167302|FG003|Overall Study|Disease Progression|3|||
129513067|NCT03307629|466167299|FG000|Overall Study|Death|0|||
129513068|NCT03307629|466167300|FG001|Overall Study|Death|3|||
129513069|NCT03307629|466167301|FG002|Overall Study|Death|0|||
129513070|NCT03307629|466167302|FG003|Overall Study|Death|1|||
129513071|NCT00719953|466167307|FG000|Overall Study|Adverse Event|4|||
129513072|NCT01626989|466167308|FG000|Screening Period|Screen Failure|15|||
129513073|NCT01626989|466167309|FG001|Screening Period|Screen Failure|0|||
129513074|NCT01626989|466167310|FG002|Screening Period|Screen Failure|0|||
129513075|NCT01626989|466167308|FG000|Screening Period|Withdrawal by Subject|2|||
129513076|NCT01626989|466167309|FG001|Screening Period|Withdrawal by Subject|0|||
129513077|NCT01626989|466167310|FG002|Screening Period|Withdrawal by Subject|0|||
129513078|NCT02947022|466167314|FG000|Overall Study|Study Stopped|1|||
129513079|NCT01230749|466167315|FG000|Overall Study|Adverse Event|0|||
129513080|NCT01230749|466167316|FG001|Overall Study|Adverse Event|0|||
129513081|NCT01230749|466167317|FG002|Overall Study|Adverse Event|0|||
129513082|NCT01230749|466167318|FG003|Overall Study|Adverse Event|1|||
129513083|NCT01230749|466167315|FG000|Overall Study|Physician Decision|0|||
129513084|NCT01230749|466167316|FG001|Overall Study|Physician Decision|0|||
129513085|NCT01230749|466167317|FG002|Overall Study|Physician Decision|1|||
129513086|NCT01230749|466167318|FG003|Overall Study|Physician Decision|0|||
129513087|NCT01230749|466167315|FG000|Overall Study|Withdrawal by Subject|0|||
129513088|NCT01230749|466167316|FG001|Overall Study|Withdrawal by Subject|1|||
129513089|NCT01230749|466167317|FG002|Overall Study|Withdrawal by Subject|0|||
129513090|NCT01230749|466167318|FG003|Overall Study|Withdrawal by Subject|0|||
129513091|NCT01230749|466167315|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
129513092|NCT01230749|466167316|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
129513093|NCT01230749|466167317|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
129513094|NCT01230749|466167318|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
129513095|NCT01281189|466169118|FG000|Overall Study|Adverse Event|7|||
129513096|NCT01281189|466169119|FG001|Overall Study|Adverse Event|9|||
129513097|NCT01281189|466169118|FG000|Overall Study|Lost to Follow-up|6|||
129513098|NCT01281189|466169119|FG001|Overall Study|Lost to Follow-up|4|||
129513099|NCT01281189|466169118|FG000|Overall Study|Withdrawal by Subject|21|||
129513100|NCT01281189|466169119|FG001|Overall Study|Withdrawal by Subject|24|||
129513101|NCT01281189|466169118|FG000|Overall Study|Physician Decision|2|||
129513102|NCT01281189|466169119|FG001|Overall Study|Physician Decision|3|||
129513103|NCT01281189|466169118|FG000|Overall Study|Death|103|||
129513104|NCT01281189|466169119|FG001|Overall Study|Death|91|||
129513105|NCT01281189|466169118|FG000|Overall Study|Other|8|||
129513106|NCT01281189|466169119|FG001|Overall Study|Other|12|||
129513107|NCT05355818|466169120|FG000|Overall Study|Adverse Event|1|||
129513108|NCT05355818|466169121|FG001|Overall Study|Adverse Event|1|||
129513109|NCT05355818|466169120|FG000|Overall Study|Lack of Efficacy|2|||
129513110|NCT05355818|466169121|FG001|Overall Study|Lack of Efficacy|1|||
129513111|NCT05355818|466169120|FG000|Overall Study|Lost to Follow-up|0|||
129513112|NCT05355818|466169121|FG001|Overall Study|Lost to Follow-up|1|||
129513113|NCT01136746|466169124|FG000|Overall Study|Lost to Follow-up|0|||
129513114|NCT01136746|466169125|FG001|Overall Study|Lost to Follow-up|2|||
129513115|NCT01136746|466169124|FG000|Overall Study|Protocol Violation|2|||
129513116|NCT01136746|466169125|FG001|Overall Study|Protocol Violation|1|||
129513117|NCT01136746|466169124|FG000|Overall Study|Death|1|||
129513118|NCT01136746|466169125|FG001|Overall Study|Death|0|||
129513119|NCT00092677|466169135|FG000|Overall Study|Lost to Follow-up|0|||
129513120|NCT00092677|466169136|FG001|Overall Study|Lost to Follow-up|2|||
129513121|NCT00092677|466169135|FG000|Overall Study|Adminstrative|5|||
129513122|NCT00092677|466169136|FG001|Overall Study|Adminstrative|9|||
129513123|NCT01090102|466169137|FG000|First 12 Weeks|Withdrawal by Subject|1|||
129513124|NCT01090102|466169138|FG001|First 12 Weeks|Withdrawal by Subject|1|||
129513125|NCT01090102|466169137|FG000|First 12 Weeks|Adverse Event|2|||
129513126|NCT01090102|466169138|FG001|First 12 Weeks|Adverse Event|0|||
129513127|NCT01090102|466169137|FG000|First 12 Weeks|Death|1|||
129513128|NCT01090102|466169138|FG001|First 12 Weeks|Death|1|||
129513129|NCT01090102|466169137|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
129513130|NCT01090102|466169138|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
129513131|NCT01601704|466169139|FG000|Overall Study|Randomized but not dispensed study med|1|||
129513132|NCT01601704|466169140|FG001|Overall Study|Randomized but not dispensed study med|4|||
129513133|NCT03518034|466169141|FG000|Overall Study|Not Treated|5|||
129513134|NCT03518034|466169142|FG001|Overall Study|Not Treated|1|||
129513135|NCT03518034|466169141|FG000|Overall Study|Withdrawal by Subject|309|||
129513136|NCT03518034|466169142|FG001|Overall Study|Withdrawal by Subject|351|||
129513137|NCT03518034|466169141|FG000|Overall Study|Lost to Follow-up|446|||
129513138|NCT03518034|466169142|FG001|Overall Study|Lost to Follow-up|458|||
129513139|NCT03518034|466169141|FG000|Overall Study|Adverse Event|138|||
129513140|NCT03518034|466169142|FG001|Overall Study|Adverse Event|130|||
129513141|NCT03518034|466169141|FG000|Overall Study|Lack of Efficacy|11|||
129513142|NCT03518034|466169142|FG001|Overall Study|Lack of Efficacy|23|||
129513143|NCT03518034|466169141|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
129513144|NCT03518034|466169142|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
129513145|NCT03518034|466169141|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
129513146|NCT03518034|466169142|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
129513147|NCT03518034|466169141|FG000|Overall Study|Other, Not Specified|84|||
129513148|NCT03518034|466169142|FG001|Overall Study|Other, Not Specified|53|||
129513149|NCT03518034|466169141|FG000|Overall Study|Reason Missing|2|||
129513150|NCT03518034|466169142|FG001|Overall Study|Reason Missing|3|||
129513151|NCT00010803|466169148|FG000|Overall Study|Withdrawal by Subject|97|||
129513152|NCT00010803|466169149|FG001|Overall Study|Withdrawal by Subject|98|||
129513153|NCT01019252|466169150|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
129513154|NCT01019252|466169151|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
129513155|NCT01019252|466169150|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
129513156|NCT01019252|466169151|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
129513157|NCT01019252|466169150|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
129513158|NCT01019252|466169151|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
129513159|NCT01019252|466169150|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
129513160|NCT01019252|466169151|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
129513161|NCT02273037|466169152|FG000|Overall Study|Lost to Follow-up|1|||
129513162|NCT02273037|466169153|FG001|Overall Study|Lost to Follow-up|0|||
129513163|NCT02273037|466169152|FG000|Overall Study|Delivered before monitoring initiated|1|||
129513164|NCT02273037|466169153|FG001|Overall Study|Delivered before monitoring initiated|3|||
129513165|NCT02273037|466169152|FG000|Overall Study|Breech delivery|2|||
129513166|NCT02273037|466169153|FG001|Overall Study|Breech delivery|3|||
129513167|NCT02273037|466169152|FG000|Overall Study|Multiple delivery|2|||
129513168|NCT02273037|466169153|FG001|Overall Study|Multiple delivery|2|||
129513169|NCT02273037|466169152|FG000|Overall Study|Other complication|2|||
129513170|NCT02273037|466169153|FG001|Overall Study|Other complication|0|||
129513171|NCT00985738|466169158|FG000|Overall Study|Study closed prematurely|8|||
129513172|NCT00985738|466169159|FG001|Overall Study|Study closed prematurely|8|||
129513173|NCT02227849|466169161|FG000|Overall Study|Adverse Event|4|||
129513174|NCT02227849|466169161|FG000|Overall Study|Physician Decision|1|||
129513175|NCT02227849|466169161|FG000|Overall Study|Withdrawal by Subject|3|||
129513176|NCT01590212|466169164|FG000|Overall Study|Withdrawal by Subject|2|||
129513177|NCT01590212|466169165|FG001|Overall Study|Withdrawal by Subject|2|||
129513178|NCT01590212|466169166|FG002|Overall Study|Withdrawal by Subject|2|||
129513179|NCT01590212|466169164|FG000|Overall Study|Lost to Follow-up|1|||
129513180|NCT01590212|466169165|FG001|Overall Study|Lost to Follow-up|2|||
129513181|NCT01590212|466169166|FG002|Overall Study|Lost to Follow-up|3|||
129513182|NCT04897594|466169170|FG000|Overall Study|Lost to Follow-up|0|||
129513183|NCT04897594|466169171|FG001|Overall Study|Lost to Follow-up|1|||
129513184|NCT04897594|466169172|FG002|Overall Study|Lost to Follow-up|1|||
129513185|NCT04897594|466169170|FG000|Overall Study|Sponsor Decision|0|||
129513186|NCT04897594|466169171|FG001|Overall Study|Sponsor Decision|0|||
129513187|NCT04897594|466169172|FG002|Overall Study|Sponsor Decision|1|||
129513188|NCT04897594|466169170|FG000|Overall Study|Withdrawal by Subject|1|||
129513189|NCT04897594|466169171|FG001|Overall Study|Withdrawal by Subject|0|||
129513190|NCT04897594|466169172|FG002|Overall Study|Withdrawal by Subject|1|||
129513191|NCT00150345|466169175|FG000|Overall Study|Death|5|||
129513192|NCT00150345|466169176|FG001|Overall Study|Death|2|||
129513193|NCT00150345|466169175|FG000|Overall Study|Adverse Event|8|||
129513194|NCT00150345|466169176|FG001|Overall Study|Adverse Event|6|||
129513195|NCT00150345|466169175|FG000|Overall Study|Lack of Efficacy|5|||
129513196|NCT00150345|466169176|FG001|Overall Study|Lack of Efficacy|4|||
129513197|NCT00150345|466169175|FG000|Overall Study|Withdrawal by Subject|3|||
129513198|NCT00150345|466169176|FG001|Overall Study|Withdrawal by Subject|4|||
129513199|NCT00150345|466169175|FG000|Overall Study|Laboratory abnormality|1|||
129513200|NCT00150345|466169176|FG001|Overall Study|Laboratory abnormality|2|||
129513201|NCT00150345|466169175|FG000|Overall Study|Other|12|||
129513202|NCT00150345|466169176|FG001|Overall Study|Other|14|||
129513203|NCT01457924|466169179|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
129513204|NCT01457924|466169180|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
129513205|NCT01457924|466169181|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
129513206|NCT01457924|466169182|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
129513207|NCT01457924|466169183|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
129513208|NCT01457924|466169179|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
129513209|NCT01457924|466169180|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
129513210|NCT01457924|466169181|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
129513211|NCT01457924|466169182|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
129513212|NCT01457924|466169183|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
129513213|NCT01457924|466169179|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
129513214|NCT01457924|466169180|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
129513215|NCT01457924|466169181|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
129513216|NCT01457924|466169182|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
129513217|NCT01457924|466169183|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
129513218|NCT01457924|466169179|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
129513219|NCT01457924|466169180|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
129513220|NCT01457924|466169181|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
129513221|NCT01457924|466169182|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
129513222|NCT01457924|466169183|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
129513223|NCT01457924|466169179|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
129513224|NCT01457924|466169180|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
129513225|NCT01457924|466169181|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
129513226|NCT01457924|466169182|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
129513227|NCT01457924|466169183|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
129513228|NCT01457924|466169179|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
129983221|NCT00506441|467900691|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
129983222|NCT00506441|467900692|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
129983223|NCT00506441|467900691|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
129983224|NCT00506441|467900692|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
129983225|NCT00506441|467900691|FG000|Period 1; Open-label Period|Physician Decision|5|||
129983226|NCT00506441|467900692|FG001|Period 1; Open-label Period|Physician Decision|0|||
129983227|NCT00506441|467900691|FG000|Period 1; Open-label Period|Protocol Violation|9|||
129983228|NCT00506441|467900692|FG001|Period 1; Open-label Period|Protocol Violation|0|||
129983229|NCT00506441|467900691|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
129983230|NCT00506441|467900692|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
129983231|NCT00506441|467900691|FG000|Period 1; Open-label Period|Other Reasons|13|||
129983232|NCT00506441|467900692|FG001|Period 1; Open-label Period|Other Reasons|0|||
129983233|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Adverse Event|0|||
129983234|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Adverse Event|1|||
129983235|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
129983236|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
129983237|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Physician Decision|1|||
129983238|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Physician Decision|1|||
129983239|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
129983240|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
129983241|NCT00506441|467900691|FG000|Period 2; Double-blind Period|Other Reason|1|||
129513229|NCT01457924|466169180|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
129513230|NCT01457924|466169181|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
129513231|NCT01457924|466169182|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
129513232|NCT01457924|466169183|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
129513233|NCT01457924|466169179|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
129513234|NCT01457924|466169180|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
129513235|NCT01457924|466169181|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
129513236|NCT01457924|466169182|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
129513237|NCT01457924|466169183|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
129513238|NCT01457924|466169179|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
129513239|NCT01457924|466169180|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
129513240|NCT01457924|466169181|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
129513241|NCT01457924|466169182|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
129513242|NCT01457924|466169183|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
129513243|NCT01457924|466169179|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
129513244|NCT01457924|466169180|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
129513245|NCT01457924|466169181|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
129513246|NCT01457924|466169182|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
129513247|NCT01457924|466169183|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
129513248|NCT01457924|466169179|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
129513249|NCT01457924|466169180|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
129513250|NCT01457924|466169181|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
129513251|NCT01457924|466169182|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
129513252|NCT01457924|466169183|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
129513253|NCT01457924|466169179|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
129513254|NCT01457924|466169180|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
129513255|NCT01457924|466169181|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
129513256|NCT01457924|466169182|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
129513257|NCT01457924|466169183|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
129513258|NCT01457924|466169179|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
129513259|NCT01457924|466169180|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
129513260|NCT01457924|466169181|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
129513261|NCT01457924|466169182|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
129513262|NCT01457924|466169183|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
129513263|NCT01457924|466169179|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
129513264|NCT01457924|466169180|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
129513265|NCT01457924|466169181|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
129513266|NCT01457924|466169182|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
129513267|NCT01457924|466169183|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
129513268|NCT00636441|466169189|FG000|Overall Study|Adverse Event|0|||
129513269|NCT00636441|466169190|FG001|Overall Study|Adverse Event|1|||
129513270|NCT00636441|466169191|FG002|Overall Study|Adverse Event|1|||
129513271|NCT00636441|466169192|FG003|Overall Study|Adverse Event|0|||
129513272|NCT00636441|466169193|FG004|Overall Study|Adverse Event|0|||
129513273|NCT00636441|466169194|FG005|Overall Study|Adverse Event|1|||
129513274|NCT00636441|466169195|FG006|Overall Study|Adverse Event|0|||
129513275|NCT00636441|466169189|FG000|Overall Study|Late, ineligible|0|||
129513276|NCT00636441|466169190|FG001|Overall Study|Late, ineligible|0|||
129513277|NCT00636441|466169191|FG002|Overall Study|Late, ineligible|0|||
129513278|NCT00636441|466169192|FG003|Overall Study|Late, ineligible|0|||
129983242|NCT00506441|467900692|FG001|Period 2; Double-blind Period|Other Reason|1|||
129513279|NCT00636441|466169193|FG004|Overall Study|Late, ineligible|0|||
129513280|NCT00636441|466169194|FG005|Overall Study|Late, ineligible|0|||
129513281|NCT00636441|466169195|FG006|Overall Study|Late, ineligible|1|||
129513282|NCT00636441|466169189|FG000|Overall Study|Screen Failure|0|||
129513283|NCT00636441|466169190|FG001|Overall Study|Screen Failure|0|||
129983243|NCT02601300|467900693|FG000|Induction Phase|Lack of Efficacy|2|||
129983244|NCT02601300|467900693|FG000|Induction Phase|Protocol Violation|1|||
129983245|NCT02601300|467900693|FG000|Extension Phase|Withdrawal by Subject|3|||
129983246|NCT02601300|467900693|FG000|Extension Phase|Adverse Event|4|||
129983247|NCT02601300|467900693|FG000|Extension Phase|Lack of Efficacy|10|||
129983248|NCT01127763|467900697|FG000|Overall Study|Adverse Event|2|||
129983249|NCT01127763|467900697|FG000|Overall Study|Withdrawal by Subject|1|||
129983250|NCT01127763|467900697|FG000|Overall Study|Physician Decision|2|||
129983251|NCT00528931|467900698|FG000|Overall Study|Lost to Follow-up|1|||
129983252|NCT00291642|467900701|FG000|Overall Study|Adverse Event|1|||
129983253|NCT00291642|467900702|FG001|Overall Study|Adverse Event|0|||
129983254|NCT00291642|467900703|FG002|Overall Study|Adverse Event|1|||
129983255|NCT00291642|467900704|FG003|Overall Study|Adverse Event|0|||
129983256|NCT00291642|467900705|FG004|Overall Study|Adverse Event|1|||
129983257|NCT00291642|467900701|FG000|Overall Study|Patient missed visit|0|||
129983258|NCT00291642|467900702|FG001|Overall Study|Patient missed visit|0|||
129983259|NCT00291642|467900703|FG002|Overall Study|Patient missed visit|1|||
129983260|NCT00291642|467900704|FG003|Overall Study|Patient missed visit|0|||
129983261|NCT00291642|467900705|FG004|Overall Study|Patient missed visit|0|||
129983262|NCT00291642|467900701|FG000|Overall Study|Intake of prohibited medication|1|||
129983263|NCT00291642|467900702|FG001|Overall Study|Intake of prohibited medication|0|||
129513284|NCT00636441|466169191|FG002|Overall Study|Screen Failure|0|||
129513285|NCT00636441|466169192|FG003|Overall Study|Screen Failure|0|||
129513286|NCT00636441|466169193|FG004|Overall Study|Screen Failure|0|||
129513287|NCT00636441|466169194|FG005|Overall Study|Screen Failure|0|||
129513288|NCT00636441|466169195|FG006|Overall Study|Screen Failure|17|||
129513289|NCT03495817|466169196|FG000|26 Week Open Label|Adverse Event|3|||
129513290|NCT03495817|466169196|FG000|26 Week Open Label|Withdrawal by Subject|4|||
129513291|NCT03495817|466169196|FG000|26 Week Open Label|Lost to Follow-up|1|||
129513292|NCT03495817|466169196|FG000|26 Week Extension|Lost to Follow-up|2|||
129513293|NCT04585451|466169201|FG000|Overall Study|Withdrawal by Subject|26|||
129513294|NCT04585451|466169202|FG001|Overall Study|Withdrawal by Subject|0|||
129513295|NCT00326417|466169203|FG000|Overall Study|Withdrawal by Subject|0|||
129513296|NCT00326417|466169204|FG001|Overall Study|Withdrawal by Subject|0|||
129513297|NCT00326417|466169205|FG002|Overall Study|Withdrawal by Subject|1|||
129513298|NCT00326417|466169206|FG003|Overall Study|Withdrawal by Subject|0|||
129513299|NCT00326417|466169203|FG000|Overall Study|Arm Closed|7|||
129983264|NCT00291642|467900703|FG002|Overall Study|Intake of prohibited medication|0|||
129983265|NCT00291642|467900704|FG003|Overall Study|Intake of prohibited medication|0|||
129983266|NCT00291642|467900705|FG004|Overall Study|Intake of prohibited medication|0|||
129983267|NCT02576587|467900710|FG000|Baseline|Equipment failure|0|||
129983268|NCT02576587|467900711|FG001|Baseline|Equipment failure|1|||
129983269|NCT02576587|467900710|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
129983270|NCT02576587|467900711|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
129983271|NCT02576587|467900710|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
129983272|NCT02576587|467900711|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
129983273|NCT02576587|467900710|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
129983274|NCT02576587|467900711|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
129983275|NCT00532493|467900712|FG000|Overall Study|Death|1|||
129983276|NCT00532493|467900713|FG001|Overall Study|Death|1|||
129983277|NCT00532493|467900712|FG000|Overall Study|Lost to Follow-up|10|||
129983278|NCT00532493|467900713|FG001|Overall Study|Lost to Follow-up|7|||
129983279|NCT00532493|467900712|FG000|Overall Study|Withdrawal by Subject|7|||
129983280|NCT00532493|467900713|FG001|Overall Study|Withdrawal by Subject|9|||
129983281|NCT00532493|467900712|FG000|Overall Study|Physician Decision|1|||
129983282|NCT00532493|467900713|FG001|Overall Study|Physician Decision|6|||
129983283|NCT00532493|467900712|FG000|Overall Study|Adverse Event|6|||
129983284|NCT00532493|467900713|FG001|Overall Study|Adverse Event|5|||
129983285|NCT00532493|467900712|FG000|Overall Study|Protocol Deviation|1|||
129983286|NCT00532493|467900713|FG001|Overall Study|Protocol Deviation|0|||
129983287|NCT00532493|467900712|FG000|Overall Study|Subject Moved Away|3|||
129983288|NCT00532493|467900713|FG001|Overall Study|Subject Moved Away|1|||
129983289|NCT00532493|467900712|FG000|Overall Study|Contraindicative Medication|1|||
129513300|NCT00326417|466169204|FG001|Overall Study|Arm Closed|0|||
129983290|NCT00532493|467900713|FG001|Overall Study|Contraindicative Medication|0|||
129983291|NCT00513305|467900714|FG000|Overall Study|Adverse Event|6|||
129983292|NCT00513305|467900715|FG001|Overall Study|Adverse Event|2|||
129983293|NCT00513305|467900714|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
129983294|NCT00513305|467900715|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
129983295|NCT00513305|467900714|FG000|Overall Study|Lack of Efficacy|8|||
129983296|NCT00513305|467900715|FG001|Overall Study|Lack of Efficacy|13|||
129983297|NCT00513305|467900714|FG000|Overall Study|Withdrawal by Subject|1|||
129983298|NCT00513305|467900715|FG001|Overall Study|Withdrawal by Subject|2|||
129983299|NCT00513305|467900714|FG000|Overall Study|Disease progression|8|||
129983300|NCT00513305|467900715|FG001|Overall Study|Disease progression|5|||
129983301|NCT00513305|467900714|FG000|Overall Study|Eligible for stem cell transplant|1|||
129983302|NCT00513305|467900715|FG001|Overall Study|Eligible for stem cell transplant|0|||
129983303|NCT00513305|467900714|FG000|Overall Study|Hematologic counts did not recover|1|||
129983304|NCT00513305|467900715|FG001|Overall Study|Hematologic counts did not recover|0|||
129983305|NCT00513305|467900714|FG000|Overall Study|Physician Decision|1|||
129983306|NCT00513305|467900715|FG001|Overall Study|Physician Decision|0|||
129983307|NCT00513305|467900714|FG000|Overall Study|Persistent hypocellularity|0|||
129983308|NCT00513305|467900715|FG001|Overall Study|Persistent hypocellularity|1|||
129983309|NCT00513305|467900714|FG000|Overall Study|Sponsor Decision|0|||
129983310|NCT00513305|467900715|FG001|Overall Study|Sponsor Decision|2|||
129983311|NCT02489968|467900722|FG000|Open-label Treatment Period|Adverse Event|14|||
129983312|NCT02489968|467900723|FG001|Open-label Treatment Period|Adverse Event|7|||
129983313|NCT02489968|467900724|FG002|Open-label Treatment Period|Adverse Event|0|||
129983314|NCT02489968|467900725|FG003|Open-label Treatment Period|Adverse Event|0|||
129983315|NCT02489968|467900726|FG004|Open-label Treatment Period|Adverse Event|0|||
129983316|NCT02489968|467900727|FG005|Open-label Treatment Period|Adverse Event|0|||
129983317|NCT02489968|467900722|FG000|Open-label Treatment Period|Protocol Violation|2|||
129983318|NCT02489968|467900723|FG001|Open-label Treatment Period|Protocol Violation|2|||
129983319|NCT02489968|467900724|FG002|Open-label Treatment Period|Protocol Violation|0|||
129983320|NCT02489968|467900725|FG003|Open-label Treatment Period|Protocol Violation|0|||
129983321|NCT02489968|467900726|FG004|Open-label Treatment Period|Protocol Violation|0|||
129983322|NCT02489968|467900727|FG005|Open-label Treatment Period|Protocol Violation|0|||
129983323|NCT02489968|467900722|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
129983324|NCT02489968|467900723|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
129983325|NCT02489968|467900724|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
129983326|NCT02489968|467900725|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
129983327|NCT02489968|467900726|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
129983328|NCT02489968|467900727|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
129983329|NCT02489968|467900722|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
129983330|NCT02489968|467900723|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
129983331|NCT02489968|467900724|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
129983332|NCT02489968|467900725|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
129983333|NCT02489968|467900726|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
129983334|NCT02489968|467900727|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
129983335|NCT02489968|467900722|FG000|Open-label Treatment Period|Other than specified above|204|||
129983336|NCT02489968|467900723|FG001|Open-label Treatment Period|Other than specified above|189|||
129983337|NCT02489968|467900724|FG002|Open-label Treatment Period|Other than specified above|0|||
129983338|NCT02489968|467900725|FG003|Open-label Treatment Period|Other than specified above|0|||
129983339|NCT02489968|467900726|FG004|Open-label Treatment Period|Other than specified above|0|||
129983340|NCT02489968|467900727|FG005|Open-label Treatment Period|Other than specified above|0|||
129983341|NCT02489968|467900722|FG000|Double-blind Treatment Period|Adverse Event|0|||
129983342|NCT02489968|467900723|FG001|Double-blind Treatment Period|Adverse Event|0|||
129983343|NCT02489968|467900724|FG002|Double-blind Treatment Period|Adverse Event|2|||
129983344|NCT02489968|467900725|FG003|Double-blind Treatment Period|Adverse Event|6|||
129983345|NCT02489968|467900726|FG004|Double-blind Treatment Period|Adverse Event|4|||
129983346|NCT02489968|467900727|FG005|Double-blind Treatment Period|Adverse Event|5|||
129983347|NCT02489968|467900722|FG000|Double-blind Treatment Period|Protocol Violation|0|||
129983348|NCT02489968|467900723|FG001|Double-blind Treatment Period|Protocol Violation|0|||
129983349|NCT02489968|467900724|FG002|Double-blind Treatment Period|Protocol Violation|0|||
129983350|NCT02489968|467900725|FG003|Double-blind Treatment Period|Protocol Violation|0|||
129983351|NCT02489968|467900726|FG004|Double-blind Treatment Period|Protocol Violation|1|||
129983352|NCT02489968|467900727|FG005|Double-blind Treatment Period|Protocol Violation|1|||
129983353|NCT02489968|467900722|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983354|NCT02489968|467900723|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983355|NCT02489968|467900724|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983356|NCT02489968|467900725|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
129983357|NCT02489968|467900726|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
129983358|NCT02489968|467900727|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
129983359|NCT02489968|467900722|FG000|Double-blind Treatment Period|Other than specified above|0|||
129983360|NCT02489968|467900723|FG001|Double-blind Treatment Period|Other than specified above|0|||
129983361|NCT02489968|467900724|FG002|Double-blind Treatment Period|Other than specified above|0|||
129983362|NCT02489968|467900725|FG003|Double-blind Treatment Period|Other than specified above|0|||
129983363|NCT02489968|467900726|FG004|Double-blind Treatment Period|Other than specified above|1|||
129983364|NCT02489968|467900727|FG005|Double-blind Treatment Period|Other than specified above|0|||
129983365|NCT00607724|467900728|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
129983366|NCT00607724|467900729|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
129983367|NCT00607724|467900730|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
129513301|NCT00326417|466169205|FG002|Overall Study|Arm Closed|0|||
129513302|NCT00326417|466169206|FG003|Overall Study|Arm Closed|3|||
129513303|NCT00326417|466169203|FG000|Overall Study|Death|7|||
129513304|NCT00326417|466169204|FG001|Overall Study|Death|0|||
129513305|NCT00326417|466169205|FG002|Overall Study|Death|0|||
129513306|NCT00326417|466169206|FG003|Overall Study|Death|0|||
129513307|NCT00844285|466169207|FG000|Overall Study|Other|0|||
129513308|NCT00844285|466169208|FG001|Overall Study|Other|1|||
129513309|NCT00844285|466169209|FG002|Overall Study|Other|0|||
129513310|NCT00844285|466169207|FG000|Overall Study|Other than specified|95|||
129513311|NCT00844285|466169208|FG001|Overall Study|Other than specified|129|||
129513312|NCT00844285|466169209|FG002|Overall Study|Other than specified|12|||
129513313|NCT00844285|466169207|FG000|Overall Study|Site closure|256|||
129513314|NCT00844285|466169208|FG001|Overall Study|Site closure|450|||
129513315|NCT00844285|466169209|FG002|Overall Study|Site closure|50|||
129513316|NCT00844285|466169207|FG000|Overall Study|Follow-up < 8 years|16|||
129513317|NCT00844285|466169208|FG001|Overall Study|Follow-up < 8 years|23|||
129513318|NCT00844285|466169209|FG002|Overall Study|Follow-up < 8 years|4|||
129513319|NCT00844285|466169207|FG000|Overall Study|Protocol Violation|26|||
129513320|NCT00844285|466169208|FG001|Overall Study|Protocol Violation|28|||
129513321|NCT00844285|466169209|FG002|Overall Study|Protocol Violation|54|||
129513322|NCT00844285|466169207|FG000|Overall Study|Death|22|||
129513323|NCT00844285|466169208|FG001|Overall Study|Death|21|||
129513324|NCT00844285|466169209|FG002|Overall Study|Death|8|||
129513325|NCT00844285|466169207|FG000|Overall Study|Withdrew Consent|344|||
129513326|NCT00844285|466169208|FG001|Overall Study|Withdrew Consent|466|||
129513327|NCT00844285|466169209|FG002|Overall Study|Withdrew Consent|70|||
129513328|NCT00844285|466169207|FG000|Overall Study|Lost to Follow-up|330|||
129513329|NCT00844285|466169208|FG001|Overall Study|Lost to Follow-up|486|||
129513330|NCT00844285|466169209|FG002|Overall Study|Lost to Follow-up|74|||
129513331|NCT03219567|466169212|FG000|Overall Study|Withdrawal by Subject|0|||
129513332|NCT03219567|466169213|FG001|Overall Study|Withdrawal by Subject|1|||
129513333|NCT02849626|466169214|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
129513334|NCT02849626|466169215|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
129513335|NCT02849626|466169216|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
129513336|NCT02849626|466169217|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
129513337|NCT02849626|466169214|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
129513338|NCT02849626|466169215|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
129513339|NCT02849626|466169216|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
129513340|NCT02849626|466169217|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
129513341|NCT02849626|466169214|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
129513342|NCT02849626|466169215|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
129513343|NCT02849626|466169216|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
129513344|NCT02849626|466169217|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
129513345|NCT02849626|466169214|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
129513346|NCT02849626|466169215|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
129513347|NCT02849626|466169216|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
129513348|NCT02849626|466169217|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
129513349|NCT02849626|466169214|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
129513350|NCT02849626|466169215|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
129513351|NCT02849626|466169216|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
129513352|NCT02849626|466169217|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
129513353|NCT02849626|466169214|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
129513354|NCT02849626|466169215|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
129513355|NCT02849626|466169216|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
129513356|NCT02849626|466169217|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
129513357|NCT02849626|466169214|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
129513358|NCT02849626|466169215|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
129513359|NCT02849626|466169216|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
129513360|NCT02849626|466169217|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
129513361|NCT02849626|466169214|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
129513362|NCT02849626|466169215|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
129513363|NCT02849626|466169216|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
129513364|NCT02849626|466169217|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
129513365|NCT02849626|466169214|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
129513366|NCT02849626|466169215|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
129513367|NCT02849626|466169216|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
129513368|NCT02849626|466169217|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
129513369|NCT02849626|466169214|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
129513370|NCT02849626|466169215|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
129513371|NCT02849626|466169216|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
129513372|NCT02849626|466169217|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
129513373|NCT02849626|466169214|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
129513374|NCT02849626|466169215|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
129513375|NCT02849626|466169216|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
129513376|NCT02849626|466169217|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
129513377|NCT01313208|466169218|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
129513378|NCT01313208|466169219|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
129513379|NCT01313208|466169218|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
129513380|NCT01313208|466169219|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
129513381|NCT01313208|466169218|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
129513382|NCT01313208|466169219|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
129513383|NCT01313208|466169218|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
129513384|NCT01313208|466169219|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
129513385|NCT01313208|466169218|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
129513386|NCT01313208|466169219|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
129513387|NCT01313208|466169218|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
129513388|NCT01313208|466169219|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
129513389|NCT01313208|466169218|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
129513390|NCT01313208|466169219|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
129513391|NCT01313208|466169218|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
129513392|NCT01313208|466169219|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
129513393|NCT01313208|466169218|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
129513394|NCT01313208|466169219|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
129513395|NCT01654523|466169220|FG000|Overall Study|Withdrawal by Subject|1|||
129513396|NCT01957787|466169221|FG000|Overall Study|Death|18|||
129513397|NCT01957787|466169221|FG000|Overall Study|Lost to Follow-up|3|||
129513398|NCT01957787|466169221|FG000|Overall Study|Withdrawal by Subject|3|||
129513399|NCT01957787|466169221|FG000|Overall Study|Entered Hospice or Similar Program|2|||
129513400|NCT01957787|466169221|FG000|Overall Study|Index Tumor(s) Resected|2|||
129513401|NCT01957787|466169221|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
129513402|NCT01957787|466169221|FG000|Overall Study|Local therapy, not cryoablation|6|||
129513403|NCT04176445|466169222|FG000|Overall Study|Adverse Event|0|||
129513404|NCT04176445|466169223|FG001|Overall Study|Adverse Event|1|||
129513405|NCT04176445|466169222|FG000|Overall Study|change plans weaning after first intervention|0|||
129513406|NCT04176445|466169223|FG001|Overall Study|change plans weaning after first intervention|1|||
129513407|NCT00405652|466169224|FG000|Overall Study|Adverse Event|4|||
129513408|NCT00435994|466169226|FG000|Overall Study|Lost to Follow-up|7|||
129513409|NCT00435994|466169227|FG001|Overall Study|Lost to Follow-up|0|||
129513410|NCT00435994|466169228|FG002|Overall Study|Lost to Follow-up|0|||
129513411|NCT03846219|466169232|FG000|Overall Study|Withdrawal by Subject|3|||
129513412|NCT03846219|466169233|FG001|Overall Study|Withdrawal by Subject|2|||
129513413|NCT03846219|466169234|FG002|Overall Study|Withdrawal by Subject|2|||
129513414|NCT03846219|466169232|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
129513415|NCT03846219|466169233|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
129513416|NCT03846219|466169234|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
129513417|NCT03846219|466169232|FG000|Overall Study|Physician Decision|0|||
129513418|NCT03846219|466169233|FG001|Overall Study|Physician Decision|0|||
129513419|NCT03846219|466169234|FG002|Overall Study|Physician Decision|2|||
129513420|NCT05109702|466169235|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
129513421|NCT05109702|466169236|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
129513422|NCT05109702|466169237|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
129513423|NCT05109702|466169235|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
129513424|NCT05109702|466169236|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
129513425|NCT05109702|466169237|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
129513426|NCT05109702|466169235|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
129513427|NCT05109702|466169236|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
129513428|NCT05109702|466169237|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
129513429|NCT05109702|466169235|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
129513430|NCT05109702|466169236|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
129513431|NCT05109702|466169237|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
129513432|NCT05109702|466169235|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
129513433|NCT05109702|466169236|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
129513434|NCT05109702|466169237|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
129513435|NCT01392378|466169242|FG000|Infant Series|Adverse Event|0|||
129513436|NCT01392378|466169243|FG001|Infant Series|Adverse Event|0|||
129513437|NCT01392378|466169244|FG002|Infant Series|Adverse Event|0|||
129513438|NCT01392378|466169245|FG003|Infant Series|Adverse Event|1|||
129513439|NCT01392378|466169246|FG004|Infant Series|Adverse Event|0|||
129513440|NCT01392378|466169242|FG000|Infant Series|Lost to Follow-up|0|||
129513441|NCT01392378|466169243|FG001|Infant Series|Lost to Follow-up|0|||
129513442|NCT01392378|466169244|FG002|Infant Series|Lost to Follow-up|0|||
129513443|NCT01392378|466169245|FG003|Infant Series|Lost to Follow-up|1|||
129513444|NCT01392378|466169246|FG004|Infant Series|Lost to Follow-up|0|||
129513445|NCT01392378|466169242|FG000|Infant Series|Protocol Violation|0|||
129513446|NCT01392378|466169243|FG001|Infant Series|Protocol Violation|1|||
129983368|NCT00607724|467900731|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129513447|NCT01392378|466169244|FG002|Infant Series|Protocol Violation|0|||
129513448|NCT01392378|466169245|FG003|Infant Series|Protocol Violation|0|||
129513449|NCT01392378|466169246|FG004|Infant Series|Protocol Violation|0|||
129513450|NCT01392378|466169242|FG000|Infant Series|Withdrawal by Parent|4|||
129513451|NCT01392378|466169243|FG001|Infant Series|Withdrawal by Parent|1|||
129513452|NCT01392378|466169244|FG002|Infant Series|Withdrawal by Parent|0|||
129513453|NCT01392378|466169245|FG003|Infant Series|Withdrawal by Parent|0|||
129513454|NCT01392378|466169246|FG004|Infant Series|Withdrawal by Parent|0|||
129513455|NCT01392378|466169242|FG000|After Infant Series|Lost to Follow-up|0|||
129513456|NCT01392378|466169243|FG001|After Infant Series|Lost to Follow-up|0|||
129513457|NCT01392378|466169244|FG002|After Infant Series|Lost to Follow-up|1|||
129513458|NCT01392378|466169245|FG003|After Infant Series|Lost to Follow-up|0|||
129513459|NCT01392378|466169246|FG004|After Infant Series|Lost to Follow-up|0|||
129513460|NCT01392378|466169242|FG000|After Infant Series|Withdrawal by Parent|0|||
129513461|NCT01392378|466169243|FG001|After Infant Series|Withdrawal by Parent|1|||
129513462|NCT01392378|466169244|FG002|After Infant Series|Withdrawal by Parent|1|||
129513463|NCT01392378|466169245|FG003|After Infant Series|Withdrawal by Parent|0|||
129513464|NCT01392378|466169246|FG004|After Infant Series|Withdrawal by Parent|1|||
129513465|NCT01392378|466169242|FG000|Toddler Dose|Lost to Follow-up|0|||
129513466|NCT01392378|466169243|FG001|Toddler Dose|Lost to Follow-up|0|||
129513467|NCT01392378|466169244|FG002|Toddler Dose|Lost to Follow-up|0|||
129513468|NCT01392378|466169245|FG003|Toddler Dose|Lost to Follow-up|1|||
129513469|NCT01392378|466169246|FG004|Toddler Dose|Lost to Follow-up|0|||
129513470|NCT01392378|466169242|FG000|Toddler Dose|Withdrawal by Parent|0|||
129513471|NCT01392378|466169243|FG001|Toddler Dose|Withdrawal by Parent|1|||
129513472|NCT01392378|466169244|FG002|Toddler Dose|Withdrawal by Parent|0|||
129513473|NCT01392378|466169245|FG003|Toddler Dose|Withdrawal by Parent|1|||
129513474|NCT01392378|466169246|FG004|Toddler Dose|Withdrawal by Parent|1|||
129513475|NCT02322411|466169251|FG000|Overall Study|Lost to Follow-up|4|||
129513476|NCT02322411|466169252|FG001|Overall Study|Lost to Follow-up|7|||
129513477|NCT02322411|466169251|FG000|Overall Study|Withdrawal by Subject|1|||
129513478|NCT02322411|466169252|FG001|Overall Study|Withdrawal by Subject|0|||
129513479|NCT02713789|466169254|FG000|Overall Study|Lost to Follow-up|0|||
129513480|NCT02713789|466169255|FG001|Overall Study|Lost to Follow-up|1|||
129513481|NCT02713789|466169256|FG002|Overall Study|Lost to Follow-up|1|||
129513482|NCT00903370|466169257|FG000|Overall Study|Death|13|||
129513483|NCT00903370|466169258|FG001|Overall Study|Death|10|||
129513484|NCT00903370|466169257|FG000|Overall Study|Withdrawal by Subject|9|||
129513485|NCT00903370|466169258|FG001|Overall Study|Withdrawal by Subject|6|||
129513486|NCT00903370|466169257|FG000|Overall Study|Lost to Follow-up|6|||
129513487|NCT00903370|466169258|FG001|Overall Study|Lost to Follow-up|8|||
129513488|NCT00367432|466169259|FG000|First Period (16 Weeks)|Adverse Event|6|||
129513489|NCT00367432|466169260|FG001|First Period (16 Weeks)|Adverse Event|0|||
129513490|NCT00367432|466169259|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
129513491|NCT00367432|466169260|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
129513492|NCT00367432|466169259|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
129513493|NCT00367432|466169260|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
129513494|NCT00367432|466169259|FG000|First Period (16 Weeks)|Other Reason|2|||
129513495|NCT00367432|466169260|FG001|First Period (16 Weeks)|Other Reason|0|||
129513496|NCT00367432|466169259|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
129513497|NCT00367432|466169260|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
129513498|NCT00367432|466169259|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
129513499|NCT00367432|466169260|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
129513500|NCT00367432|466169259|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
129513501|NCT00367432|466169260|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
129513502|NCT00367432|466169259|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
129513503|NCT00367432|466169260|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
129513504|NCT00367432|466169259|FG000|Second Period (up to 54 Months)|Other Reason|6|||
129513505|NCT00367432|466169260|FG001|Second Period (up to 54 Months)|Other Reason|2|||
129513506|NCT00014911|466169261|FG000|Overall Study|Adverse Event|1|||
129513507|NCT00014911|466169261|FG000|Overall Study|Lost to Follow-up|1|||
129513508|NCT00014911|466169261|FG000|Overall Study|Withdrawal by Subject|6|||
129513509|NCT00014911|466169261|FG000|Overall Study|Unknown Reasons|2|||
129513510|NCT00014911|466169261|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
129513511|NCT01924299|466169262|FG000|Period 2|Withdrawal by Subject|1|||
129513512|NCT01924299|466169263|FG001|Period 2|Withdrawal by Subject|0|||
129513513|NCT01924299|466169262|FG000|Period 2|Adverse Event|0|||
129513514|NCT01924299|466169263|FG001|Period 2|Adverse Event|1|||
129513515|NCT04199793|466169264|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
129513516|NCT04199793|466169265|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
129513517|NCT04199793|466169264|FG000|Overall Study|Withdrawal by Subject|1|||
129513518|NCT04199793|466169265|FG001|Overall Study|Withdrawal by Subject|1|||
129513519|NCT04179786|466169269|FG000|Overall Study|Withdrawal by Subject|8|||
129513520|NCT03310580|466169270|FG000|Overall Study|Adverse Event|0|||
129513521|NCT03310580|466169271|FG001|Overall Study|Adverse Event|1|||
129513522|NCT03310580|466169272|FG002|Overall Study|Adverse Event|0|||
129513523|NCT01999946|466169279|FG000|Overall Study|Participant not released from jail|2|||
129513524|NCT01999946|466169280|FG001|Overall Study|Participant not released from jail|2|||
129513525|NCT01999946|466169281|FG002|Overall Study|Participant not released from jail|0|||
129513526|NCT01999946|466169279|FG000|Overall Study|Not included in primary outcome analysis|0|||
129513527|NCT01999946|466169280|FG001|Overall Study|Not included in primary outcome analysis|0|||
129513528|NCT01999946|466169281|FG002|Overall Study|Not included in primary outcome analysis|79|||
129513529|NCT00355134|466170820|FG000|Core Phase|Withdrawal by Subject|35|||
129513530|NCT00355134|466170821|FG001|Core Phase|Withdrawal by Subject|24|||
129513531|NCT00355134|466170822|FG002|Core Phase|Withdrawal by Subject|35|||
129513532|NCT00355134|466170823|FG003|Core Phase|Withdrawal by Subject|0|||
129513533|NCT00355134|466170824|FG004|Core Phase|Withdrawal by Subject|0|||
129513534|NCT00355134|466170820|FG000|Core Phase|Adverse Event|28|||
129513535|NCT00355134|466170821|FG001|Core Phase|Adverse Event|22|||
129513536|NCT00355134|466170822|FG002|Core Phase|Adverse Event|16|||
129513537|NCT00355134|466170823|FG003|Core Phase|Adverse Event|0|||
129513538|NCT00355134|466170824|FG004|Core Phase|Adverse Event|0|||
129513539|NCT00355134|466170820|FG000|Core Phase|Lost to Follow-up|17|||
129513540|NCT00355134|466170821|FG001|Core Phase|Lost to Follow-up|13|||
129513541|NCT00355134|466170822|FG002|Core Phase|Lost to Follow-up|21|||
129513542|NCT00355134|466170823|FG003|Core Phase|Lost to Follow-up|0|||
129513543|NCT00355134|466170824|FG004|Core Phase|Lost to Follow-up|0|||
129513544|NCT00355134|466170820|FG000|Core Phase|Abnormal laboratory value(s)|19|||
129513545|NCT00355134|466170821|FG001|Core Phase|Abnormal laboratory value(s)|14|||
129513546|NCT00355134|466170822|FG002|Core Phase|Abnormal laboratory value(s)|2|||
129513547|NCT00355134|466170823|FG003|Core Phase|Abnormal laboratory value(s)|0|||
129513548|NCT00355134|466170824|FG004|Core Phase|Abnormal laboratory value(s)|0|||
129513549|NCT00355134|466170820|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
129513550|NCT00355134|466170821|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
129513551|NCT00355134|466170822|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
129513552|NCT00355134|466170823|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
129513553|NCT00355134|466170824|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
129513554|NCT00355134|466170820|FG000|Core Phase|Administrative problems|5|||
129513555|NCT00355134|466170821|FG001|Core Phase|Administrative problems|3|||
129513556|NCT00355134|466170822|FG002|Core Phase|Administrative problems|5|||
129513557|NCT00355134|466170823|FG003|Core Phase|Administrative problems|0|||
129513558|NCT00355134|466170824|FG004|Core Phase|Administrative problems|0|||
129513559|NCT00355134|466170820|FG000|Core Phase|Protocol Violation|3|||
129513560|NCT00355134|466170821|FG001|Core Phase|Protocol Violation|2|||
129513561|NCT00355134|466170822|FG002|Core Phase|Protocol Violation|2|||
129513562|NCT00355134|466170823|FG003|Core Phase|Protocol Violation|0|||
129513563|NCT00355134|466170824|FG004|Core Phase|Protocol Violation|0|||
129513564|NCT00355134|466170820|FG000|Core Phase|Abnormal test procedure result(s)|1|||
129513565|NCT00355134|466170821|FG001|Core Phase|Abnormal test procedure result(s)|2|||
129513566|NCT00355134|466170822|FG002|Core Phase|Abnormal test procedure result(s)|1|||
129513567|NCT00355134|466170823|FG003|Core Phase|Abnormal test procedure result(s)|0|||
129513568|NCT00355134|466170824|FG004|Core Phase|Abnormal test procedure result(s)|0|||
129513569|NCT00355134|466170820|FG000|Core Phase|Condition no longer requires study drug|1|||
129513570|NCT00355134|466170821|FG001|Core Phase|Condition no longer requires study drug|0|||
129513571|NCT00355134|466170822|FG002|Core Phase|Condition no longer requires study drug|1|||
129513572|NCT00355134|466170823|FG003|Core Phase|Condition no longer requires study drug|0|||
129513573|NCT00355134|466170824|FG004|Core Phase|Condition no longer requires study drug|0|||
129513574|NCT00355134|466170820|FG000|Extension Phase|Withdrawal by Subject|7|||
129513575|NCT00355134|466170821|FG001|Extension Phase|Withdrawal by Subject|11|||
129513576|NCT00355134|466170822|FG002|Extension Phase|Withdrawal by Subject|0|||
129513577|NCT00355134|466170823|FG003|Extension Phase|Withdrawal by Subject|7|||
129513578|NCT00355134|466170824|FG004|Extension Phase|Withdrawal by Subject|5|||
129513579|NCT00355134|466170820|FG000|Extension Phase|Adverse Event|13|||
129513580|NCT00355134|466170821|FG001|Extension Phase|Adverse Event|9|||
129513581|NCT00355134|466170822|FG002|Extension Phase|Adverse Event|0|||
129513582|NCT00355134|466170823|FG003|Extension Phase|Adverse Event|3|||
129513583|NCT00355134|466170824|FG004|Extension Phase|Adverse Event|5|||
129513584|NCT00355134|466170820|FG000|Extension Phase|Lost to Follow-up|2|||
129513585|NCT00355134|466170821|FG001|Extension Phase|Lost to Follow-up|6|||
129513586|NCT00355134|466170822|FG002|Extension Phase|Lost to Follow-up|0|||
129513587|NCT00355134|466170823|FG003|Extension Phase|Lost to Follow-up|2|||
129513588|NCT00355134|466170824|FG004|Extension Phase|Lost to Follow-up|4|||
129513589|NCT00355134|466170820|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
129513590|NCT00355134|466170821|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
129513591|NCT00355134|466170822|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
129513592|NCT00355134|466170823|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
129513593|NCT00355134|466170824|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
129513594|NCT00355134|466170820|FG000|Extension Phase|Administrative problems|2|||
129513595|NCT00355134|466170821|FG001|Extension Phase|Administrative problems|4|||
129513596|NCT00355134|466170822|FG002|Extension Phase|Administrative problems|0|||
129513597|NCT00355134|466170823|FG003|Extension Phase|Administrative problems|1|||
129513598|NCT00355134|466170824|FG004|Extension Phase|Administrative problems|1|||
129513599|NCT00355134|466170820|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
129513600|NCT00355134|466170821|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
129513601|NCT00355134|466170822|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
129513602|NCT00355134|466170823|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
129513603|NCT00355134|466170824|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
129513604|NCT00355134|466170820|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
129513605|NCT00355134|466170821|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
129513606|NCT00355134|466170822|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
129513607|NCT00355134|466170823|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
129513608|NCT00355134|466170824|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
129513609|NCT00355134|466170820|FG000|Extension Phase|Protocol Violation|0|||
129513610|NCT00355134|466170821|FG001|Extension Phase|Protocol Violation|0|||
129513611|NCT00355134|466170822|FG002|Extension Phase|Protocol Violation|0|||
129513612|NCT00355134|466170823|FG003|Extension Phase|Protocol Violation|1|||
129513613|NCT00355134|466170824|FG004|Extension Phase|Protocol Violation|0|||
129513614|NCT02848313|466170825|FG000|Overall Study|Adverse Event|1|||
129513615|NCT02848313|466170826|FG001|Overall Study|Adverse Event|2|||
129513616|NCT02848313|466170825|FG000|Overall Study|Lack of Efficacy|0|||
129513617|NCT02848313|466170826|FG001|Overall Study|Lack of Efficacy|1|||
129513618|NCT02848313|466170825|FG000|Overall Study|Withdrawal by Subject|1|||
129513619|NCT02848313|466170826|FG001|Overall Study|Withdrawal by Subject|1|||
129513620|NCT02848313|466170825|FG000|Overall Study|Lost to follow up|1|||
129513621|NCT02848313|466170826|FG001|Overall Study|Lost to follow up|0|||
129513622|NCT01544478|466170827|FG000|Overall Study|Adverse Event|1|||
129513623|NCT01544478|466170827|FG000|Overall Study|Death|1|||
129513624|NCT01544478|466170827|FG000|Overall Study|Lost to Follow-up|48|||
129513625|NCT01544478|466170827|FG000|Overall Study|Physician Decision|15|||
129513626|NCT01544478|466170827|FG000|Overall Study|Pregnancy|1|||
129513627|NCT01544478|466170827|FG000|Overall Study|Withdrawal by Subject|52|||
129513628|NCT03382262|466170831|FG000|Overall Study|Physician Decision|0|||
129513629|NCT03382262|466170832|FG001|Overall Study|Physician Decision|0|||
129513630|NCT03382262|466170833|FG002|Overall Study|Physician Decision|1|||
129513631|NCT03382262|466170834|FG003|Overall Study|Physician Decision|0|||
129513632|NCT03382262|466170831|FG000|Overall Study|Withdrawal by Subject|0|||
129513633|NCT03382262|466170832|FG001|Overall Study|Withdrawal by Subject|0|||
129513634|NCT03382262|466170833|FG002|Overall Study|Withdrawal by Subject|0|||
129513635|NCT03382262|466170834|FG003|Overall Study|Withdrawal by Subject|1|||
129513636|NCT02038790|466170836|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
129513637|NCT02038790|466170837|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
129513638|NCT00438464|466170841|FG000|Overall Study|Terminated Early|14|||
129513639|NCT00438464|466170842|FG001|Overall Study|Terminated Early|5|||
129983369|NCT00607724|467900732|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129983370|NCT00607724|467900733|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129983371|NCT00607724|467900734|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
129983372|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
129983373|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
129983374|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
129983375|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
129983376|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
129983377|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
129983378|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
129983379|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
129983380|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
129983381|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
129513640|NCT00438464|466170841|FG000|Overall Study|Incomplete data submission|0|||
129513641|NCT00438464|466170842|FG001|Overall Study|Incomplete data submission|2|||
129513642|NCT03943446|466170844|FG000|Overall Study|Lost to Follow-up|0|||
129513643|NCT03943446|466170845|FG001|Overall Study|Lost to Follow-up|0|||
129513644|NCT03943446|466170846|FG002|Overall Study|Lost to Follow-up|1|||
129513645|NCT03943446|466170844|FG000|Overall Study|Withdrawal by Subject|1|||
129513646|NCT03943446|466170845|FG001|Overall Study|Withdrawal by Subject|1|||
129513647|NCT03943446|466170846|FG002|Overall Study|Withdrawal by Subject|2|||
129513648|NCT03943446|466170844|FG000|Overall Study|Study Terminated by Sponsor|1|||
129513649|NCT03943446|466170845|FG001|Overall Study|Study Terminated by Sponsor|2|||
129513650|NCT03943446|466170846|FG002|Overall Study|Study Terminated by Sponsor|1|||
129513651|NCT03943446|466170844|FG000|Overall Study|Reason not Specified|5|||
129513652|NCT03943446|466170845|FG001|Overall Study|Reason not Specified|1|||
129513653|NCT03943446|466170846|FG002|Overall Study|Reason not Specified|3|||
129513654|NCT04209530|466170849|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
129513655|NCT04209530|466170850|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
129513656|NCT04209530|466170849|FG000|Overall Study|Withdrawal by Subject|0|||
129513657|NCT04209530|466170850|FG001|Overall Study|Withdrawal by Subject|1|||
129513658|NCT03862495|466170853|FG000|Overall Study|Lost to Follow-up|37|||
129513659|NCT03862495|466170854|FG001|Overall Study|Lost to Follow-up|35|||
129513660|NCT00615914|466170855|FG000|Overall Study|Adverse Event|274|||
129513661|NCT00615914|466170855|FG000|Overall Study|Death|20|||
129513662|NCT00615914|466170855|FG000|Overall Study|Lack of Efficacy|59|||
129513663|NCT00615914|466170855|FG000|Overall Study|Lost to Follow-up|187|||
129513664|NCT00615914|466170855|FG000|Overall Study|Withdrawal by Subject|16|||
129513665|NCT00615914|466170855|FG000|Overall Study|Physician Decision|4|||
129513666|NCT00615914|466170855|FG000|Overall Study|No data was collected.|65|||
129513667|NCT00615914|466170855|FG000|Overall Study|No treatment|2|||
129513668|NCT00615914|466170855|FG000|Overall Study|Irregularly enrolled patients|10|||
129513669|NCT01467661|466170856|FG000|Overall Study|Adverse Event|16|||
129513670|NCT01467661|466170856|FG000|Overall Study|Withdrawal by Subject|1|||
129513671|NCT01467661|466170856|FG000|Overall Study|Lack of Efficacy|3|||
129513672|NCT01467661|466170856|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
129513673|NCT03673956|466170857|FG000|Overall Study|Lost to Follow-up|1|||
129513674|NCT03673956|466170858|FG001|Overall Study|Lost to Follow-up|0|||
129513675|NCT03673956|466170859|FG002|Overall Study|Lost to Follow-up|0|||
129513676|NCT03673956|466170860|FG003|Overall Study|Lost to Follow-up|0|||
129513677|NCT03673956|466170857|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
129513678|NCT03673956|466170858|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
129513679|NCT03673956|466170859|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
129513680|NCT03673956|466170860|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
129513681|NCT00270998|466170861|FG000|3 Month Follow-up|Adverse Event|1|||
129513682|NCT00270998|466170862|FG001|3 Month Follow-up|Adverse Event|0|||
129513683|NCT00270998|466170863|FG002|3 Month Follow-up|Adverse Event|0|||
129513684|NCT00270998|466170861|FG000|3 Month Follow-up|Lack of Efficacy|1|||
129513685|NCT00270998|466170862|FG001|3 Month Follow-up|Lack of Efficacy|2|||
129513686|NCT00270998|466170863|FG002|3 Month Follow-up|Lack of Efficacy|1|||
129513687|NCT00270998|466170861|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
129513688|NCT00270998|466170862|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
129513689|NCT00270998|466170863|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
129513690|NCT00270998|466170861|FG000|3 Month Follow-up|Pessary did not fit|12|||
129513691|NCT00270998|466170862|FG001|3 Month Follow-up|Pessary did not fit|0|||
129513692|NCT00270998|466170863|FG002|3 Month Follow-up|Pessary did not fit|0|||
129513693|NCT00270998|466170861|FG000|3 Month Follow-up|Personal/family health|1|||
129513694|NCT00270998|466170862|FG001|3 Month Follow-up|Personal/family health|1|||
129983382|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
129983383|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
129983384|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
129983385|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
129983386|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
129983387|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
129983388|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
129983389|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
129983390|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
129983391|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
129983392|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
129983393|NCT00607724|467900728|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983394|NCT00607724|467900729|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983395|NCT00607724|467900730|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983396|NCT00607724|467900731|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
129983397|NCT00607724|467900732|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983398|NCT00607724|467900733|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983399|NCT00607724|467900734|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
129983400|NCT03738423|467900735|FG000|Overall Study|Withdrawal by Subject|9|||
129983401|NCT03738423|467900736|FG001|Overall Study|Withdrawal by Subject|12|||
129983402|NCT03738423|467900737|FG002|Overall Study|Withdrawal by Subject|9|||
129983403|NCT03738423|467900738|FG003|Overall Study|Withdrawal by Subject|12|||
129983404|NCT03738423|467900739|FG004|Overall Study|Withdrawal by Subject|10|||
129983405|NCT03738423|467900735|FG000|Overall Study|Lack of Efficacy|3|||
129513695|NCT00270998|466170863|FG002|3 Month Follow-up|Personal/family health|0|||
129513696|NCT00270998|466170861|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
129513697|NCT00270998|466170862|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
129513698|NCT00270998|466170863|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
129513699|NCT00270998|466170861|FG000|12 Month Follow-up|Lack of Efficacy|5|||
129513700|NCT00270998|466170862|FG001|12 Month Follow-up|Lack of Efficacy|4|||
129513701|NCT00270998|466170863|FG002|12 Month Follow-up|Lack of Efficacy|3|||
129513702|NCT00270998|466170861|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
129513703|NCT00270998|466170862|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
129513704|NCT00270998|466170863|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
129513705|NCT00270998|466170861|FG000|12 Month Follow-up|Pessary did not fit|1|||
129539301|NCT01397409|466265248|FG006|Stage 2|Adverse Event|0|||
129513706|NCT00270998|466170862|FG001|12 Month Follow-up|Pessary did not fit|0|||
129513707|NCT00270998|466170863|FG002|12 Month Follow-up|Pessary did not fit|0|||
129513708|NCT00270998|466170861|FG000|12 Month Follow-up|Personal/family health|0|||
129513709|NCT00270998|466170862|FG001|12 Month Follow-up|Personal/family health|5|||
129513710|NCT00270998|466170863|FG002|12 Month Follow-up|Personal/family health|1|||
129513711|NCT00270998|466170861|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
129513712|NCT00270998|466170862|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
129513713|NCT00270998|466170863|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
129513714|NCT00425113|466170864|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
129513715|NCT00425113|466170865|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
129513716|NCT00425113|466170864|FG000|Overall Study|diagnosis of abdominal TB|0|||
129513717|NCT00425113|466170865|FG001|Overall Study|diagnosis of abdominal TB|1|||
129513718|NCT00425113|466170864|FG000|Overall Study|missing study drug more than 14 days|0|||
129513719|NCT00425113|466170865|FG001|Overall Study|missing study drug more than 14 days|1|||
129513720|NCT00425113|466170864|FG000|Overall Study|Withdrawal by Subject|1|||
129513721|NCT00425113|466170865|FG001|Overall Study|Withdrawal by Subject|0|||
129513722|NCT00425100|466170870|FG000|Overall Study|Adverse Event|36|||
129513723|NCT00425100|466170870|FG000|Overall Study|Lack of Efficacy|4|||
129513724|NCT00425100|466170870|FG000|Overall Study|Lost to Follow-up|2|||
129513725|NCT00425100|466170870|FG000|Overall Study|Protocol Violation|4|||
129513726|NCT00425100|466170870|FG000|Overall Study|Withdrawal by Subject|7|||
129513727|NCT04169061|466170871|FG000|Overall Study|Adverse Event|2|||
129513728|NCT04169061|466170871|FG000|Overall Study|Death|1|||
129513729|NCT04169061|466170871|FG000|Overall Study|Withdrawal by Subject|1|||
129513730|NCT04169061|466170871|FG000|Overall Study|Protocol Violation|1|||
129513731|NCT00555906|466170872|FG000|Phase 1|Objective Progression or Relapse|3|||
129513732|NCT00555906|466170873|FG001|Phase 1|Objective Progression or Relapse|5|||
129513733|NCT00555906|466170874|FG002|Phase 1|Objective Progression or Relapse|3|||
129513734|NCT00555906|466170875|FG003|Phase 1|Objective Progression or Relapse|1|||
129513735|NCT00555906|466170876|FG004|Phase 1|Objective Progression or Relapse|0|||
129513736|NCT00555906|466170872|FG000|Phase 1|Global Deterioration of Health Status|0|||
129513737|NCT00555906|466170873|FG001|Phase 1|Global Deterioration of Health Status|1|||
129513738|NCT00555906|466170874|FG002|Phase 1|Global Deterioration of Health Status|1|||
129513739|NCT00555906|466170875|FG003|Phase 1|Global Deterioration of Health Status|1|||
129513740|NCT00555906|466170876|FG004|Phase 1|Global Deterioration of Health Status|0|||
129513741|NCT00555906|466170872|FG000|Phase 1|Adverse Event|0|||
129513742|NCT00555906|466170873|FG001|Phase 1|Adverse Event|0|||
129513743|NCT00555906|466170874|FG002|Phase 1|Adverse Event|3|||
129513744|NCT00555906|466170875|FG003|Phase 1|Adverse Event|2|||
129513745|NCT00555906|466170876|FG004|Phase 1|Adverse Event|0|||
129513746|NCT00555906|466170872|FG000|Phase 1|Withdrawal by Subject|0|||
129513747|NCT00555906|466170873|FG001|Phase 1|Withdrawal by Subject|0|||
129513748|NCT00555906|466170874|FG002|Phase 1|Withdrawal by Subject|0|||
129513749|NCT00555906|466170875|FG003|Phase 1|Withdrawal by Subject|1|||
129513750|NCT00555906|466170876|FG004|Phase 1|Withdrawal by Subject|0|||
129513751|NCT00555906|466170872|FG000|Phase 2|Adverse Event|0|||
129513752|NCT00555906|466170873|FG001|Phase 2|Adverse Event|0|||
129513753|NCT00555906|466170874|FG002|Phase 2|Adverse Event|0|||
129513754|NCT00555906|466170875|FG003|Phase 2|Adverse Event|0|||
129513755|NCT00555906|466170876|FG004|Phase 2|Adverse Event|4|||
129513756|NCT00555906|466170872|FG000|Phase 2|Global Deterioration of Health Status|0|||
129513757|NCT00555906|466170873|FG001|Phase 2|Global Deterioration of Health Status|0|||
129513758|NCT00555906|466170874|FG002|Phase 2|Global Deterioration of Health Status|0|||
129983406|NCT03738423|467900736|FG001|Overall Study|Lack of Efficacy|1|||
129983407|NCT03738423|467900737|FG002|Overall Study|Lack of Efficacy|1|||
129983408|NCT03738423|467900738|FG003|Overall Study|Lack of Efficacy|1|||
129983409|NCT03738423|467900739|FG004|Overall Study|Lack of Efficacy|2|||
129983410|NCT03738423|467900735|FG000|Overall Study|Lost to Follow-up|1|||
129513759|NCT00555906|466170875|FG003|Phase 2|Global Deterioration of Health Status|0|||
129513760|NCT00555906|466170876|FG004|Phase 2|Global Deterioration of Health Status|2|||
129513761|NCT00555906|466170872|FG000|Phase 2|Objective Progression or Relapse|0|||
129513762|NCT00555906|466170873|FG001|Phase 2|Objective Progression or Relapse|0|||
129983411|NCT03738423|467900736|FG001|Overall Study|Lost to Follow-up|0|||
129983412|NCT03738423|467900737|FG002|Overall Study|Lost to Follow-up|1|||
129513763|NCT00555906|466170874|FG002|Phase 2|Objective Progression or Relapse|0|||
129513764|NCT00555906|466170875|FG003|Phase 2|Objective Progression or Relapse|0|||
129513765|NCT00555906|466170876|FG004|Phase 2|Objective Progression or Relapse|16|||
129513766|NCT00555906|466170872|FG000|Phase 2|Withdrawal by Subject|0|||
129513767|NCT00555906|466170873|FG001|Phase 2|Withdrawal by Subject|0|||
129513768|NCT00555906|466170874|FG002|Phase 2|Withdrawal by Subject|0|||
129513769|NCT00555906|466170875|FG003|Phase 2|Withdrawal by Subject|0|||
129513770|NCT00555906|466170876|FG004|Phase 2|Withdrawal by Subject|2|||
129513771|NCT00555906|466170872|FG000|Phase 2|Other|0|||
129513772|NCT00555906|466170873|FG001|Phase 2|Other|0|||
129513773|NCT00555906|466170874|FG002|Phase 2|Other|0|||
129513774|NCT00555906|466170875|FG003|Phase 2|Other|0|||
129513775|NCT00555906|466170876|FG004|Phase 2|Other|6|||
129513776|NCT00555906|466170872|FG000|Phase 2|Randomized but not Treated|0|||
129513777|NCT00555906|466170873|FG001|Phase 2|Randomized but not Treated|0|||
129513778|NCT00555906|466170874|FG002|Phase 2|Randomized but not Treated|0|||
129513779|NCT00555906|466170875|FG003|Phase 2|Randomized but not Treated|0|||
129513780|NCT00555906|466170876|FG004|Phase 2|Randomized but not Treated|2|||
129513781|NCT04046341|466170880|FG000|Overall Study|Lost to Follow-up|2|||
129513782|NCT04046341|466170880|FG000|Overall Study|Withdrawal by Subject|1|||
129513783|NCT00788697|466170888|FG000|Overall Study|No study drug administered|12|||
129513784|NCT00788697|466170888|FG000|Overall Study|Training Patients|74|||
129513785|NCT00788697|466170888|FG000|Overall Study|no truth standard procedure available|5|||
129513786|NCT00788697|466170888|FG000|Overall Study|Technically inadequate truth standard|1|||
129513787|NCT00788697|466170888|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
129513788|NCT02248857|466170889|FG000|3 Month|Withdrawal by Subject|9|||
129513789|NCT02248857|466170890|FG001|3 Month|Withdrawal by Subject|3|||
129513790|NCT02248857|466170891|FG002|3 Month|Withdrawal by Subject|4|||
129513791|NCT02248857|466170889|FG000|3 Month|Unable to reach for 3 month|35|||
129513792|NCT02248857|466170890|FG001|3 Month|Unable to reach for 3 month|29|||
129513793|NCT02248857|466170891|FG002|3 Month|Unable to reach for 3 month|26|||
129513794|NCT02248857|466170889|FG000|3 Month|Partially completed, unable to finish|2|||
129513795|NCT02248857|466170890|FG001|3 Month|Partially completed, unable to finish|2|||
129513796|NCT02248857|466170891|FG002|3 Month|Partially completed, unable to finish|1|||
129513797|NCT02248857|466170889|FG000|6 Month|Lost to Follow-up|27|||
129513798|NCT02248857|466170890|FG001|6 Month|Lost to Follow-up|26|||
129513799|NCT02248857|466170891|FG002|6 Month|Lost to Follow-up|15|||
129513800|NCT02248857|466170889|FG000|6 Month|Partially completed, unable to finish|0|||
129513801|NCT02248857|466170890|FG001|6 Month|Partially completed, unable to finish|1|||
129513802|NCT02248857|466170891|FG002|6 Month|Partially completed, unable to finish|0|||
129513803|NCT02248857|466170889|FG000|6 Month|Withdrawal by Subject|0|||
129513804|NCT02248857|466170890|FG001|6 Month|Withdrawal by Subject|2|||
129513805|NCT02248857|466170891|FG002|6 Month|Withdrawal by Subject|2|||
129513806|NCT02248857|466170889|FG000|6 Month|Death|1|||
129513807|NCT02248857|466170890|FG001|6 Month|Death|0|||
129513808|NCT02248857|466170891|FG002|6 Month|Death|0|||
129513809|NCT02671461|466170892|FG000|Treatment|Adverse Event|0|||
129513810|NCT02671461|466170893|FG001|Treatment|Adverse Event|0|||
129513811|NCT02671461|466170894|FG002|Treatment|Adverse Event|1|||
129513812|NCT02671461|466170892|FG000|Treatment|Administrative Reason by Sponsor|1|||
129513813|NCT02671461|466170893|FG001|Treatment|Administrative Reason by Sponsor|3|||
129513814|NCT02671461|466170894|FG002|Treatment|Administrative Reason by Sponsor|4|||
129513815|NCT02671461|466170892|FG000|Treatment|Randomized, not treated|1|||
129513816|NCT02671461|466170893|FG001|Treatment|Randomized, not treated|0|||
129513817|NCT02671461|466170894|FG002|Treatment|Randomized, not treated|0|||
129513818|NCT02671461|466170892|FG000|Follow-up|Withdrawal by Subject|1|||
129513819|NCT02671461|466170893|FG001|Follow-up|Withdrawal by Subject|0|||
129513820|NCT02671461|466170894|FG002|Follow-up|Withdrawal by Subject|0|||
129513821|NCT02671461|466170892|FG000|Follow-up|Lost to Follow-up|0|||
129513822|NCT02671461|466170893|FG001|Follow-up|Lost to Follow-up|0|||
129513823|NCT02671461|466170894|FG002|Follow-up|Lost to Follow-up|1|||
129513824|NCT02671461|466170892|FG000|Follow-up|Administrative Reason by Sponsor|0|||
129513825|NCT02671461|466170893|FG001|Follow-up|Administrative Reason by Sponsor|1|||
129513826|NCT02671461|466170894|FG002|Follow-up|Administrative Reason by Sponsor|0|||
129513827|NCT02261883|466170895|FG000|Overall Study|Death|3|||
129513828|NCT02261883|466170896|FG001|Overall Study|Death|2|||
129513829|NCT02261883|466170895|FG000|Overall Study|Physician Decision|1|||
129513830|NCT02261883|466170896|FG001|Overall Study|Physician Decision|0|||
129513831|NCT02261883|466170895|FG000|Overall Study|Protocol Violation|1|||
129513832|NCT02261883|466170896|FG001|Overall Study|Protocol Violation|0|||
129513833|NCT02261883|466170895|FG000|Overall Study|Withdrawal by Subject|0|||
129513834|NCT02261883|466170896|FG001|Overall Study|Withdrawal by Subject|1|||
129513835|NCT02261883|466170895|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
129513836|NCT02261883|466170896|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
129513837|NCT01412060|466170897|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
129513838|NCT01412060|466170898|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
129513839|NCT01412060|466170899|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
129513840|NCT01412060|466170897|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
129513841|NCT01412060|466170898|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
129513842|NCT01412060|466170899|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
129513843|NCT01412060|466170897|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
129513844|NCT01412060|466170898|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
129513845|NCT01412060|466170899|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
129513846|NCT01412060|466170897|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
129513847|NCT01412060|466170898|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
129513848|NCT01412060|466170899|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
129513849|NCT01412060|466170897|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
129513850|NCT01412060|466170898|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
129513851|NCT01412060|466170899|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
129513852|NCT01412060|466170897|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
129513853|NCT01412060|466170898|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
129513854|NCT01412060|466170899|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
129513855|NCT01412060|466170897|FG000|Period Between RIP and SP|Adverse Event|4|||
129513856|NCT01412060|466170898|FG001|Period Between RIP and SP|Adverse Event|0|||
129513857|NCT01412060|466170899|FG002|Period Between RIP and SP|Adverse Event|0|||
129513858|NCT01412060|466170897|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
129513859|NCT01412060|466170898|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
129513860|NCT01412060|466170899|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
129513861|NCT01412060|466170897|FG000|Period Between RIP and SP|Protocol Violation|2|||
129513862|NCT01412060|466170898|FG001|Period Between RIP and SP|Protocol Violation|0|||
129513863|NCT01412060|466170899|FG002|Period Between RIP and SP|Protocol Violation|0|||
129513864|NCT01412060|466170897|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
129513865|NCT01412060|466170898|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
129513866|NCT01412060|466170899|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
129513867|NCT01412060|466170897|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
129513868|NCT01412060|466170898|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
129513869|NCT01412060|466170899|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
129513870|NCT01412060|466170897|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
129513871|NCT01412060|466170898|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
129513872|NCT01412060|466170899|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
129513873|NCT01412060|466170897|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
129513874|NCT01412060|466170898|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
129513875|NCT01412060|466170899|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
129513876|NCT01412060|466170897|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
129513877|NCT01412060|466170898|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
129513878|NCT01412060|466170899|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
129513879|NCT01412060|466170897|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
129513880|NCT01412060|466170898|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
129983413|NCT03738423|467900738|FG003|Overall Study|Lost to Follow-up|1|||
129983414|NCT03738423|467900739|FG004|Overall Study|Lost to Follow-up|0|||
129983415|NCT03738423|467900735|FG000|Overall Study|Protocol Violation|1|||
129983416|NCT03738423|467900736|FG001|Overall Study|Protocol Violation|0|||
129983417|NCT03738423|467900737|FG002|Overall Study|Protocol Violation|0|||
129983418|NCT03738423|467900738|FG003|Overall Study|Protocol Violation|0|||
129983419|NCT03738423|467900739|FG004|Overall Study|Protocol Violation|1|||
129983420|NCT03738423|467900735|FG000|Overall Study|Physician Decision|0|||
129983421|NCT03738423|467900736|FG001|Overall Study|Physician Decision|0|||
129983422|NCT03738423|467900737|FG002|Overall Study|Physician Decision|1|||
129983423|NCT03738423|467900738|FG003|Overall Study|Physician Decision|0|||
129983424|NCT03738423|467900739|FG004|Overall Study|Physician Decision|1|||
129983425|NCT03738423|467900735|FG000|Overall Study|Death|0|||
129983426|NCT03738423|467900736|FG001|Overall Study|Death|0|||
129983427|NCT03738423|467900737|FG002|Overall Study|Death|0|||
129983428|NCT03738423|467900738|FG003|Overall Study|Death|0|||
129983429|NCT03738423|467900739|FG004|Overall Study|Death|1|||
129983430|NCT03738423|467900735|FG000|Overall Study|Randomized but never treated|0|||
129983431|NCT03738423|467900736|FG001|Overall Study|Randomized but never treated|0|||
129983432|NCT03738423|467900737|FG002|Overall Study|Randomized but never treated|1|||
129983433|NCT03738423|467900738|FG003|Overall Study|Randomized but never treated|1|||
129983434|NCT03738423|467900739|FG004|Overall Study|Randomized but never treated|0|||
129983435|NCT01198756|467902210|FG000|Overall Study|Adverse Event|0|||
129983436|NCT01198756|467902211|FG001|Overall Study|Adverse Event|0|||
129983437|NCT01198756|467902212|FG002|Overall Study|Adverse Event|0|||
129983438|NCT01198756|467902213|FG003|Overall Study|Adverse Event|1|||
129983439|NCT01198756|467902210|FG000|Overall Study|Protocol Violation|0|||
129983440|NCT01198756|467902211|FG001|Overall Study|Protocol Violation|0|||
129983441|NCT01198756|467902212|FG002|Overall Study|Protocol Violation|0|||
129983442|NCT01198756|467902213|FG003|Overall Study|Protocol Violation|2|||
129983443|NCT01198756|467902210|FG000|Overall Study|Withdrawal by Subject|9|||
129983444|NCT01198756|467902211|FG001|Overall Study|Withdrawal by Subject|4|||
129983445|NCT01198756|467902212|FG002|Overall Study|Withdrawal by Subject|7|||
129983446|NCT01198756|467902213|FG003|Overall Study|Withdrawal by Subject|5|||
129983447|NCT01198756|467902210|FG000|Overall Study|Lost to Follow-up|29|||
129513881|NCT01412060|466170899|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
129513882|NCT01412060|466170897|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
129513883|NCT01412060|466170898|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
129983448|NCT01198756|467902211|FG001|Overall Study|Lost to Follow-up|36|||
129983449|NCT01198756|467902212|FG002|Overall Study|Lost to Follow-up|23|||
129983450|NCT01198756|467902213|FG003|Overall Study|Lost to Follow-up|18|||
129983451|NCT01290315|467902215|FG000|Overall Study|Adverse Event|0|||
129983452|NCT01290315|467902216|FG001|Overall Study|Adverse Event|0|||
129983453|NCT01290315|467902217|FG002|Overall Study|Adverse Event|0|||
129983454|NCT01290315|467902218|FG003|Overall Study|Adverse Event|3|||
129983455|NCT01290315|467902215|FG000|Overall Study|Selection criteria/compliance|2|||
129983456|NCT01290315|467902216|FG001|Overall Study|Selection criteria/compliance|1|||
129983457|NCT01290315|467902217|FG002|Overall Study|Selection criteria/compliance|0|||
129983458|NCT01290315|467902218|FG003|Overall Study|Selection criteria/compliance|2|||
129983459|NCT01290315|467902215|FG000|Overall Study|Lost to Follow-up|0|||
129983460|NCT01290315|467902216|FG001|Overall Study|Lost to Follow-up|1|||
129983461|NCT01290315|467902217|FG002|Overall Study|Lost to Follow-up|0|||
129983462|NCT01290315|467902218|FG003|Overall Study|Lost to Follow-up|0|||
129983463|NCT01290315|467902215|FG000|Overall Study|Withdrawal by Subject|1|||
129983464|NCT01290315|467902216|FG001|Overall Study|Withdrawal by Subject|1|||
129983465|NCT01290315|467902217|FG002|Overall Study|Withdrawal by Subject|0|||
129983466|NCT01290315|467902218|FG003|Overall Study|Withdrawal by Subject|0|||
129983467|NCT00591721|467902219|FG000|Overall Study|Withdrawal by Subject|10|||
129983468|NCT00591721|467902220|FG001|Overall Study|Withdrawal by Subject|10|||
129983469|NCT00591721|467902219|FG000|Overall Study|Lost to Follow-up|1|||
129983470|NCT00591721|467902220|FG001|Overall Study|Lost to Follow-up|4|||
129983471|NCT00591721|467902219|FG000|Overall Study|Intervention not received|10|||
129983472|NCT00591721|467902220|FG001|Overall Study|Intervention not received|8|||
129983473|NCT00901186|467902223|FG000|Overall Study|Lack of Efficacy|0|||
129983474|NCT00901186|467902224|FG001|Overall Study|Lack of Efficacy|1|||
129983475|NCT00901186|467902223|FG000|Overall Study|Abnormal laboratory values|0|||
129983476|NCT00901186|467902224|FG001|Overall Study|Abnormal laboratory values|1|||
129983477|NCT00901186|467902223|FG000|Overall Study|Lost to Follow-up|2|||
129983478|NCT00901186|467902224|FG001|Overall Study|Lost to Follow-up|0|||
129983479|NCT00901186|467902223|FG000|Overall Study|Adverse Event|2|||
129983480|NCT00901186|467902224|FG001|Overall Study|Adverse Event|4|||
129983481|NCT00901186|467902223|FG000|Overall Study|Administration problems|0|||
129983482|NCT00901186|467902224|FG001|Overall Study|Administration problems|1|||
129983483|NCT00901186|467902223|FG000|Overall Study|Protocol deviations|5|||
129983484|NCT00901186|467902224|FG001|Overall Study|Protocol deviations|4|||
129983485|NCT00581555|467902227|FG000|Overall Study|Adverse Event|4|||
129983486|NCT00581555|467902228|FG001|Overall Study|Adverse Event|3|||
129983487|NCT00581555|467902227|FG000|Overall Study|Physician Decision|3|||
129983488|NCT00581555|467902228|FG001|Overall Study|Physician Decision|2|||
129983489|NCT00581555|467902227|FG000|Overall Study|Withdrawal by Subject|18|||
129983490|NCT00581555|467902228|FG001|Overall Study|Withdrawal by Subject|9|||
129983491|NCT00581555|467902227|FG000|Overall Study|Lost to Follow-up|2|||
129983492|NCT00581555|467902228|FG001|Overall Study|Lost to Follow-up|2|||
129983493|NCT00581555|467902227|FG000|Overall Study|Other reasons|16|||
129983494|NCT00581555|467902228|FG001|Overall Study|Other reasons|4|||
129983495|NCT05816330|467902229|FG000|Overall Study|Withdrawal by Subject|4|||
129983496|NCT05816330|467902230|FG001|Overall Study|Withdrawal by Subject|1|||
129983497|NCT03900416|467902231|FG000|Six Week Follow-up|Lost to Follow-up|1|||
129983498|NCT03900416|467902232|FG001|Six Week Follow-up|Lost to Follow-up|0|||
129983499|NCT03900416|467902231|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
129983500|NCT03900416|467902232|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
129983501|NCT03900416|467902231|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
129983502|NCT03900416|467902232|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
129983503|NCT03900416|467902231|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
129983504|NCT03900416|467902232|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
129983505|NCT03900416|467902231|FG000|Twelve Week Follow-up|Adverse Event|1|||
129983506|NCT03900416|467902232|FG001|Twelve Week Follow-up|Adverse Event|1|||
129983507|NCT03900416|467902231|FG000|Six Month Follow-up|Lost to Follow-up|4|||
129983508|NCT03900416|467902232|FG001|Six Month Follow-up|Lost to Follow-up|3|||
129983509|NCT03900416|467902231|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
129983510|NCT03900416|467902232|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
129983511|NCT00772330|467902233|FG000|Overall Study|Lost to Follow-up|3|||
129983512|NCT01353859|467902234|FG000|Overall Study|Adverse Event|3|||
129983513|NCT01353859|467902234|FG000|Overall Study|Lack of Efficacy|1|||
129983514|NCT03231800|467902235|FG000|Overall Study|Lost to Follow-up|0|||
129983515|NCT03231800|467902236|FG001|Overall Study|Lost to Follow-up|2|||
129983516|NCT03231800|467902235|FG000|Overall Study|Protocol Violation|1|||
129983517|NCT03231800|467902236|FG001|Overall Study|Protocol Violation|1|||
129983518|NCT03231800|467902235|FG000|Overall Study|reason not provided|2|||
129983519|NCT03231800|467902236|FG001|Overall Study|reason not provided|0|||
129983520|NCT00859222|467902237|FG000|Overall Study|Adverse Event|2|||
129983521|NCT00859222|467902238|FG001|Overall Study|Adverse Event|3|||
129983522|NCT00859222|467902239|FG002|Overall Study|Adverse Event|6|||
129983523|NCT00859222|467902240|FG003|Overall Study|Adverse Event|24|||
129983524|NCT00859222|467902241|FG004|Overall Study|Adverse Event|15|||
129983525|NCT00859222|467902237|FG000|Overall Study|DLT|1|||
129983526|NCT00859222|467902238|FG001|Overall Study|DLT|0|||
129983527|NCT00859222|467902239|FG002|Overall Study|DLT|0|||
129983528|NCT00859222|467902240|FG003|Overall Study|DLT|0|||
129983529|NCT00859222|467902241|FG004|Overall Study|DLT|0|||
129983530|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
129983531|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
129513884|NCT01412060|466170899|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
129513885|NCT01412060|466170897|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
129513886|NCT01412060|466170898|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
129513887|NCT01412060|466170899|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
129513888|NCT01412060|466170897|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
129513889|NCT01412060|466170898|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
129513890|NCT01412060|466170899|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
129513891|NCT01412060|466170897|FG000|Period Between SP and DBP|Protocol Violation|2|||
129513892|NCT01412060|466170898|FG001|Period Between SP and DBP|Protocol Violation|0|||
129513893|NCT01412060|466170899|FG002|Period Between SP and DBP|Protocol Violation|0|||
129513894|NCT01412060|466170897|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
129513895|NCT01412060|466170898|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
129513896|NCT01412060|466170899|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
129513897|NCT01412060|466170897|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
129513898|NCT01412060|466170898|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
129513899|NCT01412060|466170899|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
129513900|NCT01412060|466170897|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
129513901|NCT01412060|466170898|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
129513902|NCT01412060|466170899|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
129513903|NCT01412060|466170897|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
129513904|NCT01412060|466170898|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
129513905|NCT01412060|466170899|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
129513906|NCT01412060|466170897|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
129513907|NCT01412060|466170898|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
129513908|NCT01412060|466170899|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
129513909|NCT01412060|466170897|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
129513910|NCT01412060|466170898|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
129513911|NCT01412060|466170899|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
129513912|NCT01412060|466170897|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
129513913|NCT01412060|466170898|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
129513914|NCT01412060|466170899|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
129513915|NCT01412060|466170897|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
129513916|NCT01412060|466170898|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
129513917|NCT01412060|466170899|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
129513918|NCT01412060|466170897|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
129513919|NCT01412060|466170898|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
129513920|NCT01412060|466170899|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
129513921|NCT01412060|466170897|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
129513922|NCT01412060|466170898|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
129513923|NCT01412060|466170899|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
129513924|NCT02674685|466170904|FG000|Overall Study|Withdrawal by Subject|4|||
129513925|NCT05567393|466170908|FG000|Overall Study|Voluntary Withdrawal|0|||
129513926|NCT05567393|466170909|FG001|Overall Study|Voluntary Withdrawal|0|||
129513927|NCT05567393|466170910|FG002|Overall Study|Voluntary Withdrawal|0|||
129513928|NCT05567393|466170911|FG003|Overall Study|Voluntary Withdrawal|0|||
129513929|NCT05567393|466170912|FG004|Overall Study|Voluntary Withdrawal|0|||
129513930|NCT05567393|466170913|FG005|Overall Study|Voluntary Withdrawal|0|||
129513931|NCT05567393|466170914|FG006|Overall Study|Voluntary Withdrawal|0|||
129513932|NCT05567393|466170915|FG007|Overall Study|Voluntary Withdrawal|0|||
129513933|NCT05567393|466170916|FG008|Overall Study|Voluntary Withdrawal|0|||
129513934|NCT05567393|466170917|FG009|Overall Study|Voluntary Withdrawal|0|||
129513935|NCT05567393|466170918|FG010|Overall Study|Voluntary Withdrawal|0|||
129513936|NCT05567393|466170919|FG011|Overall Study|Voluntary Withdrawal|0|||
129513937|NCT05567393|466170920|FG012|Overall Study|Voluntary Withdrawal|0|||
129513938|NCT05567393|466170921|FG013|Overall Study|Voluntary Withdrawal|1|||
129513939|NCT05567393|466170922|FG014|Overall Study|Voluntary Withdrawal|0|||
129513940|NCT05567393|466170923|FG015|Overall Study|Voluntary Withdrawal|0|||
129513941|NCT05567393|466170924|FG016|Overall Study|Voluntary Withdrawal|0|||
129513942|NCT05567393|466170925|FG017|Overall Study|Voluntary Withdrawal|0|||
129513943|NCT04186663|466170926|FG000|Overall Study|Lost to Follow-up|1|||
129513944|NCT04186663|466170926|FG000|Overall Study|Unable to complete blood draw|3|||
129513945|NCT01184846|466170930|FG000|Overall Study|Adverse Event|2|||
129513946|NCT01184846|466170930|FG000|Overall Study|Insufficient response|1|||
129513947|NCT00892957|466170931|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
129513948|NCT00892957|466170932|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
129513949|NCT00892957|466170931|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
129513950|NCT00892957|466170932|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
129513951|NCT04876599|466170935|FG000|Overall Study|Missed|2|||
129513952|NCT04876599|466170936|FG001|Overall Study|Missed|0|||
129513953|NCT04876599|466170935|FG000|Overall Study|Declined|2|||
129513954|NCT04876599|466170936|FG001|Overall Study|Declined|3|||
129513955|NCT03175562|466170937|FG000|Overall Study|Adverse Event|1|||
129513956|NCT03175562|466170937|FG000|Overall Study|Lost to Follow-up|3|||
129513957|NCT03175562|466170937|FG000|Overall Study|Withdrawal by Subject|7|||
129513958|NCT03175562|466170937|FG000|Overall Study|Other (Not Specified)|5|||
129513959|NCT02146833|466170938|FG000|Overall Study|Death|10|||
129513960|NCT02146833|466170938|FG000|Overall Study|No longer consented to study treatment|1|||
129513961|NCT03700736|466170941|FG000|Overall Study|Pregnancy|1|||
129513962|NCT03700736|466170942|FG001|Overall Study|Pregnancy|1|||
129513963|NCT03700736|466170941|FG000|Overall Study|Withdrawal by Subject|2|||
129513964|NCT03700736|466170942|FG001|Overall Study|Withdrawal by Subject|6|||
129513965|NCT00642018|466170943|FG000|Overall Study|Adverse Event|11|||
129513966|NCT00642018|466170944|FG001|Overall Study|Adverse Event|36|||
129513967|NCT00642018|466170943|FG000|Overall Study|Withdrawal by Subject|4|||
129513968|NCT00642018|466170944|FG001|Overall Study|Withdrawal by Subject|10|||
129513969|NCT00642018|466170943|FG000|Overall Study|Progressive Disease|13|||
129513970|NCT00642018|466170944|FG001|Overall Study|Progressive Disease|18|||
129513971|NCT00642018|466170943|FG000|Overall Study|Physician Decision|0|||
129983532|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
129983533|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
129983534|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
129983535|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
129983536|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
129983537|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
129983538|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
129983539|NCT00400725|467902242|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
129983540|NCT00400725|467902243|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
129983541|NCT00400725|467902244|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
129983542|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
129983543|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
129983544|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
129983545|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
129983546|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
129983547|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
129983548|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
129983549|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
129983550|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
129983551|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
129983552|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
129983553|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
129983554|NCT00400725|467902242|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
129983555|NCT00400725|467902243|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
129983556|NCT00400725|467902244|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
129983557|NCT01941719|467902245|FG000|Overall Study|Lost to Follow-up|20|||
129983558|NCT01941719|467902246|FG001|Overall Study|Lost to Follow-up|19|||
129983559|NCT00252577|467902247|FG000|Overall Study|Lost to Follow-up|20|||
129983560|NCT01744392|467902248|FG000|Overall Study|Physician Decision|1|||
129983561|NCT01416389|467902249|FG000|Overall Study|Lost to Follow-up|1|||
129983562|NCT01416389|467902250|FG001|Overall Study|Lost to Follow-up|0|||
129983563|NCT01416389|467902249|FG000|Overall Study|Started New Therapy|2|||
129983564|NCT01416389|467902250|FG001|Overall Study|Started New Therapy|0|||
129983565|NCT00992225|467902259|FG000|Overall Study|Entry Criteria Not Met|8|||
129983566|NCT00992225|467902259|FG000|Overall Study|Adverse Event|2|||
129983567|NCT01036438|467902260|FG000|Overall Study|Adverse Event|7|||
129983568|NCT01036438|467902261|FG001|Overall Study|Adverse Event|8|||
129983569|NCT01036438|467902260|FG000|Overall Study|Death|0|||
129983570|NCT01036438|467902261|FG001|Overall Study|Death|1|||
129983571|NCT01036438|467902260|FG000|Overall Study|No effect of study treatment|3|||
129983572|NCT01036438|467902261|FG001|Overall Study|No effect of study treatment|1|||
129983573|NCT00888927|467902262|FG000|Overall Study|Adverse Event|0|||
129983574|NCT00888927|467902263|FG001|Overall Study|Adverse Event|0|||
129513972|NCT00642018|466170944|FG001|Overall Study|Physician Decision|10|||
129513973|NCT00642018|466170943|FG000|Overall Study|Protocol Violation|0|||
129513974|NCT00642018|466170944|FG001|Overall Study|Protocol Violation|1|||
129983575|NCT00888927|467902264|FG002|Overall Study|Adverse Event|0|||
129983576|NCT00888927|467902265|FG003|Overall Study|Adverse Event|1|||
129983577|NCT00888927|467902262|FG000|Overall Study|Withdrawal of consent|0|||
129983578|NCT00888927|467902263|FG001|Overall Study|Withdrawal of consent|0|||
129513975|NCT00642018|466170943|FG000|Overall Study|Death|0|||
129513976|NCT00642018|466170944|FG001|Overall Study|Death|3|||
129513977|NCT00642018|466170943|FG000|Overall Study|Entry Criteria Not Met|0|||
129513978|NCT00642018|466170944|FG001|Overall Study|Entry Criteria Not Met|1|||
129513979|NCT04126031|466170947|FG000|Part A|Withdrawal by Subject|0|||
129513980|NCT04126031|466170948|FG001|Part A|Withdrawal by Subject|0|||
129983579|NCT00888927|467902264|FG002|Overall Study|Withdrawal of consent|0|||
129513981|NCT04126031|466170949|FG002|Part A|Withdrawal by Subject|1|||
129513982|NCT04126031|466170950|FG003|Part A|Withdrawal by Subject|0|||
129513983|NCT04126031|466170951|FG004|Part A|Withdrawal by Subject|0|||
129513984|NCT04126031|466170952|FG005|Part A|Withdrawal by Subject|0|||
129513985|NCT04126031|466170947|FG000|Part A|Other|1|||
129513986|NCT04126031|466170948|FG001|Part A|Other|0|||
129513987|NCT04126031|466170949|FG002|Part A|Other|0|||
129513988|NCT04126031|466170950|FG003|Part A|Other|0|||
129513989|NCT04126031|466170951|FG004|Part A|Other|0|||
129513990|NCT04126031|466170952|FG005|Part A|Other|0|||
129513991|NCT04126031|466170947|FG000|Part B|Adverse Event|0|||
129513992|NCT04126031|466170948|FG001|Part B|Adverse Event|0|||
129513993|NCT04126031|466170949|FG002|Part B|Adverse Event|0|||
129513994|NCT04126031|466170950|FG003|Part B|Adverse Event|0|||
129513995|NCT04126031|466170951|FG004|Part B|Adverse Event|0|||
129513996|NCT04126031|466170952|FG005|Part B|Adverse Event|2|||
129513997|NCT04126031|466170947|FG000|Part B|Pre-existing hypertransaminasemia|0|||
129513998|NCT04126031|466170948|FG001|Part B|Pre-existing hypertransaminasemia|0|||
129513999|NCT04126031|466170949|FG002|Part B|Pre-existing hypertransaminasemia|0|||
129514000|NCT04126031|466170950|FG003|Part B|Pre-existing hypertransaminasemia|0|||
129514001|NCT04126031|466170951|FG004|Part B|Pre-existing hypertransaminasemia|1|||
129514002|NCT04126031|466170952|FG005|Part B|Pre-existing hypertransaminasemia|0|||
129514003|NCT00617656|466170953|FG000|Overall Study|Inclusion error|4|||
129514004|NCT00617656|466170954|FG001|Overall Study|Inclusion error|4|||
129514005|NCT00617656|466170955|FG002|Overall Study|Inclusion error|0|||
129514006|NCT00617656|466170956|FG003|Overall Study|Inclusion error|0|||
129514007|NCT00617656|466170953|FG000|Overall Study|Missing data|44|||
129514008|NCT00617656|466170954|FG001|Overall Study|Missing data|30|||
129514009|NCT00617656|466170955|FG002|Overall Study|Missing data|13|||
129514010|NCT00617656|466170956|FG003|Overall Study|Missing data|6|||
129514011|NCT00617656|466170953|FG000|Overall Study|Withdrawal by Subject|0|||
129514012|NCT00617656|466170954|FG001|Overall Study|Withdrawal by Subject|2|||
129514013|NCT00617656|466170955|FG002|Overall Study|Withdrawal by Subject|0|||
129514014|NCT00617656|466170956|FG003|Overall Study|Withdrawal by Subject|0|||
129514015|NCT00131664|466170957|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
129514016|NCT00131664|466170958|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
129514017|NCT00131664|466170959|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
129514018|NCT00131664|466170960|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
129514019|NCT00131664|466170961|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
129514020|NCT00131664|466170962|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
129514021|NCT00131664|466170957|FG000|First Period (First 6 Months)|Death|0|||
129514022|NCT00131664|466170958|FG001|First Period (First 6 Months)|Death|1|||
129514023|NCT00131664|466170959|FG002|First Period (First 6 Months)|Death|0|||
129514024|NCT00131664|466170960|FG003|First Period (First 6 Months)|Death|0|||
129514025|NCT00131664|466170961|FG004|First Period (First 6 Months)|Death|0|||
129514026|NCT00131664|466170962|FG005|First Period (First 6 Months)|Death|0|||
129514027|NCT00131664|466170957|FG000|First Period (First 6 Months)|Protocol Violation|2|||
129514028|NCT00131664|466170958|FG001|First Period (First 6 Months)|Protocol Violation|2|||
129514029|NCT00131664|466170959|FG002|First Period (First 6 Months)|Protocol Violation|1|||
129514030|NCT00131664|466170960|FG003|First Period (First 6 Months)|Protocol Violation|0|||
129514031|NCT00131664|466170961|FG004|First Period (First 6 Months)|Protocol Violation|0|||
129514032|NCT00131664|466170962|FG005|First Period (First 6 Months)|Protocol Violation|0|||
129514033|NCT00131664|466170957|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
129514034|NCT00131664|466170958|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
129514035|NCT00131664|466170959|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
129514036|NCT00131664|466170960|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
129514037|NCT00131664|466170961|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
129514038|NCT00131664|466170962|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
129514039|NCT00131664|466170957|FG000|First Period (First 6 Months)|Adverse Event|9|||
129514040|NCT00131664|466170958|FG001|First Period (First 6 Months)|Adverse Event|4|||
129514041|NCT00131664|466170959|FG002|First Period (First 6 Months)|Adverse Event|5|||
129514042|NCT00131664|466170960|FG003|First Period (First 6 Months)|Adverse Event|0|||
129514043|NCT00131664|466170961|FG004|First Period (First 6 Months)|Adverse Event|0|||
129514044|NCT00131664|466170962|FG005|First Period (First 6 Months)|Adverse Event|0|||
129514045|NCT00131664|466170957|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
129514046|NCT00131664|466170958|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
129514047|NCT00131664|466170959|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
129514048|NCT00131664|466170960|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
129514049|NCT00131664|466170961|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
129514050|NCT00131664|466170962|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
129514051|NCT00131664|466170957|FG000|First Period (First 6 Months)|Administrative reasons|2|||
129514052|NCT00131664|466170958|FG001|First Period (First 6 Months)|Administrative reasons|0|||
129514053|NCT00131664|466170959|FG002|First Period (First 6 Months)|Administrative reasons|5|||
129514054|NCT00131664|466170960|FG003|First Period (First 6 Months)|Administrative reasons|0|||
129514055|NCT00131664|466170961|FG004|First Period (First 6 Months)|Administrative reasons|0|||
129514056|NCT00131664|466170962|FG005|First Period (First 6 Months)|Administrative reasons|0|||
129514057|NCT00131664|466170957|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
129514058|NCT00131664|466170958|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
129514059|NCT00131664|466170959|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
129514060|NCT00131664|466170960|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
129514061|NCT00131664|466170961|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
129514062|NCT00131664|466170962|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
129514063|NCT00131664|466170957|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
129514064|NCT00131664|466170958|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
129514065|NCT00131664|466170959|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
129514066|NCT00131664|466170960|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
129514067|NCT00131664|466170961|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
129514068|NCT00131664|466170962|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
129514069|NCT00131664|466170957|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
129514070|NCT00131664|466170958|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
129514071|NCT00131664|466170959|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
129514072|NCT00131664|466170960|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
129983580|NCT00888927|467902265|FG003|Overall Study|Withdrawal of consent|1|||
129983581|NCT03459443|467902266|FG000|Overall Study|Lack of Efficacy|3|||
129983582|NCT03459443|467902266|FG000|Overall Study|Adverse Event|1|||
129983583|NCT03459443|467902266|FG000|Overall Study|Sponsor's decision to close the study|18|||
129983584|NCT02153073|467902267|FG000|Overall Study|Case Report Forms Uncollected|230|||
129983585|NCT02153073|467902267|FG000|Overall Study|Protocol Deviation|68|||
129983586|NCT03702231|467902268|FG000|Overall Study|Withdrawal by Subject|1|||
129983587|NCT03702231|467902269|FG001|Overall Study|Withdrawal by Subject|0|||
129983588|NCT03702231|467902270|FG002|Overall Study|Withdrawal by Subject|0|||
129983589|NCT03702231|467902268|FG000|Overall Study|Protocol Violation|0|||
129983590|NCT03702231|467902269|FG001|Overall Study|Protocol Violation|0|||
129983591|NCT03702231|467902270|FG002|Overall Study|Protocol Violation|1|||
129983592|NCT03702231|467902268|FG000|Overall Study|Change in CLL Treatment|0|||
129983593|NCT03702231|467902269|FG001|Overall Study|Change in CLL Treatment|0|||
129983594|NCT03702231|467902270|FG002|Overall Study|Change in CLL Treatment|1|||
129983595|NCT03702231|467902268|FG000|Overall Study|COVID Pandemic|1|||
129983596|NCT03702231|467902269|FG001|Overall Study|COVID Pandemic|4|||
129983597|NCT03702231|467902270|FG002|Overall Study|COVID Pandemic|1|||
129983598|NCT03702231|467902268|FG000|Overall Study|Non-compliance|0|||
129983599|NCT03702231|467902269|FG001|Overall Study|Non-compliance|0|||
129983600|NCT03702231|467902270|FG002|Overall Study|Non-compliance|1|||
129983601|NCT03592745|467902271|FG000|Overall Study|Adverse Event|0|||
129983602|NCT03592745|467902272|FG001|Overall Study|Adverse Event|2|||
129983603|NCT03592745|467902271|FG000|Overall Study|Lost to Follow-up|2|||
129983604|NCT03592745|467902272|FG001|Overall Study|Lost to Follow-up|0|||
129983605|NCT03592745|467902271|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
129983606|NCT03592745|467902272|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
129983607|NCT03590366|467902273|FG000|Overall Study|Adverse Event|0|||
129983608|NCT03590366|467902274|FG001|Overall Study|Adverse Event|3|||
129983609|NCT03590366|467902273|FG000|Overall Study|Lost to Follow-up|3|||
129983610|NCT03590366|467902274|FG001|Overall Study|Lost to Follow-up|3|||
129983611|NCT03590366|467902273|FG000|Overall Study|Withdrawal by Subject|0|||
129983612|NCT03590366|467902274|FG001|Overall Study|Withdrawal by Subject|2|||
129983613|NCT00738894|467902275|FG000|Overall Study|Lost to Follow-up|23|||
129983614|NCT00738894|467902276|FG001|Overall Study|Lost to Follow-up|13|||
129983615|NCT00738894|467902275|FG000|Overall Study|Withdrawal by Subject|10|||
129983616|NCT00738894|467902276|FG001|Overall Study|Withdrawal by Subject|15|||
129983617|NCT00738894|467902275|FG000|Overall Study|Physician Decision|4|||
129983618|NCT00738894|467902276|FG001|Overall Study|Physician Decision|5|||
129983619|NCT00738894|467902275|FG000|Overall Study|Death|2|||
129983620|NCT00738894|467902276|FG001|Overall Study|Death|0|||
129983621|NCT01081665|467902277|FG000|Overall Study|Death|41|||
129983622|NCT01081665|467902277|FG000|Overall Study|Lost to Follow-up|18|||
129983623|NCT01081665|467902277|FG000|Overall Study|Withdrawal by Subject|17|||
129983624|NCT01081665|467902277|FG000|Overall Study|Change of dialysis unit|10|||
129514073|NCT00131664|466170961|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
129514074|NCT00131664|466170962|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
129983625|NCT01081665|467902277|FG000|Overall Study|Regulation of iPTH|5|||
129983626|NCT01081665|467902277|FG000|Overall Study|Change in renal replacement therapy|2|||
129983627|NCT01081665|467902277|FG000|Overall Study|Adverse Event|1|||
129983628|NCT01081665|467902277|FG000|Overall Study|Lack of Efficacy|1|||
129983629|NCT01413503|467902288|FG000|Overall Study|Lost to Follow-up|1|||
129983630|NCT02546921|467902289|FG000|Overall Study|Adverse Event|0|||
129983631|NCT02546921|467902290|FG001|Overall Study|Adverse Event|5|||
129983632|NCT02546921|467902291|FG002|Overall Study|Adverse Event|2|||
129983633|NCT02546921|467902292|FG003|Overall Study|Adverse Event|0|||
129514075|NCT00131664|466170957|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
129514076|NCT00131664|466170958|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
129514077|NCT00131664|466170959|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
129514078|NCT00131664|466170960|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
129514079|NCT00131664|466170961|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
129514080|NCT00131664|466170962|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
129514081|NCT00131664|466170957|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
129514082|NCT00131664|466170958|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
129514083|NCT00131664|466170959|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
129514084|NCT00131664|466170960|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
129514085|NCT00131664|466170961|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
129514086|NCT00131664|466170962|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
129514087|NCT00131664|466170957|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
129514088|NCT00131664|466170958|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
129514089|NCT00131664|466170959|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
129514090|NCT00131664|466170960|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
129983634|NCT02546921|467902293|FG004|Overall Study|Adverse Event|0|||
129983635|NCT02546921|467902294|FG005|Overall Study|Adverse Event|0|||
129983636|NCT02546921|467902295|FG006|Overall Study|Adverse Event|0|||
129983637|NCT02546921|467902289|FG000|Overall Study|Evidence of Disease Progression|1|||
129983638|NCT02546921|467902290|FG001|Overall Study|Evidence of Disease Progression|0|||
129983639|NCT02546921|467902291|FG002|Overall Study|Evidence of Disease Progression|0|||
129983640|NCT02546921|467902292|FG003|Overall Study|Evidence of Disease Progression|0|||
129983641|NCT02546921|467902293|FG004|Overall Study|Evidence of Disease Progression|1|||
129983642|NCT02546921|467902294|FG005|Overall Study|Evidence of Disease Progression|0|||
129983643|NCT02546921|467902295|FG006|Overall Study|Evidence of Disease Progression|0|||
129983644|NCT02546921|467902289|FG000|Overall Study|Patient Choice|0|||
129983645|NCT02546921|467902290|FG001|Overall Study|Patient Choice|1|||
129983646|NCT02546921|467902291|FG002|Overall Study|Patient Choice|0|||
129983647|NCT02546921|467902292|FG003|Overall Study|Patient Choice|0|||
129983648|NCT02546921|467902293|FG004|Overall Study|Patient Choice|0|||
129983649|NCT02546921|467902294|FG005|Overall Study|Patient Choice|1|||
129983650|NCT02546921|467902295|FG006|Overall Study|Patient Choice|0|||
129983651|NCT03026075|467902299|FG000|Overall Study|Physician Decision|1|||
129983652|NCT03381339|467902300|FG000|Overall Study|Protocol Violation|4|||
129983653|NCT03381339|467902301|FG001|Overall Study|Protocol Violation|3|||
129983654|NCT03381339|467902300|FG000|Overall Study|Lost to Follow-up|0|||
129983655|NCT03381339|467902301|FG001|Overall Study|Lost to Follow-up|1|||
129983656|NCT04927247|467902303|FG000|Overall Study|Other|2|||
129983657|NCT04927247|467902304|FG001|Overall Study|Other|1|||
129983658|NCT04927247|467902303|FG000|Overall Study|Physician Decision|0|||
129983659|NCT04927247|467902304|FG001|Overall Study|Physician Decision|1|||
129983660|NCT04927247|467902303|FG000|Overall Study|Adverse Event|1|||
129983661|NCT04927247|467902304|FG001|Overall Study|Adverse Event|0|||
129983662|NCT00293059|467902305|FG000|Overall Study|Adverse Event|12|||
129983663|NCT00293059|467902306|FG001|Overall Study|Adverse Event|4|||
129983664|NCT00293059|467902305|FG000|Overall Study|Lack of Efficacy|2|||
129983665|NCT00293059|467902306|FG001|Overall Study|Lack of Efficacy|0|||
129983666|NCT00293059|467902305|FG000|Overall Study|Lost to Follow-up|2|||
129983667|NCT00293059|467902306|FG001|Overall Study|Lost to Follow-up|3|||
129983668|NCT00293059|467902305|FG000|Overall Study|Pregnancy|1|||
129983669|NCT00293059|467902306|FG001|Overall Study|Pregnancy|1|||
129983670|NCT00293059|467902305|FG000|Overall Study|Protocol Violation|2|||
129983671|NCT00293059|467902306|FG001|Overall Study|Protocol Violation|0|||
129983672|NCT00293059|467902305|FG000|Overall Study|Withdrawal by Subject|11|||
129983673|NCT00293059|467902306|FG001|Overall Study|Withdrawal by Subject|5|||
129983674|NCT00293059|467902305|FG000|Overall Study|Participant moved out of state|1|||
129983675|NCT00293059|467902306|FG001|Overall Study|Participant moved out of state|0|||
129983676|NCT00293059|467902305|FG000|Overall Study|Participant stopped study drug|1|||
129983677|NCT00293059|467902306|FG001|Overall Study|Participant stopped study drug|0|||
129983678|NCT00293059|467902305|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
129983679|NCT00293059|467902306|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
129983680|NCT00293059|467902305|FG000|Overall Study|missing|3|||
129983681|NCT00293059|467902306|FG001|Overall Study|missing|5|||
129983682|NCT02227199|467902321|FG000|Overall Study|Physician Decision|0|||
129983683|NCT02227199|467902322|FG001|Overall Study|Physician Decision|0|||
129983684|NCT02227199|467902323|FG002|Overall Study|Physician Decision|1|||
129983685|NCT02227199|467902321|FG000|Overall Study|Adverse Event|0|||
129983686|NCT02227199|467902322|FG001|Overall Study|Adverse Event|0|||
129983687|NCT02227199|467902323|FG002|Overall Study|Adverse Event|3|||
129983688|NCT05597787|467902324|FG000|Overall Study|Withdrawal by Subject|0|||
129983689|NCT05597787|467902325|FG001|Overall Study|Withdrawal by Subject|0|||
129983690|NCT05597787|467902326|FG002|Overall Study|Withdrawal by Subject|1|||
129514091|NCT00131664|466170961|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
129514092|NCT00131664|466170962|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
129514093|NCT00107172|466172767|FG000|Overall Study|Withdrawal by Subject|1|||
129983691|NCT05453201|467902328|FG000|Overall Study|Withdrawal by Subject|1|||
129514094|NCT00107172|466172768|FG001|Overall Study|Withdrawal by Subject|0|||
129514095|NCT00107172|466172767|FG000|Overall Study|Death|0|||
129514096|NCT00107172|466172768|FG001|Overall Study|Death|2|||
129514097|NCT00107172|466172767|FG000|Overall Study|Other Reason|4|||
129983692|NCT01934790|467902329|FG000|Treatment|Adverse Event|3|||
129983693|NCT01934790|467902329|FG000|Treatment|Clinical progression|6|||
129983694|NCT01934790|467902329|FG000|Treatment|Radiological progression|4|||
129983695|NCT01934790|467902329|FG000|Treatment|Withdrawal by Subject|2|||
129983696|NCT01934790|467902329|FG000|Treatment|Study drug never administered|1|||
129983697|NCT01934790|467902329|FG000|Active Follow up|Death|20|||
129983698|NCT01934790|467902329|FG000|Active Follow up|Physician Decision|2|||
129983699|NCT01934790|467902329|FG000|Active Follow up|Progressive disease|1|||
129983700|NCT01934790|467902329|FG000|Active Follow up|Other reason|1|||
129983701|NCT03798691|467902330|FG000|Overall Study|Lost to Follow-up|2|||
129983702|NCT03798691|467902331|FG001|Overall Study|Lost to Follow-up|2|||
129983703|NCT01241604|467902337|FG000|Screening Period|Screen Failure|3|||
129983704|NCT01241604|467902338|FG001|Screening Period|Screen Failure|0|||
129983705|NCT01241604|467902339|FG002|Screening Period|Screen Failure|0|||
129983706|NCT01865747|467902341|FG000|Overall Study (ITT)|Adverse Event|32|||
129983707|NCT01865747|467902342|FG001|Overall Study (ITT)|Adverse Event|31|||
129983708|NCT01865747|467902341|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
129983709|NCT01865747|467902342|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
129983710|NCT01865747|467902341|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
129983711|NCT01865747|467902342|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
129983712|NCT01865747|467902341|FG000|Overall Study (ITT)|Protocol Violation|1|||
129983713|NCT01865747|467902342|FG001|Overall Study (ITT)|Protocol Violation|1|||
129983714|NCT01865747|467902341|FG000|Overall Study (ITT)|Physician Decision|5|||
129983715|NCT01865747|467902342|FG001|Overall Study (ITT)|Physician Decision|2|||
129983716|NCT01865747|467902341|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
129983717|NCT01865747|467902342|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
129983718|NCT01865747|467902341|FG000|Overall Study (ITT)|Sponsor Decision|0|||
129983719|NCT01865747|467902342|FG001|Overall Study (ITT)|Sponsor Decision|1|||
129983720|NCT01865747|467902341|FG000|Overall Study (ITT)|Progressive Disease|122|||
129983721|NCT01865747|467902342|FG001|Overall Study (ITT)|Progressive Disease|158|||
129983722|NCT01865747|467902341|FG000|Overall Study (ITT)|Reason Not Provided|0|||
129983723|NCT01865747|467902342|FG001|Overall Study (ITT)|Reason Not Provided|1|||
129983724|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
129983725|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
129983726|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
129983727|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
129983728|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
129983729|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
129983730|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
129983731|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
129983732|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
129983733|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
129983734|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
129983735|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
129983736|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
129983737|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
129983738|NCT01865747|467902341|FG000|Primary Intent to Treat (PITT)|Other|0|||
129983739|NCT01865747|467902342|FG001|Primary Intent to Treat (PITT)|Other|1|||
129983740|NCT02592876|467902343|FG000|Overall Study|Withdrawal by Subject|3|||
129983741|NCT02592876|467902344|FG001|Overall Study|Withdrawal by Subject|3|||
129983742|NCT02592876|467902343|FG000|Overall Study|Study Termination by Sponsor|32|||
129983743|NCT02592876|467902344|FG001|Overall Study|Study Termination by Sponsor|27|||
129983744|NCT02592876|467902343|FG000|Overall Study|Lost to Follow-up|0|||
129514098|NCT00107172|466172768|FG001|Overall Study|Other Reason|3|||
129514099|NCT02687711|466172769|FG000|Overall Study|Adverse Event|89|||
129514100|NCT02687711|466172769|FG000|Overall Study|Lack of Efficacy|70|||
129514101|NCT02687711|466172769|FG000|Overall Study|Lost to Follow-up|20|||
129514102|NCT02687711|466172769|FG000|Overall Study|Consent withdrawn|15|||
129514103|NCT02687711|466172769|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
129514104|NCT02687711|466172769|FG000|Overall Study|Too expensive|4|||
129514105|NCT02687711|466172769|FG000|Overall Study|Participant moved abroad|1|||
129514106|NCT02687711|466172769|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
129538499|NCT05664672|466262110|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
129983745|NCT02592876|467902344|FG001|Overall Study|Lost to Follow-up|1|||
129983746|NCT02592876|467902343|FG000|Overall Study|Death|6|||
129983747|NCT02592876|467902344|FG001|Overall Study|Death|9|||
129514107|NCT02687711|466172769|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
129514108|NCT02687711|466172769|FG000|Overall Study|Disliked taste|1|||
129514109|NCT02687711|466172769|FG000|Overall Study|Low mood|1|||
129514110|NCT02687711|466172769|FG000|Overall Study|Side effects|1|||
129514111|NCT02687711|466172769|FG000|Overall Study|Change of Hospital|1|||
129514112|NCT02687711|466172769|FG000|Overall Study|Liver Encephalopathy|1|||
129514113|NCT02687711|466172769|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
129514114|NCT02687711|466172769|FG000|Overall Study|Withdrawn due to intake interruption|1|||
129514115|NCT02687711|466172769|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
129514116|NCT02687711|466172769|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
129514117|NCT02687711|466172769|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
129514118|NCT03621189|466172770|FG000|Overall Study|Withdrawal by Subject|0|||
129514119|NCT03621189|466172771|FG001|Overall Study|Withdrawal by Subject|3|||
129514120|NCT03621189|466172770|FG000|Overall Study|Physician Decision|0|||
129514121|NCT03621189|466172771|FG001|Overall Study|Physician Decision|2|||
129514122|NCT03706040|466172774|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
129514123|NCT03706040|466172775|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
129514124|NCT03706040|466172776|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
129514125|NCT03706040|466172777|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
129514126|NCT03706040|466172778|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
129514127|NCT03706040|466172779|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
129514128|NCT03706040|466172780|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
129514129|NCT03706040|466172774|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
129514130|NCT03706040|466172775|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
129514131|NCT03706040|466172776|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
129514132|NCT03706040|466172777|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
129514133|NCT03706040|466172778|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
129514134|NCT03706040|466172779|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
129514135|NCT03706040|466172780|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
129514136|NCT03706040|466172774|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
129514137|NCT03706040|466172775|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
129514138|NCT03706040|466172776|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
129514139|NCT03706040|466172777|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
129514140|NCT03706040|466172778|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
129514141|NCT03706040|466172779|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
129514142|NCT03706040|466172780|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
129514143|NCT03706040|466172774|FG000|Period A (Week 0 to Week 16)|Other|2|||
129514144|NCT03706040|466172775|FG001|Period A (Week 0 to Week 16)|Other|0|||
129514145|NCT03706040|466172776|FG002|Period A (Week 0 to Week 16)|Other|2|||
129514146|NCT03706040|466172777|FG003|Period A (Week 0 to Week 16)|Other|0|||
129514147|NCT03706040|466172778|FG004|Period A (Week 0 to Week 16)|Other|0|||
129514148|NCT03706040|466172779|FG005|Period A (Week 0 to Week 16)|Other|0|||
129514149|NCT03706040|466172780|FG006|Period A (Week 0 to Week 16)|Other|0|||
129514150|NCT03706040|466172774|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
129514151|NCT03706040|466172775|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
129514152|NCT03706040|466172776|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
129514153|NCT03706040|466172777|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
129514154|NCT03706040|466172778|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
129514155|NCT03706040|466172779|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
129514156|NCT03706040|466172780|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
129514157|NCT03706040|466172774|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
129514158|NCT03706040|466172775|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
129514159|NCT03706040|466172776|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
129514160|NCT03706040|466172777|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
129514161|NCT03706040|466172778|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
129514162|NCT03706040|466172779|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
129514163|NCT03706040|466172780|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
129514164|NCT03706040|466172774|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129514165|NCT03706040|466172775|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129514166|NCT03706040|466172776|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129514167|NCT03706040|466172777|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129514168|NCT03706040|466172778|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
129514169|NCT03706040|466172779|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
129514170|NCT03706040|466172780|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
129514171|NCT03706040|466172774|FG000|Period B (Week 16 to Week 52)|Other|0|||
129514172|NCT03706040|466172775|FG001|Period B (Week 16 to Week 52)|Other|0|||
129514173|NCT03706040|466172776|FG002|Period B (Week 16 to Week 52)|Other|0|||
129514174|NCT03706040|466172777|FG003|Period B (Week 16 to Week 52)|Other|4|||
129514175|NCT03706040|466172778|FG004|Period B (Week 16 to Week 52)|Other|5|||
129514176|NCT03706040|466172779|FG005|Period B (Week 16 to Week 52)|Other|23|||
129514177|NCT03706040|466172780|FG006|Period B (Week 16 to Week 52)|Other|17|||
129514178|NCT03077243|466172781|FG000|Overall Study|Death|1|||
129514179|NCT03077243|466172782|FG001|Overall Study|Death|2|||
129514180|NCT03077243|466172783|FG002|Overall Study|Death|0|||
129514181|NCT03077243|466172784|FG003|Overall Study|Death|0|||
129514182|NCT03077243|466172781|FG000|Overall Study|Withdrawal by Subject|1|||
129514183|NCT03077243|466172782|FG001|Overall Study|Withdrawal by Subject|3|||
129514184|NCT03077243|466172783|FG002|Overall Study|Withdrawal by Subject|0|||
129514185|NCT03077243|466172784|FG003|Overall Study|Withdrawal by Subject|0|||
129514186|NCT03077243|466172781|FG000|Overall Study|Physician Decision|1|||
129514187|NCT03077243|466172782|FG001|Overall Study|Physician Decision|0|||
129514188|NCT03077243|466172783|FG002|Overall Study|Physician Decision|0|||
129514189|NCT03077243|466172784|FG003|Overall Study|Physician Decision|0|||
129514190|NCT03077243|466172781|FG000|Overall Study|Research at two study sites terminated early|0|||
129514191|NCT03077243|466172782|FG001|Overall Study|Research at two study sites terminated early|0|||
129514192|NCT03077243|466172783|FG002|Overall Study|Research at two study sites terminated early|0|||
129514193|NCT03077243|466172784|FG003|Overall Study|Research at two study sites terminated early|69|||
129514194|NCT00607919|466172785|FG000|Acute Phase|Adverse Event|9|||
129514195|NCT00607919|466172786|FG001|Acute Phase|Adverse Event|2|||
129514196|NCT00607919|466172785|FG000|Acute Phase|Entry Criteria Not Met|1|||
129514197|NCT00607919|466172786|FG001|Acute Phase|Entry Criteria Not Met|1|||
129514198|NCT00607919|466172785|FG000|Acute Phase|Lack of Efficacy|1|||
129514199|NCT00607919|466172786|FG001|Acute Phase|Lack of Efficacy|2|||
129514200|NCT00607919|466172785|FG000|Acute Phase|Lost to Follow-up|9|||
129514201|NCT00607919|466172786|FG001|Acute Phase|Lost to Follow-up|3|||
129514202|NCT00607919|466172785|FG000|Acute Phase|Parent/Caregiver Decision|6|||
129514203|NCT00607919|466172786|FG001|Acute Phase|Parent/Caregiver Decision|4|||
129514204|NCT00607919|466172785|FG000|Acute Phase|Protocol Violation|5|||
129514205|NCT00607919|466172786|FG001|Acute Phase|Protocol Violation|1|||
129514206|NCT00607919|466172785|FG000|Acute Phase|Withdrawal by Subject|3|||
129514207|NCT00607919|466172786|FG001|Acute Phase|Withdrawal by Subject|3|||
129514208|NCT00607919|466172785|FG000|Open-Label Phase|Adverse Event|1|||
129514209|NCT00607919|466172786|FG001|Open-Label Phase|Adverse Event|5|||
129514210|NCT00607919|466172785|FG000|Open-Label Phase|Lost to Follow-up|4|||
129514211|NCT00607919|466172786|FG001|Open-Label Phase|Lost to Follow-up|1|||
129514212|NCT00607919|466172785|FG000|Open-Label Phase|Protocol Violation|2|||
129514213|NCT00607919|466172786|FG001|Open-Label Phase|Protocol Violation|2|||
129514214|NCT00607919|466172785|FG000|Open-Label Phase|Withdrawal by Subject|2|||
129514215|NCT00607919|466172786|FG001|Open-Label Phase|Withdrawal by Subject|2|||
129514216|NCT00607919|466172785|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
129514217|NCT00607919|466172786|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
129514218|NCT02580240|466172799|FG000|Overall Study|Physician Decision|2|||
129514219|NCT02580240|466172800|FG001|Overall Study|Physician Decision|0|||
129514220|NCT02007252|466172803|FG000|Overall Study|Administrative problems|3|||
129514221|NCT02007252|466172804|FG001|Overall Study|Administrative problems|7|||
129514222|NCT02007252|466172803|FG000|Overall Study|Abnormal laboratory value(s)|1|||
129514223|NCT02007252|466172804|FG001|Overall Study|Abnormal laboratory value(s)|0|||
129514224|NCT02007252|466172803|FG000|Overall Study|Adverse Event|7|||
129514225|NCT02007252|466172804|FG001|Overall Study|Adverse Event|4|||
129514226|NCT02001688|466172805|FG000|Overall Study|Withdrawal by Subject|0|||
129514227|NCT02001688|466172806|FG001|Overall Study|Withdrawal by Subject|0|||
129514228|NCT02001688|466172807|FG002|Overall Study|Withdrawal by Subject|1|||
129514229|NCT02001688|466172805|FG000|Overall Study|Adverse Event|0|||
129514230|NCT02001688|466172806|FG001|Overall Study|Adverse Event|1|||
129514231|NCT02001688|466172807|FG002|Overall Study|Adverse Event|0|||
129514232|NCT01989754|466172808|FG000|Overall Study|Withdrawal by Subject|10|||
129514233|NCT01989754|466172809|FG001|Overall Study|Withdrawal by Subject|14|||
129514234|NCT01989754|466172808|FG000|Overall Study|Lost to Follow-up|28|||
129514235|NCT01989754|466172809|FG001|Overall Study|Lost to Follow-up|20|||
129514236|NCT01989754|466172808|FG000|Overall Study|Closed Site|1|||
129514237|NCT01989754|466172809|FG001|Overall Study|Closed Site|1|||
129514238|NCT05441540|466172810|FG000|Overall Study|Withdrawal by Subject|2|||
129514239|NCT00813917|466172811|FG000|Overall Study|Adverse Event|0|||
129514240|NCT00813917|466172812|FG001|Overall Study|Adverse Event|1|||
129514241|NCT00813917|466172811|FG000|Overall Study|Withdrawal by Subject|3|||
129514242|NCT00813917|466172812|FG001|Overall Study|Withdrawal by Subject|4|||
129514243|NCT00813917|466172811|FG000|Overall Study|Lost to Follow-up|3|||
129514244|NCT00813917|466172812|FG001|Overall Study|Lost to Follow-up|1|||
129514245|NCT00792701|466172816|FG000|Overall Study|Adverse Event|0|||
129514246|NCT00792701|466172817|FG001|Overall Study|Adverse Event|22|||
129514247|NCT00792701|466172816|FG000|Overall Study|Ineligible|1|||
129514248|NCT00792701|466172817|FG001|Overall Study|Ineligible|3|||
129514249|NCT00792701|466172816|FG000|Overall Study|Withdrawal by Subject|1|||
129514250|NCT00792701|466172817|FG001|Overall Study|Withdrawal by Subject|19|||
129514251|NCT00792701|466172816|FG000|Overall Study|Not protocol specified|17|||
129514252|NCT00792701|466172817|FG001|Overall Study|Not protocol specified|0|||
129514253|NCT02143141|466172824|FG000|Overall Study|pain scores at 24 hours not collected|1|||
129539302|NCT01397409|466265249|FG007|Stage 2|Adverse Event|0|||
129514254|NCT02143141|466172825|FG001|Overall Study|pain scores at 24 hours not collected|0|||
129514255|NCT00064077|466172826|FG000|Overall Study|Improper prior treatment|1|||
129514256|NCT00064077|466172827|FG001|Overall Study|Improper prior treatment|0|||
129514257|NCT00064077|466172828|FG002|Overall Study|Improper prior treatment|0|||
129514258|NCT00064077|466172829|FG003|Overall Study|Improper prior treatment|0|||
129514259|NCT00064077|466172826|FG000|Overall Study|Poor risk|2|||
129514260|NCT00064077|466172827|FG001|Overall Study|Poor risk|0|||
129514261|NCT00064077|466172828|FG002|Overall Study|Poor risk|1|||
129514262|NCT00064077|466172829|FG003|Overall Study|Poor risk|1|||
129514263|NCT00064077|466172826|FG000|Overall Study|Pathology|10|||
129514264|NCT00064077|466172827|FG001|Overall Study|Pathology|7|||
129514265|NCT00064077|466172828|FG002|Overall Study|Pathology|3|||
129514266|NCT00064077|466172829|FG003|Overall Study|Pathology|4|||
129514267|NCT00064077|466172826|FG000|Overall Study|No surgery|0|||
129514268|NCT00064077|466172827|FG001|Overall Study|No surgery|0|||
129514269|NCT00064077|466172828|FG002|Overall Study|No surgery|1|||
129514270|NCT00064077|466172829|FG003|Overall Study|No surgery|0|||
129514271|NCT00064077|466172826|FG000|Overall Study|No tumor|0|||
129514272|NCT00064077|466172827|FG001|Overall Study|No tumor|0|||
129514273|NCT00064077|466172828|FG002|Overall Study|No tumor|1|||
129514274|NCT00064077|466172829|FG003|Overall Study|No tumor|0|||
129514275|NCT00064077|466172826|FG000|Overall Study|Other reasons|2|||
129514276|NCT00064077|466172827|FG001|Overall Study|Other reasons|2|||
129514277|NCT00064077|466172828|FG002|Overall Study|Other reasons|1|||
129514278|NCT00064077|466172829|FG003|Overall Study|Other reasons|2|||
129514279|NCT00879437|466172830|FG000|Overall Study|Protocol Violation|0|||
129514280|NCT00879437|466172831|FG001|Overall Study|Protocol Violation|1|||
129514281|NCT00879437|466172830|FG000|Overall Study|Death|1|||
129514282|NCT00879437|466172831|FG001|Overall Study|Death|0|||
129514283|NCT03000686|466172832|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
129514284|NCT03000686|466172833|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
129514285|NCT03000686|466172834|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
129514286|NCT03000686|466172835|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
129514287|NCT01112982|466172838|FG000|Overall Study|Withdrawal by Subject|1|||
129514288|NCT01112982|466172838|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
129514289|NCT00294684|466172839|FG000|Overall Study|Lost to Follow-up|5|||
129514290|NCT00294684|466172840|FG001|Overall Study|Lost to Follow-up|8|||
129514291|NCT00389441|466172841|FG000|Overall Study|Adverse Event|7|||
129514292|NCT00389441|466172841|FG000|Overall Study|Death|4|||
129514293|NCT00389441|466172841|FG000|Overall Study|Lost to Follow-up|2|||
129514294|NCT00389441|466172841|FG000|Overall Study|Withdrawal by Subject|4|||
129514295|NCT00389441|466172841|FG000|Overall Study|Physician Decision|1|||
129514296|NCT00389441|466172841|FG000|Overall Study|Protocol Violation|1|||
129514297|NCT00389441|466172841|FG000|Overall Study|Global deterioration of health status|4|||
129514298|NCT00389441|466172841|FG000|Overall Study|Objective progression or relapse|26|||
129514299|NCT00389441|466172841|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
129514300|NCT00389441|466172841|FG000|Overall Study|Clinical progression|1|||
129514301|NCT01981109|466172842|FG000|Overall Study|Death|36|||
129514302|NCT01981109|466172842|FG000|Overall Study|Withdrawal by Subject|40|||
129514303|NCT01981109|466172842|FG000|Overall Study|Lost to Follow-up|9|||
129514304|NCT01981109|466172842|FG000|Overall Study|No Discontinuation Documentation|37|||
129514305|NCT01981109|466172842|FG000|Overall Study|Study Termination|100|||
129514306|NCT01981109|466172842|FG000|Overall Study|No data available|2|||
129514307|NCT00126672|466172844|FG000|Overall Study|Adverse Event|4|||
129514308|NCT00126672|466172844|FG000|Overall Study|Lost to Follow-up|4|||
129514309|NCT01001234|466172850|FG000|Overall Study|Withdrawal by Subject|2|||
129514310|NCT01001234|466172851|FG001|Overall Study|Withdrawal by Subject|0|||
129983748|NCT00611975|467902349|FG000|Overall Study|Withdrawal by Subject|3|||
129514311|NCT01001234|466172852|FG002|Overall Study|Withdrawal by Subject|3|||
129514312|NCT01001234|466172853|FG003|Overall Study|Withdrawal by Subject|0|||
129514313|NCT01001234|466172854|FG004|Overall Study|Withdrawal by Subject|0|||
129983749|NCT00611975|467902350|FG001|Overall Study|Withdrawal by Subject|7|||
129983750|NCT00611975|467902349|FG000|Overall Study|Pregnancy|2|||
129514314|NCT01001234|466172850|FG000|Overall Study|Protocol Violation|34|||
129514315|NCT01001234|466172851|FG001|Overall Study|Protocol Violation|3|||
129514316|NCT01001234|466172852|FG002|Overall Study|Protocol Violation|19|||
129514317|NCT01001234|466172853|FG003|Overall Study|Protocol Violation|18|||
129514318|NCT01001234|466172854|FG004|Overall Study|Protocol Violation|0|||
129514319|NCT01001234|466172850|FG000|Overall Study|Lost to Follow-up|0|||
129514320|NCT01001234|466172851|FG001|Overall Study|Lost to Follow-up|0|||
129514321|NCT01001234|466172852|FG002|Overall Study|Lost to Follow-up|1|||
129514322|NCT01001234|466172853|FG003|Overall Study|Lost to Follow-up|2|||
129514323|NCT01001234|466172854|FG004|Overall Study|Lost to Follow-up|0|||
129514324|NCT01001234|466172850|FG000|Overall Study|Physician Decision|1|||
129514325|NCT01001234|466172851|FG001|Overall Study|Physician Decision|0|||
129514326|NCT01001234|466172852|FG002|Overall Study|Physician Decision|0|||
129514327|NCT01001234|466172853|FG003|Overall Study|Physician Decision|0|||
129514328|NCT01001234|466172854|FG004|Overall Study|Physician Decision|0|||
129514329|NCT01001234|466172850|FG000|Overall Study|Not Treated: Adverse Event|1|||
129514330|NCT01001234|466172851|FG001|Overall Study|Not Treated: Adverse Event|0|||
129514331|NCT01001234|466172852|FG002|Overall Study|Not Treated: Adverse Event|0|||
129514332|NCT01001234|466172853|FG003|Overall Study|Not Treated: Adverse Event|0|||
129514333|NCT01001234|466172854|FG004|Overall Study|Not Treated: Adverse Event|0|||
129514334|NCT01001234|466172850|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
129514335|NCT01001234|466172851|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
129514336|NCT01001234|466172852|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
129514337|NCT01001234|466172853|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
129514338|NCT01001234|466172854|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
129514339|NCT01001234|466172850|FG000|Overall Study|Not Treated: Protocol Violation|3|||
129514340|NCT01001234|466172851|FG001|Overall Study|Not Treated: Protocol Violation|0|||
129514341|NCT01001234|466172852|FG002|Overall Study|Not Treated: Protocol Violation|0|||
129514342|NCT01001234|466172853|FG003|Overall Study|Not Treated: Protocol Violation|0|||
129514343|NCT01001234|466172854|FG004|Overall Study|Not Treated: Protocol Violation|0|||
129514344|NCT01001234|466172850|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
129514345|NCT01001234|466172851|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
129514346|NCT01001234|466172852|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
129514347|NCT01001234|466172853|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
129514348|NCT01001234|466172854|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
129514349|NCT01001234|466172850|FG000|Overall Study|Not Treated: Pregnancy|3|||
129514350|NCT01001234|466172851|FG001|Overall Study|Not Treated: Pregnancy|0|||
129514351|NCT01001234|466172852|FG002|Overall Study|Not Treated: Pregnancy|0|||
129514352|NCT01001234|466172853|FG003|Overall Study|Not Treated: Pregnancy|0|||
129514353|NCT01001234|466172854|FG004|Overall Study|Not Treated: Pregnancy|0|||
129514354|NCT01001234|466172850|FG000|Overall Study|Not Treated: Physician Decision|37|||
129514355|NCT01001234|466172851|FG001|Overall Study|Not Treated: Physician Decision|4|||
129514356|NCT01001234|466172852|FG002|Overall Study|Not Treated: Physician Decision|0|||
129514357|NCT01001234|466172853|FG003|Overall Study|Not Treated: Physician Decision|0|||
129514358|NCT01001234|466172854|FG004|Overall Study|Not Treated: Physician Decision|0|||
129514359|NCT01001234|466172850|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
129514360|NCT01001234|466172851|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
129514361|NCT01001234|466172852|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
129514362|NCT01001234|466172853|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
129514363|NCT01001234|466172854|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
129514364|NCT02076334|466172856|FG000|Overall Study|Protocol Violation|1|||
129514365|NCT02076334|466172857|FG001|Overall Study|Protocol Violation|0|||
129514366|NCT02076334|466172858|FG002|Overall Study|Protocol Violation|0|||
129514367|NCT02076334|466172859|FG003|Overall Study|Protocol Violation|0|||
129514368|NCT02076334|466172856|FG000|Overall Study|Lost to Follow-up|0|||
129514369|NCT02076334|466172857|FG001|Overall Study|Lost to Follow-up|1|||
129514370|NCT02076334|466172858|FG002|Overall Study|Lost to Follow-up|1|||
129514371|NCT02076334|466172859|FG003|Overall Study|Lost to Follow-up|0|||
129514372|NCT02076334|466172856|FG000|Overall Study|muscle soreness|0|||
129514373|NCT02076334|466172857|FG001|Overall Study|muscle soreness|0|||
129514374|NCT02076334|466172858|FG002|Overall Study|muscle soreness|0|||
129514375|NCT02076334|466172859|FG003|Overall Study|muscle soreness|1|||
129514376|NCT03379376|466172860|FG000|Overall Study|Lost to Follow-up|2|||
129514377|NCT03379376|466172860|FG000|Overall Study|Did not wish to complete follow up|1|||
129514378|NCT03379376|466172860|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
129514379|NCT03379376|466172860|FG000|Overall Study|Death|1|||
129514380|NCT01611298|466172861|FG000|Overall Study|Relapsed|2|||
129514381|NCT00753623|466172862|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
129514382|NCT00753623|466172863|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
129514383|NCT00753623|466172862|FG000|Phase I (14 Days)|Physician Decision|1|||
129514384|NCT00753623|466172863|FG001|Phase I (14 Days)|Physician Decision|2|||
129514385|NCT00753623|466172862|FG000|Phase I (14 Days)|Adverse Event|0|||
129514386|NCT00753623|466172863|FG001|Phase I (14 Days)|Adverse Event|1|||
129983751|NCT00611975|467902350|FG001|Overall Study|Pregnancy|1|||
129514387|NCT00753623|466172862|FG000|Washout (7 Days)|Physician Decision|1|||
129514388|NCT00753623|466172863|FG001|Washout (7 Days)|Physician Decision|0|||
129514389|NCT00753623|466172862|FG000|Phase II (14 Days)|Physician Decision|0|||
129514390|NCT00753623|466172863|FG001|Phase II (14 Days)|Physician Decision|1|||
129983752|NCT03465904|467902351|FG000|Overall Study|Withdrawal by Subject|9|||
129514391|NCT03332303|466172864|FG000|Overall Study|Participant did not dose|1|||
129514392|NCT03332303|466172865|FG001|Overall Study|Participant did not dose|2|||
129514393|NCT03332303|466172866|FG002|Overall Study|Participant did not dose|0|||
129514394|NCT03332303|466172864|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
129514395|NCT03332303|466172865|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
129514396|NCT03332303|466172866|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
129514397|NCT03332303|466172864|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
129514398|NCT03332303|466172865|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
129983753|NCT03465904|467902352|FG001|Overall Study|Withdrawal by Subject|5|||
129983754|NCT03465904|467902351|FG000|Overall Study|Lost to Follow-up|11|||
129539303|NCT01397409|466265250|FG008|Stage 2|Adverse Event|0|||
129514399|NCT03332303|466172866|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
129514400|NCT03332303|466172864|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
129514401|NCT03332303|466172865|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
129514402|NCT03332303|466172866|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
129514403|NCT03332303|466172864|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
129514404|NCT03332303|466172865|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
129514405|NCT03332303|466172866|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
129514406|NCT03332303|466172864|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
129514407|NCT03332303|466172865|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
129514408|NCT03332303|466172866|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
129514409|NCT03332303|466172864|FG000|Overall Study|Participant had a significant protocol deviation|0|||
129514410|NCT03332303|466172865|FG001|Overall Study|Participant had a significant protocol deviation|1|||
129514411|NCT03332303|466172866|FG002|Overall Study|Participant had a significant protocol deviation|0|||
129514412|NCT01296698|466172867|FG000|Overall Study|Adverse Event|1|||
129514413|NCT01296698|466172868|FG001|Overall Study|Adverse Event|0|||
129514414|NCT01296698|466172867|FG000|Overall Study|Death|1|||
129514415|NCT01296698|466172868|FG001|Overall Study|Death|0|||
129514416|NCT01296698|466172867|FG000|Overall Study|Lost to Follow-up|19|||
129514417|NCT01296698|466172868|FG001|Overall Study|Lost to Follow-up|1|||
129514418|NCT01296698|466172867|FG000|Overall Study|Withdrawal by Subject|12|||
129514419|NCT01296698|466172868|FG001|Overall Study|Withdrawal by Subject|0|||
129514420|NCT01296698|466172867|FG000|Overall Study|Difficulty Contacting Subject|2|||
129514421|NCT01296698|466172868|FG001|Overall Study|Difficulty Contacting Subject|0|||
129514422|NCT01296698|466172867|FG000|Overall Study|Study Terminated by Sponsor|209|||
129514423|NCT01296698|466172868|FG001|Overall Study|Study Terminated by Sponsor|12|||
129514424|NCT03639987|466172869|FG000|Overall Study|Study terminated by sponsor|26|||
129514425|NCT03639987|466172870|FG001|Overall Study|Study terminated by sponsor|25|||
129514426|NCT03639987|466172869|FG000|Overall Study|Lost to Follow-up|0|||
129514427|NCT03639987|466172870|FG001|Overall Study|Lost to Follow-up|1|||
129514428|NCT02559713|466172877|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
129514429|NCT00889681|466172882|FG000|Overall Study|Not meeting qualification Criteria|2|||
129514430|NCT00889681|466172882|FG000|Overall Study|Insurance disapproval|1|||
129514431|NCT01185704|466172883|FG000|Overall Study|Randomized but not treated|3|||
129514432|NCT01185704|466172884|FG001|Overall Study|Randomized but not treated|3|||
129514433|NCT01185704|466172883|FG000|Overall Study|Lack of ovarian response|5|||
129514434|NCT01185704|466172884|FG001|Overall Study|Lack of ovarian response|1|||
129514435|NCT01185704|466172883|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
129514436|NCT01185704|466172884|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
129514437|NCT01185704|466172883|FG000|Overall Study|Ectopic pregnancy|0|||
129514438|NCT01185704|466172884|FG001|Overall Study|Ectopic pregnancy|1|||
129514439|NCT01686958|466172885|FG000|Overall Study|Withdrawal by Subject|1|||
129514440|NCT01151540|466172886|FG000|Overall Study|Other|2|||
129514441|NCT01151540|466172886|FG000|Overall Study|Adverse event, non-fatal|4|||
129514442|NCT01151540|466172886|FG000|Overall Study|Withdrawal by Subject|7|||
129514443|NCT03094832|466172887|FG000|Overall Study|Lost to Follow-up|0|||
129514444|NCT03094832|466172888|FG001|Overall Study|Lost to Follow-up|0|||
129514445|NCT03094832|466172889|FG002|Overall Study|Lost to Follow-up|0|||
129514446|NCT03094832|466172890|FG003|Overall Study|Lost to Follow-up|1|||
129514447|NCT03094832|466172891|FG004|Overall Study|Lost to Follow-up|1|||
129514448|NCT03094832|466172887|FG000|Overall Study|Death|1|||
129514449|NCT03094832|466172888|FG001|Overall Study|Death|0|||
129514450|NCT03094832|466172889|FG002|Overall Study|Death|0|||
129514451|NCT03094832|466172890|FG003|Overall Study|Death|0|||
129514452|NCT03094832|466172891|FG004|Overall Study|Death|0|||
129514453|NCT03094832|466172887|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
129983755|NCT03465904|467902352|FG001|Overall Study|Lost to Follow-up|9|||
129983756|NCT03465904|467902351|FG000|Overall Study|Protocol Violation|20|||
129514454|NCT03094832|466172888|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
129514455|NCT03094832|466172889|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
129514456|NCT03094832|466172890|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
129514457|NCT03094832|466172891|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
129514458|NCT03094832|466172887|FG000|Overall Study|Other|13|||
129514459|NCT03094832|466172888|FG001|Overall Study|Other|20|||
129514460|NCT03094832|466172889|FG002|Overall Study|Other|1|||
129514461|NCT03094832|466172890|FG003|Overall Study|Other|7|||
129514462|NCT03094832|466172891|FG004|Overall Study|Other|1|||
129514463|NCT01998880|466172892|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
129514464|NCT01998880|466172893|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
129983757|NCT03465904|467902352|FG001|Overall Study|Protocol Violation|15|||
129514465|NCT01998880|466172892|FG000|Overall Study|Disease Progression|1|||
129514466|NCT01998880|466172893|FG001|Overall Study|Disease Progression|8|||
129514467|NCT01998880|466172892|FG000|Overall Study|Withdrew Consent|2|||
129514468|NCT01998880|466172893|FG001|Overall Study|Withdrew Consent|1|||
129514469|NCT01998880|466172892|FG000|Overall Study|Death|3|||
129514470|NCT01998880|466172893|FG001|Overall Study|Death|6|||
129514471|NCT01998880|466172892|FG000|Overall Study|Insufficient Therapeutic Response|1|||
129514472|NCT01998880|466172893|FG001|Overall Study|Insufficient Therapeutic Response|5|||
129514473|NCT01998880|466172892|FG000|Overall Study|Administrative/Other|1|||
129514474|NCT01998880|466172893|FG001|Overall Study|Administrative/Other|1|||
129514475|NCT01998880|466172892|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
129514476|NCT01998880|466172893|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
129514477|NCT01998880|466172892|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
129514478|NCT01998880|466172893|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
129514479|NCT01998880|466172892|FG000|Overall Study|Did Not Receive Treatment|3|||
129514480|NCT01998880|466172893|FG001|Overall Study|Did Not Receive Treatment|2|||
129514481|NCT00004732|466172894|FG000|Overall Study|Withdrawal by Subject|36|||
129514482|NCT00004732|466172895|FG001|Overall Study|Withdrawal by Subject|64|||
129514483|NCT00004732|466172894|FG000|Overall Study|Lost to Follow-up|33|||
129514484|NCT00004732|466172895|FG001|Overall Study|Lost to Follow-up|47|||
129514485|NCT03820726|466172897|FG000|Overall Study|Other than listed|23|||
129514486|NCT03820726|466172897|FG000|Overall Study|Withdrawal by Subject|37|||
129514487|NCT03820726|466172897|FG000|Overall Study|Lost to Follow-up|3|||
129514488|NCT03820726|466172897|FG000|Overall Study|Protocol deviation|1|||
129514489|NCT03820726|466172897|FG000|Overall Study|Adverse Event|146|||
129514490|NCT03820726|466172897|FG000|Overall Study|Not treated|1|||
129514491|NCT00345540|466172902|FG000|Overall Study|Withdrawal by Subject|1|||
129514492|NCT01406652|466172903|FG000|Overall Study|Lost-to-follow-up|3|||
129514493|NCT01406652|466172904|FG001|Overall Study|Lost-to-follow-up|4|||
129514494|NCT01406652|466172903|FG000|Overall Study|Withdrawal by Subject|2|||
129514495|NCT01406652|466172904|FG001|Overall Study|Withdrawal by Subject|2|||
129514496|NCT01406652|466172903|FG000|Overall Study|Insufficient follow-up|5|||
129514497|NCT01406652|466172904|FG001|Overall Study|Insufficient follow-up|4|||
129514498|NCT01406652|466172903|FG000|Overall Study|Infection not sure|10|||
129514499|NCT01406652|466172904|FG001|Overall Study|Infection not sure|10|||
129514500|NCT00141037|466172905|FG000|Overall Study|Physician Decision|1|||
129514501|NCT00141037|466172906|FG001|Overall Study|Physician Decision|2|||
129514502|NCT00141037|466172905|FG000|Overall Study|Lost to Follow-up|3|||
129514503|NCT00141037|466172906|FG001|Overall Study|Lost to Follow-up|1|||
129514504|NCT00141037|466172905|FG000|Overall Study|Protocol Violation|0|||
129514505|NCT00141037|466172906|FG001|Overall Study|Protocol Violation|2|||
129514506|NCT00141037|466172905|FG000|Overall Study|Withdrawal by Subject|2|||
129514507|NCT00141037|466172906|FG001|Overall Study|Withdrawal by Subject|1|||
129514508|NCT00141037|466172905|FG000|Overall Study|Other|0|||
129514509|NCT00141037|466172906|FG001|Overall Study|Other|1|||
129514510|NCT00141037|466172905|FG000|Overall Study|Moved from area|1|||
129514511|NCT00141037|466172906|FG001|Overall Study|Moved from area|7|||
129514512|NCT00141037|466172905|FG000|Overall Study|Graft Failure|3|||
129514513|NCT00141037|466172906|FG001|Overall Study|Graft Failure|4|||
129514514|NCT00861380|466172907|FG000|Overall Study|Withdrawal Information not recorded|8427|||
129514515|NCT00861380|466172908|FG001|Overall Study|Withdrawal Information not recorded|9112|||
129514516|NCT00861380|466172909|FG002|Overall Study|Withdrawal Information not recorded|8872|||
129514517|NCT00861380|466172910|FG003|Overall Study|Withdrawal Information not recorded|3689|||
129514518|NCT00861380|466172911|FG004|Overall Study|Withdrawal Information not recorded|1812|||
129514519|NCT00861380|466172912|FG005|Overall Study|Withdrawal Information not recorded|6249|||
129514520|NCT00861380|466172913|FG006|Overall Study|Withdrawal Information not recorded|3020|||
129514521|NCT00260429|466172914|FG000|Overall Study|failure to follow appointments|1|||
129514522|NCT00260429|466172915|FG001|Overall Study|failure to follow appointments|0|||
129514523|NCT00260429|466172914|FG000|Overall Study|scheduled hand surgery|1|||
129514524|NCT00260429|466172915|FG001|Overall Study|scheduled hand surgery|0|||
129514525|NCT00628758|466172916|FG000|Overall Study|Adverse Event|2|||
129514526|NCT00628758|466172917|FG001|Overall Study|Adverse Event|3|||
129514527|NCT00628758|466172916|FG000|Overall Study|Withdrawal by Subject|6|||
129514528|NCT00628758|466172917|FG001|Overall Study|Withdrawal by Subject|3|||
129514529|NCT00628758|466172916|FG000|Overall Study|Death|1|||
129514530|NCT00628758|466172917|FG001|Overall Study|Death|0|||
129514531|NCT00628758|466172916|FG000|Overall Study|Protocol Violation|5|||
129983758|NCT01305200|467902354|FG000|Overall Study|Physician Decision|4|||
129983759|NCT01305200|467902355|FG001|Overall Study|Physician Decision|6|||
129514532|NCT00628758|466172917|FG001|Overall Study|Protocol Violation|1|||
129514533|NCT00628758|466172916|FG000|Overall Study|Lost to Follow-up|25|||
129514534|NCT00628758|466172917|FG001|Overall Study|Lost to Follow-up|31|||
129514535|NCT00628758|466172916|FG000|Overall Study|Pregnancy|2|||
129514536|NCT00628758|466172917|FG001|Overall Study|Pregnancy|2|||
129514537|NCT00628758|466172916|FG000|Overall Study|Investigator Moved|3|||
129514538|NCT00628758|466172917|FG001|Overall Study|Investigator Moved|0|||
129983760|NCT01305200|467902356|FG002|Overall Study|Physician Decision|1|||
129514539|NCT00628758|466172916|FG000|Overall Study|Treatment Failure|0|||
129514540|NCT00628758|466172917|FG001|Overall Study|Treatment Failure|2|||
129514541|NCT00637377|466172918|FG000|Overall Study|Adverse Event|2|||
129514542|NCT00637377|466172919|FG001|Overall Study|Adverse Event|6|||
129983761|NCT01305200|467902354|FG000|Overall Study|Withdrawal by Subject|24|||
129514543|NCT00637377|466172920|FG002|Overall Study|Adverse Event|8|||
129514544|NCT00637377|466172921|FG003|Overall Study|Adverse Event|9|||
129514545|NCT00637377|466172918|FG000|Overall Study|Death|1|||
129514546|NCT00637377|466172919|FG001|Overall Study|Death|3|||
129514547|NCT00637377|466172920|FG002|Overall Study|Death|2|||
129514548|NCT00637377|466172921|FG003|Overall Study|Death|1|||
129514549|NCT00637377|466172918|FG000|Overall Study|Lack of Efficacy|0|||
129514550|NCT00637377|466172919|FG001|Overall Study|Lack of Efficacy|0|||
129514551|NCT00637377|466172920|FG002|Overall Study|Lack of Efficacy|1|||
129514552|NCT00637377|466172921|FG003|Overall Study|Lack of Efficacy|1|||
129514553|NCT00637377|466172918|FG000|Overall Study|Lost to Follow-up|4|||
129514554|NCT00637377|466172919|FG001|Overall Study|Lost to Follow-up|1|||
129514555|NCT00637377|466172920|FG002|Overall Study|Lost to Follow-up|2|||
129514556|NCT00637377|466172921|FG003|Overall Study|Lost to Follow-up|2|||
129514557|NCT00637377|466172918|FG000|Overall Study|Protocol Violation|2|||
129514558|NCT00637377|466172919|FG001|Overall Study|Protocol Violation|1|||
129514559|NCT00637377|466172920|FG002|Overall Study|Protocol Violation|1|||
129514560|NCT00637377|466172921|FG003|Overall Study|Protocol Violation|0|||
129514561|NCT00637377|466172918|FG000|Overall Study|Withdrawal by Subject|11|||
129514562|NCT00637377|466172919|FG001|Overall Study|Withdrawal by Subject|15|||
129514563|NCT00637377|466172920|FG002|Overall Study|Withdrawal by Subject|13|||
129514564|NCT00637377|466172921|FG003|Overall Study|Withdrawal by Subject|11|||
129514565|NCT00637377|466172918|FG000|Overall Study|Other (no further information available)|7|||
129514566|NCT00637377|466172919|FG001|Overall Study|Other (no further information available)|6|||
129514567|NCT00637377|466172920|FG002|Overall Study|Other (no further information available)|10|||
129514568|NCT00637377|466172921|FG003|Overall Study|Other (no further information available)|5|||
129514569|NCT01938001|466172922|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
129514570|NCT01938001|466172923|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
129514571|NCT01938001|466172922|FG000|Pre-Treatment|Death|1|||
129514572|NCT01938001|466172923|FG001|Pre-Treatment|Death|0|||
129514573|NCT01938001|466172922|FG000|Treatment|Death|2|||
129514574|NCT01938001|466172923|FG001|Treatment|Death|0|||
129514575|NCT01938001|466172922|FG000|Treatment|Adverse Event|14|||
129514576|NCT01938001|466172923|FG001|Treatment|Adverse Event|8|||
129514577|NCT01938001|466172922|FG000|Treatment|Progressive Disease|21|||
129514578|NCT01938001|466172923|FG001|Treatment|Progressive Disease|54|||
129514579|NCT01938001|466172922|FG000|Treatment|Withdrawal by Subject|13|||
129514580|NCT01938001|466172923|FG001|Treatment|Withdrawal by Subject|7|||
129514581|NCT01938001|466172922|FG000|Treatment|Other reasons|2|||
129983762|NCT01305200|467902355|FG001|Overall Study|Withdrawal by Subject|21|||
129983763|NCT01305200|467902356|FG002|Overall Study|Withdrawal by Subject|1|||
129983764|NCT01305200|467902354|FG000|Overall Study|Ineligible|1|||
129983765|NCT01305200|467902355|FG001|Overall Study|Ineligible|2|||
129983766|NCT01305200|467902356|FG002|Overall Study|Ineligible|1|||
129514582|NCT01938001|466172923|FG001|Treatment|Other reasons|1|||
129514583|NCT02762708|466172924|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
129514584|NCT02762708|466172925|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
129514585|NCT02762708|466172926|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
129514586|NCT02762708|466172927|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
129514587|NCT01468701|466172934|FG000|Overall Study|Not eligible|91|||
129514588|NCT01468701|466172935|FG001|Overall Study|Not eligible|140|||
129514589|NCT01468701|466172936|FG002|Overall Study|Not eligible|29|||
129514590|NCT01468701|466172937|FG003|Overall Study|Not eligible|12|||
129514591|NCT01468701|466172938|FG004|Overall Study|Not eligible|22|||
129514592|NCT01468701|466172939|FG005|Overall Study|Not eligible|2|||
129514593|NCT01468701|466172940|FG006|Overall Study|Not eligible|39|||
129514594|NCT01468701|466172941|FG007|Overall Study|Not eligible|1|||
129514595|NCT01468701|466172942|FG008|Overall Study|Not eligible|40|||
129514596|NCT01468701|466172943|FG009|Overall Study|Not eligible|126|||
129514597|NCT01468701|466172944|FG010|Overall Study|Not eligible|39|||
129514598|NCT01468701|466172945|FG011|Overall Study|Not eligible|33|||
129514599|NCT01468701|466172946|FG012|Overall Study|Not eligible|1|||
129514600|NCT01468701|466172947|FG013|Overall Study|Not eligible|19|||
129514601|NCT01468701|466172948|FG014|Overall Study|Not eligible|1|||
129514602|NCT01468701|466172949|FG015|Overall Study|Not eligible|32|||
129514603|NCT01468701|466172950|FG016|Overall Study|Not eligible|0|||
129514604|NCT01468701|466172934|FG000|Overall Study|Lost to Follow-up|306|||
129514605|NCT01468701|466172935|FG001|Overall Study|Lost to Follow-up|0|||
129514606|NCT01468701|466172936|FG002|Overall Study|Lost to Follow-up|0|||
129514607|NCT01468701|466172937|FG003|Overall Study|Lost to Follow-up|0|||
129514608|NCT01468701|466172938|FG004|Overall Study|Lost to Follow-up|0|||
129514609|NCT01468701|466172939|FG005|Overall Study|Lost to Follow-up|0|||
129514610|NCT01468701|466172940|FG006|Overall Study|Lost to Follow-up|0|||
129514611|NCT01468701|466172941|FG007|Overall Study|Lost to Follow-up|0|||
129514612|NCT01468701|466172942|FG008|Overall Study|Lost to Follow-up|215|||
129514613|NCT01468701|466172943|FG009|Overall Study|Lost to Follow-up|309|||
129514614|NCT01468701|466172944|FG010|Overall Study|Lost to Follow-up|224|||
129514615|NCT01468701|466172945|FG011|Overall Study|Lost to Follow-up|212|||
129514616|NCT01468701|466172946|FG012|Overall Study|Lost to Follow-up|11|||
129514617|NCT01468701|466172947|FG013|Overall Study|Lost to Follow-up|164|||
129514618|NCT01468701|466172948|FG014|Overall Study|Lost to Follow-up|17|||
129514619|NCT01468701|466172949|FG015|Overall Study|Lost to Follow-up|127|||
129514620|NCT01468701|466172950|FG016|Overall Study|Lost to Follow-up|1|||
129514621|NCT01468701|466172934|FG000|Overall Study|Withdrawal by Subject|165|||
129514622|NCT01468701|466172935|FG001|Overall Study|Withdrawal by Subject|0|||
129514623|NCT01468701|466172936|FG002|Overall Study|Withdrawal by Subject|0|||
129514624|NCT01468701|466172937|FG003|Overall Study|Withdrawal by Subject|0|||
129514625|NCT01468701|466172938|FG004|Overall Study|Withdrawal by Subject|0|||
129514626|NCT01468701|466172939|FG005|Overall Study|Withdrawal by Subject|0|||
129514627|NCT01468701|466172940|FG006|Overall Study|Withdrawal by Subject|0|||
129514628|NCT01468701|466172941|FG007|Overall Study|Withdrawal by Subject|0|||
129514629|NCT01468701|466172942|FG008|Overall Study|Withdrawal by Subject|83|||
129514630|NCT01468701|466172943|FG009|Overall Study|Withdrawal by Subject|88|||
129514631|NCT01468701|466172944|FG010|Overall Study|Withdrawal by Subject|100|||
129514632|NCT01468701|466172945|FG011|Overall Study|Withdrawal by Subject|114|||
129514633|NCT01468701|466172946|FG012|Overall Study|Withdrawal by Subject|9|||
129514634|NCT01468701|466172947|FG013|Overall Study|Withdrawal by Subject|47|||
129514635|NCT01468701|466172948|FG014|Overall Study|Withdrawal by Subject|6|||
129514636|NCT01468701|466172949|FG015|Overall Study|Withdrawal by Subject|31|||
129514637|NCT01468701|466172950|FG016|Overall Study|Withdrawal by Subject|0|||
129514638|NCT01468701|466172934|FG000|Overall Study|Other reasons than listed|437|||
129514639|NCT01468701|466172935|FG001|Overall Study|Other reasons than listed|0|||
129514640|NCT01468701|466172936|FG002|Overall Study|Other reasons than listed|0|||
129514641|NCT01468701|466172937|FG003|Overall Study|Other reasons than listed|0|||
129514642|NCT01468701|466172938|FG004|Overall Study|Other reasons than listed|0|||
129514643|NCT01468701|466172939|FG005|Overall Study|Other reasons than listed|0|||
129514644|NCT01468701|466172940|FG006|Overall Study|Other reasons than listed|0|||
129514645|NCT01468701|466172941|FG007|Overall Study|Other reasons than listed|0|||
129514646|NCT01468701|466172942|FG008|Overall Study|Other reasons than listed|318|||
129514647|NCT01468701|466172943|FG009|Overall Study|Other reasons than listed|658|||
129514648|NCT01468701|466172944|FG010|Overall Study|Other reasons than listed|433|||
129514649|NCT01468701|466172945|FG011|Overall Study|Other reasons than listed|504|||
129514650|NCT01468701|466172946|FG012|Overall Study|Other reasons than listed|28|||
129514651|NCT01468701|466172947|FG013|Overall Study|Other reasons than listed|239|||
129514652|NCT01468701|466172948|FG014|Overall Study|Other reasons than listed|39|||
129514653|NCT01468701|466172949|FG015|Overall Study|Other reasons than listed|172|||
129514654|NCT01468701|466172950|FG016|Overall Study|Other reasons than listed|0|||
129514655|NCT01468701|466172934|FG000|Overall Study|No end of study case report form|0|||
129514656|NCT01468701|466172935|FG001|Overall Study|No end of study case report form|0|||
129514657|NCT01468701|466172936|FG002|Overall Study|No end of study case report form|0|||
129514658|NCT01468701|466172937|FG003|Overall Study|No end of study case report form|0|||
129514659|NCT01468701|466172938|FG004|Overall Study|No end of study case report form|0|||
129514660|NCT01468701|466172939|FG005|Overall Study|No end of study case report form|0|||
129514661|NCT01468701|466172940|FG006|Overall Study|No end of study case report form|0|||
129514662|NCT01468701|466172941|FG007|Overall Study|No end of study case report form|0|||
129514663|NCT01468701|466172942|FG008|Overall Study|No end of study case report form|4|||
129514664|NCT01468701|466172943|FG009|Overall Study|No end of study case report form|1|||
129514665|NCT01468701|466172944|FG010|Overall Study|No end of study case report form|2|||
129514666|NCT01468701|466172945|FG011|Overall Study|No end of study case report form|3|||
129514667|NCT01468701|466172946|FG012|Overall Study|No end of study case report form|0|||
129514668|NCT01468701|466172947|FG013|Overall Study|No end of study case report form|1|||
129514669|NCT01468701|466172948|FG014|Overall Study|No end of study case report form|0|||
129514670|NCT01468701|466172949|FG015|Overall Study|No end of study case report form|0|||
129514671|NCT01468701|466172950|FG016|Overall Study|No end of study case report form|0|||
129514672|NCT01468701|466172934|FG000|Overall Study|Not being followed up|0|||
129514673|NCT01468701|466172935|FG001|Overall Study|Not being followed up|4963|||
129514674|NCT01468701|466172936|FG002|Overall Study|Not being followed up|1755|||
129514675|NCT01468701|466172937|FG003|Overall Study|Not being followed up|703|||
129514676|NCT01468701|466172938|FG004|Overall Study|Not being followed up|1714|||
129514677|NCT01468701|466172939|FG005|Overall Study|Not being followed up|126|||
129514678|NCT01468701|466172940|FG006|Overall Study|Not being followed up|1170|||
129514679|NCT01468701|466172941|FG007|Overall Study|Not being followed up|4|||
129514680|NCT01468701|466172942|FG008|Overall Study|Not being followed up|0|||
129514681|NCT01468701|466172943|FG009|Overall Study|Not being followed up|0|||
129514682|NCT01468701|466172944|FG010|Overall Study|Not being followed up|0|||
129514683|NCT01468701|466172945|FG011|Overall Study|Not being followed up|0|||
129514684|NCT01468701|466172946|FG012|Overall Study|Not being followed up|0|||
129514685|NCT01468701|466172947|FG013|Overall Study|Not being followed up|0|||
129514686|NCT01468701|466172948|FG014|Overall Study|Not being followed up|0|||
129514687|NCT01468701|466172949|FG015|Overall Study|Not being followed up|0|||
129514688|NCT01468701|466172950|FG016|Overall Study|Not being followed up|0|||
129514689|NCT01068717|466172951|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
129538500|NCT05664672|466262111|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
129514690|NCT01068717|466172952|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
129514691|NCT01068717|466172953|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
129514692|NCT01068717|466172954|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
129514693|NCT01822223|466172957|FG000|Overall Study|Death|0|||
129514694|NCT01822223|466172958|FG001|Overall Study|Death|1|||
129514695|NCT00719862|466172960|FG000|Overall Study|Adverse Event|1|||
129514696|NCT00719862|466172961|FG001|Overall Study|Adverse Event|2|||
129514697|NCT00719862|466172960|FG000|Overall Study|Lack of Efficacy|3|||
129514698|NCT00719862|466172961|FG001|Overall Study|Lack of Efficacy|0|||
129514699|NCT00719862|466172960|FG000|Overall Study|Non-Compliance|1|||
129514700|NCT00719862|466172961|FG001|Overall Study|Non-Compliance|0|||
129514701|NCT00719862|466172960|FG000|Overall Study|Withdrawal by Subject|1|||
129514702|NCT00719862|466172961|FG001|Overall Study|Withdrawal by Subject|0|||
129514703|NCT00719862|466172960|FG000|Overall Study|Lost to Follow-up|0|||
129514704|NCT00719862|466172961|FG001|Overall Study|Lost to Follow-up|1|||
129514705|NCT00719862|466172960|FG000|Overall Study|Other|2|||
129514706|NCT00719862|466172961|FG001|Overall Study|Other|3|||
129514707|NCT02688153|466175550|FG000|Overall Study|Death|7|||
129514708|NCT02688153|466175551|FG001|Overall Study|Death|5|||
129514709|NCT02688153|466175550|FG000|Overall Study|Withdrawal by Subject|4|||
129514710|NCT02688153|466175551|FG001|Overall Study|Withdrawal by Subject|2|||
129514711|NCT02688153|466175550|FG000|Overall Study|Valve Explant|1|||
129514712|NCT02688153|466175551|FG001|Overall Study|Valve Explant|0|||
129514713|NCT02688153|466175550|FG000|Overall Study|Conversion to Commercial Valve|3|||
129514714|NCT02688153|466175551|FG001|Overall Study|Conversion to Commercial Valve|0|||
129514715|NCT01102140|466175552|FG000|Overall Study|Lost to Follow-up|1|||
129514716|NCT01102140|466175553|FG001|Overall Study|Lost to Follow-up|0|||
129514717|NCT01102140|466175552|FG000|Overall Study|Investigator terminated study|2|||
129514718|NCT01102140|466175553|FG001|Overall Study|Investigator terminated study|2|||
129514719|NCT01135394|466175554|FG000|Screening|Lost to Follow-up|2|||
129514720|NCT01135394|466175554|FG000|Screening|Withdrawal by Subject|10|||
129514721|NCT01135394|466175554|FG000|Screening|Screening failure|16|||
129514722|NCT01135394|466175554|FG000|Screening|Physician Decision|5|||
129514723|NCT01135394|466175554|FG000|Baseline Assessment|Withdrawal by Subject|9|||
129514724|NCT01135394|466175554|FG000|Baseline Assessment|Physician Decision|3|||
129514725|NCT01135394|466175554|FG000|Baseline Assessment|Lost to Follow-up|2|||
129514726|NCT01135394|466175554|FG000|Baseline Assessment|Adverse Event|1|||
129514727|NCT01135394|466175554|FG000|Study Treatment|Withdrawal by Subject|1|||
129514728|NCT01135394|466175554|FG000|Study Treatment|Physician Decision|1|||
129514729|NCT01135394|466175554|FG000|Study Treatment|Adverse Event|2|||
129514730|NCT00191386|466175555|FG000|Overall Study|Adverse Event|16|||
129514731|NCT00191386|466175555|FG000|Overall Study|Lost to Follow-up|1|||
129514732|NCT00191386|466175555|FG000|Overall Study|Entry Criteria Exclusion|3|||
129514733|NCT00191386|466175555|FG000|Overall Study|Protocol Violation|18|||
129514734|NCT00191386|466175555|FG000|Overall Study|Withdrawal by Subject|96|||
129514735|NCT00191386|466175555|FG000|Overall Study|Physician Decision|11|||
129514736|NCT00191386|466175555|FG000|Overall Study|Lack of Efficacy|15|||
129514737|NCT00462488|466175556|FG000|Overall Study|Protocol Violation|1|||
129514738|NCT00462488|466175557|FG001|Overall Study|Protocol Violation|0|||
129514739|NCT00462488|466175556|FG000|Overall Study|Lack of Efficacy|19|||
129514740|NCT00462488|466175557|FG001|Overall Study|Lack of Efficacy|17|||
129514741|NCT01742091|466175560|FG000|Overall Study|Adverse Event|0|||
129514742|NCT01742091|466175561|FG001|Overall Study|Adverse Event|0|||
129514743|NCT01742091|466175562|FG002|Overall Study|Adverse Event|0|||
129514744|NCT01742091|466175563|FG003|Overall Study|Adverse Event|0|||
129514745|NCT01742091|466175564|FG004|Overall Study|Adverse Event|1|||
129514746|NCT01742091|466175565|FG005|Overall Study|Adverse Event|0|||
129514747|NCT01742091|466175560|FG000|Overall Study|Physician Decision|0|||
129514748|NCT01742091|466175561|FG001|Overall Study|Physician Decision|0|||
129514749|NCT01742091|466175562|FG002|Overall Study|Physician Decision|0|||
129514750|NCT01742091|466175563|FG003|Overall Study|Physician Decision|0|||
129514751|NCT01742091|466175564|FG004|Overall Study|Physician Decision|0|||
129514752|NCT01742091|466175565|FG005|Overall Study|Physician Decision|1|||
129514753|NCT01742091|466175560|FG000|Overall Study|Withdrawal by Subject|0|||
129514754|NCT01742091|466175561|FG001|Overall Study|Withdrawal by Subject|0|||
129514755|NCT01742091|466175562|FG002|Overall Study|Withdrawal by Subject|0|||
129514756|NCT01742091|466175563|FG003|Overall Study|Withdrawal by Subject|1|||
129514757|NCT01742091|466175564|FG004|Overall Study|Withdrawal by Subject|0|||
129514758|NCT01742091|466175565|FG005|Overall Study|Withdrawal by Subject|0|||
129514759|NCT01742091|466175560|FG000|Overall Study|Lost to Follow-up|0|||
129514760|NCT01742091|466175561|FG001|Overall Study|Lost to Follow-up|0|||
129514761|NCT01742091|466175562|FG002|Overall Study|Lost to Follow-up|0|||
129514762|NCT01742091|466175563|FG003|Overall Study|Lost to Follow-up|0|||
129514763|NCT01742091|466175564|FG004|Overall Study|Lost to Follow-up|0|||
129514764|NCT01742091|466175565|FG005|Overall Study|Lost to Follow-up|1|||
129514765|NCT00212758|466175569|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
129514766|NCT00212758|466175570|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
129514767|NCT00212758|466175569|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
129514768|NCT00212758|466175570|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
129514769|NCT00948194|466175571|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
129514770|NCT00948194|466175572|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
129514771|NCT02431793|466175573|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
129514772|NCT02431793|466175574|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
129514773|NCT02431793|466175575|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
129514774|NCT02431793|466175573|FG000|Overall Study|Withdrawal by Subject|7|||
129514775|NCT02431793|466175574|FG001|Overall Study|Withdrawal by Subject|5|||
129514776|NCT02431793|466175575|FG002|Overall Study|Withdrawal by Subject|5|||
129514777|NCT02431793|466175573|FG000|Overall Study|Lost to Follow-up|101|||
129514778|NCT02431793|466175574|FG001|Overall Study|Lost to Follow-up|122|||
129514779|NCT02431793|466175575|FG002|Overall Study|Lost to Follow-up|104|||
129514780|NCT00233324|466175576|FG000|Main Study|Death|68|||
129514781|NCT00233324|466175577|FG001|Main Study|Death|60|||
129514782|NCT00233324|466175578|FG002|Main Study|Death|62|||
129514783|NCT00233324|466175579|FG003|Main Study|Death|47|||
129514784|NCT00233324|466175576|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
129514785|NCT00233324|466175577|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
129514786|NCT00233324|466175578|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
129514787|NCT00233324|466175579|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
129514788|NCT00233324|466175576|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
129514789|NCT00233324|466175577|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
129514790|NCT00233324|466175578|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
129514791|NCT00233324|466175579|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
129514792|NCT03170258|466175585|FG000|Overall Study|Physician Decision|4|||
129514793|NCT03170258|466175586|FG001|Overall Study|Physician Decision|0|||
129514794|NCT03170258|466175585|FG000|Overall Study|Equipment issues|1|||
129514795|NCT03170258|466175586|FG001|Overall Study|Equipment issues|0|||
129514796|NCT03170258|466175585|FG000|Overall Study|Medication|1|||
129514797|NCT03170258|466175586|FG001|Overall Study|Medication|0|||
129514798|NCT03170258|466175585|FG000|Overall Study|Sleep issues|1|||
129514799|NCT03170258|466175586|FG001|Overall Study|Sleep issues|0|||
129514800|NCT01563107|466175587|FG000|Overall Study|Physician Decision|0|||
129514801|NCT01563107|466175588|FG001|Overall Study|Physician Decision|1|||
129514802|NCT01563107|466175589|FG002|Overall Study|Physician Decision|1|||
129514803|NCT01563107|466175590|FG003|Overall Study|Physician Decision|3|||
129514804|NCT01563107|466175587|FG000|Overall Study|Withdrawal by Subject|1|||
129514805|NCT01563107|466175588|FG001|Overall Study|Withdrawal by Subject|2|||
129514806|NCT01563107|466175589|FG002|Overall Study|Withdrawal by Subject|1|||
129514807|NCT01563107|466175590|FG003|Overall Study|Withdrawal by Subject|2|||
129514808|NCT00247273|466175594|FG000|Overall Study|Adverse Event|85|||
129514809|NCT00247273|466175595|FG001|Overall Study|Adverse Event|80|||
129514810|NCT00247273|466175594|FG000|Overall Study|Physician Decision|6|||
129514811|NCT00247273|466175595|FG001|Overall Study|Physician Decision|3|||
129514812|NCT00247273|466175594|FG000|Overall Study|Lost to Follow-up|7|||
129514813|NCT00247273|466175595|FG001|Overall Study|Lost to Follow-up|7|||
129514814|NCT00247273|466175594|FG000|Overall Study|Withdrawal by Subject|46|||
129514815|NCT00247273|466175595|FG001|Overall Study|Withdrawal by Subject|47|||
129514816|NCT00247273|466175594|FG000|Overall Study|Did not take any study drug|2|||
129514817|NCT00247273|466175595|FG001|Overall Study|Did not take any study drug|0|||
129514818|NCT01419015|466175597|FG000|Overall Study|Death|2|||
129514819|NCT03276572|466175599|FG000|Overall Study|In follow-up|0|||
129514820|NCT03276572|466175600|FG001|Overall Study|In follow-up|0|||
129514821|NCT03276572|466175601|FG002|Overall Study|In follow-up|0|||
129514822|NCT03276572|466175602|FG003|Overall Study|In follow-up|0|||
129514823|NCT03276572|466175603|FG004|Overall Study|In follow-up|0|||
129514824|NCT03276572|466175604|FG005|Overall Study|In follow-up|1|||
129514825|NCT03276572|466175605|FG006|Overall Study|In follow-up|1|||
129514826|NCT03276572|466175599|FG000|Overall Study|Lost to Follow-up|0|||
129514827|NCT03276572|466175600|FG001|Overall Study|Lost to Follow-up|0|||
129514828|NCT03276572|466175601|FG002|Overall Study|Lost to Follow-up|0|||
129514829|NCT03276572|466175602|FG003|Overall Study|Lost to Follow-up|0|||
129514830|NCT03276572|466175603|FG004|Overall Study|Lost to Follow-up|0|||
129514831|NCT03276572|466175604|FG005|Overall Study|Lost to Follow-up|0|||
129514832|NCT03276572|466175605|FG006|Overall Study|Lost to Follow-up|1|||
129514833|NCT01709708|466175606|FG000|Overall Study|Protocol Violation|1|||
129514834|NCT01709708|466175607|FG001|Overall Study|Protocol Violation|2|||
129514835|NCT01527110|466175608|FG000|Overall Study|Adverse Event|1|||
129514836|NCT00527072|466175609|FG000|Overall Study|Adverse Event|13|||
129514837|NCT00527072|466175609|FG000|Overall Study|Lack of Efficacy|11|||
129514838|NCT00527072|466175609|FG000|Overall Study|Lost to Follow-up|3|||
129514839|NCT00527072|466175609|FG000|Overall Study|Protocol Violation|2|||
129514840|NCT00527072|466175609|FG000|Overall Study|Withdrawal by Subject|7|||
129514841|NCT02657434|466175610|FG000|Overall Study|Study Terminated By Sponsor|64|||
129514842|NCT02657434|466175611|FG001|Overall Study|Study Terminated By Sponsor|82|||
129514843|NCT02657434|466175610|FG000|Overall Study|Death|189|||
129514844|NCT02657434|466175611|FG001|Overall Study|Death|190|||
129514845|NCT02657434|466175610|FG000|Overall Study|Lost to Follow-up|2|||
129514846|NCT02657434|466175611|FG001|Overall Study|Lost to Follow-up|2|||
129514847|NCT02657434|466175610|FG000|Overall Study|Randomization by Error|2|||
129514848|NCT02657434|466175611|FG001|Overall Study|Randomization by Error|0|||
129514849|NCT02657434|466175610|FG000|Overall Study|Withdrawal by Subject|28|||
129514850|NCT02657434|466175611|FG001|Overall Study|Withdrawal by Subject|17|||
129514851|NCT02657434|466175610|FG000|Overall Study|Protocol Violation|1|||
129514852|NCT02657434|466175611|FG001|Overall Study|Protocol Violation|0|||
129514853|NCT02657434|466175610|FG000|Overall Study|Physician Decision|0|||
129514854|NCT02657434|466175611|FG001|Overall Study|Physician Decision|1|||
129514855|NCT01628393|466175612|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
129514856|NCT01628393|466175613|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129514857|NCT01628393|466175614|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129514858|NCT01628393|466175615|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129514859|NCT01628393|466175616|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
129514860|NCT01628393|466175612|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
129514861|NCT01628393|466175613|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
129514862|NCT01628393|466175614|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
129514863|NCT01628393|466175615|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
129514864|NCT01628393|466175616|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
129514865|NCT01628393|466175612|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
129514866|NCT01628393|466175613|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
129514867|NCT01628393|466175614|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
129514868|NCT01628393|466175615|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
129514869|NCT01628393|466175616|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
129514870|NCT01628393|466175612|FG000|Blinded Active Extension Period|Adverse Event|0|||
129514871|NCT01628393|466175613|FG001|Blinded Active Extension Period|Adverse Event|1|||
129514872|NCT01628393|466175614|FG002|Blinded Active Extension Period|Adverse Event|0|||
129514873|NCT01628393|466175615|FG003|Blinded Active Extension Period|Adverse Event|2|||
129514874|NCT01628393|466175616|FG004|Blinded Active Extension Period|Adverse Event|2|||
129514875|NCT01628393|466175612|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
129514876|NCT01628393|466175613|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
129514877|NCT01628393|466175614|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
129514878|NCT01628393|466175615|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
129514879|NCT01628393|466175616|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
129514880|NCT01628393|466175612|FG000|Blinded Active Extension Period|Physician Decision|0|||
129514881|NCT01628393|466175613|FG001|Blinded Active Extension Period|Physician Decision|3|||
129514882|NCT01628393|466175614|FG002|Blinded Active Extension Period|Physician Decision|0|||
129514883|NCT01628393|466175615|FG003|Blinded Active Extension Period|Physician Decision|1|||
129514884|NCT01628393|466175616|FG004|Blinded Active Extension Period|Physician Decision|0|||
129514885|NCT01628393|466175612|FG000|Blinded Active Extension Period|Protocol Violation|0|||
129514886|NCT01628393|466175613|FG001|Blinded Active Extension Period|Protocol Violation|0|||
129514887|NCT01628393|466175614|FG002|Blinded Active Extension Period|Protocol Violation|2|||
129514888|NCT01628393|466175615|FG003|Blinded Active Extension Period|Protocol Violation|1|||
129514889|NCT01628393|466175616|FG004|Blinded Active Extension Period|Protocol Violation|0|||
129514890|NCT01628393|466175612|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
129514891|NCT01628393|466175613|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
129514892|NCT01628393|466175614|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
129514893|NCT01628393|466175615|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
129514894|NCT01628393|466175616|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
129514895|NCT01369225|466175623|FG000|Overall Study|Withdrawal by Subject|1|||
129514896|NCT01369225|466175624|FG001|Overall Study|Withdrawal by Subject|0|||
129514897|NCT01369225|466175625|FG002|Overall Study|Withdrawal by Subject|2|||
129514898|NCT01369225|466175626|FG003|Overall Study|Withdrawal by Subject|1|||
129514899|NCT01369225|466175627|FG004|Overall Study|Withdrawal by Subject|0|||
129514900|NCT01369225|466175628|FG005|Overall Study|Withdrawal by Subject|0|||
129514901|NCT01369225|466175623|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
129514902|NCT01369225|466175624|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
129514903|NCT01369225|466175625|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
129514904|NCT01369225|466175626|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
129514905|NCT01369225|466175627|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
129514906|NCT01369225|466175628|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
129514907|NCT01369225|466175623|FG000|Overall Study|Other|1|||
129514908|NCT01369225|466175624|FG001|Overall Study|Other|0|||
129514909|NCT01369225|466175625|FG002|Overall Study|Other|0|||
129514910|NCT01369225|466175626|FG003|Overall Study|Other|0|||
129514911|NCT01369225|466175627|FG004|Overall Study|Other|1|||
129514912|NCT01369225|466175628|FG005|Overall Study|Other|0|||
129514913|NCT01369225|466175623|FG000|Overall Study|Adverse Event|0|||
129514914|NCT01369225|466175624|FG001|Overall Study|Adverse Event|0|||
129514915|NCT01369225|466175625|FG002|Overall Study|Adverse Event|0|||
129514916|NCT01369225|466175626|FG003|Overall Study|Adverse Event|1|||
129514917|NCT01369225|466175627|FG004|Overall Study|Adverse Event|1|||
129514918|NCT01369225|466175628|FG005|Overall Study|Adverse Event|0|||
129514919|NCT00105183|466175629|FG000|Overall Study|Death|19|||
129514920|NCT00105183|466175630|FG001|Overall Study|Death|13|||
129514921|NCT00105183|466175631|FG002|Overall Study|Death|15|||
129514922|NCT00105183|466175629|FG000|Overall Study|Withdrawal by Subject|1|||
129514923|NCT00105183|466175630|FG001|Overall Study|Withdrawal by Subject|1|||
129514924|NCT00105183|466175631|FG002|Overall Study|Withdrawal by Subject|4|||
129514925|NCT00105183|466175629|FG000|Overall Study|Physician Decision|1|||
129514926|NCT00105183|466175630|FG001|Overall Study|Physician Decision|2|||
129514927|NCT00105183|466175631|FG002|Overall Study|Physician Decision|3|||
129514928|NCT00105183|466175629|FG000|Overall Study|Lost to Follow-up|0|||
129514929|NCT00105183|466175630|FG001|Overall Study|Lost to Follow-up|1|||
129514930|NCT00105183|466175631|FG002|Overall Study|Lost to Follow-up|1|||
129514931|NCT00105183|466175629|FG000|Overall Study|Other reason|1|||
129514932|NCT00105183|466175630|FG001|Overall Study|Other reason|2|||
129514933|NCT00105183|466175631|FG002|Overall Study|Other reason|0|||
129514934|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
129514935|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
129514936|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
129514937|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
129514938|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
129514939|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
129514940|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
129514941|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
129514942|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
129514943|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
129514944|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
129514945|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
129514946|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
129514947|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
129514948|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
129514949|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
129514950|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
129514951|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
129514952|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
129514953|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
129514954|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
129514955|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
129514956|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
129514957|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
129514958|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
129514959|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Other|1|||
129514960|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Other|0|||
129514961|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Other|0|||
129514962|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Other|0|||
129514963|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Other|1|||
129514964|NCT02980692|466175632|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
129514965|NCT02980692|466175633|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
129514966|NCT02980692|466175634|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
129514967|NCT02980692|466175635|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
129514968|NCT02980692|466175636|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
129514969|NCT02980692|466175632|FG000|Double-blind Follow-up Period|Adverse Event|0|||
129514970|NCT02980692|466175633|FG001|Double-blind Follow-up Period|Adverse Event|0|||
129514971|NCT02980692|466175634|FG002|Double-blind Follow-up Period|Adverse Event|0|||
129514972|NCT02980692|466175635|FG003|Double-blind Follow-up Period|Adverse Event|1|||
129514973|NCT02980692|466175636|FG004|Double-blind Follow-up Period|Adverse Event|1|||
129514974|NCT02980692|466175632|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
129514975|NCT02980692|466175633|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
129514976|NCT02980692|466175634|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
129514977|NCT02980692|466175635|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
129514978|NCT02980692|466175636|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
129514979|NCT02980692|466175632|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
129514980|NCT02980692|466175633|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
129983767|NCT01305200|467902354|FG000|Overall Study|Death|0|||
129514981|NCT02980692|466175634|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
129514982|NCT02980692|466175635|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
129514983|NCT02980692|466175636|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
129514984|NCT02980692|466175632|FG000|Double-blind Follow-up Period|Pregnancy|0|||
129514985|NCT02980692|466175633|FG001|Double-blind Follow-up Period|Pregnancy|0|||
129514986|NCT02980692|466175634|FG002|Double-blind Follow-up Period|Pregnancy|1|||
129514987|NCT02980692|466175635|FG003|Double-blind Follow-up Period|Pregnancy|1|||
129514988|NCT02980692|466175636|FG004|Double-blind Follow-up Period|Pregnancy|0|||
129514989|NCT02980692|466175632|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
129514990|NCT02980692|466175633|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
129514991|NCT02980692|466175634|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
129514992|NCT02980692|466175635|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
129514993|NCT02980692|466175636|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
129514994|NCT02980692|466175632|FG000|Double-blind Follow-up Period|Other|0|||
129514995|NCT02980692|466175633|FG001|Double-blind Follow-up Period|Other|0|||
129514996|NCT02980692|466175634|FG002|Double-blind Follow-up Period|Other|1|||
129514997|NCT02980692|466175635|FG003|Double-blind Follow-up Period|Other|1|||
129514998|NCT02980692|466175636|FG004|Double-blind Follow-up Period|Other|3|||
129514999|NCT00563368|466175640|FG000|Overall Study|Lost to Follow-up|14|||
129515000|NCT00563368|466175641|FG001|Overall Study|Lost to Follow-up|14|||
129515001|NCT00563368|466175642|FG002|Overall Study|Lost to Follow-up|12|||
129515002|NCT00563368|466175643|FG003|Overall Study|Lost to Follow-up|6|||
129515003|NCT00563368|466175644|FG004|Overall Study|Lost to Follow-up|9|||
129515004|NCT00563368|466175645|FG005|Overall Study|Lost to Follow-up|8|||
129515005|NCT00563368|466175646|FG006|Overall Study|Lost to Follow-up|9|||
129515006|NCT00563368|466175640|FG000|Overall Study|Adverse Event|3|||
129515007|NCT00563368|466175641|FG001|Overall Study|Adverse Event|4|||
129515008|NCT00563368|466175642|FG002|Overall Study|Adverse Event|5|||
129515009|NCT00563368|466175643|FG003|Overall Study|Adverse Event|9|||
129515010|NCT00563368|466175644|FG004|Overall Study|Adverse Event|6|||
129515011|NCT00563368|466175645|FG005|Overall Study|Adverse Event|10|||
129515012|NCT00563368|466175646|FG006|Overall Study|Adverse Event|17|||
129515013|NCT00563368|466175640|FG000|Overall Study|Withdrawal by Subject|11|||
129515014|NCT00563368|466175641|FG001|Overall Study|Withdrawal by Subject|6|||
129515015|NCT00563368|466175642|FG002|Overall Study|Withdrawal by Subject|5|||
129515016|NCT00563368|466175643|FG003|Overall Study|Withdrawal by Subject|7|||
129515017|NCT00563368|466175644|FG004|Overall Study|Withdrawal by Subject|8|||
129515018|NCT00563368|466175645|FG005|Overall Study|Withdrawal by Subject|5|||
129515019|NCT00563368|466175646|FG006|Overall Study|Withdrawal by Subject|4|||
129515020|NCT00563368|466175640|FG000|Overall Study|protocol non-compliance|1|||
129515021|NCT00563368|466175641|FG001|Overall Study|protocol non-compliance|1|||
129515022|NCT00563368|466175642|FG002|Overall Study|protocol non-compliance|2|||
129515023|NCT00563368|466175643|FG003|Overall Study|protocol non-compliance|1|||
129515024|NCT00563368|466175644|FG004|Overall Study|protocol non-compliance|0|||
129515025|NCT00563368|466175645|FG005|Overall Study|protocol non-compliance|1|||
129515026|NCT00563368|466175646|FG006|Overall Study|protocol non-compliance|3|||
129515027|NCT00563368|466175640|FG000|Overall Study|Pregnancy|1|||
129515028|NCT00563368|466175641|FG001|Overall Study|Pregnancy|0|||
129515029|NCT00563368|466175642|FG002|Overall Study|Pregnancy|1|||
129515030|NCT00563368|466175643|FG003|Overall Study|Pregnancy|2|||
129515031|NCT00563368|466175644|FG004|Overall Study|Pregnancy|1|||
129515032|NCT00563368|466175645|FG005|Overall Study|Pregnancy|2|||
129515033|NCT00563368|466175646|FG006|Overall Study|Pregnancy|0|||
129515034|NCT00563368|466175640|FG000|Overall Study|requirement for restricted medication|0|||
129515035|NCT00563368|466175641|FG001|Overall Study|requirement for restricted medication|0|||
129515036|NCT00563368|466175642|FG002|Overall Study|requirement for restricted medication|2|||
129515037|NCT00563368|466175643|FG003|Overall Study|requirement for restricted medication|0|||
129515038|NCT00563368|466175644|FG004|Overall Study|requirement for restricted medication|0|||
129515039|NCT00563368|466175645|FG005|Overall Study|requirement for restricted medication|0|||
129515040|NCT00563368|466175646|FG006|Overall Study|requirement for restricted medication|0|||
129515041|NCT00563368|466175640|FG000|Overall Study|Other|5|||
129515042|NCT00563368|466175641|FG001|Overall Study|Other|5|||
129515043|NCT00563368|466175642|FG002|Overall Study|Other|3|||
129515044|NCT00563368|466175643|FG003|Overall Study|Other|4|||
129515045|NCT00563368|466175644|FG004|Overall Study|Other|4|||
129515046|NCT00563368|466175645|FG005|Overall Study|Other|4|||
129515047|NCT00563368|466175646|FG006|Overall Study|Other|0|||
129515048|NCT01819506|466175647|FG000|Overall Study|Physician Decision|5|||
129515049|NCT01819506|466175648|FG001|Overall Study|Physician Decision|2|||
129515050|NCT01819506|466175647|FG000|Overall Study|Withdrawal by Subject|3|||
129515051|NCT01819506|466175648|FG001|Overall Study|Withdrawal by Subject|3|||
129515052|NCT00729326|466175653|FG000|Overall Study|Lost to Follow-up|2|||
129515053|NCT00729326|466175654|FG001|Overall Study|Lost to Follow-up|0|||
129515054|NCT00729326|466175653|FG000|Overall Study|Physician Decision|0|||
129515055|NCT00729326|466175654|FG001|Overall Study|Physician Decision|1|||
129515056|NCT00729326|466175653|FG000|Overall Study|Protocol Violation|3|||
129515057|NCT00729326|466175654|FG001|Overall Study|Protocol Violation|2|||
129515058|NCT00729326|466175653|FG000|Overall Study|Subject Decision|4|||
129515059|NCT00729326|466175654|FG001|Overall Study|Subject Decision|4|||
129515060|NCT00729326|466175653|FG000|Overall Study|Sponsor Decision|1|||
129515061|NCT00729326|466175654|FG001|Overall Study|Sponsor Decision|2|||
129515062|NCT01235728|466175655|FG000|Overall Study|Protocol Violation|0|||
129515063|NCT01235728|466175656|FG001|Overall Study|Protocol Violation|0|||
129515064|NCT01235728|466175657|FG002|Overall Study|Protocol Violation|0|||
129515065|NCT01235728|466175658|FG003|Overall Study|Protocol Violation|1|||
129515066|NCT01235728|466175659|FG004|Overall Study|Protocol Violation|0|||
129515067|NCT01235728|466175660|FG005|Overall Study|Protocol Violation|0|||
129515068|NCT01235728|466175661|FG006|Overall Study|Protocol Violation|0|||
129515069|NCT01235728|466175662|FG007|Overall Study|Protocol Violation|0|||
129515070|NCT02193828|466175663|FG000|Overall Study|Withdrawal by Subject|0|||
129515071|NCT02193828|466175664|FG001|Overall Study|Withdrawal by Subject|0|||
129515072|NCT02193828|466175665|FG002|Overall Study|Withdrawal by Subject|1|||
129515073|NCT02193828|466175666|FG003|Overall Study|Withdrawal by Subject|1|||
129515074|NCT01419080|466175669|FG000|Overall Study|Withdrawal by Subject|75|||
129515075|NCT01419080|466175669|FG000|Overall Study|Death|30|||
129515076|NCT01419080|466175669|FG000|Overall Study|Lost to Follow-up|23|||
129515077|NCT01419080|466175669|FG000|Overall Study|Too Ill|3|||
129515078|NCT03199638|466175673|FG000|Overall Study|inability to drink glutamine during regularly|0|||
129515079|NCT03199638|466175674|FG001|Overall Study|inability to drink glutamine during regularly|2|||
129515080|NCT01575899|466175675|FG000|Overall Study|Lost to Follow-up|3|||
129515081|NCT01575899|466175676|FG001|Overall Study|Lost to Follow-up|4|||
129515082|NCT01575899|466175677|FG002|Overall Study|Lost to Follow-up|2|||
129515083|NCT01575899|466175675|FG000|Overall Study|Protocol Violation|2|||
129515084|NCT01575899|466175676|FG001|Overall Study|Protocol Violation|1|||
129515085|NCT01575899|466175677|FG002|Overall Study|Protocol Violation|0|||
129515086|NCT02807844|466175678|FG000|Overall Study|Physician Decision|0|||
129515087|NCT02807844|466175679|FG001|Overall Study|Physician Decision|0|||
129515088|NCT02807844|466175680|FG002|Overall Study|Physician Decision|0|||
129515089|NCT02807844|466175681|FG003|Overall Study|Physician Decision|0|||
129515090|NCT02807844|466175682|FG004|Overall Study|Physician Decision|0|||
129515091|NCT02807844|466175683|FG005|Overall Study|Physician Decision|0|||
129515092|NCT02807844|466175684|FG006|Overall Study|Physician Decision|3|||
129515093|NCT02807844|466175685|FG007|Overall Study|Physician Decision|0|||
129515094|NCT02807844|466175686|FG008|Overall Study|Physician Decision|1|||
129515095|NCT02807844|466175687|FG009|Overall Study|Physician Decision|2|||
129515096|NCT02807844|466175678|FG000|Overall Study|Death|0|||
129515097|NCT02807844|466175679|FG001|Overall Study|Death|0|||
129515098|NCT02807844|466175680|FG002|Overall Study|Death|2|||
129515099|NCT02807844|466175681|FG003|Overall Study|Death|4|||
129515100|NCT02807844|466175682|FG004|Overall Study|Death|1|||
129515101|NCT02807844|466175683|FG005|Overall Study|Death|2|||
129515102|NCT02807844|466175684|FG006|Overall Study|Death|1|||
129515103|NCT02807844|466175685|FG007|Overall Study|Death|2|||
129515104|NCT02807844|466175686|FG008|Overall Study|Death|0|||
129515105|NCT02807844|466175687|FG009|Overall Study|Death|1|||
129515106|NCT02807844|466175678|FG000|Overall Study|Withdrawal by Subject|0|||
129515107|NCT02807844|466175679|FG001|Overall Study|Withdrawal by Subject|0|||
129515108|NCT02807844|466175680|FG002|Overall Study|Withdrawal by Subject|2|||
129515109|NCT02807844|466175681|FG003|Overall Study|Withdrawal by Subject|1|||
129515110|NCT02807844|466175682|FG004|Overall Study|Withdrawal by Subject|1|||
129515111|NCT02807844|466175683|FG005|Overall Study|Withdrawal by Subject|0|||
129515112|NCT02807844|466175684|FG006|Overall Study|Withdrawal by Subject|1|||
129515113|NCT02807844|466175685|FG007|Overall Study|Withdrawal by Subject|0|||
129515114|NCT02807844|466175686|FG008|Overall Study|Withdrawal by Subject|0|||
129515115|NCT02807844|466175687|FG009|Overall Study|Withdrawal by Subject|0|||
129515116|NCT02807844|466175678|FG000|Overall Study|Progressive disease|5|||
129515117|NCT02807844|466175679|FG001|Overall Study|Progressive disease|12|||
129515118|NCT02807844|466175680|FG002|Overall Study|Progressive disease|8|||
129515119|NCT02807844|466175681|FG003|Overall Study|Progressive disease|8|||
129515120|NCT02807844|466175682|FG004|Overall Study|Progressive disease|3|||
129515121|NCT02807844|466175683|FG005|Overall Study|Progressive disease|8|||
129515122|NCT02807844|466175684|FG006|Overall Study|Progressive disease|14|||
129515123|NCT02807844|466175685|FG007|Overall Study|Progressive disease|17|||
129515124|NCT02807844|466175686|FG008|Overall Study|Progressive disease|19|||
129515125|NCT02807844|466175687|FG009|Overall Study|Progressive disease|15|||
129515126|NCT02807844|466175678|FG000|Overall Study|Adverse Event|1|||
129515127|NCT02807844|466175679|FG001|Overall Study|Adverse Event|0|||
129515128|NCT02807844|466175680|FG002|Overall Study|Adverse Event|0|||
129515129|NCT02807844|466175681|FG003|Overall Study|Adverse Event|0|||
129515130|NCT02807844|466175682|FG004|Overall Study|Adverse Event|1|||
129515131|NCT02807844|466175683|FG005|Overall Study|Adverse Event|1|||
129515132|NCT02807844|466175684|FG006|Overall Study|Adverse Event|1|||
129515133|NCT02807844|466175685|FG007|Overall Study|Adverse Event|1|||
129515134|NCT02807844|466175686|FG008|Overall Study|Adverse Event|1|||
129515135|NCT02807844|466175687|FG009|Overall Study|Adverse Event|2|||
129515136|NCT04294095|466175688|FG000|Overall Study|Adverse Event|1|||
129515137|NCT04294095|466175689|FG001|Overall Study|Adverse Event|0|||
129515138|NCT02661464|466175693|FG000|Overall Study|Lost to Follow-up|28|||
129515139|NCT02661464|466175694|FG001|Overall Study|Lost to Follow-up|0|||
129515140|NCT02661464|466175695|FG002|Overall Study|Lost to Follow-up|0|||
129515141|NCT02661464|466175696|FG003|Overall Study|Lost to Follow-up|0|||
129515142|NCT02661464|466175693|FG000|Overall Study|Withdrawal by Subject|3|||
129515143|NCT02661464|466175694|FG001|Overall Study|Withdrawal by Subject|1|||
129515144|NCT02661464|466175695|FG002|Overall Study|Withdrawal by Subject|0|||
129515145|NCT02661464|466175696|FG003|Overall Study|Withdrawal by Subject|0|||
129515146|NCT02661464|466175693|FG000|Overall Study|Participants terminated prematurely|288|||
129515147|NCT02661464|466175694|FG001|Overall Study|Participants terminated prematurely|52|||
129515148|NCT02661464|466175695|FG002|Overall Study|Participants terminated prematurely|1|||
129515149|NCT02661464|466175696|FG003|Overall Study|Participants terminated prematurely|1|||
129515150|NCT02661464|466175693|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
129515151|NCT02661464|466175694|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
129515152|NCT02661464|466175695|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
129515153|NCT02661464|466175696|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
129515154|NCT03148756|466175697|FG000|Overall Study|Study Terminated|0|||
129515155|NCT03148756|466175698|FG001|Overall Study|Study Terminated|1|||
129515156|NCT02177175|466175703|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
129515157|NCT02177175|466175704|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
129515158|NCT03205982|466175710|FG000|Overall Study|Lost to Follow-up|20|||
129515159|NCT03205982|466175711|FG001|Overall Study|Lost to Follow-up|19|||
129515160|NCT03205982|466175710|FG000|Overall Study|Withdrawal by Subject|4|||
129515161|NCT03205982|466175711|FG001|Overall Study|Withdrawal by Subject|3|||
129515162|NCT03205982|466175710|FG000|Overall Study|Withdrawal by PI|0|||
129515163|NCT03205982|466175711|FG001|Overall Study|Withdrawal by PI|1|||
129515164|NCT00994162|466175712|FG000|Overall Study|Withdrawal by Subject|1|||
129515165|NCT00994162|466175712|FG000|Overall Study|Lost to Follow-up|2|||
129515166|NCT00994162|466175712|FG000|Overall Study|Product Complaint|1|||
129515167|NCT00994162|466175712|FG000|Overall Study|Poor Compliance|5|||
129515168|NCT00994162|466175712|FG000|Overall Study|Lack of Response|3|||
129515169|NCT00994162|466175712|FG000|Overall Study|Discharged from Hospital|4|||
129515170|NCT00994162|466175712|FG000|Overall Study|Death|2|||
129515171|NCT00994162|466175712|FG000|Overall Study|Care Transferred to Another Physician|2|||
129515172|NCT00994162|466175712|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
129515173|NCT00994162|466175712|FG000|Overall Study|Physician Decision|2|||
129515174|NCT00994162|466175712|FG000|Overall Study|Surrounding Wound Erythematous|1|||
129515175|NCT00994162|466175712|FG000|Overall Study|Machine Losing Vaccum|1|||
129515176|NCT00994162|466175712|FG000|Overall Study|Patient Lived Too Far Away|1|||
129515177|NCT00994162|466175712|FG000|Overall Study|Above Knee Amputation|1|||
129515178|NCT00994162|466175712|FG000|Overall Study|Reason Not Reported By Site|1|||
129515179|NCT01293084|466175713|FG000|Overall Study|Physician Decision|3|||
129515180|NCT01293084|466175713|FG000|Overall Study|Withdrawal by Subject|2|||
129515181|NCT02096042|466175714|FG000|Overall Study|Disease Progression|1|||
129515182|NCT02096042|466175715|FG001|Overall Study|Disease Progression|0|||
129515183|NCT02096042|466175716|FG002|Overall Study|Disease Progression|0|||
129515184|NCT02983799|466175717|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
129515185|NCT02983799|466175718|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
129515186|NCT02983799|466175719|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
129515187|NCT02983799|466175720|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
129515188|NCT02983799|466175721|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
129515189|NCT02983799|466175717|FG000|Overall Study|Death|20|||
129983768|NCT01305200|467902355|FG001|Overall Study|Death|2|||
129983769|NCT01305200|467902356|FG002|Overall Study|Death|0|||
129515190|NCT02983799|466175718|FG001|Overall Study|Death|5|||
129515191|NCT02983799|466175719|FG002|Overall Study|Death|23|||
129515192|NCT02983799|466175720|FG003|Overall Study|Death|47|||
129515193|NCT02983799|466175721|FG004|Overall Study|Death|7|||
129515194|NCT02983799|466175717|FG000|Overall Study|Withdrawal by Subject|1|||
129515195|NCT02983799|466175718|FG001|Overall Study|Withdrawal by Subject|0|||
129515196|NCT02983799|466175719|FG002|Overall Study|Withdrawal by Subject|3|||
129515197|NCT02983799|466175720|FG003|Overall Study|Withdrawal by Subject|4|||
129515198|NCT02983799|466175721|FG004|Overall Study|Withdrawal by Subject|1|||
129515199|NCT02983799|466175717|FG000|Overall Study|Protocol Violation|0|||
129515200|NCT02983799|466175718|FG001|Overall Study|Protocol Violation|1|||
129515201|NCT02983799|466175719|FG002|Overall Study|Protocol Violation|0|||
129515202|NCT02983799|466175720|FG003|Overall Study|Protocol Violation|0|||
129515203|NCT02983799|466175721|FG004|Overall Study|Protocol Violation|1|||
129515204|NCT02983799|466175717|FG000|Overall Study|Lost to Follow-up|1|||
129515205|NCT02983799|466175718|FG001|Overall Study|Lost to Follow-up|0|||
129515206|NCT02983799|466175719|FG002|Overall Study|Lost to Follow-up|1|||
129515207|NCT02983799|466175720|FG003|Overall Study|Lost to Follow-up|0|||
129515208|NCT02983799|466175721|FG004|Overall Study|Lost to Follow-up|0|||
129515209|NCT00631540|466175730|FG000|Overall Study|Withdrawal by Subject|5|||
129515210|NCT00631540|466175730|FG000|Overall Study|Death|4|||
129515211|NCT00631540|466175730|FG000|Overall Study|Lost to Follow-up|2|||
129515212|NCT00631540|466175730|FG000|Overall Study|Core Lab Data Unavailable|3|||
129515213|NCT03136367|466175732|FG000|T1 Consultation|discontinued mistakenly included|2|||
129515214|NCT03136367|466175733|FG001|T1 Consultation|discontinued mistakenly included|6|||
129515215|NCT03136367|466175734|FG002|T1 Consultation|discontinued mistakenly included|1|||
129515216|NCT03136367|466175732|FG000|T1 Consultation|Discontinued other|0|||
129515217|NCT03136367|466175733|FG001|T1 Consultation|Discontinued other|1|||
129515218|NCT03136367|466175734|FG002|T1 Consultation|Discontinued other|0|||
129515219|NCT03136367|466175732|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
129515220|NCT03136367|466175733|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
129515221|NCT03136367|466175734|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
129515222|NCT03136367|466175732|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
129515223|NCT03136367|466175733|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
129515224|NCT03136367|466175734|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
129515225|NCT03136367|466175732|FG000|T2 Post-consultation|Discontinued other|0|||
129515226|NCT03136367|466175733|FG001|T2 Post-consultation|Discontinued other|2|||
129515227|NCT03136367|466175734|FG002|T2 Post-consultation|Discontinued other|6|||
129515228|NCT03136367|466175732|FG000|T2 Post-consultation|Discontinued transferred care|0|||
129515229|NCT03136367|466175733|FG001|T2 Post-consultation|Discontinued transferred care|0|||
129515230|NCT03136367|466175734|FG002|T2 Post-consultation|Discontinued transferred care|3|||
129515231|NCT03136367|466175732|FG000|T2 Post-consultation|Discontinued lost contact|0|||
129515232|NCT03136367|466175733|FG001|T2 Post-consultation|Discontinued lost contact|1|||
129515233|NCT03136367|466175734|FG002|T2 Post-consultation|Discontinued lost contact|0|||
129515234|NCT03136367|466175732|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
129515235|NCT03136367|466175733|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
129515236|NCT03136367|466175734|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
129515237|NCT03136367|466175732|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
129515238|NCT03136367|466175733|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
129515239|NCT03136367|466175734|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
129515240|NCT03136367|466175732|FG000|T3 1 Week After Surgery|other discontinued|2|||
129515241|NCT03136367|466175733|FG001|T3 1 Week After Surgery|other discontinued|4|||
129515242|NCT03136367|466175734|FG002|T3 1 Week After Surgery|other discontinued|3|||
129515243|NCT03136367|466175732|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
129515244|NCT03136367|466175733|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
129515245|NCT03136367|466175734|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
129515246|NCT03136367|466175732|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
129515247|NCT03136367|466175733|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
129515248|NCT03136367|466175734|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
129515249|NCT03136367|466175732|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
129515250|NCT03136367|466175733|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
129515251|NCT03136367|466175734|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
129515252|NCT03136367|466175732|FG000|T4 12 Weeks After Surgery|Death|0|||
129515253|NCT03136367|466175733|FG001|T4 12 Weeks After Surgery|Death|1|||
129515254|NCT03136367|466175734|FG002|T4 12 Weeks After Surgery|Death|3|||
129515255|NCT03136367|466175732|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
129515256|NCT03136367|466175733|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
129515257|NCT03136367|466175734|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
129515258|NCT03136367|466175732|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
129515259|NCT03136367|466175733|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
129515260|NCT03136367|466175734|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
129515261|NCT03136367|466175732|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
129515262|NCT03136367|466175733|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
129515263|NCT03136367|466175734|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
129515264|NCT03136367|466175732|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
129515265|NCT03136367|466175733|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
129515266|NCT03136367|466175734|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
129515267|NCT03136367|466175732|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
129515268|NCT03136367|466175733|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
129515269|NCT03136367|466175734|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
129515270|NCT03136367|466175732|FG000|T5 1 Year After Surgery|Death|0|||
129515271|NCT03136367|466175733|FG001|T5 1 Year After Surgery|Death|0|||
129515272|NCT03136367|466175734|FG002|T5 1 Year After Surgery|Death|1|||
129515273|NCT03136367|466175732|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
129515274|NCT03136367|466175733|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
129515275|NCT03136367|466175734|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
129515276|NCT03136367|466175732|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
129515277|NCT03136367|466175733|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
129515278|NCT03136367|466175734|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
129515279|NCT03136367|466175732|FG000|T5 1 Year After Surgery|study ended before due|31|||
129515280|NCT03136367|466175733|FG001|T5 1 Year After Surgery|study ended before due|103|||
129515281|NCT03136367|466175734|FG002|T5 1 Year After Surgery|study ended before due|110|||
129515282|NCT03136367|466175732|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
129515283|NCT03136367|466175733|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
129515284|NCT03136367|466175734|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
129515285|NCT05200455|466175735|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
129515286|NCT01602549|466175736|FG000|Overall Study|Protocol Violation|0|||
129515287|NCT01602549|466175737|FG001|Overall Study|Protocol Violation|1|||
129515288|NCT01602549|466175736|FG000|Overall Study|Withdrawal by Subject|1|||
129515289|NCT01602549|466175737|FG001|Overall Study|Withdrawal by Subject|0|||
129515290|NCT02483078|466175746|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
129515291|NCT02483078|466175747|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
129515292|NCT02483078|466175746|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
129515293|NCT02483078|466175747|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
129515294|NCT02483078|466175746|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
129515295|NCT02483078|466175747|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
129515296|NCT02483078|466175746|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
129515297|NCT02483078|466175747|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
129515298|NCT02483078|466175746|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
129515299|NCT02483078|466175747|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
129515300|NCT02483078|466175746|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
129515301|NCT02483078|466175747|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
129515302|NCT02853032|466175748|FG000|Overall Study|Adverse Event|4|||
129515303|NCT02853032|466175749|FG001|Overall Study|Adverse Event|0|||
129515304|NCT02853032|466175748|FG000|Overall Study|Withdrawal by Subject|3|||
129515305|NCT02853032|466175749|FG001|Overall Study|Withdrawal by Subject|1|||
129515306|NCT02853032|466175748|FG000|Overall Study|Requested to withdraw from all treatment|2|||
129515307|NCT02853032|466175749|FG001|Overall Study|Requested to withdraw from all treatment|2|||
129515308|NCT00676208|466175750|FG000|Overall Study|Lost to Follow-up|0|||
129515309|NCT00676208|466175751|FG001|Overall Study|Lost to Follow-up|2|||
129515310|NCT00676208|466175750|FG000|Overall Study|Incomplete data|2|||
129515311|NCT00676208|466175751|FG001|Overall Study|Incomplete data|4|||
129515312|NCT03726333|466175752|FG000|Overall Study|Progressive Disease|0|||
129515313|NCT03726333|466175753|FG001|Overall Study|Progressive Disease|0|||
129515314|NCT03726333|466175754|FG002|Overall Study|Progressive Disease|1|||
129515315|NCT03726333|466175755|FG003|Overall Study|Progressive Disease|0|||
129515316|NCT03726333|466175756|FG004|Overall Study|Progressive Disease|0|||
129515317|NCT01410799|466175757|FG000|Overall Study|PI decision|13|||
129515318|NCT01946412|466175758|FG000|Overall Study|Adverse Event|1|||
129515319|NCT01946412|466175758|FG000|Overall Study|Non-Compliance|1|||
129515320|NCT01946412|466175758|FG000|Overall Study|Continued with commercial Kalydeco|2|||
129515321|NCT01946412|466175758|FG000|Overall Study|Difficulty in swallowing|1|||
129515322|NCT03682055|466177803|FG000|Overall Study|Lack of Efficacy|1|||
129515323|NCT03682055|466177804|FG001|Overall Study|Lack of Efficacy|2|||
129515324|NCT03682055|466177805|FG002|Overall Study|Lack of Efficacy|1|||
129515325|NCT03682055|466177806|FG003|Overall Study|Lack of Efficacy|2|||
129515326|NCT03682055|466177807|FG004|Overall Study|Lack of Efficacy|1|||
129515327|NCT03682055|466177808|FG005|Overall Study|Lack of Efficacy|3|||
129515328|NCT03682055|466177803|FG000|Overall Study|Withdrawal by Subject|0|||
129515329|NCT03682055|466177804|FG001|Overall Study|Withdrawal by Subject|0|||
129515330|NCT03682055|466177805|FG002|Overall Study|Withdrawal by Subject|0|||
129515331|NCT03682055|466177806|FG003|Overall Study|Withdrawal by Subject|0|||
129515332|NCT03682055|466177807|FG004|Overall Study|Withdrawal by Subject|0|||
129515333|NCT03682055|466177808|FG005|Overall Study|Withdrawal by Subject|1|||
129515334|NCT03682055|466177803|FG000|Overall Study|Termination of Study by Sponsor|0|||
129515335|NCT03682055|466177804|FG001|Overall Study|Termination of Study by Sponsor|0|||
129515336|NCT03682055|466177805|FG002|Overall Study|Termination of Study by Sponsor|0|||
129515337|NCT03682055|466177806|FG003|Overall Study|Termination of Study by Sponsor|0|||
129515338|NCT03682055|466177807|FG004|Overall Study|Termination of Study by Sponsor|0|||
129515339|NCT03682055|466177808|FG005|Overall Study|Termination of Study by Sponsor|3|||
129515340|NCT03750240|466177809|FG000|Overall Study|Technical Difficulties|2|||
129515341|NCT00927758|466177810|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
129515342|NCT00927758|466177811|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
129515343|NCT00927758|466177812|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
129515344|NCT00927758|466177813|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
129515345|NCT00927758|466177814|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
129515346|NCT00927758|466177815|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
129515347|NCT00927758|466177810|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
129515348|NCT00927758|466177811|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
129515349|NCT00927758|466177812|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
129515350|NCT00927758|466177813|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
129515351|NCT00927758|466177814|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
129515352|NCT00927758|466177815|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
129515353|NCT00439725|466177817|FG000|Treatment Period|Withdrawal by Subject|22|||
129515354|NCT00439725|466177818|FG001|Treatment Period|Withdrawal by Subject|19|||
129515355|NCT00439725|466177817|FG000|Treatment Period|Study terminated by sponsor|156|||
129515356|NCT00439725|466177818|FG001|Treatment Period|Study terminated by sponsor|148|||
129515357|NCT00439725|466177817|FG000|Treatment Period|Site closed by investigator|1|||
129515358|NCT00439725|466177818|FG001|Treatment Period|Site closed by investigator|2|||
129515359|NCT00439725|466177817|FG000|Treatment Period|Adverse Event|39|||
129515360|NCT00439725|466177818|FG001|Treatment Period|Adverse Event|18|||
129515361|NCT00439725|466177817|FG000|Treatment Period|Physician Decision|1|||
129515362|NCT00439725|466177818|FG001|Treatment Period|Physician Decision|1|||
129515363|NCT00439725|466177817|FG000|Treatment Period|Protocol Violation|2|||
129515364|NCT00439725|466177818|FG001|Treatment Period|Protocol Violation|1|||
129515365|NCT00439725|466177817|FG000|Treatment Period|Clinical endpoint reached|6|||
129515366|NCT00439725|466177818|FG001|Treatment Period|Clinical endpoint reached|50|||
129515367|NCT00439725|466177817|FG000|Treatment Period|Technical problems|1|||
129515368|NCT00439725|466177818|FG001|Treatment Period|Technical problems|0|||
129515369|NCT00439725|466177817|FG000|Treatment Period|Lost to Follow-up|1|||
129515370|NCT00439725|466177818|FG001|Treatment Period|Lost to Follow-up|1|||
129515371|NCT00439725|466177817|FG000|Treatment Period|Participant convenience|1|||
129515372|NCT00439725|466177818|FG001|Treatment Period|Participant convenience|0|||
129515373|NCT00439725|466177817|FG000|Treatment Period|Protocol driven decision point|1|||
129515374|NCT00439725|466177818|FG001|Treatment Period|Protocol driven decision point|1|||
129515375|NCT00439725|466177817|FG000|Treatment Period|Death|1|||
129515376|NCT00439725|466177818|FG001|Treatment Period|Death|1|||
129515377|NCT00439725|466177817|FG000|Treatment Period|Participant did not receive treatment|4|||
129515378|NCT00439725|466177818|FG001|Treatment Period|Participant did not receive treatment|4|||
129515379|NCT00439725|466177817|FG000|Observational Period|Withdrawal by Subject|2|||
129515380|NCT00439725|466177818|FG001|Observational Period|Withdrawal by Subject|2|||
129515381|NCT00439725|466177817|FG000|Observational Period|Lost to Follow-up|0|||
129515382|NCT00439725|466177818|FG001|Observational Period|Lost to Follow-up|1|||
129515383|NCT00439725|466177817|FG000|Observational Period|Death|0|||
129515384|NCT00439725|466177818|FG001|Observational Period|Death|2|||
129515385|NCT00439725|466177817|FG000|Observational Period|Study termination by sponsor|1|||
129515386|NCT00439725|466177818|FG001|Observational Period|Study termination by sponsor|1|||
129515387|NCT00439725|466177817|FG000|Observational Period|Clinical endpoint reached|3|||
129515388|NCT00439725|466177818|FG001|Observational Period|Clinical endpoint reached|1|||
129515389|NCT00439725|466177817|FG000|Observational Period|Technical problems|1|||
129515390|NCT00439725|466177818|FG001|Observational Period|Technical problems|0|||
129515391|NCT00439725|466177817|FG000|Observational Period|Participant convenience|1|||
129515392|NCT00439725|466177818|FG001|Observational Period|Participant convenience|0|||
129515393|NCT03510910|466177819|FG000|Overall Study|Incomplete Survey|2|||
129515394|NCT03510910|466177820|FG001|Overall Study|Incomplete Survey|3|||
129515395|NCT01105936|466177821|FG000|Period 1|Adverse Event|0|||
129515396|NCT01105936|466177822|FG001|Period 1|Adverse Event|0|||
129515397|NCT01105936|466177823|FG002|Period 1|Adverse Event|0|||
129515398|NCT01105936|466177824|FG003|Period 1|Adverse Event|1|||
129515399|NCT01105936|466177821|FG000|Period 2|Adverse Event|1|||
129515400|NCT01105936|466177822|FG001|Period 2|Adverse Event|0|||
129515401|NCT01105936|466177823|FG002|Period 2|Adverse Event|0|||
129515402|NCT01105936|466177824|FG003|Period 2|Adverse Event|0|||
129515403|NCT01105936|466177821|FG000|Period 3|Protocol Violation|0|||
129515404|NCT01105936|466177822|FG001|Period 3|Protocol Violation|2|||
129515405|NCT01105936|466177823|FG002|Period 3|Protocol Violation|0|||
129515406|NCT01105936|466177824|FG003|Period 3|Protocol Violation|0|||
129515407|NCT01673490|466177825|FG000|Overall Study|Lost to Follow-up|1|||
129515408|NCT01673490|466177825|FG000|Overall Study|Adverse Event|3|||
129515409|NCT01673490|466177825|FG000|Overall Study|Withdrawal by Subject|3|||
129515410|NCT00379236|466177826|FG000|Double-blind|Adverse Event|11|||
129515411|NCT00379236|466177827|FG001|Double-blind|Adverse Event|6|||
129515412|NCT00379236|466177828|FG002|Double-blind|Adverse Event|0|||
129515413|NCT00379236|466177826|FG000|Double-blind|Protocol Violation|3|||
129515414|NCT00379236|466177827|FG001|Double-blind|Protocol Violation|3|||
129515415|NCT00379236|466177828|FG002|Double-blind|Protocol Violation|0|||
129515416|NCT00379236|466177826|FG000|Double-blind|Withdrawal by Subject|12|||
129515417|NCT00379236|466177827|FG001|Double-blind|Withdrawal by Subject|13|||
129515418|NCT00379236|466177828|FG002|Double-blind|Withdrawal by Subject|0|||
129515419|NCT00379236|466177826|FG000|Double-blind|Lost to Follow-up|4|||
129515420|NCT00379236|466177827|FG001|Double-blind|Lost to Follow-up|3|||
129515421|NCT00379236|466177828|FG002|Double-blind|Lost to Follow-up|0|||
129515422|NCT00379236|466177826|FG000|Double-blind|Use of exclusionary medication|1|||
129538580|NCT04511533|466263420|FG000|Follow-Up|Death|4|||
129515423|NCT00379236|466177827|FG001|Double-blind|Use of exclusionary medication|2|||
129515424|NCT00379236|466177828|FG002|Double-blind|Use of exclusionary medication|0|||
129515425|NCT00379236|466177826|FG000|Double-blind|Other|3|||
129515426|NCT00379236|466177827|FG001|Double-blind|Other|7|||
129515427|NCT00379236|466177828|FG002|Double-blind|Other|0|||
129515428|NCT00379236|466177826|FG000|Double-blind|Data could not be retrieved|2|||
129515429|NCT00379236|466177827|FG001|Double-blind|Data could not be retrieved|2|||
129515430|NCT00379236|466177828|FG002|Double-blind|Data could not be retrieved|0|||
129515431|NCT00379236|466177826|FG000|Open-label Extension|Adverse Event|0|||
129515432|NCT00379236|466177827|FG001|Open-label Extension|Adverse Event|0|||
129515433|NCT00379236|466177828|FG002|Open-label Extension|Adverse Event|13|||
129515434|NCT00379236|466177826|FG000|Open-label Extension|Protocol Violation|0|||
129515435|NCT00379236|466177827|FG001|Open-label Extension|Protocol Violation|0|||
129515436|NCT00379236|466177828|FG002|Open-label Extension|Protocol Violation|7|||
129515437|NCT00379236|466177826|FG000|Open-label Extension|Withdrawal by Subject|0|||
129515438|NCT00379236|466177827|FG001|Open-label Extension|Withdrawal by Subject|0|||
129515439|NCT00379236|466177828|FG002|Open-label Extension|Withdrawal by Subject|13|||
129515440|NCT00379236|466177826|FG000|Open-label Extension|Lost to Follow-up|0|||
129515441|NCT00379236|466177827|FG001|Open-label Extension|Lost to Follow-up|0|||
129515442|NCT00379236|466177828|FG002|Open-label Extension|Lost to Follow-up|12|||
129515443|NCT00379236|466177826|FG000|Open-label Extension|Use of exclusionary medication|0|||
129515444|NCT00379236|466177827|FG001|Open-label Extension|Use of exclusionary medication|0|||
129515445|NCT00379236|466177828|FG002|Open-label Extension|Use of exclusionary medication|3|||
129515446|NCT00379236|466177826|FG000|Open-label Extension|Other|0|||
129515447|NCT00379236|466177827|FG001|Open-label Extension|Other|0|||
129515448|NCT00379236|466177828|FG002|Open-label Extension|Other|7|||
129515449|NCT02940860|466177836|FG000|Overall Study|Non-serious AE|1|||
129515450|NCT02940860|466177837|FG001|Overall Study|Non-serious AE|2|||
129515451|NCT02940860|466177836|FG000|Overall Study|Serious AE|7|||
129515452|NCT02940860|466177837|FG001|Overall Study|Serious AE|3|||
129515453|NCT02940860|466177836|FG000|Overall Study|Withdrawal by Subject|19|||
129515454|NCT02940860|466177837|FG001|Overall Study|Withdrawal by Subject|9|||
129515455|NCT02940860|466177836|FG000|Overall Study|Lost to Follow-up|13|||
129515456|NCT02940860|466177837|FG001|Overall Study|Lost to Follow-up|7|||
129515457|NCT02940860|466177836|FG000|Overall Study|Physician Decision|5|||
129515458|NCT02940860|466177837|FG001|Overall Study|Physician Decision|3|||
129515459|NCT02940860|466177836|FG000|Overall Study|Sponsor Decision|0|||
129515460|NCT02940860|466177837|FG001|Overall Study|Sponsor Decision|1|||
129515461|NCT02940860|466177836|FG000|Overall Study|Protocol Violation|0|||
129515462|NCT02940860|466177837|FG001|Overall Study|Protocol Violation|2|||
129515463|NCT02940860|466177836|FG000|Overall Study|Death|3|||
129515464|NCT02940860|466177837|FG001|Overall Study|Death|2|||
129515465|NCT02940860|466177836|FG000|Overall Study|Moved, poor venous access, transport|6|||
129515466|NCT02940860|466177837|FG001|Overall Study|Moved, poor venous access, transport|4|||
129515467|NCT02940860|466177836|FG000|Overall Study|Not treated|2|||
129515468|NCT02940860|466177837|FG001|Overall Study|Not treated|2|||
129515469|NCT04914819|466177838|FG000|Overall Study|Pregnancy|3|||
129515470|NCT04914819|466177839|FG001|Overall Study|Pregnancy|1|||
129515471|NCT04914819|466177838|FG000|Overall Study|Discontinued study|4|||
129515472|NCT04914819|466177839|FG001|Overall Study|Discontinued study|1|||
129515473|NCT04914819|466177838|FG000|Overall Study|Lost to Follow-up|7|||
129515474|NCT04914819|466177839|FG001|Overall Study|Lost to Follow-up|0|||
129515475|NCT02715804|466177840|FG000|Overall Study|Death|222|||
129515476|NCT02715804|466177841|FG001|Overall Study|Death|106|||
129515477|NCT02715804|466177840|FG000|Overall Study|Withdrawal by Subject|5|||
129515478|NCT02715804|466177841|FG001|Overall Study|Withdrawal by Subject|4|||
129515479|NCT02715804|466177840|FG000|Overall Study|Other than specified|2|||
129515480|NCT02715804|466177841|FG001|Overall Study|Other than specified|3|||
129515481|NCT04038385|466177842|FG000|Overall Study|Completed baseline assessment only|7|||
129515482|NCT04038385|466177843|FG001|Overall Study|Completed baseline assessment only|4|||
129515483|NCT04038385|466177842|FG000|Overall Study|Moved out of area|4|||
129515484|NCT04038385|466177843|FG001|Overall Study|Moved out of area|2|||
129515485|NCT04038385|466177842|FG000|Overall Study|Discontinued study involvement|6|||
129515486|NCT04038385|466177843|FG001|Overall Study|Discontinued study involvement|1|||
129515487|NCT01625611|466177844|FG000|Overall Study|No adlib drinks Lab 1|3|||
129515488|NCT01625611|466177845|FG001|Overall Study|No adlib drinks Lab 1|0|||
129515489|NCT01625611|466177844|FG000|Overall Study|Technical issues with PET|1|||
129515490|NCT01625611|466177845|FG001|Overall Study|Technical issues with PET|0|||
129515491|NCT01625611|466177844|FG000|Overall Study|Unable to complete study procedures|1|||
129515492|NCT01625611|466177845|FG001|Overall Study|Unable to complete study procedures|0|||
129515493|NCT01625611|466177844|FG000|Overall Study|Withdrawal by Subject|3|||
129515494|NCT01625611|466177845|FG001|Overall Study|Withdrawal by Subject|0|||
129515495|NCT01998958|466177848|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515496|NCT01998958|466177849|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
129515497|NCT01998958|466177850|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515498|NCT01998958|466177851|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515499|NCT01998958|466177852|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515500|NCT01998958|466177853|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515501|NCT01998958|466177854|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515502|NCT01998958|466177855|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515503|NCT01998958|466177856|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515504|NCT01998958|466177857|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515505|NCT01998958|466177858|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515506|NCT01998958|466177859|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515507|NCT01998958|466177860|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515508|NCT01998958|466177861|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515509|NCT01998958|466177862|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515510|NCT01998958|466177863|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515511|NCT01998958|466177864|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515512|NCT01998958|466177865|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515513|NCT01998958|466177866|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515514|NCT01998958|466177867|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515515|NCT01998958|466177868|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515516|NCT01998958|466177869|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515517|NCT01998958|466177870|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515518|NCT01998958|466177871|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515519|NCT01998958|466177872|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515520|NCT01998958|466177873|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515521|NCT01998958|466177874|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515522|NCT01998958|466177875|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515523|NCT01998958|466177876|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515524|NCT01998958|466177877|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515525|NCT01998958|466177878|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515526|NCT01998958|466177879|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
129515527|NCT01998958|466177848|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515528|NCT01998958|466177849|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
129515529|NCT01998958|466177850|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515530|NCT01998958|466177851|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515531|NCT01998958|466177852|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515532|NCT01998958|466177853|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515533|NCT01998958|466177854|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515534|NCT01998958|466177855|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515535|NCT01998958|466177856|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515536|NCT01998958|466177857|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515537|NCT01998958|466177858|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515538|NCT01998958|466177859|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515539|NCT01998958|466177860|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515540|NCT01998958|466177861|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515541|NCT01998958|466177862|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515542|NCT01998958|466177863|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515543|NCT01998958|466177864|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515544|NCT01998958|466177865|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515545|NCT01998958|466177866|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515546|NCT01998958|466177867|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515547|NCT01998958|466177868|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515548|NCT01998958|466177869|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515549|NCT01998958|466177870|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515550|NCT01998958|466177871|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515551|NCT01998958|466177872|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515552|NCT01998958|466177873|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515553|NCT01998958|466177874|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515554|NCT01998958|466177875|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515555|NCT01998958|466177876|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515556|NCT01998958|466177877|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515557|NCT01998958|466177878|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515558|NCT01998958|466177879|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
129515559|NCT01998958|466177848|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
129515560|NCT01998958|466177849|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
129515561|NCT01998958|466177850|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
129515562|NCT01998958|466177851|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
129515563|NCT01998958|466177852|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
129515564|NCT01998958|466177853|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
129515565|NCT01998958|466177854|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
129515566|NCT01998958|466177855|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
129515567|NCT01998958|466177856|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
129515568|NCT01998958|466177857|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
129515569|NCT01998958|466177858|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
129515570|NCT01998958|466177859|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
129515571|NCT01998958|466177860|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
129515572|NCT01998958|466177861|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
129515573|NCT01998958|466177862|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
129515574|NCT01998958|466177863|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
129515575|NCT01998958|466177864|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
129515576|NCT01998958|466177865|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
129515577|NCT01998958|466177866|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
129515578|NCT01998958|466177867|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
129515579|NCT01998958|466177868|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
129515580|NCT01998958|466177869|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
129515581|NCT01998958|466177870|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
129515582|NCT01998958|466177871|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
129515583|NCT01998958|466177872|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
129515584|NCT01998958|466177873|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
129515585|NCT01998958|466177874|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
129515586|NCT01998958|466177875|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
129515587|NCT01998958|466177876|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
129515588|NCT01998958|466177877|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
129515589|NCT01998958|466177878|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
129515590|NCT01998958|466177879|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
129515591|NCT01998958|466177848|FG000|Period 1 (Panel A and B)|Other|1|||
129515592|NCT01998958|466177849|FG001|Period 1 (Panel A and B)|Other|0|||
129515593|NCT01998958|466177850|FG002|Period 1 (Panel A and B)|Other|0|||
129515594|NCT01998958|466177851|FG003|Period 1 (Panel A and B)|Other|0|||
129515595|NCT01998958|466177852|FG004|Period 1 (Panel A and B)|Other|0|||
129515596|NCT01998958|466177853|FG005|Period 1 (Panel A and B)|Other|0|||
129515597|NCT01998958|466177854|FG006|Period 1 (Panel A and B)|Other|0|||
129515598|NCT01998958|466177855|FG007|Period 1 (Panel A and B)|Other|0|||
129515599|NCT01998958|466177856|FG008|Period 1 (Panel A and B)|Other|0|||
129515600|NCT01998958|466177857|FG009|Period 1 (Panel A and B)|Other|0|||
129515601|NCT01998958|466177858|FG010|Period 1 (Panel A and B)|Other|0|||
129515602|NCT01998958|466177859|FG011|Period 1 (Panel A and B)|Other|0|||
129515603|NCT01998958|466177860|FG012|Period 1 (Panel A and B)|Other|0|||
129515604|NCT01998958|466177861|FG013|Period 1 (Panel A and B)|Other|0|||
129515605|NCT01998958|466177862|FG014|Period 1 (Panel A and B)|Other|0|||
129515606|NCT01998958|466177863|FG015|Period 1 (Panel A and B)|Other|0|||
129515607|NCT01998958|466177864|FG016|Period 1 (Panel A and B)|Other|0|||
129515608|NCT01998958|466177865|FG017|Period 1 (Panel A and B)|Other|0|||
129515609|NCT01998958|466177866|FG018|Period 1 (Panel A and B)|Other|0|||
129515610|NCT01998958|466177867|FG019|Period 1 (Panel A and B)|Other|0|||
129515611|NCT01998958|466177868|FG020|Period 1 (Panel A and B)|Other|0|||
129515612|NCT01998958|466177869|FG021|Period 1 (Panel A and B)|Other|0|||
129515613|NCT01998958|466177870|FG022|Period 1 (Panel A and B)|Other|0|||
129515614|NCT01998958|466177871|FG023|Period 1 (Panel A and B)|Other|0|||
129515615|NCT01998958|466177872|FG024|Period 1 (Panel A and B)|Other|0|||
129515616|NCT01998958|466177873|FG025|Period 1 (Panel A and B)|Other|0|||
129515617|NCT01998958|466177874|FG026|Period 1 (Panel A and B)|Other|0|||
129515618|NCT01998958|466177875|FG027|Period 1 (Panel A and B)|Other|0|||
129515619|NCT01998958|466177876|FG028|Period 1 (Panel A and B)|Other|0|||
129515620|NCT01998958|466177877|FG029|Period 1 (Panel A and B)|Other|0|||
129515621|NCT01998958|466177878|FG030|Period 1 (Panel A and B)|Other|0|||
129515622|NCT01998958|466177879|FG031|Period 1 (Panel A and B)|Other|0|||
129515623|NCT01998958|466177848|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
129515624|NCT01998958|466177849|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
129515625|NCT01998958|466177850|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
129515626|NCT01998958|466177851|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
129515627|NCT01998958|466177852|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
129515628|NCT01998958|466177853|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
129515629|NCT01998958|466177854|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
129515630|NCT01998958|466177855|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
129515631|NCT01998958|466177856|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
129515632|NCT01998958|466177857|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
129515633|NCT01998958|466177858|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
129515634|NCT01998958|466177859|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
129515635|NCT01998958|466177860|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
129515636|NCT01998958|466177861|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
129515637|NCT01998958|466177862|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
129515638|NCT01998958|466177863|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
129515639|NCT01998958|466177864|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
129515640|NCT01998958|466177865|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
129515641|NCT01998958|466177866|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
129515642|NCT01998958|466177867|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
129515643|NCT01998958|466177868|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
129515644|NCT01998958|466177869|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
129515645|NCT01998958|466177870|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
129515646|NCT01998958|466177871|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
129515647|NCT01998958|466177872|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
129515648|NCT01998958|466177873|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
129515649|NCT01998958|466177874|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
129515650|NCT01998958|466177875|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
129515651|NCT01998958|466177876|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
129515652|NCT01998958|466177877|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
129515653|NCT01998958|466177878|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
129515654|NCT01998958|466177879|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
129515655|NCT01998958|466177848|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515656|NCT01998958|466177849|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515657|NCT01998958|466177850|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515658|NCT01998958|466177851|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515659|NCT01998958|466177852|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515660|NCT01998958|466177853|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515661|NCT01998958|466177854|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515662|NCT01998958|466177855|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515663|NCT01998958|466177856|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515664|NCT01998958|466177857|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515665|NCT01998958|466177858|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515666|NCT01998958|466177859|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515667|NCT01998958|466177860|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515668|NCT01998958|466177861|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515669|NCT01998958|466177862|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
129515670|NCT01998958|466177863|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515671|NCT01998958|466177864|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515672|NCT01998958|466177865|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515673|NCT01998958|466177866|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
129515674|NCT01998958|466177867|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515675|NCT01998958|466177868|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515676|NCT01998958|466177869|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515677|NCT01998958|466177870|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515678|NCT01998958|466177871|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515679|NCT01998958|466177872|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515680|NCT01998958|466177873|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515681|NCT01998958|466177874|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515682|NCT01998958|466177875|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515683|NCT01998958|466177876|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515684|NCT01998958|466177877|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515685|NCT01998958|466177878|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515686|NCT01998958|466177879|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
129515687|NCT01998958|466177848|FG000|Open Label Phase (Optional)|Adverse Event|0|||
129515688|NCT01998958|466177849|FG001|Open Label Phase (Optional)|Adverse Event|0|||
129515689|NCT01998958|466177850|FG002|Open Label Phase (Optional)|Adverse Event|0|||
129515690|NCT01998958|466177851|FG003|Open Label Phase (Optional)|Adverse Event|0|||
129515691|NCT01998958|466177852|FG004|Open Label Phase (Optional)|Adverse Event|0|||
129515692|NCT01998958|466177853|FG005|Open Label Phase (Optional)|Adverse Event|0|||
129515693|NCT01998958|466177854|FG006|Open Label Phase (Optional)|Adverse Event|0|||
129515694|NCT01998958|466177855|FG007|Open Label Phase (Optional)|Adverse Event|0|||
129515695|NCT01998958|466177856|FG008|Open Label Phase (Optional)|Adverse Event|0|||
129515696|NCT01998958|466177857|FG009|Open Label Phase (Optional)|Adverse Event|0|||
129515697|NCT01998958|466177858|FG010|Open Label Phase (Optional)|Adverse Event|0|||
129515698|NCT01998958|466177859|FG011|Open Label Phase (Optional)|Adverse Event|0|||
129515699|NCT01998958|466177860|FG012|Open Label Phase (Optional)|Adverse Event|0|||
129515700|NCT01998958|466177861|FG013|Open Label Phase (Optional)|Adverse Event|0|||
129515701|NCT01998958|466177862|FG014|Open Label Phase (Optional)|Adverse Event|0|||
129515702|NCT01998958|466177863|FG015|Open Label Phase (Optional)|Adverse Event|0|||
129515703|NCT01998958|466177864|FG016|Open Label Phase (Optional)|Adverse Event|0|||
129515704|NCT01998958|466177865|FG017|Open Label Phase (Optional)|Adverse Event|0|||
129515705|NCT01998958|466177866|FG018|Open Label Phase (Optional)|Adverse Event|0|||
129515706|NCT01998958|466177867|FG019|Open Label Phase (Optional)|Adverse Event|0|||
129515707|NCT01998958|466177868|FG020|Open Label Phase (Optional)|Adverse Event|0|||
129515708|NCT01998958|466177869|FG021|Open Label Phase (Optional)|Adverse Event|0|||
129515709|NCT01998958|466177870|FG022|Open Label Phase (Optional)|Adverse Event|0|||
129515710|NCT01998958|466177871|FG023|Open Label Phase (Optional)|Adverse Event|1|||
129515711|NCT01998958|466177872|FG024|Open Label Phase (Optional)|Adverse Event|0|||
129515712|NCT01998958|466177873|FG025|Open Label Phase (Optional)|Adverse Event|0|||
129515713|NCT01998958|466177874|FG026|Open Label Phase (Optional)|Adverse Event|0|||
129515714|NCT01998958|466177875|FG027|Open Label Phase (Optional)|Adverse Event|0|||
129515715|NCT01998958|466177876|FG028|Open Label Phase (Optional)|Adverse Event|0|||
129515716|NCT01998958|466177877|FG029|Open Label Phase (Optional)|Adverse Event|0|||
129515717|NCT01998958|466177878|FG030|Open Label Phase (Optional)|Adverse Event|0|||
129515718|NCT01998958|466177879|FG031|Open Label Phase (Optional)|Adverse Event|0|||
129515719|NCT01998958|466177848|FG000|Open Label Phase (Optional)|Other|0|||
129515720|NCT01998958|466177849|FG001|Open Label Phase (Optional)|Other|0|||
129515721|NCT01998958|466177850|FG002|Open Label Phase (Optional)|Other|0|||
129515722|NCT01998958|466177851|FG003|Open Label Phase (Optional)|Other|0|||
129515723|NCT01998958|466177852|FG004|Open Label Phase (Optional)|Other|0|||
129515724|NCT01998958|466177853|FG005|Open Label Phase (Optional)|Other|0|||
129515725|NCT01998958|466177854|FG006|Open Label Phase (Optional)|Other|0|||
129515726|NCT01998958|466177855|FG007|Open Label Phase (Optional)|Other|0|||
129515727|NCT01998958|466177856|FG008|Open Label Phase (Optional)|Other|0|||
129515728|NCT01998958|466177857|FG009|Open Label Phase (Optional)|Other|0|||
129515729|NCT01998958|466177858|FG010|Open Label Phase (Optional)|Other|0|||
129515730|NCT01998958|466177859|FG011|Open Label Phase (Optional)|Other|0|||
129515731|NCT01998958|466177860|FG012|Open Label Phase (Optional)|Other|0|||
129515732|NCT01998958|466177861|FG013|Open Label Phase (Optional)|Other|0|||
129515733|NCT01998958|466177862|FG014|Open Label Phase (Optional)|Other|0|||
129515734|NCT01998958|466177863|FG015|Open Label Phase (Optional)|Other|0|||
129515735|NCT01998958|466177864|FG016|Open Label Phase (Optional)|Other|0|||
129515736|NCT01998958|466177865|FG017|Open Label Phase (Optional)|Other|0|||
129515737|NCT01998958|466177866|FG018|Open Label Phase (Optional)|Other|0|||
129515738|NCT01998958|466177867|FG019|Open Label Phase (Optional)|Other|0|||
129515739|NCT01998958|466177868|FG020|Open Label Phase (Optional)|Other|0|||
129515740|NCT01998958|466177869|FG021|Open Label Phase (Optional)|Other|0|||
129515741|NCT01998958|466177870|FG022|Open Label Phase (Optional)|Other|5|||
129515742|NCT01998958|466177871|FG023|Open Label Phase (Optional)|Other|1|||
129515743|NCT01998958|466177872|FG024|Open Label Phase (Optional)|Other|0|||
129515744|NCT01998958|466177873|FG025|Open Label Phase (Optional)|Other|0|||
129515745|NCT01998958|466177874|FG026|Open Label Phase (Optional)|Other|0|||
129515746|NCT01998958|466177875|FG027|Open Label Phase (Optional)|Other|0|||
129515747|NCT01998958|466177876|FG028|Open Label Phase (Optional)|Other|0|||
129515748|NCT01998958|466177877|FG029|Open Label Phase (Optional)|Other|0|||
129515749|NCT01998958|466177878|FG030|Open Label Phase (Optional)|Other|0|||
129515750|NCT01998958|466177879|FG031|Open Label Phase (Optional)|Other|0|||
129515751|NCT01998958|466177848|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515752|NCT01998958|466177849|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515753|NCT01998958|466177850|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515754|NCT01998958|466177851|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515755|NCT01998958|466177852|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515756|NCT01998958|466177853|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515757|NCT01998958|466177854|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515758|NCT01998958|466177855|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515759|NCT01998958|466177856|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515760|NCT01998958|466177857|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515761|NCT01998958|466177858|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515762|NCT01998958|466177859|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515763|NCT01998958|466177860|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515764|NCT01998958|466177861|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515765|NCT01998958|466177862|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515766|NCT01998958|466177863|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515767|NCT01998958|466177864|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515768|NCT01998958|466177865|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515769|NCT01998958|466177866|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515770|NCT01998958|466177867|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515771|NCT01998958|466177868|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515772|NCT01998958|466177869|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515773|NCT01998958|466177870|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
129515774|NCT01998958|466177871|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515775|NCT01998958|466177872|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515776|NCT01998958|466177873|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515777|NCT01998958|466177874|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515778|NCT01998958|466177875|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515779|NCT01998958|466177876|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515780|NCT01998958|466177877|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515781|NCT01998958|466177878|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515782|NCT01998958|466177879|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
129515783|NCT01998958|466177848|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515784|NCT01998958|466177849|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515785|NCT01998958|466177850|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515786|NCT01998958|466177851|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515787|NCT01998958|466177852|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515788|NCT01998958|466177853|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515789|NCT01998958|466177854|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515790|NCT01998958|466177855|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515791|NCT01998958|466177856|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515792|NCT01998958|466177857|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515793|NCT01998958|466177858|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515794|NCT01998958|466177859|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515795|NCT01998958|466177860|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515796|NCT01998958|466177861|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515797|NCT01998958|466177862|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515798|NCT01998958|466177863|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515799|NCT01998958|466177864|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515800|NCT01998958|466177865|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515801|NCT01998958|466177866|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515802|NCT01998958|466177867|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515803|NCT01998958|466177868|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515804|NCT01998958|466177869|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
129515805|NCT01998958|466177870|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
129515806|NCT01998958|466177871|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515807|NCT01998958|466177872|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515808|NCT01998958|466177873|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515809|NCT01998958|466177874|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515810|NCT01998958|466177875|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515811|NCT01998958|466177876|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515812|NCT01998958|466177877|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515813|NCT01998958|466177878|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515814|NCT01998958|466177879|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
129515815|NCT01998958|466177848|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515816|NCT01998958|466177849|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515817|NCT01998958|466177850|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515818|NCT01998958|466177851|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515819|NCT01998958|466177852|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515820|NCT01998958|466177853|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515821|NCT01998958|466177854|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515822|NCT01998958|466177855|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515823|NCT01998958|466177856|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515824|NCT01998958|466177857|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515825|NCT01998958|466177858|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515826|NCT01998958|466177859|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515827|NCT01998958|466177860|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515828|NCT01998958|466177861|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515829|NCT01998958|466177862|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515830|NCT01998958|466177863|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515831|NCT01998958|466177864|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515832|NCT01998958|466177865|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515833|NCT01998958|466177866|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515834|NCT01998958|466177867|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515835|NCT01998958|466177868|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515836|NCT01998958|466177869|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
129515837|NCT01998958|466177870|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
129515838|NCT01998958|466177871|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
129515839|NCT01998958|466177872|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515840|NCT01998958|466177873|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515841|NCT01998958|466177874|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515842|NCT01998958|466177875|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515843|NCT01998958|466177876|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515844|NCT01998958|466177877|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515845|NCT01998958|466177878|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515846|NCT01998958|466177879|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
129515847|NCT00445341|466177880|FG000|Overall Study|refused further treatment|1|||
129515848|NCT00445341|466177880|FG000|Overall Study|taken off treatment too early|1|||
129515849|NCT01156532|466177888|FG000|Overall Study|Family Reasons|1|||
129515850|NCT01156532|466177888|FG000|Overall Study|Lost to Follow-up|1|||
129515851|NCT00968708|466177889|FG000|Overall Study|Adverse Event|169|||
129515852|NCT00968708|466177890|FG001|Overall Study|Adverse Event|150|||
129515853|NCT00968708|466177889|FG000|Overall Study|Major Protocol Deviation|0|||
129515854|NCT00968708|466177890|FG001|Overall Study|Major Protocol Deviation|1|||
129515855|NCT00968708|466177889|FG000|Overall Study|Lost to Follow-up|19|||
129515856|NCT00968708|466177890|FG001|Overall Study|Lost to Follow-up|11|||
129515857|NCT00968708|466177889|FG000|Overall Study|Voluntary Withdrawal|104|||
129515858|NCT00968708|466177890|FG001|Overall Study|Voluntary Withdrawal|101|||
129515859|NCT00968708|466177889|FG000|Overall Study|Investigator Discretion|0|||
129515860|NCT00968708|466177890|FG001|Overall Study|Investigator Discretion|1|||
129515861|NCT00968708|466177889|FG000|Overall Study|Other|26|||
129515862|NCT00968708|466177890|FG001|Overall Study|Other|34|||
129515863|NCT03407170|466177891|FG000|Overall Study|Adverse Event|1|||
129515864|NCT01851863|466177896|FG000|Overall Study|Did not receive study medication|2|||
129515865|NCT01851863|466177897|FG001|Overall Study|Did not receive study medication|5|||
129515866|NCT01851863|466177898|FG002|Overall Study|Did not receive study medication|3|||
129515867|NCT01851863|466177899|FG003|Overall Study|Did not receive study medication|0|||
129515868|NCT01851863|466177896|FG000|Overall Study|Lost to Follow-up|3|||
129515869|NCT01851863|466177897|FG001|Overall Study|Lost to Follow-up|4|||
129515870|NCT01851863|466177898|FG002|Overall Study|Lost to Follow-up|2|||
129515871|NCT01851863|466177899|FG003|Overall Study|Lost to Follow-up|3|||
129515872|NCT03238352|466177900|FG000|Overall Study|Lost to Follow-up|0|||
129515873|NCT03238352|466177901|FG001|Overall Study|Lost to Follow-up|2|||
129515874|NCT03238352|466177902|FG002|Overall Study|Lost to Follow-up|1|||
129515875|NCT03238352|466177900|FG000|Overall Study|Withdrawal by Subject|0|||
129515876|NCT03238352|466177901|FG001|Overall Study|Withdrawal by Subject|1|||
129515877|NCT03238352|466177902|FG002|Overall Study|Withdrawal by Subject|0|||
129515878|NCT00928512|466177903|FG000|Overall Study|Adverse Event|4|||
129515879|NCT00928512|466177904|FG001|Overall Study|Adverse Event|3|||
129515880|NCT00928512|466177905|FG002|Overall Study|Adverse Event|2|||
129515881|NCT00928512|466177906|FG003|Overall Study|Adverse Event|8|||
129515882|NCT00928512|466177907|FG004|Overall Study|Adverse Event|6|||
129515883|NCT00928512|466177903|FG000|Overall Study|Lack of Efficacy|2|||
129515884|NCT00928512|466177904|FG001|Overall Study|Lack of Efficacy|0|||
129515885|NCT00928512|466177905|FG002|Overall Study|Lack of Efficacy|4|||
129515886|NCT00928512|466177906|FG003|Overall Study|Lack of Efficacy|7|||
129515887|NCT00928512|466177907|FG004|Overall Study|Lack of Efficacy|3|||
129515888|NCT00928512|466177903|FG000|Overall Study|Protocol Violation|0|||
129515889|NCT00928512|466177904|FG001|Overall Study|Protocol Violation|1|||
129515890|NCT00928512|466177905|FG002|Overall Study|Protocol Violation|0|||
129515891|NCT00928512|466177906|FG003|Overall Study|Protocol Violation|1|||
129515892|NCT00928512|466177907|FG004|Overall Study|Protocol Violation|3|||
129515893|NCT00928512|466177903|FG000|Overall Study|Withdrawal by Subject|3|||
129515894|NCT00928512|466177904|FG001|Overall Study|Withdrawal by Subject|0|||
129515895|NCT00928512|466177905|FG002|Overall Study|Withdrawal by Subject|3|||
129515896|NCT00928512|466177906|FG003|Overall Study|Withdrawal by Subject|4|||
129515897|NCT00928512|466177907|FG004|Overall Study|Withdrawal by Subject|0|||
129515898|NCT00928512|466177903|FG000|Overall Study|Lost to Follow-up|1|||
129515899|NCT00928512|466177904|FG001|Overall Study|Lost to Follow-up|1|||
129515900|NCT00928512|466177905|FG002|Overall Study|Lost to Follow-up|2|||
129515901|NCT00928512|466177906|FG003|Overall Study|Lost to Follow-up|1|||
129515902|NCT00928512|466177907|FG004|Overall Study|Lost to Follow-up|3|||
129515903|NCT00928512|466177903|FG000|Overall Study|Administrative Problems|0|||
129515904|NCT00928512|466177904|FG001|Overall Study|Administrative Problems|1|||
129515905|NCT00928512|466177905|FG002|Overall Study|Administrative Problems|0|||
129515906|NCT00928512|466177906|FG003|Overall Study|Administrative Problems|0|||
129515907|NCT00928512|466177907|FG004|Overall Study|Administrative Problems|0|||
129515908|NCT01963780|466177908|FG000|Overall Study|Death|7|||
129515909|NCT04153929|466177909|FG000|Overall Study|Other than listed|2|||
129515910|NCT04153929|466177910|FG001|Overall Study|Other than listed|2|||
129515911|NCT04153929|466177911|FG002|Overall Study|Other than listed|0|||
129515912|NCT04153929|466177912|FG003|Overall Study|Other than listed|1|||
129515913|NCT04153929|466177913|FG004|Overall Study|Other than listed|0|||
129515914|NCT04153929|466177914|FG005|Overall Study|Other than listed|2|||
129515915|NCT04153929|466177915|FG006|Overall Study|Other than listed|2|||
129515916|NCT04153929|466177916|FG007|Overall Study|Other than listed|1|||
129515917|NCT04153929|466177909|FG000|Overall Study|Lost to Follow-up|2|||
129515918|NCT04153929|466177910|FG001|Overall Study|Lost to Follow-up|1|||
129515919|NCT04153929|466177911|FG002|Overall Study|Lost to Follow-up|0|||
129515920|NCT04153929|466177912|FG003|Overall Study|Lost to Follow-up|1|||
129515921|NCT04153929|466177913|FG004|Overall Study|Lost to Follow-up|1|||
129515922|NCT04153929|466177914|FG005|Overall Study|Lost to Follow-up|0|||
129515923|NCT04153929|466177915|FG006|Overall Study|Lost to Follow-up|0|||
129515924|NCT04153929|466177916|FG007|Overall Study|Lost to Follow-up|0|||
129515925|NCT04153929|466177909|FG000|Overall Study|Withdrawal by Subject|3|||
129515926|NCT04153929|466177910|FG001|Overall Study|Withdrawal by Subject|1|||
129515927|NCT04153929|466177911|FG002|Overall Study|Withdrawal by Subject|0|||
129515928|NCT04153929|466177912|FG003|Overall Study|Withdrawal by Subject|3|||
129515929|NCT04153929|466177913|FG004|Overall Study|Withdrawal by Subject|1|||
129515930|NCT04153929|466177914|FG005|Overall Study|Withdrawal by Subject|0|||
129515931|NCT04153929|466177915|FG006|Overall Study|Withdrawal by Subject|1|||
129515932|NCT04153929|466177916|FG007|Overall Study|Withdrawal by Subject|0|||
129515933|NCT04153929|466177909|FG000|Overall Study|Protocol Violation|0|||
129515934|NCT04153929|466177910|FG001|Overall Study|Protocol Violation|0|||
129515935|NCT04153929|466177911|FG002|Overall Study|Protocol Violation|0|||
129515936|NCT04153929|466177912|FG003|Overall Study|Protocol Violation|0|||
129515937|NCT04153929|466177913|FG004|Overall Study|Protocol Violation|0|||
129515938|NCT04153929|466177914|FG005|Overall Study|Protocol Violation|0|||
129515939|NCT04153929|466177915|FG006|Overall Study|Protocol Violation|1|||
129515940|NCT04153929|466177916|FG007|Overall Study|Protocol Violation|2|||
129515941|NCT04153929|466177909|FG000|Overall Study|Adverse Event|3|||
129515942|NCT04153929|466177910|FG001|Overall Study|Adverse Event|5|||
129515943|NCT04153929|466177911|FG002|Overall Study|Adverse Event|5|||
129515944|NCT04153929|466177912|FG003|Overall Study|Adverse Event|11|||
129515945|NCT04153929|466177913|FG004|Overall Study|Adverse Event|15|||
129515946|NCT04153929|466177914|FG005|Overall Study|Adverse Event|4|||
129515947|NCT04153929|466177915|FG006|Overall Study|Adverse Event|8|||
129515948|NCT04153929|466177916|FG007|Overall Study|Adverse Event|2|||
129515949|NCT04153929|466177909|FG000|Overall Study|Not treated|1|||
129515950|NCT04153929|466177910|FG001|Overall Study|Not treated|0|||
129515951|NCT04153929|466177911|FG002|Overall Study|Not treated|0|||
129515952|NCT04153929|466177912|FG003|Overall Study|Not treated|0|||
129515953|NCT04153929|466177913|FG004|Overall Study|Not treated|0|||
129515954|NCT04153929|466177914|FG005|Overall Study|Not treated|0|||
129515955|NCT04153929|466177915|FG006|Overall Study|Not treated|1|||
129515956|NCT04153929|466177916|FG007|Overall Study|Not treated|0|||
129515957|NCT04083794|466177917|FG000|Overall Study|Lost to Follow-up|9|||
129515958|NCT03383614|466177918|FG000|Overall Study|Withdrawal by Subject|0|||
129515959|NCT03383614|466177919|FG001|Overall Study|Withdrawal by Subject|1|||
129515960|NCT03383614|466177920|FG002|Overall Study|Withdrawal by Subject|0|||
129515961|NCT03383614|466177921|FG003|Overall Study|Withdrawal by Subject|0|||
129515962|NCT01202760|466177926|FG000|Overall Study|Entry Criteria Not Met|0|||
129515963|NCT01202760|466177927|FG001|Overall Study|Entry Criteria Not Met|3|||
129515964|NCT01202760|466177928|FG002|Overall Study|Entry Criteria Not Met|1|||
129515965|NCT01202760|466177926|FG000|Overall Study|Adverse Event|11|||
129515966|NCT01202760|466177927|FG001|Overall Study|Adverse Event|9|||
129515967|NCT01202760|466177928|FG002|Overall Study|Adverse Event|10|||
129515968|NCT01202760|466177926|FG000|Overall Study|Death|2|||
129515969|NCT01202760|466177927|FG001|Overall Study|Death|1|||
129515970|NCT01202760|466177928|FG002|Overall Study|Death|0|||
129515971|NCT01202760|466177926|FG000|Overall Study|Lack of Efficacy|6|||
129515972|NCT01202760|466177927|FG001|Overall Study|Lack of Efficacy|8|||
129515973|NCT01202760|466177928|FG002|Overall Study|Lack of Efficacy|7|||
129515974|NCT01202760|466177926|FG000|Overall Study|Lost to Follow-up|0|||
129515975|NCT01202760|466177927|FG001|Overall Study|Lost to Follow-up|2|||
129515976|NCT01202760|466177928|FG002|Overall Study|Lost to Follow-up|1|||
129515977|NCT01202760|466177926|FG000|Overall Study|Parent / Caregiver Decision|0|||
129515978|NCT01202760|466177927|FG001|Overall Study|Parent / Caregiver Decision|1|||
129515979|NCT01202760|466177928|FG002|Overall Study|Parent / Caregiver Decision|0|||
129515980|NCT01202760|466177926|FG000|Overall Study|Withdrawal by Subject|17|||
129515981|NCT01202760|466177927|FG001|Overall Study|Withdrawal by Subject|18|||
129515982|NCT01202760|466177928|FG002|Overall Study|Withdrawal by Subject|14|||
129515983|NCT01202760|466177926|FG000|Overall Study|Physician Decision|0|||
129515984|NCT01202760|466177927|FG001|Overall Study|Physician Decision|1|||
129515985|NCT01202760|466177928|FG002|Overall Study|Physician Decision|0|||
129515986|NCT01202760|466177926|FG000|Overall Study|Protocol Violation|7|||
129515987|NCT01202760|466177927|FG001|Overall Study|Protocol Violation|5|||
129515988|NCT01202760|466177928|FG002|Overall Study|Protocol Violation|2|||
129515989|NCT01202760|466177926|FG000|Overall Study|Sponsor Decision|4|||
129515990|NCT01202760|466177927|FG001|Overall Study|Sponsor Decision|4|||
129515991|NCT01202760|466177928|FG002|Overall Study|Sponsor Decision|0|||
129515992|NCT00871572|466177929|FG000|Overall Study|Adverse Event|0|||
129515993|NCT00871572|466177930|FG001|Overall Study|Adverse Event|2|||
129515994|NCT00871572|466177931|FG002|Overall Study|Adverse Event|0|||
129515995|NCT00871572|466177932|FG003|Overall Study|Adverse Event|3|||
129515996|NCT00871572|466177929|FG000|Overall Study|Investigator Decision|0|||
129515997|NCT00871572|466177930|FG001|Overall Study|Investigator Decision|1|||
129515998|NCT00871572|466177931|FG002|Overall Study|Investigator Decision|0|||
129515999|NCT00871572|466177932|FG003|Overall Study|Investigator Decision|1|||
129516000|NCT00871572|466177929|FG000|Overall Study|Lost to Follow-up|0|||
129516001|NCT00871572|466177930|FG001|Overall Study|Lost to Follow-up|1|||
129516002|NCT00871572|466177931|FG002|Overall Study|Lost to Follow-up|0|||
129516003|NCT00871572|466177932|FG003|Overall Study|Lost to Follow-up|1|||
129516004|NCT00871572|466177929|FG000|Overall Study|Protocol Violation|0|||
129516005|NCT00871572|466177930|FG001|Overall Study|Protocol Violation|0|||
129516006|NCT00871572|466177931|FG002|Overall Study|Protocol Violation|1|||
129516007|NCT00871572|466177932|FG003|Overall Study|Protocol Violation|1|||
129516008|NCT00871572|466177929|FG000|Overall Study|Sponsor Decision|1|||
129516009|NCT00871572|466177930|FG001|Overall Study|Sponsor Decision|0|||
129516010|NCT00871572|466177931|FG002|Overall Study|Sponsor Decision|0|||
129516011|NCT00871572|466177932|FG003|Overall Study|Sponsor Decision|0|||
129516012|NCT00871572|466177929|FG000|Overall Study|Withdrawal by Subject|1|||
129516013|NCT00871572|466177930|FG001|Overall Study|Withdrawal by Subject|2|||
129516014|NCT00871572|466177931|FG002|Overall Study|Withdrawal by Subject|3|||
129516015|NCT00871572|466177932|FG003|Overall Study|Withdrawal by Subject|1|||
129516016|NCT04354155|466177935|FG000|Overall Study|Withdrawal by Subject|1|||
129516017|NCT04354155|466177935|FG000|Overall Study|Did not meet criteria for study intervention|1|||
129516018|NCT00187889|466177936|FG000|Overall Study|Withdrawal by Subject|6|||
129516019|NCT00187889|466177937|FG001|Overall Study|Withdrawal by Subject|4|||
129516020|NCT03097029|466177942|FG000|Overall Study|Withdrawal by Subject|1|||
129516021|NCT00709124|466177944|FG000|Overall Study|Death|3|||
129516022|NCT00709124|466177945|FG001|Overall Study|Death|1|||
129516023|NCT00709124|466177944|FG000|Overall Study|encephalopathy; can't do assessment|1|||
129516024|NCT00709124|466177945|FG001|Overall Study|encephalopathy; can't do assessment|0|||
129516025|NCT00373490|466177946|FG000|Overall Study|Adverse Event|0|||
129516026|NCT00373490|466177947|FG001|Overall Study|Adverse Event|1|||
129516027|NCT00373490|466177946|FG000|Overall Study|Lack of Efficacy|9|||
129516028|NCT00373490|466177947|FG001|Overall Study|Lack of Efficacy|4|||
129516029|NCT00373490|466177946|FG000|Overall Study|Withdrawal by Subject|0|||
129516030|NCT00373490|466177947|FG001|Overall Study|Withdrawal by Subject|1|||
129516031|NCT00108953|466177954|FG000|Follow-up|Death|18|||
129516032|NCT00108953|466177955|FG001|Follow-up|Death|26|||
129516033|NCT00108953|466177954|FG000|Follow-up|Lost to Follow-up|1|||
129516034|NCT00108953|466177955|FG001|Follow-up|Lost to Follow-up|1|||
129516035|NCT00108953|466177954|FG000|Follow-up|Study terminated by sponsor|10|||
129516036|NCT00108953|466177955|FG001|Follow-up|Study terminated by sponsor|6|||
129516037|NCT02999100|466177961|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
129516038|NCT02999100|466177962|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
129516039|NCT02999100|466177963|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
129516040|NCT02999100|466177964|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
129516041|NCT02999100|466177965|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
129516042|NCT02999100|466177966|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
129516043|NCT02999100|466177961|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129516044|NCT02999100|466177962|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129516045|NCT02999100|466177963|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129516046|NCT02999100|466177964|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129516047|NCT02999100|466177965|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
129516048|NCT02999100|466177966|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
129516049|NCT02999100|466177961|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129516050|NCT02999100|466177962|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129516051|NCT02999100|466177963|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
129516052|NCT02999100|466177964|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129516053|NCT02999100|466177965|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129516054|NCT02999100|466177966|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
129516055|NCT01125293|466177967|FG000|Overall Study|Disease Progression|1|||
129516056|NCT01125293|466177968|FG001|Overall Study|Disease Progression|3|||
129516057|NCT01125293|466177969|FG002|Overall Study|Disease Progression|4|||
129516058|NCT01125293|466177970|FG003|Overall Study|Disease Progression|3|||
129516059|NCT01125293|466177971|FG004|Overall Study|Disease Progression|5|||
129516060|NCT01125293|466177972|FG005|Overall Study|Disease Progression|12|||
129516061|NCT01125293|466177967|FG000|Overall Study|Adverse Event|1|||
129516062|NCT01125293|466177968|FG001|Overall Study|Adverse Event|0|||
129516063|NCT01125293|466177969|FG002|Overall Study|Adverse Event|0|||
129516064|NCT01125293|466177970|FG003|Overall Study|Adverse Event|0|||
129516065|NCT01125293|466177971|FG004|Overall Study|Adverse Event|2|||
129516066|NCT01125293|466177972|FG005|Overall Study|Adverse Event|8|||
129516067|NCT01125293|466177967|FG000|Overall Study|Symptomatic Deterioration|1|||
129516068|NCT01125293|466177968|FG001|Overall Study|Symptomatic Deterioration|0|||
129516069|NCT01125293|466177969|FG002|Overall Study|Symptomatic Deterioration|0|||
129516070|NCT01125293|466177970|FG003|Overall Study|Symptomatic Deterioration|0|||
129516071|NCT01125293|466177971|FG004|Overall Study|Symptomatic Deterioration|0|||
129516072|NCT01125293|466177972|FG005|Overall Study|Symptomatic Deterioration|0|||
129516073|NCT01125293|466177967|FG000|Overall Study|Death|0|||
129516074|NCT01125293|466177968|FG001|Overall Study|Death|0|||
129516075|NCT01125293|466177969|FG002|Overall Study|Death|0|||
129516076|NCT01125293|466177970|FG003|Overall Study|Death|0|||
129516077|NCT01125293|466177971|FG004|Overall Study|Death|1|||
129516078|NCT01125293|466177972|FG005|Overall Study|Death|0|||
129516079|NCT01125293|466177967|FG000|Overall Study|Withdrawal by Subject|0|||
129516080|NCT01125293|466177968|FG001|Overall Study|Withdrawal by Subject|0|||
129516081|NCT01125293|466177969|FG002|Overall Study|Withdrawal by Subject|0|||
129516082|NCT01125293|466177970|FG003|Overall Study|Withdrawal by Subject|0|||
129516083|NCT01125293|466177971|FG004|Overall Study|Withdrawal by Subject|2|||
129516084|NCT01125293|466177972|FG005|Overall Study|Withdrawal by Subject|1|||
129516085|NCT01125293|466177967|FG000|Overall Study|Physician Decision|0|||
129516086|NCT01125293|466177968|FG001|Overall Study|Physician Decision|0|||
129516087|NCT01125293|466177969|FG002|Overall Study|Physician Decision|0|||
129516088|NCT01125293|466177970|FG003|Overall Study|Physician Decision|0|||
129516089|NCT01125293|466177971|FG004|Overall Study|Physician Decision|0|||
129516090|NCT01125293|466177972|FG005|Overall Study|Physician Decision|2|||
129516091|NCT02224638|466177973|FG000|Overall Study|Adverse Event|1|||
129516092|NCT02224638|466177974|FG001|Overall Study|Adverse Event|1|||
129516093|NCT01270958|466177977|FG000|Overall Study|Lost to Follow-up|2|||
129516094|NCT01270958|466177977|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
129516095|NCT01455415|466177983|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
129516096|NCT01455415|466177984|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
129516097|NCT01455415|466177983|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
129516098|NCT01455415|466177984|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
129516099|NCT01455415|466177983|FG000|Period 1|Drug Error not Associated to AE|0|||
129516100|NCT01455415|466177984|FG001|Period 1|Drug Error not Associated to AE|1|||
129516101|NCT01455415|466177983|FG000|Period 1|AE Not Related to Study Drug|2|||
129516102|NCT01455415|466177984|FG001|Period 1|AE Not Related to Study Drug|6|||
129516103|NCT01455415|466177983|FG000|Period 1|Withdrawal by Subject|4|||
129516104|NCT01455415|466177984|FG001|Period 1|Withdrawal by Subject|5|||
129516105|NCT01455415|466177983|FG000|Period 1|Unspecified Reason|1|||
129516106|NCT01455415|466177984|FG001|Period 1|Unspecified Reason|1|||
129516107|NCT01455415|466177983|FG000|Period 1|Protocol Violation|0|||
129516108|NCT01455415|466177984|FG001|Period 1|Protocol Violation|2|||
129516109|NCT01455415|466177983|FG000|Washout|AE Related to Study Drug|2|||
129516110|NCT01455415|466177984|FG001|Washout|AE Related to Study Drug|0|||
129516111|NCT01455415|466177983|FG000|Washout|Lost to Follow-up|1|||
129516112|NCT01455415|466177984|FG001|Washout|Lost to Follow-up|0|||
129516113|NCT01455415|466177983|FG000|Washout|Drug Error not Associated to AE|2|||
129516114|NCT01455415|466177984|FG001|Washout|Drug Error not Associated to AE|1|||
129516115|NCT01455415|466177983|FG000|Washout|AE Not Related to Study Drug|2|||
129516116|NCT01455415|466177984|FG001|Washout|AE Not Related to Study Drug|3|||
129516117|NCT01455415|466177983|FG000|Washout|Unspecified Reason|1|||
129516118|NCT01455415|466177984|FG001|Washout|Unspecified Reason|2|||
129516119|NCT01455415|466177983|FG000|Washout|Protocol Violation|0|||
129516120|NCT01455415|466177984|FG001|Washout|Protocol Violation|1|||
129516121|NCT01455415|466177983|FG000|Period 2|AE Related to Study Drug|1|||
129516122|NCT01455415|466177984|FG001|Period 2|AE Related to Study Drug|2|||
129516123|NCT01455415|466177983|FG000|Period 2|Lost to Follow-up|2|||
129516124|NCT01455415|466177984|FG001|Period 2|Lost to Follow-up|1|||
129516125|NCT01455415|466177983|FG000|Period 2|AE Not Related to Study Drug|2|||
129516126|NCT01455415|466177984|FG001|Period 2|AE Not Related to Study Drug|1|||
129516127|NCT01455415|466177983|FG000|Period 2|Lack of Efficacy|2|||
129516128|NCT01455415|466177984|FG001|Period 2|Lack of Efficacy|0|||
129516129|NCT01455415|466177983|FG000|Period 2|Withdrawal by Subject|2|||
129516130|NCT01455415|466177984|FG001|Period 2|Withdrawal by Subject|3|||
129516131|NCT01455415|466177983|FG000|Period 2|Unspecified Reason|2|||
129516132|NCT01455415|466177984|FG001|Period 2|Unspecified Reason|3|||
129516133|NCT01455415|466177983|FG000|Period 2|Protocol Violation|2|||
129516134|NCT01455415|466177984|FG001|Period 2|Protocol Violation|0|||
129516135|NCT01455415|466177983|FG000|Follow-up|AE Related to Study Drug|0|||
129516136|NCT01455415|466177984|FG001|Follow-up|AE Related to Study Drug|1|||
129516137|NCT01455415|466177983|FG000|Follow-up|Lack of Efficacy|0|||
129516138|NCT01455415|466177984|FG001|Follow-up|Lack of Efficacy|1|||
129516139|NCT01455415|466177983|FG000|Follow-up|Withdrawal by Subject|2|||
129516140|NCT01455415|466177984|FG001|Follow-up|Withdrawal by Subject|0|||
129516141|NCT01455415|466177983|FG000|Follow-up|Unspecified Reason|1|||
129516142|NCT01455415|466177984|FG001|Follow-up|Unspecified Reason|0|||
129516143|NCT00587301|466177985|FG000|Overall Study|Screen Failure|9|||
129516144|NCT00587301|466177985|FG000|Overall Study|Lost to Follow-up|22|||
129516145|NCT00587301|466177985|FG000|Overall Study|Withdrawal by Subject|7|||
129516146|NCT00587301|466177985|FG000|Overall Study|Protocol Violation|7|||
129516147|NCT02758613|466177987|FG000|Treatment|Physician and Sponsor Decision|1|||
129516148|NCT02758613|466177988|FG001|Treatment|Physician and Sponsor Decision|0|||
129516149|NCT02758613|466177989|FG002|Treatment|Physician and Sponsor Decision|0|||
129516150|NCT02758613|466177990|FG003|Treatment|Physician and Sponsor Decision|0|||
129516151|NCT02758613|466177987|FG000|Treatment|Withdrawal by Subject|1|||
129516152|NCT02758613|466177988|FG001|Treatment|Withdrawal by Subject|0|||
129516153|NCT02758613|466177989|FG002|Treatment|Withdrawal by Subject|1|||
129516154|NCT02758613|466177990|FG003|Treatment|Withdrawal by Subject|0|||
129516155|NCT01496274|466177991|FG000|Overall Study|Protocol Violation|0|||
129516156|NCT01496274|466177992|FG001|Overall Study|Protocol Violation|1|||
129516157|NCT01496274|466177991|FG000|Overall Study|Adverse Event|1|||
129516158|NCT01496274|466177992|FG001|Overall Study|Adverse Event|1|||
129516159|NCT01496274|466177991|FG000|Overall Study|Withdrawal by Subject|2|||
129516160|NCT01496274|466177992|FG001|Overall Study|Withdrawal by Subject|0|||
129516161|NCT01496274|466177991|FG000|Overall Study|Lost to Follow-up|0|||
129516162|NCT01496274|466177992|FG001|Overall Study|Lost to Follow-up|3|||
129516163|NCT00351819|466177993|FG000|Overall Study|Lost to Follow-up|4|||
129516164|NCT00351819|466177994|FG001|Overall Study|Lost to Follow-up|4|||
129516165|NCT00351819|466177993|FG000|Overall Study|Withdrawal by Subject|0|||
129516166|NCT00351819|466177994|FG001|Overall Study|Withdrawal by Subject|4|||
129516167|NCT00351819|466177993|FG000|Overall Study|Elevated PSA|1|||
129516168|NCT00351819|466177994|FG001|Overall Study|Elevated PSA|1|||
129516169|NCT00351819|466177993|FG000|Overall Study|Traumatic ankle fracture|1|||
129516170|NCT00351819|466177994|FG001|Overall Study|Traumatic ankle fracture|0|||
129516171|NCT00351819|466177993|FG000|Overall Study|Unprofessional behavior|1|||
129516172|NCT00351819|466177994|FG001|Overall Study|Unprofessional behavior|0|||
129516173|NCT00351819|466177993|FG000|Overall Study|Non-compliance|0|||
129516174|NCT00351819|466177994|FG001|Overall Study|Non-compliance|1|||
129516175|NCT00351819|466177993|FG000|Overall Study|Incarcerated|0|||
129516176|NCT00351819|466177994|FG001|Overall Study|Incarcerated|1|||
129516177|NCT00351819|466177993|FG000|Overall Study|Enrolled in another trial|0|||
129516178|NCT00351819|466177994|FG001|Overall Study|Enrolled in another trial|1|||
129516179|NCT01425749|466177995|FG000|Overall Study|progression of melanoma|0|||
129516180|NCT01425749|466177996|FG001|Overall Study|progression of melanoma|1|||
129516181|NCT00970268|466178008|FG000|Overall Study|Withdrawal by Subject|12|||
129516182|NCT00970268|466178009|FG001|Overall Study|Withdrawal by Subject|19|||
129516183|NCT00970268|466178008|FG000|Overall Study|Adverse Event|15|||
129516184|NCT00970268|466178009|FG001|Overall Study|Adverse Event|12|||
129516185|NCT00970268|466178008|FG000|Overall Study|Lack of Efficacy|3|||
129516186|NCT00970268|466178009|FG001|Overall Study|Lack of Efficacy|6|||
129516187|NCT00970268|466178008|FG000|Overall Study|Protocol Violation|4|||
129516188|NCT00970268|466178009|FG001|Overall Study|Protocol Violation|7|||
129516189|NCT00970268|466178008|FG000|Overall Study|Other Reason|3|||
129516190|NCT00970268|466178009|FG001|Overall Study|Other Reason|1|||
129516191|NCT00970268|466178008|FG000|Overall Study|COPD Exacerbation|4|||
129516192|NCT00970268|466178009|FG001|Overall Study|COPD Exacerbation|2|||
129516193|NCT00970268|466178008|FG000|Overall Study|Lost to Follow-up|1|||
129516194|NCT00970268|466178009|FG001|Overall Study|Lost to Follow-up|2|||
129516195|NCT00970268|466178008|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
129516196|NCT00970268|466178009|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
129516197|NCT03907969|466179676|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
129516198|NCT03907969|466179677|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
129516199|NCT03907969|466179678|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
129516200|NCT03907969|466179679|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
129516201|NCT03907969|466179680|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
129516202|NCT03907969|466179681|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
129516203|NCT03907969|466179682|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
129516204|NCT03907969|466179683|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
129516205|NCT03907969|466179684|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
129516206|NCT03907969|466179685|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
129516207|NCT03907969|466179686|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
129516208|NCT03907969|466179676|FG000|Monotherapy Part A|Progressive Disease|0|||
129516209|NCT03907969|466179677|FG001|Monotherapy Part A|Progressive Disease|1|||
129516210|NCT03907969|466179678|FG002|Monotherapy Part A|Progressive Disease|0|||
129516211|NCT03907969|466179679|FG003|Monotherapy Part A|Progressive Disease|0|||
129516212|NCT03907969|466179680|FG004|Monotherapy Part A|Progressive Disease|0|||
129516213|NCT03907969|466179681|FG005|Monotherapy Part A|Progressive Disease|1|||
129516214|NCT03907969|466179682|FG006|Monotherapy Part A|Progressive Disease|2|||
129516215|NCT03907969|466179683|FG007|Monotherapy Part A|Progressive Disease|0|||
129516216|NCT03907969|466179684|FG008|Monotherapy Part A|Progressive Disease|0|||
129516217|NCT03907969|466179685|FG009|Monotherapy Part A|Progressive Disease|0|||
129516218|NCT03907969|466179686|FG010|Monotherapy Part A|Progressive Disease|0|||
129516219|NCT03907969|466179676|FG000|Monotherapy Part A|Death|0|||
129516220|NCT03907969|466179677|FG001|Monotherapy Part A|Death|0|||
129516221|NCT03907969|466179678|FG002|Monotherapy Part A|Death|1|||
129516222|NCT03907969|466179679|FG003|Monotherapy Part A|Death|1|||
129516223|NCT03907969|466179680|FG004|Monotherapy Part A|Death|0|||
129516224|NCT03907969|466179681|FG005|Monotherapy Part A|Death|1|||
129516225|NCT03907969|466179682|FG006|Monotherapy Part A|Death|0|||
129516226|NCT03907969|466179683|FG007|Monotherapy Part A|Death|0|||
129516227|NCT03907969|466179684|FG008|Monotherapy Part A|Death|0|||
129516228|NCT03907969|466179685|FG009|Monotherapy Part A|Death|0|||
129516229|NCT03907969|466179686|FG010|Monotherapy Part A|Death|0|||
129516230|NCT03907969|466179676|FG000|Combination Therapy Part A|Adverse Event|0|||
129516231|NCT03907969|466179677|FG001|Combination Therapy Part A|Adverse Event|0|||
129516232|NCT03907969|466179678|FG002|Combination Therapy Part A|Adverse Event|0|||
129516233|NCT03907969|466179679|FG003|Combination Therapy Part A|Adverse Event|0|||
129538581|NCT04576702|466263421|FG000|Overall Study|Death|1|||
129516234|NCT03907969|466179680|FG004|Combination Therapy Part A|Adverse Event|0|||
129516235|NCT03907969|466179681|FG005|Combination Therapy Part A|Adverse Event|0|||
129516236|NCT03907969|466179682|FG006|Combination Therapy Part A|Adverse Event|0|||
129516237|NCT03907969|466179683|FG007|Combination Therapy Part A|Adverse Event|0|||
129516238|NCT03907969|466179684|FG008|Combination Therapy Part A|Adverse Event|0|||
129516239|NCT03907969|466179685|FG009|Combination Therapy Part A|Adverse Event|1|||
129516240|NCT03907969|466179686|FG010|Combination Therapy Part A|Adverse Event|1|||
129516241|NCT03907969|466179676|FG000|Combination Therapy Part A|Progressive disease|0|||
129516242|NCT03907969|466179677|FG001|Combination Therapy Part A|Progressive disease|0|||
129516243|NCT03907969|466179678|FG002|Combination Therapy Part A|Progressive disease|0|||
129516244|NCT03907969|466179679|FG003|Combination Therapy Part A|Progressive disease|0|||
129516245|NCT03907969|466179680|FG004|Combination Therapy Part A|Progressive disease|0|||
129516246|NCT03907969|466179681|FG005|Combination Therapy Part A|Progressive disease|0|||
129516247|NCT03907969|466179682|FG006|Combination Therapy Part A|Progressive disease|0|||
129516248|NCT03907969|466179683|FG007|Combination Therapy Part A|Progressive disease|1|||
129516249|NCT03907969|466179684|FG008|Combination Therapy Part A|Progressive disease|0|||
129516250|NCT03907969|466179685|FG009|Combination Therapy Part A|Progressive disease|2|||
129516251|NCT03907969|466179686|FG010|Combination Therapy Part A|Progressive disease|3|||
129516252|NCT03907969|466179676|FG000|Combination Therapy Part A|Death|0|||
129516253|NCT03907969|466179677|FG001|Combination Therapy Part A|Death|0|||
129516254|NCT03907969|466179678|FG002|Combination Therapy Part A|Death|0|||
129516255|NCT03907969|466179679|FG003|Combination Therapy Part A|Death|0|||
129516256|NCT03907969|466179680|FG004|Combination Therapy Part A|Death|0|||
129516257|NCT03907969|466179681|FG005|Combination Therapy Part A|Death|0|||
129516258|NCT03907969|466179682|FG006|Combination Therapy Part A|Death|0|||
129516259|NCT03907969|466179683|FG007|Combination Therapy Part A|Death|0|||
129516260|NCT03907969|466179684|FG008|Combination Therapy Part A|Death|1|||
129516261|NCT03907969|466179685|FG009|Combination Therapy Part A|Death|0|||
129516262|NCT03907969|466179686|FG010|Combination Therapy Part A|Death|1|||
129516263|NCT03907969|466179676|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
129516264|NCT03907969|466179677|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
129516265|NCT03907969|466179678|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
129516266|NCT03907969|466179679|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
129516267|NCT03907969|466179680|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
129516268|NCT03907969|466179681|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
129516269|NCT03907969|466179682|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
129516270|NCT03907969|466179683|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
129516271|NCT03907969|466179684|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
129516272|NCT03907969|466179685|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
129516273|NCT03907969|466179686|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
129516274|NCT03907969|466179676|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
129516275|NCT03907969|466179677|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
129516276|NCT03907969|466179678|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
129516277|NCT03907969|466179679|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
129516278|NCT03907969|466179680|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
129516279|NCT03907969|466179681|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
129516280|NCT03907969|466179682|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
129516281|NCT03907969|466179683|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
129516282|NCT03907969|466179684|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
129516283|NCT03907969|466179685|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
129516284|NCT03907969|466179686|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
129516285|NCT03907969|466179676|FG000|Combination Therapy Part A|Physician Decision|0|||
129516286|NCT03907969|466179677|FG001|Combination Therapy Part A|Physician Decision|0|||
129516287|NCT03907969|466179678|FG002|Combination Therapy Part A|Physician Decision|0|||
129516288|NCT03907969|466179679|FG003|Combination Therapy Part A|Physician Decision|0|||
129516289|NCT03907969|466179680|FG004|Combination Therapy Part A|Physician Decision|0|||
129516290|NCT03907969|466179681|FG005|Combination Therapy Part A|Physician Decision|0|||
129516291|NCT03907969|466179682|FG006|Combination Therapy Part A|Physician Decision|0|||
129516292|NCT03907969|466179683|FG007|Combination Therapy Part A|Physician Decision|1|||
129516293|NCT03907969|466179684|FG008|Combination Therapy Part A|Physician Decision|0|||
129516294|NCT03907969|466179685|FG009|Combination Therapy Part A|Physician Decision|0|||
129516295|NCT03907969|466179686|FG010|Combination Therapy Part A|Physician Decision|1|||
129516296|NCT00608881|466179688|FG000|Overall Study|Death|22|||
129516297|NCT00608881|466179689|FG001|Overall Study|Death|13|||
129516298|NCT00608881|466179688|FG000|Overall Study|Adverse Event|5|||
129516299|NCT00608881|466179689|FG001|Overall Study|Adverse Event|3|||
129516300|NCT00608881|466179688|FG000|Overall Study|Lost to Follow-up|28|||
129516301|NCT00608881|466179689|FG001|Overall Study|Lost to Follow-up|14|||
129516302|NCT00608881|466179688|FG000|Overall Study|Withdrawal by Subject|18|||
129516303|NCT00608881|466179689|FG001|Overall Study|Withdrawal by Subject|29|||
129516304|NCT00608881|466179688|FG000|Overall Study|Physician Decision|5|||
129516305|NCT00608881|466179689|FG001|Overall Study|Physician Decision|5|||
129516306|NCT00608881|466179688|FG000|Overall Study|Institutionalized|1|||
129516307|NCT00608881|466179689|FG001|Overall Study|Institutionalized|2|||
129516308|NCT00511108|466179691|FG000|Overall Study|Adverse Event|2|||
129516309|NCT00511108|466179692|FG001|Overall Study|Adverse Event|0|||
129516310|NCT00511108|466179693|FG002|Overall Study|Adverse Event|1|||
129516311|NCT00511108|466179694|FG003|Overall Study|Adverse Event|2|||
129516312|NCT00511108|466179691|FG000|Overall Study|Lost to Follow-up|0|||
129516313|NCT00511108|466179692|FG001|Overall Study|Lost to Follow-up|2|||
129516314|NCT00511108|466179693|FG002|Overall Study|Lost to Follow-up|1|||
129516315|NCT00511108|466179694|FG003|Overall Study|Lost to Follow-up|0|||
129516316|NCT00511108|466179691|FG000|Overall Study|Physician Decision|0|||
129516317|NCT00511108|466179692|FG001|Overall Study|Physician Decision|0|||
129516318|NCT00511108|466179693|FG002|Overall Study|Physician Decision|0|||
129516319|NCT00511108|466179694|FG003|Overall Study|Physician Decision|1|||
129516320|NCT00511108|466179691|FG000|Overall Study|Withdrawal by Subject|4|||
129516321|NCT00511108|466179692|FG001|Overall Study|Withdrawal by Subject|0|||
129516322|NCT00511108|466179693|FG002|Overall Study|Withdrawal by Subject|3|||
129516323|NCT00511108|466179694|FG003|Overall Study|Withdrawal by Subject|2|||
129516324|NCT02954952|466179697|FG000|Overall Study|Withdrawal by Subject|1|||
129516325|NCT02954952|466179698|FG001|Overall Study|Withdrawal by Subject|0|||
129516326|NCT02954952|466179699|FG002|Overall Study|Withdrawal by Subject|0|||
129516327|NCT02954952|466179697|FG000|Overall Study|No data collected|0|||
129516328|NCT02954952|466179698|FG001|Overall Study|No data collected|1|||
129516329|NCT02954952|466179699|FG002|Overall Study|No data collected|0|||
129516330|NCT04179032|466179702|FG000|Part B (Up to Week 52)|Adverse Event|1|||
129516331|NCT04179032|466179702|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
129516332|NCT04179032|466179702|FG000|Access Extension Phase|Ongoing|11|||
129516333|NCT00724815|466179703|FG000|Overall Study|Randomized, not treated|31|||
129516334|NCT00724815|466179704|FG001|Overall Study|Randomized, not treated|30|||
129516335|NCT00724815|466179703|FG000|Overall Study|Adverse Event|5|||
129516336|NCT00724815|466179704|FG001|Overall Study|Adverse Event|3|||
129516337|NCT00724815|466179703|FG000|Overall Study|Lost to Follow-up|4|||
129516338|NCT00724815|466179704|FG001|Overall Study|Lost to Follow-up|1|||
129516339|NCT00724815|466179703|FG000|Overall Study|Other Various|3|||
129516340|NCT00724815|466179704|FG001|Overall Study|Other Various|5|||
129516341|NCT00810043|466179705|FG000|Overall Study|Withdrawal by Subject|1|||
129516342|NCT00810043|466179706|FG001|Overall Study|Withdrawal by Subject|0|||
129516343|NCT00810043|466179707|FG002|Overall Study|Withdrawal by Subject|2|||
129516344|NCT00810043|466179705|FG000|Overall Study|Lost to Follow-up|1|||
129516345|NCT00810043|466179706|FG001|Overall Study|Lost to Follow-up|0|||
129516346|NCT00810043|466179707|FG002|Overall Study|Lost to Follow-up|0|||
129516347|NCT00810043|466179705|FG000|Overall Study|Physician Decision|0|||
129516348|NCT00810043|466179706|FG001|Overall Study|Physician Decision|0|||
129516349|NCT00810043|466179707|FG002|Overall Study|Physician Decision|2|||
129516350|NCT00810043|466179705|FG000|Overall Study|Death|2|||
129516351|NCT00810043|466179706|FG001|Overall Study|Death|0|||
129516352|NCT00810043|466179707|FG002|Overall Study|Death|0|||
129516353|NCT00810043|466179705|FG000|Overall Study|Unrelated medical problem|0|||
129516354|NCT00810043|466179706|FG001|Overall Study|Unrelated medical problem|1|||
129516355|NCT00810043|466179707|FG002|Overall Study|Unrelated medical problem|0|||
129516356|NCT00810043|466179705|FG000|Overall Study|Non-medical problem|0|||
129516357|NCT00810043|466179706|FG001|Overall Study|Non-medical problem|0|||
129516358|NCT00810043|466179707|FG002|Overall Study|Non-medical problem|1|||
129516359|NCT00810043|466179705|FG000|Overall Study|No longer met enrollment criteria|0|||
129516360|NCT00810043|466179706|FG001|Overall Study|No longer met enrollment criteria|0|||
129516361|NCT00810043|466179707|FG002|Overall Study|No longer met enrollment criteria|3|||
129516362|NCT01359046|466179708|FG000|Overall Study|Did not receive allocated intervention|6|||
129516363|NCT01359046|466179709|FG001|Overall Study|Did not receive allocated intervention|6|||
129516364|NCT01359046|466179708|FG000|Overall Study|Physician Decision|1|||
129516365|NCT01359046|466179709|FG001|Overall Study|Physician Decision|11|||
129516366|NCT04539262|466179713|FG000|Overall Study|Adverse Event|0|||
129516367|NCT04539262|466179714|FG001|Overall Study|Adverse Event|0|||
129516368|NCT04539262|466179715|FG002|Overall Study|Adverse Event|1|||
129516369|NCT04539262|466179716|FG003|Overall Study|Adverse Event|0|||
129516370|NCT04539262|466179717|FG004|Overall Study|Adverse Event|0|||
129516371|NCT04539262|466179718|FG005|Overall Study|Adverse Event|0|||
129516372|NCT04539262|466179719|FG006|Overall Study|Adverse Event|0|||
129516373|NCT04539262|466179720|FG007|Overall Study|Adverse Event|0|||
129516374|NCT04539262|466179713|FG000|Overall Study|Withdrew Consent|0|||
129516375|NCT04539262|466179714|FG001|Overall Study|Withdrew Consent|0|||
129516376|NCT04539262|466179715|FG002|Overall Study|Withdrew Consent|0|||
129516377|NCT04539262|466179716|FG003|Overall Study|Withdrew Consent|1|||
129516378|NCT04539262|466179717|FG004|Overall Study|Withdrew Consent|0|||
129516379|NCT04539262|466179718|FG005|Overall Study|Withdrew Consent|0|||
129516380|NCT04539262|466179719|FG006|Overall Study|Withdrew Consent|0|||
129516381|NCT04539262|466179720|FG007|Overall Study|Withdrew Consent|0|||
129516382|NCT04539262|466179713|FG000|Overall Study|Randomized, Not treated|0|||
129516383|NCT04539262|466179714|FG001|Overall Study|Randomized, Not treated|1|||
129516384|NCT04539262|466179715|FG002|Overall Study|Randomized, Not treated|0|||
129516385|NCT04539262|466179716|FG003|Overall Study|Randomized, Not treated|0|||
129516386|NCT04539262|466179717|FG004|Overall Study|Randomized, Not treated|0|||
129516387|NCT04539262|466179718|FG005|Overall Study|Randomized, Not treated|0|||
129516388|NCT04539262|466179719|FG006|Overall Study|Randomized, Not treated|1|||
129516389|NCT04539262|466179720|FG007|Overall Study|Randomized, Not treated|0|||
129516390|NCT01061567|466179727|FG000|Overall Study|Adverse Event|32|||
129516391|NCT01061567|466179727|FG000|Overall Study|Death|2|||
129516392|NCT01061567|466179727|FG000|Overall Study|Lack of Efficacy|3|||
129516393|NCT01061567|466179727|FG000|Overall Study|Lost to Follow-up|24|||
129516394|NCT01061567|466179727|FG000|Overall Study|Protocol Violation|1|||
129516395|NCT01061567|466179727|FG000|Overall Study|Withdrawal by Subject|11|||
129516396|NCT01061567|466179727|FG000|Overall Study|Other reason than stated above|3|||
129516397|NCT01831804|466179728|FG000|Overall Study|Adverse Event|0|||
129516398|NCT01831804|466179729|FG001|Overall Study|Adverse Event|0|||
129516399|NCT01831804|466179730|FG002|Overall Study|Adverse Event|0|||
129516400|NCT01831804|466179731|FG003|Overall Study|Adverse Event|0|||
129516401|NCT01831804|466179732|FG004|Overall Study|Adverse Event|0|||
129516402|NCT01831804|466179733|FG005|Overall Study|Adverse Event|0|||
129516403|NCT01831804|466179734|FG006|Overall Study|Adverse Event|1|||
129516404|NCT01831804|466179735|FG007|Overall Study|Adverse Event|0|||
129516405|NCT01831804|466179736|FG008|Overall Study|Adverse Event|1|||
129516406|NCT01831804|466179728|FG000|Overall Study|Protocol Violation|0|||
129516407|NCT01831804|466179729|FG001|Overall Study|Protocol Violation|0|||
129516408|NCT01831804|466179730|FG002|Overall Study|Protocol Violation|2|||
129516409|NCT01831804|466179731|FG003|Overall Study|Protocol Violation|0|||
129516410|NCT01831804|466179732|FG004|Overall Study|Protocol Violation|0|||
129516411|NCT01831804|466179733|FG005|Overall Study|Protocol Violation|0|||
129516412|NCT01831804|466179734|FG006|Overall Study|Protocol Violation|0|||
129516413|NCT01831804|466179735|FG007|Overall Study|Protocol Violation|0|||
129516414|NCT01831804|466179736|FG008|Overall Study|Protocol Violation|0|||
129516415|NCT01831804|466179728|FG000|Overall Study|Protocol defined stopping criteria|1|||
129516416|NCT01831804|466179729|FG001|Overall Study|Protocol defined stopping criteria|1|||
129516417|NCT01831804|466179730|FG002|Overall Study|Protocol defined stopping criteria|3|||
129516418|NCT01831804|466179731|FG003|Overall Study|Protocol defined stopping criteria|0|||
129516419|NCT01831804|466179732|FG004|Overall Study|Protocol defined stopping criteria|1|||
129516420|NCT01831804|466179733|FG005|Overall Study|Protocol defined stopping criteria|0|||
129516421|NCT01831804|466179734|FG006|Overall Study|Protocol defined stopping criteria|0|||
129516422|NCT01831804|466179735|FG007|Overall Study|Protocol defined stopping criteria|0|||
129516423|NCT01831804|466179736|FG008|Overall Study|Protocol defined stopping criteria|0|||
129516424|NCT01831804|466179728|FG000|Overall Study|Lost to Follow-up|0|||
129516425|NCT01831804|466179729|FG001|Overall Study|Lost to Follow-up|0|||
129516426|NCT01831804|466179730|FG002|Overall Study|Lost to Follow-up|1|||
129516427|NCT01831804|466179731|FG003|Overall Study|Lost to Follow-up|0|||
129516428|NCT01831804|466179732|FG004|Overall Study|Lost to Follow-up|0|||
129516429|NCT01831804|466179733|FG005|Overall Study|Lost to Follow-up|0|||
129516430|NCT01831804|466179734|FG006|Overall Study|Lost to Follow-up|0|||
129516431|NCT01831804|466179735|FG007|Overall Study|Lost to Follow-up|0|||
129516432|NCT01831804|466179736|FG008|Overall Study|Lost to Follow-up|1|||
129516433|NCT01831804|466179728|FG000|Overall Study|Investigator discretion|0|||
129516434|NCT01831804|466179729|FG001|Overall Study|Investigator discretion|0|||
129516435|NCT01831804|466179730|FG002|Overall Study|Investigator discretion|0|||
129516436|NCT01831804|466179731|FG003|Overall Study|Investigator discretion|0|||
129516437|NCT01831804|466179732|FG004|Overall Study|Investigator discretion|1|||
129516438|NCT01831804|466179733|FG005|Overall Study|Investigator discretion|0|||
129516439|NCT01831804|466179734|FG006|Overall Study|Investigator discretion|0|||
129516440|NCT01831804|466179735|FG007|Overall Study|Investigator discretion|1|||
129516441|NCT01831804|466179736|FG008|Overall Study|Investigator discretion|0|||
129516442|NCT01831804|466179728|FG000|Overall Study|Withdrew Consent|0|||
129516443|NCT01831804|466179729|FG001|Overall Study|Withdrew Consent|1|||
129516444|NCT01831804|466179730|FG002|Overall Study|Withdrew Consent|0|||
129516445|NCT01831804|466179731|FG003|Overall Study|Withdrew Consent|0|||
129516446|NCT01831804|466179732|FG004|Overall Study|Withdrew Consent|0|||
129516447|NCT01831804|466179733|FG005|Overall Study|Withdrew Consent|0|||
129516448|NCT01831804|466179734|FG006|Overall Study|Withdrew Consent|0|||
129516449|NCT01831804|466179735|FG007|Overall Study|Withdrew Consent|2|||
129516450|NCT01831804|466179736|FG008|Overall Study|Withdrew Consent|0|||
129516451|NCT00268463|466179739|FG000|Overall Study|study terminated due to low accrual|10|||
129516452|NCT00268463|466179740|FG001|Overall Study|study terminated due to low accrual|12|||
129516453|NCT02920450|466179741|FG000|Overall Study|Death|1|||
129516454|NCT02920450|466179742|FG001|Overall Study|Death|0|||
129516455|NCT02920450|466179743|FG002|Overall Study|Death|0|||
129516456|NCT02920450|466179744|FG003|Overall Study|Death|0|||
129516457|NCT02920450|466179741|FG000|Overall Study|Withdrawal by Subject|1|||
129516458|NCT02920450|466179742|FG001|Overall Study|Withdrawal by Subject|0|||
129516459|NCT02920450|466179743|FG002|Overall Study|Withdrawal by Subject|0|||
129516460|NCT02920450|466179744|FG003|Overall Study|Withdrawal by Subject|0|||
129516461|NCT00291187|466179745|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
129516462|NCT00291187|466179746|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
129516463|NCT00291187|466179747|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
129516464|NCT00291187|466179748|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
129516465|NCT02443805|466179754|FG000|Overall Study|Adverse Event|100|||
129516466|NCT02443805|466179755|FG001|Overall Study|Adverse Event|18|||
129516467|NCT02443805|466179754|FG000|Overall Study|Withdrawal by Subject|73|||
129516468|NCT02443805|466179755|FG001|Overall Study|Withdrawal by Subject|74|||
129516469|NCT02443805|466179754|FG000|Overall Study|Lost to Follow-up|19|||
129516470|NCT02443805|466179755|FG001|Overall Study|Lost to Follow-up|14|||
129516471|NCT02443805|466179754|FG000|Overall Study|Pregnancy|6|||
129516472|NCT02443805|466179755|FG001|Overall Study|Pregnancy|5|||
129516473|NCT02443805|466179754|FG000|Overall Study|Protocol Violation|2|||
129516474|NCT02443805|466179755|FG001|Overall Study|Protocol Violation|4|||
129516475|NCT02443805|466179754|FG000|Overall Study|Lack of Efficacy|1|||
129516476|NCT02443805|466179755|FG001|Overall Study|Lack of Efficacy|1|||
129516477|NCT02443805|466179754|FG000|Overall Study|Non-compliance with study drug|6|||
129516478|NCT02443805|466179755|FG001|Overall Study|Non-compliance with study drug|4|||
129516479|NCT02443805|466179754|FG000|Overall Study|Withdrawal by parent/guardian|3|||
129516480|NCT02443805|466179755|FG001|Overall Study|Withdrawal by parent/guardian|5|||
129516481|NCT02443805|466179754|FG000|Overall Study|Any other reason not above-mentioned|3|||
129516482|NCT02443805|466179755|FG001|Overall Study|Any other reason not above-mentioned|2|||
129516483|NCT04362813|466179756|FG000|Overall Study|Death|12|||
129516484|NCT04362813|466179757|FG001|Overall Study|Death|16|||
129516485|NCT04362813|466179756|FG000|Overall Study|Withdrawal by Subject|3|||
129516486|NCT04362813|466179757|FG001|Overall Study|Withdrawal by Subject|1|||
129516487|NCT04362813|466179756|FG000|Overall Study|Protocol Violation|0|||
129516488|NCT04362813|466179757|FG001|Overall Study|Protocol Violation|3|||
129516489|NCT04362813|466179756|FG000|Overall Study|Lost to Follow-up|1|||
129516490|NCT04362813|466179757|FG001|Overall Study|Lost to Follow-up|1|||
129516491|NCT04362813|466179756|FG000|Overall Study|Enrolled but did not receive treatment|2|||
129516492|NCT04362813|466179757|FG001|Overall Study|Enrolled but did not receive treatment|4|||
129516493|NCT00961116|466179758|FG000|Washout Period of 7 Days|Adverse Event|1|||
129516494|NCT00961116|466179759|FG001|Washout Period of 7 Days|Adverse Event|1|||
129516495|NCT00961116|466179758|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
129516496|NCT00961116|466179759|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
129516497|NCT00961116|466179758|FG000|Washout Period of 7 Days|Protocol Violation|0|||
129516498|NCT00961116|466179759|FG001|Washout Period of 7 Days|Protocol Violation|1|||
129516499|NCT02708966|466179760|FG000|Overall Study|Lost to Follow-up|2|||
129516500|NCT02708966|466179761|FG001|Overall Study|Lost to Follow-up|2|||
129516501|NCT01732107|466179764|FG000|Overall Study|Adverse Event|2|||
129516502|NCT01732107|466179764|FG000|Overall Study|Disease Progression|8|||
129516503|NCT01732107|466179764|FG000|Overall Study|Physician Decision|1|||
129516504|NCT01732107|466179764|FG000|Overall Study|Withdrawal by Subject|2|||
129516505|NCT02023268|466179765|FG000|Overall Study|Lack of Efficacy|0|||
129516506|NCT02023268|466179766|FG001|Overall Study|Lack of Efficacy|1|||
129516507|NCT02023268|466179765|FG000|Overall Study|Adverse Event|0|||
129516508|NCT02023268|466179766|FG001|Overall Study|Adverse Event|2|||
129516509|NCT02023268|466179765|FG000|Overall Study|Withdrawal by Subject|0|||
129516510|NCT02023268|466179766|FG001|Overall Study|Withdrawal by Subject|1|||
129516511|NCT00615459|466179767|FG000|Period I|Adverse Event|2|||
129516512|NCT00615459|466179768|FG001|Period I|Adverse Event|0|||
129516513|NCT00615459|466179769|FG002|Period I|Adverse Event|1|||
129516514|NCT00615459|466179770|FG003|Period I|Adverse Event|0|||
129516515|NCT00615459|466179767|FG000|Period I|Subject withdrew consent|1|||
129516516|NCT00615459|466179768|FG001|Period I|Subject withdrew consent|0|||
129516517|NCT00615459|466179769|FG002|Period I|Subject withdrew consent|0|||
129516518|NCT00615459|466179770|FG003|Period I|Subject withdrew consent|1|||
129516519|NCT00615459|466179767|FG000|Period I|Abnormal test procedure results|1|||
129516520|NCT00615459|466179768|FG001|Period I|Abnormal test procedure results|1|||
129516521|NCT00615459|466179769|FG002|Period I|Abnormal test procedure results|1|||
129516522|NCT00615459|466179770|FG003|Period I|Abnormal test procedure results|0|||
129516523|NCT00615459|466179767|FG000|Period II|Adverse Event|1|||
129516524|NCT00615459|466179768|FG001|Period II|Adverse Event|0|||
129516525|NCT00615459|466179769|FG002|Period II|Adverse Event|0|||
129516526|NCT00615459|466179770|FG003|Period II|Adverse Event|0|||
129516527|NCT00615459|466179767|FG000|Period II|Lost to Follow-up|0|||
129516528|NCT00615459|466179768|FG001|Period II|Lost to Follow-up|0|||
129516529|NCT00615459|466179769|FG002|Period II|Lost to Follow-up|0|||
129516530|NCT00615459|466179770|FG003|Period II|Lost to Follow-up|1|||
129516531|NCT00615459|466179767|FG000|Period III|Adverse Event|0|||
129516532|NCT00615459|466179768|FG001|Period III|Adverse Event|1|||
129516533|NCT00615459|466179769|FG002|Period III|Adverse Event|0|||
129516534|NCT00615459|466179770|FG003|Period III|Adverse Event|0|||
129516535|NCT00615459|466179767|FG000|Period III|Administrative problems|0|||
129516536|NCT00615459|466179768|FG001|Period III|Administrative problems|1|||
129516537|NCT00615459|466179769|FG002|Period III|Administrative problems|1|||
129516538|NCT00615459|466179770|FG003|Period III|Administrative problems|0|||
129516539|NCT00615459|466179767|FG000|Period III|Unsatisfactory therapeutic effect|0|||
129516540|NCT00615459|466179768|FG001|Period III|Unsatisfactory therapeutic effect|1|||
129516541|NCT00615459|466179769|FG002|Period III|Unsatisfactory therapeutic effect|0|||
129516542|NCT00615459|466179770|FG003|Period III|Unsatisfactory therapeutic effect|0|||
129516543|NCT01975675|466179771|FG000|Overall Study|Death|0|||
129516544|NCT01975675|466179772|FG001|Overall Study|Death|1|||
129516545|NCT01975675|466179773|FG002|Overall Study|Death|0|||
129516546|NCT01975675|466179774|FG003|Overall Study|Death|0|||
129516547|NCT00224003|466179775|FG000|Overall Study|Adverse Event|1|||
129516548|NCT00224003|466179775|FG000|Overall Study|Protocol Violation|2|||
129516549|NCT00224003|466179775|FG000|Overall Study|Withdrawal by Subject|1|||
129516550|NCT00224003|466179775|FG000|Overall Study|unk|3|||
129516551|NCT00753688|466179776|FG000|Overall Study|Death|102|||
129516552|NCT00753688|466179777|FG001|Overall Study|Death|203|||
129516553|NCT00753688|466179776|FG000|Overall Study|Missing|4|||
129516554|NCT00753688|466179777|FG001|Overall Study|Missing|9|||
129516555|NCT00753688|466179776|FG000|Overall Study|Participant Withdrew Consent|2|||
129516556|NCT00753688|466179777|FG001|Overall Study|Participant Withdrew Consent|2|||
129516557|NCT00753688|466179776|FG000|Overall Study|Ongoing - in Follow-up|15|||
129516558|NCT00753688|466179777|FG001|Overall Study|Ongoing - in Follow-up|31|||
129516559|NCT00753688|466179776|FG000|Overall Study|Adverse Event|0|||
129516560|NCT00753688|466179777|FG001|Overall Study|Adverse Event|1|||
129516561|NCT03595384|466179778|FG000|Overall Study|Other time commitments|8|||
129516562|NCT03595384|466179778|FG000|Overall Study|Changes to session time|7|||
129516563|NCT03595384|466179778|FG000|Overall Study|Relocation out of country|1|||
129516564|NCT00293241|466179779|FG000|Overall Study|Lost to Follow-up|9|||
129516565|NCT00293241|466179780|FG001|Overall Study|Lost to Follow-up|16|||
129516566|NCT00293241|466179779|FG000|Overall Study|Physician Decision|23|||
129516567|NCT00293241|466179780|FG001|Overall Study|Physician Decision|17|||
129516568|NCT00293241|466179779|FG000|Overall Study|Withdrawal by Subject|4|||
129516569|NCT00293241|466179780|FG001|Overall Study|Withdrawal by Subject|8|||
129516570|NCT03803202|466179781|FG000|Overall Study|Other|0|||
129516571|NCT03803202|466179782|FG001|Overall Study|Other|1|||
129516572|NCT03803202|466179783|FG002|Overall Study|Other|0|||
129516573|NCT03803202|466179784|FG003|Overall Study|Other|0|||
129516574|NCT03803202|466179785|FG004|Overall Study|Other|0|||
129516575|NCT03803202|466179786|FG005|Overall Study|Other|0|||
129516576|NCT03803202|466179787|FG006|Overall Study|Other|0|||
129516577|NCT03803202|466179788|FG007|Overall Study|Other|0|||
129516578|NCT03803202|466179789|FG008|Overall Study|Other|0|||
129516579|NCT03803202|466179781|FG000|Overall Study|Death|0|||
129516580|NCT03803202|466179782|FG001|Overall Study|Death|0|||
129516581|NCT03803202|466179783|FG002|Overall Study|Death|0|||
129516582|NCT03803202|466179784|FG003|Overall Study|Death|0|||
129516583|NCT03803202|466179785|FG004|Overall Study|Death|0|||
129516584|NCT03803202|466179786|FG005|Overall Study|Death|1|||
129516585|NCT03803202|466179787|FG006|Overall Study|Death|0|||
129516586|NCT03803202|466179788|FG007|Overall Study|Death|0|||
129516587|NCT03803202|466179789|FG008|Overall Study|Death|0|||
129516588|NCT03803202|466179781|FG000|Overall Study|Withdrawal by Subject|0|||
129516589|NCT03803202|466179782|FG001|Overall Study|Withdrawal by Subject|0|||
129516590|NCT03803202|466179783|FG002|Overall Study|Withdrawal by Subject|1|||
129516591|NCT03803202|466179784|FG003|Overall Study|Withdrawal by Subject|0|||
129516592|NCT03803202|466179785|FG004|Overall Study|Withdrawal by Subject|0|||
129516593|NCT03803202|466179786|FG005|Overall Study|Withdrawal by Subject|0|||
129516594|NCT03803202|466179787|FG006|Overall Study|Withdrawal by Subject|0|||
129516595|NCT03803202|466179788|FG007|Overall Study|Withdrawal by Subject|1|||
129516596|NCT03803202|466179789|FG008|Overall Study|Withdrawal by Subject|0|||
129516597|NCT03803202|466179781|FG000|Overall Study|Lost to Follow-up|0|||
129516598|NCT03803202|466179782|FG001|Overall Study|Lost to Follow-up|0|||
129516599|NCT03803202|466179783|FG002|Overall Study|Lost to Follow-up|0|||
129516600|NCT03803202|466179784|FG003|Overall Study|Lost to Follow-up|1|||
129516601|NCT03803202|466179785|FG004|Overall Study|Lost to Follow-up|1|||
129516602|NCT03803202|466179786|FG005|Overall Study|Lost to Follow-up|0|||
129516603|NCT03803202|466179787|FG006|Overall Study|Lost to Follow-up|1|||
129516604|NCT03803202|466179788|FG007|Overall Study|Lost to Follow-up|0|||
129516605|NCT03803202|466179789|FG008|Overall Study|Lost to Follow-up|0|||
129516606|NCT00659126|466179794|FG000|Overall Study|Adverse Event|2|||
129516607|NCT00659126|466179795|FG001|Overall Study|Adverse Event|2|||
129516608|NCT00659126|466179794|FG000|Overall Study|Screen failure|1|||
129516609|NCT00659126|466179795|FG001|Overall Study|Screen failure|1|||
129516610|NCT00659126|466179794|FG000|Overall Study|Technical problems with MRI|0|||
129516611|NCT00659126|466179795|FG001|Overall Study|Technical problems with MRI|1|||
129516612|NCT02633046|466179798|FG000|Overall Study|Adverse Event|8|||
129516613|NCT02633046|466179798|FG000|Overall Study|Physician Decision|7|||
129516614|NCT02633046|466179798|FG000|Overall Study|Withdrawal by Subject|8|||
129516615|NCT02633046|466179798|FG000|Overall Study|Increased proteinuria|2|||
129516616|NCT02633046|466179798|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
129516617|NCT02633046|466179798|FG000|Overall Study|Mutual decision patient and physician|1|||
129516618|NCT00418717|466179809|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
129516619|NCT00418717|466179809|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
129516620|NCT00719537|466179812|FG000|Overall Study|Withdrawal by Subject|1|||
129516621|NCT00719537|466179813|FG001|Overall Study|Withdrawal by Subject|0|||
129516622|NCT00719537|466179812|FG000|Overall Study|Lost to Follow-up|0|||
129516623|NCT00719537|466179813|FG001|Overall Study|Lost to Follow-up|1|||
129516624|NCT02910219|466179814|FG000|Overall Study|Withdrawal by Subject|1|||
129516625|NCT02910219|466179815|FG001|Overall Study|Withdrawal by Subject|1|||
129516626|NCT01015820|466179816|FG000|Overall Study|Suboptimal measurements|1|||
129516627|NCT01015820|466179817|FG001|Overall Study|Suboptimal measurements|0|||
129516628|NCT00701441|466179818|FG000|Overall Study|failure in cpap compliance|0|||
129516629|NCT00701441|466179819|FG001|Overall Study|failure in cpap compliance|4|||
129516630|NCT01313078|466179821|FG000|Overall Study|Death|1|||
129516631|NCT01313078|466179821|FG000|Overall Study|Discontinued study drug|1|||
129516632|NCT01313078|466179821|FG000|Overall Study|Withdrawal by Subject|1|||
129516633|NCT01225172|466179826|FG000|Overall Study|Subject decision to stop|1|||
129516634|NCT01225172|466179827|FG001|Overall Study|Subject decision to stop|0|||
129516635|NCT01225172|466179826|FG000|Overall Study|Subject request to discontinue treatment|3|||
129516636|NCT01225172|466179827|FG001|Overall Study|Subject request to discontinue treatment|1|||
129516637|NCT01225172|466179826|FG000|Overall Study|Subject no longer meets study criteria|1|||
129516638|NCT01225172|466179827|FG001|Overall Study|Subject no longer meets study criteria|0|||
129516639|NCT01225172|466179826|FG000|Overall Study|Withdrawal by Subject|1|||
129516640|NCT01225172|466179827|FG001|Overall Study|Withdrawal by Subject|0|||
129516641|NCT02679781|466179828|FG000|Overall Study|Lost to Follow-up|1|||
129516642|NCT02679781|466179829|FG001|Overall Study|Lost to Follow-up|2|||
129516643|NCT02679781|466179828|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
129516644|NCT02679781|466179829|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
129516645|NCT04209400|466179830|FG000|Overall Study|Withdrawal by Subject|0|||
129516646|NCT04209400|466179831|FG001|Overall Study|Withdrawal by Subject|1|||
129516647|NCT00795509|466179832|FG000|Overall Study|Protocol Violation|31|||
129516648|NCT01375647|466181928|FG000|Overall Study|Lost to Follow-up|3|||
129516649|NCT01375647|466181929|FG001|Overall Study|Lost to Follow-up|3|||
129516650|NCT01375647|466181930|FG002|Overall Study|Lost to Follow-up|7|||
129516651|NCT01375647|466181931|FG003|Overall Study|Lost to Follow-up|10|||
129516652|NCT01375647|466181928|FG000|Overall Study|Death|1|||
129516653|NCT01375647|466181929|FG001|Overall Study|Death|2|||
129516654|NCT01375647|466181930|FG002|Overall Study|Death|1|||
129516655|NCT01375647|466181931|FG003|Overall Study|Death|0|||
129516656|NCT01375647|466181928|FG000|Overall Study|Withdrawal by Subject|17|||
129516657|NCT01375647|466181929|FG001|Overall Study|Withdrawal by Subject|20|||
129516658|NCT01375647|466181930|FG002|Overall Study|Withdrawal by Subject|26|||
129516659|NCT01375647|466181931|FG003|Overall Study|Withdrawal by Subject|14|||
129516660|NCT01375647|466181928|FG000|Overall Study|Physician Decision|1|||
129516661|NCT01375647|466181929|FG001|Overall Study|Physician Decision|0|||
129516662|NCT01375647|466181930|FG002|Overall Study|Physician Decision|0|||
129516663|NCT01375647|466181931|FG003|Overall Study|Physician Decision|0|||
129516664|NCT03366844|466181932|FG000|Overall Study|Physician Decision|1|||
129516665|NCT03366844|466181932|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
129516666|NCT02088541|466181937|FG000|Overall Study|Adverse Event|3|||
129516667|NCT02088541|466181938|FG001|Overall Study|Adverse Event|0|||
129516668|NCT02088541|466181939|FG002|Overall Study|Adverse Event|3|||
129516669|NCT02088541|466181940|FG003|Overall Study|Adverse Event|3|||
129516670|NCT02088541|466181941|FG004|Overall Study|Adverse Event|0|||
129516671|NCT02088541|466181937|FG000|Overall Study|Death|51|||
129516672|NCT02088541|466181938|FG001|Overall Study|Death|21|||
129516673|NCT02088541|466181939|FG002|Overall Study|Death|85|||
129516674|NCT02088541|466181940|FG003|Overall Study|Death|28|||
129516675|NCT02088541|466181941|FG004|Overall Study|Death|38|||
129516676|NCT02088541|466181937|FG000|Overall Study|Lost to Follow-up|2|||
129516677|NCT02088541|466181938|FG001|Overall Study|Lost to Follow-up|0|||
129516678|NCT02088541|466181939|FG002|Overall Study|Lost to Follow-up|1|||
129516679|NCT02088541|466181940|FG003|Overall Study|Lost to Follow-up|0|||
129516680|NCT02088541|466181941|FG004|Overall Study|Lost to Follow-up|0|||
129516681|NCT02088541|466181937|FG000|Overall Study|Physician Decision|2|||
129516682|NCT02088541|466181938|FG001|Overall Study|Physician Decision|1|||
129516683|NCT02088541|466181939|FG002|Overall Study|Physician Decision|2|||
129516684|NCT02088541|466181940|FG003|Overall Study|Physician Decision|0|||
129516685|NCT02088541|466181941|FG004|Overall Study|Physician Decision|2|||
129516686|NCT02088541|466181937|FG000|Overall Study|Disease progression|7|||
129516687|NCT02088541|466181938|FG001|Overall Study|Disease progression|1|||
129516688|NCT02088541|466181939|FG002|Overall Study|Disease progression|2|||
129516689|NCT02088541|466181940|FG003|Overall Study|Disease progression|3|||
129516690|NCT02088541|466181941|FG004|Overall Study|Disease progression|1|||
129516691|NCT02088541|466181937|FG000|Overall Study|Study terminated by sponsor|1|||
129516692|NCT02088541|466181938|FG001|Overall Study|Study terminated by sponsor|1|||
129516693|NCT02088541|466181939|FG002|Overall Study|Study terminated by sponsor|12|||
129516694|NCT02088541|466181940|FG003|Overall Study|Study terminated by sponsor|2|||
129516695|NCT02088541|466181941|FG004|Overall Study|Study terminated by sponsor|6|||
129516696|NCT02088541|466181937|FG000|Overall Study|Withdrawal by Subject|3|||
129516697|NCT02088541|466181938|FG001|Overall Study|Withdrawal by Subject|2|||
129516698|NCT02088541|466181939|FG002|Overall Study|Withdrawal by Subject|9|||
129516699|NCT02088541|466181940|FG003|Overall Study|Withdrawal by Subject|7|||
129516700|NCT02088541|466181941|FG004|Overall Study|Withdrawal by Subject|10|||
129516701|NCT02088541|466181937|FG000|Overall Study|Other|2|||
129516702|NCT02088541|466181938|FG001|Overall Study|Other|1|||
129516703|NCT02088541|466181939|FG002|Overall Study|Other|3|||
129516704|NCT02088541|466181940|FG003|Overall Study|Other|1|||
129516705|NCT02088541|466181941|FG004|Overall Study|Other|1|||
129516706|NCT00323310|466181942|FG000|Overall Study|Withdrawal by Subject|1|||
129516707|NCT00323310|466181942|FG000|Overall Study|a parent refused blood draw|1|||
129516708|NCT00323310|466181942|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
129516709|NCT03984812|466181943|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516710|NCT03984812|466181944|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516711|NCT03984812|466181945|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
129516712|NCT03984812|466181946|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516713|NCT03984812|466181947|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516714|NCT03984812|466181948|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516715|NCT03984812|466181949|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516716|NCT03984812|466181950|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516717|NCT03984812|466181951|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516718|NCT03984812|466181952|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516719|NCT03984812|466181953|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
129516720|NCT02707601|466181954|FG000|Overall Study|Death|0|||
129516721|NCT02707601|466181955|FG001|Overall Study|Death|1|||
129516722|NCT02707601|466181954|FG000|Overall Study|Lack of Efficacy|0|||
129516723|NCT02707601|466181955|FG001|Overall Study|Lack of Efficacy|1|||
129516724|NCT02707601|466181954|FG000|Overall Study|Investigator's Discretion|1|||
129516725|NCT02707601|466181955|FG001|Overall Study|Investigator's Discretion|0|||
129516726|NCT02707601|466181954|FG000|Overall Study|Withdrew Consent|0|||
129516727|NCT02707601|466181955|FG001|Overall Study|Withdrew Consent|1|||
129516728|NCT02707601|466181954|FG000|Overall Study|Lost to Follow-up|1|||
129516729|NCT02707601|466181955|FG001|Overall Study|Lost to Follow-up|1|||
129516730|NCT02707601|466181954|FG000|Overall Study|Participants Randomized but Not Treated|2|||
129516731|NCT02707601|466181955|FG001|Overall Study|Participants Randomized but Not Treated|0|||
129516732|NCT00666536|466181957|FG000|Overall Study|Adverse Event|9|||
129516733|NCT00666536|466181958|FG001|Overall Study|Adverse Event|19|||
129516734|NCT00666536|466181957|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
129516735|NCT00666536|466181958|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
129516736|NCT00666536|466181957|FG000|Overall Study|Protocol deviation(s)|8|||
129516737|NCT00666536|466181958|FG001|Overall Study|Protocol deviation(s)|6|||
129516738|NCT00666536|466181957|FG000|Overall Study|Withdrawal by Subject|10|||
129516739|NCT00666536|466181958|FG001|Overall Study|Withdrawal by Subject|9|||
129516740|NCT00666536|466181957|FG000|Overall Study|Lost to Follow-up|4|||
129516741|NCT00666536|466181958|FG001|Overall Study|Lost to Follow-up|3|||
129516742|NCT02147691|466181965|FG000|Overall Study|Withdrawal by Subject|2|||
129516743|NCT02147691|466181966|FG001|Overall Study|Withdrawal by Subject|0|||
129516744|NCT02147691|466181965|FG000|Overall Study|Adverse Event|2|||
129516745|NCT02147691|466181966|FG001|Overall Study|Adverse Event|0|||
129516746|NCT02147691|466181965|FG000|Overall Study|Lost to Follow-up|0|||
129516747|NCT02147691|466181966|FG001|Overall Study|Lost to Follow-up|1|||
129516748|NCT01392742|466181967|FG000|Overall Study|Premature study termination|42|||
129516749|NCT01392742|466181967|FG000|Overall Study|Failure to return|35|||
129516750|NCT01392742|466181967|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
129516751|NCT01392742|466181967|FG000|Overall Study|Lost to Follow-up|34|||
129516752|NCT01392742|466181967|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
129516753|NCT01392742|466181967|FG000|Overall Study|ITR and Protocol deviation|1|||
129516754|NCT01392742|466181967|FG000|Overall Study|Adverse event/intercurrent illness|17|||
129516755|NCT01392742|466181967|FG000|Overall Study|Protocol Violation|14|||
129516756|NCT01392742|466181967|FG000|Overall Study|Other|3|||
129516757|NCT01392742|466181967|FG000|Overall Study|Missing information|13|||
129516758|NCT02432703|466181968|FG000|Overall Study|Adverse Event|1|||
129516759|NCT02432703|466181969|FG001|Overall Study|Adverse Event|4|||
129516760|NCT02432703|466181968|FG000|Overall Study|Lack of Efficacy|1|||
129516761|NCT02432703|466181969|FG001|Overall Study|Lack of Efficacy|0|||
129516762|NCT02432703|466181968|FG000|Overall Study|Lost to Follow-up|5|||
129516763|NCT02432703|466181969|FG001|Overall Study|Lost to Follow-up|3|||
129516764|NCT02432703|466181968|FG000|Overall Study|Withdrawal by Subject|9|||
129516765|NCT02432703|466181969|FG001|Overall Study|Withdrawal by Subject|6|||
129516766|NCT02432703|466181968|FG000|Overall Study|Other|6|||
129516767|NCT02432703|466181969|FG001|Overall Study|Other|5|||
129516768|NCT03210220|466181970|FG000|Overall Study|Physician Decision|1|||
129516769|NCT03210220|466181971|FG001|Overall Study|Physician Decision|0|||
129516770|NCT00653328|466181972|FG000|Overall Study|Withdrawal by Subject|1|||
129516771|NCT00653328|466181972|FG000|Overall Study|Adverse Event|2|||
129516772|NCT00653328|466181972|FG000|Overall Study|Disease progression|10|||
129516773|NCT00653328|466181972|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
129516774|NCT02911519|466181973|FG000|Overall Study|Lost to Follow-up|2|||
129516775|NCT02911519|466181974|FG001|Overall Study|Lost to Follow-up|2|||
129516776|NCT02911519|466181973|FG000|Overall Study|Death|0|||
129516777|NCT02911519|466181974|FG001|Overall Study|Death|2|||
129516778|NCT00839436|466181977|FG000|Overall Study|Developed exclusionary condition|1|||
129516779|NCT00839436|466181978|FG001|Overall Study|Developed exclusionary condition|0|||
129516780|NCT00839436|466181979|FG002|Overall Study|Developed exclusionary condition|0|||
129516781|NCT00839436|466181977|FG000|Overall Study|Withdrawal by Subject|0|||
129516782|NCT00839436|466181978|FG001|Overall Study|Withdrawal by Subject|1|||
129516783|NCT00839436|466181979|FG002|Overall Study|Withdrawal by Subject|0|||
129516784|NCT00839436|466181977|FG000|Overall Study|Study drug no longer available|0|||
129516785|NCT00839436|466181978|FG001|Overall Study|Study drug no longer available|0|||
129516786|NCT00839436|466181979|FG002|Overall Study|Study drug no longer available|1|||
129516787|NCT01444898|466181981|FG000|Overall Study|Withdrawal by Subject|1|||
129516788|NCT02580591|466181983|FG000|Overall Study|Adverse Event|0|||
129516789|NCT02580591|466181984|FG001|Overall Study|Adverse Event|1|||
129516790|NCT02580591|466181985|FG002|Overall Study|Adverse Event|2|||
129516791|NCT02580591|466181986|FG003|Overall Study|Adverse Event|5|||
129516792|NCT02580591|466181983|FG000|Overall Study|Protocol Violation|3|||
129516793|NCT02580591|466181984|FG001|Overall Study|Protocol Violation|2|||
129516794|NCT02580591|466181985|FG002|Overall Study|Protocol Violation|1|||
129516795|NCT02580591|466181986|FG003|Overall Study|Protocol Violation|1|||
129516796|NCT02580591|466181983|FG000|Overall Study|Lost to Follow-up|5|||
129516797|NCT02580591|466181984|FG001|Overall Study|Lost to Follow-up|3|||
129516798|NCT02580591|466181985|FG002|Overall Study|Lost to Follow-up|3|||
129516799|NCT02580591|466181986|FG003|Overall Study|Lost to Follow-up|1|||
129516800|NCT02580591|466181983|FG000|Overall Study|Withdrawal by Subject|6|||
129516801|NCT02580591|466181984|FG001|Overall Study|Withdrawal by Subject|1|||
129516802|NCT02580591|466181985|FG002|Overall Study|Withdrawal by Subject|2|||
129516803|NCT02580591|466181986|FG003|Overall Study|Withdrawal by Subject|3|||
129516804|NCT02580591|466181983|FG000|Overall Study|Not treated|1|||
129516805|NCT02580591|466181984|FG001|Overall Study|Not treated|1|||
129516806|NCT02580591|466181985|FG002|Overall Study|Not treated|0|||
129516807|NCT02580591|466181986|FG003|Overall Study|Not treated|0|||
129516808|NCT02580591|466181983|FG000|Overall Study|Other than specified|3|||
129516809|NCT02580591|466181984|FG001|Overall Study|Other than specified|2|||
129516810|NCT02580591|466181985|FG002|Overall Study|Other than specified|5|||
129516811|NCT02580591|466181986|FG003|Overall Study|Other than specified|2|||
129516812|NCT00561340|466181990|FG000|Overall Study|refused to drink pediasure|6|||
129516813|NCT00561340|466181991|FG001|Overall Study|refused to drink pediasure|0|||
129516814|NCT03051217|466181992|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
129516815|NCT03051217|466181993|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129516816|NCT03051217|466181994|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
129516817|NCT03051217|466181995|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129516818|NCT03051217|466181996|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129516819|NCT03051217|466181997|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129516820|NCT03051217|466181998|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
129516821|NCT03051217|466181992|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
129516822|NCT03051217|466181993|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
129516823|NCT03051217|466181994|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
129516824|NCT03051217|466181995|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
129516825|NCT03051217|466181996|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
129516826|NCT03051217|466181997|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
129516827|NCT03051217|466181998|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
129516828|NCT03051217|466181992|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
129516829|NCT03051217|466181993|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
129516830|NCT03051217|466181994|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
129516831|NCT03051217|466181995|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129516832|NCT03051217|466181996|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129516833|NCT03051217|466181997|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129516834|NCT03051217|466181998|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
129516835|NCT03051217|466181992|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
129516836|NCT03051217|466181993|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
129516837|NCT03051217|466181994|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
129516838|NCT03051217|466181995|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
129516839|NCT03051217|466181996|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
129516840|NCT03051217|466181997|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
129516841|NCT03051217|466181998|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
129516842|NCT03051217|466181992|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
129516843|NCT03051217|466181993|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
129516844|NCT03051217|466181994|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
129516845|NCT03051217|466181995|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
129516846|NCT03051217|466181996|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
129516847|NCT03051217|466181997|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
129516848|NCT03051217|466181998|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
129516849|NCT03051217|466181992|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
129516850|NCT03051217|466181993|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
129516851|NCT03051217|466181994|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
129516852|NCT03051217|466181995|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
129516853|NCT03051217|466181996|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
129516854|NCT03051217|466181997|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
129516855|NCT03051217|466181998|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
129516856|NCT03051217|466181992|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
129516857|NCT03051217|466181993|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
129516858|NCT03051217|466181994|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
129516859|NCT03051217|466181995|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
129516860|NCT03051217|466181996|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
129516861|NCT03051217|466181997|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
129516862|NCT03051217|466181998|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
129516863|NCT03051217|466181992|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
129516864|NCT03051217|466181993|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
129516865|NCT03051217|466181994|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
129516866|NCT03051217|466181995|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
129516867|NCT03051217|466181996|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
129516868|NCT03051217|466181997|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
129516869|NCT03051217|466181998|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
129516870|NCT00109772|466181999|FG000|Double-blind Treatment|Adverse Event|14|||
129516871|NCT00109772|466182000|FG001|Double-blind Treatment|Adverse Event|5|||
129516872|NCT00109772|466181999|FG000|Double-blind Treatment|Lack of Efficacy|1|||
129516873|NCT00109772|466182000|FG001|Double-blind Treatment|Lack of Efficacy|0|||
129516874|NCT00109772|466181999|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
129516875|NCT00109772|466182000|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
129516876|NCT00109772|466181999|FG000|Double-blind Treatment|Lost to Follow-up|2|||
129516877|NCT00109772|466182000|FG001|Double-blind Treatment|Lost to Follow-up|3|||
129516878|NCT00109772|466181999|FG000|Double-blind Treatment|Protocol Violation|0|||
129516879|NCT00109772|466182000|FG001|Double-blind Treatment|Protocol Violation|1|||
129516880|NCT00109772|466181999|FG000|Double-blind Treatment|Other|0|||
129516881|NCT00109772|466182000|FG001|Double-blind Treatment|Other|4|||
129516882|NCT00109772|466181999|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
129516883|NCT00109772|466182000|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
129516884|NCT00109772|466181999|FG000|Open-label Extension|Adverse Event|10|||
129516885|NCT00109772|466182000|FG001|Open-label Extension|Adverse Event|19|||
129516886|NCT00109772|466181999|FG000|Open-label Extension|Lack of Efficacy|19|||
129516887|NCT00109772|466182000|FG001|Open-label Extension|Lack of Efficacy|11|||
129516888|NCT00109772|466181999|FG000|Open-label Extension|Withdrawal by Subject|9|||
129516889|NCT00109772|466182000|FG001|Open-label Extension|Withdrawal by Subject|6|||
129516890|NCT00109772|466181999|FG000|Open-label Extension|Lost to Follow-up|1|||
129516891|NCT00109772|466182000|FG001|Open-label Extension|Lost to Follow-up|0|||
129516892|NCT00109772|466181999|FG000|Open-label Extension|Death|0|||
129516893|NCT00109772|466182000|FG001|Open-label Extension|Death|1|||
129516894|NCT00109772|466181999|FG000|Open-label Extension|Protocol Violation|2|||
129516895|NCT00109772|466182000|FG001|Open-label Extension|Protocol Violation|2|||
129516896|NCT00109772|466181999|FG000|Open-label Extension|Other|4|||
129516897|NCT00109772|466182000|FG001|Open-label Extension|Other|10|||
129516898|NCT01057862|466182003|FG000|Overall Study|Withdrawal by Subject|1|||
129516899|NCT01057862|466182004|FG001|Overall Study|Withdrawal by Subject|2|||
129516900|NCT00415584|466182005|FG000|Overall Study|Withdrawal by Subject|1|||
129516901|NCT00802867|466182006|FG000|Overall Study|Lost to Follow-up|6|||
129516902|NCT00802867|466182006|FG000|Overall Study|Protocol Violation|6|||
129516903|NCT00802867|466182006|FG000|Overall Study|Withdrawal by Subject|1|||
129516904|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
129516905|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
129516906|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
129516907|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
129516908|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
129516909|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
129516910|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
129516911|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
129516912|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
129516913|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
129516914|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
129516915|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
129516916|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
129516917|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
129516918|NCT03434041|466182007|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
129516919|NCT03434041|466182008|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
129516920|NCT03434041|466182007|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
129516921|NCT03434041|466182008|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
129516922|NCT03434041|466182007|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
129516923|NCT03434041|466182008|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
129516924|NCT03434041|466182007|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
129516925|NCT03434041|466182008|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
129516926|NCT04075396|466182009|FG000|Overall Study|Death|11|||
129516927|NCT04075396|466182010|FG001|Overall Study|Death|9|||
129516928|NCT04075396|466182009|FG000|Overall Study|Withdrawal by Subject|1|||
129516929|NCT04075396|466182010|FG001|Overall Study|Withdrawal by Subject|2|||
129516930|NCT04075396|466182009|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
129516931|NCT04075396|466182010|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
129516932|NCT04075396|466182009|FG000|Overall Study|Enrolled but not-treated|0|||
129516933|NCT04075396|466182010|FG001|Overall Study|Enrolled but not-treated|1|||
129516934|NCT03363165|466182017|FG000|3-month Follow-up|Death|0|||
129516935|NCT03363165|466182018|FG001|3-month Follow-up|Death|1|||
129516936|NCT03363165|466182017|FG000|6-month Follow-up|Death|0|||
129516937|NCT03363165|466182018|FG001|6-month Follow-up|Death|1|||
129516938|NCT03363165|466182017|FG000|6-month Follow-up|Withdrawal by Subject|1|||
129516939|NCT03363165|466182018|FG001|6-month Follow-up|Withdrawal by Subject|1|||
129516940|NCT03363165|466182017|FG000|12-month Follow-up|Death|1|||
129516941|NCT03363165|466182018|FG001|12-month Follow-up|Death|1|||
129516942|NCT03363165|466182017|FG000|12-month Follow-up|Withdrawal by Subject|1|||
129516943|NCT03363165|466182018|FG001|12-month Follow-up|Withdrawal by Subject|1|||
129516944|NCT02255760|466182019|FG000|Overall Study|Lost to Follow-up|0|||
129516945|NCT02255760|466182020|FG001|Overall Study|Lost to Follow-up|1|||
129516946|NCT02255760|466182021|FG002|Overall Study|Lost to Follow-up|0|||
129516947|NCT02255760|466182022|FG003|Overall Study|Lost to Follow-up|0|||
129516948|NCT02255760|466182023|FG004|Overall Study|Lost to Follow-up|0|||
129516949|NCT00618813|466182024|FG000|Overall Study|Lack of Efficacy|1|||
129516950|NCT00618813|466182024|FG000|Overall Study|Physician Decision|2|||
129516951|NCT00618813|466182024|FG000|Overall Study|Withdrawal by Subject|1|||
129516952|NCT00003838|466182025|FG000|Overall Study|Death|0|||
129516953|NCT00003838|466182026|FG001|Overall Study|Death|12|||
129516954|NCT00003838|466182027|FG002|Overall Study|Death|7|||
129516955|NCT00003838|466182025|FG000|Overall Study|Lost to Follow-up|0|||
129516956|NCT00003838|466182026|FG001|Overall Study|Lost to Follow-up|1|||
129516957|NCT00003838|466182027|FG002|Overall Study|Lost to Follow-up|1|||
129516958|NCT00003838|466182025|FG000|Overall Study|Disease Progression|0|||
129516959|NCT00003838|466182026|FG001|Overall Study|Disease Progression|12|||
129516960|NCT00003838|466182027|FG002|Overall Study|Disease Progression|0|||
129516961|NCT01809197|466182028|FG000|Overall Study|Lost to Follow-up|4|||
129516962|NCT01809197|466182029|FG001|Overall Study|Lost to Follow-up|2|||
129516963|NCT01809197|466182028|FG000|Overall Study|Adverse Event|2|||
129516964|NCT01809197|466182029|FG001|Overall Study|Adverse Event|3|||
129516965|NCT01809197|466182028|FG000|Overall Study|Failed slit lamp exam|1|||
129516966|NCT01809197|466182029|FG001|Overall Study|Failed slit lamp exam|0|||
129516967|NCT01809197|466182028|FG000|Overall Study|Non-Compliance|1|||
129516968|NCT01809197|466182029|FG001|Overall Study|Non-Compliance|1|||
129516969|NCT01809197|466182028|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
129516970|NCT01809197|466182029|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
129516971|NCT01809197|466182028|FG000|Overall Study|Withdrawal by Subject|1|||
129516972|NCT01809197|466182029|FG001|Overall Study|Withdrawal by Subject|1|||
129516973|NCT01809197|466182028|FG000|Overall Study|Product not available|0|||
129516974|NCT01809197|466182029|FG001|Overall Study|Product not available|1|||
129516975|NCT00770224|466182030|FG000|Step 1: Induction|Adverse Event|3|||
129516976|NCT00770224|466182031|FG001|Step 1: Induction|Adverse Event|0|||
129516977|NCT00770224|466182030|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
129516978|NCT00770224|466182031|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
129516979|NCT00770224|466182030|FG000|Step 1: Induction|Other reason not protocol specified|2|||
129516980|NCT00770224|466182031|FG001|Step 1: Induction|Other reason not protocol specified|0|||
129516981|NCT00770224|466182030|FG000|Step 1: Induction|Ineligible|2|||
129516982|NCT00770224|466182031|FG001|Step 1: Induction|Ineligible|0|||
129516983|NCT00770224|466182030|FG000|Step 1: Induction|No protocol treatment given|1|||
129516984|NCT00770224|466182031|FG001|Step 1: Induction|No protocol treatment given|0|||
129516985|NCT00770224|466182030|FG000|Step 2: Maintenance|Adverse Event|0|||
129516986|NCT00770224|466182031|FG001|Step 2: Maintenance|Adverse Event|10|||
129516987|NCT00770224|466182030|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
129516988|NCT00770224|466182031|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
129516989|NCT00770224|466182030|FG000|Step 2: Maintenance|Progression/relapse|0|||
129516990|NCT00770224|466182031|FG001|Step 2: Maintenance|Progression/relapse|1|||
129516991|NCT00770224|466182030|FG000|Step 2: Maintenance|Death|0|||
129516992|NCT00770224|466182031|FG001|Step 2: Maintenance|Death|2|||
129516993|NCT00770224|466182030|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
129516994|NCT00770224|466182031|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
129516995|NCT00770224|466182030|FG000|Step 2: Maintenance|Ineligible|0|||
129516996|NCT00770224|466182031|FG001|Step 2: Maintenance|Ineligible|2|||
129516997|NCT01040845|466182032|FG000|Overall Study|Withdrawal by Subject|1|||
129516998|NCT01040845|466182033|FG001|Overall Study|Withdrawal by Subject|1|||
129516999|NCT01040845|466182032|FG000|Overall Study|Physician Decision|1|||
129517000|NCT01040845|466182033|FG001|Overall Study|Physician Decision|0|||
129517001|NCT02260388|466182034|FG000|Overall Study|Lost to Follow-up|2|||
129517002|NCT02260388|466182035|FG001|Overall Study|Lost to Follow-up|8|||
129517003|NCT02260388|466182036|FG002|Overall Study|Lost to Follow-up|3|||
129517004|NCT02260388|466182037|FG003|Overall Study|Lost to Follow-up|4|||
129517005|NCT02959190|466182038|FG000|Open Label|Adverse Event|5|||
129517006|NCT02959190|466182039|FG001|Open Label|Adverse Event|7|||
129517007|NCT02959190|466182040|FG002|Open Label|Adverse Event|3|||
129517008|NCT02959190|466182041|FG003|Open Label|Adverse Event|4|||
129517009|NCT02959190|466182038|FG000|Open Label|Pregnancy|0|||
129517010|NCT02959190|466182039|FG001|Open Label|Pregnancy|1|||
129517011|NCT02959190|466182040|FG002|Open Label|Pregnancy|0|||
129517012|NCT02959190|466182041|FG003|Open Label|Pregnancy|0|||
129517013|NCT02959190|466182038|FG000|Open Label|Withdrawal by Subject|2|||
129517014|NCT02959190|466182039|FG001|Open Label|Withdrawal by Subject|8|||
129517015|NCT02959190|466182040|FG002|Open Label|Withdrawal by Subject|0|||
129517016|NCT02959190|466182041|FG003|Open Label|Withdrawal by Subject|0|||
129517017|NCT02959190|466182038|FG000|Open Label|Physician Decision|0|||
129517018|NCT02959190|466182039|FG001|Open Label|Physician Decision|0|||
129517019|NCT02959190|466182040|FG002|Open Label|Physician Decision|1|||
129517020|NCT02959190|466182041|FG003|Open Label|Physician Decision|0|||
129517021|NCT02959190|466182038|FG000|Open Label|Protocol Violation|0|||
129517022|NCT02959190|466182039|FG001|Open Label|Protocol Violation|0|||
129517023|NCT02959190|466182040|FG002|Open Label|Protocol Violation|0|||
129517024|NCT02959190|466182041|FG003|Open Label|Protocol Violation|2|||
129517025|NCT02959190|466182038|FG000|Post Treatment Follow Up|Adverse Event|1|||
129517026|NCT02959190|466182039|FG001|Post Treatment Follow Up|Adverse Event|1|||
129517027|NCT02959190|466182040|FG002|Post Treatment Follow Up|Adverse Event|0|||
129517028|NCT02959190|466182041|FG003|Post Treatment Follow Up|Adverse Event|0|||
129517029|NCT02959190|466182038|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
129517030|NCT02959190|466182039|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
129517031|NCT02959190|466182040|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
129517032|NCT02959190|466182041|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
129517033|NCT01235507|466182043|FG000|Overall Study|Adverse Event|1|||
129517034|NCT01235507|466182043|FG000|Overall Study|Withdrawal by Subject|1|||
129517035|NCT02925312|466182046|FG000|Overall Study|Lost to Follow-up|25|||
129517036|NCT02925312|466182047|FG001|Overall Study|Lost to Follow-up|0|||
129517037|NCT02925312|466182046|FG000|Overall Study|Adverse Event|2|||
129517038|NCT02925312|466182047|FG001|Overall Study|Adverse Event|0|||
129517039|NCT01142193|466182051|FG000|Overall Study|Adverse Event|12|||
129517040|NCT01142193|466182052|FG001|Overall Study|Adverse Event|4|||
129517041|NCT01142193|466182051|FG000|Overall Study|Lack of Efficacy|2|||
129517042|NCT01142193|466182052|FG001|Overall Study|Lack of Efficacy|1|||
129517043|NCT01142193|466182051|FG000|Overall Study|Physician Decision|1|||
129517044|NCT01142193|466182052|FG001|Overall Study|Physician Decision|1|||
129517045|NCT01142193|466182051|FG000|Overall Study|Withdrawal by Subject|4|||
129517046|NCT01142193|466182052|FG001|Overall Study|Withdrawal by Subject|3|||
129517047|NCT01142193|466182051|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
129517048|NCT01142193|466182052|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
129517049|NCT01142193|466182051|FG000|Overall Study|Other|1|||
129517050|NCT01142193|466182052|FG001|Overall Study|Other|2|||
129517051|NCT01459068|466182053|FG000|Overall Study|Withdrawal by Subject|8|||
129517052|NCT01459068|466182054|FG001|Overall Study|Withdrawal by Subject|18|||
129517053|NCT01459068|466182053|FG000|Overall Study|Lost to Follow-up|31|||
129517054|NCT01459068|466182054|FG001|Overall Study|Lost to Follow-up|15|||
129517055|NCT01459068|466182053|FG000|Overall Study|Death|0|||
129517056|NCT01459068|466182054|FG001|Overall Study|Death|1|||
129517057|NCT00196196|466182057|FG000|Overall Study|Withdrawal by Subject|2|||
129517058|NCT00196196|466182057|FG000|Overall Study|Did not have required condition (hydroce|5|||
129517059|NCT01601470|466182058|FG000|Period 2 - LCZ696|Physician Decision|1|||
129517060|NCT01203787|466182059|FG000|Overall Study|Death|12|||
129517061|NCT01203787|466182060|FG001|Overall Study|Death|10|||
129517062|NCT01203787|466182059|FG000|Overall Study|Withdrawal by Subject|6|||
129517063|NCT01203787|466182060|FG001|Overall Study|Withdrawal by Subject|2|||
129517064|NCT01203787|466182059|FG000|Overall Study|Lost to Follow-up|2|||
129517065|NCT01203787|466182060|FG001|Overall Study|Lost to Follow-up|0|||
129517066|NCT01203787|466182059|FG000|Overall Study|Adverse Event|11|||
129517067|NCT01203787|466182060|FG001|Overall Study|Adverse Event|15|||
129517068|NCT03404518|466182061|FG000|Overall Study|Lost to Follow-up|28|||
129517069|NCT03404518|466182062|FG001|Overall Study|Lost to Follow-up|30|||
129517070|NCT03404518|466182061|FG000|Overall Study|Protocol Violation|13|||
129517071|NCT03404518|466182062|FG001|Overall Study|Protocol Violation|6|||
129517072|NCT01079195|466182063|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
129517073|NCT01079195|466182063|FG000|Overall Study|No Documentation Available|437|||
129517074|NCT01079195|466182063|FG000|Overall Study|Adverse Event|157|||
129517075|NCT01079195|466182063|FG000|Overall Study|Reason Unknown|39|||
129517076|NCT01079195|466182063|FG000|Overall Study|Withdrawal by Subject|18|||
129517077|NCT01079195|466182063|FG000|Overall Study|Financial Reasons|15|||
129517078|NCT01079195|466182063|FG000|Overall Study|Lack of Effectiveness|12|||
129517079|NCT01079195|466182063|FG000|Overall Study|Physician Decision|4|||
129517080|NCT01079195|466182063|FG000|Overall Study|Improved Status of Participant|4|||
129517081|NCT01079195|466182063|FG000|Overall Study|No Follow-up Documentation Available|4|||
129517082|NCT01079195|466182063|FG000|Overall Study|Non-compliance|2|||
129517083|NCT03693404|466182068|FG000|Overall Study|Withdrawal by Subject|1|||
129517084|NCT03693404|466182069|FG001|Overall Study|Withdrawal by Subject|0|||
129517085|NCT03693404|466182068|FG000|Overall Study|Lost to Follow-up|0|||
129517086|NCT03693404|466182069|FG001|Overall Study|Lost to Follow-up|5|||
129517087|NCT03693404|466182068|FG000|Overall Study|Excluded from Analysis|0|||
129517088|NCT03693404|466182069|FG001|Overall Study|Excluded from Analysis|1|||
129517089|NCT02079519|466182070|FG000|Overall Study|Disease Progression|9|||
129517090|NCT02079519|466182070|FG000|Overall Study|Adverse Event|1|||
129517091|NCT01041404|466182076|FG000|Overall Study|Adverse Event|45|||
129517092|NCT01041404|466182077|FG001|Overall Study|Adverse Event|35|||
129517093|NCT01041404|466182076|FG000|Overall Study|Lack of Efficacy|200|||
129517094|NCT01041404|466182077|FG001|Overall Study|Lack of Efficacy|210|||
129517095|NCT01041404|466182076|FG000|Overall Study|Violation of Selection Criteria|0|||
129517096|NCT01041404|466182077|FG001|Overall Study|Violation of Selection Criteria|1|||
129517097|NCT01041404|466182076|FG000|Overall Study|Protocol Violation|4|||
129517098|NCT01041404|466182077|FG001|Overall Study|Protocol Violation|0|||
129517099|NCT01041404|466182076|FG000|Overall Study|Withdrawal by Subject|29|||
129517100|NCT01041404|466182077|FG001|Overall Study|Withdrawal by Subject|23|||
129517101|NCT01041404|466182076|FG000|Overall Study|Failure to Return|1|||
129517102|NCT01041404|466182077|FG001|Overall Study|Failure to Return|2|||
129517103|NCT01041404|466182076|FG000|Overall Study|Other|11|||
129517104|NCT01041404|466182077|FG001|Overall Study|Other|23|||
129517105|NCT01685203|466182079|FG000|Overall Study|Lost to Follow-up|3|||
129517106|NCT01685203|466182080|FG001|Overall Study|Lost to Follow-up|3|||
129517107|NCT01685203|466182081|FG002|Overall Study|Lost to Follow-up|0|||
129517108|NCT01685203|466182082|FG003|Overall Study|Lost to Follow-up|1|||
129517109|NCT01685203|466182083|FG004|Overall Study|Lost to Follow-up|0|||
129517110|NCT01685203|466182084|FG005|Overall Study|Lost to Follow-up|0|||
129517111|NCT01685203|466182085|FG006|Overall Study|Lost to Follow-up|0|||
129517112|NCT01685203|466182079|FG000|Overall Study|Adverse Event|0|||
129517113|NCT01685203|466182080|FG001|Overall Study|Adverse Event|0|||
129517114|NCT01685203|466182081|FG002|Overall Study|Adverse Event|0|||
129517115|NCT01685203|466182082|FG003|Overall Study|Adverse Event|0|||
129517116|NCT01685203|466182083|FG004|Overall Study|Adverse Event|0|||
129517117|NCT01685203|466182084|FG005|Overall Study|Adverse Event|2|||
129517118|NCT01685203|466182085|FG006|Overall Study|Adverse Event|0|||
129517119|NCT01685203|466182079|FG000|Overall Study|Adverse event and withdrew consent|1|||
129517120|NCT01685203|466182080|FG001|Overall Study|Adverse event and withdrew consent|0|||
129517121|NCT01685203|466182081|FG002|Overall Study|Adverse event and withdrew consent|0|||
129517122|NCT01685203|466182082|FG003|Overall Study|Adverse event and withdrew consent|0|||
129517123|NCT01685203|466182083|FG004|Overall Study|Adverse event and withdrew consent|0|||
129517124|NCT01685203|466182084|FG005|Overall Study|Adverse event and withdrew consent|0|||
129517125|NCT01685203|466182085|FG006|Overall Study|Adverse event and withdrew consent|0|||
129517126|NCT01685203|466182079|FG000|Overall Study|Patient's decision|0|||
129517127|NCT01685203|466182080|FG001|Overall Study|Patient's decision|0|||
129517128|NCT01685203|466182081|FG002|Overall Study|Patient's decision|0|||
129517129|NCT01685203|466182082|FG003|Overall Study|Patient's decision|0|||
129517130|NCT01685203|466182083|FG004|Overall Study|Patient's decision|0|||
129517131|NCT01685203|466182084|FG005|Overall Study|Patient's decision|1|||
129517132|NCT01685203|466182085|FG006|Overall Study|Patient's decision|0|||
129517133|NCT00383708|466182086|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
129517134|NCT00383708|466182086|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
129517135|NCT00383708|466182086|FG000|Run-in Period|Protocol Violation|4|||
129517136|NCT00383708|466182086|FG000|Run-in Period|Adverse Event|2|||
129517137|NCT00383708|466182086|FG000|Run-in Period|Claustrophobia|1|||
129517138|NCT00383708|466182086|FG000|Co-administration Period|Adverse Event|5|||
129517139|NCT00318370|466182087|FG000|Period 1|Lack of Efficacy|5|||
129517140|NCT00318370|466182088|FG001|Period 1|Lack of Efficacy|0|||
129517141|NCT00318370|466182089|FG002|Period 1|Lack of Efficacy|0|||
129517142|NCT00318370|466182087|FG000|Period 1|Physician Decision|1|||
129517143|NCT00318370|466182088|FG001|Period 1|Physician Decision|0|||
129517144|NCT00318370|466182089|FG002|Period 1|Physician Decision|0|||
129517145|NCT00318370|466182087|FG000|Period 1|Withdrawal by Subject|1|||
129517146|NCT00318370|466182088|FG001|Period 1|Withdrawal by Subject|0|||
129517147|NCT00318370|466182089|FG002|Period 1|Withdrawal by Subject|0|||
129517148|NCT00318370|466182087|FG000|Period 2|Adverse Event|0|||
129517149|NCT00318370|466182088|FG001|Period 2|Adverse Event|3|||
129517150|NCT00318370|466182089|FG002|Period 2|Adverse Event|0|||
129517151|NCT00318370|466182087|FG000|Period 2|Lack of Efficacy|0|||
129517152|NCT00318370|466182088|FG001|Period 2|Lack of Efficacy|5|||
129517153|NCT00318370|466182089|FG002|Period 2|Lack of Efficacy|0|||
129517154|NCT00318370|466182087|FG000|Period 2|Physician Decision|0|||
129517155|NCT00318370|466182088|FG001|Period 2|Physician Decision|1|||
129517156|NCT00318370|466182089|FG002|Period 2|Physician Decision|0|||
129517157|NCT00318370|466182087|FG000|Period 2|Withdrawal by Subject|0|||
129517158|NCT00318370|466182088|FG001|Period 2|Withdrawal by Subject|1|||
129517159|NCT00318370|466182089|FG002|Period 2|Withdrawal by Subject|0|||
129517160|NCT00318370|466182087|FG000|Period 2|Other|0|||
129517161|NCT00318370|466182088|FG001|Period 2|Other|1|||
129517162|NCT00318370|466182089|FG002|Period 2|Other|0|||
129517163|NCT00318370|466182087|FG000|Period 3|Adverse Event|0|||
129517164|NCT00318370|466182088|FG001|Period 3|Adverse Event|0|||
129517165|NCT00318370|466182089|FG002|Period 3|Adverse Event|1|||
129517166|NCT00318370|466182087|FG000|Period 3|Lack of Efficacy|0|||
129517167|NCT00318370|466182088|FG001|Period 3|Lack of Efficacy|0|||
129517168|NCT00318370|466182089|FG002|Period 3|Lack of Efficacy|24|||
129517169|NCT00318370|466182087|FG000|Period 3|Death|0|||
129517170|NCT00318370|466182088|FG001|Period 3|Death|0|||
129517171|NCT00318370|466182089|FG002|Period 3|Death|1|||
129517172|NCT00318370|466182087|FG000|Period 3|Physician Decision|0|||
129517173|NCT00318370|466182088|FG001|Period 3|Physician Decision|0|||
129517174|NCT00318370|466182089|FG002|Period 3|Physician Decision|1|||
129517175|NCT00318370|466182087|FG000|Period 3|Withdrawal by Subject|0|||
129517176|NCT00318370|466182088|FG001|Period 3|Withdrawal by Subject|0|||
129517177|NCT00318370|466182089|FG002|Period 3|Withdrawal by Subject|3|||
129517178|NCT00318370|466182087|FG000|Period 3|Other|0|||
129517179|NCT00318370|466182088|FG001|Period 3|Other|0|||
129517180|NCT00318370|466182089|FG002|Period 3|Other|3|||
129517181|NCT01750840|466182090|FG000|Overall Study|Lost to Follow-up|4|||
129517182|NCT01576406|466182092|FG000|Overall Study|Lost to Follow-up|1|||
129517183|NCT01576406|466182093|FG001|Overall Study|Lost to Follow-up|2|||
129517184|NCT01576406|466182094|FG002|Overall Study|Lost to Follow-up|0|||
129517185|NCT01576406|466182095|FG003|Overall Study|Lost to Follow-up|0|||
129517186|NCT01576406|466182096|FG004|Overall Study|Lost to Follow-up|0|||
129517187|NCT01576406|466182097|FG005|Overall Study|Lost to Follow-up|0|||
129517188|NCT01576406|466182092|FG000|Overall Study|Death|3|||
129517189|NCT01576406|466182093|FG001|Overall Study|Death|4|||
129517190|NCT01576406|466182094|FG002|Overall Study|Death|8|||
129517191|NCT01576406|466182095|FG003|Overall Study|Death|5|||
129517192|NCT01576406|466182096|FG004|Overall Study|Death|7|||
129517193|NCT01576406|466182097|FG005|Overall Study|Death|9|||
129517194|NCT01576406|466182092|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
129517195|NCT01576406|466182093|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
129517196|NCT01576406|466182094|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
129517197|NCT01576406|466182095|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
129517198|NCT01576406|466182096|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
129517199|NCT01576406|466182097|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
129517200|NCT01576406|466182092|FG000|Overall Study|Withdrawal the consent|2|||
129517201|NCT01576406|466182093|FG001|Overall Study|Withdrawal the consent|2|||
129517202|NCT01576406|466182094|FG002|Overall Study|Withdrawal the consent|5|||
129517203|NCT01576406|466182095|FG003|Overall Study|Withdrawal the consent|1|||
129517204|NCT01576406|466182096|FG004|Overall Study|Withdrawal the consent|1|||
129517205|NCT01576406|466182097|FG005|Overall Study|Withdrawal the consent|3|||
129517206|NCT01576406|466182092|FG000|Overall Study|Other|0|||
129517207|NCT01576406|466182093|FG001|Overall Study|Other|0|||
129517208|NCT01576406|466182094|FG002|Overall Study|Other|2|||
129517209|NCT01576406|466182095|FG003|Overall Study|Other|2|||
129517210|NCT01576406|466182096|FG004|Overall Study|Other|0|||
129517211|NCT01576406|466182097|FG005|Overall Study|Other|0|||
129517212|NCT00669032|466182100|FG000|Overall Study|Lost to Follow-up|6|||
129517213|NCT00669032|466182101|FG001|Overall Study|Lost to Follow-up|5|||
129517214|NCT00669032|466182100|FG000|Overall Study|Lack of Efficacy|8|||
129517215|NCT00669032|466182101|FG001|Overall Study|Lack of Efficacy|19|||
129517216|NCT00669032|466182100|FG000|Overall Study|Withdrawal by Subject|12|||
129517217|NCT00669032|466182101|FG001|Overall Study|Withdrawal by Subject|13|||
129517218|NCT00669032|466182100|FG000|Overall Study|Adverse Event|12|||
129517219|NCT00669032|466182101|FG001|Overall Study|Adverse Event|16|||
129517220|NCT00669032|466182100|FG000|Overall Study|Physician Decision|1|||
129517221|NCT00669032|466182101|FG001|Overall Study|Physician Decision|1|||
129517222|NCT00669032|466182100|FG000|Overall Study|No fulfilment of the selection criteria|5|||
129517223|NCT00669032|466182101|FG001|Overall Study|No fulfilment of the selection criteria|5|||
129517224|NCT01607073|466182102|FG000|Overall Study|Adverse Event|1|||
129517225|NCT03627494|466182103|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
129517226|NCT03627494|466182104|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517227|NCT03627494|466182105|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
129517228|NCT03627494|466182106|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517229|NCT03627494|466182107|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517230|NCT03627494|466182108|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517231|NCT03627494|466182109|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517232|NCT03627494|466182110|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517233|NCT03627494|466182111|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517234|NCT03627494|466182112|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517235|NCT03627494|466182113|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517236|NCT03627494|466182114|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
129517237|NCT03627494|466182103|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517238|NCT03627494|466182104|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517239|NCT03627494|466182105|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517240|NCT03627494|466182106|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517241|NCT03627494|466182107|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517242|NCT03627494|466182108|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517243|NCT03627494|466182109|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517244|NCT03627494|466182110|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517245|NCT03627494|466182111|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
129517246|NCT03627494|466182112|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517247|NCT03627494|466182113|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517248|NCT03627494|466182114|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
129517249|NCT03627494|466182103|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517250|NCT03627494|466182104|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517251|NCT03627494|466182105|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517252|NCT03627494|466182106|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517253|NCT03627494|466182107|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517254|NCT03627494|466182108|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517255|NCT03627494|466182109|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517256|NCT03627494|466182110|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517257|NCT03627494|466182111|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517258|NCT03627494|466182112|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
129517259|NCT03627494|466182113|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
129517260|NCT03627494|466182114|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
129517261|NCT00446641|466184213|FG000|Overall Study|Withdrawal by Subject|8|||
129517262|NCT00446641|466184214|FG001|Overall Study|Withdrawal by Subject|3|||
129517263|NCT00446641|466184213|FG000|Overall Study|poor compliance|8|||
129517264|NCT00446641|466184214|FG001|Overall Study|poor compliance|6|||
129517265|NCT00446641|466184213|FG000|Overall Study|Lost to Follow-up|1|||
129517266|NCT00446641|466184214|FG001|Overall Study|Lost to Follow-up|1|||
129517267|NCT03565991|466184215|FG000|Overall Study|Other|11|||
129517268|NCT03565991|466184216|FG001|Overall Study|Other|0|||
129517269|NCT03565991|466184215|FG000|Overall Study|Global deterioration of health status|14|||
129517270|NCT03565991|466184216|FG001|Overall Study|Global deterioration of health status|4|||
129517271|NCT03565991|466184215|FG000|Overall Study|Withdrawal by Subject|2|||
129517272|NCT03565991|466184216|FG001|Overall Study|Withdrawal by Subject|6|||
129517273|NCT03565991|466184215|FG000|Overall Study|Progressive disease|121|||
129517274|NCT03565991|466184216|FG001|Overall Study|Progressive disease|29|||
129517275|NCT03565991|466184215|FG000|Overall Study|Death|3|||
129517276|NCT03565991|466184216|FG001|Overall Study|Death|0|||
129517277|NCT03565991|466184215|FG000|Overall Study|Adverse Event|7|||
129517278|NCT03565991|466184216|FG001|Overall Study|Adverse Event|2|||
129517279|NCT00784459|466184217|FG000|Overall Study|Adverse Event|0|||
129517280|NCT00784459|466184218|FG001|Overall Study|Adverse Event|2|||
129517281|NCT00063986|466184219|FG000|Overall Study|Withdrawal by Subject|1|||
129517282|NCT00063986|466184219|FG000|Overall Study|Ineligible|1|||
129517283|NCT00063986|466184219|FG000|Overall Study|Intra-operatively ineligible|4|||
129517284|NCT04839393|466184228|FG000|Overall Study|Adverse Event|0|||
129517285|NCT04839393|466184229|FG001|Overall Study|Adverse Event|0|||
129517286|NCT04839393|466184230|FG002|Overall Study|Adverse Event|2|||
129517287|NCT04839393|466184228|FG000|Overall Study|Withdrawal by participant|0|||
129517288|NCT04839393|466184229|FG001|Overall Study|Withdrawal by participant|0|||
129517289|NCT04839393|466184230|FG002|Overall Study|Withdrawal by participant|1|||
129517290|NCT00633893|466184235|FG000|Overall Study|Death|1|||
129517291|NCT00633893|466184236|FG001|Overall Study|Death|3|||
129517292|NCT00633893|466184237|FG002|Overall Study|Death|9|||
129517293|NCT00633893|466184235|FG000|Overall Study|Adverse Event|65|||
129517294|NCT00633893|466184236|FG001|Overall Study|Adverse Event|58|||
129517295|NCT00633893|466184237|FG002|Overall Study|Adverse Event|126|||
129517296|NCT00633893|466184235|FG000|Overall Study|Withdrawal by Subject|7|||
129517297|NCT00633893|466184236|FG001|Overall Study|Withdrawal by Subject|12|||
129517298|NCT00633893|466184237|FG002|Overall Study|Withdrawal by Subject|6|||
129517299|NCT00633893|466184235|FG000|Overall Study|Lost to Follow-up|2|||
129517300|NCT00633893|466184236|FG001|Overall Study|Lost to Follow-up|4|||
129517301|NCT00633893|466184237|FG002|Overall Study|Lost to Follow-up|8|||
129517302|NCT00633893|466184235|FG000|Overall Study|Poor/non-compliance|5|||
129517303|NCT00633893|466184236|FG001|Overall Study|Poor/non-compliance|12|||
129517304|NCT00633893|466184237|FG002|Overall Study|Poor/non-compliance|3|||
129517305|NCT00633893|466184235|FG000|Overall Study|Pregnancy|2|||
129517306|NCT00633893|466184236|FG001|Overall Study|Pregnancy|1|||
129517307|NCT00633893|466184237|FG002|Overall Study|Pregnancy|1|||
129517308|NCT00633893|466184235|FG000|Overall Study|Not meet/no longer meets criteria|4|||
129517309|NCT00633893|466184236|FG001|Overall Study|Not meet/no longer meets criteria|6|||
129517310|NCT00633893|466184237|FG002|Overall Study|Not meet/no longer meets criteria|4|||
129517311|NCT00633893|466184235|FG000|Overall Study|Other|28|||
129517312|NCT00633893|466184236|FG001|Overall Study|Other|33|||
129517313|NCT00633893|466184237|FG002|Overall Study|Other|31|||
129517314|NCT02741310|466184238|FG000|Overall Study|Sponsor Decision|2|||
129517315|NCT02741310|466184239|FG001|Overall Study|Sponsor Decision|2|||
129517316|NCT05091918|466184240|FG000|Overall Study|Adverse Event|1|||
129517317|NCT05091918|466184240|FG000|Overall Study|Withdrawal by Subject|81|||
129517318|NCT00239356|466184241|FG000|Overall Study|Lack of Efficacy|1|||
129517319|NCT00239356|466184242|FG001|Overall Study|Lack of Efficacy|0|||
129517320|NCT00239356|466184241|FG000|Overall Study|Adverse Event|6|||
129517321|NCT00239356|466184242|FG001|Overall Study|Adverse Event|0|||
129517322|NCT00239356|466184241|FG000|Overall Study|Withdrawal by Subject|15|||
129517323|NCT00239356|466184242|FG001|Overall Study|Withdrawal by Subject|6|||
129517324|NCT00239356|466184241|FG000|Overall Study|Lost to Follow-up|3|||
129517325|NCT00239356|466184242|FG001|Overall Study|Lost to Follow-up|0|||
129517326|NCT00239356|466184241|FG000|Overall Study|poor/non-compliance|2|||
129517327|NCT00239356|466184242|FG001|Overall Study|poor/non-compliance|0|||
129517328|NCT00239356|466184241|FG000|Overall Study|Pregnancy|1|||
129517329|NCT00239356|466184242|FG001|Overall Study|Pregnancy|0|||
129517330|NCT00239356|466184241|FG000|Overall Study|Administrative reason|0|||
129517331|NCT00239356|466184242|FG001|Overall Study|Administrative reason|1|||
129517332|NCT00239356|466184241|FG000|Overall Study|Drug available on market|11|||
129517333|NCT00239356|466184242|FG001|Overall Study|Drug available on market|2|||
129517334|NCT02044822|466184243|FG000|Overall Study|Study Terminated by Sponsor|77|||
129517335|NCT02044822|466184243|FG000|Overall Study|Investigator's Discretion|10|||
129517336|NCT02044822|466184243|FG000|Overall Study|Withdrew Consent|3|||
129517337|NCT02044822|466184243|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
129517338|NCT02044822|466184243|FG000|Overall Study|Lost to Follow-up|1|||
129517339|NCT03417505|466184246|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
129517340|NCT03417505|466184247|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
129517341|NCT01237223|466184254|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
129517342|NCT01237223|466184255|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
129517343|NCT01237223|466184256|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
129517344|NCT01237223|466184257|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
129517345|NCT01237223|466184258|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
129517346|NCT01237223|466184259|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
129517347|NCT01237223|466184254|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
129517348|NCT01237223|466184255|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
129517349|NCT01237223|466184256|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
129517350|NCT01237223|466184257|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
129517351|NCT01237223|466184258|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
129517352|NCT01237223|466184259|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
129517353|NCT01237223|466184254|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
129517354|NCT01237223|466184255|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
129517355|NCT01237223|466184256|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
129517356|NCT01237223|466184257|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
129517357|NCT01237223|466184258|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
129517358|NCT01237223|466184259|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
129517359|NCT01237223|466184254|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
129517360|NCT01237223|466184255|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
129517361|NCT01237223|466184256|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
129517362|NCT01237223|466184257|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
129517363|NCT01237223|466184258|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
129517364|NCT01237223|466184259|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
129517365|NCT01237223|466184254|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
129517366|NCT01237223|466184255|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
129517367|NCT01237223|466184256|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
129517368|NCT01237223|466184257|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
129517369|NCT01237223|466184258|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
129517370|NCT01237223|466184259|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
129517371|NCT01237223|466184254|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
129517372|NCT01237223|466184255|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
129517373|NCT01237223|466184256|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
129517374|NCT01237223|466184257|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
129517375|NCT01237223|466184258|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
129517376|NCT01237223|466184259|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
129517377|NCT01237223|466184254|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
129517378|NCT01237223|466184255|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
129517379|NCT01237223|466184256|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
129517380|NCT01237223|466184257|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
129517381|NCT01237223|466184258|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
129517382|NCT01237223|466184259|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
129517383|NCT01237223|466184254|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
129517384|NCT01237223|466184255|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
129517385|NCT01237223|466184256|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
129517386|NCT01237223|466184257|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
129517387|NCT01237223|466184258|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
129517388|NCT01237223|466184259|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
129517389|NCT01237223|466184254|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
129517390|NCT01237223|466184255|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
129517391|NCT01237223|466184256|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
129517392|NCT01237223|466184257|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
129517393|NCT01237223|466184258|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
129517394|NCT01237223|466184259|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
129517395|NCT01237223|466184254|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
129517396|NCT01237223|466184255|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
129517397|NCT01237223|466184256|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
129517398|NCT01237223|466184257|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
129517399|NCT01237223|466184258|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
129517400|NCT01237223|466184259|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
129517401|NCT00407550|466184264|FG000|Overall Study|Adverse Event|0|||
129517402|NCT00407550|466184265|FG001|Overall Study|Adverse Event|1|||
129517403|NCT00407550|466184264|FG000|Overall Study|Withdrawal by Subject|0|||
129517404|NCT00407550|466184265|FG001|Overall Study|Withdrawal by Subject|2|||
129517405|NCT00407550|466184264|FG000|Overall Study|Death|1|||
129517406|NCT00407550|466184265|FG001|Overall Study|Death|0|||
129517407|NCT00407550|466184264|FG000|Overall Study|Insurance or Other medical condition|2|||
129517408|NCT00407550|466184265|FG001|Overall Study|Insurance or Other medical condition|1|||
129517409|NCT00443846|466184266|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
129517410|NCT00443846|466184267|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
129517411|NCT00443846|466184266|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
129517412|NCT00443846|466184267|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
129517413|NCT00443846|466184266|FG000|Overall Study|Adverse Event|0|||
129517414|NCT00443846|466184267|FG001|Overall Study|Adverse Event|1|||
129517415|NCT00443846|466184266|FG000|Overall Study|Personal reason|8|||
129517416|NCT00443846|466184267|FG001|Overall Study|Personal reason|3|||
129517417|NCT00443846|466184266|FG000|Overall Study|Lost to Follow-up|1|||
129517418|NCT00443846|466184267|FG001|Overall Study|Lost to Follow-up|2|||
129517419|NCT00641706|466184268|FG000|Overall Study|Adverse Event|2|||
129517420|NCT00641706|466184269|FG001|Overall Study|Adverse Event|1|||
129517421|NCT00641706|466184268|FG000|Overall Study|Withdrawal by Subject|6|||
129517422|NCT00641706|466184269|FG001|Overall Study|Withdrawal by Subject|1|||
129517423|NCT00641706|466184268|FG000|Overall Study|Clinical Decline|1|||
129517424|NCT00641706|466184269|FG001|Overall Study|Clinical Decline|0|||
129517425|NCT00641706|466184268|FG000|Overall Study|Lead Investigator Decision|0|||
129517426|NCT00641706|466184269|FG001|Overall Study|Lead Investigator Decision|1|||
129517427|NCT00282568|466184272|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
129517428|NCT00282568|466184272|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
129517429|NCT00282568|466184272|FG000|Extended Treatment Period|Adverse Event|17|||
129517430|NCT00282568|466184272|FG000|Extended Treatment Period|Non-compliance|4|||
129517431|NCT00282568|466184272|FG000|Extended Treatment Period|Physician Decision|1|||
129517432|NCT00282568|466184272|FG000|Extended Treatment Period|Lost to Follow-up|2|||
129517433|NCT01266070|466184273|FG000|Overall Study|Adverse Event|3|||
129517434|NCT01266070|466184273|FG000|Overall Study|Protocol Violation|1|||
129517435|NCT03006926|466184274|FG000|Overall Study|Adverse Event|0|||
129517436|NCT03006926|466184275|FG001|Overall Study|Adverse Event|27|||
129517437|NCT03006926|466184274|FG000|Overall Study|Withdrawal by Subject|0|||
129517438|NCT03006926|466184275|FG001|Overall Study|Withdrawal by Subject|1|||
129517439|NCT03006926|466184274|FG000|Overall Study|Radiological Disease Progression|0|||
129517440|NCT03006926|466184275|FG001|Overall Study|Radiological Disease Progression|52|||
129517441|NCT03006926|466184274|FG000|Overall Study|Clinical Disease Progression|0|||
129517442|NCT03006926|466184275|FG001|Overall Study|Clinical Disease Progression|10|||
129517443|NCT03006926|466184274|FG000|Overall Study|Other|0|||
129517444|NCT03006926|466184275|FG001|Overall Study|Other|8|||
129517445|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
129517446|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
129517447|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
129538582|NCT04576702|466263422|FG001|Overall Study|Death|0|||
129517448|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
129517449|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
129517450|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
129517451|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
129517452|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
129517453|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
129517454|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
129517455|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
129517456|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
129517457|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
129517458|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
129517459|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
129517460|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
129517461|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
129517462|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
129517463|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
129517464|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
129517465|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
129517466|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
129517467|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
129517468|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
129517469|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
129517470|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
129517471|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
129517472|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
129517473|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
129517474|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
129517475|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
129517476|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
129517477|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
129517478|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
129517479|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
129517480|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
129517481|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
129517482|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
129517483|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
129517484|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
129517485|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
129517486|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
129517487|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
129517488|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
129517489|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
129517490|NCT03689972|466184276|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
129517491|NCT03689972|466184277|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
129517492|NCT03689972|466184278|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
129517493|NCT03689972|466184279|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
129517494|NCT03689972|466184280|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
129517495|NCT03689972|466184276|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
129517496|NCT03689972|466184277|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
129517497|NCT03689972|466184278|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
129517498|NCT03689972|466184279|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
129517499|NCT03689972|466184280|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
129517500|NCT03689972|466184276|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
129517501|NCT03689972|466184277|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
129517502|NCT03689972|466184278|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
129517503|NCT03689972|466184279|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
129517504|NCT03689972|466184280|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
129517505|NCT03689972|466184276|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
129517506|NCT03689972|466184277|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
129517507|NCT03689972|466184278|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
129517508|NCT03689972|466184279|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
129517509|NCT03689972|466184280|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
129517510|NCT03689972|466184276|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
129517511|NCT03689972|466184277|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
129517512|NCT03689972|466184278|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
129517513|NCT03689972|466184279|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
129517514|NCT03689972|466184280|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
129517515|NCT03689972|466184276|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
129517516|NCT03689972|466184277|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
129517517|NCT03689972|466184278|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
129517518|NCT03689972|466184279|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
129517519|NCT03689972|466184280|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
129517520|NCT03689972|466184276|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
129517521|NCT03689972|466184277|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
129517522|NCT03689972|466184278|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
129517523|NCT03689972|466184279|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
129517524|NCT03689972|466184280|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
129517525|NCT03689972|466184276|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
129517526|NCT03689972|466184277|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
129517527|NCT03689972|466184278|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
129517528|NCT03689972|466184279|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
129517529|NCT03689972|466184280|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
129517530|NCT03689972|466184276|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
129517531|NCT03689972|466184277|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
129517532|NCT03689972|466184278|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
129517533|NCT03689972|466184279|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
129517534|NCT03689972|466184280|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
129517535|NCT03689972|466184276|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
129517536|NCT03689972|466184277|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
129517537|NCT03689972|466184278|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
129517538|NCT03689972|466184279|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
129517539|NCT03689972|466184280|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
129517540|NCT01838213|466184281|FG000|Overall Study|Ineligible|166|||
129517541|NCT01838213|466184282|FG001|Overall Study|Ineligible|191|||
129517542|NCT00990249|466184289|FG000|Overall Study|Disease Progression|8|||
129517543|NCT00990249|466184289|FG000|Overall Study|Non-Compliance|1|||
129517544|NCT00990249|466184289|FG000|Overall Study|Death|2|||
129517545|NCT00990249|466184289|FG000|Overall Study|Not treated|2|||
129517546|NCT01548417|466184290|FG000|Overall Study|Withdrawal by Subject|0|||
129517547|NCT01548417|466184291|FG001|Overall Study|Withdrawal by Subject|2|||
129517548|NCT03725293|466184294|FG000|Overall Study|Physician Decision|9|||
129517549|NCT03725293|466184295|FG001|Overall Study|Physician Decision|6|||
129517550|NCT03725293|466184294|FG000|Overall Study|alternative vascular access needs|1|||
129517551|NCT03725293|466184295|FG001|Overall Study|alternative vascular access needs|2|||
129517552|NCT03725293|466184294|FG000|Overall Study|venous anatomy screen failures|2|||
129517553|NCT03725293|466184295|FG001|Overall Study|venous anatomy screen failures|1|||
129517554|NCT04583969|466184296|FG000|Overall Study|Death|31|||
129517555|NCT04583969|466184297|FG001|Overall Study|Death|38|||
129517556|NCT04583969|466184296|FG000|Overall Study|Lost to Follow-up|16|||
129517557|NCT04583969|466184297|FG001|Overall Study|Lost to Follow-up|13|||
129517558|NCT04583969|466184296|FG000|Overall Study|Protocol Violation|1|||
129517559|NCT04583969|466184297|FG001|Overall Study|Protocol Violation|0|||
129517560|NCT04583969|466184296|FG000|Overall Study|Withdrawal by Subject|3|||
129517561|NCT04583969|466184297|FG001|Overall Study|Withdrawal by Subject|3|||
129517562|NCT04583969|466184296|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
129517563|NCT04583969|466184297|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
129517564|NCT04583969|466184296|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
129517565|NCT04583969|466184297|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
129517566|NCT04583969|466184296|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
129517567|NCT04583969|466184297|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
129517568|NCT04583969|466184296|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
129517569|NCT04583969|466184297|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
129517570|NCT04583969|466184296|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
129517571|NCT04583969|466184297|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
129517572|NCT04397796|466184298|FG000|Overall Study|Death|3|||
129517573|NCT04397796|466184299|FG001|Overall Study|Death|1|||
129517574|NCT02640755|466184300|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
129517575|NCT02640755|466184301|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
129517576|NCT02640755|466184300|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
129517577|NCT02640755|466184301|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
129517578|NCT02640755|466184300|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
129517579|NCT02640755|466184301|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
129517580|NCT01484561|466184313|FG000|Overall Study|Lack of Efficacy|3|||
129517581|NCT01484561|466184314|FG001|Overall Study|Lack of Efficacy|1|||
129517582|NCT01484561|466184313|FG000|Overall Study|Lost to Follow-up|1|||
129517583|NCT01484561|466184314|FG001|Overall Study|Lost to Follow-up|0|||
129517584|NCT01484561|466184313|FG000|Overall Study|Withdrawal by Subject|3|||
129517585|NCT01484561|466184314|FG001|Overall Study|Withdrawal by Subject|0|||
129517586|NCT01484561|466184313|FG000|Overall Study|Other|1|||
129517587|NCT01484561|466184314|FG001|Overall Study|Other|1|||
129517588|NCT01484561|466184313|FG000|Overall Study|Adverse Event|1|||
129517589|NCT01484561|466184314|FG001|Overall Study|Adverse Event|4|||
129517590|NCT03371251|466184323|FG000|Overall Study|Withdrawal by Subject|1|||
129517591|NCT03371251|466184324|FG001|Overall Study|Withdrawal by Subject|0|||
129517592|NCT03371251|466184325|FG002|Overall Study|Withdrawal by Subject|1|||
129517593|NCT03371251|466184326|FG003|Overall Study|Withdrawal by Subject|0|||
129517594|NCT03371251|466184327|FG004|Overall Study|Withdrawal by Subject|2|||
129517595|NCT03371251|466184328|FG005|Overall Study|Withdrawal by Subject|2|||
129517596|NCT03371251|466184323|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
129517597|NCT03371251|466184324|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
129517598|NCT03371251|466184325|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
129517599|NCT03371251|466184326|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
129517600|NCT03371251|466184327|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
129517601|NCT03371251|466184328|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
129517602|NCT03371251|466184323|FG000|Overall Study|Adverse Event|0|||
129517603|NCT03371251|466184324|FG001|Overall Study|Adverse Event|0|||
129517604|NCT03371251|466184325|FG002|Overall Study|Adverse Event|0|||
129517605|NCT03371251|466184326|FG003|Overall Study|Adverse Event|0|||
129517606|NCT03371251|466184327|FG004|Overall Study|Adverse Event|1|||
129517607|NCT03371251|466184328|FG005|Overall Study|Adverse Event|0|||
129517608|NCT03371251|466184323|FG000|Overall Study|Decision by Sponsor|0|||
129517609|NCT03371251|466184324|FG001|Overall Study|Decision by Sponsor|0|||
129517610|NCT03371251|466184325|FG002|Overall Study|Decision by Sponsor|0|||
129517611|NCT03371251|466184326|FG003|Overall Study|Decision by Sponsor|0|||
129517612|NCT03371251|466184327|FG004|Overall Study|Decision by Sponsor|2|||
129517613|NCT03371251|466184328|FG005|Overall Study|Decision by Sponsor|0|||
129517614|NCT00114218|466184329|FG000|Overall Study|Wrong Cell Type|2|||
129517615|NCT00114218|466184329|FG000|Overall Study|Wrong Primary|1|||
129517616|NCT00114218|466184329|FG000|Overall Study|Never Treated|1|||
129517617|NCT01505114|466184330|FG000|Overall Study|Withdrawal by Subject|5|||
129517618|NCT01505114|466184331|FG001|Overall Study|Withdrawal by Subject|4|||
129517619|NCT01505114|466184332|FG002|Overall Study|Withdrawal by Subject|4|||
129517620|NCT01505114|466184333|FG003|Overall Study|Withdrawal by Subject|7|||
129517621|NCT01505114|466184330|FG000|Overall Study|Death|1|||
129517622|NCT01505114|466184331|FG001|Overall Study|Death|0|||
129517623|NCT01505114|466184332|FG002|Overall Study|Death|0|||
129517624|NCT01505114|466184333|FG003|Overall Study|Death|1|||
129517625|NCT01505114|466184330|FG000|Overall Study|unable to adhere to visit schedule|3|||
129517626|NCT01505114|466184331|FG001|Overall Study|unable to adhere to visit schedule|2|||
129517627|NCT01505114|466184332|FG002|Overall Study|unable to adhere to visit schedule|3|||
129517628|NCT01505114|466184333|FG003|Overall Study|unable to adhere to visit schedule|3|||
129517629|NCT01505114|466184330|FG000|Overall Study|Lost to Follow-up|11|||
129517630|NCT01505114|466184331|FG001|Overall Study|Lost to Follow-up|5|||
129517631|NCT01505114|466184332|FG002|Overall Study|Lost to Follow-up|8|||
129517632|NCT01505114|466184333|FG003|Overall Study|Lost to Follow-up|7|||
129517633|NCT01505114|466184330|FG000|Overall Study|relocated|4|||
129517634|NCT01505114|466184331|FG001|Overall Study|relocated|2|||
129517635|NCT01505114|466184332|FG002|Overall Study|relocated|2|||
129517636|NCT01505114|466184333|FG003|Overall Study|relocated|3|||
129517637|NCT01505114|466184330|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
129517638|NCT01505114|466184331|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
129517639|NCT01505114|466184332|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
129517640|NCT01505114|466184333|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
129517641|NCT01505114|466184330|FG000|Overall Study|staff safety concerns|0|||
129517642|NCT01505114|466184331|FG001|Overall Study|staff safety concerns|0|||
129517643|NCT01505114|466184332|FG002|Overall Study|staff safety concerns|0|||
129517644|NCT01505114|466184333|FG003|Overall Study|staff safety concerns|1|||
129517645|NCT01505114|466184330|FG000|Overall Study|investigator decision|1|||
129517646|NCT01505114|466184331|FG001|Overall Study|investigator decision|0|||
129517647|NCT01505114|466184332|FG002|Overall Study|investigator decision|1|||
129517648|NCT01505114|466184333|FG003|Overall Study|investigator decision|0|||
129517649|NCT03168555|466184334|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
129517650|NCT03168555|466184334|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
129517651|NCT03168555|466184334|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
129517652|NCT03168555|466184334|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
129517653|NCT04445688|466184339|FG000|Washout (One Week)|Adverse Event|2|||
129517654|NCT04445688|466184339|FG000|Washout (One Week)|Withdrawal by Subject|1|||
129517655|NCT02738580|466184345|FG000|Overall Study|Adverse Event|1|||
129517656|NCT02738580|466184346|FG001|Overall Study|Adverse Event|0|||
129517657|NCT02738580|466184345|FG000|Overall Study|Lack of Efficacy|3|||
129517658|NCT02738580|466184346|FG001|Overall Study|Lack of Efficacy|2|||
129517659|NCT02738580|466184345|FG000|Overall Study|Withdrawal by Subject|0|||
129517660|NCT02738580|466184346|FG001|Overall Study|Withdrawal by Subject|1|||
129517661|NCT02738580|466184345|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
129517662|NCT02738580|466184346|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
129517663|NCT02565615|466184347|FG000|Overall Study|Death|0|||
129517664|NCT02565615|466184348|FG001|Overall Study|Death|1|||
129517665|NCT02565615|466184349|FG002|Overall Study|Death|0|||
129517666|NCT02565615|466184350|FG003|Overall Study|Death|0|||
129517667|NCT02565615|466184351|FG004|Overall Study|Death|4|||
129517668|NCT02565615|466184347|FG000|Overall Study|Not willing to participate in study|2|||
129517669|NCT02565615|466184348|FG001|Overall Study|Not willing to participate in study|21|||
129517670|NCT02565615|466184349|FG002|Overall Study|Not willing to participate in study|0|||
129517671|NCT02565615|466184350|FG003|Overall Study|Not willing to participate in study|1|||
129517672|NCT02565615|466184351|FG004|Overall Study|Not willing to participate in study|169|||
129517673|NCT02565615|466184347|FG000|Overall Study|Lost to Follow-up|0|||
129517674|NCT02565615|466184348|FG001|Overall Study|Lost to Follow-up|4|||
129517675|NCT02565615|466184349|FG002|Overall Study|Lost to Follow-up|0|||
129517676|NCT02565615|466184350|FG003|Overall Study|Lost to Follow-up|1|||
129517677|NCT02565615|466184351|FG004|Overall Study|Lost to Follow-up|765|||
129517678|NCT02565615|466184347|FG000|Overall Study|Not meeting eligibility criteria|0|||
129517679|NCT02565615|466184348|FG001|Overall Study|Not meeting eligibility criteria|7|||
129517680|NCT02565615|466184349|FG002|Overall Study|Not meeting eligibility criteria|0|||
129517681|NCT02565615|466184350|FG003|Overall Study|Not meeting eligibility criteria|0|||
129517682|NCT02565615|466184351|FG004|Overall Study|Not meeting eligibility criteria|25|||
129517683|NCT02565615|466184347|FG000|Overall Study|Reason not defined|0|||
129517684|NCT02565615|466184348|FG001|Overall Study|Reason not defined|2|||
129517685|NCT02565615|466184349|FG002|Overall Study|Reason not defined|0|||
129517686|NCT02565615|466184350|FG003|Overall Study|Reason not defined|1|||
129517687|NCT02565615|466184351|FG004|Overall Study|Reason not defined|62|||
129517688|NCT02565615|466184347|FG000|Overall Study|Adverse Event|1|||
129517689|NCT02565615|466184348|FG001|Overall Study|Adverse Event|1|||
129517690|NCT02565615|466184349|FG002|Overall Study|Adverse Event|0|||
129517691|NCT02565615|466184350|FG003|Overall Study|Adverse Event|0|||
129517692|NCT02565615|466184351|FG004|Overall Study|Adverse Event|9|||
129517693|NCT02565615|466184347|FG000|Overall Study|Untreated|0|||
129517694|NCT02565615|466184348|FG001|Overall Study|Untreated|0|||
129517695|NCT02565615|466184349|FG002|Overall Study|Untreated|0|||
129517696|NCT02565615|466184350|FG003|Overall Study|Untreated|0|||
129517697|NCT02565615|466184351|FG004|Overall Study|Untreated|567|||
129517698|NCT01250756|466184355|FG000|Infant Series|Withdrawal by Subject|4|||
129517699|NCT01250756|466184356|FG001|Infant Series|Withdrawal by Subject|5|||
129517700|NCT01250756|466184355|FG000|Infant Series|Randomized, Not Vaccinated|2|||
129517701|NCT01250756|466184356|FG001|Infant Series|Randomized, Not Vaccinated|2|||
129517702|NCT01250756|466184355|FG000|Infant Series|Other|22|||
129517703|NCT01250756|466184356|FG001|Infant Series|Other|0|||
129517704|NCT01250756|466184355|FG000|After Infant Series|Adverse Event|5|||
129517705|NCT01250756|466184356|FG001|After Infant Series|Adverse Event|2|||
129517706|NCT01250756|466184355|FG000|After Infant Series|Withdrawal by Subject|4|||
129517707|NCT01250756|466184356|FG001|After Infant Series|Withdrawal by Subject|1|||
129517708|NCT01250756|466184355|FG000|After Infant Series|Other|2|||
129517709|NCT01250756|466184356|FG001|After Infant Series|Other|1|||
129517710|NCT01250756|466184355|FG000|Toddler Dose|Adverse Event|0|||
129517711|NCT01250756|466184356|FG001|Toddler Dose|Adverse Event|1|||
129517712|NCT01250756|466184355|FG000|After Toddler Dose|Adverse Event|0|||
129517713|NCT01250756|466184356|FG001|After Toddler Dose|Adverse Event|1|||
129517714|NCT01815580|466184360|FG000|Overall Study|Lost to Follow-up|4|||
129517715|NCT01815580|466184361|FG001|Overall Study|Lost to Follow-up|7|||
129517716|NCT01815580|466184360|FG000|Overall Study|Withdrawal by Subject|3|||
129517717|NCT01815580|466184361|FG001|Overall Study|Withdrawal by Subject|4|||
129517718|NCT01815580|466184360|FG000|Overall Study|Excluded from analysis|5|||
129517719|NCT01815580|466184361|FG001|Overall Study|Excluded from analysis|4|||
129517720|NCT02228564|466184362|FG000|Overall Study|Withdrawal by Subject|10|||
129517721|NCT02228564|466184362|FG000|Overall Study|Death|11|||
129517722|NCT02228564|466184362|FG000|Overall Study|Physician Decision|5|||
129517723|NCT02228564|466184362|FG000|Overall Study|Lost to Follow-up|17|||
129517724|NCT02228564|466184362|FG000|Overall Study|Other|6|||
129517725|NCT02142504|466184365|FG000|Overall Study|Protocol Violation|2|||
129517726|NCT02142504|466184366|FG001|Overall Study|Protocol Violation|1|||
129517727|NCT02142504|466184367|FG002|Overall Study|Protocol Violation|2|||
129517728|NCT02142504|466184365|FG000|Overall Study|Adverse Event|2|||
129517729|NCT02142504|466184366|FG001|Overall Study|Adverse Event|3|||
129517730|NCT02142504|466184367|FG002|Overall Study|Adverse Event|4|||
129517731|NCT02142504|466184365|FG000|Overall Study|Lost to Follow-up|12|||
129517732|NCT02142504|466184366|FG001|Overall Study|Lost to Follow-up|19|||
129517733|NCT02142504|466184367|FG002|Overall Study|Lost to Follow-up|17|||
129517734|NCT02142504|466184365|FG000|Overall Study|Withdrawal by Subject|7|||
129517735|NCT02142504|466184366|FG001|Overall Study|Withdrawal by Subject|9|||
129517736|NCT02142504|466184367|FG002|Overall Study|Withdrawal by Subject|11|||
129517737|NCT02142504|466184365|FG000|Overall Study|Pregnancy|4|||
129517738|NCT02142504|466184366|FG001|Overall Study|Pregnancy|4|||
129517739|NCT02142504|466184367|FG002|Overall Study|Pregnancy|2|||
129517740|NCT02142504|466184365|FG000|Overall Study|Physician Decision|0|||
129517741|NCT02142504|466184366|FG001|Overall Study|Physician Decision|1|||
129517742|NCT02142504|466184367|FG002|Overall Study|Physician Decision|3|||
129517743|NCT02142504|466184365|FG000|Overall Study|Reason Not Specified|4|||
129517744|NCT02142504|466184366|FG001|Overall Study|Reason Not Specified|5|||
129517745|NCT02142504|466184367|FG002|Overall Study|Reason Not Specified|4|||
129517746|NCT01998399|466184368|FG000|Overall Study|Lost to Follow-up|1|||
129517747|NCT01998399|466184369|FG001|Overall Study|Lost to Follow-up|3|||
129517748|NCT01998399|466184368|FG000|Overall Study|Death|4|||
129517749|NCT01998399|466184369|FG001|Overall Study|Death|2|||
129517750|NCT01998399|466184368|FG000|Overall Study|Study stopped before dosing completed|3|||
129517751|NCT01998399|466184369|FG001|Overall Study|Study stopped before dosing completed|3|||
129517752|NCT01998399|466184368|FG000|Overall Study|Withdrawal by Subject|0|||
129517753|NCT01998399|466184369|FG001|Overall Study|Withdrawal by Subject|1|||
129517754|NCT04114539|466184373|FG000|Overall Study|Adverse Event|14|||
129517755|NCT04114539|466184373|FG000|Overall Study|Lost to Follow-up|2|||
129517756|NCT04114539|466184373|FG000|Overall Study|Non-compliance with Protocol|2|||
129517757|NCT04114539|466184373|FG000|Overall Study|Non-compliance with Study Drug|1|||
129517758|NCT04114539|466184373|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
129517759|NCT04114539|466184373|FG000|Overall Study|Withdrew consent|10|||
129517760|NCT04114539|466184373|FG000|Overall Study|Others not specified|5|||
129517761|NCT04114539|466184373|FG000|Overall Study|Investigator Decision|2|||
129517762|NCT00376246|466184374|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
129517763|NCT00376246|466184375|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
129517764|NCT00376246|466184374|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
129517765|NCT00376246|466184375|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
129517766|NCT00376246|466184374|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
129517767|NCT00376246|466184375|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129517768|NCT01072448|466184384|FG000|Overall Study|Adverse Event|9|||
129517769|NCT01072448|466184385|FG001|Overall Study|Adverse Event|10|||
129517770|NCT01072448|466184384|FG000|Overall Study|Subject withdrew consent|4|||
129517771|NCT01072448|466184385|FG001|Overall Study|Subject withdrew consent|9|||
129517772|NCT01072448|466184384|FG000|Overall Study|Protocol deviation|3|||
129517773|NCT01072448|466184385|FG001|Overall Study|Protocol deviation|4|||
129517774|NCT01072448|466184384|FG000|Overall Study|Abnormal test procedure result(s)|1|||
129517775|NCT01072448|466184385|FG001|Overall Study|Abnormal test procedure result(s)|0|||
129517776|NCT01072448|466184384|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129517777|NCT01072448|466184385|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
129517778|NCT01072448|466184384|FG000|Overall Study|Lost to Follow-up|1|||
129517779|NCT01072448|466184385|FG001|Overall Study|Lost to Follow-up|1|||
129517780|NCT01072448|466184384|FG000|Overall Study|Abnormal laboratory value(s)|0|||
129517781|NCT01072448|466184385|FG001|Overall Study|Abnormal laboratory value(s)|1|||
129517782|NCT01072448|466184384|FG000|Overall Study|Death|0|||
129517783|NCT01072448|466184385|FG001|Overall Study|Death|2|||
129517784|NCT01400139|466184386|FG000|HYD Core Study|Adverse Event|210|||
129517785|NCT01400139|466184386|FG000|HYD Core Study|Lack of Efficacy|59|||
129517786|NCT01400139|466184386|FG000|HYD Core Study|Withdrawal by Subject|114|||
129517787|NCT01400139|466184386|FG000|HYD Core Study|Lost to Follow-up|39|||
129517788|NCT01400139|466184386|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
129517789|NCT01400139|466184386|FG000|HYD Core Study|Administrative|56|||
129517790|NCT01400139|466184386|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
129517791|NCT01400139|466184386|FG000|HYD Extension Period|Adverse Event|8|||
129517792|NCT01400139|466184386|FG000|HYD Extension Period|Withdrawal by Subject|5|||
129517793|NCT01400139|466184386|FG000|HYD Extension Period|Administrative|10|||
129517794|NCT00249795|466184387|FG000|Overall Study|Not treated|16|||
129517795|NCT00249795|466184388|FG001|Overall Study|Not treated|14|||
129517796|NCT00249795|466184387|FG000|Overall Study|Symptomatic hypotension|127|||
129517797|NCT00249795|466184388|FG001|Overall Study|Symptomatic hypotension|64|||
129517798|NCT00249795|466184387|FG000|Overall Study|Other Serious Adverse Event|84|||
129517799|NCT00249795|466184388|FG001|Overall Study|Other Serious Adverse Event|93|||
129517800|NCT00249795|466184387|FG000|Overall Study|Qualifying condition not present|26|||
129517801|NCT00249795|466184388|FG001|Overall Study|Qualifying condition not present|29|||
129517802|NCT00249795|466184387|FG000|Overall Study|Withdrawal by Subject|678|||
129517803|NCT00249795|466184388|FG001|Overall Study|Withdrawal by Subject|742|||
129517804|NCT00249795|466184387|FG000|Overall Study|Thromboembolic / outcome event|39|||
129517805|NCT00249795|466184388|FG001|Overall Study|Thromboembolic / outcome event|45|||
129517806|NCT00249795|466184387|FG000|Overall Study|Oral anticoagulant required|2|||
129517807|NCT00249795|466184388|FG001|Overall Study|Oral anticoagulant required|0|||
129517808|NCT00249795|466184387|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
129517809|NCT00249795|466184388|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
129517810|NCT00249795|466184387|FG000|Overall Study|Non-compliance|71|||
129517811|NCT00249795|466184388|FG001|Overall Study|Non-compliance|69|||
129517812|NCT00249795|466184387|FG000|Overall Study|Study drug intolerance|3|||
129517813|NCT00249795|466184388|FG001|Overall Study|Study drug intolerance|3|||
129517814|NCT00249795|466184387|FG000|Overall Study|Other adverse events (non-serious)|188|||
129517815|NCT00249795|466184388|FG001|Overall Study|Other adverse events (non-serious)|159|||
129517816|NCT00249795|466184387|FG000|Overall Study|Physician withdrew consent|71|||
129517817|NCT00249795|466184388|FG001|Overall Study|Physician withdrew consent|63|||
129517818|NCT00249795|466184387|FG000|Overall Study|Surgery / procedure|4|||
129517819|NCT00249795|466184388|FG001|Overall Study|Surgery / procedure|5|||
129517820|NCT00249795|466184387|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
129517821|NCT00249795|466184388|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
129517822|NCT00249795|466184387|FG000|Overall Study|Lightheadedness / dizziness|15|||
129517823|NCT00249795|466184388|FG001|Overall Study|Lightheadedness / dizziness|11|||
129517824|NCT00249795|466184387|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
129517825|NCT00249795|466184388|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
129517826|NCT00249795|466184387|FG000|Overall Study|Other contraindicated medication|1|||
129517827|NCT00249795|466184388|FG001|Overall Study|Other contraindicated medication|1|||
129517828|NCT00249795|466184387|FG000|Overall Study|Event related to cardiac condition|17|||
129517829|NCT00249795|466184388|FG001|Overall Study|Event related to cardiac condition|16|||
129517830|NCT00249795|466184387|FG000|Overall Study|Patient not wish to continue after May08|4|||
129517831|NCT00249795|466184388|FG001|Overall Study|Patient not wish to continue after May08|6|||
129517832|NCT00249795|466184387|FG000|Overall Study|Site not agree to continue after May08|1|||
129517833|NCT00249795|466184388|FG001|Overall Study|Site not agree to continue after May08|1|||
129517834|NCT00249795|466184387|FG000|Overall Study|Lost to Follow-up|0|||
129517835|NCT00249795|466184388|FG001|Overall Study|Lost to Follow-up|2|||
129517836|NCT00249795|466184387|FG000|Overall Study|Missing|0|||
129517837|NCT00249795|466184388|FG001|Overall Study|Missing|1|||
129517838|NCT02460978|466184390|FG000|Overall Study|Adverse Event|17|||
129517839|NCT02460978|466184391|FG001|Overall Study|Adverse Event|11|||
129517840|NCT02460978|466184392|FG002|Overall Study|Adverse Event|11|||
129517841|NCT02460978|466184390|FG000|Overall Study|Withdrawal by Subject|5|||
129517842|NCT02460978|466184391|FG001|Overall Study|Withdrawal by Subject|5|||
129517843|NCT02460978|466184392|FG002|Overall Study|Withdrawal by Subject|14|||
129517844|NCT02460978|466184390|FG000|Overall Study|Lost to Follow-up|2|||
129517845|NCT02460978|466184391|FG001|Overall Study|Lost to Follow-up|3|||
129517846|NCT02460978|466184392|FG002|Overall Study|Lost to Follow-up|1|||
129517847|NCT02460978|466184390|FG000|Overall Study|Protocol Violation|1|||
129517848|NCT02460978|466184391|FG001|Overall Study|Protocol Violation|1|||
129517849|NCT02460978|466184392|FG002|Overall Study|Protocol Violation|1|||
129517850|NCT02460978|466184390|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
129517851|NCT02460978|466184391|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
129517852|NCT02460978|466184392|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
129517853|NCT02460978|466184390|FG000|Overall Study|Pregnancy|0|||
129517854|NCT02460978|466184391|FG001|Overall Study|Pregnancy|0|||
129517855|NCT02460978|466184392|FG002|Overall Study|Pregnancy|2|||
129517856|NCT03549429|466184395|FG000|Overall Study|Protocol Violation|5|||
129517857|NCT03549429|466184396|FG001|Overall Study|Protocol Violation|3|||
129517858|NCT00588523|466184400|FG000|Overall Study|Not treated|3|||
129517859|NCT03032510|466184401|FG000|Overall Study|Adverse Event|5|||
129517860|NCT03032510|466184402|FG001|Overall Study|Adverse Event|2|||
129517861|NCT03032510|466184401|FG000|Overall Study|Lost to Follow-up|8|||
129517862|NCT03032510|466184402|FG001|Overall Study|Lost to Follow-up|7|||
129517863|NCT03032510|466184401|FG000|Overall Study|Withdrawal by Subject|8|||
129517864|NCT03032510|466184402|FG001|Overall Study|Withdrawal by Subject|7|||
129517865|NCT03032510|466184401|FG000|Overall Study|Subject noncompliance|4|||
129517866|NCT03032510|466184402|FG001|Overall Study|Subject noncompliance|2|||
129517867|NCT03032510|466184401|FG000|Overall Study|Physician Decision|2|||
129517868|NCT03032510|466184402|FG001|Overall Study|Physician Decision|0|||
129517869|NCT03906136|466186481|FG000|Overall Study|Adverse Event|1|||
129517870|NCT03906136|466186482|FG001|Overall Study|Adverse Event|0|||
129517871|NCT03906136|466186481|FG000|Overall Study|Lost to Follow-up|7|||
129517872|NCT03906136|466186482|FG001|Overall Study|Lost to Follow-up|4|||
129517873|NCT03906136|466186481|FG000|Overall Study|Physician Decision|1|||
129517874|NCT03906136|466186482|FG001|Overall Study|Physician Decision|0|||
129517875|NCT03906136|466186481|FG000|Overall Study|Withdrawal by Subject|3|||
129517876|NCT03906136|466186482|FG001|Overall Study|Withdrawal by Subject|7|||
129517877|NCT02371980|466186486|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
129517878|NCT02371980|466186487|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
129517879|NCT02371980|466186488|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
129517880|NCT02371980|466186489|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
129517881|NCT02371980|466186490|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
129517882|NCT02371980|466186486|FG000|Open-label Period|Significant Protocol Deviation|19|||
129517883|NCT02371980|466186487|FG001|Open-label Period|Significant Protocol Deviation|0|||
129517884|NCT02371980|466186488|FG002|Open-label Period|Significant Protocol Deviation|0|||
129517885|NCT02371980|466186489|FG003|Open-label Period|Significant Protocol Deviation|0|||
129517886|NCT02371980|466186490|FG004|Open-label Period|Significant Protocol Deviation|0|||
129517887|NCT02371980|466186486|FG000|Open-label Period|Noncompliance with Study Drug|10|||
129517888|NCT02371980|466186487|FG001|Open-label Period|Noncompliance with Study Drug|0|||
129517889|NCT02371980|466186488|FG002|Open-label Period|Noncompliance with Study Drug|0|||
129517890|NCT02371980|466186489|FG003|Open-label Period|Noncompliance with Study Drug|0|||
129517891|NCT02371980|466186490|FG004|Open-label Period|Noncompliance with Study Drug|0|||
129517892|NCT02371980|466186486|FG000|Open-label Period|Lost to Follow-up|55|||
129517893|NCT02371980|466186487|FG001|Open-label Period|Lost to Follow-up|0|||
129517894|NCT02371980|466186488|FG002|Open-label Period|Lost to Follow-up|0|||
129517895|NCT02371980|466186489|FG003|Open-label Period|Lost to Follow-up|0|||
129517896|NCT02371980|466186490|FG004|Open-label Period|Lost to Follow-up|0|||
129517897|NCT02371980|466186486|FG000|Open-label Period|Voluntary Withdrawal|91|||
129517898|NCT02371980|466186487|FG001|Open-label Period|Voluntary Withdrawal|0|||
129517899|NCT02371980|466186488|FG002|Open-label Period|Voluntary Withdrawal|0|||
129517900|NCT02371980|466186489|FG003|Open-label Period|Voluntary Withdrawal|0|||
129517901|NCT02371980|466186490|FG004|Open-label Period|Voluntary Withdrawal|0|||
129517902|NCT02371980|466186486|FG000|Open-label Period|Pregnancy|1|||
129517903|NCT02371980|466186487|FG001|Open-label Period|Pregnancy|0|||
129517904|NCT02371980|466186488|FG002|Open-label Period|Pregnancy|0|||
129517905|NCT02371980|466186489|FG003|Open-label Period|Pregnancy|0|||
129517906|NCT02371980|466186490|FG004|Open-label Period|Pregnancy|0|||
129517907|NCT02371980|466186486|FG000|Open-label Period|Lack of Efficacy|116|||
129517908|NCT02371980|466186487|FG001|Open-label Period|Lack of Efficacy|0|||
129517909|NCT02371980|466186488|FG002|Open-label Period|Lack of Efficacy|0|||
129517910|NCT02371980|466186489|FG003|Open-label Period|Lack of Efficacy|0|||
129517911|NCT02371980|466186490|FG004|Open-label Period|Lack of Efficacy|0|||
129517912|NCT02371980|466186486|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
129517913|NCT02371980|466186487|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
129517914|NCT02371980|466186488|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
129517915|NCT02371980|466186489|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
129517916|NCT02371980|466186490|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
129517917|NCT02371980|466186486|FG000|Open-label Period|Reason not Specified|9|||
129517918|NCT02371980|466186487|FG001|Open-label Period|Reason not Specified|0|||
129517919|NCT02371980|466186488|FG002|Open-label Period|Reason not Specified|0|||
129517920|NCT02371980|466186489|FG003|Open-label Period|Reason not Specified|0|||
129517921|NCT02371980|466186490|FG004|Open-label Period|Reason not Specified|0|||
129517922|NCT02371980|466186486|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
129517923|NCT02371980|466186487|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
129517924|NCT02371980|466186488|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
129517925|NCT02371980|466186489|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
129517926|NCT02371980|466186490|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
129517927|NCT02371980|466186486|FG000|Double-blind Period|Significant Protocol Deviation|0|||
129517928|NCT02371980|466186487|FG001|Double-blind Period|Significant Protocol Deviation|2|||
129517929|NCT02371980|466186488|FG002|Double-blind Period|Significant Protocol Deviation|7|||
129517930|NCT02371980|466186489|FG003|Double-blind Period|Significant Protocol Deviation|3|||
129517931|NCT02371980|466186490|FG004|Double-blind Period|Significant Protocol Deviation|3|||
129517932|NCT02371980|466186486|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
129517933|NCT02371980|466186487|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
129517934|NCT02371980|466186488|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
129517935|NCT02371980|466186489|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
129517936|NCT02371980|466186490|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
129517937|NCT02371980|466186486|FG000|Double-blind Period|Lost to Follow-up|0|||
129517938|NCT02371980|466186487|FG001|Double-blind Period|Lost to Follow-up|8|||
129517939|NCT02371980|466186488|FG002|Double-blind Period|Lost to Follow-up|8|||
129517940|NCT02371980|466186489|FG003|Double-blind Period|Lost to Follow-up|6|||
129517941|NCT02371980|466186490|FG004|Double-blind Period|Lost to Follow-up|5|||
129517942|NCT02371980|466186486|FG000|Double-blind Period|Voluntary Withdrawal|0|||
129517943|NCT02371980|466186487|FG001|Double-blind Period|Voluntary Withdrawal|12|||
129517944|NCT02371980|466186488|FG002|Double-blind Period|Voluntary Withdrawal|8|||
129517945|NCT02371980|466186489|FG003|Double-blind Period|Voluntary Withdrawal|9|||
129517946|NCT02371980|466186490|FG004|Double-blind Period|Voluntary Withdrawal|11|||
129517947|NCT02371980|466186486|FG000|Double-blind Period|Relapse|0|||
129517948|NCT02371980|466186487|FG001|Double-blind Period|Relapse|50|||
129517949|NCT02371980|466186488|FG002|Double-blind Period|Relapse|25|||
129517950|NCT02371980|466186489|FG003|Double-blind Period|Relapse|25|||
129517951|NCT02371980|466186490|FG004|Double-blind Period|Relapse|26|||
129517952|NCT02371980|466186486|FG000|Double-blind Period|Reason not Specified|0|||
129517953|NCT02371980|466186487|FG001|Double-blind Period|Reason not Specified|3|||
129517954|NCT02371980|466186488|FG002|Double-blind Period|Reason not Specified|3|||
129517955|NCT02371980|466186489|FG003|Double-blind Period|Reason not Specified|2|||
129517956|NCT02371980|466186490|FG004|Double-blind Period|Reason not Specified|1|||
129517957|NCT02371980|466186486|FG000|Double-blind Period|Missing|0|||
129517958|NCT02371980|466186487|FG001|Double-blind Period|Missing|1|||
129517959|NCT02371980|466186488|FG002|Double-blind Period|Missing|0|||
129517960|NCT02371980|466186489|FG003|Double-blind Period|Missing|0|||
129517961|NCT02371980|466186490|FG004|Double-blind Period|Missing|0|||
129517962|NCT01826448|466186492|FG000|Overall Study|Adverse Event|1|||
129517963|NCT01826448|466186493|FG001|Overall Study|Adverse Event|3|||
129517964|NCT01826448|466186492|FG000|Overall Study|Disease progression|2|||
129517965|NCT01826448|466186493|FG001|Overall Study|Disease progression|4|||
129517966|NCT01826448|466186492|FG000|Overall Study|Withdrawal by Subject|1|||
129517967|NCT01826448|466186493|FG001|Overall Study|Withdrawal by Subject|0|||
129517968|NCT01826448|466186492|FG000|Overall Study|Physician Decision|0|||
129517969|NCT01826448|466186493|FG001|Overall Study|Physician Decision|1|||
129517970|NCT01826448|466186492|FG000|Overall Study|2 active cancers|0|||
129517971|NCT01826448|466186493|FG001|Overall Study|2 active cancers|1|||
129517972|NCT00790218|466186494|FG000|Overall Study|Death|1|||
129517973|NCT00790218|466186495|FG001|Overall Study|Death|0|||
129517974|NCT00790218|466186496|FG002|Overall Study|Death|0|||
129517975|NCT03424044|466186498|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517976|NCT03424044|466186499|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517977|NCT03424044|466186500|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
129517978|NCT03424044|466186501|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517979|NCT03424044|466186502|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517980|NCT03424044|466186503|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517981|NCT03424044|466186504|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517982|NCT03424044|466186505|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517983|NCT03424044|466186506|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
129517984|NCT03424044|466186498|FG000|First Intervention (76 Hours)|Adverse Event|0|||
129517985|NCT03424044|466186499|FG001|First Intervention (76 Hours)|Adverse Event|0|||
129517986|NCT03424044|466186500|FG002|First Intervention (76 Hours)|Adverse Event|0|||
129517987|NCT03424044|466186501|FG003|First Intervention (76 Hours)|Adverse Event|0|||
129517988|NCT03424044|466186502|FG004|First Intervention (76 Hours)|Adverse Event|1|||
129517989|NCT03424044|466186503|FG005|First Intervention (76 Hours)|Adverse Event|0|||
129517990|NCT03424044|466186504|FG006|First Intervention (76 Hours)|Adverse Event|0|||
129517991|NCT03424044|466186505|FG007|First Intervention (76 Hours)|Adverse Event|0|||
129517992|NCT03424044|466186506|FG008|First Intervention (76 Hours)|Adverse Event|0|||
129517993|NCT03424044|466186498|FG000|First Intervention (76 Hours)|device issues|0|||
129517994|NCT03424044|466186499|FG001|First Intervention (76 Hours)|device issues|0|||
129517995|NCT03424044|466186500|FG002|First Intervention (76 Hours)|device issues|0|||
129517996|NCT03424044|466186501|FG003|First Intervention (76 Hours)|device issues|0|||
129517997|NCT03424044|466186502|FG004|First Intervention (76 Hours)|device issues|0|||
129517998|NCT03424044|466186503|FG005|First Intervention (76 Hours)|device issues|0|||
129517999|NCT03424044|466186504|FG006|First Intervention (76 Hours)|device issues|1|||
129518000|NCT03424044|466186505|FG007|First Intervention (76 Hours)|device issues|1|||
129518001|NCT03424044|466186506|FG008|First Intervention (76 Hours)|device issues|1|||
129518002|NCT03424044|466186498|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
129518003|NCT03424044|466186499|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
129518004|NCT03424044|466186500|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
129518005|NCT03424044|466186501|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
129518006|NCT03424044|466186502|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
129518007|NCT03424044|466186503|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
129518008|NCT03424044|466186504|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
129518009|NCT03424044|466186505|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
129518010|NCT03424044|466186506|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
129518011|NCT03424044|466186498|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518012|NCT03424044|466186499|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518013|NCT03424044|466186500|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518014|NCT03424044|466186501|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
129518015|NCT03424044|466186502|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518016|NCT03424044|466186503|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518017|NCT03424044|466186504|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518018|NCT03424044|466186505|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518019|NCT03424044|466186506|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
129518020|NCT02971007|466186509|FG000|Overall Study|Adverse Event|1|||
129518021|NCT02971007|466186510|FG001|Overall Study|Adverse Event|0|||
129518022|NCT02971007|466186511|FG002|Overall Study|Adverse Event|0|||
129518023|NCT02971007|466186509|FG000|Overall Study|Lost to Follow-up|0|||
129518024|NCT02971007|466186510|FG001|Overall Study|Lost to Follow-up|1|||
129518025|NCT02971007|466186511|FG002|Overall Study|Lost to Follow-up|1|||
129518026|NCT02971007|466186509|FG000|Overall Study|Withdrawal by Subject|0|||
129518027|NCT02971007|466186510|FG001|Overall Study|Withdrawal by Subject|1|||
129518028|NCT02971007|466186511|FG002|Overall Study|Withdrawal by Subject|0|||
129518029|NCT02971007|466186509|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
129518030|NCT02971007|466186510|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
129518031|NCT02971007|466186511|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
129518032|NCT02971007|466186509|FG000|Overall Study|Patient discontinued study drug|0|||
129518033|NCT02971007|466186510|FG001|Overall Study|Patient discontinued study drug|1|||
129518034|NCT02971007|466186511|FG002|Overall Study|Patient discontinued study drug|0|||
129518035|NCT00402285|466186514|FG000|Overall Study|insufficient RNA quality|7|||
129518036|NCT00402285|466186515|FG001|Overall Study|insufficient RNA quality|6|||
129518037|NCT00402285|466186516|FG002|Overall Study|insufficient RNA quality|2|||
129518038|NCT02431702|466186519|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
129518039|NCT02431702|466186520|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
129518040|NCT02431702|466186521|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
129518041|NCT02431702|466186522|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
129518042|NCT02431702|466186523|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
129518043|NCT02431702|466186524|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
129518044|NCT02431702|466186525|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
129518045|NCT02431702|466186519|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
129518046|NCT02431702|466186520|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
129518047|NCT02431702|466186521|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
129518048|NCT02431702|466186522|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
129518049|NCT02431702|466186523|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
129518050|NCT02431702|466186524|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
129518051|NCT02431702|466186525|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
129518052|NCT02431702|466186519|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
129518053|NCT02431702|466186520|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
129518054|NCT02431702|466186521|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
129518055|NCT02431702|466186522|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
129518056|NCT02431702|466186523|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
129518057|NCT02431702|466186524|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
129518058|NCT02431702|466186525|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
129518059|NCT02431702|466186519|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
129518060|NCT02431702|466186520|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
129518061|NCT02431702|466186521|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
129518062|NCT02431702|466186522|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
129518063|NCT02431702|466186523|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
129518064|NCT02431702|466186524|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
129518065|NCT02431702|466186525|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
129518066|NCT02431702|466186519|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
129518067|NCT02431702|466186520|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
129518068|NCT02431702|466186521|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
129518069|NCT02431702|466186522|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
129518070|NCT02431702|466186523|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
129518071|NCT02431702|466186524|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
129518072|NCT02431702|466186525|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
129518073|NCT02431702|466186519|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
129518074|NCT02431702|466186520|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
129518075|NCT02431702|466186521|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
129518076|NCT02431702|466186522|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
129518077|NCT02431702|466186523|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
129518078|NCT02431702|466186524|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
129518079|NCT02431702|466186525|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
129518080|NCT02431702|466186519|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
129518081|NCT02431702|466186520|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
129518082|NCT02431702|466186521|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
129518083|NCT02431702|466186522|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
129518084|NCT02431702|466186523|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
129518085|NCT02431702|466186524|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
129518086|NCT02431702|466186525|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
129518087|NCT02431702|466186519|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
129518088|NCT02431702|466186520|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
129518089|NCT02431702|466186521|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
129518090|NCT02431702|466186522|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
129518091|NCT02431702|466186523|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
129518092|NCT02431702|466186524|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
129518093|NCT02431702|466186525|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
129518094|NCT02431702|466186519|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
129538583|NCT04576702|466263423|FG002|Overall Study|Death|0|||
129518095|NCT02431702|466186520|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
129518096|NCT02431702|466186521|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
129518097|NCT02431702|466186522|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
129518098|NCT02431702|466186523|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
129518099|NCT02431702|466186524|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
129518100|NCT02431702|466186525|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
129518101|NCT02431702|466186519|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
129518102|NCT02431702|466186520|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
129518103|NCT02431702|466186521|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
129518104|NCT02431702|466186522|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
129518105|NCT02431702|466186523|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
129518106|NCT02431702|466186524|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
129518107|NCT02431702|466186525|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
129518108|NCT02431702|466186519|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
129518109|NCT02431702|466186520|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
129518110|NCT02431702|466186521|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
129518111|NCT02431702|466186522|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
129518112|NCT02431702|466186523|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
129518113|NCT02431702|466186524|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
129518114|NCT02431702|466186525|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
129518115|NCT02431702|466186519|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129518116|NCT02431702|466186520|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129518117|NCT02431702|466186521|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129518118|NCT02431702|466186522|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
129518119|NCT02431702|466186523|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
129518120|NCT02431702|466186524|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129518121|NCT02431702|466186525|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
129518122|NCT02431702|466186519|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
129518123|NCT02431702|466186520|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
129518124|NCT02431702|466186521|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
129518125|NCT02431702|466186522|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
129518126|NCT02431702|466186523|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
129518127|NCT02431702|466186524|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
129518128|NCT02431702|466186525|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
129518129|NCT02431702|466186519|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
129518130|NCT02431702|466186520|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
129518131|NCT02431702|466186521|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
129518132|NCT02431702|466186522|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
129518133|NCT02431702|466186523|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
129518134|NCT02431702|466186524|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
129518135|NCT02431702|466186525|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
129518136|NCT02431702|466186519|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
129518137|NCT02431702|466186520|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
129518138|NCT02431702|466186521|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
129518139|NCT02431702|466186522|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
129518140|NCT02431702|466186523|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
129518141|NCT02431702|466186524|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
129518142|NCT02431702|466186525|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
129518143|NCT02009930|466186526|FG000|Overall Study|withdrawn|5|||
129518144|NCT02959970|466186532|FG000|Overall Study|Adverse Event|1|||
129518145|NCT02959970|466186533|FG001|Overall Study|Adverse Event|0|||
129518146|NCT02959970|466186532|FG000|Overall Study|Withdrawal by Subject|0|||
129518147|NCT02959970|466186533|FG001|Overall Study|Withdrawal by Subject|2|||
129518148|NCT02959970|466186532|FG000|Overall Study|Lost to Follow-up|1|||
129518149|NCT02959970|466186533|FG001|Overall Study|Lost to Follow-up|5|||
129518150|NCT00693420|466186536|FG000|Overall Study|Adverse Event|4|||
129518151|NCT00693420|466186537|FG001|Overall Study|Adverse Event|4|||
129518152|NCT00693420|466186536|FG000|Overall Study|Lost to Follow-up|0|||
129518153|NCT00693420|466186537|FG001|Overall Study|Lost to Follow-up|3|||
129518154|NCT00693420|466186536|FG000|Overall Study|Withdrawal by Subject|1|||
129518155|NCT00693420|466186537|FG001|Overall Study|Withdrawal by Subject|0|||
129518156|NCT00693420|466186536|FG000|Overall Study|Protocol Violation|0|||
129518157|NCT00693420|466186537|FG001|Overall Study|Protocol Violation|2|||
129518158|NCT00693420|466186536|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
129518159|NCT00693420|466186537|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
129518160|NCT00693420|466186536|FG000|Overall Study|Personal Reasons|1|||
129518161|NCT00693420|466186537|FG001|Overall Study|Personal Reasons|4|||
129518162|NCT03250624|466186543|FG000|Overall Study|Lack of Efficacy|1|||
129518163|NCT03250624|466186544|FG001|Overall Study|Lack of Efficacy|4|||
129518164|NCT03250624|466186543|FG000|Overall Study|Adverse Event|0|||
129518165|NCT03250624|466186544|FG001|Overall Study|Adverse Event|1|||
129518166|NCT03250624|466186543|FG000|Overall Study|Other|1|||
129518167|NCT03250624|466186544|FG001|Overall Study|Other|2|||
129518168|NCT00509028|466186548|FG000|Overall Study|Adverse Event|2|||
129518169|NCT00509028|466186549|FG001|Overall Study|Adverse Event|0|||
129518170|NCT00509028|466186548|FG000|Overall Study|Withdrawal by Subject|4|||
129518171|NCT00509028|466186549|FG001|Overall Study|Withdrawal by Subject|3|||
129518172|NCT00509028|466186548|FG000|Overall Study|Lost to Follow-up|0|||
129518173|NCT00509028|466186549|FG001|Overall Study|Lost to Follow-up|1|||
129518174|NCT00509028|466186548|FG000|Overall Study|Protocol Violation|4|||
129518175|NCT00509028|466186549|FG001|Overall Study|Protocol Violation|2|||
129518176|NCT00509028|466186548|FG000|Overall Study|Non-compliance|2|||
129518177|NCT00509028|466186549|FG001|Overall Study|Non-compliance|1|||
129518178|NCT00948428|466186550|FG000|Overall Study|Withdrawal by Subject|6|||
129518179|NCT00948428|466186551|FG001|Overall Study|Withdrawal by Subject|12|||
129518180|NCT00948428|466186552|FG002|Overall Study|Withdrawal by Subject|7|||
129518181|NCT00948428|466186550|FG000|Overall Study|Adverse Event|6|||
129518182|NCT00948428|466186551|FG001|Overall Study|Adverse Event|3|||
129518183|NCT00948428|466186552|FG002|Overall Study|Adverse Event|0|||
129518184|NCT00948428|466186550|FG000|Overall Study|Lost to Follow-up|2|||
129518185|NCT00948428|466186551|FG001|Overall Study|Lost to Follow-up|1|||
129518186|NCT00948428|466186552|FG002|Overall Study|Lost to Follow-up|1|||
129518187|NCT00948428|466186550|FG000|Overall Study|Death|2|||
129518188|NCT00948428|466186551|FG001|Overall Study|Death|0|||
129518189|NCT00948428|466186552|FG002|Overall Study|Death|0|||
129518190|NCT00948428|466186550|FG000|Overall Study|Intercurrent Illness|1|||
129518191|NCT00948428|466186551|FG001|Overall Study|Intercurrent Illness|0|||
129518192|NCT00948428|466186552|FG002|Overall Study|Intercurrent Illness|0|||
129518193|NCT00948428|466186550|FG000|Overall Study|Non-compliance|1|||
129518194|NCT00948428|466186551|FG001|Overall Study|Non-compliance|2|||
129518195|NCT00948428|466186552|FG002|Overall Study|Non-compliance|0|||
129518196|NCT02408484|466186553|FG000|Overall Study|Withdrawal by Subject|3|||
129518197|NCT02408484|466186553|FG000|Overall Study|Not treated during study period|1|||
129518198|NCT02471586|466186554|FG000|Overall Study|Lost to Follow-up|3|||
129518199|NCT02471586|466186555|FG001|Overall Study|Lost to Follow-up|8|||
129518200|NCT02471586|466186556|FG002|Overall Study|Lost to Follow-up|4|||
129518201|NCT02471586|466186554|FG000|Overall Study|Death|2|||
129518202|NCT02471586|466186555|FG001|Overall Study|Death|2|||
129518203|NCT02471586|466186556|FG002|Overall Study|Death|0|||
129518204|NCT00441727|466186559|FG000|Overall Study|Protocol Violation|19|||
129518205|NCT00441727|466186560|FG001|Overall Study|Protocol Violation|28|||
129518206|NCT00441727|466186561|FG002|Overall Study|Protocol Violation|32|||
129518207|NCT00441727|466186559|FG000|Overall Study|Adverse Event|26|||
129518208|NCT00441727|466186560|FG001|Overall Study|Adverse Event|33|||
129518209|NCT00441727|466186561|FG002|Overall Study|Adverse Event|28|||
129518210|NCT00441727|466186559|FG000|Overall Study|Lack of Efficacy|7|||
129518211|NCT00441727|466186560|FG001|Overall Study|Lack of Efficacy|8|||
129518212|NCT00441727|466186561|FG002|Overall Study|Lack of Efficacy|48|||
129518213|NCT00441727|466186559|FG000|Overall Study|Withdrawal by Subject|40|||
129518214|NCT00441727|466186560|FG001|Overall Study|Withdrawal by Subject|34|||
129518215|NCT00441727|466186561|FG002|Overall Study|Withdrawal by Subject|47|||
129518216|NCT00441727|466186559|FG000|Overall Study|Lost to Follow-up|5|||
129518217|NCT00441727|466186560|FG001|Overall Study|Lost to Follow-up|6|||
129518218|NCT00441727|466186561|FG002|Overall Study|Lost to Follow-up|5|||
129518219|NCT00441727|466186559|FG000|Overall Study|Safety Reasons|3|||
129518220|NCT00441727|466186560|FG001|Overall Study|Safety Reasons|1|||
129518221|NCT00441727|466186561|FG002|Overall Study|Safety Reasons|3|||
129518222|NCT00441727|466186559|FG000|Overall Study|Various reason specified|6|||
129518223|NCT00441727|466186560|FG001|Overall Study|Various reason specified|8|||
129518224|NCT00441727|466186561|FG002|Overall Study|Various reason specified|5|||
129518225|NCT03235726|466186564|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518226|NCT03235726|466186565|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518227|NCT03235726|466186566|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518228|NCT03235726|466186567|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518229|NCT03235726|466186568|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
129518230|NCT03235726|466186569|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518231|NCT03235726|466186570|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518232|NCT03235726|466186571|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518233|NCT03235726|466186572|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518234|NCT03235726|466186573|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
129518235|NCT03235726|466186564|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518236|NCT03235726|466186565|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518237|NCT03235726|466186566|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518238|NCT03235726|466186567|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518239|NCT03235726|466186568|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
129518240|NCT03235726|466186569|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518241|NCT03235726|466186570|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518242|NCT03235726|466186571|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518243|NCT03235726|466186572|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518244|NCT03235726|466186573|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
129518245|NCT03135262|466186577|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
129518246|NCT03135262|466186578|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
129518247|NCT03135262|466186579|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
129518248|NCT03135262|466186580|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
129518249|NCT03135262|466186581|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
129518250|NCT03135262|466186577|FG000|Overall Study|Progression of disease|0|||
129518251|NCT03135262|466186578|FG001|Overall Study|Progression of disease|0|||
129518252|NCT03135262|466186579|FG002|Overall Study|Progression of disease|0|||
129518253|NCT03135262|466186580|FG003|Overall Study|Progression of disease|1|||
129518254|NCT03135262|466186581|FG004|Overall Study|Progression of disease|0|||
129518255|NCT03135262|466186577|FG000|Overall Study|Death|6|||
129518256|NCT03135262|466186578|FG001|Overall Study|Death|2|||
129518257|NCT03135262|466186579|FG002|Overall Study|Death|2|||
129518258|NCT03135262|466186580|FG003|Overall Study|Death|2|||
129518259|NCT03135262|466186581|FG004|Overall Study|Death|0|||
129518260|NCT03135262|466186577|FG000|Overall Study|Withdrawal by Subject|0|||
129518261|NCT03135262|466186578|FG001|Overall Study|Withdrawal by Subject|0|||
129518262|NCT03135262|466186579|FG002|Overall Study|Withdrawal by Subject|1|||
129518263|NCT03135262|466186580|FG003|Overall Study|Withdrawal by Subject|0|||
129518264|NCT03135262|466186581|FG004|Overall Study|Withdrawal by Subject|1|||
129518265|NCT03135262|466186577|FG000|Overall Study|Study terminated by sponsor|2|||
129518266|NCT03135262|466186578|FG001|Overall Study|Study terminated by sponsor|4|||
129518267|NCT03135262|466186579|FG002|Overall Study|Study terminated by sponsor|4|||
129518268|NCT03135262|466186580|FG003|Overall Study|Study terminated by sponsor|3|||
129518269|NCT03135262|466186581|FG004|Overall Study|Study terminated by sponsor|0|||
129518270|NCT01675141|466186582|FG000|Overall Study|Lenalidomide outside NIH|3|||
129518271|NCT01675141|466186582|FG000|Overall Study|Withdrawal by Subject|3|||
129518272|NCT01675141|466186582|FG000|Overall Study|Physician Decision|4|||
129518273|NCT01675141|466186582|FG000|Overall Study|No treatment, per protocol|1|||
129518274|NCT01599806|466186587|FG000|Overall Study|Lost to Follow-up|20|||
129518275|NCT01599806|466186588|FG001|Overall Study|Lost to Follow-up|20|||
129518276|NCT01599806|466186587|FG000|Overall Study|Withdrawal by Subject|12|||
129518277|NCT01599806|466186588|FG001|Overall Study|Withdrawal by Subject|12|||
129518278|NCT01599806|466186587|FG000|Overall Study|Other Eligibility criteria|11|||
129518279|NCT01599806|466186588|FG001|Overall Study|Other Eligibility criteria|9|||
129518280|NCT00391807|466186591|FG000|Overall Study|Did not receive study medication|23|||
129518281|NCT00391807|466186591|FG000|Overall Study|Adverse Event|177|||
129518282|NCT00391807|466186591|FG000|Overall Study|Pregnancy|25|||
129518283|NCT00391807|466186591|FG000|Overall Study|Lost to Follow-up|227|||
129518284|NCT00391807|466186591|FG000|Overall Study|Withdrawal by Subject|147|||
129518285|NCT00391807|466186591|FG000|Overall Study|Protocol Violation|20|||
129518286|NCT00391807|466186591|FG000|Overall Study|Various|96|||
129518287|NCT02417064|466186600|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
129518288|NCT02417064|466186601|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
129518289|NCT02417064|466186602|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
129518290|NCT02417064|466186600|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
129518291|NCT02417064|466186601|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
129518292|NCT02417064|466186602|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
129518293|NCT02417064|466186600|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
129518294|NCT02417064|466186601|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
129518295|NCT02417064|466186602|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
129518296|NCT02417064|466186600|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
129518297|NCT02417064|466186601|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
129518298|NCT02417064|466186602|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
129518299|NCT02417064|466186600|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
129518300|NCT02417064|466186601|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
129518301|NCT02417064|466186602|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
129518302|NCT02417064|466186600|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
129518303|NCT02417064|466186601|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
129518304|NCT02417064|466186602|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
129518305|NCT02417064|466186600|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
129518306|NCT02417064|466186601|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
129518307|NCT02417064|466186602|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
129518308|NCT02417064|466186600|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
129518309|NCT02417064|466186601|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
129518310|NCT02417064|466186602|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
129518311|NCT02417064|466186600|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
129518312|NCT02417064|466186601|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
129518313|NCT02417064|466186602|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
129518314|NCT02417064|466186600|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
129518315|NCT02417064|466186601|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
129518316|NCT02417064|466186602|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
129518317|NCT02417064|466186600|FG000|Follow-up Phase (24 Weeks)|Other|2|||
129518318|NCT02417064|466186601|FG001|Follow-up Phase (24 Weeks)|Other|2|||
129518319|NCT02417064|466186602|FG002|Follow-up Phase (24 Weeks)|Other|3|||
129518320|NCT01585168|466186603|FG000|Overall Study|Lost to Follow-up|3|||
129518321|NCT01585168|466186604|FG001|Overall Study|Lost to Follow-up|1|||
129518322|NCT01585168|466186605|FG002|Overall Study|Lost to Follow-up|1|||
129518323|NCT01585168|466186606|FG003|Overall Study|Lost to Follow-up|1|||
129518324|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
129518325|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
129518326|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
129518327|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
129518328|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
129518329|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
129518330|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
129518331|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
129518332|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
129518333|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
129518334|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
129518335|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
129518336|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
129518337|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
129518338|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
129518339|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
129518340|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
129518341|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
129518342|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
129518343|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
129518344|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
129518345|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
129518346|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
129518347|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
129518348|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Other|0|||
129518349|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Other|1|||
129518350|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Other|0|||
129518351|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Other|0|||
129518352|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
129518353|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
129518354|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
129518355|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
129518356|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
129518357|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
129518358|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
129518359|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
129518360|NCT01194414|466186607|FG000|24 Weeks Double Blind Period|Death|0|||
129518361|NCT01194414|466186608|FG001|24 Weeks Double Blind Period|Death|1|||
129518362|NCT01194414|466186609|FG002|24 Weeks Double Blind Period|Death|0|||
129518363|NCT01194414|466186610|FG003|24 Weeks Double Blind Period|Death|0|||
129518364|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
129518365|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
129518366|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
129518367|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
129518368|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
129518369|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
129518370|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
129518371|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
129518372|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
129518373|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
129518374|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
129518375|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
129518376|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
129518377|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
129518378|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
129518379|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
129518380|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
129518381|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
129518382|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
129518383|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
129518384|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
129518385|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
129518386|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
129518387|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
129518388|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Other|2|||
129518389|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Other|1|||
129518390|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Other|0|||
129518391|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Other|0|||
129518392|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
129518393|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
129518394|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
129518395|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
129518396|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
129518397|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
129518398|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
129518399|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
129518400|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
129518401|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
129518402|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
129518403|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
129518404|NCT01194414|466186607|FG000|72 Weeks Open Label Extension|Death|1|||
129518405|NCT01194414|466186608|FG001|72 Weeks Open Label Extension|Death|2|||
129518406|NCT01194414|466186609|FG002|72 Weeks Open Label Extension|Death|0|||
129518407|NCT01194414|466186610|FG003|72 Weeks Open Label Extension|Death|2|||
129518408|NCT04737759|466186612|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
129518409|NCT04737759|466186613|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
129518410|NCT04737759|466186612|FG000|Overall Study|Death|2|||
129518411|NCT04737759|466186613|FG001|Overall Study|Death|0|||
129518412|NCT04737759|466186612|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
129518413|NCT04737759|466186613|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
129518414|NCT04737759|466186612|FG000|Overall Study|Lost to Follow-up|4|||
129518415|NCT04737759|466186613|FG001|Overall Study|Lost to Follow-up|12|||
129518416|NCT02017704|466186617|FG000|Overall Study|Withdrawal by Subject|2|||
129518417|NCT02017704|466186618|FG001|Overall Study|Withdrawal by Subject|0|||
129518418|NCT01587274|466186619|FG000|Overall Study|Lost to Follow-up|4|||
129518419|NCT01587274|466186620|FG001|Overall Study|Lost to Follow-up|5|||
129518420|NCT01587274|466186621|FG002|Overall Study|Lost to Follow-up|3|||
129518421|NCT00918346|466186622|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
129518422|NCT00918346|466186623|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
129518423|NCT02475629|466186624|FG000|Overall Study|Adverse Event|1|||
129518424|NCT02475629|466186624|FG000|Overall Study|Death|4|||
129518425|NCT02475629|466186624|FG000|Overall Study|Physician Decision|1|||
129518426|NCT02475629|466186624|FG000|Overall Study|Withdrawal by Subject|1|||
129518427|NCT02475629|466186624|FG000|Overall Study|Lost to Follow-up|1|||
129518428|NCT02475629|466186624|FG000|Overall Study|Subject non-compliance|1|||
129518429|NCT01451398|466186638|FG000|Overall Study|Adverse Event|7|||
129518430|NCT01451398|466186639|FG001|Overall Study|Adverse Event|9|||
129518431|NCT01451398|466186638|FG000|Overall Study|Protocol Violation|1|||
129518432|NCT01451398|466186639|FG001|Overall Study|Protocol Violation|2|||
129518433|NCT01451398|466186638|FG000|Overall Study|Physician Decision|1|||
129518434|NCT01451398|466186639|FG001|Overall Study|Physician Decision|1|||
129518435|NCT01451398|466186638|FG000|Overall Study|Withdrawal by Subject|10|||
129518436|NCT01451398|466186639|FG001|Overall Study|Withdrawal by Subject|14|||
129518437|NCT01451398|466186638|FG000|Overall Study|Lost to Follow-up|6|||
129518438|NCT01451398|466186639|FG001|Overall Study|Lost to Follow-up|4|||
129518439|NCT01451398|466186638|FG000|Overall Study|Non-compliance with study drug|1|||
129518440|NCT01451398|466186639|FG001|Overall Study|Non-compliance with study drug|3|||
129518441|NCT01451398|466186638|FG000|Overall Study|Non-compliance with protocol|1|||
129518442|NCT01451398|466186639|FG001|Overall Study|Non-compliance with protocol|1|||
129518443|NCT01451398|466186638|FG000|Overall Study|Moved out of country|0|||
129518444|NCT01451398|466186639|FG001|Overall Study|Moved out of country|1|||
129518445|NCT01451398|466186638|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
129518446|NCT01451398|466186639|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
129518447|NCT01451398|466186638|FG000|Overall Study|Lack of Efficacy|0|||
129518448|NCT01451398|466186639|FG001|Overall Study|Lack of Efficacy|1|||
129518449|NCT01000025|466186642|FG000|Overall Study|Adverse Event|43|||
129518450|NCT01000025|466186643|FG001|Overall Study|Adverse Event|2|||
129518451|NCT01000025|466186642|FG000|Overall Study|Withdrawal by Subject|13|||
129518452|NCT01000025|466186643|FG001|Overall Study|Withdrawal by Subject|8|||
129518453|NCT01000025|466186642|FG000|Overall Study|Death|23|||
129518454|NCT01000025|466186643|FG001|Overall Study|Death|13|||
129518455|NCT01000025|466186642|FG000|Overall Study|Lack of Efficacy|363|||
129518456|NCT01000025|466186643|FG001|Overall Study|Lack of Efficacy|208|||
129518457|NCT01000025|466186642|FG000|Overall Study|Intercurrent Illness|26|||
129518458|NCT01000025|466186643|FG001|Overall Study|Intercurrent Illness|7|||
129518459|NCT04423757|466186644|FG000|Overall Study|Adverse Event|2|||
129518460|NCT04423757|466186645|FG001|Overall Study|Adverse Event|0|||
129518461|NCT04423757|466186644|FG000|Overall Study|Not treated|1|||
129518462|NCT04423757|466186645|FG001|Overall Study|Not treated|1|||
129518463|NCT00422669|466186646|FG000|Overall Study|The study was terminated early.|98|||
129518464|NCT00422669|466186647|FG001|Overall Study|The study was terminated early.|100|||
129518465|NCT00422669|466186648|FG002|Overall Study|The study was terminated early.|7|||
129518466|NCT02709109|466186649|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
129518467|NCT02709109|466186650|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
129518468|NCT02709109|466186651|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
129518469|NCT02709109|466186652|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
129518470|NCT02709109|466186649|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
129518471|NCT02709109|466186650|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
129518472|NCT02709109|466186651|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
129518473|NCT02709109|466186652|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
129518474|NCT02709109|466186649|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
129518475|NCT02709109|466186650|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
129518476|NCT02709109|466186651|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
129518477|NCT02709109|466186652|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
129518478|NCT02709109|466186649|FG000|Washout Period (28 Days)|Other|2|||
129518479|NCT02709109|466186650|FG001|Washout Period (28 Days)|Other|2|||
129518480|NCT02709109|466186651|FG002|Washout Period (28 Days)|Other|3|||
129518481|NCT02709109|466186652|FG003|Washout Period (28 Days)|Other|0|||
129518482|NCT02709109|466186649|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
129518483|NCT02709109|466186650|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
129518484|NCT02709109|466186651|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
129518485|NCT02709109|466186652|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
129518486|NCT02709109|466186649|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
129518487|NCT02709109|466186650|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
129518488|NCT02709109|466186651|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
129518489|NCT02709109|466186652|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
129518490|NCT02709109|466186649|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
129518491|NCT02709109|466186650|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
129518492|NCT02709109|466186651|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
129518493|NCT02709109|466186652|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
129518494|NCT02709109|466186649|FG000|Treatment Period 2 (28 Days)|Other|0|||
129518495|NCT02709109|466186650|FG001|Treatment Period 2 (28 Days)|Other|0|||
129518496|NCT02709109|466186651|FG002|Treatment Period 2 (28 Days)|Other|1|||
129518497|NCT02709109|466186652|FG003|Treatment Period 2 (28 Days)|Other|0|||
129518498|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
129518499|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
129518500|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
129518501|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
129518502|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
129518503|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
129518504|NCT00996593|466186653|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
129518505|NCT00996593|466186653|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
129518506|NCT00996593|466186653|FG000|Long-Term Follow-Up|Site Closed|1|||
129518507|NCT00617591|466186654|FG000|Overall Study|Withdrew consent during Induction|4|||
129518508|NCT00617591|466186654|FG000|Overall Study|Withdrew consent during Maintenance|6|||
129518509|NCT01176240|466186658|FG000|Study 306A|Lack of Efficacy|2|||
129518510|NCT01176240|466186659|FG001|Study 306A|Lack of Efficacy|1|||
129518511|NCT01176240|466186658|FG000|Study 306A|Protocol Violation|0|||
129518512|NCT01176240|466186659|FG001|Study 306A|Protocol Violation|1|||
129518513|NCT01176240|466186658|FG000|Study 306A|Withdrawal by Subject|0|||
129518514|NCT01176240|466186659|FG001|Study 306A|Withdrawal by Subject|1|||
129518515|NCT01176240|466186658|FG000|Study 306A|Stop due to diverse problems|1|||
129518516|NCT01176240|466186659|FG001|Study 306A|Stop due to diverse problems|0|||
129518517|NCT01176240|466186658|FG000|Study 306B|Lack of Efficacy|5|||
129518518|NCT01176240|466186659|FG001|Study 306B|Lack of Efficacy|3|||
129518519|NCT01176240|466186658|FG000|Study 306B|Adverse Event|10|||
129518520|NCT01176240|466186659|FG001|Study 306B|Adverse Event|5|||
129518521|NCT01176240|466186658|FG000|Study 306B|Protocol Violation|2|||
129518522|NCT01176240|466186659|FG001|Study 306B|Protocol Violation|3|||
129518523|NCT01176240|466186658|FG000|Study 306B|Withdrawal by Subject|4|||
129518524|NCT01176240|466186659|FG001|Study 306B|Withdrawal by Subject|1|||
129518525|NCT01176240|466186658|FG000|Study 306B|Physician Decision|2|||
129518526|NCT01176240|466186659|FG001|Study 306B|Physician Decision|1|||
129518527|NCT01176240|466186658|FG000|Study 306B|Supine Hypertension|1|||
129518528|NCT01176240|466186659|FG001|Study 306B|Supine Hypertension|2|||
129518529|NCT01176240|466186658|FG000|Study 306B|Lost to Follow-up|0|||
129518530|NCT01176240|466186659|FG001|Study 306B|Lost to Follow-up|1|||
129518531|NCT01176240|466186658|FG000|Study 306B|withdrew prior to dosing|2|||
129518532|NCT01176240|466186659|FG001|Study 306B|withdrew prior to dosing|1|||
129518533|NCT00807014|466186665|FG000|Overall Study|Participant Considered Disease Cured|13|||
129518534|NCT00807014|466186666|FG001|Overall Study|Participant Considered Disease Cured|2|||
129518535|NCT00807014|466186665|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
129518536|NCT00807014|466186666|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
129518537|NCT00807014|466186665|FG000|Overall Study|Protocol Violation|2|||
129518538|NCT00807014|466186666|FG001|Overall Study|Protocol Violation|8|||
129518539|NCT00807014|466186665|FG000|Overall Study|Adverse Event|0|||
129518540|NCT00807014|466186666|FG001|Overall Study|Adverse Event|2|||
129518541|NCT00807014|466186665|FG000|Overall Study|Lost to Follow-up|9|||
129518542|NCT00807014|466186666|FG001|Overall Study|Lost to Follow-up|7|||
129518543|NCT00807014|466186665|FG000|Overall Study|Recovery|1|||
129518544|NCT00807014|466186666|FG001|Overall Study|Recovery|0|||
129518545|NCT00807014|466186665|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
129518546|NCT00807014|466186666|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
129518547|NCT00651313|466186667|FG000|Overall Study|Adverse Event|0|||
129518548|NCT00651313|466186668|FG001|Overall Study|Adverse Event|1|||
129518549|NCT00651313|466186667|FG000|Overall Study|Withdrawal by Subject|3|||
129518550|NCT00651313|466186668|FG001|Overall Study|Withdrawal by Subject|1|||
129518551|NCT00651313|466186667|FG000|Overall Study|Lost to Follow-up|1|||
129518552|NCT00651313|466186668|FG001|Overall Study|Lost to Follow-up|1|||
129518553|NCT00651313|466186667|FG000|Overall Study|Adminstrative Discontinuation|2|||
129518554|NCT00651313|466186668|FG001|Overall Study|Adminstrative Discontinuation|3|||
129518555|NCT02650895|466186669|FG000|Overall Study|Withdrawal by Subject|0|||
129518556|NCT02650895|466186670|FG001|Overall Study|Withdrawal by Subject|1|||
129518557|NCT02650895|466186671|FG002|Overall Study|Withdrawal by Subject|0|||
129518558|NCT02650895|466186672|FG003|Overall Study|Withdrawal by Subject|0|||
129518559|NCT02650895|466186673|FG004|Overall Study|Withdrawal by Subject|0|||
129518560|NCT02650895|466186674|FG005|Overall Study|Withdrawal by Subject|0|||
129518561|NCT00981682|466186675|FG000|Overall Study|Adverse Event|48|||
129518562|NCT00981682|466186675|FG000|Overall Study|Withdrawal by Subject|52|||
129518563|NCT00981682|466186675|FG000|Overall Study|Lost to Follow-up|14|||
129518564|NCT00981682|466186675|FG000|Overall Study|Lack of Efficacy|13|||
129518565|NCT00981682|466186675|FG000|Overall Study|Protocol Violation|6|||
129518566|NCT00981682|466186675|FG000|Overall Study|administrative|9|||
129518567|NCT01731990|466188313|FG000|Overall Study|Adverse Event|1|||
129518568|NCT01731990|466188314|FG001|Overall Study|Adverse Event|5|||
129518569|NCT01731990|466188313|FG000|Overall Study|Withdrawal by Subject|1|||
129518570|NCT01731990|466188314|FG001|Overall Study|Withdrawal by Subject|1|||
129518571|NCT01731990|466188313|FG000|Overall Study|Protocol deviation|1|||
129518572|NCT01731990|466188314|FG001|Overall Study|Protocol deviation|2|||
129518573|NCT01731990|466188313|FG000|Overall Study|Death|1|||
129518574|NCT01731990|466188314|FG001|Overall Study|Death|0|||
129518575|NCT01280812|466188315|FG000|Overall Study|Withdrawal by Subject|2|||
129518576|NCT01280812|466188316|FG001|Overall Study|Withdrawal by Subject|1|||
129518577|NCT01280812|466188317|FG002|Overall Study|Withdrawal by Subject|0|||
129518578|NCT01280812|466188315|FG000|Overall Study|Lost to Follow-up|1|||
129518579|NCT01280812|466188316|FG001|Overall Study|Lost to Follow-up|1|||
129518580|NCT01280812|466188317|FG002|Overall Study|Lost to Follow-up|1|||
129518581|NCT04483544|466188318|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
129518582|NCT04483544|466188318|FG000|Post-Treatment|Admitted to hospice|2|||
129518583|NCT04483544|466188318|FG000|Post-Treatment|Study terminated|3|||
129518584|NCT01131078|466188325|FG000|Overall Study|Adverse Event|22|||
129518585|NCT01131078|466188326|FG001|Overall Study|Adverse Event|12|||
129518586|NCT01131078|466188327|FG002|Overall Study|Adverse Event|17|||
129518587|NCT01131078|466188325|FG000|Overall Study|Progressive Disease|58|||
129518588|NCT01131078|466188326|FG001|Overall Study|Progressive Disease|77|||
129518589|NCT01131078|466188327|FG002|Overall Study|Progressive Disease|71|||
129518590|NCT01131078|466188325|FG000|Overall Study|Protocol Violation|1|||
129518591|NCT01131078|466188326|FG001|Overall Study|Protocol Violation|0|||
129518592|NCT01131078|466188327|FG002|Overall Study|Protocol Violation|0|||
129518593|NCT01131078|466188325|FG000|Overall Study|Lost to Follow-up|1|||
129518594|NCT01131078|466188326|FG001|Overall Study|Lost to Follow-up|1|||
129518595|NCT01131078|466188327|FG002|Overall Study|Lost to Follow-up|1|||
129518596|NCT01131078|466188325|FG000|Overall Study|Withdrawal by Subject|2|||
129518597|NCT01131078|466188326|FG001|Overall Study|Withdrawal by Subject|4|||
129518598|NCT01131078|466188327|FG002|Overall Study|Withdrawal by Subject|3|||
129518599|NCT01131078|466188325|FG000|Overall Study|Non-compliance|3|||
129518600|NCT01131078|466188326|FG001|Overall Study|Non-compliance|0|||
129518601|NCT01131078|466188327|FG002|Overall Study|Non-compliance|0|||
129518602|NCT01131078|466188325|FG000|Overall Study|Physician Decision|10|||
129518603|NCT01131078|466188326|FG001|Overall Study|Physician Decision|6|||
129518604|NCT01131078|466188327|FG002|Overall Study|Physician Decision|8|||
129518605|NCT01131078|466188325|FG000|Overall Study|Death|4|||
129518606|NCT01131078|466188326|FG001|Overall Study|Death|0|||
129518607|NCT01131078|466188327|FG002|Overall Study|Death|2|||
129518608|NCT01131078|466188325|FG000|Overall Study|Other|0|||
129518609|NCT01131078|466188326|FG001|Overall Study|Other|1|||
129518610|NCT01131078|466188327|FG002|Overall Study|Other|0|||
129518611|NCT01685060|466188333|FG000|Overall Study|Rollover patients|16|||
129518612|NCT01685060|466188333|FG000|Overall Study|Adverse Event|12|||
129518613|NCT01685060|466188333|FG000|Overall Study|Progressive disease|69|||
129518614|NCT01685060|466188333|FG000|Overall Study|Physician Decision|14|||
129518615|NCT01685060|466188333|FG000|Overall Study|Subject/guardian decision|20|||
129518616|NCT01685060|466188333|FG000|Overall Study|Lost to Follow-up|1|||
129518617|NCT01685060|466188333|FG000|Overall Study|Death|8|||
129518618|NCT03597503|466188334|FG000|Overall Study|Withdrawal by Subject|0|||
129518619|NCT03597503|466188335|FG001|Overall Study|Withdrawal by Subject|2|||
129518620|NCT03597503|466188334|FG000|Overall Study|Lost to Follow-up|1|||
129518621|NCT03597503|466188335|FG001|Overall Study|Lost to Follow-up|2|||
129518622|NCT03597503|466188334|FG000|Overall Study|Protocol Violation|1|||
129518623|NCT03597503|466188335|FG001|Overall Study|Protocol Violation|0|||
129518624|NCT00405275|466188338|FG000|Overall Study|Death|1|||
129518625|NCT00405275|466188339|FG001|Overall Study|Death|0|||
129518626|NCT00405275|466188338|FG000|Overall Study|Lost to Follow-up|5|||
129518627|NCT00405275|466188339|FG001|Overall Study|Lost to Follow-up|1|||
129518628|NCT00405275|466188338|FG000|Overall Study|Withdrawal by Subject|7|||
129518629|NCT00405275|466188339|FG001|Overall Study|Withdrawal by Subject|9|||
129518630|NCT00405275|466188338|FG000|Overall Study|Unwilling to continue|10|||
129518631|NCT00405275|466188339|FG001|Overall Study|Unwilling to continue|9|||
129518632|NCT00731666|466188340|FG000|Overall Study|Adverse Event|2|||
129518633|NCT00731666|466188340|FG000|Overall Study|Lost to Follow-up|8|||
129518634|NCT00731666|466188340|FG000|Overall Study|Withdrawal by Subject|2|||
129518635|NCT02853123|466188341|FG000|Treatment Period 1|Adverse Event|0|||
129518636|NCT02853123|466188342|FG001|Treatment Period 1|Adverse Event|3|||
129518637|NCT02853123|466188341|FG000|Washout Period|Worsening of COPD|0|||
129518638|NCT02853123|466188342|FG001|Washout Period|Worsening of COPD|3|||
129518639|NCT02853123|466188341|FG000|Washout Period|Adverse Event|1|||
129518640|NCT02853123|466188342|FG001|Washout Period|Adverse Event|0|||
129518641|NCT02809118|466188345|FG000|Overall Study|Withdrawal by Subject|0|||
129518642|NCT02809118|466188346|FG001|Overall Study|Withdrawal by Subject|1|||
129518643|NCT02809118|466188347|FG002|Overall Study|Withdrawal by Subject|1|||
129518644|NCT01235338|466188348|FG000|Overall Study|Adverse Event|3|||
129518645|NCT01235338|466188349|FG001|Overall Study|Adverse Event|2|||
129518646|NCT01235338|466188348|FG000|Overall Study|Protocol Violation|1|||
129518647|NCT01235338|466188349|FG001|Overall Study|Protocol Violation|1|||
129518648|NCT01235338|466188348|FG000|Overall Study|Withdrawal by Subject|5|||
129518649|NCT01235338|466188349|FG001|Overall Study|Withdrawal by Subject|0|||
129518650|NCT01235338|466188348|FG000|Overall Study|Exclusion criteria violations|1|||
129518651|NCT01235338|466188349|FG001|Overall Study|Exclusion criteria violations|1|||
129518652|NCT01235338|466188348|FG000|Overall Study|Positive drug screen|0|||
129518653|NCT01235338|466188349|FG001|Overall Study|Positive drug screen|1|||
129518654|NCT01235338|466188348|FG000|Overall Study|Prohibited meds|1|||
129518655|NCT01235338|466188349|FG001|Overall Study|Prohibited meds|0|||
129518656|NCT05283499|466188353|FG000|Overall Study|Did not receive intervention|1|||
129518657|NCT05283499|466188354|FG001|Overall Study|Did not receive intervention|2|||
129518658|NCT03805971|466188361|FG000|Overall Study|Withdrawal by Subject|1|||
129518659|NCT03805971|466188361|FG000|Overall Study|Protocol Violation|2|||
129518660|NCT00517413|466188365|FG000|Overall Study|Adverse Event|7|||
129518661|NCT00517413|466188365|FG000|Overall Study|Death|13|||
129518662|NCT00517413|466188365|FG000|Overall Study|Protocol Violation|15|||
129518663|NCT00517413|466188365|FG000|Overall Study|Withdrawal by Subject|2|||
129518664|NCT00517413|466188365|FG000|Overall Study|Failure to return|1|||
129518665|NCT00517413|466188365|FG000|Overall Study|Other-Reasons|23|||
129518666|NCT01510028|466188366|FG000|Overall Study|Lack of Efficacy|1|||
129518667|NCT01510028|466188367|FG001|Overall Study|Lack of Efficacy|0|||
129518668|NCT01510028|466188368|FG002|Overall Study|Lack of Efficacy|0|||
129518669|NCT01510028|466188369|FG003|Overall Study|Lack of Efficacy|0|||
129518670|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Death|3|||
129518671|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Death|0|||
129518672|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Death|0|||
129518673|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Death|0|||
129518674|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Death|0|||
129518675|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
129518676|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
129518677|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
129518678|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
129518679|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
129518680|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129518681|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
129518682|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
129518683|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129518684|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
129518685|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Other|0|||
129518686|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Other|0|||
129518687|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Other|1|||
129518688|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Other|0|||
129518689|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Other|0|||
129518690|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
129518691|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
129518692|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
129518693|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
129518694|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
129518695|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
129518696|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
129518697|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
129518698|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
129518699|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
129518700|NCT01224106|466188372|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129518701|NCT01224106|466188373|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129518702|NCT01224106|466188374|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129518703|NCT01224106|466188375|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129518704|NCT01224106|466188376|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129518705|NCT01224106|466188372|FG000|Open-Label Extension (OLE) Phase|Death|0|||
129518706|NCT01224106|466188373|FG001|Open-Label Extension (OLE) Phase|Death|0|||
129518707|NCT01224106|466188374|FG002|Open-Label Extension (OLE) Phase|Death|0|||
129518708|NCT01224106|466188375|FG003|Open-Label Extension (OLE) Phase|Death|1|||
129518709|NCT01224106|466188376|FG004|Open-Label Extension (OLE) Phase|Death|3|||
129518710|NCT01224106|466188372|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
129518711|NCT01224106|466188373|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
129518712|NCT01224106|466188374|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
129518713|NCT01224106|466188375|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
129518714|NCT01224106|466188376|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
129518715|NCT01224106|466188372|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
129518716|NCT01224106|466188373|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
129518717|NCT01224106|466188374|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
129518718|NCT01224106|466188375|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
129518719|NCT01224106|466188376|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
129518720|NCT01224106|466188372|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
129518721|NCT01224106|466188373|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
129518722|NCT01224106|466188374|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
129518723|NCT01224106|466188375|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
129518724|NCT01224106|466188376|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
129518725|NCT01224106|466188372|FG000|Open-Label Extension (OLE) Phase|Other|0|||
129518726|NCT01224106|466188373|FG001|Open-Label Extension (OLE) Phase|Other|0|||
129518727|NCT01224106|466188374|FG002|Open-Label Extension (OLE) Phase|Other|0|||
129518728|NCT01224106|466188375|FG003|Open-Label Extension (OLE) Phase|Other|5|||
129518729|NCT01224106|466188376|FG004|Open-Label Extension (OLE) Phase|Other|3|||
129518730|NCT00446797|466188377|FG000|Overall Study|Lack of Efficacy|0|||
129518731|NCT00446797|466188378|FG001|Overall Study|Lack of Efficacy|2|||
129518732|NCT00446797|466188377|FG000|Overall Study|Lost to Follow-up|5|||
129518733|NCT00446797|466188378|FG001|Overall Study|Lost to Follow-up|3|||
129518734|NCT00446797|466188377|FG000|Overall Study|Withdrawal by Subject|2|||
129518735|NCT00446797|466188378|FG001|Overall Study|Withdrawal by Subject|2|||
129518736|NCT00446797|466188377|FG000|Overall Study|Protocol Violation|1|||
129518737|NCT00446797|466188378|FG001|Overall Study|Protocol Violation|3|||
129518738|NCT00446797|466188377|FG000|Overall Study|subject entered at another site|0|||
129518739|NCT00446797|466188378|FG001|Overall Study|subject entered at another site|1|||
129518740|NCT00446797|466188377|FG000|Overall Study|did not meet entrance criteria|0|||
129518741|NCT00446797|466188378|FG001|Overall Study|did not meet entrance criteria|1|||
129518742|NCT03551626|466188385|FG000|Overall Study|Adverse Event|88|||
129518743|NCT03551626|466188385|FG000|Overall Study|Disease relapse|18|||
129518744|NCT03551626|466188385|FG000|Overall Study|Withdrawal of informed consent|6|||
129518745|NCT03551626|466188385|FG000|Overall Study|Patient decision|5|||
129518746|NCT03551626|466188385|FG000|Overall Study|Physician Decision|4|||
129518747|NCT03551626|466188385|FG000|Overall Study|Lost to Follow-up|3|||
129518748|NCT03551626|466188385|FG000|Overall Study|Pregnancy|1|||
129518749|NCT03551626|466188385|FG000|Overall Study|Protocol deviation|1|||
129518750|NCT03551626|466188385|FG000|Overall Study|Technical problems|1|||
129518751|NCT02133001|466188386|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
129518752|NCT02133001|466188387|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
129518753|NCT02133001|466188386|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
129518754|NCT02133001|466188387|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
129518755|NCT02133001|466188386|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
129518756|NCT02133001|466188387|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
129518757|NCT02133001|466188386|FG000|Double Blind (Day 1-25)|Other|2|||
129518758|NCT02133001|466188387|FG001|Double Blind (Day 1-25)|Other|2|||
129518759|NCT02133001|466188386|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
129518760|NCT02133001|466188387|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
129518761|NCT02133001|466188386|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
129518762|NCT02133001|466188387|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
129518763|NCT02133001|466188386|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
129518764|NCT02133001|466188387|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
129518765|NCT02133001|466188386|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
129518766|NCT02133001|466188387|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
129518767|NCT04211961|466188388|FG000|Overall Study|Death|0|||
129518768|NCT04211961|466188389|FG001|Overall Study|Death|1|||
129518769|NCT04211961|466188388|FG000|Overall Study|Lost to Follow-up|0|||
129518770|NCT04211961|466188389|FG001|Overall Study|Lost to Follow-up|1|||
129518771|NCT04211961|466188388|FG000|Overall Study|Withdrawal by Subject|0|||
129518772|NCT04211961|466188389|FG001|Overall Study|Withdrawal by Subject|1|||
129518773|NCT02498392|466188394|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
129518774|NCT02498392|466188395|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
129518775|NCT02498392|466188394|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
129518776|NCT02498392|466188395|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
129518777|NCT02498392|466188394|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
129518778|NCT02498392|466188395|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
129518779|NCT02498392|466188394|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
129518780|NCT02498392|466188395|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
129518781|NCT02498392|466188394|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
129518782|NCT02498392|466188395|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
129518783|NCT02498392|466188394|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
129518784|NCT02498392|466188395|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
129518785|NCT05784129|466188396|FG000|Overall Study|Study terminated by sponsor|2|||
129518786|NCT05784129|466188397|FG001|Overall Study|Study terminated by sponsor|2|||
129518787|NCT02873208|466188398|FG000|Overall Study|Withdrawal by Subject|36|||
129518788|NCT02873208|466188398|FG000|Overall Study|Lost to Follow-up|22|||
129518789|NCT02873208|466188398|FG000|Overall Study|Adverse Event|15|||
129518790|NCT02873208|466188398|FG000|Overall Study|Non-compliance with study drug|12|||
129518791|NCT02873208|466188398|FG000|Overall Study|Protocol Violation|8|||
129518792|NCT02873208|466188398|FG000|Overall Study|Pregnancy|2|||
129518793|NCT02873208|466188398|FG000|Overall Study|Incarceration|1|||
129518794|NCT02873208|466188398|FG000|Overall Study|Lack of Efficacy|1|||
129518795|NCT02873208|466188398|FG000|Overall Study|Physician Decision|1|||
129518796|NCT04080752|466188399|FG000|Overall Study|Adverse Event|2|||
129518797|NCT04080752|466188400|FG001|Overall Study|Adverse Event|3|||
129518798|NCT04080752|466188399|FG000|Overall Study|Lack of Efficacy|1|||
129518799|NCT04080752|466188400|FG001|Overall Study|Lack of Efficacy|0|||
129518800|NCT04080752|466188399|FG000|Overall Study|Lost to Follow-up|1|||
129518801|NCT04080752|466188400|FG001|Overall Study|Lost to Follow-up|0|||
129518802|NCT04080752|466188399|FG000|Overall Study|Pregnancy|0|||
129518803|NCT04080752|466188400|FG001|Overall Study|Pregnancy|1|||
129518804|NCT04080752|466188399|FG000|Overall Study|Withdrawal by Subject|7|||
129518805|NCT04080752|466188400|FG001|Overall Study|Withdrawal by Subject|0|||
129518806|NCT04080752|466188399|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129518807|NCT04080752|466188400|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129518808|NCT04080752|466188399|FG000|Overall Study|Other|2|||
129518809|NCT04080752|466188400|FG001|Overall Study|Other|1|||
129518810|NCT01192100|466188401|FG000|Overall Study|Withdrawal by Subject|0|||
129518811|NCT01192100|466188402|FG001|Overall Study|Withdrawal by Subject|0|||
129518812|NCT01192100|466188403|FG002|Overall Study|Withdrawal by Subject|0|||
129518813|NCT01192100|466188404|FG003|Overall Study|Withdrawal by Subject|0|||
129518814|NCT01192100|466188405|FG004|Overall Study|Withdrawal by Subject|1|||
129518815|NCT01192100|466188406|FG005|Overall Study|Withdrawal by Subject|0|||
129518816|NCT01192100|466188401|FG000|Overall Study|Protocol Violation|0|||
129518817|NCT01192100|466188402|FG001|Overall Study|Protocol Violation|0|||
129518818|NCT01192100|466188403|FG002|Overall Study|Protocol Violation|0|||
129518819|NCT01192100|466188404|FG003|Overall Study|Protocol Violation|1|||
129518820|NCT01192100|466188405|FG004|Overall Study|Protocol Violation|0|||
129518821|NCT01192100|466188406|FG005|Overall Study|Protocol Violation|0|||
129518822|NCT04685538|466188407|FG000|Overall Study|Adverse Event|0|||
129518823|NCT04685538|466188408|FG001|Overall Study|Adverse Event|1|||
129518824|NCT04685538|466188407|FG000|Overall Study|Lost to Follow-up|0|||
129518825|NCT04685538|466188408|FG001|Overall Study|Lost to Follow-up|2|||
129518826|NCT01421069|466188409|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
129518827|NCT01421069|466188409|FG000|Parent Study|Failed to return|3|||
129518828|NCT01421069|466188409|FG000|Parent Study|Withdrawal by Subject|1|||
129518829|NCT01421069|466188409|FG000|Parent Study|Lost to Follow-up|2|||
129518830|NCT01421069|466188409|FG000|Parent Study|Lack of Efficacy|1|||
129518831|NCT01421069|466188409|FG000|Overall Period for Extension Study|Other|2|||
129518832|NCT01421069|466188409|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
129518833|NCT01421069|466188409|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
129518834|NCT01421069|466188409|FG000|Overall Period for Extension Study|Pregnancy|1|||
129518835|NCT01421069|466188409|FG000|Overall Period for Extension Study|Adverse Event|1|||
129518836|NCT01421069|466188409|FG000|Overall Period for Extension Study|Protocol Violation|1|||
129518837|NCT01421069|466188409|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
129518838|NCT01421069|466188409|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
129518839|NCT01421069|466188409|FG000|Active Treatment Period|Other|1|||
129518840|NCT01421069|466188409|FG000|Active Treatment Period|No longer willing to participate in study|8|||
129518841|NCT01421069|466188409|FG000|Active Treatment Period|Insufficient clinical response|1|||
129518842|NCT01421069|466188409|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
129518843|NCT01421069|466188409|FG000|Active Treatment Period|Pregnancy|1|||
129518844|NCT01421069|466188409|FG000|Active Treatment Period|Adverse Event|1|||
129518845|NCT01421069|466188409|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
129518846|NCT01421069|466188409|FG000|Active Treatment Period|Enrolled in observational period|29|||
129518847|NCT01421069|466188409|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
129518848|NCT01421069|466188409|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
129518849|NCT01421069|466188409|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
129518850|NCT01421069|466188409|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
129518851|NCT01421069|466188409|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
129518852|NCT01421069|466188409|FG000|2b. Retreatment Period|Protocol Violation|1|||
129518853|NCT01421069|466188409|FG000|Observational Period|Other|1|||
129518854|NCT01421069|466188409|FG000|Observational Period|No longer willing to participate in study|4|||
129518855|NCT01421069|466188409|FG000|Observational Period|Lost to Follow-up|3|||
129518856|NCT01641081|466188410|FG000|Period 1|Sponsor request (potential unblinding)|0|||
129518857|NCT01641081|466188411|FG001|Period 1|Sponsor request (potential unblinding)|0|||
129518858|NCT01641081|466188412|FG002|Period 1|Sponsor request (potential unblinding)|0|||
129518859|NCT01641081|466188413|FG003|Period 1|Sponsor request (potential unblinding)|0|||
129518860|NCT01641081|466188414|FG004|Period 1|Sponsor request (potential unblinding)|0|||
129518861|NCT01641081|466188415|FG005|Period 1|Sponsor request (potential unblinding)|0|||
129518862|NCT01641081|466188416|FG006|Period 1|Sponsor request (potential unblinding)|1|||
129518863|NCT01641081|466188417|FG007|Period 1|Sponsor request (potential unblinding)|0|||
129518864|NCT01641081|466188418|FG008|Period 1|Sponsor request (potential unblinding)|0|||
129518865|NCT01641081|466188419|FG009|Period 1|Sponsor request (potential unblinding)|0|||
129518866|NCT01641081|466188410|FG000|Period 1|Protocol Violation|0|||
129518867|NCT01641081|466188411|FG001|Period 1|Protocol Violation|0|||
129518868|NCT01641081|466188412|FG002|Period 1|Protocol Violation|0|||
129518869|NCT01641081|466188413|FG003|Period 1|Protocol Violation|0|||
129518870|NCT01641081|466188414|FG004|Period 1|Protocol Violation|1|||
129518871|NCT01641081|466188415|FG005|Period 1|Protocol Violation|0|||
129518872|NCT01641081|466188416|FG006|Period 1|Protocol Violation|0|||
129518873|NCT01641081|466188417|FG007|Period 1|Protocol Violation|1|||
129518874|NCT01641081|466188418|FG008|Period 1|Protocol Violation|0|||
129518875|NCT01641081|466188419|FG009|Period 1|Protocol Violation|0|||
129518876|NCT01641081|466188410|FG000|Period 1|Adverse Event|1|||
129518877|NCT01641081|466188411|FG001|Period 1|Adverse Event|0|||
129518878|NCT01641081|466188412|FG002|Period 1|Adverse Event|0|||
129518879|NCT01641081|466188413|FG003|Period 1|Adverse Event|0|||
129518880|NCT01641081|466188414|FG004|Period 1|Adverse Event|0|||
129518881|NCT01641081|466188415|FG005|Period 1|Adverse Event|0|||
129518882|NCT01641081|466188416|FG006|Period 1|Adverse Event|0|||
129518883|NCT01641081|466188417|FG007|Period 1|Adverse Event|2|||
129518884|NCT01641081|466188418|FG008|Period 1|Adverse Event|0|||
129518885|NCT01641081|466188419|FG009|Period 1|Adverse Event|0|||
129518886|NCT01641081|466188410|FG000|Period 2|Adverse Event|0|||
129518887|NCT01641081|466188411|FG001|Period 2|Adverse Event|0|||
129518888|NCT01641081|466188412|FG002|Period 2|Adverse Event|0|||
129518889|NCT01641081|466188413|FG003|Period 2|Adverse Event|0|||
129518890|NCT01641081|466188414|FG004|Period 2|Adverse Event|0|||
129518891|NCT01641081|466188415|FG005|Period 2|Adverse Event|1|||
129518892|NCT01641081|466188416|FG006|Period 2|Adverse Event|0|||
129518893|NCT01641081|466188417|FG007|Period 2|Adverse Event|0|||
129518894|NCT01641081|466188418|FG008|Period 2|Adverse Event|0|||
129518895|NCT01641081|466188419|FG009|Period 2|Adverse Event|0|||
129518896|NCT01641081|466188410|FG000|Period 2|Withdrawal by Subject|0|||
129518897|NCT01641081|466188411|FG001|Period 2|Withdrawal by Subject|0|||
129518898|NCT01641081|466188412|FG002|Period 2|Withdrawal by Subject|0|||
129518899|NCT01641081|466188413|FG003|Period 2|Withdrawal by Subject|1|||
129518900|NCT01641081|466188414|FG004|Period 2|Withdrawal by Subject|0|||
129518901|NCT01641081|466188415|FG005|Period 2|Withdrawal by Subject|0|||
129518902|NCT01641081|466188416|FG006|Period 2|Withdrawal by Subject|2|||
129518903|NCT01641081|466188417|FG007|Period 2|Withdrawal by Subject|0|||
129518904|NCT01641081|466188418|FG008|Period 2|Withdrawal by Subject|0|||
129518905|NCT01641081|466188419|FG009|Period 2|Withdrawal by Subject|0|||
129518906|NCT01641081|466188410|FG000|Period 2|Protocol Violation|1|||
129518907|NCT01641081|466188411|FG001|Period 2|Protocol Violation|0|||
129518908|NCT01641081|466188412|FG002|Period 2|Protocol Violation|0|||
129518909|NCT01641081|466188413|FG003|Period 2|Protocol Violation|0|||
129518910|NCT01641081|466188414|FG004|Period 2|Protocol Violation|0|||
129518911|NCT01641081|466188415|FG005|Period 2|Protocol Violation|0|||
129518912|NCT01641081|466188416|FG006|Period 2|Protocol Violation|0|||
129518913|NCT01641081|466188417|FG007|Period 2|Protocol Violation|0|||
129518914|NCT01641081|466188418|FG008|Period 2|Protocol Violation|0|||
129518915|NCT01641081|466188419|FG009|Period 2|Protocol Violation|0|||
129518916|NCT01641081|466188410|FG000|Period 3|Adverse Event|0|||
129518917|NCT01641081|466188411|FG001|Period 3|Adverse Event|0|||
129518918|NCT01641081|466188412|FG002|Period 3|Adverse Event|1|||
129518919|NCT01641081|466188413|FG003|Period 3|Adverse Event|0|||
129518920|NCT01641081|466188414|FG004|Period 3|Adverse Event|0|||
129518921|NCT01641081|466188415|FG005|Period 3|Adverse Event|0|||
129518922|NCT01641081|466188416|FG006|Period 3|Adverse Event|0|||
129518923|NCT01641081|466188417|FG007|Period 3|Adverse Event|0|||
129518924|NCT01641081|466188418|FG008|Period 3|Adverse Event|0|||
129518925|NCT01641081|466188419|FG009|Period 3|Adverse Event|0|||
129518926|NCT01641081|466188410|FG000|Period 3|Withdrawal by Subject|0|||
129518927|NCT01641081|466188411|FG001|Period 3|Withdrawal by Subject|0|||
129518928|NCT01641081|466188412|FG002|Period 3|Withdrawal by Subject|0|||
129518929|NCT01641081|466188413|FG003|Period 3|Withdrawal by Subject|0|||
129518930|NCT01641081|466188414|FG004|Period 3|Withdrawal by Subject|0|||
129518931|NCT01641081|466188415|FG005|Period 3|Withdrawal by Subject|0|||
129518932|NCT01641081|466188416|FG006|Period 3|Withdrawal by Subject|0|||
129518933|NCT01641081|466188417|FG007|Period 3|Withdrawal by Subject|0|||
129518934|NCT01641081|466188418|FG008|Period 3|Withdrawal by Subject|1|||
129518935|NCT01641081|466188419|FG009|Period 3|Withdrawal by Subject|0|||
129518936|NCT01641081|466188410|FG000|Period 4|Adverse Event|0|||
129518937|NCT01641081|466188411|FG001|Period 4|Adverse Event|1|||
129518938|NCT01641081|466188412|FG002|Period 4|Adverse Event|0|||
129518939|NCT01641081|466188413|FG003|Period 4|Adverse Event|1|||
129518940|NCT01641081|466188414|FG004|Period 4|Adverse Event|0|||
129518941|NCT01641081|466188415|FG005|Period 4|Adverse Event|0|||
129518942|NCT01641081|466188416|FG006|Period 4|Adverse Event|0|||
129518943|NCT01641081|466188417|FG007|Period 4|Adverse Event|0|||
129518944|NCT01641081|466188418|FG008|Period 4|Adverse Event|0|||
129518945|NCT01641081|466188419|FG009|Period 4|Adverse Event|0|||
129518946|NCT01641081|466188410|FG000|Period 5|Adverse Event|0|||
129518947|NCT01641081|466188411|FG001|Period 5|Adverse Event|0|||
129518948|NCT01641081|466188412|FG002|Period 5|Adverse Event|2|||
129518949|NCT01641081|466188413|FG003|Period 5|Adverse Event|0|||
129518950|NCT01641081|466188414|FG004|Period 5|Adverse Event|0|||
129518951|NCT01641081|466188415|FG005|Period 5|Adverse Event|0|||
129518952|NCT01641081|466188416|FG006|Period 5|Adverse Event|0|||
129518953|NCT01641081|466188417|FG007|Period 5|Adverse Event|0|||
129518954|NCT01641081|466188418|FG008|Period 5|Adverse Event|0|||
129518955|NCT01641081|466188419|FG009|Period 5|Adverse Event|0|||
129518956|NCT01095666|466188420|FG000|Overall Study|Lack of Efficacy|0|||
129518957|NCT01095666|466188421|FG001|Overall Study|Lack of Efficacy|0|||
129518958|NCT01095666|466188422|FG002|Overall Study|Lack of Efficacy|1|||
129518959|NCT01095666|466188420|FG000|Overall Study|Adverse Event|2|||
129518960|NCT01095666|466188421|FG001|Overall Study|Adverse Event|1|||
129518961|NCT01095666|466188422|FG002|Overall Study|Adverse Event|3|||
129518962|NCT01095666|466188420|FG000|Overall Study|Lost to Follow-up|2|||
129518963|NCT01095666|466188421|FG001|Overall Study|Lost to Follow-up|2|||
129518964|NCT01095666|466188422|FG002|Overall Study|Lost to Follow-up|0|||
129518965|NCT01095666|466188420|FG000|Overall Study|Withdrawal by Subject|6|||
129518966|NCT01095666|466188421|FG001|Overall Study|Withdrawal by Subject|6|||
129518967|NCT01095666|466188422|FG002|Overall Study|Withdrawal by Subject|1|||
129518968|NCT01095666|466188420|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
129518969|NCT01095666|466188421|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
129518970|NCT01095666|466188422|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
129518971|NCT01749800|466188426|FG000|Overall Study|not meeting inclusion criteria|3|||
129518972|NCT01749800|466188427|FG001|Overall Study|not meeting inclusion criteria|0|||
129518973|NCT01749800|466188428|FG002|Overall Study|not meeting inclusion criteria|0|||
129518974|NCT01749800|466188426|FG000|Overall Study|Withdrawal by Subject|0|||
129518975|NCT01749800|466188427|FG001|Overall Study|Withdrawal by Subject|1|||
129518976|NCT01749800|466188428|FG002|Overall Study|Withdrawal by Subject|0|||
129518977|NCT02810951|466188430|FG000|Overall Study|Adverse Event|1|||
129518978|NCT01928082|466188431|FG000|Overall Study|Study terminated.|1|||
129518979|NCT05563714|466188432|FG000|Overall Study|Death|2|||
129518980|NCT05563714|466188433|FG001|Overall Study|Death|2|||
129518981|NCT05563714|466188434|FG002|Overall Study|Death|0|||
129518982|NCT05563714|466188435|FG003|Overall Study|Death|0|||
129518983|NCT05563714|466188432|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
129518984|NCT05563714|466188433|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
129518985|NCT05563714|466188434|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
129518986|NCT05563714|466188435|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
129518987|NCT05563714|466188432|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
129518988|NCT05563714|466188433|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
129518989|NCT05563714|466188434|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
129518990|NCT05563714|466188435|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
129518991|NCT05563714|466188432|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
129518992|NCT05563714|466188433|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
129518993|NCT05563714|466188434|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
129518994|NCT05563714|466188435|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
129518995|NCT05563714|466188432|FG000|Overall Study|Lost to Follow-up|22|||
129518996|NCT05563714|466188433|FG001|Overall Study|Lost to Follow-up|19|||
129518997|NCT05563714|466188434|FG002|Overall Study|Lost to Follow-up|0|||
129518998|NCT05563714|466188435|FG003|Overall Study|Lost to Follow-up|0|||
129518999|NCT01610206|466188444|FG000|Overall Study|Adverse Event|10|||
129519000|NCT01610206|466188445|FG001|Overall Study|Adverse Event|30|||
129519001|NCT00166517|466188446|FG000|Overall Study|Lost to Follow-up|1|||
129519002|NCT00166517|466188447|FG001|Overall Study|Lost to Follow-up|0|||
129519003|NCT00166517|466188446|FG000|Overall Study|Protocol Violation|4|||
129519004|NCT00166517|466188447|FG001|Overall Study|Protocol Violation|1|||
129519005|NCT00166517|466188446|FG000|Overall Study|Withdrawal by Subject|0|||
129519006|NCT00166517|466188447|FG001|Overall Study|Withdrawal by Subject|1|||
129519007|NCT02186561|466188448|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
129519008|NCT02186561|466188448|FG000|Enrollment|Enrollment Cap Reached|5|||
129519009|NCT02186561|466188448|FG000|Enrollment|Insurance Denial|2|||
129519010|NCT02186561|466188448|FG000|Enrollment|Withdrawal by Subject|2|||
129519011|NCT02186561|466188448|FG000|Enrollment|Investigator Withdrew Consent|1|||
129519012|NCT02186561|466188448|FG000|30-Day Post Index Procedure Visit|Death|1|||
129519013|NCT02186561|466188448|FG000|1- Year Post Index Procedure Visit|Death|1|||
129519014|NCT02186561|466188448|FG000|1- Year Post Index Procedure Visit|Missed|1|||
129519015|NCT04285853|466188449|FG000|Overall Study|Withdrawal by Subject|1|||
129519016|NCT04285853|466188450|FG001|Overall Study|Withdrawal by Subject|0|||
129519017|NCT04285853|466188449|FG000|Overall Study|Lost to Follow-up|9|||
129519018|NCT04285853|466188450|FG001|Overall Study|Lost to Follow-up|5|||
129519019|NCT02917629|466188451|FG000|Overall Study|Withdrawal by Subject|0|||
129519020|NCT02917629|466188452|FG001|Overall Study|Withdrawal by Subject|1|||
129519021|NCT00718523|466188453|FG000|Overall Study|Withdrawal by Subject|5|||
129519022|NCT00718523|466188454|FG001|Overall Study|Withdrawal by Subject|7|||
129519023|NCT00718523|466188453|FG000|Overall Study|Death|13|||
129519024|NCT00718523|466188454|FG001|Overall Study|Death|17|||
129519025|NCT03136484|466188455|FG000|Overall Study|Withdrawal by Subject|19|||
129519026|NCT03136484|466188456|FG001|Overall Study|Withdrawal by Subject|14|||
129519027|NCT03136484|466188455|FG000|Overall Study|Lost to Follow-up|7|||
129519028|NCT03136484|466188456|FG001|Overall Study|Lost to Follow-up|8|||
129519029|NCT03136484|466188455|FG000|Overall Study|Death|1|||
129519030|NCT03136484|466188456|FG001|Overall Study|Death|0|||
129519031|NCT05041062|466188459|FG000|Overall Study|Adverse Event|2|||
129519032|NCT01802515|466188464|FG000|Overall Study|Withdrawal by Subject|3|||
129519033|NCT01802515|466188465|FG001|Overall Study|Withdrawal by Subject|0|||
129519034|NCT01802515|466188466|FG002|Overall Study|Withdrawal by Subject|0|||
129519035|NCT03038672|466190985|FG000|Initial Treatment|Unacceptable chemistry|0|||
129519036|NCT03038672|466190986|FG001|Initial Treatment|Unacceptable chemistry|1|||
129519037|NCT03038672|466190985|FG000|Initial Treatment|Progression prior to treatment|1|||
129519038|NCT03038672|466190986|FG001|Initial Treatment|Progression prior to treatment|0|||
129519039|NCT03038672|466190985|FG000|Initial Treatment|No treatment per protocol|1|||
129519040|NCT03038672|466190986|FG001|Initial Treatment|No treatment per protocol|0|||
129519041|NCT01696396|466190987|FG000|Overall Study|Withdrawal by Subject|19|||
129519042|NCT01696396|466190988|FG001|Overall Study|Withdrawal by Subject|5|||
129519043|NCT01696396|466190989|FG002|Overall Study|Withdrawal by Subject|19|||
129519044|NCT01696396|466190990|FG003|Overall Study|Withdrawal by Subject|11|||
129519045|NCT01696396|466190987|FG000|Overall Study|Decision by Sponsor|3|||
129519046|NCT01696396|466190988|FG001|Overall Study|Decision by Sponsor|1|||
129519047|NCT01696396|466190989|FG002|Overall Study|Decision by Sponsor|2|||
129519048|NCT01696396|466190990|FG003|Overall Study|Decision by Sponsor|2|||
129519049|NCT01696396|466190987|FG000|Overall Study|Lost to Follow-up|9|||
129519050|NCT01696396|466190988|FG001|Overall Study|Lost to Follow-up|1|||
129519051|NCT01696396|466190989|FG002|Overall Study|Lost to Follow-up|4|||
129519052|NCT01696396|466190990|FG003|Overall Study|Lost to Follow-up|1|||
129519053|NCT01696396|466190987|FG000|Overall Study|Death|0|||
129519054|NCT01696396|466190988|FG001|Overall Study|Death|0|||
129519055|NCT01696396|466190989|FG002|Overall Study|Death|1|||
129519056|NCT01696396|466190990|FG003|Overall Study|Death|0|||
129519057|NCT02712008|466190996|FG000|Baseline (Day 1) up to Week 12|Death|3|||
129519058|NCT02712008|466190997|FG001|Baseline (Day 1) up to Week 12|Death|0|||
129519059|NCT02712008|466190998|FG002|Baseline (Day 1) up to Week 12|Death|0|||
129519060|NCT02712008|466190999|FG003|Baseline (Day 1) up to Week 12|Death|0|||
129519061|NCT02712008|466191000|FG004|Baseline (Day 1) up to Week 12|Death|0|||
129519062|NCT02712008|466191001|FG005|Baseline (Day 1) up to Week 12|Death|0|||
129519063|NCT02712008|466191002|FG006|Baseline (Day 1) up to Week 12|Death|0|||
129519064|NCT02712008|466191003|FG007|Baseline (Day 1) up to Week 12|Death|0|||
129519065|NCT02712008|466190996|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129519066|NCT02712008|466190997|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
129519067|NCT02712008|466190998|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
129519068|NCT02712008|466190999|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129519069|NCT02712008|466191000|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129519070|NCT02712008|466191001|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129519071|NCT02712008|466191002|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129519072|NCT02712008|466191003|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
129519073|NCT02712008|466190996|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
129519074|NCT02712008|466190997|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129519075|NCT02712008|466190998|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
129519076|NCT02712008|466190999|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129519077|NCT02712008|466191000|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129519078|NCT02712008|466191001|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129519079|NCT02712008|466191002|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129519080|NCT02712008|466191003|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
129519081|NCT02712008|466190996|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519082|NCT02712008|466190997|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519083|NCT02712008|466190998|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
129519084|NCT02712008|466190999|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519085|NCT02712008|466191000|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519086|NCT02712008|466191001|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519087|NCT02712008|466191002|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519088|NCT02712008|466191003|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
129519089|NCT02712008|466190996|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519090|NCT02712008|466190997|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
129519091|NCT02712008|466190998|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519092|NCT02712008|466190999|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519093|NCT02712008|466191000|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519094|NCT02712008|466191001|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519095|NCT02712008|466191002|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519096|NCT02712008|466191003|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
129519097|NCT02712008|466190996|FG000|From Week 12 up to Week 36|Adverse Event|0|||
129519098|NCT02712008|466190997|FG001|From Week 12 up to Week 36|Adverse Event|0|||
129519099|NCT02712008|466190998|FG002|From Week 12 up to Week 36|Adverse Event|0|||
129519100|NCT02712008|466190999|FG003|From Week 12 up to Week 36|Adverse Event|0|||
129519101|NCT02712008|466191000|FG004|From Week 12 up to Week 36|Adverse Event|1|||
129519102|NCT02712008|466191001|FG005|From Week 12 up to Week 36|Adverse Event|0|||
129519103|NCT02712008|466191002|FG006|From Week 12 up to Week 36|Adverse Event|0|||
129519104|NCT02712008|466191003|FG007|From Week 12 up to Week 36|Adverse Event|2|||
129519105|NCT02712008|466190996|FG000|From Week 12 up to Week 36|Death|1|||
129519106|NCT02712008|466190997|FG001|From Week 12 up to Week 36|Death|0|||
129519107|NCT02712008|466190998|FG002|From Week 12 up to Week 36|Death|0|||
129519108|NCT02712008|466190999|FG003|From Week 12 up to Week 36|Death|0|||
129519109|NCT02712008|466191000|FG004|From Week 12 up to Week 36|Death|0|||
129519110|NCT02712008|466191001|FG005|From Week 12 up to Week 36|Death|0|||
129519111|NCT02712008|466191002|FG006|From Week 12 up to Week 36|Death|1|||
129519112|NCT02712008|466191003|FG007|From Week 12 up to Week 36|Death|0|||
129519113|NCT02712008|466190996|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
129519114|NCT02712008|466190997|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
129519115|NCT02712008|466190998|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
129519116|NCT02712008|466190999|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
129519117|NCT02712008|466191000|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
129519118|NCT02712008|466191001|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
129519119|NCT02712008|466191002|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
129519120|NCT02712008|466191003|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
129519121|NCT02712008|466190996|FG000|From Week 12 up to Week 36|Physician Decision|0|||
129519122|NCT02712008|466190997|FG001|From Week 12 up to Week 36|Physician Decision|0|||
129519123|NCT02712008|466190998|FG002|From Week 12 up to Week 36|Physician Decision|0|||
129519124|NCT02712008|466190999|FG003|From Week 12 up to Week 36|Physician Decision|1|||
129519125|NCT02712008|466191000|FG004|From Week 12 up to Week 36|Physician Decision|1|||
129519126|NCT02712008|466191001|FG005|From Week 12 up to Week 36|Physician Decision|0|||
129519127|NCT02712008|466191002|FG006|From Week 12 up to Week 36|Physician Decision|0|||
129519128|NCT02712008|466191003|FG007|From Week 12 up to Week 36|Physician Decision|0|||
129519129|NCT02712008|466190996|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
129519130|NCT02712008|466190997|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
129519131|NCT02712008|466190998|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
129519132|NCT02712008|466190999|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
129519133|NCT02712008|466191000|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
129519134|NCT02712008|466191001|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
129519135|NCT02712008|466191002|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
129519136|NCT02712008|466191003|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
129519137|NCT00959894|466191004|FG000|Overall Study|Lost to Follow-up|10|||
129519138|NCT00959894|466191004|FG000|Overall Study|Adverse Event|3|||
129519139|NCT00959894|466191004|FG000|Overall Study|Withdrawal by Subject|1|||
129519140|NCT00959894|466191004|FG000|Overall Study|Need for contraindicated medication|1|||
129519141|NCT00959894|466191004|FG000|Overall Study|Subject moved out of town|1|||
129519142|NCT00653068|466191005|FG000|Overall Study|Death|9|||
129519143|NCT00653068|466191005|FG000|Overall Study|Lack of Efficacy|34|||
129519144|NCT00653068|466191005|FG000|Overall Study|Physician Decision|4|||
129519145|NCT00653068|466191005|FG000|Overall Study|Withdrawal by Subject|1|||
129519146|NCT00653068|466191005|FG000|Overall Study|Ineligible|2|||
129519147|NCT01305941|466191006|FG000|Overall Study|Adverse Event|6|||
129519148|NCT01305941|466191006|FG000|Overall Study|Clinical decline|2|||
129519149|NCT01305941|466191006|FG000|Overall Study|Withdrawal by Subject|1|||
129519150|NCT01305941|466191006|FG000|Overall Study|Death|1|||
129519151|NCT00608244|466191011|FG000|Overall Study|Adverse Event|1|||
129519152|NCT00608244|466191011|FG000|Overall Study|Low trough levels|1|||
129519153|NCT02944513|466191016|FG000|Overall Study|Withdrawal by Subject|4|||
129519154|NCT02944513|466191017|FG001|Overall Study|Withdrawal by Subject|1|||
129519155|NCT00937326|466191021|FG000|Overall Study|Adverse Event|0|||
129519156|NCT00937326|466191022|FG001|Overall Study|Adverse Event|3|||
129519157|NCT00937326|466191023|FG002|Overall Study|Adverse Event|1|||
129519158|NCT00937326|466191024|FG003|Overall Study|Adverse Event|1|||
129519159|NCT00937326|466191025|FG004|Overall Study|Adverse Event|2|||
129519160|NCT00937326|466191021|FG000|Overall Study|Death|0|||
129519161|NCT00937326|466191022|FG001|Overall Study|Death|0|||
129519162|NCT00937326|466191023|FG002|Overall Study|Death|1|||
129519163|NCT00937326|466191024|FG003|Overall Study|Death|0|||
129519164|NCT00937326|466191025|FG004|Overall Study|Death|0|||
129519165|NCT00937326|466191021|FG000|Overall Study|Withdrawal by Subject|3|||
129519166|NCT00937326|466191022|FG001|Overall Study|Withdrawal by Subject|4|||
129519167|NCT00937326|466191023|FG002|Overall Study|Withdrawal by Subject|1|||
129519168|NCT00937326|466191024|FG003|Overall Study|Withdrawal by Subject|4|||
129519169|NCT00937326|466191025|FG004|Overall Study|Withdrawal by Subject|3|||
129519170|NCT00937326|466191021|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
129519171|NCT00937326|466191022|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
129519172|NCT00937326|466191023|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
129519173|NCT00937326|466191024|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
129519174|NCT00937326|466191025|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
129519175|NCT02578992|466191026|FG000|Overall Study|equipment not available or malfunction|3|||
129519176|NCT02578992|466191027|FG001|Overall Study|equipment not available or malfunction|3|||
129519177|NCT00086385|466191030|FG000|Overall Study|Death|2|||
129519178|NCT00086385|466191031|FG001|Overall Study|Death|2|||
129519179|NCT00086385|466191032|FG002|Overall Study|Death|1|||
129519180|NCT00086385|466191033|FG003|Overall Study|Death|1|||
129519181|NCT00880100|466191038|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
129519182|NCT00880100|466191038|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
129519183|NCT00880100|466191038|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
129519184|NCT02443155|466191039|FG000|Overall Study|Adverse Event|3|||
129519185|NCT02443155|466191040|FG001|Overall Study|Adverse Event|4|||
129519186|NCT02443155|466191041|FG002|Overall Study|Adverse Event|1|||
129519187|NCT02443155|466191042|FG003|Overall Study|Adverse Event|2|||
129519188|NCT02443155|466191039|FG000|Overall Study|Unclassified|0|||
129519189|NCT02443155|466191040|FG001|Overall Study|Unclassified|0|||
129519190|NCT02443155|466191041|FG002|Overall Study|Unclassified|2|||
129519191|NCT02443155|466191042|FG003|Overall Study|Unclassified|1|||
129519192|NCT02443155|466191039|FG000|Overall Study|Withdrawal by Subject|4|||
129519193|NCT02443155|466191040|FG001|Overall Study|Withdrawal by Subject|7|||
129519194|NCT02443155|466191041|FG002|Overall Study|Withdrawal by Subject|3|||
129519195|NCT02443155|466191042|FG003|Overall Study|Withdrawal by Subject|9|||
129519196|NCT02443155|466191039|FG000|Overall Study|Pregnancy|3|||
129519197|NCT02443155|466191040|FG001|Overall Study|Pregnancy|1|||
129519198|NCT02443155|466191041|FG002|Overall Study|Pregnancy|1|||
129519199|NCT02443155|466191042|FG003|Overall Study|Pregnancy|2|||
129519200|NCT02443155|466191039|FG000|Overall Study|Lost to Follow-up|1|||
129519201|NCT02443155|466191040|FG001|Overall Study|Lost to Follow-up|2|||
129519202|NCT02443155|466191041|FG002|Overall Study|Lost to Follow-up|0|||
129519203|NCT02443155|466191042|FG003|Overall Study|Lost to Follow-up|1|||
129519204|NCT02443155|466191039|FG000|Overall Study|Protocol Violation|1|||
129519205|NCT02443155|466191040|FG001|Overall Study|Protocol Violation|0|||
129519206|NCT02443155|466191041|FG002|Overall Study|Protocol Violation|1|||
129519207|NCT02443155|466191042|FG003|Overall Study|Protocol Violation|1|||
129519208|NCT02443155|466191039|FG000|Overall Study|Death|0|||
129519209|NCT02443155|466191040|FG001|Overall Study|Death|0|||
129519210|NCT02443155|466191041|FG002|Overall Study|Death|1|||
129519211|NCT02443155|466191042|FG003|Overall Study|Death|0|||
129519212|NCT05516134|466191045|FG000|Overall Study|Lost to Follow-up|1|||
129519213|NCT05516134|466191046|FG001|Overall Study|Lost to Follow-up|0|||
129519214|NCT05516134|466191047|FG002|Overall Study|Lost to Follow-up|0|||
129519215|NCT00254163|466191048|FG000|Overall Study|Adverse Event|29|||
129519216|NCT00254163|466191049|FG001|Overall Study|Adverse Event|26|||
129519217|NCT00254163|466191048|FG000|Overall Study|Patient request/withdrew consent|6|||
129519218|NCT00254163|466191049|FG001|Overall Study|Patient request/withdrew consent|4|||
129519219|NCT00254163|466191048|FG000|Overall Study|Investigator request|1|||
129519220|NCT00254163|466191049|FG001|Overall Study|Investigator request|3|||
129519221|NCT00254163|466191048|FG000|Overall Study|Failed entry|1|||
129519222|NCT00254163|466191049|FG001|Overall Study|Failed entry|3|||
129519223|NCT00254163|466191048|FG000|Overall Study|Progressive disease|0|||
129519224|NCT00254163|466191049|FG001|Overall Study|Progressive disease|1|||
129519225|NCT00254163|466191048|FG000|Overall Study|Death|0|||
129519226|NCT00254163|466191049|FG001|Overall Study|Death|1|||
129519227|NCT00254163|466191048|FG000|Overall Study|Other|8|||
129519228|NCT00254163|466191049|FG001|Overall Study|Other|8|||
129519229|NCT01355497|466191052|FG000|Overall Study|Death|19|||
129519230|NCT01355497|466191053|FG001|Overall Study|Death|18|||
129519231|NCT01355497|466191052|FG000|Overall Study|Lost to Follow-up|3|||
129519232|NCT01355497|466191053|FG001|Overall Study|Lost to Follow-up|0|||
129519233|NCT01355497|466191052|FG000|Overall Study|Protocol Violation|0|||
129519234|NCT01355497|466191053|FG001|Overall Study|Protocol Violation|1|||
129519235|NCT01355497|466191052|FG000|Overall Study|other-not provided|9|||
129519236|NCT01355497|466191053|FG001|Overall Study|other-not provided|4|||
129519237|NCT01355497|466191052|FG000|Overall Study|Withdrawal by Subject|12|||
129519238|NCT01355497|466191053|FG001|Overall Study|Withdrawal by Subject|20|||
129519239|NCT01355497|466191052|FG000|Overall Study|noncompliance|1|||
129519240|NCT01355497|466191053|FG001|Overall Study|noncompliance|2|||
129519241|NCT01355497|466191052|FG000|Overall Study|progressive disease|11|||
129519242|NCT01355497|466191053|FG001|Overall Study|progressive disease|8|||
129519243|NCT01355497|466191052|FG000|Overall Study|Adverse Event|11|||
129519244|NCT01355497|466191053|FG001|Overall Study|Adverse Event|10|||
129519245|NCT01784211|466191059|FG000|Part A (Days 1-15)|Adverse Event|1|||
129519246|NCT01784211|466191060|FG001|Part A (Days 1-15)|Adverse Event|1|||
129519247|NCT01784211|466191061|FG002|Part A (Days 1-15)|Adverse Event|0|||
129519248|NCT01784211|466191062|FG003|Part A (Days 1-15)|Adverse Event|0|||
129519249|NCT01784211|466191063|FG004|Part A (Days 1-15)|Adverse Event|0|||
129519250|NCT01784211|466191064|FG005|Part A (Days 1-15)|Adverse Event|0|||
129519251|NCT01784211|466191059|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
129519252|NCT01784211|466191060|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
129519253|NCT01784211|466191061|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
129519254|NCT01784211|466191062|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
129519255|NCT01784211|466191063|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
129519256|NCT01784211|466191064|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
129519257|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
129519258|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
129519259|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
129519260|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
129519261|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
129519262|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
129519263|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
129519264|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
129519265|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
129519266|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
129519267|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
129519268|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
129519269|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
129519270|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
129519271|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
129519272|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
129519273|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
129519274|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
129519275|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
129519276|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
129519277|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
129519278|NCT01001572|466191065|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
129519279|NCT01001572|466191066|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
129519280|NCT01001572|466191067|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
129519281|NCT01001572|466191065|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
129519282|NCT01001572|466191066|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
129519283|NCT01001572|466191067|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
129519284|NCT01001572|466191065|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129519285|NCT01001572|466191066|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
129519286|NCT01001572|466191067|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
129519287|NCT01001572|466191065|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
129519288|NCT01001572|466191066|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
129519289|NCT01001572|466191067|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
129519290|NCT01001572|466191065|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
129519291|NCT01001572|466191066|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
129519292|NCT01001572|466191067|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
129519293|NCT01001572|466191065|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
129519294|NCT01001572|466191066|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
129519295|NCT01001572|466191067|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
129519296|NCT01001572|466191065|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129519297|NCT01001572|466191066|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129519298|NCT01001572|466191067|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129519299|NCT01094808|466191068|FG000|Overall Study|Withdrawal by Subject|1|||
129519300|NCT01094808|466191069|FG001|Overall Study|Withdrawal by Subject|1|||
129519301|NCT01094808|466191070|FG002|Overall Study|Withdrawal by Subject|0|||
129519302|NCT00369278|466191071|FG000|Overall Study|Adverse Event|14|||
129519303|NCT00369278|466191072|FG001|Overall Study|Adverse Event|11|||
129519304|NCT00369278|466191071|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
129519305|NCT00369278|466191072|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
129519306|NCT00369278|466191071|FG000|Overall Study|Protocol Violation|2|||
129519307|NCT00369278|466191072|FG001|Overall Study|Protocol Violation|1|||
129519308|NCT00369278|466191071|FG000|Overall Study|Withdrawal by Subject|2|||
129519309|NCT00369278|466191072|FG001|Overall Study|Withdrawal by Subject|2|||
129519310|NCT00369278|466191071|FG000|Overall Study|Lost to Follow-up|1|||
129519311|NCT00369278|466191072|FG001|Overall Study|Lost to Follow-up|0|||
129519312|NCT00369278|466191071|FG000|Overall Study|Graft loss|1|||
129519313|NCT00369278|466191072|FG001|Overall Study|Graft loss|2|||
129519314|NCT01156363|466191073|FG000|Overall Study|Adverse Event|6|||
129519315|NCT01156363|466191073|FG000|Overall Study|Insufficient Therapeutic Response|5|||
129519316|NCT01156363|466191073|FG000|Overall Study|Failure to Return|1|||
129519317|NCT01156363|466191073|FG000|Overall Study|Refused Treatment|4|||
129519318|NCT01156363|466191073|FG000|Overall Study|Other|6|||
129519319|NCT01929018|466191078|FG000|Overall Study|Lost to Follow-up|1|||
129519320|NCT01929018|466191079|FG001|Overall Study|Lost to Follow-up|0|||
129519321|NCT01929018|466191078|FG000|Overall Study|Hospitalization|0|||
129519322|NCT01929018|466191079|FG001|Overall Study|Hospitalization|1|||
129519323|NCT04882072|466191080|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
129519324|NCT04882072|466191081|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
129519325|NCT04882072|466191080|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
129519326|NCT04882072|466191081|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
129519327|NCT04882072|466191080|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
129519328|NCT04882072|466191081|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
129519329|NCT03097133|466191082|FG000|Overall Study|Lost to Follow-up|3|||
129519330|NCT03097133|466191083|FG001|Overall Study|Lost to Follow-up|2|||
129519331|NCT03097133|466191082|FG000|Overall Study|Withdrawal by Subject|2|||
129519332|NCT03097133|466191083|FG001|Overall Study|Withdrawal by Subject|5|||
129519333|NCT03097133|466191082|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
129519334|NCT03097133|466191083|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
129519335|NCT03097133|466191082|FG000|Overall Study|Other|3|||
129519336|NCT03097133|466191083|FG001|Overall Study|Other|2|||
129519337|NCT03097133|466191082|FG000|Overall Study|Adverse Event|1|||
129519338|NCT03097133|466191083|FG001|Overall Study|Adverse Event|0|||
129519339|NCT00841672|466191089|FG000|Overall Study|Adverse Event|7|||
129519340|NCT00841672|466191090|FG001|Overall Study|Adverse Event|16|||
129519341|NCT00841672|466191089|FG000|Overall Study|Abnormal test procedure result(s)|0|||
129519342|NCT00841672|466191090|FG001|Overall Study|Abnormal test procedure result(s)|1|||
129519343|NCT00841672|466191089|FG000|Overall Study|Subject withdrew consent|2|||
129519344|NCT00841672|466191090|FG001|Overall Study|Subject withdrew consent|4|||
129519345|NCT00841672|466191089|FG000|Overall Study|Lost to Follow-up|1|||
129519346|NCT00841672|466191090|FG001|Overall Study|Lost to Follow-up|1|||
129519347|NCT00841672|466191089|FG000|Overall Study|Administrative problems|9|||
129519348|NCT00841672|466191090|FG001|Overall Study|Administrative problems|9|||
129519349|NCT00841672|466191089|FG000|Overall Study|Misrandomized|1|||
129519350|NCT00841672|466191090|FG001|Overall Study|Misrandomized|0|||
129519351|NCT00841672|466191089|FG000|Overall Study|Protocol Deviation|0|||
129519352|NCT00841672|466191090|FG001|Overall Study|Protocol Deviation|1|||
129519353|NCT00741260|466191095|FG000|Overall Study|Disease Progression|3|||
129519354|NCT00741260|466191096|FG001|Overall Study|Disease Progression|5|||
129519355|NCT00741260|466191097|FG002|Overall Study|Disease Progression|3|||
129519356|NCT00741260|466191098|FG003|Overall Study|Disease Progression|3|||
129519357|NCT00741260|466191099|FG004|Overall Study|Disease Progression|5|||
129519358|NCT00741260|466191100|FG005|Overall Study|Disease Progression|37|||
129519359|NCT00741260|466191101|FG006|Overall Study|Disease Progression|4|||
129519360|NCT00741260|466191095|FG000|Overall Study|Death|0|||
129519361|NCT00741260|466191096|FG001|Overall Study|Death|1|||
129519362|NCT00741260|466191097|FG002|Overall Study|Death|0|||
129519363|NCT00741260|466191098|FG003|Overall Study|Death|1|||
129519364|NCT00741260|466191099|FG004|Overall Study|Death|2|||
129519365|NCT00741260|466191100|FG005|Overall Study|Death|2|||
129519366|NCT00741260|466191101|FG006|Overall Study|Death|1|||
129519367|NCT00741260|466191095|FG000|Overall Study|Withdrawal by Subject|0|||
129519368|NCT00741260|466191096|FG001|Overall Study|Withdrawal by Subject|0|||
129519369|NCT00741260|466191097|FG002|Overall Study|Withdrawal by Subject|0|||
129519370|NCT00741260|466191098|FG003|Overall Study|Withdrawal by Subject|0|||
129519371|NCT00741260|466191099|FG004|Overall Study|Withdrawal by Subject|1|||
129519372|NCT00741260|466191100|FG005|Overall Study|Withdrawal by Subject|3|||
129519373|NCT00741260|466191101|FG006|Overall Study|Withdrawal by Subject|1|||
129519374|NCT00741260|466191095|FG000|Overall Study|Physician Decision|1|||
129519375|NCT00741260|466191096|FG001|Overall Study|Physician Decision|1|||
129519376|NCT00741260|466191097|FG002|Overall Study|Physician Decision|0|||
129519377|NCT00741260|466191098|FG003|Overall Study|Physician Decision|0|||
129519378|NCT00741260|466191099|FG004|Overall Study|Physician Decision|0|||
129519379|NCT00741260|466191100|FG005|Overall Study|Physician Decision|0|||
129519380|NCT00741260|466191101|FG006|Overall Study|Physician Decision|0|||
129519381|NCT00741260|466191095|FG000|Overall Study|Other|2|||
129519382|NCT00741260|466191096|FG001|Overall Study|Other|1|||
129519383|NCT00741260|466191097|FG002|Overall Study|Other|1|||
129519384|NCT00741260|466191098|FG003|Overall Study|Other|2|||
129519385|NCT00741260|466191099|FG004|Overall Study|Other|1|||
129519386|NCT00741260|466191100|FG005|Overall Study|Other|3|||
129519387|NCT00741260|466191101|FG006|Overall Study|Other|1|||
129519388|NCT02427100|466191102|FG000|Overall Study|Lost to Follow-up|0|||
129519389|NCT02427100|466191103|FG001|Overall Study|Lost to Follow-up|2|||
129519390|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
129519391|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
129519392|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
129519393|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
129519394|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
129519395|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
129519396|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
129519397|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
129519398|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
129519399|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
129519400|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
129519401|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
129519402|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
129519403|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
129519404|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
129519405|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
129519406|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
129519407|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
129519408|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
129519409|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
129519410|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
129519411|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
129519412|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
129519413|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
129519414|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
129519415|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
129519416|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
129519417|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
129519418|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
129519419|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129519420|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129519421|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129519422|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129519423|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129519424|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
129519425|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
129519426|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
129519427|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
129519428|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
129519429|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
129519430|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
129519431|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
129519432|NCT02120352|466191104|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
129519433|NCT02120352|466191105|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
129519434|NCT02120352|466191106|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
129519435|NCT02120352|466191107|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
129519436|NCT02120352|466191108|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
129519437|NCT02120352|466191109|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
129519438|NCT02120352|466191110|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
129519439|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
129519440|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
129519441|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
129519442|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
129519443|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
129519444|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
129519445|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
129519446|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
129519447|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
129519448|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
129519449|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
129519450|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
129519451|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
129519452|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
129519453|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
129519454|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
129519455|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
129519456|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
129519457|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
129519458|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
129519459|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
129519460|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
129519461|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
129519462|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
129519463|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
129519464|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
129519465|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
129519466|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
129519467|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
129519468|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
129519469|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
129519470|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
129519471|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
129519472|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
129519473|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
129519474|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
129519475|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
129519476|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
129519477|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
129519478|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
129519479|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
129519480|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
129519481|NCT02120352|466191104|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
129519482|NCT02120352|466191105|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
129519483|NCT02120352|466191106|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
129519484|NCT02120352|466191107|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
129519485|NCT02120352|466191108|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
129519486|NCT02120352|466191109|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
129519487|NCT02120352|466191110|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
129519488|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
129519489|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
129519490|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
129519491|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
129519492|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
129519493|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
129519494|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
129519495|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
129519496|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
129519497|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
129519498|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
129519499|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
129519500|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
129519501|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
129519502|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
129519503|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
129519504|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
129519505|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
129519506|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
129519507|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
129519508|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
129519509|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
129519510|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
129519511|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
129519512|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
129519513|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
129519514|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
129519515|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
129519516|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
129519517|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
129519518|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
129519519|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
129519520|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
129519521|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
129519522|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
129519523|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
129519524|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
129519525|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
129519526|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
129519527|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
129519528|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
129519529|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
129519530|NCT02120352|466191104|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
129519531|NCT02120352|466191105|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
129519532|NCT02120352|466191106|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
129519533|NCT02120352|466191107|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
129519534|NCT02120352|466191108|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
129519535|NCT02120352|466191109|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
129519536|NCT02120352|466191110|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
129519537|NCT02120352|466191104|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
129519538|NCT02120352|466191105|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
129519539|NCT02120352|466191106|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
129519540|NCT02120352|466191107|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
129519541|NCT02120352|466191108|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
129519542|NCT02120352|466191109|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
129519543|NCT02120352|466191110|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
129519544|NCT00842361|466191112|FG000|Overall Study|Protocol Violation|1|||
129519545|NCT00842361|466191113|FG001|Overall Study|Protocol Violation|0|||
129519546|NCT00842361|466191112|FG000|Overall Study|Unclassified|0|||
129519547|NCT00842361|466191113|FG001|Overall Study|Unclassified|2|||
129519548|NCT03094611|466191114|FG000|Overall Study|Lack of Efficacy|1|||
129519549|NCT03094611|466191114|FG000|Overall Study|Stem Cell Transplant|1|||
129519550|NCT02023112|466191124|FG000|Overall Study|Withdrawal by Subject|2|||
129519551|NCT02023112|466191125|FG001|Overall Study|Withdrawal by Subject|1|||
129519552|NCT00981747|466191129|FG000|Losartan|Withdrawal by Subject|1|||
129519553|NCT00981747|466191129|FG000|Losartan|Death|1|||
129519554|NCT00981747|466191129|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
129519555|NCT01814826|466191132|FG000|Overall Study|Other|3|||
129519556|NCT01814826|466191133|FG001|Overall Study|Other|5|||
129519557|NCT01814826|466191134|FG002|Overall Study|Other|0|||
129519558|NCT01814826|466191132|FG000|Overall Study|Death|29|||
129519559|NCT01814826|466191133|FG001|Overall Study|Death|24|||
129519560|NCT01814826|466191134|FG002|Overall Study|Death|3|||
129519561|NCT03034057|466191135|FG000|Overall Study|Withdrawal by Subject|10|||
129519562|NCT03034057|466191135|FG000|Overall Study|Protocol Violation|1|||
129519563|NCT03034057|466191135|FG000|Overall Study|Not defined|2|||
129519564|NCT03034057|466191135|FG000|Overall Study|Lost to Follow-up|19|||
129519565|NCT03034057|466191135|FG000|Overall Study|Adverse Event|22|||
129519566|NCT03034057|466191135|FG000|Overall Study|Medication error without associated AE|1|||
129519567|NCT03339401|466191136|FG000|Overall Study|Death|2|||
129519568|NCT03339401|466191137|FG001|Overall Study|Death|1|||
129519569|NCT03339401|466191136|FG000|Overall Study|Withdrawal by Subject|2|||
129519570|NCT03339401|466191137|FG001|Overall Study|Withdrawal by Subject|0|||
129519571|NCT03339401|466191136|FG000|Overall Study|Study terminated|4|||
129519572|NCT03339401|466191137|FG001|Overall Study|Study terminated|3|||
129519573|NCT03339401|466191136|FG000|Overall Study|Investigator Decision|1|||
129519574|NCT03339401|466191137|FG001|Overall Study|Investigator Decision|0|||
129519575|NCT03271307|466191138|FG000|Overall Study|Lost to Follow-up|0|||
129519576|NCT03271307|466191139|FG001|Overall Study|Lost to Follow-up|0|||
129519577|NCT03271307|466191140|FG002|Overall Study|Lost to Follow-up|0|||
129519578|NCT03271307|466191141|FG003|Overall Study|Lost to Follow-up|28|||
129519579|NCT03271307|466191142|FG004|Overall Study|Lost to Follow-up|91|||
129519580|NCT03365947|466191143|FG000|Overall Study|Lost to Follow-up|0|||
129519581|NCT03365947|466191144|FG001|Overall Study|Lost to Follow-up|0|||
129519582|NCT03365947|466191145|FG002|Overall Study|Lost to Follow-up|0|||
129519583|NCT03365947|466191146|FG003|Overall Study|Lost to Follow-up|0|||
129519584|NCT03365947|466191147|FG004|Overall Study|Lost to Follow-up|0|||
129519585|NCT03365947|466191148|FG005|Overall Study|Lost to Follow-up|1|||
129519586|NCT03365947|466191149|FG006|Overall Study|Lost to Follow-up|0|||
129519587|NCT03365947|466191150|FG007|Overall Study|Lost to Follow-up|0|||
129519588|NCT03365947|466191151|FG008|Overall Study|Lost to Follow-up|0|||
129519589|NCT03365947|466191152|FG009|Overall Study|Lost to Follow-up|0|||
129519590|NCT03365947|466191153|FG010|Overall Study|Lost to Follow-up|0|||
129519591|NCT03365947|466191154|FG011|Overall Study|Lost to Follow-up|0|||
129519592|NCT03365947|466191155|FG012|Overall Study|Lost to Follow-up|0|||
129519593|NCT03365947|466191156|FG013|Overall Study|Lost to Follow-up|0|||
129519594|NCT03365947|466191157|FG014|Overall Study|Lost to Follow-up|0|||
129519595|NCT03365947|466191158|FG015|Overall Study|Lost to Follow-up|0|||
129519596|NCT03365947|466191159|FG016|Overall Study|Lost to Follow-up|0|||
129519597|NCT03365947|466191160|FG017|Overall Study|Lost to Follow-up|0|||
129519598|NCT03365947|466191161|FG018|Overall Study|Lost to Follow-up|0|||
129519599|NCT01042938|466191162|FG000|Overall Study|Withdrawal by Subject|1|||
129519600|NCT01042938|466191163|FG001|Overall Study|Withdrawal by Subject|1|||
129519601|NCT01042938|466191162|FG000|Overall Study|Protocol Violation|1|||
129519602|NCT01042938|466191163|FG001|Overall Study|Protocol Violation|1|||
129519603|NCT01042938|466191162|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
129519604|NCT01042938|466191163|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
129519605|NCT03997760|466191166|FG000|Overall Study|Protocol Deviation|0|||
129519606|NCT03997760|466191167|FG001|Overall Study|Protocol Deviation|1|||
129519607|NCT03997760|466191168|FG002|Overall Study|Protocol Deviation|0|||
129519608|NCT03997760|466191169|FG003|Overall Study|Protocol Deviation|0|||
129519609|NCT00856986|466191170|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
129519610|NCT00856986|466191171|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
129519611|NCT00856986|466191172|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
129519612|NCT00856986|466191173|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
129519613|NCT00856986|466191174|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
129519614|NCT00856986|466191170|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
129519615|NCT00856986|466191171|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
129519616|NCT00856986|466191172|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
129519617|NCT00856986|466191173|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
129519618|NCT00856986|466191174|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
129519619|NCT00856986|466191170|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
129519620|NCT00856986|466191171|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
129519621|NCT00856986|466191172|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
129519622|NCT00856986|466191173|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
129519623|NCT00856986|466191174|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
129519624|NCT00856986|466191170|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
129519625|NCT00856986|466191171|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
129519626|NCT00856986|466191172|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
129519627|NCT00856986|466191173|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
129519628|NCT00856986|466191174|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
129519629|NCT00856986|466191170|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
129519630|NCT00856986|466191171|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
129519631|NCT00856986|466191172|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
129519632|NCT00856986|466191173|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
129519633|NCT00856986|466191174|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
129519634|NCT00856986|466191170|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
129519635|NCT00856986|466191171|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
129519636|NCT00856986|466191172|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
129519637|NCT00856986|466191173|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
129519638|NCT00856986|466191174|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
129519639|NCT00856986|466191170|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
129519640|NCT00856986|466191171|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
129519641|NCT00856986|466191172|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
129519642|NCT00856986|466191173|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
129519643|NCT00856986|466191174|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
129519644|NCT00856986|466191170|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
129519645|NCT00856986|466191171|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
129519646|NCT00856986|466191172|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
129519647|NCT00856986|466191173|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
129519648|NCT00856986|466191174|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
129519649|NCT00856986|466191170|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
129519650|NCT00856986|466191171|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
129519651|NCT00856986|466191172|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
129519652|NCT00856986|466191173|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
129519653|NCT00856986|466191174|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
129519654|NCT00856986|466191170|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
129519655|NCT00856986|466191171|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
129519656|NCT00856986|466191172|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
129519657|NCT00856986|466191173|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
129519658|NCT00856986|466191174|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
129519659|NCT00856986|466191170|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
129519660|NCT00856986|466191171|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
129519661|NCT00856986|466191172|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
129519662|NCT00856986|466191173|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
129519663|NCT00856986|466191174|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
129519664|NCT00856986|466191170|FG000|Main Period, Weeks 0-26|Unclassified|7|||
129519665|NCT00856986|466191171|FG001|Main Period, Weeks 0-26|Unclassified|6|||
129519666|NCT00856986|466191172|FG002|Main Period, Weeks 0-26|Unclassified|7|||
129519667|NCT00856986|466191173|FG003|Main Period, Weeks 0-26|Unclassified|0|||
129519668|NCT00856986|466191174|FG004|Main Period, Weeks 0-26|Unclassified|0|||
129519669|NCT00856986|466191170|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
129519670|NCT00856986|466191171|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
129519671|NCT00856986|466191172|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
129519672|NCT00856986|466191173|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
129519673|NCT00856986|466191174|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
129519674|NCT00856986|466191170|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
129519675|NCT00856986|466191171|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
129519676|NCT00856986|466191172|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
129519677|NCT00856986|466191173|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
129519678|NCT00856986|466191174|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
129519679|NCT00856986|466191170|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
129519680|NCT00856986|466191171|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
129519681|NCT00856986|466191172|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
129519682|NCT00856986|466191173|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
129519683|NCT00856986|466191174|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
129519684|NCT00856986|466191170|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
129519685|NCT00856986|466191171|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
129519686|NCT00856986|466191172|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
129519687|NCT00856986|466191173|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
129519688|NCT00856986|466191174|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
129519689|NCT00856986|466191170|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
129519690|NCT00856986|466191171|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
129519691|NCT00856986|466191172|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
129519692|NCT00856986|466191173|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
129519693|NCT00856986|466191174|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
129519694|NCT00856986|466191170|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
129519695|NCT00856986|466191171|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
129519696|NCT00856986|466191172|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
129519697|NCT00856986|466191173|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
129519698|NCT00856986|466191174|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
129519699|NCT01915095|466191175|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
129519700|NCT01915095|466191176|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
129519701|NCT01915095|466191177|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
129519702|NCT01915095|466191178|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
129519703|NCT01915095|466191179|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
129519704|NCT02067533|466191182|FG000|Overall Study|Lost to Follow-up|4|||
129519705|NCT02067533|466191183|FG001|Overall Study|Lost to Follow-up|2|||
129519706|NCT02999191|466191185|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
129519707|NCT02999191|466191186|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
129519708|NCT02999191|466191187|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
129519709|NCT02896192|466191189|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
129519710|NCT02896192|466191189|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
129519711|NCT02896192|466191189|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
129519712|NCT01199198|466192914|FG000|Overall Study|Adverse Event|3|||
129519713|NCT01199198|466192915|FG001|Overall Study|Adverse Event|0|||
129519714|NCT01199198|466192914|FG000|Overall Study|Lost to Follow-up|1|||
129519715|NCT01199198|466192915|FG001|Overall Study|Lost to Follow-up|5|||
129519716|NCT01199198|466192914|FG000|Overall Study|Withdrawal by Subject|1|||
129519717|NCT01199198|466192915|FG001|Overall Study|Withdrawal by Subject|2|||
129519718|NCT01199198|466192914|FG000|Overall Study|ICU Transfer|1|||
129519719|NCT01199198|466192915|FG001|Overall Study|ICU Transfer|2|||
129519720|NCT01199198|466192914|FG000|Overall Study|Hospice-care transfer|1|||
129519721|NCT01199198|466192915|FG001|Overall Study|Hospice-care transfer|2|||
129519722|NCT02892734|466192916|FG000|Treatment on Study|Progressive Disease|2|||
129519723|NCT02892734|466192916|FG000|Follow up for 2 Years|Death|2|||
129519724|NCT02892734|466192916|FG000|Follow up for 2 Years|Study closed early|1|||
129519725|NCT02043509|466192917|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
129519726|NCT02043509|466192918|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
129519727|NCT02043509|466192917|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
129519728|NCT02043509|466192918|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
129519729|NCT02043509|466192917|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
129519730|NCT02043509|466192918|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
129519731|NCT02043509|466192917|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
129519732|NCT02043509|466192918|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
129519733|NCT02000219|466192922|FG000|14-Week Study Period|Physician Decision|1|||
129519734|NCT02000219|466192922|FG000|14-Week Study Period|Adverse Event|1|||
129519735|NCT02000219|466192922|FG000|14-Week Study Period|Underwent transplantation|1|||
129519736|NCT02000219|466192922|FG000|Continuation Period|Withdrawal by Subject|1|||
129519737|NCT02000219|466192922|FG000|Continuation Period|Had liver transplant|2|||
129519738|NCT02000219|466192922|FG000|Continuation Period|Non-compliance with study drug|2|||
129519739|NCT00608894|466192926|FG000|Overall Study|Withdrawal by Subject|0|||
129519740|NCT00608894|466192927|FG001|Overall Study|Withdrawal by Subject|2|||
129519741|NCT01376388|466192935|FG000|Overall Study|Adverse Event|13|||
129519742|NCT01376388|466192935|FG000|Overall Study|Lack of Efficacy|2|||
129519743|NCT01376388|466192935|FG000|Overall Study|Withdrawal by Subject|3|||
129519744|NCT00106249|466192943|FG000|Overall Study|Lost to Follow-up|3|||
129519745|NCT00106249|466192944|FG001|Overall Study|Lost to Follow-up|2|||
129519746|NCT01495689|466192952|FG000|Overall Study|Death|0|||
129519747|NCT01495689|466192953|FG001|Overall Study|Death|1|||
129519748|NCT01495689|466192952|FG000|Overall Study|Withdrawal by Subject|3|||
129519749|NCT01495689|466192953|FG001|Overall Study|Withdrawal by Subject|0|||
129519750|NCT01495689|466192952|FG000|Overall Study|Lost to Follow-up|7|||
129519751|NCT01495689|466192953|FG001|Overall Study|Lost to Follow-up|6|||
129519752|NCT00524043|466192954|FG000|Overall Study|Lack of Efficacy|15|||
129519753|NCT00524043|466192955|FG001|Overall Study|Lack of Efficacy|13|||
129519754|NCT00524043|466192956|FG002|Overall Study|Lack of Efficacy|14|||
129519755|NCT00524043|466192954|FG000|Overall Study|Withdrawal by Subject|5|||
129519756|NCT00524043|466192955|FG001|Overall Study|Withdrawal by Subject|7|||
129519757|NCT00524043|466192956|FG002|Overall Study|Withdrawal by Subject|7|||
129519758|NCT00524043|466192954|FG000|Overall Study|Adverse Event|5|||
129519759|NCT00524043|466192955|FG001|Overall Study|Adverse Event|2|||
129519760|NCT00524043|466192956|FG002|Overall Study|Adverse Event|7|||
129519761|NCT00524043|466192954|FG000|Overall Study|Lost to Follow-up|3|||
129519762|NCT00524043|466192955|FG001|Overall Study|Lost to Follow-up|5|||
129519763|NCT00524043|466192956|FG002|Overall Study|Lost to Follow-up|3|||
129519764|NCT00524043|466192954|FG000|Overall Study|Various (eg, incarceration)|2|||
129519765|NCT00524043|466192955|FG001|Overall Study|Various (eg, incarceration)|1|||
129519766|NCT00524043|466192956|FG002|Overall Study|Various (eg, incarceration)|0|||
129519767|NCT01843205|466192961|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
129519768|NCT01843205|466192962|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
129519769|NCT00606177|466192963|FG000|Overall Study|Adverse Event|9|||
129519770|NCT00606177|466192964|FG001|Overall Study|Adverse Event|5|||
129519771|NCT00606177|466192963|FG000|Overall Study|Lack of Efficacy|3|||
129519772|NCT00606177|466192964|FG001|Overall Study|Lack of Efficacy|7|||
129519773|NCT00606177|466192963|FG000|Overall Study|Physician Decision|1|||
129519774|NCT00606177|466192964|FG001|Overall Study|Physician Decision|0|||
129519775|NCT00606177|466192963|FG000|Overall Study|Protocol Violation|1|||
129519776|NCT00606177|466192964|FG001|Overall Study|Protocol Violation|4|||
129519777|NCT00606177|466192963|FG000|Overall Study|Withdrawal by Subject|5|||
129519778|NCT00606177|466192964|FG001|Overall Study|Withdrawal by Subject|6|||
129519779|NCT00606177|466192963|FG000|Overall Study|Progression to depressive phase|6|||
129519780|NCT00606177|466192964|FG001|Overall Study|Progression to depressive phase|1|||
129519781|NCT00606177|466192963|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
129519782|NCT00606177|466192964|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
129519783|NCT00606177|466192963|FG000|Overall Study|Change of residence or other commitments|1|||
129519784|NCT00606177|466192964|FG001|Overall Study|Change of residence or other commitments|1|||
129519785|NCT00136357|466192965|FG000|Overall Study|Withdrawal by Subject|3|||
129519786|NCT00136357|466192966|FG001|Overall Study|Withdrawal by Subject|2|||
129519787|NCT00216086|466192969|FG000|Overall Study|Protocol Violation|1|||
129519788|NCT00216086|466192969|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
129519789|NCT00216086|466192969|FG000|Overall Study|Social Reasons|2|||
129519790|NCT02025530|466192973|FG000|Overall Study|No longer met elligibility criteria|5|||
129519791|NCT02025530|466192974|FG001|Overall Study|No longer met elligibility criteria|1|||
129519792|NCT01017549|466192977|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
129519793|NCT01017549|466192977|FG000|One-year Follow-up|Lost to Follow-up|2|||
129519794|NCT01017549|466192977|FG000|One-year Follow-up|Withdrawal by Subject|5|||
129519795|NCT01017549|466192977|FG000|5 Year Follow-up|Lost to Follow-up|9|||
129519796|NCT01017549|466192977|FG000|5 Year Follow-up|Mastectomy|3|||
129519797|NCT02728206|466192979|FG000|Overall Study|Death|1|||
129519798|NCT02773368|466192980|FG000|Overall Study|Lost to Follow-up|4|||
129519799|NCT02773368|466192981|FG001|Overall Study|Lost to Follow-up|1|||
129519800|NCT02773368|466192980|FG000|Overall Study|Withdrawal by Subject|5|||
129519801|NCT02773368|466192981|FG001|Overall Study|Withdrawal by Subject|1|||
129519802|NCT02773368|466192980|FG000|Overall Study|Unclassified|1|||
129519803|NCT02773368|466192981|FG001|Overall Study|Unclassified|1|||
129519804|NCT02773368|466192980|FG000|Overall Study|Missing|0|||
129519805|NCT02773368|466192981|FG001|Overall Study|Missing|1|||
129519806|NCT02635867|466192984|FG000|Overall Study|Lost to Follow-up|4|||
129519807|NCT02635867|466192985|FG001|Overall Study|Lost to Follow-up|3|||
129519808|NCT02635867|466192986|FG002|Overall Study|Lost to Follow-up|3|||
129519809|NCT02635867|466192987|FG003|Overall Study|Lost to Follow-up|4|||
129519810|NCT02635867|466192988|FG004|Overall Study|Lost to Follow-up|1|||
129519811|NCT02918318|466192989|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
129519812|NCT02918318|466192990|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
129519813|NCT02918318|466192991|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
129519814|NCT02918318|466192992|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
129519815|NCT02918318|466192993|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
129519816|NCT02918318|466192989|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
129519817|NCT02918318|466192990|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
129519818|NCT02918318|466192991|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
129519819|NCT02918318|466192992|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
129519820|NCT02918318|466192993|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
129519821|NCT02918318|466192989|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
129519822|NCT02918318|466192990|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
129519823|NCT02918318|466192991|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
129519824|NCT02918318|466192992|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
129519825|NCT02918318|466192993|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
129519826|NCT02918318|466192989|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
129519827|NCT02918318|466192990|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
129519828|NCT02918318|466192991|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
129519829|NCT02918318|466192992|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
129519830|NCT02918318|466192993|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
129519831|NCT02918318|466192989|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
129519832|NCT02918318|466192990|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
129519833|NCT02918318|466192991|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
129519834|NCT02918318|466192992|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
129519835|NCT02918318|466192993|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
129519836|NCT02918318|466192989|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
129519837|NCT02918318|466192990|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
129519838|NCT02918318|466192991|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
129519839|NCT02918318|466192992|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
129519840|NCT02918318|466192993|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
129519841|NCT02918318|466192989|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
129519842|NCT02918318|466192990|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
129519843|NCT02918318|466192991|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
129519844|NCT02918318|466192992|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
129519845|NCT02918318|466192993|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
129519846|NCT02918318|466192989|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
129519847|NCT02918318|466192990|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
129519848|NCT02918318|466192991|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
129519849|NCT02918318|466192992|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
129519850|NCT02918318|466192993|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
129519851|NCT02918318|466192989|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
129519852|NCT02918318|466192990|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
129519853|NCT02918318|466192991|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
129519854|NCT02918318|466192992|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
129519855|NCT02918318|466192993|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
129519856|NCT02918318|466192989|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
129519857|NCT02918318|466192990|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
129519858|NCT02918318|466192991|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
129519859|NCT02918318|466192992|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
129519860|NCT02918318|466192993|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
129519861|NCT02918318|466192989|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
129519862|NCT02918318|466192990|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
129519863|NCT02918318|466192991|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
129519864|NCT02918318|466192992|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
129519865|NCT02918318|466192993|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
129519866|NCT02918318|466192989|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
129519867|NCT02918318|466192990|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
129519868|NCT02918318|466192991|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
129519869|NCT02918318|466192992|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
129519870|NCT02918318|466192993|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
129519871|NCT01782885|466192994|FG000|Overall Study|Lost to Follow-up|4|||
129519872|NCT01782885|466192995|FG001|Overall Study|Lost to Follow-up|6|||
129519873|NCT03447821|466192996|FG000|Overall Study|Withdrawal by Subject|1|||
129519874|NCT03447821|466192997|FG001|Overall Study|Withdrawal by Subject|1|||
129519875|NCT03447821|466192998|FG002|Overall Study|Withdrawal by Subject|0|||
129519876|NCT03447821|466192996|FG000|Overall Study|Lost to Follow-up|0|||
129519877|NCT03447821|466192997|FG001|Overall Study|Lost to Follow-up|0|||
129519878|NCT03447821|466192998|FG002|Overall Study|Lost to Follow-up|1|||
129519879|NCT00329784|466193001|FG000|Overall Study|Lost to Follow-up|0|||
129519880|NCT00329784|466193002|FG001|Overall Study|Lost to Follow-up|1|||
129519881|NCT00329784|466193003|FG002|Overall Study|Lost to Follow-up|0|||
129519882|NCT00329784|466193004|FG003|Overall Study|Lost to Follow-up|0|||
129519883|NCT00329784|466193001|FG000|Overall Study|Withdrawal by Subject|4|||
129519884|NCT00329784|466193002|FG001|Overall Study|Withdrawal by Subject|2|||
129519885|NCT00329784|466193003|FG002|Overall Study|Withdrawal by Subject|0|||
129519886|NCT00329784|466193004|FG003|Overall Study|Withdrawal by Subject|0|||
129519887|NCT00329784|466193001|FG000|Overall Study|Other|1|||
129519888|NCT00329784|466193002|FG001|Overall Study|Other|2|||
129519889|NCT00329784|466193003|FG002|Overall Study|Other|0|||
129519890|NCT00329784|466193004|FG003|Overall Study|Other|0|||
129519891|NCT00045630|466193012|FG000|Overall Study|Adverse Event|1|||
129519892|NCT00045630|466193012|FG000|Overall Study|Refusal unrelated to adverse event|1|||
129519893|NCT00045630|466193012|FG000|Overall Study|Progression/relapse|1|||
129519894|NCT00045630|466193012|FG000|Overall Study|Death|1|||
129519895|NCT00045630|466193012|FG000|Overall Study|Ineligible|2|||
129519896|NCT00924729|466193013|FG000|Overall Study|insufficient volume for analysis|1|||
129519897|NCT00924729|466193014|FG001|Overall Study|insufficient volume for analysis|0|||
129519898|NCT00924729|466193013|FG000|Overall Study|Protocol Violation|1|||
129519899|NCT00924729|466193014|FG001|Overall Study|Protocol Violation|0|||
129519900|NCT01929707|466193015|FG000|Intervention Period 1|Lost to Follow-up|0|||
129519901|NCT01929707|466193016|FG001|Intervention Period 1|Lost to Follow-up|0|||
129519902|NCT01929707|466193017|FG002|Intervention Period 1|Lost to Follow-up|0|||
129519903|NCT01929707|466193018|FG003|Intervention Period 1|Lost to Follow-up|1|||
129519904|NCT01929707|466193019|FG004|Intervention Period 1|Lost to Follow-up|0|||
129519905|NCT01929707|466193020|FG005|Intervention Period 1|Lost to Follow-up|0|||
129519906|NCT01929707|466193021|FG006|Intervention Period 1|Lost to Follow-up|0|||
129519907|NCT01929707|466193022|FG007|Intervention Period 1|Lost to Follow-up|0|||
129519908|NCT01929707|466193015|FG000|Intervention Period 1|Withdrawal by Subject|0|||
129519909|NCT01929707|466193016|FG001|Intervention Period 1|Withdrawal by Subject|0|||
129519910|NCT01929707|466193017|FG002|Intervention Period 1|Withdrawal by Subject|0|||
129519911|NCT01929707|466193018|FG003|Intervention Period 1|Withdrawal by Subject|2|||
129519912|NCT01929707|466193019|FG004|Intervention Period 1|Withdrawal by Subject|0|||
129519913|NCT01929707|466193020|FG005|Intervention Period 1|Withdrawal by Subject|0|||
129519914|NCT01929707|466193021|FG006|Intervention Period 1|Withdrawal by Subject|0|||
129519915|NCT01929707|466193022|FG007|Intervention Period 1|Withdrawal by Subject|0|||
129519916|NCT01929707|466193015|FG000|Intervention Period 2|Withdrawal by Subject|0|||
129519917|NCT01929707|466193016|FG001|Intervention Period 2|Withdrawal by Subject|0|||
129519918|NCT01929707|466193017|FG002|Intervention Period 2|Withdrawal by Subject|0|||
129519919|NCT01929707|466193018|FG003|Intervention Period 2|Withdrawal by Subject|0|||
129519920|NCT01929707|466193019|FG004|Intervention Period 2|Withdrawal by Subject|0|||
129519921|NCT01929707|466193020|FG005|Intervention Period 2|Withdrawal by Subject|2|||
129519922|NCT01929707|466193021|FG006|Intervention Period 2|Withdrawal by Subject|0|||
129519923|NCT01929707|466193022|FG007|Intervention Period 2|Withdrawal by Subject|0|||
129519924|NCT00437203|466193023|FG000|Overall Study|Death|0|||
129519925|NCT00437203|466193024|FG001|Overall Study|Death|0|||
129519926|NCT00437203|466193025|FG002|Overall Study|Death|1|||
129519927|NCT00437203|466193026|FG003|Overall Study|Death|0|||
129519928|NCT00437203|466193027|FG004|Overall Study|Death|0|||
129519929|NCT00437203|466193028|FG005|Overall Study|Death|0|||
129519930|NCT00437203|466193029|FG006|Overall Study|Death|0|||
129519931|NCT00437203|466193030|FG007|Overall Study|Death|1|||
129519932|NCT00437203|466193031|FG008|Overall Study|Death|0|||
129519933|NCT00437203|466193032|FG009|Overall Study|Death|1|||
129519934|NCT00437203|466193023|FG000|Overall Study|Adverse Event|1|||
129519935|NCT00437203|466193024|FG001|Overall Study|Adverse Event|1|||
129519936|NCT00437203|466193025|FG002|Overall Study|Adverse Event|0|||
129519937|NCT00437203|466193026|FG003|Overall Study|Adverse Event|0|||
129519938|NCT00437203|466193027|FG004|Overall Study|Adverse Event|0|||
129519939|NCT00437203|466193028|FG005|Overall Study|Adverse Event|0|||
129519940|NCT00437203|466193029|FG006|Overall Study|Adverse Event|0|||
129519941|NCT00437203|466193030|FG007|Overall Study|Adverse Event|1|||
129519942|NCT00437203|466193031|FG008|Overall Study|Adverse Event|0|||
129519943|NCT00437203|466193032|FG009|Overall Study|Adverse Event|1|||
129519944|NCT00437203|466193023|FG000|Overall Study|Study terminated by sponsor|0|||
129519945|NCT00437203|466193024|FG001|Overall Study|Study terminated by sponsor|0|||
129519946|NCT00437203|466193025|FG002|Overall Study|Study terminated by sponsor|0|||
129519947|NCT00437203|466193026|FG003|Overall Study|Study terminated by sponsor|0|||
129519948|NCT00437203|466193027|FG004|Overall Study|Study terminated by sponsor|0|||
129519949|NCT00437203|466193028|FG005|Overall Study|Study terminated by sponsor|0|||
129519950|NCT00437203|466193029|FG006|Overall Study|Study terminated by sponsor|0|||
129519951|NCT00437203|466193030|FG007|Overall Study|Study terminated by sponsor|0|||
129519952|NCT00437203|466193031|FG008|Overall Study|Study terminated by sponsor|1|||
129519953|NCT00437203|466193032|FG009|Overall Study|Study terminated by sponsor|0|||
129519954|NCT00437203|466193023|FG000|Overall Study|Objective progression or relapse|5|||
129519955|NCT00437203|466193024|FG001|Overall Study|Objective progression or relapse|6|||
129519956|NCT00437203|466193025|FG002|Overall Study|Objective progression or relapse|2|||
129519957|NCT00437203|466193026|FG003|Overall Study|Objective progression or relapse|3|||
129519958|NCT00437203|466193027|FG004|Overall Study|Objective progression or relapse|3|||
129519959|NCT00437203|466193028|FG005|Overall Study|Objective progression or relapse|3|||
129519960|NCT00437203|466193029|FG006|Overall Study|Objective progression or relapse|6|||
129519961|NCT00437203|466193030|FG007|Overall Study|Objective progression or relapse|1|||
129519962|NCT00437203|466193031|FG008|Overall Study|Objective progression or relapse|2|||
129519963|NCT00437203|466193032|FG009|Overall Study|Objective progression or relapse|2|||
129519964|NCT00437203|466193023|FG000|Overall Study|Other|0|||
129519965|NCT00437203|466193024|FG001|Overall Study|Other|1|||
129519966|NCT00437203|466193025|FG002|Overall Study|Other|0|||
129519967|NCT00437203|466193026|FG003|Overall Study|Other|0|||
129519968|NCT00437203|466193027|FG004|Overall Study|Other|0|||
129519969|NCT00437203|466193028|FG005|Overall Study|Other|0|||
129519970|NCT00437203|466193029|FG006|Overall Study|Other|1|||
129519971|NCT00437203|466193030|FG007|Overall Study|Other|0|||
129519972|NCT00437203|466193031|FG008|Overall Study|Other|0|||
129519973|NCT00437203|466193032|FG009|Overall Study|Other|0|||
129519974|NCT01449955|466193033|FG000|Overall Study|Withdrawal by Subject|1|||
129519975|NCT01449955|466193034|FG001|Overall Study|Withdrawal by Subject|2|||
129519976|NCT04018612|466193035|FG000|Overall Study|Withdrawal by Subject|1|||
129519977|NCT04018612|466193036|FG001|Overall Study|Withdrawal by Subject|0|||
129519978|NCT04018612|466193037|FG002|Overall Study|Withdrawal by Subject|1|||
129519979|NCT02671760|466193038|FG000|Overall Study|Lost to Follow-up|0|||
129519980|NCT02671760|466193039|FG001|Overall Study|Lost to Follow-up|1|||
129519981|NCT02671760|466193040|FG002|Overall Study|Lost to Follow-up|0|||
129519982|NCT01906476|466193041|FG000|Overall Study|Lost to Follow-up|17|||
129519983|NCT01906476|466193042|FG001|Overall Study|Lost to Follow-up|16|||
129519984|NCT01993667|466193043|FG000|Overall Study|Insufficient data to analyze|16|||
129519985|NCT01993667|466193044|FG001|Overall Study|Insufficient data to analyze|16|||
129519986|NCT01993667|466193043|FG000|Overall Study|Insufficient altitude reached|3|||
129519987|NCT01993667|466193044|FG001|Overall Study|Insufficient altitude reached|1|||
129519988|NCT01993667|466193043|FG000|Overall Study|Lost to Follow-up|2|||
129519989|NCT01993667|466193044|FG001|Overall Study|Lost to Follow-up|2|||
129519990|NCT00479167|466193048|FG000|Overall Study|Withdrawal by Subject|1|||
129519991|NCT01997281|466193053|FG000|Overall Study|Withdrawal by Subject|1|||
129519992|NCT01997281|466193054|FG001|Overall Study|Withdrawal by Subject|0|||
129519993|NCT00560794|466193055|FG000|Overall Study|Adverse Event|2|||
129519994|NCT00560794|466193055|FG000|Overall Study|Patient was not Compliant|1|||
129519995|NCT00560794|466193055|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
129519996|NCT00560794|466193055|FG000|Overall Study|Hematological Relapse|1|||
129519997|NCT00560794|466193055|FG000|Overall Study|Received Bone Marrow Transplant|6|||
129519998|NCT04857892|466193056|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
129519999|NCT04857892|466193057|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
129520000|NCT04857892|466193058|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
129520001|NCT04857892|466193059|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
129520002|NCT04857892|466193060|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
129520003|NCT04857892|466193056|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
129520004|NCT04857892|466193057|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
129520005|NCT04857892|466193058|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
129520006|NCT04857892|466193059|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
129520007|NCT04857892|466193060|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
129520008|NCT04857892|466193056|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
129520009|NCT04857892|466193057|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
129520010|NCT04857892|466193058|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
129520011|NCT04857892|466193059|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
129520012|NCT04857892|466193060|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
129520013|NCT02384993|466193065|FG000|Overall Study|Adverse Event|0|||
129520014|NCT02384993|466193066|FG001|Overall Study|Adverse Event|1|||
129520015|NCT03938636|466194898|FG000|Overall Study|Protocol Violation|0|||
129520016|NCT03938636|466194899|FG001|Overall Study|Protocol Violation|1|||
129520017|NCT03938636|466194900|FG002|Overall Study|Protocol Violation|1|||
129520018|NCT03938636|466194898|FG000|Overall Study|Subject withdrew due to death in family|0|||
129520019|NCT03938636|466194899|FG001|Overall Study|Subject withdrew due to death in family|1|||
129520020|NCT03938636|466194900|FG002|Overall Study|Subject withdrew due to death in family|0|||
129520021|NCT03938636|466194898|FG000|Overall Study|Missed visit|0|||
129520022|NCT03938636|466194899|FG001|Overall Study|Missed visit|1|||
129520023|NCT03938636|466194900|FG002|Overall Study|Missed visit|0|||
129520024|NCT03938636|466194898|FG000|Overall Study|Adverse Event|0|||
129520025|NCT03938636|466194899|FG001|Overall Study|Adverse Event|0|||
129520026|NCT03938636|466194900|FG002|Overall Study|Adverse Event|1|||
129520027|NCT03938636|466194898|FG000|Overall Study|Lost to Follow-up|0|||
129520028|NCT03938636|466194899|FG001|Overall Study|Lost to Follow-up|0|||
129520029|NCT03938636|466194900|FG002|Overall Study|Lost to Follow-up|1|||
129520030|NCT01100658|466194901|FG000|Overall Study|Withdrawal by Subject|1|||
129520031|NCT00711412|466194902|FG000|Induction Treatment|Death|2|||
129520032|NCT00711412|466194902|FG000|Induction Treatment|Adverse Event|1|||
129520033|NCT00711412|466194902|FG000|Induction Treatment|Other|1|||
129520034|NCT00711412|466194902|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
129520035|NCT00711412|466194902|FG000|Evaluated for Combination Treatment|Death|1|||
129520036|NCT00711412|466194902|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
129520037|NCT00711412|466194902|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
129520038|NCT00711412|466194902|FG000|Combination Treatment|Progressive Disease|1|||
129520039|NCT00711412|466194902|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
129520040|NCT00711412|466194902|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
129520041|NCT00711412|466194902|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
129520042|NCT00711412|466194902|FG000|Evaluation for Response and Surgery|Death|1|||
129520043|NCT00711412|466194902|FG000|Survival Follow up Until Death|Other|12|||
129520044|NCT00420342|466194906|FG000|Overall Study|Lost to Follow-up|1|||
129520045|NCT00420342|466194907|FG001|Overall Study|Lost to Follow-up|0|||
129520046|NCT00420342|466194908|FG002|Overall Study|Lost to Follow-up|1|||
129520047|NCT00420342|466194906|FG000|Overall Study|Withdrawal by Subject|0|||
129520048|NCT00420342|466194907|FG001|Overall Study|Withdrawal by Subject|2|||
129520049|NCT00420342|466194908|FG002|Overall Study|Withdrawal by Subject|0|||
129520050|NCT04072575|466194909|FG000|Overall Study|Physician Decision|1|||
129520051|NCT04072575|466194909|FG000|Overall Study|Adverse Event|7|||
129520052|NCT04072575|466194909|FG000|Overall Study|Withdrawal by Subject|14|||
129520053|NCT04072575|466194909|FG000|Overall Study|Other|2|||
129520054|NCT02473289|466194910|FG000|Overall Study|Adverse Event|2|||
129520055|NCT02473289|466194911|FG001|Overall Study|Adverse Event|3|||
129520056|NCT02473289|466194910|FG000|Overall Study|Lost to Follow-up|1|||
129520057|NCT02473289|466194911|FG001|Overall Study|Lost to Follow-up|1|||
129520058|NCT02473289|466194910|FG000|Overall Study|Protocol Violation|0|||
129520059|NCT02473289|466194911|FG001|Overall Study|Protocol Violation|1|||
129520060|NCT02473289|466194910|FG000|Overall Study|Withdrawal of consent|6|||
129520061|NCT02473289|466194911|FG001|Overall Study|Withdrawal of consent|7|||
129520062|NCT02473289|466194910|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
129520063|NCT02473289|466194911|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
129520064|NCT02473289|466194910|FG000|Overall Study|Other|2|||
129520065|NCT02473289|466194911|FG001|Overall Study|Other|0|||
129520066|NCT00047008|466194915|FG000|Overall Study|Withdrawn consent|2|||
129520067|NCT00047008|466194916|FG001|Overall Study|Withdrawn consent|3|||
129520068|NCT00047008|466194915|FG000|Overall Study|Ineligible|9|||
129520069|NCT00047008|466194916|FG001|Overall Study|Ineligible|8|||
129520070|NCT00429572|466194917|FG000|Overall Study|Disease progression|1|||
129520071|NCT01366534|466194918|FG000|Overall Study|Lost to Follow-up|1|||
129520072|NCT01366534|466194919|FG001|Overall Study|Lost to Follow-up|0|||
129520073|NCT01366534|466194920|FG002|Overall Study|Lost to Follow-up|0|||
129520074|NCT01366534|466194918|FG000|Overall Study|Migrated|1|||
129520075|NCT01366534|466194919|FG001|Overall Study|Migrated|1|||
129520076|NCT01366534|466194920|FG002|Overall Study|Migrated|0|||
129520077|NCT01366534|466194918|FG000|Overall Study|Declined challenged|0|||
129520078|NCT01366534|466194919|FG001|Overall Study|Declined challenged|1|||
129520079|NCT01366534|466194920|FG002|Overall Study|Declined challenged|0|||
129520080|NCT02565576|466194922|FG000|Overall Study|abnormal lab value|2|||
129520081|NCT02565576|466194923|FG001|Overall Study|abnormal lab value|0|||
129520082|NCT02565576|466194922|FG000|Overall Study|subject / guardian decision|1|||
129520083|NCT02565576|466194923|FG001|Overall Study|subject / guardian decision|3|||
129520084|NCT02565576|466194922|FG000|Overall Study|Lost to Follow-up|1|||
129520085|NCT02565576|466194923|FG001|Overall Study|Lost to Follow-up|0|||
129520086|NCT02565576|466194922|FG000|Overall Study|Death|0|||
129520087|NCT02565576|466194923|FG001|Overall Study|Death|2|||
129520088|NCT02565576|466194922|FG000|Overall Study|Adverse Event|1|||
129520089|NCT02565576|466194923|FG001|Overall Study|Adverse Event|0|||
129520090|NCT01408732|466194924|FG000|Overall Study|Withdrawal by Subject|2|||
129520091|NCT01408732|466194925|FG001|Overall Study|Withdrawal by Subject|2|||
129520092|NCT00424099|466194926|FG000|Overall Study|Adverse Event|0|||
129520093|NCT00424099|466194927|FG001|Overall Study|Adverse Event|1|||
129520094|NCT00424099|466194928|FG002|Overall Study|Adverse Event|1|||
129520095|NCT00424099|466194929|FG003|Overall Study|Adverse Event|0|||
129520096|NCT00424099|466194926|FG000|Overall Study|Death|0|||
129520097|NCT00424099|466194927|FG001|Overall Study|Death|1|||
129520098|NCT00424099|466194928|FG002|Overall Study|Death|0|||
129520099|NCT00424099|466194929|FG003|Overall Study|Death|0|||
129520100|NCT00424099|466194926|FG000|Overall Study|Illness|2|||
129520101|NCT00424099|466194927|FG001|Overall Study|Illness|0|||
129520102|NCT00424099|466194928|FG002|Overall Study|Illness|1|||
129520103|NCT00424099|466194929|FG003|Overall Study|Illness|4|||
129520104|NCT00424099|466194926|FG000|Overall Study|Lost to Follow-up|0|||
129520105|NCT00424099|466194927|FG001|Overall Study|Lost to Follow-up|0|||
129520106|NCT00424099|466194928|FG002|Overall Study|Lost to Follow-up|3|||
129520107|NCT00424099|466194929|FG003|Overall Study|Lost to Follow-up|0|||
129520108|NCT00424099|466194926|FG000|Overall Study|Hospitalized|1|||
129520109|NCT00424099|466194927|FG001|Overall Study|Hospitalized|2|||
129520110|NCT00424099|466194928|FG002|Overall Study|Hospitalized|1|||
129520111|NCT00424099|466194929|FG003|Overall Study|Hospitalized|3|||
129520112|NCT00424099|466194926|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
129520113|NCT00424099|466194927|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
129520114|NCT00424099|466194928|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
129520115|NCT00424099|466194929|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
129520116|NCT00424099|466194926|FG000|Overall Study|Withdrawal by Subject|1|||
129520117|NCT00424099|466194927|FG001|Overall Study|Withdrawal by Subject|9|||
129520118|NCT00424099|466194928|FG002|Overall Study|Withdrawal by Subject|4|||
129520119|NCT00424099|466194929|FG003|Overall Study|Withdrawal by Subject|6|||
129520120|NCT00424099|466194926|FG000|Overall Study|Physician Decision|0|||
129520121|NCT00424099|466194927|FG001|Overall Study|Physician Decision|0|||
129520122|NCT00424099|466194928|FG002|Overall Study|Physician Decision|1|||
129520123|NCT00424099|466194929|FG003|Overall Study|Physician Decision|0|||
129520124|NCT00424099|466194926|FG000|Overall Study|Missing|0|||
129520125|NCT00424099|466194927|FG001|Overall Study|Missing|0|||
129520126|NCT00424099|466194928|FG002|Overall Study|Missing|1|||
129520127|NCT00424099|466194929|FG003|Overall Study|Missing|0|||
129520128|NCT03345342|466194930|FG000|Open-Label Phase|Adverse Event|30|||
129520129|NCT03345342|466194931|FG001|Open-Label Phase|Adverse Event|0|||
129520130|NCT03345342|466194932|FG002|Open-Label Phase|Adverse Event|0|||
129520131|NCT03345342|466194933|FG003|Open-Label Phase|Adverse Event|0|||
129520132|NCT03345342|466194934|FG004|Open-Label Phase|Adverse Event|0|||
129520133|NCT03345342|466194930|FG000|Open-Label Phase|Death|1|||
129520134|NCT03345342|466194931|FG001|Open-Label Phase|Death|0|||
129520135|NCT03345342|466194932|FG002|Open-Label Phase|Death|0|||
129520136|NCT03345342|466194933|FG003|Open-Label Phase|Death|0|||
129520137|NCT03345342|466194934|FG004|Open-Label Phase|Death|0|||
129520138|NCT03345342|466194930|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
129520139|NCT03345342|466194931|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
129520140|NCT03345342|466194932|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
129520141|NCT03345342|466194933|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
129520142|NCT03345342|466194934|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
129520143|NCT03345342|466194930|FG000|Open-Label Phase|Lack of Efficacy|6|||
129520144|NCT03345342|466194931|FG001|Open-Label Phase|Lack of Efficacy|0|||
129520145|NCT03345342|466194932|FG002|Open-Label Phase|Lack of Efficacy|0|||
129520146|NCT03345342|466194933|FG003|Open-Label Phase|Lack of Efficacy|0|||
129520147|NCT03345342|466194934|FG004|Open-Label Phase|Lack of Efficacy|0|||
129520148|NCT03345342|466194930|FG000|Open-Label Phase|Lost to Follow-up|9|||
129520149|NCT03345342|466194931|FG001|Open-Label Phase|Lost to Follow-up|0|||
129520150|NCT03345342|466194932|FG002|Open-Label Phase|Lost to Follow-up|0|||
129520151|NCT03345342|466194933|FG003|Open-Label Phase|Lost to Follow-up|0|||
129520152|NCT03345342|466194934|FG004|Open-Label Phase|Lost to Follow-up|0|||
129520153|NCT03345342|466194930|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
129520154|NCT03345342|466194931|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
129520155|NCT03345342|466194932|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
129520156|NCT03345342|466194933|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
129520157|NCT03345342|466194934|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
129520158|NCT03345342|466194930|FG000|Open-Label Phase|Physician Decision|4|||
129520159|NCT03345342|466194931|FG001|Open-Label Phase|Physician Decision|0|||
129520160|NCT03345342|466194932|FG002|Open-Label Phase|Physician Decision|0|||
129520161|NCT03345342|466194933|FG003|Open-Label Phase|Physician Decision|0|||
129520162|NCT03345342|466194934|FG004|Open-Label Phase|Physician Decision|0|||
129520163|NCT03345342|466194930|FG000|Open-Label Phase|Protocol Violation|8|||
129520164|NCT03345342|466194931|FG001|Open-Label Phase|Protocol Violation|0|||
129520165|NCT03345342|466194932|FG002|Open-Label Phase|Protocol Violation|0|||
129520166|NCT03345342|466194933|FG003|Open-Label Phase|Protocol Violation|0|||
129520167|NCT03345342|466194934|FG004|Open-Label Phase|Protocol Violation|0|||
129520168|NCT03345342|466194930|FG000|Open-Label Phase|Withdrawal by Subject|57|||
129520169|NCT03345342|466194931|FG001|Open-Label Phase|Withdrawal by Subject|0|||
129520170|NCT03345342|466194932|FG002|Open-Label Phase|Withdrawal by Subject|0|||
129520171|NCT03345342|466194933|FG003|Open-Label Phase|Withdrawal by Subject|0|||
129520172|NCT03345342|466194934|FG004|Open-Label Phase|Withdrawal by Subject|0|||
129520173|NCT03345342|466194930|FG000|Open-Label Phase|Other|15|||
129520174|NCT03345342|466194931|FG001|Open-Label Phase|Other|0|||
129520175|NCT03345342|466194932|FG002|Open-Label Phase|Other|0|||
129520176|NCT03345342|466194933|FG003|Open-Label Phase|Other|0|||
129520177|NCT03345342|466194934|FG004|Open-Label Phase|Other|0|||
129520178|NCT03345342|466194930|FG000|Double-Blind Phase|Adverse Event|0|||
129520179|NCT03345342|466194931|FG001|Double-Blind Phase|Adverse Event|1|||
129520180|NCT03345342|466194932|FG002|Double-Blind Phase|Adverse Event|6|||
129520181|NCT03345342|466194933|FG003|Double-Blind Phase|Adverse Event|0|||
129520182|NCT03345342|466194934|FG004|Double-Blind Phase|Adverse Event|0|||
129520183|NCT03345342|466194930|FG000|Double-Blind Phase|Death|0|||
129520184|NCT03345342|466194931|FG001|Double-Blind Phase|Death|2|||
129520185|NCT03345342|466194932|FG002|Double-Blind Phase|Death|1|||
129520186|NCT03345342|466194933|FG003|Double-Blind Phase|Death|0|||
129520187|NCT03345342|466194934|FG004|Double-Blind Phase|Death|0|||
129520188|NCT03345342|466194930|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
129520189|NCT03345342|466194931|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
129520190|NCT03345342|466194932|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
129520191|NCT03345342|466194933|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
129520192|NCT03345342|466194934|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
129520193|NCT03345342|466194930|FG000|Double-Blind Phase|Lost to Follow-up|0|||
129520194|NCT03345342|466194931|FG001|Double-Blind Phase|Lost to Follow-up|1|||
129520195|NCT03345342|466194932|FG002|Double-Blind Phase|Lost to Follow-up|7|||
129520196|NCT03345342|466194933|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129520197|NCT03345342|466194934|FG004|Double-Blind Phase|Lost to Follow-up|0|||
129520198|NCT03345342|466194930|FG000|Double-Blind Phase|Physician Decision|0|||
129520199|NCT03345342|466194931|FG001|Double-Blind Phase|Physician Decision|1|||
129520200|NCT03345342|466194932|FG002|Double-Blind Phase|Physician Decision|4|||
129520201|NCT03345342|466194933|FG003|Double-Blind Phase|Physician Decision|0|||
129520202|NCT03345342|466194934|FG004|Double-Blind Phase|Physician Decision|0|||
129520203|NCT03345342|466194930|FG000|Double-Blind Phase|Protocol Violation|0|||
129520204|NCT03345342|466194931|FG001|Double-Blind Phase|Protocol Violation|0|||
129520205|NCT03345342|466194932|FG002|Double-Blind Phase|Protocol Violation|1|||
129520206|NCT03345342|466194933|FG003|Double-Blind Phase|Protocol Violation|0|||
129520207|NCT03345342|466194934|FG004|Double-Blind Phase|Protocol Violation|0|||
129520208|NCT03345342|466194930|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
129520209|NCT03345342|466194931|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
129520210|NCT03345342|466194932|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
129520211|NCT03345342|466194933|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
129520212|NCT03345342|466194934|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
129520213|NCT03345342|466194930|FG000|Double-Blind Phase|Other|0|||
129520214|NCT03345342|466194931|FG001|Double-Blind Phase|Other|1|||
129520215|NCT03345342|466194932|FG002|Double-Blind Phase|Other|3|||
129520216|NCT03345342|466194933|FG003|Double-Blind Phase|Other|0|||
129520217|NCT03345342|466194934|FG004|Double-Blind Phase|Other|0|||
129520218|NCT03345342|466194930|FG000|Follow-Up Phase|Adverse Event|0|||
129520219|NCT03345342|466194931|FG001|Follow-Up Phase|Adverse Event|0|||
129520220|NCT03345342|466194932|FG002|Follow-Up Phase|Adverse Event|0|||
129520221|NCT03345342|466194933|FG003|Follow-Up Phase|Adverse Event|0|||
129520222|NCT03345342|466194934|FG004|Follow-Up Phase|Adverse Event|4|||
129520223|NCT03345342|466194930|FG000|Follow-Up Phase|Lost to Follow-up|0|||
129520224|NCT03345342|466194931|FG001|Follow-Up Phase|Lost to Follow-up|0|||
129520225|NCT03345342|466194932|FG002|Follow-Up Phase|Lost to Follow-up|0|||
129520226|NCT03345342|466194933|FG003|Follow-Up Phase|Lost to Follow-up|0|||
129520227|NCT03345342|466194934|FG004|Follow-Up Phase|Lost to Follow-up|6|||
129520228|NCT03345342|466194930|FG000|Follow-Up Phase|Physician Decision|0|||
129520229|NCT03345342|466194931|FG001|Follow-Up Phase|Physician Decision|0|||
129520230|NCT03345342|466194932|FG002|Follow-Up Phase|Physician Decision|0|||
129520231|NCT03345342|466194933|FG003|Follow-Up Phase|Physician Decision|0|||
129520232|NCT03345342|466194934|FG004|Follow-Up Phase|Physician Decision|5|||
129520233|NCT03345342|466194930|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
129520234|NCT03345342|466194931|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
129520235|NCT03345342|466194932|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
129520236|NCT03345342|466194933|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
129520237|NCT03345342|466194934|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
129520238|NCT03345342|466194930|FG000|Follow-Up Phase|Other|0|||
129520239|NCT03345342|466194931|FG001|Follow-Up Phase|Other|0|||
129520240|NCT03345342|466194932|FG002|Follow-Up Phase|Other|0|||
129520241|NCT03345342|466194933|FG003|Follow-Up Phase|Other|3|||
129520242|NCT03345342|466194934|FG004|Follow-Up Phase|Other|1|||
129520243|NCT02782104|466194939|FG000|Overall Study|Other|215|||
129520244|NCT02782104|466194939|FG000|Overall Study|Induction Day 28 Non Responder|9|||
129520245|NCT02782104|466194939|FG000|Overall Study|Non-Compliance with Study Drug|2|||
129520246|NCT02782104|466194939|FG000|Overall Study|Death|8|||
129520247|NCT02782104|466194939|FG000|Overall Study|Pregnancy|6|||
129520248|NCT02782104|466194939|FG000|Overall Study|Withdrawal by Subject|63|||
129520249|NCT02782104|466194939|FG000|Overall Study|Protocol Violation|7|||
129520250|NCT02782104|466194939|FG000|Overall Study|Lack of Efficacy|61|||
129520251|NCT02782104|466194939|FG000|Overall Study|Lost to Follow-up|23|||
129520252|NCT02782104|466194939|FG000|Overall Study|Adverse Event|74|||
129520253|NCT03185819|466194940|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
129520254|NCT03185819|466194941|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
129520255|NCT03185819|466194942|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
129520256|NCT03185819|466194943|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
129520257|NCT03185819|466194940|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
129520258|NCT03185819|466194941|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
129520259|NCT03185819|466194942|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
129520260|NCT03185819|466194943|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
129520261|NCT03185819|466194940|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
129520262|NCT03185819|466194941|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
129520263|NCT03185819|466194942|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
129520264|NCT03185819|466194943|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
129520265|NCT03185819|466194940|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
129520266|NCT03185819|466194941|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
129520267|NCT03185819|466194942|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
129520268|NCT03185819|466194943|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
129520269|NCT03185819|466194940|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
129520270|NCT03185819|466194941|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
129520271|NCT03185819|466194942|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
129520272|NCT03185819|466194943|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
129520273|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
129520274|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
129520275|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
129520276|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
129520277|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
129520278|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
129520279|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
129520280|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
129520281|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
129520282|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
129520283|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
129520284|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
129520285|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
129520286|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
129520287|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
129520288|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
129520289|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
129520290|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
129520291|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
129520292|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
129520293|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
129520294|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
129520295|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
129520296|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
129520297|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
129520298|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
129520299|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
129520300|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
129520301|NCT03185819|466194940|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
129520302|NCT03185819|466194941|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
129520303|NCT03185819|466194942|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
129520304|NCT03185819|466194943|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
129520305|NCT02438787|466194944|FG000|Overall Study|Adverse Event|1|||
129520306|NCT02438787|466194945|FG001|Overall Study|Adverse Event|0|||
129520307|NCT02438787|466194946|FG002|Overall Study|Adverse Event|2|||
129520308|NCT02438787|466194944|FG000|Overall Study|Lack of Efficacy|1|||
129520309|NCT02438787|466194945|FG001|Overall Study|Lack of Efficacy|2|||
129520310|NCT02438787|466194946|FG002|Overall Study|Lack of Efficacy|0|||
129520311|NCT02438787|466194944|FG000|Overall Study|Lost to Follow-up|0|||
129520312|NCT02438787|466194945|FG001|Overall Study|Lost to Follow-up|1|||
129520313|NCT02438787|466194946|FG002|Overall Study|Lost to Follow-up|0|||
129520314|NCT02438787|466194944|FG000|Overall Study|Protocol Violation|0|||
129520315|NCT02438787|466194945|FG001|Overall Study|Protocol Violation|0|||
129520316|NCT02438787|466194946|FG002|Overall Study|Protocol Violation|1|||
129520317|NCT02438787|466194944|FG000|Overall Study|Withdrawal by Subject|15|||
129520318|NCT02438787|466194945|FG001|Overall Study|Withdrawal by Subject|7|||
129520319|NCT02438787|466194946|FG002|Overall Study|Withdrawal by Subject|10|||
129520320|NCT02438787|466194944|FG000|Overall Study|Study discontinued by sponsor|64|||
129520321|NCT02438787|466194945|FG001|Overall Study|Study discontinued by sponsor|72|||
129520322|NCT02438787|466194946|FG002|Overall Study|Study discontinued by sponsor|69|||
129520323|NCT02438787|466194944|FG000|Overall Study|Other|0|||
129520324|NCT02438787|466194945|FG001|Overall Study|Other|1|||
129520325|NCT02438787|466194946|FG002|Overall Study|Other|0|||
129520326|NCT02438787|466194944|FG000|Overall Study|Site terminated by sponsor|0|||
129520327|NCT02438787|466194945|FG001|Overall Study|Site terminated by sponsor|0|||
129520328|NCT02438787|466194946|FG002|Overall Study|Site terminated by sponsor|1|||
129520329|NCT03375203|466194947|FG000|Overall Study|Protocol Violation|0|||
129520330|NCT03375203|466194948|FG001|Overall Study|Protocol Violation|0|||
129520331|NCT03375203|466194949|FG002|Overall Study|Protocol Violation|1|||
129520332|NCT03375203|466194950|FG003|Overall Study|Protocol Violation|0|||
129520333|NCT03375203|466194951|FG004|Overall Study|Protocol Violation|0|||
129520334|NCT03375203|466194947|FG000|Overall Study|Adverse Event|2|||
129520335|NCT03375203|466194948|FG001|Overall Study|Adverse Event|3|||
129520336|NCT03375203|466194949|FG002|Overall Study|Adverse Event|0|||
129520337|NCT03375203|466194950|FG003|Overall Study|Adverse Event|2|||
129520338|NCT03375203|466194951|FG004|Overall Study|Adverse Event|2|||
129520339|NCT03375203|466194947|FG000|Overall Study|Withdrawal by Subject|3|||
129520340|NCT03375203|466194948|FG001|Overall Study|Withdrawal by Subject|0|||
129520341|NCT03375203|466194949|FG002|Overall Study|Withdrawal by Subject|1|||
129520342|NCT03375203|466194950|FG003|Overall Study|Withdrawal by Subject|0|||
129520343|NCT03375203|466194951|FG004|Overall Study|Withdrawal by Subject|2|||
129520344|NCT03375203|466194947|FG000|Overall Study|Non-compliance with study drug|1|||
129520345|NCT03375203|466194948|FG001|Overall Study|Non-compliance with study drug|0|||
129520346|NCT03375203|466194949|FG002|Overall Study|Non-compliance with study drug|0|||
129520347|NCT03375203|466194950|FG003|Overall Study|Non-compliance with study drug|0|||
129520348|NCT03375203|466194951|FG004|Overall Study|Non-compliance with study drug|0|||
129520349|NCT03375203|466194947|FG000|Overall Study|Randomized, not treated.|0|||
129520350|NCT03375203|466194948|FG001|Overall Study|Randomized, not treated.|1|||
129520351|NCT03375203|466194949|FG002|Overall Study|Randomized, not treated.|0|||
129520352|NCT03375203|466194950|FG003|Overall Study|Randomized, not treated.|0|||
129520353|NCT03375203|466194951|FG004|Overall Study|Randomized, not treated.|0|||
129520354|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
129520355|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
129520356|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
129520357|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
129520358|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
129520359|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
129520360|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
129520361|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
129520362|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
129520363|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
129520364|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
129520365|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
129520366|NCT03321526|466194952|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
129520367|NCT03321526|466194953|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
129520368|NCT03321526|466194952|FG000|Follow-up Phase (2 Weeks)|Other|24|||
129520369|NCT03321526|466194953|FG001|Follow-up Phase (2 Weeks)|Other|24|||
129520370|NCT00732641|466194957|FG000|Overall Study|Relapse or Progressive Disease|65|||
129520371|NCT00732641|466194958|FG001|Overall Study|Relapse or Progressive Disease|101|||
129520372|NCT00732641|466194957|FG000|Overall Study|Serious Adverse Events|12|||
129520373|NCT00732641|466194958|FG001|Overall Study|Serious Adverse Events|3|||
129520374|NCT00732641|466194957|FG000|Overall Study|Physician Decision|6|||
129520375|NCT00732641|466194958|FG001|Overall Study|Physician Decision|0|||
129520376|NCT00732641|466194957|FG000|Overall Study|Withdrawal by Subject|4|||
129520377|NCT00732641|466194958|FG001|Overall Study|Withdrawal by Subject|2|||
129520378|NCT00732641|466194957|FG000|Overall Study|Unable to Complete|1|||
129520379|NCT00732641|466194958|FG001|Overall Study|Unable to Complete|1|||
129520380|NCT00732641|466194957|FG000|Overall Study|Other|18|||
129520381|NCT00732641|466194958|FG001|Overall Study|Other|5|||
129520382|NCT00732238|466194959|FG000|Overall Study|Bacteremia|4|||
129520383|NCT00732238|466194960|FG001|Overall Study|Bacteremia|1|||
129520384|NCT00732238|466194959|FG000|Overall Study|Asymptomatic bacteriuria|1|||
129520385|NCT00732238|466194960|FG001|Overall Study|Asymptomatic bacteriuria|0|||
129520386|NCT02280096|466194961|FG000|Overall Study|Pregnancy|1|||
129520387|NCT02280096|466194962|FG001|Overall Study|Pregnancy|0|||
129520388|NCT02280096|466194961|FG000|Overall Study|Functional neurological disorder|1|||
129520389|NCT02280096|466194962|FG001|Overall Study|Functional neurological disorder|0|||
129520390|NCT02280096|466194961|FG000|Overall Study|Lack of attachment|0|||
129520391|NCT02280096|466194962|FG001|Overall Study|Lack of attachment|1|||
129520392|NCT02939976|466194965|FG000|Overall Study|Lost to Follow-up|7|||
129520393|NCT02939976|466194966|FG001|Overall Study|Lost to Follow-up|1|||
129520394|NCT02939976|466194967|FG002|Overall Study|Lost to Follow-up|1|||
129520395|NCT02939976|466194968|FG003|Overall Study|Lost to Follow-up|2|||
129520396|NCT02939976|466194965|FG000|Overall Study|Withdrawal by Subject|4|||
129520397|NCT02939976|466194966|FG001|Overall Study|Withdrawal by Subject|0|||
129520398|NCT02939976|466194967|FG002|Overall Study|Withdrawal by Subject|2|||
129520399|NCT02939976|466194968|FG003|Overall Study|Withdrawal by Subject|4|||
129520400|NCT02939976|466194965|FG000|Overall Study|Due to early study closure|4|||
129520401|NCT02939976|466194966|FG001|Overall Study|Due to early study closure|3|||
129520402|NCT02939976|466194967|FG002|Overall Study|Due to early study closure|2|||
129520403|NCT02939976|466194968|FG003|Overall Study|Due to early study closure|3|||
129520404|NCT00246376|466194969|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
129520405|NCT00246376|466194970|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
129520406|NCT00246376|466194971|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
129520407|NCT00246376|466194972|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
129520408|NCT00246376|466194973|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
129520409|NCT00246376|466194969|FG000|Overall Study|Adverse Event|2|||
129520410|NCT00246376|466194970|FG001|Overall Study|Adverse Event|3|||
129520411|NCT00246376|466194971|FG002|Overall Study|Adverse Event|1|||
129520412|NCT00246376|466194972|FG003|Overall Study|Adverse Event|3|||
129520413|NCT00246376|466194973|FG004|Overall Study|Adverse Event|1|||
129520414|NCT00246376|466194969|FG000|Overall Study|Lost to Follow-up|2|||
129520415|NCT00246376|466194970|FG001|Overall Study|Lost to Follow-up|11|||
129520416|NCT00246376|466194971|FG002|Overall Study|Lost to Follow-up|11|||
129520417|NCT00246376|466194972|FG003|Overall Study|Lost to Follow-up|16|||
129520418|NCT00246376|466194973|FG004|Overall Study|Lost to Follow-up|13|||
129520419|NCT01872897|466194974|FG000|Overall Study|Withdrawal by Subject|1|||
129520420|NCT01872897|466194975|FG001|Overall Study|Withdrawal by Subject|0|||
129520421|NCT02418585|466194978|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
129520422|NCT02418585|466194979|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
129520423|NCT02418585|466194978|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
129520424|NCT02418585|466194979|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
129520425|NCT02418585|466194978|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
129520426|NCT02418585|466194979|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
129520427|NCT02418585|466194978|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
129520428|NCT02418585|466194979|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
129520429|NCT02418585|466194978|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
129520430|NCT02418585|466194979|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
129520431|NCT02418585|466194978|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
129520432|NCT02418585|466194979|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
129520433|NCT02418585|466194978|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
129520434|NCT02418585|466194979|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
129520435|NCT02418585|466194978|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
129520436|NCT02418585|466194979|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
129520437|NCT02418585|466194978|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
129520438|NCT02418585|466194979|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
129520439|NCT02418585|466194978|FG000|Follow-up Phase (24 Weeks)|Other|3|||
129520440|NCT02418585|466194979|FG001|Follow-up Phase (24 Weeks)|Other|2|||
129520441|NCT02040857|466194980|FG000|Overall Study|Adverse Event|14|||
129520442|NCT02040857|466194980|FG000|Overall Study|Physician Decision|5|||
129520443|NCT02040857|466194980|FG000|Overall Study|Withdrawal by Subject|31|||
129520444|NCT02040857|466194980|FG000|Overall Study|patient non-compliance|3|||
129520445|NCT02040857|466194980|FG000|Overall Study|Lost to Follow-up|2|||
129520446|NCT02040857|466194980|FG000|Overall Study|recurrence|4|||
129520447|NCT02040857|466194980|FG000|Overall Study|ineligible|1|||
129520448|NCT04159701|466194981|FG000|Period 1: Treatment Period|Pregnancy|1|||
129520449|NCT04159701|466194982|FG001|Period 1: Treatment Period|Pregnancy|0|||
129520450|NCT04159701|466194981|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
129520451|NCT04159701|466194982|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
129520452|NCT04159701|466194981|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
129520453|NCT04159701|466194982|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
129520454|NCT04159701|466194981|FG000|Washout Period|site terminated by sponsor|0|||
129520455|NCT04159701|466194982|FG001|Washout Period|site terminated by sponsor|1|||
129520456|NCT04159701|466194981|FG000|Washout Period|study terminated by sponsor|10|||
129520457|NCT04159701|466194982|FG001|Washout Period|study terminated by sponsor|3|||
129520458|NCT04159701|466194981|FG000|Washout Period|Withdrawal by Subject|1|||
129520459|NCT04159701|466194982|FG001|Washout Period|Withdrawal by Subject|0|||
129520460|NCT04159701|466194981|FG000|Washout Period|Inadvertent Enrollment|1|||
129520461|NCT04159701|466194982|FG001|Washout Period|Inadvertent Enrollment|0|||
129520462|NCT04159701|466194981|FG000|Washout Period|Miscellaneous|1|||
129520463|NCT04159701|466194982|FG001|Washout Period|Miscellaneous|0|||
129520464|NCT04159701|466194981|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
129520465|NCT04159701|466194982|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
129520466|NCT04159701|466194981|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
129520467|NCT04159701|466194982|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
129520468|NCT04159701|466194981|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
129520469|NCT04159701|466194982|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
129520470|NCT04159701|466194981|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
129520471|NCT04159701|466194982|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
129520472|NCT04159701|466194981|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
129520473|NCT04159701|466194982|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
129520474|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
129520475|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
129520476|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
129520477|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
129520478|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
129520479|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
129520480|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
129520481|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
129520482|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
129520483|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
129520484|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
129520485|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
129520486|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
129520487|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
129520488|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
129520489|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
129520490|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
129520491|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
129520492|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
129520493|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
129520494|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
129520495|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
129520496|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
129520497|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
129520498|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
129520499|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
129520500|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
129520501|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
129520502|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
129520503|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
129520504|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
129520505|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
129520506|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
129520507|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
129520508|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
129520509|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
129520510|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
129520511|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
129520512|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
129520513|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
129520514|NCT03605836|466194983|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
129520515|NCT03605836|466194984|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
129520516|NCT03605836|466194985|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
129520517|NCT03605836|466194986|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
129520518|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
129520519|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
129520520|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
129520521|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
129520522|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
129520523|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
129520524|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
129520525|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
129520526|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
129520527|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
129520528|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
129520529|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
129520530|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
129520531|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
129520532|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
129520533|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
129520534|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
129520535|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
129520536|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
129520537|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
129520538|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
129520539|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
129520540|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
129520541|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
129520542|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
129520543|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
129520544|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
129520545|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
129520546|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
129520547|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
129520548|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
129520549|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
129520550|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
129520551|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
129520552|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
129520553|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
129520554|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
129520555|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
129520556|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
129520557|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
129520558|NCT03605836|466194983|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
129520559|NCT03605836|466194984|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
129520560|NCT03605836|466194985|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
129520561|NCT03605836|466194986|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
129520562|NCT00865046|466194987|FG000|Overall Study|Lost to Follow-up|1|||
129520563|NCT00865046|466194988|FG001|Overall Study|Lost to Follow-up|4|||
129520564|NCT00865046|466194989|FG002|Overall Study|Lost to Follow-up|0|||
129520565|NCT00865046|466194987|FG000|Overall Study|Death|0|||
129520566|NCT00865046|466194988|FG001|Overall Study|Death|1|||
129520567|NCT00865046|466194989|FG002|Overall Study|Death|1|||
129520568|NCT00865046|466194987|FG000|Overall Study|Withdrawal by Subject|5|||
129520569|NCT00865046|466194988|FG001|Overall Study|Withdrawal by Subject|0|||
129520570|NCT00865046|466194989|FG002|Overall Study|Withdrawal by Subject|0|||
129520571|NCT00481988|466194994|FG000|Overall Study|Withdrawal by Subject|1|||
129520572|NCT00481988|466194995|FG001|Overall Study|Withdrawal by Subject|1|||
129520573|NCT00654420|466194996|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
129520574|NCT00654420|466194997|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
129520575|NCT00654420|466194998|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
129520576|NCT00654420|466194999|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
129520577|NCT00654420|466194996|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
129520578|NCT00654420|466194997|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
129520579|NCT00654420|466194998|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
129520580|NCT00654420|466194999|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
129520581|NCT00654420|466194996|FG000|Phase II|Adverse Event|0|||
129520582|NCT00654420|466194997|FG001|Phase II|Adverse Event|0|||
129520583|NCT00654420|466194998|FG002|Phase II|Adverse Event|3|||
129520584|NCT00654420|466194999|FG003|Phase II|Adverse Event|3|||
129520585|NCT00654420|466194996|FG000|Phase II|Lost to Follow-up|0|||
129520586|NCT00654420|466194997|FG001|Phase II|Lost to Follow-up|0|||
129520587|NCT00654420|466194998|FG002|Phase II|Lost to Follow-up|0|||
129520588|NCT00654420|466194999|FG003|Phase II|Lost to Follow-up|1|||
129520589|NCT00654420|466194996|FG000|Phase II|Physician Decision|0|||
129520590|NCT00654420|466194997|FG001|Phase II|Physician Decision|0|||
129520591|NCT00654420|466194998|FG002|Phase II|Physician Decision|0|||
129520592|NCT00654420|466194999|FG003|Phase II|Physician Decision|4|||
129520593|NCT00654420|466194996|FG000|Phase II|Progressive Disease|0|||
129520594|NCT00654420|466194997|FG001|Phase II|Progressive Disease|0|||
129520595|NCT00654420|466194998|FG002|Phase II|Progressive Disease|29|||
129520596|NCT00654420|466194999|FG003|Phase II|Progressive Disease|29|||
129520597|NCT00654420|466194996|FG000|Phase II|Withdrawal by Subject|0|||
129520598|NCT00654420|466194997|FG001|Phase II|Withdrawal by Subject|0|||
129520599|NCT00654420|466194998|FG002|Phase II|Withdrawal by Subject|4|||
129520600|NCT00654420|466194999|FG003|Phase II|Withdrawal by Subject|1|||
129520601|NCT00654420|466194996|FG000|Phase II|Missing Disposition Record|0|||
129520602|NCT00654420|466194997|FG001|Phase II|Missing Disposition Record|0|||
129520603|NCT00654420|466194998|FG002|Phase II|Missing Disposition Record|1|||
129520604|NCT00654420|466194999|FG003|Phase II|Missing Disposition Record|0|||
129520605|NCT00471276|466195001|FG000|Overall Study|Death|2|||
129520606|NCT00471276|466195001|FG000|Overall Study|Adverse Event|16|||
129520607|NCT00471276|466195001|FG000|Overall Study|Protocol Violation|1|||
129520608|NCT00471276|466195001|FG000|Overall Study|Objective progression or relapse|54|||
129520609|NCT00471276|466195001|FG000|Overall Study|Global deterioration of health status|1|||
129520610|NCT00471276|466195001|FG000|Overall Study|Other|3|||
129520611|NCT00471276|466195001|FG000|Overall Study|Refused treatment|6|||
129520612|NCT00701103|466195002|FG000|Overall Study|Adverse Event|0|||
129520613|NCT00701103|466195003|FG001|Overall Study|Adverse Event|0|||
129520614|NCT00701103|466195004|FG002|Overall Study|Adverse Event|1|||
129520615|NCT00701103|466195005|FG003|Overall Study|Adverse Event|1|||
129520616|NCT00701103|466195006|FG004|Overall Study|Adverse Event|0|||
129520617|NCT00701103|466195007|FG005|Overall Study|Adverse Event|1|||
129520618|NCT00701103|466195008|FG006|Overall Study|Adverse Event|1|||
129520619|NCT00701103|466195009|FG007|Overall Study|Adverse Event|0|||
129520620|NCT00701103|466195010|FG008|Overall Study|Adverse Event|0|||
129520621|NCT00701103|466195011|FG009|Overall Study|Adverse Event|2|||
129520622|NCT00701103|466195012|FG010|Overall Study|Adverse Event|0|||
129520623|NCT00701103|466195002|FG000|Overall Study|Progressive Disease|5|||
129520624|NCT00701103|466195003|FG001|Overall Study|Progressive Disease|2|||
129520625|NCT00701103|466195004|FG002|Overall Study|Progressive Disease|6|||
129520626|NCT00701103|466195005|FG003|Overall Study|Progressive Disease|5|||
129520627|NCT00701103|466195006|FG004|Overall Study|Progressive Disease|6|||
129520628|NCT00701103|466195007|FG005|Overall Study|Progressive Disease|5|||
129520629|NCT00701103|466195008|FG006|Overall Study|Progressive Disease|7|||
129520630|NCT00701103|466195009|FG007|Overall Study|Progressive Disease|7|||
129520631|NCT00701103|466195010|FG008|Overall Study|Progressive Disease|8|||
129520632|NCT00701103|466195011|FG009|Overall Study|Progressive Disease|8|||
129520633|NCT00701103|466195012|FG010|Overall Study|Progressive Disease|11|||
129520634|NCT00701103|466195002|FG000|Overall Study|Withdrawal by Subject|0|||
129520635|NCT00701103|466195003|FG001|Overall Study|Withdrawal by Subject|1|||
129520636|NCT00701103|466195004|FG002|Overall Study|Withdrawal by Subject|1|||
129520637|NCT00701103|466195005|FG003|Overall Study|Withdrawal by Subject|0|||
129520638|NCT00701103|466195006|FG004|Overall Study|Withdrawal by Subject|0|||
129520639|NCT00701103|466195007|FG005|Overall Study|Withdrawal by Subject|0|||
129520640|NCT00701103|466195008|FG006|Overall Study|Withdrawal by Subject|0|||
129520641|NCT00701103|466195009|FG007|Overall Study|Withdrawal by Subject|0|||
129520642|NCT00701103|466195010|FG008|Overall Study|Withdrawal by Subject|0|||
129520643|NCT00701103|466195011|FG009|Overall Study|Withdrawal by Subject|0|||
129520644|NCT00701103|466195012|FG010|Overall Study|Withdrawal by Subject|0|||
129520645|NCT00701103|466195002|FG000|Overall Study|Other|0|||
129520646|NCT00701103|466195003|FG001|Overall Study|Other|0|||
129520647|NCT00701103|466195004|FG002|Overall Study|Other|0|||
129520648|NCT00701103|466195005|FG003|Overall Study|Other|0|||
129520649|NCT00701103|466195006|FG004|Overall Study|Other|0|||
129520650|NCT00701103|466195007|FG005|Overall Study|Other|0|||
129520651|NCT00701103|466195008|FG006|Overall Study|Other|0|||
129520652|NCT00701103|466195009|FG007|Overall Study|Other|0|||
129520653|NCT00701103|466195010|FG008|Overall Study|Other|1|||
129520654|NCT00701103|466195011|FG009|Overall Study|Other|1|||
129520655|NCT00701103|466195012|FG010|Overall Study|Other|0|||
129520656|NCT00179517|466195013|FG000|Overall Study|Withdrawal by Subject|2|||
129520657|NCT00179517|466195014|FG001|Overall Study|Withdrawal by Subject|1|||
129520658|NCT00431496|466195021|FG000|Overall Study|Adverse Event|3|||
129520659|NCT00431496|466195021|FG000|Overall Study|Lost to Follow-up|1|||
129520660|NCT00431496|466195021|FG000|Overall Study|Withdrawal by Subject|2|||
129520661|NCT00431496|466195021|FG000|Overall Study|Protocol-specified criteria|5|||
129520662|NCT00361218|466195022|FG000|Overall Study|Lost to Follow-up|11|||
129520663|NCT00361218|466195022|FG000|Overall Study|Personal Reasons|7|||
129520664|NCT00361218|466195022|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
129520665|NCT02566109|466195023|FG000|Overall Study|Withdrawal by Subject|1|||
129520666|NCT01931150|466195024|FG000|Overall Study|Withdrawal by Subject|1|||
129520667|NCT01931150|466195025|FG001|Overall Study|Withdrawal by Subject|2|||
129520668|NCT01570309|466195028|FG000|Overall Study|Withdrawal by Subject|3|||
129520669|NCT01570309|466195029|FG001|Overall Study|Withdrawal by Subject|3|||
129520670|NCT01390038|466195030|FG000|Overall Study|Death|1|||
129520671|NCT01390038|466195030|FG000|Overall Study|Lost to Follow-up|1|||
129520672|NCT01390038|466195030|FG000|Overall Study|Withdrawal by Subject|4|||
129520673|NCT01390038|466195030|FG000|Overall Study|Simpliciti System Removal|2|||
129520674|NCT00368472|466195033|FG000|Overall Study|Adverse Event|22|||
129520675|NCT00368472|466195033|FG000|Overall Study|Medication non-compliance|4|||
129520676|NCT00368472|466195033|FG000|Overall Study|Protocol Violation|2|||
129520677|NCT00368472|466195033|FG000|Overall Study|Request of Investigator or Sponsor|3|||
129520678|NCT00368472|466195033|FG000|Overall Study|Withdrawal by Subject|40|||
129520679|NCT00368472|466195033|FG000|Overall Study|Diary non-compliance|1|||
129520680|NCT00368472|466195033|FG000|Overall Study|Other|32|||
129520681|NCT00368472|466195033|FG000|Overall Study|Missing Final Disposition Date|1|||
129520682|NCT03619837|466195037|FG000|Screening|received organs from HCV-negative donors|47|||
129520683|NCT03619837|466195037|FG000|Screening|died on the wait-list|2|||
129520684|NCT03619837|466195037|FG000|Screening|remained on the wait list|40|||
129520685|NCT03619837|466195037|FG000|Screening|didn't meet eligibility criteria|3|||
129520686|NCT03619837|466195037|FG000|Screening|withdrew consent|2|||
129520687|NCT03619837|466195037|FG000|Screening|never listed for HCV-viremic donor|1|||
129520688|NCT03619837|466195037|FG000|Screening|developed exclusion criteria|2|||
129520689|NCT03619837|466195037|FG000|Screening|excluded by the investigator due to non-compliance|1|||
129520690|NCT04095793|466195038|FG000|Overall Study|Adverse Event|3|||
129520691|NCT04095793|466195038|FG000|Overall Study|Study Terminated by Sponsor|103|||
129520692|NCT04095793|466195038|FG000|Overall Study|Withdrawal by Subject|4|||
129520693|NCT00044213|466195039|FG000|Overall Study|Withdrawal by Subject|50|||
129520694|NCT00044213|466195040|FG001|Overall Study|Withdrawal by Subject|65|||
129520695|NCT00044213|466195041|FG002|Overall Study|Withdrawal by Subject|91|||
129520696|NCT00044213|466195042|FG003|Overall Study|Withdrawal by Subject|83|||
129520697|NCT00044213|466195039|FG000|Overall Study|Death|42|||
129520698|NCT00044213|466195040|FG001|Overall Study|Death|42|||
129520699|NCT00044213|466195041|FG002|Overall Study|Death|42|||
129520700|NCT00044213|466195042|FG003|Overall Study|Death|49|||
129520701|NCT00044213|466195039|FG000|Overall Study|Lost to Follow-up|8|||
129520702|NCT00044213|466195040|FG001|Overall Study|Lost to Follow-up|5|||
129520703|NCT00044213|466195041|FG002|Overall Study|Lost to Follow-up|5|||
129520704|NCT00044213|466195042|FG003|Overall Study|Lost to Follow-up|4|||
129520705|NCT01927068|466195047|FG000|Overall Study|Death|37|||
129520706|NCT01927068|466195048|FG001|Overall Study|Death|3|||
129520707|NCT01927068|466195047|FG000|Overall Study|Withdrawal by Subject|50|||
129520708|NCT01927068|466195048|FG001|Overall Study|Withdrawal by Subject|3|||
129520709|NCT01927068|466195047|FG000|Overall Study|Lost to Follow-up|10|||
129520710|NCT01927068|466195048|FG001|Overall Study|Lost to Follow-up|2|||
129520711|NCT01927068|466195047|FG000|Overall Study|Physician Decision|9|||
129520712|NCT01927068|466195048|FG001|Overall Study|Physician Decision|0|||
129520713|NCT01927068|466195047|FG000|Overall Study|Missed last follow-up visit|2|||
129520714|NCT01927068|466195048|FG001|Overall Study|Missed last follow-up visit|0|||
129520715|NCT00880607|466195049|FG000|Overall Study|Physician Decision|2|||
129520716|NCT00880607|466195050|FG001|Overall Study|Physician Decision|2|||
129520717|NCT00880607|466195049|FG000|Overall Study|Protocol Violation|2|||
129520718|NCT00880607|466195050|FG001|Overall Study|Protocol Violation|1|||
129520719|NCT00880607|466195049|FG000|Overall Study|surgery did not extend past L1 level|3|||
129520720|NCT00880607|466195050|FG001|Overall Study|surgery did not extend past L1 level|0|||
129520721|NCT02963766|466195052|FG000|Double-Blind Period|Adverse Event|1|||
129520722|NCT02963766|466195053|FG001|Double-Blind Period|Adverse Event|0|||
129520723|NCT02963766|466195054|FG002|Double-Blind Period|Adverse Event|1|||
129520724|NCT02963766|466195052|FG000|Double-Blind Period|Physician Decision|1|||
129520725|NCT02963766|466195053|FG001|Double-Blind Period|Physician Decision|0|||
129520726|NCT02963766|466195054|FG002|Double-Blind Period|Physician Decision|0|||
129520727|NCT02963766|466195052|FG000|Double-Blind Period|Withdrawal by Subject|1|||
129520728|NCT02963766|466195053|FG001|Double-Blind Period|Withdrawal by Subject|1|||
129520729|NCT02963766|466195054|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129520730|NCT02963766|466195052|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
129520731|NCT02963766|466195053|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
129520732|NCT02963766|466195054|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
129520733|NCT02963766|466195052|FG000|Double-Blind Period|Protocol Violation|1|||
129520734|NCT02963766|466195053|FG001|Double-Blind Period|Protocol Violation|0|||
129520735|NCT02963766|466195054|FG002|Double-Blind Period|Protocol Violation|0|||
129538584|NCT04576702|466263424|FG003|Overall Study|Death|0|||
129520736|NCT02963766|466195052|FG000|Double-Blind Period|Lost to Follow-up|0|||
129520737|NCT02963766|466195053|FG001|Double-Blind Period|Lost to Follow-up|1|||
129520738|NCT02963766|466195054|FG002|Double-Blind Period|Lost to Follow-up|0|||
129520739|NCT02963766|466195052|FG000|Open Label Extension (OLE)|Physician Decision|1|||
129520740|NCT02963766|466195053|FG001|Open Label Extension (OLE)|Physician Decision|2|||
129520741|NCT02963766|466195054|FG002|Open Label Extension (OLE)|Physician Decision|2|||
129520742|NCT02963766|466195052|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
129520743|NCT02963766|466195053|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
129520744|NCT02963766|466195054|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
129520745|NCT00499460|466195055|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
129520746|NCT00499460|466195056|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
129520747|NCT00499460|466195055|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
129520748|NCT00499460|466195056|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
129520749|NCT00499460|466195055|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
129520750|NCT00499460|466195056|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
129520751|NCT00814307|466195057|FG000|Overall Study|Randomized but not treated|1|||
129520752|NCT00814307|466195058|FG001|Overall Study|Randomized but not treated|0|||
129520753|NCT00814307|466195059|FG002|Overall Study|Randomized but not treated|0|||
129520754|NCT00814307|466195060|FG003|Overall Study|Randomized but not treated|0|||
129520755|NCT00814307|466195057|FG000|Overall Study|Adverse Event|3|||
129520756|NCT00814307|466195058|FG001|Overall Study|Adverse Event|9|||
129520757|NCT00814307|466195059|FG002|Overall Study|Adverse Event|3|||
129520758|NCT00814307|466195060|FG003|Overall Study|Adverse Event|2|||
129520759|NCT00814307|466195057|FG000|Overall Study|Lack of Efficacy|1|||
129520760|NCT00814307|466195058|FG001|Overall Study|Lack of Efficacy|1|||
129520761|NCT00814307|466195059|FG002|Overall Study|Lack of Efficacy|3|||
129520762|NCT00814307|466195060|FG003|Overall Study|Lack of Efficacy|4|||
129520763|NCT00814307|466195057|FG000|Overall Study|Other|1|||
129520764|NCT00814307|466195058|FG001|Overall Study|Other|2|||
129520765|NCT00814307|466195059|FG002|Overall Study|Other|0|||
129520766|NCT00814307|466195060|FG003|Overall Study|Other|1|||
129520767|NCT00814307|466195057|FG000|Overall Study|Protocol Violation|2|||
129520768|NCT00814307|466195058|FG001|Overall Study|Protocol Violation|8|||
129520769|NCT00814307|466195059|FG002|Overall Study|Protocol Violation|1|||
129520770|NCT00814307|466195060|FG003|Overall Study|Protocol Violation|1|||
129520771|NCT00814307|466195057|FG000|Overall Study|Withdrawal by Subject|4|||
129520772|NCT00814307|466195058|FG001|Overall Study|Withdrawal by Subject|6|||
129520773|NCT00814307|466195059|FG002|Overall Study|Withdrawal by Subject|0|||
129520774|NCT00814307|466195060|FG003|Overall Study|Withdrawal by Subject|2|||
129520775|NCT00814307|466195057|FG000|Overall Study|Death|0|||
129520776|NCT00814307|466195058|FG001|Overall Study|Death|1|||
129520777|NCT00814307|466195059|FG002|Overall Study|Death|0|||
129520778|NCT00814307|466195060|FG003|Overall Study|Death|0|||
129520779|NCT02290340|466195062|FG000|Overall Study|Lost to Follow-up|0|||
129520780|NCT02290340|466195063|FG001|Overall Study|Lost to Follow-up|0|||
129520781|NCT02290340|466195064|FG002|Overall Study|Lost to Follow-up|0|||
129520782|NCT02290340|466195065|FG003|Overall Study|Lost to Follow-up|1|||
129520783|NCT02290340|466195062|FG000|Overall Study|Withdrawal by Subject|1|||
129520784|NCT02290340|466195063|FG001|Overall Study|Withdrawal by Subject|0|||
129520785|NCT02290340|466195064|FG002|Overall Study|Withdrawal by Subject|0|||
129520786|NCT02290340|466195065|FG003|Overall Study|Withdrawal by Subject|0|||
129520787|NCT02290340|466195062|FG000|Overall Study|Other|1|||
129520788|NCT02290340|466195063|FG001|Overall Study|Other|0|||
129520789|NCT02290340|466195064|FG002|Overall Study|Other|0|||
129520790|NCT02290340|466195065|FG003|Overall Study|Other|1|||
129520791|NCT04315298|466197596|FG000|Overall Study|Withdrawal by Subject|0|||
129520792|NCT04315298|466197597|FG001|Overall Study|Withdrawal by Subject|0|||
129520793|NCT04315298|466197598|FG002|Overall Study|Withdrawal by Subject|0|||
129520794|NCT04315298|466197599|FG003|Overall Study|Withdrawal by Subject|2|||
129520795|NCT04315298|466197600|FG004|Overall Study|Withdrawal by Subject|2|||
129520796|NCT04315298|466197601|FG005|Overall Study|Withdrawal by Subject|2|||
129520797|NCT04315298|466197602|FG006|Overall Study|Withdrawal by Subject|0|||
129520798|NCT04315298|466197603|FG007|Overall Study|Withdrawal by Subject|1|||
129520799|NCT04315298|466197604|FG008|Overall Study|Withdrawal by Subject|1|||
129520800|NCT04315298|466197605|FG009|Overall Study|Withdrawal by Subject|1|||
129520801|NCT04315298|466197606|FG010|Overall Study|Withdrawal by Subject|0|||
129520802|NCT04315298|466197607|FG011|Overall Study|Withdrawal by Subject|0|||
129520803|NCT04315298|466197608|FG012|Overall Study|Withdrawal by Subject|0|||
129520804|NCT04315298|466197609|FG013|Overall Study|Withdrawal by Subject|0|||
129520805|NCT04315298|466197610|FG014|Overall Study|Withdrawal by Subject|0|||
129520806|NCT04315298|466197611|FG015|Overall Study|Withdrawal by Subject|0|||
129520807|NCT04315298|466197612|FG016|Overall Study|Withdrawal by Subject|0|||
129520808|NCT04315298|466197613|FG017|Overall Study|Withdrawal by Subject|0|||
129520809|NCT04315298|466197614|FG018|Overall Study|Withdrawal by Subject|0|||
129520810|NCT04315298|466197596|FG000|Overall Study|Physician Decision|0|||
129520811|NCT04315298|466197597|FG001|Overall Study|Physician Decision|0|||
129520812|NCT04315298|466197598|FG002|Overall Study|Physician Decision|0|||
129520813|NCT04315298|466197599|FG003|Overall Study|Physician Decision|0|||
129520814|NCT04315298|466197600|FG004|Overall Study|Physician Decision|1|||
129520815|NCT04315298|466197601|FG005|Overall Study|Physician Decision|0|||
129520816|NCT04315298|466197602|FG006|Overall Study|Physician Decision|0|||
129520817|NCT04315298|466197603|FG007|Overall Study|Physician Decision|0|||
129520818|NCT04315298|466197604|FG008|Overall Study|Physician Decision|0|||
129520819|NCT04315298|466197605|FG009|Overall Study|Physician Decision|0|||
129520820|NCT04315298|466197606|FG010|Overall Study|Physician Decision|0|||
129520821|NCT04315298|466197607|FG011|Overall Study|Physician Decision|0|||
129520822|NCT04315298|466197608|FG012|Overall Study|Physician Decision|0|||
129520823|NCT04315298|466197609|FG013|Overall Study|Physician Decision|0|||
129520824|NCT04315298|466197610|FG014|Overall Study|Physician Decision|0|||
129520825|NCT04315298|466197611|FG015|Overall Study|Physician Decision|0|||
129520826|NCT04315298|466197612|FG016|Overall Study|Physician Decision|0|||
129520827|NCT04315298|466197613|FG017|Overall Study|Physician Decision|0|||
129520828|NCT04315298|466197614|FG018|Overall Study|Physician Decision|0|||
129520829|NCT04315298|466197596|FG000|Overall Study|Lost to Follow-up|5|||
129520830|NCT04315298|466197597|FG001|Overall Study|Lost to Follow-up|10|||
129520831|NCT04315298|466197598|FG002|Overall Study|Lost to Follow-up|6|||
129520832|NCT04315298|466197599|FG003|Overall Study|Lost to Follow-up|8|||
129520833|NCT04315298|466197600|FG004|Overall Study|Lost to Follow-up|12|||
129520834|NCT04315298|466197601|FG005|Overall Study|Lost to Follow-up|13|||
129520835|NCT04315298|466197602|FG006|Overall Study|Lost to Follow-up|9|||
129520836|NCT04315298|466197603|FG007|Overall Study|Lost to Follow-up|16|||
129520837|NCT04315298|466197604|FG008|Overall Study|Lost to Follow-up|14|||
129520838|NCT04315298|466197605|FG009|Overall Study|Lost to Follow-up|0|||
129520839|NCT04315298|466197606|FG010|Overall Study|Lost to Follow-up|2|||
129520840|NCT04315298|466197607|FG011|Overall Study|Lost to Follow-up|1|||
129520841|NCT04315298|466197608|FG012|Overall Study|Lost to Follow-up|0|||
129520842|NCT04315298|466197609|FG013|Overall Study|Lost to Follow-up|0|||
129520843|NCT04315298|466197610|FG014|Overall Study|Lost to Follow-up|0|||
129520844|NCT04315298|466197611|FG015|Overall Study|Lost to Follow-up|2|||
129520845|NCT04315298|466197612|FG016|Overall Study|Lost to Follow-up|0|||
129520846|NCT04315298|466197613|FG017|Overall Study|Lost to Follow-up|0|||
129520847|NCT04315298|466197614|FG018|Overall Study|Lost to Follow-up|0|||
129520848|NCT04315298|466197596|FG000|Overall Study|Death|24|||
129520849|NCT04315298|466197597|FG001|Overall Study|Death|60|||
129520850|NCT04315298|466197598|FG002|Overall Study|Death|49|||
129520851|NCT04315298|466197599|FG003|Overall Study|Death|59|||
129520852|NCT04315298|466197600|FG004|Overall Study|Death|70|||
129520853|NCT04315298|466197601|FG005|Overall Study|Death|114|||
129520854|NCT04315298|466197602|FG006|Overall Study|Death|9|||
129520855|NCT04315298|466197603|FG007|Overall Study|Death|12|||
129520856|NCT04315298|466197604|FG008|Overall Study|Death|21|||
129520857|NCT04315298|466197605|FG009|Overall Study|Death|16|||
129520858|NCT04315298|466197606|FG010|Overall Study|Death|40|||
129520859|NCT04315298|466197607|FG011|Overall Study|Death|40|||
129520860|NCT04315298|466197608|FG012|Overall Study|Death|3|||
129520861|NCT04315298|466197609|FG013|Overall Study|Death|4|||
129520862|NCT04315298|466197610|FG014|Overall Study|Death|6|||
129520863|NCT04315298|466197611|FG015|Overall Study|Death|4|||
129520864|NCT04315298|466197612|FG016|Overall Study|Death|3|||
129520865|NCT04315298|466197613|FG017|Overall Study|Death|1|||
129520866|NCT04315298|466197614|FG018|Overall Study|Death|0|||
129520867|NCT00736385|466197615|FG000|Overall Study|Withdrawal by Subject|2|||
129520868|NCT00736385|466197616|FG001|Overall Study|Withdrawal by Subject|2|||
129520869|NCT00736385|466197615|FG000|Overall Study|Adverse Event|0|||
129520870|NCT00736385|466197616|FG001|Overall Study|Adverse Event|1|||
129520871|NCT03267511|466197617|FG000|Overall Study|Lost to Follow-up|0|||
129520872|NCT03267511|466197618|FG001|Overall Study|Lost to Follow-up|0|||
129520873|NCT03267511|466197619|FG002|Overall Study|Lost to Follow-up|0|||
129520874|NCT03267511|466197620|FG003|Overall Study|Lost to Follow-up|1|||
129520875|NCT01594749|466197621|FG000|Overall Study|Adverse Event|2|||
129520876|NCT01594749|466197622|FG001|Overall Study|Adverse Event|1|||
129520877|NCT01594749|466197621|FG000|Overall Study|Withdrawal by Subject|2|||
129520878|NCT01594749|466197622|FG001|Overall Study|Withdrawal by Subject|2|||
129520879|NCT01594749|466197621|FG000|Overall Study|Protocol Violation|2|||
129520880|NCT01594749|466197622|FG001|Overall Study|Protocol Violation|0|||
129520881|NCT01594749|466197621|FG000|Overall Study|Physician Decision|1|||
129520882|NCT01594749|466197622|FG001|Overall Study|Physician Decision|1|||
129520883|NCT01594749|466197621|FG000|Overall Study|Non-compliance with Protocol|0|||
129520884|NCT01594749|466197622|FG001|Overall Study|Non-compliance with Protocol|1|||
129520885|NCT01594749|466197621|FG000|Overall Study|Lost to Follow-up|1|||
129520886|NCT01594749|466197622|FG001|Overall Study|Lost to Follow-up|0|||
129520887|NCT01594749|466197621|FG000|Overall Study|Death|9|||
129520888|NCT01594749|466197622|FG001|Overall Study|Death|3|||
129520889|NCT01594749|466197621|FG000|Overall Study|Not Treated|4|||
129520890|NCT01594749|466197622|FG001|Overall Study|Not Treated|10|||
129520891|NCT01594749|466197621|FG000|Overall Study|Lost Source Documentation|1|||
129520892|NCT01594749|466197622|FG001|Overall Study|Lost Source Documentation|0|||
129520893|NCT00922974|466197623|FG000|Phase II Component|Protocol Violation|2|||
129520894|NCT00922974|466197624|FG001|Phase II Component|Protocol Violation|0|||
129520895|NCT00922974|466197623|FG000|Phase II Component|Not evaluable for treatment review|5|||
129520896|NCT00922974|466197624|FG001|Phase II Component|Not evaluable for treatment review|0|||
129520897|NCT00922974|466197623|FG000|Phase III Component|Protocol Violation|8|||
129520898|NCT00922974|466197624|FG001|Phase III Component|Protocol Violation|6|||
129520899|NCT02177786|466197625|FG000|Overall Study|Withdrew Consent|2|||
129520900|NCT02177786|466197626|FG001|Overall Study|Withdrew Consent|6|||
129520901|NCT02177786|466197627|FG002|Overall Study|Withdrew Consent|9|||
129520902|NCT02177786|466197628|FG003|Overall Study|Withdrew Consent|5|||
129520903|NCT02177786|466197625|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
129520904|NCT02177786|466197626|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
129520905|NCT02177786|466197627|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
129520906|NCT02177786|466197628|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
129520907|NCT02177786|466197625|FG000|Overall Study|Adverse Event|1|||
129520908|NCT02177786|466197626|FG001|Overall Study|Adverse Event|1|||
129520909|NCT02177786|466197627|FG002|Overall Study|Adverse Event|2|||
129520910|NCT02177786|466197628|FG003|Overall Study|Adverse Event|3|||
129520911|NCT02177786|466197625|FG000|Overall Study|Death|1|||
129520912|NCT02177786|466197626|FG001|Overall Study|Death|1|||
129520913|NCT02177786|466197627|FG002|Overall Study|Death|1|||
129520914|NCT02177786|466197628|FG003|Overall Study|Death|1|||
129520915|NCT02177786|466197625|FG000|Overall Study|Lost to Follow-up|0|||
129520916|NCT02177786|466197626|FG001|Overall Study|Lost to Follow-up|0|||
129520917|NCT02177786|466197627|FG002|Overall Study|Lost to Follow-up|2|||
129520918|NCT02177786|466197628|FG003|Overall Study|Lost to Follow-up|2|||
129520919|NCT02177786|466197625|FG000|Overall Study|Non-Compliance with Study Drug|0|||
129520920|NCT02177786|466197626|FG001|Overall Study|Non-Compliance with Study Drug|1|||
129520921|NCT02177786|466197627|FG002|Overall Study|Non-Compliance with Study Drug|0|||
129520922|NCT02177786|466197628|FG003|Overall Study|Non-Compliance with Study Drug|1|||
129520923|NCT02177786|466197625|FG000|Overall Study|Protocol Violation|0|||
129520924|NCT02177786|466197626|FG001|Overall Study|Protocol Violation|0|||
129520925|NCT02177786|466197627|FG002|Overall Study|Protocol Violation|2|||
129520926|NCT02177786|466197628|FG003|Overall Study|Protocol Violation|0|||
129520927|NCT02177786|466197625|FG000|Overall Study|Progressive Disease|0|||
129520928|NCT02177786|466197626|FG001|Overall Study|Progressive Disease|1|||
129520929|NCT02177786|466197627|FG002|Overall Study|Progressive Disease|0|||
129520930|NCT02177786|466197628|FG003|Overall Study|Progressive Disease|0|||
129520931|NCT02177786|466197625|FG000|Overall Study|Missing study completion status|0|||
129520932|NCT02177786|466197626|FG001|Overall Study|Missing study completion status|1|||
129520933|NCT02177786|466197627|FG002|Overall Study|Missing study completion status|0|||
129520934|NCT02177786|466197628|FG003|Overall Study|Missing study completion status|0|||
129520935|NCT03950440|466197629|FG000|Overall Study|Death|8|||
129520936|NCT03950440|466197630|FG001|Overall Study|Death|2|||
129520937|NCT03950440|466197631|FG002|Overall Study|Death|1|||
129520938|NCT00439309|466197632|FG000|Follow-Up|Death|1|||
129520939|NCT00439309|466197633|FG001|Follow-Up|Death|0|||
129520940|NCT00439309|466197632|FG000|Follow-Up|Lost to Follow-up|2|||
129520941|NCT00439309|466197633|FG001|Follow-Up|Lost to Follow-up|0|||
129520942|NCT00439309|466197632|FG000|Follow-Up|Withdrawal by Subject|0|||
129520943|NCT00439309|466197633|FG001|Follow-Up|Withdrawal by Subject|1|||
129520944|NCT00439309|466197632|FG000|Follow-Up|Late response by subject|0|||
129520945|NCT00439309|466197633|FG001|Follow-Up|Late response by subject|1|||
129520946|NCT00430027|466197634|FG000|Overall Study|Study terminated|8|||
129520947|NCT01957215|466197635|FG000|Overall Study|Adverse Event|2|||
129520948|NCT01957215|466197636|FG001|Overall Study|Adverse Event|2|||
129520949|NCT01957215|466197635|FG000|Overall Study|Lost to Follow-up|3|||
129520950|NCT01957215|466197636|FG001|Overall Study|Lost to Follow-up|3|||
129520951|NCT01957215|466197635|FG000|Overall Study|Protocol Violation|1|||
129520952|NCT01957215|466197636|FG001|Overall Study|Protocol Violation|2|||
129520953|NCT01957215|466197635|FG000|Overall Study|Withdrawal by Subject|7|||
129520954|NCT01957215|466197636|FG001|Overall Study|Withdrawal by Subject|5|||
129520955|NCT01977040|466197637|FG000|Overall Study|Vasa previa not confirmed|2|||
129520956|NCT00634751|466197643|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
129520957|NCT00634751|466197644|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
129520958|NCT00634751|466197645|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
129520959|NCT00634751|466197646|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
129520960|NCT00634751|466197643|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
129520961|NCT00634751|466197644|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
129520962|NCT00634751|466197645|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
129520963|NCT00634751|466197646|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
129520964|NCT00634751|466197643|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
129520965|NCT00634751|466197644|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
129520966|NCT00634751|466197645|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
129520967|NCT00634751|466197646|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
129520968|NCT04402385|466197649|FG000|Overall Study|Withdrawal by Subject|4|||
129520969|NCT04402385|466197650|FG001|Overall Study|Withdrawal by Subject|4|||
129520970|NCT04402385|466197649|FG000|Overall Study|Lost to Follow-up|1|||
129520971|NCT04402385|466197650|FG001|Overall Study|Lost to Follow-up|1|||
129520972|NCT04402385|466197649|FG000|Overall Study|Physician Decision|0|||
129520973|NCT04402385|466197650|FG001|Overall Study|Physician Decision|1|||
129520974|NCT00088595|466197651|FG000|Overall Study|Adverse Event|11|||
129520975|NCT00088595|466197651|FG000|Overall Study|Withdrawal by Subject|8|||
129520976|NCT00088595|466197651|FG000|Overall Study|Ongoing (After Core)|7|||
129520977|NCT00088595|466197651|FG000|Overall Study|New Cancer Therapy|2|||
129520978|NCT01308853|466197657|FG000|Overall Study|Adverse Event|1|||
129520979|NCT01308853|466197657|FG000|Overall Study|Lost to Follow-up|2|||
129520980|NCT01308853|466197657|FG000|Overall Study|Insertion of permanent implants|1|||
129520981|NCT01473355|466197661|FG000|Overall Study|Protocol Violation|2|||
129520982|NCT01473355|466197661|FG000|Overall Study|Adverse Event|2|||
129520983|NCT01473355|466197661|FG000|Overall Study|Lost to Follow-up|2|||
129520984|NCT01119963|466197662|FG000|Overall Study|Lost to Follow-up|1|||
129520985|NCT01119963|466197663|FG001|Overall Study|Lost to Follow-up|1|||
129520986|NCT02603172|466197664|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520987|NCT02603172|466197665|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520988|NCT02603172|466197666|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
129520989|NCT02603172|466197667|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520990|NCT02603172|466197668|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520991|NCT02603172|466197669|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520992|NCT02603172|466197670|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520993|NCT02603172|466197671|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
129520994|NCT02244619|466197672|FG000|Overall Study|Did not receive study intervention|8|||
129520995|NCT02244619|466197673|FG001|Overall Study|Did not receive study intervention|21|||
129520996|NCT03285490|466197675|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
129520997|NCT03285490|466197676|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
129520998|NCT03285490|466197675|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
129520999|NCT03285490|466197676|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
129521000|NCT03745989|466197677|FG000|Overall Study|Death|3|||
129521001|NCT03745989|466197678|FG001|Overall Study|Death|7|||
129521002|NCT03745989|466197679|FG002|Overall Study|Death|4|||
129521003|NCT03745989|466197677|FG000|Overall Study|Lost to Follow-up|0|||
129521004|NCT03745989|466197678|FG001|Overall Study|Lost to Follow-up|2|||
129521005|NCT03745989|466197679|FG002|Overall Study|Lost to Follow-up|0|||
129521006|NCT03745989|466197677|FG000|Overall Study|Sponsor Decision|0|||
129521007|NCT03745989|466197678|FG001|Overall Study|Sponsor Decision|2|||
129521008|NCT03745989|466197679|FG002|Overall Study|Sponsor Decision|8|||
129521009|NCT03745989|466197677|FG000|Overall Study|Withdrawal by Subject|0|||
129521010|NCT03745989|466197678|FG001|Overall Study|Withdrawal by Subject|1|||
129521011|NCT03745989|466197679|FG002|Overall Study|Withdrawal by Subject|3|||
129521012|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
129521013|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
129521014|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
129521015|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
129521016|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
129521017|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
129521018|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
129521019|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
129521020|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
129521021|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
129521022|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
129521023|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
129521024|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
129521025|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
129521026|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
129521027|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
129521028|NCT01291511|466197680|FG000|Cross-Titration and Stabilization Phase|Death|1|||
129521029|NCT01291511|466197681|FG001|Cross-Titration and Stabilization Phase|Death|0|||
129521030|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
129521031|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
129521032|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
129521033|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
129521034|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
129521035|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
129521036|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
129521037|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
129521038|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
129521039|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
129521040|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
129521041|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
129521042|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
129538662|NCT00764465|466263484|FG001|Overall Study|Adverse Event|0|||
129521043|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
129521044|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
129521045|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
129521046|NCT01291511|466197680|FG000|Double-blind Relapse Prevention Phase|Death|1|||
129521047|NCT01291511|466197681|FG001|Double-blind Relapse Prevention Phase|Death|0|||
129521048|NCT01047436|466197684|FG000|Overall Study|Protocol Violation|1|||
129521049|NCT01047436|466197685|FG001|Overall Study|Protocol Violation|0|||
129521050|NCT00796003|466197686|FG000|Overall Study|Disease Progression|2|||
129521051|NCT00796003|466197687|FG001|Overall Study|Disease Progression|13|||
129521052|NCT00796003|466197686|FG000|Overall Study|Adverse Event|1|||
129521053|NCT00796003|466197687|FG001|Overall Study|Adverse Event|7|||
129521054|NCT00796003|466197686|FG000|Overall Study|Specified organ function not met|0|||
129521055|NCT00796003|466197687|FG001|Overall Study|Specified organ function not met|1|||
129521056|NCT00796003|466197686|FG000|Overall Study|Physician Decision|0|||
129521057|NCT00796003|466197687|FG001|Overall Study|Physician Decision|4|||
129521058|NCT00796003|466197686|FG000|Overall Study|Withdrawal by Subject|0|||
129521059|NCT00796003|466197687|FG001|Overall Study|Withdrawal by Subject|1|||
129521060|NCT00796003|466197686|FG000|Overall Study|Other|0|||
129521061|NCT00796003|466197687|FG001|Overall Study|Other|1|||
129521062|NCT00796003|466197686|FG000|Overall Study|Participants Not treated|0|||
129521063|NCT00796003|466197687|FG001|Overall Study|Participants Not treated|2|||
129521064|NCT02437162|466197688|FG000|Overall Study|Protocol Violation|0|||
129521065|NCT02437162|466197689|FG001|Overall Study|Protocol Violation|1|||
129521066|NCT02437162|466197690|FG002|Overall Study|Protocol Violation|0|||
129521067|NCT02437162|466197688|FG000|Overall Study|Randomized but not treated|0|||
129521068|NCT02437162|466197689|FG001|Overall Study|Randomized but not treated|0|||
129521069|NCT02437162|466197690|FG002|Overall Study|Randomized but not treated|1|||
129521070|NCT02437162|466197688|FG000|Overall Study|Study discontinued by Sponsor|93|||
129521071|NCT02437162|466197689|FG001|Overall Study|Study discontinued by Sponsor|98|||
129521072|NCT02437162|466197690|FG002|Overall Study|Study discontinued by Sponsor|97|||
129521073|NCT02437162|466197688|FG000|Overall Study|Withdrawal by Subject|13|||
129521074|NCT02437162|466197689|FG001|Overall Study|Withdrawal by Subject|7|||
129521075|NCT02437162|466197690|FG002|Overall Study|Withdrawal by Subject|9|||
129521076|NCT02437162|466197688|FG000|Overall Study|Adverse Event|0|||
129521077|NCT02437162|466197689|FG001|Overall Study|Adverse Event|1|||
129521078|NCT02437162|466197690|FG002|Overall Study|Adverse Event|0|||
129521079|NCT02437162|466197688|FG000|Overall Study|Lost to Follow-up|1|||
129521080|NCT02437162|466197689|FG001|Overall Study|Lost to Follow-up|0|||
129521081|NCT02437162|466197690|FG002|Overall Study|Lost to Follow-up|1|||
129521082|NCT02437162|466197688|FG000|Overall Study|Death|0|||
129521083|NCT02437162|466197689|FG001|Overall Study|Death|1|||
129521084|NCT02437162|466197690|FG002|Overall Study|Death|0|||
129521085|NCT02437162|466197688|FG000|Overall Study|Other|0|||
129521086|NCT02437162|466197689|FG001|Overall Study|Other|0|||
129521087|NCT02437162|466197690|FG002|Overall Study|Other|1|||
129521088|NCT03981744|466197691|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
129521089|NCT03981744|466197692|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
129521090|NCT03981744|466197693|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
129521091|NCT03981744|466197694|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
129521092|NCT03981744|466197691|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
129521093|NCT03981744|466197692|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
129521094|NCT03981744|466197693|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
129521095|NCT03981744|466197694|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
129521096|NCT03981744|466197691|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
129521097|NCT03981744|466197692|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
129521098|NCT03981744|466197693|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
129521099|NCT03981744|466197694|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
129521100|NCT04338321|466197695|FG000|Overall Study|Adverse Event|4|||
129521101|NCT04338321|466197696|FG001|Overall Study|Adverse Event|10|||
129521102|NCT04338321|466197695|FG000|Overall Study|Death|1|||
129521103|NCT04338321|466197696|FG001|Overall Study|Death|1|||
129521104|NCT04338321|466197695|FG000|Overall Study|Lost to Follow-up|4|||
129521105|NCT04338321|466197696|FG001|Overall Study|Lost to Follow-up|9|||
129521106|NCT04338321|466197695|FG000|Overall Study|Withdrawal by Subject|45|||
129521107|NCT04338321|466197696|FG001|Overall Study|Withdrawal by Subject|69|||
129521108|NCT04338321|466197695|FG000|Overall Study|Physician Decision|5|||
129521109|NCT04338321|466197696|FG001|Overall Study|Physician Decision|9|||
129521110|NCT04338321|466197695|FG000|Overall Study|Other|3|||
129521111|NCT04338321|466197696|FG001|Overall Study|Other|10|||
129521112|NCT03107793|466197697|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
129521113|NCT03107793|466197698|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
129521114|NCT03107793|466197699|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
129521115|NCT03107793|466197700|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
129521116|NCT03107793|466197701|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
129521117|NCT03107793|466197697|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
129521118|NCT03107793|466197698|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
129521119|NCT03107793|466197699|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
129521120|NCT03107793|466197700|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
129521121|NCT03107793|466197701|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
129521122|NCT03107793|466197697|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
129521123|NCT03107793|466197698|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
129521124|NCT03107793|466197699|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
129521125|NCT03107793|466197700|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
129521126|NCT03107793|466197701|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
129521127|NCT03107793|466197697|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
129521128|NCT03107793|466197698|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129521129|NCT03107793|466197699|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129521130|NCT03107793|466197700|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129521131|NCT03107793|466197701|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
129521132|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129521133|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
129521134|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
129521135|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129521136|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
129521137|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129521138|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
129521139|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
129521140|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129521141|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
129521142|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
129521143|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
129521144|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
129521145|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
129521146|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
129521147|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129521148|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
129521149|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
129521150|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129521151|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
129521152|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
129521153|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
129521154|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
129521155|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
129521156|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
129521157|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
129521158|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
129521159|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
129521160|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
129521161|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
129521162|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129521163|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
129521164|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129521165|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129521166|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
129521167|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
129521168|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
129521169|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
129521170|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
129521171|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
129521172|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
129521173|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
129521174|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
129521175|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
129521176|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
129521177|NCT03107793|466197697|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129521178|NCT03107793|466197698|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
129521179|NCT03107793|466197699|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
129521180|NCT03107793|466197700|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129521181|NCT03107793|466197701|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
129521182|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
129521183|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
129521184|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
129521185|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
129521186|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
129521187|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
129521188|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
129521189|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
129521190|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
129521191|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
129521192|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
129521193|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
129521194|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
129521195|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
129521196|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
129521197|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Death|0|||
129521198|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Death|0|||
129521199|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Death|0|||
129521200|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Death|0|||
129521201|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Death|1|||
129521202|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
129521203|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
129521204|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
129521205|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
129521206|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
129521207|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
129521208|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
129521209|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
129521210|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
129521211|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
129521212|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
129521213|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
129521214|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
129521215|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
129521216|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
129521217|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
129521218|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
129521219|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
129521220|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
129521221|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
129521222|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
129521223|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
129521224|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
129521225|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
129521226|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
129521227|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Other|0|||
129521228|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Other|0|||
129521229|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Other|0|||
129521230|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Other|1|||
129521231|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Other|3|||
129521232|NCT03107793|466197697|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
129521233|NCT03107793|466197698|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
129521234|NCT03107793|466197699|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
129521235|NCT03107793|466197700|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
129521236|NCT03107793|466197701|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
129521237|NCT01989572|466197702|FG000|Overall Study|Lack of Efficacy|35|||
129521238|NCT01989572|466197703|FG001|Overall Study|Lack of Efficacy|48|||
129521239|NCT01989572|466197704|FG002|Overall Study|Lack of Efficacy|48|||
129521240|NCT01989572|466197705|FG003|Overall Study|Lack of Efficacy|43|||
129521241|NCT01989572|466197706|FG004|Overall Study|Lack of Efficacy|71|||
129521242|NCT01989572|466197707|FG005|Overall Study|Lack of Efficacy|79|||
129521243|NCT01989572|466197702|FG000|Overall Study|Adverse Event|2|||
129521244|NCT01989572|466197703|FG001|Overall Study|Adverse Event|1|||
129521245|NCT01989572|466197704|FG002|Overall Study|Adverse Event|3|||
129521246|NCT01989572|466197705|FG003|Overall Study|Adverse Event|0|||
129521247|NCT01989572|466197706|FG004|Overall Study|Adverse Event|3|||
129521248|NCT01989572|466197707|FG005|Overall Study|Adverse Event|0|||
129521249|NCT01989572|466197702|FG000|Overall Study|Death|0|||
129521250|NCT01989572|466197703|FG001|Overall Study|Death|0|||
129521251|NCT01989572|466197704|FG002|Overall Study|Death|0|||
129521252|NCT01989572|466197705|FG003|Overall Study|Death|0|||
129521253|NCT01989572|466197706|FG004|Overall Study|Death|1|||
129521254|NCT01989572|466197707|FG005|Overall Study|Death|0|||
129521255|NCT01989572|466197702|FG000|Overall Study|Withdrawal by Subject|4|||
129521256|NCT01989572|466197703|FG001|Overall Study|Withdrawal by Subject|1|||
129521257|NCT01989572|466197704|FG002|Overall Study|Withdrawal by Subject|5|||
129521258|NCT01989572|466197705|FG003|Overall Study|Withdrawal by Subject|1|||
129521259|NCT01989572|466197706|FG004|Overall Study|Withdrawal by Subject|12|||
129521260|NCT01989572|466197707|FG005|Overall Study|Withdrawal by Subject|4|||
129521261|NCT01989572|466197702|FG000|Overall Study|complicating disease|1|||
129521262|NCT01989572|466197703|FG001|Overall Study|complicating disease|1|||
129521263|NCT01989572|466197704|FG002|Overall Study|complicating disease|2|||
129521264|NCT01989572|466197705|FG003|Overall Study|complicating disease|0|||
129521265|NCT01989572|466197706|FG004|Overall Study|complicating disease|1|||
129521266|NCT01989572|466197707|FG005|Overall Study|complicating disease|0|||
129521267|NCT01989572|466197702|FG000|Overall Study|error|2|||
129521268|NCT01989572|466197703|FG001|Overall Study|error|1|||
129521269|NCT01989572|466197704|FG002|Overall Study|error|1|||
129521270|NCT01989572|466197705|FG003|Overall Study|error|1|||
129521271|NCT01989572|466197706|FG004|Overall Study|error|1|||
129521272|NCT01989572|466197707|FG005|Overall Study|error|1|||
129521273|NCT01989572|466197702|FG000|Overall Study|maximum dose reached|0|||
129521274|NCT01989572|466197703|FG001|Overall Study|maximum dose reached|1|||
129521275|NCT01989572|466197704|FG002|Overall Study|maximum dose reached|0|||
129521276|NCT01989572|466197705|FG003|Overall Study|maximum dose reached|0|||
129521277|NCT01989572|466197706|FG004|Overall Study|maximum dose reached|1|||
129521278|NCT01989572|466197707|FG005|Overall Study|maximum dose reached|0|||
129521279|NCT01989572|466197702|FG000|Overall Study|unknown/not specify|3|||
129521280|NCT01989572|466197703|FG001|Overall Study|unknown/not specify|4|||
129521281|NCT01989572|466197704|FG002|Overall Study|unknown/not specify|1|||
129521282|NCT01989572|466197705|FG003|Overall Study|unknown/not specify|3|||
129521283|NCT01989572|466197706|FG004|Overall Study|unknown/not specify|3|||
129521284|NCT01989572|466197707|FG005|Overall Study|unknown/not specify|5|||
129521285|NCT01989572|466197702|FG000|Overall Study|not start protocol therapy|5|||
129521286|NCT01989572|466197703|FG001|Overall Study|not start protocol therapy|1|||
129521287|NCT01989572|466197704|FG002|Overall Study|not start protocol therapy|2|||
129521288|NCT01989572|466197705|FG003|Overall Study|not start protocol therapy|3|||
129521289|NCT01989572|466197706|FG004|Overall Study|not start protocol therapy|4|||
129521290|NCT01989572|466197707|FG005|Overall Study|not start protocol therapy|18|||
129521291|NCT01989572|466197702|FG000|Overall Study|alternative therapy|3|||
129521292|NCT01989572|466197703|FG001|Overall Study|alternative therapy|0|||
129521293|NCT01989572|466197704|FG002|Overall Study|alternative therapy|0|||
129521294|NCT01989572|466197705|FG003|Overall Study|alternative therapy|0|||
129521295|NCT01989572|466197706|FG004|Overall Study|alternative therapy|1|||
129521296|NCT01989572|466197707|FG005|Overall Study|alternative therapy|3|||
129521297|NCT02910089|466197708|FG000|Overall Study|Lost insurance eligibility|22|||
129521298|NCT02910089|466197709|FG001|Overall Study|Lost insurance eligibility|16|||
129521299|NCT02057068|466197716|FG000|Overall Study|Withdrawal by Subject|2|||
129521300|NCT02057068|466197717|FG001|Overall Study|Withdrawal by Subject|2|||
129521301|NCT02057068|466197716|FG000|Overall Study|Caregiver (CG) Health|0|||
129521302|NCT02057068|466197717|FG001|Overall Study|Caregiver (CG) Health|2|||
129521303|NCT02057068|466197716|FG000|Overall Study|Carepartner (CP) Health|4|||
129521304|NCT02057068|466197717|FG001|Overall Study|Carepartner (CP) Health|2|||
129521305|NCT02057068|466197716|FG000|Overall Study|Lost to Follow-up|2|||
129521306|NCT02057068|466197717|FG001|Overall Study|Lost to Follow-up|2|||
129521307|NCT02977507|466197718|FG000|Overall Study|Protocol Deviation|1|||
129521308|NCT02977507|466197719|FG001|Overall Study|Protocol Deviation|0|||
129521309|NCT02977507|466197718|FG000|Overall Study|Lost to Follow-up|1|||
129521310|NCT02977507|466197719|FG001|Overall Study|Lost to Follow-up|0|||
129521311|NCT00633360|466197720|FG000|Overall Study|Lost to Follow-up|1|||
129521312|NCT00633360|466197721|FG001|Overall Study|Lost to Follow-up|1|||
129521313|NCT00633360|466197720|FG000|Overall Study|Adverse Event|3|||
129521314|NCT00633360|466197721|FG001|Overall Study|Adverse Event|1|||
129521315|NCT00633360|466197720|FG000|Overall Study|Protocol Violation|0|||
129521316|NCT00633360|466197721|FG001|Overall Study|Protocol Violation|1|||
129521317|NCT00610207|466197722|FG000|Overall Study|Lost to Follow-up|3|||
129521318|NCT02465489|466197725|FG000|Overall Study|Adverse Event|5|||
129521319|NCT01594411|466197726|FG000|Overall Study|Lost to Follow-up|2|||
129521320|NCT04449276|466197727|FG000|Overall Study|Adverse Event|1|||
129521321|NCT04449276|466197728|FG001|Overall Study|Adverse Event|2|||
129521322|NCT04449276|466197729|FG002|Overall Study|Adverse Event|0|||
129521323|NCT04449276|466197730|FG003|Overall Study|Adverse Event|0|||
129521324|NCT04449276|466197731|FG004|Overall Study|Adverse Event|2|||
129521325|NCT04449276|466197732|FG005|Overall Study|Adverse Event|0|||
129521326|NCT04449276|466197733|FG006|Overall Study|Adverse Event|0|||
129521327|NCT04449276|466197734|FG007|Overall Study|Adverse Event|1|||
129521328|NCT04449276|466197727|FG000|Overall Study|Withdrawal by Subject|2|||
129521329|NCT04449276|466197728|FG001|Overall Study|Withdrawal by Subject|0|||
129521330|NCT04449276|466197729|FG002|Overall Study|Withdrawal by Subject|0|||
129521331|NCT04449276|466197730|FG003|Overall Study|Withdrawal by Subject|1|||
129521332|NCT04449276|466197731|FG004|Overall Study|Withdrawal by Subject|0|||
129521333|NCT04449276|466197732|FG005|Overall Study|Withdrawal by Subject|0|||
129521334|NCT04449276|466197733|FG006|Overall Study|Withdrawal by Subject|0|||
129521335|NCT04449276|466197734|FG007|Overall Study|Withdrawal by Subject|0|||
129521336|NCT04449276|466197727|FG000|Overall Study|Other|0|||
129521337|NCT04449276|466197728|FG001|Overall Study|Other|2|||
129521338|NCT04449276|466197729|FG002|Overall Study|Other|3|||
129521339|NCT04449276|466197730|FG003|Overall Study|Other|2|||
129521340|NCT04449276|466197731|FG004|Overall Study|Other|0|||
129521341|NCT04449276|466197732|FG005|Overall Study|Other|0|||
129521342|NCT04449276|466197733|FG006|Overall Study|Other|0|||
129521343|NCT04449276|466197734|FG007|Overall Study|Other|1|||
129521344|NCT01614795|466197735|FG000|Overall Study|Adverse Event|0|||
129521345|NCT01614795|466197736|FG001|Overall Study|Adverse Event|0|||
129521346|NCT01614795|466197737|FG002|Overall Study|Adverse Event|1|||
129521347|NCT01614795|466197738|FG003|Overall Study|Adverse Event|1|||
129521348|NCT01614795|466197735|FG000|Overall Study|Lack of Efficacy|10|||
129521349|NCT01614795|466197736|FG001|Overall Study|Lack of Efficacy|10|||
129521350|NCT01614795|466197737|FG002|Overall Study|Lack of Efficacy|9|||
129521351|NCT01614795|466197738|FG003|Overall Study|Lack of Efficacy|8|||
129521352|NCT01614795|466197735|FG000|Overall Study|Physician Decision|1|||
129521353|NCT01614795|466197736|FG001|Overall Study|Physician Decision|0|||
129521354|NCT01614795|466197737|FG002|Overall Study|Physician Decision|1|||
129521355|NCT01614795|466197738|FG003|Overall Study|Physician Decision|1|||
129521356|NCT01614795|466197735|FG000|Overall Study|Withdrawal by Subject|0|||
129521357|NCT01614795|466197736|FG001|Overall Study|Withdrawal by Subject|1|||
129521358|NCT01614795|466197737|FG002|Overall Study|Withdrawal by Subject|0|||
129521359|NCT01614795|466197738|FG003|Overall Study|Withdrawal by Subject|2|||
129521360|NCT01614795|466197735|FG000|Overall Study|Ineligible|0|||
129521361|NCT01614795|466197736|FG001|Overall Study|Ineligible|1|||
129521362|NCT01614795|466197737|FG002|Overall Study|Ineligible|0|||
129521363|NCT01614795|466197738|FG003|Overall Study|Ineligible|0|||
129521364|NCT00910728|466197739|FG000|Overall Study|Lack of Efficacy|2|||
129521365|NCT00910728|466197740|FG001|Overall Study|Lack of Efficacy|3|||
129521366|NCT00910728|466197741|FG002|Overall Study|Lack of Efficacy|1|||
129521367|NCT00910728|466197742|FG003|Overall Study|Lack of Efficacy|2|||
129521368|NCT00910728|466197743|FG004|Overall Study|Lack of Efficacy|1|||
129521369|NCT00910728|466197744|FG005|Overall Study|Lack of Efficacy|0|||
129521370|NCT00910728|466197745|FG006|Overall Study|Lack of Efficacy|2|||
129521371|NCT00910728|466197746|FG007|Overall Study|Lack of Efficacy|2|||
129521372|NCT00910728|466197747|FG008|Overall Study|Lack of Efficacy|2|||
129521373|NCT00910728|466197739|FG000|Overall Study|Withdrawal by Subject|0|||
129521374|NCT00910728|466197740|FG001|Overall Study|Withdrawal by Subject|0|||
129521375|NCT00910728|466197741|FG002|Overall Study|Withdrawal by Subject|0|||
129521376|NCT00910728|466197742|FG003|Overall Study|Withdrawal by Subject|0|||
129521377|NCT00910728|466197743|FG004|Overall Study|Withdrawal by Subject|3|||
129521378|NCT00910728|466197744|FG005|Overall Study|Withdrawal by Subject|1|||
129521379|NCT00910728|466197745|FG006|Overall Study|Withdrawal by Subject|2|||
129521380|NCT00910728|466197746|FG007|Overall Study|Withdrawal by Subject|0|||
129521381|NCT00910728|466197747|FG008|Overall Study|Withdrawal by Subject|0|||
129521382|NCT00910728|466197739|FG000|Overall Study|(not specified)|2|||
129521383|NCT00910728|466197740|FG001|Overall Study|(not specified)|0|||
129521384|NCT00910728|466197741|FG002|Overall Study|(not specified)|1|||
129521385|NCT00910728|466197742|FG003|Overall Study|(not specified)|0|||
129521386|NCT00910728|466197743|FG004|Overall Study|(not specified)|1|||
129521387|NCT00910728|466197744|FG005|Overall Study|(not specified)|0|||
129521388|NCT00910728|466197745|FG006|Overall Study|(not specified)|0|||
129521389|NCT00910728|466197746|FG007|Overall Study|(not specified)|0|||
129521390|NCT00910728|466197747|FG008|Overall Study|(not specified)|0|||
129521391|NCT00910728|466197739|FG000|Overall Study|Adverse Event|2|||
129521392|NCT00910728|466197740|FG001|Overall Study|Adverse Event|0|||
129521393|NCT00910728|466197741|FG002|Overall Study|Adverse Event|1|||
129521394|NCT00910728|466197742|FG003|Overall Study|Adverse Event|1|||
129521395|NCT00910728|466197743|FG004|Overall Study|Adverse Event|0|||
129521396|NCT00910728|466197744|FG005|Overall Study|Adverse Event|0|||
129521397|NCT00910728|466197745|FG006|Overall Study|Adverse Event|2|||
129521398|NCT00910728|466197746|FG007|Overall Study|Adverse Event|1|||
129521399|NCT00910728|466197747|FG008|Overall Study|Adverse Event|1|||
129521400|NCT00023712|466197748|FG000|Overall Study|Not platinum sensitive|1|||
129521401|NCT00023712|466197749|FG001|Overall Study|Not platinum sensitive|0|||
129521402|NCT00023712|466197748|FG000|Overall Study|Never treated|1|||
129521403|NCT00023712|466197749|FG001|Overall Study|Never treated|1|||
129521404|NCT01810380|466197750|FG000|Overall Study|Randomised not treated|2|||
129521405|NCT01810380|466197751|FG001|Overall Study|Randomised not treated|1|||
129521406|NCT01810380|466197752|FG002|Overall Study|Randomised not treated|1|||
129521407|NCT01810380|466197750|FG000|Overall Study|Adverse Event|11|||
129521408|NCT01810380|466197751|FG001|Overall Study|Adverse Event|14|||
129521409|NCT01810380|466197752|FG002|Overall Study|Adverse Event|4|||
129521410|NCT01810380|466197750|FG000|Overall Study|Lack of Efficacy|24|||
129521411|NCT01810380|466197751|FG001|Overall Study|Lack of Efficacy|10|||
129521412|NCT01810380|466197752|FG002|Overall Study|Lack of Efficacy|11|||
129521413|NCT01810380|466197750|FG000|Overall Study|Protocol Violation|1|||
129521414|NCT01810380|466197751|FG001|Overall Study|Protocol Violation|0|||
129521415|NCT01810380|466197752|FG002|Overall Study|Protocol Violation|1|||
129521416|NCT01810380|466197750|FG000|Overall Study|Withdrawal by Subject|6|||
129521417|NCT01810380|466197751|FG001|Overall Study|Withdrawal by Subject|0|||
129521418|NCT01810380|466197752|FG002|Overall Study|Withdrawal by Subject|6|||
129521419|NCT01810380|466197750|FG000|Overall Study|Administrative or other reasons|11|||
129521420|NCT01810380|466197751|FG001|Overall Study|Administrative or other reasons|13|||
129521421|NCT01810380|466197752|FG002|Overall Study|Administrative or other reasons|9|||
129521422|NCT00251589|466197755|FG000|Overall Study|Adverse Event|5|||
129521423|NCT00251589|466197756|FG001|Overall Study|Adverse Event|1|||
129521424|NCT00251589|466197757|FG002|Overall Study|Adverse Event|2|||
129521425|NCT00251589|466197758|FG003|Overall Study|Adverse Event|1|||
129521426|NCT00251589|466197755|FG000|Overall Study|Withdrawal by Subject|1|||
129521427|NCT00251589|466197756|FG001|Overall Study|Withdrawal by Subject|1|||
129521428|NCT00251589|466197757|FG002|Overall Study|Withdrawal by Subject|0|||
129521429|NCT00251589|466197758|FG003|Overall Study|Withdrawal by Subject|0|||
129521430|NCT00251589|466197755|FG000|Overall Study|Discontinued due to progressive disease|9|||
129521431|NCT00251589|466197756|FG001|Overall Study|Discontinued due to progressive disease|1|||
129521432|NCT00251589|466197757|FG002|Overall Study|Discontinued due to progressive disease|0|||
129521433|NCT00251589|466197758|FG003|Overall Study|Discontinued due to progressive disease|1|||
129521434|NCT02571972|466197761|FG000|Overall Study|Protocol Violation|2|||
129521435|NCT02571972|466197761|FG000|Overall Study|Withdrawal by Subject|2|||
129521436|NCT03039192|466197764|FG000|Overall Study|Lost to Follow-up|4|||
129521437|NCT03039192|466197765|FG001|Overall Study|Lost to Follow-up|4|||
129521438|NCT03039192|466197764|FG000|Overall Study|Adverse event, serious fatal|0|||
129521439|NCT03039192|466197765|FG001|Overall Study|Adverse event, serious fatal|1|||
129521440|NCT03039192|466197764|FG000|Overall Study|Adverse event, non-fatal|0|||
129521441|NCT03039192|466197765|FG001|Overall Study|Adverse event, non-fatal|2|||
129521442|NCT03039192|466197764|FG000|Overall Study|Withdrawal by Subject|6|||
129521443|NCT03039192|466197765|FG001|Overall Study|Withdrawal by Subject|9|||
129521444|NCT03039192|466197764|FG000|Overall Study|Discontinued from treatment phase|19|||
129521445|NCT03039192|466197765|FG001|Overall Study|Discontinued from treatment phase|12|||
129521446|NCT03039192|466197764|FG000|Overall Study|Other|3|||
129521447|NCT03039192|466197765|FG001|Overall Study|Other|2|||
129521448|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Adverse Event|22|||
129521449|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Adverse Event|0|||
129521450|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
129521451|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
129521452|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
129521453|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
129521454|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
129521455|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
129521456|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
129521457|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
129521458|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
129521459|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
129521460|NCT02493868|466197766|FG000|Induction Phase: DE Participants|Other|8|||
129521461|NCT02493868|466197767|FG001|Induction Phase: DE Participants|Other|0|||
129521462|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
129521463|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
129521464|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
129521465|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
129521466|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
129521467|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
129521468|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
129521469|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
129521470|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
129521471|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
129521472|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
129521473|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
129521474|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
129521475|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
129521476|NCT02493868|466197766|FG000|Optimization Phase: DE+TE Participants|Other|10|||
129521477|NCT02493868|466197767|FG001|Optimization Phase: DE+TE Participants|Other|2|||
129521478|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
129521479|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
129521480|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
129521481|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
129521482|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
129521483|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
129521484|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
129521485|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
129521486|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
129521487|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
129521488|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
129521489|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
129521490|NCT02493868|466197766|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
129521491|NCT02493868|466197767|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
129521492|NCT02493868|466197766|FG000|Follow-up Phase|Lost to Follow-up|1|||
129521493|NCT02493868|466197767|FG001|Follow-up Phase|Lost to Follow-up|0|||
129521494|NCT02493868|466197766|FG000|Follow-up Phase|Withdrawal by Subject|3|||
129521495|NCT02493868|466197767|FG001|Follow-up Phase|Withdrawal by Subject|0|||
129521496|NCT02493868|466197766|FG000|Follow-up Phase|Investigator Decision|5|||
129521497|NCT02493868|466197767|FG001|Follow-up Phase|Investigator Decision|1|||
129521498|NCT02493868|466197766|FG000|Follow-up Phase|Other|2|||
129521499|NCT02493868|466197767|FG001|Follow-up Phase|Other|1|||
129521500|NCT02407236|466197768|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
129521501|NCT02407236|466197769|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
129521502|NCT02407236|466197770|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
129521503|NCT02407236|466197771|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
129521504|NCT02407236|466197772|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
129521505|NCT02407236|466197773|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
129521506|NCT02407236|466197774|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
129521507|NCT02407236|466197775|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
129521508|NCT02407236|466197776|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
129521509|NCT02407236|466197777|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
129521510|NCT02407236|466197778|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
129521511|NCT02407236|466197779|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
129521512|NCT02407236|466197780|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
129521513|NCT02407236|466197768|FG000|Induction Study (8 Weeks)|Death|0|||
129521514|NCT02407236|466197769|FG001|Induction Study (8 Weeks)|Death|0|||
129521515|NCT02407236|466197770|FG002|Induction Study (8 Weeks)|Death|1|||
129521516|NCT02407236|466197771|FG003|Induction Study (8 Weeks)|Death|0|||
129521517|NCT02407236|466197772|FG004|Induction Study (8 Weeks)|Death|0|||
129521518|NCT02407236|466197773|FG005|Induction Study (8 Weeks)|Death|0|||
129521519|NCT02407236|466197774|FG006|Induction Study (8 Weeks)|Death|0|||
129521520|NCT02407236|466197775|FG007|Induction Study (8 Weeks)|Death|0|||
129521521|NCT02407236|466197776|FG008|Induction Study (8 Weeks)|Death|0|||
129521522|NCT02407236|466197777|FG009|Induction Study (8 Weeks)|Death|0|||
129521523|NCT02407236|466197778|FG010|Induction Study (8 Weeks)|Death|0|||
129521524|NCT02407236|466197779|FG011|Induction Study (8 Weeks)|Death|0|||
129521525|NCT02407236|466197780|FG012|Induction Study (8 Weeks)|Death|0|||
129521526|NCT02407236|466197768|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
129521527|NCT02407236|466197769|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
129521528|NCT02407236|466197770|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
129521529|NCT02407236|466197771|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521530|NCT02407236|466197772|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521531|NCT02407236|466197773|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521532|NCT02407236|466197774|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521533|NCT02407236|466197775|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521534|NCT02407236|466197776|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521535|NCT02407236|466197777|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521536|NCT02407236|466197778|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521537|NCT02407236|466197779|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521538|NCT02407236|466197780|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
129521539|NCT02407236|466197768|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521540|NCT02407236|466197769|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521541|NCT02407236|466197770|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
129521542|NCT02407236|466197771|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521543|NCT02407236|466197772|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521544|NCT02407236|466197773|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521545|NCT02407236|466197774|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521546|NCT02407236|466197775|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521547|NCT02407236|466197776|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521548|NCT02407236|466197777|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521549|NCT02407236|466197778|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521550|NCT02407236|466197779|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521551|NCT02407236|466197780|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
129521552|NCT02407236|466197768|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
129521553|NCT02407236|466197769|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
129521554|NCT02407236|466197770|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
129521555|NCT02407236|466197771|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
129521556|NCT02407236|466197772|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
129521557|NCT02407236|466197773|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
129521558|NCT02407236|466197774|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
129521559|NCT02407236|466197775|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
129521560|NCT02407236|466197776|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
129521561|NCT02407236|466197777|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
129521562|NCT02407236|466197778|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
129521563|NCT02407236|466197779|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
129521564|NCT02407236|466197780|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
129521565|NCT02407236|466197768|FG000|Induction Study (8 Weeks)|Other|2|||
129521566|NCT02407236|466197769|FG001|Induction Study (8 Weeks)|Other|1|||
129521567|NCT02407236|466197770|FG002|Induction Study (8 Weeks)|Other|5|||
129521568|NCT02407236|466197771|FG003|Induction Study (8 Weeks)|Other|0|||
129521569|NCT02407236|466197772|FG004|Induction Study (8 Weeks)|Other|0|||
129521570|NCT02407236|466197773|FG005|Induction Study (8 Weeks)|Other|0|||
129521571|NCT02407236|466197774|FG006|Induction Study (8 Weeks)|Other|0|||
129521572|NCT02407236|466197775|FG007|Induction Study (8 Weeks)|Other|0|||
129521573|NCT02407236|466197776|FG008|Induction Study (8 Weeks)|Other|0|||
129521574|NCT02407236|466197777|FG009|Induction Study (8 Weeks)|Other|0|||
129521575|NCT02407236|466197778|FG010|Induction Study (8 Weeks)|Other|0|||
129521576|NCT02407236|466197779|FG011|Induction Study (8 Weeks)|Other|0|||
129521577|NCT02407236|466197780|FG012|Induction Study (8 Weeks)|Other|0|||
129521578|NCT02407236|466197768|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521579|NCT02407236|466197769|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521580|NCT02407236|466197770|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521581|NCT02407236|466197771|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
129521582|NCT02407236|466197772|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
129521583|NCT02407236|466197773|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
129521584|NCT02407236|466197774|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
129521585|NCT02407236|466197775|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
129521586|NCT02407236|466197776|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521587|NCT02407236|466197777|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521588|NCT02407236|466197778|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521589|NCT02407236|466197779|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521590|NCT02407236|466197780|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
129521591|NCT02407236|466197768|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521592|NCT02407236|466197769|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521593|NCT02407236|466197770|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521594|NCT02407236|466197771|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
129521595|NCT02407236|466197772|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
129521596|NCT02407236|466197773|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
129521597|NCT02407236|466197774|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
129521598|NCT02407236|466197775|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
129521599|NCT02407236|466197776|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521600|NCT02407236|466197777|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521601|NCT02407236|466197778|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521602|NCT02407236|466197779|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521603|NCT02407236|466197780|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
129521604|NCT02407236|466197768|FG000|Maintenance Study (44 Weeks)|Other|0|||
129521605|NCT02407236|466197769|FG001|Maintenance Study (44 Weeks)|Other|0|||
129521606|NCT02407236|466197770|FG002|Maintenance Study (44 Weeks)|Other|0|||
129521607|NCT02407236|466197771|FG003|Maintenance Study (44 Weeks)|Other|5|||
129521608|NCT02407236|466197772|FG004|Maintenance Study (44 Weeks)|Other|7|||
129521609|NCT02407236|466197773|FG005|Maintenance Study (44 Weeks)|Other|8|||
129521610|NCT02407236|466197774|FG006|Maintenance Study (44 Weeks)|Other|4|||
129521611|NCT02407236|466197775|FG007|Maintenance Study (44 Weeks)|Other|6|||
129521612|NCT02407236|466197776|FG008|Maintenance Study (44 Weeks)|Other|0|||
129521613|NCT02407236|466197777|FG009|Maintenance Study (44 Weeks)|Other|0|||
129521614|NCT02407236|466197778|FG010|Maintenance Study (44 Weeks)|Other|0|||
129521615|NCT02407236|466197779|FG011|Maintenance Study (44 Weeks)|Other|0|||
129521616|NCT02407236|466197780|FG012|Maintenance Study (44 Weeks)|Other|0|||
129521617|NCT02407236|466197768|FG000|Maintenance Study (44 Weeks)|Death|0|||
129521618|NCT02407236|466197769|FG001|Maintenance Study (44 Weeks)|Death|0|||
129521619|NCT02407236|466197770|FG002|Maintenance Study (44 Weeks)|Death|0|||
129521620|NCT02407236|466197771|FG003|Maintenance Study (44 Weeks)|Death|0|||
129521621|NCT02407236|466197772|FG004|Maintenance Study (44 Weeks)|Death|0|||
129521622|NCT02407236|466197773|FG005|Maintenance Study (44 Weeks)|Death|0|||
129521623|NCT02407236|466197774|FG006|Maintenance Study (44 Weeks)|Death|0|||
129521624|NCT02407236|466197775|FG007|Maintenance Study (44 Weeks)|Death|1|||
129521625|NCT02407236|466197776|FG008|Maintenance Study (44 Weeks)|Death|0|||
129521626|NCT02407236|466197777|FG009|Maintenance Study (44 Weeks)|Death|0|||
129521627|NCT02407236|466197778|FG010|Maintenance Study (44 Weeks)|Death|0|||
129521628|NCT02407236|466197779|FG011|Maintenance Study (44 Weeks)|Death|0|||
129521629|NCT02407236|466197780|FG012|Maintenance Study (44 Weeks)|Death|0|||
129521630|NCT02407236|466197768|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521631|NCT02407236|466197769|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521632|NCT02407236|466197770|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521633|NCT02407236|466197771|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521634|NCT02407236|466197772|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521635|NCT02407236|466197773|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521636|NCT02407236|466197774|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521637|NCT02407236|466197775|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
129521638|NCT02407236|466197776|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
129521639|NCT02407236|466197777|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
129521640|NCT02407236|466197778|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
129521641|NCT02407236|466197779|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
129521642|NCT02407236|466197780|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
129521643|NCT02407236|466197768|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521644|NCT02407236|466197769|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521645|NCT02407236|466197770|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521646|NCT02407236|466197771|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521647|NCT02407236|466197772|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521648|NCT02407236|466197773|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521649|NCT02407236|466197774|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521650|NCT02407236|466197775|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521651|NCT02407236|466197776|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521652|NCT02407236|466197777|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521653|NCT02407236|466197778|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
129521654|NCT02407236|466197779|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521655|NCT02407236|466197780|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
129521656|NCT02407236|466197768|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521657|NCT02407236|466197769|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521658|NCT02407236|466197770|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521659|NCT02407236|466197771|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521660|NCT02407236|466197772|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521661|NCT02407236|466197773|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521662|NCT02407236|466197774|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521663|NCT02407236|466197775|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
129521664|NCT02407236|466197776|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
129521665|NCT02407236|466197777|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
129521666|NCT02407236|466197778|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
129521667|NCT02407236|466197779|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
129521668|NCT02407236|466197780|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
129521669|NCT02407236|466197768|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
129521670|NCT02407236|466197769|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
129521671|NCT02407236|466197770|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
129521672|NCT02407236|466197771|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
129521673|NCT02407236|466197772|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
129521674|NCT02407236|466197773|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
129521675|NCT02407236|466197774|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
129521676|NCT02407236|466197775|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
129521677|NCT02407236|466197776|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
129521678|NCT02407236|466197777|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
129521679|NCT02407236|466197778|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
129521680|NCT02407236|466197779|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
129521681|NCT02407236|466197780|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
129521682|NCT00643448|466197782|FG000|Overall Study|Lack of Efficacy|2|||
129521683|NCT00643448|466197783|FG001|Overall Study|Lack of Efficacy|0|||
129521684|NCT00643448|466197784|FG002|Overall Study|Lack of Efficacy|4|||
129521685|NCT00643448|466197782|FG000|Overall Study|Adverse Event|2|||
129521686|NCT00643448|466197783|FG001|Overall Study|Adverse Event|2|||
129521687|NCT00643448|466197784|FG002|Overall Study|Adverse Event|2|||
129521688|NCT00643448|466197782|FG000|Overall Study|QTcF>550 ms|0|||
129521689|NCT00643448|466197783|FG001|Overall Study|QTcF>550 ms|3|||
129521690|NCT00643448|466197784|FG002|Overall Study|QTcF>550 ms|0|||
129521691|NCT05166603|466197785|FG000|Overall Study|Withdrawal by Subject|68|||
129521692|NCT05166603|466197786|FG001|Overall Study|Withdrawal by Subject|0|||
129521693|NCT00098865|466199132|FG000|Overall Study|Progressive Disease|6|||
129521694|NCT00098865|466199132|FG000|Overall Study|Adverse Event|2|||
129521695|NCT00098865|466199132|FG000|Overall Study|Alternative Therapy|1|||
129521696|NCT01183104|466199133|FG000|Overall Study|Adverse Event|8|||
129521697|NCT01183104|466199134|FG001|Overall Study|Adverse Event|6|||
129521698|NCT01183104|466199133|FG000|Overall Study|Death|0|||
129521699|NCT01183104|466199134|FG001|Overall Study|Death|1|||
129521700|NCT01183104|466199133|FG000|Overall Study|Lost to Follow-up|14|||
129521701|NCT01183104|466199134|FG001|Overall Study|Lost to Follow-up|7|||
129521702|NCT01183104|466199133|FG000|Overall Study|Physician Decision|5|||
129521703|NCT01183104|466199134|FG001|Overall Study|Physician Decision|8|||
129521704|NCT01183104|466199133|FG000|Overall Study|Withdrawal by Subject|6|||
129521705|NCT01183104|466199134|FG001|Overall Study|Withdrawal by Subject|11|||
129521706|NCT01183104|466199133|FG000|Overall Study|Nonparticipation in Extension Study|39|||
129521707|NCT01183104|466199134|FG001|Overall Study|Nonparticipation in Extension Study|50|||
129521708|NCT01183104|466199133|FG000|Overall Study|Did not receive study drug|5|||
129521709|NCT01183104|466199134|FG001|Overall Study|Did not receive study drug|9|||
129521710|NCT00364351|466199135|FG000|Overall Study|Adverse Event|90|||
129521711|NCT00364351|466199136|FG001|Overall Study|Adverse Event|44|||
129521712|NCT00364351|466199135|FG000|Overall Study|Condition under investigation worsened|469|||
129521713|NCT00364351|466199136|FG001|Overall Study|Condition under investigation worsened|497|||
129521714|NCT00364351|466199135|FG000|Overall Study|Prohibited concomitant medication|0|||
129521715|NCT00364351|466199136|FG001|Overall Study|Prohibited concomitant medication|2|||
129521716|NCT00364351|466199135|FG000|Overall Study|Lost to Follow-up|1|||
129521717|NCT00364351|466199136|FG001|Overall Study|Lost to Follow-up|1|||
129521718|NCT00364351|466199135|FG000|Overall Study|Withdrawal by Subject|30|||
129521719|NCT00364351|466199136|FG001|Overall Study|Withdrawal by Subject|29|||
129521720|NCT00364351|466199135|FG000|Overall Study|Incorrect enrollment|1|||
129521721|NCT00364351|466199136|FG001|Overall Study|Incorrect enrollment|1|||
129521722|NCT00364351|466199135|FG000|Overall Study|Sponsor decision|1|||
129521723|NCT00364351|466199136|FG001|Overall Study|Sponsor decision|0|||
129521724|NCT00364351|466199135|FG000|Overall Study|Poor treatment compliance|0|||
129521725|NCT00364351|466199136|FG001|Overall Study|Poor treatment compliance|3|||
129521726|NCT00364351|466199135|FG000|Overall Study|Investigator error|0|||
129521727|NCT00364351|466199136|FG001|Overall Study|Investigator error|2|||
129521728|NCT00364351|466199135|FG000|Overall Study|Patient could not travel to site|0|||
129521729|NCT00364351|466199136|FG001|Overall Study|Patient could not travel to site|1|||
129521730|NCT00364351|466199135|FG000|Overall Study|Randomised treatment not started|0|||
129521731|NCT00364351|466199136|FG001|Overall Study|Randomised treatment not started|3|||
129521732|NCT03654560|466199139|FG000|Overall Study|Death|3|||
129521733|NCT03654560|466199140|FG001|Overall Study|Death|1|||
129521734|NCT03654560|466199139|FG000|Overall Study|Lost to Follow-up|1|||
129521735|NCT03654560|466199140|FG001|Overall Study|Lost to Follow-up|0|||
129521736|NCT00209092|466199141|FG000|Overall Study|Progression of disease|7|||
129521737|NCT00209092|466199142|FG001|Overall Study|Progression of disease|1|||
129521738|NCT00209092|466199141|FG000|Overall Study|Adverse Event|0|||
129521739|NCT00209092|466199142|FG001|Overall Study|Adverse Event|1|||
129521740|NCT00209092|466199141|FG000|Overall Study|Withdrawal by Subject|1|||
129521741|NCT00209092|466199142|FG001|Overall Study|Withdrawal by Subject|0|||
129521742|NCT02436915|466199145|FG000|Overall Study|Withdrawal by Subject|0|||
129521743|NCT02436915|466199146|FG001|Overall Study|Withdrawal by Subject|1|||
129521744|NCT01117181|466199153|FG000|Overall Study|Lost to Follow-up|1|||
129521745|NCT01117181|466199154|FG001|Overall Study|Lost to Follow-up|0|||
129521746|NCT01117181|466199153|FG000|Overall Study|Withdrawal by Subject|0|||
129521747|NCT01117181|466199154|FG001|Overall Study|Withdrawal by Subject|2|||
129521748|NCT01518309|466199155|FG000|Overall Study|Adverse Event|6|||
129521749|NCT01518309|466199155|FG000|Overall Study|Death|6|||
129521750|NCT01518309|466199155|FG000|Overall Study|Lack of Efficacy|7|||
129521751|NCT01518309|466199155|FG000|Overall Study|Withdrawal by Subject|6|||
129521752|NCT01518309|466199155|FG000|Overall Study|Physician Decision|3|||
129521753|NCT01518309|466199155|FG000|Overall Study|Sponsor Decision|2|||
129521754|NCT01518309|466199155|FG000|Overall Study|Not in Predefined Categories|9|||
129521755|NCT00863317|466199156|FG000|Overall Study|Lost to Follow-up|8|||
129521756|NCT00863317|466199157|FG001|Overall Study|Lost to Follow-up|9|||
129521757|NCT00038142|466199160|FG000|Overall Study|Ineligible|1|||
129521758|NCT00038142|466199161|FG001|Overall Study|Ineligible|0|||
129521759|NCT00038142|466199160|FG000|Overall Study|Progressive Disease|11|||
129521760|NCT00038142|466199161|FG001|Overall Study|Progressive Disease|7|||
129521761|NCT00038142|466199160|FG000|Overall Study|Death|1|||
129521762|NCT00038142|466199161|FG001|Overall Study|Death|0|||
129521763|NCT00038142|466199160|FG000|Overall Study|Adverse Event|1|||
129521764|NCT00038142|466199161|FG001|Overall Study|Adverse Event|0|||
129521765|NCT00038142|466199160|FG000|Overall Study|Unknown Reason|8|||
129521766|NCT00038142|466199161|FG001|Overall Study|Unknown Reason|0|||
129521767|NCT00809614|466199168|FG000|Overall Study|Lack of Efficacy|2|||
129521768|NCT00809614|466199169|FG001|Overall Study|Lack of Efficacy|3|||
129521769|NCT00809614|466199168|FG000|Overall Study|Withdrawal by Subject|1|||
129521770|NCT00809614|466199169|FG001|Overall Study|Withdrawal by Subject|1|||
129521771|NCT01080625|466199170|FG000|Overall Study|Physician Decision|0|||
129521772|NCT01080625|466199171|FG001|Overall Study|Physician Decision|2|||
129521773|NCT01080625|466199172|FG002|Overall Study|Physician Decision|1|||
129521774|NCT00364832|466199176|FG000|Core Period|Early Withdrawals|2|||
129521775|NCT00364832|466199177|FG001|Core Period|Early Withdrawals|2|||
129521776|NCT00364832|466199178|FG002|Core Period|Early Withdrawals|1|||
129521777|NCT00364832|466199179|FG003|Core Period|Early Withdrawals|1|||
129521778|NCT00364832|466199180|FG004|Core Period|Early Withdrawals|0|||
129521779|NCT00364832|466199181|FG005|Core Period|Early Withdrawals|0|||
129521780|NCT00364832|466199182|FG006|Core Period|Early Withdrawals|4|||
129521781|NCT00364832|466199183|FG007|Core Period|Early Withdrawals|1|||
129521782|NCT00364832|466199184|FG008|Core Period|Early Withdrawals|0|||
129521783|NCT00364832|466199185|FG009|Core Period|Early Withdrawals|0|||
129521784|NCT00364832|466199186|FG010|Core Period|Early Withdrawals|0|||
129521785|NCT00364832|466199187|FG011|Core Period|Early Withdrawals|0|||
129521786|NCT00364832|466199176|FG000|Extension Year 1|Early Withdrawals|0|||
129521787|NCT00364832|466199177|FG001|Extension Year 1|Early Withdrawals|0|||
129521788|NCT00364832|466199178|FG002|Extension Year 1|Early Withdrawals|0|||
129521789|NCT00364832|466199179|FG003|Extension Year 1|Early Withdrawals|0|||
129521790|NCT00364832|466199180|FG004|Extension Year 1|Early Withdrawals|0|||
129521791|NCT00364832|466199181|FG005|Extension Year 1|Early Withdrawals|0|||
129521792|NCT00364832|466199182|FG006|Extension Year 1|Early Withdrawals|0|||
129521793|NCT00364832|466199183|FG007|Extension Year 1|Early Withdrawals|0|||
129521794|NCT00364832|466199184|FG008|Extension Year 1|Early Withdrawals|0|||
129521795|NCT00364832|466199185|FG009|Extension Year 1|Early Withdrawals|4|||
129521796|NCT00364832|466199186|FG010|Extension Year 1|Early Withdrawals|2|||
129521797|NCT00364832|466199187|FG011|Extension Year 1|Early Withdrawals|10|||
129521798|NCT00364832|466199176|FG000|Extension Year 2|Early Withdrawals|0|||
129521799|NCT00364832|466199177|FG001|Extension Year 2|Early Withdrawals|0|||
129521800|NCT00364832|466199178|FG002|Extension Year 2|Early Withdrawals|0|||
129521801|NCT00364832|466199179|FG003|Extension Year 2|Early Withdrawals|0|||
129521802|NCT00364832|466199180|FG004|Extension Year 2|Early Withdrawals|0|||
129521803|NCT00364832|466199181|FG005|Extension Year 2|Early Withdrawals|0|||
129521804|NCT00364832|466199182|FG006|Extension Year 2|Early Withdrawals|0|||
129521805|NCT00364832|466199183|FG007|Extension Year 2|Early Withdrawals|0|||
129521806|NCT00364832|466199184|FG008|Extension Year 2|Early Withdrawals|0|||
129521807|NCT00364832|466199185|FG009|Extension Year 2|Early Withdrawals|5|||
129521808|NCT00364832|466199186|FG010|Extension Year 2|Early Withdrawals|5|||
129521809|NCT00364832|466199187|FG011|Extension Year 2|Early Withdrawals|3|||
129521810|NCT02658149|466199189|FG000|Overall Study|Physician Decision|1|||
129521811|NCT02658149|466199190|FG001|Overall Study|Physician Decision|0|||
129521812|NCT00068822|466199191|FG000|First Randomized Intervention|Lost to Follow-up|1|||
129521813|NCT00068822|466199192|FG001|First Randomized Intervention|Lost to Follow-up|2|||
129521814|NCT00735072|466199196|FG000|Overall Study|interrupted study med during ARV change|1|||
129521815|NCT00735072|466199197|FG001|Overall Study|interrupted study med during ARV change|0|||
129521816|NCT00735072|466199196|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
129521817|NCT00735072|466199197|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
129521818|NCT00911144|466199198|FG000|Overall Study|Withdrawal by Subject|16|||
129521819|NCT00911144|466199199|FG001|Overall Study|Withdrawal by Subject|5|||
129521820|NCT00939341|466199204|FG000|Overall Study|Adverse Event|15|||
129521821|NCT00939341|466199204|FG000|Overall Study|Pregnancy|1|||
129521822|NCT00939341|466199204|FG000|Overall Study|Lost to Follow-up|23|||
129521823|NCT00939341|466199204|FG000|Overall Study|Withdrawal by Subject|13|||
129521824|NCT00939341|466199204|FG000|Overall Study|Protocol Violation|6|||
129521825|NCT00939341|466199204|FG000|Overall Study|Incorrect enrolment|8|||
129521826|NCT03377452|466199205|FG000|Overall Study|Refused assessment|0|||
129521827|NCT03377452|466199206|FG001|Overall Study|Refused assessment|2|||
129521828|NCT03377452|466199205|FG000|Overall Study|Lost to Follow-up|5|||
129521829|NCT03377452|466199206|FG001|Overall Study|Lost to Follow-up|4|||
129521830|NCT05179057|466199208|FG000|Overall Study|Adverse Event|3|||
129521831|NCT05179057|466199209|FG001|Overall Study|Adverse Event|2|||
129521832|NCT05179057|466199208|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
129521833|NCT05179057|466199209|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
129521834|NCT05179057|466199208|FG000|Overall Study|Study terminated|13|||
129521835|NCT05179057|466199209|FG001|Overall Study|Study terminated|7|||
129521836|NCT05179057|466199208|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
129521837|NCT05179057|466199209|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
129521838|NCT05179057|466199208|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
129521839|NCT05179057|466199209|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
129521840|NCT03146403|466199210|FG000|Overall Study|Withdrawal by Subject|0|||
129521841|NCT03146403|466199211|FG001|Overall Study|Withdrawal by Subject|3|||
129521842|NCT03146403|466199210|FG000|Overall Study|Lost to Follow-up|2|||
129521843|NCT03146403|466199211|FG001|Overall Study|Lost to Follow-up|0|||
129521844|NCT01024920|466199212|FG000|Overall Study|Progressive disease|47|||
129521845|NCT01024920|466199213|FG001|Overall Study|Progressive disease|25|||
129521846|NCT01024920|466199212|FG000|Overall Study|Adverse Event|8|||
129521847|NCT01024920|466199213|FG001|Overall Study|Adverse Event|4|||
129521848|NCT01024920|466199212|FG000|Overall Study|Lost to Follow-up|0|||
129521849|NCT01024920|466199213|FG001|Overall Study|Lost to Follow-up|1|||
129521850|NCT01024920|466199212|FG000|Overall Study|Patient refusal to continue|4|||
129521851|NCT01024920|466199213|FG001|Overall Study|Patient refusal to continue|0|||
129521852|NCT01024920|466199212|FG000|Overall Study|Other than listed|5|||
129521853|NCT01024920|466199213|FG001|Overall Study|Other than listed|1|||
129521854|NCT01024920|466199212|FG000|Overall Study|Not treated|3|||
129521855|NCT01024920|466199213|FG001|Overall Study|Not treated|0|||
129521856|NCT01024920|466199212|FG000|Overall Study|Protocol Violation|0|||
129521857|NCT01024920|466199213|FG001|Overall Study|Protocol Violation|1|||
129521858|NCT01098032|466199215|FG000|Overall Study|Withdrawal by Subject|1|||
129521859|NCT01098032|466199216|FG001|Overall Study|Withdrawal by Subject|1|||
129521860|NCT00693693|466199221|FG000|Overall Study|Lost to Follow-up|1|||
129521861|NCT00693693|466199222|FG001|Overall Study|Lost to Follow-up|1|||
129521862|NCT00693693|466199223|FG002|Overall Study|Lost to Follow-up|2|||
129521863|NCT02972593|466199224|FG000|Overall Study|Lost to Follow-up|19|||
129521864|NCT02972593|466199225|FG001|Overall Study|Lost to Follow-up|15|||
129521865|NCT02972593|466199224|FG000|Overall Study|Protocol Violation|1|||
129521866|NCT02972593|466199225|FG001|Overall Study|Protocol Violation|0|||
129521867|NCT04599972|466199230|FG000|Overall Study|Withdrawal by Subject|6|||
129521868|NCT04599972|466199231|FG001|Overall Study|Withdrawal by Subject|1|||
129521869|NCT04599972|466199230|FG000|Overall Study|Adverse Event|1|||
129521870|NCT04599972|466199231|FG001|Overall Study|Adverse Event|1|||
129521871|NCT04599972|466199230|FG000|Overall Study|Lost to Follow-up|1|||
129521872|NCT04599972|466199231|FG001|Overall Study|Lost to Follow-up|6|||
129521873|NCT04599972|466199230|FG000|Overall Study|Protocol Violation|1|||
129521874|NCT04599972|466199231|FG001|Overall Study|Protocol Violation|0|||
129521875|NCT04599972|466199230|FG000|Overall Study|Other reason|1|||
129521876|NCT04599972|466199231|FG001|Overall Study|Other reason|0|||
129521877|NCT00638690|466199238|FG000|Overall Study|Death|655|||
129521878|NCT00638690|466199239|FG001|Overall Study|Death|335|||
129521879|NCT00638690|466199238|FG000|Overall Study|Withdrawal by Subject|22|||
129521880|NCT00638690|466199239|FG001|Overall Study|Withdrawal by Subject|5|||
129521881|NCT00638690|466199238|FG000|Overall Study|Lost to Follow-up|4|||
129521882|NCT00638690|466199239|FG001|Overall Study|Lost to Follow-up|2|||
129521883|NCT00621244|466199245|FG000|Overall Study|Withdrawal by Subject|7|||
129521884|NCT00621244|466199246|FG001|Overall Study|Withdrawal by Subject|3|||
129521885|NCT00621244|466199247|FG002|Overall Study|Withdrawal by Subject|3|||
129521886|NCT00621244|466199248|FG003|Overall Study|Withdrawal by Subject|3|||
129521887|NCT00621244|466199245|FG000|Overall Study|Disease progression|44|||
129521888|NCT00621244|466199246|FG001|Overall Study|Disease progression|20|||
129521889|NCT00621244|466199247|FG002|Overall Study|Disease progression|20|||
129521890|NCT00621244|466199248|FG003|Overall Study|Disease progression|15|||
129521891|NCT00621244|466199245|FG000|Overall Study|Death|3|||
129521892|NCT00621244|466199246|FG001|Overall Study|Death|3|||
129521893|NCT00621244|466199247|FG002|Overall Study|Death|1|||
129521894|NCT00621244|466199248|FG003|Overall Study|Death|1|||
129521895|NCT00621244|466199245|FG000|Overall Study|Adverse Event|27|||
129521896|NCT00621244|466199246|FG001|Overall Study|Adverse Event|7|||
129521897|NCT00621244|466199247|FG002|Overall Study|Adverse Event|9|||
129521898|NCT00621244|466199248|FG003|Overall Study|Adverse Event|2|||
129521899|NCT00621244|466199245|FG000|Overall Study|Administrative problems|5|||
129521900|NCT00621244|466199246|FG001|Overall Study|Administrative problems|1|||
129521901|NCT00621244|466199247|FG002|Overall Study|Administrative problems|0|||
129521902|NCT00621244|466199248|FG003|Overall Study|Administrative problems|2|||
129521903|NCT00565812|466199261|FG000|Overall Study|Death|2|||
129521904|NCT00565812|466199262|FG001|Overall Study|Death|1|||
129521905|NCT00565812|466199263|FG002|Overall Study|Death|3|||
129521906|NCT00565812|466199261|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
129521907|NCT00565812|466199262|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
129521908|NCT00565812|466199263|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
129521909|NCT00565812|466199261|FG000|Overall Study|Lost to Follow-up|10|||
129521910|NCT00565812|466199262|FG001|Overall Study|Lost to Follow-up|8|||
129521911|NCT00565812|466199263|FG002|Overall Study|Lost to Follow-up|8|||
129521912|NCT00565812|466199261|FG000|Overall Study|Withdrawal by Subject|58|||
129521913|NCT00565812|466199262|FG001|Overall Study|Withdrawal by Subject|47|||
129521914|NCT00565812|466199263|FG002|Overall Study|Withdrawal by Subject|48|||
129521915|NCT00565812|466199261|FG000|Overall Study|Work Schedule|5|||
129521916|NCT00565812|466199262|FG001|Overall Study|Work Schedule|3|||
129521917|NCT00565812|466199263|FG002|Overall Study|Work Schedule|1|||
129521918|NCT00565812|466199261|FG000|Overall Study|Protocol Violation|2|||
129521919|NCT00565812|466199262|FG001|Overall Study|Protocol Violation|6|||
129521920|NCT00565812|466199263|FG002|Overall Study|Protocol Violation|4|||
129521921|NCT00565812|466199261|FG000|Overall Study|Adverse Event|41|||
129521922|NCT00565812|466199262|FG001|Overall Study|Adverse Event|54|||
129521923|NCT00565812|466199263|FG002|Overall Study|Adverse Event|40|||
129521924|NCT00565812|466199261|FG000|Overall Study|Jury Duty|1|||
129521925|NCT00565812|466199262|FG001|Overall Study|Jury Duty|0|||
129521926|NCT00565812|466199263|FG002|Overall Study|Jury Duty|0|||
129521927|NCT00565812|466199261|FG000|Overall Study|Relocated Out of Area|5|||
129521928|NCT00565812|466199262|FG001|Overall Study|Relocated Out of Area|8|||
129521929|NCT00565812|466199263|FG002|Overall Study|Relocated Out of Area|9|||
129521930|NCT00565812|466199261|FG000|Overall Study|Sponsor Decision|1|||
129521931|NCT00565812|466199262|FG001|Overall Study|Sponsor Decision|5|||
129521932|NCT00565812|466199263|FG002|Overall Study|Sponsor Decision|1|||
129521933|NCT00565812|466199261|FG000|Overall Study|Domestic Reasons|7|||
129521934|NCT00565812|466199262|FG001|Overall Study|Domestic Reasons|1|||
129521935|NCT00565812|466199263|FG002|Overall Study|Domestic Reasons|3|||
129521936|NCT00565812|466199261|FG000|Overall Study|Research Site Closure|6|||
129521937|NCT00565812|466199262|FG001|Overall Study|Research Site Closure|1|||
129521938|NCT00565812|466199263|FG002|Overall Study|Research Site Closure|8|||
129521939|NCT00565812|466199261|FG000|Overall Study|Surgical Intervention|0|||
129521940|NCT00565812|466199262|FG001|Overall Study|Surgical Intervention|1|||
129521941|NCT00565812|466199263|FG002|Overall Study|Surgical Intervention|2|||
129521942|NCT00565812|466199261|FG000|Overall Study|Low Compliance|1|||
129521943|NCT00565812|466199262|FG001|Overall Study|Low Compliance|0|||
129521944|NCT00565812|466199263|FG002|Overall Study|Low Compliance|1|||
129521945|NCT00565812|466199261|FG000|Overall Study|Follow-up Visit Not Completed|2|||
129521946|NCT00565812|466199262|FG001|Overall Study|Follow-up Visit Not Completed|0|||
129521947|NCT00565812|466199263|FG002|Overall Study|Follow-up Visit Not Completed|1|||
129521948|NCT00565812|466199261|FG000|Overall Study|Physician Decision|2|||
129521949|NCT00565812|466199262|FG001|Overall Study|Physician Decision|0|||
129521950|NCT00565812|466199263|FG002|Overall Study|Physician Decision|0|||
129521951|NCT04968353|466199264|FG000|Overall Study|Non-compliance|1|||
129521952|NCT04968353|466199265|FG001|Overall Study|Non-compliance|0|||
129521953|NCT04968353|466199266|FG002|Overall Study|Non-compliance|2|||
129521954|NCT04968353|466199267|FG003|Overall Study|Non-compliance|0|||
129521955|NCT02033850|466199272|FG000|Overall Study|Death|1|||
129521956|NCT02033850|466199273|FG001|Overall Study|Death|0|||
129521957|NCT02033850|466199272|FG000|Overall Study|unrelated medical reason|1|||
129521958|NCT02033850|466199273|FG001|Overall Study|unrelated medical reason|1|||
129521959|NCT03215667|466199274|FG000|Overall Study|Physician Decision|4|||
129521960|NCT00614991|466199277|FG000|Overall Study|Adverse Event|3|||
129521961|NCT00614991|466199278|FG001|Overall Study|Adverse Event|3|||
129521962|NCT00614991|466199279|FG002|Overall Study|Adverse Event|0|||
129521963|NCT00614991|466199280|FG003|Overall Study|Adverse Event|0|||
129521964|NCT00614991|466199281|FG004|Overall Study|Adverse Event|1|||
129521965|NCT00614991|466199282|FG005|Overall Study|Adverse Event|0|||
129521966|NCT03209362|466199285|FG000|Overall Study|Adverse Event|0|||
129521967|NCT03209362|466199286|FG001|Overall Study|Adverse Event|1|||
129521968|NCT03209362|466199285|FG000|Overall Study|Lost to Follow-up|0|||
129521969|NCT03209362|466199286|FG001|Overall Study|Lost to Follow-up|1|||
129521970|NCT03209362|466199285|FG000|Overall Study|Withdrawal by Subject|2|||
129521971|NCT03209362|466199286|FG001|Overall Study|Withdrawal by Subject|0|||
129521972|NCT03209362|466199285|FG000|Overall Study|Other|0|||
129521973|NCT03209362|466199286|FG001|Overall Study|Other|1|||
129521974|NCT00777257|466201420|FG000|Overall Study|Adverse Event|3|||
129521975|NCT00777257|466201421|FG001|Overall Study|Adverse Event|1|||
129521976|NCT00777257|466201422|FG002|Overall Study|Adverse Event|0|||
129521977|NCT00777257|466201420|FG000|Overall Study|Lost to Follow-up|3|||
129521978|NCT00777257|466201421|FG001|Overall Study|Lost to Follow-up|3|||
129521979|NCT00777257|466201422|FG002|Overall Study|Lost to Follow-up|2|||
129521980|NCT00777257|466201420|FG000|Overall Study|Protocol Violation|2|||
129521981|NCT00777257|466201421|FG001|Overall Study|Protocol Violation|2|||
129521982|NCT00777257|466201422|FG002|Overall Study|Protocol Violation|2|||
129521983|NCT00777257|466201420|FG000|Overall Study|Withdrawal by Subject|3|||
129521984|NCT00777257|466201421|FG001|Overall Study|Withdrawal by Subject|6|||
129521985|NCT00777257|466201422|FG002|Overall Study|Withdrawal by Subject|5|||
129521986|NCT00688623|466201424|FG000|Overall Study|Adverse Event|22|||
129521987|NCT00688623|466201424|FG000|Overall Study|abnormal lab value|1|||
129521988|NCT00688623|466201424|FG000|Overall Study|Withdrawal by Subject|4|||
129521989|NCT00688623|466201424|FG000|Overall Study|Death|3|||
129521990|NCT00688623|466201424|FG000|Overall Study|disease progression|23|||
129521991|NCT00688623|466201424|FG000|Overall Study|Protocol Violation|2|||
129521992|NCT02667236|466201425|FG000|Overall Study|Adverse Event|1|||
129521993|NCT02667236|466201426|FG001|Overall Study|Adverse Event|1|||
129521994|NCT02667236|466201425|FG000|Overall Study|Withdrawal by Subject|2|||
129521995|NCT02667236|466201426|FG001|Overall Study|Withdrawal by Subject|0|||
129521996|NCT00464620|466201427|FG000|Overall Study|Physician Decision|1|||
129521997|NCT00464620|466201428|FG001|Overall Study|Physician Decision|0|||
129521998|NCT00464620|466201429|FG002|Overall Study|Physician Decision|0|||
129521999|NCT00464620|466201427|FG000|Overall Study|Withdrawal by Subject|1|||
129522000|NCT00464620|466201428|FG001|Overall Study|Withdrawal by Subject|0|||
129522001|NCT00464620|466201429|FG002|Overall Study|Withdrawal by Subject|3|||
129522002|NCT00464620|466201427|FG000|Overall Study|Ineligible sarcoma subtype|0|||
129522003|NCT00464620|466201428|FG001|Overall Study|Ineligible sarcoma subtype|2|||
129522004|NCT00464620|466201429|FG002|Overall Study|Ineligible sarcoma subtype|2|||
129522005|NCT00464620|466201427|FG000|Overall Study|Use of prohibited concomitant medication|0|||
129522006|NCT00464620|466201428|FG001|Overall Study|Use of prohibited concomitant medication|0|||
129522007|NCT00464620|466201429|FG002|Overall Study|Use of prohibited concomitant medication|2|||
129522008|NCT04984876|466201430|FG000|Overall Study|Subject decision|2|||
129522009|NCT04984876|466201431|FG001|Overall Study|Subject decision|10|||
129522010|NCT04984876|466201432|FG002|Overall Study|Subject decision|3|||
129522011|NCT04984876|466201433|FG003|Overall Study|Subject decision|3|||
129522012|NCT04984876|466201434|FG004|Overall Study|Subject decision|3|||
129522013|NCT04984876|466201435|FG005|Overall Study|Subject decision|0|||
129522014|NCT04984876|466201430|FG000|Overall Study|Guardian decision|0|||
129522015|NCT04984876|466201431|FG001|Overall Study|Guardian decision|1|||
129522016|NCT04984876|466201432|FG002|Overall Study|Guardian decision|0|||
129522017|NCT04984876|466201433|FG003|Overall Study|Guardian decision|2|||
129522018|NCT04984876|466201434|FG004|Overall Study|Guardian decision|0|||
129522019|NCT04984876|466201435|FG005|Overall Study|Guardian decision|1|||
129522020|NCT04984876|466201430|FG000|Overall Study|Lost to Follow-up|0|||
129522021|NCT04984876|466201431|FG001|Overall Study|Lost to Follow-up|0|||
129522022|NCT04984876|466201432|FG002|Overall Study|Lost to Follow-up|1|||
129522023|NCT04984876|466201433|FG003|Overall Study|Lost to Follow-up|1|||
129522024|NCT04984876|466201434|FG004|Overall Study|Lost to Follow-up|0|||
129522025|NCT04984876|466201435|FG005|Overall Study|Lost to Follow-up|0|||
129522026|NCT04984876|466201430|FG000|Overall Study|Physician Decision|1|||
129522027|NCT04984876|466201431|FG001|Overall Study|Physician Decision|0|||
129522028|NCT04984876|466201432|FG002|Overall Study|Physician Decision|0|||
129522029|NCT04984876|466201433|FG003|Overall Study|Physician Decision|1|||
129522030|NCT04984876|466201434|FG004|Overall Study|Physician Decision|0|||
129522031|NCT04984876|466201435|FG005|Overall Study|Physician Decision|0|||
129522032|NCT04984876|466201430|FG000|Overall Study|Adverse Event|0|||
129522033|NCT04984876|466201431|FG001|Overall Study|Adverse Event|0|||
129522034|NCT04984876|466201432|FG002|Overall Study|Adverse Event|1|||
129522035|NCT04984876|466201433|FG003|Overall Study|Adverse Event|0|||
129522036|NCT04984876|466201434|FG004|Overall Study|Adverse Event|0|||
129522037|NCT04984876|466201435|FG005|Overall Study|Adverse Event|0|||
129522038|NCT02204410|466201436|FG000|Overall Study|Lost to Follow-up|5|||
129522039|NCT02204410|466201436|FG000|Overall Study|Physician Decision|2|||
129522040|NCT02204410|466201436|FG000|Overall Study|Protocol Violation|1|||
129522041|NCT02204410|466201436|FG000|Overall Study|Withdrawal by Subject|3|||
129522042|NCT01462045|466201439|FG000|Overall Study|Family matter|0|||
129522043|NCT01462045|466201440|FG001|Overall Study|Family matter|1|||
129522044|NCT01462045|466201441|FG002|Overall Study|Family matter|0|||
129522045|NCT02579863|466201442|FG000|Overall Study|Final Disposition Unknown|2|||
129522046|NCT02579863|466201443|FG001|Overall Study|Final Disposition Unknown|1|||
129522047|NCT02579863|466201442|FG000|Overall Study|Adverse Event|18|||
129522048|NCT02579863|466201443|FG001|Overall Study|Adverse Event|11|||
129522049|NCT02579863|466201442|FG000|Overall Study|Death|31|||
129522050|NCT02579863|466201443|FG001|Overall Study|Death|29|||
129522051|NCT02579863|466201442|FG000|Overall Study|Lost to Follow-up|2|||
129522052|NCT02579863|466201443|FG001|Overall Study|Lost to Follow-up|1|||
129522053|NCT02579863|466201442|FG000|Overall Study|Physician Decision|1|||
129522054|NCT02579863|466201443|FG001|Overall Study|Physician Decision|2|||
129522055|NCT02579863|466201442|FG000|Overall Study|Screen Failure|0|||
129522056|NCT02579863|466201443|FG001|Overall Study|Screen Failure|2|||
129522057|NCT02579863|466201442|FG000|Overall Study|Study Terminated at Selected Sites|82|||
129522058|NCT02579863|466201443|FG001|Overall Study|Study Terminated at Selected Sites|88|||
129522059|NCT02579863|466201442|FG000|Overall Study|Withdrawal by Subject|20|||
129522060|NCT02579863|466201443|FG001|Overall Study|Withdrawal by Subject|20|||
129522061|NCT03887052|466201454|FG000|Overall Study|Adverse Event|2|||
129522062|NCT03887052|466201454|FG000|Overall Study|Physician Decision|2|||
129522063|NCT03887052|466201454|FG000|Overall Study|Withdrawal by Subject|3|||
129522064|NCT03887052|466201454|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
129522065|NCT03887052|466201454|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
129522066|NCT01804842|466201455|FG000|Overall Study|Adverse Event|1|||
129522067|NCT01804842|466201456|FG001|Overall Study|Adverse Event|1|||
129522068|NCT01804842|466201457|FG002|Overall Study|Adverse Event|0|||
129522069|NCT01804842|466201455|FG000|Overall Study|Lost to Follow-up|1|||
129522070|NCT01804842|466201456|FG001|Overall Study|Lost to Follow-up|0|||
129522071|NCT01804842|466201457|FG002|Overall Study|Lost to Follow-up|0|||
129522072|NCT01804842|466201455|FG000|Overall Study|Non-Compliance|1|||
129522073|NCT01804842|466201456|FG001|Overall Study|Non-Compliance|1|||
129522074|NCT01804842|466201457|FG002|Overall Study|Non-Compliance|0|||
129522075|NCT01804842|466201455|FG000|Overall Study|Personal Reason|0|||
129522076|NCT01804842|466201456|FG001|Overall Study|Personal Reason|0|||
129522077|NCT01804842|466201457|FG002|Overall Study|Personal Reason|1|||
129522078|NCT01440972|466201458|FG000|Overall Study|Withdrawal by Subject|3|||
129522079|NCT01440972|466201459|FG001|Overall Study|Withdrawal by Subject|2|||
129522080|NCT04222673|466201460|FG000|Overall Study|Lost to Follow-up|5|||
129522081|NCT02352090|466201461|FG000|Overall Study|general malaise|1|||
129522082|NCT02352090|466201462|FG001|Overall Study|general malaise|0|||
129522083|NCT02352090|466201463|FG002|Overall Study|general malaise|0|||
129522084|NCT02352090|466201461|FG000|Overall Study|non-specified mild side-effects|0|||
129522085|NCT02352090|466201462|FG001|Overall Study|non-specified mild side-effects|0|||
129522086|NCT02352090|466201463|FG002|Overall Study|non-specified mild side-effects|2|||
129522087|NCT01849562|466201464|FG000|Overall Study|Lost to Follow-up|1|||
129522088|NCT01849562|466201465|FG001|Overall Study|Lost to Follow-up|0|||
129522089|NCT01849562|466201466|FG002|Overall Study|Lost to Follow-up|0|||
129522090|NCT01849562|466201464|FG000|Overall Study|Non-compliance with Study Drug|1|||
129522091|NCT01849562|466201465|FG001|Overall Study|Non-compliance with Study Drug|0|||
129522092|NCT01849562|466201466|FG002|Overall Study|Non-compliance with Study Drug|0|||
129522093|NCT02182999|466201470|FG000|Overall Study|Adverse Event|4|||
129522094|NCT02182999|466201471|FG001|Overall Study|Adverse Event|3|||
129522095|NCT02182999|466201470|FG000|Overall Study|Physician Decision|1|||
129522096|NCT02182999|466201471|FG001|Overall Study|Physician Decision|0|||
129522097|NCT02252588|466201472|FG000|Overall Study|Withdrawal by Subject|4|||
129522098|NCT02252588|466201473|FG001|Overall Study|Withdrawal by Subject|0|||
129522099|NCT03039790|466201474|FG000|Overall Study|Lost to Follow-up|2|||
129522100|NCT03039790|466201475|FG001|Overall Study|Lost to Follow-up|0|||
129522101|NCT03039790|466201476|FG002|Overall Study|Lost to Follow-up|1|||
129522102|NCT03039790|466201477|FG003|Overall Study|Lost to Follow-up|1|||
129522103|NCT03039790|466201478|FG004|Overall Study|Lost to Follow-up|0|||
129522104|NCT03039790|466201479|FG005|Overall Study|Lost to Follow-up|1|||
129522105|NCT03039790|466201480|FG006|Overall Study|Lost to Follow-up|1|||
129522106|NCT03039790|466201481|FG007|Overall Study|Lost to Follow-up|1|||
129522107|NCT03039790|466201482|FG008|Overall Study|Lost to Follow-up|0|||
129522108|NCT03039790|466201483|FG009|Overall Study|Lost to Follow-up|1|||
129522109|NCT03039790|466201484|FG010|Overall Study|Lost to Follow-up|1|||
129522110|NCT03039790|466201485|FG011|Overall Study|Lost to Follow-up|0|||
129522111|NCT03039790|466201486|FG012|Overall Study|Lost to Follow-up|1|||
129522112|NCT03039790|466201487|FG013|Overall Study|Lost to Follow-up|0|||
129522113|NCT03039790|466201488|FG014|Overall Study|Lost to Follow-up|3|||
129522114|NCT03039790|466201489|FG015|Overall Study|Lost to Follow-up|1|||
129522115|NCT03039790|466201490|FG016|Overall Study|Lost to Follow-up|2|||
129522116|NCT03039790|466201491|FG017|Overall Study|Lost to Follow-up|2|||
129522117|NCT03039790|466201492|FG018|Overall Study|Lost to Follow-up|1|||
129522118|NCT03039790|466201493|FG019|Overall Study|Lost to Follow-up|3|||
129522119|NCT03039790|466201474|FG000|Overall Study|Withdrawal of Consent|1|||
129522120|NCT03039790|466201475|FG001|Overall Study|Withdrawal of Consent|0|||
129522121|NCT03039790|466201476|FG002|Overall Study|Withdrawal of Consent|0|||
129522122|NCT03039790|466201477|FG003|Overall Study|Withdrawal of Consent|1|||
129522123|NCT03039790|466201478|FG004|Overall Study|Withdrawal of Consent|0|||
129522124|NCT03039790|466201479|FG005|Overall Study|Withdrawal of Consent|0|||
129522125|NCT03039790|466201480|FG006|Overall Study|Withdrawal of Consent|0|||
129522126|NCT03039790|466201481|FG007|Overall Study|Withdrawal of Consent|0|||
129522127|NCT03039790|466201482|FG008|Overall Study|Withdrawal of Consent|0|||
129522128|NCT03039790|466201483|FG009|Overall Study|Withdrawal of Consent|1|||
129522129|NCT03039790|466201484|FG010|Overall Study|Withdrawal of Consent|0|||
129522130|NCT03039790|466201485|FG011|Overall Study|Withdrawal of Consent|0|||
129522131|NCT03039790|466201486|FG012|Overall Study|Withdrawal of Consent|2|||
129522132|NCT03039790|466201487|FG013|Overall Study|Withdrawal of Consent|0|||
129522133|NCT03039790|466201488|FG014|Overall Study|Withdrawal of Consent|1|||
129522134|NCT03039790|466201489|FG015|Overall Study|Withdrawal of Consent|5|||
129522135|NCT03039790|466201490|FG016|Overall Study|Withdrawal of Consent|3|||
129522136|NCT03039790|466201491|FG017|Overall Study|Withdrawal of Consent|0|||
129522137|NCT03039790|466201492|FG018|Overall Study|Withdrawal of Consent|2|||
129522138|NCT03039790|466201493|FG019|Overall Study|Withdrawal of Consent|5|||
129522139|NCT03039790|466201474|FG000|Overall Study|Death|0|||
129522140|NCT03039790|466201475|FG001|Overall Study|Death|0|||
129522141|NCT03039790|466201476|FG002|Overall Study|Death|0|||
129522142|NCT03039790|466201477|FG003|Overall Study|Death|0|||
129522143|NCT03039790|466201478|FG004|Overall Study|Death|0|||
129522144|NCT03039790|466201479|FG005|Overall Study|Death|0|||
129522145|NCT03039790|466201480|FG006|Overall Study|Death|0|||
129522146|NCT03039790|466201481|FG007|Overall Study|Death|0|||
129522147|NCT03039790|466201482|FG008|Overall Study|Death|0|||
129522148|NCT03039790|466201483|FG009|Overall Study|Death|0|||
129522149|NCT03039790|466201484|FG010|Overall Study|Death|0|||
129522150|NCT03039790|466201485|FG011|Overall Study|Death|0|||
129522151|NCT03039790|466201486|FG012|Overall Study|Death|0|||
129522152|NCT03039790|466201487|FG013|Overall Study|Death|0|||
129522153|NCT03039790|466201488|FG014|Overall Study|Death|0|||
129522154|NCT03039790|466201489|FG015|Overall Study|Death|1|||
129522155|NCT03039790|466201490|FG016|Overall Study|Death|3|||
129522156|NCT03039790|466201491|FG017|Overall Study|Death|0|||
129522157|NCT03039790|466201492|FG018|Overall Study|Death|2|||
129522158|NCT03039790|466201493|FG019|Overall Study|Death|0|||
129522159|NCT03039790|466201474|FG000|Overall Study|Reason, not Specified|1|||
129522160|NCT03039790|466201475|FG001|Overall Study|Reason, not Specified|0|||
129522161|NCT03039790|466201476|FG002|Overall Study|Reason, not Specified|0|||
129522162|NCT03039790|466201477|FG003|Overall Study|Reason, not Specified|0|||
129522163|NCT03039790|466201478|FG004|Overall Study|Reason, not Specified|0|||
129522164|NCT03039790|466201479|FG005|Overall Study|Reason, not Specified|0|||
129522165|NCT03039790|466201480|FG006|Overall Study|Reason, not Specified|0|||
129522166|NCT03039790|466201481|FG007|Overall Study|Reason, not Specified|0|||
129522167|NCT03039790|466201482|FG008|Overall Study|Reason, not Specified|0|||
129522168|NCT03039790|466201483|FG009|Overall Study|Reason, not Specified|0|||
129522169|NCT03039790|466201484|FG010|Overall Study|Reason, not Specified|0|||
129522170|NCT03039790|466201485|FG011|Overall Study|Reason, not Specified|0|||
129522171|NCT03039790|466201486|FG012|Overall Study|Reason, not Specified|0|||
129522172|NCT03039790|466201487|FG013|Overall Study|Reason, not Specified|0|||
129522173|NCT03039790|466201488|FG014|Overall Study|Reason, not Specified|0|||
129522174|NCT03039790|466201489|FG015|Overall Study|Reason, not Specified|0|||
129522175|NCT03039790|466201490|FG016|Overall Study|Reason, not Specified|2|||
129522176|NCT03039790|466201491|FG017|Overall Study|Reason, not Specified|0|||
129522177|NCT03039790|466201492|FG018|Overall Study|Reason, not Specified|1|||
129522178|NCT03039790|466201493|FG019|Overall Study|Reason, not Specified|0|||
129522179|NCT00498368|466201503|FG000|Overall Study|Withdrawal by Subject|3|||
129522180|NCT00498368|466201504|FG001|Overall Study|Withdrawal by Subject|2|||
129522181|NCT02266004|466201505|FG000|Overall Study|unrelated adverse event|1|||
129522182|NCT02266004|466201505|FG000|Overall Study|Physician Decision|1|||
129522183|NCT01347073|466201515|FG000|Overall Study|Adverse Event|1|||
129522184|NCT01347073|466201515|FG000|Overall Study|Liver Transplant|1|||
129522185|NCT01690988|466201522|FG000|Overall Study|Withdrawal by Subject|2|||
129522186|NCT01690988|466201523|FG001|Overall Study|Withdrawal by Subject|2|||
129522187|NCT01690988|466201524|FG002|Overall Study|Withdrawal by Subject|3|||
129522188|NCT01690988|466201522|FG000|Overall Study|Physician Decision|0|||
129522189|NCT01690988|466201523|FG001|Overall Study|Physician Decision|0|||
129522190|NCT01690988|466201524|FG002|Overall Study|Physician Decision|1|||
129522191|NCT01690988|466201522|FG000|Overall Study|Operation Cancelled|1|||
129522192|NCT01690988|466201523|FG001|Overall Study|Operation Cancelled|1|||
129522193|NCT01690988|466201524|FG002|Overall Study|Operation Cancelled|0|||
129522194|NCT01690988|466201522|FG000|Overall Study|Determined ineligible|1|||
129522195|NCT01690988|466201523|FG001|Overall Study|Determined ineligible|0|||
129522196|NCT01690988|466201524|FG002|Overall Study|Determined ineligible|0|||
129522197|NCT01690988|466201522|FG000|Overall Study|Death|1|||
129522198|NCT01690988|466201523|FG001|Overall Study|Death|1|||
129522199|NCT01690988|466201524|FG002|Overall Study|Death|1|||
129522200|NCT01690988|466201522|FG000|Overall Study|Sedated|1|||
129522201|NCT01690988|466201523|FG001|Overall Study|Sedated|1|||
129522202|NCT01690988|466201524|FG002|Overall Study|Sedated|2|||
129522203|NCT00372489|466201527|FG000|Overall Study|Adverse Event|18|||
129522204|NCT00372489|466201527|FG000|Overall Study|Lack of Efficacy|1|||
129522205|NCT00372489|466201527|FG000|Overall Study|Lost to Follow-up|3|||
129522206|NCT00372489|466201527|FG000|Overall Study|Physician Decision|3|||
129522207|NCT00372489|466201527|FG000|Overall Study|Withdrawal by Subject|5|||
129522208|NCT00372489|466201527|FG000|Overall Study|Patient Relocation|2|||
129522209|NCT00372489|466201527|FG000|Overall Study|Renal transplant|6|||
129522210|NCT00372489|466201527|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
129522211|NCT00552344|466201532|FG000|Overall Study|Lack of Efficacy|55|||
129522212|NCT00552344|466201532|FG000|Overall Study|Loss of efficacy|75|||
129522213|NCT00552344|466201532|FG000|Overall Study|Lost to Follow-up|8|||
129522214|NCT00552344|466201532|FG000|Overall Study|Withdrawal by Subject|48|||
129522215|NCT00552344|466201532|FG000|Overall Study|SAE, non-fatal|6|||
129522216|NCT00552344|466201532|FG000|Overall Study|AE, non-serious non-fatal|38|||
129522217|NCT00552344|466201532|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
129522218|NCT00552344|466201532|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
129522219|NCT00552344|466201532|FG000|Overall Study|Other Reason|22|||
129522220|NCT01662986|466201533|FG000|Overall Study|Adverse Event|5|||
129522221|NCT01662986|466201534|FG001|Overall Study|Adverse Event|4|||
129522222|NCT01662986|466201533|FG000|Overall Study|Protocol Violation|2|||
129522223|NCT01662986|466201534|FG001|Overall Study|Protocol Violation|3|||
129522224|NCT01662986|466201533|FG000|Overall Study|Lost to Follow-up|5|||
129522225|NCT01662986|466201534|FG001|Overall Study|Lost to Follow-up|4|||
129522226|NCT01662986|466201533|FG000|Overall Study|Withdrawal by Subject|2|||
129522227|NCT01662986|466201534|FG001|Overall Study|Withdrawal by Subject|2|||
129522228|NCT01662986|466201533|FG000|Overall Study|Not Treated|1|||
129522229|NCT01662986|466201534|FG001|Overall Study|Not Treated|0|||
129522230|NCT01662986|466201533|FG000|Overall Study|Other than stated above|3|||
129522231|NCT01662986|466201534|FG001|Overall Study|Other than stated above|0|||
129522232|NCT01512693|466201537|FG000|Overall Study|Withdrawal by Subject|0|||
129522233|NCT01512693|466201538|FG001|Overall Study|Withdrawal by Subject|1|||
129522234|NCT04731922|466201539|FG000|Overall Study|Adverse Event|0|||
129522235|NCT04731922|466201540|FG001|Overall Study|Adverse Event|0|||
129522236|NCT04731922|466201541|FG002|Overall Study|Adverse Event|0|||
129522237|NCT04731922|466201542|FG003|Overall Study|Adverse Event|0|||
129522238|NCT04731922|466201543|FG004|Overall Study|Adverse Event|0|||
129522239|NCT04731922|466201544|FG005|Overall Study|Adverse Event|0|||
129522240|NCT04731922|466201545|FG006|Overall Study|Adverse Event|0|||
129522241|NCT04731922|466201546|FG007|Overall Study|Adverse Event|0|||
129522242|NCT04731922|466201547|FG008|Overall Study|Adverse Event|0|||
129522243|NCT04731922|466201548|FG009|Overall Study|Adverse Event|0|||
129522244|NCT04731922|466201549|FG010|Overall Study|Adverse Event|1|||
129522245|NCT04731922|466201550|FG011|Overall Study|Adverse Event|0|||
129522246|NCT04731922|466201551|FG012|Overall Study|Adverse Event|0|||
129522247|NCT04731922|466201552|FG013|Overall Study|Adverse Event|0|||
129522248|NCT04731922|466201553|FG014|Overall Study|Adverse Event|0|||
129522249|NCT04731922|466201554|FG015|Overall Study|Adverse Event|0|||
129522250|NCT04731922|466201555|FG016|Overall Study|Adverse Event|0|||
129522251|NCT04731922|466201539|FG000|Overall Study|Lost to Follow-up|0|||
129522252|NCT04731922|466201540|FG001|Overall Study|Lost to Follow-up|0|||
129522253|NCT04731922|466201541|FG002|Overall Study|Lost to Follow-up|0|||
129522254|NCT04731922|466201542|FG003|Overall Study|Lost to Follow-up|1|||
129522255|NCT04731922|466201543|FG004|Overall Study|Lost to Follow-up|0|||
129522256|NCT04731922|466201544|FG005|Overall Study|Lost to Follow-up|1|||
129522257|NCT04731922|466201545|FG006|Overall Study|Lost to Follow-up|0|||
129522258|NCT04731922|466201546|FG007|Overall Study|Lost to Follow-up|0|||
129522259|NCT04731922|466201547|FG008|Overall Study|Lost to Follow-up|0|||
129522260|NCT04731922|466201548|FG009|Overall Study|Lost to Follow-up|0|||
129522261|NCT04731922|466201549|FG010|Overall Study|Lost to Follow-up|0|||
129522262|NCT04731922|466201550|FG011|Overall Study|Lost to Follow-up|0|||
129522263|NCT04731922|466201551|FG012|Overall Study|Lost to Follow-up|0|||
129522264|NCT04731922|466201552|FG013|Overall Study|Lost to Follow-up|0|||
129522265|NCT04731922|466201553|FG014|Overall Study|Lost to Follow-up|0|||
129522266|NCT04731922|466201554|FG015|Overall Study|Lost to Follow-up|0|||
129522267|NCT04731922|466201555|FG016|Overall Study|Lost to Follow-up|0|||
129522268|NCT04731922|466201539|FG000|Overall Study|Withdrawal by Subject|1|||
129522269|NCT04731922|466201540|FG001|Overall Study|Withdrawal by Subject|0|||
129522270|NCT04731922|466201541|FG002|Overall Study|Withdrawal by Subject|0|||
129522271|NCT04731922|466201542|FG003|Overall Study|Withdrawal by Subject|0|||
129522272|NCT04731922|466201543|FG004|Overall Study|Withdrawal by Subject|1|||
129522273|NCT04731922|466201544|FG005|Overall Study|Withdrawal by Subject|0|||
129522274|NCT04731922|466201545|FG006|Overall Study|Withdrawal by Subject|1|||
129522275|NCT04731922|466201546|FG007|Overall Study|Withdrawal by Subject|0|||
129522276|NCT04731922|466201547|FG008|Overall Study|Withdrawal by Subject|0|||
129522277|NCT04731922|466201548|FG009|Overall Study|Withdrawal by Subject|0|||
129522278|NCT04731922|466201549|FG010|Overall Study|Withdrawal by Subject|0|||
129522279|NCT04731922|466201550|FG011|Overall Study|Withdrawal by Subject|0|||
129522280|NCT04731922|466201551|FG012|Overall Study|Withdrawal by Subject|0|||
129522281|NCT04731922|466201552|FG013|Overall Study|Withdrawal by Subject|1|||
129522282|NCT04731922|466201553|FG014|Overall Study|Withdrawal by Subject|0|||
129522283|NCT04731922|466201554|FG015|Overall Study|Withdrawal by Subject|0|||
129522284|NCT04731922|466201555|FG016|Overall Study|Withdrawal by Subject|0|||
129522285|NCT04731922|466201539|FG000|Overall Study|Other|0|||
129522286|NCT04731922|466201540|FG001|Overall Study|Other|0|||
129522287|NCT04731922|466201541|FG002|Overall Study|Other|0|||
129522288|NCT04731922|466201542|FG003|Overall Study|Other|0|||
129522289|NCT04731922|466201543|FG004|Overall Study|Other|0|||
129522290|NCT04731922|466201544|FG005|Overall Study|Other|0|||
129522291|NCT04731922|466201545|FG006|Overall Study|Other|1|||
129522292|NCT04731922|466201546|FG007|Overall Study|Other|0|||
129522293|NCT04731922|466201547|FG008|Overall Study|Other|0|||
129522294|NCT04731922|466201548|FG009|Overall Study|Other|0|||
129522295|NCT04731922|466201549|FG010|Overall Study|Other|0|||
129522296|NCT04731922|466201550|FG011|Overall Study|Other|0|||
129522297|NCT04731922|466201551|FG012|Overall Study|Other|0|||
129522298|NCT04731922|466201552|FG013|Overall Study|Other|0|||
129522299|NCT04731922|466201553|FG014|Overall Study|Other|0|||
129522300|NCT04731922|466201554|FG015|Overall Study|Other|0|||
129522301|NCT04731922|466201555|FG016|Overall Study|Other|0|||
129522302|NCT02343952|466201558|FG000|Study Treatment|Disease Progression|23|||
129522303|NCT02343952|466201558|FG000|Study Treatment|Death|3|||
129522304|NCT02343952|466201558|FG000|Study Treatment|Adverse Event|19|||
129522305|NCT02343952|466201558|FG000|Study Treatment|Withdrawal by Subject|7|||
129522306|NCT02343952|466201558|FG000|Study Treatment|other complicating Diseases|1|||
129522307|NCT02343952|466201558|FG000|Follow up|Withdrawal by Subject|3|||
129522308|NCT02343952|466201558|FG000|Follow up|Death|33|||
129522309|NCT02343952|466201558|FG000|Follow up|Patient does not meet eligibility for study.|1|||
129522310|NCT02343952|466201558|FG000|Follow up|Research department closed by the practice.|5|||
129522311|NCT02343952|466201558|FG000|Follow up|Patient went home to Russia|1|||
129522312|NCT02343952|466201558|FG000|Follow up|Disease Progression|1|||
129522313|NCT02343952|466201558|FG000|Follow up|study terminated|1|||
129522314|NCT00845845|466201562|FG000|Overall Study|Lost to Follow-up|0|||
129522315|NCT00845845|466201563|FG001|Overall Study|Lost to Follow-up|4|||
129522316|NCT02820038|466201565|FG000|Overall Study|Lost to Follow-up|7|||
129522317|NCT02820038|466201566|FG001|Overall Study|Lost to Follow-up|11|||
129522318|NCT02820038|466201567|FG002|Overall Study|Lost to Follow-up|2|||
129522319|NCT02820038|466201568|FG003|Overall Study|Lost to Follow-up|9|||
129522320|NCT02820038|466201565|FG000|Overall Study|Withdrawal by Subject|3|||
129522321|NCT02820038|466201566|FG001|Overall Study|Withdrawal by Subject|14|||
129522322|NCT02820038|466201567|FG002|Overall Study|Withdrawal by Subject|3|||
129522323|NCT02820038|466201568|FG003|Overall Study|Withdrawal by Subject|13|||
129522324|NCT02623699|466201569|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522325|NCT02623699|466201570|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
129522326|NCT02623699|466201571|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522327|NCT02623699|466201572|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522328|NCT02623699|466201573|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522329|NCT02623699|466201574|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522330|NCT02623699|466201575|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522331|NCT02623699|466201576|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522332|NCT02623699|466201577|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522333|NCT02623699|466201578|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522334|NCT02623699|466201579|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522335|NCT02623699|466201580|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
129522336|NCT02623699|466201569|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522337|NCT02623699|466201570|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522338|NCT02623699|466201571|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522339|NCT02623699|466201572|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522340|NCT02623699|466201573|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522341|NCT02623699|466201574|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522342|NCT02623699|466201575|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
129522343|NCT02623699|466201576|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522344|NCT02623699|466201577|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522345|NCT02623699|466201578|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522346|NCT02623699|466201579|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522347|NCT02623699|466201580|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
129522348|NCT02623699|466201569|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522349|NCT02623699|466201570|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522350|NCT02623699|466201571|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522351|NCT02623699|466201572|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522352|NCT02623699|466201573|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522353|NCT02623699|466201574|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
129522354|NCT02623699|466201575|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522355|NCT02623699|466201576|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522356|NCT02623699|466201577|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522357|NCT02623699|466201578|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522358|NCT02623699|466201579|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522359|NCT02623699|466201580|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
129522360|NCT02623699|466201569|FG000|Part B (Up to 289 Days)|Death|0|||
129522361|NCT02623699|466201570|FG001|Part B (Up to 289 Days)|Death|0|||
129522362|NCT02623699|466201571|FG002|Part B (Up to 289 Days)|Death|0|||
129522363|NCT02623699|466201572|FG003|Part B (Up to 289 Days)|Death|0|||
129522364|NCT02623699|466201573|FG004|Part B (Up to 289 Days)|Death|0|||
129522365|NCT02623699|466201574|FG005|Part B (Up to 289 Days)|Death|1|||
129522366|NCT02623699|466201575|FG006|Part B (Up to 289 Days)|Death|1|||
129522367|NCT02623699|466201576|FG007|Part B (Up to 289 Days)|Death|0|||
129522368|NCT02623699|466201577|FG008|Part B (Up to 289 Days)|Death|1|||
129522369|NCT02623699|466201578|FG009|Part B (Up to 289 Days)|Death|0|||
129522370|NCT02623699|466201579|FG010|Part B (Up to 289 Days)|Death|0|||
129522371|NCT02623699|466201580|FG011|Part B (Up to 289 Days)|Death|0|||
129522372|NCT02623699|466201569|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
129522373|NCT02623699|466201570|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
129522374|NCT02623699|466201571|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
129522375|NCT02623699|466201572|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
129522376|NCT02623699|466201573|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
129522377|NCT02623699|466201574|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
129522378|NCT02623699|466201575|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
129522379|NCT02623699|466201576|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
129522380|NCT02623699|466201577|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
129522381|NCT02623699|466201578|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
129522382|NCT02623699|466201579|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
129522383|NCT02623699|466201580|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
129522384|NCT02623699|466201569|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522385|NCT02623699|466201570|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522386|NCT02623699|466201571|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522387|NCT02623699|466201572|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522388|NCT02623699|466201573|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522389|NCT02623699|466201574|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522390|NCT02623699|466201575|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522391|NCT02623699|466201576|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522392|NCT02623699|466201577|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522393|NCT02623699|466201578|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
129522394|NCT02623699|466201579|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
129522395|NCT02623699|466201580|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
129522396|NCT02623699|466201569|FG000|Part C (Up to 236 Days)|Death|0|||
129522397|NCT02623699|466201570|FG001|Part C (Up to 236 Days)|Death|0|||
129522398|NCT02623699|466201571|FG002|Part C (Up to 236 Days)|Death|0|||
129522399|NCT02623699|466201572|FG003|Part C (Up to 236 Days)|Death|0|||
129522400|NCT02623699|466201573|FG004|Part C (Up to 236 Days)|Death|0|||
129522401|NCT02623699|466201574|FG005|Part C (Up to 236 Days)|Death|0|||
129522402|NCT02623699|466201575|FG006|Part C (Up to 236 Days)|Death|0|||
129522403|NCT02623699|466201576|FG007|Part C (Up to 236 Days)|Death|0|||
129522404|NCT02623699|466201577|FG008|Part C (Up to 236 Days)|Death|0|||
129522405|NCT02623699|466201578|FG009|Part C (Up to 236 Days)|Death|0|||
129522406|NCT02623699|466201579|FG010|Part C (Up to 236 Days)|Death|0|||
129522407|NCT02623699|466201580|FG011|Part C (Up to 236 Days)|Death|1|||
129522408|NCT02623699|466201569|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
129522409|NCT02623699|466201570|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
129522410|NCT02623699|466201571|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
129522411|NCT02623699|466201572|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
129522412|NCT02623699|466201573|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
129522413|NCT02623699|466201574|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
129522414|NCT02623699|466201575|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
129522415|NCT02623699|466201576|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
129522416|NCT02623699|466201577|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
129522417|NCT02623699|466201578|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
129522418|NCT02623699|466201579|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
129522419|NCT02623699|466201580|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
129522420|NCT00899678|466201581|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
129522421|NCT00899678|466201582|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
129522422|NCT00899678|466201583|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
129522423|NCT00899678|466201581|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
129522424|NCT00899678|466201582|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
129522425|NCT00899678|466201583|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
129522426|NCT00899678|466201581|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
129522427|NCT00899678|466201582|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
129522428|NCT00899678|466201583|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
129522429|NCT00899678|466201581|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
129522430|NCT00899678|466201582|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
129522431|NCT00899678|466201583|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
129522432|NCT00899678|466201581|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
129522433|NCT00899678|466201582|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
129522434|NCT00899678|466201583|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
129522435|NCT00899678|466201581|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
129522436|NCT00899678|466201582|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
129522437|NCT00899678|466201583|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
129522438|NCT00899678|466201581|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
129522439|NCT00899678|466201582|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
129522440|NCT00899678|466201583|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
129522441|NCT00899678|466201581|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
129522442|NCT00899678|466201582|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
129522443|NCT00899678|466201583|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
129522444|NCT00899678|466201581|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
129522445|NCT00899678|466201582|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
129522446|NCT00899678|466201583|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
129522447|NCT00033371|466201584|FG000|Overall Study|Adverse Event|1|||
129522448|NCT00033371|466201585|FG001|Overall Study|Adverse Event|5|||
129522449|NCT00033371|466201584|FG000|Overall Study|Lost to Follow-up|2|||
129522450|NCT00033371|466201585|FG001|Overall Study|Lost to Follow-up|1|||
129522451|NCT00033371|466201584|FG000|Overall Study|Withdrawal by Subject|3|||
129522452|NCT00033371|466201585|FG001|Overall Study|Withdrawal by Subject|3|||
129522453|NCT00033371|466201584|FG000|Overall Study|Disease Progression|0|||
129522454|NCT00033371|466201585|FG001|Overall Study|Disease Progression|1|||
129522455|NCT03799627|466201590|FG000|Overall Study|Adverse Event|1|||
129522456|NCT03799627|466201591|FG001|Overall Study|Adverse Event|2|||
129522457|NCT03799627|466201592|FG002|Overall Study|Adverse Event|0|||
129522458|NCT03799627|466201593|FG003|Overall Study|Adverse Event|0|||
129522459|NCT03799627|466201594|FG004|Overall Study|Adverse Event|2|||
129522460|NCT03799627|466201595|FG005|Overall Study|Adverse Event|5|||
129522461|NCT03799627|466201596|FG006|Overall Study|Adverse Event|0|||
129522462|NCT03799627|466201597|FG007|Overall Study|Adverse Event|2|||
129522463|NCT03799627|466201598|FG008|Overall Study|Adverse Event|0|||
129522464|NCT03799627|466201590|FG000|Overall Study|Physician Decision|2|||
129522465|NCT03799627|466201591|FG001|Overall Study|Physician Decision|2|||
129522466|NCT03799627|466201592|FG002|Overall Study|Physician Decision|0|||
129522467|NCT03799627|466201593|FG003|Overall Study|Physician Decision|0|||
129522468|NCT03799627|466201594|FG004|Overall Study|Physician Decision|2|||
129522469|NCT03799627|466201595|FG005|Overall Study|Physician Decision|2|||
129522470|NCT03799627|466201596|FG006|Overall Study|Physician Decision|0|||
129522471|NCT03799627|466201597|FG007|Overall Study|Physician Decision|0|||
129522472|NCT03799627|466201598|FG008|Overall Study|Physician Decision|0|||
129522473|NCT03799627|466201590|FG000|Overall Study|Withdrawal by Subject|1|||
129522474|NCT03799627|466201591|FG001|Overall Study|Withdrawal by Subject|1|||
129522475|NCT03799627|466201592|FG002|Overall Study|Withdrawal by Subject|0|||
129522476|NCT03799627|466201593|FG003|Overall Study|Withdrawal by Subject|2|||
129522477|NCT03799627|466201594|FG004|Overall Study|Withdrawal by Subject|0|||
129522478|NCT03799627|466201595|FG005|Overall Study|Withdrawal by Subject|3|||
129522479|NCT03799627|466201596|FG006|Overall Study|Withdrawal by Subject|0|||
129522480|NCT03799627|466201597|FG007|Overall Study|Withdrawal by Subject|0|||
129522481|NCT03799627|466201598|FG008|Overall Study|Withdrawal by Subject|0|||
129522482|NCT03799627|466201590|FG000|Overall Study|Lack of Efficacy|0|||
129522483|NCT03799627|466201591|FG001|Overall Study|Lack of Efficacy|0|||
129522484|NCT03799627|466201592|FG002|Overall Study|Lack of Efficacy|0|||
129522485|NCT03799627|466201593|FG003|Overall Study|Lack of Efficacy|1|||
129522486|NCT03799627|466201594|FG004|Overall Study|Lack of Efficacy|0|||
129522487|NCT03799627|466201595|FG005|Overall Study|Lack of Efficacy|0|||
129522488|NCT03799627|466201596|FG006|Overall Study|Lack of Efficacy|0|||
129522489|NCT03799627|466201597|FG007|Overall Study|Lack of Efficacy|0|||
129522490|NCT03799627|466201598|FG008|Overall Study|Lack of Efficacy|0|||
129522491|NCT03799627|466201590|FG000|Overall Study|Lost to Follow-up|0|||
129522492|NCT03799627|466201591|FG001|Overall Study|Lost to Follow-up|0|||
129522493|NCT03799627|466201592|FG002|Overall Study|Lost to Follow-up|0|||
129522494|NCT03799627|466201593|FG003|Overall Study|Lost to Follow-up|0|||
129522495|NCT03799627|466201594|FG004|Overall Study|Lost to Follow-up|0|||
129522496|NCT03799627|466201595|FG005|Overall Study|Lost to Follow-up|0|||
129522497|NCT03799627|466201596|FG006|Overall Study|Lost to Follow-up|1|||
129522498|NCT03799627|466201597|FG007|Overall Study|Lost to Follow-up|0|||
129522499|NCT03799627|466201598|FG008|Overall Study|Lost to Follow-up|1|||
129522500|NCT03799627|466201590|FG000|Overall Study|Death|0|||
129522501|NCT03799627|466201591|FG001|Overall Study|Death|0|||
129522502|NCT03799627|466201592|FG002|Overall Study|Death|0|||
129522503|NCT03799627|466201593|FG003|Overall Study|Death|1|||
129522504|NCT03799627|466201594|FG004|Overall Study|Death|0|||
129522505|NCT03799627|466201595|FG005|Overall Study|Death|0|||
129522506|NCT03799627|466201596|FG006|Overall Study|Death|0|||
129522507|NCT03799627|466201597|FG007|Overall Study|Death|0|||
129522508|NCT03799627|466201598|FG008|Overall Study|Death|0|||
129522509|NCT03799627|466201590|FG000|Overall Study|Study Drug Put on Hold|1|||
129522510|NCT03799627|466201591|FG001|Overall Study|Study Drug Put on Hold|0|||
129522511|NCT03799627|466201592|FG002|Overall Study|Study Drug Put on Hold|0|||
129522512|NCT03799627|466201593|FG003|Overall Study|Study Drug Put on Hold|0|||
129522513|NCT03799627|466201594|FG004|Overall Study|Study Drug Put on Hold|0|||
129522514|NCT03799627|466201595|FG005|Overall Study|Study Drug Put on Hold|0|||
129522515|NCT03799627|466201596|FG006|Overall Study|Study Drug Put on Hold|0|||
129522516|NCT03799627|466201597|FG007|Overall Study|Study Drug Put on Hold|0|||
129522517|NCT03799627|466201598|FG008|Overall Study|Study Drug Put on Hold|0|||
129522518|NCT03799627|466201590|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
129522519|NCT03799627|466201591|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
129522520|NCT03799627|466201592|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
129522521|NCT03799627|466201593|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
129522522|NCT03799627|466201594|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
129522523|NCT03799627|466201595|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
129522524|NCT03799627|466201596|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
129522525|NCT03799627|466201597|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
129522526|NCT03799627|466201598|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
129522527|NCT03799627|466201590|FG000|Overall Study|Kidney Transplantation|1|||
129522528|NCT03799627|466201591|FG001|Overall Study|Kidney Transplantation|0|||
129522529|NCT03799627|466201592|FG002|Overall Study|Kidney Transplantation|0|||
129522530|NCT03799627|466201593|FG003|Overall Study|Kidney Transplantation|1|||
129522531|NCT03799627|466201594|FG004|Overall Study|Kidney Transplantation|1|||
129522532|NCT03799627|466201595|FG005|Overall Study|Kidney Transplantation|0|||
129522533|NCT03799627|466201596|FG006|Overall Study|Kidney Transplantation|0|||
129522534|NCT03799627|466201597|FG007|Overall Study|Kidney Transplantation|0|||
129522535|NCT03799627|466201598|FG008|Overall Study|Kidney Transplantation|0|||
129522536|NCT03799627|466201590|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
129522537|NCT03799627|466201591|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
129522538|NCT03799627|466201592|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
129522539|NCT03799627|466201593|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
129522540|NCT03799627|466201594|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
129522541|NCT03799627|466201595|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
129522542|NCT03799627|466201596|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
129522543|NCT03799627|466201597|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
129522544|NCT03799627|466201598|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
129522545|NCT03799627|466201590|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522546|NCT03799627|466201591|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
129522547|NCT03799627|466201592|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522548|NCT03799627|466201593|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522549|NCT03799627|466201594|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522550|NCT03799627|466201595|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522551|NCT03799627|466201596|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522552|NCT03799627|466201597|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522553|NCT03799627|466201598|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
129522554|NCT03799627|466201590|FG000|Overall Study|Met Exclusion Criteria|0|||
129522555|NCT03799627|466201591|FG001|Overall Study|Met Exclusion Criteria|0|||
129522556|NCT03799627|466201592|FG002|Overall Study|Met Exclusion Criteria|0|||
129522557|NCT03799627|466201593|FG003|Overall Study|Met Exclusion Criteria|1|||
129522558|NCT03799627|466201594|FG004|Overall Study|Met Exclusion Criteria|0|||
129522559|NCT03799627|466201595|FG005|Overall Study|Met Exclusion Criteria|0|||
129522560|NCT03799627|466201596|FG006|Overall Study|Met Exclusion Criteria|0|||
129522561|NCT03799627|466201597|FG007|Overall Study|Met Exclusion Criteria|0|||
129522562|NCT03799627|466201598|FG008|Overall Study|Met Exclusion Criteria|0|||
129522563|NCT03799627|466201590|FG000|Overall Study|Investigational Product Noncompliance|0|||
129522564|NCT03799627|466201591|FG001|Overall Study|Investigational Product Noncompliance|0|||
129522565|NCT03799627|466201592|FG002|Overall Study|Investigational Product Noncompliance|0|||
129522566|NCT03799627|466201593|FG003|Overall Study|Investigational Product Noncompliance|1|||
129522567|NCT03799627|466201594|FG004|Overall Study|Investigational Product Noncompliance|0|||
129522568|NCT03799627|466201595|FG005|Overall Study|Investigational Product Noncompliance|0|||
129522569|NCT03799627|466201596|FG006|Overall Study|Investigational Product Noncompliance|0|||
129522570|NCT03799627|466201597|FG007|Overall Study|Investigational Product Noncompliance|0|||
129522571|NCT03799627|466201598|FG008|Overall Study|Investigational Product Noncompliance|0|||
129522572|NCT03799627|466201590|FG000|Overall Study|Participant Relocation|0|||
129522573|NCT03799627|466201591|FG001|Overall Study|Participant Relocation|0|||
129522574|NCT03799627|466201592|FG002|Overall Study|Participant Relocation|0|||
129522575|NCT03799627|466201593|FG003|Overall Study|Participant Relocation|1|||
129522576|NCT03799627|466201594|FG004|Overall Study|Participant Relocation|0|||
129522577|NCT03799627|466201595|FG005|Overall Study|Participant Relocation|1|||
129522578|NCT03799627|466201596|FG006|Overall Study|Participant Relocation|0|||
129522579|NCT03799627|466201597|FG007|Overall Study|Participant Relocation|0|||
129522580|NCT03799627|466201598|FG008|Overall Study|Participant Relocation|0|||
129522581|NCT03799627|466201590|FG000|Overall Study|Eurofin Issue|0|||
129522582|NCT03799627|466201591|FG001|Overall Study|Eurofin Issue|0|||
129522583|NCT03799627|466201592|FG002|Overall Study|Eurofin Issue|0|||
129522584|NCT03799627|466201593|FG003|Overall Study|Eurofin Issue|0|||
129522585|NCT03799627|466201594|FG004|Overall Study|Eurofin Issue|1|||
129522586|NCT03799627|466201595|FG005|Overall Study|Eurofin Issue|0|||
129522587|NCT03799627|466201596|FG006|Overall Study|Eurofin Issue|0|||
129522588|NCT03799627|466201597|FG007|Overall Study|Eurofin Issue|0|||
129522589|NCT03799627|466201598|FG008|Overall Study|Eurofin Issue|0|||
129522590|NCT03799627|466201590|FG000|Overall Study|Noncompliance with Site Instructions|0|||
129522591|NCT03799627|466201591|FG001|Overall Study|Noncompliance with Site Instructions|0|||
129522592|NCT03799627|466201592|FG002|Overall Study|Noncompliance with Site Instructions|0|||
129522593|NCT03799627|466201593|FG003|Overall Study|Noncompliance with Site Instructions|0|||
129522594|NCT03799627|466201594|FG004|Overall Study|Noncompliance with Site Instructions|1|||
129522595|NCT03799627|466201595|FG005|Overall Study|Noncompliance with Site Instructions|0|||
129522596|NCT03799627|466201596|FG006|Overall Study|Noncompliance with Site Instructions|0|||
129522597|NCT03799627|466201597|FG007|Overall Study|Noncompliance with Site Instructions|0|||
129522598|NCT03799627|466201598|FG008|Overall Study|Noncompliance with Site Instructions|0|||
129522599|NCT03799627|466201590|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522600|NCT03799627|466201591|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522601|NCT03799627|466201592|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522602|NCT03799627|466201593|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522603|NCT03799627|466201594|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
129522604|NCT03799627|466201595|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522605|NCT03799627|466201596|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522606|NCT03799627|466201597|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522607|NCT03799627|466201598|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
129522608|NCT03799627|466201590|FG000|Overall Study|Changes In Hemoglobin Values|1|||
129522609|NCT03799627|466201591|FG001|Overall Study|Changes In Hemoglobin Values|2|||
129522610|NCT03799627|466201592|FG002|Overall Study|Changes In Hemoglobin Values|1|||
129522611|NCT03799627|466201593|FG003|Overall Study|Changes In Hemoglobin Values|0|||
129522612|NCT03799627|466201594|FG004|Overall Study|Changes In Hemoglobin Values|0|||
129522613|NCT03799627|466201595|FG005|Overall Study|Changes In Hemoglobin Values|2|||
129522614|NCT03799627|466201596|FG006|Overall Study|Changes In Hemoglobin Values|1|||
129522615|NCT03799627|466201597|FG007|Overall Study|Changes In Hemoglobin Values|0|||
129522616|NCT03799627|466201598|FG008|Overall Study|Changes In Hemoglobin Values|1|||
129522617|NCT03148795|466201601|FG000|Overall Study|Progressive Disease|1|||
129522618|NCT04973085|466201608|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
129522619|NCT04973085|466201609|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
129522620|NCT02224274|466201610|FG000|Overall Study|Death|1|||
129522621|NCT02224274|466201611|FG001|Overall Study|Death|0|||
129522622|NCT01976624|466201612|FG000|Overall Study|Participants contraindicated|2|||
129522623|NCT01976624|466201612|FG000|Overall Study|Participants age less than 19 years|12|||
129522624|NCT03074318|466201613|FG000|Overall Study|Adverse Event|0|||
129522625|NCT03074318|466201614|FG001|Overall Study|Adverse Event|1|||
129522626|NCT03074318|466201615|FG002|Overall Study|Adverse Event|1|||
129522627|NCT03074318|466201616|FG003|Overall Study|Adverse Event|1|||
129522628|NCT03074318|466201613|FG000|Overall Study|Death|1|||
129522629|NCT03074318|466201614|FG001|Overall Study|Death|0|||
129522630|NCT03074318|466201615|FG002|Overall Study|Death|0|||
129522631|NCT03074318|466201616|FG003|Overall Study|Death|0|||
129522632|NCT03074318|466201613|FG000|Overall Study|Withdrawal by Subject|1|||
129522633|NCT03074318|466201614|FG001|Overall Study|Withdrawal by Subject|2|||
129522634|NCT03074318|466201615|FG002|Overall Study|Withdrawal by Subject|2|||
129522635|NCT03074318|466201616|FG003|Overall Study|Withdrawal by Subject|4|||
129522636|NCT03074318|466201613|FG000|Overall Study|Trial Closure|2|||
129522637|NCT03074318|466201614|FG001|Overall Study|Trial Closure|2|||
129522638|NCT03074318|466201615|FG002|Overall Study|Trial Closure|3|||
129522639|NCT03074318|466201616|FG003|Overall Study|Trial Closure|11|||
129522640|NCT01627782|466201619|FG000|Overall Study|Adverse Event|1|||
129522641|NCT01627782|466201620|FG001|Overall Study|Adverse Event|2|||
129522642|NCT01627782|466201621|FG002|Overall Study|Adverse Event|0|||
129522643|NCT01627782|466201622|FG003|Overall Study|Adverse Event|1|||
129522644|NCT01627782|466201619|FG000|Overall Study|Lack of Efficacy|11|||
129522645|NCT01627782|466201620|FG001|Overall Study|Lack of Efficacy|1|||
129522646|NCT01627782|466201621|FG002|Overall Study|Lack of Efficacy|15|||
129522647|NCT01627782|466201622|FG003|Overall Study|Lack of Efficacy|2|||
129522648|NCT01627782|466201619|FG000|Overall Study|Protocol Violation|1|||
129522649|NCT01627782|466201620|FG001|Overall Study|Protocol Violation|0|||
129522650|NCT01627782|466201621|FG002|Overall Study|Protocol Violation|0|||
129522651|NCT01627782|466201622|FG003|Overall Study|Protocol Violation|0|||
129522652|NCT01627782|466201619|FG000|Overall Study|Withdrawal by Subject|2|||
129522653|NCT01627782|466201620|FG001|Overall Study|Withdrawal by Subject|1|||
129522654|NCT01627782|466201621|FG002|Overall Study|Withdrawal by Subject|0|||
129522655|NCT01627782|466201622|FG003|Overall Study|Withdrawal by Subject|0|||
129522656|NCT01627782|466201619|FG000|Overall Study|Other|0|||
129522657|NCT01627782|466201620|FG001|Overall Study|Other|2|||
129522658|NCT01627782|466201621|FG002|Overall Study|Other|0|||
129522659|NCT01627782|466201622|FG003|Overall Study|Other|3|||
129522660|NCT01627782|466201619|FG000|Overall Study|Randomized But Not Treated|1|||
129522661|NCT01627782|466201620|FG001|Overall Study|Randomized But Not Treated|0|||
129522662|NCT01627782|466201621|FG002|Overall Study|Randomized But Not Treated|0|||
129522663|NCT01627782|466201622|FG003|Overall Study|Randomized But Not Treated|0|||
129522664|NCT02177812|466201623|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
129522665|NCT02177812|466201624|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
129522666|NCT02177812|466201625|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
129522667|NCT02177812|466201626|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
129522668|NCT02177812|466201627|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
129522669|NCT02177812|466201628|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
129522670|NCT02177812|466201629|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
129522671|NCT02177812|466201630|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
129522672|NCT02177812|466201631|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
129522673|NCT02177812|466201623|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522674|NCT02177812|466201624|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522675|NCT02177812|466201625|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522676|NCT02177812|466201626|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522677|NCT02177812|466201627|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522678|NCT02177812|466201628|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
129522679|NCT02177812|466201629|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
129522680|NCT02177812|466201630|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522681|NCT02177812|466201631|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
129522682|NCT02177812|466201623|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
129522683|NCT02177812|466201624|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
129522684|NCT02177812|466201625|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
129522685|NCT02177812|466201626|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
129522686|NCT02177812|466201627|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
129522687|NCT02177812|466201628|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
129522688|NCT02177812|466201629|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
129522689|NCT02177812|466201630|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
129522690|NCT02177812|466201631|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
129522691|NCT00089999|466201632|FG000|Overall Study|Adverse Event|4|||
129522692|NCT00089999|466201633|FG001|Overall Study|Adverse Event|7|||
129522693|NCT00089999|466201632|FG000|Overall Study|Withdrawal by Subject|0|||
129538663|NCT00764465|466263485|FG002|Overall Study|Adverse Event|0|||
129522694|NCT00089999|466201633|FG001|Overall Study|Withdrawal by Subject|4|||
129522695|NCT00089999|466201632|FG000|Overall Study|Lost to Follow-up|2|||
129522696|NCT00089999|466201633|FG001|Overall Study|Lost to Follow-up|1|||
129522697|NCT00089999|466201632|FG000|Overall Study|Radiological Progression of Cancer|52|||
129522698|NCT00089999|466201633|FG001|Overall Study|Radiological Progression of Cancer|44|||
129522699|NCT00089999|466201632|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
129522700|NCT00089999|466201633|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
129522701|NCT00089999|466201632|FG000|Overall Study|Death|3|||
129522702|NCT00089999|466201633|FG001|Overall Study|Death|3|||
129522703|NCT00089999|466201632|FG000|Overall Study|Poor General Condition|1|||
129522704|NCT00089999|466201633|FG001|Overall Study|Poor General Condition|0|||
129522705|NCT00089999|466201632|FG000|Overall Study|Clinical Progression|1|||
129522706|NCT00089999|466201633|FG001|Overall Study|Clinical Progression|2|||
129522707|NCT00089999|466201632|FG000|Overall Study|Physician Decision|2|||
129522708|NCT00089999|466201633|FG001|Overall Study|Physician Decision|2|||
129522709|NCT00089999|466201632|FG000|Overall Study|Patient Underwent Surgery|2|||
129522710|NCT00089999|466201633|FG001|Overall Study|Patient Underwent Surgery|0|||
129522711|NCT00089999|466201632|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
129522712|NCT00089999|466201633|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
129522713|NCT01167153|466201634|FG000|Overall Study|Non-effective therapy|1|||
129522714|NCT01167153|466201635|FG001|Overall Study|Non-effective therapy|4|||
129522715|NCT01167153|466201634|FG000|Overall Study|AE including clinical laboratory AE|2|||
129522716|NCT01167153|466201635|FG001|Overall Study|AE including clinical laboratory AE|8|||
129522717|NCT01167153|466201634|FG000|Overall Study|Hypotension|1|||
129522718|NCT01167153|466201635|FG001|Overall Study|Hypotension|0|||
129522719|NCT01167153|466201634|FG000|Overall Study|Lost to Follow-up|7|||
129522720|NCT01167153|466201635|FG001|Overall Study|Lost to Follow-up|9|||
129522721|NCT01167153|466201634|FG000|Overall Study|Non-compliance to concomitant medication|0|||
129522722|NCT01167153|466201635|FG001|Overall Study|Non-compliance to concomitant medication|2|||
129522723|NCT01167153|466201634|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
129522724|NCT01167153|466201635|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
129522725|NCT01167153|466201634|FG000|Overall Study|Withdrawal consent|1|||
129522726|NCT01167153|466201635|FG001|Overall Study|Withdrawal consent|1|||
129522727|NCT01167153|466201634|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
129522728|NCT01167153|466201635|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
129522729|NCT01004159|466203169|FG000|Overall Study|Adverse Event|2|||
129522730|NCT01004159|466203169|FG000|Overall Study|Disease Progression|18|||
129522731|NCT00444951|466203173|FG000|Overall Study|Lost to Follow-up|1|||
129522732|NCT00444951|466203174|FG001|Overall Study|Lost to Follow-up|1|||
129522733|NCT00444951|466203175|FG002|Overall Study|Lost to Follow-up|0|||
129522734|NCT00444951|466203173|FG000|Overall Study|Withdrawal by Subject|4|||
129522735|NCT00444951|466203174|FG001|Overall Study|Withdrawal by Subject|5|||
129522736|NCT00444951|466203175|FG002|Overall Study|Withdrawal by Subject|3|||
129522737|NCT01998906|466203176|FG000|Overall Study|Participants ongoing in follow-up|77|||
129522738|NCT01998906|466203177|FG001|Overall Study|Participants ongoing in follow-up|60|||
129522739|NCT01998906|466203178|FG002|Overall Study|Participants ongoing in follow-up|58|||
129522740|NCT01998906|466203176|FG000|Overall Study|Death|21|||
129522741|NCT01998906|466203177|FG001|Overall Study|Death|30|||
129522742|NCT01998906|466203178|FG002|Overall Study|Death|17|||
129522743|NCT01998906|466203176|FG000|Overall Study|Lack of Efficacy|10|||
129522744|NCT01998906|466203177|FG001|Overall Study|Lack of Efficacy|9|||
129522745|NCT01998906|466203178|FG002|Overall Study|Lack of Efficacy|8|||
129522746|NCT01998906|466203176|FG000|Overall Study|Failure to return|0|||
129522747|NCT01998906|466203177|FG001|Overall Study|Failure to return|2|||
129522748|NCT01998906|466203178|FG002|Overall Study|Failure to return|4|||
129522749|NCT01998906|466203176|FG000|Overall Study|Violation of Selection Criteria|0|||
129522750|NCT01998906|466203177|FG001|Overall Study|Violation of Selection Criteria|0|||
129522751|NCT01998906|466203178|FG002|Overall Study|Violation of Selection Criteria|1|||
129522752|NCT01998906|466203176|FG000|Overall Study|Withdrawal by Subject|1|||
129522753|NCT01998906|466203177|FG001|Overall Study|Withdrawal by Subject|4|||
129522754|NCT01998906|466203178|FG002|Overall Study|Withdrawal by Subject|3|||
129522755|NCT01998906|466203176|FG000|Overall Study|Administrative/Other|2|||
129522756|NCT01998906|466203177|FG001|Overall Study|Administrative/Other|1|||
129522757|NCT01998906|466203178|FG002|Overall Study|Administrative/Other|3|||
129522758|NCT01998906|466203176|FG000|Overall Study|Other|3|||
129522759|NCT01998906|466203177|FG001|Overall Study|Other|8|||
129522760|NCT01998906|466203178|FG002|Overall Study|Other|4|||
129522761|NCT02828644|466203181|FG000|Overall Study|Lost to Follow-up|23|||
129522762|NCT02828644|466203182|FG001|Overall Study|Lost to Follow-up|22|||
129522763|NCT06048809|466203187|FG000|Overall Study|Adverse Event|2|||
129522764|NCT06048809|466203188|FG001|Overall Study|Adverse Event|0|||
129522765|NCT06048809|466203187|FG000|Overall Study|Withdrawal by Subject|1|||
129522766|NCT06048809|466203188|FG001|Overall Study|Withdrawal by Subject|1|||
129522767|NCT02158728|466203189|FG000|Overall Study|no procedure according to CIP done|3|||
129522768|NCT02158728|466203189|FG000|Overall Study|no qualified dataset|24|||
129522769|NCT03878160|466203195|FG000|Overall Study|Lost to Follow-up|1|||
129522770|NCT03878160|466203196|FG001|Overall Study|Lost to Follow-up|1|||
129522771|NCT03878160|466203197|FG002|Overall Study|Lost to Follow-up|1|||
129522772|NCT03878160|466203195|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
129522773|NCT03878160|466203196|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
129522774|NCT03878160|466203197|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
129522775|NCT00589602|466203203|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
129522776|NCT03933215|466203210|FG000|Overall Study|Other|6|||
129522777|NCT03933215|466203210|FG000|Overall Study|Sponsor decision|5|||
129522778|NCT03933215|466203210|FG000|Overall Study|Protocol Violation|5|||
129522779|NCT03933215|466203210|FG000|Overall Study|Withdrawal by Subject|6|||
129522780|NCT03933215|466203210|FG000|Overall Study|Lost to Follow-up|6|||
129522781|NCT03933215|466203210|FG000|Overall Study|Enrolled but not treated|38|||
129522782|NCT04097028|466203211|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
129522783|NCT04097028|466203211|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
129522784|NCT04097028|466203211|FG000|Overall Study|Disease Progression prior to Surgery|2|||
129522785|NCT04097028|466203211|FG000|Overall Study|Adverse Event prior to Surgery|1|||
129522786|NCT01678313|466203212|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
129522787|NCT01678313|466203213|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
129522788|NCT01678313|466203212|FG000|Completed the 3-month Therapy|Physician Decision|3|||
129522789|NCT01678313|466203213|FG001|Completed the 3-month Therapy|Physician Decision|4|||
129522790|NCT01678313|466203212|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
129522791|NCT01678313|466203213|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
129522792|NCT01678313|466203212|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
129522793|NCT01678313|466203213|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
129522794|NCT00981292|466203216|FG000|Day 1|Protocol Violation|1|||
129522795|NCT00981292|466203217|FG001|Day 1|Protocol Violation|0|||
129522796|NCT00981292|466203218|FG002|Day 1|Protocol Violation|0|||
129522797|NCT00981292|466203219|FG003|Day 1|Protocol Violation|0|||
129522798|NCT00981292|466203220|FG004|Day 1|Protocol Violation|0|||
129522799|NCT00981292|466203221|FG005|Day 1|Protocol Violation|2|||
129522800|NCT00981292|466203216|FG000|Day 2|Protocol Violation|2|||
129522801|NCT00981292|466203217|FG001|Day 2|Protocol Violation|0|||
129522802|NCT00981292|466203218|FG002|Day 2|Protocol Violation|0|||
129522803|NCT00981292|466203219|FG003|Day 2|Protocol Violation|0|||
129522804|NCT00981292|466203220|FG004|Day 2|Protocol Violation|0|||
129522805|NCT00981292|466203221|FG005|Day 2|Protocol Violation|0|||
129522806|NCT00981292|466203216|FG000|Day 3|Protocol Violation|0|||
129522807|NCT00981292|466203217|FG001|Day 3|Protocol Violation|0|||
129522808|NCT00981292|466203218|FG002|Day 3|Protocol Violation|0|||
129522809|NCT00981292|466203219|FG003|Day 3|Protocol Violation|0|||
129522810|NCT00981292|466203220|FG004|Day 3|Protocol Violation|0|||
129522811|NCT00981292|466203221|FG005|Day 3|Protocol Violation|1|||
129522812|NCT01131130|466203222|FG000|Period 1 - Baseline|Pregnancy|1|||
129522813|NCT01131130|466203222|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
129522814|NCT03464136|466203223|FG000|Overall Study|Lost to Follow-up|5|||
129522815|NCT03464136|466203224|FG001|Overall Study|Lost to Follow-up|8|||
129522816|NCT03464136|466203223|FG000|Overall Study|Withdrawal by Subject|16|||
129522817|NCT03464136|466203224|FG001|Overall Study|Withdrawal by Subject|13|||
129522818|NCT03464136|466203223|FG000|Overall Study|Death|1|||
129522819|NCT03464136|466203224|FG001|Overall Study|Death|0|||
129522820|NCT03464136|466203223|FG000|Overall Study|Other|8|||
129522821|NCT03464136|466203224|FG001|Overall Study|Other|4|||
129522822|NCT03412565|466203225|FG000|Overall Study|Lost to Follow-up|0|||
129522823|NCT03412565|466203226|FG001|Overall Study|Lost to Follow-up|0|||
129522824|NCT03412565|466203227|FG002|Overall Study|Lost to Follow-up|1|||
129522825|NCT03412565|466203228|FG003|Overall Study|Lost to Follow-up|0|||
129522826|NCT03412565|466203225|FG000|Overall Study|Physician Decision|0|||
129522827|NCT03412565|466203226|FG001|Overall Study|Physician Decision|0|||
129522828|NCT03412565|466203227|FG002|Overall Study|Physician Decision|0|||
129522829|NCT03412565|466203228|FG003|Overall Study|Physician Decision|1|||
129522830|NCT03412565|466203225|FG000|Overall Study|Withdrawal by Subject|0|||
129522831|NCT03412565|466203226|FG001|Overall Study|Withdrawal by Subject|4|||
129522832|NCT03412565|466203227|FG002|Overall Study|Withdrawal by Subject|5|||
129522833|NCT03412565|466203228|FG003|Overall Study|Withdrawal by Subject|5|||
129522834|NCT03412565|466203225|FG000|Overall Study|Death|1|||
129522835|NCT03412565|466203226|FG001|Overall Study|Death|3|||
129522836|NCT03412565|466203227|FG002|Overall Study|Death|4|||
129522837|NCT03412565|466203228|FG003|Overall Study|Death|5|||
129522838|NCT03412565|466203225|FG000|Overall Study|Data collection ended|0|||
129522839|NCT03412565|466203226|FG001|Overall Study|Data collection ended|41|||
129522840|NCT03412565|466203227|FG002|Overall Study|Data collection ended|41|||
129522841|NCT03412565|466203228|FG003|Overall Study|Data collection ended|40|||
129522842|NCT03277105|466203229|FG000|Overall Study|Death|129|||
129522843|NCT03277105|466203230|FG001|Overall Study|Death|124|||
129522844|NCT03277105|466203229|FG000|Overall Study|Lost to Follow-up|2|||
129522845|NCT03277105|466203230|FG001|Overall Study|Lost to Follow-up|4|||
129522846|NCT03277105|466203229|FG000|Overall Study|Withdrawal by Subject|10|||
129522847|NCT03277105|466203230|FG001|Overall Study|Withdrawal by Subject|10|||
129522848|NCT03277105|466203229|FG000|Overall Study|Other|118|||
129522849|NCT03277105|466203230|FG001|Overall Study|Other|125|||
129522850|NCT00537771|466203237|FG000|Overall Study|Withdrawal by Subject|6|||
129522851|NCT00537771|466203238|FG001|Overall Study|Withdrawal by Subject|23|||
129522852|NCT00537771|466203237|FG000|Overall Study|Adverse Event|8|||
129522853|NCT00537771|466203238|FG001|Overall Study|Adverse Event|15|||
129522854|NCT00537771|466203237|FG000|Overall Study|Lost to Follow-up|9|||
129522855|NCT00537771|466203238|FG001|Overall Study|Lost to Follow-up|15|||
129522856|NCT00537771|466203237|FG000|Overall Study|Protocol Violation|2|||
129522857|NCT00537771|466203238|FG001|Overall Study|Protocol Violation|6|||
129522858|NCT00537771|466203237|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
129522859|NCT00537771|466203238|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
129522860|NCT02736929|466203240|FG000|Main Study|Lost to Follow-up|7|||
129522861|NCT02736929|466203241|FG001|Main Study|Lost to Follow-up|1|||
129522862|NCT02736929|466203242|FG002|Main Study|Lost to Follow-up|0|||
129522863|NCT02736929|466203240|FG000|Main Study|Withdrawal by Subject|1|||
129522864|NCT02736929|466203241|FG001|Main Study|Withdrawal by Subject|1|||
129522865|NCT02736929|466203242|FG002|Main Study|Withdrawal by Subject|0|||
129522866|NCT02736929|466203240|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
129522867|NCT02736929|466203241|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
129522868|NCT02736929|466203242|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
129522869|NCT00285649|466203245|FG000|Overall Study|Lost to Follow-up|6|||
129522870|NCT00285649|466203246|FG001|Overall Study|Lost to Follow-up|4|||
129522871|NCT00285649|466203247|FG002|Overall Study|Lost to Follow-up|4|||
129522872|NCT00285649|466203245|FG000|Overall Study|Withdrawal by Subject|3|||
129522873|NCT00285649|466203246|FG001|Overall Study|Withdrawal by Subject|2|||
129522874|NCT00285649|466203247|FG002|Overall Study|Withdrawal by Subject|2|||
129522875|NCT03342404|466203248|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
129522876|NCT03342404|466203249|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
129522877|NCT03342404|466203248|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
129522878|NCT03342404|466203249|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
129522879|NCT03342404|466203248|FG000|Blinded Treatment Phase|Adverse Event|5|||
129522880|NCT03342404|466203249|FG001|Blinded Treatment Phase|Adverse Event|4|||
129522881|NCT03342404|466203248|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
129522882|NCT03342404|466203249|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
129522883|NCT03342404|466203248|FG000|Blinded Treatment Phase|Other reasons|1|||
129522884|NCT03342404|466203249|FG001|Blinded Treatment Phase|Other reasons|0|||
129522885|NCT03342404|466203248|FG000|Blinded Treatment Phase|Physician Decision|1|||
129522886|NCT03342404|466203249|FG001|Blinded Treatment Phase|Physician Decision|0|||
129522887|NCT03342404|466203248|FG000|Blinded Treatment Phase|Death|1|||
129522888|NCT03342404|466203249|FG001|Blinded Treatment Phase|Death|0|||
129522889|NCT03342404|466203248|FG000|Open-Label Phase|Lost to Follow-up|0|||
129522890|NCT03342404|466203249|FG001|Open-Label Phase|Lost to Follow-up|1|||
129522891|NCT03342404|466203248|FG000|Open-Label Phase|Other reasons|0|||
129522892|NCT03342404|466203249|FG001|Open-Label Phase|Other reasons|1|||
129522893|NCT03342404|466203248|FG000|Open-Label Phase|Adverse Event|0|||
129522894|NCT03342404|466203249|FG001|Open-Label Phase|Adverse Event|3|||
129522895|NCT03342404|466203248|FG000|Open-Label Phase|Withdrawal by Subject|0|||
129522896|NCT03342404|466203249|FG001|Open-Label Phase|Withdrawal by Subject|6|||
129522897|NCT01855425|466203250|FG000|Overall Study|Physician Decision|20|||
129522898|NCT00373880|466203251|FG000|Overall Study|Physician Decision|3|||
129522899|NCT00373880|466203251|FG000|Overall Study|Arrested|1|||
129522900|NCT00373880|466203251|FG000|Overall Study|Protocol Violation|14|||
129522901|NCT01925014|466203252|FG000|Overall Study|Inappropriate enrollment|4|||
129522902|NCT01925014|466203253|FG001|Overall Study|Inappropriate enrollment|6|||
129522903|NCT01925014|466203252|FG000|Overall Study|Withdrawal by Subject|5|||
129522904|NCT01925014|466203253|FG001|Overall Study|Withdrawal by Subject|13|||
129522905|NCT03696576|466203261|FG000|Overall Study|Soreness of throat after therapy|1|||
129522906|NCT03696576|466203262|FG001|Overall Study|Soreness of throat after therapy|1|||
129522907|NCT03696576|466203261|FG000|Overall Study|Lost to Follow-up|2|||
129522908|NCT03696576|466203262|FG001|Overall Study|Lost to Follow-up|4|||
129522909|NCT00312728|466203263|FG000|Overall Study|Progressive disease|53|||
129522910|NCT00312728|466203263|FG000|Overall Study|Adverse Event|32|||
129522911|NCT00312728|466203263|FG000|Overall Study|Withdrawal by Subject|10|||
129522912|NCT00312728|466203263|FG000|Overall Study|Required non-protocol cancer treatment|2|||
129522913|NCT00312728|466203263|FG000|Overall Study|Protocol Violation|2|||
129522914|NCT00312728|466203263|FG000|Overall Study|Other|10|||
129522915|NCT00312728|466203263|FG000|Overall Study|Other|1|||
129522916|NCT01634100|466203266|FG000|Overall Study|Withdrawal by Subject|1|||
129522917|NCT01634100|466203267|FG001|Overall Study|Withdrawal by Subject|0|||
129522918|NCT01634100|466203268|FG002|Overall Study|Withdrawal by Subject|1|||
129522919|NCT01634100|466203269|FG003|Overall Study|Withdrawal by Subject|0|||
129522920|NCT01634100|466203270|FG004|Overall Study|Withdrawal by Subject|0|||
129522921|NCT01634100|466203271|FG005|Overall Study|Withdrawal by Subject|0|||
129522922|NCT01487863|466203279|FG000|Overall Study|Death|19|||
129522923|NCT01487863|466203280|FG001|Overall Study|Death|19|||
129522924|NCT00486889|466203281|FG000|Overall Study|Death|3|||
129522925|NCT00486889|466203281|FG000|Overall Study|Non-compliant|2|||
129522926|NCT00486889|466203281|FG000|Overall Study|Withdrawal by Subject|6|||
129522927|NCT00893763|466203282|FG000|Overall Study|extubated|110|||
129522928|NCT00893763|466203283|FG001|Overall Study|extubated|110|||
129522929|NCT01975376|466203284|FG000|Overall Study|Adverse Event|5|||
129522930|NCT01975376|466203285|FG001|Overall Study|Adverse Event|5|||
129522931|NCT01975376|466203284|FG000|Overall Study|Death|65|||
129522932|NCT01975376|466203285|FG001|Overall Study|Death|72|||
129522933|NCT01975376|466203284|FG000|Overall Study|Lost to Follow-up|70|||
129522934|NCT01975376|466203285|FG001|Overall Study|Lost to Follow-up|66|||
129522935|NCT01975376|466203284|FG000|Overall Study|Withdrew consent|68|||
129522936|NCT01975376|466203285|FG001|Overall Study|Withdrew consent|62|||
129522937|NCT01975376|466203284|FG000|Overall Study|Other|2|||
129522938|NCT01975376|466203285|FG001|Overall Study|Other|4|||
129522939|NCT01975376|466203284|FG000|Overall Study|Randomized, Not Treated|16|||
129522940|NCT01975376|466203285|FG001|Overall Study|Randomized, Not Treated|8|||
129522941|NCT01819194|466203290|FG000|Overall Study|Loss of study articles|2|||
129522942|NCT01448707|466203291|FG000|Overall Study|Adverse Event|3|||
129522943|NCT01448707|466203292|FG001|Overall Study|Adverse Event|1|||
129522944|NCT01448707|466203291|FG000|Overall Study|Lost to Follow-up|2|||
129522945|NCT01448707|466203292|FG001|Overall Study|Lost to Follow-up|6|||
129522946|NCT01448707|466203291|FG000|Overall Study|Withdrawal by Subject|6|||
129522947|NCT01448707|466203292|FG001|Overall Study|Withdrawal by Subject|7|||
129522948|NCT01448707|466203291|FG000|Overall Study|Other|7|||
129522949|NCT01448707|466203292|FG001|Overall Study|Other|4|||
129522950|NCT00441480|466203294|FG000|Overall Study|Protocol Violation|1|||
129522951|NCT00441480|466203295|FG001|Overall Study|Protocol Violation|1|||
129522952|NCT00441480|466203294|FG000|Overall Study|Withdrawal by Subject|2|||
129522953|NCT00441480|466203295|FG001|Overall Study|Withdrawal by Subject|3|||
129522954|NCT02699125|466203298|FG000|Placebo|Lost to Follow-up|2|||
129522955|NCT02699125|466203299|FG001|Placebo|Lost to Follow-up|0|||
129522956|NCT02699125|466203298|FG000|Placebo|Protocol Violation|1|||
129522957|NCT02699125|466203299|FG001|Placebo|Protocol Violation|0|||
129522958|NCT02699125|466203298|FG000|Placebo|Withdrawal by Subject|0|||
129522959|NCT02699125|466203299|FG001|Placebo|Withdrawal by Subject|4|||
129522960|NCT02699125|466203298|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
129522961|NCT02699125|466203299|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
129522962|NCT03796195|466203300|FG000|Overall Study|Study closed early|1|||
129522963|NCT01922739|466203301|FG000|Titration/Adjustment Period|Adverse Event|3|||
129522964|NCT01922739|466203301|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
129522965|NCT01922739|466203301|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
129522966|NCT01922739|466203301|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
129522967|NCT01922739|466203301|FG000|Open-label Treatment Period|Adverse Event|6|||
129522968|NCT01922739|466203301|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
129522969|NCT01922739|466203301|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
129522970|NCT01922739|466203301|FG000|Open-label Treatment Period|Protocol Violation|5|||
129522971|NCT01922739|466203301|FG000|Open-label Treatment Period|Pregnancy|1|||
129522972|NCT01922739|466203301|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
129522973|NCT01922739|466203301|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
129522974|NCT01922739|466203301|FG000|Open-label Treatment Period|Physician Decision|1|||
129522975|NCT01922739|466203301|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
129522976|NCT00441012|466203304|FG000|Overall Study|Adverse Event|0|||
129522977|NCT00441012|466203305|FG001|Overall Study|Adverse Event|1|||
129522978|NCT00441012|466203304|FG000|Overall Study|Lost to Follow-up|3|||
129522979|NCT00441012|466203305|FG001|Overall Study|Lost to Follow-up|3|||
129522980|NCT00441012|466203304|FG000|Overall Study|Protocol Violation|10|||
129522981|NCT00441012|466203305|FG001|Overall Study|Protocol Violation|9|||
129522982|NCT00441012|466203304|FG000|Overall Study|Withdrawal by Subject|4|||
129522983|NCT00441012|466203305|FG001|Overall Study|Withdrawal by Subject|0|||
129522984|NCT00441012|466203304|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
129522985|NCT00441012|466203305|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
129522986|NCT04489940|466203306|FG000|Overall Study|Other|2|||
129522987|NCT04489940|466203306|FG000|Overall Study|Withdrawal by Subject|2|||
129522988|NCT04489940|466203306|FG000|Overall Study|Death|5|||
129522989|NCT04489940|466203306|FG000|Overall Study|Lost to Follow-up|1|||
129522990|NCT02725268|466203307|FG000|Overall Study|Death|58|||
129522991|NCT02725268|466203308|FG001|Overall Study|Death|59|||
129522992|NCT02725268|466203309|FG002|Overall Study|Death|30|||
129522993|NCT02725268|466203310|FG003|Overall Study|Death|16|||
129522994|NCT02725268|466203307|FG000|Overall Study|Lost to Follow-up|4|||
129522995|NCT02725268|466203308|FG001|Overall Study|Lost to Follow-up|3|||
129522996|NCT02725268|466203309|FG002|Overall Study|Lost to Follow-up|0|||
129522997|NCT02725268|466203310|FG003|Overall Study|Lost to Follow-up|1|||
129522998|NCT02725268|466203307|FG000|Overall Study|Site Terminated by Sponsor|0|||
129522999|NCT02725268|466203308|FG001|Overall Study|Site Terminated by Sponsor|1|||
129523000|NCT02725268|466203309|FG002|Overall Study|Site Terminated by Sponsor|0|||
129523001|NCT02725268|466203310|FG003|Overall Study|Site Terminated by Sponsor|0|||
129523002|NCT02725268|466203307|FG000|Overall Study|Withdrawal by Subject|8|||
129523003|NCT02725268|466203308|FG001|Overall Study|Withdrawal by Subject|6|||
129523004|NCT02725268|466203309|FG002|Overall Study|Withdrawal by Subject|8|||
129523005|NCT02725268|466203310|FG003|Overall Study|Withdrawal by Subject|1|||
129523006|NCT02725268|466203307|FG000|Overall Study|Reason not Specified|2|||
129523007|NCT02725268|466203308|FG001|Overall Study|Reason not Specified|1|||
129523008|NCT02725268|466203309|FG002|Overall Study|Reason not Specified|0|||
129523009|NCT02725268|466203310|FG003|Overall Study|Reason not Specified|0|||
129523010|NCT04498468|466203311|FG000|Overall Study|Lost to Follow-up|3|||
129523011|NCT00262314|466203316|FG000|Overall Study|Changing physicians|38|||
129523012|NCT00262314|466203316|FG000|Overall Study|Death|12|||
129523013|NCT00262314|466203316|FG000|Overall Study|Patient's decision|92|||
129523014|NCT00262314|466203316|FG000|Overall Study|Other|95|||
129523015|NCT00262314|466203316|FG000|Overall Study|Lost to Follow-up|70|||
129523016|NCT00262314|466203316|FG000|Overall Study|Administrative withdrawal|30|||
129523017|NCT05104749|466203317|FG000|Overall Study|Lost to Follow-up|2|||
129523018|NCT05104749|466203318|FG001|Overall Study|Lost to Follow-up|3|||
129523019|NCT03964493|466203319|FG000|Overall Study|Withdrawal by Subject|4|||
129523020|NCT03964493|466203320|FG001|Overall Study|Withdrawal by Subject|1|||
129523021|NCT03964493|466203319|FG000|Overall Study|Lost to Follow-up|13|||
129523022|NCT03964493|466203320|FG001|Overall Study|Lost to Follow-up|4|||
129523023|NCT02470429|466203321|FG000|Overall Study|Adverse Event|1|||
129523024|NCT02470429|466203322|FG001|Overall Study|Adverse Event|0|||
129523025|NCT02470429|466203321|FG000|Overall Study|Withdrawal by Subject|1|||
129523026|NCT02470429|466203322|FG001|Overall Study|Withdrawal by Subject|0|||
129523027|NCT01300767|466203323|FG000|Overall Study|Discomfort|2|||
129523028|NCT01300767|466203323|FG000|Overall Study|Biomicroscopy|1|||
129523029|NCT01300767|466203323|FG000|Overall Study|Unacceptable fit|1|||
129523030|NCT00398138|466203324|FG000|Overall Study|Adverse Event|2|||
129523031|NCT00117572|466203326|FG000|Overall Study|Site withdrew before starting treatment|2|||
129523032|NCT00117572|466203327|FG001|Overall Study|Site withdrew before starting treatment|3|||
129523033|NCT00117572|466203326|FG000|Overall Study|Withdrawal by Subject|3|||
129523034|NCT00117572|466203327|FG001|Overall Study|Withdrawal by Subject|3|||
129523035|NCT00117572|466203326|FG000|Overall Study|Protocol Violation|1|||
129523036|NCT00117572|466203327|FG001|Overall Study|Protocol Violation|0|||
129523037|NCT00887068|466203328|FG000|Overall Study|Withdrawal by Subject|2|||
129523038|NCT00887068|466203329|FG001|Overall Study|Withdrawal by Subject|0|||
129523039|NCT00887068|466203328|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
129523040|NCT00887068|466203329|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
129523041|NCT01387594|466203330|FG000|Overall Study|Withdrawal by Subject|0|||
129523042|NCT01387594|466203331|FG001|Overall Study|Withdrawal by Subject|2|||
129523043|NCT01387594|466203330|FG000|Overall Study|Lost to Follow-up|0|||
129523044|NCT01387594|466203331|FG001|Overall Study|Lost to Follow-up|1|||
129523045|NCT04507360|466204767|FG000|Week 1|Lost to Follow-up|0|||
129523046|NCT04507360|466204768|FG001|Week 1|Lost to Follow-up|0|||
129523047|NCT04507360|466204769|FG002|Week 1|Lost to Follow-up|0|||
129523048|NCT04507360|466204770|FG003|Week 1|Lost to Follow-up|0|||
129523049|NCT04507360|466204771|FG004|Week 1|Lost to Follow-up|0|||
129523050|NCT04507360|466204772|FG005|Week 1|Lost to Follow-up|0|||
129523051|NCT04507360|466204773|FG006|Week 1|Lost to Follow-up|0|||
129523052|NCT04507360|466204774|FG007|Week 1|Lost to Follow-up|0|||
129523053|NCT04507360|466204775|FG008|Week 1|Lost to Follow-up|72|||
129523054|NCT04507360|466204776|FG009|Week 1|Lost to Follow-up|22|||
129523055|NCT04507360|466204777|FG010|Week 1|Lost to Follow-up|10|||
129523056|NCT04507360|466204767|FG000|Week 2|Lost to Follow-up|0|||
129523057|NCT04507360|466204768|FG001|Week 2|Lost to Follow-up|0|||
129523058|NCT04507360|466204769|FG002|Week 2|Lost to Follow-up|0|||
129523059|NCT04507360|466204770|FG003|Week 2|Lost to Follow-up|0|||
129523060|NCT04507360|466204771|FG004|Week 2|Lost to Follow-up|0|||
129523061|NCT04507360|466204772|FG005|Week 2|Lost to Follow-up|0|||
129523062|NCT04507360|466204773|FG006|Week 2|Lost to Follow-up|0|||
129523063|NCT04507360|466204774|FG007|Week 2|Lost to Follow-up|0|||
129523064|NCT04507360|466204775|FG008|Week 2|Lost to Follow-up|121|||
129523065|NCT04507360|466204776|FG009|Week 2|Lost to Follow-up|85|||
129523066|NCT04507360|466204777|FG010|Week 2|Lost to Follow-up|82|||
129523067|NCT04507360|466204767|FG000|Week 3|Lost to Follow-up|0|||
129523068|NCT04507360|466204768|FG001|Week 3|Lost to Follow-up|0|||
129523069|NCT04507360|466204769|FG002|Week 3|Lost to Follow-up|0|||
129523070|NCT04507360|466204770|FG003|Week 3|Lost to Follow-up|0|||
129523071|NCT04507360|466204771|FG004|Week 3|Lost to Follow-up|0|||
129523072|NCT04507360|466204772|FG005|Week 3|Lost to Follow-up|0|||
129523073|NCT04507360|466204773|FG006|Week 3|Lost to Follow-up|0|||
129523074|NCT04507360|466204774|FG007|Week 3|Lost to Follow-up|0|||
129523075|NCT04507360|466204775|FG008|Week 3|Lost to Follow-up|123|||
129523076|NCT04507360|466204776|FG009|Week 3|Lost to Follow-up|92|||
129523077|NCT04507360|466204777|FG010|Week 3|Lost to Follow-up|84|||
129523078|NCT04507360|466204767|FG000|Week 4|Lost to Follow-up|0|||
129523079|NCT04507360|466204768|FG001|Week 4|Lost to Follow-up|0|||
129523080|NCT04507360|466204769|FG002|Week 4|Lost to Follow-up|0|||
129523081|NCT04507360|466204770|FG003|Week 4|Lost to Follow-up|0|||
129523082|NCT04507360|466204771|FG004|Week 4|Lost to Follow-up|0|||
129523083|NCT04507360|466204772|FG005|Week 4|Lost to Follow-up|0|||
129523084|NCT04507360|466204773|FG006|Week 4|Lost to Follow-up|0|||
129523085|NCT04507360|466204774|FG007|Week 4|Lost to Follow-up|0|||
129523086|NCT04507360|466204775|FG008|Week 4|Lost to Follow-up|131|||
129523087|NCT04507360|466204776|FG009|Week 4|Lost to Follow-up|115|||
129523088|NCT04507360|466204777|FG010|Week 4|Lost to Follow-up|102|||
129523089|NCT04507360|466204767|FG000|Week 5|Lost to Follow-up|0|||
129523090|NCT04507360|466204768|FG001|Week 5|Lost to Follow-up|0|||
129523091|NCT04507360|466204769|FG002|Week 5|Lost to Follow-up|0|||
129523092|NCT04507360|466204770|FG003|Week 5|Lost to Follow-up|0|||
129523093|NCT04507360|466204771|FG004|Week 5|Lost to Follow-up|0|||
129523094|NCT04507360|466204772|FG005|Week 5|Lost to Follow-up|0|||
129523095|NCT04507360|466204773|FG006|Week 5|Lost to Follow-up|0|||
129523096|NCT04507360|466204774|FG007|Week 5|Lost to Follow-up|0|||
129523097|NCT04507360|466204775|FG008|Week 5|Lost to Follow-up|103|||
129523098|NCT04507360|466204776|FG009|Week 5|Lost to Follow-up|135|||
129523099|NCT04507360|466204777|FG010|Week 5|Lost to Follow-up|143|||
129523100|NCT04507360|466204767|FG000|Week 8|Lost to Follow-up|0|||
129523101|NCT04507360|466204768|FG001|Week 8|Lost to Follow-up|0|||
129523102|NCT04507360|466204769|FG002|Week 8|Lost to Follow-up|0|||
129523103|NCT04507360|466204770|FG003|Week 8|Lost to Follow-up|0|||
129523104|NCT04507360|466204771|FG004|Week 8|Lost to Follow-up|0|||
129523105|NCT04507360|466204772|FG005|Week 8|Lost to Follow-up|0|||
129523106|NCT04507360|466204773|FG006|Week 8|Lost to Follow-up|0|||
129523107|NCT04507360|466204774|FG007|Week 8|Lost to Follow-up|0|||
129523108|NCT04507360|466204775|FG008|Week 8|Lost to Follow-up|139|||
129523109|NCT04507360|466204776|FG009|Week 8|Lost to Follow-up|145|||
129523110|NCT04507360|466204777|FG010|Week 8|Lost to Follow-up|152|||
129523111|NCT03050307|466204778|FG000|Overall Study|Adverse Event|4|||
129523112|NCT03050307|466204779|FG001|Overall Study|Adverse Event|2|||
129523113|NCT03050307|466204778|FG000|Overall Study|Significant Protocol Deviation|0|||
129523114|NCT03050307|466204779|FG001|Overall Study|Significant Protocol Deviation|1|||
129523115|NCT03050307|466204778|FG000|Overall Study|Lost to Follow-up|0|||
129523116|NCT03050307|466204779|FG001|Overall Study|Lost to Follow-up|1|||
129523117|NCT03050307|466204778|FG000|Overall Study|Voluntary Withdrawal|3|||
129523118|NCT03050307|466204779|FG001|Overall Study|Voluntary Withdrawal|4|||
129523119|NCT03050307|466204778|FG000|Overall Study|Reason not Specified|1|||
129523120|NCT03050307|466204779|FG001|Overall Study|Reason not Specified|1|||
129523121|NCT02973997|466204780|FG000|Overall Study|Withdrawal by Subject|4|||
129523122|NCT02973997|466204781|FG001|Overall Study|Withdrawal by Subject|0|||
129523123|NCT02973997|466204780|FG000|Overall Study|Adverse Event|4|||
129523124|NCT02973997|466204781|FG001|Overall Study|Adverse Event|1|||
129523125|NCT02973997|466204780|FG000|Overall Study|Disease Progression|11|||
129523126|NCT02973997|466204781|FG001|Overall Study|Disease Progression|20|||
129523127|NCT02973997|466204780|FG000|Overall Study|Alternative Therapy|3|||
129523128|NCT02973997|466204781|FG001|Overall Study|Alternative Therapy|0|||
129523129|NCT02973997|466204780|FG000|Overall Study|Other complicating disease|0|||
129523130|NCT02973997|466204781|FG001|Overall Study|Other complicating disease|1|||
129523131|NCT02973997|466204780|FG000|Overall Study|Death|0|||
129523132|NCT02973997|466204781|FG001|Overall Study|Death|1|||
129523133|NCT02996110|466204788|FG000|Pre-Treatment|Other Reasons|0|||
129523134|NCT02996110|466204789|FG001|Pre-Treatment|Other Reasons|1|||
129523135|NCT02996110|466204790|FG002|Pre-Treatment|Other Reasons|0|||
129523136|NCT02996110|466204791|FG003|Pre-Treatment|Other Reasons|0|||
129523137|NCT02996110|466204792|FG004|Pre-Treatment|Other Reasons|1|||
129523138|NCT02996110|466204788|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
129523139|NCT02996110|466204789|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
129523140|NCT02996110|466204790|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
129523141|NCT02996110|466204791|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
129523142|NCT02996110|466204792|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
129523143|NCT02996110|466204788|FG000|Track 1|Disease Progression|15|||
129523144|NCT02996110|466204789|FG001|Track 1|Disease Progression|17|||
129523145|NCT02996110|466204790|FG002|Track 1|Disease Progression|0|||
129523146|NCT02996110|466204791|FG003|Track 1|Disease Progression|0|||
129523147|NCT02996110|466204792|FG004|Track 1|Disease Progression|0|||
129523148|NCT02996110|466204788|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
129523149|NCT02996110|466204789|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
129523150|NCT02996110|466204790|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
129523151|NCT02996110|466204791|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
129523152|NCT02996110|466204792|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
129523153|NCT02996110|466204788|FG000|Track 1|Study Drug Toxicity|5|||
129523154|NCT02996110|466204789|FG001|Track 1|Study Drug Toxicity|3|||
129523155|NCT02996110|466204790|FG002|Track 1|Study Drug Toxicity|0|||
129523156|NCT02996110|466204791|FG003|Track 1|Study Drug Toxicity|0|||
129523157|NCT02996110|466204792|FG004|Track 1|Study Drug Toxicity|0|||
129523158|NCT02996110|466204788|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
129523159|NCT02996110|466204789|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
129523160|NCT02996110|466204790|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
129523161|NCT02996110|466204791|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
129523162|NCT02996110|466204792|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
129523163|NCT02996110|466204788|FG000|Track 1|Administrative Reason by Sponsor|0|||
129523164|NCT02996110|466204789|FG001|Track 1|Administrative Reason by Sponsor|1|||
129523165|NCT02996110|466204790|FG002|Track 1|Administrative Reason by Sponsor|0|||
129523166|NCT02996110|466204791|FG003|Track 1|Administrative Reason by Sponsor|0|||
129523167|NCT02996110|466204792|FG004|Track 1|Administrative Reason by Sponsor|0|||
129523168|NCT02996110|466204788|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
129523169|NCT02996110|466204789|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
129523170|NCT02996110|466204790|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
129523171|NCT02996110|466204791|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
129523172|NCT02996110|466204792|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
129523173|NCT02996110|466204788|FG000|Track 2|Disease Progression|33|||
129523174|NCT02996110|466204789|FG001|Track 2|Disease Progression|26|||
129523175|NCT02996110|466204790|FG002|Track 2|Disease Progression|19|||
129523176|NCT02996110|466204791|FG003|Track 2|Disease Progression|16|||
129523177|NCT02996110|466204792|FG004|Track 2|Disease Progression|15|||
129523178|NCT02996110|466204788|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
129523179|NCT02996110|466204789|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
129523180|NCT02996110|466204790|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
129523181|NCT02996110|466204791|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
129523182|NCT02996110|466204792|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
129523183|NCT02996110|466204788|FG000|Track 2|Death|0|||
129523184|NCT02996110|466204789|FG001|Track 2|Death|0|||
129523185|NCT02996110|466204790|FG002|Track 2|Death|1|||
129523186|NCT02996110|466204791|FG003|Track 2|Death|0|||
129523187|NCT02996110|466204792|FG004|Track 2|Death|1|||
129523188|NCT02996110|466204788|FG000|Track 2|Study Drug Toxicity|4|||
129523189|NCT02996110|466204789|FG001|Track 2|Study Drug Toxicity|1|||
129523190|NCT02996110|466204790|FG002|Track 2|Study Drug Toxicity|4|||
129523191|NCT02996110|466204791|FG003|Track 2|Study Drug Toxicity|1|||
129523192|NCT02996110|466204792|FG004|Track 2|Study Drug Toxicity|0|||
129523193|NCT02996110|466204788|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
129523194|NCT02996110|466204789|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
129523195|NCT02996110|466204790|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
129523196|NCT02996110|466204791|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
129523197|NCT02996110|466204792|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
129523198|NCT02996110|466204788|FG000|Track 2|Participant Withdrew Consent|1|||
129523199|NCT02996110|466204789|FG001|Track 2|Participant Withdrew Consent|2|||
129523200|NCT02996110|466204790|FG002|Track 2|Participant Withdrew Consent|3|||
129523201|NCT02996110|466204791|FG003|Track 2|Participant Withdrew Consent|1|||
129523202|NCT02996110|466204792|FG004|Track 2|Participant Withdrew Consent|1|||
129523203|NCT02996110|466204788|FG000|Track 2|Other Reasons|0|||
129523204|NCT02996110|466204789|FG001|Track 2|Other Reasons|0|||
129523205|NCT02996110|466204790|FG002|Track 2|Other Reasons|1|||
129523206|NCT02996110|466204791|FG003|Track 2|Other Reasons|0|||
129523207|NCT02996110|466204792|FG004|Track 2|Other Reasons|1|||
129523208|NCT01938391|466204793|FG000|6 Month Follow up|Withdrawal by Subject|1|||
129523209|NCT01938391|466204793|FG000|12 Month Follow up|Physician Decision|1|||
129523210|NCT01938391|466204793|FG000|12 Month Follow up|Withdrawal by Subject|1|||
129523211|NCT01077193|466204794|FG000|Overall Study|Lost to Follow-up|1|||
129523212|NCT01077193|466204794|FG000|Overall Study|Withdrawal by Subject|2|||
129523213|NCT01077193|466204794|FG000|Overall Study|Lack of Efficacy|1|||
129523214|NCT01077193|466204794|FG000|Overall Study|Study Terminated by Sponsor|40|||
129523215|NCT01536418|466204805|FG000|Overall Study|Protocol Violation|2|||
129523216|NCT01536418|466204806|FG001|Overall Study|Protocol Violation|3|||
129523217|NCT01536418|466204805|FG000|Overall Study|Physician Decision|1|||
129523218|NCT01536418|466204806|FG001|Overall Study|Physician Decision|3|||
129523219|NCT01536418|466204805|FG000|Overall Study|Study closed/terminated|41|||
129523220|NCT01536418|466204806|FG001|Overall Study|Study closed/terminated|37|||
129523221|NCT01536418|466204805|FG000|Overall Study|Lack of Efficacy|10|||
129523222|NCT01536418|466204806|FG001|Overall Study|Lack of Efficacy|16|||
129523223|NCT01536418|466204805|FG000|Overall Study|Adverse Event|9|||
129523224|NCT01536418|466204806|FG001|Overall Study|Adverse Event|4|||
129523225|NCT01536418|466204805|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
129523226|NCT01536418|466204806|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
129523227|NCT01536418|466204805|FG000|Overall Study|Withdrawal by Subject|5|||
129523228|NCT01536418|466204806|FG001|Overall Study|Withdrawal by Subject|3|||
129523229|NCT03687827|466204807|FG000|Treatment Period 1|Death|0|||
129523230|NCT03687827|466204808|FG001|Treatment Period 1|Death|1|||
129523231|NCT03687827|466204807|FG000|Treatment Period 1|Lost to Follow-up|2|||
129523232|NCT03687827|466204808|FG001|Treatment Period 1|Lost to Follow-up|2|||
129523233|NCT03687827|466204807|FG000|Treatment Period 1|Physician Decision|5|||
129523234|NCT03687827|466204808|FG001|Treatment Period 1|Physician Decision|2|||
129523235|NCT03687827|466204807|FG000|Treatment Period 1|Withdrawal by Subject|7|||
129523236|NCT03687827|466204808|FG001|Treatment Period 1|Withdrawal by Subject|3|||
129523237|NCT03687827|466204807|FG000|Treatment Period 2|Physician Decision|4|||
129523238|NCT03687827|466204808|FG001|Treatment Period 2|Physician Decision|1|||
129523239|NCT03687827|466204807|FG000|Treatment Period 2|Withdrawal by Subject|1|||
129523240|NCT03687827|466204808|FG001|Treatment Period 2|Withdrawal by Subject|2|||
129523241|NCT03748420|466204810|FG000|Overall Study|No 12 month medication adherence data available|0|||
129523242|NCT03748420|466204811|FG001|Overall Study|No 12 month medication adherence data available|1|||
129523243|NCT03748420|466204810|FG000|Overall Study|Death|24|||
129523244|NCT03748420|466204811|FG001|Overall Study|Death|28|||
129523245|NCT03748420|466204810|FG000|Overall Study|Lost to Follow-up|231|||
129523246|NCT03748420|466204811|FG001|Overall Study|Lost to Follow-up|230|||
129523247|NCT01466062|466204813|FG000|Overall Study|Adverse Event|1|||
129523248|NCT01466062|466204813|FG000|Overall Study|Withdrawal by Subject|1|||
129523249|NCT02865928|466204814|FG000|Overall Study|Withdrawal by Subject|1|||
129523250|NCT02865928|466204815|FG001|Overall Study|Withdrawal by Subject|0|||
129523251|NCT02865928|466204814|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
129523252|NCT02865928|466204815|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
129523253|NCT02865928|466204814|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
129523254|NCT02865928|466204815|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
129523255|NCT03152110|466204822|FG000|Overall Study|Withdrawal by Subject|3|||
129523256|NCT00850135|466204823|FG000|Overall Study|Physician Decision|1|||
129523257|NCT04259346|466204824|FG000|Overall Study|Lost to Follow-up|1|||
129523258|NCT04259346|466204825|FG001|Overall Study|Lost to Follow-up|3|||
129523259|NCT04259346|466204824|FG000|Overall Study|Protocol Violation|1|||
129523260|NCT04259346|466204825|FG001|Overall Study|Protocol Violation|0|||
129523261|NCT04259346|466204824|FG000|Overall Study|Withdrawal by Subject|1|||
129523262|NCT04259346|466204825|FG001|Overall Study|Withdrawal by Subject|0|||
129523263|NCT04259346|466204824|FG000|Overall Study|Adverse Event|1|||
129523264|NCT04259346|466204825|FG001|Overall Study|Adverse Event|1|||
129523265|NCT00623766|466204829|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
129523266|NCT00623766|466204830|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
129523267|NCT00623766|466204829|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
129523268|NCT00623766|466204830|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
129523269|NCT00623766|466204829|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
129523270|NCT00623766|466204830|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
129523271|NCT00623766|466204829|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
129523272|NCT00623766|466204830|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
129523273|NCT00623766|466204829|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
129523274|NCT00623766|466204830|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
129523275|NCT00422903|466204839|FG000|Overall Study|Disease Progression|3|||
129523276|NCT00422903|466204840|FG001|Overall Study|Disease Progression|1|||
129523277|NCT00422903|466204839|FG000|Overall Study|Adverse Event|0|||
129523278|NCT00422903|466204840|FG001|Overall Study|Adverse Event|2|||
129523279|NCT00422903|466204839|FG000|Overall Study|Informed Consent Withdrawn|1|||
129523280|NCT00422903|466204840|FG001|Overall Study|Informed Consent Withdrawn|2|||
129523281|NCT02092324|466204847|FG000|Overall Study|Adverse Event|1|||
129523282|NCT02092324|466204847|FG000|Overall Study|Lack of Efficacy|6|||
129523283|NCT02092324|466204847|FG000|Overall Study|Proceed to Transplant|3|||
129523284|NCT02092324|466204847|FG000|Overall Study|Physician Decision|7|||
129523285|NCT02092324|466204847|FG000|Overall Study|Misdiagnosis|2|||
129523286|NCT01039428|466204848|FG000|Overall Study|Protocol Violation|1|||
129523287|NCT01039428|466204849|FG001|Overall Study|Protocol Violation|0|||
129523288|NCT01039428|466204848|FG000|Overall Study|Withdrawal by Subject|1|||
129523289|NCT01039428|466204849|FG001|Overall Study|Withdrawal by Subject|0|||
129523290|NCT00422240|466204856|FG000|Overall Study|Lack of Efficacy|1|||
129523291|NCT00422240|466204857|FG001|Overall Study|Lack of Efficacy|2|||
129523292|NCT00422240|466204858|FG002|Overall Study|Lack of Efficacy|0|||
129523293|NCT00422240|466204859|FG003|Overall Study|Lack of Efficacy|1|||
129523294|NCT00422240|466204856|FG000|Overall Study|Adverse Event|11|||
129523295|NCT00422240|466204857|FG001|Overall Study|Adverse Event|4|||
129523296|NCT00422240|466204858|FG002|Overall Study|Adverse Event|5|||
129523297|NCT00422240|466204859|FG003|Overall Study|Adverse Event|2|||
129523298|NCT00422240|466204856|FG000|Overall Study|Subject request|21|||
129523299|NCT00422240|466204857|FG001|Overall Study|Subject request|17|||
129523300|NCT00422240|466204858|FG002|Overall Study|Subject request|18|||
129523301|NCT00422240|466204859|FG003|Overall Study|Subject request|30|||
129523302|NCT00422240|466204856|FG000|Overall Study|Protocol Violation|0|||
129523303|NCT00422240|466204857|FG001|Overall Study|Protocol Violation|1|||
129523304|NCT00422240|466204858|FG002|Overall Study|Protocol Violation|0|||
129523305|NCT00422240|466204859|FG003|Overall Study|Protocol Violation|1|||
129523306|NCT00422240|466204856|FG000|Overall Study|Lost to Follow-up|31|||
129523307|NCT00422240|466204857|FG001|Overall Study|Lost to Follow-up|32|||
129523308|NCT00422240|466204858|FG002|Overall Study|Lost to Follow-up|19|||
129523309|NCT00422240|466204859|FG003|Overall Study|Lost to Follow-up|34|||
129523310|NCT00422240|466204856|FG000|Overall Study|Other|1|||
129523311|NCT00422240|466204857|FG001|Overall Study|Other|0|||
129523312|NCT00422240|466204858|FG002|Overall Study|Other|0|||
129523313|NCT00422240|466204859|FG003|Overall Study|Other|1|||
129523314|NCT00422240|466204856|FG000|Overall Study|Pregnancy|3|||
129523315|NCT00422240|466204857|FG001|Overall Study|Pregnancy|1|||
129523316|NCT00422240|466204858|FG002|Overall Study|Pregnancy|1|||
129523317|NCT00422240|466204859|FG003|Overall Study|Pregnancy|2|||
129523318|NCT01188811|466204867|FG000|Overall Study|Withdrawal by Subject|0|||
129523319|NCT01188811|466204868|FG001|Overall Study|Withdrawal by Subject|2|||
129523320|NCT01188811|466204867|FG000|Overall Study|Adverse Event|6|||
129523321|NCT01188811|466204868|FG001|Overall Study|Adverse Event|0|||
129523322|NCT01602744|466204869|FG000|Overall Study|Death|17|||
129523323|NCT01602744|466204870|FG001|Overall Study|Death|15|||
129523324|NCT01602744|466204869|FG000|Overall Study|Lost to Follow-up|13|||
129523325|NCT01602744|466204870|FG001|Overall Study|Lost to Follow-up|8|||
129523326|NCT03418376|466204871|FG000|Overall Study|Musculoskeletal injury|1|||
129523327|NCT03418376|466204872|FG001|Overall Study|Musculoskeletal injury|2|||
129523328|NCT03418376|466204873|FG002|Overall Study|Musculoskeletal injury|1|||
129523329|NCT03418376|466204874|FG003|Overall Study|Musculoskeletal injury|0|||
129523330|NCT03418376|466204871|FG000|Overall Study|Personal reasons|0|||
129523331|NCT03418376|466204872|FG001|Overall Study|Personal reasons|2|||
129523332|NCT03418376|466204873|FG002|Overall Study|Personal reasons|2|||
129523333|NCT03418376|466204874|FG003|Overall Study|Personal reasons|1|||
129523334|NCT03418376|466204871|FG000|Overall Study|Exacerbation|0|||
129523335|NCT03418376|466204872|FG001|Overall Study|Exacerbation|1|||
129523336|NCT03418376|466204873|FG002|Overall Study|Exacerbation|0|||
129523337|NCT03418376|466204874|FG003|Overall Study|Exacerbation|0|||
129523338|NCT04350372|466204879|FG000|Overall Study|Death|1|||
129523339|NCT00412113|466204880|FG000|Overall Study|Adverse Event|11|||
129523340|NCT00412113|466204881|FG001|Overall Study|Adverse Event|15|||
129523341|NCT00412113|466204880|FG000|Overall Study|did not receive treatment|1|||
129523342|NCT00412113|466204881|FG001|Overall Study|did not receive treatment|0|||
129523343|NCT01190020|466204882|FG000|Overall Study|Adverse Event|2|||
129523344|NCT01190020|466204883|FG001|Overall Study|Adverse Event|0|||
129523345|NCT01190020|466204882|FG000|Overall Study|Lost to Follow-up|2|||
129523346|NCT01190020|466204883|FG001|Overall Study|Lost to Follow-up|0|||
129523347|NCT01190020|466204882|FG000|Overall Study|Withdrawal by Subject|3|||
129523348|NCT01190020|466204883|FG001|Overall Study|Withdrawal by Subject|0|||
129523349|NCT04195750|466204884|FG000|Overall Study|Death|245|||
129523350|NCT04195750|466204885|FG001|Overall Study|Death|253|||
129523351|NCT04195750|466204886|FG002|Overall Study|Death|5|||
129523352|NCT04195750|466204884|FG000|Overall Study|Physician Decision|0|||
129523353|NCT04195750|466204885|FG001|Overall Study|Physician Decision|1|||
129523354|NCT04195750|466204886|FG002|Overall Study|Physician Decision|0|||
129523355|NCT04195750|466204884|FG000|Overall Study|Withdrawal by Subject|9|||
129523356|NCT04195750|466204885|FG001|Overall Study|Withdrawal by Subject|8|||
129523357|NCT04195750|466204886|FG002|Overall Study|Withdrawal by Subject|0|||
129523358|NCT04195750|466204884|FG000|Overall Study|Ongoing|120|||
129523359|NCT04195750|466204885|FG001|Overall Study|Ongoing|110|||
129523360|NCT04195750|466204886|FG002|Overall Study|Ongoing|4|||
129523361|NCT03782376|466204887|FG000|Overall Study|Lost to Follow-up|2|||
129523362|NCT03782376|466204888|FG001|Overall Study|Lost to Follow-up|2|||
129523363|NCT03782376|466204887|FG000|Overall Study|Withdrawal by Subject|7|||
129523364|NCT03782376|466204888|FG001|Overall Study|Withdrawal by Subject|11|||
129523365|NCT03782376|466204887|FG000|Overall Study|Death|1|||
129523366|NCT03782376|466204888|FG001|Overall Study|Death|0|||
129523367|NCT03782376|466204887|FG000|Overall Study|Other|16|||
129523368|NCT03782376|466204888|FG001|Overall Study|Other|17|||
129523369|NCT03559192|466204889|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
129523370|NCT03559192|466204890|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
129523371|NCT03559192|466204891|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
129523372|NCT03559192|466204889|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
129523373|NCT03559192|466204890|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
129523374|NCT03559192|466204891|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
129523375|NCT03559192|466204889|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
129523376|NCT03559192|466204890|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
129523377|NCT03559192|466204891|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
129523378|NCT03559192|466204889|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
129523379|NCT03559192|466204890|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
129523380|NCT03559192|466204891|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
129523381|NCT03559192|466204889|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
129523382|NCT03559192|466204890|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
129523383|NCT03559192|466204891|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
129523384|NCT03559192|466204889|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
129523385|NCT03559192|466204890|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
129523386|NCT03559192|466204891|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
129523387|NCT03559192|466204889|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
129523388|NCT03559192|466204890|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
129523389|NCT03559192|466204891|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
129523390|NCT03559192|466204889|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
129523391|NCT03559192|466204890|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
129523392|NCT03559192|466204891|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
129523393|NCT03559192|466204889|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
129523394|NCT03559192|466204890|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
129523395|NCT03559192|466204891|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
129523396|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
129523397|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
129523398|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Death|0|||
129523399|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Death|4|||
129523400|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
129523401|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
129523402|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
129523403|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
129523404|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
129523405|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
129523406|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
129523407|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
129523408|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
129523409|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
129523410|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Other|4|||
129523411|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Other|3|||
129523412|NCT03517722|466204892|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
129523413|NCT03517722|466204893|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
129523414|NCT03517722|466204892|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
129523415|NCT03517722|466204893|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
129523416|NCT03517722|466204892|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
129523417|NCT03517722|466204893|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
129523418|NCT03517722|466204892|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
129523419|NCT03517722|466204893|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
129523420|NCT03517722|466204892|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
129523421|NCT03517722|466204893|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
129523422|NCT02422186|466204894|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
129523423|NCT02422186|466204895|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
129523424|NCT02422186|466204894|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
129523425|NCT02422186|466204895|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
129523426|NCT02422186|466204894|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
129523427|NCT02422186|466204895|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
129523428|NCT02422186|466204894|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
129523429|NCT02422186|466204895|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
129523430|NCT02422186|466204894|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
129523431|NCT02422186|466204895|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
129523432|NCT02422186|466204894|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
129523433|NCT02422186|466204895|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
129523434|NCT02422186|466204894|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
129523435|NCT02422186|466204895|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
129523436|NCT02422186|466204894|FG000|Follow-up Phase (2 Weeks)|Other|3|||
129523437|NCT02422186|466204895|FG001|Follow-up Phase (2 Weeks)|Other|0|||
129523438|NCT03277794|466204900|FG000|Overall Study|Lost to Follow-up|2|||
129523439|NCT03277794|466204901|FG001|Overall Study|Lost to Follow-up|4|||
129523440|NCT03277794|466204900|FG000|Overall Study|Withdrew due to high acuity|1|||
129523441|NCT03277794|466204901|FG001|Overall Study|Withdrew due to high acuity|0|||
129523442|NCT03039569|466204906|FG000|Overall Study|Lost to Follow-up|5|||
129523443|NCT03039569|466204907|FG001|Overall Study|Lost to Follow-up|4|||
129523444|NCT02254304|466204908|FG000|Overall Study|Adverse Event|2|||
129523445|NCT02254304|466204909|FG001|Overall Study|Adverse Event|1|||
129523446|NCT02254304|466204908|FG000|Overall Study|Lost to Follow-up|2|||
129523447|NCT02254304|466204909|FG001|Overall Study|Lost to Follow-up|2|||
129523448|NCT02254304|466204908|FG000|Overall Study|Protocol Violation|1|||
129523449|NCT02254304|466204909|FG001|Overall Study|Protocol Violation|0|||
129523450|NCT02254304|466204908|FG000|Overall Study|Withdrawal by Subject|3|||
129523451|NCT02254304|466204909|FG001|Overall Study|Withdrawal by Subject|0|||
129523452|NCT02254304|466204908|FG000|Overall Study|Injection site pain and Injection fear|1|||
129523453|NCT02254304|466204909|FG001|Overall Study|Injection site pain and Injection fear|0|||
129523454|NCT02254304|466204908|FG000|Overall Study|Personal causes|4|||
129523455|NCT02254304|466204909|FG001|Overall Study|Personal causes|1|||
129523456|NCT02254304|466204908|FG000|Overall Study|Personal decision|1|||
129523457|NCT02254304|466204909|FG001|Overall Study|Personal decision|0|||
129523458|NCT03573804|466204910|FG000|Overall Study|claustrophobia or MRI table problems|10|||
129523459|NCT03399786|466204913|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
129523460|NCT03399786|466204914|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129523461|NCT03399786|466204915|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129523462|NCT03399786|466204916|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
129523463|NCT03399786|466204913|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
129523464|NCT03399786|466204914|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
129523465|NCT03399786|466204915|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
129523466|NCT03399786|466204916|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
129523467|NCT03399786|466204913|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
129523468|NCT03399786|466204914|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
129523469|NCT03399786|466204915|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
129523470|NCT03399786|466204916|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
129523471|NCT01673373|466207169|FG000|Overall Study|Death|2|||
129523472|NCT01572844|466207170|FG000|Overall Study|Physician Decision|1|||
129523473|NCT01572844|466207171|FG001|Overall Study|Physician Decision|1|||
129523474|NCT00366444|466207173|FG000|Overall Study|Withdrawal by Subject|1|||
129523475|NCT00366444|466207174|FG001|Overall Study|Withdrawal by Subject|1|||
129523476|NCT00366444|466207173|FG000|Overall Study|Lack of Efficacy|0|||
129523477|NCT00366444|466207174|FG001|Overall Study|Lack of Efficacy|1|||
129523478|NCT05171816|466207175|FG000|Overall Study|Death|18|||
129523479|NCT05171816|466207176|FG001|Overall Study|Death|16|||
129523480|NCT04667949|466207177|FG000|Overall Study|Adverse Event|0|||
129523481|NCT04667949|466207178|FG001|Overall Study|Adverse Event|2|||
129523482|NCT04667949|466207177|FG000|Overall Study|Lost to Follow-up|0|||
129523483|NCT04667949|466207178|FG001|Overall Study|Lost to Follow-up|1|||
129523484|NCT04667949|466207177|FG000|Overall Study|Physician Decision|0|||
129523485|NCT04667949|466207178|FG001|Overall Study|Physician Decision|2|||
129523486|NCT04667949|466207177|FG000|Overall Study|Subject decision|1|||
129523487|NCT04667949|466207178|FG001|Overall Study|Subject decision|7|||
129523488|NCT02000622|466207181|FG000|Overall Study|Withdrawal by Subject|5|||
129523489|NCT02000622|466207182|FG001|Overall Study|Withdrawal by Subject|7|||
129523490|NCT02000622|466207181|FG000|Overall Study|Lost to Follow-up|4|||
129523491|NCT02000622|466207182|FG001|Overall Study|Lost to Follow-up|0|||
129523492|NCT02000622|466207181|FG000|Overall Study|Death|159|||
129523493|NCT02000622|466207182|FG001|Overall Study|Death|73|||
129523494|NCT02000622|466207181|FG000|Overall Study|Withdrawn due to site closure|1|||
129523495|NCT02000622|466207182|FG001|Overall Study|Withdrawn due to site closure|0|||
129523496|NCT01405027|466207186|FG000|Overall Study|Withdrawn consent|3|||
129523497|NCT01405027|466207187|FG001|Overall Study|Withdrawn consent|0|||
129523498|NCT01405027|466207186|FG000|Overall Study|Lost to Follow-up|16|||
129523499|NCT01405027|466207187|FG001|Overall Study|Lost to Follow-up|24|||
129523500|NCT01405027|466207186|FG000|Overall Study|Investigator judgement|0|||
129523501|NCT01405027|466207187|FG001|Overall Study|Investigator judgement|2|||
129523502|NCT01405027|466207186|FG000|Overall Study|Death|1|||
129523503|NCT01405027|466207187|FG001|Overall Study|Death|0|||
129523504|NCT01405027|466207186|FG000|Overall Study|Other or Unknown|12|||
129523505|NCT01405027|466207187|FG001|Overall Study|Other or Unknown|25|||
129523506|NCT02234050|466207189|FG000|Overall Study|Lack of Efficacy|38|||
129523507|NCT02234050|466207190|FG001|Overall Study|Lack of Efficacy|22|||
129523508|NCT02234050|466207189|FG000|Overall Study|Adverse Event|13|||
129523509|NCT02234050|466207190|FG001|Overall Study|Adverse Event|1|||
129523510|NCT02234050|466207189|FG000|Overall Study|Withdrawal by Subject|4|||
129523511|NCT02234050|466207190|FG001|Overall Study|Withdrawal by Subject|2|||
129523512|NCT02234050|466207189|FG000|Overall Study|Sponsor's decision|6|||
129523513|NCT02234050|466207190|FG001|Overall Study|Sponsor's decision|0|||
129523514|NCT02365506|466207192|FG000|Overall Study|Investigator's Discretion|0|||
129523515|NCT02365506|466207193|FG001|Overall Study|Investigator's Discretion|0|||
129523516|NCT02365506|466207194|FG002|Overall Study|Investigator's Discretion|1|||
129523517|NCT01680991|466207195|FG000|Overall Study|Adverse Event|1|||
129523518|NCT01680991|466207196|FG001|Overall Study|Adverse Event|0|||
129523519|NCT01680991|466207197|FG002|Overall Study|Adverse Event|0|||
129523520|NCT01680991|466207195|FG000|Overall Study|Death|1|||
129523521|NCT01680991|466207196|FG001|Overall Study|Death|0|||
129523522|NCT01680991|466207197|FG002|Overall Study|Death|1|||
129523523|NCT01680991|466207195|FG000|Overall Study|Protocol Violation|0|||
129523524|NCT01680991|466207196|FG001|Overall Study|Protocol Violation|1|||
129523525|NCT01680991|466207197|FG002|Overall Study|Protocol Violation|0|||
129523526|NCT01680991|466207195|FG000|Overall Study|Withdrawal by Subject|5|||
129523527|NCT01680991|466207196|FG001|Overall Study|Withdrawal by Subject|1|||
129523528|NCT01680991|466207197|FG002|Overall Study|Withdrawal by Subject|0|||
129523529|NCT01680991|466207195|FG000|Overall Study|Progressive disease (PD)|0|||
129523530|NCT01680991|466207196|FG001|Overall Study|Progressive disease (PD)|10|||
129523531|NCT01680991|466207197|FG002|Overall Study|Progressive disease (PD)|0|||
129523532|NCT01680991|466207195|FG000|Overall Study|Physician Decision|0|||
129523533|NCT01680991|466207196|FG001|Overall Study|Physician Decision|7|||
129523534|NCT01680991|466207197|FG002|Overall Study|Physician Decision|2|||
129523535|NCT01680991|466207195|FG000|Overall Study|Bad physical condition|0|||
129523536|NCT01680991|466207196|FG001|Overall Study|Bad physical condition|0|||
129523537|NCT01680991|466207197|FG002|Overall Study|Bad physical condition|1|||
129523538|NCT01680991|466207195|FG000|Overall Study|PD confirmed in other hospital|1|||
129523539|NCT01680991|466207196|FG001|Overall Study|PD confirmed in other hospital|0|||
129523540|NCT01680991|466207197|FG002|Overall Study|PD confirmed in other hospital|0|||
129523541|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
129523542|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
129523543|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Death|1|||
129523544|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Death|1|||
129523545|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
129523546|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
129523547|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
129523548|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
129523549|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
129523550|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
129523551|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
129523552|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
129523553|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
129523554|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
129523555|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
129523556|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
129523557|NCT03728881|466207198|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
129523558|NCT03728881|466207199|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
129523559|NCT03728881|466207198|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
129523560|NCT03728881|466207199|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
129523561|NCT03728881|466207198|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
129523562|NCT03728881|466207199|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
129523563|NCT06073054|466207200|FG000|Overall Study|Withdrawal by Subject|2|||
129523564|NCT00413777|466207204|FG000|Fixed-dose Period|Lost to Follow-up|1|||
129523565|NCT00413777|466207205|FG001|Fixed-dose Period|Lost to Follow-up|1|||
129523566|NCT00413777|466207204|FG000|Fixed-dose Period|Adverse Event|2|||
129523567|NCT00413777|466207205|FG001|Fixed-dose Period|Adverse Event|1|||
129523568|NCT00413777|466207204|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
129523569|NCT00413777|466207205|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
129523570|NCT00413777|466207204|FG000|Fixed-dose Period|Withdrew Consent|0|||
129523571|NCT00413777|466207205|FG001|Fixed-dose Period|Withdrew Consent|1|||
129523572|NCT05505734|466207206|FG000|Overall Study|Withdrawal by Subject|51|||
129523573|NCT05505734|466207207|FG001|Overall Study|Withdrawal by Subject|64|||
129523574|NCT05505734|466207206|FG000|Overall Study|Adverse Event|6|||
129523575|NCT05505734|466207207|FG001|Overall Study|Adverse Event|20|||
129523576|NCT05505734|466207206|FG000|Overall Study|Protocol Violation|8|||
129523577|NCT05505734|466207207|FG001|Overall Study|Protocol Violation|15|||
129523578|NCT05505734|466207206|FG000|Overall Study|Lack of therapeutic response|0|||
129523579|NCT05505734|466207207|FG001|Overall Study|Lack of therapeutic response|1|||
129523580|NCT05505734|466207206|FG000|Overall Study|Lost to Follow-up|247|||
129523581|NCT05505734|466207207|FG001|Overall Study|Lost to Follow-up|237|||
129523582|NCT05505734|466207206|FG000|Overall Study|Physician Decision|22|||
129523583|NCT05505734|466207207|FG001|Overall Study|Physician Decision|13|||
129523584|NCT05505734|466207206|FG000|Overall Study|Death|2|||
129523585|NCT05505734|466207207|FG001|Overall Study|Death|1|||
129523586|NCT05505734|466207206|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129523587|NCT05505734|466207207|FG001|Overall Study|Withdrawal by parent/guardian|1|||
129523588|NCT05505734|466207206|FG000|Overall Study|Pregnancy|1|||
129523589|NCT05505734|466207207|FG001|Overall Study|Pregnancy|0|||
129523590|NCT05505734|466207206|FG000|Overall Study|Other|17|||
129523591|NCT05505734|466207207|FG001|Overall Study|Other|13|||
129523592|NCT00764322|466207208|FG000|Overall Study|Withdrawal by Subject|11|||
129523593|NCT00764322|466207208|FG000|Overall Study|No CYP2D6 genotyping|9|||
129523594|NCT02348840|466207212|FG000|Overall Study|Withdrawal by Subject|2|||
129523595|NCT02348840|466207213|FG001|Overall Study|Withdrawal by Subject|1|||
129523596|NCT02348840|466207214|FG002|Overall Study|Withdrawal by Subject|0|||
129523597|NCT02348840|466207215|FG003|Overall Study|Withdrawal by Subject|0|||
129523598|NCT01600105|466207216|FG000|Total Participants|Withdrawal by Subject|1|||
129523599|NCT01600105|466207217|FG001|Total Participants|Withdrawal by Subject|0|||
129523600|NCT01600105|466207216|FG000|Total Participants|No images in PACS|10|||
129523601|NCT01600105|466207217|FG001|Total Participants|No images in PACS|0|||
129523602|NCT01600105|466207216|FG000|Total Participants|Insufficient image quality|30|||
129523603|NCT01600105|466207217|FG001|Total Participants|Insufficient image quality|10|||
129523604|NCT01600105|466207216|FG000|Sub Study I|Insufficient image quality|0|||
129523605|NCT01600105|466207217|FG001|Sub Study I|Insufficient image quality|10|||
129523606|NCT01600105|466207216|FG000|Sub Study II|Withdrawal by Subject|1|||
129523607|NCT01600105|466207217|FG001|Sub Study II|Withdrawal by Subject|0|||
129523608|NCT01600105|466207216|FG000|Sub Study II|No images in PACS|1|||
129523609|NCT01600105|466207217|FG001|Sub Study II|No images in PACS|0|||
129523610|NCT01600105|466207216|FG000|Sub Study II|Insufficient image quality|3|||
129523611|NCT01600105|466207217|FG001|Sub Study II|Insufficient image quality|0|||
129523612|NCT01600105|466207216|FG000|Sub Study III|Insufficient image quality|5|||
129523613|NCT01600105|466207217|FG001|Sub Study III|Insufficient image quality|0|||
129523614|NCT01600105|466207216|FG000|Sub Study V|Poor Image Quality|2|||
129523615|NCT01600105|466207217|FG001|Sub Study V|Poor Image Quality|0|||
129523616|NCT01263444|466207218|FG000|Overall Study|Adverse Event|8|||
129523617|NCT01263444|466207218|FG000|Overall Study|Withdrawal by Subject|1|||
129523618|NCT01263444|466207218|FG000|Overall Study|Protocol Violation|1|||
129523619|NCT04007367|466207220|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
129523620|NCT04007367|466207221|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
129523621|NCT04007367|466207222|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
129523622|NCT04007367|466207220|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
129523623|NCT04007367|466207221|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
129523624|NCT04007367|466207222|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
129523625|NCT04007367|466207220|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
129523626|NCT04007367|466207221|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
129523627|NCT04007367|466207222|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
129523628|NCT04007367|466207220|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
129523629|NCT04007367|466207221|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
129523630|NCT04007367|466207222|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
129523631|NCT04007367|466207220|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
129523632|NCT04007367|466207221|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
129523633|NCT04007367|466207222|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
129523634|NCT01764022|466207223|FG000|Overall Study|Death|3|||
129523635|NCT01764022|466207224|FG001|Overall Study|Death|5|||
129523636|NCT01764022|466207223|FG000|Overall Study|Withdrawal by Subject|2|||
129523637|NCT01764022|466207224|FG001|Overall Study|Withdrawal by Subject|6|||
129523638|NCT01764022|466207223|FG000|Overall Study|Lack of Efficacy|0|||
129523639|NCT01764022|466207224|FG001|Overall Study|Lack of Efficacy|1|||
129523640|NCT01764022|466207223|FG000|Overall Study|Physician Decision|0|||
129523641|NCT01764022|466207224|FG001|Overall Study|Physician Decision|2|||
129523642|NCT01764022|466207223|FG000|Overall Study|Lost to Follow-up|2|||
129523643|NCT01764022|466207224|FG001|Overall Study|Lost to Follow-up|0|||
129523644|NCT01764022|466207223|FG000|Overall Study|Protocol Violation|1|||
129523645|NCT01764022|466207224|FG001|Overall Study|Protocol Violation|0|||
129523646|NCT01899768|466207225|FG000|Part A|Adverse Event|2|||
129523647|NCT01899768|466207225|FG000|Part A|Withdrawal by Subject|1|||
129523648|NCT01899768|466207225|FG000|Part B|Adverse Event|1|||
129523649|NCT01899768|466207225|FG000|Part B|Withdrawal by Subject|1|||
129523650|NCT02203916|466207226|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
129523651|NCT02203916|466207227|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
129523652|NCT02203916|466207228|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
129523653|NCT02203916|466207226|FG000|Overall Study|Major Protocol Deviation|1|||
129523654|NCT02203916|466207227|FG001|Overall Study|Major Protocol Deviation|1|||
129523655|NCT02203916|466207228|FG002|Overall Study|Major Protocol Deviation|0|||
129523656|NCT02203916|466207226|FG000|Overall Study|Lost to Follow-up|0|||
129523657|NCT02203916|466207227|FG001|Overall Study|Lost to Follow-up|1|||
129523658|NCT02203916|466207228|FG002|Overall Study|Lost to Follow-up|0|||
129523659|NCT02203916|466207226|FG000|Overall Study|Voluntary Withdrawal|3|||
129523660|NCT02203916|466207227|FG001|Overall Study|Voluntary Withdrawal|3|||
129523661|NCT02203916|466207228|FG002|Overall Study|Voluntary Withdrawal|8|||
129523662|NCT02203916|466207226|FG000|Overall Study|Lack of Efficacy|3|||
129523663|NCT02203916|466207227|FG001|Overall Study|Lack of Efficacy|0|||
129523664|NCT02203916|466207228|FG002|Overall Study|Lack of Efficacy|0|||
129523665|NCT02203916|466207226|FG000|Overall Study|Reason Not Specified|0|||
129523666|NCT02203916|466207227|FG001|Overall Study|Reason Not Specified|2|||
129523667|NCT02203916|466207228|FG002|Overall Study|Reason Not Specified|1|||
129523668|NCT04043416|466207230|FG000|Washout|Change in health condition|0|||
129523669|NCT04043416|466207231|FG001|Washout|Change in health condition|1|||
129523670|NCT03236506|466207232|FG000|Overall Study|Death|1|||
129523671|NCT03236506|466207233|FG001|Overall Study|Death|1|||
129523672|NCT03236506|466207234|FG002|Overall Study|Death|1|||
129523673|NCT03236506|466207232|FG000|Overall Study|Withdrawal by Subject|3|||
129523674|NCT03236506|466207233|FG001|Overall Study|Withdrawal by Subject|3|||
129523675|NCT03236506|466207234|FG002|Overall Study|Withdrawal by Subject|4|||
129523676|NCT03236506|466207232|FG000|Overall Study|Did not initiate treatment|2|||
129523677|NCT03236506|466207233|FG001|Overall Study|Did not initiate treatment|1|||
129523678|NCT03236506|466207234|FG002|Overall Study|Did not initiate treatment|2|||
129523679|NCT00414973|466207235|FG000|Overall Study|Withdrawal by Subject|14|||
129523680|NCT00414973|466207236|FG001|Overall Study|Withdrawal by Subject|4|||
129523681|NCT00414973|466207237|FG002|Overall Study|Withdrawal by Subject|1|||
129523682|NCT00414973|466207238|FG003|Overall Study|Withdrawal by Subject|0|||
129523683|NCT00414973|466207235|FG000|Overall Study|Adverse Event|10|||
129523684|NCT00414973|466207236|FG001|Overall Study|Adverse Event|0|||
129523685|NCT00414973|466207237|FG002|Overall Study|Adverse Event|1|||
129523686|NCT00414973|466207238|FG003|Overall Study|Adverse Event|0|||
129523687|NCT00414973|466207235|FG000|Overall Study|Protocol Violation|3|||
129523688|NCT00414973|466207236|FG001|Overall Study|Protocol Violation|4|||
129523689|NCT00414973|466207237|FG002|Overall Study|Protocol Violation|0|||
129523690|NCT00414973|466207238|FG003|Overall Study|Protocol Violation|0|||
129523691|NCT00414973|466207235|FG000|Overall Study|Lost to Follow-up|0|||
129523692|NCT00414973|466207236|FG001|Overall Study|Lost to Follow-up|2|||
129523693|NCT00414973|466207237|FG002|Overall Study|Lost to Follow-up|0|||
129523694|NCT00414973|466207238|FG003|Overall Study|Lost to Follow-up|0|||
129523695|NCT00414973|466207235|FG000|Overall Study|Sponsor Decision|1|||
129523696|NCT00414973|466207236|FG001|Overall Study|Sponsor Decision|0|||
129523697|NCT00414973|466207237|FG002|Overall Study|Sponsor Decision|0|||
129523698|NCT00414973|466207238|FG003|Overall Study|Sponsor Decision|0|||
129523699|NCT00414973|466207235|FG000|Overall Study|Death|0|||
129523700|NCT00414973|466207236|FG001|Overall Study|Death|0|||
129523701|NCT00414973|466207237|FG002|Overall Study|Death|1|||
129523702|NCT00414973|466207238|FG003|Overall Study|Death|0|||
129523703|NCT00338806|466207245|FG000|Acute Phase|Withdrawal by Subject|0|||
129523704|NCT00338806|466207246|FG001|Acute Phase|Withdrawal by Subject|1|||
129523705|NCT00338806|466207245|FG000|Follow-up|Lost to Follow-up|1|||
129523706|NCT00338806|466207246|FG001|Follow-up|Lost to Follow-up|3|||
129523707|NCT00744991|466207247|FG000|Overall Study|Progressive Disease|11|||
129523708|NCT00744991|466207247|FG000|Overall Study|Withdrawal by Subject|8|||
129523709|NCT00744991|466207247|FG000|Overall Study|Physician Decision|3|||
129523710|NCT00744991|466207247|FG000|Overall Study|Adverse Event|2|||
129523711|NCT00744991|466207247|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
129523712|NCT00085644|466207253|FG000|Double-Blind Period|Adverse Event|5|||
129523713|NCT00085644|466207254|FG001|Double-Blind Period|Adverse Event|2|||
129523714|NCT00085644|466207255|FG002|Double-Blind Period|Adverse Event|0|||
129523715|NCT00085644|466207253|FG000|Double-Blind Period|Withdrawal by Subject|3|||
129523716|NCT00085644|466207254|FG001|Double-Blind Period|Withdrawal by Subject|0|||
129523717|NCT00085644|466207255|FG002|Double-Blind Period|Withdrawal by Subject|0|||
129523718|NCT00085644|466207253|FG000|Double-Blind Period|Lost to Follow-up|2|||
129523719|NCT00085644|466207254|FG001|Double-Blind Period|Lost to Follow-up|1|||
129523720|NCT00085644|466207255|FG002|Double-Blind Period|Lost to Follow-up|0|||
129523721|NCT00085644|466207253|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
129523722|NCT00085644|466207254|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
129523723|NCT00085644|466207255|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
129523724|NCT00085644|466207253|FG000|Double-Blind Period|Contemplating pregnancy|1|||
129523725|NCT00085644|466207254|FG001|Double-Blind Period|Contemplating pregnancy|0|||
129523726|NCT00085644|466207255|FG002|Double-Blind Period|Contemplating pregnancy|0|||
129523727|NCT00085644|466207253|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
129523728|NCT00085644|466207254|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
129523729|NCT00085644|466207255|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
129523730|NCT00085644|466207253|FG000|Open-Label Period|Adverse Event|0|||
129523731|NCT00085644|466207254|FG001|Open-Label Period|Adverse Event|0|||
129523732|NCT00085644|466207255|FG002|Open-Label Period|Adverse Event|38|||
129523733|NCT00085644|466207253|FG000|Open-Label Period|Withdrawal by Subject|0|||
129523734|NCT00085644|466207254|FG001|Open-Label Period|Withdrawal by Subject|0|||
129523735|NCT00085644|466207255|FG002|Open-Label Period|Withdrawal by Subject|29|||
129523736|NCT00085644|466207253|FG000|Open-Label Period|Lost to Follow-up|0|||
129523737|NCT00085644|466207254|FG001|Open-Label Period|Lost to Follow-up|0|||
129523738|NCT00085644|466207255|FG002|Open-Label Period|Lost to Follow-up|13|||
129523739|NCT00085644|466207253|FG000|Open-Label Period|Lack of Efficacy|0|||
129523740|NCT00085644|466207254|FG001|Open-Label Period|Lack of Efficacy|0|||
129523741|NCT00085644|466207255|FG002|Open-Label Period|Lack of Efficacy|15|||
129523742|NCT00085644|466207253|FG000|Open-Label Period|Pregnancy|0|||
129523743|NCT00085644|466207254|FG001|Open-Label Period|Pregnancy|0|||
129523744|NCT00085644|466207255|FG002|Open-Label Period|Pregnancy|3|||
129523745|NCT00085644|466207253|FG000|Open-Label Period|Contemplating pregnancy|0|||
129523746|NCT00085644|466207254|FG001|Open-Label Period|Contemplating pregnancy|0|||
129523747|NCT00085644|466207255|FG002|Open-Label Period|Contemplating pregnancy|3|||
129523748|NCT00085644|466207253|FG000|Open-Label Period|Protocol Violation|0|||
129523749|NCT00085644|466207254|FG001|Open-Label Period|Protocol Violation|0|||
129523750|NCT00085644|466207255|FG002|Open-Label Period|Protocol Violation|4|||
129523751|NCT00085644|466207253|FG000|Open-Label Period|Personal reason|0|||
129523752|NCT00085644|466207254|FG001|Open-Label Period|Personal reason|0|||
129523753|NCT00085644|466207255|FG002|Open-Label Period|Personal reason|4|||
129523754|NCT03330106|466207256|FG000|Part A|Withdrawal by Subject|1|||
129523755|NCT03330106|466207257|FG001|Part A|Withdrawal by Subject|1|||
129523756|NCT03330106|466207258|FG002|Part A|Withdrawal by Subject|0|||
129523757|NCT03330106|466207259|FG003|Part A|Withdrawal by Subject|0|||
129523758|NCT03330106|466207256|FG000|Part A|Death|2|||
129523759|NCT03330106|466207257|FG001|Part A|Death|1|||
129523760|NCT03330106|466207258|FG002|Part A|Death|0|||
129523761|NCT03330106|466207259|FG003|Part A|Death|0|||
129523762|NCT03330106|466207256|FG000|Part A|Adverse Event|0|||
129523763|NCT03330106|466207257|FG001|Part A|Adverse Event|1|||
129523764|NCT03330106|466207258|FG002|Part A|Adverse Event|0|||
129523765|NCT03330106|466207259|FG003|Part A|Adverse Event|0|||
129523766|NCT03330106|466207256|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
129523767|NCT03330106|466207257|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
129523768|NCT03330106|466207258|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
129523769|NCT03330106|466207259|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
129523770|NCT03330106|466207256|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
129523771|NCT03330106|466207257|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
129523772|NCT03330106|466207258|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
129523773|NCT03330106|466207259|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
129523774|NCT03330106|466207256|FG000|Part A|Progressive Disease|0|||
129523775|NCT03330106|466207257|FG001|Part A|Progressive Disease|1|||
129523776|NCT03330106|466207258|FG002|Part A|Progressive Disease|0|||
129523777|NCT03330106|466207259|FG003|Part A|Progressive Disease|0|||
129523778|NCT03330106|466207256|FG000|Part B|Lost to Follow-up|0|||
129523779|NCT03330106|466207257|FG001|Part B|Lost to Follow-up|0|||
129523780|NCT03330106|466207258|FG002|Part B|Lost to Follow-up|0|||
129523781|NCT03330106|466207259|FG003|Part B|Lost to Follow-up|1|||
129523782|NCT03330106|466207256|FG000|Part B|Withdrawal by Subject|0|||
129523783|NCT03330106|466207257|FG001|Part B|Withdrawal by Subject|0|||
129523784|NCT03330106|466207258|FG002|Part B|Withdrawal by Subject|4|||
129523785|NCT03330106|466207259|FG003|Part B|Withdrawal by Subject|0|||
129523786|NCT03330106|466207256|FG000|Part B|Death|0|||
129523787|NCT03330106|466207257|FG001|Part B|Death|0|||
129523788|NCT03330106|466207258|FG002|Part B|Death|2|||
129523789|NCT03330106|466207259|FG003|Part B|Death|0|||
129523790|NCT03330106|466207256|FG000|Part B|Clinical Progression|0|||
129523791|NCT03330106|466207257|FG001|Part B|Clinical Progression|0|||
129523792|NCT03330106|466207258|FG002|Part B|Clinical Progression|1|||
129523793|NCT03330106|466207259|FG003|Part B|Clinical Progression|1|||
129523794|NCT03330106|466207256|FG000|Part B|Symptomatic Deterioration|0|||
129523795|NCT03330106|466207257|FG001|Part B|Symptomatic Deterioration|0|||
129523796|NCT03330106|466207258|FG002|Part B|Symptomatic Deterioration|0|||
129523797|NCT03330106|466207259|FG003|Part B|Symptomatic Deterioration|1|||
129523798|NCT03330106|466207256|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
129523799|NCT03330106|466207257|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
129523800|NCT03330106|466207258|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
129523801|NCT03330106|466207259|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
129523802|NCT03330106|466207256|FG000|Part B|Progressive Disease|0|||
129523803|NCT03330106|466207257|FG001|Part B|Progressive Disease|0|||
129523804|NCT03330106|466207258|FG002|Part B|Progressive Disease|11|||
129523805|NCT03330106|466207259|FG003|Part B|Progressive Disease|4|||
129523806|NCT03198728|466207260|FG000|Overall Study|Adverse Event|10|||
129523807|NCT03198728|466207261|FG001|Overall Study|Adverse Event|5|||
129523808|NCT03198728|466207260|FG000|Overall Study|Lost to Follow-up|21|||
129523809|NCT03198728|466207261|FG001|Overall Study|Lost to Follow-up|7|||
129523810|NCT03198728|466207260|FG000|Overall Study|Physician Decision|7|||
129523811|NCT03198728|466207261|FG001|Overall Study|Physician Decision|2|||
129523812|NCT03198728|466207260|FG000|Overall Study|Withdrawal by Subject|14|||
129523813|NCT03198728|466207261|FG001|Overall Study|Withdrawal by Subject|10|||
129523814|NCT04051944|466207265|FG000|Overall Study|Study ending|1|||
129523815|NCT04051944|466207266|FG001|Overall Study|Study ending|1|||
129523816|NCT04051944|466207265|FG000|Overall Study|Early study termination by participant|1|||
129523817|NCT04051944|466207266|FG001|Overall Study|Early study termination by participant|0|||
129523818|NCT04051944|466207265|FG000|Overall Study|Withdrawal by Subject|2|||
129523819|NCT04051944|466207266|FG001|Overall Study|Withdrawal by Subject|2|||
129523820|NCT04051944|466207265|FG000|Overall Study|Lack of Efficacy|3|||
129523821|NCT04051944|466207266|FG001|Overall Study|Lack of Efficacy|0|||
129523822|NCT04051944|466207265|FG000|Overall Study|Adverse event, non- fatal|1|||
129523823|NCT04051944|466207266|FG001|Overall Study|Adverse event, non- fatal|1|||
129523824|NCT02139280|466207267|FG000|Overall Study|No longer eligible|2|||
129523825|NCT02139280|466207268|FG001|Overall Study|No longer eligible|0|||
129523826|NCT00736450|466207269|FG000|Overall Study|Not ABC gene eligible|19|||
129523827|NCT00736450|466207269|FG000|Overall Study|Withdrawal by Subject|5|||
129523828|NCT00736450|466207269|FG000|Overall Study|Physician Decision|1|||
129523829|NCT04157751|466207270|FG000|Overall Study|Withdrawal by Subject|12|||
129523830|NCT04157751|466207271|FG001|Overall Study|Withdrawal by Subject|17|||
129523831|NCT04157751|466207270|FG000|Overall Study|Lost to Follow-up|6|||
129523832|NCT04157751|466207271|FG001|Overall Study|Lost to Follow-up|2|||
129523833|NCT04157751|466207270|FG000|Overall Study|Adverse Event|34|||
129523834|NCT04157751|466207271|FG001|Overall Study|Adverse Event|23|||
129523835|NCT04157751|466207270|FG000|Overall Study|Not treated|1|||
129523836|NCT04157751|466207271|FG001|Overall Study|Not treated|5|||
129523837|NCT04157751|466207270|FG000|Overall Study|Other reason not stated above|10|||
129523838|NCT04157751|466207271|FG001|Overall Study|Other reason not stated above|10|||
129523839|NCT01947894|466207284|FG000|Overall Study|Other|3|||
129523840|NCT01947894|466207285|FG001|Overall Study|Other|4|||
129523841|NCT01947894|466207286|FG002|Overall Study|Other|3|||
129523842|NCT01947894|466207284|FG000|Overall Study|Withdrawal by Subject|12|||
129523843|NCT01947894|466207285|FG001|Overall Study|Withdrawal by Subject|4|||
129523844|NCT01947894|466207286|FG002|Overall Study|Withdrawal by Subject|1|||
129523845|NCT01947894|466207284|FG000|Overall Study|Death|12|||
129523846|NCT01947894|466207285|FG001|Overall Study|Death|1|||
129523847|NCT01947894|466207286|FG002|Overall Study|Death|0|||
129523848|NCT01947894|466207284|FG000|Overall Study|Physician Decision|2|||
129523849|NCT01947894|466207285|FG001|Overall Study|Physician Decision|0|||
129523850|NCT01947894|466207286|FG002|Overall Study|Physician Decision|0|||
129523851|NCT01947894|466207284|FG000|Overall Study|Adverse Event|5|||
129523852|NCT01947894|466207285|FG001|Overall Study|Adverse Event|1|||
129523853|NCT01947894|466207286|FG002|Overall Study|Adverse Event|0|||
129523854|NCT01947894|466207284|FG000|Overall Study|Switched to other growth hormone brand|53|||
129523855|NCT01947894|466207285|FG001|Overall Study|Switched to other growth hormone brand|8|||
129523856|NCT01947894|466207286|FG002|Overall Study|Switched to other growth hormone brand|23|||
129523857|NCT01302691|466207287|FG000|Overall Study|Adverse Event|2|||
129523858|NCT01302691|466207288|FG001|Overall Study|Adverse Event|0|||
129523859|NCT01302691|466207287|FG000|Overall Study|Death|0|||
129523860|NCT01302691|466207288|FG001|Overall Study|Death|1|||
129523861|NCT01302691|466207287|FG000|Overall Study|Lost to Follow-up|1|||
129523862|NCT01302691|466207288|FG001|Overall Study|Lost to Follow-up|0|||
129523863|NCT01302691|466207287|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
129523864|NCT01302691|466207288|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
129523865|NCT01302691|466207287|FG000|Overall Study|Physician Decision|0|||
129523866|NCT01302691|466207288|FG001|Overall Study|Physician Decision|1|||
129523867|NCT01302691|466207287|FG000|Overall Study|Protocol Violation|1|||
129523868|NCT01302691|466207288|FG001|Overall Study|Protocol Violation|0|||
129523869|NCT03446612|466207289|FG000|Overall Study|Protocol defined stopping criteria|0|||
129523870|NCT03446612|466207290|FG001|Overall Study|Protocol defined stopping criteria|1|||
129523871|NCT01437267|466207292|FG000|Overall Study|Withdrawal by Subject|0|||
129523872|NCT01437267|466207293|FG001|Overall Study|Withdrawal by Subject|0|||
129523873|NCT01437267|466207294|FG002|Overall Study|Withdrawal by Subject|0|||
129523874|NCT01437267|466207295|FG003|Overall Study|Withdrawal by Subject|1|||
129523875|NCT01437267|466207296|FG004|Overall Study|Withdrawal by Subject|0|||
129523876|NCT01437267|466207297|FG005|Overall Study|Withdrawal by Subject|0|||
129523877|NCT01437267|466207292|FG000|Overall Study|Protocol Violation|0|||
129523878|NCT01437267|466207293|FG001|Overall Study|Protocol Violation|1|||
129523879|NCT01437267|466207294|FG002|Overall Study|Protocol Violation|0|||
129523880|NCT01437267|466207295|FG003|Overall Study|Protocol Violation|0|||
129523881|NCT01437267|466207296|FG004|Overall Study|Protocol Violation|0|||
129523882|NCT01437267|466207297|FG005|Overall Study|Protocol Violation|0|||
129523883|NCT03934203|466207298|FG000|Overall Study|Adverse Event|0|||
129523884|NCT03934203|466207299|FG001|Overall Study|Adverse Event|0|||
129523885|NCT03934203|466207300|FG002|Overall Study|Adverse Event|1|||
129523886|NCT03934203|466207301|FG003|Overall Study|Adverse Event|0|||
129523887|NCT03934203|466207302|FG004|Overall Study|Adverse Event|1|||
129523888|NCT03934203|466207303|FG005|Overall Study|Adverse Event|0|||
129523889|NCT03934203|466207304|FG006|Overall Study|Adverse Event|2|||
129523890|NCT03934203|466207305|FG007|Overall Study|Adverse Event|0|||
129523891|NCT03934203|466207306|FG008|Overall Study|Adverse Event|0|||
129523892|NCT03934203|466207307|FG009|Overall Study|Adverse Event|0|||
129523893|NCT03934203|466207308|FG010|Overall Study|Adverse Event|0|||
129523894|NCT03934203|466207309|FG011|Overall Study|Adverse Event|0|||
129523895|NCT03934203|466207310|FG012|Overall Study|Adverse Event|0|||
129523896|NCT03934203|466207311|FG013|Overall Study|Adverse Event|1|||
129523897|NCT03934203|466207312|FG014|Overall Study|Adverse Event|0|||
129523898|NCT04445051|466207313|FG000|Overall Study|Adverse Event|0|||
129523899|NCT04445051|466207314|FG001|Overall Study|Adverse Event|0|||
129523900|NCT04445051|466207315|FG002|Overall Study|Adverse Event|1|||
129523901|NCT04445051|466207316|FG003|Overall Study|Adverse Event|0|||
129523902|NCT04445051|466207317|FG004|Overall Study|Adverse Event|0|||
129523903|NCT04445051|466207318|FG005|Overall Study|Adverse Event|0|||
129523904|NCT01624467|466207319|FG000|Overall Study|Withdrawal by Subject|2|||
129523905|NCT01624467|466207319|FG000|Overall Study|Lost to Follow-up|1|||
129523906|NCT01624467|466207319|FG000|Overall Study|Adverse Event|7|||
129523907|NCT01624467|466207319|FG000|Overall Study|Progressive Disease|19|||
129523908|NCT01624467|466207319|FG000|Overall Study|Per Sponsor Requirement|1|||
129523909|NCT01624467|466207319|FG000|Overall Study|Subject Withdrew from Treatment|1|||
129523910|NCT02201472|466207320|FG000|Overall Study|Lack of Efficacy|2|||
129523911|NCT00901394|466207325|FG000|Overall Study|Physician Decision|1|||
129523912|NCT00901394|466207326|FG001|Overall Study|Physician Decision|1|||
129523913|NCT00901394|466207327|FG002|Overall Study|Physician Decision|2|||
129523914|NCT03864627|466207330|FG000|Overall Study|Adverse Event|0|||
129523915|NCT03864627|466207331|FG001|Overall Study|Adverse Event|1|||
129523916|NCT03864627|466207330|FG000|Overall Study|Lack of Efficacy|0|||
129523917|NCT03864627|466207331|FG001|Overall Study|Lack of Efficacy|1|||
129523918|NCT03864627|466207330|FG000|Overall Study|Lost to Follow-up|0|||
129523919|NCT03864627|466207331|FG001|Overall Study|Lost to Follow-up|1|||
129523920|NCT03864627|466207330|FG000|Overall Study|Withdrawal by Subject|4|||
129523921|NCT03864627|466207331|FG001|Overall Study|Withdrawal by Subject|8|||
129523922|NCT03864627|466207330|FG000|Overall Study|Study terminated by sponsor|0|||
129523923|NCT03864627|466207331|FG001|Overall Study|Study terminated by sponsor|1|||
129523924|NCT01388491|466207333|FG000|Overall Study|Adverse Event|10|||
129523925|NCT01388491|466207334|FG001|Overall Study|Adverse Event|9|||
129523926|NCT01388491|466207333|FG000|Overall Study|Sponsor Request|9|||
129523927|NCT01388491|466207334|FG001|Overall Study|Sponsor Request|7|||
129523928|NCT01388491|466207333|FG000|Overall Study|Withdrawal by Subject|6|||
129523929|NCT01388491|466207334|FG001|Overall Study|Withdrawal by Subject|10|||
129523930|NCT01388491|466207333|FG000|Overall Study|Lost to Follow-up|4|||
129523931|NCT01388491|466207334|FG001|Overall Study|Lost to Follow-up|3|||
129523932|NCT01388491|466207333|FG000|Overall Study|Protocol Violation|2|||
129523933|NCT01388491|466207334|FG001|Overall Study|Protocol Violation|0|||
129523934|NCT01388491|466207333|FG000|Overall Study|Noncompliance|2|||
129523935|NCT01388491|466207334|FG001|Overall Study|Noncompliance|0|||
129523936|NCT01388491|466207333|FG000|Overall Study|Pregnancy|1|||
129523937|NCT01388491|466207334|FG001|Overall Study|Pregnancy|0|||
129523938|NCT00796224|466207340|FG000|Overall Study|Adverse Event|1|||
129523939|NCT00796224|466207341|FG001|Overall Study|Adverse Event|0|||
129523940|NCT00796224|466207340|FG000|Overall Study|Protocol Violation|0|||
129523941|NCT00796224|466207341|FG001|Overall Study|Protocol Violation|1|||
129523942|NCT02569398|466207342|FG000|Overall Study|Adverse Event|0|||
129523943|NCT02569398|466207343|FG001|Overall Study|Adverse Event|1|||
129523944|NCT02569398|466207344|FG002|Overall Study|Adverse Event|6|||
129523945|NCT02569398|466207342|FG000|Overall Study|Withdrawal by Subject|43|||
129523946|NCT02569398|466207343|FG001|Overall Study|Withdrawal by Subject|43|||
129523947|NCT02569398|466207344|FG002|Overall Study|Withdrawal by Subject|30|||
129523948|NCT02569398|466207342|FG000|Overall Study|Study terminated by sponsor|130|||
129523949|NCT02569398|466207343|FG001|Overall Study|Study terminated by sponsor|131|||
129523950|NCT02569398|466207344|FG002|Overall Study|Study terminated by sponsor|134|||
129523951|NCT02569398|466207342|FG000|Overall Study|Other|12|||
129523952|NCT02569398|466207343|FG001|Overall Study|Other|14|||
129523953|NCT02569398|466207344|FG002|Overall Study|Other|13|||
129523954|NCT02116361|466207347|FG000|Overall Study|Pregnancy|0|||
129523955|NCT02116361|466207348|FG001|Overall Study|Pregnancy|0|||
129523956|NCT02116361|466207349|FG002|Overall Study|Pregnancy|0|||
129523957|NCT02116361|466207350|FG003|Overall Study|Pregnancy|1|||
129523958|NCT02116361|466207347|FG000|Overall Study|Protocol Violation|1|||
129523959|NCT02116361|466207348|FG001|Overall Study|Protocol Violation|0|||
129523960|NCT02116361|466207349|FG002|Overall Study|Protocol Violation|0|||
129523961|NCT02116361|466207350|FG003|Overall Study|Protocol Violation|2|||
129523962|NCT02116361|466207347|FG000|Overall Study|Physician Decision|2|||
129523963|NCT02116361|466207348|FG001|Overall Study|Physician Decision|3|||
129523964|NCT02116361|466207349|FG002|Overall Study|Physician Decision|0|||
129523965|NCT02116361|466207350|FG003|Overall Study|Physician Decision|0|||
129523966|NCT02116361|466207347|FG000|Overall Study|Adverse Event|1|||
129523967|NCT02116361|466207348|FG001|Overall Study|Adverse Event|0|||
129523968|NCT02116361|466207349|FG002|Overall Study|Adverse Event|0|||
129523969|NCT02116361|466207350|FG003|Overall Study|Adverse Event|3|||
129523970|NCT02116361|466207347|FG000|Overall Study|Other Reasons|3|||
129523971|NCT02116361|466207348|FG001|Overall Study|Other Reasons|3|||
129523972|NCT02116361|466207349|FG002|Overall Study|Other Reasons|3|||
129523973|NCT02116361|466207350|FG003|Overall Study|Other Reasons|3|||
129523974|NCT02116361|466207347|FG000|Overall Study|Lack of Efficacy|5|||
129523975|NCT02116361|466207348|FG001|Overall Study|Lack of Efficacy|7|||
129523976|NCT02116361|466207349|FG002|Overall Study|Lack of Efficacy|4|||
129523977|NCT02116361|466207350|FG003|Overall Study|Lack of Efficacy|3|||
129523978|NCT02116361|466207347|FG000|Overall Study|Lost to Follow-up|4|||
129523979|NCT02116361|466207348|FG001|Overall Study|Lost to Follow-up|5|||
129523980|NCT02116361|466207349|FG002|Overall Study|Lost to Follow-up|7|||
129523981|NCT02116361|466207350|FG003|Overall Study|Lost to Follow-up|5|||
129523982|NCT02116361|466207347|FG000|Overall Study|Personal Reasons|6|||
129523983|NCT02116361|466207348|FG001|Overall Study|Personal Reasons|6|||
129523984|NCT02116361|466207349|FG002|Overall Study|Personal Reasons|4|||
129523985|NCT02116361|466207350|FG003|Overall Study|Personal Reasons|9|||
129523986|NCT02116361|466207347|FG000|Overall Study|Investigator Decision - Relapse|9|||
129523987|NCT02116361|466207348|FG001|Overall Study|Investigator Decision - Relapse|7|||
129523988|NCT02116361|466207349|FG002|Overall Study|Investigator Decision - Relapse|8|||
129523989|NCT02116361|466207350|FG003|Overall Study|Investigator Decision - Relapse|5|||
129523990|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
129523991|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
129523992|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
129523993|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
129523994|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
129523995|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
129523996|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
129523997|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
129523998|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
129523999|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
129524000|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
129524001|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
129524002|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
129524003|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129524004|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129524005|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
129524006|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
129524007|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
129524008|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
129524009|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
129524010|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
129524011|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
129524012|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
129524013|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
129524014|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
129524015|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
129524016|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
129524017|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
129524018|NCT03227224|466207351|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
129524019|NCT03227224|466207352|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
129524020|NCT03227224|466207353|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
129524021|NCT03227224|466207354|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
129524022|NCT03227224|466207351|FG000|Follow-up Phase (2 Weeks)|Other|4|||
129524023|NCT03227224|466207352|FG001|Follow-up Phase (2 Weeks)|Other|4|||
129524024|NCT03227224|466207353|FG002|Follow-up Phase (2 Weeks)|Other|6|||
129524025|NCT03227224|466207354|FG003|Follow-up Phase (2 Weeks)|Other|3|||
129524026|NCT02406027|466207355|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
129524027|NCT02406027|466207356|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
129524028|NCT02406027|466207357|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
129524029|NCT02406027|466207358|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
129524030|NCT02406027|466207359|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
129524031|NCT02406027|466207360|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
129524032|NCT02406027|466207361|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
129524033|NCT02406027|466207355|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
129524034|NCT02406027|466207356|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
129524035|NCT02406027|466207357|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
129524036|NCT02406027|466207358|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
129524037|NCT02406027|466207359|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
129524038|NCT02406027|466207360|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
129524039|NCT02406027|466207361|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
129524040|NCT02406027|466207355|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
129524041|NCT02406027|466207356|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
129524042|NCT02406027|466207357|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
129524043|NCT02406027|466207358|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
129524044|NCT02406027|466207359|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
129524045|NCT02406027|466207360|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
129524046|NCT02406027|466207361|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
129524047|NCT02406027|466207355|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
129524048|NCT02406027|466207356|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
129524049|NCT02406027|466207357|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
129524050|NCT02406027|466207358|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
129524051|NCT02406027|466207359|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
129524052|NCT02406027|466207360|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
129524053|NCT02406027|466207361|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
129524054|NCT02406027|466207355|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
129524055|NCT02406027|466207356|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
129524056|NCT02406027|466207357|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
129524057|NCT02406027|466207358|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
129524058|NCT02406027|466207359|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
129524059|NCT02406027|466207360|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
129524060|NCT02406027|466207361|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
129524061|NCT02406027|466207355|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
129538664|NCT00764465|466263486|FG003|Overall Study|Adverse Event|1|||
129524062|NCT02406027|466207356|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
129524063|NCT02406027|466207357|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
129524064|NCT02406027|466207358|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
129524065|NCT02406027|466207359|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
129524066|NCT02406027|466207360|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
129524067|NCT02406027|466207361|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
129524068|NCT02406027|466207355|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
129524069|NCT02406027|466207356|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
129524070|NCT02406027|466207357|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
129524071|NCT02406027|466207358|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
129524072|NCT02406027|466207359|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
129524073|NCT02406027|466207360|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
129524074|NCT02406027|466207361|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
129524075|NCT02406027|466207355|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
129524076|NCT02406027|466207356|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
129524077|NCT02406027|466207357|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
129524078|NCT02406027|466207358|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
129524079|NCT02406027|466207359|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
129524080|NCT02406027|466207360|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
129524081|NCT02406027|466207361|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
129524082|NCT02406027|466207355|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
129524083|NCT02406027|466207356|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
129524084|NCT02406027|466207357|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
129524085|NCT02406027|466207358|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
129524086|NCT02406027|466207359|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
129524087|NCT02406027|466207360|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
129524088|NCT02406027|466207361|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
129524089|NCT02406027|466207355|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
129524090|NCT02406027|466207356|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
129524091|NCT02406027|466207357|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
129524092|NCT02406027|466207358|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
129524093|NCT02406027|466207359|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
129524094|NCT02406027|466207360|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
129524095|NCT02406027|466207361|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
129524096|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
129524097|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
129524098|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
129524099|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
129524100|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Other|13|||
129524101|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
129524102|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
129524103|NCT02497287|466207362|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
129524104|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
129524105|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
129524106|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
129524107|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
129524108|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
129524109|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
129524110|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
129524111|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
129524112|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
129524113|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
129524114|NCT02497287|466207362|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
129524115|NCT02497287|466207362|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
129524116|NCT02497287|466207362|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
129524117|NCT02497287|466207362|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
129524118|NCT02497287|466207362|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
129524119|NCT02497287|466207362|FG000|Follow-up Phase (4 Week)|Other|1|||
129524120|NCT01226472|466207363|FG000|Overall Study|Progressive Disease|1|||
129524121|NCT00952419|466207364|FG000|Overall Study|Adverse Event|2|||
129524122|NCT00952419|466207365|FG001|Overall Study|Adverse Event|0|||
129524123|NCT00952419|466207366|FG002|Overall Study|Adverse Event|0|||
129524124|NCT00952419|466207364|FG000|Overall Study|Protocol Violation|3|||
129524125|NCT00952419|466207365|FG001|Overall Study|Protocol Violation|7|||
129524126|NCT00952419|466207366|FG002|Overall Study|Protocol Violation|0|||
129524127|NCT00952419|466207364|FG000|Overall Study|Withdrawal by Subject|1|||
129524128|NCT00952419|466207365|FG001|Overall Study|Withdrawal by Subject|3|||
129524129|NCT00952419|466207366|FG002|Overall Study|Withdrawal by Subject|0|||
129524130|NCT04888507|466208863|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
129524131|NCT00636155|466208864|FG000|Overall Study|Adverse Event|8|||
129524132|NCT00636155|466208864|FG000|Overall Study|Lack of Efficacy|1|||
129524133|NCT00636155|466208864|FG000|Overall Study|Withdrawal by Subject|3|||
129524134|NCT00636155|466208864|FG000|Overall Study|Stem cell transplant|1|||
129524135|NCT00636155|466208864|FG000|Overall Study|Physician Decision|5|||
129524136|NCT00400946|466208865|FG000|Overall Study|Ineligible|0|||
129524137|NCT00400946|466208866|FG001|Overall Study|Ineligible|0|||
129524138|NCT00400946|466208867|FG002|Overall Study|Ineligible|0|||
129524139|NCT00400946|466208868|FG003|Overall Study|Ineligible|5|||
129524140|NCT00400946|466208869|FG004|Overall Study|Ineligible|1|||
129524141|NCT00400946|466208865|FG000|Overall Study|Induction Failure|0|||
129524142|NCT00400946|466208866|FG001|Overall Study|Induction Failure|0|||
129524143|NCT00400946|466208867|FG002|Overall Study|Induction Failure|0|||
129524144|NCT00400946|466208868|FG003|Overall Study|Induction Failure|11|||
129524145|NCT00400946|466208869|FG004|Overall Study|Induction Failure|8|||
129524146|NCT00400946|466208865|FG000|Overall Study|Induction Death|0|||
129524147|NCT00400946|466208866|FG001|Overall Study|Induction Death|0|||
129524148|NCT00400946|466208867|FG002|Overall Study|Induction Death|0|||
129524149|NCT00400946|466208868|FG003|Overall Study|Induction Death|13|||
129524150|NCT00400946|466208869|FG004|Overall Study|Induction Death|3|||
129524151|NCT00400946|466208865|FG000|Overall Study|Lost to Follow-up|1|||
129524152|NCT00400946|466208866|FG001|Overall Study|Lost to Follow-up|1|||
129524153|NCT00400946|466208867|FG002|Overall Study|Lost to Follow-up|0|||
129524154|NCT00400946|466208868|FG003|Overall Study|Lost to Follow-up|0|||
129524155|NCT00400946|466208869|FG004|Overall Study|Lost to Follow-up|1|||
129524156|NCT00400946|466208865|FG000|Overall Study|Remission Death|1|||
129524157|NCT00400946|466208866|FG001|Overall Study|Remission Death|1|||
129524158|NCT00400946|466208867|FG002|Overall Study|Remission Death|0|||
129524159|NCT00400946|466208868|FG003|Overall Study|Remission Death|0|||
129524160|NCT00400946|466208869|FG004|Overall Study|Remission Death|1|||
129524161|NCT00400946|466208865|FG000|Overall Study|Relapse|9|||
129524162|NCT00400946|466208866|FG001|Overall Study|Relapse|2|||
129524163|NCT00400946|466208867|FG002|Overall Study|Relapse|1|||
129524164|NCT00400946|466208868|FG003|Overall Study|Relapse|1|||
129524165|NCT00400946|466208869|FG004|Overall Study|Relapse|5|||
129524166|NCT00400946|466208865|FG000|Overall Study|Transplant in CR1|0|||
129524167|NCT00400946|466208866|FG001|Overall Study|Transplant in CR1|0|||
129524168|NCT00400946|466208867|FG002|Overall Study|Transplant in CR1|0|||
129524169|NCT00400946|466208868|FG003|Overall Study|Transplant in CR1|10|||
129524170|NCT00400946|466208869|FG004|Overall Study|Transplant in CR1|1|||
129524171|NCT00400946|466208865|FG000|Overall Study|Withdrawal by Subject|2|||
129524172|NCT00400946|466208866|FG001|Overall Study|Withdrawal by Subject|5|||
129524173|NCT00400946|466208867|FG002|Overall Study|Withdrawal by Subject|1|||
129524174|NCT00400946|466208868|FG003|Overall Study|Withdrawal by Subject|5|||
129524175|NCT00400946|466208869|FG004|Overall Study|Withdrawal by Subject|8|||
129524176|NCT00400946|466208865|FG000|Overall Study|Clinical|1|||
129524177|NCT00400946|466208866|FG001|Overall Study|Clinical|2|||
129524178|NCT00400946|466208867|FG002|Overall Study|Clinical|0|||
129524179|NCT00400946|466208868|FG003|Overall Study|Clinical|2|||
129524180|NCT00400946|466208869|FG004|Overall Study|Clinical|9|||
129524181|NCT00400946|466208865|FG000|Overall Study|Other|0|||
129524182|NCT00400946|466208866|FG001|Overall Study|Other|0|||
129524183|NCT00400946|466208867|FG002|Overall Study|Other|0|||
129524184|NCT00400946|466208868|FG003|Overall Study|Other|0|||
129524185|NCT00400946|466208869|FG004|Overall Study|Other|1|||
129524186|NCT05643170|466208870|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
129524187|NCT05643170|466208870|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
129524188|NCT01432756|466208871|FG000|Overall Study|Lost to Follow-up|1|||
129524189|NCT01432756|466208872|FG001|Overall Study|Lost to Follow-up|0|||
129524190|NCT01432756|466208873|FG002|Overall Study|Lost to Follow-up|2|||
129524191|NCT01432756|466208874|FG003|Overall Study|Lost to Follow-up|1|||
129524192|NCT05426460|466208884|FG000|Overall Study|Protocol Violation|1|||
129524193|NCT05426460|466208885|FG001|Overall Study|Protocol Violation|1|||
129524194|NCT05426460|466208886|FG002|Overall Study|Protocol Violation|1|||
129524195|NCT05426460|466208887|FG003|Overall Study|Protocol Violation|0|||
129524196|NCT01431521|466208891|FG000|Overall Study|Withdrawal by Subject|0|||
129524197|NCT01431521|466208892|FG001|Overall Study|Withdrawal by Subject|0|||
129524198|NCT01431521|466208893|FG002|Overall Study|Withdrawal by Subject|1|||
129524199|NCT01431521|466208894|FG003|Overall Study|Withdrawal by Subject|0|||
129524200|NCT01320033|466208895|FG000|Overall Study|Lack of Efficacy|0|||
129524201|NCT01320033|466208896|FG001|Overall Study|Lack of Efficacy|0|||
129524202|NCT01320033|466208897|FG002|Overall Study|Lack of Efficacy|1|||
129524203|NCT01320033|466208895|FG000|Overall Study|Adverse Event|9|||
129524204|NCT01320033|466208896|FG001|Overall Study|Adverse Event|7|||
129524205|NCT01320033|466208897|FG002|Overall Study|Adverse Event|8|||
129524206|NCT01320033|466208895|FG000|Overall Study|Withdrawal by Subject|22|||
129524207|NCT01320033|466208896|FG001|Overall Study|Withdrawal by Subject|23|||
129524208|NCT01320033|466208897|FG002|Overall Study|Withdrawal by Subject|23|||
129524209|NCT01320033|466208895|FG000|Overall Study|Protocol Violation|3|||
129524210|NCT01320033|466208896|FG001|Overall Study|Protocol Violation|5|||
129524211|NCT01320033|466208897|FG002|Overall Study|Protocol Violation|3|||
129524212|NCT01320033|466208895|FG000|Overall Study|Lost to Follow-up|22|||
129524213|NCT01320033|466208896|FG001|Overall Study|Lost to Follow-up|26|||
129524214|NCT01320033|466208897|FG002|Overall Study|Lost to Follow-up|17|||
129524215|NCT01320033|466208895|FG000|Overall Study|Other|2|||
129524216|NCT01320033|466208896|FG001|Overall Study|Other|3|||
129524217|NCT01320033|466208897|FG002|Overall Study|Other|1|||
129524218|NCT00963469|466208898|FG000|Overall Study|Adverse Event|15|||
129524219|NCT00963469|466208899|FG001|Overall Study|Adverse Event|11|||
129524220|NCT00963469|466208900|FG002|Overall Study|Adverse Event|1|||
129524221|NCT00963469|466208898|FG000|Overall Study|Lack of Efficacy|10|||
129524222|NCT00963469|466208899|FG001|Overall Study|Lack of Efficacy|7|||
129524223|NCT00963469|466208900|FG002|Overall Study|Lack of Efficacy|2|||
129524224|NCT00963469|466208898|FG000|Overall Study|Lost to Follow-up|1|||
129524225|NCT00963469|466208899|FG001|Overall Study|Lost to Follow-up|1|||
129524226|NCT00963469|466208900|FG002|Overall Study|Lost to Follow-up|0|||
129524227|NCT00963469|466208898|FG000|Overall Study|Protocol Violation|5|||
129524228|NCT00963469|466208899|FG001|Overall Study|Protocol Violation|5|||
129524229|NCT00963469|466208900|FG002|Overall Study|Protocol Violation|3|||
129524230|NCT00963469|466208898|FG000|Overall Study|Withdrawal by Subject|4|||
129524231|NCT00963469|466208899|FG001|Overall Study|Withdrawal by Subject|1|||
129524232|NCT00963469|466208900|FG002|Overall Study|Withdrawal by Subject|1|||
129524233|NCT00963469|466208898|FG000|Overall Study|Pre-randomization Adverse Event|1|||
129524234|NCT00963469|466208899|FG001|Overall Study|Pre-randomization Adverse Event|2|||
129524235|NCT00963469|466208900|FG002|Overall Study|Pre-randomization Adverse Event|0|||
129524236|NCT00963469|466208898|FG000|Overall Study|Moved|1|||
129524237|NCT00963469|466208899|FG001|Overall Study|Moved|0|||
129524238|NCT00963469|466208900|FG002|Overall Study|Moved|0|||
129524239|NCT00963469|466208898|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
129524240|NCT00963469|466208899|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
129524241|NCT00963469|466208900|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
129524242|NCT04960202|466208919|FG000|Overall Study|Other|5|||
129524243|NCT04960202|466208920|FG001|Overall Study|Other|0|||
129524244|NCT04960202|466208919|FG000|Overall Study|Withdrawal by Subject|37|||
129524245|NCT04960202|466208920|FG001|Overall Study|Withdrawal by Subject|43|||
129524246|NCT04960202|466208919|FG000|Overall Study|Lost to Follow-up|20|||
129524247|NCT04960202|466208920|FG001|Overall Study|Lost to Follow-up|16|||
129524248|NCT04960202|466208919|FG000|Overall Study|Death|0|||
129524249|NCT04960202|466208920|FG001|Overall Study|Death|15|||
129524250|NCT03558828|466208924|FG000|Overall Study|Lost to Follow-up|4|||
129524251|NCT03558828|466208925|FG001|Overall Study|Lost to Follow-up|3|||
129524252|NCT03558828|466208926|FG002|Overall Study|Lost to Follow-up|3|||
129524253|NCT03558828|466208927|FG003|Overall Study|Lost to Follow-up|5|||
129524254|NCT03558828|466208928|FG004|Overall Study|Lost to Follow-up|2|||
129524255|NCT03558828|466208929|FG005|Overall Study|Lost to Follow-up|3|||
129524256|NCT03558828|466208924|FG000|Overall Study|dropped before the intervention|1|||
129524257|NCT03558828|466208925|FG001|Overall Study|dropped before the intervention|1|||
129524258|NCT03558828|466208926|FG002|Overall Study|dropped before the intervention|0|||
129524259|NCT03558828|466208927|FG003|Overall Study|dropped before the intervention|0|||
129524260|NCT03558828|466208928|FG004|Overall Study|dropped before the intervention|0|||
129524261|NCT03558828|466208929|FG005|Overall Study|dropped before the intervention|0|||
129524262|NCT00378534|466208930|FG000|Overall Study|Participants did not receive transplant|3|||
129524263|NCT00378534|466208931|FG001|Overall Study|Participants did not receive transplant|0|||
129524264|NCT03671148|466208937|FG000|Overall Study|Adverse Event|3|||
129524265|NCT03671148|466208938|FG001|Overall Study|Adverse Event|2|||
129524266|NCT03671148|466208937|FG000|Overall Study|Withdrawal by Subject|8|||
129524267|NCT03671148|466208938|FG001|Overall Study|Withdrawal by Subject|2|||
129524268|NCT03671148|466208937|FG000|Overall Study|Lost to Follow-up|1|||
129524269|NCT03671148|466208938|FG001|Overall Study|Lost to Follow-up|2|||
129524270|NCT03671148|466208937|FG000|Overall Study|Lack of Efficacy|7|||
129524271|NCT03671148|466208938|FG001|Overall Study|Lack of Efficacy|2|||
129524272|NCT03671148|466208937|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
129524273|NCT03671148|466208938|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
129524274|NCT03671148|466208937|FG000|Overall Study|Other|1|||
129524275|NCT03671148|466208938|FG001|Overall Study|Other|0|||
129524276|NCT03671148|466208937|FG000|Overall Study|Incomplete Randomization Visit|1|||
129524277|NCT03671148|466208938|FG001|Overall Study|Incomplete Randomization Visit|0|||
129524278|NCT00673816|466208941|FG000|Overall Study|Adverse Event|1|||
129524279|NCT00673816|466208941|FG000|Overall Study|Withdrawal by Subject|1|||
129524280|NCT01852591|466208943|FG000|Overall Study|Withdrawal by Subject|2|||
129524281|NCT01852591|466208943|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
129524282|NCT03774875|466208944|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
129524283|NCT03774875|466208945|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
129524284|NCT03774875|466208944|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
129524285|NCT03774875|466208945|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
129524286|NCT03774875|466208944|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
129538665|NCT00764465|466263487|FG004|Overall Study|Adverse Event|1|||
129524287|NCT03774875|466208945|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
129524288|NCT03774875|466208944|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
129524289|NCT03774875|466208945|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
129524290|NCT03774875|466208944|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
129524291|NCT03774875|466208945|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
129524292|NCT03774875|466208944|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
129524293|NCT03774875|466208945|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
129524294|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
129524295|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
129524296|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
129524297|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
129524298|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
129524299|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
129524300|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
129524301|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
129524302|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
129524303|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
129524304|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
129524305|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
129524306|NCT03774875|466208944|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
129524307|NCT03774875|466208945|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
129524308|NCT03149029|466208946|FG000|Overall Study|Adverse Event|2|||
129524309|NCT03149029|466208947|FG001|Overall Study|Adverse Event|0|||
129524310|NCT04088331|466208949|FG000|Overall Study|Lost to Follow-up|3|||
129524311|NCT04088331|466208949|FG000|Overall Study|Withdrawal by Subject|7|||
129524312|NCT04088331|466208949|FG000|Overall Study|Adverse Event|4|||
129524313|NCT03233308|466208954|FG000|Overall Study|Adverse Event|1|||
129524314|NCT03233308|466208954|FG000|Overall Study|Protocol Violation|1|||
129524315|NCT00976963|466208961|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
129524316|NCT00976963|466208962|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
129524317|NCT00976963|466208961|FG000|Overall Study|administrative error|1|||
129524318|NCT00976963|466208962|FG001|Overall Study|administrative error|0|||
129524319|NCT00976963|466208961|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
129524320|NCT00976963|466208962|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
129524321|NCT02756845|466208965|FG000|Overall Study|Death|12|||
129524322|NCT02756845|466208966|FG001|Overall Study|Death|2|||
129524323|NCT02756845|466208965|FG000|Overall Study|Withdrawal by Subject|1|||
129524324|NCT02756845|466208966|FG001|Overall Study|Withdrawal by Subject|0|||
129524325|NCT01688999|466208969|FG000|Overall Study|Withdrawal by Subject|5|||
129524326|NCT01688999|466208970|FG001|Overall Study|Withdrawal by Subject|1|||
129524327|NCT01688999|466208971|FG002|Overall Study|Withdrawal by Subject|1|||
129524328|NCT01688999|466208969|FG000|Overall Study|Adverse Event|2|||
129524329|NCT01688999|466208970|FG001|Overall Study|Adverse Event|0|||
129524330|NCT01688999|466208971|FG002|Overall Study|Adverse Event|2|||
129524331|NCT01688999|466208969|FG000|Overall Study|Ineligible/Not treated|1|||
129524332|NCT01688999|466208970|FG001|Overall Study|Ineligible/Not treated|0|||
129524333|NCT01688999|466208971|FG002|Overall Study|Ineligible/Not treated|0|||
129524334|NCT02768103|466208972|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
129524335|NCT03369704|466208991|FG000|Treatment Epoch|technical problems|1|||
129524336|NCT03369704|466208992|FG001|Treatment Epoch|technical problems|0|||
129524337|NCT03369704|466208991|FG000|Treatment Epoch|Protocol Violation|1|||
129524338|NCT03369704|466208992|FG001|Treatment Epoch|Protocol Violation|0|||
129524339|NCT03369704|466208991|FG000|Treatment Epoch|Lost to Follow-up|0|||
129524340|NCT03369704|466208992|FG001|Treatment Epoch|Lost to Follow-up|1|||
129524341|NCT03369704|466208991|FG000|Treatment Epoch|Lack of Efficacy|0|||
129524342|NCT03369704|466208992|FG001|Treatment Epoch|Lack of Efficacy|2|||
129524343|NCT03369704|466208991|FG000|Treatment Epoch|Adverse Event|2|||
129524344|NCT03369704|466208992|FG001|Treatment Epoch|Adverse Event|0|||
129524345|NCT03369704|466208991|FG000|Follow-up Epoch|Lost to Follow-up|1|||
129524346|NCT03369704|466208992|FG001|Follow-up Epoch|Lost to Follow-up|0|||
129524347|NCT02148952|466208996|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
129524348|NCT02148952|466208997|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
129524349|NCT02148952|466208996|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
129524350|NCT02148952|466208997|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
129524351|NCT02148952|466208996|FG000|Follow-Up|Lost to Follow-up|219|||
129524352|NCT02148952|466208997|FG001|Follow-Up|Lost to Follow-up|231|||
129524353|NCT02148952|466208996|FG000|Follow-Up|Withdrawal by Subject|46|||
129524354|NCT02148952|466208997|FG001|Follow-Up|Withdrawal by Subject|48|||
129524355|NCT01025232|466208998|FG000|Overall Study|Study drug no longer available|3|||
129524356|NCT01025232|466208999|FG001|Overall Study|Study drug no longer available|6|||
129524357|NCT02324049|466209001|FG000|Part C|Study terminated|11|||
129524358|NCT00423592|466209003|FG000|Overall Study|Adverse Event (through Week 12)|2|||
129524359|NCT00423592|466209003|FG000|Overall Study|Adverse Event (post Week 12)|5|||
129524360|NCT00333970|466209006|FG000|Overall Study|Withdrawal by Subject|13|||
129524361|NCT00333970|466209007|FG001|Overall Study|Withdrawal by Subject|7|||
129524362|NCT00608842|466209008|FG000|Overall Study|Participant's Request|0|||
129524363|NCT00608842|466209009|FG001|Overall Study|Participant's Request|1|||
129524364|NCT00608842|466209010|FG002|Overall Study|Participant's Request|2|||
129524365|NCT00608842|466209011|FG003|Overall Study|Participant's Request|1|||
129524366|NCT00608842|466209008|FG000|Overall Study|Lost to Follow-up|1|||
129524367|NCT00608842|466209009|FG001|Overall Study|Lost to Follow-up|0|||
129524368|NCT00608842|466209010|FG002|Overall Study|Lost to Follow-up|0|||
129524369|NCT00608842|466209011|FG003|Overall Study|Lost to Follow-up|0|||
129524370|NCT03924427|466209013|FG000|Overall Study|Adverse Event|4|||
129524371|NCT03924427|466209013|FG000|Overall Study|Lack of Efficacy|1|||
129524372|NCT03924427|466209013|FG000|Overall Study|Withdrawal by Subject|1|||
129524373|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
129524374|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
129524375|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
129524376|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
129524377|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
129524378|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
129524379|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
129524380|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
129524381|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
129524382|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
129524383|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
129524384|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
129524385|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
129524386|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
129524387|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
129524388|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
129524389|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
129524390|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
129524391|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
129524392|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
129524393|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
129524394|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
129524395|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
129524396|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
129524397|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
129524398|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
129524399|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
129524400|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
129524401|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
129524402|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
129524403|NCT04757376|466209014|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
129524404|NCT04757376|466209015|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
129524405|NCT04757376|466209016|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
129524406|NCT04757376|466209017|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
129524407|NCT04757376|466209018|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
129524408|NCT04757376|466209014|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
129524409|NCT04757376|466209015|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
129524410|NCT04757376|466209016|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
129538666|NCT00764465|466263488|FG005|Overall Study|Adverse Event|1|||
129524411|NCT04757376|466209017|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
129524412|NCT04757376|466209018|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
129524413|NCT01307046|466209019|FG000|Overall Study|Adverse Event|3|||
129524414|NCT01307046|466209020|FG001|Overall Study|Adverse Event|3|||
129524415|NCT01307046|466209019|FG000|Overall Study|Lack of Efficacy|0|||
129524416|NCT01307046|466209020|FG001|Overall Study|Lack of Efficacy|2|||
129524417|NCT01307046|466209019|FG000|Overall Study|Physician Decision|2|||
129524418|NCT01307046|466209020|FG001|Overall Study|Physician Decision|0|||
129524419|NCT01307046|466209019|FG000|Overall Study|Withdrawal by Subject|1|||
129524420|NCT01307046|466209020|FG001|Overall Study|Withdrawal by Subject|1|||
129524421|NCT01307046|466209019|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
129524422|NCT01307046|466209020|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
129524423|NCT01307046|466209019|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
129524424|NCT01307046|466209020|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
129524425|NCT01365091|466209023|FG000|Period 1|Adverse Event|1|||
129524426|NCT01365091|466209024|FG001|Period 1|Adverse Event|0|||
129524427|NCT01365091|466209025|FG002|Period 1|Adverse Event|2|||
129524428|NCT01365091|466209026|FG003|Period 1|Adverse Event|3|||
129524429|NCT01365091|466209023|FG000|Period 1|Positive test result for drugs of abuse|1|||
129524430|NCT01365091|466209024|FG001|Period 1|Positive test result for drugs of abuse|0|||
129524431|NCT01365091|466209025|FG002|Period 1|Positive test result for drugs of abuse|0|||
129524432|NCT01365091|466209026|FG003|Period 1|Positive test result for drugs of abuse|0|||
129524433|NCT01365091|466209023|FG000|Period 1|No longer met study criteria|0|||
129524434|NCT01365091|466209024|FG001|Period 1|No longer met study criteria|1|||
129524435|NCT01365091|466209025|FG002|Period 1|No longer met study criteria|0|||
129524436|NCT01365091|466209026|FG003|Period 1|No longer met study criteria|0|||
129524437|NCT01365091|466209023|FG000|Period 1|Withdrawal by Subject|0|||
129524438|NCT01365091|466209024|FG001|Period 1|Withdrawal by Subject|1|||
129524439|NCT01365091|466209025|FG002|Period 1|Withdrawal by Subject|0|||
129524440|NCT01365091|466209026|FG003|Period 1|Withdrawal by Subject|0|||
129524441|NCT01365091|466209023|FG000|Period 1|Personal reasons|0|||
129524442|NCT01365091|466209024|FG001|Period 1|Personal reasons|0|||
129524443|NCT01365091|466209025|FG002|Period 1|Personal reasons|1|||
129524444|NCT01365091|466209026|FG003|Period 1|Personal reasons|0|||
129524445|NCT01365091|466209023|FG000|Period 2|Withdrawal by Subject|1|||
129524446|NCT01365091|466209024|FG001|Period 2|Withdrawal by Subject|0|||
129524447|NCT01365091|466209025|FG002|Period 2|Withdrawal by Subject|0|||
129524448|NCT01365091|466209026|FG003|Period 2|Withdrawal by Subject|0|||
129524449|NCT01365091|466209023|FG000|Period 2|Adverse Event|0|||
129524450|NCT01365091|466209024|FG001|Period 2|Adverse Event|0|||
129524451|NCT01365091|466209025|FG002|Period 2|Adverse Event|1|||
129524452|NCT01365091|466209026|FG003|Period 2|Adverse Event|0|||
129524453|NCT02358863|466211090|FG000|Overall Study|Physician Decision|3|||
129524454|NCT02531633|466211093|FG000|Part A (52 Weeks)|Sponsor request|24|||
129524455|NCT02531633|466211094|FG001|Part A (52 Weeks)|Sponsor request|24|||
129524456|NCT02531633|466211095|FG002|Part A (52 Weeks)|Sponsor request|18|||
129524457|NCT02531633|466211096|FG003|Part A (52 Weeks)|Sponsor request|18|||
129524458|NCT02531633|466211097|FG004|Part A (52 Weeks)|Sponsor request|19|||
129524459|NCT02531633|466211098|FG005|Part A (52 Weeks)|Sponsor request|0|||
129524460|NCT02531633|466211099|FG006|Part A (52 Weeks)|Sponsor request|0|||
129524461|NCT02531633|466211100|FG007|Part A (52 Weeks)|Sponsor request|0|||
129524462|NCT02531633|466211101|FG008|Part A (52 Weeks)|Sponsor request|0|||
129524463|NCT02531633|466211102|FG009|Part A (52 Weeks)|Sponsor request|0|||
129524464|NCT02531633|466211093|FG000|Part A (52 Weeks)|Protocol Violation|1|||
129524465|NCT02531633|466211094|FG001|Part A (52 Weeks)|Protocol Violation|0|||
129524466|NCT02531633|466211095|FG002|Part A (52 Weeks)|Protocol Violation|0|||
129524467|NCT02531633|466211096|FG003|Part A (52 Weeks)|Protocol Violation|0|||
129524468|NCT02531633|466211097|FG004|Part A (52 Weeks)|Protocol Violation|0|||
129524469|NCT02531633|466211098|FG005|Part A (52 Weeks)|Protocol Violation|0|||
129524470|NCT02531633|466211099|FG006|Part A (52 Weeks)|Protocol Violation|0|||
129524471|NCT02531633|466211100|FG007|Part A (52 Weeks)|Protocol Violation|0|||
129524472|NCT02531633|466211101|FG008|Part A (52 Weeks)|Protocol Violation|0|||
129524473|NCT02531633|466211102|FG009|Part A (52 Weeks)|Protocol Violation|0|||
129524474|NCT02531633|466211093|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
129524475|NCT02531633|466211094|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
129524476|NCT02531633|466211095|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
129524477|NCT02531633|466211096|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
129524478|NCT02531633|466211097|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
129524479|NCT02531633|466211098|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
129524480|NCT02531633|466211099|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
129524481|NCT02531633|466211100|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
129524482|NCT02531633|466211101|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
129524483|NCT02531633|466211102|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
129524484|NCT02531633|466211093|FG000|Part A (52 Weeks)|Physician Decision|1|||
129524485|NCT02531633|466211094|FG001|Part A (52 Weeks)|Physician Decision|4|||
129524486|NCT02531633|466211095|FG002|Part A (52 Weeks)|Physician Decision|3|||
129524487|NCT02531633|466211096|FG003|Part A (52 Weeks)|Physician Decision|1|||
129524488|NCT02531633|466211097|FG004|Part A (52 Weeks)|Physician Decision|0|||
129524489|NCT02531633|466211098|FG005|Part A (52 Weeks)|Physician Decision|0|||
129524490|NCT02531633|466211099|FG006|Part A (52 Weeks)|Physician Decision|0|||
129524491|NCT02531633|466211100|FG007|Part A (52 Weeks)|Physician Decision|0|||
129524492|NCT02531633|466211101|FG008|Part A (52 Weeks)|Physician Decision|0|||
129524493|NCT02531633|466211102|FG009|Part A (52 Weeks)|Physician Decision|0|||
129524494|NCT02531633|466211093|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
129524495|NCT02531633|466211094|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
129524496|NCT02531633|466211095|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
129524497|NCT02531633|466211096|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
129524498|NCT02531633|466211097|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
129524499|NCT02531633|466211098|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
129524500|NCT02531633|466211099|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
129524501|NCT02531633|466211100|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
129524502|NCT02531633|466211101|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
129524503|NCT02531633|466211102|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
129524504|NCT02531633|466211093|FG000|Part A (52 Weeks)|Other|2|||
129524505|NCT02531633|466211094|FG001|Part A (52 Weeks)|Other|0|||
129524506|NCT02531633|466211095|FG002|Part A (52 Weeks)|Other|0|||
129524507|NCT02531633|466211096|FG003|Part A (52 Weeks)|Other|0|||
129524508|NCT02531633|466211097|FG004|Part A (52 Weeks)|Other|0|||
129524509|NCT02531633|466211098|FG005|Part A (52 Weeks)|Other|0|||
129524510|NCT02531633|466211099|FG006|Part A (52 Weeks)|Other|0|||
129524511|NCT02531633|466211100|FG007|Part A (52 Weeks)|Other|0|||
129524512|NCT02531633|466211101|FG008|Part A (52 Weeks)|Other|0|||
129524513|NCT02531633|466211102|FG009|Part A (52 Weeks)|Other|0|||
129524514|NCT02531633|466211093|FG000|Part B (104 Weeks)|Sponsor request|0|||
129524515|NCT02531633|466211094|FG001|Part B (104 Weeks)|Sponsor request|0|||
129524516|NCT02531633|466211095|FG002|Part B (104 Weeks)|Sponsor request|0|||
129524517|NCT02531633|466211096|FG003|Part B (104 Weeks)|Sponsor request|0|||
129524518|NCT02531633|466211097|FG004|Part B (104 Weeks)|Sponsor request|0|||
129524519|NCT02531633|466211098|FG005|Part B (104 Weeks)|Sponsor request|8|||
129524520|NCT02531633|466211099|FG006|Part B (104 Weeks)|Sponsor request|5|||
129524521|NCT02531633|466211100|FG007|Part B (104 Weeks)|Sponsor request|3|||
129524522|NCT02531633|466211101|FG008|Part B (104 Weeks)|Sponsor request|5|||
129524523|NCT02531633|466211102|FG009|Part B (104 Weeks)|Sponsor request|4|||
129524524|NCT02531633|466211093|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
129524525|NCT02531633|466211094|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
129524526|NCT02531633|466211095|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
129524527|NCT02531633|466211096|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
129524528|NCT02531633|466211097|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
129524529|NCT02531633|466211098|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
129524530|NCT02531633|466211099|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
129524531|NCT02531633|466211100|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
129524532|NCT02531633|466211101|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
129524533|NCT02531633|466211102|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
129524534|NCT04969900|466211103|FG000|Overall Study|Physician Decision|1|||
129524535|NCT04969900|466211104|FG001|Overall Study|Physician Decision|1|||
129524536|NCT04969900|466211103|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
129524537|NCT04969900|466211104|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
129524538|NCT02155712|466211108|FG000|Overall Study|Death|12|||
129524539|NCT02155712|466211109|FG001|Overall Study|Death|0|||
129524540|NCT02155712|466211108|FG000|Overall Study|Lost to Follow-up|37|||
129524541|NCT02155712|466211109|FG001|Overall Study|Lost to Follow-up|22|||
129524542|NCT02155712|466211108|FG000|Overall Study|Revision of device|4|||
129524543|NCT02155712|466211109|FG001|Overall Study|Revision of device|3|||
129524544|NCT02155712|466211108|FG000|Overall Study|Withdrawal by Subject|39|||
129524545|NCT02155712|466211109|FG001|Overall Study|Withdrawal by Subject|21|||
129524546|NCT02155712|466211108|FG000|Overall Study|Site termination|77|||
129524547|NCT02155712|466211109|FG001|Overall Study|Site termination|19|||
129524548|NCT02155712|466211108|FG000|Overall Study|Sponsor terminated study early|150|||
129524549|NCT02155712|466211109|FG001|Overall Study|Sponsor terminated study early|0|||
129524550|NCT02155712|466211108|FG000|Overall Study|Missed final 5-year protocol visit|0|||
129524551|NCT02155712|466211109|FG001|Overall Study|Missed final 5-year protocol visit|32|||
129524552|NCT02155712|466211108|FG000|Overall Study|Censored because surgery cancelled|6|||
129524553|NCT02155712|466211109|FG001|Overall Study|Censored because surgery cancelled|10|||
129524554|NCT02155712|466211108|FG000|Overall Study|Censored because study device was not implanted|61|||
129524555|NCT02155712|466211109|FG001|Overall Study|Censored because study device was not implanted|66|||
129524556|NCT02155712|466211108|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
129524557|NCT02155712|466211109|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
129524558|NCT05016037|466211110|FG000|Overall Study|Lost to Follow-up|2|||
129524559|NCT03797144|466211118|FG000|Enrollment|Protocol Violation|4|||
129524560|NCT03797144|466211119|FG001|Enrollment|Protocol Violation|1|||
129524561|NCT03797144|466211118|FG000|Surgery|Protocol Violation|1|||
129524562|NCT03797144|466211119|FG001|Surgery|Protocol Violation|0|||
129524563|NCT03797144|466211118|FG000|3 Month|Early termination cut-off date|2|||
129524564|NCT03797144|466211119|FG001|3 Month|Early termination cut-off date|0|||
129524565|NCT03797144|466211118|FG000|12 Month|Early termination cut-off date|8|||
129524566|NCT03797144|466211119|FG001|12 Month|Early termination cut-off date|9|||
129524567|NCT03797144|466211118|FG000|24 Month|Early termination cut-off date|1|||
129524568|NCT03797144|466211119|FG001|24 Month|Early termination cut-off date|1|||
129524569|NCT00606229|466211120|FG000|Overall Study|Adverse Event|11|||
129524570|NCT00606229|466211120|FG000|Overall Study|Lack of Efficacy|1|||
129524571|NCT00606229|466211120|FG000|Overall Study|Withdrawal by Subject|4|||
129524572|NCT00606229|466211120|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
129524573|NCT00606229|466211120|FG000|Overall Study|change of residence or other commitments|2|||
129524574|NCT01526928|466211121|FG000|Overall Study|Progressive Disease|35|||
129524575|NCT01526928|466211122|FG001|Overall Study|Progressive Disease|17|||
129524576|NCT01526928|466211123|FG002|Overall Study|Progressive Disease|150|||
129524577|NCT01526928|466211124|FG003|Overall Study|Progressive Disease|182|||
129524578|NCT01526928|466211125|FG004|Overall Study|Progressive Disease|76|||
129524579|NCT01526928|466211126|FG005|Overall Study|Progressive Disease|4|||
129524580|NCT01526928|466211121|FG000|Overall Study|Adverse Event|2|||
129524581|NCT01526928|466211122|FG001|Overall Study|Adverse Event|1|||
129524582|NCT01526928|466211123|FG002|Overall Study|Adverse Event|29|||
129524583|NCT01526928|466211124|FG003|Overall Study|Adverse Event|40|||
129524584|NCT01526928|466211125|FG004|Overall Study|Adverse Event|13|||
129524585|NCT01526928|466211126|FG005|Overall Study|Adverse Event|2|||
129524586|NCT01526928|466211121|FG000|Overall Study|Death|0|||
129524587|NCT01526928|466211122|FG001|Overall Study|Death|0|||
129524588|NCT01526928|466211123|FG002|Overall Study|Death|3|||
129524589|NCT01526928|466211124|FG003|Overall Study|Death|0|||
129524590|NCT01526928|466211125|FG004|Overall Study|Death|0|||
129524591|NCT01526928|466211126|FG005|Overall Study|Death|0|||
129524592|NCT01526928|466211121|FG000|Overall Study|Withdrawal by Subject|1|||
129524593|NCT01526928|466211122|FG001|Overall Study|Withdrawal by Subject|0|||
129524594|NCT01526928|466211123|FG002|Overall Study|Withdrawal by Subject|13|||
129524595|NCT01526928|466211124|FG003|Overall Study|Withdrawal by Subject|11|||
129524596|NCT01526928|466211125|FG004|Overall Study|Withdrawal by Subject|3|||
129524597|NCT01526928|466211126|FG005|Overall Study|Withdrawal by Subject|0|||
129524598|NCT01526928|466211121|FG000|Overall Study|Physician Decision|0|||
129524599|NCT01526928|466211122|FG001|Overall Study|Physician Decision|0|||
129524600|NCT01526928|466211123|FG002|Overall Study|Physician Decision|2|||
129524601|NCT01526928|466211124|FG003|Overall Study|Physician Decision|5|||
129524602|NCT01526928|466211125|FG004|Overall Study|Physician Decision|0|||
129524603|NCT01526928|466211126|FG005|Overall Study|Physician Decision|0|||
129524604|NCT01526928|466211121|FG000|Overall Study|Other Reason|0|||
129524605|NCT01526928|466211122|FG001|Overall Study|Other Reason|1|||
129524606|NCT01526928|466211123|FG002|Overall Study|Other Reason|11|||
129524607|NCT01526928|466211124|FG003|Overall Study|Other Reason|4|||
129524608|NCT01526928|466211125|FG004|Overall Study|Other Reason|1|||
129524609|NCT01526928|466211126|FG005|Overall Study|Other Reason|0|||
129524610|NCT01526928|466211121|FG000|Overall Study|Lost to Follow-up|0|||
129524611|NCT01526928|466211122|FG001|Overall Study|Lost to Follow-up|0|||
129524612|NCT01526928|466211123|FG002|Overall Study|Lost to Follow-up|0|||
129524613|NCT01526928|466211124|FG003|Overall Study|Lost to Follow-up|1|||
129524614|NCT01526928|466211125|FG004|Overall Study|Lost to Follow-up|0|||
129524615|NCT01526928|466211126|FG005|Overall Study|Lost to Follow-up|0|||
129524616|NCT01526928|466211121|FG000|Overall Study|Protocol Deviation|0|||
129524617|NCT01526928|466211122|FG001|Overall Study|Protocol Deviation|0|||
129524618|NCT01526928|466211123|FG002|Overall Study|Protocol Deviation|0|||
129524619|NCT01526928|466211124|FG003|Overall Study|Protocol Deviation|2|||
129524620|NCT01526928|466211125|FG004|Overall Study|Protocol Deviation|0|||
129524621|NCT01526928|466211126|FG005|Overall Study|Protocol Deviation|0|||
129524622|NCT01526928|466211121|FG000|Overall Study|Missing|0|||
129524623|NCT01526928|466211122|FG001|Overall Study|Missing|0|||
129524624|NCT01526928|466211123|FG002|Overall Study|Missing|1|||
129524625|NCT01526928|466211124|FG003|Overall Study|Missing|0|||
129524626|NCT01526928|466211125|FG004|Overall Study|Missing|2|||
129524627|NCT01526928|466211126|FG005|Overall Study|Missing|0|||
129524628|NCT02829775|466211129|FG000|Overall Study|Death|1|||
129524629|NCT02829775|466211129|FG000|Overall Study|Withdrawal by Subject|3|||
129524630|NCT02829775|466211129|FG000|Overall Study|Disease remission|1|||
129524631|NCT01249157|466211130|FG000|Overall Study|Withdrawal by Subject|1|||
129524632|NCT00062647|466211131|FG000|Overall Study|Death|2|||
129524633|NCT00062647|466211132|FG001|Overall Study|Death|2|||
129524634|NCT00062647|466211131|FG000|Overall Study|Adverse Event|1|||
129524635|NCT00062647|466211132|FG001|Overall Study|Adverse Event|1|||
129524636|NCT00062647|466211131|FG000|Overall Study|Withdrawal by Subject|2|||
129524637|NCT00062647|466211132|FG001|Overall Study|Withdrawal by Subject|1|||
129524638|NCT00062647|466211131|FG000|Overall Study|Protocol Violation|1|||
129524639|NCT00062647|466211132|FG001|Overall Study|Protocol Violation|0|||
129524640|NCT00062647|466211131|FG000|Overall Study|Lost to Follow-up|1|||
129524641|NCT00062647|466211132|FG001|Overall Study|Lost to Follow-up|2|||
129538745|NCT00553319|466263519|FG001|Overall Study|moved|0|||
129524642|NCT00062647|466211131|FG000|Overall Study|Failed continuation criteria|4|||
129524643|NCT00062647|466211132|FG001|Overall Study|Failed continuation criteria|2|||
129524644|NCT00062647|466211131|FG000|Overall Study|Other|4|||
129524645|NCT00062647|466211132|FG001|Overall Study|Other|4|||
129524646|NCT00062647|466211131|FG000|Overall Study|Never received study treatment|1|||
129524647|NCT00062647|466211132|FG001|Overall Study|Never received study treatment|1|||
129524648|NCT02392468|466211140|FG000|Overall Study|Adverse Event|0|||
129524649|NCT02392468|466211141|FG001|Overall Study|Adverse Event|1|||
129524650|NCT02392468|466211142|FG002|Overall Study|Adverse Event|0|||
129524651|NCT02392468|466211143|FG003|Overall Study|Adverse Event|0|||
129524652|NCT02392468|466211144|FG004|Overall Study|Adverse Event|0|||
129524653|NCT02392468|466211145|FG005|Overall Study|Adverse Event|1|||
129524654|NCT01313039|466211146|FG000|Overall Study|Physician Decision|1|||
129524655|NCT01313039|466211146|FG000|Overall Study|Adverse Event|1|||
129524656|NCT05083949|466211152|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
129524657|NCT05083949|466211153|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
129524658|NCT05083949|466211152|FG000|Period 1|Adverse Event|1|||
129524659|NCT05083949|466211153|FG001|Period 1|Adverse Event|1|||
129524660|NCT05083949|466211152|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
129524661|NCT05083949|466211153|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
129524662|NCT05083949|466211152|FG000|Period 2|Adverse Event|0|||
129524663|NCT05083949|466211153|FG001|Period 2|Adverse Event|2|||
129524664|NCT01678560|466211154|FG000|Overall Study|Physician Decision|4|||
129524665|NCT01678560|466211155|FG001|Overall Study|Physician Decision|4|||
129524666|NCT01678560|466211154|FG000|Overall Study|Death|0|||
129524667|NCT01678560|466211155|FG001|Overall Study|Death|1|||
129524668|NCT01678560|466211154|FG000|Overall Study|Withdrawal by Subject|0|||
129524669|NCT01678560|466211155|FG001|Overall Study|Withdrawal by Subject|1|||
129524670|NCT00322387|466211159|FG000|Treatment Period|Adverse Event|0|||
129524671|NCT00322387|466211160|FG001|Treatment Period|Adverse Event|1|||
129524672|NCT00322387|466211159|FG000|Follow-up Period|Final assessment not done|1|||
129524673|NCT00322387|466211160|FG001|Follow-up Period|Final assessment not done|3|||
129524674|NCT00322387|466211159|FG000|Follow-up Period|Death|1|||
129524675|NCT00322387|466211160|FG001|Follow-up Period|Death|0|||
129524676|NCT00090766|466211165|FG000|Overall Study|Nephrectomy Planned|0|||
129524677|NCT00090766|466211166|FG001|Overall Study|Nephrectomy Planned|0|||
129524678|NCT00090766|466211167|FG002|Overall Study|Nephrectomy Planned|1|||
129524679|NCT00090766|466211165|FG000|Overall Study|Death|1|||
129524680|NCT00090766|466211166|FG001|Overall Study|Death|0|||
129524681|NCT00090766|466211167|FG002|Overall Study|Death|0|||
129524682|NCT00090766|466211165|FG000|Overall Study|Admin|0|||
129524683|NCT00090766|466211166|FG001|Overall Study|Admin|2|||
129524684|NCT00090766|466211167|FG002|Overall Study|Admin|0|||
129524685|NCT00090766|466211165|FG000|Overall Study|Lost to Follow-up|2|||
129524686|NCT00090766|466211166|FG001|Overall Study|Lost to Follow-up|0|||
129524687|NCT00090766|466211167|FG002|Overall Study|Lost to Follow-up|2|||
129524688|NCT00654368|466211168|FG000|Overall Study|Ineligibility determined|6|||
129524689|NCT00654368|466211169|FG001|Overall Study|Ineligibility determined|0|||
129524690|NCT00654368|466211170|FG002|Overall Study|Ineligibility determined|0|||
129524691|NCT00654368|466211168|FG000|Overall Study|Protocol deviation|3|||
129524692|NCT00654368|466211169|FG001|Overall Study|Protocol deviation|2|||
129524693|NCT00654368|466211170|FG002|Overall Study|Protocol deviation|1|||
129524694|NCT00654368|466211168|FG000|Overall Study|Non-compliance|2|||
129524695|NCT00654368|466211169|FG001|Overall Study|Non-compliance|1|||
129524696|NCT00654368|466211170|FG002|Overall Study|Non-compliance|2|||
129524697|NCT00654368|466211168|FG000|Overall Study|Withdrawal by Subject|5|||
129524698|NCT00654368|466211169|FG001|Overall Study|Withdrawal by Subject|2|||
129524699|NCT00654368|466211170|FG002|Overall Study|Withdrawal by Subject|2|||
129524700|NCT00654368|466211168|FG000|Overall Study|Disease progression|21|||
129524701|NCT00654368|466211169|FG001|Overall Study|Disease progression|31|||
129524702|NCT00654368|466211170|FG002|Overall Study|Disease progression|13|||
129524703|NCT00654368|466211168|FG000|Overall Study|Requirement for alternative therapy|1|||
129524704|NCT00654368|466211169|FG001|Overall Study|Requirement for alternative therapy|1|||
129524705|NCT00654368|466211170|FG002|Overall Study|Requirement for alternative therapy|1|||
129524706|NCT00654368|466211168|FG000|Overall Study|Physician Decision|0|||
129524707|NCT00654368|466211169|FG001|Overall Study|Physician Decision|0|||
129524708|NCT00654368|466211170|FG002|Overall Study|Physician Decision|2|||
129524709|NCT00654368|466211168|FG000|Overall Study|Death|1|||
129524710|NCT00654368|466211169|FG001|Overall Study|Death|0|||
129524711|NCT00654368|466211170|FG002|Overall Study|Death|0|||
129524712|NCT00654368|466211168|FG000|Overall Study|Pregnancy|0|||
129524713|NCT00654368|466211169|FG001|Overall Study|Pregnancy|0|||
129524714|NCT00654368|466211170|FG002|Overall Study|Pregnancy|2|||
129524715|NCT00654368|466211168|FG000|Overall Study|Other|0|||
129524716|NCT00654368|466211169|FG001|Overall Study|Other|2|||
129524717|NCT00654368|466211170|FG002|Overall Study|Other|3|||
129524718|NCT00654368|466211168|FG000|Overall Study|Adverse Event|14|||
129524719|NCT00654368|466211169|FG001|Overall Study|Adverse Event|9|||
129524720|NCT00654368|466211170|FG002|Overall Study|Adverse Event|6|||
129524721|NCT00804986|466211177|FG000|Overall Study|Adverse Event|0|||
129524722|NCT00804986|466211178|FG001|Overall Study|Adverse Event|1|||
129524723|NCT00804986|466211179|FG002|Overall Study|Adverse Event|2|||
129524724|NCT00804986|466211180|FG003|Overall Study|Adverse Event|1|||
129524725|NCT00804986|466211181|FG004|Overall Study|Adverse Event|3|||
129524726|NCT00804986|466211182|FG005|Overall Study|Adverse Event|0|||
129524727|NCT00804986|466211177|FG000|Overall Study|Lack of Efficacy|0|||
129524728|NCT00804986|466211178|FG001|Overall Study|Lack of Efficacy|0|||
129524729|NCT00804986|466211179|FG002|Overall Study|Lack of Efficacy|0|||
129524730|NCT00804986|466211180|FG003|Overall Study|Lack of Efficacy|1|||
129524731|NCT00804986|466211181|FG004|Overall Study|Lack of Efficacy|0|||
129524732|NCT00804986|466211182|FG005|Overall Study|Lack of Efficacy|3|||
129524733|NCT00804986|466211177|FG000|Overall Study|Lost to Follow-up|0|||
129524734|NCT00804986|466211178|FG001|Overall Study|Lost to Follow-up|0|||
129524735|NCT00804986|466211179|FG002|Overall Study|Lost to Follow-up|0|||
129524736|NCT00804986|466211180|FG003|Overall Study|Lost to Follow-up|1|||
129524737|NCT00804986|466211181|FG004|Overall Study|Lost to Follow-up|1|||
129524738|NCT00804986|466211182|FG005|Overall Study|Lost to Follow-up|3|||
129524739|NCT00804986|466211177|FG000|Overall Study|Protocol Violation|0|||
129524740|NCT00804986|466211178|FG001|Overall Study|Protocol Violation|1|||
129524741|NCT00804986|466211179|FG002|Overall Study|Protocol Violation|0|||
129524742|NCT00804986|466211180|FG003|Overall Study|Protocol Violation|1|||
129524743|NCT00804986|466211181|FG004|Overall Study|Protocol Violation|0|||
129524744|NCT00804986|466211182|FG005|Overall Study|Protocol Violation|0|||
129524745|NCT00804986|466211177|FG000|Overall Study|Withdrawal by Subject|0|||
129524746|NCT00804986|466211178|FG001|Overall Study|Withdrawal by Subject|3|||
129524747|NCT00804986|466211179|FG002|Overall Study|Withdrawal by Subject|0|||
129524748|NCT00804986|466211180|FG003|Overall Study|Withdrawal by Subject|3|||
129524749|NCT00804986|466211181|FG004|Overall Study|Withdrawal by Subject|5|||
129524750|NCT00804986|466211182|FG005|Overall Study|Withdrawal by Subject|3|||
129524751|NCT00804986|466211177|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
129524752|NCT00804986|466211178|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
129524753|NCT00804986|466211179|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
129524754|NCT00804986|466211180|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
129524755|NCT00804986|466211181|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
129524756|NCT00804986|466211182|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
129524757|NCT00804986|466211177|FG000|Overall Study|Sponsor Decision|0|||
129524758|NCT00804986|466211178|FG001|Overall Study|Sponsor Decision|1|||
129524759|NCT00804986|466211179|FG002|Overall Study|Sponsor Decision|0|||
129524760|NCT00804986|466211180|FG003|Overall Study|Sponsor Decision|0|||
129524761|NCT00804986|466211181|FG004|Overall Study|Sponsor Decision|0|||
129524762|NCT00804986|466211182|FG005|Overall Study|Sponsor Decision|0|||
129524763|NCT00804986|466211177|FG000|Overall Study|Physician Decision|1|||
129524764|NCT00804986|466211178|FG001|Overall Study|Physician Decision|0|||
129524765|NCT00804986|466211179|FG002|Overall Study|Physician Decision|0|||
129524766|NCT00804986|466211180|FG003|Overall Study|Physician Decision|0|||
129524767|NCT00804986|466211181|FG004|Overall Study|Physician Decision|0|||
129524768|NCT00804986|466211182|FG005|Overall Study|Physician Decision|0|||
129524769|NCT00959699|466211187|FG000|Treatment Period|Adverse Event|3|||
129524770|NCT00959699|466211188|FG001|Treatment Period|Adverse Event|13|||
129524771|NCT00959699|466211187|FG000|Treatment Period|Lack of Efficacy|15|||
129524772|NCT00959699|466211188|FG001|Treatment Period|Lack of Efficacy|6|||
129524773|NCT00959699|466211187|FG000|Treatment Period|Lost to Follow-up|0|||
129524774|NCT00959699|466211188|FG001|Treatment Period|Lost to Follow-up|1|||
129524775|NCT00959699|466211187|FG000|Treatment Period|Withdrawal by Subject|1|||
129524776|NCT00959699|466211188|FG001|Treatment Period|Withdrawal by Subject|3|||
129524777|NCT00959699|466211187|FG000|Treatment Period|Non-Compliance with Protocol|0|||
129524778|NCT00959699|466211188|FG001|Treatment Period|Non-Compliance with Protocol|1|||
129524779|NCT00959699|466211187|FG000|Treatment Period|Did not receive treatment|0|||
129524780|NCT00959699|466211188|FG001|Treatment Period|Did not receive treatment|1|||
129524781|NCT00959699|466211187|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
129524782|NCT00959699|466211188|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
129524783|NCT00959699|466211187|FG000|Follow-up Period|Lost to Follow-up|3|||
129524784|NCT00959699|466211188|FG001|Follow-up Period|Lost to Follow-up|2|||
129524785|NCT00959699|466211187|FG000|Follow-up Period|Withdrawal by Subject|3|||
129524786|NCT00959699|466211188|FG001|Follow-up Period|Withdrawal by Subject|4|||
129524787|NCT04228445|466211189|FG000|Overall Study|Lost to Follow-up|1|||
129524788|NCT04228445|466211190|FG001|Overall Study|Lost to Follow-up|1|||
129524789|NCT04228445|466211189|FG000|Overall Study|Physician Decision|1|||
129524790|NCT04228445|466211190|FG001|Overall Study|Physician Decision|2|||
129524791|NCT04228445|466211189|FG000|Overall Study|Withdrawal by Subject|0|||
129524792|NCT04228445|466211190|FG001|Overall Study|Withdrawal by Subject|1|||
129524793|NCT04228445|466211189|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
129524794|NCT04228445|466211190|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
129524795|NCT00606294|466211197|FG000|Overall Study|Withdrawal by Subject|36|||
129524796|NCT00606294|466211198|FG001|Overall Study|Withdrawal by Subject|0|||
129524797|NCT01316380|466211199|FG000|Overall Study|Adverse Event|0|||
129524798|NCT01316380|466211200|FG001|Overall Study|Adverse Event|2|||
129524799|NCT01316380|466211201|FG002|Overall Study|Adverse Event|1|||
129524800|NCT01316380|466211199|FG000|Overall Study|Protocol Violation|0|||
129524801|NCT01316380|466211200|FG001|Overall Study|Protocol Violation|0|||
129524802|NCT01316380|466211201|FG002|Overall Study|Protocol Violation|1|||
129524803|NCT01316380|466211199|FG000|Overall Study|Withdrawal by Subject|1|||
129524804|NCT01316380|466211200|FG001|Overall Study|Withdrawal by Subject|2|||
129524805|NCT01316380|466211201|FG002|Overall Study|Withdrawal by Subject|0|||
129524806|NCT01316380|466211199|FG000|Overall Study|Other|0|||
129524807|NCT01316380|466211200|FG001|Overall Study|Other|1|||
129524808|NCT01316380|466211201|FG002|Overall Study|Other|1|||
129524809|NCT01316380|466211199|FG000|Overall Study|Not treated|1|||
129524810|NCT01316380|466211200|FG001|Overall Study|Not treated|0|||
129524811|NCT01316380|466211201|FG002|Overall Study|Not treated|0|||
129524812|NCT00149890|466211205|FG000|Overall Study|Adverse Event|1|||
129524813|NCT00149890|466211206|FG001|Overall Study|Adverse Event|8|||
129524814|NCT00149890|466211205|FG000|Overall Study|Lack of Efficacy|8|||
129524815|NCT00149890|466211206|FG001|Overall Study|Lack of Efficacy|9|||
129524816|NCT00149890|466211205|FG000|Overall Study|Protocol Violation|1|||
129524817|NCT00149890|466211206|FG001|Overall Study|Protocol Violation|0|||
129524818|NCT00149890|466211205|FG000|Overall Study|Lost to Follow-up|1|||
129524819|NCT00149890|466211206|FG001|Overall Study|Lost to Follow-up|0|||
129524820|NCT00149890|466211205|FG000|Overall Study|Graft Loss|2|||
129524821|NCT00149890|466211206|FG001|Overall Study|Graft Loss|1|||
129524822|NCT01894776|466211207|FG000|Overall Study|Withdrawal by Subject|1|||
129524823|NCT02332876|466211208|FG000|Overall Study|Lost to Follow-up|1|||
129524824|NCT02332876|466211209|FG001|Overall Study|Lost to Follow-up|1|||
129524825|NCT02485860|466211210|FG000|Overall Study|Lost to Follow-up|4|||
129524826|NCT02485860|466211211|FG001|Overall Study|Lost to Follow-up|1|||
129524827|NCT02485860|466211210|FG000|Overall Study|Physician Decision|1|||
129524828|NCT02485860|466211211|FG001|Overall Study|Physician Decision|2|||
129524829|NCT02485860|466211210|FG000|Overall Study|Health context (COVID-19)|1|||
129524830|NCT02485860|466211211|FG001|Overall Study|Health context (COVID-19)|0|||
129524831|NCT02415595|466211213|FG000|Overall Study|Administrative reason by sponsor|39|||
129524832|NCT02415595|466211214|FG001|Overall Study|Administrative reason by sponsor|40|||
129524833|NCT02415595|466211215|FG002|Overall Study|Administrative reason by sponsor|41|||
129524834|NCT02415595|466211216|FG003|Overall Study|Administrative reason by sponsor|39|||
129524835|NCT02415595|466211213|FG000|Overall Study|Adverse Event|1|||
129524836|NCT02415595|466211214|FG001|Overall Study|Adverse Event|3|||
129524837|NCT02415595|466211215|FG002|Overall Study|Adverse Event|5|||
129524838|NCT02415595|466211216|FG003|Overall Study|Adverse Event|10|||
129524839|NCT02415595|466211213|FG000|Overall Study|Lack of Efficacy|4|||
129524840|NCT02415595|466211214|FG001|Overall Study|Lack of Efficacy|4|||
129524841|NCT02415595|466211215|FG002|Overall Study|Lack of Efficacy|0|||
129524842|NCT02415595|466211216|FG003|Overall Study|Lack of Efficacy|0|||
129524843|NCT02415595|466211213|FG000|Overall Study|Lost to Follow-up|1|||
129524844|NCT02415595|466211214|FG001|Overall Study|Lost to Follow-up|3|||
129524845|NCT02415595|466211215|FG002|Overall Study|Lost to Follow-up|1|||
129524846|NCT02415595|466211216|FG003|Overall Study|Lost to Follow-up|1|||
129524847|NCT02415595|466211213|FG000|Overall Study|Poor/Non-compliance|1|||
129524848|NCT02415595|466211214|FG001|Overall Study|Poor/Non-compliance|0|||
129524849|NCT02415595|466211215|FG002|Overall Study|Poor/Non-compliance|1|||
129524850|NCT02415595|466211216|FG003|Overall Study|Poor/Non-compliance|0|||
129524851|NCT02415595|466211213|FG000|Overall Study|Reached stopping criteria|0|||
129524852|NCT02415595|466211214|FG001|Overall Study|Reached stopping criteria|1|||
129524853|NCT02415595|466211215|FG002|Overall Study|Reached stopping criteria|1|||
129524854|NCT02415595|466211216|FG003|Overall Study|Reached stopping criteria|0|||
129524855|NCT02415595|466211213|FG000|Overall Study|Withdrawal by Subject|4|||
129524856|NCT02415595|466211214|FG001|Overall Study|Withdrawal by Subject|0|||
129524857|NCT02415595|466211215|FG002|Overall Study|Withdrawal by Subject|1|||
129524858|NCT02415595|466211216|FG003|Overall Study|Withdrawal by Subject|3|||
129524859|NCT02415595|466211213|FG000|Overall Study|Other|0|||
129524860|NCT02415595|466211214|FG001|Overall Study|Other|1|||
129524861|NCT02415595|466211215|FG002|Overall Study|Other|1|||
129524862|NCT02415595|466211216|FG003|Overall Study|Other|0|||
129524863|NCT03325010|466211219|FG000|Overall Study|Adverse Event|3|||
129524864|NCT03325010|466211220|FG001|Overall Study|Adverse Event|8|||
129524865|NCT03325010|466211219|FG000|Overall Study|Protocol Violation|1|||
129524866|NCT03325010|466211220|FG001|Overall Study|Protocol Violation|8|||
129524867|NCT03325010|466211219|FG000|Overall Study|Withdrawal by Subject|1|||
129524868|NCT03325010|466211220|FG001|Overall Study|Withdrawal by Subject|3|||
129524869|NCT03325010|466211219|FG000|Overall Study|Lost to Follow-up|1|||
129524870|NCT03325010|466211220|FG001|Overall Study|Lost to Follow-up|0|||
129524871|NCT03325010|466211219|FG000|Overall Study|Physician Decision|1|||
129524872|NCT03325010|466211220|FG001|Overall Study|Physician Decision|1|||
129524873|NCT03325010|466211219|FG000|Overall Study|Lack of Efficacy|2|||
129524874|NCT03325010|466211220|FG001|Overall Study|Lack of Efficacy|0|||
129524875|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
129524876|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
129524877|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
129524878|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
129524879|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
129524880|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129524881|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129524882|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
129524883|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
129524884|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
129524885|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
129524886|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
129524887|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
129524888|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
129524889|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
129524890|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
129524891|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
129524892|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
129524893|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
129524894|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
129524895|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
129524896|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
129524897|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
129524898|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
129524899|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Screen failure|0|||
129524900|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Screen failure|1|||
129524901|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Screen failure|2|||
129524902|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Screen failure|0|||
129524903|NCT02614261|466211221|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
129524904|NCT02614261|466211222|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
129524905|NCT02614261|466211223|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
129524906|NCT02614261|466211224|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
129524907|NCT02614261|466211221|FG000|Open-Label Extension Phase|Adverse Event|23|||
129524908|NCT02614261|466211222|FG001|Open-Label Extension Phase|Adverse Event|12|||
129524909|NCT02614261|466211223|FG002|Open-Label Extension Phase|Adverse Event|11|||
129524910|NCT02614261|466211224|FG003|Open-Label Extension Phase|Adverse Event|0|||
129524911|NCT02614261|466211221|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
129524912|NCT02614261|466211222|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
129524913|NCT02614261|466211223|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
129524914|NCT02614261|466211224|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
129524915|NCT02614261|466211221|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
129524916|NCT02614261|466211222|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
129524917|NCT02614261|466211223|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
129524918|NCT02614261|466211224|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
129524919|NCT02614261|466211221|FG000|Open-Label Extension Phase|Physician Decision|2|||
129524920|NCT02614261|466211222|FG001|Open-Label Extension Phase|Physician Decision|0|||
129524921|NCT02614261|466211223|FG002|Open-Label Extension Phase|Physician Decision|0|||
129524922|NCT02614261|466211224|FG003|Open-Label Extension Phase|Physician Decision|0|||
129524923|NCT02614261|466211221|FG000|Open-Label Extension Phase|Pregnancy|1|||
129524924|NCT02614261|466211222|FG001|Open-Label Extension Phase|Pregnancy|2|||
129524925|NCT02614261|466211223|FG002|Open-Label Extension Phase|Pregnancy|1|||
129524926|NCT02614261|466211224|FG003|Open-Label Extension Phase|Pregnancy|0|||
129524927|NCT02614261|466211221|FG000|Open-Label Extension Phase|Protocol Violation|3|||
129524928|NCT02614261|466211222|FG001|Open-Label Extension Phase|Protocol Violation|4|||
129524929|NCT02614261|466211223|FG002|Open-Label Extension Phase|Protocol Violation|1|||
129524930|NCT02614261|466211224|FG003|Open-Label Extension Phase|Protocol Violation|0|||
129524931|NCT02614261|466211221|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
129524932|NCT02614261|466211222|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
129524933|NCT02614261|466211223|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
129524934|NCT02614261|466211224|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
129524935|NCT02614261|466211221|FG000|Follow-up Phase|Adverse Event|2|||
129524936|NCT02614261|466211222|FG001|Follow-up Phase|Adverse Event|0|||
129524937|NCT02614261|466211223|FG002|Follow-up Phase|Adverse Event|1|||
129524938|NCT02614261|466211224|FG003|Follow-up Phase|Adverse Event|0|||
129524939|NCT02614261|466211221|FG000|Follow-up Phase|Lost to Follow-up|12|||
129524940|NCT02614261|466211222|FG001|Follow-up Phase|Lost to Follow-up|5|||
129524941|NCT02614261|466211223|FG002|Follow-up Phase|Lost to Follow-up|2|||
129524942|NCT02614261|466211224|FG003|Follow-up Phase|Lost to Follow-up|0|||
129524943|NCT02614261|466211221|FG000|Follow-up Phase|Physician Decision|5|||
129524944|NCT02614261|466211222|FG001|Follow-up Phase|Physician Decision|1|||
129524945|NCT02614261|466211223|FG002|Follow-up Phase|Physician Decision|0|||
129524946|NCT02614261|466211224|FG003|Follow-up Phase|Physician Decision|0|||
129524947|NCT02614261|466211221|FG000|Follow-up Phase|Pregnancy|0|||
129524948|NCT02614261|466211222|FG001|Follow-up Phase|Pregnancy|1|||
129524949|NCT02614261|466211223|FG002|Follow-up Phase|Pregnancy|0|||
129524950|NCT02614261|466211224|FG003|Follow-up Phase|Pregnancy|0|||
129524951|NCT02614261|466211221|FG000|Follow-up Phase|Protocol Violation|1|||
129524952|NCT02614261|466211222|FG001|Follow-up Phase|Protocol Violation|0|||
129524953|NCT02614261|466211223|FG002|Follow-up Phase|Protocol Violation|0|||
129524954|NCT02614261|466211224|FG003|Follow-up Phase|Protocol Violation|0|||
129524955|NCT02614261|466211221|FG000|Follow-up Phase|Withdrawal by Subject|12|||
129524956|NCT02614261|466211222|FG001|Follow-up Phase|Withdrawal by Subject|4|||
129524957|NCT02614261|466211223|FG002|Follow-up Phase|Withdrawal by Subject|11|||
129524958|NCT02614261|466211224|FG003|Follow-up Phase|Withdrawal by Subject|0|||
129524959|NCT02614261|466211221|FG000|Israel Addendum|Withdrawal by Subject|0|||
129524960|NCT02614261|466211222|FG001|Israel Addendum|Withdrawal by Subject|0|||
129524961|NCT02614261|466211223|FG002|Israel Addendum|Withdrawal by Subject|0|||
129524962|NCT02614261|466211224|FG003|Israel Addendum|Withdrawal by Subject|4|||
129524963|NCT03073200|466211233|FG000|Double Blind Treatment Period|Protocol Violation|1|||
129524964|NCT03073200|466211234|FG001|Double Blind Treatment Period|Protocol Violation|0|||
129524965|NCT03073200|466211235|FG002|Double Blind Treatment Period|Protocol Violation|0|||
129524966|NCT03073200|466211236|FG003|Double Blind Treatment Period|Protocol Violation|0|||
129524967|NCT03073200|466211237|FG004|Double Blind Treatment Period|Protocol Violation|0|||
129524968|NCT03073200|466211238|FG005|Double Blind Treatment Period|Protocol Violation|0|||
129524969|NCT03073200|466211239|FG006|Double Blind Treatment Period|Protocol Violation|0|||
129524970|NCT03073200|466211240|FG007|Double Blind Treatment Period|Protocol Violation|0|||
129524971|NCT03073200|466211241|FG008|Double Blind Treatment Period|Protocol Violation|0|||
129524972|NCT03073200|466211242|FG009|Double Blind Treatment Period|Protocol Violation|0|||
129524973|NCT03073200|466211243|FG010|Double Blind Treatment Period|Protocol Violation|0|||
129524974|NCT03073200|466211244|FG011|Double Blind Treatment Period|Protocol Violation|0|||
129524975|NCT03073200|466211245|FG012|Double Blind Treatment Period|Protocol Violation|0|||
129524976|NCT03073200|466211246|FG013|Double Blind Treatment Period|Protocol Violation|0|||
129524977|NCT03073200|466211247|FG014|Double Blind Treatment Period|Protocol Violation|0|||
129524978|NCT03073200|466211233|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524979|NCT03073200|466211234|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
129524980|NCT03073200|466211235|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524981|NCT03073200|466211236|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524982|NCT03073200|466211237|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524983|NCT03073200|466211238|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524984|NCT03073200|466211239|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524985|NCT03073200|466211240|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524986|NCT03073200|466211241|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524987|NCT03073200|466211242|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524988|NCT03073200|466211243|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524989|NCT03073200|466211244|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524990|NCT03073200|466211245|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524991|NCT03073200|466211246|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524992|NCT03073200|466211247|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
129524993|NCT03073200|466211233|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
129524994|NCT03073200|466211234|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
129524995|NCT03073200|466211235|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
129524996|NCT03073200|466211236|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
129524997|NCT03073200|466211237|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
129524998|NCT03073200|466211238|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
129524999|NCT03073200|466211239|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525000|NCT03073200|466211240|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525001|NCT03073200|466211241|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525002|NCT03073200|466211242|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525003|NCT03073200|466211243|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525004|NCT03073200|466211244|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525005|NCT03073200|466211245|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525006|NCT03073200|466211246|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525007|NCT03073200|466211247|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
129525008|NCT03073200|466211233|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525009|NCT03073200|466211234|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525010|NCT03073200|466211235|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525011|NCT03073200|466211236|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
129525012|NCT03073200|466211237|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
129525013|NCT03073200|466211238|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525014|NCT03073200|466211239|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525015|NCT03073200|466211240|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525016|NCT03073200|466211241|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525017|NCT03073200|466211242|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525018|NCT03073200|466211243|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525019|NCT03073200|466211244|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525020|NCT03073200|466211245|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525021|NCT03073200|466211246|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525022|NCT03073200|466211247|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
129525023|NCT03073200|466211233|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
129525024|NCT03073200|466211234|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
129525025|NCT03073200|466211235|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
129525026|NCT03073200|466211236|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
129525027|NCT03073200|466211237|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
129525028|NCT03073200|466211238|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
129525029|NCT03073200|466211239|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
129525030|NCT03073200|466211240|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
129525031|NCT03073200|466211241|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
129525032|NCT03073200|466211242|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
129525033|NCT03073200|466211243|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
129525034|NCT03073200|466211244|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
129525035|NCT03073200|466211245|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
129525036|NCT03073200|466211246|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
129525037|NCT03073200|466211247|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
129525038|NCT03073200|466211233|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525039|NCT03073200|466211234|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525040|NCT03073200|466211235|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525041|NCT03073200|466211236|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525042|NCT03073200|466211237|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
129525043|NCT03073200|466211238|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525044|NCT03073200|466211239|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525045|NCT03073200|466211240|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525046|NCT03073200|466211241|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525047|NCT03073200|466211242|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525048|NCT03073200|466211243|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525049|NCT03073200|466211244|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525050|NCT03073200|466211245|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525051|NCT03073200|466211246|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525052|NCT03073200|466211247|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
129525053|NCT03073200|466211233|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525054|NCT03073200|466211234|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525055|NCT03073200|466211235|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525056|NCT03073200|466211236|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
129525057|NCT03073200|466211237|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
129525058|NCT03073200|466211238|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525059|NCT03073200|466211239|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525060|NCT03073200|466211240|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525061|NCT03073200|466211241|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525062|NCT03073200|466211242|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525063|NCT03073200|466211243|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525064|NCT03073200|466211244|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525065|NCT03073200|466211245|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525066|NCT03073200|466211246|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525067|NCT03073200|466211247|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
129525068|NCT03073200|466211233|FG000|Extension Period|Lost to Follow-up|0|||
129525069|NCT03073200|466211234|FG001|Extension Period|Lost to Follow-up|0|||
129525070|NCT03073200|466211235|FG002|Extension Period|Lost to Follow-up|0|||
129525071|NCT03073200|466211236|FG003|Extension Period|Lost to Follow-up|0|||
129525072|NCT03073200|466211237|FG004|Extension Period|Lost to Follow-up|0|||
129525073|NCT03073200|466211238|FG005|Extension Period|Lost to Follow-up|0|||
129525074|NCT03073200|466211239|FG006|Extension Period|Lost to Follow-up|1|||
129525075|NCT03073200|466211240|FG007|Extension Period|Lost to Follow-up|1|||
129525076|NCT03073200|466211241|FG008|Extension Period|Lost to Follow-up|0|||
129525077|NCT03073200|466211242|FG009|Extension Period|Lost to Follow-up|0|||
129525078|NCT03073200|466211243|FG010|Extension Period|Lost to Follow-up|0|||
129525079|NCT03073200|466211244|FG011|Extension Period|Lost to Follow-up|0|||
129525080|NCT03073200|466211245|FG012|Extension Period|Lost to Follow-up|0|||
129525081|NCT03073200|466211246|FG013|Extension Period|Lost to Follow-up|0|||
129525082|NCT03073200|466211247|FG014|Extension Period|Lost to Follow-up|0|||
129525083|NCT03073200|466211233|FG000|Extension Period|Sponsor Decision|0|||
129525084|NCT03073200|466211234|FG001|Extension Period|Sponsor Decision|0|||
129525085|NCT03073200|466211235|FG002|Extension Period|Sponsor Decision|0|||
129525086|NCT03073200|466211236|FG003|Extension Period|Sponsor Decision|0|||
129525087|NCT03073200|466211237|FG004|Extension Period|Sponsor Decision|0|||
129525088|NCT03073200|466211238|FG005|Extension Period|Sponsor Decision|0|||
129525089|NCT03073200|466211239|FG006|Extension Period|Sponsor Decision|0|||
129525090|NCT03073200|466211240|FG007|Extension Period|Sponsor Decision|0|||
129525091|NCT03073200|466211241|FG008|Extension Period|Sponsor Decision|1|||
129525092|NCT03073200|466211242|FG009|Extension Period|Sponsor Decision|0|||
129525093|NCT03073200|466211243|FG010|Extension Period|Sponsor Decision|0|||
129525094|NCT03073200|466211244|FG011|Extension Period|Sponsor Decision|0|||
129525095|NCT03073200|466211245|FG012|Extension Period|Sponsor Decision|0|||
129525096|NCT03073200|466211246|FG013|Extension Period|Sponsor Decision|0|||
129525097|NCT03073200|466211247|FG014|Extension Period|Sponsor Decision|0|||
129525098|NCT03073200|466211233|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
129525099|NCT03073200|466211234|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
129525100|NCT03073200|466211235|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
129525101|NCT03073200|466211236|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
129525102|NCT03073200|466211237|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
129525103|NCT03073200|466211238|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
129525104|NCT03073200|466211239|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
129525105|NCT03073200|466211240|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
129525106|NCT03073200|466211241|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
129525107|NCT03073200|466211242|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
129525108|NCT03073200|466211243|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
129525109|NCT03073200|466211244|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
129525110|NCT03073200|466211245|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
129525111|NCT03073200|466211246|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
129525112|NCT03073200|466211247|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
129525113|NCT03073200|466211233|FG000|Extension Period|Withdrawal by Subject|0|||
129525114|NCT03073200|466211234|FG001|Extension Period|Withdrawal by Subject|0|||
129525115|NCT03073200|466211235|FG002|Extension Period|Withdrawal by Subject|0|||
129525116|NCT03073200|466211236|FG003|Extension Period|Withdrawal by Subject|0|||
129525117|NCT03073200|466211237|FG004|Extension Period|Withdrawal by Subject|0|||
129525118|NCT03073200|466211238|FG005|Extension Period|Withdrawal by Subject|0|||
129525119|NCT03073200|466211239|FG006|Extension Period|Withdrawal by Subject|1|||
129525120|NCT03073200|466211240|FG007|Extension Period|Withdrawal by Subject|2|||
129525121|NCT03073200|466211241|FG008|Extension Period|Withdrawal by Subject|0|||
129525122|NCT03073200|466211242|FG009|Extension Period|Withdrawal by Subject|0|||
129525123|NCT03073200|466211243|FG010|Extension Period|Withdrawal by Subject|0|||
129525124|NCT03073200|466211244|FG011|Extension Period|Withdrawal by Subject|0|||
129525125|NCT03073200|466211245|FG012|Extension Period|Withdrawal by Subject|0|||
129525126|NCT03073200|466211246|FG013|Extension Period|Withdrawal by Subject|0|||
129525127|NCT03073200|466211247|FG014|Extension Period|Withdrawal by Subject|0|||
129525128|NCT03073200|466211233|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525129|NCT03073200|466211234|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525130|NCT03073200|466211235|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525131|NCT03073200|466211236|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525132|NCT03073200|466211237|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525133|NCT03073200|466211238|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525134|NCT03073200|466211239|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525135|NCT03073200|466211240|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525136|NCT03073200|466211241|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525137|NCT03073200|466211242|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525138|NCT03073200|466211243|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525139|NCT03073200|466211244|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
129525140|NCT03073200|466211245|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525141|NCT03073200|466211246|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525142|NCT03073200|466211247|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
129525143|NCT03073200|466211233|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525144|NCT03073200|466211234|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525145|NCT03073200|466211235|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525146|NCT03073200|466211236|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525147|NCT03073200|466211237|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525148|NCT03073200|466211238|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525149|NCT03073200|466211239|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525150|NCT03073200|466211240|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525151|NCT03073200|466211241|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525152|NCT03073200|466211242|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525153|NCT03073200|466211243|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525154|NCT03073200|466211244|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
129525155|NCT03073200|466211245|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525156|NCT03073200|466211246|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525157|NCT03073200|466211247|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
129525158|NCT03073200|466211233|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525159|NCT03073200|466211234|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525160|NCT03073200|466211235|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525161|NCT03073200|466211236|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525162|NCT03073200|466211237|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525163|NCT03073200|466211238|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525164|NCT03073200|466211239|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525165|NCT03073200|466211240|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525166|NCT03073200|466211241|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525167|NCT03073200|466211242|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525168|NCT03073200|466211243|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
129525169|NCT03073200|466211244|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
129525170|NCT03073200|466211245|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525171|NCT03073200|466211246|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525172|NCT03073200|466211247|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
129525173|NCT03073200|466211233|FG000|Randomized Withdrawal Period|Adverse Event|0|||
129525174|NCT03073200|466211234|FG001|Randomized Withdrawal Period|Adverse Event|0|||
129525175|NCT03073200|466211235|FG002|Randomized Withdrawal Period|Adverse Event|0|||
129525176|NCT03073200|466211236|FG003|Randomized Withdrawal Period|Adverse Event|0|||
129525177|NCT03073200|466211237|FG004|Randomized Withdrawal Period|Adverse Event|0|||
129525178|NCT03073200|466211238|FG005|Randomized Withdrawal Period|Adverse Event|0|||
129525179|NCT03073200|466211239|FG006|Randomized Withdrawal Period|Adverse Event|0|||
129525180|NCT03073200|466211240|FG007|Randomized Withdrawal Period|Adverse Event|0|||
129525181|NCT03073200|466211241|FG008|Randomized Withdrawal Period|Adverse Event|0|||
129525182|NCT03073200|466211242|FG009|Randomized Withdrawal Period|Adverse Event|0|||
129525183|NCT03073200|466211243|FG010|Randomized Withdrawal Period|Adverse Event|1|||
129525184|NCT03073200|466211244|FG011|Randomized Withdrawal Period|Adverse Event|0|||
129525185|NCT03073200|466211245|FG012|Randomized Withdrawal Period|Adverse Event|0|||
129525186|NCT03073200|466211246|FG013|Randomized Withdrawal Period|Adverse Event|0|||
129525187|NCT03073200|466211247|FG014|Randomized Withdrawal Period|Adverse Event|0|||
129525188|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525189|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525190|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525191|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525192|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525193|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525194|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525195|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525196|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525197|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525198|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525199|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525200|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525201|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
129525202|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
129525203|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525204|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525205|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525206|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525207|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525208|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525209|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525210|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525211|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525212|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525213|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525214|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525215|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525216|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
129525217|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
129525218|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525219|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525220|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525221|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525222|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525223|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525224|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525225|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525226|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525227|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525228|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525229|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525230|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525231|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
129525232|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
129525233|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525234|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525235|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525236|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525237|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525238|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525239|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525240|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525241|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525242|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525243|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525244|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525245|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525246|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
129525247|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
129525248|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525249|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525250|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525251|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525252|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525253|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525254|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525255|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525256|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525257|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525258|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525259|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525260|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525261|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
129525262|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
129525263|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525264|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525265|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525266|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525267|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525268|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525269|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525270|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525271|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525272|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525273|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525274|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525275|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525276|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
129525277|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
129525278|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525279|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525280|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525281|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525282|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525283|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525284|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525285|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525286|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525287|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525288|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525289|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525290|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525291|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
129525292|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
129525293|NCT03073200|466211233|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525294|NCT03073200|466211234|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525295|NCT03073200|466211235|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525296|NCT03073200|466211236|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525297|NCT03073200|466211237|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525298|NCT03073200|466211238|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525299|NCT03073200|466211239|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525300|NCT03073200|466211240|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525301|NCT03073200|466211241|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525302|NCT03073200|466211242|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525303|NCT03073200|466211243|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525304|NCT03073200|466211244|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525305|NCT03073200|466211245|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525306|NCT03073200|466211246|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
129525307|NCT03073200|466211247|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
129525308|NCT03512275|466211248|FG000|Overall Study|Withdrawal by Subject|1|||
129525309|NCT03512275|466211249|FG001|Overall Study|Withdrawal by Subject|3|||
129525310|NCT03512275|466211248|FG000|Overall Study|Physician Decision|0|||
129525311|NCT03512275|466211249|FG001|Overall Study|Physician Decision|1|||
129525312|NCT03512275|466211248|FG000|Overall Study|Lost to Follow-up|0|||
129525313|NCT03512275|466211249|FG001|Overall Study|Lost to Follow-up|3|||
129525314|NCT03512275|466211248|FG000|Overall Study|Other|1|||
129525315|NCT03512275|466211249|FG001|Overall Study|Other|0|||
129525316|NCT00609167|466211250|FG000|Overall Study|Withdrawal by Subject|1|||
129525317|NCT00609167|466211251|FG001|Overall Study|Withdrawal by Subject|0|||
129525318|NCT00609167|466211250|FG000|Overall Study|Lack of Efficacy|1|||
129525319|NCT00609167|466211251|FG001|Overall Study|Lack of Efficacy|0|||
129525320|NCT00609167|466211250|FG000|Overall Study|Adverse Event|5|||
129525321|NCT00609167|466211251|FG001|Overall Study|Adverse Event|1|||
129525322|NCT00609167|466211250|FG000|Overall Study|Disease Progression|1|||
129525323|NCT00609167|466211251|FG001|Overall Study|Disease Progression|0|||
129525324|NCT00609167|466211250|FG000|Overall Study|Stem Cell Transplant|0|||
129525325|NCT00609167|466211251|FG001|Overall Study|Stem Cell Transplant|6|||
129525326|NCT02574520|466211252|FG000|Overall Study|Not dosed|2|||
129525327|NCT02574520|466211253|FG001|Overall Study|Not dosed|0|||
129525328|NCT02574520|466211254|FG002|Overall Study|Not dosed|5|||
129525329|NCT02574520|466211255|FG003|Overall Study|Not dosed|4|||
129525330|NCT02574520|466211252|FG000|Overall Study|Adverse Event|0|||
129525331|NCT02574520|466211253|FG001|Overall Study|Adverse Event|0|||
129525332|NCT02574520|466211254|FG002|Overall Study|Adverse Event|0|||
129525333|NCT02574520|466211255|FG003|Overall Study|Adverse Event|1|||
129525334|NCT02574520|466211252|FG000|Overall Study|Withdrawal by Subject|0|||
129525335|NCT02574520|466211253|FG001|Overall Study|Withdrawal by Subject|0|||
129525336|NCT02574520|466211254|FG002|Overall Study|Withdrawal by Subject|0|||
129525337|NCT02574520|466211255|FG003|Overall Study|Withdrawal by Subject|1|||
129525338|NCT02574520|466211252|FG000|Overall Study|Other|0|||
129525339|NCT02574520|466211253|FG001|Overall Study|Other|0|||
129525340|NCT02574520|466211254|FG002|Overall Study|Other|0|||
129525341|NCT02574520|466211255|FG003|Overall Study|Other|2|||
129525342|NCT05116683|466211258|FG000|Overall Study|Physician Decision|4|||
129525343|NCT01474889|466211260|FG000|Overall Study|Physician Decision|1|||
129525344|NCT01474889|466211261|FG001|Overall Study|Physician Decision|0|||
129525345|NCT01474889|466211262|FG002|Overall Study|Physician Decision|0|||
129525346|NCT01474889|466211260|FG000|Overall Study|Did not meet inclusion|1|||
129525347|NCT01474889|466211261|FG001|Overall Study|Did not meet inclusion|0|||
129525348|NCT01474889|466211262|FG002|Overall Study|Did not meet inclusion|0|||
129525349|NCT01474889|466211260|FG000|Overall Study|Withdrawal by Subject|0|||
129525350|NCT01474889|466211261|FG001|Overall Study|Withdrawal by Subject|1|||
129525351|NCT01474889|466211262|FG002|Overall Study|Withdrawal by Subject|0|||
129525352|NCT03935594|466211266|FG000|Overall Study|Physician Decision|3|||
129525353|NCT01435122|466211267|FG000|Overall Study|Early withdrawal due to toxicity|8|||
129525354|NCT03954704|466211270|FG000|Overall Study|Death|1|||
129525355|NCT03954704|466211271|FG001|Overall Study|Death|1|||
129525356|NCT03954704|466211272|FG002|Overall Study|Death|1|||
129525357|NCT03954704|466211273|FG003|Overall Study|Death|3|||
129525358|NCT03954704|466211274|FG004|Overall Study|Death|2|||
129525359|NCT03954704|466211275|FG005|Overall Study|Death|2|||
129525360|NCT03954704|466211276|FG006|Overall Study|Death|0|||
129525361|NCT03954704|466211270|FG000|Overall Study|Withdrew Consent|0|||
129525362|NCT03954704|466211271|FG001|Overall Study|Withdrew Consent|0|||
129525363|NCT03954704|466211272|FG002|Overall Study|Withdrew Consent|1|||
129525364|NCT03954704|466211273|FG003|Overall Study|Withdrew Consent|0|||
129525365|NCT03954704|466211274|FG004|Overall Study|Withdrew Consent|0|||
129525366|NCT03954704|466211275|FG005|Overall Study|Withdrew Consent|1|||
129525367|NCT03954704|466211276|FG006|Overall Study|Withdrew Consent|0|||
129525368|NCT03954704|466211270|FG000|Overall Study|Lost to Follow-up|0|||
129525369|NCT03954704|466211271|FG001|Overall Study|Lost to Follow-up|0|||
129525370|NCT03954704|466211272|FG002|Overall Study|Lost to Follow-up|0|||
129525371|NCT03954704|466211273|FG003|Overall Study|Lost to Follow-up|0|||
129525372|NCT03954704|466211274|FG004|Overall Study|Lost to Follow-up|0|||
129525373|NCT03954704|466211275|FG005|Overall Study|Lost to Follow-up|0|||
129525374|NCT03954704|466211276|FG006|Overall Study|Lost to Follow-up|1|||
129525375|NCT03954704|466211270|FG000|Overall Study|Study Terminated by Sponsor|0|||
129525376|NCT03954704|466211271|FG001|Overall Study|Study Terminated by Sponsor|0|||
129525377|NCT03954704|466211272|FG002|Overall Study|Study Terminated by Sponsor|1|||
129525378|NCT03954704|466211273|FG003|Overall Study|Study Terminated by Sponsor|0|||
129525379|NCT03954704|466211274|FG004|Overall Study|Study Terminated by Sponsor|1|||
129525380|NCT03954704|466211275|FG005|Overall Study|Study Terminated by Sponsor|4|||
129525381|NCT03954704|466211276|FG006|Overall Study|Study Terminated by Sponsor|2|||
129525382|NCT03954704|466211270|FG000|Overall Study|Enrolled but not Treated|0|||
129525383|NCT03954704|466211271|FG001|Overall Study|Enrolled but not Treated|0|||
129525384|NCT03954704|466211272|FG002|Overall Study|Enrolled but not Treated|0|||
129525385|NCT03954704|466211273|FG003|Overall Study|Enrolled but not Treated|0|||
129525386|NCT03954704|466211274|FG004|Overall Study|Enrolled but not Treated|0|||
129525387|NCT03954704|466211275|FG005|Overall Study|Enrolled but not Treated|1|||
129525388|NCT03954704|466211276|FG006|Overall Study|Enrolled but not Treated|0|||
129525389|NCT04412668|466211277|FG000|Overall Study|Death - multiple comorbidities|2|||
129525390|NCT04412668|466211278|FG001|Overall Study|Death - multiple comorbidities|0|||
129525391|NCT04412668|466211279|FG002|Overall Study|Death - multiple comorbidities|0|||
129525392|NCT04412668|466211277|FG000|Overall Study|Withdrawal by Subject|3|||
129525393|NCT04412668|466211278|FG001|Overall Study|Withdrawal by Subject|0|||
129525394|NCT04412668|466211279|FG002|Overall Study|Withdrawal by Subject|0|||
129525395|NCT04412668|466211277|FG000|Overall Study|Other than Specified|2|||
129525396|NCT04412668|466211278|FG001|Overall Study|Other than Specified|0|||
129525397|NCT04412668|466211279|FG002|Overall Study|Other than Specified|0|||
129525398|NCT00397891|466211285|FG000|Overall Study|Withdrawal by Subject|1|||
129525399|NCT00397891|466211286|FG001|Overall Study|Withdrawal by Subject|0|||
129525400|NCT00397891|466211287|FG002|Overall Study|Withdrawal by Subject|0|||
129525401|NCT00397891|466211288|FG003|Overall Study|Withdrawal by Subject|0|||
129525402|NCT00397891|466211289|FG004|Overall Study|Withdrawal by Subject|1|||
129525403|NCT03695471|466212653|FG000|Overall Study|Cancellation|1|||
129525404|NCT02859558|466212654|FG000|Step 1|Not Eligible|0|||
129525405|NCT02859558|466212655|FG001|Step 1|Not Eligible|0|||
129525406|NCT02859558|466212656|FG002|Step 1|Not Eligible|0|||
129525407|NCT02859558|466212657|FG003|Step 1|Not Eligible|0|||
129525408|NCT02859558|466212658|FG004|Step 1|Not Eligible|3|||
129525409|NCT02859558|466212654|FG000|Step 1|Lost to Follow-up|1|||
129525410|NCT02859558|466212655|FG001|Step 1|Lost to Follow-up|3|||
129525411|NCT02859558|466212656|FG002|Step 1|Lost to Follow-up|3|||
129525412|NCT02859558|466212657|FG003|Step 1|Lost to Follow-up|0|||
129525413|NCT02859558|466212658|FG004|Step 1|Lost to Follow-up|0|||
129525414|NCT02859558|466212654|FG000|Step 1|Did Not Return to Clinic|2|||
129525415|NCT02859558|466212655|FG001|Step 1|Did Not Return to Clinic|3|||
129525416|NCT02859558|466212656|FG002|Step 1|Did Not Return to Clinic|4|||
129525417|NCT02859558|466212657|FG003|Step 1|Did Not Return to Clinic|0|||
129525418|NCT02859558|466212658|FG004|Step 1|Did Not Return to Clinic|0|||
129525419|NCT02859558|466212654|FG000|Step 1|Moved|0|||
129525420|NCT02859558|466212655|FG001|Step 1|Moved|1|||
129525421|NCT02859558|466212656|FG002|Step 1|Moved|1|||
129525422|NCT02859558|466212657|FG003|Step 1|Moved|0|||
129525423|NCT02859558|466212658|FG004|Step 1|Moved|0|||
129525424|NCT02859558|466212654|FG000|Step 1|Withdrawal By Participant|1|||
129525425|NCT02859558|466212655|FG001|Step 1|Withdrawal By Participant|2|||
129525426|NCT02859558|466212656|FG002|Step 1|Withdrawal By Participant|1|||
129525427|NCT02859558|466212657|FG003|Step 1|Withdrawal By Participant|0|||
129525428|NCT02859558|466212658|FG004|Step 1|Withdrawal By Participant|0|||
129525429|NCT02859558|466212654|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
129525430|NCT02859558|466212655|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
129525431|NCT02859558|466212656|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
129525432|NCT02859558|466212657|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
129525433|NCT02859558|466212658|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
129525434|NCT02859558|466212654|FG000|Step 1|Incarceration|0|||
129525435|NCT02859558|466212655|FG001|Step 1|Incarceration|1|||
129525436|NCT02859558|466212656|FG002|Step 1|Incarceration|0|||
129525437|NCT02859558|466212657|FG003|Step 1|Incarceration|0|||
129525438|NCT02859558|466212658|FG004|Step 1|Incarceration|0|||
129525439|NCT02859558|466212654|FG000|Step 1|Non-Adherence to Study Drug|2|||
129525440|NCT02859558|466212655|FG001|Step 1|Non-Adherence to Study Drug|0|||
129525441|NCT02859558|466212656|FG002|Step 1|Non-Adherence to Study Drug|1|||
129525442|NCT02859558|466212657|FG003|Step 1|Non-Adherence to Study Drug|0|||
129525443|NCT02859558|466212658|FG004|Step 1|Non-Adherence to Study Drug|0|||
129525444|NCT02859558|466212654|FG000|Step 1|Non-Adherence to Study Requirements|3|||
129525445|NCT02859558|466212655|FG001|Step 1|Non-Adherence to Study Requirements|1|||
129525446|NCT02859558|466212656|FG002|Step 1|Non-Adherence to Study Requirements|0|||
129525447|NCT02859558|466212657|FG003|Step 1|Non-Adherence to Study Requirements|0|||
129525448|NCT02859558|466212658|FG004|Step 1|Non-Adherence to Study Requirements|0|||
129525449|NCT02859558|466212654|FG000|Step 1|Virologic Failure|2|||
129525450|NCT02859558|466212655|FG001|Step 1|Virologic Failure|1|||
129525451|NCT02859558|466212656|FG002|Step 1|Virologic Failure|1|||
129525452|NCT02859558|466212657|FG003|Step 1|Virologic Failure|0|||
129525453|NCT02859558|466212658|FG004|Step 1|Virologic Failure|0|||
129525454|NCT02859558|466212654|FG000|Step 2|Lost to Follow-up|3|||
129525455|NCT02859558|466212655|FG001|Step 2|Lost to Follow-up|3|||
129525456|NCT02859558|466212656|FG002|Step 2|Lost to Follow-up|1|||
129525457|NCT02859558|466212657|FG003|Step 2|Lost to Follow-up|0|||
129525458|NCT02859558|466212658|FG004|Step 2|Lost to Follow-up|0|||
129525459|NCT02859558|466212654|FG000|Step 2|Withdrawal by Subject|0|||
129525460|NCT02859558|466212655|FG001|Step 2|Withdrawal by Subject|1|||
129525461|NCT02859558|466212656|FG002|Step 2|Withdrawal by Subject|1|||
129525462|NCT02859558|466212657|FG003|Step 2|Withdrawal by Subject|0|||
129525463|NCT02859558|466212658|FG004|Step 2|Withdrawal by Subject|0|||
129525464|NCT02859558|466212654|FG000|Step 2|Unexpected Closure of Site|0|||
129525465|NCT02859558|466212655|FG001|Step 2|Unexpected Closure of Site|1|||
129525466|NCT02859558|466212656|FG002|Step 2|Unexpected Closure of Site|1|||
129525467|NCT02859558|466212657|FG003|Step 2|Unexpected Closure of Site|0|||
129525468|NCT02859558|466212658|FG004|Step 2|Unexpected Closure of Site|0|||
129525469|NCT02859558|466212654|FG000|Step 2|Death|1|||
129525470|NCT02859558|466212655|FG001|Step 2|Death|0|||
129525471|NCT02859558|466212656|FG002|Step 2|Death|0|||
129525472|NCT02859558|466212657|FG003|Step 2|Death|0|||
129525473|NCT02859558|466212658|FG004|Step 2|Death|0|||
129525474|NCT02859558|466212654|FG000|Step 2|Incarceration|0|||
129525475|NCT02859558|466212655|FG001|Step 2|Incarceration|0|||
129525476|NCT02859558|466212656|FG002|Step 2|Incarceration|1|||
129525477|NCT02859558|466212657|FG003|Step 2|Incarceration|0|||
129525478|NCT02859558|466212658|FG004|Step 2|Incarceration|0|||
129525479|NCT05665595|466212659|FG000|Overall Study|Ongoing|692|||
129525480|NCT05665595|466212660|FG001|Overall Study|Ongoing|698|||
129525481|NCT05665595|466212659|FG000|Overall Study|Withdrawal by Subject|2|||
129525482|NCT05665595|466212660|FG001|Overall Study|Withdrawal by Subject|2|||
129525483|NCT05665595|466212659|FG000|Overall Study|Lost to Follow-up|1|||
129525484|NCT05665595|466212660|FG001|Overall Study|Lost to Follow-up|0|||
129525485|NCT05665595|466212659|FG000|Overall Study|Death|6|||
129525486|NCT05665595|466212660|FG001|Overall Study|Death|1|||
129525487|NCT00766142|466212661|FG000|Overall Study|Protocol Violation|4|||
129525488|NCT02632344|466212681|FG000|Overall Study|Adverse Event|3|||
129525489|NCT02632344|466212681|FG000|Overall Study|Lack of Efficacy|3|||
129525490|NCT02632344|466212681|FG000|Overall Study|Withdrawal by Subject|2|||
129525491|NCT04076579|466212683|FG000|Overall Study|Adverse Event|2|||
129525492|NCT04076579|466212684|FG001|Overall Study|Adverse Event|0|||
129525493|NCT04076579|466212683|FG000|Overall Study|discontinued due to toxicity|1|||
129525494|NCT04076579|466212684|FG001|Overall Study|discontinued due to toxicity|0|||
129525495|NCT04076579|466212683|FG000|Overall Study|Physician Decision|1|||
129525496|NCT04076579|466212684|FG001|Overall Study|Physician Decision|0|||
129525497|NCT04076579|466212683|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
129525498|NCT04076579|466212684|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
129525499|NCT04076579|466212683|FG000|Overall Study|Noncompliance|0|||
129525500|NCT04076579|466212684|FG001|Overall Study|Noncompliance|1|||
129525501|NCT04076579|466212683|FG000|Overall Study|Withdrawal by Subject|0|||
129525502|NCT04076579|466212684|FG001|Overall Study|Withdrawal by Subject|2|||
129525503|NCT03793010|466212685|FG000|Overall Study|Withdrawal by Subject|5|||
129525504|NCT03793010|466212686|FG001|Overall Study|Withdrawal by Subject|7|||
129525505|NCT03793010|466212685|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
129525506|NCT03793010|466212686|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
129525507|NCT03793010|466212685|FG000|Overall Study|Lost to Follow-up|1|||
129525508|NCT03793010|466212686|FG001|Overall Study|Lost to Follow-up|2|||
129525509|NCT03793010|466212685|FG000|Overall Study|Patient couldn't sit still for injection|1|||
129525510|NCT03793010|466212686|FG001|Overall Study|Patient couldn't sit still for injection|0|||
129525511|NCT03793010|466212685|FG000|Overall Study|Withdrew to pursue other treatment|1|||
129525512|NCT03793010|466212686|FG001|Overall Study|Withdrew to pursue other treatment|0|||
129525513|NCT03793010|466212685|FG000|Overall Study|Did not meet eligibility criteria|1|||
129525514|NCT03793010|466212686|FG001|Overall Study|Did not meet eligibility criteria|0|||
129525515|NCT02903966|466212687|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
129525516|NCT02903966|466212688|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
129525517|NCT02903966|466212687|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
129525518|NCT02903966|466212688|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
129525519|NCT02903966|466212687|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
129525520|NCT02903966|466212688|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
129538746|NCT00553319|466263520|FG002|Overall Study|moved|1|||
129525521|NCT04924114|466212689|FG000|Overall Study|Withdrawal by Subject|0|||
129525522|NCT04924114|466212690|FG001|Overall Study|Withdrawal by Subject|2|||
129525523|NCT04924114|466212691|FG002|Overall Study|Withdrawal by Subject|2|||
129525524|NCT04924114|466212692|FG003|Overall Study|Withdrawal by Subject|0|||
129525525|NCT04924114|466212693|FG004|Overall Study|Withdrawal by Subject|2|||
129525526|NCT04423718|466212694|FG000|Main Study|Adverse Event|9|||
129525527|NCT04423718|466212695|FG001|Main Study|Adverse Event|5|||
129525528|NCT04423718|466212696|FG002|Main Study|Adverse Event|8|||
129525529|NCT04423718|466212694|FG000|Main Study|Physician Decision|3|||
129525530|NCT04423718|466212695|FG001|Main Study|Physician Decision|3|||
129525531|NCT04423718|466212696|FG002|Main Study|Physician Decision|2|||
129525532|NCT04423718|466212694|FG000|Main Study|Protocol Violation|0|||
129525533|NCT04423718|466212695|FG001|Main Study|Protocol Violation|0|||
129525534|NCT04423718|466212696|FG002|Main Study|Protocol Violation|1|||
129525535|NCT04423718|466212694|FG000|Main Study|Lost to Follow-up|3|||
129525536|NCT04423718|466212695|FG001|Main Study|Lost to Follow-up|3|||
129525537|NCT04423718|466212696|FG002|Main Study|Lost to Follow-up|4|||
129525538|NCT04423718|466212694|FG000|Main Study|Lack of Efficacy|2|||
129525539|NCT04423718|466212695|FG001|Main Study|Lack of Efficacy|1|||
129525540|NCT04423718|466212696|FG002|Main Study|Lack of Efficacy|0|||
129525541|NCT04423718|466212694|FG000|Main Study|Withdrawal by Subject|14|||
129525542|NCT04423718|466212695|FG001|Main Study|Withdrawal by Subject|20|||
129525543|NCT04423718|466212696|FG002|Main Study|Withdrawal by Subject|20|||
129525544|NCT04423718|466212694|FG000|Main Study|Death|10|||
129525545|NCT04423718|466212695|FG001|Main Study|Death|7|||
129525546|NCT04423718|466212696|FG002|Main Study|Death|7|||
129525547|NCT04423718|466212694|FG000|Main Study|COVID-19 pandemic|2|||
129525548|NCT04423718|466212695|FG001|Main Study|COVID-19 pandemic|2|||
129525549|NCT04423718|466212696|FG002|Main Study|COVID-19 pandemic|2|||
129525550|NCT04423718|466212694|FG000|Main Study|Other|7|||
129525551|NCT04423718|466212695|FG001|Main Study|Other|3|||
129525552|NCT04423718|466212696|FG002|Main Study|Other|2|||
129525553|NCT04423718|466212694|FG000|Extension Phase|Other|1|||
129525554|NCT04423718|466212695|FG001|Extension Phase|Other|0|||
129525555|NCT04423718|466212696|FG002|Extension Phase|Other|0|||
129525556|NCT04423718|466212694|FG000|Extension Phase|Logistical problems|0|||
129525557|NCT04423718|466212695|FG001|Extension Phase|Logistical problems|1|||
129525558|NCT04423718|466212696|FG002|Extension Phase|Logistical problems|1|||
129525559|NCT04423718|466212694|FG000|Extension Phase|Physician Decision|1|||
129525560|NCT04423718|466212695|FG001|Extension Phase|Physician Decision|0|||
129525561|NCT04423718|466212696|FG002|Extension Phase|Physician Decision|1|||
129525562|NCT04423718|466212694|FG000|Extension Phase|Lack of Efficacy|2|||
129525563|NCT04423718|466212695|FG001|Extension Phase|Lack of Efficacy|0|||
129525564|NCT04423718|466212696|FG002|Extension Phase|Lack of Efficacy|1|||
129525565|NCT04423718|466212694|FG000|Extension Phase|Lost to Follow-up|0|||
129525566|NCT04423718|466212695|FG001|Extension Phase|Lost to Follow-up|2|||
129525567|NCT04423718|466212696|FG002|Extension Phase|Lost to Follow-up|3|||
129525568|NCT04423718|466212694|FG000|Extension Phase|Adverse Event|2|||
129525569|NCT04423718|466212695|FG001|Extension Phase|Adverse Event|3|||
129525570|NCT04423718|466212696|FG002|Extension Phase|Adverse Event|1|||
129525571|NCT04423718|466212694|FG000|Extension Phase|Death|4|||
129525572|NCT04423718|466212695|FG001|Extension Phase|Death|7|||
129525573|NCT04423718|466212696|FG002|Extension Phase|Death|2|||
129525574|NCT04423718|466212694|FG000|Extension Phase|Withdrawal by Subject|11|||
129525575|NCT04423718|466212695|FG001|Extension Phase|Withdrawal by Subject|11|||
129525576|NCT04423718|466212696|FG002|Extension Phase|Withdrawal by Subject|7|||
129525577|NCT00425945|466212697|FG000|Overall Study|Concern about Supplement|2|||
129525578|NCT00425945|466212698|FG001|Overall Study|Concern about Supplement|0|||
129525579|NCT00425945|466212697|FG000|Overall Study|Inconvenience|0|||
129525580|NCT00425945|466212698|FG001|Overall Study|Inconvenience|2|||
129525581|NCT00425945|466212697|FG000|Overall Study|Lost to Follow-up|0|||
129525582|NCT00425945|466212698|FG001|Overall Study|Lost to Follow-up|2|||
129525583|NCT00425945|466212697|FG000|Overall Study|Began hypertension medication|1|||
129525584|NCT00425945|466212698|FG001|Overall Study|Began hypertension medication|0|||
129525585|NCT00425945|466212697|FG000|Overall Study|Began cancer treatments|1|||
129525586|NCT00425945|466212698|FG001|Overall Study|Began cancer treatments|0|||
129525587|NCT00425945|466212697|FG000|Overall Study|Moved from area|0|||
129525588|NCT00425945|466212698|FG001|Overall Study|Moved from area|1|||
129525589|NCT02881151|466212699|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
129525590|NCT04284787|466212700|FG000|Overall Study|Disease Progression|9|||
129525591|NCT04284787|466212701|FG001|Overall Study|Disease Progression|12|||
129525592|NCT04284787|466212700|FG000|Overall Study|Physician Decision|12|||
129525593|NCT04284787|466212701|FG001|Overall Study|Physician Decision|7|||
129525594|NCT04284787|466212700|FG000|Overall Study|Transplant|5|||
129525595|NCT04284787|466212701|FG001|Overall Study|Transplant|4|||
129525596|NCT04284787|466212700|FG000|Overall Study|Death|1|||
129525597|NCT04284787|466212701|FG001|Overall Study|Death|2|||
129525598|NCT04284787|466212700|FG000|Overall Study|Adverse Event|0|||
129525599|NCT04284787|466212701|FG001|Overall Study|Adverse Event|4|||
129525600|NCT04284787|466212700|FG000|Overall Study|Non-adherence|2|||
129525601|NCT04284787|466212701|FG001|Overall Study|Non-adherence|0|||
129525602|NCT04284787|466212700|FG000|Overall Study|Lack of Efficacy|2|||
129525603|NCT04284787|466212701|FG001|Overall Study|Lack of Efficacy|0|||
129525604|NCT04992507|466212704|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
129525605|NCT04992507|466212705|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
129525606|NCT04992507|466212704|FG000|Overall Study|Death|0|||
129525607|NCT04992507|466212705|FG001|Overall Study|Death|1|||
129525608|NCT03287830|466212706|FG000|Overall Study|Withdrawal by Subject|1|||
129525609|NCT03287830|466212707|FG001|Overall Study|Withdrawal by Subject|1|||
129525610|NCT03287830|466212706|FG000|Overall Study|not meeting inclusion criteria|5|||
129525611|NCT03287830|466212707|FG001|Overall Study|not meeting inclusion criteria|12|||
129525612|NCT02974621|466212708|FG000|Overall Study|Didn't receive study treatment|1|||
129525613|NCT02974621|466212709|FG001|Overall Study|Didn't receive study treatment|10|||
129525614|NCT00557323|466212710|FG000|Overall Study|Death|3|||
129525615|NCT00557323|466212710|FG000|Overall Study|Withdrawal by Subject|2|||
129525616|NCT00557323|466212710|FG000|Overall Study|Administrative change|2|||
129525617|NCT01196091|466212715|FG000|Overall Study|Adverse Event|22|||
129525618|NCT01196091|466212716|FG001|Overall Study|Adverse Event|27|||
129525619|NCT01196091|466212717|FG002|Overall Study|Adverse Event|26|||
129525620|NCT01196091|466212715|FG000|Overall Study|Death|3|||
129525621|NCT01196091|466212716|FG001|Overall Study|Death|2|||
129525622|NCT01196091|466212717|FG002|Overall Study|Death|2|||
129525623|NCT01196091|466212715|FG000|Overall Study|Entry Criteria Not Met|11|||
129525624|NCT01196091|466212716|FG001|Overall Study|Entry Criteria Not Met|11|||
129525625|NCT01196091|466212717|FG002|Overall Study|Entry Criteria Not Met|10|||
129525626|NCT01196091|466212715|FG000|Overall Study|Lack of Efficacy|15|||
129525627|NCT01196091|466212716|FG001|Overall Study|Lack of Efficacy|12|||
129525628|NCT01196091|466212717|FG002|Overall Study|Lack of Efficacy|17|||
129525629|NCT01196091|466212715|FG000|Overall Study|Lost to Follow-up|5|||
129525630|NCT01196091|466212716|FG001|Overall Study|Lost to Follow-up|5|||
129525631|NCT01196091|466212717|FG002|Overall Study|Lost to Follow-up|6|||
129525632|NCT01196091|466212715|FG000|Overall Study|Parent/Caregiver Decision|0|||
129525633|NCT01196091|466212716|FG001|Overall Study|Parent/Caregiver Decision|0|||
129525634|NCT01196091|466212717|FG002|Overall Study|Parent/Caregiver Decision|1|||
129525635|NCT01196091|466212715|FG000|Overall Study|Withdrawal by Subject|16|||
129525636|NCT01196091|466212716|FG001|Overall Study|Withdrawal by Subject|19|||
129525637|NCT01196091|466212717|FG002|Overall Study|Withdrawal by Subject|22|||
129525638|NCT01196091|466212715|FG000|Overall Study|Physician Decision|3|||
129525639|NCT01196091|466212716|FG001|Overall Study|Physician Decision|3|||
129525640|NCT01196091|466212717|FG002|Overall Study|Physician Decision|4|||
129525641|NCT01196091|466212715|FG000|Overall Study|Protocol Violation|1|||
129525642|NCT01196091|466212716|FG001|Overall Study|Protocol Violation|3|||
129525643|NCT01196091|466212717|FG002|Overall Study|Protocol Violation|3|||
129525644|NCT01196091|466212715|FG000|Overall Study|Sponsor Decision|6|||
129525645|NCT01196091|466212716|FG001|Overall Study|Sponsor Decision|5|||
129525646|NCT01196091|466212717|FG002|Overall Study|Sponsor Decision|4|||
129525647|NCT01196091|466212715|FG000|Overall Study|Excluded Site|5|||
129525648|NCT01196091|466212716|FG001|Overall Study|Excluded Site|11|||
129525649|NCT01196091|466212717|FG002|Overall Study|Excluded Site|8|||
129525650|NCT01196091|466212715|FG000|Overall Study|Randomized, No Study Drug Received|1|||
129525651|NCT01196091|466212716|FG001|Overall Study|Randomized, No Study Drug Received|0|||
129525652|NCT01196091|466212717|FG002|Overall Study|Randomized, No Study Drug Received|1|||
129525653|NCT03733249|466212718|FG000|Overall Study|Death|7|||
129525654|NCT03733249|466212718|FG000|Overall Study|Disease relapse|16|||
129525655|NCT03733249|466212718|FG000|Overall Study|Lost to Follow-up|4|||
129525656|NCT03733249|466212718|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
129525657|NCT03733249|466212718|FG000|Overall Study|Withdrawal by Subject|1|||
129525658|NCT02253992|466212719|FG000|Overall Study|Study drug toxicity|1|||
129525659|NCT02253992|466212720|FG001|Overall Study|Study drug toxicity|0|||
129525660|NCT02253992|466212721|FG002|Overall Study|Study drug toxicity|10|||
129525661|NCT02253992|466212719|FG000|Overall Study|Disease progression|4|||
129525662|NCT02253992|466212720|FG001|Overall Study|Disease progression|3|||
129525663|NCT02253992|466212721|FG002|Overall Study|Disease progression|98|||
129525664|NCT02253992|466212719|FG000|Overall Study|Withdrawal by Subject|0|||
129525665|NCT02253992|466212720|FG001|Overall Study|Withdrawal by Subject|0|||
129525666|NCT02253992|466212721|FG002|Overall Study|Withdrawal by Subject|3|||
129525667|NCT02253992|466212719|FG000|Overall Study|Adverse Event|0|||
129525668|NCT02253992|466212720|FG001|Overall Study|Adverse Event|0|||
129525669|NCT02253992|466212721|FG002|Overall Study|Adverse Event|8|||
129525670|NCT02253992|466212719|FG000|Overall Study|Death|0|||
129525671|NCT02253992|466212720|FG001|Overall Study|Death|0|||
129525672|NCT02253992|466212721|FG002|Overall Study|Death|1|||
129525673|NCT02253992|466212719|FG000|Overall Study|Subject discontinued study drug|1|||
129525674|NCT02253992|466212720|FG001|Overall Study|Subject discontinued study drug|0|||
129525675|NCT02253992|466212721|FG002|Overall Study|Subject discontinued study drug|1|||
129525676|NCT02253992|466212719|FG000|Overall Study|Completed treatment as per protocol|0|||
129525677|NCT02253992|466212720|FG001|Overall Study|Completed treatment as per protocol|1|||
129525678|NCT02253992|466212721|FG002|Overall Study|Completed treatment as per protocol|22|||
129525679|NCT02253992|466212719|FG000|Overall Study|Other|0|||
129525680|NCT02253992|466212720|FG001|Overall Study|Other|0|||
129525681|NCT02253992|466212721|FG002|Overall Study|Other|1|||
129525682|NCT00772889|466212722|FG000|Overall Study|Adverse Event|7|||
129525683|NCT00772889|466212723|FG001|Overall Study|Adverse Event|4|||
129525684|NCT00772889|466212724|FG002|Overall Study|Adverse Event|0|||
129525685|NCT00772889|466212722|FG000|Overall Study|Withdrawal by Subject|9|||
129525686|NCT00772889|466212723|FG001|Overall Study|Withdrawal by Subject|8|||
129525687|NCT00772889|466212724|FG002|Overall Study|Withdrawal by Subject|9|||
129525688|NCT00772889|466212722|FG000|Overall Study|Lost to Follow-up|6|||
129525689|NCT00772889|466212723|FG001|Overall Study|Lost to Follow-up|6|||
129525690|NCT00772889|466212724|FG002|Overall Study|Lost to Follow-up|7|||
129525691|NCT03323086|466212725|FG000|Overall Study|Lost to Follow-up|3|||
129525692|NCT03323086|466212726|FG001|Overall Study|Lost to Follow-up|2|||
129525693|NCT04247828|466212735|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
129525694|NCT02159365|466212736|FG000|Overall Study|Disease Progression|23|||
129525695|NCT02159365|466212736|FG000|Overall Study|Other reasons|11|||
129525696|NCT02159365|466212736|FG000|Overall Study|Administrative reason by Sponsor|9|||
129525697|NCT02159365|466212736|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
129525698|NCT02159365|466212736|FG000|Overall Study|Study drug toxicity|7|||
129525699|NCT02159365|466212736|FG000|Overall Study|Maximum clinical benefit|3|||
129525700|NCT02159365|466212736|FG000|Overall Study|Subject request to discontinue treatment|3|||
129525701|NCT02159365|466212736|FG000|Overall Study|Subject withdrew consent|3|||
129525702|NCT02159365|466212736|FG000|Overall Study|Death|1|||
129525703|NCT02159365|466212736|FG000|Overall Study|Lost to Follow-up|1|||
129525704|NCT03083470|466212737|FG000|Overall Study|Lost to Follow-up|0|||
129525705|NCT03083470|466212738|FG001|Overall Study|Lost to Follow-up|0|||
129525706|NCT03083470|466212739|FG002|Overall Study|Lost to Follow-up|0|||
129525707|NCT03083470|466212740|FG003|Overall Study|Lost to Follow-up|0|||
129525708|NCT03083470|466212741|FG004|Overall Study|Lost to Follow-up|1|||
129525709|NCT03083470|466212737|FG000|Overall Study|Withdrawal by Subject|0|||
129525710|NCT03083470|466212738|FG001|Overall Study|Withdrawal by Subject|0|||
129525711|NCT03083470|466212739|FG002|Overall Study|Withdrawal by Subject|0|||
129525712|NCT03083470|466212740|FG003|Overall Study|Withdrawal by Subject|0|||
129525713|NCT03083470|466212741|FG004|Overall Study|Withdrawal by Subject|1|||
129525714|NCT03077711|466212742|FG000|Overall Study|Lost to Follow-up|2|||
129525715|NCT03077711|466212743|FG001|Overall Study|Lost to Follow-up|2|||
129525716|NCT03077711|466212742|FG000|Overall Study|noncompliant taking medication|2|||
129525717|NCT03077711|466212743|FG001|Overall Study|noncompliant taking medication|0|||
129525718|NCT01108068|466212744|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
129525719|NCT01108068|466212745|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
129525720|NCT00836953|466212746|FG000|Overall Study|Withdrawal by Subject|1|||
129525721|NCT00836953|466212746|FG000|Overall Study|Lost to Follow-up|1|||
129525722|NCT00376675|466212747|FG000|Overall Study|Withdrawal by Subject|9|||
129525723|NCT00376675|466212748|FG001|Overall Study|Withdrawal by Subject|2|||
129525724|NCT00376675|466212747|FG000|Overall Study|Adverse Event|10|||
129525725|NCT00376675|466212748|FG001|Overall Study|Adverse Event|5|||
129525726|NCT00376675|466212747|FG000|Overall Study|Other Reason|1|||
129525727|NCT00376675|466212748|FG001|Overall Study|Other Reason|7|||
129525728|NCT02943668|466212750|FG000|Overall Study|Disease Progression|1|||
129525729|NCT00255008|466212751|FG000|Overall Study|Adverse Event|1|||
129525730|NCT00255008|466212752|FG001|Overall Study|Adverse Event|1|||
129525731|NCT00255008|466212753|FG002|Overall Study|Adverse Event|2|||
129525732|NCT00255008|466212754|FG003|Overall Study|Adverse Event|0|||
129525733|NCT00255008|466212751|FG000|Overall Study|Lost to Follow-up|1|||
129525734|NCT00255008|466212752|FG001|Overall Study|Lost to Follow-up|0|||
129525735|NCT00255008|466212753|FG002|Overall Study|Lost to Follow-up|1|||
129525736|NCT00255008|466212754|FG003|Overall Study|Lost to Follow-up|2|||
129525737|NCT00255008|466212751|FG000|Overall Study|Did not meet viral reduction criteria|4|||
129525738|NCT00255008|466212752|FG001|Overall Study|Did not meet viral reduction criteria|5|||
129525739|NCT00255008|466212753|FG002|Overall Study|Did not meet viral reduction criteria|0|||
129525740|NCT00255008|466212754|FG003|Overall Study|Did not meet viral reduction criteria|1|||
129525741|NCT00255008|466212751|FG000|Overall Study|Withdrew consent|0|||
129525742|NCT00255008|466212752|FG001|Overall Study|Withdrew consent|0|||
129525743|NCT00255008|466212753|FG002|Overall Study|Withdrew consent|2|||
129525744|NCT00255008|466212754|FG003|Overall Study|Withdrew consent|0|||
129525745|NCT00255008|466212751|FG000|Overall Study|Sponsor request|18|||
129525746|NCT00255008|466212752|FG001|Overall Study|Sponsor request|3|||
129525747|NCT00255008|466212753|FG002|Overall Study|Sponsor request|8|||
129525748|NCT00255008|466212754|FG003|Overall Study|Sponsor request|17|||
129525749|NCT00255008|466212751|FG000|Overall Study|Adverse lab experience|1|||
129525750|NCT00255008|466212752|FG001|Overall Study|Adverse lab experience|0|||
129525751|NCT00255008|466212753|FG002|Overall Study|Adverse lab experience|0|||
129525752|NCT00255008|466212754|FG003|Overall Study|Adverse lab experience|0|||
129525753|NCT00255008|466212751|FG000|Overall Study|Other|7|||
129525754|NCT00255008|466212752|FG001|Overall Study|Other|0|||
129525755|NCT00255008|466212753|FG002|Overall Study|Other|3|||
129525756|NCT00255008|466212754|FG003|Overall Study|Other|2|||
129525757|NCT02996500|466212755|FG000|Overall Study|Adverse Event|1|||
129525758|NCT02996500|466212756|FG001|Overall Study|Adverse Event|1|||
129525759|NCT02996500|466212757|FG002|Overall Study|Adverse Event|4|||
129525760|NCT02996500|466212758|FG003|Overall Study|Adverse Event|3|||
129525761|NCT02996500|466212759|FG004|Overall Study|Adverse Event|1|||
129525762|NCT02996500|466212760|FG005|Overall Study|Adverse Event|2|||
129525763|NCT02996500|466212755|FG000|Overall Study|Lack of Efficacy|0|||
129525764|NCT02996500|466212756|FG001|Overall Study|Lack of Efficacy|0|||
129525765|NCT02996500|466212757|FG002|Overall Study|Lack of Efficacy|0|||
129525766|NCT02996500|466212758|FG003|Overall Study|Lack of Efficacy|0|||
129525767|NCT02996500|466212759|FG004|Overall Study|Lack of Efficacy|2|||
129525768|NCT02996500|466212760|FG005|Overall Study|Lack of Efficacy|0|||
129525769|NCT02996500|466212755|FG000|Overall Study|Lost to Follow-up|1|||
129525770|NCT02996500|466212756|FG001|Overall Study|Lost to Follow-up|0|||
129525771|NCT02996500|466212757|FG002|Overall Study|Lost to Follow-up|0|||
129525772|NCT02996500|466212758|FG003|Overall Study|Lost to Follow-up|0|||
129525773|NCT02996500|466212759|FG004|Overall Study|Lost to Follow-up|0|||
129525774|NCT02996500|466212760|FG005|Overall Study|Lost to Follow-up|1|||
129525775|NCT02996500|466212755|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
129525776|NCT02996500|466212756|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
129525777|NCT02996500|466212757|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
129525778|NCT02996500|466212758|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
129525779|NCT02996500|466212759|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
129525780|NCT02996500|466212760|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
129525781|NCT02996500|466212755|FG000|Overall Study|Non-Compliance With Study Drug|0|||
129525782|NCT02996500|466212756|FG001|Overall Study|Non-Compliance With Study Drug|0|||
129525783|NCT02996500|466212757|FG002|Overall Study|Non-Compliance With Study Drug|0|||
129525784|NCT02996500|466212758|FG003|Overall Study|Non-Compliance With Study Drug|0|||
129525785|NCT02996500|466212759|FG004|Overall Study|Non-Compliance With Study Drug|0|||
129525786|NCT02996500|466212760|FG005|Overall Study|Non-Compliance With Study Drug|1|||
129525787|NCT02996500|466212755|FG000|Overall Study|Progressive Disease|1|||
129525788|NCT02996500|466212756|FG001|Overall Study|Progressive Disease|0|||
129525789|NCT02996500|466212757|FG002|Overall Study|Progressive Disease|0|||
129525790|NCT02996500|466212758|FG003|Overall Study|Progressive Disease|0|||
129525791|NCT02996500|466212759|FG004|Overall Study|Progressive Disease|0|||
129525792|NCT02996500|466212760|FG005|Overall Study|Progressive Disease|0|||
129525793|NCT02996500|466212755|FG000|Overall Study|Other|2|||
129525794|NCT02996500|466212756|FG001|Overall Study|Other|0|||
129525795|NCT02996500|466212757|FG002|Overall Study|Other|2|||
129525796|NCT02996500|466212758|FG003|Overall Study|Other|0|||
129525797|NCT02996500|466212759|FG004|Overall Study|Other|0|||
129525798|NCT02996500|466212760|FG005|Overall Study|Other|0|||
129525799|NCT02996500|466212755|FG000|Overall Study|Protocol Violation|0|||
129525800|NCT02996500|466212756|FG001|Overall Study|Protocol Violation|0|||
129525801|NCT02996500|466212757|FG002|Overall Study|Protocol Violation|0|||
129525802|NCT02996500|466212758|FG003|Overall Study|Protocol Violation|1|||
129525803|NCT02996500|466212759|FG004|Overall Study|Protocol Violation|0|||
129525804|NCT02996500|466212760|FG005|Overall Study|Protocol Violation|0|||
129525805|NCT02996500|466212755|FG000|Overall Study|Withdrawal by Subject|3|||
129525806|NCT02996500|466212756|FG001|Overall Study|Withdrawal by Subject|0|||
129525807|NCT02996500|466212757|FG002|Overall Study|Withdrawal by Subject|3|||
129525808|NCT02996500|466212758|FG003|Overall Study|Withdrawal by Subject|0|||
129525809|NCT02996500|466212759|FG004|Overall Study|Withdrawal by Subject|2|||
129525810|NCT02996500|466212760|FG005|Overall Study|Withdrawal by Subject|0|||
129525811|NCT00707486|466212761|FG000|Overall Study|Withdrawal by Subject|1|||
129525812|NCT00126425|466212767|FG000|Overall Study|Withdrawal by Subject|17|||
129525813|NCT00126425|466212768|FG001|Overall Study|Withdrawal by Subject|1|||
129525814|NCT00126425|466212767|FG000|Overall Study|Lost to Follow-up|8|||
129525815|NCT00126425|466212768|FG001|Overall Study|Lost to Follow-up|4|||
129525816|NCT00126425|466212767|FG000|Overall Study|Protocol Violation|9|||
129525817|NCT00126425|466212768|FG001|Overall Study|Protocol Violation|6|||
129525818|NCT00126425|466212767|FG000|Overall Study|Adverse Event|1|||
129525819|NCT00126425|466212768|FG001|Overall Study|Adverse Event|0|||
129525820|NCT00126425|466212767|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
129525821|NCT00126425|466212768|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
129525822|NCT00126425|466212767|FG000|Overall Study|Other|5|||
129525823|NCT00126425|466212768|FG001|Overall Study|Other|0|||
129525824|NCT02774291|466212769|FG000|Overall Study|Lost to Follow-up|1|||
129525825|NCT00471315|466212770|FG000|Overall Study|Adverse Event|7|||
129525826|NCT00471315|466212770|FG000|Overall Study|Withdrawal by Subject|1|||
129525827|NCT04474366|466212771|FG000|Overall Study|Lost to Follow-up|2|||
129525828|NCT04474366|466212772|FG001|Overall Study|Lost to Follow-up|5|||
129525829|NCT00320190|466212773|FG000|First 12 Months|Completed but did not enter extension|5|||
129525830|NCT00320190|466212774|FG001|First 12 Months|Completed but did not enter extension|3|||
129525831|NCT00320190|466212773|FG000|First 12 Months|Sponsor terminated study|2|||
129525832|NCT00320190|466212774|FG001|First 12 Months|Sponsor terminated study|2|||
129525833|NCT00320190|466212773|FG000|First 12 Months|Lost to Follow-up|0|||
129525834|NCT00320190|466212774|FG001|First 12 Months|Lost to Follow-up|1|||
129525835|NCT00320190|466212773|FG000|First 12 Months|Enrollment failure|0|||
129525836|NCT00320190|466212774|FG001|First 12 Months|Enrollment failure|1|||
129525837|NCT00320190|466212773|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
129525838|NCT00320190|466212774|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
129525839|NCT00320190|466212773|FG000|First 12 Months|Investigator request|0|||
129525840|NCT00320190|466212774|FG001|First 12 Months|Investigator request|1|||
129525841|NCT00320190|466212773|FG000|First 12 Months|Study drug toxicity|0|||
129525842|NCT00320190|466212774|FG001|First 12 Months|Study drug toxicity|1|||
129525843|NCT00320190|466212773|FG000|First 12 Months|Withdrawal by Subject|0|||
129525844|NCT00320190|466212774|FG001|First 12 Months|Withdrawal by Subject|1|||
129525845|NCT00320190|466212773|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
129525846|NCT00320190|466212774|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
129525847|NCT00320190|466212773|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
129525848|NCT00320190|466212774|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
129525849|NCT00320190|466212773|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
129525850|NCT00320190|466212774|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
129525851|NCT00712270|466212775|FG000|Overall Study|Withdrawal by Subject|11|||
129525852|NCT00712270|466212775|FG000|Overall Study|Screen Failure|3|||
129525853|NCT00102804|466212782|FG000|Overall Study|Progressive Disease (PD)|307|||
129525854|NCT00102804|466212783|FG001|Overall Study|Progressive Disease (PD)|196|||
129525855|NCT00102804|466212782|FG000|Overall Study|Withdrawal by Subject|46|||
129525856|NCT00102804|466212783|FG001|Overall Study|Withdrawal by Subject|7|||
129525857|NCT00102804|466212782|FG000|Overall Study|Adverse Event|37|||
129525858|NCT00102804|466212783|FG001|Overall Study|Adverse Event|3|||
129525859|NCT00102804|466212782|FG000|Overall Study|Physician Decision|24|||
129525860|NCT00102804|466212783|FG001|Overall Study|Physician Decision|6|||
129525861|NCT00102804|466212782|FG000|Overall Study|Death|5|||
129525862|NCT00102804|466212783|FG001|Overall Study|Death|6|||
129525863|NCT00102804|466212782|FG000|Overall Study|Enrollment Criteria Not Met|6|||
129525864|NCT00102804|466212783|FG001|Overall Study|Enrollment Criteria Not Met|0|||
129525865|NCT00102804|466212782|FG000|Overall Study|Lost to Follow-up|4|||
129525866|NCT00102804|466212783|FG001|Overall Study|Lost to Follow-up|1|||
129525867|NCT00102804|466212782|FG000|Overall Study|Protocol Violation|2|||
129525868|NCT00102804|466212783|FG001|Overall Study|Protocol Violation|1|||
129525869|NCT00102804|466212782|FG000|Overall Study|Satisfactory Response|2|||
129525870|NCT00102804|466212783|FG001|Overall Study|Satisfactory Response|0|||
129525871|NCT00102804|466212782|FG000|Overall Study|Sponsor Decision|1|||
129525872|NCT00102804|466212783|FG001|Overall Study|Sponsor Decision|0|||
129525873|NCT00102804|466212782|FG000|Overall Study|Alive, Receiving Treatment|7|||
129525874|NCT00102804|466212783|FG001|Overall Study|Alive, Receiving Treatment|2|||
129525875|NCT00683774|466212785|FG000|Overall Study|Withdrawal by Subject|0|||
129525876|NCT00683774|466212786|FG001|Overall Study|Withdrawal by Subject|1|||
129525877|NCT00683774|466212785|FG000|Overall Study|Physician Decision|3|||
129525878|NCT00683774|466212786|FG001|Overall Study|Physician Decision|0|||
129525879|NCT00691054|466212787|FG000|Overall Study|Withdrawal by Subject|1|||
129525880|NCT04964557|466212788|FG000|Overall Study|Withdrawal by Subject|3|||
129525881|NCT04964557|466212789|FG001|Overall Study|Withdrawal by Subject|2|||
129525882|NCT04964557|466212788|FG000|Overall Study|Lost to Follow-up|1|||
129525883|NCT04964557|466212789|FG001|Overall Study|Lost to Follow-up|2|||
129525884|NCT04964557|466212788|FG000|Overall Study|Physician Decision|2|||
129525885|NCT04964557|466212789|FG001|Overall Study|Physician Decision|0|||
129525886|NCT04964557|466212788|FG000|Overall Study|Death|3|||
129525887|NCT04964557|466212789|FG001|Overall Study|Death|0|||
129525888|NCT04964557|466212788|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
129525889|NCT04964557|466212789|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
129525890|NCT03991936|466214490|FG000|Overall Study|Lost to Follow-up|1|||
129525891|NCT03991936|466214491|FG001|Overall Study|Lost to Follow-up|1|||
129525892|NCT03991936|466214492|FG002|Overall Study|Lost to Follow-up|1|||
129525893|NCT03991936|466214493|FG003|Overall Study|Lost to Follow-up|1|||
129525894|NCT03991936|466214494|FG004|Overall Study|Lost to Follow-up|1|||
129525895|NCT00939055|466214495|FG000|Overall Study|Discontinuation prior to procedure|4|||
129525896|NCT00939055|466214496|FG001|Overall Study|Discontinuation prior to procedure|0|||
129525897|NCT00584987|466214499|FG000|Overall Study|Protocol Violation|1|||
129525898|NCT00584987|466214500|FG001|Overall Study|Protocol Violation|1|||
129525899|NCT00584987|466214501|FG002|Overall Study|Protocol Violation|1|||
129525900|NCT00584987|466214502|FG003|Overall Study|Protocol Violation|0|||
129525901|NCT00584987|466214499|FG000|Overall Study|Adverse Event|0|||
129525902|NCT00584987|466214500|FG001|Overall Study|Adverse Event|0|||
129525903|NCT00584987|466214501|FG002|Overall Study|Adverse Event|0|||
129525904|NCT00584987|466214502|FG003|Overall Study|Adverse Event|1|||
129525905|NCT03225833|466214503|FG000|Overall Study|Adverse Event|0|||
129525906|NCT03225833|466214504|FG001|Overall Study|Adverse Event|1|||
129525907|NCT03225833|466214505|FG002|Overall Study|Adverse Event|2|||
129525908|NCT03225833|466214506|FG003|Overall Study|Adverse Event|0|||
129525909|NCT03225833|466214507|FG004|Overall Study|Adverse Event|0|||
129525910|NCT03225833|466214508|FG005|Overall Study|Adverse Event|2|||
129525911|NCT03225833|466214503|FG000|Overall Study|Withdrawal by Subject|1|||
129525912|NCT03225833|466214504|FG001|Overall Study|Withdrawal by Subject|0|||
129525913|NCT03225833|466214505|FG002|Overall Study|Withdrawal by Subject|0|||
129525914|NCT03225833|466214506|FG003|Overall Study|Withdrawal by Subject|0|||
129525915|NCT03225833|466214507|FG004|Overall Study|Withdrawal by Subject|1|||
129525916|NCT03225833|466214508|FG005|Overall Study|Withdrawal by Subject|0|||
129525917|NCT03225833|466214503|FG000|Overall Study|Termination of Study by Sponsor|4|||
129525918|NCT03225833|466214504|FG001|Overall Study|Termination of Study by Sponsor|0|||
129525919|NCT03225833|466214505|FG002|Overall Study|Termination of Study by Sponsor|0|||
129525920|NCT03225833|466214506|FG003|Overall Study|Termination of Study by Sponsor|0|||
129525921|NCT03225833|466214507|FG004|Overall Study|Termination of Study by Sponsor|0|||
129525922|NCT03225833|466214508|FG005|Overall Study|Termination of Study by Sponsor|7|||
129525923|NCT03225833|466214503|FG000|Overall Study|Sponsor Decision|0|||
129525924|NCT03225833|466214504|FG001|Overall Study|Sponsor Decision|0|||
129525925|NCT03225833|466214505|FG002|Overall Study|Sponsor Decision|0|||
129525926|NCT03225833|466214506|FG003|Overall Study|Sponsor Decision|0|||
129525927|NCT03225833|466214507|FG004|Overall Study|Sponsor Decision|0|||
129525928|NCT03225833|466214508|FG005|Overall Study|Sponsor Decision|1|||
129525929|NCT03258593|466214510|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
129525930|NCT03258593|466214511|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
129525931|NCT03258593|466214512|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
129525932|NCT03258593|466214513|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
129525933|NCT03258593|466214510|FG000|Run-In Maintenance Phase|Disease progression|3|||
129525934|NCT03258593|466214511|FG001|Run-In Maintenance Phase|Disease progression|0|||
129525935|NCT03258593|466214512|FG002|Run-In Maintenance Phase|Disease progression|0|||
129525936|NCT03258593|466214513|FG003|Run-In Maintenance Phase|Disease progression|0|||
129525937|NCT03258593|466214510|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
129525938|NCT03258593|466214511|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
129525939|NCT03258593|466214512|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
129525940|NCT03258593|466214513|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
129525941|NCT03258593|466214510|FG000|Expansion Maintenance Phase|Physician Decision|0|||
129525942|NCT03258593|466214511|FG001|Expansion Maintenance Phase|Physician Decision|1|||
129525943|NCT03258593|466214512|FG002|Expansion Maintenance Phase|Physician Decision|0|||
129525944|NCT03258593|466214513|FG003|Expansion Maintenance Phase|Physician Decision|0|||
129525945|NCT05318183|466214517|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
129525946|NCT05318183|466214518|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
129525947|NCT05318183|466214517|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
129525948|NCT05318183|466214518|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
129525949|NCT03657576|466214519|FG000|Overall Study|Death|0|||
129525950|NCT03657576|466214520|FG001|Overall Study|Death|1|||
129525951|NCT03657576|466214521|FG002|Overall Study|Death|1|||
129525952|NCT03657576|466214522|FG003|Overall Study|Death|0|||
129525953|NCT03657576|466214523|FG004|Overall Study|Death|0|||
129525954|NCT03657576|466214524|FG005|Overall Study|Death|0|||
129525955|NCT03657576|466214519|FG000|Overall Study|Withdrawal by Subject|0|||
129525956|NCT03657576|466214520|FG001|Overall Study|Withdrawal by Subject|0|||
129525957|NCT03657576|466214521|FG002|Overall Study|Withdrawal by Subject|0|||
129525958|NCT03657576|466214522|FG003|Overall Study|Withdrawal by Subject|1|||
129525959|NCT03657576|466214523|FG004|Overall Study|Withdrawal by Subject|0|||
129525960|NCT03657576|466214524|FG005|Overall Study|Withdrawal by Subject|0|||
129525961|NCT03657576|466214519|FG000|Overall Study|Screen Fail|0|||
129525962|NCT03657576|466214520|FG001|Overall Study|Screen Fail|0|||
129525963|NCT03657576|466214521|FG002|Overall Study|Screen Fail|0|||
129525964|NCT03657576|466214522|FG003|Overall Study|Screen Fail|0|||
129525965|NCT03657576|466214523|FG004|Overall Study|Screen Fail|0|||
129525966|NCT03657576|466214524|FG005|Overall Study|Screen Fail|5|||
129525967|NCT03657576|466214519|FG000|Overall Study|Disease Progression|1|||
129525968|NCT03657576|466214520|FG001|Overall Study|Disease Progression|1|||
129525969|NCT03657576|466214521|FG002|Overall Study|Disease Progression|0|||
129525970|NCT03657576|466214522|FG003|Overall Study|Disease Progression|5|||
129525971|NCT03657576|466214523|FG004|Overall Study|Disease Progression|0|||
129525972|NCT03657576|466214524|FG005|Overall Study|Disease Progression|0|||
129525973|NCT03657576|466214519|FG000|Overall Study|Insurance Coverage|0|||
129525974|NCT03657576|466214520|FG001|Overall Study|Insurance Coverage|0|||
129525975|NCT03657576|466214521|FG002|Overall Study|Insurance Coverage|0|||
129525976|NCT03657576|466214522|FG003|Overall Study|Insurance Coverage|1|||
129525977|NCT03657576|466214523|FG004|Overall Study|Insurance Coverage|0|||
129525978|NCT03657576|466214524|FG005|Overall Study|Insurance Coverage|0|||
129525979|NCT03381274|466214527|FG000|Overall Study|Death|2|||
129525980|NCT03381274|466214528|FG001|Overall Study|Death|9|||
129525981|NCT03381274|466214529|FG002|Overall Study|Death|3|||
129525982|NCT03381274|466214530|FG003|Overall Study|Death|2|||
129525983|NCT03381274|466214531|FG004|Overall Study|Death|3|||
129525984|NCT03381274|466214527|FG000|Overall Study|Lost to Follow-up|0|||
129525985|NCT03381274|466214528|FG001|Overall Study|Lost to Follow-up|0|||
129525986|NCT03381274|466214529|FG002|Overall Study|Lost to Follow-up|0|||
129525987|NCT03381274|466214530|FG003|Overall Study|Lost to Follow-up|1|||
129525988|NCT03381274|466214531|FG004|Overall Study|Lost to Follow-up|0|||
129525989|NCT03381274|466214527|FG000|Overall Study|Withdrawal by Subject|2|||
129525990|NCT03381274|466214528|FG001|Overall Study|Withdrawal by Subject|1|||
129525991|NCT03381274|466214529|FG002|Overall Study|Withdrawal by Subject|3|||
129525992|NCT03381274|466214530|FG003|Overall Study|Withdrawal by Subject|1|||
129525993|NCT03381274|466214531|FG004|Overall Study|Withdrawal by Subject|0|||
129525994|NCT03381274|466214527|FG000|Overall Study|Other|1|||
129525995|NCT03381274|466214528|FG001|Overall Study|Other|11|||
129525996|NCT03381274|466214529|FG002|Overall Study|Other|0|||
129525997|NCT03381274|466214530|FG003|Overall Study|Other|2|||
129525998|NCT03381274|466214531|FG004|Overall Study|Other|2|||
129525999|NCT01874353|466214532|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
129526000|NCT01874353|466214533|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
129526001|NCT01874353|466214534|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
129526002|NCT01874353|466214535|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
129526003|NCT01874353|466214532|FG000|Overall Study|Lost to Follow-up|2|||
129526004|NCT01874353|466214533|FG001|Overall Study|Lost to Follow-up|2|||
129526005|NCT01874353|466214534|FG002|Overall Study|Lost to Follow-up|2|||
129526006|NCT01874353|466214535|FG003|Overall Study|Lost to Follow-up|0|||
129526007|NCT01874353|466214532|FG000|Overall Study|Death|110|||
129526008|NCT01874353|466214533|FG001|Overall Study|Death|60|||
129526009|NCT01874353|466214534|FG002|Overall Study|Death|13|||
129526010|NCT01874353|466214535|FG003|Overall Study|Death|7|||
129526011|NCT01874353|466214532|FG000|Overall Study|Withdrawal by Subject|13|||
129526012|NCT01874353|466214533|FG001|Overall Study|Withdrawal by Subject|11|||
129526013|NCT01874353|466214534|FG002|Overall Study|Withdrawal by Subject|0|||
129526014|NCT01874353|466214535|FG003|Overall Study|Withdrawal by Subject|0|||
129526015|NCT04392154|466214536|FG000|Overall Study|Adverse Event|3|||
129526016|NCT04392154|466214537|FG001|Overall Study|Adverse Event|46|||
129526017|NCT04392154|466214536|FG000|Overall Study|Due to epidemic/pandemic|0|||
129526018|NCT04392154|466214537|FG001|Overall Study|Due to epidemic/pandemic|1|||
129526019|NCT04392154|466214536|FG000|Overall Study|Lack of Efficacy|1|||
129526020|NCT04392154|466214537|FG001|Overall Study|Lack of Efficacy|47|||
129526021|NCT04392154|466214536|FG000|Overall Study|Lost to Follow-up|11|||
129526022|NCT04392154|466214537|FG001|Overall Study|Lost to Follow-up|61|||
129526023|NCT04392154|466214536|FG000|Overall Study|Geopolitical conflict|1|||
129526024|NCT04392154|466214537|FG001|Overall Study|Geopolitical conflict|1|||
129526025|NCT04392154|466214536|FG000|Overall Study|Physician Decision|1|||
129526026|NCT04392154|466214537|FG001|Overall Study|Physician Decision|5|||
129526027|NCT04392154|466214536|FG000|Overall Study|Pregnancy|1|||
129526028|NCT04392154|466214537|FG001|Overall Study|Pregnancy|8|||
129526029|NCT04392154|466214536|FG000|Overall Study|Protocol deviation|1|||
129526030|NCT04392154|466214537|FG001|Overall Study|Protocol deviation|12|||
129526031|NCT04392154|466214536|FG000|Overall Study|Withdrawal by Subject|18|||
129526032|NCT04392154|466214537|FG001|Overall Study|Withdrawal by Subject|138|||
129526033|NCT04392154|466214536|FG000|Overall Study|Sponsor Decision|1|||
129526034|NCT04392154|466214537|FG001|Overall Study|Sponsor Decision|14|||
129526035|NCT04392154|466214536|FG000|Overall Study|Site Closure|0|||
129526036|NCT04392154|466214537|FG001|Overall Study|Site Closure|4|||
129526037|NCT05180721|466214538|FG000|Overall Study|Lost to Follow-up|4|||
129526038|NCT01996865|466214540|FG000|Induction Period|Protocol Violation|1|||
129526039|NCT01996865|466214541|FG001|Induction Period|Protocol Violation|0|||
129526040|NCT01996865|466214542|FG002|Induction Period|Protocol Violation|0|||
129526041|NCT01996865|466214540|FG000|Induction Period|Progressive Disease|4|||
129526042|NCT01996865|466214541|FG001|Induction Period|Progressive Disease|0|||
129526043|NCT01996865|466214542|FG002|Induction Period|Progressive Disease|0|||
129526044|NCT01996865|466214540|FG000|Induction Period|Lost to Follow-up|10|||
129526045|NCT01996865|466214541|FG001|Induction Period|Lost to Follow-up|0|||
129526046|NCT01996865|466214542|FG002|Induction Period|Lost to Follow-up|0|||
129526047|NCT01996865|466214540|FG000|Induction Period|Other Reasons|13|||
129526048|NCT01996865|466214541|FG001|Induction Period|Other Reasons|0|||
129526049|NCT01996865|466214542|FG002|Induction Period|Other Reasons|0|||
129526050|NCT01996865|466214540|FG000|Induction Period|Adverse Event|20|||
129526051|NCT01996865|466214541|FG001|Induction Period|Adverse Event|0|||
129526052|NCT01996865|466214542|FG002|Induction Period|Adverse Event|0|||
129526053|NCT01996865|466214540|FG000|Induction Period|Withdrawal by Subject|60|||
129526054|NCT01996865|466214541|FG001|Induction Period|Withdrawal by Subject|0|||
129526055|NCT01996865|466214542|FG002|Induction Period|Withdrawal by Subject|0|||
129526056|NCT01996865|466214540|FG000|Induction Period|Death|111|||
129526057|NCT01996865|466214541|FG001|Induction Period|Death|0|||
129526058|NCT01996865|466214542|FG002|Induction Period|Death|0|||
129526059|NCT01996865|466214540|FG000|Maintenance Period|Protocol Violation|0|||
129526060|NCT01996865|466214541|FG001|Maintenance Period|Protocol Violation|1|||
129526061|NCT01996865|466214542|FG002|Maintenance Period|Protocol Violation|1|||
129526062|NCT01996865|466214540|FG000|Maintenance Period|Other reasons|0|||
129526063|NCT01996865|466214541|FG001|Maintenance Period|Other reasons|8|||
129526064|NCT01996865|466214542|FG002|Maintenance Period|Other reasons|5|||
129526065|NCT01996865|466214540|FG000|Maintenance Period|Progressive Disease|0|||
129526066|NCT01996865|466214541|FG001|Maintenance Period|Progressive Disease|6|||
129526067|NCT01996865|466214542|FG002|Maintenance Period|Progressive Disease|23|||
129526068|NCT01996865|466214540|FG000|Maintenance Period|Withdrawal by Subject|0|||
129526069|NCT01996865|466214541|FG001|Maintenance Period|Withdrawal by Subject|18|||
129526070|NCT01996865|466214542|FG002|Maintenance Period|Withdrawal by Subject|4|||
129526071|NCT01996865|466214540|FG000|Maintenance Period|Adverse Event|0|||
129526072|NCT01996865|466214541|FG001|Maintenance Period|Adverse Event|7|||
129526073|NCT01996865|466214542|FG002|Maintenance Period|Adverse Event|7|||
129526074|NCT01996865|466214540|FG000|Maintenance Period|Death|0|||
129526075|NCT01996865|466214541|FG001|Maintenance Period|Death|15|||
129526076|NCT01996865|466214542|FG002|Maintenance Period|Death|3|||
129526077|NCT01996865|466214540|FG000|Maintenance Period|Lost to Follow-up|0|||
129526078|NCT01996865|466214541|FG001|Maintenance Period|Lost to Follow-up|2|||
129526079|NCT01996865|466214542|FG002|Maintenance Period|Lost to Follow-up|0|||
129526080|NCT03575351|466214545|FG000|Overall Study|Adverse Event|1|||
129526081|NCT03575351|466214546|FG001|Overall Study|Adverse Event|0|||
129526082|NCT03575351|466214545|FG000|Overall Study|Death|2|||
129526083|NCT03575351|466214546|FG001|Overall Study|Death|2|||
129526084|NCT03575351|466214545|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
129526085|NCT03575351|466214546|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
129526086|NCT03575351|466214545|FG000|Overall Study|Lack of Efficacy|28|||
129526087|NCT03575351|466214546|FG001|Overall Study|Lack of Efficacy|0|||
129526088|NCT03575351|466214545|FG000|Overall Study|Withdrawal by Subject|1|||
129526089|NCT03575351|466214546|FG001|Overall Study|Withdrawal by Subject|1|||
129526090|NCT03575351|466214545|FG000|Overall Study|Physician Decision|3|||
129526091|NCT03575351|466214546|FG001|Overall Study|Physician Decision|0|||
129526092|NCT03575351|466214545|FG000|Overall Study|Disease relapse|15|||
129526093|NCT03575351|466214546|FG001|Overall Study|Disease relapse|6|||
129526094|NCT03575351|466214545|FG000|Overall Study|Study drug manufacturing failure|0|||
129526095|NCT03575351|466214546|FG001|Overall Study|Study drug manufacturing failure|1|||
129526096|NCT03575351|466214545|FG000|Overall Study|other reasons|5|||
129526097|NCT03575351|466214546|FG001|Overall Study|other reasons|0|||
129526098|NCT04288089|466214552|FG000|Overall Study|Ongoing Treatment|2|||
129526099|NCT04288089|466214553|FG001|Overall Study|Ongoing Treatment|1|||
129526100|NCT04288089|466214554|FG002|Overall Study|Ongoing Treatment|1|||
129526101|NCT04288089|466214555|FG003|Overall Study|Ongoing Treatment|4|||
129526102|NCT03715205|466214556|FG000|Overall Study|Death|13|||
129526103|NCT03715205|466214556|FG000|Overall Study|Lost to Follow-up|2|||
129526104|NCT03715205|466214556|FG000|Overall Study|Physician Decision|93|||
129526105|NCT03715205|466214556|FG000|Overall Study|Withdrawal by Subject|26|||
129526106|NCT00796549|466214558|FG000|Overall Study|Adverse Event|11|||
129526107|NCT00796549|466214558|FG000|Overall Study|not entered|149|||
129526108|NCT00796549|466214558|FG000|Overall Study|Other|2|||
129526109|NCT00796549|466214558|FG000|Overall Study|Progressive disease|56|||
129526110|NCT01878175|466214560|FG000|Overall Study|Developed contraindicated health problem|2|||
129526111|NCT02201251|466214561|FG000|Overall Study|Adverse Event|1|||
129526112|NCT02201251|466214562|FG001|Overall Study|Adverse Event|1|||
129526113|NCT02201251|466214561|FG000|Overall Study|Protocol Violation|1|||
129526114|NCT02201251|466214562|FG001|Overall Study|Protocol Violation|0|||
129526115|NCT02201251|466214561|FG000|Overall Study|Noncompliance with Study Drug|0|||
129526116|NCT02201251|466214562|FG001|Overall Study|Noncompliance with Study Drug|1|||
129526117|NCT02201251|466214561|FG000|Overall Study|Withdrawal by Subject|2|||
129526118|NCT02201251|466214562|FG001|Overall Study|Withdrawal by Subject|1|||
129526119|NCT02877134|466214564|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526120|NCT02877134|466214565|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
129526121|NCT02877134|466214566|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526122|NCT02877134|466214567|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526123|NCT02877134|466214568|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526124|NCT02877134|466214569|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
129526125|NCT02877134|466214570|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526126|NCT02877134|466214571|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526127|NCT02877134|466214572|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526128|NCT02877134|466214573|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526129|NCT02877134|466214574|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526130|NCT02877134|466214575|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
129526131|NCT02877134|466214564|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526132|NCT02877134|466214565|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
129526133|NCT02877134|466214566|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526134|NCT02877134|466214567|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
129526135|NCT02877134|466214568|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526136|NCT02877134|466214569|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526137|NCT02877134|466214570|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
129526138|NCT02877134|466214571|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129538747|NCT01078974|466263521|FG000|Overall Study|Adverse Event|3|||
129526139|NCT02877134|466214572|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526140|NCT02877134|466214573|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526141|NCT02877134|466214574|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526142|NCT02877134|466214575|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
129526143|NCT02877134|466214564|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
129526144|NCT02877134|466214565|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
129526145|NCT02877134|466214566|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
129526146|NCT02877134|466214567|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
129526147|NCT02877134|466214568|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
129526148|NCT02877134|466214569|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
129526149|NCT02877134|466214570|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
129526150|NCT02877134|466214571|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
129526151|NCT02877134|466214572|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
129526152|NCT02877134|466214573|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
129526153|NCT02877134|466214574|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
129526154|NCT02877134|466214575|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
129526155|NCT02877134|466214564|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
129526156|NCT02877134|466214565|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
129526157|NCT02877134|466214566|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
129526158|NCT02877134|466214567|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
129526159|NCT02877134|466214568|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
129526160|NCT02877134|466214569|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
129526161|NCT02877134|466214570|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
129526162|NCT02877134|466214571|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
129526163|NCT02877134|466214572|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
129526164|NCT02877134|466214573|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
129526165|NCT02877134|466214574|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
129526166|NCT02877134|466214575|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
129526167|NCT02877134|466214564|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526168|NCT02877134|466214565|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526169|NCT02877134|466214566|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526170|NCT02877134|466214567|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526171|NCT02877134|466214568|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526172|NCT02877134|466214569|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526173|NCT02877134|466214570|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526174|NCT02877134|466214571|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526175|NCT02877134|466214572|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
129526176|NCT02877134|466214573|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526177|NCT02877134|466214574|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526178|NCT02877134|466214575|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
129526179|NCT02877134|466214564|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526180|NCT02877134|466214565|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526181|NCT02877134|466214566|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526182|NCT02877134|466214567|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526183|NCT02877134|466214568|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526184|NCT02877134|466214569|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526185|NCT02877134|466214570|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
129526186|NCT02877134|466214571|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
129526187|NCT02877134|466214572|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
129526188|NCT02877134|466214573|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
129526189|NCT02877134|466214574|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
129526190|NCT02877134|466214575|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
129526191|NCT02877134|466214564|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526192|NCT02877134|466214565|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526193|NCT02877134|466214566|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526194|NCT02877134|466214567|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526195|NCT02877134|466214568|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526196|NCT02877134|466214569|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526197|NCT02877134|466214570|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526198|NCT02877134|466214571|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
129526199|NCT02877134|466214572|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
129526200|NCT02877134|466214573|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
129526201|NCT02877134|466214574|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526202|NCT02877134|466214575|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
129526203|NCT02877134|466214564|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
129526204|NCT02877134|466214565|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
129526205|NCT02877134|466214566|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
129526206|NCT02877134|466214567|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
129526207|NCT02877134|466214568|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
129526208|NCT02877134|466214569|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
129526209|NCT02877134|466214570|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
129526210|NCT02877134|466214571|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
129526211|NCT02877134|466214572|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
129526212|NCT02877134|466214573|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
129526213|NCT02877134|466214574|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
129526214|NCT02877134|466214575|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
129526215|NCT01332851|466214576|FG000|Overall Study|Withdrawal by Subject|4|||
129526216|NCT01332851|466214577|FG001|Overall Study|Withdrawal by Subject|2|||
129526217|NCT01332851|466214576|FG000|Overall Study|Lost to Follow-up|7|||
129526218|NCT01332851|466214577|FG001|Overall Study|Lost to Follow-up|11|||
129526219|NCT03299166|466214580|FG000|Overall Study|Adverse Event|9|||
129526220|NCT03299166|466214581|FG001|Overall Study|Adverse Event|4|||
129526221|NCT03299166|466214580|FG000|Overall Study|Withdrawal by Subject|6|||
129526222|NCT03299166|466214581|FG001|Overall Study|Withdrawal by Subject|5|||
129526223|NCT03299166|466214580|FG000|Overall Study|Physician Decision|1|||
129526224|NCT03299166|466214581|FG001|Overall Study|Physician Decision|1|||
129526225|NCT03299166|466214580|FG000|Overall Study|Sponsor Decision|3|||
129526226|NCT03299166|466214581|FG001|Overall Study|Sponsor Decision|0|||
129526227|NCT03299166|466214580|FG000|Overall Study|Lost to Follow-up|2|||
129526228|NCT03299166|466214581|FG001|Overall Study|Lost to Follow-up|4|||
129526229|NCT03299166|466214580|FG000|Overall Study|Randomization Error|0|||
129526230|NCT03299166|466214581|FG001|Overall Study|Randomization Error|1|||
129526231|NCT03299166|466214580|FG000|Overall Study|Subject unable to return due to COVID|1|||
129526232|NCT03299166|466214581|FG001|Overall Study|Subject unable to return due to COVID|0|||
129526233|NCT03299166|466214580|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
129526234|NCT03299166|466214581|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
129526235|NCT01197794|466214584|FG000|Overall Study|Adverse Event|3|||
129526236|NCT01197794|466214585|FG001|Overall Study|Adverse Event|2|||
129526237|NCT01197794|466214586|FG002|Overall Study|Adverse Event|4|||
129526238|NCT01197794|466214587|FG003|Overall Study|Adverse Event|4|||
129526239|NCT01197794|466214588|FG004|Overall Study|Adverse Event|4|||
129526240|NCT01197794|466214589|FG005|Overall Study|Adverse Event|2|||
129526241|NCT01197794|466214590|FG006|Overall Study|Adverse Event|3|||
129526242|NCT01197794|466214584|FG000|Overall Study|Protocol Violation|0|||
129526243|NCT01197794|466214585|FG001|Overall Study|Protocol Violation|0|||
129526244|NCT01197794|466214586|FG002|Overall Study|Protocol Violation|0|||
129526245|NCT01197794|466214587|FG003|Overall Study|Protocol Violation|0|||
129526246|NCT01197794|466214588|FG004|Overall Study|Protocol Violation|2|||
129526247|NCT01197794|466214589|FG005|Overall Study|Protocol Violation|0|||
129526248|NCT01197794|466214590|FG006|Overall Study|Protocol Violation|1|||
129526249|NCT01197794|466214584|FG000|Overall Study|Development of study withdrawal criteria|3|||
129526250|NCT01197794|466214585|FG001|Overall Study|Development of study withdrawal criteria|0|||
129526251|NCT01197794|466214586|FG002|Overall Study|Development of study withdrawal criteria|0|||
129526252|NCT01197794|466214587|FG003|Overall Study|Development of study withdrawal criteria|1|||
129526253|NCT01197794|466214588|FG004|Overall Study|Development of study withdrawal criteria|0|||
129526254|NCT01197794|466214589|FG005|Overall Study|Development of study withdrawal criteria|0|||
129526255|NCT01197794|466214590|FG006|Overall Study|Development of study withdrawal criteria|1|||
129526256|NCT01197794|466214584|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
129526257|NCT01197794|466214585|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
129526258|NCT01197794|466214586|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
129526259|NCT01197794|466214587|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
129526260|NCT01197794|466214588|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
129526261|NCT01197794|466214589|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
129526262|NCT01197794|466214590|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
129526263|NCT01197794|466214584|FG000|Overall Study|Withdrawal by Subject|3|||
129526264|NCT01197794|466214585|FG001|Overall Study|Withdrawal by Subject|3|||
129526265|NCT01197794|466214586|FG002|Overall Study|Withdrawal by Subject|4|||
129526266|NCT01197794|466214587|FG003|Overall Study|Withdrawal by Subject|1|||
129526267|NCT01197794|466214588|FG004|Overall Study|Withdrawal by Subject|1|||
129526268|NCT01197794|466214589|FG005|Overall Study|Withdrawal by Subject|5|||
129526269|NCT01197794|466214590|FG006|Overall Study|Withdrawal by Subject|6|||
129526270|NCT01197794|466214584|FG000|Overall Study|Lost to Follow-up|1|||
129526271|NCT01197794|466214585|FG001|Overall Study|Lost to Follow-up|1|||
129526272|NCT01197794|466214586|FG002|Overall Study|Lost to Follow-up|0|||
129526273|NCT01197794|466214587|FG003|Overall Study|Lost to Follow-up|1|||
129526274|NCT01197794|466214588|FG004|Overall Study|Lost to Follow-up|0|||
129526275|NCT01197794|466214589|FG005|Overall Study|Lost to Follow-up|1|||
129526276|NCT01197794|466214590|FG006|Overall Study|Lost to Follow-up|0|||
129526277|NCT01197794|466214584|FG000|Overall Study|Other|1|||
129526278|NCT01197794|466214585|FG001|Overall Study|Other|1|||
129526279|NCT01197794|466214586|FG002|Overall Study|Other|3|||
129526280|NCT01197794|466214587|FG003|Overall Study|Other|0|||
129526281|NCT01197794|466214588|FG004|Overall Study|Other|2|||
129526282|NCT01197794|466214589|FG005|Overall Study|Other|2|||
129526283|NCT01197794|466214590|FG006|Overall Study|Other|4|||
129526284|NCT01055457|466214591|FG000|Overall Study|Lost to Follow-up|0|||
129526285|NCT01055457|466214592|FG001|Overall Study|Lost to Follow-up|1|||
129526286|NCT01055457|466214593|FG002|Overall Study|Lost to Follow-up|0|||
129526287|NCT01055457|466214594|FG003|Overall Study|Lost to Follow-up|0|||
129526288|NCT01055457|466214595|FG004|Overall Study|Lost to Follow-up|0|||
129526289|NCT01055457|466214596|FG005|Overall Study|Lost to Follow-up|1|||
129526290|NCT01055457|466214597|FG006|Overall Study|Lost to Follow-up|0|||
129526291|NCT01055457|466214598|FG007|Overall Study|Lost to Follow-up|0|||
129526292|NCT01055457|466214599|FG008|Overall Study|Lost to Follow-up|0|||
129526293|NCT01055457|466214600|FG009|Overall Study|Lost to Follow-up|0|||
129526294|NCT01055457|466214591|FG000|Overall Study|Protocol Violation|0|||
129526295|NCT01055457|466214592|FG001|Overall Study|Protocol Violation|0|||
129526296|NCT01055457|466214593|FG002|Overall Study|Protocol Violation|1|||
129526297|NCT01055457|466214594|FG003|Overall Study|Protocol Violation|1|||
129526298|NCT01055457|466214595|FG004|Overall Study|Protocol Violation|1|||
129526299|NCT01055457|466214596|FG005|Overall Study|Protocol Violation|2|||
129526300|NCT01055457|466214597|FG006|Overall Study|Protocol Violation|1|||
129526301|NCT01055457|466214598|FG007|Overall Study|Protocol Violation|0|||
129526302|NCT01055457|466214599|FG008|Overall Study|Protocol Violation|0|||
129526303|NCT01055457|466214600|FG009|Overall Study|Protocol Violation|1|||
129526304|NCT01055457|466214591|FG000|Overall Study|Subject Disinterest|0|||
129526305|NCT01055457|466214592|FG001|Overall Study|Subject Disinterest|0|||
129526306|NCT01055457|466214593|FG002|Overall Study|Subject Disinterest|0|||
129526307|NCT01055457|466214594|FG003|Overall Study|Subject Disinterest|0|||
129526308|NCT01055457|466214595|FG004|Overall Study|Subject Disinterest|0|||
129526309|NCT01055457|466214596|FG005|Overall Study|Subject Disinterest|0|||
129526310|NCT01055457|466214597|FG006|Overall Study|Subject Disinterest|0|||
129526311|NCT01055457|466214598|FG007|Overall Study|Subject Disinterest|1|||
129526312|NCT01055457|466214599|FG008|Overall Study|Subject Disinterest|0|||
129526313|NCT01055457|466214600|FG009|Overall Study|Subject Disinterest|0|||
129526314|NCT01055457|466214591|FG000|Overall Study|Subject Ineligible|1|||
129526315|NCT01055457|466214592|FG001|Overall Study|Subject Ineligible|0|||
129526316|NCT01055457|466214593|FG002|Overall Study|Subject Ineligible|1|||
129526317|NCT01055457|466214594|FG003|Overall Study|Subject Ineligible|0|||
129526318|NCT01055457|466214595|FG004|Overall Study|Subject Ineligible|1|||
129526319|NCT01055457|466214596|FG005|Overall Study|Subject Ineligible|0|||
129526320|NCT01055457|466214597|FG006|Overall Study|Subject Ineligible|0|||
129526321|NCT01055457|466214598|FG007|Overall Study|Subject Ineligible|0|||
129526322|NCT01055457|466214599|FG008|Overall Study|Subject Ineligible|0|||
129526323|NCT01055457|466214600|FG009|Overall Study|Subject Ineligible|0|||
129526324|NCT01055457|466214591|FG000|Overall Study|Discomfort|0|||
129526325|NCT01055457|466214592|FG001|Overall Study|Discomfort|0|||
129526326|NCT01055457|466214593|FG002|Overall Study|Discomfort|0|||
129526327|NCT01055457|466214594|FG003|Overall Study|Discomfort|0|||
129526328|NCT01055457|466214595|FG004|Overall Study|Discomfort|1|||
129526329|NCT01055457|466214596|FG005|Overall Study|Discomfort|0|||
129526330|NCT01055457|466214597|FG006|Overall Study|Discomfort|0|||
129526331|NCT01055457|466214598|FG007|Overall Study|Discomfort|0|||
129526332|NCT01055457|466214599|FG008|Overall Study|Discomfort|0|||
129526333|NCT01055457|466214600|FG009|Overall Study|Discomfort|0|||
129526334|NCT01055457|466214591|FG000|Overall Study|Pregnancy|0|||
129526335|NCT01055457|466214592|FG001|Overall Study|Pregnancy|0|||
129526336|NCT01055457|466214593|FG002|Overall Study|Pregnancy|0|||
129526337|NCT01055457|466214594|FG003|Overall Study|Pregnancy|1|||
129526338|NCT01055457|466214595|FG004|Overall Study|Pregnancy|0|||
129526339|NCT01055457|466214596|FG005|Overall Study|Pregnancy|0|||
129526340|NCT01055457|466214597|FG006|Overall Study|Pregnancy|0|||
129526341|NCT01055457|466214598|FG007|Overall Study|Pregnancy|0|||
129526342|NCT01055457|466214599|FG008|Overall Study|Pregnancy|0|||
129526343|NCT01055457|466214600|FG009|Overall Study|Pregnancy|0|||
129526344|NCT01055457|466214591|FG000|Overall Study|Adverse Event|0|||
129526345|NCT01055457|466214592|FG001|Overall Study|Adverse Event|0|||
129526346|NCT01055457|466214593|FG002|Overall Study|Adverse Event|0|||
129526347|NCT01055457|466214594|FG003|Overall Study|Adverse Event|1|||
129526348|NCT01055457|466214595|FG004|Overall Study|Adverse Event|0|||
129526349|NCT01055457|466214596|FG005|Overall Study|Adverse Event|0|||
129526350|NCT01055457|466214597|FG006|Overall Study|Adverse Event|0|||
129526351|NCT01055457|466214598|FG007|Overall Study|Adverse Event|0|||
129526352|NCT01055457|466214599|FG008|Overall Study|Adverse Event|0|||
129526353|NCT01055457|466214600|FG009|Overall Study|Adverse Event|0|||
129526354|NCT00572728|466214605|FG000|Overall Study|Withdrawal by Subject|10|||
129526355|NCT00572728|466214605|FG000|Overall Study|Ineligible|3|||
129526356|NCT00572728|466214605|FG000|Overall Study|Enrolled under Amendment 4|5|||
129526357|NCT00572728|466214605|FG000|Overall Study|Offstudy due to complicating disease|1|||
129526358|NCT00572728|466214605|FG000|Overall Study|FLT1 not completed|4|||
129526359|NCT00572728|466214605|FG000|Overall Study|First Chemotherapy not initiated|2|||
129526360|NCT00572728|466214605|FG000|Overall Study|FLT2 not completed|5|||
129526361|NCT00572728|466214605|FG000|Overall Study|Second chemotherapy not initiated|1|||
129526362|NCT00572728|466214605|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
129526363|NCT00572728|466214605|FG000|Overall Study|Pathology missing|1|||
129526364|NCT03630016|466214610|FG000|Overall Study|Poor Sensor Placement|1|||
129526365|NCT00002981|466214611|FG000|Overall Study|Inevaluable|6|||
129526366|NCT01833806|466214612|FG000|Overall Study|Alternative treatment|2|||
129526367|NCT01833806|466214612|FG000|Overall Study|Death|5|||
129526368|NCT01833806|466214612|FG000|Overall Study|Physician Decision|1|||
129526369|NCT01833806|466214612|FG000|Overall Study|Lost to Follow-up|1|||
129526370|NCT03457636|466214613|FG000|Overall Study|Lost to Follow-up|2|||
129526371|NCT02724111|466214614|FG000|Overall Study|Protocol Violation|2|||
129526372|NCT02724111|466214615|FG001|Overall Study|Protocol Violation|5|||
129526373|NCT01828567|466214616|FG000|Overall Study|Lost to Follow-up|27|||
129526374|NCT01828567|466214617|FG001|Overall Study|Lost to Follow-up|9|||
129526375|NCT01828567|466214616|FG000|Overall Study|Excluded - did not meet criteria|4|||
129526376|NCT01828567|466214617|FG001|Overall Study|Excluded - did not meet criteria|1|||
129526377|NCT01885104|466214618|FG000|Overall Study|Withdrawal of Consent|1|||
129526378|NCT01885104|466214619|FG001|Overall Study|Withdrawal of Consent|0|||
129526379|NCT01885104|466214618|FG000|Overall Study|Lost to Follow-up|0|||
129526380|NCT01885104|466214619|FG001|Overall Study|Lost to Follow-up|1|||
129526381|NCT01885104|466214618|FG000|Overall Study|Physician Decision|1|||
129526382|NCT01885104|466214619|FG001|Overall Study|Physician Decision|0|||
129526383|NCT04063865|466214620|FG000|Overall Study|Physician Decision|1|||
129526384|NCT04063865|466214621|FG001|Overall Study|Physician Decision|3|||
129526385|NCT04063865|466214620|FG000|Overall Study|Study Closed Prior to Completion|4|||
129526386|NCT04063865|466214621|FG001|Overall Study|Study Closed Prior to Completion|4|||
129526387|NCT04063865|466214620|FG000|Overall Study|Withdrawal by Subject|1|||
129526388|NCT04063865|466214621|FG001|Overall Study|Withdrawal by Subject|1|||
129526389|NCT03898323|466214622|FG000|Overall Study|Physician Decision|1|||
129526390|NCT00374127|466214630|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
129526391|NCT00374127|466214630|FG000|Overall Study|Blood could not be drawn.|2|||
129526392|NCT00374127|466214630|FG000|Overall Study|Protocol Violation|5|||
129526393|NCT00374127|466214630|FG000|Overall Study|Pregnancy|1|||
129526394|NCT04035473|466214635|FG000|Screening/Baseline|Death|0|||
129526395|NCT04035473|466214636|FG001|Screening/Baseline|Death|1|||
129526396|NCT04035473|466214635|FG000|Screening/Baseline|Adverse Event|0|||
129526397|NCT04035473|466214636|FG001|Screening/Baseline|Adverse Event|1|||
129526398|NCT04035473|466214635|FG000|Follow-up Period|Adverse Event|2|||
129526399|NCT04035473|466214636|FG001|Follow-up Period|Adverse Event|0|||
129526400|NCT00112840|466214637|FG000|Overall Study|Physician Decision|1|||
129526401|NCT00112840|466214638|FG001|Overall Study|Physician Decision|0|||
129526402|NCT00112840|466214639|FG002|Overall Study|Physician Decision|0|||
129526403|NCT00112840|466214637|FG000|Overall Study|Withdrawal by Subject|1|||
129526404|NCT00112840|466214638|FG001|Overall Study|Withdrawal by Subject|0|||
129526405|NCT00112840|466214639|FG002|Overall Study|Withdrawal by Subject|1|||
129526406|NCT00112840|466214637|FG000|Overall Study|Protocol Violation|0|||
129526407|NCT00112840|466214638|FG001|Overall Study|Protocol Violation|0|||
129526408|NCT00112840|466214639|FG002|Overall Study|Protocol Violation|5|||
129526409|NCT02875366|466214640|FG000|Overall Study|Adverse Event|0|||
129526410|NCT02875366|466214641|FG001|Overall Study|Adverse Event|2|||
129526411|NCT02875366|466214640|FG000|Overall Study|Noncompliance|0|||
129526412|NCT02875366|466214641|FG001|Overall Study|Noncompliance|1|||
129526413|NCT03595176|466214642|FG000|Overall Study|Death|0|||
129526414|NCT03595176|466214643|FG001|Overall Study|Death|2|||
129526415|NCT03595176|466214642|FG000|Overall Study|Lost to Follow-up|0|||
129526416|NCT03595176|466214643|FG001|Overall Study|Lost to Follow-up|1|||
129526417|NCT02735044|466214645|FG000|Overall Study|Adverse Event|3|||
129526418|NCT02735044|466214646|FG001|Overall Study|Adverse Event|3|||
129526419|NCT02735044|466214645|FG000|Overall Study|Lack of Efficacy|1|||
129526420|NCT02735044|466214646|FG001|Overall Study|Lack of Efficacy|0|||
129526421|NCT02735044|466214645|FG000|Overall Study|Poor compliance to protocol|7|||
129526422|NCT02735044|466214646|FG001|Overall Study|Poor compliance to protocol|7|||
129526423|NCT02735044|466214645|FG000|Overall Study|Randomized and not treated|0|||
129526424|NCT02735044|466214646|FG001|Overall Study|Randomized and not treated|2|||
129526425|NCT02735044|466214645|FG000|Overall Study|Other, not specified above|5|||
129526426|NCT02735044|466214646|FG001|Overall Study|Other, not specified above|11|||
129526427|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
129526428|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129526429|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129526430|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129526431|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129526432|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
129526433|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
129526434|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129526435|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129526436|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129538748|NCT03575975|466263523|FG000|Overall Study|Lost to Follow-up|1|||
129526437|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129526438|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
129526439|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
129526440|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129526441|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129526442|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129526443|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129526444|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
129526445|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Other|14|||
129526446|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Other|0|||
129526447|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Other|0|||
129526448|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Other|0|||
129526449|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Other|0|||
129526450|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Other|0|||
129526451|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
129526452|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
129526453|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
129526454|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
129526455|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
129526456|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
129526457|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
129526458|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129526459|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129526460|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129526461|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129526462|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
129526463|NCT02141854|466214648|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
129526464|NCT02141854|466214649|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129526465|NCT02141854|466214650|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129526466|NCT02141854|466214651|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129526467|NCT02141854|466214652|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129526468|NCT02141854|466214653|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
129526469|NCT02141854|466214648|FG000|Treatment Period|Protocol Violation|0|||
129526470|NCT02141854|466214649|FG001|Treatment Period|Protocol Violation|1|||
129526471|NCT02141854|466214650|FG002|Treatment Period|Protocol Violation|0|||
129526472|NCT02141854|466214651|FG003|Treatment Period|Protocol Violation|2|||
129526473|NCT02141854|466214652|FG004|Treatment Period|Protocol Violation|2|||
129526474|NCT02141854|466214653|FG005|Treatment Period|Protocol Violation|1|||
129526475|NCT02141854|466214648|FG000|Treatment Period|Noncompliance|0|||
129526476|NCT02141854|466214649|FG001|Treatment Period|Noncompliance|0|||
129526477|NCT02141854|466214650|FG002|Treatment Period|Noncompliance|0|||
129526478|NCT02141854|466214651|FG003|Treatment Period|Noncompliance|1|||
129526479|NCT02141854|466214652|FG004|Treatment Period|Noncompliance|0|||
129526480|NCT02141854|466214653|FG005|Treatment Period|Noncompliance|0|||
129526481|NCT02141854|466214648|FG000|Treatment Period|Lack of Efficacy|0|||
129526482|NCT02141854|466214649|FG001|Treatment Period|Lack of Efficacy|0|||
129526483|NCT02141854|466214650|FG002|Treatment Period|Lack of Efficacy|0|||
129526484|NCT02141854|466214651|FG003|Treatment Period|Lack of Efficacy|1|||
129526485|NCT02141854|466214652|FG004|Treatment Period|Lack of Efficacy|1|||
129526486|NCT02141854|466214653|FG005|Treatment Period|Lack of Efficacy|7|||
129526487|NCT02141854|466214648|FG000|Treatment Period|Pregnancy|0|||
129526488|NCT02141854|466214649|FG001|Treatment Period|Pregnancy|1|||
129526489|NCT02141854|466214650|FG002|Treatment Period|Pregnancy|0|||
129526490|NCT02141854|466214651|FG003|Treatment Period|Pregnancy|0|||
129526491|NCT02141854|466214652|FG004|Treatment Period|Pregnancy|0|||
129526492|NCT02141854|466214653|FG005|Treatment Period|Pregnancy|0|||
129526493|NCT02141854|466214648|FG000|Treatment Period|Other|0|||
129526494|NCT02141854|466214649|FG001|Treatment Period|Other|1|||
129526495|NCT02141854|466214650|FG002|Treatment Period|Other|2|||
129526496|NCT02141854|466214651|FG003|Treatment Period|Other|0|||
129526497|NCT02141854|466214652|FG004|Treatment Period|Other|1|||
129526498|NCT02141854|466214653|FG005|Treatment Period|Other|2|||
129526499|NCT02141854|466214648|FG000|Treatment Period|Adverse Event|0|||
129526500|NCT02141854|466214649|FG001|Treatment Period|Adverse Event|2|||
129526501|NCT02141854|466214650|FG002|Treatment Period|Adverse Event|2|||
129526502|NCT02141854|466214651|FG003|Treatment Period|Adverse Event|0|||
129526503|NCT02141854|466214652|FG004|Treatment Period|Adverse Event|2|||
129526504|NCT02141854|466214653|FG005|Treatment Period|Adverse Event|2|||
129526505|NCT02141854|466214648|FG000|Treatment Period|Withdrawal by Subject|0|||
129526506|NCT02141854|466214649|FG001|Treatment Period|Withdrawal by Subject|2|||
129526507|NCT02141854|466214650|FG002|Treatment Period|Withdrawal by Subject|3|||
129526508|NCT02141854|466214651|FG003|Treatment Period|Withdrawal by Subject|3|||
129526509|NCT02141854|466214652|FG004|Treatment Period|Withdrawal by Subject|4|||
129526510|NCT02141854|466214653|FG005|Treatment Period|Withdrawal by Subject|7|||
129526511|NCT02141854|466214648|FG000|Treatment Period|Disease progression|0|||
129526512|NCT02141854|466214649|FG001|Treatment Period|Disease progression|2|||
129526513|NCT02141854|466214650|FG002|Treatment Period|Disease progression|1|||
129526514|NCT02141854|466214651|FG003|Treatment Period|Disease progression|3|||
129526515|NCT02141854|466214652|FG004|Treatment Period|Disease progression|0|||
129526516|NCT02141854|466214653|FG005|Treatment Period|Disease progression|18|||
129526517|NCT02141854|466214648|FG000|Treatment Period|Lost to Follow-up|0|||
129526518|NCT02141854|466214649|FG001|Treatment Period|Lost to Follow-up|1|||
129526519|NCT02141854|466214650|FG002|Treatment Period|Lost to Follow-up|1|||
129526520|NCT02141854|466214651|FG003|Treatment Period|Lost to Follow-up|1|||
129526521|NCT02141854|466214652|FG004|Treatment Period|Lost to Follow-up|0|||
129526522|NCT02141854|466214653|FG005|Treatment Period|Lost to Follow-up|1|||
129526523|NCT01868594|466214654|FG000|Overall Study|Do not meet inclusion criteria|4|||
129526524|NCT01868594|466214655|FG001|Overall Study|Do not meet inclusion criteria|3|||
129526525|NCT01201967|466214658|FG000|Overall Study|Lost to Follow-up|6|||
129526526|NCT01201967|466214659|FG001|Overall Study|Lost to Follow-up|5|||
129526527|NCT02659098|466214660|FG000|Overall Study|Withdrawal by Subject|7|||
129526528|NCT04363944|466214661|FG000|Overall Study|Withdrawal by Subject|2|||
129526529|NCT04363944|466214662|FG001|Overall Study|Withdrawal by Subject|0|||
129526530|NCT01888965|466216639|FG000|Overall Study|Adverse Event|5|||
129526531|NCT01888965|466216639|FG000|Overall Study|Lack of Efficacy|4|||
129526532|NCT01693562|466216640|FG000|Escalation Phase|Withdrawal by Subject|0|||
129526533|NCT01693562|466216641|FG001|Escalation Phase|Withdrawal by Subject|1|||
129526534|NCT01693562|466216642|FG002|Escalation Phase|Withdrawal by Subject|0|||
129526535|NCT01693562|466216643|FG003|Escalation Phase|Withdrawal by Subject|0|||
129526536|NCT01693562|466216644|FG004|Escalation Phase|Withdrawal by Subject|0|||
129526537|NCT01693562|466216645|FG005|Escalation Phase|Withdrawal by Subject|2|||
129526538|NCT01693562|466216646|FG006|Escalation Phase|Withdrawal by Subject|0|||
129526539|NCT01693562|466216647|FG007|Escalation Phase|Withdrawal by Subject|0|||
129526540|NCT01693562|466216648|FG008|Escalation Phase|Withdrawal by Subject|0|||
129526541|NCT01693562|466216649|FG009|Escalation Phase|Withdrawal by Subject|0|||
129526542|NCT01693562|466216650|FG010|Escalation Phase|Withdrawal by Subject|0|||
129526543|NCT01693562|466216651|FG011|Escalation Phase|Withdrawal by Subject|0|||
129526544|NCT01693562|466216652|FG012|Escalation Phase|Withdrawal by Subject|0|||
129526545|NCT01693562|466216653|FG013|Escalation Phase|Withdrawal by Subject|0|||
129526546|NCT01693562|466216654|FG014|Escalation Phase|Withdrawal by Subject|0|||
129526547|NCT01693562|466216655|FG015|Escalation Phase|Withdrawal by Subject|0|||
129526548|NCT01693562|466216656|FG016|Escalation Phase|Withdrawal by Subject|0|||
129526549|NCT01693562|466216657|FG017|Escalation Phase|Withdrawal by Subject|0|||
129526550|NCT01693562|466216658|FG018|Escalation Phase|Withdrawal by Subject|0|||
129526551|NCT01693562|466216659|FG019|Escalation Phase|Withdrawal by Subject|0|||
129526552|NCT01693562|466216660|FG020|Escalation Phase|Withdrawal by Subject|0|||
129526553|NCT01693562|466216661|FG021|Escalation Phase|Withdrawal by Subject|0|||
129526554|NCT01693562|466216662|FG022|Escalation Phase|Withdrawal by Subject|0|||
129526555|NCT01693562|466216640|FG000|Escalation Phase|Death|4|||
129526556|NCT01693562|466216641|FG001|Escalation Phase|Death|2|||
129526557|NCT01693562|466216642|FG002|Escalation Phase|Death|0|||
129526558|NCT01693562|466216643|FG003|Escalation Phase|Death|3|||
129526559|NCT01693562|466216644|FG004|Escalation Phase|Death|6|||
129526560|NCT01693562|466216645|FG005|Escalation Phase|Death|4|||
129526561|NCT01693562|466216646|FG006|Escalation Phase|Death|0|||
129526562|NCT01693562|466216647|FG007|Escalation Phase|Death|0|||
129526563|NCT01693562|466216648|FG008|Escalation Phase|Death|0|||
129526564|NCT01693562|466216649|FG009|Escalation Phase|Death|0|||
129526565|NCT01693562|466216650|FG010|Escalation Phase|Death|0|||
129526566|NCT01693562|466216651|FG011|Escalation Phase|Death|0|||
129526567|NCT01693562|466216652|FG012|Escalation Phase|Death|0|||
129526568|NCT01693562|466216653|FG013|Escalation Phase|Death|0|||
129526569|NCT01693562|466216654|FG014|Escalation Phase|Death|0|||
129526570|NCT01693562|466216655|FG015|Escalation Phase|Death|0|||
129526571|NCT01693562|466216656|FG016|Escalation Phase|Death|0|||
129526572|NCT01693562|466216657|FG017|Escalation Phase|Death|0|||
129526573|NCT01693562|466216658|FG018|Escalation Phase|Death|0|||
129526574|NCT01693562|466216659|FG019|Escalation Phase|Death|0|||
129526575|NCT01693562|466216660|FG020|Escalation Phase|Death|0|||
129526576|NCT01693562|466216661|FG021|Escalation Phase|Death|0|||
129526577|NCT01693562|466216662|FG022|Escalation Phase|Death|0|||
129526578|NCT01693562|466216640|FG000|Escalation Phase|Lost to Follow-up|0|||
129526579|NCT01693562|466216641|FG001|Escalation Phase|Lost to Follow-up|1|||
129526580|NCT01693562|466216642|FG002|Escalation Phase|Lost to Follow-up|1|||
129526581|NCT01693562|466216643|FG003|Escalation Phase|Lost to Follow-up|0|||
129526582|NCT01693562|466216644|FG004|Escalation Phase|Lost to Follow-up|0|||
129526583|NCT01693562|466216645|FG005|Escalation Phase|Lost to Follow-up|0|||
129526584|NCT01693562|466216646|FG006|Escalation Phase|Lost to Follow-up|0|||
129526585|NCT01693562|466216647|FG007|Escalation Phase|Lost to Follow-up|0|||
129526586|NCT01693562|466216648|FG008|Escalation Phase|Lost to Follow-up|0|||
129526587|NCT01693562|466216649|FG009|Escalation Phase|Lost to Follow-up|0|||
129526588|NCT01693562|466216650|FG010|Escalation Phase|Lost to Follow-up|0|||
129526589|NCT01693562|466216651|FG011|Escalation Phase|Lost to Follow-up|0|||
129526590|NCT01693562|466216652|FG012|Escalation Phase|Lost to Follow-up|0|||
129526591|NCT01693562|466216653|FG013|Escalation Phase|Lost to Follow-up|0|||
129526592|NCT01693562|466216654|FG014|Escalation Phase|Lost to Follow-up|0|||
129526593|NCT01693562|466216655|FG015|Escalation Phase|Lost to Follow-up|0|||
129526594|NCT01693562|466216656|FG016|Escalation Phase|Lost to Follow-up|0|||
129526595|NCT01693562|466216657|FG017|Escalation Phase|Lost to Follow-up|0|||
129526596|NCT01693562|466216658|FG018|Escalation Phase|Lost to Follow-up|0|||
129526597|NCT01693562|466216659|FG019|Escalation Phase|Lost to Follow-up|0|||
129526598|NCT01693562|466216660|FG020|Escalation Phase|Lost to Follow-up|0|||
129526599|NCT01693562|466216661|FG021|Escalation Phase|Lost to Follow-up|0|||
129526600|NCT01693562|466216662|FG022|Escalation Phase|Lost to Follow-up|0|||
129526601|NCT01693562|466216640|FG000|Escalation Phase|Other|0|||
129526602|NCT01693562|466216641|FG001|Escalation Phase|Other|0|||
129526603|NCT01693562|466216642|FG002|Escalation Phase|Other|2|||
129526604|NCT01693562|466216643|FG003|Escalation Phase|Other|0|||
129526605|NCT01693562|466216644|FG004|Escalation Phase|Other|0|||
129526606|NCT01693562|466216645|FG005|Escalation Phase|Other|1|||
129526607|NCT01693562|466216646|FG006|Escalation Phase|Other|0|||
129526608|NCT01693562|466216647|FG007|Escalation Phase|Other|0|||
129526609|NCT01693562|466216648|FG008|Escalation Phase|Other|0|||
129526610|NCT01693562|466216649|FG009|Escalation Phase|Other|0|||
129526611|NCT01693562|466216650|FG010|Escalation Phase|Other|0|||
129526612|NCT01693562|466216651|FG011|Escalation Phase|Other|0|||
129526613|NCT01693562|466216652|FG012|Escalation Phase|Other|0|||
129526614|NCT01693562|466216653|FG013|Escalation Phase|Other|0|||
129526615|NCT01693562|466216654|FG014|Escalation Phase|Other|0|||
129526616|NCT01693562|466216655|FG015|Escalation Phase|Other|0|||
129526617|NCT01693562|466216656|FG016|Escalation Phase|Other|0|||
129526618|NCT01693562|466216657|FG017|Escalation Phase|Other|0|||
129526619|NCT01693562|466216658|FG018|Escalation Phase|Other|0|||
129526620|NCT01693562|466216659|FG019|Escalation Phase|Other|0|||
129526621|NCT01693562|466216660|FG020|Escalation Phase|Other|0|||
129526622|NCT01693562|466216661|FG021|Escalation Phase|Other|0|||
129526623|NCT01693562|466216662|FG022|Escalation Phase|Other|0|||
129526624|NCT01693562|466216640|FG000|Exploration Phase|Withdrawal by Subject|0|||
129526625|NCT01693562|466216641|FG001|Exploration Phase|Withdrawal by Subject|0|||
129526626|NCT01693562|466216642|FG002|Exploration Phase|Withdrawal by Subject|0|||
129526627|NCT01693562|466216643|FG003|Exploration Phase|Withdrawal by Subject|0|||
129526628|NCT01693562|466216644|FG004|Exploration Phase|Withdrawal by Subject|0|||
129526629|NCT01693562|466216645|FG005|Exploration Phase|Withdrawal by Subject|0|||
129526630|NCT01693562|466216646|FG006|Exploration Phase|Withdrawal by Subject|2|||
129526631|NCT01693562|466216647|FG007|Exploration Phase|Withdrawal by Subject|0|||
129526632|NCT01693562|466216648|FG008|Exploration Phase|Withdrawal by Subject|0|||
129526633|NCT01693562|466216649|FG009|Exploration Phase|Withdrawal by Subject|0|||
129526634|NCT01693562|466216650|FG010|Exploration Phase|Withdrawal by Subject|0|||
129526635|NCT01693562|466216651|FG011|Exploration Phase|Withdrawal by Subject|0|||
129526636|NCT01693562|466216652|FG012|Exploration Phase|Withdrawal by Subject|0|||
129526637|NCT01693562|466216653|FG013|Exploration Phase|Withdrawal by Subject|0|||
129526638|NCT01693562|466216654|FG014|Exploration Phase|Withdrawal by Subject|0|||
129526639|NCT01693562|466216655|FG015|Exploration Phase|Withdrawal by Subject|0|||
129526640|NCT01693562|466216656|FG016|Exploration Phase|Withdrawal by Subject|0|||
129526641|NCT01693562|466216657|FG017|Exploration Phase|Withdrawal by Subject|0|||
129526642|NCT01693562|466216658|FG018|Exploration Phase|Withdrawal by Subject|0|||
129526643|NCT01693562|466216659|FG019|Exploration Phase|Withdrawal by Subject|0|||
129526644|NCT01693562|466216660|FG020|Exploration Phase|Withdrawal by Subject|0|||
129526645|NCT01693562|466216661|FG021|Exploration Phase|Withdrawal by Subject|0|||
129526646|NCT01693562|466216662|FG022|Exploration Phase|Withdrawal by Subject|0|||
129526647|NCT01693562|466216640|FG000|Exploration Phase|Death|0|||
129526648|NCT01693562|466216641|FG001|Exploration Phase|Death|0|||
129526649|NCT01693562|466216642|FG002|Exploration Phase|Death|0|||
129526650|NCT01693562|466216643|FG003|Exploration Phase|Death|0|||
129526651|NCT01693562|466216644|FG004|Exploration Phase|Death|0|||
129526652|NCT01693562|466216645|FG005|Exploration Phase|Death|0|||
129526653|NCT01693562|466216646|FG006|Exploration Phase|Death|17|||
129526654|NCT01693562|466216647|FG007|Exploration Phase|Death|0|||
129526655|NCT01693562|466216648|FG008|Exploration Phase|Death|0|||
129526656|NCT01693562|466216649|FG009|Exploration Phase|Death|0|||
129526657|NCT01693562|466216650|FG010|Exploration Phase|Death|0|||
129526658|NCT01693562|466216651|FG011|Exploration Phase|Death|0|||
129526659|NCT01693562|466216652|FG012|Exploration Phase|Death|0|||
129526660|NCT01693562|466216653|FG013|Exploration Phase|Death|0|||
129526661|NCT01693562|466216654|FG014|Exploration Phase|Death|0|||
129526662|NCT01693562|466216655|FG015|Exploration Phase|Death|0|||
129526663|NCT01693562|466216656|FG016|Exploration Phase|Death|0|||
129526664|NCT01693562|466216657|FG017|Exploration Phase|Death|0|||
129526665|NCT01693562|466216658|FG018|Exploration Phase|Death|0|||
129526666|NCT01693562|466216659|FG019|Exploration Phase|Death|0|||
129526667|NCT01693562|466216660|FG020|Exploration Phase|Death|0|||
129526668|NCT01693562|466216661|FG021|Exploration Phase|Death|0|||
129526669|NCT01693562|466216662|FG022|Exploration Phase|Death|0|||
129526670|NCT01693562|466216640|FG000|Exploration Phase|Other|0|||
129526671|NCT01693562|466216641|FG001|Exploration Phase|Other|0|||
129526672|NCT01693562|466216642|FG002|Exploration Phase|Other|0|||
129526673|NCT01693562|466216643|FG003|Exploration Phase|Other|0|||
129526674|NCT01693562|466216644|FG004|Exploration Phase|Other|0|||
129526675|NCT01693562|466216645|FG005|Exploration Phase|Other|0|||
129526676|NCT01693562|466216646|FG006|Exploration Phase|Other|2|||
129526677|NCT01693562|466216647|FG007|Exploration Phase|Other|0|||
129526678|NCT01693562|466216648|FG008|Exploration Phase|Other|0|||
129526679|NCT01693562|466216649|FG009|Exploration Phase|Other|0|||
129526680|NCT01693562|466216650|FG010|Exploration Phase|Other|0|||
129526681|NCT01693562|466216651|FG011|Exploration Phase|Other|0|||
129526682|NCT01693562|466216652|FG012|Exploration Phase|Other|0|||
129526683|NCT01693562|466216653|FG013|Exploration Phase|Other|0|||
129526684|NCT01693562|466216654|FG014|Exploration Phase|Other|0|||
129526685|NCT01693562|466216655|FG015|Exploration Phase|Other|0|||
129526686|NCT01693562|466216656|FG016|Exploration Phase|Other|0|||
129526687|NCT01693562|466216657|FG017|Exploration Phase|Other|0|||
129526688|NCT01693562|466216658|FG018|Exploration Phase|Other|0|||
129526689|NCT01693562|466216659|FG019|Exploration Phase|Other|0|||
129526690|NCT01693562|466216660|FG020|Exploration Phase|Other|0|||
129526691|NCT01693562|466216661|FG021|Exploration Phase|Other|0|||
129526692|NCT01693562|466216662|FG022|Exploration Phase|Other|0|||
129526693|NCT01693562|466216640|FG000|Expansion Phase|Withdrawal by Subject|0|||
129526694|NCT01693562|466216641|FG001|Expansion Phase|Withdrawal by Subject|0|||
129526695|NCT01693562|466216642|FG002|Expansion Phase|Withdrawal by Subject|0|||
129526696|NCT01693562|466216643|FG003|Expansion Phase|Withdrawal by Subject|0|||
129526697|NCT01693562|466216644|FG004|Expansion Phase|Withdrawal by Subject|0|||
129526698|NCT01693562|466216645|FG005|Expansion Phase|Withdrawal by Subject|0|||
129526699|NCT01693562|466216646|FG006|Expansion Phase|Withdrawal by Subject|0|||
129526700|NCT01693562|466216647|FG007|Expansion Phase|Withdrawal by Subject|16|||
129526701|NCT01693562|466216648|FG008|Expansion Phase|Withdrawal by Subject|2|||
129526702|NCT01693562|466216649|FG009|Expansion Phase|Withdrawal by Subject|54|||
129526703|NCT01693562|466216650|FG010|Expansion Phase|Withdrawal by Subject|2|||
129526704|NCT01693562|466216651|FG011|Expansion Phase|Withdrawal by Subject|2|||
129526705|NCT01693562|466216652|FG012|Expansion Phase|Withdrawal by Subject|3|||
129526706|NCT01693562|466216653|FG013|Expansion Phase|Withdrawal by Subject|5|||
129526707|NCT01693562|466216654|FG014|Expansion Phase|Withdrawal by Subject|16|||
129526708|NCT01693562|466216655|FG015|Expansion Phase|Withdrawal by Subject|7|||
129526709|NCT01693562|466216656|FG016|Expansion Phase|Withdrawal by Subject|40|||
129526710|NCT01693562|466216657|FG017|Expansion Phase|Withdrawal by Subject|4|||
129526711|NCT01693562|466216658|FG018|Expansion Phase|Withdrawal by Subject|8|||
129526712|NCT01693562|466216659|FG019|Expansion Phase|Withdrawal by Subject|3|||
129526713|NCT01693562|466216660|FG020|Expansion Phase|Withdrawal by Subject|1|||
129526714|NCT01693562|466216661|FG021|Expansion Phase|Withdrawal by Subject|8|||
129526715|NCT01693562|466216662|FG022|Expansion Phase|Withdrawal by Subject|1|||
129526716|NCT01693562|466216640|FG000|Expansion Phase|Death|0|||
129526717|NCT01693562|466216641|FG001|Expansion Phase|Death|0|||
129526718|NCT01693562|466216642|FG002|Expansion Phase|Death|0|||
129526719|NCT01693562|466216643|FG003|Expansion Phase|Death|0|||
129526720|NCT01693562|466216644|FG004|Expansion Phase|Death|0|||
129526721|NCT01693562|466216645|FG005|Expansion Phase|Death|0|||
129526722|NCT01693562|466216646|FG006|Expansion Phase|Death|0|||
129526723|NCT01693562|466216647|FG007|Expansion Phase|Death|42|||
129526724|NCT01693562|466216648|FG008|Expansion Phase|Death|17|||
129526725|NCT01693562|466216649|FG009|Expansion Phase|Death|208|||
129526726|NCT01693562|466216650|FG010|Expansion Phase|Death|30|||
129526727|NCT01693562|466216651|FG011|Expansion Phase|Death|8|||
129526728|NCT01693562|466216652|FG012|Expansion Phase|Death|19|||
129526729|NCT01693562|466216653|FG013|Expansion Phase|Death|42|||
129526730|NCT01693562|466216654|FG014|Expansion Phase|Death|23|||
129526731|NCT01693562|466216655|FG015|Expansion Phase|Death|23|||
129526732|NCT01693562|466216656|FG016|Expansion Phase|Death|128|||
129526733|NCT01693562|466216657|FG017|Expansion Phase|Death|16|||
129526734|NCT01693562|466216658|FG018|Expansion Phase|Death|36|||
129526735|NCT01693562|466216659|FG019|Expansion Phase|Death|16|||
129526736|NCT01693562|466216660|FG020|Expansion Phase|Death|17|||
129526737|NCT01693562|466216661|FG021|Expansion Phase|Death|35|||
129526738|NCT01693562|466216662|FG022|Expansion Phase|Death|7|||
129526739|NCT01693562|466216640|FG000|Expansion Phase|Lost to Follow-up|0|||
129526740|NCT01693562|466216641|FG001|Expansion Phase|Lost to Follow-up|0|||
129526741|NCT01693562|466216642|FG002|Expansion Phase|Lost to Follow-up|0|||
129526742|NCT01693562|466216643|FG003|Expansion Phase|Lost to Follow-up|0|||
129526743|NCT01693562|466216644|FG004|Expansion Phase|Lost to Follow-up|0|||
129526744|NCT01693562|466216645|FG005|Expansion Phase|Lost to Follow-up|0|||
129526745|NCT01693562|466216646|FG006|Expansion Phase|Lost to Follow-up|0|||
129526746|NCT01693562|466216647|FG007|Expansion Phase|Lost to Follow-up|1|||
129526747|NCT01693562|466216648|FG008|Expansion Phase|Lost to Follow-up|2|||
129526748|NCT01693562|466216649|FG009|Expansion Phase|Lost to Follow-up|10|||
129526749|NCT01693562|466216650|FG010|Expansion Phase|Lost to Follow-up|4|||
129526750|NCT01693562|466216651|FG011|Expansion Phase|Lost to Follow-up|4|||
129526751|NCT01693562|466216652|FG012|Expansion Phase|Lost to Follow-up|1|||
129526752|NCT01693562|466216653|FG013|Expansion Phase|Lost to Follow-up|3|||
129526753|NCT01693562|466216654|FG014|Expansion Phase|Lost to Follow-up|0|||
129526754|NCT01693562|466216655|FG015|Expansion Phase|Lost to Follow-up|1|||
129526755|NCT01693562|466216656|FG016|Expansion Phase|Lost to Follow-up|1|||
129526756|NCT01693562|466216657|FG017|Expansion Phase|Lost to Follow-up|0|||
129526757|NCT01693562|466216658|FG018|Expansion Phase|Lost to Follow-up|2|||
129526758|NCT01693562|466216659|FG019|Expansion Phase|Lost to Follow-up|1|||
129526759|NCT01693562|466216660|FG020|Expansion Phase|Lost to Follow-up|2|||
129526760|NCT01693562|466216661|FG021|Expansion Phase|Lost to Follow-up|2|||
129526761|NCT01693562|466216662|FG022|Expansion Phase|Lost to Follow-up|1|||
129526762|NCT01693562|466216640|FG000|Expansion Phase|Other|0|||
129526763|NCT01693562|466216641|FG001|Expansion Phase|Other|0|||
129526764|NCT01693562|466216642|FG002|Expansion Phase|Other|0|||
129526765|NCT01693562|466216643|FG003|Expansion Phase|Other|0|||
129526766|NCT01693562|466216644|FG004|Expansion Phase|Other|0|||
129526767|NCT01693562|466216645|FG005|Expansion Phase|Other|0|||
129526768|NCT01693562|466216646|FG006|Expansion Phase|Other|0|||
129526769|NCT01693562|466216647|FG007|Expansion Phase|Other|3|||
129526770|NCT01693562|466216648|FG008|Expansion Phase|Other|1|||
129526771|NCT01693562|466216649|FG009|Expansion Phase|Other|28|||
129526772|NCT01693562|466216650|FG010|Expansion Phase|Other|4|||
129526773|NCT01693562|466216651|FG011|Expansion Phase|Other|7|||
129526774|NCT01693562|466216652|FG012|Expansion Phase|Other|0|||
129526775|NCT01693562|466216653|FG013|Expansion Phase|Other|1|||
129526776|NCT01693562|466216654|FG014|Expansion Phase|Other|1|||
129526777|NCT01693562|466216655|FG015|Expansion Phase|Other|0|||
129526778|NCT01693562|466216656|FG016|Expansion Phase|Other|28|||
129526779|NCT01693562|466216657|FG017|Expansion Phase|Other|0|||
129526780|NCT01693562|466216658|FG018|Expansion Phase|Other|1|||
129526781|NCT01693562|466216659|FG019|Expansion Phase|Other|0|||
129526782|NCT01693562|466216660|FG020|Expansion Phase|Other|1|||
129526783|NCT01693562|466216661|FG021|Expansion Phase|Other|17|||
129526784|NCT01693562|466216662|FG022|Expansion Phase|Other|1|||
129526785|NCT00887822|466216668|FG000|Overall Study|Insufficient therapeutic response|53|||
129526786|NCT00887822|466216669|FG001|Overall Study|Insufficient therapeutic response|55|||
129526787|NCT00887822|466216668|FG000|Overall Study|Adverse Event|14|||
129526788|NCT00887822|466216669|FG001|Overall Study|Adverse Event|17|||
129526789|NCT00887822|466216668|FG000|Overall Study|Failure to return|11|||
129526790|NCT00887822|466216669|FG001|Overall Study|Failure to return|11|||
129526791|NCT00887822|466216668|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
129526792|NCT00887822|466216669|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
129526793|NCT00887822|466216668|FG000|Overall Study|Administrative/Other than specified|5|||
129526794|NCT00887822|466216669|FG001|Overall Study|Administrative/Other than specified|4|||
129526795|NCT00887822|466216668|FG000|Overall Study|Death|2|||
129526796|NCT00887822|466216669|FG001|Overall Study|Death|3|||
129526797|NCT00887822|466216668|FG000|Overall Study|Protocol Violation|0|||
129526798|NCT00887822|466216669|FG001|Overall Study|Protocol Violation|1|||
129526799|NCT00887822|466216668|FG000|Overall Study|Randomized but not treated|0|||
129526800|NCT00887822|466216669|FG001|Overall Study|Randomized but not treated|1|||
129526801|NCT02987205|466216670|FG000|Overall Study|Adverse Event|1|||
129526802|NCT02987205|466216670|FG000|Overall Study|Withdrawal by Subject|3|||
129526803|NCT04167514|466216671|FG000|Overall Study|Adverse event, not serious|0|||
129526804|NCT04167514|466216672|FG001|Overall Study|Adverse event, not serious|1|||
129526805|NCT04167514|466216671|FG000|Overall Study|Lost to Follow-up|1|||
129526806|NCT04167514|466216672|FG001|Overall Study|Lost to Follow-up|0|||
129526807|NCT04167514|466216671|FG000|Overall Study|Participant Decision|2|||
129526808|NCT04167514|466216672|FG001|Overall Study|Participant Decision|4|||
129526809|NCT04167514|466216671|FG000|Overall Study|Physician Decision|3|||
129526810|NCT04167514|466216672|FG001|Overall Study|Physician Decision|2|||
129526811|NCT04167514|466216671|FG000|Overall Study|Death|14|||
129526812|NCT04167514|466216672|FG001|Overall Study|Death|18|||
129526813|NCT04167514|466216671|FG000|Overall Study|Enrolled but treatment not administered|2|||
129526814|NCT04167514|466216672|FG001|Overall Study|Enrolled but treatment not administered|0|||
129526815|NCT04167514|466216671|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
129526816|NCT04167514|466216672|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
129526817|NCT04167514|466216671|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
129526818|NCT04167514|466216672|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
129526819|NCT03345849|466216673|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
129526820|NCT03345849|466216674|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
129526821|NCT03345849|466216675|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
129526822|NCT03345849|466216676|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
129526823|NCT03345849|466216673|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
129526824|NCT03345849|466216674|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
129526825|NCT03345849|466216675|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
129526826|NCT03345849|466216676|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
129526827|NCT03345849|466216673|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
129526828|NCT03345849|466216674|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
129526829|NCT03345849|466216675|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
129526830|NCT03345849|466216676|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
129526831|NCT03345849|466216673|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
129526832|NCT03345849|466216674|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
129526833|NCT03345849|466216675|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
129526834|NCT03345849|466216676|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
129526835|NCT03345849|466216673|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
129526836|NCT03345849|466216674|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
129526837|NCT03345849|466216675|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
129526838|NCT03345849|466216676|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
129526839|NCT03345849|466216673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
129526840|NCT03345849|466216674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
129526841|NCT03345849|466216675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
129526842|NCT03345849|466216676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
129526843|NCT03345849|466216673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
129526844|NCT03345849|466216674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
129526845|NCT03345849|466216675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
129526846|NCT03345849|466216676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
129526847|NCT03345849|466216673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
129526848|NCT03345849|466216674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
129526849|NCT03345849|466216675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
129526850|NCT03345849|466216676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
129526851|NCT03345849|466216673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129526852|NCT03345849|466216674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129526853|NCT03345849|466216675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
129526854|NCT03345849|466216676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
129526855|NCT03345849|466216673|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
129526856|NCT03345849|466216674|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
129526857|NCT03345849|466216675|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
129526858|NCT03345849|466216676|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
129526859|NCT03345849|466216673|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
129526860|NCT03345849|466216674|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
129526861|NCT03345849|466216675|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
129526862|NCT03345849|466216676|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
129526863|NCT05618808|466216679|FG000|Overall Study|Withdrawal by Subject|3|||
129526864|NCT05618808|466216680|FG001|Overall Study|Withdrawal by Subject|1|||
129526865|NCT05618808|466216681|FG002|Overall Study|Withdrawal by Subject|3|||
129526866|NCT05298774|466216688|FG000|Overall Study|Physician Decision|3|||
129526867|NCT05298774|466216688|FG000|Overall Study|Withdrawal by Subject|2|||
129526868|NCT05298774|466216688|FG000|Overall Study|Lost to Follow-up|3|||
129526869|NCT05298774|466216688|FG000|Overall Study|Screen failure|1|||
129526870|NCT06048367|466216697|FG000|Overall Study|Withdrawal by Subject|0|||
129526871|NCT06048367|466216698|FG001|Overall Study|Withdrawal by Subject|1|||
129526872|NCT06048367|466216699|FG002|Overall Study|Withdrawal by Subject|0|||
129526873|NCT06048367|466216700|FG003|Overall Study|Withdrawal by Subject|0|||
129526874|NCT06048367|466216701|FG004|Overall Study|Withdrawal by Subject|0|||
129526875|NCT06048367|466216697|FG000|Overall Study|Withdrawal by Subject|0|||
129526876|NCT06048367|466216698|FG001|Overall Study|Withdrawal by Subject|0|||
129526877|NCT06048367|466216699|FG002|Overall Study|Withdrawal by Subject|1|||
129526878|NCT06048367|466216700|FG003|Overall Study|Withdrawal by Subject|0|||
129526879|NCT06048367|466216701|FG004|Overall Study|Withdrawal by Subject|0|||
129526880|NCT06048367|466216697|FG000|Overall Study|Withdrawal by Subject|0|||
129526881|NCT06048367|466216698|FG001|Overall Study|Withdrawal by Subject|0|||
129526882|NCT06048367|466216699|FG002|Overall Study|Withdrawal by Subject|0|||
129526883|NCT06048367|466216700|FG003|Overall Study|Withdrawal by Subject|1|||
129526884|NCT06048367|466216701|FG004|Overall Study|Withdrawal by Subject|0|||
129526885|NCT06048367|466216697|FG000|Overall Study|Withdrawal by Subject|0|||
129526886|NCT06048367|466216698|FG001|Overall Study|Withdrawal by Subject|0|||
129526887|NCT06048367|466216699|FG002|Overall Study|Withdrawal by Subject|0|||
129526888|NCT06048367|466216700|FG003|Overall Study|Withdrawal by Subject|1|||
129526889|NCT06048367|466216701|FG004|Overall Study|Withdrawal by Subject|0|||
129526890|NCT01327573|466216702|FG000|Overall Study|Physician Decision|3|||
129526891|NCT01327573|466216703|FG001|Overall Study|Physician Decision|1|||
129526892|NCT02136134|466216704|FG000|Overall Study|Death|170|||
129526893|NCT02136134|466216705|FG001|Overall Study|Death|148|||
129526894|NCT02136134|466216704|FG000|Overall Study|Withdrawal by Subject|19|||
129526895|NCT02136134|466216705|FG001|Overall Study|Withdrawal by Subject|10|||
129526896|NCT02136134|466216704|FG000|Overall Study|Lost to Follow-up|3|||
129526897|NCT02136134|466216705|FG001|Overall Study|Lost to Follow-up|3|||
129526898|NCT02136134|466216704|FG000|Overall Study|Uspecified|55|||
129526899|NCT02136134|466216705|FG001|Overall Study|Uspecified|90|||
129526900|NCT03070119|466216708|FG000|Overall Study|Adverse Event|0|||
129526901|NCT03070119|466216709|FG001|Overall Study|Adverse Event|0|||
129526902|NCT03070119|466216710|FG002|Overall Study|Adverse Event|1|||
129526903|NCT03070119|466216708|FG000|Overall Study|Lost to Follow-up|0|||
129526904|NCT03070119|466216709|FG001|Overall Study|Lost to Follow-up|1|||
129526905|NCT03070119|466216710|FG002|Overall Study|Lost to Follow-up|0|||
129526906|NCT03070119|466216708|FG000|Overall Study|Consent Withdrawn|6|||
129526907|NCT03070119|466216709|FG001|Overall Study|Consent Withdrawn|5|||
129526908|NCT03070119|466216710|FG002|Overall Study|Consent Withdrawn|3|||
129526909|NCT03070119|466216708|FG000|Overall Study|Investigator Decision|0|||
129526910|NCT03070119|466216709|FG001|Overall Study|Investigator Decision|0|||
129526911|NCT03070119|466216710|FG002|Overall Study|Investigator Decision|1|||
129526912|NCT03070119|466216708|FG000|Overall Study|Death|7|||
129526913|NCT03070119|466216709|FG001|Overall Study|Death|14|||
129526914|NCT03070119|466216710|FG002|Overall Study|Death|5|||
129526915|NCT03070119|466216708|FG000|Overall Study|Disease Progression|5|||
129526916|NCT03070119|466216709|FG001|Overall Study|Disease Progression|7|||
129526917|NCT03070119|466216710|FG002|Overall Study|Disease Progression|7|||
129526918|NCT03070119|466216708|FG000|Overall Study|Reason not Specified|2|||
129526919|NCT03070119|466216709|FG001|Overall Study|Reason not Specified|2|||
129526920|NCT03070119|466216710|FG002|Overall Study|Reason not Specified|1|||
129526921|NCT00732472|466216711|FG000|Overall Study|Adverse Event|0|||
129526922|NCT00732472|466216712|FG001|Overall Study|Adverse Event|1|||
129526923|NCT00732472|466216713|FG002|Overall Study|Adverse Event|1|||
129526924|NCT00732472|466216714|FG003|Overall Study|Adverse Event|1|||
129526925|NCT00732472|466216711|FG000|Overall Study|Protocol Violation|0|||
129526926|NCT00732472|466216712|FG001|Overall Study|Protocol Violation|0|||
129526927|NCT00732472|466216713|FG002|Overall Study|Protocol Violation|0|||
129526928|NCT00732472|466216714|FG003|Overall Study|Protocol Violation|1|||
129526929|NCT00732472|466216711|FG000|Overall Study|Withdrawal by Subject|0|||
129526930|NCT00732472|466216712|FG001|Overall Study|Withdrawal by Subject|2|||
129526931|NCT00732472|466216713|FG002|Overall Study|Withdrawal by Subject|0|||
129526932|NCT00732472|466216714|FG003|Overall Study|Withdrawal by Subject|1|||
129526933|NCT01058395|466216716|FG000|Overall Study|Death|2|||
129526934|NCT01058395|466216717|FG001|Overall Study|Death|1|||
129526935|NCT01058395|466216716|FG000|Overall Study|Lost to Follow-up|1|||
129526936|NCT01058395|466216717|FG001|Overall Study|Lost to Follow-up|0|||
129526937|NCT01266876|466216718|FG000|Overall Study|Adverse Event|0|||
129526938|NCT01266876|466216719|FG001|Overall Study|Adverse Event|0|||
129526939|NCT01266876|466216720|FG002|Overall Study|Adverse Event|0|||
129526940|NCT01266876|466216721|FG003|Overall Study|Adverse Event|1|||
129526941|NCT01266876|466216722|FG004|Overall Study|Adverse Event|0|||
129526942|NCT04083781|466216723|FG000|Main Part|Physician Decision|0|||
129526943|NCT04083781|466216724|FG001|Main Part|Physician Decision|1|||
129526944|NCT04083781|466216725|FG002|Main Part|Physician Decision|2|||
129526945|NCT04083781|466216726|FG003|Main Part|Physician Decision|0|||
129526946|NCT04083781|466216723|FG000|Main Part|Death|1|||
129526947|NCT04083781|466216724|FG001|Main Part|Death|3|||
129526948|NCT04083781|466216725|FG002|Main Part|Death|1|||
129526949|NCT04083781|466216726|FG003|Main Part|Death|0|||
129526950|NCT04083781|466216723|FG000|Main Part|Withdrawal by Subject|5|||
129526951|NCT04083781|466216724|FG001|Main Part|Withdrawal by Subject|2|||
129526952|NCT04083781|466216725|FG002|Main Part|Withdrawal by Subject|3|||
129526953|NCT04083781|466216726|FG003|Main Part|Withdrawal by Subject|7|||
129526954|NCT04083781|466216723|FG000|Extension Part|Physician Decision|0|||
129526955|NCT04083781|466216724|FG001|Extension Part|Physician Decision|0|||
129526956|NCT04083781|466216725|FG002|Extension Part|Physician Decision|0|||
129526957|NCT04083781|466216726|FG003|Extension Part|Physician Decision|1|||
129526958|NCT04083781|466216723|FG000|Extension Part|Death|0|||
129526959|NCT04083781|466216724|FG001|Extension Part|Death|1|||
129526960|NCT04083781|466216725|FG002|Extension Part|Death|0|||
129526961|NCT04083781|466216726|FG003|Extension Part|Death|1|||
129526962|NCT04083781|466216723|FG000|Extension Part|Withdrawal by Subject|0|||
129526963|NCT04083781|466216724|FG001|Extension Part|Withdrawal by Subject|1|||
129526964|NCT04083781|466216725|FG002|Extension Part|Withdrawal by Subject|0|||
129526965|NCT04083781|466216726|FG003|Extension Part|Withdrawal by Subject|0|||
129526966|NCT04083781|466216723|FG000|Extension Part|Ongoing|13|||
129526967|NCT04083781|466216724|FG001|Extension Part|Ongoing|25|||
129526968|NCT04083781|466216725|FG002|Extension Part|Ongoing|15|||
129526969|NCT04083781|466216726|FG003|Extension Part|Ongoing|51|||
129526970|NCT05245071|466216727|FG000|Overall Study|Progressive disease|18|||
129526971|NCT05245071|466216727|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
129526972|NCT05245071|466216727|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
129526973|NCT05304611|466216728|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526974|NCT05304611|466216729|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526975|NCT05304611|466216730|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526976|NCT05304611|466216731|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526977|NCT05304611|466216732|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526978|NCT05304611|466216733|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526979|NCT05304611|466216734|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
129526980|NCT05304611|466216735|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526981|NCT05304611|466216736|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
129526982|NCT05304611|466216737|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526983|NCT05304611|466216738|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526984|NCT05304611|466216739|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
129526985|NCT05304611|466216728|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
129526986|NCT05304611|466216729|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
129526987|NCT05304611|466216730|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
129526988|NCT05304611|466216731|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
129526989|NCT05304611|466216732|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
129526990|NCT05304611|466216733|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
129526991|NCT05304611|466216734|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
129526992|NCT05304611|466216735|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
129526993|NCT05304611|466216736|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
129526994|NCT05304611|466216737|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
129526995|NCT05304611|466216738|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
129526996|NCT05304611|466216739|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
129526997|NCT05304611|466216728|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
129526998|NCT05304611|466216729|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
129526999|NCT05304611|466216730|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
129527000|NCT05304611|466216731|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
129527001|NCT05304611|466216732|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
129527002|NCT05304611|466216733|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
129527003|NCT05304611|466216734|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
129527004|NCT05304611|466216735|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
129527005|NCT05304611|466216736|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
129527006|NCT05304611|466216737|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
129527007|NCT05304611|466216738|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
129527008|NCT05304611|466216739|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
129527009|NCT02354690|466216740|FG000|Overall Study|Physician Decision|1|||
129527010|NCT00963820|466216741|FG000|Dose Escalation Phase|Progressive Disease|3|||
129527011|NCT00963820|466216742|FG001|Dose Escalation Phase|Progressive Disease|3|||
129527012|NCT00963820|466216743|FG002|Dose Escalation Phase|Progressive Disease|3|||
129527013|NCT00963820|466216744|FG003|Dose Escalation Phase|Progressive Disease|3|||
129527014|NCT00963820|466216745|FG004|Dose Escalation Phase|Progressive Disease|4|||
129527015|NCT00963820|466216746|FG005|Dose Escalation Phase|Progressive Disease|3|||
129527016|NCT00963820|466216747|FG006|Dose Escalation Phase|Progressive Disease|3|||
129527017|NCT00963820|466216748|FG007|Dose Escalation Phase|Progressive Disease|2|||
129527018|NCT00963820|466216749|FG008|Dose Escalation Phase|Progressive Disease|0|||
129527019|NCT00963820|466216750|FG009|Dose Escalation Phase|Progressive Disease|0|||
129527020|NCT00963820|466216751|FG010|Dose Escalation Phase|Progressive Disease|0|||
129527021|NCT00963820|466216752|FG011|Dose Escalation Phase|Progressive Disease|0|||
129527022|NCT00963820|466216741|FG000|Dose Escalation Phase|Adverse Event|0|||
129527023|NCT00963820|466216742|FG001|Dose Escalation Phase|Adverse Event|0|||
129527024|NCT00963820|466216743|FG002|Dose Escalation Phase|Adverse Event|0|||
129527025|NCT00963820|466216744|FG003|Dose Escalation Phase|Adverse Event|0|||
129527026|NCT00963820|466216745|FG004|Dose Escalation Phase|Adverse Event|0|||
129527027|NCT00963820|466216746|FG005|Dose Escalation Phase|Adverse Event|0|||
129527028|NCT00963820|466216747|FG006|Dose Escalation Phase|Adverse Event|3|||
129527029|NCT00963820|466216748|FG007|Dose Escalation Phase|Adverse Event|1|||
129527030|NCT00963820|466216749|FG008|Dose Escalation Phase|Adverse Event|0|||
129527031|NCT00963820|466216750|FG009|Dose Escalation Phase|Adverse Event|0|||
129527032|NCT00963820|466216751|FG010|Dose Escalation Phase|Adverse Event|0|||
129527033|NCT00963820|466216752|FG011|Dose Escalation Phase|Adverse Event|0|||
129527034|NCT00963820|466216741|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
129527035|NCT00963820|466216742|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
129527036|NCT00963820|466216743|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
129527037|NCT00963820|466216744|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
129527038|NCT00963820|466216745|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
129527039|NCT00963820|466216746|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
129527040|NCT00963820|466216747|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
129527041|NCT00963820|466216748|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
129527042|NCT00963820|466216749|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
129527043|NCT00963820|466216750|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
129527044|NCT00963820|466216751|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
129527045|NCT00963820|466216752|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
129527046|NCT00963820|466216741|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527047|NCT00963820|466216742|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527048|NCT00963820|466216743|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527049|NCT00963820|466216744|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527050|NCT00963820|466216745|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527051|NCT00963820|466216746|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527052|NCT00963820|466216747|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
129527053|NCT00963820|466216748|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527054|NCT00963820|466216749|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527055|NCT00963820|466216750|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527056|NCT00963820|466216751|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527057|NCT00963820|466216752|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
129527058|NCT00963820|466216741|FG000|Expansion Phase|Progressive Disease|0|||
129527059|NCT00963820|466216742|FG001|Expansion Phase|Progressive Disease|0|||
129527060|NCT00963820|466216743|FG002|Expansion Phase|Progressive Disease|0|||
129527061|NCT00963820|466216744|FG003|Expansion Phase|Progressive Disease|0|||
129527062|NCT00963820|466216745|FG004|Expansion Phase|Progressive Disease|0|||
129527063|NCT00963820|466216746|FG005|Expansion Phase|Progressive Disease|0|||
129527064|NCT00963820|466216747|FG006|Expansion Phase|Progressive Disease|0|||
129527065|NCT00963820|466216748|FG007|Expansion Phase|Progressive Disease|0|||
129527066|NCT00963820|466216749|FG008|Expansion Phase|Progressive Disease|8|||
129527067|NCT00963820|466216750|FG009|Expansion Phase|Progressive Disease|6|||
129527068|NCT00963820|466216751|FG010|Expansion Phase|Progressive Disease|4|||
129527069|NCT00963820|466216752|FG011|Expansion Phase|Progressive Disease|2|||
129527070|NCT00963820|466216741|FG000|Expansion Phase|Adverse Event|0|||
129527071|NCT00963820|466216742|FG001|Expansion Phase|Adverse Event|0|||
129527072|NCT00963820|466216743|FG002|Expansion Phase|Adverse Event|0|||
129527073|NCT00963820|466216744|FG003|Expansion Phase|Adverse Event|0|||
129527074|NCT00963820|466216745|FG004|Expansion Phase|Adverse Event|0|||
129527075|NCT00963820|466216746|FG005|Expansion Phase|Adverse Event|0|||
129527076|NCT00963820|466216747|FG006|Expansion Phase|Adverse Event|0|||
129527077|NCT00963820|466216748|FG007|Expansion Phase|Adverse Event|0|||
129527078|NCT00963820|466216749|FG008|Expansion Phase|Adverse Event|1|||
129527079|NCT00963820|466216750|FG009|Expansion Phase|Adverse Event|3|||
129527080|NCT00963820|466216751|FG010|Expansion Phase|Adverse Event|0|||
129527081|NCT00963820|466216752|FG011|Expansion Phase|Adverse Event|0|||
129527082|NCT00963820|466216741|FG000|Expansion Phase|Withdrawal by Subject|0|||
129527083|NCT00963820|466216742|FG001|Expansion Phase|Withdrawal by Subject|0|||
129527084|NCT00963820|466216743|FG002|Expansion Phase|Withdrawal by Subject|0|||
129527085|NCT00963820|466216744|FG003|Expansion Phase|Withdrawal by Subject|0|||
129527086|NCT00963820|466216745|FG004|Expansion Phase|Withdrawal by Subject|0|||
129527087|NCT00963820|466216746|FG005|Expansion Phase|Withdrawal by Subject|0|||
129527088|NCT00963820|466216747|FG006|Expansion Phase|Withdrawal by Subject|0|||
129527089|NCT00963820|466216748|FG007|Expansion Phase|Withdrawal by Subject|0|||
129527090|NCT00963820|466216749|FG008|Expansion Phase|Withdrawal by Subject|1|||
129527091|NCT00963820|466216750|FG009|Expansion Phase|Withdrawal by Subject|0|||
129527092|NCT00963820|466216751|FG010|Expansion Phase|Withdrawal by Subject|1|||
129527093|NCT00963820|466216752|FG011|Expansion Phase|Withdrawal by Subject|1|||
129527094|NCT00963820|466216741|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527095|NCT00963820|466216742|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527096|NCT00963820|466216743|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527097|NCT00963820|466216744|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527098|NCT00963820|466216745|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527099|NCT00963820|466216746|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527100|NCT00963820|466216747|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527101|NCT00963820|466216748|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527102|NCT00963820|466216749|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527103|NCT00963820|466216750|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527104|NCT00963820|466216751|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
129527105|NCT00963820|466216752|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
129527106|NCT05549505|466216760|FG000|Overall Study|Lost to Follow-up|2|||
129527107|NCT05549505|466216761|FG001|Overall Study|Lost to Follow-up|0|||
129527108|NCT05549505|466216760|FG000|Overall Study|Withdrawal by Subject|3|||
129527109|NCT05549505|466216761|FG001|Overall Study|Withdrawal by Subject|3|||
129527110|NCT05549505|466216760|FG000|Overall Study|Other: Miscellaneous|3|||
129527111|NCT05549505|466216761|FG001|Overall Study|Other: Miscellaneous|6|||
129527112|NCT01602822|466216764|FG000|Overall Study|Adverse Event|11|||
129527113|NCT05492877|466216768|FG000|Overall Study|Adverse Event|11|||
129527114|NCT05492877|466216769|FG001|Overall Study|Adverse Event|7|||
129527115|NCT05492877|466216768|FG000|Overall Study|Death|1|||
129527116|NCT05492877|466216769|FG001|Overall Study|Death|0|||
129527117|NCT05492877|466216768|FG000|Overall Study|Lost to Follow-up|1|||
129527118|NCT05492877|466216769|FG001|Overall Study|Lost to Follow-up|1|||
129527119|NCT05492877|466216768|FG000|Overall Study|Physician Decision|1|||
129527120|NCT05492877|466216769|FG001|Overall Study|Physician Decision|2|||
129527121|NCT05492877|466216768|FG000|Overall Study|Protocol Violation|1|||
129527122|NCT05492877|466216769|FG001|Overall Study|Protocol Violation|1|||
129527123|NCT05492877|466216768|FG000|Overall Study|Withdrawal by Subject|3|||
129527124|NCT05492877|466216769|FG001|Overall Study|Withdrawal by Subject|7|||
129527125|NCT05492877|466216768|FG000|Overall Study|Reason not specified|6|||
129527126|NCT05492877|466216769|FG001|Overall Study|Reason not specified|4|||
129527127|NCT02286089|466216770|FG000|Overall Study|Ongoing in Study|1|||
129527128|NCT02286089|466216771|FG001|Overall Study|Ongoing in Study|1|||
129527129|NCT02286089|466216772|FG002|Overall Study|Ongoing in Study|4|||
129527130|NCT02286089|466216773|FG003|Overall Study|Ongoing in Study|10|||
129527131|NCT02286089|466216770|FG000|Overall Study|Withdrawal by Subject|0|||
129527132|NCT02286089|466216771|FG001|Overall Study|Withdrawal by Subject|0|||
129527133|NCT02286089|466216772|FG002|Overall Study|Withdrawal by Subject|2|||
129527134|NCT02286089|466216773|FG003|Overall Study|Withdrawal by Subject|2|||
129527135|NCT00129376|466216774|FG000|Overall Study|Adverse Event|1|||
129527136|NCT00129376|466216774|FG000|Overall Study|Lack of Efficacy|1|||
129527137|NCT03218826|466216775|FG000|Overall Study|Non-compliance with protocol|1|||
129527138|NCT03218826|466216776|FG001|Overall Study|Non-compliance with protocol|0|||
129527139|NCT03218826|466216777|FG002|Overall Study|Non-compliance with protocol|2|||
129527140|NCT03218826|466216778|FG003|Overall Study|Non-compliance with protocol|1|||
129527141|NCT03218826|466216779|FG004|Overall Study|Non-compliance with protocol|1|||
129527142|NCT01426009|466216780|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
129527143|NCT01426009|466216780|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
129527144|NCT01426009|466216780|FG000|Washout 1|Withdrawal by Subject|1|||
129527145|NCT01426009|466216780|FG000|Washout 1|Personal Reasons|1|||
129527146|NCT01426009|466216780|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
129527147|NCT01426009|466216780|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
129527148|NCT01426009|466216780|FG000|Washout 2|electrive surgery|1|||
129527149|NCT01426009|466216780|FG000|Washout 3|personal reasons|1|||
129527150|NCT01426009|466216780|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
129527151|NCT01426009|466216780|FG000|Washout 4|Lost to Follow-up|1|||
129527152|NCT00515099|466216787|FG000|Overall Study|Lost to Follow-up|0|||
129527153|NCT00515099|466216788|FG001|Overall Study|Lost to Follow-up|4|||
129527154|NCT00515099|466216787|FG000|Overall Study|Withdrawal by Subject|2|||
129527155|NCT00515099|466216788|FG001|Overall Study|Withdrawal by Subject|0|||
129527156|NCT00515099|466216787|FG000|Overall Study|IRB Recommendation|1|||
129527157|NCT00515099|466216788|FG001|Overall Study|IRB Recommendation|0|||
129527158|NCT04476108|466216789|FG000|Overall Study|Adverse Event|4|||
129527159|NCT04476108|466216790|FG001|Overall Study|Adverse Event|1|||
129527160|NCT04476108|466216789|FG000|Overall Study|Lost to Follow-up|1|||
129527161|NCT04476108|466216790|FG001|Overall Study|Lost to Follow-up|0|||
129527162|NCT04476108|466216789|FG000|Overall Study|Inadvertent Enrollment|1|||
129527163|NCT04476108|466216790|FG001|Overall Study|Inadvertent Enrollment|0|||
129527164|NCT04476108|466216789|FG000|Overall Study|Protocol Violation|1|||
129527165|NCT04476108|466216790|FG001|Overall Study|Protocol Violation|1|||
129527166|NCT04476108|466216789|FG000|Overall Study|Withdrawal by Subject|1|||
129527167|NCT04476108|466216790|FG001|Overall Study|Withdrawal by Subject|1|||
129527168|NCT00355615|466216791|FG000|Randomized Double Blind Period|Adverse Event|1|||
129527169|NCT00355615|466216792|FG001|Randomized Double Blind Period|Adverse Event|0|||
129527170|NCT00355615|466216793|FG002|Randomized Double Blind Period|Adverse Event|0|||
129527171|NCT00355615|466216794|FG003|Randomized Double Blind Period|Adverse Event|0|||
129527172|NCT00355615|466216795|FG004|Randomized Double Blind Period|Adverse Event|0|||
129527173|NCT00355615|466216791|FG000|Randomized Double Blind Period|Protocol Violation|0|||
129527174|NCT00355615|466216792|FG001|Randomized Double Blind Period|Protocol Violation|0|||
129527175|NCT00355615|466216793|FG002|Randomized Double Blind Period|Protocol Violation|1|||
129527176|NCT00355615|466216794|FG003|Randomized Double Blind Period|Protocol Violation|1|||
129527177|NCT00355615|466216795|FG004|Randomized Double Blind Period|Protocol Violation|0|||
129527178|NCT00355615|466216791|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
129527179|NCT00355615|466216792|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
129527180|NCT00355615|466216793|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
129527181|NCT00355615|466216794|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
129527182|NCT00355615|466216795|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
129527183|NCT00355615|466216791|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
129527184|NCT00355615|466216792|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
129527185|NCT00355615|466216793|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
129527186|NCT00355615|466216794|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
129527187|NCT00355615|466216795|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
129527188|NCT00355615|466216791|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
129527189|NCT00355615|466216792|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
129527190|NCT00355615|466216793|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
129527191|NCT00355615|466216794|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
129527192|NCT00355615|466216795|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
129527193|NCT00355615|466216791|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
129527194|NCT00355615|466216792|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
129527195|NCT00355615|466216793|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
129527196|NCT00355615|466216794|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
129527197|NCT00355615|466216795|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
129527198|NCT03523715|466216796|FG000|Overall Study|Lost to Follow-up|11|||
129527199|NCT03523715|466216797|FG001|Overall Study|Lost to Follow-up|14|||
129527200|NCT03523715|466216796|FG000|Overall Study|Did not meet inclusion criteria|1|||
129527201|NCT03523715|466216797|FG001|Overall Study|Did not meet inclusion criteria|0|||
129527202|NCT03523715|466216796|FG000|Overall Study|Internally inconsistent reporting|0|||
129527203|NCT03523715|466216797|FG001|Overall Study|Internally inconsistent reporting|2|||
129527204|NCT04430036|466216798|FG000|Safety Run in Phase|Progression of disease|2|||
129527205|NCT01842334|466216799|FG000|Overall Study|Withdrawal by Subject|3|||
129527206|NCT01842334|466216800|FG001|Overall Study|Withdrawal by Subject|3|||
129527207|NCT01842334|466216799|FG000|Overall Study|Moved away mid-study|0|||
129527208|NCT01842334|466216800|FG001|Overall Study|Moved away mid-study|1|||
129527209|NCT04055844|466216808|FG000|Overall Study|Adverse Event|12|||
129527210|NCT04055844|466216808|FG000|Overall Study|Poor Performance|1|||
129527211|NCT04055844|466216808|FG000|Overall Study|Death|1|||
129527212|NCT00113555|466216811|FG000|Overall Study|Baseline Failure|59|||
129527213|NCT00113555|466216811|FG000|Overall Study|Permanently Explanted|7|||
129527214|NCT00113555|466216811|FG000|Overall Study|Death|1|||
129527215|NCT00113555|466216811|FG000|Overall Study|Missed Followup|4|||
129527216|NCT00113555|466216811|FG000|Overall Study|Lost to Follow-up|8|||
129527217|NCT03128307|466216818|FG000|Overall Study|Lost to Follow-up|29|||
129527218|NCT03128307|466216818|FG000|Overall Study|Withdrawal by Subject|5|||
129527219|NCT03261037|466218711|FG000|Overall Study|Withdrawal by Subject|2|||
129527220|NCT03261037|466218712|FG001|Overall Study|Withdrawal by Subject|13|||
129527221|NCT03261037|466218713|FG002|Overall Study|Withdrawal by Subject|0|||
129527222|NCT03261037|466218714|FG003|Overall Study|Withdrawal by Subject|18|||
129527223|NCT03261037|466218711|FG000|Overall Study|Non-compliance with study procedures|0|||
129527224|NCT03261037|466218712|FG001|Overall Study|Non-compliance with study procedures|2|||
129527225|NCT03261037|466218713|FG002|Overall Study|Non-compliance with study procedures|0|||
129527226|NCT03261037|466218714|FG003|Overall Study|Non-compliance with study procedures|6|||
129527227|NCT03261037|466218711|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
129527228|NCT03261037|466218712|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
129527229|NCT03261037|466218713|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
129527230|NCT03261037|466218714|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
129527231|NCT03261037|466218711|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
129527232|NCT03261037|466218712|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
129527233|NCT03261037|466218713|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
129527234|NCT03261037|466218714|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
129527235|NCT03261037|466218711|FG000|Overall Study|Diagnosed but protocol deviation|1|||
129527236|NCT03261037|466218712|FG001|Overall Study|Diagnosed but protocol deviation|0|||
129527237|NCT03261037|466218713|FG002|Overall Study|Diagnosed but protocol deviation|0|||
129527238|NCT03261037|466218714|FG003|Overall Study|Diagnosed but protocol deviation|0|||
129527239|NCT03261037|466218711|FG000|Overall Study|Participant did not want to continue the study|0|||
129527240|NCT03261037|466218712|FG001|Overall Study|Participant did not want to continue the study|1|||
129527241|NCT03261037|466218713|FG002|Overall Study|Participant did not want to continue the study|0|||
129527242|NCT03261037|466218714|FG003|Overall Study|Participant did not want to continue the study|0|||
129527243|NCT03261037|466218711|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
129527244|NCT03261037|466218712|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
129527245|NCT03261037|466218713|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
129527246|NCT03261037|466218714|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
129527247|NCT03261037|466218711|FG000|Overall Study|Participant presented clinical improvement|0|||
129527248|NCT03261037|466218712|FG001|Overall Study|Participant presented clinical improvement|2|||
129527249|NCT03261037|466218713|FG002|Overall Study|Participant presented clinical improvement|0|||
129527250|NCT03261037|466218714|FG003|Overall Study|Participant presented clinical improvement|0|||
129527251|NCT03261037|466218711|FG000|Overall Study|Technical difficulties|0|||
129527252|NCT03261037|466218712|FG001|Overall Study|Technical difficulties|0|||
129527253|NCT03261037|466218713|FG002|Overall Study|Technical difficulties|0|||
129527254|NCT03261037|466218714|FG003|Overall Study|Technical difficulties|1|||
129527255|NCT03261037|466218711|FG000|Overall Study|Equipment failed to work|0|||
129527256|NCT03261037|466218712|FG001|Overall Study|Equipment failed to work|0|||
129527257|NCT03261037|466218713|FG002|Overall Study|Equipment failed to work|0|||
129527258|NCT03261037|466218714|FG003|Overall Study|Equipment failed to work|1|||
129527259|NCT03261037|466218711|FG000|Overall Study|End of study for participant and no follow up|0|||
129527260|NCT03261037|466218712|FG001|Overall Study|End of study for participant and no follow up|0|||
129527261|NCT03261037|466218713|FG002|Overall Study|End of study for participant and no follow up|0|||
129527262|NCT03261037|466218714|FG003|Overall Study|End of study for participant and no follow up|1|||
129527263|NCT03261037|466218711|FG000|Overall Study|Participant was too weak to continue in study|1|||
129527264|NCT03261037|466218712|FG001|Overall Study|Participant was too weak to continue in study|0|||
129527265|NCT03261037|466218713|FG002|Overall Study|Participant was too weak to continue in study|0|||
129527266|NCT03261037|466218714|FG003|Overall Study|Participant was too weak to continue in study|0|||
129527267|NCT04437511|466218715|FG000|Overall Study|Adverse Event|50|||
129527268|NCT04437511|466218716|FG001|Overall Study|Adverse Event|21|||
129527269|NCT04437511|466218715|FG000|Overall Study|Death|15|||
129527270|NCT04437511|466218716|FG001|Overall Study|Death|10|||
129527271|NCT04437511|466218715|FG000|Overall Study|Lost to Follow-up|11|||
129527272|NCT04437511|466218716|FG001|Overall Study|Lost to Follow-up|11|||
129527273|NCT04437511|466218715|FG000|Overall Study|Physician Decision|19|||
129527274|NCT04437511|466218716|FG001|Overall Study|Physician Decision|10|||
129527275|NCT04437511|466218715|FG000|Overall Study|Progressive Disease|4|||
129527276|NCT04437511|466218716|FG001|Overall Study|Progressive Disease|7|||
129527277|NCT04437511|466218715|FG000|Overall Study|Withdrawal by Subject|111|||
129527278|NCT04437511|466218716|FG001|Overall Study|Withdrawal by Subject|94|||
129527279|NCT04437511|466218715|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
129527280|NCT04437511|466218716|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
129527281|NCT04437511|466218715|FG000|Overall Study|Continuing Study|7|||
129527282|NCT04437511|466218716|FG001|Overall Study|Continuing Study|5|||
129527283|NCT04654468|466218719|FG000|Overall Study|Death|1|||
129527284|NCT04654468|466218719|FG000|Overall Study|Ongoing in the Study|50|||
129527285|NCT03093350|466218724|FG000|Overall Study|Death|1|||
129527286|NCT03093350|466218724|FG000|Overall Study|Signed consent, never began treartment|1|||
129527287|NCT00081263|466218726|FG000|Overall Study|clerical error|1|||
129527288|NCT00081263|466218727|FG001|Overall Study|clerical error|0|||
129527289|NCT00081263|466218726|FG000|Overall Study|wrong cell type|7|||
129527290|NCT00081263|466218727|FG001|Overall Study|wrong cell type|5|||
129527291|NCT00081263|466218726|FG000|Overall Study|improper pre-protocol therapy|0|||
129527292|NCT00081263|466218727|FG001|Overall Study|improper pre-protocol therapy|1|||
129527293|NCT00081263|466218726|FG000|Overall Study|Inadequate pathology|0|||
129527294|NCT00081263|466218727|FG001|Overall Study|Inadequate pathology|1|||
129527295|NCT00081263|466218726|FG000|Overall Study|Never treated|4|||
129527296|NCT00081263|466218727|FG001|Overall Study|Never treated|5|||
129527297|NCT00081263|466218726|FG000|Overall Study|Inadequate data|5|||
129527298|NCT00081263|466218727|FG001|Overall Study|Inadequate data|10|||
129527299|NCT04564027|466218738|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
129527300|NCT04564027|466218739|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
129527301|NCT04564027|466218740|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
129527302|NCT04564027|466218741|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
129527303|NCT01267955|466218744|FG000|Stage 1 (6 Months)|Death|3|||
129527304|NCT01267955|466218744|FG000|Stage 2 (6 Months)|Death|5|||
129527305|NCT01267955|466218744|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
129527306|NCT04517253|466218747|FG000|Primary Treatment Period|Adverse Event|1|||
129527307|NCT04517253|466218748|FG001|Primary Treatment Period|Adverse Event|0|||
129527308|NCT04517253|466218749|FG002|Primary Treatment Period|Adverse Event|0|||
129527309|NCT04517253|466218747|FG000|Primary Treatment Period|Death|0|||
129527310|NCT04517253|466218748|FG001|Primary Treatment Period|Death|1|||
129527311|NCT04517253|466218749|FG002|Primary Treatment Period|Death|0|||
129527312|NCT04517253|466218747|FG000|Maintenance Period|Withdrawal by Subject|1|||
129527313|NCT04517253|466218748|FG001|Maintenance Period|Withdrawal by Subject|0|||
129527314|NCT04517253|466218749|FG002|Maintenance Period|Withdrawal by Subject|0|||
129527315|NCT04517253|466218747|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
129527316|NCT04517253|466218748|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
129527317|NCT04517253|466218749|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
129527318|NCT05827978|466218752|FG000|Overall Study|Adverse Event|1|||
129527319|NCT05827978|466218753|FG001|Overall Study|Adverse Event|0|||
129527320|NCT05827978|466218754|FG002|Overall Study|Adverse Event|0|||
129527321|NCT05827978|466218755|FG003|Overall Study|Adverse Event|1|||
129527322|NCT05827978|466218756|FG004|Overall Study|Adverse Event|0|||
129527323|NCT05827978|466218757|FG005|Overall Study|Adverse Event|0|||
129527324|NCT05827978|466218752|FG000|Overall Study|Death|1|||
129527325|NCT05827978|466218753|FG001|Overall Study|Death|5|||
129527326|NCT05827978|466218754|FG002|Overall Study|Death|2|||
129527327|NCT05827978|466218755|FG003|Overall Study|Death|3|||
129527328|NCT05827978|466218756|FG004|Overall Study|Death|1|||
129527329|NCT05827978|466218757|FG005|Overall Study|Death|3|||
129527330|NCT05827978|466218752|FG000|Overall Study|Lost to Follow-up|57|||
129527331|NCT05827978|466218753|FG001|Overall Study|Lost to Follow-up|88|||
129527332|NCT05827978|466218754|FG002|Overall Study|Lost to Follow-up|54|||
129527333|NCT05827978|466218755|FG003|Overall Study|Lost to Follow-up|47|||
129527334|NCT05827978|466218756|FG004|Overall Study|Lost to Follow-up|25|||
129527335|NCT05827978|466218757|FG005|Overall Study|Lost to Follow-up|10|||
129527336|NCT05827978|466218752|FG000|Overall Study|Noncompliance with Study Procedures|0|||
129527337|NCT05827978|466218753|FG001|Overall Study|Noncompliance with Study Procedures|1|||
129527338|NCT05827978|466218754|FG002|Overall Study|Noncompliance with Study Procedures|1|||
129527339|NCT05827978|466218755|FG003|Overall Study|Noncompliance with Study Procedures|1|||
129527340|NCT05827978|466218756|FG004|Overall Study|Noncompliance with Study Procedures|1|||
129527341|NCT05827978|466218757|FG005|Overall Study|Noncompliance with Study Procedures|0|||
129527342|NCT05827978|466218752|FG000|Overall Study|Physician Decision|2|||
129527343|NCT05827978|466218753|FG001|Overall Study|Physician Decision|0|||
129527344|NCT05827978|466218754|FG002|Overall Study|Physician Decision|1|||
129527345|NCT05827978|466218755|FG003|Overall Study|Physician Decision|2|||
129527346|NCT05827978|466218756|FG004|Overall Study|Physician Decision|1|||
129527347|NCT05827978|466218757|FG005|Overall Study|Physician Decision|1|||
129527348|NCT05827978|466218752|FG000|Overall Study|Protocol Violation|5|||
129527349|NCT05827978|466218753|FG001|Overall Study|Protocol Violation|2|||
129527350|NCT05827978|466218754|FG002|Overall Study|Protocol Violation|0|||
129527351|NCT05827978|466218755|FG003|Overall Study|Protocol Violation|0|||
129527352|NCT05827978|466218756|FG004|Overall Study|Protocol Violation|0|||
129527353|NCT05827978|466218757|FG005|Overall Study|Protocol Violation|0|||
129527354|NCT05827978|466218752|FG000|Overall Study|Withdrawal by Subject|17|||
129527355|NCT05827978|466218753|FG001|Overall Study|Withdrawal by Subject|16|||
129527356|NCT05827978|466218754|FG002|Overall Study|Withdrawal by Subject|10|||
129527357|NCT05827978|466218755|FG003|Overall Study|Withdrawal by Subject|12|||
129527358|NCT05827978|466218756|FG004|Overall Study|Withdrawal by Subject|10|||
129527359|NCT05827978|466218757|FG005|Overall Study|Withdrawal by Subject|9|||
129527360|NCT05827978|466218752|FG000|Overall Study|Other Than Specified|0|||
129527361|NCT05827978|466218753|FG001|Overall Study|Other Than Specified|0|||
129527362|NCT05827978|466218754|FG002|Overall Study|Other Than Specified|1|||
129527363|NCT05827978|466218755|FG003|Overall Study|Other Than Specified|0|||
129527364|NCT05827978|466218756|FG004|Overall Study|Other Than Specified|2|||
129527365|NCT05827978|466218757|FG005|Overall Study|Other Than Specified|0|||
129527366|NCT05564039|466218758|FG000|Overall Study|Adverse Event|1|||
129527367|NCT05564039|466218759|FG001|Overall Study|Adverse Event|0|||
129527368|NCT05564039|466218758|FG000|Overall Study|Death|1|||
129527369|NCT05564039|466218759|FG001|Overall Study|Death|1|||
129527370|NCT05564039|466218758|FG000|Overall Study|Lost to Follow-up|3|||
129527371|NCT05564039|466218759|FG001|Overall Study|Lost to Follow-up|2|||
129527372|NCT05564039|466218758|FG000|Overall Study|Withdrawal by Subject|2|||
129527373|NCT05564039|466218759|FG001|Overall Study|Withdrawal by Subject|0|||
129527374|NCT05564039|466218758|FG000|Overall Study|Inadvertent enrollment|3|||
129527375|NCT05564039|466218759|FG001|Overall Study|Inadvertent enrollment|6|||
129527376|NCT04566445|466218760|FG000|Overall Study|Death|4|||
129527377|NCT04566445|466218761|FG001|Overall Study|Death|1|||
129527378|NCT04566445|466218762|FG002|Overall Study|Death|1|||
129527379|NCT04566445|466218760|FG000|Overall Study|Lost to Follow-up|3|||
129527380|NCT04566445|466218761|FG001|Overall Study|Lost to Follow-up|1|||
129527381|NCT04566445|466218762|FG002|Overall Study|Lost to Follow-up|1|||
129527382|NCT04566445|466218760|FG000|Overall Study|Study terminated by sponsor|11|||
129527383|NCT04566445|466218761|FG001|Overall Study|Study terminated by sponsor|17|||
129527384|NCT04566445|466218762|FG002|Overall Study|Study terminated by sponsor|32|||
129527385|NCT04566445|466218760|FG000|Overall Study|Withdrawal by Subject|12|||
129527386|NCT04566445|466218761|FG001|Overall Study|Withdrawal by Subject|14|||
129527387|NCT04566445|466218762|FG002|Overall Study|Withdrawal by Subject|13|||
129527388|NCT04566445|466218760|FG000|Overall Study|Randomized but not treated due to AE|2|||
129527389|NCT04566445|466218761|FG001|Overall Study|Randomized but not treated due to AE|1|||
129527390|NCT04566445|466218762|FG002|Overall Study|Randomized but not treated due to AE|0|||
129527391|NCT04566445|466218760|FG000|Overall Study|Adverse Event|1|||
129527392|NCT04566445|466218761|FG001|Overall Study|Adverse Event|1|||
129527393|NCT04566445|466218762|FG002|Overall Study|Adverse Event|0|||
129527394|NCT04785144|466218763|FG000|Overall Study|Withdrawal by Subject|4|||
129527395|NCT04785144|466218764|FG001|Overall Study|Withdrawal by Subject|1|||
129527396|NCT04785144|466218765|FG002|Overall Study|Withdrawal by Subject|0|||
129527397|NCT04785144|466218766|FG003|Overall Study|Withdrawal by Subject|0|||
129527398|NCT04785144|466218767|FG004|Overall Study|Withdrawal by Subject|0|||
129527399|NCT04785144|466218768|FG005|Overall Study|Withdrawal by Subject|2|||
129527400|NCT04785144|466218769|FG006|Overall Study|Withdrawal by Subject|2|||
129527401|NCT04785144|466218770|FG007|Overall Study|Withdrawal by Subject|0|||
129527402|NCT04785144|466218771|FG008|Overall Study|Withdrawal by Subject|1|||
129527403|NCT04785144|466218772|FG009|Overall Study|Withdrawal by Subject|0|||
129527404|NCT04785144|466218763|FG000|Overall Study|Lost to Follow-up|1|||
129527405|NCT04785144|466218764|FG001|Overall Study|Lost to Follow-up|0|||
129527406|NCT04785144|466218765|FG002|Overall Study|Lost to Follow-up|0|||
129527407|NCT04785144|466218766|FG003|Overall Study|Lost to Follow-up|0|||
129527408|NCT04785144|466218767|FG004|Overall Study|Lost to Follow-up|1|||
129527409|NCT04785144|466218768|FG005|Overall Study|Lost to Follow-up|2|||
129527410|NCT04785144|466218769|FG006|Overall Study|Lost to Follow-up|1|||
129527411|NCT04785144|466218770|FG007|Overall Study|Lost to Follow-up|2|||
129527412|NCT04785144|466218771|FG008|Overall Study|Lost to Follow-up|4|||
129527413|NCT04785144|466218772|FG009|Overall Study|Lost to Follow-up|1|||
129527414|NCT04785144|466218763|FG000|Overall Study|Protocol Violation|0|||
129527415|NCT04785144|466218764|FG001|Overall Study|Protocol Violation|0|||
129527416|NCT04785144|466218765|FG002|Overall Study|Protocol Violation|0|||
129527417|NCT04785144|466218766|FG003|Overall Study|Protocol Violation|0|||
129527418|NCT04785144|466218767|FG004|Overall Study|Protocol Violation|0|||
129527419|NCT04785144|466218768|FG005|Overall Study|Protocol Violation|0|||
129527420|NCT04785144|466218769|FG006|Overall Study|Protocol Violation|1|||
129527421|NCT04785144|466218770|FG007|Overall Study|Protocol Violation|0|||
129527422|NCT04785144|466218771|FG008|Overall Study|Protocol Violation|0|||
129527423|NCT04785144|466218772|FG009|Overall Study|Protocol Violation|0|||
129527424|NCT04785144|466218763|FG000|Overall Study|Physician Decision|0|||
129527425|NCT04785144|466218764|FG001|Overall Study|Physician Decision|0|||
129527426|NCT04785144|466218765|FG002|Overall Study|Physician Decision|0|||
129527427|NCT04785144|466218766|FG003|Overall Study|Physician Decision|0|||
129527428|NCT04785144|466218767|FG004|Overall Study|Physician Decision|0|||
129527429|NCT04785144|466218768|FG005|Overall Study|Physician Decision|0|||
129527430|NCT04785144|466218769|FG006|Overall Study|Physician Decision|0|||
129527431|NCT04785144|466218770|FG007|Overall Study|Physician Decision|0|||
129527432|NCT04785144|466218771|FG008|Overall Study|Physician Decision|0|||
129527433|NCT04785144|466218772|FG009|Overall Study|Physician Decision|1|||
129527434|NCT04785144|466218763|FG000|Overall Study|Unable to continue due to work schedule|0|||
129527435|NCT04785144|466218764|FG001|Overall Study|Unable to continue due to work schedule|0|||
129527436|NCT04785144|466218765|FG002|Overall Study|Unable to continue due to work schedule|0|||
129527437|NCT04785144|466218766|FG003|Overall Study|Unable to continue due to work schedule|0|||
129527438|NCT04785144|466218767|FG004|Overall Study|Unable to continue due to work schedule|0|||
129527439|NCT04785144|466218768|FG005|Overall Study|Unable to continue due to work schedule|0|||
129527440|NCT04785144|466218769|FG006|Overall Study|Unable to continue due to work schedule|0|||
129527441|NCT04785144|466218770|FG007|Overall Study|Unable to continue due to work schedule|0|||
129527442|NCT04785144|466218771|FG008|Overall Study|Unable to continue due to work schedule|0|||
129527443|NCT04785144|466218772|FG009|Overall Study|Unable to continue due to work schedule|1|||
129527444|NCT01263470|466218775|FG000|Overall Study|Adverse Event|2|||
129527445|NCT01263470|466218776|FG001|Overall Study|Adverse Event|2|||
129527446|NCT01263470|466218777|FG002|Overall Study|Adverse Event|1|||
129527447|NCT01263470|466218778|FG003|Overall Study|Adverse Event|1|||
129527448|NCT01263470|466218779|FG004|Overall Study|Adverse Event|2|||
129527449|NCT01263470|466218780|FG005|Overall Study|Adverse Event|2|||
129527450|NCT01263470|466218775|FG000|Overall Study|Protocol Violation|0|||
129527451|NCT01263470|466218776|FG001|Overall Study|Protocol Violation|1|||
129527452|NCT01263470|466218777|FG002|Overall Study|Protocol Violation|0|||
129527453|NCT01263470|466218778|FG003|Overall Study|Protocol Violation|0|||
129527454|NCT01263470|466218779|FG004|Overall Study|Protocol Violation|0|||
129527455|NCT01263470|466218780|FG005|Overall Study|Protocol Violation|1|||
129527456|NCT01263470|466218775|FG000|Overall Study|Withdrawal by Subject|0|||
129527457|NCT01263470|466218776|FG001|Overall Study|Withdrawal by Subject|1|||
129527458|NCT01263470|466218777|FG002|Overall Study|Withdrawal by Subject|1|||
129527459|NCT01263470|466218778|FG003|Overall Study|Withdrawal by Subject|2|||
129527460|NCT01263470|466218779|FG004|Overall Study|Withdrawal by Subject|0|||
129527461|NCT01263470|466218780|FG005|Overall Study|Withdrawal by Subject|2|||
129527462|NCT01263470|466218775|FG000|Overall Study|Lack of Efficacy|0|||
129527463|NCT01263470|466218776|FG001|Overall Study|Lack of Efficacy|0|||
129527464|NCT01263470|466218777|FG002|Overall Study|Lack of Efficacy|2|||
129527465|NCT01263470|466218778|FG003|Overall Study|Lack of Efficacy|0|||
129527466|NCT01263470|466218779|FG004|Overall Study|Lack of Efficacy|0|||
129527467|NCT01263470|466218780|FG005|Overall Study|Lack of Efficacy|0|||
129527468|NCT01263470|466218775|FG000|Overall Study|Participant Unavailability|0|||
129527469|NCT01263470|466218776|FG001|Overall Study|Participant Unavailability|1|||
129527470|NCT01263470|466218777|FG002|Overall Study|Participant Unavailability|0|||
129527471|NCT01263470|466218778|FG003|Overall Study|Participant Unavailability|0|||
129527472|NCT01263470|466218779|FG004|Overall Study|Participant Unavailability|0|||
129527473|NCT01263470|466218780|FG005|Overall Study|Participant Unavailability|0|||
129527474|NCT01263470|466218775|FG000|Overall Study|Study Drug Non-compliance|0|||
129527475|NCT01263470|466218776|FG001|Overall Study|Study Drug Non-compliance|0|||
129527476|NCT01263470|466218777|FG002|Overall Study|Study Drug Non-compliance|0|||
129527477|NCT01263470|466218778|FG003|Overall Study|Study Drug Non-compliance|0|||
129527478|NCT01263470|466218779|FG004|Overall Study|Study Drug Non-compliance|1|||
129527479|NCT01263470|466218780|FG005|Overall Study|Study Drug Non-compliance|0|||
129527480|NCT00610714|466218781|FG000|Overall Study|Adverse Event|3|||
129527481|NCT00610714|466218782|FG001|Overall Study|Adverse Event|1|||
129527482|NCT00610714|466218781|FG000|Overall Study|Death|12|||
129527483|NCT00610714|466218782|FG001|Overall Study|Death|18|||
129527484|NCT00610714|466218781|FG000|Overall Study|Withdrawal by Subject|9|||
129527485|NCT00610714|466218782|FG001|Overall Study|Withdrawal by Subject|3|||
129527486|NCT00610714|466218781|FG000|Overall Study|Study completion at 120 PFS events|2|||
129527487|NCT00610714|466218782|FG001|Overall Study|Study completion at 120 PFS events|2|||
129527488|NCT00712712|466218783|FG000|Overall Study|Protocol Violation|11|||
129527489|NCT00712712|466218783|FG000|Overall Study|Radiofrequency not done|3|||
129527490|NCT00712712|466218783|FG000|Overall Study|Death|8|||
129527491|NCT00712712|466218783|FG000|Overall Study|Withdrawal by Subject|1|||
129527492|NCT00103207|466218784|FG000|Overall Study|Adverse Event|3|||
129527493|NCT00103207|466218784|FG000|Overall Study|Death|1|||
129527494|NCT00103207|466218784|FG000|Overall Study|Withdrawal by Subject|2|||
129527495|NCT00103207|466218784|FG000|Overall Study|Other complicating disease|1|||
129527496|NCT00103207|466218784|FG000|Overall Study|Ineligible|4|||
129527497|NCT00103207|466218784|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
129527498|NCT03598140|466218785|FG000|Overall Study|enrolled but didn't start|1|||
129527499|NCT03598140|466218786|FG001|Overall Study|enrolled but didn't start|0|||
129527500|NCT01029691|466218787|FG000|Continued APAP to Delivery|Death|0|||
129527501|NCT01029691|466218788|FG001|Continued APAP to Delivery|Death|0|||
129527502|NCT01029691|466218789|FG002|Continued APAP to Delivery|Death|1|||
129527503|NCT01023516|466218791|FG000|Overall Study|Voluntary discontinuation|7|||
129527504|NCT01023516|466218792|FG001|Overall Study|Voluntary discontinuation|5|||
129527505|NCT01023516|466218791|FG000|Overall Study|Adverse Event|9|||
129527506|NCT01023516|466218792|FG001|Overall Study|Adverse Event|6|||
129527507|NCT01023516|466218791|FG000|Overall Study|Safety reason|0|||
129527508|NCT01023516|466218792|FG001|Overall Study|Safety reason|3|||
129527509|NCT01023516|466218791|FG000|Overall Study|Study-specific criteria|4|||
129527510|NCT01023516|466218792|FG001|Overall Study|Study-specific criteria|2|||
129527511|NCT01023516|466218791|FG000|Overall Study|Incorrect enrolment|4|||
129527512|NCT01023516|466218792|FG001|Overall Study|Incorrect enrolment|2|||
129527513|NCT04556175|466218795|FG000|Overall Study|Study terminated due to COVID-19|8|||
129527514|NCT04556175|466218796|FG001|Overall Study|Study terminated due to COVID-19|8|||
129527515|NCT02723019|466218804|FG000|Overall Study|Death|17|||
129527516|NCT02723019|466218805|FG001|Overall Study|Death|13|||
129527517|NCT02723019|466218804|FG000|Overall Study|Withdrawal by Subject|11|||
129527518|NCT02723019|466218805|FG001|Overall Study|Withdrawal by Subject|7|||
129527519|NCT02723019|466218804|FG000|Overall Study|Lost to Follow-up|57|||
129527520|NCT02723019|466218805|FG001|Overall Study|Lost to Follow-up|70|||
129527521|NCT00592072|466218808|FG000|Wash Out Period|Lost to Follow-up|1|||
129527522|NCT00592072|466218809|FG001|Wash Out Period|Lost to Follow-up|1|||
129527523|NCT05333289|466218811|FG000|Overall Study|Other|1|||
129527524|NCT05333289|466218812|FG001|Overall Study|Other|0|||
129527525|NCT05333289|466218813|FG002|Overall Study|Other|0|||
129527526|NCT05333289|466218814|FG003|Overall Study|Other|1|||
129527527|NCT05333289|466218815|FG004|Overall Study|Other|1|||
129527528|NCT05333289|466218816|FG005|Overall Study|Other|2|||
129527529|NCT05333289|466218817|FG006|Overall Study|Other|2|||
129527530|NCT05333289|466218818|FG007|Overall Study|Other|0|||
129527531|NCT05333289|466218811|FG000|Overall Study|Withdrawal by Subject|1|||
129527532|NCT05333289|466218812|FG001|Overall Study|Withdrawal by Subject|2|||
129527533|NCT05333289|466218813|FG002|Overall Study|Withdrawal by Subject|2|||
129527534|NCT05333289|466218814|FG003|Overall Study|Withdrawal by Subject|1|||
129527535|NCT05333289|466218815|FG004|Overall Study|Withdrawal by Subject|1|||
129527536|NCT05333289|466218816|FG005|Overall Study|Withdrawal by Subject|2|||
129527537|NCT05333289|466218817|FG006|Overall Study|Withdrawal by Subject|1|||
129527538|NCT05333289|466218818|FG007|Overall Study|Withdrawal by Subject|3|||
129527539|NCT05333289|466218811|FG000|Overall Study|Protocol Violation|1|||
129527540|NCT05333289|466218812|FG001|Overall Study|Protocol Violation|0|||
129527541|NCT05333289|466218813|FG002|Overall Study|Protocol Violation|0|||
129527542|NCT05333289|466218814|FG003|Overall Study|Protocol Violation|0|||
129527543|NCT05333289|466218815|FG004|Overall Study|Protocol Violation|0|||
129527544|NCT05333289|466218816|FG005|Overall Study|Protocol Violation|0|||
129527545|NCT05333289|466218817|FG006|Overall Study|Protocol Violation|0|||
129527546|NCT05333289|466218818|FG007|Overall Study|Protocol Violation|0|||
129527547|NCT05333289|466218811|FG000|Overall Study|Physician Decision|0|||
129527548|NCT05333289|466218812|FG001|Overall Study|Physician Decision|0|||
129527549|NCT05333289|466218813|FG002|Overall Study|Physician Decision|1|||
129527550|NCT05333289|466218814|FG003|Overall Study|Physician Decision|0|||
129527551|NCT05333289|466218815|FG004|Overall Study|Physician Decision|0|||
129527552|NCT05333289|466218816|FG005|Overall Study|Physician Decision|2|||
129527553|NCT05333289|466218817|FG006|Overall Study|Physician Decision|0|||
129527554|NCT05333289|466218818|FG007|Overall Study|Physician Decision|0|||
129527555|NCT05333289|466218811|FG000|Overall Study|Lost to Follow-up|6|||
129527556|NCT05333289|466218812|FG001|Overall Study|Lost to Follow-up|0|||
129527557|NCT05333289|466218813|FG002|Overall Study|Lost to Follow-up|1|||
129527558|NCT05333289|466218814|FG003|Overall Study|Lost to Follow-up|6|||
129527559|NCT05333289|466218815|FG004|Overall Study|Lost to Follow-up|3|||
129527560|NCT05333289|466218816|FG005|Overall Study|Lost to Follow-up|3|||
129527561|NCT05333289|466218817|FG006|Overall Study|Lost to Follow-up|2|||
129527562|NCT05333289|466218818|FG007|Overall Study|Lost to Follow-up|1|||
129527563|NCT05333289|466218811|FG000|Overall Study|Death|1|||
129527564|NCT05333289|466218812|FG001|Overall Study|Death|0|||
129527565|NCT05333289|466218813|FG002|Overall Study|Death|0|||
129527566|NCT05333289|466218814|FG003|Overall Study|Death|0|||
129527567|NCT05333289|466218815|FG004|Overall Study|Death|0|||
129527568|NCT05333289|466218816|FG005|Overall Study|Death|0|||
129527569|NCT05333289|466218817|FG006|Overall Study|Death|0|||
129527570|NCT05333289|466218818|FG007|Overall Study|Death|0|||
129527571|NCT03685643|466218823|FG000|Overall Study|Lost to Follow-up|14|||
129527572|NCT03685643|466218824|FG001|Overall Study|Lost to Follow-up|22|||
129527573|NCT01347840|466218830|FG000|Overall Study|Withdrawal by Subject|1|||
129527574|NCT01060124|466218832|FG000|Overall Study|Other|16|||
129527575|NCT01060124|466218832|FG000|Overall Study|Adverse Event|14|||
129527576|NCT01060124|466218832|FG000|Overall Study|Withdrawal by Subject|7|||
129527577|NCT05307523|466218834|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
129527578|NCT05307523|466218835|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
129527579|NCT05307523|466218834|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
129527580|NCT05307523|466218835|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
129527581|NCT03858686|466218837|FG000|Period 1|Adverse Event|1|||
129527582|NCT03858686|466218838|FG001|Period 1|Adverse Event|1|||
129527583|NCT03858686|466218837|FG000|Period 1|Lack of compliance|0|||
129527584|NCT03858686|466218838|FG001|Period 1|Lack of compliance|1|||
129527585|NCT03858686|466218837|FG000|Period 1|Adverse Event|0|||
129527586|NCT03858686|466218838|FG001|Period 1|Adverse Event|1|||
129527587|NCT03858686|466218837|FG000|Period 2|Adverse Event|0|||
129527588|NCT03858686|466218838|FG001|Period 2|Adverse Event|1|||
129527589|NCT03231228|466218840|FG000|Overall Study|Lost to Follow-up|2|||
129527590|NCT03231228|466218841|FG001|Overall Study|Lost to Follow-up|0|||
129527591|NCT03231228|466218840|FG000|Overall Study|Physician Decision|1|||
129527592|NCT03231228|466218841|FG001|Overall Study|Physician Decision|0|||
129527593|NCT02299206|466218842|FG000|Overall Study|Lost to Follow-up|1|||
129527594|NCT02299206|466218842|FG000|Overall Study|Withdrawal by Subject|1|||
129527595|NCT01682759|466218844|FG000|Overall Study|Death|2|||
129527596|NCT01682759|466218845|FG001|Overall Study|Death|1|||
129527597|NCT01682759|466218844|FG000|Overall Study|Lost to Follow-up|10|||
129527598|NCT01682759|466218845|FG001|Overall Study|Lost to Follow-up|13|||
129527599|NCT01682759|466218844|FG000|Overall Study|Physician Decision|1|||
129527600|NCT01682759|466218845|FG001|Overall Study|Physician Decision|1|||
129527601|NCT01682759|466218844|FG000|Overall Study|Withdrawal by Subject|56|||
129527602|NCT01682759|466218845|FG001|Overall Study|Withdrawal by Subject|55|||
129527603|NCT04191096|466218846|FG000|Overall Study|Death|102|||
129527604|NCT04191096|466218847|FG001|Overall Study|Death|89|||
129527605|NCT04191096|466218846|FG000|Overall Study|Lost to Follow-up|1|||
129527606|NCT04191096|466218847|FG001|Overall Study|Lost to Follow-up|1|||
129527607|NCT04191096|466218846|FG000|Overall Study|Withdrawal by Subject|5|||
129527608|NCT04191096|466218847|FG001|Overall Study|Withdrawal by Subject|5|||
129527609|NCT04191096|466218846|FG000|Overall Study|Participants Ongoing|518|||
129527610|NCT04191096|466218847|FG001|Overall Study|Participants Ongoing|530|||
129527611|NCT02683668|466218851|FG000|Period 2|Withdrawal by Subject|0|||
129527612|NCT02683668|466218852|FG001|Period 2|Withdrawal by Subject|1|||
129527613|NCT02683668|466218853|FG002|Period 2|Withdrawal by Subject|0|||
129527614|NCT03893630|466218854|FG000|Overall Study|Lost to Follow-up|5|||
129527615|NCT03893630|466218855|FG001|Overall Study|Lost to Follow-up|4|||
129527616|NCT03893630|466218856|FG002|Overall Study|Lost to Follow-up|2|||
129527617|NCT03893630|466218854|FG000|Overall Study|Withdrawal by Subject|3|||
129527618|NCT03893630|466218855|FG001|Overall Study|Withdrawal by Subject|6|||
129527619|NCT03893630|466218856|FG002|Overall Study|Withdrawal by Subject|3|||
129527620|NCT03893630|466218854|FG000|Overall Study|Discontinued Intervention|0|||
129527621|NCT03893630|466218855|FG001|Overall Study|Discontinued Intervention|4|||
129527622|NCT03893630|466218856|FG002|Overall Study|Discontinued Intervention|2|||
129527623|NCT03650387|466220349|FG000|Overall Study|Withdrawal by Subject|13|||
129527624|NCT03650387|466220349|FG000|Overall Study|Lost to Follow-up|12|||
129527625|NCT03650387|466220349|FG000|Overall Study|Adverse Event (Not related)|1|||
129527626|NCT03650387|466220349|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
129527627|NCT05815758|466220350|FG000|Overall Study|Adverse Event|6|||
129527628|NCT05815758|466220351|FG001|Overall Study|Adverse Event|2|||
129527629|NCT05815758|466220350|FG000|Overall Study|Lost to Follow-up|14|||
129527630|NCT05815758|466220351|FG001|Overall Study|Lost to Follow-up|1|||
129527631|NCT05815758|466220350|FG000|Overall Study|Withdrawal by Subject|6|||
129527632|NCT05815758|466220351|FG001|Overall Study|Withdrawal by Subject|6|||
129527633|NCT05815758|466220350|FG000|Overall Study|Protocol Violation|1|||
129527634|NCT05815758|466220351|FG001|Overall Study|Protocol Violation|1|||
129527635|NCT05815758|466220350|FG000|Overall Study|Discontinued|4|||
129527636|NCT05815758|466220351|FG001|Overall Study|Discontinued|4|||
129527637|NCT03661983|466220352|FG000|Open Label Stabilization Phase|Adverse Event|5|||
129527638|NCT03661983|466220353|FG001|Open Label Stabilization Phase|Adverse Event|0|||
129527639|NCT03661983|466220354|FG002|Open Label Stabilization Phase|Adverse Event|0|||
129527640|NCT03661983|466220355|FG003|Open Label Stabilization Phase|Adverse Event|0|||
129527641|NCT03661983|466220352|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
129527642|NCT03661983|466220353|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
129527643|NCT03661983|466220354|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
129527644|NCT03661983|466220355|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
129527645|NCT03661983|466220352|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
129527646|NCT03661983|466220353|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
129527647|NCT03661983|466220354|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
129527648|NCT03661983|466220355|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
129527649|NCT03661983|466220352|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
129527650|NCT03661983|466220353|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
129527651|NCT03661983|466220354|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
129527652|NCT03661983|466220355|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
129527653|NCT03661983|466220352|FG000|Double-blind Randomized Phase|Adverse Event|0|||
129527654|NCT03661983|466220353|FG001|Double-blind Randomized Phase|Adverse Event|1|||
129527655|NCT03661983|466220354|FG002|Double-blind Randomized Phase|Adverse Event|0|||
129527656|NCT03661983|466220355|FG003|Double-blind Randomized Phase|Adverse Event|0|||
129527657|NCT03661983|466220352|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
129527658|NCT03661983|466220353|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
129527659|NCT03661983|466220354|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
129527660|NCT03661983|466220355|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
129527661|NCT03661983|466220352|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
129527662|NCT03661983|466220353|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
129527663|NCT03661983|466220354|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
129527664|NCT03661983|466220355|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
129527665|NCT03661983|466220352|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
129527666|NCT03661983|466220353|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
129527667|NCT03661983|466220354|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
129527668|NCT03661983|466220355|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
129527669|NCT02045979|466220356|FG000|Overall Study|Informed Consent Withdrawn|2|||
129527670|NCT02045979|466220357|FG001|Overall Study|Informed Consent Withdrawn|0|||
129527671|NCT02045979|466220358|FG002|Overall Study|Informed Consent Withdrawn|1|||
129527672|NCT02045979|466220356|FG000|Overall Study|not specified above|0|||
129527673|NCT02045979|466220357|FG001|Overall Study|not specified above|1|||
129527674|NCT02045979|466220358|FG002|Overall Study|not specified above|0|||
129527675|NCT02425891|466220359|FG000|Overall Study|Death|333|||
129527676|NCT02425891|466220360|FG001|Overall Study|Death|314|||
129527677|NCT02425891|466220359|FG000|Overall Study|Lost to Follow-up|4|||
129527678|NCT02425891|466220360|FG001|Overall Study|Lost to Follow-up|6|||
129527679|NCT02425891|466220359|FG000|Overall Study|Non-Compliance|1|||
129527680|NCT02425891|466220360|FG001|Overall Study|Non-Compliance|1|||
129527681|NCT02425891|466220359|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
129527682|NCT02425891|466220360|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
129527683|NCT02425891|466220359|FG000|Overall Study|Physician Decision|0|||
129527684|NCT02425891|466220360|FG001|Overall Study|Physician Decision|1|||
129527685|NCT02425891|466220359|FG000|Overall Study|Protocol Violation|1|||
129527686|NCT02425891|466220360|FG001|Overall Study|Protocol Violation|1|||
129527687|NCT02425891|466220359|FG000|Overall Study|Study Terminated By Sponsor|85|||
129527688|NCT02425891|466220360|FG001|Overall Study|Study Terminated By Sponsor|95|||
129527689|NCT02425891|466220359|FG000|Overall Study|Withdrawal by Subject|27|||
129527690|NCT02425891|466220360|FG001|Overall Study|Withdrawal by Subject|32|||
129527691|NCT04124952|466220361|FG000|Overall Study|Lost to Follow-up|1|||
129527692|NCT03558503|466220363|FG000|Overall Study|Adverse Event|1|||
129527693|NCT03558503|466220363|FG000|Overall Study|Death|1|||
129527694|NCT03558503|466220363|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
129527695|NCT02145429|466220364|FG000|Overall Study|Death|4|||
129527696|NCT02145429|466220365|FG001|Overall Study|Death|5|||
129527697|NCT02145429|466220364|FG000|Overall Study|Lost to Follow-up|4|||
129527698|NCT02145429|466220365|FG001|Overall Study|Lost to Follow-up|3|||
129527699|NCT02145429|466220364|FG000|Overall Study|Withdrawal by Subject|8|||
129527700|NCT02145429|466220365|FG001|Overall Study|Withdrawal by Subject|3|||
129527701|NCT02094612|466220366|FG000|Overall Study|Lost to Follow-up|47|||
129527702|NCT02094612|466220367|FG001|Overall Study|Lost to Follow-up|47|||
129527703|NCT02094612|466220366|FG000|Overall Study|Never started ADHD medication|32|||
129527704|NCT02094612|466220367|FG001|Overall Study|Never started ADHD medication|23|||
129527705|NCT02943577|466220370|FG000|Overall Study|Protocol Violation|0|||
129527706|NCT02943577|466220371|FG001|Overall Study|Protocol Violation|1|||
129527707|NCT02943577|466220370|FG000|Overall Study|Adverse Event|3|||
129527708|NCT02943577|466220371|FG001|Overall Study|Adverse Event|2|||
129527709|NCT02943577|466220370|FG000|Overall Study|Lost to Follow-up|0|||
129527710|NCT02943577|466220371|FG001|Overall Study|Lost to Follow-up|1|||
129527711|NCT02943577|466220370|FG000|Overall Study|Withdrawal by Subject|1|||
129527712|NCT02943577|466220371|FG001|Overall Study|Withdrawal by Subject|1|||
129527713|NCT02943577|466220370|FG000|Overall Study|Pregnancy|1|||
129527714|NCT02943577|466220371|FG001|Overall Study|Pregnancy|0|||
129527715|NCT01944462|466220376|FG000|PPPP Educational Program|Lost to Follow-up|60|||
129527716|NCT00777036|466220381|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
129527717|NCT00777036|466220382|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
129527718|NCT00777036|466220383|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
129527719|NCT00777036|466220384|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
129527720|NCT00777036|466220381|FG000|On Treatment|Administrative Reason By Sponsor|1|||
129527721|NCT00777036|466220382|FG001|On Treatment|Administrative Reason By Sponsor|0|||
129527722|NCT00777036|466220383|FG002|On Treatment|Administrative Reason By Sponsor|9|||
129527723|NCT00777036|466220384|FG003|On Treatment|Administrative Reason By Sponsor|0|||
129527724|NCT00777036|466220381|FG000|On Treatment|Failure to Meet Study Criteria|0|||
129527725|NCT00777036|466220382|FG001|On Treatment|Failure to Meet Study Criteria|1|||
129527726|NCT00777036|466220383|FG002|On Treatment|Failure to Meet Study Criteria|4|||
129527727|NCT00777036|466220384|FG003|On Treatment|Failure to Meet Study Criteria|0|||
129527728|NCT00777036|466220381|FG000|On Treatment|Pregnancy|1|||
129527729|NCT00777036|466220382|FG001|On Treatment|Pregnancy|0|||
129527730|NCT00777036|466220383|FG002|On Treatment|Pregnancy|1|||
129527731|NCT00777036|466220384|FG003|On Treatment|Pregnancy|0|||
129527732|NCT00777036|466220381|FG000|On Treatment|Non-compliance with Study Drug|1|||
129527733|NCT00777036|466220382|FG001|On Treatment|Non-compliance with Study Drug|0|||
129527734|NCT00777036|466220383|FG002|On Treatment|Non-compliance with Study Drug|1|||
129527735|NCT00777036|466220384|FG003|On Treatment|Non-compliance with Study Drug|0|||
129527736|NCT00777036|466220381|FG000|On Treatment|Maximum Clinical Benefit|2|||
129527737|NCT00777036|466220382|FG001|On Treatment|Maximum Clinical Benefit|0|||
129527738|NCT00777036|466220383|FG002|On Treatment|Maximum Clinical Benefit|5|||
129527739|NCT00777036|466220384|FG003|On Treatment|Maximum Clinical Benefit|0|||
129527740|NCT00777036|466220381|FG000|On Treatment|Withdrawal by Subject|0|||
129527741|NCT00777036|466220382|FG001|On Treatment|Withdrawal by Subject|2|||
129527742|NCT00777036|466220383|FG002|On Treatment|Withdrawal by Subject|2|||
129527743|NCT00777036|466220384|FG003|On Treatment|Withdrawal by Subject|0|||
129527744|NCT00777036|466220381|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
129527745|NCT00777036|466220382|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
129527746|NCT00777036|466220383|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
129527747|NCT00777036|466220384|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
129527748|NCT00777036|466220381|FG000|On Treatment|Death|0|||
129527749|NCT00777036|466220382|FG001|On Treatment|Death|2|||
129527750|NCT00777036|466220383|FG002|On Treatment|Death|0|||
129527751|NCT00777036|466220384|FG003|On Treatment|Death|0|||
129527752|NCT00777036|466220381|FG000|On Treatment|Study Drug Toxicity|1|||
129527753|NCT00777036|466220382|FG001|On Treatment|Study Drug Toxicity|0|||
129527754|NCT00777036|466220383|FG002|On Treatment|Study Drug Toxicity|4|||
129527755|NCT00777036|466220384|FG003|On Treatment|Study Drug Toxicity|0|||
129527756|NCT00777036|466220381|FG000|On Treatment|Progressive Disease|6|||
129527757|NCT00777036|466220382|FG001|On Treatment|Progressive Disease|4|||
129527758|NCT00777036|466220383|FG002|On Treatment|Progressive Disease|7|||
129527759|NCT00777036|466220384|FG003|On Treatment|Progressive Disease|0|||
129527760|NCT00777036|466220381|FG000|On Treatment|Not Reported|0|||
129527761|NCT00777036|466220382|FG001|On Treatment|Not Reported|0|||
129527762|NCT00777036|466220383|FG002|On Treatment|Not Reported|2|||
129527763|NCT00777036|466220384|FG003|On Treatment|Not Reported|0|||
129527764|NCT00777036|466220381|FG000|On Treatment|Site Closed|0|||
129527765|NCT00777036|466220382|FG001|On Treatment|Site Closed|1|||
129527766|NCT00777036|466220383|FG002|On Treatment|Site Closed|1|||
129527767|NCT00777036|466220384|FG003|On Treatment|Site Closed|0|||
129527768|NCT00777036|466220381|FG000|Follow-Up|Withdrawal by Subject|0|||
129527769|NCT00777036|466220382|FG001|Follow-Up|Withdrawal by Subject|0|||
129527770|NCT00777036|466220383|FG002|Follow-Up|Withdrawal by Subject|5|||
129527771|NCT00777036|466220384|FG003|Follow-Up|Withdrawal by Subject|0|||
129527772|NCT00777036|466220381|FG000|Follow-Up|Death|1|||
129527773|NCT00777036|466220382|FG001|Follow-Up|Death|9|||
129527774|NCT00777036|466220383|FG002|Follow-Up|Death|0|||
129527775|NCT00777036|466220384|FG003|Follow-Up|Death|0|||
129527776|NCT00777036|466220381|FG000|Follow-Up|Lost to Follow-up|3|||
129527777|NCT00777036|466220382|FG001|Follow-Up|Lost to Follow-up|0|||
129527778|NCT00777036|466220383|FG002|Follow-Up|Lost to Follow-up|0|||
129527779|NCT00777036|466220384|FG003|Follow-Up|Lost to Follow-up|0|||
129527780|NCT00777036|466220381|FG000|Follow-Up|Reason Not Specified|4|||
129527781|NCT00777036|466220382|FG001|Follow-Up|Reason Not Specified|0|||
129527782|NCT00777036|466220383|FG002|Follow-Up|Reason Not Specified|13|||
129527783|NCT00777036|466220384|FG003|Follow-Up|Reason Not Specified|0|||
129527784|NCT00777036|466220381|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
129527785|NCT00777036|466220382|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
129527786|NCT00777036|466220383|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
129527787|NCT00777036|466220384|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
129527788|NCT04651777|466220385|FG000|Overall Study|Adverse Event|1|||
129527789|NCT04651777|466220385|FG000|Overall Study|Withdrawal by Subject|2|||
129527790|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
129527791|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
129527792|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
129527793|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
129527794|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Death|38|||
129527795|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Death|10|||
129527796|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
129527797|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
129527798|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
129527799|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
129527800|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
129527801|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
129527802|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
129527803|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
129538749|NCT03575975|466263524|FG001|Overall Study|Lost to Follow-up|0|||
129527804|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
129527805|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
129527806|NCT02421939|466220386|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
129527807|NCT02421939|466220387|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
129527808|NCT02421939|466220386|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
129527809|NCT02421939|466220387|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
129527810|NCT02421939|466220386|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
129527811|NCT02421939|466220387|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
129527812|NCT02421939|466220386|FG000|Long Term Follow up: up to 3 Years|Death|118|||
129527813|NCT02421939|466220387|FG001|Long Term Follow up: up to 3 Years|Death|65|||
129527814|NCT02421939|466220386|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
129527815|NCT02421939|466220387|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
129527816|NCT00729560|466220388|FG000|Overall Study|Withdrawal by Subject|3|||
129527817|NCT03662789|466220389|FG000|Overall Study|Lost to Follow-up|1|||
129527818|NCT03662789|466220390|FG001|Overall Study|Lost to Follow-up|2|||
129527819|NCT03662789|466220389|FG000|Overall Study|Could not perform treadmill test|4|||
129527820|NCT03662789|466220390|FG001|Overall Study|Could not perform treadmill test|4|||
129527821|NCT03662789|466220389|FG000|Overall Study|Death|0|||
129527822|NCT03662789|466220390|FG001|Overall Study|Death|1|||
129527823|NCT02559115|466220391|FG000|Overall Study|Withdrawal by Subject|3|||
129527824|NCT02060903|466220394|FG000|Overall Study|Lost to Follow-up|4|||
129527825|NCT02060903|466220395|FG001|Overall Study|Lost to Follow-up|0|||
129527826|NCT02060903|466220394|FG000|Overall Study|Withdrawal by Subject|0|||
129527827|NCT02060903|466220395|FG001|Overall Study|Withdrawal by Subject|7|||
129527828|NCT00137267|466220396|FG000|Overall Study|Lost to Follow-up|15|||
129527829|NCT00137267|466220397|FG001|Overall Study|Lost to Follow-up|21|||
129527830|NCT00638989|466220398|FG000|Overall Study|Lost to Follow-up|0|||
129527831|NCT00638989|466220399|FG001|Overall Study|Lost to Follow-up|0|||
129527832|NCT00638989|466220400|FG002|Overall Study|Lost to Follow-up|1|||
129527833|NCT01553591|466220406|FG000|Overall Study|Voluntarily withdrew|94|||
129527834|NCT01553591|466220407|FG001|Overall Study|Voluntarily withdrew|79|||
129527835|NCT01553591|466220408|FG002|Overall Study|Voluntarily withdrew|96|||
129527836|NCT01553591|466220406|FG000|Overall Study|Adverse Event|36|||
129527837|NCT01553591|466220407|FG001|Overall Study|Adverse Event|45|||
129527838|NCT01553591|466220408|FG002|Overall Study|Adverse Event|16|||
129527839|NCT01553591|466220406|FG000|Overall Study|Lost to Follow-up|25|||
129527840|NCT01553591|466220407|FG001|Overall Study|Lost to Follow-up|23|||
129527841|NCT01553591|466220408|FG002|Overall Study|Lost to Follow-up|16|||
129527842|NCT01553591|466220406|FG000|Overall Study|Physician decision: other|11|||
129527843|NCT01553591|466220407|FG001|Overall Study|Physician decision: other|14|||
129527844|NCT01553591|466220408|FG002|Overall Study|Physician decision: other|16|||
129527845|NCT01553591|466220406|FG000|Overall Study|Physician decision: lack of efficacy|2|||
129527846|NCT01553591|466220407|FG001|Overall Study|Physician decision: lack of efficacy|3|||
129527847|NCT01553591|466220408|FG002|Overall Study|Physician decision: lack of efficacy|7|||
129527848|NCT01553591|466220406|FG000|Overall Study|Protocol Violation|3|||
129527849|NCT01553591|466220407|FG001|Overall Study|Protocol Violation|4|||
129527850|NCT01553591|466220408|FG002|Overall Study|Protocol Violation|4|||
129527851|NCT01553591|466220406|FG000|Overall Study|Sponsor decision|1|||
129527852|NCT01553591|466220407|FG001|Overall Study|Sponsor decision|0|||
129527853|NCT01553591|466220408|FG002|Overall Study|Sponsor decision|3|||
129527854|NCT01553591|466220406|FG000|Overall Study|Randomized and never dispensed drug|0|||
129527855|NCT01553591|466220407|FG001|Overall Study|Randomized and never dispensed drug|1|||
129527856|NCT01553591|466220408|FG002|Overall Study|Randomized and never dispensed drug|0|||
129527857|NCT02871791|466220409|FG000|Phase 1b|Death|0|||
129527858|NCT02871791|466220410|FG001|Phase 1b|Death|1|||
129527859|NCT02871791|466220409|FG000|Phase 1b|progressive disease|6|||
129527860|NCT02871791|466220410|FG001|Phase 1b|progressive disease|2|||
129527861|NCT02871791|466220409|FG000|Phase 2|Death|1|||
129527862|NCT02871791|466220410|FG001|Phase 2|Death|0|||
129527863|NCT02871791|466220409|FG000|Phase 2|Lost to Follow-up|2|||
129527864|NCT02871791|466220410|FG001|Phase 2|Lost to Follow-up|0|||
129527865|NCT04005755|466220411|FG000|Overall Study|Adverse Event|6|||
129527866|NCT04005755|466220411|FG000|Overall Study|Physician Decision|3|||
129527867|NCT04005755|466220411|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
129527868|NCT04005755|466220411|FG000|Overall Study|Withdrawal by Subject|3|||
129527869|NCT04005755|466220411|FG000|Overall Study|Lost to Follow-up|1|||
129527870|NCT00611767|466220412|FG000|Overall Study|Withdrawal by Subject|4|||
129527871|NCT00611767|466220413|FG001|Overall Study|Withdrawal by Subject|1|||
129527872|NCT00611767|466220412|FG000|Overall Study|Thiopental not available|3|||
129527873|NCT00611767|466220413|FG001|Overall Study|Thiopental not available|0|||
129527874|NCT00611767|466220412|FG000|Overall Study|didn't like the medication|1|||
129527875|NCT00611767|466220413|FG001|Overall Study|didn't like the medication|1|||
129527876|NCT00611767|466220412|FG000|Overall Study|Physician Decision|1|||
129527877|NCT00611767|466220413|FG001|Overall Study|Physician Decision|0|||
129527878|NCT02750501|466220414|FG000|Overall Study|Adverse Event|4|||
129527879|NCT02750501|466220414|FG000|Overall Study|Physician Decision|1|||
129527880|NCT02750501|466220414|FG000|Overall Study|Protocol Violation|1|||
129527881|NCT02750501|466220414|FG000|Overall Study|G-tube came out|1|||
129527882|NCT02750501|466220414|FG000|Overall Study|Non-compliant use of PERT|1|||
129527883|NCT01738594|466220415|FG000|Registration and Treatment Start|Adverse Event|0|||
129527884|NCT01738594|466220416|FG001|Registration and Treatment Start|Adverse Event|1|||
129527885|NCT01738594|466220417|FG002|Registration and Treatment Start|Adverse Event|0|||
129527886|NCT01738594|466220418|FG003|Registration and Treatment Start|Adverse Event|0|||
129527887|NCT01738594|466220419|FG004|Registration and Treatment Start|Adverse Event|0|||
129527888|NCT01738594|466220420|FG005|Registration and Treatment Start|Adverse Event|0|||
129527889|NCT01738594|466220421|FG006|Registration and Treatment Start|Adverse Event|0|||
129527890|NCT01738594|466220422|FG007|Registration and Treatment Start|Adverse Event|0|||
129527891|NCT01738594|466220415|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527892|NCT01738594|466220416|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527893|NCT01738594|466220417|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527894|NCT01738594|466220418|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527895|NCT01738594|466220419|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527896|NCT01738594|466220420|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
129527897|NCT01738594|466220421|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527898|NCT01738594|466220422|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
129527899|NCT01738594|466220415|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527900|NCT01738594|466220416|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
129527901|NCT01738594|466220417|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527902|NCT01738594|466220418|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527903|NCT01738594|466220419|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527904|NCT01738594|466220420|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527905|NCT01738594|466220421|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527906|NCT01738594|466220422|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
129527907|NCT01738594|466220415|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527908|NCT01738594|466220416|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527909|NCT01738594|466220417|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527910|NCT01738594|466220418|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527911|NCT01738594|466220419|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527912|NCT01738594|466220420|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
129527913|NCT01738594|466220421|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527914|NCT01738594|466220422|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
129527915|NCT01738594|466220415|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527916|NCT01738594|466220416|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527917|NCT01738594|466220417|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527918|NCT01738594|466220418|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527919|NCT01738594|466220419|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527920|NCT01738594|466220420|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
129527921|NCT01738594|466220421|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527922|NCT01738594|466220422|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
129527923|NCT01738594|466220415|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527924|NCT01738594|466220416|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527925|NCT01738594|466220417|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527926|NCT01738594|466220418|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527927|NCT01738594|466220419|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
129527928|NCT01738594|466220420|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527929|NCT01738594|466220421|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527930|NCT01738594|466220422|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
129527931|NCT01738594|466220415|FG000|Follow up for 1 Year|Death|0|||
129527932|NCT01738594|466220416|FG001|Follow up for 1 Year|Death|0|||
129527933|NCT01738594|466220417|FG002|Follow up for 1 Year|Death|0|||
129527934|NCT01738594|466220418|FG003|Follow up for 1 Year|Death|0|||
129527935|NCT01738594|466220419|FG004|Follow up for 1 Year|Death|0|||
129527936|NCT01738594|466220420|FG005|Follow up for 1 Year|Death|1|||
129527937|NCT01738594|466220421|FG006|Follow up for 1 Year|Death|0|||
129527938|NCT01738594|466220422|FG007|Follow up for 1 Year|Death|0|||
129527939|NCT01738594|466220415|FG000|Follow up for 1 Year|Other|0|||
129527940|NCT01738594|466220416|FG001|Follow up for 1 Year|Other|0|||
129527941|NCT01738594|466220417|FG002|Follow up for 1 Year|Other|0|||
129527942|NCT01738594|466220418|FG003|Follow up for 1 Year|Other|0|||
129527943|NCT01738594|466220419|FG004|Follow up for 1 Year|Other|0|||
129527944|NCT01738594|466220420|FG005|Follow up for 1 Year|Other|2|||
129527945|NCT01738594|466220421|FG006|Follow up for 1 Year|Other|0|||
129527946|NCT01738594|466220422|FG007|Follow up for 1 Year|Other|0|||
129527947|NCT00403390|466220423|FG000|Overall Study|Withdrawal by Subject|1|||
129527948|NCT00403390|466220424|FG001|Overall Study|Withdrawal by Subject|0|||
129527949|NCT00403390|466220423|FG000|Overall Study|samples lost|1|||
129527950|NCT00403390|466220424|FG001|Overall Study|samples lost|0|||
129527951|NCT00403390|466220423|FG000|Overall Study|non-compliant|1|||
129527952|NCT00403390|466220424|FG001|Overall Study|non-compliant|0|||
129527953|NCT02711553|466220425|FG000|Overall Study|Withdrawal by Subject|2|||
129527954|NCT02711553|466220426|FG001|Overall Study|Withdrawal by Subject|1|||
129527955|NCT02711553|466220427|FG002|Overall Study|Withdrawal by Subject|1|||
129527956|NCT02711553|466220428|FG003|Overall Study|Withdrawal by Subject|0|||
129527957|NCT02711553|466220425|FG000|Overall Study|Lost to Follow-up|3|||
129527958|NCT02711553|466220426|FG001|Overall Study|Lost to Follow-up|3|||
129527959|NCT02711553|466220427|FG002|Overall Study|Lost to Follow-up|6|||
129527960|NCT02711553|466220428|FG003|Overall Study|Lost to Follow-up|3|||
129527961|NCT02711553|466220425|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
129527962|NCT02711553|466220426|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
129527963|NCT02711553|466220427|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
129527964|NCT02711553|466220428|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
129527965|NCT03117309|466220429|FG000|Overall Study|Not meeting inclusion criteria|0|||
129527966|NCT03117309|466220430|FG001|Overall Study|Not meeting inclusion criteria|1|||
129527967|NCT02187224|466220431|FG000|Overall Study|Did not show up for test day|1|||
129527968|NCT02187224|466220432|FG001|Overall Study|Did not show up for test day|0|||
129527969|NCT01010776|466220438|FG000|Main Phase|Withdrawal by Subject|14|||
129527970|NCT01010776|466220438|FG000|Main Phase|Lack of Efficacy|8|||
129527971|NCT01010776|466220438|FG000|Main Phase|Adverse Event|7|||
129527972|NCT01010776|466220438|FG000|Main Phase|Lost to Follow-up|6|||
129527973|NCT01010776|466220438|FG000|Main Phase|Non-compliance to study medication|5|||
129527974|NCT01010776|466220438|FG000|Main Phase|Selection failure|2|||
129527975|NCT01010776|466220438|FG000|Main Phase|Inform consent withdrawal|1|||
129527976|NCT01010776|466220438|FG000|Main Phase|Other|1|||
129527977|NCT01010776|466220438|FG000|Main Phase|Did not received study medication|5|||
129527978|NCT01010776|466220438|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
129527979|NCT01010776|466220438|FG000|Extension Phase|Other|3|||
129527980|NCT02583711|466220444|FG000|Overall Study|Withdrawal by Subject|0|||
129527981|NCT02583711|466220445|FG001|Overall Study|Withdrawal by Subject|10|||
129527982|NCT02583711|466220446|FG002|Overall Study|Withdrawal by Subject|0|||
129527983|NCT01012037|466220447|FG000|Overall Study|Adverse Event|0|||
129527984|NCT01012037|466220448|FG001|Overall Study|Adverse Event|8|||
129527985|NCT01012037|466220449|FG002|Overall Study|Adverse Event|3|||
129527986|NCT01012037|466220447|FG000|Overall Study|Protocol Violation|0|||
129527987|NCT01012037|466220448|FG001|Overall Study|Protocol Violation|3|||
129527988|NCT01012037|466220449|FG002|Overall Study|Protocol Violation|5|||
129527989|NCT01012037|466220447|FG000|Overall Study|Withdrawal by Subject|0|||
129527990|NCT01012037|466220448|FG001|Overall Study|Withdrawal by Subject|4|||
129527991|NCT01012037|466220449|FG002|Overall Study|Withdrawal by Subject|1|||
129527992|NCT01012037|466220447|FG000|Overall Study|Other reason (not specified)|1|||
129527993|NCT01012037|466220448|FG001|Overall Study|Other reason (not specified)|1|||
129527994|NCT01012037|466220449|FG002|Overall Study|Other reason (not specified)|1|||
129527995|NCT01708915|466220456|FG000|Overall Study|Adverse Event|1|||
129527996|NCT01708915|466220457|FG001|Overall Study|Adverse Event|0|||
129527997|NCT01708915|466220458|FG002|Overall Study|Adverse Event|9|||
129527998|NCT01708915|466220459|FG003|Overall Study|Adverse Event|13|||
129527999|NCT01708915|466220456|FG000|Overall Study|Lack of Efficacy|84|||
129528000|NCT01708915|466220457|FG001|Overall Study|Lack of Efficacy|60|||
129528001|NCT01708915|466220458|FG002|Overall Study|Lack of Efficacy|35|||
129528002|NCT01708915|466220459|FG003|Overall Study|Lack of Efficacy|15|||
129528003|NCT01708915|466220456|FG000|Overall Study|Protocol Violation|0|||
129528004|NCT01708915|466220457|FG001|Overall Study|Protocol Violation|0|||
129528005|NCT01708915|466220458|FG002|Overall Study|Protocol Violation|0|||
129528006|NCT01708915|466220459|FG003|Overall Study|Protocol Violation|1|||
129528007|NCT01708915|466220456|FG000|Overall Study|Withdrawal by Subject|0|||
129528008|NCT01708915|466220457|FG001|Overall Study|Withdrawal by Subject|1|||
129528009|NCT01708915|466220458|FG002|Overall Study|Withdrawal by Subject|2|||
129528010|NCT01708915|466220459|FG003|Overall Study|Withdrawal by Subject|2|||
129528011|NCT01708915|466220456|FG000|Overall Study|Other reasons than stated above|1|||
129528012|NCT01708915|466220457|FG001|Overall Study|Other reasons than stated above|1|||
129528013|NCT01708915|466220458|FG002|Overall Study|Other reasons than stated above|0|||
129528014|NCT01708915|466220459|FG003|Overall Study|Other reasons than stated above|2|||
129528015|NCT01432938|466220460|FG000|First Intervention|Protocol Violation|1|||
129528016|NCT01432938|466220461|FG001|First Intervention|Protocol Violation|0|||
129528017|NCT01432938|466220460|FG000|First Intervention|Physician Decision|1|||
129528018|NCT01432938|466220461|FG001|First Intervention|Physician Decision|0|||
129528019|NCT01432938|466220460|FG000|Second Intervention|Adverse Event|1|||
129528020|NCT01432938|466220461|FG001|Second Intervention|Adverse Event|0|||
129528021|NCT04223778|466220462|FG000|Overall Study|Death|1|||
129528022|NCT04223778|466220463|FG001|Overall Study|Death|1|||
129528023|NCT04223778|466220462|FG000|Overall Study|Lost to Follow-up|4|||
129528024|NCT04223778|466220463|FG001|Overall Study|Lost to Follow-up|5|||
129528025|NCT04223778|466220462|FG000|Overall Study|Physician Decision|10|||
129528026|NCT04223778|466220463|FG001|Overall Study|Physician Decision|6|||
129528027|NCT04223778|466220462|FG000|Overall Study|Withdrawal by Subject|35|||
129528028|NCT04223778|466220463|FG001|Overall Study|Withdrawal by Subject|17|||
129528029|NCT04223778|466220462|FG000|Overall Study|Not Reported|7|||
129528030|NCT04223778|466220463|FG001|Overall Study|Not Reported|8|||
129528031|NCT01855919|466221743|FG000|Overall Study|Adverse Event|16|||
129528032|NCT01855919|466221744|FG001|Overall Study|Adverse Event|8|||
129528033|NCT01855919|466221743|FG000|Overall Study|Lack of Efficacy|1|||
129528034|NCT01855919|466221744|FG001|Overall Study|Lack of Efficacy|3|||
129528035|NCT01855919|466221743|FG000|Overall Study|Withdrawal by Subject|4|||
129528036|NCT01855919|466221744|FG001|Overall Study|Withdrawal by Subject|10|||
129528037|NCT01855919|466221743|FG000|Overall Study|Entry Criteria Not Met|1|||
129528038|NCT01855919|466221744|FG001|Overall Study|Entry Criteria Not Met|1|||
129528039|NCT01855919|466221743|FG000|Overall Study|Protocol Violation|1|||
129528040|NCT01855919|466221744|FG001|Overall Study|Protocol Violation|4|||
129528041|NCT04459416|466221745|FG000|Overall Study|Lost to Follow-up|2|||
129528042|NCT04459416|466221746|FG001|Overall Study|Lost to Follow-up|0|||
129528043|NCT04459416|466221745|FG000|Overall Study|Withdrawal by Subject|8|||
129528044|NCT04459416|466221746|FG001|Overall Study|Withdrawal by Subject|10|||
129528045|NCT04459416|466221745|FG000|Overall Study|Disease progression|0|||
129528046|NCT04459416|466221746|FG001|Overall Study|Disease progression|3|||
129528047|NCT04418427|466221747|FG000|Overall Study|Death|0|||
129528048|NCT04418427|466221748|FG001|Overall Study|Death|1|||
129528049|NCT04418427|466221749|FG002|Overall Study|Death|0|||
129528050|NCT04418427|466221747|FG000|Overall Study|Lost to Follow-up|0|||
129528051|NCT04418427|466221748|FG001|Overall Study|Lost to Follow-up|2|||
129528052|NCT04418427|466221749|FG002|Overall Study|Lost to Follow-up|2|||
129528053|NCT04418427|466221747|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
129528054|NCT04418427|466221748|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
129528055|NCT04418427|466221749|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
129528056|NCT04418427|466221747|FG000|Overall Study|Pre-existing medical condition|0|||
129528057|NCT04418427|466221748|FG001|Overall Study|Pre-existing medical condition|1|||
129528058|NCT04418427|466221749|FG002|Overall Study|Pre-existing medical condition|0|||
129528059|NCT01004861|466221752|FG000|Overall Study|Disease progression|3|||
129528060|NCT01004861|466221753|FG001|Overall Study|Disease progression|4|||
129528061|NCT01004861|466221754|FG002|Overall Study|Disease progression|5|||
129528062|NCT01004861|466221755|FG003|Overall Study|Disease progression|4|||
129528063|NCT01004861|466221756|FG004|Overall Study|Disease progression|4|||
129528064|NCT01004861|466221757|FG005|Overall Study|Disease progression|4|||
129528065|NCT01004861|466221758|FG006|Overall Study|Disease progression|5|||
129528066|NCT01004861|466221759|FG007|Overall Study|Disease progression|1|||
129528067|NCT01004861|466221760|FG008|Overall Study|Disease progression|4|||
129528068|NCT01004861|466221761|FG009|Overall Study|Disease progression|7|||
129528069|NCT01004861|466221762|FG010|Overall Study|Disease progression|6|||
129528070|NCT01004861|466221763|FG011|Overall Study|Disease progression|3|||
129528071|NCT01004861|466221764|FG012|Overall Study|Disease progression|8|||
129528072|NCT01004861|466221752|FG000|Overall Study|Physician Decision|0|||
129528073|NCT01004861|466221753|FG001|Overall Study|Physician Decision|2|||
129528074|NCT01004861|466221754|FG002|Overall Study|Physician Decision|1|||
129528075|NCT01004861|466221755|FG003|Overall Study|Physician Decision|1|||
129528076|NCT01004861|466221756|FG004|Overall Study|Physician Decision|1|||
129528077|NCT01004861|466221757|FG005|Overall Study|Physician Decision|0|||
129528078|NCT01004861|466221758|FG006|Overall Study|Physician Decision|0|||
129528079|NCT01004861|466221759|FG007|Overall Study|Physician Decision|1|||
129528080|NCT01004861|466221760|FG008|Overall Study|Physician Decision|0|||
129528081|NCT01004861|466221761|FG009|Overall Study|Physician Decision|0|||
129528082|NCT01004861|466221762|FG010|Overall Study|Physician Decision|0|||
129528083|NCT01004861|466221763|FG011|Overall Study|Physician Decision|0|||
129528084|NCT01004861|466221764|FG012|Overall Study|Physician Decision|3|||
129528085|NCT01004861|466221752|FG000|Overall Study|Adverse Event|0|||
129528086|NCT01004861|466221753|FG001|Overall Study|Adverse Event|0|||
129528087|NCT01004861|466221754|FG002|Overall Study|Adverse Event|0|||
129528088|NCT01004861|466221755|FG003|Overall Study|Adverse Event|1|||
129528089|NCT01004861|466221756|FG004|Overall Study|Adverse Event|0|||
129528090|NCT01004861|466221757|FG005|Overall Study|Adverse Event|2|||
129528091|NCT01004861|466221758|FG006|Overall Study|Adverse Event|1|||
129528092|NCT01004861|466221759|FG007|Overall Study|Adverse Event|1|||
129528093|NCT01004861|466221760|FG008|Overall Study|Adverse Event|13|||
129528094|NCT01004861|466221761|FG009|Overall Study|Adverse Event|1|||
129528095|NCT01004861|466221762|FG010|Overall Study|Adverse Event|1|||
129528096|NCT01004861|466221763|FG011|Overall Study|Adverse Event|0|||
129528097|NCT01004861|466221764|FG012|Overall Study|Adverse Event|2|||
129528098|NCT01004861|466221752|FG000|Overall Study|Protocol Violation|0|||
129528099|NCT01004861|466221753|FG001|Overall Study|Protocol Violation|0|||
129528100|NCT01004861|466221754|FG002|Overall Study|Protocol Violation|0|||
129528101|NCT01004861|466221755|FG003|Overall Study|Protocol Violation|0|||
129528102|NCT01004861|466221756|FG004|Overall Study|Protocol Violation|1|||
129528103|NCT01004861|466221757|FG005|Overall Study|Protocol Violation|0|||
129528104|NCT01004861|466221758|FG006|Overall Study|Protocol Violation|0|||
129528105|NCT01004861|466221759|FG007|Overall Study|Protocol Violation|0|||
129528106|NCT01004861|466221760|FG008|Overall Study|Protocol Violation|0|||
129528107|NCT01004861|466221761|FG009|Overall Study|Protocol Violation|0|||
129528108|NCT01004861|466221762|FG010|Overall Study|Protocol Violation|0|||
129528109|NCT01004861|466221763|FG011|Overall Study|Protocol Violation|0|||
129528110|NCT01004861|466221764|FG012|Overall Study|Protocol Violation|0|||
129528111|NCT01004861|466221752|FG000|Overall Study|Lost to Follow-up|0|||
129528112|NCT01004861|466221753|FG001|Overall Study|Lost to Follow-up|0|||
129528113|NCT01004861|466221754|FG002|Overall Study|Lost to Follow-up|0|||
129528114|NCT01004861|466221755|FG003|Overall Study|Lost to Follow-up|0|||
129528115|NCT01004861|466221756|FG004|Overall Study|Lost to Follow-up|0|||
129528116|NCT01004861|466221757|FG005|Overall Study|Lost to Follow-up|0|||
129528117|NCT01004861|466221758|FG006|Overall Study|Lost to Follow-up|0|||
129528118|NCT01004861|466221759|FG007|Overall Study|Lost to Follow-up|1|||
129528119|NCT01004861|466221760|FG008|Overall Study|Lost to Follow-up|3|||
129528120|NCT01004861|466221761|FG009|Overall Study|Lost to Follow-up|0|||
129528121|NCT01004861|466221762|FG010|Overall Study|Lost to Follow-up|0|||
129528122|NCT01004861|466221763|FG011|Overall Study|Lost to Follow-up|1|||
129528123|NCT01004861|466221764|FG012|Overall Study|Lost to Follow-up|0|||
129528124|NCT01004861|466221752|FG000|Overall Study|Non-compliance|0|||
129528125|NCT01004861|466221753|FG001|Overall Study|Non-compliance|0|||
129528126|NCT01004861|466221754|FG002|Overall Study|Non-compliance|0|||
129528127|NCT01004861|466221755|FG003|Overall Study|Non-compliance|0|||
129528128|NCT01004861|466221756|FG004|Overall Study|Non-compliance|0|||
129528129|NCT01004861|466221757|FG005|Overall Study|Non-compliance|0|||
129528130|NCT01004861|466221758|FG006|Overall Study|Non-compliance|0|||
129528131|NCT01004861|466221759|FG007|Overall Study|Non-compliance|0|||
129528132|NCT01004861|466221760|FG008|Overall Study|Non-compliance|5|||
129528133|NCT01004861|466221761|FG009|Overall Study|Non-compliance|0|||
129528134|NCT01004861|466221762|FG010|Overall Study|Non-compliance|0|||
129528135|NCT01004861|466221763|FG011|Overall Study|Non-compliance|0|||
129528136|NCT01004861|466221764|FG012|Overall Study|Non-compliance|1|||
129528137|NCT01004861|466221752|FG000|Overall Study|Other|0|||
129528138|NCT01004861|466221753|FG001|Overall Study|Other|0|||
129528139|NCT01004861|466221754|FG002|Overall Study|Other|0|||
129528140|NCT01004861|466221755|FG003|Overall Study|Other|0|||
129528141|NCT01004861|466221756|FG004|Overall Study|Other|0|||
129528142|NCT01004861|466221757|FG005|Overall Study|Other|0|||
129528143|NCT01004861|466221758|FG006|Overall Study|Other|0|||
129528144|NCT01004861|466221759|FG007|Overall Study|Other|0|||
129528145|NCT01004861|466221760|FG008|Overall Study|Other|0|||
129528146|NCT01004861|466221761|FG009|Overall Study|Other|2|||
129528147|NCT01004861|466221762|FG010|Overall Study|Other|1|||
129528148|NCT01004861|466221763|FG011|Overall Study|Other|2|||
129528149|NCT01004861|466221764|FG012|Overall Study|Other|3|||
129528150|NCT01004861|466221752|FG000|Overall Study|Patient decision|0|||
129528151|NCT01004861|466221753|FG001|Overall Study|Patient decision|0|||
129528152|NCT01004861|466221754|FG002|Overall Study|Patient decision|0|||
129528153|NCT01004861|466221755|FG003|Overall Study|Patient decision|0|||
129528154|NCT01004861|466221756|FG004|Overall Study|Patient decision|1|||
129528155|NCT01004861|466221757|FG005|Overall Study|Patient decision|0|||
129528156|NCT01004861|466221758|FG006|Overall Study|Patient decision|1|||
129528157|NCT01004861|466221759|FG007|Overall Study|Patient decision|0|||
129528158|NCT01004861|466221760|FG008|Overall Study|Patient decision|7|||
129528159|NCT01004861|466221761|FG009|Overall Study|Patient decision|1|||
129528160|NCT01004861|466221762|FG010|Overall Study|Patient decision|1|||
129528161|NCT01004861|466221763|FG011|Overall Study|Patient decision|2|||
129528162|NCT01004861|466221764|FG012|Overall Study|Patient decision|3|||
129528163|NCT01004861|466221752|FG000|Overall Study|Transitioned to Phase 4 study|0|||
129528164|NCT01004861|466221753|FG001|Overall Study|Transitioned to Phase 4 study|0|||
129528165|NCT01004861|466221754|FG002|Overall Study|Transitioned to Phase 4 study|0|||
129528166|NCT01004861|466221755|FG003|Overall Study|Transitioned to Phase 4 study|0|||
129528167|NCT01004861|466221756|FG004|Overall Study|Transitioned to Phase 4 study|0|||
129528168|NCT01004861|466221757|FG005|Overall Study|Transitioned to Phase 4 study|0|||
129528169|NCT01004861|466221758|FG006|Overall Study|Transitioned to Phase 4 study|0|||
129528170|NCT01004861|466221759|FG007|Overall Study|Transitioned to Phase 4 study|0|||
129528171|NCT01004861|466221760|FG008|Overall Study|Transitioned to Phase 4 study|2|||
129528172|NCT01004861|466221761|FG009|Overall Study|Transitioned to Phase 4 study|0|||
129528173|NCT01004861|466221762|FG010|Overall Study|Transitioned to Phase 4 study|0|||
129528174|NCT01004861|466221763|FG011|Overall Study|Transitioned to Phase 4 study|0|||
129528175|NCT01004861|466221764|FG012|Overall Study|Transitioned to Phase 4 study|0|||
129528176|NCT01004861|466221752|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528177|NCT01004861|466221753|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528178|NCT01004861|466221754|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528179|NCT01004861|466221755|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528180|NCT01004861|466221756|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528181|NCT01004861|466221757|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528182|NCT01004861|466221758|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528183|NCT01004861|466221759|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528184|NCT01004861|466221760|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
129528185|NCT01004861|466221761|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528186|NCT01004861|466221762|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528187|NCT01004861|466221763|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528188|NCT01004861|466221764|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
129528189|NCT01004861|466221752|FG000|Overall Study|Patient withdrew|0|||
129528190|NCT01004861|466221753|FG001|Overall Study|Patient withdrew|0|||
129528191|NCT01004861|466221754|FG002|Overall Study|Patient withdrew|0|||
129528192|NCT01004861|466221755|FG003|Overall Study|Patient withdrew|0|||
129528193|NCT01004861|466221756|FG004|Overall Study|Patient withdrew|0|||
129528194|NCT01004861|466221757|FG005|Overall Study|Patient withdrew|0|||
129528195|NCT01004861|466221758|FG006|Overall Study|Patient withdrew|0|||
129528196|NCT01004861|466221759|FG007|Overall Study|Patient withdrew|0|||
129528197|NCT01004861|466221760|FG008|Overall Study|Patient withdrew|1|||
129528198|NCT01004861|466221761|FG009|Overall Study|Patient withdrew|0|||
129528199|NCT01004861|466221762|FG010|Overall Study|Patient withdrew|0|||
129528200|NCT01004861|466221763|FG011|Overall Study|Patient withdrew|0|||
129528201|NCT01004861|466221764|FG012|Overall Study|Patient withdrew|0|||
129528202|NCT01004861|466221752|FG000|Overall Study|Surgical resection|0|||
129528203|NCT01004861|466221753|FG001|Overall Study|Surgical resection|0|||
129528204|NCT01004861|466221754|FG002|Overall Study|Surgical resection|0|||
129528205|NCT01004861|466221755|FG003|Overall Study|Surgical resection|0|||
129528206|NCT01004861|466221756|FG004|Overall Study|Surgical resection|0|||
129528207|NCT01004861|466221757|FG005|Overall Study|Surgical resection|0|||
129528208|NCT01004861|466221758|FG006|Overall Study|Surgical resection|0|||
129528209|NCT01004861|466221759|FG007|Overall Study|Surgical resection|0|||
129528210|NCT01004861|466221760|FG008|Overall Study|Surgical resection|1|||
129528211|NCT01004861|466221761|FG009|Overall Study|Surgical resection|0|||
129528212|NCT01004861|466221762|FG010|Overall Study|Surgical resection|0|||
129528213|NCT01004861|466221763|FG011|Overall Study|Surgical resection|0|||
129528214|NCT01004861|466221764|FG012|Overall Study|Surgical resection|0|||
129528215|NCT01004861|466221752|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528216|NCT01004861|466221753|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528217|NCT01004861|466221754|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528218|NCT01004861|466221755|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528219|NCT01004861|466221756|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528220|NCT01004861|466221757|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528221|NCT01004861|466221758|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528222|NCT01004861|466221759|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528223|NCT01004861|466221760|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
129528224|NCT01004861|466221761|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528225|NCT01004861|466221762|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528226|NCT01004861|466221763|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528227|NCT01004861|466221764|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
129528228|NCT01004861|466221752|FG000|Overall Study|Study termination by Sponsor|0|||
129528229|NCT01004861|466221753|FG001|Overall Study|Study termination by Sponsor|0|||
129528230|NCT01004861|466221754|FG002|Overall Study|Study termination by Sponsor|0|||
129528231|NCT01004861|466221755|FG003|Overall Study|Study termination by Sponsor|0|||
129528232|NCT01004861|466221756|FG004|Overall Study|Study termination by Sponsor|0|||
129528233|NCT01004861|466221757|FG005|Overall Study|Study termination by Sponsor|0|||
129528234|NCT01004861|466221758|FG006|Overall Study|Study termination by Sponsor|0|||
129528235|NCT01004861|466221759|FG007|Overall Study|Study termination by Sponsor|0|||
129528236|NCT01004861|466221760|FG008|Overall Study|Study termination by Sponsor|1|||
129528237|NCT01004861|466221761|FG009|Overall Study|Study termination by Sponsor|0|||
129528238|NCT01004861|466221762|FG010|Overall Study|Study termination by Sponsor|0|||
129528239|NCT01004861|466221763|FG011|Overall Study|Study termination by Sponsor|0|||
129528240|NCT01004861|466221764|FG012|Overall Study|Study termination by Sponsor|0|||
129528241|NCT02554721|466221766|FG000|Overall Study|Adverse Event|1|||
129528242|NCT02554721|466221767|FG001|Overall Study|Adverse Event|0|||
129528243|NCT02554721|466221768|FG002|Overall Study|Adverse Event|0|||
129528244|NCT02554721|466221769|FG003|Overall Study|Adverse Event|0|||
129528245|NCT02554721|466221770|FG004|Overall Study|Adverse Event|1|||
129528246|NCT02554721|466221766|FG000|Overall Study|Noncompliance|0|||
129528247|NCT02554721|466221767|FG001|Overall Study|Noncompliance|0|||
129528248|NCT02554721|466221768|FG002|Overall Study|Noncompliance|0|||
129528249|NCT02554721|466221769|FG003|Overall Study|Noncompliance|0|||
129528250|NCT02554721|466221770|FG004|Overall Study|Noncompliance|1|||
129528251|NCT00686699|466221771|FG000|Treatment Period 1|Adverse Event|0|||
129528252|NCT00686699|466221772|FG001|Treatment Period 1|Adverse Event|2|||
129528253|NCT04610827|466221773|FG000|Overall Study|Withdrawal by Subject|1|||
129528254|NCT04610827|466221774|FG001|Overall Study|Withdrawal by Subject|1|||
129528255|NCT04610827|466221775|FG002|Overall Study|Withdrawal by Subject|0|||
129528256|NCT00908895|466221776|FG000|Overall Study|Lost to Follow-up|1|||
129528257|NCT00908895|466221777|FG001|Overall Study|Lost to Follow-up|3|||
129528258|NCT00908895|466221776|FG000|Overall Study|algodystrophy|2|||
129528259|NCT00908895|466221777|FG001|Overall Study|algodystrophy|2|||
129528260|NCT00908895|466221776|FG000|Overall Study|Adverse Event|1|||
129528261|NCT00908895|466221777|FG001|Overall Study|Adverse Event|1|||
129528262|NCT02059174|466221779|FG000|Period 1|Withdrawal by Subject|0|||
129528263|NCT02059174|466221780|FG001|Period 1|Withdrawal by Subject|2|||
129528264|NCT02059174|466221779|FG000|Period 2|Withdrawal by Subject|0|||
129528265|NCT02059174|466221780|FG001|Period 2|Withdrawal by Subject|2|||
129528266|NCT02059174|466221779|FG000|Period 2|Protocol Violation|1|||
129528267|NCT02059174|466221780|FG001|Period 2|Protocol Violation|0|||
129528268|NCT02059174|466221779|FG000|Period 3|Physician Decision|1|||
129528269|NCT02059174|466221780|FG001|Period 3|Physician Decision|0|||
129528270|NCT02306148|466221781|FG000|Overall Study|Adverse Event|12|||
129528271|NCT02306148|466221782|FG001|Overall Study|Adverse Event|6|||
129528272|NCT02306148|466221781|FG000|Overall Study|Lost to Follow-up|1|||
129528273|NCT02306148|466221782|FG001|Overall Study|Lost to Follow-up|4|||
129528274|NCT00087594|466221783|FG000|Overall Study|Adverse Event|2|||
129528275|NCT00087594|466221784|FG001|Overall Study|Adverse Event|3|||
129528276|NCT00087594|466221783|FG000|Overall Study|Lost to Follow-up|0|||
129528277|NCT00087594|466221784|FG001|Overall Study|Lost to Follow-up|2|||
129528278|NCT00087594|466221783|FG000|Overall Study|Withdrawal by Subject|4|||
129528279|NCT00087594|466221784|FG001|Overall Study|Withdrawal by Subject|2|||
129528280|NCT00087594|466221783|FG000|Overall Study|Lack of Efficacy|2|||
129528281|NCT00087594|466221784|FG001|Overall Study|Lack of Efficacy|5|||
129528282|NCT01952041|466221789|FG000|Overall Study|Lost to Follow-up|9|||
129528283|NCT01952041|466221790|FG001|Overall Study|Lost to Follow-up|16|||
129528284|NCT01952041|466221789|FG000|Overall Study|Withdrawal by Subject|7|||
129528285|NCT01952041|466221790|FG001|Overall Study|Withdrawal by Subject|5|||
129528286|NCT01952041|466221789|FG000|Overall Study|Death|1|||
129528287|NCT01952041|466221790|FG001|Overall Study|Death|0|||
129528288|NCT00186121|466221791|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
129528289|NCT00186121|466221791|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
129528290|NCT00186121|466221791|FG000|Overall Study|Not eligible (no treatment)|1|||
129528291|NCT01569568|466221792|FG000|Overall Study|Physician Decision|0|||
129528292|NCT01569568|466221793|FG001|Overall Study|Physician Decision|2|||
129528293|NCT01370499|466221794|FG000|Overall Study|Adverse Event|38|||
129528294|NCT01370499|466221795|FG001|Overall Study|Adverse Event|12|||
129528295|NCT01370499|466221794|FG000|Overall Study|Lack of Efficacy|4|||
129528296|NCT01370499|466221795|FG001|Overall Study|Lack of Efficacy|2|||
129528297|NCT01370499|466221794|FG000|Overall Study|Lost to Follow-up|2|||
129528298|NCT01370499|466221795|FG001|Overall Study|Lost to Follow-up|1|||
129528299|NCT01370499|466221794|FG000|Overall Study|Physician Decision|3|||
129528300|NCT01370499|466221795|FG001|Overall Study|Physician Decision|3|||
129528301|NCT01370499|466221794|FG000|Overall Study|Protocol Violation|5|||
129528302|NCT01370499|466221795|FG001|Overall Study|Protocol Violation|4|||
129528303|NCT01370499|466221794|FG000|Overall Study|Withdrawal by Subject|18|||
129528304|NCT01370499|466221795|FG001|Overall Study|Withdrawal by Subject|7|||
129528305|NCT01370499|466221794|FG000|Overall Study|Sponsor Decision|41|||
129528306|NCT01370499|466221795|FG001|Overall Study|Sponsor Decision|15|||
129528307|NCT01654224|466221800|FG000|Overall Study|Lost to Follow-up|2|||
129528308|NCT01654224|466221801|FG001|Overall Study|Lost to Follow-up|2|||
129528309|NCT01654224|466221800|FG000|Overall Study|Did not receive allocation|1|||
129528310|NCT01654224|466221801|FG001|Overall Study|Did not receive allocation|8|||
129528311|NCT01654224|466221800|FG000|Overall Study|Insufficient blood sample|3|||
129528312|NCT01654224|466221801|FG001|Overall Study|Insufficient blood sample|2|||
129528313|NCT00166504|466221802|FG000|Overall Study|Adverse Event|3|||
129528314|NCT00166504|466221803|FG001|Overall Study|Adverse Event|3|||
129528315|NCT00166504|466221802|FG000|Overall Study|Lost to Follow-up|1|||
129528316|NCT00166504|466221803|FG001|Overall Study|Lost to Follow-up|1|||
129528317|NCT00166504|466221802|FG000|Overall Study|Withdrawal by Subject|1|||
129528318|NCT00166504|466221803|FG001|Overall Study|Withdrawal by Subject|0|||
129528319|NCT01222767|466221804|FG000|Overall Study|Progressive disease|13|||
129528320|NCT01222767|466221804|FG000|Overall Study|Adverse Event|2|||
129528321|NCT01222767|466221804|FG000|Overall Study|Surgical resection|1|||
129528322|NCT01222767|466221804|FG000|Overall Study|Never treated|1|||
129528323|NCT00723489|466221805|FG000|Overall Study|Physician Decision|0|||
129528324|NCT00723489|466221806|FG001|Overall Study|Physician Decision|1|||
129528325|NCT00723489|466221807|FG002|Overall Study|Physician Decision|0|||
129528326|NCT00723489|466221808|FG003|Overall Study|Physician Decision|0|||
129528327|NCT00723489|466221805|FG000|Overall Study|Pregnancy|0|||
129528328|NCT00723489|466221806|FG001|Overall Study|Pregnancy|0|||
129528329|NCT00723489|466221807|FG002|Overall Study|Pregnancy|0|||
129528330|NCT00723489|466221808|FG003|Overall Study|Pregnancy|1|||
129528331|NCT00723489|466221805|FG000|Overall Study|Withdrawal by Subject|0|||
129528332|NCT00723489|466221806|FG001|Overall Study|Withdrawal by Subject|0|||
129528333|NCT00723489|466221807|FG002|Overall Study|Withdrawal by Subject|0|||
129528334|NCT00723489|466221808|FG003|Overall Study|Withdrawal by Subject|1|||
129528335|NCT00723489|466221805|FG000|Overall Study|Seropositive at baseline|1|||
129528336|NCT00723489|466221806|FG001|Overall Study|Seropositive at baseline|0|||
129528337|NCT00723489|466221807|FG002|Overall Study|Seropositive at baseline|0|||
129528338|NCT00723489|466221808|FG003|Overall Study|Seropositive at baseline|0|||
129528339|NCT00723489|466221805|FG000|Overall Study|Prohibited Medication|0|||
129528340|NCT00723489|466221806|FG001|Overall Study|Prohibited Medication|0|||
129528341|NCT00723489|466221807|FG002|Overall Study|Prohibited Medication|0|||
129528342|NCT00723489|466221808|FG003|Overall Study|Prohibited Medication|1|||
129528343|NCT00723489|466221805|FG000|Overall Study|Samples Collected Out of Window|0|||
129528344|NCT00723489|466221806|FG001|Overall Study|Samples Collected Out of Window|3|||
129528345|NCT00723489|466221807|FG002|Overall Study|Samples Collected Out of Window|0|||
129528346|NCT00723489|466221808|FG003|Overall Study|Samples Collected Out of Window|0|||
129528347|NCT02477800|466221812|FG000|Placebo-Controlled Period|Adverse Event|16|||
129528348|NCT02477800|466221813|FG001|Placebo-Controlled Period|Adverse Event|25|||
129528349|NCT02477800|466221814|FG002|Placebo-Controlled Period|Adverse Event|28|||
129528350|NCT02477800|466221815|FG003|Placebo-Controlled Period|Adverse Event|0|||
129528351|NCT02477800|466221816|FG004|Placebo-Controlled Period|Adverse Event|0|||
129528352|NCT02477800|466221817|FG005|Placebo-Controlled Period|Adverse Event|0|||
129528353|NCT02477800|466221818|FG006|Placebo-Controlled Period|Adverse Event|0|||
129528354|NCT02477800|466221812|FG000|Placebo-Controlled Period|Change of Treatment|1|||
129528355|NCT02477800|466221813|FG001|Placebo-Controlled Period|Change of Treatment|2|||
129528356|NCT02477800|466221814|FG002|Placebo-Controlled Period|Change of Treatment|1|||
129528357|NCT02477800|466221815|FG003|Placebo-Controlled Period|Change of Treatment|0|||
129528358|NCT02477800|466221816|FG004|Placebo-Controlled Period|Change of Treatment|0|||
129528359|NCT02477800|466221817|FG005|Placebo-Controlled Period|Change of Treatment|0|||
129528360|NCT02477800|466221818|FG006|Placebo-Controlled Period|Change of Treatment|0|||
129528361|NCT02477800|466221812|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
129528362|NCT02477800|466221813|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
129528363|NCT02477800|466221814|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
129528364|NCT02477800|466221815|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
129528365|NCT02477800|466221816|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
129528366|NCT02477800|466221817|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
129528367|NCT02477800|466221818|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
129528368|NCT02477800|466221812|FG000|Placebo-Controlled Period|Death|0|||
129528369|NCT02477800|466221813|FG001|Placebo-Controlled Period|Death|3|||
129528370|NCT02477800|466221814|FG002|Placebo-Controlled Period|Death|2|||
129528371|NCT02477800|466221815|FG003|Placebo-Controlled Period|Death|0|||
129528372|NCT02477800|466221816|FG004|Placebo-Controlled Period|Death|0|||
129528373|NCT02477800|466221817|FG005|Placebo-Controlled Period|Death|0|||
129528374|NCT02477800|466221818|FG006|Placebo-Controlled Period|Death|0|||
129528375|NCT02477800|466221812|FG000|Placebo-Controlled Period|Disease Progression|1|||
129528376|NCT02477800|466221813|FG001|Placebo-Controlled Period|Disease Progression|0|||
129528377|NCT02477800|466221814|FG002|Placebo-Controlled Period|Disease Progression|1|||
129528378|NCT02477800|466221815|FG003|Placebo-Controlled Period|Disease Progression|0|||
129528379|NCT02477800|466221816|FG004|Placebo-Controlled Period|Disease Progression|0|||
129528380|NCT02477800|466221817|FG005|Placebo-Controlled Period|Disease Progression|0|||
129528381|NCT02477800|466221818|FG006|Placebo-Controlled Period|Disease Progression|0|||
129528382|NCT02477800|466221812|FG000|Placebo-Controlled Period|Investigator Decision|3|||
129528383|NCT02477800|466221813|FG001|Placebo-Controlled Period|Investigator Decision|2|||
129528384|NCT02477800|466221814|FG002|Placebo-Controlled Period|Investigator Decision|1|||
129528385|NCT02477800|466221815|FG003|Placebo-Controlled Period|Investigator Decision|0|||
129528386|NCT02477800|466221816|FG004|Placebo-Controlled Period|Investigator Decision|0|||
129528387|NCT02477800|466221817|FG005|Placebo-Controlled Period|Investigator Decision|0|||
129528388|NCT02477800|466221818|FG006|Placebo-Controlled Period|Investigator Decision|0|||
129528389|NCT02477800|466221812|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
129528390|NCT02477800|466221813|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
129528391|NCT02477800|466221814|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
129528392|NCT02477800|466221815|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
129528393|NCT02477800|466221816|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
129528394|NCT02477800|466221817|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
129528395|NCT02477800|466221818|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
129528396|NCT02477800|466221812|FG000|Placebo-Controlled Period|Relocation|2|||
129528397|NCT02477800|466221813|FG001|Placebo-Controlled Period|Relocation|0|||
129528398|NCT02477800|466221814|FG002|Placebo-Controlled Period|Relocation|0|||
129528399|NCT02477800|466221815|FG003|Placebo-Controlled Period|Relocation|0|||
129528400|NCT02477800|466221816|FG004|Placebo-Controlled Period|Relocation|0|||
129528401|NCT02477800|466221817|FG005|Placebo-Controlled Period|Relocation|0|||
129528402|NCT02477800|466221818|FG006|Placebo-Controlled Period|Relocation|0|||
129528403|NCT02477800|466221812|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
129528404|NCT02477800|466221813|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
129528405|NCT02477800|466221814|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
129528406|NCT02477800|466221815|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
129528407|NCT02477800|466221816|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
129528408|NCT02477800|466221817|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
129528409|NCT02477800|466221818|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
129528410|NCT02477800|466221812|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
129528411|NCT02477800|466221813|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
129528412|NCT02477800|466221814|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
129528413|NCT02477800|466221815|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
129528414|NCT02477800|466221816|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
129528415|NCT02477800|466221817|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
129528416|NCT02477800|466221818|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
129528417|NCT02477800|466221812|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
129528418|NCT02477800|466221813|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
129528419|NCT02477800|466221814|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
129528420|NCT02477800|466221815|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
129528421|NCT02477800|466221816|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
129528422|NCT02477800|466221817|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
129528423|NCT02477800|466221818|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
129528424|NCT02477800|466221812|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
129528425|NCT02477800|466221813|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
129528426|NCT02477800|466221814|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
129528427|NCT02477800|466221815|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129528428|NCT02477800|466221816|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129528429|NCT02477800|466221817|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129528430|NCT02477800|466221818|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
129528431|NCT02477800|466221812|FG000|Placebo-Controlled Period|Reason not Specified|161|||
129528432|NCT02477800|466221813|FG001|Placebo-Controlled Period|Reason not Specified|161|||
129528433|NCT02477800|466221814|FG002|Placebo-Controlled Period|Reason not Specified|189|||
129528434|NCT02477800|466221815|FG003|Placebo-Controlled Period|Reason not Specified|0|||
129528435|NCT02477800|466221816|FG004|Placebo-Controlled Period|Reason not Specified|0|||
129528436|NCT02477800|466221817|FG005|Placebo-Controlled Period|Reason not Specified|0|||
129528437|NCT02477800|466221818|FG006|Placebo-Controlled Period|Reason not Specified|0|||
129528438|NCT02477800|466221812|FG000|Long Term Extension Period|Adverse Event|0|||
129528439|NCT02477800|466221813|FG001|Long Term Extension Period|Adverse Event|0|||
129528440|NCT02477800|466221814|FG002|Long Term Extension Period|Adverse Event|0|||
129528441|NCT02477800|466221815|FG003|Long Term Extension Period|Adverse Event|6|||
129528442|NCT02477800|466221816|FG004|Long Term Extension Period|Adverse Event|2|||
129528443|NCT02477800|466221817|FG005|Long Term Extension Period|Adverse Event|4|||
129528444|NCT02477800|466221818|FG006|Long Term Extension Period|Adverse Event|3|||
129528445|NCT02477800|466221812|FG000|Long Term Extension Period|Death|0|||
129528446|NCT02477800|466221813|FG001|Long Term Extension Period|Death|0|||
129528447|NCT02477800|466221814|FG002|Long Term Extension Period|Death|0|||
129528448|NCT02477800|466221815|FG003|Long Term Extension Period|Death|1|||
129528449|NCT02477800|466221816|FG004|Long Term Extension Period|Death|1|||
129528450|NCT02477800|466221817|FG005|Long Term Extension Period|Death|1|||
129528451|NCT02477800|466221818|FG006|Long Term Extension Period|Death|2|||
129528452|NCT02477800|466221812|FG000|Long Term Extension Period|Consent Withdrawn|0|||
129528453|NCT02477800|466221813|FG001|Long Term Extension Period|Consent Withdrawn|0|||
129528454|NCT02477800|466221814|FG002|Long Term Extension Period|Consent Withdrawn|0|||
129528455|NCT02477800|466221815|FG003|Long Term Extension Period|Consent Withdrawn|10|||
129528456|NCT02477800|466221816|FG004|Long Term Extension Period|Consent Withdrawn|4|||
129528457|NCT02477800|466221817|FG005|Long Term Extension Period|Consent Withdrawn|13|||
129528458|NCT02477800|466221818|FG006|Long Term Extension Period|Consent Withdrawn|16|||
129528459|NCT02477800|466221812|FG000|Long Term Extension Period|Disease Progression|0|||
129528460|NCT02477800|466221813|FG001|Long Term Extension Period|Disease Progression|0|||
129528461|NCT02477800|466221814|FG002|Long Term Extension Period|Disease Progression|0|||
129528462|NCT02477800|466221815|FG003|Long Term Extension Period|Disease Progression|3|||
129528463|NCT02477800|466221816|FG004|Long Term Extension Period|Disease Progression|1|||
129528464|NCT02477800|466221817|FG005|Long Term Extension Period|Disease Progression|1|||
129528465|NCT02477800|466221818|FG006|Long Term Extension Period|Disease Progression|0|||
129528466|NCT02477800|466221812|FG000|Long Term Extension Period|Investigator Decision|0|||
129528467|NCT02477800|466221813|FG001|Long Term Extension Period|Investigator Decision|0|||
129528468|NCT02477800|466221814|FG002|Long Term Extension Period|Investigator Decision|0|||
129528469|NCT02477800|466221815|FG003|Long Term Extension Period|Investigator Decision|0|||
129528470|NCT02477800|466221816|FG004|Long Term Extension Period|Investigator Decision|0|||
129528471|NCT02477800|466221817|FG005|Long Term Extension Period|Investigator Decision|0|||
129528472|NCT02477800|466221818|FG006|Long Term Extension Period|Investigator Decision|2|||
129528473|NCT02477800|466221812|FG000|Long Term Extension Period|Lost to Follow-up|0|||
129528474|NCT02477800|466221813|FG001|Long Term Extension Period|Lost to Follow-up|0|||
129528475|NCT02477800|466221814|FG002|Long Term Extension Period|Lost to Follow-up|0|||
129528476|NCT02477800|466221815|FG003|Long Term Extension Period|Lost to Follow-up|0|||
129528477|NCT02477800|466221816|FG004|Long Term Extension Period|Lost to Follow-up|1|||
129528478|NCT02477800|466221817|FG005|Long Term Extension Period|Lost to Follow-up|3|||
129528479|NCT02477800|466221818|FG006|Long Term Extension Period|Lost to Follow-up|0|||
129528480|NCT02477800|466221812|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
129528481|NCT02477800|466221813|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
129528482|NCT02477800|466221814|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
129528483|NCT02477800|466221815|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
129528484|NCT02477800|466221816|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
129528485|NCT02477800|466221817|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
129528486|NCT02477800|466221818|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
129528487|NCT02477800|466221812|FG000|Long Term Extension Period|Study Visit Burden|0|||
129528488|NCT02477800|466221813|FG001|Long Term Extension Period|Study Visit Burden|0|||
129528489|NCT02477800|466221814|FG002|Long Term Extension Period|Study Visit Burden|0|||
129528490|NCT02477800|466221815|FG003|Long Term Extension Period|Study Visit Burden|3|||
129528491|NCT02477800|466221816|FG004|Long Term Extension Period|Study Visit Burden|0|||
129528492|NCT02477800|466221817|FG005|Long Term Extension Period|Study Visit Burden|2|||
129528493|NCT02477800|466221818|FG006|Long Term Extension Period|Study Visit Burden|2|||
129528494|NCT02477800|466221812|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
129528495|NCT02477800|466221813|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
129528496|NCT02477800|466221814|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
129528497|NCT02477800|466221815|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
129528498|NCT02477800|466221816|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
129528499|NCT02477800|466221817|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
129528500|NCT02477800|466221818|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
129528501|NCT02477800|466221812|FG000|Long Term Extension Period|Reason not Specified|0|||
129528502|NCT02477800|466221813|FG001|Long Term Extension Period|Reason not Specified|0|||
129528503|NCT02477800|466221814|FG002|Long Term Extension Period|Reason not Specified|0|||
129528504|NCT02477800|466221815|FG003|Long Term Extension Period|Reason not Specified|126|||
129528505|NCT02477800|466221816|FG004|Long Term Extension Period|Reason not Specified|140|||
129528506|NCT02477800|466221817|FG005|Long Term Extension Period|Reason not Specified|270|||
129528507|NCT02477800|466221818|FG006|Long Term Extension Period|Reason not Specified|224|||
129528508|NCT00958191|466221821|FG000|Overall Study|Death|4|||
129528509|NCT00958191|466221821|FG000|Overall Study|Lost to Follow-up|5|||
129528510|NCT00958191|466221821|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
129528511|NCT00958191|466221821|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
129528512|NCT00958191|466221821|FG000|Overall Study|Revision of study device|4|||
129528513|NCT00958191|466221821|FG000|Overall Study|Site termination|11|||
129528514|NCT00958191|466221821|FG000|Overall Study|No 5 yr x-rays|56|||
129528515|NCT01818765|466221822|FG000|Overall Study|Death|2|||
129528516|NCT02010567|466221823|FG000|Overall Study|Adverse Event|0|||
129528517|NCT02010567|466221824|FG001|Overall Study|Adverse Event|0|||
129528518|NCT02010567|466221825|FG002|Overall Study|Adverse Event|1|||
129528519|NCT02010567|466221826|FG003|Overall Study|Adverse Event|0|||
129528520|NCT02010567|466221827|FG004|Overall Study|Adverse Event|1|||
129528521|NCT02005211|466221828|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
129528522|NCT02005211|466221829|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
129528523|NCT02005211|466221830|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
129528524|NCT02005211|466221831|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
129528525|NCT02005211|466221832|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
129528526|NCT02005211|466221833|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
129528527|NCT02005211|466221834|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
129528528|NCT00397631|466221837|FG000|Overall Study|Adverse Event|5|||
129528529|NCT00397631|466221838|FG001|Overall Study|Adverse Event|6|||
129528530|NCT00397631|466221837|FG000|Overall Study|Lack of Efficacy|7|||
129528531|NCT00397631|466221838|FG001|Overall Study|Lack of Efficacy|10|||
129528532|NCT00397631|466221837|FG000|Overall Study|Lost to Follow-up|8|||
129528533|NCT00397631|466221838|FG001|Overall Study|Lost to Follow-up|9|||
129528534|NCT00397631|466221837|FG000|Overall Study|Physician Decision|2|||
129528535|NCT00397631|466221838|FG001|Overall Study|Physician Decision|0|||
129528536|NCT00397631|466221837|FG000|Overall Study|Protocol Violation|0|||
129528537|NCT00397631|466221838|FG001|Overall Study|Protocol Violation|1|||
129528538|NCT00397631|466221837|FG000|Overall Study|Withdrawal by Subject|7|||
129528539|NCT00397631|466221838|FG001|Overall Study|Withdrawal by Subject|14|||
129528540|NCT00397631|466221837|FG000|Overall Study|protocol discontinuation criteria|1|||
129528541|NCT00397631|466221838|FG001|Overall Study|protocol discontinuation criteria|4|||
129528542|NCT02202161|466221839|FG000|Overall Study|Adverse Event|1|||
129528543|NCT02202161|466221840|FG001|Overall Study|Adverse Event|1|||
129528544|NCT02202161|466221841|FG002|Overall Study|Adverse Event|0|||
129528545|NCT02202161|466221842|FG003|Overall Study|Adverse Event|0|||
129528546|NCT02202161|466221843|FG004|Overall Study|Adverse Event|0|||
129528547|NCT02202161|466221844|FG005|Overall Study|Adverse Event|1|||
129528548|NCT02202161|466221845|FG006|Overall Study|Adverse Event|0|||
129528549|NCT02202161|466221846|FG007|Overall Study|Adverse Event|0|||
129528550|NCT02202161|466221839|FG000|Overall Study|Did not meet continuation criteria|0|||
129528551|NCT02202161|466221840|FG001|Overall Study|Did not meet continuation criteria|0|||
129528552|NCT02202161|466221841|FG002|Overall Study|Did not meet continuation criteria|0|||
129528553|NCT02202161|466221842|FG003|Overall Study|Did not meet continuation criteria|0|||
129528554|NCT02202161|466221843|FG004|Overall Study|Did not meet continuation criteria|0|||
129528555|NCT02202161|466221844|FG005|Overall Study|Did not meet continuation criteria|0|||
129528556|NCT02202161|466221845|FG006|Overall Study|Did not meet continuation criteria|0|||
129528557|NCT02202161|466221846|FG007|Overall Study|Did not meet continuation criteria|3|||
129528558|NCT02202161|466221839|FG000|Overall Study|Physician Decision|0|||
129528559|NCT02202161|466221840|FG001|Overall Study|Physician Decision|0|||
129528560|NCT02202161|466221841|FG002|Overall Study|Physician Decision|0|||
129528561|NCT02202161|466221842|FG003|Overall Study|Physician Decision|0|||
129528562|NCT02202161|466221843|FG004|Overall Study|Physician Decision|0|||
129528563|NCT02202161|466221844|FG005|Overall Study|Physician Decision|0|||
129528564|NCT02202161|466221845|FG006|Overall Study|Physician Decision|0|||
129528565|NCT02202161|466221846|FG007|Overall Study|Physician Decision|3|||
129528566|NCT02202161|466221839|FG000|Overall Study|Withdrawal by Subject|0|||
129528567|NCT02202161|466221840|FG001|Overall Study|Withdrawal by Subject|0|||
129528568|NCT02202161|466221841|FG002|Overall Study|Withdrawal by Subject|0|||
129528569|NCT02202161|466221842|FG003|Overall Study|Withdrawal by Subject|0|||
129528570|NCT02202161|466221843|FG004|Overall Study|Withdrawal by Subject|1|||
129528571|NCT02202161|466221844|FG005|Overall Study|Withdrawal by Subject|0|||
129528572|NCT02202161|466221845|FG006|Overall Study|Withdrawal by Subject|0|||
129528573|NCT02202161|466221846|FG007|Overall Study|Withdrawal by Subject|0|||
129528574|NCT00832091|466221847|FG000|Overall Study|Adverse Event|1|||
129528575|NCT00832091|466221848|FG001|Overall Study|Adverse Event|1|||
129528576|NCT00832091|466221847|FG000|Overall Study|Protocol Violation|1|||
129528577|NCT00832091|466221848|FG001|Overall Study|Protocol Violation|0|||
129528578|NCT00832091|466221847|FG000|Overall Study|Withdrawal by Subject|2|||
129528579|NCT00832091|466221848|FG001|Overall Study|Withdrawal by Subject|1|||
129528580|NCT00832091|466221847|FG000|Overall Study|Prohibited Medication|1|||
129528581|NCT00832091|466221848|FG001|Overall Study|Prohibited Medication|0|||
129528582|NCT00942422|466221849|FG000|Overall Study|Withdrawal by Subject|1|||
129528583|NCT00942422|466221849|FG000|Overall Study|Death|1|||
129528584|NCT00942422|466221849|FG000|Overall Study|Progressive diease|1|||
129528585|NCT05559203|466221852|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
129528586|NCT04048876|466221853|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
129528587|NCT04048876|466221854|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
129528588|NCT04048876|466221855|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
129528589|NCT04048876|466221856|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
129528590|NCT04048876|466221853|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
129528591|NCT04048876|466221854|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
129528592|NCT04048876|466221855|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
129528593|NCT04048876|466221856|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
129528594|NCT04048876|466221853|FG000|Placebo Controlled Phase|Adverse Event|0|||
129528595|NCT04048876|466221854|FG001|Placebo Controlled Phase|Adverse Event|1|||
129528596|NCT04048876|466221855|FG002|Placebo Controlled Phase|Adverse Event|0|||
129528597|NCT04048876|466221856|FG003|Placebo Controlled Phase|Adverse Event|0|||
129528598|NCT04048876|466221853|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
129528599|NCT04048876|466221854|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
129528600|NCT04048876|466221855|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
129528601|NCT04048876|466221856|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
129528602|NCT00415623|466221858|FG000|Overall Study|Adverse Event|3|||
129528603|NCT00415623|466221859|FG001|Overall Study|Adverse Event|4|||
129528604|NCT00415623|466221858|FG000|Overall Study|Death|1|||
129528605|NCT00415623|466221859|FG001|Overall Study|Death|0|||
129528606|NCT00415623|466221858|FG000|Overall Study|Withdrawal by Subject|1|||
129528607|NCT00415623|466221859|FG001|Overall Study|Withdrawal by Subject|1|||
129528608|NCT00542425|466221860|FG000|Initial 24 Weeks|Administrative reasons|0|||
129528609|NCT00542425|466221861|FG001|Initial 24 Weeks|Administrative reasons|0|||
129528610|NCT00542425|466221862|FG002|Initial 24 Weeks|Administrative reasons|1|||
129528611|NCT00542425|466221863|FG003|Initial 24 Weeks|Administrative reasons|1|||
129528612|NCT00542425|466221864|FG004|Initial 24 Weeks|Administrative reasons|0|||
129528613|NCT00542425|466221860|FG000|Initial 24 Weeks|Adverse Event|0|||
129528614|NCT00542425|466221861|FG001|Initial 24 Weeks|Adverse Event|1|||
129528615|NCT00542425|466221862|FG002|Initial 24 Weeks|Adverse Event|1|||
129528616|NCT00542425|466221863|FG003|Initial 24 Weeks|Adverse Event|3|||
129528617|NCT00542425|466221864|FG004|Initial 24 Weeks|Adverse Event|2|||
129528618|NCT00542425|466221860|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
129528619|NCT00542425|466221861|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
129528620|NCT00542425|466221862|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
129528621|NCT00542425|466221863|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
129528622|NCT00542425|466221864|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
129528623|NCT00542425|466221860|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
129528624|NCT00542425|466221861|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
129528625|NCT00542425|466221862|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
129528626|NCT00542425|466221863|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
129528627|NCT00542425|466221864|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
129528628|NCT00542425|466221860|FG000|Initial 24 Weeks|Non-compliance|0|||
129528629|NCT00542425|466221861|FG001|Initial 24 Weeks|Non-compliance|0|||
129528630|NCT00542425|466221862|FG002|Initial 24 Weeks|Non-compliance|0|||
129528631|NCT00542425|466221863|FG003|Initial 24 Weeks|Non-compliance|1|||
129528632|NCT00542425|466221864|FG004|Initial 24 Weeks|Non-compliance|1|||
129528633|NCT00542425|466221860|FG000|Initial 24 Weeks|Protocol Violation|0|||
129528634|NCT00542425|466221861|FG001|Initial 24 Weeks|Protocol Violation|0|||
129528635|NCT00542425|466221862|FG002|Initial 24 Weeks|Protocol Violation|0|||
129528636|NCT00542425|466221863|FG003|Initial 24 Weeks|Protocol Violation|1|||
129528637|NCT00542425|466221864|FG004|Initial 24 Weeks|Protocol Violation|0|||
129528638|NCT00542425|466221860|FG000|Initial 24 Weeks|Refusal of treatment|2|||
129528639|NCT00542425|466221861|FG001|Initial 24 Weeks|Refusal of treatment|2|||
129528640|NCT00542425|466221862|FG002|Initial 24 Weeks|Refusal of treatment|1|||
129528641|NCT00542425|466221863|FG003|Initial 24 Weeks|Refusal of treatment|4|||
129528642|NCT00542425|466221864|FG004|Initial 24 Weeks|Refusal of treatment|1|||
129528643|NCT00542425|466221860|FG000|Initial 24 Weeks|Other|0|||
129528644|NCT00542425|466221861|FG001|Initial 24 Weeks|Other|2|||
129528645|NCT00542425|466221862|FG002|Initial 24 Weeks|Other|1|||
129528646|NCT00542425|466221863|FG003|Initial 24 Weeks|Other|0|||
129528647|NCT00542425|466221864|FG004|Initial 24 Weeks|Other|0|||
129528648|NCT00542425|466221860|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
129528649|NCT00542425|466221861|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
129528650|NCT00542425|466221862|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
129528651|NCT00542425|466221863|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
129528652|NCT00542425|466221864|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
129528653|NCT00542425|466221860|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
129528654|NCT00542425|466221861|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
129528655|NCT00542425|466221862|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
129528656|NCT00542425|466221863|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
129528657|NCT00542425|466221864|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
129528658|NCT00542425|466221860|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
129528659|NCT00542425|466221861|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
129528660|NCT00542425|466221862|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
129528661|NCT00542425|466221863|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
129528662|NCT00542425|466221864|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
129528663|NCT00542425|466221860|FG000|Extended 24 Weeks of Treatment|Other|1|||
129528664|NCT00542425|466221861|FG001|Extended 24 Weeks of Treatment|Other|1|||
129528665|NCT00542425|466221862|FG002|Extended 24 Weeks of Treatment|Other|0|||
129528666|NCT00542425|466221863|FG003|Extended 24 Weeks of Treatment|Other|0|||
129528667|NCT00542425|466221864|FG004|Extended 24 Weeks of Treatment|Other|1|||
129528668|NCT01601873|466221865|FG000|Overall Study|Lost to Follow-up|2|||
129528669|NCT01601873|466221866|FG001|Overall Study|Lost to Follow-up|3|||
129528670|NCT02096471|466221867|FG000|Overall Study|Adverse Event|1|||
129528671|NCT02096471|466221867|FG000|Overall Study|Lack of Efficacy|7|||
129528672|NCT02096471|466221867|FG000|Overall Study|Withdrawal by Subject|3|||
129528673|NCT02096471|466221867|FG000|Overall Study|Non-Compliant|2|||
129528674|NCT02449915|466221868|FG000|Overall Study|Exclusion criteria - drug use|1|||
129528675|NCT02449915|466221869|FG001|Overall Study|Exclusion criteria - drug use|0|||
129528676|NCT02449915|466221868|FG000|Overall Study|Withdrawal by Subject|0|||
129528677|NCT02449915|466221869|FG001|Overall Study|Withdrawal by Subject|2|||
129528678|NCT02449915|466221868|FG000|Overall Study|Intraoperative surgical findings|1|||
129528679|NCT02449915|466221869|FG001|Overall Study|Intraoperative surgical findings|1|||
129528680|NCT02449915|466221868|FG000|Overall Study|Abnormal preop lab|0|||
129528681|NCT02449915|466221869|FG001|Overall Study|Abnormal preop lab|1|||
129528682|NCT03455530|466224071|FG000|Overall Study|Withdrawal by Subject|9|||
129528683|NCT03455530|466224072|FG001|Overall Study|Withdrawal by Subject|1|||
129528684|NCT03455530|466224073|FG002|Overall Study|Withdrawal by Subject|3|||
129528685|NCT03455530|466224074|FG003|Overall Study|Withdrawal by Subject|3|||
129528686|NCT01592773|466224079|FG000|Overall Study|Study Terminated by Sponsor|582|||
129528687|NCT01592773|466224079|FG000|Overall Study|Withdrawal by Subject|35|||
129528688|NCT01592773|466224079|FG000|Overall Study|Lost to Follow-up|19|||
129528689|NCT01592773|466224079|FG000|Overall Study|Adverse Event|17|||
129528690|NCT01592773|466224079|FG000|Overall Study|Lack of Efficacy|9|||
129528691|NCT01592773|466224079|FG000|Overall Study|Protocol Violation|2|||
129528692|NCT01592773|466224079|FG000|Overall Study|Inclusion/exclusion not meet|1|||
129528693|NCT01592773|466224079|FG000|Overall Study|Other Reason|1|||
129528694|NCT00740116|466224084|FG000|Overall Study|Withdrawal by Subject|1|||
129528695|NCT00740116|466224085|FG001|Overall Study|Withdrawal by Subject|1|||
129528696|NCT00740116|466224084|FG000|Overall Study|Protocol Violation|1|||
129528697|NCT00740116|466224085|FG001|Overall Study|Protocol Violation|4|||
129528698|NCT03037489|466224086|FG000|Overall Study|Adverse Event|4|||
129528699|NCT03037489|466224087|FG001|Overall Study|Adverse Event|0|||
129528700|NCT03037489|466224086|FG000|Overall Study|Withdrawal by Subject|3|||
129528701|NCT03037489|466224087|FG001|Overall Study|Withdrawal by Subject|0|||
129528702|NCT00621764|466224088|FG000|Overall Study|Protocol Violation|0|||
129528703|NCT00621764|466224089|FG001|Overall Study|Protocol Violation|0|||
129528704|NCT00621764|466224090|FG002|Overall Study|Protocol Violation|0|||
129528705|NCT00621764|466224091|FG003|Overall Study|Protocol Violation|1|||
129528706|NCT02499172|466224092|FG000|Overall Study|Financial reason|0|||
129528707|NCT02499172|466224093|FG001|Overall Study|Financial reason|0|||
129528708|NCT02499172|466224094|FG002|Overall Study|Financial reason|523|||
129528709|NCT02499172|466224095|FG003|Overall Study|Financial reason|436|||
129528710|NCT02499172|466224092|FG000|Overall Study|Lost to Follow-up|65|||
129528711|NCT02499172|466224093|FG001|Overall Study|Lost to Follow-up|64|||
129528712|NCT02499172|466224094|FG002|Overall Study|Lost to Follow-up|0|||
129528713|NCT02499172|466224095|FG003|Overall Study|Lost to Follow-up|0|||
129528714|NCT01293123|466224096|FG000|Overall Study|Lost to Follow-up|0|||
129528715|NCT01293123|466224097|FG001|Overall Study|Lost to Follow-up|1|||
129528716|NCT00121485|466224098|FG000|Overall Study|Not implanted|1|||
129528717|NCT00121485|466224099|FG001|Overall Study|Not implanted|5|||
129528718|NCT00121485|466224098|FG000|Overall Study|Crossover|0|||
129528719|NCT00121485|466224099|FG001|Overall Study|Crossover|2|||
129528720|NCT00724243|466224102|FG000|Overall Study|Lack of Efficacy|10|||
129528721|NCT00724243|466224102|FG000|Overall Study|Adverse Event|5|||
129528722|NCT03031327|466224105|FG000|Overall Study|Withdrawal by Subject|0|||
129528723|NCT03031327|466224106|FG001|Overall Study|Withdrawal by Subject|1|||
129528724|NCT03031327|466224107|FG002|Overall Study|Withdrawal by Subject|1|||
129528725|NCT00211536|466224108|FG000|Overall Study|Withdrawal by Subject|2|||
129528726|NCT00211536|466224109|FG001|Overall Study|Withdrawal by Subject|2|||
129528727|NCT00211536|466224108|FG000|Overall Study|Physician Decision|0|||
129528728|NCT00211536|466224109|FG001|Overall Study|Physician Decision|5|||
129528729|NCT00211536|466224108|FG000|Overall Study|Adverse Event|2|||
129528730|NCT00211536|466224109|FG001|Overall Study|Adverse Event|0|||
129528731|NCT00003389|466224110|FG000|Overall Study|Disease progression|6|||
129528732|NCT00003389|466224111|FG001|Overall Study|Disease progression|1|||
129528733|NCT00003389|466224110|FG000|Overall Study|Adverse Event|13|||
129528734|NCT00003389|466224111|FG001|Overall Study|Adverse Event|2|||
129528735|NCT00003389|466224110|FG000|Overall Study|Death|0|||
129528736|NCT00003389|466224111|FG001|Overall Study|Death|3|||
129528737|NCT00003389|466224110|FG000|Overall Study|Withdrawal by Subject|12|||
129528738|NCT00003389|466224111|FG001|Overall Study|Withdrawal by Subject|5|||
129528739|NCT00003389|466224110|FG000|Overall Study|Alternative therapy|2|||
129528740|NCT00003389|466224111|FG001|Overall Study|Alternative therapy|1|||
129528741|NCT00003389|466224110|FG000|Overall Study|Complicating disease|1|||
129528742|NCT00003389|466224111|FG001|Overall Study|Complicating disease|0|||
129528743|NCT00003389|466224110|FG000|Overall Study|Off-treatment reason missing|31|||
129528744|NCT00003389|466224111|FG001|Overall Study|Off-treatment reason missing|21|||
129528745|NCT00003389|466224110|FG000|Overall Study|Ineligible|33|||
129528746|NCT00003389|466224111|FG001|Overall Study|Ineligible|27|||
129528747|NCT01997892|466224114|FG000|Overall Study|Physician Decision|2|||
129528748|NCT01997892|466224114|FG000|Overall Study|Lost to Follow-up|6|||
129528749|NCT01997892|466224114|FG000|Overall Study|Death|14|||
129528750|NCT01997892|466224114|FG000|Overall Study|Renal transplant|8|||
129528751|NCT01997892|466224114|FG000|Overall Study|Other|3|||
129528752|NCT01997892|466224114|FG000|Overall Study|Study completion data not recorded|35|||
129528753|NCT02710422|466224115|FG000|Overall Study|Termination of study|9|||
129528754|NCT02710422|466224116|FG001|Overall Study|Termination of study|9|||
129528755|NCT02608099|466224136|FG000|Overall Study|Ablation procedure not initiated|3|||
129528756|NCT02608099|466224137|FG001|Overall Study|Ablation procedure not initiated|2|||
129528757|NCT04657003|466224143|FG000|Overall Study|Adverse Event|5|||
129528758|NCT04657003|466224144|FG001|Overall Study|Adverse Event|1|||
129528759|NCT04657003|466224145|FG002|Overall Study|Adverse Event|5|||
129528760|NCT04657003|466224143|FG000|Overall Study|Death|0|||
129528761|NCT04657003|466224144|FG001|Overall Study|Death|2|||
129528762|NCT04657003|466224145|FG002|Overall Study|Death|0|||
129528763|NCT04657003|466224143|FG000|Overall Study|Lost to Follow-up|8|||
129528764|NCT04657003|466224144|FG001|Overall Study|Lost to Follow-up|4|||
129528765|NCT04657003|466224145|FG002|Overall Study|Lost to Follow-up|10|||
129528766|NCT04657003|466224143|FG000|Overall Study|Other - As Reported by Investigator|3|||
129528767|NCT04657003|466224144|FG001|Overall Study|Other - As Reported by Investigator|2|||
129528768|NCT04657003|466224145|FG002|Overall Study|Other - As Reported by Investigator|2|||
129528769|NCT04657003|466224143|FG000|Overall Study|Pregnancy|2|||
129528770|NCT04657003|466224144|FG001|Overall Study|Pregnancy|0|||
129528771|NCT04657003|466224145|FG002|Overall Study|Pregnancy|2|||
129528772|NCT04657003|466224143|FG000|Overall Study|Withdrawal by Subject|16|||
129528773|NCT04657003|466224144|FG001|Overall Study|Withdrawal by Subject|7|||
129528774|NCT04657003|466224145|FG002|Overall Study|Withdrawal by Subject|10|||
129528775|NCT01736176|466224146|FG000|Overall Study|Adverse Event|3|||
129528776|NCT01736176|466224146|FG000|Overall Study|Withdrawal by Subject|4|||
129528777|NCT01736176|466224146|FG000|Overall Study|Lack of Efficacy|3|||
129528778|NCT01736176|466224146|FG000|Overall Study|Unable to Complete PEG Placement|1|||
129528779|NCT00417248|466224147|FG000|Overall Study|Study Terminated|6|||
129528780|NCT00417248|466224147|FG000|Overall Study|Death|1|||
129528781|NCT00417248|466224147|FG000|Overall Study|Lack of Efficacy|1|||
129528782|NCT00934791|466224148|FG000|Overall Study|Withdrawal by Subject|1|||
129528783|NCT00934791|466224149|FG001|Overall Study|Withdrawal by Subject|0|||
129528784|NCT03763942|466224150|FG000|Overall Study|Lost to Follow-up|114|||
129528785|NCT03763942|466224151|FG001|Overall Study|Lost to Follow-up|54|||
129528786|NCT03763942|466224150|FG000|Overall Study|Protocol Violation|1|||
129528787|NCT03763942|466224151|FG001|Overall Study|Protocol Violation|0|||
129528788|NCT03763942|466224150|FG000|Overall Study|Withdrawal by Subject|2|||
129528789|NCT03763942|466224151|FG001|Overall Study|Withdrawal by Subject|0|||
129528790|NCT03763942|466224150|FG000|Overall Study|Other|2|||
129528791|NCT03763942|466224151|FG001|Overall Study|Other|3|||
129528792|NCT02646891|466224152|FG000|Overall Study|Adverse Event|0|||
129528793|NCT02646891|466224153|FG001|Overall Study|Adverse Event|1|||
129528794|NCT02646891|466224154|FG002|Overall Study|Adverse Event|0|||
129528795|NCT02646891|466224155|FG003|Overall Study|Adverse Event|0|||
129528796|NCT02646891|466224156|FG004|Overall Study|Adverse Event|0|||
129528797|NCT02646891|466224157|FG005|Overall Study|Adverse Event|0|||
129528798|NCT02646891|466224158|FG006|Overall Study|Adverse Event|0|||
129528799|NCT02646891|466224159|FG007|Overall Study|Adverse Event|0|||
129528800|NCT02646891|466224160|FG008|Overall Study|Adverse Event|0|||
129528801|NCT02646891|466224161|FG009|Overall Study|Adverse Event|0|||
129528802|NCT02646891|466224152|FG000|Overall Study|Lost to Follow-up|0|||
129528803|NCT02646891|466224153|FG001|Overall Study|Lost to Follow-up|0|||
129528804|NCT02646891|466224154|FG002|Overall Study|Lost to Follow-up|0|||
129528805|NCT02646891|466224155|FG003|Overall Study|Lost to Follow-up|0|||
129528806|NCT02646891|466224156|FG004|Overall Study|Lost to Follow-up|0|||
129528807|NCT02646891|466224157|FG005|Overall Study|Lost to Follow-up|0|||
129528808|NCT02646891|466224158|FG006|Overall Study|Lost to Follow-up|2|||
129528809|NCT02646891|466224159|FG007|Overall Study|Lost to Follow-up|2|||
129528810|NCT02646891|466224160|FG008|Overall Study|Lost to Follow-up|2|||
129528811|NCT02646891|466224161|FG009|Overall Study|Lost to Follow-up|2|||
129528812|NCT02646891|466224152|FG000|Overall Study|Protocol Violation|0|||
129528813|NCT02646891|466224153|FG001|Overall Study|Protocol Violation|0|||
129528814|NCT02646891|466224154|FG002|Overall Study|Protocol Violation|0|||
129528815|NCT02646891|466224155|FG003|Overall Study|Protocol Violation|0|||
129528816|NCT02646891|466224156|FG004|Overall Study|Protocol Violation|0|||
129528817|NCT02646891|466224157|FG005|Overall Study|Protocol Violation|0|||
129528818|NCT02646891|466224158|FG006|Overall Study|Protocol Violation|1|||
129528819|NCT02646891|466224159|FG007|Overall Study|Protocol Violation|1|||
129528820|NCT02646891|466224160|FG008|Overall Study|Protocol Violation|0|||
129528821|NCT02646891|466224161|FG009|Overall Study|Protocol Violation|0|||
129528822|NCT02646891|466224152|FG000|Overall Study|Withdrawal by Subject|2|||
129528823|NCT02646891|466224153|FG001|Overall Study|Withdrawal by Subject|0|||
129528824|NCT02646891|466224154|FG002|Overall Study|Withdrawal by Subject|1|||
129528825|NCT02646891|466224155|FG003|Overall Study|Withdrawal by Subject|0|||
129528826|NCT02646891|466224156|FG004|Overall Study|Withdrawal by Subject|0|||
129528827|NCT02646891|466224157|FG005|Overall Study|Withdrawal by Subject|0|||
129528828|NCT02646891|466224158|FG006|Overall Study|Withdrawal by Subject|5|||
129528829|NCT02646891|466224159|FG007|Overall Study|Withdrawal by Subject|9|||
129528830|NCT02646891|466224160|FG008|Overall Study|Withdrawal by Subject|7|||
129528831|NCT02646891|466224161|FG009|Overall Study|Withdrawal by Subject|3|||
129528832|NCT02646891|466224152|FG000|Overall Study|Death|0|||
129528833|NCT02646891|466224153|FG001|Overall Study|Death|0|||
129528834|NCT02646891|466224154|FG002|Overall Study|Death|0|||
129528835|NCT02646891|466224155|FG003|Overall Study|Death|0|||
129528836|NCT02646891|466224156|FG004|Overall Study|Death|0|||
129528837|NCT02646891|466224157|FG005|Overall Study|Death|0|||
129528838|NCT02646891|466224158|FG006|Overall Study|Death|1|||
129528839|NCT02646891|466224159|FG007|Overall Study|Death|1|||
129528840|NCT02646891|466224160|FG008|Overall Study|Death|1|||
129528841|NCT02646891|466224161|FG009|Overall Study|Death|0|||
129528842|NCT02274311|466224162|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
129528843|NCT01599585|466224163|FG000|Overall Study|Withdrawal by Subject|16|||
129528844|NCT01599585|466224164|FG001|Overall Study|Withdrawal by Subject|9|||
129528845|NCT01599585|466224163|FG000|Overall Study|Lost to Follow-up|3|||
129528846|NCT01599585|466224164|FG001|Overall Study|Lost to Follow-up|5|||
129528847|NCT01599585|466224163|FG000|Overall Study|randomized did not start treatment|3|||
129528848|NCT01599585|466224164|FG001|Overall Study|randomized did not start treatment|3|||
129528849|NCT00853112|466224165|FG000|Overall Study|Randomized but not treated|0|||
129528850|NCT00853112|466224166|FG001|Overall Study|Randomized but not treated|1|||
129528851|NCT00853112|466224167|FG002|Overall Study|Randomized but not treated|0|||
129528852|NCT00853112|466224168|FG003|Overall Study|Randomized but not treated|2|||
129528853|NCT00853112|466224169|FG004|Overall Study|Randomized but not treated|0|||
129528854|NCT00853112|466224170|FG005|Overall Study|Randomized but not treated|0|||
129528855|NCT00853112|466224171|FG006|Overall Study|Randomized but not treated|1|||
129528856|NCT00811395|466224176|FG000|Extension Treatment|Adverse Event|1|||
129528857|NCT00811395|466224177|FG001|Extension Treatment|Adverse Event|2|||
129528858|NCT00811395|466224178|FG002|Extension Treatment|Adverse Event|2|||
129528859|NCT00811395|466224179|FG003|Extension Treatment|Adverse Event|2|||
129528860|NCT00811395|466224180|FG004|Extension Treatment|Adverse Event|0|||
129528861|NCT00811395|466224181|FG005|Extension Treatment|Adverse Event|1|||
129528862|NCT00811395|466224176|FG000|Extension Treatment|Progressive disease|1|||
129528863|NCT00811395|466224177|FG001|Extension Treatment|Progressive disease|1|||
129528864|NCT00811395|466224178|FG002|Extension Treatment|Progressive disease|0|||
129528865|NCT00811395|466224179|FG003|Extension Treatment|Progressive disease|0|||
129528866|NCT00811395|466224180|FG004|Extension Treatment|Progressive disease|0|||
129528867|NCT00811395|466224181|FG005|Extension Treatment|Progressive disease|0|||
129528868|NCT00811395|466224176|FG000|Extension Treatment|Participant did not wish to continue|0|||
129528869|NCT00811395|466224177|FG001|Extension Treatment|Participant did not wish to continue|3|||
129528870|NCT00811395|466224178|FG002|Extension Treatment|Participant did not wish to continue|0|||
129528871|NCT00811395|466224179|FG003|Extension Treatment|Participant did not wish to continue|1|||
129528872|NCT00811395|466224180|FG004|Extension Treatment|Participant did not wish to continue|0|||
129528873|NCT00811395|466224181|FG005|Extension Treatment|Participant did not wish to continue|1|||
129528874|NCT00811395|466224176|FG000|Extension Treatment|Other than above|0|||
129528875|NCT00811395|466224177|FG001|Extension Treatment|Other than above|0|||
129528876|NCT00811395|466224178|FG002|Extension Treatment|Other than above|1|||
129528877|NCT00811395|466224179|FG003|Extension Treatment|Other than above|0|||
129528878|NCT00811395|466224180|FG004|Extension Treatment|Other than above|0|||
129528879|NCT00811395|466224181|FG005|Extension Treatment|Other than above|0|||
129528880|NCT00170846|466224188|FG000|Overall Study|Subject withdrew Informed Consent|5|||
129528881|NCT00170846|466224189|FG001|Overall Study|Subject withdrew Informed Consent|12|||
129528882|NCT00170846|466224190|FG002|Overall Study|Subject withdrew Informed Consent|8|||
129528883|NCT00170846|466224188|FG000|Overall Study|Lost to Follow-up|6|||
129528884|NCT00170846|466224189|FG001|Overall Study|Lost to Follow-up|3|||
129528885|NCT00170846|466224190|FG002|Overall Study|Lost to Follow-up|2|||
129528886|NCT00170846|466224188|FG000|Overall Study|Death|0|||
129528887|NCT00170846|466224189|FG001|Overall Study|Death|3|||
129528888|NCT00170846|466224190|FG002|Overall Study|Death|3|||
129528889|NCT00170846|466224188|FG000|Overall Study|Reason Missing|0|||
129528890|NCT00170846|466224189|FG001|Overall Study|Reason Missing|1|||
129528891|NCT00170846|466224190|FG002|Overall Study|Reason Missing|0|||
129528892|NCT00118040|466224191|FG000|Overall Study|Adverse Event|0|||
129528893|NCT00118040|466224192|FG001|Overall Study|Adverse Event|1|||
129528894|NCT00118040|466224193|FG002|Overall Study|Adverse Event|0|||
129528895|NCT00118040|466224191|FG000|Overall Study|Withdrawal by Subject|0|||
129528896|NCT00118040|466224192|FG001|Overall Study|Withdrawal by Subject|0|||
129528897|NCT00118040|466224193|FG002|Overall Study|Withdrawal by Subject|2|||
129528898|NCT00118040|466224191|FG000|Overall Study|Medical Contraindication|0|||
129528899|NCT00118040|466224192|FG001|Overall Study|Medical Contraindication|0|||
129528900|NCT00118040|466224193|FG002|Overall Study|Medical Contraindication|1|||
129528901|NCT00118040|466224191|FG000|Overall Study|Non-Compliant Participant|1|||
129528902|NCT00118040|466224192|FG001|Overall Study|Non-Compliant Participant|1|||
129528903|NCT00118040|466224193|FG002|Overall Study|Non-Compliant Participant|2|||
129528904|NCT00118040|466224191|FG000|Overall Study|Other|0|||
129528905|NCT00118040|466224192|FG001|Overall Study|Other|0|||
129528906|NCT00118040|466224193|FG002|Overall Study|Other|1|||
129528907|NCT02607865|466224196|FG000|Overall Study|Lost to Follow-up|9|||
129528908|NCT02607865|466224197|FG001|Overall Study|Lost to Follow-up|7|||
129528909|NCT02607865|466224198|FG002|Overall Study|Lost to Follow-up|7|||
129528910|NCT02607865|466224199|FG003|Overall Study|Lost to Follow-up|5|||
129528911|NCT02607865|466224196|FG000|Overall Study|Withdrawal by Subject|18|||
129528912|NCT02607865|466224197|FG001|Overall Study|Withdrawal by Subject|18|||
129528913|NCT02607865|466224198|FG002|Overall Study|Withdrawal by Subject|17|||
129528914|NCT02607865|466224199|FG003|Overall Study|Withdrawal by Subject|8|||
129528915|NCT02607865|466224196|FG000|Overall Study|Death|5|||
129528916|NCT02607865|466224197|FG001|Overall Study|Death|4|||
129528917|NCT02607865|466224198|FG002|Overall Study|Death|1|||
129528918|NCT02607865|466224199|FG003|Overall Study|Death|3|||
129528919|NCT02607865|466224196|FG000|Overall Study|Unclassified|1|||
129528920|NCT02607865|466224197|FG001|Overall Study|Unclassified|1|||
129528921|NCT02607865|466224198|FG002|Overall Study|Unclassified|2|||
129528922|NCT02607865|466224199|FG003|Overall Study|Unclassified|0|||
129528923|NCT00528840|466224200|FG000|Overall Study|Lost to Follow-up|10|||
129528924|NCT00528840|466224200|FG000|Overall Study|Adverse Event|1|||
129528925|NCT00528840|466224200|FG000|Overall Study|Withdrawal by Subject|17|||
129528926|NCT00528840|466224200|FG000|Overall Study|Death|2|||
129528927|NCT00528840|466224200|FG000|Overall Study|Administrative Reasons|1|||
129528928|NCT00528840|466224200|FG000|Overall Study|Other|2|||
129528929|NCT01970540|466224201|FG000|Overall Study|Non-treatment-related AE|0|||
129528930|NCT01970540|466224202|FG001|Overall Study|Non-treatment-related AE|0|||
129528931|NCT01970540|466224203|FG002|Overall Study|Non-treatment-related AE|1|||
129528932|NCT01970540|466224201|FG000|Overall Study|Progressive disease|55|||
129528933|NCT01970540|466224202|FG001|Overall Study|Progressive disease|23|||
129528934|NCT01970540|466224203|FG002|Overall Study|Progressive disease|10|||
129528935|NCT01970540|466224201|FG000|Overall Study|Treatment delay over protocol|0|||
129528936|NCT01970540|466224202|FG001|Overall Study|Treatment delay over protocol|0|||
129528937|NCT01970540|466224203|FG002|Overall Study|Treatment delay over protocol|1|||
129528938|NCT01970540|466224201|FG000|Overall Study|Physician Decision|7|||
129528939|NCT01970540|466224202|FG001|Overall Study|Physician Decision|2|||
129528940|NCT01970540|466224203|FG002|Overall Study|Physician Decision|0|||
129528941|NCT01970540|466224201|FG000|Overall Study|Clinical progression|0|||
129528942|NCT01970540|466224202|FG001|Overall Study|Clinical progression|1|||
129528943|NCT01970540|466224203|FG002|Overall Study|Clinical progression|1|||
129528944|NCT01970540|466224201|FG000|Overall Study|End of study|2|||
129528945|NCT01970540|466224202|FG001|Overall Study|End of study|0|||
129528946|NCT01970540|466224203|FG002|Overall Study|End of study|2|||
129528947|NCT01970540|466224201|FG000|Overall Study|Adverse Event|0|||
129528948|NCT01970540|466224202|FG001|Overall Study|Adverse Event|2|||
129528949|NCT01970540|466224203|FG002|Overall Study|Adverse Event|1|||
129528950|NCT01970540|466224201|FG000|Overall Study|Treatment-related AE|4|||
129528951|NCT01970540|466224202|FG001|Overall Study|Treatment-related AE|0|||
129528952|NCT01970540|466224203|FG002|Overall Study|Treatment-related AE|2|||
129528953|NCT01970540|466224201|FG000|Overall Study|Withdrawal by Subject|4|||
129528954|NCT01970540|466224202|FG001|Overall Study|Withdrawal by Subject|0|||
129528955|NCT01970540|466224203|FG002|Overall Study|Withdrawal by Subject|1|||
129528956|NCT01970540|466224201|FG000|Overall Study|Clinical deterioration|1|||
129528957|NCT01970540|466224202|FG001|Overall Study|Clinical deterioration|0|||
129528958|NCT01970540|466224203|FG002|Overall Study|Clinical deterioration|0|||
129528959|NCT01756833|466224212|FG000|Overall Study|Withdrawal by Subject|4|||
129528960|NCT01756833|466224213|FG001|Overall Study|Withdrawal by Subject|3|||
129528961|NCT00952588|466224214|FG000|Overall Study|Death|28|||
129528962|NCT00952588|466224215|FG001|Overall Study|Death|13|||
129528963|NCT00952588|466224214|FG000|Overall Study|Withdrawal by Subject|2|||
129528964|NCT00952588|466224215|FG001|Overall Study|Withdrawal by Subject|5|||
129528965|NCT00952588|466224214|FG000|Overall Study|Adverse Event|2|||
129528966|NCT00952588|466224215|FG001|Overall Study|Adverse Event|3|||
129528967|NCT00952588|466224214|FG000|Overall Study|Lost to Follow-up|2|||
129528968|NCT00952588|466224215|FG001|Overall Study|Lost to Follow-up|0|||
129528969|NCT00952588|466224214|FG000|Overall Study|Physician Decision|0|||
129528970|NCT00952588|466224215|FG001|Overall Study|Physician Decision|1|||
129528971|NCT00952588|466224214|FG000|Overall Study|Lack of Efficacy|2|||
129528972|NCT00952588|466224215|FG001|Overall Study|Lack of Efficacy|2|||
129528973|NCT01796106|466224216|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
129528974|NCT01796106|466224217|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
129528975|NCT01766401|466224218|FG000|Overall Study|Adverse Event|7|||
129528976|NCT01766401|466224219|FG001|Overall Study|Adverse Event|22|||
129528977|NCT01766401|466224218|FG000|Overall Study|Lack of Efficacy|1|||
129528978|NCT01766401|466224219|FG001|Overall Study|Lack of Efficacy|2|||
129528979|NCT01766401|466224218|FG000|Overall Study|Protocol Violation|3|||
129528980|NCT01766401|466224219|FG001|Overall Study|Protocol Violation|8|||
129528981|NCT01766401|466224218|FG000|Overall Study|Withdrawal by Subject|15|||
129528982|NCT01766401|466224219|FG001|Overall Study|Withdrawal by Subject|12|||
129528983|NCT01766401|466224218|FG000|Overall Study|Lost to Follow-up|10|||
129528984|NCT01766401|466224219|FG001|Overall Study|Lost to Follow-up|11|||
129528985|NCT01766401|466224218|FG000|Overall Study|Pregnancy|1|||
129528986|NCT01766401|466224219|FG001|Overall Study|Pregnancy|1|||
129528987|NCT02795182|466224223|FG000|Overall Study|Death|5|||
129528988|NCT02795182|466224224|FG001|Overall Study|Death|4|||
129528989|NCT02795182|466224225|FG002|Overall Study|Death|4|||
129528990|NCT02795182|466224226|FG003|Overall Study|Death|18|||
129528991|NCT02795182|466224223|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
129528992|NCT02795182|466224224|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
129528993|NCT02795182|466224225|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
129528994|NCT02795182|466224226|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
129528995|NCT02795182|466224223|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
129528996|NCT02795182|466224224|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
129528997|NCT02795182|466224225|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
129528998|NCT02795182|466224226|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
129528999|NCT02795182|466224223|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
129529000|NCT02795182|466224224|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
129529001|NCT02795182|466224225|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
129529002|NCT02795182|466224226|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
129529003|NCT02795182|466224223|FG000|Overall Study|Withdrawal by Subject|4|||
129529004|NCT02795182|466224224|FG001|Overall Study|Withdrawal by Subject|0|||
129529005|NCT02795182|466224225|FG002|Overall Study|Withdrawal by Subject|0|||
129529006|NCT02795182|466224226|FG003|Overall Study|Withdrawal by Subject|3|||
129529007|NCT02795182|466224223|FG000|Overall Study|Lost to Follow-up|0|||
129529008|NCT02795182|466224224|FG001|Overall Study|Lost to Follow-up|0|||
129529009|NCT02795182|466224225|FG002|Overall Study|Lost to Follow-up|1|||
129529010|NCT02795182|466224226|FG003|Overall Study|Lost to Follow-up|1|||
129529011|NCT02795182|466224223|FG000|Overall Study|Roll Over to Long Term Extension|3|||
129529012|NCT02795182|466224224|FG001|Overall Study|Roll Over to Long Term Extension|3|||
129529013|NCT02795182|466224225|FG002|Overall Study|Roll Over to Long Term Extension|2|||
129529014|NCT02795182|466224226|FG003|Overall Study|Roll Over to Long Term Extension|5|||
129529015|NCT02795182|466224223|FG000|Overall Study|Progressive Disease|0|||
129529016|NCT02795182|466224224|FG001|Overall Study|Progressive Disease|1|||
129529017|NCT02795182|466224225|FG002|Overall Study|Progressive Disease|0|||
129529018|NCT02795182|466224226|FG003|Overall Study|Progressive Disease|4|||
129529019|NCT02795182|466224223|FG000|Overall Study|Physician Decision|0|||
129529020|NCT02795182|466224224|FG001|Overall Study|Physician Decision|0|||
129529021|NCT02795182|466224225|FG002|Overall Study|Physician Decision|0|||
129529022|NCT02795182|466224226|FG003|Overall Study|Physician Decision|1|||
129529023|NCT00398086|466224228|FG000|Overall Study|Unacceptable Toxicity|2|||
129529024|NCT00398086|466224229|FG001|Overall Study|Unacceptable Toxicity|8|||
129529025|NCT00398086|466224230|FG002|Overall Study|Unacceptable Toxicity|2|||
129529026|NCT00398086|466224228|FG000|Overall Study|Adverse Event|1|||
129529027|NCT00398086|466224229|FG001|Overall Study|Adverse Event|4|||
129529028|NCT00398086|466224230|FG002|Overall Study|Adverse Event|0|||
129529029|NCT00398086|466224228|FG000|Overall Study|Physician Decision|1|||
129529030|NCT00398086|466224229|FG001|Overall Study|Physician Decision|4|||
129529031|NCT00398086|466224230|FG002|Overall Study|Physician Decision|0|||
129529032|NCT00398086|466224228|FG000|Overall Study|Withdrawal by Subject|5|||
129529033|NCT00398086|466224229|FG001|Overall Study|Withdrawal by Subject|7|||
129529034|NCT00398086|466224230|FG002|Overall Study|Withdrawal by Subject|0|||
129529035|NCT01021553|466224231|FG000|Overall Study|Adverse Event|1|||
129529036|NCT01021553|466224232|FG001|Overall Study|Adverse Event|0|||
129529037|NCT01021553|466224233|FG002|Overall Study|Adverse Event|0|||
129529038|NCT01021553|466224231|FG000|Overall Study|Lack of Efficacy|2|||
129529039|NCT01021553|466224232|FG001|Overall Study|Lack of Efficacy|2|||
129529040|NCT01021553|466224233|FG002|Overall Study|Lack of Efficacy|0|||
129529041|NCT01021553|466224231|FG000|Overall Study|Protocol Violation|0|||
129529042|NCT01021553|466224232|FG001|Overall Study|Protocol Violation|2|||
129529043|NCT01021553|466224233|FG002|Overall Study|Protocol Violation|2|||
129529044|NCT01021553|466224231|FG000|Overall Study|Lost to Follow-up|0|||
129529045|NCT01021553|466224232|FG001|Overall Study|Lost to Follow-up|0|||
129529046|NCT01021553|466224233|FG002|Overall Study|Lost to Follow-up|1|||
129529047|NCT01021553|466224231|FG000|Overall Study|Withdrawal by Subject|1|||
129529048|NCT01021553|466224232|FG001|Overall Study|Withdrawal by Subject|1|||
129529049|NCT01021553|466224233|FG002|Overall Study|Withdrawal by Subject|0|||
129529050|NCT01950364|466224234|FG000|Overall Study|Adverse Event|3|||
129529051|NCT01950364|466224235|FG001|Overall Study|Adverse Event|0|||
129529052|NCT01950364|466224234|FG000|Overall Study|Stem Cell Transplant|2|||
129529053|NCT01950364|466224235|FG001|Overall Study|Stem Cell Transplant|6|||
129529054|NCT01950364|466224234|FG000|Overall Study|Disease Progression|5|||
129529055|NCT01950364|466224235|FG001|Overall Study|Disease Progression|2|||
129529056|NCT01950364|466224234|FG000|Overall Study|Withdrawal by Subject|0|||
129529057|NCT01950364|466224235|FG001|Overall Study|Withdrawal by Subject|1|||
129529058|NCT01950364|466224234|FG000|Overall Study|Protocol Violation|0|||
129529059|NCT01950364|466224235|FG001|Overall Study|Protocol Violation|1|||
129529060|NCT00033293|466224236|FG000|Overall Study|Death|0|||
129529061|NCT00033293|466224237|FG001|Overall Study|Death|1|||
129529062|NCT00033293|466224236|FG000|Overall Study|Lack of Efficacy|5|||
129529063|NCT00033293|466224237|FG001|Overall Study|Lack of Efficacy|8|||
129529064|NCT00033293|466224236|FG000|Overall Study|Lost to Follow-up|0|||
129529065|NCT00033293|466224237|FG001|Overall Study|Lost to Follow-up|1|||
129529066|NCT00033293|466224236|FG000|Overall Study|Physician Decision|3|||
129529067|NCT00033293|466224237|FG001|Overall Study|Physician Decision|1|||
129529068|NCT00033293|466224236|FG000|Overall Study|Withdrawal by Subject|1|||
129529069|NCT00033293|466224237|FG001|Overall Study|Withdrawal by Subject|0|||
129529070|NCT00033293|466224236|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
129529071|NCT00033293|466224237|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
129529072|NCT00033293|466224236|FG000|Overall Study|Treatment refused|0|||
129529073|NCT00033293|466224237|FG001|Overall Study|Treatment refused|6|||
129529074|NCT00935701|466224238|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
129529075|NCT01700140|466224239|FG000|Overall Study|Use of rescue drugs|3|||
129529076|NCT01700140|466224240|FG001|Overall Study|Use of rescue drugs|3|||
129529077|NCT01700140|466224241|FG002|Overall Study|Use of rescue drugs|1|||
129529078|NCT01700140|466224239|FG000|Overall Study|Discontinuation of radiotherapy|1|||
129529079|NCT01700140|466224240|FG001|Overall Study|Discontinuation of radiotherapy|0|||
129529080|NCT01700140|466224241|FG002|Overall Study|Discontinuation of radiotherapy|0|||
129529081|NCT01700140|466224239|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
129529082|NCT01700140|466224240|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
129529083|NCT01700140|466224241|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
129529084|NCT01700140|466224239|FG000|Overall Study|Aggravation of symptoms|1|||
129529085|NCT01700140|466224240|FG001|Overall Study|Aggravation of symptoms|0|||
129529086|NCT01700140|466224241|FG002|Overall Study|Aggravation of symptoms|0|||
129529087|NCT01700140|466224239|FG000|Overall Study|Adverse Event|0|||
129529088|NCT01700140|466224240|FG001|Overall Study|Adverse Event|1|||
129529089|NCT01700140|466224241|FG002|Overall Study|Adverse Event|0|||
129529090|NCT01700140|466224239|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
129529091|NCT01700140|466224240|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
129529092|NCT01700140|466224241|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
129529093|NCT02573012|466224242|FG000|Overall Study|Adverse Event|5|||
129529094|NCT02573012|466224243|FG001|Overall Study|Adverse Event|5|||
129529095|NCT02573012|466224242|FG000|Overall Study|Lack of Efficacy|5|||
129529096|NCT02573012|466224243|FG001|Overall Study|Lack of Efficacy|4|||
129529097|NCT02573012|466224242|FG000|Overall Study|Non-compliance|1|||
129529098|NCT02573012|466224243|FG001|Overall Study|Non-compliance|2|||
129529099|NCT02573012|466224242|FG000|Overall Study|Withdrawal by Subject|2|||
129529100|NCT02573012|466224243|FG001|Overall Study|Withdrawal by Subject|2|||
129529101|NCT02573012|466224242|FG000|Overall Study|Study Ended per Protocol|1|||
129529102|NCT02573012|466224243|FG001|Overall Study|Study Ended per Protocol|0|||
129529103|NCT02573012|466224242|FG000|Overall Study|Physician Decision|1|||
129529104|NCT02573012|466224243|FG001|Overall Study|Physician Decision|2|||
129529105|NCT01610414|466224244|FG000|Study Start - Month 13|Serious Adverse Event|65|||
129529106|NCT01610414|466224245|FG001|Study Start - Month 13|Serious Adverse Event|67|||
129529107|NCT01610414|466224244|FG000|Study Start - Month 13|Adverse Event|14|||
129529108|NCT01610414|466224245|FG001|Study Start - Month 13|Adverse Event|14|||
129529109|NCT01610414|466224244|FG000|Study Start - Month 13|Protocol Violation|3|||
129529110|NCT01610414|466224245|FG001|Study Start - Month 13|Protocol Violation|1|||
129529111|NCT01610414|466224244|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
129529112|NCT01610414|466224245|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
129529113|NCT01610414|466224244|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
129529114|NCT01610414|466224245|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
129529115|NCT01610414|466224244|FG000|Study Start - Month 13|Lost to Follow-up|4|||
129529116|NCT01610414|466224245|FG001|Study Start - Month 13|Lost to Follow-up|6|||
129529117|NCT01610414|466224244|FG000|Study Start - Month 13|Suspected HZ episode|1|||
129529118|NCT01610414|466224245|FG001|Study Start - Month 13|Suspected HZ episode|3|||
129529119|NCT01610414|466224244|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
129529120|NCT01610414|466224245|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
129529121|NCT01610414|466224244|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
129529122|NCT01610414|466224245|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
129529123|NCT01610414|466224244|FG000|Month 13 - Month 25|Adverse Event|8|||
129529124|NCT01610414|466224245|FG001|Month 13 - Month 25|Adverse Event|4|||
129529125|NCT01610414|466224244|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
129529126|NCT01610414|466224245|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
129529127|NCT01610414|466224244|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
129529128|NCT01610414|466224245|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
129529129|NCT01610414|466224244|FG000|Month 13 - Month 25|Protocol Violation|0|||
129529130|NCT01610414|466224245|FG001|Month 13 - Month 25|Protocol Violation|2|||
129529131|NCT01610414|466224244|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
129529132|NCT01610414|466224245|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
129529133|NCT01610414|466224244|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
129529134|NCT01610414|466224245|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
129529135|NCT01610414|466224244|FG000|After Month 25|Study end not reached|48|||
129529136|NCT01610414|466224245|FG001|After Month 25|Study end not reached|53|||
129529137|NCT02736474|466224246|FG000|Overall Study|Lost to Follow-up|0|||
129529138|NCT02736474|466224247|FG001|Overall Study|Lost to Follow-up|1|||
129529139|NCT02483611|466224248|FG000|Overall Study|Protocol Violation|0|||
129529140|NCT02483611|466224249|FG001|Overall Study|Protocol Violation|0|||
129529141|NCT02483611|466224250|FG002|Overall Study|Protocol Violation|1|||
129529142|NCT00518336|466224251|FG000|Year 7|Lost to Follow-up|2|||
129529143|NCT00518336|466224252|FG001|Year 7|Lost to Follow-up|0|||
129529144|NCT00518336|466224251|FG000|Year 7|Could not attend in time|0|||
129529145|NCT00518336|466224252|FG001|Year 7|Could not attend in time|3|||
129529146|NCT00518336|466224251|FG000|Year 8|Lost to Follow-up|1|||
129529147|NCT00518336|466224252|FG001|Year 8|Lost to Follow-up|1|||
129529148|NCT00518336|466224251|FG000|Year 8|Could not attend in time|0|||
129529149|NCT00518336|466224252|FG001|Year 8|Could not attend in time|1|||
129529150|NCT00518336|466224251|FG000|Year 9|Migrated/moved from study area|1|||
129529151|NCT00518336|466224252|FG001|Year 9|Migrated/moved from study area|1|||
129529152|NCT00518336|466224251|FG000|Year 9|Lost to Follow-up|3|||
129529153|NCT00518336|466224252|FG001|Year 9|Lost to Follow-up|0|||
129529154|NCT00518336|466224251|FG000|Year 9|Personal reasons|1|||
129529155|NCT00518336|466224252|FG001|Year 9|Personal reasons|0|||
129529156|NCT00125268|466224253|FG000|Overall Study|Withdrawal by Subject|1|||
129529157|NCT00125268|466224254|FG001|Overall Study|Withdrawal by Subject|1|||
129529158|NCT00286156|466224255|FG000|Overall Study|Missed 12 month visit|0|||
129529159|NCT00286156|466224256|FG001|Overall Study|Missed 12 month visit|0|||
129529160|NCT00286156|466224257|FG002|Overall Study|Missed 12 month visit|1|||
129529161|NCT00286156|466224255|FG000|Overall Study|AE: pulmonary embolus|0|||
129529162|NCT00286156|466224256|FG001|Overall Study|AE: pulmonary embolus|1|||
129529163|NCT00286156|466224257|FG002|Overall Study|AE: pulmonary embolus|0|||
129529164|NCT00286156|466224255|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
129529165|NCT00286156|466224256|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
129529166|NCT00286156|466224257|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
129529167|NCT00286156|466224255|FG000|Overall Study|AE: pneumonia|1|||
129529168|NCT00286156|466224256|FG001|Overall Study|AE: pneumonia|0|||
129529169|NCT00286156|466224257|FG002|Overall Study|AE: pneumonia|0|||
129529170|NCT01108263|466225459|FG000|Overall Study|Adverse Event|0|||
129529171|NCT01108263|466225460|FG001|Overall Study|Adverse Event|1|||
129529172|NCT01685372|466225461|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
129529173|NCT01685372|466225462|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
129529174|NCT01488994|466225463|FG000|Overall Study|Withdrawal by Subject|0|||
129529175|NCT01488994|466225464|FG001|Overall Study|Withdrawal by Subject|1|||
129529176|NCT00829010|466225467|FG000|Overall Study|Adverse Event|1|||
129529177|NCT00829010|466225468|FG001|Overall Study|Adverse Event|0|||
129529178|NCT00829010|466225469|FG002|Overall Study|Adverse Event|0|||
129529179|NCT00829010|466225470|FG003|Overall Study|Adverse Event|0|||
129529180|NCT00829010|466225471|FG004|Overall Study|Adverse Event|0|||
129529181|NCT00829010|466225467|FG000|Overall Study|Withdrawal by Subject|0|||
129529182|NCT00829010|466225468|FG001|Overall Study|Withdrawal by Subject|1|||
129529183|NCT00829010|466225469|FG002|Overall Study|Withdrawal by Subject|1|||
129529184|NCT00829010|466225470|FG003|Overall Study|Withdrawal by Subject|0|||
129529185|NCT00829010|466225471|FG004|Overall Study|Withdrawal by Subject|2|||
129529186|NCT00829010|466225467|FG000|Overall Study|Lost to Follow-up|1|||
129529187|NCT00829010|466225468|FG001|Overall Study|Lost to Follow-up|0|||
129529188|NCT00829010|466225469|FG002|Overall Study|Lost to Follow-up|2|||
129529189|NCT00829010|466225470|FG003|Overall Study|Lost to Follow-up|0|||
129529190|NCT00829010|466225471|FG004|Overall Study|Lost to Follow-up|0|||
129529191|NCT00829010|466225467|FG000|Overall Study|Fatality|5|||
129529192|NCT00829010|466225468|FG001|Overall Study|Fatality|4|||
129529193|NCT00829010|466225469|FG002|Overall Study|Fatality|0|||
129529194|NCT00829010|466225470|FG003|Overall Study|Fatality|3|||
129529195|NCT00829010|466225471|FG004|Overall Study|Fatality|0|||
129529196|NCT00829010|466225467|FG000|Overall Study|Migrated/Moved from study area|3|||
129529197|NCT00829010|466225468|FG001|Overall Study|Migrated/Moved from study area|4|||
129529198|NCT00829010|466225469|FG002|Overall Study|Migrated/Moved from study area|0|||
129529199|NCT00829010|466225470|FG003|Overall Study|Migrated/Moved from study area|5|||
129529200|NCT00829010|466225471|FG004|Overall Study|Migrated/Moved from study area|0|||
129529201|NCT00474539|466225474|FG000|Infant Series|Withdrawal by Subject|3|||
129529202|NCT00474539|466225475|FG001|Infant Series|Withdrawal by Subject|4|||
129529203|NCT00474539|466225474|FG000|Infant Series|Randomization error|5|||
129529204|NCT00474539|466225475|FG001|Infant Series|Randomization error|0|||
129529205|NCT00474539|466225474|FG000|Infant Series|Lost to Follow-up|2|||
129529206|NCT00474539|466225475|FG001|Infant Series|Lost to Follow-up|1|||
129529207|NCT00474539|466225474|FG000|Infant Series|Protocol Violation|0|||
129529208|NCT00474539|466225475|FG001|Infant Series|Protocol Violation|1|||
129529209|NCT00474539|466225474|FG000|After Infant Series|Lost to Follow-up|3|||
129529210|NCT00474539|466225475|FG001|After Infant Series|Lost to Follow-up|0|||
129529211|NCT00474539|466225474|FG000|After Infant Series|Withdrawal by Subject|1|||
129529212|NCT00474539|466225475|FG001|After Infant Series|Withdrawal by Subject|0|||
129529213|NCT00474539|466225474|FG000|Toddler Dose|Protocol Violation|1|||
129529214|NCT00474539|466225475|FG001|Toddler Dose|Protocol Violation|0|||
129529215|NCT02061540|466225476|FG000|Overall Study|Adverse Event|2|||
129529216|NCT02061540|466225476|FG000|Overall Study|Withdrawal by Subject|2|||
129529217|NCT02289833|466225478|FG000|Overall Study|Study discontinuation|0|||
129529218|NCT02289833|466225479|FG001|Overall Study|Study discontinuation|1|||
129529219|NCT02289833|466225478|FG000|Overall Study|Lost to Follow-up|4|||
129529220|NCT02289833|466225479|FG001|Overall Study|Lost to Follow-up|0|||
129529221|NCT02289833|466225478|FG000|Overall Study|Death|23|||
129529222|NCT02289833|466225479|FG001|Overall Study|Death|16|||
129529223|NCT01227252|466225480|FG000|Overall Study|Sponsor Decision|0|||
129529224|NCT01227252|466225481|FG001|Overall Study|Sponsor Decision|1|||
129529225|NCT01227252|466225482|FG002|Overall Study|Sponsor Decision|0|||
129529226|NCT01227252|466225483|FG003|Overall Study|Sponsor Decision|0|||
129529227|NCT01227252|466225480|FG000|Overall Study|Lost to Follow-up|0|||
129529228|NCT01227252|466225481|FG001|Overall Study|Lost to Follow-up|1|||
129529229|NCT01227252|466225482|FG002|Overall Study|Lost to Follow-up|0|||
129529230|NCT01227252|466225483|FG003|Overall Study|Lost to Follow-up|0|||
129529231|NCT01227252|466225480|FG000|Overall Study|Withdrawal by Subject|0|||
129529232|NCT01227252|466225481|FG001|Overall Study|Withdrawal by Subject|1|||
129529233|NCT01227252|466225482|FG002|Overall Study|Withdrawal by Subject|0|||
129529234|NCT01227252|466225483|FG003|Overall Study|Withdrawal by Subject|0|||
129529235|NCT02561273|466225490|FG000|Overall Study|Protocol Violation|1|||
129529236|NCT02561273|466225491|FG001|Overall Study|Protocol Violation|0|||
129529237|NCT03442595|466225492|FG000|Overall Study|Lost to Follow-up|94|||
129529238|NCT03442595|466225493|FG001|Overall Study|Lost to Follow-up|0|||
129529239|NCT04107935|466225494|FG000|Overall Study|Death|1|||
129529240|NCT04107935|466225495|FG001|Overall Study|Death|0|||
129529241|NCT02181504|466225496|FG000|Overall Study|Adverse Event|1|||
129529242|NCT02181504|466225497|FG001|Overall Study|Adverse Event|1|||
129529243|NCT02181504|466225498|FG002|Overall Study|Adverse Event|1|||
129529244|NCT00998985|466225504|FG000|Overall Study|Withdrawal by Subject|0|||
129529245|NCT00998985|466225505|FG001|Overall Study|Withdrawal by Subject|0|||
129529246|NCT00998985|466225506|FG002|Overall Study|Withdrawal by Subject|0|||
129529247|NCT00998985|466225507|FG003|Overall Study|Withdrawal by Subject|0|||
129529248|NCT00998985|466225508|FG004|Overall Study|Withdrawal by Subject|0|||
129529249|NCT00998985|466225509|FG005|Overall Study|Withdrawal by Subject|0|||
129529250|NCT00998985|466225510|FG006|Overall Study|Withdrawal by Subject|0|||
129529251|NCT00998985|466225511|FG007|Overall Study|Withdrawal by Subject|0|||
129529252|NCT00998985|466225512|FG008|Overall Study|Withdrawal by Subject|1|||
129529253|NCT00998985|466225513|FG009|Overall Study|Withdrawal by Subject|0|||
129529254|NCT00998985|466225514|FG010|Overall Study|Withdrawal by Subject|0|||
129529255|NCT00998985|466225515|FG011|Overall Study|Withdrawal by Subject|0|||
129529256|NCT00998985|466225516|FG012|Overall Study|Withdrawal by Subject|0|||
129529257|NCT00998985|466225517|FG013|Overall Study|Withdrawal by Subject|0|||
129529258|NCT00998985|466225504|FG000|Overall Study|Protocol Violation|0|||
129529259|NCT00998985|466225505|FG001|Overall Study|Protocol Violation|0|||
129529260|NCT00998985|466225506|FG002|Overall Study|Protocol Violation|0|||
129529261|NCT00998985|466225507|FG003|Overall Study|Protocol Violation|0|||
129529262|NCT00998985|466225508|FG004|Overall Study|Protocol Violation|0|||
129529263|NCT00998985|466225509|FG005|Overall Study|Protocol Violation|1|||
129529264|NCT00998985|466225510|FG006|Overall Study|Protocol Violation|0|||
129529265|NCT00998985|466225511|FG007|Overall Study|Protocol Violation|0|||
129529266|NCT00998985|466225512|FG008|Overall Study|Protocol Violation|0|||
129529267|NCT00998985|466225513|FG009|Overall Study|Protocol Violation|0|||
129529268|NCT00998985|466225514|FG010|Overall Study|Protocol Violation|0|||
129529269|NCT00998985|466225515|FG011|Overall Study|Protocol Violation|0|||
129529270|NCT00998985|466225516|FG012|Overall Study|Protocol Violation|0|||
129529271|NCT00998985|466225517|FG013|Overall Study|Protocol Violation|0|||
129529272|NCT01040728|466225519|FG000|Overall Study|Adverse Event|4|||
129529273|NCT01040728|466225520|FG001|Overall Study|Adverse Event|8|||
129529274|NCT01040728|466225521|FG002|Overall Study|Adverse Event|0|||
129529275|NCT01040728|466225522|FG003|Overall Study|Adverse Event|4|||
129529276|NCT01040728|466225519|FG000|Overall Study|Withdrawal by Subject|0|||
129529277|NCT01040728|466225520|FG001|Overall Study|Withdrawal by Subject|1|||
129529278|NCT01040728|466225521|FG002|Overall Study|Withdrawal by Subject|1|||
129529279|NCT01040728|466225522|FG003|Overall Study|Withdrawal by Subject|0|||
129529280|NCT01040728|466225519|FG000|Overall Study|Protocol Violation|0|||
129529281|NCT01040728|466225520|FG001|Overall Study|Protocol Violation|0|||
129529282|NCT01040728|466225521|FG002|Overall Study|Protocol Violation|0|||
129529283|NCT01040728|466225522|FG003|Overall Study|Protocol Violation|1|||
129529284|NCT01040728|466225519|FG000|Overall Study|Lack of Efficacy|0|||
129529285|NCT01040728|466225520|FG001|Overall Study|Lack of Efficacy|1|||
129529286|NCT01040728|466225521|FG002|Overall Study|Lack of Efficacy|0|||
129529287|NCT01040728|466225522|FG003|Overall Study|Lack of Efficacy|1|||
129529288|NCT01040728|466225519|FG000|Overall Study|Other reasons not listed above|0|||
129529289|NCT01040728|466225520|FG001|Overall Study|Other reasons not listed above|1|||
129529290|NCT01040728|466225521|FG002|Overall Study|Other reasons not listed above|0|||
129529291|NCT01040728|466225522|FG003|Overall Study|Other reasons not listed above|0|||
129529292|NCT01875874|466225525|FG000|Overall Study|Death|3|||
129529293|NCT00590031|466225526|FG000|Overall Study|Adverse Event|3|||
129529294|NCT00590031|466225526|FG000|Overall Study|Withdrawal by Subject|1|||
129529295|NCT00590031|466225526|FG000|Overall Study|Metastatic Disease|1|||
129529296|NCT00590031|466225526|FG000|Overall Study|Admin Hold|1|||
129529297|NCT02463331|466225533|FG000|Overall Study|Adverse Event|4|||
129529298|NCT02463331|466225534|FG001|Overall Study|Adverse Event|2|||
129529299|NCT02463331|466225533|FG000|Overall Study|Lost to Follow-up|1|||
129529300|NCT02463331|466225534|FG001|Overall Study|Lost to Follow-up|1|||
129529301|NCT02463331|466225533|FG000|Overall Study|Pregnancy|2|||
129529302|NCT02463331|466225534|FG001|Overall Study|Pregnancy|3|||
129529303|NCT02463331|466225533|FG000|Overall Study|Lack of Efficacy|6|||
129529304|NCT02463331|466225534|FG001|Overall Study|Lack of Efficacy|0|||
129529305|NCT02463331|466225533|FG000|Overall Study|Physician Decision|3|||
129529306|NCT02463331|466225534|FG001|Overall Study|Physician Decision|0|||
129529307|NCT00826540|466225535|FG000|Overall Study|ineligible|3|||
129529308|NCT00826540|466225535|FG000|Overall Study|Withdrawal by Subject|1|||
129529309|NCT01166386|466225536|FG000|Overall Study|Withdrawal by Subject|3|||
129529310|NCT01166386|466225537|FG001|Overall Study|Withdrawal by Subject|5|||
129529311|NCT02382276|466225538|FG000|Overall Study|Withdrawal by Subject|4|||
129529312|NCT02382276|466225539|FG001|Overall Study|Withdrawal by Subject|8|||
129529313|NCT02382276|466225540|FG002|Overall Study|Withdrawal by Subject|5|||
129529314|NCT02382276|466225538|FG000|Overall Study|Adverse Event|7|||
129529315|NCT02382276|466225539|FG001|Overall Study|Adverse Event|2|||
129529316|NCT02382276|466225540|FG002|Overall Study|Adverse Event|32|||
129529317|NCT02382276|466225538|FG000|Overall Study|Physician Decision|0|||
129529318|NCT02382276|466225539|FG001|Overall Study|Physician Decision|0|||
129529319|NCT02382276|466225540|FG002|Overall Study|Physician Decision|2|||
129529320|NCT01222416|466225541|FG000|Overall Study|ineligible;metastasis|3|||
129529321|NCT01222416|466225542|FG001|Overall Study|ineligible;metastasis|0|||
129529322|NCT01222416|466225541|FG000|Overall Study|Adverse Event|4|||
129529323|NCT01222416|466225542|FG001|Overall Study|Adverse Event|0|||
129529324|NCT01222416|466225541|FG000|Overall Study|Withdrawal by Subject|5|||
129529325|NCT01222416|466225542|FG001|Overall Study|Withdrawal by Subject|0|||
129529326|NCT01222416|466225541|FG000|Overall Study|scheduling|6|||
129529327|NCT01222416|466225542|FG001|Overall Study|scheduling|0|||
129529328|NCT01222416|466225541|FG000|Overall Study|missed view/scan|1|||
129529329|NCT01222416|466225542|FG001|Overall Study|missed view/scan|0|||
129529330|NCT01222416|466225541|FG000|Overall Study|Death|1|||
129529331|NCT01222416|466225542|FG001|Overall Study|Death|0|||
129529332|NCT02178592|466225545|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
129529333|NCT02178592|466225546|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
129529334|NCT02178592|466225545|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
129529335|NCT02178592|466225546|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
129529336|NCT02178592|466225545|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
129529337|NCT02178592|466225546|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
129529338|NCT02178592|466225545|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
129529339|NCT02178592|466225546|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
129529340|NCT02178592|466225545|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
129529341|NCT02178592|466225546|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
129529342|NCT02178592|466225545|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
129529343|NCT02178592|466225546|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
129529344|NCT02178592|466225545|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
129529345|NCT02178592|466225546|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
129529346|NCT02178592|466225545|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
129529347|NCT02178592|466225546|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
129529348|NCT02178592|466225545|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
129529349|NCT02178592|466225546|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
129529350|NCT02178592|466225545|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
129529351|NCT02178592|466225546|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
129529352|NCT02178592|466225545|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
129529353|NCT02178592|466225546|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
129529354|NCT02178592|466225545|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
129529355|NCT02178592|466225546|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
129529356|NCT02520141|466225549|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
129529357|NCT00703781|466225550|FG000|Overall Study|Withdrawal by Subject|1|||
129529358|NCT00703781|466225551|FG001|Overall Study|Withdrawal by Subject|2|||
129529359|NCT00703781|466225550|FG000|Overall Study|Cancelled surgery|1|||
129529360|NCT00703781|466225551|FG001|Overall Study|Cancelled surgery|0|||
129529361|NCT03452397|466225554|FG000|Overall Study|Adverse Event|1|||
129529362|NCT03452397|466225555|FG001|Overall Study|Adverse Event|0|||
129529363|NCT03452397|466225556|FG002|Overall Study|Adverse Event|0|||
129529364|NCT03452397|466225557|FG003|Overall Study|Adverse Event|0|||
129529365|NCT03452397|466225554|FG000|Overall Study|Administrative reason|0|||
129529366|NCT03452397|466225555|FG001|Overall Study|Administrative reason|0|||
129529367|NCT03452397|466225556|FG002|Overall Study|Administrative reason|1|||
129529368|NCT03452397|466225557|FG003|Overall Study|Administrative reason|1|||
129529369|NCT03452397|466225554|FG000|Overall Study|Withdrawal by Subject|0|||
129529370|NCT03452397|466225555|FG001|Overall Study|Withdrawal by Subject|0|||
129529371|NCT03452397|466225556|FG002|Overall Study|Withdrawal by Subject|1|||
129529372|NCT03452397|466225557|FG003|Overall Study|Withdrawal by Subject|0|||
129529373|NCT02691468|466225559|FG000|Overall Study|Bronchial blocker use|2|||
129529374|NCT02691468|466225560|FG001|Overall Study|Bronchial blocker use|1|||
129529375|NCT02691468|466225559|FG000|Overall Study|Lost to Follow-up|2|||
129529376|NCT02691468|466225560|FG001|Overall Study|Lost to Follow-up|1|||
129529377|NCT02691468|466225559|FG000|Overall Study|Failure to advance FOB|2|||
129529378|NCT02691468|466225560|FG001|Overall Study|Failure to advance FOB|0|||
129529379|NCT06334055|466225561|FG000|Overall Study|Adverse Event|4|||
129529380|NCT06334055|466225561|FG000|Overall Study|Disqualified|72|||
129529381|NCT02545049|466225562|FG000|Overall Study|Withdrawal by Subject|1|||
129529382|NCT02545049|466225563|FG001|Overall Study|Withdrawal by Subject|7|||
129529383|NCT02545049|466225562|FG000|Overall Study|Lost to Follow-up|4|||
129529384|NCT02545049|466225563|FG001|Overall Study|Lost to Follow-up|6|||
129529385|NCT02545049|466225562|FG000|Overall Study|GCP violations|37|||
129529386|NCT02545049|466225563|FG001|Overall Study|GCP violations|48|||
129529387|NCT02972658|466227065|FG000|Overall Study|Adverse Event|0|||
129529388|NCT02972658|466227066|FG001|Overall Study|Adverse Event|3|||
129529389|NCT02972658|466227067|FG002|Overall Study|Adverse Event|0|||
129529390|NCT02972658|466227068|FG003|Overall Study|Adverse Event|2|||
129529391|NCT02972658|466227065|FG000|Overall Study|Other-determined by Investigator|1|||
129529392|NCT02972658|466227066|FG001|Overall Study|Other-determined by Investigator|1|||
129529393|NCT02972658|466227067|FG002|Overall Study|Other-determined by Investigator|0|||
129529394|NCT02972658|466227068|FG003|Overall Study|Other-determined by Investigator|0|||
129529395|NCT02972658|466227065|FG000|Overall Study|Death|0|||
129529396|NCT02972658|466227066|FG001|Overall Study|Death|0|||
129529397|NCT02972658|466227067|FG002|Overall Study|Death|0|||
129529398|NCT02972658|466227068|FG003|Overall Study|Death|1|||
129529399|NCT02972658|466227065|FG000|Overall Study|Lost to Follow-up|0|||
129529400|NCT02972658|466227066|FG001|Overall Study|Lost to Follow-up|1|||
129529401|NCT02972658|466227067|FG002|Overall Study|Lost to Follow-up|1|||
129529402|NCT02972658|466227068|FG003|Overall Study|Lost to Follow-up|2|||
129529403|NCT02972658|466227065|FG000|Overall Study|Progressive Disease|0|||
129529404|NCT02972658|466227066|FG001|Overall Study|Progressive Disease|1|||
129529405|NCT02972658|466227067|FG002|Overall Study|Progressive Disease|0|||
129529406|NCT02972658|466227068|FG003|Overall Study|Progressive Disease|1|||
129529407|NCT02972658|466227065|FG000|Overall Study|Withdrawal by Subject|4|||
129529408|NCT02972658|466227066|FG001|Overall Study|Withdrawal by Subject|4|||
129529409|NCT02972658|466227067|FG002|Overall Study|Withdrawal by Subject|1|||
129529410|NCT02972658|466227068|FG003|Overall Study|Withdrawal by Subject|6|||
129529411|NCT02972658|466227065|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
129529412|NCT02972658|466227066|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
129529413|NCT02972658|466227067|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
129529414|NCT02972658|466227068|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
129529415|NCT02972658|466227065|FG000|Overall Study|Sponsor Decision|70|||
129529416|NCT02972658|466227066|FG001|Overall Study|Sponsor Decision|127|||
129529417|NCT02972658|466227067|FG002|Overall Study|Sponsor Decision|72|||
129529418|NCT02972658|466227068|FG003|Overall Study|Sponsor Decision|119|||
129529419|NCT03958149|466227069|FG000|Overall Study|Withdrawal by Subject|0|||
129529420|NCT03958149|466227070|FG001|Overall Study|Withdrawal by Subject|1|||
129529421|NCT02785588|466227071|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
129529422|NCT02785588|466227071|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
129529423|NCT00768040|466227075|FG000|Overall Study|Adverse Event|3|||
129529424|NCT00768040|466227076|FG001|Overall Study|Adverse Event|2|||
129529425|NCT00768040|466227075|FG000|Overall Study|Abnormal laboratory value|1|||
129529426|NCT00768040|466227076|FG001|Overall Study|Abnormal laboratory value|1|||
129529427|NCT02185040|466227078|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
129529428|NCT02185040|466227079|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
129529429|NCT02185040|466227080|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
129529430|NCT02185040|466227081|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
129529431|NCT02185040|466227082|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
129529432|NCT02185040|466227083|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
129529433|NCT02185040|466227084|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
129529434|NCT02185040|466227078|FG000|Part 1 Treatment Phase|Adverse Event|1|||
129529435|NCT02185040|466227079|FG001|Part 1 Treatment Phase|Adverse Event|0|||
129529436|NCT02185040|466227080|FG002|Part 1 Treatment Phase|Adverse Event|0|||
129529437|NCT02185040|466227081|FG003|Part 1 Treatment Phase|Adverse Event|2|||
129529438|NCT02185040|466227082|FG004|Part 1 Treatment Phase|Adverse Event|3|||
129529439|NCT02185040|466227083|FG005|Part 1 Treatment Phase|Adverse Event|0|||
129529440|NCT02185040|466227084|FG006|Part 1 Treatment Phase|Adverse Event|0|||
129529441|NCT02185040|466227078|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
129529442|NCT02185040|466227079|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
129529443|NCT02185040|466227080|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
129529444|NCT02185040|466227081|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
129529445|NCT02185040|466227082|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
129529446|NCT02185040|466227083|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
129529447|NCT02185040|466227084|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
129529448|NCT02185040|466227078|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
129529449|NCT02185040|466227079|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
129529450|NCT02185040|466227080|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
129529451|NCT02185040|466227081|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
129529452|NCT02185040|466227082|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
129529453|NCT02185040|466227083|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
129529454|NCT02185040|466227084|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
129529455|NCT02185040|466227078|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
129529456|NCT02185040|466227079|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
129529457|NCT02185040|466227080|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
129529458|NCT02185040|466227081|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
129529459|NCT02185040|466227082|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
129529460|NCT02185040|466227083|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
129529461|NCT02185040|466227084|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
129529462|NCT02185040|466227078|FG000|Active Treatment Extension Phase|Adverse Event|0|||
129529463|NCT02185040|466227079|FG001|Active Treatment Extension Phase|Adverse Event|0|||
129529464|NCT02185040|466227080|FG002|Active Treatment Extension Phase|Adverse Event|0|||
129529465|NCT02185040|466227081|FG003|Active Treatment Extension Phase|Adverse Event|0|||
129529466|NCT02185040|466227082|FG004|Active Treatment Extension Phase|Adverse Event|0|||
129529467|NCT02185040|466227083|FG005|Active Treatment Extension Phase|Adverse Event|1|||
129529468|NCT02185040|466227084|FG006|Active Treatment Extension Phase|Adverse Event|4|||
129529469|NCT02185040|466227078|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
129529470|NCT02185040|466227079|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
129529471|NCT02185040|466227080|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
129529472|NCT02185040|466227081|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
129529473|NCT02185040|466227082|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
129529474|NCT02185040|466227083|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
129529475|NCT02185040|466227084|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
129529476|NCT02185040|466227078|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
129529477|NCT02185040|466227079|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
129529478|NCT02185040|466227080|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
129529479|NCT02185040|466227081|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
129529480|NCT02185040|466227082|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
129529481|NCT02185040|466227083|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
129529482|NCT02185040|466227084|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
129529483|NCT03347279|466227085|FG000|Overall Study|Withdrawal by Subject|8|||
129529484|NCT03347279|466227086|FG001|Overall Study|Withdrawal by Subject|15|||
129529485|NCT03347279|466227085|FG000|Overall Study|Death|0|||
129529486|NCT03347279|466227086|FG001|Overall Study|Death|2|||
129529487|NCT03347279|466227085|FG000|Overall Study|Lost to Follow-up|5|||
129529488|NCT03347279|466227086|FG001|Overall Study|Lost to Follow-up|2|||
129529489|NCT03347279|466227085|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
129529490|NCT03347279|466227086|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
129529491|NCT03818399|466227089|FG000|Overall Study|Lost to Follow-up|11|||
129529492|NCT03818399|466227089|FG000|Overall Study|Withdrawal by Subject|1|||
129529493|NCT03818399|466227089|FG000|Overall Study|Protocol Violation|2|||
129529494|NCT03557801|466227092|FG000|Overall Study|Protocol Violation|1|||
129529495|NCT03557801|466227093|FG001|Overall Study|Protocol Violation|0|||
129529496|NCT03557801|466227094|FG002|Overall Study|Protocol Violation|0|||
129529497|NCT03557801|466227092|FG000|Overall Study|Withdrawal by Subject|1|||
129529498|NCT03557801|466227093|FG001|Overall Study|Withdrawal by Subject|0|||
129529499|NCT03557801|466227094|FG002|Overall Study|Withdrawal by Subject|3|||
129529500|NCT03557801|466227092|FG000|Overall Study|Lost to Follow-up|0|||
129529501|NCT03557801|466227093|FG001|Overall Study|Lost to Follow-up|1|||
129529502|NCT03557801|466227094|FG002|Overall Study|Lost to Follow-up|0|||
129529503|NCT00141297|466227095|FG000|Overall Study|Adverse Event|0|||
129529504|NCT00141297|466227096|FG001|Overall Study|Adverse Event|0|||
129529505|NCT00141297|466227097|FG002|Overall Study|Adverse Event|1|||
129529506|NCT00141297|466227098|FG003|Overall Study|Adverse Event|0|||
129529507|NCT00141297|466227099|FG004|Overall Study|Adverse Event|1|||
129529508|NCT00141297|466227100|FG005|Overall Study|Adverse Event|1|||
129529509|NCT00141297|466227101|FG006|Overall Study|Adverse Event|0|||
129529510|NCT00141297|466227102|FG007|Overall Study|Adverse Event|1|||
129529511|NCT00141297|466227103|FG008|Overall Study|Adverse Event|1|||
129529512|NCT00141297|466227104|FG009|Overall Study|Adverse Event|0|||
129529513|NCT00141297|466227095|FG000|Overall Study|Death|1|||
129529514|NCT00141297|466227096|FG001|Overall Study|Death|0|||
129529515|NCT00141297|466227097|FG002|Overall Study|Death|0|||
129529516|NCT00141297|466227098|FG003|Overall Study|Death|0|||
129529517|NCT00141297|466227099|FG004|Overall Study|Death|0|||
129529518|NCT00141297|466227100|FG005|Overall Study|Death|0|||
129529519|NCT00141297|466227101|FG006|Overall Study|Death|0|||
129529520|NCT00141297|466227102|FG007|Overall Study|Death|0|||
129529521|NCT00141297|466227103|FG008|Overall Study|Death|1|||
129529522|NCT00141297|466227104|FG009|Overall Study|Death|0|||
129529523|NCT00141297|466227095|FG000|Overall Study|Withdrawal by Subject|0|||
129529524|NCT00141297|466227096|FG001|Overall Study|Withdrawal by Subject|0|||
129529525|NCT00141297|466227097|FG002|Overall Study|Withdrawal by Subject|0|||
129529526|NCT00141297|466227098|FG003|Overall Study|Withdrawal by Subject|0|||
129529527|NCT00141297|466227099|FG004|Overall Study|Withdrawal by Subject|0|||
129529528|NCT00141297|466227100|FG005|Overall Study|Withdrawal by Subject|0|||
129529529|NCT00141297|466227101|FG006|Overall Study|Withdrawal by Subject|0|||
129529530|NCT00141297|466227102|FG007|Overall Study|Withdrawal by Subject|0|||
129529531|NCT00141297|466227103|FG008|Overall Study|Withdrawal by Subject|1|||
129529532|NCT00141297|466227104|FG009|Overall Study|Withdrawal by Subject|0|||
129529533|NCT00141297|466227095|FG000|Overall Study|Other|0|||
129529534|NCT00141297|466227096|FG001|Overall Study|Other|0|||
129529535|NCT00141297|466227097|FG002|Overall Study|Other|0|||
129529536|NCT00141297|466227098|FG003|Overall Study|Other|1|||
129529537|NCT00141297|466227099|FG004|Overall Study|Other|5|||
129529538|NCT00141297|466227100|FG005|Overall Study|Other|0|||
129529539|NCT00141297|466227101|FG006|Overall Study|Other|0|||
129529540|NCT00141297|466227102|FG007|Overall Study|Other|0|||
129529541|NCT00141297|466227103|FG008|Overall Study|Other|2|||
129529542|NCT00141297|466227104|FG009|Overall Study|Other|0|||
129529543|NCT00141297|466227095|FG000|Overall Study|Progressive Disease|2|||
129529544|NCT00141297|466227096|FG001|Overall Study|Progressive Disease|3|||
129529545|NCT00141297|466227097|FG002|Overall Study|Progressive Disease|6|||
129529546|NCT00141297|466227098|FG003|Overall Study|Progressive Disease|2|||
129529547|NCT00141297|466227099|FG004|Overall Study|Progressive Disease|15|||
129529548|NCT00141297|466227100|FG005|Overall Study|Progressive Disease|2|||
129529549|NCT00141297|466227101|FG006|Overall Study|Progressive Disease|3|||
129529550|NCT00141297|466227102|FG007|Overall Study|Progressive Disease|3|||
129529551|NCT00141297|466227103|FG008|Overall Study|Progressive Disease|15|||
129529552|NCT00141297|466227104|FG009|Overall Study|Progressive Disease|6|||
129529553|NCT00141297|466227095|FG000|Overall Study|Transitioned|0|||
129529554|NCT00141297|466227096|FG001|Overall Study|Transitioned|0|||
129529555|NCT00141297|466227097|FG002|Overall Study|Transitioned|0|||
129529556|NCT00141297|466227098|FG003|Overall Study|Transitioned|0|||
129529557|NCT00141297|466227099|FG004|Overall Study|Transitioned|1|||
129529558|NCT00141297|466227100|FG005|Overall Study|Transitioned|0|||
129529559|NCT00141297|466227101|FG006|Overall Study|Transitioned|0|||
129529560|NCT00141297|466227102|FG007|Overall Study|Transitioned|0|||
129529561|NCT00141297|466227103|FG008|Overall Study|Transitioned|0|||
129529562|NCT00141297|466227104|FG009|Overall Study|Transitioned|0|||
129529563|NCT02200510|466227105|FG000|Overall Study|Death|1|||
129529564|NCT02200510|466227106|FG001|Overall Study|Death|1|||
129529565|NCT02200510|466227105|FG000|Overall Study|Protocol Violation|0|||
129529566|NCT02200510|466227106|FG001|Overall Study|Protocol Violation|1|||
129529567|NCT02200510|466227105|FG000|Overall Study|Lost to Follow-up|7|||
129529568|NCT02200510|466227106|FG001|Overall Study|Lost to Follow-up|1|||
129529569|NCT02200510|466227105|FG000|Overall Study|potential COI - joined study team|1|||
129529570|NCT02200510|466227106|FG001|Overall Study|potential COI - joined study team|0|||
129529571|NCT00290355|466227107|FG000|Overall Study|Serious adverse event|7|||
129529572|NCT00290355|466227108|FG001|Overall Study|Serious adverse event|4|||
129529573|NCT00290355|466227107|FG000|Overall Study|Study product reactogenicity|1|||
129529574|NCT00290355|466227108|FG001|Overall Study|Study product reactogenicity|0|||
129529575|NCT00290355|466227107|FG000|Overall Study|Protocol Violation|1|||
129529576|NCT00290355|466227108|FG001|Overall Study|Protocol Violation|0|||
129529577|NCT00290355|466227107|FG000|Overall Study|Withdrawal by Subject|2|||
129529578|NCT00290355|466227108|FG001|Overall Study|Withdrawal by Subject|0|||
129529579|NCT00290355|466227107|FG000|Overall Study|Migrated / moved from the study area|1|||
129529580|NCT00290355|466227108|FG001|Overall Study|Migrated / moved from the study area|0|||
129529581|NCT00290355|466227107|FG000|Overall Study|Lost to Follow-up|3|||
129529582|NCT00290355|466227108|FG001|Overall Study|Lost to Follow-up|1|||
129529583|NCT00290355|466227107|FG000|Overall Study|Other|2|||
129529584|NCT00290355|466227108|FG001|Overall Study|Other|0|||
129529585|NCT01542632|466227109|FG000|Overall Study|Withdrawal of Consent|0|||
129529586|NCT01542632|466227110|FG001|Overall Study|Withdrawal of Consent|0|||
129529587|NCT01542632|466227111|FG002|Overall Study|Withdrawal of Consent|0|||
129529588|NCT01542632|466227112|FG003|Overall Study|Withdrawal of Consent|2|||
129529589|NCT01542632|466227113|FG004|Overall Study|Withdrawal of Consent|3|||
129529590|NCT01542632|466227114|FG005|Overall Study|Withdrawal of Consent|0|||
129529591|NCT01542632|466227109|FG000|Overall Study|Adverse Event|0|||
129529592|NCT01542632|466227110|FG001|Overall Study|Adverse Event|0|||
129529593|NCT01542632|466227111|FG002|Overall Study|Adverse Event|1|||
129529594|NCT01542632|466227112|FG003|Overall Study|Adverse Event|0|||
129529595|NCT01542632|466227113|FG004|Overall Study|Adverse Event|0|||
129529596|NCT01542632|466227114|FG005|Overall Study|Adverse Event|0|||
129529597|NCT01542632|466227109|FG000|Overall Study|Lost to Follow-up|0|||
129529598|NCT01542632|466227110|FG001|Overall Study|Lost to Follow-up|1|||
129529599|NCT01542632|466227111|FG002|Overall Study|Lost to Follow-up|0|||
129529600|NCT01542632|466227112|FG003|Overall Study|Lost to Follow-up|0|||
129529601|NCT01542632|466227113|FG004|Overall Study|Lost to Follow-up|0|||
129529602|NCT01542632|466227114|FG005|Overall Study|Lost to Follow-up|0|||
129529603|NCT01542632|466227109|FG000|Overall Study|Sponsor/Investigator Decision|0|||
129529604|NCT01542632|466227110|FG001|Overall Study|Sponsor/Investigator Decision|0|||
129529605|NCT01542632|466227111|FG002|Overall Study|Sponsor/Investigator Decision|0|||
129529606|NCT01542632|466227112|FG003|Overall Study|Sponsor/Investigator Decision|0|||
129529607|NCT01542632|466227113|FG004|Overall Study|Sponsor/Investigator Decision|1|||
129529608|NCT01542632|466227114|FG005|Overall Study|Sponsor/Investigator Decision|0|||
129529609|NCT00033514|466227115|FG000|Overall Study|Lost to Follow-up|1|||
129529610|NCT00033514|466227116|FG001|Overall Study|Lost to Follow-up|1|||
129529611|NCT00033514|466227115|FG000|Overall Study|Withdrawal by Subject|0|||
129529612|NCT00033514|466227116|FG001|Overall Study|Withdrawal by Subject|3|||
129529613|NCT01072500|466227122|FG000|Overall Study|Death|2|||
129529614|NCT01072500|466227123|FG001|Overall Study|Death|2|||
129529615|NCT01072500|466227122|FG000|Overall Study|Lost to Follow-up|5|||
129529616|NCT01072500|466227123|FG001|Overall Study|Lost to Follow-up|2|||
129529617|NCT01072500|466227122|FG000|Overall Study|Withdrawal by Subject|17|||
129529618|NCT01072500|466227123|FG001|Overall Study|Withdrawal by Subject|10|||
129529619|NCT03798366|466227133|FG000|Overall Study|Lost to Follow-up|0|||
129529620|NCT03798366|466227134|FG001|Overall Study|Lost to Follow-up|1|||
129529621|NCT01642004|466227135|FG000|Randomization|Adverse Event unrelated to study drug|1|||
129529622|NCT01642004|466227136|FG001|Randomization|Adverse Event unrelated to study drug|0|||
129529623|NCT01642004|466227135|FG000|Randomization|Participant withdrew consent|1|||
129529624|NCT01642004|466227136|FG001|Randomization|Participant withdrew consent|6|||
129529625|NCT01642004|466227135|FG000|Randomization|No longer meets study criteria|2|||
129529626|NCT01642004|466227136|FG001|Randomization|No longer meets study criteria|2|||
129529627|NCT01642004|466227135|FG000|Treatment|Disease progression|95|||
129529628|NCT01642004|466227136|FG001|Treatment|Disease progression|79|||
129529629|NCT01642004|466227135|FG000|Treatment|Study drug toxicity|10|||
129529630|NCT01642004|466227136|FG001|Treatment|Study drug toxicity|13|||
129529631|NCT01642004|466227135|FG000|Treatment|Death|1|||
129529632|NCT01642004|466227136|FG001|Treatment|Death|1|||
129529633|NCT01642004|466227135|FG000|Treatment|Adverse event unrelated to study drug|9|||
129529634|NCT01642004|466227136|FG001|Treatment|Adverse event unrelated to study drug|13|||
129529635|NCT01642004|466227135|FG000|Treatment|Maximum clinical benefit|1|||
129529636|NCT01642004|466227136|FG001|Treatment|Maximum clinical benefit|9|||
129529637|NCT01642004|466227135|FG000|Treatment|Poor/non-compliance|1|||
129529638|NCT01642004|466227136|FG001|Treatment|Poor/non-compliance|0|||
129529639|NCT01642004|466227135|FG000|Treatment|No longer meets study criteria|1|||
129529640|NCT01642004|466227136|FG001|Treatment|No longer meets study criteria|2|||
129529641|NCT01642004|466227135|FG000|Treatment|Other reasons|2|||
129529642|NCT01642004|466227136|FG001|Treatment|Other reasons|0|||
129529643|NCT01642004|466227135|FG000|Treatment|Not reported|0|||
129529644|NCT01642004|466227136|FG001|Treatment|Not reported|3|||
129529645|NCT01642004|466227135|FG000|Treatment|Participant request to discontinue study treatment|6|||
129529646|NCT01642004|466227136|FG001|Treatment|Participant request to discontinue study treatment|4|||
129529647|NCT01642004|466227135|FG000|Treatment|Participant withdrew consent|5|||
129529648|NCT01642004|466227136|FG001|Treatment|Participant withdrew consent|5|||
129529649|NCT02192190|466227141|FG000|Overall Study|Adverse Event|1|||
129529650|NCT02192190|466227142|FG001|Overall Study|Adverse Event|1|||
129529651|NCT02192190|466227143|FG002|Overall Study|Adverse Event|0|||
129529652|NCT02192190|466227144|FG003|Overall Study|Adverse Event|0|||
129529653|NCT02192190|466227145|FG004|Overall Study|Adverse Event|0|||
129529654|NCT02192190|466227146|FG005|Overall Study|Adverse Event|0|||
129529655|NCT02192190|466227141|FG000|Overall Study|Lost to Follow-up|3|||
129529656|NCT02192190|466227142|FG001|Overall Study|Lost to Follow-up|3|||
129529657|NCT02192190|466227143|FG002|Overall Study|Lost to Follow-up|2|||
129529658|NCT02192190|466227144|FG003|Overall Study|Lost to Follow-up|1|||
129529659|NCT02192190|466227145|FG004|Overall Study|Lost to Follow-up|4|||
129529660|NCT02192190|466227146|FG005|Overall Study|Lost to Follow-up|3|||
129529661|NCT02192190|466227141|FG000|Overall Study|Physician Decision|2|||
129529662|NCT02192190|466227142|FG001|Overall Study|Physician Decision|0|||
129529663|NCT02192190|466227143|FG002|Overall Study|Physician Decision|0|||
129529664|NCT02192190|466227144|FG003|Overall Study|Physician Decision|0|||
129529665|NCT02192190|466227145|FG004|Overall Study|Physician Decision|0|||
129529666|NCT02192190|466227146|FG005|Overall Study|Physician Decision|0|||
129529667|NCT02192190|466227141|FG000|Overall Study|Terminated by Sponsor|43|||
129529668|NCT02192190|466227142|FG001|Overall Study|Terminated by Sponsor|23|||
129529669|NCT02192190|466227143|FG002|Overall Study|Terminated by Sponsor|20|||
129529670|NCT02192190|466227144|FG003|Overall Study|Terminated by Sponsor|23|||
129529671|NCT02192190|466227145|FG004|Overall Study|Terminated by Sponsor|21|||
129529672|NCT02192190|466227146|FG005|Overall Study|Terminated by Sponsor|23|||
129529673|NCT02192190|466227141|FG000|Overall Study|Withdrawal by Subject|4|||
129529674|NCT02192190|466227142|FG001|Overall Study|Withdrawal by Subject|1|||
129529675|NCT02192190|466227143|FG002|Overall Study|Withdrawal by Subject|2|||
129529676|NCT02192190|466227144|FG003|Overall Study|Withdrawal by Subject|1|||
129529677|NCT02192190|466227145|FG004|Overall Study|Withdrawal by Subject|5|||
129529678|NCT02192190|466227146|FG005|Overall Study|Withdrawal by Subject|3|||
129529679|NCT02192190|466227141|FG000|Overall Study|Could not Keep Visit Schedule|1|||
129529680|NCT02192190|466227142|FG001|Overall Study|Could not Keep Visit Schedule|0|||
129529681|NCT02192190|466227143|FG002|Overall Study|Could not Keep Visit Schedule|0|||
129529682|NCT02192190|466227144|FG003|Overall Study|Could not Keep Visit Schedule|0|||
129529683|NCT02192190|466227145|FG004|Overall Study|Could not Keep Visit Schedule|0|||
129529684|NCT02192190|466227146|FG005|Overall Study|Could not Keep Visit Schedule|0|||
129529685|NCT02192190|466227141|FG000|Overall Study|Positive Drug Screen|0|||
129529686|NCT02192190|466227142|FG001|Overall Study|Positive Drug Screen|0|||
129529687|NCT02192190|466227143|FG002|Overall Study|Positive Drug Screen|0|||
129529688|NCT02192190|466227144|FG003|Overall Study|Positive Drug Screen|1|||
129529689|NCT02192190|466227145|FG004|Overall Study|Positive Drug Screen|0|||
129529690|NCT02192190|466227146|FG005|Overall Study|Positive Drug Screen|0|||
129529691|NCT02192190|466227141|FG000|Overall Study|Inadequate Pain Relief|0|||
129529692|NCT02192190|466227142|FG001|Overall Study|Inadequate Pain Relief|1|||
129529693|NCT02192190|466227143|FG002|Overall Study|Inadequate Pain Relief|1|||
129529694|NCT02192190|466227144|FG003|Overall Study|Inadequate Pain Relief|0|||
129529695|NCT02192190|466227145|FG004|Overall Study|Inadequate Pain Relief|0|||
129529696|NCT02192190|466227146|FG005|Overall Study|Inadequate Pain Relief|0|||
129529697|NCT03227692|466227147|FG000|Overall Study|Protocol Violation|1|||
129529698|NCT03227692|466227148|FG001|Overall Study|Protocol Violation|1|||
129529699|NCT03227692|466227147|FG000|Overall Study|Lost to Follow-up|4|||
129529700|NCT03227692|466227148|FG001|Overall Study|Lost to Follow-up|2|||
129529701|NCT03227692|466227147|FG000|Overall Study|Adverse Event|0|||
129529702|NCT03227692|466227148|FG001|Overall Study|Adverse Event|2|||
129529703|NCT01657253|466227149|FG000|Overall Study|Lost to Follow-up|6|||
129529704|NCT01657253|466227150|FG001|Overall Study|Lost to Follow-up|5|||
129529705|NCT01657253|466227149|FG000|Overall Study|Withdrawal by Subject|11|||
129529706|NCT01657253|466227150|FG001|Overall Study|Withdrawal by Subject|12|||
129529707|NCT01657253|466227149|FG000|Overall Study|Adverse Event|0|||
129529708|NCT01657253|466227150|FG001|Overall Study|Adverse Event|1|||
129529709|NCT01603628|466227153|FG000|Overall Study|Personal Reasons|1|||
129529710|NCT01603628|466227154|FG001|Overall Study|Personal Reasons|1|||
129529711|NCT01603628|466227155|FG002|Overall Study|Personal Reasons|2|||
129529712|NCT01603628|466227153|FG000|Overall Study|Protocol Violation|1|||
129529713|NCT01603628|466227154|FG001|Overall Study|Protocol Violation|1|||
129529714|NCT01603628|466227155|FG002|Overall Study|Protocol Violation|0|||
129529715|NCT01603628|466227153|FG000|Overall Study|Lost to Follow-up|0|||
129529716|NCT01603628|466227154|FG001|Overall Study|Lost to Follow-up|1|||
129529717|NCT01603628|466227155|FG002|Overall Study|Lost to Follow-up|0|||
129529718|NCT01603628|466227153|FG000|Overall Study|Other Miscellaneous Reason|1|||
129529719|NCT01603628|466227154|FG001|Overall Study|Other Miscellaneous Reason|0|||
129529720|NCT01603628|466227155|FG002|Overall Study|Other Miscellaneous Reason|0|||
129529721|NCT00886587|466227157|FG000|Overall Study|Adverse Event|2|||
129529722|NCT00886587|466227158|FG001|Overall Study|Adverse Event|1|||
129529723|NCT00886587|466227157|FG000|Overall Study|Protocol Violation|2|||
129529724|NCT00886587|466227158|FG001|Overall Study|Protocol Violation|0|||
129529725|NCT00886587|466227157|FG000|Overall Study|Withdrawal by Subject|0|||
129529726|NCT00886587|466227158|FG001|Overall Study|Withdrawal by Subject|1|||
129529727|NCT00890201|466227159|FG000|Overall Study|Protocol Violation|5|||
129529728|NCT00890201|466227160|FG001|Overall Study|Protocol Violation|56|||
129529729|NCT02087241|466227161|FG000|Overall Study|Death|2|||
129529730|NCT02087241|466227162|FG001|Overall Study|Death|1|||
129529731|NCT02087241|466227163|FG002|Overall Study|Death|1|||
129529732|NCT02087241|466227164|FG003|Overall Study|Death|1|||
129529733|NCT02087241|466227161|FG000|Overall Study|Withdrawal by Subject|1|||
129529734|NCT02087241|466227162|FG001|Overall Study|Withdrawal by Subject|0|||
129529735|NCT02087241|466227163|FG002|Overall Study|Withdrawal by Subject|0|||
129529736|NCT02087241|466227164|FG003|Overall Study|Withdrawal by Subject|1|||
129529737|NCT02087241|466227161|FG000|Overall Study|Progressive Disease|0|||
129529738|NCT02087241|466227162|FG001|Overall Study|Progressive Disease|0|||
129529739|NCT02087241|466227163|FG002|Overall Study|Progressive Disease|0|||
129529740|NCT02087241|466227164|FG003|Overall Study|Progressive Disease|1|||
129529741|NCT02087241|466227161|FG000|Overall Study|Study Terminated by Sponsor|0|||
129529742|NCT02087241|466227162|FG001|Overall Study|Study Terminated by Sponsor|2|||
129529743|NCT02087241|466227163|FG002|Overall Study|Study Terminated by Sponsor|0|||
129529744|NCT02087241|466227164|FG003|Overall Study|Study Terminated by Sponsor|4|||
129529745|NCT00374452|466227165|FG000|Overall Study|Left clinic before intervention started|4|||
129529746|NCT00374452|466227166|FG001|Overall Study|Left clinic before intervention started|1|||
129529747|NCT00374452|466227165|FG000|Overall Study|Change in job role before intervention|0|||
129529748|NCT00374452|466227166|FG001|Overall Study|Change in job role before intervention|1|||
129529749|NCT00374452|466227165|FG000|Overall Study|Left clinic after intervention started|1|||
129529750|NCT00374452|466227166|FG001|Overall Study|Left clinic after intervention started|1|||
129529751|NCT00374452|466227165|FG000|Overall Study|Withdrawal by Subject|0|||
129529752|NCT00374452|466227166|FG001|Overall Study|Withdrawal by Subject|2|||
129529753|NCT01289028|466227170|FG000|Overall Study|Progressive Disease|49|||
129529754|NCT01289028|466227170|FG000|Overall Study|Adverse Event|14|||
129529755|NCT01289028|466227170|FG000|Overall Study|Withdrawal by Subject|6|||
129529756|NCT01289028|466227170|FG000|Overall Study|Death|4|||
129529757|NCT01289028|466227170|FG000|Overall Study|Lack of Efficacy|2|||
129529758|NCT01289028|466227170|FG000|Overall Study|No longer required|2|||
129529759|NCT01289028|466227170|FG000|Overall Study|Lost to Follow-up|2|||
129529760|NCT01289028|466227170|FG000|Overall Study|New Cancer Therapy|2|||
129529761|NCT01289028|466227170|FG000|Overall Study|Abnormal Lab Value|1|||
129529762|NCT01289028|466227170|FG000|Overall Study|Missing reason for discon|1|||
129529763|NCT02120469|466227171|FG000|Overall Study|HER-2/neu-amplified|1|||
129529764|NCT02120469|466227172|FG001|Overall Study|HER-2/neu-amplified|0|||
129529765|NCT02120469|466227173|FG002|Overall Study|HER-2/neu-amplified|1|||
129529766|NCT03267576|466227177|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
129529767|NCT03267576|466227178|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
129529768|NCT03267576|466227177|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
129529769|NCT03267576|466227178|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
129529770|NCT01369069|466227179|FG000|Overall Study|Lost to Follow-up|8|||
129529771|NCT01369069|466227180|FG001|Overall Study|Lost to Follow-up|9|||
129529772|NCT01369069|466227179|FG000|Overall Study|Withdrawal by Subject|9|||
129529773|NCT01369069|466227180|FG001|Overall Study|Withdrawal by Subject|7|||
129529774|NCT00882362|466227181|FG000|Overall Study|Adverse Event|13|||
129529775|NCT00882362|466227182|FG001|Overall Study|Adverse Event|10|||
129529776|NCT00882362|466227181|FG000|Overall Study|Withdrawal by Subject|13|||
129529777|NCT00882362|466227182|FG001|Overall Study|Withdrawal by Subject|10|||
129529778|NCT00882362|466227181|FG000|Overall Study|Lack of Efficacy|3|||
129529779|NCT00882362|466227182|FG001|Overall Study|Lack of Efficacy|0|||
129529780|NCT00882362|466227181|FG000|Overall Study|Protocol Violation|7|||
129529781|NCT00882362|466227182|FG001|Overall Study|Protocol Violation|2|||
129529782|NCT00882362|466227181|FG000|Overall Study|Pregnancy|1|||
129529783|NCT00882362|466227182|FG001|Overall Study|Pregnancy|0|||
129529784|NCT00882362|466227181|FG000|Overall Study|Physician Decision|5|||
129529785|NCT00882362|466227182|FG001|Overall Study|Physician Decision|1|||
129529786|NCT00882362|466227181|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
129529787|NCT00882362|466227182|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
129529788|NCT00882362|466227181|FG000|Overall Study|change of residence or other commitments|5|||
129529789|NCT00882362|466227182|FG001|Overall Study|change of residence or other commitments|0|||
129529790|NCT01846208|466227183|FG000|Overall Study|Withdrew prior to treatment|1|||
129529791|NCT01846208|466227184|FG001|Overall Study|Withdrew prior to treatment|1|||
129529792|NCT01846208|466227185|FG002|Overall Study|Withdrew prior to treatment|1|||
129529793|NCT01846208|466227183|FG000|Overall Study|Dosing Symptoms|1|||
129529794|NCT01846208|466227184|FG001|Overall Study|Dosing Symptoms|2|||
129529795|NCT01846208|466227185|FG002|Overall Study|Dosing Symptoms|6|||
129529796|NCT01846208|466227183|FG000|Overall Study|Withdrawal by Subject|5|||
129529797|NCT01846208|466227184|FG001|Overall Study|Withdrawal by Subject|0|||
129529798|NCT01846208|466227185|FG002|Overall Study|Withdrawal by Subject|0|||
129529799|NCT01846208|466227183|FG000|Overall Study|Non-compliance|1|||
129529800|NCT01846208|466227184|FG001|Overall Study|Non-compliance|1|||
129529801|NCT01846208|466227185|FG002|Overall Study|Non-compliance|0|||
129529802|NCT01846208|466227183|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
129529803|NCT01846208|466227184|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
129529804|NCT01846208|466227185|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
129529805|NCT01846208|466227183|FG000|Overall Study|Refused SU OFC|0|||
129529806|NCT01846208|466227184|FG001|Overall Study|Refused SU OFC|0|||
129529807|NCT01846208|466227185|FG002|Overall Study|Refused SU OFC|1|||
129529808|NCT01268514|466227186|FG000|Overall Study|Adverse Event|20|||
129529809|NCT01268514|466227186|FG000|Overall Study|Death|8|||
129529810|NCT01268514|466227186|FG000|Overall Study|Lost to Follow-up|5|||
129529811|NCT01268514|466227186|FG000|Overall Study|Withdrawal by Subject|3|||
129529812|NCT01268514|466227186|FG000|Overall Study|Withdrawal by Surgeon|5|||
129529813|NCT01424306|466227187|FG000|Overall Study|Protocol Violation|0|||
129529814|NCT01424306|466227188|FG001|Overall Study|Protocol Violation|0|||
129529815|NCT01424306|466227189|FG002|Overall Study|Protocol Violation|0|||
129529816|NCT01424306|466227190|FG003|Overall Study|Protocol Violation|0|||
129529817|NCT01424306|466227191|FG004|Overall Study|Protocol Violation|1|||
129529818|NCT01424306|466227192|FG005|Overall Study|Protocol Violation|0|||
129529819|NCT03196973|466227200|FG000|Overall Study|Adverse Event|1|||
129529820|NCT03196973|466227201|FG001|Overall Study|Adverse Event|1|||
129529821|NCT03196973|466227202|FG002|Overall Study|Adverse Event|2|||
129529822|NCT03196973|466227200|FG000|Overall Study|Lack of Efficacy|2|||
129529823|NCT03196973|466227201|FG001|Overall Study|Lack of Efficacy|6|||
129529824|NCT03196973|466227202|FG002|Overall Study|Lack of Efficacy|1|||
129529825|NCT03196973|466227200|FG000|Overall Study|Lost to Follow-up|4|||
129529826|NCT03196973|466227201|FG001|Overall Study|Lost to Follow-up|3|||
129529827|NCT03196973|466227202|FG002|Overall Study|Lost to Follow-up|2|||
129529828|NCT03196973|466227200|FG000|Overall Study|Consent withdrawn|2|||
129529829|NCT03196973|466227201|FG001|Overall Study|Consent withdrawn|1|||
129529830|NCT03196973|466227202|FG002|Overall Study|Consent withdrawn|0|||
129529831|NCT03196973|466227200|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
129529832|NCT03196973|466227201|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
129529833|NCT03196973|466227202|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
129529834|NCT01809327|466227203|FG000|Overall Study|Lost to Follow-up|5|||
129529835|NCT01809327|466227204|FG001|Overall Study|Lost to Follow-up|2|||
129529836|NCT01809327|466227205|FG002|Overall Study|Lost to Follow-up|4|||
129529837|NCT01809327|466227206|FG003|Overall Study|Lost to Follow-up|2|||
129529838|NCT01809327|466227207|FG004|Overall Study|Lost to Follow-up|3|||
129529839|NCT01809327|466227203|FG000|Overall Study|Withdrawal by Subject|6|||
129529840|NCT01809327|466227204|FG001|Overall Study|Withdrawal by Subject|4|||
129529841|NCT01809327|466227205|FG002|Overall Study|Withdrawal by Subject|4|||
129529842|NCT01809327|466227206|FG003|Overall Study|Withdrawal by Subject|2|||
129529843|NCT01809327|466227207|FG004|Overall Study|Withdrawal by Subject|5|||
129529844|NCT01809327|466227203|FG000|Overall Study|Adverse Event|4|||
129529845|NCT01809327|466227204|FG001|Overall Study|Adverse Event|3|||
129529846|NCT01809327|466227205|FG002|Overall Study|Adverse Event|7|||
129529847|NCT01809327|466227206|FG003|Overall Study|Adverse Event|4|||
129529848|NCT01809327|466227207|FG004|Overall Study|Adverse Event|8|||
129529849|NCT01809327|466227203|FG000|Overall Study|Death|1|||
129529850|NCT01809327|466227204|FG001|Overall Study|Death|0|||
129529851|NCT01809327|466227205|FG002|Overall Study|Death|0|||
129529852|NCT01809327|466227206|FG003|Overall Study|Death|0|||
129529853|NCT01809327|466227207|FG004|Overall Study|Death|0|||
129529854|NCT01809327|466227203|FG000|Overall Study|Protocol Violation|0|||
129529855|NCT01809327|466227204|FG001|Overall Study|Protocol Violation|1|||
129529856|NCT01809327|466227205|FG002|Overall Study|Protocol Violation|0|||
129529857|NCT01809327|466227206|FG003|Overall Study|Protocol Violation|0|||
129529858|NCT01809327|466227207|FG004|Overall Study|Protocol Violation|0|||
129529859|NCT01809327|466227203|FG000|Overall Study|Physician Decision|1|||
129529860|NCT01809327|466227204|FG001|Overall Study|Physician Decision|1|||
129529861|NCT01809327|466227205|FG002|Overall Study|Physician Decision|0|||
129529862|NCT01809327|466227206|FG003|Overall Study|Physician Decision|0|||
129529863|NCT01809327|466227207|FG004|Overall Study|Physician Decision|0|||
129529864|NCT01809327|466227203|FG000|Overall Study|Pregnancy|1|||
129529865|NCT01809327|466227204|FG001|Overall Study|Pregnancy|0|||
129529866|NCT01809327|466227205|FG002|Overall Study|Pregnancy|0|||
129529867|NCT01809327|466227206|FG003|Overall Study|Pregnancy|0|||
129529868|NCT01809327|466227207|FG004|Overall Study|Pregnancy|0|||
129529869|NCT01809327|466227203|FG000|Overall Study|Other|14|||
129529870|NCT01809327|466227204|FG001|Overall Study|Other|15|||
129529871|NCT01809327|466227205|FG002|Overall Study|Other|7|||
129529872|NCT01809327|466227206|FG003|Overall Study|Other|4|||
129529873|NCT01809327|466227207|FG004|Overall Study|Other|9|||
129529874|NCT03344562|466227208|FG000|Overall Study|Withdrawal by Subject|2|||
129529875|NCT03344562|466227209|FG001|Overall Study|Withdrawal by Subject|0|||
129529876|NCT02390362|466227223|FG000|Overall Study|Withdrawal by Subject|0|||
129529877|NCT02390362|466227224|FG001|Overall Study|Withdrawal by Subject|1|||
129529878|NCT04009824|466227225|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
129529879|NCT04009824|466227226|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
129529880|NCT04009824|466227227|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
129529881|NCT04009824|466227228|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
129529882|NCT04009824|466227229|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
129529883|NCT01024946|466227230|FG000|Overall Study|Screen Failure|3|||
129529884|NCT01024946|466227230|FG000|Overall Study|Withdrawal by Subject|1|||
129529885|NCT01024946|466227230|FG000|Overall Study|Adverse Event|1|||
129529886|NCT02274766|466227231|FG000|Overall Study|Withdrawal by Subject|3|||
129529887|NCT02274766|466227232|FG001|Overall Study|Withdrawal by Subject|6|||
129529888|NCT02274766|466227231|FG000|Overall Study|Did Not Receive Study Drug|1|||
129529889|NCT02274766|466227232|FG001|Overall Study|Did Not Receive Study Drug|1|||
129529890|NCT02274766|466227231|FG000|Overall Study|Subject Unwilling to Proceed|0|||
129529891|NCT02274766|466227232|FG001|Overall Study|Subject Unwilling to Proceed|1|||
129529892|NCT02274766|466227231|FG000|Overall Study|Adverse Event|0|||
129529893|NCT02274766|466227232|FG001|Overall Study|Adverse Event|1|||
129529894|NCT00281528|466227233|FG000|Overall Study|Progressive Disease|28|||
129529895|NCT00281528|466227234|FG001|Overall Study|Progressive Disease|18|||
129529896|NCT00281528|466227235|FG002|Overall Study|Progressive Disease|27|||
129529897|NCT00281528|466227233|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
129529898|NCT00281528|466227234|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
129529899|NCT00281528|466227235|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
129529900|NCT00281528|466227233|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
129529901|NCT00281528|466227234|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
129529902|NCT00281528|466227235|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
129529903|NCT00281528|466227233|FG000|Overall Study|Physician Decision|11|||
129529904|NCT00281528|466227234|FG001|Overall Study|Physician Decision|4|||
129529905|NCT00281528|466227235|FG002|Overall Study|Physician Decision|5|||
129529906|NCT00281528|466227233|FG000|Overall Study|Protocol Violation|1|||
129529907|NCT00281528|466227234|FG001|Overall Study|Protocol Violation|0|||
129529908|NCT00281528|466227235|FG002|Overall Study|Protocol Violation|1|||
129529909|NCT00281528|466227233|FG000|Overall Study|Withdrawal by Subject|5|||
129529910|NCT00281528|466227234|FG001|Overall Study|Withdrawal by Subject|5|||
129529911|NCT00281528|466227235|FG002|Overall Study|Withdrawal by Subject|7|||
129529912|NCT00281528|466227233|FG000|Overall Study|Other|6|||
129529913|NCT00281528|466227234|FG001|Overall Study|Other|3|||
129529914|NCT00281528|466227235|FG002|Overall Study|Other|5|||
129529915|NCT01436357|466227240|FG000|Overall Study|Death|5|||
129529916|NCT01436357|466227241|FG001|Overall Study|Death|1|||
129529917|NCT01436357|466227240|FG000|Overall Study|Enrolled but not vaccinated|1|||
129529918|NCT01436357|466227241|FG001|Overall Study|Enrolled but not vaccinated|1|||
129529919|NCT01436357|466227240|FG000|Overall Study|Incarceration|18|||
129529920|NCT01436357|466227241|FG001|Overall Study|Incarceration|20|||
129529921|NCT01436357|466227240|FG000|Overall Study|Lost to Follow-up|67|||
129529922|NCT01436357|466227241|FG001|Overall Study|Lost to Follow-up|61|||
129529923|NCT01436357|466227240|FG000|Overall Study|Protocol Violation|1|||
129529924|NCT01436357|466227241|FG001|Overall Study|Protocol Violation|0|||
129529925|NCT01436357|466227240|FG000|Overall Study|Withdrawal by Subject|26|||
129529926|NCT01436357|466227241|FG001|Overall Study|Withdrawal by Subject|38|||
129529927|NCT01436357|466227240|FG000|Overall Study|Physician Decision|3|||
129529928|NCT01436357|466227241|FG001|Overall Study|Physician Decision|4|||
129529929|NCT01436357|466227240|FG000|Overall Study|Moved out of area|1|||
129529930|NCT01436357|466227241|FG001|Overall Study|Moved out of area|2|||
129529931|NCT01436357|466227240|FG000|Overall Study|Subject in rehab|0|||
129529932|NCT01436357|466227241|FG001|Overall Study|Subject in rehab|1|||
129529933|NCT02583399|466228957|FG000|Overall Study|Able to be discharged|3|||
129529934|NCT02583399|466228957|FG000|Overall Study|Wanted to use a restricted medication|3|||
129529935|NCT00364611|466228958|FG000|Overall Study|Did not receive study medication|0|||
129529936|NCT00364611|466228959|FG001|Overall Study|Did not receive study medication|1|||
129529937|NCT00364611|466228958|FG000|Overall Study|Adverse Event|7|||
129529938|NCT00364611|466228959|FG001|Overall Study|Adverse Event|4|||
129529939|NCT00364611|466228958|FG000|Overall Study|Participant's Request|3|||
129529940|NCT00364611|466228959|FG001|Overall Study|Participant's Request|4|||
129529941|NCT00364611|466228958|FG000|Overall Study|Disease Progression|38|||
129529942|NCT00364611|466228959|FG001|Overall Study|Disease Progression|8|||
129529943|NCT00364611|466228958|FG000|Overall Study|Investigator decision|2|||
129529944|NCT00364611|466228959|FG001|Overall Study|Investigator decision|2|||
129529945|NCT00364611|466228958|FG000|Overall Study|Found Ineligible|1|||
129529946|NCT00364611|466228959|FG001|Overall Study|Found Ineligible|0|||
129529947|NCT00364611|466228958|FG000|Overall Study|Presumed CR on Study|0|||
129529948|NCT00364611|466228959|FG001|Overall Study|Presumed CR on Study|1|||
129529949|NCT00364611|466228958|FG000|Overall Study|Receiving Liver Ablation|0|||
129529950|NCT00364611|466228959|FG001|Overall Study|Receiving Liver Ablation|1|||
129529951|NCT02759939|466228964|FG000|Overall Study|Missing data on first outcome assessed|11|||
129529952|NCT02759939|466228965|FG001|Overall Study|Missing data on first outcome assessed|2|||
129529953|NCT02759939|466228966|FG002|Overall Study|Missing data on first outcome assessed|5|||
129529954|NCT02759939|466228967|FG003|Overall Study|Missing data on first outcome assessed|2|||
129529955|NCT02759939|466228964|FG000|Overall Study|Ineligible for T2 and T3|310|||
129529956|NCT02759939|466228965|FG001|Overall Study|Ineligible for T2 and T3|179|||
129529957|NCT02759939|466228966|FG002|Overall Study|Ineligible for T2 and T3|366|||
129529958|NCT02759939|466228967|FG003|Overall Study|Ineligible for T2 and T3|391|||
129529959|NCT02759939|466228964|FG000|Overall Study|Lost to Follow-up|735|||
129529960|NCT02759939|466228965|FG001|Overall Study|Lost to Follow-up|791|||
129529961|NCT02759939|466228966|FG002|Overall Study|Lost to Follow-up|783|||
129529962|NCT02759939|466228967|FG003|Overall Study|Lost to Follow-up|650|||
129529963|NCT04397757|466228969|FG000|Overall Study|Death|3|||
129529964|NCT04397757|466228970|FG001|Overall Study|Death|11|||
129529965|NCT04397757|466228969|FG000|Overall Study|Withdrawal by Subject|2|||
129529966|NCT04397757|466228970|FG001|Overall Study|Withdrawal by Subject|0|||
129529967|NCT04397757|466228969|FG000|Overall Study|Lost to Follow-up|4|||
129529968|NCT04397757|466228970|FG001|Overall Study|Lost to Follow-up|3|||
129529969|NCT00535236|466228975|FG000|Overall Study|Adverse Event|1|||
129529970|NCT00535236|466228976|FG001|Overall Study|Adverse Event|0|||
129529971|NCT00535236|466228977|FG002|Overall Study|Adverse Event|9|||
129529972|NCT00535236|466228978|FG003|Overall Study|Adverse Event|3|||
129529973|NCT00535236|466228979|FG004|Overall Study|Adverse Event|3|||
129529974|NCT00535236|466228980|FG005|Overall Study|Adverse Event|0|||
129529975|NCT00535236|466228981|FG006|Overall Study|Adverse Event|5|||
129529976|NCT00535236|466228982|FG007|Overall Study|Adverse Event|1|||
129529977|NCT00535236|466228983|FG008|Overall Study|Adverse Event|2|||
129529978|NCT00535236|466228984|FG009|Overall Study|Adverse Event|1|||
129529979|NCT00535236|466228975|FG000|Overall Study|Lost to Follow-up|1|||
129529980|NCT00535236|466228976|FG001|Overall Study|Lost to Follow-up|2|||
129529981|NCT00535236|466228977|FG002|Overall Study|Lost to Follow-up|0|||
129529982|NCT00535236|466228978|FG003|Overall Study|Lost to Follow-up|0|||
129529983|NCT00535236|466228979|FG004|Overall Study|Lost to Follow-up|2|||
129529984|NCT00535236|466228980|FG005|Overall Study|Lost to Follow-up|0|||
129529985|NCT00535236|466228981|FG006|Overall Study|Lost to Follow-up|0|||
129529986|NCT00535236|466228982|FG007|Overall Study|Lost to Follow-up|0|||
129529987|NCT00535236|466228983|FG008|Overall Study|Lost to Follow-up|6|||
129529988|NCT00535236|466228984|FG009|Overall Study|Lost to Follow-up|1|||
129529989|NCT00535236|466228975|FG000|Overall Study|Physician Decision|0|||
129529990|NCT00535236|466228976|FG001|Overall Study|Physician Decision|0|||
129529991|NCT00535236|466228977|FG002|Overall Study|Physician Decision|0|||
129529992|NCT00535236|466228978|FG003|Overall Study|Physician Decision|0|||
129529993|NCT00535236|466228979|FG004|Overall Study|Physician Decision|1|||
129529994|NCT00535236|466228980|FG005|Overall Study|Physician Decision|0|||
129529995|NCT00535236|466228981|FG006|Overall Study|Physician Decision|1|||
129529996|NCT00535236|466228982|FG007|Overall Study|Physician Decision|0|||
129529997|NCT00535236|466228983|FG008|Overall Study|Physician Decision|0|||
129529998|NCT00535236|466228984|FG009|Overall Study|Physician Decision|0|||
129529999|NCT00535236|466228975|FG000|Overall Study|Protocol Violation|2|||
129530000|NCT00535236|466228976|FG001|Overall Study|Protocol Violation|0|||
129530001|NCT00535236|466228977|FG002|Overall Study|Protocol Violation|1|||
129530002|NCT00535236|466228978|FG003|Overall Study|Protocol Violation|0|||
129530003|NCT00535236|466228979|FG004|Overall Study|Protocol Violation|0|||
129530004|NCT00535236|466228980|FG005|Overall Study|Protocol Violation|0|||
129530005|NCT00535236|466228981|FG006|Overall Study|Protocol Violation|0|||
129530006|NCT00535236|466228982|FG007|Overall Study|Protocol Violation|0|||
129530007|NCT00535236|466228983|FG008|Overall Study|Protocol Violation|1|||
129530008|NCT00535236|466228984|FG009|Overall Study|Protocol Violation|0|||
129530009|NCT00535236|466228975|FG000|Overall Study|Withdrawal by Subject|3|||
129530010|NCT00535236|466228976|FG001|Overall Study|Withdrawal by Subject|0|||
129530011|NCT00535236|466228977|FG002|Overall Study|Withdrawal by Subject|2|||
129530012|NCT00535236|466228978|FG003|Overall Study|Withdrawal by Subject|1|||
129530013|NCT00535236|466228979|FG004|Overall Study|Withdrawal by Subject|6|||
129530014|NCT00535236|466228980|FG005|Overall Study|Withdrawal by Subject|1|||
129530015|NCT00535236|466228981|FG006|Overall Study|Withdrawal by Subject|5|||
129530016|NCT00535236|466228982|FG007|Overall Study|Withdrawal by Subject|0|||
129530017|NCT00535236|466228983|FG008|Overall Study|Withdrawal by Subject|4|||
129530018|NCT00535236|466228984|FG009|Overall Study|Withdrawal by Subject|2|||
129530019|NCT03288987|466228986|FG000|Overall Study|Protocol Violation|10|||
129530020|NCT03288987|466228987|FG001|Overall Study|Protocol Violation|4|||
129530021|NCT04905563|466228990|FG000|Overall Study|Withdrawal by Subject|1|||
129530022|NCT04905563|466228991|FG001|Overall Study|Withdrawal by Subject|0|||
129530023|NCT04905563|466228990|FG000|Overall Study|Standard of care orders entered by resident|1|||
129530024|NCT04905563|466228991|FG001|Overall Study|Standard of care orders entered by resident|0|||
129530025|NCT04905563|466228990|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
129530026|NCT04905563|466228991|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
129530027|NCT04905563|466228990|FG000|Overall Study|Withdrawal by Subject|0|||
129530028|NCT04905563|466228991|FG001|Overall Study|Withdrawal by Subject|1|||
129530029|NCT02447952|466228995|FG000|Overall Study|Adverse Event|2|||
129530030|NCT02447952|466228995|FG000|Overall Study|Physician Decision|1|||
129530031|NCT02447952|466228995|FG000|Overall Study|Withdrawal by Subject|4|||
129530032|NCT04554394|466228996|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
129530033|NCT04554394|466228997|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
129530034|NCT04554394|466228996|FG000|Overall Study|Withdrawal by Subject|2|||
129530035|NCT04554394|466228997|FG001|Overall Study|Withdrawal by Subject|2|||
129530036|NCT04554394|466228996|FG000|Overall Study|Lost to Follow-up|2|||
129530037|NCT04554394|466228997|FG001|Overall Study|Lost to Follow-up|2|||
129530038|NCT04554394|466228996|FG000|Overall Study|Physician Decision|1|||
129530039|NCT04554394|466228997|FG001|Overall Study|Physician Decision|1|||
129530040|NCT02584660|466229001|FG000|Overall Study|Adverse Event|4|||
129530041|NCT02584660|466229002|FG001|Overall Study|Adverse Event|0|||
129530042|NCT02584660|466229001|FG000|Overall Study|Lost to Follow-up|3|||
129530043|NCT02584660|466229002|FG001|Overall Study|Lost to Follow-up|4|||
129530044|NCT02584660|466229001|FG000|Overall Study|Protocol Violation|0|||
129530045|NCT02584660|466229002|FG001|Overall Study|Protocol Violation|1|||
129530046|NCT02584660|466229001|FG000|Overall Study|Withdrawal by Subject|0|||
129530047|NCT02584660|466229002|FG001|Overall Study|Withdrawal by Subject|2|||
129530048|NCT02584660|466229001|FG000|Overall Study|Other|0|||
129530049|NCT02584660|466229002|FG001|Overall Study|Other|1|||
129530050|NCT03099304|466229003|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
129530051|NCT03099304|466229004|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
129530052|NCT03099304|466229005|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
129530053|NCT03099304|466229006|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
129530054|NCT03099304|466229007|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
129530055|NCT03099304|466229008|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
129530056|NCT03099304|466229003|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
129530057|NCT03099304|466229004|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
129530058|NCT03099304|466229005|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
129530059|NCT03099304|466229006|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
129530060|NCT03099304|466229007|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
129530061|NCT03099304|466229008|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
129530062|NCT03099304|466229003|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
129530063|NCT03099304|466229004|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
129530064|NCT03099304|466229005|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
129530065|NCT03099304|466229006|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
129530066|NCT03099304|466229007|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
129530067|NCT03099304|466229008|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
129530068|NCT03099304|466229003|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
129530069|NCT03099304|466229004|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
129530070|NCT03099304|466229005|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
129530071|NCT03099304|466229006|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
129530072|NCT03099304|466229007|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
129530073|NCT03099304|466229008|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
129530074|NCT03099304|466229003|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
129530075|NCT03099304|466229004|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
129530076|NCT03099304|466229005|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
129530077|NCT03099304|466229006|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
129530078|NCT03099304|466229007|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
129530079|NCT03099304|466229008|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
129530080|NCT03099304|466229003|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
129530081|NCT03099304|466229004|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
129530082|NCT03099304|466229005|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
129530083|NCT03099304|466229006|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
129530084|NCT03099304|466229007|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
129530085|NCT03099304|466229008|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
129530086|NCT03099304|466229003|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
129530087|NCT03099304|466229004|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
129530088|NCT03099304|466229005|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
129530089|NCT03099304|466229006|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
129530090|NCT03099304|466229007|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
129530091|NCT03099304|466229008|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
129530092|NCT03099304|466229003|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
129530093|NCT03099304|466229004|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
129530094|NCT03099304|466229005|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
129530095|NCT03099304|466229006|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
129530096|NCT03099304|466229007|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
129530097|NCT03099304|466229008|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
129530098|NCT03099304|466229003|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
129530099|NCT03099304|466229004|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
129530100|NCT03099304|466229005|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
129530101|NCT03099304|466229006|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
129530102|NCT03099304|466229007|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
129530103|NCT03099304|466229008|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
129530104|NCT03099304|466229003|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
129530105|NCT03099304|466229004|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
129530106|NCT03099304|466229005|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
129530107|NCT03099304|466229006|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
129530108|NCT03099304|466229007|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
129530109|NCT03099304|466229008|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
129530110|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
129530111|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
129530112|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
129530113|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
129530114|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
129530115|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
129530116|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
129530117|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
129530118|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
129530119|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
129530120|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
129530121|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
129530122|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
129530123|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
129530124|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
129530125|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
129530126|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
129530127|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
129530128|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
129530129|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
129530130|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
129530131|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
129530132|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
129530133|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
129530134|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
129530135|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
129530136|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
129530137|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
129530138|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
129530139|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
129530140|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
129530141|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
129530142|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
129530143|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
129530144|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
129530145|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
129530146|NCT03099304|466229003|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
129530147|NCT03099304|466229004|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
129530148|NCT03099304|466229005|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
129530149|NCT03099304|466229006|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
129530150|NCT03099304|466229007|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
129530151|NCT03099304|466229008|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
129530152|NCT01142791|466229010|FG000|Overall Study|Alternative Treatment|1|||
129530153|NCT01142791|466229011|FG001|Overall Study|Alternative Treatment|0|||
129530154|NCT01142791|466229010|FG000|Overall Study|Lost to Follow-up|1|||
129530155|NCT01142791|466229011|FG001|Overall Study|Lost to Follow-up|0|||
129530156|NCT01142791|466229010|FG000|Overall Study|Withdrawal by Subject|5|||
129530157|NCT01142791|466229011|FG001|Overall Study|Withdrawal by Subject|0|||
129530158|NCT01142791|466229010|FG000|Overall Study|Received only 1 sonication|0|||
129530159|NCT01142791|466229011|FG001|Overall Study|Received only 1 sonication|6|||
129530160|NCT02590406|466229012|FG000|Overall Study|Adverse Event|1|||
129530161|NCT02590406|466229013|FG001|Overall Study|Adverse Event|0|||
129530162|NCT02590406|466229012|FG000|Overall Study|Saturometer malfunction|0|||
129530163|NCT02590406|466229013|FG001|Overall Study|Saturometer malfunction|1|||
129530164|NCT03032523|466229014|FG000|Overall Study|Withdrawal by Subject|2|||
129530165|NCT03032523|466229015|FG001|Overall Study|Withdrawal by Subject|2|||
129530166|NCT03032523|466229014|FG000|Overall Study|Physician Decision|1|||
129530167|NCT03032523|466229015|FG001|Overall Study|Physician Decision|0|||
129530168|NCT00957723|466229018|FG000|Overall Study|Death|3|||
129530169|NCT00957723|466229018|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
129530170|NCT00957723|466229018|FG000|Overall Study|Lost to Follow-up|8|||
129530171|NCT00957723|466229018|FG000|Overall Study|Withdrawal by Subject|24|||
129530172|NCT00957723|466229018|FG000|Overall Study|Investigative Site Terminated|61|||
129530173|NCT00957723|466229018|FG000|Overall Study|Intercurrent Illness|2|||
129530174|NCT00957723|466229018|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
129530175|NCT05375838|466229019|FG000|Overall Study|Other|0|||
129530176|NCT05375838|466229020|FG001|Overall Study|Other|0|||
129530177|NCT05375838|466229021|FG002|Overall Study|Other|0|||
129530178|NCT05375838|466229022|FG003|Overall Study|Other|1|||
129530179|NCT05375838|466229023|FG004|Overall Study|Other|1|||
129530180|NCT05375838|466229024|FG005|Overall Study|Other|0|||
129530181|NCT05375838|466229019|FG000|Overall Study|Withdrawal by Subject|2|||
129530182|NCT05375838|466229020|FG001|Overall Study|Withdrawal by Subject|1|||
129530183|NCT05375838|466229021|FG002|Overall Study|Withdrawal by Subject|3|||
129530184|NCT05375838|466229022|FG003|Overall Study|Withdrawal by Subject|2|||
129530185|NCT05375838|466229023|FG004|Overall Study|Withdrawal by Subject|2|||
129530186|NCT05375838|466229024|FG005|Overall Study|Withdrawal by Subject|0|||
129530187|NCT05375838|466229019|FG000|Overall Study|Protocol Violation|0|||
129530188|NCT05375838|466229020|FG001|Overall Study|Protocol Violation|0|||
129530189|NCT05375838|466229021|FG002|Overall Study|Protocol Violation|0|||
129530190|NCT05375838|466229022|FG003|Overall Study|Protocol Violation|0|||
129530191|NCT05375838|466229023|FG004|Overall Study|Protocol Violation|1|||
129530192|NCT05375838|466229024|FG005|Overall Study|Protocol Violation|0|||
129530193|NCT05375838|466229019|FG000|Overall Study|Physician Decision|0|||
129530194|NCT05375838|466229020|FG001|Overall Study|Physician Decision|1|||
129530195|NCT05375838|466229021|FG002|Overall Study|Physician Decision|0|||
129530196|NCT05375838|466229022|FG003|Overall Study|Physician Decision|0|||
129530197|NCT05375838|466229023|FG004|Overall Study|Physician Decision|0|||
129530198|NCT05375838|466229024|FG005|Overall Study|Physician Decision|1|||
129530199|NCT05375838|466229019|FG000|Overall Study|Lost to Follow-up|2|||
129530200|NCT05375838|466229020|FG001|Overall Study|Lost to Follow-up|7|||
129530201|NCT05375838|466229021|FG002|Overall Study|Lost to Follow-up|0|||
129530202|NCT05375838|466229022|FG003|Overall Study|Lost to Follow-up|4|||
129530203|NCT05375838|466229023|FG004|Overall Study|Lost to Follow-up|2|||
129530204|NCT05375838|466229024|FG005|Overall Study|Lost to Follow-up|3|||
129530205|NCT00984009|466229025|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
129530206|NCT02036476|466229033|FG000|Overall Study|Withdrawal by Subject|2|||
129530207|NCT02036476|466229033|FG000|Overall Study|Progressive Disease|4|||
129530208|NCT02036476|466229033|FG000|Overall Study|Unacceptable Toxicity|2|||
129530209|NCT02168816|466229034|FG000|Overall Study|Lost to Follow-up|2|||
129530210|NCT02168816|466229035|FG001|Overall Study|Lost to Follow-up|2|||
129530211|NCT01984294|466229038|FG000|Overall Study|Randomized but Never Treated|0|||
129530212|NCT01984294|466229039|FG001|Overall Study|Randomized but Never Treated|0|||
129530213|NCT01984294|466229040|FG002|Overall Study|Randomized but Never Treated|1|||
129530214|NCT01984294|466229038|FG000|Overall Study|Lack of Efficacy|4|||
129530215|NCT01984294|466229039|FG001|Overall Study|Lack of Efficacy|2|||
129530216|NCT01984294|466229040|FG002|Overall Study|Lack of Efficacy|6|||
129530217|NCT01984294|466229038|FG000|Overall Study|Adverse Event|0|||
129530218|NCT01984294|466229039|FG001|Overall Study|Adverse Event|1|||
129530219|NCT01984294|466229040|FG002|Overall Study|Adverse Event|0|||
129530220|NCT02993783|466229043|FG000|Overall Study|Reason not Specified|6|||
129530221|NCT02993783|466229044|FG001|Overall Study|Reason not Specified|9|||
129530222|NCT01987609|466229045|FG000|Overall Study|Adverse Event|1|||
129530223|NCT02610231|466229046|FG000|Overall Study|Withdrawal by Subject|27|||
129530224|NCT02610231|466229046|FG000|Overall Study|Adverse Event|20|||
129530225|NCT02610231|466229046|FG000|Overall Study|Death|5|||
129530226|NCT02610231|466229046|FG000|Overall Study|Surgery|2|||
129530227|NCT02610231|466229046|FG000|Overall Study|Physician Decision|1|||
129530228|NCT02610231|466229046|FG000|Overall Study|Non Compliance|2|||
129530229|NCT02610231|466229046|FG000|Overall Study|Other|3|||
129530230|NCT00806494|466229047|FG000|Overall Study|Adverse Event|29|||
129530231|NCT00806494|466229047|FG000|Overall Study|Lack of Efficacy|6|||
129530232|NCT00806494|466229047|FG000|Overall Study|Lost to Follow-up|10|||
129530233|NCT00806494|466229047|FG000|Overall Study|Other|30|||
129530234|NCT00806494|466229047|FG000|Overall Study|Withdrawal by Subject|5|||
129530235|NCT01279954|466229048|FG000|Overall Study|Lack of Efficacy|3|||
129530236|NCT01279954|466229049|FG001|Overall Study|Lack of Efficacy|4|||
129530237|NCT02709889|466229050|FG000|Overall Study|Withdrawal by Subject|11|||
129530238|NCT02709889|466229051|FG001|Overall Study|Withdrawal by Subject|10|||
129530239|NCT02709889|466229052|FG002|Overall Study|Withdrawal by Subject|2|||
129530240|NCT02709889|466229053|FG003|Overall Study|Withdrawal by Subject|12|||
129530241|NCT02709889|466229050|FG000|Overall Study|Death|25|||
129530242|NCT02709889|466229051|FG001|Overall Study|Death|38|||
129530243|NCT02709889|466229052|FG002|Overall Study|Death|4|||
129530244|NCT02709889|466229053|FG003|Overall Study|Death|44|||
129530245|NCT02709889|466229050|FG000|Overall Study|Physician Decision|1|||
129530246|NCT02709889|466229051|FG001|Overall Study|Physician Decision|2|||
129530247|NCT02709889|466229052|FG002|Overall Study|Physician Decision|3|||
129530248|NCT02709889|466229053|FG003|Overall Study|Physician Decision|5|||
129530249|NCT02709889|466229050|FG000|Overall Study|Lost to Follow-up|2|||
129530250|NCT02709889|466229051|FG001|Overall Study|Lost to Follow-up|0|||
129530251|NCT02709889|466229052|FG002|Overall Study|Lost to Follow-up|0|||
129530252|NCT02709889|466229053|FG003|Overall Study|Lost to Follow-up|4|||
129530253|NCT02709889|466229050|FG000|Overall Study|Study Terminated by Sponsor|4|||
129530254|NCT02709889|466229051|FG001|Overall Study|Study Terminated by Sponsor|6|||
129530255|NCT02709889|466229052|FG002|Overall Study|Study Terminated by Sponsor|2|||
129530256|NCT02709889|466229053|FG003|Overall Study|Study Terminated by Sponsor|17|||
129530257|NCT02709889|466229050|FG000|Overall Study|Other, Not Specified|0|||
129530258|NCT02709889|466229051|FG001|Overall Study|Other, Not Specified|1|||
129530259|NCT02709889|466229052|FG002|Overall Study|Other, Not Specified|1|||
129530260|NCT02709889|466229053|FG003|Overall Study|Other, Not Specified|6|||
129530261|NCT00537810|466229054|FG000|Overall Study|Withdrawal by Subject|4|||
129530262|NCT00537810|466229055|FG001|Overall Study|Withdrawal by Subject|11|||
129530263|NCT00537810|466229056|FG002|Overall Study|Withdrawal by Subject|4|||
129530264|NCT00537810|466229057|FG003|Overall Study|Withdrawal by Subject|3|||
129530265|NCT00537810|466229054|FG000|Overall Study|Medically withdrawn|2|||
129530266|NCT00537810|466229055|FG001|Overall Study|Medically withdrawn|2|||
129530267|NCT00537810|466229056|FG002|Overall Study|Medically withdrawn|0|||
129530268|NCT00537810|466229057|FG003|Overall Study|Medically withdrawn|1|||
129530269|NCT01066546|466229058|FG000|Overall Study|Study terminated by sponsor|5|||
129530270|NCT03258762|466229063|FG000|Overall Study|Lost to Follow-up|0|||
129530271|NCT03258762|466229064|FG001|Overall Study|Lost to Follow-up|1|||
129530272|NCT01711359|466229065|FG000|Treatment Period|Withdrawal by Subject|18|||
129530273|NCT01711359|466229066|FG001|Treatment Period|Withdrawal by Subject|7|||
129530274|NCT01711359|466229067|FG002|Treatment Period|Withdrawal by Subject|13|||
129530275|NCT01711359|466229065|FG000|Treatment Period|Lack of Efficacy|13|||
129530276|NCT01711359|466229066|FG001|Treatment Period|Lack of Efficacy|2|||
129530277|NCT01711359|466229067|FG002|Treatment Period|Lack of Efficacy|2|||
129530278|NCT01711359|466229065|FG000|Treatment Period|Adverse Event|8|||
129530279|NCT01711359|466229066|FG001|Treatment Period|Adverse Event|10|||
129530280|NCT01711359|466229067|FG002|Treatment Period|Adverse Event|24|||
129530281|NCT01711359|466229065|FG000|Treatment Period|Physician Decision|4|||
129530282|NCT01711359|466229066|FG001|Treatment Period|Physician Decision|3|||
129530283|NCT01711359|466229067|FG002|Treatment Period|Physician Decision|2|||
129530284|NCT01711359|466229065|FG000|Treatment Period|Death|3|||
129530285|NCT01711359|466229066|FG001|Treatment Period|Death|0|||
129530286|NCT01711359|466229067|FG002|Treatment Period|Death|0|||
129530287|NCT01711359|466229065|FG000|Treatment Period|Entry Criteria Not Met|1|||
129530288|NCT01711359|466229066|FG001|Treatment Period|Entry Criteria Not Met|0|||
129530289|NCT01711359|466229067|FG002|Treatment Period|Entry Criteria Not Met|0|||
129530290|NCT01711359|466229065|FG000|Treatment Period|Sponsor Decision|1|||
129530291|NCT01711359|466229066|FG001|Treatment Period|Sponsor Decision|0|||
129530292|NCT01711359|466229067|FG002|Treatment Period|Sponsor Decision|0|||
129530293|NCT01711359|466229065|FG000|Treatment Period|Lost to Follow-up|1|||
129530294|NCT01711359|466229066|FG001|Treatment Period|Lost to Follow-up|1|||
129530295|NCT01711359|466229067|FG002|Treatment Period|Lost to Follow-up|1|||
129530296|NCT01711359|466229065|FG000|Treatment Period|Randomized, Not Treated|3|||
129530297|NCT01711359|466229066|FG001|Treatment Period|Randomized, Not Treated|1|||
129530298|NCT01711359|466229067|FG002|Treatment Period|Randomized, Not Treated|0|||
129530299|NCT00554840|466229068|FG000|Overall Study|Physician Decision|0|||
129530300|NCT00554840|466229069|FG001|Overall Study|Physician Decision|1|||
129530301|NCT01385098|466229070|FG000|Overall Study|Adverse Event|10|||
129530302|NCT01385098|466229070|FG000|Overall Study|Lost to Follow-up|4|||
129530303|NCT02698176|466229071|FG000|Overall Study|Progressive disease|4|||
129530304|NCT02698176|466229072|FG001|Overall Study|Progressive disease|3|||
129530305|NCT02698176|466229073|FG002|Overall Study|Progressive disease|1|||
129530306|NCT02698176|466229074|FG003|Overall Study|Progressive disease|0|||
129530307|NCT02698176|466229071|FG000|Overall Study|Adverse Event|2|||
129530308|NCT02698176|466229072|FG001|Overall Study|Adverse Event|0|||
129530309|NCT02698176|466229073|FG002|Overall Study|Adverse Event|0|||
129530310|NCT02698176|466229074|FG003|Overall Study|Adverse Event|0|||
129530311|NCT02698176|466229071|FG000|Overall Study|Clinical progression|3|||
129530312|NCT02698176|466229072|FG001|Overall Study|Clinical progression|0|||
129530313|NCT02698176|466229073|FG002|Overall Study|Clinical progression|0|||
129530314|NCT02698176|466229074|FG003|Overall Study|Clinical progression|0|||
129530315|NCT02561572|466229077|FG000|Overall Study|Inadequate time before surgery|2|||
129530316|NCT02561572|466229078|FG001|Overall Study|Inadequate time before surgery|1|||
129530317|NCT02561572|466229077|FG000|Overall Study|Protocol Violation|0|||
129530318|NCT02561572|466229078|FG001|Overall Study|Protocol Violation|1|||
129530319|NCT00795717|466229079|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
129530320|NCT00795717|466229080|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
129530321|NCT00795717|466229079|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
129530322|NCT00795717|466229080|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
129530323|NCT00795717|466229079|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
129530324|NCT00795717|466229080|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
129530325|NCT00795717|466229079|FG000|Phase II|too busy|0|||
129530326|NCT00795717|466229080|FG001|Phase II|too busy|1|||
129530327|NCT02985684|466229086|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
129530328|NCT02985684|466229086|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
129530329|NCT02985684|466229086|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
129530330|NCT00424463|466229087|FG000|Overall Study|Adverse Event|2|||
129530331|NCT00424463|466229088|FG001|Overall Study|Adverse Event|3|||
129530332|NCT00424463|466229089|FG002|Overall Study|Adverse Event|2|||
129530333|NCT00424463|466229087|FG000|Overall Study|Physician Decision|0|||
129530334|NCT00424463|466229088|FG001|Overall Study|Physician Decision|2|||
129530335|NCT00424463|466229089|FG002|Overall Study|Physician Decision|2|||
129530336|NCT00424463|466229087|FG000|Overall Study|Withdrawal by Subject|4|||
129530337|NCT00424463|466229088|FG001|Overall Study|Withdrawal by Subject|2|||
129530338|NCT00424463|466229089|FG002|Overall Study|Withdrawal by Subject|5|||
129530339|NCT00424463|466229087|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
129530340|NCT00424463|466229088|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
129530341|NCT00424463|466229089|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
129530342|NCT00424463|466229087|FG000|Overall Study|Patient's convenience|0|||
129530343|NCT00424463|466229088|FG001|Overall Study|Patient's convenience|0|||
129530344|NCT00424463|466229089|FG002|Overall Study|Patient's convenience|1|||
129530345|NCT00656799|466229090|FG000|Overall Study|Death|2|||
129530346|NCT05281094|466229091|FG000|Overall Study|Adverse Event|1|||
129530347|NCT05281094|466229092|FG001|Overall Study|Adverse Event|0|||
129530348|NCT05281094|466229091|FG000|Overall Study|Lost to Follow-up|29|||
129530349|NCT05281094|466229092|FG001|Overall Study|Lost to Follow-up|22|||
129530350|NCT05281094|466229091|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
129530351|NCT05281094|466229092|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
129530352|NCT05281094|466229091|FG000|Overall Study|Death|1|||
129530353|NCT05281094|466229092|FG001|Overall Study|Death|2|||
129530354|NCT05281094|466229091|FG000|Overall Study|Not pre-specified reason|8|||
129530355|NCT05281094|466229092|FG001|Overall Study|Not pre-specified reason|5|||
129530356|NCT00631969|466229097|FG000|Overall Study|Adverse Event|3|||
129530357|NCT00631969|466229098|FG001|Overall Study|Adverse Event|1|||
129530358|NCT00631969|466229097|FG000|Overall Study|Lack of Efficacy|2|||
129530359|NCT00631969|466229098|FG001|Overall Study|Lack of Efficacy|8|||
129530360|NCT00631969|466229097|FG000|Overall Study|Lost to Follow-up|2|||
129530361|NCT00631969|466229098|FG001|Overall Study|Lost to Follow-up|1|||
129530362|NCT00631969|466229097|FG000|Overall Study|Protocol Violation|1|||
129530363|NCT00631969|466229098|FG001|Overall Study|Protocol Violation|1|||
129530364|NCT00631969|466229097|FG000|Overall Study|Consent Withdrawn|5|||
129530365|NCT00631969|466229098|FG001|Overall Study|Consent Withdrawn|7|||
129530366|NCT00631969|466229097|FG000|Overall Study|Noncompliant With Study Medication|0|||
129530367|NCT00631969|466229098|FG001|Overall Study|Noncompliant With Study Medication|1|||
129530368|NCT00631969|466229097|FG000|Overall Study|No Drug Exposure|2|||
129530369|NCT00631969|466229098|FG001|Overall Study|No Drug Exposure|2|||
129530370|NCT05315297|466229099|FG000|Overall Study|Lost to Follow-up|6|||
129530371|NCT05315297|466229100|FG001|Overall Study|Lost to Follow-up|4|||
129530372|NCT05315297|466229099|FG000|Overall Study|Withdrawal by Subject|0|||
129530373|NCT05315297|466229100|FG001|Overall Study|Withdrawal by Subject|1|||
129530374|NCT03053180|466231173|FG000|Overall Study|Failure to Return|1|||
129530375|NCT04144140|466231178|FG000|Overall Study|Other|0|||
129530376|NCT04144140|466231179|FG001|Overall Study|Other|0|||
129530377|NCT04144140|466231180|FG002|Overall Study|Other|0|||
129530378|NCT04144140|466231181|FG003|Overall Study|Other|0|||
129530379|NCT04144140|466231182|FG004|Overall Study|Other|0|||
129530380|NCT04144140|466231183|FG005|Overall Study|Other|1|||
129530381|NCT04144140|466231184|FG006|Overall Study|Other|0|||
129530382|NCT01465958|466231185|FG000|Run-in Phase|Protocol Violation|1|||
129530383|NCT01465958|466231186|FG001|Run-in Phase|Protocol Violation|0|||
129530384|NCT01465958|466231185|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
129530385|NCT01465958|466231186|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
129530386|NCT00669240|466231195|FG000|Overall Study|Lack of Efficacy|33|||
129530387|NCT00669240|466231195|FG000|Overall Study|Withdrawal by Subject|42|||
129530388|NCT00669240|466231195|FG000|Overall Study|Lost to Follow-up|34|||
129530389|NCT00669240|466231195|FG000|Overall Study|Adverse Event|21|||
129530390|NCT00669240|466231195|FG000|Overall Study|Other|19|||
129530391|NCT00669240|466231195|FG000|Overall Study|Enrolled but not treated|15|||
129530392|NCT00669240|466231195|FG000|Overall Study|Enrolled but no dosing record|1|||
129530393|NCT00959192|466231200|FG000|Overall Study|Adverse Event|1|||
129530394|NCT00959192|466231201|FG001|Overall Study|Adverse Event|1|||
129530395|NCT00959192|466231202|FG002|Overall Study|Adverse Event|1|||
129530396|NCT00959192|466231203|FG003|Overall Study|Adverse Event|0|||
129530397|NCT00959192|466231200|FG000|Overall Study|Investigator Request|1|||
129530398|NCT00959192|466231201|FG001|Overall Study|Investigator Request|0|||
129530399|NCT00959192|466231202|FG002|Overall Study|Investigator Request|0|||
129530400|NCT00959192|466231203|FG003|Overall Study|Investigator Request|0|||
129530401|NCT00959192|466231200|FG000|Overall Study|Caregiver Request|0|||
129530402|NCT00959192|466231201|FG001|Overall Study|Caregiver Request|0|||
129530403|NCT00959192|466231202|FG002|Overall Study|Caregiver Request|2|||
129530404|NCT00959192|466231203|FG003|Overall Study|Caregiver Request|1|||
129530405|NCT00532441|466231204|FG000|Overall Study|Death|1|||
129530406|NCT00532441|466231205|FG001|Overall Study|Death|0|||
129530407|NCT01967134|466231206|FG000|Overall Study|Lost to Follow-up|0|||
129530408|NCT01967134|466231207|FG001|Overall Study|Lost to Follow-up|1|||
129530409|NCT01967134|466231208|FG002|Overall Study|Lost to Follow-up|0|||
129530410|NCT00443534|466231209|FG000|Overall Study|Lack of Efficacy|67|||
129530411|NCT00443534|466231209|FG000|Overall Study|Adverse Event|16|||
129530412|NCT00443534|466231209|FG000|Overall Study|Death|9|||
129530413|NCT00443534|466231209|FG000|Overall Study|Withdrawal by Subject|8|||
129530414|NCT00443534|466231209|FG000|Overall Study|Study Terminated by Sponsor|12|||
129530415|NCT00443534|466231209|FG000|Overall Study|Other|10|||
129530416|NCT00443534|466231209|FG000|Overall Study|Enrolled, Not Treated|1|||
129530417|NCT05466240|466231211|FG000|Overall Study|Adverse Event|1|||
129530418|NCT05466240|466231212|FG001|Overall Study|Adverse Event|0|||
129530419|NCT05466240|466231211|FG000|Overall Study|Withdrawal by Subject|1|||
129530420|NCT05466240|466231212|FG001|Overall Study|Withdrawal by Subject|0|||
129530421|NCT00305773|466231213|FG000|Overall Study|Death|3|||
129530422|NCT00305773|466231214|FG001|Overall Study|Death|2|||
129530423|NCT00305773|466231213|FG000|Overall Study|Adverse Event|1|||
129530424|NCT00305773|466231214|FG001|Overall Study|Adverse Event|2|||
129530425|NCT00305773|466231213|FG000|Overall Study|Alternative Treatment|4|||
129530426|NCT00305773|466231214|FG001|Overall Study|Alternative Treatment|4|||
129530427|NCT00305773|466231213|FG000|Overall Study|Physician Decision|1|||
129530428|NCT00305773|466231214|FG001|Overall Study|Physician Decision|1|||
129530429|NCT00305773|466231213|FG000|Overall Study|Withdrawal by Subject|1|||
129530430|NCT00305773|466231214|FG001|Overall Study|Withdrawal by Subject|4|||
129530431|NCT00305773|466231213|FG000|Overall Study|Disease Progression|1|||
129530432|NCT00305773|466231214|FG001|Overall Study|Disease Progression|3|||
129530433|NCT00305773|466231213|FG000|Overall Study|All other reasons|3|||
129530434|NCT00305773|466231214|FG001|Overall Study|All other reasons|2|||
129530435|NCT02679222|466231215|FG000|Overall Study|No time for project|1|||
129530436|NCT04097925|466231216|FG000|Overall Study|Withdrawal by Subject|1|||
129530437|NCT04735432|466231220|FG000|Overall Study|Other - due to personal reason|1|||
129530438|NCT04735432|466231221|FG001|Overall Study|Other - due to personal reason|0|||
129530439|NCT04735432|466231220|FG000|Overall Study|Adverse Event|2|||
129530440|NCT04735432|466231221|FG001|Overall Study|Adverse Event|0|||
129530441|NCT01823991|466231226|FG000|Overall Study|Withdrawal by Subject|8|||
129530442|NCT01823991|466231227|FG001|Overall Study|Withdrawal by Subject|5|||
129530443|NCT05158244|466231228|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
129530444|NCT05158244|466231229|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
129530445|NCT05158244|466231230|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
129530446|NCT05158244|466231231|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
129530447|NCT05158244|466231232|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
129530448|NCT05158244|466231228|FG000|Overall Study|Withdrawal by Subject|0|||
129530449|NCT05158244|466231229|FG001|Overall Study|Withdrawal by Subject|0|||
129530450|NCT05158244|466231230|FG002|Overall Study|Withdrawal by Subject|1|||
129530451|NCT05158244|466231231|FG003|Overall Study|Withdrawal by Subject|0|||
129530452|NCT05158244|466231232|FG004|Overall Study|Withdrawal by Subject|0|||
129530453|NCT01066819|466231234|FG000|Overall Study|Adverse Event|18|||
129530454|NCT01066819|466231235|FG001|Overall Study|Adverse Event|1|||
129530455|NCT01066819|466231236|FG002|Overall Study|Adverse Event|6|||
129530456|NCT01066819|466231237|FG003|Overall Study|Adverse Event|0|||
129530457|NCT01066819|466231238|FG004|Overall Study|Adverse Event|0|||
129530458|NCT01066819|466231239|FG005|Overall Study|Adverse Event|0|||
129530459|NCT01066819|466231234|FG000|Overall Study|Death|5|||
129530460|NCT01066819|466231235|FG001|Overall Study|Death|0|||
129530461|NCT01066819|466231236|FG002|Overall Study|Death|1|||
129530462|NCT01066819|466231237|FG003|Overall Study|Death|0|||
129530463|NCT01066819|466231238|FG004|Overall Study|Death|0|||
129530464|NCT01066819|466231239|FG005|Overall Study|Death|0|||
129530465|NCT01066819|466231234|FG000|Overall Study|Lack of Efficacy|22|||
129530466|NCT01066819|466231235|FG001|Overall Study|Lack of Efficacy|1|||
129530467|NCT01066819|466231236|FG002|Overall Study|Lack of Efficacy|2|||
129530468|NCT01066819|466231237|FG003|Overall Study|Lack of Efficacy|1|||
129530469|NCT01066819|466231238|FG004|Overall Study|Lack of Efficacy|0|||
129530470|NCT01066819|466231239|FG005|Overall Study|Lack of Efficacy|0|||
129530471|NCT01066819|466231234|FG000|Overall Study|Physician Decision|6|||
129530472|NCT01066819|466231235|FG001|Overall Study|Physician Decision|2|||
129530473|NCT01066819|466231236|FG002|Overall Study|Physician Decision|3|||
129530474|NCT01066819|466231237|FG003|Overall Study|Physician Decision|0|||
129530475|NCT01066819|466231238|FG004|Overall Study|Physician Decision|0|||
129530476|NCT01066819|466231239|FG005|Overall Study|Physician Decision|0|||
129530477|NCT01066819|466231234|FG000|Overall Study|Protocol Violation|12|||
129530478|NCT01066819|466231235|FG001|Overall Study|Protocol Violation|6|||
129530479|NCT01066819|466231236|FG002|Overall Study|Protocol Violation|0|||
129530480|NCT01066819|466231237|FG003|Overall Study|Protocol Violation|0|||
129530481|NCT01066819|466231238|FG004|Overall Study|Protocol Violation|0|||
129530482|NCT01066819|466231239|FG005|Overall Study|Protocol Violation|0|||
129530483|NCT01066819|466231234|FG000|Overall Study|Withdrawal by Subject|29|||
129530484|NCT01066819|466231235|FG001|Overall Study|Withdrawal by Subject|11|||
129530485|NCT01066819|466231236|FG002|Overall Study|Withdrawal by Subject|6|||
129530486|NCT01066819|466231237|FG003|Overall Study|Withdrawal by Subject|0|||
129530487|NCT01066819|466231238|FG004|Overall Study|Withdrawal by Subject|0|||
129530488|NCT01066819|466231239|FG005|Overall Study|Withdrawal by Subject|0|||
129530489|NCT01066819|466231234|FG000|Overall Study|Administrative|6|||
129530490|NCT01066819|466231235|FG001|Overall Study|Administrative|4|||
129530491|NCT01066819|466231236|FG002|Overall Study|Administrative|2|||
129530492|NCT01066819|466231237|FG003|Overall Study|Administrative|0|||
129530493|NCT01066819|466231238|FG004|Overall Study|Administrative|0|||
129530494|NCT01066819|466231239|FG005|Overall Study|Administrative|0|||
129530495|NCT01066819|466231234|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
129530496|NCT01066819|466231235|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
129530497|NCT01066819|466231236|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
129530498|NCT01066819|466231237|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
129530499|NCT01066819|466231238|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
129530500|NCT01066819|466231239|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
129530501|NCT01066819|466231234|FG000|Overall Study|Early termination|2|||
129530502|NCT01066819|466231235|FG001|Overall Study|Early termination|0|||
129530503|NCT01066819|466231236|FG002|Overall Study|Early termination|0|||
129530504|NCT01066819|466231237|FG003|Overall Study|Early termination|0|||
129530505|NCT01066819|466231238|FG004|Overall Study|Early termination|0|||
129530506|NCT01066819|466231239|FG005|Overall Study|Early termination|0|||
129530507|NCT01066819|466231234|FG000|Overall Study|Failed to return|298|||
129530508|NCT01066819|466231235|FG001|Overall Study|Failed to return|107|||
129530509|NCT01066819|466231236|FG002|Overall Study|Failed to return|68|||
129530510|NCT01066819|466231237|FG003|Overall Study|Failed to return|7|||
129530511|NCT01066819|466231238|FG004|Overall Study|Failed to return|2|||
129530512|NCT01066819|466231239|FG005|Overall Study|Failed to return|3|||
129530513|NCT01066819|466231234|FG000|Overall Study|Lab test not done|9|||
129530514|NCT01066819|466231235|FG001|Overall Study|Lab test not done|0|||
129530515|NCT01066819|466231236|FG002|Overall Study|Lab test not done|2|||
129530516|NCT01066819|466231237|FG003|Overall Study|Lab test not done|1|||
129530517|NCT01066819|466231238|FG004|Overall Study|Lab test not done|0|||
129530518|NCT01066819|466231239|FG005|Overall Study|Lab test not done|0|||
129530519|NCT01066819|466231234|FG000|Overall Study|Miscellaneous|28|||
129530520|NCT01066819|466231235|FG001|Overall Study|Miscellaneous|10|||
129530521|NCT01066819|466231236|FG002|Overall Study|Miscellaneous|18|||
129530522|NCT01066819|466231237|FG003|Overall Study|Miscellaneous|1|||
129530523|NCT01066819|466231238|FG004|Overall Study|Miscellaneous|0|||
129530524|NCT01066819|466231239|FG005|Overall Study|Miscellaneous|0|||
129530525|NCT01066819|466231234|FG000|Overall Study|Non responders|123|||
129530526|NCT01066819|466231235|FG001|Overall Study|Non responders|2|||
129530527|NCT01066819|466231236|FG002|Overall Study|Non responders|7|||
129530528|NCT01066819|466231237|FG003|Overall Study|Non responders|2|||
129530529|NCT01066819|466231238|FG004|Overall Study|Non responders|0|||
129530530|NCT01066819|466231239|FG005|Overall Study|Non responders|1|||
129530531|NCT01066819|466231234|FG000|Overall Study|Not categorised|9|||
129530532|NCT01066819|466231235|FG001|Overall Study|Not categorised|2|||
129530533|NCT01066819|466231236|FG002|Overall Study|Not categorised|6|||
129530534|NCT01066819|466231237|FG003|Overall Study|Not categorised|1|||
129530535|NCT01066819|466231238|FG004|Overall Study|Not categorised|0|||
129530536|NCT01066819|466231239|FG005|Overall Study|Not categorised|0|||
129530537|NCT01066819|466231234|FG000|Overall Study|Relapse|16|||
129530538|NCT01066819|466231235|FG001|Overall Study|Relapse|4|||
129530539|NCT01066819|466231236|FG002|Overall Study|Relapse|3|||
129530540|NCT01066819|466231237|FG003|Overall Study|Relapse|0|||
129530541|NCT01066819|466231238|FG004|Overall Study|Relapse|0|||
129530542|NCT01066819|466231239|FG005|Overall Study|Relapse|0|||
129530543|NCT01066819|466231234|FG000|Overall Study|Results not available|1|||
129530544|NCT01066819|466231235|FG001|Overall Study|Results not available|0|||
129530545|NCT01066819|466231236|FG002|Overall Study|Results not available|0|||
129530546|NCT01066819|466231237|FG003|Overall Study|Results not available|0|||
129530547|NCT01066819|466231238|FG004|Overall Study|Results not available|0|||
129530548|NCT01066819|466231239|FG005|Overall Study|Results not available|0|||
129530549|NCT01066819|466231234|FG000|Overall Study|Screen failure|1|||
129530550|NCT01066819|466231235|FG001|Overall Study|Screen failure|0|||
129530551|NCT01066819|466231236|FG002|Overall Study|Screen failure|0|||
129530552|NCT01066819|466231237|FG003|Overall Study|Screen failure|0|||
129530553|NCT01066819|466231238|FG004|Overall Study|Screen failure|0|||
129530554|NCT01066819|466231239|FG005|Overall Study|Screen failure|0|||
129530555|NCT01066819|466231234|FG000|Overall Study|Spontaneous cure|1|||
129530556|NCT01066819|466231235|FG001|Overall Study|Spontaneous cure|0|||
129530557|NCT01066819|466231236|FG002|Overall Study|Spontaneous cure|0|||
129530558|NCT01066819|466231237|FG003|Overall Study|Spontaneous cure|0|||
129530559|NCT01066819|466231238|FG004|Overall Study|Spontaneous cure|0|||
129530560|NCT01066819|466231239|FG005|Overall Study|Spontaneous cure|0|||
129530561|NCT01066819|466231234|FG000|Overall Study|Treatment never started|85|||
129530562|NCT01066819|466231235|FG001|Overall Study|Treatment never started|19|||
129530563|NCT01066819|466231236|FG002|Overall Study|Treatment never started|19|||
129530564|NCT01066819|466231237|FG003|Overall Study|Treatment never started|3|||
129530565|NCT01066819|466231238|FG004|Overall Study|Treatment never started|2|||
129530566|NCT01066819|466231239|FG005|Overall Study|Treatment never started|2|||
129530567|NCT01066819|466231234|FG000|Overall Study|Treatment stopped|12|||
129530568|NCT01066819|466231235|FG001|Overall Study|Treatment stopped|1|||
129530569|NCT01066819|466231236|FG002|Overall Study|Treatment stopped|2|||
129530570|NCT01066819|466231237|FG003|Overall Study|Treatment stopped|1|||
129530571|NCT01066819|466231238|FG004|Overall Study|Treatment stopped|0|||
129530572|NCT01066819|466231239|FG005|Overall Study|Treatment stopped|0|||
129530573|NCT01066819|466231234|FG000|Overall Study|Other|5|||
129530574|NCT01066819|466231235|FG001|Overall Study|Other|1|||
129530575|NCT01066819|466231236|FG002|Overall Study|Other|1|||
129530576|NCT01066819|466231237|FG003|Overall Study|Other|0|||
129530577|NCT01066819|466231238|FG004|Overall Study|Other|0|||
129530578|NCT01066819|466231239|FG005|Overall Study|Other|0|||
129530579|NCT00805194|466231240|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
129530580|NCT00805194|466231241|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
129530581|NCT00805194|466231240|FG000|Overall Study|Worsening or AE of underlying disease|64|||
129530582|NCT00805194|466231241|FG001|Overall Study|Worsening or AE of underlying disease|70|||
129530583|NCT00805194|466231240|FG000|Overall Study|Other AE|84|||
129530584|NCT00805194|466231241|FG001|Overall Study|Other AE|73|||
129530585|NCT00805194|466231240|FG000|Overall Study|Protocol Violation|9|||
129530586|NCT00805194|466231241|FG001|Overall Study|Protocol Violation|9|||
129530587|NCT00805194|466231240|FG000|Overall Study|Lost to Follow-up|5|||
129530588|NCT00805194|466231241|FG001|Overall Study|Lost to Follow-up|5|||
129530589|NCT00805194|466231240|FG000|Overall Study|Withdrawal by Subject|60|||
129530590|NCT00805194|466231241|FG001|Overall Study|Withdrawal by Subject|42|||
129530591|NCT00805194|466231240|FG000|Overall Study|Not treated|3|||
129530592|NCT00805194|466231241|FG001|Overall Study|Not treated|4|||
129530593|NCT00805194|466231240|FG000|Overall Study|Reasons other than stated above|20|||
129530594|NCT00805194|466231241|FG001|Overall Study|Reasons other than stated above|16|||
129530595|NCT02381795|466231251|FG000|Overall Study|Withdrawal by Subject|1|||
129530596|NCT02381795|466231251|FG000|Overall Study|Study Terminated|2|||
129530597|NCT02176226|466231252|FG000|Overall Study|Lost to Follow-up|3|||
129530598|NCT02176226|466231252|FG000|Overall Study|Withdrew prior to treatment|6|||
129530599|NCT02908841|466231255|FG000|Overall Study|Physician Decision|4|||
129530600|NCT02908841|466231256|FG001|Overall Study|Physician Decision|0|||
129530601|NCT01412333|466231258|FG000|Overall Study|Adverse Event|40|||
129530602|NCT01412333|466231259|FG001|Overall Study|Adverse Event|42|||
129530603|NCT01412333|466231258|FG000|Overall Study|Death|5|||
129530604|NCT01412333|466231259|FG001|Overall Study|Death|6|||
129530605|NCT01412333|466231258|FG000|Overall Study|Lack of Efficacy|22|||
129530606|NCT01412333|466231259|FG001|Overall Study|Lack of Efficacy|10|||
129530607|NCT01412333|466231258|FG000|Overall Study|Lost to Follow-up|15|||
129530608|NCT01412333|466231259|FG001|Overall Study|Lost to Follow-up|12|||
129530609|NCT01412333|466231258|FG000|Overall Study|Non-Compliance|3|||
129530610|NCT01412333|466231259|FG001|Overall Study|Non-Compliance|7|||
129530611|NCT01412333|466231258|FG000|Overall Study|Non-Compliance With Study Drug|1|||
129530612|NCT01412333|466231259|FG001|Overall Study|Non-Compliance With Study Drug|1|||
129530613|NCT01412333|466231258|FG000|Overall Study|Other|30|||
129530614|NCT01412333|466231259|FG001|Overall Study|Other|33|||
129530615|NCT01412333|466231258|FG000|Overall Study|Physician Decision|11|||
129530616|NCT01412333|466231259|FG001|Overall Study|Physician Decision|16|||
129530617|NCT01412333|466231258|FG000|Overall Study|Pregnancy|6|||
129530618|NCT01412333|466231259|FG001|Overall Study|Pregnancy|4|||
129530619|NCT01412333|466231258|FG000|Overall Study|Protocol Violation|1|||
129530620|NCT01412333|466231259|FG001|Overall Study|Protocol Violation|2|||
129530621|NCT01412333|466231258|FG000|Overall Study|Study Terminated By Sponsor|3|||
129530622|NCT01412333|466231259|FG001|Overall Study|Study Terminated By Sponsor|2|||
129530623|NCT01412333|466231258|FG000|Overall Study|Withdrawal by Subject|51|||
129530624|NCT01412333|466231259|FG001|Overall Study|Withdrawal by Subject|54|||
129530625|NCT01412333|466231258|FG000|Overall Study|Missing|1|||
129530626|NCT01412333|466231259|FG001|Overall Study|Missing|3|||
129530627|NCT04005885|466231260|FG000|First Intervention|Withdrawal by Subject|1|||
129530628|NCT04005885|466231261|FG001|First Intervention|Withdrawal by Subject|1|||
129530629|NCT04005885|466231260|FG000|Second Intervention|Withdrawal by Subject|0|||
129530630|NCT04005885|466231261|FG001|Second Intervention|Withdrawal by Subject|2|||
129530631|NCT00750867|466231262|FG000|Overall Study|Adverse Event|2|||
129530632|NCT00696774|466231263|FG000|Period II|Adverse Event|0|||
129530633|NCT00696774|466231264|FG001|Period II|Adverse Event|0|||
129530634|NCT00696774|466231265|FG002|Period II|Adverse Event|15|||
129530635|NCT00696774|466231263|FG000|Period II|Lost to Follow-up|0|||
129530636|NCT00696774|466231264|FG001|Period II|Lost to Follow-up|0|||
129530637|NCT00696774|466231265|FG002|Period II|Lost to Follow-up|4|||
129530638|NCT00696774|466231263|FG000|Period II|Protocol Violation|0|||
129530639|NCT00696774|466231264|FG001|Period II|Protocol Violation|0|||
129530640|NCT00696774|466231265|FG002|Period II|Protocol Violation|11|||
129530641|NCT00696774|466231263|FG000|Period II|Withdrawal by Subject|0|||
129530642|NCT00696774|466231264|FG001|Period II|Withdrawal by Subject|0|||
129530643|NCT00696774|466231265|FG002|Period II|Withdrawal by Subject|4|||
129530644|NCT00696774|466231263|FG000|Period II|Sponsor Decision|0|||
129530645|NCT00696774|466231264|FG001|Period II|Sponsor Decision|0|||
129530646|NCT00696774|466231265|FG002|Period II|Sponsor Decision|0|||
129530647|NCT00696774|466231263|FG000|Period II|Lack of Efficacy|0|||
129530648|NCT00696774|466231264|FG001|Period II|Lack of Efficacy|0|||
129530649|NCT00696774|466231265|FG002|Period II|Lack of Efficacy|2|||
129530650|NCT00696774|466231263|FG000|Period III|Adverse Event|1|||
129530651|NCT00696774|466231264|FG001|Period III|Adverse Event|1|||
129530652|NCT00696774|466231265|FG002|Period III|Adverse Event|0|||
129530653|NCT00696774|466231263|FG000|Period III|Lost to Follow-up|2|||
129530654|NCT00696774|466231264|FG001|Period III|Lost to Follow-up|1|||
129530655|NCT00696774|466231265|FG002|Period III|Lost to Follow-up|0|||
129530656|NCT00696774|466231263|FG000|Period III|Protocol Violation|1|||
129530657|NCT00696774|466231264|FG001|Period III|Protocol Violation|1|||
129530658|NCT00696774|466231265|FG002|Period III|Protocol Violation|0|||
129530659|NCT00696774|466231263|FG000|Period III|Withdrawal by Subject|1|||
129530660|NCT00696774|466231264|FG001|Period III|Withdrawal by Subject|2|||
129530661|NCT00696774|466231265|FG002|Period III|Withdrawal by Subject|0|||
129530662|NCT00696774|466231263|FG000|Period III|Sponsor Decision|2|||
129530663|NCT00696774|466231264|FG001|Period III|Sponsor Decision|0|||
129530664|NCT00696774|466231265|FG002|Period III|Sponsor Decision|0|||
129530665|NCT00696774|466231263|FG000|Period III|Lack of Efficacy|0|||
129530666|NCT00696774|466231264|FG001|Period III|Lack of Efficacy|2|||
129530667|NCT00696774|466231265|FG002|Period III|Lack of Efficacy|0|||
129530668|NCT03490734|466231266|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
129530669|NCT03490734|466231267|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
129530670|NCT03490734|466231268|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
129530671|NCT03490734|466231269|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
129530672|NCT03490734|466231266|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
129530673|NCT03490734|466231267|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
129530674|NCT03490734|466231268|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
129530675|NCT03490734|466231269|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
129530676|NCT03490734|466231266|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
129530677|NCT03490734|466231267|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
129530678|NCT03490734|466231268|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
129530679|NCT03490734|466231269|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
129530680|NCT03490734|466231266|FG000|Post-intervention Scan Visit|Adverse Event|2|||
129530681|NCT03490734|466231267|FG001|Post-intervention Scan Visit|Adverse Event|0|||
129530682|NCT03490734|466231268|FG002|Post-intervention Scan Visit|Adverse Event|0|||
129530683|NCT03490734|466231269|FG003|Post-intervention Scan Visit|Adverse Event|0|||
129530684|NCT03490734|466231266|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
129530685|NCT03490734|466231267|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
129530686|NCT03490734|466231268|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
129530687|NCT03490734|466231269|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
129530688|NCT03490734|466231266|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
129538750|NCT03575975|466263525|FG002|Overall Study|Lost to Follow-up|0|||
129530689|NCT03490734|466231267|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
129530690|NCT03490734|466231268|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
129530691|NCT03490734|466231269|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
129530692|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
129530693|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
129530694|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
129530695|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
129530696|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
129530697|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
129530698|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
129530699|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
129530700|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Death|0|||
129530701|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Death|0|||
129530702|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Death|0|||
129530703|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Death|1|||
129530704|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Death|1|||
129530705|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Death|0|||
129530706|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Death|2|||
129530707|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Death|0|||
129530708|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530709|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530710|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530711|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
129530712|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530713|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530714|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530715|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
129530716|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530717|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530718|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530719|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
129530720|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530721|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530722|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530723|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
129530724|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
129530725|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
129530726|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
129530727|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
129530728|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
129530729|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
129530730|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
129530731|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
129530732|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
129530733|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
129530734|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
129530735|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
129530736|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
129530737|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
129530738|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
129530739|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
129530740|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
129530741|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
129530742|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
129530743|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
129530744|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
129530745|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
129530746|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
129530747|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
129530748|NCT02442765|466231270|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129530749|NCT02442765|466231271|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129530750|NCT02442765|466231272|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129530751|NCT02442765|466231273|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129530752|NCT02442765|466231274|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
129530753|NCT02442765|466231275|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129530754|NCT02442765|466231276|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
129530755|NCT02442765|466231277|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
129530756|NCT00887913|466231280|FG000|Overall Study|Withdrawal by Subject|6|||
129530757|NCT01200758|466231281|FG000|Stage I|Death|0|||
129530758|NCT01200758|466231282|FG001|Stage I|Death|1|||
129530759|NCT01200758|466231283|FG002|Stage I|Death|0|||
129530760|NCT01200758|466231284|FG003|Stage I|Death|0|||
129530761|NCT01200758|466231281|FG000|Stage I|Physician Decision|1|||
129530762|NCT01200758|466231282|FG001|Stage I|Physician Decision|1|||
129530763|NCT01200758|466231283|FG002|Stage I|Physician Decision|0|||
129530764|NCT01200758|466231284|FG003|Stage I|Physician Decision|0|||
129530765|NCT01200758|466231281|FG000|Stage I|Lack of Efficacy|2|||
129530766|NCT01200758|466231282|FG001|Stage I|Lack of Efficacy|1|||
129530767|NCT01200758|466231283|FG002|Stage I|Lack of Efficacy|0|||
129530768|NCT01200758|466231284|FG003|Stage I|Lack of Efficacy|0|||
129530769|NCT01200758|466231281|FG000|Stage I|Adverse Event|5|||
129530770|NCT01200758|466231282|FG001|Stage I|Adverse Event|5|||
129530771|NCT01200758|466231283|FG002|Stage I|Adverse Event|0|||
129530772|NCT01200758|466231284|FG003|Stage I|Adverse Event|0|||
129530773|NCT01200758|466231281|FG000|Stage I|Withdrawal by Subject|1|||
129530774|NCT01200758|466231282|FG001|Stage I|Withdrawal by Subject|2|||
129530775|NCT01200758|466231283|FG002|Stage I|Withdrawal by Subject|0|||
129530776|NCT01200758|466231284|FG003|Stage I|Withdrawal by Subject|0|||
129530777|NCT01200758|466231281|FG000|Stage I|Disease Progression|9|||
129530778|NCT01200758|466231282|FG001|Stage I|Disease Progression|7|||
129530779|NCT01200758|466231283|FG002|Stage I|Disease Progression|0|||
129530780|NCT01200758|466231284|FG003|Stage I|Disease Progression|0|||
129530781|NCT01200758|466231281|FG000|Stage 2|Disease Progression|0|||
129530782|NCT01200758|466231282|FG001|Stage 2|Disease Progression|0|||
129530783|NCT01200758|466231283|FG002|Stage 2|Disease Progression|16|||
129530784|NCT01200758|466231284|FG003|Stage 2|Disease Progression|21|||
129530785|NCT01200758|466231281|FG000|Stage 2|Lack of Efficacy|0|||
129530786|NCT01200758|466231282|FG001|Stage 2|Lack of Efficacy|0|||
129530787|NCT01200758|466231283|FG002|Stage 2|Lack of Efficacy|4|||
129530788|NCT01200758|466231284|FG003|Stage 2|Lack of Efficacy|2|||
129530789|NCT01200758|466231281|FG000|Stage 2|Physician Decision|0|||
129530790|NCT01200758|466231282|FG001|Stage 2|Physician Decision|0|||
129530791|NCT01200758|466231283|FG002|Stage 2|Physician Decision|5|||
129530792|NCT01200758|466231284|FG003|Stage 2|Physician Decision|7|||
129530793|NCT01200758|466231281|FG000|Stage 2|Adverse Event|0|||
129530794|NCT01200758|466231282|FG001|Stage 2|Adverse Event|0|||
129530795|NCT01200758|466231283|FG002|Stage 2|Adverse Event|5|||
129530796|NCT01200758|466231284|FG003|Stage 2|Adverse Event|9|||
129530797|NCT01200758|466231281|FG000|Stage 2|Withdrawal by Subject|0|||
129530798|NCT01200758|466231282|FG001|Stage 2|Withdrawal by Subject|0|||
129530799|NCT01200758|466231283|FG002|Stage 2|Withdrawal by Subject|4|||
129530800|NCT01200758|466231284|FG003|Stage 2|Withdrawal by Subject|1|||
129530801|NCT01200758|466231281|FG000|Stage 2|Lost to Follow-up|0|||
129530802|NCT01200758|466231282|FG001|Stage 2|Lost to Follow-up|0|||
129530803|NCT01200758|466231283|FG002|Stage 2|Lost to Follow-up|3|||
129530804|NCT01200758|466231284|FG003|Stage 2|Lost to Follow-up|1|||
129530805|NCT01200758|466231281|FG000|Stage 2|Protocol Violation|0|||
129530806|NCT01200758|466231282|FG001|Stage 2|Protocol Violation|0|||
129530807|NCT01200758|466231283|FG002|Stage 2|Protocol Violation|1|||
129530808|NCT01200758|466231284|FG003|Stage 2|Protocol Violation|4|||
129530809|NCT01200758|466231281|FG000|Stage 2|Death|0|||
129530810|NCT01200758|466231282|FG001|Stage 2|Death|0|||
129530811|NCT01200758|466231283|FG002|Stage 2|Death|3|||
129530812|NCT01200758|466231284|FG003|Stage 2|Death|5|||
129530813|NCT01371721|466231285|FG000|Overall Study|Adverse Event|5|||
129530814|NCT01371721|466231286|FG001|Overall Study|Adverse Event|4|||
129530815|NCT01371721|466231287|FG002|Overall Study|Adverse Event|5|||
129530816|NCT01371721|466231285|FG000|Overall Study|Protocol Violation|6|||
129530817|NCT01371721|466231286|FG001|Overall Study|Protocol Violation|4|||
129530818|NCT01371721|466231287|FG002|Overall Study|Protocol Violation|5|||
129530819|NCT01371721|466231285|FG000|Overall Study|Lost to Follow-up|8|||
129530820|NCT01371721|466231286|FG001|Overall Study|Lost to Follow-up|2|||
129530821|NCT01371721|466231287|FG002|Overall Study|Lost to Follow-up|6|||
129530822|NCT01371721|466231285|FG000|Overall Study|Withdrawal by Subject|5|||
129530823|NCT01371721|466231286|FG001|Overall Study|Withdrawal by Subject|7|||
129530824|NCT01371721|466231287|FG002|Overall Study|Withdrawal by Subject|11|||
129530825|NCT01371721|466231285|FG000|Overall Study|Other|2|||
129530826|NCT01371721|466231286|FG001|Overall Study|Other|3|||
129530827|NCT01371721|466231287|FG002|Overall Study|Other|0|||
129530828|NCT01371721|466231285|FG000|Overall Study|Lack of Efficacy|2|||
129530829|NCT01371721|466231286|FG001|Overall Study|Lack of Efficacy|4|||
129530830|NCT01371721|466231287|FG002|Overall Study|Lack of Efficacy|3|||
129530831|NCT01371721|466231285|FG000|Overall Study|Randomized but not treated|1|||
129530832|NCT01371721|466231286|FG001|Overall Study|Randomized but not treated|0|||
129530833|NCT01371721|466231287|FG002|Overall Study|Randomized but not treated|0|||
129530834|NCT00545584|466231288|FG000|Overall Study|Only one reason for discontinuation|62|||
129530835|NCT00545584|466231289|FG001|Overall Study|Only one reason for discontinuation|61|||
129530836|NCT00545584|466231290|FG002|Overall Study|Only one reason for discontinuation|48|||
129530837|NCT00545584|466231288|FG000|Overall Study|Two or more reasons for discontinuation|17|||
129530838|NCT00545584|466231289|FG001|Overall Study|Two or more reasons for discontinuation|19|||
129530839|NCT00545584|466231290|FG002|Overall Study|Two or more reasons for discontinuation|8|||
129530840|NCT03525613|466231293|FG000|Overall Study|Adverse Event|11|||
129530841|NCT03525613|466231294|FG001|Overall Study|Adverse Event|8|||
129530842|NCT03525613|466231295|FG002|Overall Study|Adverse Event|3|||
129530843|NCT03525613|466231296|FG003|Overall Study|Adverse Event|3|||
129530844|NCT03525613|466231293|FG000|Overall Study|Lost to Follow-up|4|||
129530845|NCT03525613|466231294|FG001|Overall Study|Lost to Follow-up|5|||
129530846|NCT03525613|466231295|FG002|Overall Study|Lost to Follow-up|3|||
129530847|NCT03525613|466231296|FG003|Overall Study|Lost to Follow-up|2|||
129530848|NCT03525613|466231293|FG000|Overall Study|Physician Decision|0|||
129530849|NCT03525613|466231294|FG001|Overall Study|Physician Decision|1|||
129530850|NCT03525613|466231295|FG002|Overall Study|Physician Decision|0|||
129530851|NCT03525613|466231296|FG003|Overall Study|Physician Decision|1|||
129530852|NCT03525613|466231293|FG000|Overall Study|Consent Withdrawal|25|||
129530853|NCT03525613|466231294|FG001|Overall Study|Consent Withdrawal|16|||
129530854|NCT03525613|466231295|FG002|Overall Study|Consent Withdrawal|12|||
129530855|NCT03525613|466231296|FG003|Overall Study|Consent Withdrawal|9|||
129530856|NCT03525613|466231293|FG000|Overall Study|Death|20|||
129530857|NCT03525613|466231294|FG001|Overall Study|Death|9|||
129530858|NCT03525613|466231295|FG002|Overall Study|Death|7|||
129530859|NCT03525613|466231296|FG003|Overall Study|Death|1|||
129530860|NCT03525613|466231293|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
129530861|NCT03525613|466231294|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
129530862|NCT03525613|466231295|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
129530863|NCT03525613|466231296|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
129530864|NCT00461552|466231297|FG000|Overall Study|Drug Dispensing error|0|||
129530865|NCT00461552|466231298|FG001|Overall Study|Drug Dispensing error|2|||
129530866|NCT00523744|466231299|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
129530867|NCT00523744|466231299|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
129530868|NCT00523744|466231299|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
129530869|NCT00523744|466231299|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
129530870|NCT00523744|466231299|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
129530871|NCT00523744|466231299|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
129530872|NCT00715949|466231304|FG000|Overall Study|could not finish first test|4|||
129530873|NCT02608892|466231316|FG000|Overall Study|Lost to Follow-up|1|||
129530874|NCT02608892|466231317|FG001|Overall Study|Lost to Follow-up|0|||
129530875|NCT00925522|466231325|FG000|Overall Study|study closed -- business decision|20|||
129530876|NCT00410514|466231330|FG000|Overall Study|Adverse Event|2|||
129530877|NCT00410514|466231331|FG001|Overall Study|Adverse Event|2|||
129530878|NCT00410514|466231332|FG002|Overall Study|Adverse Event|2|||
129530879|NCT00410514|466231330|FG000|Overall Study|Protocol Violation|0|||
129530880|NCT00410514|466231331|FG001|Overall Study|Protocol Violation|1|||
129530881|NCT00410514|466231332|FG002|Overall Study|Protocol Violation|1|||
129530882|NCT00410514|466231330|FG000|Overall Study|Lost to Follow-up|0|||
129530883|NCT00410514|466231331|FG001|Overall Study|Lost to Follow-up|0|||
129530884|NCT00410514|466231332|FG002|Overall Study|Lost to Follow-up|2|||
129530885|NCT00410514|466231330|FG000|Overall Study|Non-compliant with study procedures|0|||
129530886|NCT00410514|466231331|FG001|Overall Study|Non-compliant with study procedures|0|||
129530887|NCT00410514|466231332|FG002|Overall Study|Non-compliant with study procedures|2|||
129530888|NCT04728815|466231336|FG000|Overall Study|Lost to Follow-up|3|||
129530889|NCT04728815|466231337|FG001|Overall Study|Lost to Follow-up|0|||
129530890|NCT04728815|466231338|FG002|Overall Study|Lost to Follow-up|0|||
129530891|NCT04728815|466231339|FG003|Overall Study|Lost to Follow-up|1|||
129530892|NCT04728815|466231340|FG004|Overall Study|Lost to Follow-up|1|||
129530893|NCT04728815|466231341|FG005|Overall Study|Lost to Follow-up|0|||
129530894|NCT04728815|466231342|FG006|Overall Study|Lost to Follow-up|2|||
129530895|NCT04728815|466231343|FG007|Overall Study|Lost to Follow-up|0|||
129530896|NCT04728815|466231336|FG000|Overall Study|Physician Decision|0|||
129530897|NCT04728815|466231337|FG001|Overall Study|Physician Decision|0|||
129530898|NCT04728815|466231338|FG002|Overall Study|Physician Decision|1|||
129530899|NCT04728815|466231339|FG003|Overall Study|Physician Decision|0|||
129530900|NCT04728815|466231340|FG004|Overall Study|Physician Decision|0|||
129530901|NCT04728815|466231341|FG005|Overall Study|Physician Decision|0|||
129530902|NCT04728815|466231342|FG006|Overall Study|Physician Decision|0|||
129530903|NCT04728815|466231343|FG007|Overall Study|Physician Decision|0|||
129530904|NCT04728815|466231336|FG000|Overall Study|Treatment drop|0|||
129530905|NCT04728815|466231337|FG001|Overall Study|Treatment drop|2|||
129530906|NCT04728815|466231338|FG002|Overall Study|Treatment drop|1|||
129530907|NCT04728815|466231339|FG003|Overall Study|Treatment drop|0|||
129530908|NCT04728815|466231340|FG004|Overall Study|Treatment drop|3|||
129530909|NCT04728815|466231341|FG005|Overall Study|Treatment drop|1|||
129530910|NCT04728815|466231342|FG006|Overall Study|Treatment drop|3|||
129530911|NCT04728815|466231343|FG007|Overall Study|Treatment drop|0|||
129530912|NCT04728815|466231336|FG000|Overall Study|Study drop|0|||
129530913|NCT04728815|466231337|FG001|Overall Study|Study drop|3|||
129530914|NCT04728815|466231338|FG002|Overall Study|Study drop|3|||
129530915|NCT04728815|466231339|FG003|Overall Study|Study drop|0|||
129530916|NCT04728815|466231340|FG004|Overall Study|Study drop|0|||
129530917|NCT04728815|466231341|FG005|Overall Study|Study drop|0|||
129530918|NCT04728815|466231342|FG006|Overall Study|Study drop|7|||
129530919|NCT04728815|466231343|FG007|Overall Study|Study drop|0|||
129530920|NCT00957034|466231344|FG000|Overall Study|Adverse Event|0|||
129530921|NCT00957034|466231345|FG001|Overall Study|Adverse Event|1|||
129530922|NCT00957034|466231346|FG002|Overall Study|Adverse Event|1|||
129530923|NCT00957034|466231344|FG000|Overall Study|Sponsor Terminated Study|6|||
129530924|NCT00957034|466231345|FG001|Overall Study|Sponsor Terminated Study|1|||
129530925|NCT00957034|466231346|FG002|Overall Study|Sponsor Terminated Study|5|||
129530926|NCT00957034|466231344|FG000|Overall Study|Withdrawal by Subject|0|||
129530927|NCT00957034|466231345|FG001|Overall Study|Withdrawal by Subject|2|||
129530928|NCT00957034|466231346|FG002|Overall Study|Withdrawal by Subject|0|||
129530929|NCT02390167|466233185|FG000|Overall Study|Lost to Follow-up|1|||
129530930|NCT02033369|466233186|FG000|Overall Study|Physician Decision|1|||
129530931|NCT02033369|466233187|FG001|Overall Study|Physician Decision|2|||
129530932|NCT02033369|466233186|FG000|Overall Study|Not a good demographic match|0|||
129530933|NCT02033369|466233187|FG001|Overall Study|Not a good demographic match|2|||
129530934|NCT02033369|466233186|FG000|Overall Study|Withdrawal by Subject|1|||
129530935|NCT02033369|466233187|FG001|Overall Study|Withdrawal by Subject|1|||
129530936|NCT02033369|466233186|FG000|Overall Study|Lost to Follow-up|1|||
129530937|NCT02033369|466233187|FG001|Overall Study|Lost to Follow-up|0|||
129530938|NCT02033369|466233186|FG000|Overall Study|Protocol Violation|2|||
129530939|NCT02033369|466233187|FG001|Overall Study|Protocol Violation|0|||
129530940|NCT01265719|466233193|FG000|Overall Study|Does not meet entrance criteria|0|||
129530941|NCT01265719|466233194|FG001|Overall Study|Does not meet entrance criteria|3|||
129530942|NCT01265719|466233193|FG000|Overall Study|Other reasons|2|||
129530943|NCT01265719|466233194|FG001|Overall Study|Other reasons|0|||
129530944|NCT01265719|466233193|FG000|Overall Study|Withdrawal by Subject|8|||
129530945|NCT01265719|466233194|FG001|Overall Study|Withdrawal by Subject|3|||
129530946|NCT01265719|466233193|FG000|Overall Study|Lost to Follow-up|2|||
129530947|NCT01265719|466233194|FG001|Overall Study|Lost to Follow-up|7|||
129530948|NCT01265719|466233193|FG000|Overall Study|Adverse Event|2|||
129530949|NCT01265719|466233194|FG001|Overall Study|Adverse Event|0|||
129530950|NCT04335929|466233195|FG000|Overall Study|Lost to Follow-up|10|||
129530951|NCT00413231|466233196|FG000|0 to 30-day Post Treatment|Death|5|||
129530952|NCT00413231|466233196|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
129530953|NCT00413231|466233196|FG000|30-day to 365-day Post Treatment|Death|13|||
129530954|NCT00413231|466233196|FG000|365-day to 60-month Post Treatment|Death|36|||
129530955|NCT00413231|466233196|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
129530956|NCT00413231|466233196|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
129530957|NCT00413231|466233196|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
129530958|NCT00626327|466233197|FG000|Overall Study|Withdrawal by Subject|21|||
129530959|NCT00626327|466233198|FG001|Overall Study|Withdrawal by Subject|29|||
129530960|NCT00626327|466233199|FG002|Overall Study|Withdrawal by Subject|30|||
129530961|NCT00626327|466233197|FG000|Overall Study|Adverse Event|1|||
129530962|NCT00626327|466233198|FG001|Overall Study|Adverse Event|0|||
129530963|NCT00626327|466233199|FG002|Overall Study|Adverse Event|0|||
129530964|NCT00626327|466233197|FG000|Overall Study|Lost to Follow-up|24|||
129530965|NCT00626327|466233198|FG001|Overall Study|Lost to Follow-up|21|||
129530966|NCT00626327|466233199|FG002|Overall Study|Lost to Follow-up|23|||
129530967|NCT00626327|466233197|FG000|Overall Study|Inappropriate enrollment|4|||
129530968|NCT00626327|466233198|FG001|Overall Study|Inappropriate enrollment|5|||
129530969|NCT00626327|466233199|FG002|Overall Study|Inappropriate enrollment|3|||
129530970|NCT00626327|466233197|FG000|Overall Study|Administrative Reason|2|||
129530971|NCT00626327|466233198|FG001|Overall Study|Administrative Reason|0|||
129530972|NCT00626327|466233199|FG002|Overall Study|Administrative Reason|6|||
129530973|NCT00626327|466233197|FG000|Overall Study|Protocol Violation|26|||
129530974|NCT00626327|466233198|FG001|Overall Study|Protocol Violation|4|||
129530975|NCT00626327|466233199|FG002|Overall Study|Protocol Violation|26|||
129530976|NCT00945945|466233200|FG000|Overall Study|Adverse Event|15|||
129530977|NCT00945945|466233201|FG001|Overall Study|Adverse Event|35|||
129530978|NCT00945945|466233200|FG000|Overall Study|Withdrawal by Subject|7|||
129530979|NCT00945945|466233201|FG001|Overall Study|Withdrawal by Subject|10|||
129530980|NCT00945945|466233200|FG000|Overall Study|Lost to Follow-up|4|||
129530981|NCT00945945|466233201|FG001|Overall Study|Lost to Follow-up|5|||
129530982|NCT00945945|466233200|FG000|Overall Study|Lack of Efficacy|6|||
129530983|NCT00945945|466233201|FG001|Overall Study|Lack of Efficacy|2|||
129530984|NCT00945945|466233200|FG000|Overall Study|Protocol Violation|4|||
129530985|NCT00945945|466233201|FG001|Overall Study|Protocol Violation|2|||
129530986|NCT00945945|466233200|FG000|Overall Study|Entry Criteria Not Met|0|||
129530987|NCT00945945|466233201|FG001|Overall Study|Entry Criteria Not Met|1|||
129530988|NCT02408016|466233202|FG000|Overall Study|Death|6|||
129530989|NCT02408016|466233203|FG001|Overall Study|Death|1|||
129530990|NCT02408016|466233204|FG002|Overall Study|Death|0|||
129530991|NCT02408016|466233202|FG000|Overall Study|Physician Decision|0|||
129530992|NCT02408016|466233203|FG001|Overall Study|Physician Decision|2|||
129530993|NCT02408016|466233204|FG002|Overall Study|Physician Decision|0|||
129530994|NCT02275052|466233205|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129530995|NCT02275052|466233206|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
129530996|NCT02275052|466233207|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129530997|NCT02275052|466233208|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
129530998|NCT02275052|466233205|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
129530999|NCT02275052|466233206|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
129531000|NCT02275052|466233207|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
129531001|NCT02275052|466233208|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
129531002|NCT02275052|466233205|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
129531003|NCT02275052|466233206|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
129531004|NCT02275052|466233207|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129531005|NCT02275052|466233208|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
129531006|NCT02275052|466233205|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
129531007|NCT02275052|466233206|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
129531008|NCT02275052|466233207|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
129531009|NCT02275052|466233208|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
129531010|NCT02275052|466233205|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
129531011|NCT02275052|466233206|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
129531012|NCT02275052|466233207|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
129531013|NCT02275052|466233208|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
129531014|NCT02275052|466233205|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
129531015|NCT02275052|466233206|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
129531016|NCT02275052|466233207|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
129531017|NCT02275052|466233208|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
129531018|NCT02275052|466233205|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
129531019|NCT02275052|466233206|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
129531020|NCT02275052|466233207|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
129531021|NCT02275052|466233208|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
129531022|NCT02275052|466233205|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129531023|NCT02275052|466233206|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
129531024|NCT02275052|466233207|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
129531025|NCT02275052|466233208|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
129531026|NCT02275052|466233205|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129531027|NCT02275052|466233206|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
129531028|NCT02275052|466233207|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
129531029|NCT02275052|466233208|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
129531030|NCT02275052|466233205|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129531031|NCT02275052|466233206|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
129531032|NCT02275052|466233207|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
129531033|NCT02275052|466233208|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
129531034|NCT02275052|466233205|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129531035|NCT02275052|466233206|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129531036|NCT02275052|466233207|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
129531037|NCT02275052|466233208|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
129531038|NCT02807376|466233211|FG000|Overall Study|Intra-operative exclusion criteria|3|||
129531039|NCT02807376|466233212|FG001|Overall Study|Intra-operative exclusion criteria|0|||
129531040|NCT02807376|466233211|FG000|Overall Study|Lost to Follow-up|0|||
129531041|NCT02807376|466233212|FG001|Overall Study|Lost to Follow-up|1|||
129531042|NCT00846027|466233213|FG000|Overall Study|Death|3|||
129531043|NCT00846027|466233213|FG000|Overall Study|Disease Progression|30|||
129531044|NCT00846027|466233213|FG000|Overall Study|Toxicity|12|||
129531045|NCT00846027|466233213|FG000|Overall Study|Patient Decision|7|||
129531046|NCT00846027|466233213|FG000|Overall Study|Investigator Discretion|29|||
129531047|NCT00846027|466233213|FG000|Overall Study|Protocol Violation|2|||
129531048|NCT00846027|466233213|FG000|Overall Study|Subject Not Treated|7|||
129531049|NCT00808028|466233214|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
129531050|NCT00808028|466233215|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
129531051|NCT00808028|466233216|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
129531052|NCT00808028|466233217|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
129531053|NCT00808028|466233214|FG000|Stage 1 (6 Months)|Other|1|||
129531054|NCT00808028|466233215|FG001|Stage 1 (6 Months)|Other|0|||
129531055|NCT00808028|466233216|FG002|Stage 1 (6 Months)|Other|2|||
129531056|NCT00808028|466233217|FG003|Stage 1 (6 Months)|Other|4|||
129531057|NCT00808028|466233214|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
129531058|NCT00808028|466233215|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
129531059|NCT00808028|466233216|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
129531060|NCT00808028|466233217|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
129531061|NCT00808028|466233214|FG000|Stage 1 (6 Months)|Adverse Event|0|||
129531062|NCT00808028|466233215|FG001|Stage 1 (6 Months)|Adverse Event|0|||
129531063|NCT00808028|466233216|FG002|Stage 1 (6 Months)|Adverse Event|1|||
129531064|NCT00808028|466233217|FG003|Stage 1 (6 Months)|Adverse Event|2|||
129531065|NCT00808028|466233214|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
129531066|NCT00808028|466233215|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
129531067|NCT00808028|466233216|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
129531068|NCT00808028|466233217|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
129531069|NCT00808028|466233214|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
129531070|NCT00808028|466233215|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
129531071|NCT00808028|466233216|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
129531072|NCT00808028|466233217|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
129531073|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
129531074|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
129531075|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
129531076|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
129531077|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
129531078|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
129531079|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
129531080|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
129531081|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
129531082|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
129531083|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
129531084|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
129531085|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
129531086|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
129531087|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
129531088|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
129531089|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
129531090|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
129531091|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
129531092|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
129531093|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
129531094|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
129531095|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
129531096|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
129531097|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
129531098|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
129531099|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
129531100|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
129531101|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
129531102|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
129531103|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
129531104|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
129531105|NCT00808028|466233214|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
129531106|NCT00808028|466233215|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
129531107|NCT00808028|466233216|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
129531108|NCT00808028|466233217|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
129531109|NCT01797302|466233218|FG000|Overall Study|Lost to Follow-up|16|||
129531110|NCT01797302|466233219|FG001|Overall Study|Lost to Follow-up|23|||
129531111|NCT01797302|466233220|FG002|Overall Study|Lost to Follow-up|22|||
129531112|NCT01797302|466233218|FG000|Overall Study|Withdrawal by Subject|1|||
129531113|NCT01797302|466233219|FG001|Overall Study|Withdrawal by Subject|3|||
129531114|NCT01797302|466233220|FG002|Overall Study|Withdrawal by Subject|4|||
129531115|NCT03228836|466233221|FG000|Overall Study|Adverse Event|3|||
129531116|NCT03228836|466233221|FG000|Overall Study|Withdrawal by Subject|1|||
129531117|NCT03228836|466233221|FG000|Overall Study|Death|1|||
129531118|NCT03228836|466233221|FG000|Overall Study|Physician Decision|1|||
129531119|NCT03228836|466233221|FG000|Overall Study|Disease Progression|7|||
129531120|NCT03228836|466233221|FG000|Overall Study|Other|4|||
129531121|NCT02773849|466233223|FG000|Overall Study|Lost to Follow-up|11|||
129531122|NCT02773849|466233223|FG000|Overall Study|Death|26|||
129531123|NCT02773849|466233223|FG000|Overall Study|Withdrawal by Subject|5|||
129531124|NCT02773849|466233223|FG000|Overall Study|Withdrawal of Consent|9|||
129531125|NCT02773849|466233223|FG000|Overall Study|Other: not due to lack of tolerability|11|||
129531126|NCT00948389|466233224|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
129531127|NCT00948389|466233225|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
129531128|NCT00948389|466233226|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
129531129|NCT00948389|466233227|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
129531130|NCT00948389|466233228|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
129531131|NCT00948389|466233224|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
129531132|NCT00948389|466233225|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
129531133|NCT00948389|466233226|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
129531134|NCT00948389|466233227|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
129531135|NCT00948389|466233228|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
129531136|NCT00948389|466233224|FG000|Overall Study|Both Progression and Toxicity|1|||
129531137|NCT00948389|466233225|FG001|Overall Study|Both Progression and Toxicity|0|||
129531138|NCT00948389|466233226|FG002|Overall Study|Both Progression and Toxicity|0|||
129531139|NCT00948389|466233227|FG003|Overall Study|Both Progression and Toxicity|0|||
129531140|NCT00948389|466233228|FG004|Overall Study|Both Progression and Toxicity|0|||
129531141|NCT02418000|466233233|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
129531142|NCT02418000|466233234|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531143|NCT02418000|466233235|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531144|NCT02418000|466233236|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531145|NCT02418000|466233237|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531146|NCT02418000|466233233|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
129531147|NCT02418000|466233234|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
129531148|NCT02418000|466233235|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
129531149|NCT02418000|466233236|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
129531150|NCT02418000|466233237|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
129531151|NCT02418000|466233233|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
129531152|NCT02418000|466233234|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
129531153|NCT02418000|466233235|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
129531154|NCT02418000|466233236|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
129531155|NCT02418000|466233237|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
129531156|NCT02418000|466233233|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531157|NCT02418000|466233234|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
129531158|NCT02418000|466233235|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531159|NCT02418000|466233236|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531160|NCT02418000|466233237|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
129531161|NCT02418000|466233233|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
129531162|NCT02418000|466233234|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
129531163|NCT02418000|466233235|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
129531164|NCT02418000|466233236|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
129531165|NCT02418000|466233237|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
129531166|NCT02418000|466233233|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531167|NCT02418000|466233234|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531168|NCT02418000|466233235|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
129531169|NCT02418000|466233236|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531170|NCT02418000|466233237|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531171|NCT02418000|466233233|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531172|NCT02418000|466233234|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531173|NCT02418000|466233235|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531174|NCT02418000|466233236|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
129531175|NCT02418000|466233237|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531176|NCT02418000|466233233|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
129531177|NCT02418000|466233234|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
129531178|NCT02418000|466233235|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
129531179|NCT02418000|466233236|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
129531180|NCT02418000|466233237|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
129531181|NCT02418000|466233233|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531182|NCT02418000|466233234|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531183|NCT02418000|466233235|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531184|NCT02418000|466233236|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
129531185|NCT02418000|466233237|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
129531186|NCT00508001|466233238|FG000|Overall Study|Adverse Event|2|||
129531187|NCT00508001|466233239|FG001|Overall Study|Adverse Event|0|||
129531188|NCT00508001|466233240|FG002|Overall Study|Adverse Event|4|||
129531189|NCT00508001|466233238|FG000|Overall Study|condition under investigation worsened|13|||
129531190|NCT00508001|466233239|FG001|Overall Study|condition under investigation worsened|7|||
129531191|NCT00508001|466233240|FG002|Overall Study|condition under investigation worsened|1|||
129531192|NCT00508001|466233238|FG000|Overall Study|Death|0|||
129531193|NCT00508001|466233239|FG001|Overall Study|Death|1|||
129531194|NCT00508001|466233240|FG002|Overall Study|Death|1|||
129531195|NCT00508001|466233238|FG000|Overall Study|Withdrawal by Subject|4|||
129531196|NCT00508001|466233239|FG001|Overall Study|Withdrawal by Subject|4|||
129531197|NCT00508001|466233240|FG002|Overall Study|Withdrawal by Subject|1|||
129531198|NCT01051856|466233257|FG000|Overall Study|Withdrawal by Subject|1|||
129531199|NCT01051856|466233258|FG001|Overall Study|Withdrawal by Subject|0|||
129531200|NCT01611558|466233263|FG000|Induction Phase|Study drug toxicity|15|||
129531201|NCT01611558|466233263|FG000|Induction Phase|Disease progression|18|||
129531202|NCT01611558|466233263|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
129531203|NCT01611558|466233263|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
129531204|NCT01611558|466233263|FG000|Induction Phase|Death|1|||
129531205|NCT01611558|466233263|FG000|Maintenance Phase|Withdrawal by Subject|1|||
129531206|NCT01611558|466233263|FG000|Maintenance Phase|Elevated Uric acid|1|||
129531207|NCT02718625|466233270|FG000|Overall Study|Adverse Event|0|||
129531208|NCT02718625|466233271|FG001|Overall Study|Adverse Event|1|||
129531209|NCT02718625|466233270|FG000|Overall Study|Termination of Study by Sponsor|0|||
129531210|NCT02718625|466233271|FG001|Overall Study|Termination of Study by Sponsor|1|||
129531211|NCT01947127|466233276|FG000|Overall Study|Protocol Violation|18|||
129531212|NCT01947127|466233277|FG001|Overall Study|Protocol Violation|38|||
129531213|NCT01947127|466233276|FG000|Overall Study|Withdrawal by Subject|1|||
129531214|NCT01947127|466233277|FG001|Overall Study|Withdrawal by Subject|1|||
129531215|NCT01947127|466233276|FG000|Overall Study|Data loss|4|||
129531216|NCT01947127|466233277|FG001|Overall Study|Data loss|4|||
129531217|NCT01836549|466233278|FG000|Overall Study|Did not receive study drug|0|||
129531218|NCT01836549|466233279|FG001|Overall Study|Did not receive study drug|0|||
129531219|NCT01836549|466233280|FG002|Overall Study|Did not receive study drug|1|||
129531220|NCT01836549|466233281|FG003|Overall Study|Did not receive study drug|0|||
129531221|NCT01836549|466233282|FG004|Overall Study|Did not receive study drug|0|||
129531222|NCT01836549|466233283|FG005|Overall Study|Did not receive study drug|0|||
129531223|NCT01836549|466233284|FG006|Overall Study|Did not receive study drug|0|||
129531224|NCT01836549|466233278|FG000|Overall Study|Patient declared ineligible|0|||
129531225|NCT01836549|466233279|FG001|Overall Study|Patient declared ineligible|0|||
129531226|NCT01836549|466233280|FG002|Overall Study|Patient declared ineligible|0|||
129531227|NCT01836549|466233281|FG003|Overall Study|Patient declared ineligible|1|||
129531228|NCT01836549|466233282|FG004|Overall Study|Patient declared ineligible|0|||
129531229|NCT01836549|466233283|FG005|Overall Study|Patient declared ineligible|0|||
129531230|NCT01836549|466233284|FG006|Overall Study|Patient declared ineligible|0|||
129531231|NCT01836549|466233278|FG000|Overall Study|Patient inevaluable to start therapy|0|||
129531232|NCT01836549|466233279|FG001|Overall Study|Patient inevaluable to start therapy|0|||
129531233|NCT01836549|466233280|FG002|Overall Study|Patient inevaluable to start therapy|0|||
129531234|NCT01836549|466233281|FG003|Overall Study|Patient inevaluable to start therapy|0|||
129531235|NCT01836549|466233282|FG004|Overall Study|Patient inevaluable to start therapy|0|||
129531236|NCT01836549|466233283|FG005|Overall Study|Patient inevaluable to start therapy|0|||
129531237|NCT01836549|466233284|FG006|Overall Study|Patient inevaluable to start therapy|1|||
129531238|NCT04652102|466233285|FG000|Overall Study|Adverse Event|14|||
129531239|NCT04652102|466233286|FG001|Overall Study|Adverse Event|13|||
129531240|NCT04652102|466233285|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
129531241|NCT04652102|466233286|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
129531242|NCT04652102|466233285|FG000|Overall Study|Physician Decision|78|||
129531243|NCT04652102|466233286|FG001|Overall Study|Physician Decision|40|||
129531244|NCT04652102|466233285|FG000|Overall Study|Study Ended by Sponsor|64|||
129531245|NCT04652102|466233286|FG001|Overall Study|Study Ended by Sponsor|17|||
129531246|NCT04652102|466233285|FG000|Overall Study|Withdrawal by Subject|4625|||
129531247|NCT04652102|466233286|FG001|Overall Study|Withdrawal by Subject|5594|||
129531248|NCT04652102|466233285|FG000|Overall Study|Lost to Follow-up|2019|||
129531249|NCT04652102|466233286|FG001|Overall Study|Lost to Follow-up|1082|||
129531250|NCT04652102|466233285|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
129531251|NCT04652102|466233286|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
129531252|NCT04652102|466233285|FG000|Overall Study|Miscellaneous|80|||
129531253|NCT04652102|466233286|FG001|Overall Study|Miscellaneous|64|||
129531254|NCT02516306|466233287|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
129531255|NCT02516306|466233288|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
129531256|NCT01969565|466233292|FG000|Overall Study|Withdrawal by Subject|1|||
129531257|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Adverse Event|30|||
129531258|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Adverse Event|25|||
129531259|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Adverse Event|23|||
129531260|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Adverse Event|14|||
129531261|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Death|0|||
129531262|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Death|0|||
129531263|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Death|1|||
129531264|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Death|0|||
129531265|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Physician Decision|0|||
129531266|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Physician Decision|1|||
129531267|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Physician Decision|0|||
129531268|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Physician Decision|1|||
129531269|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
129531270|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
129531271|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
129531272|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
129531273|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Other|6|||
129531274|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Other|1|||
129531275|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Other|0|||
129531276|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Other|2|||
129531277|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
129531278|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
129531279|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
129531280|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
129531281|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
129531282|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
129531283|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
129531284|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
129531285|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
129531286|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
129531287|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
129531288|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
129531289|NCT00242710|466233293|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
129531290|NCT00242710|466233294|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
129531291|NCT00242710|466233295|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
129531292|NCT00242710|466233296|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
129531293|NCT00242710|466233293|FG000|Period Between Core Study and Extension|Adverse Event|2|||
129531294|NCT00242710|466233294|FG001|Period Between Core Study and Extension|Adverse Event|3|||
129531295|NCT00242710|466233295|FG002|Period Between Core Study and Extension|Adverse Event|5|||
129531296|NCT00242710|466233296|FG003|Period Between Core Study and Extension|Adverse Event|2|||
129531297|NCT00242710|466233293|FG000|Period Between Core Study and Extension|Physician Decision|1|||
129531298|NCT00242710|466233294|FG001|Period Between Core Study and Extension|Physician Decision|1|||
129531299|NCT00242710|466233295|FG002|Period Between Core Study and Extension|Physician Decision|0|||
129531300|NCT00242710|466233296|FG003|Period Between Core Study and Extension|Physician Decision|0|||
129531301|NCT00242710|466233293|FG000|Period Between Core Study and Extension|Other|24|||
129531302|NCT00242710|466233294|FG001|Period Between Core Study and Extension|Other|24|||
129531303|NCT00242710|466233295|FG002|Period Between Core Study and Extension|Other|9|||
129531304|NCT00242710|466233296|FG003|Period Between Core Study and Extension|Other|11|||
129531305|NCT00242710|466233293|FG000|Period Between Core Study and Extension|Extension not Available|17|||
129531306|NCT00242710|466233294|FG001|Period Between Core Study and Extension|Extension not Available|21|||
129531307|NCT00242710|466233295|FG002|Period Between Core Study and Extension|Extension not Available|8|||
129531308|NCT00242710|466233296|FG003|Period Between Core Study and Extension|Extension not Available|7|||
129531309|NCT00242710|466233293|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
129531310|NCT00242710|466233294|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
129531311|NCT00242710|466233295|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
129531312|NCT00242710|466233296|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
129531313|NCT00242710|466233293|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
129531314|NCT00242710|466233294|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
129531315|NCT00242710|466233295|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
129531316|NCT00242710|466233296|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
129531317|NCT00242710|466233293|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
129531318|NCT00242710|466233294|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
129531319|NCT00242710|466233295|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
129531320|NCT00242710|466233296|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
129531321|NCT00242710|466233293|FG000|Study Extension (up to Year 2)|Death|0|||
129531322|NCT00242710|466233294|FG001|Study Extension (up to Year 2)|Death|0|||
129531323|NCT00242710|466233295|FG002|Study Extension (up to Year 2)|Death|0|||
129531324|NCT00242710|466233296|FG003|Study Extension (up to Year 2)|Death|1|||
129531325|NCT00242710|466233293|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
129531326|NCT00242710|466233294|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
129531327|NCT00242710|466233295|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
129531328|NCT00242710|466233296|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
129531329|NCT00242710|466233293|FG000|Study Extension (up to Year 2)|Other|3|||
129531330|NCT00242710|466233294|FG001|Study Extension (up to Year 2)|Other|5|||
129531331|NCT00242710|466233295|FG002|Study Extension (up to Year 2)|Other|4|||
129531332|NCT00242710|466233296|FG003|Study Extension (up to Year 2)|Other|3|||
129531333|NCT00242710|466233293|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
129531334|NCT00242710|466233294|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
129531335|NCT00242710|466233295|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
129531336|NCT00242710|466233296|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
129531337|NCT00242710|466233293|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
129531338|NCT00242710|466233294|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
129531339|NCT00242710|466233295|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
129531340|NCT00242710|466233296|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
129531341|NCT00579527|466233297|FG000|Overall Study|Death|4|||
129531342|NCT03961529|466233298|FG000|Overall Study|Adverse Event|13|||
129531343|NCT03961529|466233299|FG001|Overall Study|Adverse Event|5|||
129531344|NCT03961529|466233300|FG002|Overall Study|Adverse Event|2|||
129531345|NCT03961529|466233298|FG000|Overall Study|Withdrawal by Subject|17|||
129531346|NCT03961529|466233299|FG001|Overall Study|Withdrawal by Subject|2|||
129531347|NCT03961529|466233300|FG002|Overall Study|Withdrawal by Subject|1|||
129531348|NCT03961529|466233298|FG000|Overall Study|Withdrawal by parent/guardian|0|||
129531349|NCT03961529|466233299|FG001|Overall Study|Withdrawal by parent/guardian|7|||
129531350|NCT03961529|466233300|FG002|Overall Study|Withdrawal by parent/guardian|0|||
129531351|NCT03961529|466233298|FG000|Overall Study|Physician Decision|2|||
129531352|NCT03961529|466233299|FG001|Overall Study|Physician Decision|1|||
129531353|NCT03961529|466233300|FG002|Overall Study|Physician Decision|1|||
129531354|NCT03961529|466233298|FG000|Overall Study|Lost to Follow-up|2|||
129531355|NCT03961529|466233299|FG001|Overall Study|Lost to Follow-up|1|||
129531356|NCT03961529|466233300|FG002|Overall Study|Lost to Follow-up|0|||
129531357|NCT03961529|466233298|FG000|Overall Study|Lack of Efficacy|2|||
129531358|NCT03961529|466233299|FG001|Overall Study|Lack of Efficacy|0|||
129531359|NCT03961529|466233300|FG002|Overall Study|Lack of Efficacy|1|||
129531360|NCT03961529|466233298|FG000|Overall Study|Other|6|||
129531361|NCT03961529|466233299|FG001|Overall Study|Other|1|||
129531362|NCT03961529|466233300|FG002|Overall Study|Other|0|||
129531363|NCT03644173|466233303|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
129531364|NCT03644173|466233303|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
129531365|NCT03644173|466233303|FG000|Participants at the 1-month Follow up|Death|2|||
129531366|NCT03644173|466233303|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
129531367|NCT00381706|466233304|FG000|Overall Study|Never treated|7|||
129531368|NCT00381706|466233305|FG001|Overall Study|Never treated|2|||
129531369|NCT00381706|466233306|FG002|Overall Study|Never treated|1|||
129531370|NCT02555722|466233327|FG000|Week 2|Adverse Event|0|||
129531371|NCT02555722|466233328|FG001|Week 2|Adverse Event|1|||
129531372|NCT02555722|466233327|FG000|Week 2|Withdrawal by Subject|1|||
129531373|NCT02555722|466233328|FG001|Week 2|Withdrawal by Subject|0|||
129531374|NCT02555722|466233327|FG000|Month 1|Lens Discomfort|1|||
129531375|NCT02555722|466233328|FG001|Month 1|Lens Discomfort|0|||
129531376|NCT02555722|466233327|FG000|Month 2|Withdrawal by Subject|3|||
129531377|NCT02555722|466233328|FG001|Month 2|Withdrawal by Subject|0|||
129531378|NCT02555722|466233327|FG000|Month 2|Lost to Follow-up|1|||
129531379|NCT02555722|466233328|FG001|Month 2|Lost to Follow-up|0|||
129531380|NCT04491591|466233330|FG000|Overall Study|Accidently randomized|3|||
129531381|NCT04491591|466233331|FG001|Overall Study|Accidently randomized|1|||
129531382|NCT04491591|466233332|FG002|Overall Study|Accidently randomized|0|||
129531383|NCT04491591|466233330|FG000|Overall Study|Did not complete survey|28|||
129531384|NCT04491591|466233331|FG001|Overall Study|Did not complete survey|20|||
129531385|NCT04491591|466233332|FG002|Overall Study|Did not complete survey|3|||
129531386|NCT00135694|466233333|FG000|Overall Study|Adverse Event|17|||
129531387|NCT00135694|466233334|FG001|Overall Study|Adverse Event|4|||
129531388|NCT00135694|466233335|FG002|Overall Study|Adverse Event|0|||
129531389|NCT00135694|466233333|FG000|Overall Study|Death|14|||
129531390|NCT00135694|466233334|FG001|Overall Study|Death|1|||
129531391|NCT00135694|466233335|FG002|Overall Study|Death|2|||
129531392|NCT00135694|466233333|FG000|Overall Study|Lost to Follow-up|8|||
129531393|NCT00135694|466233334|FG001|Overall Study|Lost to Follow-up|7|||
129531394|NCT00135694|466233335|FG002|Overall Study|Lost to Follow-up|1|||
129531395|NCT00135694|466233333|FG000|Overall Study|Withdrawal by Subject|41|||
129531396|NCT00135694|466233334|FG001|Overall Study|Withdrawal by Subject|7|||
129531397|NCT00135694|466233335|FG002|Overall Study|Withdrawal by Subject|4|||
129531398|NCT00135694|466233333|FG000|Overall Study|Protocol Violation|19|||
129531399|NCT00135694|466233334|FG001|Overall Study|Protocol Violation|1|||
129531400|NCT00135694|466233335|FG002|Overall Study|Protocol Violation|0|||
129531401|NCT00135694|466233333|FG000|Overall Study|Hepatitis C related reasons|39|||
129531402|NCT00135694|466233334|FG001|Overall Study|Hepatitis C related reasons|1|||
129531403|NCT00135694|466233335|FG002|Overall Study|Hepatitis C related reasons|0|||
129531404|NCT00135694|466233333|FG000|Overall Study|Ineligible for Random assignment|42|||
129531405|NCT00135694|466233334|FG001|Overall Study|Ineligible for Random assignment|0|||
129531406|NCT00135694|466233335|FG002|Overall Study|Ineligible for Random assignment|0|||
129531407|NCT00472043|466233337|FG000|Overall Study|Withdrawal by Subject|1|||
129531408|NCT00472043|466233338|FG001|Overall Study|Withdrawal by Subject|0|||
129531409|NCT00472043|466233337|FG000|Overall Study|Death|1|||
129531410|NCT00472043|466233338|FG001|Overall Study|Death|0|||
129531411|NCT02802735|466233339|FG000|Overall Study|Withdrawal by Subject|0|||
129531412|NCT02802735|466233340|FG001|Overall Study|Withdrawal by Subject|1|||
129531413|NCT02802735|466233341|FG002|Overall Study|Withdrawal by Subject|0|||
129531414|NCT02802735|466233342|FG003|Overall Study|Withdrawal by Subject|0|||
129531415|NCT02802735|466233343|FG004|Overall Study|Withdrawal by Subject|0|||
129531416|NCT03922711|466233344|FG000|Overall Study|Adverse Event|3|||
129531417|NCT03922711|466233345|FG001|Overall Study|Adverse Event|2|||
129531418|NCT03922711|466233346|FG002|Overall Study|Adverse Event|2|||
129531419|NCT03922711|466233344|FG000|Overall Study|Protocol Violation|1|||
129531420|NCT03922711|466233345|FG001|Overall Study|Protocol Violation|0|||
129531421|NCT03922711|466233346|FG002|Overall Study|Protocol Violation|0|||
129531422|NCT03922711|466233344|FG000|Overall Study|Withdrawal by Subject|0|||
129531423|NCT03922711|466233345|FG001|Overall Study|Withdrawal by Subject|3|||
129531424|NCT03922711|466233346|FG002|Overall Study|Withdrawal by Subject|1|||
129531425|NCT03922711|466233344|FG000|Overall Study|Not further specified|0|||
129531426|NCT03922711|466233345|FG001|Overall Study|Not further specified|0|||
129531427|NCT03922711|466233346|FG002|Overall Study|Not further specified|1|||
129531428|NCT00420212|466233349|FG000|Overall Study|Adverse Event|22|||
129531429|NCT00420212|466233350|FG001|Overall Study|Adverse Event|40|||
129531430|NCT00420212|466233351|FG002|Overall Study|Adverse Event|36|||
129531431|NCT00420212|466233349|FG000|Overall Study|Lost to Follow-up|9|||
129531432|NCT00420212|466233350|FG001|Overall Study|Lost to Follow-up|11|||
129531433|NCT00420212|466233351|FG002|Overall Study|Lost to Follow-up|11|||
129531434|NCT00420212|466233349|FG000|Overall Study|Withdrawal by Subject|31|||
129531435|NCT00420212|466233350|FG001|Overall Study|Withdrawal by Subject|22|||
129531436|NCT00420212|466233351|FG002|Overall Study|Withdrawal by Subject|19|||
129531437|NCT00420212|466233349|FG000|Overall Study|Physician Decision|4|||
129531438|NCT00420212|466233350|FG001|Overall Study|Physician Decision|4|||
129531439|NCT00420212|466233351|FG002|Overall Study|Physician Decision|3|||
129531440|NCT00420212|466233349|FG000|Overall Study|Protocol Violation|4|||
129531441|NCT00420212|466233350|FG001|Overall Study|Protocol Violation|4|||
129531442|NCT00420212|466233351|FG002|Overall Study|Protocol Violation|8|||
129531443|NCT00420212|466233349|FG000|Overall Study|Death|0|||
129531444|NCT00420212|466233350|FG001|Overall Study|Death|0|||
129531445|NCT00420212|466233351|FG002|Overall Study|Death|1|||
129531446|NCT00420212|466233349|FG000|Overall Study|Other-Unspecified|21|||
129531447|NCT00420212|466233350|FG001|Overall Study|Other-Unspecified|14|||
129531448|NCT00420212|466233351|FG002|Overall Study|Other-Unspecified|18|||
129531449|NCT00877890|466233354|FG000|Overall Study|Adverse Event|6|||
129531450|NCT00877890|466233355|FG001|Overall Study|Adverse Event|6|||
129531451|NCT00877890|466233354|FG000|Overall Study|Lost to Follow-up|5|||
129531452|NCT00877890|466233355|FG001|Overall Study|Lost to Follow-up|5|||
129531453|NCT00877890|466233354|FG000|Overall Study|Protocol Violation|0|||
129531454|NCT00877890|466233355|FG001|Overall Study|Protocol Violation|1|||
129531455|NCT00877890|466233354|FG000|Overall Study|Withdrawal of Consent|6|||
129531456|NCT00877890|466233355|FG001|Overall Study|Withdrawal of Consent|12|||
129531457|NCT00877890|466233354|FG000|Overall Study|Investigator Decision|0|||
129531458|NCT00877890|466233355|FG001|Overall Study|Investigator Decision|2|||
129531459|NCT00877890|466233354|FG000|Overall Study|Loss of Glucose Control|3|||
129531460|NCT00877890|466233355|FG001|Overall Study|Loss of Glucose Control|4|||
129531461|NCT03049852|466233358|FG000|Overall Study|Lost to Follow-up|0|||
129531462|NCT03049852|466233359|FG001|Overall Study|Lost to Follow-up|1|||
129531463|NCT03049852|466233360|FG002|Overall Study|Lost to Follow-up|0|||
129531464|NCT01021423|466233362|FG000|Overall Study|Study terminated|4|||
129531465|NCT01021423|466233363|FG001|Overall Study|Study terminated|5|||
129531466|NCT00303329|466235616|FG000|Overall Study|Adverse Event|7|||
129531467|NCT00303329|466235617|FG001|Overall Study|Adverse Event|14|||
129531468|NCT00303329|466235616|FG000|Overall Study|Abnormal Laboratory Values|0|||
129531469|NCT00303329|466235617|FG001|Overall Study|Abnormal Laboratory Values|1|||
129531470|NCT00303329|466235616|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
129531471|NCT00303329|466235617|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
129531472|NCT00303329|466235616|FG000|Overall Study|Condition no longer requires study drug|0|||
129531473|NCT00303329|466235617|FG001|Overall Study|Condition no longer requires study drug|8|||
129531474|NCT00303329|466235616|FG000|Overall Study|Protocol Violation|3|||
129531475|NCT00303329|466235617|FG001|Overall Study|Protocol Violation|0|||
129531476|NCT00303329|466235616|FG000|Overall Study|Withdrawal by Subject|9|||
129531477|NCT00303329|466235617|FG001|Overall Study|Withdrawal by Subject|15|||
129531478|NCT00303329|466235616|FG000|Overall Study|Lost to Follow-up|0|||
129531479|NCT00303329|466235617|FG001|Overall Study|Lost to Follow-up|1|||
129531480|NCT00303329|466235616|FG000|Overall Study|Administrative problems|1|||
129531481|NCT00303329|466235617|FG001|Overall Study|Administrative problems|0|||
129531482|NCT00303329|466235616|FG000|Overall Study|Death|2|||
129531483|NCT00303329|466235617|FG001|Overall Study|Death|12|||
129531484|NCT00303329|466235616|FG000|Overall Study|Stopped at end of core|3|||
129531485|NCT00303329|466235617|FG001|Overall Study|Stopped at end of core|9|||
129531486|NCT00303329|466235616|FG000|Overall Study|Stopped at end of extension 1|1|||
129531487|NCT00303329|466235617|FG001|Overall Study|Stopped at end of extension 1|0|||
129531488|NCT02967562|466235619|FG000|Overall Study|Consent not obtained|1|||
129531489|NCT02967562|466235620|FG001|Overall Study|Consent not obtained|0|||
129531490|NCT02967562|466235619|FG000|Overall Study|High leak precluding analysis|1|||
129531491|NCT02967562|466235620|FG001|Overall Study|High leak precluding analysis|1|||
129531492|NCT00106626|466235621|FG000|Overall Study|Adverse Event|5|||
129531493|NCT00106626|466235622|FG001|Overall Study|Adverse Event|4|||
129531494|NCT00106626|466235623|FG002|Overall Study|Adverse Event|3|||
129531495|NCT00106626|466235624|FG003|Overall Study|Adverse Event|3|||
129531496|NCT00106626|466235621|FG000|Overall Study|Progressive Disease|4|||
129531497|NCT00106626|466235622|FG001|Overall Study|Progressive Disease|1|||
129531498|NCT00106626|466235623|FG002|Overall Study|Progressive Disease|9|||
129531499|NCT00106626|466235624|FG003|Overall Study|Progressive Disease|10|||
129531500|NCT00106626|466235621|FG000|Overall Study|Received radiation on new therapy|1|||
129531501|NCT00106626|466235622|FG001|Overall Study|Received radiation on new therapy|0|||
129531502|NCT00106626|466235623|FG002|Overall Study|Received radiation on new therapy|0|||
129531503|NCT00106626|466235624|FG003|Overall Study|Received radiation on new therapy|0|||
129531504|NCT00106626|466235621|FG000|Overall Study|> 14 day delay in therapy start|0|||
129531505|NCT00106626|466235622|FG001|Overall Study|> 14 day delay in therapy start|1|||
129531506|NCT00106626|466235623|FG002|Overall Study|> 14 day delay in therapy start|0|||
129531507|NCT00106626|466235624|FG003|Overall Study|> 14 day delay in therapy start|0|||
129531508|NCT00732199|466235625|FG000|Overall Study|Withdrawal by Subject|25|||
129531509|NCT00732199|466235626|FG001|Overall Study|Withdrawal by Subject|18|||
129531510|NCT00732199|466235625|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
129531511|NCT00732199|466235626|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
129531512|NCT02870348|466235631|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
129531513|NCT00672139|466235632|FG000|Overall Study|Death|14|||
129531514|NCT00672139|466235633|FG001|Overall Study|Death|23|||
129531515|NCT00672139|466235632|FG000|Overall Study|Withdrawal by Subject|2|||
129531516|NCT00672139|466235633|FG001|Overall Study|Withdrawal by Subject|11|||
129531517|NCT00672139|466235632|FG000|Overall Study|Adverse Event|4|||
129531518|NCT00672139|466235633|FG001|Overall Study|Adverse Event|7|||
129531519|NCT00672139|466235632|FG000|Overall Study|Physician Decision|2|||
129531520|NCT00672139|466235633|FG001|Overall Study|Physician Decision|0|||
129531521|NCT00672139|466235632|FG000|Overall Study|Lack of Efficacy|4|||
129531522|NCT00672139|466235633|FG001|Overall Study|Lack of Efficacy|1|||
129531523|NCT00672139|466235632|FG000|Overall Study|Protocol Violation|1|||
129531524|NCT00672139|466235633|FG001|Overall Study|Protocol Violation|1|||
129531525|NCT00672139|466235632|FG000|Overall Study|hospice discharge, caregiver requests|3|||
129531526|NCT00672139|466235633|FG001|Overall Study|hospice discharge, caregiver requests|2|||
129531527|NCT01038635|466235640|FG000|Overall Study|Disease Progression|2|||
129531528|NCT01038635|466235641|FG001|Overall Study|Disease Progression|0|||
129531529|NCT01038635|466235642|FG002|Overall Study|Disease Progression|0|||
129531530|NCT01038635|466235643|FG003|Overall Study|Disease Progression|0|||
129531531|NCT01038635|466235644|FG004|Overall Study|Disease Progression|0|||
129531532|NCT01038635|466235645|FG005|Overall Study|Disease Progression|0|||
129531533|NCT01038635|466235646|FG006|Overall Study|Disease Progression|1|||
129531534|NCT01038635|466235647|FG007|Overall Study|Disease Progression|4|||
129531535|NCT01038635|466235648|FG008|Overall Study|Disease Progression|0|||
129531536|NCT01038635|466235640|FG000|Overall Study|Death|0|||
129531537|NCT01038635|466235641|FG001|Overall Study|Death|0|||
129531538|NCT01038635|466235642|FG002|Overall Study|Death|0|||
129531539|NCT01038635|466235643|FG003|Overall Study|Death|0|||
129531540|NCT01038635|466235644|FG004|Overall Study|Death|1|||
129531541|NCT01038635|466235645|FG005|Overall Study|Death|0|||
129531542|NCT01038635|466235646|FG006|Overall Study|Death|1|||
129531543|NCT01038635|466235647|FG007|Overall Study|Death|1|||
129531544|NCT01038635|466235648|FG008|Overall Study|Death|2|||
129531545|NCT01562327|466235649|FG000|Overall Study|Adverse Event|2|||
129531546|NCT01562327|466235649|FG000|Overall Study|Lack of Efficacy|1|||
129531547|NCT01562327|466235649|FG000|Overall Study|Participant drop-out|1|||
129531548|NCT01562327|466235649|FG000|Overall Study|Infusion not received at 6 month window|4|||
129531549|NCT01060150|466235650|FG000|Overall Study|Adverse Event|6|||
129531550|NCT01060150|466235650|FG000|Overall Study|Lost to Follow-up|1|||
129531551|NCT01060150|466235650|FG000|Overall Study|Protocol Violation|6|||
129531552|NCT01060150|466235650|FG000|Overall Study|Withdrawal by Subject|8|||
129531553|NCT01060150|466235650|FG000|Overall Study|Enrolled, but not treated|2|||
129531554|NCT03018340|466235651|FG000|Overall Study|Adverse Event|1|||
129531555|NCT03018340|466235652|FG001|Overall Study|Adverse Event|2|||
129531556|NCT03018340|466235651|FG000|Overall Study|Withdrawal by Subject|0|||
129531557|NCT03018340|466235652|FG001|Overall Study|Withdrawal by Subject|8|||
129531558|NCT03018340|466235651|FG000|Overall Study|Lack of Efficacy|0|||
129531559|NCT03018340|466235652|FG001|Overall Study|Lack of Efficacy|1|||
129531560|NCT03018340|466235651|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
129531561|NCT03018340|466235652|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
129531562|NCT03018340|466235651|FG000|Overall Study|Lost to Follow-up|1|||
129531563|NCT03018340|466235652|FG001|Overall Study|Lost to Follow-up|7|||
129531564|NCT03018340|466235651|FG000|Overall Study|Protocol Violation|3|||
129531565|NCT03018340|466235652|FG001|Overall Study|Protocol Violation|7|||
129531566|NCT03018340|466235651|FG000|Overall Study|Not further specified|0|||
129531567|NCT03018340|466235652|FG001|Overall Study|Not further specified|1|||
129531568|NCT00256204|466235653|FG000|Overall Study|Adverse Event|10|||
129531569|NCT00256204|466235654|FG001|Overall Study|Adverse Event|14|||
129531570|NCT00256204|466235655|FG002|Overall Study|Adverse Event|16|||
129531571|NCT00256204|466235656|FG003|Overall Study|Adverse Event|14|||
129531572|NCT00256204|466235653|FG000|Overall Study|Death|0|||
129531573|NCT00256204|466235654|FG001|Overall Study|Death|1|||
129531574|NCT00256204|466235655|FG002|Overall Study|Death|0|||
129531575|NCT00256204|466235656|FG003|Overall Study|Death|0|||
129531576|NCT00256204|466235653|FG000|Overall Study|Lost to Follow-up|1|||
129531577|NCT00256204|466235654|FG001|Overall Study|Lost to Follow-up|1|||
129531578|NCT00256204|466235655|FG002|Overall Study|Lost to Follow-up|1|||
129531579|NCT00256204|466235656|FG003|Overall Study|Lost to Follow-up|2|||
129531580|NCT00256204|466235653|FG000|Overall Study|Protocol Violation|1|||
129531581|NCT00256204|466235654|FG001|Overall Study|Protocol Violation|0|||
129531582|NCT00256204|466235655|FG002|Overall Study|Protocol Violation|2|||
129531583|NCT00256204|466235656|FG003|Overall Study|Protocol Violation|1|||
129531584|NCT00256204|466235653|FG000|Overall Study|Physician Decision|0|||
129531585|NCT00256204|466235654|FG001|Overall Study|Physician Decision|0|||
129531586|NCT00256204|466235655|FG002|Overall Study|Physician Decision|1|||
129531587|NCT00256204|466235656|FG003|Overall Study|Physician Decision|2|||
129531588|NCT00256204|466235653|FG000|Overall Study|Withdrawal by Subject|17|||
129531589|NCT00256204|466235654|FG001|Overall Study|Withdrawal by Subject|6|||
129531590|NCT00256204|466235655|FG002|Overall Study|Withdrawal by Subject|7|||
129531591|NCT00256204|466235656|FG003|Overall Study|Withdrawal by Subject|5|||
129531592|NCT00256204|466235653|FG000|Overall Study|Need for additional prohibited treatment|38|||
129531593|NCT00256204|466235654|FG001|Overall Study|Need for additional prohibited treatment|28|||
129531594|NCT00256204|466235655|FG002|Overall Study|Need for additional prohibited treatment|27|||
129531595|NCT00256204|466235656|FG003|Overall Study|Need for additional prohibited treatment|25|||
129531596|NCT00808132|466235659|FG000|Overall Study|Adverse Event|34|||
129531597|NCT00808132|466235660|FG001|Overall Study|Adverse Event|33|||
129531598|NCT00808132|466235661|FG002|Overall Study|Adverse Event|16|||
129531599|NCT00808132|466235662|FG003|Overall Study|Adverse Event|31|||
129531600|NCT00808132|466235663|FG004|Overall Study|Adverse Event|33|||
129531601|NCT00808132|466235659|FG000|Overall Study|Death|0|||
129531602|NCT00808132|466235660|FG001|Overall Study|Death|0|||
129531603|NCT00808132|466235661|FG002|Overall Study|Death|0|||
129531604|NCT00808132|466235662|FG003|Overall Study|Death|0|||
129531605|NCT00808132|466235663|FG004|Overall Study|Death|1|||
129531606|NCT00808132|466235659|FG000|Overall Study|Physician Decision|0|||
129531607|NCT00808132|466235660|FG001|Overall Study|Physician Decision|1|||
129531608|NCT00808132|466235661|FG002|Overall Study|Physician Decision|0|||
129531609|NCT00808132|466235662|FG003|Overall Study|Physician Decision|0|||
129531610|NCT00808132|466235663|FG004|Overall Study|Physician Decision|0|||
129531611|NCT00808132|466235659|FG000|Overall Study|Lost to Follow-up|8|||
129531612|NCT00808132|466235660|FG001|Overall Study|Lost to Follow-up|10|||
129531613|NCT00808132|466235661|FG002|Overall Study|Lost to Follow-up|11|||
129531614|NCT00808132|466235662|FG003|Overall Study|Lost to Follow-up|8|||
129531615|NCT00808132|466235663|FG004|Overall Study|Lost to Follow-up|9|||
129531616|NCT00808132|466235659|FG000|Overall Study|Protocol Violation|8|||
129531617|NCT00808132|466235660|FG001|Overall Study|Protocol Violation|9|||
129531618|NCT00808132|466235661|FG002|Overall Study|Protocol Violation|4|||
129531619|NCT00808132|466235662|FG003|Overall Study|Protocol Violation|9|||
129531620|NCT00808132|466235663|FG004|Overall Study|Protocol Violation|5|||
129531621|NCT00808132|466235659|FG000|Overall Study|Withdrawal by Subject|27|||
129531622|NCT00808132|466235660|FG001|Overall Study|Withdrawal by Subject|18|||
129531623|NCT00808132|466235661|FG002|Overall Study|Withdrawal by Subject|2|||
129531624|NCT00808132|466235662|FG003|Overall Study|Withdrawal by Subject|7|||
129531625|NCT00808132|466235663|FG004|Overall Study|Withdrawal by Subject|16|||
129531626|NCT00808132|466235659|FG000|Overall Study|Other|6|||
129531627|NCT00808132|466235660|FG001|Overall Study|Other|4|||
129531628|NCT00808132|466235661|FG002|Overall Study|Other|6|||
129531629|NCT00808132|466235662|FG003|Overall Study|Other|2|||
129531630|NCT00808132|466235663|FG004|Overall Study|Other|15|||
129531631|NCT00808132|466235659|FG000|Overall Study|Randomized, but not treated|10|||
129531632|NCT00808132|466235660|FG001|Overall Study|Randomized, but not treated|7|||
129531633|NCT00808132|466235661|FG002|Overall Study|Randomized, but not treated|9|||
129531634|NCT00808132|466235662|FG003|Overall Study|Randomized, but not treated|8|||
129531635|NCT00808132|466235663|FG004|Overall Study|Randomized, but not treated|9|||
129531636|NCT00808132|466235659|FG000|Overall Study|Unsatisfactory response|5|||
129531637|NCT00808132|466235660|FG001|Overall Study|Unsatisfactory response|6|||
129531638|NCT00808132|466235661|FG002|Overall Study|Unsatisfactory response|6|||
129531639|NCT00808132|466235662|FG003|Overall Study|Unsatisfactory response|4|||
129531640|NCT00808132|466235663|FG004|Overall Study|Unsatisfactory response|12|||
129531641|NCT00550615|466235664|FG000|Overall Study|Withdrawal by Subject|0|||
129531642|NCT00550615|466235665|FG001|Overall Study|Withdrawal by Subject|0|||
129531643|NCT00550615|466235666|FG002|Overall Study|Withdrawal by Subject|2|||
129531644|NCT00550615|466235667|FG003|Overall Study|Withdrawal by Subject|3|||
129531645|NCT00550615|466235664|FG000|Overall Study|Not evaluable|0|||
129531646|NCT00550615|466235665|FG001|Overall Study|Not evaluable|0|||
129531647|NCT00550615|466235666|FG002|Overall Study|Not evaluable|2|||
129531648|NCT00550615|466235667|FG003|Overall Study|Not evaluable|7|||
129531649|NCT02405091|466235668|FG000|Overall Study|Adverse Event|16|||
129531650|NCT02405091|466235669|FG001|Overall Study|Adverse Event|10|||
129531651|NCT02405091|466235670|FG002|Overall Study|Adverse Event|0|||
129531652|NCT02405091|466235668|FG000|Overall Study|Protocol Violation|1|||
129531653|NCT02405091|466235669|FG001|Overall Study|Protocol Violation|0|||
129531654|NCT02405091|466235670|FG002|Overall Study|Protocol Violation|0|||
129531655|NCT02405091|466235668|FG000|Overall Study|Noncompliance|1|||
129531656|NCT02405091|466235669|FG001|Overall Study|Noncompliance|6|||
129531657|NCT02405091|466235670|FG002|Overall Study|Noncompliance|2|||
129531658|NCT02405091|466235668|FG000|Overall Study|Withdrawal by Subject|4|||
129531659|NCT02405091|466235669|FG001|Overall Study|Withdrawal by Subject|8|||
129531660|NCT02405091|466235670|FG002|Overall Study|Withdrawal by Subject|0|||
129531661|NCT02405091|466235668|FG000|Overall Study|Death|0|||
129531662|NCT02405091|466235669|FG001|Overall Study|Death|1|||
129531663|NCT02405091|466235670|FG002|Overall Study|Death|0|||
129531664|NCT02405091|466235668|FG000|Overall Study|Lost to Follow-up|5|||
129531665|NCT02405091|466235669|FG001|Overall Study|Lost to Follow-up|6|||
129531666|NCT02405091|466235670|FG002|Overall Study|Lost to Follow-up|0|||
129531667|NCT02405091|466235668|FG000|Overall Study|Physician Decision|2|||
129531668|NCT02405091|466235669|FG001|Overall Study|Physician Decision|2|||
129531669|NCT02405091|466235670|FG002|Overall Study|Physician Decision|0|||
129531670|NCT01948791|466235677|FG000|Overall Study|Adverse Event|12|||
129531671|NCT01948791|466235677|FG000|Overall Study|Lack of Efficacy|3|||
129531672|NCT01948791|466235677|FG000|Overall Study|Protocol Violation|2|||
129531673|NCT01948791|466235677|FG000|Overall Study|Withdrawal by Subject|5|||
129531674|NCT01948791|466235677|FG000|Overall Study|Lost to Follow-up|6|||
129531675|NCT01948791|466235677|FG000|Overall Study|Management issues|1|||
129531676|NCT01948791|466235677|FG000|Overall Study|Others|7|||
129531677|NCT01948791|466235677|FG000|Overall Study|Screening failure|35|||
129531678|NCT01955005|466235689|FG000|Overall Study|Withdrawal by Subject|3|||
129531679|NCT01955005|466235690|FG001|Overall Study|Withdrawal by Subject|5|||
129531680|NCT00352027|466235691|FG000|Overall Study|Progressive disease|3|||
129531681|NCT00702949|466235692|FG000|Overall Study|Refusal|3|||
129531682|NCT00702949|466235693|FG001|Overall Study|Refusal|2|||
129531683|NCT00702949|466235694|FG002|Overall Study|Refusal|2|||
129531684|NCT00702949|466235692|FG000|Overall Study|Adverse Event|1|||
129531685|NCT00702949|466235693|FG001|Overall Study|Adverse Event|6|||
129531686|NCT00702949|466235694|FG002|Overall Study|Adverse Event|3|||
129531687|NCT00702949|466235692|FG000|Overall Study|Other Medical Reason/unknown|1|||
129531688|NCT00702949|466235693|FG001|Overall Study|Other Medical Reason/unknown|1|||
129531689|NCT00702949|466235694|FG002|Overall Study|Other Medical Reason/unknown|3|||
129531690|NCT03147495|466235700|FG000|Overall Study|Physician Decision|0|||
129531691|NCT03147495|466235701|FG001|Overall Study|Physician Decision|6|||
129531692|NCT00742391|466235704|FG000|Overall Study|Adverse Event|2|||
129531693|NCT00742391|466235705|FG001|Overall Study|Adverse Event|1|||
129531694|NCT00742391|466235704|FG000|Overall Study|Lost to Follow-up|1|||
129531695|NCT00742391|466235705|FG001|Overall Study|Lost to Follow-up|0|||
129531696|NCT00742391|466235704|FG000|Overall Study|Protocol Violation|1|||
129531697|NCT00742391|466235705|FG001|Overall Study|Protocol Violation|0|||
129531698|NCT02975206|466235712|FG000|Overall Study|Withdrawal by Subject|14|||
129531699|NCT02975206|466235713|FG001|Overall Study|Withdrawal by Subject|11|||
129531700|NCT02975206|466235714|FG002|Overall Study|Withdrawal by Subject|11|||
129531701|NCT02975206|466235712|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
129531702|NCT02975206|466235713|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
129531703|NCT02975206|466235714|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
129531704|NCT01981096|466235716|FG000|Overall Study|Parent illness|1|||
129531705|NCT01981096|466235717|FG001|Overall Study|Parent illness|0|||
129531706|NCT01981096|466235716|FG000|Overall Study|Withdrawal by Subject|0|||
129531707|NCT01981096|466235717|FG001|Overall Study|Withdrawal by Subject|1|||
129531708|NCT01981096|466235716|FG000|Overall Study|Lost to Follow-up|2|||
129531709|NCT01981096|466235717|FG001|Overall Study|Lost to Follow-up|0|||
129531710|NCT00866606|466235718|FG000|Overall Study|Lost to Follow-up|3|||
129531711|NCT00866606|466235718|FG000|Overall Study|Adverse Event|1|||
129531712|NCT01225211|466235719|FG000|Overall Study|Adverse Event|0|||
129531713|NCT01225211|466235720|FG001|Overall Study|Adverse Event|0|||
129531714|NCT01225211|466235721|FG002|Overall Study|Adverse Event|1|||
129531715|NCT01225211|466235722|FG003|Overall Study|Adverse Event|0|||
129531716|NCT01225211|466235723|FG004|Overall Study|Adverse Event|0|||
129531717|NCT01225211|466235724|FG005|Overall Study|Adverse Event|0|||
129531718|NCT01225211|466235725|FG006|Overall Study|Adverse Event|0|||
129531719|NCT01225211|466235726|FG007|Overall Study|Adverse Event|0|||
129531720|NCT01225211|466235727|FG008|Overall Study|Adverse Event|0|||
129531721|NCT01225211|466235728|FG009|Overall Study|Adverse Event|1|||
129531722|NCT01225211|466235719|FG000|Overall Study|Withdrawal by Subject|0|||
129531723|NCT01225211|466235720|FG001|Overall Study|Withdrawal by Subject|0|||
129531724|NCT01225211|466235721|FG002|Overall Study|Withdrawal by Subject|0|||
129531725|NCT01225211|466235722|FG003|Overall Study|Withdrawal by Subject|0|||
129531726|NCT01225211|466235723|FG004|Overall Study|Withdrawal by Subject|0|||
129531727|NCT01225211|466235724|FG005|Overall Study|Withdrawal by Subject|0|||
129531728|NCT01225211|466235725|FG006|Overall Study|Withdrawal by Subject|1|||
129531729|NCT01225211|466235726|FG007|Overall Study|Withdrawal by Subject|0|||
129531730|NCT01225211|466235727|FG008|Overall Study|Withdrawal by Subject|1|||
129531731|NCT01225211|466235728|FG009|Overall Study|Withdrawal by Subject|3|||
129531732|NCT01225211|466235719|FG000|Overall Study|Other|0|||
129531733|NCT01225211|466235720|FG001|Overall Study|Other|0|||
129531734|NCT01225211|466235721|FG002|Overall Study|Other|0|||
129531735|NCT01225211|466235722|FG003|Overall Study|Other|0|||
129531736|NCT01225211|466235723|FG004|Overall Study|Other|0|||
129531737|NCT01225211|466235724|FG005|Overall Study|Other|0|||
129531738|NCT01225211|466235725|FG006|Overall Study|Other|0|||
129531739|NCT01225211|466235726|FG007|Overall Study|Other|0|||
129531740|NCT01225211|466235727|FG008|Overall Study|Other|0|||
129531741|NCT01225211|466235728|FG009|Overall Study|Other|1|||
129531742|NCT01058356|466235749|FG000|Overall Study|Adverse Event|5|||
129531743|NCT01058356|466235749|FG000|Overall Study|Administration of contraindicated drugs|12|||
129531744|NCT01058356|466235749|FG000|Overall Study|Withdrawal by Subject|21|||
129531745|NCT01058356|466235749|FG000|Overall Study|Lost to Follow-up|4|||
129531746|NCT00606021|466235756|FG000|Induction Phase|Death|73|||
129531747|NCT00606021|466235757|FG001|Induction Phase|Death|0|||
129531748|NCT00606021|466235758|FG002|Induction Phase|Death|0|||
129531749|NCT00606021|466235756|FG000|Induction Phase|Physician Decision|2|||
129531750|NCT00606021|466235757|FG001|Induction Phase|Physician Decision|0|||
129531751|NCT00606021|466235758|FG002|Induction Phase|Physician Decision|0|||
129531752|NCT00606021|466235756|FG000|Induction Phase|Withdrawal by Subject|2|||
129531753|NCT00606021|466235757|FG001|Induction Phase|Withdrawal by Subject|0|||
129531754|NCT00606021|466235758|FG002|Induction Phase|Withdrawal by Subject|0|||
129531755|NCT00606021|466235756|FG000|Induction Phase|Lost to Follow-up|10|||
129531756|NCT00606021|466235757|FG001|Induction Phase|Lost to Follow-up|0|||
129531757|NCT00606021|466235758|FG002|Induction Phase|Lost to Follow-up|0|||
129531758|NCT00606021|466235756|FG000|Maintenance Phase|Death|0|||
129531759|NCT00606021|466235757|FG001|Maintenance Phase|Death|17|||
129531760|NCT00606021|466235758|FG002|Maintenance Phase|Death|15|||
129531761|NCT00606021|466235756|FG000|Maintenance Phase|Physician Decision|0|||
129531762|NCT00606021|466235757|FG001|Maintenance Phase|Physician Decision|1|||
129531763|NCT00606021|466235758|FG002|Maintenance Phase|Physician Decision|0|||
129531764|NCT00606021|466235756|FG000|Maintenance Phase|Lost to Follow-up|0|||
129531765|NCT00606021|466235757|FG001|Maintenance Phase|Lost to Follow-up|5|||
129531766|NCT00606021|466235758|FG002|Maintenance Phase|Lost to Follow-up|2|||
129531767|NCT00392210|466235759|FG000|First Voiding Trial|Physician Decision|2|||
129531768|NCT00392210|466235760|FG001|First Voiding Trial|Physician Decision|2|||
129531769|NCT02067104|466235761|FG000|Overall Study|Study termination due to low accrual|4|||
129531770|NCT02067104|466235762|FG001|Overall Study|Study termination due to low accrual|5|||
129531771|NCT04815291|466235774|FG000|Overall Study|Lost to Follow-up|1|||
129531772|NCT04815291|466235774|FG000|Overall Study|Physician Decision|4|||
129531773|NCT04815291|466235774|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
129531774|NCT02140762|466235775|FG000|Overall Study|Adverse Event|1|||
129531775|NCT02140762|466235776|FG001|Overall Study|Adverse Event|1|||
129531776|NCT02140762|466235775|FG000|Overall Study|Lost to Follow-up|9|||
129531777|NCT02140762|466235776|FG001|Overall Study|Lost to Follow-up|5|||
129531778|NCT02140762|466235775|FG000|Overall Study|Protocol Violation|1|||
129531779|NCT02140762|466235776|FG001|Overall Study|Protocol Violation|1|||
129531780|NCT02140762|466235775|FG000|Overall Study|Withdrawal by Subject|6|||
129531781|NCT02140762|466235776|FG001|Overall Study|Withdrawal by Subject|4|||
129531782|NCT02140762|466235775|FG000|Overall Study|Other|0|||
129531783|NCT02140762|466235776|FG001|Overall Study|Other|1|||
129531784|NCT00989664|466235778|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
129531785|NCT00989664|466235778|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
129531786|NCT00989664|466235778|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
129531787|NCT00989664|466235778|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
129531788|NCT00989664|466235778|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
129531789|NCT00989664|466235778|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
129531790|NCT00989664|466235778|FG000|Long-Term Follow-Up|Death|3|||
129531791|NCT00095836|466235779|FG000|Overall Study|Lost to Follow-up|1|||
129531792|NCT00095836|466235779|FG000|Overall Study|Adverse Event|1|||
129531793|NCT00095836|466235779|FG000|Overall Study|Death|2|||
129531794|NCT00962780|466235783|FG000|Overall Study|Death|0|||
129531795|NCT00962780|466235784|FG001|Overall Study|Death|1|||
129531796|NCT00962780|466235783|FG000|Overall Study|Protocol Violation|9|||
129531797|NCT00962780|466235784|FG001|Overall Study|Protocol Violation|4|||
129531798|NCT00962780|466235783|FG000|Overall Study|Withdrawal by Subject|1|||
129531799|NCT00962780|466235784|FG001|Overall Study|Withdrawal by Subject|8|||
129531800|NCT00962780|466235783|FG000|Overall Study|Other|0|||
129531801|NCT00962780|466235784|FG001|Overall Study|Other|1|||
129531802|NCT02363322|466235785|FG000|Overall Study|Lost to Follow-up|1|||
129531803|NCT02363322|466235786|FG001|Overall Study|Lost to Follow-up|0|||
129531804|NCT02055976|466235787|FG000|Overall Study|Other|0|||
129531805|NCT02055976|466235788|FG001|Overall Study|Other|0|||
129531806|NCT02055976|466235789|FG002|Overall Study|Other|1|||
129531807|NCT02055976|466235790|FG003|Overall Study|Other|0|||
129531808|NCT02055976|466235791|FG004|Overall Study|Other|0|||
129531809|NCT02055976|466235792|FG005|Overall Study|Other|0|||
129531810|NCT02055976|466235793|FG006|Overall Study|Other|0|||
129531811|NCT02055976|466235794|FG007|Overall Study|Other|0|||
129531812|NCT02055976|466235795|FG008|Overall Study|Other|0|||
129531813|NCT02055976|466235787|FG000|Overall Study|Adverse Event|0|||
129531814|NCT02055976|466235788|FG001|Overall Study|Adverse Event|0|||
129531815|NCT02055976|466235789|FG002|Overall Study|Adverse Event|0|||
129531816|NCT02055976|466235790|FG003|Overall Study|Adverse Event|0|||
129531817|NCT02055976|466235791|FG004|Overall Study|Adverse Event|0|||
129531818|NCT02055976|466235792|FG005|Overall Study|Adverse Event|1|||
129531819|NCT02055976|466235793|FG006|Overall Study|Adverse Event|1|||
129531820|NCT02055976|466235794|FG007|Overall Study|Adverse Event|0|||
129531821|NCT02055976|466235795|FG008|Overall Study|Adverse Event|0|||
129531822|NCT02055976|466235787|FG000|Overall Study|Does not meet entrance criteria|0|||
129531823|NCT02055976|466235788|FG001|Overall Study|Does not meet entrance criteria|0|||
129531824|NCT02055976|466235789|FG002|Overall Study|Does not meet entrance criteria|0|||
129531825|NCT02055976|466235790|FG003|Overall Study|Does not meet entrance criteria|0|||
129531826|NCT02055976|466235791|FG004|Overall Study|Does not meet entrance criteria|0|||
129531827|NCT02055976|466235792|FG005|Overall Study|Does not meet entrance criteria|0|||
129531828|NCT02055976|466235793|FG006|Overall Study|Does not meet entrance criteria|1|||
129531829|NCT02055976|466235794|FG007|Overall Study|Does not meet entrance criteria|0|||
129531830|NCT02055976|466235795|FG008|Overall Study|Does not meet entrance criteria|0|||
129531831|NCT02055976|466235787|FG000|Overall Study|Lost to Follow-up|0|||
129531832|NCT02055976|466235788|FG001|Overall Study|Lost to Follow-up|0|||
129531833|NCT02055976|466235789|FG002|Overall Study|Lost to Follow-up|0|||
129531834|NCT02055976|466235790|FG003|Overall Study|Lost to Follow-up|1|||
129531835|NCT02055976|466235791|FG004|Overall Study|Lost to Follow-up|0|||
129531836|NCT02055976|466235792|FG005|Overall Study|Lost to Follow-up|0|||
129531837|NCT02055976|466235793|FG006|Overall Study|Lost to Follow-up|0|||
129531838|NCT02055976|466235794|FG007|Overall Study|Lost to Follow-up|0|||
129531839|NCT02055976|466235795|FG008|Overall Study|Lost to Follow-up|0|||
129531840|NCT01230827|466235796|FG000|Overall Study|Lost to Follow-up|0|||
129531841|NCT01230827|466235797|FG001|Overall Study|Lost to Follow-up|0|||
129531842|NCT01230827|466235798|FG002|Overall Study|Lost to Follow-up|1|||
129531843|NCT01230827|466235799|FG003|Overall Study|Lost to Follow-up|3|||
129531844|NCT01230827|466235796|FG000|Overall Study|Withdrawal by Subject|1|||
129531845|NCT01230827|466235797|FG001|Overall Study|Withdrawal by Subject|0|||
129531846|NCT01230827|466235798|FG002|Overall Study|Withdrawal by Subject|3|||
129531847|NCT01230827|466235799|FG003|Overall Study|Withdrawal by Subject|2|||
129531848|NCT01230827|466235796|FG000|Overall Study|Lack of Efficacy|14|||
129531849|NCT01230827|466235797|FG001|Overall Study|Lack of Efficacy|1|||
129531850|NCT01230827|466235798|FG002|Overall Study|Lack of Efficacy|2|||
129531851|NCT01230827|466235799|FG003|Overall Study|Lack of Efficacy|3|||
129531852|NCT01230827|466235796|FG000|Overall Study|Adverse Event|4|||
129531853|NCT01230827|466235797|FG001|Overall Study|Adverse Event|2|||
129531854|NCT01230827|466235798|FG002|Overall Study|Adverse Event|3|||
129531855|NCT01230827|466235799|FG003|Overall Study|Adverse Event|7|||
129531856|NCT01230827|466235796|FG000|Overall Study|Recovery|0|||
129531857|NCT01230827|466235797|FG001|Overall Study|Recovery|6|||
129531858|NCT01230827|466235798|FG002|Overall Study|Recovery|0|||
129531859|NCT01230827|466235799|FG003|Overall Study|Recovery|0|||
129531860|NCT01230827|466235796|FG000|Overall Study|Study terminated by Sponsor|0|||
129531861|NCT01230827|466235797|FG001|Overall Study|Study terminated by Sponsor|2|||
129531862|NCT01230827|466235798|FG002|Overall Study|Study terminated by Sponsor|56|||
129531863|NCT01230827|466235799|FG003|Overall Study|Study terminated by Sponsor|63|||
129531864|NCT00805142|466235800|FG000|Titration Period|Adverse Event|3|||
129531865|NCT00805142|466235801|FG001|Titration Period|Adverse Event|3|||
129531866|NCT00805142|466235800|FG000|Titration Period|Lack of Efficacy|1|||
129531867|NCT00805142|466235801|FG001|Titration Period|Lack of Efficacy|1|||
129531868|NCT00805142|466235800|FG000|Titration Period|Lost to Follow-up|0|||
129531869|NCT00805142|466235801|FG001|Titration Period|Lost to Follow-up|1|||
129531870|NCT00805142|466235800|FG000|Titration Period|Disease Progression|2|||
129531871|NCT00805142|466235801|FG001|Titration Period|Disease Progression|1|||
129531872|NCT00805142|466235800|FG000|Titration Period|Withdrawal of consent|0|||
129531873|NCT00805142|466235801|FG001|Titration Period|Withdrawal of consent|1|||
129531874|NCT00805142|466235800|FG000|Titration Period|Other|0|||
129531875|NCT00805142|466235801|FG001|Titration Period|Other|3|||
129531876|NCT00805142|466235800|FG000|Maintenance Period|Adverse Event|0|||
129531877|NCT00805142|466235801|FG001|Maintenance Period|Adverse Event|1|||
129531878|NCT00805142|466235800|FG000|Maintenance Period|Other|0|||
129531879|NCT00805142|466235801|FG001|Maintenance Period|Other|1|||
129531880|NCT02886338|466235802|FG000|Overall Study|Withdrawal by Subject|1|||
129531881|NCT00122317|466235803|FG000|Overall Study|Death|3|||
129531882|NCT00122317|466235803|FG000|Overall Study|Adverse Event|4|||
129531883|NCT00122317|466235803|FG000|Overall Study|Physician Decision|2|||
129531884|NCT00122317|466235803|FG000|Overall Study|patient non-compliance|1|||
129531885|NCT00122317|466235803|FG000|Overall Study|Withdrawal by Subject|1|||
129531886|NCT00394654|466235804|FG000|Overall Study|Lost to Follow-up|1|||
129531887|NCT00394654|466235805|FG001|Overall Study|Lost to Follow-up|0|||
129531888|NCT00394654|466235804|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
129531889|NCT00394654|466235805|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
129531890|NCT03756285|466235806|FG000|Overall Study|Lost to Follow-up|0|||
129531891|NCT03756285|466235807|FG001|Overall Study|Lost to Follow-up|1|||
129531892|NCT03756285|466235806|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
129531893|NCT03756285|466235807|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
129531894|NCT03756285|466235806|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
129531895|NCT03756285|466235807|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
129531896|NCT03458234|466235810|FG000|Overall Study|Withdrawal by Subject|1|||
129531897|NCT01021293|466235812|FG000|Overall Study|Serious Adverse Event|2|||
129531898|NCT01021293|466235813|FG001|Overall Study|Serious Adverse Event|1|||
129531899|NCT01021293|466235812|FG000|Overall Study|Adverse Event|2|||
129531900|NCT01021293|466235813|FG001|Overall Study|Adverse Event|1|||
129531901|NCT01021293|466235812|FG000|Overall Study|Withdrawal by Subject|1|||
129531902|NCT01021293|466235813|FG001|Overall Study|Withdrawal by Subject|3|||
129531903|NCT01021293|466235812|FG000|Overall Study|Migrated/moved from study area|6|||
129531904|NCT01021293|466235813|FG001|Overall Study|Migrated/moved from study area|18|||
129531905|NCT01021293|466235812|FG000|Overall Study|Lost to Follow-up|1|||
129531906|NCT01021293|466235813|FG001|Overall Study|Lost to Follow-up|1|||
129531907|NCT00027846|466238174|FG000|Overall Study|Lost to Follow-up|0|||
129531908|NCT00027846|466238175|FG001|Overall Study|Lost to Follow-up|41|||
129531909|NCT00027846|466238176|FG002|Overall Study|Lost to Follow-up|9|||
129531910|NCT00027846|466238174|FG000|Overall Study|Withdrawal by Subject|0|||
129531911|NCT00027846|466238175|FG001|Overall Study|Withdrawal by Subject|14|||
129531912|NCT00027846|466238176|FG002|Overall Study|Withdrawal by Subject|7|||
129531913|NCT00027846|466238174|FG000|Overall Study|Ineligible for study|2|||
129531914|NCT00027846|466238175|FG001|Overall Study|Ineligible for study|6|||
129531915|NCT00027846|466238176|FG002|Overall Study|Ineligible for study|14|||
129531916|NCT00027846|466238174|FG000|Overall Study|Entry into another COG therapeutic study|0|||
129531917|NCT00027846|466238175|FG001|Overall Study|Entry into another COG therapeutic study|5|||
129531918|NCT00027846|466238176|FG002|Overall Study|Entry into another COG therapeutic study|2|||
129531919|NCT00027846|466238174|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
129531920|NCT00027846|466238175|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
129531921|NCT00027846|466238176|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
129531922|NCT05604781|466238182|FG000|Overall Study|Lost to Follow-up|3|||
129531923|NCT05604781|466238182|FG000|Overall Study|Adverse Event|1|||
129531924|NCT02889861|466238193|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
129531925|NCT01864746|466238194|FG000|Overall Study|Disease recurrence|25|||
129531926|NCT01864746|466238195|FG001|Overall Study|Disease recurrence|40|||
129531927|NCT01864746|466238194|FG000|Overall Study|Second primary invasive nonbreast|2|||
129531928|NCT01864746|466238195|FG001|Overall Study|Second primary invasive nonbreast|3|||
129531929|NCT01864746|466238194|FG000|Overall Study|Death|2|||
129531930|NCT01864746|466238195|FG001|Overall Study|Death|1|||
129531931|NCT01864746|466238194|FG000|Overall Study|Adverse Event|33|||
129531932|NCT01864746|466238195|FG001|Overall Study|Adverse Event|5|||
129531933|NCT01864746|466238194|FG000|Overall Study|Withdrawal by Subject|56|||
129531934|NCT01864746|466238195|FG001|Overall Study|Withdrawal by Subject|41|||
129531935|NCT01864746|466238194|FG000|Overall Study|Physician Decision|5|||
129531936|NCT01864746|466238195|FG001|Overall Study|Physician Decision|6|||
129531937|NCT01005966|466238196|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
129531938|NCT01005966|466238197|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
129531939|NCT01005966|466238198|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
129531940|NCT01005966|466238199|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
129531941|NCT01005966|466238200|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
129531942|NCT01005966|466238196|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
129531943|NCT01005966|466238197|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
129531944|NCT01005966|466238198|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
129531945|NCT01005966|466238199|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
129531946|NCT01005966|466238200|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
129531947|NCT01005966|466238196|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
129531948|NCT01005966|466238197|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
129531949|NCT01005966|466238198|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
129531950|NCT01005966|466238199|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
129531951|NCT01005966|466238200|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
129531952|NCT01005966|466238196|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
129531953|NCT01005966|466238197|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
129531954|NCT01005966|466238198|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
129531955|NCT01005966|466238199|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
129531956|NCT01005966|466238200|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
129531957|NCT01005966|466238196|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129531958|NCT01005966|466238197|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129531959|NCT01005966|466238198|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129531960|NCT01005966|466238199|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
129531961|NCT01005966|466238200|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
129531962|NCT01005966|466238196|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129531963|NCT01005966|466238197|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129531964|NCT01005966|466238198|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
129531965|NCT01005966|466238199|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129531966|NCT01005966|466238200|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
129531967|NCT01005966|466238196|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
129531968|NCT01005966|466238197|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
129531969|NCT01005966|466238198|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
129531970|NCT01005966|466238199|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
129531971|NCT01005966|466238200|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
129531972|NCT01005966|466238196|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
129531973|NCT01005966|466238197|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
129531974|NCT01005966|466238198|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
129531975|NCT01005966|466238199|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
129531976|NCT01005966|466238200|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
129531977|NCT01005966|466238196|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
129531978|NCT01005966|466238197|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
129531979|NCT01005966|466238198|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
129531980|NCT01005966|466238199|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
129531981|NCT01005966|466238200|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
129531982|NCT01451203|466238201|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
129531983|NCT01451203|466238202|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
129531984|NCT01451203|466238201|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
129531985|NCT01451203|466238202|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
129531986|NCT01451203|466238201|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
129531987|NCT01451203|466238202|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
129531988|NCT01451203|466238201|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
129531989|NCT01451203|466238202|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
129531990|NCT01451203|466238201|FG000|Double-blind Treatment Period|Adverse Event|6|||
129531991|NCT01451203|466238202|FG001|Double-blind Treatment Period|Adverse Event|9|||
129531992|NCT01451203|466238201|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
129531993|NCT01451203|466238202|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
129531994|NCT01451203|466238201|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
129531995|NCT01451203|466238202|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
129531996|NCT01451203|466238201|FG000|Double-blind Treatment Period|Investigator decision|2|||
129531997|NCT01451203|466238202|FG001|Double-blind Treatment Period|Investigator decision|0|||
129531998|NCT01451203|466238201|FG000|Post-treatment Period|Consent withdrawn|2|||
129531999|NCT01451203|466238202|FG001|Post-treatment Period|Consent withdrawn|4|||
129532000|NCT01451203|466238201|FG000|Post-treatment Period|Lack of Efficacy|12|||
129532001|NCT01451203|466238202|FG001|Post-treatment Period|Lack of Efficacy|28|||
129532002|NCT01451203|466238201|FG000|Post-treatment Period|Adverse Event|0|||
129532003|NCT01451203|466238202|FG001|Post-treatment Period|Adverse Event|1|||
129532004|NCT01451203|466238201|FG000|Post-treatment Period|Investigator decision|0|||
129532005|NCT01451203|466238202|FG001|Post-treatment Period|Investigator decision|1|||
129532006|NCT03890731|466238203|FG000|Overall Study|Progressive disease|1|||
129532007|NCT03890731|466238203|FG000|Overall Study|Patient's decision|1|||
129532008|NCT03890731|466238203|FG000|Overall Study|Adverse Event|4|||
129532009|NCT00027027|466238207|FG000|Overall Study|Adverse Event|0|||
129532010|NCT00027027|466238208|FG001|Overall Study|Adverse Event|0|||
129532011|NCT00027027|466238209|FG002|Overall Study|Adverse Event|1|||
129532012|NCT00027027|466238210|FG003|Overall Study|Adverse Event|0|||
129532013|NCT00027027|466238211|FG004|Overall Study|Adverse Event|1|||
129532014|NCT00027027|466238207|FG000|Overall Study|Admitted for Signs of PD|0|||
129532015|NCT00027027|466238208|FG001|Overall Study|Admitted for Signs of PD|0|||
129532016|NCT00027027|466238209|FG002|Overall Study|Admitted for Signs of PD|0|||
129532017|NCT00027027|466238210|FG003|Overall Study|Admitted for Signs of PD|0|||
129532018|NCT00027027|466238211|FG004|Overall Study|Admitted for Signs of PD|1|||
129532019|NCT00027027|466238207|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
129532020|NCT00027027|466238208|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
129532021|NCT00027027|466238209|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
129532022|NCT00027027|466238210|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
129532023|NCT00027027|466238211|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
129532024|NCT00027027|466238207|FG000|Overall Study|PD Requiring Surgery|0|||
129532025|NCT00027027|466238208|FG001|Overall Study|PD Requiring Surgery|0|||
129532026|NCT00027027|466238209|FG002|Overall Study|PD Requiring Surgery|1|||
129532027|NCT00027027|466238210|FG003|Overall Study|PD Requiring Surgery|0|||
129532028|NCT00027027|466238211|FG004|Overall Study|PD Requiring Surgery|0|||
129532029|NCT00027027|466238207|FG000|Overall Study|Physician Decision Due To PD|2|||
129532030|NCT00027027|466238208|FG001|Overall Study|Physician Decision Due To PD|3|||
129532031|NCT00027027|466238209|FG002|Overall Study|Physician Decision Due To PD|2|||
129532032|NCT00027027|466238210|FG003|Overall Study|Physician Decision Due To PD|3|||
129532033|NCT00027027|466238211|FG004|Overall Study|Physician Decision Due To PD|5|||
129532034|NCT00027027|466238207|FG000|Overall Study|Withdrawal by Subject|0|||
129532035|NCT00027027|466238208|FG001|Overall Study|Withdrawal by Subject|0|||
129532036|NCT00027027|466238209|FG002|Overall Study|Withdrawal by Subject|0|||
129532037|NCT00027027|466238210|FG003|Overall Study|Withdrawal by Subject|0|||
129532038|NCT00027027|466238211|FG004|Overall Study|Withdrawal by Subject|1|||
129532039|NCT02039687|466238217|FG000|Overall Study|Adverse Event|0|||
129532040|NCT02039687|466238218|FG001|Overall Study|Adverse Event|0|||
129532041|NCT02039687|466238219|FG002|Overall Study|Adverse Event|1|||
129532042|NCT02039687|466238220|FG003|Overall Study|Adverse Event|0|||
129532043|NCT02039687|466238217|FG000|Overall Study|Withdrawal by Subject|0|||
129532044|NCT02039687|466238218|FG001|Overall Study|Withdrawal by Subject|1|||
129532045|NCT02039687|466238219|FG002|Overall Study|Withdrawal by Subject|0|||
129532046|NCT02039687|466238220|FG003|Overall Study|Withdrawal by Subject|0|||
129532047|NCT02039687|466238217|FG000|Overall Study|treatment assignment could not be confir|0|||
129532048|NCT02039687|466238218|FG001|Overall Study|treatment assignment could not be confir|0|||
129532049|NCT02039687|466238219|FG002|Overall Study|treatment assignment could not be confir|2|||
129532050|NCT02039687|466238220|FG003|Overall Study|treatment assignment could not be confir|0|||
129532051|NCT03812224|466238236|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
129532052|NCT03812224|466238237|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
129532053|NCT03812224|466238236|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
129532054|NCT03812224|466238237|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
129532055|NCT03812224|466238236|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
129532056|NCT03812224|466238237|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
129532057|NCT03812224|466238236|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
129532058|NCT03812224|466238237|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
129532059|NCT02500901|466238238|FG000|Overall Study|Disease ProgressionDD|2|||
129532060|NCT03055806|466238242|FG000|Overall Study|Adverse Event|0|||
129532061|NCT03055806|466238243|FG001|Overall Study|Adverse Event|0|||
129532062|NCT03055806|466238244|FG002|Overall Study|Adverse Event|1|||
129532063|NCT03055806|466238245|FG003|Overall Study|Adverse Event|1|||
129532064|NCT03055806|466238242|FG000|Overall Study|Lost to Follow-up|0|||
129532065|NCT03055806|466238243|FG001|Overall Study|Lost to Follow-up|3|||
129532066|NCT03055806|466238244|FG002|Overall Study|Lost to Follow-up|6|||
129532067|NCT03055806|466238245|FG003|Overall Study|Lost to Follow-up|7|||
129532068|NCT03055806|466238242|FG000|Overall Study|Physician Decision|1|||
129532069|NCT03055806|466238243|FG001|Overall Study|Physician Decision|0|||
129532070|NCT03055806|466238244|FG002|Overall Study|Physician Decision|0|||
129532071|NCT03055806|466238245|FG003|Overall Study|Physician Decision|1|||
129532072|NCT03055806|466238242|FG000|Overall Study|Protocol Violation|1|||
129532073|NCT03055806|466238243|FG001|Overall Study|Protocol Violation|0|||
129532074|NCT03055806|466238244|FG002|Overall Study|Protocol Violation|0|||
129532075|NCT03055806|466238245|FG003|Overall Study|Protocol Violation|0|||
129532076|NCT03055806|466238242|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
129532077|NCT03055806|466238243|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
129532078|NCT03055806|466238244|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
129532079|NCT03055806|466238245|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
129532080|NCT03055806|466238242|FG000|Overall Study|Withdrawal of consent to continue study|2|||
129532081|NCT03055806|466238243|FG001|Overall Study|Withdrawal of consent to continue study|3|||
129532082|NCT03055806|466238244|FG002|Overall Study|Withdrawal of consent to continue study|4|||
129532083|NCT03055806|466238245|FG003|Overall Study|Withdrawal of consent to continue study|6|||
129532084|NCT03055806|466238242|FG000|Overall Study|Partner not willing to try intercourse|1|||
129532085|NCT03055806|466238243|FG001|Overall Study|Partner not willing to try intercourse|0|||
129532086|NCT03055806|466238244|FG002|Overall Study|Partner not willing to try intercourse|0|||
129532087|NCT03055806|466238245|FG003|Overall Study|Partner not willing to try intercourse|0|||
129532088|NCT00125138|466238246|FG000|Overall Study|Adverse Event|1|||
129532089|NCT00125138|466238247|FG001|Overall Study|Adverse Event|0|||
129532090|NCT00125138|466238248|FG002|Overall Study|Adverse Event|3|||
129532091|NCT00125138|466238249|FG003|Overall Study|Adverse Event|2|||
129532092|NCT00125138|466238246|FG000|Overall Study|Withdrawal by Subject|2|||
129532093|NCT00125138|466238247|FG001|Overall Study|Withdrawal by Subject|3|||
129532094|NCT00125138|466238248|FG002|Overall Study|Withdrawal by Subject|1|||
129532095|NCT00125138|466238249|FG003|Overall Study|Withdrawal by Subject|1|||
129532096|NCT00125138|466238246|FG000|Overall Study|Lack of Efficacy|0|||
129532097|NCT00125138|466238247|FG001|Overall Study|Lack of Efficacy|0|||
129532098|NCT00125138|466238248|FG002|Overall Study|Lack of Efficacy|0|||
129532099|NCT00125138|466238249|FG003|Overall Study|Lack of Efficacy|1|||
129532100|NCT00125138|466238246|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
129532101|NCT00125138|466238247|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
129532102|NCT00125138|466238248|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
129532103|NCT00125138|466238249|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
129532104|NCT00783263|466238262|FG000|Overall Study|Adverse Event|3|||
129532105|NCT00783263|466238263|FG001|Overall Study|Adverse Event|0|||
129532106|NCT00783263|466238264|FG002|Overall Study|Adverse Event|2|||
129532107|NCT00783263|466238265|FG003|Overall Study|Adverse Event|1|||
129532108|NCT00783263|466238262|FG000|Overall Study|Lost to Follow-up|1|||
129532109|NCT00783263|466238263|FG001|Overall Study|Lost to Follow-up|1|||
129532110|NCT00783263|466238264|FG002|Overall Study|Lost to Follow-up|0|||
129532111|NCT00783263|466238265|FG003|Overall Study|Lost to Follow-up|0|||
129532112|NCT00783263|466238262|FG000|Overall Study|Withdrawal by Subject|0|||
129532113|NCT00783263|466238263|FG001|Overall Study|Withdrawal by Subject|1|||
129532114|NCT00783263|466238264|FG002|Overall Study|Withdrawal by Subject|1|||
129532115|NCT00783263|466238265|FG003|Overall Study|Withdrawal by Subject|2|||
129532116|NCT00405756|466238266|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
129532117|NCT00405756|466238267|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
129532118|NCT00405756|466238268|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
129532119|NCT00405756|466238266|FG000|Double-blind Treatment|Adverse Event|31|||
129532120|NCT00405756|466238267|FG001|Double-blind Treatment|Adverse Event|27|||
129532121|NCT00405756|466238268|FG002|Double-blind Treatment|Adverse Event|12|||
129532122|NCT00405756|466238266|FG000|Double-blind Treatment|Disease Progression|47|||
129532123|NCT00405756|466238267|FG001|Double-blind Treatment|Disease Progression|81|||
129532124|NCT00405756|466238268|FG002|Double-blind Treatment|Disease Progression|102|||
129532125|NCT00405756|466238266|FG000|Double-blind Treatment|Lack of Efficacy|1|||
129532126|NCT00405756|466238267|FG001|Double-blind Treatment|Lack of Efficacy|4|||
129532127|NCT00405756|466238268|FG002|Double-blind Treatment|Lack of Efficacy|2|||
129532128|NCT00405756|466238266|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
129532129|NCT00405756|466238267|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
129532130|NCT00405756|466238268|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
129532131|NCT00405756|466238266|FG000|Double-blind Treatment|Lost to Follow-up|1|||
129532132|NCT00405756|466238267|FG001|Double-blind Treatment|Lost to Follow-up|0|||
129532133|NCT00405756|466238268|FG002|Double-blind Treatment|Lost to Follow-up|0|||
129532134|NCT00405756|466238266|FG000|Double-blind Treatment|Death|4|||
129532135|NCT00405756|466238267|FG001|Double-blind Treatment|Death|4|||
129532136|NCT00405756|466238268|FG002|Double-blind Treatment|Death|4|||
129532137|NCT00405756|466238266|FG000|Double-blind Treatment|Protocol Violation|1|||
129532138|NCT00405756|466238267|FG001|Double-blind Treatment|Protocol Violation|0|||
129532139|NCT00405756|466238268|FG002|Double-blind Treatment|Protocol Violation|2|||
129532140|NCT00405756|466238266|FG000|Double-blind Treatment|Other|7|||
129532141|NCT00405756|466238267|FG001|Double-blind Treatment|Other|4|||
129532142|NCT00405756|466238268|FG002|Double-blind Treatment|Other|4|||
129532143|NCT00405756|466238266|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
129532144|NCT00405756|466238267|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
129532145|NCT00405756|466238268|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
129532146|NCT00405756|466238266|FG000|Open-label Extension|Adverse Event|1|||
129532147|NCT00405756|466238267|FG001|Open-label Extension|Adverse Event|3|||
129532148|NCT00405756|466238268|FG002|Open-label Extension|Adverse Event|7|||
129532149|NCT00405756|466238266|FG000|Open-label Extension|Disease Progression|8|||
129532150|NCT00405756|466238267|FG001|Open-label Extension|Disease Progression|23|||
129532151|NCT00405756|466238268|FG002|Open-label Extension|Disease Progression|26|||
129532152|NCT00405756|466238266|FG000|Open-label Extension|Withdrawal by Subject|2|||
129532153|NCT00405756|466238267|FG001|Open-label Extension|Withdrawal by Subject|3|||
129532154|NCT00405756|466238268|FG002|Open-label Extension|Withdrawal by Subject|3|||
129532155|NCT00405756|466238266|FG000|Open-label Extension|Death|1|||
129532156|NCT00405756|466238267|FG001|Open-label Extension|Death|2|||
129532157|NCT00405756|466238268|FG002|Open-label Extension|Death|4|||
129532158|NCT00405756|466238266|FG000|Open-label Extension|Other|0|||
129532159|NCT00405756|466238267|FG001|Open-label Extension|Other|1|||
129532160|NCT00405756|466238268|FG002|Open-label Extension|Other|7|||
129532161|NCT00405756|466238266|FG000|Follow-up|Ongoing in Follow-up Period|52|||
129532162|NCT00405756|466238267|FG001|Follow-up|Ongoing in Follow-up Period|51|||
129532163|NCT00405756|466238268|FG002|Follow-up|Ongoing in Follow-up Period|60|||
129532164|NCT00405756|466238266|FG000|Follow-up|Death|21|||
129532165|NCT00405756|466238267|FG001|Follow-up|Death|31|||
129532166|NCT00405756|466238268|FG002|Follow-up|Death|24|||
129532167|NCT00405756|466238266|FG000|Follow-up|Lost to Follow-up|2|||
129532168|NCT00405756|466238267|FG001|Follow-up|Lost to Follow-up|8|||
129532169|NCT00405756|466238268|FG002|Follow-up|Lost to Follow-up|4|||
129532170|NCT01683058|466238270|FG000|Overall Study|Lost to Follow-up|9|||
129532171|NCT01683058|466238270|FG000|Overall Study|Adverse Event|6|||
129532172|NCT01683058|466238270|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
129532173|NCT01683058|466238270|FG000|Overall Study|Withdrawal by Subject|7|||
129532174|NCT01683058|466238270|FG000|Overall Study|Lack of Efficacy|2|||
129532175|NCT04062240|466238274|FG000|Overall Study|equipment malfunction|1|||
129532176|NCT01957111|466238275|FG000|Overall Study|Withdrawal by Subject|1|||
129532177|NCT01957111|466238276|FG001|Overall Study|Withdrawal by Subject|1|||
129532178|NCT01057394|466238277|FG000|Overall Study|Not eligible|0|||
129532179|NCT01057394|466238278|FG001|Overall Study|Not eligible|2|||
129532180|NCT01195636|466238279|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
129532181|NCT01195636|466238280|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
129532182|NCT01195636|466238279|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
129532183|NCT01195636|466238280|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
129532184|NCT01195636|466238279|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129532185|NCT01195636|466238280|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
129532186|NCT01195636|466238279|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
129532187|NCT01195636|466238280|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
129532188|NCT01195636|466238279|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
129532189|NCT01195636|466238280|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
129532190|NCT01195636|466238279|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
129532191|NCT01195636|466238280|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
129532192|NCT01195636|466238279|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
129532193|NCT01195636|466238280|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
129532194|NCT01195636|466238279|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
129532195|NCT01195636|466238280|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
129532196|NCT03500419|466238281|FG000|Overall Study|Withdrawal by Subject|2|||
129532197|NCT03500419|466238282|FG001|Overall Study|Withdrawal by Subject|25|||
129532198|NCT00203294|466238283|FG000|Overall Study|Withdrawal by Subject|8|||
129532199|NCT00203294|466238284|FG001|Overall Study|Withdrawal by Subject|13|||
129532200|NCT00082628|466238285|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
129532201|NCT00082628|466238286|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
129532202|NCT00082628|466238287|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
129532203|NCT00082628|466238288|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
129532204|NCT00082628|466238289|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
129532205|NCT00082628|466238285|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
129532206|NCT00082628|466238286|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
129532207|NCT00082628|466238287|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
129532208|NCT00082628|466238288|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
129532209|NCT00082628|466238289|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
129532210|NCT00082628|466238285|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
129532211|NCT00082628|466238286|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
129532212|NCT00082628|466238287|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
129532213|NCT00082628|466238288|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
129532214|NCT00082628|466238289|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
129532215|NCT00082628|466238285|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
129532216|NCT00082628|466238286|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
129532217|NCT00082628|466238287|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
129532218|NCT00082628|466238288|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
129532219|NCT00082628|466238289|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
129532220|NCT00082628|466238285|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
129532221|NCT00082628|466238286|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
129532222|NCT00082628|466238287|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
129532223|NCT00082628|466238288|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
129532224|NCT00082628|466238289|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
129532225|NCT00082628|466238285|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
129532226|NCT00082628|466238286|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
129532227|NCT00082628|466238287|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
129532228|NCT00082628|466238288|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
129532229|NCT00082628|466238289|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
129532230|NCT00082628|466238285|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
129532231|NCT00082628|466238286|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
129532232|NCT00082628|466238287|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
129532233|NCT00082628|466238288|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
129532234|NCT00082628|466238289|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
129532235|NCT01566981|466238290|FG000|Overall Study|Lost to Follow-up|5|||
129532236|NCT01566981|466238291|FG001|Overall Study|Lost to Follow-up|8|||
129532237|NCT01234337|466238295|FG000|Overall Study|Adverse Event|58|||
129532238|NCT01234337|466238296|FG001|Overall Study|Adverse Event|21|||
129532239|NCT01234337|466238295|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
129532240|NCT01234337|466238296|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
129532241|NCT01234337|466238295|FG000|Overall Study|Investi. decision not protocol driven|5|||
129532242|NCT01234337|466238296|FG001|Overall Study|Investi. decision not protocol driven|6|||
129532243|NCT01234337|466238295|FG000|Overall Study|Non-compliant with study medication|3|||
129532244|NCT01234337|466238296|FG001|Overall Study|Non-compliant with study medication|2|||
129532245|NCT01234337|466238295|FG000|Overall Study|Randomized but not treated|6|||
129532246|NCT01234337|466238296|FG001|Overall Study|Randomized but not treated|4|||
129532247|NCT01234337|466238295|FG000|Overall Study|Lost to Follow-up|0|||
129532248|NCT01234337|466238296|FG001|Overall Study|Lost to Follow-up|1|||
129532249|NCT01234337|466238295|FG000|Overall Study|Protocol Violation|2|||
129532250|NCT01234337|466238296|FG001|Overall Study|Protocol Violation|3|||
129532251|NCT01234337|466238295|FG000|Overall Study|Withdrawal by Subject|11|||
129532252|NCT01234337|466238296|FG001|Overall Study|Withdrawal by Subject|9|||
129532253|NCT01234337|466238295|FG000|Overall Study|Death|0|||
129532254|NCT01234337|466238296|FG001|Overall Study|Death|1|||
129532255|NCT01234337|466238295|FG000|Overall Study|Switch to commercial drug|0|||
129532256|NCT01234337|466238296|FG001|Overall Study|Switch to commercial drug|1|||
129532257|NCT03481634|466238297|FG000|Overall Study|Withdrawal by Subject|16|||
129532258|NCT03481634|466238298|FG001|Overall Study|Withdrawal by Subject|19|||
129532259|NCT03481634|466238299|FG002|Overall Study|Withdrawal by Subject|14|||
129532260|NCT03481634|466238297|FG000|Overall Study|Protocol Violation|1|||
129532261|NCT03481634|466238298|FG001|Overall Study|Protocol Violation|0|||
129532262|NCT03481634|466238299|FG002|Overall Study|Protocol Violation|1|||
129532263|NCT03481634|466238297|FG000|Overall Study|Progressive disease|0|||
129532264|NCT03481634|466238298|FG001|Overall Study|Progressive disease|1|||
129532265|NCT03481634|466238299|FG002|Overall Study|Progressive disease|0|||
129532266|NCT03481634|466238297|FG000|Overall Study|Physician Decision|3|||
129532267|NCT03481634|466238298|FG001|Overall Study|Physician Decision|0|||
129532268|NCT03481634|466238299|FG002|Overall Study|Physician Decision|1|||
129532269|NCT03481634|466238297|FG000|Overall Study|Lost to Follow-up|3|||
129532270|NCT03481634|466238298|FG001|Overall Study|Lost to Follow-up|4|||
129532271|NCT03481634|466238299|FG002|Overall Study|Lost to Follow-up|4|||
129532272|NCT03481634|466238297|FG000|Overall Study|Death|4|||
129532273|NCT03481634|466238298|FG001|Overall Study|Death|8|||
129532274|NCT03481634|466238299|FG002|Overall Study|Death|7|||
129532275|NCT03481634|466238297|FG000|Overall Study|Adverse Event|6|||
129532276|NCT03481634|466238298|FG001|Overall Study|Adverse Event|3|||
129532277|NCT03481634|466238299|FG002|Overall Study|Adverse Event|7|||
129532278|NCT00994890|466238302|FG000|Overall Study|Adverse Event|13|||
129532279|NCT00994890|466238303|FG001|Overall Study|Adverse Event|9|||
129532280|NCT00994890|466238304|FG002|Overall Study|Adverse Event|11|||
129532281|NCT00994890|466238302|FG000|Overall Study|Lack of Efficacy|0|||
129532282|NCT00994890|466238303|FG001|Overall Study|Lack of Efficacy|0|||
129532283|NCT00994890|466238304|FG002|Overall Study|Lack of Efficacy|1|||
129532284|NCT00994890|466238302|FG000|Overall Study|Lost to Follow-up|6|||
129532285|NCT00994890|466238303|FG001|Overall Study|Lost to Follow-up|1|||
129532286|NCT00994890|466238304|FG002|Overall Study|Lost to Follow-up|3|||
129532287|NCT00994890|466238302|FG000|Overall Study|No longer willing to participate|8|||
129532288|NCT00994890|466238303|FG001|Overall Study|No longer willing to participate|5|||
129532289|NCT00994890|466238304|FG002|Overall Study|No longer willing to participate|13|||
129532290|NCT00994890|466238302|FG000|Overall Study|Protocol Violation|2|||
129532291|NCT00994890|466238303|FG001|Overall Study|Protocol Violation|4|||
129532292|NCT00994890|466238304|FG002|Overall Study|Protocol Violation|0|||
129532293|NCT00994890|466238302|FG000|Overall Study|Study terminated by sponsor|199|||
129532294|NCT00994890|466238303|FG001|Overall Study|Study terminated by sponsor|201|||
129532295|NCT00994890|466238304|FG002|Overall Study|Study terminated by sponsor|197|||
129532296|NCT00994890|466238302|FG000|Overall Study|Randomized, but not treated|1|||
129532297|NCT00994890|466238303|FG001|Overall Study|Randomized, but not treated|0|||
129532298|NCT00994890|466238304|FG002|Overall Study|Randomized, but not treated|0|||
129532299|NCT00994890|466238302|FG000|Overall Study|Other|2|||
129532300|NCT00994890|466238303|FG001|Overall Study|Other|2|||
129532301|NCT00994890|466238304|FG002|Overall Study|Other|1|||
129532302|NCT03323385|466238309|FG000|Overall Study|Withdrawal by Subject|1|||
129532303|NCT03323385|466238310|FG001|Overall Study|Withdrawal by Subject|2|||
129532304|NCT03323385|466238309|FG000|Overall Study|Noncompliance|0|||
129532305|NCT03323385|466238310|FG001|Overall Study|Noncompliance|1|||
129532306|NCT00247962|466238311|FG000|Overall Study|Adverse Event|15|||
129532307|NCT00247962|466238312|FG001|Overall Study|Adverse Event|12|||
129532308|NCT00247962|466238311|FG000|Overall Study|Lost to Follow-up|3|||
129532309|NCT00247962|466238312|FG001|Overall Study|Lost to Follow-up|1|||
129532310|NCT00247962|466238311|FG000|Overall Study|Physician Decision|0|||
129532311|NCT00247962|466238312|FG001|Overall Study|Physician Decision|1|||
129532312|NCT00247962|466238311|FG000|Overall Study|Protocol Violation|1|||
129532313|NCT00247962|466238312|FG001|Overall Study|Protocol Violation|1|||
129532314|NCT00247962|466238311|FG000|Overall Study|Withdrawal by Subject|3|||
129532315|NCT00247962|466238312|FG001|Overall Study|Withdrawal by Subject|2|||
129532316|NCT00247962|466238311|FG000|Overall Study|Lack of Efficacy|4|||
129532317|NCT00247962|466238312|FG001|Overall Study|Lack of Efficacy|2|||
129532318|NCT01849289|466238313|FG000|Overall Study|Adverse Event|3|||
129532319|NCT01849289|466238314|FG001|Overall Study|Adverse Event|3|||
129532320|NCT01849289|466238313|FG000|Overall Study|Protocol Violation|3|||
129532321|NCT01849289|466238314|FG001|Overall Study|Protocol Violation|3|||
129532322|NCT01849289|466238313|FG000|Overall Study|Withdrawal criteria|1|||
129532323|NCT01849289|466238314|FG001|Overall Study|Withdrawal criteria|0|||
129532324|NCT01849289|466238313|FG000|Overall Study|Unclassified|25|||
129532325|NCT01849289|466238314|FG001|Overall Study|Unclassified|18|||
129532326|NCT01469637|466238315|FG000|First Intervention|Unacceptable behavior|0|||
129532327|NCT01469637|466238316|FG001|First Intervention|Unacceptable behavior|1|||
129532328|NCT01469637|466238315|FG000|Second Intervention|Incarcerated|1|||
129532329|NCT01469637|466238316|FG001|Second Intervention|Incarcerated|0|||
129532330|NCT00598585|466238317|FG000|Overall Study|Lost to Follow-up|1|||
129532331|NCT00598585|466238318|FG001|Overall Study|Lost to Follow-up|0|||
129532332|NCT02607735|466238319|FG000|Primary Study|Randomized but Never Treated|1|||
129532333|NCT02607735|466238320|FG001|Primary Study|Randomized but Never Treated|0|||
129532334|NCT02607735|466238321|FG002|Primary Study|Randomized but Never Treated|0|||
129532335|NCT02607735|466238319|FG000|Primary Study|Lost to Follow-up|4|||
129532336|NCT02607735|466238320|FG001|Primary Study|Lost to Follow-up|0|||
129532337|NCT02607735|466238321|FG002|Primary Study|Lost to Follow-up|0|||
129532338|NCT02607735|466238319|FG000|Primary Study|Withdrew Consent|2|||
129532339|NCT02607735|466238320|FG001|Primary Study|Withdrew Consent|0|||
129532340|NCT02607735|466238321|FG002|Primary Study|Withdrew Consent|0|||
129532341|NCT02607735|466238319|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
129532342|NCT02607735|466238320|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
129532343|NCT02607735|466238321|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
129532344|NCT02607735|466238319|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
129532345|NCT02607735|466238320|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
129532346|NCT02607735|466238321|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
129532347|NCT02394028|466238322|FG000|Induction Phase|Adverse Event|2|||
129532348|NCT02394028|466238323|FG001|Induction Phase|Adverse Event|4|||
129532349|NCT02394028|466238324|FG002|Induction Phase|Adverse Event|1|||
129532350|NCT02394028|466238325|FG003|Induction Phase|Adverse Event|2|||
129532351|NCT02394028|466238326|FG004|Induction Phase|Adverse Event|5|||
129532352|NCT02394028|466238327|FG005|Induction Phase|Adverse Event|2|||
129532353|NCT02394028|466238328|FG006|Induction Phase|Adverse Event|0|||
129532354|NCT02394028|466238329|FG007|Induction Phase|Adverse Event|0|||
129532355|NCT02394028|466238330|FG008|Induction Phase|Adverse Event|0|||
129532356|NCT02394028|466238331|FG009|Induction Phase|Adverse Event|0|||
129532357|NCT02394028|466238332|FG010|Induction Phase|Adverse Event|0|||
129532358|NCT02394028|466238322|FG000|Induction Phase|Lack of Efficacy|3|||
129532359|NCT02394028|466238323|FG001|Induction Phase|Lack of Efficacy|6|||
129532360|NCT02394028|466238324|FG002|Induction Phase|Lack of Efficacy|2|||
129532361|NCT02394028|466238325|FG003|Induction Phase|Lack of Efficacy|17|||
129532362|NCT02394028|466238326|FG004|Induction Phase|Lack of Efficacy|14|||
129532363|NCT02394028|466238327|FG005|Induction Phase|Lack of Efficacy|8|||
129532364|NCT02394028|466238328|FG006|Induction Phase|Lack of Efficacy|17|||
129532365|NCT02394028|466238329|FG007|Induction Phase|Lack of Efficacy|23|||
129532366|NCT02394028|466238330|FG008|Induction Phase|Lack of Efficacy|0|||
129532367|NCT02394028|466238331|FG009|Induction Phase|Lack of Efficacy|0|||
129532368|NCT02394028|466238332|FG010|Induction Phase|Lack of Efficacy|0|||
129532369|NCT02394028|466238322|FG000|Induction Phase|Lost to Follow-up|1|||
129532370|NCT02394028|466238323|FG001|Induction Phase|Lost to Follow-up|0|||
129532371|NCT02394028|466238324|FG002|Induction Phase|Lost to Follow-up|0|||
129532372|NCT02394028|466238325|FG003|Induction Phase|Lost to Follow-up|1|||
129532373|NCT02394028|466238326|FG004|Induction Phase|Lost to Follow-up|0|||
129532374|NCT02394028|466238327|FG005|Induction Phase|Lost to Follow-up|0|||
129532375|NCT02394028|466238328|FG006|Induction Phase|Lost to Follow-up|1|||
129532376|NCT02394028|466238329|FG007|Induction Phase|Lost to Follow-up|0|||
129532377|NCT02394028|466238330|FG008|Induction Phase|Lost to Follow-up|0|||
129532378|NCT02394028|466238331|FG009|Induction Phase|Lost to Follow-up|0|||
129532379|NCT02394028|466238332|FG010|Induction Phase|Lost to Follow-up|0|||
129532380|NCT02394028|466238322|FG000|Induction Phase|Non-compliance|0|||
129532381|NCT02394028|466238323|FG001|Induction Phase|Non-compliance|1|||
129532382|NCT02394028|466238324|FG002|Induction Phase|Non-compliance|3|||
129532383|NCT02394028|466238325|FG003|Induction Phase|Non-compliance|1|||
129532384|NCT02394028|466238326|FG004|Induction Phase|Non-compliance|3|||
129532385|NCT02394028|466238327|FG005|Induction Phase|Non-compliance|0|||
129532386|NCT02394028|466238328|FG006|Induction Phase|Non-compliance|1|||
129532387|NCT02394028|466238329|FG007|Induction Phase|Non-compliance|1|||
129532388|NCT02394028|466238330|FG008|Induction Phase|Non-compliance|0|||
129532389|NCT02394028|466238331|FG009|Induction Phase|Non-compliance|0|||
129532390|NCT02394028|466238332|FG010|Induction Phase|Non-compliance|0|||
129532391|NCT02394028|466238322|FG000|Induction Phase|Physician Decision|0|||
129532392|NCT02394028|466238323|FG001|Induction Phase|Physician Decision|0|||
129532393|NCT02394028|466238324|FG002|Induction Phase|Physician Decision|1|||
129532394|NCT02394028|466238325|FG003|Induction Phase|Physician Decision|4|||
129532395|NCT02394028|466238326|FG004|Induction Phase|Physician Decision|0|||
129532396|NCT02394028|466238327|FG005|Induction Phase|Physician Decision|2|||
129532397|NCT02394028|466238328|FG006|Induction Phase|Physician Decision|1|||
129532398|NCT02394028|466238329|FG007|Induction Phase|Physician Decision|0|||
129532399|NCT02394028|466238330|FG008|Induction Phase|Physician Decision|0|||
129532400|NCT02394028|466238331|FG009|Induction Phase|Physician Decision|0|||
129532401|NCT02394028|466238332|FG010|Induction Phase|Physician Decision|0|||
129532402|NCT02394028|466238322|FG000|Induction Phase|Protocol Violation|0|||
129532403|NCT02394028|466238323|FG001|Induction Phase|Protocol Violation|2|||
129532404|NCT02394028|466238324|FG002|Induction Phase|Protocol Violation|0|||
129532405|NCT02394028|466238325|FG003|Induction Phase|Protocol Violation|3|||
129538828|NCT02911285|466263542|FG000|Overall Study|Lost to Follow-up|8|||
129532406|NCT02394028|466238326|FG004|Induction Phase|Protocol Violation|0|||
129532407|NCT02394028|466238327|FG005|Induction Phase|Protocol Violation|1|||
129532408|NCT02394028|466238328|FG006|Induction Phase|Protocol Violation|1|||
129532409|NCT02394028|466238329|FG007|Induction Phase|Protocol Violation|0|||
129532410|NCT02394028|466238330|FG008|Induction Phase|Protocol Violation|0|||
129532411|NCT02394028|466238331|FG009|Induction Phase|Protocol Violation|0|||
129532412|NCT02394028|466238332|FG010|Induction Phase|Protocol Violation|0|||
129532413|NCT02394028|466238322|FG000|Induction Phase|Withdrawal by Subject|1|||
129532414|NCT02394028|466238323|FG001|Induction Phase|Withdrawal by Subject|2|||
129532415|NCT02394028|466238324|FG002|Induction Phase|Withdrawal by Subject|4|||
129532416|NCT02394028|466238325|FG003|Induction Phase|Withdrawal by Subject|6|||
129532417|NCT02394028|466238326|FG004|Induction Phase|Withdrawal by Subject|7|||
129532418|NCT02394028|466238327|FG005|Induction Phase|Withdrawal by Subject|4|||
129532419|NCT02394028|466238328|FG006|Induction Phase|Withdrawal by Subject|3|||
129532420|NCT02394028|466238329|FG007|Induction Phase|Withdrawal by Subject|6|||
129532421|NCT02394028|466238330|FG008|Induction Phase|Withdrawal by Subject|0|||
129532422|NCT02394028|466238331|FG009|Induction Phase|Withdrawal by Subject|0|||
129532423|NCT02394028|466238332|FG010|Induction Phase|Withdrawal by Subject|0|||
129532424|NCT02394028|466238322|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532425|NCT02394028|466238323|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532426|NCT02394028|466238324|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532427|NCT02394028|466238325|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532428|NCT02394028|466238326|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532429|NCT02394028|466238327|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532430|NCT02394028|466238328|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
129532431|NCT02394028|466238329|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532432|NCT02394028|466238330|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532433|NCT02394028|466238331|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532434|NCT02394028|466238332|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
129532435|NCT02394028|466238322|FG000|Induction Phase|Sponsor decision|0|||
129532436|NCT02394028|466238323|FG001|Induction Phase|Sponsor decision|1|||
129532437|NCT02394028|466238324|FG002|Induction Phase|Sponsor decision|2|||
129532438|NCT02394028|466238325|FG003|Induction Phase|Sponsor decision|0|||
129532439|NCT02394028|466238326|FG004|Induction Phase|Sponsor decision|0|||
129532440|NCT02394028|466238327|FG005|Induction Phase|Sponsor decision|0|||
129532441|NCT02394028|466238328|FG006|Induction Phase|Sponsor decision|0|||
129532442|NCT02394028|466238329|FG007|Induction Phase|Sponsor decision|0|||
129532443|NCT02394028|466238330|FG008|Induction Phase|Sponsor decision|0|||
129532444|NCT02394028|466238331|FG009|Induction Phase|Sponsor decision|0|||
129532445|NCT02394028|466238332|FG010|Induction Phase|Sponsor decision|0|||
129532446|NCT02394028|466238322|FG000|Induction Phase|Technical reason|0|||
129532447|NCT02394028|466238323|FG001|Induction Phase|Technical reason|0|||
129532448|NCT02394028|466238324|FG002|Induction Phase|Technical reason|0|||
129532449|NCT02394028|466238325|FG003|Induction Phase|Technical reason|1|||
129532450|NCT02394028|466238326|FG004|Induction Phase|Technical reason|0|||
129532451|NCT02394028|466238327|FG005|Induction Phase|Technical reason|0|||
129532452|NCT02394028|466238328|FG006|Induction Phase|Technical reason|0|||
129532453|NCT02394028|466238329|FG007|Induction Phase|Technical reason|0|||
129532454|NCT02394028|466238330|FG008|Induction Phase|Technical reason|0|||
129532455|NCT02394028|466238331|FG009|Induction Phase|Technical reason|0|||
129532456|NCT02394028|466238332|FG010|Induction Phase|Technical reason|0|||
129532457|NCT02394028|466238322|FG000|Induction Phase|:ack of calculation|0|||
129532458|NCT02394028|466238323|FG001|Induction Phase|:ack of calculation|0|||
129532459|NCT02394028|466238324|FG002|Induction Phase|:ack of calculation|0|||
129532460|NCT02394028|466238325|FG003|Induction Phase|:ack of calculation|0|||
129532461|NCT02394028|466238326|FG004|Induction Phase|:ack of calculation|0|||
129532462|NCT02394028|466238327|FG005|Induction Phase|:ack of calculation|0|||
129532463|NCT02394028|466238328|FG006|Induction Phase|:ack of calculation|0|||
129532464|NCT02394028|466238329|FG007|Induction Phase|:ack of calculation|1|||
129532465|NCT02394028|466238330|FG008|Induction Phase|:ack of calculation|0|||
129532466|NCT02394028|466238331|FG009|Induction Phase|:ack of calculation|0|||
129532467|NCT02394028|466238332|FG010|Induction Phase|:ack of calculation|0|||
129532468|NCT02394028|466238322|FG000|Maintenance Phase|Protocol Violation|0|||
129532469|NCT02394028|466238323|FG001|Maintenance Phase|Protocol Violation|0|||
129532470|NCT02394028|466238324|FG002|Maintenance Phase|Protocol Violation|0|||
129532471|NCT02394028|466238325|FG003|Maintenance Phase|Protocol Violation|0|||
129532472|NCT02394028|466238326|FG004|Maintenance Phase|Protocol Violation|0|||
129532473|NCT02394028|466238327|FG005|Maintenance Phase|Protocol Violation|0|||
129532474|NCT02394028|466238328|FG006|Maintenance Phase|Protocol Violation|0|||
129532475|NCT02394028|466238329|FG007|Maintenance Phase|Protocol Violation|0|||
129532476|NCT02394028|466238330|FG008|Maintenance Phase|Protocol Violation|0|||
129532477|NCT02394028|466238331|FG009|Maintenance Phase|Protocol Violation|0|||
129532478|NCT02394028|466238332|FG010|Maintenance Phase|Protocol Violation|1|||
129532479|NCT02394028|466238322|FG000|Maintenance Phase|Physician Decision|0|||
129532480|NCT02394028|466238323|FG001|Maintenance Phase|Physician Decision|0|||
129532481|NCT02394028|466238324|FG002|Maintenance Phase|Physician Decision|0|||
129532482|NCT02394028|466238325|FG003|Maintenance Phase|Physician Decision|0|||
129532483|NCT02394028|466238326|FG004|Maintenance Phase|Physician Decision|0|||
129532484|NCT02394028|466238327|FG005|Maintenance Phase|Physician Decision|0|||
129532485|NCT02394028|466238328|FG006|Maintenance Phase|Physician Decision|0|||
129532486|NCT02394028|466238329|FG007|Maintenance Phase|Physician Decision|0|||
129532487|NCT02394028|466238330|FG008|Maintenance Phase|Physician Decision|1|||
129532488|NCT02394028|466238331|FG009|Maintenance Phase|Physician Decision|3|||
129532489|NCT02394028|466238332|FG010|Maintenance Phase|Physician Decision|2|||
129532490|NCT02394028|466238322|FG000|Maintenance Phase|Lack of Efficacy|0|||
129532491|NCT02394028|466238323|FG001|Maintenance Phase|Lack of Efficacy|0|||
129532492|NCT02394028|466238324|FG002|Maintenance Phase|Lack of Efficacy|0|||
129532493|NCT02394028|466238325|FG003|Maintenance Phase|Lack of Efficacy|0|||
129532494|NCT02394028|466238326|FG004|Maintenance Phase|Lack of Efficacy|0|||
129532495|NCT02394028|466238327|FG005|Maintenance Phase|Lack of Efficacy|0|||
129532496|NCT02394028|466238328|FG006|Maintenance Phase|Lack of Efficacy|0|||
129532497|NCT02394028|466238329|FG007|Maintenance Phase|Lack of Efficacy|0|||
129532498|NCT02394028|466238330|FG008|Maintenance Phase|Lack of Efficacy|7|||
129532499|NCT02394028|466238331|FG009|Maintenance Phase|Lack of Efficacy|25|||
129532500|NCT02394028|466238332|FG010|Maintenance Phase|Lack of Efficacy|33|||
129532501|NCT02394028|466238322|FG000|Maintenance Phase|Death|0|||
129532502|NCT02394028|466238323|FG001|Maintenance Phase|Death|0|||
129532503|NCT02394028|466238324|FG002|Maintenance Phase|Death|0|||
129532504|NCT02394028|466238325|FG003|Maintenance Phase|Death|0|||
129532505|NCT02394028|466238326|FG004|Maintenance Phase|Death|0|||
129532506|NCT02394028|466238327|FG005|Maintenance Phase|Death|0|||
129532507|NCT02394028|466238328|FG006|Maintenance Phase|Death|0|||
129532508|NCT02394028|466238329|FG007|Maintenance Phase|Death|0|||
129532509|NCT02394028|466238330|FG008|Maintenance Phase|Death|0|||
129532510|NCT02394028|466238331|FG009|Maintenance Phase|Death|0|||
129532511|NCT02394028|466238332|FG010|Maintenance Phase|Death|1|||
129532512|NCT02394028|466238322|FG000|Maintenance Phase|Adverse Event|0|||
129532513|NCT02394028|466238323|FG001|Maintenance Phase|Adverse Event|0|||
129532514|NCT02394028|466238324|FG002|Maintenance Phase|Adverse Event|0|||
129532515|NCT02394028|466238325|FG003|Maintenance Phase|Adverse Event|0|||
129532516|NCT02394028|466238326|FG004|Maintenance Phase|Adverse Event|0|||
129532517|NCT02394028|466238327|FG005|Maintenance Phase|Adverse Event|0|||
129532518|NCT02394028|466238328|FG006|Maintenance Phase|Adverse Event|0|||
129532519|NCT02394028|466238329|FG007|Maintenance Phase|Adverse Event|0|||
129532520|NCT02394028|466238330|FG008|Maintenance Phase|Adverse Event|1|||
129532521|NCT02394028|466238331|FG009|Maintenance Phase|Adverse Event|1|||
129532522|NCT02394028|466238332|FG010|Maintenance Phase|Adverse Event|3|||
129532523|NCT02394028|466238322|FG000|Maintenance Phase|Site closure|0|||
129532524|NCT02394028|466238323|FG001|Maintenance Phase|Site closure|0|||
129532525|NCT02394028|466238324|FG002|Maintenance Phase|Site closure|0|||
129532526|NCT02394028|466238325|FG003|Maintenance Phase|Site closure|0|||
129532527|NCT02394028|466238326|FG004|Maintenance Phase|Site closure|0|||
129532528|NCT02394028|466238327|FG005|Maintenance Phase|Site closure|0|||
129532529|NCT02394028|466238328|FG006|Maintenance Phase|Site closure|0|||
129532530|NCT02394028|466238329|FG007|Maintenance Phase|Site closure|0|||
129532531|NCT02394028|466238330|FG008|Maintenance Phase|Site closure|0|||
129532532|NCT02394028|466238331|FG009|Maintenance Phase|Site closure|1|||
129532533|NCT02394028|466238332|FG010|Maintenance Phase|Site closure|0|||
129532534|NCT02394028|466238322|FG000|Maintenance Phase|Withdrawal by Subject|0|||
129532535|NCT02394028|466238323|FG001|Maintenance Phase|Withdrawal by Subject|0|||
129532536|NCT02394028|466238324|FG002|Maintenance Phase|Withdrawal by Subject|0|||
129532537|NCT02394028|466238325|FG003|Maintenance Phase|Withdrawal by Subject|0|||
129532538|NCT02394028|466238326|FG004|Maintenance Phase|Withdrawal by Subject|0|||
129532539|NCT02394028|466238327|FG005|Maintenance Phase|Withdrawal by Subject|0|||
129532540|NCT02394028|466238328|FG006|Maintenance Phase|Withdrawal by Subject|0|||
129532541|NCT02394028|466238329|FG007|Maintenance Phase|Withdrawal by Subject|0|||
129532542|NCT02394028|466238330|FG008|Maintenance Phase|Withdrawal by Subject|3|||
129532543|NCT02394028|466238331|FG009|Maintenance Phase|Withdrawal by Subject|12|||
129532544|NCT02394028|466238332|FG010|Maintenance Phase|Withdrawal by Subject|12|||
129532545|NCT02355665|466238335|FG000|Overall Study|Adverse Event|16|||
129532546|NCT02355665|466238336|FG001|Overall Study|Adverse Event|24|||
129532547|NCT02355665|466238335|FG000|Overall Study|Protocol Violation|2|||
129532548|NCT02355665|466238336|FG001|Overall Study|Protocol Violation|0|||
129532549|NCT02355665|466238335|FG000|Overall Study|Withdrawal by Subject|90|||
129532550|NCT02355665|466238336|FG001|Overall Study|Withdrawal by Subject|100|||
129532551|NCT02355665|466238335|FG000|Overall Study|Lost to Follow-up|131|||
129532552|NCT02355665|466238336|FG001|Overall Study|Lost to Follow-up|103|||
129532553|NCT02355665|466238335|FG000|Overall Study|Death|4|||
129532554|NCT02355665|466238336|FG001|Overall Study|Death|2|||
129532555|NCT02355665|466238335|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
129532556|NCT02355665|466238336|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
129532557|NCT04129242|466238337|FG000|Overall Study|Physician Decision|1|||
129532558|NCT04129242|466238338|FG001|Overall Study|Physician Decision|1|||
129532559|NCT04129242|466238337|FG000|Overall Study|Protocol Violation|0|||
129532560|NCT04129242|466238338|FG001|Overall Study|Protocol Violation|1|||
129532561|NCT01775995|466238339|FG000|Overall Study|Lost to Follow-up|1|||
129532562|NCT01775995|466238340|FG001|Overall Study|Lost to Follow-up|1|||
129532563|NCT02918006|466238342|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
129532564|NCT02918006|466238343|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
129532565|NCT02918006|466238344|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
129532566|NCT02918006|466238342|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
129532567|NCT02918006|466238343|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
129532568|NCT02918006|466238344|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
129532569|NCT02918006|466238342|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
129532570|NCT02918006|466238343|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
129532571|NCT02918006|466238344|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
129532572|NCT02918006|466238342|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
129532573|NCT02918006|466238343|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
129532574|NCT02918006|466238344|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
129532575|NCT02918006|466238342|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
129532576|NCT02918006|466238343|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
129532577|NCT02918006|466238344|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
129532578|NCT02918006|466238342|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
129532579|NCT02918006|466238343|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
129532580|NCT02918006|466238344|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
129532581|NCT02918006|466238342|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
129532582|NCT02918006|466238343|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
129532583|NCT02918006|466238344|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
129532584|NCT02918006|466238342|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
129532585|NCT02918006|466238343|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
129532586|NCT02918006|466238344|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
129532587|NCT02918006|466238342|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
129532588|NCT02918006|466238343|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
129532589|NCT02918006|466238344|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
129532590|NCT01156012|466238346|FG000|Overall Study|Adverse Event|3|||
129532591|NCT01156012|466238347|FG001|Overall Study|Adverse Event|1|||
129532592|NCT01156012|466238346|FG000|Overall Study|Lost to Follow-up|1|||
129532593|NCT01156012|466238347|FG001|Overall Study|Lost to Follow-up|0|||
129532594|NCT01156012|466238346|FG000|Overall Study|Withdrawal by Subject|1|||
129532595|NCT01156012|466238347|FG001|Overall Study|Withdrawal by Subject|0|||
129532596|NCT01156012|466238346|FG000|Overall Study|use of commercial drug instead of study|0|||
129532597|NCT01156012|466238347|FG001|Overall Study|use of commercial drug instead of study|1|||
129532598|NCT01156012|466238346|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
129532599|NCT01156012|466238347|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
129532600|NCT02475564|466238348|FG000|Overall Study|Withdrawal by Subject|1|||
129532601|NCT02475564|466238349|FG001|Overall Study|Withdrawal by Subject|0|||
129532602|NCT02475564|466238348|FG000|Overall Study|Lost to Follow-up|2|||
129532603|NCT02475564|466238349|FG001|Overall Study|Lost to Follow-up|1|||
129532604|NCT02475564|466238348|FG000|Overall Study|Intense Menstrual bleeding|1|||
129532605|NCT02475564|466238349|FG001|Overall Study|Intense Menstrual bleeding|0|||
129532606|NCT02705755|466238351|FG000|Part A (6 Days)|Adverse Event|1|||
129532607|NCT02705755|466238352|FG001|Part A (6 Days)|Adverse Event|0|||
129532608|NCT02705755|466238353|FG002|Part A (6 Days)|Adverse Event|0|||
129532609|NCT02705755|466238354|FG003|Part A (6 Days)|Adverse Event|0|||
129532610|NCT02705755|466238351|FG000|Part A (6 Days)|Physician Decision|3|||
129532611|NCT02705755|466238352|FG001|Part A (6 Days)|Physician Decision|0|||
129532612|NCT02705755|466238353|FG002|Part A (6 Days)|Physician Decision|0|||
129532613|NCT02705755|466238354|FG003|Part A (6 Days)|Physician Decision|0|||
129532614|NCT02705755|466238351|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
129532615|NCT02705755|466238352|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
129532616|NCT02705755|466238353|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
129532617|NCT02705755|466238354|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
129532618|NCT02705755|466238351|FG000|Part C (20 Weeks)|Physician Decision|0|||
129532619|NCT02705755|466238352|FG001|Part C (20 Weeks)|Physician Decision|0|||
129532620|NCT02705755|466238353|FG002|Part C (20 Weeks)|Physician Decision|0|||
129532621|NCT02705755|466238354|FG003|Part C (20 Weeks)|Physician Decision|2|||
129532622|NCT02705755|466238351|FG000|Part C (20 Weeks)|Adverse Event|0|||
129532623|NCT02705755|466238352|FG001|Part C (20 Weeks)|Adverse Event|0|||
129532624|NCT02705755|466238353|FG002|Part C (20 Weeks)|Adverse Event|0|||
129532625|NCT02705755|466238354|FG003|Part C (20 Weeks)|Adverse Event|6|||
129532626|NCT02705755|466238351|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
129532627|NCT02705755|466238352|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
129532628|NCT02705755|466238353|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
129532629|NCT02705755|466238354|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
129532630|NCT01084096|466240160|FG000|Overall Study|Lost to Follow-up|1501|||
129532631|NCT01084096|466240161|FG001|Overall Study|Lost to Follow-up|1833|||
129532632|NCT01084096|466240160|FG000|Overall Study|Withdrawal by Subject|3|||
129532633|NCT01084096|466240161|FG001|Overall Study|Withdrawal by Subject|0|||
129532634|NCT01084096|466240160|FG000|Overall Study|Woman had a miscarriage|21|||
129532635|NCT01084096|466240161|FG001|Overall Study|Woman had a miscarriage|17|||
129532636|NCT01354964|466240162|FG000|Overall Study|Lost to Follow-up|2|||
129532637|NCT01354964|466240163|FG001|Overall Study|Lost to Follow-up|0|||
129532638|NCT01354964|466240162|FG000|Overall Study|IV access issues|1|||
129532639|NCT01354964|466240163|FG001|Overall Study|IV access issues|1|||
129532640|NCT01354964|466240162|FG000|Overall Study|Physician Decision|1|||
129532641|NCT01354964|466240163|FG001|Overall Study|Physician Decision|0|||
129532642|NCT04450394|466240172|FG000|Overall Study|Adverse Event|2|||
129532643|NCT04450394|466240173|FG001|Overall Study|Adverse Event|0|||
129532644|NCT04450394|466240174|FG002|Overall Study|Adverse Event|0|||
129532645|NCT04450394|466240172|FG000|Overall Study|Death|0|||
129532646|NCT04450394|466240173|FG001|Overall Study|Death|1|||
129532647|NCT04450394|466240174|FG002|Overall Study|Death|0|||
129532648|NCT04450394|466240172|FG000|Overall Study|Lost to Follow-up|0|||
129532649|NCT04450394|466240173|FG001|Overall Study|Lost to Follow-up|3|||
129532650|NCT04450394|466240174|FG002|Overall Study|Lost to Follow-up|0|||
129532651|NCT04450394|466240172|FG000|Overall Study|Physician Decision|0|||
129532652|NCT04450394|466240173|FG001|Overall Study|Physician Decision|1|||
129532653|NCT04450394|466240174|FG002|Overall Study|Physician Decision|0|||
129532654|NCT04450394|466240172|FG000|Overall Study|Protocol Violation|2|||
129532655|NCT04450394|466240173|FG001|Overall Study|Protocol Violation|0|||
129532656|NCT04450394|466240174|FG002|Overall Study|Protocol Violation|0|||
129532657|NCT04450394|466240172|FG000|Overall Study|Withdrawal by Subject|6|||
129532658|NCT04450394|466240173|FG001|Overall Study|Withdrawal by Subject|9|||
129532659|NCT04450394|466240174|FG002|Overall Study|Withdrawal by Subject|0|||
129532660|NCT02155660|466240179|FG000|Overall Study|Other Reason|8|||
129532661|NCT02155660|466240180|FG001|Overall Study|Other Reason|6|||
129532662|NCT02155660|466240181|FG002|Overall Study|Other Reason|10|||
129532663|NCT02155660|466240182|FG003|Overall Study|Other Reason|10|||
129532664|NCT02155660|466240179|FG000|Overall Study|Study-specific withdrawal criteria|0|||
129532665|NCT02155660|466240180|FG001|Overall Study|Study-specific withdrawal criteria|1|||
129532666|NCT02155660|466240181|FG002|Overall Study|Study-specific withdrawal criteria|1|||
129532667|NCT02155660|466240182|FG003|Overall Study|Study-specific withdrawal criteria|1|||
129532668|NCT02155660|466240179|FG000|Overall Study|Severe non-compliance|0|||
129532669|NCT02155660|466240180|FG001|Overall Study|Severe non-compliance|4|||
129532670|NCT02155660|466240181|FG002|Overall Study|Severe non-compliance|0|||
129532671|NCT02155660|466240182|FG003|Overall Study|Severe non-compliance|1|||
129532672|NCT02155660|466240179|FG000|Overall Study|Adverse Event|2|||
129532673|NCT02155660|466240180|FG001|Overall Study|Adverse Event|6|||
129532674|NCT02155660|466240181|FG002|Overall Study|Adverse Event|3|||
129532675|NCT02155660|466240182|FG003|Overall Study|Adverse Event|1|||
129532676|NCT02155660|466240179|FG000|Overall Study|Lost to Follow-up|3|||
129532677|NCT02155660|466240180|FG001|Overall Study|Lost to Follow-up|6|||
129532678|NCT02155660|466240181|FG002|Overall Study|Lost to Follow-up|5|||
129532679|NCT02155660|466240182|FG003|Overall Study|Lost to Follow-up|8|||
129532680|NCT02155660|466240179|FG000|Overall Study|Death|17|||
129532681|NCT02155660|466240180|FG001|Overall Study|Death|19|||
129532682|NCT02155660|466240181|FG002|Overall Study|Death|17|||
129532683|NCT02155660|466240182|FG003|Overall Study|Death|19|||
129532684|NCT02155660|466240179|FG000|Overall Study|Withdrawal by Subject|28|||
129532685|NCT02155660|466240180|FG001|Overall Study|Withdrawal by Subject|31|||
129532686|NCT02155660|466240181|FG002|Overall Study|Withdrawal by Subject|24|||
129532687|NCT02155660|466240182|FG003|Overall Study|Withdrawal by Subject|21|||
129532688|NCT00303719|466240183|FG000|Overall Study|Not evaluable, prior therapies|0|||
129532689|NCT00303719|466240184|FG001|Overall Study|Not evaluable, prior therapies|30|||
129532690|NCT00303719|466240183|FG000|Overall Study|Lost to Follow-up|0|||
129532691|NCT00303719|466240184|FG001|Overall Study|Lost to Follow-up|7|||
129532692|NCT01641952|466240185|FG000|Overall Study|Lost to Follow-up|28|||
129532693|NCT01641952|466240185|FG000|Overall Study|Adverse Event|6|||
129532694|NCT00561912|466240195|FG000|Overall Study|ineligible|1|||
129532695|NCT02643420|466240196|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
129532696|NCT02643420|466240197|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
129532697|NCT02643420|466240196|FG000|Overall Study|Withdrawal by Subject|25|||
129532698|NCT02643420|466240197|FG001|Overall Study|Withdrawal by Subject|19|||
129532699|NCT02643420|466240196|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
129532700|NCT02643420|466240197|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
129532701|NCT02643420|466240196|FG000|Overall Study|Lost to Follow-up|6|||
129532702|NCT02643420|466240197|FG001|Overall Study|Lost to Follow-up|10|||
129532703|NCT02643420|466240196|FG000|Overall Study|Investigator Decision|2|||
129532704|NCT02643420|466240197|FG001|Overall Study|Investigator Decision|4|||
129532705|NCT02643420|466240196|FG000|Overall Study|Sponsor decision|1|||
129532706|NCT02643420|466240197|FG001|Overall Study|Sponsor decision|1|||
129532707|NCT02643420|466240196|FG000|Overall Study|Death|0|||
129532708|NCT02643420|466240197|FG001|Overall Study|Death|2|||
129532709|NCT02643420|466240196|FG000|Overall Study|Reason not Specified|8|||
129532710|NCT02643420|466240197|FG001|Overall Study|Reason not Specified|7|||
129532711|NCT02127970|466240198|FG000|Overall Study|Adverse Event|2|||
129532712|NCT02127970|466240199|FG001|Overall Study|Adverse Event|1|||
129532713|NCT02127970|466240198|FG000|Overall Study|Death|1|||
129532714|NCT02127970|466240199|FG001|Overall Study|Death|1|||
129532715|NCT02127970|466240198|FG000|Overall Study|Lost to Follow-up|14|||
129532716|NCT02127970|466240199|FG001|Overall Study|Lost to Follow-up|14|||
129532717|NCT02127970|466240198|FG000|Overall Study|Reason not Specified|4|||
129532718|NCT02127970|466240199|FG001|Overall Study|Reason not Specified|7|||
129532719|NCT02127970|466240198|FG000|Overall Study|Pregnancy|0|||
129532720|NCT02127970|466240199|FG001|Overall Study|Pregnancy|1|||
129532721|NCT02127970|466240198|FG000|Overall Study|Subject Withdrew Consent|5|||
129532722|NCT02127970|466240199|FG001|Overall Study|Subject Withdrew Consent|3|||
129532723|NCT00542321|466240200|FG000|Overall Study|Death|0|||
129532724|NCT00542321|466240201|FG001|Overall Study|Death|1|||
129532725|NCT00253747|466240207|FG000|Overall Study|Lost to Follow-up|13|||
129532726|NCT00253747|466240208|FG001|Overall Study|Lost to Follow-up|14|||
129532727|NCT00253747|466240207|FG000|Overall Study|Withdrawal by Subject|10|||
129532728|NCT00253747|466240208|FG001|Overall Study|Withdrawal by Subject|11|||
129532729|NCT00253747|466240207|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
129532730|NCT00253747|466240208|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
129532731|NCT00718887|466240209|FG000|Overall Study|Withdrawal by Subject|3|||
129532732|NCT00718887|466240210|FG001|Overall Study|Withdrawal by Subject|2|||
129532733|NCT00718887|466240209|FG000|Overall Study|Not identified|2|||
129532734|NCT00718887|466240210|FG001|Overall Study|Not identified|7|||
129532735|NCT05102734|466240212|FG000|Overall Study|Did not require vasopressors|1|||
129532736|NCT05102734|466240213|FG001|Overall Study|Did not require vasopressors|0|||
129532737|NCT05102734|466240212|FG000|Overall Study|Did not have functioning PA catheter|1|||
129532738|NCT05102734|466240213|FG001|Overall Study|Did not have functioning PA catheter|0|||
129532739|NCT05102734|466240212|FG000|Overall Study|Inadequate video quality|2|||
129532740|NCT05102734|466240213|FG001|Overall Study|Inadequate video quality|0|||
129532741|NCT04235959|466240214|FG000|Overall Study|Protocol Violation|0|||
129532742|NCT04235959|466240215|FG001|Overall Study|Protocol Violation|1|||
129532743|NCT04235959|466240216|FG002|Overall Study|Protocol Violation|0|||
129532744|NCT04235959|466240214|FG000|Overall Study|Adverse Event|1|||
129532745|NCT04235959|466240215|FG001|Overall Study|Adverse Event|0|||
129532746|NCT04235959|466240216|FG002|Overall Study|Adverse Event|0|||
129532747|NCT00608426|466240217|FG000|Overall Study|Death|32|||
129532748|NCT00608426|466240218|FG001|Overall Study|Death|36|||
129532749|NCT00608426|466240217|FG000|Overall Study|Lost to Follow-up|485|||
129532750|NCT00608426|466240218|FG001|Overall Study|Lost to Follow-up|521|||
129532751|NCT00608426|466240217|FG000|Overall Study|refused, health issues, wrong address|319|||
129532752|NCT00608426|466240218|FG001|Overall Study|refused, health issues, wrong address|348|||
129532753|NCT04601194|466240222|FG000|Overall Study|Lost to Follow-up|7|||
129532754|NCT02630459|466240223|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
129532755|NCT02630459|466240224|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
129532756|NCT02630459|466240225|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
129532757|NCT02630459|466240226|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
129532758|NCT02630459|466240227|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
129532759|NCT02630459|466240228|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
129532760|NCT02630459|466240229|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
129532761|NCT02630459|466240230|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
129532762|NCT02630459|466240223|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532763|NCT02630459|466240224|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532764|NCT02630459|466240225|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
129532765|NCT02630459|466240226|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532766|NCT02630459|466240227|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532767|NCT02630459|466240228|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532768|NCT02630459|466240229|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532769|NCT02630459|466240230|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
129532770|NCT02630459|466240223|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
129532771|NCT02630459|466240224|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
129532772|NCT02630459|466240225|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
129532773|NCT02630459|466240226|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
129532774|NCT02630459|466240227|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
129532775|NCT02630459|466240228|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
129532776|NCT02630459|466240229|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
129532777|NCT02630459|466240230|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
129532778|NCT02630459|466240223|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
129532779|NCT02630459|466240224|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129532780|NCT02630459|466240225|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129538829|NCT02911285|466263543|FG001|Overall Study|Lost to Follow-up|5|||
129532781|NCT02630459|466240226|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129532782|NCT02630459|466240227|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129532783|NCT02630459|466240228|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129532784|NCT02630459|466240229|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129532785|NCT02630459|466240230|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
129532786|NCT02630459|466240223|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129532787|NCT02630459|466240224|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129532788|NCT02630459|466240225|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129532789|NCT02630459|466240226|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129532790|NCT02630459|466240227|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
129532791|NCT02630459|466240228|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
129532792|NCT02630459|466240229|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129532793|NCT02630459|466240230|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
129532794|NCT02630459|466240223|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
129532795|NCT02630459|466240224|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
129532796|NCT02630459|466240225|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
129532797|NCT02630459|466240226|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
129532798|NCT02630459|466240227|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
129532799|NCT02630459|466240228|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
129532800|NCT02630459|466240229|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
129532801|NCT02630459|466240230|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
129532802|NCT02630459|466240223|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532803|NCT02630459|466240224|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532804|NCT02630459|466240225|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532805|NCT02630459|466240226|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532806|NCT02630459|466240227|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
129532807|NCT02630459|466240228|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532808|NCT02630459|466240229|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532809|NCT02630459|466240230|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
129532810|NCT00348686|466240231|FG000|Overall Study|Withdrawal by Subject|45|||
129532811|NCT00348686|466240231|FG000|Overall Study|Adverse Event|5|||
129532812|NCT00348686|466240231|FG000|Overall Study|Protocol Violation|6|||
129532813|NCT00348686|466240231|FG000|Overall Study|Lost to Follow-up|2|||
129532814|NCT00348686|466240231|FG000|Overall Study|Multiple Reasons|8|||
129532815|NCT01258738|466240232|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
129532816|NCT01258738|466240233|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
129532817|NCT01258738|466240232|FG000|Double-blind Period|Withdrawal by Subject|2|||
129532818|NCT01258738|466240233|FG001|Double-blind Period|Withdrawal by Subject|2|||
129532819|NCT01258738|466240232|FG000|Double-blind Period|Protocol Violation|1|||
129532820|NCT01258738|466240233|FG001|Double-blind Period|Protocol Violation|1|||
129532821|NCT01258738|466240232|FG000|Double-blind Period|Adverse Event|3|||
129532822|NCT01258738|466240233|FG001|Double-blind Period|Adverse Event|1|||
129532823|NCT01258738|466240232|FG000|Open-label Period|Did not meet inclusion criteria|0|||
129532824|NCT01258738|466240233|FG001|Open-label Period|Did not meet inclusion criteria|1|||
129532825|NCT01258738|466240232|FG000|Open-label Period|Insufficient clinical response|5|||
129532826|NCT01258738|466240233|FG001|Open-label Period|Insufficient clinical response|3|||
129532827|NCT01258738|466240232|FG000|Open-label Period|Lost to Follow-up|0|||
129532828|NCT01258738|466240233|FG001|Open-label Period|Lost to Follow-up|2|||
129532829|NCT01258738|466240232|FG000|Open-label Period|Withdrawal by Subject|5|||
129532830|NCT01258738|466240233|FG001|Open-label Period|Withdrawal by Subject|6|||
129532831|NCT01258738|466240232|FG000|Open-label Period|Protocol Violation|2|||
129532832|NCT01258738|466240233|FG001|Open-label Period|Protocol Violation|2|||
129532833|NCT01258738|466240232|FG000|Open-label Period|Adverse Event|4|||
129532834|NCT01258738|466240233|FG001|Open-label Period|Adverse Event|5|||
129532835|NCT01258738|466240232|FG000|Open-label Period|Other Reasons|0|||
129532836|NCT01258738|466240233|FG001|Open-label Period|Other Reasons|1|||
129532837|NCT01258738|466240232|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
129532838|NCT01258738|466240233|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
129532839|NCT00689611|466240234|FG000|Overall Study|Death|6|||
129532840|NCT00689611|466240235|FG001|Overall Study|Death|9|||
129532841|NCT00689611|466240234|FG000|Overall Study|Withdrawal by Subject|8|||
129532842|NCT00689611|466240235|FG001|Overall Study|Withdrawal by Subject|9|||
129532843|NCT00689611|466240234|FG000|Overall Study|Lost to Follow-up|27|||
129532844|NCT00689611|466240235|FG001|Overall Study|Lost to Follow-up|28|||
129532845|NCT00568399|466240236|FG000|Overall Study|Death|2|||
129532846|NCT00568399|466240236|FG000|Overall Study|Adverse Event|5|||
129532847|NCT00568399|466240236|FG000|Overall Study|Withdrawal by Subject|8|||
129532848|NCT01904760|466240237|FG000|Overall Study|Protocol Violation|1|||
129532849|NCT01904760|466240238|FG001|Overall Study|Protocol Violation|0|||
129532850|NCT04249076|466240248|FG000|Overall Study|Adverse Event|1|||
129532851|NCT04249076|466240249|FG001|Overall Study|Adverse Event|1|||
129532852|NCT04249076|466240248|FG000|Overall Study|Protocol Violation|1|||
129532853|NCT04249076|466240249|FG001|Overall Study|Protocol Violation|2|||
129532854|NCT04249076|466240248|FG000|Overall Study|Lack of Efficacy|0|||
129532855|NCT04249076|466240249|FG001|Overall Study|Lack of Efficacy|1|||
129532856|NCT04249076|466240248|FG000|Overall Study|Withdrawal by Subject|0|||
129532857|NCT04249076|466240249|FG001|Overall Study|Withdrawal by Subject|1|||
129532858|NCT01117428|466240250|FG000|Overall Study|Lack of Efficacy|1|||
129532859|NCT01117428|466240251|FG001|Overall Study|Lack of Efficacy|0|||
129532860|NCT01117428|466240252|FG002|Overall Study|Lack of Efficacy|0|||
129532861|NCT01117428|466240253|FG003|Overall Study|Lack of Efficacy|0|||
129532862|NCT01117428|466240254|FG004|Overall Study|Lack of Efficacy|0|||
129532863|NCT01117428|466240255|FG005|Overall Study|Lack of Efficacy|0|||
129532864|NCT01117428|466240250|FG000|Overall Study|Adverse Event|4|||
129532865|NCT01117428|466240251|FG001|Overall Study|Adverse Event|0|||
129532866|NCT01117428|466240252|FG002|Overall Study|Adverse Event|0|||
129532867|NCT01117428|466240253|FG003|Overall Study|Adverse Event|0|||
129532868|NCT01117428|466240254|FG004|Overall Study|Adverse Event|1|||
129532869|NCT01117428|466240255|FG005|Overall Study|Adverse Event|2|||
129532870|NCT01117428|466240250|FG000|Overall Study|Death|0|||
129532871|NCT01117428|466240251|FG001|Overall Study|Death|1|||
129532872|NCT01117428|466240252|FG002|Overall Study|Death|2|||
129532873|NCT01117428|466240253|FG003|Overall Study|Death|0|||
129532874|NCT01117428|466240254|FG004|Overall Study|Death|0|||
129532875|NCT01117428|466240255|FG005|Overall Study|Death|1|||
129532876|NCT01117428|466240250|FG000|Overall Study|Physician Decision|0|||
129532877|NCT01117428|466240251|FG001|Overall Study|Physician Decision|1|||
129532878|NCT01117428|466240252|FG002|Overall Study|Physician Decision|0|||
129532879|NCT01117428|466240253|FG003|Overall Study|Physician Decision|0|||
129532880|NCT01117428|466240254|FG004|Overall Study|Physician Decision|0|||
129532881|NCT01117428|466240255|FG005|Overall Study|Physician Decision|0|||
129532882|NCT01117428|466240250|FG000|Overall Study|Withdrawal by Subject|0|||
129532883|NCT01117428|466240251|FG001|Overall Study|Withdrawal by Subject|0|||
129532884|NCT01117428|466240252|FG002|Overall Study|Withdrawal by Subject|1|||
129532885|NCT01117428|466240253|FG003|Overall Study|Withdrawal by Subject|0|||
129532886|NCT01117428|466240254|FG004|Overall Study|Withdrawal by Subject|0|||
129532887|NCT01117428|466240255|FG005|Overall Study|Withdrawal by Subject|0|||
129532888|NCT01117428|466240250|FG000|Overall Study|Progressive disease|15|||
129532889|NCT01117428|466240251|FG001|Overall Study|Progressive disease|27|||
129532890|NCT01117428|466240252|FG002|Overall Study|Progressive disease|10|||
129532891|NCT01117428|466240253|FG003|Overall Study|Progressive disease|12|||
129532892|NCT01117428|466240254|FG004|Overall Study|Progressive disease|16|||
129532893|NCT01117428|466240255|FG005|Overall Study|Progressive disease|17|||
129532894|NCT03018028|466240256|FG000|Overall Study|Withdrawal by Subject|3|||
129532895|NCT03018028|466240257|FG001|Overall Study|Withdrawal by Subject|0|||
129532896|NCT03018028|466240258|FG002|Overall Study|Withdrawal by Subject|1|||
129532897|NCT03018028|466240259|FG003|Overall Study|Withdrawal by Subject|2|||
129532898|NCT03018028|466240260|FG004|Overall Study|Withdrawal by Subject|0|||
129532899|NCT02519777|466240262|FG000|Overall Study|Death|1|||
129532900|NCT02519777|466240263|FG001|Overall Study|Death|0|||
129532901|NCT02519777|466240264|FG002|Overall Study|Death|0|||
129532902|NCT02519777|466240262|FG000|Overall Study|Lost to Follow-up|0|||
129532903|NCT02519777|466240263|FG001|Overall Study|Lost to Follow-up|4|||
129532904|NCT02519777|466240264|FG002|Overall Study|Lost to Follow-up|2|||
129532905|NCT02519777|466240262|FG000|Overall Study|Withdrawal by Subject|3|||
129532906|NCT02519777|466240263|FG001|Overall Study|Withdrawal by Subject|1|||
129532907|NCT02519777|466240264|FG002|Overall Study|Withdrawal by Subject|0|||
129532908|NCT02519777|466240262|FG000|Overall Study|Severe Debilitation|1|||
129532909|NCT02519777|466240263|FG001|Overall Study|Severe Debilitation|1|||
129532910|NCT02519777|466240264|FG002|Overall Study|Severe Debilitation|1|||
129532911|NCT02519777|466240262|FG000|Overall Study|Not able to get to clinic|1|||
129532912|NCT02519777|466240263|FG001|Overall Study|Not able to get to clinic|2|||
129532913|NCT02519777|466240264|FG002|Overall Study|Not able to get to clinic|1|||
129532914|NCT02195531|466240265|FG000|Overall Study|Withdrawal by Subject|1|||
129532915|NCT02195531|466240266|FG001|Overall Study|Withdrawal by Subject|1|||
129532916|NCT02195531|466240267|FG002|Overall Study|Withdrawal by Subject|1|||
129532917|NCT02543801|466240269|FG000|Overall Study|Protocol Violation|1|||
129532918|NCT02543801|466240270|FG001|Overall Study|Protocol Violation|2|||
129532919|NCT02543801|466240271|FG002|Overall Study|Protocol Violation|0|||
129532920|NCT02543801|466240272|FG003|Overall Study|Protocol Violation|0|||
129532921|NCT01034709|466240275|FG000|Overall Study|Protocol Violation|9|||
129532922|NCT01034709|466240276|FG001|Overall Study|Protocol Violation|16|||
129532923|NCT02364999|466240292|FG000|Overall Study|Death|136|||
129532924|NCT02364999|466240293|FG001|Overall Study|Death|138|||
129532925|NCT02364999|466240292|FG000|Overall Study|Lost to Follow-up|10|||
129532926|NCT02364999|466240293|FG001|Overall Study|Lost to Follow-up|15|||
129532927|NCT02364999|466240292|FG000|Overall Study|Protocol Violation|3|||
129532928|NCT02364999|466240293|FG001|Overall Study|Protocol Violation|2|||
129532929|NCT02364999|466240292|FG000|Overall Study|Withdrawal by Subject|14|||
129532930|NCT02364999|466240293|FG001|Overall Study|Withdrawal by Subject|14|||
129532931|NCT02364999|466240292|FG000|Overall Study|Other|0|||
129532932|NCT02364999|466240293|FG001|Overall Study|Other|1|||
129532933|NCT02364999|466240292|FG000|Overall Study|Randomized but did not receive treatment|2|||
129532934|NCT02364999|466240293|FG001|Overall Study|Randomized but did not receive treatment|3|||
129532935|NCT02177942|466240294|FG000|Overall Study|Adverse Event|1|||
129532936|NCT02177942|466240295|FG001|Overall Study|Adverse Event|0|||
129532937|NCT02177942|466240294|FG000|Overall Study|Lost to Follow-up|1|||
129532938|NCT02177942|466240295|FG001|Overall Study|Lost to Follow-up|1|||
129532939|NCT02177942|466240294|FG000|Overall Study|Protocol Violation|4|||
129532940|NCT02177942|466240295|FG001|Overall Study|Protocol Violation|6|||
129532941|NCT02177942|466240294|FG000|Overall Study|Withdrawal by Subject|71|||
129532942|NCT02177942|466240295|FG001|Overall Study|Withdrawal by Subject|81|||
129532943|NCT01351415|466240296|FG000|Overall Study|Withdrawal by Subject|15|||
129532944|NCT01351415|466240297|FG001|Overall Study|Withdrawal by Subject|17|||
129532945|NCT01351415|466240296|FG000|Overall Study|Trial termination by the Sponsor|28|||
129532946|NCT01351415|466240297|FG001|Overall Study|Trial termination by the Sponsor|19|||
129532947|NCT01351415|466240296|FG000|Overall Study|Lost to Follow-up|5|||
129532948|NCT01351415|466240297|FG001|Overall Study|Lost to Follow-up|7|||
129532949|NCT01351415|466240296|FG000|Overall Study|Death|190|||
129532950|NCT01351415|466240297|FG001|Overall Study|Death|187|||
129532951|NCT01351415|466240296|FG000|Overall Study|Physician Decision|2|||
129532952|NCT01351415|466240297|FG001|Overall Study|Physician Decision|3|||
129532953|NCT01351415|466240296|FG000|Overall Study|Reason unknown|0|||
129532954|NCT01351415|466240297|FG001|Overall Study|Reason unknown|2|||
129532955|NCT01351415|466240296|FG000|Overall Study|Never Started|5|||
129532956|NCT01351415|466240297|FG001|Overall Study|Never Started|5|||
129532957|NCT00699582|466240302|FG000|Overall Study|Adverse Event|4|||
129532958|NCT00699582|466240303|FG001|Overall Study|Adverse Event|11|||
129532959|NCT00699582|466240304|FG002|Overall Study|Adverse Event|23|||
129532960|NCT00699582|466240302|FG000|Overall Study|Withdrawal by Subject|6|||
129532961|NCT00699582|466240303|FG001|Overall Study|Withdrawal by Subject|7|||
129532962|NCT00699582|466240304|FG002|Overall Study|Withdrawal by Subject|4|||
129532963|NCT00699582|466240302|FG000|Overall Study|Lack of Efficacy|1|||
129532964|NCT00699582|466240303|FG001|Overall Study|Lack of Efficacy|0|||
129532965|NCT00699582|466240304|FG002|Overall Study|Lack of Efficacy|1|||
129532966|NCT00699582|466240302|FG000|Overall Study|Progressive Disease|1|||
129532967|NCT00699582|466240303|FG001|Overall Study|Progressive Disease|0|||
129532968|NCT00699582|466240304|FG002|Overall Study|Progressive Disease|0|||
129532969|NCT00699582|466240302|FG000|Overall Study|Administrative/Other|4|||
129532970|NCT00699582|466240303|FG001|Overall Study|Administrative/Other|3|||
129532971|NCT00699582|466240304|FG002|Overall Study|Administrative/Other|0|||
129532972|NCT00699582|466240302|FG000|Overall Study|Randomized, Not Treated|2|||
129532973|NCT00699582|466240303|FG001|Overall Study|Randomized, Not Treated|1|||
129532974|NCT00699582|466240304|FG002|Overall Study|Randomized, Not Treated|0|||
129532975|NCT04118127|466240305|FG000|Overall Study|Trial terminated by sponsor|0|||
129532976|NCT04118127|466240306|FG001|Overall Study|Trial terminated by sponsor|12|||
129532977|NCT04118127|466240305|FG000|Overall Study|Adverse Event|1|||
129532978|NCT04118127|466240306|FG001|Overall Study|Adverse Event|2|||
129532979|NCT04118127|466240305|FG000|Overall Study|Physician Decision|0|||
129532980|NCT04118127|466240306|FG001|Overall Study|Physician Decision|1|||
129532981|NCT04118127|466240305|FG000|Overall Study|Withdrawal by Subject|2|||
129532982|NCT04118127|466240306|FG001|Overall Study|Withdrawal by Subject|1|||
129532983|NCT03480360|466240307|FG000|Overall Study|Death|2|||
129532984|NCT00660816|466240312|FG000|Overall Study|Adverse Event|1|||
129532985|NCT00660816|466240313|FG001|Overall Study|Adverse Event|2|||
129532986|NCT00660816|466240312|FG000|Overall Study|Withdrawal by Subject|1|||
129532987|NCT00660816|466240313|FG001|Overall Study|Withdrawal by Subject|0|||
129532988|NCT00660816|466240312|FG000|Overall Study|Death|0|||
129532989|NCT00660816|466240313|FG001|Overall Study|Death|2|||
129532990|NCT00660816|466240312|FG000|Overall Study|Lack of Efficacy|1|||
129532991|NCT00660816|466240313|FG001|Overall Study|Lack of Efficacy|0|||
129532992|NCT00660816|466240312|FG000|Overall Study|Physician Decision|0|||
129532993|NCT00660816|466240313|FG001|Overall Study|Physician Decision|2|||
129532994|NCT00660816|466240312|FG000|Overall Study|Protocol Violation|1|||
129532995|NCT00660816|466240313|FG001|Overall Study|Protocol Violation|0|||
129532996|NCT00660816|466240312|FG000|Overall Study|Disease Progression|16|||
129532997|NCT00660816|466240313|FG001|Overall Study|Disease Progression|12|||
129532998|NCT00660816|466240312|FG000|Overall Study|Complicating Disease|0|||
129532999|NCT00660816|466240313|FG001|Overall Study|Complicating Disease|1|||
129533000|NCT02692560|466240314|FG000|Overall Study|Withdrawal by Subject|0|||
129533001|NCT02692560|466240315|FG001|Overall Study|Withdrawal by Subject|6|||
129533002|NCT01326910|466240316|FG000|Overall Study|Withdrawal by Subject|3|||
129533003|NCT01326910|466240317|FG001|Overall Study|Withdrawal by Subject|2|||
129533004|NCT01326910|466240316|FG000|Overall Study|Protocol Violation|1|||
129533005|NCT01326910|466240317|FG001|Overall Study|Protocol Violation|1|||
129533006|NCT01681836|466240320|FG000|Second Intervention|Withdrawal by Subject|0|||
129533007|NCT01681836|466240321|FG001|Second Intervention|Withdrawal by Subject|1|||
129533008|NCT01241318|466240324|FG000|Overall Study|Woman: false pregnancies|27|||
129533009|NCT01241318|466240325|FG001|Overall Study|Woman: false pregnancies|15|||
129533010|NCT01241318|466240324|FG000|Overall Study|Woman: miscarriage/abortion|46|||
129533011|NCT01241318|466240325|FG001|Overall Study|Woman: miscarriage/abortion|38|||
129533012|NCT01241318|466240324|FG000|Overall Study|Withdrawal by Subject|175|||
129533013|NCT01241318|466240325|FG001|Overall Study|Withdrawal by Subject|46|||
129533014|NCT01241318|466240324|FG000|Overall Study|Lost to Follow-up|740|||
129533015|NCT01241318|466240325|FG001|Overall Study|Lost to Follow-up|455|||
129533016|NCT01241318|466240324|FG000|Overall Study|Death|2|||
129533017|NCT01241318|466240325|FG001|Overall Study|Death|4|||
129533018|NCT01241318|466240324|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
129533019|NCT01241318|466240325|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
129533020|NCT01241318|466240324|FG000|Overall Study|Woman: Stillborn infant|129|||
129533021|NCT01241318|466240325|FG001|Overall Study|Woman: Stillborn infant|146|||
129533022|NCT02728804|466240335|FG000|Overall Study|Ineligible|3|||
129533023|NCT02728804|466240335|FG000|Overall Study|Did not complete baseline questionnaire|9|||
129533024|NCT02728804|466240335|FG000|Overall Study|Death|99|||
129533025|NCT02551874|466242294|FG000|Overall Study|Lost to Follow-up|0|||
129533026|NCT02551874|466242295|FG001|Overall Study|Lost to Follow-up|2|||
129533027|NCT02551874|466242294|FG000|Overall Study|Pregnancy|0|||
129533028|NCT02551874|466242295|FG001|Overall Study|Pregnancy|1|||
129533029|NCT02551874|466242294|FG000|Overall Study|Reason not reported|10|||
129533030|NCT02551874|466242295|FG001|Overall Study|Reason not reported|4|||
129533031|NCT02551874|466242294|FG000|Overall Study|Did not receive randomized treatment|0|||
129533032|NCT02551874|466242295|FG001|Overall Study|Did not receive randomized treatment|7|||
129533033|NCT02551874|466242294|FG000|Overall Study|Did not enter long-term study|18|||
129533034|NCT02551874|466242295|FG001|Overall Study|Did not enter long-term study|25|||
129533035|NCT01640353|466242298|FG000|Overall Study|Withdrew prior to treatment|10|||
129533036|NCT01640353|466242298|FG000|Overall Study|Withdrawn from analysis at term site|12|||
129533037|NCT01640353|466242298|FG000|Overall Study|Withdrawal by Subject|5|||
129533038|NCT01640353|466242298|FG000|Overall Study|Death|2|||
129533039|NCT01640353|466242298|FG000|Overall Study|Early site termination|3|||
129533040|NCT01640353|466242298|FG000|Overall Study|Lost to Follow-up|12|||
129533041|NCT01640353|466242298|FG000|Overall Study|Physician Decision|1|||
129533042|NCT01524900|466242303|FG000|Overall Study|Lost to Follow-up|3|||
129533043|NCT01524900|466242304|FG001|Overall Study|Lost to Follow-up|12|||
129533044|NCT01524900|466242305|FG002|Overall Study|Lost to Follow-up|1|||
129533045|NCT01524900|466242306|FG003|Overall Study|Lost to Follow-up|0|||
129533046|NCT01524900|466242307|FG004|Overall Study|Lost to Follow-up|0|||
129533047|NCT01524900|466242303|FG000|Overall Study|Other reason than stated above|1|||
129533048|NCT01524900|466242304|FG001|Overall Study|Other reason than stated above|1|||
129533049|NCT01524900|466242305|FG002|Overall Study|Other reason than stated above|0|||
129533050|NCT01524900|466242306|FG003|Overall Study|Other reason than stated above|0|||
129533051|NCT01524900|466242307|FG004|Overall Study|Other reason than stated above|0|||
129533052|NCT01524900|466242303|FG000|Overall Study|No reason documented|2|||
129533053|NCT01524900|466242304|FG001|Overall Study|No reason documented|1|||
129533054|NCT01524900|466242305|FG002|Overall Study|No reason documented|0|||
129533055|NCT01524900|466242306|FG003|Overall Study|No reason documented|1|||
129533056|NCT01524900|466242307|FG004|Overall Study|No reason documented|0|||
129533057|NCT03758612|466242308|FG000|Washout Period|Withdrawal by Subject|0|||
129533058|NCT03758612|466242309|FG001|Washout Period|Withdrawal by Subject|0|||
129533059|NCT03758612|466242310|FG002|Washout Period|Withdrawal by Subject|2|||
129533060|NCT03758612|466242311|FG003|Washout Period|Withdrawal by Subject|0|||
129533061|NCT03758612|466242312|FG004|Washout Period|Withdrawal by Subject|0|||
129533062|NCT03758612|466242313|FG005|Washout Period|Withdrawal by Subject|0|||
129533063|NCT03758612|466242314|FG006|Washout Period|Withdrawal by Subject|0|||
129533064|NCT03758612|466242315|FG007|Washout Period|Withdrawal by Subject|0|||
129533065|NCT03758612|466242316|FG008|Washout Period|Withdrawal by Subject|0|||
129533066|NCT03758612|466242317|FG009|Washout Period|Withdrawal by Subject|0|||
129533067|NCT03758612|466242318|FG010|Washout Period|Withdrawal by Subject|0|||
129533068|NCT03758612|466242319|FG011|Washout Period|Withdrawal by Subject|0|||
129533069|NCT03758612|466242308|FG000|Period 2|Protocol Violation|0|||
129533070|NCT03758612|466242309|FG001|Period 2|Protocol Violation|0|||
129533071|NCT03758612|466242310|FG002|Period 2|Protocol Violation|0|||
129533072|NCT03758612|466242311|FG003|Period 2|Protocol Violation|0|||
129533073|NCT03758612|466242312|FG004|Period 2|Protocol Violation|1|||
129533074|NCT03758612|466242313|FG005|Period 2|Protocol Violation|0|||
129533075|NCT03758612|466242314|FG006|Period 2|Protocol Violation|0|||
129533076|NCT03758612|466242315|FG007|Period 2|Protocol Violation|0|||
129533077|NCT03758612|466242316|FG008|Period 2|Protocol Violation|0|||
129533078|NCT03758612|466242317|FG009|Period 2|Protocol Violation|0|||
129533079|NCT03758612|466242318|FG010|Period 2|Protocol Violation|0|||
129533080|NCT03758612|466242319|FG011|Period 2|Protocol Violation|0|||
129533081|NCT01603615|466242321|FG000|Overall Study|Did not Receive Treatment|7|||
129533082|NCT01603615|466242321|FG000|Overall Study|Lost to Follow-up|9|||
129533083|NCT01603615|466242321|FG000|Overall Study|Personal Reasons|17|||
129533084|NCT01603615|466242321|FG000|Overall Study|Other Miscellaneous|1|||
129533085|NCT03419741|466242322|FG000|Overall Study|Adverse Event|1|||
129533086|NCT03419741|466242323|FG001|Overall Study|Adverse Event|0|||
129533087|NCT03419741|466242322|FG000|Overall Study|Withdrawal by Subject|1|||
129533088|NCT03419741|466242323|FG001|Overall Study|Withdrawal by Subject|2|||
129533089|NCT04354870|466242324|FG000|Overall Study|Lost to Follow-up|32|||
129533090|NCT04354870|466242325|FG001|Overall Study|Lost to Follow-up|12|||
129533091|NCT04354870|466242324|FG000|Overall Study|Withdrawal by Subject|10|||
129533092|NCT04354870|466242325|FG001|Overall Study|Withdrawal by Subject|16|||
129533093|NCT04354870|466242324|FG000|Overall Study|Did not complete all study visits|6|||
129533094|NCT04354870|466242325|FG001|Overall Study|Did not complete all study visits|5|||
129533095|NCT03384316|466242326|FG000|Overall Study|Screen failure|0|||
129533096|NCT03384316|466242327|FG001|Overall Study|Screen failure|1|||
129533097|NCT02194699|466242338|FG000|Randomised|Did not receive treatment|1|||
129533098|NCT02194699|466242339|FG001|Randomised|Did not receive treatment|5|||
129533099|NCT02194699|466242338|FG000|Randomised|Without potential for 52 weeks of IP|5|||
129533100|NCT02194699|466242339|FG001|Randomised|Without potential for 52 weeks of IP|5|||
129533101|NCT02194699|466242338|FG000|Randomised|Duplicate patient|2|||
129533102|NCT02194699|466242339|FG001|Randomised|Duplicate patient|1|||
129533103|NCT02194699|466242338|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
129533104|NCT02194699|466242339|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
129533105|NCT02194699|466242338|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
129533106|NCT02194699|466242339|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
129533107|NCT02194699|466242338|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
129533108|NCT02194699|466242339|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
129533109|NCT02194699|466242338|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
129533110|NCT02194699|466242339|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
129533111|NCT02194699|466242338|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
129533112|NCT02194699|466242339|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
129533113|NCT02194699|466242338|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
129533114|NCT02194699|466242339|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
129533115|NCT00298766|466242340|FG000|Overall Study|Adverse Event|18|||
129533116|NCT00298766|466242340|FG000|Overall Study|Death|2|||
129533117|NCT00298766|466242340|FG000|Overall Study|Withdrawal by Subject|9|||
129533118|NCT00298766|466242340|FG000|Overall Study|Treatment ongoing|4|||
129533119|NCT00298766|466242340|FG000|Overall Study|Progression of amyloid markers|4|||
129533120|NCT00298766|466242340|FG000|Overall Study|Deterioration in KPS and organ function|1|||
129533121|NCT00298766|466242340|FG000|Overall Study|Subjects overall condition deterioration|4|||
129533122|NCT00298766|466242340|FG000|Overall Study|Other|4|||
129533123|NCT00386152|466242341|FG000|Overall Study|Adverse Event|6|||
129533124|NCT00386152|466242342|FG001|Overall Study|Adverse Event|5|||
129533125|NCT00386152|466242343|FG002|Overall Study|Adverse Event|4|||
129533126|NCT00386152|466242341|FG000|Overall Study|Chang from original chemo stratification|4|||
129533127|NCT00386152|466242342|FG001|Overall Study|Chang from original chemo stratification|5|||
129533128|NCT00386152|466242343|FG002|Overall Study|Chang from original chemo stratification|6|||
129533129|NCT00386152|466242341|FG000|Overall Study|Death|3|||
129533130|NCT00386152|466242342|FG001|Overall Study|Death|0|||
129533131|NCT00386152|466242343|FG002|Overall Study|Death|1|||
129533132|NCT00386152|466242341|FG000|Overall Study|Disease progression|7|||
129533133|NCT00386152|466242342|FG001|Overall Study|Disease progression|4|||
129533134|NCT00386152|466242343|FG002|Overall Study|Disease progression|5|||
129533135|NCT00386152|466242341|FG000|Overall Study|Physician Decision|13|||
129533136|NCT00386152|466242342|FG001|Overall Study|Physician Decision|10|||
129533137|NCT00386152|466242343|FG002|Overall Study|Physician Decision|4|||
129533138|NCT00386152|466242341|FG000|Overall Study|Lost to Follow-up|1|||
129533139|NCT00386152|466242342|FG001|Overall Study|Lost to Follow-up|0|||
129533140|NCT00386152|466242343|FG002|Overall Study|Lost to Follow-up|0|||
129533141|NCT00386152|466242341|FG000|Overall Study|Completed chemotherapy|4|||
129533142|NCT00386152|466242342|FG001|Overall Study|Completed chemotherapy|5|||
129533143|NCT00386152|466242343|FG002|Overall Study|Completed chemotherapy|1|||
129533144|NCT00386152|466242341|FG000|Overall Study|Protocol Violation|3|||
129533145|NCT00386152|466242342|FG001|Overall Study|Protocol Violation|5|||
129533146|NCT00386152|466242343|FG002|Overall Study|Protocol Violation|2|||
129533147|NCT00386152|466242341|FG000|Overall Study|Withdrawal by Subject|3|||
129533148|NCT00386152|466242342|FG001|Overall Study|Withdrawal by Subject|6|||
129533149|NCT00386152|466242343|FG002|Overall Study|Withdrawal by Subject|10|||
129533150|NCT01710709|466242353|FG000|Overall Study|Lost to Follow-up|29|||
129533151|NCT01710709|466242353|FG000|Overall Study|Adverse Event|48|||
129533152|NCT01710709|466242353|FG000|Overall Study|Participant met withdrawal criteria|33|||
129533153|NCT01710709|466242353|FG000|Overall Study|Participant withdrawn by investigator|2|||
129533154|NCT01710709|466242353|FG000|Overall Study|Withdrawal by Subject|53|||
129533155|NCT01710709|466242353|FG000|Overall Study|Protocol Violation|5|||
129533156|NCT01710709|466242353|FG000|Overall Study|Lack of Efficacy|3|||
129533157|NCT01398176|466242355|FG000|Overall Study|Lost to Follow-up|1|||
129533158|NCT01398176|466242356|FG001|Overall Study|Lost to Follow-up|3|||
129533159|NCT01398176|466242355|FG000|Overall Study|Physician Decision|2|||
129533160|NCT01398176|466242356|FG001|Overall Study|Physician Decision|3|||
129533161|NCT03007472|466242357|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
129533162|NCT03007472|466242357|FG000|Overall Study|Death|2|||
129533163|NCT03007472|466242357|FG000|Overall Study|Loss to Follow Up|1|||
129533164|NCT02988115|466242361|FG000|Overall Study|Adverse Event|6|||
129533165|NCT02988115|466242362|FG001|Overall Study|Adverse Event|1|||
129533166|NCT02988115|466242361|FG000|Overall Study|Sponsor Decision|5|||
129533167|NCT02988115|466242362|FG001|Overall Study|Sponsor Decision|2|||
129533168|NCT02988115|466242361|FG000|Overall Study|Withdrawal by Subject|1|||
129533169|NCT02988115|466242362|FG001|Overall Study|Withdrawal by Subject|1|||
129533170|NCT02988115|466242361|FG000|Overall Study|Withdrawn by Mistake|1|||
129533171|NCT02988115|466242362|FG001|Overall Study|Withdrawn by Mistake|0|||
129533172|NCT02988115|466242361|FG000|Overall Study|Lost to Follow-up|1|||
129533173|NCT02988115|466242362|FG001|Overall Study|Lost to Follow-up|0|||
129533174|NCT01731951|466242363|FG000|Overall Study|Documented Disease Progression|1|||
129533175|NCT01731951|466242364|FG001|Overall Study|Documented Disease Progression|0|||
129533176|NCT01731951|466242365|FG002|Overall Study|Documented Disease Progression|0|||
129533177|NCT01731951|466242366|FG003|Overall Study|Documented Disease Progression|0|||
129533178|NCT01731951|466242367|FG004|Overall Study|Documented Disease Progression|0|||
129533179|NCT01731951|466242368|FG005|Overall Study|Documented Disease Progression|0|||
129533180|NCT01731951|466242363|FG000|Overall Study|Lost to Follow-up|2|||
129533181|NCT01731951|466242364|FG001|Overall Study|Lost to Follow-up|0|||
129533182|NCT01731951|466242365|FG002|Overall Study|Lost to Follow-up|0|||
129533183|NCT01731951|466242366|FG003|Overall Study|Lost to Follow-up|1|||
129533184|NCT01731951|466242367|FG004|Overall Study|Lost to Follow-up|3|||
129533185|NCT01731951|466242368|FG005|Overall Study|Lost to Follow-up|1|||
129533186|NCT01731951|466242363|FG000|Overall Study|Withdrawal of Consent|1|||
129533187|NCT01731951|466242364|FG001|Overall Study|Withdrawal of Consent|0|||
129533188|NCT01731951|466242365|FG002|Overall Study|Withdrawal of Consent|0|||
129533189|NCT01731951|466242366|FG003|Overall Study|Withdrawal of Consent|0|||
129533190|NCT01731951|466242367|FG004|Overall Study|Withdrawal of Consent|0|||
129533191|NCT01731951|466242368|FG005|Overall Study|Withdrawal of Consent|2|||
129533192|NCT01731951|466242363|FG000|Overall Study|Death|13|||
129533193|NCT01731951|466242364|FG001|Overall Study|Death|15|||
129533194|NCT01731951|466242365|FG002|Overall Study|Death|9|||
129533195|NCT01731951|466242366|FG003|Overall Study|Death|8|||
129533196|NCT01731951|466242367|FG004|Overall Study|Death|9|||
129533197|NCT01731951|466242368|FG005|Overall Study|Death|6|||
129533198|NCT01977651|466242375|FG000|4 Month Treatment Period|Adverse Event|34|||
129533199|NCT01977651|466242375|FG000|4 Month Treatment Period|Death|3|||
129533200|NCT01977651|466242375|FG000|4 Month Treatment Period|Progressive Disease|43|||
129533201|NCT01977651|466242375|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
129533202|NCT01977651|466242375|FG000|4 Month Treatment Period|Physician Decision|4|||
129533203|NCT01977651|466242375|FG000|1 Year Extension Period|Adverse Event|14|||
129533204|NCT01977651|466242375|FG000|1 Year Extension Period|Death|10|||
129533205|NCT01977651|466242375|FG000|1 Year Extension Period|Lost to Follow-up|2|||
129533206|NCT01977651|466242375|FG000|1 Year Extension Period|Progressive Disease|86|||
129533207|NCT01977651|466242375|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
129533208|NCT01977651|466242375|FG000|1 Year Extension Period|Physician Decision|6|||
129533209|NCT01977651|466242375|FG000|1 Year Extension Period|Miscellaneous|1|||
129533210|NCT01977651|466242375|FG000|Post 1 Year Extension Period|Adverse Event|5|||
129533211|NCT01977651|466242375|FG000|Post 1 Year Extension Period|Death|13|||
129533212|NCT01977651|466242375|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
129533213|NCT01977651|466242375|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
129533214|NCT01977651|466242375|FG000|Post 1 Year Extension Period|Physician Decision|4|||
129533215|NCT01977651|466242375|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
129533216|NCT03287089|466242376|FG000|Overall Study|Lost to Follow-up|0|||
129533217|NCT03287089|466242377|FG001|Overall Study|Lost to Follow-up|2|||
129533218|NCT03287089|466242376|FG000|Overall Study|Physician Decision|0|||
129533219|NCT03287089|466242377|FG001|Overall Study|Physician Decision|2|||
129533220|NCT03287089|466242376|FG000|Overall Study|Withdrawal by Subject|0|||
129533221|NCT03287089|466242377|FG001|Overall Study|Withdrawal by Subject|2|||
129533222|NCT00661362|466242378|FG000|Overall Study|Adverse Event|5|||
129533223|NCT00661362|466242379|FG001|Overall Study|Adverse Event|4|||
129533224|NCT00661362|466242378|FG000|Overall Study|Incorrect enrollment|2|||
129533225|NCT00661362|466242379|FG001|Overall Study|Incorrect enrollment|0|||
129533226|NCT00661362|466242378|FG000|Overall Study|Study specific discontinuation criteria|4|||
129533227|NCT00661362|466242379|FG001|Overall Study|Study specific discontinuation criteria|11|||
129533228|NCT00661362|466242378|FG000|Overall Study|Withdrawal by Subject|13|||
129533229|NCT00661362|466242379|FG001|Overall Study|Withdrawal by Subject|23|||
129533230|NCT00661362|466242378|FG000|Overall Study|Lost to Follow-up|3|||
129533231|NCT00661362|466242379|FG001|Overall Study|Lost to Follow-up|1|||
129533232|NCT00661362|466242378|FG000|Overall Study|Severe non-compliance to protocol|0|||
129533233|NCT00661362|466242379|FG001|Overall Study|Severe non-compliance to protocol|1|||
129533234|NCT00661362|466242378|FG000|Overall Study|Safety reasons|1|||
129533235|NCT00661362|466242379|FG001|Overall Study|Safety reasons|0|||
129533236|NCT00661362|466242378|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
129533237|NCT00661362|466242379|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
129533238|NCT00775138|466242380|FG000|Overall Study|Withdrawal by Subject|0|||
129533239|NCT00775138|466242381|FG001|Overall Study|Withdrawal by Subject|0|||
129533240|NCT00775138|466242382|FG002|Overall Study|Withdrawal by Subject|2|||
129533241|NCT00775138|466242383|FG003|Overall Study|Withdrawal by Subject|2|||
129533242|NCT00775138|466242380|FG000|Overall Study|Adverse Event|0|||
129533243|NCT00775138|466242381|FG001|Overall Study|Adverse Event|0|||
129533244|NCT00775138|466242382|FG002|Overall Study|Adverse Event|1|||
129533245|NCT00775138|466242383|FG003|Overall Study|Adverse Event|0|||
129533246|NCT04880642|466242384|FG000|Randomization|Withdrawal by Subject|2|||
129533247|NCT04880642|466242385|FG001|Randomization|Withdrawal by Subject|3|||
129533248|NCT04880642|466242384|FG000|Treatment Period|Adverse Event|0|||
129533249|NCT04880642|466242385|FG001|Treatment Period|Adverse Event|1|||
129533250|NCT04880642|466242384|FG000|Treatment Period|Death|6|||
129533251|NCT04880642|466242385|FG001|Treatment Period|Death|6|||
129533252|NCT04880642|466242384|FG000|Treatment Period|Lost to Follow-up|1|||
129533253|NCT04880642|466242385|FG001|Treatment Period|Lost to Follow-up|0|||
129533254|NCT04880642|466242384|FG000|Treatment Period|Protocol Violation|0|||
129533255|NCT04880642|466242385|FG001|Treatment Period|Protocol Violation|1|||
129533256|NCT04880642|466242384|FG000|Treatment Period|Withdrawal by Subject|5|||
129533257|NCT04880642|466242385|FG001|Treatment Period|Withdrawal by Subject|3|||
129533258|NCT04880642|466242384|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
129533259|NCT04880642|466242385|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
129533260|NCT04880642|466242384|FG000|Follow-up|Death|4|||
129533261|NCT04880642|466242385|FG001|Follow-up|Death|3|||
129533262|NCT04880642|466242384|FG000|Follow-up|Withdrawal by Subject|1|||
129533263|NCT04880642|466242385|FG001|Follow-up|Withdrawal by Subject|0|||
129533264|NCT00104299|466242386|FG000|Overall Study|Adverse Event|3|||
129533265|NCT00104299|466242387|FG001|Overall Study|Adverse Event|1|||
129533266|NCT00104299|466242386|FG000|Overall Study|Death|2|||
129533267|NCT00104299|466242387|FG001|Overall Study|Death|2|||
129533268|NCT00104299|466242386|FG000|Overall Study|Withdrawal by Subject|2|||
129533269|NCT00104299|466242387|FG001|Overall Study|Withdrawal by Subject|6|||
129533270|NCT00104299|466242386|FG000|Overall Study|Physician Decision|1|||
129533271|NCT00104299|466242387|FG001|Overall Study|Physician Decision|1|||
129533272|NCT00104299|466242386|FG000|Overall Study|To have renal transplant|1|||
129533273|NCT00104299|466242387|FG001|Overall Study|To have renal transplant|0|||
129533274|NCT02906644|466242388|FG000|First 2 Weeks|Withdrawal by Subject|0|||
129533275|NCT02906644|466242389|FG001|First 2 Weeks|Withdrawal by Subject|2|||
129533276|NCT02906644|466242388|FG000|First 2 Weeks|Physician Decision|1|||
129533277|NCT02906644|466242389|FG001|First 2 Weeks|Physician Decision|1|||
129533278|NCT02906644|466242388|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
129533279|NCT02906644|466242389|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
129533280|NCT02906644|466242388|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
129533281|NCT02906644|466242389|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
129533282|NCT02452034|466242390|FG000|Overall Study|Adverse Event|0|||
129533283|NCT02452034|466242391|FG001|Overall Study|Adverse Event|0|||
129533284|NCT02452034|466242392|FG002|Overall Study|Adverse Event|0|||
129533285|NCT02452034|466242393|FG003|Overall Study|Adverse Event|0|||
129533286|NCT02452034|466242394|FG004|Overall Study|Adverse Event|0|||
129533287|NCT02452034|466242395|FG005|Overall Study|Adverse Event|1|||
129533288|NCT02452034|466242390|FG000|Overall Study|Death|0|||
129533289|NCT02452034|466242391|FG001|Overall Study|Death|0|||
129533290|NCT02452034|466242392|FG002|Overall Study|Death|0|||
129533291|NCT02452034|466242393|FG003|Overall Study|Death|0|||
129533292|NCT02452034|466242394|FG004|Overall Study|Death|1|||
129533293|NCT02452034|466242395|FG005|Overall Study|Death|1|||
129533294|NCT02452034|466242390|FG000|Overall Study|Physician Decision|0|||
129533295|NCT02452034|466242391|FG001|Overall Study|Physician Decision|1|||
129533296|NCT02452034|466242392|FG002|Overall Study|Physician Decision|1|||
129533297|NCT02452034|466242393|FG003|Overall Study|Physician Decision|0|||
129533298|NCT02452034|466242394|FG004|Overall Study|Physician Decision|0|||
129533299|NCT02452034|466242395|FG005|Overall Study|Physician Decision|0|||
129533300|NCT02452034|466242390|FG000|Overall Study|Protocol Violation|0|||
129533301|NCT02452034|466242391|FG001|Overall Study|Protocol Violation|0|||
129533302|NCT02452034|466242392|FG002|Overall Study|Protocol Violation|0|||
129533303|NCT02452034|466242393|FG003|Overall Study|Protocol Violation|0|||
129533304|NCT02452034|466242394|FG004|Overall Study|Protocol Violation|0|||
129533305|NCT02452034|466242395|FG005|Overall Study|Protocol Violation|1|||
129533306|NCT02452034|466242390|FG000|Overall Study|Screen Failure|1|||
129533307|NCT02452034|466242391|FG001|Overall Study|Screen Failure|0|||
129533308|NCT02452034|466242392|FG002|Overall Study|Screen Failure|0|||
129533309|NCT02452034|466242393|FG003|Overall Study|Screen Failure|1|||
129533310|NCT02452034|466242394|FG004|Overall Study|Screen Failure|0|||
129533311|NCT02452034|466242395|FG005|Overall Study|Screen Failure|0|||
129533312|NCT02452034|466242390|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
129533313|NCT02452034|466242391|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
129533314|NCT02452034|466242392|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
129533315|NCT02452034|466242393|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
129538906|NCT01238861|466265107|FG000|Overall Study|Lost to Follow-up|4|||
129533316|NCT02452034|466242394|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
129533317|NCT02452034|466242395|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
129533318|NCT00561795|466242396|FG000|Overall Study|Adverse Event|3|||
129533319|NCT00561795|466242397|FG001|Overall Study|Adverse Event|3|||
129533320|NCT00561795|466242398|FG002|Overall Study|Adverse Event|0|||
129533321|NCT00561795|466242399|FG003|Overall Study|Adverse Event|0|||
129533322|NCT00561795|466242396|FG000|Overall Study|Study Closed/Terminated|0|||
129533323|NCT00561795|466242397|FG001|Overall Study|Study Closed/Terminated|3|||
129533324|NCT00561795|466242398|FG002|Overall Study|Study Closed/Terminated|0|||
129533325|NCT00561795|466242399|FG003|Overall Study|Study Closed/Terminated|0|||
129533326|NCT00561795|466242396|FG000|Overall Study|Physician Decision|1|||
129533327|NCT00561795|466242397|FG001|Overall Study|Physician Decision|0|||
129533328|NCT00561795|466242398|FG002|Overall Study|Physician Decision|0|||
129533329|NCT00561795|466242399|FG003|Overall Study|Physician Decision|0|||
129533330|NCT03672006|466242401|FG000|Overall Study|exclusion criteria met|0|||
129533331|NCT03672006|466242402|FG001|Overall Study|exclusion criteria met|1|||
129533332|NCT01453439|466242403|FG000|Treatment Phase|Withdrawal by Subject|13|||
129533333|NCT01453439|466242404|FG001|Treatment Phase|Withdrawal by Subject|10|||
129533334|NCT01453439|466242403|FG000|Treatment Phase|Suicidal Ideation|2|||
129533335|NCT01453439|466242404|FG001|Treatment Phase|Suicidal Ideation|0|||
129533336|NCT01453439|466242403|FG000|Treatment Phase|Need for higher level of care|1|||
129533337|NCT01453439|466242404|FG001|Treatment Phase|Need for higher level of care|1|||
129533338|NCT01453439|466242403|FG000|Treatment Phase|Therapist conflict of interest|1|||
129533339|NCT01453439|466242404|FG001|Treatment Phase|Therapist conflict of interest|0|||
129533340|NCT01453439|466242403|FG000|Follow-up|Withdrawal by Subject|0|||
129533341|NCT01453439|466242404|FG001|Follow-up|Withdrawal by Subject|1|||
129533342|NCT01453439|466242403|FG000|Follow-up|Lost to Follow-up|5|||
129533343|NCT01453439|466242404|FG001|Follow-up|Lost to Follow-up|10|||
129533344|NCT02135848|466242410|FG000|Overall Study|Adverse Event|2|||
129533345|NCT02135848|466242411|FG001|Overall Study|Adverse Event|0|||
129533346|NCT02135848|466242410|FG000|Overall Study|Withdrawal by Subject|1|||
129533347|NCT02135848|466242411|FG001|Overall Study|Withdrawal by Subject|1|||
129533348|NCT00089505|466242412|FG000|Overall Study|Death|4|||
129533349|NCT00089505|466242413|FG001|Overall Study|Death|1|||
129533350|NCT00089505|466242414|FG002|Overall Study|Death|5|||
129533351|NCT00089505|466242415|FG003|Overall Study|Death|8|||
129533352|NCT00089505|466242412|FG000|Overall Study|Withdrawal by Subject|3|||
129533353|NCT00089505|466242413|FG001|Overall Study|Withdrawal by Subject|0|||
129533354|NCT00089505|466242414|FG002|Overall Study|Withdrawal by Subject|6|||
129533355|NCT00089505|466242415|FG003|Overall Study|Withdrawal by Subject|6|||
129533356|NCT00089505|466242412|FG000|Overall Study|Lost to Follow-up|1|||
129533357|NCT00089505|466242413|FG001|Overall Study|Lost to Follow-up|1|||
129533358|NCT00089505|466242414|FG002|Overall Study|Lost to Follow-up|9|||
129533359|NCT00089505|466242415|FG003|Overall Study|Lost to Follow-up|7|||
129533360|NCT00089505|466242412|FG000|Overall Study|Physician Decision|1|||
129533361|NCT00089505|466242413|FG001|Overall Study|Physician Decision|0|||
129533362|NCT00089505|466242414|FG002|Overall Study|Physician Decision|0|||
129533363|NCT00089505|466242415|FG003|Overall Study|Physician Decision|0|||
129533364|NCT00089505|466242412|FG000|Overall Study|Protocol Violation|0|||
129533365|NCT00089505|466242413|FG001|Overall Study|Protocol Violation|0|||
129533366|NCT00089505|466242414|FG002|Overall Study|Protocol Violation|1|||
129533367|NCT00089505|466242415|FG003|Overall Study|Protocol Violation|0|||
129533368|NCT01646255|466242420|FG000|Overall Study|Adverse Event|7|||
129533369|NCT01646255|466242421|FG001|Overall Study|Adverse Event|8|||
129533370|NCT01646255|466242420|FG000|Overall Study|Lack of Efficacy|2|||
129533371|NCT01646255|466242421|FG001|Overall Study|Lack of Efficacy|0|||
129533372|NCT01646255|466242420|FG000|Overall Study|Withdrawal by Subject|10|||
129533373|NCT01646255|466242421|FG001|Overall Study|Withdrawal by Subject|6|||
129533374|NCT01646255|466242420|FG000|Overall Study|Compliance is not well|1|||
129533375|NCT01646255|466242421|FG001|Overall Study|Compliance is not well|0|||
129533376|NCT01646255|466242420|FG000|Overall Study|Inclusion Criteria Deviation|1|||
129533377|NCT01646255|466242421|FG001|Overall Study|Inclusion Criteria Deviation|0|||
129533378|NCT03480841|466242424|FG000|Overall Study|Lost to Follow-up|2|||
129533379|NCT00266695|466242425|FG000|Overall Study|Adverse Event|1|||
129533380|NCT00266695|466242425|FG000|Overall Study|Death|9|||
129533381|NCT00266695|466242425|FG000|Overall Study|Physician Decision|1|||
129533382|NCT00266695|466242425|FG000|Overall Study|Lost to Follow-up|3|||
129533383|NCT00266695|466242425|FG000|Overall Study|Withdrawal by Subject|15|||
129533384|NCT02380703|466242426|FG000|Overall Study|Withdrawal by Subject|12|||
129533385|NCT02380703|466242427|FG001|Overall Study|Withdrawal by Subject|9|||
129533386|NCT02380703|466242426|FG000|Overall Study|Lost to Follow-up|12|||
129533387|NCT02380703|466242427|FG001|Overall Study|Lost to Follow-up|12|||
129533388|NCT02380703|466242426|FG000|Overall Study|Caregiver death|1|||
129533389|NCT02380703|466242427|FG001|Overall Study|Caregiver death|0|||
129533390|NCT02380703|466242426|FG000|Overall Study|Person with dementia (PWD) death|7|||
129533391|NCT02380703|466242427|FG001|Overall Study|Person with dementia (PWD) death|8|||
129533392|NCT02380703|466242426|FG000|Overall Study|Entered Long-term Care|4|||
129533393|NCT02380703|466242427|FG001|Overall Study|Entered Long-term Care|7|||
129533394|NCT01362049|466242428|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
129533395|NCT01362049|466242429|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
129533396|NCT01362049|466242430|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
129533397|NCT01362049|466242431|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
129533398|NCT01362049|466242428|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
129533399|NCT01362049|466242429|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
129533400|NCT01362049|466242430|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
129533401|NCT01362049|466242431|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
129533402|NCT03607994|466242432|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
129533403|NCT03607994|466242433|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
129533404|NCT02417935|466242434|FG000|Treatment Period|Adverse Event|12|||
129533405|NCT02417935|466242435|FG001|Treatment Period|Adverse Event|10|||
129533406|NCT02417935|466242434|FG000|Treatment Period|Lost to Follow-up|1|||
129533407|NCT02417935|466242435|FG001|Treatment Period|Lost to Follow-up|0|||
129533408|NCT02417935|466242434|FG000|Treatment Period|Entry Criteria not met|0|||
129533409|NCT02417935|466242435|FG001|Treatment Period|Entry Criteria not met|1|||
129533410|NCT02417935|466242434|FG000|Treatment Period|Protocol Violation|2|||
129533411|NCT02417935|466242435|FG001|Treatment Period|Protocol Violation|1|||
129533412|NCT02417935|466242434|FG000|Treatment Period|Withdrawal by Subject|3|||
129533413|NCT02417935|466242435|FG001|Treatment Period|Withdrawal by Subject|3|||
129533414|NCT02417935|466242434|FG000|Treatment Period|Physician Decision|3|||
129533415|NCT02417935|466242435|FG001|Treatment Period|Physician Decision|1|||
129533416|NCT02850276|466242440|FG000|Overall Study|screen failure|43|||
129533417|NCT02850276|466242440|FG000|Overall Study|Withdrawal by Subject|14|||
129533418|NCT02850276|466242440|FG000|Overall Study|Physician Decision|2|||
129533419|NCT02850276|466242440|FG000|Overall Study|Lost to Follow-up|2|||
129533420|NCT01454531|466242443|FG000|Overall Study|Adverse Event|14|||
129533421|NCT01454531|466242443|FG000|Overall Study|Withdrawal by Subject|5|||
129533422|NCT01454531|466242443|FG000|Overall Study|Lost to Follow-up|1|||
129533423|NCT01454531|466242443|FG000|Overall Study|Physician Decision|1|||
129533424|NCT01454531|466242443|FG000|Overall Study|Delay in IMP administration|1|||
129533425|NCT01454531|466242443|FG000|Overall Study|Other|1|||
129533426|NCT02504424|466242448|FG000|Overall Study|Withdrawal by Subject|2|||
129533427|NCT00440232|466242449|FG000|Overall Study|Lost to Follow-up|1|||
129533428|NCT00440232|466242450|FG001|Overall Study|Lost to Follow-up|1|||
129533429|NCT00440232|466242449|FG000|Overall Study|Unable to treat within allowed time|0|||
129533430|NCT00440232|466242450|FG001|Overall Study|Unable to treat within allowed time|1|||
129533431|NCT00440232|466242449|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
129533432|NCT00440232|466242450|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
129533433|NCT00819052|466242451|FG000|Overall Study|Adverse Event|0|||
129533434|NCT00819052|466242452|FG001|Overall Study|Adverse Event|5|||
129533435|NCT00819052|466242451|FG000|Overall Study|Protocol Violation|1|||
129533436|NCT00819052|466242452|FG001|Overall Study|Protocol Violation|2|||
129533437|NCT00819052|466242451|FG000|Overall Study|Lost to Follow-up|1|||
129533438|NCT00819052|466242452|FG001|Overall Study|Lost to Follow-up|2|||
129533439|NCT00819052|466242451|FG000|Overall Study|Withdrawal by Subject|1|||
129533440|NCT00819052|466242452|FG001|Overall Study|Withdrawal by Subject|2|||
129533441|NCT00819052|466242451|FG000|Overall Study|Lack of Efficacy|1|||
129533442|NCT00819052|466242452|FG001|Overall Study|Lack of Efficacy|1|||
129533443|NCT00819052|466242451|FG000|Overall Study|Pregnancy|1|||
129533444|NCT00819052|466242452|FG001|Overall Study|Pregnancy|2|||
129533445|NCT00819052|466242451|FG000|Overall Study|Death or events leading to death|1|||
129533446|NCT00819052|466242452|FG001|Overall Study|Death or events leading to death|0|||
129533447|NCT00426842|466242453|FG000|Overall Study|Lost to Follow-up|1|||
129533448|NCT00362297|466242454|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
129533449|NCT00362297|466242455|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
129533450|NCT01277666|466242460|FG000|Overall Study|Adverse Event|26|||
129533451|NCT01277666|466242461|FG001|Overall Study|Adverse Event|25|||
129533452|NCT01277666|466242462|FG002|Overall Study|Adverse Event|20|||
129533453|NCT01277666|466242460|FG000|Overall Study|Lack of Efficacy|8|||
129533454|NCT01277666|466242461|FG001|Overall Study|Lack of Efficacy|20|||
129533455|NCT01277666|466242462|FG002|Overall Study|Lack of Efficacy|12|||
129533456|NCT01277666|466242460|FG000|Overall Study|Protocol Violation|2|||
129533457|NCT01277666|466242461|FG001|Overall Study|Protocol Violation|3|||
129533458|NCT01277666|466242462|FG002|Overall Study|Protocol Violation|2|||
129533459|NCT01277666|466242460|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
129533460|NCT01277666|466242461|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
129533461|NCT01277666|466242462|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
129533462|NCT01277666|466242460|FG000|Overall Study|Lost to Follow-up|1|||
129533463|NCT01277666|466242461|FG001|Overall Study|Lost to Follow-up|1|||
129533464|NCT01277666|466242462|FG002|Overall Study|Lost to Follow-up|2|||
129533465|NCT01277666|466242460|FG000|Overall Study|Withdrawal by Subject|7|||
129533466|NCT01277666|466242461|FG001|Overall Study|Withdrawal by Subject|8|||
129533467|NCT01277666|466242462|FG002|Overall Study|Withdrawal by Subject|6|||
129533468|NCT01277666|466242460|FG000|Overall Study|Death|0|||
129533469|NCT01277666|466242461|FG001|Overall Study|Death|0|||
129533470|NCT01277666|466242462|FG002|Overall Study|Death|1|||
129533471|NCT01747655|466242463|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
129533472|NCT01747655|466242464|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
129533473|NCT01747655|466242463|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
129533474|NCT01747655|466242464|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
129533475|NCT01747655|466242463|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
129533476|NCT01747655|466242464|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
129533477|NCT00982111|466242465|FG000|Overall Study|Adverse Event|1|||
129533478|NCT00982111|466242466|FG001|Overall Study|Adverse Event|1|||
129533479|NCT00982111|466242465|FG000|Overall Study|Progressive Disease|46|||
129533480|NCT00982111|466242466|FG001|Overall Study|Progressive Disease|39|||
129533481|NCT00982111|466242465|FG000|Overall Study|Lost to Follow-up|9|||
129533482|NCT00982111|466242466|FG001|Overall Study|Lost to Follow-up|6|||
129533483|NCT00982111|466242465|FG000|Overall Study|New Anti-Cancer Therapy|5|||
129533484|NCT00982111|466242466|FG001|Overall Study|New Anti-Cancer Therapy|5|||
129533485|NCT00982111|466242465|FG000|Overall Study|Medical Decision|1|||
129533486|NCT00982111|466242466|FG001|Overall Study|Medical Decision|0|||
129533487|NCT00982111|466242465|FG000|Overall Study|Withdrawal by Subject|17|||
129533488|NCT00982111|466242466|FG001|Overall Study|Withdrawal by Subject|19|||
129533489|NCT00982111|466242465|FG000|Overall Study|Global Study End|0|||
129533490|NCT00982111|466242466|FG001|Overall Study|Global Study End|1|||
129533491|NCT00982111|466242465|FG000|Overall Study|Sponsor's Decision|0|||
129533492|NCT00982111|466242466|FG001|Overall Study|Sponsor's Decision|1|||
129533493|NCT01070381|466242467|FG000|Period 2, 1 Week of Wear|Handling|0|||
129533494|NCT01070381|466242468|FG001|Period 2, 1 Week of Wear|Handling|1|||
129533495|NCT01070381|466242467|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
129533496|NCT01070381|466242468|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
129533497|NCT03512028|466242470|FG000|Overall Study|Withdrawal by Subject|2|||
129533498|NCT03512028|466242471|FG001|Overall Study|Withdrawal by Subject|0|||
129533499|NCT03512028|466242470|FG000|Overall Study|Protocol Violation|2|||
129533500|NCT03512028|466242471|FG001|Overall Study|Protocol Violation|0|||
129533501|NCT01259388|466242472|FG000|Overall Study|Adverse Event|3|||
129533502|NCT01259388|466242473|FG001|Overall Study|Adverse Event|0|||
129533503|NCT01259388|466242472|FG000|Overall Study|Withdrawal by Subject|1|||
129533504|NCT01259388|466242473|FG001|Overall Study|Withdrawal by Subject|1|||
129533505|NCT01259388|466242472|FG000|Overall Study|Physician Decision|1|||
129533506|NCT01259388|466242473|FG001|Overall Study|Physician Decision|0|||
129533507|NCT02743494|466242476|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
129533508|NCT02743494|466242477|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
129533509|NCT02743494|466242476|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
129533510|NCT02743494|466242477|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
129533511|NCT02743494|466242476|FG000|Treatment Period|Completed treatment|229|||
129533512|NCT02743494|466242477|FG001|Treatment Period|Completed treatment|99|||
129533513|NCT02743494|466242476|FG000|Treatment Period|Disease recurrence|149|||
129533514|NCT02743494|466242477|FG001|Treatment Period|Disease recurrence|113|||
129533515|NCT02743494|466242476|FG000|Treatment Period|Study drug toxicity|57|||
129533516|NCT02743494|466242477|FG001|Treatment Period|Study drug toxicity|8|||
129533517|NCT02743494|466242476|FG000|Treatment Period|Death|1|||
129533518|NCT02743494|466242477|FG001|Treatment Period|Death|0|||
129533519|NCT02743494|466242476|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
129533520|NCT02743494|466242477|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
129533521|NCT02743494|466242476|FG000|Treatment Period|Participant request to discontinue treatment|30|||
129533522|NCT02743494|466242477|FG001|Treatment Period|Participant request to discontinue treatment|5|||
129533523|NCT02743494|466242476|FG000|Treatment Period|Participant withdrew consent|12|||
129533524|NCT02743494|466242477|FG001|Treatment Period|Participant withdrew consent|4|||
129533525|NCT02743494|466242476|FG000|Treatment Period|Lost to Follow-up|0|||
129533526|NCT02743494|466242477|FG001|Treatment Period|Lost to Follow-up|1|||
129533527|NCT02743494|466242476|FG000|Treatment Period|Poor/Non-compliance|1|||
129533528|NCT02743494|466242477|FG001|Treatment Period|Poor/Non-compliance|0|||
129533529|NCT02743494|466242476|FG000|Treatment Period|Other reasons|7|||
129533530|NCT02743494|466242477|FG001|Treatment Period|Other reasons|2|||
129533531|NCT03529162|466242478|FG000|Overall Study|Lost to Follow-up|2|||
129533532|NCT03529162|466242479|FG001|Overall Study|Lost to Follow-up|2|||
129533533|NCT00983827|466242480|FG000|Overall Study|Withdrawal by Subject|1|||
129533534|NCT01521494|466242481|FG000|Overall Study|Adverse Event|1|||
129533535|NCT01521494|466242482|FG001|Overall Study|Adverse Event|2|||
129533536|NCT01521494|466242483|FG002|Overall Study|Adverse Event|9|||
129533537|NCT01521494|466242484|FG003|Overall Study|Adverse Event|6|||
129533538|NCT01521494|466242485|FG004|Overall Study|Adverse Event|2|||
129533539|NCT01521494|466242481|FG000|Overall Study|Lack of Efficacy|0|||
129533540|NCT01521494|466242482|FG001|Overall Study|Lack of Efficacy|0|||
129533541|NCT01521494|466242483|FG002|Overall Study|Lack of Efficacy|0|||
129533542|NCT01521494|466242484|FG003|Overall Study|Lack of Efficacy|0|||
129533543|NCT01521494|466242485|FG004|Overall Study|Lack of Efficacy|2|||
129533544|NCT01521494|466242481|FG000|Overall Study|Withdrawal by Subject|1|||
129533545|NCT01521494|466242482|FG001|Overall Study|Withdrawal by Subject|1|||
129533546|NCT01521494|466242483|FG002|Overall Study|Withdrawal by Subject|0|||
129533547|NCT01521494|466242484|FG003|Overall Study|Withdrawal by Subject|2|||
129533548|NCT01521494|466242485|FG004|Overall Study|Withdrawal by Subject|0|||
129533549|NCT01521494|466242481|FG000|Overall Study|Decrease in serum phosphate|0|||
129533550|NCT01521494|466242482|FG001|Overall Study|Decrease in serum phosphate|2|||
129533551|NCT01521494|466242483|FG002|Overall Study|Decrease in serum phosphate|3|||
129533552|NCT01521494|466242484|FG003|Overall Study|Decrease in serum phosphate|12|||
129533553|NCT01521494|466242485|FG004|Overall Study|Decrease in serum phosphate|0|||
129533554|NCT01521494|466242481|FG000|Overall Study|Decrease in serum calcium|0|||
129533555|NCT01521494|466242482|FG001|Overall Study|Decrease in serum calcium|0|||
129533556|NCT01521494|466242483|FG002|Overall Study|Decrease in serum calcium|0|||
129533557|NCT01521494|466242484|FG003|Overall Study|Decrease in serum calcium|1|||
129533558|NCT01521494|466242485|FG004|Overall Study|Decrease in serum calcium|1|||
129533559|NCT01521494|466242481|FG000|Overall Study|Physician Decision|0|||
129533560|NCT01521494|466242482|FG001|Overall Study|Physician Decision|0|||
129533561|NCT01521494|466242483|FG002|Overall Study|Physician Decision|0|||
129533562|NCT01521494|466242484|FG003|Overall Study|Physician Decision|0|||
129533563|NCT01521494|466242485|FG004|Overall Study|Physician Decision|2|||
129533564|NCT01854918|466242488|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
129533565|NCT01854918|466242489|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
129533566|NCT01854918|466242488|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
129533567|NCT01854918|466242489|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
129533568|NCT01854918|466242488|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
129533569|NCT01854918|466242489|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
129533570|NCT01854918|466242488|FG000|SOC-controlled Period (Year 1)|Death|5|||
129533571|NCT01854918|466242489|FG001|SOC-controlled Period (Year 1)|Death|5|||
129533572|NCT01854918|466242488|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
129533573|NCT01854918|466242489|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
129533574|NCT01854918|466242488|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
129533575|NCT01854918|466242489|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
129533576|NCT01854918|466242488|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
129533577|NCT01854918|466242489|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
129533578|NCT01854918|466242488|FG000|All-IP Period (Years 2 and 3)|Death|5|||
129533579|NCT01854918|466242489|FG001|All-IP Period (Years 2 and 3)|Death|16|||
129533580|NCT02146352|466242490|FG000|Overall Study|Death|1|||
129533581|NCT02146352|466242490|FG000|Overall Study|Patient entered hospice care|1|||
129533582|NCT00939094|466242491|FG000|Overall Study|Adverse Event|9|||
129533583|NCT00939094|466242492|FG001|Overall Study|Adverse Event|0|||
129533584|NCT00939094|466242491|FG000|Overall Study|Withdrawal by Subject|1|||
129533585|NCT00939094|466242492|FG001|Overall Study|Withdrawal by Subject|6|||
129533586|NCT00939094|466242491|FG000|Overall Study|Lost to Follow-up|1|||
129533587|NCT00939094|466242492|FG001|Overall Study|Lost to Follow-up|1|||
129533588|NCT00939094|466242491|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
129533589|NCT00939094|466242492|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
129533590|NCT00939094|466242491|FG000|Overall Study|Severe non-compliance to protocol|0|||
129533591|NCT00939094|466242492|FG001|Overall Study|Severe non-compliance to protocol|1|||
129533592|NCT00939094|466242491|FG000|Overall Study|Study stopped by sponsor|0|||
129533593|NCT00939094|466242492|FG001|Overall Study|Study stopped by sponsor|2|||
129533594|NCT00939094|466242491|FG000|Overall Study|Abnormal ECG findings|1|||
129533595|NCT00939094|466242492|FG001|Overall Study|Abnormal ECG findings|0|||
129533596|NCT01906489|466242493|FG000|Overall Study|Adverse Event|10|||
129533597|NCT01906489|466242494|FG001|Overall Study|Adverse Event|3|||
129533598|NCT01906489|466242493|FG000|Overall Study|Worsening of CKD|6|||
129533599|NCT01906489|466242494|FG001|Overall Study|Worsening of CKD|4|||
129533600|NCT01906489|466242493|FG000|Overall Study|Withdrawal by Subject|5|||
129533601|NCT01906489|466242494|FG001|Overall Study|Withdrawal by Subject|0|||
129533602|NCT01906489|466242493|FG000|Overall Study|Worsening of Anemia|1|||
129533603|NCT01906489|466242494|FG001|Overall Study|Worsening of Anemia|0|||
129533604|NCT01906489|466242493|FG000|Overall Study|Protocol Violation|0|||
129533605|NCT01906489|466242494|FG001|Overall Study|Protocol Violation|1|||
129533606|NCT01906489|466242493|FG000|Overall Study|Non- Compliance|1|||
129533607|NCT01906489|466242494|FG001|Overall Study|Non- Compliance|0|||
129533608|NCT01906489|466242493|FG000|Overall Study|Sponsor Decision|1|||
129533609|NCT01906489|466242494|FG001|Overall Study|Sponsor Decision|0|||
129533610|NCT01906489|466242493|FG000|Overall Study|Lost to Follow-up|1|||
129533611|NCT01906489|466242494|FG001|Overall Study|Lost to Follow-up|1|||
129533612|NCT01906489|466242493|FG000|Overall Study|Other|1|||
129533613|NCT01906489|466242494|FG001|Overall Study|Other|0|||
129533614|NCT00303602|466244212|FG000|Overall Study|Adverse Event|2|||
129533615|NCT00303602|466244213|FG001|Overall Study|Adverse Event|2|||
129533616|NCT00303602|466244212|FG000|Overall Study|Withdrawal by Subject|5|||
129533617|NCT00303602|466244213|FG001|Overall Study|Withdrawal by Subject|6|||
129533618|NCT00303602|466244212|FG000|Overall Study|Lost to Follow-up|5|||
129533619|NCT00303602|466244213|FG001|Overall Study|Lost to Follow-up|2|||
129533620|NCT00303602|466244212|FG000|Overall Study|Protocol entry criteria not met|2|||
129533621|NCT00303602|466244213|FG001|Overall Study|Protocol entry criteria not met|2|||
129533622|NCT00303602|466244212|FG000|Overall Study|Physician Decision|2|||
129533623|NCT00303602|466244213|FG001|Overall Study|Physician Decision|1|||
129533624|NCT00303602|466244212|FG000|Overall Study|Noncompliance|2|||
129533625|NCT00303602|466244213|FG001|Overall Study|Noncompliance|2|||
129533626|NCT00303602|466244212|FG000|Overall Study|Protocol Violation|1|||
129533627|NCT00303602|466244213|FG001|Overall Study|Protocol Violation|0|||
129533628|NCT00313716|466244216|FG000|Overall Study|Death|3|||
129533629|NCT00313716|466244217|FG001|Overall Study|Death|2|||
129533630|NCT00313716|466244218|FG002|Overall Study|Death|9|||
129533631|NCT00313716|466244219|FG003|Overall Study|Death|3|||
129533632|NCT00313716|466244220|FG004|Overall Study|Death|5|||
129533633|NCT00313716|466244221|FG005|Overall Study|Death|9|||
129533634|NCT00313716|466244216|FG000|Overall Study|Lost to Follow-up|2|||
129533635|NCT00313716|466244217|FG001|Overall Study|Lost to Follow-up|5|||
129533636|NCT00313716|466244218|FG002|Overall Study|Lost to Follow-up|2|||
129533637|NCT00313716|466244219|FG003|Overall Study|Lost to Follow-up|1|||
129533638|NCT00313716|466244220|FG004|Overall Study|Lost to Follow-up|0|||
129533639|NCT00313716|466244221|FG005|Overall Study|Lost to Follow-up|4|||
129533640|NCT00313716|466244216|FG000|Overall Study|Withdrawal by Subject|0|||
129533641|NCT00313716|466244217|FG001|Overall Study|Withdrawal by Subject|1|||
129533642|NCT00313716|466244218|FG002|Overall Study|Withdrawal by Subject|1|||
129533643|NCT00313716|466244219|FG003|Overall Study|Withdrawal by Subject|0|||
129533644|NCT00313716|466244220|FG004|Overall Study|Withdrawal by Subject|1|||
129533645|NCT00313716|466244221|FG005|Overall Study|Withdrawal by Subject|0|||
129533646|NCT00663208|466244222|FG000|Treatment Period|Lost to Follow-up|0|||
129533647|NCT00663208|466244223|FG001|Treatment Period|Lost to Follow-up|1|||
129533648|NCT00663208|466244224|FG002|Treatment Period|Lost to Follow-up|0|||
129533649|NCT00663208|466244225|FG003|Treatment Period|Lost to Follow-up|0|||
129533650|NCT00663208|466244226|FG004|Treatment Period|Lost to Follow-up|0|||
129533651|NCT00663208|466244227|FG005|Treatment Period|Lost to Follow-up|0|||
129533652|NCT00663208|466244228|FG006|Treatment Period|Lost to Follow-up|0|||
129533653|NCT00663208|466244222|FG000|Follow-up Period|Lost to Follow-up|2|||
129533654|NCT00663208|466244223|FG001|Follow-up Period|Lost to Follow-up|0|||
129533655|NCT00663208|466244224|FG002|Follow-up Period|Lost to Follow-up|3|||
129533656|NCT00663208|466244225|FG003|Follow-up Period|Lost to Follow-up|2|||
129533657|NCT00663208|466244226|FG004|Follow-up Period|Lost to Follow-up|0|||
129533658|NCT00663208|466244227|FG005|Follow-up Period|Lost to Follow-up|0|||
129533659|NCT00663208|466244228|FG006|Follow-up Period|Lost to Follow-up|0|||
129533660|NCT00663208|466244222|FG000|Follow-up Period|Other reason|1|||
129533661|NCT00663208|466244223|FG001|Follow-up Period|Other reason|0|||
129533662|NCT00663208|466244224|FG002|Follow-up Period|Other reason|0|||
129533663|NCT00663208|466244225|FG003|Follow-up Period|Other reason|0|||
129533664|NCT00663208|466244226|FG004|Follow-up Period|Other reason|0|||
129533665|NCT00663208|466244227|FG005|Follow-up Period|Other reason|0|||
129533666|NCT00663208|466244228|FG006|Follow-up Period|Other reason|1|||
129533667|NCT03633461|466244236|FG000|Overall Study|Lost to Follow-up|0|||
129533668|NCT03633461|466244237|FG001|Overall Study|Lost to Follow-up|1|||
129533669|NCT03938857|466244238|FG000|Overall Study|Physician Decision|1|||
129533670|NCT03938857|466244239|FG001|Overall Study|Physician Decision|0|||
129533671|NCT03938857|466244240|FG002|Overall Study|Physician Decision|0|||
129533672|NCT03938857|466244241|FG003|Overall Study|Physician Decision|0|||
129533673|NCT02516605|466244242|FG000|Overall Study|Protocol Violation|0|||
129533674|NCT02516605|466244243|FG001|Overall Study|Protocol Violation|0|||
129533675|NCT02516605|466244244|FG002|Overall Study|Protocol Violation|0|||
129533676|NCT02516605|466244245|FG003|Overall Study|Protocol Violation|0|||
129533677|NCT02516605|466244246|FG004|Overall Study|Protocol Violation|1|||
129533678|NCT02516605|466244242|FG000|Overall Study|Withdrawal by Subject|0|||
129533679|NCT02516605|466244243|FG001|Overall Study|Withdrawal by Subject|0|||
129533680|NCT02516605|466244244|FG002|Overall Study|Withdrawal by Subject|0|||
129533681|NCT02516605|466244245|FG003|Overall Study|Withdrawal by Subject|1|||
129533682|NCT02516605|466244246|FG004|Overall Study|Withdrawal by Subject|0|||
129533683|NCT02577107|466244247|FG000|Overall Study|Protocol deviation|0|||
129533684|NCT02577107|466244248|FG001|Overall Study|Protocol deviation|1|||
129533685|NCT00577382|466244249|FG000|Overall Study|Adverse Event|0|||
129533686|NCT00577382|466244250|FG001|Overall Study|Adverse Event|6|||
129533687|NCT00577382|466244249|FG000|Overall Study|Withdrawal by Subject|0|||
129533688|NCT00577382|466244250|FG001|Overall Study|Withdrawal by Subject|1|||
129533689|NCT00577382|466244249|FG000|Overall Study|Progressive Disease|17|||
129533690|NCT00577382|466244250|FG001|Overall Study|Progressive Disease|19|||
129533691|NCT00577382|466244249|FG000|Overall Study|Intercurrent Illness|1|||
129533692|NCT00577382|466244250|FG001|Overall Study|Intercurrent Illness|2|||
129533693|NCT00577382|466244249|FG000|Overall Study|Death|1|||
129533694|NCT00577382|466244250|FG001|Overall Study|Death|1|||
129533695|NCT00577382|466244249|FG000|Overall Study|Lost to Follow-up|2|||
129533696|NCT00577382|466244250|FG001|Overall Study|Lost to Follow-up|2|||
129533697|NCT00508872|466244251|FG000|Overall Study|Lost to Follow-up|1|||
129533698|NCT00508872|466244251|FG000|Overall Study|Physician Decision|1|||
129533699|NCT01014442|466244252|FG000|Overall Study|Adverse Event|0|||
129533700|NCT01014442|466244253|FG001|Overall Study|Adverse Event|8|||
129533701|NCT01014442|466244252|FG000|Overall Study|Withdrawal by Subject|4|||
129533702|NCT01014442|466244253|FG001|Overall Study|Withdrawal by Subject|4|||
129533703|NCT01014442|466244252|FG000|Overall Study|Protocol Violation|2|||
129533704|NCT01014442|466244253|FG001|Overall Study|Protocol Violation|5|||
129533705|NCT01014442|466244252|FG000|Overall Study|Lack of Compliance|0|||
129533706|NCT01014442|466244253|FG001|Overall Study|Lack of Compliance|1|||
129533707|NCT01014442|466244252|FG000|Overall Study|Unspecified Reason|1|||
129533708|NCT01014442|466244253|FG001|Overall Study|Unspecified Reason|1|||
129533709|NCT01220024|466244260|FG000|Overall Study|Lost to Follow-up|1|||
129533710|NCT01220024|466244261|FG001|Overall Study|Lost to Follow-up|1|||
129533711|NCT00490815|466244262|FG000|Overall Study|Adverse Event|2|||
129533712|NCT00490815|466244263|FG001|Overall Study|Adverse Event|3|||
129533713|NCT00490815|466244262|FG000|Overall Study|Withdrawal by Subject|4|||
129533714|NCT00490815|466244263|FG001|Overall Study|Withdrawal by Subject|0|||
129533715|NCT00490815|466244262|FG000|Overall Study|Lost to Follow-up|1|||
129533716|NCT00490815|466244263|FG001|Overall Study|Lost to Follow-up|3|||
129533717|NCT00490815|466244262|FG000|Overall Study|Death|1|||
129533718|NCT00490815|466244263|FG001|Overall Study|Death|3|||
129533719|NCT01756846|466244265|FG000|Overall Study|Lost to Follow-up|5|||
129533720|NCT01756846|466244266|FG001|Overall Study|Lost to Follow-up|10|||
129533721|NCT01756846|466244265|FG000|Overall Study|Withdrawal by Subject|1|||
129533722|NCT01756846|466244266|FG001|Overall Study|Withdrawal by Subject|2|||
129533723|NCT01284127|466244269|FG000|Overall Study|Adverse Event|2|||
129533724|NCT01284127|466244269|FG000|Overall Study|Withdrawal by Subject|4|||
129533725|NCT01284127|466244269|FG000|Overall Study|Physician Decision|1|||
129533726|NCT00545740|466244270|FG000|Overall Study|Lack of Efficacy|34|||
129533727|NCT00545740|466244271|FG001|Overall Study|Lack of Efficacy|35|||
129533728|NCT00545740|466244272|FG002|Overall Study|Lack of Efficacy|47|||
129533729|NCT00545740|466244273|FG003|Overall Study|Lack of Efficacy|36|||
129533730|NCT00545740|466244270|FG000|Overall Study|Withdrawal by Subject|17|||
129533731|NCT00545740|466244271|FG001|Overall Study|Withdrawal by Subject|15|||
129533732|NCT00545740|466244272|FG002|Overall Study|Withdrawal by Subject|16|||
129533733|NCT00545740|466244273|FG003|Overall Study|Withdrawal by Subject|18|||
129533734|NCT00545740|466244270|FG000|Overall Study|Adverse Event|10|||
129533735|NCT00545740|466244271|FG001|Overall Study|Adverse Event|18|||
129533736|NCT00545740|466244272|FG002|Overall Study|Adverse Event|19|||
129533737|NCT00545740|466244273|FG003|Overall Study|Adverse Event|9|||
129533738|NCT00545740|466244270|FG000|Overall Study|Lost to Follow-up|7|||
129533739|NCT00545740|466244271|FG001|Overall Study|Lost to Follow-up|5|||
129533740|NCT00545740|466244272|FG002|Overall Study|Lost to Follow-up|5|||
129533741|NCT00545740|466244273|FG003|Overall Study|Lost to Follow-up|6|||
129533742|NCT00545740|466244270|FG000|Overall Study|Protocol Violation|1|||
129533743|NCT00545740|466244271|FG001|Overall Study|Protocol Violation|3|||
129533744|NCT00545740|466244272|FG002|Overall Study|Protocol Violation|1|||
129533745|NCT00545740|466244273|FG003|Overall Study|Protocol Violation|0|||
129533746|NCT00545740|466244270|FG000|Overall Study|Non-compliance|0|||
129533747|NCT00545740|466244271|FG001|Overall Study|Non-compliance|2|||
129533748|NCT00545740|466244272|FG002|Overall Study|Non-compliance|1|||
129533749|NCT00545740|466244273|FG003|Overall Study|Non-compliance|0|||
129533750|NCT00545740|466244270|FG000|Overall Study|Moved|2|||
129533751|NCT00545740|466244271|FG001|Overall Study|Moved|0|||
129533752|NCT00545740|466244272|FG002|Overall Study|Moved|1|||
129533753|NCT00545740|466244273|FG003|Overall Study|Moved|0|||
129533754|NCT00545740|466244270|FG000|Overall Study|Diverticulitis attack|0|||
129533755|NCT00545740|466244271|FG001|Overall Study|Diverticulitis attack|0|||
129533756|NCT00545740|466244272|FG002|Overall Study|Diverticulitis attack|1|||
129533757|NCT00545740|466244273|FG003|Overall Study|Diverticulitis attack|1|||
129533758|NCT00545740|466244270|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
129533759|NCT00545740|466244271|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
129533760|NCT00545740|466244272|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
129533761|NCT00545740|466244273|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
129533762|NCT00545740|466244270|FG000|Overall Study|Site closure|1|||
129533763|NCT00545740|466244271|FG001|Overall Study|Site closure|0|||
129533764|NCT00545740|466244272|FG002|Overall Study|Site closure|0|||
129533765|NCT00545740|466244273|FG003|Overall Study|Site closure|0|||
129533766|NCT00545740|466244270|FG000|Overall Study|Missed visit|1|||
129533767|NCT00545740|466244271|FG001|Overall Study|Missed visit|0|||
129533768|NCT00545740|466244272|FG002|Overall Study|Missed visit|0|||
129533769|NCT00545740|466244273|FG003|Overall Study|Missed visit|0|||
129533770|NCT00545740|466244270|FG000|Overall Study|Physician Decision|0|||
129533771|NCT00545740|466244271|FG001|Overall Study|Physician Decision|0|||
129533772|NCT00545740|466244272|FG002|Overall Study|Physician Decision|3|||
129533773|NCT00545740|466244273|FG003|Overall Study|Physician Decision|0|||
129533774|NCT00545740|466244270|FG000|Overall Study|Accepted only monthly telephone calls|1|||
129533775|NCT00545740|466244271|FG001|Overall Study|Accepted only monthly telephone calls|0|||
129533776|NCT00545740|466244272|FG002|Overall Study|Accepted only monthly telephone calls|0|||
129533777|NCT00545740|466244273|FG003|Overall Study|Accepted only monthly telephone calls|0|||
129533778|NCT00545740|466244270|FG000|Overall Study|Sponsor decision|0|||
129533779|NCT00545740|466244271|FG001|Overall Study|Sponsor decision|1|||
129533780|NCT00545740|466244272|FG002|Overall Study|Sponsor decision|0|||
129533781|NCT00545740|466244273|FG003|Overall Study|Sponsor decision|0|||
129533782|NCT00545740|466244270|FG000|Overall Study|Lack of time|0|||
129533783|NCT00545740|466244271|FG001|Overall Study|Lack of time|1|||
129533784|NCT00545740|466244272|FG002|Overall Study|Lack of time|0|||
129533785|NCT00545740|466244273|FG003|Overall Study|Lack of time|0|||
129533786|NCT00545740|466244270|FG000|Overall Study|Non-adherence to visits|0|||
129533787|NCT00545740|466244271|FG001|Overall Study|Non-adherence to visits|1|||
129533788|NCT00545740|466244272|FG002|Overall Study|Non-adherence to visits|0|||
129533789|NCT00545740|466244273|FG003|Overall Study|Non-adherence to visits|0|||
129533790|NCT00545740|466244270|FG000|Overall Study|Patient difficulties|0|||
129533791|NCT00545740|466244271|FG001|Overall Study|Patient difficulties|1|||
129533792|NCT00545740|466244272|FG002|Overall Study|Patient difficulties|0|||
129533793|NCT00545740|466244273|FG003|Overall Study|Patient difficulties|0|||
129533794|NCT00545740|466244270|FG000|Overall Study|Husband against study|0|||
129533795|NCT00545740|466244271|FG001|Overall Study|Husband against study|0|||
129533796|NCT00545740|466244272|FG002|Overall Study|Husband against study|1|||
129533797|NCT00545740|466244273|FG003|Overall Study|Husband against study|0|||
129533798|NCT04212221|466244279|FG000|Overall Study|Remained on Treatment|0|||
129533799|NCT04212221|466244280|FG001|Overall Study|Remained on Treatment|0|||
129533800|NCT04212221|466244281|FG002|Overall Study|Remained on Treatment|0|||
129533801|NCT04212221|466244282|FG003|Overall Study|Remained on Treatment|1|||
129533802|NCT04212221|466244283|FG004|Overall Study|Remained on Treatment|0|||
129533803|NCT04212221|466244284|FG005|Overall Study|Remained on Treatment|0|||
129533804|NCT04212221|466244285|FG006|Overall Study|Remained on Treatment|3|||
129533805|NCT04212221|466244286|FG007|Overall Study|Remained on Treatment|9|||
129533806|NCT04212221|466244279|FG000|Overall Study|Adverse Event|0|||
129533807|NCT04212221|466244280|FG001|Overall Study|Adverse Event|0|||
129533808|NCT04212221|466244281|FG002|Overall Study|Adverse Event|0|||
129533809|NCT04212221|466244282|FG003|Overall Study|Adverse Event|0|||
129533810|NCT04212221|466244283|FG004|Overall Study|Adverse Event|0|||
129533811|NCT04212221|466244284|FG005|Overall Study|Adverse Event|0|||
129533812|NCT04212221|466244285|FG006|Overall Study|Adverse Event|2|||
129533813|NCT04212221|466244286|FG007|Overall Study|Adverse Event|3|||
129533814|NCT04212221|466244279|FG000|Overall Study|Death|0|||
129533815|NCT04212221|466244280|FG001|Overall Study|Death|0|||
129533816|NCT04212221|466244281|FG002|Overall Study|Death|0|||
129533817|NCT04212221|466244282|FG003|Overall Study|Death|0|||
129533818|NCT04212221|466244283|FG004|Overall Study|Death|0|||
129533819|NCT04212221|466244284|FG005|Overall Study|Death|0|||
129533820|NCT04212221|466244285|FG006|Overall Study|Death|0|||
129533821|NCT04212221|466244286|FG007|Overall Study|Death|2|||
129533822|NCT04212221|466244279|FG000|Overall Study|Disease progression according to irRECIST|1|||
129533823|NCT04212221|466244280|FG001|Overall Study|Disease progression according to irRECIST|2|||
129533824|NCT04212221|466244281|FG002|Overall Study|Disease progression according to irRECIST|3|||
129533825|NCT04212221|466244282|FG003|Overall Study|Disease progression according to irRECIST|3|||
129533826|NCT04212221|466244283|FG004|Overall Study|Disease progression according to irRECIST|2|||
129533827|NCT04212221|466244284|FG005|Overall Study|Disease progression according to irRECIST|2|||
129533828|NCT04212221|466244285|FG006|Overall Study|Disease progression according to irRECIST|21|||
129533829|NCT04212221|466244286|FG007|Overall Study|Disease progression according to irRECIST|17|||
129533830|NCT04212221|466244279|FG000|Overall Study|Global Deterioration of Health Status|0|||
129533831|NCT04212221|466244280|FG001|Overall Study|Global Deterioration of Health Status|0|||
129533832|NCT04212221|466244281|FG002|Overall Study|Global Deterioration of Health Status|0|||
129533833|NCT04212221|466244282|FG003|Overall Study|Global Deterioration of Health Status|0|||
129533834|NCT04212221|466244283|FG004|Overall Study|Global Deterioration of Health Status|0|||
129533835|NCT04212221|466244284|FG005|Overall Study|Global Deterioration of Health Status|0|||
129533836|NCT04212221|466244285|FG006|Overall Study|Global Deterioration of Health Status|0|||
129533837|NCT04212221|466244286|FG007|Overall Study|Global Deterioration of Health Status|2|||
129533838|NCT04212221|466244279|FG000|Overall Study|Investigator's Decision|0|||
129533839|NCT04212221|466244280|FG001|Overall Study|Investigator's Decision|0|||
129533840|NCT04212221|466244281|FG002|Overall Study|Investigator's Decision|0|||
129533841|NCT04212221|466244282|FG003|Overall Study|Investigator's Decision|1|||
129533842|NCT04212221|466244283|FG004|Overall Study|Investigator's Decision|0|||
129533843|NCT04212221|466244284|FG005|Overall Study|Investigator's Decision|0|||
129533844|NCT04212221|466244285|FG006|Overall Study|Investigator's Decision|3|||
129533845|NCT04212221|466244286|FG007|Overall Study|Investigator's Decision|0|||
129533846|NCT04212221|466244279|FG000|Overall Study|Participant refused to continue treatment|0|||
129533847|NCT04212221|466244280|FG001|Overall Study|Participant refused to continue treatment|1|||
129533848|NCT04212221|466244281|FG002|Overall Study|Participant refused to continue treatment|0|||
129533849|NCT04212221|466244282|FG003|Overall Study|Participant refused to continue treatment|1|||
129533850|NCT04212221|466244283|FG004|Overall Study|Participant refused to continue treatment|1|||
129533851|NCT04212221|466244284|FG005|Overall Study|Participant refused to continue treatment|2|||
129533852|NCT04212221|466244285|FG006|Overall Study|Participant refused to continue treatment|4|||
129533853|NCT04212221|466244286|FG007|Overall Study|Participant refused to continue treatment|2|||
129533854|NCT04212221|466244279|FG000|Overall Study|Protocol Violation|0|||
129533855|NCT04212221|466244280|FG001|Overall Study|Protocol Violation|0|||
129533856|NCT04212221|466244281|FG002|Overall Study|Protocol Violation|0|||
129533857|NCT04212221|466244282|FG003|Overall Study|Protocol Violation|0|||
129533858|NCT04212221|466244283|FG004|Overall Study|Protocol Violation|0|||
129533859|NCT04212221|466244284|FG005|Overall Study|Protocol Violation|0|||
129533860|NCT04212221|466244285|FG006|Overall Study|Protocol Violation|0|||
129533861|NCT04212221|466244286|FG007|Overall Study|Protocol Violation|1|||
129533862|NCT03742271|466244291|FG000|Overall Study|Unsatisfactory Visual Response|1|||
129533863|NCT03742271|466244291|FG000|Overall Study|Withdrawal by Subject|3|||
129533864|NCT03742271|466244291|FG000|Overall Study|Lost to Follow-up|4|||
129533865|NCT03742271|466244291|FG000|Overall Study|Failed Insertion & removal|3|||
129533866|NCT03742271|466244291|FG000|Overall Study|Protocol Violation|1|||
129533867|NCT01624974|466244294|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
129533868|NCT01624974|466244295|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
129533869|NCT01624974|466244294|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
129533870|NCT01624974|466244295|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
129533871|NCT01624974|466244294|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
129533872|NCT01624974|466244295|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
129533873|NCT01624974|466244294|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
129533874|NCT01624974|466244295|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
129533875|NCT01624974|466244294|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
129533876|NCT01624974|466244295|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
129533877|NCT01624974|466244294|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
129533878|NCT01624974|466244295|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
129533879|NCT01624974|466244294|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
129533880|NCT01624974|466244295|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
129533881|NCT01624974|466244294|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
129533882|NCT01624974|466244295|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
129533883|NCT01624974|466244294|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
129533884|NCT01624974|466244295|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
129533885|NCT01624974|466244294|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
129533886|NCT01624974|466244295|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
129533887|NCT01624974|466244294|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
129533888|NCT01624974|466244295|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
129533889|NCT01624974|466244294|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
129533890|NCT01624974|466244295|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
129533891|NCT01376908|466244296|FG000|Overall Study|Protocol Violation|1|||
129533892|NCT01376908|466244297|FG001|Overall Study|Protocol Violation|1|||
129533893|NCT01376908|466244296|FG000|Overall Study|Withdrawal by Subject|1|||
129533894|NCT01376908|466244297|FG001|Overall Study|Withdrawal by Subject|2|||
129533895|NCT01468844|466244298|FG000|Overall Study|Adverse Event|1|||
129533896|NCT01468844|466244299|FG001|Overall Study|Adverse Event|0|||
129533897|NCT01468844|466244298|FG000|Overall Study|Withdrawal by Subject|1|||
129533898|NCT01468844|466244299|FG001|Overall Study|Withdrawal by Subject|0|||
129533899|NCT02142712|466244300|FG000|Overall Study|Lost to Follow-up|1|||
129533900|NCT02142712|466244301|FG001|Overall Study|Lost to Follow-up|1|||
129533901|NCT02142712|466244302|FG002|Overall Study|Lost to Follow-up|1|||
129533902|NCT02142712|466244303|FG003|Overall Study|Lost to Follow-up|0|||
129533903|NCT01899729|466244304|FG000|Overall Study|Adverse Event|1|||
129533904|NCT01899729|466244305|FG001|Overall Study|Adverse Event|0|||
129533905|NCT01899729|466244306|FG002|Overall Study|Adverse Event|0|||
129533906|NCT01899729|466244307|FG003|Overall Study|Adverse Event|0|||
129533907|NCT01899729|466244308|FG004|Overall Study|Adverse Event|1|||
129533908|NCT01899729|466244304|FG000|Overall Study|Withdrawal by Subject|1|||
129533909|NCT01899729|466244305|FG001|Overall Study|Withdrawal by Subject|2|||
129533910|NCT01899729|466244306|FG002|Overall Study|Withdrawal by Subject|0|||
129533911|NCT01899729|466244307|FG003|Overall Study|Withdrawal by Subject|0|||
129533912|NCT01899729|466244308|FG004|Overall Study|Withdrawal by Subject|0|||
129533913|NCT01899729|466244304|FG000|Overall Study|Lack of Efficacy|0|||
129533914|NCT01899729|466244305|FG001|Overall Study|Lack of Efficacy|0|||
129533915|NCT01899729|466244306|FG002|Overall Study|Lack of Efficacy|2|||
129533916|NCT01899729|466244307|FG003|Overall Study|Lack of Efficacy|0|||
129533917|NCT01899729|466244308|FG004|Overall Study|Lack of Efficacy|1|||
129533918|NCT02853318|466244311|FG000|Overall Study|Withdrawal by Subject|1|||
129533919|NCT02646332|466244314|FG000|Overall Study|Lost to Follow-up|0|||
129533920|NCT02646332|466244315|FG001|Overall Study|Lost to Follow-up|3|||
129533921|NCT04490499|466244316|FG000|Overall Study|Withdrawal by Subject|2|||
129533922|NCT00252499|466244317|FG000|Overall Study|Lost to Follow-up|1|||
129533923|NCT00252499|466244318|FG001|Overall Study|Lost to Follow-up|0|||
129533924|NCT00252499|466244319|FG002|Overall Study|Lost to Follow-up|0|||
129533925|NCT01882439|466244325|FG000|Overall Study|Adverse event related to study drug|3|||
129533926|NCT01882439|466244326|FG001|Overall Study|Adverse event related to study drug|8|||
129533927|NCT01882439|466244327|FG002|Overall Study|Adverse event related to study drug|1|||
129533928|NCT01882439|466244328|FG003|Overall Study|Adverse event related to study drug|2|||
129533929|NCT01882439|466244325|FG000|Overall Study|Pregnancy|0|||
129533930|NCT01882439|466244326|FG001|Overall Study|Pregnancy|1|||
129533931|NCT01882439|466244327|FG002|Overall Study|Pregnancy|0|||
129533932|NCT01882439|466244328|FG003|Overall Study|Pregnancy|0|||
129533933|NCT01882439|466244325|FG000|Overall Study|Protocol Violation|2|||
129533934|NCT01882439|466244326|FG001|Overall Study|Protocol Violation|2|||
129533935|NCT01882439|466244327|FG002|Overall Study|Protocol Violation|0|||
129533936|NCT01882439|466244328|FG003|Overall Study|Protocol Violation|1|||
129533937|NCT01882439|466244325|FG000|Overall Study|No longer willing to participate|1|||
129533938|NCT01882439|466244326|FG001|Overall Study|No longer willing to participate|4|||
129533939|NCT01882439|466244327|FG002|Overall Study|No longer willing to participate|2|||
129533940|NCT01882439|466244328|FG003|Overall Study|No longer willing to participate|3|||
129533941|NCT01882439|466244325|FG000|Overall Study|Medication error with no associated AE|0|||
129533942|NCT01882439|466244326|FG001|Overall Study|Medication error with no associated AE|0|||
129533943|NCT01882439|466244327|FG002|Overall Study|Medication error with no associated AE|2|||
129533944|NCT01882439|466244328|FG003|Overall Study|Medication error with no associated AE|0|||
129533945|NCT01882439|466244325|FG000|Overall Study|Insufficient clinical response|1|||
129533946|NCT01882439|466244326|FG001|Overall Study|Insufficient clinical response|4|||
129533947|NCT01882439|466244327|FG002|Overall Study|Insufficient clinical response|4|||
129533948|NCT01882439|466244328|FG003|Overall Study|Insufficient clinical response|2|||
129533949|NCT01882439|466244325|FG000|Overall Study|Adverse event unrelated to study drug|2|||
129533950|NCT01882439|466244326|FG001|Overall Study|Adverse event unrelated to study drug|2|||
129533951|NCT01882439|466244327|FG002|Overall Study|Adverse event unrelated to study drug|1|||
129533952|NCT01882439|466244328|FG003|Overall Study|Adverse event unrelated to study drug|1|||
129533953|NCT01997333|466244333|FG000|Randomization and Treatment|Disease Progression|70|||
129533954|NCT01997333|466244334|FG001|Randomization and Treatment|Disease Progression|159|||
129533955|NCT01997333|466244333|FG000|Randomization and Treatment|Adverse Event|10|||
129533956|NCT01997333|466244334|FG001|Randomization and Treatment|Adverse Event|32|||
129533957|NCT01997333|466244333|FG000|Randomization and Treatment|Physician Decision|0|||
129533958|NCT01997333|466244334|FG001|Randomization and Treatment|Physician Decision|4|||
129533959|NCT01997333|466244333|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
129533960|NCT01997333|466244334|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
129533961|NCT01997333|466244333|FG000|Randomization and Treatment|Did not receive treatment|17|||
129533962|NCT01997333|466244334|FG001|Randomization and Treatment|Did not receive treatment|5|||
129533963|NCT01997333|466244333|FG000|Survival Follow up|Withdrawal by Subject|15|||
129533964|NCT01997333|466244334|FG001|Survival Follow up|Withdrawal by Subject|6|||
129533965|NCT01997333|466244333|FG000|Survival Follow up|Lost to Follow-up|0|||
129533966|NCT01997333|466244334|FG001|Survival Follow up|Lost to Follow-up|6|||
129533967|NCT01997333|466244333|FG000|Survival Follow up|Various|1|||
129533968|NCT01997333|466244334|FG001|Survival Follow up|Various|2|||
129533969|NCT02269709|466244335|FG000|Time of Enrollment|Withdrawal by Subject|3|||
129533970|NCT02269709|466244335|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
129533971|NCT02269709|466244335|FG000|Six Month Follow-up|Lost to Follow-up|12|||
129533972|NCT02909504|466244336|FG000|Overall Study|Adverse Event|2|||
129533973|NCT02909504|466244336|FG000|Overall Study|Lack of Efficacy|3|||
129533974|NCT02909504|466244336|FG000|Overall Study|Withdrawal by Subject|4|||
129533975|NCT02909504|466244336|FG000|Overall Study|Pregnancy|1|||
129533976|NCT02909504|466244336|FG000|Overall Study|Subject moved|1|||
129533977|NCT02909504|466244336|FG000|Overall Study|Lost to Follow-up|1|||
129533978|NCT04411472|466244337|FG000|Overall Study|Adverse Event|5|||
129533979|NCT04411472|466244338|FG001|Overall Study|Adverse Event|10|||
129533980|NCT04411472|466244339|FG002|Overall Study|Adverse Event|1|||
129533981|NCT04411472|466244340|FG003|Overall Study|Adverse Event|0|||
129533982|NCT04411472|466244341|FG004|Overall Study|Adverse Event|0|||
129533983|NCT04411472|466244342|FG005|Overall Study|Adverse Event|0|||
129533984|NCT04411472|466244337|FG000|Overall Study|Protocol Violation|1|||
129533985|NCT04411472|466244338|FG001|Overall Study|Protocol Violation|0|||
129533986|NCT04411472|466244339|FG002|Overall Study|Protocol Violation|0|||
129533987|NCT04411472|466244340|FG003|Overall Study|Protocol Violation|0|||
129533988|NCT04411472|466244341|FG004|Overall Study|Protocol Violation|0|||
129533989|NCT04411472|466244342|FG005|Overall Study|Protocol Violation|0|||
129533990|NCT04411472|466244337|FG000|Overall Study|Withdrawal by Subject|0|||
129533991|NCT04411472|466244338|FG001|Overall Study|Withdrawal by Subject|1|||
129533992|NCT04411472|466244339|FG002|Overall Study|Withdrawal by Subject|0|||
129533993|NCT04411472|466244340|FG003|Overall Study|Withdrawal by Subject|1|||
129533994|NCT04411472|466244341|FG004|Overall Study|Withdrawal by Subject|0|||
129533995|NCT04411472|466244342|FG005|Overall Study|Withdrawal by Subject|0|||
129533996|NCT04411472|466244337|FG000|Overall Study|Physician Decision|1|||
129533997|NCT04411472|466244338|FG001|Overall Study|Physician Decision|0|||
129533998|NCT04411472|466244339|FG002|Overall Study|Physician Decision|0|||
129533999|NCT04411472|466244340|FG003|Overall Study|Physician Decision|0|||
129534000|NCT04411472|466244341|FG004|Overall Study|Physician Decision|0|||
129534001|NCT04411472|466244342|FG005|Overall Study|Physician Decision|0|||
129534002|NCT04411472|466244337|FG000|Overall Study|Study terminated by sponsor|17|||
129534003|NCT04411472|466244338|FG001|Overall Study|Study terminated by sponsor|20|||
129534004|NCT04411472|466244339|FG002|Overall Study|Study terminated by sponsor|3|||
129534005|NCT04411472|466244340|FG003|Overall Study|Study terminated by sponsor|0|||
129534006|NCT04411472|466244341|FG004|Overall Study|Study terminated by sponsor|0|||
129534007|NCT04411472|466244342|FG005|Overall Study|Study terminated by sponsor|0|||
129534008|NCT05060003|466244344|FG000|Overall Study|ctDNA negative|7|||
129534009|NCT03969589|466244347|FG000|Overall Study|Lost to Follow-up|3|||
129534010|NCT03969589|466244348|FG001|Overall Study|Lost to Follow-up|2|||
129534011|NCT03969589|466244347|FG000|Overall Study|Declined Follow-Up|0|||
129534012|NCT03969589|466244348|FG001|Overall Study|Declined Follow-Up|1|||
129534013|NCT00517634|466244349|FG000|Second Treatment Period|Withdrawal by Subject|0|||
129534014|NCT00517634|466244350|FG001|Second Treatment Period|Withdrawal by Subject|0|||
129534015|NCT00517634|466244351|FG002|Second Treatment Period|Withdrawal by Subject|0|||
129534016|NCT00517634|466244352|FG003|Second Treatment Period|Withdrawal by Subject|0|||
129534017|NCT00517634|466244353|FG004|Second Treatment Period|Withdrawal by Subject|1|||
129534018|NCT00517634|466244354|FG005|Second Treatment Period|Withdrawal by Subject|0|||
129534019|NCT03091920|466244357|FG000|Overall Study|Adverse Event|0|||
129534020|NCT03091920|466244358|FG001|Overall Study|Adverse Event|1|||
129534021|NCT03091920|466244359|FG002|Overall Study|Adverse Event|0|||
129534022|NCT03143855|466244360|FG000|Overall Study|Withdrawal by Subject|4|||
129534023|NCT03143855|466244361|FG001|Overall Study|Withdrawal by Subject|3|||
129534024|NCT03143855|466244360|FG000|Overall Study|Protocol Violation|1|||
129534025|NCT03143855|466244361|FG001|Overall Study|Protocol Violation|0|||
129534026|NCT03143855|466244360|FG000|Overall Study|Participant experienced withdrawal|0|||
129534027|NCT03143855|466244361|FG001|Overall Study|Participant experienced withdrawal|1|||
129534028|NCT00453349|466244363|FG000|Randomized|Adverse Event|12|||
129534029|NCT00453349|466244364|FG001|Randomized|Adverse Event|11|||
129534030|NCT00453349|466244363|FG000|Randomized|Lack of Efficacy|2|||
129534031|NCT00453349|466244364|FG001|Randomized|Lack of Efficacy|1|||
129534032|NCT00453349|466244363|FG000|Randomized|Lost to Follow-up|7|||
129534033|NCT00453349|466244364|FG001|Randomized|Lost to Follow-up|5|||
129534034|NCT00453349|466244363|FG000|Randomized|Protocol Violation|1|||
129534035|NCT00453349|466244364|FG001|Randomized|Protocol Violation|1|||
129534036|NCT00453349|466244363|FG000|Randomized|Withdrawal by Subject|3|||
129534037|NCT00453349|466244364|FG001|Randomized|Withdrawal by Subject|5|||
129534038|NCT00453349|466244363|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
129534039|NCT00453349|466244364|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
129534040|NCT00453349|466244363|FG000|Completed Study|Adverse Event|12|||
129534041|NCT00453349|466244364|FG001|Completed Study|Adverse Event|11|||
129534042|NCT00453349|466244363|FG000|Completed Study|Lack of Efficacy|2|||
129534043|NCT00453349|466244364|FG001|Completed Study|Lack of Efficacy|1|||
129534044|NCT00453349|466244363|FG000|Completed Study|Lost to Follow-up|7|||
129534045|NCT00453349|466244364|FG001|Completed Study|Lost to Follow-up|5|||
129534046|NCT00453349|466244363|FG000|Completed Study|Protocol Violation|1|||
129534047|NCT00453349|466244364|FG001|Completed Study|Protocol Violation|1|||
129534048|NCT00453349|466244363|FG000|Completed Study|Withdrawal by Subject|3|||
129534049|NCT00453349|466244364|FG001|Completed Study|Withdrawal by Subject|5|||
129534050|NCT00453349|466244363|FG000|Completed Study|Lost to follow up after study treatment|2|||
129534051|NCT00453349|466244364|FG001|Completed Study|Lost to follow up after study treatment|11|||
129534052|NCT01503229|466246454|FG000|Overall Study|Withdrew consent|1|||
129534053|NCT01078389|466246455|FG000|Overall Study|Adverse Event|10|||
129534054|NCT01078389|466246456|FG001|Overall Study|Adverse Event|6|||
129534055|NCT01078389|466246455|FG000|Overall Study|Major Protocol Deviation|2|||
129534056|NCT01078389|466246456|FG001|Overall Study|Major Protocol Deviation|0|||
129534057|NCT01078389|466246455|FG000|Overall Study|Lost to Follow-up|23|||
129534058|NCT01078389|466246456|FG001|Overall Study|Lost to Follow-up|23|||
129534059|NCT01078389|466246455|FG000|Overall Study|Voluntary Withdrawal|20|||
129534060|NCT01078389|466246456|FG001|Overall Study|Voluntary Withdrawal|36|||
129534061|NCT01078389|466246455|FG000|Overall Study|Other|9|||
129534062|NCT01078389|466246456|FG001|Overall Study|Other|2|||
129534063|NCT01002573|466246457|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
129534064|NCT01002573|466246458|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
129534065|NCT02028182|466246459|FG000|Overall Study|Protocol Violation|2|||
129534066|NCT02198040|466246462|FG000|Overall Study|Work reasons|0|||
129534067|NCT02198040|466246463|FG001|Overall Study|Work reasons|1|||
129534068|NCT02198040|466246464|FG002|Overall Study|Work reasons|0|||
129534069|NCT02198040|466246462|FG000|Overall Study|Withdrawal by Subject|0|||
129534070|NCT02198040|466246463|FG001|Overall Study|Withdrawal by Subject|0|||
129534071|NCT02198040|466246464|FG002|Overall Study|Withdrawal by Subject|1|||
129534072|NCT04524663|466246465|FG000|Overall Study|Withdrawal by Subject|0|||
129534073|NCT04524663|466246466|FG001|Overall Study|Withdrawal by Subject|2|||
129534074|NCT00337935|466246467|FG000|Overall Study|Adverse Event|2|||
129534075|NCT00337935|466246468|FG001|Overall Study|Adverse Event|5|||
129534076|NCT00337935|466246467|FG000|Overall Study|Death|2|||
129534077|NCT00337935|466246468|FG001|Overall Study|Death|8|||
129534078|NCT00337935|466246467|FG000|Overall Study|Physician Decision|1|||
129534079|NCT00337935|466246468|FG001|Overall Study|Physician Decision|1|||
129534080|NCT00337935|466246467|FG000|Overall Study|Lost to Follow-up|0|||
129534081|NCT00337935|466246468|FG001|Overall Study|Lost to Follow-up|1|||
129534082|NCT00337935|466246467|FG000|Overall Study|Protocol Violation|4|||
129534083|NCT00337935|466246468|FG001|Overall Study|Protocol Violation|3|||
129534084|NCT00337935|466246467|FG000|Overall Study|Withdrawal by Subject|1|||
129534085|NCT00337935|466246468|FG001|Overall Study|Withdrawal by Subject|7|||
129534086|NCT00337935|466246467|FG000|Overall Study|Other|0|||
129534087|NCT00337935|466246468|FG001|Overall Study|Other|1|||
129534088|NCT00337935|466246467|FG000|Overall Study|Lack of Efficacy|0|||
129534089|NCT00337935|466246468|FG001|Overall Study|Lack of Efficacy|1|||
129534090|NCT01884675|466246469|FG000|Overall Study|Study closed/terminated|3|||
129534091|NCT01884675|466246470|FG001|Overall Study|Study closed/terminated|2|||
129534092|NCT02361307|466246471|FG000|Overall Study|Unstable medical condition.|0|||
129534093|NCT02361307|466246472|FG001|Overall Study|Unstable medical condition.|1|||
129534094|NCT00711009|466246473|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
129534095|NCT00711009|466246474|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
129534096|NCT00711009|466246473|FG000|Overall Study|Withdrawal by Subject|4|||
129534097|NCT00711009|466246474|FG001|Overall Study|Withdrawal by Subject|2|||
129534098|NCT00711009|466246473|FG000|Overall Study|Lost to Follow-up|3|||
129534099|NCT00711009|466246474|FG001|Overall Study|Lost to Follow-up|9|||
129534100|NCT00711009|466246473|FG000|Overall Study|Participant Noncompliant|0|||
129534101|NCT00711009|466246474|FG001|Overall Study|Participant Noncompliant|1|||
129534102|NCT00711009|466246473|FG000|Overall Study|Virologic Failure|2|||
129534103|NCT00711009|466246474|FG001|Overall Study|Virologic Failure|1|||
129534104|NCT00711009|466246473|FG000|Overall Study|Pregnancy|1|||
129534105|NCT00711009|466246474|FG001|Overall Study|Pregnancy|0|||
129534106|NCT00711009|466246473|FG000|Overall Study|Site closing|0|||
129534107|NCT00711009|466246474|FG001|Overall Study|Site closing|1|||
129534108|NCT00711009|466246473|FG000|Overall Study|Dose adjustment|1|||
129534109|NCT00711009|466246474|FG001|Overall Study|Dose adjustment|0|||
129534110|NCT03359811|466246475|FG000|Overall Study|Protocol Violation|2|||
129534111|NCT03359811|466246476|FG001|Overall Study|Protocol Violation|0|||
129534112|NCT01682876|466246477|FG000|Overall Study|Administrative reason|4|||
129534113|NCT01682876|466246478|FG001|Overall Study|Administrative reason|4|||
129534114|NCT01682876|466246479|FG002|Overall Study|Administrative reason|0|||
129534115|NCT01682876|466246480|FG003|Overall Study|Administrative reason|3|||
129534116|NCT01682876|466246477|FG000|Overall Study|Adverse Event|0|||
129534117|NCT01682876|466246478|FG001|Overall Study|Adverse Event|0|||
129534118|NCT01682876|466246479|FG002|Overall Study|Adverse Event|0|||
129534119|NCT01682876|466246480|FG003|Overall Study|Adverse Event|1|||
129534120|NCT01682876|466246477|FG000|Overall Study|Lost to Follow-up|11|||
129534121|NCT01682876|466246478|FG001|Overall Study|Lost to Follow-up|15|||
129534122|NCT01682876|466246479|FG002|Overall Study|Lost to Follow-up|9|||
129534123|NCT01682876|466246480|FG003|Overall Study|Lost to Follow-up|11|||
129534124|NCT01682876|466246477|FG000|Overall Study|Protocol Violation|1|||
129534125|NCT01682876|466246478|FG001|Overall Study|Protocol Violation|1|||
129534126|NCT01682876|466246479|FG002|Overall Study|Protocol Violation|1|||
129534127|NCT01682876|466246480|FG003|Overall Study|Protocol Violation|1|||
129534128|NCT01682876|466246477|FG000|Overall Study|Withdrawal by Subject|4|||
129534129|NCT01682876|466246478|FG001|Overall Study|Withdrawal by Subject|0|||
129534130|NCT01682876|466246479|FG002|Overall Study|Withdrawal by Subject|0|||
129534131|NCT01682876|466246480|FG003|Overall Study|Withdrawal by Subject|2|||
129534132|NCT01682876|466246477|FG000|Overall Study|Other|1|||
129534133|NCT01682876|466246478|FG001|Overall Study|Other|0|||
129534134|NCT01682876|466246479|FG002|Overall Study|Other|1|||
129534135|NCT01682876|466246480|FG003|Overall Study|Other|1|||
129534136|NCT02534324|466246482|FG000|Overall Study|Protocol Violation|4|||
129534137|NCT02534324|466246483|FG001|Overall Study|Protocol Violation|1|||
129534138|NCT02534324|466246482|FG000|Overall Study|Lost to Follow-up|20|||
129534139|NCT02534324|466246483|FG001|Overall Study|Lost to Follow-up|7|||
129534140|NCT02534324|466246482|FG000|Overall Study|Adverse Event|1|||
129534141|NCT02534324|466246483|FG001|Overall Study|Adverse Event|0|||
129534142|NCT01459016|466246486|FG000|Overall Study|Withdrawal by Subject|11|||
129534143|NCT01459016|466246486|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
129534144|NCT00240331|466246487|FG000|Overall Study|Withdrawal by Subject|125|||
129534145|NCT00240331|466246488|FG001|Overall Study|Withdrawal by Subject|132|||
129534146|NCT00240331|466246487|FG000|Overall Study|Option selected by investigator|1|||
129534147|NCT00240331|466246488|FG001|Overall Study|Option selected by investigator|2|||
129534148|NCT02491463|466246491|FG000|Overall Study|Withdrawal by Subject|1|||
129534149|NCT02491463|466246492|FG001|Overall Study|Withdrawal by Subject|2|||
129534150|NCT02491463|466246493|FG002|Overall Study|Withdrawal by Subject|0|||
129534151|NCT02491463|466246494|FG003|Overall Study|Withdrawal by Subject|0|||
129534152|NCT02491463|466246491|FG000|Overall Study|Migrated/moved from study area|1|||
129534153|NCT02491463|466246492|FG001|Overall Study|Migrated/moved from study area|5|||
129534154|NCT02491463|466246493|FG002|Overall Study|Migrated/moved from study area|1|||
129534155|NCT02491463|466246494|FG003|Overall Study|Migrated/moved from study area|1|||
129534156|NCT02491463|466246491|FG000|Overall Study|Lost to Follow-up|0|||
129534157|NCT02491463|466246492|FG001|Overall Study|Lost to Follow-up|3|||
129534158|NCT02491463|466246493|FG002|Overall Study|Lost to Follow-up|3|||
129534159|NCT02491463|466246494|FG003|Overall Study|Lost to Follow-up|0|||
129534160|NCT01491802|466246495|FG000|Overall Study|Adverse Event|1|||
129534161|NCT01491802|466246496|FG001|Overall Study|Adverse Event|1|||
129534162|NCT01491802|466246495|FG000|Overall Study|Withdrawal by Subject|0|||
129534163|NCT01491802|466246496|FG001|Overall Study|Withdrawal by Subject|1|||
129534164|NCT01249404|466246500|FG000|Overall Study|Study treatment not received|0|||
129534165|NCT01249404|466246501|FG001|Overall Study|Study treatment not received|1|||
129534166|NCT01249404|466246502|FG002|Overall Study|Study treatment not received|2|||
129534167|NCT01249404|466246500|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
129534168|NCT01249404|466246501|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
129534169|NCT01249404|466246502|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
129534170|NCT01249404|466246500|FG000|Overall Study|Adverse Event|2|||
129534171|NCT01249404|466246501|FG001|Overall Study|Adverse Event|2|||
129534172|NCT01249404|466246502|FG002|Overall Study|Adverse Event|2|||
129534173|NCT01249404|466246500|FG000|Overall Study|Withdrawal by Subject|2|||
129534174|NCT01249404|466246501|FG001|Overall Study|Withdrawal by Subject|2|||
129534175|NCT01249404|466246502|FG002|Overall Study|Withdrawal by Subject|0|||
129534176|NCT01249404|466246500|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
129534177|NCT01249404|466246501|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
129534178|NCT01249404|466246502|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
129534179|NCT01249404|466246500|FG000|Overall Study|Non compliance to visit schedule|0|||
129534180|NCT01249404|466246501|FG001|Overall Study|Non compliance to visit schedule|1|||
129534181|NCT01249404|466246502|FG002|Overall Study|Non compliance to visit schedule|0|||
129534182|NCT04563845|466246503|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534183|NCT04563845|466246504|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534184|NCT04563845|466246505|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534185|NCT04563845|466246506|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534186|NCT04563845|466246507|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534187|NCT04563845|466246508|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534188|NCT04563845|466246509|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534189|NCT04563845|466246510|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
129534190|NCT04563845|466246511|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534191|NCT04563845|466246512|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534192|NCT04563845|466246513|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534193|NCT04563845|466246514|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534194|NCT04563845|466246515|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534195|NCT04563845|466246516|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
129534196|NCT04563845|466246503|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534197|NCT04563845|466246504|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534198|NCT04563845|466246505|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534199|NCT04563845|466246506|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534200|NCT04563845|466246507|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
129534201|NCT04563845|466246508|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534202|NCT04563845|466246509|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534203|NCT04563845|466246510|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534204|NCT04563845|466246511|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534205|NCT04563845|466246512|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534206|NCT04563845|466246513|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534207|NCT04563845|466246514|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534208|NCT04563845|466246515|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534209|NCT04563845|466246516|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
129534210|NCT02927990|466246517|FG000|Overall Study|Protocol Violation|4|||
129534211|NCT02927990|466246517|FG000|Overall Study|Physician Decision|9|||
129534212|NCT02927990|466246517|FG000|Overall Study|Room switched and therefore no study device available|15|||
129534213|NCT02927990|466246517|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
129534214|NCT00960323|466246518|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
129534215|NCT02146274|466246519|FG000|Overall Study|Protocol Violation|73|||
129534216|NCT03824704|466246525|FG000|Overall Study|Study Terminated by Sponsor|1|||
129534217|NCT02719028|466246527|FG000|Overall Study|Adverse Event|2|||
129534218|NCT02719028|466246528|FG001|Overall Study|Adverse Event|1|||
129534219|NCT02719028|466246529|FG002|Overall Study|Adverse Event|4|||
129534220|NCT02719028|466246530|FG003|Overall Study|Adverse Event|8|||
129534221|NCT02719028|466246527|FG000|Overall Study|Physician Decision|0|||
129534222|NCT02719028|466246528|FG001|Overall Study|Physician Decision|1|||
129534223|NCT02719028|466246529|FG002|Overall Study|Physician Decision|1|||
129534224|NCT02719028|466246530|FG003|Overall Study|Physician Decision|1|||
129534225|NCT02719028|466246527|FG000|Overall Study|Use of prohibited medication|0|||
129534226|NCT02719028|466246528|FG001|Overall Study|Use of prohibited medication|0|||
129534227|NCT02719028|466246529|FG002|Overall Study|Use of prohibited medication|1|||
129534228|NCT02719028|466246530|FG003|Overall Study|Use of prohibited medication|0|||
129534229|NCT02719028|466246527|FG000|Overall Study|Protocol Violation|0|||
129534230|NCT02719028|466246528|FG001|Overall Study|Protocol Violation|0|||
129534231|NCT02719028|466246529|FG002|Overall Study|Protocol Violation|0|||
129534232|NCT02719028|466246530|FG003|Overall Study|Protocol Violation|1|||
129534233|NCT01539720|466246531|FG000|Overall Study|Screen Fail|15|||
129534234|NCT01539720|466246532|FG001|Overall Study|Screen Fail|3|||
129534235|NCT01539720|466246531|FG000|Overall Study|Lost to Follow-up|14|||
129534236|NCT01539720|466246532|FG001|Overall Study|Lost to Follow-up|7|||
129534237|NCT03287960|466246533|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
129534238|NCT03287960|466246533|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
129534239|NCT03730987|466246536|FG000|Overall Study|Lost to Follow-up|2|||
129534240|NCT03730987|466246537|FG001|Overall Study|Lost to Follow-up|0|||
129534241|NCT03730987|466246538|FG002|Overall Study|Lost to Follow-up|2|||
129534242|NCT03730987|466246539|FG003|Overall Study|Lost to Follow-up|0|||
129534243|NCT01667731|466246543|FG000|Overall Study|Enrolled but not treated|0|||
129534244|NCT01667731|466246544|FG001|Overall Study|Enrolled but not treated|0|||
129534245|NCT01667731|466246545|FG002|Overall Study|Enrolled but not treated|0|||
129534246|NCT01667731|466246546|FG003|Overall Study|Enrolled but not treated|0|||
129534247|NCT01667731|466246547|FG004|Overall Study|Enrolled but not treated|1|||
129534248|NCT01667731|466246543|FG000|Overall Study|Efficacy Failure|1|||
129534249|NCT01667731|466246544|FG001|Overall Study|Efficacy Failure|12|||
129534250|NCT01667731|466246545|FG002|Overall Study|Efficacy Failure|0|||
129534251|NCT01667731|466246546|FG003|Overall Study|Efficacy Failure|1|||
129534252|NCT01667731|466246547|FG004|Overall Study|Efficacy Failure|24|||
129534253|NCT01667731|466246543|FG000|Overall Study|Lost to Follow-up|2|||
129534254|NCT01667731|466246544|FG001|Overall Study|Lost to Follow-up|3|||
129534255|NCT01667731|466246545|FG002|Overall Study|Lost to Follow-up|1|||
129534256|NCT01667731|466246546|FG003|Overall Study|Lost to Follow-up|1|||
129534257|NCT01667731|466246547|FG004|Overall Study|Lost to Follow-up|2|||
129534258|NCT01667731|466246543|FG000|Overall Study|Subject Withdrew Consent|2|||
129534259|NCT01667731|466246544|FG001|Overall Study|Subject Withdrew Consent|0|||
129534260|NCT01667731|466246545|FG002|Overall Study|Subject Withdrew Consent|1|||
129534261|NCT01667731|466246546|FG003|Overall Study|Subject Withdrew Consent|0|||
129534262|NCT01667731|466246547|FG004|Overall Study|Subject Withdrew Consent|1|||
129534263|NCT01667731|466246543|FG000|Overall Study|Death|0|||
129534264|NCT01667731|466246544|FG001|Overall Study|Death|1|||
129534265|NCT01667731|466246545|FG002|Overall Study|Death|0|||
129534266|NCT01667731|466246546|FG003|Overall Study|Death|0|||
129534267|NCT01667731|466246547|FG004|Overall Study|Death|0|||
129534268|NCT01425268|466246548|FG000|Overall Study|Withdrawal by Subject|2|||
129534269|NCT01425268|466246549|FG001|Overall Study|Withdrawal by Subject|0|||
129534270|NCT01425268|466246548|FG000|Overall Study|Sponsor Decision|5|||
129534271|NCT01425268|466246549|FG001|Overall Study|Sponsor Decision|0|||
129534272|NCT01425268|466246548|FG000|Overall Study|Physician Decision|1|||
129534273|NCT01425268|466246549|FG001|Overall Study|Physician Decision|0|||
129534274|NCT02839330|466246550|FG000|Overall Study|Adverse Event|0|||
129534275|NCT02839330|466246551|FG001|Overall Study|Adverse Event|1|||
129534276|NCT02839330|466246552|FG002|Overall Study|Adverse Event|2|||
129534277|NCT02839330|466246553|FG003|Overall Study|Adverse Event|2|||
129534278|NCT02839330|466246550|FG000|Overall Study|Death|4|||
129534279|NCT02839330|466246551|FG001|Overall Study|Death|6|||
129534280|NCT02839330|466246552|FG002|Overall Study|Death|1|||
129534281|NCT02839330|466246553|FG003|Overall Study|Death|1|||
129534282|NCT02839330|466246550|FG000|Overall Study|Withdrawal by Subject|27|||
129534283|NCT02839330|466246551|FG001|Overall Study|Withdrawal by Subject|19|||
129534284|NCT02839330|466246552|FG002|Overall Study|Withdrawal by Subject|11|||
129534285|NCT02839330|466246553|FG003|Overall Study|Withdrawal by Subject|13|||
129534286|NCT02839330|466246550|FG000|Overall Study|Lost to Follow-up|22|||
129534287|NCT02839330|466246551|FG001|Overall Study|Lost to Follow-up|27|||
129534288|NCT02839330|466246552|FG002|Overall Study|Lost to Follow-up|29|||
129534289|NCT02839330|466246553|FG003|Overall Study|Lost to Follow-up|25|||
129534290|NCT02839330|466246550|FG000|Overall Study|Administrative Reason|0|||
129534291|NCT02839330|466246551|FG001|Overall Study|Administrative Reason|0|||
129534292|NCT02839330|466246552|FG002|Overall Study|Administrative Reason|0|||
129534293|NCT02839330|466246553|FG003|Overall Study|Administrative Reason|1|||
129534294|NCT02839330|466246550|FG000|Overall Study|Protocol Violation|1|||
129534295|NCT02839330|466246551|FG001|Overall Study|Protocol Violation|2|||
129534296|NCT02839330|466246552|FG002|Overall Study|Protocol Violation|2|||
129534297|NCT02839330|466246553|FG003|Overall Study|Protocol Violation|3|||
129534298|NCT02839330|466246550|FG000|Overall Study|Other reason, not specified|4|||
129534299|NCT02839330|466246551|FG001|Overall Study|Other reason, not specified|3|||
129534300|NCT02839330|466246552|FG002|Overall Study|Other reason, not specified|3|||
129534301|NCT02839330|466246553|FG003|Overall Study|Other reason, not specified|6|||
129534302|NCT01345162|466246558|FG000|Overall Study|Protocol Violation|2|||
129534303|NCT01345162|466246559|FG001|Overall Study|Protocol Violation|4|||
129534304|NCT00883896|466246561|FG000|Overall Study|Lost to Follow-up|0|||
129534305|NCT00883896|466246562|FG001|Overall Study|Lost to Follow-up|0|||
129534306|NCT00883896|466246563|FG002|Overall Study|Lost to Follow-up|0|||
129534307|NCT00883896|466246564|FG003|Overall Study|Lost to Follow-up|2|||
129534308|NCT00883896|466246561|FG000|Overall Study|Withdrawal by Subject|5|||
129534309|NCT00883896|466246562|FG001|Overall Study|Withdrawal by Subject|0|||
129534310|NCT00883896|466246563|FG002|Overall Study|Withdrawal by Subject|1|||
129534311|NCT00883896|466246564|FG003|Overall Study|Withdrawal by Subject|3|||
129534312|NCT00883896|466246561|FG000|Overall Study|Lack of Efficacy|0|||
129534313|NCT00883896|466246562|FG001|Overall Study|Lack of Efficacy|0|||
129534314|NCT00883896|466246563|FG002|Overall Study|Lack of Efficacy|0|||
129534315|NCT00883896|466246564|FG003|Overall Study|Lack of Efficacy|2|||
129534316|NCT00883896|466246561|FG000|Overall Study|Other|1|||
129534317|NCT00883896|466246562|FG001|Overall Study|Other|0|||
129534318|NCT00883896|466246563|FG002|Overall Study|Other|0|||
129534319|NCT00883896|466246564|FG003|Overall Study|Other|0|||
129534320|NCT00174460|466246571|FG000|Overall Study|Withdrawal by Subject|0|||
129534321|NCT00174460|466246572|FG001|Overall Study|Withdrawal by Subject|1|||
129534322|NCT00579059|466246573|FG000|Overall Study|Study Canceled at 1 Year|21|||
129534323|NCT00579059|466246574|FG001|Overall Study|Study Canceled at 1 Year|10|||
129534324|NCT00779506|466246576|FG000|Overall Study|Screening Failed|2|||
129534325|NCT00779506|466246576|FG000|Overall Study|Adverse Event|4|||
129534326|NCT00779506|466246576|FG000|Overall Study|Lack of Efficacy|11|||
129534327|NCT00779506|466246576|FG000|Overall Study|Protocol Violation|5|||
129534328|NCT00779506|466246576|FG000|Overall Study|Withdrawal by Subject|6|||
129534329|NCT00779506|466246576|FG000|Overall Study|Lost to Follow-up|1|||
129534330|NCT04047472|466246577|FG000|Overall Study|Adverse Event|3|||
129534331|NCT04047472|466246578|FG001|Overall Study|Adverse Event|3|||
129534332|NCT04047472|466246577|FG000|Overall Study|Death|0|||
129534333|NCT04047472|466246578|FG001|Overall Study|Death|1|||
129534334|NCT04047472|466246577|FG000|Overall Study|Lost to Follow-up|1|||
129534335|NCT04047472|466246578|FG001|Overall Study|Lost to Follow-up|0|||
129534336|NCT04047472|466246577|FG000|Overall Study|Physician Decision|1|||
129534337|NCT04047472|466246578|FG001|Overall Study|Physician Decision|2|||
129534338|NCT04047472|466246577|FG000|Overall Study|Protocol Violation|1|||
129534339|NCT04047472|466246578|FG001|Overall Study|Protocol Violation|0|||
129534340|NCT04047472|466246577|FG000|Overall Study|Withdrawal by Subject|10|||
129534341|NCT04047472|466246578|FG001|Overall Study|Withdrawal by Subject|10|||
129534342|NCT02030067|466246579|FG000|Overall Study|Disease Progression|1|||
129534343|NCT02030067|466246580|FG001|Overall Study|Disease Progression|1|||
129534344|NCT02030067|466246581|FG002|Overall Study|Disease Progression|2|||
129534345|NCT02030067|466246582|FG003|Overall Study|Disease Progression|2|||
129534346|NCT02030067|466246583|FG004|Overall Study|Disease Progression|3|||
129534347|NCT02030067|466246584|FG005|Overall Study|Disease Progression|2|||
129534348|NCT02030067|466246585|FG006|Overall Study|Disease Progression|3|||
129534349|NCT02030067|466246586|FG007|Overall Study|Disease Progression|3|||
129534350|NCT02030067|466246587|FG008|Overall Study|Disease Progression|4|||
129534351|NCT02030067|466246588|FG009|Overall Study|Disease Progression|3|||
129534352|NCT02030067|466246589|FG010|Overall Study|Disease Progression|7|||
129534353|NCT02030067|466246590|FG011|Overall Study|Disease Progression|2|||
129534354|NCT02030067|466246591|FG012|Overall Study|Disease Progression|59|||
129534355|NCT02030067|466246579|FG000|Overall Study|Withdrawal by Subject|0|||
129534356|NCT02030067|466246580|FG001|Overall Study|Withdrawal by Subject|0|||
129534357|NCT02030067|466246581|FG002|Overall Study|Withdrawal by Subject|0|||
129534358|NCT02030067|466246582|FG003|Overall Study|Withdrawal by Subject|1|||
129534359|NCT02030067|466246583|FG004|Overall Study|Withdrawal by Subject|0|||
129534360|NCT02030067|466246584|FG005|Overall Study|Withdrawal by Subject|0|||
129534361|NCT02030067|466246585|FG006|Overall Study|Withdrawal by Subject|0|||
129534362|NCT02030067|466246586|FG007|Overall Study|Withdrawal by Subject|1|||
129534363|NCT02030067|466246587|FG008|Overall Study|Withdrawal by Subject|0|||
129534364|NCT02030067|466246588|FG009|Overall Study|Withdrawal by Subject|0|||
129534365|NCT02030067|466246589|FG010|Overall Study|Withdrawal by Subject|3|||
129534366|NCT02030067|466246590|FG011|Overall Study|Withdrawal by Subject|0|||
129534367|NCT02030067|466246591|FG012|Overall Study|Withdrawal by Subject|6|||
129534368|NCT02030067|466246579|FG000|Overall Study|Physician Decision|0|||
129534369|NCT02030067|466246580|FG001|Overall Study|Physician Decision|0|||
129534370|NCT02030067|466246581|FG002|Overall Study|Physician Decision|0|||
129534371|NCT02030067|466246582|FG003|Overall Study|Physician Decision|0|||
129534372|NCT02030067|466246583|FG004|Overall Study|Physician Decision|0|||
129534373|NCT02030067|466246584|FG005|Overall Study|Physician Decision|0|||
129534374|NCT02030067|466246585|FG006|Overall Study|Physician Decision|0|||
129534375|NCT02030067|466246586|FG007|Overall Study|Physician Decision|0|||
129534376|NCT02030067|466246587|FG008|Overall Study|Physician Decision|0|||
129534377|NCT02030067|466246588|FG009|Overall Study|Physician Decision|0|||
129534378|NCT02030067|466246589|FG010|Overall Study|Physician Decision|1|||
129534379|NCT02030067|466246590|FG011|Overall Study|Physician Decision|0|||
129534380|NCT02030067|466246591|FG012|Overall Study|Physician Decision|3|||
129534381|NCT02030067|466246579|FG000|Overall Study|other reasons|0|||
129534382|NCT02030067|466246580|FG001|Overall Study|other reasons|0|||
129534383|NCT02030067|466246581|FG002|Overall Study|other reasons|0|||
129534384|NCT02030067|466246582|FG003|Overall Study|other reasons|0|||
129534385|NCT02030067|466246583|FG004|Overall Study|other reasons|0|||
129534386|NCT02030067|466246584|FG005|Overall Study|other reasons|1|||
129534387|NCT02030067|466246585|FG006|Overall Study|other reasons|0|||
129534388|NCT02030067|466246586|FG007|Overall Study|other reasons|0|||
129534389|NCT02030067|466246587|FG008|Overall Study|other reasons|2|||
129534390|NCT02030067|466246588|FG009|Overall Study|other reasons|0|||
129534391|NCT02030067|466246589|FG010|Overall Study|other reasons|0|||
129534392|NCT02030067|466246590|FG011|Overall Study|other reasons|0|||
129534393|NCT02030067|466246591|FG012|Overall Study|other reasons|4|||
129534394|NCT02030067|466246579|FG000|Overall Study|Adverse Event|0|||
129534395|NCT02030067|466246580|FG001|Overall Study|Adverse Event|0|||
129534396|NCT02030067|466246581|FG002|Overall Study|Adverse Event|0|||
129534397|NCT02030067|466246582|FG003|Overall Study|Adverse Event|0|||
129534398|NCT02030067|466246583|FG004|Overall Study|Adverse Event|0|||
129534399|NCT02030067|466246584|FG005|Overall Study|Adverse Event|0|||
129534400|NCT02030067|466246585|FG006|Overall Study|Adverse Event|0|||
129534401|NCT02030067|466246586|FG007|Overall Study|Adverse Event|0|||
129534402|NCT02030067|466246587|FG008|Overall Study|Adverse Event|0|||
129534403|NCT02030067|466246588|FG009|Overall Study|Adverse Event|0|||
129534404|NCT02030067|466246589|FG010|Overall Study|Adverse Event|0|||
129534405|NCT02030067|466246590|FG011|Overall Study|Adverse Event|1|||
129534406|NCT02030067|466246591|FG012|Overall Study|Adverse Event|8|||
129534407|NCT01632345|466246592|FG000|Treatment: Part I|Adverse Event|1|||
129534408|NCT01632345|466246593|FG001|Treatment: Part I|Adverse Event|4|||
129534409|NCT01632345|466246594|FG002|Treatment: Part I|Adverse Event|2|||
129534410|NCT01632345|466246595|FG003|Treatment: Part I|Adverse Event|1|||
129534411|NCT01632345|466246596|FG004|Treatment: Part I|Adverse Event|3|||
129534412|NCT01632345|466246597|FG005|Treatment: Part I|Adverse Event|0|||
129534413|NCT01632345|466246598|FG006|Treatment: Part I|Adverse Event|0|||
129534414|NCT01632345|466246592|FG000|Treatment: Part I|Lack of Efficacy|0|||
129534415|NCT01632345|466246593|FG001|Treatment: Part I|Lack of Efficacy|1|||
129534416|NCT01632345|466246594|FG002|Treatment: Part I|Lack of Efficacy|0|||
129534417|NCT01632345|466246595|FG003|Treatment: Part I|Lack of Efficacy|1|||
129534418|NCT01632345|466246596|FG004|Treatment: Part I|Lack of Efficacy|1|||
129534419|NCT01632345|466246597|FG005|Treatment: Part I|Lack of Efficacy|0|||
129534420|NCT01632345|466246598|FG006|Treatment: Part I|Lack of Efficacy|0|||
129534421|NCT01632345|466246592|FG000|Treatment: Part I|Lost to Follow-up|3|||
129534422|NCT01632345|466246593|FG001|Treatment: Part I|Lost to Follow-up|2|||
129534423|NCT01632345|466246594|FG002|Treatment: Part I|Lost to Follow-up|1|||
129534424|NCT01632345|466246595|FG003|Treatment: Part I|Lost to Follow-up|3|||
129534425|NCT01632345|466246596|FG004|Treatment: Part I|Lost to Follow-up|4|||
129534426|NCT01632345|466246597|FG005|Treatment: Part I|Lost to Follow-up|0|||
129534427|NCT01632345|466246598|FG006|Treatment: Part I|Lost to Follow-up|0|||
129534428|NCT01632345|466246592|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
129534429|NCT01632345|466246593|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
129534430|NCT01632345|466246594|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
129534431|NCT01632345|466246595|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
129534432|NCT01632345|466246596|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
129534433|NCT01632345|466246597|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
129534434|NCT01632345|466246598|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
129534435|NCT01632345|466246592|FG000|Treatment: Part I|Physician Decision|2|||
129534436|NCT01632345|466246593|FG001|Treatment: Part I|Physician Decision|1|||
129534437|NCT01632345|466246594|FG002|Treatment: Part I|Physician Decision|0|||
129534438|NCT01632345|466246595|FG003|Treatment: Part I|Physician Decision|0|||
129534439|NCT01632345|466246596|FG004|Treatment: Part I|Physician Decision|1|||
129534440|NCT01632345|466246597|FG005|Treatment: Part I|Physician Decision|0|||
129534441|NCT01632345|466246598|FG006|Treatment: Part I|Physician Decision|0|||
129534442|NCT01632345|466246592|FG000|Treatment: Part I|Pregnancy|0|||
129534443|NCT01632345|466246593|FG001|Treatment: Part I|Pregnancy|1|||
129534444|NCT01632345|466246594|FG002|Treatment: Part I|Pregnancy|0|||
129534445|NCT01632345|466246595|FG003|Treatment: Part I|Pregnancy|0|||
129534446|NCT01632345|466246596|FG004|Treatment: Part I|Pregnancy|0|||
129534447|NCT01632345|466246597|FG005|Treatment: Part I|Pregnancy|0|||
129534448|NCT01632345|466246598|FG006|Treatment: Part I|Pregnancy|0|||
129534449|NCT01632345|466246592|FG000|Treatment: Part I|Protocol Deviation|0|||
129534450|NCT01632345|466246593|FG001|Treatment: Part I|Protocol Deviation|0|||
129534451|NCT01632345|466246594|FG002|Treatment: Part I|Protocol Deviation|1|||
129534452|NCT01632345|466246595|FG003|Treatment: Part I|Protocol Deviation|1|||
129534453|NCT01632345|466246596|FG004|Treatment: Part I|Protocol Deviation|0|||
129534454|NCT01632345|466246597|FG005|Treatment: Part I|Protocol Deviation|0|||
129534455|NCT01632345|466246598|FG006|Treatment: Part I|Protocol Deviation|0|||
129534456|NCT01632345|466246592|FG000|Treatment: Part I|Withdrawal by Subject|3|||
129534457|NCT01632345|466246593|FG001|Treatment: Part I|Withdrawal by Subject|4|||
129534458|NCT01632345|466246594|FG002|Treatment: Part I|Withdrawal by Subject|4|||
129534459|NCT01632345|466246595|FG003|Treatment: Part I|Withdrawal by Subject|1|||
129534460|NCT01632345|466246596|FG004|Treatment: Part I|Withdrawal by Subject|4|||
129534461|NCT01632345|466246597|FG005|Treatment: Part I|Withdrawal by Subject|0|||
129534462|NCT01632345|466246598|FG006|Treatment: Part I|Withdrawal by Subject|0|||
129534463|NCT01632345|466246592|FG000|Treatment: Part II|Adverse Event|0|||
129534464|NCT01632345|466246593|FG001|Treatment: Part II|Adverse Event|0|||
129534465|NCT01632345|466246594|FG002|Treatment: Part II|Adverse Event|0|||
129534466|NCT01632345|466246595|FG003|Treatment: Part II|Adverse Event|0|||
129534467|NCT01632345|466246596|FG004|Treatment: Part II|Adverse Event|0|||
129534468|NCT01632345|466246597|FG005|Treatment: Part II|Adverse Event|3|||
129534469|NCT01632345|466246598|FG006|Treatment: Part II|Adverse Event|8|||
129534470|NCT01632345|466246592|FG000|Treatment: Part II|Lost to Follow-up|0|||
129534471|NCT01632345|466246593|FG001|Treatment: Part II|Lost to Follow-up|0|||
129534472|NCT01632345|466246594|FG002|Treatment: Part II|Lost to Follow-up|0|||
129534473|NCT01632345|466246595|FG003|Treatment: Part II|Lost to Follow-up|0|||
129534474|NCT01632345|466246596|FG004|Treatment: Part II|Lost to Follow-up|0|||
129534475|NCT01632345|466246597|FG005|Treatment: Part II|Lost to Follow-up|3|||
129534476|NCT01632345|466246598|FG006|Treatment: Part II|Lost to Follow-up|1|||
129534477|NCT01632345|466246592|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
129534478|NCT01632345|466246593|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
129534479|NCT01632345|466246594|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
129534480|NCT01632345|466246595|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
129534481|NCT01632345|466246596|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
129534482|NCT01632345|466246597|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
129534483|NCT01632345|466246598|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
129534484|NCT01632345|466246592|FG000|Treatment: Part II|Withdrawal by Subject|0|||
129534485|NCT01632345|466246593|FG001|Treatment: Part II|Withdrawal by Subject|0|||
129534486|NCT01632345|466246594|FG002|Treatment: Part II|Withdrawal by Subject|0|||
129534487|NCT01632345|466246595|FG003|Treatment: Part II|Withdrawal by Subject|0|||
129534488|NCT01632345|466246596|FG004|Treatment: Part II|Withdrawal by Subject|0|||
129534489|NCT01632345|466246597|FG005|Treatment: Part II|Withdrawal by Subject|2|||
129534490|NCT01632345|466246598|FG006|Treatment: Part II|Withdrawal by Subject|2|||
129534491|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
129534492|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
129534493|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
129534494|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
129534495|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
129534496|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
129534497|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Death|1|||
129534498|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Death|1|||
129534499|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Death|1|||
129534500|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Death|0|||
129534501|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Death|0|||
129534502|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Death|0|||
129534503|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
129534504|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
129534505|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
129534506|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
129534507|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
129534508|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
129534509|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
129534510|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
129534511|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
129534512|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
129534513|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
129534514|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
129534515|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
129534516|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
129534517|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
129534518|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
129534519|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
129534520|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
129534521|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
129534522|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
129534523|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
129534524|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
129534525|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
129534526|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
129534527|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
129534528|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
129534529|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
129534530|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
129534531|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
129534532|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
129534533|NCT03370133|466246606|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
129534534|NCT03370133|466246607|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
129534535|NCT03370133|466246608|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
129534536|NCT03370133|466246609|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
129534537|NCT03370133|466246610|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
129534538|NCT03370133|466246611|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
129534539|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
129534540|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
129534541|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
129534542|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
129534543|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
129534544|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
129534545|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
129534546|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
129534547|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
129534548|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
129534549|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
129534550|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
129534551|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
129534552|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
129534553|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
129534554|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
129534555|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
129534556|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
129534557|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
129534558|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
129534559|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
129534560|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
129534561|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
129534562|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
129534563|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
129534564|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
129534565|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
129534566|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
129534567|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
129534568|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
129534569|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
129534570|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
129534571|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
129534572|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
129534573|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
129534574|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
129534575|NCT03370133|466246606|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
129534576|NCT03370133|466246607|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
129534577|NCT03370133|466246608|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
129534578|NCT03370133|466246609|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
129534579|NCT03370133|466246610|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
129534580|NCT03370133|466246611|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
129534581|NCT00636506|466246612|FG000|Overall Study|Lost to Follow-up|8|||
129534582|NCT00636506|466246612|FG000|Overall Study|Explanted|1|||
129534583|NCT00636506|466246612|FG000|Overall Study|Withdrawal by Subject|6|||
129534584|NCT00636506|466246612|FG000|Overall Study|Procedure aborted|1|||
129534585|NCT03125902|466246613|FG000|Overall Study|Adverse Event|0|||
129534586|NCT03125902|466246614|FG001|Overall Study|Adverse Event|1|||
129534587|NCT03125902|466246613|FG000|Overall Study|Death|119|||
129534588|NCT03125902|466246614|FG001|Overall Study|Death|229|||
129534589|NCT03125902|466246613|FG000|Overall Study|Lost to Follow-up|4|||
129534590|NCT03125902|466246614|FG001|Overall Study|Lost to Follow-up|13|||
129534591|NCT03125902|466246613|FG000|Overall Study|Other|0|||
129534592|NCT03125902|466246614|FG001|Overall Study|Other|4|||
129534593|NCT03125902|466246613|FG000|Overall Study|Physician Decision|2|||
129534594|NCT03125902|466246614|FG001|Overall Study|Physician Decision|1|||
129534595|NCT03125902|466246613|FG000|Overall Study|Progressive Disease|0|||
129534596|NCT03125902|466246614|FG001|Overall Study|Progressive Disease|3|||
129534597|NCT03125902|466246613|FG000|Overall Study|Study Terminated By Sponsor|74|||
129534598|NCT03125902|466246614|FG001|Overall Study|Study Terminated By Sponsor|143|||
129534599|NCT03125902|466246613|FG000|Overall Study|Withdrawal by Subject|21|||
129534600|NCT03125902|466246614|FG001|Overall Study|Withdrawal by Subject|37|||
129534601|NCT01843933|466246615|FG000|Overall Study|Data lost|6|||
129534602|NCT01843933|466246616|FG001|Overall Study|Data lost|4|||
129534603|NCT01535638|466246617|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
129534604|NCT01535638|466246618|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
129534605|NCT01535638|466246619|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
129534606|NCT01535638|466246620|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
129534607|NCT01535638|466246621|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
129534608|NCT01535638|466246622|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
129534609|NCT01535638|466246617|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
129534610|NCT01535638|466246618|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
129534611|NCT01535638|466246619|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
129534612|NCT01535638|466246620|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
129534613|NCT01535638|466246621|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
129534614|NCT01535638|466246622|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
129534615|NCT03769753|466246623|FG000|Overall Study|Not Treated|6|||
129534616|NCT03769753|466246623|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
129534617|NCT01482598|466246624|FG000|Overall Study|Death|7|||
129534618|NCT01482598|466246625|FG001|Overall Study|Death|10|||
129534619|NCT01482598|466246624|FG000|Overall Study|Physician Decision|0|||
129534620|NCT01482598|466246625|FG001|Overall Study|Physician Decision|3|||
129534621|NCT01482598|466246624|FG000|Overall Study|Withdrawal by Subject|4|||
129534622|NCT01482598|466246625|FG001|Overall Study|Withdrawal by Subject|5|||
129534623|NCT01482598|466246624|FG000|Overall Study|Lost to Follow-up|5|||
129534624|NCT01482598|466246625|FG001|Overall Study|Lost to Follow-up|4|||
129534625|NCT02694562|466246626|FG000|Overall Study|Death|8|||
129534626|NCT02694562|466246626|FG000|Overall Study|Protocol Violation|4|||
129534627|NCT02694562|466246626|FG000|Overall Study|Lost to Follow-up|3|||
129534628|NCT02694562|466246626|FG000|Overall Study|Screen Failure|2|||
129534629|NCT02694562|466246626|FG000|Overall Study|Physician Decision|1|||
129534630|NCT01373294|466246627|FG000|Overall Study|Adverse Event|1|||
129534631|NCT01373294|466246628|FG001|Overall Study|Adverse Event|0|||
129534632|NCT03702166|466246629|FG000|Overall Study|Lost to Follow-up|1|||
129534633|NCT03702166|466246629|FG000|Overall Study|Withdrawal by Subject|1|||
129534634|NCT01333865|466246630|FG000|Overall Study|Adverse Event|2|||
129534635|NCT00684073|466246631|FG000|Selection|Selection/non-selection criteria|3|||
129534636|NCT00684073|466246631|FG000|Selection|Death|1|||
129534637|NCT00684073|466246631|FG000|Selection|noncompliance|1|||
129534638|NCT00684073|466246631|FG000|Selection|Lost to Follow-up|1|||
129534639|NCT00684073|466246631|FG000|Selection|request of the sponsor|1|||
129534640|NCT00684073|466246631|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
129534641|NCT01657903|466246632|FG000|Overall Study|Lost to Follow-up|1|||
129534642|NCT01657903|466246632|FG000|Overall Study|Withdrawal by Subject|1|||
129534643|NCT01888367|466246636|FG000|Overall Study|Physician Decision|3|||
129534644|NCT01888367|466246637|FG001|Overall Study|Physician Decision|4|||
129534645|NCT01888367|466246638|FG002|Overall Study|Physician Decision|2|||
129534646|NCT01888367|466246636|FG000|Overall Study|Death|2|||
129534647|NCT01888367|466246637|FG001|Overall Study|Death|0|||
129534648|NCT01888367|466246638|FG002|Overall Study|Death|1|||
129534649|NCT01888367|466246636|FG000|Overall Study|Withdrawal by Subject|1|||
129534650|NCT01888367|466246637|FG001|Overall Study|Withdrawal by Subject|0|||
129534651|NCT01888367|466246638|FG002|Overall Study|Withdrawal by Subject|1|||
129534652|NCT01888367|466246636|FG000|Overall Study|Lost to Follow-up|1|||
129534653|NCT01888367|466246637|FG001|Overall Study|Lost to Follow-up|1|||
129534654|NCT01888367|466246638|FG002|Overall Study|Lost to Follow-up|0|||
129534655|NCT01888367|466246636|FG000|Overall Study|Protocol Violation|0|||
129534656|NCT01888367|466246637|FG001|Overall Study|Protocol Violation|0|||
129534657|NCT01888367|466246638|FG002|Overall Study|Protocol Violation|1|||
129534658|NCT01888367|466246636|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
129534659|NCT01888367|466246637|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
129534660|NCT01888367|466246638|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
129534661|NCT01513460|466246640|FG000|Overall Study|Death|0|||
129534662|NCT01513460|466246641|FG001|Overall Study|Death|0|||
129534663|NCT01513460|466246642|FG002|Overall Study|Death|1|||
129534664|NCT01513460|466246640|FG000|Overall Study|Lost to Follow-up|0|||
129534665|NCT01513460|466246641|FG001|Overall Study|Lost to Follow-up|0|||
129534666|NCT01513460|466246642|FG002|Overall Study|Lost to Follow-up|2|||
129534667|NCT01513460|466246640|FG000|Overall Study|Abnormal laboratory value|1|||
129534668|NCT01513460|466246641|FG001|Overall Study|Abnormal laboratory value|0|||
129534669|NCT01513460|466246642|FG002|Overall Study|Abnormal laboratory value|1|||
129534670|NCT01513460|466246640|FG000|Overall Study|Lack of Efficacy|1|||
129534671|NCT01513460|466246641|FG001|Overall Study|Lack of Efficacy|2|||
129534672|NCT01513460|466246642|FG002|Overall Study|Lack of Efficacy|5|||
129534673|NCT01513460|466246640|FG000|Overall Study|Protocol deviations|3|||
129534674|NCT01513460|466246641|FG001|Overall Study|Protocol deviations|4|||
129534675|NCT01513460|466246642|FG002|Overall Study|Protocol deviations|3|||
129534676|NCT01513460|466246640|FG000|Overall Study|Withdrawal by Subject|7|||
129534677|NCT01513460|466246641|FG001|Overall Study|Withdrawal by Subject|8|||
129534678|NCT01513460|466246642|FG002|Overall Study|Withdrawal by Subject|21|||
129534679|NCT01513460|466246640|FG000|Overall Study|Adverse Event|16|||
129534680|NCT01513460|466246641|FG001|Overall Study|Adverse Event|18|||
129534681|NCT01513460|466246642|FG002|Overall Study|Adverse Event|23|||
129534682|NCT01513460|466246640|FG000|Overall Study|Abnormal test procedure|1|||
129534683|NCT01513460|466246641|FG001|Overall Study|Abnormal test procedure|0|||
129534684|NCT01513460|466246642|FG002|Overall Study|Abnormal test procedure|0|||
129534685|NCT00489216|466246646|FG000|Overall Study|Adverse Event|1|||
129534686|NCT01684930|466248686|FG000|Overall Study|Withdrawal by Subject|3|||
129534687|NCT01684930|466248687|FG001|Overall Study|Withdrawal by Subject|1|||
129534688|NCT01041027|466248695|FG000|Overall Study|Withdrawal by Subject|2|||
129534689|NCT01041027|466248695|FG000|Overall Study|Protocol Violation|1|||
129534690|NCT01041027|466248695|FG000|Overall Study|Delayed Radiation Therapy|1|||
129534691|NCT01041027|466248695|FG000|Overall Study|Adverse Event|4|||
129534692|NCT01020812|466248696|FG000|Overall Study|Physician Decision|1|||
129534693|NCT01020812|466248696|FG000|Overall Study|Withdrawal by Subject|1|||
129534694|NCT01020812|466248696|FG000|Overall Study|Protocol Violation|1|||
129534695|NCT02528643|466248697|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
129534696|NCT02528643|466248698|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
129534697|NCT02528643|466248697|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
129534698|NCT02528643|466248698|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
129534699|NCT02528643|466248697|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
129534700|NCT02528643|466248698|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
129534701|NCT02528643|466248697|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
129534702|NCT02528643|466248698|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
129534703|NCT02528643|466248697|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
129534704|NCT02528643|466248698|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
129534705|NCT02528643|466248697|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
129534706|NCT02528643|466248698|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
129534707|NCT02528643|466248697|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
129534708|NCT02528643|466248698|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
129534709|NCT01191190|466248699|FG000|Overall Study|Withdrawal by Subject|1|||
129534710|NCT01871870|466248703|FG000|Overall Study|Hardware issues|7|||
129534711|NCT01871870|466248703|FG000|Overall Study|hyperglycemia|2|||
129534712|NCT01856920|466248709|FG000|Overall Study|Disease Progression On Study|3|||
129534713|NCT01856920|466248710|FG001|Overall Study|Disease Progression On Study|4|||
129534714|NCT01856920|466248709|FG000|Overall Study|Disease Progression before Treatment|1|||
129534715|NCT01856920|466248710|FG001|Overall Study|Disease Progression before Treatment|0|||
129534716|NCT01856920|466248709|FG000|Overall Study|Ineligible|0|||
129534717|NCT01856920|466248710|FG001|Overall Study|Ineligible|1|||
129534718|NCT01856920|466248709|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
129534719|NCT01856920|466248710|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
129534720|NCT01856920|466248709|FG000|Overall Study|Refused further Treatment|5|||
129534721|NCT01856920|466248710|FG001|Overall Study|Refused further Treatment|1|||
129534722|NCT01856920|466248709|FG000|Overall Study|Other Reasons|0|||
129534723|NCT01856920|466248710|FG001|Overall Study|Other Reasons|1|||
129534724|NCT01856920|466248709|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
129534725|NCT01856920|466248710|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
129534726|NCT02545270|466248711|FG000|Overall Study|technical difficulties|0|||
129534727|NCT02545270|466248712|FG001|Overall Study|technical difficulties|1|||
129534728|NCT02545270|466248713|FG002|Overall Study|technical difficulties|0|||
129534729|NCT02545270|466248711|FG000|Overall Study|Videos being too similar to other|0|||
129534730|NCT02545270|466248712|FG001|Overall Study|Videos being too similar to other|0|||
129534731|NCT02545270|466248713|FG002|Overall Study|Videos being too similar to other|2|||
129534732|NCT01716585|466248720|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
129534733|NCT01716585|466248721|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
129534734|NCT01716585|466248720|FG000|Double-blind Treatment|Adverse Event|2|||
129534735|NCT01716585|466248721|FG001|Double-blind Treatment|Adverse Event|1|||
129534736|NCT01716585|466248720|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
129534737|NCT01716585|466248721|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
129534738|NCT01716585|466248720|FG000|Double-blind Treatment|Lost to Follow-up|2|||
129534739|NCT01716585|466248721|FG001|Double-blind Treatment|Lost to Follow-up|0|||
129534740|NCT01716585|466248720|FG000|Double-blind Treatment|Subject Noncompliant|1|||
129534741|NCT01716585|466248721|FG001|Double-blind Treatment|Subject Noncompliant|0|||
129534742|NCT01716585|466248720|FG000|Double-blind Treatment|Other|1|||
129534743|NCT01716585|466248721|FG001|Double-blind Treatment|Other|0|||
129534744|NCT01716585|466248720|FG000|Open-label Treatment|Adverse Event|0|||
129534745|NCT01716585|466248721|FG001|Open-label Treatment|Adverse Event|2|||
129534746|NCT01716585|466248720|FG000|Open-label Treatment|Virologic Failure|0|||
129534747|NCT01716585|466248721|FG001|Open-label Treatment|Virologic Failure|2|||
129534748|NCT01716585|466248720|FG000|Open-label Treatment|Withdrawal by Subject|0|||
129534749|NCT01716585|466248721|FG001|Open-label Treatment|Withdrawal by Subject|3|||
129534750|NCT00761891|466248724|FG000|Overall Study|Withdrawal by Subject|10|||
129534751|NCT01707667|466248725|FG000|Period 1|expulsion of colonic sensor catheter|1|||
129534752|NCT01707667|466248726|FG001|Period 1|expulsion of colonic sensor catheter|0|||
129534753|NCT02074059|466248732|FG000|Overall Study|Death|0|||
129534754|NCT02074059|466248733|FG001|Overall Study|Death|0|||
129534755|NCT02074059|466248734|FG002|Overall Study|Death|0|||
129534756|NCT02074059|466248735|FG003|Overall Study|Death|0|||
129534757|NCT02074059|466248736|FG004|Overall Study|Death|1|||
129534758|NCT02074059|466248737|FG005|Overall Study|Death|1|||
129534759|NCT02764229|466248743|FG000|Overall Study|Withdrawal by Subject|15|||
129534760|NCT02764229|466248743|FG000|Overall Study|Adverse Event|9|||
129534761|NCT02764229|466248743|FG000|Overall Study|Physician Decision|5|||
129534762|NCT02764229|466248743|FG000|Overall Study|Lost to Follow-up|3|||
129534763|NCT02764229|466248743|FG000|Overall Study|Lack of Efficacy|1|||
129534764|NCT02764229|466248743|FG000|Overall Study|Study Stopped by Sponsor|69|||
129534765|NCT00779142|466248744|FG000|Overall Study|Screen Failures|3|||
129534766|NCT00265382|466248747|FG000|Overall Study|Adverse Event|21|||
129534767|NCT00265382|466248747|FG000|Overall Study|Laboratory Abnormality|1|||
129534768|NCT00265382|466248747|FG000|Overall Study|Lost to Follow-up|3|||
129534769|NCT00265382|466248747|FG000|Overall Study|Lack of Efficacy|6|||
129534770|NCT00265382|466248747|FG000|Overall Study|Miscellaneous|6|||
129534771|NCT00265382|466248747|FG000|Overall Study|Withdrawal by Subject|13|||
129534772|NCT00265382|466248747|FG000|Overall Study|Study terminated by sponsor|94|||
129534773|NCT00265382|466248747|FG000|Overall Study|Death|1|||
129534774|NCT01724021|466248751|FG000|Overall Study|Adverse Event|11|||
129534775|NCT01724021|466248752|FG001|Overall Study|Adverse Event|6|||
129534776|NCT01724021|466248751|FG000|Overall Study|Death|46|||
129534777|NCT01724021|466248752|FG001|Overall Study|Death|58|||
129534778|NCT01724021|466248751|FG000|Overall Study|Participant request/ Withdrew consent|18|||
129534779|NCT01724021|466248752|FG001|Overall Study|Participant request/ Withdrew consent|14|||
129534780|NCT01724021|466248751|FG000|Overall Study|Lost to Follow-up|15|||
129534781|NCT01724021|466248752|FG001|Overall Study|Lost to Follow-up|15|||
129534782|NCT01724021|466248751|FG000|Overall Study|Reason Not Specified|36|||
129534783|NCT01724021|466248752|FG001|Overall Study|Reason Not Specified|39|||
129534784|NCT01724021|466248751|FG000|Overall Study|Missing|1|||
129534785|NCT01724021|466248752|FG001|Overall Study|Missing|1|||
129534786|NCT00529152|466248753|FG000|Overall Study|Adverse Event|2|||
129534787|NCT00529152|466248753|FG000|Overall Study|Withdrawal by Subject|2|||
129534788|NCT00529152|466248753|FG000|Overall Study|Lost to Follow-up|1|||
129534789|NCT03524664|466248759|FG000|Overall Study|Withdrawal by Subject|1|||
129534790|NCT03524664|466248760|FG001|Overall Study|Withdrawal by Subject|2|||
129534791|NCT03524664|466248759|FG000|Overall Study|Lost to Follow-up|4|||
129534792|NCT03524664|466248760|FG001|Overall Study|Lost to Follow-up|13|||
129534793|NCT00620815|466248763|FG000|Overall Study|Adverse Event|1|||
129534794|NCT00620815|466248764|FG001|Overall Study|Adverse Event|1|||
129534795|NCT00620815|466248765|FG002|Overall Study|Adverse Event|2|||
129534796|NCT00620815|466248763|FG000|Overall Study|Withdrawal by Subject|1|||
129534797|NCT00620815|466248764|FG001|Overall Study|Withdrawal by Subject|2|||
129534798|NCT00620815|466248765|FG002|Overall Study|Withdrawal by Subject|0|||
129534799|NCT00620815|466248763|FG000|Overall Study|Lost to Follow-up|1|||
129534800|NCT00620815|466248764|FG001|Overall Study|Lost to Follow-up|6|||
129534801|NCT00620815|466248765|FG002|Overall Study|Lost to Follow-up|3|||
129534802|NCT00620815|466248763|FG000|Overall Study|Inappropriate enrolment|0|||
129534803|NCT00620815|466248764|FG001|Overall Study|Inappropriate enrolment|0|||
129534804|NCT00620815|466248765|FG002|Overall Study|Inappropriate enrolment|1|||
129534805|NCT00620815|466248763|FG000|Overall Study|Protocol Violation|1|||
129534806|NCT00620815|466248764|FG001|Overall Study|Protocol Violation|2|||
129534807|NCT00620815|466248765|FG002|Overall Study|Protocol Violation|1|||
129534808|NCT01920061|466248767|FG000|Overall Study|Death|1|||
129534809|NCT01920061|466248768|FG001|Overall Study|Death|1|||
129534810|NCT01920061|466248769|FG002|Overall Study|Death|0|||
129534811|NCT01920061|466248770|FG003|Overall Study|Death|1|||
129534812|NCT01920061|466248771|FG004|Overall Study|Death|1|||
129534813|NCT01920061|466248772|FG005|Overall Study|Death|0|||
129534814|NCT01920061|466248773|FG006|Overall Study|Death|0|||
129534815|NCT01920061|466248774|FG007|Overall Study|Death|1|||
129534816|NCT01920061|466248775|FG008|Overall Study|Death|0|||
129534817|NCT01920061|466248776|FG009|Overall Study|Death|1|||
129534818|NCT01920061|466248777|FG010|Overall Study|Death|0|||
129534819|NCT01920061|466248778|FG011|Overall Study|Death|1|||
129534820|NCT01920061|466248779|FG012|Overall Study|Death|0|||
129534821|NCT01920061|466248780|FG013|Overall Study|Death|2|||
129534822|NCT01920061|466248781|FG014|Overall Study|Death|0|||
129534823|NCT01920061|466248782|FG015|Overall Study|Death|0|||
129534824|NCT01920061|466248783|FG016|Overall Study|Death|0|||
129534825|NCT01920061|466248784|FG017|Overall Study|Death|0|||
129534826|NCT01920061|466248785|FG018|Overall Study|Death|1|||
129534827|NCT01920061|466248786|FG019|Overall Study|Death|0|||
129534828|NCT01920061|466248767|FG000|Overall Study|Lost to Follow-up|0|||
129534829|NCT01920061|466248768|FG001|Overall Study|Lost to Follow-up|2|||
129534830|NCT01920061|466248769|FG002|Overall Study|Lost to Follow-up|0|||
129534831|NCT01920061|466248770|FG003|Overall Study|Lost to Follow-up|0|||
129534832|NCT01920061|466248771|FG004|Overall Study|Lost to Follow-up|0|||
129534833|NCT01920061|466248772|FG005|Overall Study|Lost to Follow-up|0|||
129534834|NCT01920061|466248773|FG006|Overall Study|Lost to Follow-up|1|||
129534835|NCT01920061|466248774|FG007|Overall Study|Lost to Follow-up|0|||
129534836|NCT01920061|466248775|FG008|Overall Study|Lost to Follow-up|0|||
129534837|NCT01920061|466248776|FG009|Overall Study|Lost to Follow-up|0|||
129534838|NCT01920061|466248777|FG010|Overall Study|Lost to Follow-up|3|||
129534839|NCT01920061|466248778|FG011|Overall Study|Lost to Follow-up|0|||
129534840|NCT01920061|466248779|FG012|Overall Study|Lost to Follow-up|0|||
129534841|NCT01920061|466248780|FG013|Overall Study|Lost to Follow-up|0|||
129534842|NCT01920061|466248781|FG014|Overall Study|Lost to Follow-up|0|||
129534843|NCT01920061|466248782|FG015|Overall Study|Lost to Follow-up|0|||
129534844|NCT01920061|466248783|FG016|Overall Study|Lost to Follow-up|0|||
129534845|NCT01920061|466248784|FG017|Overall Study|Lost to Follow-up|1|||
129534846|NCT01920061|466248785|FG018|Overall Study|Lost to Follow-up|4|||
129534847|NCT01920061|466248786|FG019|Overall Study|Lost to Follow-up|3|||
129534848|NCT01920061|466248767|FG000|Overall Study|Other|1|||
129534849|NCT01920061|466248768|FG001|Overall Study|Other|1|||
129534850|NCT01920061|466248769|FG002|Overall Study|Other|2|||
129534851|NCT01920061|466248770|FG003|Overall Study|Other|1|||
129534852|NCT01920061|466248771|FG004|Overall Study|Other|0|||
129534853|NCT01920061|466248772|FG005|Overall Study|Other|1|||
129534854|NCT01920061|466248773|FG006|Overall Study|Other|0|||
129534855|NCT01920061|466248774|FG007|Overall Study|Other|0|||
129534856|NCT01920061|466248775|FG008|Overall Study|Other|0|||
129534857|NCT01920061|466248776|FG009|Overall Study|Other|1|||
129534858|NCT01920061|466248777|FG010|Overall Study|Other|1|||
129534859|NCT01920061|466248778|FG011|Overall Study|Other|2|||
129534860|NCT01920061|466248779|FG012|Overall Study|Other|1|||
129534861|NCT01920061|466248780|FG013|Overall Study|Other|4|||
129534862|NCT01920061|466248781|FG014|Overall Study|Other|0|||
129534863|NCT01920061|466248782|FG015|Overall Study|Other|1|||
129534864|NCT01920061|466248783|FG016|Overall Study|Other|1|||
129534865|NCT01920061|466248784|FG017|Overall Study|Other|0|||
129534866|NCT01920061|466248785|FG018|Overall Study|Other|1|||
129534867|NCT01920061|466248786|FG019|Overall Study|Other|1|||
129534868|NCT01920061|466248767|FG000|Overall Study|Participant refused further follow-up|0|||
129534869|NCT01920061|466248768|FG001|Overall Study|Participant refused further follow-up|0|||
129534870|NCT01920061|466248769|FG002|Overall Study|Participant refused further follow-up|0|||
129534871|NCT01920061|466248770|FG003|Overall Study|Participant refused further follow-up|0|||
129534872|NCT01920061|466248771|FG004|Overall Study|Participant refused further follow-up|1|||
129534873|NCT01920061|466248772|FG005|Overall Study|Participant refused further follow-up|1|||
129534874|NCT01920061|466248773|FG006|Overall Study|Participant refused further follow-up|0|||
129534875|NCT01920061|466248774|FG007|Overall Study|Participant refused further follow-up|0|||
129534876|NCT01920061|466248775|FG008|Overall Study|Participant refused further follow-up|1|||
129534877|NCT01920061|466248776|FG009|Overall Study|Participant refused further follow-up|0|||
129534878|NCT01920061|466248777|FG010|Overall Study|Participant refused further follow-up|1|||
129534879|NCT01920061|466248778|FG011|Overall Study|Participant refused further follow-up|0|||
129534880|NCT01920061|466248779|FG012|Overall Study|Participant refused further follow-up|1|||
129534881|NCT01920061|466248780|FG013|Overall Study|Participant refused further follow-up|0|||
129534882|NCT01920061|466248781|FG014|Overall Study|Participant refused further follow-up|1|||
129534883|NCT01920061|466248782|FG015|Overall Study|Participant refused further follow-up|2|||
129534884|NCT01920061|466248783|FG016|Overall Study|Participant refused further follow-up|1|||
129534885|NCT01920061|466248784|FG017|Overall Study|Participant refused further follow-up|1|||
129534886|NCT01920061|466248785|FG018|Overall Study|Participant refused further follow-up|0|||
129534887|NCT01920061|466248786|FG019|Overall Study|Participant refused further follow-up|0|||
129534888|NCT00877929|466248787|FG000|Overall Study|Adverse Event|11|||
129534889|NCT00877929|466248788|FG001|Overall Study|Adverse Event|20|||
129534890|NCT00877929|466248787|FG000|Overall Study|Protocol Violation|3|||
129534891|NCT00877929|466248788|FG001|Overall Study|Protocol Violation|3|||
129534892|NCT00877929|466248787|FG000|Overall Study|Lost to Follow-up|0|||
129534893|NCT00877929|466248788|FG001|Overall Study|Lost to Follow-up|1|||
129534894|NCT00877929|466248787|FG000|Overall Study|Withdrawal by Subject|4|||
129534895|NCT00877929|466248788|FG001|Overall Study|Withdrawal by Subject|4|||
129534896|NCT00877929|466248787|FG000|Overall Study|Lack of Efficacy|0|||
129534897|NCT00877929|466248788|FG001|Overall Study|Lack of Efficacy|1|||
129534898|NCT00877929|466248787|FG000|Overall Study|Other reason (not specified)|2|||
129534899|NCT00877929|466248788|FG001|Overall Study|Other reason (not specified)|6|||
129534900|NCT00689728|466248790|FG000|Double-Blind Treatment|Adverse Event|1|||
129534901|NCT00689728|466248791|FG001|Double-Blind Treatment|Adverse Event|0|||
129534902|NCT00689728|466248792|FG002|Double-Blind Treatment|Adverse Event|0|||
129534903|NCT00689728|466248790|FG000|Double-Blind Treatment|Protocol Violation|0|||
129534904|NCT00689728|466248791|FG001|Double-Blind Treatment|Protocol Violation|0|||
129534905|NCT00689728|466248792|FG002|Double-Blind Treatment|Protocol Violation|1|||
129534906|NCT00689728|466248790|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
129534907|NCT00689728|466248791|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
129534908|NCT00689728|466248792|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
129538907|NCT01238861|466265108|FG001|Overall Study|Lost to Follow-up|2|||
129534909|NCT00689728|466248790|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
129534910|NCT00689728|466248791|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
129534911|NCT00689728|466248792|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
129534912|NCT00689728|466248790|FG000|Rescue|Adverse Event|0|||
129534913|NCT00689728|466248791|FG001|Rescue|Adverse Event|1|||
129534914|NCT00689728|466248792|FG002|Rescue|Adverse Event|0|||
129534915|NCT00689728|466248790|FG000|Rescue|Withdrawal by Subject|1|||
129534916|NCT00689728|466248791|FG001|Rescue|Withdrawal by Subject|1|||
129534917|NCT00689728|466248792|FG002|Rescue|Withdrawal by Subject|1|||
129534918|NCT00689728|466248790|FG000|Optional Follow-Up|Adverse Event|1|||
129534919|NCT00689728|466248791|FG001|Optional Follow-Up|Adverse Event|0|||
129534920|NCT00689728|466248792|FG002|Optional Follow-Up|Adverse Event|0|||
129534921|NCT00689728|466248790|FG000|Optional Follow-Up|Lack of Efficacy|0|||
129534922|NCT00689728|466248791|FG001|Optional Follow-Up|Lack of Efficacy|1|||
129534923|NCT00689728|466248792|FG002|Optional Follow-Up|Lack of Efficacy|1|||
129534924|NCT00689728|466248790|FG000|Optional Follow-Up|Lost to Follow-up|0|||
129534925|NCT00689728|466248791|FG001|Optional Follow-Up|Lost to Follow-up|1|||
129534926|NCT00689728|466248792|FG002|Optional Follow-Up|Lost to Follow-up|1|||
129534927|NCT00689728|466248790|FG000|Optional Follow-Up|Protocol Violation|0|||
129534928|NCT00689728|466248791|FG001|Optional Follow-Up|Protocol Violation|0|||
129534929|NCT00689728|466248792|FG002|Optional Follow-Up|Protocol Violation|1|||
129534930|NCT00689728|466248790|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
129534931|NCT00689728|466248791|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
129534932|NCT00689728|466248792|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
129534933|NCT00842829|466248793|FG000|Dose Titration Period|Adverse Event|11|||
129534934|NCT00842829|466248794|FG001|Dose Titration Period|Adverse Event|10|||
129534935|NCT00842829|466248795|FG002|Dose Titration Period|Adverse Event|0|||
129534936|NCT00842829|466248793|FG000|Dose Titration Period|Lack of Efficacy|4|||
129534937|NCT00842829|466248794|FG001|Dose Titration Period|Lack of Efficacy|1|||
129534938|NCT00842829|466248795|FG002|Dose Titration Period|Lack of Efficacy|0|||
129534939|NCT00842829|466248793|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
129534940|NCT00842829|466248794|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
129534941|NCT00842829|466248795|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
129534942|NCT00842829|466248793|FG000|Dose Titration Period|Withdrawal by Subject|2|||
129534943|NCT00842829|466248794|FG001|Dose Titration Period|Withdrawal by Subject|6|||
129534944|NCT00842829|466248795|FG002|Dose Titration Period|Withdrawal by Subject|0|||
129534945|NCT00842829|466248793|FG000|Dose Titration Period|Other|5|||
129534946|NCT00842829|466248794|FG001|Dose Titration Period|Other|4|||
129534947|NCT00842829|466248795|FG002|Dose Titration Period|Other|0|||
129534948|NCT00842829|466248793|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
129534949|NCT00842829|466248794|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
129534950|NCT00842829|466248795|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
129534951|NCT00842829|466248793|FG000|Dose Titration Period|Non-compliance to study drug|2|||
129534952|NCT00842829|466248794|FG001|Dose Titration Period|Non-compliance to study drug|1|||
129534953|NCT00842829|466248795|FG002|Dose Titration Period|Non-compliance to study drug|0|||
129534954|NCT00842829|466248793|FG000|Treatment Period|Adverse Event|0|||
129534955|NCT00842829|466248794|FG001|Treatment Period|Adverse Event|0|||
129534956|NCT00842829|466248795|FG002|Treatment Period|Adverse Event|15|||
129534957|NCT00842829|466248793|FG000|Treatment Period|Lack of Efficacy|0|||
129534958|NCT00842829|466248794|FG001|Treatment Period|Lack of Efficacy|0|||
129534959|NCT00842829|466248795|FG002|Treatment Period|Lack of Efficacy|6|||
129534960|NCT00842829|466248793|FG000|Treatment Period|Unstable persistent cancer pain|0|||
129534961|NCT00842829|466248794|FG001|Treatment Period|Unstable persistent cancer pain|0|||
129534962|NCT00842829|466248795|FG002|Treatment Period|Unstable persistent cancer pain|5|||
129534963|NCT00842829|466248793|FG000|Treatment Period|Withdrawal by Subject|0|||
129534964|NCT00842829|466248794|FG001|Treatment Period|Withdrawal by Subject|0|||
129534965|NCT00842829|466248795|FG002|Treatment Period|Withdrawal by Subject|11|||
129534966|NCT00842829|466248793|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
129534967|NCT00842829|466248794|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
129534968|NCT00842829|466248795|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
129534969|NCT00842829|466248793|FG000|Treatment Period|Protocol Violation|0|||
129534970|NCT00842829|466248794|FG001|Treatment Period|Protocol Violation|0|||
129534971|NCT00842829|466248795|FG002|Treatment Period|Protocol Violation|2|||
129534972|NCT00842829|466248793|FG000|Treatment Period|Other|0|||
129534973|NCT00842829|466248794|FG001|Treatment Period|Other|0|||
129534974|NCT00842829|466248795|FG002|Treatment Period|Other|18|||
129534975|NCT00842829|466248793|FG000|Treatment Period|Non-compliance to study procedures|0|||
129534976|NCT00842829|466248794|FG001|Treatment Period|Non-compliance to study procedures|0|||
129534977|NCT00842829|466248795|FG002|Treatment Period|Non-compliance to study procedures|4|||
129534978|NCT00842829|466248793|FG000|Treatment Period|Unclear completion status|0|||
129534979|NCT00842829|466248794|FG001|Treatment Period|Unclear completion status|0|||
129534980|NCT00842829|466248795|FG002|Treatment Period|Unclear completion status|1|||
129534981|NCT00842829|466248793|FG000|Continuation Period|Adverse Event|0|||
129534982|NCT00842829|466248794|FG001|Continuation Period|Adverse Event|0|||
129534983|NCT00842829|466248795|FG002|Continuation Period|Adverse Event|32|||
129534984|NCT00842829|466248793|FG000|Continuation Period|Lack of Efficacy|0|||
129534985|NCT00842829|466248794|FG001|Continuation Period|Lack of Efficacy|0|||
129534986|NCT00842829|466248795|FG002|Continuation Period|Lack of Efficacy|6|||
129534987|NCT00842829|466248793|FG000|Continuation Period|Unstable persistent cancer pain|0|||
129534988|NCT00842829|466248794|FG001|Continuation Period|Unstable persistent cancer pain|0|||
129534989|NCT00842829|466248795|FG002|Continuation Period|Unstable persistent cancer pain|3|||
129534990|NCT00842829|466248793|FG000|Continuation Period|Withdrawal by Subject|0|||
129534991|NCT00842829|466248794|FG001|Continuation Period|Withdrawal by Subject|0|||
129534992|NCT00842829|466248795|FG002|Continuation Period|Withdrawal by Subject|10|||
129534993|NCT00842829|466248793|FG000|Continuation Period|Other|0|||
129534994|NCT00842829|466248794|FG001|Continuation Period|Other|0|||
129534995|NCT00842829|466248795|FG002|Continuation Period|Other|7|||
129534996|NCT00842829|466248793|FG000|Continuation Period|Non-compliance to study procedures|0|||
129534997|NCT00842829|466248794|FG001|Continuation Period|Non-compliance to study procedures|0|||
129534998|NCT00842829|466248795|FG002|Continuation Period|Non-compliance to study procedures|2|||
129534999|NCT00842829|466248793|FG000|Continuation Period|Non-compliance to study drug|0|||
129535000|NCT00842829|466248794|FG001|Continuation Period|Non-compliance to study drug|0|||
129535001|NCT00842829|466248795|FG002|Continuation Period|Non-compliance to study drug|1|||
129535002|NCT03590613|466248799|FG000|Period 2, 4 Days|Physician Decision|0|||
129535003|NCT03590613|466248800|FG001|Period 2, 4 Days|Physician Decision|0|||
129535004|NCT03590613|466248801|FG002|Period 2, 4 Days|Physician Decision|0|||
129535005|NCT03590613|466248802|FG003|Period 2, 4 Days|Physician Decision|1|||
129535006|NCT04369742|466248803|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
129535007|NCT04369742|466248804|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
129535008|NCT04369742|466248803|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
129535009|NCT04369742|466248804|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
129535010|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Death|2|||
129535011|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Death|0|||
129535012|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Adverse Event|33|||
129535013|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Adverse Event|31|||
129535014|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
129535015|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
129535016|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
129535017|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
129535018|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
129535019|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
129535020|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Other|7|||
129535021|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Other|8|||
129535022|NCT00280059|466248805|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
129535023|NCT00280059|466248806|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
129535024|NCT01130831|466248811|FG000|Overall Study|Withdrawal by Subject|7|||
129535025|NCT01130831|466248811|FG000|Overall Study|Death|4|||
129535026|NCT01130831|466248811|FG000|Overall Study|Information was missing|3|||
129535027|NCT00951912|466248812|FG000|Overall Study|Lack of Efficacy|1|||
129535028|NCT00951912|466248813|FG001|Overall Study|Lack of Efficacy|0|||
129535029|NCT00951912|466248814|FG002|Overall Study|Lack of Efficacy|0|||
129535030|NCT00951912|466248812|FG000|Overall Study|Adverse Event|0|||
129535031|NCT00951912|466248813|FG001|Overall Study|Adverse Event|1|||
129535032|NCT00951912|466248814|FG002|Overall Study|Adverse Event|1|||
129535033|NCT00951912|466248812|FG000|Overall Study|Lost to Follow-up|2|||
129535034|NCT00951912|466248813|FG001|Overall Study|Lost to Follow-up|2|||
129535035|NCT00951912|466248814|FG002|Overall Study|Lost to Follow-up|0|||
129535036|NCT00951912|466248812|FG000|Overall Study|Physician Decision|1|||
129535037|NCT00951912|466248813|FG001|Overall Study|Physician Decision|0|||
129535038|NCT00951912|466248814|FG002|Overall Study|Physician Decision|1|||
129535039|NCT00951912|466248812|FG000|Overall Study|Withdrawal by Subject|1|||
129535040|NCT00951912|466248813|FG001|Overall Study|Withdrawal by Subject|1|||
129535041|NCT00951912|466248814|FG002|Overall Study|Withdrawal by Subject|0|||
129535042|NCT00951912|466248812|FG000|Overall Study|Other:Depression|1|||
129535043|NCT00951912|466248813|FG001|Overall Study|Other:Depression|0|||
129535044|NCT00951912|466248814|FG002|Overall Study|Other:Depression|0|||
129535045|NCT00951912|466248812|FG000|Overall Study|Other: Colon cancer|1|||
129535046|NCT00951912|466248813|FG001|Overall Study|Other: Colon cancer|0|||
129535047|NCT00951912|466248814|FG002|Overall Study|Other: Colon cancer|0|||
129535048|NCT00951912|466248812|FG000|Overall Study|Other: Stroke|0|||
129535049|NCT00951912|466248813|FG001|Overall Study|Other: Stroke|1|||
129535050|NCT00951912|466248814|FG002|Overall Study|Other: Stroke|0|||
129535051|NCT03417999|466248815|FG000|Overall Study|Withdrawal by Subject|1|||
129535052|NCT03417999|466248816|FG001|Overall Study|Withdrawal by Subject|0|||
129535053|NCT03417999|466248817|FG002|Overall Study|Withdrawal by Subject|0|||
129535054|NCT03417999|466248815|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
129535055|NCT03417999|466248816|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
129535056|NCT03417999|466248817|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
129535057|NCT03417999|466248815|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
129535058|NCT03417999|466248816|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
129535059|NCT03417999|466248817|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
129535060|NCT03417999|466248815|FG000|Overall Study|Inadequate study staff available to process samples|0|||
129535061|NCT03417999|466248816|FG001|Overall Study|Inadequate study staff available to process samples|0|||
129535062|NCT03417999|466248817|FG002|Overall Study|Inadequate study staff available to process samples|1|||
129535063|NCT00422942|466248823|FG000|Overall Study|Study terminated by Sponsor|3|||
129535064|NCT02612194|466248824|FG000|Overall Study|Death|5|||
129535065|NCT02612194|466248825|FG001|Overall Study|Death|0|||
129535066|NCT02612194|466248826|FG002|Overall Study|Death|2|||
129535067|NCT02612194|466248824|FG000|Overall Study|Early Study Termination|1|||
129535068|NCT02612194|466248825|FG001|Overall Study|Early Study Termination|0|||
129535069|NCT02612194|466248826|FG002|Overall Study|Early Study Termination|0|||
129535070|NCT02539160|466248827|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
129535071|NCT02539160|466248828|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
129535072|NCT02539160|466248829|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
129535073|NCT02539160|466248830|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
129535074|NCT02539160|466248827|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
129535075|NCT02539160|466248828|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
129535076|NCT02539160|466248829|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
129535077|NCT02539160|466248830|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
129535078|NCT02539160|466248827|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
129535079|NCT02539160|466248828|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
129535080|NCT02539160|466248829|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
129535081|NCT02539160|466248830|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
129535082|NCT01681004|466248833|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
129535083|NCT01681004|466248834|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
129535084|NCT01681004|466248833|FG000|Study Completion|Lost to Follow-up|8|||
129535085|NCT01681004|466248834|FG001|Study Completion|Lost to Follow-up|3|||
129535086|NCT01681004|466248833|FG000|Study Completion|Physician Decision|1|||
129535087|NCT01681004|466248834|FG001|Study Completion|Physician Decision|3|||
129535088|NCT01681004|466248833|FG000|Study Completion|Site Termination|2|||
129535089|NCT01681004|466248834|FG001|Study Completion|Site Termination|1|||
129535090|NCT01681004|466248833|FG000|Study Completion|Death|1|||
129535091|NCT01681004|466248834|FG001|Study Completion|Death|1|||
129535092|NCT00372905|466248835|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
129535093|NCT00372905|466248836|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
129535094|NCT00372905|466248837|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
129535095|NCT00372905|466248838|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
129535096|NCT00372905|466248835|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
129535097|NCT00372905|466248836|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
129535098|NCT00372905|466248837|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
129535099|NCT00372905|466248838|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
129535100|NCT00372905|466248835|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
129535101|NCT00372905|466248836|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
129535102|NCT00372905|466248837|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
129535103|NCT00372905|466248838|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
129535104|NCT00372905|466248835|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
129535105|NCT00372905|466248836|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
129535106|NCT00372905|466248837|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
129535107|NCT00372905|466248838|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
129535108|NCT00372905|466248835|FG000|Follow up Until Relapse or Progression|Study closed|0|||
129535109|NCT00372905|466248836|FG001|Follow up Until Relapse or Progression|Study closed|0|||
129535110|NCT00372905|466248837|FG002|Follow up Until Relapse or Progression|Study closed|0|||
129535111|NCT00372905|466248838|FG003|Follow up Until Relapse or Progression|Study closed|3|||
129535112|NCT00372905|466248835|FG000|Follow up Until Relapse or Progression|Other|0|||
129535113|NCT00372905|466248836|FG001|Follow up Until Relapse or Progression|Other|1|||
129535114|NCT00372905|466248837|FG002|Follow up Until Relapse or Progression|Other|0|||
129535115|NCT00372905|466248838|FG003|Follow up Until Relapse or Progression|Other|0|||
129535116|NCT02312934|466248839|FG000|Overall Study|Lost to Follow-up|1|||
129535117|NCT02312934|466248840|FG001|Overall Study|Lost to Follow-up|0|||
129535118|NCT02312934|466248839|FG000|Overall Study|Physician Decision|1|||
129535119|NCT02312934|466248840|FG001|Overall Study|Physician Decision|0|||
129535120|NCT00701064|466248842|FG000|Overall Study|Protocol Violation|1|||
129535121|NCT00701064|466248843|FG001|Overall Study|Protocol Violation|1|||
129535122|NCT00701064|466248842|FG000|Overall Study|Withdrawal by Subject|1|||
129535123|NCT00701064|466248843|FG001|Overall Study|Withdrawal by Subject|1|||
129535124|NCT00701064|466248842|FG000|Overall Study|initiated other PTSD treatment|2|||
129535125|NCT00701064|466248843|FG001|Overall Study|initiated other PTSD treatment|2|||
129535126|NCT00689299|466248844|FG000|Overall Study|Adverse Event|2|||
129535127|NCT00689299|466248845|FG001|Overall Study|Adverse Event|1|||
129535128|NCT00689299|466248846|FG002|Overall Study|Adverse Event|1|||
129535129|NCT00689299|466248844|FG000|Overall Study|Lost to Follow-up|0|||
129535130|NCT00689299|466248845|FG001|Overall Study|Lost to Follow-up|1|||
129535131|NCT00689299|466248846|FG002|Overall Study|Lost to Follow-up|1|||
129535132|NCT00689299|466248844|FG000|Overall Study|Withdrawal by Subject|4|||
129535133|NCT00689299|466248845|FG001|Overall Study|Withdrawal by Subject|1|||
129535134|NCT00689299|466248846|FG002|Overall Study|Withdrawal by Subject|3|||
129535135|NCT00689299|466248844|FG000|Overall Study|Protocol Violation|1|||
129535136|NCT00689299|466248845|FG001|Overall Study|Protocol Violation|0|||
129535137|NCT00689299|466248846|FG002|Overall Study|Protocol Violation|0|||
129535138|NCT02613910|466248849|FG000|Overall Study|Termination of study|1|||
129535139|NCT02098733|466248850|FG000|Overall Study|Data Not Available|5|||
129535140|NCT02098733|466248850|FG000|Overall Study|Lost to Follow-up|5|||
129535141|NCT00695318|466248851|FG000|Overall Study|Lost to Follow-up|1|||
129535142|NCT00695318|466248852|FG001|Overall Study|Lost to Follow-up|0|||
129535143|NCT00695318|466248851|FG000|Overall Study|Withdrawal by Subject|2|||
129535144|NCT00695318|466248852|FG001|Overall Study|Withdrawal by Subject|0|||
129535145|NCT00695318|466248851|FG000|Overall Study|Death|1|||
129535146|NCT00695318|466248852|FG001|Overall Study|Death|1|||
129535147|NCT00695318|466248851|FG000|Overall Study|Study Terminated|1|||
129535148|NCT00695318|466248852|FG001|Overall Study|Study Terminated|0|||
129535149|NCT03395704|466248853|FG000|Overall Study|Adverse Event|2|||
129535150|NCT03395704|466248854|FG001|Overall Study|Adverse Event|1|||
129535151|NCT03395704|466248853|FG000|Overall Study|Withdrawal by Subject|2|||
129535152|NCT03395704|466248854|FG001|Overall Study|Withdrawal by Subject|1|||
129535153|NCT03395704|466248853|FG000|Overall Study|Physician Decision|0|||
129535154|NCT03395704|466248854|FG001|Overall Study|Physician Decision|1|||
129535155|NCT04823494|466250156|FG000|Overall Study|Programming software malfunction.|1|||
129535156|NCT04823494|466250157|FG001|Overall Study|Programming software malfunction.|0|||
129535157|NCT04823494|466250156|FG000|Overall Study|Withdrawal by Subject|1|||
129535158|NCT04823494|466250157|FG001|Overall Study|Withdrawal by Subject|0|||
129535159|NCT04823494|466250156|FG000|Overall Study|Devices lost|0|||
129535160|NCT04823494|466250157|FG001|Overall Study|Devices lost|1|||
129535161|NCT03726320|466250158|FG000|Overall Study|Lost to Follow-up|2|||
129535162|NCT03726320|466250159|FG001|Overall Study|Lost to Follow-up|4|||
129535163|NCT03726320|466250160|FG002|Overall Study|Lost to Follow-up|0|||
129535164|NCT03726320|466250158|FG000|Overall Study|Time Constraints|4|||
129535165|NCT03726320|466250159|FG001|Overall Study|Time Constraints|1|||
129535166|NCT03726320|466250160|FG002|Overall Study|Time Constraints|0|||
129535167|NCT03726320|466250158|FG000|Overall Study|Ineligible after enrollment|3|||
129535168|NCT03726320|466250159|FG001|Overall Study|Ineligible after enrollment|3|||
129535169|NCT03726320|466250160|FG002|Overall Study|Ineligible after enrollment|0|||
129535170|NCT03726320|466250158|FG000|Overall Study|Clinic / insurance issue|2|||
129535171|NCT03726320|466250159|FG001|Overall Study|Clinic / insurance issue|0|||
129535172|NCT03726320|466250160|FG002|Overall Study|Clinic / insurance issue|0|||
129535173|NCT03726320|466250158|FG000|Overall Study|Language barrier|1|||
129535174|NCT03726320|466250159|FG001|Overall Study|Language barrier|0|||
129535175|NCT03726320|466250160|FG002|Overall Study|Language barrier|0|||
129535176|NCT03726320|466250158|FG000|Overall Study|Provider left the clinic|0|||
129535177|NCT03726320|466250159|FG001|Overall Study|Provider left the clinic|0|||
129535178|NCT03726320|466250160|FG002|Overall Study|Provider left the clinic|1|||
129535179|NCT03691831|466250163|FG000|Overall Study|Lost to Follow-up|16|||
129535180|NCT03691831|466250164|FG001|Overall Study|Lost to Follow-up|12|||
129535181|NCT03691831|466250163|FG000|Overall Study|Withdrawal by Subject|9|||
129535182|NCT03691831|466250164|FG001|Overall Study|Withdrawal by Subject|17|||
129535183|NCT03691831|466250163|FG000|Overall Study|Investigator Decision|2|||
129535184|NCT03691831|466250164|FG001|Overall Study|Investigator Decision|2|||
129535185|NCT03922945|466250165|FG000|Overall Study|Adverse Event|1|||
129535186|NCT03922945|466250166|FG001|Overall Study|Adverse Event|1|||
129535187|NCT03922945|466250167|FG002|Overall Study|Adverse Event|2|||
129535188|NCT03922945|466250165|FG000|Overall Study|Lost to Follow-up|13|||
129535189|NCT03922945|466250166|FG001|Overall Study|Lost to Follow-up|9|||
129535190|NCT03922945|466250167|FG002|Overall Study|Lost to Follow-up|20|||
129535191|NCT03922945|466250165|FG000|Overall Study|Lack of Efficacy|2|||
129535192|NCT03922945|466250166|FG001|Overall Study|Lack of Efficacy|0|||
129535193|NCT03922945|466250167|FG002|Overall Study|Lack of Efficacy|1|||
129535194|NCT03922945|466250165|FG000|Overall Study|Protocol Non-Compliance|0|||
129535195|NCT03922945|466250166|FG001|Overall Study|Protocol Non-Compliance|0|||
129535196|NCT03922945|466250167|FG002|Overall Study|Protocol Non-Compliance|1|||
129535197|NCT03922945|466250165|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
129535198|NCT03922945|466250166|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
129535199|NCT03922945|466250167|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
129535200|NCT03922945|466250165|FG000|Overall Study|All Other Personal Reasons|1|||
129535201|NCT03922945|466250166|FG001|Overall Study|All Other Personal Reasons|1|||
129535202|NCT03922945|466250167|FG002|Overall Study|All Other Personal Reasons|2|||
129535203|NCT00039377|466250169|FG000|Initial Registration|Adverse Event|2|||
129535204|NCT00039377|466250170|FG001|Initial Registration|Adverse Event|0|||
129535205|NCT00039377|466250171|FG002|Initial Registration|Adverse Event|0|||
129535206|NCT00039377|466250172|FG003|Initial Registration|Adverse Event|0|||
129535207|NCT00039377|466250169|FG000|Initial Registration|Relapsed|6|||
129535208|NCT00039377|466250170|FG001|Initial Registration|Relapsed|0|||
129535209|NCT00039377|466250171|FG002|Initial Registration|Relapsed|0|||
129535210|NCT00039377|466250172|FG003|Initial Registration|Relapsed|0|||
129535211|NCT00039377|466250169|FG000|Initial Registration|Received non-protocol therapy|11|||
129535212|NCT00039377|466250170|FG001|Initial Registration|Received non-protocol therapy|0|||
129535213|NCT00039377|466250171|FG002|Initial Registration|Received non-protocol therapy|0|||
129535214|NCT00039377|466250172|FG003|Initial Registration|Received non-protocol therapy|0|||
129535215|NCT00039377|466250169|FG000|Initial Registration|Withdrawal by Subject|3|||
129535216|NCT00039377|466250170|FG001|Initial Registration|Withdrawal by Subject|0|||
129535217|NCT00039377|466250171|FG002|Initial Registration|Withdrawal by Subject|0|||
129535218|NCT00039377|466250172|FG003|Initial Registration|Withdrawal by Subject|0|||
129535219|NCT04067310|466250176|FG000|Overall Study|Physician Decision|2|||
129535220|NCT04067310|466250177|FG001|Overall Study|Physician Decision|6|||
129535221|NCT04067310|466250176|FG000|Overall Study|Lost to Follow-up|0|||
129535222|NCT04067310|466250177|FG001|Overall Study|Lost to Follow-up|1|||
129535223|NCT04067310|466250176|FG000|Overall Study|Withdrawal by Subject|3|||
129535224|NCT04067310|466250177|FG001|Overall Study|Withdrawal by Subject|0|||
129535225|NCT01347931|466250178|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
129535226|NCT02493712|466250179|FG000|Overall Study|Withdrawal by Subject|1|||
129535227|NCT02493712|466250180|FG001|Overall Study|Withdrawal by Subject|0|||
129535228|NCT02493712|466250181|FG002|Overall Study|Withdrawal by Subject|2|||
129535229|NCT02493712|466250179|FG000|Overall Study|Protocol Violation|0|||
129535230|NCT02493712|466250180|FG001|Overall Study|Protocol Violation|0|||
129535231|NCT02493712|466250181|FG002|Overall Study|Protocol Violation|1|||
129535232|NCT02493712|466250179|FG000|Overall Study|Lost to Follow-up|1|||
129535233|NCT02493712|466250180|FG001|Overall Study|Lost to Follow-up|0|||
129535234|NCT02493712|466250181|FG002|Overall Study|Lost to Follow-up|0|||
129535235|NCT02493712|466250179|FG000|Overall Study|Physician Decision|0|||
129535236|NCT02493712|466250180|FG001|Overall Study|Physician Decision|1|||
129535237|NCT02493712|466250181|FG002|Overall Study|Physician Decision|0|||
129535238|NCT02493712|466250179|FG000|Overall Study|Lack of Efficacy|0|||
129535239|NCT02493712|466250180|FG001|Overall Study|Lack of Efficacy|5|||
129535240|NCT02493712|466250181|FG002|Overall Study|Lack of Efficacy|3|||
129535241|NCT04120116|466250182|FG000|Overall Study|Lost to Follow-up|0|||
129535242|NCT04120116|466250183|FG001|Overall Study|Lost to Follow-up|1|||
129535243|NCT04120116|466250184|FG002|Overall Study|Lost to Follow-up|0|||
129535244|NCT04120116|466250185|FG003|Overall Study|Lost to Follow-up|2|||
129535245|NCT04120116|466250182|FG000|Overall Study|Withdrawal by Subject|1|||
129535246|NCT04120116|466250183|FG001|Overall Study|Withdrawal by Subject|0|||
129535247|NCT04120116|466250184|FG002|Overall Study|Withdrawal by Subject|1|||
129535248|NCT04120116|466250185|FG003|Overall Study|Withdrawal by Subject|1|||
129535249|NCT04120116|466250182|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
129535250|NCT04120116|466250183|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
129535251|NCT04120116|466250184|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
129535252|NCT04120116|466250185|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
129535253|NCT02087085|466250186|FG000|Overall Study|Adverse Event|10|||
129535254|NCT02087085|466250187|FG001|Overall Study|Adverse Event|14|||
129535255|NCT02087085|466250186|FG000|Overall Study|Lack of Efficacy|4|||
129535256|NCT02087085|466250187|FG001|Overall Study|Lack of Efficacy|3|||
129535257|NCT02087085|466250186|FG000|Overall Study|Lost to Follow-up|6|||
129535258|NCT02087085|466250187|FG001|Overall Study|Lost to Follow-up|4|||
129535259|NCT02087085|466250186|FG000|Overall Study|Withdrawal by Subject|9|||
129535260|NCT02087085|466250187|FG001|Overall Study|Withdrawal by Subject|11|||
129535261|NCT02087085|466250186|FG000|Overall Study|Protocol Violation|1|||
129535262|NCT02087085|466250187|FG001|Overall Study|Protocol Violation|0|||
129535263|NCT02087085|466250186|FG000|Overall Study|Study Terminated by Sponsor|87|||
129535264|NCT02087085|466250187|FG001|Overall Study|Study Terminated by Sponsor|80|||
129535265|NCT02087085|466250186|FG000|Overall Study|Other Miscellaneous Reasons|3|||
129535266|NCT02087085|466250187|FG001|Overall Study|Other Miscellaneous Reasons|4|||
129535267|NCT03339999|466250195|FG000|Overall Study|Adverse Event|1|||
129535268|NCT03339999|466250196|FG001|Overall Study|Adverse Event|2|||
129535269|NCT03339999|466250197|FG002|Overall Study|Adverse Event|2|||
129535270|NCT03339999|466250198|FG003|Overall Study|Adverse Event|1|||
129535271|NCT03339999|466250195|FG000|Overall Study|Lack of Efficacy|0|||
129535272|NCT03339999|466250196|FG001|Overall Study|Lack of Efficacy|1|||
129535273|NCT03339999|466250197|FG002|Overall Study|Lack of Efficacy|0|||
129535274|NCT03339999|466250198|FG003|Overall Study|Lack of Efficacy|0|||
129535275|NCT03339999|466250195|FG000|Overall Study|Lost to Follow-up|0|||
129535276|NCT03339999|466250196|FG001|Overall Study|Lost to Follow-up|0|||
129535277|NCT03339999|466250197|FG002|Overall Study|Lost to Follow-up|0|||
129535278|NCT03339999|466250198|FG003|Overall Study|Lost to Follow-up|1|||
129535279|NCT03339999|466250195|FG000|Overall Study|Study Terminated by Sponsor|6|||
129535280|NCT03339999|466250196|FG001|Overall Study|Study Terminated by Sponsor|3|||
129535281|NCT03339999|466250197|FG002|Overall Study|Study Terminated by Sponsor|4|||
129535282|NCT03339999|466250198|FG003|Overall Study|Study Terminated by Sponsor|3|||
129535283|NCT01729559|466250204|FG000|Overall Study|Protocol Violation|31|||
129535284|NCT01729559|466250205|FG001|Overall Study|Protocol Violation|28|||
129535285|NCT03764813|466250206|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
129535286|NCT03764813|466250207|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
129535287|NCT03764813|466250208|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
129535288|NCT03764813|466250209|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
129535289|NCT04382066|466250210|FG000|Overall Study|Adverse Event|1|||
129535290|NCT04382066|466250211|FG001|Overall Study|Adverse Event|0|||
129535291|NCT04382066|466250212|FG002|Overall Study|Adverse Event|0|||
129535292|NCT04382066|466250210|FG000|Overall Study|Death|1|||
129535293|NCT04382066|466250211|FG001|Overall Study|Death|0|||
129535294|NCT04382066|466250212|FG002|Overall Study|Death|1|||
129535295|NCT00504595|466250213|FG000|Overall Study|Lack of Efficacy|1|||
129535296|NCT00504595|466250214|FG001|Overall Study|Lack of Efficacy|0|||
129535297|NCT00504595|466250215|FG002|Overall Study|Lack of Efficacy|0|||
129535298|NCT00504595|466250216|FG003|Overall Study|Lack of Efficacy|0|||
129535299|NCT00504595|466250213|FG000|Overall Study|Other|0|||
129535300|NCT00504595|466250214|FG001|Overall Study|Other|0|||
129535301|NCT00504595|466250215|FG002|Overall Study|Other|2|||
129535302|NCT00504595|466250216|FG003|Overall Study|Other|0|||
129535303|NCT03326323|466250217|FG000|Overall Study|Unable to receive ANH protocol|3|||
129535304|NCT04225026|466250219|FG000|Overall Study|Withdrawal by Subject|4|||
129535305|NCT04225026|466250219|FG000|Overall Study|Adverse Event|1|||
129535306|NCT04225026|466250219|FG000|Overall Study|Other|1|||
129535307|NCT04225026|466250219|FG000|Overall Study|Death|11|||
129535308|NCT04225026|466250219|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
129535309|NCT00851721|466250223|FG000|Overall Study|planned surgery|1|||
129535310|NCT00851721|466250224|FG001|Overall Study|planned surgery|0|||
129535311|NCT00851721|466250223|FG000|Overall Study|Death|1|||
129535312|NCT00851721|466250224|FG001|Overall Study|Death|0|||
129535313|NCT00851721|466250223|FG000|Overall Study|Adverse Event|0|||
129535314|NCT00851721|466250224|FG001|Overall Study|Adverse Event|1|||
129535315|NCT03137433|466250226|FG000|Overall Study|Withdrawal by Subject|11|||
129535316|NCT03137433|466250227|FG001|Overall Study|Withdrawal by Subject|11|||
129535317|NCT03137433|466250226|FG000|Overall Study|Lost to Follow-up|5|||
129535318|NCT03137433|466250227|FG001|Overall Study|Lost to Follow-up|6|||
129535319|NCT03137433|466250226|FG000|Overall Study|Physician Decision|2|||
129535320|NCT03137433|466250227|FG001|Overall Study|Physician Decision|0|||
129535321|NCT03137433|466250226|FG000|Overall Study|Moved out of study area|1|||
129535322|NCT03137433|466250227|FG001|Overall Study|Moved out of study area|0|||
129535323|NCT03137433|466250226|FG000|Overall Study|Too far out of window due to COVID|0|||
129535324|NCT03137433|466250227|FG001|Overall Study|Too far out of window due to COVID|1|||
129535325|NCT02132312|466250228|FG000|Overall Study|Adverse Event|2|||
129535326|NCT02132312|466250229|FG001|Overall Study|Adverse Event|0|||
129535327|NCT02132312|466250228|FG000|Overall Study|Physician Decision|1|||
129535328|NCT02132312|466250229|FG001|Overall Study|Physician Decision|1|||
129535329|NCT02132312|466250228|FG000|Overall Study|Protocol Violation|0|||
129535330|NCT02132312|466250229|FG001|Overall Study|Protocol Violation|1|||
129535331|NCT02132312|466250228|FG000|Overall Study|Withdrawal by Subject|1|||
129535332|NCT02132312|466250229|FG001|Overall Study|Withdrawal by Subject|0|||
129535333|NCT02132312|466250228|FG000|Overall Study|Lost to Follow-up|2|||
129535334|NCT02132312|466250229|FG001|Overall Study|Lost to Follow-up|1|||
129535335|NCT03258710|466250230|FG000|Overall Study|Adverse Event|1|||
129535336|NCT03258710|466250230|FG000|Overall Study|Protocol-defined stopping criteria|1|||
129535337|NCT03258710|466250230|FG000|Overall Study|Physician Decision|1|||
129535338|NCT02242305|466250231|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
129535339|NCT02242305|466250232|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
129535340|NCT02242305|466250231|FG000|Overall Study|Adverse Event|1|||
129535341|NCT02242305|466250232|FG001|Overall Study|Adverse Event|0|||
129535342|NCT02242305|466250231|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
129535343|NCT02242305|466250232|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
129535344|NCT02242305|466250231|FG000|Overall Study|Subject withdraws inform consent|0|||
129535345|NCT02242305|466250232|FG001|Overall Study|Subject withdraws inform consent|4|||
129535346|NCT02242305|466250231|FG000|Overall Study|Lost to Follow-up|2|||
129535347|NCT02242305|466250232|FG001|Overall Study|Lost to Follow-up|0|||
129535348|NCT03451630|466250233|FG000|Overall Study|Death|15|||
129535349|NCT03451630|466250234|FG001|Overall Study|Death|16|||
129535350|NCT03451630|466250235|FG002|Overall Study|Death|11|||
129535351|NCT03451630|466250233|FG000|Overall Study|Lost to Follow-up|9|||
129535352|NCT03451630|466250234|FG001|Overall Study|Lost to Follow-up|0|||
129535353|NCT03451630|466250235|FG002|Overall Study|Lost to Follow-up|4|||
129535354|NCT03451630|466250233|FG000|Overall Study|Withdrawal by Subject|0|||
129535355|NCT03451630|466250234|FG001|Overall Study|Withdrawal by Subject|3|||
129535356|NCT03451630|466250235|FG002|Overall Study|Withdrawal by Subject|0|||
129535357|NCT03451630|466250233|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
129535358|NCT03451630|466250234|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
129535359|NCT03451630|466250235|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
129535360|NCT02041533|466250239|FG000|Pre-Treatment Period|Disease Progression|1|||
129535361|NCT02041533|466250240|FG001|Pre-Treatment Period|Disease Progression|1|||
129535362|NCT02041533|466250239|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
129535363|NCT02041533|466250240|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
129535364|NCT02041533|466250239|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
129535365|NCT02041533|466250240|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
129535366|NCT02041533|466250239|FG000|Treatment Period|Disease progression|189|||
129535367|NCT02041533|466250240|FG001|Treatment Period|Disease progression|146|||
129535368|NCT02041533|466250239|FG000|Treatment Period|Study drug toxicity|30|||
129535369|NCT02041533|466250240|FG001|Treatment Period|Study drug toxicity|34|||
129535370|NCT02041533|466250239|FG000|Treatment Period|Death|1|||
129535371|NCT02041533|466250240|FG001|Treatment Period|Death|0|||
129535372|NCT02041533|466250239|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
129535373|NCT02041533|466250240|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
129535374|NCT02041533|466250239|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
129535375|NCT02041533|466250240|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
129535376|NCT02041533|466250239|FG000|Treatment Period|Participant withdrew consent|2|||
129535377|NCT02041533|466250240|FG001|Treatment Period|Participant withdrew consent|2|||
129535378|NCT02041533|466250239|FG000|Treatment Period|Maximum clinical benefit|0|||
129535379|NCT02041533|466250240|FG001|Treatment Period|Maximum clinical benefit|18|||
129535380|NCT02041533|466250239|FG000|Treatment Period|Poor/Non-compliance|1|||
129535381|NCT02041533|466250240|FG001|Treatment Period|Poor/Non-compliance|0|||
129535382|NCT02041533|466250239|FG000|Treatment Period|Administrative reason by sponsor|1|||
129535383|NCT02041533|466250240|FG001|Treatment Period|Administrative reason by sponsor|0|||
129535384|NCT02041533|466250239|FG000|Treatment Period|Other reasons|9|||
129535385|NCT02041533|466250240|FG001|Treatment Period|Other reasons|2|||
129535386|NCT02041533|466250239|FG000|Treatment Period|Not Reported|0|||
129535387|NCT02041533|466250240|FG001|Treatment Period|Not Reported|1|||
129535388|NCT01874288|466250241|FG000|Overall Study|Withdrawal by Subject|1|||
129535389|NCT01874288|466250242|FG001|Overall Study|Withdrawal by Subject|0|||
129535390|NCT01874288|466250243|FG002|Overall Study|Withdrawal by Subject|2|||
129535391|NCT01874288|466250244|FG003|Overall Study|Withdrawal by Subject|1|||
129535392|NCT01874288|466250245|FG004|Overall Study|Withdrawal by Subject|1|||
129535393|NCT01874288|466250241|FG000|Overall Study|Physician Decision|0|||
129535394|NCT01874288|466250242|FG001|Overall Study|Physician Decision|0|||
129535395|NCT01874288|466250243|FG002|Overall Study|Physician Decision|0|||
129535396|NCT01874288|466250244|FG003|Overall Study|Physician Decision|1|||
129535397|NCT01874288|466250245|FG004|Overall Study|Physician Decision|0|||
129535398|NCT01874288|466250241|FG000|Overall Study|Progressive disease|2|||
129535399|NCT01874288|466250242|FG001|Overall Study|Progressive disease|0|||
129535400|NCT01874288|466250243|FG002|Overall Study|Progressive disease|3|||
129535401|NCT01874288|466250244|FG003|Overall Study|Progressive disease|5|||
129535402|NCT01874288|466250245|FG004|Overall Study|Progressive disease|1|||
129535403|NCT00591786|466250250|FG000|Overall Study|Withdrawal of Informed Consent|0|||
129535404|NCT00591786|466250251|FG001|Overall Study|Withdrawal of Informed Consent|0|||
129535405|NCT00591786|466250252|FG002|Overall Study|Withdrawal of Informed Consent|1|||
129535406|NCT00591786|466250253|FG003|Overall Study|Withdrawal of Informed Consent|0|||
129535407|NCT00591786|466250254|FG004|Overall Study|Withdrawal of Informed Consent|0|||
129535408|NCT00591786|466250255|FG005|Overall Study|Withdrawal of Informed Consent|0|||
129535409|NCT00591786|466250256|FG006|Overall Study|Withdrawal of Informed Consent|0|||
129535410|NCT00591786|466250257|FG007|Overall Study|Withdrawal of Informed Consent|0|||
129535411|NCT00591786|466250258|FG008|Overall Study|Withdrawal of Informed Consent|0|||
129535412|NCT00591786|466250259|FG009|Overall Study|Withdrawal of Informed Consent|0|||
129535413|NCT00554229|466250260|FG000|Overall Study|Lost to Follow-up|3|||
129535414|NCT00554229|466250261|FG001|Overall Study|Lost to Follow-up|6|||
129535415|NCT00554229|466250260|FG000|Overall Study|Withdrawal by Subject|29|||
129535416|NCT00554229|466250261|FG001|Overall Study|Withdrawal by Subject|37|||
129535417|NCT00554229|466250260|FG000|Overall Study|Adverse Event|71|||
129535418|NCT00554229|466250261|FG001|Overall Study|Adverse Event|39|||
129535419|NCT00554229|466250260|FG000|Overall Study|Protocol Violation|3|||
129535420|NCT00554229|466250261|FG001|Overall Study|Protocol Violation|3|||
129535421|NCT00554229|466250260|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
129535422|NCT00554229|466250261|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
129535423|NCT00554229|466250260|FG000|Overall Study|Randomised but no treatment received|1|||
129535424|NCT00554229|466250261|FG001|Overall Study|Randomised but no treatment received|0|||
129535425|NCT01140646|466250262|FG000|Overall Study|Adverse Event|4|||
129535426|NCT01140646|466250262|FG000|Overall Study|Refused Further Treatment|5|||
129535427|NCT00784836|466250267|FG000|Overall Study|Early Study Termination|3|||
129535428|NCT00660829|466250268|FG000|Overall Study|Adverse Event|3|||
129535429|NCT00660829|466250269|FG001|Overall Study|Adverse Event|4|||
129535430|NCT00660829|466250268|FG000|Overall Study|Lack of Efficacy|2|||
129535431|NCT00660829|466250269|FG001|Overall Study|Lack of Efficacy|3|||
129535432|NCT00660829|466250268|FG000|Overall Study|Non-Compliance|0|||
129535433|NCT00660829|466250269|FG001|Overall Study|Non-Compliance|4|||
129535434|NCT00660829|466250268|FG000|Overall Study|Withdrawal by Subject|1|||
129535435|NCT00660829|466250269|FG001|Overall Study|Withdrawal by Subject|2|||
129535436|NCT00660829|466250268|FG000|Overall Study|Lost to Follow-up|3|||
129535437|NCT00660829|466250269|FG001|Overall Study|Lost to Follow-up|2|||
129535438|NCT00660829|466250268|FG000|Overall Study|Other|9|||
129535439|NCT00660829|466250269|FG001|Overall Study|Other|4|||
129535440|NCT02127931|466250270|FG000|Overall Study|Glitch in Game|1|||
129535441|NCT02828982|466250271|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129535442|NCT02828982|466250272|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
129535443|NCT00434876|466250275|FG000|Overall Study|Lost to Follow-up|1|||
129535444|NCT00434876|466250276|FG001|Overall Study|Lost to Follow-up|1|||
129535445|NCT00758394|466250277|FG000|2nd Intervention Order|Lost to Follow-up|0|||
129535446|NCT00758394|466250278|FG001|2nd Intervention Order|Lost to Follow-up|1|||
129535447|NCT00758394|466250279|FG002|2nd Intervention Order|Lost to Follow-up|0|||
129535448|NCT00758394|466250280|FG003|2nd Intervention Order|Lost to Follow-up|0|||
129535449|NCT00758394|466250277|FG000|3rd Intervention|Lost to Follow-up|1|||
129535450|NCT00758394|466250278|FG001|3rd Intervention|Lost to Follow-up|0|||
129535451|NCT00758394|466250279|FG002|3rd Intervention|Lost to Follow-up|0|||
129535452|NCT00758394|466250280|FG003|3rd Intervention|Lost to Follow-up|1|||
129535453|NCT03044730|466250291|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
129535454|NCT03044730|466250291|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
129535455|NCT03044730|466250291|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
129535456|NCT03044730|466250291|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
129535457|NCT03044730|466250291|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
129535458|NCT03044730|466250291|FG000|Cycles 4 and Beyond|Adverse Event|1|||
129535459|NCT03044730|466250291|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
129535460|NCT03044730|466250291|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
129535461|NCT03044730|466250291|FG000|On Follow-up for 2 Years|Death|17|||
129535462|NCT00690612|466251973|FG000|Overall Study|Adverse Event|1|||
129535463|NCT00690612|466251973|FG000|Overall Study|Withdrawal by Subject|2|||
129535464|NCT01233076|466251974|FG000|Period 2, One Week|Lost to Follow-up|1|||
129535465|NCT01233076|466251975|FG001|Period 2, One Week|Lost to Follow-up|0|||
129535466|NCT01786707|466251977|FG000|Overall Study|Lost to Follow-up|1|||
129535467|NCT01786707|466251978|FG001|Overall Study|Lost to Follow-up|1|||
129535468|NCT02058940|466251979|FG000|Overall Study|Discharged from Critical Care Unit|1|||
129535469|NCT01519700|466251980|FG000|Overall Study|Death|1|||
129535470|NCT01519700|466251981|FG001|Overall Study|Death|0|||
129535471|NCT01519700|466251982|FG002|Overall Study|Death|0|||
129535472|NCT01519700|466251983|FG003|Overall Study|Death|0|||
129535473|NCT01519700|466251980|FG000|Overall Study|Lost to Follow-up|0|||
129535474|NCT01519700|466251981|FG001|Overall Study|Lost to Follow-up|0|||
129535475|NCT01519700|466251982|FG002|Overall Study|Lost to Follow-up|1|||
129535476|NCT01519700|466251983|FG003|Overall Study|Lost to Follow-up|1|||
129535477|NCT01519700|466251980|FG000|Overall Study|Physician Decision|1|||
129535478|NCT01519700|466251981|FG001|Overall Study|Physician Decision|1|||
129535479|NCT01519700|466251982|FG002|Overall Study|Physician Decision|3|||
129535480|NCT01519700|466251983|FG003|Overall Study|Physician Decision|0|||
129535481|NCT01519700|466251980|FG000|Overall Study|Withdrawal by Subject|5|||
129535482|NCT01519700|466251981|FG001|Overall Study|Withdrawal by Subject|3|||
129535483|NCT01519700|466251982|FG002|Overall Study|Withdrawal by Subject|3|||
129535484|NCT01519700|466251983|FG003|Overall Study|Withdrawal by Subject|2|||
129535485|NCT01519700|466251980|FG000|Overall Study|Other Reason|2|||
129535486|NCT01519700|466251981|FG001|Overall Study|Other Reason|2|||
129535487|NCT01519700|466251982|FG002|Overall Study|Other Reason|0|||
129535488|NCT01519700|466251983|FG003|Overall Study|Other Reason|4|||
129535489|NCT05637515|466251984|FG000|Overall Study|Withdrawal by Subject|17|||
129535490|NCT05637515|466251985|FG001|Overall Study|Withdrawal by Subject|17|||
129535491|NCT00772031|466251987|FG000|Overall Study|Early termination of trial|12|||
129535492|NCT00772031|466251988|FG001|Overall Study|Early termination of trial|10|||
129535493|NCT00772031|466251987|FG000|Overall Study|Lost to Follow-up|20|||
129535494|NCT00772031|466251988|FG001|Overall Study|Lost to Follow-up|33|||
129535495|NCT00635804|466251989|FG000|Overall Study|Adverse Event|0|||
129535496|NCT00635804|466251990|FG001|Overall Study|Adverse Event|0|||
129535497|NCT00635804|466251991|FG002|Overall Study|Adverse Event|0|||
129535498|NCT00635804|466251992|FG003|Overall Study|Adverse Event|0|||
129535499|NCT00635804|466251993|FG004|Overall Study|Adverse Event|0|||
129535500|NCT00635804|466251994|FG005|Overall Study|Adverse Event|1|||
129535501|NCT00635804|466251995|FG006|Overall Study|Adverse Event|0|||
129535502|NCT00635804|466251996|FG007|Overall Study|Adverse Event|0|||
129535503|NCT00635804|466251989|FG000|Overall Study|Withdrawal by Subject|1|||
129535504|NCT00635804|466251990|FG001|Overall Study|Withdrawal by Subject|0|||
129535505|NCT00635804|466251991|FG002|Overall Study|Withdrawal by Subject|0|||
129535506|NCT00635804|466251992|FG003|Overall Study|Withdrawal by Subject|0|||
129535507|NCT00635804|466251993|FG004|Overall Study|Withdrawal by Subject|0|||
129535508|NCT00635804|466251994|FG005|Overall Study|Withdrawal by Subject|0|||
129535509|NCT00635804|466251995|FG006|Overall Study|Withdrawal by Subject|0|||
129538908|NCT01238861|466265109|FG002|Overall Study|Lost to Follow-up|3|||
129535510|NCT00635804|466251996|FG007|Overall Study|Withdrawal by Subject|0|||
129535511|NCT02718131|466251997|FG000|Overall Study|Withdrawal by Subject|1|||
129535512|NCT02718131|466251998|FG001|Overall Study|Withdrawal by Subject|0|||
129535513|NCT02718131|466251997|FG000|Overall Study|Adverse Event|1|||
129535514|NCT02718131|466251998|FG001|Overall Study|Adverse Event|0|||
129535515|NCT02718131|466251997|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
129535516|NCT02718131|466251998|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
129535517|NCT01101321|466251999|FG000|Period 1|Withdrawal by Subject|1|||
129535518|NCT01101321|466252000|FG001|Period 1|Withdrawal by Subject|1|||
129535519|NCT01101321|466251999|FG000|Period 1|Adverse Event|3|||
129535520|NCT01101321|466252000|FG001|Period 1|Adverse Event|3|||
129535521|NCT03382639|466252001|FG000|Overall Study|Adverse Event|2|||
129535522|NCT03382639|466252002|FG001|Overall Study|Adverse Event|0|||
129535523|NCT03382639|466252003|FG002|Overall Study|Adverse Event|1|||
129535524|NCT03382639|466252004|FG003|Overall Study|Adverse Event|1|||
129535525|NCT03382639|466252001|FG000|Overall Study|Lost to Follow-up|1|||
129535526|NCT03382639|466252002|FG001|Overall Study|Lost to Follow-up|0|||
129535527|NCT03382639|466252003|FG002|Overall Study|Lost to Follow-up|0|||
129535528|NCT03382639|466252004|FG003|Overall Study|Lost to Follow-up|0|||
129535529|NCT03382639|466252001|FG000|Overall Study|Withdrawal by Subject|4|||
129535530|NCT03382639|466252002|FG001|Overall Study|Withdrawal by Subject|3|||
129535531|NCT03382639|466252003|FG002|Overall Study|Withdrawal by Subject|2|||
129535532|NCT03382639|466252004|FG003|Overall Study|Withdrawal by Subject|3|||
129535533|NCT03382639|466252001|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
129535534|NCT03382639|466252002|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
129535535|NCT03382639|466252003|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
129535536|NCT03382639|466252004|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
129535537|NCT03382639|466252001|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
129535538|NCT03382639|466252002|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
129535539|NCT03382639|466252003|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
129535540|NCT03382639|466252004|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
129535541|NCT03382639|466252001|FG000|Overall Study|Other|2|||
129535542|NCT03382639|466252002|FG001|Overall Study|Other|0|||
129535543|NCT03382639|466252003|FG002|Overall Study|Other|0|||
129535544|NCT03382639|466252004|FG003|Overall Study|Other|3|||
129535545|NCT02406586|466252005|FG000|Overall Study|Lost to Follow-up|0|||
129535546|NCT02406586|466252006|FG001|Overall Study|Lost to Follow-up|4|||
129535547|NCT02406586|466252007|FG002|Overall Study|Lost to Follow-up|2|||
129535548|NCT02406586|466252005|FG000|Overall Study|Withdrawal by Subject|1|||
129535549|NCT02406586|466252006|FG001|Overall Study|Withdrawal by Subject|0|||
129535550|NCT02406586|466252007|FG002|Overall Study|Withdrawal by Subject|0|||
129535551|NCT00682539|466252008|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
129535552|NCT00682539|466252009|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
129535553|NCT00682539|466252010|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
129535554|NCT00682539|466252008|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
129535555|NCT00682539|466252009|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
129535556|NCT00682539|466252010|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
129535557|NCT02477215|466252013|FG000|Dose Escalation Phase|Physician Decision|1|||
129535558|NCT02477215|466252014|FG001|Dose Escalation Phase|Physician Decision|2|||
129535559|NCT02477215|466252015|FG002|Dose Escalation Phase|Physician Decision|0|||
129535560|NCT02477215|466252013|FG000|Fixed Dose Phase|Physician Decision|0|||
129535561|NCT02477215|466252014|FG001|Fixed Dose Phase|Physician Decision|7|||
129535562|NCT02477215|466252015|FG002|Fixed Dose Phase|Physician Decision|0|||
129535563|NCT00679354|466252025|FG000|Overall Study|Death|3|||
129535564|NCT00679354|466252025|FG000|Overall Study|Lack of Efficacy|22|||
129535565|NCT00679354|466252025|FG000|Overall Study|Physician Decision|4|||
129535566|NCT00679354|466252025|FG000|Overall Study|Ineligible|1|||
129535567|NCT01654666|466252030|FG000|Overall Study|Protocol Violation|7|||
129535568|NCT01654666|466252031|FG001|Overall Study|Protocol Violation|4|||
129535569|NCT01654666|466252032|FG002|Overall Study|Protocol Violation|8|||
129535570|NCT01654666|466252030|FG000|Overall Study|Lost to Follow-up|4|||
129535571|NCT01654666|466252031|FG001|Overall Study|Lost to Follow-up|5|||
129535572|NCT01654666|466252032|FG002|Overall Study|Lost to Follow-up|5|||
129535573|NCT01654666|466252030|FG000|Overall Study|Withdrawal by Subject|4|||
129535574|NCT01654666|466252031|FG001|Overall Study|Withdrawal by Subject|4|||
129535575|NCT01654666|466252032|FG002|Overall Study|Withdrawal by Subject|1|||
129535576|NCT00535262|466252035|FG000|Overall Study|No funding|3|||
129535577|NCT02898662|466252036|FG000|Overall Study|Adverse Event|1|||
129535578|NCT02898662|466252037|FG001|Overall Study|Adverse Event|0|||
129535579|NCT02898662|466252036|FG000|Overall Study|Loss of asthma control|23|||
129535580|NCT02898662|466252037|FG001|Overall Study|Loss of asthma control|24|||
129535581|NCT02898662|466252036|FG000|Overall Study|Withdrawal by Subject|4|||
129535582|NCT02898662|466252037|FG001|Overall Study|Withdrawal by Subject|1|||
129535583|NCT02898662|466252036|FG000|Overall Study|Technical issue|0|||
129535584|NCT02898662|466252037|FG001|Overall Study|Technical issue|1|||
129535585|NCT02898662|466252036|FG000|Overall Study|Randomized in error|0|||
129535586|NCT02898662|466252037|FG001|Overall Study|Randomized in error|1|||
129535587|NCT02898662|466252036|FG000|Overall Study|Subject decision|1|||
129535588|NCT02898662|466252037|FG001|Overall Study|Subject decision|0|||
129535589|NCT02898662|466252036|FG000|Overall Study|Other|0|||
129535590|NCT02898662|466252037|FG001|Overall Study|Other|1|||
129535591|NCT03802331|466252038|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
129535592|NCT03802331|466252039|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
129535593|NCT00917553|466252040|FG000|Overall Study|Lost to Follow-up|2|||
129535594|NCT00917553|466252041|FG001|Overall Study|Lost to Follow-up|1|||
129535595|NCT01616173|466252042|FG000|Overall Study|Lost to Follow-up|0|||
129535596|NCT01616173|466252043|FG001|Overall Study|Lost to Follow-up|2|||
129535597|NCT01616173|466252044|FG002|Overall Study|Lost to Follow-up|0|||
129535598|NCT03432819|466252047|FG000|Overall Study|Lost to Follow-up|2|||
129535599|NCT03432819|466252048|FG001|Overall Study|Lost to Follow-up|2|||
129535600|NCT03432819|466252047|FG000|Overall Study|Withdrawal by Subject|5|||
129535601|NCT03432819|466252048|FG001|Overall Study|Withdrawal by Subject|3|||
129535602|NCT00672490|466252050|FG000|Overall Study|Withdrawal by Subject|8|||
129535603|NCT00672490|466252051|FG001|Overall Study|Withdrawal by Subject|8|||
129535604|NCT00672490|466252050|FG000|Overall Study|Lack of Compliance|2|||
129535605|NCT00672490|466252051|FG001|Overall Study|Lack of Compliance|7|||
129535606|NCT00672490|466252050|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
129535607|NCT00672490|466252051|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
129535608|NCT00672490|466252050|FG000|Overall Study|Adverse Event|5|||
129535609|NCT00672490|466252051|FG001|Overall Study|Adverse Event|8|||
129535610|NCT00672490|466252050|FG000|Overall Study|Violation of Concomitant Medicine|1|||
129535611|NCT00672490|466252051|FG001|Overall Study|Violation of Concomitant Medicine|0|||
129535612|NCT00672490|466252050|FG000|Overall Study|Intolerance|0|||
129535613|NCT00672490|466252051|FG001|Overall Study|Intolerance|2|||
129535614|NCT00672490|466252050|FG000|Overall Study|Lost to Follow-up|1|||
129535615|NCT00672490|466252051|FG001|Overall Study|Lost to Follow-up|5|||
129535616|NCT00672490|466252050|FG000|Overall Study|No reason was provided|6|||
129535617|NCT00672490|466252051|FG001|Overall Study|No reason was provided|2|||
129535618|NCT04738123|466252054|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
129535619|NCT04738123|466252055|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
129535620|NCT04738123|466252054|FG000|Overall Study|Progressive Disease|0|||
129535621|NCT04738123|466252055|FG001|Overall Study|Progressive Disease|4|||
129535622|NCT04738123|466252054|FG000|Overall Study|Adverse Event|8|||
129535623|NCT04738123|466252055|FG001|Overall Study|Adverse Event|7|||
129535624|NCT04738123|466252054|FG000|Overall Study|Other Reasons|0|||
129535625|NCT04738123|466252055|FG001|Overall Study|Other Reasons|1|||
129535626|NCT04738123|466252054|FG000|Overall Study|Suicidal or assaultive behavior|0|||
129535627|NCT04738123|466252055|FG001|Overall Study|Suicidal or assaultive behavior|2|||
129535628|NCT04738123|466252054|FG000|Overall Study|Protocol Violation|2|||
129535629|NCT04738123|466252055|FG001|Overall Study|Protocol Violation|2|||
129535630|NCT04738123|466252054|FG000|Overall Study|Consent Withdrawn|35|||
129535631|NCT04738123|466252055|FG001|Overall Study|Consent Withdrawn|22|||
129535632|NCT03604159|466252056|FG000|Overall Study|Lost to Follow-up|6|||
129535633|NCT03604159|466252057|FG001|Overall Study|Lost to Follow-up|7|||
129535634|NCT04533204|466252062|FG000|Overall Study|Unable to understand training instructions|1|||
129535635|NCT04533204|466252063|FG001|Overall Study|Unable to understand training instructions|1|||
129535636|NCT03982069|466252064|FG000|Overall Study|Lost to Follow-up|5|||
129535637|NCT03982069|466252065|FG001|Overall Study|Lost to Follow-up|5|||
129535638|NCT03982069|466252066|FG002|Overall Study|Lost to Follow-up|3|||
129535639|NCT03982069|466252067|FG003|Overall Study|Lost to Follow-up|5|||
129535640|NCT03982069|466252064|FG000|Overall Study|Physician Decision|0|||
129535641|NCT03982069|466252065|FG001|Overall Study|Physician Decision|1|||
129535642|NCT03982069|466252066|FG002|Overall Study|Physician Decision|0|||
129535643|NCT03982069|466252067|FG003|Overall Study|Physician Decision|0|||
129535644|NCT03982069|466252064|FG000|Overall Study|Withdrawal by Subject|2|||
129535645|NCT03982069|466252065|FG001|Overall Study|Withdrawal by Subject|1|||
129535646|NCT03982069|466252066|FG002|Overall Study|Withdrawal by Subject|5|||
129535647|NCT03982069|466252067|FG003|Overall Study|Withdrawal by Subject|2|||
129535648|NCT03982069|466252064|FG000|Overall Study|Specimen loss|3|||
129535649|NCT03982069|466252065|FG001|Overall Study|Specimen loss|3|||
129535650|NCT03982069|466252066|FG002|Overall Study|Specimen loss|1|||
129535651|NCT03982069|466252067|FG003|Overall Study|Specimen loss|1|||
129535652|NCT01218477|466252068|FG000|Overall Study|Disease progression|2|||
129535653|NCT01218477|466252069|FG001|Overall Study|Disease progression|3|||
129535654|NCT01218477|466252070|FG002|Overall Study|Disease progression|6|||
129535655|NCT01218477|466252071|FG003|Overall Study|Disease progression|2|||
129535656|NCT01218477|466252068|FG000|Overall Study|Study drug toxicity|0|||
129535657|NCT01218477|466252069|FG001|Overall Study|Study drug toxicity|2|||
129535658|NCT01218477|466252070|FG002|Overall Study|Study drug toxicity|5|||
129535659|NCT01218477|466252071|FG003|Overall Study|Study drug toxicity|0|||
129535660|NCT01218477|466252068|FG000|Overall Study|No longer meets study criteria|1|||
129535661|NCT01218477|466252069|FG001|Overall Study|No longer meets study criteria|0|||
129535662|NCT01218477|466252070|FG002|Overall Study|No longer meets study criteria|0|||
129535663|NCT01218477|466252071|FG003|Overall Study|No longer meets study criteria|0|||
129535664|NCT01218477|466252068|FG000|Overall Study|Withdrawal by Subject|0|||
129535665|NCT01218477|466252069|FG001|Overall Study|Withdrawal by Subject|0|||
129535666|NCT01218477|466252070|FG002|Overall Study|Withdrawal by Subject|1|||
129535667|NCT01218477|466252071|FG003|Overall Study|Withdrawal by Subject|0|||
129535668|NCT01218477|466252068|FG000|Overall Study|Prepared for cell transplantation|0|||
129535669|NCT01218477|466252069|FG001|Overall Study|Prepared for cell transplantation|1|||
129535670|NCT01218477|466252070|FG002|Overall Study|Prepared for cell transplantation|1|||
129535671|NCT01218477|466252071|FG003|Overall Study|Prepared for cell transplantation|0|||
129535672|NCT01218477|466252068|FG000|Overall Study|Administrative reason by sponsor|0|||
129535673|NCT01218477|466252069|FG001|Overall Study|Administrative reason by sponsor|0|||
129535674|NCT01218477|466252070|FG002|Overall Study|Administrative reason by sponsor|1|||
129535675|NCT01218477|466252071|FG003|Overall Study|Administrative reason by sponsor|0|||
129535676|NCT01218477|466252068|FG000|Overall Study|Maximum clinical benefit|0|||
129535677|NCT01218477|466252069|FG001|Overall Study|Maximum clinical benefit|2|||
129535678|NCT01218477|466252070|FG002|Overall Study|Maximum clinical benefit|0|||
129535679|NCT01218477|466252071|FG003|Overall Study|Maximum clinical benefit|0|||
129535680|NCT00787527|466252074|FG000|Overall Study|Toxicity|3|||
129535681|NCT00083616|466252075|FG000|Overall Study|Disease Progression|16|||
129535682|NCT00083616|466252075|FG000|Overall Study|Lost to Follow-up|1|||
129535683|NCT00083616|466252075|FG000|Overall Study|Physician Decision|2|||
129535684|NCT00083616|466252075|FG000|Overall Study|Withdrawal by Subject|3|||
129535685|NCT00083616|466252075|FG000|Overall Study|Ineligibility determined|2|||
129535686|NCT00083616|466252075|FG000|Overall Study|Non-compliance|1|||
129535687|NCT00083616|466252075|FG000|Overall Study|Other|6|||
129535688|NCT01474993|466252078|FG000|Overall Study|Lost to Follow-up|1|||
129535689|NCT01474993|466252079|FG001|Overall Study|Lost to Follow-up|2|||
129535690|NCT01474993|466252078|FG000|Overall Study|Adverse Event|0|||
129535691|NCT01474993|466252079|FG001|Overall Study|Adverse Event|1|||
129535692|NCT00760994|466252080|FG000|Overall Study|Lost to Follow-up|4|||
129535693|NCT00760994|466252081|FG001|Overall Study|Lost to Follow-up|4|||
129535694|NCT00760994|466252082|FG002|Overall Study|Lost to Follow-up|3|||
129535695|NCT01853397|466252083|FG000|Overall Study|Withdrawal by Subject|0|||
129535696|NCT01853397|466252084|FG001|Overall Study|Withdrawal by Subject|0|||
129535697|NCT01853397|466252085|FG002|Overall Study|Withdrawal by Subject|0|||
129535698|NCT01853397|466252086|FG003|Overall Study|Withdrawal by Subject|1|||
129535699|NCT01853397|466252083|FG000|Overall Study|Subject Noncompliance|0|||
129535700|NCT01853397|466252084|FG001|Overall Study|Subject Noncompliance|0|||
129535701|NCT01853397|466252085|FG002|Overall Study|Subject Noncompliance|0|||
129535702|NCT01853397|466252086|FG003|Overall Study|Subject Noncompliance|1|||
129535703|NCT00486720|466252087|FG000|Overall Study|Adverse Event|1|||
129535704|NCT00486720|466252088|FG001|Overall Study|Adverse Event|2|||
129535705|NCT00486720|466252087|FG000|Overall Study|Lack of Efficacy|4|||
129535706|NCT00486720|466252088|FG001|Overall Study|Lack of Efficacy|6|||
129535707|NCT00486720|466252087|FG000|Overall Study|Physician Decision|1|||
129535708|NCT00486720|466252088|FG001|Overall Study|Physician Decision|2|||
129535709|NCT00486720|466252087|FG000|Overall Study|Protocol Violation|1|||
129535710|NCT00486720|466252088|FG001|Overall Study|Protocol Violation|0|||
129535711|NCT00486720|466252087|FG000|Overall Study|Withdrawal by Subject|3|||
129535712|NCT00486720|466252088|FG001|Overall Study|Withdrawal by Subject|1|||
129535713|NCT00486720|466252087|FG000|Overall Study|Progressive Disease|0|||
129535714|NCT00486720|466252088|FG001|Overall Study|Progressive Disease|1|||
129535715|NCT02452892|466252089|FG000|Week 1 Initial Randommization|Adverse Event|1|||
129535716|NCT02452892|466252090|FG001|Week 1 Initial Randommization|Adverse Event|0|||
129535717|NCT02452892|466252091|FG002|Week 1 Initial Randommization|Adverse Event|0|||
129535718|NCT02452892|466252092|FG003|Week 1 Initial Randommization|Adverse Event|0|||
129535719|NCT02452892|466252089|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
129535720|NCT02452892|466252090|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
129535721|NCT02452892|466252091|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
129535722|NCT02452892|466252092|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
129535723|NCT02452892|466252089|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
129535724|NCT02452892|466252090|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
129535725|NCT02452892|466252091|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
129535726|NCT02452892|466252092|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
129535727|NCT02452892|466252089|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
129535728|NCT02452892|466252090|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
129535729|NCT02452892|466252091|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
129535730|NCT02452892|466252092|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
129535731|NCT02452892|466252089|FG000|Follow-up|Withdrawal by Subject|0|||
129535732|NCT02452892|466252090|FG001|Follow-up|Withdrawal by Subject|0|||
129535733|NCT02452892|466252091|FG002|Follow-up|Withdrawal by Subject|0|||
129535734|NCT02452892|466252092|FG003|Follow-up|Withdrawal by Subject|1|||
129535735|NCT02452892|466252089|FG000|Follow-up|Subject left town on Day 42|1|||
129535736|NCT02452892|466252090|FG001|Follow-up|Subject left town on Day 42|0|||
129535737|NCT02452892|466252091|FG002|Follow-up|Subject left town on Day 42|0|||
129535738|NCT02452892|466252092|FG003|Follow-up|Subject left town on Day 42|0|||
129535739|NCT00955682|466252093|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
129535740|NCT00955682|466252094|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
129535741|NCT02117024|466252095|FG000|Overall Study|Progressive Disease|26|||
129535742|NCT02117024|466252096|FG001|Overall Study|Progressive Disease|9|||
129535743|NCT02117024|466252095|FG000|Overall Study|Significant Clinical Progression|7|||
129535744|NCT02117024|466252096|FG001|Overall Study|Significant Clinical Progression|4|||
129535745|NCT02117024|466252095|FG000|Overall Study|Death|5|||
129535746|NCT02117024|466252096|FG001|Overall Study|Death|0|||
129535747|NCT02117024|466252095|FG000|Overall Study|Withdrawal by Subject|3|||
129535748|NCT02117024|466252096|FG001|Overall Study|Withdrawal by Subject|1|||
129535749|NCT02117024|466252095|FG000|Overall Study|Protocol Violation|1|||
129535750|NCT02117024|466252096|FG001|Overall Study|Protocol Violation|0|||
129535751|NCT02117024|466252095|FG000|Overall Study|Adverse Event|1|||
129535752|NCT02117024|466252096|FG001|Overall Study|Adverse Event|2|||
129535753|NCT02117024|466252095|FG000|Overall Study|Randomized in Error|1|||
129535754|NCT02117024|466252096|FG001|Overall Study|Randomized in Error|0|||
129535755|NCT02117024|466252095|FG000|Overall Study|Patient returned to primary oncologist|0|||
129535756|NCT02117024|466252096|FG001|Overall Study|Patient returned to primary oncologist|1|||
129535757|NCT02117024|466252095|FG000|Overall Study|Patient took treatment break|0|||
129535758|NCT02117024|466252096|FG001|Overall Study|Patient took treatment break|1|||
129535759|NCT02117024|466252095|FG000|Overall Study|Physician Decision|0|||
129535760|NCT02117024|466252096|FG001|Overall Study|Physician Decision|2|||
129535761|NCT00565721|466252099|FG000|Overall Study|Screen Failure|2|||
129535762|NCT00565721|466252099|FG000|Overall Study|Lost to Follow-up|6|||
129535763|NCT00565721|466252099|FG000|Overall Study|Technical Problems|1|||
129535764|NCT00565721|466252099|FG000|Overall Study|Physician Decision|2|||
129535765|NCT00565721|466252099|FG000|Overall Study|Other reasons|6|||
129535766|NCT02813681|466252100|FG000|Overall Study|Physician Decision|5|||
129535767|NCT02813681|466252101|FG001|Overall Study|Physician Decision|5|||
129535768|NCT02813681|466252102|FG002|Overall Study|Physician Decision|0|||
129535769|NCT02813681|466252100|FG000|Overall Study|Lost to Follow-up|0|||
129535770|NCT02813681|466252101|FG001|Overall Study|Lost to Follow-up|1|||
129535771|NCT02813681|466252102|FG002|Overall Study|Lost to Follow-up|0|||
129535772|NCT02500706|466252103|FG000|Overall Study|Adverse Event|0|||
129535773|NCT02500706|466252104|FG001|Overall Study|Adverse Event|0|||
129535774|NCT02500706|466252105|FG002|Overall Study|Adverse Event|1|||
129535775|NCT02500706|466252103|FG000|Overall Study|Lost to Follow-up|0|||
129535776|NCT02500706|466252104|FG001|Overall Study|Lost to Follow-up|1|||
129535777|NCT02500706|466252105|FG002|Overall Study|Lost to Follow-up|1|||
129535778|NCT02500706|466252103|FG000|Overall Study|Withdrawal by Subject|4|||
129535779|NCT02500706|466252104|FG001|Overall Study|Withdrawal by Subject|6|||
129535780|NCT02500706|466252105|FG002|Overall Study|Withdrawal by Subject|4|||
129535781|NCT02500706|466252103|FG000|Overall Study|Unclassified|0|||
129535782|NCT02500706|466252104|FG001|Overall Study|Unclassified|0|||
129535783|NCT02500706|466252105|FG002|Overall Study|Unclassified|1|||
129535784|NCT01497899|466252110|FG000|Double-Blind Phase|Randomized but not Treated|1|||
129535785|NCT01497899|466252111|FG001|Double-Blind Phase|Randomized but not Treated|0|||
129535786|NCT01497899|466252112|FG002|Double-Blind Phase|Randomized but not Treated|0|||
129535787|NCT01497899|466252113|FG003|Double-Blind Phase|Randomized but not Treated|0|||
129535788|NCT01497899|466252110|FG000|Double-Blind Phase|Adverse Event|1|||
129535789|NCT01497899|466252111|FG001|Double-Blind Phase|Adverse Event|0|||
129535790|NCT01497899|466252112|FG002|Double-Blind Phase|Adverse Event|0|||
129535791|NCT01497899|466252113|FG003|Double-Blind Phase|Adverse Event|0|||
129535792|NCT01497899|466252110|FG000|Double-Blind Phase|Lack of Efficacy|0|||
129535793|NCT01497899|466252111|FG001|Double-Blind Phase|Lack of Efficacy|1|||
129535794|NCT01497899|466252112|FG002|Double-Blind Phase|Lack of Efficacy|0|||
129535795|NCT01497899|466252113|FG003|Double-Blind Phase|Lack of Efficacy|0|||
129535796|NCT01497899|466252110|FG000|Double-Blind Phase|Investigator's Discretion|1|||
129535797|NCT01497899|466252111|FG001|Double-Blind Phase|Investigator's Discretion|0|||
129535798|NCT01497899|466252112|FG002|Double-Blind Phase|Investigator's Discretion|0|||
129535799|NCT01497899|466252113|FG003|Double-Blind Phase|Investigator's Discretion|0|||
129535800|NCT01497899|466252110|FG000|Double-Blind Phase|Withdrew Consent|0|||
129535801|NCT01497899|466252111|FG001|Double-Blind Phase|Withdrew Consent|1|||
129535802|NCT01497899|466252112|FG002|Double-Blind Phase|Withdrew Consent|0|||
129535803|NCT01497899|466252113|FG003|Double-Blind Phase|Withdrew Consent|0|||
129535804|NCT01497899|466252110|FG000|Double-Blind Phase|Lost to Follow-up|3|||
129535805|NCT01497899|466252111|FG001|Double-Blind Phase|Lost to Follow-up|2|||
129535806|NCT01497899|466252112|FG002|Double-Blind Phase|Lost to Follow-up|0|||
129535807|NCT01497899|466252113|FG003|Double-Blind Phase|Lost to Follow-up|0|||
129535808|NCT01497899|466252110|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
129535809|NCT01497899|466252111|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
129535810|NCT01497899|466252112|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
129535811|NCT01497899|466252113|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
129535812|NCT01497899|466252110|FG000|Open-Label Extension Phase|Adverse Event|1|||
129535813|NCT01497899|466252111|FG001|Open-Label Extension Phase|Adverse Event|0|||
129535814|NCT01497899|466252112|FG002|Open-Label Extension Phase|Adverse Event|0|||
129535815|NCT01497899|466252113|FG003|Open-Label Extension Phase|Adverse Event|0|||
129535816|NCT01497899|466252110|FG000|Open-Label Extension Phase|Death|1|||
129535817|NCT01497899|466252111|FG001|Open-Label Extension Phase|Death|0|||
129535818|NCT01497899|466252112|FG002|Open-Label Extension Phase|Death|0|||
129535819|NCT01497899|466252113|FG003|Open-Label Extension Phase|Death|0|||
129535820|NCT01497899|466252110|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
129535821|NCT01497899|466252111|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
129535822|NCT01497899|466252112|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
129535823|NCT01497899|466252113|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
129535824|NCT01497899|466252110|FG000|Open-Label Extension Phase|Pregnancy|0|||
129535825|NCT01497899|466252111|FG001|Open-Label Extension Phase|Pregnancy|1|||
129535826|NCT01497899|466252112|FG002|Open-Label Extension Phase|Pregnancy|1|||
129535827|NCT01497899|466252113|FG003|Open-Label Extension Phase|Pregnancy|0|||
129535828|NCT01497899|466252110|FG000|Open-Label Extension Phase|Protocol Violation|0|||
129535829|NCT01497899|466252111|FG001|Open-Label Extension Phase|Protocol Violation|0|||
129535830|NCT01497899|466252112|FG002|Open-Label Extension Phase|Protocol Violation|1|||
129535831|NCT01497899|466252113|FG003|Open-Label Extension Phase|Protocol Violation|0|||
129535832|NCT01497899|466252110|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
129535833|NCT01497899|466252111|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
129535834|NCT01497899|466252112|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
129535835|NCT01497899|466252113|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
129535836|NCT05047601|466252115|FG000|Overall Study|Lost to Follow-up|9|||
129535837|NCT05047601|466252116|FG001|Overall Study|Lost to Follow-up|11|||
129535838|NCT05047601|466252117|FG002|Overall Study|Lost to Follow-up|7|||
129535839|NCT05047601|466252115|FG000|Overall Study|Withdrawal by Subject|25|||
129535840|NCT05047601|466252116|FG001|Overall Study|Withdrawal by Subject|36|||
129535841|NCT05047601|466252117|FG002|Overall Study|Withdrawal by Subject|23|||
129535842|NCT05047601|466252115|FG000|Overall Study|Other|10|||
129535843|NCT05047601|466252116|FG001|Overall Study|Other|6|||
129535844|NCT05047601|466252117|FG002|Overall Study|Other|5|||
129535845|NCT00286234|466252118|FG000|Overall Study|Protocol Violation|1|||
129535846|NCT00286234|466252119|FG001|Overall Study|Protocol Violation|2|||
129535847|NCT00286234|466252120|FG002|Overall Study|Protocol Violation|0|||
129535848|NCT00286234|466252121|FG003|Overall Study|Protocol Violation|1|||
129535849|NCT00286234|466252118|FG000|Overall Study|Physician Decision|1|||
129535850|NCT00286234|466252119|FG001|Overall Study|Physician Decision|0|||
129535851|NCT00286234|466252120|FG002|Overall Study|Physician Decision|0|||
129535852|NCT00286234|466252121|FG003|Overall Study|Physician Decision|1|||
129535853|NCT00286234|466252118|FG000|Overall Study|Adverse Event|0|||
129535854|NCT00286234|466252119|FG001|Overall Study|Adverse Event|0|||
129535855|NCT00286234|466252120|FG002|Overall Study|Adverse Event|0|||
129535856|NCT00286234|466252121|FG003|Overall Study|Adverse Event|1|||
129535857|NCT00286234|466252118|FG000|Overall Study|Adverse Event|0|||
129535858|NCT00286234|466252119|FG001|Overall Study|Adverse Event|0|||
129535859|NCT00286234|466252120|FG002|Overall Study|Adverse Event|0|||
129535860|NCT00286234|466252121|FG003|Overall Study|Adverse Event|1|||
129535861|NCT00283062|466252128|FG000|Overall Study|Did not receive any study medication|5|||
129535862|NCT00283062|466252129|FG001|Overall Study|Did not receive any study medication|4|||
129535863|NCT00283062|466252130|FG002|Overall Study|Did not receive any study medication|36|||
129535864|NCT00283062|466252131|FG003|Overall Study|Did not receive any study medication|45|||
129535865|NCT00283062|466252128|FG000|Overall Study|Adverse Event|2|||
129535866|NCT00283062|466252129|FG001|Overall Study|Adverse Event|0|||
129535867|NCT00283062|466252130|FG002|Overall Study|Adverse Event|1|||
129535868|NCT00283062|466252131|FG003|Overall Study|Adverse Event|0|||
129535869|NCT00283062|466252128|FG000|Overall Study|Lost to Follow-up|1|||
129535870|NCT00283062|466252129|FG001|Overall Study|Lost to Follow-up|0|||
129535871|NCT00283062|466252130|FG002|Overall Study|Lost to Follow-up|1|||
129535872|NCT00283062|466252131|FG003|Overall Study|Lost to Follow-up|0|||
129535873|NCT00283062|466252128|FG000|Overall Study|Progressive disease|0|||
129535874|NCT00283062|466252129|FG001|Overall Study|Progressive disease|0|||
129535875|NCT00283062|466252130|FG002|Overall Study|Progressive disease|1|||
129535876|NCT00283062|466252131|FG003|Overall Study|Progressive disease|0|||
129535877|NCT00283062|466252128|FG000|Overall Study|Participant did not wish to continue|3|||
129535878|NCT00283062|466252129|FG001|Overall Study|Participant did not wish to continue|2|||
129535879|NCT00283062|466252130|FG002|Overall Study|Participant did not wish to continue|1|||
129535880|NCT00283062|466252131|FG003|Overall Study|Participant did not wish to continue|0|||
129535881|NCT00283062|466252128|FG000|Overall Study|Undefined|0|||
129535882|NCT00283062|466252129|FG001|Overall Study|Undefined|1|||
129535883|NCT00283062|466252130|FG002|Overall Study|Undefined|1|||
129535884|NCT00283062|466252131|FG003|Overall Study|Undefined|4|||
129535885|NCT00283062|466252128|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
129535886|NCT00283062|466252129|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
129535887|NCT00283062|466252130|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
129535888|NCT00283062|466252131|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
129535889|NCT03137173|466252132|FG000|Overall Study|Withdrawal by Subject|8|||
129535890|NCT03137173|466252133|FG001|Overall Study|Withdrawal by Subject|13|||
129535891|NCT03137173|466252132|FG000|Overall Study|Death|1|||
129535892|NCT03137173|466252133|FG001|Overall Study|Death|3|||
129535893|NCT03137173|466252132|FG000|Overall Study|Physician Decision|1|||
129535894|NCT03137173|466252133|FG001|Overall Study|Physician Decision|0|||
129535895|NCT03137173|466252132|FG000|Overall Study|Lost to Follow-up|13|||
129535896|NCT03137173|466252133|FG001|Overall Study|Lost to Follow-up|18|||
129535897|NCT03137173|466252132|FG000|Overall Study|Other reasons|3|||
129535898|NCT03137173|466252133|FG001|Overall Study|Other reasons|2|||
129535899|NCT01365468|466252134|FG000|Overall Study|Physician Decision|1|||
129535900|NCT01365468|466252135|FG001|Overall Study|Physician Decision|0|||
129535901|NCT01365468|466252134|FG000|Overall Study|Disease progression|1|||
129535902|NCT01365468|466252135|FG001|Overall Study|Disease progression|0|||
129535903|NCT01365468|466252134|FG000|Overall Study|Lost to Follow-up|2|||
129535904|NCT01365468|466252135|FG001|Overall Study|Lost to Follow-up|0|||
129535905|NCT00423267|466252138|FG000|Period A|Withdrawal by Subject|0|||
129535906|NCT00423267|466252139|FG001|Period A|Withdrawal by Subject|1|||
129535907|NCT00423267|466252138|FG000|Period A|Non-compliance with protocol|1|||
129535908|NCT00423267|466252139|FG001|Period A|Non-compliance with protocol|0|||
129535909|NCT00423267|466252138|FG000|Period A|Administrative|1|||
129535910|NCT00423267|466252139|FG001|Period A|Administrative|0|||
129535911|NCT00827112|466252140|FG000|Overall Study|Adverse Event|2|||
129535912|NCT00827112|466252141|FG001|Overall Study|Adverse Event|0|||
129535913|NCT00827112|466252140|FG000|Overall Study|Lack of Efficacy|2|||
129535914|NCT00827112|466252141|FG001|Overall Study|Lack of Efficacy|0|||
129535915|NCT00827112|466252140|FG000|Overall Study|Lost to Follow-up|3|||
129535916|NCT00827112|466252141|FG001|Overall Study|Lost to Follow-up|2|||
129535917|NCT00827112|466252140|FG000|Overall Study|Pregnancy|0|||
129535918|NCT00827112|466252141|FG001|Overall Study|Pregnancy|1|||
129535919|NCT00827112|466252140|FG000|Overall Study|Protocol Violation|0|||
129535920|NCT00827112|466252141|FG001|Overall Study|Protocol Violation|2|||
129535921|NCT00827112|466252140|FG000|Overall Study|Withdrawal by Subject|2|||
129535922|NCT00827112|466252141|FG001|Overall Study|Withdrawal by Subject|1|||
129535923|NCT00827112|466252140|FG000|Overall Study|Randomized but not treated|5|||
129535924|NCT00827112|466252141|FG001|Overall Study|Randomized but not treated|3|||
129535925|NCT00827112|466252140|FG000|Overall Study|Other|1|||
129535926|NCT00827112|466252141|FG001|Overall Study|Other|3|||
129535927|NCT01475214|466252142|FG000|Overall Study|Lost to Follow-up|1|||
129535928|NCT01475214|466252143|FG001|Overall Study|Lost to Follow-up|0|||
129535929|NCT01475214|466252144|FG002|Overall Study|Lost to Follow-up|1|||
129535930|NCT01475214|466252142|FG000|Overall Study|Physician Decision|2|||
129535931|NCT01475214|466252143|FG001|Overall Study|Physician Decision|0|||
129535932|NCT01475214|466252144|FG002|Overall Study|Physician Decision|0|||
129535933|NCT01475214|466252142|FG000|Overall Study|Withdrawal by Subject|2|||
129535934|NCT01475214|466252143|FG001|Overall Study|Withdrawal by Subject|4|||
129535935|NCT01475214|466252144|FG002|Overall Study|Withdrawal by Subject|1|||
129535936|NCT00911508|466253921|FG000|Overall Study|Lost to Follow-up|27|||
129535937|NCT00911508|466253922|FG001|Overall Study|Lost to Follow-up|18|||
129535938|NCT00911508|466253921|FG000|Overall Study|Withdrawal by Subject|79|||
129535939|NCT00911508|466253922|FG001|Overall Study|Withdrawal by Subject|112|||
129535940|NCT01409382|466253923|FG000|Overall Study|Lost to Follow-up|1|||
129535941|NCT01409382|466253924|FG001|Overall Study|Lost to Follow-up|1|||
129535942|NCT01409382|466253923|FG000|Overall Study|Protocol Violation|0|||
129535943|NCT01409382|466253924|FG001|Overall Study|Protocol Violation|3|||
129535944|NCT01409382|466253923|FG000|Overall Study|Multiple pregnancy|2|||
129535945|NCT01409382|466253924|FG001|Overall Study|Multiple pregnancy|4|||
129535946|NCT01409382|466253923|FG000|Overall Study|Still pregnant when study ended|13|||
129535947|NCT01409382|466253924|FG001|Overall Study|Still pregnant when study ended|2|||
129535948|NCT01409382|466253923|FG000|Overall Study|Did not manage to get pregnant|64|||
129535949|NCT01409382|466253924|FG001|Overall Study|Did not manage to get pregnant|70|||
129535950|NCT01409382|466253923|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
129535951|NCT01409382|466253924|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
129535952|NCT01004822|466253925|FG000|Overall Study|Objective progression or relapse|3|||
129535953|NCT01004822|466253926|FG001|Overall Study|Objective progression or relapse|3|||
129535954|NCT01004822|466253927|FG002|Overall Study|Objective progression or relapse|0|||
129535955|NCT01004822|466253928|FG003|Overall Study|Objective progression or relapse|1|||
129535956|NCT01004822|466253929|FG004|Overall Study|Objective progression or relapse|2|||
129535957|NCT01004822|466253930|FG005|Overall Study|Objective progression or relapse|2|||
129535958|NCT01004822|466253931|FG006|Overall Study|Objective progression or relapse|1|||
129535959|NCT01004822|466253932|FG007|Overall Study|Objective progression or relapse|4|||
129535960|NCT01004822|466253925|FG000|Overall Study|Global deterioration of health status|0|||
129535961|NCT01004822|466253926|FG001|Overall Study|Global deterioration of health status|0|||
129535962|NCT01004822|466253927|FG002|Overall Study|Global deterioration of health status|0|||
129535963|NCT01004822|466253928|FG003|Overall Study|Global deterioration of health status|1|||
129535964|NCT01004822|466253929|FG004|Overall Study|Global deterioration of health status|0|||
129535965|NCT01004822|466253930|FG005|Overall Study|Global deterioration of health status|0|||
129535966|NCT01004822|466253931|FG006|Overall Study|Global deterioration of health status|1|||
129535967|NCT01004822|466253932|FG007|Overall Study|Global deterioration of health status|0|||
129535968|NCT01004822|466253925|FG000|Overall Study|No longer willing to continue|0|||
129535969|NCT01004822|466253926|FG001|Overall Study|No longer willing to continue|0|||
129535970|NCT01004822|466253927|FG002|Overall Study|No longer willing to continue|0|||
129535971|NCT01004822|466253928|FG003|Overall Study|No longer willing to continue|1|||
129535972|NCT01004822|466253929|FG004|Overall Study|No longer willing to continue|2|||
129535973|NCT01004822|466253930|FG005|Overall Study|No longer willing to continue|1|||
129535974|NCT01004822|466253931|FG006|Overall Study|No longer willing to continue|1|||
129535975|NCT01004822|466253932|FG007|Overall Study|No longer willing to continue|0|||
129535976|NCT01004822|466253925|FG000|Overall Study|Adverse Event|0|||
129535977|NCT01004822|466253926|FG001|Overall Study|Adverse Event|0|||
129535978|NCT01004822|466253927|FG002|Overall Study|Adverse Event|0|||
129535979|NCT01004822|466253928|FG003|Overall Study|Adverse Event|0|||
129535980|NCT01004822|466253929|FG004|Overall Study|Adverse Event|0|||
129535981|NCT01004822|466253930|FG005|Overall Study|Adverse Event|0|||
129535982|NCT01004822|466253931|FG006|Overall Study|Adverse Event|1|||
129535983|NCT01004822|466253932|FG007|Overall Study|Adverse Event|1|||
129535984|NCT01004822|466253925|FG000|Overall Study|Other|0|||
129535985|NCT01004822|466253926|FG001|Overall Study|Other|0|||
129535986|NCT01004822|466253927|FG002|Overall Study|Other|4|||
129535987|NCT01004822|466253928|FG003|Overall Study|Other|1|||
129535988|NCT01004822|466253929|FG004|Overall Study|Other|0|||
129535989|NCT01004822|466253930|FG005|Overall Study|Other|1|||
129535990|NCT01004822|466253931|FG006|Overall Study|Other|0|||
129535991|NCT01004822|466253932|FG007|Overall Study|Other|0|||
129535992|NCT01858701|466253933|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
129535993|NCT01858701|466253934|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
129535994|NCT01858701|466253933|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
129535995|NCT01858701|466253934|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
129535996|NCT01858701|466253933|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
129535997|NCT01858701|466253934|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
129535998|NCT01858701|466253933|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
129535999|NCT01858701|466253934|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
129536000|NCT01789476|466253942|FG000|Overall Study|Lack of Efficacy|6|||
129536001|NCT01789476|466253943|FG001|Overall Study|Lack of Efficacy|2|||
129536002|NCT01789476|466253942|FG000|Overall Study|Adverse Event|1|||
129536003|NCT01789476|466253943|FG001|Overall Study|Adverse Event|0|||
129536004|NCT01789476|466253942|FG000|Overall Study|Unable to get IV access|1|||
129536005|NCT01789476|466253943|FG001|Overall Study|Unable to get IV access|0|||
129536006|NCT00501969|466253944|FG000|Overall Study|Major Protocol Violation|4|||
129536007|NCT00501969|466253944|FG000|Overall Study|Lack of Efficacy|29|||
129536008|NCT00501969|466253944|FG000|Overall Study|Adverse Event|76|||
129536009|NCT00501969|466253944|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
129536010|NCT00501969|466253944|FG000|Overall Study|Subject withdrew consent|51|||
129536011|NCT00501969|466253944|FG000|Overall Study|Lost to Follow-up|4|||
129536012|NCT00501969|466253944|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
129536013|NCT00501969|466253944|FG000|Overall Study|Other: Sponsors Request|10|||
129536014|NCT00501969|466253944|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
129536015|NCT00501969|466253944|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
129536016|NCT00501969|466253944|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
129536017|NCT00501969|466253944|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
129536018|NCT00501969|466253944|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
129536019|NCT00501969|466253944|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
129536020|NCT00501969|466253944|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
129536021|NCT00501969|466253944|FG000|Overall Study|Other: As Required by Local EC|2|||
129536022|NCT00501969|466253944|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
129536023|NCT00501969|466253944|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
129536024|NCT00965458|466253945|FG000|Overall Study|Adverse Event|1|||
129536025|NCT00965458|466253946|FG001|Overall Study|Adverse Event|0|||
129536026|NCT00965458|466253945|FG000|Overall Study|Lost to Follow-up|1|||
129536027|NCT00965458|466253946|FG001|Overall Study|Lost to Follow-up|3|||
129536028|NCT00965458|466253945|FG000|Overall Study|Withdrawal by Subject|0|||
129536029|NCT00965458|466253946|FG001|Overall Study|Withdrawal by Subject|1|||
129536030|NCT05111548|466253953|FG000|Overall Study|Withdrawal by Subject|2|||
129536031|NCT05111548|466253954|FG001|Overall Study|Withdrawal by Subject|1|||
129536032|NCT05111548|466253953|FG000|Overall Study|Adverse Event|1|||
129536033|NCT05111548|466253954|FG001|Overall Study|Adverse Event|0|||
129536034|NCT00379639|466253955|FG000|Overall Study|Disease Progression|3|||
129536035|NCT00379639|466253956|FG001|Overall Study|Disease Progression|3|||
129536036|NCT00379639|466253957|FG002|Overall Study|Disease Progression|3|||
129536037|NCT00379639|466253958|FG003|Overall Study|Disease Progression|4|||
129536038|NCT00379639|466253959|FG004|Overall Study|Disease Progression|4|||
129536039|NCT00379639|466253955|FG000|Overall Study|Physician Decision|0|||
129536040|NCT00379639|466253956|FG001|Overall Study|Physician Decision|2|||
129536041|NCT00379639|466253957|FG002|Overall Study|Physician Decision|1|||
129536042|NCT00379639|466253958|FG003|Overall Study|Physician Decision|1|||
129536043|NCT00379639|466253959|FG004|Overall Study|Physician Decision|0|||
129536044|NCT00379639|466253955|FG000|Overall Study|Symptomatic Deterioration|0|||
129536045|NCT00379639|466253956|FG001|Overall Study|Symptomatic Deterioration|0|||
129536046|NCT00379639|466253957|FG002|Overall Study|Symptomatic Deterioration|1|||
129536047|NCT00379639|466253958|FG003|Overall Study|Symptomatic Deterioration|0|||
129536048|NCT00379639|466253959|FG004|Overall Study|Symptomatic Deterioration|1|||
129536049|NCT00379639|466253955|FG000|Overall Study|Adverse Event|0|||
129536050|NCT00379639|466253956|FG001|Overall Study|Adverse Event|0|||
129536051|NCT00379639|466253957|FG002|Overall Study|Adverse Event|1|||
129536052|NCT00379639|466253958|FG003|Overall Study|Adverse Event|0|||
129536053|NCT00379639|466253959|FG004|Overall Study|Adverse Event|1|||
129536054|NCT00379639|466253955|FG000|Overall Study|Lost to Follow-up|0|||
129536055|NCT00379639|466253956|FG001|Overall Study|Lost to Follow-up|0|||
129536056|NCT00379639|466253957|FG002|Overall Study|Lost to Follow-up|0|||
129536057|NCT00379639|466253958|FG003|Overall Study|Lost to Follow-up|1|||
129536058|NCT00379639|466253959|FG004|Overall Study|Lost to Follow-up|0|||
129536059|NCT00379639|466253955|FG000|Overall Study|Other|0|||
129536060|NCT00379639|466253956|FG001|Overall Study|Other|0|||
129536061|NCT00379639|466253957|FG002|Overall Study|Other|3|||
129536062|NCT00379639|466253958|FG003|Overall Study|Other|0|||
129536063|NCT00379639|466253959|FG004|Overall Study|Other|0|||
129536064|NCT00594958|466253960|FG000|Overall Study|Withdrawal by Subject|1|||
129536065|NCT00594958|466253961|FG001|Overall Study|Withdrawal by Subject|0|||
129536066|NCT00594958|466253962|FG002|Overall Study|Withdrawal by Subject|1|||
129536067|NCT00594958|466253960|FG000|Overall Study|Adverse Event|4|||
129536068|NCT00594958|466253961|FG001|Overall Study|Adverse Event|1|||
129536069|NCT00594958|466253962|FG002|Overall Study|Adverse Event|2|||
129536070|NCT00594958|466253960|FG000|Overall Study|Pregnancy|0|||
129536071|NCT00594958|466253961|FG001|Overall Study|Pregnancy|2|||
129536072|NCT00594958|466253962|FG002|Overall Study|Pregnancy|0|||
129536073|NCT00594958|466253960|FG000|Overall Study|Protocol Violation|1|||
129536074|NCT00594958|466253961|FG001|Overall Study|Protocol Violation|0|||
129536075|NCT00594958|466253962|FG002|Overall Study|Protocol Violation|2|||
129536076|NCT00594958|466253960|FG000|Overall Study|Lost to Follow-up|5|||
129536077|NCT00594958|466253961|FG001|Overall Study|Lost to Follow-up|0|||
129536078|NCT00594958|466253962|FG002|Overall Study|Lost to Follow-up|3|||
129536079|NCT00594958|466253960|FG000|Overall Study|administrative|3|||
129536080|NCT00594958|466253961|FG001|Overall Study|administrative|0|||
129536081|NCT00594958|466253962|FG002|Overall Study|administrative|2|||
129536082|NCT03039686|466253963|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
129536083|NCT03039686|466253964|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
129536084|NCT03039686|466253965|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
129536085|NCT03039686|466253963|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
129536086|NCT03039686|466253964|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
129536087|NCT03039686|466253965|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
129536088|NCT03039686|466253963|FG000|Double-blind Period|Withdrawal by Subject|2|||
129536089|NCT03039686|466253964|FG001|Double-blind Period|Withdrawal by Subject|2|||
129536090|NCT03039686|466253965|FG002|Double-blind Period|Withdrawal by Subject|1|||
129536091|NCT03039686|466253963|FG000|Double-blind Period|Death|0|||
129536092|NCT03039686|466253964|FG001|Double-blind Period|Death|0|||
129536093|NCT03039686|466253965|FG002|Double-blind Period|Death|1|||
129536094|NCT03039686|466253963|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
129536095|NCT03039686|466253964|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
129536096|NCT03039686|466253965|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
129536097|NCT03039686|466253963|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
129536098|NCT03039686|466253964|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
129536099|NCT03039686|466253965|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
129536100|NCT03039686|466253963|FG000|Open Label Period|Withdrawal by Subject|0|||
129536101|NCT03039686|466253964|FG001|Open Label Period|Withdrawal by Subject|3|||
129536102|NCT03039686|466253965|FG002|Open Label Period|Withdrawal by Subject|1|||
129536103|NCT02158949|466253966|FG000|Overall Study|Withdrawal by Subject|1|||
129536104|NCT02158949|466253967|FG001|Overall Study|Withdrawal by Subject|0|||
129536105|NCT02158949|466253966|FG000|Overall Study|Lost to Follow-up|5|||
129536106|NCT02158949|466253967|FG001|Overall Study|Lost to Follow-up|11|||
129536107|NCT02181634|466253968|FG000|Overall Study|Lack of Efficacy|33|||
129536108|NCT02181634|466253968|FG000|Overall Study|Adverse Event|17|||
129536109|NCT02181634|466253968|FG000|Overall Study|Physician Decision|8|||
129536110|NCT02181634|466253968|FG000|Overall Study|Withdrawal by Subject|5|||
129536111|NCT02181634|466253968|FG000|Overall Study|Death|2|||
129536112|NCT02181634|466253968|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
129536113|NCT02181634|466253968|FG000|Overall Study|Ineligible|1|||
129536114|NCT02181634|466253968|FG000|Overall Study|Max number of dose reduction|1|||
129536115|NCT02181634|466253968|FG000|Overall Study|Symptomatic progression|1|||
129536116|NCT02181634|466253968|FG000|Overall Study|Patient opted to proceed to surgery|1|||
129536117|NCT02079077|466253972|FG000|Overall Study|Lost to Follow-up|5|||
129536118|NCT02079077|466253973|FG001|Overall Study|Lost to Follow-up|7|||
129536119|NCT02079077|466253972|FG000|Overall Study|Became STIs Positive|1|||
129538909|NCT01238861|466265110|FG003|Overall Study|Lost to Follow-up|1|||
129536120|NCT02079077|466253973|FG001|Overall Study|Became STIs Positive|2|||
129536121|NCT00656136|466253974|FG000|Overall Study|Progressive disease|177|||
129536122|NCT00656136|466253975|FG001|Overall Study|Progressive disease|322|||
129536123|NCT00656136|466253974|FG000|Overall Study|Other Adverse Event|5|||
129536124|NCT00656136|466253975|FG001|Overall Study|Other Adverse Event|51|||
129536125|NCT00656136|466253974|FG000|Overall Study|Protocol Violation|2|||
129536126|NCT00656136|466253975|FG001|Overall Study|Protocol Violation|3|||
129536127|NCT00656136|466253974|FG000|Overall Study|Patient refused to take study medication|7|||
129536128|NCT00656136|466253975|FG001|Overall Study|Patient refused to take study medication|10|||
129536129|NCT00656136|466253974|FG000|Overall Study|Unknown and others|4|||
129536130|NCT00656136|466253975|FG001|Overall Study|Unknown and others|4|||
129536131|NCT02505945|466253976|FG000|Overall Study|Withdrawal by Subject|13|||
129536132|NCT02505945|466253977|FG001|Overall Study|Withdrawal by Subject|2|||
129536133|NCT02505945|466253976|FG000|Overall Study|Adverse Event|1|||
129536134|NCT02505945|466253977|FG001|Overall Study|Adverse Event|0|||
129536135|NCT02505945|466253976|FG000|Overall Study|Physician Decision|2|||
129536136|NCT02505945|466253977|FG001|Overall Study|Physician Decision|1|||
129536137|NCT02505945|466253976|FG000|Overall Study|Lost to Follow-up|6|||
129536138|NCT02505945|466253977|FG001|Overall Study|Lost to Follow-up|1|||
129536139|NCT01097057|466253978|FG000|Overall Study|Physician Decision|3|||
129536140|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
129536141|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
129536142|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
129536143|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
129536144|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
129536145|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
129536146|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
129536147|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
129536148|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
129536149|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
129536150|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
129536151|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
129536152|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
129536153|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
129536154|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
129536155|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|Other|6|||
129536156|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|Other|6|||
129536157|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|Other|7|||
129536158|NCT02681094|466253979|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
129536159|NCT02681094|466253980|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
129536160|NCT02681094|466253981|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
129536161|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|Participant decision|7|||
129536162|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|Participant decision|10|||
129536163|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|Participant decision|9|||
129536164|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
129536165|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
129536166|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
129536167|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
129536168|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
129536169|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
129536170|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
129536171|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
129536172|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
129536173|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
129536174|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
129536175|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
129536176|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|Other|6|||
129536177|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|Other|6|||
129536178|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|Other|7|||
129536179|NCT02681094|466253979|FG000|2 - Enrolled Participants Set|No treatment given|0|||
129536180|NCT02681094|466253980|FG001|2 - Enrolled Participants Set|No treatment given|1|||
129536181|NCT02681094|466253981|FG002|2 - Enrolled Participants Set|No treatment given|1|||
129536182|NCT01270139|466253982|FG000|Overall Study|Adverse Event|8|||
129536183|NCT01270139|466253983|FG001|Overall Study|Adverse Event|17|||
129536184|NCT01270139|466253984|FG002|Overall Study|Adverse Event|18|||
129536185|NCT01270139|466253982|FG000|Overall Study|Lost to Follow-up|10|||
129536186|NCT01270139|466253983|FG001|Overall Study|Lost to Follow-up|9|||
129536187|NCT01270139|466253984|FG002|Overall Study|Lost to Follow-up|2|||
129538910|NCT01238861|466265111|FG004|Overall Study|Lost to Follow-up|1|||
129536188|NCT00134563|466253987|FG000|Overall Study|Not treated due to protocol violation|0|||
129536189|NCT00134563|466253988|FG001|Overall Study|Not treated due to protocol violation|1|||
129536190|NCT00134563|466253989|FG002|Overall Study|Not treated due to protocol violation|1|||
129536191|NCT00134563|466253987|FG000|Overall Study|Adverse Event|29|||
129536192|NCT00134563|466253988|FG001|Overall Study|Adverse Event|37|||
129536193|NCT00134563|466253989|FG002|Overall Study|Adverse Event|38|||
129536194|NCT00134563|466253987|FG000|Overall Study|Lack of Efficacy|24|||
129536195|NCT00134563|466253988|FG001|Overall Study|Lack of Efficacy|14|||
129536196|NCT00134563|466253989|FG002|Overall Study|Lack of Efficacy|17|||
129536197|NCT00134563|466253987|FG000|Overall Study|Protocol Violation|3|||
129536198|NCT00134563|466253988|FG001|Overall Study|Protocol Violation|2|||
129536199|NCT00134563|466253989|FG002|Overall Study|Protocol Violation|5|||
129536200|NCT00134563|466253987|FG000|Overall Study|Lost to Follow-up|4|||
129536201|NCT00134563|466253988|FG001|Overall Study|Lost to Follow-up|0|||
129536202|NCT00134563|466253989|FG002|Overall Study|Lost to Follow-up|2|||
129536203|NCT00134563|466253987|FG000|Overall Study|progressive disease|11|||
129536204|NCT00134563|466253988|FG001|Overall Study|progressive disease|4|||
129536205|NCT00134563|466253989|FG002|Overall Study|progressive disease|2|||
129536206|NCT00134563|466253987|FG000|Overall Study|did not wish to continue|33|||
129536207|NCT00134563|466253988|FG001|Overall Study|did not wish to continue|32|||
129536208|NCT00134563|466253989|FG002|Overall Study|did not wish to continue|26|||
129536209|NCT00134563|466253987|FG000|Overall Study|Reason other than above|0|||
129536210|NCT00134563|466253988|FG001|Overall Study|Reason other than above|2|||
129536211|NCT00134563|466253989|FG002|Overall Study|Reason other than above|5|||
129536212|NCT01911546|466253994|FG000|Overall Study|Lost to Follow-up|1|||
129536213|NCT01911546|466253994|FG000|Overall Study|Everolimus was discontinued|5|||
129536214|NCT02210559|466253995|FG000|Overall Study|Progressive Disease|3|||
129536215|NCT02210559|466253996|FG001|Overall Study|Progressive Disease|2|||
129536216|NCT02210559|466253995|FG000|Overall Study|Adverse Event|2|||
129536217|NCT02210559|466253996|FG001|Overall Study|Adverse Event|2|||
129536218|NCT02210559|466253995|FG000|Overall Study|Physician Decision|1|||
129536219|NCT02210559|466253996|FG001|Overall Study|Physician Decision|0|||
129536220|NCT02210559|466253995|FG000|Overall Study|Withdrawal by Subject|0|||
129536221|NCT02210559|466253996|FG001|Overall Study|Withdrawal by Subject|1|||
129536222|NCT02210559|466253995|FG000|Overall Study|Other than specified|0|||
129536223|NCT02210559|466253996|FG001|Overall Study|Other than specified|1|||
129536224|NCT02546193|466253997|FG000|Overall Study|Withdrawal by Subject|2|||
129536225|NCT02546193|466253998|FG001|Overall Study|Withdrawal by Subject|0|||
129536226|NCT02546193|466253999|FG002|Overall Study|Withdrawal by Subject|1|||
129536227|NCT02546193|466254000|FG003|Overall Study|Withdrawal by Subject|0|||
129536228|NCT02546193|466253997|FG000|Overall Study|Not eligible at time of induction|4|||
129536229|NCT02546193|466253998|FG001|Overall Study|Not eligible at time of induction|6|||
129536230|NCT02546193|466253999|FG002|Overall Study|Not eligible at time of induction|1|||
129536231|NCT02546193|466254000|FG003|Overall Study|Not eligible at time of induction|0|||
129536232|NCT00310440|466254001|FG000|Overall Study|Lost to Follow-up|17|||
129536233|NCT00310440|466254002|FG001|Overall Study|Lost to Follow-up|8|||
129536234|NCT00310440|466254001|FG000|Overall Study|Withdrawal by Subject|2|||
129536235|NCT00310440|466254002|FG001|Overall Study|Withdrawal by Subject|1|||
129536236|NCT00310440|466254001|FG000|Overall Study|Missed 12 Month Visit|7|||
129536237|NCT00310440|466254002|FG001|Overall Study|Missed 12 Month Visit|4|||
129536238|NCT01474291|466254003|FG000|Overall Study|Not Evaluable for Efficacy|26|||
129536239|NCT01474291|466254003|FG000|Overall Study|Lack of Treatment Efficacy|88|||
129536240|NCT01474291|466254003|FG000|Overall Study|Adverse Event|53|||
129536241|NCT01474291|466254003|FG000|Overall Study|Lost to Follow-up|29|||
129536242|NCT01474291|466254003|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
129536243|NCT01474291|466254003|FG000|Overall Study|No Reason Reported|10|||
129536244|NCT01474291|466254003|FG000|Overall Study|Death|2|||
129536245|NCT01287403|466254004|FG000|1st Intervention (1 Day)|Adverse Event|1|||
129536246|NCT00148109|466254005|FG000|Overall Study|Lack of Efficacy|10|||
129536247|NCT00148109|466254006|FG001|Overall Study|Lack of Efficacy|18|||
129536248|NCT00148109|466254005|FG000|Overall Study|Adverse Event|0|||
129536249|NCT00148109|466254006|FG001|Overall Study|Adverse Event|2|||
129536250|NCT00148109|466254005|FG000|Overall Study|Withdrawal by Subject|2|||
129536251|NCT00148109|466254006|FG001|Overall Study|Withdrawal by Subject|0|||
129536252|NCT01098266|466254007|FG000|Overall Study|Physician Decision|1|||
129536253|NCT01098266|466254008|FG001|Overall Study|Physician Decision|0|||
129536254|NCT01098266|466254007|FG000|Overall Study|Death|3|||
129536255|NCT01098266|466254008|FG001|Overall Study|Death|2|||
129536256|NCT01098266|466254007|FG000|Overall Study|Withdrawal by Subject|3|||
129536257|NCT01098266|466254008|FG001|Overall Study|Withdrawal by Subject|5|||
129536258|NCT00525499|466254012|FG000|Overall Study|Lost to Follow-up|2|||
129536259|NCT00525499|466254013|FG001|Overall Study|Lost to Follow-up|4|||
129536260|NCT00525499|466254014|FG002|Overall Study|Lost to Follow-up|1|||
129536261|NCT00525499|466254015|FG003|Overall Study|Lost to Follow-up|4|||
129536262|NCT00525499|466254012|FG000|Overall Study|Adverse Event|0|||
129536263|NCT00525499|466254013|FG001|Overall Study|Adverse Event|1|||
129536264|NCT00525499|466254014|FG002|Overall Study|Adverse Event|0|||
129536265|NCT00525499|466254015|FG003|Overall Study|Adverse Event|1|||
129536266|NCT00525499|466254012|FG000|Overall Study|Withdrawal by Subject|5|||
129536267|NCT00525499|466254013|FG001|Overall Study|Withdrawal by Subject|1|||
129536268|NCT00525499|466254014|FG002|Overall Study|Withdrawal by Subject|5|||
129536269|NCT00525499|466254015|FG003|Overall Study|Withdrawal by Subject|2|||
129536270|NCT00525499|466254012|FG000|Overall Study|Protocol Violation|0|||
129536271|NCT00525499|466254013|FG001|Overall Study|Protocol Violation|1|||
129536272|NCT00525499|466254014|FG002|Overall Study|Protocol Violation|1|||
129536273|NCT00525499|466254015|FG003|Overall Study|Protocol Violation|0|||
129536274|NCT00438815|466254016|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
129536275|NCT00438815|466254016|FG000|Overall Study|3-month follow-up no longer required|12|||
129536276|NCT00438815|466254016|FG000|Overall Study|Noncompliance with protocol requirements|9|||
129536277|NCT00438815|466254016|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
129536278|NCT00438815|466254016|FG000|Overall Study|Lost to Follow-up|6|||
129536279|NCT00438815|466254016|FG000|Overall Study|Withdrawal by Subject|6|||
129536280|NCT00438815|466254016|FG000|Overall Study|Death|1|||
129536281|NCT01733758|466254019|FG000|Overall Study|Adverse Event|5|||
129536282|NCT01733758|466254020|FG001|Overall Study|Adverse Event|7|||
129536283|NCT01733758|466254021|FG002|Overall Study|Adverse Event|8|||
129536284|NCT01733758|466254022|FG003|Overall Study|Adverse Event|1|||
129536285|NCT01733758|466254019|FG000|Overall Study|Withdrawal by Subject|1|||
129536286|NCT01733758|466254020|FG001|Overall Study|Withdrawal by Subject|1|||
129536287|NCT01733758|466254021|FG002|Overall Study|Withdrawal by Subject|5|||
129536288|NCT01733758|466254022|FG003|Overall Study|Withdrawal by Subject|3|||
129536289|NCT01733758|466254019|FG000|Overall Study|Persistent Hyperglycemia|3|||
129536290|NCT01733758|466254020|FG001|Overall Study|Persistent Hyperglycemia|2|||
129536291|NCT01733758|466254021|FG002|Overall Study|Persistent Hyperglycemia|0|||
129536292|NCT01733758|466254022|FG003|Overall Study|Persistent Hyperglycemia|0|||
129536293|NCT01733758|466254019|FG000|Overall Study|Protocol Violation|0|||
129536294|NCT01733758|466254020|FG001|Overall Study|Protocol Violation|1|||
129536295|NCT01733758|466254021|FG002|Overall Study|Protocol Violation|2|||
129536296|NCT01733758|466254022|FG003|Overall Study|Protocol Violation|2|||
129536297|NCT01733758|466254019|FG000|Overall Study|Non-compliance|1|||
129536298|NCT01733758|466254020|FG001|Overall Study|Non-compliance|0|||
129536299|NCT01733758|466254021|FG002|Overall Study|Non-compliance|0|||
129536300|NCT01733758|466254022|FG003|Overall Study|Non-compliance|0|||
129536301|NCT01733758|466254019|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
129536302|NCT01733758|466254020|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
129536303|NCT01733758|466254021|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
129536304|NCT01733758|466254022|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
129536305|NCT01733758|466254019|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
129536306|NCT01733758|466254020|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
129536307|NCT01733758|466254021|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
129536308|NCT01733758|466254022|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
129536309|NCT03380091|466254025|FG000|Overall Study|Withdrawal by Subject|2|||
129536310|NCT03380091|466254026|FG001|Overall Study|Withdrawal by Subject|1|||
129536311|NCT05602818|466254027|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
129536312|NCT05602818|466254028|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
129536313|NCT05602818|466254029|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
129536314|NCT05602818|466254030|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
129536315|NCT05602818|466254031|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
129536316|NCT05602818|466254032|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
129536317|NCT05602818|466254033|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
129536318|NCT05602818|466254034|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
129536319|NCT05602818|466254035|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
129536320|NCT05602818|466254036|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
129536321|NCT05602818|466254037|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
129536322|NCT05602818|466254038|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
129536323|NCT05602818|466254027|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
129536324|NCT05602818|466254028|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
129536325|NCT05602818|466254029|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536326|NCT05602818|466254030|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536327|NCT05602818|466254031|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536328|NCT05602818|466254032|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536329|NCT05602818|466254033|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536330|NCT05602818|466254034|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536331|NCT05602818|466254035|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536332|NCT05602818|466254036|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536333|NCT05602818|466254037|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536334|NCT05602818|466254038|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
129536335|NCT05602818|466254027|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
129536336|NCT05602818|466254028|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536337|NCT05602818|466254029|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536338|NCT05602818|466254030|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536339|NCT05602818|466254031|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536340|NCT05602818|466254032|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536341|NCT05602818|466254033|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536342|NCT05602818|466254034|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536343|NCT05602818|466254035|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536344|NCT05602818|466254036|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536345|NCT05602818|466254037|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536346|NCT05602818|466254038|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
129536347|NCT05602818|466254027|FG000|Qualification Phase (3 Days)|Other|1|||
129536348|NCT05602818|466254028|FG001|Qualification Phase (3 Days)|Other|0|||
129536349|NCT05602818|466254029|FG002|Qualification Phase (3 Days)|Other|0|||
129536350|NCT05602818|466254030|FG003|Qualification Phase (3 Days)|Other|0|||
129536351|NCT05602818|466254031|FG004|Qualification Phase (3 Days)|Other|0|||
129536352|NCT05602818|466254032|FG005|Qualification Phase (3 Days)|Other|0|||
129536353|NCT05602818|466254033|FG006|Qualification Phase (3 Days)|Other|0|||
129536354|NCT05602818|466254034|FG007|Qualification Phase (3 Days)|Other|0|||
129536355|NCT05602818|466254035|FG008|Qualification Phase (3 Days)|Other|0|||
129536356|NCT05602818|466254036|FG009|Qualification Phase (3 Days)|Other|0|||
129536357|NCT05602818|466254037|FG010|Qualification Phase (3 Days)|Other|0|||
129536358|NCT05602818|466254038|FG011|Qualification Phase (3 Days)|Other|0|||
129536359|NCT05602818|466254027|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536360|NCT05602818|466254028|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
129536361|NCT05602818|466254029|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536362|NCT05602818|466254030|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536363|NCT05602818|466254031|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536364|NCT05602818|466254032|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536365|NCT05602818|466254033|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536366|NCT05602818|466254034|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536367|NCT05602818|466254035|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536368|NCT05602818|466254036|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536369|NCT05602818|466254037|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536370|NCT05602818|466254038|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
129536371|NCT05602818|466254027|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
129536372|NCT05602818|466254028|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
129536373|NCT05602818|466254029|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
129536374|NCT05602818|466254030|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
129536375|NCT05602818|466254031|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
129536376|NCT05602818|466254032|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
129536377|NCT05602818|466254033|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
129536378|NCT05602818|466254034|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
129536379|NCT05602818|466254035|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
129536380|NCT05602818|466254036|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
129536381|NCT05602818|466254037|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
129536382|NCT05602818|466254038|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
129536383|NCT05602818|466254027|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536384|NCT05602818|466254028|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536385|NCT05602818|466254029|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536386|NCT05602818|466254030|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536387|NCT05602818|466254031|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536388|NCT05602818|466254032|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536389|NCT05602818|466254033|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536390|NCT05602818|466254034|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536391|NCT05602818|466254035|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536392|NCT05602818|466254036|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
129536393|NCT05602818|466254037|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
129536394|NCT05602818|466254038|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
129536395|NCT05602818|466254027|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
129536396|NCT05602818|466254028|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
129536397|NCT05602818|466254029|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
129536398|NCT05602818|466254030|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
129536399|NCT05602818|466254031|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
129536400|NCT05602818|466254032|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
129536401|NCT05602818|466254033|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
129536402|NCT05602818|466254034|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
129536403|NCT05602818|466254035|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
129536404|NCT05602818|466254036|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
129536405|NCT05602818|466254037|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
129536406|NCT05602818|466254038|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
129536407|NCT04594213|466254043|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
129536408|NCT04594213|466254044|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
129536409|NCT04594213|466254045|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
129536410|NCT04594213|466254046|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129536411|NCT04594213|466254047|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129536412|NCT04594213|466254048|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
129536413|NCT04594213|466254043|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
129536414|NCT04594213|466254044|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
129536415|NCT04594213|466254045|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
129536416|NCT04594213|466254046|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
129536417|NCT04594213|466254047|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
129536418|NCT04594213|466254048|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
129536419|NCT04594213|466254043|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
129536420|NCT04594213|466254044|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129536421|NCT04594213|466254045|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
129536422|NCT04594213|466254046|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129536423|NCT04594213|466254047|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129536424|NCT04594213|466254048|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
129536425|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129536426|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129536427|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129536428|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129536429|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
129536430|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
129536431|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129536432|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129536433|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
129536434|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
129536435|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
129536436|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
129536437|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129536438|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129536439|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129536440|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129536441|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
129536442|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
129536443|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129536444|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129536445|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129536446|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
129536447|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129536448|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
129536449|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
129536450|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
129536451|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
129536452|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
129536453|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
129536454|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
129536455|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129536456|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129536457|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
129536458|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
129536459|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
129536460|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
129536461|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129536462|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129536463|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
129536464|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
129536465|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
129536466|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
129536467|NCT04594213|466254043|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
129536468|NCT04594213|466254044|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
129536469|NCT04594213|466254045|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
129536470|NCT04594213|466254046|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
129536471|NCT04594213|466254047|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
129536472|NCT04594213|466254048|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
129536473|NCT03814499|466254050|FG000|Overall Study|Lost to Follow-up|3|||
129536474|NCT01589185|466254051|FG000|Overall Study|Death|1|||
129536475|NCT01589185|466254052|FG001|Overall Study|Death|2|||
129536476|NCT01589185|466254053|FG002|Overall Study|Death|2|||
129536477|NCT01589185|466254054|FG003|Overall Study|Death|0|||
129536478|NCT01589185|466254055|FG004|Overall Study|Death|1|||
129536479|NCT01589185|466254051|FG000|Overall Study|Lost to Follow-up|1|||
129536480|NCT01589185|466254052|FG001|Overall Study|Lost to Follow-up|0|||
129536481|NCT01589185|466254053|FG002|Overall Study|Lost to Follow-up|2|||
129536482|NCT01589185|466254054|FG003|Overall Study|Lost to Follow-up|3|||
129536483|NCT01589185|466254055|FG004|Overall Study|Lost to Follow-up|0|||
129536484|NCT02046993|466254056|FG000|Overall Study|Withdrawal by Subject|2|||
129536485|NCT02046993|466254057|FG001|Overall Study|Withdrawal by Subject|10|||
129536486|NCT02046993|466254056|FG000|Overall Study|Lost to Follow-up|1|||
129536487|NCT02046993|466254057|FG001|Overall Study|Lost to Follow-up|1|||
129536488|NCT00598442|466254060|FG000|Overall Study|Adverse Event|3|||
129536489|NCT00598442|466254061|FG001|Overall Study|Adverse Event|0|||
129536490|NCT00598442|466254062|FG002|Overall Study|Adverse Event|0|||
129536491|NCT00598442|466254060|FG000|Overall Study|Death|19|||
129536492|NCT00598442|466254061|FG001|Overall Study|Death|11|||
129536493|NCT00598442|466254062|FG002|Overall Study|Death|11|||
129536494|NCT00598442|466254060|FG000|Overall Study|Lost to Follow-up|4|||
129536495|NCT00598442|466254061|FG001|Overall Study|Lost to Follow-up|3|||
129536496|NCT00598442|466254062|FG002|Overall Study|Lost to Follow-up|3|||
129536497|NCT00598442|466254060|FG000|Overall Study|Physician Decision|2|||
129536498|NCT00598442|466254061|FG001|Overall Study|Physician Decision|1|||
129536499|NCT00598442|466254062|FG002|Overall Study|Physician Decision|1|||
129536500|NCT00598442|466254060|FG000|Overall Study|Withdrawal by Subject|8|||
129536501|NCT00598442|466254061|FG001|Overall Study|Withdrawal by Subject|16|||
129536502|NCT00598442|466254062|FG002|Overall Study|Withdrawal by Subject|6|||
129536503|NCT00598442|466254060|FG000|Overall Study|Noncompliance|0|||
129536504|NCT00598442|466254061|FG001|Overall Study|Noncompliance|2|||
129536505|NCT00598442|466254062|FG002|Overall Study|Noncompliance|1|||
129536506|NCT00598442|466254060|FG000|Overall Study|Relocation|1|||
129536507|NCT00598442|466254061|FG001|Overall Study|Relocation|4|||
129536508|NCT00598442|466254062|FG002|Overall Study|Relocation|0|||
129536509|NCT00598442|466254060|FG000|Overall Study|Renal transplant|0|||
129536510|NCT00598442|466254061|FG001|Overall Study|Renal transplant|0|||
129536511|NCT00598442|466254062|FG002|Overall Study|Renal transplant|1|||
129536512|NCT00598442|466254060|FG000|Overall Study|Site closed by sponsor|5|||
129536513|NCT00598442|466254061|FG001|Overall Study|Site closed by sponsor|2|||
129536514|NCT00598442|466254062|FG002|Overall Study|Site closed by sponsor|1|||
129536515|NCT00598442|466254060|FG000|Overall Study|Started dialysis|1|||
129536516|NCT00598442|466254061|FG001|Overall Study|Started dialysis|0|||
129536517|NCT00598442|466254062|FG002|Overall Study|Started dialysis|0|||
129536518|NCT00697255|466254063|FG000|Stage 1a|Insufficient ovarian response|1|||
129536519|NCT00697255|466254064|FG001|Stage 1a|Insufficient ovarian response|0|||
129536520|NCT00697255|466254063|FG000|Stage 1a|Multifollicular growth|1|||
129536521|NCT00697255|466254064|FG001|Stage 1a|Multifollicular growth|0|||
129536522|NCT00697255|466254063|FG000|Stage 1a|Not growing of dominant follicle|1|||
129536523|NCT00697255|466254064|FG001|Stage 1a|Not growing of dominant follicle|0|||
129536524|NCT00697255|466254063|FG000|Stage 1b|Not growing of dominant follicle|0|||
129536525|NCT00697255|466254064|FG001|Stage 1b|Not growing of dominant follicle|1|||
129536526|NCT00697255|466254063|FG000|Stage 1b|Insufficient ovarian response|0|||
129536527|NCT00697255|466254064|FG001|Stage 1b|Insufficient ovarian response|1|||
129536528|NCT01005875|466254074|FG000|Overall Study|Death|3|||
129536529|NCT03077646|466254080|FG000|Overall Study|Lost to Follow-up|29|||
129536530|NCT03077646|466254081|FG001|Overall Study|Lost to Follow-up|30|||
129536531|NCT03077646|466254082|FG002|Overall Study|Lost to Follow-up|31|||
129536532|NCT00765726|466254083|FG000|Overall Study|Withdrawal by Subject|1|||
129536533|NCT00765726|466254083|FG000|Overall Study|Discontinuation of study by sponsor|8|||
129536534|NCT02058966|466254084|FG000|Open-Label Methamphetamine|Adverse Event|1|||
129536535|NCT02058966|466254084|FG000|First Intervention|Withdrawal by Subject|1|||
129536536|NCT01265511|466254085|FG000|Overall Study|Lack of Efficacy|2|||
129536537|NCT01265511|466254086|FG001|Overall Study|Lack of Efficacy|1|||
129536538|NCT01265511|466254085|FG000|Overall Study|Met stopping rules|0|||
129536539|NCT01265511|466254086|FG001|Overall Study|Met stopping rules|2|||
129536540|NCT02993731|466254087|FG000|Overall Study|Study Termination|101|||
129536541|NCT02993731|466254088|FG001|Overall Study|Study Termination|105|||
129536542|NCT00323479|466254089|FG000|Overall Study|Adverse Event|2|||
129536543|NCT00323479|466254089|FG000|Overall Study|Withdrawal by Subject|2|||
129536544|NCT00323479|466254089|FG000|Overall Study|Protocol Violation|3|||
129536545|NCT00323479|466254089|FG000|Overall Study|house moving|1|||
129536546|NCT01362062|466254092|FG000|Overall Study|Adverse Event|1|||
129536547|NCT01362062|466254093|FG001|Overall Study|Adverse Event|0|||
129536548|NCT01362062|466254092|FG000|Overall Study|Lost to Follow-up|11|||
129536549|NCT01362062|466254093|FG001|Overall Study|Lost to Follow-up|0|||
129536550|NCT01362062|466254092|FG000|Overall Study|Withdrawal by Subject|2|||
129536551|NCT01362062|466254093|FG001|Overall Study|Withdrawal by Subject|0|||
129536552|NCT01362062|466254092|FG000|Overall Study|Non-compliant participant|2|||
129536553|NCT01362062|466254093|FG001|Overall Study|Non-compliant participant|0|||
129536554|NCT01362062|466254092|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
129536555|NCT01362062|466254093|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
129536556|NCT01362062|466254092|FG000|Overall Study|Had significant improvement|9|||
129536557|NCT01362062|466254093|FG001|Overall Study|Had significant improvement|0|||
129536558|NCT02545504|466254095|FG000|Overall Study|Death|174|||
129536559|NCT02545504|466254096|FG001|Overall Study|Death|168|||
129536560|NCT02545504|466254095|FG000|Overall Study|Unknown reason|30|||
129536561|NCT02545504|466254096|FG001|Overall Study|Unknown reason|32|||
129536562|NCT02545504|466254095|FG000|Overall Study|Withdrew consent|9|||
129536563|NCT02545504|466254096|FG001|Overall Study|Withdrew consent|11|||
129536564|NCT02545504|466254095|FG000|Overall Study|Investigator's discretion|3|||
129536565|NCT02545504|466254096|FG001|Overall Study|Investigator's discretion|1|||
129536566|NCT02545504|466254095|FG000|Overall Study|Lost to Follow-up|2|||
129536567|NCT02545504|466254096|FG001|Overall Study|Lost to Follow-up|2|||
129536568|NCT00967343|466254097|FG000|Overall Study|Study termination by sponsor|12|||
129536569|NCT00967343|466254097|FG000|Overall Study|Death|24|||
129536570|NCT00967343|466254097|FG000|Overall Study|Relapse|1|||
129536571|NCT00967343|466254097|FG000|Overall Study|Lost to Follow-up|1|||
129536572|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
129536573|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
129536574|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
129536575|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
129536576|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
129536577|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
129536578|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
129536579|NCT00950755|466254099|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
129536580|NCT00950755|466254099|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
129536581|NCT00950755|466254099|FG000|Long-Term Follow-Up|Death|8|||
129536582|NCT01336647|466256153|FG000|Overall Study|Lost to Follow-up|4|||
129536583|NCT01336647|466256154|FG001|Overall Study|Lost to Follow-up|1|||
129536584|NCT01336647|466256155|FG002|Overall Study|Lost to Follow-up|3|||
129536585|NCT00665366|466256161|FG000|Overall Study|Lack of Efficacy|11|||
129536586|NCT00665366|466256162|FG001|Overall Study|Lack of Efficacy|10|||
129536587|NCT00665366|466256161|FG000|Overall Study|Adverse Event|25|||
129536588|NCT00665366|466256162|FG001|Overall Study|Adverse Event|23|||
129536589|NCT00665366|466256161|FG000|Overall Study|Withdrawal by Subject|11|||
129536590|NCT00665366|466256162|FG001|Overall Study|Withdrawal by Subject|14|||
129536591|NCT00665366|466256161|FG000|Overall Study|Lost to Follow-up|3|||
129536592|NCT00665366|466256162|FG001|Overall Study|Lost to Follow-up|5|||
129536593|NCT00665366|466256161|FG000|Overall Study|Poor compliance/noncompliance|3|||
129536594|NCT00665366|466256162|FG001|Overall Study|Poor compliance/noncompliance|5|||
129536595|NCT00665366|466256161|FG000|Overall Study|Pregnancy|1|||
129536596|NCT00665366|466256162|FG001|Overall Study|Pregnancy|0|||
129536597|NCT00665366|466256161|FG000|Overall Study|No longer meets study criteria|0|||
129536598|NCT00665366|466256162|FG001|Overall Study|No longer meets study criteria|1|||
129536599|NCT00665366|466256161|FG000|Overall Study|Other reasons|4|||
129536600|NCT00665366|466256162|FG001|Overall Study|Other reasons|1|||
129536601|NCT04177862|466256163|FG000|Overall Study|Protocol Violation|2|||
129536602|NCT04177862|466256164|FG001|Overall Study|Protocol Violation|7|||
129536603|NCT03233009|466256177|FG000|Overall Study|Lost to Follow-up|1|||
129536604|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
129536605|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
129536606|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536607|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536608|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536609|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536610|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536611|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536612|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536613|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536614|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536615|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
129536616|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
129536617|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536618|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536619|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536620|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536621|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536622|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
129536623|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536624|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536625|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536626|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
129536627|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
129536628|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536629|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
129536630|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536631|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536632|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536633|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536634|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536635|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536636|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536637|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536638|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536639|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
129536640|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
129536641|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
129536642|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
129536643|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
129536644|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
129536645|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
129536646|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
129536647|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
129536648|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
129536649|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
129536650|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
129536651|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
129536652|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536653|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536654|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536655|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536656|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536657|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
129536658|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536659|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536660|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536661|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536662|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536663|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
129536664|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536665|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536666|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536667|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536668|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536669|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
129536670|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536671|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536672|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536673|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536674|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536675|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
129536676|NCT00151775|466256178|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536677|NCT00151775|466256179|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536678|NCT00151775|466256180|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536679|NCT00151775|466256181|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536680|NCT00151775|466256182|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536681|NCT00151775|466256183|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536682|NCT00151775|466256184|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
129536683|NCT00151775|466256185|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536684|NCT00151775|466256186|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536685|NCT00151775|466256187|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536686|NCT00151775|466256188|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536687|NCT00151775|466256189|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
129536688|NCT00151775|466256178|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536689|NCT00151775|466256179|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536690|NCT00151775|466256180|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536691|NCT00151775|466256181|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536692|NCT00151775|466256182|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536693|NCT00151775|466256183|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
129536694|NCT00151775|466256184|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536695|NCT00151775|466256185|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536696|NCT00151775|466256186|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536697|NCT00151775|466256187|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536698|NCT00151775|466256188|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536699|NCT00151775|466256189|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
129536700|NCT00151775|466256178|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
129536701|NCT00151775|466256179|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
129536702|NCT00151775|466256180|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
129536703|NCT00151775|466256181|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
129536704|NCT00151775|466256182|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
129536705|NCT00151775|466256183|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
129536706|NCT00151775|466256184|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
129536707|NCT00151775|466256185|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
129536708|NCT00151775|466256186|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
129536709|NCT00151775|466256187|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
129536710|NCT00151775|466256188|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
129536711|NCT00151775|466256189|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
129536712|NCT00151775|466256178|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536713|NCT00151775|466256179|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536714|NCT00151775|466256180|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536715|NCT00151775|466256181|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536716|NCT00151775|466256182|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536717|NCT00151775|466256183|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536718|NCT00151775|466256184|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
129536719|NCT00151775|466256185|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536720|NCT00151775|466256186|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536721|NCT00151775|466256187|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536722|NCT00151775|466256188|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536723|NCT00151775|466256189|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
129536724|NCT00151775|466256178|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536725|NCT00151775|466256179|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536726|NCT00151775|466256180|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
129536727|NCT00151775|466256181|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536728|NCT00151775|466256182|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536729|NCT00151775|466256183|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536730|NCT00151775|466256184|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536731|NCT00151775|466256185|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536732|NCT00151775|466256186|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536733|NCT00151775|466256187|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536734|NCT00151775|466256188|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536735|NCT00151775|466256189|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
129536736|NCT00151775|466256178|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536737|NCT00151775|466256179|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536738|NCT00151775|466256180|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
129536739|NCT00151775|466256181|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536740|NCT00151775|466256182|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536741|NCT00151775|466256183|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536742|NCT00151775|466256184|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536743|NCT00151775|466256185|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536744|NCT00151775|466256186|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536745|NCT00151775|466256187|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536746|NCT00151775|466256188|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536747|NCT00151775|466256189|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
129536748|NCT00151775|466256178|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536749|NCT00151775|466256179|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536750|NCT00151775|466256180|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536751|NCT00151775|466256181|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536752|NCT00151775|466256182|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536753|NCT00151775|466256183|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536754|NCT00151775|466256184|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536755|NCT00151775|466256185|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536756|NCT00151775|466256186|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536757|NCT00151775|466256187|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536758|NCT00151775|466256188|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
129536759|NCT00151775|466256189|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
129536760|NCT00151775|466256178|FG000|Period 4: Open Label|Increased blood pressure|0|||
129536761|NCT00151775|466256179|FG001|Period 4: Open Label|Increased blood pressure|0|||
129536762|NCT00151775|466256180|FG002|Period 4: Open Label|Increased blood pressure|0|||
129536763|NCT00151775|466256181|FG003|Period 4: Open Label|Increased blood pressure|0|||
129536764|NCT00151775|466256182|FG004|Period 4: Open Label|Increased blood pressure|1|||
129536765|NCT00151775|466256183|FG005|Period 4: Open Label|Increased blood pressure|0|||
129536766|NCT00151775|466256184|FG006|Period 4: Open Label|Increased blood pressure|0|||
129536767|NCT00151775|466256185|FG007|Period 4: Open Label|Increased blood pressure|0|||
129538911|NCT01238861|466265112|FG005|Overall Study|Lost to Follow-up|2|||
129536768|NCT00151775|466256186|FG008|Period 4: Open Label|Increased blood pressure|0|||
129536769|NCT00151775|466256187|FG009|Period 4: Open Label|Increased blood pressure|1|||
129536770|NCT00151775|466256188|FG010|Period 4: Open Label|Increased blood pressure|0|||
129536771|NCT00151775|466256189|FG011|Period 4: Open Label|Increased blood pressure|0|||
129536772|NCT00151775|466256178|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
129536773|NCT00151775|466256179|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
129536774|NCT00151775|466256180|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
129536775|NCT00151775|466256181|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
129536776|NCT00151775|466256182|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
129536777|NCT00151775|466256183|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
129536778|NCT00151775|466256184|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
129536779|NCT00151775|466256185|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
129536780|NCT00151775|466256186|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
129536781|NCT00151775|466256187|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
129536782|NCT00151775|466256188|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
129536783|NCT00151775|466256189|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
129536784|NCT00151775|466256178|FG000|Period 4: Open Label|Adverse Event|0|||
129536785|NCT00151775|466256179|FG001|Period 4: Open Label|Adverse Event|0|||
129536786|NCT00151775|466256180|FG002|Period 4: Open Label|Adverse Event|0|||
129536787|NCT00151775|466256181|FG003|Period 4: Open Label|Adverse Event|0|||
129536788|NCT00151775|466256182|FG004|Period 4: Open Label|Adverse Event|1|||
129536789|NCT00151775|466256183|FG005|Period 4: Open Label|Adverse Event|0|||
129536790|NCT00151775|466256184|FG006|Period 4: Open Label|Adverse Event|0|||
129536791|NCT00151775|466256185|FG007|Period 4: Open Label|Adverse Event|0|||
129536792|NCT00151775|466256186|FG008|Period 4: Open Label|Adverse Event|0|||
129536793|NCT00151775|466256187|FG009|Period 4: Open Label|Adverse Event|2|||
129536794|NCT00151775|466256188|FG010|Period 4: Open Label|Adverse Event|0|||
129536795|NCT00151775|466256189|FG011|Period 4: Open Label|Adverse Event|0|||
129536796|NCT00151775|466256178|FG000|Period 4: Open Label|Lost to Follow-up|0|||
129536797|NCT00151775|466256179|FG001|Period 4: Open Label|Lost to Follow-up|0|||
129536798|NCT00151775|466256180|FG002|Period 4: Open Label|Lost to Follow-up|0|||
129536799|NCT00151775|466256181|FG003|Period 4: Open Label|Lost to Follow-up|0|||
129536800|NCT00151775|466256182|FG004|Period 4: Open Label|Lost to Follow-up|17|||
129536801|NCT00151775|466256183|FG005|Period 4: Open Label|Lost to Follow-up|0|||
129536802|NCT00151775|466256184|FG006|Period 4: Open Label|Lost to Follow-up|0|||
129536803|NCT00151775|466256185|FG007|Period 4: Open Label|Lost to Follow-up|0|||
129536804|NCT00151775|466256186|FG008|Period 4: Open Label|Lost to Follow-up|0|||
129536805|NCT00151775|466256187|FG009|Period 4: Open Label|Lost to Follow-up|7|||
129536806|NCT00151775|466256188|FG010|Period 4: Open Label|Lost to Follow-up|0|||
129536807|NCT00151775|466256189|FG011|Period 4: Open Label|Lost to Follow-up|0|||
129536808|NCT00151775|466256178|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
129536809|NCT00151775|466256179|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
129536810|NCT00151775|466256180|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
129536811|NCT00151775|466256181|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
129536812|NCT00151775|466256182|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
129536813|NCT00151775|466256183|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
129536814|NCT00151775|466256184|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
129536815|NCT00151775|466256185|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
129536816|NCT00151775|466256186|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
129536817|NCT00151775|466256187|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
129536818|NCT00151775|466256188|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
129536819|NCT00151775|466256189|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
129536820|NCT00151775|466256178|FG000|Period 4: Open Label|Other|0|||
129536821|NCT00151775|466256179|FG001|Period 4: Open Label|Other|0|||
129536822|NCT00151775|466256180|FG002|Period 4: Open Label|Other|0|||
129536823|NCT00151775|466256181|FG003|Period 4: Open Label|Other|0|||
129536824|NCT00151775|466256182|FG004|Period 4: Open Label|Other|1|||
129536825|NCT00151775|466256183|FG005|Period 4: Open Label|Other|0|||
129536826|NCT00151775|466256184|FG006|Period 4: Open Label|Other|0|||
129536827|NCT00151775|466256185|FG007|Period 4: Open Label|Other|0|||
129536828|NCT00151775|466256186|FG008|Period 4: Open Label|Other|0|||
129536829|NCT00151775|466256187|FG009|Period 4: Open Label|Other|3|||
129536830|NCT00151775|466256188|FG010|Period 4: Open Label|Other|0|||
129536831|NCT00151775|466256189|FG011|Period 4: Open Label|Other|0|||
129536832|NCT00151775|466256178|FG000|Period 4: Open Label|Physician Decision|0|||
129536833|NCT00151775|466256179|FG001|Period 4: Open Label|Physician Decision|0|||
129536834|NCT00151775|466256180|FG002|Period 4: Open Label|Physician Decision|0|||
129536835|NCT00151775|466256181|FG003|Period 4: Open Label|Physician Decision|0|||
129536836|NCT00151775|466256182|FG004|Period 4: Open Label|Physician Decision|0|||
129536837|NCT00151775|466256183|FG005|Period 4: Open Label|Physician Decision|0|||
129536838|NCT00151775|466256184|FG006|Period 4: Open Label|Physician Decision|0|||
129536839|NCT00151775|466256185|FG007|Period 4: Open Label|Physician Decision|0|||
129536840|NCT00151775|466256186|FG008|Period 4: Open Label|Physician Decision|0|||
129536841|NCT00151775|466256187|FG009|Period 4: Open Label|Physician Decision|2|||
129536842|NCT00151775|466256188|FG010|Period 4: Open Label|Physician Decision|0|||
129536843|NCT00151775|466256189|FG011|Period 4: Open Label|Physician Decision|0|||
129536844|NCT00151775|466256178|FG000|Period 4: Open Label|Protocol Violation|0|||
129536845|NCT00151775|466256179|FG001|Period 4: Open Label|Protocol Violation|0|||
129536846|NCT00151775|466256180|FG002|Period 4: Open Label|Protocol Violation|0|||
129536847|NCT00151775|466256181|FG003|Period 4: Open Label|Protocol Violation|0|||
129536848|NCT00151775|466256182|FG004|Period 4: Open Label|Protocol Violation|1|||
129536849|NCT00151775|466256183|FG005|Period 4: Open Label|Protocol Violation|0|||
129536850|NCT00151775|466256184|FG006|Period 4: Open Label|Protocol Violation|0|||
129536851|NCT00151775|466256185|FG007|Period 4: Open Label|Protocol Violation|0|||
129536852|NCT00151775|466256186|FG008|Period 4: Open Label|Protocol Violation|0|||
129536853|NCT00151775|466256187|FG009|Period 4: Open Label|Protocol Violation|0|||
129536854|NCT00151775|466256188|FG010|Period 4: Open Label|Protocol Violation|0|||
129536855|NCT00151775|466256189|FG011|Period 4: Open Label|Protocol Violation|0|||
129536856|NCT00474994|466256199|FG000|Overall Study|Patient Not treated|1|||
129536857|NCT00474994|466256199|FG000|Overall Study|Patient evaluable for toxicity only|3|||
129536858|NCT00474994|466256199|FG000|Overall Study|Patient found to be ineligible|1|||
129536859|NCT00278473|466256200|FG000|Overall Study|drop out|4|||
129536860|NCT00278473|466256201|FG001|Overall Study|drop out|3|||
129536861|NCT04516291|466256202|FG000|Treatment Period (24 Weeks)|Other|1|||
129536862|NCT04516291|466256203|FG001|Treatment Period (24 Weeks)|Other|0|||
129536863|NCT04516291|466256204|FG002|Treatment Period (24 Weeks)|Other|0|||
129536864|NCT04516291|466256205|FG003|Treatment Period (24 Weeks)|Other|2|||
129536865|NCT04516291|466256206|FG004|Treatment Period (24 Weeks)|Other|2|||
129536866|NCT04516291|466256207|FG005|Treatment Period (24 Weeks)|Other|4|||
129536867|NCT04516291|466256208|FG006|Treatment Period (24 Weeks)|Other|2|||
129536868|NCT04516291|466256209|FG007|Treatment Period (24 Weeks)|Other|0|||
129536869|NCT04516291|466256202|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129536870|NCT04516291|466256203|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
129536871|NCT04516291|466256204|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129536872|NCT04516291|466256205|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129536873|NCT04516291|466256206|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
129536874|NCT04516291|466256207|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129536875|NCT04516291|466256208|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129536876|NCT04516291|466256209|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
129536877|NCT04516291|466256202|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536878|NCT04516291|466256203|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536879|NCT04516291|466256204|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536880|NCT04516291|466256205|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
129536881|NCT04516291|466256206|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536882|NCT04516291|466256207|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536883|NCT04516291|466256208|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536884|NCT04516291|466256209|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
129536885|NCT04516291|466256202|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536886|NCT04516291|466256203|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
129536887|NCT04516291|466256204|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536888|NCT04516291|466256205|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536889|NCT04516291|466256206|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536890|NCT04516291|466256207|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536891|NCT04516291|466256208|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536892|NCT04516291|466256209|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
129536893|NCT04516291|466256202|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
129536894|NCT04516291|466256203|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
129536895|NCT04516291|466256204|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
129536896|NCT04516291|466256205|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
129536897|NCT04516291|466256206|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
129536898|NCT04516291|466256207|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
129536899|NCT04516291|466256208|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
129536900|NCT04516291|466256209|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
129536901|NCT04516291|466256202|FG000|Follow-up Period (12 Weeks)|Other|0|||
129536902|NCT04516291|466256203|FG001|Follow-up Period (12 Weeks)|Other|1|||
129536903|NCT04516291|466256204|FG002|Follow-up Period (12 Weeks)|Other|0|||
129536904|NCT04516291|466256205|FG003|Follow-up Period (12 Weeks)|Other|2|||
129536905|NCT04516291|466256206|FG004|Follow-up Period (12 Weeks)|Other|0|||
129536906|NCT04516291|466256207|FG005|Follow-up Period (12 Weeks)|Other|0|||
129536907|NCT04516291|466256208|FG006|Follow-up Period (12 Weeks)|Other|0|||
129536908|NCT04516291|466256209|FG007|Follow-up Period (12 Weeks)|Other|0|||
129536909|NCT04516291|466256202|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536910|NCT04516291|466256203|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536911|NCT04516291|466256204|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536912|NCT04516291|466256205|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536913|NCT04516291|466256206|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
129536914|NCT04516291|466256207|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536915|NCT04516291|466256208|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536916|NCT04516291|466256209|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
129536917|NCT04516291|466256202|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
129536918|NCT04516291|466256203|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
129536919|NCT04516291|466256204|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
129536920|NCT04516291|466256205|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
129536921|NCT04516291|466256206|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
129536922|NCT04516291|466256207|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
129536923|NCT04516291|466256208|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
129536924|NCT04516291|466256209|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
129536925|NCT02322866|466256211|FG000|Overall Study|Adverse Event|6|||
129536926|NCT02322866|466256212|FG001|Overall Study|Adverse Event|11|||
129536927|NCT02322866|466256211|FG000|Overall Study|Withdrawal of Consent|16|||
129536928|NCT02322866|466256212|FG001|Overall Study|Withdrawal of Consent|25|||
129536929|NCT02322866|466256211|FG000|Overall Study|Lost to Follow-up|36|||
129536930|NCT02322866|466256212|FG001|Overall Study|Lost to Follow-up|39|||
129536931|NCT02322866|466256211|FG000|Overall Study|Protocol Violation|1|||
129536932|NCT02322866|466256212|FG001|Overall Study|Protocol Violation|0|||
129536933|NCT02322866|466256211|FG000|Overall Study|Noncompliance with Treatment|3|||
129536934|NCT02322866|466256212|FG001|Overall Study|Noncompliance with Treatment|4|||
129536935|NCT02322866|466256211|FG000|Overall Study|Lack of Efficacy|3|||
129536936|NCT02322866|466256212|FG001|Overall Study|Lack of Efficacy|1|||
129536937|NCT02322866|466256211|FG000|Overall Study|Other Miscellaneous Reasons|6|||
129536938|NCT02322866|466256212|FG001|Overall Study|Other Miscellaneous Reasons|6|||
129536939|NCT06045026|466256217|FG000|Overall Study|Lost to Follow-up|60|||
129536940|NCT06045026|466256217|FG000|Overall Study|Adverse Event|12|||
129536941|NCT06045026|466256217|FG000|Overall Study|Withdrawal by Subject|3|||
129536942|NCT06045026|466256217|FG000|Overall Study|Enrollment closed|1|||
129536943|NCT01928758|466256226|FG000|Overall Study|Lost to Follow-up|14|||
129536944|NCT01928758|466256227|FG001|Overall Study|Lost to Follow-up|9|||
129536945|NCT01928758|466256226|FG000|Overall Study|Withdrawal by Subject|5|||
129536946|NCT01928758|466256227|FG001|Overall Study|Withdrawal by Subject|2|||
129536947|NCT01928758|466256226|FG000|Overall Study|Adverse Event|3|||
129536948|NCT01928758|466256227|FG001|Overall Study|Adverse Event|5|||
129536949|NCT01928758|466256226|FG000|Overall Study|Protocol Violation|3|||
129536950|NCT01928758|466256227|FG001|Overall Study|Protocol Violation|4|||
129536951|NCT00719706|466256228|FG000|Overall Study|Adverse Event|5|||
129536952|NCT00719706|466256229|FG001|Overall Study|Adverse Event|4|||
129536953|NCT00719706|466256228|FG000|Overall Study|Withdrawal by Subject|1|||
129536954|NCT00719706|466256229|FG001|Overall Study|Withdrawal by Subject|2|||
129536955|NCT00719706|466256228|FG000|Overall Study|Protocol Violation|3|||
129536956|NCT00719706|466256229|FG001|Overall Study|Protocol Violation|0|||
129536957|NCT02452320|466256233|FG000|Overall Study|Adverse Event|0|||
129536958|NCT02452320|466256234|FG001|Overall Study|Adverse Event|1|||
129536959|NCT03198559|466256235|FG000|Overall Study|Adverse Event|2|||
129536960|NCT01072175|466256236|FG000|Part A (Drug-Drug Interaction)|Death|1|||
129536961|NCT01072175|466256237|FG001|Part A (Drug-Drug Interaction)|Death|0|||
129536962|NCT01072175|466256238|FG002|Part A (Drug-Drug Interaction)|Death|0|||
129536963|NCT01072175|466256239|FG003|Part A (Drug-Drug Interaction)|Death|0|||
129536964|NCT01072175|466256240|FG004|Part A (Drug-Drug Interaction)|Death|0|||
129536965|NCT01072175|466256241|FG005|Part A (Drug-Drug Interaction)|Death|0|||
129536966|NCT01072175|466256242|FG006|Part A (Drug-Drug Interaction)|Death|0|||
129536967|NCT01072175|466256243|FG007|Part A (Drug-Drug Interaction)|Death|0|||
129536968|NCT01072175|466256244|FG008|Part A (Drug-Drug Interaction)|Death|0|||
129536969|NCT01072175|466256245|FG009|Part A (Drug-Drug Interaction)|Death|0|||
129536970|NCT01072175|466256246|FG010|Part A (Drug-Drug Interaction)|Death|0|||
129536971|NCT01072175|466256247|FG011|Part A (Drug-Drug Interaction)|Death|0|||
129536972|NCT01072175|466256248|FG012|Part A (Drug-Drug Interaction)|Death|0|||
129536973|NCT01072175|466256236|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
129536974|NCT01072175|466256237|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536975|NCT01072175|466256238|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536976|NCT01072175|466256239|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536977|NCT01072175|466256240|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536978|NCT01072175|466256241|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536979|NCT01072175|466256242|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536980|NCT01072175|466256243|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536981|NCT01072175|466256244|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536982|NCT01072175|466256245|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536983|NCT01072175|466256246|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536984|NCT01072175|466256247|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536985|NCT01072175|466256248|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
129536986|NCT01072175|466256236|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
129536987|NCT01072175|466256237|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536988|NCT01072175|466256238|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536989|NCT01072175|466256239|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536990|NCT01072175|466256240|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536991|NCT01072175|466256241|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536992|NCT01072175|466256242|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536993|NCT01072175|466256243|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536994|NCT01072175|466256244|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536995|NCT01072175|466256245|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536996|NCT01072175|466256246|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536997|NCT01072175|466256247|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536998|NCT01072175|466256248|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
129536999|NCT01072175|466256236|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
129537000|NCT01072175|466256237|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
129537001|NCT01072175|466256238|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
129537002|NCT01072175|466256239|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
129537003|NCT01072175|466256240|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
129537004|NCT01072175|466256241|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
129537005|NCT01072175|466256242|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
129537006|NCT01072175|466256243|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
129537007|NCT01072175|466256244|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
129537008|NCT01072175|466256245|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
129537009|NCT01072175|466256246|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
129537010|NCT01072175|466256247|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
129537011|NCT01072175|466256248|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
129537012|NCT01072175|466256236|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537013|NCT01072175|466256237|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537014|NCT01072175|466256238|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
129537015|NCT01072175|466256239|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537016|NCT01072175|466256240|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
129537017|NCT01072175|466256241|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537018|NCT01072175|466256242|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537019|NCT01072175|466256243|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537020|NCT01072175|466256244|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537021|NCT01072175|466256245|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537022|NCT01072175|466256246|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537023|NCT01072175|466256247|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537024|NCT01072175|466256248|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
129537025|NCT01072175|466256236|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537026|NCT01072175|466256237|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
129537027|NCT01072175|466256238|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537028|NCT01072175|466256239|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
129537029|NCT01072175|466256240|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
129537030|NCT01072175|466256241|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537031|NCT01072175|466256242|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537032|NCT01072175|466256243|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537033|NCT01072175|466256244|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537034|NCT01072175|466256245|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537035|NCT01072175|466256246|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537036|NCT01072175|466256247|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537037|NCT01072175|466256248|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
129537038|NCT01072175|466256236|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537039|NCT01072175|466256237|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537040|NCT01072175|466256238|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
129537041|NCT01072175|466256239|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
129537042|NCT01072175|466256240|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
129537043|NCT01072175|466256241|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537044|NCT01072175|466256242|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537045|NCT01072175|466256243|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537046|NCT01072175|466256244|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537047|NCT01072175|466256245|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537048|NCT01072175|466256246|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537049|NCT01072175|466256247|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537050|NCT01072175|466256248|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
129537051|NCT01072175|466256236|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537052|NCT01072175|466256237|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
129537053|NCT01072175|466256238|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537054|NCT01072175|466256239|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
129537055|NCT01072175|466256240|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
129537056|NCT01072175|466256241|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537057|NCT01072175|466256242|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537058|NCT01072175|466256243|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537059|NCT01072175|466256244|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537060|NCT01072175|466256245|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537061|NCT01072175|466256246|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537062|NCT01072175|466256247|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537063|NCT01072175|466256248|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
129537064|NCT01072175|466256236|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
129537065|NCT01072175|466256237|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
129537066|NCT01072175|466256238|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
129537067|NCT01072175|466256239|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
129537068|NCT01072175|466256240|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
129537069|NCT01072175|466256241|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
129537070|NCT01072175|466256242|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
129537071|NCT01072175|466256243|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
129537072|NCT01072175|466256244|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
129537073|NCT01072175|466256245|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
129537074|NCT01072175|466256246|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
129537075|NCT01072175|466256247|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
129537076|NCT01072175|466256248|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
129537077|NCT01072175|466256236|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537078|NCT01072175|466256237|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537079|NCT01072175|466256238|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537080|NCT01072175|466256239|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537081|NCT01072175|466256240|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537082|NCT01072175|466256241|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
129537083|NCT01072175|466256242|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
129537084|NCT01072175|466256243|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
129537085|NCT01072175|466256244|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537086|NCT01072175|466256245|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537087|NCT01072175|466256246|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537088|NCT01072175|466256247|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537089|NCT01072175|466256248|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
129537090|NCT01072175|466256236|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537091|NCT01072175|466256237|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537092|NCT01072175|466256238|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537093|NCT01072175|466256239|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537094|NCT01072175|466256240|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537095|NCT01072175|466256241|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537096|NCT01072175|466256242|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
129537097|NCT01072175|466256243|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
129537098|NCT01072175|466256244|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537099|NCT01072175|466256245|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537100|NCT01072175|466256246|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537101|NCT01072175|466256247|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537102|NCT01072175|466256248|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
129537103|NCT01072175|466256236|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537104|NCT01072175|466256237|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537105|NCT01072175|466256238|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537106|NCT01072175|466256239|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537107|NCT01072175|466256240|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537108|NCT01072175|466256241|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
129537109|NCT01072175|466256242|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
129537110|NCT01072175|466256243|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
129537111|NCT01072175|466256244|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537112|NCT01072175|466256245|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537113|NCT01072175|466256246|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537114|NCT01072175|466256247|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537115|NCT01072175|466256248|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
129537116|NCT01072175|466256236|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537117|NCT01072175|466256237|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537118|NCT01072175|466256238|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537119|NCT01072175|466256239|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537120|NCT01072175|466256240|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537121|NCT01072175|466256241|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
129537122|NCT01072175|466256242|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
129537123|NCT01072175|466256243|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537124|NCT01072175|466256244|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537125|NCT01072175|466256245|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537126|NCT01072175|466256246|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537127|NCT01072175|466256247|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537128|NCT01072175|466256248|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
129537129|NCT01072175|466256236|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537130|NCT01072175|466256237|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537131|NCT01072175|466256238|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537132|NCT01072175|466256239|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537133|NCT01072175|466256240|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537134|NCT01072175|466256241|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537135|NCT01072175|466256242|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537136|NCT01072175|466256243|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537137|NCT01072175|466256244|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
129537138|NCT01072175|466256245|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537139|NCT01072175|466256246|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537140|NCT01072175|466256247|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537141|NCT01072175|466256248|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
129537142|NCT01072175|466256236|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537143|NCT01072175|466256237|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537144|NCT01072175|466256238|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537145|NCT01072175|466256239|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537146|NCT01072175|466256240|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537147|NCT01072175|466256241|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537148|NCT01072175|466256242|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537149|NCT01072175|466256243|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537150|NCT01072175|466256244|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
129537151|NCT01072175|466256245|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537152|NCT01072175|466256246|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537153|NCT01072175|466256247|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537154|NCT01072175|466256248|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
129537155|NCT01072175|466256236|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537156|NCT01072175|466256237|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537157|NCT01072175|466256238|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537158|NCT01072175|466256239|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537159|NCT01072175|466256240|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537160|NCT01072175|466256241|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537161|NCT01072175|466256242|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537162|NCT01072175|466256243|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537163|NCT01072175|466256244|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
129537164|NCT01072175|466256245|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537165|NCT01072175|466256246|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537166|NCT01072175|466256247|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537167|NCT01072175|466256248|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
129537168|NCT01072175|466256236|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537169|NCT01072175|466256237|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537170|NCT01072175|466256238|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537171|NCT01072175|466256239|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537172|NCT01072175|466256240|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537173|NCT01072175|466256241|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537174|NCT01072175|466256242|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537175|NCT01072175|466256243|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537176|NCT01072175|466256244|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
129537177|NCT01072175|466256245|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537178|NCT01072175|466256246|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537179|NCT01072175|466256247|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537180|NCT01072175|466256248|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
129537181|NCT01072175|466256236|FG000|Part D (HPMC Capsules)|Death|0|||
129537182|NCT01072175|466256237|FG001|Part D (HPMC Capsules)|Death|0|||
129537183|NCT01072175|466256238|FG002|Part D (HPMC Capsules)|Death|0|||
129537184|NCT01072175|466256239|FG003|Part D (HPMC Capsules)|Death|0|||
129537185|NCT01072175|466256240|FG004|Part D (HPMC Capsules)|Death|0|||
129537186|NCT01072175|466256241|FG005|Part D (HPMC Capsules)|Death|0|||
129537187|NCT01072175|466256242|FG006|Part D (HPMC Capsules)|Death|0|||
129537188|NCT01072175|466256243|FG007|Part D (HPMC Capsules)|Death|0|||
129537189|NCT01072175|466256244|FG008|Part D (HPMC Capsules)|Death|0|||
129537190|NCT01072175|466256245|FG009|Part D (HPMC Capsules)|Death|10|||
129537191|NCT01072175|466256246|FG010|Part D (HPMC Capsules)|Death|12|||
129537192|NCT01072175|466256247|FG011|Part D (HPMC Capsules)|Death|28|||
129537193|NCT01072175|466256248|FG012|Part D (HPMC Capsules)|Death|26|||
129537194|NCT01072175|466256236|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
129537195|NCT01072175|466256237|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
129537196|NCT01072175|466256238|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
129537197|NCT01072175|466256239|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
129537198|NCT01072175|466256240|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
129537199|NCT01072175|466256241|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
129537200|NCT01072175|466256242|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
129537201|NCT01072175|466256243|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
129537202|NCT01072175|466256244|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
129537203|NCT01072175|466256245|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
129537204|NCT01072175|466256246|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
129537205|NCT01072175|466256247|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
129537206|NCT01072175|466256248|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
129537207|NCT01072175|466256236|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537208|NCT01072175|466256237|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537209|NCT01072175|466256238|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537210|NCT01072175|466256239|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537211|NCT01072175|466256240|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537212|NCT01072175|466256241|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537213|NCT01072175|466256242|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537214|NCT01072175|466256243|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537215|NCT01072175|466256244|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537216|NCT01072175|466256245|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
129537217|NCT01072175|466256246|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
129537218|NCT01072175|466256247|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
129537219|NCT01072175|466256248|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
129537220|NCT01072175|466256236|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537221|NCT01072175|466256237|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537222|NCT01072175|466256238|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537223|NCT01072175|466256239|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537224|NCT01072175|466256240|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537225|NCT01072175|466256241|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537226|NCT01072175|466256242|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537227|NCT01072175|466256243|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537228|NCT01072175|466256244|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
129537229|NCT01072175|466256245|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
129537230|NCT01072175|466256246|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
129537231|NCT01072175|466256247|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
129537232|NCT01072175|466256248|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
129537233|NCT01072175|466256236|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537234|NCT01072175|466256237|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537235|NCT01072175|466256238|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537236|NCT01072175|466256239|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537237|NCT01072175|466256240|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537238|NCT01072175|466256241|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537239|NCT01072175|466256242|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537240|NCT01072175|466256243|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537241|NCT01072175|466256244|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537242|NCT01072175|466256245|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537243|NCT01072175|466256246|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
129537244|NCT01072175|466256247|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
129537245|NCT01072175|466256248|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
129537246|NCT00649220|466256249|FG000|Overall Study|Adverse Event|2|||
129537247|NCT00649220|466256249|FG000|Overall Study|Withdrawal by Subject|1|||
129537248|NCT02557308|466256250|FG000|Overall Study|Withdrawal by Subject|11|||
129537249|NCT02557308|466256251|FG001|Overall Study|Withdrawal by Subject|3|||
129537250|NCT02557308|466256252|FG002|Overall Study|Withdrawal by Subject|2|||
129537251|NCT02557308|466256253|FG003|Overall Study|Withdrawal by Subject|0|||
129537252|NCT02557308|466256254|FG004|Overall Study|Withdrawal by Subject|1|||
129537253|NCT02557308|466256255|FG005|Overall Study|Withdrawal by Subject|0|||
129537254|NCT02557308|466256256|FG006|Overall Study|Withdrawal by Subject|10|||
129537255|NCT02557308|466256257|FG007|Overall Study|Withdrawal by Subject|1|||
129537256|NCT02557308|466256250|FG000|Overall Study|Disease Progression|0|||
129537257|NCT02557308|466256251|FG001|Overall Study|Disease Progression|1|||
129537258|NCT02557308|466256252|FG002|Overall Study|Disease Progression|0|||
129537259|NCT02557308|466256253|FG003|Overall Study|Disease Progression|0|||
129537260|NCT02557308|466256254|FG004|Overall Study|Disease Progression|0|||
129537261|NCT02557308|466256255|FG005|Overall Study|Disease Progression|0|||
129537262|NCT02557308|466256256|FG006|Overall Study|Disease Progression|0|||
129537263|NCT02557308|466256257|FG007|Overall Study|Disease Progression|0|||
129537264|NCT02557308|466256250|FG000|Overall Study|Lack of Efficacy|3|||
129537265|NCT02557308|466256251|FG001|Overall Study|Lack of Efficacy|0|||
129537266|NCT02557308|466256252|FG002|Overall Study|Lack of Efficacy|0|||
129537267|NCT02557308|466256253|FG003|Overall Study|Lack of Efficacy|0|||
129537268|NCT02557308|466256254|FG004|Overall Study|Lack of Efficacy|0|||
129537269|NCT02557308|466256255|FG005|Overall Study|Lack of Efficacy|0|||
129537270|NCT02557308|466256256|FG006|Overall Study|Lack of Efficacy|1|||
129537271|NCT02557308|466256257|FG007|Overall Study|Lack of Efficacy|0|||
129537272|NCT02557308|466256250|FG000|Overall Study|Adverse Event|4|||
129537273|NCT02557308|466256251|FG001|Overall Study|Adverse Event|1|||
129537274|NCT02557308|466256252|FG002|Overall Study|Adverse Event|2|||
129537275|NCT02557308|466256253|FG003|Overall Study|Adverse Event|0|||
129537276|NCT02557308|466256254|FG004|Overall Study|Adverse Event|0|||
129537277|NCT02557308|466256255|FG005|Overall Study|Adverse Event|0|||
129537278|NCT02557308|466256256|FG006|Overall Study|Adverse Event|4|||
129537279|NCT02557308|466256257|FG007|Overall Study|Adverse Event|1|||
129537280|NCT02557308|466256250|FG000|Overall Study|Lost to Follow-up|2|||
129537281|NCT02557308|466256251|FG001|Overall Study|Lost to Follow-up|0|||
129537282|NCT02557308|466256252|FG002|Overall Study|Lost to Follow-up|1|||
129537283|NCT02557308|466256253|FG003|Overall Study|Lost to Follow-up|0|||
129537284|NCT02557308|466256254|FG004|Overall Study|Lost to Follow-up|0|||
129537285|NCT02557308|466256255|FG005|Overall Study|Lost to Follow-up|0|||
129537286|NCT02557308|466256256|FG006|Overall Study|Lost to Follow-up|2|||
129537287|NCT02557308|466256257|FG007|Overall Study|Lost to Follow-up|0|||
129537288|NCT02557308|466256250|FG000|Overall Study|Death|1|||
129537289|NCT02557308|466256251|FG001|Overall Study|Death|0|||
129537290|NCT02557308|466256252|FG002|Overall Study|Death|0|||
129537291|NCT02557308|466256253|FG003|Overall Study|Death|0|||
129537292|NCT02557308|466256254|FG004|Overall Study|Death|0|||
129537293|NCT02557308|466256255|FG005|Overall Study|Death|0|||
129537294|NCT02557308|466256256|FG006|Overall Study|Death|0|||
129537295|NCT02557308|466256257|FG007|Overall Study|Death|0|||
129537296|NCT02557308|466256250|FG000|Overall Study|Study Close|98|||
129537297|NCT02557308|466256251|FG001|Overall Study|Study Close|18|||
129537298|NCT02557308|466256252|FG002|Overall Study|Study Close|5|||
129537299|NCT02557308|466256253|FG003|Overall Study|Study Close|3|||
129537300|NCT02557308|466256254|FG004|Overall Study|Study Close|1|||
129537301|NCT02557308|466256255|FG005|Overall Study|Study Close|0|||
129537302|NCT02557308|466256256|FG006|Overall Study|Study Close|123|||
129537303|NCT02557308|466256257|FG007|Overall Study|Study Close|5|||
129537304|NCT02557308|466256250|FG000|Overall Study|Except for study close|5|||
129537305|NCT02557308|466256251|FG001|Overall Study|Except for study close|0|||
129537306|NCT02557308|466256252|FG002|Overall Study|Except for study close|0|||
129537307|NCT02557308|466256253|FG003|Overall Study|Except for study close|0|||
129537308|NCT02557308|466256254|FG004|Overall Study|Except for study close|3|||
129537309|NCT02557308|466256255|FG005|Overall Study|Except for study close|0|||
129537310|NCT02557308|466256256|FG006|Overall Study|Except for study close|6|||
129537311|NCT02557308|466256257|FG007|Overall Study|Except for study close|10|||
129537312|NCT01980056|466256260|FG000|Overall Study|Death|1|||
129537313|NCT01980056|466256261|FG001|Overall Study|Death|1|||
129537314|NCT01980056|466256262|FG002|Overall Study|Death|0|||
129537315|NCT00351611|466256263|FG000|Overall Study|Adverse Event|11|||
129537316|NCT00351611|466256264|FG001|Overall Study|Adverse Event|3|||
129537317|NCT00351611|466256263|FG000|Overall Study|Death|1|||
129537318|NCT00351611|466256264|FG001|Overall Study|Death|0|||
129537319|NCT00351611|466256263|FG000|Overall Study|Lost to Follow-up|1|||
129537320|NCT00351611|466256264|FG001|Overall Study|Lost to Follow-up|0|||
129537321|NCT00351611|466256263|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
129537322|NCT00351611|466256264|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
129537323|NCT00351611|466256263|FG000|Overall Study|Other|1|||
129537324|NCT00351611|466256264|FG001|Overall Study|Other|0|||
129537325|NCT00351611|466256263|FG000|Overall Study|Protocol Violation|0|||
129537326|NCT00351611|466256264|FG001|Overall Study|Protocol Violation|2|||
129537327|NCT00368069|466256265|FG000|Overall Study|Adverse Event|5|||
129537328|NCT00368069|466256266|FG001|Overall Study|Adverse Event|2|||
129537329|NCT00368069|466256265|FG000|Overall Study|Lack of Efficacy|0|||
129537330|NCT00368069|466256266|FG001|Overall Study|Lack of Efficacy|1|||
129537331|NCT00368069|466256265|FG000|Overall Study|Lost to Follow-up|1|||
129537332|NCT00368069|466256266|FG001|Overall Study|Lost to Follow-up|0|||
129537333|NCT00368069|466256265|FG000|Overall Study|Protocol Violation|0|||
129537334|NCT00368069|466256266|FG001|Overall Study|Protocol Violation|2|||
129537335|NCT00368069|466256265|FG000|Overall Study|Withdrawal of Consent|2|||
129537336|NCT00368069|466256266|FG001|Overall Study|Withdrawal of Consent|1|||
129537337|NCT00368069|466256265|FG000|Overall Study|no blood sampling possible|0|||
129537338|NCT00368069|466256266|FG001|Overall Study|no blood sampling possible|1|||
129537339|NCT03907072|466256270|FG000|Overall Study|Study Terminated by Sponsor|2|||
129537340|NCT03907072|466256271|FG001|Overall Study|Study Terminated by Sponsor|2|||
129537341|NCT03907072|466256272|FG002|Overall Study|Study Terminated by Sponsor|2|||
129537342|NCT01430559|466256275|FG000|Overall Study|Adverse Event|7|||
129537343|NCT01430559|466256276|FG001|Overall Study|Adverse Event|3|||
129537344|NCT01430559|466256275|FG000|Overall Study|Entry criteria not met|1|||
129537345|NCT01430559|466256276|FG001|Overall Study|Entry criteria not met|1|||
129537346|NCT01430559|466256275|FG000|Overall Study|Lost to Follow-up|1|||
129537347|NCT01430559|466256276|FG001|Overall Study|Lost to Follow-up|0|||
129537348|NCT01430559|466256275|FG000|Overall Study|Medication error|1|||
129537349|NCT01430559|466256276|FG001|Overall Study|Medication error|0|||
129537350|NCT01430559|466256275|FG000|Overall Study|Withdrawal by Subject|3|||
129537351|NCT01430559|466256276|FG001|Overall Study|Withdrawal by Subject|2|||
129537352|NCT01430559|466256275|FG000|Overall Study|Protocol Violation|1|||
129537353|NCT01430559|466256276|FG001|Overall Study|Protocol Violation|0|||
129537354|NCT01430559|466256275|FG000|Overall Study|Other|3|||
129537355|NCT01430559|466256276|FG001|Overall Study|Other|3|||
129537356|NCT01430559|466256275|FG000|Overall Study|Randomized, Not Treated|3|||
129537357|NCT01430559|466256276|FG001|Overall Study|Randomized, Not Treated|3|||
129537358|NCT01177943|466256278|FG000|First Intervention|Withdrawal by Subject|2|||
129537359|NCT01177943|466256279|FG001|First Intervention|Withdrawal by Subject|0|||
129537360|NCT00808665|466256280|FG000|Overall Study|Withdrawal by Subject|1|||
129537361|NCT00808665|466256281|FG001|Overall Study|Withdrawal by Subject|0|||
129537362|NCT00808665|466256280|FG000|Overall Study|only required minimally invasive surgery|1|||
129537363|NCT00808665|466256281|FG001|Overall Study|only required minimally invasive surgery|0|||
129537364|NCT00808665|466256280|FG000|Overall Study|surgery cancelled|1|||
129537365|NCT00808665|466256281|FG001|Overall Study|surgery cancelled|0|||
129537366|NCT00808665|466256280|FG000|Overall Study|required an additional procedure|0|||
129537367|NCT00808665|466256281|FG001|Overall Study|required an additional procedure|1|||
129537368|NCT00808665|466256280|FG000|Overall Study|Physician Decision|3|||
129537369|NCT00808665|466256281|FG001|Overall Study|Physician Decision|1|||
129537370|NCT00808665|466256280|FG000|Overall Study|Medication stopped by resident|0|||
129537371|NCT00808665|466256281|FG001|Overall Study|Medication stopped by resident|1|||
129537372|NCT03319160|466256282|FG000|Overall Study|Data not available.|7|||
129537373|NCT00665002|466256283|FG000|Overall Study|Progression/relapse during treatment|11|||
129537374|NCT00665002|466256283|FG000|Overall Study|Cytogenetic resistance|1|||
129537375|NCT01303159|466256291|FG000|Overall Study|Death|16|||
129537376|NCT01303159|466256291|FG000|Overall Study|Study Termination|7|||
129537377|NCT00496782|466256295|FG000|Overall Study|Protocol Violation|1|||
129537378|NCT00496782|466256296|FG001|Overall Study|Protocol Violation|2|||
129537379|NCT01288911|466256297|FG000|Double-blind Period|Death|11|||
129537380|NCT01288911|466256298|FG001|Double-blind Period|Death|7|||
129537381|NCT01288911|466256297|FG000|Double-blind Period|Lost to Follow-up|0|||
129537382|NCT01288911|466256298|FG001|Double-blind Period|Lost to Follow-up|2|||
129537383|NCT01288911|466256297|FG000|Double-blind Period|Progressive Disease|75|||
129537384|NCT01288911|466256298|FG001|Double-blind Period|Progressive Disease|103|||
129537385|NCT01288911|466256297|FG000|Double-blind Period|Protocol Violation|1|||
129537386|NCT01288911|466256298|FG001|Double-blind Period|Protocol Violation|0|||
129537387|NCT01288911|466256297|FG000|Double-blind Period|Withdrawal by Subject|25|||
129537388|NCT01288911|466256298|FG001|Double-blind Period|Withdrawal by Subject|26|||
129537389|NCT01288911|466256297|FG000|Double-blind Period|Miscellaneous Reason|29|||
129537390|NCT01288911|466256298|FG001|Double-blind Period|Miscellaneous Reason|42|||
129537391|NCT01288911|466256297|FG000|Double-blind Period|Randomized but never received study drug|1|||
129537392|NCT01288911|466256298|FG001|Double-blind Period|Randomized but never received study drug|2|||
129537393|NCT01288911|466256297|FG000|Open-label Period (All Enzalutamide)|Death|0|||
129537394|NCT01288911|466256298|FG001|Open-label Period (All Enzalutamide)|Death|1|||
129537395|NCT01288911|466256297|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
129537396|NCT01288911|466256298|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
129537397|NCT01288911|466256297|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
129537398|NCT01288911|466256298|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
129537399|NCT01288911|466256297|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
129537400|NCT01288911|466256298|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
129537401|NCT01288911|466256297|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
129537402|NCT01288911|466256298|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
129537403|NCT01288911|466256297|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
129537404|NCT01288911|466256298|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
129537405|NCT02431559|466256299|FG000|Overall Study|Adverse Event|0|||
129537406|NCT02431559|466256300|FG001|Overall Study|Adverse Event|1|||
129537407|NCT02431559|466256301|FG002|Overall Study|Adverse Event|0|||
129537408|NCT02431559|466256302|FG003|Overall Study|Adverse Event|4|||
129537409|NCT02431559|466256299|FG000|Overall Study|Progressive disease|2|||
129537410|NCT02431559|466256300|FG001|Overall Study|Progressive disease|1|||
129537411|NCT02431559|466256301|FG002|Overall Study|Progressive disease|4|||
129537412|NCT02431559|466256302|FG003|Overall Study|Progressive disease|22|||
129537413|NCT02431559|466256299|FG000|Overall Study|Withdrawal by Subject|0|||
129537414|NCT02431559|466256300|FG001|Overall Study|Withdrawal by Subject|1|||
129537415|NCT02431559|466256301|FG002|Overall Study|Withdrawal by Subject|0|||
129537416|NCT02431559|466256302|FG003|Overall Study|Withdrawal by Subject|4|||
129537417|NCT02431559|466256299|FG000|Overall Study|Physician Decision|0|||
129537418|NCT02431559|466256300|FG001|Overall Study|Physician Decision|0|||
129537419|NCT02431559|466256301|FG002|Overall Study|Physician Decision|0|||
129537420|NCT02431559|466256302|FG003|Overall Study|Physician Decision|1|||
129537421|NCT02543918|466256303|FG000|Overall Study|Never treated|0|||
129537422|NCT02543918|466256304|FG001|Overall Study|Never treated|1|||
129537423|NCT02543918|466256303|FG000|Overall Study|Lost to Follow-up|1|||
129537424|NCT02543918|466256304|FG001|Overall Study|Lost to Follow-up|1|||
129537425|NCT02543918|466256303|FG000|Overall Study|Withdrawal by Subject|1|||
129537426|NCT02543918|466256304|FG001|Overall Study|Withdrawal by Subject|1|||
129537427|NCT02543918|466256303|FG000|Overall Study|Adverse Event|1|||
129537428|NCT02543918|466256304|FG001|Overall Study|Adverse Event|1|||
129537429|NCT01348828|466256307|FG000|Overall Study|Death|20|||
129537430|NCT01348828|466256307|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
129537431|NCT01348828|466256307|FG000|Overall Study|Conversion|2|||
129537432|NCT01348828|466256307|FG000|Overall Study|missed visit|1|||
129537433|NCT00242658|466256310|FG000|Overall Study|Lost to Follow-up|22|||
129537434|NCT00242658|466256311|FG001|Overall Study|Lost to Follow-up|19|||
129537435|NCT01815099|466256312|FG000|Overall Study|Lack of Efficacy|1|||
129537436|NCT01815099|466256312|FG000|Overall Study|unable to attend study visits|1|||
129537437|NCT00643851|466256313|FG000|Overall Study|Death|0|||
129537438|NCT00643851|466256314|FG001|Overall Study|Death|1|||
129537439|NCT00643851|466256315|FG002|Overall Study|Death|0|||
129537440|NCT00643851|466256313|FG000|Overall Study|Lack of Efficacy|0|||
129537441|NCT00643851|466256314|FG001|Overall Study|Lack of Efficacy|1|||
129537442|NCT00643851|466256315|FG002|Overall Study|Lack of Efficacy|0|||
129537443|NCT00643851|466256313|FG000|Overall Study|Adverse Event|2|||
129537444|NCT00643851|466256314|FG001|Overall Study|Adverse Event|6|||
129537445|NCT00643851|466256315|FG002|Overall Study|Adverse Event|6|||
129537446|NCT00643851|466256313|FG000|Overall Study|Lost to Follow-up|4|||
129537447|NCT00643851|466256314|FG001|Overall Study|Lost to Follow-up|6|||
129537448|NCT00643851|466256315|FG002|Overall Study|Lost to Follow-up|9|||
129537449|NCT00643851|466256313|FG000|Overall Study|Withdrawal by Subject|8|||
129537450|NCT00643851|466256314|FG001|Overall Study|Withdrawal by Subject|15|||
129537451|NCT00643851|466256315|FG002|Overall Study|Withdrawal by Subject|9|||
129537452|NCT00643851|466256313|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
129537453|NCT00643851|466256314|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
129537454|NCT00643851|466256315|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
129537455|NCT04806334|466256318|FG000|Overall Study|Withdrawal by Subject|1|||
129537456|NCT04557189|466256319|FG000|Overall Study|Adverse Event|0|||
129537457|NCT04557189|466256320|FG001|Overall Study|Adverse Event|1|||
129537458|NCT04557189|466256319|FG000|Overall Study|Lost to Follow-up|1|||
129537459|NCT04557189|466256320|FG001|Overall Study|Lost to Follow-up|1|||
129537460|NCT04557189|466256319|FG000|Overall Study|Withdrawal by Subject|2|||
129537461|NCT04557189|466256320|FG001|Overall Study|Withdrawal by Subject|1|||
129537462|NCT04557189|466256319|FG000|Overall Study|Reason not Specified|3|||
129537463|NCT04557189|466256320|FG001|Overall Study|Reason not Specified|6|||
129537464|NCT01731600|466256323|FG000|Overall Study|Adverse Event|2|||
129537465|NCT01731600|466256324|FG001|Overall Study|Adverse Event|0|||
129537466|NCT01731600|466256323|FG000|Overall Study|Withdrawal criteria|1|||
129537467|NCT01731600|466256324|FG001|Overall Study|Withdrawal criteria|0|||
129537468|NCT01731600|466256323|FG000|Overall Study|Other reasons|3|||
129537469|NCT01731600|466256324|FG001|Overall Study|Other reasons|0|||
129537470|NCT00465894|466256325|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
129537471|NCT00465894|466256326|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
129537472|NCT00465894|466256325|FG000|Treatment For 12 Weeks|Family Issues|1|||
129537473|NCT00465894|466256326|FG001|Treatment For 12 Weeks|Family Issues|1|||
129537474|NCT00465894|466256325|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
129537475|NCT00465894|466256326|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
129537476|NCT01636076|466256327|FG000|Overall Study|Terminated by sponsor|1|||
129537477|NCT01636076|466256328|FG001|Overall Study|Terminated by sponsor|1|||
129537478|NCT01636076|466256327|FG000|Overall Study|Lack of Efficacy|0|||
129537479|NCT01636076|466256328|FG001|Overall Study|Lack of Efficacy|1|||
129537480|NCT01636076|466256327|FG000|Overall Study|Lost to Follow-up|1|||
129537481|NCT01636076|466256328|FG001|Overall Study|Lost to Follow-up|0|||
129537482|NCT01636076|466256327|FG000|Overall Study|Physician Decision|1|||
129537483|NCT01636076|466256328|FG001|Overall Study|Physician Decision|1|||
129537484|NCT01636076|466256327|FG000|Overall Study|Non-compliance with study treatment|1|||
129537485|NCT01636076|466256328|FG001|Overall Study|Non-compliance with study treatment|1|||
129537486|NCT01636076|466256327|FG000|Overall Study|Adverse Event|6|||
129537487|NCT01636076|466256328|FG001|Overall Study|Adverse Event|11|||
129537488|NCT01636076|466256327|FG000|Overall Study|Withdrawal by Subject|7|||
129537489|NCT01636076|466256328|FG001|Overall Study|Withdrawal by Subject|10|||
129537490|NCT02173158|466256330|FG000|Efficacy Phase|Adverse Event|1|||
129537491|NCT01728454|466256342|FG000|Stage 1 and 2|Pregnancy|1|||
129537492|NCT01728454|466256343|FG001|Stage 1 and 2|Pregnancy|0|||
129537493|NCT01728454|466256344|FG002|Stage 1 and 2|Pregnancy|0|||
129537494|NCT01728454|466256342|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
129537495|NCT01728454|466256343|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
129537496|NCT01728454|466256344|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
129537497|NCT01728454|466256342|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
129537498|NCT01728454|466256343|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
129537499|NCT01728454|466256344|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
129537500|NCT01728454|466256342|FG000|Stage 1 and 2|Lost to Follow-up|1|||
129537501|NCT01728454|466256343|FG001|Stage 1 and 2|Lost to Follow-up|1|||
129537502|NCT01728454|466256344|FG002|Stage 1 and 2|Lost to Follow-up|0|||
129537503|NCT01728454|466256342|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
129537504|NCT01728454|466256343|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
129537505|NCT01728454|466256344|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
129537506|NCT01728454|466256342|FG000|Stage 3|Reason Missing|0|||
129537507|NCT01728454|466256343|FG001|Stage 3|Reason Missing|0|||
129537508|NCT01728454|466256344|FG002|Stage 3|Reason Missing|1|||
129537509|NCT01728454|466256342|FG000|Stage 3|Subject Required Other Treatment|0|||
129537510|NCT01728454|466256343|FG001|Stage 3|Subject Required Other Treatment|1|||
129537511|NCT01728454|466256344|FG002|Stage 3|Subject Required Other Treatment|0|||
129537512|NCT01728454|466256342|FG000|Stage 3|Pregnancy|1|||
129537513|NCT01728454|466256343|FG001|Stage 3|Pregnancy|0|||
129537514|NCT01728454|466256344|FG002|Stage 3|Pregnancy|0|||
129537515|NCT01728454|466256342|FG000|Stage 3|Withdrew Consent|1|||
129537516|NCT01728454|466256343|FG001|Stage 3|Withdrew Consent|0|||
129537517|NCT01728454|466256344|FG002|Stage 3|Withdrew Consent|1|||
129537518|NCT01728454|466256342|FG000|Stage 3|Non-compliance with Protocol|0|||
129537519|NCT01728454|466256343|FG001|Stage 3|Non-compliance with Protocol|0|||
129537520|NCT01728454|466256344|FG002|Stage 3|Non-compliance with Protocol|1|||
129537521|NCT01728454|466256342|FG000|Stage 3|Lost to Follow-up|0|||
129537522|NCT01728454|466256343|FG001|Stage 3|Lost to Follow-up|3|||
129537523|NCT01728454|466256344|FG002|Stage 3|Lost to Follow-up|1|||
129537524|NCT01728454|466256342|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
129537525|NCT01728454|466256343|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
129537526|NCT01728454|466256344|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
129537527|NCT01190839|466256345|FG000|Overall Study|Adverse Event|32|||
129537528|NCT01190839|466256346|FG001|Overall Study|Adverse Event|41|||
129537529|NCT01190839|466256345|FG000|Overall Study|Protocol Violation|2|||
129537530|NCT01190839|466256346|FG001|Overall Study|Protocol Violation|2|||
129537531|NCT01190839|466256345|FG000|Overall Study|Lost to Follow-up|7|||
129537532|NCT01190839|466256346|FG001|Overall Study|Lost to Follow-up|1|||
129537533|NCT01190839|466256345|FG000|Overall Study|Death|1|||
129537534|NCT01190839|466256346|FG001|Overall Study|Death|0|||
129537535|NCT01190839|466256345|FG000|Overall Study|Trial stopped by Sponsor|71|||
129537536|NCT01190839|466256346|FG001|Overall Study|Trial stopped by Sponsor|68|||
129537537|NCT01190839|466256345|FG000|Overall Study|Undefined|35|||
129537538|NCT01190839|466256346|FG001|Overall Study|Undefined|31|||
129537539|NCT01190839|466256345|FG000|Overall Study|Randomized but not treated|2|||
129537540|NCT01190839|466256346|FG001|Overall Study|Randomized but not treated|4|||
129537541|NCT00508820|466256348|FG000|Overall Study|Adverse Event|6|||
129537542|NCT00508820|466256349|FG001|Overall Study|Adverse Event|10|||
129537543|NCT00508820|466256348|FG000|Overall Study|Death|6|||
129537544|NCT00508820|466256349|FG001|Overall Study|Death|8|||
129537545|NCT00508820|466256348|FG000|Overall Study|Lost to Follow-up|1|||
129537546|NCT00508820|466256349|FG001|Overall Study|Lost to Follow-up|1|||
129537547|NCT00508820|466256348|FG000|Overall Study|Physician Decision|8|||
129537548|NCT00508820|466256349|FG001|Overall Study|Physician Decision|2|||
129537549|NCT00508820|466256348|FG000|Overall Study|Pregnancy|0|||
129537550|NCT00508820|466256349|FG001|Overall Study|Pregnancy|2|||
129537551|NCT00508820|466256348|FG000|Overall Study|Protocol Violation|2|||
129537552|NCT00508820|466256349|FG001|Overall Study|Protocol Violation|0|||
129537553|NCT00508820|466256348|FG000|Overall Study|Withdrawal by Subject|10|||
129537554|NCT00508820|466256349|FG001|Overall Study|Withdrawal by Subject|12|||
129537555|NCT00508820|466256348|FG000|Overall Study|Other|11|||
129537556|NCT00508820|466256349|FG001|Overall Study|Other|2|||
129537557|NCT00508820|466256348|FG000|Overall Study|Noncompliance|1|||
129537558|NCT00508820|466256349|FG001|Overall Study|Noncompliance|0|||
129537559|NCT00508820|466256348|FG000|Overall Study|Requirement for alternative therapy|7|||
129537560|NCT00508820|466256349|FG001|Overall Study|Requirement for alternative therapy|15|||
129537561|NCT00508820|466256348|FG000|Overall Study|Protocol-specified Criteria|3|||
129537562|NCT00508820|466256349|FG001|Overall Study|Protocol-specified Criteria|12|||
129537563|NCT02926833|466258337|FG000|Overall Study|Death|1|||
129537564|NCT02926833|466258338|FG001|Overall Study|Death|1|||
129537565|NCT02926833|466258339|FG002|Overall Study|Death|2|||
129537566|NCT02926833|466258340|FG003|Overall Study|Death|13|||
129537567|NCT02926833|466258337|FG000|Overall Study|Lost to Follow-up|1|||
129537568|NCT02926833|466258338|FG001|Overall Study|Lost to Follow-up|2|||
129537569|NCT02926833|466258339|FG002|Overall Study|Lost to Follow-up|0|||
129537570|NCT02926833|466258340|FG003|Overall Study|Lost to Follow-up|3|||
129537571|NCT02926833|466258337|FG000|Overall Study|Full Consent Withdrawal|0|||
129537572|NCT02926833|466258338|FG001|Overall Study|Full Consent Withdrawal|0|||
129537573|NCT02926833|466258339|FG002|Overall Study|Full Consent Withdrawal|0|||
129537574|NCT02926833|466258340|FG003|Overall Study|Full Consent Withdrawal|2|||
129537575|NCT02926833|466258337|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
129537576|NCT02926833|466258338|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
129537577|NCT02926833|466258339|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
129537578|NCT02926833|466258340|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
129537579|NCT02926833|466258337|FG000|Overall Study|Investigator Decision|0|||
129537580|NCT02926833|466258338|FG001|Overall Study|Investigator Decision|1|||
129537581|NCT02926833|466258339|FG002|Overall Study|Investigator Decision|0|||
129537582|NCT02926833|466258340|FG003|Overall Study|Investigator Decision|0|||
129537583|NCT02926833|466258337|FG000|Overall Study|Adverse Event|0|||
129537584|NCT02926833|466258338|FG001|Overall Study|Adverse Event|0|||
129537585|NCT02926833|466258339|FG002|Overall Study|Adverse Event|1|||
129537586|NCT02926833|466258340|FG003|Overall Study|Adverse Event|0|||
129537587|NCT02926833|466258337|FG000|Overall Study|Partial Withdrawal of Consent|0|||
129537588|NCT02926833|466258338|FG001|Overall Study|Partial Withdrawal of Consent|0|||
129537589|NCT02926833|466258339|FG002|Overall Study|Partial Withdrawal of Consent|0|||
129537590|NCT02926833|466258340|FG003|Overall Study|Partial Withdrawal of Consent|1|||
129537591|NCT01189201|466258343|FG000|Overall Study|Adverse Event|1|||
129537592|NCT01277757|466258344|FG000|Overall Study|Disease Progression|1|||
129537593|NCT01277757|466258344|FG000|Overall Study|Withdrawal by Subject|1|||
129537594|NCT04308668|466258345|FG000|Overall Study|Lost to Follow-up|32|||
129537595|NCT04308668|466258346|FG001|Overall Study|Lost to Follow-up|38|||
129537596|NCT04308668|466258345|FG000|Overall Study|Withdrawal by Subject|4|||
129537597|NCT04308668|466258346|FG001|Overall Study|Withdrawal by Subject|4|||
129537598|NCT03808298|466258347|FG000|Overall Study|Adverse Event|3|||
129537599|NCT03808298|466258347|FG000|Overall Study|Physician Decision|1|||
129537600|NCT03808298|466258347|FG000|Overall Study|Withdrawal by Subject|1|||
129537601|NCT03808298|466258347|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
129537602|NCT01674010|466258348|FG000|Open Treatment Phase 1|Adverse Event|10|||
129537603|NCT01674010|466258349|FG001|Open Treatment Phase 1|Adverse Event|0|||
129537604|NCT01674010|466258350|FG002|Open Treatment Phase 1|Adverse Event|0|||
129537605|NCT01674010|466258348|FG000|Open Treatment Phase 1|Death|1|||
129537606|NCT01674010|466258349|FG001|Open Treatment Phase 1|Death|0|||
129537607|NCT01674010|466258350|FG002|Open Treatment Phase 1|Death|0|||
129537608|NCT01674010|466258348|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
129537609|NCT01674010|466258349|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
129537610|NCT01674010|466258350|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
129537611|NCT01674010|466258348|FG000|Open Treatment Phase 1|Physician Decision|9|||
129537612|NCT01674010|466258349|FG001|Open Treatment Phase 1|Physician Decision|0|||
129537613|NCT01674010|466258350|FG002|Open Treatment Phase 1|Physician Decision|0|||
129537614|NCT01674010|466258348|FG000|Open Treatment Phase 1|Protocol Violation|7|||
129537615|NCT01674010|466258349|FG001|Open Treatment Phase 1|Protocol Violation|0|||
129537616|NCT01674010|466258350|FG002|Open Treatment Phase 1|Protocol Violation|0|||
129537617|NCT01674010|466258348|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
129537618|NCT01674010|466258349|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
129537619|NCT01674010|466258350|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
129537620|NCT01674010|466258348|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
129537621|NCT01674010|466258349|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
129537622|NCT01674010|466258350|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
129537623|NCT01674010|466258348|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
129537624|NCT01674010|466258349|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
129537625|NCT01674010|466258350|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
129537626|NCT01674010|466258348|FG000|Randomization Phase 2|Adverse Event|0|||
129537627|NCT01674010|466258349|FG001|Randomization Phase 2|Adverse Event|1|||
129537628|NCT01674010|466258350|FG002|Randomization Phase 2|Adverse Event|1|||
129537629|NCT01674010|466258348|FG000|Randomization Phase 2|Lost to Follow-up|0|||
129537630|NCT01674010|466258349|FG001|Randomization Phase 2|Lost to Follow-up|1|||
129537631|NCT01674010|466258350|FG002|Randomization Phase 2|Lost to Follow-up|2|||
129537632|NCT01674010|466258348|FG000|Randomization Phase 2|Mood episode recurrence|0|||
129537633|NCT01674010|466258349|FG001|Randomization Phase 2|Mood episode recurrence|8|||
129537634|NCT01674010|466258350|FG002|Randomization Phase 2|Mood episode recurrence|2|||
129537635|NCT01674010|466258348|FG000|Randomization Phase 2|Physician Decision|0|||
129537636|NCT01674010|466258349|FG001|Randomization Phase 2|Physician Decision|0|||
129537637|NCT01674010|466258350|FG002|Randomization Phase 2|Physician Decision|2|||
129537638|NCT01674010|466258348|FG000|Randomization Phase 2|Pregnancy|0|||
129537639|NCT01674010|466258349|FG001|Randomization Phase 2|Pregnancy|1|||
129537640|NCT01674010|466258350|FG002|Randomization Phase 2|Pregnancy|1|||
129537641|NCT01674010|466258348|FG000|Randomization Phase 2|Protocol Violation|0|||
129537642|NCT01674010|466258349|FG001|Randomization Phase 2|Protocol Violation|1|||
129537643|NCT01674010|466258350|FG002|Randomization Phase 2|Protocol Violation|1|||
129537644|NCT01674010|466258348|FG000|Randomization Phase 2|Sponsor Decision|0|||
129537645|NCT01674010|466258349|FG001|Randomization Phase 2|Sponsor Decision|42|||
129537646|NCT01674010|466258350|FG002|Randomization Phase 2|Sponsor Decision|45|||
129537647|NCT01674010|466258348|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
129537648|NCT01674010|466258349|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
129537649|NCT01674010|466258350|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
129537650|NCT01801475|466258354|FG000|Overall Study|Withdrawal by Subject|0|||
129537651|NCT01801475|466258355|FG001|Overall Study|Withdrawal by Subject|0|||
129537652|NCT01801475|466258356|FG002|Overall Study|Withdrawal by Subject|0|||
129537653|NCT01801475|466258357|FG003|Overall Study|Withdrawal by Subject|0|||
129537654|NCT01801475|466258358|FG004|Overall Study|Withdrawal by Subject|1|||
129537655|NCT00421928|466258359|FG000|Overall Study|Adverse Event|61|||
129537656|NCT00421928|466258360|FG001|Overall Study|Adverse Event|140|||
129537657|NCT00421928|466258361|FG002|Overall Study|Adverse Event|22|||
129537658|NCT00421928|466258359|FG000|Overall Study|Lost to Follow-up|5|||
129537659|NCT00421928|466258360|FG001|Overall Study|Lost to Follow-up|0|||
129537660|NCT00421928|466258361|FG002|Overall Study|Lost to Follow-up|3|||
129537661|NCT00421928|466258359|FG000|Overall Study|Withdrawal by Subject|50|||
129537662|NCT00421928|466258360|FG001|Overall Study|Withdrawal by Subject|48|||
129537663|NCT00421928|466258361|FG002|Overall Study|Withdrawal by Subject|43|||
129537664|NCT00421928|466258359|FG000|Overall Study|Lack of Efficacy|15|||
129537665|NCT00421928|466258360|FG001|Overall Study|Lack of Efficacy|7|||
129537666|NCT00421928|466258361|FG002|Overall Study|Lack of Efficacy|35|||
129537667|NCT00421928|466258359|FG000|Overall Study|Study drug non-compliant|6|||
129537668|NCT00421928|466258360|FG001|Overall Study|Study drug non-compliant|7|||
129537669|NCT00421928|466258361|FG002|Overall Study|Study drug non-compliant|4|||
129537670|NCT00421928|466258359|FG000|Overall Study|All other|26|||
129537671|NCT00421928|466258360|FG001|Overall Study|All other|21|||
129537672|NCT00421928|466258361|FG002|Overall Study|All other|27|||
129537673|NCT00421928|466258359|FG000|Overall Study|Death|0|||
129537674|NCT00421928|466258360|FG001|Overall Study|Death|1|||
129537675|NCT00421928|466258361|FG002|Overall Study|Death|0|||
129537676|NCT05056311|466258368|FG000|Overall Study|Lost to Follow-up|14|||
129537677|NCT05056311|466258368|FG000|Overall Study|Withdrawal by Subject|1|||
129537678|NCT05056311|466258368|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
129537679|NCT02713490|466258369|FG000|Overall Study|Withdrawal by Subject|2|||
129537680|NCT02713490|466258370|FG001|Overall Study|Withdrawal by Subject|1|||
129537681|NCT02713490|466258369|FG000|Overall Study|Did not receive study drug|1|||
129537682|NCT02713490|466258370|FG001|Overall Study|Did not receive study drug|0|||
129537683|NCT02713490|466258369|FG000|Overall Study|Met exclusion criteria|0|||
129537684|NCT02713490|466258370|FG001|Overall Study|Met exclusion criteria|1|||
129537685|NCT00346775|466258371|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
129537686|NCT00346775|466258372|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
129537687|NCT00346775|466258371|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
129537688|NCT00346775|466258372|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
129537689|NCT00346775|466258371|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
129537690|NCT00346775|466258372|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
129537691|NCT02946515|466258373|FG000|Overall Study|Lost to Follow-up|2|||
129537692|NCT02946515|466258374|FG001|Overall Study|Lost to Follow-up|1|||
129537693|NCT03799198|466258375|FG000|Overall Study|Lost to Follow-up|4|||
129537694|NCT03799198|466258376|FG001|Overall Study|Lost to Follow-up|8|||
129537695|NCT03799198|466258375|FG000|Overall Study|Death|0|||
129537696|NCT03799198|466258376|FG001|Overall Study|Death|1|||
129537697|NCT00960869|466258380|FG000|Overall Study|Adverse Event|17|||
129537698|NCT00960869|466258381|FG001|Overall Study|Adverse Event|26|||
129537699|NCT00960869|466258380|FG000|Overall Study|Withdrawal by Subject|16|||
129537700|NCT00960869|466258381|FG001|Overall Study|Withdrawal by Subject|14|||
129537701|NCT00960869|466258380|FG000|Overall Study|Lost to Follow-up|1|||
129537702|NCT00960869|466258381|FG001|Overall Study|Lost to Follow-up|4|||
129537703|NCT00960869|466258380|FG000|Overall Study|Misc|19|||
129537704|NCT00960869|466258381|FG001|Overall Study|Misc|18|||
129537705|NCT01714726|466258382|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
129537706|NCT01714726|466258383|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
129537707|NCT01714726|466258384|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
129537708|NCT01714726|466258385|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
129537709|NCT01714726|466258382|FG000|Double-Blinded Induction Period|Adverse Event|0|||
129537710|NCT01714726|466258383|FG001|Double-Blinded Induction Period|Adverse Event|1|||
129537711|NCT01714726|466258384|FG002|Double-Blinded Induction Period|Adverse Event|0|||
129537712|NCT01714726|466258385|FG003|Double-Blinded Induction Period|Adverse Event|0|||
129537713|NCT01714726|466258382|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
129537714|NCT01714726|466258383|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
129537715|NCT01714726|466258384|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
129537716|NCT01714726|466258385|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
129537717|NCT01714726|466258382|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
129537718|NCT01714726|466258383|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
129537719|NCT01714726|466258384|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
129537720|NCT01714726|466258385|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
129537721|NCT01714726|466258382|FG000|Open-Label Period|Other|0|||
129537722|NCT01714726|466258383|FG001|Open-Label Period|Other|0|||
129537723|NCT01714726|466258384|FG002|Open-Label Period|Other|1|||
129537724|NCT01714726|466258385|FG003|Open-Label Period|Other|3|||
129537725|NCT01714726|466258382|FG000|Open-Label Period|Adverse Event|0|||
129537726|NCT01714726|466258383|FG001|Open-Label Period|Adverse Event|0|||
129537727|NCT01714726|466258384|FG002|Open-Label Period|Adverse Event|1|||
129537728|NCT01714726|466258385|FG003|Open-Label Period|Adverse Event|0|||
129537729|NCT01714726|466258382|FG000|Open-Label Period|Withdrawal by Subject|0|||
129537730|NCT01714726|466258383|FG001|Open-Label Period|Withdrawal by Subject|0|||
129537731|NCT01714726|466258384|FG002|Open-Label Period|Withdrawal by Subject|9|||
129537732|NCT01714726|466258385|FG003|Open-Label Period|Withdrawal by Subject|19|||
129537733|NCT01714726|466258382|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
129537734|NCT01714726|466258383|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
129537735|NCT01714726|466258384|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
129537736|NCT01714726|466258385|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
129537737|NCT01714726|466258382|FG000|Open-Label Period|Lost to Follow-up|0|||
129537738|NCT01714726|466258383|FG001|Open-Label Period|Lost to Follow-up|0|||
129537739|NCT01714726|466258384|FG002|Open-Label Period|Lost to Follow-up|3|||
129537740|NCT01714726|466258385|FG003|Open-Label Period|Lost to Follow-up|4|||
129537741|NCT00548340|466258388|FG000|Overall Study|Protocol Violation|2|||
129537742|NCT00548340|466258389|FG001|Overall Study|Protocol Violation|3|||
129537743|NCT00548340|466258390|FG002|Overall Study|Protocol Violation|3|||
129537744|NCT00548340|466258388|FG000|Overall Study|Adverse Event|2|||
129537745|NCT00548340|466258389|FG001|Overall Study|Adverse Event|2|||
129537746|NCT00548340|466258390|FG002|Overall Study|Adverse Event|2|||
129537747|NCT00548340|466258388|FG000|Overall Study|Lost to Follow-up|1|||
129537748|NCT00548340|466258389|FG001|Overall Study|Lost to Follow-up|1|||
129537749|NCT00548340|466258390|FG002|Overall Study|Lost to Follow-up|0|||
129537750|NCT00548340|466258388|FG000|Overall Study|Withdrawal by Subject|2|||
129537751|NCT00548340|466258389|FG001|Overall Study|Withdrawal by Subject|4|||
129537752|NCT00548340|466258390|FG002|Overall Study|Withdrawal by Subject|3|||
129537753|NCT00548340|466258388|FG000|Overall Study|Other|1|||
129537754|NCT00548340|466258389|FG001|Overall Study|Other|1|||
129537755|NCT00548340|466258390|FG002|Overall Study|Other|1|||
129537756|NCT01096017|466258391|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
129537757|NCT01096017|466258392|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
129537758|NCT01399619|466258400|FG000|Overall Study|Adverse Event|10|||
129537759|NCT01399619|466258401|FG001|Overall Study|Adverse Event|0|||
129537760|NCT01399619|466258402|FG002|Overall Study|Adverse Event|4|||
129537761|NCT01399619|466258403|FG003|Overall Study|Adverse Event|10|||
129537762|NCT01399619|466258400|FG000|Overall Study|Lack of Efficacy|9|||
129537763|NCT01399619|466258401|FG001|Overall Study|Lack of Efficacy|0|||
129537764|NCT01399619|466258402|FG002|Overall Study|Lack of Efficacy|5|||
129537765|NCT01399619|466258403|FG003|Overall Study|Lack of Efficacy|0|||
129537766|NCT01399619|466258400|FG000|Overall Study|Withdrawal by Subject|6|||
129537767|NCT01399619|466258401|FG001|Overall Study|Withdrawal by Subject|0|||
129537768|NCT01399619|466258402|FG002|Overall Study|Withdrawal by Subject|3|||
129537769|NCT01399619|466258403|FG003|Overall Study|Withdrawal by Subject|4|||
129537770|NCT01399619|466258400|FG000|Overall Study|Protocol Violation|0|||
129537771|NCT01399619|466258401|FG001|Overall Study|Protocol Violation|0|||
129537772|NCT01399619|466258402|FG002|Overall Study|Protocol Violation|0|||
129537773|NCT01399619|466258403|FG003|Overall Study|Protocol Violation|1|||
129537774|NCT01399619|466258400|FG000|Overall Study|Not treated|0|||
129537775|NCT01399619|466258401|FG001|Overall Study|Not treated|0|||
129537776|NCT01399619|466258402|FG002|Overall Study|Not treated|0|||
129537777|NCT01399619|466258403|FG003|Overall Study|Not treated|2|||
129537778|NCT00998166|466258404|FG000|Overall Study|Early Study Termination|8|||
129537779|NCT00408408|466258405|FG000|Overall Study|No follow up data|2|||
129537780|NCT00408408|466258406|FG001|Overall Study|No follow up data|3|||
129537781|NCT00408408|466258407|FG002|Overall Study|No follow up data|0|||
129537782|NCT00408408|466258408|FG003|Overall Study|No follow up data|7|||
129537783|NCT00408408|466258409|FG004|Overall Study|No follow up data|5|||
129537784|NCT00408408|466258410|FG005|Overall Study|No follow up data|3|||
129537785|NCT00267202|466258413|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
129537786|NCT00267202|466258414|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
129537787|NCT00267202|466258413|FG000|Overall Study|Withdrawal by Subject|12|||
129537788|NCT00267202|466258414|FG001|Overall Study|Withdrawal by Subject|15|||
129537789|NCT00267202|466258413|FG000|Overall Study|Adverse Event|13|||
129537790|NCT00267202|466258414|FG001|Overall Study|Adverse Event|7|||
129537791|NCT00267202|466258413|FG000|Overall Study|Protocol Violation|2|||
129537792|NCT00267202|466258414|FG001|Overall Study|Protocol Violation|3|||
129537793|NCT00267202|466258413|FG000|Overall Study|Administrative problems|2|||
129537794|NCT00267202|466258414|FG001|Overall Study|Administrative problems|1|||
129537795|NCT00267202|466258413|FG000|Overall Study|Lost to Follow-up|3|||
129537796|NCT00267202|466258414|FG001|Overall Study|Lost to Follow-up|0|||
129537797|NCT00612456|466258417|FG000|Overall Study|Adverse Event|1|||
129537798|NCT00612456|466258418|FG001|Overall Study|Adverse Event|0|||
129537799|NCT00612456|466258419|FG002|Overall Study|Adverse Event|0|||
129537800|NCT00612456|466258417|FG000|Overall Study|Lack of Efficacy|1|||
129537801|NCT00612456|466258418|FG001|Overall Study|Lack of Efficacy|1|||
129537802|NCT00612456|466258419|FG002|Overall Study|Lack of Efficacy|0|||
129537803|NCT00612456|466258417|FG000|Overall Study|Withdrawal by Subject|0|||
129537804|NCT00612456|466258418|FG001|Overall Study|Withdrawal by Subject|1|||
129537805|NCT00612456|466258419|FG002|Overall Study|Withdrawal by Subject|0|||
129537806|NCT00265109|466258420|FG000|Overall Study|Withdrawal by Subject|5|||
129537807|NCT00265109|466258420|FG000|Overall Study|Adverse Event|1|||
129537808|NCT00920582|466258421|FG000|Overall Study|Lost to Follow-up|5|||
129537809|NCT00920582|466258422|FG001|Overall Study|Lost to Follow-up|1|||
129537810|NCT00920582|466258423|FG002|Overall Study|Lost to Follow-up|2|||
129537811|NCT00920582|466258424|FG003|Overall Study|Lost to Follow-up|0|||
129537812|NCT00920582|466258421|FG000|Overall Study|Withdrawal by Subject|5|||
129537813|NCT00920582|466258422|FG001|Overall Study|Withdrawal by Subject|4|||
129537814|NCT00920582|466258423|FG002|Overall Study|Withdrawal by Subject|6|||
129537815|NCT00920582|466258424|FG003|Overall Study|Withdrawal by Subject|3|||
129537816|NCT00920582|466258421|FG000|Overall Study|Protocol Violation|1|||
129537817|NCT00920582|466258422|FG001|Overall Study|Protocol Violation|0|||
129537818|NCT00920582|466258423|FG002|Overall Study|Protocol Violation|0|||
129537819|NCT00920582|466258424|FG003|Overall Study|Protocol Violation|0|||
129537820|NCT00920582|466258421|FG000|Overall Study|Other|2|||
129537821|NCT00920582|466258422|FG001|Overall Study|Other|1|||
129537822|NCT00920582|466258423|FG002|Overall Study|Other|3|||
129537823|NCT00920582|466258424|FG003|Overall Study|Other|2|||
129537824|NCT03457701|466258427|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
129537825|NCT03457701|466258428|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
129537826|NCT03457701|466258427|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
129537827|NCT03457701|466258428|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
129537828|NCT02243306|466258429|FG000|Overall Study|Adverse Event|0|||
129537829|NCT02243306|466258430|FG001|Overall Study|Adverse Event|1|||
129537830|NCT02243306|466258429|FG000|Overall Study|Other: Reached stopping criteria|0|||
129537831|NCT02243306|466258430|FG001|Overall Study|Other: Reached stopping criteria|1|||
129537832|NCT02243306|466258429|FG000|Overall Study|Physician Decision|0|||
129537833|NCT02243306|466258430|FG001|Overall Study|Physician Decision|1|||
129537834|NCT00606931|466258434|FG000|Overall Study|Withdrawal by Subject|3|||
129537835|NCT02924129|466258448|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
129537836|NCT02924129|466258449|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
129537837|NCT02924129|466258448|FG000|Overall Study|Withdrawal by Subject|2|||
129537838|NCT02924129|466258449|FG001|Overall Study|Withdrawal by Subject|2|||
129537839|NCT02924129|466258448|FG000|Overall Study|Physician Decision|1|||
129537840|NCT02924129|466258449|FG001|Overall Study|Physician Decision|0|||
129537841|NCT02924129|466258448|FG000|Overall Study|Missed Visit|0|||
129537842|NCT02924129|466258449|FG001|Overall Study|Missed Visit|1|||
129537843|NCT00302731|466258454|FG000|Overall Study|Lost to Follow-up|1|||
129537844|NCT00302731|466258455|FG001|Overall Study|Lost to Follow-up|2|||
129537845|NCT00302731|466258456|FG002|Overall Study|Lost to Follow-up|0|||
129537846|NCT00302731|466258457|FG003|Overall Study|Lost to Follow-up|0|||
129537847|NCT00302731|466258454|FG000|Overall Study|Adverse Event|0|||
129537848|NCT00302731|466258455|FG001|Overall Study|Adverse Event|2|||
129537849|NCT00302731|466258456|FG002|Overall Study|Adverse Event|2|||
129537850|NCT00302731|466258457|FG003|Overall Study|Adverse Event|0|||
129537851|NCT00302731|466258454|FG000|Overall Study|Withdrawal by Subject|1|||
129537852|NCT00302731|466258455|FG001|Overall Study|Withdrawal by Subject|1|||
129537853|NCT00302731|466258456|FG002|Overall Study|Withdrawal by Subject|0|||
129537854|NCT00302731|466258457|FG003|Overall Study|Withdrawal by Subject|0|||
129537855|NCT00302731|466258454|FG000|Overall Study|Protocol Violation|1|||
129537856|NCT00302731|466258455|FG001|Overall Study|Protocol Violation|0|||
129537857|NCT00302731|466258456|FG002|Overall Study|Protocol Violation|0|||
129537858|NCT00302731|466258457|FG003|Overall Study|Protocol Violation|0|||
129537859|NCT00302731|466258454|FG000|Overall Study|cancer unrelated to study discovered|1|||
129537860|NCT00302731|466258455|FG001|Overall Study|cancer unrelated to study discovered|0|||
129537861|NCT00302731|466258456|FG002|Overall Study|cancer unrelated to study discovered|1|||
129537862|NCT00302731|466258457|FG003|Overall Study|cancer unrelated to study discovered|0|||
129537863|NCT01000311|466258458|FG000|Overall Study|Adverse Event|2|||
129537864|NCT01000311|466258459|FG001|Overall Study|Adverse Event|5|||
129537865|NCT01000311|466258458|FG000|Overall Study|Withdrawal by Subject|16|||
129537866|NCT01000311|466258459|FG001|Overall Study|Withdrawal by Subject|24|||
129537867|NCT01000311|466258458|FG000|Overall Study|Lost to Follow-up|15|||
129537868|NCT01000311|466258459|FG001|Overall Study|Lost to Follow-up|24|||
129537869|NCT01000311|466258458|FG000|Overall Study|Protocol Violation|1|||
129537870|NCT01000311|466258459|FG001|Overall Study|Protocol Violation|2|||
129537871|NCT01000311|466258458|FG000|Overall Study|Inappropriate enrollment|2|||
129537872|NCT01000311|466258459|FG001|Overall Study|Inappropriate enrollment|0|||
129537873|NCT01000311|466258458|FG000|Overall Study|Administrative reason|9|||
129537874|NCT01000311|466258459|FG001|Overall Study|Administrative reason|15|||
129537875|NCT01610752|466258462|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
129537876|NCT01610752|466258463|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
129538912|NCT01238861|466265107|FG000|Overall Study|Unplanned surgery|1|||
129537877|NCT01610752|466258464|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
129537878|NCT01411917|466258465|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
129537879|NCT01411917|466258466|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
129537880|NCT02815670|466258467|FG000|Overall Study|Prematurely discontinued of the trial|1|||
129537881|NCT02354599|466258473|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
129537882|NCT02354599|466258474|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
129537883|NCT02354599|466258475|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
129537884|NCT02354599|466258476|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
129537885|NCT02354599|466258477|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
129537886|NCT02354599|466258478|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
129537887|NCT02354599|466258473|FG000|Overall Study|Withdrawal by Subject|1|||
129537888|NCT02354599|466258474|FG001|Overall Study|Withdrawal by Subject|1|||
129537889|NCT02354599|466258475|FG002|Overall Study|Withdrawal by Subject|0|||
129537890|NCT02354599|466258476|FG003|Overall Study|Withdrawal by Subject|0|||
129537891|NCT02354599|466258477|FG004|Overall Study|Withdrawal by Subject|0|||
129537892|NCT02354599|466258478|FG005|Overall Study|Withdrawal by Subject|0|||
129537893|NCT01087944|466258498|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
129537894|NCT01087944|466258499|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
129537895|NCT01087944|466258498|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
129537896|NCT01087944|466258499|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
129537897|NCT01159665|466258500|FG000|Overall Study|Withdrawal by Subject|0|||
129537898|NCT01159665|466258501|FG001|Overall Study|Withdrawal by Subject|1|||
129537899|NCT01159665|466258502|FG002|Overall Study|Withdrawal by Subject|0|||
129537900|NCT01159665|466258503|FG003|Overall Study|Withdrawal by Subject|0|||
129537901|NCT01159665|466258504|FG004|Overall Study|Withdrawal by Subject|0|||
129537902|NCT01159665|466258505|FG005|Overall Study|Withdrawal by Subject|0|||
129537903|NCT00540228|466258507|FG000|Overall Study|Adverse Event|2|||
129537904|NCT00540228|466258508|FG001|Overall Study|Adverse Event|0|||
129537905|NCT00540228|466258509|FG002|Overall Study|Adverse Event|0|||
129537906|NCT00540228|466258510|FG003|Overall Study|Adverse Event|0|||
129537907|NCT00540228|466258511|FG004|Overall Study|Adverse Event|0|||
129537908|NCT00540228|466258507|FG000|Overall Study|Lost to Follow-up|1|||
129537909|NCT00540228|466258508|FG001|Overall Study|Lost to Follow-up|1|||
129537910|NCT00540228|466258509|FG002|Overall Study|Lost to Follow-up|0|||
129537911|NCT00540228|466258510|FG003|Overall Study|Lost to Follow-up|0|||
129537912|NCT00540228|466258511|FG004|Overall Study|Lost to Follow-up|0|||
129537913|NCT01377194|466258512|FG000|Overall Study|Adverse Event|3|||
129537914|NCT01377194|466258513|FG001|Overall Study|Adverse Event|12|||
129537915|NCT01377194|466258514|FG002|Overall Study|Adverse Event|19|||
129537916|NCT01377194|466258512|FG000|Overall Study|Lack of Efficacy|3|||
129537917|NCT01377194|466258513|FG001|Overall Study|Lack of Efficacy|3|||
129537918|NCT01377194|466258514|FG002|Overall Study|Lack of Efficacy|3|||
129537919|NCT01377194|466258512|FG000|Overall Study|Protocol Violation|4|||
129537920|NCT01377194|466258513|FG001|Overall Study|Protocol Violation|10|||
129537921|NCT01377194|466258514|FG002|Overall Study|Protocol Violation|6|||
129537922|NCT01377194|466258512|FG000|Overall Study|Withdrawal by Subject|8|||
129537923|NCT01377194|466258513|FG001|Overall Study|Withdrawal by Subject|10|||
129537924|NCT01377194|466258514|FG002|Overall Study|Withdrawal by Subject|7|||
129537925|NCT01377194|466258512|FG000|Overall Study|Lost to Follow-up|14|||
129537926|NCT01377194|466258513|FG001|Overall Study|Lost to Follow-up|8|||
129537927|NCT01377194|466258514|FG002|Overall Study|Lost to Follow-up|11|||
129537928|NCT02451137|466258517|FG000|Overall Study|Randomized but not treated|19|||
129537929|NCT02451137|466258518|FG001|Overall Study|Randomized but not treated|27|||
129537930|NCT02451137|466258517|FG000|Overall Study|Adverse Event|43|||
129537931|NCT02451137|466258518|FG001|Overall Study|Adverse Event|42|||
129537932|NCT02451137|466258517|FG000|Overall Study|Lack of Efficacy|4|||
129537933|NCT02451137|466258518|FG001|Overall Study|Lack of Efficacy|9|||
129537934|NCT02451137|466258517|FG000|Overall Study|Participant decision:discontinue insulin|41|||
129537935|NCT02451137|466258518|FG001|Overall Study|Participant decision:discontinue insulin|43|||
129537936|NCT02451137|466258517|FG000|Overall Study|Hypoglycemia|2|||
129537937|NCT02451137|466258518|FG001|Overall Study|Hypoglycemia|1|||
129537938|NCT02451137|466258517|FG000|Overall Study|Investigator's decision|23|||
129537939|NCT02451137|466258518|FG001|Overall Study|Investigator's decision|19|||
129537940|NCT02451137|466258517|FG000|Overall Study|Lost to Follow-up|53|||
129537941|NCT02451137|466258518|FG001|Overall Study|Lost to Follow-up|61|||
129537942|NCT02451137|466258517|FG000|Overall Study|Physician Decision|6|||
129537943|NCT02451137|466258518|FG001|Overall Study|Physician Decision|5|||
129537944|NCT02451137|466258517|FG000|Overall Study|Sponsor decision|13|||
129537945|NCT02451137|466258518|FG001|Overall Study|Sponsor decision|25|||
129537946|NCT02451137|466258517|FG000|Overall Study|Withdrawal by Subject|40|||
129537947|NCT02451137|466258518|FG001|Overall Study|Withdrawal by Subject|63|||
129537948|NCT02451137|466258517|FG000|Overall Study|Other than specified above|2|||
129537949|NCT02451137|466258518|FG001|Overall Study|Other than specified above|3|||
129537950|NCT01977573|466258521|FG000|Overall Study|Adverse Event|7|||
129537951|NCT01977573|466258522|FG001|Overall Study|Adverse Event|0|||
129537952|NCT01977573|466258523|FG002|Overall Study|Adverse Event|2|||
129537953|NCT01977573|466258524|FG003|Overall Study|Adverse Event|1|||
129537954|NCT01977573|466258521|FG000|Overall Study|Lost to Follow-up|1|||
129537955|NCT01977573|466258522|FG001|Overall Study|Lost to Follow-up|0|||
129537956|NCT01977573|466258523|FG002|Overall Study|Lost to Follow-up|0|||
129537957|NCT01977573|466258524|FG003|Overall Study|Lost to Follow-up|1|||
129537958|NCT01977573|466258521|FG000|Overall Study|Physician Decision|1|||
129537959|NCT01977573|466258522|FG001|Overall Study|Physician Decision|0|||
129537960|NCT01977573|466258523|FG002|Overall Study|Physician Decision|0|||
129537961|NCT01977573|466258524|FG003|Overall Study|Physician Decision|0|||
129537962|NCT01977573|466258521|FG000|Overall Study|Protocol Violation|3|||
129537963|NCT01977573|466258522|FG001|Overall Study|Protocol Violation|1|||
129537964|NCT01977573|466258523|FG002|Overall Study|Protocol Violation|0|||
129537965|NCT01977573|466258524|FG003|Overall Study|Protocol Violation|0|||
129537966|NCT01977573|466258521|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
129537967|NCT01977573|466258522|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
129537968|NCT01977573|466258523|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
129537969|NCT01977573|466258524|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
129537970|NCT01977573|466258521|FG000|Overall Study|Withdrawal by Subject|6|||
129537971|NCT01977573|466258522|FG001|Overall Study|Withdrawal by Subject|1|||
129537972|NCT01977573|466258523|FG002|Overall Study|Withdrawal by Subject|1|||
129537973|NCT01977573|466258524|FG003|Overall Study|Withdrawal by Subject|1|||
129537974|NCT01266967|466260147|FG000|Overall Study|Death|69|||
129537975|NCT01266967|466260148|FG001|Overall Study|Death|61|||
129537976|NCT01266967|466260147|FG000|Overall Study|Study Closed/Terminated|15|||
129537977|NCT01266967|466260148|FG001|Overall Study|Study Closed/Terminated|17|||
129537978|NCT01266967|466260147|FG000|Overall Study|Lost to Follow-up|2|||
129537979|NCT01266967|466260148|FG001|Overall Study|Lost to Follow-up|1|||
129537980|NCT01266967|466260147|FG000|Overall Study|Physician Decision|0|||
129537981|NCT01266967|466260148|FG001|Overall Study|Physician Decision|1|||
129537982|NCT01266967|466260147|FG000|Overall Study|Withdrawal by Subject|3|||
129537983|NCT01266967|466260148|FG001|Overall Study|Withdrawal by Subject|3|||
129537984|NCT01945866|466260149|FG000|Overall Study|Eyes did not complete or were dropped|2|||
129537985|NCT01945866|466260150|FG001|Overall Study|Eyes did not complete or were dropped|0|||
129537986|NCT04398030|466260151|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
129537987|NCT04398030|466260152|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
129537988|NCT04398030|466260151|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
129537989|NCT04398030|466260152|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
129537990|NCT03159455|466260155|FG000|Overall Study|Adverse Event|0|||
129537991|NCT03159455|466260156|FG001|Overall Study|Adverse Event|0|||
129537992|NCT03159455|466260157|FG002|Overall Study|Adverse Event|0|||
129537993|NCT03159455|466260158|FG003|Overall Study|Adverse Event|0|||
129537994|NCT03159455|466260159|FG004|Overall Study|Adverse Event|0|||
129537995|NCT03159455|466260160|FG005|Overall Study|Adverse Event|1|||
129537996|NCT02501642|466260167|FG000|Overall Study|Lost to Follow-up|7|||
129537997|NCT02501642|466260168|FG001|Overall Study|Lost to Follow-up|11|||
129537998|NCT01846442|466260172|FG000|Overall Study|Adverse Event|2|||
129537999|NCT01846442|466260173|FG001|Overall Study|Adverse Event|4|||
129538000|NCT01846442|466260174|FG002|Overall Study|Adverse Event|2|||
129538001|NCT01846442|466260175|FG003|Overall Study|Adverse Event|1|||
129538002|NCT01846442|466260172|FG000|Overall Study|Lost to Follow-up|0|||
129538003|NCT01846442|466260173|FG001|Overall Study|Lost to Follow-up|0|||
129538004|NCT01846442|466260174|FG002|Overall Study|Lost to Follow-up|1|||
129538005|NCT01846442|466260175|FG003|Overall Study|Lost to Follow-up|0|||
129538006|NCT01846442|466260172|FG000|Overall Study|Withdrawal by Subject|3|||
129538007|NCT01846442|466260173|FG001|Overall Study|Withdrawal by Subject|2|||
129538008|NCT01846442|466260174|FG002|Overall Study|Withdrawal by Subject|0|||
129538009|NCT01846442|466260175|FG003|Overall Study|Withdrawal by Subject|1|||
129538010|NCT01846442|466260172|FG000|Overall Study|Left the city/Lost medication|1|||
129538011|NCT01846442|466260173|FG001|Overall Study|Left the city/Lost medication|0|||
129538012|NCT01846442|466260174|FG002|Overall Study|Left the city/Lost medication|1|||
129538013|NCT01846442|466260175|FG003|Overall Study|Left the city/Lost medication|1|||
129538014|NCT02600559|466260186|FG000|Overall Study|Withdrawal by Subject|3|||
129538015|NCT02600559|466260186|FG000|Overall Study|Lost to Follow-up|20|||
129538016|NCT01153971|466260189|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
129538017|NCT01153971|466260189|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
129538018|NCT01153971|466260189|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
129538019|NCT01153971|466260189|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
129538020|NCT01153971|466260189|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
129538021|NCT01153971|466260189|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
129538022|NCT01153971|466260189|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
129538023|NCT03410693|466260190|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
129538024|NCT03410693|466260191|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
129538025|NCT03410693|466260190|FG000|Overall Study|Disc trt: Lost to follow up|0|||
129538026|NCT03410693|466260191|FG001|Overall Study|Disc trt: Lost to follow up|1|||
129538027|NCT03410693|466260190|FG000|Overall Study|Disc trt: radiological progression|58|||
129538028|NCT03410693|466260191|FG001|Overall Study|Disc trt: radiological progression|50|||
129538029|NCT03410693|466260190|FG000|Overall Study|Disc trt: Other|1|||
129538030|NCT03410693|466260191|FG001|Overall Study|Disc trt: Other|0|||
129538031|NCT03410693|466260190|FG000|Overall Study|Study drug never administered|1|||
129538032|NCT03410693|466260191|FG001|Overall Study|Study drug never administered|6|||
129538033|NCT03410693|466260190|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
129538034|NCT03410693|466260191|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
129538035|NCT03410693|466260190|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
129538036|NCT03410693|466260191|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
129538037|NCT03410693|466260190|FG000|Overall Study|Disc trt: Physician decision|0|||
129538038|NCT03410693|466260191|FG001|Overall Study|Disc trt: Physician decision|5|||
129538039|NCT03410693|466260190|FG000|Overall Study|Disc trt: clinical progression|1|||
129538040|NCT03410693|466260191|FG001|Overall Study|Disc trt: clinical progression|5|||
129538041|NCT03410693|466260190|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
129538042|NCT03410693|466260191|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
129538043|NCT00953576|466260192|FG000|Overall Study|Adverse Event|0|||
129538044|NCT00953576|466260193|FG001|Overall Study|Adverse Event|1|||
129538045|NCT00953576|466260192|FG000|Overall Study|Ineligible after Consent|2|||
129538046|NCT00953576|466260193|FG001|Overall Study|Ineligible after Consent|0|||
129538047|NCT03628781|466260198|FG000|Overall Study|Lost to Follow-up|16|||
129538048|NCT03628781|466260199|FG001|Overall Study|Lost to Follow-up|8|||
129538049|NCT03628781|466260198|FG000|Overall Study|Withdrawal by Subject|16|||
129538050|NCT03628781|466260199|FG001|Overall Study|Withdrawal by Subject|1|||
129538051|NCT01545375|466260202|FG000|Overall Study|Adverse Event|2|||
129538052|NCT01545375|466260203|FG001|Overall Study|Adverse Event|1|||
129538053|NCT01545375|466260202|FG000|Overall Study|Lost to Follow-up|34|||
129538054|NCT01545375|466260203|FG001|Overall Study|Lost to Follow-up|31|||
129538055|NCT01545375|466260202|FG000|Overall Study|Protocol Violation|3|||
129538056|NCT01545375|466260203|FG001|Overall Study|Protocol Violation|3|||
129538057|NCT01545375|466260202|FG000|Overall Study|Withdrawal by Subject|58|||
129538058|NCT01545375|466260203|FG001|Overall Study|Withdrawal by Subject|55|||
129538059|NCT02687815|466260204|FG000|Overall Study|Lost to Follow-up|2|||
129538060|NCT02687815|466260205|FG001|Overall Study|Lost to Follow-up|4|||
129538061|NCT02687815|466260204|FG000|Overall Study|Withdrawal by Subject|2|||
129538062|NCT02687815|466260205|FG001|Overall Study|Withdrawal by Subject|4|||
129538063|NCT01846039|466260206|FG000|Overall Study|Protocol Violation|1|||
129538064|NCT01846039|466260206|FG000|Overall Study|Subject Withdrew Consent|1|||
129538065|NCT04854421|466260207|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
129538066|NCT04854421|466260208|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
129538067|NCT03472586|466260214|FG000|Overall Study|Physician Decision|6|||
129538068|NCT03472586|466260214|FG000|Overall Study|Death|6|||
129538069|NCT03472586|466260214|FG000|Overall Study|Adverse Event|1|||
129538070|NCT02528331|466260215|FG000|Overall Study|Withdrawal by Subject|2|||
129538071|NCT00462501|466260216|FG000|Overall Study|Not treated|3|||
129538072|NCT00462501|466260216|FG000|Overall Study|Adverse Event|2|||
129538073|NCT04988035|466260219|FG000|Overall Study|Death|19|||
129538074|NCT04988035|466260220|FG001|Overall Study|Death|13|||
129538075|NCT04988035|466260219|FG000|Overall Study|Lost to Follow-up|12|||
129538076|NCT04988035|466260220|FG001|Overall Study|Lost to Follow-up|6|||
129538077|NCT04988035|466260219|FG000|Overall Study|Protocol Violation|0|||
129538078|NCT04988035|466260220|FG001|Overall Study|Protocol Violation|1|||
129538079|NCT04988035|466260219|FG000|Overall Study|Withdrawal by Subject|2|||
129538080|NCT04988035|466260220|FG001|Overall Study|Withdrawal by Subject|4|||
129538081|NCT04988035|466260219|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
129538082|NCT04988035|466260220|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
129538083|NCT00399542|466260221|FG000|Overall Study|Adverse Event|18|||
129538084|NCT00399542|466260222|FG001|Overall Study|Adverse Event|15|||
129538085|NCT00399542|466260221|FG000|Overall Study|Protocol Violation|13|||
129538086|NCT00399542|466260222|FG001|Overall Study|Protocol Violation|3|||
129538087|NCT00399542|466260221|FG000|Overall Study|Withdrawal by Subject|28|||
129538088|NCT00399542|466260222|FG001|Overall Study|Withdrawal by Subject|10|||
129538089|NCT00399542|466260221|FG000|Overall Study|Lack of Efficacy|18|||
129538090|NCT00399542|466260222|FG001|Overall Study|Lack of Efficacy|8|||
129538091|NCT00399542|466260221|FG000|Overall Study|Lost to Follow-up|6|||
129538092|NCT00399542|466260222|FG001|Overall Study|Lost to Follow-up|6|||
129538093|NCT00399542|466260221|FG000|Overall Study|Other|1|||
129538094|NCT00399542|466260222|FG001|Overall Study|Other|0|||
129538095|NCT00399542|466260221|FG000|Overall Study|Physician Decision|0|||
129538096|NCT00399542|466260222|FG001|Overall Study|Physician Decision|1|||
129538097|NCT03172026|466260223|FG000|Overall Study|Withdrawal by Subject|1|||
129538098|NCT03172026|466260224|FG001|Overall Study|Withdrawal by Subject|0|||
129538099|NCT03172026|466260223|FG000|Overall Study|COVID restrictions|1|||
129538100|NCT03172026|466260224|FG001|Overall Study|COVID restrictions|0|||
129538101|NCT01552408|466260225|FG000|Overall Study|Lost to Follow-up|2|||
129538102|NCT01552408|466260226|FG001|Overall Study|Lost to Follow-up|0|||
129538103|NCT01552408|466260225|FG000|Overall Study|Relocation|0|||
129538104|NCT01552408|466260226|FG001|Overall Study|Relocation|1|||
129538105|NCT01552408|466260225|FG000|Overall Study|Withdrawal by Subject|2|||
129538106|NCT01552408|466260226|FG001|Overall Study|Withdrawal by Subject|1|||
129538107|NCT00383292|466260229|FG000|Overall Study|Adverse Event|4|||
129538108|NCT00383292|466260230|FG001|Overall Study|Adverse Event|1|||
129538109|NCT00383292|466260231|FG002|Overall Study|Adverse Event|2|||
129538110|NCT00383292|466260229|FG000|Overall Study|Death|3|||
129538111|NCT00383292|466260230|FG001|Overall Study|Death|3|||
129538112|NCT00383292|466260231|FG002|Overall Study|Death|3|||
129538113|NCT00383292|466260229|FG000|Overall Study|Physician Decision|4|||
129538114|NCT00383292|466260230|FG001|Overall Study|Physician Decision|0|||
129538115|NCT00383292|466260231|FG002|Overall Study|Physician Decision|1|||
129538116|NCT00383292|466260229|FG000|Overall Study|Withdrawal by Subject|3|||
129538117|NCT00383292|466260230|FG001|Overall Study|Withdrawal by Subject|2|||
129538118|NCT00383292|466260231|FG002|Overall Study|Withdrawal by Subject|2|||
129538119|NCT00383292|466260229|FG000|Overall Study|Other|1|||
129538120|NCT00383292|466260230|FG001|Overall Study|Other|0|||
129538121|NCT00383292|466260231|FG002|Overall Study|Other|0|||
129538122|NCT01016912|466260232|FG000|End of Treatment Period|Lack of Efficacy|0|||
129538123|NCT01016912|466260233|FG001|End of Treatment Period|Lack of Efficacy|1|||
129538124|NCT01016912|466260234|FG002|End of Treatment Period|Lack of Efficacy|0|||
129538125|NCT01016912|466260235|FG003|End of Treatment Period|Lack of Efficacy|4|||
129538126|NCT01016912|466260236|FG004|End of Treatment Period|Lack of Efficacy|4|||
129538127|NCT01016912|466260232|FG000|End of Treatment Period|Adverse Event|0|||
129538128|NCT01016912|466260233|FG001|End of Treatment Period|Adverse Event|1|||
129538129|NCT01016912|466260234|FG002|End of Treatment Period|Adverse Event|1|||
129538130|NCT01016912|466260235|FG003|End of Treatment Period|Adverse Event|0|||
129538131|NCT01016912|466260236|FG004|End of Treatment Period|Adverse Event|0|||
129538132|NCT01016912|466260232|FG000|End of Treatment Period|Completed double-blind period only|0|||
129538133|NCT01016912|466260233|FG001|End of Treatment Period|Completed double-blind period only|1|||
129538134|NCT01016912|466260234|FG002|End of Treatment Period|Completed double-blind period only|0|||
129538135|NCT01016912|466260235|FG003|End of Treatment Period|Completed double-blind period only|0|||
129538136|NCT01016912|466260236|FG004|End of Treatment Period|Completed double-blind period only|0|||
129538137|NCT01016912|466260232|FG000|Follow-up Period|Other reason|0|||
129538138|NCT01016912|466260233|FG001|Follow-up Period|Other reason|0|||
129538139|NCT01016912|466260234|FG002|Follow-up Period|Other reason|1|||
129538140|NCT01016912|466260235|FG003|Follow-up Period|Other reason|1|||
129538141|NCT01016912|466260236|FG004|Follow-up Period|Other reason|0|||
129538142|NCT02370173|466260239|FG000|Overall Study|Protocol Violation|1|||
129538143|NCT02370173|466260240|FG001|Overall Study|Protocol Violation|1|||
129538144|NCT02370173|466260239|FG000|Overall Study|Withdrawal by Subject|2|||
129538145|NCT02370173|466260240|FG001|Overall Study|Withdrawal by Subject|2|||
129538146|NCT00307736|466260241|FG000|Overall Study|Adverse Event|0|||
129538147|NCT00307736|466260242|FG001|Overall Study|Adverse Event|0|||
129538148|NCT00307736|466260243|FG002|Overall Study|Adverse Event|1|||
129538149|NCT00307736|466260244|FG003|Overall Study|Adverse Event|3|||
129538150|NCT00307736|466260241|FG000|Overall Study|Withdrawal by Subject|0|||
129538151|NCT00307736|466260242|FG001|Overall Study|Withdrawal by Subject|0|||
129538152|NCT00307736|466260243|FG002|Overall Study|Withdrawal by Subject|2|||
129538153|NCT00307736|466260244|FG003|Overall Study|Withdrawal by Subject|0|||
129538154|NCT00656669|466262000|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
129538155|NCT00656669|466262000|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
129538156|NCT00656669|466262000|FG000|AC (Cycles 6-9)|Adverse Event|1|||
129538157|NCT00656669|466262000|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
129538158|NCT03778021|466262001|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
129538159|NCT03778021|466262002|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
129538160|NCT00679042|466262003|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
129538161|NCT00679042|466262003|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
129538162|NCT00679042|466262003|FG000|5-Year Follow Up|Death|1|||
129538163|NCT00679042|466262003|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
129538164|NCT00679042|466262003|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
129538165|NCT00247416|466262006|FG000|Overall Study|3 patients were found to be ineligible|1|||
129538166|NCT00247416|466262007|FG001|Overall Study|3 patients were found to be ineligible|2|||
129538167|NCT00798161|466262008|FG000|Overall Study|Adverse Event|3|||
129538168|NCT00798161|466262009|FG001|Overall Study|Adverse Event|4|||
129538169|NCT00798161|466262010|FG002|Overall Study|Adverse Event|6|||
129538170|NCT00798161|466262011|FG003|Overall Study|Adverse Event|6|||
129538171|NCT00798161|466262012|FG004|Overall Study|Adverse Event|5|||
129538172|NCT00798161|466262013|FG005|Overall Study|Adverse Event|2|||
129538173|NCT00798161|466262014|FG006|Overall Study|Adverse Event|4|||
129538174|NCT00798161|466262008|FG000|Overall Study|Protocol Violation|2|||
129538175|NCT00798161|466262009|FG001|Overall Study|Protocol Violation|1|||
129538176|NCT00798161|466262010|FG002|Overall Study|Protocol Violation|3|||
129538177|NCT00798161|466262011|FG003|Overall Study|Protocol Violation|3|||
129538178|NCT00798161|466262012|FG004|Overall Study|Protocol Violation|3|||
129538179|NCT00798161|466262013|FG005|Overall Study|Protocol Violation|2|||
129538180|NCT00798161|466262014|FG006|Overall Study|Protocol Violation|0|||
129538181|NCT00798161|466262008|FG000|Overall Study|Lost to Follow-up|1|||
129538182|NCT00798161|466262009|FG001|Overall Study|Lost to Follow-up|3|||
129538183|NCT00798161|466262010|FG002|Overall Study|Lost to Follow-up|4|||
129538184|NCT00798161|466262011|FG003|Overall Study|Lost to Follow-up|3|||
129538185|NCT00798161|466262012|FG004|Overall Study|Lost to Follow-up|4|||
129538186|NCT00798161|466262013|FG005|Overall Study|Lost to Follow-up|0|||
129538187|NCT00798161|466262014|FG006|Overall Study|Lost to Follow-up|0|||
129538188|NCT00798161|466262008|FG000|Overall Study|Withdrawal by Subject|5|||
129538189|NCT00798161|466262009|FG001|Overall Study|Withdrawal by Subject|4|||
129538190|NCT00798161|466262010|FG002|Overall Study|Withdrawal by Subject|5|||
129538191|NCT00798161|466262011|FG003|Overall Study|Withdrawal by Subject|4|||
129538192|NCT00798161|466262012|FG004|Overall Study|Withdrawal by Subject|2|||
129538193|NCT00798161|466262013|FG005|Overall Study|Withdrawal by Subject|3|||
129538194|NCT00798161|466262014|FG006|Overall Study|Withdrawal by Subject|1|||
129538195|NCT00798161|466262008|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
129538196|NCT00798161|466262009|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
129538197|NCT00798161|466262010|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
129538198|NCT00798161|466262011|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
129538199|NCT00798161|466262012|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
129538200|NCT00798161|466262013|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
129538201|NCT00798161|466262014|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
129538202|NCT00761761|466262015|FG000|Overall Study|Lost to Follow-up|3|||
129538203|NCT00761761|466262016|FG001|Overall Study|Lost to Follow-up|1|||
129538204|NCT00761761|466262015|FG000|Overall Study|Withdrawal by Subject|3|||
129538205|NCT00761761|466262016|FG001|Overall Study|Withdrawal by Subject|0|||
129538206|NCT01224171|466262018|FG000|Overall Study|Adverse Event|8|||
129538207|NCT01224171|466262019|FG001|Overall Study|Adverse Event|4|||
129538208|NCT01224171|466262018|FG000|Overall Study|Protocol Violation|0|||
129538209|NCT01224171|466262019|FG001|Overall Study|Protocol Violation|1|||
129538210|NCT01224171|466262018|FG000|Overall Study|Lack of Efficacy|5|||
129538211|NCT01224171|466262019|FG001|Overall Study|Lack of Efficacy|1|||
129538212|NCT01224171|466262018|FG000|Overall Study|Withdrawal of Consent|2|||
129538213|NCT01224171|466262019|FG001|Overall Study|Withdrawal of Consent|4|||
129538214|NCT01224171|466262018|FG000|Overall Study|Lost to Follow-up|0|||
129538215|NCT01224171|466262019|FG001|Overall Study|Lost to Follow-up|3|||
129538216|NCT03737812|466262020|FG000|Overall Study|Withdrawal by Subject|1|||
129538217|NCT03737812|466262021|FG001|Overall Study|Withdrawal by Subject|2|||
129538218|NCT03737812|466262022|FG002|Overall Study|Withdrawal by Subject|1|||
129538219|NCT03737812|466262020|FG000|Overall Study|Sponsor Discontinued the Study|4|||
129538220|NCT03737812|466262021|FG001|Overall Study|Sponsor Discontinued the Study|3|||
129538221|NCT03737812|466262022|FG002|Overall Study|Sponsor Discontinued the Study|2|||
129538222|NCT03737812|466262020|FG000|Overall Study|Adverse Event|0|||
129538223|NCT03737812|466262021|FG001|Overall Study|Adverse Event|1|||
129538224|NCT03737812|466262022|FG002|Overall Study|Adverse Event|0|||
129538225|NCT03737812|466262020|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
129538226|NCT03737812|466262021|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
129538227|NCT03737812|466262022|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
129538228|NCT02624713|466262023|FG000|Overall Study|Lost to Follow-up|14|||
129538229|NCT02624713|466262024|FG001|Overall Study|Lost to Follow-up|0|||
129538230|NCT00285857|466262028|FG000|Overall Study|Withdrawal by Subject|2|||
129538231|NCT00285857|466262028|FG000|Overall Study|Inadequate initial breast cytology|1|||
129538232|NCT00285857|466262028|FG000|Overall Study|Adverse Event|1|||
129538233|NCT01161173|466262034|FG000|Overall Study|Protocol Violation|13|||
129538234|NCT01161173|466262034|FG000|Overall Study|Lost to Follow-up|7|||
129538235|NCT01161173|466262034|FG000|Overall Study|Progressive Disease|82|||
129538236|NCT01161173|466262034|FG000|Overall Study|Withdrawal of Consent|5|||
129538237|NCT01161173|466262034|FG000|Overall Study|Unacceptable Toxicity|21|||
129538238|NCT01161173|466262034|FG000|Overall Study|Death|194|||
129538239|NCT01161173|466262034|FG000|Overall Study|End of Study|2|||
129538240|NCT01161173|466262034|FG000|Overall Study|Reasons Not Specified|23|||
129538241|NCT00792467|466262037|FG000|Overall Study|progression of disease|17|||
129538242|NCT00792467|466262037|FG000|Overall Study|Adverse Event|1|||
129538243|NCT00792467|466262037|FG000|Overall Study|patient request|1|||
129538244|NCT00792467|466262037|FG000|Overall Study|Lost to Follow-up|1|||
129538245|NCT00792467|466262037|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
129538246|NCT00792467|466262037|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
129538247|NCT03911401|466262038|FG000|Overall Study|Adverse Event|1|||
129538248|NCT03911401|466262039|FG001|Overall Study|Adverse Event|2|||
129538249|NCT03911401|466262040|FG002|Overall Study|Adverse Event|5|||
129538250|NCT03911401|466262038|FG000|Overall Study|Lack of Efficacy|1|||
129538251|NCT03911401|466262039|FG001|Overall Study|Lack of Efficacy|1|||
129538252|NCT03911401|466262040|FG002|Overall Study|Lack of Efficacy|8|||
129538253|NCT03911401|466262038|FG000|Overall Study|Physician Decision|0|||
129538254|NCT03911401|466262039|FG001|Overall Study|Physician Decision|0|||
129538255|NCT03911401|466262040|FG002|Overall Study|Physician Decision|1|||
129538256|NCT03911401|466262038|FG000|Overall Study|Withdrawal by Subject|1|||
129538257|NCT03911401|466262039|FG001|Overall Study|Withdrawal by Subject|2|||
129538258|NCT03911401|466262040|FG002|Overall Study|Withdrawal by Subject|0|||
129538259|NCT03911401|466262038|FG000|Overall Study|Withdrawal by parent/guardian|4|||
129538260|NCT03911401|466262039|FG001|Overall Study|Withdrawal by parent/guardian|4|||
129538261|NCT03911401|466262040|FG002|Overall Study|Withdrawal by parent/guardian|11|||
129538262|NCT02918968|466262041|FG000|1st Line AAT|Progressive disease|9|||
129538263|NCT02918968|466262042|FG001|1st Line AAT|Progressive disease|4|||
129538264|NCT02918968|466262041|FG000|1st Line AAT|Adverse Event|12|||
129538265|NCT02918968|466262042|FG001|1st Line AAT|Adverse Event|3|||
129538266|NCT02918968|466262041|FG000|1st Line AAT|Physician Decision|4|||
129538267|NCT02918968|466262042|FG001|1st Line AAT|Physician Decision|2|||
129538268|NCT02918968|466262041|FG000|1st Line AAT|Withdrawal by Subject|2|||
129538269|NCT02918968|466262042|FG001|1st Line AAT|Withdrawal by Subject|1|||
129538270|NCT02918968|466262041|FG000|1st Line AAT|Lost to Follow-up|0|||
129538271|NCT02918968|466262042|FG001|1st Line AAT|Lost to Follow-up|1|||
129538272|NCT02918968|466262041|FG000|1st Line AAT|Death|1|||
129538273|NCT02918968|466262042|FG001|1st Line AAT|Death|0|||
129538274|NCT02918968|466262041|FG000|1st Line AAT|Miscellaneous|1|||
129538275|NCT02918968|466262042|FG001|1st Line AAT|Miscellaneous|0|||
129538276|NCT02918968|466262041|FG000|2nd Line AAT|Progressive disease|21|||
129538277|NCT02918968|466262042|FG001|2nd Line AAT|Progressive disease|3|||
129538278|NCT02918968|466262041|FG000|2nd Line AAT|Adverse Event|2|||
129538279|NCT02918968|466262042|FG001|2nd Line AAT|Adverse Event|5|||
129538280|NCT02918968|466262041|FG000|2nd Line AAT|Physician Decision|0|||
129538281|NCT02918968|466262042|FG001|2nd Line AAT|Physician Decision|1|||
129538282|NCT02918968|466262041|FG000|2nd Line AAT|Withdrawal by Subject|2|||
129538283|NCT02918968|466262042|FG001|2nd Line AAT|Withdrawal by Subject|2|||
129538284|NCT02918968|466262041|FG000|2nd Line AAT|Death|0|||
129538285|NCT02918968|466262042|FG001|2nd Line AAT|Death|1|||
129538286|NCT03781167|466262052|FG000|Overall Study|Adverse Event|23|||
129538287|NCT03781167|466262053|FG001|Overall Study|Adverse Event|25|||
129538288|NCT03781167|466262052|FG000|Overall Study|Withdrew consent|16|||
129538289|NCT03781167|466262053|FG001|Overall Study|Withdrew consent|12|||
129538290|NCT03781167|466262052|FG000|Overall Study|Lost to Follow-up|0|||
129538291|NCT03781167|466262053|FG001|Overall Study|Lost to Follow-up|1|||
129538292|NCT03781167|466262052|FG000|Overall Study|Lack of Efficacy|4|||
129538293|NCT03781167|466262053|FG001|Overall Study|Lack of Efficacy|5|||
129538294|NCT03781167|466262052|FG000|Overall Study|Difficulty with drug delivery system|2|||
129538295|NCT03781167|466262053|FG001|Overall Study|Difficulty with drug delivery system|3|||
129538296|NCT03781167|466262052|FG000|Overall Study|Other, not specified|2|||
129538297|NCT03781167|466262053|FG001|Overall Study|Other, not specified|2|||
129538298|NCT01590628|466262055|FG000|Overall Study|Death|2|||
129538299|NCT01590628|466262056|FG001|Overall Study|Death|0|||
129538300|NCT00475657|466262057|FG000|Overall Study|Death|1|||
129538301|NCT00475657|466262057|FG000|Overall Study|Sponsor's Decision|3|||
129538302|NCT00381680|466262058|FG000|Overall Study|Adverse Event|9|||
129538303|NCT00381680|466262059|FG001|Overall Study|Adverse Event|3|||
129538304|NCT00381680|466262058|FG000|Overall Study|Death|10|||
129538305|NCT00381680|466262059|FG001|Overall Study|Death|7|||
129538306|NCT00381680|466262058|FG000|Overall Study|Lost to Follow-up|3|||
129538307|NCT00381680|466262059|FG001|Overall Study|Lost to Follow-up|2|||
129538308|NCT00381680|466262058|FG000|Overall Study|Physician Decision|25|||
129538309|NCT00381680|466262059|FG001|Overall Study|Physician Decision|6|||
129538310|NCT00381680|466262058|FG000|Overall Study|Withdrawal by Subject|3|||
129538311|NCT00381680|466262059|FG001|Overall Study|Withdrawal by Subject|1|||
129538312|NCT00381680|466262058|FG000|Overall Study|Entry onto another COG Trial|1|||
129538313|NCT00381680|466262059|FG001|Overall Study|Entry onto another COG Trial|2|||
129538314|NCT00381680|466262058|FG000|Overall Study|Alternative Therapy|11|||
129538315|NCT00381680|466262059|FG001|Overall Study|Alternative Therapy|5|||
129538316|NCT00381680|466262058|FG000|Overall Study|Secondary Malignancy|3|||
129538317|NCT00381680|466262059|FG001|Overall Study|Secondary Malignancy|0|||
129538318|NCT00381680|466262058|FG000|Overall Study|Delay initiation|1|||
129538319|NCT00381680|466262059|FG001|Overall Study|Delay initiation|0|||
129538320|NCT00381680|466262058|FG000|Overall Study|Stem Cell Transplant|26|||
129538321|NCT00381680|466262059|FG001|Overall Study|Stem Cell Transplant|10|||
129538322|NCT00381680|466262058|FG000|Overall Study|Relapse|18|||
129538323|NCT00381680|466262059|FG001|Overall Study|Relapse|9|||
129538324|NCT00381680|466262058|FG000|Overall Study|Induction Failure|4|||
129538325|NCT00381680|466262059|FG001|Overall Study|Induction Failure|1|||
129538326|NCT00381680|466262058|FG000|Overall Study|Progression|1|||
129538327|NCT00381680|466262059|FG001|Overall Study|Progression|1|||
129538328|NCT00381680|466262058|FG000|Overall Study|Other not otherwise specified|7|||
129538329|NCT00381680|466262059|FG001|Overall Study|Other not otherwise specified|2|||
129538330|NCT00381680|466262058|FG000|Overall Study|Ineligible|3|||
129538331|NCT00381680|466262059|FG001|Overall Study|Ineligible|1|||
129538332|NCT00933543|466262075|FG000|Overall Study|Adverse Event|2|||
129538333|NCT00933543|466262076|FG001|Overall Study|Adverse Event|1|||
129538334|NCT00933543|466262075|FG000|Overall Study|Lost to Follow-up|0|||
129538335|NCT00933543|466262076|FG001|Overall Study|Lost to Follow-up|1|||
129538336|NCT00933543|466262075|FG000|Overall Study|Withdrawal by Subject|0|||
129538337|NCT00933543|466262076|FG001|Overall Study|Withdrawal by Subject|1|||
129538338|NCT00933543|466262075|FG000|Overall Study|Lack of Efficacy|0|||
129538339|NCT00933543|466262076|FG001|Overall Study|Lack of Efficacy|3|||
129538340|NCT00933543|466262075|FG000|Overall Study|Other|1|||
129538341|NCT00933543|466262076|FG001|Overall Study|Other|1|||
129538342|NCT04626947|466262077|FG000|Overall Study|Study terminated|14|||
129538343|NCT02463097|466262078|FG000|Overall Study|Withdrawal by Subject|1|||
129538344|NCT01757821|466262079|FG000|Overall Study|Adverse Event|1|||
129538345|NCT00334893|466262080|FG000|Overall Study|Not Treated|1|||
129538346|NCT00334893|466262081|FG001|Overall Study|Not Treated|0|||
129538347|NCT01258803|466262082|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
129538348|NCT01258803|466262083|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
129538349|NCT01258803|466262084|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
129538350|NCT01258803|466262085|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
129538351|NCT01258803|466262086|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
129538352|NCT01258803|466262087|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
129538353|NCT01258803|466262082|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
129538354|NCT01258803|466262083|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
129538355|NCT01258803|466262084|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
129538356|NCT01258803|466262085|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
129538357|NCT01258803|466262086|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
129538358|NCT01258803|466262087|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
129538359|NCT01258803|466262082|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129538360|NCT01258803|466262083|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129538361|NCT01258803|466262084|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
129538362|NCT01258803|466262085|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129538363|NCT01258803|466262086|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129538364|NCT01258803|466262087|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
129538365|NCT03556202|466262096|FG000|Extension Treatment Period|Adverse Event|18|||
129538366|NCT03556202|466262097|FG001|Extension Treatment Period|Adverse Event|14|||
129538367|NCT03556202|466262098|FG002|Extension Treatment Period|Adverse Event|9|||
129538368|NCT03556202|466262096|FG000|Extension Treatment Period|Death|2|||
129538369|NCT03556202|466262097|FG001|Extension Treatment Period|Death|6|||
129538370|NCT03556202|466262098|FG002|Extension Treatment Period|Death|0|||
129538371|NCT03556202|466262096|FG000|Extension Treatment Period|Lack of Efficacy|5|||
129538372|NCT03556202|466262097|FG001|Extension Treatment Period|Lack of Efficacy|12|||
129538373|NCT03556202|466262098|FG002|Extension Treatment Period|Lack of Efficacy|18|||
129538374|NCT03556202|466262096|FG000|Extension Treatment Period|Lost to Follow-up|9|||
129538375|NCT03556202|466262097|FG001|Extension Treatment Period|Lost to Follow-up|20|||
129538376|NCT03556202|466262098|FG002|Extension Treatment Period|Lost to Follow-up|2|||
129538377|NCT03556202|466262096|FG000|Extension Treatment Period|Pregnancy|2|||
129538378|NCT03556202|466262097|FG001|Extension Treatment Period|Pregnancy|4|||
129538379|NCT03556202|466262098|FG002|Extension Treatment Period|Pregnancy|3|||
129538380|NCT03556202|466262096|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
129538381|NCT03556202|466262097|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
129538382|NCT03556202|466262098|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
129538383|NCT03556202|466262096|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
129538384|NCT03556202|466262097|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
129538385|NCT03556202|466262098|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
129538386|NCT03556202|466262096|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
129538387|NCT03556202|466262097|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
129538388|NCT03556202|466262098|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
129538389|NCT03556202|466262096|FG000|Extension Treatment Period|Physician Decision|0|||
129538390|NCT03556202|466262097|FG001|Extension Treatment Period|Physician Decision|8|||
129538391|NCT03556202|466262098|FG002|Extension Treatment Period|Physician Decision|2|||
129538392|NCT03556202|466262096|FG000|Extension Treatment Period|Protocol Violation|0|||
129538393|NCT03556202|466262097|FG001|Extension Treatment Period|Protocol Violation|1|||
129538394|NCT03556202|466262098|FG002|Extension Treatment Period|Protocol Violation|1|||
129538395|NCT03556202|466262096|FG000|Extension Treatment Period|Sponsor Decision|0|||
129538396|NCT03556202|466262097|FG001|Extension Treatment Period|Sponsor Decision|1|||
129538397|NCT03556202|466262098|FG002|Extension Treatment Period|Sponsor Decision|0|||
129538398|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
129538399|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
129538400|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
129538401|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Death|1|||
129538402|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Death|0|||
129538403|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Death|0|||
129538404|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
129538405|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
129538406|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
129538407|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
129538408|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
129538409|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
129538410|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
129538411|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
129538412|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
129538413|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
129538414|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
129538415|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
129538416|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
129538417|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
129538418|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
129538419|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
129538420|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
129538421|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
129538422|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
129538423|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
129538424|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
129538425|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
129538426|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
129538427|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
129538428|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
129538429|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
129538430|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
129538431|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
129538432|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
129538433|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
129538434|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
129538435|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
129538436|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
129538437|NCT03556202|466262096|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
129538438|NCT03556202|466262097|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
129538439|NCT03556202|466262098|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
129538440|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Adverse Event|6|||
129538441|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Adverse Event|6|||
129538442|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Death|14|||
129538443|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Death|11|||
129538444|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
129538445|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
129538446|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
129538447|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
129538448|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
129538449|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
129538450|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Disease Progression|1|||
129538451|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Disease Progression|0|||
129538452|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
129538453|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
129538454|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
129538455|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
129538456|NCT04419558|466262099|FG000|DB Period (48 Weeks)|Participant Decision|4|||
129538457|NCT04419558|466262100|FG001|DB Period (48 Weeks)|Participant Decision|3|||
129538458|NCT04419558|466262099|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
129538459|NCT04419558|466262100|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
129538460|NCT04419558|466262099|FG000|OLE Period (48 Weeks)|Death|4|||
129538461|NCT04419558|466262100|FG001|OLE Period (48 Weeks)|Death|6|||
129538462|NCT04419558|466262099|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
129538463|NCT04419558|466262100|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
129538464|NCT04419558|466262099|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
129538465|NCT04419558|466262100|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
129538466|NCT02221882|466262101|FG000|Overall Study|Withdrawal by Subject|0|||
129538467|NCT02221882|466262102|FG001|Overall Study|Withdrawal by Subject|0|||
129538468|NCT02221882|466262103|FG002|Overall Study|Withdrawal by Subject|4|||
129538469|NCT02221882|466262104|FG003|Overall Study|Withdrawal by Subject|2|||
129538470|NCT02221882|466262105|FG004|Overall Study|Withdrawal by Subject|2|||
129538471|NCT02221882|466262106|FG005|Overall Study|Withdrawal by Subject|2|||
129538472|NCT02221882|466262101|FG000|Overall Study|Death|0|||
129538473|NCT02221882|466262102|FG001|Overall Study|Death|1|||
129538474|NCT02221882|466262103|FG002|Overall Study|Death|0|||
129538475|NCT02221882|466262104|FG003|Overall Study|Death|0|||
129538476|NCT02221882|466262105|FG004|Overall Study|Death|0|||
129538477|NCT02221882|466262106|FG005|Overall Study|Death|0|||
129538478|NCT05664672|466262107|FG000|Overall Study|Adverse Event|0|||
129538501|NCT05664672|466262112|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
129538502|NCT04236986|466262121|FG000|Overall Study|Withdrawal by Subject|3|||
129538503|NCT04236986|466262122|FG001|Overall Study|Withdrawal by Subject|1|||
129538504|NCT04034225|466262123|FG000|Overall Study|Death|3|||
129538505|NCT04034225|466262123|FG000|Overall Study|Withdrawal by Subject|2|||
129538506|NCT04034225|466262123|FG000|Overall Study|Study termination by Sponsor|18|||
129538507|NCT04034225|466262123|FG000|Overall Study|Physician Decision|1|||
129538508|NCT04034225|466262123|FG000|Overall Study|Lack of Efficacy|1|||
129538509|NCT01326481|466262129|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
129538510|NCT02260791|466262132|FG000|Overall Study|Lost to Follow-up|4|||
129538511|NCT02260791|466262133|FG001|Overall Study|Lost to Follow-up|4|||
129538512|NCT02260791|466262132|FG000|Overall Study|Lack of Efficacy|2|||
129538513|NCT02260791|466262133|FG001|Overall Study|Lack of Efficacy|1|||
129538514|NCT02260791|466262132|FG000|Overall Study|Adverse Event|13|||
129538515|NCT02260791|466262133|FG001|Overall Study|Adverse Event|9|||
129538516|NCT02260791|466262132|FG000|Overall Study|Death|1|||
129538517|NCT02260791|466262133|FG001|Overall Study|Death|0|||
129538518|NCT02260791|466262132|FG000|Overall Study|Withdrawal by Subject|11|||
129538519|NCT02260791|466262133|FG001|Overall Study|Withdrawal by Subject|16|||
129538520|NCT02260791|466262132|FG000|Overall Study|Screen failure|0|||
129538521|NCT02260791|466262133|FG001|Overall Study|Screen failure|1|||
129538522|NCT02260791|466262132|FG000|Overall Study|Protocol deviation|2|||
129538523|NCT02260791|466262133|FG001|Overall Study|Protocol deviation|3|||
129538524|NCT04246996|466262135|FG000|Overall Study|Physician Decision|1|||
129538525|NCT04246996|466262136|FG001|Overall Study|Physician Decision|1|||
129538526|NCT04246996|466262135|FG000|Overall Study|Did not meet eligibility criteria|1|||
129538527|NCT04246996|466262136|FG001|Overall Study|Did not meet eligibility criteria|4|||
129538528|NCT02442284|466262137|FG000|Overall Study|Adverse Event|1|||
129538529|NCT02442284|466262137|FG000|Overall Study|Withdrew Consent|2|||
129538530|NCT02442284|466262137|FG000|Overall Study|Lost to Follow-up|3|||
129538531|NCT02442284|466262137|FG000|Overall Study|Other|1|||
129538532|NCT01365182|466262138|FG000|Overall Study|Withdrawal by Subject|10|||
129538533|NCT01365182|466262139|FG001|Overall Study|Withdrawal by Subject|13|||
129538534|NCT01365182|466262140|FG002|Overall Study|Withdrawal by Subject|12|||
129538535|NCT01728194|466262145|FG000|Overall Study|Lost to Follow-up|4|||
129538536|NCT01728194|466262146|FG001|Overall Study|Lost to Follow-up|3|||
129538537|NCT01728194|466262145|FG000|Overall Study|Physician Decision|4|||
129538538|NCT01728194|466262146|FG001|Overall Study|Physician Decision|0|||
129538539|NCT01728194|466262145|FG000|Overall Study|Withdrawal by Subject|7|||
129538540|NCT01728194|466262146|FG001|Overall Study|Withdrawal by Subject|3|||
129538541|NCT01728194|466262145|FG000|Overall Study|Perceived Medication Side Effects|4|||
129538542|NCT01728194|466262146|FG001|Overall Study|Perceived Medication Side Effects|0|||
129538543|NCT01728194|466262145|FG000|Overall Study|Family Member Request|1|||
129538544|NCT01728194|466262146|FG001|Overall Study|Family Member Request|0|||
129538545|NCT04604015|466262148|FG000|Overall Study|Incomplete Data Collection|33|||
129538546|NCT02129192|466262149|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
129538547|NCT02129192|466262150|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
129538548|NCT01231620|466262151|FG000|Overall Study|Physician Decision|3|||
129538549|NCT01231620|466262152|FG001|Overall Study|Physician Decision|5|||
129538550|NCT01231620|466262153|FG002|Overall Study|Physician Decision|10|||
129538551|NCT01231620|466262151|FG000|Overall Study|Death|12|||
129538552|NCT01231620|466262152|FG001|Overall Study|Death|14|||
129538553|NCT01231620|466262153|FG002|Overall Study|Death|11|||
129538554|NCT01231620|466262151|FG000|Overall Study|Adverse Event|2|||
129538555|NCT01231620|466262152|FG001|Overall Study|Adverse Event|2|||
129538556|NCT01231620|466262153|FG002|Overall Study|Adverse Event|1|||
129538557|NCT01231620|466262151|FG000|Overall Study|Withdrawal by Subject|6|||
129538558|NCT01231620|466262152|FG001|Overall Study|Withdrawal by Subject|6|||
129538559|NCT01231620|466262153|FG002|Overall Study|Withdrawal by Subject|8|||
129538560|NCT01231620|466262151|FG000|Overall Study|Lost to Follow-up|3|||
129538561|NCT01231620|466262152|FG001|Overall Study|Lost to Follow-up|4|||
129538562|NCT01231620|466262153|FG002|Overall Study|Lost to Follow-up|9|||
129538563|NCT02576652|466262156|FG000|Overall Study|Withdrawal by Subject|2|||
129538564|NCT02985541|466263415|FG000|Overall Study|Withdrawal by Subject|33|||
129538565|NCT02985541|466263415|FG000|Overall Study|Lost to Follow-up|26|||
129538566|NCT02985541|466263415|FG000|Overall Study|Adverse Event|27|||
129538567|NCT02985541|466263415|FG000|Overall Study|Physician Decision|2|||
129538568|NCT02985541|466263415|FG000|Overall Study|Pregnancy|2|||
129538569|NCT02985541|466263415|FG000|Overall Study|Wish for pregnancy|44|||
129538570|NCT02985541|466263415|FG000|Overall Study|Other reason|5|||
129538571|NCT02985541|466263415|FG000|Overall Study|Not valid for analysis|2|||
129538572|NCT04511533|466263420|FG000|Treatment|Other|2|||
129538573|NCT04511533|466263420|FG000|Treatment|Withdrawal by Subject|11|||
129538574|NCT04511533|466263420|FG000|Treatment|Death|5|||
129538575|NCT04511533|466263420|FG000|Treatment|Physician Decision|1|||
129538576|NCT04511533|466263420|FG000|Treatment|Progressive Disease|61|||
129538577|NCT04511533|466263420|FG000|Follow-Up|Other|7|||
129538578|NCT04511533|466263420|FG000|Follow-Up|Withdrawal by Subject|5|||
129538579|NCT04511533|466263420|FG000|Follow-Up|Lost to Follow-up|2|||
129538585|NCT04576702|466263421|FG000|Overall Study|Withdrawal by Subject|0|||
129538586|NCT04576702|466263422|FG001|Overall Study|Withdrawal by Subject|2|||
129538587|NCT04576702|466263423|FG002|Overall Study|Withdrawal by Subject|1|||
129538588|NCT04576702|466263424|FG003|Overall Study|Withdrawal by Subject|0|||
129538589|NCT04576702|466263421|FG000|Overall Study|Lost to Follow-up|3|||
129538590|NCT04576702|466263422|FG001|Overall Study|Lost to Follow-up|3|||
129538591|NCT04576702|466263423|FG002|Overall Study|Lost to Follow-up|3|||
129538592|NCT04576702|466263424|FG003|Overall Study|Lost to Follow-up|4|||
129538593|NCT01319422|466263427|FG000|Overall Study|Withdrawal by Subject|1|||
129538594|NCT01319422|466263428|FG001|Overall Study|Withdrawal by Subject|0|||
129538595|NCT06104423|466263431|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
129538596|NCT06104423|466263432|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
129538597|NCT06104423|466263433|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
129538598|NCT06104423|466263431|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
129538599|NCT06104423|466263432|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
129538600|NCT06104423|466263433|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
129538601|NCT00727246|466263434|FG000|Overall Study|could not complete MRI|0|||
129538602|NCT00727246|466263435|FG001|Overall Study|could not complete MRI|1|||
129538603|NCT00727246|466263436|FG002|Overall Study|could not complete MRI|0|||
129538604|NCT00727246|466263437|FG003|Overall Study|could not complete MRI|1|||
129538605|NCT00727246|466263434|FG000|Overall Study|incidental finding|0|||
129538606|NCT00727246|466263435|FG001|Overall Study|incidental finding|0|||
129538607|NCT00727246|466263436|FG002|Overall Study|incidental finding|0|||
129538608|NCT00727246|466263437|FG003|Overall Study|incidental finding|1|||
129538609|NCT00727246|466263434|FG000|Overall Study|withdrawn|0|||
129538610|NCT00727246|466263435|FG001|Overall Study|withdrawn|0|||
129538611|NCT00727246|466263436|FG002|Overall Study|withdrawn|1|||
129538612|NCT00727246|466263437|FG003|Overall Study|withdrawn|0|||
129538613|NCT02696382|466263440|FG000|Overall Study|Death|7|||
129538614|NCT02696382|466263441|FG001|Overall Study|Death|2|||
129538615|NCT02696382|466263440|FG000|Overall Study|Withdrawal by Subject|5|||
129538616|NCT02696382|466263441|FG001|Overall Study|Withdrawal by Subject|12|||
129538617|NCT02696382|466263440|FG000|Overall Study|Lost to Follow-up|4|||
129538618|NCT02696382|466263441|FG001|Overall Study|Lost to Follow-up|7|||
129538619|NCT01428882|466263451|FG000|Overall Study|Lack of Efficacy|2|||
129538620|NCT01428882|466263452|FG001|Overall Study|Lack of Efficacy|7|||
129538621|NCT01428882|466263451|FG000|Overall Study|Protocol Violation|4|||
129538622|NCT01428882|466263452|FG001|Overall Study|Protocol Violation|3|||
129538623|NCT00429026|466263455|FG000|Overall Study|Inevaluable for response.|40|||
129538624|NCT03831282|466263458|FG000|Overall Study|Could not place sensor|1|||
129538625|NCT04652245|466263459|FG000|Wash-Out Period|Adverse Event|0|||
129538626|NCT04652245|466263460|FG001|Wash-Out Period|Adverse Event|2|||
129538627|NCT04652245|466263459|FG000|Wash-Out Period|Withdrawal by Subject|0|||
129538628|NCT04652245|466263460|FG001|Wash-Out Period|Withdrawal by Subject|2|||
129538629|NCT00903357|466263463|FG000|First Intervention|Withdrawal by Subject|5|||
129538630|NCT00903357|466263464|FG001|First Intervention|Withdrawal by Subject|3|||
129538631|NCT00903357|466263463|FG000|First Intervention|Flu|0|||
129538632|NCT00903357|466263464|FG001|First Intervention|Flu|1|||
129538633|NCT00903357|466263463|FG000|Wash Out Period of 2 Weeks|Flu|0|||
129538634|NCT00903357|466263464|FG001|Wash Out Period of 2 Weeks|Flu|1|||
129538635|NCT00903357|466263463|FG000|Second Intervention|Lost to Follow-up|1|||
129538636|NCT00903357|466263464|FG001|Second Intervention|Lost to Follow-up|0|||
129538637|NCT01539512|466263465|FG000|Overall Study|Adverse Event|9|||
129538638|NCT01539512|466263466|FG001|Overall Study|Adverse Event|7|||
129538639|NCT01539512|466263465|FG000|Overall Study|Physician Decision|1|||
129538640|NCT01539512|466263466|FG001|Overall Study|Physician Decision|1|||
129538641|NCT01539512|466263465|FG000|Overall Study|Withdrawal by Subject|12|||
129538642|NCT01539512|466263466|FG001|Overall Study|Withdrawal by Subject|5|||
129538643|NCT01539512|466263465|FG000|Overall Study|Richter's Transformation|1|||
129538644|NCT01539512|466263466|FG001|Overall Study|Richter's Transformation|0|||
129538645|NCT05146999|466263467|FG000|Overall Study|Withdrew consent|6|||
129538646|NCT05146999|466263468|FG001|Overall Study|Withdrew consent|1|||
129538647|NCT05146999|466263467|FG000|Overall Study|Lost to Follow-up|3|||
129538648|NCT05146999|466263468|FG001|Overall Study|Lost to Follow-up|2|||
129538649|NCT05146999|466263467|FG000|Overall Study|Other|1|||
129538650|NCT05146999|466263468|FG001|Overall Study|Other|3|||
129538651|NCT04668157|466263469|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
129538652|NCT04668157|466263470|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
129538653|NCT04668157|466263469|FG000|Treatment Period (52 Weeks)|Other|0|||
129538654|NCT04668157|466263470|FG001|Treatment Period (52 Weeks)|Other|2|||
129538655|NCT04479358|466263477|FG000|Overall Study|Withdrawal by Subject|0|||
129538656|NCT04479358|466263478|FG001|Overall Study|Withdrawal by Subject|0|||
129538657|NCT04479358|466263479|FG002|Overall Study|Withdrawal by Subject|1|||
129538658|NCT04479358|466263480|FG003|Overall Study|Withdrawal by Subject|0|||
129538659|NCT04479358|466263481|FG004|Overall Study|Withdrawal by Subject|0|||
129538660|NCT04479358|466263482|FG005|Overall Study|Withdrawal by Subject|1|||
129538661|NCT00764465|466263483|FG000|Overall Study|Adverse Event|2|||
129538667|NCT00764465|466263483|FG000|Overall Study|Withdrawal by Subject|0|||
129538668|NCT00764465|466263484|FG001|Overall Study|Withdrawal by Subject|1|||
129538669|NCT00764465|466263485|FG002|Overall Study|Withdrawal by Subject|1|||
129538670|NCT00764465|466263486|FG003|Overall Study|Withdrawal by Subject|0|||
129538671|NCT00764465|466263487|FG004|Overall Study|Withdrawal by Subject|0|||
129538672|NCT00764465|466263488|FG005|Overall Study|Withdrawal by Subject|0|||
129538673|NCT01333501|466263489|FG000|Overall Study|Adverse Event|3|||
129538674|NCT01333501|466263490|FG001|Overall Study|Adverse Event|1|||
129538675|NCT01333501|466263489|FG000|Overall Study|Abnormal laboratory value|2|||
129538676|NCT01333501|466263490|FG001|Overall Study|Abnormal laboratory value|1|||
129538677|NCT01333501|466263489|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
129538678|NCT01333501|466263490|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
129538679|NCT01333501|466263489|FG000|Overall Study|Withdrawn consent|3|||
129538680|NCT01333501|466263490|FG001|Overall Study|Withdrawn consent|12|||
129538681|NCT00674440|466263491|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
129538682|NCT00674440|466263491|FG000|Overall Study|did not have surgery, so unevaluable|7|||
129538683|NCT00674440|466263491|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
129538684|NCT03329404|466263492|FG000|Overall Study|The study was suspended.|1|||
129538685|NCT03329404|466263493|FG001|Overall Study|The study was suspended.|4|||
129538686|NCT00914940|466263494|FG000|D0 to D100 Post-transplant|Death|2|||
129538687|NCT00914940|466263494|FG000|D101 to 2 Years Post-transplant|Death|8|||
129538688|NCT00914940|466263494|FG000|2 Years to 5 Years Post-transplant|Death|3|||
129538689|NCT00796367|466263495|FG000|Overall Study|Adverse Event|6|||
129538690|NCT00796367|466263496|FG001|Overall Study|Adverse Event|4|||
129538691|NCT00796367|466263497|FG002|Overall Study|Adverse Event|7|||
129538692|NCT00796367|466263495|FG000|Overall Study|Lost to Follow-up|5|||
129538693|NCT00796367|466263496|FG001|Overall Study|Lost to Follow-up|4|||
129538694|NCT00796367|466263497|FG002|Overall Study|Lost to Follow-up|21|||
129538695|NCT00796367|466263495|FG000|Overall Study|Withdrawal by Subject|9|||
129538696|NCT00796367|466263496|FG001|Overall Study|Withdrawal by Subject|11|||
129538697|NCT00796367|466263497|FG002|Overall Study|Withdrawal by Subject|12|||
129538698|NCT00796367|466263495|FG000|Overall Study|Lack of Efficacy|2|||
129538699|NCT00796367|466263496|FG001|Overall Study|Lack of Efficacy|1|||
129538700|NCT00796367|466263497|FG002|Overall Study|Lack of Efficacy|0|||
129538701|NCT00796367|466263495|FG000|Overall Study|non compliance|3|||
129538702|NCT00796367|466263496|FG001|Overall Study|non compliance|1|||
129538703|NCT00796367|466263497|FG002|Overall Study|non compliance|1|||
129538704|NCT00796367|466263495|FG000|Overall Study|Pregnancy|1|||
129538705|NCT00796367|466263496|FG001|Overall Study|Pregnancy|0|||
129538706|NCT00796367|466263497|FG002|Overall Study|Pregnancy|1|||
129538707|NCT00796367|466263495|FG000|Overall Study|Requirement for restricted medication|2|||
129538708|NCT00796367|466263496|FG001|Overall Study|Requirement for restricted medication|0|||
129538709|NCT00796367|466263497|FG002|Overall Study|Requirement for restricted medication|2|||
129538710|NCT00796367|466263495|FG000|Overall Study|other|2|||
129538711|NCT00796367|466263496|FG001|Overall Study|other|4|||
129538712|NCT00796367|466263497|FG002|Overall Study|other|3|||
129538713|NCT02309372|466263502|FG000|Overall Study|Lost to Follow-up|3|||
129538714|NCT02309372|466263503|FG001|Overall Study|Lost to Follow-up|2|||
129538715|NCT01590810|466263505|FG000|Overall Study|Physician Decision|0|||
129538716|NCT01590810|466263506|FG001|Overall Study|Physician Decision|1|||
129538717|NCT01590810|466263507|FG002|Overall Study|Physician Decision|1|||
129538718|NCT01590810|466263508|FG003|Overall Study|Physician Decision|0|||
129538719|NCT01590810|466263509|FG004|Overall Study|Physician Decision|0|||
129538720|NCT02400281|466263510|FG000|Overall Study|Adverse Event|0|||
129538721|NCT02400281|466263511|FG001|Overall Study|Adverse Event|0|||
129538722|NCT02400281|466263512|FG002|Overall Study|Adverse Event|1|||
129538723|NCT02400281|466263513|FG003|Overall Study|Adverse Event|0|||
129538724|NCT02400281|466263514|FG004|Overall Study|Adverse Event|1|||
129538725|NCT02400281|466263515|FG005|Overall Study|Adverse Event|0|||
129538726|NCT02400281|466263510|FG000|Overall Study|Physician Decision|0|||
129538727|NCT02400281|466263511|FG001|Overall Study|Physician Decision|0|||
129538728|NCT02400281|466263512|FG002|Overall Study|Physician Decision|1|||
129538729|NCT02400281|466263513|FG003|Overall Study|Physician Decision|0|||
129538730|NCT02400281|466263514|FG004|Overall Study|Physician Decision|0|||
129538731|NCT02400281|466263515|FG005|Overall Study|Physician Decision|0|||
129538732|NCT00553319|466263518|FG000|Overall Study|Lost to Follow-up|10|||
129538733|NCT00553319|466263519|FG001|Overall Study|Lost to Follow-up|9|||
129538734|NCT00553319|466263520|FG002|Overall Study|Lost to Follow-up|5|||
129538735|NCT00553319|466263518|FG000|Overall Study|wanted treatment elsewhere|2|||
129538736|NCT00553319|466263519|FG001|Overall Study|wanted treatment elsewhere|1|||
129538737|NCT00553319|466263520|FG002|Overall Study|wanted treatment elsewhere|1|||
129538738|NCT00553319|466263518|FG000|Overall Study|non-compliance|0|||
129538739|NCT00553319|466263519|FG001|Overall Study|non-compliance|0|||
129538740|NCT00553319|466263520|FG002|Overall Study|non-compliance|2|||
129538741|NCT00553319|466263518|FG000|Overall Study|incarceration|1|||
129538742|NCT00553319|466263519|FG001|Overall Study|incarceration|0|||
129538743|NCT00553319|466263520|FG002|Overall Study|incarceration|0|||
129538744|NCT00553319|466263518|FG000|Overall Study|moved|1|||
129538751|NCT00495794|466263526|FG000|Overall Study|Pharmacist did not activate patient|522|||
129538752|NCT00495794|466263527|FG001|Overall Study|Pharmacist did not activate patient|0|||
129538753|NCT02441517|466263528|FG000|Overall Study|Lost to Follow-up|1|||
129538754|NCT02441517|466263528|FG000|Overall Study|Withdrawal by Subject|2|||
129538755|NCT02441517|466263528|FG000|Overall Study|Study Terminated by Sponsor|1|||
129538756|NCT01393444|466263529|FG000|Overall Study|Withdrawal by Subject|1|||
129538757|NCT01393444|466263529|FG000|Overall Study|Determined ineligible during screening.|2|||
129538758|NCT03039699|466263531|FG000|Overall Study|Incorrect inclusion|5|||
129538759|NCT03039699|466263532|FG001|Overall Study|Incorrect inclusion|4|||
129538760|NCT03039699|466263531|FG000|Overall Study|Lack of data to assess study endpoint|5|||
129538761|NCT03039699|466263532|FG001|Overall Study|Lack of data to assess study endpoint|3|||
129538762|NCT03039699|466263531|FG000|Overall Study|Bacterial infection|12|||
129538763|NCT03039699|466263532|FG001|Overall Study|Bacterial infection|28|||
129538764|NCT00129220|466263533|FG000|Study Period II|Adverse Event|9|||
129538765|NCT00129220|466263534|FG001|Study Period II|Adverse Event|5|||
129538766|NCT00129220|466263535|FG002|Study Period II|Adverse Event|7|||
129538767|NCT00129220|466263533|FG000|Study Period II|Lack of Efficacy|15|||
129538768|NCT00129220|466263534|FG001|Study Period II|Lack of Efficacy|1|||
129538769|NCT00129220|466263535|FG002|Study Period II|Lack of Efficacy|28|||
129538770|NCT00129220|466263533|FG000|Study Period II|Entry Criteria Not Met|2|||
129538771|NCT00129220|466263534|FG001|Study Period II|Entry Criteria Not Met|0|||
129538772|NCT00129220|466263535|FG002|Study Period II|Entry Criteria Not Met|2|||
129538773|NCT00129220|466263533|FG000|Study Period II|Protocol Violation|4|||
129538774|NCT00129220|466263534|FG001|Study Period II|Protocol Violation|2|||
129538775|NCT00129220|466263535|FG002|Study Period II|Protocol Violation|1|||
129538776|NCT00129220|466263533|FG000|Study Period II|Physician Decision|0|||
129538777|NCT00129220|466263534|FG001|Study Period II|Physician Decision|1|||
129538778|NCT00129220|466263535|FG002|Study Period II|Physician Decision|0|||
129538779|NCT00129220|466263533|FG000|Study Period II|Withdrawal by Subject|1|||
129538780|NCT00129220|466263534|FG001|Study Period II|Withdrawal by Subject|3|||
129538781|NCT00129220|466263535|FG002|Study Period II|Withdrawal by Subject|4|||
129538782|NCT00129220|466263533|FG000|Study Period II|Reason Not Specified|2|||
129538783|NCT00129220|466263534|FG001|Study Period II|Reason Not Specified|0|||
129538784|NCT00129220|466263535|FG002|Study Period II|Reason Not Specified|5|||
129538785|NCT00129220|466263533|FG000|Study Period III|Adverse Event|1|||
129538786|NCT00129220|466263534|FG001|Study Period III|Adverse Event|0|||
129538787|NCT00129220|466263535|FG002|Study Period III|Adverse Event|3|||
129538788|NCT00129220|466263533|FG000|Study Period III|Protocol Violation|1|||
129538789|NCT00129220|466263534|FG001|Study Period III|Protocol Violation|1|||
129538790|NCT00129220|466263535|FG002|Study Period III|Protocol Violation|2|||
129538791|NCT00129220|466263533|FG000|Study Period III|Withdrawal by Subject|1|||
129538792|NCT00129220|466263534|FG001|Study Period III|Withdrawal by Subject|0|||
129538793|NCT00129220|466263535|FG002|Study Period III|Withdrawal by Subject|3|||
129538794|NCT00129220|466263533|FG000|Study Period III|Sponsor Decision|1|||
129538795|NCT00129220|466263534|FG001|Study Period III|Sponsor Decision|0|||
129538796|NCT00129220|466263535|FG002|Study Period III|Sponsor Decision|0|||
129538797|NCT00129220|466263533|FG000|Study Period III|Reason Not Specified|9|||
129538798|NCT00129220|466263534|FG001|Study Period III|Reason Not Specified|0|||
129538799|NCT00129220|466263535|FG002|Study Period III|Reason Not Specified|2|||
129538800|NCT01883362|466263536|FG000|Treatment|Adverse Event|1|||
129538801|NCT01883362|466263537|FG001|Treatment|Adverse Event|8|||
129538802|NCT01883362|466263536|FG000|Treatment|Withdrawal by Subject|6|||
129538803|NCT01883362|466263537|FG001|Treatment|Withdrawal by Subject|2|||
129538804|NCT01883362|466263536|FG000|Treatment|Administrative problems|4|||
129538805|NCT01883362|466263537|FG001|Treatment|Administrative problems|1|||
129538806|NCT01883362|466263536|FG000|Treatment|Relapse|4|||
129538807|NCT01883362|466263537|FG001|Treatment|Relapse|2|||
129538808|NCT01883362|466263536|FG000|Treatment|Randomized, not treated|1|||
129538809|NCT01883362|466263537|FG001|Treatment|Randomized, not treated|1|||
129538810|NCT01883362|466263536|FG000|Post Treatment Follow-up|Protocol Violation|0|||
129538811|NCT01883362|466263537|FG001|Post Treatment Follow-up|Protocol Violation|1|||
129538812|NCT01883362|466263536|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
129538813|NCT01883362|466263537|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
129538814|NCT01883362|466263536|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
129538815|NCT01883362|466263537|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
129538816|NCT01883362|466263536|FG000|Post Treatment Follow-up|Administrative problems|2|||
129538817|NCT01883362|466263537|FG001|Post Treatment Follow-up|Administrative problems|0|||
129538818|NCT01883362|466263536|FG000|Post Treatment Follow-up|Death|8|||
129538819|NCT01883362|466263537|FG001|Post Treatment Follow-up|Death|4|||
129538820|NCT01883362|466263536|FG000|Post Treatment Follow-up|Relapse|1|||
129538821|NCT01883362|466263537|FG001|Post Treatment Follow-up|Relapse|2|||
129538822|NCT01349816|466263538|FG000|Overall Study|Withdrawal by Subject|4|||
129538823|NCT01349816|466263538|FG000|Overall Study|Physician Decision|1|||
129538824|NCT01349816|466263538|FG000|Overall Study|Adverse Event|14|||
129538825|NCT01349816|466263538|FG000|Overall Study|Lost to Follow-up|2|||
129538826|NCT01349816|466263538|FG000|Overall Study|Protocol Violation|1|||
129538827|NCT01349816|466263538|FG000|Overall Study|Protocol-specified criteria|8|||
129538830|NCT02911285|466263542|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
129538831|NCT02911285|466263543|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
129538832|NCT01230489|466263544|FG000|Overall Study|Death|2|||
129538833|NCT01230489|466263544|FG000|Overall Study|Adverse Event|2|||
129538834|NCT01230489|466263544|FG000|Overall Study|Treatment modality changed|1|||
129538835|NCT01791543|466263545|FG000|Overall Study|Lost to Follow-up|1|||
129538836|NCT01791543|466263545|FG000|Overall Study|Adverse Event|1|||
129538837|NCT01018680|466265084|FG000|Overall Study|Adverse Event|23|||
129538838|NCT01018680|466265085|FG001|Overall Study|Adverse Event|40|||
129538839|NCT01018680|466265084|FG000|Overall Study|Withdrawal by Subject|10|||
129538840|NCT01018680|466265085|FG001|Overall Study|Withdrawal by Subject|10|||
129538841|NCT01018680|466265084|FG000|Overall Study|Protocol Violation|5|||
129538842|NCT01018680|466265085|FG001|Overall Study|Protocol Violation|8|||
129538843|NCT01018680|466265084|FG000|Overall Study|Sponsor Decision|6|||
129538844|NCT01018680|466265085|FG001|Overall Study|Sponsor Decision|7|||
129538845|NCT01018680|466265084|FG000|Overall Study|Lack of Efficacy|8|||
129538846|NCT01018680|466265085|FG001|Overall Study|Lack of Efficacy|2|||
129538847|NCT01018680|466265084|FG000|Overall Study|Lost to Follow-up|5|||
129538848|NCT01018680|466265085|FG001|Overall Study|Lost to Follow-up|3|||
129538849|NCT01018680|466265084|FG000|Overall Study|Entry Criteria Not Met|1|||
129538850|NCT01018680|466265085|FG001|Overall Study|Entry Criteria Not Met|4|||
129538851|NCT01018680|466265084|FG000|Overall Study|Physician Decision|3|||
129538852|NCT01018680|466265085|FG001|Overall Study|Physician Decision|1|||
129538853|NCT02930889|466265086|FG000|Overall Study|Lost to Follow-up|2|||
129538854|NCT02930889|466265086|FG000|Overall Study|Withdrawal by Subject|6|||
129538855|NCT02930889|466265086|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
129538856|NCT03996694|466265092|FG000|First Washout (7 Days)|positive urine drug screen|0|||
129538857|NCT03996694|466265093|FG001|First Washout (7 Days)|positive urine drug screen|0|||
129538858|NCT03996694|466265094|FG002|First Washout (7 Days)|positive urine drug screen|1|||
129538859|NCT03996694|466265095|FG003|First Washout (7 Days)|positive urine drug screen|0|||
129538860|NCT03996694|466265096|FG004|First Washout (7 Days)|positive urine drug screen|0|||
129538861|NCT03996694|466265097|FG005|First Washout (7 Days)|positive urine drug screen|0|||
129538862|NCT03996694|466265092|FG000|First Washout (7 Days)|Adverse Event|0|||
129538863|NCT03996694|466265093|FG001|First Washout (7 Days)|Adverse Event|1|||
129538864|NCT03996694|466265094|FG002|First Washout (7 Days)|Adverse Event|0|||
129538865|NCT03996694|466265095|FG003|First Washout (7 Days)|Adverse Event|0|||
129538866|NCT03996694|466265096|FG004|First Washout (7 Days)|Adverse Event|0|||
129538867|NCT03996694|466265097|FG005|First Washout (7 Days)|Adverse Event|0|||
129538868|NCT03996694|466265092|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
129538869|NCT03996694|466265093|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
129538870|NCT03996694|466265094|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
129538871|NCT03996694|466265095|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
129538872|NCT03996694|466265096|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
129538873|NCT03996694|466265097|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
129538874|NCT03996694|466265092|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
129538875|NCT03996694|466265093|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
129538876|NCT03996694|466265094|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
129538877|NCT03996694|466265095|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
129538878|NCT03996694|466265096|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
129538879|NCT03996694|466265097|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
129538880|NCT03053102|466265100|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
129538881|NCT03053102|466265100|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
129538882|NCT01458535|466265101|FG000|Overall Study|Other|0|||
129538883|NCT01458535|466265102|FG001|Overall Study|Other|0|||
129538884|NCT01458535|466265103|FG002|Overall Study|Other|0|||
129538885|NCT01458535|466265104|FG003|Overall Study|Other|0|||
129538886|NCT01458535|466265105|FG004|Overall Study|Other|1|||
129538887|NCT01458535|466265106|FG005|Overall Study|Other|1|||
129538888|NCT01458535|466265101|FG000|Overall Study|Withdrawal by Subject|0|||
129538889|NCT01458535|466265102|FG001|Overall Study|Withdrawal by Subject|0|||
129538890|NCT01458535|466265103|FG002|Overall Study|Withdrawal by Subject|2|||
129538891|NCT01458535|466265104|FG003|Overall Study|Withdrawal by Subject|0|||
129538892|NCT01458535|466265105|FG004|Overall Study|Withdrawal by Subject|1|||
129538893|NCT01458535|466265106|FG005|Overall Study|Withdrawal by Subject|1|||
129538894|NCT01458535|466265101|FG000|Overall Study|Lost to Follow-up|0|||
129538895|NCT01458535|466265102|FG001|Overall Study|Lost to Follow-up|2|||
129538896|NCT01458535|466265103|FG002|Overall Study|Lost to Follow-up|0|||
129538897|NCT01458535|466265104|FG003|Overall Study|Lost to Follow-up|3|||
129538898|NCT01458535|466265105|FG004|Overall Study|Lost to Follow-up|2|||
129538899|NCT01458535|466265106|FG005|Overall Study|Lost to Follow-up|2|||
129538900|NCT01458535|466265101|FG000|Overall Study|Adverse Event|0|||
129538901|NCT01458535|466265102|FG001|Overall Study|Adverse Event|0|||
129538902|NCT01458535|466265103|FG002|Overall Study|Adverse Event|0|||
129538903|NCT01458535|466265104|FG003|Overall Study|Adverse Event|1|||
129538904|NCT01458535|466265105|FG004|Overall Study|Adverse Event|0|||
129538905|NCT01458535|466265106|FG005|Overall Study|Adverse Event|0|||
129538918|NCT01238861|466265107|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
129538919|NCT01238861|466265108|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
129538920|NCT01238861|466265109|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
129538921|NCT01238861|466265110|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
129538922|NCT01238861|466265111|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
129538923|NCT01238861|466265112|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
129538924|NCT01238861|466265107|FG000|Overall Study|Incorrect enrollment/randomization|0|||
129538925|NCT01238861|466265108|FG001|Overall Study|Incorrect enrollment/randomization|0|||
129538926|NCT01238861|466265109|FG002|Overall Study|Incorrect enrollment/randomization|1|||
129538927|NCT01238861|466265110|FG003|Overall Study|Incorrect enrollment/randomization|0|||
129538928|NCT01238861|466265111|FG004|Overall Study|Incorrect enrollment/randomization|1|||
129538929|NCT01238861|466265112|FG005|Overall Study|Incorrect enrollment/randomization|0|||
129538930|NCT01238861|466265107|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
129538931|NCT01238861|466265108|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
129538932|NCT01238861|466265109|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
129538933|NCT01238861|466265110|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
129538934|NCT01238861|466265111|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
129538935|NCT01238861|466265112|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
129538936|NCT01238861|466265107|FG000|Overall Study|Subject moved out of state/area|0|||
129538937|NCT01238861|466265108|FG001|Overall Study|Subject moved out of state/area|0|||
129538938|NCT01238861|466265109|FG002|Overall Study|Subject moved out of state/area|1|||
129538939|NCT01238861|466265110|FG003|Overall Study|Subject moved out of state/area|1|||
129538940|NCT01238861|466265111|FG004|Overall Study|Subject moved out of state/area|0|||
129538941|NCT01238861|466265112|FG005|Overall Study|Subject moved out of state/area|0|||
129538942|NCT01238861|466265107|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
129538943|NCT01238861|466265108|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
129538944|NCT01238861|466265109|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
129538945|NCT01238861|466265110|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
129538946|NCT01238861|466265111|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
129538947|NCT01238861|466265112|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
129538948|NCT01238861|466265107|FG000|Overall Study|Personal problems|0|||
129538949|NCT01238861|466265108|FG001|Overall Study|Personal problems|0|||
129538950|NCT01238861|466265109|FG002|Overall Study|Personal problems|0|||
129538951|NCT01238861|466265110|FG003|Overall Study|Personal problems|1|||
129538952|NCT01238861|466265111|FG004|Overall Study|Personal problems|0|||
129538953|NCT01238861|466265112|FG005|Overall Study|Personal problems|0|||
129538954|NCT01238861|466265107|FG000|Overall Study|Unable to continue visits|0|||
129538955|NCT01238861|466265108|FG001|Overall Study|Unable to continue visits|0|||
129538956|NCT01238861|466265109|FG002|Overall Study|Unable to continue visits|0|||
129538957|NCT01238861|466265110|FG003|Overall Study|Unable to continue visits|1|||
129538958|NCT01238861|466265111|FG004|Overall Study|Unable to continue visits|0|||
129538959|NCT01238861|466265112|FG005|Overall Study|Unable to continue visits|1|||
129538960|NCT01238861|466265107|FG000|Overall Study|Serious adverse event|0|||
129538961|NCT01238861|466265108|FG001|Overall Study|Serious adverse event|0|||
129538962|NCT01238861|466265109|FG002|Overall Study|Serious adverse event|0|||
129538963|NCT01238861|466265110|FG003|Overall Study|Serious adverse event|0|||
129538964|NCT01238861|466265111|FG004|Overall Study|Serious adverse event|0|||
129538965|NCT01238861|466265112|FG005|Overall Study|Serious adverse event|1|||
129538966|NCT01238861|466265107|FG000|Overall Study|Lack of compliance|0|||
129538967|NCT01238861|466265108|FG001|Overall Study|Lack of compliance|0|||
129538968|NCT01238861|466265109|FG002|Overall Study|Lack of compliance|0|||
129538969|NCT01238861|466265110|FG003|Overall Study|Lack of compliance|0|||
129538970|NCT01238861|466265111|FG004|Overall Study|Lack of compliance|0|||
129538971|NCT01238861|466265112|FG005|Overall Study|Lack of compliance|1|||
129538972|NCT01238861|466265107|FG000|Overall Study|Adverse Event|0|||
129538973|NCT01238861|466265108|FG001|Overall Study|Adverse Event|1|||
129538974|NCT01238861|466265109|FG002|Overall Study|Adverse Event|0|||
129538975|NCT01238861|466265110|FG003|Overall Study|Adverse Event|0|||
129538976|NCT01238861|466265111|FG004|Overall Study|Adverse Event|0|||
129538977|NCT01238861|466265112|FG005|Overall Study|Adverse Event|0|||
129538978|NCT01238861|466265107|FG000|Overall Study|Withdrawal by Subject|6|||
129538979|NCT01238861|466265108|FG001|Overall Study|Withdrawal by Subject|5|||
129538980|NCT01238861|466265109|FG002|Overall Study|Withdrawal by Subject|4|||
129538981|NCT01238861|466265110|FG003|Overall Study|Withdrawal by Subject|8|||
129538982|NCT01238861|466265111|FG004|Overall Study|Withdrawal by Subject|10|||
129538983|NCT01238861|466265112|FG005|Overall Study|Withdrawal by Subject|9|||
129538984|NCT01269346|466265113|FG000|Treatment Phase|Disease progression|3|||
129538985|NCT01269346|466265113|FG000|Treatment Phase|Adverse Event|3|||
129538986|NCT01269346|466265113|FG000|Treatment Phase|Withdrawal by Subject|1|||
129538987|NCT01269346|466265113|FG000|Treatment Phase|Other|2|||
129538988|NCT01269346|466265113|FG000|Extension Phase|Adverse Event|6|||
129538989|NCT01269346|466265113|FG000|Extension Phase|Withdrawal by Subject|4|||
129538990|NCT01269346|466265113|FG000|Extension Phase|Disease progression|22|||
129538991|NCT01269346|466265113|FG000|Extension Phase|Physician decision or participant choice|9|||
129538992|NCT01269346|466265113|FG000|Extension Phase|Clinical progression|1|||
129538993|NCT01269346|466265113|FG000|Extension Phase|Started a prohibited con med|1|||
129538994|NCT01855607|466265114|FG000|Overall Study|Withdrawal by Subject|1|||
129538995|NCT01855607|466265114|FG000|Overall Study|Study was terminated|11|||
129538996|NCT04001790|466265119|FG000|Overall Study|Withdrawal by Subject|1|||
129538997|NCT04001790|466265120|FG001|Overall Study|Withdrawal by Subject|2|||
129538998|NCT02706327|466265121|FG000|Overall Study|Lost to Follow-up|1|||
129538999|NCT02706327|466265122|FG001|Overall Study|Lost to Follow-up|1|||
129539000|NCT02706327|466265123|FG002|Overall Study|Lost to Follow-up|2|||
129539001|NCT04963231|466265126|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
129539002|NCT04963231|466265127|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
129539003|NCT04963231|466265128|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
129539004|NCT04963231|466265126|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
129539005|NCT04963231|466265127|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
129539006|NCT04963231|466265128|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
129539007|NCT04963231|466265126|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
129539008|NCT04963231|466265127|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
129539009|NCT04963231|466265128|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
129539010|NCT04963231|466265126|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
129539011|NCT04963231|466265127|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
129539012|NCT04963231|466265128|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
129539013|NCT04963231|466265126|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
129539014|NCT04963231|466265127|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
129539015|NCT04963231|466265128|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
129539016|NCT04963231|466265126|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
129539017|NCT04963231|466265127|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
129539018|NCT04963231|466265128|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
129539019|NCT04963231|466265126|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
129539020|NCT04963231|466265127|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
129539021|NCT04963231|466265128|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
129539022|NCT01982942|466265129|FG000|Overall Study|Adverse Event|10|||
129539023|NCT01982942|466265130|FG001|Overall Study|Adverse Event|5|||
129539024|NCT01982942|466265129|FG000|Overall Study|Lost to Follow-up|4|||
129539025|NCT01982942|466265130|FG001|Overall Study|Lost to Follow-up|3|||
129539026|NCT01982942|466265129|FG000|Overall Study|Multiple sclerosis progression|3|||
129539027|NCT01982942|466265130|FG001|Overall Study|Multiple sclerosis progression|2|||
129539028|NCT01982942|466265129|FG000|Overall Study|Wanted to try therapy not permitted|1|||
129539029|NCT01982942|466265130|FG001|Overall Study|Wanted to try therapy not permitted|0|||
129539030|NCT01982942|466265129|FG000|Overall Study|Subject declined future visits|0|||
129539031|NCT01982942|466265130|FG001|Overall Study|Subject declined future visits|1|||
129539032|NCT01982942|466265129|FG000|Overall Study|Left geographical area|2|||
129539033|NCT01982942|466265130|FG001|Overall Study|Left geographical area|0|||
129539034|NCT01982942|466265129|FG000|Overall Study|Too many pills|1|||
129539035|NCT01982942|466265130|FG001|Overall Study|Too many pills|0|||
129539036|NCT01982942|466265129|FG000|Overall Study|MS Relapse|0|||
129539037|NCT01982942|466265130|FG001|Overall Study|MS Relapse|1|||
129539038|NCT01982942|466265129|FG000|Overall Study|Chose to join a stem cell trial|0|||
129539039|NCT01982942|466265130|FG001|Overall Study|Chose to join a stem cell trial|1|||
129539040|NCT01982942|466265129|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
129539041|NCT01982942|466265130|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
129539042|NCT03471507|466265131|FG000|Overall Study|Lost to Follow-up|1|||
129539043|NCT03471507|466265132|FG001|Overall Study|Lost to Follow-up|3|||
129539044|NCT03471507|466265131|FG000|Overall Study|Physician Decision|0|||
129539045|NCT03471507|466265132|FG001|Overall Study|Physician Decision|1|||
129539046|NCT03471507|466265131|FG000|Overall Study|Withdrawal by Subject|2|||
129539047|NCT03471507|466265132|FG001|Overall Study|Withdrawal by Subject|1|||
129539048|NCT00750061|466265133|FG000|Overall Study|Adverse Event|2|||
129539049|NCT00750061|466265134|FG001|Overall Study|Adverse Event|0|||
129539050|NCT00750061|466265133|FG000|Overall Study|Withdrawal by Subject|0|||
129539051|NCT00750061|466265134|FG001|Overall Study|Withdrawal by Subject|1|||
129539052|NCT00750061|466265133|FG000|Overall Study|Physician Decision|0|||
129539053|NCT00750061|466265134|FG001|Overall Study|Physician Decision|1|||
129539054|NCT03417245|466265135|FG000|Overall Study|Adverse Event|1|||
129539055|NCT03417245|466265136|FG001|Overall Study|Adverse Event|0|||
129539056|NCT03417245|466265135|FG000|Overall Study|Protocol Violation|1|||
129539057|NCT03417245|466265136|FG001|Overall Study|Protocol Violation|0|||
129539058|NCT03417245|466265135|FG000|Overall Study|Withdrawal by Subject|1|||
129539059|NCT03417245|466265136|FG001|Overall Study|Withdrawal by Subject|1|||
129539060|NCT02708524|466265144|FG000|Overall Study|Adverse Event|0|||
129539061|NCT02708524|466265145|FG001|Overall Study|Adverse Event|1|||
129539062|NCT02708524|466265146|FG002|Overall Study|Adverse Event|0|||
129539063|NCT02708524|466265147|FG003|Overall Study|Adverse Event|0|||
129539076|NCT02708524|466265144|FG000|Overall Study|Withdrawal by Subject|1|||
129539077|NCT02708524|466265145|FG001|Overall Study|Withdrawal by Subject|1|||
129539078|NCT02708524|466265146|FG002|Overall Study|Withdrawal by Subject|0|||
129539079|NCT02708524|466265147|FG003|Overall Study|Withdrawal by Subject|0|||
129539080|NCT02708524|466265144|FG000|Overall Study|Dispensed incorrect study lens|0|||
129539081|NCT02708524|466265145|FG001|Overall Study|Dispensed incorrect study lens|1|||
129539082|NCT02708524|466265146|FG002|Overall Study|Dispensed incorrect study lens|1|||
129539083|NCT02708524|466265147|FG003|Overall Study|Dispensed incorrect study lens|0|||
129539084|NCT02708524|466265144|FG000|Overall Study|Did not wear lens at final visit|0|||
129539085|NCT02708524|466265145|FG001|Overall Study|Did not wear lens at final visit|1|||
129539086|NCT02708524|466265146|FG002|Overall Study|Did not wear lens at final visit|0|||
129539087|NCT02708524|466265147|FG003|Overall Study|Did not wear lens at final visit|0|||
129539088|NCT02708524|466265144|FG000|Overall Study|Subject lost study lens|1|||
129539089|NCT02708524|466265145|FG001|Overall Study|Subject lost study lens|0|||
129539090|NCT02708524|466265146|FG002|Overall Study|Subject lost study lens|0|||
129539091|NCT02708524|466265147|FG003|Overall Study|Subject lost study lens|0|||
129539092|NCT00229931|466265154|FG000|Overall Study|Death|1|||
129539093|NCT00229931|466265155|FG001|Overall Study|Death|0|||
129539094|NCT00229931|466265154|FG000|Overall Study|Lost to Follow-up|3|||
129539095|NCT00229931|466265155|FG001|Overall Study|Lost to Follow-up|2|||
129539096|NCT02992743|466265156|FG000|Overall Study|Withdrawal by Subject|1|||
129539097|NCT02992743|466265157|FG001|Overall Study|Withdrawal by Subject|1|||
129539098|NCT02992743|466265156|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
129539099|NCT02992743|466265157|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
129539100|NCT02992743|466265156|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
129539101|NCT02992743|466265157|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
129539102|NCT02992743|466265156|FG000|Overall Study|No measurable disease|1|||
129539103|NCT02992743|466265157|FG001|Overall Study|No measurable disease|0|||
129539104|NCT02992743|466265156|FG000|Overall Study|Lost to Follow-up|0|||
129539105|NCT02992743|466265157|FG001|Overall Study|Lost to Follow-up|1|||
129539106|NCT00761735|466265158|FG000|Overall Study|Lost to Follow-up|6|||
129539107|NCT00761735|466265158|FG000|Overall Study|Withdrawal by Subject|6|||
129539108|NCT00761735|466265158|FG000|Overall Study|Non-compliance with protocol|1|||
129539109|NCT00761735|466265158|FG000|Overall Study|Administrative|1|||
129539110|NCT03290131|466265159|FG000|Overall Study|Adverse Event|22|||
129539111|NCT03290131|466265160|FG001|Overall Study|Adverse Event|57|||
129539112|NCT03290131|466265161|FG002|Overall Study|Adverse Event|11|||
129539113|NCT03290131|466265159|FG000|Overall Study|Withdrawal by Subject|18|||
129539114|NCT03290131|466265160|FG001|Overall Study|Withdrawal by Subject|13|||
129539115|NCT03290131|466265161|FG002|Overall Study|Withdrawal by Subject|8|||
129539116|NCT03290131|466265159|FG000|Overall Study|MS Relapse|2|||
129539117|NCT03290131|466265160|FG001|Overall Study|MS Relapse|1|||
129539118|NCT03290131|466265161|FG002|Overall Study|MS Relapse|0|||
129539119|NCT03290131|466265159|FG000|Overall Study|Unknown reason|0|||
129539120|NCT03290131|466265160|FG001|Overall Study|Unknown reason|1|||
129539121|NCT03290131|466265161|FG002|Overall Study|Unknown reason|0|||
129539122|NCT00465101|466265162|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
129539123|NCT00465101|466265162|FG000|Overall Study|Change in health precluded follow up|4|||
129539124|NCT00465101|466265162|FG000|Overall Study|Did not meet study criteria|4|||
129539125|NCT00465101|466265162|FG000|Overall Study|Lost to Follow-up|5|||
129539126|NCT00465101|466265162|FG000|Overall Study|Other|6|||
129539127|NCT00465101|466265162|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
129539128|NCT00465101|466265162|FG000|Overall Study|Patient postponed procedure|1|||
129539129|NCT00465101|466265162|FG000|Overall Study|Site closed due to IRB expiration|1|||
129539130|NCT00465101|466265162|FG000|Overall Study|Unable to obtain IRB approval|1|||
129539131|NCT00465101|466265162|FG000|Overall Study|Death|3|||
129539132|NCT00465101|466265162|FG000|Overall Study|Withdrawal by Subject|25|||
129539133|NCT00465101|466265162|FG000|Overall Study|Physician Decision|1|||
129539134|NCT00465101|466265162|FG000|Overall Study|Withdrew consent prior to procedure|3|||
129539135|NCT00483574|466265163|FG000|Overall Study|Adverse Event|6|||
129539136|NCT00483574|466265164|FG001|Overall Study|Adverse Event|0|||
129539137|NCT00483574|466265163|FG000|Overall Study|Protocol Violation|28|||
129539138|NCT00483574|466265164|FG001|Overall Study|Protocol Violation|9|||
129539139|NCT00483574|466265163|FG000|Overall Study|Lost to Follow-up|16|||
129539140|NCT00483574|466265164|FG001|Overall Study|Lost to Follow-up|4|||
129539141|NCT00483574|466265163|FG000|Overall Study|Withdrawal by Subject|52|||
129539142|NCT00483574|466265164|FG001|Overall Study|Withdrawal by Subject|0|||
129539143|NCT03099096|466265165|FG000|Overall Study|Adverse Event|1|||
129539144|NCT03099096|466265165|FG000|Overall Study|Physician Decision|1|||
129539145|NCT00361504|466265168|FG000|Overall Study|Withdrawal by Subject|94|||
129539146|NCT00361504|466265169|FG001|Overall Study|Withdrawal by Subject|31|||
129539147|NCT00361504|466265168|FG000|Overall Study|Lost to Follow-up|40|||
129539148|NCT00361504|466265169|FG001|Overall Study|Lost to Follow-up|7|||
129539149|NCT00361504|466265168|FG000|Overall Study|Adverse Event|203|||
129539150|NCT00361504|466265169|FG001|Overall Study|Adverse Event|82|||
129539151|NCT00361504|466265168|FG000|Overall Study|Lack of Efficacy|72|||
129539152|NCT00361504|466265169|FG001|Overall Study|Lack of Efficacy|7|||
129539155|NCT00361504|466265168|FG000|Overall Study|Study medication non compliant|42|||
129539156|NCT00361504|466265169|FG001|Overall Study|Study medication non compliant|15|||
129539157|NCT00361504|466265168|FG000|Overall Study|All other|28|||
129539158|NCT00361504|466265169|FG001|Overall Study|All other|3|||
129539159|NCT00450814|466265172|FG000|Overall Study|Failed to complete the initial therapy|0|||
129539160|NCT00450814|466265173|FG001|Overall Study|Failed to complete the initial therapy|0|||
129539161|NCT00450814|466265174|FG002|Overall Study|Failed to complete the initial therapy|0|||
129539162|NCT00450814|466265175|FG003|Overall Study|Failed to complete the initial therapy|1|||
129539163|NCT00450814|466265176|FG004|Overall Study|Failed to complete the initial therapy|1|||
129539164|NCT00450814|466265177|FG005|Overall Study|Failed to complete the initial therapy|1|||
129539165|NCT00450814|466265178|FG006|Overall Study|Failed to complete the initial therapy|0|||
129539166|NCT00450814|466265179|FG007|Overall Study|Failed to complete the initial therapy|0|||
129539167|NCT00450814|466265180|FG008|Overall Study|Failed to complete the initial therapy|0|||
129539168|NCT00450814|466265181|FG009|Overall Study|Failed to complete the initial therapy|0|||
129539169|NCT00450814|466265182|FG010|Overall Study|Failed to complete the initial therapy|0|||
129539170|NCT00450814|466265172|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
129539171|NCT00450814|466265173|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
129539172|NCT00450814|466265174|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
129539173|NCT00450814|466265175|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
129539174|NCT00450814|466265176|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
129539175|NCT00450814|466265177|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
129539176|NCT00450814|466265178|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
129539177|NCT00450814|466265179|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
129539178|NCT00450814|466265180|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
129539179|NCT00450814|466265181|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
129539180|NCT00450814|466265182|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
129539181|NCT02067728|466265183|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
129539182|NCT02067728|466265184|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
129539183|NCT02067728|466265183|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
129539184|NCT02067728|466265184|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
129539185|NCT02067728|466265183|FG000|6 Month Measurements|Unable to attend|114|||
129539186|NCT02067728|466265184|FG001|6 Month Measurements|Unable to attend|97|||
129539187|NCT03602976|466265188|FG000|Overall Study|Withdrawal by Subject|1|||
129539188|NCT04837807|466265189|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
129539189|NCT04837807|466265190|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
129539190|NCT02190604|466265191|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539191|NCT02190604|466265192|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539192|NCT02190604|466265193|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539193|NCT02190604|466265194|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539194|NCT02190604|466265195|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539195|NCT02190604|466265196|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539196|NCT02190604|466265197|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539197|NCT02190604|466265198|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539198|NCT02190604|466265199|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539199|NCT02190604|466265200|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539200|NCT02190604|466265201|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539201|NCT02190604|466265202|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539202|NCT02190604|466265203|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539203|NCT02190604|466265204|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539204|NCT02190604|466265205|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
129539205|NCT02190604|466265206|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539206|NCT02190604|466265207|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539207|NCT02190604|466265208|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539208|NCT02190604|466265209|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
129539209|NCT02190604|466265191|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539210|NCT02190604|466265192|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539211|NCT02190604|466265193|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539212|NCT02190604|466265194|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539213|NCT02190604|466265195|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539214|NCT02190604|466265196|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539215|NCT02190604|466265197|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539216|NCT02190604|466265198|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539217|NCT02190604|466265199|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539218|NCT02190604|466265200|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539219|NCT02190604|466265201|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539220|NCT02190604|466265202|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539221|NCT02190604|466265203|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539222|NCT02190604|466265204|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
129539223|NCT02190604|466265205|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539224|NCT02190604|466265206|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539225|NCT02190604|466265207|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539226|NCT02190604|466265208|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539227|NCT02190604|466265209|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
129539228|NCT01484691|466265212|FG000|Overall Study|Withdrawal by Subject|1|||
129539229|NCT01484691|466265213|FG001|Overall Study|Withdrawal by Subject|1|||
129539230|NCT01484691|466265214|FG002|Overall Study|Withdrawal by Subject|1|||
129539231|NCT01484691|466265212|FG000|Overall Study|Physician Decision|0|||
129539232|NCT01484691|466265213|FG001|Overall Study|Physician Decision|2|||
129539233|NCT01484691|466265214|FG002|Overall Study|Physician Decision|1|||
129539234|NCT04095039|466265217|FG000|Overall Study|Withdrawal by Subject|2|||
129539235|NCT04095039|466265218|FG001|Overall Study|Withdrawal by Subject|16|||
129539236|NCT04095039|466265217|FG000|Overall Study|Transplanted|21|||
129539237|NCT04095039|466265218|FG001|Overall Study|Transplanted|24|||
129539238|NCT04095039|466265217|FG000|Overall Study|Transferred to Non-study Facility|47|||
129539239|NCT04095039|466265218|FG001|Overall Study|Transferred to Non-study Facility|44|||
129539240|NCT04095039|466265217|FG000|Overall Study|Withdrawal from internvention target|0|||
129539241|NCT04095039|466265218|FG001|Overall Study|Withdrawal from internvention target|2|||
129539242|NCT04095039|466265217|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
129539243|NCT04095039|466265218|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
129539244|NCT04095039|466265217|FG000|Overall Study|Cacliphylaxis|0|||
129539245|NCT04095039|466265218|FG001|Overall Study|Cacliphylaxis|1|||
129539246|NCT04095039|466265217|FG000|Overall Study|Pregnancy|1|||
129539247|NCT04095039|466265218|FG001|Overall Study|Pregnancy|0|||
129539248|NCT03205605|466265219|FG000|Overall Study|Withdrawal by Subject|1|||
129539249|NCT03328325|466265220|FG000|Overall Study|Lost to Follow-up|4|||
129539250|NCT03328325|466265220|FG000|Overall Study|Physician Decision|1|||
129539251|NCT03328325|466265220|FG000|Overall Study|Withdrawal by Subject|3|||
129539252|NCT03328325|466265220|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
129539253|NCT00736840|466265222|FG000|Overall Study|Lost to Follow-up|13|||
129539254|NCT01990339|466265223|FG000|Overall Study|Data Not Available|49|||
129539255|NCT01990339|466265223|FG000|Overall Study|Voluntary Withdrawal|1402|||
129539256|NCT01990339|466265223|FG000|Overall Study|Lost to Follow-up|861|||
129539257|NCT01038609|466265224|FG000|Overall Study|Adverse Event|0|||
129539258|NCT01038609|466265225|FG001|Overall Study|Adverse Event|0|||
129539259|NCT01038609|466265226|FG002|Overall Study|Adverse Event|1|||
129539260|NCT01038609|466265227|FG003|Overall Study|Adverse Event|0|||
129539261|NCT01038609|466265228|FG004|Overall Study|Adverse Event|0|||
129539262|NCT01038609|466265224|FG000|Overall Study|Dosing Error|0|||
129539263|NCT01038609|466265225|FG001|Overall Study|Dosing Error|0|||
129539264|NCT01038609|466265226|FG002|Overall Study|Dosing Error|0|||
129539265|NCT01038609|466265227|FG003|Overall Study|Dosing Error|1|||
129539266|NCT01038609|466265228|FG004|Overall Study|Dosing Error|1|||
129539267|NCT01038609|466265224|FG000|Overall Study|Death in the Family|1|||
129539268|NCT01038609|466265225|FG001|Overall Study|Death in the Family|0|||
129539269|NCT01038609|466265226|FG002|Overall Study|Death in the Family|0|||
129539270|NCT01038609|466265227|FG003|Overall Study|Death in the Family|0|||
129539271|NCT01038609|466265228|FG004|Overall Study|Death in the Family|0|||
129539272|NCT01038609|466265224|FG000|Overall Study|Refusal of Blood Draws|0|||
129539273|NCT01038609|466265225|FG001|Overall Study|Refusal of Blood Draws|1|||
129539274|NCT01038609|466265226|FG002|Overall Study|Refusal of Blood Draws|0|||
129539275|NCT01038609|466265227|FG003|Overall Study|Refusal of Blood Draws|0|||
129539276|NCT01038609|466265228|FG004|Overall Study|Refusal of Blood Draws|0|||
129539277|NCT00412360|466265229|FG000|Overall Study|Lost to Follow-up|0|||
129539278|NCT00412360|466265230|FG001|Overall Study|Lost to Follow-up|1|||
129539279|NCT00412360|466265229|FG000|Overall Study|Not Transplanted|1|||
129539280|NCT00412360|466265230|FG001|Overall Study|Not Transplanted|2|||
129539281|NCT03655951|466265231|FG000|Overall Study|Lost to Follow-up|39|||
129539282|NCT03655951|466265232|FG001|Overall Study|Lost to Follow-up|20|||
129539283|NCT03655951|466265231|FG000|Overall Study|Withdrawal by Subject|0|||
129539284|NCT03655951|466265232|FG001|Overall Study|Withdrawal by Subject|1|||
129539285|NCT02811640|466265233|FG000|Overall Study|Technology malfunction|2|||
129539286|NCT02569996|466265240|FG000|Overall Study|Adverse Event|6|||
129539287|NCT02569996|466265240|FG000|Overall Study|Physician Decision|3|||
129539288|NCT02569996|466265240|FG000|Overall Study|Progression of the disease|18|||
129539289|NCT02569996|466265240|FG000|Overall Study|New anti-lymphoma treatment|1|||
129539290|NCT02569996|466265240|FG000|Overall Study|Non-compliance|9|||
129539291|NCT02569996|466265240|FG000|Overall Study|Withdrawal by Subject|5|||
129539292|NCT02569996|466265240|FG000|Overall Study|Lost to Follow-up|5|||
129539293|NCT02569996|466265240|FG000|Overall Study|Complete remission|7|||
129539294|NCT02569996|466265240|FG000|Overall Study|Unknown reason|1|||
129539295|NCT01397409|466265242|FG000|Stage 2|Adverse Event|0|||
129539296|NCT01397409|466265243|FG001|Stage 2|Adverse Event|0|||
129539297|NCT01397409|466265244|FG002|Stage 2|Adverse Event|0|||
129539298|NCT01397409|466265245|FG003|Stage 2|Adverse Event|0|||
129539299|NCT01397409|466265246|FG004|Stage 2|Adverse Event|6|||
129539339|NCT01397409|466265246|FG004|Stage 3|Other Miscellaneous Reasons|0|||
129539340|NCT01397409|466265247|FG005|Stage 3|Other Miscellaneous Reasons|0|||
129539341|NCT01397409|466265248|FG006|Stage 3|Other Miscellaneous Reasons|0|||
129539342|NCT01397409|466265249|FG007|Stage 3|Other Miscellaneous Reasons|1|||
129539343|NCT01397409|466265250|FG008|Stage 3|Other Miscellaneous Reasons|0|||
129539344|NCT01397409|466265251|FG009|Stage 3|Other Miscellaneous Reasons|0|||
129539345|NCT01207427|466265252|FG000|Double-blind Treatment Period|Adverse Event|0|||
129539346|NCT01207427|466265253|FG001|Double-blind Treatment Period|Adverse Event|1|||
129539347|NCT01207427|466265254|FG002|Double-blind Treatment Period|Adverse Event|0|||
129539348|NCT01207427|466265252|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
129539349|NCT01207427|466265253|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
129539350|NCT01207427|466265254|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
129539351|NCT01207427|466265252|FG000|Double-blind Treatment Period|Protocol Violation|2|||
129539352|NCT01207427|466265253|FG001|Double-blind Treatment Period|Protocol Violation|1|||
129539353|NCT01207427|466265254|FG002|Double-blind Treatment Period|Protocol Violation|1|||
129539354|NCT01207427|466265252|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
129539355|NCT01207427|466265253|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
129539356|NCT01207427|466265254|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
